id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
41927830|NCT04508023|75584237|FG000|Overall Study|Withdrawal by Subject|1|||
41927831|NCT04508023|75584238|FG001|Overall Study|Withdrawal by Subject|2|||
41927832|NCT04187144|75584246|FG000|Overall Study|Lost to Follow-up|12|||
41927833|NCT04187144|75584247|FG001|Overall Study|Lost to Follow-up|11|||
41927834|NCT04187144|75584246|FG000|Overall Study|Withdrawal by Subject|20|||
41927835|NCT04187144|75584247|FG001|Overall Study|Withdrawal by Subject|18|||
41927836|NCT04187144|75584246|FG000|Overall Study|Adverse Event|19|||
41927837|NCT04187144|75584247|FG001|Overall Study|Adverse Event|4|||
41927838|NCT04187144|75584246|FG000|Overall Study|Physician Decision|5|||
41927839|NCT04187144|75584247|FG001|Overall Study|Physician Decision|3|||
41927840|NCT04187144|75584246|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
41927841|NCT04187144|75584247|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
41927842|NCT04187144|75584246|FG000|Overall Study|Protocol Deviation|1|||
42299409|NCT02553265|76134499|FG000|Enrollment|Death|0|||
42299410|NCT02553265|76134500|FG001|Enrollment|Death|0|||
42299411|NCT02553265|76134501|FG002|Enrollment|Death|1|||
42299412|NCT02553265|76134499|FG000|First Intervention (28 Days)|Adverse Event|1|||
41927843|NCT04187144|75584247|FG001|Overall Study|Protocol Deviation|4|||
41927844|NCT04027946|75584253|FG000|Overall Study|Screen failures|3|||
41927845|NCT03856047|75584274|FG000|Overall Study|Withdrawal by Subject|0|||
41927846|NCT03856047|75584275|FG001|Overall Study|Withdrawal by Subject|1|||
41927847|NCT03856047|75584276|FG002|Overall Study|Withdrawal by Subject|1|||
41927848|NCT03856047|75584277|FG003|Overall Study|Withdrawal by Subject|0|||
41927849|NCT03856047|75584278|FG004|Overall Study|Withdrawal by Subject|3|||
41927850|NCT03856047|75584279|FG005|Overall Study|Withdrawal by Subject|0|||
41927851|NCT03856047|75584280|FG006|Overall Study|Withdrawal by Subject|2|||
41927852|NCT03856047|75584274|FG000|Overall Study|Lost to Follow-up|4|||
42206343|NCT01471444|76019118|FG000|Overall Study|Physician Decision|3|||
42206344|NCT01471444|76019119|FG001|Overall Study|Physician Decision|2|||
42206345|NCT01471444|76019118|FG000|Overall Study|Withdrawal by Subject|0|||
42206346|NCT01471444|76019119|FG001|Overall Study|Withdrawal by Subject|1|||
42206347|NCT03443427|76019137|FG000|Overall Study|Adverse Event|2|||
42206348|NCT03443427|76019138|FG001|Overall Study|Adverse Event|3|||
42206349|NCT03443427|76019137|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
42206350|NCT03443427|76019138|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
42299413|NCT02553265|76134500|FG001|First Intervention (28 Days)|Adverse Event|0|||
42299414|NCT02553265|76134501|FG002|First Intervention (28 Days)|Adverse Event|0|||
42299415|NCT02553265|76134499|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
42299416|NCT02553265|76134500|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
42299417|NCT02553265|76134501|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
42299418|NCT02553265|76134499|FG000|Second Intervention (28 Days)|Adverse Event|1|||
42299419|NCT02553265|76134500|FG001|Second Intervention (28 Days)|Adverse Event|0|||
42206351|NCT03443427|76019137|FG000|Overall Study|Other|4|||
42206352|NCT03443427|76019138|FG001|Overall Study|Other|6|||
42206353|NCT03417219|76019146|FG000|Overall Study|Lost to Follow-up|0|||
42206354|NCT03417219|76019147|FG001|Overall Study|Lost to Follow-up|3|||
42299420|NCT02553265|76134501|FG002|Second Intervention (28 Days)|Adverse Event|0|||
42299421|NCT02553265|76134499|FG000|Third Intervention (28 Days)|Adverse Event|1|||
42299422|NCT02553265|76134500|FG001|Third Intervention (28 Days)|Adverse Event|0|||
42206355|NCT02953821|76019155|FG000|Overall Study|Adverse Event|0|||
42206356|NCT02953821|76019156|FG001|Overall Study|Adverse Event|4|||
42206357|NCT02953821|76019155|FG000|Overall Study|Death|1|||
42206358|NCT02953821|76019156|FG001|Overall Study|Death|0|||
42206359|NCT02953821|76019155|FG000|Overall Study|Progressive Disease|5|||
42206360|NCT02953821|76019156|FG001|Overall Study|Progressive Disease|1|||
42206361|NCT02953821|76019155|FG000|Overall Study|Lost to Follow-up|2|||
42206362|NCT02953821|76019156|FG001|Overall Study|Lost to Follow-up|0|||
42206363|NCT02953821|76019155|FG000|Overall Study|Physician Decision|1|||
42206364|NCT02953821|76019156|FG001|Overall Study|Physician Decision|1|||
42206365|NCT02953821|76019155|FG000|Overall Study|Withdrawal by Subject|3|||
42206366|NCT02953821|76019156|FG001|Overall Study|Withdrawal by Subject|3|||
42206367|NCT02953821|76019155|FG000|Overall Study|Change of address|0|||
42299423|NCT02553265|76134501|FG002|Third Intervention (28 Days)|Adverse Event|0|||
42299424|NCT02553265|76134499|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
42299425|NCT02553265|76134500|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
42299426|NCT02553265|76134501|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
42299427|NCT02561195|76134518|FG000|Vaccination 1 to 3|Adverse Event|4|||
42299428|NCT02561195|76134519|FG001|Vaccination 1 to 3|Adverse Event|5|||
42299429|NCT02561195|76134520|FG002|Vaccination 1 to 3|Adverse Event|0|||
42299430|NCT02561195|76134521|FG003|Vaccination 1 to 3|Adverse Event|3|||
42299431|NCT02561195|76134522|FG004|Vaccination 1 to 3|Adverse Event|4|||
42299432|NCT02561195|76134523|FG005|Vaccination 1 to 3|Adverse Event|0|||
42299433|NCT02561195|76134524|FG006|Vaccination 1 to 3|Adverse Event|0|||
42299434|NCT02561195|76134525|FG007|Vaccination 1 to 3|Adverse Event|0|||
42036440|NCT01017120|75844853|FG001|Overall Study|Adverse Event|0|||
42299435|NCT02561195|76134526|FG008|Vaccination 1 to 3|Adverse Event|0|||
42299436|NCT02561195|76134527|FG009|Vaccination 1 to 3|Adverse Event|0|||
42299437|NCT02561195|76134528|FG010|Vaccination 1 to 3|Adverse Event|0|||
42299438|NCT02561195|76134529|FG011|Vaccination 1 to 3|Adverse Event|0|||
42299439|NCT02561195|76134530|FG012|Vaccination 1 to 3|Adverse Event|0|||
42299440|NCT02561195|76134531|FG013|Vaccination 1 to 3|Adverse Event|0|||
42299441|NCT02561195|76134518|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
42299442|NCT02561195|76134519|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
42299443|NCT02561195|76134520|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
42299444|NCT02561195|76134521|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
42299445|NCT02561195|76134522|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
42299446|NCT02561195|76134523|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
42299447|NCT02561195|76134524|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
42299448|NCT02561195|76134525|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
42299449|NCT02561195|76134526|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
42299450|NCT02561195|76134527|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
42299451|NCT02561195|76134528|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
42299452|NCT02561195|76134529|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
42299453|NCT02561195|76134530|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
42299454|NCT02561195|76134531|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
42299455|NCT02561195|76134518|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
42299456|NCT02561195|76134519|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
42299457|NCT02561195|76134520|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
42299458|NCT02561195|76134521|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
42299459|NCT02561195|76134522|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
42299460|NCT02561195|76134523|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
42299461|NCT02561195|76134524|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
42299462|NCT02561195|76134525|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
42299463|NCT02561195|76134526|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
42299464|NCT02561195|76134527|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
42299465|NCT02561195|76134528|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
42299466|NCT02561195|76134529|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
42299467|NCT02561195|76134530|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
42299468|NCT02561195|76134531|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
42299469|NCT02561195|76134518|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
42299470|NCT02561195|76134519|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
42299471|NCT02561195|76134520|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
42299472|NCT02561195|76134521|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
42299473|NCT02561195|76134522|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
42299474|NCT02561195|76134523|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
42299475|NCT02561195|76134524|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
42299476|NCT02561195|76134525|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
42299477|NCT02561195|76134526|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
42299478|NCT02561195|76134527|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
42299479|NCT02561195|76134528|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
42299480|NCT02561195|76134529|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
42299481|NCT02561195|76134530|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
42299482|NCT02561195|76134531|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
42299483|NCT02561195|76134518|FG000|Vaccination 1 to 3|Other|7|||
42299484|NCT02561195|76134519|FG001|Vaccination 1 to 3|Other|3|||
42299485|NCT02561195|76134520|FG002|Vaccination 1 to 3|Other|1|||
42206368|NCT02953821|76019156|FG001|Overall Study|Change of address|1|||
42206369|NCT02953821|76019155|FG000|Overall Study|Lack of Efficacy|1|||
42206370|NCT02953821|76019156|FG001|Overall Study|Lack of Efficacy|0|||
42206371|NCT02953821|76019155|FG000|Overall Study|Out of state for indeterminate time|0|||
42206372|NCT02953821|76019156|FG001|Overall Study|Out of state for indeterminate time|1|||
42206373|NCT02953821|76019155|FG000|Overall Study|No improvement|0|||
42206374|NCT02953821|76019156|FG001|Overall Study|No improvement|1|||
42206375|NCT02953821|76019155|FG000|Overall Study|Refused follow-up visit|2|||
42206376|NCT02953821|76019156|FG001|Overall Study|Refused follow-up visit|1|||
42206377|NCT03783923|76019166|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
42206378|NCT03783923|76019167|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
42206379|NCT03783923|76019166|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
42206380|NCT03783923|76019167|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
42299486|NCT02561195|76134521|FG003|Vaccination 1 to 3|Other|7|||
42299487|NCT02561195|76134522|FG004|Vaccination 1 to 3|Other|5|||
42299488|NCT02561195|76134523|FG005|Vaccination 1 to 3|Other|1|||
42299489|NCT02561195|76134524|FG006|Vaccination 1 to 3|Other|0|||
42299490|NCT02561195|76134525|FG007|Vaccination 1 to 3|Other|0|||
41927853|NCT03856047|75584275|FG001|Overall Study|Lost to Follow-up|2|||
41927854|NCT03856047|75584276|FG002|Overall Study|Lost to Follow-up|3|||
42206381|NCT03783923|76019166|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
42299491|NCT02561195|76134526|FG008|Vaccination 1 to 3|Other|0|||
42299492|NCT02561195|76134527|FG009|Vaccination 1 to 3|Other|0|||
42299493|NCT02561195|76134528|FG010|Vaccination 1 to 3|Other|0|||
42299494|NCT02561195|76134529|FG011|Vaccination 1 to 3|Other|0|||
42299495|NCT02561195|76134530|FG012|Vaccination 1 to 3|Other|0|||
42299496|NCT02561195|76134531|FG013|Vaccination 1 to 3|Other|0|||
42299497|NCT02561195|76134518|FG000|Vaccination 1 to 3|Protocol Violation|1|||
42299498|NCT02561195|76134519|FG001|Vaccination 1 to 3|Protocol Violation|0|||
41927855|NCT03856047|75584277|FG003|Overall Study|Lost to Follow-up|1|||
41927856|NCT03856047|75584278|FG004|Overall Study|Lost to Follow-up|4|||
41927857|NCT03856047|75584279|FG005|Overall Study|Lost to Follow-up|4|||
41927858|NCT03856047|75584280|FG006|Overall Study|Lost to Follow-up|4|||
41927859|NCT03112603|75584331|FG000|End of Randomization Period|Lost to Follow-up|3|||
41927860|NCT03112603|75584332|FG001|End of Randomization Period|Lost to Follow-up|0|||
41927861|NCT03112603|75584333|FG002|End of Randomization Period|Lost to Follow-up|0|||
41927862|NCT03112603|75584331|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
41927863|NCT03112603|75584332|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
41927864|NCT03112603|75584333|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
41927865|NCT03112603|75584331|FG000|End of Randomization Period|Physician Decision|43|||
41927866|NCT03112603|75584332|FG001|End of Randomization Period|Physician Decision|18|||
41927867|NCT03112603|75584333|FG002|End of Randomization Period|Physician Decision|0|||
41927868|NCT03112603|75584331|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
41927869|NCT03112603|75584332|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
41927870|NCT03112603|75584333|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
41927871|NCT03112603|75584331|FG000|End of Randomization Period|Death|10|||
41927872|NCT03112603|75584332|FG001|End of Randomization Period|Death|7|||
41927873|NCT03112603|75584333|FG002|End of Randomization Period|Death|0|||
41927874|NCT03112603|75584331|FG000|End of Randomization Period|Disease Relapse|12|||
41927875|NCT03112603|75584332|FG001|End of Randomization Period|Disease Relapse|7|||
42206382|NCT03783923|76019167|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
42206383|NCT03783923|76019166|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
42206384|NCT03783923|76019167|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
42206385|NCT03783923|76019166|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
42206386|NCT03783923|76019167|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
42206387|NCT03417141|76019171|FG000|Overall Study|Withdrawal by Subject|1|||
42206388|NCT03417141|76019171|FG000|Overall Study|Protocol Violation|3|||
42206389|NCT03724981|76019179|FG000|First Device|Protocol Violation|1|||
42206390|NCT03724981|76019180|FG001|First Device|Protocol Violation|1|||
42206391|NCT01347879|76019190|FG000|Overall Study|Adverse Event|0|||
42206392|NCT01347879|76019191|FG001|Overall Study|Adverse Event|12|||
42206393|NCT01347879|76019190|FG000|Overall Study|Lost to Follow-up|2|||
42206394|NCT01347879|76019191|FG001|Overall Study|Lost to Follow-up|0|||
42206395|NCT01347879|76019190|FG000|Overall Study|Withdrawal by Subject|3|||
42206396|NCT01347879|76019191|FG001|Overall Study|Withdrawal by Subject|2|||
42206397|NCT01347879|76019190|FG000|Overall Study|Other|2|||
42206398|NCT01347879|76019191|FG001|Overall Study|Other|3|||
42299499|NCT02561195|76134520|FG002|Vaccination 1 to 3|Protocol Violation|1|||
42299500|NCT02561195|76134521|FG003|Vaccination 1 to 3|Protocol Violation|2|||
42299501|NCT02561195|76134522|FG004|Vaccination 1 to 3|Protocol Violation|5|||
42299502|NCT02561195|76134523|FG005|Vaccination 1 to 3|Protocol Violation|2|||
42299503|NCT02561195|76134524|FG006|Vaccination 1 to 3|Protocol Violation|0|||
42299504|NCT02561195|76134525|FG007|Vaccination 1 to 3|Protocol Violation|0|||
42299505|NCT02561195|76134526|FG008|Vaccination 1 to 3|Protocol Violation|0|||
42299506|NCT02561195|76134527|FG009|Vaccination 1 to 3|Protocol Violation|0|||
42299507|NCT02561195|76134528|FG010|Vaccination 1 to 3|Protocol Violation|0|||
42299508|NCT02561195|76134529|FG011|Vaccination 1 to 3|Protocol Violation|0|||
42299509|NCT02561195|76134530|FG012|Vaccination 1 to 3|Protocol Violation|0|||
42299510|NCT02561195|76134531|FG013|Vaccination 1 to 3|Protocol Violation|0|||
42299511|NCT02561195|76134518|FG000|Vaccination 1 to 3|Death|2|||
42299512|NCT02561195|76134519|FG001|Vaccination 1 to 3|Death|1|||
42299513|NCT02561195|76134520|FG002|Vaccination 1 to 3|Death|0|||
42299514|NCT02561195|76134521|FG003|Vaccination 1 to 3|Death|2|||
42299515|NCT02561195|76134522|FG004|Vaccination 1 to 3|Death|0|||
42299516|NCT02561195|76134523|FG005|Vaccination 1 to 3|Death|0|||
42299517|NCT02561195|76134524|FG006|Vaccination 1 to 3|Death|0|||
42299518|NCT02561195|76134525|FG007|Vaccination 1 to 3|Death|0|||
42299519|NCT02561195|76134526|FG008|Vaccination 1 to 3|Death|0|||
42299520|NCT02561195|76134527|FG009|Vaccination 1 to 3|Death|0|||
42299521|NCT02561195|76134528|FG010|Vaccination 1 to 3|Death|0|||
42299522|NCT02561195|76134529|FG011|Vaccination 1 to 3|Death|0|||
41927876|NCT03112603|75584333|FG002|End of Randomization Period|Disease Relapse|0|||
41927877|NCT03112603|75584331|FG000|End of Randomization Period|Lack of Efficacy|25|||
42299523|NCT02561195|76134530|FG012|Vaccination 1 to 3|Death|0|||
42299524|NCT02561195|76134531|FG013|Vaccination 1 to 3|Death|0|||
42299525|NCT02561195|76134518|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
42299526|NCT02561195|76134519|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
42299527|NCT02561195|76134520|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
42299528|NCT02561195|76134521|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
41927878|NCT03112603|75584332|FG001|End of Randomization Period|Lack of Efficacy|77|||
41927879|NCT03112603|75584333|FG002|End of Randomization Period|Lack of Efficacy|0|||
41927880|NCT03112603|75584331|FG000|End of Randomization Period|Adverse Event|32|||
41927881|NCT03112603|75584332|FG001|End of Randomization Period|Adverse Event|12|||
41927882|NCT03112603|75584333|FG002|End of Randomization Period|Adverse Event|0|||
41927883|NCT03112603|75584331|FG000|End of Cross Over Period|Death|0|||
41927884|NCT03112603|75584332|FG001|End of Cross Over Period|Death|0|||
41927885|NCT03112603|75584333|FG002|End of Cross Over Period|Death|2|||
41927886|NCT03112603|75584331|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
41927887|NCT03112603|75584332|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
41927888|NCT03112603|75584333|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
41927889|NCT03112603|75584331|FG000|End of Cross Over Period|Physician Decision|0|||
41927890|NCT03112603|75584332|FG001|End of Cross Over Period|Physician Decision|0|||
41927891|NCT03112603|75584333|FG002|End of Cross Over Period|Physician Decision|29|||
42299529|NCT02561195|76134522|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
42299530|NCT02561195|76134523|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
42299531|NCT02561195|76134524|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
42299532|NCT02561195|76134525|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
42299533|NCT02561195|76134526|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
42299534|NCT02561195|76134527|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
42299535|NCT02561195|76134528|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
42299536|NCT02561195|76134529|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
42299537|NCT02561195|76134530|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
41927892|NCT03112603|75584331|FG000|End of Cross Over Period|Lack of Efficacy|0|||
41927893|NCT03112603|75584332|FG001|End of Cross Over Period|Lack of Efficacy|0|||
41927894|NCT03112603|75584333|FG002|End of Cross Over Period|Lack of Efficacy|8|||
41927895|NCT03112603|75584331|FG000|End of Cross Over Period|Adverse Event|0|||
41927896|NCT03112603|75584332|FG001|End of Cross Over Period|Adverse Event|0|||
41927897|NCT03112603|75584333|FG002|End of Cross Over Period|Adverse Event|6|||
41927898|NCT03112603|75584331|FG000|End of Cross Over Period|Disease Relapse|0|||
41927899|NCT03112603|75584332|FG001|End of Cross Over Period|Disease Relapse|0|||
41927900|NCT03112603|75584333|FG002|End of Cross Over Period|Disease Relapse|2|||
41927901|NCT02725528|75584348|FG000|Overall Study|Lost to Follow-up|1|||
41927902|NCT02725528|75584349|FG001|Overall Study|Lost to Follow-up|4|||
41927903|NCT02725528|75584348|FG000|Overall Study|Withdrawal by Subject|0|||
41927904|NCT02725528|75584349|FG001|Overall Study|Withdrawal by Subject|1|||
41927905|NCT02627963|75584366|FG000|Overall Study|Randomized but not treated|2|||
41927906|NCT02627963|75584367|FG001|Overall Study|Randomized but not treated|6|||
41927907|NCT02585258|75584375|FG000|Overall Study|Adverse Event|28|||
41927908|NCT02585258|75584376|FG001|Overall Study|Adverse Event|29|||
41927909|NCT02585258|75584375|FG000|Overall Study|Death|3|||
41927910|NCT02585258|75584376|FG001|Overall Study|Death|2|||
41927911|NCT02585258|75584375|FG000|Overall Study|Lack of Efficacy|7|||
41927912|NCT02585258|75584376|FG001|Overall Study|Lack of Efficacy|9|||
41927913|NCT02585258|75584375|FG000|Overall Study|includes covid-related access problems|42|||
41927914|NCT02585258|75584376|FG001|Overall Study|includes covid-related access problems|46|||
41927915|NCT02585258|75584375|FG000|Overall Study|Lost to Follow-up|5|||
41927916|NCT02585258|75584376|FG001|Overall Study|Lost to Follow-up|2|||
41927917|NCT02132611|75584393|FG000|Overall Study|Death|2|||
41927918|NCT01941030|75584399|FG000|Overall Study|Death|3|||
41927919|NCT01941030|75584400|FG001|Overall Study|Death|2|||
41927920|NCT01941030|75584399|FG000|Overall Study|Lost to Follow-up|6|||
41927921|NCT01941030|75584400|FG001|Overall Study|Lost to Follow-up|5|||
41927922|NCT01941030|75584399|FG000|Overall Study|Withdrawal by Subject|4|||
41927923|NCT01941030|75584400|FG001|Overall Study|Withdrawal by Subject|6|||
41927924|NCT01092416|75584411|FG000|Enrollment|Atherectomy device not inserted|3|||
41927925|NCT01092416|75584411|FG000|30-Day Follow-up|Death|2|||
41927926|NCT01092416|75584411|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
41927927|NCT01092416|75584411|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
41927928|NCT01092416|75584411|FG000|12-Month Follow-up|Death|16|||
41927929|NCT01092416|75584411|FG000|12-Month Follow-up|Lost to Follow-up|4|||
41927930|NCT01092416|75584411|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
42206399|NCT03441789|76019208|FG000|Overall Study|Withdrawal by Subject|1|||
42206400|NCT03441789|76019209|FG001|Overall Study|Withdrawal by Subject|1|||
41927931|NCT01092416|75584411|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
41927932|NCT01092416|75584411|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
41927933|NCT00701220|75584420|FG000|Overall Study|Withdrawal by Subject|0|||
41927934|NCT00701220|75584421|FG001|Overall Study|Withdrawal by Subject|2|||
41927935|NCT00701220|75584420|FG000|Overall Study|Protocol Violation|2|||
41927936|NCT00701220|75584421|FG001|Overall Study|Protocol Violation|0|||
41927937|NCT00559845|75584495|FG000|Overall Study|Withdrew Consent|1|||
41927938|NCT00559845|75584495|FG000|Overall Study|Disease Progression|1|||
42206401|NCT03441789|76019208|FG000|Overall Study|Adverse Event|0|||
41927939|NCT00559845|75584495|FG000|Overall Study|Adverse Event|3|||
42299538|NCT02561195|76134531|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
41927940|NCT00559845|75584495|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
41927941|NCT00559845|75584495|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
41927942|NCT01393964|75584598|FG000|Overall Study|Disease Progression|4|||
41927943|NCT01393964|75584599|FG001|Overall Study|Disease Progression|3|||
41927944|NCT01393964|75584600|FG002|Overall Study|Disease Progression|5|||
41927945|NCT01393964|75584598|FG000|Overall Study|Study drug toxicity|1|||
41927946|NCT01393964|75584599|FG001|Overall Study|Study drug toxicity|0|||
42206402|NCT03441789|76019209|FG001|Overall Study|Adverse Event|1|||
42206403|NCT03441789|76019208|FG000|Overall Study|Protocol Violation|0|||
42206404|NCT03441789|76019209|FG001|Overall Study|Protocol Violation|1|||
42206405|NCT03441789|76019208|FG000|Overall Study|Lost to Follow-up|0|||
42206406|NCT03441789|76019209|FG001|Overall Study|Lost to Follow-up|1|||
42206407|NCT03387735|76019221|FG000|Overall Study|Lost to Follow-up|4|||
42206408|NCT03387735|76019222|FG001|Overall Study|Lost to Follow-up|8|||
42206409|NCT03387735|76019221|FG000|Overall Study|Death|4|||
42206410|NCT03387735|76019222|FG001|Overall Study|Death|8|||
42206411|NCT04055090|76019230|FG000|Overall Study|screen failure|1|||
42206412|NCT04055090|76019231|FG001|Overall Study|screen failure|0|||
42206413|NCT04055090|76019230|FG000|Overall Study|Withdrawal by Subject|1|||
42206414|NCT04055090|76019231|FG001|Overall Study|Withdrawal by Subject|0|||
42206415|NCT03403413|76019254|FG000|Overall Study|Lack of Efficacy|2|||
42206416|NCT03721705|76019271|FG000|Overall Study|Adverse Event|2|||
42206417|NCT03721705|76019272|FG001|Overall Study|Adverse Event|0|||
41927947|NCT01393964|75584600|FG002|Overall Study|Study drug toxicity|0|||
41927948|NCT01393964|75584598|FG000|Overall Study|Withdrawal by Subject|0|||
41927949|NCT01393964|75584599|FG001|Overall Study|Withdrawal by Subject|0|||
41927950|NCT01393964|75584600|FG002|Overall Study|Withdrawal by Subject|1|||
41927951|NCT01393964|75584598|FG000|Overall Study|Adverse event unrelated to study drug|0|||
41927952|NCT01393964|75584599|FG001|Overall Study|Adverse event unrelated to study drug|3|||
41927953|NCT01393964|75584600|FG002|Overall Study|Adverse event unrelated to study drug|0|||
41927954|NCT01393964|75584598|FG000|Overall Study|Subject request stop study treatment|0|||
41927955|NCT01393964|75584599|FG001|Overall Study|Subject request stop study treatment|1|||
41927956|NCT01393964|75584600|FG002|Overall Study|Subject request stop study treatment|0|||
42206418|NCT03721705|76019271|FG000|Overall Study|Withdrawal by Subject|4|||
42206419|NCT03721705|76019272|FG001|Overall Study|Withdrawal by Subject|10|||
42206420|NCT03721705|76019271|FG000|Overall Study|No Suitable Study Partner|1|||
42206421|NCT03721705|76019272|FG001|Overall Study|No Suitable Study Partner|0|||
42206422|NCT03721705|76019271|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
42206423|NCT03721705|76019272|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
42206424|NCT03721705|76019271|FG000|Overall Study|Death|0|||
42206425|NCT03721705|76019272|FG001|Overall Study|Death|1|||
42206426|NCT03720847|76019278|FG000|Washout|Physician Decision|1|||
42206427|NCT03720847|76019279|FG001|Washout|Physician Decision|2|||
42206428|NCT02631070|76019288|FG000|Overall Study|Withdrawal by Subject|35|||
42206429|NCT02631070|76019289|FG001|Overall Study|Withdrawal by Subject|13|||
42206430|NCT02631070|76019288|FG000|Overall Study|Death|45|||
42206431|NCT02631070|76019289|FG001|Overall Study|Death|24|||
42206432|NCT02631070|76019288|FG000|Overall Study|Lost to Follow-up|5|||
41927957|NCT01393964|75584598|FG000|Overall Study|Subject decided to move to transplant|1|||
41927958|NCT01393964|75584599|FG001|Overall Study|Subject decided to move to transplant|0|||
41927959|NCT01393964|75584600|FG002|Overall Study|Subject decided to move to transplant|0|||
41927960|NCT01393964|75584598|FG000|Overall Study|Subject switched to commercial supply|1|||
41927961|NCT01393964|75584599|FG001|Overall Study|Subject switched to commercial supply|0|||
41927962|NCT01393964|75584600|FG002|Overall Study|Subject switched to commercial supply|2|||
41927963|NCT01393964|75584598|FG000|Overall Study|Subject plateaued in terms of effect|1|||
41927964|NCT01393964|75584599|FG001|Overall Study|Subject plateaued in terms of effect|0|||
41927965|NCT01393964|75584600|FG002|Overall Study|Subject plateaued in terms of effect|0|||
41927966|NCT01393964|75584598|FG000|Overall Study|Investigator removed subject from study|0|||
42206433|NCT02631070|76019289|FG001|Overall Study|Lost to Follow-up|1|||
42206434|NCT02631070|76019288|FG000|Overall Study|Transition to rollover protocol|52|||
41927967|NCT01393964|75584599|FG001|Overall Study|Investigator removed subject from study|1|||
41927968|NCT01393964|75584600|FG002|Overall Study|Investigator removed subject from study|0|||
41927969|NCT01393964|75584598|FG000|Overall Study|Subject converted to roll-over study|0|||
41927970|NCT01393964|75584599|FG001|Overall Study|Subject converted to roll-over study|1|||
41927971|NCT01393964|75584600|FG002|Overall Study|Subject converted to roll-over study|0|||
42206435|NCT02631070|76019289|FG001|Overall Study|Transition to rollover protocol|21|||
42206436|NCT02631070|76019288|FG000|Overall Study|Other reasons|12|||
42206437|NCT02631070|76019289|FG001|Overall Study|Other reasons|5|||
42206438|NCT00741988|76019297|FG000|Overall Study|Adverse Event|2|||
42206439|NCT00741988|76019298|FG001|Overall Study|Adverse Event|4|||
42206440|NCT00741988|76019297|FG000|Overall Study|Lack of Efficacy|2|||
42206441|NCT00741988|76019298|FG001|Overall Study|Lack of Efficacy|0|||
42206442|NCT03354429|76019306|FG000|Overall Study|Withdrawal by Subject|8|||
42206443|NCT03354429|76019307|FG001|Overall Study|Withdrawal by Subject|7|||
42206444|NCT03354429|76019306|FG000|Overall Study|Lost to Follow-up|1|||
42206445|NCT03354429|76019307|FG001|Overall Study|Lost to Follow-up|0|||
42206446|NCT03352713|76019313|FG000|Overall Study|Lost to Follow-up|8|||
42206447|NCT03352713|76019313|FG000|Overall Study|Withdrawn by investigator|5|||
42206448|NCT03352713|76019313|FG000|Overall Study|Completed 0 EMAs|8|||
42206449|NCT03352713|76019313|FG000|Overall Study|Device incompatible/stolen|5|||
42206450|NCT03901144|76019317|FG000|Overall Study|Lost to Follow-up|1|||
42206451|NCT03901144|76019318|FG001|Overall Study|Lost to Follow-up|1|||
42206452|NCT03901144|76019319|FG002|Overall Study|Lost to Follow-up|1|||
42206453|NCT03901144|76019320|FG003|Overall Study|Lost to Follow-up|1|||
42206454|NCT02952261|76019332|FG000|Overall Study|Withdrawal by Subject|4|||
42206455|NCT02952261|76019333|FG001|Overall Study|Withdrawal by Subject|5|||
42206456|NCT02952261|76019332|FG000|Overall Study|Protocol Violation|1|||
42206457|NCT02952261|76019333|FG001|Overall Study|Protocol Violation|0|||
42206458|NCT03384693|76019339|FG000|Overall Study|Adverse Event|3|||
42206459|NCT03718429|76019351|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
42206460|NCT03718429|76019352|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
42206461|NCT03718429|76019353|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
42206462|NCT03718429|76019354|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
42206463|NCT01285102|76019374|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
42206464|NCT03382899|76019408|FG000|Overall Study|Ineligibility Determined|0|||
42206465|NCT03382899|76019409|FG001|Overall Study|Ineligibility Determined|1|||
42206466|NCT03382899|76019408|FG000|Overall Study|Lost to Follow-up|0|||
42206467|NCT03382899|76019409|FG001|Overall Study|Lost to Follow-up|1|||
42206468|NCT03382899|76019408|FG000|Overall Study|Sponsor's decision|31|||
42206469|NCT03382899|76019409|FG001|Overall Study|Sponsor's decision|28|||
42206470|NCT03382899|76019408|FG000|Overall Study|Withdrawal by Subject|0|||
42206471|NCT03382899|76019409|FG001|Overall Study|Withdrawal by Subject|5|||
42206472|NCT00709852|76019415|FG000|Period 1|Adverse Event|2|||
42206473|NCT00709852|76019416|FG001|Period 1|Adverse Event|0|||
42206474|NCT00709852|76019415|FG000|Period 1|Withdrawal by Subject|4|||
42206475|NCT00709852|76019416|FG001|Period 1|Withdrawal by Subject|2|||
42206476|NCT00709852|76019415|FG000|Period 1|Protocol Violation|1|||
42206477|NCT00709852|76019416|FG001|Period 1|Protocol Violation|0|||
42206478|NCT00709852|76019415|FG000|Period 1|Defective scanner|0|||
42206479|NCT00709852|76019416|FG001|Period 1|Defective scanner|1|||
42206480|NCT00709852|76019415|FG000|Period 1|Lost to Follow-up|1|||
42206481|NCT00709852|76019416|FG001|Period 1|Lost to Follow-up|0|||
42206482|NCT00709852|76019415|FG000|Period 2|Protocol Violation|4|||
42206483|NCT00709852|76019416|FG001|Period 2|Protocol Violation|1|||
42299539|NCT02561195|76134518|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
42299540|NCT02561195|76134519|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
42299541|NCT02561195|76134520|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
42299542|NCT02561195|76134521|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
42299543|NCT02561195|76134522|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
42299544|NCT02561195|76134523|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
42299545|NCT02561195|76134524|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
42299546|NCT02561195|76134525|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
42299547|NCT02561195|76134526|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
42299548|NCT02561195|76134527|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
42299549|NCT02561195|76134528|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
42299550|NCT02561195|76134529|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
42299551|NCT02561195|76134530|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
42299552|NCT02561195|76134531|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
42299553|NCT02561195|76134518|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
42299554|NCT02561195|76134519|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
42299555|NCT02561195|76134520|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
42206484|NCT00709852|76019415|FG000|Period 2|Adverse Event|1|||
42206485|NCT00709852|76019416|FG001|Period 2|Adverse Event|1|||
42299556|NCT02561195|76134521|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
42299557|NCT02561195|76134522|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
42299558|NCT02561195|76134523|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
42299559|NCT02561195|76134524|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
42299560|NCT02561195|76134525|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
42299561|NCT02561195|76134526|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
42299562|NCT02561195|76134527|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
42299563|NCT02561195|76134528|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
42299564|NCT02561195|76134529|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
42206486|NCT00709852|76019415|FG000|Period 2|Lost to Follow-up|1|||
42206487|NCT00709852|76019416|FG001|Period 2|Lost to Follow-up|0|||
42206488|NCT00709852|76019415|FG000|Period 2|No 72-hour follow-up|3|||
42206489|NCT00709852|76019416|FG001|Period 2|No 72-hour follow-up|0|||
42206490|NCT03382041|76019433|FG000|Overall Study|Consent Form Lost|2|||
42206491|NCT03382041|76019434|FG001|Overall Study|Consent Form Lost|1|||
42299565|NCT02561195|76134530|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
42206492|NCT03382041|76019433|FG000|Overall Study|Withdrawal by Subject|1|||
42299566|NCT02561195|76134531|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
42299567|NCT02561195|76134518|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299568|NCT02561195|76134519|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299569|NCT02561195|76134520|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299570|NCT02561195|76134521|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299571|NCT02561195|76134522|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299572|NCT02561195|76134523|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299573|NCT02561195|76134524|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299574|NCT02561195|76134525|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299575|NCT02561195|76134526|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299576|NCT02561195|76134527|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299577|NCT02561195|76134528|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299578|NCT02561195|76134529|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299579|NCT02561195|76134530|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
42299580|NCT02561195|76134531|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
42299581|NCT02561195|76134518|FG000|Extension Stage (Vaccination 4)|Death|0|||
42299582|NCT02561195|76134519|FG001|Extension Stage (Vaccination 4)|Death|0|||
42299583|NCT02561195|76134520|FG002|Extension Stage (Vaccination 4)|Death|0|||
42299584|NCT02561195|76134521|FG003|Extension Stage (Vaccination 4)|Death|0|||
42299585|NCT02561195|76134522|FG004|Extension Stage (Vaccination 4)|Death|0|||
42299586|NCT02561195|76134523|FG005|Extension Stage (Vaccination 4)|Death|0|||
42299587|NCT02561195|76134524|FG006|Extension Stage (Vaccination 4)|Death|0|||
42299588|NCT02561195|76134525|FG007|Extension Stage (Vaccination 4)|Death|0|||
42299589|NCT02561195|76134526|FG008|Extension Stage (Vaccination 4)|Death|0|||
42299590|NCT02561195|76134527|FG009|Extension Stage (Vaccination 4)|Death|1|||
42299591|NCT02561195|76134528|FG010|Extension Stage (Vaccination 4)|Death|0|||
42299592|NCT02561195|76134529|FG011|Extension Stage (Vaccination 4)|Death|0|||
42299593|NCT02561195|76134530|FG012|Extension Stage (Vaccination 4)|Death|0|||
42299594|NCT02561195|76134531|FG013|Extension Stage (Vaccination 4)|Death|0|||
42299595|NCT02561195|76134518|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
42299596|NCT02561195|76134519|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
42299597|NCT02561195|76134520|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
42299598|NCT02561195|76134521|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
42299599|NCT02561195|76134522|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
42299600|NCT02561195|76134523|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
42299601|NCT02561195|76134524|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
42299602|NCT02561195|76134525|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
42299603|NCT02561195|76134526|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
42299604|NCT02561195|76134527|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
42299605|NCT02561195|76134528|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
42299606|NCT02561195|76134529|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
42299607|NCT02561195|76134530|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
42299608|NCT02561195|76134531|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
42299609|NCT02561195|76134518|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
42299610|NCT02561195|76134519|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
42299611|NCT02561195|76134520|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
42299612|NCT02561195|76134521|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
42299613|NCT02561195|76134522|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
42299614|NCT02561195|76134523|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
42299615|NCT02561195|76134524|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
41927972|NCT01393964|75584598|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
41927973|NCT01393964|75584599|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
41927974|NCT01393964|75584600|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
41927975|NCT01393730|75584688|FG000|Overall Study|Withdrawal by Subject|3|||
41927976|NCT01393730|75584688|FG000|Overall Study|Other|2|||
41927977|NCT01393730|75584688|FG000|Overall Study|Adverse Event|1|||
41927978|NCT01393106|75584707|FG000|Overall Study|Adverse Event|3|||
41927979|NCT01393106|75584707|FG000|Overall Study|Withdrawal by Subject|1|||
41927980|NCT01393106|75584707|FG000|Overall Study|Lack of Efficacy|1|||
41927981|NCT00553059|75584713|FG000|Overall Study|Deemed ineligible|1|||
41927982|NCT00553059|75584714|FG001|Overall Study|Deemed ineligible|1|||
41927983|NCT00553059|75584713|FG000|Overall Study|Drug supply not available|0|||
42299616|NCT02561195|76134525|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
42299617|NCT02561195|76134526|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
41927984|NCT00553059|75584714|FG001|Overall Study|Drug supply not available|1|||
41927985|NCT01413542|75584736|FG000|Overall Study|Physician Decision|1|||
42206493|NCT03382041|76019434|FG001|Overall Study|Withdrawal by Subject|4|||
42206494|NCT03382041|76019433|FG000|Overall Study|Lost to Follow-up|1|||
42299618|NCT02561195|76134527|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
42299619|NCT02561195|76134528|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
42299620|NCT02561195|76134529|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
42299621|NCT02561195|76134530|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
42299622|NCT02561195|76134531|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
42299623|NCT02561195|76134518|FG000|Extension Stage (Vaccination 4)|Other|0|||
42299624|NCT02561195|76134519|FG001|Extension Stage (Vaccination 4)|Other|0|||
42299625|NCT02561195|76134520|FG002|Extension Stage (Vaccination 4)|Other|0|||
42299626|NCT02561195|76134521|FG003|Extension Stage (Vaccination 4)|Other|0|||
42299627|NCT02561195|76134522|FG004|Extension Stage (Vaccination 4)|Other|0|||
42299628|NCT02561195|76134523|FG005|Extension Stage (Vaccination 4)|Other|0|||
42299629|NCT02561195|76134524|FG006|Extension Stage (Vaccination 4)|Other|0|||
42299630|NCT02561195|76134525|FG007|Extension Stage (Vaccination 4)|Other|0|||
42299631|NCT02561195|76134526|FG008|Extension Stage (Vaccination 4)|Other|0|||
42299632|NCT02561195|76134527|FG009|Extension Stage (Vaccination 4)|Other|0|||
42299633|NCT02561195|76134528|FG010|Extension Stage (Vaccination 4)|Other|2|||
42299634|NCT02561195|76134529|FG011|Extension Stage (Vaccination 4)|Other|2|||
42299635|NCT02561195|76134530|FG012|Extension Stage (Vaccination 4)|Other|1|||
42299636|NCT02561195|76134531|FG013|Extension Stage (Vaccination 4)|Other|0|||
42299637|NCT02561195|76134518|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
42299638|NCT02561195|76134519|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
42299639|NCT02561195|76134520|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
42299640|NCT02561195|76134521|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
42299641|NCT02561195|76134522|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
42299642|NCT02561195|76134523|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
42299643|NCT02561195|76134524|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
42299644|NCT02561195|76134525|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
42299645|NCT02561195|76134526|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
42299646|NCT02561195|76134527|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
42299647|NCT02561195|76134528|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
42299648|NCT02561195|76134529|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
42299649|NCT02561195|76134530|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
42299650|NCT02561195|76134531|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
42299651|NCT01663103|76134565|FG000|Overall Study|Withdrawal by Subject|1|||
42299652|NCT01663103|76134566|FG001|Overall Study|Withdrawal by Subject|2|||
42299653|NCT01663103|76134565|FG000|Overall Study|Adverse Event|1|||
42299654|NCT01663103|76134566|FG001|Overall Study|Adverse Event|0|||
42299655|NCT01663103|76134565|FG000|Overall Study|dog bite|1|||
42299656|NCT01663103|76134566|FG001|Overall Study|dog bite|0|||
42299657|NCT02560025|76134585|FG000|Overall Study|Ineligible after consent/ registration|3|||
42299658|NCT02566889|76134600|FG000|Overall Study|Withdrawal by Subject|3|||
42299659|NCT02566889|76134601|FG001|Overall Study|Withdrawal by Subject|1|||
42299660|NCT02566889|76134600|FG000|Overall Study|Adverse Event|4|||
42299661|NCT02566889|76134601|FG001|Overall Study|Adverse Event|2|||
41927986|NCT01413542|75584737|FG001|Overall Study|Physician Decision|0|||
41927987|NCT01413542|75584738|FG002|Overall Study|Physician Decision|3|||
41927988|NCT01413542|75584739|FG003|Overall Study|Physician Decision|0|||
41927989|NCT01413542|75584736|FG000|Overall Study|Adverse Event|0|||
41927990|NCT01413542|75584737|FG001|Overall Study|Adverse Event|0|||
42020743|NCT00975676|75828136|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
42020744|NCT00975676|75828137|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
42020745|NCT00975286|75828150|FG000|Overall Study|Adverse Event|9|||
42020746|NCT00975286|75828151|FG001|Overall Study|Adverse Event|19|||
42020747|NCT00975286|75828150|FG000|Overall Study|Protocol Violation|1|||
42020748|NCT00975286|75828151|FG001|Overall Study|Protocol Violation|2|||
42020749|NCT00975286|75828150|FG000|Overall Study|Withdrawal by Subject|0|||
42020750|NCT00975286|75828151|FG001|Overall Study|Withdrawal by Subject|2|||
42020751|NCT00975286|75828150|FG000|Overall Study|Familial and Personal Reasons|2|||
42020752|NCT00975286|75828151|FG001|Overall Study|Familial and Personal Reasons|2|||
42299662|NCT02566889|76134600|FG000|Overall Study|Other|6|||
42299663|NCT02566889|76134601|FG001|Overall Study|Other|2|||
42299664|NCT02566577|76134608|FG000|Overall Study|Withdrawal by Subject|1|||
42299665|NCT02566577|76134609|FG001|Overall Study|Withdrawal by Subject|1|||
42299666|NCT02566577|76134608|FG000|Overall Study|Equipment failure|1|||
42299667|NCT02566577|76134609|FG001|Overall Study|Equipment failure|1|||
42299668|NCT02566577|76134608|FG000|Overall Study|Physical limitation|1|||
42299669|NCT02566577|76134609|FG001|Overall Study|Physical limitation|0|||
42299670|NCT02559713|76134621|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
42299671|NCT01358981|76134632|FG000|Period 1|Withdrawal by Subject|0|||
42299672|NCT01358981|76134633|FG001|Period 1|Withdrawal by Subject|0|||
42299673|NCT01358981|76134634|FG002|Period 1|Withdrawal by Subject|0|||
42299674|NCT01358981|76134635|FG003|Period 1|Withdrawal by Subject|1|||
42299675|NCT01358981|76134636|FG004|Period 1|Withdrawal by Subject|0|||
41927991|NCT01413542|75584738|FG002|Overall Study|Adverse Event|0|||
41927992|NCT01413542|75584739|FG003|Overall Study|Adverse Event|1|||
42020753|NCT00975286|75828150|FG000|Overall Study|Poor Compliance to Protocol|0|||
42020754|NCT00975286|75828151|FG001|Overall Study|Poor Compliance to Protocol|2|||
42020755|NCT00975286|75828150|FG000|Overall Study|Sponsor Decision|0|||
42020756|NCT00975286|75828151|FG001|Overall Study|Sponsor Decision|2|||
42020757|NCT00907777|75828159|FG000|Overall Study|Withdrawal by Subject|0|||
42020758|NCT00907777|75828160|FG001|Overall Study|Withdrawal by Subject|1|||
42020759|NCT00908011|75828168|FG000|Overall Study|Withdrawal by Subject|2|||
42020760|NCT00908011|75828169|FG001|Overall Study|Withdrawal by Subject|2|||
42020761|NCT00976456|75828177|FG000|Overall Study|Adverse Event|17|||
42020762|NCT00976456|75828178|FG001|Overall Study|Adverse Event|22|||
42020763|NCT00976456|75828177|FG000|Overall Study|Death|7|||
42020764|NCT00976456|75828178|FG001|Overall Study|Death|9|||
42020765|NCT00976456|75828177|FG000|Overall Study|Lack of Efficacy|5|||
42020766|NCT00976456|75828178|FG001|Overall Study|Lack of Efficacy|2|||
42020767|NCT00976456|75828177|FG000|Overall Study|Withdrawal by Subject|3|||
42020768|NCT00976456|75828178|FG001|Overall Study|Withdrawal by Subject|1|||
42020769|NCT00976456|75828177|FG000|Overall Study|screening failure, unknown|11|||
42020770|NCT00976456|75828178|FG001|Overall Study|screening failure, unknown|4|||
42020771|NCT01243151|75828189|FG000|Overall Study|Adverse Event|0|||
42020772|NCT01243151|75828190|FG001|Overall Study|Adverse Event|1|||
42020773|NCT01243151|75828191|FG002|Overall Study|Adverse Event|0|||
42020774|NCT01243151|75828192|FG003|Overall Study|Adverse Event|0|||
42020775|NCT01243151|75828193|FG004|Overall Study|Adverse Event|0|||
42020776|NCT01243151|75828189|FG000|Overall Study|Protocol Violation|0|||
42020777|NCT01243151|75828190|FG001|Overall Study|Protocol Violation|0|||
42020778|NCT01243151|75828191|FG002|Overall Study|Protocol Violation|1|||
42020779|NCT01243151|75828192|FG003|Overall Study|Protocol Violation|0|||
42020780|NCT01243151|75828193|FG004|Overall Study|Protocol Violation|0|||
42020781|NCT01243151|75828189|FG000|Overall Study|Other|0|||
42020782|NCT01243151|75828190|FG001|Overall Study|Other|0|||
42020783|NCT01243151|75828191|FG002|Overall Study|Other|0|||
42020784|NCT01243151|75828192|FG003|Overall Study|Other|1|||
42020785|NCT01243151|75828193|FG004|Overall Study|Other|0|||
42020786|NCT01243151|75828189|FG000|Overall Study|Randomized but not treated|0|||
42020787|NCT01243151|75828190|FG001|Overall Study|Randomized but not treated|0|||
42020788|NCT01243151|75828191|FG002|Overall Study|Randomized but not treated|0|||
42020789|NCT01243151|75828192|FG003|Overall Study|Randomized but not treated|1|||
42020790|NCT01243151|75828193|FG004|Overall Study|Randomized but not treated|0|||
42020791|NCT00993148|75828217|FG000|Overall Study|Lost to Follow-up|2|||
42020792|NCT00993148|75828217|FG000|Overall Study|never initiated treatment|1|||
42020793|NCT00907621|75828223|FG000|Overall Study|Lost to Follow-up|6|||
42020794|NCT00907621|75828224|FG001|Overall Study|Lost to Follow-up|3|||
42020795|NCT00907621|75828223|FG000|Overall Study|intercurrent febrile illness|1|||
42020796|NCT00907621|75828224|FG001|Overall Study|intercurrent febrile illness|1|||
42020797|NCT00907153|75828243|FG000|Overall Study|Lost to Follow-up|1|||
42020798|NCT00907153|75828244|FG001|Overall Study|Lost to Follow-up|1|||
42020799|NCT00907153|75828243|FG000|Overall Study|Withdrawal by Subject|1|||
42020800|NCT00907153|75828244|FG001|Overall Study|Withdrawal by Subject|3|||
42020801|NCT00904033|75828254|FG000|Overall Study|Withdrawal by Subject|1|||
42020802|NCT00904033|75828255|FG001|Overall Study|Withdrawal by Subject|1|||
42020803|NCT00904033|75828256|FG002|Overall Study|Withdrawal by Subject|0|||
42020804|NCT00904033|75828257|FG003|Overall Study|Withdrawal by Subject|0|||
42020805|NCT00904033|75828254|FG000|Overall Study|Physician Decision|0|||
42020806|NCT00904033|75828255|FG001|Overall Study|Physician Decision|0|||
42020807|NCT00904033|75828256|FG002|Overall Study|Physician Decision|1|||
42020808|NCT00904033|75828257|FG003|Overall Study|Physician Decision|0|||
42020809|NCT00904033|75828254|FG000|Overall Study|Unable to obtain final blood draw|0|||
42020810|NCT00904033|75828255|FG001|Overall Study|Unable to obtain final blood draw|0|||
42020811|NCT00904033|75828256|FG002|Overall Study|Unable to obtain final blood draw|0|||
42020812|NCT00904033|75828257|FG003|Overall Study|Unable to obtain final blood draw|2|||
42020813|NCT00903877|75828268|FG000|Overall Study|Did not meet study criteria|33|||
42020814|NCT00903877|75828268|FG000|Overall Study|Withdrawal by Subject|3|||
42020815|NCT00903877|75828268|FG000|Overall Study|Adverse Event|2|||
42020816|NCT00903877|75828268|FG000|Overall Study|Lost to Follow-up|1|||
42020817|NCT00903877|75828268|FG000|Overall Study|Participation put on hold|4|||
42020818|NCT01241591|75828276|FG000|Overall Study|Lack of Efficacy|5|||
42020819|NCT01241591|75828277|FG001|Overall Study|Lack of Efficacy|2|||
42020820|NCT01241591|75828278|FG002|Overall Study|Lack of Efficacy|2|||
42020821|NCT01241591|75828279|FG003|Overall Study|Lack of Efficacy|3|||
42020822|NCT01241591|75828276|FG000|Overall Study|Protocol Violation|5|||
42020823|NCT01241591|75828277|FG001|Overall Study|Protocol Violation|2|||
42020824|NCT01241591|75828278|FG002|Overall Study|Protocol Violation|3|||
42020825|NCT01241591|75828279|FG003|Overall Study|Protocol Violation|0|||
42020826|NCT01241591|75828276|FG000|Overall Study|Lost to Follow-up|1|||
42020827|NCT01241591|75828277|FG001|Overall Study|Lost to Follow-up|2|||
42020828|NCT01241591|75828278|FG002|Overall Study|Lost to Follow-up|2|||
42020829|NCT01241591|75828279|FG003|Overall Study|Lost to Follow-up|2|||
42020830|NCT01241591|75828276|FG000|Overall Study|Screen Failure|3|||
42020831|NCT01241591|75828277|FG001|Overall Study|Screen Failure|2|||
42020832|NCT01241591|75828278|FG002|Overall Study|Screen Failure|1|||
42020833|NCT01241591|75828279|FG003|Overall Study|Screen Failure|0|||
42020834|NCT01241591|75828276|FG000|Overall Study|Withdrawal by Subject|6|||
42020835|NCT01241591|75828277|FG001|Overall Study|Withdrawal by Subject|4|||
42020836|NCT01241591|75828278|FG002|Overall Study|Withdrawal by Subject|2|||
42020837|NCT01241591|75828279|FG003|Overall Study|Withdrawal by Subject|2|||
42020838|NCT01241591|75828276|FG000|Overall Study|Other|0|||
42020839|NCT01241591|75828277|FG001|Overall Study|Other|1|||
42020840|NCT01241591|75828278|FG002|Overall Study|Other|0|||
42020841|NCT01241591|75828279|FG003|Overall Study|Other|1|||
42020842|NCT01241591|75828276|FG000|Overall Study|Adverse Event|3|||
42020843|NCT01241591|75828277|FG001|Overall Study|Adverse Event|11|||
42020844|NCT01241591|75828278|FG002|Overall Study|Adverse Event|12|||
42020845|NCT01241591|75828279|FG003|Overall Study|Adverse Event|4|||
42020846|NCT00906373|75828291|FG000|Overall Study|Withdrawal by Subject|0|||
42020847|NCT00906373|75828292|FG001|Overall Study|Withdrawal by Subject|5|||
42020848|NCT00906373|75828291|FG000|Overall Study|Other|0|||
42020849|NCT00906373|75828292|FG001|Overall Study|Other|1|||
42020850|NCT00906373|75828291|FG000|Overall Study|Still on treatment at cutoff date|0|||
42020851|NCT00906373|75828292|FG001|Overall Study|Still on treatment at cutoff date|2|||
42020852|NCT00905437|75828305|FG000|Overall Study|Adverse Event|3|||
42020853|NCT00905437|75828306|FG001|Overall Study|Adverse Event|2|||
42020854|NCT00905437|75828305|FG000|Overall Study|Lost to Follow-up|0|||
42020855|NCT00905437|75828306|FG001|Overall Study|Lost to Follow-up|1|||
42020856|NCT00905437|75828305|FG000|Overall Study|Withdrawal by Subject|0|||
42020857|NCT00905437|75828306|FG001|Overall Study|Withdrawal by Subject|1|||
42020858|NCT00905437|75828305|FG000|Overall Study|Other|5|||
42020859|NCT00905437|75828306|FG001|Overall Study|Other|6|||
42020860|NCT01238861|75828318|FG000|Overall Study|Lost to Follow-up|4|||
42020861|NCT01238861|75828319|FG001|Overall Study|Lost to Follow-up|2|||
42020862|NCT01238861|75828320|FG002|Overall Study|Lost to Follow-up|3|||
42020863|NCT01238861|75828321|FG003|Overall Study|Lost to Follow-up|1|||
42020864|NCT01238861|75828322|FG004|Overall Study|Lost to Follow-up|1|||
42020865|NCT01238861|75828323|FG005|Overall Study|Lost to Follow-up|2|||
42020866|NCT01238861|75828318|FG000|Overall Study|Unplanned surgery|1|||
42020867|NCT01238861|75828319|FG001|Overall Study|Unplanned surgery|0|||
42020868|NCT01238861|75828320|FG002|Overall Study|Unplanned surgery|0|||
42020869|NCT01238861|75828321|FG003|Overall Study|Unplanned surgery|0|||
42020870|NCT01238861|75828322|FG004|Overall Study|Unplanned surgery|0|||
42020871|NCT01238861|75828323|FG005|Overall Study|Unplanned surgery|0|||
42020872|NCT01238861|75828318|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
42020873|NCT01238861|75828319|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
42020874|NCT01238861|75828320|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
42020875|NCT01238861|75828321|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
42020876|NCT01238861|75828322|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
42020877|NCT01238861|75828323|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
42020878|NCT01238861|75828318|FG000|Overall Study|Incorrect enrollment/randomization|0|||
42020879|NCT01238861|75828319|FG001|Overall Study|Incorrect enrollment/randomization|0|||
42020880|NCT01238861|75828320|FG002|Overall Study|Incorrect enrollment/randomization|1|||
42020881|NCT01238861|75828321|FG003|Overall Study|Incorrect enrollment/randomization|0|||
42020882|NCT01238861|75828322|FG004|Overall Study|Incorrect enrollment/randomization|1|||
42020883|NCT01238861|75828323|FG005|Overall Study|Incorrect enrollment/randomization|0|||
42020884|NCT01238861|75828318|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
42020885|NCT01238861|75828319|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
42020886|NCT01238861|75828320|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
42020887|NCT01238861|75828321|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
42020888|NCT01238861|75828322|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
42020889|NCT01238861|75828323|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
42020890|NCT01238861|75828318|FG000|Overall Study|Subject moved out of state/area|0|||
42020891|NCT01238861|75828319|FG001|Overall Study|Subject moved out of state/area|0|||
42020892|NCT01238861|75828320|FG002|Overall Study|Subject moved out of state/area|1|||
42020893|NCT01238861|75828321|FG003|Overall Study|Subject moved out of state/area|1|||
42020894|NCT01238861|75828322|FG004|Overall Study|Subject moved out of state/area|0|||
42020895|NCT01238861|75828323|FG005|Overall Study|Subject moved out of state/area|0|||
42020896|NCT01238861|75828318|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
42020897|NCT01238861|75828319|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
42020898|NCT01238861|75828320|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
42020899|NCT01238861|75828321|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
42020900|NCT01238861|75828322|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
42020901|NCT01238861|75828323|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
42020902|NCT01238861|75828318|FG000|Overall Study|Personal problems|0|||
42020903|NCT01238861|75828319|FG001|Overall Study|Personal problems|0|||
42020904|NCT01238861|75828320|FG002|Overall Study|Personal problems|0|||
42020905|NCT01238861|75828321|FG003|Overall Study|Personal problems|1|||
42020906|NCT01238861|75828322|FG004|Overall Study|Personal problems|0|||
42020907|NCT01238861|75828323|FG005|Overall Study|Personal problems|0|||
42020908|NCT01238861|75828318|FG000|Overall Study|Unable to continue visits|0|||
42020909|NCT01238861|75828319|FG001|Overall Study|Unable to continue visits|0|||
42020910|NCT01238861|75828320|FG002|Overall Study|Unable to continue visits|0|||
42020911|NCT01238861|75828321|FG003|Overall Study|Unable to continue visits|1|||
42020912|NCT01238861|75828322|FG004|Overall Study|Unable to continue visits|0|||
42020913|NCT01238861|75828323|FG005|Overall Study|Unable to continue visits|1|||
42020914|NCT01238861|75828318|FG000|Overall Study|Serious adverse event|0|||
42020915|NCT01238861|75828319|FG001|Overall Study|Serious adverse event|0|||
42020916|NCT01238861|75828320|FG002|Overall Study|Serious adverse event|0|||
42020917|NCT01238861|75828321|FG003|Overall Study|Serious adverse event|0|||
42020918|NCT01238861|75828322|FG004|Overall Study|Serious adverse event|0|||
42020919|NCT01238861|75828323|FG005|Overall Study|Serious adverse event|1|||
42020920|NCT01238861|75828318|FG000|Overall Study|Lack of compliance|0|||
42020921|NCT01238861|75828319|FG001|Overall Study|Lack of compliance|0|||
42020922|NCT01238861|75828320|FG002|Overall Study|Lack of compliance|0|||
42020923|NCT01238861|75828321|FG003|Overall Study|Lack of compliance|0|||
42020924|NCT01238861|75828322|FG004|Overall Study|Lack of compliance|0|||
42020925|NCT01238861|75828323|FG005|Overall Study|Lack of compliance|1|||
42020926|NCT01238861|75828318|FG000|Overall Study|Adverse Event|0|||
42020927|NCT01238861|75828319|FG001|Overall Study|Adverse Event|1|||
42020928|NCT01238861|75828320|FG002|Overall Study|Adverse Event|0|||
42020929|NCT01238861|75828321|FG003|Overall Study|Adverse Event|0|||
42020930|NCT01238861|75828322|FG004|Overall Study|Adverse Event|0|||
42020931|NCT01238861|75828323|FG005|Overall Study|Adverse Event|0|||
42020932|NCT01238861|75828318|FG000|Overall Study|Withdrawal by Subject|6|||
42020933|NCT01238861|75828319|FG001|Overall Study|Withdrawal by Subject|5|||
42020934|NCT01238861|75828320|FG002|Overall Study|Withdrawal by Subject|4|||
42020935|NCT01238861|75828321|FG003|Overall Study|Withdrawal by Subject|8|||
42020936|NCT01238861|75828322|FG004|Overall Study|Withdrawal by Subject|10|||
42020937|NCT01238861|75828323|FG005|Overall Study|Withdrawal by Subject|9|||
42020938|NCT00903409|75828346|FG000|Overall Study|Adverse Event|11|||
42020939|NCT00903409|75828347|FG001|Overall Study|Adverse Event|9|||
42020940|NCT00903409|75828346|FG000|Overall Study|Non-compliance with Protocol|1|||
42020941|NCT00903409|75828347|FG001|Overall Study|Non-compliance with Protocol|1|||
42020942|NCT00903409|75828346|FG000|Overall Study|Laboratory Abnormality|2|||
42020943|NCT00903409|75828347|FG001|Overall Study|Laboratory Abnormality|0|||
42020944|NCT00903409|75828346|FG000|Overall Study|Withdrawal by Subject|8|||
42020945|NCT00903409|75828347|FG001|Overall Study|Withdrawal by Subject|8|||
42020946|NCT00903409|75828346|FG000|Overall Study|Other|2|||
42020947|NCT00903409|75828347|FG001|Overall Study|Other|3|||
42020948|NCT00903409|75828346|FG000|Overall Study|Lost to Follow-up|2|||
42020949|NCT00903409|75828347|FG001|Overall Study|Lost to Follow-up|6|||
42020950|NCT01237223|75828361|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
42020951|NCT01237223|75828362|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
42020952|NCT01237223|75828363|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
42020953|NCT01237223|75828364|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
42020954|NCT01237223|75828365|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
42020955|NCT01237223|75828366|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
42020956|NCT01237223|75828361|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
42020957|NCT01237223|75828362|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
42020958|NCT01237223|75828363|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
42020959|NCT01237223|75828364|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
42020960|NCT01237223|75828365|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
42020961|NCT01237223|75828366|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
42020962|NCT01237223|75828361|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
42020963|NCT01237223|75828362|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
42020964|NCT01237223|75828363|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
42020965|NCT01237223|75828364|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
42020966|NCT01237223|75828365|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
42020967|NCT01237223|75828366|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
42020968|NCT01237223|75828361|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
42020969|NCT01237223|75828362|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
42020970|NCT01237223|75828363|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
42020971|NCT01237223|75828364|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
42020972|NCT01237223|75828365|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
42020973|NCT01237223|75828366|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
42020974|NCT01237223|75828361|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
42020975|NCT01237223|75828362|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
42020976|NCT01237223|75828363|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
42036441|NCT01017120|75844852|FG000|Overall Study|Lost to Follow-up|13|||
42020977|NCT01237223|75828364|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
42020978|NCT01237223|75828365|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
42020979|NCT01237223|75828366|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
42020980|NCT01237223|75828361|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
42020981|NCT01237223|75828362|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
42020982|NCT01237223|75828363|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
42020983|NCT01237223|75828364|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
42020984|NCT01237223|75828365|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
42020985|NCT01237223|75828366|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
42020986|NCT01237223|75828361|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
42020987|NCT01237223|75828362|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
42020988|NCT01237223|75828363|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
42020989|NCT01237223|75828364|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
42020990|NCT01237223|75828365|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
42020991|NCT01237223|75828366|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
42020992|NCT01237223|75828361|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
42020993|NCT01237223|75828362|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
42020994|NCT01237223|75828363|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
42020995|NCT01237223|75828364|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
42020996|NCT01237223|75828365|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
42020997|NCT01237223|75828366|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
42020998|NCT01237223|75828361|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
42020999|NCT01237223|75828362|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
42021000|NCT01237223|75828363|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
42021001|NCT01237223|75828364|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
42021002|NCT01237223|75828365|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
42021003|NCT01237223|75828366|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
42021004|NCT01237223|75828361|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
42021005|NCT01237223|75828362|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
42021006|NCT01237223|75828363|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
42021007|NCT01237223|75828364|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
42021008|NCT01237223|75828365|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
42021009|NCT01237223|75828366|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
42021010|NCT01236755|75828382|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
42021011|NCT01236755|75828382|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
42021012|NCT01236755|75828382|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
42021013|NCT01236755|75828382|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
42021014|NCT01236365|75828389|FG000|Overall Study|Lost to Follow-up|0|||
42021015|NCT01236365|75828390|FG001|Overall Study|Lost to Follow-up|2|||
42021016|NCT01236365|75828389|FG000|Overall Study|Moved Out of State|1|||
42021017|NCT01236365|75828390|FG001|Overall Study|Moved Out of State|0|||
42021018|NCT01236365|75828389|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
42021019|NCT01236365|75828390|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
42021020|NCT01235975|75828410|FG000|Overall Study|Serious Adverse Event|0|||
42021021|NCT01235975|75828411|FG001|Overall Study|Serious Adverse Event|1|||
42021022|NCT01235975|75828410|FG000|Overall Study|Withdrawal by Subject|8|||
42021023|NCT01235975|75828411|FG001|Overall Study|Withdrawal by Subject|2|||
42021024|NCT01235975|75828410|FG000|Overall Study|Migrated/moved from study area|2|||
42021025|NCT01235975|75828411|FG001|Overall Study|Migrated/moved from study area|1|||
42021026|NCT01235975|75828410|FG000|Overall Study|Lost to Follow-up|7|||
42021027|NCT01235975|75828411|FG001|Overall Study|Lost to Follow-up|3|||
42021028|NCT00903331|75828419|FG000|Overall Study|Death|4|||
42021029|NCT00903331|75828420|FG001|Overall Study|Death|8|||
42021030|NCT00903331|75828419|FG000|Overall Study|Withdrawal of consent|1|||
42021031|NCT00903331|75828420|FG001|Overall Study|Withdrawal of consent|8|||
42021032|NCT00903331|75828419|FG000|Overall Study|Lung transplant|0|||
42021033|NCT00903331|75828420|FG001|Overall Study|Lung transplant|2|||
42021034|NCT01235741|75828429|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
42021035|NCT01235741|75828430|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
42021036|NCT01235741|75828431|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
42021037|NCT01235741|75828429|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
42021038|NCT01235741|75828430|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
42021039|NCT01235741|75828431|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
42021040|NCT01235741|75828429|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
42021041|NCT01235741|75828430|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
42036442|NCT01017120|75844853|FG001|Overall Study|Lost to Follow-up|11|||
42021042|NCT01235741|75828431|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
42021043|NCT01235741|75828429|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
42021044|NCT01235741|75828430|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
42021045|NCT01235741|75828431|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
42021046|NCT01235741|75828429|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
42021047|NCT01235741|75828430|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
42021048|NCT01235741|75828431|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
42021049|NCT01235741|75828429|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
42021050|NCT01235741|75828430|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
42021051|NCT01235741|75828431|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
42021052|NCT01235741|75828429|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
42021053|NCT01235741|75828430|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
42021054|NCT01235741|75828431|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
42021055|NCT01235741|75828429|FG000|Randomized to Treatment|Adverse Event|0|||
42021056|NCT01235741|75828430|FG001|Randomized to Treatment|Adverse Event|1|||
42021057|NCT01235741|75828431|FG002|Randomized to Treatment|Adverse Event|1|||
42021058|NCT01235741|75828429|FG000|Randomized to Treatment|Sponsor terminated study|0|||
42021059|NCT01235741|75828430|FG001|Randomized to Treatment|Sponsor terminated study|35|||
42021060|NCT01235741|75828431|FG002|Randomized to Treatment|Sponsor terminated study|34|||
42021061|NCT01235741|75828429|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
42021062|NCT01235741|75828430|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
42021063|NCT01235741|75828431|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
42021064|NCT01235741|75828429|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
42021065|NCT01235741|75828430|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
42021066|NCT01235741|75828431|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
42021067|NCT01235741|75828429|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
42021068|NCT01235741|75828430|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
42021069|NCT01235741|75828431|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
42021070|NCT01235507|75828443|FG000|Overall Study|Adverse Event|1|||
42021071|NCT01235507|75828443|FG000|Overall Study|Withdrawal by Subject|1|||
42021072|NCT01235351|75828449|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
42021073|NCT01235351|75828450|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
42021074|NCT01076205|75828460|FG000|Overall Study|Adverse Drug Reaction|299|||
42021075|NCT01076205|75828460|FG000|Overall Study|Lack of Effectiveness|1423|||
42021076|NCT01076205|75828460|FG000|Overall Study|Other Reason|1075|||
42021077|NCT01076205|75828460|FG000|Overall Study|Unknown Reason|71|||
42021078|NCT01076205|75828460|FG000|Overall Study|Lost to Follow-up|3151|||
42021079|NCT01234883|75828482|FG000|Overall Study|Early treatment release|8|||
42021080|NCT01234883|75828483|FG001|Overall Study|Early treatment release|10|||
42021081|NCT01234883|75828482|FG000|Overall Study|Parent/guardian withdrew consent|1|||
42021082|NCT01234883|75828483|FG001|Overall Study|Parent/guardian withdrew consent|2|||
42021083|NCT01234883|75828482|FG000|Overall Study|Technical difficulties with IV infusion|0|||
42021084|NCT01234883|75828483|FG001|Overall Study|Technical difficulties with IV infusion|1|||
42021085|NCT01234883|75828482|FG000|Overall Study|Inclusion/exclusion failure|1|||
42021086|NCT01234883|75828483|FG001|Overall Study|Inclusion/exclusion failure|0|||
42021087|NCT01234649|75828491|FG000|Overall Study|Withdrawal by Subject|32|||
42021088|NCT01234649|75828492|FG001|Overall Study|Withdrawal by Subject|26|||
42021089|NCT01234649|75828491|FG000|Overall Study|Pregnancy|6|||
42021090|NCT01234649|75828492|FG001|Overall Study|Pregnancy|6|||
42021091|NCT01234649|75828491|FG000|Overall Study|intolerant to side effects|4|||
42021092|NCT01234649|75828492|FG001|Overall Study|intolerant to side effects|3|||
42021093|NCT01234649|75828491|FG000|Overall Study|Allergic reaction|1|||
42021094|NCT01234649|75828492|FG001|Overall Study|Allergic reaction|0|||
42021095|NCT01234649|75828491|FG000|Overall Study|Lack of Efficacy|0|||
42021096|NCT01234649|75828492|FG001|Overall Study|Lack of Efficacy|3|||
42021097|NCT01075815|75828500|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
42021098|NCT01075815|75828501|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
42021099|NCT01075815|75828500|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
42021100|NCT01075815|75828501|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
42021101|NCT01075815|75828500|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
42021102|NCT01075815|75828501|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
42021103|NCT01075191|75828507|FG000|Overall Study|Death|1|||
42021104|NCT01075191|75828507|FG000|Overall Study|Intensification|3|||
42021105|NCT01075191|75828507|FG000|Overall Study|Co-morbidities|1|||
42021106|NCT01075191|75828507|FG000|Overall Study|Adverse Event|4|||
42021107|NCT01075191|75828507|FG000|Overall Study|Noncompliance|3|||
42021108|NCT01075191|75828507|FG000|Overall Study|Therapy Break|3|||
42021109|NCT01075191|75828507|FG000|Overall Study|Patient's Wish|2|||
42021110|NCT01075191|75828507|FG000|Overall Study|Unknown Reasons|1|||
42021111|NCT00905359|75828513|FG000|Overall Study|Lost to Follow-up|17|||
42021112|NCT00905359|75828514|FG001|Overall Study|Lost to Follow-up|10|||
42021113|NCT00905359|75828513|FG000|Overall Study|Death|2|||
42021114|NCT00905359|75828514|FG001|Overall Study|Death|0|||
42021115|NCT00905359|75828513|FG000|Overall Study|Withdrawal consent|5|||
42021116|NCT00905359|75828514|FG001|Overall Study|Withdrawal consent|6|||
42021117|NCT01072149|75828520|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021118|NCT01072149|75828521|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021119|NCT01072149|75828522|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
42021120|NCT01072149|75828523|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021121|NCT01072149|75828524|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021122|NCT01072149|75828525|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021123|NCT01072149|75828526|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021124|NCT01072149|75828527|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021125|NCT01072149|75828528|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021126|NCT01072149|75828529|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021127|NCT01072149|75828530|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021128|NCT01072149|75828531|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021129|NCT01072149|75828532|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021130|NCT01072149|75828533|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021131|NCT01072149|75828534|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021132|NCT01072149|75828535|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021133|NCT01072149|75828536|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021134|NCT01072149|75828537|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42021135|NCT01072149|75828520|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021136|NCT01072149|75828521|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021137|NCT01072149|75828522|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021138|NCT01072149|75828523|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021139|NCT01072149|75828524|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021140|NCT01072149|75828525|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021141|NCT01072149|75828526|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021142|NCT01072149|75828527|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021143|NCT01072149|75828528|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021144|NCT01072149|75828529|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021145|NCT01072149|75828530|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021146|NCT01072149|75828531|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021147|NCT01072149|75828532|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021148|NCT01072149|75828533|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021149|NCT01072149|75828534|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021150|NCT01072149|75828535|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021151|NCT01072149|75828536|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
42021152|NCT01072149|75828537|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
42021153|NCT01072149|75828520|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021154|NCT01072149|75828521|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021155|NCT01072149|75828522|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021156|NCT01072149|75828523|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021157|NCT01072149|75828524|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021158|NCT01072149|75828525|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021159|NCT01072149|75828526|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021160|NCT01072149|75828527|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021161|NCT01072149|75828528|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021162|NCT01072149|75828529|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021163|NCT01072149|75828530|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
42021164|NCT01072149|75828531|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021165|NCT01072149|75828532|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021166|NCT01072149|75828533|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021167|NCT01072149|75828534|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021168|NCT01072149|75828535|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021169|NCT01072149|75828536|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021170|NCT01072149|75828537|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42021171|NCT01072149|75828520|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021172|NCT01072149|75828521|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
42021173|NCT01072149|75828522|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021174|NCT01072149|75828523|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021175|NCT01072149|75828524|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021176|NCT01072149|75828525|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021177|NCT01072149|75828526|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021178|NCT01072149|75828527|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021179|NCT01072149|75828528|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021180|NCT01072149|75828529|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021181|NCT01072149|75828530|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42036443|NCT01017120|75844852|FG000|Overall Study|Lack of Efficacy|1|||
42021182|NCT01072149|75828531|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021183|NCT01072149|75828532|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021184|NCT01072149|75828533|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021185|NCT01072149|75828534|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021186|NCT01072149|75828535|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021187|NCT01072149|75828536|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021188|NCT01072149|75828537|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42021189|NCT01072149|75828520|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021190|NCT01072149|75828521|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021191|NCT01072149|75828522|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
42021192|NCT01072149|75828523|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021193|NCT01072149|75828524|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021194|NCT01072149|75828525|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021195|NCT01072149|75828526|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021196|NCT01072149|75828527|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021197|NCT01072149|75828528|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021198|NCT01072149|75828529|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021199|NCT01072149|75828530|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021200|NCT01072149|75828531|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021201|NCT01072149|75828532|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021202|NCT01072149|75828533|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021203|NCT01072149|75828534|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021204|NCT01072149|75828535|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021205|NCT01072149|75828536|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021206|NCT01072149|75828537|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42021207|NCT01072149|75828520|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021208|NCT01072149|75828521|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021209|NCT01072149|75828522|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021210|NCT01072149|75828523|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021211|NCT01072149|75828524|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021212|NCT01072149|75828525|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021213|NCT01072149|75828526|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021214|NCT01072149|75828527|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
42021215|NCT01072149|75828528|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021216|NCT01072149|75828529|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021217|NCT01072149|75828530|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021218|NCT01072149|75828531|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021219|NCT01072149|75828532|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021220|NCT01072149|75828533|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021221|NCT01072149|75828534|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021222|NCT01072149|75828535|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021223|NCT01072149|75828536|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021224|NCT01072149|75828537|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
42021225|NCT01072149|75828520|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
42021226|NCT01072149|75828521|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
42021227|NCT01072149|75828522|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
42021228|NCT01072149|75828523|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
42021229|NCT01072149|75828524|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
42021230|NCT01072149|75828525|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
42021231|NCT01072149|75828526|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
42021232|NCT01072149|75828527|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
42021233|NCT01072149|75828528|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
42021234|NCT01072149|75828529|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
42021235|NCT01072149|75828530|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
42021236|NCT01072149|75828531|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
42021237|NCT01072149|75828532|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
42021238|NCT01072149|75828533|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
42021239|NCT01072149|75828534|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
42021240|NCT01072149|75828535|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
42021241|NCT01072149|75828536|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
42021242|NCT01072149|75828537|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
42021243|NCT01072149|75828520|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021244|NCT01072149|75828521|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021245|NCT01072149|75828522|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021246|NCT01072149|75828523|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021247|NCT01072149|75828524|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021248|NCT01072149|75828525|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021249|NCT01072149|75828526|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021250|NCT01072149|75828527|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021251|NCT01072149|75828528|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021252|NCT01072149|75828529|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021253|NCT01072149|75828530|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021254|NCT01072149|75828531|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021255|NCT01072149|75828532|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021256|NCT01072149|75828533|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021257|NCT01072149|75828534|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021258|NCT01072149|75828535|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
42021259|NCT01072149|75828536|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021260|NCT01072149|75828537|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
42021261|NCT01072149|75828520|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
42021262|NCT01072149|75828521|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
42113499|NCT04270760|75923797|FG000|Overall Study|Withdrawal by Subject|0|||
42113500|NCT04270760|75923798|FG001|Overall Study|Withdrawal by Subject|1|||
42113501|NCT04270760|75923799|FG002|Overall Study|Withdrawal by Subject|3|||
42113502|NCT04270760|75923800|FG003|Overall Study|Withdrawal by Subject|0|||
42113503|NCT04270760|75923801|FG004|Overall Study|Withdrawal by Subject|0|||
42113504|NCT04270760|75923797|FG000|Overall Study|Lost to Follow-up|1|||
42113505|NCT04270760|75923798|FG001|Overall Study|Lost to Follow-up|2|||
42113506|NCT04270760|75923799|FG002|Overall Study|Lost to Follow-up|1|||
42113507|NCT04270760|75923800|FG003|Overall Study|Lost to Follow-up|0|||
42113508|NCT04270760|75923801|FG004|Overall Study|Lost to Follow-up|0|||
42113509|NCT04270760|75923797|FG000|Overall Study|Death|0|||
42113510|NCT04270760|75923798|FG001|Overall Study|Death|0|||
42113511|NCT04270760|75923799|FG002|Overall Study|Death|0|||
42113512|NCT04270760|75923800|FG003|Overall Study|Death|0|||
42113513|NCT04270760|75923801|FG004|Overall Study|Death|1|||
42113514|NCT04198363|75923820|FG000|Overall Study|Adverse Event|1|||
42113515|NCT04198363|75923821|FG001|Overall Study|Adverse Event|1|||
42113516|NCT04198363|75923820|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
42113517|NCT04198363|75923821|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
42113518|NCT04198363|75923820|FG000|Overall Study|Reason not Specified|1|||
42113519|NCT04198363|75923821|FG001|Overall Study|Reason not Specified|0|||
42113520|NCT04173247|75923829|FG000|Overall Study|Withdrawal by Subject|0|||
42113521|NCT04173247|75923830|FG001|Overall Study|Withdrawal by Subject|2|||
42113522|NCT04173247|75923829|FG000|Overall Study|Death|1|||
42113523|NCT04173247|75923830|FG001|Overall Study|Death|0|||
42113524|NCT04173247|75923829|FG000|Overall Study|Physician Decision|1|||
42113525|NCT04173247|75923830|FG001|Overall Study|Physician Decision|0|||
42113526|NCT03943446|75923843|FG000|Overall Study|Lost to Follow-up|0|||
42113527|NCT03943446|75923844|FG001|Overall Study|Lost to Follow-up|0|||
42113528|NCT03943446|75923845|FG002|Overall Study|Lost to Follow-up|1|||
42113529|NCT03943446|75923843|FG000|Overall Study|Withdrawal by Subject|1|||
42113530|NCT03943446|75923844|FG001|Overall Study|Withdrawal by Subject|1|||
42113531|NCT03943446|75923845|FG002|Overall Study|Withdrawal by Subject|2|||
42113532|NCT03943446|75923843|FG000|Overall Study|Study Terminated by Sponsor|1|||
42113533|NCT03943446|75923844|FG001|Overall Study|Study Terminated by Sponsor|2|||
42113534|NCT03943446|75923845|FG002|Overall Study|Study Terminated by Sponsor|1|||
42113535|NCT03943446|75923843|FG000|Overall Study|Reason not Specified|5|||
42113536|NCT03943446|75923844|FG001|Overall Study|Reason not Specified|1|||
42113537|NCT03943446|75923845|FG002|Overall Study|Reason not Specified|3|||
42113538|NCT03632993|75923922|FG000|Overall Study|Withdrawal by Subject|1|||
42113539|NCT03632993|75923923|FG001|Overall Study|Withdrawal by Subject|0|||
42113540|NCT03632993|75923924|FG002|Overall Study|Withdrawal by Subject|0|||
42113541|NCT03632993|75923925|FG003|Overall Study|Withdrawal by Subject|0|||
42113542|NCT03632993|75923926|FG004|Overall Study|Withdrawal by Subject|0|||
42113543|NCT03632993|75923927|FG005|Overall Study|Withdrawal by Subject|0|||
42113544|NCT03632993|75923928|FG006|Overall Study|Withdrawal by Subject|0|||
42113545|NCT03632993|75923929|FG007|Overall Study|Withdrawal by Subject|0|||
42113546|NCT03632993|75923930|FG008|Overall Study|Withdrawal by Subject|0|||
42113547|NCT03632993|75923931|FG009|Overall Study|Withdrawal by Subject|1|||
42113548|NCT03632993|75923922|FG000|Overall Study|Protocol Non-compliance|0|||
42113549|NCT03632993|75923923|FG001|Overall Study|Protocol Non-compliance|1|||
42113550|NCT03632993|75923924|FG002|Overall Study|Protocol Non-compliance|0|||
42113551|NCT03632993|75923925|FG003|Overall Study|Protocol Non-compliance|0|||
42113552|NCT03632993|75923926|FG004|Overall Study|Protocol Non-compliance|0|||
42206495|NCT03382041|76019434|FG001|Overall Study|Lost to Follow-up|4|||
42299676|NCT01358981|76134637|FG005|Period 1|Withdrawal by Subject|0|||
42113553|NCT03632993|75923927|FG005|Overall Study|Protocol Non-compliance|0|||
42113554|NCT03632993|75923928|FG006|Overall Study|Protocol Non-compliance|0|||
42113555|NCT03632993|75923929|FG007|Overall Study|Protocol Non-compliance|0|||
42113556|NCT03632993|75923930|FG008|Overall Study|Protocol Non-compliance|0|||
42113557|NCT03632993|75923931|FG009|Overall Study|Protocol Non-compliance|0|||
42113558|NCT03632993|75923922|FG000|Overall Study|Lost to Follow-up|0|||
42113559|NCT03632993|75923923|FG001|Overall Study|Lost to Follow-up|0|||
42113560|NCT03632993|75923924|FG002|Overall Study|Lost to Follow-up|0|||
42113561|NCT03632993|75923925|FG003|Overall Study|Lost to Follow-up|0|||
42113562|NCT03632993|75923926|FG004|Overall Study|Lost to Follow-up|0|||
42113563|NCT03632993|75923927|FG005|Overall Study|Lost to Follow-up|1|||
42113564|NCT03632993|75923928|FG006|Overall Study|Lost to Follow-up|0|||
42113565|NCT03632993|75923929|FG007|Overall Study|Lost to Follow-up|1|||
42113566|NCT03632993|75923930|FG008|Overall Study|Lost to Follow-up|0|||
42113567|NCT03632993|75923931|FG009|Overall Study|Lost to Follow-up|0|||
42113568|NCT03632993|75923922|FG000|Overall Study|Adverse Event|0|||
42113569|NCT03632993|75923923|FG001|Overall Study|Adverse Event|0|||
42113570|NCT03632993|75923924|FG002|Overall Study|Adverse Event|0|||
42113571|NCT03632993|75923925|FG003|Overall Study|Adverse Event|0|||
42113572|NCT03632993|75923926|FG004|Overall Study|Adverse Event|0|||
42113573|NCT03632993|75923927|FG005|Overall Study|Adverse Event|1|||
42113574|NCT03632993|75923928|FG006|Overall Study|Adverse Event|0|||
42113575|NCT03632993|75923929|FG007|Overall Study|Adverse Event|1|||
42113576|NCT03632993|75923930|FG008|Overall Study|Adverse Event|0|||
42113577|NCT03632993|75923931|FG009|Overall Study|Adverse Event|0|||
42113582|NCT03493282|75923960|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
42113583|NCT03493282|75923961|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
42113584|NCT03493282|75923962|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
42113585|NCT03493282|75923960|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
42113586|NCT03493282|75923961|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
42113587|NCT03493282|75923962|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
42113588|NCT02998203|75924015|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
42113589|NCT02998203|75924016|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
42113590|NCT02998203|75924015|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
42113591|NCT02998203|75924016|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
42299677|NCT01358981|76134638|FG006|Period 1|Withdrawal by Subject|0|||
42299678|NCT02548585|76134670|FG000|Overall Study|Withdrawal by Subject|0|||
42299679|NCT02548585|76134671|FG001|Overall Study|Withdrawal by Subject|0|||
42299680|NCT02548585|76134672|FG002|Overall Study|Withdrawal by Subject|0|||
42299681|NCT02548585|76134673|FG003|Overall Study|Withdrawal by Subject|0|||
42299682|NCT02548585|76134674|FG004|Overall Study|Withdrawal by Subject|0|||
42299683|NCT02548585|76134675|FG005|Overall Study|Withdrawal by Subject|1|||
42299684|NCT02548585|76134676|FG006|Overall Study|Withdrawal by Subject|0|||
42299685|NCT02548585|76134670|FG000|Overall Study|Lost to Follow-up|1|||
42299686|NCT02548585|76134671|FG001|Overall Study|Lost to Follow-up|0|||
42299687|NCT02548585|76134672|FG002|Overall Study|Lost to Follow-up|0|||
42299688|NCT02548585|76134673|FG003|Overall Study|Lost to Follow-up|0|||
42299689|NCT02548585|76134674|FG004|Overall Study|Lost to Follow-up|0|||
42299690|NCT02548585|76134675|FG005|Overall Study|Lost to Follow-up|0|||
42113606|NCT02873338|75924051|FG000|Overall Study|Adverse Event|0|||
42113607|NCT02873338|75924052|FG001|Overall Study|Adverse Event|2|||
42113608|NCT02873338|75924053|FG002|Overall Study|Adverse Event|1|||
42113609|NCT02873338|75924051|FG000|Overall Study|Death|2|||
42113610|NCT02873338|75924052|FG001|Overall Study|Death|1|||
42113611|NCT02873338|75924053|FG002|Overall Study|Death|1|||
42113612|NCT02873338|75924051|FG000|Overall Study|Withdrawal by Subject|2|||
42113613|NCT02873338|75924052|FG001|Overall Study|Withdrawal by Subject|1|||
42113614|NCT02873338|75924053|FG002|Overall Study|Withdrawal by Subject|3|||
42113615|NCT02873338|75924051|FG000|Overall Study|Lack of Efficacy|0|||
42113616|NCT02873338|75924052|FG001|Overall Study|Lack of Efficacy|2|||
42113617|NCT02873338|75924053|FG002|Overall Study|Lack of Efficacy|0|||
42113618|NCT02873338|75924051|FG000|Overall Study|Other or Missing|14|||
42113619|NCT02873338|75924052|FG001|Overall Study|Other or Missing|15|||
42113620|NCT02873338|75924053|FG002|Overall Study|Other or Missing|13|||
42113621|NCT02725567|75924068|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
42113622|NCT02725567|75924069|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
42113623|NCT02725567|75924068|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
42113624|NCT02725567|75924069|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
42113625|NCT02725567|75924068|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
42113626|NCT02725567|75924069|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
42113627|NCT02108964|75924101|FG000|Overall Study|Progressive disease|12|||
42206496|NCT03351231|76019440|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
42299691|NCT02548585|76134676|FG006|Overall Study|Lost to Follow-up|0|||
42113628|NCT02108964|75924102|FG001|Overall Study|Progressive disease|25|||
42113629|NCT02108964|75924103|FG002|Overall Study|Progressive disease|50|||
42113630|NCT02108964|75924104|FG003|Overall Study|Progressive disease|6|||
42113631|NCT02108964|75924105|FG004|Overall Study|Progressive disease|18|||
42113632|NCT02108964|75924106|FG005|Overall Study|Progressive disease|5|||
42113633|NCT02108964|75924107|FG006|Overall Study|Progressive disease|7|||
42113634|NCT02108964|75924108|FG007|Overall Study|Progressive disease|9|||
42113635|NCT02108964|75924101|FG000|Overall Study|Physician Decision|1|||
42113636|NCT02108964|75924102|FG001|Overall Study|Physician Decision|5|||
42113637|NCT02108964|75924103|FG002|Overall Study|Physician Decision|6|||
42113638|NCT02108964|75924104|FG003|Overall Study|Physician Decision|0|||
42113639|NCT02108964|75924105|FG004|Overall Study|Physician Decision|1|||
42113640|NCT02108964|75924106|FG005|Overall Study|Physician Decision|0|||
42113641|NCT02108964|75924107|FG006|Overall Study|Physician Decision|0|||
42113642|NCT02108964|75924108|FG007|Overall Study|Physician Decision|0|||
42113643|NCT02108964|75924101|FG000|Overall Study|Adverse Event|0|||
42113644|NCT02108964|75924102|FG001|Overall Study|Adverse Event|0|||
42113645|NCT02108964|75924103|FG002|Overall Study|Adverse Event|4|||
42113646|NCT02108964|75924104|FG003|Overall Study|Adverse Event|0|||
42113647|NCT02108964|75924105|FG004|Overall Study|Adverse Event|1|||
42113648|NCT02108964|75924106|FG005|Overall Study|Adverse Event|0|||
42113649|NCT02108964|75924107|FG006|Overall Study|Adverse Event|3|||
42113650|NCT02108964|75924108|FG007|Overall Study|Adverse Event|1|||
42113651|NCT02108964|75924101|FG000|Overall Study|Death|1|||
42113652|NCT02108964|75924102|FG001|Overall Study|Death|1|||
42113653|NCT02108964|75924103|FG002|Overall Study|Death|2|||
42113654|NCT02108964|75924104|FG003|Overall Study|Death|0|||
42113655|NCT02108964|75924105|FG004|Overall Study|Death|3|||
42113656|NCT02108964|75924106|FG005|Overall Study|Death|0|||
42113657|NCT02108964|75924107|FG006|Overall Study|Death|0|||
42113658|NCT02108964|75924108|FG007|Overall Study|Death|1|||
42113659|NCT02108964|75924101|FG000|Overall Study|Subject/Guardian decision|0|||
42113660|NCT02108964|75924102|FG001|Overall Study|Subject/Guardian decision|1|||
42113661|NCT02108964|75924103|FG002|Overall Study|Subject/Guardian decision|3|||
42113662|NCT02108964|75924104|FG003|Overall Study|Subject/Guardian decision|0|||
42113663|NCT02108964|75924105|FG004|Overall Study|Subject/Guardian decision|2|||
42113664|NCT02108964|75924106|FG005|Overall Study|Subject/Guardian decision|0|||
42113665|NCT02108964|75924107|FG006|Overall Study|Subject/Guardian decision|1|||
42113666|NCT02108964|75924108|FG007|Overall Study|Subject/Guardian decision|1|||
42113667|NCT01909453|75924132|FG000|Overall Study|Ongoing|118|||
42113668|NCT01909453|75924133|FG001|Overall Study|Ongoing|103|||
42113669|NCT01909453|75924134|FG002|Overall Study|Ongoing|83|||
42113670|NCT01909453|75924135|FG003|Overall Study|Ongoing|164|||
42113671|NCT01909453|75924136|FG004|Overall Study|Ongoing|50|||
42113672|NCT01909453|75924132|FG000|Overall Study|Death|69|||
42113673|NCT01909453|75924133|FG001|Overall Study|Death|74|||
42113674|NCT01909453|75924134|FG002|Overall Study|Death|88|||
42113675|NCT01909453|75924135|FG003|Overall Study|Death|86|||
42113676|NCT01909453|75924136|FG004|Overall Study|Death|29|||
42113677|NCT01909453|75924132|FG000|Overall Study|Lost to Follow-up|3|||
42113678|NCT01909453|75924133|FG001|Overall Study|Lost to Follow-up|4|||
42113679|NCT01909453|75924134|FG002|Overall Study|Lost to Follow-up|4|||
42113680|NCT01909453|75924135|FG003|Overall Study|Lost to Follow-up|3|||
42113681|NCT01909453|75924136|FG004|Overall Study|Lost to Follow-up|3|||
42113682|NCT01909453|75924132|FG000|Overall Study|Withdrawal by Subject|2|||
42113683|NCT01909453|75924133|FG001|Overall Study|Withdrawal by Subject|13|||
42113684|NCT01909453|75924134|FG002|Overall Study|Withdrawal by Subject|16|||
42113685|NCT01909453|75924135|FG003|Overall Study|Withdrawal by Subject|5|||
42113686|NCT01909453|75924136|FG004|Overall Study|Withdrawal by Subject|4|||
42113687|NCT01882803|75924154|FG000|Overall Study|Disease Progression|1|||
42113688|NCT01882803|75924154|FG000|Overall Study|Withdrawal by Subject|9|||
42113689|NCT01882803|75924154|FG000|Overall Study|Death|68|||
42113690|NCT01882803|75924154|FG000|Overall Study|Physician Decision|3|||
42113691|NCT01882803|75924154|FG000|Overall Study|Lost to Follow-up|3|||
42113692|NCT01882803|75924154|FG000|Overall Study|Follow-up Completed|39|||
42113693|NCT01882803|75924154|FG000|Overall Study|Study Terminated by the Sponsor|6|||
42113694|NCT01196390|75924165|FG000|Overall Study|Protocol Violation|4|||
42113695|NCT01196390|75924166|FG001|Overall Study|Protocol Violation|5|||
42113696|NCT00659126|75924189|FG000|Overall Study|Adverse Event|2|||
42113697|NCT00659126|75924190|FG001|Overall Study|Adverse Event|2|||
42113698|NCT00659126|75924189|FG000|Overall Study|Screen failure|1|||
42113699|NCT00659126|75924190|FG001|Overall Study|Screen failure|1|||
42113700|NCT00659126|75924189|FG000|Overall Study|Technical problems with MRI|0|||
42113701|NCT00659126|75924190|FG001|Overall Study|Technical problems with MRI|1|||
42113702|NCT00152503|75924221|FG000|Overall Study|Adverse Event|4|||
42113703|NCT03865407|75924227|FG000|Overall Study|Adverse Event|1|||
42113704|NCT03865407|75924228|FG001|Overall Study|Adverse Event|0|||
42113705|NCT03865407|75924227|FG000|Overall Study|Withdrawal by Subject|1|||
42113706|NCT03865407|75924228|FG001|Overall Study|Withdrawal by Subject|0|||
42113707|NCT03865407|75924227|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
42113708|NCT03865407|75924228|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
42113709|NCT00487942|75924238|FG000|Overall Study|Adverse Event|1|||
42113710|NCT00487942|75924239|FG001|Overall Study|Adverse Event|1|||
42113711|NCT00487942|75924240|FG002|Overall Study|Adverse Event|1|||
42113712|NCT00487942|75924241|FG003|Overall Study|Adverse Event|1|||
42113713|NCT00487942|75924238|FG000|Overall Study|Lost to Follow-up|1|||
42113714|NCT00487942|75924239|FG001|Overall Study|Lost to Follow-up|0|||
42113715|NCT00487942|75924240|FG002|Overall Study|Lost to Follow-up|0|||
42113716|NCT00487942|75924241|FG003|Overall Study|Lost to Follow-up|1|||
42113717|NCT00487942|75924238|FG000|Overall Study|Protocol Violation|1|||
42113718|NCT00487942|75924239|FG001|Overall Study|Protocol Violation|1|||
42113719|NCT00487942|75924240|FG002|Overall Study|Protocol Violation|0|||
42113720|NCT00487942|75924241|FG003|Overall Study|Protocol Violation|0|||
42113721|NCT00487942|75924238|FG000|Overall Study|Withdrawal by Subject|0|||
42113722|NCT00487942|75924239|FG001|Overall Study|Withdrawal by Subject|1|||
42113723|NCT00487942|75924240|FG002|Overall Study|Withdrawal by Subject|2|||
42113724|NCT00487942|75924241|FG003|Overall Study|Withdrawal by Subject|0|||
42113725|NCT00132301|75924253|FG000|Overall Study|Death|7|||
42113726|NCT00132301|75924254|FG001|Overall Study|Death|6|||
42113727|NCT00132301|75924253|FG000|Overall Study|Withdrawal by Subject|5|||
42113728|NCT00132301|75924254|FG001|Overall Study|Withdrawal by Subject|2|||
42113729|NCT00132301|75924253|FG000|Overall Study|Physician Decision|1|||
42113730|NCT00132301|75924254|FG001|Overall Study|Physician Decision|1|||
42113731|NCT00132301|75924253|FG000|Overall Study|Lost to Follow-up|5|||
42113732|NCT00132301|75924254|FG001|Overall Study|Lost to Follow-up|3|||
42113733|NCT00132301|75924253|FG000|Overall Study|Other|1|||
42113734|NCT00132301|75924254|FG001|Overall Study|Other|1|||
42113735|NCT00132301|75924253|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
42113736|NCT00132301|75924254|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
42113737|NCT00522873|75924262|FG000|Overall Study|Adverse Event|41|||
42113738|NCT00522873|75924263|FG001|Overall Study|Adverse Event|26|||
42113739|NCT00522873|75924262|FG000|Overall Study|Withdrawal by Subject|20|||
42206497|NCT03351231|76019440|FG000|Combination Therapy Period|Disease progression|2|||
42206498|NCT03351231|76019440|FG000|Combination Therapy Period|Study drug toxicity|1|||
42206499|NCT03351231|76019440|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
42206500|NCT03351231|76019440|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
42206501|NCT03351231|76019440|FG000|Safety Follow-Up Period|Other reason|2|||
42206502|NCT03381339|76019446|FG000|Overall Study|Protocol Violation|4|||
42206503|NCT03381339|76019447|FG001|Overall Study|Protocol Violation|3|||
42206504|NCT03381339|76019446|FG000|Overall Study|Lost to Follow-up|0|||
42206505|NCT03381339|76019447|FG001|Overall Study|Lost to Follow-up|1|||
42206506|NCT03401229|76019455|FG000|Overall Study|Lost to Follow-up|2|||
42206507|NCT03401229|76019456|FG001|Overall Study|Lost to Follow-up|1|||
42206508|NCT03401229|76019455|FG000|Overall Study|Other|1|||
42206509|NCT03401229|76019456|FG001|Overall Study|Other|3|||
42206510|NCT03401229|76019455|FG000|Overall Study|Adverse Event|8|||
42206511|NCT03401229|76019456|FG001|Overall Study|Adverse Event|6|||
42206512|NCT03401229|76019455|FG000|Overall Study|Withdrawal by Subject|29|||
42206513|NCT03401229|76019456|FG001|Overall Study|Withdrawal by Subject|26|||
42206514|NCT03401229|76019455|FG000|Overall Study|COVID-19|0|||
42206515|NCT03401229|76019456|FG001|Overall Study|COVID-19|1|||
42206516|NCT03349515|76019464|FG000|Overall Study|Lack of Efficacy|2|||
42206517|NCT03349515|76019465|FG001|Overall Study|Lack of Efficacy|0|||
42206518|NCT03349515|76019464|FG000|Overall Study|Physician Decision|3|||
42206519|NCT03349515|76019465|FG001|Overall Study|Physician Decision|1|||
42206520|NCT03349437|76019471|FG000|Screening|Screen Fail|4|||
42206521|NCT03349437|76019472|FG001|Screening|Screen Fail|0|||
42206522|NCT03349437|76019473|FG002|Screening|Screen Fail|0|||
42206523|NCT03349437|76019471|FG000|Screening|Withdrawn|1|||
42206524|NCT03349437|76019472|FG001|Screening|Withdrawn|0|||
42206525|NCT03349437|76019473|FG002|Screening|Withdrawn|0|||
42206526|NCT03380091|76019482|FG000|Overall Study|Withdrawal by Subject|2|||
42206527|NCT03380091|76019483|FG001|Overall Study|Withdrawal by Subject|1|||
42206528|NCT03379233|76019493|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
42206529|NCT03379233|76019494|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
42206530|NCT01377922|76019502|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
42206531|NCT01377922|76019503|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
42206532|NCT03372603|76019509|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
42206533|NCT03372603|76019510|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
42206534|NCT03372603|76019509|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
42206535|NCT03372603|76019510|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
42206536|NCT01377844|76019518|FG000|Overall Study|Withdrawal by Subject|25|||
42206537|NCT01377844|76019519|FG001|Overall Study|Withdrawal by Subject|28|||
42206538|NCT01377844|76019518|FG000|Overall Study|Protocol Violation|2|||
42206539|NCT01377844|76019519|FG001|Overall Study|Protocol Violation|3|||
42206540|NCT01377844|76019518|FG000|Overall Study|Adverse Event|3|||
42206541|NCT01377844|76019519|FG001|Overall Study|Adverse Event|0|||
42206542|NCT01377844|76019518|FG000|Overall Study|Physician Decision|6|||
42113740|NCT00522873|75924263|FG001|Overall Study|Withdrawal by Subject|9|||
42113741|NCT00522873|75924262|FG000|Overall Study|Protocol Violation|14|||
42113742|NCT00522873|75924263|FG001|Overall Study|Protocol Violation|4|||
42206543|NCT01377844|76019519|FG001|Overall Study|Physician Decision|3|||
42206544|NCT01377844|76019518|FG000|Overall Study|Study terminated by Sponsor|0|||
42206545|NCT01377844|76019519|FG001|Overall Study|Study terminated by Sponsor|1|||
42206546|NCT03372369|76019528|FG000|Qualification Period|Withdrawal by Subject|16|||
42206547|NCT03372369|76019529|FG001|Qualification Period|Withdrawal by Subject|13|||
42206548|NCT03372369|76019528|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
42206549|NCT03372369|76019529|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
42206550|NCT03372369|76019528|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
42206551|NCT03372369|76019529|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
42206552|NCT03371355|76019539|FG000|Overall Study|Investigator judgment|0|||
42206553|NCT03371355|76019540|FG001|Overall Study|Investigator judgment|0|||
42206554|NCT03371355|76019541|FG002|Overall Study|Investigator judgment|1|||
42206555|NCT03371355|76019542|FG003|Overall Study|Investigator judgment|1|||
42206556|NCT03371355|76019539|FG000|Overall Study|Voluntary withdrawal|1|||
42206557|NCT03371355|76019540|FG001|Overall Study|Voluntary withdrawal|0|||
42206558|NCT03371355|76019541|FG002|Overall Study|Voluntary withdrawal|1|||
42206559|NCT03371355|76019542|FG003|Overall Study|Voluntary withdrawal|2|||
42206560|NCT03371355|76019539|FG000|Overall Study|Adverse Event|0|||
42206561|NCT03371355|76019540|FG001|Overall Study|Adverse Event|1|||
42206562|NCT03371355|76019541|FG002|Overall Study|Adverse Event|2|||
42206563|NCT03371355|76019542|FG003|Overall Study|Adverse Event|3|||
42206564|NCT03371355|76019539|FG000|Overall Study|Reason not Specified|0|||
42206565|NCT03371355|76019540|FG001|Overall Study|Reason not Specified|1|||
42206566|NCT03371355|76019541|FG002|Overall Study|Reason not Specified|0|||
42206567|NCT03371355|76019542|FG003|Overall Study|Reason not Specified|1|||
42206568|NCT03370419|76019556|FG000|Overall Study|Lost to Follow-up|16|||
42206569|NCT03369951|76019564|FG000|Overall Study|Withdrawal by Subject|3|||
42206570|NCT03369951|76019564|FG000|Overall Study|Death|1|||
42206571|NCT03369951|76019564|FG000|Overall Study|Lost to Follow-up|1|||
42206572|NCT03369951|76019564|FG000|Overall Study|Protocol Violation|1|||
42206573|NCT04040192|76019568|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
42206574|NCT04040192|76019569|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
42206575|NCT04040192|76019570|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
42206576|NCT04040192|76019568|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
42206577|NCT04040192|76019569|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
42206578|NCT04040192|76019570|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
42206579|NCT04040192|76019568|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
42206580|NCT04040192|76019569|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
42206581|NCT04040192|76019570|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
42206582|NCT04040192|76019568|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
42206583|NCT04040192|76019569|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
42206584|NCT04040192|76019570|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
42206585|NCT04040192|76019568|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
42206586|NCT04040192|76019569|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
42206587|NCT04040192|76019570|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
42206588|NCT04040192|76019568|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
42206589|NCT04040192|76019569|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
42206590|NCT04040192|76019570|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
42206591|NCT04040192|76019568|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
42206592|NCT04040192|76019569|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
42206593|NCT04040192|76019570|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
42206594|NCT04040192|76019568|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
42206595|NCT04040192|76019569|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
42206596|NCT04040192|76019570|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
42206597|NCT04040192|76019568|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
42206598|NCT04040192|76019569|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
42206599|NCT04040192|76019570|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
42206600|NCT04040192|76019568|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
42206601|NCT04040192|76019569|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
42206602|NCT04040192|76019570|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
42206603|NCT04040192|76019568|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
42206604|NCT04040192|76019569|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
42206605|NCT04040192|76019570|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
42206606|NCT04040192|76019568|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
42206607|NCT04040192|76019569|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
42206608|NCT04040192|76019570|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
42206609|NCT04040192|76019568|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
42206610|NCT04040192|76019569|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
42206611|NCT04040192|76019570|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
42206612|NCT04040192|76019568|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
42206613|NCT04040192|76019569|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
42206614|NCT04040192|76019570|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
42206615|NCT04040192|76019568|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
42206616|NCT04040192|76019569|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
42206617|NCT04040192|76019570|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
42206618|NCT04040192|76019568|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
42206619|NCT04040192|76019569|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
42206620|NCT04040192|76019570|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
42206621|NCT04040192|76019568|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
42206622|NCT04040192|76019569|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
42206623|NCT04040192|76019570|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
42206624|NCT03368859|76019594|FG000|Overall Study|Withdrew Consent|5|||
42206625|NCT03368859|76019595|FG001|Overall Study|Withdrew Consent|4|||
42206626|NCT03368859|76019594|FG000|Overall Study|Death|12|||
42206627|NCT03368859|76019595|FG001|Overall Study|Death|6|||
42206628|NCT03368859|76019594|FG000|Overall Study|Study terminated by Sponsor|18|||
42206629|NCT03368859|76019595|FG001|Overall Study|Study terminated by Sponsor|23|||
42206630|NCT03368859|76019594|FG000|Overall Study|Other|1|||
42206631|NCT03368859|76019595|FG001|Overall Study|Other|1|||
42206632|NCT03096314|76019609|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
42206633|NCT03096314|76019610|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
42206634|NCT03335163|76019616|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
42206635|NCT03335163|76019616|FG000|Overall Study|Withdrawal by Subject|18|||
42206636|NCT03364335|76019642|FG000|Overall Study|Adverse Event|3|||
42206637|NCT03364335|76019643|FG001|Overall Study|Adverse Event|4|||
42206638|NCT03364335|76019644|FG002|Overall Study|Adverse Event|1|||
42206639|NCT03364335|76019645|FG003|Overall Study|Adverse Event|2|||
42206640|NCT03364335|76019646|FG004|Overall Study|Adverse Event|0|||
42206641|NCT03364335|76019642|FG000|Overall Study|Lost to Follow-up|7|||
42206642|NCT03364335|76019643|FG001|Overall Study|Lost to Follow-up|7|||
42206643|NCT03364335|76019644|FG002|Overall Study|Lost to Follow-up|10|||
42206644|NCT03364335|76019645|FG003|Overall Study|Lost to Follow-up|11|||
42206645|NCT03364335|76019646|FG004|Overall Study|Lost to Follow-up|11|||
42206646|NCT03334695|76019669|FG000|Overall Study|Lost to Follow-up|3|||
42206647|NCT03334695|76019670|FG001|Overall Study|Lost to Follow-up|3|||
42206648|NCT03334695|76019669|FG000|Overall Study|Physician Decision|1|||
42206649|NCT03334695|76019670|FG001|Overall Study|Physician Decision|2|||
42206650|NCT03334695|76019669|FG000|Overall Study|Protocol Violation|0|||
42206651|NCT03334695|76019670|FG001|Overall Study|Protocol Violation|1|||
42206652|NCT03364023|76019678|FG000|Overall Study|Lost to Follow-up|3|||
42206653|NCT03364023|76019678|FG000|Overall Study|Death|14|||
42206654|NCT03764813|76019702|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
42206655|NCT03764813|76019703|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
42206656|NCT03764813|76019704|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
42206657|NCT03764813|76019705|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
42206658|NCT03363321|76019726|FG000|Overall Study|Withdrawal by Subject|0|||
42206659|NCT03363321|76019727|FG001|Overall Study|Withdrawal by Subject|1|||
42206660|NCT03363321|76019728|FG002|Overall Study|Withdrawal by Subject|0|||
42206661|NCT03363321|76019729|FG003|Overall Study|Withdrawal by Subject|1|||
42206662|NCT03363321|76019730|FG004|Overall Study|Withdrawal by Subject|0|||
42206663|NCT03361605|76019743|FG000|Overall Study|Analyzable data not available|3|||
42206664|NCT03829046|76019749|FG000|Overall Study|Withdrawal by Subject|1|||
42206665|NCT03829046|76019750|FG001|Overall Study|Withdrawal by Subject|0|||
42206666|NCT03361293|76019758|FG000|Overall Study|Lost to Follow-up|0|||
42206667|NCT03361293|76019759|FG001|Overall Study|Lost to Follow-up|2|||
42206668|NCT03361293|76019758|FG000|Overall Study|Withdrawal by Subject|1|||
42206669|NCT03361293|76019759|FG001|Overall Study|Withdrawal by Subject|3|||
42206670|NCT03361137|76019770|FG000|Overall Study|Reason not specified|1|||
42206671|NCT03361137|76019771|FG001|Overall Study|Reason not specified|0|||
42206672|NCT03361137|76019772|FG002|Overall Study|Reason not specified|0|||
42206673|NCT03361137|76019773|FG003|Overall Study|Reason not specified|0|||
42206674|NCT03361137|76019774|FG004|Overall Study|Reason not specified|0|||
42206675|NCT03360747|76019788|FG000|Overall Study|Voluntary Withdrawal|1|||
42206676|NCT03359811|76019794|FG000|Overall Study|Protocol Violation|2|||
42206677|NCT03359811|76019795|FG001|Overall Study|Protocol Violation|0|||
42206678|NCT03728426|76019802|FG000|Overall Study|Death|3|||
42206679|NCT02095678|76019808|FG000|Overall Study|Withdrawal by Subject|0|||
42206680|NCT02095678|76019809|FG001|Overall Study|Withdrawal by Subject|1|||
42206681|NCT02095678|76019808|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
42206682|NCT02095678|76019809|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
42206683|NCT02095678|76019808|FG000|Overall Study|lesion impacted by previous treatment|1|||
42206684|NCT02095678|76019809|FG001|Overall Study|lesion impacted by previous treatment|1|||
42206685|NCT02095678|76019808|FG000|Overall Study|No Confirmed Diagnosis|0|||
42206686|NCT02095678|76019809|FG001|Overall Study|No Confirmed Diagnosis|3|||
42206687|NCT02095678|76019808|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
42206688|NCT02095678|76019809|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
42206689|NCT02095678|76019808|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
42206690|NCT02095678|76019809|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
42206691|NCT03763877|76019822|FG000|Overall Study|Withdrawal by Subject|3|||
42206692|NCT03763877|76019823|FG001|Overall Study|Withdrawal by Subject|1|||
42206693|NCT03763877|76019824|FG002|Overall Study|Withdrawal by Subject|3|||
42206694|NCT03763877|76019825|FG003|Overall Study|Withdrawal by Subject|4|||
42206695|NCT03763877|76019822|FG000|Overall Study|Adverse Event|1|||
42206696|NCT03763877|76019823|FG001|Overall Study|Adverse Event|1|||
42206697|NCT03763877|76019824|FG002|Overall Study|Adverse Event|3|||
42206698|NCT03763877|76019825|FG003|Overall Study|Adverse Event|1|||
42206699|NCT03763877|76019822|FG000|Overall Study|Protocol Violation|1|||
42206700|NCT03763877|76019823|FG001|Overall Study|Protocol Violation|1|||
42206701|NCT03763877|76019824|FG002|Overall Study|Protocol Violation|0|||
42206702|NCT03763877|76019825|FG003|Overall Study|Protocol Violation|0|||
42206703|NCT03763877|76019822|FG000|Overall Study|Lost to Follow-up|0|||
42206704|NCT03763877|76019823|FG001|Overall Study|Lost to Follow-up|1|||
42206705|NCT03763877|76019824|FG002|Overall Study|Lost to Follow-up|1|||
42206706|NCT03763877|76019825|FG003|Overall Study|Lost to Follow-up|0|||
42206707|NCT03358407|76019858|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
42206708|NCT03358407|76019859|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
42206709|NCT03358407|76019860|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
42206710|NCT03358407|76019861|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
42206711|NCT03358407|76019862|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
42206712|NCT03358407|76019863|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
42206713|NCT03358407|76019864|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
42206714|NCT03358407|76019865|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
42206715|NCT03358407|76019866|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
42206716|NCT03358407|76019867|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
42206717|NCT03358407|76019858|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206718|NCT03358407|76019859|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206719|NCT03358407|76019860|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206720|NCT03358407|76019861|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206721|NCT03358407|76019862|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
42206722|NCT03358407|76019863|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206723|NCT03358407|76019864|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206724|NCT03358407|76019865|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206725|NCT03358407|76019866|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206726|NCT03358407|76019867|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206727|NCT03358407|76019858|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
42206728|NCT03358407|76019859|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
42206729|NCT03358407|76019860|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
42206730|NCT03358407|76019861|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
42206731|NCT03358407|76019862|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
42206732|NCT03358407|76019863|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
42206733|NCT03358407|76019864|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
42206734|NCT03358407|76019865|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
42206735|NCT03358407|76019866|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
42206736|NCT03358407|76019867|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
42206737|NCT03358407|76019858|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
42206738|NCT03358407|76019859|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
42206739|NCT03358407|76019860|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
42206740|NCT03358407|76019861|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
42206741|NCT03358407|76019862|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
42206742|NCT03358407|76019863|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
42206743|NCT03358407|76019864|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
42206744|NCT03358407|76019865|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
42206745|NCT03358407|76019866|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
42206746|NCT03358407|76019867|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
42206747|NCT03358407|76019858|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206748|NCT03358407|76019859|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206749|NCT03358407|76019860|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206750|NCT03358407|76019861|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206751|NCT03358407|76019862|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206752|NCT03358407|76019863|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
42206753|NCT03358407|76019864|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
42299692|NCT02548585|76134670|FG000|Overall Study|Other|1|||
42299693|NCT02548585|76134671|FG001|Overall Study|Other|0|||
42206754|NCT03358407|76019865|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206755|NCT03358407|76019866|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206756|NCT03358407|76019867|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
42206757|NCT03358407|76019858|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
42206758|NCT03358407|76019859|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
42206759|NCT03358407|76019860|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
42206760|NCT03358407|76019861|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
42206761|NCT03358407|76019862|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
42206762|NCT03358407|76019863|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
42206763|NCT03358407|76019864|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
42206764|NCT03358407|76019865|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
42206765|NCT03358407|76019866|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
42206766|NCT03358407|76019867|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
42206767|NCT02950545|76019909|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
42206768|NCT02950545|76019910|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
42206769|NCT02950545|76019911|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
42206770|NCT02950545|76019912|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
42206771|NCT02950545|76019913|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
42206772|NCT02950545|76019914|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
42206773|NCT02950545|76019909|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
42206774|NCT02950545|76019910|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
42206775|NCT02950545|76019911|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
42206776|NCT02950545|76019912|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
42206777|NCT02950545|76019913|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
42206778|NCT02950545|76019914|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
42206779|NCT02950545|76019909|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
42206780|NCT02950545|76019910|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
42206781|NCT02950545|76019911|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
42206782|NCT02950545|76019912|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
42206783|NCT02950545|76019913|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
42206784|NCT02950545|76019914|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
42206785|NCT02950545|76019909|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
42206786|NCT02950545|76019910|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
42206787|NCT02950545|76019911|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
42206788|NCT02950545|76019912|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
42206789|NCT02950545|76019913|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
42206790|NCT02950545|76019914|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
42206791|NCT02950545|76019909|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
42206792|NCT02950545|76019910|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
42206793|NCT02950545|76019911|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
42206794|NCT02950545|76019912|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
42206795|NCT02950545|76019913|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
42206796|NCT02950545|76019914|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
42206797|NCT03358329|76019920|FG000|Overall Study|Lost to Follow-up|2|||
42206798|NCT03358329|76019920|FG000|Overall Study|Withdrawal by Subject|2|||
42206799|NCT03357471|76019936|FG000|Overall Study|Adverse Event|1|||
42206800|NCT03357471|76019937|FG001|Overall Study|Adverse Event|0|||
42206801|NCT03357471|76019936|FG000|Overall Study|Lost to Follow-up|1|||
42206802|NCT03357471|76019937|FG001|Overall Study|Lost to Follow-up|0|||
42206803|NCT03342963|76019947|FG000|Overall Study|Adverse Event|1|||
42206804|NCT03342963|76019948|FG001|Overall Study|Adverse Event|2|||
42206805|NCT03342963|76019949|FG002|Overall Study|Adverse Event|0|||
42206806|NCT03342963|76019950|FG003|Overall Study|Adverse Event|0|||
42206807|NCT03342963|76019947|FG000|Overall Study|Withdrawal by Subject|1|||
42206808|NCT03342963|76019948|FG001|Overall Study|Withdrawal by Subject|0|||
42206809|NCT03342963|76019949|FG002|Overall Study|Withdrawal by Subject|0|||
42206810|NCT03342963|76019950|FG003|Overall Study|Withdrawal by Subject|0|||
42206811|NCT03361956|76019965|FG000|Overall Study|Adverse Event|1|||
42206812|NCT03361956|76019966|FG001|Overall Study|Adverse Event|0|||
42206813|NCT03361956|76019967|FG002|Overall Study|Adverse Event|1|||
42206814|NCT03361956|76019968|FG003|Overall Study|Adverse Event|1|||
42206815|NCT03361956|76019969|FG004|Overall Study|Adverse Event|0|||
42206816|NCT03361956|76019965|FG000|Overall Study|Other|0|||
42206817|NCT03361956|76019966|FG001|Overall Study|Other|0|||
42206818|NCT03361956|76019967|FG002|Overall Study|Other|0|||
42206819|NCT03361956|76019968|FG003|Overall Study|Other|1|||
42206820|NCT03361956|76019969|FG004|Overall Study|Other|0|||
42206821|NCT03361956|76019965|FG000|Overall Study|Withdrawal by Subject|2|||
42206822|NCT03361956|76019966|FG001|Overall Study|Withdrawal by Subject|2|||
42206823|NCT03361956|76019967|FG002|Overall Study|Withdrawal by Subject|2|||
42206824|NCT03361956|76019968|FG003|Overall Study|Withdrawal by Subject|0|||
42206825|NCT03361956|76019969|FG004|Overall Study|Withdrawal by Subject|3|||
42206826|NCT03361956|76019965|FG000|Overall Study|Disease Relapse|0|||
42206827|NCT03361956|76019966|FG001|Overall Study|Disease Relapse|0|||
42206828|NCT03361956|76019967|FG002|Overall Study|Disease Relapse|1|||
42206829|NCT03361956|76019968|FG003|Overall Study|Disease Relapse|0|||
42206830|NCT03361956|76019969|FG004|Overall Study|Disease Relapse|0|||
42206831|NCT03361956|76019965|FG000|Overall Study|Physician Decision|0|||
42206832|NCT03361956|76019966|FG001|Overall Study|Physician Decision|2|||
42206833|NCT03361956|76019967|FG002|Overall Study|Physician Decision|0|||
42206834|NCT03361956|76019968|FG003|Overall Study|Physician Decision|1|||
42206835|NCT03361956|76019969|FG004|Overall Study|Physician Decision|0|||
42206836|NCT03361956|76019965|FG000|Overall Study|Lost to Follow-up|0|||
42206837|NCT03361956|76019966|FG001|Overall Study|Lost to Follow-up|0|||
42206838|NCT03361956|76019967|FG002|Overall Study|Lost to Follow-up|1|||
42206839|NCT03361956|76019968|FG003|Overall Study|Lost to Follow-up|1|||
42206840|NCT03361956|76019969|FG004|Overall Study|Lost to Follow-up|2|||
42206841|NCT03361176|76020040|FG000|Overall Study|Lost to Follow-up|1|||
42206842|NCT03361176|76020041|FG001|Overall Study|Lost to Follow-up|2|||
42206843|NCT03361176|76020040|FG000|Overall Study|Adverse Event|0|||
42206844|NCT03361176|76020041|FG001|Overall Study|Adverse Event|2|||
42206845|NCT03361176|76020040|FG000|Overall Study|Withdrawal by Subject|0|||
42206846|NCT03361176|76020041|FG001|Overall Study|Withdrawal by Subject|1|||
42206847|NCT05283499|76020049|FG000|Overall Study|Did not receive intervention|1|||
42206848|NCT05283499|76020050|FG001|Overall Study|Did not receive intervention|2|||
42206849|NCT05271175|76020059|FG000|One Week Follow up|Lost to Follow-up|10|||
42206850|NCT05271175|76020060|FG001|One Week Follow up|Lost to Follow-up|7|||
42206851|NCT05271175|76020061|FG002|One Week Follow up|Lost to Follow-up|5|||
42206852|NCT05271175|76020059|FG000|One Month Follow up|Lost to Follow-up|12|||
42206853|NCT05271175|76020060|FG001|One Month Follow up|Lost to Follow-up|7|||
42206854|NCT05271175|76020061|FG002|One Month Follow up|Lost to Follow-up|9|||
42206855|NCT05271175|76020059|FG000|Six Months Follow up|Lost to Follow-up|8|||
42206856|NCT05271175|76020060|FG001|Six Months Follow up|Lost to Follow-up|2|||
42206857|NCT05271175|76020061|FG002|Six Months Follow up|Lost to Follow-up|2|||
42206858|NCT03098030|76020073|FG000|Overall Study|Death|10|||
42206859|NCT03098030|76020074|FG001|Overall Study|Death|156|||
42206860|NCT03098030|76020075|FG002|Overall Study|Death|156|||
42206861|NCT03098030|76020076|FG003|Overall Study|Death|82|||
42206862|NCT03098030|76020073|FG000|Overall Study|Withdrawal by Subject|0|||
42206863|NCT03098030|76020074|FG001|Overall Study|Withdrawal by Subject|7|||
42206864|NCT03098030|76020075|FG002|Overall Study|Withdrawal by Subject|8|||
42206865|NCT03098030|76020076|FG003|Overall Study|Withdrawal by Subject|2|||
42206866|NCT03098030|76020073|FG000|Overall Study|Lost to Follow-up|0|||
42206867|NCT03098030|76020074|FG001|Overall Study|Lost to Follow-up|0|||
42206868|NCT03098030|76020075|FG002|Overall Study|Lost to Follow-up|2|||
42206869|NCT03098030|76020076|FG003|Overall Study|Lost to Follow-up|1|||
42206870|NCT03341637|76020087|FG000|Overall Study|Lost to Follow-up|1|||
42206871|NCT03341637|76020088|FG001|Overall Study|Lost to Follow-up|0|||
42206872|NCT03341637|76020087|FG000|Overall Study|Withdrawal by Subject|3|||
42206873|NCT03341637|76020088|FG001|Overall Study|Withdrawal by Subject|3|||
42206874|NCT03341637|76020087|FG000|Overall Study|Reason not Specified|1|||
42206875|NCT03341637|76020088|FG001|Overall Study|Reason not Specified|1|||
42206876|NCT01378858|76020096|FG000|Overall Study|Withdrawal by Subject|4|||
42206877|NCT01378858|76020097|FG001|Overall Study|Withdrawal by Subject|4|||
42206878|NCT02891850|76020105|FG000|Overall Study|Adverse Event|3|||
42206879|NCT02891850|76020106|FG001|Overall Study|Adverse Event|0|||
42206880|NCT02891850|76020105|FG000|Overall Study|Death|0|||
42206881|NCT02891850|76020106|FG001|Overall Study|Death|4|||
42206882|NCT02891850|76020105|FG000|Overall Study|Physician Decision|1|||
42206883|NCT02891850|76020106|FG001|Overall Study|Physician Decision|0|||
42206884|NCT02891850|76020105|FG000|Overall Study|Pregnancy|1|||
42206885|NCT02891850|76020106|FG001|Overall Study|Pregnancy|0|||
42206886|NCT02891850|76020105|FG000|Overall Study|Withdrawal by Subject|2|||
42206887|NCT02891850|76020106|FG001|Overall Study|Withdrawal by Subject|3|||
42206888|NCT05594173|76020112|FG000|Overall Study|Adverse Event|1|||
42206889|NCT05594173|76020112|FG000|Overall Study|COVID-19 Pandemic|2|||
42206890|NCT03339999|76020125|FG000|Overall Study|Adverse Event|1|||
42206891|NCT03339999|76020126|FG001|Overall Study|Adverse Event|2|||
42206892|NCT03339999|76020127|FG002|Overall Study|Adverse Event|2|||
42206893|NCT03339999|76020128|FG003|Overall Study|Adverse Event|1|||
42206894|NCT03339999|76020125|FG000|Overall Study|Lack of Efficacy|0|||
42206895|NCT03339999|76020126|FG001|Overall Study|Lack of Efficacy|1|||
42206896|NCT03339999|76020127|FG002|Overall Study|Lack of Efficacy|0|||
42206897|NCT03339999|76020128|FG003|Overall Study|Lack of Efficacy|0|||
42206898|NCT03339999|76020125|FG000|Overall Study|Lost to Follow-up|0|||
42206899|NCT03339999|76020126|FG001|Overall Study|Lost to Follow-up|0|||
42206900|NCT03339999|76020127|FG002|Overall Study|Lost to Follow-up|0|||
42206901|NCT03339999|76020128|FG003|Overall Study|Lost to Follow-up|1|||
42206902|NCT03339999|76020125|FG000|Overall Study|Study Terminated by Sponsor|6|||
42206903|NCT03339999|76020126|FG001|Overall Study|Study Terminated by Sponsor|3|||
42206904|NCT03339999|76020127|FG002|Overall Study|Study Terminated by Sponsor|4|||
42206905|NCT03339999|76020128|FG003|Overall Study|Study Terminated by Sponsor|3|||
42206906|NCT03339453|76020141|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
42206907|NCT03339453|76020142|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
42206908|NCT03359850|76020186|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
42206909|NCT03359850|76020187|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
42206910|NCT03359850|76020186|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
42206911|NCT03359850|76020187|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
42206912|NCT03359850|76020186|FG000|Extension Phase (Up to 28 Months)|Death|2|||
42206913|NCT03359850|76020187|FG001|Extension Phase (Up to 28 Months)|Death|4|||
42206914|NCT03359850|76020186|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
42206915|NCT03359850|76020187|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
42206916|NCT03359850|76020186|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
42206917|NCT03359850|76020187|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
42206918|NCT00114140|76020206|FG000|Overall Study|Protocol Violation|7|||
42206919|NCT03712345|76020220|FG000|Overall Study|Failure to meet randomization criteria|0|||
42206920|NCT03712345|76020221|FG001|Overall Study|Failure to meet randomization criteria|0|||
42206921|NCT03712345|76020222|FG002|Overall Study|Failure to meet randomization criteria|1|||
42206922|NCT03358290|76020235|FG000|Overall Study|Study discontinued by Sponsor|0|||
42206923|NCT03358290|76020236|FG001|Overall Study|Study discontinued by Sponsor|1|||
42206924|NCT03358290|76020237|FG002|Overall Study|Study discontinued by Sponsor|1|||
42206925|NCT03358290|76020238|FG003|Overall Study|Study discontinued by Sponsor|0|||
42206926|NCT03358290|76020239|FG004|Overall Study|Study discontinued by Sponsor|0|||
42206927|NCT03358290|76020235|FG000|Overall Study|Adverse Event|0|||
42206928|NCT03358290|76020236|FG001|Overall Study|Adverse Event|0|||
42299694|NCT02548585|76134672|FG002|Overall Study|Other|0|||
42299695|NCT02548585|76134673|FG003|Overall Study|Other|2|||
42299696|NCT02548585|76134674|FG004|Overall Study|Other|3|||
42299697|NCT02548585|76134675|FG005|Overall Study|Other|0|||
42299698|NCT02548585|76134676|FG006|Overall Study|Other|1|||
42299699|NCT02548585|76134670|FG000|Overall Study|Randomized but not treated|0|||
42299700|NCT02548585|76134671|FG001|Overall Study|Randomized but not treated|0|||
42299701|NCT02548585|76134672|FG002|Overall Study|Randomized but not treated|0|||
42299702|NCT02548585|76134673|FG003|Overall Study|Randomized but not treated|0|||
42299703|NCT02548585|76134674|FG004|Overall Study|Randomized but not treated|0|||
42299704|NCT02548585|76134675|FG005|Overall Study|Randomized but not treated|1|||
42299705|NCT02548585|76134676|FG006|Overall Study|Randomized but not treated|0|||
42299706|NCT02547649|76134720|FG000|Overall Study|Lost to Follow-up|3|||
42299707|NCT02547649|76134721|FG001|Overall Study|Lost to Follow-up|1|||
42299708|NCT02547649|76134722|FG002|Overall Study|Lost to Follow-up|1|||
42299709|NCT02547649|76134720|FG000|Overall Study|Not vaccinated|0|||
42299710|NCT02547649|76134721|FG001|Overall Study|Not vaccinated|0|||
42299711|NCT02547649|76134722|FG002|Overall Study|Not vaccinated|1|||
42299712|NCT02547649|76134720|FG000|Overall Study|Withdrawal by Subject|0|||
42299713|NCT02547649|76134721|FG001|Overall Study|Withdrawal by Subject|4|||
42299714|NCT02547649|76134722|FG002|Overall Study|Withdrawal by Subject|2|||
42299715|NCT02535715|76134742|FG000|Overall Study|Withdrawal by Subject|0|||
42299716|NCT02535715|76134743|FG001|Overall Study|Withdrawal by Subject|0|||
42299717|NCT02535715|76134744|FG002|Overall Study|Withdrawal by Subject|1|||
42299718|NCT02336815|76134757|FG000|Overall Study|Disease Progression|45|||
42299719|NCT02336815|76134758|FG001|Overall Study|Disease Progression|70|||
42299720|NCT02336815|76134757|FG000|Overall Study|Adverse Event|18|||
42299721|NCT02336815|76134758|FG001|Overall Study|Adverse Event|39|||
42299722|NCT02336815|76134757|FG000|Overall Study|Physician Decision|11|||
42299723|NCT02336815|76134758|FG001|Overall Study|Physician Decision|4|||
42299724|NCT02336815|76134757|FG000|Overall Study|Withdrawal by Subject|3|||
42299725|NCT02336815|76134758|FG001|Overall Study|Withdrawal by Subject|2|||
42299726|NCT02336815|76134757|FG000|Overall Study|Lost to Follow-up|1|||
42299727|NCT02336815|76134758|FG001|Overall Study|Lost to Follow-up|3|||
42299728|NCT02336815|76134757|FG000|Overall Study|Other|1|||
42299729|NCT02336815|76134758|FG001|Overall Study|Other|5|||
42299730|NCT02543203|76134768|FG000|Overall Study|Unpalatable Fragrance|2|||
42299731|NCT02543203|76134769|FG001|Overall Study|Unpalatable Fragrance|2|||
42299732|NCT02543203|76134768|FG000|Overall Study|Lost to Follow-up|1|||
42299733|NCT02543203|76134769|FG001|Overall Study|Lost to Follow-up|0|||
42299734|NCT02543203|76134768|FG000|Overall Study|Increased Irritability|1|||
42299735|NCT02543203|76134769|FG001|Overall Study|Increased Irritability|0|||
42299736|NCT02543203|76134768|FG000|Overall Study|Family|1|||
42299737|NCT02543203|76134769|FG001|Overall Study|Family|2|||
42299738|NCT02543203|76134768|FG000|Overall Study|Negative Behavior|1|||
42299739|NCT02543203|76134769|FG001|Overall Study|Negative Behavior|0|||
42299740|NCT02543203|76134768|FG000|Overall Study|Withdrawal by Subject|0|||
42299741|NCT02543203|76134769|FG001|Overall Study|Withdrawal by Subject|1|||
42299742|NCT02546323|76134785|FG000|Overall Study|Withdrawal by Subject|36|||
42299743|NCT02546323|76134786|FG001|Overall Study|Withdrawal by Subject|33|||
42299744|NCT02546323|76134785|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
42299745|NCT02546323|76134786|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
42299746|NCT02546323|76134785|FG000|Overall Study|Adverse Event|17|||
42299747|NCT02546323|76134786|FG001|Overall Study|Adverse Event|11|||
42299748|NCT02546323|76134785|FG000|Overall Study|Patient Specific Reasons|1|||
42299749|NCT02546323|76134786|FG001|Overall Study|Patient Specific Reasons|2|||
42299750|NCT02546323|76134785|FG000|Overall Study|Lost to Follow-up|2|||
42299751|NCT02546323|76134786|FG001|Overall Study|Lost to Follow-up|3|||
42299752|NCT02546323|76134785|FG000|Overall Study|Non-compliance with Study Drug|2|||
42299753|NCT02546323|76134786|FG001|Overall Study|Non-compliance with Study Drug|2|||
42299754|NCT02546323|76134785|FG000|Overall Study|Met Withdrawal Criteria|2|||
42299755|NCT02546323|76134786|FG001|Overall Study|Met Withdrawal Criteria|14|||
42299756|NCT02545933|76134795|FG000|Overall Study|Adverse Event|3|||
42299757|NCT02545933|76134796|FG001|Overall Study|Adverse Event|0|||
42299758|NCT02545933|76134797|FG002|Overall Study|Adverse Event|0|||
42299759|NCT02545933|76134795|FG000|Overall Study|Withdrawal by Subject|2|||
42299760|NCT02545933|76134796|FG001|Overall Study|Withdrawal by Subject|3|||
42299761|NCT02545933|76134797|FG002|Overall Study|Withdrawal by Subject|3|||
42021263|NCT01072149|75828522|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
42021264|NCT01072149|75828523|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
42021265|NCT01072149|75828524|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
42021266|NCT01072149|75828525|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
42021267|NCT01072149|75828526|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
42021268|NCT01072149|75828527|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
42021269|NCT01072149|75828528|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
42021270|NCT01072149|75828529|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
42021271|NCT01072149|75828530|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
42021272|NCT01072149|75828531|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
42021273|NCT01072149|75828532|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
42021274|NCT01072149|75828533|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
42021275|NCT01072149|75828534|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
42021276|NCT01072149|75828535|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
42021277|NCT01072149|75828536|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
42021278|NCT01072149|75828537|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
42021279|NCT01072149|75828520|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021280|NCT01072149|75828521|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021281|NCT01072149|75828522|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021282|NCT01072149|75828523|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021283|NCT01072149|75828524|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021284|NCT01072149|75828525|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021285|NCT01072149|75828526|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021286|NCT01072149|75828527|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021287|NCT01072149|75828528|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021288|NCT01072149|75828529|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021289|NCT01072149|75828530|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021290|NCT01072149|75828531|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021291|NCT01072149|75828532|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
42021292|NCT01072149|75828533|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021293|NCT01072149|75828534|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021294|NCT01072149|75828535|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021295|NCT01072149|75828536|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021296|NCT01072149|75828537|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
42021297|NCT01072149|75828520|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021298|NCT01072149|75828521|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021299|NCT01072149|75828522|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
42021300|NCT01072149|75828523|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021301|NCT01072149|75828524|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021302|NCT01072149|75828525|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021303|NCT01072149|75828526|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021304|NCT01072149|75828527|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021305|NCT01072149|75828528|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021306|NCT01072149|75828529|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021307|NCT01072149|75828530|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021308|NCT01072149|75828531|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021309|NCT01072149|75828532|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021310|NCT01072149|75828533|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
42021311|NCT01072149|75828534|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021312|NCT01072149|75828535|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021313|NCT01072149|75828536|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021314|NCT01072149|75828537|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
42021315|NCT01071915|75828547|FG000|Overall Study|Adverse Event|3|||
42021316|NCT01071915|75828547|FG000|Overall Study|Physician Decision|2|||
42021317|NCT01071915|75828547|FG000|Overall Study|Withdrawal by Subject|2|||
42021318|NCT01071915|75828547|FG000|Overall Study|Miscellaneous Reasons|2|||
42021319|NCT00904969|75828551|FG000|Overall Study|Lost to Follow-up|4|||
42021320|NCT00904969|75828551|FG000|Overall Study|Withdrawal by Subject|3|||
42021321|NCT00904969|75828551|FG000|Overall Study|Additional Treatments|11|||
42021322|NCT00904969|75828551|FG000|Overall Study|Case Aborted; Subject Exited|1|||
42021323|NCT01070979|75828573|FG000|Overall Study|Adverse Event|2|||
42021324|NCT01070979|75828574|FG001|Overall Study|Adverse Event|3|||
42021325|NCT01070979|75828575|FG002|Overall Study|Adverse Event|3|||
42021326|NCT01070979|75828573|FG000|Overall Study|Lost to Follow-up|2|||
42021327|NCT01070979|75828574|FG001|Overall Study|Lost to Follow-up|1|||
42021328|NCT01070979|75828575|FG002|Overall Study|Lost to Follow-up|1|||
42021329|NCT01070979|75828573|FG000|Overall Study|Protocol Violation|0|||
42021330|NCT01070979|75828574|FG001|Overall Study|Protocol Violation|2|||
42021331|NCT01070979|75828575|FG002|Overall Study|Protocol Violation|6|||
42021332|NCT01070979|75828573|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
42021333|NCT01070979|75828574|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
42021334|NCT01070979|75828575|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
42021335|NCT01070979|75828573|FG000|Overall Study|Withdrawal by Subject|3|||
42021336|NCT01070979|75828574|FG001|Overall Study|Withdrawal by Subject|1|||
42021337|NCT01070979|75828575|FG002|Overall Study|Withdrawal by Subject|1|||
42021338|NCT01070979|75828573|FG000|Overall Study|No study drug taken|0|||
42021339|NCT01070979|75828574|FG001|Overall Study|No study drug taken|1|||
42021340|NCT01070979|75828575|FG002|Overall Study|No study drug taken|0|||
42021341|NCT01234337|75828585|FG000|Overall Study|Adverse Event|58|||
42021342|NCT01234337|75828586|FG001|Overall Study|Adverse Event|21|||
42021343|NCT01234337|75828585|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
42021344|NCT01234337|75828586|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
42021345|NCT01234337|75828585|FG000|Overall Study|Investi. decision not protocol driven|5|||
42021346|NCT01234337|75828586|FG001|Overall Study|Investi. decision not protocol driven|6|||
42021347|NCT01234337|75828585|FG000|Overall Study|Non-compliant with study medication|3|||
42021348|NCT01234337|75828586|FG001|Overall Study|Non-compliant with study medication|2|||
42021349|NCT01234337|75828585|FG000|Overall Study|Randomized but not treated|6|||
42021350|NCT01234337|75828586|FG001|Overall Study|Randomized but not treated|4|||
42021351|NCT01234337|75828585|FG000|Overall Study|Lost to Follow-up|0|||
42021352|NCT01234337|75828586|FG001|Overall Study|Lost to Follow-up|1|||
42021353|NCT01234337|75828585|FG000|Overall Study|Protocol Violation|2|||
42021354|NCT01234337|75828586|FG001|Overall Study|Protocol Violation|3|||
42021355|NCT01234337|75828585|FG000|Overall Study|Withdrawal by Subject|11|||
42021356|NCT01234337|75828586|FG001|Overall Study|Withdrawal by Subject|9|||
42021357|NCT01234337|75828585|FG000|Overall Study|Death|0|||
42021358|NCT01234337|75828586|FG001|Overall Study|Death|1|||
42021359|NCT01234337|75828585|FG000|Overall Study|Switch to commercial drug|0|||
42021360|NCT01234337|75828586|FG001|Overall Study|Switch to commercial drug|1|||
42021361|NCT01070043|75828594|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
42021362|NCT01070043|75828595|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
42021363|NCT01070043|75828596|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
42021364|NCT01070043|75828594|FG000|Double-Blind Treatment|Adverse Event|0|||
42021365|NCT01070043|75828595|FG001|Double-Blind Treatment|Adverse Event|0|||
42021366|NCT01070043|75828596|FG002|Double-Blind Treatment|Adverse Event|2|||
42021367|NCT01074255|75828602|FG000|Overall Study|Did not receive EMEND|2|||
42021368|NCT01073943|75828608|FG000|Overall Study|Withdrawal by Subject|8|||
42021369|NCT01073943|75828609|FG001|Overall Study|Withdrawal by Subject|2|||
42021370|NCT01073943|75828608|FG000|Overall Study|Protocol Violation|2|||
42021371|NCT01073943|75828609|FG001|Overall Study|Protocol Violation|1|||
42021372|NCT01073943|75828608|FG000|Overall Study|Adverse Event|1|||
42021373|NCT01073943|75828609|FG001|Overall Study|Adverse Event|1|||
42021374|NCT01073943|75828608|FG000|Overall Study|Lost to Follow-up|0|||
42021375|NCT01073943|75828609|FG001|Overall Study|Lost to Follow-up|2|||
42021376|NCT01073943|75828608|FG000|Overall Study|Power outage; colonoscopy not done|1|||
42021377|NCT01073943|75828609|FG001|Overall Study|Power outage; colonoscopy not done|0|||
42021378|NCT01073943|75828608|FG000|Overall Study|Subject forgot|0|||
42021379|NCT01073943|75828609|FG001|Overall Study|Subject forgot|1|||
42021380|NCT01073943|75828608|FG000|Overall Study|Unable to return for follow-up|0|||
42021381|NCT01073943|75828609|FG001|Overall Study|Unable to return for follow-up|1|||
42021382|NCT01073943|75828608|FG000|Overall Study|Could not tolerate prep|1|||
42021383|NCT01073943|75828609|FG001|Overall Study|Could not tolerate prep|0|||
42021384|NCT01073865|75828617|FG000|Overall Study|Reasons other than below|19|||
42021385|NCT01073865|75828618|FG001|Overall Study|Reasons other than below|31|||
42021386|NCT01073865|75828617|FG000|Overall Study|Lost to Follow-up|1|||
42021387|NCT01073865|75828618|FG001|Overall Study|Lost to Follow-up|1|||
42021388|NCT01073865|75828617|FG000|Overall Study|Death|3|||
42021389|NCT01073865|75828618|FG001|Overall Study|Death|2|||
42021390|NCT01073865|75828617|FG000|Overall Study|Withdrawal by Subject|5|||
42021391|NCT01073865|75828618|FG001|Overall Study|Withdrawal by Subject|5|||
42021392|NCT04862065|75828627|FG000|Screening|Protocol Violation|54|||
42021393|NCT04862065|75828628|FG001|Screening|Protocol Violation|0|||
42021394|NCT04862065|75828629|FG002|Screening|Protocol Violation|0|||
42021395|NCT04862065|75828627|FG000|Screening|Insufficient Sample|1|||
42021396|NCT04862065|75828628|FG001|Screening|Insufficient Sample|0|||
42021397|NCT04862065|75828629|FG002|Screening|Insufficient Sample|0|||
42021398|NCT04862065|75828627|FG000|Follow-Up|Lost to Follow-up|3|||
42021399|NCT04862065|75828628|FG001|Follow-Up|Lost to Follow-up|0|||
42021400|NCT04862065|75828629|FG002|Follow-Up|Lost to Follow-up|0|||
42021401|NCT01073631|75828635|FG000|Overall Study|Death|82|||
42021402|NCT01073631|75828635|FG000|Overall Study|Adverse Event|24|||
42021403|NCT01073631|75828635|FG000|Overall Study|Other|63|||
42021404|NCT01073163|75828639|FG000|Overall Study|Adverse Event|1|||
42021405|NCT01073163|75828639|FG000|Overall Study|Disease Progression|1|||
42021406|NCT01073163|75828639|FG000|Overall Study|Early termination|1|||
42021407|NCT01072929|75828650|FG000|Overall Study|Adverse Event|8|||
42021408|NCT01072929|75828651|FG001|Overall Study|Adverse Event|11|||
42021409|NCT01072929|75828652|FG002|Overall Study|Adverse Event|2|||
42021410|NCT01072929|75828650|FG000|Overall Study|Lack of Efficacy|7|||
42021411|NCT01072929|75828651|FG001|Overall Study|Lack of Efficacy|4|||
42021412|NCT01072929|75828652|FG002|Overall Study|Lack of Efficacy|0|||
42021413|NCT01072929|75828650|FG000|Overall Study|Withdrawal by Subject|7|||
42021414|NCT01072929|75828651|FG001|Overall Study|Withdrawal by Subject|15|||
42021415|NCT01072929|75828652|FG002|Overall Study|Withdrawal by Subject|3|||
42021416|NCT01072929|75828650|FG000|Overall Study|Protocol Violation|13|||
42021417|NCT01072929|75828651|FG001|Overall Study|Protocol Violation|11|||
42021418|NCT01072929|75828652|FG002|Overall Study|Protocol Violation|2|||
42021419|NCT01072929|75828650|FG000|Overall Study|Lost to Follow-up|8|||
42021420|NCT01072929|75828651|FG001|Overall Study|Lost to Follow-up|4|||
42021421|NCT01072929|75828652|FG002|Overall Study|Lost to Follow-up|1|||
42021422|NCT01072929|75828650|FG000|Overall Study|Noncompliance with study medication|0|||
42021423|NCT01072929|75828651|FG001|Overall Study|Noncompliance with study medication|3|||
42021424|NCT01072929|75828652|FG002|Overall Study|Noncompliance with study medication|0|||
42021425|NCT01072929|75828650|FG000|Overall Study|Noncompliance with study procedures|1|||
42021426|NCT01072929|75828651|FG001|Overall Study|Noncompliance with study procedures|0|||
42021427|NCT01072929|75828652|FG002|Overall Study|Noncompliance with study procedures|1|||
42021428|NCT01072929|75828650|FG000|Overall Study|Other|0|||
42021429|NCT01072929|75828651|FG001|Overall Study|Other|3|||
42021430|NCT01072929|75828652|FG002|Overall Study|Other|0|||
42021431|NCT01231607|75828666|FG000|Overall Study|Adverse Event|0|||
42021432|NCT01231607|75828667|FG001|Overall Study|Adverse Event|8|||
42021433|NCT01231607|75828668|FG002|Overall Study|Adverse Event|4|||
42021434|NCT01231607|75828669|FG003|Overall Study|Adverse Event|4|||
42021435|NCT01231607|75828670|FG004|Overall Study|Adverse Event|5|||
42021436|NCT01231607|75828666|FG000|Overall Study|Lost to Follow-up|13|||
42021437|NCT01231607|75828667|FG001|Overall Study|Lost to Follow-up|11|||
42021438|NCT01231607|75828668|FG002|Overall Study|Lost to Follow-up|10|||
42021439|NCT01231607|75828669|FG003|Overall Study|Lost to Follow-up|10|||
42021440|NCT01231607|75828670|FG004|Overall Study|Lost to Follow-up|4|||
42021441|NCT01231607|75828666|FG000|Overall Study|Physician Decision|4|||
42021442|NCT01231607|75828667|FG001|Overall Study|Physician Decision|4|||
42021443|NCT01231607|75828668|FG002|Overall Study|Physician Decision|3|||
42021444|NCT01231607|75828669|FG003|Overall Study|Physician Decision|5|||
42021445|NCT01231607|75828670|FG004|Overall Study|Physician Decision|4|||
42021446|NCT01231607|75828666|FG000|Overall Study|Protocol Violation|3|||
42021447|NCT01231607|75828667|FG001|Overall Study|Protocol Violation|2|||
42021448|NCT01231607|75828668|FG002|Overall Study|Protocol Violation|0|||
42021449|NCT01231607|75828669|FG003|Overall Study|Protocol Violation|2|||
42021450|NCT01231607|75828670|FG004|Overall Study|Protocol Violation|2|||
42021451|NCT01231607|75828666|FG000|Overall Study|Withdrawal by Subject|9|||
42021452|NCT01231607|75828667|FG001|Overall Study|Withdrawal by Subject|9|||
42021453|NCT01231607|75828668|FG002|Overall Study|Withdrawal by Subject|14|||
42021454|NCT01231607|75828669|FG003|Overall Study|Withdrawal by Subject|17|||
42021455|NCT01231607|75828670|FG004|Overall Study|Withdrawal by Subject|9|||
42021456|NCT01231373|75828689|FG000|Overall Study|Withdrew consent prior to randomization|2|||
42021457|NCT01231373|75828690|FG001|Overall Study|Withdrew consent prior to randomization|1|||
42021458|NCT01231373|75828691|FG002|Overall Study|Withdrew consent prior to randomization|0|||
42021459|NCT01231373|75828692|FG003|Overall Study|Withdrew consent prior to randomization|0|||
42021460|NCT01231373|75828689|FG000|Overall Study|Lost to Follow-up|0|||
42021461|NCT01231373|75828690|FG001|Overall Study|Lost to Follow-up|0|||
42021462|NCT01231373|75828691|FG002|Overall Study|Lost to Follow-up|0|||
42021463|NCT01231373|75828692|FG003|Overall Study|Lost to Follow-up|1|||
42021464|NCT01231373|75828689|FG000|Overall Study|Withdrew Consent|1|||
42021465|NCT01231373|75828690|FG001|Overall Study|Withdrew Consent|0|||
42021466|NCT01231373|75828691|FG002|Overall Study|Withdrew Consent|0|||
42021467|NCT01231373|75828692|FG003|Overall Study|Withdrew Consent|0|||
42021468|NCT00975130|75828704|FG000|Study Part 1|Adverse Event|150|||
42021469|NCT00975130|75828705|FG001|Study Part 1|Adverse Event|0|||
42021470|NCT00975130|75828706|FG002|Study Part 1|Adverse Event|0|||
42021471|NCT00975130|75828704|FG000|Study Part 1|Lost to Follow-up|19|||
42021472|NCT00975130|75828705|FG001|Study Part 1|Lost to Follow-up|0|||
42021473|NCT00975130|75828706|FG002|Study Part 1|Lost to Follow-up|0|||
42021474|NCT00975130|75828704|FG000|Study Part 1|Withdrawal by Subject|61|||
42021475|NCT00975130|75828705|FG001|Study Part 1|Withdrawal by Subject|0|||
42021476|NCT00975130|75828706|FG002|Study Part 1|Withdrawal by Subject|0|||
42021477|NCT00975130|75828704|FG000|Study Part 1|Protocol Violation|13|||
42021478|NCT00975130|75828705|FG001|Study Part 1|Protocol Violation|0|||
42021479|NCT00975130|75828706|FG002|Study Part 1|Protocol Violation|0|||
42021480|NCT00975130|75828704|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
42021481|NCT00975130|75828705|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
42021482|NCT00975130|75828706|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
42021483|NCT00975130|75828704|FG000|Study Part 1|Administrative|4|||
42021484|NCT00975130|75828705|FG001|Study Part 1|Administrative|0|||
42021485|NCT00975130|75828706|FG002|Study Part 1|Administrative|0|||
42021486|NCT00975130|75828704|FG000|Study Part 1|Withdrew Consent|24|||
42021487|NCT00975130|75828705|FG001|Study Part 1|Withdrew Consent|0|||
42021488|NCT00975130|75828706|FG002|Study Part 1|Withdrew Consent|0|||
42021489|NCT00975130|75828704|FG000|Study Part 2|Adverse Event|0|||
42021490|NCT00975130|75828705|FG001|Study Part 2|Adverse Event|14|||
42021491|NCT00975130|75828706|FG002|Study Part 2|Adverse Event|7|||
42021492|NCT00975130|75828704|FG000|Study Part 2|Lost to Follow-up|0|||
42021493|NCT00975130|75828705|FG001|Study Part 2|Lost to Follow-up|0|||
42021494|NCT00975130|75828706|FG002|Study Part 2|Lost to Follow-up|1|||
42021495|NCT00975130|75828704|FG000|Study Part 2|Withdrawal by Subject|0|||
42021496|NCT00975130|75828705|FG001|Study Part 2|Withdrawal by Subject|13|||
42021497|NCT00975130|75828706|FG002|Study Part 2|Withdrawal by Subject|5|||
42021498|NCT00975130|75828704|FG000|Study Part 2|Withdrew Consent|0|||
42021499|NCT00975130|75828705|FG001|Study Part 2|Withdrew Consent|6|||
42021500|NCT00975130|75828706|FG002|Study Part 2|Withdrew Consent|2|||
42021501|NCT00975130|75828704|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
42021502|NCT00975130|75828705|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
42021503|NCT00975130|75828706|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
42021504|NCT00975130|75828704|FG000|Study Part 2|Administrative|0|||
42021505|NCT00975130|75828705|FG001|Study Part 2|Administrative|1|||
42021506|NCT00975130|75828706|FG002|Study Part 2|Administrative|0|||
42021507|NCT00975130|75828704|FG000|Study Part 2|Protocol Violation|0|||
42021508|NCT00975130|75828705|FG001|Study Part 2|Protocol Violation|0|||
42021509|NCT00975130|75828706|FG002|Study Part 2|Protocol Violation|1|||
42021510|NCT01230827|75828723|FG000|Overall Study|Lost to Follow-up|0|||
42021511|NCT01230827|75828724|FG001|Overall Study|Lost to Follow-up|0|||
42021512|NCT01230827|75828725|FG002|Overall Study|Lost to Follow-up|1|||
42021513|NCT01230827|75828726|FG003|Overall Study|Lost to Follow-up|3|||
42021514|NCT01230827|75828723|FG000|Overall Study|Withdrawal by Subject|1|||
42021515|NCT01230827|75828724|FG001|Overall Study|Withdrawal by Subject|0|||
42021516|NCT01230827|75828725|FG002|Overall Study|Withdrawal by Subject|3|||
42021517|NCT01230827|75828726|FG003|Overall Study|Withdrawal by Subject|2|||
42021518|NCT01230827|75828723|FG000|Overall Study|Lack of Efficacy|14|||
42021519|NCT01230827|75828724|FG001|Overall Study|Lack of Efficacy|1|||
42021520|NCT01230827|75828725|FG002|Overall Study|Lack of Efficacy|2|||
42021521|NCT01230827|75828726|FG003|Overall Study|Lack of Efficacy|3|||
42021522|NCT01230827|75828723|FG000|Overall Study|Adverse Event|4|||
42021523|NCT01230827|75828724|FG001|Overall Study|Adverse Event|2|||
42021524|NCT01230827|75828725|FG002|Overall Study|Adverse Event|3|||
42021525|NCT01230827|75828726|FG003|Overall Study|Adverse Event|7|||
42021526|NCT01230827|75828723|FG000|Overall Study|Recovery|0|||
42021527|NCT01230827|75828724|FG001|Overall Study|Recovery|6|||
42021528|NCT01230827|75828725|FG002|Overall Study|Recovery|0|||
42021529|NCT01230827|75828726|FG003|Overall Study|Recovery|0|||
42021530|NCT01230827|75828723|FG000|Overall Study|Study terminated by Sponsor|0|||
42021531|NCT01230827|75828724|FG001|Overall Study|Study terminated by Sponsor|2|||
42021532|NCT01230827|75828725|FG002|Overall Study|Study terminated by Sponsor|56|||
42021533|NCT01230827|75828726|FG003|Overall Study|Study terminated by Sponsor|63|||
42021534|NCT01230749|75828738|FG000|Overall Study|Adverse Event|0|||
42021535|NCT01230749|75828739|FG001|Overall Study|Adverse Event|0|||
42021536|NCT01230749|75828740|FG002|Overall Study|Adverse Event|0|||
42021537|NCT01230749|75828741|FG003|Overall Study|Adverse Event|1|||
42021538|NCT01230749|75828738|FG000|Overall Study|Physician Decision|0|||
42021539|NCT01230749|75828739|FG001|Overall Study|Physician Decision|0|||
42021540|NCT01230749|75828740|FG002|Overall Study|Physician Decision|1|||
42021541|NCT01230749|75828741|FG003|Overall Study|Physician Decision|0|||
42021542|NCT01230749|75828738|FG000|Overall Study|Withdrawal by Subject|0|||
42021543|NCT01230749|75828739|FG001|Overall Study|Withdrawal by Subject|1|||
42021544|NCT01230749|75828740|FG002|Overall Study|Withdrawal by Subject|0|||
42021545|NCT01230749|75828741|FG003|Overall Study|Withdrawal by Subject|0|||
42021546|NCT01230749|75828738|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
42021547|NCT01230749|75828739|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
42021548|NCT01230749|75828740|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
42021549|NCT01230749|75828741|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
42021550|NCT00903175|75828756|FG000|Period 1 - First Line|Adverse Event|36|||
42021551|NCT00903175|75828757|FG001|Period 1 - First Line|Adverse Event|50|||
42021552|NCT00903175|75828756|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
42021553|NCT00903175|75828757|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
42021554|NCT00903175|75828756|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
42021555|NCT00903175|75828757|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
42021556|NCT00903175|75828756|FG000|Period 1 - First Line|Protocol Violation|3|||
42021557|NCT00903175|75828757|FG001|Period 1 - First Line|Protocol Violation|3|||
42021558|NCT00903175|75828756|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
42021559|NCT00903175|75828757|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
42021560|NCT00903175|75828756|FG000|Period 1 - First Line|Administrative problems|12|||
42021561|NCT00903175|75828757|FG001|Period 1 - First Line|Administrative problems|13|||
42021562|NCT00903175|75828756|FG000|Period 1 - First Line|Death|17|||
42021563|NCT00903175|75828757|FG001|Period 1 - First Line|Death|10|||
42021564|NCT00903175|75828756|FG000|Period 2 - Second Line|Missing|1|||
42021565|NCT00903175|75828757|FG001|Period 2 - Second Line|Missing|0|||
42021566|NCT00903175|75828756|FG000|Period 2 - Second Line|Adverse Event|16|||
42021567|NCT00903175|75828757|FG001|Period 2 - Second Line|Adverse Event|20|||
42021568|NCT00903175|75828756|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
42021569|NCT00903175|75828757|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
42021570|NCT00903175|75828756|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
42021571|NCT00903175|75828757|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
42021572|NCT00903175|75828756|FG000|Period 2 - Second Line|Administrative problems|19|||
42021573|NCT00903175|75828757|FG001|Period 2 - Second Line|Administrative problems|9|||
42021574|NCT00903175|75828756|FG000|Period 2 - Second Line|Death|5|||
42021575|NCT00903175|75828757|FG001|Period 2 - Second Line|Death|2|||
42021576|NCT01229735|75828765|FG000|Overall Study|Lack of Efficacy|8|||
42021577|NCT01229735|75828766|FG001|Overall Study|Lack of Efficacy|8|||
42021578|NCT01229735|75828765|FG000|Overall Study|Protocol Violation|13|||
42021579|NCT01229735|75828766|FG001|Overall Study|Protocol Violation|8|||
42021580|NCT01229735|75828765|FG000|Overall Study|Lost to Follow-up|0|||
42021581|NCT01229735|75828766|FG001|Overall Study|Lost to Follow-up|2|||
42021582|NCT01229735|75828765|FG000|Overall Study|Withdrawal by Subject|18|||
42021583|NCT01229735|75828766|FG001|Overall Study|Withdrawal by Subject|17|||
42021584|NCT01229735|75828765|FG000|Overall Study|Other Reason|13|||
42021585|NCT01229735|75828766|FG001|Overall Study|Other Reason|10|||
42021586|NCT01229735|75828765|FG000|Overall Study|SAE, non-fatal|0|||
42021587|NCT01229735|75828766|FG001|Overall Study|SAE, non-fatal|4|||
42021588|NCT01229735|75828765|FG000|Overall Study|AE, non-serious non-fatal|13|||
42021589|NCT01229735|75828766|FG001|Overall Study|AE, non-serious non-fatal|17|||
42021590|NCT01229735|75828765|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
42021591|NCT01229735|75828766|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
42021592|NCT00974974|75828785|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
42021593|NCT00974974|75828786|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
42021594|NCT00974974|75828785|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
42021595|NCT00974974|75828786|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
42021596|NCT00974974|75828785|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
42021597|NCT00974974|75828786|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
42021598|NCT00974974|75828785|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
42021599|NCT00974974|75828786|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
42021600|NCT00974974|75828785|FG000|IR CD-LD Dose Adjustment|Various|0|||
42021601|NCT00974974|75828786|FG001|IR CD-LD Dose Adjustment|Various|9|||
42021602|NCT00974974|75828785|FG000|IPX066 Dose Conversion|Adverse Event|23|||
42021603|NCT00974974|75828786|FG001|IPX066 Dose Conversion|Adverse Event|0|||
42021604|NCT00974974|75828785|FG000|IPX066 Dose Conversion|Death|2|||
42021605|NCT00974974|75828786|FG001|IPX066 Dose Conversion|Death|0|||
42021606|NCT00974974|75828785|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
42021607|NCT00974974|75828786|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
42021608|NCT00974974|75828785|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
42021609|NCT00974974|75828786|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
42021610|NCT00974974|75828785|FG000|IPX066 Dose Conversion|Various|3|||
42021611|NCT00974974|75828786|FG001|IPX066 Dose Conversion|Various|0|||
42021612|NCT00974974|75828785|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
42021613|NCT00974974|75828786|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
42021614|NCT00974974|75828785|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
42021615|NCT00974974|75828786|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
42021616|NCT00974974|75828785|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
42021617|NCT00974974|75828786|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
42021618|NCT00974974|75828785|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
42021619|NCT00974974|75828786|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
42021620|NCT00974974|75828785|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
42021621|NCT00974974|75828786|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
42021622|NCT00974974|75828785|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
42021623|NCT00974974|75828786|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
42021624|NCT00974974|75828785|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
42021625|NCT00974974|75828786|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
42021626|NCT00974974|75828785|FG000|Maintenance - Double Blind Treatment|Various|4|||
42021627|NCT00974974|75828786|FG001|Maintenance - Double Blind Treatment|Various|0|||
42021628|NCT01233869|75828796|FG000|Initial Treatment Period (24 Months)|Death|1|||
42021629|NCT01233869|75828797|FG001|Initial Treatment Period (24 Months)|Death|0|||
42021630|NCT01233869|75828798|FG002|Initial Treatment Period (24 Months)|Death|0|||
42021631|NCT01233869|75828799|FG003|Initial Treatment Period (24 Months)|Death|0|||
42021632|NCT01233869|75828796|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
42021633|NCT01233869|75828797|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
42021634|NCT01233869|75828798|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
42021635|NCT01233869|75828799|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
42021636|NCT01233869|75828796|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
42021637|NCT01233869|75828797|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
42021638|NCT01233869|75828798|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
42021639|NCT01233869|75828799|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
42021640|NCT01233869|75828796|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
42021641|NCT01233869|75828797|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
42021642|NCT01233869|75828798|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
42021643|NCT01233869|75828799|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
42021644|NCT01233869|75828796|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
42021645|NCT01233869|75828797|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
42021646|NCT01233869|75828798|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
42021647|NCT01233869|75828799|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
42021648|NCT01233869|75828796|FG000|Extended Treatment Period (46 Months)|Other|3|||
42021649|NCT01233869|75828797|FG001|Extended Treatment Period (46 Months)|Other|0|||
42021650|NCT01233869|75828798|FG002|Extended Treatment Period (46 Months)|Other|0|||
42021651|NCT01233869|75828799|FG003|Extended Treatment Period (46 Months)|Other|3|||
42021652|NCT01233869|75828796|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
42021653|NCT01233869|75828797|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
42021654|NCT01233869|75828798|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
42021655|NCT01233869|75828799|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
42021656|NCT00992992|75828809|FG000|Overall Study|Lost to Follow-up|3|||
42021657|NCT00992992|75828809|FG000|Overall Study|Death|16|||
42021658|NCT00992992|75828809|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
42021659|NCT00992992|75828809|FG000|Overall Study|Sponsor Closed the Study|4|||
42021660|NCT00992836|75828813|FG000|Overall Study|Lost to Follow-up|1|||
42021661|NCT00992836|75828813|FG000|Overall Study|Withdrawal by Subject|2|||
42021662|NCT00992836|75828813|FG000|Overall Study|Protocol Violation|2|||
42021663|NCT00992446|75828823|FG000|Overall Study|Disease Progression|1|||
42021664|NCT00992446|75828823|FG000|Overall Study|Withdrawal by Subject|2|||
42021665|NCT00992446|75828823|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
42021666|NCT04344301|75828829|FG000|Overall Study|Withdrawal by Subject|1|||
42021667|NCT04344301|75828830|FG001|Overall Study|Withdrawal by Subject|0|||
42021668|NCT04344301|75828829|FG000|Overall Study|Death|0|||
42021669|NCT04344301|75828830|FG001|Overall Study|Death|1|||
42021670|NCT00970294|75828837|FG000|Overall Study|Physician Decision|4|||
42021671|NCT00970294|75828837|FG000|Overall Study|Withdrawal by Subject|1|||
42021672|NCT00969436|75828844|FG000|Overall Study|Protocol Violation|1|||
42021673|NCT00969436|75828845|FG001|Overall Study|Protocol Violation|3|||
42021674|NCT00969436|75828846|FG002|Overall Study|Protocol Violation|0|||
42021675|NCT00969436|75828844|FG000|Overall Study|Migrated/moved from study area|12|||
42021676|NCT00969436|75828845|FG001|Overall Study|Migrated/moved from study area|10|||
42021677|NCT00969436|75828846|FG002|Overall Study|Migrated/moved from study area|2|||
42021678|NCT00969436|75828844|FG000|Overall Study|Father - serious health problem|0|||
42021679|NCT00969436|75828845|FG001|Overall Study|Father - serious health problem|0|||
42021680|NCT00969436|75828846|FG002|Overall Study|Father - serious health problem|1|||
42021681|NCT00969436|75828844|FG000|Overall Study|Parents personal problem|0|||
42021682|NCT00969436|75828845|FG001|Overall Study|Parents personal problem|0|||
42021683|NCT00969436|75828846|FG002|Overall Study|Parents personal problem|1|||
42021684|NCT00969436|75828844|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
42021685|NCT00969436|75828845|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
42021686|NCT00969436|75828846|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
42021687|NCT00969436|75828844|FG000|Overall Study|Withdrawal by Subject|3|||
42021688|NCT00969436|75828845|FG001|Overall Study|Withdrawal by Subject|0|||
42021689|NCT00969436|75828846|FG002|Overall Study|Withdrawal by Subject|2|||
42021690|NCT00969436|75828844|FG000|Overall Study|Lost to Follow-up|8|||
42021691|NCT00969436|75828845|FG001|Overall Study|Lost to Follow-up|8|||
42021692|NCT00969436|75828846|FG002|Overall Study|Lost to Follow-up|5|||
42021693|NCT00900757|75828854|FG000|Overall Study|screen failure|19|||
42021694|NCT00969280|75828860|FG000|Overall Study|Protocol Violation|2|||
42021695|NCT00969280|75828861|FG001|Overall Study|Protocol Violation|1|||
42021696|NCT00969280|75828860|FG000|Overall Study|Withdrawal by Subject|0|||
42021697|NCT00969280|75828861|FG001|Overall Study|Withdrawal by Subject|1|||
42021698|NCT00969280|75828860|FG000|Overall Study|infection of influenza A(H1N1)|0|||
42021699|NCT00969280|75828861|FG001|Overall Study|infection of influenza A(H1N1)|1|||
42021700|NCT00969124|75828867|FG000|Overall Study|Protocol Violation|2|||
42021701|NCT00969124|75828867|FG000|Overall Study|Inadequate bowel preparation|15|||
42021702|NCT00969124|75828867|FG000|Overall Study|Inability to reach cecum|9|||
42021703|NCT00969124|75828867|FG000|Overall Study|Previously unrecognized disease|3|||
42021704|NCT00969124|75828867|FG000|Overall Study|Technical error|1|||
42021705|NCT00900601|75828872|FG000|Overall Study|Physician Decision|1|||
42021706|NCT00901927|75828899|FG000|Overall Study|Lack of Efficacy|1|||
42021707|NCT00901927|75828899|FG000|Overall Study|Protocol Violation|3|||
42021708|NCT00901927|75828899|FG000|Overall Study|Withdrawal by Subject|2|||
42021709|NCT00968968|75828905|FG000|Overall Study|Study closed/terminated|10|||
42021710|NCT00968968|75828906|FG001|Overall Study|Study closed/terminated|10|||
42021711|NCT00968968|75828905|FG000|Overall Study|Protocol defined stopping criteria|3|||
42021712|NCT00968968|75828906|FG001|Overall Study|Protocol defined stopping criteria|1|||
42021713|NCT00968968|75828905|FG000|Overall Study|Withdrawal by Subject|2|||
42021714|NCT00968968|75828906|FG001|Overall Study|Withdrawal by Subject|0|||
42021715|NCT00968968|75828905|FG000|Overall Study|Physician Decision|1|||
42021716|NCT00968968|75828906|FG001|Overall Study|Physician Decision|2|||
42021717|NCT00968968|75828905|FG000|Overall Study|Lost to Follow-up|0|||
42021718|NCT00968968|75828906|FG001|Overall Study|Lost to Follow-up|1|||
42021719|NCT00973102|75828915|FG000|Overall Study|Protocol Violation|1|||
42021720|NCT00973102|75828916|FG001|Overall Study|Protocol Violation|0|||
42021721|NCT00973102|75828915|FG000|Overall Study|Prisoner|0|||
42021722|NCT00973102|75828916|FG001|Overall Study|Prisoner|1|||
42021723|NCT00901459|75828922|FG000|Overall Study|Withdrawal by Subject|6|||
42021724|NCT00896233|75828933|FG000|Overall Study|Claustrophobia during MRI|1|||
42021725|NCT00899431|75828958|FG000|Overall Study|Physician Decision|1|||
42021726|NCT00899431|75828959|FG001|Overall Study|Physician Decision|0|||
42021727|NCT00899431|75828960|FG002|Overall Study|Physician Decision|0|||
42021728|NCT00899353|75828971|FG000|Overall Study|Adverse Event|2|||
42021729|NCT00899353|75828971|FG000|Overall Study|Lost to Follow-up|1|||
42021730|NCT00899353|75828971|FG000|Overall Study|Withdrawal by Subject|2|||
42021731|NCT00898807|75828994|FG000|Overall Study|Withdrawal by Subject|5|||
42021732|NCT00898807|75828995|FG001|Overall Study|Withdrawal by Subject|3|||
42021733|NCT00898807|75828994|FG000|Overall Study|Family pressure to discontinue|2|||
42021734|NCT00898807|75828995|FG001|Overall Study|Family pressure to discontinue|2|||
42021735|NCT00898807|75828994|FG000|Overall Study|Lost to Follow-up|1|||
42021736|NCT00898807|75828995|FG001|Overall Study|Lost to Follow-up|3|||
42021737|NCT00898807|75828994|FG000|Overall Study|Death|0|||
42021738|NCT00898807|75828995|FG001|Overall Study|Death|1|||
42021739|NCT01229267|75829006|FG000|Overall Study|Adverse Event|4|||
42021740|NCT01229267|75829007|FG001|Overall Study|Adverse Event|6|||
42021741|NCT01229267|75829008|FG002|Overall Study|Adverse Event|3|||
42021742|NCT01229267|75829009|FG003|Overall Study|Adverse Event|2|||
42021743|NCT01229267|75829010|FG004|Overall Study|Adverse Event|10|||
42021744|NCT01229267|75829006|FG000|Overall Study|Death|40|||
42021745|NCT01229267|75829007|FG001|Overall Study|Death|37|||
42021746|NCT01229267|75829008|FG002|Overall Study|Death|35|||
42021747|NCT01229267|75829009|FG003|Overall Study|Death|13|||
42021748|NCT01229267|75829010|FG004|Overall Study|Death|103|||
42021749|NCT01229267|75829006|FG000|Overall Study|Withdrawal by Subject|23|||
42021750|NCT01229267|75829007|FG001|Overall Study|Withdrawal by Subject|22|||
42021751|NCT01229267|75829008|FG002|Overall Study|Withdrawal by Subject|32|||
42021752|NCT01229267|75829009|FG003|Overall Study|Withdrawal by Subject|14|||
42021753|NCT01229267|75829010|FG004|Overall Study|Withdrawal by Subject|59|||
42021754|NCT01229267|75829006|FG000|Overall Study|Protocol Violation|0|||
42021755|NCT01229267|75829007|FG001|Overall Study|Protocol Violation|1|||
42021756|NCT01229267|75829008|FG002|Overall Study|Protocol Violation|0|||
42021757|NCT01229267|75829009|FG003|Overall Study|Protocol Violation|0|||
42021758|NCT01229267|75829010|FG004|Overall Study|Protocol Violation|0|||
42021759|NCT01229267|75829006|FG000|Overall Study|Progressive disease|0|||
42021760|NCT01229267|75829007|FG001|Overall Study|Progressive disease|0|||
42021761|NCT01229267|75829008|FG002|Overall Study|Progressive disease|0|||
42021762|NCT01229267|75829009|FG003|Overall Study|Progressive disease|0|||
42021763|NCT01229267|75829010|FG004|Overall Study|Progressive disease|1|||
42021764|NCT01229267|75829006|FG000|Overall Study|Physician Decision|8|||
42021765|NCT01229267|75829007|FG001|Overall Study|Physician Decision|11|||
42021766|NCT01229267|75829008|FG002|Overall Study|Physician Decision|8|||
42021767|NCT01229267|75829009|FG003|Overall Study|Physician Decision|3|||
42021768|NCT01229267|75829010|FG004|Overall Study|Physician Decision|25|||
42021769|NCT01229267|75829006|FG000|Overall Study|Lost to Follow-up|6|||
42299762|NCT02545933|76134795|FG000|Overall Study|Protocol Violation|1|||
42021770|NCT01229267|75829007|FG001|Overall Study|Lost to Follow-up|5|||
42021771|NCT01229267|75829008|FG002|Overall Study|Lost to Follow-up|8|||
42021772|NCT01229267|75829009|FG003|Overall Study|Lost to Follow-up|3|||
42021773|NCT01229267|75829010|FG004|Overall Study|Lost to Follow-up|22|||
42021774|NCT00897715|75829019|FG000|Overall Study|Lost to Follow-up|0|||
42021775|NCT00897715|75829020|FG001|Overall Study|Lost to Follow-up|1|||
42021776|NCT00897715|75829019|FG000|Overall Study|Physician Decision|1|||
42021777|NCT00897715|75829020|FG001|Overall Study|Physician Decision|0|||
42021778|NCT00897715|75829019|FG000|Overall Study|increased risk of infection|1|||
42021779|NCT00897715|75829020|FG001|Overall Study|increased risk of infection|0|||
42021780|NCT01229111|75829026|FG000|Overall Study|Death|1|||
42021781|NCT00894361|75829032|FG000|Overall Study|deaths and less than 2 years followup|24|||
42021782|NCT00894361|75829033|FG001|Overall Study|deaths and less than 2 years followup|64|||
42021783|NCT01228175|75829043|FG000|Overall Study|Lost to Follow-up|64|||
42021784|NCT01228175|75829044|FG001|Overall Study|Lost to Follow-up|50|||
42021785|NCT01228175|75829043|FG000|Overall Study|Withdrawal by Subject|1|||
42021786|NCT01228175|75829044|FG001|Overall Study|Withdrawal by Subject|2|||
42021787|NCT01228175|75829043|FG000|Overall Study|Physician Decision|1|||
42021788|NCT01228175|75829044|FG001|Overall Study|Physician Decision|1|||
42021789|NCT01228019|75829050|FG000|Overall Study|Dose Violation|70|||
42021790|NCT01228019|75829050|FG000|Overall Study|Duplicate enrollment|1|||
42021791|NCT01228019|75829050|FG000|Overall Study|Missing pre-treatment data|72|||
42021792|NCT01228019|75829050|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
42021793|NCT01228019|75829050|FG000|Overall Study|Violation of Entry Criterion|9|||
42021794|NCT02987959|75829054|FG000|Overall Study|Grantor stopped supply of drugs|6|||
42021795|NCT01227707|75829058|FG000|Overall Study|Adverse Event|10|||
42021796|NCT01227707|75829058|FG000|Overall Study|Progression of disease|3|||
42021797|NCT01227707|75829058|FG000|Overall Study|Withdrawal by Subject|1|||
42021798|NCT01227707|75829058|FG000|Overall Study|Patient non-compliance|3|||
42021799|NCT01227707|75829058|FG000|Overall Study|Medical decision|6|||
42021800|NCT01227707|75829058|FG000|Overall Study|Death|1|||
42021801|NCT00895843|75829064|FG000|Overall Study|Protocol Violation|12|||
42021802|NCT00895843|75829065|FG001|Overall Study|Protocol Violation|12|||
42021803|NCT00895453|75829074|FG000|Overall Study|Lost to Follow-up|25|||
42021804|NCT00895453|75829075|FG001|Overall Study|Lost to Follow-up|25|||
42021805|NCT00895453|75829076|FG002|Overall Study|Lost to Follow-up|23|||
42021806|NCT00893971|75829084|FG000|Overall Study|Physician Decision|3|||
42021807|NCT00893737|75829097|FG000|Overall Study|Adverse Event|4|||
42021808|NCT00893737|75829097|FG000|Overall Study|Withdrawal by Subject|2|||
42021809|NCT00893737|75829097|FG000|Overall Study|Lost to Follow-up|6|||
42021810|NCT00893113|75829103|FG000|Overall Study|Lost to Follow-up|4|||
42021811|NCT00893113|75829104|FG001|Overall Study|Lost to Follow-up|8|||
42021812|NCT00893113|75829103|FG000|Overall Study|Early Termination|1|||
42021813|NCT00893113|75829104|FG001|Overall Study|Early Termination|1|||
42021814|NCT00893113|75829103|FG000|Overall Study|Withdrew Consent|8|||
42021815|NCT00893113|75829104|FG001|Overall Study|Withdrew Consent|7|||
42021816|NCT00892957|75829112|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
42021817|NCT00892957|75829113|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
42021818|NCT00892957|75829112|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
42021819|NCT00892957|75829113|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
42021820|NCT00968812|75829136|FG000|Overall Study|Adverse Event|30|||
42021821|NCT00968812|75829137|FG001|Overall Study|Adverse Event|46|||
42021822|NCT00968812|75829138|FG002|Overall Study|Adverse Event|33|||
42021823|NCT00968812|75829136|FG000|Overall Study|Death|2|||
42021824|NCT00968812|75829137|FG001|Overall Study|Death|2|||
42021825|NCT00968812|75829138|FG002|Overall Study|Death|1|||
42021826|NCT00968812|75829136|FG000|Overall Study|Lack of Efficacy|9|||
42021827|NCT00968812|75829137|FG001|Overall Study|Lack of Efficacy|7|||
42021828|NCT00968812|75829138|FG002|Overall Study|Lack of Efficacy|16|||
42021829|NCT00968812|75829136|FG000|Overall Study|Lost to Follow-up|17|||
42021830|NCT00968812|75829137|FG001|Overall Study|Lost to Follow-up|12|||
42021831|NCT00968812|75829138|FG002|Overall Study|Lost to Follow-up|11|||
42021832|NCT00968812|75829136|FG000|Overall Study|Physician Decision|8|||
42021833|NCT00968812|75829137|FG001|Overall Study|Physician Decision|5|||
42021834|NCT00968812|75829138|FG002|Overall Study|Physician Decision|9|||
42021835|NCT00968812|75829136|FG000|Overall Study|Protocol Violation|7|||
42021836|NCT00968812|75829137|FG001|Overall Study|Protocol Violation|4|||
42021837|NCT00968812|75829138|FG002|Overall Study|Protocol Violation|3|||
42021838|NCT00968812|75829136|FG000|Overall Study|Withdrawal by Subject|17|||
42021839|NCT00968812|75829137|FG001|Overall Study|Withdrawal by Subject|23|||
42021840|NCT00968812|75829138|FG002|Overall Study|Withdrawal by Subject|25|||
42021841|NCT00968812|75829136|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
42021842|NCT00968812|75829137|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
42021843|NCT00968812|75829138|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
42021844|NCT00968812|75829136|FG000|Overall Study|Noncompliance with study drug|4|||
42021845|NCT00968812|75829137|FG001|Overall Study|Noncompliance with study drug|1|||
42021846|NCT00968812|75829138|FG002|Overall Study|Noncompliance with study drug|6|||
42021847|NCT00968812|75829136|FG000|Overall Study|Unable to take rescue therapy|12|||
42021848|NCT00968812|75829137|FG001|Overall Study|Unable to take rescue therapy|12|||
42021849|NCT00968812|75829138|FG002|Overall Study|Unable to take rescue therapy|17|||
42021850|NCT00968812|75829136|FG000|Overall Study|Other|25|||
42021851|NCT00968812|75829137|FG001|Overall Study|Other|37|||
42021852|NCT00968812|75829138|FG002|Overall Study|Other|40|||
42021853|NCT00992056|75829151|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
42021854|NCT00992056|75829152|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
42021855|NCT00992056|75829151|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
42021856|NCT00992056|75829152|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
42021857|NCT00972322|75829160|FG000|Overall Study|Adverse Event|2|||
42021858|NCT00972322|75829161|FG001|Overall Study|Adverse Event|1|||
42021859|NCT00972322|75829160|FG000|Overall Study|Positive drug screen|0|||
42021860|NCT00972322|75829161|FG001|Overall Study|Positive drug screen|1|||
42021861|NCT00972322|75829160|FG000|Overall Study|Lost to Follow-up|0|||
42021862|NCT00972322|75829161|FG001|Overall Study|Lost to Follow-up|1|||
42021863|NCT00972322|75829160|FG000|Overall Study|Consistently high glucose values|1|||
42021864|NCT00972322|75829161|FG001|Overall Study|Consistently high glucose values|0|||
42021865|NCT00967798|75829169|FG000|Overall Study|Withdrawal by Subject|5|||
42021866|NCT00967798|75829170|FG001|Overall Study|Withdrawal by Subject|2|||
42021867|NCT00967798|75829169|FG000|Overall Study|Lost to Follow-up|4|||
42021868|NCT00967798|75829170|FG001|Overall Study|Lost to Follow-up|1|||
42021869|NCT00965458|75829178|FG000|Overall Study|Adverse Event|1|||
42021870|NCT00965458|75829179|FG001|Overall Study|Adverse Event|0|||
42021871|NCT00965458|75829178|FG000|Overall Study|Lost to Follow-up|1|||
42021872|NCT00965458|75829179|FG001|Overall Study|Lost to Follow-up|3|||
42021873|NCT00965458|75829178|FG000|Overall Study|Withdrawal by Subject|0|||
42021874|NCT00965458|75829179|FG001|Overall Study|Withdrawal by Subject|1|||
42021875|NCT00972244|75829192|FG000|Overall Study|Incorrect Enrolment|1|||
42021876|NCT00972244|75829193|FG001|Overall Study|Incorrect Enrolment|0|||
42021877|NCT00972244|75829194|FG002|Overall Study|Incorrect Enrolment|0|||
42021878|NCT00972244|75829195|FG003|Overall Study|Incorrect Enrolment|0|||
42021879|NCT00972244|75829196|FG004|Overall Study|Incorrect Enrolment|0|||
42021880|NCT00972244|75829192|FG000|Overall Study|Adverse Event|0|||
42021881|NCT00972244|75829193|FG001|Overall Study|Adverse Event|1|||
42021882|NCT00972244|75829194|FG002|Overall Study|Adverse Event|1|||
42021883|NCT00972244|75829195|FG003|Overall Study|Adverse Event|0|||
42021884|NCT00972244|75829196|FG004|Overall Study|Adverse Event|0|||
42021885|NCT00972244|75829192|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
42021886|NCT00972244|75829193|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
42021887|NCT00972244|75829194|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
42021888|NCT00972244|75829195|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
42021889|NCT00972244|75829196|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
42021890|NCT00972244|75829192|FG000|Overall Study|Withdrawal by Subject|1|||
42021891|NCT00972244|75829193|FG001|Overall Study|Withdrawal by Subject|2|||
42021892|NCT00972244|75829194|FG002|Overall Study|Withdrawal by Subject|1|||
42021893|NCT00972244|75829195|FG003|Overall Study|Withdrawal by Subject|0|||
42021894|NCT00972244|75829196|FG004|Overall Study|Withdrawal by Subject|1|||
42021895|NCT00972244|75829192|FG000|Overall Study|Safety|0|||
42021896|NCT00972244|75829193|FG001|Overall Study|Safety|0|||
42021897|NCT00972244|75829194|FG002|Overall Study|Safety|0|||
42021898|NCT00972244|75829195|FG003|Overall Study|Safety|0|||
42021899|NCT00972244|75829196|FG004|Overall Study|Safety|1|||
42021900|NCT00972244|75829192|FG000|Overall Study|Death|1|||
42021901|NCT00972244|75829193|FG001|Overall Study|Death|0|||
42021902|NCT00972244|75829194|FG002|Overall Study|Death|0|||
42021903|NCT00972244|75829195|FG003|Overall Study|Death|0|||
42021904|NCT00972244|75829196|FG004|Overall Study|Death|0|||
42021905|NCT00972244|75829192|FG000|Overall Study|Various|0|||
42021906|NCT00972244|75829193|FG001|Overall Study|Various|0|||
42021907|NCT00972244|75829194|FG002|Overall Study|Various|0|||
42021908|NCT00972244|75829195|FG003|Overall Study|Various|0|||
42021909|NCT00972244|75829196|FG004|Overall Study|Various|2|||
42021910|NCT00892723|75829211|FG000|Overall Study|Lost to Follow-up|1|||
42021911|NCT00892723|75829212|FG001|Overall Study|Lost to Follow-up|3|||
42021912|NCT00892723|75829213|FG002|Overall Study|Lost to Follow-up|1|||
42021913|NCT00892723|75829211|FG000|Overall Study|Withdrawal by Subject|1|||
42021914|NCT00892723|75829212|FG001|Overall Study|Withdrawal by Subject|1|||
42021915|NCT00892723|75829213|FG002|Overall Study|Withdrawal by Subject|1|||
42021916|NCT03811912|75829256|FG000|Overall Study|Withdrew Consent|4|||
42021917|NCT03811912|75829257|FG001|Overall Study|Withdrew Consent|2|||
42021918|NCT00971932|75829263|FG000|Overall Study|Withdrawal by Subject|1|||
42021919|NCT00971932|75829263|FG000|Overall Study|Investigator's decision|2|||
42021920|NCT00971932|75829263|FG000|Overall Study|Ongoing|4|||
42021921|NCT00970684|75829267|FG000|Overall Study|Lack of Efficacy|5|||
42021922|NCT00970684|75829267|FG000|Overall Study|Adverse Event|4|||
42021923|NCT00970684|75829267|FG000|Overall Study|Withdrawal by Subject|1|||
42021924|NCT00967330|75829273|FG000|Overall Study|Protocol Violation|3|||
42021925|NCT00967330|75829274|FG001|Overall Study|Protocol Violation|4|||
42021926|NCT00967330|75829273|FG000|Overall Study|Regular|10|||
42021927|NCT00967330|75829274|FG001|Overall Study|Regular|3|||
42021928|NCT00967330|75829273|FG000|Overall Study|Withdrawal by Subject|6|||
42021929|NCT00967330|75829274|FG001|Overall Study|Withdrawal by Subject|0|||
42021930|NCT00967330|75829273|FG000|Overall Study|Lost to Follow-up|1|||
42021931|NCT00967330|75829274|FG001|Overall Study|Lost to Follow-up|1|||
42021932|NCT00967330|75829273|FG000|Overall Study|Death|102|||
42021933|NCT00967330|75829274|FG001|Overall Study|Death|51|||
42021934|NCT00967330|75829273|FG000|Overall Study|Severe protocol deviation|0|||
42021935|NCT00967330|75829274|FG001|Overall Study|Severe protocol deviation|1|||
42021936|NCT00967018|75829280|FG000|Overall Study|Adverse Event|2|||
42021937|NCT00967018|75829280|FG000|Overall Study|Physician Decision|7|||
42021938|NCT00967018|75829280|FG000|Overall Study|Lost to Follow-up|2|||
42021939|NCT00967018|75829280|FG000|Overall Study|Withdrawal by Subject|1|||
42021940|NCT00967018|75829280|FG000|Overall Study|Miscellaneous Reasons|9|||
42021941|NCT00965146|75829284|FG000|Overall Study|Death|7|||
42021942|NCT00965146|75829284|FG000|Overall Study|Lost to Follow-up|22|||
42021943|NCT00965146|75829284|FG000|Overall Study|Withdrawal by Subject|17|||
42021944|NCT00965146|75829284|FG000|Overall Study|Unable to return|1|||
42021945|NCT00965146|75829284|FG000|Overall Study|Unwilling to return|11|||
42021946|NCT00965146|75829284|FG000|Overall Study|Intercurrent illness|1|||
42021947|NCT00965146|75829284|FG000|Overall Study|Revision / Removal of Study Implant|6|||
42021948|NCT00965146|75829284|FG000|Overall Study|Overall Study Termination|145|||
42021949|NCT00966940|75829290|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
42021950|NCT00966940|75829291|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
42021951|NCT00966940|75829290|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
42021952|NCT00966940|75829291|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
42021953|NCT00965848|75829297|FG000|Overall Study|Protocol Violation|3|||
42021954|NCT00965848|75829298|FG001|Overall Study|Protocol Violation|0|||
42021955|NCT00965848|75829299|FG002|Overall Study|Protocol Violation|1|||
42021956|NCT00965848|75829297|FG000|Overall Study|Death|11|||
42021957|NCT00965848|75829298|FG001|Overall Study|Death|1|||
42113743|NCT00522873|75924262|FG000|Overall Study|Lost to Follow-up|11|||
42113744|NCT00522873|75924263|FG001|Overall Study|Lost to Follow-up|3|||
42113745|NCT00522873|75924262|FG000|Overall Study|Personal Reasons|8|||
42113746|NCT00522873|75924263|FG001|Overall Study|Personal Reasons|1|||
42113747|NCT00522873|75924262|FG000|Overall Study|Medication Errors|1|||
42113748|NCT00522873|75924263|FG001|Overall Study|Medication Errors|1|||
42113749|NCT00522873|75924262|FG000|Overall Study|Never Received Medication|1|||
42113750|NCT00522873|75924263|FG001|Overall Study|Never Received Medication|0|||
42113751|NCT03684057|75924271|FG000|Overall Study|Withdrawal by Subject|4|||
42113752|NCT03684057|75924272|FG001|Overall Study|Withdrawal by Subject|5|||
42113753|NCT03864627|75924281|FG000|Overall Study|Adverse Event|0|||
42113754|NCT03864627|75924282|FG001|Overall Study|Adverse Event|1|||
42113755|NCT03864627|75924281|FG000|Overall Study|Lack of Efficacy|0|||
42113756|NCT03864627|75924282|FG001|Overall Study|Lack of Efficacy|1|||
42113757|NCT03864627|75924281|FG000|Overall Study|Lost to Follow-up|0|||
42113758|NCT03864627|75924282|FG001|Overall Study|Lost to Follow-up|1|||
42113759|NCT03864627|75924281|FG000|Overall Study|Withdrawal by Subject|4|||
42113760|NCT03864627|75924282|FG001|Overall Study|Withdrawal by Subject|8|||
42113761|NCT03864627|75924281|FG000|Overall Study|Study terminated by sponsor|0|||
42113762|NCT03864627|75924282|FG001|Overall Study|Study terminated by sponsor|1|||
42113763|NCT00519831|75924289|FG000|Overall Study|Adverse Event|3|||
42113764|NCT00131911|75924299|FG000|Overall Study|Withdrawal by Subject|1|||
42021958|NCT00965848|75829299|FG002|Overall Study|Death|5|||
42021959|NCT00965848|75829297|FG000|Overall Study|Lost to Follow-up|0|||
42021960|NCT00965848|75829298|FG001|Overall Study|Lost to Follow-up|0|||
42021961|NCT00965848|75829299|FG002|Overall Study|Lost to Follow-up|1|||
42021962|NCT00965848|75829297|FG000|Overall Study|Withdrawal by Subject|1|||
42021963|NCT00965848|75829298|FG001|Overall Study|Withdrawal by Subject|0|||
42021964|NCT00965848|75829299|FG002|Overall Study|Withdrawal by Subject|0|||
42021965|NCT00965848|75829297|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
42021966|NCT00965848|75829298|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
42021967|NCT00965848|75829299|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
42021968|NCT00965848|75829297|FG000|Overall Study|Not Clinically Evaluable|7|||
42021969|NCT00965848|75829298|FG001|Overall Study|Not Clinically Evaluable|1|||
42021970|NCT00965848|75829299|FG002|Overall Study|Not Clinically Evaluable|1|||
42021971|NCT00965848|75829297|FG000|Overall Study|Other|5|||
42021972|NCT00965848|75829298|FG001|Overall Study|Other|0|||
42021973|NCT00965848|75829299|FG002|Overall Study|Other|1|||
42021974|NCT00961636|75829310|FG000|Overall Study|Adverse Event|35|||
42021975|NCT00961636|75829311|FG001|Overall Study|Adverse Event|54|||
42021976|NCT00961636|75829312|FG002|Overall Study|Adverse Event|13|||
42021977|NCT00961636|75829310|FG000|Overall Study|Flushing Symptoms|29|||
42021978|NCT00961636|75829311|FG001|Overall Study|Flushing Symptoms|46|||
42021979|NCT00961636|75829312|FG002|Overall Study|Flushing Symptoms|3|||
42113765|NCT00131911|75924300|FG001|Overall Study|Withdrawal by Subject|0|||
42113766|NCT00184093|75924305|FG000|Overall Study|Adverse Event|3|||
42113767|NCT00184093|75924305|FG000|Overall Study|Lost to Follow-up|3|||
42113768|NCT00184093|75924305|FG000|Overall Study|Physician Decision|1|||
42113769|NCT00184093|75924305|FG000|Overall Study|Withdrawal by Subject|2|||
42113770|NCT00183625|75924311|FG000|Overall Study|Withdrawal by Subject|18|||
42113771|NCT00183625|75924312|FG001|Overall Study|Withdrawal by Subject|18|||
42113772|NCT00183625|75924313|FG002|Overall Study|Withdrawal by Subject|19|||
42113773|NCT00183625|75924314|FG003|Overall Study|Withdrawal by Subject|14|||
42113774|NCT00511875|75924324|FG000|Overall Study|Lost to Follow-up|4|||
42113775|NCT00511875|75924325|FG001|Overall Study|Lost to Follow-up|0|||
42113776|NCT00511875|75924324|FG000|Overall Study|Missing variables|1|||
42113777|NCT00511875|75924325|FG001|Overall Study|Missing variables|0|||
42113778|NCT00183391|75924333|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
42113779|NCT00183391|75924334|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
42113780|NCT00183391|75924333|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
42113781|NCT00183391|75924334|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
42113782|NCT00493246|75924350|FG000|Overall Study|Withdrawal by Subject|0|||
42113783|NCT00493246|75924351|FG001|Overall Study|Withdrawal by Subject|0|||
42113784|NCT00493246|75924352|FG002|Overall Study|Withdrawal by Subject|0|||
42113785|NCT00493246|75924353|FG003|Overall Study|Withdrawal by Subject|0|||
42113786|NCT00493246|75924354|FG004|Overall Study|Withdrawal by Subject|1|||
42113787|NCT00493246|75924355|FG005|Overall Study|Withdrawal by Subject|0|||
42113788|NCT00493246|75924356|FG006|Overall Study|Withdrawal by Subject|0|||
42113789|NCT00493246|75924357|FG007|Overall Study|Withdrawal by Subject|0|||
42113790|NCT00493246|75924350|FG000|Overall Study|No access to draw blood|0|||
42113791|NCT00493246|75924351|FG001|Overall Study|No access to draw blood|0|||
42113792|NCT00493246|75924352|FG002|Overall Study|No access to draw blood|0|||
42113793|NCT00493246|75924353|FG003|Overall Study|No access to draw blood|0|||
42113794|NCT00493246|75924354|FG004|Overall Study|No access to draw blood|0|||
42113795|NCT00493246|75924355|FG005|Overall Study|No access to draw blood|1|||
42113796|NCT00493246|75924356|FG006|Overall Study|No access to draw blood|0|||
42113797|NCT00493246|75924357|FG007|Overall Study|No access to draw blood|0|||
42113798|NCT00493246|75924350|FG000|Overall Study|Lost to Follow-up|0|||
42113799|NCT00493246|75924351|FG001|Overall Study|Lost to Follow-up|0|||
42113800|NCT00493246|75924352|FG002|Overall Study|Lost to Follow-up|0|||
42113801|NCT00493246|75924353|FG003|Overall Study|Lost to Follow-up|0|||
42113802|NCT00493246|75924354|FG004|Overall Study|Lost to Follow-up|0|||
42113803|NCT00493246|75924355|FG005|Overall Study|Lost to Follow-up|0|||
42113804|NCT00493246|75924356|FG006|Overall Study|Lost to Follow-up|1|||
42113805|NCT00493246|75924357|FG007|Overall Study|Lost to Follow-up|0|||
42113806|NCT02281955|75924375|FG000|Overall Study|Death|1|||
42113807|NCT00511797|75924383|FG000|Overall Study|Adverse Event|1|||
42113808|NCT00511797|75924384|FG001|Overall Study|Adverse Event|2|||
42113809|NCT00511797|75924385|FG002|Overall Study|Adverse Event|2|||
42113810|NCT00511797|75924386|FG003|Overall Study|Adverse Event|2|||
42113811|NCT00511797|75924383|FG000|Overall Study|Lost to Follow-up|1|||
42113812|NCT00511797|75924384|FG001|Overall Study|Lost to Follow-up|0|||
42113813|NCT00511797|75924385|FG002|Overall Study|Lost to Follow-up|0|||
42113814|NCT00511797|75924386|FG003|Overall Study|Lost to Follow-up|1|||
42113815|NCT00511797|75924383|FG000|Overall Study|Pregnancy|0|||
42113816|NCT00511797|75924384|FG001|Overall Study|Pregnancy|0|||
42113817|NCT00511797|75924385|FG002|Overall Study|Pregnancy|0|||
42113818|NCT00511797|75924386|FG003|Overall Study|Pregnancy|1|||
42113819|NCT00511797|75924383|FG000|Overall Study|Protocol Violation|0|||
42113820|NCT00511797|75924384|FG001|Overall Study|Protocol Violation|2|||
42113821|NCT00511797|75924385|FG002|Overall Study|Protocol Violation|2|||
42113822|NCT00511797|75924386|FG003|Overall Study|Protocol Violation|3|||
42113823|NCT00511797|75924383|FG000|Overall Study|Withdrawal by Subject|3|||
42113824|NCT00511797|75924384|FG001|Overall Study|Withdrawal by Subject|3|||
42113825|NCT00511797|75924385|FG002|Overall Study|Withdrawal by Subject|4|||
42113826|NCT00511797|75924386|FG003|Overall Study|Withdrawal by Subject|2|||
42113827|NCT00511797|75924383|FG000|Overall Study|Never dispensed|1|||
42113828|NCT00511797|75924384|FG001|Overall Study|Never dispensed|0|||
42113829|NCT00511797|75924385|FG002|Overall Study|Never dispensed|1|||
42113830|NCT00511797|75924386|FG003|Overall Study|Never dispensed|3|||
42113831|NCT00511797|75924383|FG000|Overall Study|Study drug not taken|0|||
42113832|NCT00511797|75924384|FG001|Overall Study|Study drug not taken|1|||
42113833|NCT00511797|75924385|FG002|Overall Study|Study drug not taken|0|||
42113834|NCT00511797|75924386|FG003|Overall Study|Study drug not taken|1|||
42113835|NCT00511797|75924383|FG000|Overall Study|Partially missing diary|0|||
42113836|NCT00511797|75924384|FG001|Overall Study|Partially missing diary|0|||
42113837|NCT00511797|75924385|FG002|Overall Study|Partially missing diary|1|||
42113838|NCT00511797|75924386|FG003|Overall Study|Partially missing diary|0|||
42113839|NCT00511797|75924383|FG000|Overall Study|Other (moving etc)|1|||
42113840|NCT00511797|75924384|FG001|Overall Study|Other (moving etc)|0|||
42113841|NCT00511797|75924385|FG002|Overall Study|Other (moving etc)|1|||
42113842|NCT00511797|75924386|FG003|Overall Study|Other (moving etc)|2|||
42113843|NCT00487552|75924396|FG000|Overall Study|Unsuccessful magnet placements|3|||
42113844|NCT00487552|75924396|FG000|Overall Study|Death due to progressive malignancy|2|||
42113845|NCT00487552|75924396|FG000|Overall Study|Stent not placed|1|||
42113846|NCT00182689|75924403|FG000|Overall Study|Adverse Event|8|||
42113847|NCT00182689|75924404|FG001|Overall Study|Adverse Event|11|||
42113848|NCT00182689|75924403|FG000|Overall Study|Withdrawal by Subject|2|||
42113849|NCT00182689|75924404|FG001|Overall Study|Withdrawal by Subject|2|||
42113850|NCT00182689|75924403|FG000|Overall Study|Progression|27|||
42113851|NCT00182689|75924404|FG001|Overall Study|Progression|29|||
42113852|NCT00182689|75924403|FG000|Overall Study|Death|1|||
42113853|NCT00182689|75924404|FG001|Overall Study|Death|0|||
42113854|NCT00182689|75924403|FG000|Overall Study|not protocol specified|0|||
42113855|NCT00182689|75924404|FG001|Overall Study|not protocol specified|3|||
42113856|NCT00182689|75924403|FG000|Overall Study|Ineligible|1|||
42113857|NCT00182689|75924404|FG001|Overall Study|Ineligible|4|||
42113858|NCT00182689|75924403|FG000|Overall Study|Never received treatment|1|||
42113859|NCT00182689|75924404|FG001|Overall Study|Never received treatment|0|||
42113860|NCT03860259|75924416|FG000|Overall Study|Lost to Follow-up|5|||
42113861|NCT03860259|75924417|FG001|Overall Study|Lost to Follow-up|5|||
42113862|NCT03860259|75924416|FG000|Overall Study|Protocol Violation|1|||
42113863|NCT03860259|75924417|FG001|Overall Study|Protocol Violation|0|||
42113864|NCT00131365|75924423|FG000|Overall Study|Withdrawal by Subject|1|||
42113865|NCT00131365|75924423|FG000|Overall Study|Alternative treatment|3|||
42113866|NCT00487240|75924430|FG000|Overall Study|Withdrawal by Subject|12|||
42113867|NCT00487240|75924431|FG001|Overall Study|Withdrawal by Subject|6|||
42113868|NCT00487240|75924430|FG000|Overall Study|Lost to Follow-up|7|||
42113869|NCT00487240|75924431|FG001|Overall Study|Lost to Follow-up|6|||
42113870|NCT00487240|75924430|FG000|Overall Study|Adverse Event|0|||
42113871|NCT00487240|75924431|FG001|Overall Study|Adverse Event|4|||
42113872|NCT00487240|75924430|FG000|Overall Study|Protocol Violation|5|||
42113873|NCT00487240|75924431|FG001|Overall Study|Protocol Violation|5|||
42113874|NCT00487240|75924430|FG000|Overall Study|Entry Criteria Not Met|3|||
42113875|NCT00487240|75924431|FG001|Overall Study|Entry Criteria Not Met|4|||
42113876|NCT00487240|75924430|FG000|Overall Study|Sponsor Decision|2|||
42113877|NCT00487240|75924431|FG001|Overall Study|Sponsor Decision|1|||
42113878|NCT00487240|75924430|FG000|Overall Study|Physician Decision|2|||
42113879|NCT00487240|75924431|FG001|Overall Study|Physician Decision|0|||
42113880|NCT02224391|75924439|FG000|Overall Study|Lost to Follow-up|26|||
42113881|NCT02224391|75924440|FG001|Overall Study|Lost to Follow-up|19|||
42113882|NCT02224391|75924439|FG000|Overall Study|Withdrawal by Subject|6|||
42113883|NCT02224391|75924440|FG001|Overall Study|Withdrawal by Subject|5|||
42113884|NCT00487162|75924448|FG000|Overall Study|Adverse Event|0|||
42113885|NCT00487162|75924449|FG001|Overall Study|Adverse Event|1|||
42113886|NCT00487162|75924448|FG000|Overall Study|Physician Decision|0|||
42113887|NCT00487162|75924449|FG001|Overall Study|Physician Decision|1|||
42113888|NCT00487162|75924448|FG000|Overall Study|Withdrawal by Subject|2|||
42113889|NCT00487162|75924449|FG001|Overall Study|Withdrawal by Subject|3|||
42113890|NCT00487084|75924458|FG000|Overall Study|Did not receive intervention|4|||
42113891|NCT00487084|75924459|FG001|Overall Study|Did not receive intervention|3|||
42113892|NCT00487084|75924460|FG002|Overall Study|Did not receive intervention|5|||
42113893|NCT00466726|75924468|FG000|Overall Study|Not evaluable for response|14|||
42113894|NCT01721291|75924474|FG000|Overall Study|Withdrawal by Subject|1|||
42113895|NCT01721291|75924475|FG001|Overall Study|Withdrawal by Subject|0|||
42113896|NCT01721291|75924474|FG000|Overall Study|did not like the treatment|1|||
42113897|NCT01721291|75924475|FG001|Overall Study|did not like the treatment|0|||
42113898|NCT00486226|75924501|FG000|Overall Study|Death|3|||
42113899|NCT00486226|75924501|FG000|Overall Study|Adverse Event|1|||
42113900|NCT00486226|75924501|FG000|Overall Study|Withdrawal by Subject|1|||
42113901|NCT00486226|75924501|FG000|Overall Study|Lost to Follow-up|8|||
42113902|NCT00485758|75924510|FG000|Overall Study|Adverse Event|102|||
42113903|NCT00485758|75924511|FG001|Overall Study|Adverse Event|31|||
42113904|NCT00485758|75924510|FG000|Overall Study|Death|0|||
42113905|NCT00485758|75924511|FG001|Overall Study|Death|1|||
42113906|NCT00485758|75924510|FG000|Overall Study|Lost to Follow-up|5|||
42113907|NCT00485758|75924511|FG001|Overall Study|Lost to Follow-up|1|||
42113908|NCT00485758|75924510|FG000|Overall Study|Physician Decision|3|||
42113909|NCT00485758|75924511|FG001|Overall Study|Physician Decision|3|||
42113910|NCT00485758|75924510|FG000|Overall Study|Protocol Violation|11|||
42113911|NCT00485758|75924511|FG001|Overall Study|Protocol Violation|2|||
42113912|NCT00485758|75924510|FG000|Overall Study|Withdrawal by Subject|32|||
42113913|NCT00485758|75924511|FG001|Overall Study|Withdrawal by Subject|27|||
42113914|NCT00485758|75924510|FG000|Overall Study|Study Terminated by Sponsor|3|||
42113915|NCT00485758|75924511|FG001|Overall Study|Study Terminated by Sponsor|0|||
42113916|NCT00469612|75924519|FG000|Overall Study|Study terminated before data collected|2|||
42113917|NCT00469612|75924520|FG001|Overall Study|Study terminated before data collected|0|||
42113918|NCT00469456|75924528|FG000|Overall Study|Adverse Event|4|||
42113919|NCT00469456|75924529|FG001|Overall Study|Adverse Event|3|||
42113920|NCT00469456|75924528|FG000|Overall Study|Protocol Violation|1|||
42113921|NCT00469456|75924529|FG001|Overall Study|Protocol Violation|0|||
42113922|NCT00469456|75924528|FG000|Overall Study|Withdrawal by Subject|4|||
42113923|NCT00469456|75924529|FG001|Overall Study|Withdrawal by Subject|1|||
42113924|NCT00581555|75924537|FG000|Overall Study|Adverse Event|4|||
42113925|NCT00581555|75924538|FG001|Overall Study|Adverse Event|3|||
42113926|NCT00581555|75924537|FG000|Overall Study|Physician Decision|3|||
42113927|NCT00581555|75924538|FG001|Overall Study|Physician Decision|2|||
42113928|NCT00581555|75924537|FG000|Overall Study|Withdrawal by Subject|18|||
42113929|NCT00581555|75924538|FG001|Overall Study|Withdrawal by Subject|9|||
42113930|NCT00581555|75924537|FG000|Overall Study|Lost to Follow-up|2|||
42113931|NCT00581555|75924538|FG001|Overall Study|Lost to Follow-up|2|||
42113932|NCT00581555|75924537|FG000|Overall Study|Other reasons|16|||
42113933|NCT00581555|75924538|FG001|Overall Study|Other reasons|4|||
42113934|NCT00469144|75924546|FG000|Overall Study|Death|0|||
42113935|NCT00469144|75924547|FG001|Overall Study|Death|1|||
42113936|NCT00469144|75924546|FG000|Overall Study|No Response|5|||
42113937|NCT00469144|75924547|FG001|Overall Study|No Response|5|||
42113938|NCT00469144|75924546|FG000|Overall Study|Progressive Disease|1|||
42113939|NCT00469144|75924547|FG001|Overall Study|Progressive Disease|0|||
42113940|NCT00468910|75924559|FG000|Overall Study|Lost to Follow-up|2|||
42113941|NCT00468910|75924560|FG001|Overall Study|Lost to Follow-up|1|||
42113942|NCT00468910|75924559|FG000|Overall Study|Withdrawal by Subject|2|||
42113943|NCT00468910|75924560|FG001|Overall Study|Withdrawal by Subject|1|||
42113944|NCT00468910|75924559|FG000|Overall Study|Medical Contraindication|0|||
42113945|NCT00468910|75924560|FG001|Overall Study|Medical Contraindication|1|||
42113946|NCT01412333|75924569|FG000|Overall Study|Death|1|||
42113947|NCT01412333|75924570|FG001|Overall Study|Death|1|||
42113948|NCT01412333|75924569|FG000|Overall Study|Physician Decision|0|||
42113949|NCT01412333|75924570|FG001|Overall Study|Physician Decision|1|||
42113950|NCT01412333|75924569|FG000|Overall Study|Reason not specified|16|||
42113951|NCT01412333|75924570|FG001|Overall Study|Reason not specified|10|||
42113952|NCT01412333|75924569|FG000|Overall Study|Non-compliance with study drug|1|||
42113953|NCT01412333|75924570|FG001|Overall Study|Non-compliance with study drug|1|||
42113954|NCT01412333|75924569|FG000|Overall Study|Protocol Violation|1|||
42113955|NCT01412333|75924570|FG001|Overall Study|Protocol Violation|1|||
42113956|NCT01412333|75924569|FG000|Overall Study|Non-compliance|1|||
42113957|NCT01412333|75924570|FG001|Overall Study|Non-compliance|3|||
42113958|NCT01412333|75924569|FG000|Overall Study|Lack of Efficacy|15|||
42113959|NCT01412333|75924570|FG001|Overall Study|Lack of Efficacy|6|||
42113960|NCT01412333|75924569|FG000|Overall Study|Pregnancy|3|||
42113961|NCT01412333|75924570|FG001|Overall Study|Pregnancy|0|||
42113962|NCT01412333|75924569|FG000|Overall Study|Consent withdrawn by participant|25|||
42113963|NCT01412333|75924570|FG001|Overall Study|Consent withdrawn by participant|12|||
42113964|NCT01412333|75924569|FG000|Overall Study|Adverse Event|25|||
42113965|NCT01412333|75924570|FG001|Overall Study|Adverse Event|16|||
42113966|NCT01412333|75924569|FG000|Overall Study|Lost to Follow-up|10|||
42113967|NCT01412333|75924570|FG001|Overall Study|Lost to Follow-up|6|||
42113968|NCT00519285|75924579|FG000|Overall Study|Adverse Event|127|||
42113969|NCT00519285|75924580|FG001|Overall Study|Adverse Event|266|||
42113970|NCT00519285|75924579|FG000|Overall Study|Disease progression|334|||
42113971|NCT00519285|75924580|FG001|Overall Study|Disease progression|186|||
42113972|NCT00519285|75924579|FG000|Overall Study|Physician Decision|75|||
42113973|NCT00519285|75924580|FG001|Overall Study|Physician Decision|47|||
42113974|NCT00519285|75924579|FG000|Overall Study|Participant's request|53|||
42113975|NCT00519285|75924580|FG001|Overall Study|Participant's request|84|||
42113976|NCT00519285|75924579|FG000|Overall Study|Consent withdrawn|4|||
42113977|NCT00519285|75924580|FG001|Overall Study|Consent withdrawn|5|||
42113978|NCT00519285|75924579|FG000|Overall Study|Poor compliance to protocol|5|||
42113979|NCT00519285|75924580|FG001|Overall Study|Poor compliance to protocol|7|||
42113980|NCT00519285|75924579|FG000|Overall Study|Reason unspecified|5|||
42113981|NCT00519285|75924580|FG001|Overall Study|Reason unspecified|8|||
42113982|NCT00519285|75924579|FG000|Overall Study|Not treated|8|||
42113983|NCT00519285|75924580|FG001|Overall Study|Not treated|7|||
42113984|NCT00519285|75924579|FG000|Overall Study|Treatment ongoing|1|||
42113985|NCT00519285|75924580|FG001|Overall Study|Treatment ongoing|2|||
42113986|NCT00464620|75924586|FG000|Overall Study|Physician Decision|1|||
42113987|NCT00464620|75924587|FG001|Overall Study|Physician Decision|0|||
42113988|NCT00464620|75924588|FG002|Overall Study|Physician Decision|0|||
42113989|NCT00464620|75924586|FG000|Overall Study|Withdrawal by Subject|1|||
42113990|NCT00464620|75924587|FG001|Overall Study|Withdrawal by Subject|0|||
42113991|NCT00464620|75924588|FG002|Overall Study|Withdrawal by Subject|3|||
42113992|NCT00464620|75924586|FG000|Overall Study|Ineligible sarcoma subtype|0|||
42113993|NCT00464620|75924587|FG001|Overall Study|Ineligible sarcoma subtype|2|||
42113994|NCT00464620|75924588|FG002|Overall Study|Ineligible sarcoma subtype|2|||
42113995|NCT00464620|75924586|FG000|Overall Study|Use of prohibited concomitant medication|0|||
42113996|NCT00464620|75924587|FG001|Overall Study|Use of prohibited concomitant medication|0|||
42113997|NCT00464620|75924588|FG002|Overall Study|Use of prohibited concomitant medication|2|||
42113998|NCT00464542|75924601|FG000|Pre-treatment|Withdrawal by Subject|2|||
42113999|NCT00468676|75924607|FG000|Overall Study|Lost to Follow-up|14|||
42114000|NCT00468676|75924608|FG001|Overall Study|Lost to Follow-up|11|||
42114001|NCT00468676|75924607|FG000|Overall Study|Death|2|||
42114002|NCT00468676|75924608|FG001|Overall Study|Death|1|||
42114003|NCT00464308|75924619|FG000|Overall Study|Adverse Event|22|||
42114004|NCT00464308|75924620|FG001|Overall Study|Adverse Event|27|||
42114005|NCT00464308|75924621|FG002|Overall Study|Adverse Event|16|||
42114006|NCT00464308|75924619|FG000|Overall Study|Lost to Follow-up|29|||
42114007|NCT00464308|75924620|FG001|Overall Study|Lost to Follow-up|19|||
42114008|NCT00464308|75924621|FG002|Overall Study|Lost to Follow-up|20|||
42114009|NCT00464308|75924619|FG000|Overall Study|Patient discontinued and other reasons|17|||
42114010|NCT00464308|75924620|FG001|Overall Study|Patient discontinued and other reasons|17|||
42114011|NCT00464308|75924621|FG002|Overall Study|Patient discontinued and other reasons|23|||
42114012|NCT00464308|75924619|FG000|Overall Study|Physician Decision|1|||
42114013|NCT00464308|75924620|FG001|Overall Study|Physician Decision|0|||
42114014|NCT00464308|75924621|FG002|Overall Study|Physician Decision|0|||
42114015|NCT00468286|75924631|FG000|Overall Study|Adverse Event|1|||
42114016|NCT00468286|75924632|FG001|Overall Study|Adverse Event|6|||
42114017|NCT00468286|75924631|FG000|Overall Study|Protocol Violation|2|||
42114018|NCT00468286|75924632|FG001|Overall Study|Protocol Violation|2|||
42114019|NCT00468286|75924631|FG000|Overall Study|Withdrawal by Subject|4|||
42114020|NCT00468286|75924632|FG001|Overall Study|Withdrawal by Subject|3|||
42114021|NCT00468286|75924631|FG000|Overall Study|Physician Decision|0|||
42114022|NCT00468286|75924632|FG001|Overall Study|Physician Decision|1|||
42114023|NCT00463840|75924638|FG000|Overall Study|Disease progression|7|||
42114024|NCT00463840|75924638|FG000|Overall Study|Withdrawal by Subject|2|||
42114025|NCT00463840|75924638|FG000|Overall Study|Adverse Event|3|||
42114026|NCT00129389|75924644|FG000|Overall Study|Adverse Event|19|||
42114027|NCT00129389|75924645|FG001|Overall Study|Adverse Event|87|||
42114028|NCT00129389|75924644|FG000|Overall Study|Death|0|||
42114029|NCT00129389|75924645|FG001|Overall Study|Death|1|||
42114030|NCT00129389|75924644|FG000|Overall Study|Lost to Follow-up|2|||
42114031|NCT00129389|75924645|FG001|Overall Study|Lost to Follow-up|1|||
42114032|NCT00129389|75924644|FG000|Overall Study|Physician Decision|0|||
42114033|NCT00129389|75924645|FG001|Overall Study|Physician Decision|4|||
42114034|NCT00129389|75924644|FG000|Overall Study|Protocol Violation|0|||
42114035|NCT00129389|75924645|FG001|Overall Study|Protocol Violation|6|||
42114036|NCT00129389|75924644|FG000|Overall Study|Withdrawal by Subject|9|||
42114037|NCT00129389|75924645|FG001|Overall Study|Withdrawal by Subject|23|||
42114038|NCT00129389|75924644|FG000|Overall Study|Relapse|1|||
42114039|NCT00129389|75924645|FG001|Overall Study|Relapse|0|||
42114040|NCT00129389|75924644|FG000|Overall Study|Not eligible|1|||
42114041|NCT00129389|75924645|FG001|Overall Study|Not eligible|2|||
42114042|NCT00129389|75924644|FG000|Overall Study|Crossed to the other arm|1|||
42114043|NCT00129389|75924645|FG001|Overall Study|Crossed to the other arm|16|||
42114044|NCT00468052|75924653|FG000|Overall Study|Protocol Violation|7|||
42114045|NCT00468052|75924654|FG001|Overall Study|Protocol Violation|8|||
42114046|NCT00453310|75924662|FG000|Overall Study|Progression of Disease|10|||
42114047|NCT00124657|75924669|FG000|Overall Study|Toxicity|0|||
42114048|NCT00124657|75924670|FG001|Overall Study|Toxicity|0|||
42114049|NCT00124657|75924671|FG002|Overall Study|Toxicity|1|||
42114050|NCT00124657|75924669|FG000|Overall Study|Non-compliance|1|||
42114051|NCT00124657|75924670|FG001|Overall Study|Non-compliance|0|||
42114052|NCT00124657|75924671|FG002|Overall Study|Non-compliance|4|||
42114053|NCT00124657|75924669|FG000|Overall Study|Progressive disease|14|||
42114054|NCT00124657|75924670|FG001|Overall Study|Progressive disease|5|||
42114055|NCT00124657|75924671|FG002|Overall Study|Progressive disease|27|||
42114056|NCT00124657|75924669|FG000|Overall Study|Intercurrent illness|1|||
42114057|NCT00124657|75924670|FG001|Overall Study|Intercurrent illness|0|||
42114058|NCT00124657|75924671|FG002|Overall Study|Intercurrent illness|0|||
42114059|NCT00581945|75924694|FG000|Overall Study|Adverse Event|4|||
42114060|NCT00581945|75924695|FG001|Overall Study|Adverse Event|4|||
42114061|NCT00581945|75924694|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
42114062|NCT00581945|75924695|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42114063|NCT00581945|75924694|FG000|Overall Study|Withdrawal by Subject|2|||
42114064|NCT00581945|75924695|FG001|Overall Study|Withdrawal by Subject|6|||
42114065|NCT00581945|75924694|FG000|Overall Study|Death|1|||
42114066|NCT00581945|75924695|FG001|Overall Study|Death|0|||
42114067|NCT00555906|75924704|FG000|Phase 1|Objective Progression or Relapse|3|||
42114068|NCT00555906|75924705|FG001|Phase 1|Objective Progression or Relapse|5|||
42114069|NCT00555906|75924706|FG002|Phase 1|Objective Progression or Relapse|3|||
42114070|NCT00555906|75924707|FG003|Phase 1|Objective Progression or Relapse|1|||
42114071|NCT00555906|75924708|FG004|Phase 1|Objective Progression or Relapse|0|||
42114072|NCT00555906|75924704|FG000|Phase 1|Global Deterioration of Health Status|0|||
42114073|NCT00555906|75924705|FG001|Phase 1|Global Deterioration of Health Status|1|||
42114074|NCT00555906|75924706|FG002|Phase 1|Global Deterioration of Health Status|1|||
42114075|NCT00555906|75924707|FG003|Phase 1|Global Deterioration of Health Status|1|||
42114076|NCT00555906|75924708|FG004|Phase 1|Global Deterioration of Health Status|0|||
42114077|NCT00555906|75924704|FG000|Phase 1|Adverse Event|0|||
42114078|NCT00555906|75924705|FG001|Phase 1|Adverse Event|0|||
42114079|NCT00555906|75924706|FG002|Phase 1|Adverse Event|3|||
42114080|NCT00555906|75924707|FG003|Phase 1|Adverse Event|2|||
42114081|NCT00555906|75924708|FG004|Phase 1|Adverse Event|0|||
42114082|NCT00555906|75924704|FG000|Phase 1|Withdrawal by Subject|0|||
42114083|NCT00555906|75924705|FG001|Phase 1|Withdrawal by Subject|0|||
42114084|NCT00555906|75924706|FG002|Phase 1|Withdrawal by Subject|0|||
42114085|NCT00555906|75924707|FG003|Phase 1|Withdrawal by Subject|1|||
42114086|NCT00555906|75924708|FG004|Phase 1|Withdrawal by Subject|0|||
42114087|NCT00555906|75924704|FG000|Phase 2|Adverse Event|0|||
42114088|NCT00555906|75924705|FG001|Phase 2|Adverse Event|0|||
42114089|NCT00555906|75924706|FG002|Phase 2|Adverse Event|0|||
42114090|NCT00555906|75924707|FG003|Phase 2|Adverse Event|0|||
42114091|NCT00555906|75924708|FG004|Phase 2|Adverse Event|4|||
42114092|NCT00555906|75924704|FG000|Phase 2|Global Deterioration of Health Status|0|||
42114093|NCT00555906|75924705|FG001|Phase 2|Global Deterioration of Health Status|0|||
42114094|NCT00555906|75924706|FG002|Phase 2|Global Deterioration of Health Status|0|||
42114095|NCT00555906|75924707|FG003|Phase 2|Global Deterioration of Health Status|0|||
42114096|NCT00555906|75924708|FG004|Phase 2|Global Deterioration of Health Status|2|||
42114097|NCT00555906|75924704|FG000|Phase 2|Objective Progression or Relapse|0|||
42114098|NCT00555906|75924705|FG001|Phase 2|Objective Progression or Relapse|0|||
42114099|NCT00555906|75924706|FG002|Phase 2|Objective Progression or Relapse|0|||
42114100|NCT00555906|75924707|FG003|Phase 2|Objective Progression or Relapse|0|||
42114101|NCT00555906|75924708|FG004|Phase 2|Objective Progression or Relapse|16|||
42114102|NCT00555906|75924704|FG000|Phase 2|Withdrawal by Subject|0|||
42114103|NCT00555906|75924705|FG001|Phase 2|Withdrawal by Subject|0|||
42114104|NCT00555906|75924706|FG002|Phase 2|Withdrawal by Subject|0|||
42114105|NCT00555906|75924707|FG003|Phase 2|Withdrawal by Subject|0|||
42114106|NCT00555906|75924708|FG004|Phase 2|Withdrawal by Subject|2|||
42114107|NCT00555906|75924704|FG000|Phase 2|Other|0|||
42114108|NCT00555906|75924705|FG001|Phase 2|Other|0|||
42114109|NCT00555906|75924706|FG002|Phase 2|Other|0|||
42114110|NCT00555906|75924707|FG003|Phase 2|Other|0|||
42114111|NCT00555906|75924708|FG004|Phase 2|Other|6|||
42114112|NCT00555906|75924704|FG000|Phase 2|Randomized but not Treated|0|||
42114113|NCT00555906|75924705|FG001|Phase 2|Randomized but not Treated|0|||
42114114|NCT00555906|75924706|FG002|Phase 2|Randomized but not Treated|0|||
42114115|NCT00555906|75924707|FG003|Phase 2|Randomized but not Treated|0|||
42114116|NCT00555906|75924708|FG004|Phase 2|Randomized but not Treated|2|||
42114117|NCT03817879|75924725|FG000|Overall Study|Drop out|5|||
42114118|NCT03817879|75924726|FG001|Overall Study|Drop out|12|||
42114119|NCT03817879|75924725|FG000|Overall Study|Withdrawal by Subject|0|||
42114120|NCT03817879|75924726|FG001|Overall Study|Withdrawal by Subject|1|||
42114121|NCT00555672|75924734|FG000|Overall Study|Death|0|||
42114122|NCT00555672|75924735|FG001|Overall Study|Death|2|||
42114123|NCT00555672|75924734|FG000|Overall Study|Adverse Event|8|||
42114124|NCT00555672|75924735|FG001|Overall Study|Adverse Event|2|||
42114125|NCT00555672|75924734|FG000|Overall Study|Objective progression or relapse|11|||
42114126|NCT00555672|75924735|FG001|Overall Study|Objective progression or relapse|5|||
42114127|NCT00555672|75924734|FG000|Overall Study|Other|3|||
42114128|NCT00555672|75924735|FG001|Overall Study|Other|1|||
42114129|NCT00555672|75924734|FG000|Overall Study|Participant refused|2|||
42114130|NCT00555672|75924735|FG001|Overall Study|Participant refused|0|||
42114131|NCT03958656|75924745|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
42114132|NCT03958656|75924746|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
42114133|NCT03958656|75924747|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
42114134|NCT03958656|75924748|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
42114135|NCT03958656|75924745|FG000|Overall Study|No longer meets eligibility criteria|0|||
42114136|NCT03958656|75924746|FG001|Overall Study|No longer meets eligibility criteria|0|||
42114137|NCT03958656|75924747|FG002|Overall Study|No longer meets eligibility criteria|1|||
42114138|NCT03958656|75924748|FG003|Overall Study|No longer meets eligibility criteria|0|||
42114139|NCT03958656|75924745|FG000|Overall Study|Started anti-cancer treatment|0|||
42114140|NCT03958656|75924746|FG001|Overall Study|Started anti-cancer treatment|0|||
42114141|NCT03958656|75924747|FG002|Overall Study|Started anti-cancer treatment|1|||
42114142|NCT03958656|75924748|FG003|Overall Study|Started anti-cancer treatment|0|||
42114143|NCT00561912|75924758|FG000|Overall Study|ineligible|1|||
42114144|NCT00561678|75924764|FG000|Overall Study|Withdrawal by Subject|4|||
42114145|NCT00561678|75924765|FG001|Overall Study|Withdrawal by Subject|3|||
42114146|NCT00561678|75924764|FG000|Overall Study|surgery cancelled|1|||
42114147|NCT00561678|75924765|FG001|Overall Study|surgery cancelled|1|||
42114148|NCT00561678|75924764|FG000|Overall Study|surgery rescheduled to different site|2|||
42114149|NCT00561678|75924765|FG001|Overall Study|surgery rescheduled to different site|2|||
42114150|NCT00561678|75924764|FG000|Overall Study|anesthesia provider refusal|1|||
42114151|NCT00561678|75924765|FG001|Overall Study|anesthesia provider refusal|0|||
42114152|NCT00463684|75924771|FG000|Overall Study|Withdrawal by Subject|1|||
42114153|NCT00463684|75924771|FG000|Overall Study|Lost to Follow-up|3|||
42114154|NCT00463606|75924778|FG000|Overall Study|Adverse Event|21|||
42114155|NCT00463606|75924779|FG001|Overall Study|Adverse Event|18|||
42114156|NCT00463606|75924780|FG002|Overall Study|Adverse Event|11|||
42114157|NCT00463606|75924778|FG000|Overall Study|Withdrawal by Subject|11|||
42114158|NCT00463606|75924779|FG001|Overall Study|Withdrawal by Subject|11|||
42114159|NCT00463606|75924780|FG002|Overall Study|Withdrawal by Subject|5|||
42114160|NCT00463606|75924778|FG000|Overall Study|Lost to Follow-up|2|||
42114161|NCT00463606|75924779|FG001|Overall Study|Lost to Follow-up|2|||
42114162|NCT00463606|75924780|FG002|Overall Study|Lost to Follow-up|3|||
42114163|NCT00463606|75924778|FG000|Overall Study|Subject noncompliance|1|||
42114164|NCT00463606|75924779|FG001|Overall Study|Subject noncompliance|1|||
42114165|NCT00463606|75924780|FG002|Overall Study|Subject noncompliance|0|||
42114166|NCT00463606|75924778|FG000|Overall Study|Subject moved out of town|1|||
42114167|NCT00463606|75924779|FG001|Overall Study|Subject moved out of town|0|||
42114168|NCT00463606|75924780|FG002|Overall Study|Subject moved out of town|0|||
42114169|NCT00463606|75924778|FG000|Overall Study|Physician Decision|0|||
42114170|NCT00463606|75924779|FG001|Overall Study|Physician Decision|1|||
42114171|NCT00463606|75924780|FG002|Overall Study|Physician Decision|0|||
42114172|NCT00463606|75924778|FG000|Overall Study|Sponsor request|0|||
42114173|NCT00463606|75924779|FG001|Overall Study|Sponsor request|1|||
42114174|NCT00463606|75924780|FG002|Overall Study|Sponsor request|0|||
42114175|NCT00463606|75924778|FG000|Overall Study|Exclusion criteria violation|2|||
42114176|NCT00463606|75924779|FG001|Overall Study|Exclusion criteria violation|0|||
42114177|NCT00463606|75924780|FG002|Overall Study|Exclusion criteria violation|0|||
42114178|NCT00463606|75924778|FG000|Overall Study|Coordinator error|1|||
42114179|NCT00463606|75924779|FG001|Overall Study|Coordinator error|0|||
42114180|NCT00463606|75924780|FG002|Overall Study|Coordinator error|0|||
42114181|NCT00463606|75924778|FG000|Overall Study|Patient randomized in error|1|||
42114182|NCT00463606|75924779|FG001|Overall Study|Patient randomized in error|0|||
42114183|NCT00463606|75924780|FG002|Overall Study|Patient randomized in error|0|||
42114184|NCT00463606|75924778|FG000|Overall Study|Participation in another ABT-335 trial|1|||
42114185|NCT00463606|75924779|FG001|Overall Study|Participation in another ABT-335 trial|0|||
42114186|NCT00463606|75924780|FG002|Overall Study|Participation in another ABT-335 trial|0|||
42114187|NCT00463606|75924778|FG000|Overall Study|Protocol Violation|0|||
42114188|NCT00463606|75924779|FG001|Overall Study|Protocol Violation|0|||
42114189|NCT00463606|75924780|FG002|Overall Study|Protocol Violation|1|||
42114190|NCT03961308|75924790|FG000|Overall Study|Withdrawal by Subject|1|||
42114191|NCT03961308|75924791|FG001|Overall Study|Withdrawal by Subject|0|||
42114192|NCT03961308|75924790|FG000|Overall Study|Other|1|||
42114193|NCT03961308|75924791|FG001|Overall Study|Other|0|||
42114194|NCT03961308|75924790|FG000|Overall Study|Lost to Follow-up|0|||
42114195|NCT03961308|75924791|FG001|Overall Study|Lost to Follow-up|1|||
42114196|NCT03961308|75924790|FG000|Overall Study|Adverse Event|0|||
42114197|NCT03961308|75924791|FG001|Overall Study|Adverse Event|1|||
42114198|NCT00174187|75924799|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
42114199|NCT00174187|75924800|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
42114200|NCT00174187|75924801|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
42114201|NCT00174187|75924799|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
42114202|NCT00174187|75924800|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
42114203|NCT00174187|75924801|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
42114204|NCT00174187|75924799|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
42114205|NCT00174187|75924800|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
42114206|NCT00174187|75924801|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
42114207|NCT00174187|75924799|FG000|Period 1 (up to 3 Years)|Other|0|||
42114208|NCT00174187|75924800|FG001|Period 1 (up to 3 Years)|Other|1|||
42114209|NCT00174187|75924801|FG002|Period 1 (up to 3 Years)|Other|0|||
42114210|NCT00174187|75924799|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
42114211|NCT00174187|75924800|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
42114212|NCT00174187|75924801|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
42114213|NCT00174187|75924799|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
42114214|NCT00174187|75924800|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
42114215|NCT00174187|75924801|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
42114216|NCT00174187|75924799|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
42114217|NCT00174187|75924800|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
42114218|NCT00174187|75924801|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
42114219|NCT00174187|75924799|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
42114220|NCT00174187|75924800|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
42114221|NCT00174187|75924801|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
42114222|NCT00174187|75924799|FG000|Period 2 (After 3 Years)|Other|0|||
42114223|NCT00174187|75924800|FG001|Period 2 (After 3 Years)|Other|0|||
42114224|NCT00174187|75924801|FG002|Period 2 (After 3 Years)|Other|5|||
42114225|NCT01011335|75924813|FG000|Overall Study|Lost to Follow-up|0|||
42114226|NCT01011335|75924814|FG001|Overall Study|Lost to Follow-up|0|||
42114227|NCT01011335|75924815|FG002|Overall Study|Lost to Follow-up|1|||
42114228|NCT01011335|75924816|FG003|Overall Study|Lost to Follow-up|1|||
42114229|NCT01011335|75924817|FG004|Overall Study|Lost to Follow-up|1|||
42114230|NCT01011335|75924818|FG005|Overall Study|Lost to Follow-up|1|||
42114231|NCT01011335|75924819|FG006|Overall Study|Lost to Follow-up|2|||
42114232|NCT01011335|75924820|FG007|Overall Study|Lost to Follow-up|2|||
42114233|NCT01011335|75924821|FG008|Overall Study|Lost to Follow-up|1|||
42114234|NCT01011335|75924822|FG009|Overall Study|Lost to Follow-up|0|||
42114235|NCT01011335|75924823|FG010|Overall Study|Lost to Follow-up|0|||
42114236|NCT01011335|75924824|FG011|Overall Study|Lost to Follow-up|1|||
42114237|NCT01011335|75924825|FG012|Overall Study|Lost to Follow-up|2|||
42114238|NCT01011335|75924813|FG000|Overall Study|Protocol Violation|0|||
42114239|NCT01011335|75924814|FG001|Overall Study|Protocol Violation|1|||
42114240|NCT01011335|75924815|FG002|Overall Study|Protocol Violation|0|||
42114241|NCT01011335|75924816|FG003|Overall Study|Protocol Violation|0|||
42114242|NCT01011335|75924817|FG004|Overall Study|Protocol Violation|0|||
42114243|NCT01011335|75924818|FG005|Overall Study|Protocol Violation|0|||
42114244|NCT01011335|75924819|FG006|Overall Study|Protocol Violation|0|||
42114245|NCT01011335|75924820|FG007|Overall Study|Protocol Violation|0|||
42114246|NCT01011335|75924821|FG008|Overall Study|Protocol Violation|0|||
42114247|NCT01011335|75924822|FG009|Overall Study|Protocol Violation|0|||
42114248|NCT01011335|75924823|FG010|Overall Study|Protocol Violation|0|||
42114249|NCT01011335|75924824|FG011|Overall Study|Protocol Violation|0|||
42114250|NCT01011335|75924825|FG012|Overall Study|Protocol Violation|0|||
42114251|NCT01011335|75924813|FG000|Overall Study|Moved/deployed or no booster|1|||
42114252|NCT01011335|75924814|FG001|Overall Study|Moved/deployed or no booster|0|||
42114253|NCT01011335|75924815|FG002|Overall Study|Moved/deployed or no booster|0|||
42114254|NCT01011335|75924816|FG003|Overall Study|Moved/deployed or no booster|1|||
42114255|NCT01011335|75924817|FG004|Overall Study|Moved/deployed or no booster|0|||
42114256|NCT01011335|75924818|FG005|Overall Study|Moved/deployed or no booster|0|||
42114257|NCT01011335|75924819|FG006|Overall Study|Moved/deployed or no booster|1|||
42114258|NCT01011335|75924820|FG007|Overall Study|Moved/deployed or no booster|0|||
42114259|NCT01011335|75924821|FG008|Overall Study|Moved/deployed or no booster|1|||
42114260|NCT01011335|75924822|FG009|Overall Study|Moved/deployed or no booster|0|||
42114261|NCT01011335|75924823|FG010|Overall Study|Moved/deployed or no booster|2|||
42114262|NCT01011335|75924824|FG011|Overall Study|Moved/deployed or no booster|0|||
42114263|NCT01011335|75924825|FG012|Overall Study|Moved/deployed or no booster|0|||
42114264|NCT01011335|75924813|FG000|Overall Study|Adverse Event|0|||
42114265|NCT01011335|75924814|FG001|Overall Study|Adverse Event|0|||
42114266|NCT01011335|75924815|FG002|Overall Study|Adverse Event|0|||
42114267|NCT01011335|75924816|FG003|Overall Study|Adverse Event|0|||
42114268|NCT01011335|75924817|FG004|Overall Study|Adverse Event|0|||
42114269|NCT01011335|75924818|FG005|Overall Study|Adverse Event|0|||
42114270|NCT01011335|75924819|FG006|Overall Study|Adverse Event|0|||
42114271|NCT01011335|75924820|FG007|Overall Study|Adverse Event|0|||
42114272|NCT01011335|75924821|FG008|Overall Study|Adverse Event|0|||
42114273|NCT01011335|75924822|FG009|Overall Study|Adverse Event|0|||
42114274|NCT01011335|75924823|FG010|Overall Study|Adverse Event|4|||
42114275|NCT01011335|75924824|FG011|Overall Study|Adverse Event|0|||
42114276|NCT01011335|75924825|FG012|Overall Study|Adverse Event|1|||
42114277|NCT00467896|75924862|FG000|Overall Study|Consent Withdrawal|18|||
42114278|NCT00467896|75924862|FG000|Overall Study|Adverse Event|7|||
42114279|NCT00467896|75924862|FG000|Overall Study|Serious Adverse Event|13|||
42114280|NCT00467896|75924862|FG000|Overall Study|Non-compliance|3|||
42114281|NCT00467896|75924862|FG000|Overall Study|Changed therapy|2|||
42114282|NCT00467896|75924862|FG000|Overall Study|Patient received transplant|2|||
42114283|NCT00467896|75924862|FG000|Overall Study|Patient had atrial septostomy|1|||
42114284|NCT00467896|75924862|FG000|Overall Study|Patient weaned off iloprost|1|||
42114285|NCT00467896|75924862|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
42114286|NCT00467896|75924862|FG000|Overall Study|Started intravenous prostacyclin|1|||
42114287|NCT00467896|75924862|FG000|Overall Study|Started inhaled Remodulin|1|||
42114288|NCT00467896|75924862|FG000|Overall Study|Patient had no improvement|1|||
42114289|NCT00579059|75924870|FG000|Overall Study|Study Canceled at 1 Year|21|||
42114290|NCT00579059|75924871|FG001|Overall Study|Study Canceled at 1 Year|10|||
42114291|NCT00467818|75924879|FG000|Overall Study|Adverse Event|1|||
42114292|NCT00467818|75924880|FG001|Overall Study|Adverse Event|0|||
42114293|NCT00467818|75924879|FG000|Overall Study|Lost to Follow-up|2|||
42114294|NCT00467818|75924880|FG001|Overall Study|Lost to Follow-up|2|||
42114295|NCT00467740|75924893|FG000|Overall Study|Adverse Event|0|||
42114296|NCT00467740|75924894|FG001|Overall Study|Adverse Event|0|||
42114297|NCT00467740|75924895|FG002|Overall Study|Adverse Event|1|||
42114298|NCT00467740|75924896|FG003|Overall Study|Adverse Event|0|||
42114299|NCT00467740|75924897|FG004|Overall Study|Adverse Event|0|||
42114300|NCT00467740|75924893|FG000|Overall Study|Protocol Violation|0|||
42114301|NCT00467740|75924894|FG001|Overall Study|Protocol Violation|0|||
42114302|NCT00467740|75924895|FG002|Overall Study|Protocol Violation|1|||
42114303|NCT00467740|75924896|FG003|Overall Study|Protocol Violation|0|||
42114304|NCT00467740|75924897|FG004|Overall Study|Protocol Violation|0|||
42114305|NCT00467740|75924893|FG000|Overall Study|Lost to Follow-up|0|||
42114306|NCT00467740|75924894|FG001|Overall Study|Lost to Follow-up|1|||
42114307|NCT00467740|75924895|FG002|Overall Study|Lost to Follow-up|0|||
42114308|NCT00467740|75924896|FG003|Overall Study|Lost to Follow-up|0|||
42114309|NCT00467740|75924897|FG004|Overall Study|Lost to Follow-up|0|||
42114310|NCT00467740|75924893|FG000|Overall Study|Withdrawal by Subject|1|||
42114311|NCT00467740|75924894|FG001|Overall Study|Withdrawal by Subject|1|||
42114312|NCT00467740|75924895|FG002|Overall Study|Withdrawal by Subject|0|||
42114313|NCT00467740|75924896|FG003|Overall Study|Withdrawal by Subject|1|||
42114314|NCT00467740|75924897|FG004|Overall Study|Withdrawal by Subject|0|||
42114315|NCT00467740|75924893|FG000|Overall Study|Lack of Efficacy|0|||
42114316|NCT00467740|75924894|FG001|Overall Study|Lack of Efficacy|1|||
42114317|NCT00467740|75924895|FG002|Overall Study|Lack of Efficacy|0|||
42114318|NCT00467740|75924896|FG003|Overall Study|Lack of Efficacy|0|||
42114319|NCT00467740|75924897|FG004|Overall Study|Lack of Efficacy|0|||
42114320|NCT00553254|75924911|FG000|Overall Study|Death|3|||
42114321|NCT00553254|75924912|FG001|Overall Study|Death|6|||
42114322|NCT00553254|75924913|FG002|Overall Study|Death|25|||
42114323|NCT00553254|75924911|FG000|Overall Study|Lost to Follow-up|0|||
42114324|NCT00553254|75924912|FG001|Overall Study|Lost to Follow-up|0|||
42114325|NCT00553254|75924913|FG002|Overall Study|Lost to Follow-up|2|||
42114326|NCT00553254|75924911|FG000|Overall Study|Withdrawal by Subject|2|||
42114327|NCT00553254|75924912|FG001|Overall Study|Withdrawal by Subject|0|||
42114328|NCT00553254|75924913|FG002|Overall Study|Withdrawal by Subject|2|||
42114329|NCT00553254|75924911|FG000|Overall Study|Study terminated by Sponsor|0|||
42114330|NCT00553254|75924912|FG001|Overall Study|Study terminated by Sponsor|0|||
42114331|NCT00553254|75924913|FG002|Overall Study|Study terminated by Sponsor|1|||
42114332|NCT00553254|75924911|FG000|Overall Study|Other|1|||
42114333|NCT00553254|75924912|FG001|Overall Study|Other|0|||
42114334|NCT00553254|75924913|FG002|Overall Study|Other|13|||
42114335|NCT00168805|75924928|FG000|Overall Study|Adverse Event|7|||
42114336|NCT00168805|75924929|FG001|Overall Study|Adverse Event|11|||
42114337|NCT00168805|75924930|FG002|Overall Study|Adverse Event|16|||
42114338|NCT00168805|75924928|FG000|Overall Study|Protocol Violation|12|||
42114339|NCT00168805|75924929|FG001|Overall Study|Protocol Violation|11|||
42114340|NCT00168805|75924930|FG002|Overall Study|Protocol Violation|8|||
42114341|NCT00168805|75924928|FG000|Overall Study|Lost to Follow-up|12|||
42114342|NCT00168805|75924929|FG001|Overall Study|Lost to Follow-up|17|||
42114343|NCT00168805|75924930|FG002|Overall Study|Lost to Follow-up|11|||
42114344|NCT00168805|75924928|FG000|Overall Study|Withdrawal by Subject|16|||
42114345|NCT00168805|75924929|FG001|Overall Study|Withdrawal by Subject|18|||
42114346|NCT00168805|75924930|FG002|Overall Study|Withdrawal by Subject|21|||
42114347|NCT00168805|75924928|FG000|Overall Study|Other|24|||
42114348|NCT00168805|75924929|FG001|Overall Study|Other|21|||
42114349|NCT00168805|75924930|FG002|Overall Study|Other|22|||
42114350|NCT00168805|75924928|FG000|Treatment|Adverse Event|25|||
42114351|NCT00168805|75924929|FG001|Treatment|Adverse Event|26|||
42114352|NCT00168805|75924930|FG002|Treatment|Adverse Event|32|||
42114353|NCT00168805|75924928|FG000|Treatment|Protocol Violation|3|||
42114354|NCT00168805|75924929|FG001|Treatment|Protocol Violation|5|||
42114355|NCT00168805|75924930|FG002|Treatment|Protocol Violation|5|||
42114356|NCT00168805|75924928|FG000|Treatment|Withdrawal by Subject|3|||
42114357|NCT00168805|75924929|FG001|Treatment|Withdrawal by Subject|7|||
42114358|NCT00168805|75924930|FG002|Treatment|Withdrawal by Subject|8|||
42114359|NCT00168805|75924928|FG000|Treatment|Other|18|||
42114360|NCT00168805|75924929|FG001|Treatment|Other|18|||
42114361|NCT00168805|75924930|FG002|Treatment|Other|17|||
42114362|NCT00467584|75924941|FG000|Overall Study|Withdrawal by Subject|4|||
42114363|NCT00467584|75924942|FG001|Overall Study|Withdrawal by Subject|5|||
42114364|NCT00467584|75924943|FG002|Overall Study|Withdrawal by Subject|1|||
42114365|NCT03839212|75924951|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
42114366|NCT00168103|75924958|FG000|Overall Study|Withdrawal by Subject|1|||
42114367|NCT00168103|75924959|FG001|Overall Study|Withdrawal by Subject|2|||
42114368|NCT00168103|75924960|FG002|Overall Study|Withdrawal by Subject|1|||
42114369|NCT00168103|75924961|FG003|Overall Study|Withdrawal by Subject|0|||
42114370|NCT00168103|75924958|FG000|Overall Study|Lost to Follow-up|1|||
42114371|NCT00168103|75924959|FG001|Overall Study|Lost to Follow-up|3|||
42114372|NCT00168103|75924960|FG002|Overall Study|Lost to Follow-up|0|||
42114373|NCT00168103|75924961|FG003|Overall Study|Lost to Follow-up|0|||
42114374|NCT00463060|75924971|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
42114375|NCT00463060|75924971|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
42114376|NCT00462982|75924980|FG000|Overall Study|Adverse Event|1|||
42114377|NCT00462982|75924980|FG000|Overall Study|Patient Not Treated|2|||
42114378|NCT00462904|75925001|FG000|Overall Study|Lost to Follow-up|1|||
42114379|NCT00467272|75925005|FG000|Overall Study|Pneumonia|2|||
42114380|NCT00467272|75925005|FG000|Overall Study|Thrombophlebitis|1|||
42114381|NCT00462826|75925009|FG000|Overall Study|Ineligible - second primary|1|||
42114382|NCT00462826|75925009|FG000|Overall Study|Ineligible - wrong cell type|1|||
42114383|NCT00462826|75925009|FG000|Overall Study|Ineligible - wrong primary|2|||
42114384|NCT00462826|75925009|FG000|Overall Study|Never treated|1|||
42114385|NCT00551616|75925021|FG000|Overall Study|Lost to Follow-up|48|||
42114386|NCT00551616|75925022|FG001|Overall Study|Lost to Follow-up|40|||
42114387|NCT00452530|75925030|FG000|Overall Study|Death|1|||
42114388|NCT00452530|75925031|FG001|Overall Study|Death|0|||
42114389|NCT00452530|75925030|FG000|Overall Study|Adverse Event|40|||
42114390|NCT00452530|75925031|FG001|Overall Study|Adverse Event|44|||
42114391|NCT00452530|75925030|FG000|Overall Study|Withdrawal by Subject|68|||
42114392|NCT00452530|75925031|FG001|Overall Study|Withdrawal by Subject|57|||
42114393|NCT00452530|75925030|FG000|Overall Study|Lost to Follow-up|1|||
42114394|NCT00452530|75925031|FG001|Overall Study|Lost to Follow-up|0|||
42114395|NCT00452530|75925030|FG000|Overall Study|Poor compliance/noncompliance|1|||
42114396|NCT00452530|75925031|FG001|Overall Study|Poor compliance/noncompliance|2|||
42114397|NCT00452530|75925030|FG000|Overall Study|No longer met study criteria|18|||
42114398|NCT00452530|75925031|FG001|Overall Study|No longer met study criteria|22|||
42114399|NCT00452530|75925030|FG000|Overall Study|Other|7|||
42114400|NCT00452530|75925031|FG001|Overall Study|Other|11|||
42114401|NCT00549198|75925043|FG000|Overall Study|Adverse Event|28|||
42114402|NCT00549198|75925044|FG001|Overall Study|Adverse Event|26|||
42114403|NCT00549198|75925043|FG000|Overall Study|Insufficient Viral Load Response|4|||
42114404|NCT00549198|75925044|FG001|Overall Study|Insufficient Viral Load Response|2|||
42114405|NCT00549198|75925043|FG000|Overall Study|Protocol-defined Virological Failure|7|||
42114406|NCT00549198|75925044|FG001|Overall Study|Protocol-defined Virological Failure|0|||
42114407|NCT00549198|75925043|FG000|Overall Study|Non-compliance|2|||
42114408|NCT00549198|75925044|FG001|Overall Study|Non-compliance|4|||
42114409|NCT00549198|75925043|FG000|Overall Study|Lost to Follow-up|7|||
42114410|NCT00549198|75925044|FG001|Overall Study|Lost to Follow-up|8|||
42114411|NCT00549198|75925043|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
42114412|NCT00549198|75925044|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
42114413|NCT00549198|75925043|FG000|Overall Study|Protocol Violation|7|||
42114414|NCT00549198|75925044|FG001|Overall Study|Protocol Violation|2|||
42114415|NCT00549198|75925043|FG000|Overall Study|Investigator Decision|4|||
42114416|NCT00549198|75925044|FG001|Overall Study|Investigator Decision|3|||
42114417|NCT00549198|75925043|FG000|Overall Study|Withdrawal by Subject|7|||
42114418|NCT00549198|75925044|FG001|Overall Study|Withdrawal by Subject|7|||
42114419|NCT00549198|75925043|FG000|Overall Study|Disease Progression|1|||
42114420|NCT00549198|75925044|FG001|Overall Study|Disease Progression|0|||
42114421|NCT00549198|75925043|FG000|Overall Study|Participant Moved|2|||
42114422|NCT00549198|75925044|FG001|Overall Study|Participant Moved|0|||
42114423|NCT00549198|75925043|FG000|Overall Study|Participant not able to perform Week 96|1|||
42114424|NCT00549198|75925044|FG001|Overall Study|Participant not able to perform Week 96|0|||
42114425|NCT00549198|75925043|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
42114426|NCT00549198|75925044|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
42114427|NCT00549198|75925043|FG000|Overall Study|Prohibited Medication|1|||
42114428|NCT00549198|75925044|FG001|Overall Study|Prohibited Medication|2|||
42114429|NCT00549198|75925043|FG000|Overall Study|Participant planning pregnancy|1|||
42114430|NCT00549198|75925044|FG001|Overall Study|Participant planning pregnancy|0|||
42114431|NCT00549198|75925043|FG000|Overall Study|Participant overweight, no scan possible|1|||
42114432|NCT00549198|75925044|FG001|Overall Study|Participant overweight, no scan possible|0|||
42114433|NCT00549198|75925043|FG000|Overall Study|No scan facilities|0|||
42114434|NCT00549198|75925044|FG001|Overall Study|No scan facilities|2|||
42114435|NCT00549198|75925043|FG000|Overall Study|Pregnancy|0|||
42114436|NCT00549198|75925044|FG001|Overall Study|Pregnancy|3|||
42114437|NCT00549198|75925043|FG000|Overall Study|Not Exposed to Study Drug|3|||
42114438|NCT00549198|75925044|FG001|Overall Study|Not Exposed to Study Drug|4|||
42114439|NCT00607724|75925057|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
42114440|NCT00607724|75925058|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
42114441|NCT00607724|75925059|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
42114442|NCT00607724|75925060|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
42114443|NCT00607724|75925061|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
42114444|NCT00607724|75925062|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
42114445|NCT00607724|75925063|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
42114446|NCT00607724|75925057|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
42114447|NCT00607724|75925058|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
42114448|NCT00607724|75925059|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
42114449|NCT00607724|75925060|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
42114450|NCT00607724|75925061|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
42114451|NCT00607724|75925062|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
42114452|NCT00607724|75925063|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
42114453|NCT00607724|75925057|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
42114454|NCT00607724|75925058|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
42114455|NCT00607724|75925059|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
42114456|NCT00607724|75925060|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
42114457|NCT00607724|75925061|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
42114458|NCT00607724|75925062|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
42114459|NCT00607724|75925063|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
42114460|NCT00607724|75925057|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
42114461|NCT00607724|75925058|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
42114462|NCT00607724|75925059|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
42114463|NCT00607724|75925060|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
42114464|NCT00607724|75925061|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
42114465|NCT00607724|75925062|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
42114466|NCT00607724|75925063|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
42114467|NCT00607724|75925057|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
42114468|NCT00607724|75925058|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
42114469|NCT00607724|75925059|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
42114470|NCT00607724|75925060|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
42114471|NCT00607724|75925061|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
42114472|NCT00607724|75925062|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
42114473|NCT00607724|75925063|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
42114474|NCT00506415|75925087|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
42114475|NCT00506415|75925088|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
42114476|NCT00506415|75925089|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
42114477|NCT00506415|75925090|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
42114478|NCT00506415|75925087|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
42114479|NCT00506415|75925088|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
42114480|NCT00506415|75925089|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
42114481|NCT00506415|75925090|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
42114482|NCT00506415|75925087|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
42114483|NCT00506415|75925088|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
42114484|NCT00506415|75925089|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
42114485|NCT00506415|75925090|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
42114486|NCT00506415|75925087|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
42114487|NCT00506415|75925088|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
42114488|NCT00506415|75925089|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
42114489|NCT00506415|75925090|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
42114490|NCT00506415|75925087|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
42114491|NCT00506415|75925088|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
42114492|NCT00506415|75925089|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
42114493|NCT00506415|75925090|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
42114494|NCT00506415|75925087|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
42114495|NCT00506415|75925088|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
42114496|NCT00506415|75925089|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
42114497|NCT00506415|75925090|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
42114498|NCT00506415|75925087|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
42114499|NCT00506415|75925088|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
42114500|NCT00506415|75925089|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
42114501|NCT00506415|75925090|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
42114502|NCT00506415|75925087|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
42114503|NCT00506415|75925088|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
42114504|NCT00506415|75925089|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
42114505|NCT00506415|75925090|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
42114506|NCT00506415|75925087|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
42114507|NCT00506415|75925088|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
42114508|NCT00506415|75925089|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
42114509|NCT00506415|75925090|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
42114510|NCT00506415|75925087|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
42114511|NCT00506415|75925088|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
42114512|NCT00506415|75925089|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
42114513|NCT00506415|75925090|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
42114514|NCT00506415|75925087|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
42114515|NCT00506415|75925088|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
42114516|NCT00506415|75925089|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
42114517|NCT00506415|75925090|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
42114518|NCT00506415|75925087|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
42114519|NCT00506415|75925088|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
42114520|NCT00506415|75925089|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
42114521|NCT00506415|75925090|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
42114522|NCT00506415|75925087|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
42114523|NCT00506415|75925088|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
42114524|NCT00506415|75925089|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
42114525|NCT00506415|75925090|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
42114526|NCT00506415|75925087|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
42114527|NCT00506415|75925088|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
42114528|NCT00506415|75925089|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
42114529|NCT00506415|75925090|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
42114530|NCT00506415|75925087|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
42114531|NCT00506415|75925088|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
42206929|NCT03358290|76020237|FG002|Overall Study|Adverse Event|1|||
42114532|NCT00506415|75925089|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
42114533|NCT00506415|75925090|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
42114534|NCT00506415|75925087|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
42114535|NCT00506415|75925088|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
42114536|NCT00506415|75925089|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
42114537|NCT00506415|75925090|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
42114538|NCT00506415|75925087|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
42114539|NCT00506415|75925088|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
42114540|NCT00506415|75925089|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
42114541|NCT00506415|75925090|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
42114542|NCT00506415|75925087|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
42114543|NCT00506415|75925088|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
42114544|NCT00506415|75925089|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
42114545|NCT00506415|75925090|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
42114546|NCT00506415|75925087|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
42114547|NCT00506415|75925088|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
42114548|NCT00506415|75925089|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
42114549|NCT00506415|75925090|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
42114550|NCT00506415|75925087|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
42114551|NCT00506415|75925088|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
42114552|NCT00506415|75925089|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
42114553|NCT00506415|75925090|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
42114554|NCT00506415|75925087|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
42114555|NCT00506415|75925088|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
42114556|NCT00506415|75925089|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
42114557|NCT00506415|75925090|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
42114558|NCT00506415|75925087|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
42114559|NCT00506415|75925088|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
42114560|NCT00506415|75925089|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
42114561|NCT00506415|75925090|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
42114562|NCT00506415|75925087|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
42114563|NCT00506415|75925088|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
42114564|NCT00506415|75925089|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
42114565|NCT00506415|75925090|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
42114566|NCT00506415|75925087|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
42114567|NCT00506415|75925088|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
42114568|NCT00506415|75925089|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
42114569|NCT00506415|75925090|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
42114570|NCT00452452|75925106|FG000|Overall Study|Protocol Violation|0|||
42114571|NCT00452452|75925107|FG001|Overall Study|Protocol Violation|0|||
42114572|NCT00452452|75925108|FG002|Overall Study|Protocol Violation|1|||
42114573|NCT00452452|75925106|FG000|Overall Study|Withdrawal by Subject|1|||
42114574|NCT00452452|75925107|FG001|Overall Study|Withdrawal by Subject|0|||
42114575|NCT00452452|75925108|FG002|Overall Study|Withdrawal by Subject|0|||
42114576|NCT00452452|75925106|FG000|Overall Study|Lost to Follow-up|1|||
42114577|NCT00452452|75925107|FG001|Overall Study|Lost to Follow-up|0|||
42114578|NCT00452452|75925108|FG002|Overall Study|Lost to Follow-up|0|||
42114579|NCT00510783|75925124|FG000|Overall Study|Lost to Follow-up|29|||
42114580|NCT00510783|75925125|FG001|Overall Study|Lost to Follow-up|25|||
42114581|NCT00510783|75925124|FG000|Overall Study|Withdrawal by Subject|2|||
42114582|NCT00510783|75925125|FG001|Overall Study|Withdrawal by Subject|3|||
42114583|NCT00510783|75925124|FG000|Overall Study|Protocol Violation|0|||
42114584|NCT00510783|75925125|FG001|Overall Study|Protocol Violation|1|||
42114585|NCT00518973|75925133|FG000|Overall Study|Withdrawal by Subject|3|||
42114586|NCT00518973|75925134|FG001|Overall Study|Withdrawal by Subject|2|||
42114587|NCT00462670|75925142|FG000|Overall Study|Adverse Event|3|||
42114588|NCT00462670|75925143|FG001|Overall Study|Adverse Event|5|||
42114589|NCT00462670|75925142|FG000|Overall Study|Lack of Efficacy|1|||
42114590|NCT00462670|75925143|FG001|Overall Study|Lack of Efficacy|0|||
42114591|NCT00462670|75925142|FG000|Overall Study|Protocol Violation|1|||
42114592|NCT00462670|75925143|FG001|Overall Study|Protocol Violation|0|||
42114593|NCT00462670|75925142|FG000|Overall Study|Resolution of signs and symptoms|0|||
42114594|NCT00462670|75925143|FG001|Overall Study|Resolution of signs and symptoms|2|||
42114595|NCT00606086|75925151|FG000|Overall Study|Adverse Event|1|||
42114596|NCT00606086|75925152|FG001|Overall Study|Adverse Event|1|||
42114597|NCT00606086|75925151|FG000|Overall Study|Lost to Follow-up|4|||
42114598|NCT00606086|75925152|FG001|Overall Study|Lost to Follow-up|8|||
42114599|NCT00606086|75925151|FG000|Overall Study|Protocol Violation|1|||
42114600|NCT00606086|75925152|FG001|Overall Study|Protocol Violation|0|||
42114601|NCT00606086|75925151|FG000|Overall Study|Withdrawal by Subject|5|||
42114602|NCT00606086|75925152|FG001|Overall Study|Withdrawal by Subject|3|||
42114603|NCT00606086|75925151|FG000|Overall Study|Non-compliance|0|||
42114604|NCT00606086|75925152|FG001|Overall Study|Non-compliance|1|||
42114605|NCT00606086|75925151|FG000|Overall Study|Randomized, not treated|1|||
42114606|NCT00606086|75925152|FG001|Overall Study|Randomized, not treated|2|||
42114607|NCT00609986|75925160|FG000|Overall Study|Did not receive transplant or treatment|8|||
42114608|NCT00609986|75925161|FG001|Overall Study|Did not receive transplant or treatment|3|||
42114609|NCT00451906|75925167|FG000|Overall Study|Adverse Event|515|||
42114610|NCT00451906|75925167|FG000|Overall Study|Lost to Follow-up|31|||
42114611|NCT00451906|75925167|FG000|Overall Study|Withdrawal by Subject|111|||
42114612|NCT00451906|75925167|FG000|Overall Study|Protocol Violation|21|||
42114613|NCT00451906|75925167|FG000|Overall Study|Progressive disease|1328|||
42114614|NCT00451906|75925167|FG000|Overall Study|Termination of the study|108|||
42114615|NCT00451906|75925167|FG000|Overall Study|Other Reasons|121|||
42114616|NCT00451906|75925167|FG000|Overall Study|Did not complete final visit|4|||
42114617|NCT00451282|75925173|FG000|Overall Study|Lost to Follow-up|6|||
42114618|NCT00451282|75925174|FG001|Overall Study|Lost to Follow-up|5|||
42114619|NCT03838198|75925182|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
42114620|NCT03838198|75925183|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
42114621|NCT03838198|75925184|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
42114622|NCT03838198|75925185|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
42114623|NCT03838198|75925182|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
42114624|NCT03838198|75925183|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
42114625|NCT03838198|75925184|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
42114626|NCT03838198|75925185|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
42114627|NCT00115765|75925200|FG000|Overall Study|Withdrawal by Subject|22|||
42114628|NCT00115765|75925201|FG001|Overall Study|Withdrawal by Subject|53|||
42114629|NCT00115765|75925202|FG002|Overall Study|Withdrawal by Subject|76|||
42114630|NCT00115765|75925203|FG003|Overall Study|Withdrawal by Subject|15|||
42114631|NCT00115765|75925200|FG000|Overall Study|Physician Decision|4|||
42114632|NCT00115765|75925201|FG001|Overall Study|Physician Decision|15|||
42114633|NCT00115765|75925202|FG002|Overall Study|Physician Decision|18|||
42114634|NCT00115765|75925203|FG003|Overall Study|Physician Decision|13|||
42114635|NCT00115765|75925200|FG000|Overall Study|Lost to Follow-up|3|||
42114636|NCT00115765|75925201|FG001|Overall Study|Lost to Follow-up|20|||
42114637|NCT00115765|75925202|FG002|Overall Study|Lost to Follow-up|18|||
42114638|NCT00115765|75925203|FG003|Overall Study|Lost to Follow-up|1|||
42114639|NCT00115765|75925200|FG000|Overall Study|Other|6|||
42114640|NCT00115765|75925201|FG001|Overall Study|Other|12|||
42114641|NCT00115765|75925202|FG002|Overall Study|Other|9|||
42114642|NCT00115765|75925203|FG003|Overall Study|Other|2|||
42114643|NCT00606008|75925211|FG000|Overall Study|Adverse Event|1|||
42114644|NCT00606008|75925211|FG000|Overall Study|Withdrawal by Subject|4|||
42114645|NCT00461812|75925223|FG000|Overall Study|study terminated|10|||
42114646|NCT00123955|75925230|FG000|Overall Study|Adverse Event|1|||
42114647|NCT00123955|75925231|FG001|Overall Study|Adverse Event|0|||
42114648|NCT00123955|75925230|FG000|Overall Study|Withdrawal by Subject|4|||
42114649|NCT00123955|75925231|FG001|Overall Study|Withdrawal by Subject|3|||
42114650|NCT00123955|75925230|FG000|Overall Study|Death|0|||
42114651|NCT00123955|75925231|FG001|Overall Study|Death|1|||
42114652|NCT03837028|75925241|FG000|Overall Study|Lost to Follow-up|4|||
42114653|NCT03837028|75925242|FG001|Overall Study|Lost to Follow-up|0|||
42114654|NCT03837028|75925243|FG002|Overall Study|Lost to Follow-up|2|||
42114655|NCT03837028|75925244|FG003|Overall Study|Lost to Follow-up|0|||
42114656|NCT03837028|75925241|FG000|Overall Study|Withdrawal by Subject|12|||
42114657|NCT03837028|75925242|FG001|Overall Study|Withdrawal by Subject|11|||
42114658|NCT03837028|75925243|FG002|Overall Study|Withdrawal by Subject|11|||
42114659|NCT03837028|75925244|FG003|Overall Study|Withdrawal by Subject|7|||
42114660|NCT00115063|75925256|FG000|Overall Study|Lost to Follow-up|98|||
42114661|NCT00115063|75925257|FG001|Overall Study|Lost to Follow-up|104|||
42114662|NCT00115063|75925256|FG000|Overall Study|Death|1|||
42114663|NCT00115063|75925257|FG001|Overall Study|Death|0|||
42114664|NCT00461500|75925265|FG000|Overall Study|Adverse Event|1|||
42114665|NCT00461500|75925266|FG001|Overall Study|Adverse Event|0|||
42114666|NCT00461500|75925265|FG000|Overall Study|Lack of Efficacy|0|||
42114667|NCT00461500|75925266|FG001|Overall Study|Lack of Efficacy|1|||
42114668|NCT00461500|75925265|FG000|Overall Study|Expired Drug Treatment|1|||
42114669|NCT00461500|75925266|FG001|Overall Study|Expired Drug Treatment|1|||
42114670|NCT00461500|75925265|FG000|Overall Study|Study Stopped|1|||
42114671|NCT00461500|75925266|FG001|Overall Study|Study Stopped|2|||
42114672|NCT00461500|75925265|FG000|Overall Study|Drug Treatment Misuse|1|||
42114673|NCT00461500|75925266|FG001|Overall Study|Drug Treatment Misuse|0|||
42114674|NCT00461500|75925265|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
42114675|NCT00461500|75925266|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
42114676|NCT00461500|75925265|FG000|Overall Study|Lost to Follow-up|2|||
42114677|NCT00461500|75925266|FG001|Overall Study|Lost to Follow-up|2|||
42114678|NCT00167245|75925274|FG000|Overall Study|Lost to Follow-up|20|||
42114679|NCT00167245|75925275|FG001|Overall Study|Lost to Follow-up|31|||
42114680|NCT00167245|75925274|FG000|Overall Study|Withdrawal by Subject|5|||
42114681|NCT00167245|75925275|FG001|Overall Study|Withdrawal by Subject|8|||
42114682|NCT00167245|75925274|FG000|Overall Study|Incarcerated|3|||
42114683|NCT00167245|75925275|FG001|Overall Study|Incarcerated|2|||
42114684|NCT00167245|75925274|FG000|Overall Study|Drowsy|1|||
42114685|NCT00167245|75925275|FG001|Overall Study|Drowsy|0|||
42114686|NCT00443560|75925286|FG000|Overall Study|No intrathecal dose|58|||
42114687|NCT00443560|75925287|FG001|Overall Study|No intrathecal dose|26|||
42114688|NCT00443560|75925286|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
42114689|NCT00443560|75925287|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
42114690|NCT00451204|75925295|FG000|Overall Study|Adverse Event|4|||
42114691|NCT00451204|75925296|FG001|Overall Study|Adverse Event|6|||
42114692|NCT00451204|75925295|FG000|Overall Study|Lack of Efficacy|4|||
42114693|NCT00451204|75925296|FG001|Overall Study|Lack of Efficacy|4|||
42114694|NCT00451204|75925295|FG000|Overall Study|Lost to Follow-up|4|||
42114695|NCT00451204|75925296|FG001|Overall Study|Lost to Follow-up|4|||
42114696|NCT00451204|75925295|FG000|Overall Study|Protocol Violation|1|||
42114697|NCT00451204|75925296|FG001|Overall Study|Protocol Violation|0|||
42114698|NCT00451204|75925295|FG000|Overall Study|Patient refusal|8|||
42114699|NCT00451204|75925296|FG001|Overall Study|Patient refusal|4|||
42114700|NCT00451204|75925295|FG000|Overall Study|Other|1|||
42114701|NCT00451204|75925296|FG001|Overall Study|Other|2|||
42114702|NCT00605540|75925305|FG000|Overall Study|Death|15|||
42114703|NCT00605540|75925305|FG000|Overall Study|Lost to Follow-up|23|||
42114704|NCT00605306|75925311|FG000|Overall Study|Adverse Event|0|||
42114705|NCT00605306|75925312|FG001|Overall Study|Adverse Event|1|||
42114706|NCT00607022|75925321|FG000|Overall Study|Withdrawal by Subject|1|||
42114707|NCT00607022|75925322|FG001|Overall Study|Withdrawal by Subject|0|||
42114708|NCT00607022|75925323|FG002|Overall Study|Withdrawal by Subject|0|||
42114709|NCT00606632|75925331|FG000|Overall Study|Withdrawal by Subject|13|||
42114710|NCT00606632|75925331|FG000|Overall Study|Miscellaneous reasons|9|||
42114711|NCT00450814|75925350|FG000|Overall Study|Failed to complete the initial therapy|0|||
42114712|NCT00450814|75925351|FG001|Overall Study|Failed to complete the initial therapy|0|||
42114713|NCT00450814|75925352|FG002|Overall Study|Failed to complete the initial therapy|0|||
42114714|NCT00450814|75925353|FG003|Overall Study|Failed to complete the initial therapy|1|||
42114715|NCT00450814|75925354|FG004|Overall Study|Failed to complete the initial therapy|1|||
42114716|NCT00450814|75925355|FG005|Overall Study|Failed to complete the initial therapy|1|||
42114717|NCT00450814|75925356|FG006|Overall Study|Failed to complete the initial therapy|0|||
42114718|NCT00450814|75925357|FG007|Overall Study|Failed to complete the initial therapy|0|||
42114719|NCT00450814|75925358|FG008|Overall Study|Failed to complete the initial therapy|0|||
42114720|NCT00450814|75925359|FG009|Overall Study|Failed to complete the initial therapy|0|||
42114721|NCT00450814|75925360|FG010|Overall Study|Failed to complete the initial therapy|0|||
42114722|NCT00450814|75925350|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
42114723|NCT00450814|75925351|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
42114724|NCT00450814|75925352|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
42114725|NCT00450814|75925353|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
42114726|NCT00450814|75925354|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
42114727|NCT00450814|75925355|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
42114728|NCT00450814|75925356|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
42114729|NCT00450814|75925357|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
42114730|NCT00450814|75925358|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
42114731|NCT00450814|75925359|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
42114732|NCT00450814|75925360|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
42114733|NCT00518115|75925395|FG000|Overall Study|Adverse Event|6|||
42114734|NCT00518115|75925396|FG001|Overall Study|Adverse Event|1|||
42114735|NCT00518115|75925397|FG002|Overall Study|Adverse Event|5|||
42114736|NCT00518115|75925398|FG003|Overall Study|Adverse Event|6|||
42114737|NCT00518115|75925399|FG004|Overall Study|Adverse Event|5|||
42114738|NCT00518115|75925400|FG005|Overall Study|Adverse Event|5|||
42114739|NCT00518115|75925401|FG006|Overall Study|Adverse Event|5|||
42114740|NCT00518115|75925402|FG007|Overall Study|Adverse Event|10|||
42114741|NCT00518115|75925403|FG008|Overall Study|Adverse Event|2|||
42114742|NCT00518115|75925404|FG009|Overall Study|Adverse Event|9|||
42114743|NCT00518115|75925395|FG000|Overall Study|Lost to Follow-up|0|||
42114744|NCT00518115|75925396|FG001|Overall Study|Lost to Follow-up|0|||
42114745|NCT00518115|75925397|FG002|Overall Study|Lost to Follow-up|2|||
42114746|NCT00518115|75925398|FG003|Overall Study|Lost to Follow-up|3|||
42114747|NCT00518115|75925399|FG004|Overall Study|Lost to Follow-up|1|||
42114748|NCT00518115|75925400|FG005|Overall Study|Lost to Follow-up|3|||
42114749|NCT00518115|75925401|FG006|Overall Study|Lost to Follow-up|0|||
42114750|NCT00518115|75925402|FG007|Overall Study|Lost to Follow-up|1|||
42114751|NCT00518115|75925403|FG008|Overall Study|Lost to Follow-up|1|||
42114752|NCT00518115|75925404|FG009|Overall Study|Lost to Follow-up|1|||
42114753|NCT00518115|75925395|FG000|Overall Study|Protocol Violation|1|||
42114754|NCT00518115|75925396|FG001|Overall Study|Protocol Violation|3|||
42114755|NCT00518115|75925397|FG002|Overall Study|Protocol Violation|1|||
42114756|NCT00518115|75925398|FG003|Overall Study|Protocol Violation|0|||
42114757|NCT00518115|75925399|FG004|Overall Study|Protocol Violation|0|||
42114758|NCT00518115|75925400|FG005|Overall Study|Protocol Violation|0|||
42114759|NCT00518115|75925401|FG006|Overall Study|Protocol Violation|0|||
42114760|NCT00518115|75925402|FG007|Overall Study|Protocol Violation|0|||
42114761|NCT00518115|75925403|FG008|Overall Study|Protocol Violation|0|||
42114762|NCT00518115|75925404|FG009|Overall Study|Protocol Violation|0|||
42114763|NCT00518115|75925395|FG000|Overall Study|Withdrawal by Subject|1|||
42114764|NCT00518115|75925396|FG001|Overall Study|Withdrawal by Subject|1|||
42114765|NCT00518115|75925397|FG002|Overall Study|Withdrawal by Subject|5|||
42114766|NCT00518115|75925398|FG003|Overall Study|Withdrawal by Subject|0|||
42114767|NCT00518115|75925399|FG004|Overall Study|Withdrawal by Subject|2|||
42114768|NCT00518115|75925400|FG005|Overall Study|Withdrawal by Subject|1|||
42114769|NCT00518115|75925401|FG006|Overall Study|Withdrawal by Subject|0|||
42114770|NCT00518115|75925402|FG007|Overall Study|Withdrawal by Subject|2|||
42114771|NCT00518115|75925403|FG008|Overall Study|Withdrawal by Subject|1|||
42114772|NCT00518115|75925404|FG009|Overall Study|Withdrawal by Subject|3|||
42114773|NCT00518115|75925395|FG000|Overall Study|Lack of Efficacy|1|||
42114774|NCT00518115|75925396|FG001|Overall Study|Lack of Efficacy|0|||
42114775|NCT00518115|75925397|FG002|Overall Study|Lack of Efficacy|1|||
42114776|NCT00518115|75925398|FG003|Overall Study|Lack of Efficacy|1|||
42114777|NCT00518115|75925399|FG004|Overall Study|Lack of Efficacy|0|||
42114778|NCT00518115|75925400|FG005|Overall Study|Lack of Efficacy|0|||
42114779|NCT00518115|75925401|FG006|Overall Study|Lack of Efficacy|0|||
42114780|NCT00518115|75925402|FG007|Overall Study|Lack of Efficacy|1|||
42114781|NCT00518115|75925403|FG008|Overall Study|Lack of Efficacy|0|||
42114782|NCT00518115|75925404|FG009|Overall Study|Lack of Efficacy|0|||
42114783|NCT00518115|75925395|FG000|Overall Study|Non-Compliance|1|||
42114784|NCT00518115|75925396|FG001|Overall Study|Non-Compliance|0|||
42114785|NCT00518115|75925397|FG002|Overall Study|Non-Compliance|1|||
42114786|NCT00518115|75925398|FG003|Overall Study|Non-Compliance|0|||
42114787|NCT00518115|75925399|FG004|Overall Study|Non-Compliance|1|||
42114788|NCT00518115|75925400|FG005|Overall Study|Non-Compliance|1|||
42114789|NCT00518115|75925401|FG006|Overall Study|Non-Compliance|1|||
42114790|NCT00518115|75925402|FG007|Overall Study|Non-Compliance|1|||
42114791|NCT00518115|75925403|FG008|Overall Study|Non-Compliance|0|||
42114792|NCT00518115|75925404|FG009|Overall Study|Non-Compliance|1|||
42114793|NCT00518115|75925395|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
42114794|NCT00518115|75925396|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
42114795|NCT00518115|75925397|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
42114796|NCT00518115|75925398|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
42114797|NCT00518115|75925399|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
42114798|NCT00518115|75925400|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
42114799|NCT00518115|75925401|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
42114800|NCT00518115|75925402|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
42114801|NCT00518115|75925403|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
42114802|NCT00518115|75925404|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
42114803|NCT00518115|75925395|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
42114804|NCT00518115|75925396|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
42114805|NCT00518115|75925397|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
42114806|NCT00518115|75925398|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
42114807|NCT00518115|75925399|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
42114808|NCT00518115|75925400|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
42114809|NCT00518115|75925401|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
42114810|NCT00518115|75925402|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
42114811|NCT00518115|75925403|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
42114812|NCT00518115|75925404|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
42114813|NCT00518115|75925395|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
42114814|NCT00518115|75925396|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
42114815|NCT00518115|75925397|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
42114816|NCT00518115|75925398|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
42114817|NCT00518115|75925399|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
42114818|NCT00518115|75925400|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
42114819|NCT00518115|75925401|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
42114820|NCT00518115|75925402|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
42114821|NCT00518115|75925403|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
42114822|NCT00518115|75925404|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
42114823|NCT00518115|75925395|FG000|Overall Study|Wrong Monotherapy Administered|0|||
42114824|NCT00518115|75925396|FG001|Overall Study|Wrong Monotherapy Administered|0|||
42114825|NCT00518115|75925397|FG002|Overall Study|Wrong Monotherapy Administered|1|||
42114826|NCT00518115|75925398|FG003|Overall Study|Wrong Monotherapy Administered|0|||
42114827|NCT00518115|75925399|FG004|Overall Study|Wrong Monotherapy Administered|0|||
42114828|NCT00518115|75925400|FG005|Overall Study|Wrong Monotherapy Administered|0|||
42114829|NCT00518115|75925401|FG006|Overall Study|Wrong Monotherapy Administered|1|||
42114830|NCT00518115|75925402|FG007|Overall Study|Wrong Monotherapy Administered|0|||
42114831|NCT00518115|75925403|FG008|Overall Study|Wrong Monotherapy Administered|0|||
42114832|NCT00518115|75925404|FG009|Overall Study|Wrong Monotherapy Administered|0|||
42114833|NCT00518115|75925395|FG000|Overall Study|Violation of Exclusion Criteria|0|||
42114834|NCT00518115|75925396|FG001|Overall Study|Violation of Exclusion Criteria|0|||
42114835|NCT00518115|75925397|FG002|Overall Study|Violation of Exclusion Criteria|0|||
42114836|NCT00518115|75925398|FG003|Overall Study|Violation of Exclusion Criteria|1|||
42114837|NCT00518115|75925399|FG004|Overall Study|Violation of Exclusion Criteria|0|||
42114838|NCT00518115|75925400|FG005|Overall Study|Violation of Exclusion Criteria|0|||
42114839|NCT00518115|75925401|FG006|Overall Study|Violation of Exclusion Criteria|1|||
42114840|NCT00518115|75925402|FG007|Overall Study|Violation of Exclusion Criteria|0|||
42114841|NCT00518115|75925403|FG008|Overall Study|Violation of Exclusion Criteria|0|||
42114842|NCT00518115|75925404|FG009|Overall Study|Violation of Exclusion Criteria|0|||
42114843|NCT00518115|75925395|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
42114844|NCT00518115|75925396|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
42114845|NCT00518115|75925397|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
42114846|NCT00518115|75925398|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
42114847|NCT00518115|75925399|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
42114848|NCT00518115|75925400|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
42114849|NCT00518115|75925401|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
42114850|NCT00518115|75925402|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
42114851|NCT00518115|75925403|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
42114852|NCT00518115|75925404|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
42114853|NCT00518115|75925395|FG000|Overall Study|Withdrew Consent|0|||
42114854|NCT00518115|75925396|FG001|Overall Study|Withdrew Consent|0|||
42114855|NCT00518115|75925397|FG002|Overall Study|Withdrew Consent|0|||
42114856|NCT00518115|75925398|FG003|Overall Study|Withdrew Consent|0|||
42114857|NCT00518115|75925399|FG004|Overall Study|Withdrew Consent|0|||
42114858|NCT00518115|75925400|FG005|Overall Study|Withdrew Consent|1|||
42114859|NCT00518115|75925401|FG006|Overall Study|Withdrew Consent|0|||
42114860|NCT00518115|75925402|FG007|Overall Study|Withdrew Consent|0|||
42114861|NCT00518115|75925403|FG008|Overall Study|Withdrew Consent|0|||
42114862|NCT00518115|75925404|FG009|Overall Study|Withdrew Consent|0|||
42114863|NCT00518115|75925395|FG000|Overall Study|Moved Out of State|0|||
42114864|NCT00518115|75925396|FG001|Overall Study|Moved Out of State|0|||
42114865|NCT00518115|75925397|FG002|Overall Study|Moved Out of State|0|||
42114866|NCT00518115|75925398|FG003|Overall Study|Moved Out of State|0|||
42114867|NCT00518115|75925399|FG004|Overall Study|Moved Out of State|0|||
42114868|NCT00518115|75925400|FG005|Overall Study|Moved Out of State|0|||
42114869|NCT00518115|75925401|FG006|Overall Study|Moved Out of State|0|||
42114870|NCT00518115|75925402|FG007|Overall Study|Moved Out of State|0|||
42114871|NCT00518115|75925403|FG008|Overall Study|Moved Out of State|0|||
42114872|NCT00518115|75925404|FG009|Overall Study|Moved Out of State|1|||
42114873|NCT00450658|75925429|FG000|Overall Study|Adverse Event|24|||
42114874|NCT00450658|75925430|FG001|Overall Study|Adverse Event|15|||
42114875|NCT00450658|75925429|FG000|Overall Study|Withdrawal by Subject|43|||
42114876|NCT00450658|75925430|FG001|Overall Study|Withdrawal by Subject|26|||
42114877|NCT00450658|75925429|FG000|Overall Study|Lost to Follow-up|22|||
42114878|NCT00450658|75925430|FG001|Overall Study|Lost to Follow-up|5|||
42114879|NCT00450658|75925429|FG000|Overall Study|UGI ulcer|33|||
42114880|NCT00450658|75925430|FG001|Overall Study|UGI ulcer|34|||
42114881|NCT00450658|75925429|FG000|Overall Study|misc|21|||
42114882|NCT00450658|75925430|FG001|Overall Study|misc|10|||
42114883|NCT00517881|75925436|FG000|Overall Study|Protocol Violation|2|||
42114884|NCT00517881|75925436|FG000|Overall Study|Adverse Event|1|||
42114885|NCT00517881|75925436|FG000|Overall Study|Renal transplantation|2|||
42114886|NCT00517413|75925457|FG000|Overall Study|Adverse Event|7|||
42114887|NCT00517413|75925457|FG000|Overall Study|Death|13|||
42114888|NCT00517413|75925457|FG000|Overall Study|Protocol Violation|15|||
42114889|NCT00517413|75925457|FG000|Overall Study|Withdrawal by Subject|2|||
42114890|NCT00517413|75925457|FG000|Overall Study|Failure to return|1|||
42114891|NCT00517413|75925457|FG000|Overall Study|Other-Reasons|23|||
42114892|NCT00604214|75925471|FG000|Baseline to Day 28|Death|223|||
42114893|NCT00604214|75925472|FG001|Baseline to Day 28|Death|202|||
42114894|NCT00604214|75925471|FG000|Baseline to Day 28|Lost to Follow-up|2|||
42114895|NCT00604214|75925472|FG001|Baseline to Day 28|Lost to Follow-up|4|||
42114896|NCT00604214|75925471|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
42114897|NCT00604214|75925472|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
42114898|NCT00604214|75925471|FG000|Day 29 to Day 90|Death|64|||
42114899|NCT00604214|75925472|FG001|Day 29 to Day 90|Death|67|||
42114900|NCT00604214|75925471|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
42114901|NCT00604214|75925472|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
42114902|NCT00604214|75925471|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
42114903|NCT00604214|75925472|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
42114904|NCT00604214|75925471|FG000|Day 91 to Day 180|Death|19|||
42114905|NCT00604214|75925472|FG001|Day 91 to Day 180|Death|23|||
42114906|NCT00604214|75925471|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
42114907|NCT00604214|75925472|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
42114908|NCT00604214|75925471|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
42114909|NCT00604214|75925472|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
42114910|NCT00450580|75925480|FG000|Overall Study|Adverse Event|5|||
42114911|NCT00450580|75925481|FG001|Overall Study|Adverse Event|7|||
42114912|NCT00450580|75925480|FG000|Overall Study|Lost to Follow-up|4|||
42114913|NCT00450580|75925481|FG001|Overall Study|Lost to Follow-up|5|||
42114914|NCT00450580|75925480|FG000|Overall Study|Withdrawal by Subject|2|||
42114915|NCT00450580|75925481|FG001|Overall Study|Withdrawal by Subject|2|||
42114916|NCT00450580|75925480|FG000|Overall Study|Protocol Violation|1|||
42114917|NCT00450580|75925481|FG001|Overall Study|Protocol Violation|1|||
42114918|NCT00450580|75925480|FG000|Overall Study|Protocol-defined virologic failure|1|||
42114919|NCT00450580|75925481|FG001|Overall Study|Protocol-defined virologic failure|0|||
42114920|NCT00450580|75925480|FG000|Overall Study|Could not comply with scheduled visits|1|||
42114921|NCT00450580|75925481|FG001|Overall Study|Could not comply with scheduled visits|0|||
42114922|NCT00450580|75925480|FG000|Overall Study|Patient went to Brazil|1|||
42114923|NCT00450580|75925481|FG001|Overall Study|Patient went to Brazil|0|||
42114924|NCT00450580|75925480|FG000|Overall Study|Patient could not swallow Norvir|1|||
42114925|NCT00450580|75925481|FG001|Overall Study|Patient could not swallow Norvir|0|||
42114926|NCT00450580|75925480|FG000|Overall Study|Withdrawal due to pregnancy|0|||
42114927|NCT00450580|75925481|FG001|Overall Study|Withdrawal due to pregnancy|1|||
42114928|NCT00123487|75925489|FG000|Randomized|Death prior to starting treatment|0|||
42114929|NCT00123487|75925490|FG001|Randomized|Death prior to starting treatment|1|||
42114930|NCT00123487|75925489|FG000|Randomized|SAE prior to starting treatment|1|||
42114931|NCT00123487|75925490|FG001|Randomized|SAE prior to starting treatment|0|||
42114932|NCT00123487|75925489|FG000|Treated With Study Drug|Adverse Event|23|||
42114933|NCT00123487|75925490|FG001|Treated With Study Drug|Adverse Event|22|||
42114934|NCT00123487|75925489|FG000|Treated With Study Drug|Disease Progression|141|||
42114935|NCT00123487|75925490|FG001|Treated With Study Drug|Disease Progression|122|||
42114936|NCT00123487|75925489|FG000|Treated With Study Drug|Physician Decision|8|||
42114937|NCT00123487|75925490|FG001|Treated With Study Drug|Physician Decision|9|||
42114938|NCT00123487|75925489|FG000|Treated With Study Drug|Other|59|||
42114939|NCT00123487|75925490|FG001|Treated With Study Drug|Other|58|||
42114940|NCT00123487|75925489|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
42114941|NCT00123487|75925490|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
42114942|NCT00123487|75925489|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
42114943|NCT00123487|75925490|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
42114944|NCT00123487|75925489|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
42114945|NCT00123487|75925490|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
42114946|NCT00509925|75925497|FG000|Overall Study|Personal reasons|0|||
42114947|NCT00509925|75925498|FG001|Overall Study|Personal reasons|1|||
42114948|NCT00504777|75925506|FG000|Overall Study|Adverse Event|1|||
42114949|NCT00509769|75925510|FG000|Overall Study|Progressive disease|77|||
42114950|NCT00509769|75925510|FG000|Overall Study|Adverse Event|4|||
42114951|NCT00509769|75925510|FG000|Overall Study|Patient's decision|1|||
42114952|NCT00509769|75925510|FG000|Overall Study|Physician Decision|8|||
42114953|NCT00509769|75925510|FG000|Overall Study|Use of prohibited therapies during study|1|||
42114954|NCT00114127|75925516|FG000|Overall Study|Adverse Event|2|||
42114955|NCT00114127|75925517|FG001|Overall Study|Adverse Event|1|||
42114956|NCT00114127|75925516|FG000|Overall Study|Lost to Follow-up|1|||
42114957|NCT00114127|75925517|FG001|Overall Study|Lost to Follow-up|0|||
42114958|NCT00114127|75925516|FG000|Overall Study|Withdrawal by Subject|1|||
42114959|NCT00114127|75925517|FG001|Overall Study|Withdrawal by Subject|3|||
42114960|NCT00572624|75925529|FG000|Overall Study|Lost to Follow-up|10|||
42114961|NCT00572624|75925530|FG001|Overall Study|Lost to Follow-up|4|||
42114962|NCT00572624|75925529|FG000|Overall Study|Wanted to do a different diet program|1|||
42114963|NCT00572624|75925530|FG001|Overall Study|Wanted to do a different diet program|0|||
42114964|NCT00572624|75925529|FG000|Overall Study|Medication change|1|||
42114965|NCT00572624|75925530|FG001|Overall Study|Medication change|0|||
42114966|NCT00572624|75925529|FG000|Overall Study|Started a new job-- no time for study|1|||
42114967|NCT00572624|75925530|FG001|Overall Study|Started a new job-- no time for study|0|||
42114968|NCT00572624|75925529|FG000|Overall Study|Admitted to being a smoker|1|||
42114969|NCT00572624|75925530|FG001|Overall Study|Admitted to being a smoker|0|||
42114970|NCT00572624|75925529|FG000|Overall Study|Refused to do the stress test|1|||
42114971|NCT00572624|75925530|FG001|Overall Study|Refused to do the stress test|0|||
42114972|NCT00572624|75925529|FG000|Overall Study|Problem with vascular access|1|||
42114973|NCT00572624|75925530|FG001|Overall Study|Problem with vascular access|0|||
42114974|NCT00572624|75925529|FG000|Overall Study|Health issues unrelated to the study|1|||
42114975|NCT00572624|75925530|FG001|Overall Study|Health issues unrelated to the study|0|||
42114976|NCT00122317|75925536|FG000|Overall Study|Death|3|||
42114977|NCT00122317|75925536|FG000|Overall Study|Adverse Event|4|||
42114978|NCT00122317|75925536|FG000|Overall Study|Physician Decision|2|||
42114979|NCT00122317|75925536|FG000|Overall Study|patient non-compliance|1|||
42114980|NCT00122317|75925536|FG000|Overall Study|Withdrawal by Subject|1|||
42114981|NCT03870555|75925543|FG000|Period 3 (2 Days)|Adverse Event|1|||
42114982|NCT03870555|75925544|FG001|Period 3 (2 Days)|Adverse Event|0|||
42114983|NCT03870555|75925545|FG002|Period 3 (2 Days)|Adverse Event|0|||
42114984|NCT03870477|75925556|FG000|Overall Study|Early Study Termination|1|||
42114985|NCT00165841|75925562|FG000|Overall Study|Adverse Event|2|||
42114986|NCT00165841|75925563|FG001|Overall Study|Adverse Event|3|||
42114987|NCT00165841|75925562|FG000|Overall Study|Lack of Efficacy|6|||
42114988|NCT00165841|75925563|FG001|Overall Study|Lack of Efficacy|33|||
42114989|NCT00165841|75925562|FG000|Overall Study|Lost to Follow-up|4|||
42114990|NCT00165841|75925563|FG001|Overall Study|Lost to Follow-up|4|||
42114991|NCT00165841|75925562|FG000|Overall Study|Withdrawal by Subject|7|||
42114992|NCT00165841|75925563|FG001|Overall Study|Withdrawal by Subject|8|||
42114993|NCT00165841|75925562|FG000|Overall Study|Physician Decision|1|||
42114994|NCT00165841|75925563|FG001|Overall Study|Physician Decision|0|||
42114995|NCT00165841|75925562|FG000|Overall Study|Protocol Violation|6|||
42114996|NCT00165841|75925563|FG001|Overall Study|Protocol Violation|8|||
42114997|NCT00165841|75925562|FG000|Overall Study|Other|3|||
42114998|NCT00165841|75925563|FG001|Overall Study|Other|5|||
42114999|NCT00165841|75925562|FG000|Overall Study|Medication Noncompliance|1|||
42115000|NCT00165841|75925563|FG001|Overall Study|Medication Noncompliance|1|||
42115001|NCT00509223|75925571|FG000|Overall Study|Lost to Follow-up|1|||
42115002|NCT00509223|75925572|FG001|Overall Study|Lost to Follow-up|1|||
42115003|NCT00509223|75925571|FG000|Overall Study|Adverse Event|1|||
42115004|NCT00509223|75925572|FG001|Overall Study|Adverse Event|1|||
42115005|NCT00509223|75925571|FG000|Overall Study|Withdrawal by Subject|25|||
42115006|NCT00509223|75925572|FG001|Overall Study|Withdrawal by Subject|6|||
42115007|NCT00509223|75925571|FG000|Overall Study|Including: subject change of address|5|||
42115008|NCT00509223|75925572|FG001|Overall Study|Including: subject change of address|2|||
42115009|NCT00509223|75925571|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
42115010|NCT00509223|75925572|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
42115011|NCT00460798|75925578|FG000|Overall Study|Death|59|||
42115012|NCT00460798|75925578|FG000|Overall Study|Adverse Event|27|||
42115013|NCT00460798|75925578|FG000|Overall Study|Lost to Follow-up|19|||
42115014|NCT00460798|75925578|FG000|Overall Study|Progressive Disease|99|||
42115015|NCT00460798|75925578|FG000|Overall Study|Other|27|||
42115016|NCT00460798|75925578|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
42115017|NCT00460798|75925578|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
42115018|NCT00603980|75925582|FG000|Study Qualification|Protocol Violation|3|||
42115019|NCT00603980|75925582|FG000|Study Qualification|Inconsistent data reporting|13|||
42115020|NCT00603980|75925582|FG000|Main Study|14th subject completed trial|1|||
42115021|NCT00450190|75925602|FG000|Overall Study|Withdrawal by Subject|2|||
42115022|NCT00450112|75925608|FG000|Overall Study|Other Treatment Required|5|||
42115023|NCT00450112|75925609|FG001|Overall Study|Other Treatment Required|1|||
42115024|NCT00450112|75925608|FG000|Overall Study|Withdrawal by Subject|4|||
42115025|NCT00450112|75925609|FG001|Overall Study|Withdrawal by Subject|1|||
42115026|NCT00450112|75925608|FG000|Overall Study|Lost to Follow-up|2|||
42115027|NCT00450112|75925609|FG001|Overall Study|Lost to Follow-up|1|||
42115028|NCT00450112|75925608|FG000|Overall Study|Others|2|||
42115029|NCT00450112|75925609|FG001|Overall Study|Others|3|||
42115030|NCT00449956|75925618|FG000|Overall Study|Adverse Event|7|||
42115031|NCT00449956|75925619|FG001|Overall Study|Adverse Event|1|||
42115032|NCT00449956|75925620|FG002|Overall Study|Adverse Event|6|||
42115033|NCT00449956|75925618|FG000|Overall Study|Lack of Efficacy|0|||
42115034|NCT00449956|75925619|FG001|Overall Study|Lack of Efficacy|0|||
42115035|NCT00449956|75925620|FG002|Overall Study|Lack of Efficacy|1|||
42115036|NCT00449956|75925618|FG000|Overall Study|Protocol Violation|1|||
42115037|NCT00449956|75925619|FG001|Overall Study|Protocol Violation|1|||
42115038|NCT00449956|75925620|FG002|Overall Study|Protocol Violation|1|||
42115039|NCT00449956|75925618|FG000|Overall Study|Withdrawal by Subject|0|||
42115040|NCT00449956|75925619|FG001|Overall Study|Withdrawal by Subject|1|||
42115041|NCT00449956|75925620|FG002|Overall Study|Withdrawal by Subject|0|||
42115042|NCT00449956|75925618|FG000|Overall Study|Physician Decision|2|||
42115043|NCT00449956|75925619|FG001|Overall Study|Physician Decision|1|||
42115044|NCT00449956|75925620|FG002|Overall Study|Physician Decision|1|||
42115045|NCT00509145|75925630|FG000|Overall Study|Death|0|||
42115046|NCT00509145|75925631|FG001|Overall Study|Death|2|||
42115047|NCT00509145|75925630|FG000|Overall Study|Adverse Event|42|||
42115048|NCT00509145|75925631|FG001|Overall Study|Adverse Event|28|||
42115049|NCT00509145|75925630|FG000|Overall Study|Withdrawal by Subject|32|||
42115050|NCT00509145|75925631|FG001|Overall Study|Withdrawal by Subject|38|||
42115051|NCT00509145|75925630|FG000|Overall Study|Physician Decision|11|||
42115052|NCT00509145|75925631|FG001|Overall Study|Physician Decision|14|||
42115053|NCT00509145|75925630|FG000|Overall Study|Protocol Violation|1|||
42115054|NCT00509145|75925631|FG001|Overall Study|Protocol Violation|6|||
42115055|NCT00509145|75925630|FG000|Overall Study|Pregnancy|3|||
42115056|NCT00509145|75925631|FG001|Overall Study|Pregnancy|8|||
42115057|NCT00509145|75925630|FG000|Overall Study|Lost to Follow-up|6|||
42115058|NCT00509145|75925631|FG001|Overall Study|Lost to Follow-up|5|||
42115059|NCT00509145|75925630|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
42115060|NCT00509145|75925631|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
42115061|NCT00509145|75925630|FG000|Overall Study|Other|6|||
42115062|NCT00509145|75925631|FG001|Overall Study|Other|6|||
42115063|NCT00509067|75925639|FG000|Overall Study|Lost to Follow-up|1|||
42115064|NCT00509067|75925640|FG001|Overall Study|Lost to Follow-up|1|||
42115065|NCT00509067|75925639|FG000|Overall Study|Adverse Event|3|||
42115066|NCT00509067|75925640|FG001|Overall Study|Adverse Event|1|||
42115067|NCT00509067|75925639|FG000|Overall Study|Protocol Violation|0|||
42115068|NCT00509067|75925640|FG001|Overall Study|Protocol Violation|3|||
42115069|NCT00504309|75925656|FG000|Overall Study|Death|0|||
42115070|NCT00504309|75925657|FG001|Overall Study|Death|0|||
42115071|NCT00504309|75925658|FG002|Overall Study|Death|0|||
42115072|NCT00504309|75925659|FG003|Overall Study|Death|0|||
42115073|NCT00504309|75925660|FG004|Overall Study|Death|1|||
42115074|NCT00504309|75925661|FG005|Overall Study|Death|0|||
42115075|NCT00504309|75925656|FG000|Overall Study|Withdrawal by Subject|0|||
42115076|NCT00504309|75925657|FG001|Overall Study|Withdrawal by Subject|0|||
42115077|NCT00504309|75925658|FG002|Overall Study|Withdrawal by Subject|1|||
42115078|NCT00504309|75925659|FG003|Overall Study|Withdrawal by Subject|0|||
42115079|NCT00504309|75925660|FG004|Overall Study|Withdrawal by Subject|0|||
42115080|NCT00504309|75925661|FG005|Overall Study|Withdrawal by Subject|0|||
42115081|NCT00508755|75925673|FG000|Overall Study|Withdrawal by Subject|1|||
42115082|NCT00504231|75925683|FG000|Overall Study|Discrepant chart documentation re route|0|||
42115083|NCT00504231|75925684|FG001|Overall Study|Discrepant chart documentation re route|0|||
42115084|NCT00504231|75925685|FG002|Overall Study|Discrepant chart documentation re route|1|||
42115085|NCT00504231|75925686|FG003|Overall Study|Discrepant chart documentation re route|0|||
42115086|NCT00568178|75925747|FG000|Double Blind Base Study|Adverse Event|0|||
42115087|NCT00568178|75925748|FG001|Double Blind Base Study|Adverse Event|2|||
42115088|NCT00568178|75925749|FG002|Double Blind Base Study|Adverse Event|1|||
42115089|NCT00568178|75925750|FG003|Double Blind Base Study|Adverse Event|2|||
42115090|NCT00568178|75925751|FG004|Double Blind Base Study|Adverse Event|0|||
42115091|NCT00568178|75925752|FG005|Double Blind Base Study|Adverse Event|0|||
42115092|NCT00568178|75925747|FG000|Double Blind Base Study|Lost to Follow-up|1|||
42115093|NCT00568178|75925748|FG001|Double Blind Base Study|Lost to Follow-up|0|||
42115094|NCT00568178|75925749|FG002|Double Blind Base Study|Lost to Follow-up|0|||
42115095|NCT00568178|75925750|FG003|Double Blind Base Study|Lost to Follow-up|1|||
42115096|NCT00568178|75925751|FG004|Double Blind Base Study|Lost to Follow-up|0|||
42115097|NCT00568178|75925752|FG005|Double Blind Base Study|Lost to Follow-up|0|||
42115098|NCT00568178|75925747|FG000|Double Blind Base Study|Physician Decision|1|||
42115099|NCT00568178|75925748|FG001|Double Blind Base Study|Physician Decision|1|||
42115100|NCT00568178|75925749|FG002|Double Blind Base Study|Physician Decision|0|||
42115101|NCT00568178|75925750|FG003|Double Blind Base Study|Physician Decision|1|||
42115102|NCT00568178|75925751|FG004|Double Blind Base Study|Physician Decision|0|||
42115103|NCT00568178|75925752|FG005|Double Blind Base Study|Physician Decision|0|||
42115104|NCT00568178|75925747|FG000|Double Blind Base Study|Protocol Violation|3|||
42115105|NCT00568178|75925748|FG001|Double Blind Base Study|Protocol Violation|2|||
42115106|NCT00568178|75925749|FG002|Double Blind Base Study|Protocol Violation|0|||
42115107|NCT00568178|75925750|FG003|Double Blind Base Study|Protocol Violation|0|||
42115108|NCT00568178|75925751|FG004|Double Blind Base Study|Protocol Violation|0|||
42115109|NCT00568178|75925752|FG005|Double Blind Base Study|Protocol Violation|0|||
42115110|NCT00568178|75925747|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
42115111|NCT00568178|75925748|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
42115112|NCT00568178|75925749|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
42115113|NCT00568178|75925750|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
42115114|NCT00568178|75925751|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
42115115|NCT00568178|75925752|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
42115116|NCT00568178|75925747|FG000|Double Blind Base Study|Progressive Disease|0|||
42115117|NCT00568178|75925748|FG001|Double Blind Base Study|Progressive Disease|0|||
42115118|NCT00568178|75925749|FG002|Double Blind Base Study|Progressive Disease|0|||
42115119|NCT00568178|75925750|FG003|Double Blind Base Study|Progressive Disease|1|||
42115120|NCT00568178|75925751|FG004|Double Blind Base Study|Progressive Disease|0|||
42115121|NCT00568178|75925752|FG005|Double Blind Base Study|Progressive Disease|0|||
42115122|NCT00568178|75925747|FG000|Open Label Extension|Adverse Event|0|||
42115123|NCT00568178|75925748|FG001|Open Label Extension|Adverse Event|0|||
42115124|NCT00568178|75925749|FG002|Open Label Extension|Adverse Event|0|||
42115125|NCT00568178|75925750|FG003|Open Label Extension|Adverse Event|0|||
42115126|NCT00568178|75925751|FG004|Open Label Extension|Adverse Event|11|||
42115127|NCT00568178|75925752|FG005|Open Label Extension|Adverse Event|8|||
42115128|NCT00568178|75925747|FG000|Open Label Extension|Protocol Violation|0|||
42115129|NCT00568178|75925748|FG001|Open Label Extension|Protocol Violation|0|||
42115130|NCT00568178|75925749|FG002|Open Label Extension|Protocol Violation|0|||
42115131|NCT00568178|75925750|FG003|Open Label Extension|Protocol Violation|0|||
42115132|NCT00568178|75925751|FG004|Open Label Extension|Protocol Violation|1|||
42115133|NCT00568178|75925752|FG005|Open Label Extension|Protocol Violation|0|||
42115134|NCT00568178|75925747|FG000|Open Label Extension|Lost to Follow-up|0|||
42115135|NCT00568178|75925748|FG001|Open Label Extension|Lost to Follow-up|0|||
42115136|NCT00568178|75925749|FG002|Open Label Extension|Lost to Follow-up|0|||
42115137|NCT00568178|75925750|FG003|Open Label Extension|Lost to Follow-up|0|||
42115138|NCT00568178|75925751|FG004|Open Label Extension|Lost to Follow-up|6|||
42115139|NCT00568178|75925752|FG005|Open Label Extension|Lost to Follow-up|11|||
42115140|NCT00568178|75925747|FG000|Open Label Extension|Physician Decision|0|||
42115141|NCT00568178|75925748|FG001|Open Label Extension|Physician Decision|0|||
42115142|NCT00568178|75925749|FG002|Open Label Extension|Physician Decision|0|||
42115143|NCT00568178|75925750|FG003|Open Label Extension|Physician Decision|0|||
42115144|NCT00568178|75925751|FG004|Open Label Extension|Physician Decision|9|||
42115145|NCT00568178|75925752|FG005|Open Label Extension|Physician Decision|8|||
42115146|NCT00568178|75925747|FG000|Open Label Extension|Pregnancy|0|||
42115147|NCT00568178|75925748|FG001|Open Label Extension|Pregnancy|0|||
42115148|NCT00568178|75925749|FG002|Open Label Extension|Pregnancy|0|||
42115149|NCT00568178|75925750|FG003|Open Label Extension|Pregnancy|0|||
42115150|NCT00568178|75925751|FG004|Open Label Extension|Pregnancy|0|||
42115151|NCT00568178|75925752|FG005|Open Label Extension|Pregnancy|1|||
42115152|NCT00568178|75925747|FG000|Open Label Extension|Progressive Disease|0|||
42115153|NCT00568178|75925748|FG001|Open Label Extension|Progressive Disease|0|||
42115154|NCT00568178|75925749|FG002|Open Label Extension|Progressive Disease|0|||
42115155|NCT00568178|75925750|FG003|Open Label Extension|Progressive Disease|0|||
42115156|NCT00568178|75925751|FG004|Open Label Extension|Progressive Disease|3|||
42115157|NCT00568178|75925752|FG005|Open Label Extension|Progressive Disease|1|||
42115158|NCT00568178|75925747|FG000|Open Label Extension|Termination of Trial|0|||
42115159|NCT00568178|75925748|FG001|Open Label Extension|Termination of Trial|0|||
42115160|NCT00568178|75925749|FG002|Open Label Extension|Termination of Trial|0|||
42115161|NCT00568178|75925750|FG003|Open Label Extension|Termination of Trial|0|||
42115162|NCT00568178|75925751|FG004|Open Label Extension|Termination of Trial|45|||
42115163|NCT00568178|75925752|FG005|Open Label Extension|Termination of Trial|47|||
42115164|NCT00568178|75925747|FG000|Open Label Extension|Withdrawal by Subject|0|||
42115165|NCT00568178|75925748|FG001|Open Label Extension|Withdrawal by Subject|0|||
42115166|NCT00568178|75925749|FG002|Open Label Extension|Withdrawal by Subject|0|||
42115167|NCT00568178|75925750|FG003|Open Label Extension|Withdrawal by Subject|0|||
42115168|NCT00568178|75925751|FG004|Open Label Extension|Withdrawal by Subject|4|||
42115169|NCT00568178|75925752|FG005|Open Label Extension|Withdrawal by Subject|4|||
42115170|NCT00577889|75925769|FG000|Overall Study|Withdrawal by Subject|1|||
42115171|NCT00577889|75925770|FG001|Overall Study|Withdrawal by Subject|0|||
42115172|NCT00577889|75925771|FG002|Overall Study|Withdrawal by Subject|0|||
42115173|NCT00460564|75925783|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
42115174|NCT00460564|75925784|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
42115175|NCT00460564|75925785|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
42115176|NCT00460564|75925786|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
42115177|NCT00460564|75925787|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
42115178|NCT00460564|75925788|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
42115179|NCT00460564|75925789|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
42115180|NCT00460564|75925790|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
42115181|NCT00460564|75925783|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
42115182|NCT00460564|75925784|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
42115183|NCT00460564|75925785|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
42115184|NCT00460564|75925786|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
42115185|NCT00460564|75925787|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
42115186|NCT00460564|75925788|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
42115187|NCT00460564|75925789|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
42115188|NCT00460564|75925790|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
42115189|NCT00460564|75925783|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
42115190|NCT00460564|75925784|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
42115191|NCT00460564|75925785|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
42115192|NCT00460564|75925786|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
42115193|NCT00460564|75925787|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
42115194|NCT00460564|75925788|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
42115195|NCT00460564|75925789|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
42115196|NCT00460564|75925790|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
42115197|NCT00460564|75925783|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
42115198|NCT00460564|75925784|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
42115199|NCT00460564|75925785|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
42115200|NCT00460564|75925786|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
42115201|NCT00460564|75925787|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
42115202|NCT00460564|75925788|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
42115203|NCT00460564|75925789|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
42115204|NCT00460564|75925790|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
42115205|NCT00460564|75925783|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
42115206|NCT00460564|75925784|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
42115207|NCT00460564|75925785|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
42115208|NCT00460564|75925786|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
42115209|NCT00460564|75925787|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
42115210|NCT00460564|75925788|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
42115211|NCT00460564|75925789|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
42115212|NCT00460564|75925790|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
42115213|NCT00567476|75925812|FG000|Overall Study|Adverse Event|2|||
42115214|NCT00567476|75925813|FG001|Overall Study|Adverse Event|0|||
42115215|NCT00567476|75925812|FG000|Overall Study|Pregnancy|1|||
42115216|NCT00567476|75925813|FG001|Overall Study|Pregnancy|0|||
42115217|NCT00567476|75925812|FG000|Overall Study|Protocol Violation|4|||
42115218|NCT00567476|75925813|FG001|Overall Study|Protocol Violation|1|||
42115219|NCT00567476|75925812|FG000|Overall Study|Lost to Follow-up|0|||
42115220|NCT00567476|75925813|FG001|Overall Study|Lost to Follow-up|1|||
42115221|NCT00567476|75925812|FG000|Overall Study|Administrative issues|1|||
42115222|NCT00567476|75925813|FG001|Overall Study|Administrative issues|0|||
42115223|NCT00567476|75925812|FG000|Overall Study|Medical Decision|0|||
42115224|NCT00567476|75925813|FG001|Overall Study|Medical Decision|1|||
42115225|NCT00567476|75925812|FG000|Overall Study|Non-adherence to protocol|0|||
42115226|NCT00567476|75925813|FG001|Overall Study|Non-adherence to protocol|1|||
42115227|NCT00516321|75925821|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
42115228|NCT00516321|75925822|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
42115229|NCT00516321|75925823|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
42115230|NCT00516321|75925821|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
42115231|NCT00516321|75925822|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
42115232|NCT00516321|75925823|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
42115233|NCT00516321|75925821|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
42115234|NCT00516321|75925822|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
42115235|NCT00516321|75925823|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
42115236|NCT00516321|75925821|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
42115237|NCT00516321|75925822|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
42115238|NCT00516321|75925823|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
42115239|NCT00516321|75925821|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
42115240|NCT00516321|75925822|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
42115241|NCT00516321|75925823|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
42115242|NCT00516321|75925821|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
42115243|NCT00516321|75925822|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
42115244|NCT00516321|75925823|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
42115245|NCT00516321|75925821|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
42115246|NCT00516321|75925822|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
42115247|NCT00516321|75925823|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
42115248|NCT00516321|75925821|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
42115249|NCT00516321|75925822|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
42115250|NCT00516321|75925823|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
42115251|NCT00516321|75925821|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
42115252|NCT00516321|75925822|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
42115253|NCT00516321|75925823|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
42115254|NCT00516321|75925821|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
42115255|NCT00516321|75925822|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
42115256|NCT00516321|75925823|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
42115257|NCT00516321|75925821|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
42115258|NCT00516321|75925822|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
42115259|NCT00516321|75925823|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
42115260|NCT00460408|75925835|FG000|Overall Study|Adverse Event|1|||
42115261|NCT00460408|75925836|FG001|Overall Study|Adverse Event|0|||
42115262|NCT00460408|75925837|FG002|Overall Study|Adverse Event|0|||
42115263|NCT00460408|75925838|FG003|Overall Study|Adverse Event|0|||
42115264|NCT00460408|75925835|FG000|Overall Study|Death|7|||
42115265|NCT00460408|75925836|FG001|Overall Study|Death|0|||
42115266|NCT00460408|75925837|FG002|Overall Study|Death|0|||
42115267|NCT00460408|75925838|FG003|Overall Study|Death|0|||
42115268|NCT00460408|75925835|FG000|Overall Study|Lost to Follow-up|11|||
42115269|NCT00460408|75925836|FG001|Overall Study|Lost to Follow-up|0|||
42115270|NCT00460408|75925837|FG002|Overall Study|Lost to Follow-up|1|||
42115271|NCT00460408|75925838|FG003|Overall Study|Lost to Follow-up|0|||
42115272|NCT00460408|75925835|FG000|Overall Study|Withdrawal by Subject|31|||
42115273|NCT00460408|75925836|FG001|Overall Study|Withdrawal by Subject|0|||
42115274|NCT00460408|75925837|FG002|Overall Study|Withdrawal by Subject|0|||
42115275|NCT00460408|75925838|FG003|Overall Study|Withdrawal by Subject|0|||
42115276|NCT00460408|75925835|FG000|Overall Study|Insufficient clinical response|5|||
42115277|NCT00460408|75925836|FG001|Overall Study|Insufficient clinical response|1|||
42115278|NCT00460408|75925837|FG002|Overall Study|Insufficient clinical response|5|||
42115279|NCT00460408|75925838|FG003|Overall Study|Insufficient clinical response|0|||
42115280|NCT00460408|75925835|FG000|Overall Study|Other|12|||
42115281|NCT00460408|75925836|FG001|Overall Study|Other|2|||
42115282|NCT00460408|75925837|FG002|Overall Study|Other|0|||
42115283|NCT00460408|75925838|FG003|Overall Study|Other|0|||
42115284|NCT00507819|75925848|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
42115285|NCT00507819|75925849|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
42115286|NCT00442936|75925879|FG000|Overall Study|Protocol Violation|1|||
42115287|NCT00442936|75925880|FG001|Overall Study|Protocol Violation|0|||
42115288|NCT00442936|75925881|FG002|Overall Study|Protocol Violation|1|||
42115289|NCT00442936|75925882|FG003|Overall Study|Protocol Violation|1|||
42115290|NCT00577655|75925894|FG000|Overall Study|Patient Request|0|||
42115291|NCT00577655|75925895|FG001|Overall Study|Patient Request|2|||
42115292|NCT00577655|75925894|FG000|Overall Study|Protocol Violation|0|||
42115293|NCT00577655|75925895|FG001|Overall Study|Protocol Violation|1|||
42115294|NCT00577655|75925894|FG000|Overall Study|Lost to Follow-up|1|||
42115295|NCT00577655|75925895|FG001|Overall Study|Lost to Follow-up|1|||
42115296|NCT00113269|75925906|FG000|Overall Study|Not transplanted, donor issues|4|||
42115297|NCT00113269|75925907|FG001|Overall Study|Not transplanted, donor issues|0|||
42115298|NCT00113269|75925908|FG002|Overall Study|Not transplanted, donor issues|2|||
42115299|NCT00113269|75925909|FG003|Overall Study|Not transplanted, donor issues|2|||
42115300|NCT00113269|75925906|FG000|Overall Study|Not transplanted, recipient issues|2|||
42115301|NCT00113269|75925907|FG001|Overall Study|Not transplanted, recipient issues|1|||
42115302|NCT00113269|75925908|FG002|Overall Study|Not transplanted, recipient issues|7|||
42115303|NCT00113269|75925909|FG003|Overall Study|Not transplanted, recipient issues|4|||
42115304|NCT00113269|75925906|FG000|Overall Study|Early graft loss, technical|0|||
42115305|NCT00113269|75925907|FG001|Overall Study|Early graft loss, technical|0|||
42115306|NCT00113269|75925908|FG002|Overall Study|Early graft loss, technical|2|||
42115307|NCT00113269|75925909|FG003|Overall Study|Early graft loss, technical|0|||
42115308|NCT00113269|75925906|FG000|Overall Study|Death in operating room|0|||
42115309|NCT00113269|75925907|FG001|Overall Study|Death in operating room|0|||
42115310|NCT00113269|75925908|FG002|Overall Study|Death in operating room|0|||
42115311|NCT00113269|75925909|FG003|Overall Study|Death in operating room|1|||
42115312|NCT00113269|75925906|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
42115313|NCT00113269|75925907|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
42115314|NCT00113269|75925908|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
42115315|NCT00113269|75925909|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
42115316|NCT00113269|75925906|FG000|Overall Study|Adverse Event|2|||
42115317|NCT00113269|75925907|FG001|Overall Study|Adverse Event|7|||
42115318|NCT00113269|75925908|FG002|Overall Study|Adverse Event|11|||
42115319|NCT00113269|75925909|FG003|Overall Study|Adverse Event|7|||
42115320|NCT00113269|75925906|FG000|Overall Study|Withdrawal by Subject|4|||
42115321|NCT00113269|75925907|FG001|Overall Study|Withdrawal by Subject|3|||
42115322|NCT00113269|75925908|FG002|Overall Study|Withdrawal by Subject|4|||
42115323|NCT00113269|75925909|FG003|Overall Study|Withdrawal by Subject|2|||
42115324|NCT00113269|75925906|FG000|Overall Study|Graft loss|6|||
42115325|NCT00113269|75925907|FG001|Overall Study|Graft loss|6|||
42115326|NCT00113269|75925908|FG002|Overall Study|Graft loss|4|||
42115327|NCT00113269|75925909|FG003|Overall Study|Graft loss|9|||
42115328|NCT00113269|75925906|FG000|Overall Study|Protocol Violation|1|||
42115329|NCT00113269|75925907|FG001|Overall Study|Protocol Violation|0|||
42115330|NCT00113269|75925908|FG002|Overall Study|Protocol Violation|4|||
42115331|NCT00113269|75925909|FG003|Overall Study|Protocol Violation|2|||
42115332|NCT00113269|75925906|FG000|Overall Study|Lost to Follow-up|2|||
42115333|NCT00113269|75925907|FG001|Overall Study|Lost to Follow-up|3|||
42115334|NCT00113269|75925908|FG002|Overall Study|Lost to Follow-up|6|||
42115335|NCT00113269|75925909|FG003|Overall Study|Lost to Follow-up|3|||
42115336|NCT00113269|75925906|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
42115337|NCT00113269|75925907|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
42115338|NCT00113269|75925908|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
42115339|NCT00113269|75925909|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
42115340|NCT00113269|75925906|FG000|Overall Study|Discontinued due to rejection|0|||
42115341|NCT00113269|75925907|FG001|Overall Study|Discontinued due to rejection|0|||
42115342|NCT00113269|75925908|FG002|Overall Study|Discontinued due to rejection|1|||
42115343|NCT00113269|75925909|FG003|Overall Study|Discontinued due to rejection|0|||
42115344|NCT00113269|75925906|FG000|Overall Study|Moved|0|||
42115345|NCT00113269|75925907|FG001|Overall Study|Moved|1|||
42115346|NCT00113269|75925908|FG002|Overall Study|Moved|0|||
42115347|NCT00113269|75925909|FG003|Overall Study|Moved|3|||
42115348|NCT00113269|75925906|FG000|Overall Study|Received pancreas transplant|0|||
42115349|NCT00113269|75925907|FG001|Overall Study|Received pancreas transplant|0|||
42115350|NCT00113269|75925908|FG002|Overall Study|Received pancreas transplant|0|||
42115351|NCT00113269|75925909|FG003|Overall Study|Received pancreas transplant|2|||
42115352|NCT00113269|75925906|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
42115353|NCT00113269|75925907|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
42115354|NCT00113269|75925908|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
42115355|NCT00113269|75925909|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
42115356|NCT00113269|75925906|FG000|Overall Study|Did not meet eligibility criteria|1|||
42115357|NCT00113269|75925907|FG001|Overall Study|Did not meet eligibility criteria|0|||
42115358|NCT00113269|75925908|FG002|Overall Study|Did not meet eligibility criteria|0|||
42115359|NCT00113269|75925909|FG003|Overall Study|Did not meet eligibility criteria|1|||
42115360|NCT00113269|75925906|FG000|Overall Study|Unable to return for follow up|2|||
42115361|NCT00113269|75925907|FG001|Overall Study|Unable to return for follow up|1|||
42115362|NCT00113269|75925908|FG002|Overall Study|Unable to return for follow up|0|||
42115363|NCT00113269|75925909|FG003|Overall Study|Unable to return for follow up|0|||
42115364|NCT00515619|75925919|FG000|Overall Study|Adverse Event|34|||
42115365|NCT00515619|75925919|FG000|Overall Study|Lack of Efficacy|92|||
42115366|NCT00515619|75925919|FG000|Overall Study|Withdrawal by Subject|66|||
42115367|NCT00515619|75925919|FG000|Overall Study|Protocol Violation|3|||
42115368|NCT00515619|75925919|FG000|Overall Study|Lost to Follow-up|4|||
42115369|NCT00515619|75925919|FG000|Overall Study|Unsatisfactory compliance|6|||
42115370|NCT00515619|75925919|FG000|Overall Study|Other: Site discontinuing trials|2|||
42115371|NCT00515619|75925919|FG000|Overall Study|Other: Subject cannot attend visits|2|||
42115372|NCT00515619|75925919|FG000|Overall Study|Other: Subject required surgery|1|||
42115373|NCT00515619|75925919|FG000|Overall Study|Other: Subject moved to another country|1|||
42115374|NCT00515619|75925919|FG000|Overall Study|Other: Investigator decision|1|||
42115375|NCT00515619|75925919|FG000|Overall Study|Other: Subject became pregnant|1|||
42115376|NCT00515619|75925919|FG000|Overall Study|Other: Request from sponsor|1|||
42115377|NCT00515619|75925919|FG000|Overall Study|Other: Drug available on license|1|||
42115378|NCT00515619|75925919|FG000|Overall Study|Other: Subject interested in other AED|1|||
42115379|NCT00449644|75925927|FG000|Overall Study|Adverse Event|0|||
42115380|NCT00449644|75925928|FG001|Overall Study|Adverse Event|0|||
42115381|NCT00449644|75925929|FG002|Overall Study|Adverse Event|3|||
42115382|NCT00449644|75925930|FG003|Overall Study|Adverse Event|5|||
42115383|NCT00449644|75925927|FG000|Overall Study|Death|1|||
42115384|NCT00449644|75925928|FG001|Overall Study|Death|0|||
42115385|NCT00449644|75925929|FG002|Overall Study|Death|6|||
42115386|NCT00449644|75925930|FG003|Overall Study|Death|1|||
42115387|NCT00449644|75925927|FG000|Overall Study|Lost to Follow-up|1|||
42115388|NCT00449644|75925928|FG001|Overall Study|Lost to Follow-up|1|||
42115389|NCT00449644|75925929|FG002|Overall Study|Lost to Follow-up|5|||
42115390|NCT00449644|75925930|FG003|Overall Study|Lost to Follow-up|3|||
42115391|NCT00449644|75925927|FG000|Overall Study|Pregnancy|0|||
42115392|NCT00449644|75925928|FG001|Overall Study|Pregnancy|0|||
42115393|NCT00449644|75925929|FG002|Overall Study|Pregnancy|3|||
42115394|NCT00449644|75925930|FG003|Overall Study|Pregnancy|2|||
42115395|NCT00449644|75925927|FG000|Overall Study|Protocol Violation|4|||
42115396|NCT00449644|75925928|FG001|Overall Study|Protocol Violation|4|||
42115397|NCT00449644|75925929|FG002|Overall Study|Protocol Violation|3|||
42115398|NCT00449644|75925930|FG003|Overall Study|Protocol Violation|7|||
42115399|NCT00449644|75925927|FG000|Overall Study|Withdrawal by Subject|3|||
42115400|NCT00449644|75925928|FG001|Overall Study|Withdrawal by Subject|4|||
42115401|NCT00449644|75925929|FG002|Overall Study|Withdrawal by Subject|6|||
42115402|NCT00449644|75925930|FG003|Overall Study|Withdrawal by Subject|7|||
42115403|NCT00449644|75925927|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
42115404|NCT00449644|75925928|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
42115405|NCT00449644|75925929|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
42115406|NCT00449644|75925930|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
42115407|NCT00449644|75925927|FG000|Overall Study|Other|1|||
42115408|NCT00449644|75925928|FG001|Overall Study|Other|4|||
42115409|NCT00449644|75925929|FG002|Overall Study|Other|1|||
42115410|NCT00449644|75925930|FG003|Overall Study|Other|0|||
42115411|NCT00449644|75925927|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
42115412|NCT00449644|75925928|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
42115413|NCT00449644|75925929|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
42115414|NCT00449644|75925930|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
42115415|NCT00515541|75925947|FG000|Overall Study|Physician Decision|0|||
42115416|NCT00515541|75925948|FG001|Overall Study|Physician Decision|2|||
42115417|NCT00515541|75925949|FG002|Overall Study|Physician Decision|0|||
42115418|NCT00515541|75925950|FG003|Overall Study|Physician Decision|1|||
42115419|NCT00515541|75925947|FG000|Overall Study|No show for appointments|0|||
42115420|NCT00515541|75925948|FG001|Overall Study|No show for appointments|1|||
42115421|NCT00515541|75925949|FG002|Overall Study|No show for appointments|0|||
42115422|NCT00515541|75925950|FG003|Overall Study|No show for appointments|2|||
42115423|NCT00515541|75925947|FG000|Overall Study|Withdrawal by Subject|0|||
42115424|NCT00515541|75925948|FG001|Overall Study|Withdrawal by Subject|2|||
42115425|NCT00515541|75925949|FG002|Overall Study|Withdrawal by Subject|0|||
42115426|NCT00515541|75925950|FG003|Overall Study|Withdrawal by Subject|2|||
42115427|NCT00112489|75925960|FG000|Overall Study|Refused further treatment|8|||
42115428|NCT00112489|75925960|FG000|Overall Study|Adverse Event|12|||
42115429|NCT00112489|75925960|FG000|Overall Study|Death|2|||
42115430|NCT00112489|75925960|FG000|Overall Study|Other, Not Specified|9|||
42115431|NCT00112489|75925960|FG000|Overall Study|Patient never treated|2|||
42115432|NCT00112489|75925960|FG000|Overall Study|Ineligible|7|||
42115433|NCT00711971|75925973|FG000|Overall Study|Lost to Follow-up|3|||
42115434|NCT00711971|75925974|FG001|Overall Study|Lost to Follow-up|4|||
42115435|NCT00711971|75925975|FG002|Overall Study|Lost to Follow-up|1|||
42115436|NCT00515463|75925989|FG000|Overall Study|Physician Decision|4|||
42115437|NCT00515463|75925990|FG001|Overall Study|Physician Decision|2|||
42115438|NCT00515463|75925989|FG000|Overall Study|Adverse Event|1|||
42115439|NCT00515463|75925990|FG001|Overall Study|Adverse Event|2|||
42115440|NCT00515463|75925989|FG000|Overall Study|Withdrawal by Subject|3|||
42115441|NCT00515463|75925990|FG001|Overall Study|Withdrawal by Subject|4|||
42115442|NCT00515463|75925989|FG000|Overall Study|Lost to Follow-up|6|||
42115443|NCT00515463|75925990|FG001|Overall Study|Lost to Follow-up|5|||
42115444|NCT00515463|75925989|FG000|Overall Study|Other|0|||
42115445|NCT00515463|75925990|FG001|Overall Study|Other|1|||
42115446|NCT00507507|75925999|FG000|Treatment Period|Lost to Follow-up|0|||
42115447|NCT00507507|75926000|FG001|Treatment Period|Lost to Follow-up|2|||
42115448|NCT00507507|75925999|FG000|Treatment Period|Physician Decision|4|||
42115449|NCT00507507|75926000|FG001|Treatment Period|Physician Decision|1|||
42115450|NCT00507507|75925999|FG000|Treatment Period|Protocol Violation|1|||
42115451|NCT00507507|75926000|FG001|Treatment Period|Protocol Violation|2|||
42115452|NCT00507507|75925999|FG000|Treatment Period|Adverse Event|1|||
42115453|NCT00507507|75926000|FG001|Treatment Period|Adverse Event|1|||
42115454|NCT00507507|75925999|FG000|Treatment Period|Withdrawal by Subject|46|||
42115455|NCT00507507|75926000|FG001|Treatment Period|Withdrawal by Subject|47|||
42115456|NCT00507507|75925999|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
42115457|NCT00507507|75926000|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
42115458|NCT00507507|75925999|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
42115459|NCT00507507|75926000|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
42115460|NCT00507507|75925999|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
42115461|NCT00507507|75926000|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
42115462|NCT00459706|75926010|FG000|Overall Study|Adverse Event|19|||
42115463|NCT00459706|75926011|FG001|Overall Study|Adverse Event|13|||
42115464|NCT00459706|75926010|FG000|Overall Study|Withdrawal by Subject|1|||
42115465|NCT00459706|75926011|FG001|Overall Study|Withdrawal by Subject|6|||
42115466|NCT00459706|75926010|FG000|Overall Study|Physician Decision|2|||
42115467|NCT00459706|75926011|FG001|Overall Study|Physician Decision|0|||
42115468|NCT00459706|75926010|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
42115469|NCT00459706|75926011|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
42115470|NCT00459706|75926010|FG000|Overall Study|Protocol Violation|2|||
42115471|NCT00459706|75926011|FG001|Overall Study|Protocol Violation|1|||
42115472|NCT00459706|75926010|FG000|Overall Study|Failed to Return|1|||
42115473|NCT00459706|75926011|FG001|Overall Study|Failed to Return|0|||
42115474|NCT00459706|75926010|FG000|Overall Study|Other|0|||
42115475|NCT00459706|75926011|FG001|Overall Study|Other|1|||
42115476|NCT00507429|75926019|FG000|Treatment Phase|Disease Progression|12|||
42115477|NCT00507429|75926020|FG001|Treatment Phase|Disease Progression|5|||
42115478|NCT00507429|75926019|FG000|Treatment Phase|Adverse Event|12|||
42115479|NCT00507429|75926020|FG001|Treatment Phase|Adverse Event|5|||
42115480|NCT00507429|75926019|FG000|Treatment Phase|Withdrawal by Subject|3|||
42115481|NCT00507429|75926020|FG001|Treatment Phase|Withdrawal by Subject|3|||
42115482|NCT00507429|75926019|FG000|Treatment Phase|Physician Decision|4|||
42115483|NCT00507429|75926020|FG001|Treatment Phase|Physician Decision|2|||
42115484|NCT00507429|75926019|FG000|Treatment Phase|Other|6|||
42115485|NCT00507429|75926020|FG001|Treatment Phase|Other|3|||
42115486|NCT00507429|75926019|FG000|Maintenance Phase|Progressive Disease|14|||
42115487|NCT00507429|75926020|FG001|Maintenance Phase|Progressive Disease|0|||
42115488|NCT00449176|75926031|FG000|Overall Study|Withdrawal by Subject|39|||
42115489|NCT00449176|75926032|FG001|Overall Study|Withdrawal by Subject|43|||
42115490|NCT00449176|75926033|FG002|Overall Study|Withdrawal by Subject|59|||
42115491|NCT00449176|75926031|FG000|Overall Study|Lost to Follow-up|13|||
42115492|NCT00449176|75926032|FG001|Overall Study|Lost to Follow-up|8|||
42115493|NCT00449176|75926033|FG002|Overall Study|Lost to Follow-up|12|||
42115494|NCT00449176|75926031|FG000|Overall Study|Adverse Event|51|||
42115495|NCT00449176|75926032|FG001|Overall Study|Adverse Event|107|||
42115496|NCT00449176|75926033|FG002|Overall Study|Adverse Event|15|||
42115497|NCT00449176|75926031|FG000|Overall Study|Lack of Efficacy|13|||
42115498|NCT00449176|75926032|FG001|Overall Study|Lack of Efficacy|7|||
42115499|NCT00449176|75926033|FG002|Overall Study|Lack of Efficacy|50|||
42115500|NCT00449176|75926031|FG000|Overall Study|Study drug non-compliant|14|||
42115501|NCT00449176|75926032|FG001|Overall Study|Study drug non-compliant|11|||
42115502|NCT00449176|75926033|FG002|Overall Study|Study drug non-compliant|11|||
42115503|NCT00449176|75926031|FG000|Overall Study|all other|22|||
42115504|NCT00449176|75926032|FG001|Overall Study|all other|19|||
42115505|NCT00449176|75926033|FG002|Overall Study|all other|20|||
42115506|NCT00515073|75926041|FG000|Overall Study|Withdrawal by Subject|1|||
42115507|NCT00515073|75926041|FG000|Overall Study|Physician Decision|1|||
42115508|NCT00710021|75926048|FG000|Overall Study|Lost to Follow-up|1|||
42115509|NCT00710021|75926049|FG001|Overall Study|Lost to Follow-up|0|||
42115510|NCT00710021|75926050|FG002|Overall Study|Lost to Follow-up|0|||
42115511|NCT00710021|75926048|FG000|Overall Study|Subject's Decision|0|||
42115512|NCT00710021|75926049|FG001|Overall Study|Subject's Decision|1|||
42115513|NCT00710021|75926050|FG002|Overall Study|Subject's Decision|0|||
42115514|NCT00710021|75926048|FG000|Overall Study|Subject misrandomized|0|||
42115515|NCT00710021|75926049|FG001|Overall Study|Subject misrandomized|1|||
42115516|NCT00710021|75926050|FG002|Overall Study|Subject misrandomized|1|||
42115517|NCT00710021|75926048|FG000|Overall Study|Physician Decision|0|||
42115518|NCT00710021|75926049|FG001|Overall Study|Physician Decision|1|||
42115519|NCT00710021|75926050|FG002|Overall Study|Physician Decision|0|||
42115520|NCT00504153|75926059|FG000|Overall Study|Withdrawal by Subject|1|||
42115521|NCT00504153|75926059|FG000|Overall Study|Adverse Event|4|||
42115522|NCT00504153|75926059|FG000|Overall Study|Death|1|||
42115523|NCT00442702|75926065|FG000|Titration Period|Adverse Event|2|||
42115524|NCT00442702|75926066|FG001|Titration Period|Adverse Event|0|||
42115525|NCT00442702|75926065|FG000|Titration Period|Death|3|||
42115526|NCT00442702|75926066|FG001|Titration Period|Death|2|||
42115527|NCT00442702|75926065|FG000|Titration Period|Insufficient Therapeutic Response|1|||
42115528|NCT00442702|75926066|FG001|Titration Period|Insufficient Therapeutic Response|0|||
42115529|NCT00442702|75926065|FG000|Titration Period|Refused Treatment|4|||
42115530|NCT00442702|75926066|FG001|Titration Period|Refused Treatment|1|||
42115531|NCT00442702|75926065|FG000|Titration Period|Failure to return|1|||
42115532|NCT00442702|75926066|FG001|Titration Period|Failure to return|0|||
42115533|NCT00442702|75926065|FG000|Titration Period|Hospitalized in another hospital|1|||
42115534|NCT00442702|75926066|FG001|Titration Period|Hospitalized in another hospital|0|||
42115535|NCT00442702|75926065|FG000|Evaluation Period|Adverse Event|1|||
42115536|NCT00442702|75926066|FG001|Evaluation Period|Adverse Event|0|||
42115537|NCT00442702|75926065|FG000|Evaluation Period|Death|1|||
42115538|NCT00442702|75926066|FG001|Evaluation Period|Death|1|||
42115539|NCT00442702|75926065|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
42115540|NCT00442702|75926066|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
42115541|NCT00442702|75926065|FG000|Evaluation Period|Refused treatment|1|||
42115542|NCT00442702|75926066|FG001|Evaluation Period|Refused treatment|1|||
42115543|NCT00442702|75926065|FG000|Evaluation Period|Renal transplant|0|||
42115544|NCT00442702|75926066|FG001|Evaluation Period|Renal transplant|1|||
42115545|NCT00442702|75926065|FG000|Evaluation Period|Failure to return|1|||
42115546|NCT00442702|75926066|FG001|Evaluation Period|Failure to return|0|||
42115547|NCT00442702|75926065|FG000|Evaluation Period|Site closure|0|||
42115548|NCT00442702|75926066|FG001|Evaluation Period|Site closure|1|||
42115549|NCT00514917|75926074|FG000|Overall Study|Death|4|||
42115550|NCT00514917|75926075|FG001|Overall Study|Death|10|||
42115551|NCT00514917|75926074|FG000|Overall Study|Protocol Violation|1|||
42115552|NCT00514917|75926075|FG001|Overall Study|Protocol Violation|0|||
42115553|NCT00514917|75926074|FG000|Overall Study|Lost to Follow-up|4|||
42115554|NCT00514917|75926075|FG001|Overall Study|Lost to Follow-up|3|||
42115555|NCT00514917|75926074|FG000|Overall Study|Withdrawal by Subject|18|||
42115556|NCT00514917|75926075|FG001|Overall Study|Withdrawal by Subject|16|||
42115557|NCT00514917|75926074|FG000|Overall Study|Discontinued due to study closure|88|||
42115558|NCT00514917|75926075|FG001|Overall Study|Discontinued due to study closure|81|||
42115559|NCT00514917|75926074|FG000|Overall Study|Undefined|11|||
42115560|NCT00514917|75926075|FG001|Overall Study|Undefined|5|||
42115561|NCT00711425|75926083|FG000|Overall Study|Protocol Violation|1|||
42115562|NCT00711425|75926083|FG000|Overall Study|Death|2|||
42115563|NCT00711425|75926083|FG000|Overall Study|Lost to Follow-up|1|||
42115564|NCT00504075|75926087|FG000|Overall Study|Adverse Event|1|||
42115565|NCT00504075|75926087|FG000|Overall Study|Lost to Follow-up|5|||
42115566|NCT00504075|75926087|FG000|Overall Study|Withdrawal by Subject|1|||
42115567|NCT00504075|75926087|FG000|Overall Study|Required other therapeutic intervention|1|||
42115568|NCT00503997|75926092|FG000|Overall Study|disease progression|1|||
42115569|NCT00503997|75926092|FG000|Overall Study|Adverse Event|5|||
42115570|NCT00503997|75926092|FG000|Overall Study|Death|1|||
42115571|NCT00503997|75926092|FG000|Overall Study|Withdrawal by Subject|1|||
42115572|NCT00096265|75926099|FG000|Overall Study|Ineligible|1|||
42115573|NCT00096265|75926100|FG001|Overall Study|Ineligible|0|||
42115574|NCT00096265|75926101|FG002|Overall Study|Ineligible|0|||
42115575|NCT00711191|75926113|FG000|Overall Study|Adverse Event|1|||
42115576|NCT00711191|75926114|FG001|Overall Study|Adverse Event|1|||
42115577|NCT00711191|75926115|FG002|Overall Study|Adverse Event|2|||
42115578|NCT00711191|75926113|FG000|Overall Study|Objective progression or relapse|2|||
42115579|NCT00711191|75926114|FG001|Overall Study|Objective progression or relapse|3|||
42115580|NCT00711191|75926115|FG002|Overall Study|Objective progression or relapse|7|||
42115581|NCT00711191|75926113|FG000|Overall Study|Withdrawal by Subject|0|||
42115582|NCT00711191|75926114|FG001|Overall Study|Withdrawal by Subject|1|||
42115583|NCT00711191|75926115|FG002|Overall Study|Withdrawal by Subject|3|||
42115584|NCT00706511|75926130|FG000|Overall Study|Withdrawal by Subject|1|||
42115585|NCT00706511|75926131|FG001|Overall Study|Withdrawal by Subject|0|||
42115586|NCT00706511|75926132|FG002|Overall Study|Withdrawal by Subject|0|||
42115587|NCT00706511|75926133|FG003|Overall Study|Withdrawal by Subject|0|||
42115588|NCT00448864|75926144|FG000|Overall Study|Death|1|||
42115589|NCT00448864|75926145|FG001|Overall Study|Death|0|||
42115590|NCT00448864|75926146|FG002|Overall Study|Death|0|||
42115591|NCT00448864|75926144|FG000|Overall Study|Lost to Follow-up|3|||
42115592|NCT00448864|75926145|FG001|Overall Study|Lost to Follow-up|1|||
42115593|NCT00448864|75926146|FG002|Overall Study|Lost to Follow-up|0|||
42115594|NCT00448864|75926144|FG000|Overall Study|Physician Decision|1|||
42115595|NCT00448864|75926145|FG001|Overall Study|Physician Decision|0|||
42115596|NCT00448864|75926146|FG002|Overall Study|Physician Decision|1|||
42115597|NCT00448864|75926144|FG000|Overall Study|Withdrawal by Subject|0|||
42115598|NCT00448864|75926145|FG001|Overall Study|Withdrawal by Subject|2|||
42115599|NCT00448864|75926146|FG002|Overall Study|Withdrawal by Subject|0|||
42115600|NCT00448864|75926144|FG000|Overall Study|Protocol Violation|0|||
42115601|NCT00448864|75926145|FG001|Overall Study|Protocol Violation|2|||
42115602|NCT00448864|75926146|FG002|Overall Study|Protocol Violation|0|||
42115603|NCT00567398|75926158|FG000|Overall Study|Adverse Event|6|||
42115604|NCT00567398|75926159|FG001|Overall Study|Adverse Event|14|||
42115605|NCT00567398|75926158|FG000|Overall Study|Physician Decision|0|||
42115606|NCT00567398|75926159|FG001|Overall Study|Physician Decision|4|||
42115607|NCT00567398|75926158|FG000|Overall Study|Withdrawal by Subject|0|||
42115608|NCT00567398|75926159|FG001|Overall Study|Withdrawal by Subject|2|||
42115609|NCT00567398|75926158|FG000|Overall Study|Renal Transplantation|0|||
42115610|NCT00567398|75926159|FG001|Overall Study|Renal Transplantation|3|||
42115611|NCT00567398|75926158|FG000|Overall Study|Other|1|||
42115612|NCT00567398|75926159|FG001|Overall Study|Other|0|||
42115613|NCT00448708|75926167|FG000|Overall Study|Death|21|||
42115614|NCT00448708|75926168|FG001|Overall Study|Death|17|||
42115615|NCT00448708|75926167|FG000|Overall Study|Withdrawal by Subject|8|||
42115616|NCT00448708|75926168|FG001|Overall Study|Withdrawal by Subject|4|||
42115617|NCT00448708|75926167|FG000|Overall Study|Lost to Follow-up|6|||
42115618|NCT00448708|75926168|FG001|Overall Study|Lost to Follow-up|8|||
42115619|NCT00448708|75926167|FG000|Overall Study|not listed|0|||
42115620|NCT00448708|75926168|FG001|Overall Study|not listed|2|||
42115621|NCT00706355|75926178|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
42115622|NCT00706355|75926179|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
42115623|NCT00706355|75926180|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
42115624|NCT00706355|75926181|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
42115625|NCT00706355|75926178|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
42115626|NCT00706355|75926179|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
42115627|NCT00706355|75926180|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
42115628|NCT00706355|75926181|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
42115629|NCT00706355|75926178|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
42115630|NCT00706355|75926179|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
42115631|NCT00706355|75926180|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
42115632|NCT00706355|75926181|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
42115633|NCT00706355|75926178|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
42115634|NCT00706355|75926179|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
42115635|NCT00706355|75926180|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
42115636|NCT00706355|75926181|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
42115637|NCT00706355|75926178|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
42115638|NCT00706355|75926179|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
42115639|NCT00706355|75926180|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
42115640|NCT00706355|75926181|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
42115641|NCT00706355|75926178|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
42115642|NCT00706355|75926179|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
42115643|NCT00706355|75926180|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
42115644|NCT00706355|75926181|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
42115645|NCT00706355|75926178|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
42115646|NCT00706355|75926179|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
42115647|NCT00706355|75926180|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
42115648|NCT00706355|75926181|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
42115649|NCT00706355|75926178|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
42206930|NCT03358290|76020238|FG003|Overall Study|Adverse Event|2|||
42115650|NCT00706355|75926179|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
42115651|NCT00706355|75926180|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
42115652|NCT00706355|75926181|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
42115653|NCT00706355|75926178|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
42115654|NCT00706355|75926179|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
42115655|NCT00706355|75926180|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
42115656|NCT00706355|75926181|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
42115657|NCT00711113|75926193|FG000|Overall Study|Lost to Follow-up|9|||
42115658|NCT00711113|75926193|FG000|Overall Study|Implant lost|2|||
42115659|NCT00710879|75926203|FG000|Overall Study|Lost to Follow-up|2|||
42115660|NCT00710879|75926204|FG001|Overall Study|Lost to Follow-up|1|||
42115661|NCT00710879|75926203|FG000|Overall Study|Protocol Violation|0|||
42115662|NCT00710879|75926204|FG001|Overall Study|Protocol Violation|3|||
42115663|NCT03979274|75926210|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42115664|NCT03979274|75926211|FG001|Treatment Period 2|Withdrawal by Subject|1|||
42115665|NCT00459316|75926221|FG000|Steps 1 & 2|Other eligibility failure|1|||
42115666|NCT00459316|75926222|FG001|Steps 1 & 2|Other eligibility failure|1|||
42115667|NCT00459316|75926223|FG002|Steps 1 & 2|Other eligibility failure|0|||
42115668|NCT00459316|75926221|FG000|Steps 1 & 2|Death|1|||
42115669|NCT00459316|75926222|FG001|Steps 1 & 2|Death|1|||
42115670|NCT00459316|75926223|FG002|Steps 1 & 2|Death|0|||
42115671|NCT00459316|75926221|FG000|Steps 1 & 2|Not able to get to clinic|7|||
42115672|NCT00459316|75926222|FG001|Steps 1 & 2|Not able to get to clinic|4|||
42115673|NCT00459316|75926223|FG002|Steps 1 & 2|Not able to get to clinic|0|||
42115674|NCT00459316|75926221|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
42115675|NCT00459316|75926222|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
42115676|NCT00459316|75926223|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
42115677|NCT00459316|75926221|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
42115678|NCT00459316|75926222|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
42115679|NCT00459316|75926223|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
42115680|NCT00459316|75926221|FG000|Steps 1 & 2|Lost to Follow-up|5|||
42115681|NCT00459316|75926222|FG001|Steps 1 & 2|Lost to Follow-up|0|||
42115682|NCT00459316|75926223|FG002|Steps 1 & 2|Lost to Follow-up|2|||
42115683|NCT00459316|75926221|FG000|Step 3|Withdrawal by Subject|3|||
42115684|NCT00459316|75926222|FG001|Step 3|Withdrawal by Subject|0|||
42115685|NCT00459316|75926223|FG002|Step 3|Withdrawal by Subject|1|||
42115686|NCT05445557|75926246|FG000|Double Blind Part|Lost to Follow-up|1|||
42115687|NCT05074498|75926280|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
42115688|NCT05074498|75926281|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
42115689|NCT05074498|75926282|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
42115690|NCT05074498|75926283|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
42115691|NCT05074498|75926284|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
42115692|NCT05074498|75926285|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
42115693|NCT05074498|75926280|FG000|Part 1 (Upto Day 104)|Other|1|||
42115694|NCT05074498|75926281|FG001|Part 1 (Upto Day 104)|Other|0|||
42115695|NCT05074498|75926282|FG002|Part 1 (Upto Day 104)|Other|0|||
42115696|NCT05074498|75926283|FG003|Part 1 (Upto Day 104)|Other|0|||
42115697|NCT05074498|75926284|FG004|Part 1 (Upto Day 104)|Other|0|||
42115698|NCT05074498|75926285|FG005|Part 1 (Upto Day 104)|Other|0|||
42115699|NCT05074498|75926280|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
42115700|NCT05074498|75926281|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
42115701|NCT05074498|75926282|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
42115702|NCT05074498|75926283|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
42115703|NCT05074498|75926284|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
42115704|NCT05074498|75926285|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
42115705|NCT05074498|75926280|FG000|Part 2 (Upto Day 104)|Death|0|||
42115706|NCT05074498|75926281|FG001|Part 2 (Upto Day 104)|Death|0|||
42115707|NCT05074498|75926282|FG002|Part 2 (Upto Day 104)|Death|0|||
42115708|NCT05074498|75926283|FG003|Part 2 (Upto Day 104)|Death|0|||
42115709|NCT05074498|75926284|FG004|Part 2 (Upto Day 104)|Death|1|||
42115710|NCT05074498|75926285|FG005|Part 2 (Upto Day 104)|Death|0|||
42115711|NCT05074498|75926280|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
42115712|NCT05074498|75926281|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
42115713|NCT05074498|75926282|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
42115714|NCT05074498|75926283|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
42115715|NCT05074498|75926284|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
42115716|NCT05074498|75926285|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
42115717|NCT05074498|75926280|FG000|Part 2 (Upto Day 104)|Other|0|||
42115718|NCT05074498|75926281|FG001|Part 2 (Upto Day 104)|Other|0|||
42115719|NCT05074498|75926282|FG002|Part 2 (Upto Day 104)|Other|0|||
42115720|NCT05074498|75926283|FG003|Part 2 (Upto Day 104)|Other|0|||
42115721|NCT05074498|75926284|FG004|Part 2 (Upto Day 104)|Other|1|||
42115722|NCT05074498|75926285|FG005|Part 2 (Upto Day 104)|Other|0|||
42115723|NCT04871113|75926322|FG000|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
42115724|NCT04871113|75926323|FG001|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
42115725|NCT04871113|75926324|FG002|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
42115726|NCT04871113|75926325|FG003|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
42115727|NCT04871113|75926326|FG004|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|0|||
42115728|NCT04871113|75926327|FG005|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|7|||
42115729|NCT04871113|75926328|FG006|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|5|||
42115730|NCT04871113|75926329|FG007|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
42115731|NCT04871113|75926330|FG008|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
42115732|NCT04871113|75926331|FG009|SOC Follow-up (SOC Day 1 to 27 Months)|Ongoing|16|||
42115733|NCT04871113|75926322|FG000|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
42115734|NCT04871113|75926323|FG001|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
42115735|NCT04871113|75926324|FG002|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
42115736|NCT04871113|75926325|FG003|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
42115737|NCT04871113|75926326|FG004|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
42115738|NCT04871113|75926327|FG005|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
42115739|NCT04871113|75926328|FG006|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|1|||
42115740|NCT04871113|75926329|FG007|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
42115741|NCT04871113|75926330|FG008|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
42115742|NCT04871113|75926331|FG009|SOC Follow-up (SOC Day 1 to 27 Months)|Withdrawal by Subject|0|||
42115743|NCT04715230|75926355|FG000|Overall Study|Withdrawal by Subject|1|||
42115744|NCT04715230|75926356|FG001|Overall Study|Withdrawal by Subject|0|||
42115745|NCT04715230|75926357|FG002|Overall Study|Withdrawal by Subject|0|||
42115746|NCT04715230|75926355|FG000|Overall Study|Lost to Follow-up|0|||
42115747|NCT04715230|75926356|FG001|Overall Study|Lost to Follow-up|5|||
42115748|NCT04715230|75926357|FG002|Overall Study|Lost to Follow-up|1|||
42115749|NCT04710368|75926365|FG000|Overall Study|Withdrawal by Subject|9|||
42115750|NCT04710368|75926365|FG000|Overall Study|Lost to Follow-up|4|||
42115751|NCT04710368|75926365|FG000|Overall Study|Death|2|||
42115752|NCT04710368|75926365|FG000|Overall Study|Patient preference|11|||
42115753|NCT04710368|75926365|FG000|Overall Study|Treatment discontinuation|1|||
42115754|NCT04590963|75926397|FG000|Overall Study|Death|118|||
42115755|NCT04590963|75926398|FG001|Overall Study|Death|59|||
42115756|NCT04590963|75926397|FG000|Overall Study|Lost to Follow-up|1|||
42115757|NCT04590963|75926398|FG001|Overall Study|Lost to Follow-up|1|||
42115758|NCT04590963|75926397|FG000|Overall Study|Progressive disease|0|||
42115759|NCT04590963|75926398|FG001|Overall Study|Progressive disease|1|||
42115760|NCT04590963|75926397|FG000|Overall Study|Study terminated by sponsor|103|||
42115761|NCT04590963|75926398|FG001|Overall Study|Study terminated by sponsor|50|||
42115762|NCT04590963|75926397|FG000|Overall Study|Withdrawal by Subject|15|||
42115763|NCT04590963|75926398|FG001|Overall Study|Withdrawal by Subject|8|||
42115764|NCT04590963|75926397|FG000|Overall Study|Ongoing at data cut-off|9|||
42115765|NCT04590963|75926398|FG001|Overall Study|Ongoing at data cut-off|4|||
42115766|NCT04590963|75926397|FG000|Overall Study|Screen failure|1|||
42115767|NCT04590963|75926398|FG001|Overall Study|Screen failure|0|||
42115768|NCT04493216|75926408|FG000|Overall Study|Adverse Event|1|||
42115769|NCT04493216|75926409|FG001|Overall Study|Adverse Event|4|||
42115770|NCT04493216|75926410|FG002|Overall Study|Adverse Event|5|||
42115771|NCT04493216|75926411|FG003|Overall Study|Adverse Event|2|||
42115772|NCT04493216|75926408|FG000|Overall Study|Lost to Follow-up|1|||
42115773|NCT04493216|75926409|FG001|Overall Study|Lost to Follow-up|1|||
42115774|NCT04493216|75926410|FG002|Overall Study|Lost to Follow-up|0|||
42115775|NCT04493216|75926411|FG003|Overall Study|Lost to Follow-up|1|||
42115776|NCT04493216|75926408|FG000|Overall Study|Physician Decision|0|||
42115777|NCT04493216|75926409|FG001|Overall Study|Physician Decision|0|||
42115778|NCT04493216|75926410|FG002|Overall Study|Physician Decision|1|||
42115779|NCT04493216|75926411|FG003|Overall Study|Physician Decision|0|||
42115780|NCT04493216|75926408|FG000|Overall Study|Withdrawal by Subject|1|||
42115781|NCT04493216|75926409|FG001|Overall Study|Withdrawal by Subject|1|||
42115782|NCT04493216|75926410|FG002|Overall Study|Withdrawal by Subject|1|||
42115783|NCT04493216|75926411|FG003|Overall Study|Withdrawal by Subject|2|||
42115784|NCT04493216|75926408|FG000|Overall Study|Ongoing|18|||
42115785|NCT04493216|75926409|FG001|Overall Study|Ongoing|18|||
42115786|NCT04493216|75926410|FG002|Overall Study|Ongoing|16|||
42115787|NCT04493216|75926411|FG003|Overall Study|Ongoing|16|||
42115788|NCT04493216|75926408|FG000|Overall Study|Site closed|14|||
42115789|NCT04493216|75926409|FG001|Overall Study|Site closed|15|||
42115790|NCT04493216|75926410|FG002|Overall Study|Site closed|11|||
42115791|NCT04493216|75926411|FG003|Overall Study|Site closed|11|||
42115792|NCT04493216|75926408|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|4|||
42115793|NCT04493216|75926409|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|2|||
42115794|NCT04493216|75926410|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|8|||
42115795|NCT04493216|75926411|FG003|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|2|||
42115796|NCT04493216|75926408|FG000|Overall Study|Protocol Deviation|1|||
42115797|NCT04493216|75926409|FG001|Overall Study|Protocol Deviation|2|||
42115798|NCT04493216|75926410|FG002|Overall Study|Protocol Deviation|0|||
42115799|NCT04493216|75926411|FG003|Overall Study|Protocol Deviation|2|||
42115800|NCT04329949|75926442|FG000|Overall Study|Death|36|||
42115801|NCT04329949|75926442|FG000|Overall Study|Withdrawal by Subject|4|||
42115802|NCT04329949|75926442|FG000|Overall Study|Termination of study by sponsor|3|||
42115803|NCT04290624|75926448|FG000|Overall Study|Adverse Event|1|||
42115804|NCT04290624|75926449|FG001|Overall Study|Adverse Event|0|||
42115805|NCT04288115|75926457|FG000|Overall Study|Withdrawal by Subject|0|||
42115806|NCT04288115|75926458|FG001|Overall Study|Withdrawal by Subject|1|||
42115807|NCT04288115|75926457|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
42115808|NCT04288115|75926458|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
42115809|NCT04287868|75926469|FG000|Overall Study|Screening fail|1|||
42115810|NCT04287868|75926470|FG001|Overall Study|Screening fail|0|||
42115811|NCT04276935|75926481|FG000|Overall Study|Lost to Follow-up|3|||
42115812|NCT04191096|75926487|FG000|Overall Study|Death|102|||
42115813|NCT04191096|75926488|FG001|Overall Study|Death|89|||
42115814|NCT04191096|75926487|FG000|Overall Study|Lost to Follow-up|1|||
42115815|NCT04191096|75926488|FG001|Overall Study|Lost to Follow-up|1|||
42115816|NCT04191096|75926487|FG000|Overall Study|Withdrawal by Subject|5|||
42115817|NCT04191096|75926488|FG001|Overall Study|Withdrawal by Subject|5|||
42115818|NCT04191096|75926487|FG000|Overall Study|Participants Ongoing|518|||
42115819|NCT04191096|75926488|FG001|Overall Study|Participants Ongoing|530|||
42115820|NCT04145531|75926498|FG000|Part A|Adverse Event|2|||
42115821|NCT04145531|75926499|FG001|Part A|Adverse Event|12|||
42115822|NCT04145531|75926500|FG002|Part A|Adverse Event|6|||
42115823|NCT04145531|75926501|FG003|Part A|Adverse Event|0|||
42115824|NCT04145531|75926498|FG000|Part A|Death|1|||
42115825|NCT04145531|75926499|FG001|Part A|Death|2|||
42115826|NCT04145531|75926500|FG002|Part A|Death|0|||
42115827|NCT04145531|75926501|FG003|Part A|Death|0|||
42115828|NCT04145531|75926498|FG000|Part A|Physician Decision|2|||
42115829|NCT04145531|75926499|FG001|Part A|Physician Decision|5|||
42115830|NCT04145531|75926500|FG002|Part A|Physician Decision|2|||
42115831|NCT04145531|75926501|FG003|Part A|Physician Decision|0|||
42115832|NCT04145531|75926498|FG000|Part A|Progressive disease|0|||
42115833|NCT04145531|75926499|FG001|Part A|Progressive disease|2|||
42115834|NCT04145531|75926500|FG002|Part A|Progressive disease|1|||
42115835|NCT04145531|75926501|FG003|Part A|Progressive disease|0|||
42115836|NCT04145531|75926498|FG000|Part A|Protocol deviation|0|||
42115837|NCT04145531|75926499|FG001|Part A|Protocol deviation|0|||
42115838|NCT04145531|75926500|FG002|Part A|Protocol deviation|1|||
42115839|NCT04145531|75926501|FG003|Part A|Protocol deviation|0|||
42115840|NCT04145531|75926498|FG000|Part A|Withdrawal by parent or guardian|1|||
42115841|NCT04145531|75926499|FG001|Part A|Withdrawal by parent or guardian|0|||
42115842|NCT04145531|75926500|FG002|Part A|Withdrawal by parent or guardian|0|||
42115843|NCT04145531|75926501|FG003|Part A|Withdrawal by parent or guardian|0|||
42115844|NCT04145531|75926498|FG000|Part A|Withdrawal by participant|0|||
42115845|NCT04145531|75926499|FG001|Part A|Withdrawal by participant|0|||
42115846|NCT04145531|75926500|FG002|Part A|Withdrawal by participant|1|||
42115847|NCT04145531|75926501|FG003|Part A|Withdrawal by participant|0|||
42115848|NCT04145531|75926498|FG000|Part A|Other|0|||
42115849|NCT04145531|75926499|FG001|Part A|Other|0|||
42115850|NCT04145531|75926500|FG002|Part A|Other|1|||
42115851|NCT04145531|75926501|FG003|Part A|Other|0|||
42115852|NCT04145531|75926498|FG000|Part B|Adverse Event|0|||
42115853|NCT04145531|75926499|FG001|Part B|Adverse Event|0|||
42115854|NCT04145531|75926500|FG002|Part B|Adverse Event|0|||
42115855|NCT04145531|75926501|FG003|Part B|Adverse Event|21|||
42115856|NCT04145531|75926498|FG000|Part B|Physician Decision|0|||
42115857|NCT04145531|75926499|FG001|Part B|Physician Decision|0|||
42115858|NCT04145531|75926500|FG002|Part B|Physician Decision|0|||
42115859|NCT04145531|75926501|FG003|Part B|Physician Decision|7|||
42115860|NCT04145531|75926498|FG000|Part B|Progressive disease|0|||
42115861|NCT04145531|75926499|FG001|Part B|Progressive disease|0|||
42115862|NCT04145531|75926500|FG002|Part B|Progressive disease|0|||
42115863|NCT04145531|75926501|FG003|Part B|Progressive disease|1|||
42115864|NCT04145531|75926498|FG000|Part B|Recurrent disease|0|||
42115865|NCT04145531|75926499|FG001|Part B|Recurrent disease|0|||
42115866|NCT04145531|75926500|FG002|Part B|Recurrent disease|0|||
42115867|NCT04145531|75926501|FG003|Part B|Recurrent disease|1|||
42115868|NCT04145531|75926498|FG000|Part B|Withdrawal by parent or guardian|0|||
42115869|NCT04145531|75926499|FG001|Part B|Withdrawal by parent or guardian|0|||
42115870|NCT04145531|75926500|FG002|Part B|Withdrawal by parent or guardian|0|||
42115871|NCT04145531|75926501|FG003|Part B|Withdrawal by parent or guardian|3|||
42115872|NCT04145531|75926498|FG000|Part B|Withdrawal by participant|0|||
42115873|NCT04145531|75926499|FG001|Part B|Withdrawal by participant|0|||
42115874|NCT04145531|75926500|FG002|Part B|Withdrawal by participant|0|||
42115875|NCT04145531|75926501|FG003|Part B|Withdrawal by participant|1|||
42115876|NCT04145531|75926498|FG000|Part B|Other|0|||
42115877|NCT04145531|75926499|FG001|Part B|Other|0|||
42115878|NCT04145531|75926500|FG002|Part B|Other|0|||
42115879|NCT04145531|75926501|FG003|Part B|Other|1|||
42115880|NCT04124692|75926513|FG000|Overall Study|Medical reason|0|||
42115881|NCT04124692|75926514|FG001|Overall Study|Medical reason|1|||
42115882|NCT04124692|75926513|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
42115883|NCT04124692|75926514|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
42115884|NCT04124692|75926513|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
42115885|NCT04124692|75926514|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
42115886|NCT04124692|75926513|FG000|Overall Study|Lost to Follow-up|2|||
42115887|NCT04124692|75926514|FG001|Overall Study|Lost to Follow-up|4|||
42115888|NCT04124692|75926513|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
42115889|NCT04124692|75926514|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
42115890|NCT04018066|75926536|FG000|Overall Study|participants started taking medications during the study period|3|||
42115891|NCT04018066|75926536|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
42115892|NCT03811249|75926541|FG000|Overall Study|Withdrawal by Subject|44|||
42115893|NCT03811249|75926541|FG000|Overall Study|Missed Visit|24|||
42115894|NCT03678688|75926555|FG000|Overall Study|Reason not Specified|0|||
42115895|NCT03678688|75926556|FG001|Overall Study|Reason not Specified|0|||
42115896|NCT03678688|75926557|FG002|Overall Study|Reason not Specified|3|||
42115897|NCT03678688|75926558|FG003|Overall Study|Reason not Specified|0|||
42115898|NCT03678688|75926559|FG004|Overall Study|Reason not Specified|1|||
42115899|NCT03678688|75926560|FG005|Overall Study|Reason not Specified|0|||
42115900|NCT03678688|75926561|FG006|Overall Study|Reason not Specified|0|||
42115901|NCT03678688|75926562|FG007|Overall Study|Reason not Specified|0|||
42115902|NCT03678688|75926563|FG008|Overall Study|Reason not Specified|0|||
42115903|NCT03678688|75926555|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
42115904|NCT03678688|75926556|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
42115905|NCT03678688|75926557|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
42115906|NCT03678688|75926558|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
42115907|NCT03678688|75926559|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
42115908|NCT03678688|75926560|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
42115909|NCT03678688|75926561|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
42115910|NCT03678688|75926562|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
42115911|NCT03678688|75926563|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
42115912|NCT03678688|75926555|FG000|Overall Study|Covid Related Adverse Event|0|||
42115913|NCT03678688|75926556|FG001|Overall Study|Covid Related Adverse Event|0|||
42115914|NCT03678688|75926557|FG002|Overall Study|Covid Related Adverse Event|0|||
42115915|NCT03678688|75926558|FG003|Overall Study|Covid Related Adverse Event|0|||
42115916|NCT03678688|75926559|FG004|Overall Study|Covid Related Adverse Event|0|||
42115917|NCT03678688|75926560|FG005|Overall Study|Covid Related Adverse Event|3|||
42115918|NCT03678688|75926561|FG006|Overall Study|Covid Related Adverse Event|1|||
42115919|NCT03678688|75926562|FG007|Overall Study|Covid Related Adverse Event|1|||
42115920|NCT03678688|75926563|FG008|Overall Study|Covid Related Adverse Event|0|||
42115921|NCT03678688|75926555|FG000|Overall Study|Physician Decision|0|||
42115922|NCT03678688|75926556|FG001|Overall Study|Physician Decision|0|||
42115923|NCT03678688|75926557|FG002|Overall Study|Physician Decision|0|||
42115924|NCT03678688|75926558|FG003|Overall Study|Physician Decision|0|||
42115925|NCT03678688|75926559|FG004|Overall Study|Physician Decision|0|||
42115926|NCT03678688|75926560|FG005|Overall Study|Physician Decision|1|||
42115927|NCT03678688|75926561|FG006|Overall Study|Physician Decision|0|||
42115928|NCT03678688|75926562|FG007|Overall Study|Physician Decision|0|||
42115929|NCT03678688|75926563|FG008|Overall Study|Physician Decision|0|||
42115930|NCT03678688|75926555|FG000|Overall Study|Withdrawal by Subject|0|||
42115931|NCT03678688|75926556|FG001|Overall Study|Withdrawal by Subject|0|||
42115932|NCT03678688|75926557|FG002|Overall Study|Withdrawal by Subject|0|||
42115933|NCT03678688|75926558|FG003|Overall Study|Withdrawal by Subject|0|||
42115934|NCT03678688|75926559|FG004|Overall Study|Withdrawal by Subject|0|||
42115935|NCT03678688|75926560|FG005|Overall Study|Withdrawal by Subject|0|||
42115936|NCT03678688|75926561|FG006|Overall Study|Withdrawal by Subject|2|||
42115937|NCT03678688|75926562|FG007|Overall Study|Withdrawal by Subject|1|||
42115938|NCT03678688|75926563|FG008|Overall Study|Withdrawal by Subject|0|||
42115939|NCT03624036|75926610|FG000|Overall Study|Death|2|||
42115940|NCT03624036|75926611|FG001|Overall Study|Death|3|||
42115941|NCT03624036|75926612|FG002|Overall Study|Death|0|||
42115942|NCT03624036|75926613|FG003|Overall Study|Death|1|||
42115943|NCT03624036|75926610|FG000|Overall Study|Withdrawal by Subject|1|||
42115944|NCT03624036|75926611|FG001|Overall Study|Withdrawal by Subject|0|||
42115945|NCT03624036|75926612|FG002|Overall Study|Withdrawal by Subject|1|||
42115946|NCT03624036|75926613|FG003|Overall Study|Withdrawal by Subject|0|||
42115947|NCT03624036|75926610|FG000|Overall Study|Enrolled but Never Treated|1|||
42115948|NCT03624036|75926611|FG001|Overall Study|Enrolled but Never Treated|0|||
42115949|NCT03624036|75926612|FG002|Overall Study|Enrolled but Never Treated|0|||
42115950|NCT03624036|75926613|FG003|Overall Study|Enrolled but Never Treated|0|||
42115951|NCT03624036|75926610|FG000|Overall Study|Reason not Specified|3|||
42115952|NCT03624036|75926611|FG001|Overall Study|Reason not Specified|0|||
42115953|NCT03624036|75926612|FG002|Overall Study|Reason not Specified|2|||
42115954|NCT03624036|75926613|FG003|Overall Study|Reason not Specified|2|||
42115955|NCT03442569|75926662|FG000|Overall Study|Subject was ineligible after enrollment|1|||
42206931|NCT03358290|76020239|FG004|Overall Study|Adverse Event|0|||
42115956|NCT03235544|75926670|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
42115957|NCT03235544|75926671|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
42115958|NCT03235544|75926672|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
42115959|NCT03235544|75926673|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
42115960|NCT03235544|75926670|FG000|Overall Study|Death|11|||
42115961|NCT03235544|75926671|FG001|Overall Study|Death|23|||
42115962|NCT03235544|75926672|FG002|Overall Study|Death|11|||
42115963|NCT03235544|75926673|FG003|Overall Study|Death|20|||
42115964|NCT03235544|75926670|FG000|Overall Study|Lost to Follow-up|0|||
42115965|NCT03235544|75926671|FG001|Overall Study|Lost to Follow-up|1|||
42115966|NCT03235544|75926672|FG002|Overall Study|Lost to Follow-up|0|||
42115967|NCT03235544|75926673|FG003|Overall Study|Lost to Follow-up|1|||
42115968|NCT03235544|75926670|FG000|Overall Study|Withdrawal by Participant|0|||
42115969|NCT03235544|75926671|FG001|Overall Study|Withdrawal by Participant|0|||
42115970|NCT03235544|75926672|FG002|Overall Study|Withdrawal by Participant|1|||
42115971|NCT03235544|75926673|FG003|Overall Study|Withdrawal by Participant|0|||
42115972|NCT03235544|75926670|FG000|Overall Study|Reason not Specified|0|||
42115973|NCT03235544|75926671|FG001|Overall Study|Reason not Specified|4|||
42115974|NCT03235544|75926672|FG002|Overall Study|Reason not Specified|0|||
42115975|NCT03235544|75926673|FG003|Overall Study|Reason not Specified|1|||
42115976|NCT03187353|75926686|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
42115977|NCT03187353|75926687|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
42115978|NCT03187353|75926686|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
42115979|NCT03187353|75926687|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
42115980|NCT03187353|75926686|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
42115981|NCT03187353|75926687|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
42115982|NCT03187353|75926686|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
42115983|NCT03187353|75926687|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
42115984|NCT03187353|75926686|FG000|Washout (2 Weeks)|Adverse Event|2|||
42115985|NCT03187353|75926687|FG001|Washout (2 Weeks)|Adverse Event|0|||
42115986|NCT03187353|75926686|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
42115987|NCT03187353|75926687|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
42115988|NCT03056001|75926723|FG000|Overall Study|Death|24|||
42115989|NCT02998918|75926733|FG000|Overall Study|Withdrawal by Subject|1|||
42115990|NCT02998918|75926734|FG001|Overall Study|Withdrawal by Subject|0|||
42115991|NCT02990338|75926742|FG000|Overall Study|Ongoing|30|||
42115992|NCT02990338|75926743|FG001|Overall Study|Ongoing|36|||
42115993|NCT02742246|75926764|FG000|Overall Study|Never initiated treatment|5|||
42115994|NCT02742246|75926765|FG001|Overall Study|Never initiated treatment|3|||
42115995|NCT02742246|75926766|FG002|Overall Study|Never initiated treatment|1|||
42115996|NCT02742246|75926764|FG000|Overall Study|dropped out during treatment|7|||
42115997|NCT02742246|75926765|FG001|Overall Study|dropped out during treatment|13|||
42115998|NCT02742246|75926766|FG002|Overall Study|dropped out during treatment|10|||
42115999|NCT02742246|75926764|FG000|Overall Study|Death|1|||
42116000|NCT02742246|75926765|FG001|Overall Study|Death|0|||
42116001|NCT02742246|75926766|FG002|Overall Study|Death|0|||
42116002|NCT02733042|75926793|FG000|Overall Study|Adverse Event|1|||
42116003|NCT02733042|75926794|FG001|Overall Study|Adverse Event|0|||
42116004|NCT02733042|75926795|FG002|Overall Study|Adverse Event|1|||
42116005|NCT02733042|75926796|FG003|Overall Study|Adverse Event|1|||
42116006|NCT02733042|75926797|FG004|Overall Study|Adverse Event|0|||
42116007|NCT02733042|75926798|FG005|Overall Study|Adverse Event|0|||
42116008|NCT02733042|75926799|FG006|Overall Study|Adverse Event|0|||
42116009|NCT02733042|75926800|FG007|Overall Study|Adverse Event|0|||
42116010|NCT02733042|75926801|FG008|Overall Study|Adverse Event|0|||
42116011|NCT02733042|75926802|FG009|Overall Study|Adverse Event|0|||
42116012|NCT02733042|75926803|FG010|Overall Study|Adverse Event|2|||
42116013|NCT02733042|75926804|FG011|Overall Study|Adverse Event|2|||
42116014|NCT02733042|75926805|FG012|Overall Study|Adverse Event|0|||
42116015|NCT02733042|75926806|FG013|Overall Study|Adverse Event|2|||
42116016|NCT02733042|75926807|FG014|Overall Study|Adverse Event|0|||
42116017|NCT02733042|75926808|FG015|Overall Study|Adverse Event|0|||
42116018|NCT02733042|75926809|FG016|Overall Study|Adverse Event|0|||
42116019|NCT02733042|75926810|FG017|Overall Study|Adverse Event|1|||
42116020|NCT02733042|75926811|FG018|Overall Study|Adverse Event|0|||
42116021|NCT02733042|75926793|FG000|Overall Study|Progressive Disease|2|||
42116022|NCT02733042|75926794|FG001|Overall Study|Progressive Disease|1|||
42116023|NCT02733042|75926795|FG002|Overall Study|Progressive Disease|3|||
42116024|NCT02733042|75926796|FG003|Overall Study|Progressive Disease|1|||
42116025|NCT02733042|75926797|FG004|Overall Study|Progressive Disease|2|||
42116026|NCT02733042|75926798|FG005|Overall Study|Progressive Disease|3|||
42116027|NCT02733042|75926799|FG006|Overall Study|Progressive Disease|0|||
42116028|NCT02733042|75926800|FG007|Overall Study|Progressive Disease|3|||
42116029|NCT02733042|75926801|FG008|Overall Study|Progressive Disease|3|||
42116030|NCT02733042|75926802|FG009|Overall Study|Progressive Disease|2|||
42116031|NCT02733042|75926803|FG010|Overall Study|Progressive Disease|2|||
42116032|NCT02733042|75926804|FG011|Overall Study|Progressive Disease|2|||
42116033|NCT02733042|75926805|FG012|Overall Study|Progressive Disease|8|||
42116034|NCT02733042|75926806|FG013|Overall Study|Progressive Disease|1|||
42116035|NCT02733042|75926807|FG014|Overall Study|Progressive Disease|4|||
42116036|NCT02733042|75926808|FG015|Overall Study|Progressive Disease|7|||
42116037|NCT02733042|75926809|FG016|Overall Study|Progressive Disease|2|||
42116038|NCT02733042|75926810|FG017|Overall Study|Progressive Disease|3|||
42116039|NCT02733042|75926811|FG018|Overall Study|Progressive Disease|4|||
42116040|NCT02733042|75926793|FG000|Overall Study|Withdrawal by Subject|0|||
42116041|NCT02733042|75926794|FG001|Overall Study|Withdrawal by Subject|1|||
42116042|NCT02733042|75926795|FG002|Overall Study|Withdrawal by Subject|2|||
42116043|NCT02733042|75926796|FG003|Overall Study|Withdrawal by Subject|1|||
42116044|NCT02733042|75926797|FG004|Overall Study|Withdrawal by Subject|1|||
42116045|NCT02733042|75926798|FG005|Overall Study|Withdrawal by Subject|0|||
42116046|NCT02733042|75926799|FG006|Overall Study|Withdrawal by Subject|0|||
42116047|NCT02733042|75926800|FG007|Overall Study|Withdrawal by Subject|0|||
42116048|NCT02733042|75926801|FG008|Overall Study|Withdrawal by Subject|1|||
42116049|NCT02733042|75926802|FG009|Overall Study|Withdrawal by Subject|1|||
42116050|NCT02733042|75926803|FG010|Overall Study|Withdrawal by Subject|0|||
42116051|NCT02733042|75926804|FG011|Overall Study|Withdrawal by Subject|2|||
42116052|NCT02733042|75926805|FG012|Overall Study|Withdrawal by Subject|1|||
42116053|NCT02733042|75926806|FG013|Overall Study|Withdrawal by Subject|1|||
42116054|NCT02733042|75926807|FG014|Overall Study|Withdrawal by Subject|0|||
42116055|NCT02733042|75926808|FG015|Overall Study|Withdrawal by Subject|0|||
42116056|NCT02733042|75926809|FG016|Overall Study|Withdrawal by Subject|0|||
42116057|NCT02733042|75926810|FG017|Overall Study|Withdrawal by Subject|0|||
42116058|NCT02733042|75926811|FG018|Overall Study|Withdrawal by Subject|0|||
42116059|NCT02733042|75926793|FG000|Overall Study|Other Reasons|0|||
42116060|NCT02733042|75926794|FG001|Overall Study|Other Reasons|0|||
42116061|NCT02733042|75926795|FG002|Overall Study|Other Reasons|1|||
42116062|NCT02733042|75926796|FG003|Overall Study|Other Reasons|0|||
42116063|NCT02733042|75926797|FG004|Overall Study|Other Reasons|0|||
42116064|NCT02733042|75926798|FG005|Overall Study|Other Reasons|0|||
42116065|NCT02733042|75926799|FG006|Overall Study|Other Reasons|0|||
42116066|NCT02733042|75926800|FG007|Overall Study|Other Reasons|0|||
42116067|NCT02733042|75926801|FG008|Overall Study|Other Reasons|0|||
42116068|NCT02733042|75926802|FG009|Overall Study|Other Reasons|1|||
42116069|NCT02733042|75926803|FG010|Overall Study|Other Reasons|1|||
42116070|NCT02733042|75926804|FG011|Overall Study|Other Reasons|0|||
42116071|NCT02733042|75926805|FG012|Overall Study|Other Reasons|0|||
42116072|NCT02733042|75926806|FG013|Overall Study|Other Reasons|0|||
42116073|NCT02733042|75926807|FG014|Overall Study|Other Reasons|0|||
42116074|NCT02733042|75926808|FG015|Overall Study|Other Reasons|1|||
42116075|NCT02733042|75926809|FG016|Overall Study|Other Reasons|0|||
42116076|NCT02733042|75926810|FG017|Overall Study|Other Reasons|1|||
42116077|NCT02733042|75926811|FG018|Overall Study|Other Reasons|0|||
42116078|NCT02733042|75926793|FG000|Overall Study|Death|0|||
42116079|NCT02733042|75926794|FG001|Overall Study|Death|0|||
42116080|NCT02733042|75926795|FG002|Overall Study|Death|0|||
42116081|NCT02733042|75926796|FG003|Overall Study|Death|0|||
42116082|NCT02733042|75926797|FG004|Overall Study|Death|0|||
42116083|NCT02733042|75926798|FG005|Overall Study|Death|0|||
42116084|NCT02733042|75926799|FG006|Overall Study|Death|1|||
42116085|NCT02733042|75926800|FG007|Overall Study|Death|0|||
42116086|NCT02733042|75926801|FG008|Overall Study|Death|1|||
42116087|NCT02733042|75926802|FG009|Overall Study|Death|0|||
42116088|NCT02733042|75926803|FG010|Overall Study|Death|1|||
42116089|NCT02733042|75926804|FG011|Overall Study|Death|0|||
42116090|NCT02733042|75926805|FG012|Overall Study|Death|0|||
42116091|NCT02733042|75926806|FG013|Overall Study|Death|0|||
42116092|NCT02733042|75926807|FG014|Overall Study|Death|1|||
42116093|NCT02733042|75926808|FG015|Overall Study|Death|2|||
42116094|NCT02733042|75926809|FG016|Overall Study|Death|0|||
42116095|NCT02733042|75926810|FG017|Overall Study|Death|0|||
42116096|NCT02733042|75926811|FG018|Overall Study|Death|0|||
42116097|NCT02614066|75926868|FG000|Overall Study|Initiated KTE-X19 and Died|5|||
42116098|NCT02614066|75926869|FG001|Overall Study|Initiated KTE-X19 and Died|12|||
42116099|NCT02614066|75926870|FG002|Overall Study|Initiated KTE-X19 and Died|11|||
42116100|NCT02614066|75926871|FG003|Overall Study|Initiated KTE-X19 and Died|20|||
42116101|NCT02614066|75926868|FG000|Overall Study|Full Consent Withdrawn|0|||
42116102|NCT02614066|75926869|FG001|Overall Study|Full Consent Withdrawn|1|||
42116103|NCT02614066|75926870|FG002|Overall Study|Full Consent Withdrawn|0|||
42116104|NCT02614066|75926871|FG003|Overall Study|Full Consent Withdrawn|3|||
42116105|NCT02614066|75926868|FG000|Overall Study|Lost to Follow-up|0|||
42116106|NCT02614066|75926869|FG001|Overall Study|Lost to Follow-up|1|||
42116107|NCT02614066|75926870|FG002|Overall Study|Lost to Follow-up|0|||
42116108|NCT02614066|75926871|FG003|Overall Study|Lost to Follow-up|0|||
42116109|NCT02614066|75926868|FG000|Overall Study|Still on-study|1|||
42116110|NCT02614066|75926869|FG001|Overall Study|Still on-study|9|||
42116111|NCT02614066|75926870|FG002|Overall Study|Still on-study|5|||
42116112|NCT02614066|75926871|FG003|Overall Study|Still on-study|32|||
42116113|NCT02614066|75926868|FG000|Overall Study|Enrolled But Did Not Initiate KTE-X19|0|||
42116114|NCT02614066|75926869|FG001|Overall Study|Enrolled But Did Not Initiate KTE-X19|5|||
42116115|NCT02614066|75926870|FG002|Overall Study|Enrolled But Did Not Initiate KTE-X19|4|||
42116116|NCT02614066|75926871|FG003|Overall Study|Enrolled But Did Not Initiate KTE-X19|16|||
42116117|NCT02504866|75926935|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
42116118|NCT02504866|75926936|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
42116119|NCT02504866|75926937|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
42116120|NCT02459769|75926949|FG000|Overall Study|Withdrawal by Subject|7|||
42116121|NCT02459769|75926950|FG001|Overall Study|Withdrawal by Subject|4|||
42116122|NCT02459769|75926951|FG002|Overall Study|Withdrawal by Subject|8|||
42116123|NCT02459769|75926952|FG003|Overall Study|Withdrawal by Subject|5|||
42116124|NCT02459769|75926949|FG000|Overall Study|Lost to Follow-up|1|||
42116125|NCT02459769|75926950|FG001|Overall Study|Lost to Follow-up|0|||
42116126|NCT02459769|75926951|FG002|Overall Study|Lost to Follow-up|1|||
42116127|NCT02459769|75926952|FG003|Overall Study|Lost to Follow-up|0|||
42116128|NCT02369016|75926964|FG000|Overall Study|AE associated with clinical disease progression|2|||
42116129|NCT02369016|75926965|FG001|Overall Study|AE associated with clinical disease progression|1|||
42116130|NCT02369016|75926964|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
42116131|NCT02369016|75926965|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
42116132|NCT02369016|75926964|FG000|Overall Study|Progressive disease - clinical progression|1|||
42116133|NCT02369016|75926965|FG001|Overall Study|Progressive disease - clinical progression|4|||
42116134|NCT02369016|75926964|FG000|Overall Study|withdrawal by patient|4|||
42116135|NCT02369016|75926965|FG001|Overall Study|withdrawal by patient|0|||
42116136|NCT02369016|75926964|FG000|Overall Study|Progressive disease - radiological progression|6|||
42116137|NCT02369016|75926965|FG001|Overall Study|Progressive disease - radiological progression|2|||
42116138|NCT02363959|75926978|FG000|Overall Study|Medical instability|1|||
42116139|NCT02363959|75926979|FG001|Overall Study|Medical instability|0|||
42116140|NCT02337829|75926999|FG000|Overall Study|Death|0|||
42116141|NCT02337829|75927000|FG001|Overall Study|Death|1|||
42116142|NCT02337829|75927001|FG002|Overall Study|Death|0|||
42116143|NCT02337829|75927002|FG003|Overall Study|Death|0|||
42116144|NCT02337829|75926999|FG000|Overall Study|Study terminated by sponsor|12|||
42116145|NCT02337829|75927000|FG001|Overall Study|Study terminated by sponsor|10|||
42116146|NCT02337829|75927001|FG002|Overall Study|Study terminated by sponsor|5|||
42116147|NCT02337829|75927002|FG003|Overall Study|Study terminated by sponsor|6|||
42116148|NCT02337829|75926999|FG000|Overall Study|discontinued for other reasons|6|||
42116149|NCT02337829|75927000|FG001|Overall Study|discontinued for other reasons|3|||
42116150|NCT02337829|75927001|FG002|Overall Study|discontinued for other reasons|1|||
42116151|NCT02337829|75927002|FG003|Overall Study|discontinued for other reasons|4|||
42116152|NCT01824875|75927024|FG000|Overall Study|Disease progression|22|||
42116153|NCT01824875|75927025|FG001|Overall Study|Disease progression|15|||
42116154|NCT01824875|75927024|FG000|Overall Study|Withdrawal by Subject|5|||
42116155|NCT01824875|75927025|FG001|Overall Study|Withdrawal by Subject|4|||
42116156|NCT01824875|75927024|FG000|Overall Study|Adverse Event|4|||
42116157|NCT01824875|75927025|FG001|Overall Study|Adverse Event|10|||
42116158|NCT01824875|75927024|FG000|Overall Study|Alternative therapy|3|||
42116159|NCT01824875|75927025|FG001|Overall Study|Alternative therapy|0|||
42116160|NCT01824875|75927024|FG000|Overall Study|Complicating disease|1|||
42116161|NCT01824875|75927025|FG001|Overall Study|Complicating disease|0|||
42116162|NCT01824875|75927024|FG000|Overall Study|Physician Decision|0|||
42116163|NCT01824875|75927025|FG001|Overall Study|Physician Decision|1|||
42116164|NCT01824875|75927024|FG000|Overall Study|Non-compliance|1|||
42116165|NCT01824875|75927025|FG001|Overall Study|Non-compliance|1|||
42116166|NCT01824875|75927024|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
42116167|NCT01824875|75927025|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
42116168|NCT01824875|75927024|FG000|Overall Study|Administrative issues|0|||
42116169|NCT01824875|75927025|FG001|Overall Study|Administrative issues|2|||
42116170|NCT01824875|75927024|FG000|Overall Study|Ineligible or never started treatment|9|||
42116171|NCT01824875|75927025|FG001|Overall Study|Ineligible or never started treatment|5|||
42116172|NCT01824875|75927024|FG000|Overall Study|Other|0|||
42116173|NCT01824875|75927025|FG001|Overall Study|Other|2|||
42116174|NCT01756040|75927044|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
42116175|NCT01756040|75927044|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
42116176|NCT01756040|75927044|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
42116177|NCT00567164|75927063|FG000|Overall Study|Withdrawal by Subject|171|||
42116178|NCT00567164|75927064|FG001|Overall Study|Withdrawal by Subject|21|||
42116179|NCT00567164|75927065|FG002|Overall Study|Withdrawal by Subject|17|||
42116180|NCT00567164|75927063|FG000|Overall Study|Protocol Violation|23|||
42116181|NCT00567164|75927064|FG001|Overall Study|Protocol Violation|4|||
42116182|NCT00567164|75927065|FG002|Overall Study|Protocol Violation|2|||
42116183|NCT00567164|75927063|FG000|Overall Study|Adverse Event|92|||
42116184|NCT00567164|75927064|FG001|Overall Study|Adverse Event|13|||
42116185|NCT00567164|75927065|FG002|Overall Study|Adverse Event|9|||
42116186|NCT00567164|75927063|FG000|Overall Study|Death|0|||
42116187|NCT00567164|75927064|FG001|Overall Study|Death|0|||
42116188|NCT00567164|75927065|FG002|Overall Study|Death|1|||
42116189|NCT00567164|75927063|FG000|Overall Study|Lost to Follow-up|202|||
42116190|NCT00567164|75927064|FG001|Overall Study|Lost to Follow-up|23|||
42116191|NCT00567164|75927065|FG002|Overall Study|Lost to Follow-up|21|||
42116192|NCT00567164|75927063|FG000|Overall Study|Pregnancy|20|||
42116193|NCT00567164|75927064|FG001|Overall Study|Pregnancy|4|||
42116194|NCT00567164|75927065|FG002|Overall Study|Pregnancy|6|||
42116195|NCT00567164|75927063|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
42116196|NCT00567164|75927064|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
42116197|NCT00567164|75927065|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
42116198|NCT00567164|75927063|FG000|Overall Study|Missing|1|||
42116199|NCT00567164|75927064|FG001|Overall Study|Missing|0|||
42116200|NCT00567164|75927065|FG002|Overall Study|Missing|0|||
42116201|NCT00713219|75927077|FG000|Overall Study|Death|1|||
42116202|NCT00713219|75927077|FG000|Overall Study|Protocol Violation|1|||
42116203|NCT00712985|75927081|FG000|Overall Study|1 withdrew prior to start of drug|1|||
42116204|NCT00712985|75927081|FG000|Overall Study|1 patient moved out of state|1|||
42116205|NCT00712985|75927081|FG000|Overall Study|Lack of Efficacy|3|||
42116206|NCT00700115|75927087|FG000|Overall Study|Withdrawal by Subject|1|||
42116207|NCT00700115|75927088|FG001|Overall Study|Withdrawal by Subject|0|||
42116208|NCT00700115|75927087|FG000|Overall Study|Lost to Follow-up|0|||
42116209|NCT00700115|75927088|FG001|Overall Study|Lost to Follow-up|1|||
42116210|NCT00566852|75927096|FG000|Overall Study|Protocol Violation|22|||
42116211|NCT00566852|75927097|FG001|Overall Study|Protocol Violation|24|||
42116212|NCT00566852|75927096|FG000|Overall Study|Death|95|||
42116213|NCT00566852|75927097|FG001|Overall Study|Death|78|||
42116214|NCT00566852|75927096|FG000|Overall Study|Withdrawal by Subject|30|||
42116215|NCT00566852|75927097|FG001|Overall Study|Withdrawal by Subject|25|||
42116216|NCT00566852|75927096|FG000|Overall Study|Patient refusal|37|||
42116217|NCT00566852|75927097|FG001|Overall Study|Patient refusal|37|||
42116218|NCT00566852|75927096|FG000|Overall Study|Not tested due to disability|6|||
42116219|NCT00566852|75927097|FG001|Overall Study|Not tested due to disability|12|||
42116220|NCT00566852|75927096|FG000|Overall Study|Missing reason not specified|1|||
42116221|NCT00566852|75927097|FG001|Overall Study|Missing reason not specified|2|||
42116222|NCT00566852|75927096|FG000|Overall Study|Missing reason not reported|16|||
42116223|NCT00566852|75927097|FG001|Overall Study|Missing reason not reported|20|||
42116224|NCT00442546|75927106|FG000|Overall Study|Adverse Event|11|||
42116225|NCT00442546|75927107|FG001|Overall Study|Adverse Event|17|||
42116226|NCT00442546|75927108|FG002|Overall Study|Adverse Event|13|||
42116227|NCT00442546|75927106|FG000|Overall Study|Lost to Follow-up|1|||
42116228|NCT00442546|75927107|FG001|Overall Study|Lost to Follow-up|2|||
42116229|NCT00442546|75927108|FG002|Overall Study|Lost to Follow-up|1|||
42116230|NCT00442546|75927106|FG000|Overall Study|Other|4|||
42116231|NCT00442546|75927107|FG001|Overall Study|Other|9|||
42116232|NCT00442546|75927108|FG002|Overall Study|Other|6|||
42116233|NCT00442546|75927106|FG000|Overall Study|Withdrawal by Subject|5|||
42116234|NCT00442546|75927107|FG001|Overall Study|Withdrawal by Subject|5|||
42116235|NCT00442546|75927108|FG002|Overall Study|Withdrawal by Subject|7|||
42116236|NCT00442546|75927106|FG000|Overall Study|Randomized But Not Treated|5|||
42116237|NCT00442546|75927107|FG001|Overall Study|Randomized But Not Treated|4|||
42116238|NCT00442546|75927108|FG002|Overall Study|Randomized But Not Treated|6|||
42116239|NCT00514683|75927123|FG000|Overall Study|Not treated|2|||
42116240|NCT00514683|75927124|FG001|Overall Study|Not treated|1|||
42116241|NCT00514683|75927125|FG002|Overall Study|Not treated|0|||
42116242|NCT00514683|75927126|FG003|Overall Study|Not treated|0|||
42116243|NCT00514683|75927127|FG004|Overall Study|Not treated|1|||
42116244|NCT00514683|75927123|FG000|Overall Study|Adverse Event|21|||
42116245|NCT00514683|75927124|FG001|Overall Study|Adverse Event|20|||
42116246|NCT00514683|75927125|FG002|Overall Study|Adverse Event|15|||
42116247|NCT00514683|75927126|FG003|Overall Study|Adverse Event|13|||
42116248|NCT00514683|75927127|FG004|Overall Study|Adverse Event|27|||
42116249|NCT00514683|75927123|FG000|Overall Study|Protocol Violation|1|||
42116250|NCT00514683|75927124|FG001|Overall Study|Protocol Violation|1|||
42116251|NCT00514683|75927125|FG002|Overall Study|Protocol Violation|0|||
42116252|NCT00514683|75927126|FG003|Overall Study|Protocol Violation|1|||
42116253|NCT00514683|75927127|FG004|Overall Study|Protocol Violation|0|||
42116254|NCT00514683|75927123|FG000|Overall Study|Withdrawal by Subject|2|||
42116255|NCT00514683|75927124|FG001|Overall Study|Withdrawal by Subject|2|||
42116256|NCT00514683|75927125|FG002|Overall Study|Withdrawal by Subject|1|||
42116257|NCT00514683|75927126|FG003|Overall Study|Withdrawal by Subject|0|||
42116258|NCT00514683|75927127|FG004|Overall Study|Withdrawal by Subject|4|||
42116259|NCT00514683|75927123|FG000|Overall Study|Reason other than listed above|0|||
42116260|NCT00514683|75927124|FG001|Overall Study|Reason other than listed above|1|||
42116261|NCT00514683|75927125|FG002|Overall Study|Reason other than listed above|2|||
42116262|NCT00514683|75927126|FG003|Overall Study|Reason other than listed above|0|||
42116263|NCT00514683|75927127|FG004|Overall Study|Reason other than listed above|1|||
42116264|NCT00566696|75927143|FG000|Overall Study|Met Exclusion Criteria|2|||
42116265|NCT00566696|75927143|FG000|Overall Study|Muromonab not available|1|||
42116266|NCT00566696|75927143|FG000|Overall Study|Health Status Change|1|||
42116267|NCT00566696|75927143|FG000|Overall Study|Physician Decision|1|||
42116268|NCT00566696|75927143|FG000|Overall Study|Non-Patient Donors|37|||
42116269|NCT00503841|75927147|FG000|Overall Study|All screen failures|44|||
42116270|NCT00442468|75927153|FG000|Overall Study|Adverse Event|4|||
42116271|NCT00442468|75927153|FG000|Overall Study|Withdrawal by Subject|91|||
42116272|NCT00442468|75927153|FG000|Overall Study|Did not complete all study procedures|88|||
42116273|NCT00506883|75927160|FG000|Overall Study|Lost to Follow-up|1|||
42116274|NCT00506883|75927161|FG001|Overall Study|Lost to Follow-up|1|||
42116275|NCT00506883|75927162|FG002|Overall Study|Lost to Follow-up|1|||
42116276|NCT00506883|75927160|FG000|Overall Study|Withdrawal by Subject|1|||
42116277|NCT00506883|75927161|FG001|Overall Study|Withdrawal by Subject|0|||
42116278|NCT00506883|75927162|FG002|Overall Study|Withdrawal by Subject|1|||
42116279|NCT00506883|75927160|FG000|Overall Study|Lack of Efficacy|0|||
42116280|NCT00506883|75927161|FG001|Overall Study|Lack of Efficacy|1|||
42116281|NCT00506883|75927162|FG002|Overall Study|Lack of Efficacy|1|||
42116282|NCT00506883|75927160|FG000|Overall Study|Other|5|||
42116283|NCT00506883|75927161|FG001|Overall Study|Other|1|||
42116284|NCT00506883|75927162|FG002|Overall Study|Other|1|||
42116285|NCT00503685|75927173|FG000|Overall Study|Adverse Event|0|||
42116286|NCT00503685|75927174|FG001|Overall Study|Adverse Event|0|||
42116287|NCT00503685|75927175|FG002|Overall Study|Adverse Event|2|||
42116288|NCT00503685|75927173|FG000|Overall Study|Withdrawal by Subject|0|||
42116289|NCT00503685|75927174|FG001|Overall Study|Withdrawal by Subject|1|||
42116290|NCT00503685|75927175|FG002|Overall Study|Withdrawal by Subject|0|||
42116291|NCT00503685|75927173|FG000|Overall Study|Protocol Violation|0|||
42116292|NCT00503685|75927174|FG001|Overall Study|Protocol Violation|1|||
42116293|NCT00503685|75927175|FG002|Overall Study|Protocol Violation|0|||
42116294|NCT00503685|75927173|FG000|Overall Study|Eligibility Criteria Not Met|0|||
42116295|NCT00503685|75927174|FG001|Overall Study|Eligibility Criteria Not Met|1|||
42116296|NCT00503685|75927175|FG002|Overall Study|Eligibility Criteria Not Met|0|||
42116297|NCT00712673|75927187|FG000|Overall Study|Adverse Event|3|||
42116298|NCT00712673|75927188|FG001|Overall Study|Adverse Event|3|||
42116299|NCT00712673|75927189|FG002|Overall Study|Adverse Event|21|||
42116300|NCT00712673|75927190|FG003|Overall Study|Adverse Event|26|||
42116301|NCT00712673|75927187|FG000|Overall Study|Lack of Efficacy|2|||
42116302|NCT00712673|75927188|FG001|Overall Study|Lack of Efficacy|8|||
42116303|NCT00712673|75927189|FG002|Overall Study|Lack of Efficacy|8|||
42116304|NCT00712673|75927190|FG003|Overall Study|Lack of Efficacy|6|||
42116305|NCT00712673|75927187|FG000|Overall Study|Poor Compliance to Protocol|3|||
42116306|NCT00712673|75927188|FG001|Overall Study|Poor Compliance to Protocol|3|||
42116307|NCT00712673|75927189|FG002|Overall Study|Poor Compliance to Protocol|4|||
42116308|NCT00712673|75927190|FG003|Overall Study|Poor Compliance to Protocol|16|||
42116309|NCT00712673|75927187|FG000|Overall Study|Lost to Follow-up|1|||
42116310|NCT00712673|75927188|FG001|Overall Study|Lost to Follow-up|0|||
42116311|NCT00712673|75927189|FG002|Overall Study|Lost to Follow-up|2|||
42116312|NCT00712673|75927190|FG003|Overall Study|Lost to Follow-up|0|||
42116313|NCT00712673|75927187|FG000|Overall Study|Withdrawal by Subject|6|||
42116314|NCT00712673|75927188|FG001|Overall Study|Withdrawal by Subject|7|||
42116315|NCT00712673|75927189|FG002|Overall Study|Withdrawal by Subject|15|||
42116316|NCT00712673|75927190|FG003|Overall Study|Withdrawal by Subject|20|||
42116317|NCT00712673|75927187|FG000|Overall Study|Familial and Personal Reasons|5|||
42116318|NCT00712673|75927188|FG001|Overall Study|Familial and Personal Reasons|0|||
42116319|NCT00712673|75927189|FG002|Overall Study|Familial and Personal Reasons|5|||
42116320|NCT00712673|75927190|FG003|Overall Study|Familial and Personal Reasons|2|||
42116321|NCT00712673|75927187|FG000|Overall Study|Investigator's Decision|1|||
42116322|NCT00712673|75927188|FG001|Overall Study|Investigator's Decision|0|||
42116323|NCT00712673|75927189|FG002|Overall Study|Investigator's Decision|0|||
42116324|NCT00712673|75927190|FG003|Overall Study|Investigator's Decision|0|||
42116325|NCT00712673|75927187|FG000|Overall Study|Protocol Violation|0|||
42116326|NCT00712673|75927188|FG001|Overall Study|Protocol Violation|0|||
42116327|NCT00712673|75927189|FG002|Overall Study|Protocol Violation|2|||
42116328|NCT00712673|75927190|FG003|Overall Study|Protocol Violation|0|||
42116329|NCT03976466|75927211|FG000|Overall Study|Lost to Follow-up|1|||
42116330|NCT03976466|75927212|FG001|Overall Study|Lost to Follow-up|3|||
42116331|NCT02536755|75927220|FG000|Overall Study|Adverse Event|4|||
42299763|NCT02545933|76134796|FG001|Overall Study|Protocol Violation|0|||
42116332|NCT03303105|75927229|FG000|Overall Study|Adverse Event|0|||
42116333|NCT03303105|75927230|FG001|Overall Study|Adverse Event|2|||
42116334|NCT03303105|75927229|FG000|Overall Study|Lack of Efficacy|1|||
42116335|NCT03303105|75927230|FG001|Overall Study|Lack of Efficacy|0|||
42116336|NCT03303105|75927229|FG000|Overall Study|Protocol Violation|1|||
42116337|NCT03303105|75927230|FG001|Overall Study|Protocol Violation|0|||
42116338|NCT03303105|75927229|FG000|Overall Study|Withdrawal by Subject|0|||
42116339|NCT03303105|75927230|FG001|Overall Study|Withdrawal by Subject|2|||
42116340|NCT00447694|75927236|FG000|Overall Study|Adverse Event|2|||
42116341|NCT00447694|75927236|FG000|Overall Study|Abnormal laboratory value|1|||
42116342|NCT00447694|75927236|FG000|Overall Study|Abnormal test procedure result|1|||
42116343|NCT00447694|75927236|FG000|Overall Study|Withdrawal by Subject|2|||
42116344|NCT00564278|75927242|FG000|Overall Study|Lost to Follow-up|35|||
42116345|NCT00564278|75927243|FG001|Overall Study|Lost to Follow-up|33|||
42116346|NCT00564278|75927242|FG000|Overall Study|Physician Decision|1|||
42116347|NCT00564278|75927243|FG001|Overall Study|Physician Decision|2|||
42116348|NCT00564278|75927242|FG000|Overall Study|Withdrawal by Subject|11|||
42116349|NCT00564278|75927243|FG001|Overall Study|Withdrawal by Subject|7|||
42116350|NCT00565604|75927249|FG000|Overall Study|Failure to treat|2|||
42116351|NCT00565604|75927249|FG000|Overall Study|Lost to Follow-up|2|||
42116352|NCT00447226|75927253|FG000|12-Week Open-label Phase|Adverse Event|0|||
42116353|NCT00447226|75927254|FG001|12-Week Open-label Phase|Adverse Event|3|||
42116354|NCT00447226|75927253|FG000|12-Week Open-label Phase|Protocol Violation|0|||
42116355|NCT00447226|75927254|FG001|12-Week Open-label Phase|Protocol Violation|1|||
42116356|NCT00447226|75927253|FG000|12-Week Open-label Phase|Disease Progression|0|||
42116357|NCT00447226|75927254|FG001|12-Week Open-label Phase|Disease Progression|20|||
42116358|NCT00447226|75927253|FG000|12-Week Open-label Phase|Physician Decision|0|||
42116359|NCT00447226|75927254|FG001|12-Week Open-label Phase|Physician Decision|1|||
42116360|NCT00447226|75927253|FG000|Double-blind Phase|Disease Progression|4|||
42116361|NCT00447226|75927254|FG001|Double-blind Phase|Disease Progression|3|||
42116362|NCT00446992|75927269|FG000|Overall Study|Adverse Event|11|||
42116363|NCT00446992|75927269|FG000|Overall Study|Lost to Follow-up|5|||
42116364|NCT00503139|75927273|FG000|Overall Study|Case Report Forms were not collected|4|||
42116365|NCT00503139|75927273|FG000|Overall Study|Protocol Violation|4|||
42116366|NCT00577031|75927277|FG000|Overall Study|Adverse Event|52|||
42116367|NCT00577031|75927277|FG000|Overall Study|Progression of disease|93|||
42116368|NCT00577031|75927277|FG000|Overall Study|Protocol Violation|5|||
42116369|NCT00577031|75927277|FG000|Overall Study|Participant withdrew consent|13|||
42116370|NCT00577031|75927277|FG000|Overall Study|Participant non-compliance|5|||
42116371|NCT00577031|75927277|FG000|Overall Study|Need for surgery|17|||
42116372|NCT00577031|75927277|FG000|Overall Study|Medical decision|14|||
42116373|NCT00577031|75927277|FG000|Overall Study|Death|6|||
42116374|NCT00565448|75927286|FG000|Overall Study|Adverse Event|1|||
42116375|NCT00565448|75927287|FG001|Overall Study|Adverse Event|2|||
42116376|NCT00565448|75927286|FG000|Overall Study|Disease progression|1|||
42116377|NCT00565448|75927287|FG001|Overall Study|Disease progression|0|||
42116378|NCT00565448|75927286|FG000|Overall Study|Withdrawal by Subject|1|||
42116379|NCT00565448|75927287|FG001|Overall Study|Withdrawal by Subject|0|||
42116380|NCT00446446|75927296|FG000|Overall Study|Death|10|||
42116381|NCT00446446|75927296|FG000|Overall Study|Withdrawal by Subject|6|||
42116382|NCT00446446|75927296|FG000|Overall Study|Other|4|||
42116383|NCT00446446|75927296|FG000|Overall Study|Disease Progession|2|||
42116384|NCT00446446|75927296|FG000|Overall Study|Adverse Event|1|||
42116385|NCT00446446|75927296|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
42116386|NCT00514449|75927302|FG000|Overall Study|Withdrawal by Subject|1|||
42116387|NCT00514449|75927303|FG001|Overall Study|Withdrawal by Subject|2|||
42116388|NCT00514449|75927302|FG000|Overall Study|Protocol Violation|1|||
42116389|NCT00514449|75927303|FG001|Overall Study|Protocol Violation|2|||
42116390|NCT00514449|75927302|FG000|Overall Study|Lost to Follow-up|1|||
42116391|NCT00514449|75927303|FG001|Overall Study|Lost to Follow-up|0|||
42116392|NCT00565136|75927312|FG000|Overall Study|Lost to Follow-up|1|||
42116393|NCT00565136|75927312|FG000|Overall Study|Withdrawal by Subject|1|||
42116394|NCT00565136|75927312|FG000|Overall Study|Protocol Violation|1|||
42116395|NCT00492921|75927316|FG000|Overall Study|Death|1|||
42116396|NCT00492921|75927317|FG001|Overall Study|Death|0|||
42116397|NCT00492921|75927318|FG002|Overall Study|Death|1|||
42116398|NCT00502671|75927326|FG000|Overall Study|Disease Progression|13|||
42116399|NCT00502671|75927326|FG000|Overall Study|Personal Reasons|22|||
42116400|NCT00502671|75927326|FG000|Overall Study|Lost to Follow-up|7|||
42116401|NCT00502671|75927326|FG000|Overall Study|Protocol Violation|16|||
42116402|NCT00502671|75927326|FG000|Overall Study|Adverse Event|19|||
42116403|NCT00697463|75927330|FG000|Overall Study|Withdrawal by Subject|1|||
42116404|NCT00492531|75927336|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
42116405|NCT00492531|75927337|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
42116406|NCT00111475|75927353|FG000|Overall Study|Lost to Follow-up|0|||
42116407|NCT00111475|75927354|FG001|Overall Study|Lost to Follow-up|0|||
42116408|NCT00111475|75927355|FG002|Overall Study|Lost to Follow-up|0|||
42116409|NCT00111475|75927356|FG003|Overall Study|Lost to Follow-up|0|||
42299764|NCT02545933|76134797|FG002|Overall Study|Protocol Violation|1|||
42299765|NCT01661179|76134805|FG000|Overall Study|Death|1|||
42299766|NCT01661179|76134805|FG000|Overall Study|Withdrawal by Subject|1|||
42116410|NCT00111475|75927357|FG004|Overall Study|Lost to Follow-up|0|||
42116411|NCT00111475|75927358|FG005|Overall Study|Lost to Follow-up|1|||
42116412|NCT00111475|75927359|FG006|Overall Study|Lost to Follow-up|0|||
42116413|NCT00111475|75927360|FG007|Overall Study|Lost to Follow-up|0|||
42116414|NCT00111475|75927361|FG008|Overall Study|Lost to Follow-up|0|||
42116415|NCT00111475|75927362|FG009|Overall Study|Lost to Follow-up|0|||
42116416|NCT00111241|75927391|FG000|Overall Study|Lost to Follow-up|1|||
42116417|NCT00111241|75927392|FG001|Overall Study|Lost to Follow-up|0|||
42116418|NCT00111241|75927391|FG000|Overall Study|Withdrawal by Subject|4|||
42116419|NCT00111241|75927392|FG001|Overall Study|Withdrawal by Subject|0|||
42116420|NCT00111241|75927391|FG000|Overall Study|Protocol Violation|9|||
42116421|NCT00111241|75927392|FG001|Overall Study|Protocol Violation|8|||
42116422|NCT00111241|75927391|FG000|Overall Study|Adverse Event|1|||
42116423|NCT00111241|75927392|FG001|Overall Study|Adverse Event|0|||
42116424|NCT00492297|75927400|FG000|Treatment|Death|2|||
42116425|NCT00492297|75927400|FG000|Treatment|Study terminated by sponsor|3|||
42116426|NCT00492297|75927400|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
42116427|NCT00492297|75927400|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
42116428|NCT00492297|75927400|FG000|Survival Only Follow-up|Death|46|||
42116429|NCT00492297|75927400|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
42116430|NCT00492297|75927400|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
42116431|NCT00565058|75927406|FG000|Overall Study|Adverse Event|1|||
42116432|NCT00565058|75927407|FG001|Overall Study|Adverse Event|0|||
42116433|NCT00564902|75927416|FG000|Overall Study|Withdrawal by Subject|0|||
42116434|NCT00564902|75927417|FG001|Overall Study|Withdrawal by Subject|3|||
42116435|NCT00564902|75927418|FG002|Overall Study|Withdrawal by Subject|4|||
42116436|NCT00564902|75927416|FG000|Overall Study|Death|1|||
42116437|NCT00564902|75927417|FG001|Overall Study|Death|1|||
42116438|NCT00564902|75927418|FG002|Overall Study|Death|0|||
42116439|NCT00446134|75927430|FG000|Overall Study|Adverse Event|7|||
42116440|NCT00446134|75927431|FG001|Overall Study|Adverse Event|17|||
42116441|NCT00446134|75927432|FG002|Overall Study|Adverse Event|13|||
42116442|NCT00446134|75927433|FG003|Overall Study|Adverse Event|18|||
42116443|NCT00446134|75927430|FG000|Overall Study|Lack of Efficacy|19|||
42116444|NCT00446134|75927431|FG001|Overall Study|Lack of Efficacy|19|||
42116445|NCT00446134|75927432|FG002|Overall Study|Lack of Efficacy|24|||
42116446|NCT00446134|75927433|FG003|Overall Study|Lack of Efficacy|19|||
42116447|NCT00446134|75927430|FG000|Overall Study|Protocol Violation|0|||
42116448|NCT00446134|75927431|FG001|Overall Study|Protocol Violation|2|||
42116449|NCT00446134|75927432|FG002|Overall Study|Protocol Violation|1|||
42116450|NCT00446134|75927433|FG003|Overall Study|Protocol Violation|0|||
42116451|NCT00446134|75927430|FG000|Overall Study|Lost to Follow-up|1|||
42116452|NCT00446134|75927431|FG001|Overall Study|Lost to Follow-up|3|||
42116453|NCT00446134|75927432|FG002|Overall Study|Lost to Follow-up|1|||
42116454|NCT00446134|75927433|FG003|Overall Study|Lost to Follow-up|1|||
42116455|NCT00446134|75927430|FG000|Overall Study|Withdrawal by Subject|3|||
42116456|NCT00446134|75927431|FG001|Overall Study|Withdrawal by Subject|3|||
42116457|NCT00446134|75927432|FG002|Overall Study|Withdrawal by Subject|1|||
42116458|NCT00446134|75927433|FG003|Overall Study|Withdrawal by Subject|3|||
42116459|NCT00446134|75927430|FG000|Overall Study|Physician Decision|0|||
42116460|NCT00446134|75927431|FG001|Overall Study|Physician Decision|0|||
42116461|NCT00446134|75927432|FG002|Overall Study|Physician Decision|0|||
42116462|NCT00446134|75927433|FG003|Overall Study|Physician Decision|2|||
42116463|NCT00446134|75927430|FG000|Overall Study|Adverse Event-Diarrhea|1|||
42116464|NCT00446134|75927431|FG001|Overall Study|Adverse Event-Diarrhea|1|||
42116465|NCT00446134|75927432|FG002|Overall Study|Adverse Event-Diarrhea|2|||
42116466|NCT00446134|75927433|FG003|Overall Study|Adverse Event-Diarrhea|0|||
42116467|NCT00446134|75927430|FG000|Overall Study|Reason Not Completed|3|||
42116468|NCT00446134|75927431|FG001|Overall Study|Reason Not Completed|0|||
42116469|NCT00446134|75927432|FG002|Overall Study|Reason Not Completed|1|||
42116470|NCT00446134|75927433|FG003|Overall Study|Reason Not Completed|2|||
42116471|NCT00563186|75927445|FG000|Overall Study|LOS<48 hours|97|||
42116472|NCT00563186|75927446|FG001|Overall Study|LOS<48 hours|74|||
42116473|NCT00563186|75927445|FG000|Overall Study|Incomplete data|1|||
42116474|NCT00563186|75927446|FG001|Overall Study|Incomplete data|1|||
42116475|NCT00699413|75927457|FG000|Overall Study|Withdrawal by Subject|0|||
42116476|NCT00699413|75927458|FG001|Overall Study|Withdrawal by Subject|2|||
42116477|NCT00699413|75927457|FG000|Overall Study|Study terminated by sponsor|4|||
42116478|NCT00699413|75927458|FG001|Overall Study|Study terminated by sponsor|2|||
42116479|NCT04808609|75927466|FG000|Overall Study|Lost to Follow-up|0|||
42116480|NCT04808609|75927467|FG001|Overall Study|Lost to Follow-up|2|||
42116481|NCT04808609|75927466|FG000|Overall Study|Administrative Withdrawal|0|||
42116482|NCT04808609|75927467|FG001|Overall Study|Administrative Withdrawal|1|||
42116483|NCT00111007|75927475|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
42116484|NCT00111007|75927476|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
42116485|NCT00111007|75927475|FG000|Double-blind (DB) Treatment|Death|5|||
42116486|NCT00111007|75927476|FG001|Double-blind (DB) Treatment|Death|2|||
42116487|NCT00111007|75927475|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
42116488|NCT00111007|75927476|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
42116489|NCT00111007|75927475|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
42116490|NCT00111007|75927476|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
42116491|NCT00111007|75927475|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
42116492|NCT00111007|75927476|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
42116493|NCT00111007|75927475|FG000|Double-blind (DB) Treatment|Relapse|1|||
42116494|NCT00111007|75927476|FG001|Double-blind (DB) Treatment|Relapse|0|||
42116495|NCT00111007|75927475|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
42116496|NCT00111007|75927476|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
42116497|NCT00111007|75927475|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
42116498|NCT00111007|75927476|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
42116499|NCT00111007|75927475|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
42116500|NCT00111007|75927476|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
42116501|NCT00111007|75927475|FG000|Active Follow-up|Adverse Event|1|||
42116502|NCT00111007|75927476|FG001|Active Follow-up|Adverse Event|0|||
42116503|NCT00111007|75927475|FG000|Active Follow-up|Death|2|||
42116504|NCT00111007|75927476|FG001|Active Follow-up|Death|0|||
42116505|NCT00111007|75927475|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
42116506|NCT00111007|75927476|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
42116507|NCT00111007|75927475|FG000|Long Term Follow-up|Death|34|||
42116508|NCT00111007|75927476|FG001|Long Term Follow-up|Death|39|||
42116509|NCT00111007|75927475|FG000|Long Term Follow-up|Lost to Follow-up|1|||
42116510|NCT00111007|75927476|FG001|Long Term Follow-up|Lost to Follow-up|1|||
42116511|NCT00111007|75927475|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
42116512|NCT00111007|75927476|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
42116513|NCT00111007|75927475|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
42116514|NCT00111007|75927476|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
42116515|NCT00111007|75927475|FG000|Long Term Follow-up|Missing|10|||
42116516|NCT00111007|75927476|FG001|Long Term Follow-up|Missing|3|||
42116517|NCT03975920|75927484|FG000|Overall Study|Lost to Follow-up|1|||
42116518|NCT03975920|75927485|FG001|Overall Study|Lost to Follow-up|2|||
42116519|NCT03975920|75927484|FG000|Overall Study|Protocol Violation|1|||
42116520|NCT03975920|75927485|FG001|Overall Study|Protocol Violation|1|||
42116521|NCT03975920|75927484|FG000|Overall Study|Did not complete survey|2|||
42116522|NCT03975920|75927485|FG001|Overall Study|Did not complete survey|1|||
42116523|NCT00699335|75927491|FG000|Overall Study|Combination of multiple reasons|176|||
42116524|NCT00699335|75927491|FG000|Overall Study|Missing data|52|||
42116525|NCT00445978|75927498|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
42116526|NCT00445978|75927498|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
42116527|NCT00445978|75927498|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
42116528|NCT00445978|75927498|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
42116529|NCT00445978|75927498|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
42116530|NCT00445978|75927498|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
42116531|NCT00445978|75927498|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
42116532|NCT00445978|75927498|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
42116533|NCT00445978|75927498|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
42116534|NCT00566228|75927511|FG000|Overall Study|Withdrawal by Subject|1|||
42116535|NCT00566228|75927512|FG001|Overall Study|Withdrawal by Subject|0|||
42116536|NCT00566228|75927511|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
42116537|NCT00566228|75927512|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
42116538|NCT00566228|75927511|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
42116539|NCT00566228|75927512|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
42116540|NCT00566228|75927511|FG000|Overall Study|progressed before infusion could occur|0|||
42116541|NCT00566228|75927512|FG001|Overall Study|progressed before infusion could occur|1|||
42116542|NCT00698009|75927518|FG000|Overall Study|Withdrawal by Subject|1|||
42116543|NCT03968978|75927524|FG000|Overall Study|Adverse Event|1|||
42116544|NCT03968978|75927525|FG001|Overall Study|Adverse Event|0|||
42116545|NCT00562718|75927531|FG000|Overall Study|Death|1|||
42116546|NCT00562718|75927531|FG000|Overall Study|Withdrawal by Subject|3|||
42116547|NCT00562718|75927531|FG000|Overall Study|Adverse Event|4|||
42116548|NCT00562718|75927531|FG000|Overall Study|Lack of Efficacy|2|||
42116549|NCT00562718|75927531|FG000|Overall Study|not stated|1|||
42116550|NCT00697619|75927537|FG000|Overall Study|Lack of Efficacy|2|||
42116551|NCT00697619|75927538|FG001|Overall Study|Lack of Efficacy|2|||
42116552|NCT00697619|75927537|FG000|Overall Study|Adverse Event|4|||
42116553|NCT00697619|75927538|FG001|Overall Study|Adverse Event|6|||
42116554|NCT00445432|75927547|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
42116555|NCT00445432|75927548|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
42116556|NCT00445432|75927549|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
42116557|NCT00445432|75927550|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
42116558|NCT00445432|75927547|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
42116559|NCT00445432|75927548|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
42116560|NCT00445432|75927549|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
42116561|NCT00445432|75927550|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
42116562|NCT00445432|75927547|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
42116563|NCT00445432|75927548|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
42116564|NCT00445432|75927549|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
42116565|NCT00445432|75927550|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
42116566|NCT00445432|75927547|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
42116567|NCT00445432|75927548|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
42116568|NCT00445432|75927549|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
42116569|NCT00445432|75927550|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
42116570|NCT00445432|75927547|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
42116571|NCT00445432|75927548|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
42116572|NCT00445432|75927549|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
42116573|NCT00445432|75927550|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
42116574|NCT00445432|75927547|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
42116575|NCT00445432|75927548|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
42116576|NCT00445432|75927549|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
42116577|NCT00445432|75927550|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
42116578|NCT00445432|75927547|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
42116579|NCT00445432|75927548|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
42116580|NCT00445432|75927549|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
42116581|NCT00445432|75927550|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
42116582|NCT00696137|75927561|FG000|Overall Study|Withdrawal by Subject|2|||
42116583|NCT00441142|75927569|FG000|Overall Study|Adverse Event|2|||
42116584|NCT00441142|75927570|FG001|Overall Study|Adverse Event|3|||
42116585|NCT00441142|75927571|FG002|Overall Study|Adverse Event|3|||
42116586|NCT00441142|75927572|FG003|Overall Study|Adverse Event|22|||
42116587|NCT00441142|75927569|FG000|Overall Study|Lack of Efficacy|3|||
42116588|NCT00441142|75927570|FG001|Overall Study|Lack of Efficacy|3|||
42116589|NCT00441142|75927571|FG002|Overall Study|Lack of Efficacy|17|||
42116590|NCT00441142|75927572|FG003|Overall Study|Lack of Efficacy|32|||
42116591|NCT00441142|75927569|FG000|Overall Study|Withdrawal by Subject|0|||
42116592|NCT00441142|75927570|FG001|Overall Study|Withdrawal by Subject|0|||
42116593|NCT00441142|75927571|FG002|Overall Study|Withdrawal by Subject|2|||
42116594|NCT00441142|75927572|FG003|Overall Study|Withdrawal by Subject|10|||
42116595|NCT00441142|75927569|FG000|Overall Study|Patient still receiving active study tx|1|||
42116596|NCT00441142|75927570|FG001|Overall Study|Patient still receiving active study tx|0|||
42116597|NCT00441142|75927571|FG002|Overall Study|Patient still receiving active study tx|0|||
42116598|NCT00441142|75927572|FG003|Overall Study|Patient still receiving active study tx|2|||
42116599|NCT00441142|75927569|FG000|Overall Study|Physician Decision|0|||
42116600|NCT00441142|75927570|FG001|Overall Study|Physician Decision|1|||
42116601|NCT00441142|75927571|FG002|Overall Study|Physician Decision|0|||
42116602|NCT00441142|75927572|FG003|Overall Study|Physician Decision|1|||
42116603|NCT00441142|75927569|FG000|Overall Study|Death|0|||
42116604|NCT00441142|75927570|FG001|Overall Study|Death|0|||
42116605|NCT00441142|75927571|FG002|Overall Study|Death|0|||
42116606|NCT00441142|75927572|FG003|Overall Study|Death|1|||
42116607|NCT04025021|75927586|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
42116608|NCT04025021|75927587|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
42116609|NCT03848416|75927597|FG000|Overall Study|Withdrawal by Subject|1|||
42116610|NCT03848416|75927598|FG001|Overall Study|Withdrawal by Subject|0|||
42116611|NCT03848416|75927599|FG002|Overall Study|Withdrawal by Subject|0|||
42299767|NCT01661179|76134805|FG000|Overall Study|Other Eligibility criteria|4|||
42116612|NCT03848416|75927597|FG000|Overall Study|Death|0|||
42116613|NCT03848416|75927598|FG001|Overall Study|Death|0|||
42116614|NCT03848416|75927599|FG002|Overall Study|Death|1|||
42116615|NCT00458302|75927609|FG000|Overall Study|Adverse Event|4|||
42116616|NCT00458302|75927610|FG001|Overall Study|Adverse Event|14|||
42116617|NCT00458302|75927609|FG000|Overall Study|Pregnancy|2|||
42116618|NCT00458302|75927610|FG001|Overall Study|Pregnancy|1|||
42116619|NCT00458302|75927609|FG000|Overall Study|Protocol Violation|0|||
42116620|NCT00458302|75927610|FG001|Overall Study|Protocol Violation|2|||
42116621|NCT00458302|75927609|FG000|Overall Study|Withdrawal by Subject|6|||
42116622|NCT00458302|75927610|FG001|Overall Study|Withdrawal by Subject|4|||
42116623|NCT00458302|75927609|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
42116624|NCT00458302|75927610|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
42116625|NCT00458302|75927609|FG000|Overall Study|Study Termination By Sponsor|1|||
42116626|NCT00458302|75927610|FG001|Overall Study|Study Termination By Sponsor|0|||
42116627|NCT00458302|75927609|FG000|Overall Study|Lost to Follow-up|2|||
42116628|NCT00458302|75927610|FG001|Overall Study|Lost to Follow-up|0|||
42116629|NCT00458302|75927609|FG000|Overall Study|Other|4|||
42116630|NCT00458302|75927610|FG001|Overall Study|Other|2|||
42116631|NCT00444106|75927620|FG000|Overall Study|Lost to Follow-up|2|||
42116632|NCT00444106|75927621|FG001|Overall Study|Lost to Follow-up|1|||
42116633|NCT00444106|75927622|FG002|Overall Study|Lost to Follow-up|0|||
42116634|NCT00444106|75927620|FG000|Overall Study|Abnormal Test Procedure Results|0|||
42116635|NCT00444106|75927621|FG001|Overall Study|Abnormal Test Procedure Results|0|||
42116636|NCT00444106|75927622|FG002|Overall Study|Abnormal Test Procedure Results|1|||
42116637|NCT00561470|75927635|FG000|Overall Study|Adverse Event|74|||
42116638|NCT00561470|75927636|FG001|Overall Study|Adverse Event|163|||
42116639|NCT00561470|75927635|FG000|Overall Study|Disease progression|437|||
42116640|NCT00561470|75927636|FG001|Overall Study|Disease progression|305|||
42116641|NCT00561470|75927635|FG000|Overall Study|poor compliance to protocol|4|||
42116642|NCT00561470|75927636|FG001|Overall Study|poor compliance to protocol|4|||
42116643|NCT00561470|75927635|FG000|Overall Study|Lost to Follow-up|2|||
42116644|NCT00561470|75927636|FG001|Overall Study|Lost to Follow-up|0|||
42116645|NCT00561470|75927635|FG000|Overall Study|Physician Decision|21|||
42116646|NCT00561470|75927636|FG001|Overall Study|Physician Decision|20|||
42116647|NCT00561470|75927635|FG000|Overall Study|Consent Withdrawn|2|||
42116648|NCT00561470|75927636|FG001|Overall Study|Consent Withdrawn|6|||
42116649|NCT00561470|75927635|FG000|Overall Study|Subject request|43|||
42116650|NCT00561470|75927636|FG001|Overall Study|Subject request|77|||
42116651|NCT00561470|75927635|FG000|Overall Study|Metastatic surgery|10|||
42116652|NCT00561470|75927636|FG001|Overall Study|Metastatic surgery|12|||
42116653|NCT00561470|75927635|FG000|Overall Study|Unauthorized procedure|3|||
42116654|NCT00561470|75927636|FG001|Overall Study|Unauthorized procedure|1|||
42116655|NCT00561470|75927635|FG000|Overall Study|Randomized but not treated|5|||
42116656|NCT00561470|75927636|FG001|Overall Study|Randomized but not treated|5|||
42116657|NCT00561470|75927635|FG000|Overall Study|Missed visit window|1|||
42116658|NCT00561470|75927636|FG001|Overall Study|Missed visit window|4|||
42116659|NCT00561470|75927635|FG000|Overall Study|Planning surgery|1|||
42116660|NCT00561470|75927636|FG001|Overall Study|Planning surgery|1|||
42116661|NCT00561470|75927635|FG000|Overall Study|Ongoing Treatment|11|||
42116662|NCT00561470|75927636|FG001|Overall Study|Ongoing Treatment|14|||
42116663|NCT00443872|75927644|FG000|Overall Study|Protocol Violation|7|||
42116664|NCT00443872|75927644|FG000|Overall Study|Lost to Follow-up|2|||
42116665|NCT00443872|75927644|FG000|Overall Study|Adverse Event|8|||
42116666|NCT00441064|75927659|FG000|Overall Study|Adverse Event|1|||
42116667|NCT00441064|75927660|FG001|Overall Study|Adverse Event|0|||
42116668|NCT00441064|75927659|FG000|Overall Study|Abnormal laboratory values|0|||
42116669|NCT00441064|75927660|FG001|Overall Study|Abnormal laboratory values|2|||
42116670|NCT00441064|75927659|FG000|Overall Study|Abnormal test procedure results|0|||
42116671|NCT00441064|75927660|FG001|Overall Study|Abnormal test procedure results|1|||
42116672|NCT00441064|75927659|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42116673|NCT00441064|75927660|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42116674|NCT00441064|75927659|FG000|Overall Study|Protocol Deviation|3|||
42116675|NCT00441064|75927660|FG001|Overall Study|Protocol Deviation|2|||
42116676|NCT00441064|75927659|FG000|Overall Study|Patient withdrew consent|5|||
42116677|NCT00441064|75927660|FG001|Overall Study|Patient withdrew consent|2|||
42116678|NCT03962738|75927670|FG000|Overall Study|Protocol Deviation|3|||
42116679|NCT03962738|75927671|FG001|Overall Study|Protocol Deviation|0|||
42116680|NCT03962738|75927672|FG002|Overall Study|Protocol Deviation|1|||
42116681|NCT03962738|75927673|FG003|Overall Study|Protocol Deviation|1|||
42116682|NCT03962738|75927670|FG000|Overall Study|Withdrawal by Subject|4|||
42116683|NCT03962738|75927671|FG001|Overall Study|Withdrawal by Subject|0|||
42116684|NCT03962738|75927672|FG002|Overall Study|Withdrawal by Subject|0|||
42116685|NCT03962738|75927673|FG003|Overall Study|Withdrawal by Subject|0|||
42116686|NCT03962738|75927670|FG000|Overall Study|Lost to Follow-up|0|||
42116687|NCT03962738|75927671|FG001|Overall Study|Lost to Follow-up|0|||
42116688|NCT03962738|75927672|FG002|Overall Study|Lost to Follow-up|1|||
42116689|NCT03962738|75927673|FG003|Overall Study|Lost to Follow-up|0|||
42116690|NCT00561392|75927691|FG000|Overall Study|Adverse Event|38|||
42116691|NCT00561392|75927691|FG000|Overall Study|Lack of Efficacy|2|||
42116692|NCT00561392|75927691|FG000|Overall Study|Protocol Violation|1|||
42116693|NCT00561392|75927691|FG000|Overall Study|Withdrawal by Subject|8|||
42116694|NCT00561392|75927691|FG000|Overall Study|Administrative problems|4|||
42116695|NCT00694109|75927695|FG000|Overall Study|Physician Decision|3|||
42116696|NCT00694109|75927695|FG000|Overall Study|Adverse Event|74|||
42116697|NCT00694109|75927695|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
42116698|NCT00694109|75927695|FG000|Overall Study|Lack of Efficacy|2|||
42116699|NCT00694109|75927695|FG000|Overall Study|Withdrawal by Subject|13|||
42116700|NCT00694109|75927695|FG000|Overall Study|Pregnancy|1|||
42116701|NCT00694109|75927695|FG000|Overall Study|Enrolled but not treated|1|||
42116702|NCT00694109|75927695|FG000|Overall Study|Other|2|||
42116703|NCT00694109|75927695|FG000|Overall Study|Consented but no additional treatment|3|||
42116704|NCT00562484|75927706|FG000|Overall Study|Adverse Event|6|||
42116705|NCT00562484|75927707|FG001|Overall Study|Adverse Event|1|||
42116706|NCT00562484|75927706|FG000|Overall Study|Protocol Violation|11|||
42116707|NCT00562484|75927707|FG001|Overall Study|Protocol Violation|2|||
42116708|NCT00562484|75927706|FG000|Overall Study|Withdrawal by Subject|12|||
42299768|NCT02545543|76134811|FG000|Overall Study|Lost to Follow-up|67|||
42299769|NCT02545543|76134812|FG001|Overall Study|Lost to Follow-up|25|||
42299770|NCT02545543|76134811|FG000|Overall Study|Physician Decision|3|||
42116709|NCT00562484|75927707|FG001|Overall Study|Withdrawal by Subject|9|||
42116710|NCT00562484|75927706|FG000|Overall Study|Moved away from the study area|20|||
42116711|NCT00562484|75927707|FG001|Overall Study|Moved away from the study area|9|||
42116712|NCT00562484|75927706|FG000|Overall Study|Lost to Follow-up|132|||
42116713|NCT00562484|75927707|FG001|Overall Study|Lost to Follow-up|71|||
42116714|NCT00562484|75927706|FG000|Overall Study|Reason not provided or not specified|25|||
42116715|NCT00562484|75927707|FG001|Overall Study|Reason not provided or not specified|12|||
42299771|NCT02545543|76134812|FG001|Overall Study|Physician Decision|0|||
42116716|NCT00561080|75927716|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
42116717|NCT00561080|75927717|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
42116718|NCT00561080|75927718|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
42116719|NCT00561080|75927716|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
42116720|NCT00561080|75927717|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
42116721|NCT00561080|75927718|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
42116722|NCT00561080|75927716|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
42116723|NCT00561080|75927717|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
42116724|NCT00561080|75927718|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
42116725|NCT00561080|75927716|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
42116726|NCT00561080|75927717|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
42116727|NCT00561080|75927718|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
42116728|NCT00561080|75927716|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
42116729|NCT00561080|75927717|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
42116730|NCT00561080|75927718|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
42116731|NCT00561080|75927716|FG000|Vaccination Period (up to Month 4)|Other|0|||
42116732|NCT00561080|75927717|FG001|Vaccination Period (up to Month 4)|Other|2|||
42116733|NCT00561080|75927718|FG002|Vaccination Period (up to Month 4)|Other|1|||
42116734|NCT00561080|75927716|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
42116735|NCT00561080|75927717|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
42116736|NCT00561080|75927718|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
42116737|NCT00561080|75927716|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
42116738|NCT00561080|75927717|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
42116739|NCT00561080|75927718|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
42116740|NCT00561080|75927716|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
42116741|NCT00561080|75927717|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
42116742|NCT00561080|75927718|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
42116743|NCT00561080|75927716|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
42116744|NCT00561080|75927717|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
42116745|NCT00561080|75927718|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
42116746|NCT00562094|75927728|FG000|Overall Study|Lost to Follow-up|62|||
42116747|NCT03817853|75927736|FG000|Induction Phase|Adverse Event|5|||
42116748|NCT03817853|75927737|FG001|Induction Phase|Adverse Event|0|||
42116749|NCT03817853|75927738|FG002|Induction Phase|Adverse Event|0|||
42116750|NCT03817853|75927736|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
42116751|NCT03817853|75927737|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
42116752|NCT03817853|75927738|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
42116753|NCT03817853|75927736|FG000|Induction Phase|Physician Decision|2|||
42116754|NCT03817853|75927737|FG001|Induction Phase|Physician Decision|0|||
42116755|NCT03817853|75927738|FG002|Induction Phase|Physician Decision|0|||
42116756|NCT03817853|75927736|FG000|Induction Phase|Progressive Disease|4|||
42116757|NCT03817853|75927737|FG001|Induction Phase|Progressive Disease|0|||
42116758|NCT03817853|75927738|FG002|Induction Phase|Progressive Disease|0|||
42116759|NCT03817853|75927736|FG000|Induction Phase|Withdrawal by Subject|3|||
42116760|NCT03817853|75927737|FG001|Induction Phase|Withdrawal by Subject|0|||
42116761|NCT03817853|75927738|FG002|Induction Phase|Withdrawal by Subject|0|||
42116762|NCT03817853|75927736|FG000|Induction Phase|Continuing on Study|34|||
42116763|NCT03817853|75927737|FG001|Induction Phase|Continuing on Study|0|||
42116764|NCT03817853|75927738|FG002|Induction Phase|Continuing on Study|0|||
42116765|NCT03817853|75927736|FG000|Maintenance/ Follow-up Phase|Adverse Event|0|||
42116766|NCT03817853|75927737|FG001|Maintenance/ Follow-up Phase|Adverse Event|1|||
42116767|NCT03817853|75927738|FG002|Maintenance/ Follow-up Phase|Adverse Event|0|||
42116768|NCT03817853|75927736|FG000|Maintenance/ Follow-up Phase|Death|0|||
42116769|NCT03817853|75927737|FG001|Maintenance/ Follow-up Phase|Death|1|||
42116770|NCT03817853|75927738|FG002|Maintenance/ Follow-up Phase|Death|1|||
42116771|NCT03817853|75927736|FG000|Maintenance/ Follow-up Phase|Progressive Disease|0|||
42116772|NCT03817853|75927737|FG001|Maintenance/ Follow-up Phase|Progressive Disease|1|||
42116773|NCT03817853|75927738|FG002|Maintenance/ Follow-up Phase|Progressive Disease|3|||
42116774|NCT03817853|75927736|FG000|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
42116775|NCT03817853|75927737|FG001|Maintenance/ Follow-up Phase|Withdrawal by Subject|1|||
42116776|NCT03817853|75927738|FG002|Maintenance/ Follow-up Phase|Withdrawal by Subject|0|||
42116777|NCT03817853|75927736|FG000|Maintenance/ Follow-up Phase|Continuing on Study|0|||
42116778|NCT03817853|75927737|FG001|Maintenance/ Follow-up Phase|Continuing on Study|52|||
42299772|NCT02545543|76134811|FG000|Overall Study|Withdrawal by Subject|9|||
42299773|NCT02545543|76134812|FG001|Overall Study|Withdrawal by Subject|8|||
42299774|NCT02545543|76134811|FG000|Overall Study|Noncomplaince|1|||
42299775|NCT02545543|76134812|FG001|Overall Study|Noncomplaince|0|||
42299776|NCT02545543|76134811|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
42299777|NCT02545543|76134812|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
42116779|NCT03817853|75927738|FG002|Maintenance/ Follow-up Phase|Continuing on Study|2|||
42116780|NCT00439270|75927751|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
42116781|NCT00439270|75927752|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
42116782|NCT00439270|75927753|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
42116783|NCT00439270|75927754|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
42116784|NCT00439270|75927755|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
42116785|NCT00439270|75927751|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
42116786|NCT00439270|75927752|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
42116787|NCT00439270|75927753|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
42116788|NCT00439270|75927754|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
42116789|NCT00439270|75927755|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
42116790|NCT00439270|75927751|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
42116791|NCT00439270|75927752|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
42116792|NCT00439270|75927753|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
42116793|NCT00439270|75927754|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
42116794|NCT00439270|75927755|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
42116795|NCT00439270|75927751|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
42116796|NCT00439270|75927752|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
42116797|NCT00439270|75927753|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
42116798|NCT00439270|75927754|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
42116799|NCT00439270|75927755|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
42116800|NCT00439270|75927751|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
42116801|NCT00439270|75927752|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
42116802|NCT00439270|75927753|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
42116803|NCT00439270|75927754|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
42116804|NCT00439270|75927755|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
42116805|NCT00439270|75927751|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
42116806|NCT00439270|75927752|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
42116807|NCT00439270|75927753|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
42116808|NCT00439270|75927754|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
42116809|NCT00439270|75927755|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
42116810|NCT00439270|75927751|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
42116811|NCT00439270|75927752|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
42116812|NCT00439270|75927753|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
42116813|NCT00439270|75927754|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
42116814|NCT00439270|75927755|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
42116815|NCT00439270|75927751|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
42116816|NCT00439270|75927752|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
42116817|NCT00439270|75927753|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
42116818|NCT00439270|75927754|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
42116819|NCT00439270|75927755|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
42116820|NCT00439270|75927751|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
42116821|NCT00439270|75927752|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
42116822|NCT00439270|75927753|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
42116823|NCT00439270|75927754|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
42116824|NCT00439270|75927755|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
42116825|NCT00439270|75927751|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
42116826|NCT00439270|75927752|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
42116827|NCT00439270|75927753|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
42116828|NCT00439270|75927754|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
42116829|NCT00439270|75927755|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
42116830|NCT00553280|75927774|FG000|Overall Study|Adverse Event|19|||
42116831|NCT00553280|75927774|FG000|Overall Study|Lack of Efficacy|3|||
42116832|NCT00553280|75927774|FG000|Overall Study|Withdrawal by Subject|3|||
42116833|NCT00553280|75927774|FG000|Overall Study|Physician Decision|1|||
42116834|NCT00440518|75927781|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
42116835|NCT00440518|75927782|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
42116836|NCT00440518|75927783|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
42116837|NCT00440518|75927781|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
42116838|NCT00440518|75927782|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
42116839|NCT00440518|75927783|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
42116840|NCT00440518|75927781|FG000|Randomized /Titration Period|Protocol Deviation|1|||
42116841|NCT00440518|75927782|FG001|Randomized /Titration Period|Protocol Deviation|0|||
42116842|NCT00440518|75927783|FG002|Randomized /Titration Period|Protocol Deviation|0|||
42116843|NCT00440518|75927781|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
42116844|NCT00440518|75927782|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
42116845|NCT00440518|75927783|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
42116846|NCT00440518|75927781|FG000|Randomized /Titration Period|Other|1|||
42116847|NCT00440518|75927782|FG001|Randomized /Titration Period|Other|0|||
42116848|NCT00440518|75927783|FG002|Randomized /Titration Period|Other|0|||
42116849|NCT00440518|75927781|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
42116850|NCT00440518|75927782|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
42116851|NCT00440518|75927783|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
42116852|NCT00440518|75927781|FG000|Randomized /Titration Period|Adverse Event|2|||
42116853|NCT00440518|75927782|FG001|Randomized /Titration Period|Adverse Event|3|||
42116854|NCT00440518|75927783|FG002|Randomized /Titration Period|Adverse Event|0|||
42116855|NCT00440518|75927781|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
42116856|NCT00440518|75927782|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
42116857|NCT00440518|75927783|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
42116858|NCT00440518|75927781|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
42116859|NCT00440518|75927782|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
42116860|NCT00440518|75927783|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
42116861|NCT00440518|75927781|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
42116862|NCT00440518|75927782|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
42116863|NCT00440518|75927783|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
42116864|NCT00440518|75927781|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
42116865|NCT00440518|75927782|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
42116866|NCT00440518|75927783|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
42116867|NCT00440518|75927781|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
42116868|NCT00440518|75927782|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
42116869|NCT00440518|75927783|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
42116870|NCT00440518|75927781|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
42116871|NCT00440518|75927782|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
42116872|NCT00440518|75927783|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
42116873|NCT00438256|75927791|FG000|Overall Study|Ineligible for Resection|2|||
42116874|NCT00438256|75927792|FG001|Overall Study|Ineligible for Resection|1|||
42116875|NCT00438256|75927793|FG002|Overall Study|Ineligible for Resection|1|||
42116876|NCT00438256|75927794|FG003|Overall Study|Ineligible for Resection|7|||
42116877|NCT00438256|75927791|FG000|Overall Study|Excluded final Diagnosis|0|||
42116878|NCT00438256|75927792|FG001|Overall Study|Excluded final Diagnosis|0|||
42116879|NCT00438256|75927793|FG002|Overall Study|Excluded final Diagnosis|0|||
42116880|NCT00438256|75927794|FG003|Overall Study|Excluded final Diagnosis|2|||
42116881|NCT00436852|75927813|FG000|Overall Study|Death|23|||
42116882|NCT00436852|75927814|FG001|Overall Study|Death|34|||
42116883|NCT00436852|75927813|FG000|Overall Study|Lack of Efficacy|9|||
42116884|NCT00436852|75927814|FG001|Overall Study|Lack of Efficacy|7|||
42116885|NCT00436852|75927813|FG000|Overall Study|Withdrawal by Subject|2|||
42116886|NCT00436852|75927814|FG001|Overall Study|Withdrawal by Subject|4|||
42116887|NCT00436852|75927813|FG000|Overall Study|Ineligible|1|||
42116888|NCT00436852|75927814|FG001|Overall Study|Ineligible|0|||
42116889|NCT00120289|75927825|FG000|Overall Study|Death|96|||
42116890|NCT00120289|75927826|FG001|Overall Study|Death|82|||
42116891|NCT00120289|75927825|FG000|Overall Study|Lost to Follow-up|11|||
42116892|NCT00120289|75927826|FG001|Overall Study|Lost to Follow-up|14|||
42116893|NCT00120289|75927825|FG000|Overall Study|Withdrawal by Subject|14|||
42116894|NCT00120289|75927826|FG001|Overall Study|Withdrawal by Subject|13|||
42116895|NCT00550446|75927839|FG000|Up To Week 12|Adverse Event|2|||
42116896|NCT00550446|75927840|FG001|Up To Week 12|Adverse Event|2|||
42116897|NCT00550446|75927841|FG002|Up To Week 12|Adverse Event|0|||
42116898|NCT00550446|75927842|FG003|Up To Week 12|Adverse Event|0|||
42116899|NCT00550446|75927843|FG004|Up To Week 12|Adverse Event|2|||
42116900|NCT00550446|75927844|FG005|Up To Week 12|Adverse Event|2|||
42116901|NCT00550446|75927845|FG006|Up To Week 12|Adverse Event|1|||
42116902|NCT00550446|75927846|FG007|Up To Week 12|Adverse Event|0|||
42116903|NCT00550446|75927847|FG008|Up To Week 12|Adverse Event|0|||
42116904|NCT00550446|75927848|FG009|Up To Week 12|Adverse Event|0|||
42116905|NCT00550446|75927849|FG010|Up To Week 12|Adverse Event|0|||
42116906|NCT00550446|75927839|FG000|Up To Week 12|Lack of Efficacy|3|||
42116907|NCT00550446|75927840|FG001|Up To Week 12|Lack of Efficacy|1|||
42116908|NCT00550446|75927841|FG002|Up To Week 12|Lack of Efficacy|0|||
42116909|NCT00550446|75927842|FG003|Up To Week 12|Lack of Efficacy|1|||
42116910|NCT00550446|75927843|FG004|Up To Week 12|Lack of Efficacy|0|||
42116911|NCT00550446|75927844|FG005|Up To Week 12|Lack of Efficacy|3|||
42116912|NCT00550446|75927845|FG006|Up To Week 12|Lack of Efficacy|3|||
42116913|NCT00550446|75927846|FG007|Up To Week 12|Lack of Efficacy|0|||
42116914|NCT00550446|75927847|FG008|Up To Week 12|Lack of Efficacy|0|||
42116915|NCT00550446|75927848|FG009|Up To Week 12|Lack of Efficacy|0|||
42116916|NCT00550446|75927849|FG010|Up To Week 12|Lack of Efficacy|0|||
42116917|NCT00550446|75927839|FG000|Up To Week 12|Lost to Follow-up|0|||
42116918|NCT00550446|75927840|FG001|Up To Week 12|Lost to Follow-up|1|||
42116919|NCT00550446|75927841|FG002|Up To Week 12|Lost to Follow-up|0|||
42116920|NCT00550446|75927842|FG003|Up To Week 12|Lost to Follow-up|0|||
42116921|NCT00550446|75927843|FG004|Up To Week 12|Lost to Follow-up|1|||
42116922|NCT00550446|75927844|FG005|Up To Week 12|Lost to Follow-up|1|||
42116923|NCT00550446|75927845|FG006|Up To Week 12|Lost to Follow-up|2|||
42116924|NCT00550446|75927846|FG007|Up To Week 12|Lost to Follow-up|0|||
42116925|NCT00550446|75927847|FG008|Up To Week 12|Lost to Follow-up|0|||
42116926|NCT00550446|75927848|FG009|Up To Week 12|Lost to Follow-up|0|||
42116927|NCT00550446|75927849|FG010|Up To Week 12|Lost to Follow-up|0|||
42116928|NCT00550446|75927839|FG000|Up To Week 12|Withdrawal by Subject|2|||
42116929|NCT00550446|75927840|FG001|Up To Week 12|Withdrawal by Subject|0|||
42116930|NCT00550446|75927841|FG002|Up To Week 12|Withdrawal by Subject|3|||
42116931|NCT00550446|75927842|FG003|Up To Week 12|Withdrawal by Subject|2|||
42116932|NCT00550446|75927843|FG004|Up To Week 12|Withdrawal by Subject|0|||
42116933|NCT00550446|75927844|FG005|Up To Week 12|Withdrawal by Subject|1|||
42116934|NCT00550446|75927845|FG006|Up To Week 12|Withdrawal by Subject|3|||
42116935|NCT00550446|75927846|FG007|Up To Week 12|Withdrawal by Subject|0|||
42116936|NCT00550446|75927847|FG008|Up To Week 12|Withdrawal by Subject|0|||
42116937|NCT00550446|75927848|FG009|Up To Week 12|Withdrawal by Subject|0|||
42116938|NCT00550446|75927849|FG010|Up To Week 12|Withdrawal by Subject|0|||
42116939|NCT00550446|75927839|FG000|Up To Week 12|Other|3|||
42116940|NCT00550446|75927840|FG001|Up To Week 12|Other|0|||
42116941|NCT00550446|75927841|FG002|Up To Week 12|Other|0|||
42116942|NCT00550446|75927842|FG003|Up To Week 12|Other|0|||
42116943|NCT00550446|75927843|FG004|Up To Week 12|Other|0|||
42116944|NCT00550446|75927844|FG005|Up To Week 12|Other|1|||
42116945|NCT00550446|75927845|FG006|Up To Week 12|Other|4|||
42116946|NCT00550446|75927846|FG007|Up To Week 12|Other|0|||
42116947|NCT00550446|75927847|FG008|Up To Week 12|Other|0|||
42116948|NCT00550446|75927848|FG009|Up To Week 12|Other|0|||
42116949|NCT00550446|75927849|FG010|Up To Week 12|Other|0|||
42116950|NCT00550446|75927839|FG000|Up To Week 12|Randomized not treated|0|||
42116951|NCT00550446|75927840|FG001|Up To Week 12|Randomized not treated|1|||
42116952|NCT00550446|75927841|FG002|Up To Week 12|Randomized not treated|1|||
42116953|NCT00550446|75927842|FG003|Up To Week 12|Randomized not treated|0|||
42116954|NCT00550446|75927843|FG004|Up To Week 12|Randomized not treated|0|||
42116955|NCT00550446|75927844|FG005|Up To Week 12|Randomized not treated|0|||
42116956|NCT00550446|75927845|FG006|Up To Week 12|Randomized not treated|0|||
42116957|NCT00550446|75927846|FG007|Up To Week 12|Randomized not treated|0|||
42116958|NCT00550446|75927847|FG008|Up To Week 12|Randomized not treated|0|||
42116959|NCT00550446|75927848|FG009|Up To Week 12|Randomized not treated|0|||
42116960|NCT00550446|75927849|FG010|Up To Week 12|Randomized not treated|0|||
42116961|NCT00550446|75927839|FG000|Post Week 12|Adverse Event|2|||
42116962|NCT00550446|75927840|FG001|Post Week 12|Adverse Event|1|||
42116963|NCT00550446|75927841|FG002|Post Week 12|Adverse Event|1|||
42116964|NCT00550446|75927842|FG003|Post Week 12|Adverse Event|1|||
42116965|NCT00550446|75927843|FG004|Post Week 12|Adverse Event|1|||
42116966|NCT00550446|75927844|FG005|Post Week 12|Adverse Event|1|||
42116967|NCT00550446|75927845|FG006|Post Week 12|Adverse Event|0|||
42116968|NCT00550446|75927846|FG007|Post Week 12|Adverse Event|0|||
42116969|NCT00550446|75927847|FG008|Post Week 12|Adverse Event|0|||
42116970|NCT00550446|75927848|FG009|Post Week 12|Adverse Event|4|||
42116971|NCT00550446|75927849|FG010|Post Week 12|Adverse Event|0|||
42116972|NCT00550446|75927839|FG000|Post Week 12|Lack of Efficacy|0|||
42116973|NCT00550446|75927840|FG001|Post Week 12|Lack of Efficacy|0|||
42116974|NCT00550446|75927841|FG002|Post Week 12|Lack of Efficacy|1|||
42116975|NCT00550446|75927842|FG003|Post Week 12|Lack of Efficacy|0|||
42116976|NCT00550446|75927843|FG004|Post Week 12|Lack of Efficacy|0|||
42116977|NCT00550446|75927844|FG005|Post Week 12|Lack of Efficacy|0|||
42116978|NCT00550446|75927845|FG006|Post Week 12|Lack of Efficacy|0|||
42116979|NCT00550446|75927846|FG007|Post Week 12|Lack of Efficacy|1|||
42116980|NCT00550446|75927847|FG008|Post Week 12|Lack of Efficacy|1|||
42116981|NCT00550446|75927848|FG009|Post Week 12|Lack of Efficacy|2|||
42116982|NCT00550446|75927849|FG010|Post Week 12|Lack of Efficacy|1|||
42116983|NCT00550446|75927839|FG000|Post Week 12|Lost to Follow-up|0|||
42116984|NCT00550446|75927840|FG001|Post Week 12|Lost to Follow-up|0|||
42116985|NCT00550446|75927841|FG002|Post Week 12|Lost to Follow-up|1|||
42116986|NCT00550446|75927842|FG003|Post Week 12|Lost to Follow-up|1|||
42116987|NCT00550446|75927843|FG004|Post Week 12|Lost to Follow-up|0|||
42116988|NCT00550446|75927844|FG005|Post Week 12|Lost to Follow-up|0|||
42116989|NCT00550446|75927845|FG006|Post Week 12|Lost to Follow-up|1|||
42116990|NCT00550446|75927846|FG007|Post Week 12|Lost to Follow-up|0|||
42116991|NCT00550446|75927847|FG008|Post Week 12|Lost to Follow-up|0|||
42116992|NCT00550446|75927848|FG009|Post Week 12|Lost to Follow-up|0|||
42116993|NCT00550446|75927849|FG010|Post Week 12|Lost to Follow-up|0|||
42116994|NCT00550446|75927839|FG000|Post Week 12|Withdrawal by Subject|0|||
42116995|NCT00550446|75927840|FG001|Post Week 12|Withdrawal by Subject|0|||
42116996|NCT00550446|75927841|FG002|Post Week 12|Withdrawal by Subject|0|||
42116997|NCT00550446|75927842|FG003|Post Week 12|Withdrawal by Subject|0|||
42116998|NCT00550446|75927843|FG004|Post Week 12|Withdrawal by Subject|1|||
42116999|NCT00550446|75927844|FG005|Post Week 12|Withdrawal by Subject|0|||
42117000|NCT00550446|75927845|FG006|Post Week 12|Withdrawal by Subject|0|||
42117001|NCT00550446|75927846|FG007|Post Week 12|Withdrawal by Subject|0|||
42117002|NCT00550446|75927847|FG008|Post Week 12|Withdrawal by Subject|0|||
42117003|NCT00550446|75927848|FG009|Post Week 12|Withdrawal by Subject|0|||
42117004|NCT00550446|75927849|FG010|Post Week 12|Withdrawal by Subject|0|||
42117005|NCT00550446|75927839|FG000|Post Week 12|Other|1|||
42117006|NCT00550446|75927840|FG001|Post Week 12|Other|1|||
42117007|NCT00550446|75927841|FG002|Post Week 12|Other|0|||
42117008|NCT00550446|75927842|FG003|Post Week 12|Other|1|||
42117009|NCT00550446|75927843|FG004|Post Week 12|Other|0|||
42117010|NCT00550446|75927844|FG005|Post Week 12|Other|0|||
42117011|NCT00550446|75927845|FG006|Post Week 12|Other|1|||
42117012|NCT00550446|75927846|FG007|Post Week 12|Other|0|||
42117013|NCT00550446|75927847|FG008|Post Week 12|Other|1|||
42117014|NCT00550446|75927848|FG009|Post Week 12|Other|1|||
42117015|NCT00550446|75927849|FG010|Post Week 12|Other|0|||
42117016|NCT00436618|75927890|FG000|Overall Study|Withdrawal by Subject|5|||
42117017|NCT00436618|75927891|FG001|Overall Study|Withdrawal by Subject|8|||
42117018|NCT00436618|75927892|FG002|Overall Study|Withdrawal by Subject|11|||
42117019|NCT00436618|75927890|FG000|Overall Study|Adverse Event|8|||
42117020|NCT00436618|75927891|FG001|Overall Study|Adverse Event|8|||
42117021|NCT00436618|75927892|FG002|Overall Study|Adverse Event|9|||
42117022|NCT00436618|75927890|FG000|Overall Study|Alternate Treatment|3|||
42117023|NCT00436618|75927891|FG001|Overall Study|Alternate Treatment|4|||
42117024|NCT00436618|75927892|FG002|Overall Study|Alternate Treatment|12|||
42117025|NCT00436618|75927890|FG000|Overall Study|Other Medical Problems|3|||
42117026|NCT00436618|75927891|FG001|Overall Study|Other Medical Problems|1|||
42117027|NCT00436618|75927892|FG002|Overall Study|Other Medical Problems|7|||
42117028|NCT00436618|75927890|FG000|Overall Study|Death|4|||
42117029|NCT00436618|75927891|FG001|Overall Study|Death|2|||
42117030|NCT00436618|75927892|FG002|Overall Study|Death|3|||
42117031|NCT00436618|75927890|FG000|Overall Study|New Primary or Other Reasons|6|||
42117032|NCT00436618|75927891|FG001|Overall Study|New Primary or Other Reasons|2|||
42117033|NCT00436618|75927892|FG002|Overall Study|New Primary or Other Reasons|12|||
42117034|NCT00436618|75927890|FG000|Overall Study|Still on treatment|1|||
42117035|NCT00436618|75927891|FG001|Overall Study|Still on treatment|2|||
42117036|NCT00436618|75927892|FG002|Overall Study|Still on treatment|7|||
42117037|NCT00548808|75927929|FG000|Overall Study|Lost to Follow-up|9|||
42117038|NCT00548808|75927930|FG001|Overall Study|Lost to Follow-up|3|||
42117039|NCT00548808|75927929|FG000|Overall Study|Protocol Violation|8|||
42117040|NCT00548808|75927930|FG001|Overall Study|Protocol Violation|8|||
42117041|NCT00548808|75927929|FG000|Overall Study|Withdrawal by Subject|8|||
42117042|NCT00548808|75927930|FG001|Overall Study|Withdrawal by Subject|4|||
42117043|NCT00548808|75927929|FG000|Overall Study|Physician Decision|6|||
42117044|NCT00548808|75927930|FG001|Overall Study|Physician Decision|3|||
42117045|NCT00548808|75927929|FG000|Overall Study|Adverse Event|4|||
42117046|NCT00548808|75927930|FG001|Overall Study|Adverse Event|5|||
42117047|NCT00548808|75927929|FG000|Overall Study|Death|2|||
42117048|NCT00548808|75927930|FG001|Overall Study|Death|0|||
42117049|NCT00548808|75927929|FG000|Overall Study|Entry Criteria Not Met|2|||
42117050|NCT00548808|75927930|FG001|Overall Study|Entry Criteria Not Met|2|||
42117051|NCT00548808|75927929|FG000|Overall Study|Lack of Efficacy|2|||
42117052|NCT00548808|75927930|FG001|Overall Study|Lack of Efficacy|0|||
42117053|NCT00548808|75927929|FG000|Overall Study|Sponsor Decision|1|||
42117054|NCT00548808|75927930|FG001|Overall Study|Sponsor Decision|1|||
42117055|NCT00110617|75927938|FG000|Overall Study|Adverse Event|2|||
42117056|NCT00110617|75927939|FG001|Overall Study|Adverse Event|4|||
42117057|NCT00110617|75927938|FG000|Overall Study|Abnormal Laboratory Value|4|||
42117058|NCT00110617|75927939|FG001|Overall Study|Abnormal Laboratory Value|2|||
42117059|NCT00110617|75927938|FG000|Overall Study|Lack of Efficacy|1|||
42117060|NCT00110617|75927939|FG001|Overall Study|Lack of Efficacy|0|||
42117061|NCT00110617|75927938|FG000|Overall Study|Patient no longer requires study drug|1|||
42117062|NCT00110617|75927939|FG001|Overall Study|Patient no longer requires study drug|0|||
42117063|NCT00110617|75927938|FG000|Overall Study|Protocol Violation|5|||
42117064|NCT00110617|75927939|FG001|Overall Study|Protocol Violation|0|||
42117065|NCT00110617|75927938|FG000|Overall Study|Withdrawal by Subject|10|||
42117066|NCT00110617|75927939|FG001|Overall Study|Withdrawal by Subject|4|||
42117067|NCT00110617|75927938|FG000|Overall Study|Lost to Follow-up|9|||
42117068|NCT00110617|75927939|FG001|Overall Study|Lost to Follow-up|1|||
42117069|NCT00110617|75927938|FG000|Overall Study|Administrative problems|6|||
42117070|NCT00110617|75927939|FG001|Overall Study|Administrative problems|5|||
42117071|NCT00110617|75927938|FG000|Overall Study|Death|1|||
42117072|NCT00110617|75927939|FG001|Overall Study|Death|1|||
42117073|NCT00110617|75927938|FG000|Overall Study|Did not receive study drug|0|||
42117074|NCT00110617|75927939|FG001|Overall Study|Did not receive study drug|12|||
42117075|NCT03956862|75927949|FG000|Overall Study|Lost to Follow-up|1|||
42117076|NCT03956862|75927950|FG001|Overall Study|Lost to Follow-up|1|||
42117077|NCT03956862|75927949|FG000|Overall Study|Withdrawal by Subject|1|||
42117078|NCT03956862|75927950|FG001|Overall Study|Withdrawal by Subject|1|||
42117079|NCT00550238|75927956|FG000|Overall Study|Adverse Event|88|||
42117080|NCT00550238|75927956|FG000|Overall Study|Death|34|||
42117081|NCT00550238|75927956|FG000|Overall Study|Disease progression|46|||
42117082|NCT00550238|75927956|FG000|Overall Study|Withdrawal by Subject|167|||
42117083|NCT00550238|75927956|FG000|Overall Study|Physician Decision|31|||
42117084|NCT00550238|75927956|FG000|Overall Study|Patient noncompliance|25|||
42117085|NCT00550238|75927956|FG000|Overall Study|Lost to Follow-up|13|||
42117086|NCT00550238|75927956|FG000|Overall Study|Sponsor decision|55|||
42117087|NCT03956550|75927963|FG000|Overall Study|Sponsor decision|65|||
42117088|NCT03956550|75927964|FG001|Overall Study|Sponsor decision|66|||
42117089|NCT03956550|75927965|FG002|Overall Study|Sponsor decision|64|||
42117090|NCT03956550|75927963|FG000|Overall Study|Adverse Event|0|||
42117091|NCT03956550|75927964|FG001|Overall Study|Adverse Event|1|||
42117092|NCT03956550|75927965|FG002|Overall Study|Adverse Event|0|||
42117093|NCT03956550|75927963|FG000|Overall Study|Withdrawal by Subject|5|||
42117094|NCT03956550|75927964|FG001|Overall Study|Withdrawal by Subject|5|||
42117095|NCT03956550|75927965|FG002|Overall Study|Withdrawal by Subject|6|||
42117096|NCT00110305|75927977|FG000|Overall Study|Adverse Event|46|||
42117097|NCT00110305|75927978|FG001|Overall Study|Adverse Event|13|||
42117098|NCT00110305|75927977|FG000|Overall Study|Sponsors Decision|1|||
42117099|NCT00110305|75927978|FG001|Overall Study|Sponsors Decision|0|||
42117100|NCT00110305|75927977|FG000|Overall Study|Subject Non-Compliant|9|||
42117101|NCT00110305|75927978|FG001|Overall Study|Subject Non-Compliant|2|||
42117102|NCT00110305|75927977|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
42117103|NCT00110305|75927978|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
42117104|NCT00110305|75927977|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
42117105|NCT00110305|75927978|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
42117106|NCT00110305|75927977|FG000|Overall Study|Protocol Violation|0|||
42117107|NCT00110305|75927978|FG001|Overall Study|Protocol Violation|1|||
42117108|NCT00110305|75927977|FG000|Overall Study|Withdrawal by Subject|7|||
42117109|NCT00110305|75927978|FG001|Overall Study|Withdrawal by Subject|7|||
42117110|NCT00110305|75927977|FG000|Overall Study|Lost to Follow-up|20|||
42117111|NCT00110305|75927978|FG001|Overall Study|Lost to Follow-up|3|||
42117112|NCT00110305|75927977|FG000|Overall Study|Other|8|||
42117113|NCT00110305|75927978|FG001|Overall Study|Other|2|||
42117114|NCT00428116|75927997|FG000|Overall Study|Death|1|||
42117115|NCT00428116|75927998|FG001|Overall Study|Death|0|||
42117116|NCT00428116|75927997|FG000|Overall Study|Withdrawal by Subject|1|||
42117117|NCT00428116|75927998|FG001|Overall Study|Withdrawal by Subject|0|||
42117118|NCT00428116|75927997|FG000|Overall Study|Lost to Follow-up|1|||
42117119|NCT00428116|75927998|FG001|Overall Study|Lost to Follow-up|0|||
42117120|NCT00560066|75928007|FG000|Overall Study|Death|2|||
42117121|NCT00560066|75928008|FG001|Overall Study|Death|1|||
42117122|NCT00560066|75928007|FG000|Overall Study|Withdrawal by Subject|0|||
42117123|NCT00560066|75928008|FG001|Overall Study|Withdrawal by Subject|3|||
42117124|NCT00560066|75928007|FG000|Overall Study|Lost to Follow-up|4|||
42117125|NCT00560066|75928008|FG001|Overall Study|Lost to Follow-up|10|||
42117126|NCT00560066|75928007|FG000|Overall Study|Protocol Violation|0|||
42117127|NCT00560066|75928008|FG001|Overall Study|Protocol Violation|1|||
42117128|NCT00560066|75928007|FG000|Overall Study|Administrative reason|0|||
42117129|NCT00560066|75928008|FG001|Overall Study|Administrative reason|5|||
42117130|NCT00560066|75928007|FG000|Overall Study|Missing primary reason|0|||
42117131|NCT00560066|75928008|FG001|Overall Study|Missing primary reason|2|||
42117132|NCT00549900|75928019|FG000|Overall Study|Adverse Event|1|||
42117133|NCT00435994|75928026|FG000|Overall Study|Lost to Follow-up|7|||
42117134|NCT00435994|75928027|FG001|Overall Study|Lost to Follow-up|0|||
42117135|NCT00435994|75928028|FG002|Overall Study|Lost to Follow-up|0|||
42117136|NCT00435370|75928039|FG000|Overall Study|Adverse Event|8|||
42117137|NCT00435370|75928040|FG001|Overall Study|Adverse Event|8|||
42117138|NCT00435370|75928039|FG000|Overall Study|Withdrawal by Subject|10|||
42117139|NCT00435370|75928040|FG001|Overall Study|Withdrawal by Subject|10|||
42117140|NCT00435370|75928039|FG000|Overall Study|Antipsychotic medication changed|4|||
42117141|NCT00435370|75928040|FG001|Overall Study|Antipsychotic medication changed|2|||
42117142|NCT00096031|75928046|FG000|Overall Study|Adverse Event|3|||
42117143|NCT00096031|75928046|FG000|Overall Study|Lack of Efficacy|42|||
42117144|NCT00096031|75928046|FG000|Overall Study|Death|4|||
42117145|NCT00096031|75928046|FG000|Overall Study|Withdrawal by Subject|1|||
42117146|NCT00096031|75928046|FG000|Overall Study|Ineligible|8|||
42117147|NCT00096031|75928046|FG000|Overall Study|Not protocol specified|5|||
42117148|NCT00118417|75928050|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
42117149|NCT00118417|75928051|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
42117150|NCT00118417|75928050|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
42117151|NCT00118417|75928051|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
42117152|NCT00118417|75928050|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
42117153|NCT00118417|75928051|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
42117154|NCT00118417|75928050|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
42117155|NCT00118417|75928051|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
42117156|NCT00118417|75928050|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
42117157|NCT00118417|75928051|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
42117158|NCT00549848|75928064|FG000|Overall Study|Death|1|||
42117159|NCT00549848|75928065|FG001|Overall Study|Death|4|||
42117160|NCT00549848|75928066|FG002|Overall Study|Death|13|||
42117161|NCT00549848|75928064|FG000|Overall Study|Physician Decision|0|||
42117162|NCT00549848|75928065|FG001|Overall Study|Physician Decision|0|||
42117163|NCT00549848|75928066|FG002|Overall Study|Physician Decision|4|||
42117164|NCT00549848|75928064|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
42117165|NCT00549848|75928065|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
42117166|NCT00549848|75928066|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
42117167|NCT00549848|75928064|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
42117168|NCT00549848|75928065|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
42117169|NCT00549848|75928066|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
42117170|NCT00549848|75928064|FG000|Overall Study|Participant/Family Withdraw|2|||
42117171|NCT00549848|75928065|FG001|Overall Study|Participant/Family Withdraw|3|||
42117172|NCT00549848|75928066|FG002|Overall Study|Participant/Family Withdraw|5|||
42117173|NCT00549848|75928064|FG000|Overall Study|Second Malignancy|1|||
42117174|NCT00549848|75928065|FG001|Overall Study|Second Malignancy|0|||
42117175|NCT00549848|75928066|FG002|Overall Study|Second Malignancy|0|||
42117176|NCT00549848|75928064|FG000|Overall Study|Transplant|3|||
42117177|NCT00549848|75928065|FG001|Overall Study|Transplant|3|||
42117178|NCT00549848|75928066|FG002|Overall Study|Transplant|18|||
42117179|NCT00549848|75928064|FG000|Overall Study|Unacceptable Toxicity|1|||
42117180|NCT00549848|75928065|FG001|Overall Study|Unacceptable Toxicity|6|||
42117181|NCT00549848|75928066|FG002|Overall Study|Unacceptable Toxicity|6|||
42117182|NCT00549770|75928090|FG000|Overall Study|Protocol deviation|1|||
42117183|NCT00549770|75928091|FG001|Overall Study|Protocol deviation|1|||
42117184|NCT00549770|75928092|FG002|Overall Study|Protocol deviation|1|||
42117185|NCT00549770|75928093|FG003|Overall Study|Protocol deviation|2|||
42117186|NCT00549770|75928094|FG004|Overall Study|Protocol deviation|2|||
42117187|NCT00549770|75928095|FG005|Overall Study|Protocol deviation|2|||
42117188|NCT00549770|75928096|FG006|Overall Study|Protocol deviation|1|||
42117189|NCT00549770|75928097|FG007|Overall Study|Protocol deviation|2|||
42117190|NCT00549770|75928090|FG000|Overall Study|Administrative problems|0|||
42117191|NCT00549770|75928091|FG001|Overall Study|Administrative problems|1|||
42117192|NCT00549770|75928092|FG002|Overall Study|Administrative problems|0|||
42117193|NCT00549770|75928093|FG003|Overall Study|Administrative problems|0|||
42117194|NCT00549770|75928094|FG004|Overall Study|Administrative problems|0|||
42117195|NCT00549770|75928095|FG005|Overall Study|Administrative problems|0|||
42117196|NCT00549770|75928096|FG006|Overall Study|Administrative problems|0|||
42117197|NCT00549770|75928097|FG007|Overall Study|Administrative problems|1|||
42117198|NCT00549770|75928090|FG000|Overall Study|Lost to Follow-up|0|||
42117199|NCT00549770|75928091|FG001|Overall Study|Lost to Follow-up|0|||
42117200|NCT00549770|75928092|FG002|Overall Study|Lost to Follow-up|2|||
42117201|NCT00549770|75928093|FG003|Overall Study|Lost to Follow-up|2|||
42117202|NCT00549770|75928094|FG004|Overall Study|Lost to Follow-up|3|||
42117203|NCT00549770|75928095|FG005|Overall Study|Lost to Follow-up|2|||
42117204|NCT00549770|75928096|FG006|Overall Study|Lost to Follow-up|0|||
42117205|NCT00549770|75928097|FG007|Overall Study|Lost to Follow-up|0|||
42117206|NCT00549770|75928090|FG000|Overall Study|Withdrawal by Subject|4|||
42117207|NCT00549770|75928091|FG001|Overall Study|Withdrawal by Subject|6|||
42117208|NCT00549770|75928092|FG002|Overall Study|Withdrawal by Subject|4|||
42117209|NCT00549770|75928093|FG003|Overall Study|Withdrawal by Subject|5|||
42117210|NCT00549770|75928094|FG004|Overall Study|Withdrawal by Subject|6|||
42117211|NCT00549770|75928095|FG005|Overall Study|Withdrawal by Subject|6|||
42117212|NCT00549770|75928096|FG006|Overall Study|Withdrawal by Subject|4|||
42117213|NCT00549770|75928097|FG007|Overall Study|Withdrawal by Subject|9|||
42117214|NCT00549770|75928090|FG000|Overall Study|Lack of Efficacy|1|||
42117215|NCT00549770|75928091|FG001|Overall Study|Lack of Efficacy|0|||
42117216|NCT00549770|75928092|FG002|Overall Study|Lack of Efficacy|2|||
42117217|NCT00549770|75928093|FG003|Overall Study|Lack of Efficacy|3|||
42117218|NCT00549770|75928094|FG004|Overall Study|Lack of Efficacy|5|||
42117219|NCT00549770|75928095|FG005|Overall Study|Lack of Efficacy|1|||
42117220|NCT00549770|75928096|FG006|Overall Study|Lack of Efficacy|3|||
42117221|NCT00549770|75928097|FG007|Overall Study|Lack of Efficacy|8|||
42117222|NCT00549770|75928090|FG000|Overall Study|Abnormal test procedure results|0|||
42117223|NCT00549770|75928091|FG001|Overall Study|Abnormal test procedure results|0|||
42117224|NCT00549770|75928092|FG002|Overall Study|Abnormal test procedure results|0|||
42117225|NCT00549770|75928093|FG003|Overall Study|Abnormal test procedure results|2|||
42117226|NCT00549770|75928094|FG004|Overall Study|Abnormal test procedure results|0|||
42117227|NCT00549770|75928095|FG005|Overall Study|Abnormal test procedure results|1|||
42117228|NCT00549770|75928096|FG006|Overall Study|Abnormal test procedure results|1|||
42117229|NCT00549770|75928097|FG007|Overall Study|Abnormal test procedure results|1|||
42117230|NCT00549770|75928090|FG000|Overall Study|Abnormal laboratory values|0|||
42117231|NCT00549770|75928091|FG001|Overall Study|Abnormal laboratory values|0|||
42117232|NCT00549770|75928092|FG002|Overall Study|Abnormal laboratory values|0|||
42117233|NCT00549770|75928093|FG003|Overall Study|Abnormal laboratory values|0|||
42117234|NCT00549770|75928094|FG004|Overall Study|Abnormal laboratory values|0|||
42117235|NCT00549770|75928095|FG005|Overall Study|Abnormal laboratory values|1|||
42299778|NCT02545075|76134822|FG000|Randomization|Lost to Follow-up|0|||
42117236|NCT00549770|75928096|FG006|Overall Study|Abnormal laboratory values|0|||
42117237|NCT00549770|75928097|FG007|Overall Study|Abnormal laboratory values|0|||
42117238|NCT00549770|75928090|FG000|Overall Study|Adverse Event|1|||
42117239|NCT00549770|75928091|FG001|Overall Study|Adverse Event|3|||
42117240|NCT00549770|75928092|FG002|Overall Study|Adverse Event|1|||
42117241|NCT00549770|75928093|FG003|Overall Study|Adverse Event|2|||
42117242|NCT00549770|75928094|FG004|Overall Study|Adverse Event|1|||
42117243|NCT00549770|75928095|FG005|Overall Study|Adverse Event|0|||
42117244|NCT00549770|75928096|FG006|Overall Study|Adverse Event|5|||
42117245|NCT00549770|75928097|FG007|Overall Study|Adverse Event|4|||
42117246|NCT00548184|75928115|FG000|Overall Study|Adverse Event|3|||
42117247|NCT00548184|75928115|FG000|Overall Study|took other drug|1|||
42117248|NCT00548184|75928115|FG000|Overall Study|Found Her2 negative|1|||
42117249|NCT00454636|75928123|FG000|Overall Study|Adverse Event|10|||
42117250|NCT00454636|75928124|FG001|Overall Study|Adverse Event|6|||
42117251|NCT00454636|75928125|FG002|Overall Study|Adverse Event|9|||
42117252|NCT00454636|75928126|FG003|Overall Study|Adverse Event|15|||
42117253|NCT00454636|75928123|FG000|Overall Study|Disease Progression|11|||
42117254|NCT00454636|75928124|FG001|Overall Study|Disease Progression|12|||
42117255|NCT00454636|75928125|FG002|Overall Study|Disease Progression|4|||
42117256|NCT00454636|75928126|FG003|Overall Study|Disease Progression|11|||
42117257|NCT00454636|75928123|FG000|Overall Study|Protocol Violation|3|||
42117258|NCT00454636|75928124|FG001|Overall Study|Protocol Violation|2|||
42117259|NCT00454636|75928125|FG002|Overall Study|Protocol Violation|3|||
42117260|NCT00454636|75928126|FG003|Overall Study|Protocol Violation|3|||
42117261|NCT00454636|75928123|FG000|Overall Study|Death|6|||
42117262|NCT00454636|75928124|FG001|Overall Study|Death|1|||
42117263|NCT00454636|75928125|FG002|Overall Study|Death|1|||
42117264|NCT00454636|75928126|FG003|Overall Study|Death|1|||
42117265|NCT00454636|75928123|FG000|Overall Study|Patient refusal|1|||
42117266|NCT00454636|75928124|FG001|Overall Study|Patient refusal|1|||
42117267|NCT00454636|75928125|FG002|Overall Study|Patient refusal|3|||
42117268|NCT00454636|75928126|FG003|Overall Study|Patient refusal|2|||
42117269|NCT00454636|75928123|FG000|Overall Study|Lost to Follow-up|0|||
42117270|NCT00454636|75928124|FG001|Overall Study|Lost to Follow-up|1|||
42117271|NCT00454636|75928125|FG002|Overall Study|Lost to Follow-up|0|||
42117272|NCT00454636|75928126|FG003|Overall Study|Lost to Follow-up|0|||
42117273|NCT00427960|75928138|FG000|Overall Study|Adverse Event|2|||
42117274|NCT00427960|75928139|FG001|Overall Study|Adverse Event|0|||
42117275|NCT00427960|75928138|FG000|Overall Study|Withdrawal by Subject|0|||
42117276|NCT00427960|75928139|FG001|Overall Study|Withdrawal by Subject|3|||
42117277|NCT00427960|75928138|FG000|Overall Study|Other|0|||
42117278|NCT00427960|75928139|FG001|Overall Study|Other|1|||
42117279|NCT00548340|75928148|FG000|Overall Study|Protocol Violation|2|||
42117280|NCT00548340|75928149|FG001|Overall Study|Protocol Violation|3|||
42117281|NCT00548340|75928150|FG002|Overall Study|Protocol Violation|3|||
42117282|NCT00548340|75928148|FG000|Overall Study|Adverse Event|2|||
42117283|NCT00548340|75928149|FG001|Overall Study|Adverse Event|2|||
42117284|NCT00548340|75928150|FG002|Overall Study|Adverse Event|2|||
42117285|NCT00548340|75928148|FG000|Overall Study|Lost to Follow-up|1|||
42117286|NCT00548340|75928149|FG001|Overall Study|Lost to Follow-up|1|||
42117287|NCT00548340|75928150|FG002|Overall Study|Lost to Follow-up|0|||
42117288|NCT00548340|75928148|FG000|Overall Study|Withdrawal by Subject|2|||
42117289|NCT00548340|75928149|FG001|Overall Study|Withdrawal by Subject|4|||
42117290|NCT00548340|75928150|FG002|Overall Study|Withdrawal by Subject|3|||
42117291|NCT00548340|75928148|FG000|Overall Study|Other|1|||
42117292|NCT00548340|75928149|FG001|Overall Study|Other|1|||
42117293|NCT00548340|75928150|FG002|Overall Study|Other|1|||
42117294|NCT00454246|75928161|FG000|Overall Study|Adverse Event|2|||
42117295|NCT00454246|75928162|FG001|Overall Study|Adverse Event|2|||
42117296|NCT00454246|75928163|FG002|Overall Study|Adverse Event|0|||
42117297|NCT00454246|75928161|FG000|Overall Study|Violation of selection criteria at entry|6|||
42117298|NCT00454246|75928162|FG001|Overall Study|Violation of selection criteria at entry|0|||
42117299|NCT00454246|75928163|FG002|Overall Study|Violation of selection criteria at entry|0|||
42117300|NCT00454246|75928161|FG000|Overall Study|Protocol Violation|1|||
42117301|NCT00454246|75928162|FG001|Overall Study|Protocol Violation|0|||
42117302|NCT00454246|75928163|FG002|Overall Study|Protocol Violation|0|||
42117303|NCT00454246|75928161|FG000|Overall Study|Refused Treatment|1|||
42117304|NCT00454246|75928162|FG001|Overall Study|Refused Treatment|1|||
42117305|NCT00454246|75928163|FG002|Overall Study|Refused Treatment|0|||
42117306|NCT00454246|75928161|FG000|Overall Study|Failure to return|1|||
42117307|NCT00454246|75928162|FG001|Overall Study|Failure to return|0|||
42117308|NCT00454246|75928163|FG002|Overall Study|Failure to return|0|||
42117309|NCT00454246|75928161|FG000|Overall Study|Early termination of study|62|||
42117310|NCT00454246|75928162|FG001|Overall Study|Early termination of study|26|||
42117311|NCT00454246|75928163|FG002|Overall Study|Early termination of study|9|||
42117312|NCT00434590|75928173|FG000|Overall Study|Administrative problems|5|||
42117313|NCT00434590|75928174|FG001|Overall Study|Administrative problems|5|||
42117314|NCT02891837|75928182|FG000|Overall Study|Lost to Follow-up|2|||
42117315|NCT02891837|75928183|FG001|Overall Study|Lost to Follow-up|0|||
42117316|NCT02891837|75928182|FG000|Overall Study|Withdrawal by Subject|1|||
42117317|NCT02891837|75928183|FG001|Overall Study|Withdrawal by Subject|0|||
42117318|NCT00695903|75928207|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
42117319|NCT00695903|75928208|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
42117320|NCT00695903|75928207|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
42117321|NCT00695903|75928208|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
42117322|NCT00695903|75928207|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
42117323|NCT00695903|75928208|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
42117324|NCT00695903|75928207|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
42117325|NCT00695903|75928208|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
42117326|NCT00695903|75928207|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
42117327|NCT00695903|75928208|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
42117328|NCT00695903|75928207|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
42117329|NCT00695903|75928208|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
42117330|NCT00695903|75928207|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
42117331|NCT00695903|75928208|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
42117332|NCT00695903|75928207|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
42117333|NCT00695903|75928208|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
42117334|NCT00695903|75928207|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
42117335|NCT00695903|75928208|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
42117336|NCT00548262|75928214|FG000|Overall Study|Death|21|||
42117337|NCT00548262|75928214|FG000|Overall Study|Adverse Event|2|||
42117338|NCT00548262|75928214|FG000|Overall Study|Lack of Efficacy|4|||
42117339|NCT00548262|75928214|FG000|Overall Study|Lost to Follow-up|1|||
42117340|NCT00548262|75928214|FG000|Overall Study|Other|3|||
42117341|NCT00548262|75928214|FG000|Overall Study|Withdrawal by Subject|1|||
42117342|NCT00095173|75928218|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
42117343|NCT00095173|75928219|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
42117344|NCT00095173|75928220|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
42117345|NCT00095173|75928221|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
42117346|NCT00095173|75928222|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
42117347|NCT00095173|75928223|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
42117348|NCT00095173|75928218|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
42117349|NCT00095173|75928219|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
42117350|NCT00095173|75928220|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
42117351|NCT00095173|75928221|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
42117352|NCT00095173|75928222|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
42117353|NCT00095173|75928223|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
42117354|NCT00095173|75928218|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
42117355|NCT00095173|75928219|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
42117356|NCT00095173|75928220|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
42117357|NCT00095173|75928221|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
42117358|NCT00095173|75928222|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
42117359|NCT00095173|75928223|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
42117360|NCT00095173|75928218|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
42117361|NCT00095173|75928219|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
42117362|NCT00095173|75928220|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
42117363|NCT00095173|75928221|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
42117364|NCT00095173|75928222|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
42117365|NCT00095173|75928223|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
42117366|NCT00095173|75928218|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
42117367|NCT00095173|75928219|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
42117368|NCT00095173|75928220|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
42117369|NCT00095173|75928221|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
42117370|NCT00095173|75928222|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
42117371|NCT00095173|75928223|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
42117372|NCT00095173|75928218|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
42117373|NCT00095173|75928219|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
42117374|NCT00095173|75928220|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
42117375|NCT00095173|75928221|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
42117376|NCT00095173|75928222|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
42117377|NCT00095173|75928223|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
42117378|NCT00095173|75928218|FG000|Open-Label Extension Phase (Period C)|Death|0|||
42117379|NCT00095173|75928219|FG001|Open-Label Extension Phase (Period C)|Death|0|||
42117380|NCT00095173|75928220|FG002|Open-Label Extension Phase (Period C)|Death|0|||
42117381|NCT00095173|75928221|FG003|Open-Label Extension Phase (Period C)|Death|0|||
42117382|NCT00095173|75928222|FG004|Open-Label Extension Phase (Period C)|Death|0|||
42117383|NCT00095173|75928223|FG005|Open-Label Extension Phase (Period C)|Death|1|||
42117384|NCT00095173|75928218|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
42117385|NCT00095173|75928219|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
42117386|NCT00095173|75928220|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
42117387|NCT00095173|75928221|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
42117388|NCT00095173|75928222|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
42117389|NCT00095173|75928223|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
42117390|NCT00095173|75928218|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
42117391|NCT00095173|75928219|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
42117392|NCT00095173|75928220|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
42117393|NCT00095173|75928221|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
42117394|NCT00095173|75928222|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
42117395|NCT00095173|75928223|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
42117396|NCT00095173|75928218|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
42117397|NCT00095173|75928219|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
42117398|NCT00095173|75928220|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
42117399|NCT00095173|75928221|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
42117400|NCT00095173|75928222|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
42117401|NCT00095173|75928223|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
42117402|NCT00095173|75928218|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
42117403|NCT00095173|75928219|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
42117404|NCT00095173|75928220|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
42117405|NCT00095173|75928221|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
42117406|NCT00095173|75928222|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
42117407|NCT00095173|75928223|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
42117408|NCT00095173|75928218|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
42117409|NCT00095173|75928219|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
42117410|NCT00095173|75928220|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
42117411|NCT00095173|75928221|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
42117412|NCT00095173|75928222|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
42117413|NCT00095173|75928223|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
42117414|NCT00095173|75928218|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
42117415|NCT00095173|75928219|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
42117416|NCT00095173|75928220|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
42117417|NCT00095173|75928221|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
42117418|NCT00095173|75928222|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
42117419|NCT00095173|75928223|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
42117420|NCT00095173|75928218|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
42117421|NCT00095173|75928219|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
42117422|NCT00095173|75928220|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
42117423|NCT00095173|75928221|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
42117424|NCT00095173|75928222|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
42117425|NCT00095173|75928223|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
42117426|NCT00095173|75928218|FG000|Open-Label Extension Phase (Period C)|Other|0|||
42117427|NCT00095173|75928219|FG001|Open-Label Extension Phase (Period C)|Other|0|||
42117428|NCT00095173|75928220|FG002|Open-Label Extension Phase (Period C)|Other|0|||
42117429|NCT00095173|75928221|FG003|Open-Label Extension Phase (Period C)|Other|4|||
42117430|NCT00095173|75928222|FG004|Open-Label Extension Phase (Period C)|Other|6|||
42117431|NCT00095173|75928223|FG005|Open-Label Extension Phase (Period C)|Other|8|||
42117432|NCT00690443|75928239|FG000|Overall Study|Adverse Event|1|||
42117433|NCT00690443|75928240|FG001|Overall Study|Adverse Event|2|||
42117434|NCT03954834|75928250|FG000|Overall Study|Adverse Event|1|||
42117435|NCT03954834|75928251|FG001|Overall Study|Adverse Event|3|||
42117436|NCT03954834|75928252|FG002|Overall Study|Adverse Event|1|||
42117437|NCT03954834|75928253|FG003|Overall Study|Adverse Event|1|||
42117438|NCT03954834|75928250|FG000|Overall Study|Death|0|||
42117439|NCT03954834|75928251|FG001|Overall Study|Death|0|||
42117440|NCT03954834|75928252|FG002|Overall Study|Death|0|||
42117441|NCT03954834|75928253|FG003|Overall Study|Death|1|||
42117442|NCT03954834|75928250|FG000|Overall Study|Physician Decision|0|||
42117443|NCT03954834|75928251|FG001|Overall Study|Physician Decision|1|||
42117444|NCT03954834|75928252|FG002|Overall Study|Physician Decision|0|||
42117445|NCT03954834|75928253|FG003|Overall Study|Physician Decision|2|||
42117446|NCT03954834|75928250|FG000|Overall Study|Protocol Violation|1|||
42117447|NCT03954834|75928251|FG001|Overall Study|Protocol Violation|0|||
42117448|NCT03954834|75928252|FG002|Overall Study|Protocol Violation|0|||
42117449|NCT03954834|75928253|FG003|Overall Study|Protocol Violation|1|||
42117450|NCT03954834|75928250|FG000|Overall Study|Withdrawal by Subject|2|||
42117451|NCT03954834|75928251|FG001|Overall Study|Withdrawal by Subject|3|||
42117452|NCT03954834|75928252|FG002|Overall Study|Withdrawal by Subject|13|||
42299779|NCT02545075|76134823|FG001|Randomization|Lost to Follow-up|1|||
42117453|NCT03954834|75928253|FG003|Overall Study|Withdrawal by Subject|6|||
42117454|NCT03954834|75928250|FG000|Overall Study|Participant left the country|0|||
42117455|NCT03954834|75928251|FG001|Overall Study|Participant left the country|0|||
42117456|NCT03954834|75928252|FG002|Overall Study|Participant left the country|1|||
42117457|NCT03954834|75928253|FG003|Overall Study|Participant left the country|0|||
42117458|NCT03954834|75928250|FG000|Overall Study|Lost to Follow-up|3|||
42117459|NCT03954834|75928251|FG001|Overall Study|Lost to Follow-up|2|||
42117460|NCT03954834|75928252|FG002|Overall Study|Lost to Follow-up|3|||
42117461|NCT03954834|75928253|FG003|Overall Study|Lost to Follow-up|5|||
42117462|NCT00693017|75928265|FG000|Overall Study|Sponsor Decision|2|||
42117463|NCT00693017|75928266|FG001|Overall Study|Sponsor Decision|1|||
42117464|NCT00693017|75928265|FG000|Overall Study|Death|0|||
42117465|NCT00693017|75928266|FG001|Overall Study|Death|1|||
42117466|NCT00692237|75928274|FG000|Overall Study|Withdrawal by Subject|1|||
42117467|NCT00692237|75928275|FG001|Overall Study|Withdrawal by Subject|3|||
42117468|NCT00692237|75928274|FG000|Overall Study|Adverse Event|0|||
42117469|NCT00692237|75928275|FG001|Overall Study|Adverse Event|1|||
42117470|NCT00110149|75928281|FG000|Overall Study|Physician Decision|3|||
42117471|NCT03954444|75928289|FG000|Overall Study|Withdrawal by Subject|5|||
42117472|NCT03954444|75928290|FG001|Overall Study|Withdrawal by Subject|5|||
42117473|NCT03954444|75928291|FG002|Overall Study|Withdrawal by Subject|5|||
42117474|NCT03954444|75928289|FG000|Overall Study|Adverse Event|1|||
42117475|NCT03954444|75928290|FG001|Overall Study|Adverse Event|3|||
42117476|NCT03954444|75928291|FG002|Overall Study|Adverse Event|2|||
42117477|NCT03954444|75928289|FG000|Overall Study|Protocol Violation|0|||
42117478|NCT03954444|75928290|FG001|Overall Study|Protocol Violation|3|||
42117479|NCT03954444|75928291|FG002|Overall Study|Protocol Violation|5|||
42117480|NCT03954444|75928289|FG000|Overall Study|Use of prohibited therapy|1|||
42117481|NCT03954444|75928290|FG001|Overall Study|Use of prohibited therapy|1|||
42117482|NCT03954444|75928291|FG002|Overall Study|Use of prohibited therapy|2|||
42117483|NCT03954444|75928289|FG000|Overall Study|Lost to Follow-up|1|||
42117484|NCT03954444|75928290|FG001|Overall Study|Lost to Follow-up|0|||
42117485|NCT03954444|75928291|FG002|Overall Study|Lost to Follow-up|1|||
42117486|NCT03954444|75928289|FG000|Overall Study|Non-compliant with study drug application|2|||
42117487|NCT03954444|75928290|FG001|Overall Study|Non-compliant with study drug application|2|||
42117488|NCT03954444|75928291|FG002|Overall Study|Non-compliant with study drug application|0|||
42117489|NCT03954444|75928289|FG000|Overall Study|Administrative reasons|0|||
42117490|NCT03954444|75928290|FG001|Overall Study|Administrative reasons|0|||
42117491|NCT03954444|75928291|FG002|Overall Study|Administrative reasons|1|||
42117492|NCT03954444|75928289|FG000|Overall Study|Miscellaneous|3|||
42117493|NCT03954444|75928290|FG001|Overall Study|Miscellaneous|2|||
42117494|NCT03954444|75928291|FG002|Overall Study|Miscellaneous|1|||
42117495|NCT03953820|75928299|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
42117496|NCT03953820|75928300|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
42117497|NCT03953820|75928301|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
42117498|NCT03953820|75928299|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
42117499|NCT03953820|75928300|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
42117500|NCT03953820|75928301|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
42117501|NCT00117949|75928318|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
42117502|NCT00117949|75928319|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
42117503|NCT00117949|75928320|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
42117504|NCT00117949|75928321|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
42117505|NCT00117949|75928318|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
42117506|NCT00117949|75928319|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
42117507|NCT00117949|75928320|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
42117508|NCT00117949|75928321|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
42117509|NCT00117949|75928318|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
42117510|NCT00117949|75928319|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
42117511|NCT00117949|75928320|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
42117512|NCT00117949|75928321|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
42117513|NCT00117949|75928318|FG000|Overall Study|PSA increase >=10ng/mL|0|||
42117514|NCT00117949|75928319|FG001|Overall Study|PSA increase >=10ng/mL|1|||
42117515|NCT00117949|75928320|FG002|Overall Study|PSA increase >=10ng/mL|1|||
42117516|NCT00117949|75928321|FG003|Overall Study|PSA increase >=10ng/mL|0|||
42117517|NCT00117949|75928318|FG000|Overall Study|PSA reduction <=50%|0|||
42117518|NCT00117949|75928319|FG001|Overall Study|PSA reduction <=50%|2|||
42117519|NCT00117949|75928320|FG002|Overall Study|PSA reduction <=50%|2|||
42117520|NCT00117949|75928321|FG003|Overall Study|PSA reduction <=50%|4|||
42117521|NCT00117949|75928318|FG000|Overall Study|Hepatic abnormalities|0|||
42117522|NCT00117949|75928319|FG001|Overall Study|Hepatic abnormalities|1|||
42117523|NCT00117949|75928320|FG002|Overall Study|Hepatic abnormalities|0|||
42117524|NCT00117949|75928321|FG003|Overall Study|Hepatic abnormalities|1|||
42117525|NCT00117793|75928331|FG000|Overall Study|Withdrawal by Subject|12|||
42117526|NCT00695669|75928340|FG000|Overall Study|Adverse Event|0|||
42117527|NCT00695669|75928341|FG001|Overall Study|Adverse Event|0|||
42117528|NCT00695669|75928342|FG002|Overall Study|Adverse Event|2|||
42117529|NCT00695669|75928343|FG003|Overall Study|Adverse Event|0|||
42117530|NCT00695669|75928340|FG000|Overall Study|Lost to Follow-up|4|||
42117531|NCT00695669|75928341|FG001|Overall Study|Lost to Follow-up|4|||
42117532|NCT00695669|75928342|FG002|Overall Study|Lost to Follow-up|1|||
42117533|NCT00695669|75928343|FG003|Overall Study|Lost to Follow-up|4|||
42117534|NCT03671369|75928356|FG000|Overall Study|Other|1|||
42117535|NCT03671369|75928356|FG000|Overall Study|Withdrawal by Subject|289|||
42117536|NCT03671369|75928356|FG000|Overall Study|Not willing to be vaccinated|1|||
42117537|NCT00692003|75928362|FG000|Overall Study|Sponsor Decision|5|||
42117538|NCT00692003|75928363|FG001|Overall Study|Sponsor Decision|1|||
42117539|NCT00434512|75928375|FG000|Overall Study|Migrated/moved from study area|0|||
42117540|NCT00434512|75928376|FG001|Overall Study|Migrated/moved from study area|0|||
42117541|NCT00434512|75928377|FG002|Overall Study|Migrated/moved from study area|0|||
42117542|NCT00434512|75928378|FG003|Overall Study|Migrated/moved from study area|1|||
42117543|NCT00434512|75928379|FG004|Overall Study|Migrated/moved from study area|1|||
42117544|NCT00434512|75928380|FG005|Overall Study|Migrated/moved from study area|1|||
42117545|NCT00434512|75928375|FG000|Overall Study|Other|0|||
42117546|NCT00434512|75928376|FG001|Overall Study|Other|1|||
42117547|NCT00434512|75928377|FG002|Overall Study|Other|0|||
42117548|NCT00434512|75928378|FG003|Overall Study|Other|0|||
42117549|NCT00434512|75928379|FG004|Overall Study|Other|0|||
42117550|NCT00434512|75928380|FG005|Overall Study|Other|0|||
42117551|NCT00427648|75928400|FG000|Overall Study|Protocol Violation|1|||
42117552|NCT00427648|75928401|FG001|Overall Study|Protocol Violation|2|||
42117553|NCT00427648|75928400|FG000|Overall Study|Adverse Event|0|||
42117554|NCT00427648|75928401|FG001|Overall Study|Adverse Event|1|||
42117555|NCT00416884|75928409|FG000|Overall Study|Study terminated due to low accrual|1|||
42117556|NCT00434122|75928415|FG000|Overall Study|Non-compliance with protocol|0|||
42117557|NCT00434122|75928416|FG001|Overall Study|Non-compliance with protocol|1|||
42117558|NCT00434122|75928415|FG000|Overall Study|loss of subject contact|1|||
42117559|NCT00434122|75928416|FG001|Overall Study|loss of subject contact|1|||
42117560|NCT00434122|75928415|FG000|Overall Study|Personal reasons|1|||
42117561|NCT00434122|75928416|FG001|Overall Study|Personal reasons|1|||
42117562|NCT00434122|75928415|FG000|Overall Study|Large follicle size|2|||
42117563|NCT00434122|75928416|FG001|Overall Study|Large follicle size|2|||
42117564|NCT00434122|75928415|FG000|Overall Study|Low follicular response.|1|||
42117565|NCT00434122|75928416|FG001|Overall Study|Low follicular response.|2|||
42117566|NCT00434122|75928415|FG000|Overall Study|Travelling of subject.|1|||
42117567|NCT00434122|75928416|FG001|Overall Study|Travelling of subject.|0|||
42117568|NCT00555620|75928430|FG000|Overall Study|Death|0|||
42117569|NCT00555620|75928431|FG001|Overall Study|Death|1|||
42117570|NCT00555620|75928432|FG002|Overall Study|Death|0|||
42117571|NCT00555620|75928433|FG003|Overall Study|Death|0|||
42117572|NCT00555620|75928434|FG004|Overall Study|Death|0|||
42117573|NCT00555620|75928435|FG005|Overall Study|Death|1|||
42117574|NCT00555620|75928430|FG000|Overall Study|Study terminated by sponsor|0|||
42117575|NCT00555620|75928431|FG001|Overall Study|Study terminated by sponsor|0|||
42117576|NCT00555620|75928432|FG002|Overall Study|Study terminated by sponsor|1|||
42117577|NCT00555620|75928433|FG003|Overall Study|Study terminated by sponsor|0|||
42117578|NCT00555620|75928434|FG004|Overall Study|Study terminated by sponsor|0|||
42117579|NCT00555620|75928435|FG005|Overall Study|Study terminated by sponsor|0|||
42117580|NCT00555620|75928430|FG000|Overall Study|Adverse Event|0|||
42117581|NCT00555620|75928431|FG001|Overall Study|Adverse Event|0|||
42117582|NCT00555620|75928432|FG002|Overall Study|Adverse Event|1|||
42117583|NCT00555620|75928433|FG003|Overall Study|Adverse Event|5|||
42117584|NCT00555620|75928434|FG004|Overall Study|Adverse Event|0|||
42117585|NCT00555620|75928435|FG005|Overall Study|Adverse Event|1|||
42117586|NCT00555620|75928430|FG000|Overall Study|Objective progression or relapse|6|||
42117587|NCT00555620|75928431|FG001|Overall Study|Objective progression or relapse|5|||
42117588|NCT00555620|75928432|FG002|Overall Study|Objective progression or relapse|12|||
42117589|NCT00555620|75928433|FG003|Overall Study|Objective progression or relapse|17|||
42117590|NCT00555620|75928434|FG004|Overall Study|Objective progression or relapse|3|||
42117591|NCT00555620|75928435|FG005|Overall Study|Objective progression or relapse|16|||
42117592|NCT00555620|75928430|FG000|Overall Study|Participant refused treatment|0|||
42117593|NCT00555620|75928431|FG001|Overall Study|Participant refused treatment|1|||
42117594|NCT00555620|75928432|FG002|Overall Study|Participant refused treatment|1|||
42117595|NCT00555620|75928433|FG003|Overall Study|Participant refused treatment|0|||
42117596|NCT00555620|75928434|FG004|Overall Study|Participant refused treatment|0|||
42117597|NCT00555620|75928435|FG005|Overall Study|Participant refused treatment|1|||
42117598|NCT00555620|75928430|FG000|Overall Study|Other|0|||
42117599|NCT00555620|75928431|FG001|Overall Study|Other|0|||
42117600|NCT00555620|75928432|FG002|Overall Study|Other|0|||
42117601|NCT00555620|75928433|FG003|Overall Study|Other|1|||
42117602|NCT00555620|75928434|FG004|Overall Study|Other|0|||
42117603|NCT00555620|75928435|FG005|Overall Study|Other|3|||
42117604|NCT00433966|75928455|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
42117605|NCT00433966|75928456|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
42117606|NCT00433966|75928457|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
42117607|NCT00433966|75928458|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
42117608|NCT00433966|75928455|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
42117609|NCT00433966|75928456|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
42117610|NCT00433966|75928457|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
42117611|NCT00433966|75928458|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
42117612|NCT00433966|75928455|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
42117613|NCT00433966|75928456|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
42117614|NCT00433966|75928457|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
42117615|NCT00433966|75928458|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
42117616|NCT00433966|75928455|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
42117617|NCT00433966|75928456|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
42117618|NCT00433966|75928457|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
42117619|NCT00433966|75928458|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
42117620|NCT00433966|75928455|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
42117621|NCT00433966|75928456|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
42117622|NCT00433966|75928457|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
42117623|NCT00433966|75928458|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
42117624|NCT03952650|75928475|FG000|Overall Study|TRAVEL|0|||
42117625|NCT03952650|75928476|FG001|Overall Study|TRAVEL|4|||
42117626|NCT03952650|75928477|FG002|Overall Study|TRAVEL|0|||
42117627|NCT03952650|75928478|FG003|Overall Study|TRAVEL|4|||
42117628|NCT03952650|75928479|FG004|Overall Study|TRAVEL|0|||
42117629|NCT03952650|75928480|FG005|Overall Study|TRAVEL|3|||
42117630|NCT03952650|75928481|FG006|Overall Study|TRAVEL|2|||
42117631|NCT03952650|75928475|FG000|Overall Study|Withdrawal by Subject|0|||
42117632|NCT03952650|75928476|FG001|Overall Study|Withdrawal by Subject|2|||
42117633|NCT03952650|75928477|FG002|Overall Study|Withdrawal by Subject|0|||
42117634|NCT03952650|75928478|FG003|Overall Study|Withdrawal by Subject|3|||
42117635|NCT03952650|75928479|FG004|Overall Study|Withdrawal by Subject|0|||
42117636|NCT03952650|75928480|FG005|Overall Study|Withdrawal by Subject|1|||
42117637|NCT03952650|75928481|FG006|Overall Study|Withdrawal by Subject|1|||
42117638|NCT03952650|75928475|FG000|Overall Study|Lost to Follow-up|0|||
42117639|NCT03952650|75928476|FG001|Overall Study|Lost to Follow-up|1|||
42117640|NCT03952650|75928477|FG002|Overall Study|Lost to Follow-up|0|||
42117641|NCT03952650|75928478|FG003|Overall Study|Lost to Follow-up|0|||
42117642|NCT03952650|75928479|FG004|Overall Study|Lost to Follow-up|0|||
42117643|NCT03952650|75928480|FG005|Overall Study|Lost to Follow-up|1|||
42117644|NCT03952650|75928481|FG006|Overall Study|Lost to Follow-up|1|||
42117645|NCT03952650|75928475|FG000|Overall Study|Received wrong vaccine and travelled|0|||
42117646|NCT03952650|75928476|FG001|Overall Study|Received wrong vaccine and travelled|0|||
42117647|NCT03952650|75928477|FG002|Overall Study|Received wrong vaccine and travelled|0|||
42117648|NCT03952650|75928478|FG003|Overall Study|Received wrong vaccine and travelled|0|||
42117649|NCT03952650|75928479|FG004|Overall Study|Received wrong vaccine and travelled|0|||
42117650|NCT03952650|75928480|FG005|Overall Study|Received wrong vaccine and travelled|1|||
42117651|NCT03952650|75928481|FG006|Overall Study|Received wrong vaccine and travelled|0|||
42117652|NCT03952650|75928475|FG000|Overall Study|Unable to make study visit|0|||
42117653|NCT03952650|75928476|FG001|Overall Study|Unable to make study visit|0|||
42117654|NCT03952650|75928477|FG002|Overall Study|Unable to make study visit|0|||
42117655|NCT03952650|75928478|FG003|Overall Study|Unable to make study visit|0|||
42117656|NCT03952650|75928479|FG004|Overall Study|Unable to make study visit|0|||
42117657|NCT03952650|75928480|FG005|Overall Study|Unable to make study visit|1|||
42117658|NCT03952650|75928481|FG006|Overall Study|Unable to make study visit|0|||
42299780|NCT02545075|76134822|FG000|Randomization|Withdrawal by Subject|0|||
42299781|NCT02545075|76134823|FG001|Randomization|Withdrawal by Subject|6|||
42299782|NCT02545075|76134822|FG000|Treatment|Disease progression|71|||
42299783|NCT02545075|76134823|FG001|Treatment|Disease progression|32|||
42299784|NCT02545075|76134822|FG000|Treatment|Participant dicontinued study treatment|7|||
42299785|NCT02545075|76134823|FG001|Treatment|Participant dicontinued study treatment|9|||
42299786|NCT02545075|76134822|FG000|Treatment|Withdrawal by Subject|1|||
42299787|NCT02545075|76134823|FG001|Treatment|Withdrawal by Subject|0|||
42299788|NCT02545075|76134822|FG000|Treatment|Adverse event not related to study drug|1|||
42117659|NCT00691301|75928497|FG000|Overall Study|Adverse Event|10|||
42117660|NCT00691301|75928497|FG000|Overall Study|Death|2|||
42117661|NCT00691301|75928497|FG000|Overall Study|Lack of Efficacy|32|||
42117662|NCT00691301|75928497|FG000|Overall Study|Withdrawal by Subject|4|||
42299789|NCT02545075|76134823|FG001|Treatment|Adverse event not related to study drug|0|||
42299790|NCT02545075|76134822|FG000|Treatment|Death|1|||
42117663|NCT00691301|75928497|FG000|Overall Study|Concurrent illness|2|||
42117664|NCT00691301|75928497|FG000|Overall Study|other reason|3|||
42117665|NCT00691301|75928497|FG000|Overall Study|Did not initiate study treatment|1|||
42117666|NCT00927563|75928507|FG000|Overall Study|Lost to Follow-up|1|||
42299791|NCT02545075|76134823|FG001|Treatment|Death|0|||
42117667|NCT00927563|75928507|FG000|Overall Study|Withdrawal by Subject|1|||
42117668|NCT00653159|75928522|FG000|Overall Study|Adverse Event|4|||
42117669|NCT00653159|75928523|FG001|Overall Study|Adverse Event|1|||
42206932|NCT03358290|76020235|FG000|Overall Study|Withdrawal by Subject|0|||
42206933|NCT03358290|76020236|FG001|Overall Study|Withdrawal by Subject|0|||
42206934|NCT03358290|76020237|FG002|Overall Study|Withdrawal by Subject|0|||
42206935|NCT03358290|76020238|FG003|Overall Study|Withdrawal by Subject|0|||
42206936|NCT03358290|76020239|FG004|Overall Study|Withdrawal by Subject|1|||
42206937|NCT03089216|76020255|FG000|Overall Study|Adverse Event|0|||
42206938|NCT03089216|76020256|FG001|Overall Study|Adverse Event|0|||
42206939|NCT03089216|76020257|FG002|Overall Study|Adverse Event|0|||
42206940|NCT03089216|76020258|FG003|Overall Study|Adverse Event|1|||
42206941|NCT03339726|76020275|FG000|Overall Study|Withdrawal by Subject|1|||
42206942|NCT03339726|76020276|FG001|Overall Study|Withdrawal by Subject|0|||
42206943|NCT03339726|76020277|FG002|Overall Study|Withdrawal by Subject|0|||
42206944|NCT03339726|76020275|FG000|Overall Study|Lost to Follow-up|0|||
42206945|NCT03339726|76020276|FG001|Overall Study|Lost to Follow-up|1|||
42206946|NCT03339726|76020277|FG002|Overall Study|Lost to Follow-up|0|||
42206947|NCT03339297|76020287|FG000|Overall Study|Relapse of Hematologic Disease|1|||
42206948|NCT03339297|76020288|FG001|Overall Study|Relapse of Hematologic Disease|0|||
42206949|NCT03339297|76020287|FG000|Overall Study|Death|10|||
42206950|NCT03339297|76020288|FG001|Overall Study|Death|7|||
42206951|NCT03339297|76020287|FG000|Overall Study|Hepatic Candidosis|1|||
42206952|NCT03339297|76020288|FG001|Overall Study|Hepatic Candidosis|0|||
42206953|NCT03339297|76020287|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
42206954|NCT03339297|76020288|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
42206955|NCT03339297|76020287|FG000|Overall Study|Consent Withdrawn by Participant|3|||
42206956|NCT03339297|76020288|FG001|Overall Study|Consent Withdrawn by Participant|3|||
42206957|NCT03339297|76020287|FG000|Overall Study|Disease Relapse|2|||
42206958|NCT03339297|76020288|FG001|Overall Study|Disease Relapse|0|||
42206959|NCT03339297|76020287|FG000|Overall Study|Physician Decision|1|||
42206960|NCT03339297|76020288|FG001|Overall Study|Physician Decision|1|||
42206961|NCT03339297|76020287|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
42206962|NCT03339297|76020288|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
42206963|NCT03339297|76020287|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
42206964|NCT03339297|76020288|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
42206965|NCT03339297|76020287|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
42206966|NCT03339297|76020288|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
42206967|NCT03339297|76020287|FG000|Overall Study|Adverse Event, Non-fatal|1|||
42206968|NCT03339297|76020288|FG001|Overall Study|Adverse Event, Non-fatal|0|||
42206969|NCT03339297|76020287|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
42206970|NCT03339297|76020288|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
42206971|NCT03339297|76020287|FG000|Overall Study|Patient Was Not Eligible|1|||
42206972|NCT03339297|76020288|FG001|Overall Study|Patient Was Not Eligible|0|||
42206973|NCT03713281|76020314|FG000|Overall Study|Lens handling difficuluties|2|||
42206974|NCT03713281|76020314|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
42206975|NCT03339219|76020318|FG000|Overall Study|Death|12|||
42206976|NCT03339219|76020318|FG000|Overall Study|Site Terminated by Sponsor|22|||
42206977|NCT03339219|76020318|FG000|Overall Study|Withdrawal by Subject|1|||
42206978|NCT03338673|76020324|FG000|Overall Study|Lost to Follow-up|1|||
42206979|NCT03338673|76020325|FG001|Overall Study|Lost to Follow-up|1|||
42206980|NCT02949024|76020333|FG000|Overall Study|Withdrawal by Subject|0|||
42206981|NCT02949024|76020334|FG001|Overall Study|Withdrawal by Subject|1|||
42206982|NCT03093428|76020344|FG000|Overall Study|Not eligible for treatment|2|||
42206983|NCT03093428|76020345|FG001|Overall Study|Not eligible for treatment|1|||
42206984|NCT03093428|76020344|FG000|Overall Study|Progression|14|||
42206985|NCT03093428|76020345|FG001|Overall Study|Progression|4|||
42206986|NCT03093428|76020344|FG000|Overall Study|Death|1|||
42206987|NCT03093428|76020345|FG001|Overall Study|Death|0|||
42206988|NCT03093428|76020344|FG000|Overall Study|Adverse Event|1|||
42206989|NCT03093428|76020345|FG001|Overall Study|Adverse Event|0|||
42117670|NCT00653159|75928522|FG000|Overall Study|Lost to Follow-up|1|||
42117671|NCT00653159|75928523|FG001|Overall Study|Lost to Follow-up|2|||
42117672|NCT00117637|75928531|FG000|First Intervention (Period 1)|Adverse Event|11|||
42117673|NCT00117637|75928532|FG001|First Intervention (Period 1)|Adverse Event|16|||
42117674|NCT00117637|75928531|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
42117675|NCT00117637|75928532|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
42117676|NCT00117637|75928531|FG000|First Intervention (Period 1)|Protocol Violation|1|||
42117677|NCT00117637|75928532|FG001|First Intervention (Period 1)|Protocol Violation|0|||
42117678|NCT00117637|75928531|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
42117679|NCT00117637|75928532|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
42117680|NCT00117637|75928531|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
42117681|NCT00117637|75928532|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
42206990|NCT03093428|76020344|FG000|Overall Study|Withdrawal by Subject|1|||
42206991|NCT03093428|76020345|FG001|Overall Study|Withdrawal by Subject|1|||
42206992|NCT02735980|76020354|FG000|Overall Study|Adverse Event|0|||
42206993|NCT02735980|76020355|FG001|Overall Study|Adverse Event|4|||
42206994|NCT02735980|76020356|FG002|Overall Study|Adverse Event|1|||
42206995|NCT02735980|76020354|FG000|Overall Study|Death|5|||
42206996|NCT02735980|76020355|FG001|Overall Study|Death|4|||
42206997|NCT02735980|76020356|FG002|Overall Study|Death|0|||
42206998|NCT02735980|76020354|FG000|Overall Study|Physician Decision|3|||
42206999|NCT02735980|76020355|FG001|Overall Study|Physician Decision|1|||
42207000|NCT02735980|76020356|FG002|Overall Study|Physician Decision|0|||
42207001|NCT02735980|76020354|FG000|Overall Study|Screen failure|1|||
42207002|NCT02735980|76020355|FG001|Overall Study|Screen failure|0|||
42207003|NCT02735980|76020356|FG002|Overall Study|Screen failure|0|||
42207004|NCT02735980|76020354|FG000|Overall Study|Withdrawal by Subject|1|||
42207005|NCT02735980|76020355|FG001|Overall Study|Withdrawal by Subject|2|||
42207006|NCT02735980|76020356|FG002|Overall Study|Withdrawal by Subject|0|||
42207007|NCT03338400|76020371|FG000|Overall Study|Lost to Follow-up|1|||
42207008|NCT03338400|76020372|FG001|Overall Study|Lost to Follow-up|2|||
42207009|NCT03337113|76020390|FG000|Overall Study|Adverse Event|1|||
42207010|NCT03337113|76020391|FG001|Overall Study|Adverse Event|1|||
42207011|NCT03337113|76020392|FG002|Overall Study|Adverse Event|0|||
42207012|NCT03337113|76020393|FG003|Overall Study|Adverse Event|1|||
42207013|NCT03337113|76020390|FG000|Overall Study|Physician Decision|0|||
42207014|NCT03337113|76020391|FG001|Overall Study|Physician Decision|2|||
42207015|NCT03337113|76020392|FG002|Overall Study|Physician Decision|0|||
42207016|NCT03337113|76020393|FG003|Overall Study|Physician Decision|1|||
42207017|NCT03337113|76020390|FG000|Overall Study|Withdrawal by Subject|0|||
42207018|NCT03337113|76020391|FG001|Overall Study|Withdrawal by Subject|0|||
42207019|NCT03337113|76020392|FG002|Overall Study|Withdrawal by Subject|1|||
42207020|NCT03337113|76020393|FG003|Overall Study|Withdrawal by Subject|0|||
42207021|NCT03092726|76020405|FG000|Overall Study|Adverse Event|3|||
42207022|NCT03092726|76020406|FG001|Overall Study|Adverse Event|10|||
42207023|NCT03092726|76020405|FG000|Overall Study|Lack of Efficacy|0|||
42207024|NCT03092726|76020406|FG001|Overall Study|Lack of Efficacy|1|||
42207025|NCT03092726|76020405|FG000|Overall Study|Lost to Follow-up|1|||
42207026|NCT03092726|76020406|FG001|Overall Study|Lost to Follow-up|0|||
42207027|NCT03092726|76020405|FG000|Overall Study|Withdrawal by Subject|5|||
42207028|NCT03092726|76020406|FG001|Overall Study|Withdrawal by Subject|3|||
42207029|NCT03338010|76020414|FG000|Overall Study|Withdrawal by Subject|14|||
42207030|NCT03338010|76020415|FG001|Overall Study|Withdrawal by Subject|8|||
42207031|NCT03338010|76020414|FG000|Overall Study|Lost to Follow-up|4|||
42207032|NCT03338010|76020415|FG001|Overall Study|Lost to Follow-up|2|||
42207033|NCT03338010|76020414|FG000|Overall Study|Adverse Event|3|||
42207034|NCT03338010|76020415|FG001|Overall Study|Adverse Event|2|||
42207035|NCT03338010|76020414|FG000|Overall Study|Physician Decision|2|||
42207036|NCT03338010|76020415|FG001|Overall Study|Physician Decision|2|||
42207037|NCT03338010|76020414|FG000|Overall Study|Non-Compliance with Study Drug|0|||
42207038|NCT03338010|76020415|FG001|Overall Study|Non-Compliance with Study Drug|3|||
42207039|NCT03338010|76020414|FG000|Overall Study|Protocol Violation|0|||
42207040|NCT03338010|76020415|FG001|Overall Study|Protocol Violation|1|||
42207041|NCT03337542|76020421|FG000|Overall Study|Withdrew Consent|17|||
42207042|NCT03337542|76020421|FG000|Overall Study|Allergic Adverse Event|1|||
42207043|NCT03337542|76020421|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
42207044|NCT03337542|76020421|FG000|Overall Study|Lost to Follow-up|1|||
42207045|NCT03337542|76020421|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
42207046|NCT01328548|76020428|FG000|Overall Study|Death|3|||
42207047|NCT01328548|76020429|FG001|Overall Study|Death|0|||
42207048|NCT01328548|76020428|FG000|Overall Study|Protocol Violation|1|||
42207049|NCT01328548|76020429|FG001|Overall Study|Protocol Violation|0|||
42207050|NCT03337308|76020467|FG000|Overall Study|Adverse Event|2|||
42207051|NCT03337308|76020468|FG001|Overall Study|Adverse Event|3|||
42207052|NCT03337308|76020469|FG002|Overall Study|Adverse Event|3|||
42299792|NCT02545075|76134822|FG000|Treatment|Participant drug toxicity|1|||
42207053|NCT03337308|76020470|FG003|Overall Study|Adverse Event|1|||
42299793|NCT02545075|76134823|FG001|Treatment|Participant drug toxicity|0|||
42299794|NCT02545075|76134822|FG000|Treatment|Completed treatment|40|||
42207054|NCT03337308|76020467|FG000|Overall Study|Lost to Follow-up|1|||
42207055|NCT03337308|76020468|FG001|Overall Study|Lost to Follow-up|2|||
42207056|NCT03337308|76020469|FG002|Overall Study|Lost to Follow-up|0|||
42207057|NCT03337308|76020470|FG003|Overall Study|Lost to Follow-up|0|||
42207058|NCT03337308|76020467|FG000|Overall Study|Withdrawal by Subject|2|||
42207059|NCT03337308|76020468|FG001|Overall Study|Withdrawal by Subject|1|||
42207060|NCT03337308|76020469|FG002|Overall Study|Withdrawal by Subject|2|||
42207061|NCT03337308|76020470|FG003|Overall Study|Withdrawal by Subject|1|||
42207062|NCT03337308|76020467|FG000|Overall Study|Protocol Violation|0|||
42207063|NCT03337308|76020468|FG001|Overall Study|Protocol Violation|1|||
42207064|NCT03337308|76020469|FG002|Overall Study|Protocol Violation|0|||
42207065|NCT03337308|76020470|FG003|Overall Study|Protocol Violation|0|||
42207066|NCT03337152|76020482|FG000|Overall Study|Physician Decision|1|||
42207067|NCT03337152|76020483|FG001|Overall Study|Physician Decision|0|||
42207068|NCT03337152|76020482|FG000|Overall Study|Lost to Follow-up|1|||
42207069|NCT03337152|76020483|FG001|Overall Study|Lost to Follow-up|3|||
42207070|NCT03337152|76020482|FG000|Overall Study|Adverse Event|3|||
42207071|NCT03337152|76020483|FG001|Overall Study|Adverse Event|1|||
42207072|NCT03337152|76020482|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
42207073|NCT03337152|76020483|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
42207074|NCT03091400|76020497|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
42207075|NCT03091400|76020498|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
42207076|NCT01318993|76020504|FG000|Overall Study|Adverse Event|53|||
42207077|NCT01318993|76020504|FG000|Overall Study|Lack of Efficacy|121|||
42207078|NCT01318993|76020504|FG000|Overall Study|Protocol Violation|3|||
42207079|NCT01318993|76020504|FG000|Overall Study|Protocol based stopping criteria|6|||
42207080|NCT01318993|76020504|FG000|Overall Study|Study closed or terminated|174|||
42207081|NCT01318993|76020504|FG000|Overall Study|Lost to Follow-up|4|||
42207082|NCT01318993|76020504|FG000|Overall Study|Physician Decision|13|||
42207083|NCT01318993|76020504|FG000|Overall Study|Withdrawal by Subject|24|||
42207084|NCT03090152|76020511|FG000|Overall Study|Withdrawal by Subject|0|||
42207085|NCT03090152|76020512|FG001|Overall Study|Withdrawal by Subject|2|||
42207086|NCT03090152|76020513|FG002|Overall Study|Withdrawal by Subject|1|||
42207087|NCT03090152|76020511|FG000|Overall Study|Surgery Canceled|1|||
42207088|NCT03090152|76020512|FG001|Overall Study|Surgery Canceled|0|||
42207089|NCT03090152|76020513|FG002|Overall Study|Surgery Canceled|0|||
42207090|NCT03090152|76020511|FG000|Overall Study|Epidural catheter could not be placed|0|||
42207091|NCT03090152|76020512|FG001|Overall Study|Epidural catheter could not be placed|2|||
42207092|NCT03090152|76020513|FG002|Overall Study|Epidural catheter could not be placed|0|||
42207093|NCT04252287|76020523|FG000|Overall Study|Death|5|||
42207094|NCT04252287|76020524|FG001|Overall Study|Death|3|||
42207095|NCT04252287|76020523|FG000|Overall Study|Lost to Follow-up|4|||
42207096|NCT04252287|76020524|FG001|Overall Study|Lost to Follow-up|6|||
42207097|NCT04252287|76020523|FG000|Overall Study|Withdrawal by Subject|19|||
42207098|NCT04252287|76020524|FG001|Overall Study|Withdrawal by Subject|16|||
42207099|NCT04252287|76020523|FG000|Overall Study|Protocol Violation|3|||
42207100|NCT04252287|76020524|FG001|Overall Study|Protocol Violation|4|||
42207101|NCT02735200|76020536|FG000|Overall Study|Lost to Follow-up|0|||
42207102|NCT02735200|76020537|FG001|Overall Study|Lost to Follow-up|5|||
42299795|NCT02545075|76134823|FG001|Treatment|Completed treatment|12|||
42299796|NCT03004183|76134838|FG000|Overall Study|Adverse Event|7|||
42299797|NCT03004183|76134838|FG000|Overall Study|Lost to Follow-up|1|||
42299798|NCT03004183|76134838|FG000|Overall Study|Physician Decision|40|||
42299799|NCT03004183|76134838|FG000|Overall Study|Withdrawal by Subject|1|||
42299800|NCT03004183|76134838|FG000|Overall Study|COVID-19|1|||
42299801|NCT02544763|76134845|FG000|Overall Study|Adverse Event|8|||
42299802|NCT02544763|76134846|FG001|Overall Study|Adverse Event|8|||
42299803|NCT02544763|76134847|FG002|Overall Study|Adverse Event|0|||
42299804|NCT02544763|76134845|FG000|Overall Study|Withdrawn by parent/guardian|1|||
42299805|NCT02544763|76134846|FG001|Overall Study|Withdrawn by parent/guardian|1|||
42299806|NCT02544763|76134847|FG002|Overall Study|Withdrawn by parent/guardian|1|||
42299807|NCT02544763|76134845|FG000|Overall Study|Met withdrawal criteria|0|||
42299808|NCT02544763|76134846|FG001|Overall Study|Met withdrawal criteria|2|||
42299809|NCT02544763|76134847|FG002|Overall Study|Met withdrawal criteria|0|||
42299810|NCT02544763|76134845|FG000|Overall Study|Physician Decision|0|||
42299811|NCT02544763|76134846|FG001|Overall Study|Physician Decision|1|||
42299812|NCT02544763|76134847|FG002|Overall Study|Physician Decision|0|||
42299813|NCT02544763|76134845|FG000|Overall Study|Difficulties taking IMP|1|||
42299814|NCT02544763|76134846|FG001|Overall Study|Difficulties taking IMP|0|||
42299815|NCT02544763|76134847|FG002|Overall Study|Difficulties taking IMP|0|||
42299816|NCT02556203|76134857|FG000|Overall Study|Withdrawal by Subject|21|||
42299817|NCT02556203|76134858|FG001|Overall Study|Withdrawal by Subject|21|||
42299818|NCT02556203|76134857|FG000|Overall Study|Lost to Follow-up|5|||
42299819|NCT02556203|76134858|FG001|Overall Study|Lost to Follow-up|5|||
42207103|NCT02735200|76020536|FG000|Overall Study|Withdrawal by Subject|8|||
42207104|NCT02735200|76020537|FG001|Overall Study|Withdrawal by Subject|0|||
42207105|NCT02946918|76020545|FG000|Overall Study|Patient unblinded himself|1|||
42207106|NCT02946918|76020546|FG001|Overall Study|Patient unblinded himself|0|||
42207107|NCT02946918|76020545|FG000|Overall Study|Physician Decision|0|||
42207108|NCT02946918|76020546|FG001|Overall Study|Physician Decision|2|||
42207109|NCT02946918|76020545|FG000|Overall Study|Ran out of study medication|0|||
42207110|NCT02946918|76020546|FG001|Overall Study|Ran out of study medication|1|||
42207111|NCT02734810|76020567|FG000|Overall Study|Adverse Event|1|||
42207112|NCT02734810|76020568|FG001|Overall Study|Adverse Event|0|||
42207113|NCT02734810|76020567|FG000|Overall Study|Lack of Efficacy|1|||
42207114|NCT02734810|76020568|FG001|Overall Study|Lack of Efficacy|0|||
42207115|NCT03656068|76020593|FG000|Overall Study|Withdrawal by Subject|4|||
42207116|NCT03656068|76020593|FG000|Overall Study|Adverse Event|1|||
42299820|NCT02556203|76134857|FG000|Overall Study|Adverse Event|1|||
42299821|NCT02556203|76134858|FG001|Overall Study|Adverse Event|0|||
42207117|NCT02944383|76020600|FG000|Overall Study|Lost to Follow-up|0|||
42207118|NCT02944383|76020601|FG001|Overall Study|Lost to Follow-up|0|||
42207119|NCT02944383|76020602|FG002|Overall Study|Lost to Follow-up|1|||
42207120|NCT02944383|76020600|FG000|Overall Study|Withdrawal by Subject|1|||
42207121|NCT02944383|76020601|FG001|Overall Study|Withdrawal by Subject|0|||
42207122|NCT02944383|76020602|FG002|Overall Study|Withdrawal by Subject|0|||
42207123|NCT03768089|76020630|FG000|Part A|Lost to Follow-up|0|||
42207124|NCT03768089|76020631|FG001|Part A|Lost to Follow-up|0|||
42207125|NCT03768089|76020632|FG002|Part A|Lost to Follow-up|0|||
42207126|NCT03768089|76020633|FG003|Part A|Lost to Follow-up|0|||
42207127|NCT03768089|76020634|FG004|Part A|Lost to Follow-up|1|||
42207128|NCT03768089|76020635|FG005|Part A|Lost to Follow-up|0|||
42207129|NCT03768089|76020636|FG006|Part A|Lost to Follow-up|0|||
42207130|NCT03768089|76020637|FG007|Part A|Lost to Follow-up|0|||
42207131|NCT03768089|76020638|FG008|Part A|Lost to Follow-up|0|||
42207132|NCT03768089|76020639|FG009|Part A|Lost to Follow-up|0|||
42207133|NCT03768089|76020640|FG010|Part A|Lost to Follow-up|0|||
42207134|NCT03768089|76020641|FG011|Part A|Lost to Follow-up|0|||
42207135|NCT03768089|76020642|FG012|Part A|Lost to Follow-up|0|||
42207136|NCT03768089|76020643|FG013|Part A|Lost to Follow-up|0|||
42207137|NCT03768089|76020644|FG014|Part A|Lost to Follow-up|0|||
42207138|NCT03768089|76020645|FG015|Part A|Lost to Follow-up|0|||
42207139|NCT03768089|76020646|FG016|Part A|Lost to Follow-up|0|||
42207140|NCT03768089|76020647|FG017|Part A|Lost to Follow-up|0|||
42207141|NCT03768089|76020630|FG000|Part C|Randomized, Never Dosed|0|||
42207142|NCT03768089|76020631|FG001|Part C|Randomized, Never Dosed|0|||
42207143|NCT03768089|76020632|FG002|Part C|Randomized, Never Dosed|0|||
42207144|NCT03768089|76020633|FG003|Part C|Randomized, Never Dosed|0|||
42207145|NCT03768089|76020634|FG004|Part C|Randomized, Never Dosed|0|||
42207146|NCT03768089|76020635|FG005|Part C|Randomized, Never Dosed|0|||
42207147|NCT03768089|76020636|FG006|Part C|Randomized, Never Dosed|0|||
42207148|NCT03768089|76020637|FG007|Part C|Randomized, Never Dosed|0|||
42207149|NCT03768089|76020638|FG008|Part C|Randomized, Never Dosed|0|||
42207150|NCT03768089|76020639|FG009|Part C|Randomized, Never Dosed|0|||
42207151|NCT03768089|76020640|FG010|Part C|Randomized, Never Dosed|0|||
42207152|NCT03768089|76020641|FG011|Part C|Randomized, Never Dosed|0|||
42207153|NCT03768089|76020642|FG012|Part C|Randomized, Never Dosed|0|||
42207154|NCT03768089|76020643|FG013|Part C|Randomized, Never Dosed|0|||
42207155|NCT03768089|76020644|FG014|Part C|Randomized, Never Dosed|1|||
42207156|NCT03768089|76020645|FG015|Part C|Randomized, Never Dosed|0|||
42207157|NCT03768089|76020646|FG016|Part C|Randomized, Never Dosed|0|||
42207158|NCT03768089|76020647|FG017|Part C|Randomized, Never Dosed|0|||
42207159|NCT03548584|76020705|FG000|Overall Study|Lost to Follow-up|0|||
42207160|NCT03548584|76020706|FG001|Overall Study|Lost to Follow-up|0|||
42207161|NCT03548584|76020707|FG002|Overall Study|Lost to Follow-up|1|||
42207162|NCT03548584|76020705|FG000|Overall Study|Adverse Event|1|||
42207163|NCT03548584|76020706|FG001|Overall Study|Adverse Event|11|||
42207164|NCT03548584|76020707|FG002|Overall Study|Adverse Event|5|||
42207165|NCT03548584|76020705|FG000|Overall Study|Site Terminated by Sponsor|1|||
42207166|NCT03548584|76020706|FG001|Overall Study|Site Terminated by Sponsor|3|||
42207167|NCT03548584|76020707|FG002|Overall Study|Site Terminated by Sponsor|2|||
42207168|NCT03548584|76020705|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
42207169|NCT03548584|76020706|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
42207170|NCT03548584|76020707|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
42207171|NCT03548584|76020705|FG000|Overall Study|Lack of Efficacy|0|||
42207172|NCT03548584|76020706|FG001|Overall Study|Lack of Efficacy|1|||
42207173|NCT03548584|76020707|FG002|Overall Study|Lack of Efficacy|0|||
42207174|NCT03548584|76020705|FG000|Overall Study|Non-compliance with Study Drug|0|||
42207175|NCT03548584|76020706|FG001|Overall Study|Non-compliance with Study Drug|1|||
42207176|NCT03548584|76020707|FG002|Overall Study|Non-compliance with Study Drug|0|||
42207177|NCT03548584|76020705|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
42207178|NCT03548584|76020706|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
42207179|NCT03548584|76020707|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
42207180|NCT03086330|76020720|FG000|Overall Study|Withdrawal by Subject|3|||
42207181|NCT03086330|76020721|FG001|Overall Study|Withdrawal by Subject|2|||
42207182|NCT03086330|76020720|FG000|Overall Study|Lost to Follow-up|1|||
42207183|NCT03086330|76020721|FG001|Overall Study|Lost to Follow-up|2|||
42299822|NCT02558231|76134875|FG000|Overall Study|Death|4|||
42021980|NCT00961636|75829310|FG000|Overall Study|Lost to Follow-up|2|||
42207184|NCT02943993|76020753|FG000|Overall Study|Withdrawal by Subject|52|||
42207185|NCT02943993|76020753|FG000|Overall Study|Transfer to another institution|6|||
42207186|NCT02943993|76020753|FG000|Overall Study|Lost to Follow-up|135|||
42207187|NCT02943993|76020753|FG000|Overall Study|Death|98|||
42207188|NCT02943993|76020753|FG000|Overall Study|Other reason for premature termination|32|||
42207189|NCT02943993|76020753|FG000|Overall Study|Missing reason for termination|7|||
42207190|NCT02943447|76020777|FG000|Blinded Study Phase|Withdrew Consent|1|||
42207191|NCT02943447|76020778|FG001|Blinded Study Phase|Withdrew Consent|2|||
42021981|NCT00961636|75829311|FG001|Overall Study|Lost to Follow-up|3|||
42299823|NCT02558231|76134876|FG001|Overall Study|Death|12|||
42207192|NCT02943447|76020779|FG002|Blinded Study Phase|Withdrew Consent|1|||
42207193|NCT02943447|76020777|FG000|Blinded Study Phase|Adverse Event|3|||
42207194|NCT02943447|76020778|FG001|Blinded Study Phase|Adverse Event|0|||
42207195|NCT02943447|76020779|FG002|Blinded Study Phase|Adverse Event|0|||
42207196|NCT02943447|76020777|FG000|Blinded Study Phase|Investigator's discretion|1|||
42207197|NCT02943447|76020778|FG001|Blinded Study Phase|Investigator's discretion|0|||
42207198|NCT02943447|76020779|FG002|Blinded Study Phase|Investigator's discretion|0|||
42207199|NCT02943447|76020777|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
42207200|NCT02943447|76020778|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
42207201|NCT02943447|76020779|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
42207202|NCT02943447|76020777|FG000|Open-Label Extension Phase|Adverse Event|4|||
42207203|NCT02943447|76020778|FG001|Open-Label Extension Phase|Adverse Event|7|||
42207204|NCT02943447|76020779|FG002|Open-Label Extension Phase|Adverse Event|3|||
42207205|NCT02943447|76020777|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
42207206|NCT02943447|76020778|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
42207207|NCT02943447|76020779|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
42207208|NCT02943447|76020777|FG000|Open-Label Extension Phase|Withdrew consent|1|||
42207209|NCT02943447|76020778|FG001|Open-Label Extension Phase|Withdrew consent|1|||
42207210|NCT02943447|76020779|FG002|Open-Label Extension Phase|Withdrew consent|1|||
42207211|NCT02943447|76020777|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
42207212|NCT02943447|76020778|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
42207213|NCT02943447|76020779|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
42207214|NCT02844777|76020808|FG000|Overall Study|Withdrawal by Subject|2|||
42207215|NCT02844777|76020809|FG001|Overall Study|Withdrawal by Subject|0|||
42207216|NCT02844777|76020810|FG002|Overall Study|Withdrawal by Subject|0|||
42207217|NCT02612337|76020820|FG000|Overall Study|Lack of Efficacy|1|||
42207218|NCT02612337|76020821|FG001|Overall Study|Lack of Efficacy|0|||
42207219|NCT02612337|76020820|FG000|Overall Study|Withdrawal by Subject|2|||
42207220|NCT02612337|76020821|FG001|Overall Study|Withdrawal by Subject|2|||
42207221|NCT02612337|76020820|FG000|Overall Study|Did not receive study drug|0|||
42207222|NCT02612337|76020821|FG001|Overall Study|Did not receive study drug|1|||
42207223|NCT03532451|76020835|FG000|Overall Study|Withdrawal by Subject|0|||
42207224|NCT03532451|76020836|FG001|Overall Study|Withdrawal by Subject|1|||
42207225|NCT03532451|76020835|FG000|Overall Study|Progression prior to the surgery|1|||
42207226|NCT03532451|76020836|FG001|Overall Study|Progression prior to the surgery|0|||
42207227|NCT03085238|76020842|FG000|Overall Study|Adverse Event|2|||
42207228|NCT03085238|76020842|FG000|Overall Study|Death|2|||
42207229|NCT03383666|76020855|FG000|Overall Study|Withdrawal by Subject|2|||
42207230|NCT03383666|76020855|FG000|Overall Study|Lost to Follow-up|2|||
42207231|NCT03086018|76020859|FG000|Final Testing for End of Trial|Adverse Event|1|||
42207232|NCT03086018|76020859|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
42207233|NCT03319953|76020869|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
42207234|NCT03319953|76020870|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
42207235|NCT03319953|76020871|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
42207236|NCT03319953|76020872|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
42207237|NCT03319953|76020869|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
42207238|NCT03319953|76020870|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
42207239|NCT03319953|76020871|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
42207240|NCT03319953|76020872|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
42207241|NCT02927834|76020883|FG000|Overall Study|Lost to Follow-up|1|||
42207242|NCT02927834|76020884|FG001|Overall Study|Lost to Follow-up|2|||
42207243|NCT02927834|76020885|FG002|Overall Study|Lost to Follow-up|2|||
42207244|NCT01964547|76020899|FG000|Overall Study|Adverse Event|8|||
42207245|NCT01964547|76020900|FG001|Overall Study|Adverse Event|2|||
42207246|NCT01964547|76020899|FG000|Overall Study|Withdrawal by Subject|4|||
42207247|NCT01964547|76020900|FG001|Overall Study|Withdrawal by Subject|7|||
42207248|NCT01964547|76020899|FG000|Overall Study|Lost to Follow-up|0|||
42207249|NCT01964547|76020900|FG001|Overall Study|Lost to Follow-up|1|||
42207250|NCT01964547|76020899|FG000|Overall Study|Withdrawal by Investigator|0|||
42207251|NCT01964547|76020900|FG001|Overall Study|Withdrawal by Investigator|1|||
42207252|NCT03319719|76020906|FG000|Overall Study|Lost to Follow-up|1|||
42207253|NCT03318783|76020914|FG000|Overall Study|Withdrawal by Subject|0|||
42207254|NCT03318783|76020915|FG001|Overall Study|Withdrawal by Subject|1|||
42207255|NCT03318783|76020914|FG000|Overall Study|Death|0|||
42207256|NCT03318783|76020915|FG001|Overall Study|Death|1|||
42207257|NCT01313689|76020926|FG000|24-Week Randomization 1|Adverse Event|10|||
42207258|NCT01313689|76020927|FG001|24-Week Randomization 1|Adverse Event|5|||
42207259|NCT01313689|76020928|FG002|24-Week Randomization 1|Adverse Event|0|||
42021982|NCT00961636|75829312|FG002|Overall Study|Lost to Follow-up|1|||
42207260|NCT01313689|76020929|FG003|24-Week Randomization 1|Adverse Event|0|||
42207261|NCT01313689|76020930|FG004|24-Week Randomization 1|Adverse Event|0|||
42207262|NCT01313689|76020926|FG000|24-Week Randomization 1|Physician Decision|4|||
42207263|NCT01313689|76020927|FG001|24-Week Randomization 1|Physician Decision|5|||
42207264|NCT01313689|76020928|FG002|24-Week Randomization 1|Physician Decision|0|||
42207265|NCT01313689|76020929|FG003|24-Week Randomization 1|Physician Decision|0|||
42207266|NCT01313689|76020930|FG004|24-Week Randomization 1|Physician Decision|0|||
42207267|NCT01313689|76020926|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
42207268|NCT01313689|76020927|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
42207269|NCT01313689|76020928|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
42207270|NCT01313689|76020929|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
42207271|NCT01313689|76020930|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
42207272|NCT01313689|76020926|FG000|24-Week Randomization 2|Adverse Event|0|||
42207273|NCT01313689|76020927|FG001|24-Week Randomization 2|Adverse Event|0|||
42207274|NCT01313689|76020928|FG002|24-Week Randomization 2|Adverse Event|2|||
42207275|NCT01313689|76020929|FG003|24-Week Randomization 2|Adverse Event|0|||
42207276|NCT01313689|76020930|FG004|24-Week Randomization 2|Adverse Event|8|||
42207277|NCT01313689|76020926|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
42207278|NCT01313689|76020927|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
42207279|NCT01313689|76020928|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
42207280|NCT01313689|76020929|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
42207281|NCT01313689|76020930|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
42207282|NCT01313689|76020926|FG000|24-Week Randomization 2|Physician Decision|0|||
42207283|NCT01313689|76020927|FG001|24-Week Randomization 2|Physician Decision|0|||
42207284|NCT01313689|76020928|FG002|24-Week Randomization 2|Physician Decision|0|||
42207285|NCT01313689|76020929|FG003|24-Week Randomization 2|Physician Decision|0|||
42207286|NCT01313689|76020930|FG004|24-Week Randomization 2|Physician Decision|4|||
42207287|NCT03318315|76020952|FG000|Overall Study|Lost to Follow-up|3|||
42207288|NCT03318315|76020953|FG001|Overall Study|Lost to Follow-up|2|||
42207289|NCT03318315|76020954|FG002|Overall Study|Lost to Follow-up|1|||
42207290|NCT03318315|76020952|FG000|Overall Study|Protocol Violation|1|||
42207291|NCT03318315|76020953|FG001|Overall Study|Protocol Violation|1|||
42207292|NCT03318315|76020954|FG002|Overall Study|Protocol Violation|1|||
42207293|NCT03318315|76020952|FG000|Overall Study|Withdrawal by Subject|0|||
42207294|NCT03318315|76020953|FG001|Overall Study|Withdrawal by Subject|0|||
42207295|NCT03318315|76020954|FG002|Overall Study|Withdrawal by Subject|2|||
42207296|NCT04460183|76020965|FG000|Overall Study|Lost to Follow-up|3|||
42207297|NCT04460183|76020966|FG001|Overall Study|Lost to Follow-up|1|||
42207298|NCT04460183|76020965|FG000|Overall Study|Withdrawal by Subject|1|||
42207299|NCT04460183|76020966|FG001|Overall Study|Withdrawal by Subject|0|||
42207300|NCT03710083|76020972|FG000|Overall Study|Withdrawal by Subject|2|||
42207301|NCT03710083|76020972|FG000|Overall Study|Unsuccessful Procedure|1|||
42207302|NCT03318003|76020978|FG000|Overall Study|Withdrawal by Subject|1|||
42207303|NCT03318003|76020979|FG001|Overall Study|Withdrawal by Subject|1|||
42207304|NCT03318003|76020978|FG000|Overall Study|fetal loss|0|||
42207305|NCT03318003|76020979|FG001|Overall Study|fetal loss|1|||
42207306|NCT03317379|76020988|FG000|Overall Study|Lost to Follow-up|0|||
42207307|NCT03317379|76020989|FG001|Overall Study|Lost to Follow-up|3|||
42207308|NCT03317379|76020990|FG002|Overall Study|Lost to Follow-up|2|||
42207309|NCT03316911|76021000|FG000|Overall Study|Lost to Follow-up|33|||
42207310|NCT03316911|76021001|FG001|Overall Study|Lost to Follow-up|29|||
42207311|NCT01106391|76021007|FG000|Overall Study|Death|12|||
42207312|NCT01106391|76021007|FG000|Overall Study|Withdrawal by Subject|7|||
42207313|NCT03316131|76021011|FG000|Treatment Period 2|Protocol deviation|1|||
42207314|NCT03316131|76021012|FG001|Treatment Period 2|Protocol deviation|0|||
42207315|NCT03301415|76021018|FG000|Overall Study|Lost to Follow-up|2|||
42207316|NCT03301415|76021018|FG000|Overall Study|Unable to comply with visit schedule|2|||
42207317|NCT02732938|76021024|FG000|Overall Study|Death|0|||
42207318|NCT02732938|76021025|FG001|Overall Study|Death|11|||
42207319|NCT02732938|76021026|FG002|Overall Study|Death|0|||
42207320|NCT02732938|76021024|FG000|Overall Study|Randomized but did not receive treatment|0|||
42207321|NCT02732938|76021025|FG001|Overall Study|Randomized but did not receive treatment|1|||
42207322|NCT02732938|76021026|FG002|Overall Study|Randomized but did not receive treatment|0|||
42207323|NCT02732938|76021024|FG000|Overall Study|Refused further follow-up|1|||
42207324|NCT02732938|76021025|FG001|Overall Study|Refused further follow-up|0|||
42207325|NCT02732938|76021026|FG002|Overall Study|Refused further follow-up|0|||
42207326|NCT02732938|76021024|FG000|Overall Study|Study terminated by sponsor|3|||
42207327|NCT02732938|76021025|FG001|Overall Study|Study terminated by sponsor|6|||
42207328|NCT02732938|76021026|FG002|Overall Study|Study terminated by sponsor|0|||
42207329|NCT04647721|76021034|FG000|Overall Study|Withdrawal by Subject|0|||
42207330|NCT04647721|76021035|FG001|Overall Study|Withdrawal by Subject|2|||
42207331|NCT04647721|76021034|FG000|Overall Study|Lost to Follow-up|2|||
42207332|NCT04647721|76021035|FG001|Overall Study|Lost to Follow-up|0|||
42207333|NCT03718000|76021056|FG000|Overall Study|Relocation|2|||
42207334|NCT03718000|76021057|FG001|Overall Study|Relocation|4|||
42207335|NCT03718000|76021056|FG000|Overall Study|Pregnancy|0|||
42207336|NCT03718000|76021057|FG001|Overall Study|Pregnancy|1|||
42207337|NCT03063203|76021064|FG000|Overall Study|Chose alternative therapy|3|||
42207338|NCT03063203|76021064|FG000|Overall Study|Death|2|||
42207339|NCT03063203|76021064|FG000|Overall Study|Disease progression|4|||
42207340|NCT03063203|76021064|FG000|Overall Study|Physician Decision|5|||
42207341|NCT02891226|76021083|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
42207342|NCT02891226|76021084|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
42207343|NCT02891226|76021085|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
42207344|NCT02891226|76021086|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207345|NCT02891226|76021087|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207346|NCT02891226|76021088|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207347|NCT02891226|76021089|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207348|NCT02891226|76021090|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207349|NCT02891226|76021091|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207350|NCT02891226|76021092|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207351|NCT02891226|76021093|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207352|NCT02891226|76021094|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207353|NCT02891226|76021095|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207354|NCT02891226|76021096|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207355|NCT02891226|76021097|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207356|NCT02891226|76021098|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
42207357|NCT02891226|76021083|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
42207358|NCT02891226|76021084|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
42207359|NCT02891226|76021085|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207360|NCT02891226|76021086|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207361|NCT02891226|76021087|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207362|NCT02891226|76021088|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207363|NCT02891226|76021089|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207364|NCT02891226|76021090|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207365|NCT02891226|76021091|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207366|NCT02891226|76021092|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207367|NCT02891226|76021093|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207368|NCT02891226|76021094|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207369|NCT02891226|76021095|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207370|NCT02891226|76021096|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207371|NCT02891226|76021097|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207372|NCT02891226|76021098|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42207373|NCT02891226|76021083|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207374|NCT02891226|76021084|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207375|NCT02891226|76021085|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207376|NCT02891226|76021086|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
42207377|NCT02891226|76021087|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207378|NCT02891226|76021088|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207379|NCT02891226|76021089|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207380|NCT02891226|76021090|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207381|NCT02891226|76021091|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207382|NCT02891226|76021092|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207383|NCT02891226|76021093|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207384|NCT02891226|76021094|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207385|NCT02891226|76021095|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207386|NCT02891226|76021096|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207387|NCT02891226|76021097|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207388|NCT02891226|76021098|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42207389|NCT02891226|76021083|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207390|NCT02891226|76021084|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207391|NCT02891226|76021085|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
42207392|NCT02891226|76021086|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207393|NCT02891226|76021087|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207394|NCT02891226|76021088|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207395|NCT02891226|76021089|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207396|NCT02891226|76021090|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207397|NCT02891226|76021091|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207398|NCT02891226|76021092|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207399|NCT02891226|76021093|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207400|NCT02891226|76021094|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207401|NCT02891226|76021095|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207402|NCT02891226|76021096|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42299824|NCT02558231|76134875|FG000|Overall Study|Lost to Follow-up|7|||
42207403|NCT02891226|76021097|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207404|NCT02891226|76021098|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
42207405|NCT02891226|76021083|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207406|NCT02891226|76021084|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207407|NCT02891226|76021085|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207408|NCT02891226|76021086|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
42207409|NCT02891226|76021087|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207410|NCT02891226|76021088|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42299825|NCT02558231|76134876|FG001|Overall Study|Lost to Follow-up|4|||
42207411|NCT02891226|76021089|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207412|NCT02891226|76021090|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207413|NCT02891226|76021091|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207414|NCT02891226|76021092|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207415|NCT02891226|76021093|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207416|NCT02891226|76021094|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207417|NCT02891226|76021095|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207418|NCT02891226|76021096|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207419|NCT02891226|76021097|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207420|NCT02891226|76021098|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
42207421|NCT02891226|76021083|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207422|NCT02891226|76021084|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207423|NCT02891226|76021085|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207424|NCT02891226|76021086|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
42207425|NCT02891226|76021087|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207426|NCT02891226|76021088|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207427|NCT02891226|76021089|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207428|NCT02891226|76021090|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207429|NCT02891226|76021091|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207430|NCT02891226|76021092|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207431|NCT02891226|76021093|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207432|NCT02891226|76021094|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207433|NCT02891226|76021095|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207434|NCT02891226|76021096|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207435|NCT02891226|76021097|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207436|NCT02891226|76021098|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
42207437|NCT02891226|76021083|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207438|NCT02891226|76021084|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207439|NCT02891226|76021085|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207440|NCT02891226|76021086|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207441|NCT02891226|76021087|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207442|NCT02891226|76021088|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207443|NCT02891226|76021089|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
42207444|NCT02891226|76021090|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
42207445|NCT02891226|76021091|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
42207446|NCT02891226|76021092|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
42207447|NCT02891226|76021093|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207448|NCT02891226|76021094|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207449|NCT02891226|76021095|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207450|NCT02891226|76021096|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207451|NCT02891226|76021097|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207452|NCT02891226|76021098|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
42207453|NCT02891226|76021083|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207454|NCT02891226|76021084|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207455|NCT02891226|76021085|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207456|NCT02891226|76021086|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207457|NCT02891226|76021087|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207458|NCT02891226|76021088|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
42207459|NCT02891226|76021089|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207460|NCT02891226|76021090|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207461|NCT02891226|76021091|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207462|NCT02891226|76021092|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
42207463|NCT02891226|76021093|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207464|NCT02891226|76021094|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207465|NCT02891226|76021095|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207466|NCT02891226|76021096|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207467|NCT02891226|76021097|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207468|NCT02891226|76021098|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
42207469|NCT02891226|76021083|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42207470|NCT02891226|76021084|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42299826|NCT02558231|76134875|FG000|Overall Study|Withdrawal by Subject|7|||
42299827|NCT02558231|76134876|FG001|Overall Study|Withdrawal by Subject|4|||
42207471|NCT02891226|76021085|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42207472|NCT02891226|76021086|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42207473|NCT02891226|76021087|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42207474|NCT02891226|76021088|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42207475|NCT02891226|76021089|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
42207476|NCT02891226|76021090|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
42207477|NCT02891226|76021091|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
42207478|NCT02891226|76021092|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
42207479|NCT02891226|76021093|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42207480|NCT02891226|76021094|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42207481|NCT02891226|76021095|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42207482|NCT02891226|76021096|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42207483|NCT02891226|76021097|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42207484|NCT02891226|76021098|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
42207485|NCT02891226|76021083|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207486|NCT02891226|76021084|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207487|NCT02891226|76021085|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207488|NCT02891226|76021086|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207489|NCT02891226|76021087|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
42207490|NCT02891226|76021088|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207491|NCT02891226|76021089|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207492|NCT02891226|76021090|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207493|NCT02891226|76021091|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207494|NCT02891226|76021092|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207495|NCT02891226|76021093|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207496|NCT02891226|76021094|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207497|NCT02891226|76021095|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207498|NCT02891226|76021096|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207499|NCT02891226|76021097|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207500|NCT02891226|76021098|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
42207501|NCT02891226|76021083|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207502|NCT02891226|76021084|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207503|NCT02891226|76021085|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207504|NCT02891226|76021086|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207505|NCT02891226|76021087|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207506|NCT02891226|76021088|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207507|NCT02891226|76021089|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
42207508|NCT02891226|76021090|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207509|NCT02891226|76021091|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207510|NCT02891226|76021092|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207511|NCT02891226|76021093|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207512|NCT02891226|76021094|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207513|NCT02891226|76021095|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207514|NCT02891226|76021096|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207515|NCT02891226|76021097|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207516|NCT02891226|76021098|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
42207517|NCT02891226|76021083|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207518|NCT02891226|76021084|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207519|NCT02891226|76021085|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207520|NCT02891226|76021086|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207521|NCT02891226|76021087|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207522|NCT02891226|76021088|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207523|NCT02891226|76021089|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207524|NCT02891226|76021090|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
42207525|NCT02891226|76021091|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
42207526|NCT02891226|76021092|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
42207527|NCT02891226|76021093|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207528|NCT02891226|76021094|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207529|NCT02891226|76021095|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207530|NCT02891226|76021096|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207531|NCT02891226|76021097|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207532|NCT02891226|76021098|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
42207533|NCT02891226|76021083|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207534|NCT02891226|76021084|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207535|NCT02891226|76021085|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207536|NCT02891226|76021086|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207537|NCT02891226|76021087|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207538|NCT02891226|76021088|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207539|NCT02891226|76021089|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207540|NCT02891226|76021090|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
42207541|NCT02891226|76021091|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207542|NCT02891226|76021092|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42299828|NCT02558231|76134875|FG000|Overall Study|Physician Decision|7|||
42299829|NCT02558231|76134876|FG001|Overall Study|Physician Decision|5|||
42207543|NCT02891226|76021093|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207544|NCT02891226|76021094|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207545|NCT02891226|76021095|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207546|NCT02891226|76021096|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207547|NCT02891226|76021097|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207548|NCT02891226|76021098|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
42207549|NCT02891226|76021083|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207550|NCT02891226|76021084|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207551|NCT02891226|76021085|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207552|NCT02891226|76021086|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207553|NCT02891226|76021087|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207554|NCT02891226|76021088|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207555|NCT02891226|76021089|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207556|NCT02891226|76021090|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207557|NCT02891226|76021091|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
42207558|NCT02891226|76021092|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207559|NCT02891226|76021093|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207560|NCT02891226|76021094|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207561|NCT02891226|76021095|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207562|NCT02891226|76021096|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207563|NCT02891226|76021097|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207564|NCT02891226|76021098|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
42207565|NCT02891226|76021083|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207566|NCT02891226|76021084|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207567|NCT02891226|76021085|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207568|NCT02891226|76021086|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207569|NCT02891226|76021087|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207570|NCT02891226|76021088|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207571|NCT02891226|76021089|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207572|NCT02891226|76021090|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207573|NCT02891226|76021091|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207574|NCT02891226|76021092|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
42207575|NCT02891226|76021093|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207576|NCT02891226|76021094|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207577|NCT02891226|76021095|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207578|NCT02891226|76021096|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207579|NCT02891226|76021097|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42299830|NCT02558231|76134875|FG000|Overall Study|Sponsor Decision|0|||
42299831|NCT02558231|76134876|FG001|Overall Study|Sponsor Decision|1|||
42299832|NCT02554877|76134886|FG000|Overall Study|Adverse Event|2|||
42299833|NCT02554877|76134887|FG001|Overall Study|Adverse Event|0|||
42299834|NCT02554877|76134888|FG002|Overall Study|Adverse Event|0|||
42299835|NCT02554877|76134889|FG003|Overall Study|Adverse Event|1|||
42299836|NCT02554877|76134886|FG000|Overall Study|Lost to Follow-up|1|||
42299837|NCT02554877|76134887|FG001|Overall Study|Lost to Follow-up|1|||
42299838|NCT02554877|76134888|FG002|Overall Study|Lost to Follow-up|1|||
42299839|NCT02554877|76134889|FG003|Overall Study|Lost to Follow-up|2|||
42299840|NCT02554877|76134886|FG000|Overall Study|Did not meet entrance criteria|0|||
42299841|NCT02554877|76134887|FG001|Overall Study|Did not meet entrance criteria|0|||
42299842|NCT02554877|76134888|FG002|Overall Study|Did not meet entrance criteria|1|||
42299843|NCT02554877|76134889|FG003|Overall Study|Did not meet entrance criteria|0|||
42299844|NCT02554877|76134886|FG000|Overall Study|No longer met eligibility criteria|1|||
42299845|NCT02554877|76134887|FG001|Overall Study|No longer met eligibility criteria|0|||
42299846|NCT02554877|76134888|FG002|Overall Study|No longer met eligibility criteria|1|||
42299847|NCT02554877|76134889|FG003|Overall Study|No longer met eligibility criteria|1|||
42207580|NCT02891226|76021098|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
42207581|NCT02891226|76021083|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207582|NCT02891226|76021084|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42299848|NCT02554877|76134886|FG000|Overall Study|Protocol Violation|3|||
42299849|NCT02554877|76134887|FG001|Overall Study|Protocol Violation|1|||
42299850|NCT02554877|76134888|FG002|Overall Study|Protocol Violation|1|||
42207583|NCT02891226|76021085|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207584|NCT02891226|76021086|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207585|NCT02891226|76021087|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42299851|NCT02554877|76134889|FG003|Overall Study|Protocol Violation|0|||
42299852|NCT02554877|76134886|FG000|Overall Study|Other|1|||
42207586|NCT02891226|76021088|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207587|NCT02891226|76021089|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207588|NCT02891226|76021090|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207589|NCT02891226|76021091|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207590|NCT02891226|76021092|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
42207591|NCT02891226|76021093|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207592|NCT02891226|76021094|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207593|NCT02891226|76021095|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207594|NCT02891226|76021096|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207595|NCT02891226|76021097|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207596|NCT02891226|76021098|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
42207597|NCT02891226|76021083|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207598|NCT02891226|76021084|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207599|NCT02891226|76021085|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207600|NCT02891226|76021086|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207601|NCT02891226|76021087|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207602|NCT02891226|76021088|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207603|NCT02891226|76021089|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207604|NCT02891226|76021090|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207605|NCT02891226|76021091|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207606|NCT02891226|76021092|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207607|NCT02891226|76021093|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
42207608|NCT02891226|76021094|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207609|NCT02891226|76021095|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207610|NCT02891226|76021096|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207611|NCT02891226|76021097|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207612|NCT02891226|76021098|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
42207613|NCT02891226|76021083|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207614|NCT02891226|76021084|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207615|NCT02891226|76021085|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207616|NCT02891226|76021086|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207617|NCT02891226|76021087|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207618|NCT02891226|76021088|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207619|NCT02891226|76021089|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207620|NCT02891226|76021090|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207621|NCT02891226|76021091|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207622|NCT02891226|76021092|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207623|NCT02891226|76021093|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
42207624|NCT02891226|76021094|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207625|NCT02891226|76021095|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207626|NCT02891226|76021096|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207627|NCT02891226|76021097|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207628|NCT02891226|76021098|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
42207629|NCT02891226|76021083|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207630|NCT02891226|76021084|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207631|NCT02891226|76021085|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207632|NCT02891226|76021086|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207633|NCT02891226|76021087|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207634|NCT02891226|76021088|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207635|NCT02891226|76021089|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207636|NCT02891226|76021090|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207637|NCT02891226|76021091|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207638|NCT02891226|76021092|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207639|NCT02891226|76021093|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
42207640|NCT02891226|76021094|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207641|NCT02891226|76021095|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207642|NCT02891226|76021096|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207643|NCT02891226|76021097|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42021983|NCT00961636|75829310|FG000|Overall Study|Physician Decision|3|||
42021984|NCT00961636|75829311|FG001|Overall Study|Physician Decision|1|||
42207644|NCT02891226|76021098|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
42207645|NCT02891226|76021083|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207646|NCT02891226|76021084|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207647|NCT02891226|76021085|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207648|NCT02891226|76021086|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207649|NCT02891226|76021087|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207650|NCT02891226|76021088|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207651|NCT02891226|76021089|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207652|NCT02891226|76021090|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207653|NCT02891226|76021091|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207654|NCT02891226|76021092|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207655|NCT02891226|76021093|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
42207656|NCT02891226|76021094|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207657|NCT02891226|76021095|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207658|NCT02891226|76021096|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207659|NCT02891226|76021097|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207660|NCT02891226|76021098|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
42207661|NCT02891226|76021083|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207662|NCT02891226|76021084|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207663|NCT02891226|76021085|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207664|NCT02891226|76021086|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207665|NCT02891226|76021087|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207666|NCT02891226|76021088|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207667|NCT02891226|76021089|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207668|NCT02891226|76021090|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207669|NCT02891226|76021091|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207670|NCT02891226|76021092|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207671|NCT02891226|76021093|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
42207672|NCT02891226|76021094|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207673|NCT02891226|76021095|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207674|NCT02891226|76021096|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207675|NCT02891226|76021097|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207676|NCT02891226|76021098|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
42207677|NCT02891226|76021083|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207678|NCT02891226|76021084|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207679|NCT02891226|76021085|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207680|NCT02891226|76021086|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207681|NCT02891226|76021087|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207682|NCT02891226|76021088|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207683|NCT02891226|76021089|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207684|NCT02891226|76021090|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207685|NCT02891226|76021091|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207686|NCT02891226|76021092|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207687|NCT02891226|76021093|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
42207688|NCT02891226|76021094|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207689|NCT02891226|76021095|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207690|NCT02891226|76021096|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207691|NCT02891226|76021097|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207692|NCT02891226|76021098|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
42207693|NCT02891226|76021083|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207694|NCT02891226|76021084|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207695|NCT02891226|76021085|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207696|NCT02891226|76021086|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207697|NCT02891226|76021087|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207698|NCT02891226|76021088|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207699|NCT02891226|76021089|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207700|NCT02891226|76021090|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207701|NCT02891226|76021091|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207702|NCT02891226|76021092|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207703|NCT02891226|76021093|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
42207704|NCT02891226|76021094|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207705|NCT02891226|76021095|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207706|NCT02891226|76021096|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207707|NCT02891226|76021097|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207708|NCT02891226|76021098|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
42207709|NCT02891226|76021083|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207710|NCT02891226|76021084|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207711|NCT02891226|76021085|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207712|NCT02891226|76021086|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42299853|NCT02554877|76134887|FG001|Overall Study|Other|3|||
42299854|NCT02554877|76134888|FG002|Overall Study|Other|0|||
42207713|NCT02891226|76021087|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207714|NCT02891226|76021088|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207715|NCT02891226|76021089|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207716|NCT02891226|76021090|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207717|NCT02891226|76021091|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207718|NCT02891226|76021092|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207719|NCT02891226|76021093|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
42207720|NCT02891226|76021094|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207721|NCT02891226|76021095|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207722|NCT02891226|76021096|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207723|NCT02891226|76021097|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207724|NCT02891226|76021098|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
42207725|NCT02891226|76021083|FG000|Follow-up Period|Withdrawal by Subject|0|||
42207726|NCT02891226|76021084|FG001|Follow-up Period|Withdrawal by Subject|0|||
42207727|NCT02891226|76021085|FG002|Follow-up Period|Withdrawal by Subject|0|||
42207728|NCT02891226|76021086|FG003|Follow-up Period|Withdrawal by Subject|0|||
42207729|NCT02891226|76021087|FG004|Follow-up Period|Withdrawal by Subject|0|||
42207730|NCT02891226|76021088|FG005|Follow-up Period|Withdrawal by Subject|0|||
42207731|NCT02891226|76021089|FG006|Follow-up Period|Withdrawal by Subject|0|||
42207732|NCT02891226|76021090|FG007|Follow-up Period|Withdrawal by Subject|0|||
42207733|NCT02891226|76021091|FG008|Follow-up Period|Withdrawal by Subject|0|||
42207734|NCT02891226|76021092|FG009|Follow-up Period|Withdrawal by Subject|0|||
42207735|NCT02891226|76021093|FG010|Follow-up Period|Withdrawal by Subject|0|||
42207736|NCT02891226|76021094|FG011|Follow-up Period|Withdrawal by Subject|1|||
42207737|NCT02891226|76021095|FG012|Follow-up Period|Withdrawal by Subject|0|||
42207738|NCT02891226|76021096|FG013|Follow-up Period|Withdrawal by Subject|0|||
42207739|NCT02891226|76021097|FG014|Follow-up Period|Withdrawal by Subject|1|||
42207740|NCT02891226|76021098|FG015|Follow-up Period|Withdrawal by Subject|1|||
42207741|NCT03612856|76021125|FG000|Pre-dose Period|Physician Decision|0|||
42207742|NCT03612856|76021126|FG001|Pre-dose Period|Physician Decision|1|||
42207743|NCT03612856|76021127|FG002|Pre-dose Period|Physician Decision|1|||
42207744|NCT03612856|76021125|FG000|Pre-dose Period|Withdrawal by Subject|0|||
42207745|NCT03612856|76021126|FG001|Pre-dose Period|Withdrawal by Subject|1|||
42207746|NCT03612856|76021127|FG002|Pre-dose Period|Withdrawal by Subject|0|||
42207747|NCT03333837|76021140|FG000|Overall Study|Adverse Event|2|||
42207748|NCT03333837|76021141|FG001|Overall Study|Adverse Event|1|||
42299855|NCT02554877|76134889|FG003|Overall Study|Other|3|||
42299856|NCT02554877|76134886|FG000|Overall Study|Insufficient clinical response|4|||
42299857|NCT02554877|76134887|FG001|Overall Study|Insufficient clinical response|0|||
42299858|NCT02554877|76134888|FG002|Overall Study|Insufficient clinical response|0|||
42207749|NCT03333837|76021142|FG002|Overall Study|Adverse Event|1|||
42207750|NCT03333837|76021143|FG003|Overall Study|Adverse Event|1|||
42207751|NCT03333837|76021144|FG004|Overall Study|Adverse Event|0|||
42207752|NCT03333837|76021140|FG000|Overall Study|Caregiver withdrew|0|||
42207753|NCT03333837|76021141|FG001|Overall Study|Caregiver withdrew|2|||
42207754|NCT03333837|76021142|FG002|Overall Study|Caregiver withdrew|1|||
42207755|NCT03333837|76021143|FG003|Overall Study|Caregiver withdrew|0|||
42207756|NCT03333837|76021144|FG004|Overall Study|Caregiver withdrew|0|||
42207757|NCT03333837|76021140|FG000|Overall Study|Withdrawal by Subject|0|||
42207758|NCT03333837|76021141|FG001|Overall Study|Withdrawal by Subject|0|||
42207759|NCT03333837|76021142|FG002|Overall Study|Withdrawal by Subject|1|||
42207760|NCT03333837|76021143|FG003|Overall Study|Withdrawal by Subject|1|||
42207761|NCT03333837|76021144|FG004|Overall Study|Withdrawal by Subject|3|||
42207762|NCT03333837|76021140|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
42207763|NCT03333837|76021141|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
42207764|NCT03333837|76021142|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
42207765|NCT03333837|76021143|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
42207766|NCT03333837|76021144|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
42207767|NCT03708211|76021162|FG000|Overall Study|Progressive Disease|10|||
42207768|NCT03708211|76021163|FG001|Overall Study|Progressive Disease|7|||
42207769|NCT03708211|76021162|FG000|Overall Study|Withdrawal by Subject|0|||
42207770|NCT03708211|76021163|FG001|Overall Study|Withdrawal by Subject|1|||
42207771|NCT03708211|76021162|FG000|Overall Study|Other|2|||
42207772|NCT03708211|76021163|FG001|Overall Study|Other|0|||
42207773|NCT02948634|76021173|FG000|Overall Study|Lack of efficacy and study suspended|10|||
42299859|NCT02554877|76134889|FG003|Overall Study|Insufficient clinical response|0|||
42299860|NCT02554877|76134886|FG000|Overall Study|No longer willing to participate|0|||
42207774|NCT02948634|76021174|FG001|Overall Study|Lack of efficacy and study suspended|2|||
42207775|NCT02945046|76021183|FG000|Overall Study|Adverse Event|1|||
42207776|NCT02945046|76021184|FG001|Overall Study|Adverse Event|0|||
42207777|NCT02945046|76021185|FG002|Overall Study|Adverse Event|2|||
42207778|NCT02945046|76021183|FG000|Overall Study|Withdrawal by Subject|3|||
42207779|NCT02945046|76021184|FG001|Overall Study|Withdrawal by Subject|3|||
42207780|NCT02945046|76021185|FG002|Overall Study|Withdrawal by Subject|3|||
42207781|NCT02945046|76021183|FG000|Overall Study|Protocol Violation|2|||
42207782|NCT02945046|76021184|FG001|Overall Study|Protocol Violation|3|||
42207783|NCT02945046|76021185|FG002|Overall Study|Protocol Violation|2|||
42207784|NCT02945046|76021183|FG000|Overall Study|Lost to Follow-up|1|||
42207785|NCT02945046|76021184|FG001|Overall Study|Lost to Follow-up|1|||
42207786|NCT02945046|76021185|FG002|Overall Study|Lost to Follow-up|0|||
42207787|NCT02945046|76021183|FG000|Overall Study|Lack of Efficacy|1|||
42207788|NCT02945046|76021184|FG001|Overall Study|Lack of Efficacy|2|||
42207789|NCT02945046|76021185|FG002|Overall Study|Lack of Efficacy|1|||
42207790|NCT02945046|76021183|FG000|Overall Study|Other than specified|5|||
42207791|NCT02945046|76021184|FG001|Overall Study|Other than specified|4|||
42207792|NCT02945046|76021185|FG002|Overall Study|Other than specified|7|||
42207793|NCT03705793|76021195|FG000|Overall Study|Lost to Follow-up|3|||
42207794|NCT03705793|76021196|FG001|Overall Study|Lost to Follow-up|4|||
42207795|NCT03705793|76021195|FG000|Overall Study|Withdrawal by Subject|2|||
42207796|NCT03705793|76021196|FG001|Overall Study|Withdrawal by Subject|1|||
42207797|NCT02944968|76021215|FG000|Overall Study|Subject excluded before study procedure|1|||
42207798|NCT02944968|76021215|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
42207799|NCT03761797|76021219|FG000|Overall Study|Changing hospital|11|||
42207800|NCT03761797|76021219|FG000|Overall Study|Improvement/remission|6|||
42207801|NCT03761797|76021219|FG000|Overall Study|Withdrawal by Subject|19|||
42207802|NCT03761797|76021219|FG000|Overall Study|Lost to Follow-up|33|||
42207803|NCT03761797|76021219|FG000|Overall Study|Adverse Event|37|||
42207804|NCT03761797|76021219|FG000|Overall Study|Case report form (CRF) not collected|5|||
42207805|NCT03761797|76021219|FG000|Overall Study|No patient visit after entry|13|||
42207806|NCT03761797|76021219|FG000|Overall Study|Switch to other diabetes medication|10|||
42207807|NCT03761797|76021219|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
42207808|NCT03761797|76021219|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
42207809|NCT03761797|76021219|FG000|Overall Study|Insufficient effectives|2|||
42207810|NCT03761797|76021219|FG000|Overall Study|Excessive alcohol intake|1|||
42207811|NCT02944656|76021225|FG000|Overall Study|No longer eligible|3|||
42207812|NCT02944656|76021226|FG001|Overall Study|No longer eligible|0|||
42207813|NCT02944656|76021225|FG000|Overall Study|Lost to Follow-up|7|||
42207814|NCT02944656|76021226|FG001|Overall Study|Lost to Follow-up|10|||
42207815|NCT02713529|76021239|FG000|Overall Study|Withdrawal by Subject|3|||
42207816|NCT02713529|76021240|FG001|Overall Study|Withdrawal by Subject|1|||
42207817|NCT02713529|76021241|FG002|Overall Study|Withdrawal by Subject|4|||
42207818|NCT02713529|76021242|FG003|Overall Study|Withdrawal by Subject|2|||
42207819|NCT02713529|76021243|FG004|Overall Study|Withdrawal by Subject|0|||
42207820|NCT02713529|76021244|FG005|Overall Study|Withdrawal by Subject|1|||
42207821|NCT02713529|76021245|FG006|Overall Study|Withdrawal by Subject|1|||
42207822|NCT02713529|76021239|FG000|Overall Study|Lost to Follow-up|1|||
42207823|NCT02713529|76021240|FG001|Overall Study|Lost to Follow-up|0|||
42207824|NCT02713529|76021241|FG002|Overall Study|Lost to Follow-up|1|||
42207825|NCT02713529|76021242|FG003|Overall Study|Lost to Follow-up|0|||
42207826|NCT02713529|76021243|FG004|Overall Study|Lost to Follow-up|0|||
42207827|NCT02713529|76021244|FG005|Overall Study|Lost to Follow-up|0|||
42207828|NCT02713529|76021245|FG006|Overall Study|Lost to Follow-up|0|||
42207829|NCT02713529|76021239|FG000|Overall Study|Death|3|||
42207830|NCT02713529|76021240|FG001|Overall Study|Death|3|||
42207831|NCT02713529|76021241|FG002|Overall Study|Death|26|||
42207832|NCT02713529|76021242|FG003|Overall Study|Death|27|||
42207833|NCT02713529|76021243|FG004|Overall Study|Death|3|||
42207834|NCT02713529|76021244|FG005|Overall Study|Death|13|||
42207835|NCT02713529|76021245|FG006|Overall Study|Death|3|||
42207836|NCT03707821|76021271|FG000|Overall Study|Protocol Violation|0|||
42207837|NCT03707821|76021272|FG001|Overall Study|Protocol Violation|1|||
42207838|NCT03707821|76021271|FG000|Overall Study|Unsatisfactory Visual Response|1|||
42207839|NCT03707821|76021272|FG001|Overall Study|Unsatisfactory Visual Response|0|||
42207840|NCT03707821|76021271|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
42207841|NCT03707821|76021272|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
42207842|NCT04546581|76021280|FG000|Overall Study|Adverse Event|9|||
42207843|NCT04546581|76021281|FG001|Overall Study|Adverse Event|3|||
42207844|NCT04546581|76021280|FG000|Overall Study|Physician Decision|0|||
42207845|NCT04546581|76021281|FG001|Overall Study|Physician Decision|1|||
42207846|NCT04546581|76021280|FG000|Overall Study|Protocol Violation|1|||
42207847|NCT04546581|76021281|FG001|Overall Study|Protocol Violation|2|||
42207848|NCT04546581|76021280|FG000|Overall Study|Withdrawal by Subject|3|||
42207849|NCT04546581|76021281|FG001|Overall Study|Withdrawal by Subject|7|||
42207850|NCT03707587|76021289|FG000|Overall Study|Death|0|||
42207851|NCT03707587|76021290|FG001|Overall Study|Death|1|||
42207852|NCT03312933|76021300|FG000|Overall Study|Protocol Violation|15|||
42207853|NCT03312933|76021300|FG000|Overall Study|Lost to Follow-up|36|||
42207854|NCT03312933|76021300|FG000|Overall Study|Withdrawal by Subject|3|||
42207855|NCT03312543|76021306|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
42207856|NCT03312543|76021307|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
42207857|NCT03312543|76021306|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
42207858|NCT03312543|76021307|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
42207859|NCT03312543|76021306|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
42207860|NCT03312543|76021307|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
42207861|NCT03312543|76021306|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
42207862|NCT03312543|76021307|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
42207863|NCT03312543|76021306|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
42207864|NCT03312543|76021307|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
42207865|NCT03312543|76021306|FG000|Regression (Week 12 to Week 24)|Death|0|||
42207866|NCT03312543|76021307|FG001|Regression (Week 12 to Week 24)|Death|1|||
42207867|NCT02392559|76021336|FG000|Overall Study|Withdrawal by Subject|0|||
42207868|NCT02392559|76021337|FG001|Overall Study|Withdrawal by Subject|1|||
42207869|NCT03332589|76021351|FG000|Overall Study|Lack of Efficacy|2|||
42207870|NCT03332589|76021352|FG001|Overall Study|Lack of Efficacy|0|||
42207871|NCT03332589|76021353|FG002|Overall Study|Lack of Efficacy|0|||
42207872|NCT03332589|76021351|FG000|Overall Study|Adverse Event|1|||
42207873|NCT03332589|76021352|FG001|Overall Study|Adverse Event|0|||
42207874|NCT03332589|76021353|FG002|Overall Study|Adverse Event|0|||
42207875|NCT03332589|76021351|FG000|Overall Study|Death|1|||
42207876|NCT03332589|76021352|FG001|Overall Study|Death|0|||
42207877|NCT03332589|76021353|FG002|Overall Study|Death|0|||
42207878|NCT00458003|76021363|FG000|Overall Study|Non protocol spinal anesthesia|1|||
42207879|NCT00458003|76021364|FG001|Overall Study|Non protocol spinal anesthesia|1|||
42207880|NCT02061293|76021374|FG000|Overall Study|Elevated Blood Pressure|1|||
42207881|NCT02061293|76021375|FG001|Overall Study|Elevated Blood Pressure|1|||
42207882|NCT02913612|76021385|FG000|Overall Study|Lost to Follow-up|6|||
42207883|NCT02913612|76021386|FG001|Overall Study|Lost to Follow-up|5|||
42207884|NCT02913612|76021387|FG002|Overall Study|Lost to Follow-up|2|||
42207885|NCT02913612|76021388|FG003|Overall Study|Lost to Follow-up|0|||
42207886|NCT02913612|76021385|FG000|Overall Study|Physician Decision|1|||
42207887|NCT02913612|76021386|FG001|Overall Study|Physician Decision|4|||
42207888|NCT02913612|76021387|FG002|Overall Study|Physician Decision|1|||
42207889|NCT02913612|76021388|FG003|Overall Study|Physician Decision|0|||
42207890|NCT02913612|76021385|FG000|Overall Study|Withdrawal by Subject|2|||
42207891|NCT02913612|76021386|FG001|Overall Study|Withdrawal by Subject|4|||
42207892|NCT02913612|76021387|FG002|Overall Study|Withdrawal by Subject|0|||
42207893|NCT02913612|76021388|FG003|Overall Study|Withdrawal by Subject|0|||
42207894|NCT02913612|76021385|FG000|Overall Study|Hemangioma resolved|1|||
42207895|NCT02913612|76021386|FG001|Overall Study|Hemangioma resolved|0|||
42207896|NCT02913612|76021387|FG002|Overall Study|Hemangioma resolved|0|||
42207897|NCT02913612|76021388|FG003|Overall Study|Hemangioma resolved|0|||
42207898|NCT02913612|76021385|FG000|Overall Study|Local IRB decision|1|||
42207899|NCT02913612|76021386|FG001|Overall Study|Local IRB decision|0|||
42207900|NCT02913612|76021387|FG002|Overall Study|Local IRB decision|0|||
42207901|NCT02913612|76021388|FG003|Overall Study|Local IRB decision|0|||
42207902|NCT02913612|76021385|FG000|Overall Study|Study drug non-compliance|1|||
42207903|NCT02913612|76021386|FG001|Overall Study|Study drug non-compliance|1|||
42207904|NCT02913612|76021387|FG002|Overall Study|Study drug non-compliance|0|||
42207905|NCT02913612|76021388|FG003|Overall Study|Study drug non-compliance|0|||
42207906|NCT02913612|76021385|FG000|Overall Study|Insurance issues|0|||
42207907|NCT02913612|76021386|FG001|Overall Study|Insurance issues|1|||
42207908|NCT02913612|76021387|FG002|Overall Study|Insurance issues|0|||
42207909|NCT02913612|76021388|FG003|Overall Study|Insurance issues|0|||
42207910|NCT02913612|76021385|FG000|Overall Study|Needed to treat second hemangioma|0|||
42207911|NCT02913612|76021386|FG001|Overall Study|Needed to treat second hemangioma|1|||
42207912|NCT02913612|76021387|FG002|Overall Study|Needed to treat second hemangioma|0|||
42207913|NCT02913612|76021388|FG003|Overall Study|Needed to treat second hemangioma|0|||
42207914|NCT02913612|76021385|FG000|Overall Study|Study completion criteria not met|0|||
42207915|NCT02913612|76021386|FG001|Overall Study|Study completion criteria not met|1|||
42207916|NCT02913612|76021387|FG002|Overall Study|Study completion criteria not met|0|||
42207917|NCT02913612|76021388|FG003|Overall Study|Study completion criteria not met|0|||
42207918|NCT02913612|76021385|FG000|Overall Study|Ineligible|0|||
42207919|NCT02913612|76021386|FG001|Overall Study|Ineligible|1|||
42207920|NCT02913612|76021387|FG002|Overall Study|Ineligible|0|||
42207921|NCT02913612|76021388|FG003|Overall Study|Ineligible|0|||
42207922|NCT03323736|76021400|FG000|Overall Study|Screen Failure|14|||
42207923|NCT03323736|76021401|FG001|Overall Study|Screen Failure|9|||
42207924|NCT03323736|76021402|FG002|Overall Study|Screen Failure|1|||
42207925|NCT03323736|76021400|FG000|Overall Study|Withdrawal Before Treatment|3|||
42207926|NCT03323736|76021401|FG001|Overall Study|Withdrawal Before Treatment|1|||
42207927|NCT03323736|76021402|FG002|Overall Study|Withdrawal Before Treatment|1|||
42207928|NCT03323736|76021400|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
42207929|NCT03323736|76021401|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
42207930|NCT03323736|76021402|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
42207931|NCT03311841|76021417|FG000|14-day Wash-out|Adverse Event|0|||
42207932|NCT03311841|76021418|FG001|14-day Wash-out|Adverse Event|1|||
42207933|NCT03311841|76021419|FG002|14-day Wash-out|Adverse Event|0|||
42207934|NCT03311841|76021420|FG003|14-day Wash-out|Adverse Event|0|||
42207935|NCT03311841|76021421|FG004|14-day Wash-out|Adverse Event|0|||
42207936|NCT03311841|76021417|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
42207937|NCT03311841|76021418|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
42207938|NCT03311841|76021419|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
42207939|NCT03311841|76021420|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
42207940|NCT03311841|76021421|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
42207941|NCT03311373|76021454|FG000|Overall Study|Adverse Event|1|||
42207942|NCT03311373|76021454|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
42207943|NCT03311373|76021454|FG000|Overall Study|Lost to Follow-up|1|||
42207944|NCT03311373|76021454|FG000|Overall Study|Physician Decision|1|||
42207945|NCT03311373|76021454|FG000|Overall Study|Withdrawal by Subject|3|||
42207946|NCT01155375|76021466|FG000|Overall Study|Adverse Event|1|||
42207947|NCT01155375|76021467|FG001|Overall Study|Adverse Event|0|||
42207948|NCT00628095|76021485|FG000|Overall Study|Adverse Event|5|||
42207949|NCT00628095|76021486|FG001|Overall Study|Adverse Event|3|||
42207950|NCT00628095|76021485|FG000|Overall Study|Lack of Efficacy|0|||
42207951|NCT00628095|76021486|FG001|Overall Study|Lack of Efficacy|3|||
42207952|NCT00628095|76021485|FG000|Overall Study|Withdrawal by Subject|2|||
42207953|NCT00628095|76021486|FG001|Overall Study|Withdrawal by Subject|0|||
42207954|NCT00628095|76021485|FG000|Overall Study|Other|0|||
42207955|NCT00628095|76021486|FG001|Overall Study|Other|1|||
42207956|NCT02889861|76021494|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
42207957|NCT03325881|76021505|FG000|Overall Study|Protocol Violation|0|||
42207958|NCT03325881|76021506|FG001|Overall Study|Protocol Violation|1|||
42207959|NCT03325881|76021505|FG000|Overall Study|Withdrawal by Subject|0|||
42207960|NCT03325881|76021506|FG001|Overall Study|Withdrawal by Subject|2|||
42207961|NCT03325881|76021505|FG000|Overall Study|Lack of Efficacy|2|||
42207962|NCT03325881|76021506|FG001|Overall Study|Lack of Efficacy|0|||
42207963|NCT03325881|76021505|FG000|Overall Study|Not treated|1|||
42207964|NCT03325881|76021506|FG001|Overall Study|Not treated|0|||
42207965|NCT02887989|76021516|FG000|Overall Study|Withdrawal by Subject|8|||
42207966|NCT02887989|76021517|FG001|Overall Study|Withdrawal by Subject|11|||
42207967|NCT02887989|76021516|FG000|Overall Study|Death|1|||
42207968|NCT02887989|76021517|FG001|Overall Study|Death|0|||
42207969|NCT02887521|76021525|FG000|Overall Study|Withdrawal by Subject|0|||
42207970|NCT02887521|76021526|FG001|Overall Study|Withdrawal by Subject|3|||
42207971|NCT03305055|76021534|FG000|Overall Study|Withdrawal by Subject|0|||
42207972|NCT03305055|76021535|FG001|Overall Study|Withdrawal by Subject|1|||
42207973|NCT03305055|76021534|FG000|Overall Study|Adverse Event|1|||
42207974|NCT03305055|76021535|FG001|Overall Study|Adverse Event|1|||
42207975|NCT02763189|76021543|FG000|Overall Study|Device failure|0|||
42207976|NCT02763189|76021544|FG001|Overall Study|Device failure|2|||
42207977|NCT03273387|76021552|FG000|Overall Study|Death|2|||
42207978|NCT03273387|76021553|FG001|Overall Study|Death|2|||
42207979|NCT03273387|76021552|FG000|Overall Study|Withdrawal by Subject|1|||
42207980|NCT03273387|76021553|FG001|Overall Study|Withdrawal by Subject|1|||
42207981|NCT01328080|76021559|FG000|Overall Study|Lost to Follow-up|5|||
42207982|NCT02649946|76021578|FG000|Overall Study|Withdrawal by Subject|1|||
42207983|NCT02649946|76021579|FG001|Overall Study|Withdrawal by Subject|1|||
42207984|NCT02649946|76021578|FG000|Overall Study|Death|7|||
42207985|NCT02649946|76021579|FG001|Overall Study|Death|9|||
42207986|NCT02649946|76021578|FG000|Overall Study|Physician Decision|1|||
42207987|NCT02649946|76021579|FG001|Overall Study|Physician Decision|0|||
42207988|NCT02649946|76021578|FG000|Overall Study|Lost to Follow-up|2|||
42207989|NCT02649946|76021579|FG001|Overall Study|Lost to Follow-up|1|||
42207990|NCT02649946|76021578|FG000|Overall Study|Erroneously enrolled|1|||
42207991|NCT02649946|76021579|FG001|Overall Study|Erroneously enrolled|0|||
42207992|NCT02649946|76021578|FG000|Overall Study|Missed 6-month follow-up visit|0|||
42207993|NCT02649946|76021579|FG001|Overall Study|Missed 6-month follow-up visit|4|||
42207994|NCT03273153|76021587|FG000|Overall Study|Adverse Event|1|||
42207995|NCT03273153|76021588|FG001|Overall Study|Adverse Event|2|||
42299861|NCT02554877|76134887|FG001|Overall Study|No longer willing to participate|2|||
42207996|NCT03273153|76021587|FG000|Overall Study|Missing|0|||
42207997|NCT03273153|76021588|FG001|Overall Study|Missing|2|||
42207998|NCT03273153|76021587|FG000|Overall Study|Other|3|||
42207999|NCT03273153|76021588|FG001|Overall Study|Other|2|||
42208000|NCT03273153|76021587|FG000|Overall Study|Symptomatic Deterioration|0|||
42208001|NCT03273153|76021588|FG001|Overall Study|Symptomatic Deterioration|1|||
42208002|NCT03273153|76021587|FG000|Overall Study|Progressive Disease|6|||
42208003|NCT03273153|76021588|FG001|Overall Study|Progressive Disease|5|||
42208004|NCT03273153|76021587|FG000|Overall Study|Physician Decision|1|||
42208005|NCT03273153|76021588|FG001|Overall Study|Physician Decision|3|||
42208006|NCT03273153|76021587|FG000|Overall Study|Study Terminated by Sponsor|112|||
42208007|NCT03273153|76021588|FG001|Overall Study|Study Terminated by Sponsor|102|||
42208008|NCT03273153|76021587|FG000|Overall Study|Withdrawal by Subject|26|||
42208009|NCT03273153|76021588|FG001|Overall Study|Withdrawal by Subject|25|||
42208010|NCT03273153|76021587|FG000|Overall Study|Protocol Deviation|3|||
42208011|NCT03273153|76021588|FG001|Overall Study|Protocol Deviation|0|||
42208012|NCT03273153|76021587|FG000|Overall Study|Lost to Follow-up|6|||
42208013|NCT03273153|76021588|FG001|Overall Study|Lost to Follow-up|11|||
42208014|NCT03273153|76021587|FG000|Overall Study|Death|66|||
42208015|NCT03273153|76021588|FG001|Overall Study|Death|69|||
42208016|NCT03270657|76021613|FG000|Overall Study|Withdrawal by Subject|1|||
42208017|NCT03303417|76021617|FG000|Overall Study|Withdrawal by Subject|1|||
42208018|NCT03303417|76021618|FG001|Overall Study|Withdrawal by Subject|1|||
42208019|NCT02943564|76021636|FG000|Overall Study|Miscellaneous Reasons|0|||
42208020|NCT02943564|76021637|FG001|Overall Study|Miscellaneous Reasons|0|||
42208021|NCT02943564|76021638|FG002|Overall Study|Miscellaneous Reasons|3|||
42208022|NCT02943564|76021636|FG000|Overall Study|Site terminated by sponsor|0|||
42208023|NCT02943564|76021637|FG001|Overall Study|Site terminated by sponsor|1|||
42208024|NCT02943564|76021638|FG002|Overall Study|Site terminated by sponsor|0|||
42208025|NCT02943564|76021636|FG000|Overall Study|Non-compliance with study drug|0|||
42208026|NCT02943564|76021637|FG001|Overall Study|Non-compliance with study drug|1|||
42208027|NCT02943564|76021638|FG002|Overall Study|Non-compliance with study drug|0|||
42208028|NCT02943564|76021636|FG000|Overall Study|Pregnancy|0|||
42208029|NCT02943564|76021637|FG001|Overall Study|Pregnancy|1|||
42208030|NCT02943564|76021638|FG002|Overall Study|Pregnancy|1|||
42208031|NCT02943564|76021636|FG000|Overall Study|Protocol Violation|2|||
42208032|NCT02943564|76021637|FG001|Overall Study|Protocol Violation|2|||
42208033|NCT02943564|76021638|FG002|Overall Study|Protocol Violation|2|||
42208034|NCT02943564|76021636|FG000|Overall Study|Lost to Follow-up|1|||
42208035|NCT02943564|76021637|FG001|Overall Study|Lost to Follow-up|0|||
42208036|NCT02943564|76021638|FG002|Overall Study|Lost to Follow-up|0|||
42208037|NCT02943564|76021636|FG000|Overall Study|Withdrawal by Subject|6|||
42208038|NCT02943564|76021637|FG001|Overall Study|Withdrawal by Subject|5|||
42208039|NCT02943564|76021638|FG002|Overall Study|Withdrawal by Subject|2|||
42208040|NCT02943564|76021636|FG000|Overall Study|Adverse Event|1|||
42208041|NCT02943564|76021637|FG001|Overall Study|Adverse Event|2|||
42208042|NCT02943564|76021638|FG002|Overall Study|Adverse Event|1|||
42208043|NCT02943564|76021636|FG000|Overall Study|Lack of Efficacy|0|||
42208044|NCT02943564|76021637|FG001|Overall Study|Lack of Efficacy|1|||
42208045|NCT02943564|76021638|FG002|Overall Study|Lack of Efficacy|0|||
42208046|NCT03268941|76021650|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
42208047|NCT03268941|76021651|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
42208048|NCT03268941|76021652|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
42208049|NCT03268941|76021653|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
42208050|NCT03268941|76021654|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
42208051|NCT03268941|76021655|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
42208052|NCT03268941|76021656|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
42208053|NCT03268941|76021650|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
42208054|NCT03268941|76021651|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
42208055|NCT03268941|76021652|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
42208056|NCT03268941|76021653|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
42208057|NCT03268941|76021654|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
42208058|NCT03268941|76021655|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
42208059|NCT03268941|76021656|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
42208060|NCT03268941|76021650|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
42208061|NCT03268941|76021651|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
42208062|NCT03268941|76021652|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
42208063|NCT03268941|76021653|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
42208064|NCT03268941|76021654|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
42208065|NCT03268941|76021655|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
42208066|NCT03268941|76021656|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
42208067|NCT03268941|76021650|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
42208068|NCT03268941|76021651|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
42208069|NCT03268941|76021652|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
42208070|NCT03268941|76021653|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
42208071|NCT03268941|76021654|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
42208072|NCT03268941|76021655|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
42208073|NCT03268941|76021656|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
42208074|NCT03268941|76021650|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
42208075|NCT03268941|76021651|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
42208076|NCT03268941|76021652|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
42208077|NCT03268941|76021653|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
42208078|NCT03268941|76021654|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
42208079|NCT03268941|76021655|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
42208080|NCT03268941|76021656|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
42208081|NCT03245619|76021733|FG000|Part A (Up to Day 22)|Physician Decision|4|||
42208082|NCT03245619|76021734|FG001|Part A (Up to Day 22)|Physician Decision|6|||
42208083|NCT03245619|76021735|FG002|Part A (Up to Day 22)|Physician Decision|6|||
42208084|NCT03245619|76021736|FG003|Part A (Up to Day 22)|Physician Decision|0|||
42208085|NCT03245619|76021737|FG004|Part A (Up to Day 22)|Physician Decision|0|||
42208086|NCT03245619|76021738|FG005|Part A (Up to Day 22)|Physician Decision|0|||
42208087|NCT03245619|76021739|FG006|Part A (Up to Day 22)|Physician Decision|0|||
42208088|NCT03245619|76021740|FG007|Part A (Up to Day 22)|Physician Decision|0|||
42208089|NCT03245619|76021741|FG008|Part A (Up to Day 22)|Physician Decision|0|||
42208090|NCT03245619|76021742|FG009|Part A (Up to Day 22)|Physician Decision|0|||
42208091|NCT03245619|76021743|FG010|Part A (Up to Day 22)|Physician Decision|0|||
42208092|NCT03245619|76021744|FG011|Part A (Up to Day 22)|Physician Decision|0|||
42208093|NCT03245619|76021745|FG012|Part A (Up to Day 22)|Physician Decision|0|||
42208094|NCT03245619|76021746|FG013|Part A (Up to Day 22)|Physician Decision|0|||
42208095|NCT03245619|76021747|FG014|Part A (Up to Day 22)|Physician Decision|0|||
42208096|NCT03245619|76021748|FG015|Part A (Up to Day 22)|Physician Decision|0|||
42208097|NCT03245619|76021749|FG016|Part A (Up to Day 22)|Physician Decision|0|||
42208098|NCT04472650|76021810|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
42208099|NCT04472650|76021811|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
42208100|NCT02606461|76021823|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
42208101|NCT02606461|76021824|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
42208102|NCT02606461|76021825|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
42208103|NCT02606461|76021826|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
42208104|NCT02606461|76021827|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
42208105|NCT02606461|76021828|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
42208106|NCT03321396|76021843|FG000|Overall Study|Physician Decision|1|||
42208107|NCT03244917|76021849|FG000|Overall Study|Lost to Follow-up|2|||
42208108|NCT03244917|76021850|FG001|Overall Study|Lost to Follow-up|2|||
42208109|NCT03321006|76021858|FG000|Overall Study|Death|1|||
42208110|NCT03321006|76021859|FG001|Overall Study|Death|0|||
42208111|NCT03321006|76021858|FG000|Overall Study|Lack of Efficacy|1|||
42208112|NCT03321006|76021859|FG001|Overall Study|Lack of Efficacy|0|||
42208113|NCT02593123|76021876|FG000|Overall Study|Physician Decision|2|||
42208114|NCT02593123|76021877|FG001|Overall Study|Physician Decision|1|||
42208115|NCT02593123|76021876|FG000|Overall Study|Relapse|1|||
42208116|NCT02593123|76021877|FG001|Overall Study|Relapse|1|||
42208117|NCT03302559|76021885|FG000|Overall Study|Adverse Event|2|||
42208118|NCT03302559|76021885|FG000|Overall Study|Lost to Follow-up|1|||
42208119|NCT03302559|76021885|FG000|Overall Study|Withdrew Consent|3|||
42208120|NCT03302247|76021889|FG000|Overall Study|the study has closed prematurely|2|||
42208121|NCT03302247|76021889|FG000|Overall Study|Death|1|||
42208122|NCT04993339|76021895|FG000|Overall Study|Lost to Follow-up|0|||
42208123|NCT04993339|76021896|FG001|Overall Study|Lost to Follow-up|1|||
42208124|NCT04993339|76021895|FG000|Overall Study|no MRI scan|3|||
42208125|NCT04993339|76021896|FG001|Overall Study|no MRI scan|1|||
42208126|NCT04974697|76021904|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
42208127|NCT04974697|76021904|FG000|Overall Study|Lens discomfort|1|||
42208128|NCT03265119|76021912|FG000|Overall Study|Adverse Event|2|||
42208129|NCT03265119|76021913|FG001|Overall Study|Adverse Event|1|||
42208130|NCT03265119|76021912|FG000|Overall Study|Lack of Efficacy|3|||
42208131|NCT03265119|76021913|FG001|Overall Study|Lack of Efficacy|0|||
42208132|NCT03265119|76021912|FG000|Overall Study|Protocol Violation|1|||
42208133|NCT03265119|76021913|FG001|Overall Study|Protocol Violation|2|||
42208134|NCT03265119|76021912|FG000|Overall Study|Withdrawal by Subject|2|||
42208135|NCT03265119|76021913|FG001|Overall Study|Withdrawal by Subject|4|||
42208136|NCT03265119|76021912|FG000|Overall Study|Lost to Follow-up|1|||
42208137|NCT03265119|76021913|FG001|Overall Study|Lost to Follow-up|0|||
42208138|NCT03265119|76021912|FG000|Overall Study|Lack of Compliance|1|||
42208139|NCT03265119|76021913|FG001|Overall Study|Lack of Compliance|0|||
42208140|NCT04952701|76021919|FG000|Control Lens|Physician Decision|4|||
42208141|NCT04952701|76021919|FG000|Test Lens|Physician Decision|1|||
42208142|NCT04723173|76021925|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
42208143|NCT04919161|76021939|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
42208144|NCT04919161|76021940|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
42208145|NCT04919161|76021939|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
42208146|NCT04919161|76021940|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
42208147|NCT04919161|76021939|FG000|Overall Study|Acute ankle sprain after session 1|0|||
42208148|NCT04919161|76021940|FG001|Overall Study|Acute ankle sprain after session 1|1|||
42208149|NCT03262389|76021968|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
42208150|NCT03262389|76021968|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
42208151|NCT03262389|76021968|FG000|Overall Study|opted out of PET/MR|1|||
42208152|NCT03262233|76021976|FG000|Overall Study|Withdrawal by Subject|12|||
42208153|NCT03262233|76021977|FG001|Overall Study|Withdrawal by Subject|8|||
42208154|NCT03262233|76021978|FG002|Overall Study|Withdrawal by Subject|21|||
42299862|NCT02554877|76134888|FG002|Overall Study|No longer willing to participate|2|||
42208155|NCT03262233|76021979|FG003|Overall Study|Withdrawal by Subject|13|||
42208156|NCT03262233|76021976|FG000|Overall Study|Declined due to shock|1|||
42208157|NCT03262233|76021977|FG001|Overall Study|Declined due to shock|2|||
42208158|NCT03262233|76021978|FG002|Overall Study|Declined due to shock|2|||
42208159|NCT03262233|76021979|FG003|Overall Study|Declined due to shock|3|||
42208160|NCT03262233|76021976|FG000|Overall Study|Protocol Violation|5|||
42208161|NCT03262233|76021977|FG001|Overall Study|Protocol Violation|10|||
42208162|NCT03262233|76021978|FG002|Overall Study|Protocol Violation|2|||
42208163|NCT03262233|76021979|FG003|Overall Study|Protocol Violation|13|||
42208164|NCT03262233|76021976|FG000|Overall Study|data collection artifact|0|||
42208165|NCT03262233|76021977|FG001|Overall Study|data collection artifact|1|||
42208166|NCT03262233|76021978|FG002|Overall Study|data collection artifact|0|||
42208167|NCT03262233|76021979|FG003|Overall Study|data collection artifact|0|||
42208168|NCT03261531|76021990|FG000|Overall Study|Withdrawal by Subject|4|||
42208169|NCT04151290|76021994|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
42208170|NCT03260205|76022013|FG000|Overall Study|Adverse Event|2|||
42208171|NCT03260205|76022014|FG001|Overall Study|Adverse Event|0|||
42208172|NCT03260205|76022015|FG002|Overall Study|Adverse Event|2|||
42208173|NCT03260205|76022016|FG003|Overall Study|Adverse Event|2|||
42208174|NCT03260205|76022017|FG004|Overall Study|Adverse Event|4|||
42208175|NCT03260205|76022013|FG000|Overall Study|Lost to Follow-up|2|||
42208176|NCT03260205|76022014|FG001|Overall Study|Lost to Follow-up|2|||
42208177|NCT03260205|76022015|FG002|Overall Study|Lost to Follow-up|1|||
42208178|NCT03260205|76022016|FG003|Overall Study|Lost to Follow-up|1|||
42208179|NCT03260205|76022017|FG004|Overall Study|Lost to Follow-up|5|||
42208180|NCT03260205|76022013|FG000|Overall Study|Protocol Violation|0|||
42208181|NCT03260205|76022014|FG001|Overall Study|Protocol Violation|0|||
42208182|NCT03260205|76022015|FG002|Overall Study|Protocol Violation|2|||
42208183|NCT03260205|76022016|FG003|Overall Study|Protocol Violation|0|||
42208184|NCT03260205|76022017|FG004|Overall Study|Protocol Violation|1|||
42208185|NCT03260205|76022013|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
42208186|NCT03260205|76022014|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
42208187|NCT03260205|76022015|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
42208188|NCT03260205|76022016|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
42208189|NCT03260205|76022017|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
42208190|NCT03260205|76022013|FG000|Overall Study|Other: Unspecified|0|||
42208191|NCT03260205|76022014|FG001|Overall Study|Other: Unspecified|0|||
42208192|NCT03260205|76022015|FG002|Overall Study|Other: Unspecified|3|||
42208193|NCT03260205|76022016|FG003|Overall Study|Other: Unspecified|1|||
42208194|NCT03260205|76022017|FG004|Overall Study|Other: Unspecified|1|||
42208195|NCT03260205|76022013|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
42208196|NCT03260205|76022014|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
42208197|NCT03260205|76022015|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
42208198|NCT03260205|76022016|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
42208199|NCT03260205|76022017|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
42208200|NCT04666441|76022042|FG000|Overall Study|Lost to Follow-up|1|||
42208201|NCT04666441|76022043|FG001|Overall Study|Lost to Follow-up|4|||
42208202|NCT04666441|76022044|FG002|Overall Study|Lost to Follow-up|1|||
42208203|NCT04666441|76022045|FG003|Overall Study|Lost to Follow-up|3|||
42208204|NCT04666441|76022046|FG004|Overall Study|Lost to Follow-up|0|||
42208205|NCT04666441|76022047|FG005|Overall Study|Lost to Follow-up|2|||
42208206|NCT04666441|76022048|FG006|Overall Study|Lost to Follow-up|2|||
42208207|NCT04666441|76022049|FG007|Overall Study|Lost to Follow-up|2|||
42208208|NCT04666441|76022042|FG000|Overall Study|Subject Decision|1|||
42208209|NCT04666441|76022043|FG001|Overall Study|Subject Decision|1|||
42208210|NCT04666441|76022044|FG002|Overall Study|Subject Decision|3|||
42208211|NCT04666441|76022045|FG003|Overall Study|Subject Decision|1|||
42208212|NCT04666441|76022046|FG004|Overall Study|Subject Decision|0|||
42208213|NCT04666441|76022047|FG005|Overall Study|Subject Decision|1|||
42208214|NCT04666441|76022048|FG006|Overall Study|Subject Decision|3|||
42208215|NCT04666441|76022049|FG007|Overall Study|Subject Decision|2|||
42208216|NCT03320850|76022086|FG000|Overall Study|Lost to Follow-up|0|||
42208217|NCT03320850|76022087|FG001|Overall Study|Lost to Follow-up|0|||
42208218|NCT03320850|76022088|FG002|Overall Study|Lost to Follow-up|0|||
42208219|NCT03320850|76022089|FG003|Overall Study|Lost to Follow-up|0|||
42208220|NCT03320850|76022090|FG004|Overall Study|Lost to Follow-up|1|||
42208221|NCT03320850|76022091|FG005|Overall Study|Lost to Follow-up|2|||
42208222|NCT03320850|76022092|FG006|Overall Study|Lost to Follow-up|2|||
42021985|NCT00961636|75829312|FG002|Overall Study|Physician Decision|1|||
42208223|NCT03320850|76022093|FG007|Overall Study|Lost to Follow-up|0|||
42208224|NCT03320850|76022094|FG008|Overall Study|Lost to Follow-up|6|||
42208225|NCT03320850|76022095|FG009|Overall Study|Lost to Follow-up|4|||
42208226|NCT03320850|76022086|FG000|Overall Study|Withdrawal by Subject|0|||
42208227|NCT03320850|76022087|FG001|Overall Study|Withdrawal by Subject|0|||
42208228|NCT03320850|76022088|FG002|Overall Study|Withdrawal by Subject|0|||
42208229|NCT03320850|76022089|FG003|Overall Study|Withdrawal by Subject|0|||
42208230|NCT03320850|76022090|FG004|Overall Study|Withdrawal by Subject|1|||
42208231|NCT03320850|76022091|FG005|Overall Study|Withdrawal by Subject|2|||
42208232|NCT03320850|76022092|FG006|Overall Study|Withdrawal by Subject|4|||
42208233|NCT03320850|76022093|FG007|Overall Study|Withdrawal by Subject|5|||
42208234|NCT03320850|76022094|FG008|Overall Study|Withdrawal by Subject|2|||
42208235|NCT03320850|76022095|FG009|Overall Study|Withdrawal by Subject|1|||
42208236|NCT03320850|76022086|FG000|Overall Study|Lack of Efficacy|0|||
42208237|NCT03320850|76022087|FG001|Overall Study|Lack of Efficacy|0|||
42208238|NCT03320850|76022088|FG002|Overall Study|Lack of Efficacy|0|||
42208239|NCT03320850|76022089|FG003|Overall Study|Lack of Efficacy|1|||
42208240|NCT03320850|76022090|FG004|Overall Study|Lack of Efficacy|0|||
42208241|NCT03320850|76022091|FG005|Overall Study|Lack of Efficacy|1|||
42208242|NCT03320850|76022092|FG006|Overall Study|Lack of Efficacy|0|||
42208243|NCT03320850|76022093|FG007|Overall Study|Lack of Efficacy|2|||
42208244|NCT03320850|76022094|FG008|Overall Study|Lack of Efficacy|0|||
42208245|NCT03320850|76022095|FG009|Overall Study|Lack of Efficacy|3|||
42208246|NCT03320850|76022086|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
42208247|NCT03320850|76022087|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
42208248|NCT03320850|76022088|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
42208249|NCT03320850|76022089|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
42208250|NCT03320850|76022090|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
42208251|NCT03320850|76022091|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
42208252|NCT03320850|76022092|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
42208253|NCT03320850|76022093|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
42208254|NCT03320850|76022094|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
42208255|NCT03320850|76022095|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
42208256|NCT03320850|76022086|FG000|Overall Study|Adverse Event|0|||
42208257|NCT03320850|76022087|FG001|Overall Study|Adverse Event|0|||
42208258|NCT03320850|76022088|FG002|Overall Study|Adverse Event|0|||
42208259|NCT03320850|76022089|FG003|Overall Study|Adverse Event|0|||
42208260|NCT03320850|76022090|FG004|Overall Study|Adverse Event|0|||
42208261|NCT03320850|76022091|FG005|Overall Study|Adverse Event|2|||
42208262|NCT03320850|76022092|FG006|Overall Study|Adverse Event|1|||
42208263|NCT03320850|76022093|FG007|Overall Study|Adverse Event|0|||
42208264|NCT03320850|76022094|FG008|Overall Study|Adverse Event|2|||
42208265|NCT03320850|76022095|FG009|Overall Study|Adverse Event|0|||
42208266|NCT03320850|76022086|FG000|Overall Study|Reason Not Specified|0|||
42208267|NCT03320850|76022087|FG001|Overall Study|Reason Not Specified|0|||
42208268|NCT03320850|76022088|FG002|Overall Study|Reason Not Specified|0|||
42208269|NCT03320850|76022089|FG003|Overall Study|Reason Not Specified|0|||
42208270|NCT03320850|76022090|FG004|Overall Study|Reason Not Specified|0|||
42208271|NCT03320850|76022091|FG005|Overall Study|Reason Not Specified|1|||
42208272|NCT03320850|76022092|FG006|Overall Study|Reason Not Specified|0|||
42208273|NCT03320850|76022093|FG007|Overall Study|Reason Not Specified|0|||
42208274|NCT03320850|76022094|FG008|Overall Study|Reason Not Specified|0|||
42208275|NCT03320850|76022095|FG009|Overall Study|Reason Not Specified|1|||
42208276|NCT03301623|76022124|FG000|Overall Study|Death|3|||
42208277|NCT03301623|76022125|FG001|Overall Study|Death|1|||
42208278|NCT03301623|76022124|FG000|Overall Study|Withdrawal by Subject|11|||
42208279|NCT03301623|76022125|FG001|Overall Study|Withdrawal by Subject|13|||
42208280|NCT03301623|76022124|FG000|Overall Study|Lost to Follow-up|3|||
42208281|NCT03301623|76022125|FG001|Overall Study|Lost to Follow-up|1|||
42208282|NCT03319212|76022133|FG000|Overall Study|Discontinued as moving out of local area|0|||
42208283|NCT03319212|76022134|FG001|Overall Study|Discontinued as moving out of local area|1|||
42208284|NCT03319212|76022133|FG000|Overall Study|Adverse Event|2|||
42208285|NCT03319212|76022134|FG001|Overall Study|Adverse Event|2|||
42208286|NCT03319212|76022133|FG000|Overall Study|Withdrawal by Subject|0|||
42208287|NCT03319212|76022134|FG001|Overall Study|Withdrawal by Subject|1|||
42208288|NCT03319212|76022133|FG000|Overall Study|Lost to Follow-up|0|||
42208289|NCT03319212|76022134|FG001|Overall Study|Lost to Follow-up|1|||
42208290|NCT03319212|76022133|FG000|Overall Study|Physician Decision|1|||
42208291|NCT03319212|76022134|FG001|Overall Study|Physician Decision|0|||
42208292|NCT04656691|76022139|FG000|Overall Study|Adverse Event|1|||
42208293|NCT03301155|76022145|FG000|Overall Study|Сompliance with exclusion criteria|8|||
42208294|NCT03301155|76022146|FG001|Overall Study|Сompliance with exclusion criteria|7|||
42208295|NCT01952730|76022152|FG000|Overall Study|FDA shut down core lab used by study|1|||
42208296|NCT03316170|76022158|FG000|Overall Study|Death|1|||
42208297|NCT03316170|76022159|FG001|Overall Study|Death|0|||
42208298|NCT03316170|76022158|FG000|Overall Study|Lost to Follow-up|6|||
42208299|NCT03316170|76022159|FG001|Overall Study|Lost to Follow-up|7|||
42208300|NCT03257865|76022168|FG000|Overall Study|Adverse Event|4|||
42208301|NCT03257865|76022169|FG001|Overall Study|Adverse Event|8|||
42208302|NCT03257865|76022168|FG000|Overall Study|Lack of Efficacy|1|||
42208303|NCT03257865|76022169|FG001|Overall Study|Lack of Efficacy|2|||
42208304|NCT03257865|76022168|FG000|Overall Study|Non-compliance with Study Drug|0|||
42208305|NCT03257865|76022169|FG001|Overall Study|Non-compliance with Study Drug|2|||
42208306|NCT03257865|76022168|FG000|Overall Study|Withdrawal by Subject|23|||
42208307|NCT03257865|76022169|FG001|Overall Study|Withdrawal by Subject|17|||
42208308|NCT03257865|76022168|FG000|Overall Study|Physician Decision|3|||
42208309|NCT03257865|76022169|FG001|Overall Study|Physician Decision|1|||
42208310|NCT03257865|76022168|FG000|Overall Study|Other|0|||
42208311|NCT03257865|76022169|FG001|Overall Study|Other|1|||
42208312|NCT03257865|76022168|FG000|Overall Study|Lost to Follow-up|4|||
42208313|NCT03257865|76022169|FG001|Overall Study|Lost to Follow-up|4|||
42208314|NCT04617847|76022177|FG000|Overall Study|Withdrawal by Subject|1|||
42208315|NCT04617847|76022178|FG001|Overall Study|Withdrawal by Subject|0|||
42208316|NCT04617847|76022177|FG000|Overall Study|Adverse Event|0|||
42208317|NCT04617847|76022178|FG001|Overall Study|Adverse Event|2|||
42208318|NCT04617847|76022177|FG000|Overall Study|Death|0|||
42208319|NCT04617847|76022178|FG001|Overall Study|Death|1|||
42208320|NCT04617847|76022177|FG000|Overall Study|Termination of Study by Sponsor|2|||
42208321|NCT04617847|76022178|FG001|Overall Study|Termination of Study by Sponsor|21|||
42208322|NCT04615507|76022188|FG000|Period 1|Covid-19 exposure|2|||
42208323|NCT04615507|76022189|FG001|Period 1|Covid-19 exposure|1|||
42208324|NCT04615507|76022188|FG000|Period 2|Covid-19 exposure|0|||
42208325|NCT04615507|76022189|FG001|Period 2|Covid-19 exposure|1|||
42208326|NCT04615507|76022188|FG000|Period 2|Protocol Violation|1|||
42208327|NCT04615507|76022189|FG001|Period 2|Protocol Violation|0|||
42208328|NCT04615507|76022188|FG000|Period 2|Withdrawal by Subject|1|||
42208329|NCT04615507|76022189|FG001|Period 2|Withdrawal by Subject|0|||
42208330|NCT04615507|76022188|FG000|Period 2|Adverse Event|0|||
42208331|NCT04615507|76022189|FG001|Period 2|Adverse Event|1|||
42208332|NCT04615507|76022188|FG000|Period 3|Covid-19 exposure|0|||
42208333|NCT04615507|76022189|FG001|Period 3|Covid-19 exposure|1|||
42208334|NCT04120233|76022201|FG000|Overall Study|Adverse Event|0|||
42208335|NCT04120233|76022202|FG001|Overall Study|Adverse Event|0|||
42208336|NCT04120233|76022203|FG002|Overall Study|Adverse Event|0|||
42208337|NCT04120233|76022204|FG003|Overall Study|Adverse Event|0|||
42208338|NCT04120233|76022205|FG004|Overall Study|Adverse Event|1|||
42208339|NCT04120233|76022206|FG005|Overall Study|Adverse Event|0|||
42208340|NCT01610700|76022222|FG000|Overall Study|Adverse Event|3|||
42208341|NCT01610700|76022223|FG001|Overall Study|Adverse Event|1|||
42208342|NCT01610700|76022222|FG000|Overall Study|Withdrawal by Subject|0|||
42208343|NCT01610700|76022223|FG001|Overall Study|Withdrawal by Subject|1|||
42208344|NCT01610700|76022222|FG000|Overall Study|subject took one dose of street cannabis|0|||
42208345|NCT01610700|76022223|FG001|Overall Study|subject took one dose of street cannabis|1|||
42208346|NCT03256851|76022232|FG000|Overall Study|Withdrawal by Subject|1|||
42208347|NCT03256851|76022233|FG001|Overall Study|Withdrawal by Subject|0|||
42208348|NCT04837807|76022239|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
42208349|NCT04837807|76022240|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
42208350|NCT03256695|76022246|FG000|Overall Study|Adverse Event|8|||
42208351|NCT03256695|76022246|FG000|Overall Study|Death|2|||
42208352|NCT03256695|76022246|FG000|Overall Study|Withdrawal by Subject|14|||
42208353|NCT03256695|76022246|FG000|Overall Study|Non-compliance with study drug|1|||
42208354|NCT03256695|76022246|FG000|Overall Study|Lost to Follow-up|3|||
42208355|NCT03256695|76022246|FG000|Overall Study|Lack of Efficacy|3|||
42208356|NCT03256695|76022246|FG000|Overall Study|Protocol Violation|5|||
42208357|NCT03256695|76022246|FG000|Overall Study|Other than specified|3|||
42208358|NCT03305016|76022250|FG000|Overall Study|Withdrawal by Subject|2|||
42208359|NCT03297021|76022257|FG000|Overall Study|Incomplete/illegible data sheet|4|||
42208360|NCT03297021|76022258|FG001|Overall Study|Incomplete/illegible data sheet|2|||
42208361|NCT03297021|76022259|FG002|Overall Study|Incomplete/illegible data sheet|3|||
42208362|NCT03297021|76022257|FG000|Overall Study|Missing Post-Op Data|1|||
42208363|NCT03297021|76022258|FG001|Overall Study|Missing Post-Op Data|2|||
42208364|NCT03297021|76022259|FG002|Overall Study|Missing Post-Op Data|1|||
42208365|NCT04820491|76022269|FG000|Overall Study|Withdrawal by Subject|1|||
42208366|NCT04820491|76022270|FG001|Overall Study|Withdrawal by Subject|0|||
42208367|NCT01988571|76022278|FG000|Overall Study|Death|3|||
42208368|NCT01988571|76022279|FG001|Overall Study|Death|1|||
42208369|NCT01988571|76022278|FG000|Overall Study|Physician Decision|2|||
42208370|NCT01988571|76022279|FG001|Overall Study|Physician Decision|1|||
42208371|NCT01988571|76022278|FG000|Overall Study|Lost to Follow-up|3|||
42208372|NCT01988571|76022279|FG001|Overall Study|Lost to Follow-up|0|||
42208373|NCT01988571|76022278|FG000|Overall Study|Withdrawal by Subject|31|||
42208374|NCT01988571|76022279|FG001|Overall Study|Withdrawal by Subject|33|||
42208375|NCT04794751|76022285|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
42208376|NCT04794751|76022286|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
42208377|NCT04794751|76022285|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
42208378|NCT04794751|76022286|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
42208379|NCT04794751|76022285|FG000|Period 1|Protocol Violation|0|||
42208380|NCT04794751|76022286|FG001|Period 1|Protocol Violation|2|||
42208381|NCT04794751|76022285|FG000|Period 1|Withdrawal by Subject|0|||
42208382|NCT04794751|76022286|FG001|Period 1|Withdrawal by Subject|1|||
42208383|NCT04794751|76022285|FG000|Period 2|Withdrawal by Subject|0|||
42208384|NCT04794751|76022286|FG001|Period 2|Withdrawal by Subject|1|||
42208385|NCT04794751|76022285|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
42208386|NCT04794751|76022286|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
42208387|NCT04794751|76022285|FG000|Period 2|Protocol Violation|1|||
42208388|NCT04794751|76022286|FG001|Period 2|Protocol Violation|0|||
42208389|NCT04578457|76022292|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
42208390|NCT04578457|76022292|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
42208391|NCT04578457|76022292|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
42208392|NCT04578457|76022292|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
42208393|NCT03334188|76022302|FG000|Overall Study|Withdrawal by Subject|0|||
42208394|NCT03334188|76022303|FG001|Overall Study|Withdrawal by Subject|1|||
42208395|NCT03334188|76022302|FG000|Overall Study|Death|1|||
42208396|NCT03334188|76022303|FG001|Overall Study|Death|0|||
42208397|NCT03334188|76022302|FG000|Overall Study|Never had qualifying clinic visit|7|||
42208398|NCT03334188|76022303|FG001|Overall Study|Never had qualifying clinic visit|7|||
42208399|NCT03333876|76022312|FG000|Screening Period|Screen Failure|4|||
42208400|NCT03333876|76022312|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
42208401|NCT03333876|76022312|FG000|Mandibular Advancement|Adverse Event|2|||
42208402|NCT03333876|76022312|FG000|Mandibular Advancement|Product Damage|2|||
42208403|NCT03294681|76022325|FG000|Overall Study|Withdrawal by Subject|1|||
42208404|NCT01140867|76022329|FG000|Overall Study|Adverse Event|22|||
42208405|NCT01140867|76022329|FG000|Overall Study|Lack of Efficacy|3|||
42208406|NCT01140867|76022329|FG000|Overall Study|Lost to Follow-up|2|||
42208407|NCT01140867|76022329|FG000|Overall Study|Withdrawal by Subject|1|||
42208408|NCT01140867|76022329|FG000|Overall Study|Protocol Violation|1|||
42208409|NCT01140867|76022329|FG000|Overall Study|Uncooperative patient|2|||
42208410|NCT01140867|76022329|FG000|Overall Study|Medication Noncompliance|2|||
42208411|NCT04572997|76022333|FG000|Overall Study|Adverse Event|1|||
42208412|NCT02943096|76022343|FG000|Overall Study|Lack of Efficacy|0|||
42208413|NCT02943096|76022344|FG001|Overall Study|Lack of Efficacy|1|||
42208414|NCT04571515|76022355|FG000|Overall Study|Physician Decision|0|||
42208415|NCT04571515|76022356|FG001|Overall Study|Physician Decision|0|||
42208416|NCT04571515|76022357|FG002|Overall Study|Physician Decision|0|||
42208417|NCT04571515|76022358|FG003|Overall Study|Physician Decision|0|||
42208418|NCT04571515|76022359|FG004|Overall Study|Physician Decision|1|||
42208419|NCT04571515|76022355|FG000|Overall Study|Withdrawal by Subject|0|||
42208420|NCT04571515|76022356|FG001|Overall Study|Withdrawal by Subject|0|||
42208421|NCT04571515|76022357|FG002|Overall Study|Withdrawal by Subject|0|||
42208422|NCT04571515|76022358|FG003|Overall Study|Withdrawal by Subject|0|||
42208423|NCT04571515|76022359|FG004|Overall Study|Withdrawal by Subject|1|||
42208424|NCT04571515|76022355|FG000|Overall Study|insufficient pain|1|||
42208425|NCT04571515|76022356|FG001|Overall Study|insufficient pain|0|||
42208426|NCT04571515|76022357|FG002|Overall Study|insufficient pain|0|||
42208427|NCT04571515|76022358|FG003|Overall Study|insufficient pain|0|||
42208428|NCT04571515|76022359|FG004|Overall Study|insufficient pain|1|||
42208429|NCT03292653|76022374|FG000|Overall Study|Adverse Event|0|||
42208430|NCT03292653|76022375|FG001|Overall Study|Adverse Event|0|||
42208431|NCT03292653|76022376|FG002|Overall Study|Adverse Event|1|||
42208432|NCT03292653|76022374|FG000|Overall Study|Did not Receive Treatment|1|||
42208433|NCT03292653|76022375|FG001|Overall Study|Did not Receive Treatment|0|||
42208434|NCT03292653|76022376|FG002|Overall Study|Did not Receive Treatment|0|||
42208435|NCT03858634|76022387|FG000|Overall Study|Withdrawal by Subject|1|||
42208436|NCT03858634|76022388|FG001|Overall Study|Withdrawal by Subject|0|||
42208437|NCT03858634|76022387|FG000|Overall Study|Adverse Event|1|||
42208438|NCT03858634|76022388|FG001|Overall Study|Adverse Event|0|||
42208439|NCT03858634|76022387|FG000|Overall Study|Lost to Follow-up|0|||
42208440|NCT03858634|76022388|FG001|Overall Study|Lost to Follow-up|1|||
42208441|NCT03858634|76022387|FG000|Overall Study|Other, Not Specified|1|||
42208442|NCT03858634|76022388|FG001|Overall Study|Other, Not Specified|1|||
42208443|NCT02891070|76022404|FG000|Overall Study|Adverse Event|1|||
42208444|NCT02891070|76022405|FG001|Overall Study|Adverse Event|0|||
42208445|NCT02891070|76022404|FG000|Overall Study|Physician Decision|0|||
42208446|NCT02891070|76022405|FG001|Overall Study|Physician Decision|1|||
42208447|NCT02891070|76022404|FG000|Overall Study|Lost to Follow-up|4|||
42208448|NCT02891070|76022405|FG001|Overall Study|Lost to Follow-up|4|||
42208449|NCT02891070|76022404|FG000|Overall Study|Other|1|||
42208450|NCT02891070|76022405|FG001|Overall Study|Other|0|||
42208451|NCT02891070|76022404|FG000|Overall Study|Protocol Violation|0|||
42208452|NCT02891070|76022405|FG001|Overall Study|Protocol Violation|1|||
42208453|NCT02891070|76022404|FG000|Overall Study|Withdrawal by Subject|1|||
42208454|NCT02891070|76022405|FG001|Overall Study|Withdrawal by Subject|2|||
42208455|NCT02891070|76022404|FG000|Overall Study|Death|3|||
42208456|NCT02891070|76022405|FG001|Overall Study|Death|0|||
42208457|NCT03255291|76022417|FG000|Overall Study|Determined to be ineligible|10|||
42208458|NCT03255291|76022418|FG001|Overall Study|Determined to be ineligible|12|||
42208459|NCT03255291|76022419|FG002|Overall Study|Determined to be ineligible|6|||
42208460|NCT03255291|76022420|FG003|Overall Study|Determined to be ineligible|6|||
42208461|NCT03255291|76022421|FG004|Overall Study|Determined to be ineligible|5|||
42208462|NCT03255291|76022422|FG005|Overall Study|Determined to be ineligible|10|||
42208463|NCT03255291|76022417|FG000|Overall Study|Baseline data collection issues|3|||
42208464|NCT03255291|76022418|FG001|Overall Study|Baseline data collection issues|0|||
42208465|NCT03255291|76022419|FG002|Overall Study|Baseline data collection issues|0|||
42208466|NCT03255291|76022420|FG003|Overall Study|Baseline data collection issues|0|||
42208467|NCT03255291|76022421|FG004|Overall Study|Baseline data collection issues|2|||
42208468|NCT03255291|76022422|FG005|Overall Study|Baseline data collection issues|0|||
42208469|NCT00381381|76022440|FG000|Overall Study|Adverse Event|3|||
42208470|NCT00381381|76022440|FG000|Overall Study|Lost to Follow-up|52|||
42208471|NCT00381381|76022440|FG000|Overall Study|Withdrawal by Subject|9|||
42208472|NCT02939937|76022446|FG000|Overall Study|Adverse Event|5|||
42208473|NCT02939937|76022447|FG001|Overall Study|Adverse Event|0|||
42208474|NCT02939937|76022446|FG000|Overall Study|Lost to Follow-up|1|||
42208475|NCT02939937|76022447|FG001|Overall Study|Lost to Follow-up|3|||
42208476|NCT02939079|76022455|FG000|Overall Study|Adverse Event|2|||
42208477|NCT02939079|76022456|FG001|Overall Study|Adverse Event|1|||
42208478|NCT02939079|76022455|FG000|Overall Study|Lost to Follow-up|0|||
42208479|NCT02939079|76022456|FG001|Overall Study|Lost to Follow-up|2|||
42208480|NCT02939079|76022455|FG000|Overall Study|Protocol Violation|1|||
42208481|NCT02939079|76022456|FG001|Overall Study|Protocol Violation|0|||
42208482|NCT02939079|76022455|FG000|Overall Study|Withdrawal by Subject|0|||
42208483|NCT02939079|76022456|FG001|Overall Study|Withdrawal by Subject|1|||
42208484|NCT02939079|76022455|FG000|Overall Study|relapse during the study|1|||
42208485|NCT02939079|76022456|FG001|Overall Study|relapse during the study|1|||
42208486|NCT04562155|76022466|FG000|Overall Study|COVID-19 pandemic|0|||
42208487|NCT04562155|76022467|FG001|Overall Study|COVID-19 pandemic|0|||
42208488|NCT04562155|76022468|FG002|Overall Study|COVID-19 pandemic|0|||
42208489|NCT04562155|76022469|FG003|Overall Study|COVID-19 pandemic|1|||
42208490|NCT04562155|76022466|FG000|Overall Study|Adverse Event|7|||
42208491|NCT04562155|76022467|FG001|Overall Study|Adverse Event|3|||
42208492|NCT04562155|76022468|FG002|Overall Study|Adverse Event|8|||
42208493|NCT04562155|76022469|FG003|Overall Study|Adverse Event|1|||
42208494|NCT04562155|76022466|FG000|Overall Study|Withdrawal by Subject|3|||
42208495|NCT04562155|76022467|FG001|Overall Study|Withdrawal by Subject|6|||
42208496|NCT04562155|76022468|FG002|Overall Study|Withdrawal by Subject|3|||
42208497|NCT04562155|76022469|FG003|Overall Study|Withdrawal by Subject|3|||
42208498|NCT04562155|76022466|FG000|Overall Study|Participant personal reason|1|||
42208499|NCT04562155|76022467|FG001|Overall Study|Participant personal reason|0|||
42208500|NCT04562155|76022468|FG002|Overall Study|Participant personal reason|2|||
42208501|NCT04562155|76022469|FG003|Overall Study|Participant personal reason|1|||
42208502|NCT03313050|76022483|FG000|Stage 2: 12 Months|Adverse Event|0|||
42208503|NCT03313050|76022484|FG001|Stage 2: 12 Months|Adverse Event|0|||
42208504|NCT03313050|76022485|FG002|Stage 2: 12 Months|Adverse Event|0|||
42208505|NCT03313050|76022486|FG003|Stage 2: 12 Months|Adverse Event|1|||
42208506|NCT03313050|76022483|FG000|Stage 2: 12 Months|Death|0|||
42208507|NCT03313050|76022484|FG001|Stage 2: 12 Months|Death|0|||
42208508|NCT03313050|76022485|FG002|Stage 2: 12 Months|Death|3|||
42208509|NCT03313050|76022486|FG003|Stage 2: 12 Months|Death|0|||
42208510|NCT03313050|76022483|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
42208511|NCT03313050|76022484|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
42208512|NCT03313050|76022485|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
42208513|NCT03313050|76022486|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
42208514|NCT03313050|76022483|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
42208515|NCT03313050|76022484|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
42208516|NCT03313050|76022485|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
42208517|NCT03313050|76022486|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
42208518|NCT03313050|76022483|FG000|Stage 2: 12 Months|Protocol deviation|0|||
42208519|NCT03313050|76022484|FG001|Stage 2: 12 Months|Protocol deviation|0|||
42208520|NCT03313050|76022485|FG002|Stage 2: 12 Months|Protocol deviation|7|||
42208521|NCT03313050|76022486|FG003|Stage 2: 12 Months|Protocol deviation|7|||
42208522|NCT03313050|76022483|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
42208523|NCT03313050|76022484|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
42208524|NCT03313050|76022485|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
42208525|NCT03313050|76022486|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
42208526|NCT03313050|76022483|FG000|Stage 2: 12 Months|Other|0|||
42299863|NCT02554877|76134889|FG003|Overall Study|No longer willing to participate|0|||
42208527|NCT03313050|76022484|FG001|Stage 2: 12 Months|Other|0|||
42208528|NCT03313050|76022485|FG002|Stage 2: 12 Months|Other|0|||
42208529|NCT03313050|76022486|FG003|Stage 2: 12 Months|Other|1|||
42208530|NCT04755595|76022505|FG000|Overall Study|Lost to Follow-up|1|||
42208531|NCT04749745|76022510|FG000|Overall Study|Withdrawal by Subject|1|||
42208532|NCT04749745|76022511|FG001|Overall Study|Withdrawal by Subject|0|||
42208533|NCT03257436|76022517|FG000|Overall Study|Withdrawal by Subject|76|||
42208534|NCT03257436|76022517|FG000|Overall Study|Death|19|||
42208535|NCT04748341|76022523|FG000|Overall Study|Lost to Follow-up|1|||
42208536|NCT04748341|76022524|FG001|Overall Study|Lost to Follow-up|1|||
42208537|NCT01328002|76022530|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
42208538|NCT01328002|76022531|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
42208539|NCT01328002|76022530|FG000|Open-Label Period|Adverse Event|8|||
42208540|NCT01328002|76022531|FG001|Open-Label Period|Adverse Event|0|||
42208541|NCT01328002|76022530|FG000|Open-Label Period|Lack of Efficacy|3|||
42208542|NCT01328002|76022531|FG001|Open-Label Period|Lack of Efficacy|0|||
42208543|NCT01328002|76022530|FG000|Open-Label Period|Protocol Violation|2|||
42208544|NCT01328002|76022531|FG001|Open-Label Period|Protocol Violation|0|||
42208545|NCT01328002|76022530|FG000|Open-Label Period|Withdrawal by Subject|9|||
42208546|NCT01328002|76022531|FG001|Open-Label Period|Withdrawal by Subject|0|||
42208547|NCT01328002|76022530|FG000|Open-Label Period|Lost to Follow-up|6|||
42208548|NCT01328002|76022531|FG001|Open-Label Period|Lost to Follow-up|0|||
42208549|NCT01328002|76022530|FG000|Open-Label Period|Other Reason|2|||
42208550|NCT01328002|76022531|FG001|Open-Label Period|Other Reason|0|||
42208551|NCT01328002|76022530|FG000|Double-Blind Period|Adverse Event|1|||
42208552|NCT01328002|76022531|FG001|Double-Blind Period|Adverse Event|0|||
42208553|NCT01328002|76022530|FG000|Double-Blind Period|Lack of Efficacy|1|||
42208554|NCT01328002|76022531|FG001|Double-Blind Period|Lack of Efficacy|0|||
42208555|NCT02579265|76022540|FG000|Overall Study|Weaned off earlier than 28 days|44|||
42208556|NCT02579265|76022541|FG001|Overall Study|Weaned off earlier than 28 days|43|||
42208557|NCT02579265|76022540|FG000|Overall Study|Adverse Event|2|||
42208558|NCT02579265|76022541|FG001|Overall Study|Adverse Event|0|||
42208559|NCT02579265|76022540|FG000|Overall Study|Any other reason not specified|0|||
42208560|NCT02579265|76022541|FG001|Overall Study|Any other reason not specified|2|||
42208561|NCT02579265|76022540|FG000|Overall Study|Withdrawal by Subject|2|||
42208562|NCT02579265|76022541|FG001|Overall Study|Withdrawal by Subject|0|||
42208563|NCT02579265|76022540|FG000|Overall Study|Physician Decision|1|||
42208564|NCT02579265|76022541|FG001|Overall Study|Physician Decision|0|||
42208565|NCT02579265|76022540|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
42208566|NCT02579265|76022541|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
42208567|NCT03289533|76022547|FG000|Overall Study|Death|12|||
42208568|NCT03289533|76022547|FG000|Overall Study|Terminated from study by sponsor|10|||
42208569|NCT04727749|76022553|FG000|Overall Study|Lost to Follow-up|10|||
42208570|NCT04727749|76022554|FG001|Overall Study|Lost to Follow-up|3|||
42208571|NCT04547023|76022564|FG000|Overall Study|Did Not Receive Intervention|3|||
42208572|NCT04547023|76022565|FG001|Overall Study|Did Not Receive Intervention|2|||
42208573|NCT04547023|76022564|FG000|Overall Study|Lost to Follow-up|1|||
42208574|NCT04547023|76022565|FG001|Overall Study|Lost to Follow-up|1|||
42208575|NCT03697993|76022575|FG000|Overall Study|Became Ineligible after Enrollment|1|||
42208576|NCT03697993|76022576|FG001|Overall Study|Became Ineligible after Enrollment|3|||
42208577|NCT03697993|76022575|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
42208578|NCT03697993|76022576|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
42208579|NCT03697993|76022575|FG000|Overall Study|Lost to Follow-up|3|||
42208580|NCT03697993|76022576|FG001|Overall Study|Lost to Follow-up|0|||
42208581|NCT03697993|76022575|FG000|Overall Study|Physician Decision|4|||
42208582|NCT03697993|76022576|FG001|Overall Study|Physician Decision|0|||
42208583|NCT03697993|76022575|FG000|Overall Study|Initial Urine Culture Negative|0|||
42299864|NCT02554721|76134904|FG000|Overall Study|Adverse Event|1|||
42208584|NCT03697993|76022576|FG001|Overall Study|Initial Urine Culture Negative|1|||
42208585|NCT03289455|76022586|FG000|Overall Study|Death|1|||
42208586|NCT03289455|76022587|FG001|Overall Study|Death|0|||
42208587|NCT03289455|76022588|FG002|Overall Study|Death|0|||
42208588|NCT03289455|76022586|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
42208589|NCT03289455|76022587|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
42208590|NCT03289455|76022588|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
42208591|NCT03289455|76022586|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
42208592|NCT03289455|76022587|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
42208593|NCT03289455|76022588|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
42208594|NCT03289455|76022586|FG000|Overall Study|Progressive disease|3|||
42208595|NCT03289455|76022587|FG001|Overall Study|Progressive disease|4|||
42208596|NCT03289455|76022588|FG002|Overall Study|Progressive disease|5|||
42208597|NCT04484857|76022597|FG000|Overall Study|Adverse Event|2|||
42208598|NCT04484857|76022597|FG000|Overall Study|Death|10|||
42208599|NCT04484857|76022597|FG000|Overall Study|Withdrawal by Subject|3|||
42208600|NCT04484857|76022597|FG000|Overall Study|Transferred/Relocation|5|||
42208601|NCT04484857|76022597|FG000|Overall Study|Kidney Transplant|7|||
42208602|NCT04484857|76022597|FG000|Overall Study|Other than specified|4|||
42208603|NCT04484857|76022597|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
42208604|NCT04095793|76022601|FG000|Overall Study|Adverse Event|3|||
42208605|NCT04095793|76022601|FG000|Overall Study|Study Terminated by Sponsor|103|||
42208606|NCT04095793|76022601|FG000|Overall Study|Withdrawal by Subject|4|||
42299865|NCT02554721|76134905|FG001|Overall Study|Adverse Event|0|||
42299866|NCT02554721|76134906|FG002|Overall Study|Adverse Event|0|||
42208607|NCT04482439|76022605|FG000|Overall Study|Lost to Follow-up|1|||
42208608|NCT04482439|76022605|FG000|Overall Study|Unrelated illness|1|||
42208609|NCT04535947|76022612|FG000|Overall Study|Adverse Event|1|||
42208610|NCT04535947|76022613|FG001|Overall Study|Adverse Event|4|||
42208611|NCT04535947|76022612|FG000|Overall Study|Other reasons not specified|2|||
42208612|NCT04535947|76022613|FG001|Overall Study|Other reasons not specified|0|||
42208613|NCT04535947|76022612|FG000|Overall Study|Withdrawal by Subject|1|||
42208614|NCT04535947|76022613|FG001|Overall Study|Withdrawal by Subject|1|||
42208615|NCT04474405|76022625|FG000|Overall Study|Withdrawal by Subject|0|||
42208616|NCT04474405|76022626|FG001|Overall Study|Withdrawal by Subject|0|||
42208617|NCT04474405|76022627|FG002|Overall Study|Withdrawal by Subject|1|||
42208618|NCT04474405|76022628|FG003|Overall Study|Withdrawal by Subject|0|||
42208619|NCT04474405|76022629|FG004|Overall Study|Withdrawal by Subject|1|||
42208620|NCT04474405|76022630|FG005|Overall Study|Withdrawal by Subject|0|||
42208621|NCT04474405|76022625|FG000|Overall Study|Other|0|||
42208622|NCT04474405|76022626|FG001|Overall Study|Other|0|||
42208623|NCT04474405|76022627|FG002|Overall Study|Other|0|||
42208624|NCT04474405|76022628|FG003|Overall Study|Other|0|||
42208625|NCT04474405|76022629|FG004|Overall Study|Other|3|||
42208626|NCT04474405|76022630|FG005|Overall Study|Other|0|||
42208627|NCT04531813|76022644|FG000|Overall Study|Protocol Violation|1|||
42208628|NCT04531813|76022644|FG000|Overall Study|Withdrawal by Subject|1|||
42208629|NCT03538444|76022650|FG000|Overall Study|opioid withdrawal|1|||
42208630|NCT03538444|76022651|FG001|Overall Study|opioid withdrawal|0|||
42208631|NCT01199302|76022661|FG000|Overall Study|Adverse Event|1|||
42208632|NCT01199302|76022662|FG001|Overall Study|Adverse Event|1|||
42208633|NCT01199302|76022663|FG002|Overall Study|Adverse Event|2|||
42208634|NCT01199302|76022664|FG003|Overall Study|Adverse Event|0|||
42208635|NCT01199302|76022661|FG000|Overall Study|Withdrawal by Subject|2|||
42208636|NCT01199302|76022662|FG001|Overall Study|Withdrawal by Subject|2|||
42208637|NCT01199302|76022663|FG002|Overall Study|Withdrawal by Subject|3|||
42208638|NCT01199302|76022664|FG003|Overall Study|Withdrawal by Subject|0|||
42208639|NCT01199302|76022661|FG000|Overall Study|Disease Progression|3|||
42208640|NCT01199302|76022662|FG001|Overall Study|Disease Progression|4|||
42208641|NCT01199302|76022663|FG002|Overall Study|Disease Progression|4|||
42208642|NCT01199302|76022664|FG003|Overall Study|Disease Progression|2|||
42208643|NCT01199302|76022661|FG000|Overall Study|Study Termination|13|||
42208644|NCT01199302|76022662|FG001|Overall Study|Study Termination|8|||
42208645|NCT01199302|76022663|FG002|Overall Study|Study Termination|11|||
42208646|NCT01199302|76022664|FG003|Overall Study|Study Termination|9|||
42208647|NCT01199302|76022661|FG000|Overall Study|Lost to Follow-up|0|||
42208648|NCT01199302|76022662|FG001|Overall Study|Lost to Follow-up|1|||
42208649|NCT01199302|76022663|FG002|Overall Study|Lost to Follow-up|0|||
42208650|NCT01199302|76022664|FG003|Overall Study|Lost to Follow-up|0|||
42208651|NCT01199302|76022661|FG000|Overall Study|Other|1|||
42208652|NCT01199302|76022662|FG001|Overall Study|Other|0|||
42208653|NCT01199302|76022663|FG002|Overall Study|Other|0|||
42208654|NCT01199302|76022664|FG003|Overall Study|Other|0|||
42208655|NCT03332784|76022691|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208656|NCT03332784|76022692|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
42208657|NCT03332784|76022693|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208658|NCT03332784|76022694|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208659|NCT03332784|76022695|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208660|NCT03332784|76022696|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208661|NCT03332784|76022697|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208662|NCT03332784|76022698|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208663|NCT03332784|76022699|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208664|NCT03332784|76022700|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208665|NCT03332784|76022701|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208666|NCT03332784|76022702|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208667|NCT03332784|76022703|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208668|NCT03332784|76022704|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208669|NCT03332784|76022705|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
42208670|NCT03332784|76022706|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208671|NCT03332784|76022707|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208672|NCT03332784|76022708|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208673|NCT03332784|76022709|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208674|NCT03332784|76022710|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
42208675|NCT04465357|76022774|FG000|Overall Study|Adverse Event|2|||
42208676|NCT04465357|76022774|FG000|Overall Study|Lack of Efficacy|1|||
42208677|NCT04465357|76022774|FG000|Overall Study|Lost to Follow-up|2|||
42208678|NCT04465357|76022774|FG000|Overall Study|Withdrawal by Subject|6|||
42208679|NCT04465357|76022774|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
42208680|NCT03332628|76022778|FG000|Overall Study|Physician Decision|2|||
42208681|NCT04516759|76022785|FG000|Overall Study|Withdrawal by Subject|1|||
42208682|NCT04516759|76022786|FG001|Overall Study|Withdrawal by Subject|1|||
42208683|NCT04516759|76022785|FG000|Overall Study|Other|0|||
42208684|NCT04516759|76022786|FG001|Overall Study|Other|1|||
42208685|NCT03332160|76022794|FG000|Overall Study|Withdrawal by Subject|1|||
42208686|NCT03332160|76022795|FG001|Overall Study|Withdrawal by Subject|1|||
42208687|NCT03332160|76022794|FG000|Overall Study|Adverse Event|0|||
42208688|NCT03332160|76022795|FG001|Overall Study|Adverse Event|1|||
42208689|NCT03332160|76022794|FG000|Overall Study|Developed Exclusion Criteria|0|||
42208690|NCT03332160|76022795|FG001|Overall Study|Developed Exclusion Criteria|1|||
42208691|NCT03332160|76022794|FG000|Overall Study|Non-adherence to treatment|0|||
42208692|NCT03332160|76022795|FG001|Overall Study|Non-adherence to treatment|2|||
42208693|NCT03312114|76022802|FG000|Overall Study|All the five enrolled dropped out of the|5|||
42208694|NCT03694327|76022809|FG000|Overall Study|Lost to Follow-up|13|||
42208695|NCT03694327|76022810|FG001|Overall Study|Lost to Follow-up|23|||
42208696|NCT03330288|76022818|FG000|Overall Study|Other reason|1|||
42208697|NCT03330288|76022819|FG001|Overall Study|Other reason|1|||
42208698|NCT03330288|76022818|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
42208699|NCT03330288|76022819|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
42208700|NCT03330288|76022818|FG000|Overall Study|Adverse Event|1|||
42208701|NCT03330288|76022819|FG001|Overall Study|Adverse Event|0|||
42208702|NCT03330288|76022818|FG000|Overall Study|Withdrawal by Subject|1|||
42208703|NCT03330288|76022819|FG001|Overall Study|Withdrawal by Subject|0|||
42208704|NCT03330288|76022818|FG000|Overall Study|Lost to Follow-up|26|||
42208705|NCT03330288|76022819|FG001|Overall Study|Lost to Follow-up|7|||
42208706|NCT03084536|76022828|FG000|Overall Study|Determined to be ineligible|0|||
42208707|NCT03084536|76022829|FG001|Overall Study|Determined to be ineligible|0|||
42208708|NCT03084536|76022830|FG002|Overall Study|Determined to be ineligible|16|||
42208709|NCT03084536|76022828|FG000|Overall Study|Withdrawal by Subject|0|||
42208710|NCT03084536|76022829|FG001|Overall Study|Withdrawal by Subject|0|||
42208711|NCT03084536|76022830|FG002|Overall Study|Withdrawal by Subject|4|||
42208712|NCT03084536|76022828|FG000|Overall Study|Physician Decision|0|||
42208713|NCT03084536|76022829|FG001|Overall Study|Physician Decision|0|||
42208714|NCT03084536|76022830|FG002|Overall Study|Physician Decision|3|||
42208715|NCT03084536|76022828|FG000|Overall Study|Death|0|||
42208716|NCT03084536|76022829|FG001|Overall Study|Death|0|||
42208717|NCT03084536|76022830|FG002|Overall Study|Death|1|||
42208718|NCT03084536|76022828|FG000|Overall Study|Lost to Follow-up|0|||
42208719|NCT03084536|76022829|FG001|Overall Study|Lost to Follow-up|0|||
42208720|NCT03084536|76022830|FG002|Overall Study|Lost to Follow-up|1|||
42208721|NCT03084536|76022828|FG000|Overall Study|Protocol Violation|0|||
42208722|NCT03084536|76022829|FG001|Overall Study|Protocol Violation|0|||
42208723|NCT03084536|76022830|FG002|Overall Study|Protocol Violation|1|||
42208724|NCT03084536|76022828|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
42208725|NCT03084536|76022829|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
42208726|NCT03084536|76022830|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
42208727|NCT05291936|76022837|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
42208728|NCT05291936|76022838|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
42208729|NCT05291936|76022837|FG000|Period 1|Withdrew Consent during study|1|||
42208730|NCT05291936|76022838|FG001|Period 1|Withdrew Consent during study|0|||
42208731|NCT05291936|76022837|FG000|Period 2|Adverse Event|0|||
42208732|NCT05291936|76022838|FG001|Period 2|Adverse Event|1|||
42208733|NCT05291936|76022837|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
42208734|NCT05291936|76022838|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
42208735|NCT03289143|76022848|FG000|Overall Study|Caregiver Unavailability|1|||
42208736|NCT03289143|76022849|FG001|Overall Study|Caregiver Unavailability|1|||
42208737|NCT03289143|76022850|FG002|Overall Study|Caregiver Unavailability|0|||
42208738|NCT03289143|76022851|FG003|Overall Study|Caregiver Unavailability|0|||
42208739|NCT03289143|76022848|FG000|Overall Study|Research Department Closure|0|||
42208740|NCT03289143|76022849|FG001|Overall Study|Research Department Closure|0|||
42208741|NCT03289143|76022850|FG002|Overall Study|Research Department Closure|1|||
42208742|NCT03289143|76022851|FG003|Overall Study|Research Department Closure|0|||
42208743|NCT03289143|76022848|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
42208744|NCT03289143|76022849|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
42208745|NCT03289143|76022850|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
42208746|NCT03289143|76022851|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
42208747|NCT03289143|76022848|FG000|Overall Study|Medical Monitor Decision|1|||
42299867|NCT02554721|76134907|FG003|Overall Study|Adverse Event|0|||
42299868|NCT02554721|76134908|FG004|Overall Study|Adverse Event|1|||
42299869|NCT02554721|76134904|FG000|Overall Study|Noncompliance|0|||
42299870|NCT02554721|76134905|FG001|Overall Study|Noncompliance|0|||
42208748|NCT03289143|76022849|FG001|Overall Study|Medical Monitor Decision|0|||
42208749|NCT03289143|76022850|FG002|Overall Study|Medical Monitor Decision|0|||
42208750|NCT03289143|76022851|FG003|Overall Study|Medical Monitor Decision|0|||
42208751|NCT03289143|76022848|FG000|Overall Study|Participant Non-Compliance|0|||
42208752|NCT03289143|76022849|FG001|Overall Study|Participant Non-Compliance|0|||
42208753|NCT03289143|76022850|FG002|Overall Study|Participant Non-Compliance|1|||
42208754|NCT03289143|76022851|FG003|Overall Study|Participant Non-Compliance|0|||
42299871|NCT02554721|76134906|FG002|Overall Study|Noncompliance|0|||
42208755|NCT03289143|76022848|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
42208756|NCT03289143|76022849|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
42208757|NCT03289143|76022850|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
42208758|NCT03289143|76022851|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
42208759|NCT03289143|76022848|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
42208760|NCT03289143|76022849|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
42208761|NCT03289143|76022850|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
42208762|NCT03289143|76022851|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
42208763|NCT03289143|76022848|FG000|Overall Study|Caregiver Passed Away|1|||
42208764|NCT03289143|76022849|FG001|Overall Study|Caregiver Passed Away|0|||
42208765|NCT03289143|76022850|FG002|Overall Study|Caregiver Passed Away|0|||
42208766|NCT03289143|76022851|FG003|Overall Study|Caregiver Passed Away|0|||
42208767|NCT03289143|76022848|FG000|Overall Study|Physician Decision|0|||
42208768|NCT03289143|76022849|FG001|Overall Study|Physician Decision|2|||
42208769|NCT03289143|76022850|FG002|Overall Study|Physician Decision|2|||
42208770|NCT03289143|76022851|FG003|Overall Study|Physician Decision|2|||
42208771|NCT03289143|76022848|FG000|Overall Study|Protocol Deviation|2|||
42208772|NCT03289143|76022849|FG001|Overall Study|Protocol Deviation|1|||
42208773|NCT03289143|76022850|FG002|Overall Study|Protocol Deviation|3|||
42208774|NCT03289143|76022851|FG003|Overall Study|Protocol Deviation|1|||
42208775|NCT03289143|76022848|FG000|Overall Study|Study Terminated By Sponsor|101|||
42208776|NCT03289143|76022849|FG001|Overall Study|Study Terminated By Sponsor|75|||
42208777|NCT03289143|76022850|FG002|Overall Study|Study Terminated By Sponsor|100|||
42208778|NCT03289143|76022851|FG003|Overall Study|Study Terminated By Sponsor|69|||
42208779|NCT03289143|76022848|FG000|Overall Study|Withdrawal by Subject|14|||
42208780|NCT03289143|76022849|FG001|Overall Study|Withdrawal by Subject|6|||
42208781|NCT03289143|76022850|FG002|Overall Study|Withdrawal by Subject|14|||
42208782|NCT03289143|76022851|FG003|Overall Study|Withdrawal by Subject|12|||
42208783|NCT03289143|76022848|FG000|Overall Study|Adverse Event|10|||
42208784|NCT03289143|76022849|FG001|Overall Study|Adverse Event|7|||
42208785|NCT03289143|76022850|FG002|Overall Study|Adverse Event|6|||
42208786|NCT03289143|76022851|FG003|Overall Study|Adverse Event|5|||
42208787|NCT03289143|76022848|FG000|Overall Study|Death|2|||
42208788|NCT03289143|76022849|FG001|Overall Study|Death|0|||
42208789|NCT03289143|76022850|FG002|Overall Study|Death|2|||
42208790|NCT03289143|76022851|FG003|Overall Study|Death|1|||
42208791|NCT03289143|76022848|FG000|Overall Study|Lost to Follow-up|2|||
42208792|NCT03289143|76022849|FG001|Overall Study|Lost to Follow-up|1|||
42208793|NCT03289143|76022850|FG002|Overall Study|Lost to Follow-up|1|||
42208794|NCT03289143|76022851|FG003|Overall Study|Lost to Follow-up|0|||
42208795|NCT03289143|76022848|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
42208796|NCT03289143|76022849|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
42208797|NCT03289143|76022850|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
42208798|NCT03289143|76022851|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
42208799|NCT03289143|76022848|FG000|Overall Study|Withdrawal by Caregiver|0|||
42208800|NCT03289143|76022849|FG001|Overall Study|Withdrawal by Caregiver|1|||
42208801|NCT03289143|76022850|FG002|Overall Study|Withdrawal by Caregiver|0|||
42208802|NCT03289143|76022851|FG003|Overall Study|Withdrawal by Caregiver|0|||
42208803|NCT03289143|76022848|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
42208804|NCT03289143|76022849|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
42208805|NCT03289143|76022850|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
42208806|NCT03289143|76022851|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
42208807|NCT03289143|76022848|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
42208808|NCT03289143|76022849|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
42208809|NCT03289143|76022850|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
42208810|NCT03289143|76022851|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
42208811|NCT03311724|76022870|FG000|Overall Study|Physician Decision|0|||
42208812|NCT03311724|76022871|FG001|Overall Study|Physician Decision|0|||
42208813|NCT03311724|76022872|FG002|Overall Study|Physician Decision|0|||
42208814|NCT03311724|76022873|FG003|Overall Study|Physician Decision|1|||
42208815|NCT03311724|76022870|FG000|Overall Study|Protocol Violation|1|||
42208816|NCT03311724|76022871|FG001|Overall Study|Protocol Violation|0|||
42208817|NCT03311724|76022872|FG002|Overall Study|Protocol Violation|1|||
42208818|NCT03311724|76022873|FG003|Overall Study|Protocol Violation|0|||
42208819|NCT03311724|76022870|FG000|Overall Study|Withdrawal by Subject|1|||
42208820|NCT03311724|76022871|FG001|Overall Study|Withdrawal by Subject|1|||
42208821|NCT03311724|76022872|FG002|Overall Study|Withdrawal by Subject|0|||
42208822|NCT03311724|76022873|FG003|Overall Study|Withdrawal by Subject|0|||
42208823|NCT03311724|76022870|FG000|Overall Study|Lost to Follow-up|1|||
42299872|NCT02554721|76134907|FG003|Overall Study|Noncompliance|0|||
42299873|NCT02554721|76134908|FG004|Overall Study|Noncompliance|1|||
42208824|NCT03311724|76022871|FG001|Overall Study|Lost to Follow-up|0|||
42299874|NCT02552225|76134919|FG000|Overall Study|Withdrawal by Subject|1|||
42208825|NCT03311724|76022872|FG002|Overall Study|Lost to Follow-up|0|||
42208826|NCT03311724|76022873|FG003|Overall Study|Lost to Follow-up|0|||
42208827|NCT03311724|76022870|FG000|Overall Study|Sponsor Decision|0|||
42208828|NCT03311724|76022871|FG001|Overall Study|Sponsor Decision|0|||
42208829|NCT03311724|76022872|FG002|Overall Study|Sponsor Decision|1|||
42208830|NCT03311724|76022873|FG003|Overall Study|Sponsor Decision|0|||
42208831|NCT03311646|76022895|FG000|Overall Study|Physician Decision|1|||
42208832|NCT03311646|76022895|FG000|Overall Study|Withdrawal by Subject|5|||
42208833|NCT03311646|76022895|FG000|Overall Study|Lost to Follow-up|5|||
42208834|NCT03311646|76022895|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
42208835|NCT01672892|76022902|FG000|Overall Study|Protocol Violation|7|||
42208836|NCT01672892|76022903|FG001|Overall Study|Protocol Violation|3|||
42208837|NCT03288987|76022914|FG000|Overall Study|Protocol Violation|10|||
42208838|NCT03288987|76022915|FG001|Overall Study|Protocol Violation|4|||
42208839|NCT02939781|76022921|FG000|Overall Study|Protocol Violation|8|||
42299875|NCT02552225|76134920|FG001|Overall Study|Withdrawal by Subject|0|||
42299876|NCT02552147|76134926|FG000|First Intervention (7 Days)|Protocol Violation|1|||
42299877|NCT02552147|76134927|FG001|First Intervention (7 Days)|Protocol Violation|0|||
42299878|NCT02552147|76134926|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
42299879|NCT02552147|76134927|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
42299880|NCT01662635|76134933|FG000|Overall Study|scarce samples for evaluation|30|||
42299881|NCT02534935|76134942|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
42299882|NCT02534935|76134943|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
42299883|NCT02534935|76134944|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
42299884|NCT02534935|76134942|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
42299885|NCT02534935|76134943|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
42299886|NCT02534935|76134944|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
42299887|NCT02534935|76134942|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
42299888|NCT02534935|76134943|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
42299889|NCT02534935|76134944|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
42299890|NCT02534935|76134942|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
42299891|NCT02534935|76134943|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
42299892|NCT02534935|76134944|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
42299893|NCT02534935|76134942|FG000|Stage 1: 24 Months|Adverse Event|0|||
42299894|NCT02534935|76134943|FG001|Stage 1: 24 Months|Adverse Event|2|||
42299895|NCT02534935|76134944|FG002|Stage 1: 24 Months|Adverse Event|0|||
42299896|NCT02534935|76134942|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
42299897|NCT02534935|76134943|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
42299898|NCT02534935|76134944|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
42299899|NCT02534935|76134942|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
42299900|NCT02534935|76134943|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
42299901|NCT02534935|76134944|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
42299902|NCT02544451|76134973|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
42299903|NCT02544451|76134974|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
42299904|NCT02544451|76134975|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
42299905|NCT02544451|76134976|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
42299906|NCT02544451|76134973|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
42299907|NCT02544451|76134974|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
42299908|NCT02544451|76134975|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
42299909|NCT02544451|76134976|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
42299910|NCT02544451|76134973|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
42299911|NCT02544451|76134974|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
42299912|NCT02544451|76134975|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
42299913|NCT02544451|76134976|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
42299914|NCT02544451|76134973|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
42299915|NCT02544451|76134974|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
42299916|NCT02544451|76134975|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
42299917|NCT02544451|76134976|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
42299918|NCT02544451|76134973|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
42299919|NCT02544451|76134974|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
42299920|NCT02544451|76134975|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
42299921|NCT02544451|76134976|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
42299922|NCT02544451|76134973|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
42299923|NCT02544451|76134974|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
42208840|NCT02939781|76022921|FG000|Overall Study|Withdrawal by Subject|1|||
42208841|NCT03083990|76022937|FG000|Overall Study|Adverse Event|1|||
42346915|NCT01707693|76185933|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
42208842|NCT03083990|76022938|FG001|Overall Study|Adverse Event|0|||
42208843|NCT03252015|76022956|FG000|Overall Study|Withdrawal by Subject|0|||
42208844|NCT03252015|76022957|FG001|Overall Study|Withdrawal by Subject|1|||
42299924|NCT02544451|76134975|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
42299925|NCT02544451|76134976|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
42299926|NCT02544373|76134996|FG000|Overall Study|Lost to Follow-up|5|||
42299927|NCT02544373|76134997|FG001|Overall Study|Lost to Follow-up|3|||
42299928|NCT02544373|76134996|FG000|Overall Study|Withdrawal by Subject|8|||
42299929|NCT02544373|76134997|FG001|Overall Study|Withdrawal by Subject|2|||
42299930|NCT02551991|76135009|FG000|Overall Study|Death|5|||
42299931|NCT02551991|76135010|FG001|Overall Study|Death|7|||
42299932|NCT02551991|76135011|FG002|Overall Study|Death|8|||
42299933|NCT02551991|76135012|FG003|Overall Study|Death|7|||
42299934|NCT02551991|76135013|FG004|Overall Study|Death|17|||
42299935|NCT02551991|76135009|FG000|Overall Study|Withdrawal by Subject|1|||
42299936|NCT02551991|76135010|FG001|Overall Study|Withdrawal by Subject|0|||
42299937|NCT02551991|76135011|FG002|Overall Study|Withdrawal by Subject|0|||
42299938|NCT02551991|76135012|FG003|Overall Study|Withdrawal by Subject|0|||
42299939|NCT02551991|76135013|FG004|Overall Study|Withdrawal by Subject|2|||
42299940|NCT02551991|76135009|FG000|Overall Study|Lost to Follow-up|0|||
42299941|NCT02551991|76135010|FG001|Overall Study|Lost to Follow-up|0|||
42299942|NCT02551991|76135011|FG002|Overall Study|Lost to Follow-up|1|||
42299943|NCT02551991|76135012|FG003|Overall Study|Lost to Follow-up|0|||
42299944|NCT02551991|76135013|FG004|Overall Study|Lost to Follow-up|0|||
42299945|NCT02551991|76135009|FG000|Overall Study|Sponsor Decision|1|||
42299946|NCT02551991|76135010|FG001|Overall Study|Sponsor Decision|0|||
42299947|NCT02551991|76135011|FG002|Overall Study|Sponsor Decision|1|||
42299948|NCT02551991|76135012|FG003|Overall Study|Sponsor Decision|0|||
42299949|NCT02551991|76135013|FG004|Overall Study|Sponsor Decision|5|||
42299950|NCT02551991|76135009|FG000|Overall Study|Other|0|||
42299951|NCT02551991|76135010|FG001|Overall Study|Other|0|||
42299952|NCT02551991|76135011|FG002|Overall Study|Other|0|||
42299953|NCT02551991|76135012|FG003|Overall Study|Other|0|||
42299954|NCT02551991|76135013|FG004|Overall Study|Other|1|||
42299955|NCT01661933|76135026|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
42299956|NCT01661933|76135026|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
42299957|NCT02544217|76135038|FG000|Overall Study|Withdrawal by Subject|1|||
42299958|NCT02544217|76135039|FG001|Overall Study|Withdrawal by Subject|1|||
42299959|NCT02544217|76135040|FG002|Overall Study|Withdrawal by Subject|0|||
42299960|NCT02544217|76135041|FG003|Overall Study|Withdrawal by Subject|0|||
42299961|NCT02544217|76135042|FG004|Overall Study|Withdrawal by Subject|0|||
42299962|NCT02544217|76135043|FG005|Overall Study|Withdrawal by Subject|0|||
42299963|NCT02533999|76135112|FG000|Overall Study|Lost to Follow-up|3|||
42299964|NCT02533999|76135113|FG001|Overall Study|Lost to Follow-up|5|||
42299965|NCT02533999|76135112|FG000|Overall Study|Protocol Violation|3|||
42299966|NCT02533999|76135113|FG001|Overall Study|Protocol Violation|0|||
42299967|NCT02533999|76135112|FG000|Overall Study|Adverse Event|0|||
42299968|NCT02533999|76135113|FG001|Overall Study|Adverse Event|1|||
42299969|NCT02533999|76135112|FG000|Overall Study|Randomized but intervention not received|0|||
42299970|NCT02533999|76135113|FG001|Overall Study|Randomized but intervention not received|1|||
42299971|NCT02533531|76135119|FG000|Overall Study|Device did not turn on|1|||
42299972|NCT02533453|76135123|FG000|Overall Study|Adverse Event|6|||
42299973|NCT02533453|76135123|FG000|Overall Study|Protocol Violation|1|||
42299974|NCT02533453|76135123|FG000|Overall Study|Withdrawal by Subject|2|||
42299975|NCT02533375|76135127|FG000|Overall Study|Lack of Efficacy|3|||
42299976|NCT02533375|76135127|FG000|Overall Study|Adverse Event|2|||
42299977|NCT02551055|76135138|FG000|Overall Study|Death|2|||
42299978|NCT02551055|76135139|FG001|Overall Study|Death|4|||
42299979|NCT02551055|76135140|FG002|Overall Study|Death|2|||
42299980|NCT02551055|76135141|FG003|Overall Study|Death|2|||
42299981|NCT02551055|76135142|FG004|Overall Study|Death|2|||
42299982|NCT02551055|76135143|FG005|Overall Study|Death|1|||
42299983|NCT02551055|76135144|FG006|Overall Study|Death|2|||
42299984|NCT02551055|76135145|FG007|Overall Study|Death|0|||
42299985|NCT02551055|76135138|FG000|Overall Study|Study Terminated by Sponsor|1|||
42299986|NCT02551055|76135139|FG001|Overall Study|Study Terminated by Sponsor|1|||
42299987|NCT02551055|76135140|FG002|Overall Study|Study Terminated by Sponsor|0|||
42299988|NCT02551055|76135141|FG003|Overall Study|Study Terminated by Sponsor|2|||
42299989|NCT02551055|76135142|FG004|Overall Study|Study Terminated by Sponsor|2|||
42299990|NCT02551055|76135143|FG005|Overall Study|Study Terminated by Sponsor|0|||
42299991|NCT02551055|76135144|FG006|Overall Study|Study Terminated by Sponsor|0|||
42299992|NCT02551055|76135145|FG007|Overall Study|Study Terminated by Sponsor|0|||
42299993|NCT02551055|76135138|FG000|Overall Study|Withdrawal by Subject|1|||
42299994|NCT02551055|76135139|FG001|Overall Study|Withdrawal by Subject|1|||
42299995|NCT02551055|76135140|FG002|Overall Study|Withdrawal by Subject|0|||
42299996|NCT02551055|76135141|FG003|Overall Study|Withdrawal by Subject|1|||
42299997|NCT02551055|76135142|FG004|Overall Study|Withdrawal by Subject|2|||
42299998|NCT02551055|76135143|FG005|Overall Study|Withdrawal by Subject|0|||
42299999|NCT02551055|76135144|FG006|Overall Study|Withdrawal by Subject|0|||
42300000|NCT02551055|76135145|FG007|Overall Study|Withdrawal by Subject|0|||
42300001|NCT02551055|76135138|FG000|Overall Study|Reason not specified|0|||
42300002|NCT02551055|76135139|FG001|Overall Study|Reason not specified|0|||
42300003|NCT02551055|76135140|FG002|Overall Study|Reason not specified|0|||
42300004|NCT02551055|76135141|FG003|Overall Study|Reason not specified|0|||
42300005|NCT02551055|76135142|FG004|Overall Study|Reason not specified|1|||
42300006|NCT02551055|76135143|FG005|Overall Study|Reason not specified|0|||
42300007|NCT02551055|76135144|FG006|Overall Study|Reason not specified|1|||
42300008|NCT02551055|76135145|FG007|Overall Study|Reason not specified|0|||
42300009|NCT02542943|76135166|FG000|Overall Study|Lost to Follow-up|1|||
42300010|NCT02542943|76135167|FG001|Overall Study|Lost to Follow-up|0|||
42300011|NCT02542943|76135168|FG002|Overall Study|Lost to Follow-up|0|||
42300012|NCT02542943|76135166|FG000|Overall Study|Withdrawal by Subject|0|||
42300013|NCT02542943|76135167|FG001|Overall Study|Withdrawal by Subject|1|||
42300014|NCT02542943|76135168|FG002|Overall Study|Withdrawal by Subject|0|||
42300015|NCT02542865|76135179|FG000|Overall Study|Identified as screen failure|1|||
42300016|NCT02542865|76135180|FG001|Overall Study|Identified as screen failure|0|||
42300017|NCT02542865|76135179|FG000|Overall Study|Withdrawal by Subject|16|||
42300018|NCT02542865|76135180|FG001|Overall Study|Withdrawal by Subject|0|||
42300019|NCT03644927|76135186|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
42300020|NCT03644927|76135187|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
42300021|NCT02542631|76135194|FG000|Overall Study|Adverse Event|1|||
42300022|NCT02542631|76135195|FG001|Overall Study|Adverse Event|1|||
42300023|NCT02542631|76135194|FG000|Overall Study|Sponsor Termination|1|||
42300024|NCT02542631|76135195|FG001|Overall Study|Sponsor Termination|0|||
42300025|NCT02542631|76135194|FG000|Overall Study|Withdrawal by Subject|11|||
42300026|NCT02542631|76135195|FG001|Overall Study|Withdrawal by Subject|16|||
42300027|NCT02542631|76135194|FG000|Overall Study|Protocol Violation|1|||
42300028|NCT02542631|76135195|FG001|Overall Study|Protocol Violation|1|||
42300029|NCT02542631|76135194|FG000|Overall Study|Physician Decision|6|||
42300030|NCT02542631|76135195|FG001|Overall Study|Physician Decision|4|||
42300031|NCT02542631|76135194|FG000|Overall Study|Lost to Follow-up|6|||
42300032|NCT02542631|76135195|FG001|Overall Study|Lost to Follow-up|5|||
42300033|NCT02542631|76135194|FG000|Overall Study|Death|1|||
42300034|NCT02542631|76135195|FG001|Overall Study|Death|2|||
42300035|NCT02542631|76135194|FG000|Overall Study|Other|2|||
42300036|NCT02542631|76135195|FG001|Overall Study|Other|1|||
42300037|NCT02542631|76135194|FG000|Overall Study|Used Prohibited Medication|2|||
42300038|NCT02542631|76135195|FG001|Overall Study|Used Prohibited Medication|1|||
42300039|NCT02542397|76135201|FG000|Overall Study|Death|2|||
42300040|NCT02542397|76135201|FG000|Overall Study|Physician Decision|6|||
42300041|NCT02542397|76135201|FG000|Overall Study|Withdrawal by Subject|6|||
42300042|NCT02542397|76135201|FG000|Overall Study|Lost to Follow-up|2|||
42300043|NCT02549339|76135208|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
42300044|NCT02549339|76135209|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
42300045|NCT02549339|76135208|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
42300046|NCT02549339|76135209|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
42300047|NCT02549339|76135208|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
42300048|NCT02549339|76135209|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
42300049|NCT02549339|76135208|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
42300050|NCT02549339|76135209|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
42300051|NCT02549339|76135208|FG000|12-month Follow-up|Lack of Efficacy|0|||
41927993|NCT01432730|75584771|FG000|Period 1|Adverse Event|2|||
41927994|NCT01432730|75584772|FG001|Period 1|Adverse Event|0|||
41927995|NCT01432730|75584771|FG000|Period 2|Adverse Event|0|||
41927996|NCT01432730|75584772|FG001|Period 2|Adverse Event|4|||
41927997|NCT01432574|75584787|FG000|Overall Study|Moved|2|||
41927998|NCT01432574|75584787|FG000|Overall Study|Not interested|1|||
41927999|NCT01392560|75584820|FG000|Overall Study|Adverse Event|2|||
41928000|NCT01392560|75584820|FG000|Overall Study|not entered|8|||
41928001|NCT01392560|75584820|FG000|Overall Study|discontinued during placebo run-in|2|||
41928002|NCT00552279|75584881|FG000|Overall Study|Adverse Event|0|||
41928003|NCT00552279|75584882|FG001|Overall Study|Adverse Event|1|||
41928004|NCT00552279|75584881|FG000|Overall Study|Withdrawal by Subject|12|||
41928005|NCT00552279|75584882|FG001|Overall Study|Withdrawal by Subject|1|||
41928006|NCT00552279|75584881|FG000|Overall Study|Lost to Follow-up|1|||
41928007|NCT00552279|75584882|FG001|Overall Study|Lost to Follow-up|0|||
41928008|NCT00552279|75584881|FG000|Overall Study|Other|1|||
41928009|NCT00552279|75584882|FG001|Overall Study|Other|1|||
41928010|NCT00559377|75584923|FG000|Overall Study|Withdrawal by Subject|9|||
41928011|NCT01412060|75584930|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
41928012|NCT01412060|75584931|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
42208845|NCT03252015|76022958|FG002|Overall Study|Withdrawal by Subject|1|||
42208846|NCT03252015|76022959|FG003|Overall Study|Withdrawal by Subject|0|||
42208847|NCT03252015|76022956|FG000|Overall Study|Adverse Event|1|||
42208848|NCT03252015|76022957|FG001|Overall Study|Adverse Event|0|||
42208849|NCT03252015|76022958|FG002|Overall Study|Adverse Event|0|||
42208850|NCT03252015|76022959|FG003|Overall Study|Adverse Event|1|||
42208851|NCT03083132|76022985|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
41928013|NCT01412060|75584932|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
41928014|NCT01412060|75584930|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
41928015|NCT01412060|75584931|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
41928016|NCT01412060|75584932|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
41928017|NCT01412060|75584930|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
41928018|NCT01412060|75584931|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
41928019|NCT01412060|75584932|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
41928020|NCT01412060|75584930|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
41928021|NCT01412060|75584931|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
41928022|NCT01412060|75584932|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
41928023|NCT01412060|75584930|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
41928024|NCT01412060|75584931|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
41928025|NCT01412060|75584932|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
41928026|NCT01412060|75584930|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
41928027|NCT01412060|75584931|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
41928028|NCT01412060|75584932|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
41928029|NCT01412060|75584930|FG000|Period Between RIP and SP|Adverse Event|4|||
41928030|NCT01412060|75584931|FG001|Period Between RIP and SP|Adverse Event|0|||
41928031|NCT01412060|75584932|FG002|Period Between RIP and SP|Adverse Event|0|||
41928032|NCT01412060|75584930|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
42208852|NCT03083132|76022986|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
41928033|NCT01412060|75584931|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
41928034|NCT01412060|75584932|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
41928035|NCT01412060|75584930|FG000|Period Between RIP and SP|Protocol Violation|2|||
41928036|NCT01412060|75584931|FG001|Period Between RIP and SP|Protocol Violation|0|||
41928037|NCT01412060|75584932|FG002|Period Between RIP and SP|Protocol Violation|0|||
41928038|NCT01412060|75584930|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
41928039|NCT01412060|75584931|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
41928040|NCT01412060|75584932|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
41928041|NCT01412060|75584930|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
41928042|NCT01412060|75584931|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
41928043|NCT01412060|75584932|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
41928044|NCT01412060|75584930|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
41928045|NCT01412060|75584931|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
41928046|NCT01412060|75584932|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
41928047|NCT01412060|75584930|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
41928048|NCT01412060|75584931|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
41928049|NCT01412060|75584932|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
41928050|NCT01412060|75584930|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
41928051|NCT01412060|75584931|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
41928052|NCT01412060|75584932|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
41928053|NCT01412060|75584930|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
41928054|NCT01412060|75584931|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
41928055|NCT01412060|75584932|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
41928056|NCT01412060|75584930|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
41928057|NCT01412060|75584931|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
41928058|NCT01412060|75584932|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
41928059|NCT01412060|75584930|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
41928060|NCT01412060|75584931|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
41928061|NCT01412060|75584932|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
41928062|NCT01412060|75584930|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
41928063|NCT01412060|75584931|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
41928064|NCT01412060|75584932|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
41928065|NCT01412060|75584930|FG000|Period Between SP and DBP|Protocol Violation|2|||
41928066|NCT01412060|75584931|FG001|Period Between SP and DBP|Protocol Violation|0|||
41928067|NCT01412060|75584932|FG002|Period Between SP and DBP|Protocol Violation|0|||
41928068|NCT01412060|75584930|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
41928069|NCT01412060|75584931|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
41928070|NCT01412060|75584932|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
41928071|NCT01412060|75584930|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
41928072|NCT01412060|75584931|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
41928073|NCT01412060|75584932|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
41928074|NCT01412060|75584930|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
41928075|NCT01412060|75584931|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
41928076|NCT01412060|75584932|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
41928077|NCT01412060|75584930|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
41928078|NCT01412060|75584931|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
41928079|NCT01412060|75584932|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
41928080|NCT01412060|75584930|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
41928081|NCT01412060|75584931|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
41928082|NCT01412060|75584932|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
41928083|NCT01412060|75584930|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
41928084|NCT01412060|75584931|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
41928085|NCT01412060|75584932|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
41928086|NCT01412060|75584930|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
42010362|NCT01290068|75817491|FG000|Overall Study|Adverse Event|1|||
42208853|NCT03083132|76022985|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
42208854|NCT03083132|76022986|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
42208855|NCT03083132|76022985|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
42208856|NCT03083132|76022986|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
42208857|NCT03683823|76022994|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
42208858|NCT03683823|76022995|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
42208859|NCT03683823|76022994|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
42208860|NCT03683823|76022995|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
42208861|NCT03683823|76022994|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
42208862|NCT03683823|76022995|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
42300052|NCT02549339|76135209|FG001|12-month Follow-up|Lack of Efficacy|2|||
41928087|NCT01412060|75584931|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
41928088|NCT01412060|75584932|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
41928089|NCT01412060|75584930|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
41928090|NCT01412060|75584931|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
41928091|NCT01412060|75584932|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
41928092|NCT01412060|75584930|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
41928093|NCT01412060|75584931|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
41928094|NCT01412060|75584932|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
41928095|NCT01412060|75584930|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
41928096|NCT01412060|75584931|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
41928097|NCT01412060|75584932|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
41928098|NCT00551421|75584963|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
41928099|NCT01891643|75584983|FG000|Overall Study|Adverse event unrelated to study drug|2|||
41928100|NCT01891643|75584984|FG001|Overall Study|Adverse event unrelated to study drug|5|||
41928101|NCT01891643|75584983|FG000|Overall Study|Disease Progression|4|||
41928102|NCT01891643|75584984|FG001|Overall Study|Disease Progression|3|||
41928103|NCT01891643|75584983|FG000|Overall Study|Study Drug Toxicity|3|||
41928104|NCT01891643|75584984|FG001|Overall Study|Study Drug Toxicity|0|||
41928105|NCT01891643|75584983|FG000|Overall Study|Maximum Clinical Benefit|0|||
41928106|NCT01891643|75584984|FG001|Overall Study|Maximum Clinical Benefit|1|||
41928107|NCT01891643|75584983|FG000|Overall Study|Poor/Non-compliance|0|||
41928108|NCT01891643|75584984|FG001|Overall Study|Poor/Non-compliance|1|||
41928109|NCT01891643|75584983|FG000|Overall Study|Participant request to discontinue|1|||
41928110|NCT01891643|75584984|FG001|Overall Study|Participant request to discontinue|0|||
41928111|NCT01392326|75585118|FG000|Overall Study|Death|2|||
41928112|NCT01392326|75585119|FG001|Overall Study|Death|0|||
41928113|NCT01392326|75585120|FG002|Overall Study|Death|0|||
41928114|NCT01392326|75585118|FG000|Overall Study|Withdrawal by Subject|12|||
41928115|NCT01392326|75585119|FG001|Overall Study|Withdrawal by Subject|11|||
41928116|NCT01392326|75585120|FG002|Overall Study|Withdrawal by Subject|15|||
41928117|NCT01392326|75585118|FG000|Overall Study|Protocol Violation|2|||
41928118|NCT01392326|75585119|FG001|Overall Study|Protocol Violation|0|||
41928119|NCT01392326|75585120|FG002|Overall Study|Protocol Violation|0|||
41928120|NCT01392326|75585118|FG000|Overall Study|Pregnancy|0|||
41928121|NCT01392326|75585119|FG001|Overall Study|Pregnancy|0|||
41928122|NCT01392326|75585120|FG002|Overall Study|Pregnancy|1|||
41928123|NCT01392326|75585118|FG000|Overall Study|Physician Decision|7|||
41928124|NCT01392326|75585119|FG001|Overall Study|Physician Decision|5|||
41928125|NCT01392326|75585120|FG002|Overall Study|Physician Decision|2|||
41928126|NCT01392326|75585118|FG000|Overall Study|Lost to Follow-up|1|||
41928127|NCT01392326|75585119|FG001|Overall Study|Lost to Follow-up|3|||
41928128|NCT01392326|75585120|FG002|Overall Study|Lost to Follow-up|4|||
41928129|NCT01392326|75585118|FG000|Overall Study|Lack of Efficacy|14|||
41928130|NCT01392326|75585119|FG001|Overall Study|Lack of Efficacy|10|||
41928131|NCT01392326|75585120|FG002|Overall Study|Lack of Efficacy|15|||
41928132|NCT01392326|75585118|FG000|Overall Study|Adverse Event|9|||
41928133|NCT01392326|75585119|FG001|Overall Study|Adverse Event|6|||
41928134|NCT01392326|75585120|FG002|Overall Study|Adverse Event|11|||
41928135|NCT01432262|75585163|FG000|Overall Study|Withdrawal by Subject|2|||
41928136|NCT01432262|75585164|FG001|Overall Study|Withdrawal by Subject|1|||
41928137|NCT01410890|75585184|FG000|Overall Study|Withdrawal by Subject|0|||
41928138|NCT01410890|75585185|FG001|Overall Study|Withdrawal by Subject|1|||
41928139|NCT01431950|75585195|FG000|Overall Study|Study Site Closed/Terminated|7|||
41928140|NCT01431950|75585196|FG001|Overall Study|Study Site Closed/Terminated|3|||
41928141|NCT01431950|75585195|FG000|Overall Study|Withdrawal by Subject|4|||
41928142|NCT01431950|75585196|FG001|Overall Study|Withdrawal by Subject|3|||
41928143|NCT01431950|75585195|FG000|Overall Study|Protocol Violation|2|||
41928144|NCT01431950|75585196|FG001|Overall Study|Protocol Violation|3|||
41928145|NCT01431950|75585195|FG000|Overall Study|Adverse Event|2|||
41928146|NCT01431950|75585196|FG001|Overall Study|Adverse Event|2|||
41928147|NCT01431950|75585195|FG000|Overall Study|Physician Decision|2|||
41928148|NCT01431950|75585196|FG001|Overall Study|Physician Decision|1|||
41928149|NCT01431950|75585195|FG000|Overall Study|Lack of Efficacy|2|||
41928150|NCT01431950|75585196|FG001|Overall Study|Lack of Efficacy|1|||
41928151|NCT01431950|75585195|FG000|Overall Study|Lost to Follow-up|0|||
41928152|NCT01431950|75585196|FG001|Overall Study|Lost to Follow-up|1|||
41928153|NCT01431950|75585195|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
41928154|NCT01431950|75585196|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
41928155|NCT00551031|75585207|FG000|Overall Study|Adverse Event|0|||
41928156|NCT00551031|75585208|FG001|Overall Study|Adverse Event|1|||
42021986|NCT00961636|75829310|FG000|Overall Study|Protocol Violation|9|||
41928157|NCT00551031|75585209|FG002|Overall Study|Adverse Event|0|||
41928158|NCT00551031|75585210|FG003|Overall Study|Adverse Event|0|||
41928159|NCT00551031|75585211|FG004|Overall Study|Adverse Event|0|||
41928160|NCT00551031|75585207|FG000|Overall Study|Protocol Violation|1|||
41928161|NCT00551031|75585208|FG001|Overall Study|Protocol Violation|1|||
41928162|NCT00551031|75585209|FG002|Overall Study|Protocol Violation|0|||
41928163|NCT00551031|75585210|FG003|Overall Study|Protocol Violation|0|||
41928164|NCT00551031|75585211|FG004|Overall Study|Protocol Violation|0|||
41928165|NCT00551031|75585207|FG000|Overall Study|Lost to Follow-up|0|||
41928166|NCT00551031|75585208|FG001|Overall Study|Lost to Follow-up|1|||
41928167|NCT00551031|75585209|FG002|Overall Study|Lost to Follow-up|0|||
41928168|NCT00551031|75585210|FG003|Overall Study|Lost to Follow-up|1|||
41928169|NCT00551031|75585211|FG004|Overall Study|Lost to Follow-up|1|||
41928170|NCT00551031|75585207|FG000|Overall Study|Withdrawal by Subject|0|||
41928171|NCT00551031|75585208|FG001|Overall Study|Withdrawal by Subject|4|||
41928172|NCT00551031|75585209|FG002|Overall Study|Withdrawal by Subject|1|||
41928173|NCT00551031|75585210|FG003|Overall Study|Withdrawal by Subject|2|||
41928174|NCT00551031|75585211|FG004|Overall Study|Withdrawal by Subject|0|||
41928175|NCT00551031|75585207|FG000|Overall Study|Serious Adverse Event|0|||
41928176|NCT00551031|75585208|FG001|Overall Study|Serious Adverse Event|2|||
41928177|NCT00551031|75585209|FG002|Overall Study|Serious Adverse Event|1|||
41928178|NCT00551031|75585210|FG003|Overall Study|Serious Adverse Event|0|||
41928179|NCT00551031|75585211|FG004|Overall Study|Serious Adverse Event|0|||
41928180|NCT00551031|75585207|FG000|Overall Study|Did not receive vaccine|1|||
41928181|NCT00551031|75585208|FG001|Overall Study|Did not receive vaccine|2|||
41928182|NCT00551031|75585209|FG002|Overall Study|Did not receive vaccine|0|||
41928183|NCT00551031|75585210|FG003|Overall Study|Did not receive vaccine|0|||
41928184|NCT00551031|75585211|FG004|Overall Study|Did not receive vaccine|0|||
41928185|NCT01431716|75585223|FG000|Overall Study|Withdrawal of consent|1|||
41928186|NCT00550953|75585229|FG000|Overall Study|Adverse Event|4|||
41928187|NCT00550953|75585230|FG001|Overall Study|Adverse Event|3|||
41928188|NCT00550953|75585229|FG000|Overall Study|Not able to visit the site|2|||
41928189|NCT00550953|75585230|FG001|Overall Study|Not able to visit the site|3|||
41928190|NCT00558831|75585265|FG000|Overall Study|Lost to Follow-up|1|||
41928191|NCT01431638|75585274|FG000|Overall Study|Adverse Event|1|||
41928192|NCT01431638|75585275|FG001|Overall Study|Adverse Event|3|||
41928193|NCT01431638|75585276|FG002|Overall Study|Adverse Event|1|||
41928194|NCT01431638|75585274|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
41928195|NCT01431638|75585275|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
41928196|NCT01431638|75585276|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
41928197|NCT01431638|75585274|FG000|Overall Study|Participants condition no longer requires study drug|0|||
41928198|NCT01431638|75585275|FG001|Overall Study|Participants condition no longer requires study drug|1|||
41928199|NCT01431638|75585276|FG002|Overall Study|Participants condition no longer requires study drug|0|||
41928200|NCT01431638|75585274|FG000|Overall Study|Participant withdrew consent|14|||
41928201|NCT01431638|75585275|FG001|Overall Study|Participant withdrew consent|5|||
41928202|NCT01431638|75585276|FG002|Overall Study|Participant withdrew consent|8|||
41928203|NCT01431638|75585274|FG000|Overall Study|Lost to Follow-up|7|||
41928204|NCT01431638|75585275|FG001|Overall Study|Lost to Follow-up|9|||
41928205|NCT01431638|75585276|FG002|Overall Study|Lost to Follow-up|7|||
41928206|NCT01431638|75585274|FG000|Overall Study|Administrative problems|1|||
41928207|NCT01431638|75585275|FG001|Overall Study|Administrative problems|4|||
41928208|NCT01431638|75585276|FG002|Overall Study|Administrative problems|6|||
41928209|NCT01431638|75585274|FG000|Overall Study|Death|1|||
41928210|NCT01431638|75585275|FG001|Overall Study|Death|0|||
41928211|NCT01431638|75585276|FG002|Overall Study|Death|0|||
41928212|NCT01431638|75585274|FG000|Overall Study|Protocol deviation|1|||
41928213|NCT01431638|75585275|FG001|Overall Study|Protocol deviation|1|||
41928214|NCT01431638|75585276|FG002|Overall Study|Protocol deviation|4|||
41928215|NCT01431638|75585274|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
41928216|NCT01431638|75585275|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
41928217|NCT01431638|75585276|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
42208863|NCT03285711|76023003|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
42208864|NCT03285711|76023004|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
41928218|NCT01392170|75585284|FG000|Overall Study|Withdrawal by Subject|1|||
42208865|NCT03285711|76023005|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
42208866|NCT03285711|76023006|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
42208867|NCT03285711|76023003|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
42208868|NCT03285711|76023004|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
42208869|NCT03285711|76023005|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
42208870|NCT03285711|76023006|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
42208871|NCT03285711|76023003|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
42208872|NCT03285711|76023004|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
42208873|NCT03285711|76023005|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
42208874|NCT03285711|76023006|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
42208875|NCT03285711|76023003|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
42208876|NCT03285711|76023004|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
42208877|NCT03285711|76023005|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
42208878|NCT03285711|76023006|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
41928219|NCT01392170|75585284|FG000|Overall Study|Ineligible|1|||
41928220|NCT00558753|75585290|FG000|Overall Study|Lost to Follow-up|5|||
41928221|NCT00558753|75585291|FG001|Overall Study|Lost to Follow-up|7|||
41928222|NCT01391546|75585299|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
41928223|NCT01391546|75585300|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
41928224|NCT01410110|75585309|FG000|Overall Study|Withdrawal by Subject|4|||
41928225|NCT01410110|75585310|FG001|Overall Study|Withdrawal by Subject|2|||
41928226|NCT01391000|75585318|FG000|Overall Study|Lost to Follow-up|2|||
41928227|NCT01391000|75585319|FG001|Overall Study|Lost to Follow-up|0|||
41928228|NCT01390844|75585394|FG000|Treatment Phase|Adverse Event|12|||
41928229|NCT01390844|75585395|FG001|Treatment Phase|Adverse Event|2|||
41928230|NCT01390844|75585396|FG002|Treatment Phase|Adverse Event|3|||
41928231|NCT01390844|75585397|FG003|Treatment Phase|Adverse Event|2|||
41928232|NCT01390844|75585394|FG000|Treatment Phase|Treatment Failure|23|||
41928233|NCT01390844|75585395|FG001|Treatment Phase|Treatment Failure|25|||
41928234|NCT01390844|75585396|FG002|Treatment Phase|Treatment Failure|10|||
41928235|NCT01390844|75585397|FG003|Treatment Phase|Treatment Failure|13|||
41928236|NCT01390844|75585394|FG000|Treatment Phase|Non-Medical Reasons|5|||
41928237|NCT01390844|75585395|FG001|Treatment Phase|Non-Medical Reasons|1|||
41928238|NCT01390844|75585396|FG002|Treatment Phase|Non-Medical Reasons|8|||
41928239|NCT01390844|75585397|FG003|Treatment Phase|Non-Medical Reasons|1|||
41928240|NCT01390844|75585394|FG000|Treatment Phase|Non-GCP Compliant|0|||
41928241|NCT01390844|75585395|FG001|Treatment Phase|Non-GCP Compliant|0|||
41928242|NCT01390844|75585396|FG002|Treatment Phase|Non-GCP Compliant|10|||
41928243|NCT01390844|75585397|FG003|Treatment Phase|Non-GCP Compliant|3|||
41928244|NCT01390844|75585394|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
41928245|NCT01390844|75585395|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
41928246|NCT01390844|75585396|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
41928247|NCT01390844|75585397|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
41928248|NCT01430624|75585410|FG000|Overall Study|Lost to Follow-up|23|||
41928249|NCT01430624|75585411|FG001|Overall Study|Lost to Follow-up|29|||
41928250|NCT01430624|75585412|FG002|Overall Study|Lost to Follow-up|27|||
41928251|NCT01430624|75585410|FG000|Overall Study|technical or eligibility|5|||
41928252|NCT01430624|75585411|FG001|Overall Study|technical or eligibility|5|||
41928253|NCT01430624|75585412|FG002|Overall Study|technical or eligibility|2|||
41928254|NCT01430468|75585437|FG000|Overall Study|Physician Decision|2|||
41928255|NCT01430468|75585438|FG001|Overall Study|Physician Decision|1|||
41928256|NCT01430468|75585437|FG000|Overall Study|Withdrawal by Subject|5|||
41928257|NCT01430468|75585438|FG001|Overall Study|Withdrawal by Subject|5|||
41928258|NCT01409564|75585459|FG000|Overall Study|low medication compliance|4|||
41928259|NCT01409564|75585460|FG001|Overall Study|low medication compliance|3|||
41928260|NCT01409564|75585459|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
41928261|NCT01409564|75585460|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
41928262|NCT01390298|75585470|FG000|Overall Study|Death|1|||
41928263|NCT01390298|75585470|FG000|Overall Study|long term ICU admission|1|||
41928264|NCT01390298|75585470|FG000|Overall Study|Withdrawal by Subject|14|||
41928265|NCT01390298|75585470|FG000|Overall Study|Lost to Follow-up|7|||
41928266|NCT01390298|75585470|FG000|Overall Study|Surgery cancelled|1|||
41928267|NCT01390220|75585488|FG000|Test Dose Phase|Adverse Event|17|||
41928268|NCT01390220|75585489|FG001|Test Dose Phase|Adverse Event|0|||
41928269|NCT01390220|75585490|FG002|Test Dose Phase|Adverse Event|0|||
41928270|NCT01390220|75585488|FG000|Test Dose Phase|Withdrawal by Subject|8|||
41928271|NCT01390220|75585489|FG001|Test Dose Phase|Withdrawal by Subject|0|||
41928272|NCT01390220|75585490|FG002|Test Dose Phase|Withdrawal by Subject|0|||
41928273|NCT01390220|75585488|FG000|Test Dose Phase|Lost to Follow-up|2|||
41928274|NCT01390220|75585489|FG001|Test Dose Phase|Lost to Follow-up|0|||
41928275|NCT01390220|75585490|FG002|Test Dose Phase|Lost to Follow-up|0|||
41928276|NCT01390220|75585488|FG000|Test Dose Phase|Protocol Violation|8|||
41928277|NCT01390220|75585489|FG001|Test Dose Phase|Protocol Violation|0|||
41928278|NCT01390220|75585490|FG002|Test Dose Phase|Protocol Violation|0|||
41928279|NCT01390220|75585488|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
41928280|NCT01390220|75585489|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
41928281|NCT01390220|75585490|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
41928282|NCT01390220|75585488|FG000|Test Dose Phase|Study/Site closure|6|||
41928283|NCT01390220|75585489|FG001|Test Dose Phase|Study/Site closure|0|||
41928284|NCT01390220|75585490|FG002|Test Dose Phase|Study/Site closure|0|||
41928285|NCT01390220|75585488|FG000|Test Dose Phase|Caregiver no longer available|5|||
41928286|NCT01390220|75585489|FG001|Test Dose Phase|Caregiver no longer available|0|||
41928287|NCT01390220|75585490|FG002|Test Dose Phase|Caregiver no longer available|0|||
41928288|NCT01390220|75585488|FG000|Test Dose Phase|Noncompliance|2|||
41928289|NCT01390220|75585489|FG001|Test Dose Phase|Noncompliance|0|||
42208879|NCT02927366|76023018|FG000|Overall Study|Adverse Event|1|||
42208880|NCT02927366|76023019|FG001|Overall Study|Adverse Event|0|||
41928290|NCT01390220|75585490|FG002|Test Dose Phase|Noncompliance|0|||
41928291|NCT01390220|75585488|FG000|Test Dose Phase|Logistical|6|||
41928292|NCT01390220|75585489|FG001|Test Dose Phase|Logistical|0|||
41928293|NCT01390220|75585490|FG002|Test Dose Phase|Logistical|0|||
41928294|NCT01390220|75585488|FG000|Comparative Phase|Withdrawal by Subject|0|||
41928295|NCT01390220|75585489|FG001|Comparative Phase|Withdrawal by Subject|1|||
41928296|NCT01390220|75585490|FG002|Comparative Phase|Withdrawal by Subject|0|||
41928297|NCT00550173|75585520|FG000|Overall Study|Death|45|||
41928298|NCT00550173|75585521|FG001|Overall Study|Death|38|||
41928299|NCT00550173|75585522|FG002|Overall Study|Death|50|||
41928300|NCT00550173|75585520|FG000|Overall Study|Physician Decision|1|||
41928301|NCT00550173|75585521|FG001|Overall Study|Physician Decision|2|||
41928302|NCT00550173|75585522|FG002|Overall Study|Physician Decision|2|||
41928303|NCT00550173|75585520|FG000|Overall Study|Withdrawal by Subject|9|||
41928304|NCT00550173|75585521|FG001|Overall Study|Withdrawal by Subject|12|||
41928305|NCT00550173|75585522|FG002|Overall Study|Withdrawal by Subject|17|||
41928306|NCT00550173|75585520|FG000|Overall Study|Sponsor Decision|13|||
41928307|NCT00550173|75585521|FG001|Overall Study|Sponsor Decision|7|||
41928308|NCT00550173|75585522|FG002|Overall Study|Sponsor Decision|1|||
41928309|NCT00550173|75585520|FG000|Overall Study|Lost to Follow-up|4|||
41928310|NCT00550173|75585521|FG001|Overall Study|Lost to Follow-up|4|||
41928311|NCT00550173|75585522|FG002|Overall Study|Lost to Follow-up|3|||
41928312|NCT01429298|75585533|FG000|Overall Study|Protocol Violation|4|||
41928313|NCT01429298|75585534|FG001|Overall Study|Protocol Violation|6|||
41928314|NCT01408706|75585546|FG000|Overall Study|Physician Decision|1|||
41928315|NCT01408706|75585547|FG001|Overall Study|Physician Decision|0|||
41928316|NCT01408628|75585555|FG000|Consented|Withdrawal by Subject|12|||
41928317|NCT01408628|75585555|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
41928318|NCT01408628|75585555|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
41928319|NCT01408628|75585555|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
41928320|NCT01389752|75585560|FG000|Study Period 1|Sponsor decision|0|||
41928321|NCT01389752|75585561|FG001|Study Period 1|Sponsor decision|2|||
41928322|NCT01389752|75585560|FG000|Study Period 2|Sponsor decision|1|||
41928323|NCT01389752|75585561|FG001|Study Period 2|Sponsor decision|0|||
41928324|NCT01428128|75585568|FG000|Overall Study|Withdrawal by Subject|4|||
41928325|NCT01428128|75585568|FG000|Overall Study|Screen failure by p53|10|||
41928326|NCT01428128|75585568|FG000|Overall Study|Received Neulasta in one cycle|2|||
41928327|NCT01428128|75585568|FG000|Overall Study|Adverse Event|1|||
41928328|NCT01407926|75585573|FG000|Overall Study|Lost to Follow-up|55|||
41928329|NCT01427972|75585600|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
41928330|NCT01427972|75585601|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
41928331|NCT01427972|75585602|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
41928332|NCT01427972|75585603|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
41928333|NCT01427972|75585604|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
41928334|NCT01427972|75585605|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
41928335|NCT01427972|75585606|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
41928336|NCT01427972|75585607|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
41928337|NCT01427972|75585608|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
41928338|NCT01427972|75585609|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
41928339|NCT01427972|75585610|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
41928340|NCT01427972|75585611|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
41928341|NCT01427972|75585600|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
41928342|NCT01427972|75585601|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
41928343|NCT01427972|75585602|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
41928344|NCT01427972|75585603|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
41928345|NCT01427972|75585604|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
41928346|NCT01427972|75585605|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
41928347|NCT01427972|75585606|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
41928348|NCT01427972|75585607|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
41928349|NCT01427972|75585608|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
41928350|NCT01427972|75585609|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
41928351|NCT01427972|75585610|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
41928352|NCT01427972|75585611|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
41928353|NCT01427972|75585600|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
41928354|NCT01427972|75585601|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
41928355|NCT01427972|75585602|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
41928356|NCT01427972|75585603|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
41928357|NCT01427972|75585604|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
41928358|NCT01427972|75585605|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
41928359|NCT01427972|75585606|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
41928360|NCT01427972|75585607|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
41928361|NCT01427972|75585608|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
41928362|NCT01427972|75585609|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
41928363|NCT01427972|75585610|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
41928364|NCT01427972|75585611|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
41928365|NCT01427738|75585648|FG000|Overall Study|Death|12|||
42021987|NCT00961636|75829311|FG001|Overall Study|Protocol Violation|5|||
42021988|NCT00961636|75829312|FG002|Overall Study|Protocol Violation|1|||
41928366|NCT01427738|75585649|FG001|Overall Study|Death|9|||
41928367|NCT01427738|75585648|FG000|Overall Study|Severe debilitation, unable to continue|0|||
41928368|NCT01427738|75585649|FG001|Overall Study|Severe debilitation, unable to continue|1|||
41928369|NCT01427738|75585648|FG000|Overall Study|Subject unable to get to clinic|5|||
41928370|NCT01427738|75585649|FG001|Overall Study|Subject unable to get to clinic|2|||
41928371|NCT01427738|75585648|FG000|Overall Study|Withdrawal by Subject|0|||
41928372|NCT01427738|75585649|FG001|Overall Study|Withdrawal by Subject|2|||
41928373|NCT01427738|75585648|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
41928374|NCT01427738|75585649|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
41928375|NCT01427738|75585648|FG000|Overall Study|Lost to Follow-up|1|||
41928376|NCT01427738|75585649|FG001|Overall Study|Lost to Follow-up|5|||
41928377|NCT01426958|75585655|FG000|Overall Study|Adverse Event|2|||
41928378|NCT02578992|75585833|FG000|Overall Study|equipment not available or malfunction|3|||
41928379|NCT02578992|75585834|FG001|Overall Study|equipment not available or malfunction|3|||
41928380|NCT00558519|75585898|FG000|Overall Study|Ph+|20|||
41928381|NCT00558519|75585898|FG000|Overall Study|Ineligible|1|||
41928382|NCT00558519|75585898|FG000|Overall Study|Insufficient data|1|||
41928383|NCT00558519|75585898|FG000|Overall Study|Never received treatment|1|||
41928384|NCT00558285|75585942|FG000|Overall Study|Adverse Event|1|||
41928385|NCT00558285|75585943|FG001|Overall Study|Adverse Event|1|||
41928386|NCT00558285|75585944|FG002|Overall Study|Adverse Event|4|||
41928387|NCT00558285|75585945|FG003|Overall Study|Adverse Event|1|||
41928388|NCT00558285|75585946|FG004|Overall Study|Adverse Event|2|||
41928389|NCT00558285|75585942|FG000|Overall Study|Abnormal test procedure result(s)|1|||
41928390|NCT00558285|75585943|FG001|Overall Study|Abnormal test procedure result(s)|0|||
41928391|NCT00558285|75585944|FG002|Overall Study|Abnormal test procedure result(s)|0|||
41928392|NCT00558285|75585945|FG003|Overall Study|Abnormal test procedure result(s)|0|||
41928393|NCT00558285|75585946|FG004|Overall Study|Abnormal test procedure result(s)|0|||
41928394|NCT00558285|75585942|FG000|Overall Study|Subject withdrew consent|2|||
41928395|NCT00558285|75585943|FG001|Overall Study|Subject withdrew consent|0|||
41928396|NCT00558285|75585944|FG002|Overall Study|Subject withdrew consent|1|||
41928397|NCT00558285|75585945|FG003|Overall Study|Subject withdrew consent|1|||
41928398|NCT00558285|75585946|FG004|Overall Study|Subject withdrew consent|1|||
41928399|NCT00558285|75585942|FG000|Overall Study|Lost to Follow-up|1|||
41928400|NCT00558285|75585943|FG001|Overall Study|Lost to Follow-up|1|||
41928401|NCT00558285|75585944|FG002|Overall Study|Lost to Follow-up|0|||
41928402|NCT00558285|75585945|FG003|Overall Study|Lost to Follow-up|0|||
41928403|NCT00558285|75585946|FG004|Overall Study|Lost to Follow-up|0|||
41928404|NCT00558285|75585942|FG000|Overall Study|Administrative problems|0|||
41928405|NCT00558285|75585943|FG001|Overall Study|Administrative problems|0|||
41928406|NCT00558285|75585944|FG002|Overall Study|Administrative problems|0|||
41928407|NCT00558285|75585945|FG003|Overall Study|Administrative problems|1|||
41928408|NCT00558285|75585946|FG004|Overall Study|Administrative problems|1|||
41928409|NCT00558285|75585942|FG000|Overall Study|Protocol deviation|1|||
41928410|NCT00558285|75585943|FG001|Overall Study|Protocol deviation|1|||
41928411|NCT00558285|75585944|FG002|Overall Study|Protocol deviation|0|||
41928412|NCT00558285|75585945|FG003|Overall Study|Protocol deviation|1|||
41928413|NCT00558285|75585946|FG004|Overall Study|Protocol deviation|0|||
41928414|NCT01389596|75585961|FG000|Overall Study|Protocol Violation|3|||
41928415|NCT01389596|75585962|FG001|Overall Study|Protocol Violation|4|||
41928416|NCT01389596|75585963|FG002|Overall Study|Protocol Violation|3|||
41928417|NCT01389596|75585961|FG000|Overall Study|Withdrawal by Subject|1|||
41928418|NCT01389596|75585962|FG001|Overall Study|Withdrawal by Subject|2|||
41928419|NCT01389596|75585963|FG002|Overall Study|Withdrawal by Subject|2|||
41928420|NCT01389596|75585961|FG000|Overall Study|Insufficient Clinical Response|3|||
41928421|NCT01389596|75585962|FG001|Overall Study|Insufficient Clinical Response|4|||
41928422|NCT01389596|75585963|FG002|Overall Study|Insufficient Clinical Response|5|||
41928423|NCT01389596|75585961|FG000|Overall Study|Adverse Event|1|||
41928424|NCT01389596|75585962|FG001|Overall Study|Adverse Event|4|||
41928425|NCT01389596|75585963|FG002|Overall Study|Adverse Event|0|||
41928426|NCT01389596|75585961|FG000|Overall Study|Death|0|||
41928427|NCT01389596|75585962|FG001|Overall Study|Death|1|||
41928428|NCT01389596|75585963|FG002|Overall Study|Death|0|||
41928429|NCT01389596|75585961|FG000|Overall Study|Other Unspecified|2|||
41928430|NCT01389596|75585962|FG001|Overall Study|Other Unspecified|1|||
41928431|NCT01389596|75585963|FG002|Overall Study|Other Unspecified|0|||
41928432|NCT01405898|75585999|FG000|Overall Study|Withdrawal by Subject|2|||
41928433|NCT01405898|75586000|FG001|Overall Study|Withdrawal by Subject|2|||
41928434|NCT01389128|75586026|FG000|Overall Study|Fetal distress|1|||
41928435|NCT01389128|75586027|FG001|Overall Study|Fetal distress|0|||
41928436|NCT01389128|75586026|FG000|Overall Study|Cervix dilation stop|1|||
41928437|NCT01389128|75586027|FG001|Overall Study|Cervix dilation stop|2|||
41928438|NCT01389128|75586026|FG000|Overall Study|Rapid labor evolution|3|||
41928439|NCT01389128|75586027|FG001|Overall Study|Rapid labor evolution|2|||
41928440|NCT01389128|75586026|FG000|Overall Study|Intolerance to procedure|0|||
41928441|NCT01389128|75586027|FG001|Overall Study|Intolerance to procedure|2|||
41928442|NCT01388816|75586058|FG000|Overall Study|Adverse Event|0|||
41928443|NCT01388816|75586059|FG001|Overall Study|Adverse Event|2|||
41928444|NCT01388816|75586060|FG002|Overall Study|Adverse Event|0|||
41928445|NCT01388816|75586061|FG003|Overall Study|Adverse Event|0|||
41928446|NCT01388816|75586058|FG000|Overall Study|Lost to Follow-up|0|||
41928447|NCT01388816|75586059|FG001|Overall Study|Lost to Follow-up|1|||
41928448|NCT01388816|75586060|FG002|Overall Study|Lost to Follow-up|0|||
41928449|NCT01388816|75586061|FG003|Overall Study|Lost to Follow-up|0|||
41928450|NCT01388816|75586058|FG000|Overall Study|Withdrawal by Subject|2|||
41928451|NCT01388816|75586059|FG001|Overall Study|Withdrawal by Subject|1|||
41928452|NCT01388816|75586060|FG002|Overall Study|Withdrawal by Subject|1|||
41928453|NCT01388816|75586061|FG003|Overall Study|Withdrawal by Subject|0|||
41928454|NCT01388816|75586058|FG000|Overall Study|Protocol Violation|0|||
41928455|NCT01388816|75586059|FG001|Overall Study|Protocol Violation|0|||
41928456|NCT01388816|75586060|FG002|Overall Study|Protocol Violation|2|||
41928457|NCT01388816|75586061|FG003|Overall Study|Protocol Violation|0|||
41928458|NCT00555477|75586215|FG000|Overall Study|Adverse Event|0|||
41928459|NCT00555477|75586216|FG001|Overall Study|Adverse Event|9|||
41928460|NCT00555477|75586215|FG000|Overall Study|Withdrawal by Subject|1|||
41928461|NCT00555477|75586216|FG001|Overall Study|Withdrawal by Subject|2|||
41928462|NCT00555477|75586215|FG000|Overall Study|Physician Decision|1|||
41928463|NCT00555477|75586216|FG001|Overall Study|Physician Decision|2|||
41928464|NCT00554619|75586233|FG000|Overall Study|Adverse Event|1|||
41928465|NCT00554619|75586233|FG000|Overall Study|Physician Decision|1|||
41928466|NCT00554619|75586233|FG000|Overall Study|Liver Function Test Abnormality|1|||
41928467|NCT01426412|75586293|FG000|Overall Study|Withdrawal by Subject|1|||
41928468|NCT01426412|75586294|FG001|Overall Study|Withdrawal by Subject|0|||
41928469|NCT01426412|75586295|FG002|Overall Study|Withdrawal by Subject|0|||
41928470|NCT01426412|75586296|FG003|Overall Study|Withdrawal by Subject|0|||
41928471|NCT01426412|75586297|FG004|Overall Study|Withdrawal by Subject|1|||
41928472|NCT01426412|75586298|FG005|Overall Study|Withdrawal by Subject|0|||
41928473|NCT01426412|75586299|FG006|Overall Study|Withdrawal by Subject|0|||
41928474|NCT01426412|75586300|FG007|Overall Study|Withdrawal by Subject|3|||
41928475|NCT01426412|75586301|FG008|Overall Study|Withdrawal by Subject|1|||
41928476|NCT00554229|75586505|FG000|Overall Study|Lost to Follow-up|3|||
41928477|NCT00554229|75586506|FG001|Overall Study|Lost to Follow-up|6|||
41928478|NCT00554229|75586505|FG000|Overall Study|Withdrawal by Subject|29|||
41928479|NCT00554229|75586506|FG001|Overall Study|Withdrawal by Subject|37|||
41928480|NCT00554229|75586505|FG000|Overall Study|Adverse Event|71|||
41928481|NCT00554229|75586506|FG001|Overall Study|Adverse Event|39|||
41928482|NCT00554229|75586505|FG000|Overall Study|Protocol Violation|3|||
41928483|NCT00554229|75586506|FG001|Overall Study|Protocol Violation|3|||
41928484|NCT00554229|75586505|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
41928485|NCT00554229|75586506|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
41928486|NCT00554229|75586505|FG000|Overall Study|Randomised but no treatment received|1|||
41928487|NCT00554229|75586506|FG001|Overall Study|Randomised but no treatment received|0|||
41928488|NCT01405820|75586616|FG000|Randomized Treatment Period|Adverse Event|3|||
41928489|NCT01405820|75586617|FG001|Randomized Treatment Period|Adverse Event|3|||
41928490|NCT01405820|75586618|FG002|Randomized Treatment Period|Adverse Event|3|||
41928491|NCT01405820|75586619|FG003|Randomized Treatment Period|Adverse Event|0|||
41928492|NCT01405820|75586620|FG004|Randomized Treatment Period|Adverse Event|2|||
41928493|NCT01405820|75586621|FG005|Randomized Treatment Period|Adverse Event|1|||
41928494|NCT01405820|75586616|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
41928495|NCT01405820|75586617|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
41928496|NCT01405820|75586618|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
41928497|NCT01405820|75586619|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
41928498|NCT01405820|75586620|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
41928499|NCT01405820|75586621|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
41928500|NCT01405820|75586616|FG000|Randomized Treatment Period|Other|2|||
41928501|NCT01405820|75586617|FG001|Randomized Treatment Period|Other|2|||
41928502|NCT01405820|75586618|FG002|Randomized Treatment Period|Other|1|||
41928503|NCT01405820|75586619|FG003|Randomized Treatment Period|Other|1|||
41928504|NCT01405820|75586620|FG004|Randomized Treatment Period|Other|0|||
41928505|NCT01405820|75586621|FG005|Randomized Treatment Period|Other|0|||
41928506|NCT01405820|75586616|FG000|Randomized Treatment Period|Physician Decision|0|||
41928507|NCT01405820|75586617|FG001|Randomized Treatment Period|Physician Decision|2|||
41928508|NCT01405820|75586618|FG002|Randomized Treatment Period|Physician Decision|1|||
41928509|NCT01405820|75586619|FG003|Randomized Treatment Period|Physician Decision|0|||
41928510|NCT01405820|75586620|FG004|Randomized Treatment Period|Physician Decision|0|||
41928511|NCT01405820|75586621|FG005|Randomized Treatment Period|Physician Decision|0|||
41928512|NCT01405820|75586616|FG000|Randomized Treatment Period|Rescue|0|||
41928513|NCT01405820|75586617|FG001|Randomized Treatment Period|Rescue|1|||
42208881|NCT02927366|76023018|FG000|Overall Study|Patient schedule|1|||
41928514|NCT01405820|75586618|FG002|Randomized Treatment Period|Rescue|13|||
41928515|NCT01405820|75586619|FG003|Randomized Treatment Period|Rescue|10|||
41928516|NCT01405820|75586620|FG004|Randomized Treatment Period|Rescue|8|||
41928517|NCT01405820|75586621|FG005|Randomized Treatment Period|Rescue|8|||
41928518|NCT01405820|75586616|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
41928519|NCT01405820|75586617|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
41928520|NCT01405820|75586618|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
41928521|NCT01405820|75586619|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
41928522|NCT01405820|75586620|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
41928523|NCT01405820|75586621|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
41928524|NCT01405820|75586616|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
41928525|NCT01405820|75586617|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
41928526|NCT01405820|75586618|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
41928527|NCT01405820|75586619|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
41928528|NCT01405820|75586620|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
41928529|NCT01405820|75586621|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
41928530|NCT01405820|75586616|FG000|Randomized Treatment Period|Death|0|||
41928531|NCT01405820|75586617|FG001|Randomized Treatment Period|Death|0|||
41928532|NCT01405820|75586618|FG002|Randomized Treatment Period|Death|0|||
41928533|NCT01405820|75586619|FG003|Randomized Treatment Period|Death|1|||
41928534|NCT01405820|75586620|FG004|Randomized Treatment Period|Death|0|||
41928535|NCT01405820|75586621|FG005|Randomized Treatment Period|Death|0|||
41928536|NCT01405820|75586616|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
41928537|NCT01405820|75586617|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
41928538|NCT01405820|75586618|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
41928539|NCT01405820|75586619|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
41928540|NCT01405820|75586620|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
41928541|NCT01405820|75586621|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
41928542|NCT01405820|75586616|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
41928543|NCT01405820|75586617|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
41928544|NCT01405820|75586618|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
41928545|NCT01405820|75586619|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
41928546|NCT01405820|75586620|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
41928547|NCT01405820|75586621|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
41928548|NCT01405820|75586616|FG000|Open-Label Treatment Period|Other|1|||
41928549|NCT01405820|75586617|FG001|Open-Label Treatment Period|Other|1|||
41928550|NCT01405820|75586618|FG002|Open-Label Treatment Period|Other|1|||
41928551|NCT01405820|75586619|FG003|Open-Label Treatment Period|Other|1|||
41928552|NCT01405820|75586620|FG004|Open-Label Treatment Period|Other|1|||
41928553|NCT01405820|75586621|FG005|Open-Label Treatment Period|Other|1|||
41928554|NCT01405820|75586616|FG000|Open-Label Treatment Period|Physician Decision|0|||
41928555|NCT01405820|75586617|FG001|Open-Label Treatment Period|Physician Decision|0|||
41928556|NCT01405820|75586618|FG002|Open-Label Treatment Period|Physician Decision|1|||
41928557|NCT01405820|75586619|FG003|Open-Label Treatment Period|Physician Decision|2|||
41928558|NCT01405820|75586620|FG004|Open-Label Treatment Period|Physician Decision|1|||
41928559|NCT01405820|75586621|FG005|Open-Label Treatment Period|Physician Decision|0|||
41928560|NCT01405820|75586616|FG000|Open-Label Treatment Period|Adverse Event|0|||
41928561|NCT01405820|75586617|FG001|Open-Label Treatment Period|Adverse Event|0|||
41928562|NCT01405820|75586618|FG002|Open-Label Treatment Period|Adverse Event|0|||
41928563|NCT01405820|75586619|FG003|Open-Label Treatment Period|Adverse Event|1|||
41928564|NCT01405820|75586620|FG004|Open-Label Treatment Period|Adverse Event|0|||
41928565|NCT01405820|75586621|FG005|Open-Label Treatment Period|Adverse Event|0|||
41928566|NCT01405742|75586650|FG000|Overall Study|Lost to Follow-up|1|||
41928567|NCT01405742|75586651|FG001|Overall Study|Lost to Follow-up|0|||
41928568|NCT01425632|75586680|FG000|Overall Study|Adverse Event|0|||
41928569|NCT01425632|75586681|FG001|Overall Study|Adverse Event|1|||
41928570|NCT01425632|75586682|FG002|Overall Study|Adverse Event|1|||
41928571|NCT01425632|75586680|FG000|Overall Study|Physician Decision|1|||
41928572|NCT01425632|75586681|FG001|Overall Study|Physician Decision|0|||
41928573|NCT01425632|75586682|FG002|Overall Study|Physician Decision|0|||
41928574|NCT01425632|75586680|FG000|Overall Study|Protocol Violation|0|||
41928575|NCT01425632|75586681|FG001|Overall Study|Protocol Violation|0|||
41928576|NCT01425632|75586682|FG002|Overall Study|Protocol Violation|2|||
41928577|NCT01425632|75586680|FG000|Overall Study|Withdrawal by Subject|0|||
41928578|NCT01425632|75586681|FG001|Overall Study|Withdrawal by Subject|0|||
41928579|NCT01425632|75586682|FG002|Overall Study|Withdrawal by Subject|1|||
41928580|NCT01405508|75586719|FG000|Overall Study|AE, non-serious non-fatal|1|||
41928581|NCT01405508|75586720|FG001|Overall Study|AE, non-serious non-fatal|1|||
42021989|NCT00961636|75829310|FG000|Overall Study|Withdrawal by Subject|29|||
42208882|NCT02927366|76023019|FG001|Overall Study|Patient schedule|0|||
41928582|NCT01405508|75586721|FG002|Overall Study|AE, non-serious non-fatal|0|||
41928583|NCT01405508|75586722|FG003|Overall Study|AE, non-serious non-fatal|0|||
41928584|NCT01405196|75586858|FG000|Overall Study|Study Terminated by Sponsor|0|||
41928585|NCT01405196|75586859|FG001|Overall Study|Study Terminated by Sponsor|0|||
41928586|NCT01405196|75586860|FG002|Overall Study|Study Terminated by Sponsor|9|||
41928587|NCT01405196|75586861|FG003|Overall Study|Study Terminated by Sponsor|0|||
42021990|NCT00961636|75829311|FG001|Overall Study|Withdrawal by Subject|22|||
42021991|NCT00961636|75829312|FG002|Overall Study|Withdrawal by Subject|13|||
41928588|NCT01405196|75586858|FG000|Overall Study|Other|2|||
41928589|NCT01405196|75586859|FG001|Overall Study|Other|2|||
41928590|NCT01405196|75586860|FG002|Overall Study|Other|5|||
41928591|NCT01405196|75586861|FG003|Overall Study|Other|0|||
41928592|NCT01405196|75586858|FG000|Overall Study|Withdrawal by Subject|4|||
41928593|NCT01405196|75586859|FG001|Overall Study|Withdrawal by Subject|6|||
41928594|NCT01405196|75586860|FG002|Overall Study|Withdrawal by Subject|3|||
41928595|NCT01405196|75586861|FG003|Overall Study|Withdrawal by Subject|6|||
41928596|NCT01405196|75586858|FG000|Overall Study|Adverse Event|2|||
41928597|NCT01405196|75586859|FG001|Overall Study|Adverse Event|2|||
41928598|NCT01405196|75586860|FG002|Overall Study|Adverse Event|0|||
41928599|NCT01405196|75586861|FG003|Overall Study|Adverse Event|2|||
41928600|NCT01405196|75586858|FG000|Overall Study|Death|1|||
41928601|NCT01405196|75586859|FG001|Overall Study|Death|0|||
41928602|NCT01405196|75586860|FG002|Overall Study|Death|3|||
41928603|NCT01405196|75586861|FG003|Overall Study|Death|0|||
41928604|NCT01405196|75586858|FG000|Overall Study|Lost to Follow-up|2|||
41928605|NCT01405196|75586859|FG001|Overall Study|Lost to Follow-up|2|||
41928606|NCT01405196|75586860|FG002|Overall Study|Lost to Follow-up|3|||
41928607|NCT01405196|75586861|FG003|Overall Study|Lost to Follow-up|1|||
41928608|NCT01402700|75586911|FG000|Overall Study|Death|3|||
41928609|NCT01402700|75586911|FG000|Overall Study|Withdrawal by Subject|3|||
41928610|NCT01402700|75586911|FG000|Overall Study|Missed Visit|1|||
41928611|NCT01424930|75587033|FG000|Overall Study|Adverse Event|0|||
41928612|NCT01424930|75587034|FG001|Overall Study|Adverse Event|1|||
41928613|NCT01424930|75587033|FG000|Overall Study|Death|1|||
41928614|NCT01424930|75587034|FG001|Overall Study|Death|0|||
41928615|NCT01424930|75587033|FG000|Overall Study|Progressive Disease|3|||
41928616|NCT01424930|75587034|FG001|Overall Study|Progressive Disease|6|||
41928617|NCT01424930|75587033|FG000|Overall Study|Screen Failure|0|||
41928618|NCT01424930|75587034|FG001|Overall Study|Screen Failure|1|||
41928619|NCT01424930|75587033|FG000|Overall Study|Reason not specified|0|||
41928620|NCT01424930|75587034|FG001|Overall Study|Reason not specified|6|||
41928621|NCT01424306|75587049|FG000|Overall Study|Protocol Violation|0|||
41928622|NCT01424306|75587050|FG001|Overall Study|Protocol Violation|0|||
41928623|NCT01424306|75587051|FG002|Overall Study|Protocol Violation|0|||
41928624|NCT01424306|75587052|FG003|Overall Study|Protocol Violation|0|||
41928625|NCT01424306|75587053|FG004|Overall Study|Protocol Violation|1|||
41928626|NCT01424306|75587054|FG005|Overall Study|Protocol Violation|0|||
41928627|NCT01424228|75587098|FG000|Overall Study|Withdrawal by Subject|27|||
41928628|NCT01424228|75587099|FG001|Overall Study|Withdrawal by Subject|11|||
41928629|NCT01424228|75587098|FG000|Overall Study|Adverse Event|10|||
41928630|NCT01424228|75587099|FG001|Overall Study|Adverse Event|14|||
41928631|NCT01424228|75587098|FG000|Overall Study|Sponsor's decision|9|||
41928632|NCT01424228|75587099|FG001|Overall Study|Sponsor's decision|12|||
41928633|NCT01424228|75587098|FG000|Overall Study|Lack of Efficacy|5|||
41928634|NCT01424228|75587099|FG001|Overall Study|Lack of Efficacy|7|||
41928635|NCT01424228|75587098|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
41928636|NCT01424228|75587099|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
41928637|NCT01424228|75587098|FG000|Overall Study|Non-compliance|2|||
41928638|NCT01424228|75587099|FG001|Overall Study|Non-compliance|0|||
41928639|NCT01424228|75587098|FG000|Overall Study|Worsening of symptoms|1|||
41928640|NCT01424228|75587099|FG001|Overall Study|Worsening of symptoms|0|||
41928641|NCT01424228|75587098|FG000|Overall Study|Unplanned journey|0|||
41928642|NCT01424228|75587099|FG001|Overall Study|Unplanned journey|1|||
41928643|NCT01423916|75587108|FG000|Overall Study|Adverse Event|5|||
41928644|NCT01423916|75587109|FG001|Overall Study|Adverse Event|9|||
41928645|NCT01423916|75587110|FG002|Overall Study|Adverse Event|2|||
41928646|NCT01423916|75587108|FG000|Overall Study|Met Withdrawal Criteria|1|||
41928647|NCT01423916|75587109|FG001|Overall Study|Met Withdrawal Criteria|1|||
41928648|NCT01423916|75587110|FG002|Overall Study|Met Withdrawal Criteria|1|||
41928649|NCT01423916|75587108|FG000|Overall Study|Physician Decision|1|||
41928650|NCT01423916|75587109|FG001|Overall Study|Physician Decision|0|||
41928651|NCT01423916|75587110|FG002|Overall Study|Physician Decision|1|||
41928652|NCT01423916|75587108|FG000|Overall Study|Withdrawal by Subject|3|||
41928653|NCT01423916|75587109|FG001|Overall Study|Withdrawal by Subject|10|||
41928654|NCT01423916|75587110|FG002|Overall Study|Withdrawal by Subject|3|||
41928655|NCT01423916|75587108|FG000|Overall Study|Protocol Deviation|1|||
41928656|NCT01423916|75587109|FG001|Overall Study|Protocol Deviation|0|||
41928657|NCT01423916|75587110|FG002|Overall Study|Protocol Deviation|0|||
41928658|NCT01423604|75587229|FG000|Safety Run-In|Adverse Event|3|||
41928659|NCT01423604|75587230|FG001|Safety Run-In|Adverse Event|0|||
41928660|NCT01423604|75587229|FG000|Safety Run-In|Death|1|||
41928661|NCT01423604|75587230|FG001|Safety Run-In|Death|0|||
41928662|NCT01423604|75587229|FG000|Safety Run-In|Physician Decision|1|||
41928663|NCT01423604|75587230|FG001|Safety Run-In|Physician Decision|0|||
41928664|NCT01423604|75587229|FG000|Safety Run-In|Disease progression|3|||
41928665|NCT01423604|75587230|FG001|Safety Run-In|Disease progression|0|||
41928666|NCT01423604|75587229|FG000|Safety Run-In|Patient decision|1|||
41928667|NCT01423604|75587230|FG001|Safety Run-In|Patient decision|0|||
41928668|NCT01423604|75587229|FG000|Randomized|Adverse Event|4|||
41928669|NCT01423604|75587230|FG001|Randomized|Adverse Event|10|||
41928670|NCT01423604|75587229|FG000|Randomized|Death|1|||
41928671|NCT01423604|75587230|FG001|Randomized|Death|0|||
41928672|NCT01423604|75587229|FG000|Randomized|Physician Decision|16|||
41928673|NCT01423604|75587230|FG001|Randomized|Physician Decision|13|||
41928674|NCT01423604|75587229|FG000|Randomized|Other - unspecified|37|||
41928675|NCT01423604|75587230|FG001|Randomized|Other - unspecified|31|||
41928676|NCT01423604|75587229|FG000|Randomized|Patient decision|5|||
41928677|NCT01423604|75587230|FG001|Randomized|Patient decision|9|||
41928678|NCT01402544|75587246|FG000|Overall Study|Withdrawal by Subject|6|||
41928679|NCT01401842|75587252|FG000|Overall Study|Withdrawal by Subject|3|||
41928680|NCT01401842|75587253|FG001|Overall Study|Withdrawal by Subject|2|||
41928681|NCT01401842|75587252|FG000|Overall Study|academic reason|4|||
41928682|NCT01401842|75587253|FG001|Overall Study|academic reason|1|||
41928683|NCT01401842|75587252|FG000|Overall Study|changed companies|20|||
41928684|NCT01401842|75587253|FG001|Overall Study|changed companies|34|||
41928685|NCT01401842|75587252|FG000|Overall Study|discharged from US Army|3|||
41928686|NCT01401842|75587253|FG001|Overall Study|discharged from US Army|4|||
41928687|NCT01401842|75587252|FG000|Overall Study|invalid follow-up strength data|1|||
41928688|NCT01401842|75587253|FG001|Overall Study|invalid follow-up strength data|4|||
41928689|NCT01401842|75587252|FG000|Overall Study|on profile|9|||
41928690|NCT01401842|75587253|FG001|Overall Study|on profile|5|||
41928691|NCT01401842|75587252|FG000|Overall Study|other/unknown|28|||
41928692|NCT01401842|75587253|FG001|Overall Study|other/unknown|17|||
41928693|NCT01422824|75587259|FG000|Overall Study|Case record form not evaluated|1|||
41928694|NCT01422824|75587259|FG000|Overall Study|Lost to Follow-up|37|||
41928695|NCT01401530|75587322|FG000|Overall Study|Disease Progression|1|||
41928696|NCT01401530|75587323|FG001|Overall Study|Disease Progression|2|||
41928697|NCT01401530|75587324|FG002|Overall Study|Disease Progression|1|||
41928698|NCT01401530|75587322|FG000|Overall Study|Adverse Event|1|||
41928699|NCT01401530|75587323|FG001|Overall Study|Adverse Event|1|||
41928700|NCT01401530|75587324|FG002|Overall Study|Adverse Event|1|||
41928701|NCT01401530|75587322|FG000|Overall Study|Participant Choice|1|||
41928702|NCT01401530|75587323|FG001|Overall Study|Participant Choice|2|||
41928703|NCT01401530|75587324|FG002|Overall Study|Participant Choice|1|||
41928704|NCT01401530|75587322|FG000|Overall Study|Physician Decision|0|||
41928705|NCT01401530|75587323|FG001|Overall Study|Physician Decision|1|||
41928706|NCT01401530|75587324|FG002|Overall Study|Physician Decision|0|||
41928707|NCT01387022|75587336|FG000|Overall Study|Death|1|||
41928708|NCT01387022|75587337|FG001|Overall Study|Death|1|||
41928709|NCT01387022|75587336|FG000|Overall Study|Lost to Follow-up|0|||
41928710|NCT01387022|75587337|FG001|Overall Study|Lost to Follow-up|3|||
41928711|NCT01386944|75587363|FG000|Overall Study|Adverse Event|26|||
41928712|NCT01386944|75587363|FG000|Overall Study|Lack of Efficacy|14|||
41928713|NCT01386944|75587363|FG000|Overall Study|Lost to Follow-up|8|||
41928714|NCT01386944|75587363|FG000|Overall Study|Unspecified reason|8|||
41928715|NCT01386788|75587374|FG000|Overall Study|Lost to Follow-up|2|||
41928716|NCT01386554|75587439|FG000|Overall Study|Lost to Follow-up|0|||
41928717|NCT01386554|75587440|FG001|Overall Study|Lost to Follow-up|0|||
41928718|NCT01386554|75587441|FG002|Overall Study|Lost to Follow-up|1|||
41928719|NCT01386554|75587439|FG000|Overall Study|Adverse Event|2|||
41928720|NCT01386554|75587440|FG001|Overall Study|Adverse Event|5|||
41928721|NCT01386554|75587441|FG002|Overall Study|Adverse Event|2|||
41928722|NCT01386554|75587439|FG000|Overall Study|Progressive disease|1|||
41928723|NCT01386554|75587440|FG001|Overall Study|Progressive disease|2|||
41928724|NCT01386554|75587441|FG002|Overall Study|Progressive disease|2|||
41928725|NCT01386554|75587439|FG000|Overall Study|Administration of live vaccines|0|||
41928726|NCT01386554|75587440|FG001|Overall Study|Administration of live vaccines|1|||
41928727|NCT01386554|75587441|FG002|Overall Study|Administration of live vaccines|0|||
41928728|NCT01386554|75587439|FG000|Overall Study|Investigator discretion|0|||
41928729|NCT01386554|75587440|FG001|Overall Study|Investigator discretion|0|||
41928730|NCT01386554|75587441|FG002|Overall Study|Investigator discretion|1|||
41928731|NCT01386554|75587439|FG000|Overall Study|Reason not collected|0|||
41928732|NCT01386554|75587440|FG001|Overall Study|Reason not collected|1|||
41928733|NCT01386554|75587441|FG002|Overall Study|Reason not collected|0|||
42117682|NCT00117637|75928531|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
41928734|NCT01386008|75587466|FG000|Overall Study|exited w/o incident /study discontinued|17|||
41928735|NCT01386008|75587466|FG000|Overall Study|Adverse Event|3|||
41928736|NCT01421342|75587614|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
41928737|NCT01421342|75587615|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
41928738|NCT01421342|75587616|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
41928739|NCT01421342|75587614|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
41928740|NCT01421342|75587615|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
41928741|NCT01421342|75587616|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
41928742|NCT01421342|75587614|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
41928743|NCT01421342|75587615|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
41928744|NCT01421342|75587616|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
41928745|NCT01421342|75587614|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
41928746|NCT01421342|75587615|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
41928747|NCT01421342|75587616|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
41928748|NCT01421342|75587614|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
41928749|NCT01421342|75587615|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
41928750|NCT01421342|75587616|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
41928751|NCT01421342|75587614|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
41928752|NCT01421342|75587615|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
41928753|NCT01421342|75587616|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
41928754|NCT01421342|75587614|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
41928755|NCT01421342|75587615|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
41928756|NCT01421342|75587616|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
41928757|NCT01421342|75587614|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
41928758|NCT01421342|75587615|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
41928759|NCT01421342|75587616|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
41928760|NCT01421342|75587614|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
41928761|NCT01421342|75587615|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
41928762|NCT01421342|75587616|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
41928763|NCT01421342|75587614|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
41928764|NCT01421342|75587615|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
41928765|NCT01421342|75587616|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
41928766|NCT01421342|75587614|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
41928767|NCT01421342|75587615|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
41928768|NCT01421342|75587616|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
41928769|NCT01421342|75587614|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
41928770|NCT01421342|75587615|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
41928771|NCT01421342|75587616|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
41928772|NCT01421342|75587614|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
41928773|NCT01421342|75587615|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
41928774|NCT01421342|75587616|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
41928775|NCT01421342|75587614|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
41928776|NCT01421342|75587615|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
41928777|NCT01421342|75587616|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
41928778|NCT01421342|75587614|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
41928779|NCT01421342|75587615|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
41928780|NCT01421342|75587616|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
41928781|NCT01421342|75587614|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
41928782|NCT01421342|75587615|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
41928783|NCT01421342|75587616|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
41928784|NCT01421342|75587614|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
41928785|NCT01421342|75587615|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
41928786|NCT01421342|75587616|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
41928787|NCT01421342|75587614|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
41928788|NCT01421342|75587615|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
41928789|NCT01421342|75587616|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
41928790|NCT01421342|75587614|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
41928791|NCT01421342|75587615|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
41928792|NCT01421342|75587616|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
41928793|NCT01421342|75587614|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
41928794|NCT01421342|75587615|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
41928795|NCT01421342|75587616|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
41928796|NCT01421342|75587614|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
41928797|NCT01421342|75587615|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
41928798|NCT01421342|75587616|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
41928799|NCT01421342|75587614|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
41928800|NCT01421342|75587615|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
41928801|NCT01421342|75587616|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
41928802|NCT01421342|75587614|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
41928803|NCT01421342|75587615|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
41928804|NCT01421342|75587616|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
41928805|NCT01421342|75587614|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
41928806|NCT01421342|75587615|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
41928807|NCT01421342|75587616|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
41928808|NCT01421342|75587614|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
42010363|NCT01290068|75817492|FG001|Overall Study|Adverse Event|3|||
41928809|NCT01421342|75587615|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
41928810|NCT01421342|75587616|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
41928811|NCT01421342|75587614|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
41928812|NCT01421342|75587615|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
41928813|NCT01421342|75587616|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
41928814|NCT01421342|75587614|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
41928815|NCT01421342|75587615|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
41928816|NCT01421342|75587616|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
41928817|NCT01421342|75587614|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
41928818|NCT01421342|75587615|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
41928819|NCT01421342|75587616|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
41928820|NCT01384760|75587639|FG000|Overall Study|Lost to Follow-up|0|||
41928821|NCT01384760|75587640|FG001|Overall Study|Lost to Follow-up|6|||
41928822|NCT01384760|75587639|FG000|Overall Study|Protocol Violation|16|||
41928823|NCT01384760|75587640|FG001|Overall Study|Protocol Violation|0|||
41928824|NCT01384292|75587680|FG000|Part B|Severe non-compliance to protocol|1|||
41928825|NCT01384292|75587681|FG001|Part B|Severe non-compliance to protocol|0|||
41928826|NCT01384292|75587682|FG002|Part B|Severe non-compliance to protocol|0|||
41928827|NCT01401452|75587692|FG000|Overall Study|Adverse reaction|9|||
41928828|NCT01401452|75587692|FG000|Overall Study|Lost to Follow-up|12|||
41928829|NCT01401452|75587692|FG000|Overall Study|Lack of Efficacy|30|||
41928830|NCT01401452|75587692|FG000|Overall Study|Participant developed breast cancer|1|||
41928831|NCT01401452|75587692|FG000|Overall Study|Tx stopped due to financial reasons|1|||
41928832|NCT01401452|75587692|FG000|Overall Study|Tx stopped by psychiatrist|1|||
41928833|NCT01401452|75587692|FG000|Overall Study|No more visits within the 36 wk followup|4|||
41928834|NCT01401452|75587692|FG000|Overall Study|Subject did not come to follow up visits|2|||
41928835|NCT01401452|75587692|FG000|Overall Study|Subject didn't return for routine visits|1|||
41928836|NCT01401452|75587692|FG000|Overall Study|Subject moved to another city|1|||
41928837|NCT01401452|75587692|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
41928838|NCT01401452|75587692|FG000|Overall Study|Psoriatic arthritis|1|||
41928839|NCT01401452|75587692|FG000|Overall Study|Participant stopped Tx|2|||
41928840|NCT01401452|75587692|FG000|Overall Study|Discontinuation for personal reasons|1|||
41928841|NCT01401452|75587692|FG000|Overall Study|Treatment failure|1|||
41928842|NCT01401452|75587692|FG000|Overall Study|Unsatisfactory output|1|||
41928843|NCT01401452|75587692|FG000|Overall Study|Subject withdrew because of Tx success|1|||
41928844|NCT01401452|75587692|FG000|Overall Study|Subject chose to discontinue treatment|1|||
41928845|NCT01401452|75587692|FG000|Overall Study|Participant withdrew consent|1|||
41928846|NCT01401062|75587727|FG000|Overall Study|Death|9|||
41928847|NCT01401062|75587728|FG001|Overall Study|Death|7|||
41928848|NCT01401062|75587727|FG000|Overall Study|Physician Decision|1|||
41928849|NCT01401062|75587728|FG001|Overall Study|Physician Decision|0|||
41928850|NCT01401062|75587727|FG000|Overall Study|Withdrawal by Subject|1|||
41928851|NCT01401062|75587728|FG001|Overall Study|Withdrawal by Subject|1|||
41928852|NCT01400516|75587761|FG000|Primary Trial|Withdrawal by Subject|0|||
41928853|NCT01400516|75587762|FG001|Primary Trial|Withdrawal by Subject|2|||
41928854|NCT01383356|75587768|FG000|Period 1|Adverse Event|5|||
41928855|NCT01383356|75587769|FG001|Period 1|Adverse Event|3|||
41928856|NCT01383356|75587768|FG000|Period 1|Non-compliance|3|||
41928857|NCT01383356|75587769|FG001|Period 1|Non-compliance|0|||
41928858|NCT01383356|75587768|FG000|Period 1|Out of Range Mid-study-Test|0|||
41928859|NCT01383356|75587769|FG001|Period 1|Out of Range Mid-study-Test|1|||
41928860|NCT01383356|75587768|FG000|Period 1|Personal|0|||
41928861|NCT01383356|75587769|FG001|Period 1|Personal|2|||
41928862|NCT05740098|75587795|FG000|Overall Study|Lost to Follow-up|26|||
41928863|NCT05740098|75587796|FG001|Overall Study|Lost to Follow-up|17|||
41928864|NCT05740098|75587797|FG002|Overall Study|Lost to Follow-up|21|||
41928865|NCT05059080|75587808|FG000|Overall Study|Withdrawal by Subject|3|||
41928866|NCT05059080|75587808|FG000|Overall Study|Study Terminated by Sponsor|64|||
41928867|NCT05012163|75587816|FG000|Overall Study|Protocol Violation|0|||
41928868|NCT05012163|75587817|FG001|Overall Study|Protocol Violation|0|||
41928869|NCT05012163|75587818|FG002|Overall Study|Protocol Violation|1|||
41928870|NCT05012163|75587819|FG003|Overall Study|Protocol Violation|1|||
41928871|NCT05009251|75587834|FG000|Overall Study|Protocol Violation|100|||
41928872|NCT05009251|75587835|FG001|Overall Study|Protocol Violation|105|||
41928873|NCT05009251|75587836|FG002|Overall Study|Protocol Violation|119|||
41928874|NCT05009251|75587837|FG003|Overall Study|Protocol Violation|120|||
41928875|NCT05009251|75587838|FG004|Overall Study|Protocol Violation|119|||
41928876|NCT05009251|75587834|FG000|Overall Study|Death|25|||
41928877|NCT05009251|75587835|FG001|Overall Study|Death|22|||
41928878|NCT05009251|75587836|FG002|Overall Study|Death|24|||
41928879|NCT05009251|75587837|FG003|Overall Study|Death|19|||
41928880|NCT05009251|75587838|FG004|Overall Study|Death|15|||
41928881|NCT04839692|75587852|FG000|Overall Study|Withdrawal by Subject|0|||
41928882|NCT04839692|75587853|FG001|Overall Study|Withdrawal by Subject|3|||
41928883|NCT04839692|75587852|FG000|Overall Study|Physician Decision|1|||
41928884|NCT04839692|75587853|FG001|Overall Study|Physician Decision|0|||
41928885|NCT04476017|75587881|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
41928886|NCT04476017|75587882|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
41928887|NCT04422639|75587891|FG000|Overall Study|Death|1|||
41928888|NCT04422639|75587892|FG001|Overall Study|Death|0|||
41928889|NCT04422639|75587891|FG000|Overall Study|study closed prior to completion of FU visits|0|||
41928890|NCT04422639|75587892|FG001|Overall Study|study closed prior to completion of FU visits|2|||
41928891|NCT04384107|75587900|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
41928892|NCT04384107|75587901|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
41928893|NCT04384107|75587900|FG000|Overall Study|Lost to Follow-up|1|||
41928894|NCT04384107|75587901|FG001|Overall Study|Lost to Follow-up|0|||
41928895|NCT04275089|75587907|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
41928896|NCT04096326|75587942|FG000|Overall Study|Withdrawal by Subject|0|||
41928897|NCT04096326|75587943|FG001|Overall Study|Withdrawal by Subject|0|||
41928898|NCT04096326|75587944|FG002|Overall Study|Withdrawal by Subject|0|||
41928899|NCT04096326|75587945|FG003|Overall Study|Withdrawal by Subject|0|||
41928900|NCT04096326|75587946|FG004|Overall Study|Withdrawal by Subject|0|||
41928901|NCT04096326|75587947|FG005|Overall Study|Withdrawal by Subject|0|||
41928902|NCT04096326|75587948|FG006|Overall Study|Withdrawal by Subject|1|||
41928903|NCT04096326|75587949|FG007|Overall Study|Withdrawal by Subject|0|||
41928904|NCT04096326|75587950|FG008|Overall Study|Withdrawal by Subject|0|||
41928905|NCT04096326|75587951|FG009|Overall Study|Withdrawal by Subject|0|||
41928906|NCT04096326|75587942|FG000|Overall Study|Lost to Follow-up|0|||
41928907|NCT04096326|75587943|FG001|Overall Study|Lost to Follow-up|1|||
41928908|NCT04096326|75587944|FG002|Overall Study|Lost to Follow-up|0|||
41928909|NCT04096326|75587945|FG003|Overall Study|Lost to Follow-up|0|||
41928910|NCT04096326|75587946|FG004|Overall Study|Lost to Follow-up|0|||
41928911|NCT04096326|75587947|FG005|Overall Study|Lost to Follow-up|0|||
41928912|NCT04096326|75587948|FG006|Overall Study|Lost to Follow-up|0|||
41928913|NCT04096326|75587949|FG007|Overall Study|Lost to Follow-up|0|||
41928914|NCT04096326|75587950|FG008|Overall Study|Lost to Follow-up|0|||
41928915|NCT04096326|75587951|FG009|Overall Study|Lost to Follow-up|0|||
41928916|NCT04096326|75587942|FG000|Overall Study|COVID-19-related reasons|0|||
41928917|NCT04096326|75587943|FG001|Overall Study|COVID-19-related reasons|0|||
41928918|NCT04096326|75587944|FG002|Overall Study|COVID-19-related reasons|0|||
41928919|NCT04096326|75587945|FG003|Overall Study|COVID-19-related reasons|0|||
41928920|NCT04096326|75587946|FG004|Overall Study|COVID-19-related reasons|1|||
41928921|NCT04096326|75587947|FG005|Overall Study|COVID-19-related reasons|5|||
41928922|NCT04096326|75587948|FG006|Overall Study|COVID-19-related reasons|0|||
41928923|NCT04096326|75587949|FG007|Overall Study|COVID-19-related reasons|0|||
41928924|NCT04096326|75587950|FG008|Overall Study|COVID-19-related reasons|0|||
41928925|NCT04096326|75587951|FG009|Overall Study|COVID-19-related reasons|0|||
41928926|NCT04072822|75587975|FG000|Treatment|Adverse Event|9|||
41928927|NCT04072822|75587976|FG001|Treatment|Adverse Event|5|||
41928928|NCT04072822|75587975|FG000|Treatment|Met Stopping Criteria|13|||
41928929|NCT04072822|75587976|FG001|Treatment|Met Stopping Criteria|24|||
41928930|NCT04072822|75587975|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
41928931|NCT04072822|75587976|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
41928932|NCT04072822|75587975|FG000|Treatment|Withdrawal by Subject|0|||
41928933|NCT04072822|75587976|FG001|Treatment|Withdrawal by Subject|2|||
41928934|NCT04072822|75587975|FG000|Treatment|Death|0|||
41928935|NCT04072822|75587976|FG001|Treatment|Death|2|||
41928936|NCT04072822|75587975|FG000|Treatment|Lost to Follow-up|11|||
41928937|NCT04072822|75587976|FG001|Treatment|Lost to Follow-up|3|||
41928938|NCT04072822|75587975|FG000|Treatment|Physician Decision|1|||
41928939|NCT04072822|75587976|FG001|Treatment|Physician Decision|0|||
41928940|NCT04072822|75587975|FG000|Treatment|Other|7|||
41928941|NCT04072822|75587976|FG001|Treatment|Other|9|||
41928942|NCT04072822|75587975|FG000|Follow-up|Withdrawal by Subject|1|||
41928943|NCT04072822|75587976|FG001|Follow-up|Withdrawal by Subject|0|||
41928944|NCT04072822|75587975|FG000|Follow-up|Lost to Follow-up|5|||
41928945|NCT04072822|75587976|FG001|Follow-up|Lost to Follow-up|4|||
41928946|NCT04031846|75587984|FG000|Overall Study|Lost to Follow-up|4|||
41928947|NCT04031846|75587985|FG001|Overall Study|Lost to Follow-up|4|||
41928948|NCT04031846|75587984|FG000|Overall Study|Physician Decision|0|||
41928949|NCT04031846|75587985|FG001|Overall Study|Physician Decision|1|||
41928950|NCT04031846|75587984|FG000|Overall Study|Protocol Violation|1|||
41928951|NCT04031846|75587985|FG001|Overall Study|Protocol Violation|1|||
41928952|NCT04031846|75587984|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
42208883|NCT03249909|76023028|FG000|Overall Study|Withdrawal by Subject|3|||
41928953|NCT04031846|75587985|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
41928954|NCT03893448|75587994|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
41928955|NCT03893448|75587995|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
41928956|NCT03893448|75587994|FG000|Overall Study|Physician Decision|8|||
41928957|NCT03893448|75587995|FG001|Overall Study|Physician Decision|14|||
41928958|NCT03893448|75587994|FG000|Overall Study|Lost to Follow-up|34|||
41928959|NCT03893448|75587995|FG001|Overall Study|Lost to Follow-up|27|||
41928960|NCT03893448|75587994|FG000|Overall Study|Death|1|||
41928961|NCT03893448|75587995|FG001|Overall Study|Death|0|||
41928962|NCT03692871|75588018|FG000|Overall Study|Death|1|||
41928963|NCT03692871|75588019|FG001|Overall Study|Death|1|||
41928964|NCT03692871|75588018|FG000|Overall Study|Lost to Follow-up|24|||
41928965|NCT03692871|75588019|FG001|Overall Study|Lost to Follow-up|9|||
41928966|NCT03692871|75588018|FG000|Overall Study|Physician Decision|22|||
41928967|NCT03692871|75588019|FG001|Overall Study|Physician Decision|7|||
41928968|NCT03692871|75588018|FG000|Overall Study|Protocol Deviation|1|||
41928969|NCT03692871|75588019|FG001|Overall Study|Protocol Deviation|0|||
41928970|NCT03692871|75588018|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
41928971|NCT03692871|75588019|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
41928972|NCT03565900|75588027|FG000|Overall Study|Disposition Unknown|4|||
41928973|NCT03565900|75588028|FG001|Overall Study|Disposition Unknown|1|||
41928974|NCT03565900|75588027|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
41928975|NCT03565900|75588028|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
41928976|NCT03565900|75588027|FG000|Overall Study|Withdrawal by Subject|4|||
41928977|NCT03565900|75588028|FG001|Overall Study|Withdrawal by Subject|5|||
41928978|NCT03565900|75588027|FG000|Overall Study|Randomized By Mistake|0|||
41928979|NCT03565900|75588028|FG001|Overall Study|Randomized By Mistake|2|||
41928980|NCT03565900|75588027|FG000|Overall Study|Physician Decision|7|||
41928981|NCT03565900|75588028|FG001|Overall Study|Physician Decision|11|||
41928982|NCT03565900|75588027|FG000|Overall Study|Death|9|||
41928983|NCT03565900|75588028|FG001|Overall Study|Death|7|||
41928984|NCT03443869|75588067|FG000|Overall Study|Death|3|||
41928985|NCT03443869|75588068|FG001|Overall Study|Death|3|||
41928986|NCT03443869|75588067|FG000|Overall Study|Withdrawal by Subject|34|||
41928987|NCT03443869|75588068|FG001|Overall Study|Withdrawal by Subject|22|||
41928988|NCT03443869|75588067|FG000|Overall Study|Lost to Follow-up|1|||
41928989|NCT03443869|75588068|FG001|Overall Study|Lost to Follow-up|2|||
41928990|NCT03443869|75588067|FG000|Overall Study|Physician Decision|3|||
41928991|NCT03443869|75588068|FG001|Overall Study|Physician Decision|3|||
41928992|NCT03443869|75588067|FG000|Overall Study|Other|4|||
41928993|NCT03443869|75588068|FG001|Overall Study|Other|4|||
41928994|NCT03260140|75588076|FG000|Overall Study|Death|4|||
41928995|NCT03260140|75588077|FG001|Overall Study|Death|1|||
41928996|NCT03260140|75588076|FG000|Overall Study|Withdrawal by Subject|1|||
41928997|NCT03260140|75588077|FG001|Overall Study|Withdrawal by Subject|4|||
41928998|NCT03253796|75588088|FG000|Period 1: Run-In|Adverse Event|4|||
41928999|NCT03253796|75588089|FG001|Period 1: Run-In|Adverse Event|0|||
41929000|NCT03253796|75588090|FG002|Period 1: Run-In|Adverse Event|0|||
41929001|NCT03253796|75588091|FG003|Period 1: Run-In|Adverse Event|0|||
41929002|NCT03253796|75588092|FG004|Period 1: Run-In|Adverse Event|0|||
41929003|NCT03253796|75588088|FG000|Period 1: Run-In|Lack of Efficacy|1|||
41929004|NCT03253796|75588089|FG001|Period 1: Run-In|Lack of Efficacy|0|||
41929005|NCT03253796|75588090|FG002|Period 1: Run-In|Lack of Efficacy|0|||
41929006|NCT03253796|75588091|FG003|Period 1: Run-In|Lack of Efficacy|0|||
41929007|NCT03253796|75588092|FG004|Period 1: Run-In|Lack of Efficacy|0|||
41929008|NCT03253796|75588088|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
41929009|NCT03253796|75588089|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
41929010|NCT03253796|75588090|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
41929011|NCT03253796|75588091|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
41929012|NCT03253796|75588092|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
41929013|NCT03253796|75588088|FG000|Period 1: Run-In|Protocol Violation|5|||
41929014|NCT03253796|75588089|FG001|Period 1: Run-In|Protocol Violation|0|||
41929015|NCT03253796|75588090|FG002|Period 1: Run-In|Protocol Violation|0|||
42208884|NCT03249909|76023029|FG001|Overall Study|Withdrawal by Subject|0|||
42208885|NCT03249909|76023030|FG002|Overall Study|Withdrawal by Subject|0|||
42208886|NCT03249909|76023028|FG000|Overall Study|Adverse Event|3|||
42208887|NCT03249909|76023029|FG001|Overall Study|Adverse Event|0|||
42208888|NCT03249909|76023030|FG002|Overall Study|Adverse Event|0|||
42208889|NCT03249909|76023028|FG000|Overall Study|Lost to Follow-up|0|||
42208890|NCT03249909|76023029|FG001|Overall Study|Lost to Follow-up|1|||
42208891|NCT03249909|76023030|FG002|Overall Study|Lost to Follow-up|0|||
42208892|NCT03081884|76023041|FG000|Overall Study|deferred prostate cancer treatment|1|||
42208893|NCT03081884|76023041|FG000|Overall Study|metastasis managed with systemic therapy|3|||
42208894|NCT03077438|76023048|FG000|Overall Study|Protocol Violation|3|||
42208895|NCT03077438|76023049|FG001|Overall Study|Protocol Violation|5|||
42208896|NCT03077438|76023048|FG000|Overall Study|Withdrawal by Subject|3|||
41929016|NCT03253796|75588091|FG003|Period 1: Run-In|Protocol Violation|0|||
41929017|NCT03253796|75588092|FG004|Period 1: Run-In|Protocol Violation|0|||
41929018|NCT03253796|75588088|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
41929019|NCT03253796|75588089|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
41929020|NCT03253796|75588090|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
41929021|NCT03253796|75588091|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
41929022|NCT03253796|75588092|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
41929023|NCT03253796|75588088|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
41929024|NCT03253796|75588089|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
41929025|NCT03253796|75588090|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
41929026|NCT03253796|75588091|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
41929027|NCT03253796|75588092|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
41929028|NCT03253796|75588088|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
41929029|NCT03253796|75588089|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
41929030|NCT03253796|75588090|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
41929031|NCT03253796|75588091|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
41929032|NCT03253796|75588092|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
41929033|NCT03253796|75588088|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
41929034|NCT03253796|75588089|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
41929035|NCT03253796|75588090|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
41929036|NCT03253796|75588091|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
41929037|NCT03253796|75588092|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
41929038|NCT03253796|75588088|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
41929039|NCT03253796|75588089|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
41929040|NCT03253796|75588090|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
41929041|NCT03253796|75588091|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
41929042|NCT03253796|75588092|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
41929043|NCT03253796|75588088|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
41929044|NCT03253796|75588089|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
41929045|NCT03253796|75588090|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
41929046|NCT03253796|75588091|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
41929047|NCT03253796|75588092|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
41929048|NCT03253796|75588088|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
41929049|NCT03253796|75588089|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
41929050|NCT03253796|75588090|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
41929051|NCT03253796|75588091|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
41929052|NCT03253796|75588092|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
41929053|NCT03073733|75588110|FG000|Overall Study|Lost to Follow-up|1|||
41929054|NCT03073733|75588111|FG001|Overall Study|Lost to Follow-up|0|||
41929055|NCT03073733|75588112|FG002|Overall Study|Lost to Follow-up|0|||
41929056|NCT03073733|75588110|FG000|Overall Study|Physician Decision|0|||
41929057|NCT03073733|75588111|FG001|Overall Study|Physician Decision|1|||
41929058|NCT03073733|75588112|FG002|Overall Study|Physician Decision|0|||
41929059|NCT03073733|75588110|FG000|Overall Study|Withdrawal by Subject|0|||
41929060|NCT03073733|75588111|FG001|Overall Study|Withdrawal by Subject|0|||
41929061|NCT03073733|75588112|FG002|Overall Study|Withdrawal by Subject|1|||
41929062|NCT03029143|75588122|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
41929063|NCT03029143|75588123|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
41929064|NCT03029143|75588124|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
41929065|NCT03029143|75588122|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
41929066|NCT03029143|75588123|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
41929067|NCT03029143|75588124|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
41929068|NCT03029143|75588122|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
41929069|NCT03029143|75588123|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
41929070|NCT03029143|75588124|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
41929071|NCT03029143|75588122|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
41929072|NCT03029143|75588123|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
41929073|NCT03029143|75588124|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
41929074|NCT03029143|75588122|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
41929075|NCT03029143|75588123|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
41929076|NCT03029143|75588124|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
41929077|NCT03029143|75588122|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
41929078|NCT03029143|75588123|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
41929079|NCT03029143|75588124|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
41929080|NCT03029143|75588122|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
41929081|NCT03029143|75588123|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
41929082|NCT03029143|75588124|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
41929083|NCT03029143|75588122|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
41929084|NCT03029143|75588123|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
41929085|NCT03029143|75588124|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
41929086|NCT03029143|75588122|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
41929087|NCT03029143|75588123|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
41929088|NCT03029143|75588124|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
42010364|NCT01290068|75817491|FG000|Overall Study|Lost to Follow-up|3|||
41929089|NCT03029143|75588122|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
41929090|NCT03029143|75588123|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
41929091|NCT03029143|75588124|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
41929092|NCT03029143|75588122|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
41929093|NCT03029143|75588123|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
41929094|NCT03029143|75588124|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
41929095|NCT02971137|75588135|FG000|Overall Study|Lost to Follow-up|44|||
41929096|NCT02971137|75588136|FG001|Overall Study|Lost to Follow-up|56|||
41929097|NCT02953262|75588146|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
41929098|NCT02953262|75588147|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
41929099|NCT02953262|75588148|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
41929100|NCT02953262|75588149|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
41929101|NCT02763579|75588165|FG000|Global Period|Death|167|||
41929102|NCT02763579|75588166|FG001|Global Period|Death|151|||
41929103|NCT02763579|75588167|FG002|Global Period|Death|0|||
41929104|NCT02763579|75588168|FG003|Global Period|Death|0|||
41929105|NCT02763579|75588165|FG000|Global Period|Lost to Follow-up|2|||
41929106|NCT02763579|75588166|FG001|Global Period|Lost to Follow-up|4|||
41929107|NCT02763579|75588167|FG002|Global Period|Lost to Follow-up|0|||
41929108|NCT02763579|75588168|FG003|Global Period|Lost to Follow-up|0|||
41929109|NCT02763579|75588165|FG000|Global Period|Physician Decision|0|||
41929110|NCT02763579|75588166|FG001|Global Period|Physician Decision|2|||
41929111|NCT02763579|75588167|FG002|Global Period|Physician Decision|0|||
41929112|NCT02763579|75588168|FG003|Global Period|Physician Decision|0|||
41929113|NCT02763579|75588165|FG000|Global Period|Study Terminated By Sponsor|21|||
41929114|NCT02763579|75588166|FG001|Global Period|Study Terminated By Sponsor|26|||
41929115|NCT02763579|75588167|FG002|Global Period|Study Terminated By Sponsor|0|||
41929116|NCT02763579|75588168|FG003|Global Period|Study Terminated By Sponsor|0|||
41929117|NCT02763579|75588165|FG000|Global Period|Withdrawal by Subject|12|||
41929118|NCT02763579|75588166|FG001|Global Period|Withdrawal by Subject|18|||
41929119|NCT02763579|75588167|FG002|Global Period|Withdrawal by Subject|0|||
41929120|NCT02763579|75588168|FG003|Global Period|Withdrawal by Subject|0|||
41929121|NCT02763579|75588165|FG000|China Period|Death|0|||
41929122|NCT02763579|75588166|FG001|China Period|Death|0|||
41929123|NCT02763579|75588167|FG002|China Period|Death|46|||
41929124|NCT02763579|75588168|FG003|China Period|Death|48|||
41929125|NCT02763579|75588165|FG000|China Period|Lost to Follow-up|0|||
41929126|NCT02763579|75588166|FG001|China Period|Lost to Follow-up|0|||
41929127|NCT02763579|75588167|FG002|China Period|Lost to Follow-up|1|||
41929128|NCT02763579|75588168|FG003|China Period|Lost to Follow-up|1|||
41929129|NCT02763579|75588165|FG000|China Period|Physician Decision|0|||
41929130|NCT02763579|75588166|FG001|China Period|Physician Decision|0|||
41929131|NCT02763579|75588167|FG002|China Period|Physician Decision|0|||
41929132|NCT02763579|75588168|FG003|China Period|Physician Decision|1|||
41929133|NCT02763579|75588165|FG000|China Period|Study Terminated By Sponsor|0|||
41929134|NCT02763579|75588166|FG001|China Period|Study Terminated By Sponsor|0|||
41929135|NCT02763579|75588167|FG002|China Period|Study Terminated By Sponsor|3|||
42208897|NCT03077438|76023049|FG001|Overall Study|Withdrawal by Subject|6|||
42208898|NCT03077438|76023048|FG000|Overall Study|Lost to Follow-up|6|||
42208899|NCT03077438|76023049|FG001|Overall Study|Lost to Follow-up|3|||
42208900|NCT03076970|76023059|FG000|Washout Period 2|Adverse Event|0|||
42208901|NCT03076970|76023060|FG001|Washout Period 2|Adverse Event|0|||
42208902|NCT03076970|76023061|FG002|Washout Period 2|Adverse Event|0|||
42208903|NCT03076970|76023062|FG003|Washout Period 2|Adverse Event|0|||
42208904|NCT03076970|76023063|FG004|Washout Period 2|Adverse Event|1|||
42208905|NCT03076970|76023064|FG005|Washout Period 2|Adverse Event|0|||
42208906|NCT03076970|76023059|FG000|Period 3|Withdrawal by Subject|0|||
42208907|NCT03076970|76023060|FG001|Period 3|Withdrawal by Subject|0|||
42208908|NCT03076970|76023061|FG002|Period 3|Withdrawal by Subject|0|||
42208909|NCT03076970|76023062|FG003|Period 3|Withdrawal by Subject|0|||
42208910|NCT03076970|76023063|FG004|Period 3|Withdrawal by Subject|0|||
42208911|NCT03076970|76023064|FG005|Period 3|Withdrawal by Subject|1|||
42208912|NCT03076970|76023059|FG000|Period 3|Failure to meet I/E criteria|0|||
41929136|NCT02763579|75588168|FG003|China Period|Study Terminated By Sponsor|4|||
41929137|NCT02763579|75588165|FG000|China Period|Withdrawal by Subject|0|||
41929138|NCT02763579|75588166|FG001|China Period|Withdrawal by Subject|0|||
41929139|NCT02763579|75588167|FG002|China Period|Withdrawal by Subject|3|||
42208913|NCT03076970|76023060|FG001|Period 3|Failure to meet I/E criteria|0|||
42208914|NCT03076970|76023061|FG002|Period 3|Failure to meet I/E criteria|0|||
42208915|NCT03076970|76023062|FG003|Period 3|Failure to meet I/E criteria|0|||
41929140|NCT02763579|75588168|FG003|China Period|Withdrawal by Subject|3|||
41929141|NCT02623699|75588212|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
42208916|NCT03076970|76023063|FG004|Period 3|Failure to meet I/E criteria|1|||
42208917|NCT03076970|76023064|FG005|Period 3|Failure to meet I/E criteria|0|||
42208918|NCT00726596|76023077|FG000|Overall Study|Adverse Event|2|||
41929142|NCT02623699|75588213|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
42208919|NCT00726596|76023078|FG001|Overall Study|Adverse Event|1|||
41929143|NCT02623699|75588214|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
41929144|NCT02623699|75588215|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
41929145|NCT02623699|75588216|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
41929146|NCT02623699|75588217|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
41929147|NCT02623699|75588218|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
41929148|NCT02623699|75588219|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
41929149|NCT02623699|75588220|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
41929150|NCT02623699|75588221|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
41929151|NCT02623699|75588222|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
41929152|NCT02623699|75588223|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
41929153|NCT02623699|75588212|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
41929154|NCT02623699|75588213|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
41929155|NCT02623699|75588214|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
41929156|NCT02623699|75588215|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
41929157|NCT02623699|75588216|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
41929158|NCT02623699|75588217|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
41929159|NCT02623699|75588218|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
41929160|NCT02623699|75588219|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
41929161|NCT02623699|75588220|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
41929162|NCT02623699|75588221|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
41929163|NCT02623699|75588222|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
41929164|NCT02623699|75588223|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
41929165|NCT02623699|75588212|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
41929166|NCT02623699|75588213|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
41929167|NCT02623699|75588214|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
41929168|NCT02623699|75588215|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
41929169|NCT02623699|75588216|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
41929170|NCT02623699|75588217|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
41929171|NCT02623699|75588218|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
41929172|NCT02623699|75588219|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
41929173|NCT02623699|75588220|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
41929174|NCT02623699|75588221|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
41929175|NCT02623699|75588222|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
41929176|NCT02623699|75588223|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
41929177|NCT02623699|75588212|FG000|Part B (Up to 289 Days)|Death|0|||
41929178|NCT02623699|75588213|FG001|Part B (Up to 289 Days)|Death|0|||
41929179|NCT02623699|75588214|FG002|Part B (Up to 289 Days)|Death|0|||
41929180|NCT02623699|75588215|FG003|Part B (Up to 289 Days)|Death|0|||
41929181|NCT02623699|75588216|FG004|Part B (Up to 289 Days)|Death|0|||
41929182|NCT02623699|75588217|FG005|Part B (Up to 289 Days)|Death|1|||
41929183|NCT02623699|75588218|FG006|Part B (Up to 289 Days)|Death|1|||
41929184|NCT02623699|75588219|FG007|Part B (Up to 289 Days)|Death|0|||
41929185|NCT02623699|75588220|FG008|Part B (Up to 289 Days)|Death|1|||
41929186|NCT02623699|75588221|FG009|Part B (Up to 289 Days)|Death|0|||
41929187|NCT02623699|75588222|FG010|Part B (Up to 289 Days)|Death|0|||
41929188|NCT02623699|75588223|FG011|Part B (Up to 289 Days)|Death|0|||
41929189|NCT02623699|75588212|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
41929190|NCT02623699|75588213|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
41929191|NCT02623699|75588214|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
41929192|NCT02623699|75588215|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
41929193|NCT02623699|75588216|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
41929194|NCT02623699|75588217|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
41929195|NCT02623699|75588218|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
41929196|NCT02623699|75588219|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
41929197|NCT02623699|75588220|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
41929198|NCT02623699|75588221|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
41929199|NCT02623699|75588222|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
41929200|NCT02623699|75588223|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
41929201|NCT02623699|75588212|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
41929202|NCT02623699|75588213|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
41929203|NCT02623699|75588214|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
41929204|NCT02623699|75588215|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
41929205|NCT02623699|75588216|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
41929206|NCT02623699|75588217|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
41929207|NCT02623699|75588218|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
41929208|NCT02623699|75588219|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
41929209|NCT02623699|75588220|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
41929210|NCT02623699|75588221|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
41929211|NCT02623699|75588222|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
41929212|NCT02623699|75588223|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
41929213|NCT02623699|75588212|FG000|Part C (Up to 236 Days)|Death|0|||
41929214|NCT02623699|75588213|FG001|Part C (Up to 236 Days)|Death|0|||
41929215|NCT02623699|75588214|FG002|Part C (Up to 236 Days)|Death|0|||
41929216|NCT02623699|75588215|FG003|Part C (Up to 236 Days)|Death|0|||
41929217|NCT02623699|75588216|FG004|Part C (Up to 236 Days)|Death|0|||
41929218|NCT02623699|75588217|FG005|Part C (Up to 236 Days)|Death|0|||
42208920|NCT00726596|76023077|FG000|Overall Study|Withdrawal by Subject|3|||
42208921|NCT00726596|76023078|FG001|Overall Study|Withdrawal by Subject|3|||
42208922|NCT02890992|76023101|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
42208923|NCT02890992|76023102|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
42208924|NCT02890992|76023103|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
42208925|NCT02890992|76023104|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
42208926|NCT02890992|76023105|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
42208927|NCT02890992|76023106|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
42208928|NCT02890992|76023107|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
42208929|NCT02890992|76023108|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
42208930|NCT02890992|76023101|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
42208931|NCT02890992|76023102|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
42208932|NCT02890992|76023103|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
42208933|NCT02890992|76023104|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
42208934|NCT02890992|76023105|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
42208935|NCT02890992|76023106|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
42208936|NCT02890992|76023107|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
42208937|NCT02890992|76023108|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
42208938|NCT02890992|76023101|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
42208939|NCT02890992|76023102|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
42208940|NCT02890992|76023103|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
42208941|NCT02890992|76023104|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
42208942|NCT02890992|76023105|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
42208943|NCT02890992|76023106|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
42208944|NCT02890992|76023107|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
42208945|NCT02890992|76023108|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
42208946|NCT03076190|76023153|FG000|Overall Study|Lost to Follow-up|9|||
42208947|NCT03076190|76023154|FG001|Overall Study|Lost to Follow-up|34|||
42208948|NCT03076190|76023153|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
42208949|NCT03076190|76023154|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
42208950|NCT03328182|76023163|FG000|Overall Study|Withdrawal by Subject|1|||
42208951|NCT03328182|76023163|FG000|Overall Study|Protocol Violation|2|||
42208952|NCT03328182|76023163|FG000|Overall Study|No Product Evaluated|1|||
42208953|NCT03327402|76023167|FG000|Overall Study|Withdrawal by Subject|1|||
42208954|NCT03327402|76023167|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
42208955|NCT03075878|76023171|FG000|Overall Study|Physician Decision|1|||
42208956|NCT03326856|76023180|FG000|Overall Study|Lost to Follow-up|1|||
42208957|NCT03326856|76023181|FG001|Overall Study|Lost to Follow-up|1|||
42208958|NCT03326856|76023182|FG002|Overall Study|Lost to Follow-up|0|||
42208959|NCT03326856|76023183|FG003|Overall Study|Lost to Follow-up|0|||
42208960|NCT03326856|76023184|FG004|Overall Study|Lost to Follow-up|0|||
42208961|NCT03309696|76023198|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
42208962|NCT03309696|76023199|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
42208963|NCT03309696|76023200|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
42208964|NCT03309696|76023201|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
42208965|NCT03075644|76023215|FG000|Overall Study|Withdrawal by Subject|1|||
42208966|NCT03075644|76023216|FG001|Overall Study|Withdrawal by Subject|1|||
42208967|NCT03075410|76023232|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
42208968|NCT03075410|76023233|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
42208969|NCT03075410|76023234|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
42208970|NCT03075410|76023235|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
42208971|NCT03075410|76023236|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
42208972|NCT03075410|76023237|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
42208973|NCT03075410|76023238|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
42208974|NCT03075410|76023239|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
42208975|NCT03075410|76023240|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
42208976|NCT03075410|76023232|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
42208977|NCT03075410|76023233|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
42208978|NCT03075410|76023234|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
42208979|NCT03075410|76023235|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
42208980|NCT03075410|76023236|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
42208981|NCT03075410|76023237|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
42208982|NCT03075410|76023238|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
42021992|NCT00964678|75829320|FG000|Overall Study|Physician Decision|4|||
42208983|NCT03075410|76023239|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
42208984|NCT03075410|76023240|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
42300053|NCT02549339|76135208|FG000|12-month Follow-up|Withdrawal by Subject|8|||
42300054|NCT02549339|76135209|FG001|12-month Follow-up|Withdrawal by Subject|3|||
41929219|NCT02623699|75588218|FG006|Part C (Up to 236 Days)|Death|0|||
41929220|NCT02623699|75588219|FG007|Part C (Up to 236 Days)|Death|0|||
41929221|NCT02623699|75588220|FG008|Part C (Up to 236 Days)|Death|0|||
41929222|NCT02623699|75588221|FG009|Part C (Up to 236 Days)|Death|0|||
41929223|NCT02623699|75588222|FG010|Part C (Up to 236 Days)|Death|0|||
41929224|NCT02623699|75588223|FG011|Part C (Up to 236 Days)|Death|1|||
41929225|NCT02623699|75588212|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
41929226|NCT02623699|75588213|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
41929227|NCT02623699|75588214|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
41929228|NCT02623699|75588215|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
41929229|NCT02623699|75588216|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
41929230|NCT02623699|75588217|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
41929231|NCT02623699|75588218|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
41929232|NCT02623699|75588219|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
41929233|NCT02623699|75588220|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
41929234|NCT02623699|75588221|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
41929235|NCT02623699|75588222|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
41929236|NCT02623699|75588223|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
41929237|NCT02501642|75588264|FG000|Overall Study|Lost to Follow-up|7|||
41929238|NCT02501642|75588265|FG001|Overall Study|Lost to Follow-up|11|||
41929239|NCT02475954|75588273|FG000|Overall Study|Withdrawal by Subject|2|||
41929240|NCT02475954|75588274|FG001|Overall Study|Withdrawal by Subject|2|||
41929241|NCT02475954|75588273|FG000|Overall Study|Lost to Follow-up|11|||
41929242|NCT02475954|75588274|FG001|Overall Study|Lost to Follow-up|9|||
41929243|NCT02475954|75588273|FG000|Overall Study|Death|1|||
41929244|NCT02475954|75588274|FG001|Overall Study|Death|1|||
41929245|NCT02459587|75588283|FG000|3-Month Follow-up Assessment|Death|0|||
41929246|NCT02459587|75588284|FG001|3-Month Follow-up Assessment|Death|2|||
41929247|NCT02459587|75588283|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
41929248|NCT02459587|75588284|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
41929249|NCT02459587|75588283|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
41929250|NCT02459587|75588284|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
41929251|NCT02459587|75588283|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
41929252|NCT02459587|75588284|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
41929253|NCT02459587|75588283|FG000|6-month Follow-up Assessment|Death|2|||
41929254|NCT02459587|75588284|FG001|6-month Follow-up Assessment|Death|1|||
41929255|NCT02459587|75588283|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
41929256|NCT02459587|75588284|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
41929257|NCT02459587|75588283|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
41929258|NCT02459587|75588284|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
41929259|NCT02459587|75588283|FG000|12-month Follow-up Assessment|Death|2|||
41929260|NCT02459587|75588284|FG001|12-month Follow-up Assessment|Death|0|||
41929261|NCT02459587|75588283|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
41929262|NCT02459587|75588284|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
41929263|NCT02459587|75588283|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
41929264|NCT02459587|75588284|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
41929265|NCT02459587|75588283|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
41929266|NCT02459587|75588284|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
41929267|NCT02281084|75588295|FG000|Overall Study|Adverse Event|1|||
41929268|NCT02281084|75588296|FG001|Overall Study|Adverse Event|0|||
41929269|NCT02281084|75588297|FG002|Overall Study|Adverse Event|0|||
41929270|NCT02281084|75588298|FG003|Overall Study|Adverse Event|0|||
41929271|NCT02281084|75588295|FG000|Overall Study|Withdrawal by Subject|1|||
41929272|NCT02281084|75588296|FG001|Overall Study|Withdrawal by Subject|2|||
42208985|NCT03071276|76023282|FG000|Overall Study|Adverse Event|1|||
42208986|NCT03071276|76023282|FG000|Overall Study|Lack of Efficacy|14|||
42208987|NCT03074162|76023292|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
42208988|NCT03074162|76023293|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
42208989|NCT03074162|76023294|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
42208990|NCT03074162|76023295|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
42208991|NCT03074162|76023296|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
42208992|NCT03074162|76023297|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
42208993|NCT03074162|76023292|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
41929273|NCT02281084|75588297|FG002|Overall Study|Withdrawal by Subject|0|||
41929274|NCT02281084|75588298|FG003|Overall Study|Withdrawal by Subject|0|||
41929275|NCT02281084|75588295|FG000|Overall Study|Death|20|||
41929276|NCT02281084|75588296|FG001|Overall Study|Death|16|||
41929277|NCT02281084|75588297|FG002|Overall Study|Death|3|||
41929278|NCT02281084|75588298|FG003|Overall Study|Death|5|||
41929279|NCT02281084|75588295|FG000|Overall Study|Physician Decision|0|||
41929280|NCT02281084|75588296|FG001|Overall Study|Physician Decision|0|||
41929281|NCT02281084|75588297|FG002|Overall Study|Physician Decision|1|||
42208994|NCT03074162|76023293|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
41929282|NCT02281084|75588298|FG003|Overall Study|Physician Decision|0|||
41929283|NCT01966120|75588319|FG000|Overall Study|Withdrawal by Subject|0|||
41929284|NCT01966120|75588320|FG001|Overall Study|Withdrawal by Subject|5|||
41929285|NCT01966120|75588319|FG000|Overall Study|Lost to Follow-up|1|||
41929286|NCT01966120|75588320|FG001|Overall Study|Lost to Follow-up|1|||
41929287|NCT01399736|75588363|FG000|Overall Study|Withdrawal by Subject|4|||
41929288|NCT01399736|75588364|FG001|Overall Study|Withdrawal by Subject|2|||
41929289|NCT01399736|75588363|FG000|Overall Study|Lost to Follow-up|0|||
41929290|NCT01399736|75588364|FG001|Overall Study|Lost to Follow-up|2|||
41929291|NCT04372927|75588494|FG000|Overall Study|Death|1|||
41929292|NCT01381874|75588501|FG000|Overall Study|Lost to Follow-up|1|||
41929293|NCT01381874|75588502|FG001|Overall Study|Lost to Follow-up|1|||
41929294|NCT01381874|75588503|FG002|Overall Study|Lost to Follow-up|0|||
41929295|NCT01381874|75588501|FG000|Overall Study|Withdrawal by Subject|9|||
41929296|NCT01381874|75588502|FG001|Overall Study|Withdrawal by Subject|10|||
41929297|NCT01381874|75588503|FG002|Overall Study|Withdrawal by Subject|9|||
41929298|NCT01381874|75588501|FG000|Overall Study|Other|67|||
41929299|NCT01381874|75588502|FG001|Overall Study|Other|52|||
41929300|NCT01381874|75588503|FG002|Overall Study|Other|67|||
41929301|NCT01399190|75588511|FG000|Overall Study|Not Eligible for Final Analysis|5|||
41929302|NCT01399190|75588511|FG000|Overall Study|Adverse Event|8|||
41929303|NCT01399190|75588511|FG000|Overall Study|Participant's Request|5|||
41929304|NCT01399190|75588511|FG000|Overall Study|Physician Decision|2|||
41929305|NCT01381718|75588529|FG000|Overall Study|Withdrawal by Subject|2|||
41929306|NCT01381718|75588530|FG001|Overall Study|Withdrawal by Subject|5|||
41929307|NCT01381718|75588529|FG000|Overall Study|Lost to Follow-up|3|||
41929308|NCT01381718|75588530|FG001|Overall Study|Lost to Follow-up|5|||
41929309|NCT01381718|75588529|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
41929310|NCT01381718|75588530|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
41929311|NCT01398956|75588549|FG000|Overall Study|Withdrawal by Subject|4|||
41929312|NCT01398956|75588549|FG000|Overall Study|AE, non-serious non-fatal|4|||
41929313|NCT01398956|75588549|FG000|Overall Study|Withdrawal Criteria No.3|1|||
41929314|NCT01398956|75588549|FG000|Overall Study|Subject moved a long distance|1|||
41929315|NCT01381562|75588575|FG000|Overall Study|Adverse Event|0|||
41929316|NCT01381562|75588576|FG001|Overall Study|Adverse Event|1|||
41929317|NCT01381562|75588577|FG002|Overall Study|Adverse Event|0|||
41929318|NCT01381016|75588600|FG000|Overall Study|Lost to Follow-up|1|||
41929319|NCT01381016|75588601|FG001|Overall Study|Lost to Follow-up|1|||
41929320|NCT01381016|75588600|FG000|Overall Study|Screen Failure|2|||
41929321|NCT01381016|75588601|FG001|Overall Study|Screen Failure|2|||
41929322|NCT01381016|75588600|FG000|Overall Study|Withdrawal by Subject|0|||
41929323|NCT01381016|75588601|FG001|Overall Study|Withdrawal by Subject|1|||
41929324|NCT01381016|75588600|FG000|Overall Study|Physician Decision|0|||
41929325|NCT01381016|75588601|FG001|Overall Study|Physician Decision|2|||
41929326|NCT01398410|75588628|FG000|Overall Study|Adverse Event|12|||
41929327|NCT01398410|75588629|FG001|Overall Study|Adverse Event|16|||
41929328|NCT01398410|75588628|FG000|Overall Study|Participants Choice|8|||
41929329|NCT01398410|75588629|FG001|Overall Study|Participants Choice|11|||
41929330|NCT01398410|75588628|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
41929331|NCT01398410|75588629|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
41929332|NCT01398410|75588628|FG000|Overall Study|Other|36|||
41929333|NCT01398410|75588629|FG001|Overall Study|Other|29|||
41929334|NCT01380782|75588695|FG000|Overall Study|Adverse Event|0|||
41929335|NCT01380782|75588696|FG001|Overall Study|Adverse Event|1|||
41929336|NCT01380782|75588697|FG002|Overall Study|Adverse Event|0|||
41929337|NCT01380782|75588698|FG003|Overall Study|Adverse Event|0|||
41929338|NCT01380782|75588695|FG000|Overall Study|Death|1|||
41929339|NCT01380782|75588696|FG001|Overall Study|Death|0|||
41929340|NCT01380782|75588697|FG002|Overall Study|Death|0|||
41929341|NCT01380782|75588698|FG003|Overall Study|Death|0|||
41929342|NCT01380782|75588695|FG000|Overall Study|Lack of Efficacy|10|||
41929343|NCT01380782|75588696|FG001|Overall Study|Lack of Efficacy|9|||
41929344|NCT01380782|75588697|FG002|Overall Study|Lack of Efficacy|10|||
41929345|NCT01380782|75588698|FG003|Overall Study|Lack of Efficacy|3|||
41929346|NCT01380782|75588695|FG000|Overall Study|Physician Decision|1|||
41929347|NCT01380782|75588696|FG001|Overall Study|Physician Decision|0|||
41929348|NCT01380782|75588697|FG002|Overall Study|Physician Decision|0|||
41929349|NCT01380782|75588698|FG003|Overall Study|Physician Decision|0|||
41929350|NCT01380782|75588695|FG000|Overall Study|Withdrawal by Subject|0|||
41929351|NCT01380782|75588696|FG001|Overall Study|Withdrawal by Subject|0|||
41929352|NCT01380782|75588697|FG002|Overall Study|Withdrawal by Subject|1|||
41929353|NCT01380782|75588698|FG003|Overall Study|Withdrawal by Subject|1|||
41929354|NCT01398176|75588712|FG000|Overall Study|Lost to Follow-up|1|||
41929355|NCT01398176|75588713|FG001|Overall Study|Lost to Follow-up|3|||
41929356|NCT01398176|75588712|FG000|Overall Study|Physician Decision|2|||
41929357|NCT01398176|75588713|FG001|Overall Study|Physician Decision|3|||
41929358|NCT01397786|75588766|FG000|Phase A|Lost to Follow-up|0|||
41929359|NCT01397786|75588767|FG001|Phase A|Lost to Follow-up|0|||
41929360|NCT01397786|75588768|FG002|Phase A|Lost to Follow-up|6|||
41929361|NCT01397786|75588766|FG000|Phase A|Adverse Event|0|||
41929362|NCT01397786|75588767|FG001|Phase A|Adverse Event|0|||
41929363|NCT01397786|75588768|FG002|Phase A|Adverse Event|8|||
41929364|NCT01397786|75588766|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
41929365|NCT01397786|75588767|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
41929366|NCT01397786|75588768|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
41929367|NCT01397786|75588766|FG000|Phase A|Physician Decision|0|||
41929368|NCT01397786|75588767|FG001|Phase A|Physician Decision|0|||
41929369|NCT01397786|75588768|FG002|Phase A|Physician Decision|1|||
41929370|NCT01397786|75588766|FG000|Phase A|Withdrawal by Subject|0|||
41929371|NCT01397786|75588767|FG001|Phase A|Withdrawal by Subject|0|||
41929372|NCT01397786|75588768|FG002|Phase A|Withdrawal by Subject|5|||
41929373|NCT01397786|75588766|FG000|Phase A|Lack of Efficacy|0|||
41929374|NCT01397786|75588767|FG001|Phase A|Lack of Efficacy|0|||
41929375|NCT01397786|75588768|FG002|Phase A|Lack of Efficacy|1|||
41929376|NCT01397786|75588766|FG000|Phase B|Lost to Follow-up|22|||
41929377|NCT01397786|75588767|FG001|Phase B|Lost to Follow-up|12|||
41929378|NCT01397786|75588768|FG002|Phase B|Lost to Follow-up|22|||
41929379|NCT01397786|75588766|FG000|Phase B|Adverse Event|109|||
41929380|NCT01397786|75588767|FG001|Phase B|Adverse Event|23|||
41929381|NCT01397786|75588768|FG002|Phase B|Adverse Event|27|||
41929382|NCT01397786|75588766|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
41929383|NCT01397786|75588767|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
41929384|NCT01397786|75588768|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
41929385|NCT01397786|75588766|FG000|Phase B|Physician Decision|9|||
41929386|NCT01397786|75588767|FG001|Phase B|Physician Decision|1|||
41929387|NCT01397786|75588768|FG002|Phase B|Physician Decision|3|||
41929388|NCT01397786|75588766|FG000|Phase B|Withdrawal by Subject|102|||
41929389|NCT01397786|75588767|FG001|Phase B|Withdrawal by Subject|45|||
41929390|NCT01397786|75588768|FG002|Phase B|Withdrawal by Subject|30|||
41929391|NCT01397786|75588766|FG000|Phase B|Protocol Deviation|1|||
41929392|NCT01397786|75588767|FG001|Phase B|Protocol Deviation|2|||
41929393|NCT01397786|75588768|FG002|Phase B|Protocol Deviation|4|||
41929394|NCT01397786|75588766|FG000|Phase B|Lack of Efficacy|22|||
41929395|NCT01397786|75588767|FG001|Phase B|Lack of Efficacy|7|||
41929396|NCT01397786|75588768|FG002|Phase B|Lack of Efficacy|14|||
41929397|NCT01397162|75588830|FG000|Overall Study|Adverse Event|4|||
41929398|NCT01397162|75588831|FG001|Overall Study|Adverse Event|0|||
41929399|NCT01397162|75588832|FG002|Overall Study|Adverse Event|0|||
41929400|NCT01397162|75588833|FG003|Overall Study|Adverse Event|0|||
41929401|NCT01397162|75588834|FG004|Overall Study|Adverse Event|0|||
41929402|NCT01397162|75588830|FG000|Overall Study|Not yet defined|3|||
42208995|NCT03074162|76023294|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
42208996|NCT03074162|76023295|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
42208997|NCT03074162|76023296|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
42208998|NCT03074162|76023297|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
42208999|NCT03074162|76023292|FG000|Period 3|Withdrawal by Subject|1|||
42209000|NCT03074162|76023293|FG001|Period 3|Withdrawal by Subject|0|||
42209001|NCT03074162|76023294|FG002|Period 3|Withdrawal by Subject|0|||
42209002|NCT03074162|76023295|FG003|Period 3|Withdrawal by Subject|0|||
42209003|NCT03074162|76023296|FG004|Period 3|Withdrawal by Subject|1|||
42209004|NCT03074162|76023297|FG005|Period 3|Withdrawal by Subject|0|||
42209005|NCT03070964|76023305|FG000|Overall Study|Progressive disease|8|||
42209006|NCT03070964|76023305|FG000|Overall Study|Treatment-unrelated adverse event|2|||
42209007|NCT03070964|76023305|FG000|Overall Study|Never treated|1|||
42209008|NCT03070964|76023305|FG000|Overall Study|Physician Decision|1|||
42209009|NCT03070964|76023305|FG000|Overall Study|Withdrawal by Subject|1|||
42209010|NCT03070964|76023305|FG000|Overall Study|Adverse Event|1|||
42209011|NCT02888106|76023315|FG000|Overall Study|Withdrawal by Subject|1|||
42209012|NCT02888106|76023316|FG001|Overall Study|Withdrawal by Subject|2|||
42209013|NCT02888106|76023317|FG002|Overall Study|Withdrawal by Subject|0|||
42209014|NCT02888106|76023318|FG003|Overall Study|Withdrawal by Subject|1|||
42209015|NCT02888106|76023319|FG004|Overall Study|Withdrawal by Subject|0|||
42209016|NCT02888106|76023320|FG005|Overall Study|Withdrawal by Subject|0|||
41929403|NCT01397162|75588831|FG001|Overall Study|Not yet defined|4|||
41929404|NCT01397162|75588832|FG002|Overall Study|Not yet defined|3|||
41929405|NCT01397162|75588833|FG003|Overall Study|Not yet defined|5|||
41929406|NCT01397162|75588834|FG004|Overall Study|Not yet defined|3|||
41929407|NCT01397084|75588867|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
41929408|NCT01397084|75588867|FG000|Overall Study|Protocol Violation|2|||
41929409|NCT01397084|75588867|FG000|Overall Study|Adverse Event|2|||
41929410|NCT01397084|75588867|FG000|Overall Study|Withdrawal by Subject|1|||
41929411|NCT01397084|75588867|FG000|Overall Study|Lost to Follow-up|1|||
42209017|NCT02888106|76023315|FG000|Overall Study|Lost to Follow-up|1|||
41929412|NCT01397084|75588867|FG000|Overall Study|Used other proton pump inhibitor|1|||
41929413|NCT01396148|75588907|FG000|Overall Study|Patient Decision|1|||
42209018|NCT02888106|76023316|FG001|Overall Study|Lost to Follow-up|0|||
42209019|NCT02888106|76023317|FG002|Overall Study|Lost to Follow-up|0|||
42209020|NCT02888106|76023318|FG003|Overall Study|Lost to Follow-up|1|||
42209021|NCT02888106|76023319|FG004|Overall Study|Lost to Follow-up|0|||
41929414|NCT01396070|75588940|FG000|Overall Study|Withdrawal by Subject|2|||
41929415|NCT01396070|75588940|FG000|Overall Study|Death|2|||
41929416|NCT01396070|75588940|FG000|Overall Study|Adverse Event|8|||
41929417|NCT01396070|75588940|FG000|Overall Study|Physician Decision|3|||
41929418|NCT01396070|75588940|FG000|Overall Study|Lack of Efficacy|4|||
41929419|NCT01395914|75588957|FG000|Overall Study|Unrelated to study drug AE|6|||
41929420|NCT01395914|75588958|FG001|Overall Study|Unrelated to study drug AE|1|||
41929421|NCT01395914|75588957|FG000|Overall Study|Death|23|||
41929422|NCT01395914|75588958|FG001|Overall Study|Death|17|||
41929423|NCT01395914|75588957|FG000|Overall Study|Other|9|||
41929424|NCT01395914|75588958|FG001|Overall Study|Other|3|||
41929425|NCT01395914|75588957|FG000|Overall Study|Withdrawal by patient|27|||
41929426|NCT01395914|75588958|FG001|Overall Study|Withdrawal by patient|14|||
41929427|NCT01395914|75588957|FG000|Overall Study|Study drug-related AE|1|||
41929428|NCT01395914|75588958|FG001|Overall Study|Study drug-related AE|0|||
41929429|NCT01395914|75588957|FG000|Overall Study|Lost to Follow-up|6|||
41929430|NCT01395914|75588958|FG001|Overall Study|Lost to Follow-up|2|||
41929431|NCT01395758|75589199|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
41929432|NCT01395758|75589200|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
41929433|NCT01395758|75589201|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
41929434|NCT01395524|75589259|FG000|Overall Study|Non-compliance with study schedule|1|||
41929435|NCT01395524|75589260|FG001|Overall Study|Non-compliance with study schedule|0|||
41929436|NCT01395524|75589261|FG002|Overall Study|Non-compliance with study schedule|1|||
41929437|NCT01395524|75589259|FG000|Overall Study|Lost to Follow-up|3|||
41929438|NCT01395524|75589260|FG001|Overall Study|Lost to Follow-up|1|||
41929439|NCT01395524|75589261|FG002|Overall Study|Lost to Follow-up|1|||
41929440|NCT01395524|75589259|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
41929441|NCT01395524|75589260|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
41929442|NCT01395524|75589261|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
41929443|NCT01395524|75589259|FG000|Overall Study|Severe noncompliance with protocol|1|||
41929444|NCT01395524|75589260|FG001|Overall Study|Severe noncompliance with protocol|0|||
41929445|NCT01395524|75589261|FG002|Overall Study|Severe noncompliance with protocol|0|||
41929446|NCT01395524|75589259|FG000|Overall Study|Adverse Event|4|||
41929447|NCT01395524|75589260|FG001|Overall Study|Adverse Event|4|||
41929448|NCT01395524|75589261|FG002|Overall Study|Adverse Event|3|||
41929449|NCT01395524|75589259|FG000|Overall Study|Death|1|||
41929450|NCT01395524|75589260|FG001|Overall Study|Death|0|||
41929451|NCT01395524|75589261|FG002|Overall Study|Death|0|||
41929452|NCT01395524|75589259|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
41929453|NCT01395524|75589260|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
41929454|NCT01395524|75589261|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
41929455|NCT01395524|75589259|FG000|Overall Study|Withdrawal by Subject|4|||
41929456|NCT01395524|75589260|FG001|Overall Study|Withdrawal by Subject|8|||
41929457|NCT01395524|75589261|FG002|Overall Study|Withdrawal by Subject|8|||
41929458|NCT01395524|75589259|FG000|Overall Study|Did not receive treatment|1|||
41929459|NCT01395524|75589260|FG001|Overall Study|Did not receive treatment|1|||
41929460|NCT01395524|75589261|FG002|Overall Study|Did not receive treatment|3|||
41929461|NCT01395524|75589259|FG000|Overall Study|Subject had spinal surgery|0|||
41929462|NCT01395524|75589260|FG001|Overall Study|Subject had spinal surgery|0|||
41929463|NCT01395524|75589261|FG002|Overall Study|Subject had spinal surgery|1|||
41929464|NCT01395368|75589269|FG000|Overall Study|Physician Decision|14|||
41929465|NCT01395368|75589269|FG000|Overall Study|Withdrawal by Subject|2|||
42021993|NCT00964366|75829327|FG000|Overall Study|Did not qualify at Day 1|1|||
42021994|NCT00964366|75829328|FG001|Overall Study|Did not qualify at Day 1|0|||
42209022|NCT02888106|76023320|FG005|Overall Study|Lost to Follow-up|1|||
42209023|NCT02888106|76023315|FG000|Overall Study|Adverse Event|2|||
42209024|NCT02888106|76023316|FG001|Overall Study|Adverse Event|0|||
42209025|NCT02888106|76023317|FG002|Overall Study|Adverse Event|0|||
42209026|NCT02888106|76023318|FG003|Overall Study|Adverse Event|0|||
42209027|NCT02888106|76023319|FG004|Overall Study|Adverse Event|0|||
42209028|NCT02888106|76023320|FG005|Overall Study|Adverse Event|0|||
42209029|NCT02888106|76023315|FG000|Overall Study|Withdrawal of consent|0|||
42209030|NCT02888106|76023316|FG001|Overall Study|Withdrawal of consent|0|||
42209031|NCT02888106|76023317|FG002|Overall Study|Withdrawal of consent|0|||
42209032|NCT02888106|76023318|FG003|Overall Study|Withdrawal of consent|0|||
42209033|NCT02888106|76023319|FG004|Overall Study|Withdrawal of consent|1|||
42209034|NCT02888106|76023320|FG005|Overall Study|Withdrawal of consent|0|||
41929466|NCT01394978|75589276|FG000|Overall Study|Withdrawal by Subject|2|||
41929467|NCT01394978|75589277|FG001|Overall Study|Withdrawal by Subject|4|||
41929468|NCT01394978|75589276|FG000|Overall Study|Lost to Follow-up|13|||
41929469|NCT01394978|75589277|FG001|Overall Study|Lost to Follow-up|20|||
41929470|NCT01394978|75589276|FG000|Overall Study|Death|6|||
41929471|NCT01394978|75589277|FG001|Overall Study|Death|7|||
42209035|NCT02888106|76023315|FG000|Overall Study|Pregnancy|1|||
42209036|NCT02888106|76023316|FG001|Overall Study|Pregnancy|0|||
42209037|NCT02888106|76023317|FG002|Overall Study|Pregnancy|0|||
42209038|NCT02888106|76023318|FG003|Overall Study|Pregnancy|0|||
42209039|NCT02888106|76023319|FG004|Overall Study|Pregnancy|0|||
42021995|NCT00964366|75829327|FG000|Overall Study|Withdrawal by Subject|0|||
42021996|NCT00964366|75829328|FG001|Overall Study|Withdrawal by Subject|1|||
42021997|NCT00960154|75829336|FG000|Overall Study|Study termination|25|||
42117683|NCT00117637|75928532|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
42117684|NCT00117637|75928531|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
42117685|NCT00117637|75928532|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
42117686|NCT00117637|75928531|FG000|First Intervention (Period 1)|reason not reported|0|||
42209040|NCT02888106|76023320|FG005|Overall Study|Pregnancy|0|||
42209041|NCT03304626|76023342|FG000|Overall Study|Adverse Event|1|||
42209042|NCT03304626|76023343|FG001|Overall Study|Adverse Event|0|||
42209043|NCT03304626|76023342|FG000|Overall Study|Lack of Efficacy|1|||
42209044|NCT03304626|76023343|FG001|Overall Study|Lack of Efficacy|1|||
42209045|NCT03274986|76023352|FG000|Overall Study|Withdrawal by Subject|0|||
42209046|NCT03274986|76023353|FG001|Overall Study|Withdrawal by Subject|1|||
42209047|NCT03274986|76023352|FG000|Overall Study|Lost to Follow-up|0|||
42209048|NCT03274986|76023353|FG001|Overall Study|Lost to Follow-up|1|||
42209049|NCT02919306|76023368|FG000|Overall Study|Withdrawal by Subject|1|||
42209050|NCT02919306|76023369|FG001|Overall Study|Withdrawal by Subject|0|||
42209051|NCT02919306|76023368|FG000|Overall Study|Protocol Violation|1|||
42209052|NCT02919306|76023369|FG001|Overall Study|Protocol Violation|0|||
42209053|NCT03274440|76023375|FG000|Overall Study|Time commitment too great|1|||
42209054|NCT03274440|76023376|FG001|Overall Study|Time commitment too great|0|||
42209055|NCT03274440|76023377|FG002|Overall Study|Time commitment too great|0|||
42209056|NCT03274440|76023378|FG003|Overall Study|Time commitment too great|1|||
42209057|NCT03274440|76023379|FG004|Overall Study|Time commitment too great|0|||
42209058|NCT03274440|76023380|FG005|Overall Study|Time commitment too great|0|||
42209059|NCT03268746|76023388|FG000|Overall Study|Withdrawal by Subject|1|||
42209060|NCT03268590|76023399|FG000|Overall Study|Previously unknown exclusion criteria|1|||
42209061|NCT03267576|76023408|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
42209062|NCT03267576|76023409|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
42209063|NCT03267576|76023408|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
42209064|NCT03267576|76023409|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
42209065|NCT03267264|76023419|FG000|Overall Study|Withdrawal by Subject|1|||
42209066|NCT03267264|76023420|FG001|Overall Study|Withdrawal by Subject|0|||
42209067|NCT03267264|76023421|FG002|Overall Study|Withdrawal by Subject|2|||
42209068|NCT03267264|76023422|FG003|Overall Study|Withdrawal by Subject|4|||
42209069|NCT03244800|76023439|FG000|Overall Study|Adverse Event|0|||
42209070|NCT03244800|76023440|FG001|Overall Study|Adverse Event|1|||
42209071|NCT03244800|76023441|FG002|Overall Study|Adverse Event|0|||
42209072|NCT03244800|76023442|FG003|Overall Study|Adverse Event|1|||
42209073|NCT03244800|76023439|FG000|Overall Study|Withdrew treatment|0|||
42209074|NCT03244800|76023440|FG001|Overall Study|Withdrew treatment|0|||
42209075|NCT03244800|76023441|FG002|Overall Study|Withdrew treatment|0|||
42209076|NCT03244800|76023442|FG003|Overall Study|Withdrew treatment|1|||
42209077|NCT04516291|76023463|FG000|Treatment Period (24 Weeks)|Other|1|||
42209078|NCT04516291|76023464|FG001|Treatment Period (24 Weeks)|Other|0|||
42209079|NCT04516291|76023465|FG002|Treatment Period (24 Weeks)|Other|0|||
42209080|NCT04516291|76023466|FG003|Treatment Period (24 Weeks)|Other|2|||
42209081|NCT04516291|76023467|FG004|Treatment Period (24 Weeks)|Other|2|||
42209082|NCT04516291|76023468|FG005|Treatment Period (24 Weeks)|Other|4|||
41929472|NCT01394276|75589284|FG000|Overall Study|Related Adverse event (AEs)|15|||
41929473|NCT01394276|75589284|FG000|Overall Study|Not related AEs|9|||
41929474|NCT01394276|75589284|FG000|Overall Study|Remission of disease|2|||
41929475|NCT01394276|75589284|FG000|Overall Study|Insufficient therapeutic effect|17|||
41929476|NCT01394276|75589284|FG000|Overall Study|Insufficient compliance|9|||
41929477|NCT01394276|75589284|FG000|Overall Study|Lost to Follow-up|5|||
41929478|NCT01394276|75589284|FG000|Overall Study|Participant moved to another site|1|||
42117687|NCT00117637|75928532|FG001|First Intervention (Period 1)|reason not reported|1|||
42117688|NCT00117637|75928531|FG000|Second Intervention (Period 2)|Adverse Event|0|||
42117689|NCT00117637|75928532|FG001|Second Intervention (Period 2)|Adverse Event|9|||
42117690|NCT00117637|75928531|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
42117691|NCT00117637|75928532|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
42117692|NCT00117637|75928531|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
42117693|NCT00117637|75928532|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
42117694|NCT00117637|75928531|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
42117695|NCT00117637|75928532|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
42209083|NCT04516291|76023469|FG006|Treatment Period (24 Weeks)|Other|2|||
42209084|NCT04516291|76023470|FG007|Treatment Period (24 Weeks)|Other|0|||
42209085|NCT04516291|76023463|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
42209086|NCT04516291|76023464|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
42209087|NCT04516291|76023465|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
42209088|NCT04516291|76023466|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
42209089|NCT04516291|76023467|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
42209090|NCT04516291|76023468|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
41929479|NCT01394276|75589284|FG000|Overall Study|Pregnancy|1|||
41929480|NCT01394276|75589284|FG000|Overall Study|unavailability of drug at the Hospital|2|||
41929481|NCT01394276|75589284|FG000|Overall Study|Symptoms of concurrent diseases|1|||
41929482|NCT00211172|75589384|FG000|Overall Study|Died or lost health plan eligibility|39|||
41929483|NCT00211172|75589385|FG001|Overall Study|Died or lost health plan eligibility|32|||
42209091|NCT04516291|76023469|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
42209092|NCT04516291|76023470|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
41929484|NCT00210626|75589436|FG000|Overall Study|Adverse Event|1|||
42209093|NCT04516291|76023463|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
42209094|NCT04516291|76023464|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
42209095|NCT04516291|76023465|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
42209096|NCT04516291|76023466|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
42209097|NCT04516291|76023467|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
42209098|NCT04516291|76023468|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
42209099|NCT04516291|76023469|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
41929485|NCT00210626|75589437|FG001|Overall Study|Adverse Event|2|||
41929486|NCT00210626|75589436|FG000|Overall Study|Protocol Violation|1|||
41929487|NCT00210626|75589437|FG001|Overall Study|Protocol Violation|5|||
41929488|NCT00210626|75589436|FG000|Overall Study|Lost to Follow-up|11|||
41929489|NCT00210626|75589437|FG001|Overall Study|Lost to Follow-up|11|||
41929490|NCT00210626|75589436|FG000|Overall Study|Death|1|||
41929491|NCT00210626|75589437|FG001|Overall Study|Death|0|||
41929492|NCT00210626|75589436|FG000|Overall Study|Withdrawal by Subject|29|||
41929493|NCT00210626|75589437|FG001|Overall Study|Withdrawal by Subject|20|||
41929494|NCT00210626|75589436|FG000|Overall Study|Physician Decision|0|||
41929495|NCT00210626|75589437|FG001|Overall Study|Physician Decision|2|||
41929496|NCT00210626|75589436|FG000|Overall Study|Sponser Request|1|||
41929497|NCT00210626|75589437|FG001|Overall Study|Sponser Request|0|||
41929498|NCT00210626|75589436|FG000|Overall Study|Other|4|||
41929499|NCT00210626|75589437|FG001|Overall Study|Other|5|||
41929500|NCT00217022|75589459|FG000|Overall Study|Withdrawal by Subject|1|||
41929501|NCT00217022|75589460|FG001|Overall Study|Withdrawal by Subject|1|||
41929502|NCT00219284|75589807|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
41929503|NCT00219284|75589808|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
41929504|NCT00219284|75589807|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
41929505|NCT00219284|75589808|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
41929506|NCT00219284|75589807|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
41929507|NCT00219284|75589808|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
41929508|NCT00219284|75589807|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
41929509|NCT00219284|75589808|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
41929510|NCT00219284|75589807|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
41929511|NCT00219284|75589808|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
41929512|NCT00219284|75589807|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
41929513|NCT00219284|75589808|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
41929514|NCT00219284|75589807|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
41929515|NCT00219284|75589808|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
41929516|NCT00219284|75589807|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
41929517|NCT00219284|75589808|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
41929518|NCT00219284|75589807|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
41929519|NCT00219284|75589808|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
41929520|NCT00216476|75589947|FG000|Overall Study|Withdrawal by Subject|59|||
41929521|NCT00216476|75589948|FG001|Overall Study|Withdrawal by Subject|72|||
41929522|NCT00216476|75589949|FG002|Overall Study|Withdrawal by Subject|9|||
41929523|NCT00216476|75589947|FG000|Overall Study|Lost to Follow-up|10|||
41929524|NCT00216476|75589948|FG001|Overall Study|Lost to Follow-up|9|||
41929525|NCT00216476|75589949|FG002|Overall Study|Lost to Follow-up|1|||
41929526|NCT00216476|75589947|FG000|Overall Study|Adverse Event|6|||
41929527|NCT00216476|75589948|FG001|Overall Study|Adverse Event|10|||
41929528|NCT00216476|75589949|FG002|Overall Study|Adverse Event|1|||
41929529|NCT00216476|75589947|FG000|Overall Study|Lack of Efficacy|4|||
41929530|NCT00216476|75589948|FG001|Overall Study|Lack of Efficacy|3|||
41929531|NCT00216476|75589949|FG002|Overall Study|Lack of Efficacy|0|||
41929532|NCT00216476|75589947|FG000|Overall Study|Death|2|||
41929533|NCT00216476|75589948|FG001|Overall Study|Death|0|||
42209100|NCT04516291|76023470|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
42209101|NCT04516291|76023463|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42209102|NCT04516291|76023464|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
41929534|NCT00216476|75589949|FG002|Overall Study|Death|0|||
41929535|NCT00216476|75589947|FG000|Overall Study|Pregnancy|0|||
41929536|NCT00216476|75589948|FG001|Overall Study|Pregnancy|1|||
41929537|NCT00216476|75589949|FG002|Overall Study|Pregnancy|1|||
41929538|NCT00216476|75589947|FG000|Overall Study|Other|0|||
41929539|NCT00216476|75589948|FG001|Overall Study|Other|0|||
41929540|NCT00216476|75589949|FG002|Overall Study|Other|1|||
42209103|NCT04516291|76023465|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42209104|NCT04516291|76023466|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42209105|NCT04516291|76023467|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42209106|NCT04516291|76023468|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42209107|NCT04516291|76023469|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42209108|NCT04516291|76023470|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42209109|NCT04516291|76023463|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
42209110|NCT04516291|76023464|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
42209111|NCT04516291|76023465|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
42209112|NCT04516291|76023466|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
42209113|NCT04516291|76023467|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
42209114|NCT04516291|76023468|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
42209115|NCT04516291|76023469|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
42209116|NCT04516291|76023470|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
42209117|NCT04516291|76023463|FG000|Follow-up Period (12 Weeks)|Other|0|||
42209118|NCT04516291|76023464|FG001|Follow-up Period (12 Weeks)|Other|1|||
42209119|NCT04516291|76023465|FG002|Follow-up Period (12 Weeks)|Other|0|||
42209120|NCT04516291|76023466|FG003|Follow-up Period (12 Weeks)|Other|2|||
42209121|NCT04516291|76023467|FG004|Follow-up Period (12 Weeks)|Other|0|||
42209122|NCT04516291|76023468|FG005|Follow-up Period (12 Weeks)|Other|0|||
42209123|NCT04516291|76023469|FG006|Follow-up Period (12 Weeks)|Other|0|||
42209124|NCT04516291|76023470|FG007|Follow-up Period (12 Weeks)|Other|0|||
42209125|NCT04516291|76023463|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
42209126|NCT04516291|76023464|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
42209127|NCT04516291|76023465|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
42209128|NCT04516291|76023466|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
42209129|NCT04516291|76023467|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
42209130|NCT04516291|76023468|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
42209131|NCT04516291|76023469|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
42209132|NCT04516291|76023470|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
42209133|NCT04516291|76023463|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
42209134|NCT04516291|76023464|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
42209135|NCT04516291|76023465|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
42209136|NCT04516291|76023466|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
42209137|NCT04516291|76023467|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
42209138|NCT04516291|76023468|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
42209139|NCT04516291|76023469|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
42209140|NCT04516291|76023470|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
42209141|NCT03243630|76023488|FG000|Overall Study|Protocol Violation|1|||
42209142|NCT03243630|76023488|FG000|Overall Study|Physician Decision|1|||
42209143|NCT04450381|76023496|FG000|Overall Study|Protocol Violation|4|||
42209144|NCT04450381|76023496|FG000|Overall Study|Wrong device setting|2|||
42209145|NCT03068468|76023502|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
42209146|NCT03068468|76023503|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
42209147|NCT03068468|76023504|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
42209148|NCT03068468|76023505|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
42209149|NCT03068468|76023502|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
42209150|NCT03068468|76023503|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
42209151|NCT03068468|76023504|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
42209152|NCT03068468|76023505|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
42209153|NCT03068468|76023502|FG000|Placebo-Controlled Period|Adverse Event|16|||
42209154|NCT03068468|76023503|FG001|Placebo-Controlled Period|Adverse Event|21|||
42209155|NCT03068468|76023504|FG002|Placebo-Controlled Period|Adverse Event|0|||
42209156|NCT03068468|76023505|FG003|Placebo-Controlled Period|Adverse Event|0|||
42209157|NCT03068468|76023502|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
42209158|NCT03068468|76023503|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
42209159|NCT03068468|76023504|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
42209160|NCT03068468|76023505|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
42209161|NCT03068468|76023502|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
42209162|NCT03068468|76023503|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
42209163|NCT03068468|76023504|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
42209164|NCT03068468|76023505|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
42209165|NCT03068468|76023502|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
42209166|NCT03068468|76023503|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
42209167|NCT03068468|76023504|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
42209168|NCT03068468|76023505|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
42209169|NCT03068468|76023502|FG000|Placebo-Controlled Period|Death|0|||
42209170|NCT03068468|76023503|FG001|Placebo-Controlled Period|Death|1|||
42209171|NCT03068468|76023504|FG002|Placebo-Controlled Period|Death|0|||
42209172|NCT03068468|76023505|FG003|Placebo-Controlled Period|Death|0|||
42209173|NCT03068468|76023502|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
42209174|NCT03068468|76023503|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
42209175|NCT03068468|76023504|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
42209176|NCT03068468|76023505|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
42209177|NCT03068468|76023502|FG000|Open-Label Extension Period|Adverse Event|0|||
41929541|NCT00216476|75589947|FG000|Overall Study|Refuses Injection|11|||
41929542|NCT00216476|75589948|FG001|Overall Study|Refuses Injection|0|||
41929543|NCT00216476|75589949|FG002|Overall Study|Refuses Injection|0|||
41929544|NCT00216476|75589947|FG000|Overall Study|No Further Need for Treatment|3|||
41929545|NCT00216476|75589948|FG001|Overall Study|No Further Need for Treatment|4|||
41929546|NCT00216476|75589949|FG002|Overall Study|No Further Need for Treatment|1|||
41929547|NCT00216476|75589947|FG000|Overall Study|Non-compliance|0|||
41929548|NCT00216476|75589948|FG001|Overall Study|Non-compliance|4|||
41929549|NCT00216476|75589949|FG002|Overall Study|Non-compliance|1|||
41929550|NCT00216476|75589947|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
41929551|NCT00216476|75589948|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
41929552|NCT00216476|75589949|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
41929553|NCT00216476|75589947|FG000|Overall Study|Administrative Reasons|1|||
41929554|NCT00216476|75589948|FG001|Overall Study|Administrative Reasons|1|||
41929555|NCT00216476|75589949|FG002|Overall Study|Administrative Reasons|0|||
41929556|NCT00216476|75589947|FG000|Overall Study|Protocol Deviation|5|||
41929557|NCT00216476|75589948|FG001|Overall Study|Protocol Deviation|1|||
41929558|NCT00216476|75589949|FG002|Overall Study|Protocol Deviation|0|||
41929559|NCT00216476|75589947|FG000|Overall Study|Patient Moved|2|||
41929560|NCT00216476|75589948|FG001|Overall Study|Patient Moved|2|||
41929561|NCT00216476|75589949|FG002|Overall Study|Patient Moved|0|||
41929562|NCT00216086|75590000|FG000|Overall Study|Protocol Violation|1|||
41929563|NCT00216086|75590000|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
41929564|NCT00216086|75590000|FG000|Overall Study|Social Reasons|2|||
41929565|NCT00215150|75590031|FG000|Open Label Phase|Lost to Follow-up|7|||
41929566|NCT00215150|75590031|FG000|Open Label Phase|Withdrawal by Subject|1|||
41929567|NCT00215150|75590031|FG000|Open Label Phase|Did not complete a post base visit|13|||
41929568|NCT00215150|75590031|FG000|Open Label Phase|Did not meet randomization criteria|9|||
41929569|NCT00215150|75590031|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
41929570|NCT00215150|75590031|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
41929571|NCT00215150|75590031|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
41929572|NCT00214136|75590039|FG000|Overall Study|Death|5|||
41929573|NCT00213980|75590045|FG000|Overall Study|Withdrawal by Subject|3|||
41929574|NCT00213980|75590046|FG001|Overall Study|Withdrawal by Subject|1|||
41929575|NCT00213980|75590045|FG000|Overall Study|Adverse Event|1|||
41929576|NCT00213980|75590046|FG001|Overall Study|Adverse Event|1|||
41929577|NCT00213980|75590045|FG000|Overall Study|Disease progression|0|||
41929578|NCT00213980|75590046|FG001|Overall Study|Disease progression|2|||
41929579|NCT00213980|75590045|FG000|Overall Study|Developed ovarian cancer|1|||
41929580|NCT00213980|75590046|FG001|Overall Study|Developed ovarian cancer|0|||
41929581|NCT00213980|75590045|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
41929582|NCT00213980|75590046|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
41929583|NCT05086289|75590105|FG000|Overall Study|Adverse Event|4|||
41929584|NCT05086289|75590106|FG001|Overall Study|Adverse Event|2|||
41929585|NCT05086289|75590105|FG000|Overall Study|Lost to Follow-up|2|||
41929586|NCT05086289|75590106|FG001|Overall Study|Lost to Follow-up|0|||
41929587|NCT05086289|75590105|FG000|Overall Study|Non-compliance with study drug|2|||
41929588|NCT05086289|75590106|FG001|Overall Study|Non-compliance with study drug|1|||
41929589|NCT05086289|75590105|FG000|Overall Study|Physician Decision|2|||
41929590|NCT05086289|75590106|FG001|Overall Study|Physician Decision|0|||
41929591|NCT05086289|75590105|FG000|Overall Study|Withdrawal by Subject|5|||
41929592|NCT05086289|75590106|FG001|Overall Study|Withdrawal by Subject|2|||
41929593|NCT05045144|75590119|FG000|Overall Study|Lost to Follow-up|3|||
41929594|NCT05045144|75590120|FG001|Overall Study|Lost to Follow-up|2|||
41929595|NCT05045144|75590121|FG002|Overall Study|Lost to Follow-up|3|||
41929596|NCT05045144|75590122|FG003|Overall Study|Lost to Follow-up|5|||
41929597|NCT05045144|75590123|FG004|Overall Study|Lost to Follow-up|13|||
41929598|NCT05045144|75590119|FG000|Overall Study|Withdrawal by Subject|0|||
41929599|NCT05045144|75590120|FG001|Overall Study|Withdrawal by Subject|1|||
41929600|NCT05045144|75590121|FG002|Overall Study|Withdrawal by Subject|0|||
41929601|NCT05045144|75590122|FG003|Overall Study|Withdrawal by Subject|0|||
41929602|NCT05045144|75590123|FG004|Overall Study|Withdrawal by Subject|0|||
41929603|NCT05045144|75590119|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
41929604|NCT05045144|75590120|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
41929605|NCT05045144|75590121|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
41929606|NCT05045144|75590122|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
41929607|NCT05045144|75590123|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
41929608|NCT05016765|75590139|FG000|Overall Study|Lost to Follow-up|4|||
41929609|NCT04982029|75590146|FG000|Overall Study|Lost to Follow-up|2|||
41929610|NCT04982029|75590147|FG001|Overall Study|Lost to Follow-up|3|||
41929611|NCT04897867|75590161|FG000|Overall Study|Withdrawal of Consent|1|||
41929612|NCT04897867|75590161|FG000|Overall Study|Pregnancy|1|||
41929613|NCT04897867|75590161|FG000|Overall Study|Lost to Follow-up|7|||
41929614|NCT04897867|75590161|FG000|Overall Study|Reason not Specified|2|||
41929615|NCT04161157|75590202|FG000|Overall Study|Lost to Follow-up|4|||
41929616|NCT04161157|75590202|FG000|Overall Study|Death|3|||
41929617|NCT04161157|75590202|FG000|Overall Study|Ineligible|2|||
41929618|NCT04161157|75590202|FG000|Overall Study|Withdrawal by Subject|4|||
41929619|NCT04035187|75590210|FG000|Overall Study|Withdrawal by Subject|2|||
41929620|NCT04035187|75590211|FG001|Overall Study|Withdrawal by Subject|1|||
41929621|NCT04035187|75590212|FG002|Overall Study|Withdrawal by Subject|0|||
41929622|NCT04035187|75590213|FG003|Overall Study|Withdrawal by Subject|0|||
41929623|NCT04035187|75590210|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
41929624|NCT04035187|75590211|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
41929625|NCT04035187|75590212|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
41929626|NCT04035187|75590213|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
41929627|NCT03852719|75590226|FG000|Overall Study|Still on study after Week 96|49|||
41929628|NCT03852719|75590227|FG001|Overall Study|Still on study after Week 96|47|||
41929629|NCT03852719|75590228|FG002|Overall Study|Still on study after Week 96|47|||
41929630|NCT03852719|75590226|FG000|Overall Study|Withdrawal of consent|0|||
41929631|NCT03852719|75590227|FG001|Overall Study|Withdrawal of consent|2|||
41929632|NCT03852719|75590228|FG002|Overall Study|Withdrawal of consent|2|||
41929633|NCT03852719|75590226|FG000|Overall Study|Physician Decision|0|||
41929634|NCT03852719|75590227|FG001|Overall Study|Physician Decision|0|||
41929635|NCT03852719|75590228|FG002|Overall Study|Physician Decision|1|||
41929636|NCT03852719|75590226|FG000|Overall Study|Pregnancy|1|||
41929637|NCT03852719|75590227|FG001|Overall Study|Pregnancy|0|||
41929638|NCT03852719|75590228|FG002|Overall Study|Pregnancy|0|||
41929639|NCT03852719|75590226|FG000|Overall Study|Death|1|||
41929640|NCT03852719|75590227|FG001|Overall Study|Death|0|||
41929641|NCT03852719|75590228|FG002|Overall Study|Death|0|||
41929642|NCT03785145|75590245|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
41929643|NCT03785145|75590246|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
41929644|NCT03785145|75590245|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
41929645|NCT03785145|75590246|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
41929646|NCT03785145|75590245|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
41929647|NCT03785145|75590246|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
41929648|NCT03785145|75590245|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
41929649|NCT03785145|75590246|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
41929650|NCT03785145|75590245|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
41929651|NCT03785145|75590246|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
41929652|NCT03785145|75590245|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
41929653|NCT03785145|75590246|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
41929654|NCT03785145|75590245|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
41929655|NCT03785145|75590246|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
41929656|NCT03785145|75590245|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
41929657|NCT03785145|75590246|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
41929658|NCT03785145|75590245|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
41929659|NCT03785145|75590246|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
41929660|NCT03785145|75590245|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
41929661|NCT03785145|75590246|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
41929662|NCT03785145|75590245|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
41929663|NCT03785145|75590246|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
41929664|NCT03320330|75590272|FG000|Overall Study|Lack of Efficacy|5|||
41929665|NCT03320330|75590273|FG001|Overall Study|Lack of Efficacy|5|||
41929666|NCT03320330|75590274|FG002|Overall Study|Lack of Efficacy|14|||
41929667|NCT03320330|75590272|FG000|Overall Study|Physician Decision|1|||
41929668|NCT03320330|75590273|FG001|Overall Study|Physician Decision|0|||
41929669|NCT03320330|75590274|FG002|Overall Study|Physician Decision|0|||
41929670|NCT03284788|75590307|FG000|Overall Study|Withdrawal by Subject|2|||
41929671|NCT03082612|75590313|FG000|Overall Study|Lost to Follow-up|2|||
41929672|NCT03082612|75590314|FG001|Overall Study|Lost to Follow-up|0|||
41929673|NCT02824627|75590353|FG000|Overall Study|Adverse Event|1|||
41929674|NCT02824627|75590354|FG001|Overall Study|Adverse Event|2|||
41929675|NCT02824627|75590353|FG000|Overall Study|Lost to Follow-up|2|||
41929676|NCT02824627|75590354|FG001|Overall Study|Lost to Follow-up|1|||
41929677|NCT02743611|75590360|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
41929678|NCT02743611|75590361|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
41929679|NCT02743611|75590362|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
41929680|NCT02743611|75590363|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
41929681|NCT01873833|75590381|FG000|Overall Study|Withdrawal by Subject|1|||
41929682|NCT04388527|75590818|FG000|Overall Study|Death|14|||
41929683|NCT04388527|75590818|FG000|Overall Study|Withdrawal by Subject|2|||
41929684|NCT04388527|75590818|FG000|Overall Study|Lost to Follow-up|1|||
41929685|NCT03649321|75590845|FG000|Overall Study|Withdrawal by Subject|1|||
41929686|NCT03649321|75590846|FG001|Overall Study|Withdrawal by Subject|0|||
41929687|NCT03649321|75590845|FG000|Overall Study|Death|1|||
41929688|NCT03649321|75590846|FG001|Overall Study|Death|0|||
41929689|NCT04149002|75591079|FG000|Overall Study|Lost to Follow-up|1|||
41929690|NCT04149002|75591080|FG001|Overall Study|Lost to Follow-up|0|||
41929691|NCT04149002|75591079|FG000|Overall Study|Withdrawal by Subject|1|||
41929692|NCT04149002|75591080|FG001|Overall Study|Withdrawal by Subject|0|||
41929693|NCT00555321|75591154|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
41929694|NCT00555321|75591155|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
41929695|NCT00555321|75591156|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
41929696|NCT00555321|75591157|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
41929697|NCT00555321|75591158|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
41929698|NCT00555321|75591154|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
41929699|NCT00555321|75591155|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
41929700|NCT00555321|75591156|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
41929701|NCT00555321|75591157|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
41929702|NCT00555321|75591158|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
41929703|NCT00555321|75591154|FG000|Treatment Phase up to 12-months|Death|2|||
41929704|NCT00555321|75591155|FG001|Treatment Phase up to 12-months|Death|1|||
41929705|NCT00555321|75591156|FG002|Treatment Phase up to 12-months|Death|4|||
41929706|NCT00555321|75591157|FG003|Treatment Phase up to 12-months|Death|0|||
42209178|NCT03068468|76023503|FG001|Open-Label Extension Period|Adverse Event|0|||
41929707|NCT00555321|75591158|FG004|Treatment Phase up to 12-months|Death|0|||
41929708|NCT00555321|75591154|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
41929709|NCT00555321|75591155|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
41929710|NCT00555321|75591156|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
41929711|NCT00555321|75591157|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
41929712|NCT00555321|75591158|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
41929713|NCT00555321|75591154|FG000|Treatment Phase up to 12-months|Other Reason|1|||
41929714|NCT00555321|75591155|FG001|Treatment Phase up to 12-months|Other Reason|3|||
41929715|NCT00555321|75591156|FG002|Treatment Phase up to 12-months|Other Reason|2|||
41929716|NCT00555321|75591157|FG003|Treatment Phase up to 12-months|Other Reason|0|||
41929717|NCT00555321|75591158|FG004|Treatment Phase up to 12-months|Other Reason|0|||
41929718|NCT00555321|75591154|FG000|Treatment Phase up to 12-months|Never treated|2|||
41929719|NCT00555321|75591155|FG001|Treatment Phase up to 12-months|Never treated|3|||
41929720|NCT00555321|75591156|FG002|Treatment Phase up to 12-months|Never treated|1|||
41929721|NCT00555321|75591157|FG003|Treatment Phase up to 12-months|Never treated|0|||
41929722|NCT00555321|75591158|FG004|Treatment Phase up to 12-months|Never treated|4|||
41929723|NCT00555321|75591154|FG000|Long-term Extension Phase|Adverse Event|2|||
41929724|NCT00555321|75591155|FG001|Long-term Extension Phase|Adverse Event|5|||
41929725|NCT00555321|75591156|FG002|Long-term Extension Phase|Adverse Event|2|||
41929726|NCT00555321|75591157|FG003|Long-term Extension Phase|Adverse Event|1|||
41929727|NCT00555321|75591158|FG004|Long-term Extension Phase|Adverse Event|0|||
41929728|NCT00555321|75591154|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
41929729|NCT00555321|75591155|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
41929730|NCT00555321|75591156|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
41929731|NCT00555321|75591157|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
41929732|NCT00555321|75591158|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
41929733|NCT00555321|75591154|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
41929734|NCT00555321|75591155|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
41929735|NCT00555321|75591156|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
41929736|NCT00555321|75591157|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
41929737|NCT00555321|75591158|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
41929738|NCT00555321|75591154|FG000|Long-term Extension Phase|Death|2|||
42209179|NCT03068468|76023504|FG002|Open-Label Extension Period|Adverse Event|13|||
42209180|NCT03068468|76023505|FG003|Open-Label Extension Period|Adverse Event|17|||
42209181|NCT03068468|76023502|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
42209182|NCT03068468|76023503|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
42209183|NCT03068468|76023504|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
42209184|NCT03068468|76023505|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
42209185|NCT03068468|76023502|FG000|Open-Label Extension Period|Death|0|||
42209186|NCT03068468|76023503|FG001|Open-Label Extension Period|Death|0|||
42209187|NCT03068468|76023504|FG002|Open-Label Extension Period|Death|0|||
42209188|NCT03068468|76023505|FG003|Open-Label Extension Period|Death|1|||
42209189|NCT03068468|76023502|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
42209190|NCT03068468|76023503|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
42209191|NCT03068468|76023504|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
42209192|NCT03068468|76023505|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
42209193|NCT03068468|76023502|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
41929739|NCT00555321|75591155|FG001|Long-term Extension Phase|Death|0|||
41929740|NCT00555321|75591156|FG002|Long-term Extension Phase|Death|0|||
41929741|NCT00555321|75591157|FG003|Long-term Extension Phase|Death|3|||
41929742|NCT00555321|75591158|FG004|Long-term Extension Phase|Death|0|||
41929743|NCT00555321|75591154|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
41929744|NCT00555321|75591155|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
41929745|NCT00555321|75591156|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
41929746|NCT00555321|75591157|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
41929747|NCT00555321|75591158|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
41929748|NCT00555321|75591154|FG000|Long-term Extension Phase|Other Reason|1|||
41929749|NCT00555321|75591155|FG001|Long-term Extension Phase|Other Reason|0|||
41929750|NCT00555321|75591156|FG002|Long-term Extension Phase|Other Reason|2|||
41929751|NCT00555321|75591157|FG003|Long-term Extension Phase|Other Reason|0|||
41929752|NCT00555321|75591158|FG004|Long-term Extension Phase|Other Reason|0|||
41929753|NCT03589976|75591670|FG000|Overall Study|Death|5|||
41929754|NCT03589976|75591671|FG001|Overall Study|Death|1|||
41929755|NCT03589976|75591670|FG000|Overall Study|Adverse Event|5|||
41929756|NCT03589976|75591671|FG001|Overall Study|Adverse Event|1|||
41929757|NCT03589976|75591670|FG000|Overall Study|Withdrawal by Subject|4|||
41929758|NCT03589976|75591671|FG001|Overall Study|Withdrawal by Subject|1|||
41929759|NCT03589976|75591670|FG000|Overall Study|Lost to Follow-up|1|||
41929760|NCT03589976|75591671|FG001|Overall Study|Lost to Follow-up|0|||
41929761|NCT03589976|75591670|FG000|Overall Study|Other|4|||
41929762|NCT03589976|75591671|FG001|Overall Study|Other|3|||
41929763|NCT03029780|75591827|FG000|Overall Study|Disease Progression|20|||
41929764|NCT03029780|75591828|FG001|Overall Study|Disease Progression|22|||
41929765|NCT03029780|75591827|FG000|Overall Study|Study Drug Toxicity|15|||
41929766|NCT03029780|75591828|FG001|Overall Study|Study Drug Toxicity|11|||
41929767|NCT03029780|75591827|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
41929768|NCT03029780|75591828|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
41929769|NCT03029780|75591827|FG000|Overall Study|Participant request to discontinue study treatment|4|||
41929770|NCT03029780|75591828|FG001|Overall Study|Participant request to discontinue study treatment|1|||
41929771|NCT03029780|75591827|FG000|Overall Study|Maximum clinical benefit|1|||
41929772|NCT03029780|75591828|FG001|Overall Study|Maximum clinical benefit|0|||
41929773|NCT03029780|75591827|FG000|Overall Study|Participant no longer meets study criteria|0|||
41929774|NCT03029780|75591828|FG001|Overall Study|Participant no longer meets study criteria|1|||
41929775|NCT03029780|75591827|FG000|Overall Study|Other reasons|6|||
41929776|NCT03029780|75591828|FG001|Overall Study|Other reasons|6|||
41929777|NCT03029780|75591827|FG000|Overall Study|Not reported|1|||
41929778|NCT03029780|75591828|FG001|Overall Study|Not reported|1|||
41929779|NCT03029780|75591827|FG000|Overall Study|Death|2|||
41929780|NCT03029780|75591828|FG001|Overall Study|Death|6|||
41929781|NCT03029234|75591888|FG000|Overall Study|Sponsor Decision|1|||
41929782|NCT03029234|75591888|FG000|Overall Study|Withdrawal by Subject|5|||
41929783|NCT03029234|75591888|FG000|Overall Study|Death|91|||
41929784|NCT03029234|75591888|FG000|Overall Study|Lost to Follow-up|2|||
41929785|NCT03991299|75592559|FG000|Overall Study|Study closed, sponsor decision|3|||
41929786|NCT03991299|75592559|FG000|Overall Study|Withdrawal by Subject|1|||
41929787|NCT03155373|75592577|FG000|Overall Study|No longer required surgery|1|||
41929788|NCT03155373|75592577|FG000|Overall Study|Protocol Violation|1|||
41929789|NCT03155373|75592577|FG000|Overall Study|Death|2|||
41929790|NCT03155373|75592577|FG000|Overall Study|Withdrawal by Subject|3|||
41929791|NCT05310084|75592995|FG000|Overall Study|Withdrawal by Subject|2|||
41929792|NCT05310084|75592996|FG001|Overall Study|Withdrawal by Subject|3|||
41929793|NCT05310084|75592995|FG000|Overall Study|Participant availability|0|||
41929794|NCT05310084|75592996|FG001|Overall Study|Participant availability|4|||
41929795|NCT05310084|75592995|FG000|Overall Study|Lost to Follow-up|1|||
41929796|NCT05310084|75592996|FG001|Overall Study|Lost to Follow-up|1|||
41929797|NCT05310084|75592995|FG000|Overall Study|Adverse Event|1|||
41929798|NCT05310084|75592996|FG001|Overall Study|Adverse Event|1|||
41929799|NCT05310084|75592995|FG000|Overall Study|Randomized but not vaccinated|4|||
41929800|NCT05310084|75592996|FG001|Overall Study|Randomized but not vaccinated|2|||
41929801|NCT04581863|75593031|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
41929802|NCT04581863|75593032|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
41929803|NCT04349891|75593049|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
41929804|NCT04349891|75593050|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
41929805|NCT04349891|75593049|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
41929806|NCT04349891|75593050|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
41929807|NCT04349891|75593049|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
41929808|NCT04349891|75593050|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
41929809|NCT04349891|75593049|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
41929810|NCT04349891|75593050|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
41929811|NCT02258451|75593058|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
41929812|NCT02258451|75593059|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
41929813|NCT02258451|75593058|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
41929814|NCT02258451|75593059|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
41929815|NCT02258451|75593058|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
41929816|NCT02258451|75593059|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
41929817|NCT02258451|75593058|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
41929818|NCT02258451|75593059|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
41929819|NCT02258451|75593058|FG000|Overall Study|Discontinuation all treatment due to death|4|||
41929820|NCT02258451|75593059|FG001|Overall Study|Discontinuation all treatment due to death|3|||
41929821|NCT02258451|75593058|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
41929822|NCT02258451|75593059|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
41929823|NCT02258451|75593058|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
41929824|NCT02258451|75593059|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
41929825|NCT02258451|75593058|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
41929826|NCT02258451|75593059|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
41929827|NCT02258451|75593058|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
41929828|NCT02258451|75593059|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
41929829|NCT02258451|75593058|FG000|Overall Study|Other reason|1|||
41929830|NCT02258451|75593059|FG001|Overall Study|Other reason|1|||
41929831|NCT02258451|75593058|FG000|Overall Study|Never treated|2|||
41929832|NCT02258451|75593059|FG001|Overall Study|Never treated|3|||
41929833|NCT02168270|75593067|FG000|Overall Study|Lack of Efficacy|4|||
41929834|NCT02775903|75593368|FG000|Overall Study|Death|7|||
41929835|NCT02775903|75593369|FG001|Overall Study|Death|11|||
41929836|NCT02775903|75593370|FG002|Overall Study|Death|12|||
41929837|NCT02775903|75593371|FG003|Overall Study|Death|11|||
41929838|NCT02775903|75593368|FG000|Overall Study|Adverse Event|0|||
41929839|NCT02775903|75593369|FG001|Overall Study|Adverse Event|1|||
41929840|NCT02775903|75593370|FG002|Overall Study|Adverse Event|12|||
41929841|NCT02775903|75593371|FG003|Overall Study|Adverse Event|3|||
41929842|NCT02775903|75593368|FG000|Overall Study|Progressive disease|15|||
41929843|NCT02775903|75593369|FG001|Overall Study|Progressive disease|14|||
41929844|NCT02775903|75593370|FG002|Overall Study|Progressive disease|30|||
41929845|NCT02775903|75593371|FG003|Overall Study|Progressive disease|20|||
41929846|NCT02775903|75593368|FG000|Overall Study|Lack of Efficacy|2|||
41929847|NCT02775903|75593369|FG001|Overall Study|Lack of Efficacy|2|||
41929848|NCT02775903|75593370|FG002|Overall Study|Lack of Efficacy|2|||
41929849|NCT02775903|75593371|FG003|Overall Study|Lack of Efficacy|6|||
41929850|NCT02775903|75593368|FG000|Overall Study|Withdrawal by Subject|7|||
41929851|NCT02775903|75593369|FG001|Overall Study|Withdrawal by Subject|5|||
41929852|NCT02775903|75593370|FG002|Overall Study|Withdrawal by Subject|5|||
41929853|NCT02775903|75593371|FG003|Overall Study|Withdrawal by Subject|8|||
41929854|NCT02775903|75593368|FG000|Overall Study|Other reasons|7|||
41929855|NCT02775903|75593369|FG001|Overall Study|Other reasons|8|||
41929856|NCT02775903|75593370|FG002|Overall Study|Other reasons|2|||
41929857|NCT02775903|75593371|FG003|Overall Study|Other reasons|12|||
41929858|NCT02723019|75593440|FG000|Overall Study|Death|17|||
41929859|NCT02723019|75593441|FG001|Overall Study|Death|13|||
41929860|NCT02723019|75593440|FG000|Overall Study|Withdrawal by Subject|11|||
41929861|NCT02723019|75593441|FG001|Overall Study|Withdrawal by Subject|7|||
41929862|NCT02723019|75593440|FG000|Overall Study|Lost to Follow-up|57|||
41929863|NCT02723019|75593441|FG001|Overall Study|Lost to Follow-up|70|||
41929864|NCT00088166|75593691|FG000|Overall Study|Adverse Event|11|||
41929865|NCT00088166|75593692|FG001|Overall Study|Adverse Event|9|||
41929866|NCT00088166|75593691|FG000|Overall Study|Death|3|||
41929867|NCT00088166|75593692|FG001|Overall Study|Death|1|||
41929868|NCT00088166|75593691|FG000|Overall Study|Lost to Follow-up|0|||
41929869|NCT00088166|75593692|FG001|Overall Study|Lost to Follow-up|1|||
41929870|NCT00088166|75593691|FG000|Overall Study|Physician Decision|4|||
41929871|NCT00088166|75593692|FG001|Overall Study|Physician Decision|1|||
41929872|NCT00088166|75593691|FG000|Overall Study|Protocol Violation|1|||
41929873|NCT00088166|75593692|FG001|Overall Study|Protocol Violation|5|||
41929874|NCT00088166|75593691|FG000|Overall Study|Patient deterioration|29|||
41929875|NCT00088166|75593692|FG001|Overall Study|Patient deterioration|39|||
41929876|NCT00088166|75593691|FG000|Overall Study|Withdrawal by Subject|5|||
41929877|NCT00088166|75593692|FG001|Overall Study|Withdrawal by Subject|5|||
41929878|NCT00087698|75593736|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
41929879|NCT00087698|75593736|FG000|Overall Study|Death from Other Causes|3|||
41929880|NCT00087698|75593736|FG000|Overall Study|Adverse Event|4|||
41929881|NCT00087698|75593736|FG000|Overall Study|Withdrawal by Subject|4|||
41929882|NCT00087698|75593736|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
41929883|NCT00087698|75593736|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
41929884|NCT00087698|75593736|FG000|Overall Study|Clinical Relapse|1|||
41929885|NCT00087698|75593736|FG000|Overall Study|Death from Study Disease|2|||
41929886|NCT00087698|75593736|FG000|Overall Study|Death from Study Drug Toxicity|2|||
41929887|NCT00087698|75593736|FG000|Overall Study|Protocol Violation|1|||
41929888|NCT00087152|75593754|FG000|Overall Study|Ineligible|6|||
41929889|NCT00086996|75593806|FG000|Overall Study|Adverse Event|29|||
41929890|NCT00086996|75593806|FG000|Overall Study|Death|4|||
41929891|NCT00086996|75593806|FG000|Overall Study|progression/relapse|7|||
41929892|NCT00086996|75593806|FG000|Overall Study|Withdrawal by Subject|13|||
41929893|NCT00086996|75593806|FG000|Overall Study|Other|6|||
41929894|NCT00086996|75593806|FG000|Overall Study|not eligible|5|||
41929895|NCT00086684|75594108|FG000|Overall Study|Adverse Event|12|||
41929896|NCT00086684|75594109|FG001|Overall Study|Adverse Event|17|||
41929897|NCT00086684|75594110|FG002|Overall Study|Adverse Event|14|||
41929898|NCT00086684|75594108|FG000|Overall Study|Lack of Efficacy|6|||
41929899|NCT00086684|75594109|FG001|Overall Study|Lack of Efficacy|6|||
41929900|NCT00086684|75594110|FG002|Overall Study|Lack of Efficacy|5|||
41929901|NCT00086684|75594108|FG000|Overall Study|Lost to Follow-up|15|||
41929902|NCT00086684|75594109|FG001|Overall Study|Lost to Follow-up|8|||
41929903|NCT00086684|75594110|FG002|Overall Study|Lost to Follow-up|10|||
41929904|NCT00086684|75594108|FG000|Overall Study|Protocol Violation|8|||
41929905|NCT00086684|75594109|FG001|Overall Study|Protocol Violation|3|||
41929906|NCT00086684|75594110|FG002|Overall Study|Protocol Violation|0|||
41929907|NCT00086684|75594108|FG000|Overall Study|Withdrawal by Subject|0|||
41929908|NCT00086684|75594109|FG001|Overall Study|Withdrawal by Subject|4|||
41929909|NCT00086684|75594110|FG002|Overall Study|Withdrawal by Subject|10|||
41929910|NCT00086684|75594108|FG000|Overall Study|NONCOMPLIANCE|5|||
41929911|NCT00086684|75594109|FG001|Overall Study|NONCOMPLIANCE|7|||
41929912|NCT00086684|75594110|FG002|Overall Study|NONCOMPLIANCE|6|||
41929913|NCT00086684|75594108|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
41929914|NCT00086684|75594109|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
41929915|NCT00086684|75594110|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
41929916|NCT00086684|75594108|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
41929917|NCT00086684|75594109|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
41929918|NCT00086684|75594110|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
41929919|NCT00086684|75594108|FG000|Overall Study|Other|4|||
41929920|NCT00086684|75594109|FG001|Overall Study|Other|2|||
41929921|NCT00086684|75594110|FG002|Overall Study|Other|3|||
41929922|NCT00082628|75594174|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
41929923|NCT00082628|75594175|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
41929924|NCT00082628|75594176|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
41929925|NCT00082628|75594177|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
41929926|NCT00082628|75594178|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
41929927|NCT00082628|75594174|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
41929928|NCT00082628|75594175|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
41929929|NCT00082628|75594176|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
41929930|NCT00082628|75594177|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
41929931|NCT00082628|75594178|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
41929932|NCT00082628|75594174|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
41929933|NCT00082628|75594175|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
41929934|NCT00082628|75594176|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
41929935|NCT00082628|75594177|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
41929936|NCT00082628|75594178|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
41929937|NCT00082628|75594174|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
41929938|NCT00082628|75594175|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
41929939|NCT00082628|75594176|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
41929940|NCT00082628|75594177|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
41929941|NCT00082628|75594178|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
41929942|NCT00082628|75594174|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
41929943|NCT00082628|75594175|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
41929944|NCT00082628|75594176|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
41929945|NCT00082628|75594177|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
41929946|NCT00082628|75594178|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
41929947|NCT00082628|75594174|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
41929948|NCT00082628|75594175|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
41929949|NCT00082628|75594176|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
41929950|NCT00082628|75594177|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
41929951|NCT00082628|75594178|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
41929952|NCT00082628|75594174|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
41929953|NCT00082628|75594175|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
41929954|NCT00082628|75594176|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
41929955|NCT00082628|75594177|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
41929956|NCT00082628|75594178|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
41929957|NCT02993263|75594520|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
41929958|NCT01274533|75594548|FG000|Overall Study|Withdrawal by Subject|1|||
41929959|NCT01274533|75594548|FG000|Overall Study|Non-compliance|1|||
41929960|NCT01274533|75594548|FG000|Overall Study|Disease progression|2|||
41929961|NCT01273597|75594552|FG000|Overall Study|Adverse Event|5|||
41929962|NCT01273597|75594552|FG000|Overall Study|Underwent Kidney Transplantation|2|||
41929963|NCT01273597|75594552|FG000|Overall Study|Reason Not Reported|1|||
41929964|NCT01273519|75594559|FG000|Overall Study|Adverse Event|3|||
41929965|NCT01273519|75594560|FG001|Overall Study|Adverse Event|0|||
41929966|NCT01273519|75594561|FG002|Overall Study|Adverse Event|0|||
41929967|NCT01273519|75594559|FG000|Overall Study|Lost to Follow-up|2|||
41929968|NCT01273519|75594560|FG001|Overall Study|Lost to Follow-up|1|||
41929969|NCT01273519|75594561|FG002|Overall Study|Lost to Follow-up|3|||
41929970|NCT01273519|75594559|FG000|Overall Study|Lack of Efficacy|8|||
41929971|NCT01273519|75594560|FG001|Overall Study|Lack of Efficacy|3|||
41929972|NCT01273519|75594561|FG002|Overall Study|Lack of Efficacy|4|||
41929973|NCT01273519|75594559|FG000|Overall Study|Other|6|||
41929974|NCT01273519|75594560|FG001|Overall Study|Other|1|||
41929975|NCT01273519|75594561|FG002|Overall Study|Other|1|||
41929976|NCT01272661|75594618|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
41929977|NCT01272661|75594619|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
42209194|NCT03068468|76023503|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
42209195|NCT03068468|76023504|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
42209196|NCT03068468|76023505|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
42209197|NCT03068468|76023502|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
42209198|NCT03068468|76023503|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
42209199|NCT03068468|76023504|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
42209200|NCT03068468|76023505|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
42209201|NCT03068468|76023502|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
42209202|NCT03068468|76023503|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
42209203|NCT03068468|76023504|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
42209204|NCT03068468|76023505|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
42209205|NCT03068468|76023502|FG000|Open-Label Extension Period|Reason not Specified|0|||
42209206|NCT03068468|76023503|FG001|Open-Label Extension Period|Reason not Specified|0|||
42209207|NCT03068468|76023504|FG002|Open-Label Extension Period|Reason not Specified|1|||
42209208|NCT03068468|76023505|FG003|Open-Label Extension Period|Reason not Specified|4|||
42209209|NCT04512001|76023515|FG000|Week 0 to Week 24|Adverse Event|14|||
42209210|NCT04512001|76023516|FG001|Week 0 to Week 24|Adverse Event|10|||
42209211|NCT04512001|76023517|FG002|Week 0 to Week 24|Adverse Event|0|||
42209212|NCT04512001|76023518|FG003|Week 0 to Week 24|Adverse Event|0|||
42209213|NCT04512001|76023519|FG004|Week 0 to Week 24|Adverse Event|0|||
42209214|NCT04512001|76023515|FG000|Week 0 to Week 24|Death|0|||
42209215|NCT04512001|76023516|FG001|Week 0 to Week 24|Death|2|||
42209216|NCT04512001|76023517|FG002|Week 0 to Week 24|Death|0|||
42209217|NCT04512001|76023518|FG003|Week 0 to Week 24|Death|0|||
42209218|NCT04512001|76023519|FG004|Week 0 to Week 24|Death|0|||
42209219|NCT04512001|76023515|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
42209220|NCT04512001|76023516|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
42209221|NCT04512001|76023517|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
42209222|NCT04512001|76023518|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
42209223|NCT04512001|76023519|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
42209224|NCT04512001|76023515|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
42209225|NCT04512001|76023516|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
42209226|NCT04512001|76023517|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
42209227|NCT04512001|76023518|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
42209228|NCT04512001|76023519|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
42209229|NCT04512001|76023515|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
42209230|NCT04512001|76023516|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
42209231|NCT04512001|76023517|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
42209232|NCT04512001|76023518|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
42209233|NCT04512001|76023519|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
42209234|NCT04512001|76023515|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
42300055|NCT02549339|76135208|FG000|12-month Follow-up|Lost to Follow-up|1|||
41929978|NCT01272661|75594620|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
41929979|NCT04276051|75594786|FG000|Overall Study|Lost to Follow-up|0|||
41929980|NCT04276051|75594787|FG001|Overall Study|Lost to Follow-up|1|||
41929981|NCT04276051|75594786|FG000|Overall Study|Physician Decision|0|||
41929982|NCT04276051|75594787|FG001|Overall Study|Physician Decision|1|||
42209235|NCT04512001|76023516|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
42209236|NCT04512001|76023517|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
42209237|NCT04512001|76023518|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
42209238|NCT04512001|76023519|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
42209239|NCT04512001|76023515|FG000|Week 24 to Week 63|Adverse Event|0|||
42209240|NCT04512001|76023516|FG001|Week 24 to Week 63|Adverse Event|0|||
42209241|NCT04512001|76023517|FG002|Week 24 to Week 63|Adverse Event|13|||
42209242|NCT04512001|76023518|FG003|Week 24 to Week 63|Adverse Event|8|||
42209243|NCT04512001|76023519|FG004|Week 24 to Week 63|Adverse Event|6|||
42209244|NCT04512001|76023515|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
42209245|NCT04512001|76023516|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
42209246|NCT04512001|76023517|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
42209247|NCT04512001|76023518|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
42209248|NCT04512001|76023519|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
42209249|NCT04512001|76023515|FG000|Week 24 to Week 63|Death|0|||
42209250|NCT04512001|76023516|FG001|Week 24 to Week 63|Death|0|||
42209251|NCT04512001|76023517|FG002|Week 24 to Week 63|Death|0|||
42209252|NCT04512001|76023518|FG003|Week 24 to Week 63|Death|1|||
42209253|NCT04512001|76023519|FG004|Week 24 to Week 63|Death|1|||
42209254|NCT04512001|76023515|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
42209255|NCT04512001|76023516|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
42209256|NCT04512001|76023517|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
42209257|NCT04512001|76023518|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
42209258|NCT04512001|76023519|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
42209259|NCT04512001|76023515|FG000|Week 24 to Week 63|Miscellaneous|0|||
42209260|NCT04512001|76023516|FG001|Week 24 to Week 63|Miscellaneous|0|||
42209261|NCT04512001|76023517|FG002|Week 24 to Week 63|Miscellaneous|3|||
42209262|NCT04512001|76023518|FG003|Week 24 to Week 63|Miscellaneous|2|||
42209263|NCT04512001|76023519|FG004|Week 24 to Week 63|Miscellaneous|1|||
42209264|NCT04447417|76023534|FG000|Overall Study|Withdrawal by Subject|1|||
42209265|NCT04447417|76023535|FG001|Overall Study|Withdrawal by Subject|0|||
42209266|NCT04447417|76023534|FG000|Overall Study|Failure to meet inclusion criteria|1|||
42209267|NCT04447417|76023535|FG001|Overall Study|Failure to meet inclusion criteria|0|||
42209268|NCT04447417|76023534|FG000|Overall Study|Lost to Follow-up|1|||
42209269|NCT04447417|76023535|FG001|Overall Study|Lost to Follow-up|0|||
42209270|NCT02787044|76023543|FG000|Overall Study|Lost to Follow-up|15|||
42209271|NCT02787044|76023544|FG001|Overall Study|Lost to Follow-up|19|||
42209272|NCT01345019|76023556|FG000|Blinded Treatment Phase|Death|147|||
42209273|NCT01345019|76023557|FG001|Blinded Treatment Phase|Death|137|||
42209274|NCT01345019|76023556|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
42209275|NCT01345019|76023557|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
42209276|NCT01345019|76023556|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
42209277|NCT01345019|76023557|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
42209278|NCT01345019|76023556|FG000|Blinded Treatment Phase|Disease Progression|12|||
42209279|NCT01345019|76023557|FG001|Blinded Treatment Phase|Disease Progression|10|||
42209280|NCT01345019|76023556|FG000|Blinded Treatment Phase|Adverse Event|6|||
42209281|NCT01345019|76023557|FG001|Blinded Treatment Phase|Adverse Event|13|||
42209282|NCT01345019|76023556|FG000|Blinded Treatment Phase|Administrative Decision|10|||
42209283|NCT01345019|76023557|FG001|Blinded Treatment Phase|Administrative Decision|8|||
42209284|NCT01345019|76023556|FG000|Blinded Treatment Phase|Noncompliance|5|||
42209285|NCT01345019|76023557|FG001|Blinded Treatment Phase|Noncompliance|3|||
42209286|NCT01345019|76023556|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
42209287|NCT01345019|76023557|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
42209288|NCT01345019|76023556|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
42209289|NCT01345019|76023557|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
42209290|NCT01345019|76023556|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
42209291|NCT01345019|76023557|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
42209292|NCT01345019|76023556|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
42209293|NCT01345019|76023557|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
42209294|NCT01345019|76023556|FG000|Open Label Treatment Phase|Death|49|||
42209295|NCT01345019|76023557|FG001|Open Label Treatment Phase|Death|48|||
42209296|NCT01345019|76023556|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
42209297|NCT01345019|76023557|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
42209298|NCT01345019|76023556|FG000|Open Label Treatment Phase|Adverse Event|30|||
42209299|NCT01345019|76023557|FG001|Open Label Treatment Phase|Adverse Event|51|||
42209300|NCT01345019|76023556|FG000|Open Label Treatment Phase|Administrative Decision|30|||
42209301|NCT01345019|76023557|FG001|Open Label Treatment Phase|Administrative Decision|15|||
42209302|NCT01345019|76023556|FG000|Open Label Treatment Phase|Disease Progression|17|||
42209303|NCT01345019|76023557|FG001|Open Label Treatment Phase|Disease Progression|18|||
42209304|NCT01345019|76023556|FG000|Open Label Treatment Phase|Noncompliance|5|||
42209305|NCT01345019|76023557|FG001|Open Label Treatment Phase|Noncompliance|4|||
42209306|NCT01345019|76023556|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
42209307|NCT01345019|76023557|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
42209308|NCT01345019|76023556|FG000|Open Label Treatment Phase|Pregnancy|1|||
41929983|NCT04276051|75594786|FG000|Overall Study|Withdrawal by Subject|1|||
41929984|NCT04276051|75594787|FG001|Overall Study|Withdrawal by Subject|1|||
41929985|NCT00081770|75595047|FG000|Overall Study|Adverse Event|130|||
41929986|NCT00081770|75595048|FG001|Overall Study|Adverse Event|98|||
41929987|NCT00081770|75595049|FG002|Overall Study|Adverse Event|136|||
41929988|NCT00081770|75595047|FG000|Overall Study|Lack of Efficacy|262|||
41929989|NCT00081770|75595048|FG001|Overall Study|Lack of Efficacy|357|||
41929990|NCT00081770|75595049|FG002|Overall Study|Lack of Efficacy|211|||
41929991|NCT00081770|75595047|FG000|Overall Study|Lost to Follow-up|45|||
41929992|NCT00081770|75595048|FG001|Overall Study|Lost to Follow-up|34|||
41929993|NCT00081770|75595049|FG002|Overall Study|Lost to Follow-up|45|||
41929994|NCT00081770|75595047|FG000|Overall Study|Protocol Violation|15|||
41929995|NCT00081770|75595048|FG001|Overall Study|Protocol Violation|10|||
41929996|NCT00081770|75595049|FG002|Overall Study|Protocol Violation|10|||
41929997|NCT00081770|75595047|FG000|Overall Study|Withdrawal by Subject|45|||
41929998|NCT00081770|75595048|FG001|Overall Study|Withdrawal by Subject|40|||
41929999|NCT00081770|75595049|FG002|Overall Study|Withdrawal by Subject|42|||
41930000|NCT00081770|75595047|FG000|Overall Study|Did not meet protocol eligibility|2|||
41930001|NCT00081770|75595048|FG001|Overall Study|Did not meet protocol eligibility|0|||
41930002|NCT00081770|75595049|FG002|Overall Study|Did not meet protocol eligibility|3|||
41930003|NCT00081770|75595047|FG000|Overall Study|Administrative|1|||
41930004|NCT00081770|75595048|FG001|Overall Study|Administrative|0|||
41930005|NCT00081770|75595049|FG002|Overall Study|Administrative|1|||
41930006|NCT00081770|75595047|FG000|Overall Study|Other|2|||
41930007|NCT00081770|75595048|FG001|Overall Study|Other|7|||
41930008|NCT00081770|75595049|FG002|Overall Study|Other|8|||
41930009|NCT00081458|75595149|FG000|Overall Study|Adverse Event|1|||
41930010|NCT00081458|75595150|FG001|Overall Study|Adverse Event|5|||
41930011|NCT00081458|75595151|FG002|Overall Study|Adverse Event|2|||
41930012|NCT00081458|75595149|FG000|Overall Study|Withdrawal by Subject|0|||
41930013|NCT00081458|75595150|FG001|Overall Study|Withdrawal by Subject|3|||
41930014|NCT00081458|75595151|FG002|Overall Study|Withdrawal by Subject|1|||
41930015|NCT00081458|75595149|FG000|Overall Study|Randomized but not dosed|0|||
41930016|NCT00081458|75595150|FG001|Overall Study|Randomized but not dosed|0|||
41930017|NCT00081458|75595151|FG002|Overall Study|Randomized but not dosed|1|||
41930018|NCT01271803|75595228|FG000|Overall Study|Progressive disease|0|||
41930019|NCT01271803|75595229|FG001|Overall Study|Progressive disease|0|||
41930020|NCT01271803|75595230|FG002|Overall Study|Progressive disease|2|||
41930021|NCT01271803|75595228|FG000|Overall Study|Death|53|||
41930022|NCT01271803|75595229|FG001|Overall Study|Death|34|||
41930023|NCT01271803|75595230|FG002|Overall Study|Death|0|||
41930024|NCT01271803|75595228|FG000|Overall Study|Withdrawal by Subject|1|||
41930025|NCT01271803|75595229|FG001|Overall Study|Withdrawal by Subject|5|||
41930026|NCT01271803|75595230|FG002|Overall Study|Withdrawal by Subject|0|||
41930027|NCT01271803|75595228|FG000|Overall Study|Lost to Follow-up|1|||
41930028|NCT01271803|75595229|FG001|Overall Study|Lost to Follow-up|0|||
41930029|NCT01271803|75595230|FG002|Overall Study|Lost to Follow-up|0|||
41930030|NCT00080288|75595281|FG000|Overall Study|Adverse Event|7|||
41930031|NCT00080288|75595282|FG001|Overall Study|Adverse Event|4|||
41930032|NCT00080288|75595281|FG000|Overall Study|Lost to Follow-up|3|||
41930033|NCT00080288|75595282|FG001|Overall Study|Lost to Follow-up|5|||
41930034|NCT00080288|75595281|FG000|Overall Study|Physician Decision|6|||
41930035|NCT00080288|75595282|FG001|Overall Study|Physician Decision|2|||
41930036|NCT00080288|75595281|FG000|Overall Study|Withdrawal by Subject|3|||
41930037|NCT00080288|75595282|FG001|Overall Study|Withdrawal by Subject|16|||
41930038|NCT00080288|75595281|FG000|Overall Study|Miscellaneous|11|||
41930039|NCT00080288|75595282|FG001|Overall Study|Miscellaneous|11|||
41930040|NCT01271725|75595348|FG000|Part A|Progressive disease according to RECIST|8|||
41930041|NCT01271725|75595349|FG001|Part A|Progressive disease according to RECIST|0|||
41930042|NCT01271725|75595348|FG000|Part A|Clinical signs/symptoms of progression|2|||
41930043|NCT01271725|75595349|FG001|Part A|Clinical signs/symptoms of progression|0|||
41930044|NCT01271725|75595348|FG000|Part A|Other Adverse Event|8|||
41930045|NCT01271725|75595349|FG001|Part A|Other Adverse Event|0|||
41930046|NCT01271725|75595348|FG000|Part A|Lost to Follow-up|1|||
41930047|NCT01271725|75595349|FG001|Part A|Lost to Follow-up|0|||
41930048|NCT01271725|75595348|FG000|Part A|Withdrawal by Subject|12|||
41930049|NCT01271725|75595349|FG001|Part A|Withdrawal by Subject|0|||
42117696|NCT00117637|75928531|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
41930050|NCT01271725|75595348|FG000|Part A|Other than specified|3|||
41930051|NCT01271725|75595349|FG001|Part A|Other than specified|0|||
41930052|NCT01271725|75595348|FG000|Part A|Protocol Violation|1|||
41930053|NCT01271725|75595349|FG001|Part A|Protocol Violation|0|||
42117697|NCT00117637|75928532|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
41930054|NCT01271725|75595348|FG000|Part B|Other than specified|0|||
41930055|NCT01271725|75595349|FG001|Part B|Other than specified|2|||
41930056|NCT01271725|75595348|FG000|Part B|Clinical signs/symptoms of progression|0|||
41930057|NCT01271725|75595349|FG001|Part B|Clinical signs/symptoms of progression|2|||
41930058|NCT01271725|75595348|FG000|Part B|Other Adverse Event|0|||
41930059|NCT01271725|75595349|FG001|Part B|Other Adverse Event|1|||
41930060|NCT01271725|75595348|FG000|Part B|Protocol Violation|0|||
41930061|NCT01271725|75595349|FG001|Part B|Protocol Violation|1|||
41930062|NCT01271725|75595348|FG000|Part B|Withdrawal by Subject|0|||
41930063|NCT01271725|75595349|FG001|Part B|Withdrawal by Subject|6|||
41930064|NCT01270321|75595374|FG000|Overall Study|Death|3|||
41930065|NCT01270321|75595375|FG001|Overall Study|Death|1|||
41930066|NCT01270321|75595376|FG002|Overall Study|Death|4|||
41930067|NCT01270321|75595374|FG000|Overall Study|Adverse Event|7|||
41930068|NCT01270321|75595375|FG001|Overall Study|Adverse Event|9|||
41930069|NCT01270321|75595376|FG002|Overall Study|Adverse Event|5|||
41930070|NCT00249769|75595470|FG000|Overall Study|Withdrawal by Subject|1|||
41930071|NCT00249769|75595471|FG001|Overall Study|Withdrawal by Subject|10|||
41930072|NCT00249769|75595472|FG002|Overall Study|Withdrawal by Subject|6|||
41930073|NCT00249769|75595470|FG000|Overall Study|Migration from Study Area|1|||
41930074|NCT00249769|75595471|FG001|Overall Study|Migration from Study Area|3|||
41930075|NCT00249769|75595472|FG002|Overall Study|Migration from Study Area|14|||
41930076|NCT00249769|75595470|FG000|Overall Study|Miscellaneous|0|||
41930077|NCT00249769|75595471|FG001|Overall Study|Miscellaneous|2|||
41930078|NCT00249769|75595472|FG002|Overall Study|Miscellaneous|2|||
41930079|NCT00249769|75595470|FG000|Overall Study|Adverse Event|0|||
41930080|NCT00249769|75595471|FG001|Overall Study|Adverse Event|0|||
41930081|NCT00249769|75595472|FG002|Overall Study|Adverse Event|1|||
41930082|NCT00249769|75595470|FG000|Overall Study|Physician Decision|0|||
41930083|NCT00249769|75595471|FG001|Overall Study|Physician Decision|0|||
41930084|NCT00249769|75595472|FG002|Overall Study|Physician Decision|2|||
41930085|NCT00249769|75595470|FG000|Overall Study|Lost to Follow-up|0|||
41930086|NCT00249769|75595471|FG001|Overall Study|Lost to Follow-up|0|||
41930087|NCT00249769|75595472|FG002|Overall Study|Lost to Follow-up|3|||
41930088|NCT00249613|75595482|FG000|12 Month Follow-up|Death|1|||
41930089|NCT00249613|75595483|FG001|12 Month Follow-up|Death|1|||
41930090|NCT00249613|75595482|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
41930091|NCT00249613|75595483|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
41930092|NCT00249613|75595482|FG000|12 Month Follow-up|Lost to Follow-up|10|||
41930093|NCT00249613|75595483|FG001|12 Month Follow-up|Lost to Follow-up|8|||
41930094|NCT00248833|75595519|FG000|Overall Study|Adverse Event|2|||
41930095|NCT00248833|75595520|FG001|Overall Study|Adverse Event|0|||
41930096|NCT00248833|75595521|FG002|Overall Study|Adverse Event|0|||
41930097|NCT00248833|75595519|FG000|Overall Study|Withdrawal by Subject|0|||
41930098|NCT00248833|75595520|FG001|Overall Study|Withdrawal by Subject|1|||
41930099|NCT00248833|75595521|FG002|Overall Study|Withdrawal by Subject|1|||
41930100|NCT00248833|75595519|FG000|Overall Study|Lost to Follow-up|1|||
41930101|NCT00248833|75595520|FG001|Overall Study|Lost to Follow-up|1|||
41930102|NCT00248833|75595521|FG002|Overall Study|Lost to Follow-up|1|||
41930103|NCT00248833|75595519|FG000|Overall Study|Other|0|||
41930104|NCT00248833|75595520|FG001|Overall Study|Other|1|||
41930105|NCT00248833|75595521|FG002|Overall Study|Other|0|||
41930106|NCT00247273|75595683|FG000|Overall Study|Adverse Event|85|||
41930107|NCT00247273|75595684|FG001|Overall Study|Adverse Event|80|||
41930108|NCT00247273|75595683|FG000|Overall Study|Physician Decision|6|||
41930109|NCT00247273|75595684|FG001|Overall Study|Physician Decision|3|||
41930110|NCT00247273|75595683|FG000|Overall Study|Lost to Follow-up|7|||
41930111|NCT00247273|75595684|FG001|Overall Study|Lost to Follow-up|7|||
41930112|NCT00247273|75595683|FG000|Overall Study|Withdrawal by Subject|46|||
41930113|NCT00247273|75595684|FG001|Overall Study|Withdrawal by Subject|47|||
41930114|NCT00247273|75595683|FG000|Overall Study|Did not take any study drug|2|||
41930115|NCT00247273|75595684|FG001|Overall Study|Did not take any study drug|0|||
41930116|NCT00246259|75595772|FG000|Overall Study|Other|3|||
41930117|NCT00246259|75595773|FG001|Overall Study|Other|3|||
41930118|NCT00246259|75595772|FG000|Overall Study|Not stable by Week 18|2|||
41930119|NCT00246259|75595773|FG001|Overall Study|Not stable by Week 18|1|||
41930120|NCT00246259|75595772|FG000|Overall Study|Participant non-compliant|4|||
41930121|NCT00246259|75595773|FG001|Overall Study|Participant non-compliant|9|||
41930122|NCT00246259|75595772|FG000|Overall Study|Lack of Efficacy|2|||
41930123|NCT00246259|75595773|FG001|Overall Study|Lack of Efficacy|2|||
41930124|NCT00246259|75595772|FG000|Overall Study|Investigator withdrew participant|2|||
41930125|NCT00246259|75595773|FG001|Overall Study|Investigator withdrew participant|0|||
41930126|NCT00246259|75595772|FG000|Overall Study|Adverse Event|5|||
42117698|NCT00117637|75928531|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
41930127|NCT00246259|75595773|FG001|Overall Study|Adverse Event|0|||
41930128|NCT00246259|75595772|FG000|Overall Study|Lost to Follow-up|3|||
41930129|NCT00246259|75595773|FG001|Overall Study|Lost to Follow-up|4|||
41930130|NCT00246259|75595772|FG000|Overall Study|Withdrawal by Subject|5|||
41930131|NCT00246259|75595773|FG001|Overall Study|Withdrawal by Subject|1|||
41930132|NCT00246259|75595772|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
41930133|NCT00246259|75595773|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
41930134|NCT00246025|75595825|FG000|Overall Study|Adverse Event|7|||
41930135|NCT00246025|75595826|FG001|Overall Study|Adverse Event|9|||
41930136|NCT00246025|75595827|FG002|Overall Study|Adverse Event|9|||
41930137|NCT00246025|75595828|FG003|Overall Study|Adverse Event|10|||
41930138|NCT00246025|75595825|FG000|Overall Study|Withdrawal by Subject|3|||
41930139|NCT00246025|75595826|FG001|Overall Study|Withdrawal by Subject|0|||
41930140|NCT00246025|75595827|FG002|Overall Study|Withdrawal by Subject|1|||
41930141|NCT00246025|75595828|FG003|Overall Study|Withdrawal by Subject|2|||
41930142|NCT00246025|75595825|FG000|Overall Study|unsuitable medical history was found|0|||
41930143|NCT00246025|75595826|FG001|Overall Study|unsuitable medical history was found|0|||
41930144|NCT00246025|75595827|FG002|Overall Study|unsuitable medical history was found|0|||
41930145|NCT00246025|75595828|FG003|Overall Study|unsuitable medical history was found|1|||
41930146|NCT00245011|75595958|FG000|Overall Study|Lack of Efficacy|1|||
41930147|NCT00244855|75595977|FG000|Overall Study|Withdrawal by Subject|0|||
41930148|NCT00244855|75595978|FG001|Overall Study|Withdrawal by Subject|1|||
41930149|NCT00244621|75596008|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
41930150|NCT00244621|75596009|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
41930151|NCT00244621|75596010|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
41930152|NCT00244621|75596008|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
41930153|NCT00244621|75596009|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
41930154|NCT00244621|75596010|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
41930155|NCT00244621|75596008|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
41930156|NCT00244621|75596009|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
41930157|NCT00244621|75596010|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
41930158|NCT00244621|75596008|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
41930159|NCT00244621|75596009|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
41930160|NCT00244621|75596010|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
41930161|NCT00244621|75596008|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
41930162|NCT00244621|75596009|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
41930163|NCT00244621|75596010|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
41930164|NCT00244621|75596008|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
41930165|NCT00244621|75596009|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
41930166|NCT00244621|75596010|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
41930167|NCT00244621|75596008|FG000|Open-label Treatment Period|Adverse Event|0|||
41930168|NCT00244621|75596009|FG001|Open-label Treatment Period|Adverse Event|0|||
41930169|NCT00244621|75596010|FG002|Open-label Treatment Period|Adverse Event|1|||
41930170|NCT00244621|75596008|FG000|Open-label Treatment Period|Moved abroad|0|||
41930171|NCT00244621|75596009|FG001|Open-label Treatment Period|Moved abroad|0|||
41930172|NCT00244621|75596010|FG002|Open-label Treatment Period|Moved abroad|1|||
41930173|NCT00243841|75596093|FG000|Overall Study|Physician Decision|0|||
41930174|NCT00243841|75596094|FG001|Overall Study|Physician Decision|0|||
41930175|NCT00243841|75596095|FG002|Overall Study|Physician Decision|1|||
41930176|NCT00243841|75596096|FG003|Overall Study|Physician Decision|0|||
41930177|NCT00243841|75596097|FG004|Overall Study|Physician Decision|0|||
41930178|NCT00243841|75596098|FG005|Overall Study|Physician Decision|2|||
41930179|NCT02980731|75596291|FG000|Overall Study|Death|63|||
41930180|NCT02980731|75596291|FG000|Overall Study|Withdrawal by Subject|6|||
41930181|NCT02980731|75596291|FG000|Overall Study|Lost to Follow-up|5|||
41930182|NCT02980731|75596291|FG000|Overall Study|Study terminated by Sponsor|4|||
41930183|NCT02980731|75596291|FG000|Overall Study|Completed survival follow-up period|65|||
41930184|NCT02980731|75596291|FG000|Overall Study|COVID-19 infection|1|||
41930185|NCT02980731|75596291|FG000|Overall Study|Other, not specified|66|||
41930186|NCT02641587|75596331|FG000|Confinement Period|Adverse Event|1|||
41930187|NCT02641587|75596332|FG001|Confinement Period|Adverse Event|0|||
41930188|NCT02641587|75596331|FG000|Confinement Period|Withdrawal by Subject|2|||
41930189|NCT02641587|75596332|FG001|Confinement Period|Withdrawal by Subject|1|||
41930190|NCT02641587|75596331|FG000|Ambulatory Period|Withdrawal by Subject|1|||
41930191|NCT02641587|75596332|FG001|Ambulatory Period|Withdrawal by Subject|0|||
41930192|NCT04672083|75596439|FG000|Overall Study|Lost to Follow-up|1|||
41930193|NCT04672083|75596440|FG001|Overall Study|Lost to Follow-up|0|||
41930194|NCT04672083|75596441|FG002|Overall Study|Lost to Follow-up|0|||
41930195|NCT04672083|75596442|FG003|Overall Study|Lost to Follow-up|0|||
41930196|NCT04672083|75596443|FG004|Overall Study|Lost to Follow-up|0|||
41930197|NCT01781637|75596546|FG000|Overall Study|Adverse Event|1|||
41930198|NCT01781637|75596547|FG001|Overall Study|Adverse Event|0|||
41930199|NCT01781637|75596546|FG000|Overall Study|Lack of Efficacy|2|||
41930200|NCT01781637|75596547|FG001|Overall Study|Lack of Efficacy|6|||
41930201|NCT01781637|75596546|FG000|Overall Study|Withdrawal by Subject|1|||
41930202|NCT01781637|75596547|FG001|Overall Study|Withdrawal by Subject|0|||
41930203|NCT04575584|75596936|FG000|Overall Study|Death|6|||
41930204|NCT04575584|75596937|FG001|Overall Study|Death|4|||
41930205|NCT04575584|75596938|FG002|Overall Study|Death|6|||
41930206|NCT04575584|75596939|FG003|Overall Study|Death|2|||
41930207|NCT04575584|75596940|FG004|Overall Study|Death|0|||
41930208|NCT04575584|75596941|FG005|Overall Study|Death|0|||
41930209|NCT04575584|75596936|FG000|Overall Study|Lost to Follow-up|1|||
41930210|NCT04575584|75596937|FG001|Overall Study|Lost to Follow-up|1|||
41930211|NCT04575584|75596938|FG002|Overall Study|Lost to Follow-up|1|||
41930212|NCT04575584|75596939|FG003|Overall Study|Lost to Follow-up|1|||
41930213|NCT04575584|75596940|FG004|Overall Study|Lost to Follow-up|0|||
41930214|NCT04575584|75596941|FG005|Overall Study|Lost to Follow-up|0|||
41930215|NCT04575584|75596936|FG000|Overall Study|Physician Decision|0|||
41930216|NCT04575584|75596937|FG001|Overall Study|Physician Decision|1|||
41930217|NCT04575584|75596938|FG002|Overall Study|Physician Decision|1|||
41930218|NCT04575584|75596939|FG003|Overall Study|Physician Decision|1|||
41930219|NCT04575584|75596940|FG004|Overall Study|Physician Decision|0|||
41930220|NCT04575584|75596941|FG005|Overall Study|Physician Decision|0|||
41930221|NCT04575584|75596936|FG000|Overall Study|Withdrawal by Subject|7|||
41930222|NCT04575584|75596937|FG001|Overall Study|Withdrawal by Subject|9|||
41930223|NCT04575584|75596938|FG002|Overall Study|Withdrawal by Subject|5|||
41930224|NCT04575584|75596939|FG003|Overall Study|Withdrawal by Subject|3|||
41930225|NCT04575584|75596940|FG004|Overall Study|Withdrawal by Subject|0|||
41930226|NCT04575584|75596941|FG005|Overall Study|Withdrawal by Subject|0|||
41930227|NCT04575584|75596936|FG000|Overall Study|Not recorded|0|||
41930228|NCT04575584|75596937|FG001|Overall Study|Not recorded|0|||
41930229|NCT04575584|75596938|FG002|Overall Study|Not recorded|0|||
41930230|NCT04575584|75596939|FG003|Overall Study|Not recorded|1|||
41930231|NCT04575584|75596940|FG004|Overall Study|Not recorded|0|||
41930232|NCT04575584|75596941|FG005|Overall Study|Not recorded|0|||
41930233|NCT03721965|75596980|FG000|Overall Study|Death|1|||
41930234|NCT03721965|75596980|FG000|Overall Study|Study Terminated by Sponsor|1|||
41930235|NCT03873116|75597036|FG000|Overall Study|Study drug discontinuation due to rash|0|||
41930236|NCT03873116|75597037|FG001|Overall Study|Study drug discontinuation due to rash|0|||
41930237|NCT03873116|75597038|FG002|Overall Study|Study drug discontinuation due to rash|1|||
41930238|NCT03686384|75597486|FG000|Overall Study|Lack of Efficacy|4|||
41930239|NCT03686384|75597487|FG001|Overall Study|Lack of Efficacy|13|||
41930240|NCT03686384|75597486|FG000|Overall Study|Lost to Follow-up|3|||
41930241|NCT03686384|75597487|FG001|Overall Study|Lost to Follow-up|0|||
41930242|NCT03686384|75597486|FG000|Overall Study|Physician Decision|0|||
41930243|NCT03686384|75597487|FG001|Overall Study|Physician Decision|1|||
41930244|NCT03686384|75597486|FG000|Overall Study|Took prohibited medication|0|||
41930245|NCT03686384|75597487|FG001|Overall Study|Took prohibited medication|1|||
41930246|NCT00240331|75597559|FG000|Overall Study|Withdrawal by Subject|125|||
41930247|NCT00240331|75597560|FG001|Overall Study|Withdrawal by Subject|132|||
41930248|NCT00240331|75597559|FG000|Overall Study|Option selected by investigator|1|||
41930249|NCT00240331|75597560|FG001|Overall Study|Option selected by investigator|2|||
41930250|NCT00240097|75597566|FG000|Part I|Adverse Event|1|||
41930251|NCT00240097|75597566|FG000|Part I|Death|1|||
41930252|NCT00240097|75597566|FG000|Part I|histology|1|||
41930253|NCT00240097|75597566|FG000|Part I|unevaluable|1|||
42209309|NCT01345019|76023557|FG001|Open Label Treatment Phase|Pregnancy|0|||
42209310|NCT01345019|76023556|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
42209311|NCT01345019|76023557|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
42209312|NCT01345019|76023556|FG000|Open Label Treatment Phase|Protocol Violation|0|||
42209313|NCT01345019|76023557|FG001|Open Label Treatment Phase|Protocol Violation|1|||
42209314|NCT04507867|76023567|FG000|Overall Study|Death|7|||
42209315|NCT04507867|76023568|FG001|Overall Study|Death|1|||
42209316|NCT03069716|76023592|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
42209317|NCT03069716|76023593|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
42209318|NCT03069716|76023594|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
42209319|NCT03069716|76023592|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
42209320|NCT03069716|76023593|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
41930254|NCT00240097|75597566|FG000|Part II|did not continue from Part I|23|||
41930255|NCT03620162|75597657|FG000|Overall Study|Physician Decision|4|||
41930256|NCT03620162|75597658|FG001|Overall Study|Physician Decision|0|||
42209321|NCT03069716|76023594|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
41930257|NCT03620162|75597659|FG002|Overall Study|Physician Decision|1|||
41930258|NCT03620162|75597660|FG003|Overall Study|Physician Decision|0|||
41930259|NCT03620162|75597661|FG004|Overall Study|Physician Decision|2|||
41930260|NCT03620162|75597657|FG000|Overall Study|Lost to Follow-up|2|||
41930261|NCT03620162|75597658|FG001|Overall Study|Lost to Follow-up|6|||
41930262|NCT03620162|75597659|FG002|Overall Study|Lost to Follow-up|7|||
41930263|NCT03620162|75597660|FG003|Overall Study|Lost to Follow-up|3|||
41930264|NCT03620162|75597661|FG004|Overall Study|Lost to Follow-up|2|||
41930265|NCT03620162|75597657|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
41930266|NCT03620162|75597658|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
41930267|NCT03620162|75597659|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
41930268|NCT03620162|75597660|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
41930269|NCT03620162|75597661|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
41930270|NCT03084302|75597802|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
41930271|NCT03084302|75597802|FG000|Overall Study|No valid objective monitor data|6|||
41930272|NCT01279681|75597944|FG000|Overall Study|Disease Progression|9|||
41930273|NCT01279681|75597945|FG001|Overall Study|Disease Progression|6|||
41930274|NCT01279681|75597944|FG000|Overall Study|Withdrawal by Subject|3|||
41930275|NCT01279681|75597945|FG001|Overall Study|Withdrawal by Subject|4|||
41930276|NCT01279681|75597944|FG000|Overall Study|Adverse Event|2|||
41930277|NCT01279681|75597945|FG001|Overall Study|Adverse Event|3|||
41930278|NCT01279681|75597944|FG000|Overall Study|Death|0|||
41930279|NCT01279681|75597945|FG001|Overall Study|Death|1|||
41930280|NCT01279681|75597944|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
41930281|NCT01279681|75597945|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
41930282|NCT01279681|75597944|FG000|Overall Study|Physician Decision|1|||
41930283|NCT01279681|75597945|FG001|Overall Study|Physician Decision|0|||
41930284|NCT01279681|75597944|FG000|Overall Study|Other Reason|0|||
41930285|NCT01279681|75597945|FG001|Overall Study|Other Reason|2|||
41930286|NCT01279057|75597963|FG000|Overall Study|Adverse Event|1|||
41930287|NCT01279057|75597964|FG001|Overall Study|Adverse Event|0|||
41930288|NCT01279057|75597965|FG002|Overall Study|Adverse Event|1|||
41930289|NCT01279057|75597963|FG000|Overall Study|Insufficient therapeutic response|0|||
41930290|NCT01279057|75597964|FG001|Overall Study|Insufficient therapeutic response|0|||
41930291|NCT01279057|75597965|FG002|Overall Study|Insufficient therapeutic response|1|||
41930292|NCT01279057|75597963|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
41930293|NCT01279057|75597964|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
41930294|NCT01279057|75597965|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
41930295|NCT01279057|75597963|FG000|Overall Study|Withdrew consent|2|||
41930296|NCT01279057|75597964|FG001|Overall Study|Withdrew consent|0|||
41930297|NCT01279057|75597965|FG002|Overall Study|Withdrew consent|1|||
41930298|NCT01279057|75597963|FG000|Overall Study|Pregnancy|0|||
41930299|NCT01279057|75597964|FG001|Overall Study|Pregnancy|1|||
41930300|NCT01279057|75597965|FG002|Overall Study|Pregnancy|0|||
41930301|NCT01279057|75597963|FG000|Overall Study|Other|3|||
41930302|NCT01279057|75597964|FG001|Overall Study|Other|3|||
41930303|NCT01279057|75597965|FG002|Overall Study|Other|0|||
41930304|NCT02999633|75597973|FG000|Overall Study|Adverse Event|2|||
41930305|NCT02999633|75597973|FG000|Overall Study|Progressive disease|12|||
41930306|NCT01278745|75598075|FG000|Overall Study|Death|2|||
41930307|NCT01278745|75598076|FG001|Overall Study|Death|5|||
41930308|NCT01278745|75598077|FG002|Overall Study|Death|7|||
41930309|NCT01278745|75598078|FG003|Overall Study|Death|0|||
41930310|NCT01278745|75598075|FG000|Overall Study|Physician Decision|1|||
41930311|NCT01278745|75598076|FG001|Overall Study|Physician Decision|0|||
41930312|NCT01278745|75598077|FG002|Overall Study|Physician Decision|0|||
41930313|NCT01278745|75598078|FG003|Overall Study|Physician Decision|9|||
41930314|NCT01278745|75598075|FG000|Overall Study|Withdrawal by Subject|1|||
41930315|NCT01278745|75598076|FG001|Overall Study|Withdrawal by Subject|1|||
41930316|NCT01278745|75598077|FG002|Overall Study|Withdrawal by Subject|5|||
41930317|NCT01278745|75598078|FG003|Overall Study|Withdrawal by Subject|1|||
41930318|NCT01278745|75598075|FG000|Overall Study|Sponsor Decision|1|||
41930319|NCT01278745|75598076|FG001|Overall Study|Sponsor Decision|0|||
41930320|NCT01278745|75598077|FG002|Overall Study|Sponsor Decision|62|||
41930321|NCT01278745|75598078|FG003|Overall Study|Sponsor Decision|6|||
41930322|NCT01278745|75598075|FG000|Overall Study|Ineligible|0|||
42209322|NCT03069716|76023592|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
42209323|NCT03069716|76023593|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
41930323|NCT01278745|75598076|FG001|Overall Study|Ineligible|0|||
41930324|NCT01278745|75598077|FG002|Overall Study|Ineligible|42|||
41930325|NCT01278745|75598078|FG003|Overall Study|Ineligible|61|||
41930326|NCT01278745|75598075|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
41930327|NCT01278745|75598076|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
41930328|NCT01278745|75598077|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
41930329|NCT01278745|75598078|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
41930330|NCT01277887|75598140|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
41930331|NCT01277887|75598141|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
41930332|NCT01277887|75598140|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
41930333|NCT01277887|75598141|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
41930334|NCT01277887|75598140|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
42010365|NCT01290068|75817492|FG001|Overall Study|Lost to Follow-up|0|||
41930335|NCT01277887|75598141|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
41930336|NCT01276327|75598155|FG000|Overall Study|Adverse Event|1|||
41930337|NCT01276327|75598156|FG001|Overall Study|Adverse Event|3|||
41930338|NCT01276327|75598155|FG000|Overall Study|Withdrawal by Subject|1|||
41930339|NCT01276327|75598156|FG001|Overall Study|Withdrawal by Subject|0|||
41930340|NCT00639002|75598278|FG000|Overall Study|Death|1|||
41930341|NCT00639002|75598278|FG000|Overall Study|Adverse Event|1|||
41930342|NCT00639002|75598278|FG000|Overall Study|Protocol Violation|1|||
41930343|NCT00639002|75598278|FG000|Overall Study|Disease progression|3|||
41930344|NCT00639002|75598278|FG000|Overall Study|Physician Decision|6|||
41930345|NCT00639002|75598278|FG000|Overall Study|Lack of Efficacy|1|||
41930346|NCT00638846|75598314|FG000|Overall Study|Adverse Event|0|||
41930347|NCT00638846|75598315|FG001|Overall Study|Adverse Event|1|||
41930348|NCT00638846|75598314|FG000|Overall Study|Lost to Follow-up|3|||
41930349|NCT00638846|75598315|FG001|Overall Study|Lost to Follow-up|2|||
41930350|NCT00638846|75598314|FG000|Overall Study|lens issue|1|||
41930351|NCT00638846|75598315|FG001|Overall Study|lens issue|3|||
41930352|NCT00638456|75598323|FG000|Overall Study|Withdrawal by Subject|6|||
41930353|NCT00638456|75598324|FG001|Overall Study|Withdrawal by Subject|2|||
41930354|NCT00638378|75598353|FG000|Overall Study|Death|2|||
41930355|NCT00638378|75598353|FG000|Overall Study|Adverse Event|1|||
41930356|NCT00638378|75598353|FG000|Overall Study|Disease progression|15|||
41930357|NCT00638378|75598353|FG000|Overall Study|Physician Decision|4|||
41930358|NCT03807349|75598530|FG000|Overall Study|Early Study Termination|9|||
41930359|NCT03802825|75598540|FG000|Overall Study|Lost to follow-up for intervention|12|||
41930360|NCT03802825|75598541|FG001|Overall Study|Lost to follow-up for intervention|3|||
41930361|NCT03802825|75598540|FG000|Overall Study|Received only 1 component of intervention|0|||
41930362|NCT03802825|75598541|FG001|Overall Study|Received only 1 component of intervention|13|||
41930363|NCT03808909|75598560|FG000|Overall Study|Lost to Follow-up|3|||
41930364|NCT03808909|75598561|FG001|Overall Study|Lost to Follow-up|0|||
41930365|NCT03802513|75598582|FG000|Overall Study|Lost to Follow-up|1|||
41930366|NCT01276223|75598773|FG000|Overall Study|Adverse Event|7|||
41930367|NCT01276223|75598774|FG001|Overall Study|Adverse Event|4|||
41930368|NCT01276223|75598775|FG002|Overall Study|Adverse Event|1|||
41930369|NCT01276223|75598773|FG000|Overall Study|Lost to Follow-up|0|||
41930370|NCT01276223|75598774|FG001|Overall Study|Lost to Follow-up|0|||
41930371|NCT01276223|75598775|FG002|Overall Study|Lost to Follow-up|1|||
41930372|NCT01276223|75598773|FG000|Overall Study|Other|0|||
41930373|NCT01276223|75598774|FG001|Overall Study|Other|0|||
41930374|NCT01276223|75598775|FG002|Overall Study|Other|1|||
41930375|NCT01276223|75598773|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
41930376|NCT01276223|75598774|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
41930377|NCT01276223|75598775|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
41930378|NCT01276223|75598773|FG000|Overall Study|Protocol Violation|1|||
41930379|NCT01276223|75598774|FG001|Overall Study|Protocol Violation|0|||
41930380|NCT01276223|75598775|FG002|Overall Study|Protocol Violation|0|||
41930381|NCT01275833|75598784|FG000|Overall Study|Study terminated|1|||
41930382|NCT01275833|75598785|FG001|Overall Study|Study terminated|1|||
41930383|NCT01275755|75598793|FG000|Double-blind Treatment Period|Adverse Event|0|||
41930384|NCT01275755|75598794|FG001|Double-blind Treatment Period|Adverse Event|2|||
41930385|NCT01275755|75598793|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
41930386|NCT01275755|75598794|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
41930387|NCT01275755|75598793|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
41930388|NCT01275755|75598794|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
41930389|NCT01275755|75598793|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
41930390|NCT01275755|75598794|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
41930391|NCT01275131|75598825|FG000|Period 1|Withdrawal by Subject|1|||
41930392|NCT01275131|75598826|FG001|Period 1|Withdrawal by Subject|0|||
41930393|NCT01275131|75598827|FG002|Period 1|Withdrawal by Subject|3|||
41930394|NCT01275131|75598828|FG003|Period 1|Withdrawal by Subject|2|||
41930395|NCT01275131|75598825|FG000|Period 1|Physician Decision|1|||
41930396|NCT01275131|75598826|FG001|Period 1|Physician Decision|0|||
41930397|NCT01275131|75598827|FG002|Period 1|Physician Decision|0|||
41930398|NCT01275131|75598828|FG003|Period 1|Physician Decision|0|||
41930399|NCT01275131|75598825|FG000|Period 2 (Crossover)|Adverse Event|0|||
41930400|NCT01275131|75598826|FG001|Period 2 (Crossover)|Adverse Event|1|||
41930401|NCT01275131|75598827|FG002|Period 2 (Crossover)|Adverse Event|0|||
41930402|NCT01275131|75598828|FG003|Period 2 (Crossover)|Adverse Event|0|||
41930403|NCT01275131|75598825|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
41930404|NCT01275131|75598826|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
41930405|NCT01275131|75598827|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
41930406|NCT01275131|75598828|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
41930407|NCT01274429|75598857|FG000|Overall Study|Study closed do to lack of funding|5|||
41930408|NCT01273883|75598861|FG000|First Intervention|Adverse Event|2|||
41930409|NCT01273883|75598862|FG001|First Intervention|Adverse Event|1|||
41930410|NCT01273883|75598861|FG000|Second Intervention|Lost to Follow-up|1|||
41930411|NCT01273883|75598862|FG001|Second Intervention|Lost to Follow-up|1|||
41930412|NCT01273883|75598861|FG000|Second Intervention|Lack of Efficacy|1|||
41930413|NCT01273883|75598862|FG001|Second Intervention|Lack of Efficacy|0|||
41930414|NCT01273805|75598870|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
41930415|NCT01273805|75598871|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
41930416|NCT01273181|75598881|FG000|Phase I, Dose 1|Study termination|1|||
41930417|NCT01273181|75598882|FG001|Phase I, Dose 1|Study termination|0|||
41930418|NCT01273181|75598883|FG002|Phase I, Dose 1|Study termination|0|||
41930419|NCT01273181|75598884|FG003|Phase I, Dose 1|Study termination|0|||
41930420|NCT01273181|75598881|FG000|Phase I, Dose 2|Death during treatment|0|||
41930421|NCT01273181|75598882|FG001|Phase I, Dose 2|Death during treatment|1|||
41930422|NCT01273181|75598883|FG002|Phase I, Dose 2|Death during treatment|0|||
41930423|NCT01273181|75598884|FG003|Phase I, Dose 2|Death during treatment|0|||
41930424|NCT01273181|75598881|FG000|Phase 2, Dose 1|Study termination|0|||
41930425|NCT01273181|75598882|FG001|Phase 2, Dose 1|Study termination|0|||
41930426|NCT01273181|75598883|FG002|Phase 2, Dose 1|Study termination|1|||
41930427|NCT01273181|75598884|FG003|Phase 2, Dose 1|Study termination|0|||
41930428|NCT01273181|75598881|FG000|Phase 2, Dose 2|Death during treatment|0|||
41930429|NCT01273181|75598882|FG001|Phase 2, Dose 2|Death during treatment|0|||
41930430|NCT01273181|75598883|FG002|Phase 2, Dose 2|Death during treatment|0|||
41930431|NCT01273181|75598884|FG003|Phase 2, Dose 2|Death during treatment|1|||
41930432|NCT01272947|75598900|FG000|Overall Study|Abnormal Laboratory Value|2|||
41930433|NCT01272947|75598901|FG001|Overall Study|Abnormal Laboratory Value|2|||
41930434|NCT01279343|75598909|FG000|Overall Study|Did not receive treatment|2|||
41930435|NCT01279343|75598910|FG001|Overall Study|Did not receive treatment|6|||
41930436|NCT01278797|75598916|FG000|Period 1|Adverse Event|0|||
41930437|NCT01278797|75598917|FG001|Period 1|Adverse Event|1|||
41930438|NCT01278797|75598916|FG000|Period 1|Protocol Violation|1|||
41930439|NCT01278797|75598917|FG001|Period 1|Protocol Violation|0|||
41930440|NCT01272869|75598925|FG000|Period 2 (14 Days)|Adverse Event|1|||
41930441|NCT01272869|75598926|FG001|Period 2 (14 Days)|Adverse Event|0|||
41930442|NCT01272635|75598934|FG000|Overall Study|Lost to Follow-up|31|||
41930443|NCT01272635|75598935|FG001|Overall Study|Lost to Follow-up|20|||
41930444|NCT01272635|75598936|FG002|Overall Study|Lost to Follow-up|31|||
41930445|NCT01272635|75598937|FG003|Overall Study|Lost to Follow-up|23|||
41930446|NCT01272011|75598948|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
41930447|NCT01272011|75598949|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
41930448|NCT01272011|75598950|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
41930449|NCT01270841|75598971|FG000|Overall Study|Adverse Event|0|||
41930450|NCT01270841|75598972|FG001|Overall Study|Adverse Event|1|||
41930451|NCT01270841|75598973|FG002|Overall Study|Adverse Event|0|||
41930452|NCT01270841|75598974|FG003|Overall Study|Adverse Event|3|||
42209324|NCT03069716|76023594|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
42209325|NCT03069716|76023592|FG000|Randomized Treatment|Withdrawal by Subject|0|||
42209326|NCT03069716|76023593|FG001|Randomized Treatment|Withdrawal by Subject|2|||
42209327|NCT03069716|76023594|FG002|Randomized Treatment|Withdrawal by Subject|0|||
42209328|NCT03693625|76023607|FG000|Overall Study|Adverse Event|2|||
42209329|NCT03693625|76023608|FG001|Overall Study|Adverse Event|0|||
42209330|NCT03693625|76023607|FG000|Overall Study|Study Terminated By Sponsor|20|||
42209331|NCT03693625|76023608|FG001|Overall Study|Study Terminated By Sponsor|7|||
42209332|NCT03693625|76023607|FG000|Overall Study|Withdrawal by Subject|1|||
42209333|NCT03693625|76023608|FG001|Overall Study|Withdrawal by Subject|1|||
42209334|NCT01265537|76023616|FG000|Overall Study|Adverse Event|2|||
42209335|NCT01265537|76023617|FG001|Overall Study|Adverse Event|1|||
41930453|NCT01270841|75598971|FG000|Overall Study|Withdrawal by Subject|3|||
41930454|NCT01270841|75598972|FG001|Overall Study|Withdrawal by Subject|2|||
41930455|NCT01270841|75598973|FG002|Overall Study|Withdrawal by Subject|3|||
41930456|NCT01270841|75598974|FG003|Overall Study|Withdrawal by Subject|3|||
41930457|NCT01270841|75598971|FG000|Overall Study|Lost to Follow-up|3|||
41930458|NCT01270841|75598972|FG001|Overall Study|Lost to Follow-up|1|||
41930459|NCT01270841|75598973|FG002|Overall Study|Lost to Follow-up|4|||
41930460|NCT01270841|75598974|FG003|Overall Study|Lost to Follow-up|2|||
41930461|NCT01270841|75598971|FG000|Overall Study|Physician Decision|0|||
41930462|NCT01270841|75598972|FG001|Overall Study|Physician Decision|1|||
41930463|NCT01270841|75598973|FG002|Overall Study|Physician Decision|0|||
41930464|NCT01270841|75598974|FG003|Overall Study|Physician Decision|0|||
41930465|NCT01270841|75598971|FG000|Overall Study|Did not qualify|6|||
41930466|NCT01270841|75598972|FG001|Overall Study|Did not qualify|3|||
41930467|NCT01270841|75598973|FG002|Overall Study|Did not qualify|4|||
41930468|NCT01270841|75598974|FG003|Overall Study|Did not qualify|5|||
42209336|NCT01265537|76023616|FG000|Overall Study|Physician Decision|0|||
41930469|NCT01270841|75598971|FG000|Overall Study|Protocol Violation|1|||
41930470|NCT01270841|75598972|FG001|Overall Study|Protocol Violation|5|||
41930471|NCT01270841|75598973|FG002|Overall Study|Protocol Violation|0|||
42209337|NCT01265537|76023617|FG001|Overall Study|Physician Decision|1|||
42209338|NCT04396639|76023623|FG000|Overall Study|Withdrawal by Subject|1|||
41930472|NCT01270841|75598974|FG003|Overall Study|Protocol Violation|0|||
41930473|NCT01270841|75598971|FG000|Overall Study|Enrolled in error|0|||
42209339|NCT04396639|76023623|FG000|Overall Study|Other|1|||
41930474|NCT01270841|75598972|FG001|Overall Study|Enrolled in error|1|||
41930475|NCT01270841|75598973|FG002|Overall Study|Enrolled in error|0|||
41930476|NCT01270841|75598974|FG003|Overall Study|Enrolled in error|0|||
41930477|NCT01270139|75598987|FG000|Overall Study|Adverse Event|8|||
41930478|NCT01270139|75598988|FG001|Overall Study|Adverse Event|17|||
41930479|NCT01270139|75598989|FG002|Overall Study|Adverse Event|18|||
41930480|NCT01270139|75598987|FG000|Overall Study|Lost to Follow-up|10|||
41930481|NCT01270139|75598988|FG001|Overall Study|Lost to Follow-up|9|||
41930482|NCT01270139|75598989|FG002|Overall Study|Lost to Follow-up|2|||
41930483|NCT01278407|75599007|FG000|Confirmatory Phase|Adverse Event|5|||
41930484|NCT01278407|75599008|FG001|Confirmatory Phase|Adverse Event|10|||
41930485|NCT01278407|75599009|FG002|Confirmatory Phase|Adverse Event|1|||
41930486|NCT01278407|75599010|FG003|Confirmatory Phase|Adverse Event|0|||
41930487|NCT01278407|75599011|FG004|Confirmatory Phase|Adverse Event|0|||
41930488|NCT01278407|75599007|FG000|Confirmatory Phase|Participant's Choice|3|||
41930489|NCT01278407|75599008|FG001|Confirmatory Phase|Participant's Choice|5|||
41930490|NCT01278407|75599009|FG002|Confirmatory Phase|Participant's Choice|3|||
41930491|NCT01278407|75599010|FG003|Confirmatory Phase|Participant's Choice|0|||
41930492|NCT01278407|75599011|FG004|Confirmatory Phase|Participant's Choice|0|||
41930493|NCT01278407|75599007|FG000|Confirmatory Phase|Other|1|||
41930494|NCT01278407|75599008|FG001|Confirmatory Phase|Other|1|||
41930495|NCT01278407|75599009|FG002|Confirmatory Phase|Other|2|||
41930496|NCT01278407|75599010|FG003|Confirmatory Phase|Other|0|||
41930497|NCT01278407|75599011|FG004|Confirmatory Phase|Other|0|||
41930498|NCT01278407|75599007|FG000|Extension Phase|Adverse Event|0|||
41930499|NCT01278407|75599008|FG001|Extension Phase|Adverse Event|0|||
41930500|NCT01278407|75599009|FG002|Extension Phase|Adverse Event|0|||
41930501|NCT01278407|75599010|FG003|Extension Phase|Adverse Event|7|||
41930502|NCT01278407|75599011|FG004|Extension Phase|Adverse Event|16|||
41930503|NCT01278407|75599007|FG000|Extension Phase|Participant's Choice|0|||
41930504|NCT01278407|75599008|FG001|Extension Phase|Participant's Choice|0|||
41930505|NCT01278407|75599009|FG002|Extension Phase|Participant's Choice|0|||
41930506|NCT01278407|75599010|FG003|Extension Phase|Participant's Choice|4|||
41930507|NCT01278407|75599011|FG004|Extension Phase|Participant's Choice|11|||
41930508|NCT01278407|75599007|FG000|Extension Phase|Other|0|||
41930509|NCT01278407|75599008|FG001|Extension Phase|Other|0|||
41930510|NCT01278407|75599009|FG002|Extension Phase|Other|0|||
41930511|NCT01278407|75599010|FG003|Extension Phase|Other|1|||
41930512|NCT01278407|75599011|FG004|Extension Phase|Other|3|||
41930513|NCT01278173|75599021|FG000|Overall Study|Lack of Efficacy|13|||
41930514|NCT01278173|75599021|FG000|Overall Study|Adverse Event|8|||
41930515|NCT01278173|75599021|FG000|Overall Study|Administrative or other reason|4|||
41930516|NCT01278173|75599021|FG000|Overall Study|Protocol Violation|1|||
41930517|NCT01278173|75599021|FG000|Overall Study|Withdrawal by Subject|1|||
41930518|NCT01277861|75599054|FG000|Overall Study|Physician Decision|2|||
41930519|NCT01277861|75599055|FG001|Overall Study|Physician Decision|2|||
41930520|NCT01277549|75599082|FG000|Overall Study|Failed to meet eligibility criteria|13|||
41930521|NCT01277549|75599083|FG001|Overall Study|Failed to meet eligibility criteria|9|||
41930522|NCT01277549|75599082|FG000|Overall Study|Withdrawal by Subject|1|||
41930523|NCT01277549|75599083|FG001|Overall Study|Withdrawal by Subject|3|||
41930524|NCT01277549|75599082|FG000|Overall Study|Protocol Violation|10|||
41930525|NCT01277549|75599083|FG001|Overall Study|Protocol Violation|1|||
41930526|NCT01277549|75599082|FG000|Overall Study|Physician Decision|2|||
41930527|NCT01277549|75599083|FG001|Overall Study|Physician Decision|1|||
41930528|NCT01276847|75599095|FG000|Overall Study|Withdrawal by Subject|1|||
41930529|NCT01276847|75599096|FG001|Overall Study|Withdrawal by Subject|0|||
41930530|NCT01276847|75599097|FG002|Overall Study|Withdrawal by Subject|0|||
41930531|NCT01276457|75599129|FG000|Core Study|Adverse Event|6|||
41930532|NCT01276457|75599130|FG001|Core Study|Adverse Event|3|||
41930533|NCT01276457|75599129|FG000|Core Study|Lost to Follow-up|1|||
41930534|NCT01276457|75599130|FG001|Core Study|Lost to Follow-up|2|||
41930535|NCT01276457|75599129|FG000|Core Study|Administrative problems|1|||
41930536|NCT01276457|75599130|FG001|Core Study|Administrative problems|1|||
41930537|NCT01276457|75599129|FG000|Core Study|Death|2|||
41930538|NCT01276457|75599130|FG001|Core Study|Death|2|||
41930539|NCT01276457|75599129|FG000|Core Study|Lack of Efficacy|3|||
41930540|NCT01276457|75599130|FG001|Core Study|Lack of Efficacy|12|||
41930541|NCT01276457|75599129|FG000|Extension Study|Lost to Follow-up|3|||
41930542|NCT01276457|75599130|FG001|Extension Study|Lost to Follow-up|0|||
41930543|NCT01276457|75599129|FG000|Extension Study|Death|0|||
41930544|NCT01276457|75599130|FG001|Extension Study|Death|1|||
41930545|NCT01276457|75599129|FG000|Extension Study|Lack of Efficacy|3|||
41930546|NCT01276457|75599130|FG001|Extension Study|Lack of Efficacy|1|||
41930547|NCT01276379|75599220|FG000|Overall Study|Screening failure|40|||
41930548|NCT03809663|75599516|FG000|Overall Study|Decision by sponsor|24|||
41930549|NCT03809663|75599517|FG001|Overall Study|Decision by sponsor|18|||
41930550|NCT03809663|75599518|FG002|Overall Study|Decision by sponsor|20|||
41930551|NCT03809663|75599519|FG003|Overall Study|Decision by sponsor|20|||
41930552|NCT03809663|75599520|FG004|Overall Study|Decision by sponsor|0|||
41930553|NCT03809663|75599521|FG005|Overall Study|Decision by sponsor|0|||
41930554|NCT03809663|75599516|FG000|Overall Study|Withdrawal by Subject|26|||
41930555|NCT03809663|75599517|FG001|Overall Study|Withdrawal by Subject|22|||
41930556|NCT03809663|75599518|FG002|Overall Study|Withdrawal by Subject|27|||
41930557|NCT03809663|75599519|FG003|Overall Study|Withdrawal by Subject|26|||
41930558|NCT03809663|75599520|FG004|Overall Study|Withdrawal by Subject|0|||
41930559|NCT03809663|75599521|FG005|Overall Study|Withdrawal by Subject|0|||
41930560|NCT03809663|75599516|FG000|Overall Study|Lost to Follow-up|1|||
41930561|NCT03809663|75599517|FG001|Overall Study|Lost to Follow-up|4|||
41930562|NCT03809663|75599518|FG002|Overall Study|Lost to Follow-up|1|||
41930563|NCT03809663|75599519|FG003|Overall Study|Lost to Follow-up|1|||
41930564|NCT03809663|75599520|FG004|Overall Study|Lost to Follow-up|0|||
41930565|NCT03809663|75599521|FG005|Overall Study|Lost to Follow-up|0|||
41930566|NCT00249821|75599583|FG000|Overall Study|Technical problem|0|||
41930567|NCT00249821|75599584|FG001|Overall Study|Technical problem|1|||
41930568|NCT00248651|75599659|FG000|Overall Study|Withdrawal by Subject|28|||
41930569|NCT00248651|75599660|FG001|Overall Study|Withdrawal by Subject|40|||
41930570|NCT00248651|75599661|FG002|Overall Study|Withdrawal by Subject|32|||
41930571|NCT00248495|75599698|FG000|Overall Study|Withdrawal by Subject|1|||
41930572|NCT03802565|75599795|FG000|Overall Study|Adverse Event|0|||
41930573|NCT03802565|75599796|FG001|Overall Study|Adverse Event|1|||
41930574|NCT03802565|75599797|FG002|Overall Study|Adverse Event|2|||
41930575|NCT03802565|75599798|FG003|Overall Study|Adverse Event|1|||
41930576|NCT03802565|75599799|FG004|Overall Study|Adverse Event|1|||
41930577|NCT03802565|75599795|FG000|Overall Study|Withdrawal by Subject|2|||
41930578|NCT03802565|75599796|FG001|Overall Study|Withdrawal by Subject|2|||
41930579|NCT03802565|75599797|FG002|Overall Study|Withdrawal by Subject|2|||
41930580|NCT03802565|75599798|FG003|Overall Study|Withdrawal by Subject|0|||
41930581|NCT03802565|75599799|FG004|Overall Study|Withdrawal by Subject|1|||
41930582|NCT03802565|75599795|FG000|Overall Study|Protocol Violation|2|||
41930583|NCT03802565|75599796|FG001|Overall Study|Protocol Violation|1|||
41930584|NCT03802565|75599797|FG002|Overall Study|Protocol Violation|4|||
41930585|NCT03802565|75599798|FG003|Overall Study|Protocol Violation|5|||
41930586|NCT03802565|75599799|FG004|Overall Study|Protocol Violation|1|||
41930587|NCT03802565|75599795|FG000|Overall Study|Lost to Follow-up|0|||
41930588|NCT03802565|75599796|FG001|Overall Study|Lost to Follow-up|0|||
41930589|NCT03802565|75599797|FG002|Overall Study|Lost to Follow-up|1|||
41930590|NCT03802565|75599798|FG003|Overall Study|Lost to Follow-up|0|||
41930591|NCT03802565|75599799|FG004|Overall Study|Lost to Follow-up|0|||
41930592|NCT03802565|75599795|FG000|Overall Study|Subjects Related to Each Other|1|||
41930593|NCT03802565|75599796|FG001|Overall Study|Subjects Related to Each Other|0|||
41930594|NCT03802565|75599797|FG002|Overall Study|Subjects Related to Each Other|0|||
41930595|NCT03802565|75599798|FG003|Overall Study|Subjects Related to Each Other|2|||
41930596|NCT03802565|75599799|FG004|Overall Study|Subjects Related to Each Other|1|||
41930597|NCT03802565|75599795|FG000|Overall Study|Elevated Enzymes|0|||
41930598|NCT03802565|75599796|FG001|Overall Study|Elevated Enzymes|0|||
41930599|NCT03802565|75599797|FG002|Overall Study|Elevated Enzymes|0|||
41930600|NCT03802565|75599798|FG003|Overall Study|Elevated Enzymes|0|||
41930601|NCT03802565|75599799|FG004|Overall Study|Elevated Enzymes|2|||
41930602|NCT00245765|75599843|FG000|Overall Study|Adverse Event|1|||
41930603|NCT00245765|75599844|FG001|Overall Study|Adverse Event|1|||
41930604|NCT00245765|75599845|FG002|Overall Study|Adverse Event|0|||
41930605|NCT00245765|75599843|FG000|Overall Study|Lack of Efficacy|14|||
41930606|NCT00245765|75599844|FG001|Overall Study|Lack of Efficacy|7|||
41930607|NCT00245765|75599845|FG002|Overall Study|Lack of Efficacy|0|||
41930608|NCT00245765|75599843|FG000|Overall Study|Lost to Follow-up|1|||
41930609|NCT00245765|75599844|FG001|Overall Study|Lost to Follow-up|2|||
41930610|NCT00245765|75599845|FG002|Overall Study|Lost to Follow-up|0|||
41930611|NCT00245765|75599843|FG000|Overall Study|Withdrawal by Subject|1|||
41930612|NCT00245765|75599844|FG001|Overall Study|Withdrawal by Subject|0|||
41930613|NCT00245765|75599845|FG002|Overall Study|Withdrawal by Subject|3|||
41930614|NCT00245765|75599843|FG000|Overall Study|Other reason|2|||
41930615|NCT00245765|75599844|FG001|Overall Study|Other reason|0|||
41930616|NCT00245765|75599845|FG002|Overall Study|Other reason|1|||
41930617|NCT00245765|75599843|FG000|Overall Study|Other|13|||
41930618|NCT00245765|75599844|FG001|Overall Study|Other|4|||
41930619|NCT00245765|75599845|FG002|Overall Study|Other|4|||
41930620|NCT00245063|75599917|FG000|Overall Study|Adverse Event|6|||
41930621|NCT00245063|75599918|FG001|Overall Study|Adverse Event|5|||
41930622|NCT00245063|75599917|FG000|Overall Study|Death|1|||
41930623|NCT00245063|75599918|FG001|Overall Study|Death|0|||
41930624|NCT04329091|75599983|FG000|Overall Study|Physician Decision|5|||
41930625|NCT00244751|75599990|FG000|Overall Study|Adverse Event|7|||
41930626|NCT00244751|75599991|FG001|Overall Study|Adverse Event|7|||
41930627|NCT00244751|75599992|FG002|Overall Study|Adverse Event|5|||
41930628|NCT00244751|75599990|FG000|Overall Study|Lost to Follow-up|0|||
41930629|NCT00244751|75599991|FG001|Overall Study|Lost to Follow-up|1|||
41930630|NCT00244751|75599992|FG002|Overall Study|Lost to Follow-up|0|||
41930631|NCT00244751|75599990|FG000|Overall Study|Protocol Violation|1|||
41930632|NCT00244751|75599991|FG001|Overall Study|Protocol Violation|0|||
41930633|NCT00244751|75599992|FG002|Overall Study|Protocol Violation|1|||
41930634|NCT00244751|75599990|FG000|Overall Study|Withdrawal by Subject|7|||
41930635|NCT00244751|75599991|FG001|Overall Study|Withdrawal by Subject|5|||
41930636|NCT00244751|75599992|FG002|Overall Study|Withdrawal by Subject|3|||
41930637|NCT00244751|75599990|FG000|Overall Study|Elevated liver enzymes|1|||
41930638|NCT00244751|75599991|FG001|Overall Study|Elevated liver enzymes|0|||
41930639|NCT00244751|75599992|FG002|Overall Study|Elevated liver enzymes|0|||
41930640|NCT00244751|75599990|FG000|Overall Study|Lack of compliance with protocol|0|||
41930641|NCT00244751|75599991|FG001|Overall Study|Lack of compliance with protocol|1|||
41930642|NCT00244751|75599992|FG002|Overall Study|Lack of compliance with protocol|0|||
41930643|NCT00244751|75599990|FG000|Overall Study|Safety reasons|0|||
41930644|NCT00244751|75599991|FG001|Overall Study|Safety reasons|1|||
41930645|NCT00244751|75599992|FG002|Overall Study|Safety reasons|0|||
41930646|NCT00244751|75599990|FG000|Overall Study|Participant randomized by mistake|0|||
41930647|NCT00244751|75599991|FG001|Overall Study|Participant randomized by mistake|0|||
41930648|NCT00244751|75599992|FG002|Overall Study|Participant randomized by mistake|1|||
41930649|NCT00243659|75600034|FG000|Overall Study|Withdrawal by Subject|1|||
41930650|NCT00243659|75600035|FG001|Overall Study|Withdrawal by Subject|1|||
41930651|NCT00243659|75600034|FG000|Overall Study|Protocol Violation|1|||
41930652|NCT00243659|75600035|FG001|Overall Study|Protocol Violation|2|||
41930653|NCT00243347|75600050|FG000|Overall Study|Lack of Efficacy|4|||
41930654|NCT00243347|75600050|FG000|Overall Study|Adverse Event|2|||
41930655|NCT00243347|75600050|FG000|Overall Study|Death|1|||
41930656|NCT00243347|75600050|FG000|Overall Study|Withdrawal by Subject|5|||
41930657|NCT00243347|75600050|FG000|Overall Study|Condition worsened|7|||
41930658|NCT00243269|75600058|FG000|Overall Study|Protocol Violation|2|||
41930659|NCT00243269|75600059|FG001|Overall Study|Protocol Violation|1|||
41930660|NCT00243269|75600060|FG002|Overall Study|Protocol Violation|0|||
41930661|NCT00243269|75600061|FG003|Overall Study|Protocol Violation|1|||
41930662|NCT00243269|75600058|FG000|Overall Study|Lost to Follow-up|1|||
41930663|NCT00243269|75600059|FG001|Overall Study|Lost to Follow-up|0|||
41930664|NCT00243269|75600060|FG002|Overall Study|Lost to Follow-up|1|||
41930665|NCT00243269|75600061|FG003|Overall Study|Lost to Follow-up|3|||
41930666|NCT00242567|75601276|FG000|Overall Study|Adverse Event|70|||
41930667|NCT00242567|75601277|FG001|Overall Study|Adverse Event|43|||
41930668|NCT00242567|75601276|FG000|Overall Study|Disease Progression|17|||
41930669|NCT00242567|75601277|FG001|Overall Study|Disease Progression|22|||
41930670|NCT00242567|75601276|FG000|Overall Study|Symptomatic deterioration|9|||
41930671|NCT00242567|75601277|FG001|Overall Study|Symptomatic deterioration|3|||
41930672|NCT00242567|75601276|FG000|Overall Study|Lack of Efficacy|2|||
41930673|NCT00242567|75601277|FG001|Overall Study|Lack of Efficacy|2|||
41930674|NCT00242567|75601276|FG000|Overall Study|Lost to Follow-up|9|||
41930675|NCT00242567|75601277|FG001|Overall Study|Lost to Follow-up|19|||
41930676|NCT00242567|75601276|FG000|Overall Study|Withdrawal by Subject|33|||
41930677|NCT00242567|75601277|FG001|Overall Study|Withdrawal by Subject|28|||
41930678|NCT00242567|75601276|FG000|Overall Study|Protocol Violation|12|||
41930679|NCT00242567|75601277|FG001|Overall Study|Protocol Violation|12|||
41930680|NCT00242567|75601276|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
41930681|NCT00242567|75601277|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
41930682|NCT00242567|75601276|FG000|Overall Study|Other|14|||
41930683|NCT00242567|75601277|FG001|Overall Study|Other|9|||
41930684|NCT00241631|75601287|FG000|Run in (2 Weeks)|Physician Decision|3|||
41930685|NCT00241631|75601288|FG001|Run in (2 Weeks)|Physician Decision|3|||
41930686|NCT00241631|75601287|FG000|Phase 1 (4 Weeks)|sore throat|1|||
41930687|NCT00241631|75601288|FG001|Phase 1 (4 Weeks)|sore throat|0|||
41930688|NCT00241631|75601287|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
42209340|NCT04432298|76023629|FG000|Overall Study|Other than specified|1|||
42209341|NCT04432298|76023630|FG001|Overall Study|Other than specified|0|||
42209342|NCT04432298|76023629|FG000|Overall Study|Lost to Follow-up|0|||
42209343|NCT04432298|76023630|FG001|Overall Study|Lost to Follow-up|1|||
42209344|NCT04432298|76023629|FG000|Overall Study|Death|3|||
42209345|NCT04432298|76023630|FG001|Overall Study|Death|2|||
42209346|NCT04432298|76023629|FG000|Overall Study|Withdrawal by Subject|2|||
41930689|NCT00241631|75601288|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
41930690|NCT00241631|75601287|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
41930691|NCT00241631|75601288|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
41930692|NCT00241631|75601287|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
41930693|NCT00241631|75601288|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
42209347|NCT04432298|76023630|FG001|Overall Study|Withdrawal by Subject|0|||
42209348|NCT04167085|76023638|FG000|Baseline|Withdrawal by Subject|2|||
41930694|NCT00240071|75601303|FG000|Overall Study|Withdrawal by Subject|3|||
41930695|NCT03761277|75602286|FG000|Enrollment to Implant|Screen Failure|17|||
41930696|NCT03761277|75602286|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
41930697|NCT03761277|75602286|FG000|Enrollment to Implant|Physician Decision|2|||
41930698|NCT03761277|75602286|FG000|Enrollment to Implant|Site Closure|3|||
41930699|NCT03761277|75602286|FG000|Enrollment to Implant|Sponsor Request|2|||
41930700|NCT03761277|75602286|FG000|Post-Implant to 6 Months|Adverse Event|2|||
41930701|NCT03761277|75602286|FG000|Post-Implant to 6 Months|Death|1|||
42209349|NCT04167085|76023639|FG001|Baseline|Withdrawal by Subject|1|||
41930702|NCT03761277|75602286|FG000|Post-Implant to 6 Months|Site Closure|2|||
41930703|NCT03761277|75602286|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
41930704|NCT03761277|75602286|FG000|6 Months to 12 Months|Physician Decision|2|||
41930705|NCT03761277|75602286|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
41930706|NCT04099641|75602337|FG000|Overall Study|Death|46|||
41930707|NCT04099641|75602338|FG001|Overall Study|Death|12|||
41930708|NCT04099641|75602337|FG000|Overall Study|Lost to Follow-up|1|||
41930709|NCT04099641|75602338|FG001|Overall Study|Lost to Follow-up|0|||
41930710|NCT04099641|75602337|FG000|Overall Study|Withdrawal by Subject|2|||
41930711|NCT04099641|75602338|FG001|Overall Study|Withdrawal by Subject|0|||
41930712|NCT03123393|75602464|FG000|Overall Study|Study Terminated by Sponsor|6|||
41930713|NCT03123393|75602465|FG001|Overall Study|Study Terminated by Sponsor|9|||
41930714|NCT03123393|75602464|FG000|Overall Study|Withdrawal by Subject|2|||
41930715|NCT03123393|75602465|FG001|Overall Study|Withdrawal by Subject|1|||
41930716|NCT03123393|75602464|FG000|Overall Study|Reason not Specified|13|||
41930717|NCT03123393|75602465|FG001|Overall Study|Reason not Specified|13|||
41930718|NCT02834247|75603087|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
41930719|NCT02834247|75603088|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
41930720|NCT02834247|75603089|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
41930721|NCT02834247|75603090|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
41930722|NCT02834247|75603087|FG000|Dose Escalation Phase|Death|5|||
41930723|NCT02834247|75603088|FG001|Dose Escalation Phase|Death|6|||
41930724|NCT02834247|75603089|FG002|Dose Escalation Phase|Death|5|||
41930725|NCT02834247|75603090|FG003|Dose Escalation Phase|Death|0|||
41930726|NCT02834247|75603087|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
41930727|NCT02834247|75603088|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
41930728|NCT02834247|75603089|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
41930729|NCT02834247|75603090|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
41930730|NCT02834247|75603087|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
41930731|NCT02834247|75603088|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
41930732|NCT02834247|75603089|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
41930733|NCT02834247|75603090|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
41930734|NCT02834247|75603087|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
41930735|NCT02834247|75603088|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
41930736|NCT02834247|75603089|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
41930737|NCT02834247|75603090|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
41930738|NCT02834247|75603087|FG000|Dose Expansion Phase|Death|0|||
41930739|NCT02834247|75603088|FG001|Dose Expansion Phase|Death|0|||
41930740|NCT02834247|75603089|FG002|Dose Expansion Phase|Death|0|||
42209350|NCT04167085|76023638|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
42209351|NCT04167085|76023639|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
42209352|NCT04162795|76023645|FG000|Overall Study|Other|16|||
42209353|NCT04162795|76023645|FG000|Overall Study|Screen failures|10|||
42209354|NCT03069482|76023651|FG000|Overall Study|Lost to Follow-up|0|||
42209355|NCT03069482|76023652|FG001|Overall Study|Lost to Follow-up|1|||
42209356|NCT03069482|76023651|FG000|Overall Study|Physician Decision|1|||
42209357|NCT03069482|76023652|FG001|Overall Study|Physician Decision|0|||
42209358|NCT03266172|76023664|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
42209359|NCT03266172|76023665|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
42209360|NCT03266172|76023666|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
42209361|NCT03266172|76023664|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
42209362|NCT03266172|76023665|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
42209363|NCT03266172|76023666|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
42209364|NCT03266172|76023664|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
42209365|NCT03266172|76023665|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
42209366|NCT03266172|76023666|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
42209367|NCT03266172|76023664|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
42209368|NCT03266172|76023665|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
42209369|NCT03266172|76023666|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
42209370|NCT03266172|76023664|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
42209371|NCT03266172|76023665|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
42209372|NCT03266172|76023666|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
42209373|NCT03266172|76023664|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
42209374|NCT03266172|76023665|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
42209375|NCT03266172|76023666|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
42209376|NCT04356937|76023718|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
41930741|NCT02834247|75603090|FG003|Dose Expansion Phase|Death|8|||
41930742|NCT02834247|75603087|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
41930743|NCT02834247|75603088|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
41930744|NCT02834247|75603089|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
41930745|NCT02834247|75603090|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
41930746|NCT02834247|75603087|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
41930747|NCT02834247|75603088|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
42209377|NCT04356937|76023719|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
42209378|NCT03301740|76023731|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
41930748|NCT02834247|75603089|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
41930749|NCT02834247|75603090|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
41930750|NCT01839331|75604355|FG000|Overall Study|Early Termination|3|||
41930751|NCT01839331|75604356|FG001|Overall Study|Early Termination|0|||
41930752|NCT01839331|75604357|FG002|Overall Study|Early Termination|1|||
41930753|NCT01839331|75604358|FG003|Overall Study|Early Termination|2|||
41930754|NCT01839331|75604355|FG000|Overall Study|Protocol Violation|1|||
41930755|NCT01839331|75604356|FG001|Overall Study|Protocol Violation|6|||
41930756|NCT01839331|75604357|FG002|Overall Study|Protocol Violation|4|||
41930757|NCT01839331|75604358|FG003|Overall Study|Protocol Violation|3|||
41930758|NCT01606176|75604696|FG000|Overall Study|Adverse Event|2|||
41930759|NCT01606176|75604697|FG001|Overall Study|Adverse Event|3|||
41930760|NCT01606176|75604696|FG000|Overall Study|Disease progression|1|||
41930761|NCT01606176|75604697|FG001|Overall Study|Disease progression|0|||
41930762|NCT01606176|75604696|FG000|Overall Study|Withdrawal by Subject|1|||
41930763|NCT01606176|75604697|FG001|Overall Study|Withdrawal by Subject|0|||
41930764|NCT01663896|75604763|FG000|Overall Study|Various reasons|43|||
41930765|NCT02576652|75604816|FG000|Overall Study|Withdrawal by Subject|2|||
41930766|NCT02575950|75604900|FG000|Overall Study|Withdrawal by Subject|0|||
41930767|NCT02575950|75604901|FG001|Overall Study|Withdrawal by Subject|0|||
41930768|NCT02575950|75604902|FG002|Overall Study|Withdrawal by Subject|0|||
41930769|NCT02575950|75604903|FG003|Overall Study|Withdrawal by Subject|2|||
41930770|NCT02575950|75604900|FG000|Overall Study|Lost to Follow-up|0|||
41930771|NCT02575950|75604901|FG001|Overall Study|Lost to Follow-up|1|||
41930772|NCT02575950|75604902|FG002|Overall Study|Lost to Follow-up|0|||
41930773|NCT02575950|75604903|FG003|Overall Study|Lost to Follow-up|3|||
41930774|NCT01049581|75604985|FG000|Overall Study|Lost to Follow-up|2|||
41930775|NCT01049581|75604986|FG001|Overall Study|Lost to Follow-up|1|||
41930776|NCT02571972|75605004|FG000|Overall Study|Protocol Violation|2|||
41930777|NCT02571972|75605004|FG000|Overall Study|Withdrawal by Subject|2|||
41930778|NCT02166905|75605102|FG000|Overall Study|Withdrawal by Subject|1|||
41930779|NCT02166905|75605103|FG001|Overall Study|Withdrawal by Subject|0|||
41930780|NCT02166905|75605104|FG002|Overall Study|Withdrawal by Subject|0|||
41930781|NCT02166905|75605105|FG003|Overall Study|Withdrawal by Subject|0|||
41930782|NCT01501955|75605152|FG000|Overall Study|Withdrawal by Subject|1|||
41930783|NCT01501955|75605153|FG001|Overall Study|Withdrawal by Subject|0|||
41930784|NCT01501955|75605152|FG000|Overall Study|Adverse Event|1|||
41930785|NCT01501955|75605153|FG001|Overall Study|Adverse Event|3|||
41930786|NCT02574312|75605281|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
41930787|NCT02574312|75605282|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
41930788|NCT01049035|75605304|FG000|Overall Study|Serious adverse event|0|||
41930789|NCT01049035|75605305|FG001|Overall Study|Serious adverse event|1|||
41930790|NCT01049035|75605306|FG002|Overall Study|Serious adverse event|1|||
41930791|NCT01049035|75605307|FG003|Overall Study|Serious adverse event|2|||
41930792|NCT01049035|75605308|FG004|Overall Study|Serious adverse event|0|||
41930793|NCT01049035|75605309|FG005|Overall Study|Serious adverse event|0|||
41930794|NCT01049035|75605310|FG006|Overall Study|Serious adverse event|0|||
41930795|NCT01049035|75605304|FG000|Overall Study|Other adverse event (AE)|0|||
41930796|NCT01049035|75605305|FG001|Overall Study|Other adverse event (AE)|0|||
41930797|NCT01049035|75605306|FG002|Overall Study|Other adverse event (AE)|0|||
41930798|NCT01049035|75605307|FG003|Overall Study|Other adverse event (AE)|1|||
41930799|NCT01049035|75605308|FG004|Overall Study|Other adverse event (AE)|0|||
41930800|NCT01049035|75605309|FG005|Overall Study|Other adverse event (AE)|0|||
41930801|NCT01049035|75605310|FG006|Overall Study|Other adverse event (AE)|0|||
41930802|NCT01049035|75605304|FG000|Overall Study|Non-compliance with the protocol|12|||
41930803|NCT01049035|75605305|FG001|Overall Study|Non-compliance with the protocol|6|||
41930804|NCT01049035|75605306|FG002|Overall Study|Non-compliance with the protocol|14|||
41930805|NCT01049035|75605307|FG003|Overall Study|Non-compliance with the protocol|5|||
41930806|NCT01049035|75605308|FG004|Overall Study|Non-compliance with the protocol|3|||
41930807|NCT01049035|75605309|FG005|Overall Study|Non-compliance with the protocol|4|||
41930808|NCT01049035|75605310|FG006|Overall Study|Non-compliance with the protocol|10|||
41930809|NCT01049035|75605304|FG000|Overall Study|Lost to Follow-up|5|||
41930810|NCT01049035|75605305|FG001|Overall Study|Lost to Follow-up|4|||
41930811|NCT01049035|75605306|FG002|Overall Study|Lost to Follow-up|4|||
41930812|NCT01049035|75605307|FG003|Overall Study|Lost to Follow-up|1|||
41930813|NCT01049035|75605308|FG004|Overall Study|Lost to Follow-up|0|||
41930814|NCT01049035|75605309|FG005|Overall Study|Lost to Follow-up|3|||
41930815|NCT01049035|75605310|FG006|Overall Study|Lost to Follow-up|3|||
42209379|NCT03301740|76023732|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
41930816|NCT01049035|75605304|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
41930817|NCT01049035|75605305|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
41930818|NCT01049035|75605306|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
41930819|NCT01049035|75605307|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
41930820|NCT01049035|75605308|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
41930821|NCT01049035|75605309|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
41930822|NCT01049035|75605310|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
41930823|NCT01048333|75605336|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
41930824|NCT01048333|75605337|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
41930825|NCT01048333|75605338|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
41930826|NCT01048333|75605339|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
41930827|NCT01048333|75605340|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
41930828|NCT01048333|75605341|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
41930829|NCT02323113|75605356|FG000|Overall Study|Adverse Event|3|||
41930830|NCT02323113|75605357|FG001|Overall Study|Adverse Event|3|||
41930831|NCT02323113|75605358|FG002|Overall Study|Adverse Event|2|||
41930832|NCT02323113|75605359|FG003|Overall Study|Adverse Event|5|||
41930833|NCT02323113|75605360|FG004|Overall Study|Adverse Event|8|||
41930834|NCT02323113|75605361|FG005|Overall Study|Adverse Event|3|||
41930835|NCT02323113|75605362|FG006|Overall Study|Adverse Event|6|||
41930836|NCT02323113|75605363|FG007|Overall Study|Adverse Event|0|||
41930837|NCT02323113|75605356|FG000|Overall Study|Progressive Disease|0|||
41930838|NCT02323113|75605357|FG001|Overall Study|Progressive Disease|1|||
41930839|NCT02323113|75605358|FG002|Overall Study|Progressive Disease|1|||
41930840|NCT02323113|75605359|FG003|Overall Study|Progressive Disease|0|||
41930841|NCT02323113|75605360|FG004|Overall Study|Progressive Disease|0|||
41930842|NCT02323113|75605361|FG005|Overall Study|Progressive Disease|3|||
41930843|NCT02323113|75605362|FG006|Overall Study|Progressive Disease|0|||
41930844|NCT02323113|75605363|FG007|Overall Study|Progressive Disease|0|||
41930845|NCT02323113|75605356|FG000|Overall Study|Symptomatic Deterioration|0|||
41930846|NCT02323113|75605357|FG001|Overall Study|Symptomatic Deterioration|0|||
41930847|NCT02323113|75605358|FG002|Overall Study|Symptomatic Deterioration|1|||
41930848|NCT02323113|75605359|FG003|Overall Study|Symptomatic Deterioration|0|||
41930849|NCT02323113|75605360|FG004|Overall Study|Symptomatic Deterioration|1|||
41930850|NCT02323113|75605361|FG005|Overall Study|Symptomatic Deterioration|0|||
41930851|NCT02323113|75605362|FG006|Overall Study|Symptomatic Deterioration|0|||
41930852|NCT02323113|75605363|FG007|Overall Study|Symptomatic Deterioration|0|||
41930853|NCT02323113|75605356|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
41930854|NCT02323113|75605357|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
41930855|NCT02323113|75605358|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
41930856|NCT02323113|75605359|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
41930857|NCT02323113|75605360|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
41930858|NCT02323113|75605361|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
41930859|NCT02323113|75605362|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
41930860|NCT02323113|75605363|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
41930861|NCT02323113|75605356|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
41930862|NCT02323113|75605357|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
41930863|NCT02323113|75605358|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
41930864|NCT02323113|75605359|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
41930865|NCT02323113|75605360|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
41930866|NCT02323113|75605361|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
41930867|NCT02323113|75605362|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
41930868|NCT02323113|75605363|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
41930869|NCT02281383|75605410|FG000|Overall Study|Progressive Disease|1|||
41930870|NCT02281383|75605410|FG000|Overall Study|Withdrawal by Subject|6|||
41930871|NCT02281383|75605410|FG000|Overall Study|Protocol Violation|2|||
41930872|NCT02281383|75605410|FG000|Overall Study|Death|1|||
41930873|NCT02281383|75605410|FG000|Overall Study|Adverse Event|2|||
41930874|NCT01047553|75605416|FG000|Overall Study|Adverse Event|10|||
41930875|NCT01047553|75605417|FG001|Overall Study|Adverse Event|5|||
41930876|NCT01047553|75605416|FG000|Overall Study|Withdrawal by Subject|4|||
41930877|NCT01047553|75605417|FG001|Overall Study|Withdrawal by Subject|2|||
41930878|NCT01047553|75605416|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
41930879|NCT01047553|75605417|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
41930880|NCT01047553|75605416|FG000|Overall Study|Lost to Follow-up|1|||
41930881|NCT01047553|75605417|FG001|Overall Study|Lost to Follow-up|0|||
41930882|NCT01047553|75605416|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
42209380|NCT03301740|76023731|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
42209381|NCT03301740|76023732|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
42209382|NCT04355767|76023740|FG000|Overall Study|Withdrawal by Subject|2|||
42209383|NCT04355767|76023741|FG001|Overall Study|Withdrawal by Subject|2|||
42209384|NCT04355767|76023740|FG000|Overall Study|Death|5|||
41930883|NCT01047553|75605417|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
41930884|NCT01047553|75605416|FG000|Overall Study|PI's decision|0|||
42209385|NCT04355767|76023741|FG001|Overall Study|Death|1|||
42209386|NCT00882050|76023750|FG000|Overall Study|Physician Decision|1|||
42209387|NCT00882050|76023751|FG001|Overall Study|Physician Decision|0|||
42209388|NCT00882050|76023752|FG002|Overall Study|Physician Decision|0|||
42209389|NCT03266094|76023760|FG000|Overall Study|Lost to Follow-up|1|||
42209390|NCT03266094|76023760|FG000|Overall Study|Withdrawal by Subject|1|||
42209391|NCT04161079|76023766|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
42209392|NCT03243084|76023776|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
42209393|NCT03243084|76023777|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
42209394|NCT04353817|76023786|FG000|Overall Study|Adverse Event|0|||
42209395|NCT04353817|76023787|FG001|Overall Study|Adverse Event|1|||
42209396|NCT00159588|76023796|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
42209397|NCT00159588|76023797|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
42209398|NCT00159588|76023798|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
42209399|NCT03265938|76023809|FG000|Overall Study|Withdrawal by Subject|1|||
42209400|NCT03265938|76023809|FG000|Overall Study|Physician Decision|1|||
42209401|NCT03265938|76023809|FG000|Overall Study|friable mass|6|||
42209402|NCT04353037|76023818|FG000|Overall Study|Lost to Follow-up|0|||
42209403|NCT04353037|76023819|FG001|Overall Study|Lost to Follow-up|1|||
42209404|NCT04353037|76023820|FG002|Overall Study|Lost to Follow-up|2|||
42209405|NCT04353037|76023821|FG003|Overall Study|Lost to Follow-up|3|||
42209406|NCT04353037|76023818|FG000|Overall Study|Withdrawal by Subject|0|||
42209407|NCT04353037|76023819|FG001|Overall Study|Withdrawal by Subject|2|||
42209408|NCT04353037|76023820|FG002|Overall Study|Withdrawal by Subject|3|||
42209409|NCT04353037|76023821|FG003|Overall Study|Withdrawal by Subject|5|||
42209410|NCT04353037|76023818|FG000|Overall Study|Adverse Event|0|||
42209411|NCT04353037|76023819|FG001|Overall Study|Adverse Event|0|||
42209412|NCT04353037|76023820|FG002|Overall Study|Adverse Event|2|||
42209413|NCT04353037|76023821|FG003|Overall Study|Adverse Event|0|||
42209414|NCT04353037|76023818|FG000|Overall Study|Exposure Change|0|||
42209415|NCT04353037|76023819|FG001|Overall Study|Exposure Change|0|||
42209416|NCT04353037|76023820|FG002|Overall Study|Exposure Change|0|||
42209417|NCT04353037|76023821|FG003|Overall Study|Exposure Change|2|||
42209418|NCT04349917|76023835|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
42209419|NCT04349917|76023836|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
42209420|NCT04349917|76023835|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
42209421|NCT04349917|76023836|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
42209422|NCT04156399|76023843|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
42209423|NCT04156399|76023843|FG000|Overall Study|study suspension due to COVID pandemic|3|||
42209424|NCT03300570|76023849|FG000|Overall Study|Adverse Event|0|||
41930885|NCT01047553|75605417|FG001|Overall Study|PI's decision|1|||
41930886|NCT01046695|75605449|FG000|Overall Study|Subject had a pacemaker|0|||
41930887|NCT01046695|75605450|FG001|Overall Study|Subject had a pacemaker|1|||
41930888|NCT01046695|75605449|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
41930889|NCT01046695|75605450|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
41930890|NCT03304379|75605465|FG000|Overall Study|Protocol Violation|8|||
41930891|NCT03304379|75605466|FG001|Overall Study|Protocol Violation|10|||
41930892|NCT03304379|75605467|FG002|Overall Study|Protocol Violation|5|||
41930893|NCT03304379|75605468|FG003|Overall Study|Protocol Violation|0|||
41930894|NCT03304379|75605469|FG004|Overall Study|Protocol Violation|2|||
41930895|NCT03304379|75605465|FG000|Overall Study|Adverse Event|4|||
41930896|NCT03304379|75605466|FG001|Overall Study|Adverse Event|20|||
41930897|NCT03304379|75605467|FG002|Overall Study|Adverse Event|17|||
41930898|NCT03304379|75605468|FG003|Overall Study|Adverse Event|1|||
41930899|NCT03304379|75605469|FG004|Overall Study|Adverse Event|0|||
41930900|NCT03304379|75605465|FG000|Overall Study|Lack of Efficacy|17|||
41930901|NCT03304379|75605466|FG001|Overall Study|Lack of Efficacy|16|||
41930902|NCT03304379|75605467|FG002|Overall Study|Lack of Efficacy|20|||
41930903|NCT03304379|75605468|FG003|Overall Study|Lack of Efficacy|0|||
41930904|NCT03304379|75605469|FG004|Overall Study|Lack of Efficacy|0|||
41930905|NCT03304379|75605465|FG000|Overall Study|Physician Decision|6|||
41930906|NCT03304379|75605466|FG001|Overall Study|Physician Decision|10|||
42209425|NCT03300570|76023850|FG001|Overall Study|Adverse Event|1|||
42209426|NCT03300570|76023849|FG000|Overall Study|Withdrawal by Subject|1|||
42209427|NCT03300570|76023850|FG001|Overall Study|Withdrawal by Subject|0|||
42209428|NCT03300570|76023849|FG000|Overall Study|Inadequate bowel prep|1|||
42209429|NCT03300570|76023850|FG001|Overall Study|Inadequate bowel prep|0|||
41930907|NCT03304379|75605467|FG002|Overall Study|Physician Decision|6|||
41930908|NCT03304379|75605468|FG003|Overall Study|Physician Decision|9|||
41930909|NCT03304379|75605469|FG004|Overall Study|Physician Decision|10|||
41930910|NCT03304379|75605465|FG000|Overall Study|Withdrawal by Subject|26|||
42209430|NCT04154605|76023859|FG000|Overall Study|Procedure Canceled|1|||
42209431|NCT04154605|76023860|FG001|Overall Study|Procedure Canceled|1|||
42209432|NCT04154605|76023859|FG000|Overall Study|Missed follow up|1|||
42209433|NCT04154605|76023860|FG001|Overall Study|Missed follow up|1|||
42209434|NCT04154605|76023859|FG000|Overall Study|Withdrawal by Subject|1|||
42209435|NCT04154605|76023860|FG001|Overall Study|Withdrawal by Subject|0|||
42209436|NCT03264456|76023866|FG000|Overall Study|Withdrawal by Subject|3|||
41930911|NCT03304379|75605466|FG001|Overall Study|Withdrawal by Subject|58|||
41930912|NCT03304379|75605467|FG002|Overall Study|Withdrawal by Subject|66|||
41930913|NCT03304379|75605468|FG003|Overall Study|Withdrawal by Subject|3|||
41930914|NCT03304379|75605469|FG004|Overall Study|Withdrawal by Subject|5|||
41930915|NCT03304379|75605465|FG000|Overall Study|Lost to Follow-up|8|||
41930916|NCT03304379|75605466|FG001|Overall Study|Lost to Follow-up|24|||
41930917|NCT03304379|75605467|FG002|Overall Study|Lost to Follow-up|35|||
41930918|NCT03304379|75605468|FG003|Overall Study|Lost to Follow-up|4|||
41930919|NCT03304379|75605469|FG004|Overall Study|Lost to Follow-up|0|||
41930920|NCT03304379|75605465|FG000|Overall Study|Death|1|||
41930921|NCT03304379|75605466|FG001|Overall Study|Death|2|||
41930922|NCT03304379|75605467|FG002|Overall Study|Death|0|||
41930923|NCT03304379|75605468|FG003|Overall Study|Death|0|||
41930924|NCT03304379|75605469|FG004|Overall Study|Death|0|||
41930925|NCT03304379|75605465|FG000|Overall Study|Other|0|||
41930926|NCT03304379|75605466|FG001|Overall Study|Other|1|||
41930927|NCT03304379|75605467|FG002|Overall Study|Other|0|||
41930928|NCT03304379|75605468|FG003|Overall Study|Other|0|||
41930929|NCT03304379|75605469|FG004|Overall Study|Other|0|||
41930930|NCT01044433|75605542|FG000|Overall Study|Lost to Follow-up|3|||
41930931|NCT01044433|75605542|FG000|Overall Study|Withdrawal by Subject|3|||
41930932|NCT01043185|75605551|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
41930933|NCT01043185|75605552|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
41930934|NCT01043185|75605553|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
41930935|NCT01043185|75605554|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
41930936|NCT01043185|75605555|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
41930937|NCT01043185|75605556|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
41930938|NCT01043185|75605557|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
41930939|NCT01043185|75605558|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
41930940|NCT01043185|75605559|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
41930941|NCT01043185|75605560|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
41930942|NCT01042093|75605585|FG000|Overall Study|Protocol Violation|2|||
41930943|NCT01042093|75605586|FG001|Overall Study|Protocol Violation|2|||
41930944|NCT01042093|75605587|FG002|Overall Study|Protocol Violation|2|||
41930945|NCT01042093|75605588|FG003|Overall Study|Protocol Violation|3|||
41930946|NCT01042093|75605585|FG000|Overall Study|Withdrawal by Subject|0|||
41930947|NCT01042093|75605586|FG001|Overall Study|Withdrawal by Subject|0|||
41930948|NCT01042093|75605587|FG002|Overall Study|Withdrawal by Subject|0|||
41930949|NCT01042093|75605588|FG003|Overall Study|Withdrawal by Subject|1|||
41930950|NCT01041859|75605618|FG000|Open-Label Titration|Adverse Event|69|||
41930951|NCT01041859|75605619|FG001|Open-Label Titration|Adverse Event|0|||
41930952|NCT01041859|75605620|FG002|Open-Label Titration|Adverse Event|0|||
41930953|NCT01041859|75605618|FG000|Open-Label Titration|Lack of Efficacy|3|||
41930954|NCT01041859|75605619|FG001|Open-Label Titration|Lack of Efficacy|0|||
41930955|NCT01041859|75605620|FG002|Open-Label Titration|Lack of Efficacy|0|||
41930956|NCT01041859|75605618|FG000|Open-Label Titration|Lost to Follow-up|1|||
41930957|NCT01041859|75605619|FG001|Open-Label Titration|Lost to Follow-up|0|||
41930958|NCT01041859|75605620|FG002|Open-Label Titration|Lost to Follow-up|0|||
41930959|NCT01041859|75605618|FG000|Open-Label Titration|Physician Decision|1|||
41930960|NCT01041859|75605619|FG001|Open-Label Titration|Physician Decision|0|||
41930961|NCT01041859|75605620|FG002|Open-Label Titration|Physician Decision|0|||
41930962|NCT01041859|75605618|FG000|Open-Label Titration|Protocol Violation|1|||
41930963|NCT01041859|75605619|FG001|Open-Label Titration|Protocol Violation|0|||
41930964|NCT01041859|75605620|FG002|Open-Label Titration|Protocol Violation|0|||
41930965|NCT01041859|75605618|FG000|Open-Label Titration|Other|7|||
41930966|NCT01041859|75605619|FG001|Open-Label Titration|Other|0|||
41930967|NCT01041859|75605620|FG002|Open-Label Titration|Other|0|||
42209437|NCT03264456|76023866|FG000|Overall Study|Lost to Follow-up|1|||
42209438|NCT03853694|76023873|FG000|Overall Study|Protocol Violation|3|||
42209439|NCT03853694|76023874|FG001|Overall Study|Protocol Violation|5|||
42209440|NCT03853694|76023875|FG002|Overall Study|Protocol Violation|3|||
42209441|NCT03853694|76023873|FG000|Overall Study|Delivered early|0|||
42209442|NCT03853694|76023874|FG001|Overall Study|Delivered early|1|||
42209443|NCT03853694|76023875|FG002|Overall Study|Delivered early|0|||
41930968|NCT01041859|75605618|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
41930969|NCT01041859|75605619|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
41930970|NCT01041859|75605620|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
41930971|NCT01041859|75605618|FG000|Open-Label Titration|Withdrawal by Subject|11|||
41930972|NCT01041859|75605619|FG001|Open-Label Titration|Withdrawal by Subject|0|||
41930973|NCT01041859|75605620|FG002|Open-Label Titration|Withdrawal by Subject|0|||
41930974|NCT01041859|75605618|FG000|Double-Blind Maintenance|Adverse Event|0|||
41930975|NCT01041859|75605619|FG001|Double-Blind Maintenance|Adverse Event|23|||
41930976|NCT01041859|75605620|FG002|Double-Blind Maintenance|Adverse Event|13|||
41930977|NCT01041859|75605618|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
42209444|NCT03853694|76023873|FG000|Overall Study|not suitable to proceed|0|||
42209445|NCT03853694|76023874|FG001|Overall Study|not suitable to proceed|1|||
41930978|NCT01041859|75605619|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
42209446|NCT03853694|76023875|FG002|Overall Study|not suitable to proceed|0|||
42209447|NCT03853694|76023873|FG000|Overall Study|difficult surgery|0|||
42209448|NCT03853694|76023874|FG001|Overall Study|difficult surgery|0|||
42209449|NCT03853694|76023875|FG002|Overall Study|difficult surgery|1|||
42209450|NCT03853694|76023873|FG000|Overall Study|Lost to Follow-up|0|||
42209451|NCT03853694|76023874|FG001|Overall Study|Lost to Follow-up|1|||
42209452|NCT03853694|76023875|FG002|Overall Study|Lost to Follow-up|0|||
42209453|NCT03853694|76023873|FG000|Overall Study|Withdrawal by Subject|0|||
42209454|NCT03853694|76023874|FG001|Overall Study|Withdrawal by Subject|1|||
42209455|NCT03853694|76023875|FG002|Overall Study|Withdrawal by Subject|0|||
42209456|NCT04154293|76023886|FG000|Overall Study|Withdrawal by Subject|2|||
42209457|NCT04154293|76023887|FG001|Overall Study|Withdrawal by Subject|3|||
42209458|NCT04154293|76023888|FG002|Overall Study|Withdrawal by Subject|1|||
42209459|NCT04154293|76023886|FG000|Overall Study|Physician Decision|0|||
42209460|NCT04154293|76023887|FG001|Overall Study|Physician Decision|0|||
42209461|NCT04154293|76023888|FG002|Overall Study|Physician Decision|1|||
41930979|NCT01041859|75605620|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
41930980|NCT01041859|75605618|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
41930981|NCT01041859|75605619|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
41930982|NCT01041859|75605620|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
41930983|NCT01041859|75605618|FG000|Double-Blind Maintenance|Physician Decision|0|||
41930984|NCT01041859|75605619|FG001|Double-Blind Maintenance|Physician Decision|2|||
41930985|NCT01041859|75605620|FG002|Double-Blind Maintenance|Physician Decision|1|||
41930986|NCT01041859|75605618|FG000|Double-Blind Maintenance|Protocol Violation|0|||
41930987|NCT01041859|75605619|FG001|Double-Blind Maintenance|Protocol Violation|1|||
41930988|NCT01041859|75605620|FG002|Double-Blind Maintenance|Protocol Violation|3|||
41930989|NCT01041859|75605618|FG000|Double-Blind Maintenance|Other|0|||
41930990|NCT01041859|75605619|FG001|Double-Blind Maintenance|Other|6|||
41930991|NCT01041859|75605620|FG002|Double-Blind Maintenance|Other|2|||
41930992|NCT01041859|75605618|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
41930993|NCT01041859|75605619|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
41930994|NCT01041859|75605620|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
41930995|NCT01041859|75605618|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
41930996|NCT01041859|75605619|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
41930997|NCT01041859|75605620|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
41930998|NCT01040845|75605629|FG000|Overall Study|Withdrawal by Subject|1|||
41930999|NCT01040845|75605630|FG001|Overall Study|Withdrawal by Subject|1|||
41931000|NCT01040845|75605629|FG000|Overall Study|Physician Decision|1|||
41931001|NCT01040845|75605630|FG001|Overall Study|Physician Decision|0|||
41931002|NCT01040689|75605638|FG000|Overall Study|Adverse Event|0|||
41931003|NCT01040689|75605639|FG001|Overall Study|Adverse Event|0|||
41931004|NCT01040689|75605640|FG002|Overall Study|Adverse Event|2|||
41931005|NCT01040689|75605641|FG003|Overall Study|Adverse Event|4|||
41931006|NCT01040689|75605638|FG000|Overall Study|Lack of Efficacy|0|||
41931007|NCT01040689|75605639|FG001|Overall Study|Lack of Efficacy|0|||
41931008|NCT01040689|75605640|FG002|Overall Study|Lack of Efficacy|1|||
41931009|NCT01040689|75605641|FG003|Overall Study|Lack of Efficacy|0|||
41931010|NCT01040689|75605638|FG000|Overall Study|Lost to Follow-up|1|||
41931011|NCT01040689|75605639|FG001|Overall Study|Lost to Follow-up|0|||
41931012|NCT01040689|75605640|FG002|Overall Study|Lost to Follow-up|0|||
41931013|NCT01040689|75605641|FG003|Overall Study|Lost to Follow-up|0|||
41931014|NCT01040689|75605638|FG000|Overall Study|Withdrawal by Subject|2|||
41931015|NCT01040689|75605639|FG001|Overall Study|Withdrawal by Subject|1|||
41931016|NCT01040689|75605640|FG002|Overall Study|Withdrawal by Subject|1|||
41931017|NCT01040689|75605641|FG003|Overall Study|Withdrawal by Subject|0|||
41931018|NCT01040689|75605638|FG000|Overall Study|Other reasons not listed above|0|||
41931019|NCT01040689|75605639|FG001|Overall Study|Other reasons not listed above|1|||
41931020|NCT01040689|75605640|FG002|Overall Study|Other reasons not listed above|0|||
41931021|NCT01040689|75605641|FG003|Overall Study|Other reasons not listed above|0|||
41931022|NCT01047319|75605690|FG000|Overall Study|Teva requested participant withdrawal|3|||
42209462|NCT04342897|76023898|FG000|Overall Study|Death|7|||
42209463|NCT04342897|76023899|FG001|Overall Study|Death|4|||
42209464|NCT04342897|76023898|FG000|Overall Study|Lost to Follow-up|6|||
42209465|NCT04342897|76023899|FG001|Overall Study|Lost to Follow-up|6|||
41931023|NCT01047319|75605691|FG001|Overall Study|Teva requested participant withdrawal|0|||
41931024|NCT01047319|75605692|FG002|Overall Study|Teva requested participant withdrawal|1|||
41931025|NCT01047319|75605690|FG000|Overall Study|Protocol Violation|3|||
41931026|NCT01047319|75605691|FG001|Overall Study|Protocol Violation|2|||
41931027|NCT01047319|75605692|FG002|Overall Study|Protocol Violation|4|||
42209466|NCT04342897|76023898|FG000|Overall Study|Withdrawal by Subject|1|||
42209467|NCT04342897|76023899|FG001|Overall Study|Withdrawal by Subject|2|||
42209468|NCT04340557|76023907|FG000|Overall Study|Transferred to ICU and/or death|1|||
42209469|NCT04340557|76023908|FG001|Overall Study|Transferred to ICU and/or death|2|||
42209470|NCT04382053|76023916|FG000|Overall Study|Death|6|||
42209471|NCT04382053|76023917|FG001|Overall Study|Death|8|||
41931028|NCT01047319|75605690|FG000|Overall Study|Lack of Efficacy|4|||
41931029|NCT01047319|75605691|FG001|Overall Study|Lack of Efficacy|3|||
41931030|NCT01047319|75605692|FG002|Overall Study|Lack of Efficacy|3|||
41931031|NCT01047319|75605690|FG000|Overall Study|Death|5|||
41931032|NCT01047319|75605691|FG001|Overall Study|Death|1|||
41931033|NCT01047319|75605692|FG002|Overall Study|Death|5|||
41931034|NCT01047319|75605690|FG000|Overall Study|Pregnancy|13|||
41931035|NCT01047319|75605691|FG001|Overall Study|Pregnancy|8|||
41931036|NCT01047319|75605692|FG002|Overall Study|Pregnancy|8|||
41931037|NCT01047319|75605690|FG000|Overall Study|Physician Decision|12|||
41931038|NCT01047319|75605691|FG001|Overall Study|Physician Decision|9|||
41931039|NCT01047319|75605692|FG002|Overall Study|Physician Decision|10|||
41931040|NCT01047319|75605690|FG000|Overall Study|Lost to Follow-up|14|||
41931041|NCT01047319|75605691|FG001|Overall Study|Lost to Follow-up|10|||
41931042|NCT01047319|75605692|FG002|Overall Study|Lost to Follow-up|10|||
41931043|NCT01047319|75605690|FG000|Overall Study|Adverse Event|16|||
41931044|NCT01047319|75605691|FG001|Overall Study|Adverse Event|27|||
41931045|NCT01047319|75605692|FG002|Overall Study|Adverse Event|21|||
41931046|NCT01047319|75605690|FG000|Overall Study|Withdrawal by Subject|77|||
41931047|NCT01047319|75605691|FG001|Overall Study|Withdrawal by Subject|75|||
41931048|NCT01047319|75605692|FG002|Overall Study|Withdrawal by Subject|87|||
41931049|NCT01047319|75605690|FG000|Overall Study|Study terminated by Sponsor|198|||
41931050|NCT01047319|75605691|FG001|Overall Study|Study terminated by Sponsor|215|||
41931051|NCT01047319|75605692|FG002|Overall Study|Study terminated by Sponsor|203|||
41931052|NCT00014911|75606009|FG000|Overall Study|Adverse Event|1|||
41931053|NCT00014911|75606009|FG000|Overall Study|Lost to Follow-up|1|||
41931054|NCT00014911|75606009|FG000|Overall Study|Withdrawal by Subject|6|||
41931055|NCT00014911|75606009|FG000|Overall Study|Unknown Reasons|2|||
41931056|NCT00014911|75606009|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
41931057|NCT01049009|75606556|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
41931058|NCT01049009|75606557|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
41931059|NCT01049009|75606556|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
41931060|NCT01049009|75606557|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
41931061|NCT01049009|75606556|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
41931062|NCT01049009|75606557|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
41931063|NCT01049009|75606556|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
41931064|NCT01049009|75606557|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
41931065|NCT01047683|75606579|FG000|Overall Study|Adverse Event|3|||
41931066|NCT01047683|75606580|FG001|Overall Study|Adverse Event|1|||
41931067|NCT01047683|75606581|FG002|Overall Study|Adverse Event|0|||
41931068|NCT01047683|75606579|FG000|Overall Study|Withdrew Consent|1|||
41931069|NCT01047683|75606580|FG001|Overall Study|Withdrew Consent|4|||
41931070|NCT01047683|75606581|FG002|Overall Study|Withdrew Consent|2|||
41931071|NCT01047683|75606579|FG000|Overall Study|Lost to Follow-up|0|||
41931072|NCT01047683|75606580|FG001|Overall Study|Lost to Follow-up|1|||
41931073|NCT01047683|75606581|FG002|Overall Study|Lost to Follow-up|0|||
41931074|NCT01047683|75606579|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
41931075|NCT01047683|75606580|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
41931076|NCT01047683|75606581|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
41931077|NCT01047293|75606669|FG000|Overall Study|DLT criteria not fulfilled|1|||
41931078|NCT01047293|75606670|FG001|Overall Study|DLT criteria not fulfilled|1|||
41931079|NCT01047293|75606671|FG002|Overall Study|DLT criteria not fulfilled|0|||
41931080|NCT01047293|75606672|FG003|Overall Study|DLT criteria not fulfilled|0|||
41931081|NCT01045967|75606681|FG000|Second Intervention|Protocol Violation|0|||
41931082|NCT01045967|75606682|FG001|Second Intervention|Protocol Violation|1|||
41931083|NCT01045421|75607268|FG000|Phase 1|Progressive Disease|0|||
41931084|NCT01045421|75607269|FG001|Phase 1|Progressive Disease|0|||
41931085|NCT01045421|75607270|FG002|Phase 1|Progressive Disease|0|||
41931086|NCT01045421|75607271|FG003|Phase 1|Progressive Disease|0|||
41931087|NCT01045421|75607272|FG004|Phase 1|Progressive Disease|1|||
41931088|NCT01045421|75607273|FG005|Phase 1|Progressive Disease|0|||
41931089|NCT01045421|75607274|FG006|Phase 1|Progressive Disease|0|||
41931090|NCT01045421|75607275|FG007|Phase 1|Progressive Disease|0|||
41931091|NCT01045421|75607276|FG008|Phase 1|Progressive Disease|0|||
41931092|NCT01045421|75607277|FG009|Phase 1|Progressive Disease|0|||
41931093|NCT01045421|75607278|FG010|Phase 1|Progressive Disease|0|||
41931094|NCT01045421|75607268|FG000|Phase 1|Withdrawal by Subject|0|||
41931095|NCT01045421|75607269|FG001|Phase 1|Withdrawal by Subject|0|||
41931096|NCT01045421|75607270|FG002|Phase 1|Withdrawal by Subject|0|||
41931097|NCT01045421|75607271|FG003|Phase 1|Withdrawal by Subject|1|||
41931098|NCT01045421|75607272|FG004|Phase 1|Withdrawal by Subject|0|||
41931099|NCT01045421|75607273|FG005|Phase 1|Withdrawal by Subject|0|||
41931100|NCT01045421|75607274|FG006|Phase 1|Withdrawal by Subject|0|||
41931101|NCT01045421|75607275|FG007|Phase 1|Withdrawal by Subject|0|||
41931102|NCT01045421|75607276|FG008|Phase 1|Withdrawal by Subject|0|||
41931103|NCT01045421|75607277|FG009|Phase 1|Withdrawal by Subject|0|||
41931104|NCT01045421|75607278|FG010|Phase 1|Withdrawal by Subject|0|||
41931105|NCT01045421|75607268|FG000|Phase 2|Progressive Disease|0|||
41931106|NCT01045421|75607269|FG001|Phase 2|Progressive Disease|0|||
41931107|NCT01045421|75607270|FG002|Phase 2|Progressive Disease|0|||
41931108|NCT01045421|75607271|FG003|Phase 2|Progressive Disease|0|||
41931109|NCT01045421|75607272|FG004|Phase 2|Progressive Disease|0|||
41931110|NCT01045421|75607273|FG005|Phase 2|Progressive Disease|0|||
41931111|NCT01045421|75607274|FG006|Phase 2|Progressive Disease|0|||
41931112|NCT01045421|75607275|FG007|Phase 2|Progressive Disease|1|||
41931113|NCT01045421|75607276|FG008|Phase 2|Progressive Disease|1|||
41931114|NCT01045421|75607277|FG009|Phase 2|Progressive Disease|1|||
41931115|NCT01045421|75607278|FG010|Phase 2|Progressive Disease|1|||
41931116|NCT01045421|75607268|FG000|Phase 2|Death|0|||
41931117|NCT01045421|75607269|FG001|Phase 2|Death|0|||
41931118|NCT01045421|75607270|FG002|Phase 2|Death|0|||
41931119|NCT01045421|75607271|FG003|Phase 2|Death|0|||
41931120|NCT01045421|75607272|FG004|Phase 2|Death|0|||
41931121|NCT01045421|75607273|FG005|Phase 2|Death|0|||
41931122|NCT01045421|75607274|FG006|Phase 2|Death|0|||
41931123|NCT01045421|75607275|FG007|Phase 2|Death|1|||
41931124|NCT01045421|75607276|FG008|Phase 2|Death|1|||
41931125|NCT01045421|75607277|FG009|Phase 2|Death|2|||
41931126|NCT01045421|75607278|FG010|Phase 2|Death|0|||
41931127|NCT01045421|75607268|FG000|Phase 2|Other|0|||
41931128|NCT01045421|75607269|FG001|Phase 2|Other|0|||
41931129|NCT01045421|75607270|FG002|Phase 2|Other|0|||
41931130|NCT01045421|75607271|FG003|Phase 2|Other|0|||
41931131|NCT01045421|75607272|FG004|Phase 2|Other|0|||
41931132|NCT01045421|75607273|FG005|Phase 2|Other|0|||
41931133|NCT01045421|75607274|FG006|Phase 2|Other|0|||
41931134|NCT01045421|75607275|FG007|Phase 2|Other|3|||
41931135|NCT01045421|75607276|FG008|Phase 2|Other|0|||
41931136|NCT01045421|75607277|FG009|Phase 2|Other|0|||
41931137|NCT01045421|75607278|FG010|Phase 2|Other|1|||
41931138|NCT01042535|75607326|FG000|Overall Study|disease progression prior to treatment|3|||
41931139|NCT01042535|75607326|FG000|Overall Study|disease progression during treatment|3|||
41931140|NCT01042535|75607326|FG000|Overall Study|complications from other disease|2|||
41931141|NCT01041287|75607332|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
41931142|NCT01041287|75607333|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
41931143|NCT01041287|75607332|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
41931144|NCT01041287|75607333|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
41931145|NCT01040351|75607354|FG000|Overall Study|poor ovarian response|1|||
41931146|NCT01040351|75607355|FG001|Overall Study|poor ovarian response|2|||
41931147|NCT02049957|75607375|FG000|Overall Study|Progressive Disease|5|||
41931148|NCT02049957|75607376|FG001|Overall Study|Progressive Disease|4|||
41931149|NCT02049957|75607377|FG002|Overall Study|Progressive Disease|2|||
41931150|NCT02049957|75607378|FG003|Overall Study|Progressive Disease|2|||
41931151|NCT02049957|75607379|FG004|Overall Study|Progressive Disease|6|||
41931152|NCT02049957|75607380|FG005|Overall Study|Progressive Disease|35|||
41931153|NCT02049957|75607381|FG006|Overall Study|Progressive Disease|7|||
41931154|NCT02049957|75607382|FG007|Overall Study|Progressive Disease|26|||
41931155|NCT02049957|75607383|FG008|Overall Study|Progressive Disease|6|||
41931156|NCT02049957|75607375|FG000|Overall Study|Adverse Event|1|||
41931157|NCT02049957|75607376|FG001|Overall Study|Adverse Event|1|||
41931158|NCT02049957|75607377|FG002|Overall Study|Adverse Event|1|||
41931159|NCT02049957|75607378|FG003|Overall Study|Adverse Event|0|||
41931160|NCT02049957|75607379|FG004|Overall Study|Adverse Event|0|||
41931161|NCT02049957|75607380|FG005|Overall Study|Adverse Event|5|||
41931162|NCT02049957|75607381|FG006|Overall Study|Adverse Event|0|||
41931163|NCT02049957|75607382|FG007|Overall Study|Adverse Event|6|||
41931164|NCT02049957|75607383|FG008|Overall Study|Adverse Event|1|||
41931165|NCT02049957|75607375|FG000|Overall Study|Study Terminated by Sponsor|0|||
41931166|NCT02049957|75607376|FG001|Overall Study|Study Terminated by Sponsor|1|||
41931167|NCT02049957|75607377|FG002|Overall Study|Study Terminated by Sponsor|0|||
41931168|NCT02049957|75607378|FG003|Overall Study|Study Terminated by Sponsor|0|||
41931169|NCT02049957|75607379|FG004|Overall Study|Study Terminated by Sponsor|0|||
41931170|NCT02049957|75607380|FG005|Overall Study|Study Terminated by Sponsor|0|||
41931171|NCT02049957|75607381|FG006|Overall Study|Study Terminated by Sponsor|1|||
41931172|NCT02049957|75607382|FG007|Overall Study|Study Terminated by Sponsor|0|||
41931173|NCT02049957|75607383|FG008|Overall Study|Study Terminated by Sponsor|0|||
41931174|NCT02049957|75607375|FG000|Overall Study|Withdrawal by Subject|0|||
41931175|NCT02049957|75607376|FG001|Overall Study|Withdrawal by Subject|0|||
41931176|NCT02049957|75607377|FG002|Overall Study|Withdrawal by Subject|0|||
41931177|NCT02049957|75607378|FG003|Overall Study|Withdrawal by Subject|1|||
41931178|NCT02049957|75607379|FG004|Overall Study|Withdrawal by Subject|0|||
41931179|NCT02049957|75607380|FG005|Overall Study|Withdrawal by Subject|2|||
42209472|NCT04382053|76023916|FG000|Overall Study|Lost to Follow-up|0|||
41931180|NCT02049957|75607381|FG006|Overall Study|Withdrawal by Subject|0|||
41931181|NCT02049957|75607382|FG007|Overall Study|Withdrawal by Subject|3|||
41931182|NCT02049957|75607383|FG008|Overall Study|Withdrawal by Subject|1|||
41931183|NCT02049957|75607375|FG000|Overall Study|Physician Decision|0|||
41931184|NCT02049957|75607376|FG001|Overall Study|Physician Decision|0|||
41931185|NCT02049957|75607377|FG002|Overall Study|Physician Decision|0|||
41931186|NCT02049957|75607378|FG003|Overall Study|Physician Decision|0|||
41931187|NCT02049957|75607379|FG004|Overall Study|Physician Decision|0|||
41931188|NCT02049957|75607380|FG005|Overall Study|Physician Decision|1|||
41931189|NCT02049957|75607381|FG006|Overall Study|Physician Decision|0|||
41931190|NCT02049957|75607382|FG007|Overall Study|Physician Decision|0|||
41931191|NCT02049957|75607383|FG008|Overall Study|Physician Decision|0|||
41931192|NCT00014495|75607646|FG000|Overall Study|Death|0|||
41931193|NCT00014495|75607647|FG001|Overall Study|Death|0|||
41931194|NCT00014495|75607648|FG002|Overall Study|Death|1|||
41931195|NCT00014495|75607649|FG003|Overall Study|Death|0|||
41931196|NCT00014495|75607646|FG000|Overall Study|Clinical deterioration|0|||
41931197|NCT00014495|75607647|FG001|Overall Study|Clinical deterioration|0|||
41931198|NCT00014495|75607648|FG002|Overall Study|Clinical deterioration|0|||
41931199|NCT00014495|75607649|FG003|Overall Study|Clinical deterioration|1|||
41931200|NCT01351623|75609661|FG000|Overall Study|Protocol Violation|2|||
41931201|NCT01351623|75609661|FG000|Overall Study|Adverse Event|4|||
41931202|NCT01351623|75609661|FG000|Overall Study|Withdrawal by Subject|1|||
41931203|NCT01351623|75609661|FG000|Overall Study|Death|2|||
41931204|NCT03670953|75609802|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
41931205|NCT03670953|75609803|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
41931206|NCT03670953|75609804|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
41931207|NCT03670953|75609805|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
41931208|NCT03670953|75609802|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
41931209|NCT03670953|75609803|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
41931210|NCT03670953|75609804|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
41931211|NCT03670953|75609805|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
41931212|NCT03670953|75609802|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
41931213|NCT03670953|75609803|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
41931214|NCT03670953|75609804|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
41931215|NCT03670953|75609805|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
41931216|NCT03670953|75609802|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
41931217|NCT03670953|75609803|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
41931218|NCT03670953|75609804|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
41931219|NCT03670953|75609805|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
41931220|NCT03670953|75609802|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
41931221|NCT03670953|75609803|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
41931222|NCT03670953|75609804|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
41931223|NCT03670953|75609805|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
41931224|NCT03670953|75609802|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
41931225|NCT03670953|75609803|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
41931226|NCT03670953|75609804|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
41931227|NCT03670953|75609805|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
41931228|NCT03670953|75609802|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
41931229|NCT03670953|75609803|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
41931230|NCT03670953|75609804|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
41931231|NCT03670953|75609805|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
41931232|NCT03670953|75609802|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
41931233|NCT03670953|75609803|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
41931234|NCT03670953|75609804|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
41931235|NCT03670953|75609805|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
41931236|NCT03670953|75609802|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
41931237|NCT03670953|75609803|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
41931238|NCT03670953|75609804|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
41931239|NCT03670953|75609805|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
41931240|NCT03670953|75609802|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
41931241|NCT03670953|75609803|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
41931242|NCT03670953|75609804|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
41931243|NCT03670953|75609805|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
41931244|NCT03670953|75609802|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
41931245|NCT03670953|75609803|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
41931246|NCT03670953|75609804|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
41931247|NCT03670953|75609805|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
41931248|NCT03670953|75609802|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
41931249|NCT03670953|75609803|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
41931250|NCT03670953|75609804|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
41931251|NCT03670953|75609805|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
41931252|NCT03670953|75609802|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
41931253|NCT03670953|75609803|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
41931254|NCT03670953|75609804|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
41931255|NCT03670953|75609805|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
41931256|NCT03670953|75609802|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
41931257|NCT03670953|75609803|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
42209473|NCT04382053|76023917|FG001|Overall Study|Lost to Follow-up|2|||
41931258|NCT03670953|75609804|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
41931259|NCT03670953|75609805|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
41931260|NCT03670953|75609802|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
41931261|NCT03670953|75609803|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
41931262|NCT03670953|75609804|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
41931263|NCT03670953|75609805|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
41931264|NCT03670953|75609802|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
42209474|NCT04382053|76023916|FG000|Overall Study|Protocol Deviation|1|||
42209475|NCT04382053|76023917|FG001|Overall Study|Protocol Deviation|2|||
42209476|NCT04382053|76023916|FG000|Overall Study|Withdrawal by Subject|2|||
42209477|NCT04382053|76023917|FG001|Overall Study|Withdrawal by Subject|1|||
42209478|NCT03066830|76023926|FG000|Overall Study|At the Participant's own Request|16|||
41931265|NCT03670953|75609803|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
41931266|NCT03670953|75609804|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
41931267|NCT03670953|75609805|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
41931268|NCT03670953|75609802|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
41931269|NCT03670953|75609803|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
41931270|NCT03670953|75609804|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
41931271|NCT03670953|75609805|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
41931272|NCT03670953|75609802|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
41931273|NCT03670953|75609803|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
41931274|NCT03670953|75609804|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
41931275|NCT03670953|75609805|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
41931276|NCT00636818|75609831|FG000|Overall Study|Adverse Event|1|||
41931277|NCT00636818|75609831|FG000|Overall Study|Lost to Follow-up|2|||
41931278|NCT00636818|75609831|FG000|Overall Study|Entry Criteria Exclusion|3|||
41931279|NCT00636818|75609831|FG000|Overall Study|Protocol Violation|1|||
41931280|NCT00636818|75609831|FG000|Overall Study|Withdrawal by Subject|4|||
41931281|NCT03127137|75609837|FG000|Overall Study|Requested sedation after consent|1|||
41931282|NCT03127137|75609838|FG001|Overall Study|Requested sedation after consent|0|||
41931283|NCT03127137|75609837|FG000|Overall Study|Malfunction in electronic data collection|1|||
41931284|NCT03127137|75609838|FG001|Overall Study|Malfunction in electronic data collection|0|||
41931285|NCT03127137|75609837|FG000|Overall Study|Post procedure testing could not be obtained|0|||
41931286|NCT03127137|75609838|FG001|Overall Study|Post procedure testing could not be obtained|1|||
41931287|NCT00636506|75609846|FG000|Overall Study|Lost to Follow-up|8|||
41931288|NCT00636506|75609846|FG000|Overall Study|Explanted|1|||
41931289|NCT00636506|75609846|FG000|Overall Study|Withdrawal by Subject|6|||
41931290|NCT00636506|75609846|FG000|Overall Study|Procedure aborted|1|||
41931291|NCT00636194|75609870|FG000|Overall Study|Study related symptoms and complaints|1|||
41931292|NCT00636194|75609871|FG001|Overall Study|Study related symptoms and complaints|0|||
41931293|NCT00636194|75609870|FG000|Overall Study|Protocol Violation|2|||
41931294|NCT00636194|75609871|FG001|Overall Study|Protocol Violation|0|||
41931295|NCT00635804|75609937|FG000|Overall Study|Adverse Event|0|||
41931296|NCT00635804|75609938|FG001|Overall Study|Adverse Event|0|||
41931297|NCT00635804|75609939|FG002|Overall Study|Adverse Event|0|||
41931298|NCT00635804|75609940|FG003|Overall Study|Adverse Event|0|||
41931299|NCT00635804|75609941|FG004|Overall Study|Adverse Event|0|||
41931300|NCT00635804|75609942|FG005|Overall Study|Adverse Event|1|||
41931301|NCT00635804|75609943|FG006|Overall Study|Adverse Event|0|||
41931302|NCT00635804|75609944|FG007|Overall Study|Adverse Event|0|||
41931303|NCT00635804|75609937|FG000|Overall Study|Withdrawal by Subject|1|||
41931304|NCT00635804|75609938|FG001|Overall Study|Withdrawal by Subject|0|||
41931305|NCT00635804|75609939|FG002|Overall Study|Withdrawal by Subject|0|||
41931306|NCT00635804|75609940|FG003|Overall Study|Withdrawal by Subject|0|||
41931307|NCT00635804|75609941|FG004|Overall Study|Withdrawal by Subject|0|||
41931308|NCT00635804|75609942|FG005|Overall Study|Withdrawal by Subject|0|||
41931309|NCT00635804|75609943|FG006|Overall Study|Withdrawal by Subject|0|||
41931310|NCT00635804|75609944|FG007|Overall Study|Withdrawal by Subject|0|||
41931311|NCT00635648|75609974|FG000|Overall Study|Adverse Event|12|||
41931312|NCT00635648|75609974|FG000|Overall Study|Withdrawal by Subject|9|||
41931313|NCT00635648|75609974|FG000|Overall Study|Physician Decision|4|||
41931314|NCT00635648|75609974|FG000|Overall Study|Rapid progression of baseline disease|4|||
41931315|NCT00635648|75609974|FG000|Overall Study|Use of other antifungal agent needed|1|||
41931316|NCT00635648|75609974|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
41931317|NCT00635648|75609974|FG000|Overall Study|Noncompliance with protocol|1|||
41931318|NCT00635648|75609974|FG000|Overall Study|Other reason|2|||
41931319|NCT00635102|75609999|FG000|Overall Study|Withdrawal by Subject|7|||
41931320|NCT00635102|75610000|FG001|Overall Study|Withdrawal by Subject|8|||
41931321|NCT00635024|75610015|FG000|Overall Study|Adverse Event|1|||
41931322|NCT00634244|75610073|FG000|Overall Study|Never started treatment|0|||
41931323|NCT00634244|75610074|FG001|Overall Study|Never started treatment|1|||
42209479|NCT03066830|76023927|FG001|Overall Study|At the Participant's own Request|17|||
41931324|NCT00634244|75610075|FG002|Overall Study|Never started treatment|0|||
41931325|NCT00634244|75610073|FG000|Overall Study|Death|1|||
41931326|NCT00634244|75610074|FG001|Overall Study|Death|6|||
41931327|NCT00634244|75610075|FG002|Overall Study|Death|0|||
41931328|NCT00634244|75610073|FG000|Overall Study|Adverse Event|0|||
41931329|NCT00634244|75610074|FG001|Overall Study|Adverse Event|2|||
41931330|NCT00634244|75610075|FG002|Overall Study|Adverse Event|0|||
41931331|NCT00634244|75610073|FG000|Overall Study|Withdrawal by Subject|0|||
41931332|NCT00634244|75610074|FG001|Overall Study|Withdrawal by Subject|1|||
41931333|NCT00634244|75610075|FG002|Overall Study|Withdrawal by Subject|0|||
41931334|NCT00634244|75610073|FG000|Overall Study|Physician Decision|0|||
41931335|NCT00634244|75610074|FG001|Overall Study|Physician Decision|1|||
41931336|NCT00634244|75610075|FG002|Overall Study|Physician Decision|0|||
41931337|NCT00634244|75610073|FG000|Overall Study|Disease progression/relapse|0|||
41931338|NCT00634244|75610074|FG001|Overall Study|Disease progression/relapse|1|||
41931339|NCT00634244|75610075|FG002|Overall Study|Disease progression/relapse|0|||
41931340|NCT00634244|75610073|FG000|Overall Study|Other complicating disease|0|||
41931341|NCT00634244|75610074|FG001|Overall Study|Other complicating disease|1|||
41931342|NCT00634244|75610075|FG002|Overall Study|Other complicating disease|0|||
41931343|NCT00634088|75610259|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
41931344|NCT00634088|75610260|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
41931345|NCT00634088|75610261|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
41931346|NCT00634088|75610262|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
41931347|NCT00634088|75610259|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
41931348|NCT00634088|75610260|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
41931349|NCT00634088|75610261|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
41931350|NCT00634088|75610262|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
41931351|NCT00634088|75610259|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
41931352|NCT00634088|75610260|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
41931353|NCT00634088|75610261|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
41931354|NCT00634088|75610262|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
41931355|NCT00634088|75610259|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
41931356|NCT00634088|75610260|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
41931357|NCT00634088|75610261|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
41931358|NCT00634088|75610262|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
41931359|NCT00634088|75610259|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
41931360|NCT00634088|75610260|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
41931361|NCT00634088|75610261|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
41931362|NCT00634088|75610262|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
41931363|NCT00634088|75610259|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
41931364|NCT00634088|75610260|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
41931365|NCT00634088|75610261|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
41931366|NCT00634088|75610262|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
41931367|NCT00634010|75610362|FG000|Overall Study|Adverse Event|2|||
41931368|NCT00634010|75610363|FG001|Overall Study|Adverse Event|5|||
41931369|NCT00634010|75610362|FG000|Overall Study|Withdrawal by Subject|5|||
41931370|NCT00634010|75610363|FG001|Overall Study|Withdrawal by Subject|6|||
41931371|NCT00634010|75610362|FG000|Overall Study|Physician Decision|1|||
41931372|NCT00634010|75610363|FG001|Overall Study|Physician Decision|1|||
41931373|NCT00634010|75610362|FG000|Overall Study|Disease Progression|1|||
41931374|NCT00634010|75610363|FG001|Overall Study|Disease Progression|1|||
41931375|NCT00634010|75610362|FG000|Overall Study|Non-Compliant|1|||
41931376|NCT00634010|75610363|FG001|Overall Study|Non-Compliant|1|||
41931377|NCT00633932|75610376|FG000|Overall Study|Adverse Event|1|||
41931378|NCT00633932|75610377|FG001|Overall Study|Adverse Event|3|||
41931379|NCT00633932|75610378|FG002|Overall Study|Adverse Event|4|||
41931380|NCT00633932|75610376|FG000|Overall Study|Withdrawal by Subject|3|||
41931381|NCT00633932|75610377|FG001|Overall Study|Withdrawal by Subject|9|||
42209480|NCT03066830|76023926|FG000|Overall Study|Other|3|||
42209481|NCT03066830|76023927|FG001|Overall Study|Other|0|||
42209482|NCT03066830|76023926|FG000|Overall Study|Poor Compliance to Protocol|1|||
42209483|NCT03066830|76023927|FG001|Overall Study|Poor Compliance to Protocol|0|||
41931382|NCT00633932|75610378|FG002|Overall Study|Withdrawal by Subject|1|||
41931383|NCT00633932|75610376|FG000|Overall Study|Lost to Follow-up|1|||
41931384|NCT00633932|75610377|FG001|Overall Study|Lost to Follow-up|0|||
41931385|NCT00633932|75610378|FG002|Overall Study|Lost to Follow-up|2|||
41931386|NCT00633932|75610376|FG000|Overall Study|Protocol Violation|5|||
41931387|NCT00633932|75610377|FG001|Overall Study|Protocol Violation|2|||
42117699|NCT00117637|75928532|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
41931388|NCT00633932|75610378|FG002|Overall Study|Protocol Violation|3|||
41931389|NCT00633932|75610376|FG000|Overall Study|Physician Decision|0|||
41931390|NCT00633932|75610377|FG001|Overall Study|Physician Decision|0|||
41931391|NCT00633932|75610378|FG002|Overall Study|Physician Decision|1|||
41931392|NCT00633932|75610376|FG000|Overall Study|Doctor's judgement|1|||
41931393|NCT00633932|75610377|FG001|Overall Study|Doctor's judgement|0|||
42209484|NCT03066830|76023926|FG000|Overall Study|Adverse Event|2|||
41931394|NCT00633932|75610378|FG002|Overall Study|Doctor's judgement|0|||
41931395|NCT00633932|75610376|FG000|Overall Study|Moved Away|1|||
41931396|NCT00633932|75610377|FG001|Overall Study|Moved Away|0|||
41931397|NCT00633932|75610378|FG002|Overall Study|Moved Away|0|||
41931398|NCT00633464|75610508|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
41931399|NCT00633464|75610509|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
41931400|NCT00633464|75610508|FG000|Overall Study|Never Treated (Randomized in error)|0|||
41931401|NCT00633464|75610509|FG001|Overall Study|Never Treated (Randomized in error)|1|||
41931402|NCT00633152|75610550|FG000|Overall Study|Adverse Event|1|||
41931403|NCT00633152|75610551|FG001|Overall Study|Adverse Event|0|||
41931404|NCT00633152|75610550|FG000|Overall Study|Randomized, did not receive study drug|5|||
41931405|NCT00633152|75610551|FG001|Overall Study|Randomized, did not receive study drug|2|||
41931406|NCT00633152|75610550|FG000|Overall Study|Withdrawal by Subject|1|||
41931407|NCT00633152|75610551|FG001|Overall Study|Withdrawal by Subject|1|||
41931408|NCT00633152|75610550|FG000|Overall Study|Lost to Follow-up|4|||
41931409|NCT00633152|75610551|FG001|Overall Study|Lost to Follow-up|1|||
41931410|NCT00633152|75610550|FG000|Overall Study|Miscellaneous Other|3|||
41931411|NCT00633152|75610551|FG001|Overall Study|Miscellaneous Other|2|||
41931412|NCT00633074|75610570|FG000|Overall Study|Adverse Event|1|||
41931413|NCT00633074|75610571|FG001|Overall Study|Adverse Event|0|||
41931414|NCT00630344|75610758|FG000|Overall Study|Adverse Event|5|||
41931415|NCT00630344|75610758|FG000|Overall Study|Progressive Disease|19|||
41931416|NCT00630344|75610758|FG000|Overall Study|Physician Decision|9|||
41931417|NCT00630344|75610758|FG000|Overall Study|Withdrawal by Subject|1|||
41931418|NCT00630344|75610758|FG000|Overall Study|Intercurrent Illness|1|||
41931419|NCT00630344|75610758|FG000|Overall Study|Other|1|||
41931420|NCT02913261|75610784|FG000|Overall Study|Technical problems|0|||
41931421|NCT02913261|75610785|FG001|Overall Study|Technical problems|1|||
41931422|NCT02913261|75610784|FG000|Overall Study|Lack of Efficacy|32|||
41931423|NCT02913261|75610785|FG001|Overall Study|Lack of Efficacy|69|||
41931424|NCT02913261|75610784|FG000|Overall Study|Adverse Event|27|||
41931425|NCT02913261|75610785|FG001|Overall Study|Adverse Event|5|||
41931426|NCT02913261|75610784|FG000|Overall Study|Death|25|||
41931427|NCT02913261|75610785|FG001|Overall Study|Death|22|||
41931428|NCT02913261|75610784|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
41931429|NCT02913261|75610785|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
41931430|NCT02913261|75610784|FG000|Overall Study|Disease relapse|8|||
41931431|NCT02913261|75610785|FG001|Overall Study|Disease relapse|13|||
41931432|NCT02913261|75610784|FG000|Overall Study|Physician Decision|8|||
41931433|NCT02913261|75610785|FG001|Overall Study|Physician Decision|9|||
41931434|NCT02913261|75610784|FG000|Overall Study|Subject/guardian decision|4|||
41931435|NCT02913261|75610785|FG001|Overall Study|Subject/guardian decision|6|||
41931436|NCT02913261|75610784|FG000|Overall Study|Graft loss|2|||
41931437|NCT02913261|75610785|FG001|Overall Study|Graft loss|0|||
41931438|NCT00635882|75610849|FG000|Overall Study|Protocol Violation|1|||
41931439|NCT00635882|75610850|FG001|Overall Study|Protocol Violation|0|||
41931440|NCT00635882|75610851|FG002|Overall Study|Protocol Violation|0|||
41931441|NCT00635882|75610852|FG003|Overall Study|Protocol Violation|0|||
41931442|NCT00635882|75610853|FG004|Overall Study|Protocol Violation|0|||
41931443|NCT00635882|75610854|FG005|Overall Study|Protocol Violation|0|||
41931444|NCT00986570|75611105|FG000|Overall Study|Lost to Follow-up|6|||
41931445|NCT00986570|75611105|FG000|Overall Study|Potential bias for objective assessment|1|||
41931446|NCT00986258|75611109|FG000|Observation Period|Not eligible to be dosed|11|||
41931447|NCT00986258|75611109|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
41931448|NCT00986258|75611109|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
41931449|NCT00986258|75611109|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
41931450|NCT00986258|75611109|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
41931451|NCT00986258|75611109|FG000|Titration and Optimal Dose Period|Other|1|||
41931452|NCT00986258|75611109|FG000|Maintenance Period|Adverse Event|5|||
41931453|NCT00986258|75611109|FG000|Maintenance Period|Lack of Efficacy|2|||
41931454|NCT00986258|75611109|FG000|Maintenance Period|Withdrawal by Subject|2|||
41931455|NCT00986180|75611125|FG000|Overall Study|Adverse Event|21|||
41931456|NCT00986180|75611126|FG001|Overall Study|Adverse Event|23|||
41931457|NCT00986180|75611125|FG000|Overall Study|Lack of Efficacy|4|||
41931458|NCT00986180|75611126|FG001|Overall Study|Lack of Efficacy|3|||
41931459|NCT00986180|75611125|FG000|Overall Study|Lost to Follow-up|5|||
41931460|NCT00986180|75611126|FG001|Overall Study|Lost to Follow-up|7|||
41931461|NCT00986180|75611125|FG000|Overall Study|Physician Decision|1|||
41931462|NCT00986180|75611126|FG001|Overall Study|Physician Decision|3|||
41931463|NCT00986180|75611125|FG000|Overall Study|Protocol Violation|2|||
41931464|NCT00986180|75611126|FG001|Overall Study|Protocol Violation|0|||
41931465|NCT00986180|75611125|FG000|Overall Study|Withdrawal by Subject|1|||
41931466|NCT00986180|75611126|FG001|Overall Study|Withdrawal by Subject|9|||
41931467|NCT00986180|75611125|FG000|Overall Study|Miscellanies|10|||
41931468|NCT00986180|75611126|FG001|Overall Study|Miscellanies|11|||
41931469|NCT00986102|75611308|FG000|Overall Study|Lost to Follow-up|0|||
41931470|NCT00986102|75611309|FG001|Overall Study|Lost to Follow-up|1|||
41931471|NCT00986102|75611310|FG002|Overall Study|Lost to Follow-up|0|||
41931472|NCT00986102|75611311|FG003|Overall Study|Lost to Follow-up|1|||
41931473|NCT00986102|75611308|FG000|Overall Study|Withdrawal by Subject|1|||
41931474|NCT00986102|75611309|FG001|Overall Study|Withdrawal by Subject|1|||
41931475|NCT00986102|75611310|FG002|Overall Study|Withdrawal by Subject|0|||
41931476|NCT00986102|75611311|FG003|Overall Study|Withdrawal by Subject|0|||
41931477|NCT00985946|75611334|FG000|Overall Study|Lost to Follow-up|6|||
41931478|NCT00985946|75611334|FG000|Overall Study|Withdrawal by Subject|1|||
41931479|NCT00985790|75611349|FG000|Overall Study|Withdrawal by Subject|1|||
41931480|NCT00985790|75611350|FG001|Overall Study|Withdrawal by Subject|1|||
41931481|NCT00985790|75611349|FG000|Overall Study|Lost to Follow-up|6|||
41931482|NCT00985790|75611350|FG001|Overall Study|Lost to Follow-up|7|||
41931483|NCT00985712|75611377|FG000|Overall Study|Adverse Event|0|||
41931484|NCT00985712|75611378|FG001|Overall Study|Adverse Event|1|||
41931485|NCT00985712|75611377|FG000|Overall Study|Lost to Follow-up|2|||
41931486|NCT00985712|75611378|FG001|Overall Study|Lost to Follow-up|2|||
41931487|NCT00985712|75611377|FG000|Overall Study|Protocol Violation|0|||
41931488|NCT00985712|75611378|FG001|Overall Study|Protocol Violation|1|||
41931489|NCT00985712|75611377|FG000|Overall Study|Withdrawal by Subject|4|||
41931490|NCT00985712|75611378|FG001|Overall Study|Withdrawal by Subject|1|||
41931491|NCT00985712|75611377|FG000|Overall Study|Sponsor decision|0|||
41931492|NCT00985712|75611378|FG001|Overall Study|Sponsor decision|2|||
41931493|NCT00985166|75611485|FG000|Overall Study|Lost to Follow-up|3|||
41931494|NCT00985166|75611486|FG001|Overall Study|Lost to Follow-up|2|||
41931495|NCT00985166|75611487|FG002|Overall Study|Lost to Follow-up|2|||
41931496|NCT00985166|75611485|FG000|Overall Study|Withdrawal by Subject|3|||
41931497|NCT00985166|75611486|FG001|Overall Study|Withdrawal by Subject|2|||
41931498|NCT00985166|75611487|FG002|Overall Study|Withdrawal by Subject|0|||
41931499|NCT00985166|75611485|FG000|Overall Study|Test not done|2|||
41931500|NCT00985166|75611486|FG001|Overall Study|Test not done|0|||
41931501|NCT00985166|75611487|FG002|Overall Study|Test not done|4|||
41931502|NCT00985166|75611485|FG000|Overall Study|Other|1|||
41931503|NCT00985166|75611486|FG001|Overall Study|Other|0|||
41931504|NCT00985166|75611487|FG002|Overall Study|Other|1|||
41931505|NCT01341405|75611733|FG000|Overall Study|Adverse Event|0|||
41931506|NCT01341405|75611734|FG001|Overall Study|Adverse Event|1|||
41931507|NCT01341405|75611735|FG002|Overall Study|Adverse Event|1|||
41931508|NCT01341405|75611733|FG000|Overall Study|Withdrawal by Subject|3|||
41931509|NCT01341405|75611734|FG001|Overall Study|Withdrawal by Subject|2|||
41931510|NCT01341405|75611735|FG002|Overall Study|Withdrawal by Subject|1|||
41931511|NCT00633945|75612973|FG000|Overall Study|Physician Decision|2|||
41931512|NCT02574078|75613237|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41931513|NCT02574078|75613238|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41931514|NCT02574078|75613239|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41931515|NCT02574078|75613240|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41931516|NCT02574078|75613241|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41931517|NCT02574078|75613242|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
41931518|NCT02574078|75613243|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
41931519|NCT02574078|75613244|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41931520|NCT02574078|75613245|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
41931521|NCT02574078|75613246|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41931522|NCT02574078|75613247|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41931523|NCT02574078|75613248|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41931524|NCT02574078|75613249|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41931525|NCT02574078|75613237|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
41931526|NCT02574078|75613238|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
41931527|NCT02574078|75613239|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
41931528|NCT02574078|75613240|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
41931529|NCT02574078|75613241|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
41931530|NCT02574078|75613242|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
41931531|NCT02574078|75613243|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
41931532|NCT02574078|75613244|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
41931533|NCT02574078|75613245|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
41931534|NCT02574078|75613246|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
41931535|NCT02574078|75613247|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
41931536|NCT02574078|75613248|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
41931537|NCT02574078|75613249|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
41931538|NCT02574078|75613237|FG000|Pre-Treatment Period|Other reasons|0|||
41931539|NCT02574078|75613238|FG001|Pre-Treatment Period|Other reasons|0|||
41931540|NCT02574078|75613239|FG002|Pre-Treatment Period|Other reasons|0|||
41931541|NCT02574078|75613240|FG003|Pre-Treatment Period|Other reasons|0|||
41931542|NCT02574078|75613241|FG004|Pre-Treatment Period|Other reasons|0|||
41931543|NCT02574078|75613242|FG005|Pre-Treatment Period|Other reasons|0|||
41931544|NCT02574078|75613243|FG006|Pre-Treatment Period|Other reasons|2|||
41931545|NCT02574078|75613244|FG007|Pre-Treatment Period|Other reasons|0|||
41931546|NCT02574078|75613245|FG008|Pre-Treatment Period|Other reasons|0|||
41931547|NCT02574078|75613246|FG009|Pre-Treatment Period|Other reasons|0|||
41931548|NCT02574078|75613247|FG010|Pre-Treatment Period|Other reasons|2|||
41931549|NCT02574078|75613248|FG011|Pre-Treatment Period|Other reasons|0|||
41931550|NCT02574078|75613249|FG012|Pre-Treatment Period|Other reasons|0|||
41931551|NCT02574078|75613237|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
41931552|NCT02574078|75613238|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
41931553|NCT02574078|75613239|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
41931554|NCT02574078|75613240|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
41931555|NCT02574078|75613241|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
41931556|NCT02574078|75613242|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
41931557|NCT02574078|75613243|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
41931558|NCT02574078|75613244|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
41931559|NCT02574078|75613245|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
41931560|NCT02574078|75613246|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
41931561|NCT02574078|75613247|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
41931562|NCT02574078|75613248|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
41931563|NCT02574078|75613249|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
41931564|NCT02574078|75613237|FG000|Treatment Period|Disease progression|6|||
41931565|NCT02574078|75613238|FG001|Treatment Period|Disease progression|4|||
41931566|NCT02574078|75613239|FG002|Treatment Period|Disease progression|7|||
41931567|NCT02574078|75613240|FG003|Treatment Period|Disease progression|18|||
41931568|NCT02574078|75613241|FG004|Treatment Period|Disease progression|16|||
41931569|NCT02574078|75613242|FG005|Treatment Period|Disease progression|26|||
41931570|NCT02574078|75613243|FG006|Treatment Period|Disease progression|5|||
41931571|NCT02574078|75613244|FG007|Treatment Period|Disease progression|9|||
41931572|NCT02574078|75613245|FG008|Treatment Period|Disease progression|8|||
41931573|NCT02574078|75613246|FG009|Treatment Period|Disease progression|5|||
41931574|NCT02574078|75613247|FG010|Treatment Period|Disease progression|20|||
41931575|NCT02574078|75613248|FG011|Treatment Period|Disease progression|29|||
41931576|NCT02574078|75613249|FG012|Treatment Period|Disease progression|2|||
41931577|NCT02574078|75613237|FG000|Treatment Period|Study drug toxicity|1|||
41931578|NCT02574078|75613238|FG001|Treatment Period|Study drug toxicity|1|||
41931579|NCT02574078|75613239|FG002|Treatment Period|Study drug toxicity|0|||
41931580|NCT02574078|75613240|FG003|Treatment Period|Study drug toxicity|5|||
41931581|NCT02574078|75613241|FG004|Treatment Period|Study drug toxicity|3|||
41931582|NCT02574078|75613242|FG005|Treatment Period|Study drug toxicity|1|||
41931583|NCT02574078|75613243|FG006|Treatment Period|Study drug toxicity|2|||
41931584|NCT02574078|75613244|FG007|Treatment Period|Study drug toxicity|0|||
41931585|NCT02574078|75613245|FG008|Treatment Period|Study drug toxicity|2|||
41931586|NCT02574078|75613246|FG009|Treatment Period|Study drug toxicity|1|||
41931587|NCT02574078|75613247|FG010|Treatment Period|Study drug toxicity|16|||
41931588|NCT02574078|75613248|FG011|Treatment Period|Study drug toxicity|2|||
41931589|NCT02574078|75613249|FG012|Treatment Period|Study drug toxicity|4|||
41931590|NCT02574078|75613237|FG000|Treatment Period|Death|2|||
41931591|NCT02574078|75613238|FG001|Treatment Period|Death|0|||
41931592|NCT02574078|75613239|FG002|Treatment Period|Death|0|||
41931593|NCT02574078|75613240|FG003|Treatment Period|Death|0|||
41931594|NCT02574078|75613241|FG004|Treatment Period|Death|1|||
41931595|NCT02574078|75613242|FG005|Treatment Period|Death|1|||
41931596|NCT02574078|75613243|FG006|Treatment Period|Death|1|||
41931597|NCT02574078|75613244|FG007|Treatment Period|Death|1|||
41931598|NCT02574078|75613245|FG008|Treatment Period|Death|7|||
41931599|NCT02574078|75613246|FG009|Treatment Period|Death|1|||
41931600|NCT02574078|75613247|FG010|Treatment Period|Death|0|||
41931601|NCT02574078|75613248|FG011|Treatment Period|Death|2|||
41931602|NCT02574078|75613249|FG012|Treatment Period|Death|1|||
41931603|NCT02574078|75613237|FG000|Treatment Period|Adverse event unrelated to drug|0|||
41931604|NCT02574078|75613238|FG001|Treatment Period|Adverse event unrelated to drug|0|||
41931605|NCT02574078|75613239|FG002|Treatment Period|Adverse event unrelated to drug|1|||
41931606|NCT02574078|75613240|FG003|Treatment Period|Adverse event unrelated to drug|0|||
41931607|NCT02574078|75613241|FG004|Treatment Period|Adverse event unrelated to drug|2|||
41931608|NCT02574078|75613242|FG005|Treatment Period|Adverse event unrelated to drug|3|||
41931609|NCT02574078|75613243|FG006|Treatment Period|Adverse event unrelated to drug|0|||
41931610|NCT02574078|75613244|FG007|Treatment Period|Adverse event unrelated to drug|0|||
41931611|NCT02574078|75613245|FG008|Treatment Period|Adverse event unrelated to drug|1|||
41931612|NCT02574078|75613246|FG009|Treatment Period|Adverse event unrelated to drug|2|||
41931613|NCT02574078|75613247|FG010|Treatment Period|Adverse event unrelated to drug|4|||
41931614|NCT02574078|75613248|FG011|Treatment Period|Adverse event unrelated to drug|1|||
41931615|NCT02574078|75613249|FG012|Treatment Period|Adverse event unrelated to drug|0|||
41931616|NCT02574078|75613237|FG000|Treatment Period|Administrative reason by Sponsor|0|||
41931617|NCT02574078|75613238|FG001|Treatment Period|Administrative reason by Sponsor|1|||
41931618|NCT02574078|75613239|FG002|Treatment Period|Administrative reason by Sponsor|0|||
41931619|NCT02574078|75613240|FG003|Treatment Period|Administrative reason by Sponsor|0|||
41931620|NCT02574078|75613241|FG004|Treatment Period|Administrative reason by Sponsor|0|||
41931621|NCT02574078|75613242|FG005|Treatment Period|Administrative reason by Sponsor|0|||
41931622|NCT02574078|75613243|FG006|Treatment Period|Administrative reason by Sponsor|1|||
41931623|NCT02574078|75613244|FG007|Treatment Period|Administrative reason by Sponsor|0|||
41931624|NCT02574078|75613245|FG008|Treatment Period|Administrative reason by Sponsor|0|||
41931625|NCT02574078|75613246|FG009|Treatment Period|Administrative reason by Sponsor|0|||
41931626|NCT02574078|75613247|FG010|Treatment Period|Administrative reason by Sponsor|0|||
41931627|NCT02574078|75613248|FG011|Treatment Period|Administrative reason by Sponsor|0|||
41931628|NCT02574078|75613249|FG012|Treatment Period|Administrative reason by Sponsor|3|||
41931629|NCT02574078|75613237|FG000|Treatment Period|Other reasons|1|||
41931630|NCT02574078|75613238|FG001|Treatment Period|Other reasons|0|||
41931631|NCT02574078|75613239|FG002|Treatment Period|Other reasons|1|||
41931632|NCT02574078|75613240|FG003|Treatment Period|Other reasons|3|||
41931633|NCT02574078|75613241|FG004|Treatment Period|Other reasons|3|||
41931634|NCT02574078|75613242|FG005|Treatment Period|Other reasons|1|||
41931635|NCT02574078|75613243|FG006|Treatment Period|Other reasons|2|||
41931636|NCT02574078|75613244|FG007|Treatment Period|Other reasons|1|||
41931637|NCT02574078|75613245|FG008|Treatment Period|Other reasons|3|||
41931638|NCT02574078|75613246|FG009|Treatment Period|Other reasons|1|||
41931639|NCT02574078|75613247|FG010|Treatment Period|Other reasons|1|||
41931640|NCT02574078|75613248|FG011|Treatment Period|Other reasons|3|||
41931641|NCT02574078|75613249|FG012|Treatment Period|Other reasons|1|||
41931642|NCT02574078|75613237|FG000|Treatment Period|Participant request to stop drug|0|||
41931643|NCT02574078|75613238|FG001|Treatment Period|Participant request to stop drug|0|||
41931644|NCT02574078|75613239|FG002|Treatment Period|Participant request to stop drug|0|||
41931645|NCT02574078|75613240|FG003|Treatment Period|Participant request to stop drug|2|||
41931646|NCT02574078|75613241|FG004|Treatment Period|Participant request to stop drug|4|||
41931647|NCT02574078|75613242|FG005|Treatment Period|Participant request to stop drug|0|||
41931648|NCT02574078|75613243|FG006|Treatment Period|Participant request to stop drug|1|||
41931649|NCT02574078|75613244|FG007|Treatment Period|Participant request to stop drug|0|||
41931650|NCT02574078|75613245|FG008|Treatment Period|Participant request to stop drug|3|||
41931651|NCT02574078|75613246|FG009|Treatment Period|Participant request to stop drug|2|||
41931652|NCT02574078|75613247|FG010|Treatment Period|Participant request to stop drug|2|||
41931653|NCT02574078|75613248|FG011|Treatment Period|Participant request to stop drug|4|||
41931654|NCT02574078|75613249|FG012|Treatment Period|Participant request to stop drug|1|||
41931655|NCT02574078|75613237|FG000|Treatment Period|Participant withdrew consent|0|||
41931656|NCT02574078|75613238|FG001|Treatment Period|Participant withdrew consent|0|||
41931657|NCT02574078|75613239|FG002|Treatment Period|Participant withdrew consent|0|||
41931658|NCT02574078|75613240|FG003|Treatment Period|Participant withdrew consent|0|||
41931659|NCT02574078|75613241|FG004|Treatment Period|Participant withdrew consent|1|||
41931660|NCT02574078|75613242|FG005|Treatment Period|Participant withdrew consent|1|||
41931661|NCT02574078|75613243|FG006|Treatment Period|Participant withdrew consent|0|||
41931662|NCT02574078|75613244|FG007|Treatment Period|Participant withdrew consent|1|||
41931663|NCT02574078|75613245|FG008|Treatment Period|Participant withdrew consent|0|||
41931664|NCT02574078|75613246|FG009|Treatment Period|Participant withdrew consent|2|||
41931665|NCT02574078|75613247|FG010|Treatment Period|Participant withdrew consent|1|||
41931666|NCT02574078|75613248|FG011|Treatment Period|Participant withdrew consent|4|||
41931667|NCT02574078|75613249|FG012|Treatment Period|Participant withdrew consent|1|||
41931668|NCT02574078|75613237|FG000|Treatment Period|Participant no longer meets criteria|0|||
41931669|NCT02574078|75613238|FG001|Treatment Period|Participant no longer meets criteria|0|||
41931670|NCT02574078|75613239|FG002|Treatment Period|Participant no longer meets criteria|0|||
41931671|NCT02574078|75613240|FG003|Treatment Period|Participant no longer meets criteria|0|||
41931672|NCT02574078|75613241|FG004|Treatment Period|Participant no longer meets criteria|1|||
41931673|NCT02574078|75613242|FG005|Treatment Period|Participant no longer meets criteria|0|||
41931674|NCT02574078|75613243|FG006|Treatment Period|Participant no longer meets criteria|0|||
41931675|NCT02574078|75613244|FG007|Treatment Period|Participant no longer meets criteria|0|||
41931676|NCT02574078|75613245|FG008|Treatment Period|Participant no longer meets criteria|0|||
41931677|NCT02574078|75613246|FG009|Treatment Period|Participant no longer meets criteria|1|||
41931678|NCT02574078|75613247|FG010|Treatment Period|Participant no longer meets criteria|1|||
41931679|NCT02574078|75613248|FG011|Treatment Period|Participant no longer meets criteria|1|||
41931680|NCT02574078|75613249|FG012|Treatment Period|Participant no longer meets criteria|0|||
41931681|NCT02574078|75613237|FG000|Treatment Period|Lost to Follow-up|0|||
41931682|NCT02574078|75613238|FG001|Treatment Period|Lost to Follow-up|0|||
41931683|NCT02574078|75613239|FG002|Treatment Period|Lost to Follow-up|0|||
41931684|NCT02574078|75613240|FG003|Treatment Period|Lost to Follow-up|0|||
41931685|NCT02574078|75613241|FG004|Treatment Period|Lost to Follow-up|0|||
41931686|NCT02574078|75613242|FG005|Treatment Period|Lost to Follow-up|0|||
41931687|NCT02574078|75613243|FG006|Treatment Period|Lost to Follow-up|0|||
41931688|NCT02574078|75613244|FG007|Treatment Period|Lost to Follow-up|0|||
41931689|NCT02574078|75613245|FG008|Treatment Period|Lost to Follow-up|0|||
41931690|NCT02574078|75613246|FG009|Treatment Period|Lost to Follow-up|1|||
41931691|NCT02574078|75613247|FG010|Treatment Period|Lost to Follow-up|0|||
41931692|NCT02574078|75613248|FG011|Treatment Period|Lost to Follow-up|1|||
41931693|NCT02574078|75613249|FG012|Treatment Period|Lost to Follow-up|0|||
41931694|NCT02574078|75613237|FG000|Treatment Period|Maximum clinical benefit|0|||
41931695|NCT02574078|75613238|FG001|Treatment Period|Maximum clinical benefit|0|||
41931696|NCT02574078|75613239|FG002|Treatment Period|Maximum clinical benefit|0|||
41931697|NCT02574078|75613240|FG003|Treatment Period|Maximum clinical benefit|0|||
41931698|NCT02574078|75613241|FG004|Treatment Period|Maximum clinical benefit|0|||
41931699|NCT02574078|75613242|FG005|Treatment Period|Maximum clinical benefit|0|||
41931700|NCT02574078|75613243|FG006|Treatment Period|Maximum clinical benefit|0|||
41931701|NCT02574078|75613244|FG007|Treatment Period|Maximum clinical benefit|0|||
41931702|NCT02574078|75613245|FG008|Treatment Period|Maximum clinical benefit|0|||
41931703|NCT02574078|75613246|FG009|Treatment Period|Maximum clinical benefit|1|||
41931704|NCT02574078|75613247|FG010|Treatment Period|Maximum clinical benefit|0|||
41931705|NCT02574078|75613248|FG011|Treatment Period|Maximum clinical benefit|0|||
41931706|NCT02574078|75613249|FG012|Treatment Period|Maximum clinical benefit|0|||
41931707|NCT02565810|75613367|FG000|Overall Study|Withdrawal by Subject|1|||
41931708|NCT02561832|75613532|FG000|Overall Study|Withdrawal by Subject|1|||
42209485|NCT03066830|76023927|FG001|Overall Study|Adverse Event|2|||
42209486|NCT03066830|76023926|FG000|Overall Study|Lost to Follow-up|11|||
42209487|NCT03066830|76023927|FG001|Overall Study|Lost to Follow-up|3|||
42209488|NCT04380961|76023936|FG000|Overall Study|Lost to Follow-up|17|||
42209489|NCT04380961|76023937|FG001|Overall Study|Lost to Follow-up|11|||
42209490|NCT04380961|76023936|FG000|Overall Study|Withdrawal by Subject|3|||
42209491|NCT04380961|76023937|FG001|Overall Study|Withdrawal by Subject|0|||
42209492|NCT04380961|76023936|FG000|Overall Study|Death|22|||
42209493|NCT04380961|76023937|FG001|Overall Study|Death|16|||
42209494|NCT04380961|76023936|FG000|Overall Study|Other|1|||
42209495|NCT04380961|76023937|FG001|Overall Study|Other|0|||
42209496|NCT04380961|76023936|FG000|Overall Study|Randomized but Not Treated|1|||
42209497|NCT04380961|76023937|FG001|Overall Study|Randomized but Not Treated|2|||
42209498|NCT04331899|76023947|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
42209499|NCT04331899|76023948|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
42209500|NCT04328467|76023957|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
42300056|NCT02549339|76135209|FG001|12-month Follow-up|Lost to Follow-up|3|||
41931709|NCT02561832|75613533|FG001|Overall Study|Withdrawal by Subject|1|||
41931710|NCT02561832|75613532|FG000|Overall Study|Adverse Event|3|||
41931711|NCT02561832|75613533|FG001|Overall Study|Adverse Event|0|||
41931712|NCT02561832|75613532|FG000|Overall Study|Disease progression|3|||
41931713|NCT02561832|75613533|FG001|Overall Study|Disease progression|3|||
41931714|NCT00985088|75615168|FG000|Overall Study|Serious Adverse Event|1|||
41931715|NCT00985088|75615169|FG001|Overall Study|Serious Adverse Event|1|||
41931716|NCT00985088|75615170|FG002|Overall Study|Serious Adverse Event|0|||
41931717|NCT00985088|75615171|FG003|Overall Study|Serious Adverse Event|0|||
41931718|NCT00985088|75615172|FG004|Overall Study|Serious Adverse Event|0|||
41931719|NCT00985088|75615173|FG005|Overall Study|Serious Adverse Event|0|||
41931720|NCT00985088|75615174|FG006|Overall Study|Serious Adverse Event|0|||
41931721|NCT00985088|75615175|FG007|Overall Study|Serious Adverse Event|1|||
41931722|NCT00985088|75615168|FG000|Overall Study|Adverse Event|0|||
41931723|NCT00985088|75615169|FG001|Overall Study|Adverse Event|0|||
41931724|NCT00985088|75615170|FG002|Overall Study|Adverse Event|1|||
41931725|NCT00985088|75615171|FG003|Overall Study|Adverse Event|0|||
41931726|NCT00985088|75615172|FG004|Overall Study|Adverse Event|0|||
41931727|NCT00985088|75615173|FG005|Overall Study|Adverse Event|0|||
41931728|NCT00985088|75615174|FG006|Overall Study|Adverse Event|0|||
41931729|NCT00985088|75615175|FG007|Overall Study|Adverse Event|0|||
41931730|NCT00985088|75615168|FG000|Overall Study|Withdrawal by Subject|4|||
41931731|NCT00985088|75615169|FG001|Overall Study|Withdrawal by Subject|0|||
41931732|NCT00985088|75615170|FG002|Overall Study|Withdrawal by Subject|0|||
41931733|NCT00985088|75615171|FG003|Overall Study|Withdrawal by Subject|1|||
41931734|NCT00985088|75615172|FG004|Overall Study|Withdrawal by Subject|3|||
41931735|NCT00985088|75615173|FG005|Overall Study|Withdrawal by Subject|2|||
41931736|NCT00985088|75615174|FG006|Overall Study|Withdrawal by Subject|1|||
41931737|NCT00985088|75615175|FG007|Overall Study|Withdrawal by Subject|2|||
41931738|NCT00985088|75615168|FG000|Overall Study|Migrated/moved from study area|0|||
41931739|NCT00985088|75615169|FG001|Overall Study|Migrated/moved from study area|0|||
41931740|NCT00985088|75615170|FG002|Overall Study|Migrated/moved from study area|1|||
41931741|NCT00985088|75615171|FG003|Overall Study|Migrated/moved from study area|0|||
41931742|NCT00985088|75615172|FG004|Overall Study|Migrated/moved from study area|0|||
41931743|NCT00985088|75615173|FG005|Overall Study|Migrated/moved from study area|0|||
41931744|NCT00985088|75615174|FG006|Overall Study|Migrated/moved from study area|0|||
41931745|NCT00985088|75615175|FG007|Overall Study|Migrated/moved from study area|1|||
41931746|NCT00985088|75615168|FG000|Overall Study|Lost to Follow-up|6|||
42209501|NCT04328467|76023958|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
42209502|NCT04328467|76023959|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
42209503|NCT04328077|76023971|FG000|Overall Study|Lost to Follow-up|0|||
41931747|NCT00985088|75615169|FG001|Overall Study|Lost to Follow-up|1|||
41931748|NCT00985088|75615170|FG002|Overall Study|Lost to Follow-up|2|||
41931749|NCT00985088|75615171|FG003|Overall Study|Lost to Follow-up|6|||
41931750|NCT00985088|75615172|FG004|Overall Study|Lost to Follow-up|6|||
41931751|NCT00985088|75615173|FG005|Overall Study|Lost to Follow-up|5|||
41931752|NCT00985088|75615174|FG006|Overall Study|Lost to Follow-up|3|||
41931753|NCT00985088|75615175|FG007|Overall Study|Lost to Follow-up|2|||
41931754|NCT00984542|75615221|FG000|Overall Study|disease progression|19|||
41931755|NCT00984542|75615221|FG000|Overall Study|toxicity|7|||
41931756|NCT00984542|75615221|FG000|Overall Study|Death|7|||
41931757|NCT00984542|75615221|FG000|Overall Study|complicating disease|3|||
41931758|NCT00984542|75615221|FG000|Overall Study|Withdrawal by Subject|3|||
41931759|NCT00984542|75615221|FG000|Overall Study|clinical deterioration|2|||
41931760|NCT00983918|75615230|FG000|Overall Study|conversion to open cholecystectomy|0|||
41931761|NCT00983918|75615231|FG001|Overall Study|conversion to open cholecystectomy|2|||
41931762|NCT00983918|75615232|FG002|Overall Study|conversion to open cholecystectomy|2|||
41931763|NCT00983918|75615233|FG003|Overall Study|conversion to open cholecystectomy|2|||
41931764|NCT00983528|75615243|FG000|Overall Study|Death|4|||
41931765|NCT00983528|75615243|FG000|Overall Study|Lost to Follow-up|1|||
41931766|NCT00983528|75615243|FG000|Overall Study|Study Terminated|1|||
41931767|NCT00983372|75615247|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
41931768|NCT00983372|75615247|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
41931769|NCT00983372|75615247|FG000|Diltiazem ER Alone|Adverse Event|1|||
41931770|NCT00983294|75615279|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
41931771|NCT00983294|75615279|FG000|Colchicine With Azithromycin|Adverse Event|1|||
41931772|NCT00982280|75615295|FG000|Observation Period|Not eligible to be dosed|19|||
41931773|NCT00982280|75615295|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
41931774|NCT00982280|75615295|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
41931775|NCT00982280|75615295|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
41931776|NCT00982280|75615295|FG000|Maintenance Period|Adverse Event|1|||
41931777|NCT00981578|75615313|FG000|Overall Study|Death|1|||
41931778|NCT00981578|75615313|FG000|Overall Study|Withdrawal by Subject|2|||
41931779|NCT00980798|75615336|FG000|Overall Study|Adverse Event|7|||
41931780|NCT00980798|75615337|FG001|Overall Study|Adverse Event|36|||
41931781|NCT00980798|75615336|FG000|Overall Study|Lack of Efficacy|16|||
41931782|NCT00980798|75615337|FG001|Overall Study|Lack of Efficacy|5|||
41931783|NCT00980798|75615336|FG000|Overall Study|Lost to Follow-up|0|||
41931784|NCT00980798|75615337|FG001|Overall Study|Lost to Follow-up|1|||
41931785|NCT00980798|75615336|FG000|Overall Study|Physician Decision|2|||
41931786|NCT00980798|75615337|FG001|Overall Study|Physician Decision|1|||
41931787|NCT00980798|75615336|FG000|Overall Study|Withdrawal by Subject|8|||
41931788|NCT00980798|75615337|FG001|Overall Study|Withdrawal by Subject|11|||
41931789|NCT00980798|75615336|FG000|Overall Study|Other|0|||
41931790|NCT00980798|75615337|FG001|Overall Study|Other|1|||
41931791|NCT00980330|75615482|FG000|Overall Study|Adverse Event|0|||
41931792|NCT00980330|75615483|FG001|Overall Study|Adverse Event|0|||
41931793|NCT00980330|75615484|FG002|Overall Study|Adverse Event|0|||
41931794|NCT00980330|75615485|FG003|Overall Study|Adverse Event|1|||
41931795|NCT00980330|75615486|FG004|Overall Study|Adverse Event|0|||
41931796|NCT00980330|75615487|FG005|Overall Study|Adverse Event|0|||
41931797|NCT00980330|75615488|FG006|Overall Study|Adverse Event|0|||
41931798|NCT00980330|75615482|FG000|Overall Study|Lost to Follow-up|1|||
41931799|NCT00980330|75615483|FG001|Overall Study|Lost to Follow-up|1|||
41931800|NCT00980330|75615484|FG002|Overall Study|Lost to Follow-up|4|||
41931801|NCT00980330|75615485|FG003|Overall Study|Lost to Follow-up|2|||
41931802|NCT00980330|75615486|FG004|Overall Study|Lost to Follow-up|1|||
41931803|NCT00980330|75615487|FG005|Overall Study|Lost to Follow-up|1|||
41931804|NCT00980330|75615488|FG006|Overall Study|Lost to Follow-up|2|||
41931805|NCT00980330|75615482|FG000|Overall Study|Withdrawal by Subject|2|||
41931806|NCT00980330|75615483|FG001|Overall Study|Withdrawal by Subject|4|||
41931807|NCT00980330|75615484|FG002|Overall Study|Withdrawal by Subject|4|||
41931808|NCT00980330|75615485|FG003|Overall Study|Withdrawal by Subject|1|||
41931809|NCT00980330|75615486|FG004|Overall Study|Withdrawal by Subject|3|||
41931810|NCT00980330|75615487|FG005|Overall Study|Withdrawal by Subject|2|||
41931811|NCT00980330|75615488|FG006|Overall Study|Withdrawal by Subject|5|||
41931812|NCT00980330|75615482|FG000|Overall Study|(not specified)|2|||
41931813|NCT00980330|75615483|FG001|Overall Study|(not specified)|0|||
42300057|NCT02549339|76135208|FG000|12-month Follow-up|Other|0|||
41931814|NCT00980330|75615484|FG002|Overall Study|(not specified)|0|||
42021998|NCT00960154|75829337|FG001|Overall Study|Study termination|25|||
41931815|NCT00980330|75615485|FG003|Overall Study|(not specified)|1|||
41931816|NCT00980330|75615486|FG004|Overall Study|(not specified)|1|||
41931817|NCT00980330|75615487|FG005|Overall Study|(not specified)|1|||
41931818|NCT00980330|75615488|FG006|Overall Study|(not specified)|0|||
41931819|NCT00980174|75615532|FG000|Overall Study|Withdrawal by Subject|1|||
41931820|NCT00980174|75615533|FG001|Overall Study|Withdrawal by Subject|4|||
41931821|NCT00980174|75615532|FG000|Overall Study|Adverse Event|0|||
41931822|NCT00980174|75615533|FG001|Overall Study|Adverse Event|3|||
41931823|NCT00980174|75615532|FG000|Overall Study|Ineligibility determined|2|||
41931824|NCT00980174|75615533|FG001|Overall Study|Ineligibility determined|1|||
41931825|NCT00980174|75615532|FG000|Overall Study|Death|1|||
41931826|NCT00980174|75615533|FG001|Overall Study|Death|1|||
41931827|NCT00980174|75615532|FG000|Overall Study|Other|0|||
41931828|NCT00980174|75615533|FG001|Overall Study|Other|1|||
41931829|NCT00980018|75615561|FG000|Overall Study|Adverse Event|8|||
41931830|NCT00980018|75615561|FG000|Overall Study|Patient withdrew consent|3|||
41931831|NCT00980018|75615561|FG000|Overall Study|Lost to Follow-up|1|||
41931832|NCT00988052|75615579|FG000|Overall Study|Missing|1|||
41931833|NCT00988052|75615580|FG001|Overall Study|Missing|0|||
41931834|NCT00988052|75615579|FG000|Overall Study|Teva requested subject withdrawal|3|||
41931835|NCT00988052|75615580|FG001|Overall Study|Teva requested subject withdrawal|1|||
41931836|NCT00988052|75615579|FG000|Overall Study|Death|1|||
41931837|NCT00988052|75615580|FG001|Overall Study|Death|3|||
41931838|NCT00988052|75615579|FG000|Overall Study|Protocol Violation|6|||
41931839|NCT00988052|75615580|FG001|Overall Study|Protocol Violation|5|||
41931840|NCT00988052|75615579|FG000|Overall Study|Pregnancy|6|||
41931841|NCT00988052|75615580|FG001|Overall Study|Pregnancy|6|||
41931842|NCT00988052|75615579|FG000|Overall Study|Lack of Efficacy|8|||
41931843|NCT00988052|75615580|FG001|Overall Study|Lack of Efficacy|7|||
41931844|NCT00988052|75615579|FG000|Overall Study|Lost to Follow-up|6|||
41931845|NCT00988052|75615580|FG001|Overall Study|Lost to Follow-up|11|||
41931846|NCT00988052|75615579|FG000|Overall Study|Physician Decision|27|||
41931847|NCT00988052|75615580|FG001|Overall Study|Physician Decision|28|||
41931848|NCT00988052|75615579|FG000|Overall Study|Adverse Event|35|||
41931849|NCT00988052|75615580|FG001|Overall Study|Adverse Event|28|||
41931850|NCT00988052|75615579|FG000|Overall Study|Withdrawal by Subject|90|||
41931851|NCT00988052|75615580|FG001|Overall Study|Withdrawal by Subject|91|||
41931852|NCT00988052|75615579|FG000|Overall Study|Study terminated by sponsor|240|||
41931853|NCT00988052|75615580|FG001|Overall Study|Study terminated by sponsor|236|||
41931854|NCT02569710|75615681|FG000|Overall Study|Adverse Event|1|||
41931855|NCT02569710|75615682|FG001|Overall Study|Adverse Event|0|||
41931856|NCT02569710|75615683|FG002|Overall Study|Adverse Event|0|||
41931857|NCT02569710|75615684|FG003|Overall Study|Adverse Event|0|||
41931858|NCT02569710|75615685|FG004|Overall Study|Adverse Event|0|||
41931859|NCT02569710|75615686|FG005|Overall Study|Adverse Event|0|||
41931860|NCT02569710|75615687|FG006|Overall Study|Adverse Event|0|||
41931861|NCT02569710|75615688|FG007|Overall Study|Adverse Event|0|||
41931862|NCT02569710|75615689|FG008|Overall Study|Adverse Event|0|||
41931863|NCT02569710|75615690|FG009|Overall Study|Adverse Event|0|||
41931864|NCT02569710|75615681|FG000|Overall Study|Lost to Follow-up|0|||
41931865|NCT02569710|75615682|FG001|Overall Study|Lost to Follow-up|0|||
41931866|NCT02569710|75615683|FG002|Overall Study|Lost to Follow-up|0|||
41931867|NCT02569710|75615684|FG003|Overall Study|Lost to Follow-up|0|||
41931868|NCT02569710|75615685|FG004|Overall Study|Lost to Follow-up|0|||
41931869|NCT02569710|75615686|FG005|Overall Study|Lost to Follow-up|0|||
41931870|NCT02569710|75615687|FG006|Overall Study|Lost to Follow-up|1|||
41931871|NCT02569710|75615688|FG007|Overall Study|Lost to Follow-up|0|||
41931872|NCT02569710|75615689|FG008|Overall Study|Lost to Follow-up|1|||
41931873|NCT02569710|75615690|FG009|Overall Study|Lost to Follow-up|0|||
41931874|NCT02569710|75615681|FG000|Overall Study|Virologic failure|0|||
41931875|NCT02569710|75615682|FG001|Overall Study|Virologic failure|0|||
41931876|NCT02569710|75615683|FG002|Overall Study|Virologic failure|0|||
41931877|NCT02569710|75615684|FG003|Overall Study|Virologic failure|0|||
41931878|NCT02569710|75615685|FG004|Overall Study|Virologic failure|1|||
41931879|NCT02569710|75615686|FG005|Overall Study|Virologic failure|0|||
41931880|NCT02569710|75615687|FG006|Overall Study|Virologic failure|1|||
41931881|NCT02569710|75615688|FG007|Overall Study|Virologic failure|0|||
41931882|NCT02569710|75615689|FG008|Overall Study|Virologic failure|0|||
41931883|NCT02569710|75615690|FG009|Overall Study|Virologic failure|0|||
41931884|NCT02569710|75615681|FG000|Overall Study|Withdrawal by Subject|0|||
41931885|NCT02569710|75615682|FG001|Overall Study|Withdrawal by Subject|0|||
41931886|NCT02569710|75615683|FG002|Overall Study|Withdrawal by Subject|0|||
42117700|NCT00117637|75928531|FG000|Second Intervention (Period 2)|reason not reported|1|||
42209504|NCT04328077|76023972|FG001|Overall Study|Lost to Follow-up|1|||
41931887|NCT02569710|75615684|FG003|Overall Study|Withdrawal by Subject|0|||
41931888|NCT02569710|75615685|FG004|Overall Study|Withdrawal by Subject|0|||
41931889|NCT02569710|75615686|FG005|Overall Study|Withdrawal by Subject|1|||
41931890|NCT02569710|75615687|FG006|Overall Study|Withdrawal by Subject|0|||
41931891|NCT02569710|75615688|FG007|Overall Study|Withdrawal by Subject|0|||
41931892|NCT02569710|75615689|FG008|Overall Study|Withdrawal by Subject|0|||
41931893|NCT02569710|75615690|FG009|Overall Study|Withdrawal by Subject|0|||
41931894|NCT02569476|75615792|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
41931895|NCT02569476|75615792|FG000|Overall Study|Death|33|||
41931896|NCT02569476|75615792|FG000|Overall Study|Withdrawal by Subject|9|||
41931897|NCT02569476|75615792|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
41931898|NCT02569476|75615792|FG000|Overall Study|Palliative care|1|||
41931899|NCT02569476|75615792|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
41931900|NCT02569476|75615792|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
41931901|NCT02565576|75615864|FG000|Overall Study|abnormal lab value|2|||
41931902|NCT02565576|75615865|FG001|Overall Study|abnormal lab value|0|||
41931903|NCT02565576|75615864|FG000|Overall Study|subject / guardian decision|1|||
41931904|NCT02565576|75615865|FG001|Overall Study|subject / guardian decision|3|||
41931905|NCT02565576|75615864|FG000|Overall Study|Lost to Follow-up|1|||
41931906|NCT02565576|75615865|FG001|Overall Study|Lost to Follow-up|0|||
41931907|NCT02565576|75615864|FG000|Overall Study|Death|0|||
41931908|NCT02565576|75615865|FG001|Overall Study|Death|2|||
41931909|NCT02565576|75615864|FG000|Overall Study|Adverse Event|1|||
41931910|NCT02565576|75615865|FG001|Overall Study|Adverse Event|0|||
41931911|NCT02569398|75615896|FG000|Overall Study|Adverse Event|0|||
41931912|NCT02569398|75615897|FG001|Overall Study|Adverse Event|1|||
41931913|NCT02569398|75615898|FG002|Overall Study|Adverse Event|6|||
41931914|NCT02569398|75615896|FG000|Overall Study|Withdrawal by Subject|43|||
41931915|NCT02569398|75615897|FG001|Overall Study|Withdrawal by Subject|43|||
41931916|NCT02569398|75615898|FG002|Overall Study|Withdrawal by Subject|30|||
41931917|NCT02569398|75615896|FG000|Overall Study|Study terminated by sponsor|130|||
41931918|NCT02569398|75615897|FG001|Overall Study|Study terminated by sponsor|131|||
41931919|NCT02569398|75615898|FG002|Overall Study|Study terminated by sponsor|134|||
41931920|NCT02569398|75615896|FG000|Overall Study|Other|12|||
41931921|NCT02569398|75615897|FG001|Overall Study|Other|14|||
41931922|NCT02569398|75615898|FG002|Overall Study|Other|13|||
41931923|NCT02569242|75615942|FG000|Overall Study|Death|1|||
41931924|NCT02569242|75615943|FG001|Overall Study|Death|0|||
41931925|NCT02569242|75615942|FG000|Overall Study|Withdrawal by Subject|0|||
41931926|NCT02569242|75615943|FG001|Overall Study|Withdrawal by Subject|1|||
41931927|NCT01663740|75616011|FG000|Overall Study|Lost to Follow-up|1|||
41931928|NCT01663740|75616012|FG001|Overall Study|Lost to Follow-up|4|||
41931929|NCT01663740|75616011|FG000|Overall Study|Other|9|||
41931930|NCT01663740|75616012|FG001|Overall Study|Other|2|||
41931931|NCT01663740|75616011|FG000|Overall Study|Inclusion/Exclusion not met|1|||
41931932|NCT01663740|75616012|FG001|Overall Study|Inclusion/Exclusion not met|0|||
41931933|NCT01663740|75616011|FG000|Overall Study|Death|0|||
41931934|NCT01663740|75616012|FG001|Overall Study|Death|1|||
41931935|NCT01663740|75616011|FG000|Overall Study|Withdrawal by Subject|2|||
41931936|NCT01663740|75616012|FG001|Overall Study|Withdrawal by Subject|1|||
41931937|NCT01663740|75616011|FG000|Overall Study|No end of study status|3|||
41931938|NCT01663740|75616012|FG001|Overall Study|No end of study status|0|||
41931939|NCT01663506|75616128|FG000|Overall Study|Lack of Efficacy|3|||
41931940|NCT01663506|75616128|FG000|Overall Study|Consent Withdrawal by Subject|1|||
41931941|NCT01663506|75616128|FG000|Overall Study|Lost to Follow-up|1|||
41931942|NCT01663506|75616128|FG000|Overall Study|Adverse Event|1|||
41931943|NCT01663506|75616128|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
41931944|NCT02568384|75616132|FG000|Overall Study|Mobile devices incompatible with App|2|||
41931945|NCT02965976|75616239|FG000|Overall Study|Withdrawal by Subject|2|||
41931946|NCT02965976|75616240|FG001|Overall Study|Withdrawal by Subject|0|||
41931947|NCT04125680|75616258|FG000|Overall Study|Lost to Follow-up|15|||
41931948|NCT02565186|75616282|FG000|Overall Study|Adverse Event|113|||
41931949|NCT02565186|75616283|FG001|Overall Study|Adverse Event|148|||
41931950|NCT02565186|75616282|FG000|Overall Study|Lost to Follow-up|102|||
41931951|NCT02565186|75616283|FG001|Overall Study|Lost to Follow-up|93|||
41931952|NCT02565186|75616282|FG000|Overall Study|Non-Compliance|57|||
41931953|NCT02565186|75616283|FG001|Overall Study|Non-Compliance|55|||
41931954|NCT02565186|75616282|FG000|Overall Study|Withdrawal by Subject|229|||
41931955|NCT02565186|75616283|FG001|Overall Study|Withdrawal by Subject|214|||
41931956|NCT02565186|75616282|FG000|Overall Study|Physician Decision|18|||
41931957|NCT02565186|75616283|FG001|Overall Study|Physician Decision|16|||
41931958|NCT02565186|75616282|FG000|Overall Study|Sponsor Request|5|||
41931959|NCT02565186|75616283|FG001|Overall Study|Sponsor Request|9|||
41931960|NCT02565186|75616282|FG000|Overall Study|Missing|1|||
41931961|NCT02565186|75616283|FG001|Overall Study|Missing|0|||
41931962|NCT02565186|75616282|FG000|Overall Study|Did Not Receive Study Drug|55|||
41931963|NCT02565186|75616283|FG001|Overall Study|Did Not Receive Study Drug|86|||
41931964|NCT02568072|75616289|FG000|Overall Study|Unavailable for appointment|23|||
41931965|NCT02568072|75616289|FG000|Overall Study|Unable to contact|3|||
41931966|NCT02568072|75616289|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
41931967|NCT02568072|75616289|FG000|Overall Study|Withdrawal by Subject|1|||
41931968|NCT02568072|75616289|FG000|Overall Study|Sustained injury, marathon not run|24|||
41931969|NCT02565108|75616296|FG000|Overall Study|Adverse Event|1|||
41931970|NCT02565108|75616297|FG001|Overall Study|Adverse Event|0|||
41931971|NCT02565108|75616296|FG000|Overall Study|Withdrew Consent|1|||
41931972|NCT02565108|75616297|FG001|Overall Study|Withdrew Consent|0|||
41931973|NCT02564952|75616303|FG000|Overall Study|Adverse Event|6|||
41931974|NCT02564952|75616303|FG000|Overall Study|Lost to Follow-up|1|||
41931975|NCT02564952|75616303|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
41931976|NCT02564952|75616303|FG000|Overall Study|Withdrawal by Subject|1|||
41931977|NCT02564952|75616303|FG000|Overall Study|Low Efficacy|1|||
41931978|NCT02564952|75616303|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
41931979|NCT02566902|75616309|FG000|Overall Study|Protocol Violation|2|||
41931980|NCT02566902|75616310|FG001|Overall Study|Protocol Violation|1|||
41931981|NCT02564796|75616318|FG000|Overall Study|Physician Decision|2|||
41931982|NCT02564796|75616319|FG001|Overall Study|Physician Decision|2|||
41931983|NCT02564718|75616327|FG000|Overall Study|Withdrew from treatment|0|||
41931984|NCT02564718|75616328|FG001|Overall Study|Withdrew from treatment|1|||
41931985|NCT01453946|75616334|FG000|Overall Study|Did not receive drug for the taper phase|1|||
41931986|NCT01453946|75616334|FG000|Overall Study|Protocol Violation|2|||
41931987|NCT01453946|75616334|FG000|Overall Study|Lack of Efficacy|3|||
41931988|NCT01453946|75616334|FG000|Overall Study|Adverse Event|3|||
41931989|NCT02563548|75616456|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
41931990|NCT02563548|75616457|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
41931991|NCT02563548|75616458|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
41931992|NCT02563548|75616459|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
41931993|NCT02563548|75616460|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
41931994|NCT02563548|75616461|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
41931995|NCT02563548|75616456|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
41931996|NCT02563548|75616457|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
41931997|NCT02563548|75616458|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
41931998|NCT02563548|75616459|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
41931999|NCT02563548|75616460|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
41932000|NCT02563548|75616461|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
41932001|NCT02563548|75616456|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
41932002|NCT02563548|75616457|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
41932003|NCT02563548|75616458|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
41932004|NCT02563548|75616459|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
41932005|NCT02563548|75616460|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
41932006|NCT02563548|75616461|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
41932007|NCT02563548|75616456|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
41932008|NCT02563548|75616457|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
41932009|NCT02563548|75616458|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
41932010|NCT02563548|75616459|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
41932011|NCT02563548|75616460|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
41932012|NCT02563548|75616461|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
41932013|NCT02563548|75616456|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
41932014|NCT02563548|75616457|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
41932015|NCT02563548|75616458|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
41932016|NCT02563548|75616459|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
41932017|NCT02563548|75616460|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
41932018|NCT02563548|75616461|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
41932019|NCT02563548|75616456|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
41932020|NCT02563548|75616457|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
41932021|NCT02563548|75616458|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
41932022|NCT02563548|75616459|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
41932023|NCT02563548|75616460|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
41932024|NCT02563548|75616461|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
41932025|NCT02563548|75616456|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
41932026|NCT02563548|75616457|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
41932027|NCT02563548|75616458|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
41932028|NCT02563548|75616459|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
41932029|NCT02563548|75616460|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
41932030|NCT02563548|75616461|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
41932031|NCT02563548|75616456|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
41932032|NCT02563548|75616457|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
41932033|NCT02563548|75616458|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
41932034|NCT02563548|75616459|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
41932035|NCT02563548|75616460|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
41932036|NCT02563548|75616461|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
41932037|NCT02563548|75616456|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
41932038|NCT02563548|75616457|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
41932039|NCT02563548|75616458|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
41932040|NCT02563548|75616459|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
41932041|NCT02563548|75616460|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
41932042|NCT02563548|75616461|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
41932043|NCT02563548|75616456|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
41932044|NCT02563548|75616457|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
41932045|NCT02563548|75616458|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
41932046|NCT02563548|75616459|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
42021999|NCT00960076|75829345|FG000|Overall Study|Adverse Event|1|||
41932047|NCT02563548|75616460|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
41932048|NCT02563548|75616461|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
41932049|NCT02563548|75616456|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
41932050|NCT02563548|75616457|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
41932051|NCT02563548|75616458|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
41932052|NCT02563548|75616459|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
41932053|NCT02563548|75616460|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
41932054|NCT02563548|75616461|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
41932055|NCT02563548|75616456|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
41932056|NCT02563548|75616457|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
41932057|NCT02563548|75616458|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
41932058|NCT02563548|75616459|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
41932059|NCT02563548|75616460|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
41932060|NCT02563548|75616461|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
41932061|NCT02559570|75616542|FG000|Overall Study|Adverse Event|0|||
41932062|NCT02559570|75616543|FG001|Overall Study|Adverse Event|2|||
41932063|NCT02559570|75616544|FG002|Overall Study|Adverse Event|0|||
41932064|NCT02559570|75616545|FG003|Overall Study|Adverse Event|1|||
41932065|NCT02559570|75616546|FG004|Overall Study|Adverse Event|0|||
41932066|NCT02559570|75616542|FG000|Overall Study|Withdrawal of Consent|0|||
41932067|NCT02559570|75616543|FG001|Overall Study|Withdrawal of Consent|0|||
41932068|NCT02559570|75616544|FG002|Overall Study|Withdrawal of Consent|1|||
41932069|NCT02559570|75616545|FG003|Overall Study|Withdrawal of Consent|2|||
41932070|NCT02559570|75616546|FG004|Overall Study|Withdrawal of Consent|1|||
41932071|NCT02559570|75616542|FG000|Overall Study|Lost to Follow-up|1|||
41932072|NCT02559570|75616543|FG001|Overall Study|Lost to Follow-up|0|||
41932073|NCT02559570|75616544|FG002|Overall Study|Lost to Follow-up|0|||
41932074|NCT02559570|75616545|FG003|Overall Study|Lost to Follow-up|0|||
41932075|NCT02559570|75616546|FG004|Overall Study|Lost to Follow-up|0|||
41932076|NCT02559570|75616542|FG000|Overall Study|Protocol Violation|1|||
41932077|NCT02559570|75616543|FG001|Overall Study|Protocol Violation|0|||
41932078|NCT02559570|75616544|FG002|Overall Study|Protocol Violation|0|||
41932079|NCT02559570|75616545|FG003|Overall Study|Protocol Violation|0|||
41932080|NCT02559570|75616546|FG004|Overall Study|Protocol Violation|1|||
41932081|NCT02559570|75616542|FG000|Overall Study|Other Miscellaneous Reasons|0|||
41932082|NCT02559570|75616543|FG001|Overall Study|Other Miscellaneous Reasons|0|||
41932083|NCT02559570|75616544|FG002|Overall Study|Other Miscellaneous Reasons|1|||
41932084|NCT02559570|75616545|FG003|Overall Study|Other Miscellaneous Reasons|0|||
41932085|NCT02559570|75616546|FG004|Overall Study|Other Miscellaneous Reasons|0|||
41932086|NCT02559414|75616901|FG000|Overall Study|Lost to Follow-up|0|||
41932087|NCT02559414|75616902|FG001|Overall Study|Lost to Follow-up|1|||
41932088|NCT02559414|75616903|FG002|Overall Study|Lost to Follow-up|0|||
41932089|NCT02559414|75616901|FG000|Overall Study|Withdrawal by Subject|1|||
41932090|NCT02559414|75616902|FG001|Overall Study|Withdrawal by Subject|0|||
41932091|NCT02559414|75616903|FG002|Overall Study|Withdrawal by Subject|1|||
41932092|NCT02559414|75616901|FG000|Overall Study|Other|0|||
41932093|NCT02559414|75616902|FG001|Overall Study|Other|1|||
41932094|NCT02559414|75616903|FG002|Overall Study|Other|1|||
41932095|NCT02558790|75616978|FG000|Overall Study|Lost to Follow-up|2|||
41932096|NCT02558790|75616978|FG000|Overall Study|Physician Decision|1|||
41932097|NCT02558790|75616978|FG000|Overall Study|Withdrawal by Subject|1|||
41932098|NCT02558790|75616978|FG000|Overall Study|Screen Fail|3|||
41932099|NCT02556138|75617004|FG000|Overall Study|Withdrawal by Subject|1|||
41932100|NCT02558400|75617087|FG000|Overall Study|Adverse Event|47|||
41932101|NCT02558400|75617088|FG001|Overall Study|Adverse Event|53|||
41932102|NCT02558400|75617089|FG002|Overall Study|Adverse Event|4|||
41932103|NCT02558400|75617087|FG000|Overall Study|Withdrawal by Subject|13|||
42209505|NCT04328077|76023973|FG002|Overall Study|Lost to Follow-up|0|||
42209506|NCT04328077|76023974|FG003|Overall Study|Lost to Follow-up|0|||
42209507|NCT04328077|76023971|FG000|Overall Study|Withdrawal by Subject|0|||
41932104|NCT02558400|75617088|FG001|Overall Study|Withdrawal by Subject|9|||
41932105|NCT02558400|75617089|FG002|Overall Study|Withdrawal by Subject|8|||
41932106|NCT02558400|75617087|FG000|Overall Study|Non-Compliant|0|||
41932107|NCT02558400|75617088|FG001|Overall Study|Non-Compliant|1|||
41932108|NCT02558400|75617089|FG002|Overall Study|Non-Compliant|3|||
41932109|NCT02558400|75617087|FG000|Overall Study|Lost to Follow-up|5|||
41932110|NCT02558400|75617088|FG001|Overall Study|Lost to Follow-up|5|||
42209508|NCT04328077|76023972|FG001|Overall Study|Withdrawal by Subject|1|||
41932111|NCT02558400|75617089|FG002|Overall Study|Lost to Follow-up|4|||
41932112|NCT02558400|75617087|FG000|Overall Study|Lack of Efficacy|0|||
41932113|NCT02558400|75617088|FG001|Overall Study|Lack of Efficacy|13|||
41932114|NCT02558400|75617089|FG002|Overall Study|Lack of Efficacy|1|||
41932115|NCT02558400|75617087|FG000|Overall Study|Disallowed Concurrent Medication|6|||
41932116|NCT02558400|75617088|FG001|Overall Study|Disallowed Concurrent Medication|7|||
41932117|NCT02558400|75617089|FG002|Overall Study|Disallowed Concurrent Medication|5|||
41932118|NCT02558400|75617087|FG000|Overall Study|Physician Decision|2|||
41932119|NCT02558400|75617088|FG001|Overall Study|Physician Decision|2|||
41932120|NCT02558400|75617089|FG002|Overall Study|Physician Decision|0|||
41932121|NCT02558400|75617087|FG000|Overall Study|Protocol Violation|6|||
41932122|NCT02558400|75617088|FG001|Overall Study|Protocol Violation|3|||
41932123|NCT02558400|75617089|FG002|Overall Study|Protocol Violation|8|||
41932124|NCT02558400|75617087|FG000|Overall Study|Death|0|||
41932125|NCT02558400|75617088|FG001|Overall Study|Death|1|||
41932126|NCT02558400|75617089|FG002|Overall Study|Death|0|||
41932127|NCT02558400|75617087|FG000|Overall Study|Ineligible for the study|0|||
41932128|NCT02558400|75617088|FG001|Overall Study|Ineligible for the study|2|||
41932129|NCT02558400|75617089|FG002|Overall Study|Ineligible for the study|0|||
41932130|NCT01662648|75617221|FG000|Overall Study|Death|1|||
41932131|NCT01662648|75617222|FG001|Overall Study|Death|3|||
41932132|NCT01662648|75617221|FG000|Overall Study|Adverse Event|40|||
41932133|NCT01662648|75617222|FG001|Overall Study|Adverse Event|37|||
41932134|NCT01662648|75617221|FG000|Overall Study|Lack of Efficacy|17|||
41932135|NCT01662648|75617222|FG001|Overall Study|Lack of Efficacy|16|||
41932136|NCT01662648|75617221|FG000|Overall Study|Participant ineligible to continue trial|1|||
41932137|NCT01662648|75617222|FG001|Overall Study|Participant ineligible to continue trial|1|||
41932138|NCT01662648|75617221|FG000|Overall Study|Lost to Follow-up|24|||
41932139|NCT01662648|75617222|FG001|Overall Study|Lost to Follow-up|36|||
41932140|NCT01662648|75617221|FG000|Overall Study|Withdrawal by Subject|36|||
41932141|NCT01662648|75617222|FG001|Overall Study|Withdrawal by Subject|53|||
41932142|NCT01662648|75617221|FG000|Overall Study|Participant non-compliant|16|||
41932143|NCT01662648|75617222|FG001|Overall Study|Participant non-compliant|20|||
41932144|NCT01662648|75617221|FG000|Overall Study|Other|8|||
41932145|NCT01662648|75617222|FG001|Overall Study|Other|11|||
41932146|NCT01662648|75617221|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
41932147|NCT01662648|75617222|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
41932148|NCT01662648|75617221|FG000|Overall Study|LOE and other reason unspecified|1|||
41932149|NCT01662648|75617222|FG001|Overall Study|LOE and other reason unspecified|0|||
41932150|NCT01662648|75617221|FG000|Overall Study|LOE and Participant non-compliant|0|||
41932151|NCT01662648|75617222|FG001|Overall Study|LOE and Participant non-compliant|1|||
41932152|NCT02556918|75617287|FG000|Overall Study|Protocol Violation|5|||
41932153|NCT02556918|75617288|FG001|Overall Study|Protocol Violation|6|||
41932154|NCT02556918|75617287|FG000|Overall Study|Withdrawal by Subject|4|||
41932155|NCT02556918|75617288|FG001|Overall Study|Withdrawal by Subject|4|||
41932156|NCT01662492|75617404|FG000|Overall Study|Other miscellaneous reasons.|1|||
41932157|NCT01662492|75617405|FG001|Overall Study|Other miscellaneous reasons.|0|||
41932158|NCT01662492|75617406|FG002|Overall Study|Other miscellaneous reasons.|1|||
41932159|NCT01662492|75617404|FG000|Overall Study|Withdrawal by Subject|0|||
41932160|NCT01662492|75617405|FG001|Overall Study|Withdrawal by Subject|0|||
41932161|NCT01662492|75617406|FG002|Overall Study|Withdrawal by Subject|1|||
41932162|NCT01662492|75617404|FG000|Overall Study|Protocol Violation|1|||
41932163|NCT01662492|75617405|FG001|Overall Study|Protocol Violation|0|||
41932164|NCT01662492|75617406|FG002|Overall Study|Protocol Violation|0|||
41932165|NCT01662492|75617404|FG000|Overall Study|Lost to Follow-up|0|||
41932166|NCT01662492|75617405|FG001|Overall Study|Lost to Follow-up|0|||
41932167|NCT01662492|75617406|FG002|Overall Study|Lost to Follow-up|2|||
41932168|NCT01662492|75617404|FG000|Overall Study|Lack of Efficacy|1|||
41932169|NCT01662492|75617405|FG001|Overall Study|Lack of Efficacy|1|||
41932170|NCT01662492|75617406|FG002|Overall Study|Lack of Efficacy|2|||
41932171|NCT02552238|75617576|FG000|Overall Study|Withdrawal by Subject|2|||
41932172|NCT02552238|75617576|FG000|Overall Study|Adverse Event|2|||
41932173|NCT01662102|75617794|FG000|Overall Study|Sponsor's decision|1|||
41932174|NCT01662102|75617795|FG001|Overall Study|Sponsor's decision|0|||
41932175|NCT02554656|75617835|FG000|Overall Study|Protocol Violation|3|||
41932176|NCT04053868|75617883|FG000|Overall Study|Withdrawal by Subject|1|||
41932177|NCT04053868|75617884|FG001|Overall Study|Withdrawal by Subject|0|||
41932178|NCT02551692|75618059|FG000|Overall Study|Lost to Follow-up|0|||
41932179|NCT02551692|75618060|FG001|Overall Study|Lost to Follow-up|1|||
41932180|NCT02551692|75618061|FG002|Overall Study|Lost to Follow-up|4|||
41932181|NCT02551692|75618059|FG000|Overall Study|Withdrawal by Subject|1|||
41932182|NCT02551692|75618060|FG001|Overall Study|Withdrawal by Subject|0|||
41932183|NCT02551692|75618061|FG002|Overall Study|Withdrawal by Subject|1|||
41932184|NCT02553330|75618148|FG000|Overall Study|Study Terminated by Sponsor|2|||
41932185|NCT02553330|75618149|FG001|Overall Study|Study Terminated by Sponsor|13|||
41932186|NCT02553330|75618150|FG002|Overall Study|Study Terminated by Sponsor|12|||
41932187|NCT02553330|75618148|FG000|Overall Study|Withdrawal by Subject|3|||
41932188|NCT02553330|75618149|FG001|Overall Study|Withdrawal by Subject|19|||
41932189|NCT02553330|75618150|FG002|Overall Study|Withdrawal by Subject|21|||
41932190|NCT02553330|75618148|FG000|Overall Study|Other|0|||
41932191|NCT02553330|75618149|FG001|Overall Study|Other|1|||
41932192|NCT02553330|75618150|FG002|Overall Study|Other|0|||
41932193|NCT02553330|75618148|FG000|Overall Study|Non compliance to study treatment|0|||
41932194|NCT02553330|75618149|FG001|Overall Study|Non compliance to study treatment|1|||
41932195|NCT02553330|75618150|FG002|Overall Study|Non compliance to study treatment|0|||
41932196|NCT02553330|75618148|FG000|Overall Study|Adverse Event|0|||
41932197|NCT02553330|75618149|FG001|Overall Study|Adverse Event|1|||
41932198|NCT02553330|75618150|FG002|Overall Study|Adverse Event|0|||
41932199|NCT02553330|75618148|FG000|Overall Study|Lost to Follow-up|0|||
41932200|NCT02553330|75618149|FG001|Overall Study|Lost to Follow-up|4|||
41932201|NCT02553330|75618150|FG002|Overall Study|Lost to Follow-up|4|||
41932202|NCT02550288|75618192|FG000|Overall Study|Adverse Event|0|||
41932203|NCT02550288|75618193|FG001|Overall Study|Adverse Event|1|||
41932204|NCT02550288|75618194|FG002|Overall Study|Adverse Event|0|||
41932205|NCT02550288|75618195|FG003|Overall Study|Adverse Event|0|||
41932206|NCT02550288|75618196|FG004|Overall Study|Adverse Event|0|||
41932207|NCT02550288|75618192|FG000|Overall Study|Physician Decision|0|||
41932208|NCT02550288|75618193|FG001|Overall Study|Physician Decision|0|||
41932209|NCT02550288|75618194|FG002|Overall Study|Physician Decision|0|||
41932210|NCT02550288|75618195|FG003|Overall Study|Physician Decision|1|||
41932211|NCT02550288|75618196|FG004|Overall Study|Physician Decision|0|||
41932212|NCT02550288|75618192|FG000|Overall Study|Protocol Violation|2|||
41932213|NCT02550288|75618193|FG001|Overall Study|Protocol Violation|2|||
41932214|NCT02550288|75618194|FG002|Overall Study|Protocol Violation|1|||
41932215|NCT02550288|75618195|FG003|Overall Study|Protocol Violation|0|||
41932216|NCT02550288|75618196|FG004|Overall Study|Protocol Violation|3|||
41932217|NCT02550288|75618192|FG000|Overall Study|Participant moved|0|||
41932218|NCT02550288|75618193|FG001|Overall Study|Participant moved|0|||
41932219|NCT02550288|75618194|FG002|Overall Study|Participant moved|0|||
41932220|NCT02550288|75618195|FG003|Overall Study|Participant moved|1|||
41932221|NCT02550288|75618196|FG004|Overall Study|Participant moved|0|||
41932222|NCT02550288|75618192|FG000|Overall Study|Withdrawal by Subject|0|||
41932223|NCT02550288|75618193|FG001|Overall Study|Withdrawal by Subject|0|||
41932224|NCT02550288|75618194|FG002|Overall Study|Withdrawal by Subject|0|||
41932225|NCT02550288|75618195|FG003|Overall Study|Withdrawal by Subject|1|||
41932226|NCT02550288|75618196|FG004|Overall Study|Withdrawal by Subject|0|||
41932227|NCT01662336|75618257|FG000|Overall Study|Adverse Event|1|||
41932228|NCT01662336|75618257|FG000|Overall Study|No longer on LPV/r|30|||
41932229|NCT01662336|75618257|FG000|Overall Study|Other|29|||
41932230|NCT01662336|75618257|FG000|Overall Study|Withdrawal by Subject|6|||
41932231|NCT02549352|75618276|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
41932232|NCT02549352|75618277|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
41932233|NCT02549352|75618276|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
41932234|NCT02549352|75618277|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
41932235|NCT02549352|75618276|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
41932236|NCT02549352|75618277|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
41932237|NCT02549352|75618276|FG000|12-month Follow-up|Withdrawal by Subject|4|||
41932238|NCT02549352|75618277|FG001|12-month Follow-up|Withdrawal by Subject|5|||
41932239|NCT02549352|75618276|FG000|12-month Follow-up|Lost to Follow-up|3|||
41932240|NCT02549352|75618277|FG001|12-month Follow-up|Lost to Follow-up|2|||
41932241|NCT02549352|75618276|FG000|12-month Follow-up|Death|0|||
41932242|NCT02549352|75618277|FG001|12-month Follow-up|Death|1|||
41932243|NCT02549352|75618276|FG000|12-month Follow-up|Protocol Violation|0|||
41932244|NCT02549352|75618277|FG001|12-month Follow-up|Protocol Violation|1|||
41932245|NCT02549352|75618276|FG000|12-month Follow-up|Other|1|||
41932246|NCT02549352|75618277|FG001|12-month Follow-up|Other|3|||
41932247|NCT02554890|75618454|FG000|Double-blind|Adverse Event|45|||
41932248|NCT02554890|75618455|FG001|Double-blind|Adverse Event|51|||
41932249|NCT02554890|75618454|FG000|Double-blind|Death|6|||
41932250|NCT02554890|75618455|FG001|Double-blind|Death|4|||
41932251|NCT02554890|75618454|FG000|Double-blind|Protocol Violation|1|||
41932252|NCT02554890|75618455|FG001|Double-blind|Protocol Violation|1|||
41932253|NCT02554890|75618454|FG000|Double-blind|Physician Decision|4|||
41932254|NCT02554890|75618455|FG001|Double-blind|Physician Decision|3|||
41932255|NCT02554890|75618454|FG000|Double-blind|Subject/Guardian decision|21|||
41932256|NCT02554890|75618455|FG001|Double-blind|Subject/Guardian decision|16|||
41932257|NCT02554890|75618454|FG000|Double-blind|Lost to Follow-up|7|||
41932258|NCT02554890|75618455|FG001|Double-blind|Lost to Follow-up|5|||
41932259|NCT02554890|75618454|FG000|Double-blind|Technical problems|1|||
41932260|NCT02554890|75618455|FG001|Double-blind|Technical problems|0|||
41932261|NCT02554890|75618454|FG000|Double-blind|Withdrawal by Subject|5|||
41932262|NCT02554890|75618455|FG001|Double-blind|Withdrawal by Subject|6|||
41932263|NCT02554890|75618454|FG000|Double-blind|Noncompliance with study treatment|6|||
41932264|NCT02554890|75618455|FG001|Double-blind|Noncompliance with study treatment|5|||
41932265|NCT02554890|75618454|FG000|Open-label|Adverse Event|0|||
41932266|NCT02554890|75618455|FG001|Open-label|Adverse Event|30|||
41932267|NCT02554890|75618454|FG000|Open-label|Death|0|||
41932268|NCT02554890|75618455|FG001|Open-label|Death|1|||
41932269|NCT02554890|75618454|FG000|Open-label|Physician Decision|0|||
41932270|NCT02554890|75618455|FG001|Open-label|Physician Decision|1|||
41932271|NCT02554890|75618454|FG000|Open-label|Subject/Guardian decision|0|||
41932272|NCT02554890|75618455|FG001|Open-label|Subject/Guardian decision|11|||
41932273|NCT02554890|75618454|FG000|Open-label|Lost to Follow-up|0|||
41932274|NCT02554890|75618455|FG001|Open-label|Lost to Follow-up|7|||
41932275|NCT02554890|75618454|FG000|Open-label|Technical problems|0|||
41932276|NCT02554890|75618455|FG001|Open-label|Technical problems|1|||
41932277|NCT02554890|75618454|FG000|Open-label|Withdrawal by Subject|0|||
41932278|NCT02554890|75618455|FG001|Open-label|Withdrawal by Subject|1|||
41932279|NCT02552316|75618472|FG000|Overall Study|Withdrawal by Subject|1|||
41932280|NCT02552316|75618472|FG000|Overall Study|Withdrawal due to non-compliance|1|||
41932281|NCT02543346|75618520|FG000|Second Priming Visit|Withdrawal by Subject|0|||
41932282|NCT02543346|75618521|FG001|Second Priming Visit|Withdrawal by Subject|2|||
41932283|NCT02543346|75618522|FG002|Second Priming Visit|Withdrawal by Subject|2|||
41932284|NCT02543346|75618523|FG003|Second Priming Visit|Withdrawal by Subject|2|||
41932285|NCT02543346|75618520|FG000|Second Priming Visit|Adverse Event|1|||
41932286|NCT02543346|75618521|FG001|Second Priming Visit|Adverse Event|0|||
41932287|NCT02543346|75618522|FG002|Second Priming Visit|Adverse Event|0|||
41932288|NCT02543346|75618523|FG003|Second Priming Visit|Adverse Event|0|||
41932289|NCT02549196|75618537|FG000|Overall Study|Protocol Violation|0|||
41932290|NCT02549196|75618538|FG001|Overall Study|Protocol Violation|0|||
41932291|NCT02549196|75618539|FG002|Overall Study|Protocol Violation|0|||
41932292|NCT02549196|75618540|FG003|Overall Study|Protocol Violation|1|||
41932293|NCT02549196|75618537|FG000|Overall Study|Withdrawal by Subject|1|||
41932294|NCT02549196|75618538|FG001|Overall Study|Withdrawal by Subject|0|||
41932295|NCT02549196|75618539|FG002|Overall Study|Withdrawal by Subject|1|||
41932296|NCT02549196|75618540|FG003|Overall Study|Withdrawal by Subject|0|||
41932297|NCT02904954|75618552|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
41932298|NCT02904954|75618553|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
41932299|NCT02904954|75618552|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
41932300|NCT02904954|75618553|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
41932301|NCT02904954|75618552|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
41932302|NCT02904954|75618553|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
41932303|NCT02904954|75618552|FG000|Adjuvant Durvalumab|Recurrence|2|||
41932304|NCT02904954|75618553|FG001|Adjuvant Durvalumab|Recurrence|0|||
41932305|NCT02904954|75618552|FG000|Adjuvant Durvalumab|Adverse Event|2|||
41932306|NCT02904954|75618553|FG001|Adjuvant Durvalumab|Adverse Event|6|||
41932307|NCT02904954|75618552|FG000|Adjuvant Durvalumab|Participant wishes|12|||
41932308|NCT02904954|75618553|FG001|Adjuvant Durvalumab|Participant wishes|7|||
41932309|NCT02904954|75618552|FG000|Adjuvant Durvalumab|Physician Decision|2|||
41932310|NCT02904954|75618553|FG001|Adjuvant Durvalumab|Physician Decision|1|||
41932311|NCT02904954|75618552|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
41932312|NCT02904954|75618553|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
41932313|NCT02904954|75618552|FG000|Adjuvant Durvalumab|Death|0|||
41932314|NCT02904954|75618553|FG001|Adjuvant Durvalumab|Death|1|||
41932315|NCT02904954|75618552|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
41932316|NCT02904954|75618553|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
41932317|NCT02548962|75618669|FG000|Overall Study|Withdrawal by Subject|1|||
41932318|NCT02548962|75618670|FG001|Overall Study|Withdrawal by Subject|0|||
41932319|NCT02548650|75618697|FG000|Triple Therapy|Adverse Event|1|||
41932320|NCT02548650|75618698|FG001|Triple Therapy|Adverse Event|0|||
41932321|NCT02548650|75618697|FG000|Triple Therapy|Withdrawal by Subject|0|||
41932322|NCT02548650|75618698|FG001|Triple Therapy|Withdrawal by Subject|4|||
41932323|NCT02548650|75618697|FG000|Double Therapy|Adverse Event|1|||
41932324|NCT02548650|75618698|FG001|Double Therapy|Adverse Event|1|||
41932325|NCT02548650|75618697|FG000|Double Therapy|Withdrawal by Subject|0|||
41932326|NCT02548650|75618698|FG001|Double Therapy|Withdrawal by Subject|1|||
41932327|NCT02535000|75618774|FG000|Overall Study|Cancellation of surgery.|1|||
41932328|NCT02535000|75618775|FG001|Overall Study|Cancellation of surgery.|2|||
41932329|NCT03110562|75618904|FG000|Overall Study|Withdrawal by Subject|37|||
41932330|NCT03110562|75618905|FG001|Overall Study|Withdrawal by Subject|35|||
41932331|NCT03110562|75618904|FG000|Overall Study|Death|47|||
41932332|NCT03110562|75618905|FG001|Overall Study|Death|61|||
41932333|NCT03110562|75618904|FG000|Overall Study|Lost to Follow-up|7|||
41932334|NCT03110562|75618905|FG001|Overall Study|Lost to Follow-up|6|||
41932335|NCT03110562|75618904|FG000|Overall Study|Other|2|||
41932336|NCT03110562|75618905|FG001|Overall Study|Other|1|||
41932337|NCT03110562|75618904|FG000|Overall Study|Randomized but never treated|0|||
41932338|NCT03110562|75618905|FG001|Overall Study|Randomized but never treated|3|||
41932339|NCT03110562|75618904|FG000|Overall Study|Ongoing|102|||
41932340|NCT03110562|75618905|FG001|Overall Study|Ongoing|101|||
41932341|NCT02546856|75618948|FG000|4 Months Evaluation|Death|2|||
41932342|NCT02546856|75618949|FG001|4 Months Evaluation|Death|3|||
41932343|NCT02546856|75618948|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
41932344|NCT02546856|75618949|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
41932345|NCT02546856|75618948|FG000|4 Months Evaluation|Lost to Follow-up|3|||
41932346|NCT02546856|75618949|FG001|4 Months Evaluation|Lost to Follow-up|3|||
41932347|NCT02546856|75618948|FG000|4 Months Evaluation|Physician Decision|3|||
41932348|NCT02546856|75618949|FG001|4 Months Evaluation|Physician Decision|0|||
41932349|NCT02546856|75618948|FG000|4 Months Evaluation|Working or living abroad|5|||
41932350|NCT02546856|75618949|FG001|4 Months Evaluation|Working or living abroad|1|||
41932351|NCT02546856|75618948|FG000|4 Months Evaluation|reasons not due to titration|4|||
41932352|NCT02546856|75618949|FG001|4 Months Evaluation|reasons not due to titration|1|||
41932353|NCT02546856|75618948|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
41932354|NCT02546856|75618949|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
41932355|NCT02546856|75618948|FG000|6 Months Evaluation|Death|1|||
41932356|NCT02546856|75618949|FG001|6 Months Evaluation|Death|1|||
41932357|NCT02546856|75618948|FG000|6 Months Evaluation|Lost to Follow-up|1|||
41932358|NCT02546856|75618949|FG001|6 Months Evaluation|Lost to Follow-up|1|||
41932359|NCT02546856|75618948|FG000|6 Months Evaluation|Working or living abroad|6|||
41932360|NCT02546856|75618949|FG001|6 Months Evaluation|Working or living abroad|4|||
41932361|NCT02546856|75618948|FG000|6 Months Evaluation|reasons not due to titration|0|||
41932362|NCT02546856|75618949|FG001|6 Months Evaluation|reasons not due to titration|1|||
41932363|NCT02696616|75619074|FG000|Overall Study|Adverse Event|0|||
41932364|NCT02696616|75619075|FG001|Overall Study|Adverse Event|1|||
41932365|NCT02696616|75619076|FG002|Overall Study|Adverse Event|0|||
41932366|NCT02696616|75619077|FG003|Overall Study|Adverse Event|0|||
41932367|NCT02696616|75619078|FG004|Overall Study|Adverse Event|0|||
41932368|NCT02696616|75619079|FG005|Overall Study|Adverse Event|0|||
41932369|NCT02696616|75619080|FG006|Overall Study|Adverse Event|0|||
41932370|NCT01661790|75619123|FG000|Overall Study|Lost to Follow-up|0|||
41932371|NCT01661790|75619124|FG001|Overall Study|Lost to Follow-up|2|||
41932372|NCT02546544|75619144|FG000|Overall Study|Disease Progression|14|||
41932373|NCT02546544|75619144|FG000|Overall Study|Adverse Event|1|||
41932374|NCT02546544|75619144|FG000|Overall Study|Withdrawal by Subject|1|||
41932375|NCT05593211|75619435|FG000|Overall Study|Withdrawal by Subject|1|||
41932376|NCT02533674|75619774|FG000|Dose Level I|Progressive disease|1|||
41932377|NCT02533674|75619775|FG001|Dose Level I|Progressive disease|0|||
41932378|NCT02533674|75619776|FG002|Dose Level I|Progressive disease|0|||
41932379|NCT02533674|75619777|FG003|Dose Level I|Progressive disease|0|||
41932380|NCT02533674|75619778|FG004|Dose Level I|Progressive disease|0|||
41932381|NCT02533674|75619779|FG005|Dose Level I|Progressive disease|0|||
41932382|NCT02533674|75619780|FG006|Dose Level I|Progressive disease|0|||
41932383|NCT02533674|75619781|FG007|Dose Level I|Progressive disease|0|||
41932384|NCT02533674|75619774|FG000|Dose Level I|Withdrawal by Subject|1|||
41932385|NCT02533674|75619775|FG001|Dose Level I|Withdrawal by Subject|0|||
41932386|NCT02533674|75619776|FG002|Dose Level I|Withdrawal by Subject|0|||
41932387|NCT02533674|75619777|FG003|Dose Level I|Withdrawal by Subject|0|||
41932388|NCT02533674|75619778|FG004|Dose Level I|Withdrawal by Subject|0|||
41932389|NCT02533674|75619779|FG005|Dose Level I|Withdrawal by Subject|0|||
41932390|NCT02533674|75619780|FG006|Dose Level I|Withdrawal by Subject|0|||
41932391|NCT02533674|75619781|FG007|Dose Level I|Withdrawal by Subject|0|||
41932392|NCT02533674|75619774|FG000|Dose Level I|Physician Decision|1|||
41932393|NCT02533674|75619775|FG001|Dose Level I|Physician Decision|0|||
41932394|NCT02533674|75619776|FG002|Dose Level I|Physician Decision|0|||
41932395|NCT02533674|75619777|FG003|Dose Level I|Physician Decision|0|||
41932396|NCT02533674|75619778|FG004|Dose Level I|Physician Decision|0|||
41932397|NCT02533674|75619779|FG005|Dose Level I|Physician Decision|0|||
41932398|NCT02533674|75619780|FG006|Dose Level I|Physician Decision|0|||
41932399|NCT02533674|75619781|FG007|Dose Level I|Physician Decision|0|||
41932400|NCT02533674|75619774|FG000|Dose Level I|Death|1|||
41932401|NCT02533674|75619775|FG001|Dose Level I|Death|0|||
41932402|NCT02533674|75619776|FG002|Dose Level I|Death|0|||
41932403|NCT02533674|75619777|FG003|Dose Level I|Death|0|||
41932404|NCT02533674|75619778|FG004|Dose Level I|Death|0|||
41932405|NCT02533674|75619779|FG005|Dose Level I|Death|0|||
41932406|NCT02533674|75619780|FG006|Dose Level I|Death|0|||
41932407|NCT02533674|75619781|FG007|Dose Level I|Death|0|||
41932408|NCT02533674|75619774|FG000|Dose Level I|Never Treated|1|||
41932409|NCT02533674|75619775|FG001|Dose Level I|Never Treated|0|||
41932410|NCT02533674|75619776|FG002|Dose Level I|Never Treated|0|||
41932411|NCT02533674|75619777|FG003|Dose Level I|Never Treated|0|||
41932412|NCT02533674|75619778|FG004|Dose Level I|Never Treated|0|||
41932413|NCT02533674|75619779|FG005|Dose Level I|Never Treated|0|||
41932414|NCT02533674|75619780|FG006|Dose Level I|Never Treated|0|||
41932415|NCT02533674|75619781|FG007|Dose Level I|Never Treated|0|||
41932416|NCT02533674|75619774|FG000|Dose Level II|Progressive disease|0|||
41932417|NCT02533674|75619775|FG001|Dose Level II|Progressive disease|3|||
41932418|NCT02533674|75619776|FG002|Dose Level II|Progressive disease|0|||
41932419|NCT02533674|75619777|FG003|Dose Level II|Progressive disease|0|||
42300058|NCT02549339|76135209|FG001|12-month Follow-up|Other|3|||
41932420|NCT02533674|75619778|FG004|Dose Level II|Progressive disease|0|||
41932421|NCT02533674|75619779|FG005|Dose Level II|Progressive disease|0|||
41932422|NCT02533674|75619780|FG006|Dose Level II|Progressive disease|0|||
41932423|NCT02533674|75619781|FG007|Dose Level II|Progressive disease|0|||
41932424|NCT02533674|75619774|FG000|Dose Level II|Withdrawal by Subject|0|||
41932425|NCT02533674|75619775|FG001|Dose Level II|Withdrawal by Subject|1|||
41932426|NCT02533674|75619776|FG002|Dose Level II|Withdrawal by Subject|0|||
41932427|NCT02533674|75619777|FG003|Dose Level II|Withdrawal by Subject|0|||
41932428|NCT02533674|75619778|FG004|Dose Level II|Withdrawal by Subject|0|||
41932429|NCT02533674|75619779|FG005|Dose Level II|Withdrawal by Subject|0|||
41932430|NCT02533674|75619780|FG006|Dose Level II|Withdrawal by Subject|0|||
41932431|NCT02533674|75619781|FG007|Dose Level II|Withdrawal by Subject|0|||
41932432|NCT02533674|75619774|FG000|Dose Level II|Treatment-related AE|0|||
41932433|NCT02533674|75619775|FG001|Dose Level II|Treatment-related AE|1|||
41932434|NCT02533674|75619776|FG002|Dose Level II|Treatment-related AE|0|||
41932435|NCT02533674|75619777|FG003|Dose Level II|Treatment-related AE|0|||
41932436|NCT02533674|75619778|FG004|Dose Level II|Treatment-related AE|0|||
41932437|NCT02533674|75619779|FG005|Dose Level II|Treatment-related AE|0|||
41932438|NCT02533674|75619780|FG006|Dose Level II|Treatment-related AE|0|||
41932439|NCT02533674|75619781|FG007|Dose Level II|Treatment-related AE|0|||
41932440|NCT02533674|75619774|FG000|Dose Level II|Physician Decision|0|||
41932441|NCT02533674|75619775|FG001|Dose Level II|Physician Decision|1|||
41932442|NCT02533674|75619776|FG002|Dose Level II|Physician Decision|0|||
41932443|NCT02533674|75619777|FG003|Dose Level II|Physician Decision|0|||
41932444|NCT02533674|75619778|FG004|Dose Level II|Physician Decision|0|||
41932445|NCT02533674|75619779|FG005|Dose Level II|Physician Decision|0|||
41932446|NCT02533674|75619780|FG006|Dose Level II|Physician Decision|0|||
41932447|NCT02533674|75619781|FG007|Dose Level II|Physician Decision|0|||
41932448|NCT02533674|75619774|FG000|Dose Level II|Non-treatment-related AE|0|||
41932449|NCT02533674|75619775|FG001|Dose Level II|Non-treatment-related AE|1|||
41932450|NCT02533674|75619776|FG002|Dose Level II|Non-treatment-related AE|0|||
41932451|NCT02533674|75619777|FG003|Dose Level II|Non-treatment-related AE|0|||
41932452|NCT02533674|75619778|FG004|Dose Level II|Non-treatment-related AE|0|||
41932453|NCT02533674|75619779|FG005|Dose Level II|Non-treatment-related AE|0|||
41932454|NCT02533674|75619780|FG006|Dose Level II|Non-treatment-related AE|0|||
41932455|NCT02533674|75619781|FG007|Dose Level II|Non-treatment-related AE|0|||
41932456|NCT02533674|75619774|FG000|Dose Level III|Progressive disease|0|||
41932457|NCT02533674|75619775|FG001|Dose Level III|Progressive disease|0|||
41932458|NCT02533674|75619776|FG002|Dose Level III|Progressive disease|2|||
41932459|NCT02533674|75619777|FG003|Dose Level III|Progressive disease|0|||
41932460|NCT02533674|75619778|FG004|Dose Level III|Progressive disease|0|||
41932461|NCT02533674|75619779|FG005|Dose Level III|Progressive disease|0|||
41932462|NCT02533674|75619780|FG006|Dose Level III|Progressive disease|0|||
41932463|NCT02533674|75619781|FG007|Dose Level III|Progressive disease|0|||
41932464|NCT02533674|75619774|FG000|Dose Level III|Withdrawal by Subject|0|||
41932465|NCT02533674|75619775|FG001|Dose Level III|Withdrawal by Subject|0|||
41932466|NCT02533674|75619776|FG002|Dose Level III|Withdrawal by Subject|1|||
41932467|NCT02533674|75619777|FG003|Dose Level III|Withdrawal by Subject|0|||
41932468|NCT02533674|75619778|FG004|Dose Level III|Withdrawal by Subject|0|||
41932469|NCT02533674|75619779|FG005|Dose Level III|Withdrawal by Subject|0|||
41932470|NCT02533674|75619780|FG006|Dose Level III|Withdrawal by Subject|0|||
41932471|NCT02533674|75619781|FG007|Dose Level III|Withdrawal by Subject|0|||
41932472|NCT02533674|75619774|FG000|Dose Level III|Treatment-related AE|0|||
41932473|NCT02533674|75619775|FG001|Dose Level III|Treatment-related AE|0|||
41932474|NCT02533674|75619776|FG002|Dose Level III|Treatment-related AE|1|||
41932475|NCT02533674|75619777|FG003|Dose Level III|Treatment-related AE|0|||
41932476|NCT02533674|75619778|FG004|Dose Level III|Treatment-related AE|0|||
41932477|NCT02533674|75619779|FG005|Dose Level III|Treatment-related AE|0|||
41932478|NCT02533674|75619780|FG006|Dose Level III|Treatment-related AE|0|||
41932479|NCT02533674|75619781|FG007|Dose Level III|Treatment-related AE|0|||
41932480|NCT02533674|75619774|FG000|Dose Level IV|Progressive disease|0|||
41932481|NCT02533674|75619775|FG001|Dose Level IV|Progressive disease|0|||
41932482|NCT02533674|75619776|FG002|Dose Level IV|Progressive disease|0|||
41932483|NCT02533674|75619777|FG003|Dose Level IV|Progressive disease|3|||
41932484|NCT02533674|75619778|FG004|Dose Level IV|Progressive disease|0|||
41932485|NCT02533674|75619779|FG005|Dose Level IV|Progressive disease|0|||
41932486|NCT02533674|75619780|FG006|Dose Level IV|Progressive disease|0|||
41932487|NCT02533674|75619781|FG007|Dose Level IV|Progressive disease|0|||
41932488|NCT02533674|75619774|FG000|Dose Level IV|Withdrawal by Subject|0|||
41932489|NCT02533674|75619775|FG001|Dose Level IV|Withdrawal by Subject|0|||
41932490|NCT02533674|75619776|FG002|Dose Level IV|Withdrawal by Subject|0|||
41932491|NCT02533674|75619777|FG003|Dose Level IV|Withdrawal by Subject|1|||
41932492|NCT02533674|75619778|FG004|Dose Level IV|Withdrawal by Subject|0|||
41932493|NCT02533674|75619779|FG005|Dose Level IV|Withdrawal by Subject|0|||
41932494|NCT02533674|75619780|FG006|Dose Level IV|Withdrawal by Subject|0|||
41932495|NCT02533674|75619781|FG007|Dose Level IV|Withdrawal by Subject|0|||
41932496|NCT02533674|75619774|FG000|Dose Level IV|Physician Decision|0|||
41932497|NCT02533674|75619775|FG001|Dose Level IV|Physician Decision|0|||
41932498|NCT02533674|75619776|FG002|Dose Level IV|Physician Decision|0|||
41932499|NCT02533674|75619777|FG003|Dose Level IV|Physician Decision|1|||
41932500|NCT02533674|75619778|FG004|Dose Level IV|Physician Decision|0|||
42300059|NCT02549027|76135217|FG000|Washout After Period 4|Withdrawal by Subject|0|||
41932501|NCT02533674|75619779|FG005|Dose Level IV|Physician Decision|0|||
41932502|NCT02533674|75619780|FG006|Dose Level IV|Physician Decision|0|||
41932503|NCT02533674|75619781|FG007|Dose Level IV|Physician Decision|0|||
41932504|NCT02533674|75619774|FG000|Dose Level V|Progressive disease|0|||
41932505|NCT02533674|75619775|FG001|Dose Level V|Progressive disease|0|||
41932506|NCT02533674|75619776|FG002|Dose Level V|Progressive disease|0|||
41932507|NCT02533674|75619777|FG003|Dose Level V|Progressive disease|0|||
41932508|NCT02533674|75619778|FG004|Dose Level V|Progressive disease|3|||
41932509|NCT02533674|75619779|FG005|Dose Level V|Progressive disease|0|||
41932510|NCT02533674|75619780|FG006|Dose Level V|Progressive disease|0|||
41932511|NCT02533674|75619781|FG007|Dose Level V|Progressive disease|0|||
41932512|NCT02533674|75619774|FG000|Dose Level V|Withdrawal by Subject|0|||
41932513|NCT02533674|75619775|FG001|Dose Level V|Withdrawal by Subject|0|||
41932514|NCT02533674|75619776|FG002|Dose Level V|Withdrawal by Subject|0|||
41932515|NCT02533674|75619777|FG003|Dose Level V|Withdrawal by Subject|0|||
41932516|NCT02533674|75619778|FG004|Dose Level V|Withdrawal by Subject|1|||
41932517|NCT02533674|75619779|FG005|Dose Level V|Withdrawal by Subject|0|||
41932518|NCT02533674|75619780|FG006|Dose Level V|Withdrawal by Subject|0|||
41932519|NCT02533674|75619781|FG007|Dose Level V|Withdrawal by Subject|0|||
41932520|NCT02533674|75619774|FG000|Dose Level V|Physician Decision|0|||
41932521|NCT02533674|75619775|FG001|Dose Level V|Physician Decision|0|||
41932522|NCT02533674|75619776|FG002|Dose Level V|Physician Decision|0|||
41932523|NCT02533674|75619777|FG003|Dose Level V|Physician Decision|0|||
41932524|NCT02533674|75619778|FG004|Dose Level V|Physician Decision|1|||
41932525|NCT02533674|75619779|FG005|Dose Level V|Physician Decision|0|||
41932526|NCT02533674|75619780|FG006|Dose Level V|Physician Decision|0|||
41932527|NCT02533674|75619781|FG007|Dose Level V|Physician Decision|0|||
41932528|NCT02533674|75619774|FG000|Dose Level VI|Progressive disease|0|||
41932529|NCT02533674|75619775|FG001|Dose Level VI|Progressive disease|0|||
41932530|NCT02533674|75619776|FG002|Dose Level VI|Progressive disease|0|||
41932531|NCT02533674|75619777|FG003|Dose Level VI|Progressive disease|0|||
41932532|NCT02533674|75619778|FG004|Dose Level VI|Progressive disease|0|||
41932533|NCT02533674|75619779|FG005|Dose Level VI|Progressive disease|7|||
41932534|NCT02533674|75619780|FG006|Dose Level VI|Progressive disease|0|||
42209509|NCT04328077|76023973|FG002|Overall Study|Withdrawal by Subject|1|||
42209510|NCT04328077|76023974|FG003|Overall Study|Withdrawal by Subject|3|||
42209511|NCT03691831|76023992|FG000|Overall Study|Lost to Follow-up|16|||
42209512|NCT03691831|76023993|FG001|Overall Study|Lost to Follow-up|12|||
42209513|NCT03691831|76023992|FG000|Overall Study|Withdrawal by Subject|9|||
42209514|NCT03691831|76023993|FG001|Overall Study|Withdrawal by Subject|17|||
42209515|NCT03691831|76023992|FG000|Overall Study|Investigator Decision|2|||
42209516|NCT03691831|76023993|FG001|Overall Study|Investigator Decision|2|||
42209517|NCT04320745|76024010|FG000|Overall Study|Adverse Event|26|||
42209518|NCT04320745|76024010|FG000|Overall Study|Withdrawal by Subject|4|||
42209519|NCT04320745|76024010|FG000|Overall Study|Lost to Follow-up|12|||
42209520|NCT04320745|76024010|FG000|Overall Study|Protocol Deviation|2|||
42209521|NCT04320745|76024010|FG000|Overall Study|Non-compliance With Study Drug|2|||
42209522|NCT04320745|76024010|FG000|Overall Study|Reason Not Specified|1|||
42209523|NCT03063086|76024014|FG000|Overall Study|technical problems|1|||
42209524|NCT03063086|76024015|FG001|Overall Study|technical problems|0|||
42209525|NCT03063086|76024016|FG002|Overall Study|technical problems|0|||
42022000|NCT00960076|75829346|FG001|Overall Study|Adverse Event|7|||
42022001|NCT00960076|75829345|FG000|Overall Study|No longer met study criteria|1|||
42022002|NCT00960076|75829346|FG001|Overall Study|No longer met study criteria|5|||
42022003|NCT00960076|75829345|FG000|Overall Study|Withdrawal by Subject|1|||
42022004|NCT00960076|75829346|FG001|Overall Study|Withdrawal by Subject|2|||
42022005|NCT00960076|75829345|FG000|Overall Study|Lost to Follow-up|3|||
42022006|NCT00960076|75829346|FG001|Overall Study|Lost to Follow-up|3|||
42022007|NCT00960076|75829345|FG000|Overall Study|Severe non-compliance to protocol|1|||
42022008|NCT00960076|75829346|FG001|Overall Study|Severe non-compliance to protocol|2|||
42022009|NCT00960076|75829345|FG000|Overall Study|Hyperglycemia|1|||
42022010|NCT00960076|75829346|FG001|Overall Study|Hyperglycemia|5|||
42209526|NCT03063086|76024017|FG003|Overall Study|technical problems|0|||
42209527|NCT03063086|76024018|FG004|Overall Study|technical problems|0|||
42209528|NCT03063086|76024019|FG005|Overall Study|technical problems|0|||
42209529|NCT03063086|76024014|FG000|Overall Study|Adverse Event|1|||
42209530|NCT03063086|76024015|FG001|Overall Study|Adverse Event|1|||
42209531|NCT03063086|76024016|FG002|Overall Study|Adverse Event|1|||
42209532|NCT03063086|76024017|FG003|Overall Study|Adverse Event|1|||
42209533|NCT03063086|76024018|FG004|Overall Study|Adverse Event|0|||
42209534|NCT03063086|76024019|FG005|Overall Study|Adverse Event|0|||
42209535|NCT03063086|76024014|FG000|Overall Study|subject/guardian decision|1|||
42209536|NCT03063086|76024015|FG001|Overall Study|subject/guardian decision|0|||
42209537|NCT03063086|76024016|FG002|Overall Study|subject/guardian decision|0|||
42209538|NCT03063086|76024017|FG003|Overall Study|subject/guardian decision|0|||
42209539|NCT03063086|76024018|FG004|Overall Study|subject/guardian decision|0|||
41932535|NCT02533674|75619781|FG007|Dose Level VI|Progressive disease|0|||
41932536|NCT02533674|75619774|FG000|Dose Level VI|Withdrawal by Subject|0|||
41932537|NCT02533674|75619775|FG001|Dose Level VI|Withdrawal by Subject|0|||
41932538|NCT02533674|75619776|FG002|Dose Level VI|Withdrawal by Subject|0|||
41932539|NCT02533674|75619777|FG003|Dose Level VI|Withdrawal by Subject|0|||
41932540|NCT02533674|75619778|FG004|Dose Level VI|Withdrawal by Subject|0|||
41932541|NCT02533674|75619779|FG005|Dose Level VI|Withdrawal by Subject|1|||
42209540|NCT03063086|76024019|FG005|Overall Study|subject/guardian decision|0|||
42209541|NCT03063086|76024014|FG000|Overall Study|Non-compliance with study treatment|0|||
42209542|NCT03063086|76024015|FG001|Overall Study|Non-compliance with study treatment|0|||
42209543|NCT03063086|76024016|FG002|Overall Study|Non-compliance with study treatment|0|||
41932542|NCT02533674|75619780|FG006|Dose Level VI|Withdrawal by Subject|0|||
41932543|NCT02533674|75619781|FG007|Dose Level VI|Withdrawal by Subject|0|||
41932544|NCT02533674|75619774|FG000|Dose Level VI|Treatment-related AE|0|||
41932545|NCT02533674|75619775|FG001|Dose Level VI|Treatment-related AE|0|||
41932546|NCT02533674|75619776|FG002|Dose Level VI|Treatment-related AE|0|||
41932547|NCT02533674|75619777|FG003|Dose Level VI|Treatment-related AE|0|||
41932548|NCT02533674|75619778|FG004|Dose Level VI|Treatment-related AE|0|||
41932549|NCT02533674|75619779|FG005|Dose Level VI|Treatment-related AE|1|||
41932550|NCT02533674|75619780|FG006|Dose Level VI|Treatment-related AE|0|||
41932551|NCT02533674|75619781|FG007|Dose Level VI|Treatment-related AE|0|||
41932552|NCT02533674|75619774|FG000|Dose Level VII|Progressive disease|0|||
41932553|NCT02533674|75619775|FG001|Dose Level VII|Progressive disease|0|||
41932554|NCT02533674|75619776|FG002|Dose Level VII|Progressive disease|0|||
41932555|NCT02533674|75619777|FG003|Dose Level VII|Progressive disease|0|||
41932556|NCT02533674|75619778|FG004|Dose Level VII|Progressive disease|0|||
41932557|NCT02533674|75619779|FG005|Dose Level VII|Progressive disease|0|||
41932558|NCT02533674|75619780|FG006|Dose Level VII|Progressive disease|10|||
41932559|NCT02533674|75619781|FG007|Dose Level VII|Progressive disease|0|||
41932560|NCT02533674|75619774|FG000|Dose Level VII|Withdrawal by Subject|0|||
41932561|NCT02533674|75619775|FG001|Dose Level VII|Withdrawal by Subject|0|||
41932562|NCT02533674|75619776|FG002|Dose Level VII|Withdrawal by Subject|0|||
41932563|NCT02533674|75619777|FG003|Dose Level VII|Withdrawal by Subject|0|||
41932564|NCT02533674|75619778|FG004|Dose Level VII|Withdrawal by Subject|0|||
41932565|NCT02533674|75619779|FG005|Dose Level VII|Withdrawal by Subject|0|||
41932566|NCT02533674|75619780|FG006|Dose Level VII|Withdrawal by Subject|3|||
41932567|NCT02533674|75619781|FG007|Dose Level VII|Withdrawal by Subject|0|||
41932568|NCT02533674|75619774|FG000|Dose Level VII|Treatment-related AE|0|||
41932569|NCT02533674|75619775|FG001|Dose Level VII|Treatment-related AE|0|||
41932570|NCT02533674|75619776|FG002|Dose Level VII|Treatment-related AE|0|||
41932571|NCT02533674|75619777|FG003|Dose Level VII|Treatment-related AE|0|||
41932572|NCT02533674|75619778|FG004|Dose Level VII|Treatment-related AE|0|||
41932573|NCT02533674|75619779|FG005|Dose Level VII|Treatment-related AE|0|||
41932574|NCT02533674|75619780|FG006|Dose Level VII|Treatment-related AE|1|||
41932575|NCT02533674|75619781|FG007|Dose Level VII|Treatment-related AE|0|||
41932576|NCT02533674|75619774|FG000|Dose Level VII|Death|0|||
41932577|NCT02533674|75619775|FG001|Dose Level VII|Death|0|||
41932578|NCT02533674|75619776|FG002|Dose Level VII|Death|0|||
41932579|NCT02533674|75619777|FG003|Dose Level VII|Death|0|||
41932580|NCT02533674|75619778|FG004|Dose Level VII|Death|0|||
41932581|NCT02533674|75619779|FG005|Dose Level VII|Death|0|||
41932582|NCT02533674|75619780|FG006|Dose Level VII|Death|2|||
41932583|NCT02533674|75619781|FG007|Dose Level VII|Death|0|||
41932584|NCT02533674|75619774|FG000|Dose Level VIII|Progressive disease|0|||
41932585|NCT02533674|75619775|FG001|Dose Level VIII|Progressive disease|0|||
41932586|NCT02533674|75619776|FG002|Dose Level VIII|Progressive disease|0|||
41932587|NCT02533674|75619777|FG003|Dose Level VIII|Progressive disease|0|||
41932588|NCT02533674|75619778|FG004|Dose Level VIII|Progressive disease|0|||
41932589|NCT02533674|75619779|FG005|Dose Level VIII|Progressive disease|0|||
41932590|NCT02533674|75619780|FG006|Dose Level VIII|Progressive disease|0|||
41932591|NCT02533674|75619781|FG007|Dose Level VIII|Progressive disease|3|||
41932592|NCT02533674|75619774|FG000|Dose Level VIII|Withdrawal by Subject|0|||
41932593|NCT02533674|75619775|FG001|Dose Level VIII|Withdrawal by Subject|0|||
41932594|NCT02533674|75619776|FG002|Dose Level VIII|Withdrawal by Subject|0|||
41932595|NCT02533674|75619777|FG003|Dose Level VIII|Withdrawal by Subject|0|||
41932596|NCT02533674|75619778|FG004|Dose Level VIII|Withdrawal by Subject|0|||
41932597|NCT02533674|75619779|FG005|Dose Level VIII|Withdrawal by Subject|0|||
41932598|NCT02533674|75619780|FG006|Dose Level VIII|Withdrawal by Subject|0|||
41932599|NCT02533674|75619781|FG007|Dose Level VIII|Withdrawal by Subject|1|||
41932600|NCT02533674|75619774|FG000|Dose Level VIII|Treatment-related AE|0|||
41932601|NCT02533674|75619775|FG001|Dose Level VIII|Treatment-related AE|0|||
42117701|NCT00117637|75928532|FG001|Second Intervention (Period 2)|reason not reported|0|||
41932602|NCT02533674|75619776|FG002|Dose Level VIII|Treatment-related AE|0|||
41932603|NCT02533674|75619777|FG003|Dose Level VIII|Treatment-related AE|0|||
41932604|NCT02533674|75619778|FG004|Dose Level VIII|Treatment-related AE|0|||
42209544|NCT03063086|76024017|FG003|Overall Study|Non-compliance with study treatment|1|||
41932605|NCT02533674|75619779|FG005|Dose Level VIII|Treatment-related AE|0|||
41932606|NCT02533674|75619780|FG006|Dose Level VIII|Treatment-related AE|0|||
41932607|NCT02533674|75619781|FG007|Dose Level VIII|Treatment-related AE|1|||
41932608|NCT02533674|75619774|FG000|Dose Level VIII|Never treated|0|||
41932609|NCT02533674|75619775|FG001|Dose Level VIII|Never treated|0|||
41932610|NCT02533674|75619776|FG002|Dose Level VIII|Never treated|0|||
41932611|NCT02533674|75619777|FG003|Dose Level VIII|Never treated|0|||
41932612|NCT02533674|75619778|FG004|Dose Level VIII|Never treated|0|||
41932613|NCT02533674|75619779|FG005|Dose Level VIII|Never treated|0|||
41932614|NCT02533674|75619780|FG006|Dose Level VIII|Never treated|0|||
41932615|NCT02533674|75619781|FG007|Dose Level VIII|Never treated|1|||
41932616|NCT02540850|75619802|FG000|Overall Study|Lost to Follow-up|69|||
41932617|NCT02540850|75619803|FG001|Overall Study|Lost to Follow-up|66|||
41932618|NCT02540850|75619804|FG002|Overall Study|Lost to Follow-up|34|||
41932619|NCT01662024|75619812|FG000|Overall Study|Pregnancy|2|||
41932620|NCT01662024|75619812|FG000|Overall Study|Withdrawal by Subject|3|||
41932621|NCT02544750|75619881|FG000|Overall Study|Physician Decision|3|||
41932622|NCT02544750|75619882|FG001|Overall Study|Physician Decision|1|||
41932623|NCT02544750|75619881|FG000|Overall Study|Other reasons|69|||
41932624|NCT02544750|75619882|FG001|Overall Study|Other reasons|39|||
41932625|NCT02544750|75619881|FG000|Overall Study|Met withdrawal criteria|2|||
41932626|NCT02544750|75619882|FG001|Overall Study|Met withdrawal criteria|2|||
41932627|NCT02544750|75619881|FG000|Overall Study|Transition To Commercial Product|1|||
41932628|NCT02544750|75619882|FG001|Overall Study|Transition To Commercial Product|0|||
41932629|NCT02544750|75619881|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
41932630|NCT02544750|75619882|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
41932631|NCT02544750|75619881|FG000|Overall Study|Adverse Event|8|||
41932632|NCT02544750|75619882|FG001|Overall Study|Adverse Event|10|||
41932633|NCT02544750|75619881|FG000|Overall Study|Withdrawal by Subject|10|||
41932634|NCT02544750|75619882|FG001|Overall Study|Withdrawal by Subject|4|||
41932635|NCT02544750|75619881|FG000|Overall Study|Lost to Follow-up|1|||
41932636|NCT02544750|75619882|FG001|Overall Study|Lost to Follow-up|0|||
41932637|NCT02540538|75619928|FG000|Overall Study|Pregnancy|0|||
41932638|NCT02540538|75619929|FG001|Overall Study|Pregnancy|1|||
41932639|NCT02540538|75619930|FG002|Overall Study|Pregnancy|0|||
41932640|NCT04697056|75619963|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
41932641|NCT04697056|75619964|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
41932642|NCT02532972|75620102|FG000|Overall Study|Withdrawal by Subject|1|||
41932643|NCT03187834|75620155|FG000|Overall Study|Lost to Follow-up|0|||
41932644|NCT03187834|75620156|FG001|Overall Study|Lost to Follow-up|1|||
41932645|NCT03187834|75620157|FG002|Overall Study|Lost to Follow-up|2|||
41932646|NCT03187834|75620158|FG003|Overall Study|Lost to Follow-up|2|||
41932647|NCT03187834|75620155|FG000|Overall Study|Had invalid anthropometric measurements|5|||
41932648|NCT03187834|75620156|FG001|Overall Study|Had invalid anthropometric measurements|3|||
41932649|NCT03187834|75620157|FG002|Overall Study|Had invalid anthropometric measurements|4|||
41932650|NCT03187834|75620158|FG003|Overall Study|Had invalid anthropometric measurements|2|||
41932651|NCT03713944|75620311|FG000|Study Treatment|Patient non-compliance|1|||
41932652|NCT03713944|75620311|FG000|Study Treatment|Alternative Cancer Therapy|3|||
41932653|NCT03713944|75620311|FG000|Study Treatment|Disease Progression|18|||
41932654|NCT03713944|75620311|FG000|Study Treatment|AE/Side Effects/Complications|2|||
41932655|NCT03713944|75620311|FG000|Study Treatment|Death|2|||
41932656|NCT03713944|75620311|FG000|Study Treatment|Withdrawal by Subject|1|||
41932657|NCT03713944|75620311|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
41932658|NCT03713944|75620311|FG000|Study Treatment|Symptomatic Deterioration|2|||
41932659|NCT03713944|75620311|FG000|Follow up|Withdrawal by Subject|2|||
41932660|NCT03713944|75620311|FG000|Follow up|Death|11|||
41932661|NCT03713944|75620311|FG000|Follow up|Study Terminated|3|||
41932662|NCT01572662|75620389|FG000|Overall Study|Withdrawal by Subject|1|||
41932663|NCT01572662|75620390|FG001|Overall Study|Withdrawal by Subject|0|||
41932664|NCT01572662|75620389|FG000|Overall Study|Physician Decision|0|||
41932665|NCT01572662|75620390|FG001|Overall Study|Physician Decision|1|||
41932666|NCT02325154|75620420|FG000|Overall Study|Physician Decision|1|||
41932667|NCT00493870|75620547|FG000|Overall Study|Lost to Follow-up|12|||
41932668|NCT00493870|75620548|FG001|Overall Study|Lost to Follow-up|15|||
41932669|NCT03951753|75620817|FG000|Overall Study|Adverse Event|1|||
41932670|NCT03951753|75620818|FG001|Overall Study|Adverse Event|0|||
41932671|NCT03951753|75620819|FG002|Overall Study|Adverse Event|3|||
41932672|NCT03951753|75620817|FG000|Overall Study|Withdrawal by Subject|3|||
41932673|NCT03951753|75620818|FG001|Overall Study|Withdrawal by Subject|1|||
41932674|NCT03951753|75620819|FG002|Overall Study|Withdrawal by Subject|0|||
41932675|NCT03951753|75620817|FG000|Overall Study|Lost to Follow-up|0|||
41932676|NCT03951753|75620818|FG001|Overall Study|Lost to Follow-up|0|||
41932677|NCT03951753|75620819|FG002|Overall Study|Lost to Follow-up|1|||
41932678|NCT03941964|75620829|FG000|Overall Study|Adverse Event|1|||
41932679|NCT03941964|75620830|FG001|Overall Study|Adverse Event|8|||
41932680|NCT03941964|75620829|FG000|Overall Study|Progressive disease|7|||
41932681|NCT03941964|75620830|FG001|Overall Study|Progressive disease|3|||
41932682|NCT03941964|75620829|FG000|Overall Study|Lack of Efficacy|0|||
41932683|NCT03941964|75620830|FG001|Overall Study|Lack of Efficacy|1|||
41932684|NCT03941964|75620829|FG000|Overall Study|Death|3|||
41932685|NCT03941964|75620830|FG001|Overall Study|Death|1|||
41932686|NCT03941964|75620829|FG000|Overall Study|Withdrew consent|1|||
42022011|NCT00960076|75829345|FG000|Overall Study|Did not attend the termination visit|0|||
41932687|NCT03941964|75620830|FG001|Overall Study|Withdrew consent|3|||
41932688|NCT03941964|75620829|FG000|Overall Study|Physician Decision|9|||
41932689|NCT03941964|75620830|FG001|Overall Study|Physician Decision|2|||
41932690|NCT03941964|75620829|FG000|Overall Study|Other, not specified|2|||
41932691|NCT03941964|75620830|FG001|Overall Study|Other, not specified|1|||
41932692|NCT03837509|75620860|FG000|Phase 1|Death|5|||
41932693|NCT03837509|75620861|FG001|Phase 1|Death|2|||
41932694|NCT03837509|75620862|FG002|Phase 1|Death|0|||
41932695|NCT03837509|75620863|FG003|Phase 1|Death|0|||
41932696|NCT03837509|75620864|FG004|Phase 1|Death|0|||
41932697|NCT03837509|75620860|FG000|Phase 2|Death|0|||
41932698|NCT03837509|75620861|FG001|Phase 2|Death|0|||
42209545|NCT03063086|76024018|FG004|Overall Study|Non-compliance with study treatment|0|||
42209546|NCT03063086|76024019|FG005|Overall Study|Non-compliance with study treatment|1|||
41932699|NCT03837509|75620862|FG002|Phase 2|Death|0|||
41932700|NCT03837509|75620863|FG003|Phase 2|Death|1|||
41932701|NCT03837509|75620864|FG004|Phase 2|Death|1|||
41932702|NCT03822117|75620884|FG000|Overall Study|Death|18|||
41932703|NCT03822117|75620885|FG001|Overall Study|Death|17|||
41932704|NCT03822117|75620886|FG002|Overall Study|Death|12|||
41932705|NCT03822117|75620887|FG003|Overall Study|Death|4|||
41932706|NCT03822117|75620884|FG000|Overall Study|Lost to Follow-up|1|||
41932707|NCT03822117|75620885|FG001|Overall Study|Lost to Follow-up|2|||
41932708|NCT03822117|75620886|FG002|Overall Study|Lost to Follow-up|3|||
41932709|NCT03822117|75620887|FG003|Overall Study|Lost to Follow-up|0|||
41932710|NCT03822117|75620884|FG000|Overall Study|Study Terminated by Sponsor|25|||
41932711|NCT03822117|75620885|FG001|Overall Study|Study Terminated by Sponsor|11|||
41932712|NCT03822117|75620886|FG002|Overall Study|Study Terminated by Sponsor|6|||
41932713|NCT03822117|75620887|FG003|Overall Study|Study Terminated by Sponsor|0|||
41932714|NCT03822117|75620884|FG000|Overall Study|Withdrawal by Subject|4|||
41932715|NCT03822117|75620885|FG001|Overall Study|Withdrawal by Subject|0|||
41932716|NCT03822117|75620886|FG002|Overall Study|Withdrawal by Subject|3|||
41932717|NCT03822117|75620887|FG003|Overall Study|Withdrawal by Subject|0|||
41932718|NCT03822117|75620884|FG000|Overall Study|Disease Progression|1|||
41932719|NCT03822117|75620885|FG001|Overall Study|Disease Progression|2|||
41932720|NCT03822117|75620886|FG002|Overall Study|Disease Progression|1|||
41932721|NCT03822117|75620887|FG003|Overall Study|Disease Progression|0|||
41932722|NCT03822117|75620884|FG000|Overall Study|Never Returned to Hospital|0|||
41932723|NCT03822117|75620885|FG001|Overall Study|Never Returned to Hospital|0|||
41932724|NCT03822117|75620886|FG002|Overall Study|Never Returned to Hospital|1|||
41932725|NCT03822117|75620887|FG003|Overall Study|Never Returned to Hospital|0|||
41932726|NCT03497897|75620901|FG000|Overall Study|Adverse Event|1|||
41932727|NCT03497897|75620902|FG001|Overall Study|Adverse Event|1|||
41932728|NCT03497897|75620903|FG002|Overall Study|Adverse Event|1|||
41932729|NCT03497897|75620901|FG000|Overall Study|Lost to Follow-up|2|||
41932730|NCT03497897|75620902|FG001|Overall Study|Lost to Follow-up|0|||
41932731|NCT03497897|75620903|FG002|Overall Study|Lost to Follow-up|2|||
41932732|NCT03497897|75620901|FG000|Overall Study|Physician Decision|1|||
41932733|NCT03497897|75620902|FG001|Overall Study|Physician Decision|0|||
41932734|NCT03497897|75620903|FG002|Overall Study|Physician Decision|0|||
41932735|NCT03497897|75620901|FG000|Overall Study|Subject/Guardian Decision|2|||
41932736|NCT03497897|75620902|FG001|Overall Study|Subject/Guardian Decision|1|||
41932737|NCT03497897|75620903|FG002|Overall Study|Subject/Guardian Decision|3|||
41932738|NCT03428217|75620914|FG000|Overall Study|Death|89|||
41932739|NCT03428217|75620915|FG001|Overall Study|Death|93|||
41932740|NCT03428217|75620914|FG000|Overall Study|Withdrawal by Subject|8|||
41932741|NCT03428217|75620915|FG001|Overall Study|Withdrawal by Subject|7|||
41932742|NCT03428217|75620914|FG000|Overall Study|Lost to Follow-up|1|||
41932743|NCT03428217|75620915|FG001|Overall Study|Lost to Follow-up|3|||
41932744|NCT03428217|75620914|FG000|Overall Study|Study terminated by sponsor|124|||
41932745|NCT03428217|75620915|FG001|Overall Study|Study terminated by sponsor|118|||
41932746|NCT03428217|75620914|FG000|Overall Study|Other, Not Specified|1|||
41932747|NCT03428217|75620915|FG001|Overall Study|Other, Not Specified|0|||
41932748|NCT03189719|75620925|FG000|Overall Study|Death|260|||
41932749|NCT03189719|75620926|FG001|Overall Study|Death|308|||
41932750|NCT03189719|75620925|FG000|Overall Study|Withdrawal by Subject|5|||
41932751|NCT03189719|75620926|FG001|Overall Study|Withdrawal by Subject|3|||
41932752|NCT03189719|75620925|FG000|Overall Study|Ongoing in Study|108|||
41932753|NCT03189719|75620926|FG001|Overall Study|Ongoing in Study|65|||
42209547|NCT03063086|76024014|FG000|Overall Study|Physician Decision|0|||
42209548|NCT03063086|76024015|FG001|Overall Study|Physician Decision|0|||
41932754|NCT02969525|75620937|FG000|Double-Blind Period|Adverse Event|0|||
41932755|NCT02969525|75620938|FG001|Double-Blind Period|Adverse Event|0|||
41932756|NCT02969525|75620939|FG002|Double-Blind Period|Adverse Event|1|||
41932757|NCT02969525|75620940|FG003|Double-Blind Period|Adverse Event|1|||
41932758|NCT02969525|75620941|FG004|Double-Blind Period|Adverse Event|0|||
41932759|NCT02969525|75620942|FG005|Double-Blind Period|Adverse Event|0|||
41932760|NCT02969525|75620943|FG006|Double-Blind Period|Adverse Event|0|||
41932761|NCT02969525|75620944|FG007|Double-Blind Period|Adverse Event|0|||
41932762|NCT02969525|75620945|FG008|Double-Blind Period|Adverse Event|0|||
41932763|NCT02969525|75620946|FG009|Double-Blind Period|Adverse Event|0|||
41932764|NCT02969525|75620947|FG010|Double-Blind Period|Adverse Event|0|||
41932765|NCT02969525|75620948|FG011|Double-Blind Period|Adverse Event|0|||
41932766|NCT02969525|75620937|FG000|Double-Blind Period|LOW EGFR|0|||
41932767|NCT02969525|75620938|FG001|Double-Blind Period|LOW EGFR|0|||
41932768|NCT02969525|75620939|FG002|Double-Blind Period|LOW EGFR|0|||
41932769|NCT02969525|75620940|FG003|Double-Blind Period|LOW EGFR|1|||
41932770|NCT02969525|75620941|FG004|Double-Blind Period|LOW EGFR|0|||
42117702|NCT00690755|75928552|FG000|Overall Study|Physician Decision|2|||
42117703|NCT00690755|75928553|FG001|Overall Study|Physician Decision|0|||
42117704|NCT00690755|75928554|FG002|Overall Study|Physician Decision|46|||
42117705|NCT00690755|75928555|FG003|Overall Study|Physician Decision|5|||
42117706|NCT00690755|75928556|FG004|Overall Study|Physician Decision|0|||
42117707|NCT00690755|75928557|FG005|Overall Study|Physician Decision|4|||
42117708|NCT00690755|75928558|FG006|Overall Study|Physician Decision|0|||
42117709|NCT00549302|75928576|FG000|Double-Blind|Death|2|||
42117710|NCT00549302|75928577|FG001|Double-Blind|Death|9|||
42117711|NCT00549302|75928578|FG002|Double-Blind|Death|0|||
42117712|NCT00549302|75928576|FG000|Double-Blind|Adverse Event|3|||
42117713|NCT00549302|75928577|FG001|Double-Blind|Adverse Event|16|||
42117714|NCT00549302|75928578|FG002|Double-Blind|Adverse Event|0|||
42117715|NCT00549302|75928576|FG000|Double-Blind|Withdrawal by Subject|3|||
42117716|NCT00549302|75928577|FG001|Double-Blind|Withdrawal by Subject|8|||
42117717|NCT00549302|75928578|FG002|Double-Blind|Withdrawal by Subject|0|||
42117718|NCT00549302|75928576|FG000|Double-Blind|Investigator Decision|1|||
42117719|NCT00549302|75928577|FG001|Double-Blind|Investigator Decision|5|||
42209549|NCT03063086|76024016|FG002|Overall Study|Physician Decision|0|||
42209550|NCT03063086|76024017|FG003|Overall Study|Physician Decision|1|||
42209551|NCT03063086|76024018|FG004|Overall Study|Physician Decision|0|||
41932771|NCT02969525|75620942|FG005|Double-Blind Period|LOW EGFR|0|||
41932772|NCT02969525|75620943|FG006|Double-Blind Period|LOW EGFR|0|||
41932773|NCT02969525|75620944|FG007|Double-Blind Period|LOW EGFR|0|||
41932774|NCT02969525|75620945|FG008|Double-Blind Period|LOW EGFR|0|||
41932775|NCT02969525|75620946|FG009|Double-Blind Period|LOW EGFR|0|||
41932776|NCT02969525|75620947|FG010|Double-Blind Period|LOW EGFR|0|||
41932777|NCT02969525|75620948|FG011|Double-Blind Period|LOW EGFR|0|||
41932778|NCT02969525|75620937|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
41932779|NCT02969525|75620938|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
41932780|NCT02969525|75620939|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
41932781|NCT02969525|75620940|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
41932782|NCT02969525|75620941|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
41932783|NCT02969525|75620942|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
41932784|NCT02969525|75620943|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
41932785|NCT02969525|75620944|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
41932786|NCT02969525|75620945|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
41932787|NCT02969525|75620946|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
41932788|NCT02969525|75620947|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
41932789|NCT02969525|75620948|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
41932790|NCT02969525|75620937|FG000|Dose-Blind Period|Adverse Event|0|||
41932791|NCT02969525|75620938|FG001|Dose-Blind Period|Adverse Event|0|||
41932792|NCT02969525|75620939|FG002|Dose-Blind Period|Adverse Event|0|||
41932793|NCT02969525|75620940|FG003|Dose-Blind Period|Adverse Event|0|||
41932794|NCT02969525|75620941|FG004|Dose-Blind Period|Adverse Event|0|||
41932795|NCT02969525|75620942|FG005|Dose-Blind Period|Adverse Event|0|||
41932796|NCT02969525|75620943|FG006|Dose-Blind Period|Adverse Event|0|||
41932797|NCT02969525|75620944|FG007|Dose-Blind Period|Adverse Event|0|||
41932798|NCT02969525|75620945|FG008|Dose-Blind Period|Adverse Event|0|||
41932799|NCT02969525|75620946|FG009|Dose-Blind Period|Adverse Event|1|||
41932800|NCT02969525|75620947|FG010|Dose-Blind Period|Adverse Event|1|||
41932801|NCT02969525|75620948|FG011|Dose-Blind Period|Adverse Event|1|||
41932802|NCT02969525|75620937|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
41932803|NCT02969525|75620938|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
41932804|NCT02969525|75620939|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
41932805|NCT02969525|75620940|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
41932806|NCT02969525|75620941|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
41932807|NCT02969525|75620942|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
41932808|NCT02969525|75620943|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
41932809|NCT02969525|75620944|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
41932810|NCT02969525|75620945|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
41932811|NCT02969525|75620946|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
41932812|NCT02969525|75620947|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
41932813|NCT02969525|75620948|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
42117720|NCT00549302|75928578|FG002|Double-Blind|Investigator Decision|0|||
42117721|NCT00549302|75928576|FG000|Double-Blind|Sponsor Decision|0|||
42117722|NCT00549302|75928577|FG001|Double-Blind|Sponsor Decision|1|||
42117723|NCT00549302|75928578|FG002|Double-Blind|Sponsor Decision|0|||
42117724|NCT00549302|75928576|FG000|Double-Blind|Lost to Follow-up|1|||
42209552|NCT03063086|76024019|FG005|Overall Study|Physician Decision|0|||
41932814|NCT02969525|75620937|FG000|Dose-Blind Period|Non-cooperating patient|0|||
41932815|NCT02969525|75620938|FG001|Dose-Blind Period|Non-cooperating patient|0|||
41932816|NCT02969525|75620939|FG002|Dose-Blind Period|Non-cooperating patient|0|||
41932817|NCT02969525|75620940|FG003|Dose-Blind Period|Non-cooperating patient|0|||
41932818|NCT02969525|75620941|FG004|Dose-Blind Period|Non-cooperating patient|0|||
41932819|NCT02969525|75620942|FG005|Dose-Blind Period|Non-cooperating patient|0|||
41932820|NCT02969525|75620943|FG006|Dose-Blind Period|Non-cooperating patient|0|||
41932821|NCT02969525|75620944|FG007|Dose-Blind Period|Non-cooperating patient|0|||
41932822|NCT02969525|75620945|FG008|Dose-Blind Period|Non-cooperating patient|0|||
41932823|NCT02969525|75620946|FG009|Dose-Blind Period|Non-cooperating patient|0|||
41932824|NCT02969525|75620947|FG010|Dose-Blind Period|Non-cooperating patient|0|||
41932825|NCT02969525|75620948|FG011|Dose-Blind Period|Non-cooperating patient|1|||
41932826|NCT02969525|75620937|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
41932827|NCT02969525|75620938|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
41932828|NCT02969525|75620939|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
41932829|NCT02969525|75620940|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
41932830|NCT02969525|75620941|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
41932831|NCT02969525|75620942|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
41932832|NCT02969525|75620943|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
41932833|NCT02969525|75620944|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
41932834|NCT02969525|75620945|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
42209553|NCT04128007|76024030|FG000|Overall Study|Withdrawal by Subject|9|||
42209554|NCT04128007|76024031|FG001|Overall Study|Withdrawal by Subject|6|||
42209555|NCT04128007|76024030|FG000|Overall Study|Protocol Violation|1|||
42209556|NCT04128007|76024031|FG001|Overall Study|Protocol Violation|0|||
42209557|NCT04128007|76024030|FG000|Overall Study|Lost to Follow-up|8|||
42209558|NCT04128007|76024031|FG001|Overall Study|Lost to Follow-up|7|||
42209559|NCT04128007|76024030|FG000|Overall Study|Adverse Event|5|||
41932835|NCT02969525|75620946|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
41932836|NCT02969525|75620947|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
41932837|NCT02969525|75620948|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
41932838|NCT04232215|75620979|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
41932839|NCT04232215|75620980|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
41932840|NCT02399813|75620995|FG000|Overall Study|Progressive Disease-Radiographic|2|||
41932841|NCT02399813|75620995|FG000|Overall Study|Death|20|||
41932842|NCT02399813|75620995|FG000|Overall Study|Withdrawal by Subject|3|||
41932843|NCT02399813|75620995|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
41932844|NCT02399813|75620995|FG000|Overall Study|Lost to Follow-up|2|||
41932845|NCT02399813|75620995|FG000|Overall Study|Other than specified|5|||
41932846|NCT02291055|75621004|FG000|Overall Study|Death|2|||
41932847|NCT02291055|75621005|FG001|Overall Study|Death|2|||
41932848|NCT02291055|75621006|FG002|Overall Study|Death|5|||
41932849|NCT02291055|75621007|FG003|Overall Study|Death|8|||
41932850|NCT02291055|75621008|FG004|Overall Study|Death|12|||
41932851|NCT02291055|75621004|FG000|Overall Study|Lost to Follow-up|0|||
41932852|NCT02291055|75621005|FG001|Overall Study|Lost to Follow-up|0|||
41932853|NCT02291055|75621006|FG002|Overall Study|Lost to Follow-up|0|||
41932854|NCT02291055|75621007|FG003|Overall Study|Lost to Follow-up|1|||
41932855|NCT02291055|75621008|FG004|Overall Study|Lost to Follow-up|2|||
41932856|NCT02291055|75621004|FG000|Overall Study|Withdrawal by Subject|3|||
41932857|NCT02291055|75621005|FG001|Overall Study|Withdrawal by Subject|1|||
41932858|NCT02291055|75621006|FG002|Overall Study|Withdrawal by Subject|1|||
41932859|NCT02291055|75621007|FG003|Overall Study|Withdrawal by Subject|5|||
41932860|NCT02291055|75621008|FG004|Overall Study|Withdrawal by Subject|10|||
41932861|NCT02291055|75621004|FG000|Overall Study|Progressive Disease|0|||
42209560|NCT04128007|76024031|FG001|Overall Study|Adverse Event|2|||
42209561|NCT04128007|76024030|FG000|Overall Study|Not reported|0|||
42209562|NCT04128007|76024031|FG001|Overall Study|Not reported|2|||
42209563|NCT04318093|76024039|FG000|Overall Study|Adverse Event|2|||
42209564|NCT04318093|76024040|FG001|Overall Study|Adverse Event|2|||
42209565|NCT04318093|76024039|FG000|Overall Study|Participant withdrew consent|1|||
42209566|NCT04318093|76024040|FG001|Overall Study|Participant withdrew consent|0|||
42209567|NCT04318093|76024039|FG000|Overall Study|Other reasons|0|||
42209568|NCT04318093|76024040|FG001|Overall Study|Other reasons|1|||
42209569|NCT04123405|76024051|FG000|Overall Study|Adverse Event|1|||
42209570|NCT04123405|76024052|FG001|Overall Study|Adverse Event|2|||
41932862|NCT02291055|75621005|FG001|Overall Study|Progressive Disease|0|||
41932863|NCT02291055|75621006|FG002|Overall Study|Progressive Disease|1|||
41932864|NCT02291055|75621007|FG003|Overall Study|Progressive Disease|4|||
41932865|NCT02291055|75621008|FG004|Overall Study|Progressive Disease|2|||
41932866|NCT02291055|75621004|FG000|Overall Study|Study Terminated by Sponsor|0|||
42209571|NCT04123405|76024053|FG002|Overall Study|Adverse Event|3|||
42209572|NCT04123405|76024054|FG003|Overall Study|Adverse Event|3|||
42209573|NCT04123405|76024051|FG000|Overall Study|Exclusion criteria met|1|||
42209574|NCT04123405|76024052|FG001|Overall Study|Exclusion criteria met|2|||
42209575|NCT04123405|76024053|FG002|Overall Study|Exclusion criteria met|0|||
41932867|NCT02291055|75621005|FG001|Overall Study|Study Terminated by Sponsor|0|||
41932868|NCT02291055|75621006|FG002|Overall Study|Study Terminated by Sponsor|0|||
41932869|NCT02291055|75621007|FG003|Overall Study|Study Terminated by Sponsor|5|||
41932870|NCT02291055|75621008|FG004|Overall Study|Study Terminated by Sponsor|1|||
41932871|NCT02291055|75621004|FG000|Overall Study|Other|0|||
41932872|NCT02291055|75621005|FG001|Overall Study|Other|2|||
41932873|NCT02291055|75621006|FG002|Overall Study|Other|1|||
41932874|NCT02291055|75621007|FG003|Overall Study|Other|4|||
41932875|NCT02291055|75621008|FG004|Overall Study|Other|0|||
41932876|NCT00723697|75621024|FG000|Overall Study|Physician questionnaires not received|2|||
41932877|NCT00723697|75621024|FG000|Overall Study|Missing Informed Consent Form|10|||
41932878|NCT00723697|75621024|FG000|Overall Study|Other exclusion criteria applied|6|||
41932879|NCT00684073|75621031|FG000|Selection|Selection/non-selection criteria|3|||
41932880|NCT00684073|75621031|FG000|Selection|Death|1|||
41932881|NCT00684073|75621031|FG000|Selection|noncompliance|1|||
41932882|NCT00684073|75621031|FG000|Selection|Lost to Follow-up|1|||
41932883|NCT00684073|75621031|FG000|Selection|request of the sponsor|1|||
41932884|NCT00684073|75621031|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
41932885|NCT02539368|75622972|FG000|Overall Study|Death|4|||
41932886|NCT02539368|75622973|FG001|Overall Study|Death|2|||
41932887|NCT02539368|75622974|FG002|Overall Study|Death|1|||
41932888|NCT02539368|75622975|FG003|Overall Study|Death|0|||
41932889|NCT02539368|75622976|FG004|Overall Study|Death|0|||
41932890|NCT02539368|75622972|FG000|Overall Study|Withdrawal by Subject|44|||
41932891|NCT02539368|75622973|FG001|Overall Study|Withdrawal by Subject|35|||
41932892|NCT02539368|75622974|FG002|Overall Study|Withdrawal by Subject|9|||
41932893|NCT02539368|75622975|FG003|Overall Study|Withdrawal by Subject|1|||
41932894|NCT02539368|75622976|FG004|Overall Study|Withdrawal by Subject|3|||
41932895|NCT02539368|75622972|FG000|Overall Study|Physician Decision|49|||
41932896|NCT02539368|75622973|FG001|Overall Study|Physician Decision|15|||
41932897|NCT02539368|75622974|FG002|Overall Study|Physician Decision|7|||
41932898|NCT02539368|75622975|FG003|Overall Study|Physician Decision|0|||
41932899|NCT02539368|75622976|FG004|Overall Study|Physician Decision|2|||
41932900|NCT02539368|75622972|FG000|Overall Study|Lost to Follow-up|96|||
41932901|NCT02539368|75622973|FG001|Overall Study|Lost to Follow-up|21|||
41932902|NCT02539368|75622974|FG002|Overall Study|Lost to Follow-up|16|||
41932903|NCT02539368|75622975|FG003|Overall Study|Lost to Follow-up|4|||
41932904|NCT02539368|75622976|FG004|Overall Study|Lost to Follow-up|3|||
41932905|NCT02539368|75622972|FG000|Overall Study|Adverse Event|44|||
41932906|NCT02539368|75622973|FG001|Overall Study|Adverse Event|5|||
41932907|NCT02539368|75622974|FG002|Overall Study|Adverse Event|9|||
41932908|NCT02539368|75622975|FG003|Overall Study|Adverse Event|0|||
41932909|NCT02539368|75622976|FG004|Overall Study|Adverse Event|3|||
41932910|NCT02539368|75622972|FG000|Overall Study|Participant Non-compliant|13|||
41932911|NCT02539368|75622973|FG001|Overall Study|Participant Non-compliant|2|||
41932912|NCT02539368|75622974|FG002|Overall Study|Participant Non-compliant|1|||
41932913|NCT02539368|75622975|FG003|Overall Study|Participant Non-compliant|1|||
41932914|NCT02539368|75622976|FG004|Overall Study|Participant Non-compliant|0|||
41932915|NCT02539368|75622972|FG000|Overall Study|Other|145|||
41932916|NCT02539368|75622973|FG001|Overall Study|Other|18|||
41932917|NCT02539368|75622974|FG002|Overall Study|Other|24|||
41932918|NCT02539368|75622975|FG003|Overall Study|Other|1|||
41932919|NCT02539368|75622976|FG004|Overall Study|Other|3|||
41932920|NCT02539368|75622972|FG000|Overall Study|Missing|10|||
41932921|NCT02539368|75622973|FG001|Overall Study|Missing|3|||
41932922|NCT02539368|75622974|FG002|Overall Study|Missing|0|||
41932923|NCT02539368|75622975|FG003|Overall Study|Missing|0|||
41932924|NCT02539368|75622976|FG004|Overall Study|Missing|0|||
41932925|NCT02539134|75623129|FG000|Overall Study|Lost to Follow-up|1|||
41932926|NCT02539134|75623130|FG001|Overall Study|Lost to Follow-up|0|||
41932927|NCT02539134|75623131|FG002|Overall Study|Lost to Follow-up|0|||
41932928|NCT02539134|75623132|FG003|Overall Study|Lost to Follow-up|0|||
41932929|NCT02539134|75623133|FG004|Overall Study|Lost to Follow-up|0|||
41932930|NCT02539134|75623134|FG005|Overall Study|Lost to Follow-up|0|||
41932931|NCT02538900|75623238|FG000|Overall Study|Death|2|||
42209576|NCT04123405|76024054|FG003|Overall Study|Exclusion criteria met|2|||
42209577|NCT04123405|76024051|FG000|Overall Study|Withdrawal by Subject|1|||
41932932|NCT02538900|75623239|FG001|Overall Study|Death|2|||
41932933|NCT02538900|75623240|FG002|Overall Study|Death|2|||
42022012|NCT00960076|75829346|FG001|Overall Study|Did not attend the termination visit|1|||
41932934|NCT02538900|75623238|FG000|Overall Study|Withdrawal by Subject|18|||
41932935|NCT02538900|75623239|FG001|Overall Study|Withdrawal by Subject|16|||
41932936|NCT02538900|75623240|FG002|Overall Study|Withdrawal by Subject|15|||
41932937|NCT01986348|75623720|FG000|Overall Study|Death|8|||
41932938|NCT01986348|75623721|FG001|Overall Study|Death|22|||
41932939|NCT01986348|75623722|FG002|Overall Study|Death|10|||
41932940|NCT01986348|75623723|FG003|Overall Study|Death|21|||
41932941|NCT01986348|75623720|FG000|Overall Study|Lost to Follow-up|0|||
41932942|NCT01986348|75623721|FG001|Overall Study|Lost to Follow-up|0|||
41932943|NCT01986348|75623722|FG002|Overall Study|Lost to Follow-up|0|||
41932944|NCT01986348|75623723|FG003|Overall Study|Lost to Follow-up|2|||
41932945|NCT01986348|75623720|FG000|Overall Study|Physician Decision|0|||
41932946|NCT01986348|75623721|FG001|Overall Study|Physician Decision|0|||
41932947|NCT01986348|75623722|FG002|Overall Study|Physician Decision|0|||
41932948|NCT01986348|75623723|FG003|Overall Study|Physician Decision|1|||
41932949|NCT01986348|75623720|FG000|Overall Study|Progressive Disease|0|||
41932950|NCT01986348|75623721|FG001|Overall Study|Progressive Disease|0|||
41932951|NCT01986348|75623722|FG002|Overall Study|Progressive Disease|2|||
41932952|NCT01986348|75623723|FG003|Overall Study|Progressive Disease|0|||
41932953|NCT01986348|75623720|FG000|Overall Study|Withdrawal by Participant|0|||
41932954|NCT01986348|75623721|FG001|Overall Study|Withdrawal by Participant|1|||
41932955|NCT01986348|75623722|FG002|Overall Study|Withdrawal by Participant|2|||
41932956|NCT01986348|75623723|FG003|Overall Study|Withdrawal by Participant|1|||
41932957|NCT01986348|75623720|FG000|Overall Study|Study Terminated by Sponsor|0|||
41932958|NCT01986348|75623721|FG001|Overall Study|Study Terminated by Sponsor|0|||
41932959|NCT01986348|75623722|FG002|Overall Study|Study Terminated by Sponsor|0|||
41932960|NCT01986348|75623723|FG003|Overall Study|Study Terminated by Sponsor|3|||
41932961|NCT01986348|75623720|FG000|Overall Study|Other-unspecified|0|||
41932962|NCT01986348|75623721|FG001|Overall Study|Other-unspecified|1|||
41932963|NCT01986348|75623722|FG002|Overall Study|Other-unspecified|0|||
41932964|NCT01986348|75623723|FG003|Overall Study|Other-unspecified|2|||
41932965|NCT02543892|75624296|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
41932966|NCT02543892|75624297|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
41932967|NCT02543892|75624298|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
41932968|NCT02543892|75624299|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
41932969|NCT02543892|75624300|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
41932970|NCT02543892|75624301|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
41932971|NCT02543892|75624302|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
41932972|NCT02543892|75624303|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
41932973|NCT02543892|75624296|FG000|Received Vaccination 2|Physician Decision|0|||
41932974|NCT02543892|75624297|FG001|Received Vaccination 2|Physician Decision|0|||
41932975|NCT02543892|75624298|FG002|Received Vaccination 2|Physician Decision|0|||
41932976|NCT02543892|75624299|FG003|Received Vaccination 2|Physician Decision|0|||
41932977|NCT02543892|75624300|FG004|Received Vaccination 2|Physician Decision|0|||
41932978|NCT02543892|75624301|FG005|Received Vaccination 2|Physician Decision|1|||
41932979|NCT02543892|75624302|FG006|Received Vaccination 2|Physician Decision|0|||
41932980|NCT02543892|75624303|FG007|Received Vaccination 2|Physician Decision|0|||
41932981|NCT02543892|75624296|FG000|Received Vaccination 2|Adverse Event|0|||
41932982|NCT02543892|75624297|FG001|Received Vaccination 2|Adverse Event|1|||
41932983|NCT02543892|75624298|FG002|Received Vaccination 2|Adverse Event|0|||
41932984|NCT02543892|75624299|FG003|Received Vaccination 2|Adverse Event|0|||
41932985|NCT02543892|75624300|FG004|Received Vaccination 2|Adverse Event|0|||
41932986|NCT02543892|75624301|FG005|Received Vaccination 2|Adverse Event|0|||
41932987|NCT02543892|75624302|FG006|Received Vaccination 2|Adverse Event|0|||
41932988|NCT02543892|75624303|FG007|Received Vaccination 2|Adverse Event|0|||
41932989|NCT02543892|75624296|FG000|Had Immunology Data|Withdrawal by Subject|0|||
41932990|NCT02543892|75624297|FG001|Had Immunology Data|Withdrawal by Subject|0|||
41932991|NCT02543892|75624298|FG002|Had Immunology Data|Withdrawal by Subject|0|||
41932992|NCT02543892|75624299|FG003|Had Immunology Data|Withdrawal by Subject|0|||
41932993|NCT02543892|75624300|FG004|Had Immunology Data|Withdrawal by Subject|0|||
41932994|NCT02543892|75624301|FG005|Had Immunology Data|Withdrawal by Subject|0|||
41932995|NCT02543892|75624302|FG006|Had Immunology Data|Withdrawal by Subject|1|||
41932996|NCT02543892|75624303|FG007|Had Immunology Data|Withdrawal by Subject|0|||
41932997|NCT02543658|75624384|FG000|Overall Study|Lack of Efficacy|0|||
41932998|NCT02543658|75624385|FG001|Overall Study|Lack of Efficacy|4|||
41932999|NCT01607892|75625140|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
41933000|NCT01607892|75625141|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
41933001|NCT01607892|75625142|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
41933002|NCT01607892|75625143|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
41933003|NCT01607892|75625144|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
41933004|NCT01607892|75625140|FG000|Overall Study|Death|4|||
41933005|NCT01607892|75625141|FG001|Overall Study|Death|2|||
41933006|NCT01607892|75625142|FG002|Overall Study|Death|8|||
41933007|NCT01607892|75625143|FG003|Overall Study|Death|10|||
41933008|NCT01607892|75625144|FG004|Overall Study|Death|3|||
41933009|NCT01607892|75625140|FG000|Overall Study|Investigator discretion|2|||
41933010|NCT01607892|75625141|FG001|Overall Study|Investigator discretion|4|||
41933011|NCT01607892|75625142|FG002|Overall Study|Investigator discretion|4|||
41933012|NCT01607892|75625143|FG003|Overall Study|Investigator discretion|8|||
41933013|NCT01607892|75625144|FG004|Overall Study|Investigator discretion|0|||
42209578|NCT04123405|76024052|FG001|Overall Study|Withdrawal by Subject|3|||
41933014|NCT01607892|75625140|FG000|Overall Study|Other treatments became available|1|||
41933015|NCT01607892|75625141|FG001|Overall Study|Other treatments became available|1|||
41933016|NCT01607892|75625142|FG002|Overall Study|Other treatments became available|0|||
41933017|NCT01607892|75625143|FG003|Overall Study|Other treatments became available|0|||
41933018|NCT01607892|75625144|FG004|Overall Study|Other treatments became available|2|||
41933019|NCT01607892|75625140|FG000|Overall Study|Intercurrent illness|1|||
41933020|NCT01607892|75625141|FG001|Overall Study|Intercurrent illness|0|||
41933021|NCT01607892|75625142|FG002|Overall Study|Intercurrent illness|0|||
41933022|NCT01607892|75625143|FG003|Overall Study|Intercurrent illness|3|||
41933023|NCT01607892|75625144|FG004|Overall Study|Intercurrent illness|0|||
41933024|NCT01607892|75625140|FG000|Overall Study|Non-Compliance with study procedures|0|||
41933025|NCT01607892|75625141|FG001|Overall Study|Non-Compliance with study procedures|0|||
41933026|NCT01607892|75625142|FG002|Overall Study|Non-Compliance with study procedures|1|||
41933027|NCT01607892|75625143|FG003|Overall Study|Non-Compliance with study procedures|0|||
41933028|NCT01607892|75625144|FG004|Overall Study|Non-Compliance with study procedures|0|||
41933029|NCT01607892|75625140|FG000|Overall Study|Consent withdrawn by participant|9|||
41933030|NCT01607892|75625141|FG001|Overall Study|Consent withdrawn by participant|4|||
41933031|NCT01607892|75625142|FG002|Overall Study|Consent withdrawn by participant|24|||
41933032|NCT01607892|75625143|FG003|Overall Study|Consent withdrawn by participant|14|||
41933033|NCT01607892|75625144|FG004|Overall Study|Consent withdrawn by participant|4|||
41933034|NCT01607892|75625140|FG000|Overall Study|Disease progression|38|||
41933035|NCT01607892|75625141|FG001|Overall Study|Disease progression|13|||
41933036|NCT01607892|75625142|FG002|Overall Study|Disease progression|37|||
41933037|NCT01607892|75625143|FG003|Overall Study|Disease progression|57|||
41933038|NCT01607892|75625144|FG004|Overall Study|Disease progression|9|||
41933039|NCT01607892|75625140|FG000|Overall Study|Incidence or severity of Adverse events|3|||
41933040|NCT01607892|75625141|FG001|Overall Study|Incidence or severity of Adverse events|3|||
41933041|NCT01607892|75625142|FG002|Overall Study|Incidence or severity of Adverse events|7|||
41933042|NCT01607892|75625143|FG003|Overall Study|Incidence or severity of Adverse events|2|||
41933043|NCT01607892|75625144|FG004|Overall Study|Incidence or severity of Adverse events|6|||
41933044|NCT02530242|75625190|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
41933045|NCT02530242|75625191|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
41933046|NCT02537574|75625215|FG000|Overall Study|Adverse Event|1|||
41933047|NCT02537574|75625216|FG001|Overall Study|Adverse Event|3|||
41933048|NCT02537574|75625217|FG002|Overall Study|Adverse Event|2|||
41933049|NCT02537574|75625215|FG000|Overall Study|Lost to Follow-up|40|||
41933050|NCT02537574|75625216|FG001|Overall Study|Lost to Follow-up|51|||
41933051|NCT02537574|75625217|FG002|Overall Study|Lost to Follow-up|55|||
41933052|NCT02537574|75625215|FG000|Overall Study|Noncompliance with study drug|0|||
41933053|NCT02537574|75625216|FG001|Overall Study|Noncompliance with study drug|1|||
41933054|NCT02537574|75625217|FG002|Overall Study|Noncompliance with study drug|1|||
41933055|NCT02537574|75625215|FG000|Overall Study|Physician Decision|2|||
41933056|NCT02537574|75625216|FG001|Overall Study|Physician Decision|0|||
41933057|NCT02537574|75625217|FG002|Overall Study|Physician Decision|0|||
41933058|NCT02537574|75625215|FG000|Overall Study|Protocol Violation|4|||
41933059|NCT02537574|75625216|FG001|Overall Study|Protocol Violation|2|||
41933060|NCT02537574|75625217|FG002|Overall Study|Protocol Violation|3|||
41933061|NCT02537574|75625215|FG000|Overall Study|Withdrawal by Subject|37|||
41933062|NCT02537574|75625216|FG001|Overall Study|Withdrawal by Subject|27|||
41933063|NCT02537574|75625217|FG002|Overall Study|Withdrawal by Subject|29|||
41933064|NCT02537574|75625215|FG000|Overall Study|Lack of Efficacy|14|||
41933065|NCT02537574|75625216|FG001|Overall Study|Lack of Efficacy|16|||
41933066|NCT02537574|75625217|FG002|Overall Study|Lack of Efficacy|15|||
41933067|NCT02537574|75625215|FG000|Overall Study|Duplicate Patient|1|||
41933068|NCT02537574|75625216|FG001|Overall Study|Duplicate Patient|0|||
41933069|NCT02537574|75625217|FG002|Overall Study|Duplicate Patient|0|||
41933070|NCT02537574|75625215|FG000|Overall Study|Patient not Stable|0|||
42209579|NCT04123405|76024053|FG002|Overall Study|Withdrawal by Subject|0|||
42209580|NCT04123405|76024054|FG003|Overall Study|Withdrawal by Subject|2|||
42209581|NCT04123405|76024051|FG000|Overall Study|Contact to subject lost|0|||
42209582|NCT04123405|76024052|FG001|Overall Study|Contact to subject lost|0|||
42209583|NCT04123405|76024053|FG002|Overall Study|Contact to subject lost|0|||
42209584|NCT04123405|76024054|FG003|Overall Study|Contact to subject lost|1|||
42209585|NCT04123405|76024051|FG000|Overall Study|screening failure|1|||
42209586|NCT04123405|76024052|FG001|Overall Study|screening failure|0|||
42209587|NCT04123405|76024053|FG002|Overall Study|screening failure|0|||
42209588|NCT04123405|76024054|FG003|Overall Study|screening failure|0|||
42209589|NCT04314037|76024083|FG000|Treatment Period 2|Adverse Event|1|||
42209590|NCT04314037|76024084|FG001|Treatment Period 2|Adverse Event|0|||
42209591|NCT04314037|76024083|FG000|Treatment Period 3|Protocol Violation|1|||
42209592|NCT04314037|76024084|FG001|Treatment Period 3|Protocol Violation|0|||
42209593|NCT04314037|76024083|FG000|Treatment Period 3|Adverse Event|0|||
42209594|NCT04314037|76024084|FG001|Treatment Period 3|Adverse Event|1|||
42209595|NCT03056300|76024100|FG000|Overall Study|Surgical reason per study protocol|3|||
42209596|NCT03061214|76024107|FG000|Overall Study|Withdrawal by Subject|21|||
42209597|NCT03061214|76024108|FG001|Overall Study|Withdrawal by Subject|26|||
42209598|NCT03061214|76024109|FG002|Overall Study|Withdrawal by Subject|9|||
42209599|NCT03061214|76024107|FG000|Overall Study|Lost to Follow-up|3|||
42209600|NCT03061214|76024108|FG001|Overall Study|Lost to Follow-up|1|||
41933071|NCT02537574|75625216|FG001|Overall Study|Patient not Stable|1|||
42209601|NCT03061214|76024109|FG002|Overall Study|Lost to Follow-up|1|||
42209602|NCT03061214|76024107|FG000|Overall Study|Death|1|||
42209603|NCT03061214|76024108|FG001|Overall Study|Death|1|||
42209604|NCT03061214|76024109|FG002|Overall Study|Death|0|||
42209605|NCT04115839|76024120|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
42209606|NCT04115839|76024121|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
42209607|NCT04115839|76024122|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
42209608|NCT04115839|76024123|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
42209609|NCT04115839|76024124|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
42209610|NCT04115839|76024125|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
42209611|NCT04115839|76024126|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
42209612|NCT04115839|76024120|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
42209613|NCT04115839|76024121|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
42209614|NCT04115839|76024122|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
42209615|NCT04115839|76024123|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
42209616|NCT04115839|76024124|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
42209617|NCT04115839|76024125|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
41933072|NCT02537574|75625217|FG002|Overall Study|Patient not Stable|0|||
41933073|NCT02537574|75625215|FG000|Overall Study|Incarceration|0|||
41933074|NCT02537574|75625216|FG001|Overall Study|Incarceration|1|||
41933075|NCT02537574|75625217|FG002|Overall Study|Incarceration|0|||
41933076|NCT02537574|75625215|FG000|Overall Study|Failed Naloxone Challenge|0|||
41933077|NCT02537574|75625216|FG001|Overall Study|Failed Naloxone Challenge|1|||
41933078|NCT02537574|75625217|FG002|Overall Study|Failed Naloxone Challenge|0|||
41933079|NCT02537574|75625215|FG000|Overall Study|Transportation Issues|0|||
41933080|NCT02537574|75625216|FG001|Overall Study|Transportation Issues|0|||
41933081|NCT02537574|75625217|FG002|Overall Study|Transportation Issues|1|||
41933082|NCT02537574|75625215|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
41933083|NCT02537574|75625216|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
41933084|NCT02537574|75625217|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
41933085|NCT02537574|75625215|FG000|Overall Study|Noncompliance with Protocol|0|||
41933086|NCT02537574|75625216|FG001|Overall Study|Noncompliance with Protocol|0|||
41933087|NCT02537574|75625217|FG002|Overall Study|Noncompliance with Protocol|1|||
41933088|NCT02531802|75625882|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
41933089|NCT02531802|75625883|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
41933090|NCT02531802|75625884|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
41933091|NCT02531802|75625885|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
41933092|NCT02531802|75625886|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
41933093|NCT02531802|75625887|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
41933094|NCT02531802|75625888|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
41933095|NCT02531802|75625889|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
41933096|NCT02531802|75625890|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
41933097|NCT02531802|75625891|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
41933098|NCT02531802|75625892|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
41933099|NCT02531802|75625893|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
41933100|NCT02531802|75625894|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
41933101|NCT02531802|75625895|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
41933102|NCT02531802|75625896|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
41933103|NCT02531802|75625897|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
41933104|NCT02531802|75625898|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
41933105|NCT02531802|75625899|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
41933106|NCT02531802|75625900|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
41933107|NCT02531802|75625901|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
42209618|NCT04115839|76024126|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
42209619|NCT04115839|76024120|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
42209620|NCT04115839|76024121|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
42209621|NCT04115839|76024122|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
42209622|NCT04115839|76024123|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
42209623|NCT04115839|76024124|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
41933108|NCT02531802|75625902|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
41933109|NCT02531802|75625882|FG000|Received Vaccination 2|Physician Decision|0|||
41933110|NCT02531802|75625883|FG001|Received Vaccination 2|Physician Decision|0|||
41933111|NCT02531802|75625884|FG002|Received Vaccination 2|Physician Decision|0|||
41933112|NCT02531802|75625885|FG003|Received Vaccination 2|Physician Decision|0|||
41933113|NCT02531802|75625886|FG004|Received Vaccination 2|Physician Decision|0|||
41933114|NCT02531802|75625887|FG005|Received Vaccination 2|Physician Decision|1|||
42209624|NCT04115839|76024125|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
42209625|NCT04115839|76024126|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
42209626|NCT04115839|76024120|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
42209627|NCT04115839|76024121|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
42209628|NCT04115839|76024122|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
42209629|NCT04115839|76024123|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
42209630|NCT04115839|76024124|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
42209631|NCT04115839|76024125|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
42209632|NCT04115839|76024126|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
42209633|NCT04115839|76024120|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
42209634|NCT04115839|76024121|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
42209635|NCT04115839|76024122|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
42209636|NCT04115839|76024123|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
42209637|NCT04115839|76024124|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
42209638|NCT04115839|76024125|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
42209639|NCT04115839|76024126|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
42209640|NCT04115839|76024120|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
42209641|NCT04115839|76024121|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
42209642|NCT04115839|76024122|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
42209643|NCT04115839|76024123|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
42209644|NCT04115839|76024124|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
42209645|NCT04115839|76024125|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
42209646|NCT04115839|76024126|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
42209647|NCT01561430|76024155|FG000|Overall Study|Adverse Event|0|||
42209648|NCT01561430|76024156|FG001|Overall Study|Adverse Event|0|||
42209649|NCT01561430|76024157|FG002|Overall Study|Adverse Event|3|||
42209650|NCT01561430|76024158|FG003|Overall Study|Adverse Event|1|||
42209651|NCT01561430|76024155|FG000|Overall Study|Withdrawal by Subject|0|||
42209652|NCT01561430|76024156|FG001|Overall Study|Withdrawal by Subject|0|||
42209653|NCT01561430|76024157|FG002|Overall Study|Withdrawal by Subject|1|||
42209654|NCT01561430|76024158|FG003|Overall Study|Withdrawal by Subject|0|||
42209655|NCT01561430|76024155|FG000|Overall Study|Physician Decision|0|||
42209656|NCT01561430|76024156|FG001|Overall Study|Physician Decision|1|||
42209657|NCT01561430|76024157|FG002|Overall Study|Physician Decision|0|||
42209658|NCT01561430|76024158|FG003|Overall Study|Physician Decision|0|||
42209659|NCT01561430|76024155|FG000|Overall Study|Sponsor Decision|1|||
42209660|NCT01561430|76024156|FG001|Overall Study|Sponsor Decision|14|||
42209661|NCT01561430|76024157|FG002|Overall Study|Sponsor Decision|13|||
42209662|NCT01561430|76024158|FG003|Overall Study|Sponsor Decision|12|||
42209663|NCT03060512|76024193|FG000|Overall Study|Adverse Event|4|||
42209664|NCT03060512|76024194|FG001|Overall Study|Adverse Event|6|||
42209665|NCT03060512|76024193|FG000|Overall Study|Lost to Follow-up|1|||
42209666|NCT03060512|76024194|FG001|Overall Study|Lost to Follow-up|1|||
42209667|NCT03060512|76024193|FG000|Overall Study|Withdrawal by Subject|1|||
42209668|NCT03060512|76024194|FG001|Overall Study|Withdrawal by Subject|0|||
42209669|NCT03060512|76024193|FG000|Overall Study|Non-compliance with study medication|1|||
42209670|NCT03060512|76024194|FG001|Overall Study|Non-compliance with study medication|2|||
42209671|NCT02539160|76024282|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
42209672|NCT02539160|76024283|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
42209673|NCT02539160|76024284|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
42209674|NCT02539160|76024285|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
42209675|NCT02539160|76024282|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
42209676|NCT02539160|76024283|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
42209677|NCT02539160|76024284|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
42209678|NCT02539160|76024285|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
42209679|NCT02539160|76024282|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
42209680|NCT02539160|76024283|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
42209681|NCT02539160|76024284|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
42209682|NCT02539160|76024285|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
42209683|NCT04292899|76024299|FG000|Overall Study|Death|21|||
42209684|NCT04292899|76024300|FG001|Overall Study|Death|28|||
42209685|NCT04292899|76024301|FG002|Overall Study|Death|188|||
42209686|NCT04292899|76024302|FG003|Overall Study|Death|371|||
42209687|NCT04292899|76024299|FG000|Overall Study|Lost to Follow-up|8|||
42209688|NCT04292899|76024300|FG001|Overall Study|Lost to Follow-up|4|||
42209689|NCT04292899|76024301|FG002|Overall Study|Lost to Follow-up|22|||
42209690|NCT04292899|76024302|FG003|Overall Study|Lost to Follow-up|235|||
42209691|NCT04292899|76024299|FG000|Overall Study|Withdrew consent|1|||
42209692|NCT04292899|76024300|FG001|Overall Study|Withdrew consent|0|||
42209693|NCT04292899|76024301|FG002|Overall Study|Withdrew consent|11|||
42209694|NCT04292899|76024302|FG003|Overall Study|Withdrew consent|32|||
42209695|NCT04292899|76024299|FG000|Overall Study|Adverse Event|2|||
42209696|NCT04292899|76024300|FG001|Overall Study|Adverse Event|1|||
42209697|NCT04292899|76024301|FG002|Overall Study|Adverse Event|2|||
42209698|NCT04292899|76024302|FG003|Overall Study|Adverse Event|2|||
42209699|NCT04292899|76024299|FG000|Overall Study|Investigator's Discretion|0|||
42209700|NCT04292899|76024300|FG001|Overall Study|Investigator's Discretion|0|||
42209701|NCT04292899|76024301|FG002|Overall Study|Investigator's Discretion|0|||
42209702|NCT04292899|76024302|FG003|Overall Study|Investigator's Discretion|3|||
42209703|NCT04292899|76024299|FG000|Overall Study|Non-compliance With Study Drug|0|||
42209704|NCT04292899|76024300|FG001|Overall Study|Non-compliance With Study Drug|0|||
41933115|NCT02531802|75625888|FG006|Received Vaccination 2|Physician Decision|0|||
42209705|NCT04292899|76024301|FG002|Overall Study|Non-compliance With Study Drug|0|||
42209706|NCT04292899|76024302|FG003|Overall Study|Non-compliance With Study Drug|1|||
42209707|NCT04292899|76024299|FG000|Overall Study|Protocol Violation|0|||
42209708|NCT04292899|76024300|FG001|Overall Study|Protocol Violation|0|||
42209709|NCT04292899|76024301|FG002|Overall Study|Protocol Violation|0|||
42209710|NCT04292899|76024302|FG003|Overall Study|Protocol Violation|1|||
42209711|NCT03241173|76024321|FG000|Overall Study|Death|3|||
42209712|NCT03241173|76024322|FG001|Overall Study|Death|2|||
41933116|NCT02531802|75625889|FG007|Received Vaccination 2|Physician Decision|0|||
41933117|NCT02531802|75625890|FG008|Received Vaccination 2|Physician Decision|0|||
41933118|NCT02531802|75625891|FG009|Received Vaccination 2|Physician Decision|2|||
41933119|NCT02531802|75625892|FG010|Received Vaccination 2|Physician Decision|0|||
41933120|NCT02531802|75625893|FG011|Received Vaccination 2|Physician Decision|0|||
41933121|NCT02531802|75625894|FG012|Received Vaccination 2|Physician Decision|0|||
42209713|NCT03241173|76024323|FG002|Overall Study|Death|4|||
42209714|NCT03241173|76024324|FG003|Overall Study|Death|4|||
42209715|NCT03241173|76024325|FG004|Overall Study|Death|2|||
42209716|NCT03241173|76024326|FG005|Overall Study|Death|2|||
42209717|NCT03241173|76024327|FG006|Overall Study|Death|3|||
42209718|NCT03241173|76024328|FG007|Overall Study|Death|1|||
42209719|NCT03241173|76024329|FG008|Overall Study|Death|0|||
42209720|NCT03241173|76024330|FG009|Overall Study|Death|5|||
42209721|NCT03241173|76024331|FG010|Overall Study|Death|4|||
42209722|NCT03241173|76024332|FG011|Overall Study|Death|3|||
42209723|NCT03241173|76024333|FG012|Overall Study|Death|0|||
42209724|NCT03241173|76024334|FG013|Overall Study|Death|0|||
42209725|NCT03241173|76024335|FG014|Overall Study|Death|0|||
42209726|NCT03241173|76024321|FG000|Overall Study|Withdrawal by Subject|0|||
42209727|NCT03241173|76024322|FG001|Overall Study|Withdrawal by Subject|0|||
42209728|NCT03241173|76024323|FG002|Overall Study|Withdrawal by Subject|1|||
42209729|NCT03241173|76024324|FG003|Overall Study|Withdrawal by Subject|0|||
42209730|NCT03241173|76024325|FG004|Overall Study|Withdrawal by Subject|0|||
42209731|NCT03241173|76024326|FG005|Overall Study|Withdrawal by Subject|1|||
42209732|NCT03241173|76024327|FG006|Overall Study|Withdrawal by Subject|0|||
42209733|NCT03241173|76024328|FG007|Overall Study|Withdrawal by Subject|0|||
42209734|NCT03241173|76024329|FG008|Overall Study|Withdrawal by Subject|0|||
42209735|NCT03241173|76024330|FG009|Overall Study|Withdrawal by Subject|0|||
42209736|NCT03241173|76024331|FG010|Overall Study|Withdrawal by Subject|0|||
42209737|NCT03241173|76024332|FG011|Overall Study|Withdrawal by Subject|0|||
42209738|NCT03241173|76024333|FG012|Overall Study|Withdrawal by Subject|0|||
42209739|NCT03241173|76024334|FG013|Overall Study|Withdrawal by Subject|0|||
42209740|NCT03241173|76024335|FG014|Overall Study|Withdrawal by Subject|0|||
42209741|NCT03241173|76024321|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
42209742|NCT03241173|76024322|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
42209743|NCT03241173|76024323|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
42209744|NCT03241173|76024324|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
42209745|NCT03241173|76024325|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
42209746|NCT03241173|76024326|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
42209747|NCT03241173|76024327|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
42209748|NCT03241173|76024328|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
42209749|NCT03241173|76024329|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
42209750|NCT03241173|76024330|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
42209751|NCT03241173|76024331|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
42209752|NCT03241173|76024332|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
42117725|NCT00549302|75928577|FG001|Double-Blind|Lost to Follow-up|2|||
42209753|NCT03241173|76024333|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
41933122|NCT02531802|75625895|FG013|Received Vaccination 2|Physician Decision|1|||
41933123|NCT02531802|75625896|FG014|Received Vaccination 2|Physician Decision|0|||
42209754|NCT03241173|76024334|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
41933124|NCT02531802|75625897|FG015|Received Vaccination 2|Physician Decision|0|||
42117726|NCT00549302|75928578|FG002|Double-Blind|Lost to Follow-up|0|||
42117727|NCT00549302|75928576|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
42117728|NCT00549302|75928577|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
42117729|NCT00549302|75928578|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
42117730|NCT00549302|75928576|FG000|Double-Blind|New condition or starts new therapy|0|||
42117731|NCT00549302|75928577|FG001|Double-Blind|New condition or starts new therapy|2|||
42209755|NCT03241173|76024335|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
42209756|NCT03241173|76024321|FG000|Overall Study|Lost to Follow-up|0|||
42209757|NCT03241173|76024322|FG001|Overall Study|Lost to Follow-up|0|||
42209758|NCT03241173|76024323|FG002|Overall Study|Lost to Follow-up|0|||
42209759|NCT03241173|76024324|FG003|Overall Study|Lost to Follow-up|0|||
42209760|NCT03241173|76024325|FG004|Overall Study|Lost to Follow-up|1|||
42209761|NCT03241173|76024326|FG005|Overall Study|Lost to Follow-up|0|||
42209762|NCT03241173|76024327|FG006|Overall Study|Lost to Follow-up|0|||
42209763|NCT03241173|76024328|FG007|Overall Study|Lost to Follow-up|0|||
42209764|NCT03241173|76024329|FG008|Overall Study|Lost to Follow-up|0|||
42209765|NCT03241173|76024330|FG009|Overall Study|Lost to Follow-up|1|||
42209766|NCT03241173|76024331|FG010|Overall Study|Lost to Follow-up|0|||
42209767|NCT03241173|76024332|FG011|Overall Study|Lost to Follow-up|0|||
42209768|NCT03241173|76024333|FG012|Overall Study|Lost to Follow-up|0|||
42209769|NCT03241173|76024334|FG013|Overall Study|Lost to Follow-up|0|||
42209770|NCT03241173|76024335|FG014|Overall Study|Lost to Follow-up|0|||
42209771|NCT03264066|76024369|FG000|Overall Study|Adverse Event|1|||
42209772|NCT03264066|76024370|FG001|Overall Study|Adverse Event|1|||
42209773|NCT03264066|76024371|FG002|Overall Study|Adverse Event|0|||
42209774|NCT03264066|76024372|FG003|Overall Study|Adverse Event|0|||
42209775|NCT03264066|76024373|FG004|Overall Study|Adverse Event|0|||
42209776|NCT03264066|76024374|FG005|Overall Study|Adverse Event|0|||
42209777|NCT03264066|76024369|FG000|Overall Study|Death|12|||
42209778|NCT03264066|76024370|FG001|Overall Study|Death|12|||
42209779|NCT03264066|76024371|FG002|Overall Study|Death|8|||
42209780|NCT03264066|76024372|FG003|Overall Study|Death|10|||
42209781|NCT03264066|76024373|FG004|Overall Study|Death|6|||
42209782|NCT03264066|76024374|FG005|Overall Study|Death|1|||
42209783|NCT03264066|76024369|FG000|Overall Study|Lost to Follow-up|1|||
42209784|NCT03264066|76024370|FG001|Overall Study|Lost to Follow-up|0|||
42209785|NCT03264066|76024371|FG002|Overall Study|Lost to Follow-up|0|||
42209786|NCT03264066|76024372|FG003|Overall Study|Lost to Follow-up|0|||
42209787|NCT03264066|76024373|FG004|Overall Study|Lost to Follow-up|0|||
42209788|NCT03264066|76024374|FG005|Overall Study|Lost to Follow-up|0|||
42209789|NCT03264066|76024369|FG000|Overall Study|Progressive Disease|0|||
42209790|NCT03264066|76024370|FG001|Overall Study|Progressive Disease|2|||
42209791|NCT03264066|76024371|FG002|Overall Study|Progressive Disease|1|||
42209792|NCT03264066|76024372|FG003|Overall Study|Progressive Disease|0|||
42209793|NCT03264066|76024373|FG004|Overall Study|Progressive Disease|0|||
42209794|NCT03264066|76024374|FG005|Overall Study|Progressive Disease|0|||
42209795|NCT03264066|76024369|FG000|Overall Study|Study Terminated by Sponsor|5|||
42209796|NCT03264066|76024370|FG001|Overall Study|Study Terminated by Sponsor|5|||
42209797|NCT03264066|76024371|FG002|Overall Study|Study Terminated by Sponsor|8|||
42209798|NCT03264066|76024372|FG003|Overall Study|Study Terminated by Sponsor|5|||
42209799|NCT03264066|76024373|FG004|Overall Study|Study Terminated by Sponsor|1|||
42209800|NCT03264066|76024374|FG005|Overall Study|Study Terminated by Sponsor|2|||
42209801|NCT03264066|76024369|FG000|Overall Study|Withdrawal by Subject|1|||
42209802|NCT03264066|76024370|FG001|Overall Study|Withdrawal by Subject|0|||
42209803|NCT03264066|76024371|FG002|Overall Study|Withdrawal by Subject|0|||
42209804|NCT03264066|76024372|FG003|Overall Study|Withdrawal by Subject|5|||
42209805|NCT03264066|76024373|FG004|Overall Study|Withdrawal by Subject|0|||
41933125|NCT02531802|75625898|FG016|Received Vaccination 2|Physician Decision|0|||
41933126|NCT02531802|75625899|FG017|Received Vaccination 2|Physician Decision|1|||
41933127|NCT02531802|75625900|FG018|Received Vaccination 2|Physician Decision|0|||
41933128|NCT02531802|75625901|FG019|Received Vaccination 2|Physician Decision|0|||
42209806|NCT03264066|76024374|FG005|Overall Study|Withdrawal by Subject|0|||
42209807|NCT03759041|76024392|FG000|Overall Study|Withdrawal by Subject|4|||
42209808|NCT03759041|76024393|FG001|Overall Study|Withdrawal by Subject|10|||
42209809|NCT03759041|76024394|FG002|Overall Study|Withdrawal by Subject|10|||
41933129|NCT02531802|75625902|FG020|Received Vaccination 2|Physician Decision|0|||
41933130|NCT02531802|75625882|FG000|Received Vaccination 2|Adverse Event|0|||
42209810|NCT03759041|76024392|FG000|Overall Study|Adverse Event|1|||
42209811|NCT03759041|76024393|FG001|Overall Study|Adverse Event|3|||
42209812|NCT03759041|76024394|FG002|Overall Study|Adverse Event|4|||
42209813|NCT03759041|76024392|FG000|Overall Study|Lack of Efficacy|0|||
42209814|NCT03759041|76024393|FG001|Overall Study|Lack of Efficacy|0|||
42209815|NCT03759041|76024394|FG002|Overall Study|Lack of Efficacy|1|||
42209816|NCT03759041|76024392|FG000|Overall Study|Study Terminated by Sponsor|15|||
41933131|NCT02531802|75625883|FG001|Received Vaccination 2|Adverse Event|0|||
42209817|NCT03759041|76024393|FG001|Overall Study|Study Terminated by Sponsor|16|||
42209818|NCT03759041|76024394|FG002|Overall Study|Study Terminated by Sponsor|10|||
42209819|NCT03759041|76024392|FG000|Overall Study|Other reason for discontinuation|0|||
42209820|NCT03759041|76024393|FG001|Overall Study|Other reason for discontinuation|2|||
42209821|NCT03759041|76024394|FG002|Overall Study|Other reason for discontinuation|1|||
42209822|NCT03759041|76024392|FG000|Overall Study|Lost to Follow-up|7|||
41933132|NCT02531802|75625884|FG002|Received Vaccination 2|Adverse Event|0|||
41933133|NCT02531802|75625885|FG003|Received Vaccination 2|Adverse Event|0|||
42209823|NCT03759041|76024393|FG001|Overall Study|Lost to Follow-up|2|||
42209824|NCT03759041|76024394|FG002|Overall Study|Lost to Follow-up|2|||
42209825|NCT03759041|76024392|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
42209826|NCT03759041|76024393|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
42209827|NCT03759041|76024394|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
42209828|NCT04110145|76024407|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
42209829|NCT04110145|76024408|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
42209830|NCT04110145|76024409|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
42209831|NCT04110145|76024410|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
42209832|NCT04110145|76024411|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
42209833|NCT02477618|76024425|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
42209834|NCT02477618|76024426|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
42209835|NCT02477618|76024425|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
42209836|NCT02477618|76024426|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
42209837|NCT02477618|76024425|FG000|Overall Study|Adverse Event|1|||
42209838|NCT02477618|76024426|FG001|Overall Study|Adverse Event|1|||
42209839|NCT02477618|76024425|FG000|Overall Study|Transferred Away from Study Site|1|||
42209840|NCT02477618|76024426|FG001|Overall Study|Transferred Away from Study Site|0|||
42209841|NCT02477618|76024425|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
42209842|NCT02477618|76024426|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
42209843|NCT04102501|76024434|FG000|Overall Study|Withdrawal by Subject|7|||
42209844|NCT04102501|76024435|FG001|Overall Study|Withdrawal by Subject|9|||
42209845|NCT04102501|76024434|FG000|Overall Study|Adverse Event|1|||
41933134|NCT02531802|75625886|FG004|Received Vaccination 2|Adverse Event|0|||
41933135|NCT02531802|75625887|FG005|Received Vaccination 2|Adverse Event|2|||
41933136|NCT02531802|75625888|FG006|Received Vaccination 2|Adverse Event|0|||
41933137|NCT02531802|75625889|FG007|Received Vaccination 2|Adverse Event|0|||
41933138|NCT02531802|75625890|FG008|Received Vaccination 2|Adverse Event|0|||
42209846|NCT04102501|76024435|FG001|Overall Study|Adverse Event|3|||
41933139|NCT02531802|75625891|FG009|Received Vaccination 2|Adverse Event|0|||
42209847|NCT03285477|76024445|FG000|Treatment and Response Assessment Period|Death|1|||
42209848|NCT03285477|76024446|FG001|Treatment and Response Assessment Period|Death|0|||
42209849|NCT03285477|76024445|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
42209850|NCT03285477|76024446|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
42209851|NCT03285477|76024445|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
42209852|NCT03285477|76024446|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
42209853|NCT03285477|76024445|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
42209854|NCT03285477|76024446|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
42209855|NCT03285477|76024445|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
42209856|NCT03285477|76024446|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
42209857|NCT04289623|76024463|FG000|Wave 1 Emails|Email was not delivered|268|||
42209858|NCT04289623|76024464|FG001|Wave 1 Emails|Email was not delivered|257|||
42209859|NCT04289623|76024465|FG002|Wave 1 Emails|Email was not delivered|0|||
42209860|NCT04289623|76024466|FG003|Wave 1 Emails|Email was not delivered|0|||
42209861|NCT04289623|76024467|FG004|Wave 1 Emails|Email was not delivered|0|||
42209862|NCT04289623|76024468|FG005|Wave 1 Emails|Email was not delivered|0|||
42209863|NCT03248037|76024484|FG000|Overall Study|Withdrawal by Subject|6|||
42209864|NCT03248037|76024485|FG001|Overall Study|Withdrawal by Subject|9|||
42209865|NCT03248037|76024484|FG000|Overall Study|Adverse Event|15|||
42209866|NCT03248037|76024485|FG001|Overall Study|Adverse Event|0|||
42209867|NCT04287517|76024500|FG000|Overall Study|Withdrawal by Subject|1|||
42209868|NCT04287517|76024501|FG001|Overall Study|Withdrawal by Subject|1|||
42209869|NCT03284229|76024507|FG000|Overall Study|Lost to Follow-up|3|||
42209870|NCT03242928|76024514|FG000|Overall Study|Adverse Event|2|||
42209871|NCT03242928|76024515|FG001|Overall Study|Adverse Event|1|||
42209872|NCT03242928|76024514|FG000|Overall Study|Lost to Follow-up|2|||
42209873|NCT03242928|76024515|FG001|Overall Study|Lost to Follow-up|0|||
42209874|NCT03242928|76024514|FG000|Overall Study|Physician Decision|0|||
42209875|NCT03242928|76024515|FG001|Overall Study|Physician Decision|1|||
42209876|NCT03242928|76024514|FG000|Overall Study|Withdrawal by Subject|5|||
42209877|NCT03242928|76024515|FG001|Overall Study|Withdrawal by Subject|3|||
42209878|NCT03300024|76024523|FG000|Overall Study|Physician Decision|4|||
42209879|NCT03300024|76024524|FG001|Overall Study|Physician Decision|6|||
42209880|NCT04276207|76024532|FG000|Period 1|Withdrawal by Subject|0|||
42209881|NCT04276207|76024533|FG001|Period 1|Withdrawal by Subject|1|||
42209882|NCT03282357|76024539|FG000|Overall Study|Lost to Follow-up|3|||
42209883|NCT03282357|76024539|FG000|Overall Study|Withdrawal by Subject|4|||
42209884|NCT03282357|76024539|FG000|Overall Study|Adverse Event|1|||
42209885|NCT03282357|76024539|FG000|Overall Study|Other|9|||
42209886|NCT04272775|76024546|FG000|Overall Study|Study Terminated by Sponsor|1|||
42209887|NCT04272775|76024547|FG001|Overall Study|Study Terminated by Sponsor|0|||
42209888|NCT04272775|76024546|FG000|Overall Study|Protocol Violation|0|||
42209889|NCT04272775|76024547|FG001|Overall Study|Protocol Violation|1|||
41933140|NCT02531802|75625892|FG010|Received Vaccination 2|Adverse Event|0|||
42209890|NCT04272775|76024546|FG000|Overall Study|Symptomatic Deterioration|1|||
42209891|NCT04272775|76024547|FG001|Overall Study|Symptomatic Deterioration|1|||
42209892|NCT04272775|76024546|FG000|Overall Study|Withdrawal by Subject|1|||
42209893|NCT04272775|76024547|FG001|Overall Study|Withdrawal by Subject|2|||
42209894|NCT04272775|76024546|FG000|Overall Study|Adverse Event|1|||
42209895|NCT04272775|76024547|FG001|Overall Study|Adverse Event|2|||
42209896|NCT04272775|76024546|FG000|Overall Study|Progressive Disease|3|||
42209897|NCT04272775|76024547|FG001|Overall Study|Progressive Disease|1|||
42209898|NCT03232983|76024553|FG000|Period 1|Physician Decision|0|||
42209899|NCT03232983|76024554|FG001|Period 1|Physician Decision|0|||
42209900|NCT03232983|76024555|FG002|Period 1|Physician Decision|1|||
42209901|NCT03232983|76024556|FG003|Period 1|Physician Decision|0|||
42209902|NCT03232983|76024553|FG000|Washout Period 2|Physician Decision|0|||
42209903|NCT03232983|76024554|FG001|Washout Period 2|Physician Decision|0|||
42209904|NCT03232983|76024555|FG002|Washout Period 2|Physician Decision|1|||
42209905|NCT03232983|76024556|FG003|Washout Period 2|Physician Decision|0|||
42209906|NCT03232983|76024553|FG000|Washout Period 2|Withdrawal by Subject|0|||
42209907|NCT03232983|76024554|FG001|Washout Period 2|Withdrawal by Subject|0|||
42209908|NCT03232983|76024555|FG002|Washout Period 2|Withdrawal by Subject|0|||
42209909|NCT03232983|76024556|FG003|Washout Period 2|Withdrawal by Subject|1|||
42209910|NCT03232983|76024553|FG000|Period 4|Withdrawal by Subject|1|||
42209911|NCT03232983|76024554|FG001|Period 4|Withdrawal by Subject|0|||
42209912|NCT03232983|76024555|FG002|Period 4|Withdrawal by Subject|0|||
42209913|NCT03232983|76024556|FG003|Period 4|Withdrawal by Subject|0|||
42209914|NCT04102345|76024570|FG000|Overall Study|Withdrawal by Subject|1|||
42209915|NCT04102345|76024571|FG001|Overall Study|Withdrawal by Subject|0|||
42209916|NCT04271605|76024577|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
42209917|NCT03299244|76024583|FG000|Overall Study|Withdrawal by Subject|34|||
42209918|NCT03299244|76024584|FG001|Overall Study|Withdrawal by Subject|29|||
42209919|NCT03299244|76024583|FG000|Overall Study|Decision by Sponsor|4|||
42209920|NCT03299244|76024584|FG001|Overall Study|Decision by Sponsor|5|||
42209921|NCT03299244|76024583|FG000|Overall Study|Death|9|||
42209922|NCT03299244|76024584|FG001|Overall Study|Death|4|||
42209923|NCT03757715|76024593|FG000|Overall Study|Lost to Follow-up|4|||
42209924|NCT03757715|76024594|FG001|Overall Study|Lost to Follow-up|9|||
42209925|NCT03757715|76024593|FG000|Overall Study|Withdrawal by Subject|1|||
42209926|NCT03757715|76024594|FG001|Overall Study|Withdrawal by Subject|1|||
42209927|NCT03281577|76024604|FG000|Overall Study|Adverse Event|0|||
42209928|NCT03281577|76024605|FG001|Overall Study|Adverse Event|0|||
42209929|NCT03281577|76024606|FG002|Overall Study|Adverse Event|0|||
42209930|NCT03281577|76024607|FG003|Overall Study|Adverse Event|1|||
42209931|NCT03281577|76024604|FG000|Overall Study|Withdrawal by Subject|1|||
42209932|NCT03281577|76024605|FG001|Overall Study|Withdrawal by Subject|0|||
42209933|NCT03281577|76024606|FG002|Overall Study|Withdrawal by Subject|0|||
42209934|NCT03281577|76024607|FG003|Overall Study|Withdrawal by Subject|0|||
42209935|NCT04098367|76024623|FG000|Overall Study|Adverse Event|0|||
42209936|NCT04098367|76024624|FG001|Overall Study|Adverse Event|0|||
42209937|NCT04098367|76024625|FG002|Overall Study|Adverse Event|1|||
42209938|NCT04098367|76024623|FG000|Overall Study|Lost to Follow-up|1|||
42209939|NCT04098367|76024624|FG001|Overall Study|Lost to Follow-up|5|||
42209940|NCT04098367|76024625|FG002|Overall Study|Lost to Follow-up|2|||
42209941|NCT04098367|76024623|FG000|Overall Study|Withdrawal by Subject|0|||
42209942|NCT04098367|76024624|FG001|Overall Study|Withdrawal by Subject|0|||
42209943|NCT04098367|76024625|FG002|Overall Study|Withdrawal by Subject|1|||
42209944|NCT04098367|76024623|FG000|Overall Study|Sick . Could not attend visit|1|||
42209945|NCT04098367|76024624|FG001|Overall Study|Sick . Could not attend visit|0|||
42209946|NCT04098367|76024625|FG002|Overall Study|Sick . Could not attend visit|0|||
42209947|NCT04091659|76024642|FG000|Overall Study|Protocol Violation|3|||
42209948|NCT04091659|76024643|FG001|Overall Study|Protocol Violation|0|||
42209949|NCT04091659|76024642|FG000|Overall Study|Lost to Follow-up|0|||
42209950|NCT04091659|76024643|FG001|Overall Study|Lost to Follow-up|1|||
41933141|NCT02531802|75625893|FG011|Received Vaccination 2|Adverse Event|0|||
41933142|NCT02531802|75625894|FG012|Received Vaccination 2|Adverse Event|0|||
41933143|NCT02531802|75625895|FG013|Received Vaccination 2|Adverse Event|0|||
42209951|NCT04256785|76024680|FG000|Overall Study|Adverse Event|8|||
42209952|NCT04256785|76024681|FG001|Overall Study|Adverse Event|6|||
42209953|NCT04256785|76024680|FG000|Overall Study|Lack of Efficacy|3|||
42209954|NCT04256785|76024681|FG001|Overall Study|Lack of Efficacy|4|||
42209955|NCT04256785|76024680|FG000|Overall Study|Lost to Follow-up|7|||
42209956|NCT04256785|76024681|FG001|Overall Study|Lost to Follow-up|7|||
42209957|NCT04256785|76024680|FG000|Overall Study|Protocol Violation|1|||
42209958|NCT04256785|76024681|FG001|Overall Study|Protocol Violation|0|||
42209959|NCT04256785|76024680|FG000|Overall Study|Withdrawal by Subject|4|||
42209960|NCT04256785|76024681|FG001|Overall Study|Withdrawal by Subject|1|||
42209961|NCT04256785|76024680|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
42209962|NCT04256785|76024681|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
42209963|NCT02959918|76024703|FG000|Overall Study|Adverse Event|1|||
41933144|NCT02531802|75625896|FG014|Received Vaccination 2|Adverse Event|0|||
41933145|NCT02531802|75625897|FG015|Received Vaccination 2|Adverse Event|0|||
41933146|NCT02531802|75625898|FG016|Received Vaccination 2|Adverse Event|0|||
41933147|NCT02531802|75625899|FG017|Received Vaccination 2|Adverse Event|2|||
41933148|NCT02531802|75625900|FG018|Received Vaccination 2|Adverse Event|1|||
41933149|NCT02531802|75625901|FG019|Received Vaccination 2|Adverse Event|0|||
41933150|NCT02531802|75625902|FG020|Received Vaccination 2|Adverse Event|1|||
41933151|NCT02531802|75625882|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
41933152|NCT02531802|75625883|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
41933153|NCT02531802|75625884|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
41933154|NCT02531802|75625885|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
41933155|NCT02531802|75625886|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
41933156|NCT02531802|75625887|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
41933157|NCT02531802|75625888|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
41933158|NCT02531802|75625889|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
41933159|NCT02531802|75625890|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
41933160|NCT02531802|75625891|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
41933161|NCT02531802|75625892|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
41933162|NCT02531802|75625893|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
41933163|NCT02531802|75625894|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
41933164|NCT02531802|75625895|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
41933165|NCT02531802|75625896|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
41933166|NCT02531802|75625897|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
41933167|NCT02531802|75625898|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
42209964|NCT02959918|76024704|FG001|Overall Study|Adverse Event|1|||
42209965|NCT02959918|76024705|FG002|Overall Study|Adverse Event|2|||
42209966|NCT02959918|76024706|FG003|Overall Study|Adverse Event|0|||
42209967|NCT02959918|76024707|FG004|Overall Study|Adverse Event|0|||
42209968|NCT02959918|76024708|FG005|Overall Study|Adverse Event|2|||
42209969|NCT02959918|76024709|FG006|Overall Study|Adverse Event|2|||
42209970|NCT02959918|76024710|FG007|Overall Study|Adverse Event|1|||
42209971|NCT02959918|76024711|FG008|Overall Study|Adverse Event|2|||
42209972|NCT02959918|76024712|FG009|Overall Study|Adverse Event|1|||
41933168|NCT02531802|75625899|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
41933169|NCT02531802|75625900|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
41933170|NCT02531802|75625901|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
41933171|NCT02531802|75625902|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
41933172|NCT01602666|75626005|FG000|Induction Chemotherapy|Death|2|||
41933173|NCT01602666|75626006|FG001|Induction Chemotherapy|Death|1|||
41933174|NCT01602666|75626005|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
41933175|NCT01602666|75626006|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
41933176|NCT01602666|75626005|FG000|Induction Chemotherapy|Physician Decision|12|||
41933177|NCT01602666|75626006|FG001|Induction Chemotherapy|Physician Decision|5|||
41933178|NCT01602666|75626005|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
41933179|NCT01602666|75626006|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
41933180|NCT01602666|75626005|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
41933181|NCT01602666|75626006|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
41933182|NCT01602666|75626005|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
41933183|NCT01602666|75626006|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
41933184|NCT01602666|75626005|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
41933185|NCT01602666|75626006|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
41933186|NCT01602666|75626005|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
41933187|NCT01602666|75626006|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
42022013|NCT01227629|75829362|FG000|Overall Study|Adverse Event|2|||
41933188|NCT01602666|75626005|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
41933189|NCT01602666|75626006|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
41933190|NCT01602666|75626005|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
41933191|NCT01602666|75626006|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
41933192|NCT01602666|75626005|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
41933193|NCT01602666|75626006|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
41933194|NCT02531646|75626017|FG000|Overall Study|equip. image processing issue|5|||
41933195|NCT02531646|75626018|FG001|Overall Study|equip. image processing issue|1|||
41933196|NCT02531646|75626019|FG002|Overall Study|equip. image processing issue|0|||
41933197|NCT02536404|75626084|FG000|Overall Study|Adverse Event|5|||
41933198|NCT02536404|75626085|FG001|Overall Study|Adverse Event|0|||
41933199|NCT02536404|75626084|FG000|Overall Study|Withdrawal by Subject|4|||
41933200|NCT02536404|75626085|FG001|Overall Study|Withdrawal by Subject|1|||
41933201|NCT02536404|75626084|FG000|Overall Study|Physician Decision|10|||
41933202|NCT02536404|75626085|FG001|Overall Study|Physician Decision|0|||
41933203|NCT02536404|75626084|FG000|Overall Study|Sponsor decision|1|||
42209973|NCT02959918|76024713|FG010|Overall Study|Adverse Event|1|||
42209974|NCT02959918|76024714|FG011|Overall Study|Adverse Event|3|||
42209975|NCT02959918|76024715|FG012|Overall Study|Adverse Event|2|||
41933204|NCT02536404|75626085|FG001|Overall Study|Sponsor decision|0|||
41933205|NCT01659996|75627045|FG000|Overall Study|Protocol Violation|3|||
41933206|NCT01659996|75627046|FG001|Overall Study|Protocol Violation|3|||
41933207|NCT01659996|75627047|FG002|Overall Study|Protocol Violation|3|||
41933208|NCT01659996|75627045|FG000|Overall Study|Lost to Follow-up|1|||
41933209|NCT01659996|75627046|FG001|Overall Study|Lost to Follow-up|3|||
41933210|NCT01659996|75627047|FG002|Overall Study|Lost to Follow-up|2|||
41933211|NCT01659996|75627045|FG000|Overall Study|Adverse Event|0|||
41933212|NCT01659996|75627046|FG001|Overall Study|Adverse Event|0|||
41933213|NCT01659996|75627047|FG002|Overall Study|Adverse Event|1|||
41933214|NCT01659996|75627045|FG000|Overall Study|Withdrawal by Subject|4|||
41933215|NCT01659996|75627046|FG001|Overall Study|Withdrawal by Subject|1|||
41933216|NCT01659996|75627047|FG002|Overall Study|Withdrawal by Subject|5|||
41933217|NCT02525874|75627406|FG000|Overall Study|Other|1|||
41933218|NCT02525874|75627406|FG000|Overall Study|Investigator Decision|1|||
41933219|NCT02525874|75627406|FG000|Overall Study|Consent withdrawn|22|||
41933220|NCT02525874|75627406|FG000|Overall Study|Non-compliance with study drug|3|||
41933221|NCT02525874|75627406|FG000|Overall Study|Adverse Event|17|||
41933222|NCT02525874|75627406|FG000|Overall Study|Lost to Follow-up|7|||
41933223|NCT02525874|75627406|FG000|Overall Study|Disease progression, defined by protocol|2|||
42022014|NCT01227629|75829363|FG001|Overall Study|Adverse Event|2|||
42209976|NCT02959918|76024716|FG013|Overall Study|Adverse Event|4|||
41933224|NCT02525874|75627406|FG000|Overall Study|Disease relapse|4|||
41933225|NCT02525874|75627406|FG000|Overall Study|Alternative Treatment for MS|2|||
41933226|NCT02525874|75627406|FG000|Overall Study|New lesions in Brain|1|||
41933227|NCT02528214|75627416|FG000|Overall Study|Protocol Violation|0|||
41933228|NCT02528214|75627417|FG001|Overall Study|Protocol Violation|1|||
41933229|NCT02528214|75627416|FG000|Overall Study|Adverse Event|0|||
41933230|NCT02528214|75627417|FG001|Overall Study|Adverse Event|1|||
41933231|NCT02528214|75627416|FG000|Overall Study|Other than specified above|0|||
41933232|NCT02528214|75627417|FG001|Overall Study|Other than specified above|1|||
41933233|NCT05348681|75627461|FG000|Overall Study|Study terminated by Sponsor|8|||
41933234|NCT05348681|75627462|FG001|Overall Study|Study terminated by Sponsor|3|||
41933235|NCT05348681|75627461|FG000|Overall Study|Withdrawal by Subject|1|||
41933236|NCT05348681|75627462|FG001|Overall Study|Withdrawal by Subject|1|||
41933237|NCT05348681|75627461|FG000|Overall Study|Lost to Follow-up|1|||
41933238|NCT05348681|75627462|FG001|Overall Study|Lost to Follow-up|1|||
41933239|NCT05348681|75627461|FG000|Overall Study|Adverse Event|1|||
41933240|NCT05348681|75627462|FG001|Overall Study|Adverse Event|0|||
41933241|NCT05348681|75627461|FG000|Overall Study|Other|2|||
41933242|NCT05348681|75627462|FG001|Overall Study|Other|1|||
41933243|NCT04423757|75627488|FG000|Overall Study|Adverse Event|2|||
41933244|NCT04423757|75627489|FG001|Overall Study|Adverse Event|0|||
41933245|NCT04423757|75627488|FG000|Overall Study|Not treated|1|||
41933246|NCT04423757|75627489|FG001|Overall Study|Not treated|1|||
41933247|NCT04379713|75627497|FG000|Overall Study|Adverse Event|2|||
41933248|NCT04379713|75627498|FG001|Overall Study|Adverse Event|0|||
41933249|NCT04379713|75627497|FG000|Overall Study|Physician Decision|2|||
41933250|NCT04379713|75627498|FG001|Overall Study|Physician Decision|1|||
41933251|NCT04379713|75627497|FG000|Overall Study|Protocol Violation|11|||
41933252|NCT04379713|75627498|FG001|Overall Study|Protocol Violation|6|||
41933253|NCT04379713|75627497|FG000|Overall Study|No longer met eligibility criteria|14|||
41933254|NCT04379713|75627498|FG001|Overall Study|No longer met eligibility criteria|11|||
41933255|NCT04379713|75627497|FG000|Overall Study|Withdrawal by parent/guardian|36|||
41933256|NCT04379713|75627498|FG001|Overall Study|Withdrawal by parent/guardian|15|||
41933257|NCT04379713|75627497|FG000|Overall Study|Lost to Follow-up|31|||
41933258|NCT04379713|75627498|FG001|Overall Study|Lost to Follow-up|21|||
41933259|NCT04085328|75627506|FG000|Overall Study|Witihdrew Consent|16|||
41933260|NCT04085328|75627507|FG001|Overall Study|Witihdrew Consent|16|||
41933261|NCT04085328|75627506|FG000|Overall Study|Adverse Event|8|||
41933262|NCT04085328|75627507|FG001|Overall Study|Adverse Event|7|||
41933263|NCT04085328|75627506|FG000|Overall Study|Lost to Follow-up|7|||
41933264|NCT04085328|75627507|FG001|Overall Study|Lost to Follow-up|2|||
41933265|NCT04085328|75627506|FG000|Overall Study|Physician Decision|0|||
41933266|NCT04085328|75627507|FG001|Overall Study|Physician Decision|1|||
41933267|NCT04085328|75627506|FG000|Overall Study|Pregnancy|0|||
41933268|NCT04085328|75627507|FG001|Overall Study|Pregnancy|1|||
41933269|NCT04085328|75627506|FG000|Overall Study|Reasons Related to COVID-19|5|||
41933270|NCT04085328|75627507|FG001|Overall Study|Reasons Related to COVID-19|8|||
41933271|NCT04085328|75627506|FG000|Overall Study|Did not meet inclusion criteria|1|||
41933272|NCT04085328|75627507|FG001|Overall Study|Did not meet inclusion criteria|1|||
41933273|NCT04085328|75627506|FG000|Overall Study|Early termination|1|||
41933274|NCT04085328|75627507|FG001|Overall Study|Early termination|0|||
41933275|NCT03074474|75627538|FG000|Overall Study|Lost to Follow-up|10|||
41933276|NCT03074474|75627538|FG000|Overall Study|Withdrawal by Subject|10|||
41933277|NCT03074474|75627538|FG000|Overall Study|Death|4|||
41933278|NCT03074474|75627538|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
41933279|NCT02744391|75627547|FG000|Overall Study|Lost to Follow-up|9|||
41933280|NCT02744391|75627547|FG000|Overall Study|Physician Decision|2|||
41933281|NCT02744391|75627547|FG000|Overall Study|Withdrawal by Subject|3|||
41933282|NCT02462837|75627553|FG000|Overall Study|pt developed hives|1|||
41933283|NCT02462837|75627554|FG001|Overall Study|pt developed hives|0|||
41933284|NCT02462837|75627553|FG000|Overall Study|Withdrawal by Subject|1|||
41933285|NCT02462837|75627554|FG001|Overall Study|Withdrawal by Subject|0|||
41933286|NCT02346201|75627562|FG000|Overall Study|Adverse Event|3|||
41933287|NCT02346201|75627563|FG001|Overall Study|Adverse Event|2|||
41933288|NCT02346201|75627562|FG000|Overall Study|Lost to Follow-up|1|||
41933289|NCT02346201|75627563|FG001|Overall Study|Lost to Follow-up|0|||
41933290|NCT02346201|75627562|FG000|Overall Study|Withdrawal by Subject|6|||
41933291|NCT02346201|75627563|FG001|Overall Study|Withdrawal by Subject|3|||
41933292|NCT02346201|75627562|FG000|Overall Study|Unavailable for future follow-up|0|||
41933293|NCT02346201|75627563|FG001|Overall Study|Unavailable for future follow-up|1|||
41933294|NCT02346201|75627562|FG000|Overall Study|Physician Decision|0|||
41933295|NCT02346201|75627563|FG001|Overall Study|Physician Decision|1|||
41933296|NCT02346201|75627562|FG000|Overall Study|Missed final visit|0|||
41933297|NCT02346201|75627563|FG001|Overall Study|Missed final visit|2|||
41933298|NCT01866930|75627583|FG000|Treatment Period|Other|1|||
41933299|NCT01866930|75627584|FG001|Treatment Period|Other|0|||
42209977|NCT02959918|76024703|FG000|Overall Study|Lost to Follow-up|0|||
42209978|NCT02959918|76024704|FG001|Overall Study|Lost to Follow-up|0|||
42209979|NCT02959918|76024705|FG002|Overall Study|Lost to Follow-up|0|||
42209980|NCT02959918|76024706|FG003|Overall Study|Lost to Follow-up|0|||
41933300|NCT01866930|75627583|FG000|Treatment Period|Death|0|||
41933301|NCT01866930|75627584|FG001|Treatment Period|Death|2|||
42209981|NCT02959918|76024707|FG004|Overall Study|Lost to Follow-up|0|||
42209982|NCT02959918|76024708|FG005|Overall Study|Lost to Follow-up|0|||
42209983|NCT02959918|76024709|FG006|Overall Study|Lost to Follow-up|0|||
42209984|NCT02959918|76024710|FG007|Overall Study|Lost to Follow-up|0|||
42209985|NCT02959918|76024711|FG008|Overall Study|Lost to Follow-up|0|||
42209986|NCT02959918|76024712|FG009|Overall Study|Lost to Follow-up|1|||
42209987|NCT02959918|76024713|FG010|Overall Study|Lost to Follow-up|0|||
42209988|NCT02959918|76024714|FG011|Overall Study|Lost to Follow-up|0|||
42209989|NCT02959918|76024715|FG012|Overall Study|Lost to Follow-up|1|||
42209990|NCT02959918|76024716|FG013|Overall Study|Lost to Follow-up|0|||
42209991|NCT02959918|76024703|FG000|Overall Study|Withdrawal by Subject|0|||
42209992|NCT02959918|76024704|FG001|Overall Study|Withdrawal by Subject|0|||
42209993|NCT02959918|76024705|FG002|Overall Study|Withdrawal by Subject|1|||
42209994|NCT02959918|76024706|FG003|Overall Study|Withdrawal by Subject|2|||
42209995|NCT02959918|76024707|FG004|Overall Study|Withdrawal by Subject|0|||
42209996|NCT02959918|76024708|FG005|Overall Study|Withdrawal by Subject|0|||
42300060|NCT02549027|76135218|FG001|Washout After Period 4|Withdrawal by Subject|1|||
42300061|NCT02549027|76135219|FG002|Washout After Period 4|Withdrawal by Subject|1|||
42300062|NCT02549027|76135220|FG003|Washout After Period 4|Withdrawal by Subject|1|||
42300063|NCT02549027|76135221|FG004|Washout After Period 4|Withdrawal by Subject|0|||
42300064|NCT02549027|76135222|FG005|Washout After Period 4|Withdrawal by Subject|0|||
42300065|NCT02549027|76135217|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
42300066|NCT02549027|76135218|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
42300067|NCT02549027|76135219|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
42300068|NCT02549027|76135220|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
42300069|NCT02549027|76135221|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
42300070|NCT02549027|76135222|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
42300071|NCT02529553|76135250|FG000|Overall Study|Progressive Disease|1|||
42300072|NCT02529553|76135251|FG001|Overall Study|Progressive Disease|0|||
42300073|NCT02529553|76135252|FG002|Overall Study|Progressive Disease|1|||
42300074|NCT02529553|76135253|FG003|Overall Study|Progressive Disease|3|||
42300075|NCT02529553|76135254|FG004|Overall Study|Progressive Disease|2|||
42300076|NCT02529553|76135255|FG005|Overall Study|Progressive Disease|3|||
42300077|NCT02529553|76135256|FG006|Overall Study|Progressive Disease|3|||
42300078|NCT02529553|76135257|FG007|Overall Study|Progressive Disease|5|||
42300079|NCT02529553|76135258|FG008|Overall Study|Progressive Disease|3|||
42300080|NCT02529553|76135250|FG000|Overall Study|Physician Decision|0|||
42300081|NCT02529553|76135251|FG001|Overall Study|Physician Decision|1|||
42300082|NCT02529553|76135252|FG002|Overall Study|Physician Decision|0|||
42300083|NCT02529553|76135253|FG003|Overall Study|Physician Decision|0|||
42300084|NCT02529553|76135254|FG004|Overall Study|Physician Decision|1|||
42300085|NCT02529553|76135255|FG005|Overall Study|Physician Decision|0|||
42300086|NCT02529553|76135256|FG006|Overall Study|Physician Decision|0|||
42300087|NCT02529553|76135257|FG007|Overall Study|Physician Decision|0|||
42300088|NCT02529553|76135258|FG008|Overall Study|Physician Decision|0|||
42300089|NCT02529553|76135250|FG000|Overall Study|Withdrawal by Subject|0|||
42300090|NCT02529553|76135251|FG001|Overall Study|Withdrawal by Subject|0|||
42300091|NCT02529553|76135252|FG002|Overall Study|Withdrawal by Subject|0|||
42300092|NCT02529553|76135253|FG003|Overall Study|Withdrawal by Subject|0|||
42300093|NCT02529553|76135254|FG004|Overall Study|Withdrawal by Subject|0|||
42300094|NCT02529553|76135255|FG005|Overall Study|Withdrawal by Subject|1|||
42300095|NCT02529553|76135256|FG006|Overall Study|Withdrawal by Subject|0|||
42300096|NCT02529553|76135257|FG007|Overall Study|Withdrawal by Subject|1|||
42300097|NCT02529553|76135258|FG008|Overall Study|Withdrawal by Subject|0|||
42300098|NCT02547935|76135282|FG000|Overall Study|Other|0|||
42300099|NCT02547935|76135283|FG001|Overall Study|Other|1|||
42300100|NCT02547935|76135284|FG002|Overall Study|Other|0|||
42300101|NCT02547935|76135282|FG000|Overall Study|Withdrawal by Subject|2|||
42300102|NCT02547935|76135283|FG001|Overall Study|Withdrawal by Subject|3|||
42300103|NCT02547935|76135284|FG002|Overall Study|Withdrawal by Subject|4|||
42300104|NCT02547935|76135282|FG000|Overall Study|Screen Failure|2|||
42300105|NCT02547935|76135283|FG001|Overall Study|Screen Failure|0|||
42300106|NCT02547935|76135284|FG002|Overall Study|Screen Failure|0|||
42300107|NCT02547935|76135282|FG000|Overall Study|Physician Decision|0|||
42300108|NCT02547935|76135283|FG001|Overall Study|Physician Decision|1|||
42300109|NCT02547935|76135284|FG002|Overall Study|Physician Decision|0|||
42300110|NCT02547935|76135282|FG000|Overall Study|Lost to Follow-up|0|||
42300111|NCT02547935|76135283|FG001|Overall Study|Lost to Follow-up|2|||
42300112|NCT02547935|76135284|FG002|Overall Study|Lost to Follow-up|1|||
41933302|NCT01866930|75627583|FG000|Treatment Period|Poor/non compliance|0|||
42117732|NCT00549302|75928578|FG002|Double-Blind|New condition or starts new therapy|0|||
42117733|NCT00549302|75928576|FG000|Open-Label|Adverse Event|0|||
42117734|NCT00549302|75928577|FG001|Open-Label|Adverse Event|0|||
41933303|NCT01866930|75627584|FG001|Treatment Period|Poor/non compliance|2|||
41933304|NCT01866930|75627583|FG000|Treatment Period|No longer meets study criteria|0|||
41933305|NCT01866930|75627584|FG001|Treatment Period|No longer meets study criteria|1|||
41933306|NCT01866930|75627583|FG000|Treatment Period|Withdrawal by Subject|2|||
41933307|NCT01866930|75627584|FG001|Treatment Period|Withdrawal by Subject|8|||
41933308|NCT01866930|75627583|FG000|Treatment Period|Lack of Efficacy|1|||
41933309|NCT01866930|75627584|FG001|Treatment Period|Lack of Efficacy|9|||
41933310|NCT01866930|75627583|FG000|Treatment Period|Adverse Event|4|||
41933311|NCT01866930|75627584|FG001|Treatment Period|Adverse Event|12|||
41933312|NCT01866930|75627583|FG000|Treatment Period|Lost to Follow-up|1|||
42022015|NCT01227629|75829364|FG002|Overall Study|Adverse Event|1|||
42209997|NCT02959918|76024709|FG006|Overall Study|Withdrawal by Subject|1|||
41933313|NCT01866930|75627584|FG001|Treatment Period|Lost to Follow-up|1|||
42209998|NCT02959918|76024710|FG007|Overall Study|Withdrawal by Subject|0|||
42209999|NCT02959918|76024711|FG008|Overall Study|Withdrawal by Subject|1|||
41933314|NCT01866930|75627583|FG000|Follow-up Period|Lost to Follow-up|1|||
41933315|NCT01866930|75627584|FG001|Follow-up Period|Lost to Follow-up|1|||
41933316|NCT01866930|75627583|FG000|Follow-up Period|Other|1|||
41933317|NCT01866930|75627584|FG001|Follow-up Period|Other|5|||
41933318|NCT01866930|75627583|FG000|Follow-up Period|No longer required per protocol|1|||
41933319|NCT01866930|75627584|FG001|Follow-up Period|No longer required per protocol|0|||
41933320|NCT01866930|75627583|FG000|Follow-up Period|Withdrawal by Subject|3|||
41933321|NCT01866930|75627584|FG001|Follow-up Period|Withdrawal by Subject|3|||
42022016|NCT01227629|75829365|FG003|Overall Study|Adverse Event|6|||
42022017|NCT01227629|75829366|FG004|Overall Study|Adverse Event|1|||
42300113|NCT02547935|76135282|FG000|Overall Study|Death|1|||
42300114|NCT02547935|76135283|FG001|Overall Study|Death|1|||
42300115|NCT02547935|76135284|FG002|Overall Study|Death|0|||
42300116|NCT02554019|76135297|FG000|Overall Study|Withdrawal by Subject|1|||
42300117|NCT02554019|76135298|FG001|Overall Study|Withdrawal by Subject|0|||
42300118|NCT02554019|76135299|FG002|Overall Study|Withdrawal by Subject|2|||
42300119|NCT02554019|76135297|FG000|Overall Study|Adverse Event|1|||
42300120|NCT02554019|76135298|FG001|Overall Study|Adverse Event|0|||
42300121|NCT02554019|76135299|FG002|Overall Study|Adverse Event|0|||
42300122|NCT02327169|76135322|FG000|Overall Study|Progressive Disease|1|||
42300123|NCT02327169|76135323|FG001|Overall Study|Progressive Disease|3|||
41933322|NCT01621568|75627592|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
41933323|NCT01621568|75627593|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
41933324|NCT01621568|75627592|FG000|Week 5-6 No Treatment|Death|1|||
41933325|NCT01621568|75627593|FG001|Week 5-6 No Treatment|Death|0|||
41933326|NCT00813293|75627613|FG000|Overall Study|Intercurrent illness|1|||
41933327|NCT00813293|75627614|FG001|Overall Study|Intercurrent illness|0|||
41933328|NCT00813293|75627613|FG000|Overall Study|Adverse Event|0|||
41933329|NCT00813293|75627614|FG001|Overall Study|Adverse Event|1|||
41933330|NCT00481091|75627630|FG000|Overall Study|Withdrawal by Subject|0|||
41933331|NCT00481091|75627631|FG001|Overall Study|Withdrawal by Subject|1|||
41933332|NCT00481091|75627632|FG002|Overall Study|Withdrawal by Subject|1|||
41933333|NCT00481091|75627633|FG003|Overall Study|Withdrawal by Subject|0|||
41933334|NCT00481091|75627634|FG004|Overall Study|Withdrawal by Subject|0|||
41933335|NCT00481091|75627635|FG005|Overall Study|Withdrawal by Subject|0|||
41933336|NCT00481091|75627636|FG006|Overall Study|Withdrawal by Subject|0|||
41933337|NCT00481091|75627637|FG007|Overall Study|Withdrawal by Subject|0|||
41933338|NCT00481091|75627638|FG008|Overall Study|Withdrawal by Subject|1|||
41933339|NCT00481091|75627639|FG009|Overall Study|Withdrawal by Subject|6|||
41933340|NCT00481091|75627630|FG000|Overall Study|Other, Not Specified|0|||
41933341|NCT00481091|75627631|FG001|Overall Study|Other, Not Specified|1|||
41933342|NCT00481091|75627632|FG002|Overall Study|Other, Not Specified|1|||
41933343|NCT00481091|75627633|FG003|Overall Study|Other, Not Specified|0|||
41933344|NCT00481091|75627634|FG004|Overall Study|Other, Not Specified|0|||
41933345|NCT00481091|75627635|FG005|Overall Study|Other, Not Specified|1|||
41933346|NCT00481091|75627636|FG006|Overall Study|Other, Not Specified|0|||
41933347|NCT00481091|75627637|FG007|Overall Study|Other, Not Specified|0|||
41933348|NCT00481091|75627638|FG008|Overall Study|Other, Not Specified|0|||
41933349|NCT00481091|75627639|FG009|Overall Study|Other, Not Specified|4|||
41933350|NCT00481091|75627630|FG000|Overall Study|Adverse Event|1|||
41933351|NCT00481091|75627631|FG001|Overall Study|Adverse Event|2|||
41933352|NCT00481091|75627632|FG002|Overall Study|Adverse Event|0|||
41933353|NCT00481091|75627633|FG003|Overall Study|Adverse Event|1|||
41933354|NCT00481091|75627634|FG004|Overall Study|Adverse Event|1|||
41933355|NCT00481091|75627635|FG005|Overall Study|Adverse Event|1|||
41933356|NCT00481091|75627636|FG006|Overall Study|Adverse Event|2|||
41933357|NCT00481091|75627637|FG007|Overall Study|Adverse Event|1|||
41933358|NCT00481091|75627638|FG008|Overall Study|Adverse Event|1|||
41933359|NCT00481091|75627639|FG009|Overall Study|Adverse Event|6|||
41933360|NCT00481091|75627630|FG000|Overall Study|Progressive disease clinical|0|||
41933361|NCT00481091|75627631|FG001|Overall Study|Progressive disease clinical|0|||
42022018|NCT01227629|75829367|FG005|Overall Study|Adverse Event|1|||
41933362|NCT00481091|75627632|FG002|Overall Study|Progressive disease clinical|0|||
41933363|NCT00481091|75627633|FG003|Overall Study|Progressive disease clinical|0|||
41933364|NCT00481091|75627634|FG004|Overall Study|Progressive disease clinical|0|||
41933365|NCT00481091|75627635|FG005|Overall Study|Progressive disease clinical|0|||
41933366|NCT00481091|75627636|FG006|Overall Study|Progressive disease clinical|0|||
41933367|NCT00481091|75627637|FG007|Overall Study|Progressive disease clinical|0|||
41933368|NCT00481091|75627638|FG008|Overall Study|Progressive disease clinical|1|||
41933369|NCT00481091|75627639|FG009|Overall Study|Progressive disease clinical|7|||
41933370|NCT00481091|75627630|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
41933371|NCT00481091|75627631|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
41933372|NCT00481091|75627632|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
41933373|NCT00481091|75627633|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
41933374|NCT00481091|75627634|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
41933375|NCT00481091|75627635|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
41933376|NCT00481091|75627636|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
41933377|NCT00481091|75627637|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
41933378|NCT00481091|75627638|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
41933379|NCT00481091|75627639|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
41933380|NCT00481091|75627630|FG000|Overall Study|Progressive disease other|1|||
41933381|NCT00481091|75627631|FG001|Overall Study|Progressive disease other|1|||
41933382|NCT00481091|75627632|FG002|Overall Study|Progressive disease other|0|||
41933383|NCT00481091|75627633|FG003|Overall Study|Progressive disease other|1|||
41933384|NCT00481091|75627634|FG004|Overall Study|Progressive disease other|1|||
41933385|NCT00481091|75627635|FG005|Overall Study|Progressive disease other|1|||
41933386|NCT00481091|75627636|FG006|Overall Study|Progressive disease other|0|||
41933387|NCT00481091|75627637|FG007|Overall Study|Progressive disease other|2|||
41933388|NCT00481091|75627638|FG008|Overall Study|Progressive disease other|0|||
41933389|NCT00481091|75627639|FG009|Overall Study|Progressive disease other|0|||
42210000|NCT02959918|76024712|FG009|Overall Study|Withdrawal by Subject|1|||
42210001|NCT02959918|76024713|FG010|Overall Study|Withdrawal by Subject|2|||
42210002|NCT02959918|76024714|FG011|Overall Study|Withdrawal by Subject|3|||
41933390|NCT00481091|75627630|FG000|Overall Study|No reason given|0|||
41933391|NCT00481091|75627631|FG001|Overall Study|No reason given|0|||
41933392|NCT00481091|75627632|FG002|Overall Study|No reason given|1|||
41933393|NCT00481091|75627633|FG003|Overall Study|No reason given|1|||
41933394|NCT00481091|75627634|FG004|Overall Study|No reason given|1|||
41933395|NCT00481091|75627635|FG005|Overall Study|No reason given|0|||
41933396|NCT00481091|75627636|FG006|Overall Study|No reason given|1|||
41933397|NCT00481091|75627637|FG007|Overall Study|No reason given|1|||
41933398|NCT00481091|75627638|FG008|Overall Study|No reason given|1|||
42210003|NCT02959918|76024715|FG012|Overall Study|Withdrawal by Subject|1|||
42210004|NCT02959918|76024716|FG013|Overall Study|Withdrawal by Subject|1|||
42210005|NCT02959918|76024703|FG000|Overall Study|Protocol Violation|0|||
42210006|NCT02959918|76024704|FG001|Overall Study|Protocol Violation|0|||
42210007|NCT02959918|76024705|FG002|Overall Study|Protocol Violation|1|||
42210008|NCT02959918|76024706|FG003|Overall Study|Protocol Violation|0|||
42210009|NCT02959918|76024707|FG004|Overall Study|Protocol Violation|0|||
42210010|NCT02959918|76024708|FG005|Overall Study|Protocol Violation|1|||
42210011|NCT02959918|76024709|FG006|Overall Study|Protocol Violation|0|||
42210012|NCT02959918|76024710|FG007|Overall Study|Protocol Violation|0|||
42300124|NCT02327169|76135324|FG002|Overall Study|Progressive Disease|4|||
42300125|NCT02327169|76135325|FG003|Overall Study|Progressive Disease|3|||
42300126|NCT02327169|76135326|FG004|Overall Study|Progressive Disease|4|||
42300127|NCT02327169|76135327|FG005|Overall Study|Progressive Disease|3|||
42300128|NCT02327169|76135328|FG006|Overall Study|Progressive Disease|3|||
42300129|NCT02327169|76135329|FG007|Overall Study|Progressive Disease|3|||
42300130|NCT02327169|76135330|FG008|Overall Study|Progressive Disease|4|||
42300131|NCT02327169|76135331|FG009|Overall Study|Progressive Disease|4|||
42300132|NCT02327169|76135332|FG010|Overall Study|Progressive Disease|4|||
42300133|NCT02327169|76135333|FG011|Overall Study|Progressive Disease|3|||
42300134|NCT02327169|76135334|FG012|Overall Study|Progressive Disease|1|||
42300135|NCT02327169|76135335|FG013|Overall Study|Progressive Disease|3|||
42300136|NCT02327169|76135336|FG014|Overall Study|Progressive Disease|3|||
42210013|NCT02959918|76024711|FG008|Overall Study|Protocol Violation|2|||
42300137|NCT02327169|76135322|FG000|Overall Study|Adverse Event|2|||
42210014|NCT02959918|76024712|FG009|Overall Study|Protocol Violation|1|||
41933399|NCT00481091|75627639|FG009|Overall Study|No reason given|4|||
41933400|NCT00003641|75627670|FG000|Overall Study|Withdrawal by Subject|0|||
41933401|NCT00003641|75627671|FG001|Overall Study|Withdrawal by Subject|100|||
41933402|NCT00003641|75627670|FG000|Overall Study|Adverse Event|0|||
41933403|NCT00003641|75627671|FG001|Overall Study|Adverse Event|38|||
41933404|NCT00003641|75627670|FG000|Overall Study|Disease progression|0|||
41933405|NCT00003641|75627671|FG001|Overall Study|Disease progression|2|||
41933406|NCT00003641|75627670|FG000|Overall Study|Unknown/missing|0|||
41933407|NCT00003641|75627671|FG001|Overall Study|Unknown/missing|22|||
41933408|NCT00003641|75627670|FG000|Overall Study|Should not receive interferon therapy|2|||
41933409|NCT00003641|75627671|FG001|Overall Study|Should not receive interferon therapy|0|||
41933410|NCT00003641|75627670|FG000|Overall Study|Never started interferon|567|||
41933411|NCT00003641|75627671|FG001|Overall Study|Never started interferon|12|||
41933412|NCT02524158|75627701|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
42210015|NCT02959918|76024713|FG010|Overall Study|Protocol Violation|0|||
42210016|NCT02959918|76024714|FG011|Overall Study|Protocol Violation|1|||
42210017|NCT02959918|76024715|FG012|Overall Study|Protocol Violation|1|||
42210018|NCT02959918|76024716|FG013|Overall Study|Protocol Violation|0|||
42210019|NCT02959918|76024703|FG000|Overall Study|Stopping Rule Met|1|||
42210020|NCT02959918|76024704|FG001|Overall Study|Stopping Rule Met|0|||
42210021|NCT02959918|76024705|FG002|Overall Study|Stopping Rule Met|3|||
42210022|NCT02959918|76024706|FG003|Overall Study|Stopping Rule Met|4|||
42210023|NCT02959918|76024707|FG004|Overall Study|Stopping Rule Met|5|||
42210024|NCT02959918|76024708|FG005|Overall Study|Stopping Rule Met|3|||
41933413|NCT02524158|75627702|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
41933414|NCT02524158|75627701|FG000|12-weeks Assessment|Lost to Follow-up|18|||
41933415|NCT02524158|75627702|FG001|12-weeks Assessment|Lost to Follow-up|12|||
41933416|NCT02524158|75627701|FG000|6-month Assessment|Withdrawal by Subject|1|||
41933417|NCT02524158|75627702|FG001|6-month Assessment|Withdrawal by Subject|1|||
41933418|NCT02524158|75627701|FG000|6-month Assessment|Lost to Follow-up|21|||
41933419|NCT02524158|75627702|FG001|6-month Assessment|Lost to Follow-up|20|||
42022019|NCT01227629|75829368|FG006|Overall Study|Adverse Event|6|||
42022020|NCT01227629|75829369|FG007|Overall Study|Adverse Event|6|||
42022021|NCT01227629|75829370|FG008|Overall Study|Adverse Event|4|||
42022022|NCT01227629|75829371|FG009|Overall Study|Adverse Event|0|||
42022023|NCT01227629|75829362|FG000|Overall Study|Protocol Violation|0|||
42022024|NCT01227629|75829363|FG001|Overall Study|Protocol Violation|0|||
42210025|NCT02959918|76024709|FG006|Overall Study|Stopping Rule Met|2|||
42210026|NCT02959918|76024710|FG007|Overall Study|Stopping Rule Met|4|||
42210027|NCT02959918|76024711|FG008|Overall Study|Stopping Rule Met|1|||
42210028|NCT02959918|76024712|FG009|Overall Study|Stopping Rule Met|1|||
42210029|NCT02959918|76024713|FG010|Overall Study|Stopping Rule Met|3|||
42210030|NCT02959918|76024714|FG011|Overall Study|Stopping Rule Met|5|||
42210031|NCT02959918|76024715|FG012|Overall Study|Stopping Rule Met|2|||
42210032|NCT02959918|76024716|FG013|Overall Study|Stopping Rule Met|1|||
42210033|NCT02959918|76024703|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
41933420|NCT02525094|75627722|FG000|Overall Study|Lost to Follow-up|2|||
41933421|NCT02525094|75627723|FG001|Overall Study|Lost to Follow-up|1|||
41933422|NCT02525094|75627722|FG000|Overall Study|Withdrawal by Subject|5|||
42210034|NCT02959918|76024704|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
42210035|NCT02959918|76024705|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
42210036|NCT02959918|76024706|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
41933423|NCT02525094|75627723|FG001|Overall Study|Withdrawal by Subject|6|||
42210037|NCT02959918|76024707|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
42210038|NCT02959918|76024708|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
42210039|NCT02959918|76024709|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
42210040|NCT02959918|76024710|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
42210041|NCT02959918|76024711|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
42210042|NCT02959918|76024712|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
42210043|NCT02959918|76024713|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
42210044|NCT02959918|76024714|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
42210045|NCT02959918|76024715|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
42210046|NCT02959918|76024716|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
42210047|NCT02959918|76024703|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210048|NCT02959918|76024704|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210049|NCT02959918|76024705|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210050|NCT02959918|76024706|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210051|NCT02959918|76024707|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210052|NCT02959918|76024708|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210053|NCT02959918|76024709|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210054|NCT02959918|76024710|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
42210055|NCT02959918|76024711|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210056|NCT02959918|76024712|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210057|NCT02959918|76024713|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210058|NCT02959918|76024714|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
41933424|NCT02525094|75627722|FG000|Overall Study|Not Treated|1|||
41933425|NCT02525094|75627723|FG001|Overall Study|Not Treated|1|||
41933426|NCT01657266|75627880|FG000|Overall Study|Lost to Follow-up|2|||
41933427|NCT01657266|75627881|FG001|Overall Study|Lost to Follow-up|2|||
41933428|NCT01657266|75627880|FG000|Overall Study|Adverse Event|2|||
41933429|NCT01657266|75627881|FG001|Overall Study|Adverse Event|3|||
41933430|NCT01657032|75627935|FG000|Overall Study|Lost to Follow-up|0|||
41933431|NCT01657032|75627936|FG001|Overall Study|Lost to Follow-up|7|||
41933432|NCT01657500|75628039|FG000|Overall Study|set impropperly matched|3|||
41933433|NCT01657500|75628040|FG001|Overall Study|set impropperly matched|3|||
41933434|NCT01657500|75628039|FG000|Overall Study|Lost to Follow-up|2|||
41933435|NCT01657500|75628040|FG001|Overall Study|Lost to Follow-up|2|||
41933436|NCT01658904|75628053|FG000|Overall Study|Principal Investigator discretion|2|||
41933437|NCT01658904|75628054|FG001|Overall Study|Principal Investigator discretion|0|||
41933438|NCT01658904|75628055|FG002|Overall Study|Principal Investigator discretion|0|||
41933439|NCT01658514|75628239|FG000|Overall Study|Protocol Violation|1|||
41933440|NCT01658514|75628240|FG001|Overall Study|Protocol Violation|0|||
41933441|NCT01658514|75628241|FG002|Overall Study|Protocol Violation|2|||
41933442|NCT01658436|75628262|FG000|Overall Study|Adverse Event|6|||
41933443|NCT01658436|75628263|FG001|Overall Study|Adverse Event|5|||
41933444|NCT01658436|75628262|FG000|Overall Study|Physician Decision|1|||
41933445|NCT01658436|75628263|FG001|Overall Study|Physician Decision|0|||
41933446|NCT01658436|75628262|FG000|Overall Study|Progressive disease|12|||
41933447|NCT01658436|75628263|FG001|Overall Study|Progressive disease|4|||
41933448|NCT01658436|75628262|FG000|Overall Study|Study terminated by sponsor|0|||
41933449|NCT01658436|75628263|FG001|Overall Study|Study terminated by sponsor|1|||
41933450|NCT01658436|75628262|FG000|Overall Study|Subject/guardian decision|0|||
41933451|NCT01658436|75628263|FG001|Overall Study|Subject/guardian decision|1|||
41933452|NCT01658436|75628262|FG000|Overall Study|Death|1|||
41933453|NCT01658436|75628263|FG001|Overall Study|Death|0|||
41933454|NCT01656408|75628808|FG000|Overall Study|Adverse Event|0|||
41933455|NCT01656408|75628809|FG001|Overall Study|Adverse Event|0|||
42210059|NCT02959918|76024715|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210060|NCT02959918|76024716|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
42210061|NCT02959918|76024703|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210062|NCT02959918|76024704|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210063|NCT02959918|76024705|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210064|NCT02959918|76024706|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210065|NCT02959918|76024707|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210066|NCT02959918|76024708|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210067|NCT02959918|76024709|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42300138|NCT02327169|76135323|FG001|Overall Study|Adverse Event|0|||
42300139|NCT02327169|76135324|FG002|Overall Study|Adverse Event|1|||
41933456|NCT01656408|75628810|FG002|Overall Study|Adverse Event|1|||
41933457|NCT01656408|75628811|FG003|Overall Study|Adverse Event|0|||
41933458|NCT01656408|75628812|FG004|Overall Study|Adverse Event|0|||
41933459|NCT01656408|75628813|FG005|Overall Study|Adverse Event|1|||
41933460|NCT01656408|75628814|FG006|Overall Study|Adverse Event|1|||
41933461|NCT01656408|75628815|FG007|Overall Study|Adverse Event|0|||
42210068|NCT02959918|76024710|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210069|NCT02959918|76024711|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
42210070|NCT02959918|76024712|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210071|NCT02959918|76024713|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210072|NCT02959918|76024714|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210073|NCT02959918|76024715|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210074|NCT02959918|76024716|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
42210075|NCT02959918|76024703|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210076|NCT02959918|76024704|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210077|NCT02959918|76024705|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210078|NCT02959918|76024706|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210079|NCT02959918|76024707|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210080|NCT02959918|76024708|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210081|NCT02959918|76024709|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210082|NCT02959918|76024710|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210083|NCT02959918|76024711|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210084|NCT02959918|76024712|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
42210085|NCT02959918|76024713|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210086|NCT02959918|76024714|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210087|NCT02959918|76024715|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210088|NCT02959918|76024716|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
42210089|NCT03263442|76024751|FG000|Inpatient Phase|Death|1|||
42210090|NCT03263442|76024752|FG001|Inpatient Phase|Death|0|||
42210091|NCT03263442|76024751|FG000|Inpatient Phase|Withdrawal by Subject|1|||
42210092|NCT03263442|76024752|FG001|Inpatient Phase|Withdrawal by Subject|0|||
42210093|NCT03263442|76024751|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
42210094|NCT03263442|76024752|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
42210095|NCT03263442|76024751|FG000|1-month Follow-Up|Lost to Follow-up|1|||
41933462|NCT01656408|75628816|FG008|Overall Study|Adverse Event|1|||
41933463|NCT01656408|75628817|FG009|Overall Study|Adverse Event|0|||
41933464|NCT01656408|75628808|FG000|Overall Study|Physician Decision|1|||
42210096|NCT03263442|76024752|FG001|1-month Follow-Up|Lost to Follow-up|0|||
42022025|NCT01227629|75829364|FG002|Overall Study|Protocol Violation|0|||
42022026|NCT01227629|75829365|FG003|Overall Study|Protocol Violation|1|||
42022027|NCT01227629|75829366|FG004|Overall Study|Protocol Violation|0|||
42022028|NCT01227629|75829367|FG005|Overall Study|Protocol Violation|0|||
41933465|NCT01656408|75628809|FG001|Overall Study|Physician Decision|0|||
42022029|NCT01227629|75829368|FG006|Overall Study|Protocol Violation|0|||
42022030|NCT01227629|75829369|FG007|Overall Study|Protocol Violation|0|||
42022031|NCT01227629|75829370|FG008|Overall Study|Protocol Violation|0|||
42022032|NCT01227629|75829371|FG009|Overall Study|Protocol Violation|0|||
42022033|NCT01227629|75829362|FG000|Overall Study|Lost to Follow-up|0|||
42022034|NCT01227629|75829363|FG001|Overall Study|Lost to Follow-up|0|||
42117735|NCT00549302|75928578|FG002|Open-Label|Adverse Event|11|||
42117736|NCT00549302|75928576|FG000|Open-Label|Death|0|||
42117737|NCT00549302|75928577|FG001|Open-Label|Death|0|||
42117738|NCT00549302|75928578|FG002|Open-Label|Death|40|||
42022035|NCT01227629|75829364|FG002|Overall Study|Lost to Follow-up|0|||
42117739|NCT00549302|75928576|FG000|Open-Label|Investigator Decision|0|||
41933466|NCT01656408|75628810|FG002|Overall Study|Physician Decision|1|||
41933467|NCT01656408|75628811|FG003|Overall Study|Physician Decision|0|||
41933468|NCT01656408|75628812|FG004|Overall Study|Physician Decision|1|||
41933469|NCT01656408|75628813|FG005|Overall Study|Physician Decision|1|||
41933470|NCT01656408|75628814|FG006|Overall Study|Physician Decision|0|||
41933471|NCT01656408|75628815|FG007|Overall Study|Physician Decision|1|||
41933472|NCT01656408|75628816|FG008|Overall Study|Physician Decision|1|||
41933473|NCT01656408|75628817|FG009|Overall Study|Physician Decision|3|||
41933474|NCT01364298|75629265|FG000|Overall Study|Adverse Event|3|||
41933475|NCT01364298|75629266|FG001|Overall Study|Adverse Event|4|||
41933476|NCT01364298|75629265|FG000|Overall Study|Lack of adherence to treatment|1|||
41933477|NCT01364298|75629266|FG001|Overall Study|Lack of adherence to treatment|3|||
41933478|NCT01364298|75629265|FG000|Overall Study|Lack of Efficacy|1|||
41933479|NCT01364298|75629266|FG001|Overall Study|Lack of Efficacy|0|||
41933480|NCT01364298|75629265|FG000|Overall Study|Lost to Follow-up|5|||
41933481|NCT01364298|75629266|FG001|Overall Study|Lost to Follow-up|10|||
41933482|NCT01364298|75629265|FG000|Overall Study|Withdrawal by Subject|3|||
41933483|NCT01364298|75629266|FG001|Overall Study|Withdrawal by Subject|3|||
41933484|NCT01364298|75629265|FG000|Overall Study|Other|1|||
41933485|NCT01364298|75629266|FG001|Overall Study|Other|3|||
41933486|NCT01364922|75629325|FG000|Open-label (OL) Period|Adverse Event|7|||
41933487|NCT01364922|75629326|FG001|Open-label (OL) Period|Adverse Event|0|||
41933488|NCT01364922|75629327|FG002|Open-label (OL) Period|Adverse Event|0|||
41933489|NCT01364922|75629325|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
41933490|NCT01364922|75629326|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
41933491|NCT01364922|75629327|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
41933492|NCT01364922|75629325|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
41933493|NCT01364922|75629326|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
41933494|NCT01364922|75629327|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
41933495|NCT01364922|75629325|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
41933496|NCT01364922|75629326|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
41933497|NCT01364922|75629327|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
41933498|NCT01364922|75629325|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
41933499|NCT01364922|75629326|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
41933500|NCT01364922|75629327|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
41933501|NCT01364922|75629325|FG000|Open-label (OL) Period|Other, Unspecified|1|||
41933502|NCT01364922|75629326|FG001|Open-label (OL) Period|Other, Unspecified|0|||
41933503|NCT01364922|75629327|FG002|Open-label (OL) Period|Other, Unspecified|0|||
41933504|NCT01364922|75629325|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
41933505|NCT01364922|75629326|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
41933506|NCT01364922|75629327|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
41933507|NCT01364922|75629325|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
41933508|NCT01364922|75629326|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
41933509|NCT01364922|75629327|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
41933510|NCT01364922|75629325|FG000|Double-Blind (DB) Period|Adverse Event|0|||
41933511|NCT01364922|75629326|FG001|Double-Blind (DB) Period|Adverse Event|0|||
42022036|NCT01227629|75829365|FG003|Overall Study|Lost to Follow-up|0|||
41933512|NCT01364922|75629327|FG002|Double-Blind (DB) Period|Adverse Event|1|||
41933513|NCT01364922|75629325|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
41933514|NCT01364922|75629326|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
42022037|NCT01227629|75829366|FG004|Overall Study|Lost to Follow-up|1|||
42022038|NCT01227629|75829367|FG005|Overall Study|Lost to Follow-up|0|||
41933515|NCT01364922|75629327|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
41933516|NCT02522286|75629501|FG000|Overall Study|Withdrawal by Subject|3|||
42022039|NCT01227629|75829368|FG006|Overall Study|Lost to Follow-up|0|||
41933517|NCT02522286|75629502|FG001|Overall Study|Withdrawal by Subject|0|||
41933518|NCT02522286|75629503|FG002|Overall Study|Withdrawal by Subject|0|||
41933519|NCT02522286|75629504|FG003|Overall Study|Withdrawal by Subject|3|||
41933520|NCT02520726|75629525|FG000|Overall Study|Lost to Follow-up|3|||
41933521|NCT02520726|75629526|FG001|Overall Study|Lost to Follow-up|2|||
41933522|NCT02519712|75629549|FG000|Overall Study|Disease Relapse|1|||
41933523|NCT02519712|75629549|FG000|Overall Study|Disease Progression|1|||
41933524|NCT02519712|75629549|FG000|Overall Study|Accruals are donors|2|||
41933525|NCT02516202|75629792|FG000|Overall Study|Withdrawal by Subject|1|||
42210097|NCT03263442|76024751|FG000|3-month Follow-Up|Lost to Follow-up|1|||
42210098|NCT03263442|76024752|FG001|3-month Follow-Up|Lost to Follow-up|3|||
42210099|NCT03263442|76024751|FG000|6-month Follow-Up|Lost to Follow-up|2|||
42210100|NCT03263442|76024752|FG001|6-month Follow-Up|Lost to Follow-up|2|||
42210101|NCT04245709|76024760|FG000|Overall Study|Adverse Event|13|||
41933526|NCT02516202|75629793|FG001|Overall Study|Withdrawal by Subject|0|||
41933527|NCT02516202|75629794|FG002|Overall Study|Withdrawal by Subject|1|||
42022040|NCT01227629|75829369|FG007|Overall Study|Lost to Follow-up|0|||
42210102|NCT04245709|76024760|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
42210103|NCT04091581|76024766|FG000|Overall Study|Lost to Follow-up|0|||
42210104|NCT04091581|76024767|FG001|Overall Study|Lost to Follow-up|1|||
42210105|NCT02940522|76024775|FG000|Overall Study|Lost to Follow-up|1|||
42210106|NCT02940522|76024776|FG001|Overall Study|Lost to Follow-up|2|||
42210107|NCT02940522|76024775|FG000|Overall Study|Withdrawal by Subject|1|||
42210108|NCT02940522|76024776|FG001|Overall Study|Withdrawal by Subject|0|||
42210109|NCT03262038|76024784|FG000|Overall Study|Withdrawal by Subject|0|||
42210110|NCT03262038|76024785|FG001|Overall Study|Withdrawal by Subject|1|||
42210111|NCT02472964|76024793|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
42210112|NCT02472964|76024794|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
42210113|NCT02472964|76024793|FG000|Part 1 (up to Week 24)|disease progression|58|||
42210114|NCT02472964|76024794|FG001|Part 1 (up to Week 24)|disease progression|47|||
42210115|NCT02472964|76024793|FG000|Part 1 (up to Week 24)|Death|3|||
42210116|NCT02472964|76024794|FG001|Part 1 (up to Week 24)|Death|6|||
42210117|NCT02472964|76024793|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
42210118|NCT02472964|76024794|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
42210119|NCT02472964|76024793|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
42210120|NCT02472964|76024794|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
42210121|NCT02472964|76024793|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
42210122|NCT02472964|76024794|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
42210123|NCT02472964|76024793|FG000|Part 1 (up to Week 24)|Other|2|||
42210124|NCT02472964|76024794|FG001|Part 1 (up to Week 24)|Other|1|||
42210125|NCT02472964|76024793|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
41933528|NCT02516202|75629792|FG000|Overall Study|Lost to Follow-up|1|||
41933529|NCT02516202|75629793|FG001|Overall Study|Lost to Follow-up|1|||
41933530|NCT02516202|75629794|FG002|Overall Study|Lost to Follow-up|1|||
41933531|NCT02516202|75629792|FG000|Overall Study|Stopped Follow-up|0|||
41933532|NCT02516202|75629793|FG001|Overall Study|Stopped Follow-up|0|||
41933533|NCT02516202|75629794|FG002|Overall Study|Stopped Follow-up|1|||
41933534|NCT02518620|75629991|FG000|Overall Study|Adverse Event|23|||
41933535|NCT02518620|75629992|FG001|Overall Study|Adverse Event|11|||
41933536|NCT02518620|75629991|FG000|Overall Study|Lack of Efficacy|2|||
41933537|NCT02518620|75629992|FG001|Overall Study|Lack of Efficacy|0|||
41933538|NCT02518620|75629991|FG000|Overall Study|Non-Compliance with Study Drug|1|||
41933539|NCT02518620|75629992|FG001|Overall Study|Non-Compliance with Study Drug|0|||
41933540|NCT02518620|75629991|FG000|Overall Study|Physician Decision|1|||
41933541|NCT02518620|75629992|FG001|Overall Study|Physician Decision|1|||
41933542|NCT02518620|75629991|FG000|Overall Study|Sponsor's Decision|0|||
41933543|NCT02518620|75629992|FG001|Overall Study|Sponsor's Decision|3|||
41933544|NCT02518620|75629991|FG000|Overall Study|Lost to Follow-up|1|||
41933545|NCT02518620|75629992|FG001|Overall Study|Lost to Follow-up|1|||
41933546|NCT02518620|75629991|FG000|Overall Study|Withdrawal by Subject|17|||
41933547|NCT02518620|75629992|FG001|Overall Study|Withdrawal by Subject|9|||
41933548|NCT02518620|75629991|FG000|Overall Study|Death|1|||
41933549|NCT02518620|75629992|FG001|Overall Study|Death|0|||
42210126|NCT02472964|76024794|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
42022041|NCT01227629|75829370|FG008|Overall Study|Lost to Follow-up|0|||
41933550|NCT02518620|75629991|FG000|Overall Study|Pregnancy Wish|3|||
41933551|NCT02518620|75629992|FG001|Overall Study|Pregnancy Wish|0|||
41933552|NCT02518620|75629991|FG000|Overall Study|Pregnancy|1|||
41933553|NCT02518620|75629992|FG001|Overall Study|Pregnancy|0|||
41933554|NCT02518620|75629991|FG000|Overall Study|Relocation|2|||
41933555|NCT02518620|75629992|FG001|Overall Study|Relocation|1|||
41933556|NCT01653912|75630171|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
41933557|NCT01653912|75630172|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
41933558|NCT01653912|75630173|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
41933559|NCT01653912|75630174|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
41933560|NCT01653912|75630175|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
41933561|NCT01653912|75630176|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
41933562|NCT01653912|75630171|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
41933563|NCT01653912|75630172|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
41933564|NCT01653912|75630173|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
41933565|NCT01653912|75630174|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
41933566|NCT01653912|75630175|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
41933567|NCT01653912|75630176|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
41933568|NCT01653912|75630171|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
41933569|NCT01653912|75630172|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
41933570|NCT01653912|75630173|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
41933571|NCT01653912|75630174|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
41933572|NCT01653912|75630175|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
41933573|NCT01653912|75630176|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
42210127|NCT02472964|76024793|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
42210128|NCT02472964|76024794|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
41933574|NCT01653912|75630171|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
41933575|NCT01653912|75630172|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
41933576|NCT01653912|75630173|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
41933577|NCT01653912|75630174|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
41933578|NCT01653912|75630175|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
42022042|NCT01227629|75829371|FG009|Overall Study|Lost to Follow-up|0|||
42022043|NCT01227629|75829362|FG000|Overall Study|Withdrawal by Subject|0|||
41933579|NCT01653912|75630176|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
42022044|NCT01227629|75829363|FG001|Overall Study|Withdrawal by Subject|0|||
42022045|NCT01227629|75829364|FG002|Overall Study|Withdrawal by Subject|0|||
42210129|NCT02472964|76024793|FG000|Part 2 (Week 24-week 48)|Death|0|||
41933580|NCT01653912|75630171|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
41933581|NCT01653912|75630172|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
41933582|NCT01653912|75630173|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
41933583|NCT01653912|75630174|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
41933584|NCT01653912|75630175|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
41933585|NCT01653912|75630176|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
41933586|NCT01653912|75630171|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
41933587|NCT01653912|75630172|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
41933588|NCT01653912|75630173|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
42022046|NCT01227629|75829365|FG003|Overall Study|Withdrawal by Subject|0|||
42022047|NCT01227629|75829366|FG004|Overall Study|Withdrawal by Subject|0|||
41933589|NCT01653912|75630174|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
41933590|NCT01653912|75630175|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
41933591|NCT01653912|75630176|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
41933592|NCT01653912|75630171|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
41933593|NCT01653912|75630172|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
41933594|NCT01653912|75630173|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
41933595|NCT01653912|75630174|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
41933596|NCT01653912|75630175|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
41933597|NCT01653912|75630176|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
41933598|NCT02483520|75630202|FG000|Overall Study|Lost to Follow-up|3|||
41933599|NCT02483520|75630203|FG001|Overall Study|Lost to Follow-up|4|||
41933600|NCT02483520|75630202|FG000|Overall Study|Withdrawal by Subject|4|||
41933601|NCT02483520|75630203|FG001|Overall Study|Withdrawal by Subject|14|||
41933602|NCT02483520|75630202|FG000|Overall Study|Hospitalized|2|||
41933603|NCT02483520|75630203|FG001|Overall Study|Hospitalized|3|||
41933604|NCT02483520|75630202|FG000|Overall Study|Moved to LTC|2|||
41933605|NCT02483520|75630203|FG001|Overall Study|Moved to LTC|3|||
41933606|NCT02514174|75630209|FG000|Overall Study|Patient refused to continue medication|1|||
41933607|NCT02514174|75630209|FG000|Overall Study|Adverse Event|2|||
41933608|NCT02514174|75630209|FG000|Overall Study|Study closed by sponsor|9|||
41933609|NCT02514174|75630209|FG000|Overall Study|Progressive disease|11|||
42210130|NCT02472964|76024794|FG001|Part 2 (Week 24-week 48)|Death|1|||
42210131|NCT02472964|76024793|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
42210132|NCT02472964|76024794|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
42210133|NCT02472964|76024793|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
42210134|NCT02472964|76024794|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
42210135|NCT02472964|76024793|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
42210136|NCT02472964|76024794|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
42210137|NCT02472964|76024793|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
42210138|NCT02472964|76024794|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
42210139|NCT04079803|76024807|FG000|Overall Study|Withdrawal by Subject|0|||
42210140|NCT04079803|76024808|FG001|Overall Study|Withdrawal by Subject|0|||
42210141|NCT04079803|76024809|FG002|Overall Study|Withdrawal by Subject|1|||
42210142|NCT03278613|76024837|FG000|Overall Study|Lost to Follow-up|3|||
42210143|NCT03278613|76024838|FG001|Overall Study|Lost to Follow-up|1|||
42210144|NCT03761147|76024846|FG000|Overall Study|Withdrawal by Subject|6|||
42210145|NCT03761147|76024847|FG001|Overall Study|Withdrawal by Subject|1|||
42210146|NCT03761147|76024846|FG000|Overall Study|Adverse Event|1|||
42210147|NCT03761147|76024847|FG001|Overall Study|Adverse Event|3|||
42210148|NCT04076917|76024853|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
42210149|NCT04076917|76024853|FG000|Overall Study|Study closure|13|||
42210150|NCT04076917|76024853|FG000|Overall Study|Physician Decision|3|||
42210151|NCT04076917|76024853|FG000|Overall Study|Death|1|||
42210152|NCT04076917|76024853|FG000|Overall Study|Lost to Follow-up|1|||
42210153|NCT04076917|76024853|FG000|Overall Study|Withdrawal by Subject|1|||
42210154|NCT04076917|76024853|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
42210155|NCT04222699|76024857|FG000|Overall Study|Lost to Follow-up|2|||
42210156|NCT02731690|76024870|FG000|Overall Study|Adverse Event|1|||
41933610|NCT02514174|75630209|FG000|Overall Study|Treatment change|1|||
41933611|NCT02514174|75630209|FG000|Overall Study|Treated off study with Afatinib.|1|||
42210157|NCT02731690|76024870|FG000|Overall Study|Withdrawal by Subject|3|||
42210158|NCT02731690|76024870|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
42210159|NCT04075513|76024876|FG000|Overall Study|Withdrawal by Subject|2|||
42210160|NCT04075513|76024877|FG001|Overall Study|Withdrawal by Subject|2|||
42210161|NCT04075513|76024876|FG000|Overall Study|Lack of Efficacy|1|||
41933612|NCT02482428|75630269|FG000|Overall Study|Lost to Follow-up|4|||
41933613|NCT02482428|75630270|FG001|Overall Study|Lost to Follow-up|9|||
41933614|NCT02482428|75630271|FG002|Overall Study|Lost to Follow-up|1|||
41933615|NCT02482428|75630272|FG003|Overall Study|Lost to Follow-up|2|||
41933616|NCT02482428|75630273|FG004|Overall Study|Lost to Follow-up|4|||
41933617|NCT02482428|75630269|FG000|Overall Study|Physician Decision|0|||
41933618|NCT02482428|75630270|FG001|Overall Study|Physician Decision|0|||
41933619|NCT02482428|75630271|FG002|Overall Study|Physician Decision|0|||
41933620|NCT02482428|75630272|FG003|Overall Study|Physician Decision|0|||
41933621|NCT02482428|75630273|FG004|Overall Study|Physician Decision|1|||
41933622|NCT02482428|75630269|FG000|Overall Study|protocol deviation|1|||
41933623|NCT02482428|75630270|FG001|Overall Study|protocol deviation|1|||
41933624|NCT02482428|75630271|FG002|Overall Study|protocol deviation|0|||
41933625|NCT02482428|75630272|FG003|Overall Study|protocol deviation|0|||
41933626|NCT02482428|75630273|FG004|Overall Study|protocol deviation|0|||
41933627|NCT02482428|75630269|FG000|Overall Study|subject/guardian decision|4|||
41933628|NCT02482428|75630270|FG001|Overall Study|subject/guardian decision|2|||
41933629|NCT02482428|75630271|FG002|Overall Study|subject/guardian decision|0|||
41933630|NCT02482428|75630272|FG003|Overall Study|subject/guardian decision|0|||
41933631|NCT02482428|75630273|FG004|Overall Study|subject/guardian decision|2|||
41933632|NCT02480712|75630321|FG000|Overall Study|Enrolled but Never Treated|1|||
41933633|NCT02480712|75630321|FG000|Overall Study|Lost to Follow-up|5|||
41933634|NCT02480712|75630321|FG000|Overall Study|Withdrew Consent|3|||
41933635|NCT02480712|75630321|FG000|Overall Study|Death|1|||
41933636|NCT02480712|75630321|FG000|Overall Study|Lack of Efficacy|1|||
41933637|NCT02513550|75631590|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
41933638|NCT02513550|75631591|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
41933639|NCT02513550|75631592|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
41933640|NCT02513550|75631593|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
41933641|NCT02513550|75631594|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
41933642|NCT02513550|75631595|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
41933643|NCT02513550|75631590|FG000|Double Blind Treatment Period|Adverse Event|5|||
41933644|NCT02513550|75631591|FG001|Double Blind Treatment Period|Adverse Event|13|||
41933645|NCT02513550|75631592|FG002|Double Blind Treatment Period|Adverse Event|17|||
41933646|NCT02513550|75631593|FG003|Double Blind Treatment Period|Adverse Event|0|||
41933647|NCT02513550|75631594|FG004|Double Blind Treatment Period|Adverse Event|1|||
41933648|NCT02513550|75631595|FG005|Double Blind Treatment Period|Adverse Event|0|||
41933649|NCT02513550|75631590|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
41933650|NCT02513550|75631591|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
41933651|NCT02513550|75631592|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
41933652|NCT02513550|75631593|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
41933653|NCT02513550|75631594|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
41933654|NCT02513550|75631595|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
41933655|NCT02513550|75631590|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
41933656|NCT02513550|75631591|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
41933657|NCT02513550|75631592|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
41933658|NCT02513550|75631593|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
41933659|NCT02513550|75631594|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
41933660|NCT02513550|75631595|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
41933661|NCT02513550|75631590|FG000|Double Blind Treatment Period|Protocol Violation|1|||
42210162|NCT04075513|76024877|FG001|Overall Study|Lack of Efficacy|0|||
41933662|NCT02513550|75631591|FG001|Double Blind Treatment Period|Protocol Violation|1|||
41933663|NCT02513550|75631592|FG002|Double Blind Treatment Period|Protocol Violation|4|||
41933664|NCT02513550|75631593|FG003|Double Blind Treatment Period|Protocol Violation|0|||
41933665|NCT02513550|75631594|FG004|Double Blind Treatment Period|Protocol Violation|0|||
41933666|NCT02513550|75631595|FG005|Double Blind Treatment Period|Protocol Violation|0|||
41933667|NCT02513550|75631590|FG000|Double Blind Treatment Period|Physician Decision|2|||
41933668|NCT02513550|75631591|FG001|Double Blind Treatment Period|Physician Decision|0|||
41933669|NCT02513550|75631592|FG002|Double Blind Treatment Period|Physician Decision|4|||
42210163|NCT04075513|76024876|FG000|Overall Study|Lost to Follow-up|4|||
41933670|NCT02513550|75631593|FG003|Double Blind Treatment Period|Physician Decision|0|||
41933671|NCT02513550|75631594|FG004|Double Blind Treatment Period|Physician Decision|0|||
41933672|NCT02513550|75631595|FG005|Double Blind Treatment Period|Physician Decision|0|||
42210164|NCT04075513|76024877|FG001|Overall Study|Lost to Follow-up|2|||
41933673|NCT02513550|75631590|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
41933674|NCT02513550|75631591|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
41933675|NCT02513550|75631592|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
41933676|NCT02513550|75631593|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
41933677|NCT02513550|75631594|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
41933678|NCT02513550|75631595|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
41933679|NCT02513550|75631590|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
41933680|NCT02513550|75631591|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
42022048|NCT01227629|75829367|FG005|Overall Study|Withdrawal by Subject|0|||
41933681|NCT02513550|75631592|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
41933682|NCT02513550|75631593|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
41933683|NCT02513550|75631594|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
41933684|NCT02513550|75631595|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
41933685|NCT02513550|75631590|FG000|Double Blind Treatment Period|Due to personal business|2|||
41933686|NCT02513550|75631591|FG001|Double Blind Treatment Period|Due to personal business|0|||
41933687|NCT02513550|75631592|FG002|Double Blind Treatment Period|Due to personal business|1|||
41933688|NCT02513550|75631593|FG003|Double Blind Treatment Period|Due to personal business|0|||
41933689|NCT02513550|75631594|FG004|Double Blind Treatment Period|Due to personal business|0|||
41933690|NCT02513550|75631595|FG005|Double Blind Treatment Period|Due to personal business|0|||
41933691|NCT02513550|75631590|FG000|Double Blind Treatment Period|Death|1|||
41933692|NCT02513550|75631591|FG001|Double Blind Treatment Period|Death|0|||
41933693|NCT02513550|75631592|FG002|Double Blind Treatment Period|Death|2|||
41933694|NCT02513550|75631593|FG003|Double Blind Treatment Period|Death|0|||
41933695|NCT02513550|75631594|FG004|Double Blind Treatment Period|Death|0|||
41933696|NCT02513550|75631595|FG005|Double Blind Treatment Period|Death|0|||
41933697|NCT02513550|75631590|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
41933698|NCT02513550|75631591|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
41933699|NCT02513550|75631592|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
41933700|NCT02513550|75631593|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
41933701|NCT02513550|75631594|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
41933702|NCT02513550|75631595|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
41933703|NCT02513550|75631590|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
41933704|NCT02513550|75631591|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
41933705|NCT02513550|75631592|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
41933706|NCT02513550|75631593|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
42036444|NCT01017120|75844853|FG001|Overall Study|Lack of Efficacy|0|||
41933707|NCT02513550|75631594|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
41933708|NCT02513550|75631595|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
41933709|NCT02513550|75631590|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
41933710|NCT02513550|75631591|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
41933711|NCT02513550|75631592|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
42117740|NCT00549302|75928577|FG001|Open-Label|Investigator Decision|0|||
42117741|NCT00549302|75928578|FG002|Open-Label|Investigator Decision|5|||
41933712|NCT02513550|75631593|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
41933713|NCT02513550|75631594|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
41933714|NCT02513550|75631595|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
41933715|NCT02513550|75631590|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
41933716|NCT02513550|75631591|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
41933717|NCT02513550|75631592|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
41933718|NCT02513550|75631593|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
41933719|NCT02513550|75631594|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
41933720|NCT02513550|75631595|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
41933721|NCT02513550|75631590|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
41933722|NCT02513550|75631591|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
41933723|NCT02513550|75631592|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
41933724|NCT02513550|75631593|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
41933725|NCT02513550|75631594|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
41933726|NCT02513550|75631595|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
41933727|NCT02513550|75631590|FG000|Post-Treatment Follow-up Period|Death|0|||
41933728|NCT02513550|75631591|FG001|Post-Treatment Follow-up Period|Death|0|||
41933729|NCT02513550|75631592|FG002|Post-Treatment Follow-up Period|Death|1|||
41933730|NCT02513550|75631593|FG003|Post-Treatment Follow-up Period|Death|0|||
41933731|NCT02513550|75631594|FG004|Post-Treatment Follow-up Period|Death|0|||
41933732|NCT02513550|75631595|FG005|Post-Treatment Follow-up Period|Death|0|||
41933733|NCT02513550|75631590|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
41933734|NCT02513550|75631591|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
41933735|NCT02513550|75631592|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
41933736|NCT02513550|75631593|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
41933737|NCT02513550|75631594|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
41933738|NCT02513550|75631595|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
42010366|NCT01290068|75817491|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
41933739|NCT02513550|75631590|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
41933740|NCT02513550|75631591|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
41933741|NCT02513550|75631592|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
41933742|NCT02513550|75631593|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
41933743|NCT02513550|75631594|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
41933744|NCT02513550|75631595|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
41933745|NCT02513550|75631590|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
41933746|NCT02513550|75631591|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
41933747|NCT02513550|75631592|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
41933748|NCT02513550|75631593|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
41933749|NCT02513550|75631594|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
41933750|NCT02513550|75631595|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
41933751|NCT02513472|75631912|FG000|Overall Study|Radiological Disease Progression|45|||
41933752|NCT02513472|75631913|FG001|Overall Study|Radiological Disease Progression|57|||
41933753|NCT02513472|75631912|FG000|Overall Study|Clinical Disease Progression|5|||
41933754|NCT02513472|75631913|FG001|Overall Study|Clinical Disease Progression|13|||
41933755|NCT02513472|75631912|FG000|Overall Study|Adverse Event|8|||
41933756|NCT02513472|75631913|FG001|Overall Study|Adverse Event|11|||
41933757|NCT02513472|75631912|FG000|Overall Study|Withdrawal by Subject|0|||
41933758|NCT02513472|75631913|FG001|Overall Study|Withdrawal by Subject|4|||
41933759|NCT02513472|75631912|FG000|Overall Study|Subject Choice|2|||
41933760|NCT02513472|75631913|FG001|Overall Study|Subject Choice|7|||
41933761|NCT02513472|75631912|FG000|Overall Study|Treatment Completed as per Protocol|3|||
41933762|NCT02513472|75631913|FG001|Overall Study|Treatment Completed as per Protocol|3|||
41933763|NCT02513472|75631912|FG000|Overall Study|Other|3|||
42117742|NCT00549302|75928576|FG000|Open-Label|Lost to Follow-up|0|||
42117743|NCT00549302|75928577|FG001|Open-Label|Lost to Follow-up|0|||
42117744|NCT00549302|75928578|FG002|Open-Label|Lost to Follow-up|2|||
42117745|NCT00549302|75928576|FG000|Open-Label|Other|0|||
42117746|NCT00549302|75928577|FG001|Open-Label|Other|0|||
42210165|NCT04075513|76024876|FG000|Overall Study|Switch to insulin pump|1|||
42117747|NCT00549302|75928578|FG002|Open-Label|Other|3|||
42117748|NCT00549302|75928576|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
42117749|NCT00549302|75928577|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
42117750|NCT00549302|75928578|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
42117751|NCT00549302|75928576|FG000|Open-Label|Withdrawal by Subject|0|||
42117752|NCT00549302|75928577|FG001|Open-Label|Withdrawal by Subject|0|||
42117753|NCT00549302|75928578|FG002|Open-Label|Withdrawal by Subject|6|||
42117754|NCT00117325|75928588|FG000|Overall Study|Adverse Event|3|||
42117755|NCT00117325|75928589|FG001|Overall Study|Adverse Event|3|||
42117756|NCT00117325|75928588|FG000|Overall Study|Lost to Follow-up|1|||
42117757|NCT00117325|75928589|FG001|Overall Study|Lost to Follow-up|1|||
42117758|NCT00117325|75928588|FG000|Overall Study|Protocol Violation|2|||
42117759|NCT00117325|75928589|FG001|Overall Study|Protocol Violation|3|||
42117760|NCT00117325|75928588|FG000|Overall Study|Withdrawal by Subject|3|||
42117761|NCT00117325|75928589|FG001|Overall Study|Withdrawal by Subject|2|||
42117762|NCT00117325|75928588|FG000|Overall Study|Lack of Efficacy|1|||
41933764|NCT02513472|75631913|FG001|Overall Study|Other|6|||
41933765|NCT04490395|75632133|FG000|Overall Study|Lost to Follow-up|0|||
42210166|NCT04075513|76024877|FG001|Overall Study|Switch to insulin pump|0|||
41933766|NCT04490395|75632134|FG001|Overall Study|Lost to Follow-up|1|||
41933767|NCT03843541|75632577|FG000|Overall Study|Adverse Event|4|||
41933768|NCT03843541|75632578|FG001|Overall Study|Adverse Event|2|||
42117763|NCT00117325|75928589|FG001|Overall Study|Lack of Efficacy|0|||
42117764|NCT00117325|75928588|FG000|Overall Study|Use of prohibited medicine|1|||
42117765|NCT00117325|75928589|FG001|Overall Study|Use of prohibited medicine|2|||
42117766|NCT00117325|75928588|FG000|Overall Study|Early termination|1|||
42117767|NCT00117325|75928589|FG001|Overall Study|Early termination|1|||
42117768|NCT00117325|75928588|FG000|Overall Study|Admisnitrative|1|||
42210167|NCT04073407|76024885|FG000|Part 1|Withdrawal by Subject|1|||
42210168|NCT04073407|76024886|FG001|Part 1|Withdrawal by Subject|0|||
42022049|NCT01227629|75829368|FG006|Overall Study|Withdrawal by Subject|2|||
41933769|NCT03843541|75632579|FG002|Overall Study|Adverse Event|3|||
41933770|NCT03843541|75632577|FG000|Overall Study|Death|1|||
41933771|NCT03843541|75632578|FG001|Overall Study|Death|0|||
41933772|NCT03843541|75632579|FG002|Overall Study|Death|0|||
41933773|NCT03843541|75632577|FG000|Overall Study|Lack of adherence to study medication|0|||
41933774|NCT03843541|75632578|FG001|Overall Study|Lack of adherence to study medication|0|||
41933775|NCT03843541|75632579|FG002|Overall Study|Lack of adherence to study medication|1|||
41933776|NCT03843541|75632577|FG000|Overall Study|Physician Decision|1|||
41933777|NCT03843541|75632578|FG001|Overall Study|Physician Decision|2|||
41933778|NCT03843541|75632579|FG002|Overall Study|Physician Decision|2|||
41933779|NCT03843541|75632577|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
41933780|NCT03843541|75632578|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
41933781|NCT03843541|75632579|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
41933782|NCT03843541|75632577|FG000|Overall Study|Withdrawal by Subject|6|||
41933783|NCT03843541|75632578|FG001|Overall Study|Withdrawal by Subject|9|||
41933784|NCT03843541|75632579|FG002|Overall Study|Withdrawal by Subject|7|||
41933785|NCT03843541|75632577|FG000|Overall Study|Administration of rescue mucolytic|0|||
41933786|NCT03843541|75632578|FG001|Overall Study|Administration of rescue mucolytic|0|||
41933787|NCT03843541|75632579|FG002|Overall Study|Administration of rescue mucolytic|1|||
41933788|NCT03843541|75632577|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
41933789|NCT03843541|75632578|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
41933790|NCT03843541|75632579|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
41933791|NCT02992418|75633842|FG000|Overall Study|Withdrawal by Subject|11|||
41933792|NCT02992418|75633843|FG001|Overall Study|Withdrawal by Subject|12|||
41933793|NCT02992418|75633842|FG000|Overall Study|Non-compliance with the protocol|308|||
41933794|NCT02992418|75633843|FG001|Overall Study|Non-compliance with the protocol|308|||
41933795|NCT02992418|75633842|FG000|Overall Study|Lost to Follow-up|27|||
41933796|NCT02992418|75633843|FG001|Overall Study|Lost to Follow-up|22|||
42117769|NCT00117325|75928589|FG001|Overall Study|Admisnitrative|0|||
41933797|NCT01276106|75634085|FG000|Overall Study|Adverse Event|3|||
41933798|NCT01276106|75634086|FG001|Overall Study|Adverse Event|3|||
41933799|NCT01276106|75634087|FG002|Overall Study|Adverse Event|11|||
41933800|NCT01276106|75634088|FG003|Overall Study|Adverse Event|3|||
41933801|NCT01276106|75634085|FG000|Overall Study|Withdrawal by Subject|6|||
42022050|NCT01227629|75829369|FG007|Overall Study|Withdrawal by Subject|0|||
42022051|NCT01227629|75829370|FG008|Overall Study|Withdrawal by Subject|0|||
42022052|NCT01227629|75829371|FG009|Overall Study|Withdrawal by Subject|1|||
42022053|NCT01227629|75829362|FG000|Overall Study|Other|0|||
42022054|NCT01227629|75829363|FG001|Overall Study|Other|0|||
42022055|NCT01227629|75829364|FG002|Overall Study|Other|0|||
42022056|NCT01227629|75829365|FG003|Overall Study|Other|1|||
42022057|NCT01227629|75829366|FG004|Overall Study|Other|0|||
41933802|NCT01276106|75634086|FG001|Overall Study|Withdrawal by Subject|3|||
41933803|NCT01276106|75634087|FG002|Overall Study|Withdrawal by Subject|1|||
41933804|NCT01276106|75634088|FG003|Overall Study|Withdrawal by Subject|6|||
41933805|NCT01276106|75634085|FG000|Overall Study|Lack of Efficacy|0|||
41933806|NCT01276106|75634086|FG001|Overall Study|Lack of Efficacy|1|||
41933807|NCT01276106|75634087|FG002|Overall Study|Lack of Efficacy|0|||
41933808|NCT01276106|75634088|FG003|Overall Study|Lack of Efficacy|1|||
41933809|NCT01276106|75634085|FG000|Overall Study|Lost to Follow-up|2|||
41933810|NCT01276106|75634086|FG001|Overall Study|Lost to Follow-up|1|||
41933811|NCT01276106|75634087|FG002|Overall Study|Lost to Follow-up|1|||
41933812|NCT01276106|75634088|FG003|Overall Study|Lost to Follow-up|0|||
41933813|NCT01276106|75634085|FG000|Overall Study|Physician Decision|0|||
41933814|NCT01276106|75634086|FG001|Overall Study|Physician Decision|0|||
41933815|NCT01276106|75634087|FG002|Overall Study|Physician Decision|1|||
41933816|NCT01276106|75634088|FG003|Overall Study|Physician Decision|1|||
41933817|NCT01276106|75634085|FG000|Overall Study|Protocol Violation|1|||
41933818|NCT01276106|75634086|FG001|Overall Study|Protocol Violation|1|||
41933819|NCT01276106|75634087|FG002|Overall Study|Protocol Violation|0|||
41933820|NCT01276106|75634088|FG003|Overall Study|Protocol Violation|2|||
41933821|NCT01276106|75634085|FG000|Overall Study|Insufficient therapeutic effects|0|||
41933822|NCT01276106|75634086|FG001|Overall Study|Insufficient therapeutic effects|0|||
41933823|NCT01276106|75634087|FG002|Overall Study|Insufficient therapeutic effects|2|||
41933824|NCT01276106|75634088|FG003|Overall Study|Insufficient therapeutic effects|0|||
41933825|NCT01275170|75634106|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
41933826|NCT01275170|75634107|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
42022058|NCT01227629|75829367|FG005|Overall Study|Other|0|||
42022059|NCT01227629|75829368|FG006|Overall Study|Other|0|||
41933827|NCT01275170|75634108|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
41933828|NCT01275170|75634109|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
41933829|NCT01275170|75634110|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
41933830|NCT01275170|75634111|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
42117770|NCT00108433|75928598|FG000|Overall Study|Lack of Efficacy|1|||
42300140|NCT02327169|76135325|FG003|Overall Study|Adverse Event|0|||
42117771|NCT00108433|75928599|FG001|Overall Study|Lack of Efficacy|2|||
41933831|NCT01275170|75634112|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
41933832|NCT01275170|75634113|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
41933833|NCT01273064|75634160|FG000|Overall Study|Adverse Event|5|||
41933834|NCT01273064|75634161|FG001|Overall Study|Adverse Event|1|||
41933835|NCT01273064|75634162|FG002|Overall Study|Adverse Event|3|||
41933836|NCT01273064|75634163|FG003|Overall Study|Adverse Event|2|||
41933837|NCT01273064|75634164|FG004|Overall Study|Adverse Event|1|||
41933838|NCT01273064|75634160|FG000|Overall Study|Withdrawal by Subject|4|||
41933839|NCT01273064|75634161|FG001|Overall Study|Withdrawal by Subject|2|||
41933840|NCT01273064|75634162|FG002|Overall Study|Withdrawal by Subject|2|||
41933841|NCT01273064|75634163|FG003|Overall Study|Withdrawal by Subject|2|||
41933842|NCT01273064|75634164|FG004|Overall Study|Withdrawal by Subject|0|||
41933843|NCT01273064|75634160|FG000|Overall Study|Study Termination|13|||
41933844|NCT01273064|75634161|FG001|Overall Study|Study Termination|27|||
41933845|NCT01273064|75634162|FG002|Overall Study|Study Termination|26|||
41933846|NCT01273064|75634163|FG003|Overall Study|Study Termination|16|||
41933847|NCT01273064|75634164|FG004|Overall Study|Study Termination|8|||
41933848|NCT01273064|75634160|FG000|Overall Study|Lost to Follow-up|1|||
41933849|NCT01273064|75634161|FG001|Overall Study|Lost to Follow-up|0|||
41933850|NCT01273064|75634162|FG002|Overall Study|Lost to Follow-up|0|||
41933851|NCT01273064|75634163|FG003|Overall Study|Lost to Follow-up|0|||
41933852|NCT01273064|75634164|FG004|Overall Study|Lost to Follow-up|0|||
41933853|NCT01273064|75634160|FG000|Overall Study|Physician Decision|0|||
41933854|NCT01273064|75634161|FG001|Overall Study|Physician Decision|0|||
41933855|NCT01273064|75634162|FG002|Overall Study|Physician Decision|0|||
41933856|NCT01273064|75634163|FG003|Overall Study|Physician Decision|0|||
41933857|NCT01273064|75634164|FG004|Overall Study|Physician Decision|1|||
41933858|NCT01272908|75634176|FG000|Initial Treatment Period|Adverse Event|1|||
41933859|NCT01272908|75634176|FG000|Initial Treatment Period|Lack of Efficacy|5|||
41933860|NCT01272908|75634176|FG000|Initial Treatment Period|Protocol Violation|1|||
41933861|NCT01272908|75634176|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
41933862|NCT01272908|75634176|FG000|Re-Treatment Period|Adverse Event|2|||
41933863|NCT01272908|75634176|FG000|Re-Treatment Period|Lack of Efficacy|3|||
41933864|NCT01272908|75634176|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
41933865|NCT01271504|75634186|FG000|Overall Study|Death|7|||
41933866|NCT01271504|75634187|FG001|Overall Study|Death|6|||
41933867|NCT01271504|75634188|FG002|Overall Study|Death|32|||
41933868|NCT01271504|75634189|FG003|Overall Study|Death|32|||
41933869|NCT01271504|75634186|FG000|Overall Study|Lost to Follow-up|0|||
41933870|NCT01271504|75634187|FG001|Overall Study|Lost to Follow-up|1|||
41933871|NCT01271504|75634188|FG002|Overall Study|Lost to Follow-up|3|||
41933872|NCT01271504|75634189|FG003|Overall Study|Lost to Follow-up|1|||
42117772|NCT00108433|75928598|FG000|Overall Study|Death|3|||
42117773|NCT00108433|75928599|FG001|Overall Study|Death|0|||
42022060|NCT01227629|75829369|FG007|Overall Study|Other|0|||
41933873|NCT01271504|75634186|FG000|Overall Study|Protocol Violation|0|||
41933874|NCT01271504|75634187|FG001|Overall Study|Protocol Violation|0|||
41933875|NCT01271504|75634188|FG002|Overall Study|Protocol Violation|0|||
42117774|NCT00108433|75928598|FG000|Overall Study|Adverse Event|3|||
41933876|NCT01271504|75634189|FG003|Overall Study|Protocol Violation|2|||
42117775|NCT00108433|75928599|FG001|Overall Study|Adverse Event|1|||
42272598|NCT01352741|76102820|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
41933877|NCT01271504|75634186|FG000|Overall Study|Administrative Reasons|0|||
41933878|NCT01271504|75634187|FG001|Overall Study|Administrative Reasons|0|||
41933879|NCT01271504|75634188|FG002|Overall Study|Administrative Reasons|6|||
41933880|NCT01271504|75634189|FG003|Overall Study|Administrative Reasons|5|||
41933881|NCT01271504|75634186|FG000|Overall Study|Withdrawal by Subject|0|||
41933882|NCT01271504|75634187|FG001|Overall Study|Withdrawal by Subject|0|||
41933883|NCT01271504|75634188|FG002|Overall Study|Withdrawal by Subject|1|||
41933884|NCT01271504|75634189|FG003|Overall Study|Withdrawal by Subject|3|||
41933885|NCT01271504|75634186|FG000|Overall Study|Other|0|||
41933886|NCT01271504|75634187|FG001|Overall Study|Other|1|||
41933887|NCT01271504|75634188|FG002|Overall Study|Other|2|||
41933888|NCT01271504|75634189|FG003|Overall Study|Other|0|||
41933889|NCT01270958|75634232|FG000|Overall Study|Lost to Follow-up|2|||
42022061|NCT01227629|75829370|FG008|Overall Study|Other|2|||
41933890|NCT01270958|75634232|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
41933891|NCT01270880|75634236|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
41933892|NCT01270802|75634242|FG000|Overall Study|Withdrawal by Subject|1|||
41933893|NCT01270802|75634243|FG001|Overall Study|Withdrawal by Subject|0|||
41933894|NCT01270802|75634242|FG000|Overall Study|Adverse Event|1|||
41933895|NCT01270802|75634243|FG001|Overall Study|Adverse Event|0|||
41933896|NCT01270802|75634242|FG000|Overall Study|Lost to Follow-up|0|||
41933897|NCT01270802|75634243|FG001|Overall Study|Lost to Follow-up|1|||
41933898|NCT01270256|75634252|FG000|Overall Study|Withdrawal by Subject|1|||
41933899|NCT01270256|75634253|FG001|Overall Study|Withdrawal by Subject|0|||
41933900|NCT01279616|75634323|FG000|Overall Study|donor could not be located|5|||
41933901|NCT01279616|75634323|FG000|Overall Study|no signs of sickle cell disease|2|||
41933902|NCT01279070|75634334|FG000|Overall Study|Withdrawal by Subject|2|||
41933903|NCT01279070|75634335|FG001|Overall Study|Withdrawal by Subject|3|||
41933904|NCT01279070|75634334|FG000|Overall Study|Acute exacerbation|3|||
41933905|NCT01279070|75634335|FG001|Overall Study|Acute exacerbation|1|||
41933906|NCT01277744|75634345|FG000|Overall Study|Physician Decision|2|||
41933907|NCT01277822|75634351|FG000|Overall Study|Adverse Event|2|||
41933908|NCT01277822|75634352|FG001|Overall Study|Adverse Event|1|||
41933909|NCT01277822|75634351|FG000|Overall Study|Withdrawal by Subject|6|||
41933910|NCT01277822|75634352|FG001|Overall Study|Withdrawal by Subject|7|||
41933911|NCT01277822|75634351|FG000|Overall Study|Physician Decision|1|||
41933912|NCT01277822|75634352|FG001|Overall Study|Physician Decision|1|||
41933913|NCT01277822|75634351|FG000|Overall Study|Protocol Violation|1|||
41933914|NCT01277822|75634352|FG001|Overall Study|Protocol Violation|0|||
41933915|NCT01277822|75634351|FG000|Overall Study|Lost to Follow-up|2|||
41933916|NCT01277822|75634352|FG001|Overall Study|Lost to Follow-up|1|||
41933917|NCT01277822|75634351|FG000|Overall Study|Contraindicated medication used|2|||
41933918|NCT01277822|75634352|FG001|Overall Study|Contraindicated medication used|1|||
41933919|NCT01277822|75634351|FG000|Overall Study|Participant moved|1|||
41933920|NCT01277822|75634352|FG001|Overall Study|Participant moved|0|||
41933921|NCT01277666|75634361|FG000|Overall Study|Adverse Event|26|||
41933922|NCT01277666|75634362|FG001|Overall Study|Adverse Event|25|||
41933923|NCT01277666|75634363|FG002|Overall Study|Adverse Event|20|||
41933924|NCT01277666|75634361|FG000|Overall Study|Lack of Efficacy|8|||
41933925|NCT01277666|75634362|FG001|Overall Study|Lack of Efficacy|20|||
41933926|NCT01277666|75634363|FG002|Overall Study|Lack of Efficacy|12|||
41933927|NCT01277666|75634361|FG000|Overall Study|Protocol Violation|2|||
41933928|NCT01277666|75634362|FG001|Overall Study|Protocol Violation|3|||
41933929|NCT01277666|75634363|FG002|Overall Study|Protocol Violation|2|||
41933930|NCT01277666|75634361|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
41933931|NCT01277666|75634362|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
41933932|NCT01277666|75634363|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
41933933|NCT01277666|75634361|FG000|Overall Study|Lost to Follow-up|1|||
41933934|NCT01277666|75634362|FG001|Overall Study|Lost to Follow-up|1|||
41933935|NCT01277666|75634363|FG002|Overall Study|Lost to Follow-up|2|||
41933936|NCT01277666|75634361|FG000|Overall Study|Withdrawal by Subject|7|||
41933937|NCT01277666|75634362|FG001|Overall Study|Withdrawal by Subject|8|||
41933938|NCT01277666|75634363|FG002|Overall Study|Withdrawal by Subject|6|||
41933939|NCT01277666|75634361|FG000|Overall Study|Death|0|||
41933940|NCT01277666|75634362|FG001|Overall Study|Death|0|||
41933941|NCT01277666|75634363|FG002|Overall Study|Death|1|||
41933942|NCT00249002|75634371|FG000|Overall Study|Adverse Event|2|||
41933943|NCT00249002|75634371|FG000|Overall Study|Study cancellation|3|||
41933944|NCT00249002|75634371|FG000|Overall Study|Other|2|||
41933945|NCT01277042|75634377|FG000|Overall Study|Adverse Event|4|||
41933946|NCT01277042|75634378|FG001|Overall Study|Adverse Event|3|||
41933947|NCT01277042|75634377|FG000|Overall Study|Lost to Follow-up|2|||
41933948|NCT01277042|75634378|FG001|Overall Study|Lost to Follow-up|2|||
41933949|NCT01277042|75634377|FG000|Overall Study|Withdrawal by Subject|2|||
41933950|NCT01277042|75634378|FG001|Overall Study|Withdrawal by Subject|0|||
41933951|NCT00246740|75634418|FG000|Initial Enrollment|Death|1|||
41933952|NCT00246740|75634419|FG001|Initial Enrollment|Death|0|||
41933953|NCT00246740|75634418|FG000|Initial Enrollment|Additional surgery scheduled|0|||
41933954|NCT00246740|75634419|FG001|Initial Enrollment|Additional surgery scheduled|2|||
41933955|NCT00246740|75634418|FG000|Initial Enrollment|Surgery schedule change|4|||
41933956|NCT00246740|75634419|FG001|Initial Enrollment|Surgery schedule change|4|||
41933957|NCT00246740|75634418|FG000|Initial Enrollment|Other|1|||
41933958|NCT00246740|75634419|FG001|Initial Enrollment|Other|2|||
41933959|NCT00245102|75634464|FG000|Overall Study|Not Treated|1|||
41933960|NCT00245102|75634465|FG001|Overall Study|Not Treated|0|||
41933961|NCT00245102|75634466|FG002|Overall Study|Not Treated|1|||
41933962|NCT00245102|75634467|FG003|Overall Study|Not Treated|0|||
41933963|NCT00245102|75634468|FG004|Overall Study|Not Treated|0|||
41933964|NCT00245102|75634469|FG005|Overall Study|Not Treated|0|||
41933965|NCT00245102|75634464|FG000|Overall Study|Protocol Violation|1|||
41933966|NCT00245102|75634465|FG001|Overall Study|Protocol Violation|0|||
41933967|NCT00245102|75634466|FG002|Overall Study|Protocol Violation|0|||
41933968|NCT00245102|75634467|FG003|Overall Study|Protocol Violation|0|||
41933969|NCT00245102|75634468|FG004|Overall Study|Protocol Violation|0|||
41933970|NCT00245102|75634469|FG005|Overall Study|Protocol Violation|0|||
41933971|NCT00245102|75634464|FG000|Overall Study|Death|0|||
41933972|NCT00245102|75634465|FG001|Overall Study|Death|0|||
41933973|NCT00245102|75634466|FG002|Overall Study|Death|0|||
41933974|NCT00245102|75634467|FG003|Overall Study|Death|1|||
41933975|NCT00245102|75634468|FG004|Overall Study|Death|0|||
41933976|NCT00245102|75634469|FG005|Overall Study|Death|0|||
41933977|NCT00245102|75634464|FG000|Overall Study|Adverse Event|4|||
41933978|NCT00245102|75634465|FG001|Overall Study|Adverse Event|2|||
41933979|NCT00245102|75634466|FG002|Overall Study|Adverse Event|5|||
41933980|NCT00245102|75634467|FG003|Overall Study|Adverse Event|1|||
41933981|NCT00245102|75634468|FG004|Overall Study|Adverse Event|0|||
41933982|NCT00245102|75634469|FG005|Overall Study|Adverse Event|2|||
41933983|NCT00245102|75634464|FG000|Overall Study|Decline in performance|0|||
41933984|NCT00245102|75634465|FG001|Overall Study|Decline in performance|2|||
41933985|NCT00245102|75634466|FG002|Overall Study|Decline in performance|0|||
41933986|NCT00245102|75634467|FG003|Overall Study|Decline in performance|1|||
41933987|NCT00245102|75634468|FG004|Overall Study|Decline in performance|0|||
41933988|NCT00245102|75634469|FG005|Overall Study|Decline in performance|2|||
41933989|NCT00245102|75634464|FG000|Overall Study|Participant needed surgery|0|||
41933990|NCT00245102|75634465|FG001|Overall Study|Participant needed surgery|0|||
41933991|NCT00245102|75634466|FG002|Overall Study|Participant needed surgery|1|||
41933992|NCT00245102|75634467|FG003|Overall Study|Participant needed surgery|0|||
41933993|NCT00245102|75634468|FG004|Overall Study|Participant needed surgery|0|||
41933994|NCT00245102|75634469|FG005|Overall Study|Participant needed surgery|0|||
41933995|NCT00245102|75634464|FG000|Overall Study|Clinical progression|1|||
41933996|NCT00245102|75634465|FG001|Overall Study|Clinical progression|0|||
41933997|NCT00245102|75634466|FG002|Overall Study|Clinical progression|0|||
41933998|NCT00245102|75634467|FG003|Overall Study|Clinical progression|0|||
41933999|NCT00245102|75634468|FG004|Overall Study|Clinical progression|0|||
41934000|NCT00245102|75634469|FG005|Overall Study|Clinical progression|0|||
41934001|NCT00244712|75634514|FG000|Overall Study|Adverse Event|20|||
41934002|NCT00244712|75634515|FG001|Overall Study|Adverse Event|21|||
41934003|NCT00244712|75634514|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
41934004|NCT00244712|75634515|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
41934005|NCT00244712|75634514|FG000|Overall Study|Lack of Compliance|10|||
41934006|NCT00244712|75634515|FG001|Overall Study|Lack of Compliance|11|||
41934007|NCT00244712|75634514|FG000|Overall Study|Lost to Follow-up|45|||
41934008|NCT00244712|75634515|FG001|Overall Study|Lost to Follow-up|52|||
41934009|NCT00244712|75634514|FG000|Overall Study|Withdrawal by Subject|13|||
41934010|NCT00244712|75634515|FG001|Overall Study|Withdrawal by Subject|23|||
41934011|NCT00244712|75634514|FG000|Overall Study|Protocol Violation, disease progression|13|||
41934012|NCT00244712|75634515|FG001|Overall Study|Protocol Violation, disease progression|11|||
41934013|NCT00243932|75634533|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
41934014|NCT00243932|75634534|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
41934015|NCT00243932|75634535|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
41934016|NCT00243386|75634543|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
41934017|NCT00243386|75634544|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
41934018|NCT00243386|75634545|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
41934019|NCT00243386|75634543|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
41934020|NCT00243386|75634544|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
41934021|NCT00243386|75634545|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
41934022|NCT00243386|75634543|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
41934023|NCT00243386|75634544|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
41934024|NCT00243386|75634545|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
41934025|NCT00243386|75634543|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
41934026|NCT00243386|75634544|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
41934027|NCT00243386|75634545|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
41934028|NCT00243386|75634543|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
41934029|NCT00243386|75634544|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
42117776|NCT00108433|75928598|FG000|Overall Study|Other|14|||
42117777|NCT00108433|75928599|FG001|Overall Study|Other|14|||
42117778|NCT00116779|75928607|FG000|Overall Study|Adverse Event|4|||
41934030|NCT00243386|75634545|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
41934031|NCT00243386|75634543|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
41934032|NCT00243386|75634544|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
41934033|NCT00243386|75634545|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
41934034|NCT00243386|75634543|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
41934035|NCT00243386|75634544|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
41934036|NCT00243386|75634545|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
41934037|NCT00243386|75634543|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
41934038|NCT00243386|75634544|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
41934039|NCT00243386|75634545|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
41934040|NCT00243230|75634604|FG000|Double-Blind Period|Adverse Event|0|||
41934041|NCT00243230|75634605|FG001|Double-Blind Period|Adverse Event|2|||
41934042|NCT00243230|75634606|FG002|Double-Blind Period|Adverse Event|2|||
41934043|NCT00243230|75634607|FG003|Double-Blind Period|Adverse Event|0|||
41934044|NCT00243230|75634604|FG000|Double-Blind Period|Withdrawal by Subject|1|||
41934045|NCT00243230|75634605|FG001|Double-Blind Period|Withdrawal by Subject|0|||
41934046|NCT00243230|75634606|FG002|Double-Blind Period|Withdrawal by Subject|0|||
41934047|NCT00243230|75634607|FG003|Double-Blind Period|Withdrawal by Subject|0|||
41934048|NCT00243230|75634604|FG000|Double-Blind Period|Protocol Violation|0|||
41934049|NCT00243230|75634605|FG001|Double-Blind Period|Protocol Violation|0|||
41934050|NCT00243230|75634606|FG002|Double-Blind Period|Protocol Violation|1|||
41934051|NCT00243230|75634607|FG003|Double-Blind Period|Protocol Violation|0|||
41934052|NCT00243230|75634604|FG000|Double-Blind Period|Randomized but Not Treated|0|||
42022062|NCT01227629|75829371|FG009|Overall Study|Other|1|||
42022063|NCT00963820|75829417|FG000|Dose Escalation Phase|Progressive Disease|3|||
42022064|NCT00963820|75829418|FG001|Dose Escalation Phase|Progressive Disease|3|||
42022065|NCT00963820|75829419|FG002|Dose Escalation Phase|Progressive Disease|3|||
42022066|NCT00963820|75829420|FG003|Dose Escalation Phase|Progressive Disease|3|||
42022067|NCT00963820|75829421|FG004|Dose Escalation Phase|Progressive Disease|4|||
42022068|NCT00963820|75829422|FG005|Dose Escalation Phase|Progressive Disease|3|||
42022069|NCT00963820|75829423|FG006|Dose Escalation Phase|Progressive Disease|3|||
42022070|NCT00963820|75829424|FG007|Dose Escalation Phase|Progressive Disease|2|||
42022071|NCT00963820|75829425|FG008|Dose Escalation Phase|Progressive Disease|0|||
42022072|NCT00963820|75829426|FG009|Dose Escalation Phase|Progressive Disease|0|||
42022073|NCT00963820|75829427|FG010|Dose Escalation Phase|Progressive Disease|0|||
42022074|NCT00963820|75829428|FG011|Dose Escalation Phase|Progressive Disease|0|||
42022075|NCT00963820|75829417|FG000|Dose Escalation Phase|Adverse Event|0|||
42022076|NCT00963820|75829418|FG001|Dose Escalation Phase|Adverse Event|0|||
42022077|NCT00963820|75829419|FG002|Dose Escalation Phase|Adverse Event|0|||
42022078|NCT00963820|75829420|FG003|Dose Escalation Phase|Adverse Event|0|||
42022079|NCT00963820|75829421|FG004|Dose Escalation Phase|Adverse Event|0|||
42022080|NCT00963820|75829422|FG005|Dose Escalation Phase|Adverse Event|0|||
42022081|NCT00963820|75829423|FG006|Dose Escalation Phase|Adverse Event|3|||
42022082|NCT00963820|75829424|FG007|Dose Escalation Phase|Adverse Event|1|||
42022083|NCT00963820|75829425|FG008|Dose Escalation Phase|Adverse Event|0|||
42022084|NCT00963820|75829426|FG009|Dose Escalation Phase|Adverse Event|0|||
42022085|NCT00963820|75829427|FG010|Dose Escalation Phase|Adverse Event|0|||
42022086|NCT00963820|75829428|FG011|Dose Escalation Phase|Adverse Event|0|||
42022087|NCT00963820|75829417|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
41934053|NCT00243230|75634605|FG001|Double-Blind Period|Randomized but Not Treated|0|||
41934054|NCT00243230|75634606|FG002|Double-Blind Period|Randomized but Not Treated|2|||
41934055|NCT00243230|75634607|FG003|Double-Blind Period|Randomized but Not Treated|0|||
42022088|NCT00963820|75829418|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
42022089|NCT00963820|75829419|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
42022090|NCT00963820|75829420|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
42022091|NCT00963820|75829421|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
42022092|NCT00963820|75829422|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
42022093|NCT00963820|75829423|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
42117779|NCT00116779|75928608|FG001|Overall Study|Adverse Event|2|||
41934056|NCT00243230|75634604|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
41934057|NCT00243230|75634605|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
41934058|NCT00243230|75634606|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
41934059|NCT00243230|75634607|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
41934060|NCT00243230|75634604|FG000|Open Label Period|Adverse Event|0|||
41934061|NCT00243230|75634605|FG001|Open Label Period|Adverse Event|0|||
41934062|NCT00243230|75634606|FG002|Open Label Period|Adverse Event|0|||
41934063|NCT00243230|75634607|FG003|Open Label Period|Adverse Event|2|||
41934064|NCT00243230|75634604|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
41934065|NCT00243230|75634605|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
41934066|NCT00243230|75634606|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
41934067|NCT00243230|75634607|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
41934068|NCT00243230|75634604|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
41934069|NCT00243230|75634605|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
41934070|NCT00243230|75634606|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
41934071|NCT00243230|75634607|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
41934072|NCT00243230|75634604|FG000|Open Label Period|Lost to Follow-up|0|||
41934073|NCT00243230|75634605|FG001|Open Label Period|Lost to Follow-up|0|||
41934074|NCT00243230|75634606|FG002|Open Label Period|Lost to Follow-up|0|||
41934075|NCT00243230|75634607|FG003|Open Label Period|Lost to Follow-up|2|||
41934076|NCT00243230|75634604|FG000|Open Label Period|Withdrawal by Subject|0|||
41934077|NCT00243230|75634605|FG001|Open Label Period|Withdrawal by Subject|0|||
41934078|NCT00243230|75634606|FG002|Open Label Period|Withdrawal by Subject|0|||
41934079|NCT00243230|75634607|FG003|Open Label Period|Withdrawal by Subject|2|||
41934080|NCT00243230|75634604|FG000|Open Label Period|Protocol Violation|0|||
41934081|NCT00243230|75634605|FG001|Open Label Period|Protocol Violation|0|||
41934082|NCT00243230|75634606|FG002|Open Label Period|Protocol Violation|0|||
41934083|NCT00243230|75634607|FG003|Open Label Period|Protocol Violation|2|||
41934084|NCT00243230|75634604|FG000|Open Label Period|Administrative Reason|0|||
41934085|NCT00243230|75634605|FG001|Open Label Period|Administrative Reason|0|||
41934086|NCT00243230|75634606|FG002|Open Label Period|Administrative Reason|0|||
41934087|NCT00243230|75634607|FG003|Open Label Period|Administrative Reason|63|||
41934088|NCT00243074|75634617|FG000|Overall Study|Ineligible|6|||
41934089|NCT00243074|75634617|FG000|Overall Study|Adverse Event|6|||
41934090|NCT00243074|75634617|FG000|Overall Study|Withdrawal by Subject|2|||
41934091|NCT00243074|75634617|FG000|Overall Study|Lack of Efficacy|36|||
41934092|NCT00243074|75634617|FG000|Overall Study|Death|2|||
41934093|NCT00243074|75634617|FG000|Overall Study|not protocol specified|1|||
41934094|NCT00243074|75634617|FG000|Overall Study|Did not receive any treatment|1|||
41934095|NCT00241358|75634625|FG000|Overall Study|Determined to be not ineligible|0|||
41934096|NCT00241358|75634626|FG001|Overall Study|Determined to be not ineligible|1|||
41934097|NCT00241358|75634627|FG002|Overall Study|Determined to be not ineligible|1|||
41934098|NCT00241280|75634636|FG000|Overall Study|Adverse Event|2|||
41934099|NCT00241280|75634637|FG001|Overall Study|Adverse Event|6|||
41934100|NCT00241280|75634636|FG000|Overall Study|Discomfort|11|||
41934101|NCT00241280|75634637|FG001|Overall Study|Discomfort|16|||
41934102|NCT00241280|75634636|FG000|Overall Study|Pregnancy|1|||
41934103|NCT00241280|75634637|FG001|Overall Study|Pregnancy|5|||
41934104|NCT00241280|75634636|FG000|Overall Study|Lost to Follow-up|5|||
41934105|NCT00241280|75634637|FG001|Overall Study|Lost to Follow-up|8|||
41934106|NCT00241280|75634636|FG000|Overall Study|Withdrawal by Subject|7|||
41934107|NCT00241280|75634637|FG001|Overall Study|Withdrawal by Subject|4|||
41934108|NCT00241280|75634636|FG000|Overall Study|Protocol Violation|4|||
41934109|NCT00241280|75634637|FG001|Overall Study|Protocol Violation|10|||
41934110|NCT00241280|75634636|FG000|Overall Study|Relocation|4|||
41934111|NCT00241280|75634637|FG001|Overall Study|Relocation|4|||
41934112|NCT00241280|75634636|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
41934113|NCT00241280|75634637|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
41934114|NCT00241280|75634636|FG000|Overall Study|Unsatisfactory Visual Response|1|||
41934115|NCT00241280|75634637|FG001|Overall Study|Unsatisfactory Visual Response|1|||
41934116|NCT00241280|75634636|FG000|Overall Study|Diabetic|1|||
41934117|NCT00241280|75634637|FG001|Overall Study|Diabetic|0|||
41934118|NCT00241280|75634636|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
41934119|NCT00241280|75634637|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
41934120|NCT00241280|75634636|FG000|Overall Study|Dispensed incorrect test article|1|||
41934121|NCT00241280|75634637|FG001|Overall Study|Dispensed incorrect test article|2|||
41934122|NCT00241280|75634636|FG000|Overall Study|Unacceptable Fit|0|||
41934123|NCT00241280|75634637|FG001|Overall Study|Unacceptable Fit|1|||
41934124|NCT00241280|75634636|FG000|Overall Study|Scheduling Conflict|0|||
41934125|NCT00241280|75634637|FG001|Overall Study|Scheduling Conflict|2|||
41934126|NCT00241280|75634636|FG000|Overall Study|History of Ocular Surgery|0|||
41934127|NCT00241280|75634637|FG001|Overall Study|History of Ocular Surgery|1|||
41934128|NCT00241280|75634636|FG000|Overall Study|Coating on Lens|1|||
41934129|NCT00241280|75634637|FG001|Overall Study|Coating on Lens|0|||
41934130|NCT00241280|75634636|FG000|Overall Study|Excessive Dryness|0|||
41934131|NCT00241280|75634637|FG001|Overall Study|Excessive Dryness|1|||
41934132|NCT04278872|75635205|FG000|Overall Study|Adverse Event|1|||
41934133|NCT04278872|75635206|FG001|Overall Study|Adverse Event|0|||
41934134|NCT04278872|75635205|FG000|Overall Study|Protocol Violation|0|||
41934135|NCT04278872|75635206|FG001|Overall Study|Protocol Violation|1|||
41934136|NCT04278872|75635205|FG000|Overall Study|Study Termination|2|||
41934137|NCT04278872|75635206|FG001|Overall Study|Study Termination|0|||
41934138|NCT05497557|75635913|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
41934139|NCT05497557|75635914|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
41934140|NCT05497557|75635915|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
42022094|NCT00963820|75829424|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
41934141|NCT05024032|75635927|FG000|Overall Study|Withdrawal by Subject|0|||
41934142|NCT05024032|75635928|FG001|Overall Study|Withdrawal by Subject|3|||
41934143|NCT05024032|75635929|FG002|Overall Study|Withdrawal by Subject|4|||
41934144|NCT05024032|75635927|FG000|Overall Study|Adverse Event|0|||
42117780|NCT00116779|75928607|FG000|Overall Study|Protocol Violation|1|||
41934145|NCT05024032|75635928|FG001|Overall Study|Adverse Event|1|||
41934146|NCT05024032|75635929|FG002|Overall Study|Adverse Event|0|||
41934147|NCT05024032|75635927|FG000|Overall Study|Protocol Deviation|1|||
41934148|NCT05024032|75635928|FG001|Overall Study|Protocol Deviation|0|||
41934149|NCT05024032|75635929|FG002|Overall Study|Protocol Deviation|0|||
41934150|NCT04696055|75635941|FG000|Overall Study|Adverse Event|10|||
41934151|NCT04696055|75635942|FG001|Overall Study|Adverse Event|0|||
41934152|NCT04696055|75635941|FG000|Overall Study|Death|2|||
41934153|NCT04696055|75635942|FG001|Overall Study|Death|1|||
41934154|NCT04696055|75635941|FG000|Overall Study|Other|4|||
42117781|NCT00116779|75928608|FG001|Overall Study|Protocol Violation|4|||
41934155|NCT04696055|75635942|FG001|Overall Study|Other|0|||
41934156|NCT04696055|75635941|FG000|Overall Study|Physician Decision|1|||
41934157|NCT04696055|75635942|FG001|Overall Study|Physician Decision|0|||
41934158|NCT04696055|75635941|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
42272599|NCT01657292|76102840|FG000|Overall Study|Adverse Event|6|||
41934159|NCT04696055|75635942|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
41934160|NCT04696055|75635941|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
41934161|NCT04696055|75635942|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
41934162|NCT04696055|75635941|FG000|Overall Study|Subject Decision|1|||
41934163|NCT04696055|75635942|FG001|Overall Study|Subject Decision|2|||
41934164|NCT04696055|75635941|FG000|Overall Study|Ongoing with study treatment|13|||
41934165|NCT04696055|75635942|FG001|Overall Study|Ongoing with study treatment|10|||
42022095|NCT00963820|75829425|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
42022096|NCT00963820|75829426|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
42022097|NCT00963820|75829427|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
42022098|NCT00963820|75829428|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
42022099|NCT00963820|75829417|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
42022100|NCT00963820|75829418|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41934166|NCT04432376|75635951|FG000|Double-blind Treatment Period|Adverse Event|2|||
41934167|NCT04432376|75635952|FG001|Double-blind Treatment Period|Adverse Event|6|||
41934168|NCT04432376|75635953|FG002|Double-blind Treatment Period|Adverse Event|0|||
41934169|NCT04432376|75635951|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
41934170|NCT04432376|75635952|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
41934171|NCT04432376|75635953|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
41934172|NCT04432376|75635951|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
41934173|NCT04432376|75635952|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
41934174|NCT04432376|75635953|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
41934175|NCT04432376|75635951|FG000|Double-blind Treatment Period|Protocol Violation|0|||
41934176|NCT04432376|75635952|FG001|Double-blind Treatment Period|Protocol Violation|1|||
42022101|NCT00963820|75829419|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41934177|NCT04432376|75635953|FG002|Double-blind Treatment Period|Protocol Violation|0|||
41934178|NCT04432376|75635951|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
41934179|NCT04432376|75635952|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
41934180|NCT04432376|75635953|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
41934181|NCT04409834|75635962|FG000|Overall Study|Death|55|||
41934182|NCT04409834|75635963|FG001|Overall Study|Death|62|||
41934183|NCT04320849|75635975|FG000|Overall Study|Withdrawal by Subject|4|||
41934184|NCT04320849|75635975|FG000|Overall Study|Imaging data unavailable|2|||
42210169|NCT04073407|76024885|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
42210170|NCT04073407|76024886|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
42210171|NCT04073407|76024885|FG000|Part 2|Withdrawal by Subject|0|||
42210172|NCT04073407|76024886|FG001|Part 2|Withdrawal by Subject|1|||
42210173|NCT02778204|76024896|FG000|Overall Study|Adverse Event|1|||
42210174|NCT02778204|76024897|FG001|Overall Study|Adverse Event|0|||
42210175|NCT02778204|76024898|FG002|Overall Study|Adverse Event|0|||
42210176|NCT02778204|76024899|FG003|Overall Study|Adverse Event|0|||
41934185|NCT04320849|75635975|FG000|Overall Study|Incomplete imaging|2|||
42022102|NCT00963820|75829420|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
42022103|NCT00963820|75829421|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
42022104|NCT00963820|75829422|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
42022105|NCT00963820|75829423|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
42022106|NCT00963820|75829424|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
42022107|NCT00963820|75829425|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
42022108|NCT00963820|75829426|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41934186|NCT03946670|75635981|FG000|Overall Study|Progressive Disease|26|||
41934187|NCT03946670|75635982|FG001|Overall Study|Progressive Disease|23|||
41934188|NCT03946670|75635981|FG000|Overall Study|Adverse Event|7|||
41934189|NCT03946670|75635982|FG001|Overall Study|Adverse Event|9|||
41934190|NCT03946670|75635981|FG000|Overall Study|Death|5|||
41934191|NCT03946670|75635982|FG001|Overall Study|Death|6|||
41934192|NCT03946670|75635981|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
41934193|NCT03946670|75635982|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
41934194|NCT03946670|75635981|FG000|Overall Study|Subject Decision|4|||
41934195|NCT03946670|75635982|FG001|Overall Study|Subject Decision|4|||
41934196|NCT03946670|75635981|FG000|Overall Study|Physician Decision|3|||
41934197|NCT03946670|75635982|FG001|Overall Study|Physician Decision|3|||
41934198|NCT03946670|75635981|FG000|Overall Study|New Therapy for Study Indication|1|||
42117782|NCT00116779|75928607|FG000|Overall Study|Withdrawal by Subject|4|||
42117783|NCT00116779|75928608|FG001|Overall Study|Withdrawal by Subject|1|||
42117784|NCT00116779|75928607|FG000|Overall Study|Inadequate testosterone suppression|7|||
41934199|NCT03946670|75635982|FG001|Overall Study|New Therapy for Study Indication|0|||
41934200|NCT03946670|75635981|FG000|Overall Study|Not treated|1|||
41934201|NCT03946670|75635982|FG001|Overall Study|Not treated|1|||
41934202|NCT03750838|75636005|FG000|Overall Study|Lost to Follow-up|10|||
41934203|NCT03750838|75636006|FG001|Overall Study|Lost to Follow-up|6|||
42022109|NCT00963820|75829427|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
42022110|NCT00963820|75829428|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
42022111|NCT00963820|75829417|FG000|Expansion Phase|Progressive Disease|0|||
42022112|NCT00963820|75829418|FG001|Expansion Phase|Progressive Disease|0|||
42022113|NCT00963820|75829419|FG002|Expansion Phase|Progressive Disease|0|||
42022114|NCT00963820|75829420|FG003|Expansion Phase|Progressive Disease|0|||
42022115|NCT00963820|75829421|FG004|Expansion Phase|Progressive Disease|0|||
42022116|NCT00963820|75829422|FG005|Expansion Phase|Progressive Disease|0|||
42022117|NCT00963820|75829423|FG006|Expansion Phase|Progressive Disease|0|||
42022118|NCT00963820|75829424|FG007|Expansion Phase|Progressive Disease|0|||
42022119|NCT00963820|75829425|FG008|Expansion Phase|Progressive Disease|8|||
42022120|NCT00963820|75829426|FG009|Expansion Phase|Progressive Disease|6|||
42022121|NCT00963820|75829427|FG010|Expansion Phase|Progressive Disease|4|||
42022122|NCT00963820|75829428|FG011|Expansion Phase|Progressive Disease|2|||
42022123|NCT00963820|75829417|FG000|Expansion Phase|Adverse Event|0|||
42022124|NCT00963820|75829418|FG001|Expansion Phase|Adverse Event|0|||
42022125|NCT00963820|75829419|FG002|Expansion Phase|Adverse Event|0|||
41934204|NCT03692052|75636015|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
41934205|NCT03692052|75636015|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
41934206|NCT03692052|75636015|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
41934207|NCT03692052|75636015|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
41934208|NCT03395197|75636085|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
41934209|NCT03395197|75636086|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
41934210|NCT03395197|75636087|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
41934211|NCT03395197|75636088|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
41934212|NCT03395197|75636089|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
41934213|NCT03395197|75636090|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
41934214|NCT03395197|75636085|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
41934215|NCT03395197|75636086|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
41934216|NCT03395197|75636087|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
41934217|NCT03395197|75636088|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
41934218|NCT03395197|75636089|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
41934219|NCT03395197|75636090|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
41934220|NCT03395197|75636085|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
41934221|NCT03395197|75636086|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
41934222|NCT03395197|75636087|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
41934223|NCT03395197|75636088|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
41934224|NCT03395197|75636089|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
41934225|NCT03395197|75636090|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
41934226|NCT03395197|75636085|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
41934227|NCT03395197|75636086|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
41934228|NCT03395197|75636087|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
41934229|NCT03395197|75636088|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
41934230|NCT03395197|75636089|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
42010367|NCT01290068|75817492|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
42010368|NCT01290068|75817491|FG000|Overall Study|Other|3|||
42010369|NCT01290068|75817492|FG001|Overall Study|Other|1|||
42010370|NCT00998881|75817500|FG000|Overall Study|Adverse Event|2|||
42010371|NCT00998881|75817501|FG001|Overall Study|Adverse Event|2|||
42010372|NCT00998881|75817500|FG000|Overall Study|Lack of Efficacy|1|||
42022126|NCT00963820|75829420|FG003|Expansion Phase|Adverse Event|0|||
42022127|NCT00963820|75829421|FG004|Expansion Phase|Adverse Event|0|||
42117785|NCT00116779|75928608|FG001|Overall Study|Inadequate testosterone suppression|9|||
42117786|NCT00116779|75928607|FG000|Overall Study|Physician Decision|3|||
42117787|NCT00116779|75928608|FG001|Overall Study|Physician Decision|1|||
42117788|NCT00116779|75928607|FG000|Overall Study|Elevated PSA levels|2|||
42117789|NCT00116779|75928608|FG001|Overall Study|Elevated PSA levels|2|||
42117790|NCT03943290|75928623|FG000|Overall Study|Sponsor Terminated Study|6|||
42117791|NCT03943290|75928624|FG001|Overall Study|Sponsor Terminated Study|1|||
42117792|NCT03943290|75928625|FG002|Overall Study|Sponsor Terminated Study|11|||
42117793|NCT03943290|75928626|FG003|Overall Study|Sponsor Terminated Study|6|||
42117794|NCT03943290|75928627|FG004|Overall Study|Sponsor Terminated Study|7|||
42117795|NCT03943290|75928628|FG005|Overall Study|Sponsor Terminated Study|6|||
42117796|NCT03943290|75928629|FG006|Overall Study|Sponsor Terminated Study|6|||
42117797|NCT03943290|75928630|FG007|Overall Study|Sponsor Terminated Study|7|||
42022128|NCT00963820|75829422|FG005|Expansion Phase|Adverse Event|0|||
42022129|NCT00963820|75829423|FG006|Expansion Phase|Adverse Event|0|||
42022130|NCT00963820|75829424|FG007|Expansion Phase|Adverse Event|0|||
42022131|NCT00963820|75829425|FG008|Expansion Phase|Adverse Event|1|||
42022132|NCT00963820|75829426|FG009|Expansion Phase|Adverse Event|3|||
42022133|NCT00963820|75829427|FG010|Expansion Phase|Adverse Event|0|||
42022134|NCT00963820|75829428|FG011|Expansion Phase|Adverse Event|0|||
42022135|NCT00963820|75829417|FG000|Expansion Phase|Withdrawal by Subject|0|||
41934231|NCT03395197|75636090|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
41934232|NCT03395197|75636085|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
41934233|NCT03395197|75636086|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
41934234|NCT03395197|75636087|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
41934235|NCT03395197|75636088|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
41934236|NCT03395197|75636089|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
41934237|NCT03395197|75636090|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
41934238|NCT03395197|75636085|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
42117798|NCT03943290|75928631|FG008|Overall Study|Sponsor Terminated Study|8|||
42117799|NCT03943290|75928623|FG000|Overall Study|Lost to Follow-up|1|||
42210177|NCT02778204|76024896|FG000|Overall Study|Withdrawal by Subject|0|||
42210178|NCT02778204|76024897|FG001|Overall Study|Withdrawal by Subject|0|||
42117800|NCT03943290|75928624|FG001|Overall Study|Lost to Follow-up|0|||
42117801|NCT03943290|75928625|FG002|Overall Study|Lost to Follow-up|1|||
42117802|NCT03943290|75928626|FG003|Overall Study|Lost to Follow-up|0|||
42210179|NCT02778204|76024898|FG002|Overall Study|Withdrawal by Subject|1|||
42210180|NCT02778204|76024899|FG003|Overall Study|Withdrawal by Subject|2|||
42210181|NCT02778204|76024896|FG000|Overall Study|Lost to Follow-up|1|||
42210182|NCT02778204|76024897|FG001|Overall Study|Lost to Follow-up|0|||
42210183|NCT02778204|76024898|FG002|Overall Study|Lost to Follow-up|2|||
42210184|NCT02778204|76024899|FG003|Overall Study|Lost to Follow-up|1|||
42210185|NCT02778204|76024896|FG000|Overall Study|Protocol Violation|0|||
42210186|NCT02778204|76024897|FG001|Overall Study|Protocol Violation|0|||
42117803|NCT03943290|75928627|FG004|Overall Study|Lost to Follow-up|0|||
42117804|NCT03943290|75928628|FG005|Overall Study|Lost to Follow-up|0|||
42117805|NCT03943290|75928629|FG006|Overall Study|Lost to Follow-up|0|||
41934239|NCT03395197|75636086|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
41934240|NCT03395197|75636087|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
41934241|NCT03395197|75636088|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
41934242|NCT03395197|75636089|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
41934243|NCT03395197|75636090|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
42117806|NCT03943290|75928630|FG007|Overall Study|Lost to Follow-up|1|||
42117807|NCT03943290|75928631|FG008|Overall Study|Lost to Follow-up|0|||
42210187|NCT02778204|76024898|FG002|Overall Study|Protocol Violation|1|||
42210188|NCT02778204|76024899|FG003|Overall Study|Protocol Violation|0|||
42117808|NCT03943290|75928623|FG000|Overall Study|Withdrawal by Subject|0|||
42117809|NCT03943290|75928624|FG001|Overall Study|Withdrawal by Subject|0|||
42117810|NCT03943290|75928625|FG002|Overall Study|Withdrawal by Subject|1|||
42117811|NCT03943290|75928626|FG003|Overall Study|Withdrawal by Subject|0|||
42117812|NCT03943290|75928627|FG004|Overall Study|Withdrawal by Subject|0|||
42117813|NCT03943290|75928628|FG005|Overall Study|Withdrawal by Subject|0|||
42117814|NCT03943290|75928629|FG006|Overall Study|Withdrawal by Subject|0|||
42117815|NCT03943290|75928630|FG007|Overall Study|Withdrawal by Subject|0|||
42117816|NCT03943290|75928631|FG008|Overall Study|Withdrawal by Subject|0|||
42117817|NCT00108355|75928666|FG000|Overall Study|Peritonitis at index paracentesis|1|||
42117818|NCT00108355|75928667|FG001|Overall Study|Peritonitis at index paracentesis|1|||
42117819|NCT00108355|75928666|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
42117820|NCT00108355|75928667|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
42117821|NCT00094861|75928688|FG000|Overall Study|Adverse Event|5|||
42117822|NCT00094861|75928689|FG001|Overall Study|Adverse Event|2|||
42117823|NCT00094861|75928688|FG000|Overall Study|Withdrawal by Subject|5|||
42117824|NCT00094861|75928689|FG001|Overall Study|Withdrawal by Subject|3|||
42117825|NCT00094861|75928688|FG000|Overall Study|Physician Decision|1|||
42117826|NCT00094861|75928689|FG001|Overall Study|Physician Decision|1|||
42117827|NCT00094861|75928688|FG000|Overall Study|Lost to Follow-up|0|||
42117828|NCT00094861|75928689|FG001|Overall Study|Lost to Follow-up|1|||
42117829|NCT00094861|75928688|FG000|Overall Study|Death|4|||
42117830|NCT00094861|75928689|FG001|Overall Study|Death|2|||
42117831|NCT00094861|75928688|FG000|Overall Study|Other|3|||
42117832|NCT00094861|75928689|FG001|Overall Study|Other|0|||
42117833|NCT00426556|75928699|FG000|Phase I - Core Phase|Disease Progression|0|||
42117834|NCT00426556|75928700|FG001|Phase I - Core Phase|Disease Progression|6|||
42117835|NCT00426556|75928701|FG002|Phase I - Core Phase|Disease Progression|2|||
42117836|NCT00426556|75928702|FG003|Phase I - Core Phase|Disease Progression|0|||
42117837|NCT00426556|75928699|FG000|Phase I - Core Phase|Adverse Event|1|||
42117838|NCT00426556|75928700|FG001|Phase I - Core Phase|Adverse Event|3|||
42117839|NCT00426556|75928701|FG002|Phase I - Core Phase|Adverse Event|1|||
42117840|NCT00426556|75928702|FG003|Phase I - Core Phase|Adverse Event|0|||
42117841|NCT00426556|75928699|FG000|Phase I - Core Phase|Death|0|||
42117842|NCT00426556|75928700|FG001|Phase I - Core Phase|Death|1|||
42117843|NCT00426556|75928701|FG002|Phase I - Core Phase|Death|0|||
42117844|NCT00426556|75928702|FG003|Phase I - Core Phase|Death|0|||
42117845|NCT00426556|75928699|FG000|Phase I - Extension Phase|Adverse Event|0|||
42117846|NCT00426556|75928700|FG001|Phase I - Extension Phase|Adverse Event|1|||
42117847|NCT00426556|75928701|FG002|Phase I - Extension Phase|Adverse Event|1|||
42117848|NCT00426556|75928702|FG003|Phase I - Extension Phase|Adverse Event|0|||
42117849|NCT00426556|75928699|FG000|Phase I - Extension Phase|Disease Progression|5|||
42117850|NCT00426556|75928700|FG001|Phase I - Extension Phase|Disease Progression|5|||
42117851|NCT00426556|75928701|FG002|Phase I - Extension Phase|Disease Progression|6|||
42117852|NCT00426556|75928702|FG003|Phase I - Extension Phase|Disease Progression|0|||
42117853|NCT00426556|75928699|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
42117854|NCT00426556|75928700|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
42117855|NCT00426556|75928701|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
42117856|NCT00426556|75928702|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
42117857|NCT00426556|75928699|FG000|Phase II - Core Phase|Disease Progression|0|||
42117858|NCT00426556|75928700|FG001|Phase II - Core Phase|Disease Progression|0|||
42117859|NCT00426556|75928701|FG002|Phase II - Core Phase|Disease Progression|0|||
42117860|NCT00426556|75928702|FG003|Phase II - Core Phase|Disease Progression|16|||
42117861|NCT00426556|75928699|FG000|Phase II - Core Phase|Adverse Event|0|||
42117862|NCT00426556|75928700|FG001|Phase II - Core Phase|Adverse Event|0|||
42117863|NCT00426556|75928701|FG002|Phase II - Core Phase|Adverse Event|0|||
42117864|NCT00426556|75928702|FG003|Phase II - Core Phase|Adverse Event|8|||
42117865|NCT00426556|75928699|FG000|Phase II - Extension Phase|Disease Progression|0|||
41934244|NCT03395197|75636085|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
41934245|NCT03395197|75636086|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
41934246|NCT03395197|75636087|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
42117866|NCT00426556|75928700|FG001|Phase II - Extension Phase|Disease Progression|0|||
42117867|NCT00426556|75928701|FG002|Phase II - Extension Phase|Disease Progression|0|||
42117868|NCT00426556|75928702|FG003|Phase II - Extension Phase|Disease Progression|21|||
42117869|NCT00426556|75928699|FG000|Phase II - Extension Phase|Adverse Event|0|||
42117870|NCT00426556|75928700|FG001|Phase II - Extension Phase|Adverse Event|0|||
42117871|NCT00426556|75928701|FG002|Phase II - Extension Phase|Adverse Event|0|||
42117872|NCT00426556|75928702|FG003|Phase II - Extension Phase|Adverse Event|2|||
42117873|NCT00107653|75928714|FG000|Overall Study|Adverse Event|24|||
42117874|NCT00107653|75928715|FG001|Overall Study|Adverse Event|43|||
42117875|NCT00107653|75928714|FG000|Overall Study|Insufficient Therapeutic Response|25|||
42117876|NCT00107653|75928715|FG001|Overall Study|Insufficient Therapeutic Response|11|||
42117877|NCT00107653|75928714|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
42117878|NCT00107653|75928715|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
42117879|NCT00107653|75928714|FG000|Overall Study|Protocol Violation|1|||
42117880|NCT00107653|75928715|FG001|Overall Study|Protocol Violation|0|||
42117881|NCT00107653|75928714|FG000|Overall Study|Withdrawal by Subject|12|||
42117882|NCT00107653|75928715|FG001|Overall Study|Withdrawal by Subject|13|||
42117883|NCT00107653|75928714|FG000|Overall Study|Lost to Follow-up|13|||
42117884|NCT00107653|75928715|FG001|Overall Study|Lost to Follow-up|5|||
42117885|NCT00107653|75928714|FG000|Overall Study|Administrative Reasons|3|||
42117886|NCT00107653|75928715|FG001|Overall Study|Administrative Reasons|3|||
42117887|NCT03950856|75928725|FG000|Overall Study|Death|1|||
42117888|NCT03950856|75928726|FG001|Overall Study|Death|2|||
42117889|NCT03950856|75928727|FG002|Overall Study|Death|0|||
42117890|NCT03950856|75928728|FG003|Overall Study|Death|0|||
42117891|NCT03950856|75928725|FG000|Overall Study|Lost to Follow-up|5|||
42117892|NCT03950856|75928726|FG001|Overall Study|Lost to Follow-up|6|||
42117893|NCT03950856|75928727|FG002|Overall Study|Lost to Follow-up|8|||
42117894|NCT03950856|75928728|FG003|Overall Study|Lost to Follow-up|2|||
42117895|NCT03950856|75928725|FG000|Overall Study|Protocol Violation|2|||
42117896|NCT03950856|75928726|FG001|Overall Study|Protocol Violation|0|||
42117897|NCT03950856|75928727|FG002|Overall Study|Protocol Violation|0|||
42117898|NCT03950856|75928728|FG003|Overall Study|Protocol Violation|1|||
42117899|NCT03950856|75928725|FG000|Overall Study|Withdrawal by Subject|4|||
42117900|NCT03950856|75928726|FG001|Overall Study|Withdrawal by Subject|1|||
42117901|NCT03950856|75928727|FG002|Overall Study|Withdrawal by Subject|3|||
42117902|NCT03950856|75928728|FG003|Overall Study|Withdrawal by Subject|1|||
42117903|NCT03950856|75928725|FG000|Overall Study|Unable to phone|7|||
42117904|NCT03950856|75928726|FG001|Overall Study|Unable to phone|6|||
42117905|NCT03950856|75928727|FG002|Overall Study|Unable to phone|7|||
42117906|NCT03950856|75928728|FG003|Overall Study|Unable to phone|2|||
42117907|NCT00433654|75928742|FG000|Overall Study|Death|4|||
42117908|NCT00433654|75928743|FG001|Overall Study|Death|0|||
42117909|NCT00433654|75928742|FG000|Overall Study|Missed visit|6|||
42117910|NCT00433654|75928743|FG001|Overall Study|Missed visit|3|||
42117911|NCT00433654|75928742|FG000|Overall Study|Subject not yet due for visit|4|||
42117912|NCT00433654|75928743|FG001|Overall Study|Subject not yet due for visit|0|||
42117913|NCT00433654|75928742|FG000|Overall Study|Withdrawal by Subject|1|||
42117914|NCT00433654|75928743|FG001|Overall Study|Withdrawal by Subject|2|||
42117915|NCT00689351|75928757|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
42117916|NCT00689351|75928758|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
42117917|NCT00689351|75928757|FG000|Infant Series of Dosing|Adverse Event|1|||
42117918|NCT00689351|75928758|FG001|Infant Series of Dosing|Adverse Event|0|||
42117919|NCT00689351|75928757|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
42117920|NCT00689351|75928758|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
42117921|NCT00689351|75928757|FG000|After Infant Series|Parent/legal guardian request|1|||
42117922|NCT00689351|75928758|FG001|After Infant Series|Parent/legal guardian request|0|||
42117923|NCT03950622|75928770|FG000|Overall Study|Withdrawal by Subject|1|||
42117924|NCT03950622|75928771|FG001|Overall Study|Withdrawal by Subject|0|||
42117925|NCT03950622|75928770|FG000|Overall Study|Protocol Deviation|0|||
42117926|NCT03950622|75928771|FG001|Overall Study|Protocol Deviation|1|||
42117927|NCT03950622|75928770|FG000|Overall Study|Physician Decision|1|||
42117928|NCT03950622|75928771|FG001|Overall Study|Physician Decision|0|||
42117929|NCT03950622|75928770|FG000|Overall Study|Lost to Follow-up|5|||
42117930|NCT03950622|75928771|FG001|Overall Study|Lost to Follow-up|5|||
42117931|NCT03950622|75928770|FG000|Overall Study|Death|1|||
42117932|NCT03950622|75928771|FG001|Overall Study|Death|1|||
42117933|NCT03937908|75928777|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
42117934|NCT03937908|75928778|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
42022136|NCT00963820|75829418|FG001|Expansion Phase|Withdrawal by Subject|0|||
42022137|NCT00963820|75829419|FG002|Expansion Phase|Withdrawal by Subject|0|||
42022138|NCT00963820|75829420|FG003|Expansion Phase|Withdrawal by Subject|0|||
42022139|NCT00963820|75829421|FG004|Expansion Phase|Withdrawal by Subject|0|||
42117935|NCT00689273|75928786|FG000|Overall Study|Adverse Event|3|||
42117936|NCT00689273|75928787|FG001|Overall Study|Adverse Event|1|||
42117937|NCT00689273|75928786|FG000|Overall Study|Lack of Efficacy|3|||
42117938|NCT00689273|75928787|FG001|Overall Study|Lack of Efficacy|0|||
42117939|NCT00689273|75928786|FG000|Overall Study|Lost to Follow-up|0|||
42117940|NCT00689273|75928787|FG001|Overall Study|Lost to Follow-up|2|||
42117941|NCT00689273|75928786|FG000|Overall Study|Other|6|||
42117942|NCT00689273|75928787|FG001|Overall Study|Other|2|||
42117943|NCT00689273|75928786|FG000|Overall Study|Randomized but not Treated|1|||
42117944|NCT00689273|75928787|FG001|Overall Study|Randomized but not Treated|0|||
42117945|NCT00553358|75928796|FG000|Overall Study|Randomized but did not receive treatment|3|||
42117946|NCT00553358|75928797|FG001|Overall Study|Randomized but did not receive treatment|3|||
42117947|NCT00553358|75928798|FG002|Overall Study|Randomized but did not receive treatment|1|||
42022140|NCT00963820|75829422|FG005|Expansion Phase|Withdrawal by Subject|0|||
42022141|NCT00963820|75829423|FG006|Expansion Phase|Withdrawal by Subject|0|||
41934247|NCT03395197|75636088|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
41934248|NCT03395197|75636089|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
42010373|NCT00998881|75817501|FG001|Overall Study|Lack of Efficacy|0|||
41934249|NCT03395197|75636090|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
42010374|NCT00998881|75817500|FG000|Overall Study|Physician Decision|3|||
41934250|NCT03395197|75636085|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
41934251|NCT03395197|75636086|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
41934252|NCT03395197|75636087|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
41934253|NCT03395197|75636088|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
41934254|NCT03395197|75636089|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
41934255|NCT03395197|75636090|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
41934256|NCT03395197|75636085|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
41934257|NCT03395197|75636086|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
41934258|NCT03395197|75636087|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
41934259|NCT03395197|75636088|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
41934260|NCT03395197|75636089|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
42210189|NCT02778204|76024896|FG000|Overall Study|Eligibility Violation|0|||
42210190|NCT02778204|76024897|FG001|Overall Study|Eligibility Violation|0|||
42210191|NCT02778204|76024898|FG002|Overall Study|Eligibility Violation|0|||
42210192|NCT02778204|76024899|FG003|Overall Study|Eligibility Violation|1|||
42210193|NCT04072159|76024913|FG000|Overall Study|Lost to Follow-up|6|||
42210194|NCT04072159|76024914|FG001|Overall Study|Lost to Follow-up|6|||
42210195|NCT04072159|76024913|FG000|Overall Study|Withdrawal by Subject|2|||
42210196|NCT04072159|76024914|FG001|Overall Study|Withdrawal by Subject|0|||
42210197|NCT03232281|76024924|FG000|Overall Study|Adverse Event|1|||
42210198|NCT03232281|76024925|FG001|Overall Study|Adverse Event|1|||
42210199|NCT03232281|76024924|FG000|Overall Study|Withdrawal by Subject|5|||
42300141|NCT02327169|76135326|FG004|Overall Study|Adverse Event|1|||
42300142|NCT02327169|76135327|FG005|Overall Study|Adverse Event|0|||
41934261|NCT03395197|75636090|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
41934262|NCT03395197|75636085|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
41934263|NCT03395197|75636086|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
41934264|NCT03395197|75636087|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
41934265|NCT03395197|75636088|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
41934266|NCT03395197|75636089|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
41934267|NCT03395197|75636090|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
41934268|NCT03395197|75636085|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
41934269|NCT03395197|75636086|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
41934270|NCT03395197|75636087|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
41934271|NCT03395197|75636088|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
41934272|NCT03395197|75636089|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
42210200|NCT03232281|76024925|FG001|Overall Study|Withdrawal by Subject|4|||
42210201|NCT03232281|76024924|FG000|Overall Study|Protocol Deviation|1|||
42210202|NCT03232281|76024925|FG001|Overall Study|Protocol Deviation|1|||
42210203|NCT04071301|76024931|FG000|Overall Study|Withdrawal by Subject|6|||
42210204|NCT04071301|76024931|FG000|Overall Study|Death|1|||
42300143|NCT02327169|76135328|FG006|Overall Study|Adverse Event|0|||
42300144|NCT02327169|76135329|FG007|Overall Study|Adverse Event|0|||
42300145|NCT02327169|76135330|FG008|Overall Study|Adverse Event|0|||
42300146|NCT02327169|76135331|FG009|Overall Study|Adverse Event|2|||
42300147|NCT02327169|76135332|FG010|Overall Study|Adverse Event|0|||
42300148|NCT02327169|76135333|FG011|Overall Study|Adverse Event|3|||
42300149|NCT02327169|76135334|FG012|Overall Study|Adverse Event|0|||
42300150|NCT02327169|76135335|FG013|Overall Study|Adverse Event|2|||
42300151|NCT02327169|76135336|FG014|Overall Study|Adverse Event|1|||
42300152|NCT02327169|76135322|FG000|Overall Study|Symptomatic Deterioration|0|||
42300153|NCT02327169|76135323|FG001|Overall Study|Symptomatic Deterioration|0|||
42300154|NCT02327169|76135324|FG002|Overall Study|Symptomatic Deterioration|1|||
42300155|NCT02327169|76135325|FG003|Overall Study|Symptomatic Deterioration|0|||
42300156|NCT02327169|76135326|FG004|Overall Study|Symptomatic Deterioration|1|||
42300157|NCT02327169|76135327|FG005|Overall Study|Symptomatic Deterioration|1|||
42300158|NCT02327169|76135328|FG006|Overall Study|Symptomatic Deterioration|0|||
42300159|NCT02327169|76135329|FG007|Overall Study|Symptomatic Deterioration|0|||
42300160|NCT02327169|76135330|FG008|Overall Study|Symptomatic Deterioration|2|||
42300161|NCT02327169|76135331|FG009|Overall Study|Symptomatic Deterioration|1|||
41934273|NCT03395197|75636090|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
41934274|NCT03395197|75636085|FG000|Analysis for DDR-Deficient Participants|Death|0|||
41934275|NCT03395197|75636086|FG001|Analysis for DDR-Deficient Participants|Death|0|||
41934276|NCT03395197|75636087|FG002|Analysis for DDR-Deficient Participants|Death|0|||
41934277|NCT03395197|75636088|FG003|Analysis for DDR-Deficient Participants|Death|0|||
41934278|NCT03395197|75636089|FG004|Analysis for DDR-Deficient Participants|Death|1|||
41934279|NCT03395197|75636090|FG005|Analysis for DDR-Deficient Participants|Death|4|||
41934280|NCT03395197|75636085|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
41934281|NCT03395197|75636086|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
41934282|NCT03395197|75636087|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
41934283|NCT03395197|75636088|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
41934284|NCT03395197|75636089|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
41934285|NCT03395197|75636090|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
41934286|NCT03395197|75636085|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
41934287|NCT03395197|75636086|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
41934288|NCT03395197|75636087|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
41934289|NCT03395197|75636088|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
41934290|NCT03395197|75636089|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
41934291|NCT03395197|75636090|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
41934292|NCT03395197|75636085|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
41934293|NCT03395197|75636086|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
41934294|NCT03395197|75636087|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
41934295|NCT03395197|75636088|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
41934296|NCT03395197|75636089|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
41934297|NCT03395197|75636090|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
41934298|NCT03395197|75636085|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
41934299|NCT03395197|75636086|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
41934300|NCT03395197|75636087|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
41934301|NCT03395197|75636088|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
41934302|NCT03395197|75636089|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
41934303|NCT03395197|75636090|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
41934304|NCT03395197|75636085|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
41934305|NCT03395197|75636086|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
41934306|NCT03395197|75636087|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
41934307|NCT03395197|75636088|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
41934308|NCT03395197|75636089|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
41934309|NCT03395197|75636090|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
41934310|NCT03395197|75636085|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
41934311|NCT03395197|75636086|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
41934312|NCT03395197|75636087|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
41934313|NCT03395197|75636088|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
41934314|NCT03395197|75636089|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
41934315|NCT03395197|75636090|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
41934316|NCT03395197|75636085|FG000|Analysis for DDR-Deficient Participants|Other|0|||
41934317|NCT03395197|75636086|FG001|Analysis for DDR-Deficient Participants|Other|0|||
41934318|NCT03395197|75636087|FG002|Analysis for DDR-Deficient Participants|Other|0|||
41934319|NCT03395197|75636088|FG003|Analysis for DDR-Deficient Participants|Other|0|||
41934320|NCT03395197|75636089|FG004|Analysis for DDR-Deficient Participants|Other|3|||
41934321|NCT03395197|75636090|FG005|Analysis for DDR-Deficient Participants|Other|3|||
41934322|NCT03395197|75636085|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
41934323|NCT03395197|75636086|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
42117948|NCT00553358|75928796|FG000|Overall Study|Lost to Follow-up|22|||
41934324|NCT03395197|75636087|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
41934325|NCT03395197|75636088|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
41934326|NCT03395197|75636089|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
41934327|NCT03395197|75636090|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
41934328|NCT02726386|75636106|FG000|Overall Study|Adverse Event|17|||
41934329|NCT02726386|75636107|FG001|Overall Study|Adverse Event|20|||
41934330|NCT02726386|75636106|FG000|Overall Study|Withdrawal by Subject|14|||
41934331|NCT02726386|75636107|FG001|Overall Study|Withdrawal by Subject|28|||
41934332|NCT02726386|75636106|FG000|Overall Study|Other reasons|7|||
41934333|NCT02726386|75636107|FG001|Overall Study|Other reasons|8|||
41934334|NCT02711553|75636117|FG000|Overall Study|Withdrawal by Subject|2|||
41934335|NCT02711553|75636118|FG001|Overall Study|Withdrawal by Subject|1|||
41934336|NCT02711553|75636119|FG002|Overall Study|Withdrawal by Subject|1|||
41934337|NCT02711553|75636120|FG003|Overall Study|Withdrawal by Subject|0|||
41934338|NCT02711553|75636117|FG000|Overall Study|Lost to Follow-up|3|||
41934339|NCT02711553|75636118|FG001|Overall Study|Lost to Follow-up|3|||
41934340|NCT02711553|75636119|FG002|Overall Study|Lost to Follow-up|6|||
41934341|NCT02711553|75636120|FG003|Overall Study|Lost to Follow-up|3|||
41934342|NCT02711553|75636117|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
41934343|NCT02711553|75636118|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
41934344|NCT02711553|75636119|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
41934345|NCT02711553|75636120|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
41934346|NCT02667587|75636134|FG000|Pre-Treatment|Not reported|1|||
41934347|NCT02667587|75636135|FG001|Pre-Treatment|Not reported|0|||
41934348|NCT02667587|75636134|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
41934349|NCT02667587|75636135|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
41934350|NCT02667587|75636134|FG000|Pre-Treatment|Participant withdrew consent|0|||
41934351|NCT02667587|75636135|FG001|Pre-Treatment|Participant withdrew consent|1|||
41934352|NCT02667587|75636134|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
41934353|NCT02667587|75636135|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
41934354|NCT02667587|75636134|FG000|End of Treatment|Other reasons|11|||
41934355|NCT02667587|75636135|FG001|End of Treatment|Other reasons|8|||
41934356|NCT02667587|75636134|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
41934357|NCT02667587|75636135|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
41934358|NCT02667587|75636134|FG000|End of Treatment|Poor/Non-Compliance|0|||
41934359|NCT02667587|75636135|FG001|End of Treatment|Poor/Non-Compliance|1|||
42210205|NCT03261336|76024935|FG000|Overall Study|Adverse Event|1|||
42210206|NCT00462748|76024942|FG000|Overall Study|Adverse Event|7|||
42210207|NCT00462748|76024943|FG001|Overall Study|Adverse Event|5|||
41934360|NCT02667587|75636134|FG000|End of Treatment|Maximum Clinical Benefit|3|||
41934361|NCT02667587|75636135|FG001|End of Treatment|Maximum Clinical Benefit|3|||
42210208|NCT00462748|76024944|FG002|Overall Study|Adverse Event|9|||
41934362|NCT02667587|75636134|FG000|End of Treatment|Participant Withdrew Consent|5|||
41934363|NCT02667587|75636135|FG001|End of Treatment|Participant Withdrew Consent|6|||
41934364|NCT02667587|75636134|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
41934365|NCT02667587|75636135|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
41934366|NCT02667587|75636134|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
41934367|NCT02667587|75636135|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
41934368|NCT02667587|75636134|FG000|End of Treatment|Death|2|||
41934369|NCT02667587|75636135|FG001|End of Treatment|Death|1|||
41934370|NCT02667587|75636134|FG000|End of Treatment|Study Drug Toxicity|74|||
41934371|NCT02667587|75636135|FG001|End of Treatment|Study Drug Toxicity|18|||
41934372|NCT02667587|75636134|FG000|End of Treatment|Disease progression|177|||
41934373|NCT02667587|75636135|FG001|End of Treatment|Disease progression|222|||
41934374|NCT02667587|75636134|FG000|End of Treatment|Lost to Follow-up|1|||
41934375|NCT02667587|75636135|FG001|End of Treatment|Lost to Follow-up|3|||
41934376|NCT02576509|75636143|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
41934377|NCT02576509|75636144|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
41934378|NCT02576509|75636143|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
41934379|NCT02576509|75636144|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
41934380|NCT02576509|75636143|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
41934381|NCT02576509|75636144|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
41934382|NCT02576509|75636143|FG000|Treatment Period|Disease progression|245|||
41934383|NCT02576509|75636144|FG001|Treatment Period|Disease progression|240|||
41934384|NCT02576509|75636143|FG000|Treatment Period|Study drug toxicity|32|||
41934385|NCT02576509|75636144|FG001|Treatment Period|Study drug toxicity|41|||
41934386|NCT02576509|75636143|FG000|Treatment Period|Death|1|||
41934387|NCT02576509|75636144|FG001|Treatment Period|Death|1|||
41934388|NCT02576509|75636143|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
41934389|NCT02576509|75636144|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
41934390|NCT02576509|75636143|FG000|Treatment Period|Participant request to stop treatment|8|||
41934391|NCT02576509|75636144|FG001|Treatment Period|Participant request to stop treatment|17|||
41934392|NCT02576509|75636143|FG000|Treatment Period|Participant withdrew consent|2|||
41934393|NCT02576509|75636144|FG001|Treatment Period|Participant withdrew consent|7|||
41934394|NCT02576509|75636143|FG000|Treatment Period|Lost to Follow-up|0|||
41934395|NCT02576509|75636144|FG001|Treatment Period|Lost to Follow-up|1|||
41934396|NCT02576509|75636143|FG000|Treatment Period|Maximum clinical benefit|1|||
41934397|NCT02576509|75636144|FG001|Treatment Period|Maximum clinical benefit|0|||
41934398|NCT02576509|75636143|FG000|Treatment Period|Poor/non-compliance|0|||
41934399|NCT02576509|75636144|FG001|Treatment Period|Poor/non-compliance|1|||
41934400|NCT02576509|75636143|FG000|Treatment Period|Participant no longer meets criteria|1|||
41934401|NCT02576509|75636144|FG001|Treatment Period|Participant no longer meets criteria|0|||
41934402|NCT02576509|75636143|FG000|Treatment Period|Other reason|2|||
41934403|NCT02576509|75636144|FG001|Treatment Period|Other reason|7|||
41934404|NCT02576509|75636143|FG000|Follow-up Period|Death|41|||
41934405|NCT02576509|75636144|FG001|Follow-up Period|Death|35|||
41934406|NCT02576509|75636143|FG000|Follow-up Period|Participant withdrew consent|7|||
41934407|NCT02576509|75636144|FG001|Follow-up Period|Participant withdrew consent|14|||
41934408|NCT02576509|75636143|FG000|Follow-up Period|Lost to Follow-up|0|||
41934409|NCT02576509|75636144|FG001|Follow-up Period|Lost to Follow-up|1|||
41934410|NCT02576509|75636143|FG000|Follow-up Period|Other reason|1|||
41934411|NCT02576509|75636144|FG001|Follow-up Period|Other reason|2|||
41934412|NCT02476916|75636152|FG000|Core Period|Adverse Event|2|||
41934413|NCT02476916|75636153|FG001|Core Period|Adverse Event|2|||
41934414|NCT02476916|75636152|FG000|Core Period|Investigator decision|1|||
41934415|NCT02476916|75636153|FG001|Core Period|Investigator decision|1|||
41934416|NCT02476916|75636152|FG000|Core Period|Withdrawal by Subject|3|||
41934417|NCT02476916|75636153|FG001|Core Period|Withdrawal by Subject|0|||
41934418|NCT02476916|75636152|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
41934419|NCT02476916|75636153|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
41934420|NCT02476916|75636152|FG000|Extension Period|On Treatment|12|||
41934421|NCT02476916|75636153|FG001|Extension Period|On Treatment|17|||
41934422|NCT02203799|75636160|FG000|Overall Study|Withdrawal by Subject|3|||
41934423|NCT02180724|75636167|FG000|Overall Study|Death|26|||
41934424|NCT02180724|75636168|FG001|Overall Study|Death|1|||
41934425|NCT02180724|75636167|FG000|Overall Study|Lost to Follow-up|3|||
41934426|NCT02180724|75636168|FG001|Overall Study|Lost to Follow-up|1|||
41934427|NCT02180724|75636167|FG000|Overall Study|Withdrawal by Subject|4|||
41934428|NCT02180724|75636168|FG001|Overall Study|Withdrawal by Subject|2|||
41934429|NCT02180724|75636167|FG000|Overall Study|PI Decision|5|||
41934430|NCT02180724|75636168|FG001|Overall Study|PI Decision|2|||
41934431|NCT02180724|75636167|FG000|Overall Study|Study terminated by sponsor|54|||
41934432|NCT02180724|75636168|FG001|Overall Study|Study terminated by sponsor|8|||
41934433|NCT02043678|75636191|FG000|Overall Study|Never treated|11|||
41934434|NCT02043678|75636192|FG001|Overall Study|Never treated|9|||
41934435|NCT02043678|75636191|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
42010375|NCT00998881|75817501|FG001|Overall Study|Physician Decision|0|||
41934436|NCT02043678|75636192|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
41934437|NCT02043678|75636191|FG000|Overall Study|AE without clinical PD|51|||
41934438|NCT02043678|75636192|FG001|Overall Study|AE without clinical PD|34|||
41934439|NCT02043678|75636191|FG000|Overall Study|Lost to Follow-up|1|||
41934440|NCT02043678|75636192|FG001|Overall Study|Lost to Follow-up|1|||
41934441|NCT02043678|75636191|FG000|Overall Study|Other|19|||
41934442|NCT02043678|75636192|FG001|Overall Study|Other|16|||
41934443|NCT02043678|75636191|FG000|Overall Study|Clinical PD|108|||
41934444|NCT02043678|75636192|FG001|Overall Study|Clinical PD|138|||
41934445|NCT02043678|75636191|FG000|Overall Study|Radiological PD|91|||
41934446|NCT02043678|75636192|FG001|Overall Study|Radiological PD|80|||
41934447|NCT02043678|75636191|FG000|Overall Study|Protocol-driven decision point|56|||
41934448|NCT02043678|75636192|FG001|Overall Study|Protocol-driven decision point|56|||
41934449|NCT02043678|75636191|FG000|Overall Study|Withdrawal by Subject|12|||
41934450|NCT02043678|75636192|FG001|Overall Study|Withdrawal by Subject|15|||
41934451|NCT02043678|75636191|FG000|Overall Study|Ongoing with treatment|34|||
41934452|NCT02043678|75636192|FG001|Overall Study|Ongoing with treatment|38|||
41934453|NCT01853748|75636200|FG000|Allocation|Withdrawal by Subject|1|||
41934454|NCT01853748|75636201|FG001|Allocation|Withdrawal by Subject|13|||
41934455|NCT01853748|75636200|FG000|Allocation|not sufficient to receive intervention|0|||
41934456|NCT01853748|75636201|FG001|Allocation|not sufficient to receive intervention|1|||
41934457|NCT01853748|75636200|FG000|Follow-Up|Withdrawal by Subject|7|||
41934458|NCT01853748|75636201|FG001|Follow-Up|Withdrawal by Subject|6|||
41934459|NCT01853748|75636200|FG000|Follow-Up|Adverse Event|67|||
41934460|NCT01853748|75636201|FG001|Follow-Up|Adverse Event|7|||
41934461|NCT01853748|75636200|FG000|Follow-Up|not available for data collection|16|||
41934462|NCT01853748|75636201|FG001|Follow-Up|not available for data collection|4|||
41934463|NCT01843374|75636218|FG000|Overall Study|Death|155|||
41934464|NCT01843374|75636219|FG001|Overall Study|Death|313|||
41934465|NCT01843374|75636218|FG000|Overall Study|Withdrawal by Subject|14|||
41934466|NCT01843374|75636219|FG001|Overall Study|Withdrawal by Subject|20|||
41934467|NCT01843374|75636218|FG000|Overall Study|Withdrawing due to Other reason|20|||
41934468|NCT01843374|75636219|FG001|Overall Study|Withdrawing due to Other reason|46|||
41934469|NCT01773733|75636230|FG000|Overall Study|Adverse Event|3286|||
41934470|NCT01773733|75636231|FG001|Overall Study|Adverse Event|540|||
41934471|NCT01773733|75636230|FG000|Overall Study|Pregnancy|28|||
41934472|NCT01773733|75636231|FG001|Overall Study|Pregnancy|0|||
41934473|NCT01773733|75636230|FG000|Overall Study|Other different categories of not compl|55415|||
41934474|NCT01773733|75636231|FG001|Overall Study|Other different categories of not compl|7781|||
41934475|NCT01757535|75636241|FG000|Overall Study|Disease Relapse|143|||
41934476|NCT01757535|75636242|FG001|Overall Study|Disease Relapse|180|||
41934477|NCT01757535|75636241|FG000|Overall Study|Adverse Event|29|||
41934478|NCT01757535|75636242|FG001|Overall Study|Adverse Event|11|||
41934479|NCT01757535|75636241|FG000|Overall Study|Withdrawal by Subject|9|||
41934480|NCT01757535|75636242|FG001|Overall Study|Withdrawal by Subject|13|||
41934481|NCT01757535|75636241|FG000|Overall Study|Miscellaneous|5|||
41934482|NCT01757535|75636242|FG001|Overall Study|Miscellaneous|2|||
41934483|NCT01757535|75636241|FG000|Overall Study|Physician Decision|6|||
41934484|NCT01757535|75636242|FG001|Overall Study|Physician Decision|0|||
41934485|NCT01757535|75636241|FG000|Overall Study|Death|1|||
41934486|NCT01757535|75636242|FG001|Overall Study|Death|2|||
42022142|NCT00963820|75829424|FG007|Expansion Phase|Withdrawal by Subject|0|||
42022143|NCT00963820|75829425|FG008|Expansion Phase|Withdrawal by Subject|1|||
42022144|NCT00963820|75829426|FG009|Expansion Phase|Withdrawal by Subject|0|||
42117949|NCT00553358|75928797|FG001|Overall Study|Lost to Follow-up|26|||
41934487|NCT01110005|75636270|FG000|Overall Study|ineligible|1|||
41934488|NCT01110005|75636271|FG001|Overall Study|ineligible|2|||
41934489|NCT01110005|75636270|FG000|Overall Study|missing consent|3|||
41934490|NCT01110005|75636271|FG001|Overall Study|missing consent|2|||
41934491|NCT01110005|75636270|FG000|Overall Study|Withdrawal by Subject|0|||
41934492|NCT01110005|75636271|FG001|Overall Study|Withdrawal by Subject|1|||
41934493|NCT00840801|75636279|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
41934494|NCT00840801|75636280|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
41934495|NCT00840801|75636281|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
41934496|NCT00840801|75636279|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
41934497|NCT00840801|75636280|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
41934498|NCT00840801|75636281|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
41934499|NCT00840801|75636279|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
41934500|NCT00840801|75636280|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
41934501|NCT00840801|75636281|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
41934502|NCT00840801|75636279|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
41934503|NCT00840801|75636280|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
41934504|NCT00840801|75636281|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
41934505|NCT00494234|75636315|FG000|Overall Study|Withdrawal by Subject|1|||
41934506|NCT00494234|75636316|FG001|Overall Study|Withdrawal by Subject|0|||
41934507|NCT00494234|75636315|FG000|Overall Study|Disease progression|11|||
41934508|NCT00494234|75636316|FG001|Overall Study|Disease progression|8|||
41934509|NCT00494234|75636315|FG000|Overall Study|Death|2|||
41934510|NCT00494234|75636316|FG001|Overall Study|Death|1|||
41934511|NCT02513160|75638091|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
41934512|NCT02513160|75638092|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
41934513|NCT02513160|75638093|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
41934514|NCT02513160|75638094|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
41934515|NCT02513160|75638091|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
41934516|NCT02513160|75638092|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
41934517|NCT02513160|75638093|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
41934518|NCT02513160|75638094|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
41934519|NCT02513160|75638091|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
41934520|NCT02513160|75638092|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
41934521|NCT02513160|75638093|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
41934522|NCT02513160|75638094|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
41934523|NCT02513160|75638091|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
41934524|NCT02513160|75638092|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
41934525|NCT02513160|75638093|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
41934526|NCT02513160|75638094|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
41934527|NCT02513160|75638091|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
41934528|NCT02513160|75638092|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
41934529|NCT02513160|75638093|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
41934530|NCT02513160|75638094|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
41934531|NCT02513160|75638091|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
41934532|NCT02513160|75638092|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
41934533|NCT02513160|75638093|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
41934534|NCT02513160|75638094|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
41934535|NCT02513160|75638091|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
41934536|NCT02513160|75638092|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
41934537|NCT02513160|75638093|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
41934538|NCT02513160|75638094|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
41934539|NCT02513160|75638091|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
41934540|NCT02513160|75638092|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
41934541|NCT02513160|75638093|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
41934542|NCT02513160|75638094|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
41934543|NCT02513160|75638091|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
41934544|NCT02513160|75638092|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
41934545|NCT02513160|75638093|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
41934546|NCT02513160|75638094|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
41934547|NCT02513160|75638091|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
41934548|NCT02513160|75638092|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
41934549|NCT02513160|75638093|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
41934550|NCT02513160|75638094|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
41934551|NCT02513160|75638091|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
41934552|NCT02513160|75638092|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
41934553|NCT02513160|75638093|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
41934554|NCT02513160|75638094|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
41934555|NCT02513160|75638091|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
41934556|NCT02513160|75638092|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
41934557|NCT02513160|75638093|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
41934558|NCT02513160|75638094|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
41934559|NCT02480010|75638129|FG000|Overall Study|Adverse Event|3|||
41934560|NCT02480010|75638130|FG001|Overall Study|Adverse Event|1|||
41934561|NCT02480010|75638129|FG000|Overall Study|Death|1|||
41934562|NCT02480010|75638130|FG001|Overall Study|Death|0|||
41934563|NCT02480010|75638129|FG000|Overall Study|Insufficient therapeutic response|31|||
41934564|NCT02480010|75638130|FG001|Overall Study|Insufficient therapeutic response|29|||
41934565|NCT02480010|75638129|FG000|Overall Study|Refused Treatment|0|||
41934566|NCT02480010|75638130|FG001|Overall Study|Refused Treatment|3|||
41934567|NCT02512302|75638158|FG000|Period 1|Adverse Event|0|||
41934568|NCT02512302|75638159|FG001|Period 1|Adverse Event|1|||
41934569|NCT02512302|75638160|FG002|Period 1|Adverse Event|0|||
41934570|NCT02512302|75638161|FG003|Period 1|Adverse Event|0|||
41934571|NCT02512302|75638162|FG004|Period 1|Adverse Event|0|||
41934572|NCT02512302|75638163|FG005|Period 1|Adverse Event|0|||
41934573|NCT02512302|75638164|FG006|Period 1|Adverse Event|0|||
41934574|NCT02512302|75638165|FG007|Period 1|Adverse Event|0|||
41934575|NCT02512302|75638166|FG008|Period 1|Adverse Event|0|||
41934576|NCT02512302|75638167|FG009|Period 1|Adverse Event|0|||
41934577|NCT02512302|75638158|FG000|Period 2|Adverse Event|0|||
41934578|NCT02512302|75638159|FG001|Period 2|Adverse Event|0|||
41934579|NCT02512302|75638160|FG002|Period 2|Adverse Event|0|||
41934580|NCT02512302|75638161|FG003|Period 2|Adverse Event|0|||
41934581|NCT02512302|75638162|FG004|Period 2|Adverse Event|0|||
41934582|NCT02512302|75638163|FG005|Period 2|Adverse Event|0|||
41934583|NCT02512302|75638164|FG006|Period 2|Adverse Event|0|||
41934584|NCT02512302|75638165|FG007|Period 2|Adverse Event|0|||
41934585|NCT02512302|75638166|FG008|Period 2|Adverse Event|0|||
41934586|NCT02512302|75638167|FG009|Period 2|Adverse Event|1|||
41934587|NCT02512302|75638158|FG000|Period 3|Lost to Follow-up|0|||
41934588|NCT02512302|75638159|FG001|Period 3|Lost to Follow-up|0|||
41934589|NCT02512302|75638160|FG002|Period 3|Lost to Follow-up|1|||
41934590|NCT02512302|75638161|FG003|Period 3|Lost to Follow-up|0|||
41934591|NCT02512302|75638162|FG004|Period 3|Lost to Follow-up|0|||
41934592|NCT02512302|75638163|FG005|Period 3|Lost to Follow-up|0|||
41934593|NCT02512302|75638164|FG006|Period 3|Lost to Follow-up|0|||
41934594|NCT02512302|75638165|FG007|Period 3|Lost to Follow-up|0|||
41934595|NCT02512302|75638166|FG008|Period 3|Lost to Follow-up|0|||
41934596|NCT02512302|75638167|FG009|Period 3|Lost to Follow-up|0|||
41934597|NCT02512302|75638158|FG000|Period 4|Adverse Event|0|||
41934598|NCT02512302|75638159|FG001|Period 4|Adverse Event|0|||
41934599|NCT02512302|75638160|FG002|Period 4|Adverse Event|0|||
41934600|NCT02512302|75638161|FG003|Period 4|Adverse Event|0|||
41934601|NCT02512302|75638162|FG004|Period 4|Adverse Event|0|||
41934602|NCT02512302|75638163|FG005|Period 4|Adverse Event|0|||
41934603|NCT02512302|75638164|FG006|Period 4|Adverse Event|1|||
41934604|NCT02512302|75638165|FG007|Period 4|Adverse Event|0|||
41934605|NCT02512302|75638166|FG008|Period 4|Adverse Event|0|||
41934606|NCT02512302|75638167|FG009|Period 4|Adverse Event|0|||
41934607|NCT02511678|75638282|FG000|Overall Study|Withdrawal by Subject|2|||
41934608|NCT02511678|75638282|FG000|Overall Study|Lost to Follow-up|4|||
41934609|NCT02511678|75638282|FG000|Overall Study|Death|19|||
41934610|NCT02511678|75638282|FG000|Overall Study|Adverse Event|1|||
41934611|NCT02511678|75638282|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
41934612|NCT02511678|75638282|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
41934613|NCT02511678|75638282|FG000|Overall Study|Required Radiofrequency Ablation|1|||
41934614|NCT02511678|75638282|FG000|Overall Study|Biopsy was Negative|1|||
41934615|NCT02511678|75638282|FG000|Overall Study|Protocol Violation|1|||
41934616|NCT02511678|75638282|FG000|Overall Study|Received Radiation Treatment|1|||
41934617|NCT02518464|75638309|FG000|Overall Study|Adverse Event|2|||
41934618|NCT02510820|75638313|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
41934619|NCT02510820|75638314|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
41934620|NCT02510820|75638313|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
41934621|NCT02510820|75638314|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
41934622|NCT02510664|75638324|FG000|Overall Study|Transferred Care|9|||
41934623|NCT02510664|75638325|FG001|Overall Study|Transferred Care|9|||
41934624|NCT02510664|75638326|FG002|Overall Study|Transferred Care|0|||
41934625|NCT02510664|75638324|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
41934626|NCT02510664|75638325|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
41934627|NCT02510664|75638326|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
41934628|NCT02510664|75638324|FG000|Overall Study|Time Constraints|1|||
41934629|NCT02510664|75638325|FG001|Overall Study|Time Constraints|1|||
41934630|NCT02510664|75638326|FG002|Overall Study|Time Constraints|0|||
41934631|NCT01363986|75638357|FG000|Overall Study|Disease progression|1|||
41934632|NCT02478372|75638391|FG000|Overall Study|Protocol Violation|12|||
41934633|NCT02478372|75638392|FG001|Overall Study|Protocol Violation|8|||
41934634|NCT02478372|75638391|FG000|Overall Study|Lost to Follow-up|1|||
42022145|NCT00963820|75829427|FG010|Expansion Phase|Withdrawal by Subject|1|||
41934635|NCT02478372|75638392|FG001|Overall Study|Lost to Follow-up|4|||
42300162|NCT02327169|76135332|FG010|Overall Study|Symptomatic Deterioration|0|||
41934636|NCT02478372|75638391|FG000|Overall Study|Death|0|||
41934637|NCT02478372|75638392|FG001|Overall Study|Death|2|||
41934638|NCT01654536|75638404|FG000|Overall Study|Lost to Follow-up|5|||
41934639|NCT01654536|75638405|FG001|Overall Study|Lost to Follow-up|5|||
41934640|NCT01654536|75638404|FG000|Overall Study|Physician Decision|12|||
41934641|NCT01654536|75638405|FG001|Overall Study|Physician Decision|8|||
41934642|NCT01654536|75638404|FG000|Overall Study|Withdrawal by Subject|27|||
41934643|NCT01654536|75638405|FG001|Overall Study|Withdrawal by Subject|25|||
41934644|NCT01654380|75638414|FG000|Part B, Period 1|Physician Decision|0|||
41934645|NCT01654380|75638415|FG001|Part B, Period 1|Physician Decision|0|||
41934646|NCT01654380|75638416|FG002|Part B, Period 1|Physician Decision|1|||
41934647|NCT01654380|75638417|FG003|Part B, Period 1|Physician Decision|0|||
41934648|NCT02477670|75638436|FG000|Stage 1|Adverse Event|2|||
41934649|NCT02477670|75638437|FG001|Stage 1|Adverse Event|7|||
41934650|NCT02477670|75638438|FG002|Stage 1|Adverse Event|0|||
41934651|NCT02477670|75638439|FG003|Stage 1|Adverse Event|0|||
41934652|NCT02477670|75638440|FG004|Stage 1|Adverse Event|0|||
41934653|NCT02477670|75638441|FG005|Stage 1|Adverse Event|0|||
41934654|NCT02477670|75638442|FG006|Stage 1|Adverse Event|0|||
41934655|NCT02477670|75638436|FG000|Stage 1|Lost to Follow-up|0|||
41934656|NCT02477670|75638437|FG001|Stage 1|Lost to Follow-up|2|||
41934657|NCT02477670|75638438|FG002|Stage 1|Lost to Follow-up|0|||
41934658|NCT02477670|75638439|FG003|Stage 1|Lost to Follow-up|0|||
41934659|NCT02477670|75638440|FG004|Stage 1|Lost to Follow-up|0|||
41934660|NCT02477670|75638441|FG005|Stage 1|Lost to Follow-up|0|||
41934661|NCT02477670|75638442|FG006|Stage 1|Lost to Follow-up|0|||
41934662|NCT02477670|75638436|FG000|Stage 1|Withdrawal by Subject|1|||
41934663|NCT02477670|75638437|FG001|Stage 1|Withdrawal by Subject|2|||
41934664|NCT02477670|75638438|FG002|Stage 1|Withdrawal by Subject|0|||
41934665|NCT02477670|75638439|FG003|Stage 1|Withdrawal by Subject|0|||
41934666|NCT02477670|75638440|FG004|Stage 1|Withdrawal by Subject|0|||
41934667|NCT02477670|75638441|FG005|Stage 1|Withdrawal by Subject|0|||
41934668|NCT02477670|75638442|FG006|Stage 1|Withdrawal by Subject|0|||
41934669|NCT02477670|75638436|FG000|Stage 1|Non-compliance with Study Drug|1|||
41934670|NCT02477670|75638437|FG001|Stage 1|Non-compliance with Study Drug|2|||
41934671|NCT02477670|75638438|FG002|Stage 1|Non-compliance with Study Drug|0|||
41934672|NCT02477670|75638439|FG003|Stage 1|Non-compliance with Study Drug|0|||
41934673|NCT02477670|75638440|FG004|Stage 1|Non-compliance with Study Drug|0|||
41934674|NCT02477670|75638441|FG005|Stage 1|Non-compliance with Study Drug|0|||
41934675|NCT02477670|75638442|FG006|Stage 1|Non-compliance with Study Drug|0|||
41934676|NCT02477670|75638436|FG000|Stage 2|Adverse Event|0|||
41934677|NCT02477670|75638437|FG001|Stage 2|Adverse Event|0|||
41934678|NCT02477670|75638438|FG002|Stage 2|Adverse Event|1|||
41934679|NCT02477670|75638439|FG003|Stage 2|Adverse Event|0|||
41934680|NCT02477670|75638440|FG004|Stage 2|Adverse Event|0|||
41934681|NCT02477670|75638441|FG005|Stage 2|Adverse Event|0|||
41934682|NCT02477670|75638442|FG006|Stage 2|Adverse Event|0|||
41934683|NCT02477670|75638436|FG000|Stage 2|Antipsychotic Medication Changed|0|||
41934684|NCT02477670|75638437|FG001|Stage 2|Antipsychotic Medication Changed|0|||
41934685|NCT02477670|75638438|FG002|Stage 2|Antipsychotic Medication Changed|1|||
41934686|NCT02477670|75638439|FG003|Stage 2|Antipsychotic Medication Changed|0|||
41934687|NCT02477670|75638440|FG004|Stage 2|Antipsychotic Medication Changed|0|||
41934688|NCT02477670|75638441|FG005|Stage 2|Antipsychotic Medication Changed|0|||
41934689|NCT02477670|75638442|FG006|Stage 2|Antipsychotic Medication Changed|0|||
41934690|NCT02477670|75638436|FG000|Stage 2|Withdrawal by Subject|0|||
41934691|NCT02477670|75638437|FG001|Stage 2|Withdrawal by Subject|0|||
41934692|NCT02477670|75638438|FG002|Stage 2|Withdrawal by Subject|0|||
41934693|NCT02477670|75638439|FG003|Stage 2|Withdrawal by Subject|1|||
41934694|NCT02477670|75638440|FG004|Stage 2|Withdrawal by Subject|0|||
41934695|NCT02477670|75638441|FG005|Stage 2|Withdrawal by Subject|0|||
41934696|NCT02477670|75638442|FG006|Stage 2|Withdrawal by Subject|0|||
41934697|NCT02509026|75638453|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
41934698|NCT02509026|75638453|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
41934699|NCT02509026|75638453|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
41934700|NCT02509026|75638453|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
41934701|NCT02509026|75638453|FG000|Induction Period (24 Weeks)|Other|2|||
41934702|NCT02509026|75638453|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
41934703|NCT02509026|75638453|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
41934704|NCT02509026|75638453|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
41934705|NCT02509026|75638453|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
41934706|NCT02509026|75638453|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
41934707|NCT02509026|75638453|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
41934708|NCT02509026|75638453|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
41934709|NCT02509026|75638453|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
41934710|NCT02476968|75638827|FG000|Overall Study|Other|0|||
41934711|NCT02476968|75638828|FG001|Overall Study|Other|2|||
41934712|NCT02476968|75638829|FG002|Overall Study|Other|0|||
41934713|NCT02476968|75638827|FG000|Overall Study|Lost to Follow-up|10|||
41934714|NCT02476968|75638828|FG001|Overall Study|Lost to Follow-up|0|||
41934715|NCT02476968|75638829|FG002|Overall Study|Lost to Follow-up|1|||
41934716|NCT02476968|75638827|FG000|Overall Study|Death|48|||
41934717|NCT02476968|75638828|FG001|Overall Study|Death|8|||
41934718|NCT02476968|75638829|FG002|Overall Study|Death|1|||
41934719|NCT02476968|75638827|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
41934720|NCT02476968|75638828|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
41934721|NCT02476968|75638829|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
41934722|NCT02476968|75638827|FG000|Overall Study|Patient decision|37|||
41934723|NCT02476968|75638828|FG001|Overall Study|Patient decision|8|||
41934724|NCT02476968|75638829|FG002|Overall Study|Patient decision|0|||
41934725|NCT02476578|75638850|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
41934726|NCT02476578|75638851|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
41934727|NCT02476578|75638850|FG000|Overall Study|Lost to Follow-up|6|||
41934728|NCT02476578|75638851|FG001|Overall Study|Lost to Follow-up|13|||
41934729|NCT02504892|75638869|FG000|Overall Study|Adverse event-pneumonitis|2|||
41934730|NCT02504502|75638875|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
41934731|NCT02504502|75638876|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
41934732|NCT02504502|75638875|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
41934733|NCT02504502|75638876|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
41934734|NCT04184622|75638899|FG000|Overall Study|Adverse Event|7|||
41934735|NCT04184622|75638900|FG001|Overall Study|Adverse Event|7|||
41934736|NCT04184622|75638901|FG002|Overall Study|Adverse Event|11|||
41934737|NCT04184622|75638902|FG003|Overall Study|Adverse Event|8|||
41934738|NCT04184622|75638899|FG000|Overall Study|Death|4|||
41934739|NCT04184622|75638900|FG001|Overall Study|Death|4|||
41934740|NCT04184622|75638901|FG002|Overall Study|Death|2|||
41934741|NCT04184622|75638902|FG003|Overall Study|Death|1|||
41934742|NCT04184622|75638899|FG000|Overall Study|Lost to Follow-up|41|||
41934743|NCT04184622|75638900|FG001|Overall Study|Lost to Follow-up|19|||
41934744|NCT04184622|75638901|FG002|Overall Study|Lost to Follow-up|20|||
41934745|NCT04184622|75638902|FG003|Overall Study|Lost to Follow-up|15|||
41934746|NCT04184622|75638899|FG000|Overall Study|Missing Weight at Week 72|1|||
41934747|NCT04184622|75638900|FG001|Overall Study|Missing Weight at Week 72|0|||
41934748|NCT04184622|75638901|FG002|Overall Study|Missing Weight at Week 72|1|||
41934749|NCT04184622|75638902|FG003|Overall Study|Missing Weight at Week 72|0|||
41934750|NCT04184622|75638899|FG000|Overall Study|Other - as reported by the investigator|22|||
41934751|NCT04184622|75638900|FG001|Overall Study|Other - as reported by the investigator|7|||
41934752|NCT04184622|75638901|FG002|Overall Study|Other - as reported by the investigator|5|||
41934753|NCT04184622|75638902|FG003|Overall Study|Other - as reported by the investigator|12|||
41934754|NCT04184622|75638899|FG000|Overall Study|Physician Decision|0|||
41934755|NCT04184622|75638900|FG001|Overall Study|Physician Decision|0|||
41934756|NCT04184622|75638901|FG002|Overall Study|Physician Decision|3|||
41934757|NCT04184622|75638902|FG003|Overall Study|Physician Decision|1|||
41934758|NCT04184622|75638899|FG000|Overall Study|Pregnancy|4|||
41934759|NCT04184622|75638900|FG001|Overall Study|Pregnancy|4|||
41934760|NCT04184622|75638901|FG002|Overall Study|Pregnancy|3|||
41934761|NCT04184622|75638902|FG003|Overall Study|Pregnancy|5|||
41934762|NCT04184622|75638899|FG000|Overall Study|Protocol Deviation|1|||
41934763|NCT04184622|75638900|FG001|Overall Study|Protocol Deviation|0|||
41934764|NCT04184622|75638901|FG002|Overall Study|Protocol Deviation|0|||
41934765|NCT04184622|75638902|FG003|Overall Study|Protocol Deviation|0|||
41934766|NCT04184622|75638899|FG000|Overall Study|Withdrawal by Subject|68|||
41934767|NCT04184622|75638900|FG001|Overall Study|Withdrawal by Subject|28|||
41934768|NCT04184622|75638901|FG002|Overall Study|Withdrawal by Subject|29|||
41934769|NCT04184622|75638902|FG003|Overall Study|Withdrawal by Subject|22|||
42022146|NCT00963820|75829428|FG011|Expansion Phase|Withdrawal by Subject|1|||
42022147|NCT00963820|75829417|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
42022148|NCT00963820|75829418|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
42022149|NCT00963820|75829419|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41934770|NCT03772717|75638935|FG000|Overall Study|Withdrawal by Subject|2|||
41934771|NCT03770403|75638939|FG000|Overall Study|Adverse Event|8|||
42022150|NCT00963820|75829420|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41934772|NCT03770403|75638939|FG000|Overall Study|Death|5|||
41934773|NCT03770403|75638939|FG000|Overall Study|Physician Decision|1|||
41934774|NCT03770403|75638939|FG000|Overall Study|Sponsor decision|1|||
41934775|NCT03770403|75638939|FG000|Overall Study|Study terminated by Sponsor|1|||
41934776|NCT03770403|75638939|FG000|Overall Study|Withdrawal by Subject|13|||
41934777|NCT03770403|75638939|FG000|Overall Study|Other|88|||
41934778|NCT03740100|75638943|FG000|Overall Study|Adverse Event|1|||
41934779|NCT03740100|75638943|FG000|Overall Study|Death|1|||
41934780|NCT03499795|75638947|FG000|Overall Study|Adverse Event|1|||
41934781|NCT03499795|75638947|FG000|Overall Study|Lost to Follow-up|1|||
41934782|NCT03456700|75638964|FG000|Overall Study|Withdrawal by Subject|1|||
41934783|NCT03401450|75638970|FG000|Overall Study|Lost to Follow-up|4|||
42117950|NCT00553358|75928798|FG002|Overall Study|Lost to Follow-up|18|||
41934784|NCT03401450|75638971|FG001|Overall Study|Lost to Follow-up|6|||
41934785|NCT03401450|75638970|FG000|Overall Study|Anesthesia plan changed|2|||
41934786|NCT03401450|75638971|FG001|Overall Study|Anesthesia plan changed|2|||
41934787|NCT03401450|75638970|FG000|Overall Study|Did not complete medication diary|4|||
41934788|NCT03401450|75638971|FG001|Overall Study|Did not complete medication diary|2|||
41934789|NCT03401450|75638970|FG000|Overall Study|post surgery medication change|2|||
42022151|NCT00963820|75829421|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
42117951|NCT00553358|75928796|FG000|Overall Study|Withdrew completely|23|||
41934790|NCT03401450|75638971|FG001|Overall Study|post surgery medication change|1|||
41934791|NCT03401450|75638970|FG000|Overall Study|Cancelled surgery|0|||
41934792|NCT03401450|75638971|FG001|Overall Study|Cancelled surgery|2|||
41934793|NCT03326063|75638979|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
41934794|NCT03326063|75638980|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
41934795|NCT03155997|75639001|FG000|Overall Study|Withdrawal by Subject|119|||
41934796|NCT03155997|75639002|FG001|Overall Study|Withdrawal by Subject|134|||
41934797|NCT03155997|75639001|FG000|Overall Study|Lost to Follow-up|12|||
41934798|NCT03155997|75639002|FG001|Overall Study|Lost to Follow-up|13|||
41934799|NCT03155997|75639001|FG000|Overall Study|Missing disposition data|0|||
41934800|NCT03155997|75639002|FG001|Overall Study|Missing disposition data|1|||
41934801|NCT03155997|75639001|FG000|Overall Study|On study treatment|2027|||
41934802|NCT03155997|75639002|FG001|Overall Study|On study treatment|2074|||
41934803|NCT02764762|75639008|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
41934804|NCT02764762|75639008|FG000|Overall Study|Lost to Follow-up|4|||
41934805|NCT02764762|75639008|FG000|Overall Study|Voluntary Withdrawal|8|||
41934806|NCT02764762|75639008|FG000|Overall Study|Site Termination|1|||
41934807|NCT02764762|75639008|FG000|Overall Study|Lack of Efficacy|16|||
41934808|NCT02764762|75639008|FG000|Overall Study|Reason not Specified|1|||
41934809|NCT02340962|75639018|FG000|Overall Study|Lost to Follow-up|1|||
41934810|NCT02340962|75639019|FG001|Overall Study|Lost to Follow-up|0|||
41934811|NCT02272634|75639039|FG000|Overall Study|Adverse Event|1|||
41934812|NCT02272634|75639040|FG001|Overall Study|Adverse Event|0|||
41934813|NCT02272634|75639041|FG002|Overall Study|Adverse Event|0|||
41934814|NCT02272634|75639039|FG000|Overall Study|Protocol Violation|0|||
41934815|NCT02272634|75639040|FG001|Overall Study|Protocol Violation|0|||
41934816|NCT02272634|75639041|FG002|Overall Study|Protocol Violation|1|||
41934817|NCT02272634|75639039|FG000|Overall Study|Withdrawal by Subject|0|||
41934818|NCT02272634|75639040|FG001|Overall Study|Withdrawal by Subject|1|||
41934819|NCT02272634|75639041|FG002|Overall Study|Withdrawal by Subject|0|||
41934820|NCT00788125|75639052|FG000|Overall Study|Death|6|||
41934821|NCT02504424|75639065|FG000|Overall Study|Withdrawal by Subject|2|||
41934822|NCT02548832|75639395|FG000|Overall Study|Lost to Follow-up|2|||
41934823|NCT02548832|75639396|FG001|Overall Study|Lost to Follow-up|2|||
41934824|NCT02548832|75639397|FG002|Overall Study|Lost to Follow-up|2|||
41934825|NCT03215264|75639586|FG000|Dose Level 2|Adverse Event|0|||
41934826|NCT03215264|75639587|FG001|Dose Level 2|Adverse Event|1|||
41934827|NCT03215264|75639588|FG002|Dose Level 2|Adverse Event|0|||
41934828|NCT03215264|75639586|FG000|Dose Level 3|Withdrawal by Subject|0|||
41934829|NCT03215264|75639587|FG001|Dose Level 3|Withdrawal by Subject|0|||
41934830|NCT03215264|75639588|FG002|Dose Level 3|Withdrawal by Subject|1|||
41934831|NCT02504268|75639659|FG000|Overall Study|Adverse Event|18|||
41934832|NCT02504268|75639660|FG001|Overall Study|Adverse Event|8|||
41934833|NCT02504268|75639661|FG002|Overall Study|Adverse Event|14|||
41934834|NCT02504268|75639662|FG003|Overall Study|Adverse Event|0|||
41934835|NCT02504268|75639663|FG004|Overall Study|Adverse Event|0|||
41934836|NCT02504268|75639664|FG005|Overall Study|Adverse Event|0|||
41934837|NCT02504268|75639665|FG006|Overall Study|Adverse Event|0|||
41934838|NCT02504268|75639666|FG007|Overall Study|Adverse Event|0|||
41934839|NCT02504268|75639667|FG008|Overall Study|Adverse Event|0|||
41934840|NCT02504268|75639659|FG000|Overall Study|Withdrawal of Consent|11|||
41934841|NCT02504268|75639660|FG001|Overall Study|Withdrawal of Consent|10|||
41934842|NCT02504268|75639661|FG002|Overall Study|Withdrawal of Consent|3|||
41934843|NCT02504268|75639662|FG003|Overall Study|Withdrawal of Consent|0|||
41934844|NCT02504268|75639663|FG004|Overall Study|Withdrawal of Consent|0|||
41934845|NCT02504268|75639664|FG005|Overall Study|Withdrawal of Consent|0|||
41934846|NCT02504268|75639665|FG006|Overall Study|Withdrawal of Consent|0|||
41934847|NCT02504268|75639666|FG007|Overall Study|Withdrawal of Consent|0|||
42022152|NCT00963820|75829422|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
42022153|NCT00963820|75829423|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
42117952|NCT00553358|75928797|FG001|Overall Study|Withdrew completely|33|||
41934848|NCT02504268|75639667|FG008|Overall Study|Withdrawal of Consent|0|||
41934849|NCT02504268|75639659|FG000|Overall Study|Pregnancy|2|||
41934850|NCT02504268|75639660|FG001|Overall Study|Pregnancy|0|||
41934851|NCT02504268|75639661|FG002|Overall Study|Pregnancy|0|||
41934852|NCT02504268|75639662|FG003|Overall Study|Pregnancy|0|||
41934853|NCT02504268|75639663|FG004|Overall Study|Pregnancy|0|||
41934854|NCT02504268|75639664|FG005|Overall Study|Pregnancy|0|||
41934855|NCT02504268|75639665|FG006|Overall Study|Pregnancy|0|||
41934856|NCT02504268|75639666|FG007|Overall Study|Pregnancy|0|||
41934857|NCT02504268|75639667|FG008|Overall Study|Pregnancy|0|||
41934858|NCT02504268|75639659|FG000|Overall Study|Lost to Follow-up|3|||
41934859|NCT02504268|75639660|FG001|Overall Study|Lost to Follow-up|6|||
41934860|NCT02504268|75639661|FG002|Overall Study|Lost to Follow-up|4|||
41934861|NCT02504268|75639662|FG003|Overall Study|Lost to Follow-up|0|||
41934862|NCT02504268|75639663|FG004|Overall Study|Lost to Follow-up|0|||
41934863|NCT02504268|75639664|FG005|Overall Study|Lost to Follow-up|0|||
41934864|NCT02504268|75639665|FG006|Overall Study|Lost to Follow-up|0|||
41934865|NCT02504268|75639666|FG007|Overall Study|Lost to Follow-up|0|||
41934866|NCT02504268|75639667|FG008|Overall Study|Lost to Follow-up|0|||
41934867|NCT02504268|75639659|FG000|Overall Study|Death|1|||
41934868|NCT02504268|75639660|FG001|Overall Study|Death|1|||
41934869|NCT02504268|75639661|FG002|Overall Study|Death|0|||
42022154|NCT00963820|75829424|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
42022155|NCT00963820|75829425|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
42022156|NCT00963820|75829426|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
42022157|NCT00963820|75829427|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
42022158|NCT00963820|75829428|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
42022159|NCT01227395|75829447|FG000|Overall Study|Protocol Violation|0|||
42022160|NCT01227395|75829448|FG001|Overall Study|Protocol Violation|1|||
42022161|NCT01226459|75829475|FG000|Overall Study|Adverse Event|2|||
42022162|NCT01226459|75829476|FG001|Overall Study|Adverse Event|8|||
42022163|NCT01226459|75829475|FG000|Overall Study|Protocol Violation|4|||
42022164|NCT01226459|75829476|FG001|Overall Study|Protocol Violation|3|||
42022165|NCT01226459|75829475|FG000|Overall Study|Withdrawal by Subject|10|||
42022166|NCT01226459|75829476|FG001|Overall Study|Withdrawal by Subject|13|||
42022167|NCT01226459|75829475|FG000|Overall Study|Lost to Follow-up|4|||
42022168|NCT01226459|75829476|FG001|Overall Study|Lost to Follow-up|8|||
42022169|NCT01226459|75829475|FG000|Overall Study|Pregnancy|1|||
42022170|NCT01226459|75829476|FG001|Overall Study|Pregnancy|0|||
42022171|NCT01225991|75829482|FG000|Overall Study|Withdrawal by Subject|6|||
42022172|NCT00959374|75829486|FG000|Overall Study|Withdrawal by Subject|2|||
42022173|NCT00959374|75829486|FG000|Overall Study|Lost to Follow-up|14|||
42022174|NCT00959374|75829486|FG000|Overall Study|Death|1|||
42022175|NCT00959374|75829486|FG000|Overall Study|Protocol Violation|1|||
42022176|NCT00959374|75829486|FG000|Overall Study|Implant Removed/Not Replaced|4|||
41934870|NCT02504268|75639662|FG003|Overall Study|Death|0|||
41934871|NCT02504268|75639663|FG004|Overall Study|Death|0|||
41934872|NCT02504268|75639664|FG005|Overall Study|Death|0|||
41934873|NCT02504268|75639665|FG006|Overall Study|Death|0|||
41934874|NCT02504268|75639666|FG007|Overall Study|Death|0|||
41934875|NCT02504268|75639667|FG008|Overall Study|Death|0|||
41934876|NCT02504268|75639659|FG000|Overall Study|Subject Request to Discontinue|11|||
41934877|NCT02504268|75639660|FG001|Overall Study|Subject Request to Discontinue|3|||
41934878|NCT02504268|75639661|FG002|Overall Study|Subject Request to Discontinue|6|||
41934879|NCT02504268|75639662|FG003|Overall Study|Subject Request to Discontinue|0|||
41934880|NCT02504268|75639663|FG004|Overall Study|Subject Request to Discontinue|0|||
41934881|NCT02504268|75639664|FG005|Overall Study|Subject Request to Discontinue|0|||
41934882|NCT02504268|75639665|FG006|Overall Study|Subject Request to Discontinue|0|||
41934883|NCT02504268|75639666|FG007|Overall Study|Subject Request to Discontinue|0|||
41934884|NCT02504268|75639667|FG008|Overall Study|Subject Request to Discontinue|0|||
41934885|NCT02504268|75639659|FG000|Overall Study|No Longer Meets Study Criteria|2|||
41934886|NCT02504268|75639660|FG001|Overall Study|No Longer Meets Study Criteria|3|||
41934887|NCT02504268|75639661|FG002|Overall Study|No Longer Meets Study Criteria|0|||
41934888|NCT02504268|75639662|FG003|Overall Study|No Longer Meets Study Criteria|0|||
41934889|NCT02504268|75639663|FG004|Overall Study|No Longer Meets Study Criteria|0|||
41934890|NCT02504268|75639664|FG005|Overall Study|No Longer Meets Study Criteria|0|||
41934891|NCT02504268|75639665|FG006|Overall Study|No Longer Meets Study Criteria|0|||
41934892|NCT02504268|75639666|FG007|Overall Study|No Longer Meets Study Criteria|0|||
41934893|NCT02504268|75639667|FG008|Overall Study|No Longer Meets Study Criteria|0|||
41934894|NCT02504268|75639659|FG000|Overall Study|Lack of Efficacy|11|||
41934895|NCT02504268|75639660|FG001|Overall Study|Lack of Efficacy|35|||
41934896|NCT02504268|75639661|FG002|Overall Study|Lack of Efficacy|9|||
41934897|NCT02504268|75639662|FG003|Overall Study|Lack of Efficacy|0|||
41934898|NCT02504268|75639663|FG004|Overall Study|Lack of Efficacy|0|||
41934899|NCT02504268|75639664|FG005|Overall Study|Lack of Efficacy|0|||
41934900|NCT02504268|75639665|FG006|Overall Study|Lack of Efficacy|0|||
41934901|NCT02504268|75639666|FG007|Overall Study|Lack of Efficacy|0|||
41934902|NCT02504268|75639667|FG008|Overall Study|Lack of Efficacy|0|||
41934903|NCT02504268|75639659|FG000|Overall Study|Poor/Non-Compliance|3|||
41934904|NCT02504268|75639660|FG001|Overall Study|Poor/Non-Compliance|2|||
41934905|NCT02504268|75639661|FG002|Overall Study|Poor/Non-Compliance|3|||
41934906|NCT02504268|75639662|FG003|Overall Study|Poor/Non-Compliance|0|||
41934907|NCT02504268|75639663|FG004|Overall Study|Poor/Non-Compliance|0|||
41934908|NCT02504268|75639664|FG005|Overall Study|Poor/Non-Compliance|0|||
41934909|NCT02504268|75639665|FG006|Overall Study|Poor/Non-Compliance|0|||
41934910|NCT02504268|75639666|FG007|Overall Study|Poor/Non-Compliance|0|||
41934911|NCT02504268|75639667|FG008|Overall Study|Poor/Non-Compliance|0|||
41934912|NCT02504268|75639659|FG000|Overall Study|Not Disclosed|1|||
41934913|NCT02504268|75639660|FG001|Overall Study|Not Disclosed|0|||
41934914|NCT02504268|75639661|FG002|Overall Study|Not Disclosed|2|||
41934915|NCT02504268|75639662|FG003|Overall Study|Not Disclosed|0|||
41934916|NCT02504268|75639663|FG004|Overall Study|Not Disclosed|0|||
41934917|NCT02504268|75639664|FG005|Overall Study|Not Disclosed|0|||
42022177|NCT00959374|75829486|FG000|Overall Study|Physician Decision|1|||
42022178|NCT01225835|75829496|FG000|Overall Study|Completed protocol|2|||
42022179|NCT01225835|75829497|FG001|Overall Study|Completed protocol|1|||
42022180|NCT01225835|75829496|FG000|Overall Study|Did not meet hCG criterion|2|||
42022181|NCT01225835|75829497|FG001|Overall Study|Did not meet hCG criterion|0|||
42022182|NCT01225835|75829496|FG000|Overall Study|Adverse Event|2|||
41934918|NCT02504268|75639665|FG006|Overall Study|Not Disclosed|0|||
41934919|NCT02504268|75639666|FG007|Overall Study|Not Disclosed|0|||
41934920|NCT02504268|75639667|FG008|Overall Study|Not Disclosed|0|||
41934921|NCT01654302|75639711|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
41934922|NCT01654302|75639712|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
41934923|NCT02476422|75639728|FG000|Overall Study|Subject/guardian decision|0|||
41934924|NCT02476422|75639729|FG001|Overall Study|Subject/guardian decision|1|||
41934925|NCT02475564|75639759|FG000|Overall Study|Withdrawal by Subject|1|||
41934926|NCT02475564|75639760|FG001|Overall Study|Withdrawal by Subject|0|||
41934927|NCT02475564|75639759|FG000|Overall Study|Lost to Follow-up|2|||
41934928|NCT02475564|75639760|FG001|Overall Study|Lost to Follow-up|1|||
41934929|NCT02475564|75639759|FG000|Overall Study|Intense Menstrual bleeding|1|||
41934930|NCT02475564|75639760|FG001|Overall Study|Intense Menstrual bleeding|0|||
41934931|NCT02503332|75640048|FG000|Overall Study|Adverse Event|17|||
41934932|NCT02503332|75640049|FG001|Overall Study|Adverse Event|5|||
41934933|NCT02503332|75640050|FG002|Overall Study|Adverse Event|3|||
41934934|NCT02503332|75640051|FG003|Overall Study|Adverse Event|1|||
41934935|NCT02503332|75640048|FG000|Overall Study|Investigator's Decision|5|||
41934936|NCT02503332|75640049|FG001|Overall Study|Investigator's Decision|1|||
41934937|NCT02503332|75640050|FG002|Overall Study|Investigator's Decision|0|||
41934938|NCT02503332|75640051|FG003|Overall Study|Investigator's Decision|0|||
41934939|NCT02503332|75640048|FG000|Overall Study|Sponsor's Decision|1|||
41934940|NCT02503332|75640049|FG001|Overall Study|Sponsor's Decision|0|||
41934941|NCT02503332|75640050|FG002|Overall Study|Sponsor's Decision|0|||
41934942|NCT02503332|75640051|FG003|Overall Study|Sponsor's Decision|1|||
41934943|NCT02503332|75640048|FG000|Overall Study|Subject Request|6|||
41934944|NCT02503332|75640049|FG001|Overall Study|Subject Request|5|||
41934945|NCT02503332|75640050|FG002|Overall Study|Subject Request|2|||
41934946|NCT02503332|75640051|FG003|Overall Study|Subject Request|1|||
41934947|NCT02503332|75640048|FG000|Overall Study|Death|0|||
41934948|NCT02503332|75640049|FG001|Overall Study|Death|2|||
41934949|NCT02503332|75640050|FG002|Overall Study|Death|2|||
41934950|NCT02503332|75640051|FG003|Overall Study|Death|0|||
41934951|NCT02503332|75640048|FG000|Overall Study|Other|5|||
41934952|NCT02503332|75640049|FG001|Overall Study|Other|6|||
41934953|NCT02503332|75640050|FG002|Overall Study|Other|1|||
41934954|NCT02503332|75640051|FG003|Overall Study|Other|1|||
41934955|NCT02502864|75640069|FG000|Overall Study|Withdrawal by Subject|1|||
41934956|NCT02474082|75640103|FG000|Overall Study|Adverse Event|2|||
41934957|NCT02474082|75640104|FG001|Overall Study|Adverse Event|32|||
41934958|NCT02474082|75640103|FG000|Overall Study|Withdrawal of informed consent|1|||
41934959|NCT02474082|75640104|FG001|Overall Study|Withdrawal of informed consent|11|||
41934960|NCT02474082|75640103|FG000|Overall Study|Lost to Follow-up|2|||
41934961|NCT02474082|75640104|FG001|Overall Study|Lost to Follow-up|2|||
41934962|NCT02474082|75640103|FG000|Overall Study|Dose tapering not achieved|0|||
41934963|NCT02474082|75640104|FG001|Overall Study|Dose tapering not achieved|4|||
41934964|NCT02474082|75640103|FG000|Overall Study|Participant/guardian decision|1|||
41934965|NCT02474082|75640104|FG001|Overall Study|Participant/guardian decision|2|||
41934966|NCT02474082|75640103|FG000|Overall Study|Non-compliance with study treatment|0|||
41934967|NCT02474082|75640104|FG001|Overall Study|Non-compliance with study treatment|2|||
41934968|NCT02474082|75640103|FG000|Overall Study|Protocol deviation|0|||
41934969|NCT02474082|75640104|FG001|Overall Study|Protocol deviation|1|||
41934970|NCT02501928|75640214|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
41934971|NCT02501928|75640215|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
41934972|NCT02501928|75640216|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
41934973|NCT02501928|75640217|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
41934974|NCT02501928|75640218|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
41934975|NCT02501928|75640219|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
41934976|NCT02473614|75640283|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
41934977|NCT02473614|75640284|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
41934978|NCT02500758|75640306|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
41934979|NCT02500758|75640307|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
41934980|NCT02500758|75640306|FG000|Washout (1 Week)|Lost to Follow-up|2|||
41934981|NCT02500758|75640307|FG001|Washout (1 Week)|Lost to Follow-up|2|||
42022183|NCT01225835|75829497|FG001|Overall Study|Adverse Event|1|||
41934982|NCT02500758|75640306|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
41934983|NCT02500758|75640307|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
41934984|NCT02500758|75640306|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
41934985|NCT02500758|75640307|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
42022184|NCT01225835|75829496|FG000|Overall Study|Other|1|||
42022185|NCT01225835|75829497|FG001|Overall Study|Other|1|||
42022186|NCT00962650|75829509|FG000|Overall Study|Transgastric DP was not completed|2|||
41934986|NCT02500758|75640306|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
41934987|NCT02500758|75640307|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
41934988|NCT02500056|75640321|FG000|Overall Study|Lost to Follow-up|3|||
41934989|NCT02500056|75640322|FG001|Overall Study|Lost to Follow-up|7|||
41934990|NCT02500056|75640321|FG000|Overall Study|Recurrence|1|||
41934991|NCT02500056|75640322|FG001|Overall Study|Recurrence|0|||
41934992|NCT02500056|75640321|FG000|Overall Study|Death|3|||
41934993|NCT02500056|75640322|FG001|Overall Study|Death|1|||
41934994|NCT02472756|75640371|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
41934995|NCT02472756|75640371|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
41934996|NCT02472756|75640371|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
41934997|NCT02472756|75640371|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
41934998|NCT02472756|75640371|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
41934999|NCT02498652|75640381|FG000|Overall Study|Protocol Violation|0|||
41935000|NCT02498652|75640382|FG001|Overall Study|Protocol Violation|1|||
41935001|NCT03213158|75640406|FG000|Overall Study|Withdrawal by Subject|1|||
41935002|NCT03213158|75640406|FG000|Overall Study|Physician Decision|2|||
41935003|NCT02498418|75640413|FG000|Overall Study|Lack of Efficacy|0|||
41935004|NCT02498418|75640414|FG001|Overall Study|Lack of Efficacy|0|||
41935005|NCT02498418|75640415|FG002|Overall Study|Lack of Efficacy|1|||
41935006|NCT02498418|75640413|FG000|Overall Study|Withdrawal by Subject|2|||
41935007|NCT02498418|75640414|FG001|Overall Study|Withdrawal by Subject|0|||
41935008|NCT02498418|75640415|FG002|Overall Study|Withdrawal by Subject|3|||
41935009|NCT02498418|75640413|FG000|Overall Study|Lost to Follow-up|0|||
42022187|NCT00958828|75829517|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
42022188|NCT00958828|75829518|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
42022189|NCT00958828|75829517|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
42022190|NCT00958828|75829518|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
42022191|NCT00960934|75829530|FG000|Overall Study|Adverse Event|2|||
42022192|NCT00960934|75829531|FG001|Overall Study|Adverse Event|3|||
42022193|NCT00960934|75829532|FG002|Overall Study|Adverse Event|3|||
41935010|NCT02498418|75640414|FG001|Overall Study|Lost to Follow-up|1|||
41935011|NCT02498418|75640415|FG002|Overall Study|Lost to Follow-up|1|||
41935012|NCT02498418|75640413|FG000|Overall Study|Participant taken prohibited medication|0|||
41935013|NCT02498418|75640414|FG001|Overall Study|Participant taken prohibited medication|1|||
41935014|NCT02498418|75640415|FG002|Overall Study|Participant taken prohibited medication|1|||
41935015|NCT02472366|75640433|FG000|Overall Study|Lost to Follow-up|1|||
41935016|NCT02472366|75640434|FG001|Overall Study|Lost to Follow-up|0|||
41935017|NCT03219164|75640442|FG000|Overall Study|Study Terminated by Sponsor|16|||
41935018|NCT03219164|75640443|FG001|Overall Study|Study Terminated by Sponsor|12|||
41935019|NCT03219164|75640442|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
41935020|NCT03219164|75640443|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
41935021|NCT03219164|75640442|FG000|Overall Study|Lost to Follow-up|1|||
41935022|NCT03219164|75640443|FG001|Overall Study|Lost to Follow-up|1|||
41935023|NCT03219164|75640442|FG000|Overall Study|Adverse Event|1|||
41935024|NCT03219164|75640443|FG001|Overall Study|Adverse Event|0|||
41935025|NCT03219164|75640442|FG000|Overall Study|Non-Compliance with Study Drug|1|||
41935026|NCT03219164|75640443|FG001|Overall Study|Non-Compliance with Study Drug|0|||
41935027|NCT03219164|75640442|FG000|Overall Study|Protocol Violation|0|||
41935028|NCT03219164|75640443|FG001|Overall Study|Protocol Violation|1|||
41935029|NCT03219164|75640442|FG000|Overall Study|Withdrew Assent|1|||
41935030|NCT03219164|75640443|FG001|Overall Study|Withdrew Assent|0|||
41935031|NCT02471586|75640461|FG000|Overall Study|Lost to Follow-up|3|||
41935032|NCT02471586|75640462|FG001|Overall Study|Lost to Follow-up|8|||
41935033|NCT02471586|75640463|FG002|Overall Study|Lost to Follow-up|4|||
41935034|NCT02471586|75640461|FG000|Overall Study|Death|2|||
41935035|NCT02471586|75640462|FG001|Overall Study|Death|2|||
41935036|NCT02471586|75640463|FG002|Overall Study|Death|0|||
41935037|NCT02470806|75640614|FG000|Overall Study|Lost to Follow-up|1|||
41935038|NCT02470806|75640615|FG001|Overall Study|Lost to Follow-up|1|||
41935039|NCT02470806|75640614|FG000|Overall Study|Adverse Event|5|||
41935040|NCT02470806|75640615|FG001|Overall Study|Adverse Event|2|||
41935041|NCT02470806|75640614|FG000|Overall Study|Protocol Violation|4|||
41935042|NCT02470806|75640615|FG001|Overall Study|Protocol Violation|11|||
41935043|NCT02470806|75640614|FG000|Overall Study|Physician Decision|0|||
41935044|NCT02470806|75640615|FG001|Overall Study|Physician Decision|3|||
41935045|NCT02470806|75640614|FG000|Overall Study|Withdrawal by Subject|3|||
41935046|NCT02470806|75640615|FG001|Overall Study|Withdrawal by Subject|10|||
42022194|NCT00960934|75829533|FG003|Overall Study|Adverse Event|2|||
42022195|NCT00960934|75829534|FG004|Overall Study|Adverse Event|4|||
41935047|NCT02470806|75640614|FG000|Overall Study|Lack of Efficacy|5|||
42022196|NCT00960934|75829535|FG005|Overall Study|Adverse Event|3|||
42022197|NCT00960934|75829530|FG000|Overall Study|Lack of Efficacy|1|||
41935048|NCT02470806|75640615|FG001|Overall Study|Lack of Efficacy|15|||
41935049|NCT01363908|75640657|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
41935050|NCT01363908|75640658|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
41935051|NCT01363908|75640657|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
41935052|NCT01363908|75640658|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
41935053|NCT01363908|75640657|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
41935054|NCT01363908|75640658|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
41935055|NCT01363908|75640657|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
42022198|NCT00960934|75829531|FG001|Overall Study|Lack of Efficacy|0|||
42022199|NCT00960934|75829532|FG002|Overall Study|Lack of Efficacy|0|||
42022200|NCT00960934|75829533|FG003|Overall Study|Lack of Efficacy|0|||
41935056|NCT01363908|75640658|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
41935057|NCT02497404|75640696|FG000|Overall Study|Adverse Event|1|||
41935058|NCT02496702|75640729|FG000|Overall Study|Lost to Follow-up|8|||
41935059|NCT02496702|75640730|FG001|Overall Study|Lost to Follow-up|6|||
41935060|NCT02496702|75640729|FG000|Overall Study|Only partially tested|0|||
41935061|NCT02496702|75640730|FG001|Overall Study|Only partially tested|2|||
41935062|NCT02469246|75640806|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
41935063|NCT02469246|75640807|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
41935064|NCT02469246|75640806|FG000|Double-Blind Phase|Adverse Event|12|||
41935065|NCT02469246|75640807|FG001|Double-Blind Phase|Adverse Event|9|||
41935066|NCT02469246|75640806|FG000|Double-Blind Phase|Death|2|||
41935067|NCT02469246|75640807|FG001|Double-Blind Phase|Death|0|||
41935068|NCT02469246|75640806|FG000|Double-Blind Phase|Lack of Efficacy|2|||
41935069|NCT02469246|75640807|FG001|Double-Blind Phase|Lack of Efficacy|1|||
41935070|NCT02469246|75640806|FG000|Double-Blind Phase|Investigator's Discretion|8|||
41935071|NCT02469246|75640807|FG001|Double-Blind Phase|Investigator's Discretion|8|||
41935072|NCT02469246|75640806|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
41935073|NCT02469246|75640807|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
41935074|NCT02469246|75640806|FG000|Double-Blind Phase|Protocol Violation|1|||
41935075|NCT02469246|75640807|FG001|Double-Blind Phase|Protocol Violation|1|||
41935076|NCT02469246|75640806|FG000|Double-Blind Phase|Withdrew Consent|25|||
41935077|NCT02469246|75640807|FG001|Double-Blind Phase|Withdrew Consent|25|||
41935078|NCT02469246|75640806|FG000|Double-Blind Phase|Lost to Follow-up|9|||
41935079|NCT02469246|75640807|FG001|Double-Blind Phase|Lost to Follow-up|5|||
41935080|NCT02469168|75640826|FG000|Overall Study|Trial closed|1|||
41935081|NCT02469168|75640827|FG001|Overall Study|Trial closed|0|||
41935082|NCT02469090|75640835|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
41935083|NCT02469090|75640836|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
41935084|NCT02469090|75640837|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
41935085|NCT02469090|75640835|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
41935086|NCT02469090|75640836|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
41935087|NCT02469090|75640837|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
41935088|NCT02469090|75640835|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
41935089|NCT02469090|75640836|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
41935090|NCT02469090|75640837|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
41935091|NCT02469090|75640835|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
41935092|NCT02469090|75640836|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
41935093|NCT02469090|75640837|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
41935094|NCT02469090|75640835|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
41935095|NCT02469090|75640836|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
41935096|NCT02469090|75640837|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
41935097|NCT02469090|75640835|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
41935098|NCT02469090|75640836|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
41935099|NCT02469090|75640837|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
41935100|NCT02469090|75640835|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
41935101|NCT02469090|75640836|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
41935102|NCT02469090|75640837|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
41935103|NCT02469090|75640835|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
41935104|NCT02469090|75640836|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
41935105|NCT02469090|75640837|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
41935106|NCT02496000|75640847|FG000|Overall Study|Withdrawal by Subject|1|||
41935107|NCT02496000|75640848|FG001|Overall Study|Withdrawal by Subject|2|||
41935108|NCT02496000|75640849|FG002|Overall Study|Withdrawal by Subject|0|||
41935109|NCT02496000|75640847|FG000|Overall Study|Lost to Follow-up|1|||
42300163|NCT02327169|76135333|FG011|Overall Study|Symptomatic Deterioration|0|||
41935110|NCT02496000|75640848|FG001|Overall Study|Lost to Follow-up|0|||
41935111|NCT02496000|75640849|FG002|Overall Study|Lost to Follow-up|1|||
41935112|NCT02496000|75640847|FG000|Overall Study|Protocol Violation|0|||
41935113|NCT02496000|75640848|FG001|Overall Study|Protocol Violation|0|||
41935114|NCT02496000|75640849|FG002|Overall Study|Protocol Violation|1|||
41935115|NCT02496000|75640847|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
41935116|NCT02496000|75640848|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
41935117|NCT02496000|75640849|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
41935118|NCT02496000|75640847|FG000|Overall Study|undetermined|0|||
41935119|NCT02496000|75640848|FG001|Overall Study|undetermined|1|||
41935120|NCT02496000|75640849|FG002|Overall Study|undetermined|0|||
41935121|NCT02468934|75640858|FG000|Overall Study|Withdrawal by Subject|4|||
41935122|NCT02468934|75640858|FG000|Overall Study|Screen Failure|3|||
41935123|NCT02517528|75640864|FG000|Overall Study|Withdrawal by Subject|1|||
41935124|NCT02495844|75640870|FG000|Overall Study|Lack of Efficacy|1|||
41935125|NCT02495844|75640871|FG001|Overall Study|Lack of Efficacy|2|||
41935126|NCT02495844|75640870|FG000|Overall Study|AE, non-fatal|0|||
41935127|NCT02495844|75640871|FG001|Overall Study|AE, non-fatal|1|||
41935128|NCT02495844|75640870|FG000|Overall Study|Hepatitis Positivity|0|||
41935129|NCT02495844|75640871|FG001|Overall Study|Hepatitis Positivity|1|||
41935130|NCT02468778|75640882|FG000|Overall Study|Death|2|||
41935131|NCT02468778|75640883|FG001|Overall Study|Death|1|||
41935132|NCT02468778|75640884|FG002|Overall Study|Death|0|||
41935133|NCT02468778|75640882|FG000|Overall Study|Lost to Follow-up|1|||
41935134|NCT02468778|75640883|FG001|Overall Study|Lost to Follow-up|2|||
41935135|NCT02468778|75640884|FG002|Overall Study|Lost to Follow-up|2|||
41935136|NCT02468778|75640882|FG000|Overall Study|Withdrawal by Subject|0|||
41935137|NCT02468778|75640883|FG001|Overall Study|Withdrawal by Subject|1|||
41935138|NCT02468778|75640884|FG002|Overall Study|Withdrawal by Subject|1|||
41935139|NCT01727336|75640898|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
42022201|NCT00960934|75829534|FG004|Overall Study|Lack of Efficacy|0|||
42022202|NCT00960934|75829535|FG005|Overall Study|Lack of Efficacy|0|||
42022203|NCT00960934|75829530|FG000|Overall Study|Lost to Follow-up|0|||
41935140|NCT01727336|75640899|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
41935141|NCT01727336|75640900|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
41935142|NCT01727336|75640901|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
41935143|NCT01727336|75640902|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
41935144|NCT01727336|75640903|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
41935145|NCT01727336|75640898|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
41935146|NCT01727336|75640899|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
41935147|NCT01727336|75640900|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
41935148|NCT01727336|75640901|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
41935149|NCT01727336|75640902|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
41935150|NCT01727336|75640903|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
41935151|NCT01727336|75640898|FG000|Part 2 Blinded|Death|0|||
41935152|NCT01727336|75640899|FG001|Part 2 Blinded|Death|0|||
41935153|NCT01727336|75640900|FG002|Part 2 Blinded|Death|0|||
41935154|NCT01727336|75640901|FG003|Part 2 Blinded|Death|0|||
41935155|NCT01727336|75640902|FG004|Part 2 Blinded|Death|20|||
41935156|NCT01727336|75640903|FG005|Part 2 Blinded|Death|16|||
41935157|NCT01727336|75640898|FG000|Part 2 Blinded|Lack of Efficacy|0|||
41935158|NCT01727336|75640899|FG001|Part 2 Blinded|Lack of Efficacy|0|||
41935159|NCT01727336|75640900|FG002|Part 2 Blinded|Lack of Efficacy|0|||
41935160|NCT01727336|75640901|FG003|Part 2 Blinded|Lack of Efficacy|0|||
42022204|NCT00960934|75829531|FG001|Overall Study|Lost to Follow-up|1|||
42022205|NCT00960934|75829532|FG002|Overall Study|Lost to Follow-up|0|||
42022206|NCT00960934|75829533|FG003|Overall Study|Lost to Follow-up|0|||
42022207|NCT00960934|75829534|FG004|Overall Study|Lost to Follow-up|0|||
41935161|NCT01727336|75640902|FG004|Part 2 Blinded|Lack of Efficacy|42|||
41935162|NCT01727336|75640903|FG005|Part 2 Blinded|Lack of Efficacy|44|||
41935163|NCT01727336|75640898|FG000|Part 2 Blinded|Lost to Follow-up|0|||
41935164|NCT01727336|75640899|FG001|Part 2 Blinded|Lost to Follow-up|0|||
41935165|NCT01727336|75640900|FG002|Part 2 Blinded|Lost to Follow-up|0|||
41935166|NCT01727336|75640901|FG003|Part 2 Blinded|Lost to Follow-up|0|||
41935167|NCT01727336|75640902|FG004|Part 2 Blinded|Lost to Follow-up|0|||
41935168|NCT01727336|75640903|FG005|Part 2 Blinded|Lost to Follow-up|1|||
41935169|NCT01727336|75640898|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
41935170|NCT01727336|75640899|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
41935171|NCT01727336|75640900|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
41935172|NCT01727336|75640901|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
41935173|NCT01727336|75640902|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
42022208|NCT00960934|75829535|FG005|Overall Study|Lost to Follow-up|0|||
42022209|NCT00960934|75829530|FG000|Overall Study|Other|2|||
42022210|NCT00960934|75829531|FG001|Overall Study|Other|1|||
42022211|NCT00960934|75829532|FG002|Overall Study|Other|5|||
42022212|NCT00960934|75829533|FG003|Overall Study|Other|4|||
42022213|NCT00960934|75829534|FG004|Overall Study|Other|2|||
42117953|NCT00553358|75928798|FG002|Overall Study|Withdrew completely|34|||
42117954|NCT00553358|75928796|FG000|Overall Study|Died during clinical follow-up|25|||
41935174|NCT01727336|75640903|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
41935175|NCT01727336|75640898|FG000|Part 2 Blinded|use of prohibited medications|0|||
42022214|NCT00960934|75829535|FG005|Overall Study|Other|2|||
41935176|NCT01727336|75640899|FG001|Part 2 Blinded|use of prohibited medications|0|||
42022215|NCT00960934|75829530|FG000|Overall Study|Physician Decision|0|||
41935177|NCT01727336|75640900|FG002|Part 2 Blinded|use of prohibited medications|0|||
41935178|NCT01727336|75640901|FG003|Part 2 Blinded|use of prohibited medications|0|||
41935179|NCT01727336|75640902|FG004|Part 2 Blinded|use of prohibited medications|1|||
41935180|NCT01727336|75640903|FG005|Part 2 Blinded|use of prohibited medications|3|||
41935181|NCT02466516|75640937|FG000|Overall Study|Adverse Event|1|||
41935182|NCT02466516|75640938|FG001|Overall Study|Adverse Event|1|||
41935183|NCT02466516|75640939|FG002|Overall Study|Adverse Event|0|||
41935184|NCT02466516|75640940|FG003|Overall Study|Adverse Event|0|||
41935185|NCT02466516|75640941|FG004|Overall Study|Adverse Event|0|||
41935186|NCT02466516|75640937|FG000|Overall Study|Withdrew Consent|1|||
41935187|NCT02466516|75640938|FG001|Overall Study|Withdrew Consent|0|||
41935188|NCT02466516|75640939|FG002|Overall Study|Withdrew Consent|0|||
41935189|NCT02466516|75640940|FG003|Overall Study|Withdrew Consent|0|||
41935190|NCT02466516|75640941|FG004|Overall Study|Withdrew Consent|0|||
41935191|NCT02466516|75640937|FG000|Overall Study|Lost to Follow-up|2|||
41935192|NCT02466516|75640938|FG001|Overall Study|Lost to Follow-up|0|||
41935193|NCT02466516|75640939|FG002|Overall Study|Lost to Follow-up|1|||
41935194|NCT02466516|75640940|FG003|Overall Study|Lost to Follow-up|0|||
41935195|NCT02466516|75640941|FG004|Overall Study|Lost to Follow-up|0|||
41935196|NCT01725152|75640955|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
41935197|NCT01725152|75640956|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
41935198|NCT01725152|75640955|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
41935199|NCT01725152|75640956|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
41935200|NCT01725152|75640955|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
41935201|NCT01725152|75640956|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
41935202|NCT01725152|75640955|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
41935203|NCT01725152|75640956|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
41935204|NCT01049984|75640972|FG000|Overall Study|Withdrawal by Subject|1|||
41935205|NCT01049984|75640973|FG001|Overall Study|Withdrawal by Subject|5|||
41935206|NCT01049984|75640972|FG000|Overall Study|Protocol Violation|3|||
41935207|NCT01049984|75640973|FG001|Overall Study|Protocol Violation|4|||
41935208|NCT01049984|75640972|FG000|Overall Study|Lost to Follow-up|2|||
41935209|NCT01049984|75640973|FG001|Overall Study|Lost to Follow-up|1|||
41935210|NCT01049984|75640972|FG000|Overall Study|Adverse Event|13|||
41935211|NCT01049984|75640973|FG001|Overall Study|Adverse Event|7|||
41935212|NCT01049984|75640972|FG000|Overall Study|Treatment failure|0|||
41935213|NCT01049984|75640973|FG001|Overall Study|Treatment failure|2|||
41935214|NCT01049360|75640979|FG000|Period 1|Adverse Event|0|||
41935215|NCT01049360|75640980|FG001|Period 1|Adverse Event|1|||
41935216|NCT01049360|75640981|FG002|Period 1|Adverse Event|0|||
41935217|NCT01049360|75640982|FG003|Period 1|Adverse Event|1|||
41935218|NCT01049360|75640983|FG004|Period 1|Adverse Event|0|||
41935219|NCT01049360|75640984|FG005|Period 1|Adverse Event|0|||
41935220|NCT01049360|75640985|FG006|Period 1|Adverse Event|0|||
41935221|NCT01049360|75640986|FG007|Period 1|Adverse Event|1|||
41935222|NCT01049360|75640987|FG008|Period 1|Adverse Event|0|||
41935223|NCT01049360|75640988|FG009|Period 1|Adverse Event|0|||
41935224|NCT01049360|75640989|FG010|Period 1|Adverse Event|0|||
41935225|NCT01049360|75640990|FG011|Period 1|Adverse Event|0|||
41935226|NCT01049360|75640991|FG012|Period 1|Adverse Event|1|||
41935227|NCT01049360|75640992|FG013|Period 1|Adverse Event|1|||
41935228|NCT01049360|75640993|FG014|Period 1|Adverse Event|0|||
41935229|NCT01049360|75640994|FG015|Period 1|Adverse Event|0|||
41935230|NCT01049360|75640995|FG016|Period 1|Adverse Event|1|||
42210209|NCT00462748|76024942|FG000|Overall Study|Protocol Violation|0|||
42210210|NCT00462748|76024943|FG001|Overall Study|Protocol Violation|2|||
41935231|NCT01049360|75640996|FG017|Period 1|Adverse Event|0|||
41935232|NCT01049360|75640997|FG018|Period 1|Adverse Event|1|||
41935233|NCT01049360|75640998|FG019|Period 1|Adverse Event|0|||
41935234|NCT01049360|75640979|FG000|Period 1|Did not meet inc/exc criteria|0|||
41935235|NCT01049360|75640980|FG001|Period 1|Did not meet inc/exc criteria|0|||
41935236|NCT01049360|75640981|FG002|Period 1|Did not meet inc/exc criteria|0|||
41935237|NCT01049360|75640982|FG003|Period 1|Did not meet inc/exc criteria|0|||
41935238|NCT01049360|75640983|FG004|Period 1|Did not meet inc/exc criteria|0|||
41935239|NCT01049360|75640984|FG005|Period 1|Did not meet inc/exc criteria|0|||
41935240|NCT01049360|75640985|FG006|Period 1|Did not meet inc/exc criteria|0|||
41935241|NCT01049360|75640986|FG007|Period 1|Did not meet inc/exc criteria|1|||
41935242|NCT01049360|75640987|FG008|Period 1|Did not meet inc/exc criteria|1|||
41935243|NCT01049360|75640988|FG009|Period 1|Did not meet inc/exc criteria|0|||
41935244|NCT01049360|75640989|FG010|Period 1|Did not meet inc/exc criteria|0|||
41935245|NCT01049360|75640990|FG011|Period 1|Did not meet inc/exc criteria|0|||
41935246|NCT01049360|75640991|FG012|Period 1|Did not meet inc/exc criteria|0|||
41935247|NCT01049360|75640992|FG013|Period 1|Did not meet inc/exc criteria|0|||
41935248|NCT01049360|75640993|FG014|Period 1|Did not meet inc/exc criteria|0|||
41935249|NCT01049360|75640994|FG015|Period 1|Did not meet inc/exc criteria|0|||
41935250|NCT01049360|75640995|FG016|Period 1|Did not meet inc/exc criteria|0|||
41935251|NCT01049360|75640996|FG017|Period 1|Did not meet inc/exc criteria|0|||
41935252|NCT01049360|75640997|FG018|Period 1|Did not meet inc/exc criteria|0|||
41935253|NCT01049360|75640998|FG019|Period 1|Did not meet inc/exc criteria|0|||
41935254|NCT01049360|75640979|FG000|Period 1|Withdrawal by Subject|0|||
41935255|NCT01049360|75640980|FG001|Period 1|Withdrawal by Subject|0|||
41935256|NCT01049360|75640981|FG002|Period 1|Withdrawal by Subject|0|||
41935257|NCT01049360|75640982|FG003|Period 1|Withdrawal by Subject|0|||
41935258|NCT01049360|75640983|FG004|Period 1|Withdrawal by Subject|0|||
41935259|NCT01049360|75640984|FG005|Period 1|Withdrawal by Subject|0|||
41935260|NCT01049360|75640985|FG006|Period 1|Withdrawal by Subject|0|||
41935261|NCT01049360|75640986|FG007|Period 1|Withdrawal by Subject|0|||
41935262|NCT01049360|75640987|FG008|Period 1|Withdrawal by Subject|1|||
41935263|NCT01049360|75640988|FG009|Period 1|Withdrawal by Subject|0|||
41935264|NCT01049360|75640989|FG010|Period 1|Withdrawal by Subject|1|||
41935265|NCT01049360|75640990|FG011|Period 1|Withdrawal by Subject|0|||
41935266|NCT01049360|75640991|FG012|Period 1|Withdrawal by Subject|1|||
41935267|NCT01049360|75640992|FG013|Period 1|Withdrawal by Subject|0|||
41935268|NCT01049360|75640993|FG014|Period 1|Withdrawal by Subject|0|||
41935269|NCT01049360|75640994|FG015|Period 1|Withdrawal by Subject|0|||
41935270|NCT01049360|75640995|FG016|Period 1|Withdrawal by Subject|0|||
41935271|NCT01049360|75640996|FG017|Period 1|Withdrawal by Subject|0|||
41935272|NCT01049360|75640997|FG018|Period 1|Withdrawal by Subject|0|||
41935273|NCT01049360|75640998|FG019|Period 1|Withdrawal by Subject|0|||
41935274|NCT01049360|75640979|FG000|Period 2|Protocol Violation|0|||
41935275|NCT01049360|75640980|FG001|Period 2|Protocol Violation|0|||
41935276|NCT01049360|75640981|FG002|Period 2|Protocol Violation|0|||
41935277|NCT01049360|75640982|FG003|Period 2|Protocol Violation|1|||
41935278|NCT01049360|75640983|FG004|Period 2|Protocol Violation|0|||
41935279|NCT01049360|75640984|FG005|Period 2|Protocol Violation|0|||
41935280|NCT01049360|75640985|FG006|Period 2|Protocol Violation|0|||
41935281|NCT01049360|75640986|FG007|Period 2|Protocol Violation|0|||
41935282|NCT01049360|75640987|FG008|Period 2|Protocol Violation|0|||
41935283|NCT01049360|75640988|FG009|Period 2|Protocol Violation|0|||
41935284|NCT01049360|75640989|FG010|Period 2|Protocol Violation|0|||
41935285|NCT01049360|75640990|FG011|Period 2|Protocol Violation|0|||
41935286|NCT01049360|75640991|FG012|Period 2|Protocol Violation|0|||
41935287|NCT01049360|75640992|FG013|Period 2|Protocol Violation|0|||
41935288|NCT01049360|75640993|FG014|Period 2|Protocol Violation|1|||
41935289|NCT01049360|75640994|FG015|Period 2|Protocol Violation|1|||
41935290|NCT01049360|75640995|FG016|Period 2|Protocol Violation|0|||
41935291|NCT01049360|75640996|FG017|Period 2|Protocol Violation|0|||
41935292|NCT01049360|75640997|FG018|Period 2|Protocol Violation|0|||
41935293|NCT01049360|75640998|FG019|Period 2|Protocol Violation|0|||
41935294|NCT01049360|75640979|FG000|Period 2|Adverse Event|0|||
41935295|NCT01049360|75640980|FG001|Period 2|Adverse Event|1|||
41935296|NCT01049360|75640981|FG002|Period 2|Adverse Event|0|||
41935297|NCT01049360|75640982|FG003|Period 2|Adverse Event|0|||
42022216|NCT00960934|75829531|FG001|Overall Study|Physician Decision|1|||
42022217|NCT00960934|75829532|FG002|Overall Study|Physician Decision|0|||
41935298|NCT01049360|75640983|FG004|Period 2|Adverse Event|0|||
41935299|NCT01049360|75640984|FG005|Period 2|Adverse Event|0|||
41935300|NCT01049360|75640985|FG006|Period 2|Adverse Event|0|||
41935301|NCT01049360|75640986|FG007|Period 2|Adverse Event|0|||
41935302|NCT01049360|75640987|FG008|Period 2|Adverse Event|1|||
41935303|NCT01049360|75640988|FG009|Period 2|Adverse Event|0|||
41935304|NCT01049360|75640989|FG010|Period 2|Adverse Event|0|||
41935305|NCT01049360|75640990|FG011|Period 2|Adverse Event|0|||
41935306|NCT01049360|75640991|FG012|Period 2|Adverse Event|0|||
42022218|NCT00960934|75829533|FG003|Overall Study|Physician Decision|0|||
41935307|NCT01049360|75640992|FG013|Period 2|Adverse Event|0|||
41935308|NCT01049360|75640993|FG014|Period 2|Adverse Event|0|||
41935309|NCT01049360|75640994|FG015|Period 2|Adverse Event|0|||
41935310|NCT01049360|75640995|FG016|Period 2|Adverse Event|0|||
41935311|NCT01049360|75640996|FG017|Period 2|Adverse Event|0|||
41935312|NCT01049360|75640997|FG018|Period 2|Adverse Event|0|||
41935313|NCT01049360|75640998|FG019|Period 2|Adverse Event|1|||
41935314|NCT01049360|75640979|FG000|Period 2|Withdrawal by Subject|0|||
41935315|NCT01049360|75640980|FG001|Period 2|Withdrawal by Subject|0|||
42022219|NCT00960934|75829534|FG004|Overall Study|Physician Decision|0|||
41935316|NCT01049360|75640981|FG002|Period 2|Withdrawal by Subject|0|||
41935317|NCT01049360|75640982|FG003|Period 2|Withdrawal by Subject|1|||
41935318|NCT01049360|75640983|FG004|Period 2|Withdrawal by Subject|0|||
41935319|NCT01049360|75640984|FG005|Period 2|Withdrawal by Subject|0|||
41935320|NCT01049360|75640985|FG006|Period 2|Withdrawal by Subject|0|||
41935321|NCT01049360|75640986|FG007|Period 2|Withdrawal by Subject|0|||
41935322|NCT01049360|75640987|FG008|Period 2|Withdrawal by Subject|0|||
41935323|NCT01049360|75640988|FG009|Period 2|Withdrawal by Subject|0|||
41935324|NCT01049360|75640989|FG010|Period 2|Withdrawal by Subject|0|||
41935325|NCT01049360|75640990|FG011|Period 2|Withdrawal by Subject|0|||
41935326|NCT01049360|75640991|FG012|Period 2|Withdrawal by Subject|0|||
41935327|NCT01049360|75640992|FG013|Period 2|Withdrawal by Subject|0|||
41935328|NCT01049360|75640993|FG014|Period 2|Withdrawal by Subject|1|||
41935329|NCT01049360|75640994|FG015|Period 2|Withdrawal by Subject|0|||
41935330|NCT01049360|75640995|FG016|Period 2|Withdrawal by Subject|0|||
41935331|NCT01049360|75640996|FG017|Period 2|Withdrawal by Subject|0|||
41935332|NCT01049360|75640997|FG018|Period 2|Withdrawal by Subject|0|||
41935333|NCT01049360|75640998|FG019|Period 2|Withdrawal by Subject|1|||
41935334|NCT01049360|75640979|FG000|Period 2|Lack of Efficacy|0|||
41935335|NCT01049360|75640980|FG001|Period 2|Lack of Efficacy|0|||
41935336|NCT01049360|75640981|FG002|Period 2|Lack of Efficacy|0|||
41935337|NCT01049360|75640982|FG003|Period 2|Lack of Efficacy|0|||
41935338|NCT01049360|75640983|FG004|Period 2|Lack of Efficacy|0|||
41935339|NCT01049360|75640984|FG005|Period 2|Lack of Efficacy|1|||
41935340|NCT01049360|75640985|FG006|Period 2|Lack of Efficacy|0|||
41935341|NCT01049360|75640986|FG007|Period 2|Lack of Efficacy|0|||
41935342|NCT01049360|75640987|FG008|Period 2|Lack of Efficacy|0|||
41935343|NCT01049360|75640988|FG009|Period 2|Lack of Efficacy|0|||
41935344|NCT01049360|75640989|FG010|Period 2|Lack of Efficacy|0|||
41935345|NCT01049360|75640990|FG011|Period 2|Lack of Efficacy|0|||
41935346|NCT01049360|75640991|FG012|Period 2|Lack of Efficacy|0|||
41935347|NCT01049360|75640992|FG013|Period 2|Lack of Efficacy|0|||
41935348|NCT01049360|75640993|FG014|Period 2|Lack of Efficacy|0|||
41935349|NCT01049360|75640994|FG015|Period 2|Lack of Efficacy|0|||
41935350|NCT01049360|75640995|FG016|Period 2|Lack of Efficacy|0|||
41935351|NCT01049360|75640996|FG017|Period 2|Lack of Efficacy|0|||
41935352|NCT01049360|75640997|FG018|Period 2|Lack of Efficacy|0|||
41935353|NCT01049360|75640998|FG019|Period 2|Lack of Efficacy|0|||
41935354|NCT01049360|75640979|FG000|Period 4|Protocol Violation|0|||
41935355|NCT01049360|75640980|FG001|Period 4|Protocol Violation|0|||
41935356|NCT01049360|75640981|FG002|Period 4|Protocol Violation|0|||
41935357|NCT01049360|75640982|FG003|Period 4|Protocol Violation|0|||
41935358|NCT01049360|75640983|FG004|Period 4|Protocol Violation|0|||
41935359|NCT01049360|75640984|FG005|Period 4|Protocol Violation|0|||
41935360|NCT01049360|75640985|FG006|Period 4|Protocol Violation|0|||
41935361|NCT01049360|75640986|FG007|Period 4|Protocol Violation|0|||
41935362|NCT01049360|75640987|FG008|Period 4|Protocol Violation|0|||
41935363|NCT01049360|75640988|FG009|Period 4|Protocol Violation|0|||
41935364|NCT01049360|75640989|FG010|Period 4|Protocol Violation|0|||
41935365|NCT01049360|75640990|FG011|Period 4|Protocol Violation|0|||
41935366|NCT01049360|75640991|FG012|Period 4|Protocol Violation|0|||
41935367|NCT01049360|75640992|FG013|Period 4|Protocol Violation|0|||
41935368|NCT01049360|75640993|FG014|Period 4|Protocol Violation|0|||
41935369|NCT01049360|75640994|FG015|Period 4|Protocol Violation|0|||
41935370|NCT01049360|75640995|FG016|Period 4|Protocol Violation|0|||
41935371|NCT01049360|75640996|FG017|Period 4|Protocol Violation|1|||
41935372|NCT01049360|75640997|FG018|Period 4|Protocol Violation|0|||
41935373|NCT01049360|75640998|FG019|Period 4|Protocol Violation|0|||
41935374|NCT01049360|75640979|FG000|Period 4|Withdrawal by Subject|0|||
41935375|NCT01049360|75640980|FG001|Period 4|Withdrawal by Subject|0|||
41935376|NCT01049360|75640981|FG002|Period 4|Withdrawal by Subject|0|||
41935377|NCT01049360|75640982|FG003|Period 4|Withdrawal by Subject|1|||
41935378|NCT01049360|75640983|FG004|Period 4|Withdrawal by Subject|0|||
41935379|NCT01049360|75640984|FG005|Period 4|Withdrawal by Subject|0|||
41935380|NCT01049360|75640985|FG006|Period 4|Withdrawal by Subject|0|||
41935381|NCT01049360|75640986|FG007|Period 4|Withdrawal by Subject|0|||
42022220|NCT00960934|75829535|FG005|Overall Study|Physician Decision|0|||
42022221|NCT00960934|75829530|FG000|Overall Study|Progressive Disease|1|||
42022222|NCT00960934|75829531|FG001|Overall Study|Progressive Disease|1|||
41935382|NCT01049360|75640987|FG008|Period 4|Withdrawal by Subject|0|||
41935383|NCT01049360|75640988|FG009|Period 4|Withdrawal by Subject|0|||
41935384|NCT01049360|75640989|FG010|Period 4|Withdrawal by Subject|0|||
41935385|NCT01049360|75640990|FG011|Period 4|Withdrawal by Subject|0|||
41935386|NCT01049360|75640991|FG012|Period 4|Withdrawal by Subject|0|||
41935387|NCT01049360|75640992|FG013|Period 4|Withdrawal by Subject|0|||
41935388|NCT01049360|75640993|FG014|Period 4|Withdrawal by Subject|0|||
41935389|NCT01049360|75640994|FG015|Period 4|Withdrawal by Subject|0|||
42022223|NCT00960934|75829532|FG002|Overall Study|Progressive Disease|0|||
41935390|NCT01049360|75640995|FG016|Period 4|Withdrawal by Subject|0|||
41935391|NCT01049360|75640996|FG017|Period 4|Withdrawal by Subject|0|||
41935392|NCT01049360|75640997|FG018|Period 4|Withdrawal by Subject|0|||
41935393|NCT01049360|75640998|FG019|Period 4|Withdrawal by Subject|0|||
41935394|NCT02494596|75641010|FG000|Overall Study|Insufficient Therapeutic Response|3|||
41935395|NCT02494596|75641011|FG001|Overall Study|Insufficient Therapeutic Response|3|||
41935396|NCT02494596|75641012|FG002|Overall Study|Insufficient Therapeutic Response|1|||
41935397|NCT02494596|75641010|FG000|Overall Study|Adverse Event|0|||
41935398|NCT02494596|75641011|FG001|Overall Study|Adverse Event|1|||
41935399|NCT02494596|75641012|FG002|Overall Study|Adverse Event|0|||
41935400|NCT02494596|75641010|FG000|Overall Study|Refused Treatment|0|||
41935401|NCT02494596|75641011|FG001|Overall Study|Refused Treatment|1|||
41935402|NCT02494596|75641012|FG002|Overall Study|Refused Treatment|0|||
41935403|NCT02494206|75641031|FG000|Overall Study|Adverse Event|1|||
41935404|NCT02494206|75641031|FG000|Overall Study|Disease Progression|1|||
41935405|NCT01048502|75641048|FG000|Overall Study|Lost to Follow-up|2|||
41935406|NCT01048502|75641049|FG001|Overall Study|Lost to Follow-up|0|||
41935407|NCT01048502|75641050|FG002|Overall Study|Lost to Follow-up|0|||
41935408|NCT01048502|75641051|FG003|Overall Study|Lost to Follow-up|0|||
41935409|NCT01048502|75641048|FG000|Overall Study|Adverse Event|1|||
41935410|NCT01048502|75641049|FG001|Overall Study|Adverse Event|0|||
41935411|NCT01048502|75641050|FG002|Overall Study|Adverse Event|0|||
41935412|NCT01048502|75641051|FG003|Overall Study|Adverse Event|0|||
41935413|NCT01048502|75641048|FG000|Overall Study|Withdrawal by Subject|1|||
41935414|NCT01048502|75641049|FG001|Overall Study|Withdrawal by Subject|4|||
41935415|NCT01048502|75641050|FG002|Overall Study|Withdrawal by Subject|5|||
41935416|NCT01048502|75641051|FG003|Overall Study|Withdrawal by Subject|3|||
41935417|NCT01048502|75641048|FG000|Overall Study|Physician Decision|0|||
41935418|NCT01048502|75641049|FG001|Overall Study|Physician Decision|3|||
41935419|NCT01048502|75641050|FG002|Overall Study|Physician Decision|0|||
41935420|NCT01048502|75641051|FG003|Overall Study|Physician Decision|1|||
41935421|NCT02465034|75641064|FG000|Overall Study|Withdrawal by Subject|1|||
41935422|NCT02465034|75641065|FG001|Overall Study|Withdrawal by Subject|1|||
41935423|NCT02465034|75641064|FG000|Overall Study|Screen fail|2|||
41935424|NCT02465034|75641065|FG001|Overall Study|Screen fail|0|||
41935425|NCT02465034|75641064|FG000|Overall Study|Could not be scheduled for study visit|0|||
41935426|NCT02465034|75641065|FG001|Overall Study|Could not be scheduled for study visit|5|||
41935427|NCT02516982|75641092|FG000|Overall Study|Called in to antenatal appointment|32|||
41935428|NCT02516982|75641093|FG001|Overall Study|Called in to antenatal appointment|35|||
41935429|NCT02516982|75641094|FG002|Overall Study|Called in to antenatal appointment|0|||
41935430|NCT02516982|75641095|FG003|Overall Study|Called in to antenatal appointment|0|||
41935431|NCT02516982|75641092|FG000|Overall Study|Withdrawal by Subject|0|||
41935432|NCT02516982|75641093|FG001|Overall Study|Withdrawal by Subject|0|||
41935433|NCT02516982|75641094|FG002|Overall Study|Withdrawal by Subject|1|||
41935434|NCT02516982|75641095|FG003|Overall Study|Withdrawal by Subject|2|||
41935435|NCT02516982|75641092|FG000|Overall Study|Protocol Violation|0|||
41935436|NCT02516982|75641093|FG001|Overall Study|Protocol Violation|0|||
41935437|NCT02516982|75641094|FG002|Overall Study|Protocol Violation|1|||
41935438|NCT02516982|75641095|FG003|Overall Study|Protocol Violation|1|||
41935439|NCT02516982|75641092|FG000|Overall Study|Did not install the app|0|||
41935440|NCT02516982|75641093|FG001|Overall Study|Did not install the app|0|||
41935441|NCT02516982|75641094|FG002|Overall Study|Did not install the app|46|||
41935442|NCT02516982|75641095|FG003|Overall Study|Did not install the app|47|||
41935443|NCT02464410|75641140|FG000|Overall Study|Death|3|||
41935444|NCT02464410|75641141|FG001|Overall Study|Death|4|||
41935445|NCT02464410|75641140|FG000|Overall Study|Lost to Follow-up|7|||
41935446|NCT02464410|75641141|FG001|Overall Study|Lost to Follow-up|9|||
41935447|NCT02464410|75641140|FG000|Overall Study|Withdrawal by Subject|12|||
41935448|NCT02464410|75641141|FG001|Overall Study|Withdrawal by Subject|3|||
41935449|NCT01047332|75641149|FG000|Overall Study|SEMS Obstruction|11|||
41935450|NCT01047332|75641150|FG001|Overall Study|SEMS Obstruction|20|||
41935451|NCT01047332|75641149|FG000|Overall Study|Died Unobstructed|38|||
41935452|NCT01047332|75641150|FG001|Overall Study|Died Unobstructed|41|||
41935453|NCT01047332|75641149|FG000|Overall Study|Lost to Follow-up|8|||
41935454|NCT01047332|75641150|FG001|Overall Study|Lost to Follow-up|3|||
41935455|NCT01046396|75641156|FG000|Overall Study|Withdrawal by Subject|5|||
41935456|NCT01046084|75641182|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
41935457|NCT01046084|75641183|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
41935458|NCT01045694|75641202|FG000|Overall Study|Withdrawal by Subject|2|||
41935459|NCT01044290|75641262|FG000|Follow-up 1|Death|3|||
41935460|NCT01044290|75641263|FG001|Follow-up 1|Death|3|||
41935461|NCT01044290|75641264|FG002|Follow-up 1|Death|1|||
41935462|NCT01044290|75641262|FG000|Follow-up 1|Withdrawal by Subject|2|||
41935463|NCT01044290|75641263|FG001|Follow-up 1|Withdrawal by Subject|2|||
41935464|NCT01044290|75641264|FG002|Follow-up 1|Withdrawal by Subject|0|||
41935465|NCT01044290|75641262|FG000|Follow-Up 2|Death|0|||
41935466|NCT01044290|75641263|FG001|Follow-Up 2|Death|1|||
41935467|NCT01044290|75641264|FG002|Follow-Up 2|Death|1|||
41935468|NCT01044290|75641262|FG000|Follow-Up 2|Withdrawal by Subject|0|||
41935469|NCT01044290|75641263|FG001|Follow-Up 2|Withdrawal by Subject|1|||
41935470|NCT01044290|75641264|FG002|Follow-Up 2|Withdrawal by Subject|1|||
41935471|NCT01041638|75641345|FG000|Overall Study|Adverse Event|4|||
41935472|NCT01041638|75641345|FG000|Overall Study|Death|1|||
41935473|NCT01041638|75641345|FG000|Overall Study|Lack of Efficacy|7|||
41935474|NCT01041638|75641345|FG000|Overall Study|Physician Decision|4|||
41935475|NCT01041638|75641345|FG000|Overall Study|Withdrawal by Subject|11|||
41935476|NCT01045460|75641369|FG000|Overall Study|Physician Decision|3|||
41935477|NCT01045460|75641370|FG001|Overall Study|Physician Decision|2|||
41935478|NCT01045460|75641369|FG000|Overall Study|Lost to Follow-up|0|||
41935479|NCT01045460|75641370|FG001|Overall Study|Lost to Follow-up|1|||
41935480|NCT01045460|75641369|FG000|Overall Study|Lack of Efficacy|3|||
41935481|NCT01045460|75641370|FG001|Overall Study|Lack of Efficacy|0|||
41935482|NCT05014919|75641381|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
41935483|NCT05014919|75641382|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
41935484|NCT05014919|75641383|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
41935485|NCT05014919|75641381|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
41935486|NCT05014919|75641382|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
41935487|NCT05014919|75641383|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
41935488|NCT05014919|75641381|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
41935489|NCT05014919|75641382|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
41935490|NCT05014919|75641383|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
41935491|NCT05014919|75641381|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
41935492|NCT05014919|75641382|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
41935493|NCT05014919|75641383|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
41935494|NCT05014919|75641381|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
41935495|NCT05014919|75641382|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
41935496|NCT05014919|75641383|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
41935497|NCT05014919|75641381|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
41935498|NCT05014919|75641382|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
41935499|NCT05014919|75641383|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
41935500|NCT05014919|75641381|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
41935501|NCT05014919|75641382|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
41935502|NCT05014919|75641383|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
41935503|NCT05014919|75641381|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
41935504|NCT05014919|75641382|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
41935505|NCT05014919|75641383|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
41935506|NCT03409796|75641426|FG000|Overall Study|Adverse Event|2|||
41935507|NCT03409796|75641427|FG001|Overall Study|Adverse Event|0|||
41935508|NCT03409796|75641426|FG000|Overall Study|Other|0|||
41935509|NCT03409796|75641427|FG001|Overall Study|Other|1|||
41935510|NCT02462928|75641436|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
41935511|NCT02462928|75641437|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
41935512|NCT02462928|75641438|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
41935513|NCT02462928|75641436|FG000|Overall Study|Adverse Event|47|||
42210211|NCT00462748|76024944|FG002|Overall Study|Protocol Violation|1|||
41935514|NCT02462928|75641437|FG001|Overall Study|Adverse Event|51|||
41935515|NCT02462928|75641438|FG002|Overall Study|Adverse Event|25|||
41935516|NCT02462928|75641436|FG000|Overall Study|Lack of Efficacy|3|||
41935517|NCT02462928|75641437|FG001|Overall Study|Lack of Efficacy|8|||
41935518|NCT02462928|75641438|FG002|Overall Study|Lack of Efficacy|3|||
41935519|NCT02462928|75641436|FG000|Overall Study|Lost to Follow-up|4|||
41935520|NCT02462928|75641437|FG001|Overall Study|Lost to Follow-up|4|||
41935521|NCT02462928|75641438|FG002|Overall Study|Lost to Follow-up|1|||
41935522|NCT02462928|75641436|FG000|Overall Study|Withdrawal by Patient|31|||
42210212|NCT00462748|76024942|FG000|Overall Study|Withdrew consent|3|||
41935523|NCT02462928|75641437|FG001|Overall Study|Withdrawal by Patient|21|||
41935524|NCT02462928|75641438|FG002|Overall Study|Withdrawal by Patient|21|||
41935525|NCT02462928|75641436|FG000|Overall Study|Protocol Violation|0|||
41935526|NCT02462928|75641437|FG001|Overall Study|Protocol Violation|1|||
41935527|NCT02462928|75641438|FG002|Overall Study|Protocol Violation|0|||
41935528|NCT02462928|75641436|FG000|Overall Study|Reason not Specified|4|||
42210213|NCT00462748|76024943|FG001|Overall Study|Withdrew consent|3|||
42210214|NCT00462748|76024944|FG002|Overall Study|Withdrew consent|0|||
42210215|NCT00462748|76024942|FG000|Overall Study|Lost to Follow-up|1|||
41935529|NCT02462928|75641437|FG001|Overall Study|Reason not Specified|6|||
41935530|NCT02462928|75641438|FG002|Overall Study|Reason not Specified|5|||
41935531|NCT00019604|75641455|FG000|Overall Study|Death|1|||
41935532|NCT00019604|75641455|FG000|Overall Study|Progressive disease|23|||
41935533|NCT00019604|75641455|FG000|Overall Study|Refused treatment|1|||
41935534|NCT00019604|75641455|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
41935535|NCT00019604|75641455|FG000|Overall Study|Going to have liver transplant|1|||
41935536|NCT00019604|75641455|FG000|Overall Study|Move to a different study|1|||
41935537|NCT00019604|75641455|FG000|Overall Study|Non compliant on systemic CH|1|||
41935538|NCT00019604|75641455|FG000|Overall Study|Non compliant|1|||
41935539|NCT00019604|75641455|FG000|Overall Study|Resectable disease|1|||
41935540|NCT00019604|75641455|FG000|Overall Study|Started new chemo regimen|1|||
41935541|NCT00019604|75641455|FG000|Overall Study|Pt going to immunotherapy study|1|||
41935542|NCT00019604|75641455|FG000|Overall Study|Too much disease|1|||
41935543|NCT00019604|75641455|FG000|Overall Study|Unable to evaluate|1|||
41935544|NCT00019604|75641455|FG000|Overall Study|Details for other not available|4|||
41935545|NCT02492958|75641471|FG000|Overall Study|Withdrawal by Subject|0|||
41935546|NCT02492958|75641472|FG001|Overall Study|Withdrawal by Subject|0|||
41935547|NCT02492958|75641473|FG002|Overall Study|Withdrawal by Subject|1|||
41935548|NCT02492958|75641474|FG003|Overall Study|Withdrawal by Subject|0|||
41935549|NCT02492958|75641471|FG000|Overall Study|Adverse Event|1|||
41935550|NCT02492958|75641472|FG001|Overall Study|Adverse Event|0|||
41935551|NCT02492958|75641473|FG002|Overall Study|Adverse Event|1|||
41935552|NCT02492958|75641474|FG003|Overall Study|Adverse Event|0|||
41935553|NCT02492880|75641484|FG000|Overall Study|Lost to Follow-up|1|||
41935554|NCT02492880|75641484|FG000|Overall Study|Protocol Violation|1|||
41935555|NCT02516592|75641490|FG000|Overall Study|Patient withdrew consent|5|||
41935556|NCT02516592|75641491|FG001|Overall Study|Patient withdrew consent|2|||
41935557|NCT02516592|75641490|FG000|Overall Study|Protocol deviation|4|||
41935558|NCT02516592|75641491|FG001|Overall Study|Protocol deviation|4|||
41935559|NCT02516592|75641490|FG000|Overall Study|Lost to Follow-up|2|||
41935560|NCT02516592|75641491|FG001|Overall Study|Lost to Follow-up|3|||
41935561|NCT02516592|75641490|FG000|Overall Study|Patient/guardian decision|2|||
41935562|NCT02516592|75641491|FG001|Overall Study|Patient/guardian decision|1|||
41935563|NCT02516592|75641490|FG000|Overall Study|Adverse Event|1|||
41935564|NCT02516592|75641491|FG001|Overall Study|Adverse Event|2|||
41935565|NCT02516592|75641490|FG000|Overall Study|Abnormal test procedure result|1|||
41935566|NCT02516592|75641491|FG001|Overall Study|Abnormal test procedure result|0|||
41935567|NCT02516592|75641490|FG000|Overall Study|Death|1|||
41935568|NCT02516592|75641491|FG001|Overall Study|Death|1|||
41935569|NCT02492100|75641519|FG000|Overall Study|Death|1|||
41935570|NCT02461758|75641537|FG000|Overall Study|Lost to Follow-up|0|||
41935571|NCT02461758|75641538|FG001|Overall Study|Lost to Follow-up|1|||
41935572|NCT02461758|75641539|FG002|Overall Study|Lost to Follow-up|1|||
41935573|NCT02461758|75641540|FG003|Overall Study|Lost to Follow-up|0|||
41935574|NCT02461290|75641562|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
41935575|NCT02461290|75641562|FG000|Overall Study|Lost to Follow-up|3|||
41935576|NCT02461134|75641566|FG000|Overall Study|Adverse Event|1|||
41935577|NCT02460978|75641595|FG000|Overall Study|Adverse Event|17|||
41935578|NCT02460978|75641596|FG001|Overall Study|Adverse Event|11|||
41935579|NCT02460978|75641597|FG002|Overall Study|Adverse Event|11|||
41935580|NCT02460978|75641595|FG000|Overall Study|Withdrawal by Subject|5|||
41935581|NCT02460978|75641596|FG001|Overall Study|Withdrawal by Subject|5|||
41935582|NCT02460978|75641597|FG002|Overall Study|Withdrawal by Subject|14|||
41935583|NCT02460978|75641595|FG000|Overall Study|Lost to Follow-up|2|||
41935584|NCT02460978|75641596|FG001|Overall Study|Lost to Follow-up|3|||
41935585|NCT02460978|75641597|FG002|Overall Study|Lost to Follow-up|1|||
41935586|NCT02460978|75641595|FG000|Overall Study|Protocol Violation|1|||
41935587|NCT02460978|75641596|FG001|Overall Study|Protocol Violation|1|||
41935588|NCT02460978|75641597|FG002|Overall Study|Protocol Violation|1|||
41935589|NCT02460978|75641595|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
41935590|NCT02460978|75641596|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
41935591|NCT02460978|75641597|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
41935592|NCT02460978|75641595|FG000|Overall Study|Pregnancy|0|||
41935593|NCT02460978|75641596|FG001|Overall Study|Pregnancy|0|||
41935594|NCT02460978|75641597|FG002|Overall Study|Pregnancy|2|||
41935595|NCT02489448|75641612|FG000|Overall Study|Death|3|||
41935596|NCT02489448|75641612|FG000|Overall Study|Withdrawal by Subject|2|||
41935597|NCT02488980|75641633|FG000|Overall Study|Protocol Violation|2|||
41935598|NCT02488980|75641634|FG001|Overall Study|Protocol Violation|2|||
41935599|NCT02488980|75641635|FG002|Overall Study|Protocol Violation|2|||
41935600|NCT02460822|75641647|FG000|Overall Study|Withdrawal by Subject|1|||
41935601|NCT02488824|75641653|FG000|Overall Study|Adverse Event|1|||
41935602|NCT02488824|75641654|FG001|Overall Study|Adverse Event|1|||
41935603|NCT02308241|75641766|FG000|Overall Study|Withdrawal by Subject|3|||
41935604|NCT02460198|75641805|FG000|Overall Study|Adverse Event|1|||
41935605|NCT02460198|75641806|FG001|Overall Study|Adverse Event|3|||
41935606|NCT02460198|75641805|FG000|Overall Study|Death|36|||
41935607|NCT02460198|75641806|FG001|Overall Study|Death|28|||
41935608|NCT02460198|75641805|FG000|Overall Study|Lost to Follow-up|1|||
41935609|NCT02460198|75641806|FG001|Overall Study|Lost to Follow-up|1|||
41935610|NCT02460198|75641805|FG000|Overall Study|Transferred to Extension Study|15|||
41935611|NCT02460198|75641806|FG001|Overall Study|Transferred to Extension Study|15|||
41935612|NCT02460198|75641805|FG000|Overall Study|Withdrawal by Subject|2|||
41935613|NCT02460198|75641806|FG001|Overall Study|Withdrawal by Subject|4|||
41935614|NCT02460198|75641805|FG000|Overall Study|Site Terminated By Sponsor|0|||
41935615|NCT02460198|75641806|FG001|Overall Study|Site Terminated By Sponsor|1|||
41935616|NCT02460198|75641805|FG000|Overall Study|Did Not Continue on Extension Study|6|||
41935617|NCT02460198|75641806|FG001|Overall Study|Did Not Continue on Extension Study|11|||
41935618|NCT02487810|75641826|FG000|Overall Study|Withdrawal by Subject|1|||
41935619|NCT02487810|75641827|FG001|Overall Study|Withdrawal by Subject|0|||
41935620|NCT02452320|75641835|FG000|Overall Study|Adverse Event|0|||
41935621|NCT02452320|75641836|FG001|Overall Study|Adverse Event|1|||
41935622|NCT02459964|75641845|FG000|Overall Study|Withdrawal by Subject|0|||
41935623|NCT02459964|75641846|FG001|Overall Study|Withdrawal by Subject|0|||
41935624|NCT02459964|75641847|FG002|Overall Study|Withdrawal by Subject|1|||
41935625|NCT02459964|75641845|FG000|Overall Study|Abnormal EKG changes|0|||
41935626|NCT02459964|75641846|FG001|Overall Study|Abnormal EKG changes|0|||
41935627|NCT02459964|75641847|FG002|Overall Study|Abnormal EKG changes|1|||
41935628|NCT02451930|75641924|FG000|Overall Study|Death|0|||
41935629|NCT02451930|75641925|FG001|Overall Study|Death|15|||
41935630|NCT02451930|75641924|FG000|Overall Study|Lost to Follow-up|0|||
41935631|NCT02451930|75641925|FG001|Overall Study|Lost to Follow-up|3|||
41935632|NCT02451930|75641924|FG000|Overall Study|Sponsor Decision|2|||
41935633|NCT02451930|75641925|FG001|Overall Study|Sponsor Decision|10|||
41935634|NCT02451930|75641924|FG000|Overall Study|Withdrawal by Subject|0|||
41935635|NCT02451930|75641925|FG001|Overall Study|Withdrawal by Subject|1|||
41935636|NCT02451930|75641924|FG000|Overall Study|Other|0|||
41935637|NCT02451930|75641925|FG001|Overall Study|Other|1|||
41935638|NCT02451696|75641961|FG000|Overall Study|Surgery postponed|1|||
41935639|NCT02451696|75641962|FG001|Overall Study|Surgery postponed|0|||
41935640|NCT02459418|75641985|FG000|Overall Study|Exclusion Criteria|4|||
41935641|NCT02459418|75641986|FG001|Overall Study|Exclusion Criteria|0|||
41935642|NCT02459418|75641985|FG000|Overall Study|Protocol Violation|0|||
41935643|NCT02459418|75641986|FG001|Overall Study|Protocol Violation|2|||
41935644|NCT02459418|75641985|FG000|Overall Study|Physician Decision|0|||
41935645|NCT02459418|75641986|FG001|Overall Study|Physician Decision|2|||
41935646|NCT02459418|75641985|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
41935647|NCT02459418|75641986|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
41935648|NCT02459418|75641985|FG000|Overall Study|Adverse Event|0|||
41935649|NCT02459418|75641986|FG001|Overall Study|Adverse Event|1|||
41935650|NCT02459418|75641985|FG000|Overall Study|Withdrawal by Subject|1|||
41935651|NCT02459418|75641986|FG001|Overall Study|Withdrawal by Subject|1|||
41935652|NCT02459418|75641985|FG000|Overall Study|Elevated Creatine Kinase|1|||
41935653|NCT02459418|75641986|FG001|Overall Study|Elevated Creatine Kinase|0|||
41935654|NCT02459418|75641985|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
41935655|NCT02459418|75641986|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
42022224|NCT00960934|75829533|FG003|Overall Study|Progressive Disease|0|||
42022225|NCT00960934|75829534|FG004|Overall Study|Progressive Disease|1|||
41935656|NCT02487498|75642016|FG000|Period: Period 1|Adverse Event|2|||
41935657|NCT02487498|75642017|FG001|Period: Period 1|Adverse Event|4|||
41935658|NCT02487498|75642016|FG000|Period: Period 1|Subject/guardian decision|2|||
41935659|NCT02487498|75642017|FG001|Period: Period 1|Subject/guardian decision|4|||
41935660|NCT02487498|75642016|FG000|Period: Period 1|Lost to Follow-up|0|||
42022226|NCT00960934|75829535|FG005|Overall Study|Progressive Disease|1|||
42022227|NCT00960934|75829530|FG000|Overall Study|Protocol Violation|3|||
41935661|NCT02487498|75642017|FG001|Period: Period 1|Lost to Follow-up|2|||
41935662|NCT02487498|75642016|FG000|Period: Period 1|Lack of Efficacy|1|||
41935663|NCT02487498|75642017|FG001|Period: Period 1|Lack of Efficacy|0|||
41935664|NCT02487498|75642016|FG000|Period: Period 1|Physician Decision|0|||
41935665|NCT02487498|75642017|FG001|Period: Period 1|Physician Decision|1|||
41935666|NCT02487498|75642016|FG000|Period: Period 1|Protocol deviation|1|||
41935667|NCT02487498|75642017|FG001|Period: Period 1|Protocol deviation|0|||
41935668|NCT02487498|75642016|FG000|Period: Washout|Subject/guardian decision|0|||
41935669|NCT02487498|75642017|FG001|Period: Washout|Subject/guardian decision|5|||
41935670|NCT02487498|75642016|FG000|Period: Washout|Lack of Efficacy|1|||
41935671|NCT02487498|75642017|FG001|Period: Washout|Lack of Efficacy|1|||
41935672|NCT02487498|75642016|FG000|Period: Washout|Physician Decision|1|||
41935673|NCT02487498|75642017|FG001|Period: Washout|Physician Decision|0|||
41935674|NCT02487498|75642016|FG000|Period: Washout|Non-compliance with study treatment|0|||
41935675|NCT02487498|75642017|FG001|Period: Washout|Non-compliance with study treatment|1|||
41935676|NCT02487498|75642016|FG000|Period: Period 2|Adverse Event|2|||
41935677|NCT02487498|75642017|FG001|Period: Period 2|Adverse Event|2|||
41935678|NCT02487498|75642016|FG000|Period: Period 2|Subject/guardian decision|2|||
41935679|NCT02487498|75642017|FG001|Period: Period 2|Subject/guardian decision|1|||
41935680|NCT02487498|75642016|FG000|Period: Period 2|Lost to Follow-up|1|||
41935681|NCT02487498|75642017|FG001|Period: Period 2|Lost to Follow-up|1|||
41935682|NCT02487498|75642016|FG000|Period: Period 2|Death|0|||
41935683|NCT02487498|75642017|FG001|Period: Period 2|Death|1|||
41935684|NCT02487498|75642016|FG000|Period: Period 2|Physician Decision|1|||
41935685|NCT02487498|75642017|FG001|Period: Period 2|Physician Decision|0|||
41935686|NCT02487108|75642028|FG000|Overall Study|Adverse Event|1|||
41935687|NCT02487108|75642029|FG001|Overall Study|Adverse Event|6|||
41935688|NCT02487108|75642030|FG002|Overall Study|Adverse Event|12|||
41935689|NCT02487108|75642031|FG003|Overall Study|Adverse Event|6|||
41935690|NCT02487108|75642028|FG000|Overall Study|Withdrawal by Subject|8|||
41935691|NCT02487108|75642029|FG001|Overall Study|Withdrawal by Subject|5|||
41935692|NCT02487108|75642030|FG002|Overall Study|Withdrawal by Subject|5|||
41935693|NCT02487108|75642031|FG003|Overall Study|Withdrawal by Subject|0|||
41935694|NCT02487108|75642028|FG000|Overall Study|Non-compliance to study medication|3|||
41935695|NCT02487108|75642029|FG001|Overall Study|Non-compliance to study medication|2|||
41935696|NCT02487108|75642030|FG002|Overall Study|Non-compliance to study medication|5|||
41935697|NCT02487108|75642031|FG003|Overall Study|Non-compliance to study medication|4|||
41935698|NCT02487108|75642028|FG000|Overall Study|Protocol Violation|1|||
41935699|NCT02487108|75642029|FG001|Overall Study|Protocol Violation|1|||
41935700|NCT02487108|75642030|FG002|Overall Study|Protocol Violation|2|||
42022228|NCT00960934|75829531|FG001|Overall Study|Protocol Violation|4|||
42022229|NCT00960934|75829532|FG002|Overall Study|Protocol Violation|0|||
42022230|NCT00960934|75829533|FG003|Overall Study|Protocol Violation|3|||
42210216|NCT00462748|76024943|FG001|Overall Study|Lost to Follow-up|1|||
41935701|NCT02487108|75642031|FG003|Overall Study|Protocol Violation|0|||
42022231|NCT00960934|75829534|FG004|Overall Study|Protocol Violation|3|||
41935702|NCT02487108|75642028|FG000|Overall Study|Non-compliance to study procedures|0|||
41935703|NCT02487108|75642029|FG001|Overall Study|Non-compliance to study procedures|0|||
41935704|NCT02487108|75642030|FG002|Overall Study|Non-compliance to study procedures|0|||
41935705|NCT02487108|75642031|FG003|Overall Study|Non-compliance to study procedures|1|||
41935706|NCT02487108|75642028|FG000|Overall Study|Other than specified|3|||
41935707|NCT02487108|75642029|FG001|Overall Study|Other than specified|2|||
41935708|NCT02487108|75642030|FG002|Overall Study|Other than specified|2|||
41935709|NCT02487108|75642031|FG003|Overall Study|Other than specified|0|||
41935710|NCT02487030|75642048|FG000|Overall Study|Lack of Efficacy|2|||
41935711|NCT02487030|75642049|FG001|Overall Study|Lack of Efficacy|4|||
41935712|NCT02487030|75642050|FG002|Overall Study|Lack of Efficacy|1|||
41935713|NCT02487030|75642051|FG003|Overall Study|Lack of Efficacy|0|||
41935714|NCT02487030|75642052|FG004|Overall Study|Lack of Efficacy|1|||
41935715|NCT02487030|75642053|FG005|Overall Study|Lack of Efficacy|0|||
41935716|NCT02487030|75642054|FG006|Overall Study|Lack of Efficacy|0|||
41935717|NCT02487030|75642048|FG000|Overall Study|Lost to Follow-up|0|||
41935718|NCT02487030|75642049|FG001|Overall Study|Lost to Follow-up|0|||
41935719|NCT02487030|75642050|FG002|Overall Study|Lost to Follow-up|1|||
41935720|NCT02487030|75642051|FG003|Overall Study|Lost to Follow-up|1|||
41935721|NCT02487030|75642052|FG004|Overall Study|Lost to Follow-up|0|||
41935722|NCT02487030|75642053|FG005|Overall Study|Lost to Follow-up|1|||
41935723|NCT02487030|75642054|FG006|Overall Study|Lost to Follow-up|0|||
41935724|NCT02487030|75642048|FG000|Overall Study|Adverse Event|0|||
41935725|NCT02487030|75642049|FG001|Overall Study|Adverse Event|0|||
41935726|NCT02487030|75642050|FG002|Overall Study|Adverse Event|0|||
41935727|NCT02487030|75642051|FG003|Overall Study|Adverse Event|1|||
41935728|NCT02487030|75642052|FG004|Overall Study|Adverse Event|0|||
41935729|NCT02487030|75642053|FG005|Overall Study|Adverse Event|0|||
41935730|NCT02487030|75642054|FG006|Overall Study|Adverse Event|0|||
41935731|NCT02487030|75642048|FG000|Overall Study|Death|0|||
41935732|NCT02487030|75642049|FG001|Overall Study|Death|0|||
41935733|NCT02487030|75642050|FG002|Overall Study|Death|0|||
41935734|NCT02487030|75642051|FG003|Overall Study|Death|0|||
41935735|NCT02487030|75642052|FG004|Overall Study|Death|1|||
41935736|NCT02487030|75642053|FG005|Overall Study|Death|0|||
41935737|NCT02487030|75642054|FG006|Overall Study|Death|0|||
41935738|NCT02486952|75642071|FG000|Overall Study|Not Started Induction Therapy|3|||
41935739|NCT02486952|75642071|FG000|Overall Study|Adverse Event|1|||
41935740|NCT02486952|75642071|FG000|Overall Study|Death|15|||
41935741|NCT02486952|75642071|FG000|Overall Study|Lack of Efficacy|3|||
41935742|NCT02486952|75642071|FG000|Overall Study|Lost to Follow-up|26|||
41935743|NCT02486952|75642071|FG000|Overall Study|Other|2|||
41935744|NCT02486796|75642077|FG000|Overall Study|Withdrawal by Subject|1|||
41935745|NCT02486796|75642078|FG001|Overall Study|Withdrawal by Subject|1|||
41935746|NCT02486796|75642077|FG000|Overall Study|Physician Decision|1|||
41935747|NCT02486796|75642078|FG001|Overall Study|Physician Decision|0|||
41935748|NCT02459262|75642095|FG000|Overall Study|Withdrawal by Subject|0|||
41935749|NCT02459262|75642096|FG001|Overall Study|Withdrawal by Subject|0|||
41935750|NCT02459262|75642097|FG002|Overall Study|Withdrawal by Subject|0|||
41935751|NCT02459262|75642098|FG003|Overall Study|Withdrawal by Subject|0|||
41935752|NCT02459262|75642099|FG004|Overall Study|Withdrawal by Subject|0|||
41935753|NCT02459262|75642100|FG005|Overall Study|Withdrawal by Subject|0|||
41935754|NCT02459262|75642101|FG006|Overall Study|Withdrawal by Subject|0|||
41935755|NCT02459262|75642102|FG007|Overall Study|Withdrawal by Subject|0|||
41935756|NCT02459262|75642103|FG008|Overall Study|Withdrawal by Subject|0|||
41935757|NCT02459262|75642104|FG009|Overall Study|Withdrawal by Subject|1|||
41935758|NCT02459262|75642105|FG010|Overall Study|Withdrawal by Subject|0|||
41935759|NCT02450526|75642189|FG000|DB Period (Cycle 1)|Adverse Event|0|||
41935760|NCT02450526|75642190|FG001|DB Period (Cycle 1)|Adverse Event|0|||
41935761|NCT02450526|75642191|FG002|DB Period (Cycle 1)|Adverse Event|2|||
41935762|NCT02450526|75642192|FG003|DB Period (Cycle 1)|Adverse Event|0|||
41935763|NCT02450526|75642193|FG004|DB Period (Cycle 1)|Adverse Event|0|||
41935764|NCT02450526|75642189|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
41935765|NCT02450526|75642190|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
41935766|NCT02450526|75642191|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
41935767|NCT02450526|75642192|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
41935768|NCT02450526|75642193|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
41935769|NCT02450526|75642189|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
41935770|NCT02450526|75642190|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
41935771|NCT02450526|75642191|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
41935772|NCT02450526|75642192|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
42022232|NCT00960934|75829535|FG005|Overall Study|Protocol Violation|2|||
42022233|NCT00960934|75829530|FG000|Overall Study|Withdrawal by Subject|5|||
41935773|NCT02450526|75642193|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
42210217|NCT00462748|76024944|FG002|Overall Study|Lost to Follow-up|1|||
42300164|NCT02327169|76135334|FG012|Overall Study|Symptomatic Deterioration|0|||
41935774|NCT02450526|75642189|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
41935775|NCT02450526|75642190|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
41935776|NCT02450526|75642191|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
41935777|NCT02450526|75642192|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
41935778|NCT02450526|75642193|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
41935779|NCT02450526|75642189|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
42022234|NCT00960934|75829531|FG001|Overall Study|Withdrawal by Subject|6|||
41935780|NCT02450526|75642190|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
41935781|NCT02450526|75642191|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
41935782|NCT02450526|75642192|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
41935783|NCT02450526|75642193|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
41935784|NCT02450526|75642189|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
41935785|NCT02450526|75642190|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
41935786|NCT02450526|75642191|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
41935787|NCT02450526|75642192|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
41935788|NCT02450526|75642193|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
41935789|NCT02450526|75642189|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
41935790|NCT02450526|75642190|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
41935791|NCT02450526|75642191|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
41935792|NCT02450526|75642192|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
41935793|NCT02450526|75642193|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
41935794|NCT02450526|75642189|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
41935795|NCT02450526|75642190|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
41935796|NCT02450526|75642191|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
41935797|NCT02450526|75642192|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
41935798|NCT02450526|75642193|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
41935799|NCT02458638|75642260|FG000|Overall Study|Death|309|||
41935800|NCT02458638|75642260|FG000|Overall Study|End of Cohort/End of Study|67|||
41935801|NCT02458638|75642260|FG000|Overall Study|Lost to Follow-up|31|||
41935802|NCT02458638|75642260|FG000|Overall Study|Other Reasons|4|||
41935803|NCT02458638|75642260|FG000|Overall Study|Physician Decision|1|||
41935804|NCT02458638|75642260|FG000|Overall Study|Withdrawal by Subject|47|||
41935805|NCT02458092|75642398|FG000|Overall Study|Withdrawal by Subject|1|||
41935806|NCT02458092|75642399|FG001|Overall Study|Withdrawal by Subject|0|||
41935807|NCT02449902|75642422|FG000|Overall Study|Adverse Event|0|||
41935808|NCT02449902|75642423|FG001|Overall Study|Adverse Event|1|||
41935809|NCT02449902|75642422|FG000|Overall Study|Withdrawal by Subject|0|||
41935810|NCT02449902|75642423|FG001|Overall Study|Withdrawal by Subject|1|||
41935811|NCT02449044|75642431|FG000|Overall Study|Lost to Follow-up|2|||
41935812|NCT02449044|75642431|FG000|Overall Study|Withdrawal by Subject|13|||
41935813|NCT02449044|75642431|FG000|Overall Study|Adverse Event|30|||
41935814|NCT02449044|75642431|FG000|Overall Study|Met Withdrawal Criteria|7|||
41935815|NCT02449044|75642431|FG000|Overall Study|Physician Decision|9|||
41935816|NCT02449044|75642431|FG000|Overall Study|Sponsor Discontinued Trial|3|||
41935817|NCT02448810|75643293|FG000|Overall Study|Adverse Event|0|||
41935818|NCT02448810|75643294|FG001|Overall Study|Adverse Event|0|||
41935819|NCT02448810|75643295|FG002|Overall Study|Adverse Event|1|||
41935820|NCT02448810|75643296|FG003|Overall Study|Adverse Event|0|||
41935821|NCT02448810|75643297|FG004|Overall Study|Adverse Event|0|||
41935822|NCT02448810|75643298|FG005|Overall Study|Adverse Event|0|||
41935823|NCT02448810|75643299|FG006|Overall Study|Adverse Event|0|||
41935824|NCT02448810|75643300|FG007|Overall Study|Adverse Event|0|||
41935825|NCT02448810|75643293|FG000|Overall Study|Withdrawal by Subject|0|||
41935826|NCT02448810|75643294|FG001|Overall Study|Withdrawal by Subject|0|||
41935827|NCT02448810|75643295|FG002|Overall Study|Withdrawal by Subject|1|||
41935828|NCT02448810|75643296|FG003|Overall Study|Withdrawal by Subject|0|||
41935829|NCT02448810|75643297|FG004|Overall Study|Withdrawal by Subject|3|||
41935830|NCT02448810|75643298|FG005|Overall Study|Withdrawal by Subject|5|||
41935831|NCT02448810|75643299|FG006|Overall Study|Withdrawal by Subject|0|||
41935832|NCT02448810|75643300|FG007|Overall Study|Withdrawal by Subject|2|||
41935833|NCT02448810|75643293|FG000|Overall Study|Other (study terminated by sponsor)|0|||
41935834|NCT02448810|75643294|FG001|Overall Study|Other (study terminated by sponsor)|0|||
41935835|NCT02448810|75643295|FG002|Overall Study|Other (study terminated by sponsor)|0|||
41935836|NCT02448810|75643296|FG003|Overall Study|Other (study terminated by sponsor)|0|||
41935837|NCT02448810|75643297|FG004|Overall Study|Other (study terminated by sponsor)|4|||
41935838|NCT02448810|75643298|FG005|Overall Study|Other (study terminated by sponsor)|2|||
41935839|NCT02448810|75643299|FG006|Overall Study|Other (study terminated by sponsor)|2|||
41935840|NCT02448810|75643300|FG007|Overall Study|Other (study terminated by sponsor)|1|||
41935841|NCT02448810|75643293|FG000|Overall Study|Death|1|||
41935842|NCT02448810|75643294|FG001|Overall Study|Death|0|||
41935843|NCT02448810|75643295|FG002|Overall Study|Death|1|||
41935844|NCT02448810|75643296|FG003|Overall Study|Death|0|||
41935845|NCT02448810|75643297|FG004|Overall Study|Death|1|||
41935846|NCT02448810|75643298|FG005|Overall Study|Death|0|||
41935847|NCT02448810|75643299|FG006|Overall Study|Death|0|||
41935848|NCT02448810|75643300|FG007|Overall Study|Death|0|||
41935849|NCT02448810|75643293|FG000|Overall Study|Other (Progressive disease)|2|||
41935850|NCT02448810|75643294|FG001|Overall Study|Other (Progressive disease)|2|||
41935851|NCT02448810|75643295|FG002|Overall Study|Other (Progressive disease)|0|||
41935852|NCT02448810|75643296|FG003|Overall Study|Other (Progressive disease)|3|||
41935853|NCT02448810|75643297|FG004|Overall Study|Other (Progressive disease)|23|||
41935854|NCT02448810|75643298|FG005|Overall Study|Other (Progressive disease)|9|||
41935855|NCT02448810|75643299|FG006|Overall Study|Other (Progressive disease)|14|||
41935856|NCT02448810|75643300|FG007|Overall Study|Other (Progressive disease)|5|||
41935857|NCT02448810|75643293|FG000|Overall Study|Lost to Follow-up|0|||
41935858|NCT02448810|75643294|FG001|Overall Study|Lost to Follow-up|1|||
41935859|NCT02448810|75643295|FG002|Overall Study|Lost to Follow-up|0|||
41935860|NCT02448810|75643296|FG003|Overall Study|Lost to Follow-up|0|||
41935861|NCT02448810|75643297|FG004|Overall Study|Lost to Follow-up|0|||
41935862|NCT02448810|75643298|FG005|Overall Study|Lost to Follow-up|0|||
41935863|NCT02448810|75643299|FG006|Overall Study|Lost to Follow-up|0|||
41935864|NCT02448810|75643300|FG007|Overall Study|Lost to Follow-up|0|||
41935865|NCT02448810|75643293|FG000|Overall Study|Other (unspecified)|0|||
41935866|NCT02448810|75643294|FG001|Overall Study|Other (unspecified)|0|||
41935867|NCT02448810|75643295|FG002|Overall Study|Other (unspecified)|0|||
41935868|NCT02448810|75643296|FG003|Overall Study|Other (unspecified)|0|||
41935869|NCT02448810|75643297|FG004|Overall Study|Other (unspecified)|0|||
41935870|NCT02448810|75643298|FG005|Overall Study|Other (unspecified)|0|||
41935871|NCT02448810|75643299|FG006|Overall Study|Other (unspecified)|2|||
41935872|NCT02448810|75643300|FG007|Overall Study|Other (unspecified)|0|||
41935873|NCT02457546|75643373|FG000|Overall Study|Other reasons|4|||
41935874|NCT02457546|75643374|FG001|Overall Study|Other reasons|1|||
41935875|NCT02457546|75643373|FG000|Overall Study|Refused to complete study/procedures|1|||
41935876|NCT02457546|75643374|FG001|Overall Study|Refused to complete study/procedures|1|||
41935877|NCT02457546|75643373|FG000|Overall Study|Lost to Follow-up|4|||
41935878|NCT02457546|75643374|FG001|Overall Study|Lost to Follow-up|1|||
41935879|NCT02457546|75643373|FG000|Overall Study|Adverse Event|0|||
41935880|NCT02457546|75643374|FG001|Overall Study|Adverse Event|1|||
41935881|NCT02447952|75643395|FG000|Overall Study|Adverse Event|2|||
41935882|NCT02447952|75643395|FG000|Overall Study|Physician Decision|1|||
41935883|NCT02447952|75643395|FG000|Overall Study|Withdrawal by Subject|4|||
41935884|NCT02447718|75643429|FG000|Overall Study|Lost to Follow-up|8|||
41935885|NCT02447718|75643430|FG001|Overall Study|Lost to Follow-up|0|||
42210218|NCT00462748|76024942|FG000|Overall Study|Discontinued after 41 days Rx|1|||
42210219|NCT00462748|76024943|FG001|Overall Study|Discontinued after 41 days Rx|0|||
42210220|NCT00462748|76024944|FG002|Overall Study|Discontinued after 41 days Rx|0|||
42210221|NCT04206085|76024955|FG000|Overall Study|Lost to Follow-up|0|||
42210222|NCT04206085|76024956|FG001|Overall Study|Lost to Follow-up|1|||
42210223|NCT04206085|76024957|FG002|Overall Study|Lost to Follow-up|0|||
42210224|NCT04206085|76024955|FG000|Overall Study|Lost to Follow-up|0|||
42210225|NCT04206085|76024956|FG001|Overall Study|Lost to Follow-up|0|||
42210226|NCT04206085|76024957|FG002|Overall Study|Lost to Follow-up|1|||
42210227|NCT04202497|76024965|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
42210228|NCT04202497|76024966|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
42210229|NCT04202497|76024967|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
42210230|NCT04202497|76024968|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
42210231|NCT03297294|76024984|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
42210232|NCT03297294|76024985|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
42210233|NCT03297294|76024986|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
42210234|NCT03297294|76024987|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
42210235|NCT03297294|76024988|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
42210236|NCT03297294|76024984|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
42210237|NCT03297294|76024985|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
42210238|NCT03297294|76024986|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
41935886|NCT02447718|75643429|FG000|Overall Study|Withdrawal by Subject|3|||
41935887|NCT02447718|75643430|FG001|Overall Study|Withdrawal by Subject|0|||
41935888|NCT02447718|75643429|FG000|Overall Study|Screen Failure|1|||
41935889|NCT02447718|75643430|FG001|Overall Study|Screen Failure|0|||
41935890|NCT02486406|75643607|FG000|Overall Study|Withdrew consent|1|||
41935891|NCT02486406|75643608|FG001|Overall Study|Withdrew consent|0|||
41935892|NCT02486406|75643609|FG002|Overall Study|Withdrew consent|0|||
41935893|NCT02486406|75643610|FG003|Overall Study|Withdrew consent|1|||
41935894|NCT02486406|75643607|FG000|Overall Study|Lost to Follow-up|1|||
41935895|NCT02486406|75643608|FG001|Overall Study|Lost to Follow-up|3|||
41935896|NCT02486406|75643609|FG002|Overall Study|Lost to Follow-up|1|||
41935897|NCT02486406|75643610|FG003|Overall Study|Lost to Follow-up|3|||
41935898|NCT02486406|75643607|FG000|Overall Study|Other, not specified|0|||
41935899|NCT02486406|75643608|FG001|Overall Study|Other, not specified|0|||
41935900|NCT02486406|75643609|FG002|Overall Study|Other, not specified|1|||
41935901|NCT02486406|75643610|FG003|Overall Study|Other, not specified|0|||
41935902|NCT02485704|75643682|FG000|Overall Study|Lost to Follow-up|4|||
41935903|NCT02485704|75643683|FG001|Overall Study|Lost to Follow-up|5|||
41935904|NCT02485704|75643682|FG000|Overall Study|Withdrawal by Subject|0|||
41935905|NCT02485704|75643683|FG001|Overall Study|Withdrawal by Subject|3|||
41935906|NCT02485704|75643682|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
41935907|NCT02485704|75643683|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
41935908|NCT02485158|75643693|FG000|Overall Study|Withdrawal by Subject|3|||
41935909|NCT02485158|75643693|FG000|Overall Study|expected drug side effect|1|||
41935910|NCT02455518|75643712|FG000|Overall Study|Protocol Violation|0|||
41935911|NCT02455518|75643713|FG001|Overall Study|Protocol Violation|1|||
41935912|NCT02455518|75643714|FG002|Overall Study|Protocol Violation|1|||
41935913|NCT02455518|75643715|FG003|Overall Study|Protocol Violation|3|||
41935914|NCT02240069|75643933|FG000|Overall Study|Withdrawal by Subject|5|||
41935915|NCT02240069|75643934|FG001|Overall Study|Withdrawal by Subject|5|||
41935916|NCT02240069|75643935|FG002|Overall Study|Withdrawal by Subject|2|||
41935917|NCT02484690|75644021|FG000|Overall Study|Adverse Event|1|||
41935918|NCT02484690|75644022|FG001|Overall Study|Adverse Event|3|||
41935919|NCT02484690|75644023|FG002|Overall Study|Adverse Event|0|||
41935920|NCT02484690|75644024|FG003|Overall Study|Adverse Event|0|||
41935921|NCT02484690|75644025|FG004|Overall Study|Adverse Event|5|||
41935922|NCT02484690|75644021|FG000|Overall Study|Death|0|||
41935923|NCT02484690|75644022|FG001|Overall Study|Death|0|||
41935924|NCT02484690|75644023|FG002|Overall Study|Death|0|||
41935925|NCT02484690|75644024|FG003|Overall Study|Death|0|||
41935926|NCT02484690|75644025|FG004|Overall Study|Death|1|||
41935927|NCT02484690|75644021|FG000|Overall Study|Withdrawal by Subject|1|||
41935928|NCT02484690|75644022|FG001|Overall Study|Withdrawal by Subject|3|||
41935929|NCT02484690|75644023|FG002|Overall Study|Withdrawal by Subject|1|||
41935930|NCT02484690|75644024|FG003|Overall Study|Withdrawal by Subject|2|||
41935931|NCT02484690|75644025|FG004|Overall Study|Withdrawal by Subject|0|||
41935932|NCT02484690|75644021|FG000|Overall Study|Physician Decision|2|||
41935933|NCT02484690|75644022|FG001|Overall Study|Physician Decision|0|||
41935934|NCT02484690|75644023|FG002|Overall Study|Physician Decision|1|||
41935935|NCT02484690|75644024|FG003|Overall Study|Physician Decision|0|||
41935936|NCT02484690|75644025|FG004|Overall Study|Physician Decision|0|||
41935937|NCT02484690|75644021|FG000|Overall Study|Lost to Follow-up|0|||
41935938|NCT02484690|75644022|FG001|Overall Study|Lost to Follow-up|0|||
41935939|NCT02484690|75644023|FG002|Overall Study|Lost to Follow-up|1|||
41935940|NCT02484690|75644024|FG003|Overall Study|Lost to Follow-up|0|||
41935941|NCT02484690|75644025|FG004|Overall Study|Lost to Follow-up|0|||
42022235|NCT00960934|75829532|FG002|Overall Study|Withdrawal by Subject|4|||
42117955|NCT00553358|75928797|FG001|Overall Study|Died during clinical follow-up|29|||
42117956|NCT00553358|75928798|FG002|Overall Study|Died during clinical follow-up|32|||
42117957|NCT00553358|75928796|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
41935942|NCT01654224|75644049|FG000|Overall Study|Lost to Follow-up|2|||
41935943|NCT01654224|75644050|FG001|Overall Study|Lost to Follow-up|2|||
41935944|NCT01654224|75644049|FG000|Overall Study|Did not receive allocation|1|||
41935945|NCT01654224|75644050|FG001|Overall Study|Did not receive allocation|8|||
41935946|NCT01654224|75644049|FG000|Overall Study|Insufficient blood sample|3|||
41935947|NCT01654224|75644050|FG001|Overall Study|Insufficient blood sample|2|||
41935948|NCT02447328|75644056|FG000|Overall Study|Withdrawal by Subject|1|||
41935949|NCT02447250|75644060|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
41935950|NCT02447250|75644060|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
41935951|NCT02447250|75644060|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
41935952|NCT02447172|75644164|FG000|Overall Study|Adverse Event|11|||
41935953|NCT02447172|75644165|FG001|Overall Study|Adverse Event|8|||
42022236|NCT00960934|75829533|FG003|Overall Study|Withdrawal by Subject|5|||
41935954|NCT02447172|75644166|FG002|Overall Study|Adverse Event|7|||
41935955|NCT02447172|75644164|FG000|Overall Study|Death|3|||
41935956|NCT02447172|75644165|FG001|Overall Study|Death|1|||
41935957|NCT02447172|75644166|FG002|Overall Study|Death|0|||
41935958|NCT02447172|75644164|FG000|Overall Study|Protocol Violation|2|||
41935959|NCT02447172|75644165|FG001|Overall Study|Protocol Violation|1|||
41935960|NCT02447172|75644166|FG002|Overall Study|Protocol Violation|2|||
41935961|NCT02447172|75644164|FG000|Overall Study|Lost to Follow-up|7|||
41935962|NCT02447172|75644165|FG001|Overall Study|Lost to Follow-up|4|||
41935963|NCT02447172|75644166|FG002|Overall Study|Lost to Follow-up|4|||
41935964|NCT02447172|75644164|FG000|Overall Study|Withdrawal by Subject|5|||
41935965|NCT02447172|75644165|FG001|Overall Study|Withdrawal by Subject|1|||
41935966|NCT02447172|75644166|FG002|Overall Study|Withdrawal by Subject|3|||
41935967|NCT02447172|75644164|FG000|Overall Study|protocol specific treatment unrelated|3|||
41935968|NCT02447172|75644165|FG001|Overall Study|protocol specific treatment unrelated|0|||
41935969|NCT02447172|75644166|FG002|Overall Study|protocol specific treatment unrelated|2|||
41935970|NCT02455050|75644199|FG000|Treatment Period 1|Lost to Follow-up|1|||
41935971|NCT02455050|75644200|FG001|Treatment Period 1|Lost to Follow-up|1|||
41935972|NCT02455050|75644201|FG002|Treatment Period 1|Lost to Follow-up|1|||
41935973|NCT02455050|75644202|FG003|Treatment Period 1|Lost to Follow-up|2|||
41935974|NCT02455050|75644199|FG000|Treatment Period 2|Lost to Follow-up|1|||
41935975|NCT02455050|75644200|FG001|Treatment Period 2|Lost to Follow-up|0|||
41935976|NCT02455050|75644201|FG002|Treatment Period 2|Lost to Follow-up|2|||
41935977|NCT02455050|75644202|FG003|Treatment Period 2|Lost to Follow-up|1|||
41935978|NCT02418468|75644242|FG000|Overall Study|Adverse Event|1|||
41935979|NCT02418468|75644243|FG001|Overall Study|Adverse Event|0|||
41935980|NCT02418468|75644242|FG000|Overall Study|Withdrawal of informed consent|1|||
41935981|NCT02418468|75644243|FG001|Overall Study|Withdrawal of informed consent|1|||
41935982|NCT02418000|75644374|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
41935983|NCT02418000|75644375|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
41935984|NCT02418000|75644376|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
41935985|NCT02418000|75644377|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
41935986|NCT02418000|75644378|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
41935987|NCT02418000|75644374|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
41935988|NCT02418000|75644375|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
41935989|NCT02418000|75644376|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
41935990|NCT02418000|75644377|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
41935991|NCT02418000|75644378|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
41935992|NCT02418000|75644374|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
41935993|NCT02418000|75644375|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
41935994|NCT02418000|75644376|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
41935995|NCT02418000|75644377|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
41935996|NCT02418000|75644378|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
41935997|NCT02418000|75644374|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
41935998|NCT02418000|75644375|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
41935999|NCT02418000|75644376|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
41936000|NCT02418000|75644377|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
41936001|NCT02418000|75644378|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
41936002|NCT02418000|75644374|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
41936003|NCT02418000|75644375|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
41936004|NCT02418000|75644376|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
41936005|NCT02418000|75644377|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
41936006|NCT02418000|75644378|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
41936007|NCT02418000|75644374|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
41936008|NCT02418000|75644375|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
41936009|NCT02418000|75644376|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
41936010|NCT02418000|75644377|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
41936011|NCT02418000|75644378|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
41936012|NCT02418000|75644374|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
41936013|NCT02418000|75644375|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
42022237|NCT00960934|75829534|FG004|Overall Study|Withdrawal by Subject|5|||
42022238|NCT00960934|75829535|FG005|Overall Study|Withdrawal by Subject|7|||
42117958|NCT00553358|75928797|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
41936014|NCT02418000|75644376|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
41936015|NCT02418000|75644377|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
41936016|NCT02418000|75644378|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
41936017|NCT02418000|75644374|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
41936018|NCT02418000|75644375|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
41936019|NCT02418000|75644376|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
41936020|NCT02418000|75644377|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
41936021|NCT02418000|75644378|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
41936022|NCT02418000|75644374|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
41936023|NCT02418000|75644375|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
41936024|NCT02418000|75644376|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
41936025|NCT02418000|75644377|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
41936026|NCT02418000|75644378|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
42117959|NCT00553358|75928798|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
41936027|NCT02417064|75644482|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
41936028|NCT02417064|75644483|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
41936029|NCT02417064|75644484|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
41936030|NCT02417064|75644482|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
41936031|NCT02417064|75644483|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
41936032|NCT02417064|75644484|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
41936033|NCT02417064|75644482|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
41936034|NCT02417064|75644483|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
41936035|NCT02417064|75644484|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
41936036|NCT02417064|75644482|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
41936037|NCT02417064|75644483|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
41936038|NCT02417064|75644484|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
41936039|NCT02417064|75644482|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
41936040|NCT02417064|75644483|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
41936041|NCT02417064|75644484|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
41936042|NCT02417064|75644482|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
41936043|NCT02417064|75644483|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
41936044|NCT02417064|75644484|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
41936045|NCT02417064|75644482|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
41936046|NCT02417064|75644483|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
41936047|NCT02417064|75644484|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
41936048|NCT02417064|75644482|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
41936049|NCT02417064|75644483|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
41936050|NCT02417064|75644484|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
41936051|NCT02417064|75644482|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
41936052|NCT02417064|75644483|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
41936053|NCT02417064|75644484|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
41936054|NCT02417064|75644482|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
41936055|NCT02417064|75644483|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
41936056|NCT02417064|75644484|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
41936057|NCT02417064|75644482|FG000|Follow-up Phase (24 Weeks)|Other|2|||
41936058|NCT02417064|75644483|FG001|Follow-up Phase (24 Weeks)|Other|2|||
41936059|NCT02417064|75644484|FG002|Follow-up Phase (24 Weeks)|Other|3|||
41936060|NCT01653132|75644499|FG000|First Intervention|Protocol Violation|1|||
41936061|NCT01653132|75644500|FG001|First Intervention|Protocol Violation|0|||
41936062|NCT02453334|75644525|FG000|Overall Study|Death|15|||
41936063|NCT02453334|75644526|FG001|Overall Study|Death|13|||
41936064|NCT02453334|75644525|FG000|Overall Study|Adverse Event|2|||
41936065|NCT02453334|75644526|FG001|Overall Study|Adverse Event|1|||
41936066|NCT02453334|75644525|FG000|Overall Study|Lost to Follow-up|5|||
41936067|NCT02453334|75644526|FG001|Overall Study|Lost to Follow-up|9|||
41936068|NCT02453334|75644525|FG000|Overall Study|Physician Decision|1|||
41936069|NCT02453334|75644526|FG001|Overall Study|Physician Decision|0|||
41936070|NCT02453334|75644525|FG000|Overall Study|Withdrawal by Subject|17|||
41936071|NCT02453334|75644526|FG001|Overall Study|Withdrawal by Subject|13|||
41936072|NCT02453334|75644525|FG000|Overall Study|Other reason|1|||
41936073|NCT02453334|75644526|FG001|Overall Study|Other reason|4|||
41936074|NCT02443740|75644612|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
41936075|NCT02443740|75644613|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
42022239|NCT00960934|75829530|FG000|Overall Study|Study Terminated by Sponsor|50|||
42022240|NCT00960934|75829531|FG001|Overall Study|Study Terminated by Sponsor|46|||
42022241|NCT00960934|75829532|FG002|Overall Study|Study Terminated by Sponsor|52|||
41936076|NCT02443740|75644614|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
41936077|NCT02443740|75644615|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
41936078|NCT02443740|75644616|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
41936079|NCT02443740|75644617|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
41936080|NCT02443740|75644618|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
41936081|NCT02443740|75644619|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
41936082|NCT02443740|75644620|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
41936083|NCT02443740|75644621|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
41936084|NCT02443740|75644622|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
41936085|NCT02443740|75644612|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
41936086|NCT02443740|75644613|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
41936087|NCT02443740|75644614|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
41936088|NCT02443740|75644615|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
41936089|NCT02443740|75644616|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
41936090|NCT02443740|75644617|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
41936091|NCT02443740|75644618|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
41936092|NCT02443740|75644619|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
41936093|NCT02443740|75644620|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
41936094|NCT02443740|75644621|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
41936095|NCT02443740|75644622|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
41936096|NCT02443740|75644612|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
41936097|NCT02443740|75644613|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
41936098|NCT02443740|75644614|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
41936099|NCT02443740|75644615|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
41936100|NCT02443740|75644616|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
41936101|NCT02443740|75644617|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
41936102|NCT02443740|75644618|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
41936103|NCT02443740|75644619|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
41936104|NCT02443740|75644620|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
41936105|NCT02443740|75644621|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
41936106|NCT02443740|75644622|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
41936107|NCT02416908|75644853|FG000|Dose Escalation Phase|Adverse Event|0|||
41936108|NCT02416908|75644854|FG001|Dose Escalation Phase|Adverse Event|0|||
41936109|NCT02416908|75644855|FG002|Dose Escalation Phase|Adverse Event|3|||
41936110|NCT02416908|75644856|FG003|Dose Escalation Phase|Adverse Event|0|||
41936111|NCT02416908|75644853|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
41936112|NCT02416908|75644854|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
41936113|NCT02416908|75644855|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
41936114|NCT02416908|75644856|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
41936115|NCT02453256|75644946|FG000|Double Blind Period|Death|1|||
41936116|NCT02453256|75644947|FG001|Double Blind Period|Death|1|||
41936117|NCT02453256|75644946|FG000|Double Blind Period|Adverse Event|3|||
41936118|NCT02453256|75644947|FG001|Double Blind Period|Adverse Event|2|||
42022242|NCT00960934|75829533|FG003|Overall Study|Study Terminated by Sponsor|50|||
42022243|NCT00960934|75829534|FG004|Overall Study|Study Terminated by Sponsor|49|||
42022244|NCT00960934|75829535|FG005|Overall Study|Study Terminated by Sponsor|49|||
42022245|NCT00892177|75829552|FG000|Phase II|Ineligible|0|||
42022246|NCT00892177|75829553|FG001|Phase II|Ineligible|0|||
42022247|NCT00892177|75829554|FG002|Phase II|Ineligible|0|||
42022248|NCT00892177|75829555|FG003|Phase II|Ineligible|0|||
42022249|NCT00892177|75829556|FG004|Phase II|Ineligible|1|||
42022250|NCT00892177|75829557|FG005|Phase II|Ineligible|1|||
42022251|NCT00892177|75829552|FG000|Phase II|Withdrawal by Subject|0|||
42022252|NCT00892177|75829553|FG001|Phase II|Withdrawal by Subject|0|||
41936119|NCT02453256|75644946|FG000|Double Blind Period|Withdrawal by Subject|9|||
41936120|NCT02453256|75644947|FG001|Double Blind Period|Withdrawal by Subject|5|||
41936121|NCT02453256|75644946|FG000|Double Blind Period|Other|0|||
41936122|NCT02453256|75644947|FG001|Double Blind Period|Other|1|||
41936123|NCT02453256|75644946|FG000|Open Label Period|Adverse Event|1|||
41936124|NCT02453256|75644947|FG001|Open Label Period|Adverse Event|3|||
41936125|NCT02453256|75644946|FG000|Open Label Period|Death|0|||
41936126|NCT02453256|75644947|FG001|Open Label Period|Death|1|||
42022253|NCT00892177|75829554|FG002|Phase II|Withdrawal by Subject|0|||
42022254|NCT00892177|75829555|FG003|Phase II|Withdrawal by Subject|0|||
42022255|NCT00892177|75829556|FG004|Phase II|Withdrawal by Subject|4|||
41936127|NCT02453256|75644946|FG000|Open Label Period|Lost to Follow-up|1|||
41936128|NCT02453256|75644947|FG001|Open Label Period|Lost to Follow-up|0|||
42022256|NCT00892177|75829557|FG005|Phase II|Withdrawal by Subject|1|||
42022257|NCT00962104|75829574|FG000|Overall Study|Adverse Event|10|||
41936129|NCT02453256|75644946|FG000|Open Label Period|Other|0|||
41936130|NCT02453256|75644947|FG001|Open Label Period|Other|2|||
42022258|NCT00962104|75829575|FG001|Overall Study|Adverse Event|3|||
41936131|NCT02453256|75644946|FG000|Open Label Period|Withdrawal by Subject|5|||
42022259|NCT00962104|75829574|FG000|Overall Study|Entry Criteria Not Met|1|||
42022260|NCT00962104|75829575|FG001|Overall Study|Entry Criteria Not Met|2|||
41936132|NCT02453256|75644947|FG001|Open Label Period|Withdrawal by Subject|1|||
41936133|NCT02442804|75644962|FG000|Overall Study|Withdrawal by Subject|0|||
41936134|NCT02442804|75644963|FG001|Overall Study|Withdrawal by Subject|1|||
41936135|NCT02442804|75644962|FG000|Overall Study|Adverse Event|1|||
41936136|NCT02442804|75644963|FG001|Overall Study|Adverse Event|0|||
41936137|NCT02414958|75645052|FG000|Overall Study|Adverse Event|6|||
41936138|NCT02414958|75645053|FG001|Overall Study|Adverse Event|6|||
41936139|NCT02414958|75645054|FG002|Overall Study|Adverse Event|3|||
41936140|NCT02414958|75645052|FG000|Overall Study|Protocol Violation|10|||
41936141|NCT02414958|75645053|FG001|Overall Study|Protocol Violation|3|||
41936142|NCT02414958|75645054|FG002|Overall Study|Protocol Violation|1|||
41936143|NCT02414958|75645052|FG000|Overall Study|Lost to Follow-up|7|||
41936144|NCT02414958|75645053|FG001|Overall Study|Lost to Follow-up|4|||
41936145|NCT02414958|75645054|FG002|Overall Study|Lost to Follow-up|0|||
41936146|NCT02414958|75645052|FG000|Overall Study|Withdrawal by Subject|5|||
41936147|NCT02414958|75645053|FG001|Overall Study|Withdrawal by Subject|3|||
41936148|NCT02414958|75645054|FG002|Overall Study|Withdrawal by Subject|5|||
41936149|NCT02414958|75645052|FG000|Overall Study|Other than specified|4|||
41936150|NCT02414958|75645053|FG001|Overall Study|Other than specified|4|||
41936151|NCT02414958|75645054|FG002|Overall Study|Other than specified|5|||
42210239|NCT03297294|76024987|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
42210240|NCT03297294|76024988|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
42210241|NCT03297294|76024984|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
42210242|NCT03297294|76024985|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
41936152|NCT02452476|75645127|FG000|Overall Study|Death|4|||
41936153|NCT02452476|75645128|FG001|Overall Study|Death|7|||
41936154|NCT02452476|75645127|FG000|Overall Study|Lost to Follow-up|1|||
41936155|NCT02452476|75645128|FG001|Overall Study|Lost to Follow-up|1|||
41936156|NCT02452476|75645127|FG000|Overall Study|Physician Decision|1|||
41936157|NCT02452476|75645128|FG001|Overall Study|Physician Decision|1|||
41936158|NCT02452476|75645127|FG000|Overall Study|Not treated|5|||
41936159|NCT02452476|75645128|FG001|Overall Study|Not treated|1|||
41936160|NCT02442336|75645143|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
41936161|NCT02442336|75645143|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
41936162|NCT02442336|75645143|FG000|Overall Study|Lost to Follow-up|11|||
41936163|NCT02452398|75645147|FG000|Overall Study|Adverse Event|1|||
41936164|NCT02452398|75645147|FG000|Overall Study|Lost to Follow-up|28|||
41936165|NCT02452398|75645147|FG000|Overall Study|Physician Decision|2|||
41936166|NCT02452398|75645147|FG000|Overall Study|Withdrawal by Subject|6|||
41936167|NCT02452398|75645147|FG000|Overall Study|Moved away|4|||
41936168|NCT02413398|75645153|FG000|Overall Study|Lost to Follow-up|2|||
41936169|NCT02413398|75645154|FG001|Overall Study|Lost to Follow-up|4|||
41936170|NCT02413398|75645153|FG000|Overall Study|Withdrawal by Subject|1|||
41936171|NCT02413398|75645154|FG001|Overall Study|Withdrawal by Subject|1|||
41936172|NCT02413398|75645153|FG000|Overall Study|Other Eligibility criteria|1|||
41936173|NCT02413398|75645154|FG001|Overall Study|Other Eligibility criteria|2|||
41936174|NCT02441946|75645163|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
41936175|NCT02441946|75645164|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
41936176|NCT02441946|75645165|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
41936177|NCT02441946|75645163|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
41936178|NCT02441946|75645164|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
42022261|NCT00962104|75829574|FG000|Overall Study|Lack of Efficacy|0|||
42022262|NCT00962104|75829575|FG001|Overall Study|Lack of Efficacy|1|||
42022263|NCT00962104|75829574|FG000|Overall Study|Lost to Follow-up|10|||
42022264|NCT00962104|75829575|FG001|Overall Study|Lost to Follow-up|4|||
42022265|NCT00962104|75829574|FG000|Overall Study|Physician Decision|1|||
42022266|NCT00962104|75829575|FG001|Overall Study|Physician Decision|0|||
42022267|NCT00962104|75829574|FG000|Overall Study|Protocol Violation|6|||
42022268|NCT00962104|75829575|FG001|Overall Study|Protocol Violation|8|||
42022269|NCT00962104|75829574|FG000|Overall Study|Sponsor Decision|0|||
42022270|NCT00962104|75829575|FG001|Overall Study|Sponsor Decision|1|||
42117960|NCT00553358|75928796|FG000|Overall Study|Died after clinical follow-up ended|1|||
42117961|NCT00553358|75928797|FG001|Overall Study|Died after clinical follow-up ended|2|||
42117962|NCT00553358|75928798|FG002|Overall Study|Died after clinical follow-up ended|0|||
41936179|NCT02441946|75645165|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
41936180|NCT02441946|75645163|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
41936181|NCT02441946|75645164|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
42022271|NCT00962104|75829574|FG000|Overall Study|Withdrawal by Subject|10|||
42022272|NCT00962104|75829575|FG001|Overall Study|Withdrawal by Subject|6|||
42022273|NCT00962104|75829574|FG000|Overall Study|Other|2|||
42117963|NCT00553358|75928796|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
42117964|NCT00553358|75928797|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
42022274|NCT00962104|75829575|FG001|Overall Study|Other|0|||
42022275|NCT02821000|75829581|FG000|Overall Study|Death|44|||
42117965|NCT00553358|75928798|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
42117966|NCT00688259|75928814|FG000|Overall Study|Lost to Follow-up|2|||
41936182|NCT02441946|75645165|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
41936183|NCT02441946|75645163|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
41936184|NCT02441946|75645164|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
41936185|NCT02441946|75645165|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
41936186|NCT02441946|75645163|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
41936187|NCT02441946|75645164|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
41936188|NCT02441946|75645165|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
41936189|NCT02441946|75645163|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
41936190|NCT02441946|75645164|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
41936191|NCT02441946|75645165|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
41936192|NCT02441946|75645163|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
41936193|NCT02441946|75645164|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
41936194|NCT02441946|75645165|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
41936195|NCT02441946|75645163|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
41936196|NCT02441946|75645164|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
41936197|NCT02441946|75645165|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
41936198|NCT02441946|75645163|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
41936199|NCT02441946|75645164|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
41936200|NCT02441946|75645165|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
41936201|NCT02441946|75645163|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
41936202|NCT02441946|75645164|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
41936203|NCT02441946|75645165|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
41936204|NCT02441946|75645163|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
41936205|NCT02441946|75645164|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
41936206|NCT02441946|75645165|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
41936207|NCT02387580|75645199|FG000|Overall Study|Withdrawal by Subject|0|||
41936208|NCT02387580|75645200|FG001|Overall Study|Withdrawal by Subject|0|||
41936209|NCT02387580|75645201|FG002|Overall Study|Withdrawal by Subject|0|||
41936210|NCT02387580|75645202|FG003|Overall Study|Withdrawal by Subject|1|||
41936211|NCT02387580|75645203|FG004|Overall Study|Withdrawal by Subject|0|||
41936212|NCT02387580|75645204|FG005|Overall Study|Withdrawal by Subject|0|||
41936213|NCT02440854|75645220|FG000|Overall Study|Relocation of patient|1|||
41936214|NCT02440854|75645220|FG000|Overall Study|Death|6|||
41936215|NCT02440854|75645220|FG000|Overall Study|Lost to Follow-up|10|||
41936216|NCT02440854|75645220|FG000|Overall Study|Afatinib discontinuation|46|||
41936217|NCT02440854|75645220|FG000|Overall Study|stopped study at earlier timepoint|14|||
41936218|NCT02440854|75645220|FG000|Overall Study|Study medication not received|1|||
41936219|NCT02440854|75645220|FG000|Overall Study|Violation of inclusion criteria|2|||
41936220|NCT02412852|75645275|FG000|Overall Study|Withdrawal by Subject|0|||
41936221|NCT02412852|75645276|FG001|Overall Study|Withdrawal by Subject|1|||
41936222|NCT02412852|75645277|FG002|Overall Study|Withdrawal by Subject|0|||
41936223|NCT02412852|75645278|FG003|Overall Study|Withdrawal by Subject|0|||
41936224|NCT02412852|75645275|FG000|Overall Study|Physician Decision|0|||
41936225|NCT02412852|75645276|FG001|Overall Study|Physician Decision|0|||
41936226|NCT02412852|75645277|FG002|Overall Study|Physician Decision|0|||
41936227|NCT02412852|75645278|FG003|Overall Study|Physician Decision|1|||
41936228|NCT02386098|75645334|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
41936229|NCT02386098|75645335|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
41936230|NCT02386098|75645336|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
41936231|NCT02386098|75645337|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
41936232|NCT02386098|75645338|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
41936233|NCT02386098|75645334|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
41936234|NCT02386098|75645335|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
41936235|NCT02386098|75645336|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
41936236|NCT02386098|75645337|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
41936237|NCT02386098|75645338|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
41936238|NCT02386098|75645334|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
41936239|NCT02386098|75645335|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
41936240|NCT02386098|75645336|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
41936241|NCT02386098|75645337|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
41936242|NCT02386098|75645338|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
41936243|NCT02386098|75645334|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
41936244|NCT02386098|75645335|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
41936245|NCT02386098|75645336|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
41936246|NCT02386098|75645337|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
41936247|NCT02386098|75645338|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
41936248|NCT02386098|75645334|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
41936249|NCT02386098|75645335|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
41936250|NCT02386098|75645336|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
41936251|NCT02386098|75645337|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
41936252|NCT02386098|75645338|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
41936253|NCT02386098|75645334|FG000|Stage 1 (96 Weeks)|Other|1|||
41936254|NCT02386098|75645335|FG001|Stage 1 (96 Weeks)|Other|0|||
41936255|NCT02386098|75645336|FG002|Stage 1 (96 Weeks)|Other|0|||
41936256|NCT02386098|75645337|FG003|Stage 1 (96 Weeks)|Other|0|||
41936257|NCT02386098|75645338|FG004|Stage 1 (96 Weeks)|Other|0|||
41936258|NCT02386098|75645334|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
41936259|NCT02386098|75645335|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
41936260|NCT02386098|75645336|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
41936261|NCT02386098|75645337|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
41936262|NCT02386098|75645338|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
41936263|NCT02412618|75645381|FG000|Overall Study|Withdrawal by Subject|1|||
41936264|NCT02412618|75645382|FG001|Overall Study|Withdrawal by Subject|1|||
41936265|NCT02412618|75645381|FG000|Overall Study|Expulsion|1|||
41936266|NCT02412618|75645382|FG001|Overall Study|Expulsion|1|||
41936267|NCT00585195|75645579|FG000|Overall Study|Adverse Event|0|||
41936268|NCT00585195|75645580|FG001|Overall Study|Adverse Event|0|||
41936269|NCT00585195|75645581|FG002|Overall Study|Adverse Event|0|||
41936270|NCT00585195|75645582|FG003|Overall Study|Adverse Event|0|||
41936271|NCT00585195|75645583|FG004|Overall Study|Adverse Event|2|||
41936272|NCT00585195|75645584|FG005|Overall Study|Adverse Event|1|||
41936273|NCT00585195|75645585|FG006|Overall Study|Adverse Event|0|||
41936274|NCT00585195|75645586|FG007|Overall Study|Adverse Event|1|||
41936275|NCT00585195|75645587|FG008|Overall Study|Adverse Event|0|||
41936276|NCT00585195|75645588|FG009|Overall Study|Adverse Event|0|||
41936277|NCT00585195|75645589|FG010|Overall Study|Adverse Event|3|||
41936278|NCT00585195|75645590|FG011|Overall Study|Adverse Event|0|||
41936279|NCT00585195|75645591|FG012|Overall Study|Adverse Event|8|||
41936280|NCT00585195|75645592|FG013|Overall Study|Adverse Event|6|||
41936281|NCT00585195|75645593|FG014|Overall Study|Adverse Event|4|||
41936282|NCT00585195|75645594|FG015|Overall Study|Adverse Event|1|||
41936283|NCT00585195|75645595|FG016|Overall Study|Adverse Event|14|||
41936284|NCT00585195|75645596|FG017|Overall Study|Adverse Event|9|||
41936285|NCT00585195|75645597|FG018|Overall Study|Adverse Event|2|||
41936286|NCT00585195|75645598|FG019|Overall Study|Adverse Event|3|||
41936287|NCT00585195|75645599|FG020|Overall Study|Adverse Event|1|||
41936288|NCT00585195|75645579|FG000|Overall Study|Progressive Disease|2|||
41936289|NCT00585195|75645580|FG001|Overall Study|Progressive Disease|2|||
41936290|NCT00585195|75645581|FG002|Overall Study|Progressive Disease|5|||
41936291|NCT00585195|75645582|FG003|Overall Study|Progressive Disease|4|||
41936292|NCT00585195|75645583|FG004|Overall Study|Progressive Disease|6|||
41936293|NCT00585195|75645584|FG005|Overall Study|Progressive Disease|4|||
41936294|NCT00585195|75645585|FG006|Overall Study|Progressive Disease|6|||
41936295|NCT00585195|75645586|FG007|Overall Study|Progressive Disease|3|||
41936296|NCT00585195|75645587|FG008|Overall Study|Progressive Disease|0|||
41936297|NCT00585195|75645588|FG009|Overall Study|Progressive Disease|5|||
41936298|NCT00585195|75645589|FG010|Overall Study|Progressive Disease|2|||
41936299|NCT00585195|75645590|FG011|Overall Study|Progressive Disease|25|||
41936300|NCT00585195|75645591|FG012|Overall Study|Progressive Disease|29|||
41936301|NCT00585195|75645592|FG013|Overall Study|Progressive Disease|26|||
41936302|NCT00585195|75645593|FG014|Overall Study|Progressive Disease|21|||
41936303|NCT00585195|75645594|FG015|Overall Study|Progressive Disease|12|||
41936304|NCT00585195|75645595|FG016|Overall Study|Progressive Disease|94|||
41936305|NCT00585195|75645596|FG017|Overall Study|Progressive Disease|42|||
41936306|NCT00585195|75645597|FG018|Overall Study|Progressive Disease|4|||
41936307|NCT00585195|75645598|FG019|Overall Study|Progressive Disease|9|||
41936308|NCT00585195|75645599|FG020|Overall Study|Progressive Disease|8|||
41936309|NCT00585195|75645579|FG000|Overall Study|Withdrawal by Subject|1|||
41936310|NCT00585195|75645580|FG001|Overall Study|Withdrawal by Subject|1|||
41936311|NCT00585195|75645581|FG002|Overall Study|Withdrawal by Subject|2|||
41936312|NCT00585195|75645582|FG003|Overall Study|Withdrawal by Subject|2|||
41936313|NCT00585195|75645583|FG004|Overall Study|Withdrawal by Subject|0|||
41936314|NCT00585195|75645584|FG005|Overall Study|Withdrawal by Subject|0|||
41936315|NCT00585195|75645585|FG006|Overall Study|Withdrawal by Subject|0|||
41936316|NCT00585195|75645586|FG007|Overall Study|Withdrawal by Subject|1|||
42022276|NCT02821000|75829581|FG000|Overall Study|Withdrawal by Subject|1|||
42022277|NCT02821000|75829581|FG000|Overall Study|Ongoing in Study|58|||
42022278|NCT00892099|75829588|FG000|Overall Study|Death|1|||
41936317|NCT00585195|75645587|FG008|Overall Study|Withdrawal by Subject|0|||
41936318|NCT00585195|75645588|FG009|Overall Study|Withdrawal by Subject|0|||
41936319|NCT00585195|75645589|FG010|Overall Study|Withdrawal by Subject|3|||
41936320|NCT00585195|75645590|FG011|Overall Study|Withdrawal by Subject|8|||
41936321|NCT00585195|75645591|FG012|Overall Study|Withdrawal by Subject|15|||
41936322|NCT00585195|75645592|FG013|Overall Study|Withdrawal by Subject|0|||
41936323|NCT00585195|75645593|FG014|Overall Study|Withdrawal by Subject|3|||
41936324|NCT00585195|75645594|FG015|Overall Study|Withdrawal by Subject|0|||
41936325|NCT00585195|75645595|FG016|Overall Study|Withdrawal by Subject|7|||
41936326|NCT00585195|75645596|FG017|Overall Study|Withdrawal by Subject|1|||
41936327|NCT00585195|75645597|FG018|Overall Study|Withdrawal by Subject|2|||
41936328|NCT00585195|75645598|FG019|Overall Study|Withdrawal by Subject|2|||
41936329|NCT00585195|75645599|FG020|Overall Study|Withdrawal by Subject|0|||
41936330|NCT00585195|75645579|FG000|Overall Study|Other|0|||
41936331|NCT00585195|75645580|FG001|Overall Study|Other|1|||
41936332|NCT00585195|75645581|FG002|Overall Study|Other|1|||
41936333|NCT00585195|75645582|FG003|Overall Study|Other|1|||
41936334|NCT00585195|75645583|FG004|Overall Study|Other|0|||
41936335|NCT00585195|75645584|FG005|Overall Study|Other|1|||
41936336|NCT00585195|75645585|FG006|Overall Study|Other|0|||
41936337|NCT00585195|75645586|FG007|Overall Study|Other|0|||
41936338|NCT00585195|75645587|FG008|Overall Study|Other|2|||
41936339|NCT00585195|75645588|FG009|Overall Study|Other|1|||
41936340|NCT00585195|75645589|FG010|Overall Study|Other|0|||
41936341|NCT00585195|75645590|FG011|Overall Study|Other|19|||
42210243|NCT03297294|76024986|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
42210244|NCT03297294|76024987|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
41936342|NCT00585195|75645591|FG012|Overall Study|Other|24|||
41936343|NCT00585195|75645592|FG013|Overall Study|Other|7|||
41936344|NCT00585195|75645593|FG014|Overall Study|Other|11|||
41936345|NCT00585195|75645594|FG015|Overall Study|Other|3|||
41936346|NCT00585195|75645595|FG016|Overall Study|Other|28|||
41936347|NCT00585195|75645596|FG017|Overall Study|Other|12|||
41936348|NCT00585195|75645597|FG018|Overall Study|Other|10|||
41936349|NCT00585195|75645598|FG019|Overall Study|Other|4|||
41936350|NCT00585195|75645599|FG020|Overall Study|Other|2|||
41936351|NCT00585195|75645579|FG000|Overall Study|Randomized not treated|0|||
41936352|NCT00585195|75645580|FG001|Overall Study|Randomized not treated|0|||
41936353|NCT00585195|75645581|FG002|Overall Study|Randomized not treated|1|||
41936354|NCT00585195|75645582|FG003|Overall Study|Randomized not treated|0|||
41936355|NCT00585195|75645583|FG004|Overall Study|Randomized not treated|1|||
41936356|NCT00585195|75645584|FG005|Overall Study|Randomized not treated|0|||
41936357|NCT00585195|75645585|FG006|Overall Study|Randomized not treated|1|||
41936358|NCT00585195|75645586|FG007|Overall Study|Randomized not treated|0|||
41936359|NCT00585195|75645587|FG008|Overall Study|Randomized not treated|0|||
41936360|NCT00585195|75645588|FG009|Overall Study|Randomized not treated|0|||
41936361|NCT00585195|75645589|FG010|Overall Study|Randomized not treated|2|||
41936362|NCT00585195|75645590|FG011|Overall Study|Randomized not treated|0|||
41936363|NCT00585195|75645591|FG012|Overall Study|Randomized not treated|0|||
41936364|NCT00585195|75645592|FG013|Overall Study|Randomized not treated|0|||
41936365|NCT00585195|75645593|FG014|Overall Study|Randomized not treated|0|||
41936366|NCT00585195|75645594|FG015|Overall Study|Randomized not treated|1|||
41936367|NCT00585195|75645595|FG016|Overall Study|Randomized not treated|0|||
41936368|NCT00585195|75645596|FG017|Overall Study|Randomized not treated|1|||
41936369|NCT00585195|75645597|FG018|Overall Study|Randomized not treated|3|||
41936370|NCT00585195|75645598|FG019|Overall Study|Randomized not treated|0|||
41936371|NCT00585195|75645599|FG020|Overall Study|Randomized not treated|2|||
41936372|NCT00585195|75645579|FG000|Overall Study|Death|0|||
41936373|NCT00585195|75645580|FG001|Overall Study|Death|0|||
41936374|NCT00585195|75645581|FG002|Overall Study|Death|0|||
41936375|NCT00585195|75645582|FG003|Overall Study|Death|0|||
41936376|NCT00585195|75645583|FG004|Overall Study|Death|0|||
41936377|NCT00585195|75645584|FG005|Overall Study|Death|0|||
41936378|NCT00585195|75645585|FG006|Overall Study|Death|0|||
41936379|NCT00585195|75645586|FG007|Overall Study|Death|0|||
41936380|NCT00585195|75645587|FG008|Overall Study|Death|1|||
41936381|NCT00585195|75645588|FG009|Overall Study|Death|0|||
41936382|NCT00585195|75645589|FG010|Overall Study|Death|1|||
41936383|NCT00585195|75645590|FG011|Overall Study|Death|1|||
41936384|NCT00585195|75645591|FG012|Overall Study|Death|7|||
41936385|NCT00585195|75645592|FG013|Overall Study|Death|2|||
41936386|NCT00585195|75645593|FG014|Overall Study|Death|8|||
41936387|NCT00585195|75645594|FG015|Overall Study|Death|2|||
41936388|NCT00585195|75645595|FG016|Overall Study|Death|11|||
41936389|NCT00585195|75645596|FG017|Overall Study|Death|0|||
41936390|NCT00585195|75645597|FG018|Overall Study|Death|0|||
41936391|NCT00585195|75645598|FG019|Overall Study|Death|0|||
41936392|NCT00585195|75645599|FG020|Overall Study|Death|1|||
42117967|NCT00688259|75928815|FG001|Overall Study|Lost to Follow-up|4|||
42117968|NCT00688259|75928814|FG000|Overall Study|Physician Decision|1|||
41936393|NCT00585195|75645579|FG000|Overall Study|Lost to Follow-up|0|||
41936394|NCT00585195|75645580|FG001|Overall Study|Lost to Follow-up|0|||
41936395|NCT00585195|75645581|FG002|Overall Study|Lost to Follow-up|0|||
41936396|NCT00585195|75645582|FG003|Overall Study|Lost to Follow-up|0|||
41936397|NCT00585195|75645583|FG004|Overall Study|Lost to Follow-up|0|||
41936398|NCT00585195|75645584|FG005|Overall Study|Lost to Follow-up|0|||
41936399|NCT00585195|75645585|FG006|Overall Study|Lost to Follow-up|0|||
41936400|NCT00585195|75645586|FG007|Overall Study|Lost to Follow-up|0|||
41936401|NCT00585195|75645587|FG008|Overall Study|Lost to Follow-up|0|||
41936402|NCT00585195|75645588|FG009|Overall Study|Lost to Follow-up|0|||
41936403|NCT00585195|75645589|FG010|Overall Study|Lost to Follow-up|0|||
41936404|NCT00585195|75645590|FG011|Overall Study|Lost to Follow-up|0|||
41936405|NCT00585195|75645591|FG012|Overall Study|Lost to Follow-up|1|||
41936406|NCT00585195|75645592|FG013|Overall Study|Lost to Follow-up|0|||
41936407|NCT00585195|75645593|FG014|Overall Study|Lost to Follow-up|0|||
41936408|NCT00585195|75645594|FG015|Overall Study|Lost to Follow-up|0|||
41936409|NCT00585195|75645595|FG016|Overall Study|Lost to Follow-up|0|||
41936410|NCT00585195|75645596|FG017|Overall Study|Lost to Follow-up|2|||
41936411|NCT00585195|75645597|FG018|Overall Study|Lost to Follow-up|0|||
41936412|NCT00585195|75645598|FG019|Overall Study|Lost to Follow-up|0|||
41936413|NCT00585195|75645599|FG020|Overall Study|Lost to Follow-up|0|||
41936414|NCT00585195|75645579|FG000|Overall Study|Site Terminated by Sponsor|0|||
41936415|NCT00585195|75645580|FG001|Overall Study|Site Terminated by Sponsor|0|||
41936416|NCT00585195|75645581|FG002|Overall Study|Site Terminated by Sponsor|0|||
41936417|NCT00585195|75645582|FG003|Overall Study|Site Terminated by Sponsor|0|||
41936418|NCT00585195|75645583|FG004|Overall Study|Site Terminated by Sponsor|0|||
41936419|NCT00585195|75645584|FG005|Overall Study|Site Terminated by Sponsor|0|||
41936420|NCT00585195|75645585|FG006|Overall Study|Site Terminated by Sponsor|0|||
41936421|NCT00585195|75645586|FG007|Overall Study|Site Terminated by Sponsor|0|||
41936422|NCT00585195|75645587|FG008|Overall Study|Site Terminated by Sponsor|0|||
41936423|NCT00585195|75645588|FG009|Overall Study|Site Terminated by Sponsor|0|||
41936424|NCT00585195|75645589|FG010|Overall Study|Site Terminated by Sponsor|0|||
41936425|NCT00585195|75645590|FG011|Overall Study|Site Terminated by Sponsor|0|||
41936426|NCT00585195|75645591|FG012|Overall Study|Site Terminated by Sponsor|1|||
41936427|NCT00585195|75645592|FG013|Overall Study|Site Terminated by Sponsor|0|||
41936428|NCT00585195|75645593|FG014|Overall Study|Site Terminated by Sponsor|0|||
41936429|NCT00585195|75645594|FG015|Overall Study|Site Terminated by Sponsor|0|||
41936430|NCT00585195|75645595|FG016|Overall Study|Site Terminated by Sponsor|0|||
41936431|NCT00585195|75645596|FG017|Overall Study|Site Terminated by Sponsor|0|||
41936432|NCT00585195|75645597|FG018|Overall Study|Site Terminated by Sponsor|0|||
41936433|NCT00585195|75645598|FG019|Overall Study|Site Terminated by Sponsor|0|||
41936434|NCT00585195|75645599|FG020|Overall Study|Site Terminated by Sponsor|0|||
41936435|NCT00585195|75645579|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
41936436|NCT00585195|75645580|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
41936437|NCT00585195|75645581|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
41936438|NCT00585195|75645582|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
41936439|NCT00585195|75645583|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
41936440|NCT00585195|75645584|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
41936441|NCT00585195|75645585|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
41936442|NCT00585195|75645586|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
41936443|NCT00585195|75645587|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
41936444|NCT00585195|75645588|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
41936445|NCT00585195|75645589|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
41936446|NCT00585195|75645590|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
41936447|NCT00585195|75645591|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
41936448|NCT00585195|75645592|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
41936449|NCT00585195|75645593|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
41936450|NCT00585195|75645594|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
41936451|NCT00585195|75645595|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
41936452|NCT00585195|75645596|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
41936453|NCT00585195|75645597|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
41936454|NCT00585195|75645598|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
41936455|NCT00585195|75645599|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
41936456|NCT02439216|75645771|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
41936457|NCT02439216|75645772|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
41936458|NCT02439216|75645773|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
41936459|NCT02439216|75645774|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
41936460|NCT02439216|75645775|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
41936461|NCT02439216|75645776|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
41936462|NCT02439216|75645777|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
41936463|NCT02439216|75645778|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
41936464|NCT02439216|75645779|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
41936465|NCT02439216|75645771|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
41936466|NCT02439216|75645772|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
41936467|NCT02439216|75645773|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
41936468|NCT02439216|75645774|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
41936469|NCT02439216|75645775|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
41936470|NCT02439216|75645776|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
41936471|NCT02439216|75645777|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
41936472|NCT02439216|75645778|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
41936473|NCT02439216|75645779|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
41936474|NCT02439216|75645771|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
41936475|NCT02439216|75645772|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
41936476|NCT02439216|75645773|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
41936477|NCT02439216|75645774|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
41936478|NCT02439216|75645775|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
41936479|NCT02439216|75645776|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
41936480|NCT02439216|75645777|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
41936481|NCT02439216|75645778|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
41936482|NCT02439216|75645779|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
41936483|NCT02439216|75645771|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
41936484|NCT02439216|75645772|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
41936485|NCT02439216|75645773|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
41936486|NCT02439216|75645774|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
41936487|NCT02439216|75645775|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
41936488|NCT02439216|75645776|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
41936489|NCT02439216|75645777|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
41936490|NCT02439216|75645778|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
41936491|NCT02439216|75645779|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
41936492|NCT02439216|75645771|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
41936493|NCT02439216|75645772|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
41936494|NCT02439216|75645773|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
41936495|NCT02439216|75645774|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
41936496|NCT02439216|75645775|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
41936497|NCT02439216|75645776|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
41936498|NCT02439216|75645777|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
41936499|NCT02439216|75645778|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
41936500|NCT02439216|75645779|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
41936501|NCT02439138|75645803|FG000|Overall Study|Adverse Event|1|||
41936502|NCT02439138|75645803|FG000|Overall Study|PI decision to terminate the study|2|||
41936503|NCT02438826|75646179|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
41936504|NCT02438826|75646180|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
41936505|NCT02438826|75646181|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
41936506|NCT02438826|75646182|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
41936507|NCT02438826|75646179|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
41936508|NCT02438826|75646180|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
41936509|NCT02438826|75646181|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
41936510|NCT02438826|75646182|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
41936511|NCT02438826|75646179|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
41936512|NCT02438826|75646180|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
41936513|NCT02438826|75646181|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
41936514|NCT02438826|75646182|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
41936515|NCT02438826|75646179|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
41936516|NCT02438826|75646180|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
41936517|NCT02438826|75646181|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
41936518|NCT02438826|75646182|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
41936519|NCT02438826|75646179|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
41936520|NCT02438826|75646180|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
41936521|NCT02438826|75646181|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
41936522|NCT02438826|75646182|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
41936523|NCT02438826|75646179|FG000|Open-Label Treatment Phase|Adverse Event|11|||
41936524|NCT02438826|75646180|FG001|Open-Label Treatment Phase|Adverse Event|6|||
41936525|NCT02438826|75646181|FG002|Open-Label Treatment Phase|Adverse Event|0|||
41936526|NCT02438826|75646182|FG003|Open-Label Treatment Phase|Adverse Event|0|||
41936527|NCT02438826|75646179|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
41936528|NCT02438826|75646180|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
41936529|NCT02438826|75646181|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
41936530|NCT02438826|75646182|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
41936531|NCT02438826|75646179|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
41936532|NCT02438826|75646180|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
41936533|NCT02438826|75646181|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
41936534|NCT02438826|75646182|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
41936535|NCT02438826|75646179|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
41936536|NCT02438826|75646180|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
41936537|NCT02438826|75646181|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
41936538|NCT02438826|75646182|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
41936539|NCT02438826|75646179|FG000|Post-Treatment Phase|Adverse Event|3|||
41936540|NCT02438826|75646180|FG001|Post-Treatment Phase|Adverse Event|0|||
41936541|NCT02438826|75646181|FG002|Post-Treatment Phase|Adverse Event|0|||
41936542|NCT02438826|75646182|FG003|Post-Treatment Phase|Adverse Event|0|||
41936543|NCT02438826|75646179|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
41936544|NCT02438826|75646180|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
42022279|NCT00892099|75829589|FG001|Overall Study|Death|0|||
42022280|NCT00892099|75829590|FG002|Overall Study|Death|1|||
42022281|NCT00892099|75829588|FG000|Overall Study|Adverse Event|1|||
42022282|NCT00892099|75829589|FG001|Overall Study|Adverse Event|0|||
42022283|NCT00892099|75829590|FG002|Overall Study|Adverse Event|0|||
42022284|NCT00892099|75829588|FG000|Overall Study|replocated|1|||
42022285|NCT00892099|75829589|FG001|Overall Study|replocated|0|||
42022286|NCT00892099|75829590|FG002|Overall Study|replocated|2|||
42022287|NCT00892099|75829588|FG000|Overall Study|Prolonged hospitalization|1|||
42022288|NCT00892099|75829589|FG001|Overall Study|Prolonged hospitalization|0|||
42022289|NCT00892099|75829590|FG002|Overall Study|Prolonged hospitalization|1|||
42022290|NCT00892099|75829588|FG000|Overall Study|no further details|1|||
42022291|NCT00892099|75829589|FG001|Overall Study|no further details|0|||
42022292|NCT00892099|75829590|FG002|Overall Study|no further details|1|||
42022293|NCT00892099|75829588|FG000|Overall Study|kidney function recovered|0|||
42022294|NCT00892099|75829589|FG001|Overall Study|kidney function recovered|1|||
42022295|NCT00892099|75829590|FG002|Overall Study|kidney function recovered|0|||
42022296|NCT00892099|75829588|FG000|Overall Study|investigator decision|0|||
42022297|NCT00892099|75829589|FG001|Overall Study|investigator decision|0|||
42022298|NCT00892099|75829590|FG002|Overall Study|investigator decision|1|||
42022299|NCT00892099|75829588|FG000|Overall Study|Lost to Follow-up|0|||
42022300|NCT00892099|75829589|FG001|Overall Study|Lost to Follow-up|0|||
42022301|NCT00892099|75829590|FG002|Overall Study|Lost to Follow-up|1|||
42022302|NCT00960856|75829598|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
42022303|NCT00960856|75829599|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
42022304|NCT00960856|75829600|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
42022305|NCT00960856|75829601|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
42022306|NCT00960856|75829598|FG000|Washout Period of 7 Days|Adverse Event|0|||
42022307|NCT00960856|75829599|FG001|Washout Period of 7 Days|Adverse Event|0|||
42022308|NCT00960856|75829600|FG002|Washout Period of 7 Days|Adverse Event|1|||
42022309|NCT00960856|75829601|FG003|Washout Period of 7 Days|Adverse Event|0|||
42022310|NCT00958438|75829614|FG000|Overall Study|Protocol Violation|3|||
42022311|NCT00958438|75829615|FG001|Overall Study|Protocol Violation|2|||
42022312|NCT00958438|75829616|FG002|Overall Study|Protocol Violation|2|||
42022313|NCT00958438|75829614|FG000|Overall Study|Withdrawal by Subject|4|||
42022314|NCT00958438|75829615|FG001|Overall Study|Withdrawal by Subject|2|||
42022315|NCT00958438|75829616|FG002|Overall Study|Withdrawal by Subject|1|||
42022316|NCT00958438|75829614|FG000|Overall Study|Adverse Event|0|||
42022317|NCT00958438|75829615|FG001|Overall Study|Adverse Event|3|||
42022318|NCT00958438|75829616|FG002|Overall Study|Adverse Event|0|||
42022319|NCT00958438|75829614|FG000|Overall Study|Physician Decision|1|||
42022320|NCT00958438|75829615|FG001|Overall Study|Physician Decision|0|||
42022321|NCT00958438|75829616|FG002|Overall Study|Physician Decision|1|||
42022322|NCT00958438|75829614|FG000|Overall Study|Other than specified above|2|||
42022323|NCT00958438|75829615|FG001|Overall Study|Other than specified above|3|||
42022324|NCT00958438|75829616|FG002|Overall Study|Other than specified above|2|||
42022325|NCT00958360|75829626|FG000|Overall Study|Withdrawal by Subject|3|||
42022326|NCT00958360|75829627|FG001|Overall Study|Withdrawal by Subject|1|||
42022327|NCT00958360|75829626|FG000|Overall Study|Death|6|||
42022328|NCT00958360|75829627|FG001|Overall Study|Death|7|||
42022329|NCT00958360|75829626|FG000|Overall Study|Physician Decision|2|||
42022330|NCT00958360|75829627|FG001|Overall Study|Physician Decision|1|||
42022331|NCT00958360|75829626|FG000|Overall Study|Lost to Follow-up|0|||
42210245|NCT03297294|76024988|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
42210246|NCT03297294|76024984|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
42210247|NCT03297294|76024985|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
42022332|NCT00958360|75829627|FG001|Overall Study|Lost to Follow-up|1|||
42022333|NCT00888433|75829635|FG000|Overall Study|Withdrawal by Subject|1|||
42022334|NCT00888433|75829636|FG001|Overall Study|Withdrawal by Subject|2|||
42022335|NCT00888433|75829635|FG000|Overall Study|Missed Visit|2|||
42022336|NCT00888433|75829636|FG001|Overall Study|Missed Visit|1|||
42022337|NCT01243424|75829644|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
42022338|NCT01243424|75829645|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
42022339|NCT01243424|75829644|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
42022340|NCT01243424|75829645|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
42022341|NCT01243424|75829644|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
42022342|NCT01243424|75829645|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
42022343|NCT01243424|75829644|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
42022344|NCT01243424|75829645|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
42022345|NCT01243424|75829644|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
42022346|NCT01243424|75829645|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
42022347|NCT01243424|75829644|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
42022348|NCT01243424|75829645|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
42022349|NCT01243424|75829644|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
42022350|NCT01243424|75829645|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
42022351|NCT01243424|75829644|FG000|Discontinuation From Treatment|Not treated|5|||
42022352|NCT01243424|75829645|FG001|Discontinuation From Treatment|Not treated|4|||
42022353|NCT01243424|75829644|FG000|Discontinuation From Treatment|Adverse Event|457|||
42022354|NCT01243424|75829645|FG001|Discontinuation From Treatment|Adverse Event|523|||
42022355|NCT01243424|75829644|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
42022356|NCT01243424|75829645|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
42022357|NCT01243424|75829644|FG000|Discontinuation From Treatment|Protocol Violation|46|||
42022358|NCT01243424|75829645|FG001|Discontinuation From Treatment|Protocol Violation|47|||
42022359|NCT01243424|75829644|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
42022360|NCT01243424|75829645|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
42022361|NCT01243424|75829644|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
42022362|NCT01243424|75829645|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
42022363|NCT01243424|75829644|FG000|Discontinuation From Treatment|Other than listed above|230|||
42022364|NCT01243424|75829645|FG001|Discontinuation From Treatment|Other than listed above|211|||
42022365|NCT00887809|75829654|FG000|Overall Study|Patient Not Treated|3|||
42022366|NCT00887809|75829655|FG001|Overall Study|Patient Not Treated|0|||
42022367|NCT00887809|75829654|FG000|Overall Study|Death|1|||
42022368|NCT00887809|75829655|FG001|Overall Study|Death|0|||
42022369|NCT00958126|75829669|FG000|Overall Study|Serious Adverse Event|0|||
42022370|NCT00958126|75829670|FG001|Overall Study|Serious Adverse Event|2|||
42022371|NCT00958126|75829671|FG002|Overall Study|Serious Adverse Event|0|||
42022372|NCT00958126|75829672|FG003|Overall Study|Serious Adverse Event|0|||
42022373|NCT00958126|75829673|FG004|Overall Study|Serious Adverse Event|0|||
42022374|NCT00958126|75829674|FG005|Overall Study|Serious Adverse Event|0|||
42022375|NCT00958126|75829675|FG006|Overall Study|Serious Adverse Event|1|||
42022376|NCT00958126|75829676|FG007|Overall Study|Serious Adverse Event|0|||
42022377|NCT00958126|75829669|FG000|Overall Study|Withdrawal by Subject|0|||
42022378|NCT00958126|75829670|FG001|Overall Study|Withdrawal by Subject|2|||
42022379|NCT00958126|75829671|FG002|Overall Study|Withdrawal by Subject|0|||
42022380|NCT00958126|75829672|FG003|Overall Study|Withdrawal by Subject|0|||
42022381|NCT00958126|75829673|FG004|Overall Study|Withdrawal by Subject|0|||
42022382|NCT00958126|75829674|FG005|Overall Study|Withdrawal by Subject|0|||
42022383|NCT00958126|75829675|FG006|Overall Study|Withdrawal by Subject|0|||
42022384|NCT00958126|75829676|FG007|Overall Study|Withdrawal by Subject|0|||
42022385|NCT00958126|75829669|FG000|Overall Study|Moved away from study area|0|||
42022386|NCT00958126|75829670|FG001|Overall Study|Moved away from study area|0|||
42022387|NCT00958126|75829671|FG002|Overall Study|Moved away from study area|1|||
42022388|NCT00958126|75829672|FG003|Overall Study|Moved away from study area|1|||
42022389|NCT00958126|75829673|FG004|Overall Study|Moved away from study area|0|||
42022390|NCT00958126|75829674|FG005|Overall Study|Moved away from study area|0|||
42022391|NCT00958126|75829675|FG006|Overall Study|Moved away from study area|0|||
42022392|NCT00958126|75829676|FG007|Overall Study|Moved away from study area|0|||
42022393|NCT00958126|75829669|FG000|Overall Study|Lost to Follow-up|1|||
42022394|NCT00958126|75829670|FG001|Overall Study|Lost to Follow-up|5|||
42022395|NCT00958126|75829671|FG002|Overall Study|Lost to Follow-up|9|||
42022396|NCT00958126|75829672|FG003|Overall Study|Lost to Follow-up|8|||
42022397|NCT00958126|75829673|FG004|Overall Study|Lost to Follow-up|0|||
42022398|NCT00958126|75829674|FG005|Overall Study|Lost to Follow-up|0|||
42022399|NCT00958126|75829675|FG006|Overall Study|Lost to Follow-up|0|||
42022400|NCT00958126|75829676|FG007|Overall Study|Lost to Follow-up|0|||
42022401|NCT00958126|75829669|FG000|Overall Study|Sponsor/Investigator decision|0|||
42022402|NCT00958126|75829670|FG001|Overall Study|Sponsor/Investigator decision|0|||
42022403|NCT00958126|75829671|FG002|Overall Study|Sponsor/Investigator decision|0|||
42022404|NCT00958126|75829672|FG003|Overall Study|Sponsor/Investigator decision|1|||
42022405|NCT00958126|75829673|FG004|Overall Study|Sponsor/Investigator decision|0|||
42117969|NCT00688259|75928815|FG001|Overall Study|Physician Decision|0|||
42210248|NCT03297294|76024986|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
42022406|NCT00958126|75829674|FG005|Overall Study|Sponsor/Investigator decision|0|||
42022407|NCT00958126|75829675|FG006|Overall Study|Sponsor/Investigator decision|0|||
42022408|NCT00958126|75829676|FG007|Overall Study|Sponsor/Investigator decision|0|||
42022409|NCT00958126|75829669|FG000|Overall Study|Other Reason|0|||
42022410|NCT00958126|75829670|FG001|Overall Study|Other Reason|0|||
42022411|NCT00958126|75829671|FG002|Overall Study|Other Reason|0|||
42022412|NCT00958126|75829672|FG003|Overall Study|Other Reason|1|||
42022413|NCT00958126|75829673|FG004|Overall Study|Other Reason|0|||
42022414|NCT00958126|75829674|FG005|Overall Study|Other Reason|1|||
42022415|NCT00958126|75829675|FG006|Overall Study|Other Reason|0|||
42022416|NCT00958126|75829676|FG007|Overall Study|Other Reason|0|||
42022417|NCT00887341|75829700|FG000|Overall Study|Refused treatment|1|||
42022418|NCT00887341|75829701|FG001|Overall Study|Refused treatment|0|||
42022419|NCT00887341|75829700|FG000|Overall Study|Withdrawal by Subject|1|||
42022420|NCT00887341|75829701|FG001|Overall Study|Withdrawal by Subject|1|||
42022421|NCT00887341|75829700|FG000|Overall Study|Adverse Event|0|||
42022422|NCT00887341|75829701|FG001|Overall Study|Adverse Event|1|||
42022423|NCT00887341|75829700|FG000|Overall Study|Lost to Follow-up|0|||
42022424|NCT00887341|75829701|FG001|Overall Study|Lost to Follow-up|1|||
42022425|NCT00886795|75829707|FG000|Overall Study|Lack of Efficacy|1|||
42022426|NCT00889681|75829724|FG000|Overall Study|Not meeting qualification Criteria|2|||
42022427|NCT00889681|75829724|FG000|Overall Study|Insurance disapproval|1|||
42022428|NCT00957658|75829728|FG000|Overall Study|Death|1|||
42022429|NCT00957658|75829728|FG000|Overall Study|Lost to Follow-up|4|||
42022430|NCT00957658|75829728|FG000|Overall Study|Withdrawal by Subject|12|||
42022431|NCT00957658|75829728|FG000|Overall Study|Revision|1|||
42022432|NCT00957658|75829728|FG000|Overall Study|Incomplete 2 yr data|28|||
42022433|NCT00957658|75829728|FG000|Overall Study|Site termination|10|||
42022434|NCT00957658|75829728|FG000|Overall Study|unwilling/unable to return|2|||
42022435|NCT00957658|75829728|FG000|Overall Study|surgery cancelled|2|||
42022436|NCT00957658|75829728|FG000|Overall Study|Protocol Violation|5|||
42022437|NCT00953680|75829734|FG000|Period 1|Withdrawal by Subject|0|||
42022438|NCT00953680|75829735|FG001|Period 1|Withdrawal by Subject|1|||
42022439|NCT00890929|75829741|FG000|Overall Study|Death before treatment|2|||
42022440|NCT00890929|75829741|FG000|Overall Study|Withdrawal by Subject|3|||
42022441|NCT00890929|75829741|FG000|Overall Study|Physician Decision|1|||
42022442|NCT00886639|75829745|FG000|Overall Study|acute exacerbation|14|||
42022443|NCT00886639|75829745|FG000|Overall Study|non-compliance|2|||
42022444|NCT00889603|75829749|FG000|Overall Study|Adverse Event|7|||
42022445|NCT00889603|75829749|FG000|Overall Study|Death|3|||
42022446|NCT00889603|75829749|FG000|Overall Study|Lost to Follow-up|19|||
42022447|NCT00889603|75829749|FG000|Overall Study|No longer willing to participant in stud|4|||
42022448|NCT00889603|75829749|FG000|Overall Study|Other|4|||
42022449|NCT00886483|75829755|FG000|Overall Study|Lost to Follow-up|0|||
42022450|NCT00886483|75829756|FG001|Overall Study|Lost to Follow-up|1|||
42022451|NCT00886483|75829755|FG000|Overall Study|Pursue medications|1|||
42022452|NCT00886483|75829756|FG001|Overall Study|Pursue medications|2|||
42022453|NCT00886483|75829755|FG000|Overall Study|Distance to center, poor grades|1|||
42022454|NCT00886483|75829756|FG001|Overall Study|Distance to center, poor grades|0|||
42022455|NCT00886015|75829772|FG000|Overall Study|Death|0|||
42022456|NCT00886015|75829773|FG001|Overall Study|Death|2|||
42022457|NCT00890695|75829781|FG000|Overall Study|Protocol Violation|1|||
42022458|NCT00890695|75829782|FG001|Overall Study|Protocol Violation|0|||
42022459|NCT00957580|75829791|FG000|Overall Study|Ongoing at data cut-off|0|||
42022460|NCT00957580|75829792|FG001|Overall Study|Ongoing at data cut-off|1|||
42022461|NCT00957580|75829793|FG002|Overall Study|Ongoing at data cut-off|0|||
42022462|NCT00957580|75829791|FG000|Overall Study|Enrolled but not treated|0|||
42022463|NCT00957580|75829792|FG001|Overall Study|Enrolled but not treated|1|||
42022464|NCT00957580|75829793|FG002|Overall Study|Enrolled but not treated|0|||
42022465|NCT00957424|75829814|FG000|Overall Study|Lost to Follow-up|19|||
42022466|NCT00957424|75829814|FG000|Overall Study|Protocol Violation|3|||
42022467|NCT00957424|75829814|FG000|Overall Study|Withdrawal by Subject|1|||
42022468|NCT01061151|75829822|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
42022469|NCT01061151|75829823|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
42022470|NCT01061151|75829824|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
42022471|NCT01061151|75829825|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
42022472|NCT01061151|75829822|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
42022473|NCT01061151|75829823|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
42022474|NCT01061151|75829824|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
42022475|NCT01061151|75829825|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
42210249|NCT03297294|76024987|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
42210250|NCT03297294|76024988|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
42022476|NCT01061151|75829822|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
42022477|NCT01061151|75829823|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
42022478|NCT01061151|75829824|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
42022479|NCT01061151|75829825|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
42022480|NCT01061151|75829822|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
42022481|NCT01061151|75829823|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
42022482|NCT01061151|75829824|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
42022483|NCT01061151|75829825|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
42022484|NCT01061151|75829822|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
42022485|NCT01061151|75829823|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
42022486|NCT01061151|75829824|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
42022487|NCT01061151|75829825|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
42022488|NCT01061151|75829822|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
42022489|NCT01061151|75829823|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
42022490|NCT01061151|75829824|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
42022491|NCT01061151|75829825|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
42022492|NCT01061151|75829822|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
42022493|NCT01061151|75829823|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
42022494|NCT01061151|75829824|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
42022495|NCT01061151|75829825|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
42022496|NCT01061151|75829822|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
42022497|NCT01061151|75829823|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
42022498|NCT01061151|75829824|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
42022499|NCT01061151|75829825|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
42022500|NCT01061151|75829822|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
41936545|NCT02438826|75646181|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
41936546|NCT02438826|75646182|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
41936547|NCT02438826|75646179|FG000|Post-Treatment Phase|Physician Decision|1|||
41936548|NCT02438826|75646180|FG001|Post-Treatment Phase|Physician Decision|0|||
41936549|NCT02438826|75646181|FG002|Post-Treatment Phase|Physician Decision|0|||
41936550|NCT02438826|75646182|FG003|Post-Treatment Phase|Physician Decision|0|||
41936551|NCT02438826|75646179|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
41936552|NCT02438826|75646180|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
41936553|NCT02438826|75646181|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
41936554|NCT02438826|75646182|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
41936555|NCT02438280|75646199|FG000|Overall Study|Physician Decision|1|||
41936556|NCT02438280|75646200|FG001|Overall Study|Physician Decision|0|||
41936557|NCT02385708|75646218|FG000|Overall Study|Withdrawal by Subject|0|||
41936558|NCT02385708|75646219|FG001|Overall Study|Withdrawal by Subject|2|||
41936559|NCT02385708|75646218|FG000|Overall Study|Withdrawn - surgery canceled|2|||
41936560|NCT02385708|75646219|FG001|Overall Study|Withdrawn - surgery canceled|5|||
41936561|NCT02385708|75646218|FG000|Overall Study|Investigator decision|5|||
41936562|NCT02385708|75646219|FG001|Overall Study|Investigator decision|7|||
41936563|NCT02385708|75646218|FG000|Overall Study|Protocol Violation|1|||
41936564|NCT02385708|75646219|FG001|Overall Study|Protocol Violation|1|||
41936565|NCT02385084|75646958|FG000|Period 2|Protocol Violation|0|||
41936566|NCT02385084|75646959|FG001|Period 2|Protocol Violation|0|||
41936567|NCT02385084|75646960|FG002|Period 2|Protocol Violation|1|||
41936568|NCT02385084|75646961|FG003|Period 2|Protocol Violation|0|||
41936569|NCT02385084|75646962|FG004|Period 2|Protocol Violation|0|||
41936570|NCT02385084|75646963|FG005|Period 2|Protocol Violation|0|||
41936571|NCT02411292|75646972|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
41936572|NCT02411292|75646972|FG000|Overall Study|Death|2|||
41936573|NCT02411292|75646972|FG000|Overall Study|Lost to Follow-up|3|||
41936574|NCT02384850|75647035|FG000|Overall Study|Withdrawal by Subject|2|||
41936575|NCT02384850|75647036|FG001|Overall Study|Withdrawal by Subject|2|||
41936576|NCT02437890|75647258|FG000|Overall Study|Non-compliance to study drug|0|||
41936577|NCT02437890|75647259|FG001|Overall Study|Non-compliance to study drug|1|||
41936578|NCT02437890|75647260|FG002|Overall Study|Non-compliance to study drug|0|||
41936579|NCT02437890|75647261|FG003|Overall Study|Non-compliance to study drug|0|||
41936580|NCT02437890|75647262|FG004|Overall Study|Non-compliance to study drug|1|||
41936581|NCT02437890|75647258|FG000|Overall Study|Sponsor's decision|1|||
41936582|NCT02437890|75647259|FG001|Overall Study|Sponsor's decision|1|||
41936583|NCT02437890|75647260|FG002|Overall Study|Sponsor's decision|4|||
41936584|NCT02437890|75647261|FG003|Overall Study|Sponsor's decision|0|||
41936585|NCT02437890|75647262|FG004|Overall Study|Sponsor's decision|2|||
41936586|NCT02437890|75647258|FG000|Overall Study|Physician Decision|0|||
41936587|NCT02437890|75647259|FG001|Overall Study|Physician Decision|0|||
41936588|NCT02437890|75647260|FG002|Overall Study|Physician Decision|0|||
41936589|NCT02437890|75647261|FG003|Overall Study|Physician Decision|1|||
41936590|NCT02437890|75647262|FG004|Overall Study|Physician Decision|0|||
41936591|NCT02437890|75647258|FG000|Overall Study|Unable to attend visit(s)|1|||
42022501|NCT01061151|75829823|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
41936592|NCT02437890|75647259|FG001|Overall Study|Unable to attend visit(s)|0|||
41936593|NCT02437890|75647260|FG002|Overall Study|Unable to attend visit(s)|0|||
41936594|NCT02437890|75647261|FG003|Overall Study|Unable to attend visit(s)|0|||
41936595|NCT02437890|75647262|FG004|Overall Study|Unable to attend visit(s)|0|||
41936596|NCT02437890|75647258|FG000|Overall Study|Lack of Efficacy|1|||
41936597|NCT02437890|75647259|FG001|Overall Study|Lack of Efficacy|3|||
41936598|NCT02437890|75647260|FG002|Overall Study|Lack of Efficacy|0|||
41936599|NCT02437890|75647261|FG003|Overall Study|Lack of Efficacy|3|||
41936600|NCT02437890|75647262|FG004|Overall Study|Lack of Efficacy|1|||
41936601|NCT02437890|75647258|FG000|Overall Study|Adverse Event|4|||
41936602|NCT02437890|75647259|FG001|Overall Study|Adverse Event|9|||
41936603|NCT02437890|75647260|FG002|Overall Study|Adverse Event|5|||
41936604|NCT02437890|75647261|FG003|Overall Study|Adverse Event|11|||
41936605|NCT02437890|75647262|FG004|Overall Study|Adverse Event|7|||
41936606|NCT02437890|75647258|FG000|Overall Study|Withdrawal by Subject|1|||
41936607|NCT02437890|75647259|FG001|Overall Study|Withdrawal by Subject|2|||
41936608|NCT02437890|75647260|FG002|Overall Study|Withdrawal by Subject|6|||
41936609|NCT02437890|75647261|FG003|Overall Study|Withdrawal by Subject|5|||
41936610|NCT02437890|75647262|FG004|Overall Study|Withdrawal by Subject|5|||
41936611|NCT02437890|75647258|FG000|Overall Study|Death|0|||
41936612|NCT02437890|75647259|FG001|Overall Study|Death|0|||
41936613|NCT02437890|75647260|FG002|Overall Study|Death|0|||
41936614|NCT02437890|75647261|FG003|Overall Study|Death|2|||
41936615|NCT02437890|75647262|FG004|Overall Study|Death|0|||
41936616|NCT02384538|75647323|FG000|Overall Study|Adverse Event|1|||
41936617|NCT02384538|75647324|FG001|Overall Study|Adverse Event|4|||
41936618|NCT02384538|75647323|FG000|Overall Study|Lack of Efficacy|4|||
41936619|NCT02384538|75647324|FG001|Overall Study|Lack of Efficacy|4|||
41936620|NCT02384538|75647323|FG000|Overall Study|Withdrew Consent|0|||
41936621|NCT02384538|75647324|FG001|Overall Study|Withdrew Consent|4|||
41936622|NCT02384538|75647323|FG000|Overall Study|Other|1|||
41936623|NCT02384538|75647324|FG001|Overall Study|Other|3|||
41936624|NCT02410824|75647348|FG000|First Intervention (One Week)|Headache|0|||
41936625|NCT02410824|75647349|FG001|First Intervention (One Week)|Headache|1|||
41936626|NCT02384460|75647379|FG000|Overall Study|Protocol Violation|0|||
41936627|NCT02384460|75647380|FG001|Overall Study|Protocol Violation|1|||
41936628|NCT02384460|75647379|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
41936629|NCT02384460|75647380|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
41936630|NCT02384460|75647379|FG000|Overall Study|Adverse Event|5|||
41936631|NCT02384460|75647380|FG001|Overall Study|Adverse Event|2|||
41936632|NCT02384460|75647379|FG000|Overall Study|Withdrawal by Subject|0|||
41936633|NCT02384460|75647380|FG001|Overall Study|Withdrawal by Subject|3|||
41936634|NCT02384460|75647379|FG000|Overall Study|Elective medical treatment|1|||
41936635|NCT02384460|75647380|FG001|Overall Study|Elective medical treatment|0|||
41936636|NCT02384460|75647379|FG000|Overall Study|Non-compliance|1|||
41936637|NCT02384460|75647380|FG001|Overall Study|Non-compliance|0|||
41936638|NCT02384382|75647403|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
41936639|NCT02384382|75647403|FG000|Overall Study|Death|1|||
41936640|NCT02384382|75647403|FG000|Overall Study|Adverse Event|1|||
41936641|NCT02384382|75647403|FG000|Overall Study|Disease progression|16|||
42022502|NCT01061151|75829824|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
42022503|NCT01061151|75829825|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
42022504|NCT01061151|75829822|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
42117970|NCT00688259|75928814|FG000|Overall Study|Withdrawal by Subject|2|||
42117971|NCT00688259|75928815|FG001|Overall Study|Withdrawal by Subject|0|||
42117972|NCT00688259|75928814|FG000|Overall Study|Declined Interview|2|||
41936642|NCT02437188|75647423|FG000|Overall Study|Randomized but did not receive surgery|4|||
41936643|NCT02437188|75647424|FG001|Overall Study|Randomized but did not receive surgery|8|||
41936644|NCT02437188|75647423|FG000|Overall Study|Adverse Event|0|||
41936645|NCT02437188|75647424|FG001|Overall Study|Adverse Event|1|||
41936646|NCT02383758|75647446|FG000|Overall Study|Withdrawal by Subject|0|||
41936647|NCT02383758|75647447|FG001|Overall Study|Withdrawal by Subject|2|||
41936648|NCT02410278|75647497|FG000|Run-in Period|Adverse Event|5|||
41936649|NCT02410278|75647498|FG001|Run-in Period|Adverse Event|0|||
41936650|NCT02410278|75647499|FG002|Run-in Period|Adverse Event|0|||
41936651|NCT02410278|75647497|FG000|Run-in Period|GSRS Threshold Not Met|30|||
41936652|NCT02410278|75647498|FG001|Run-in Period|GSRS Threshold Not Met|0|||
42022505|NCT01061151|75829823|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
42022506|NCT01061151|75829824|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
42022507|NCT01061151|75829825|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
41936653|NCT02410278|75647499|FG002|Run-in Period|GSRS Threshold Not Met|0|||
41936654|NCT02410278|75647497|FG000|Run-in Period|Lost to Follow-up|1|||
41936655|NCT02410278|75647498|FG001|Run-in Period|Lost to Follow-up|0|||
41936656|NCT02410278|75647499|FG002|Run-in Period|Lost to Follow-up|0|||
41936657|NCT02410278|75647497|FG000|Run-in Period|Withdrawal by Subject|1|||
41936658|NCT02410278|75647498|FG001|Run-in Period|Withdrawal by Subject|0|||
41936659|NCT02410278|75647499|FG002|Run-in Period|Withdrawal by Subject|0|||
41936660|NCT02410278|75647497|FG000|Run-in Period|Pregnancy|1|||
41936661|NCT02410278|75647498|FG001|Run-in Period|Pregnancy|0|||
41936662|NCT02410278|75647499|FG002|Run-in Period|Pregnancy|0|||
41936663|NCT02410278|75647497|FG000|Study Treatment Period|Adverse Event|0|||
41936664|NCT02410278|75647498|FG001|Study Treatment Period|Adverse Event|6|||
41936665|NCT02410278|75647499|FG002|Study Treatment Period|Adverse Event|3|||
41936666|NCT02410278|75647497|FG000|Study Treatment Period|Physician Decision|0|||
41936667|NCT02410278|75647498|FG001|Study Treatment Period|Physician Decision|0|||
41936668|NCT02410278|75647499|FG002|Study Treatment Period|Physician Decision|1|||
41936669|NCT02410278|75647497|FG000|Study Treatment Period|Withdrawal by Subject|0|||
41936670|NCT02410278|75647498|FG001|Study Treatment Period|Withdrawal by Subject|1|||
41936671|NCT02410278|75647499|FG002|Study Treatment Period|Withdrawal by Subject|0|||
41936672|NCT02410278|75647497|FG000|Study Treatment Period|Other|0|||
41936673|NCT02410278|75647498|FG001|Study Treatment Period|Other|3|||
41936674|NCT02410278|75647499|FG002|Study Treatment Period|Other|0|||
41936675|NCT02410278|75647497|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
41936676|NCT02410278|75647498|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
41936677|NCT02410278|75647499|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
41936678|NCT02410200|75647532|FG000|Overall Study|Adverse Event|2|||
41936679|NCT02383056|75647551|FG000|Overall Study|Adverse Event|1|||
41936680|NCT02383056|75647552|FG001|Overall Study|Adverse Event|0|||
41936681|NCT02383056|75647551|FG000|Overall Study|Lost to Follow-up|0|||
41936682|NCT02383056|75647552|FG001|Overall Study|Lost to Follow-up|2|||
41936683|NCT02409732|75647558|FG000|Overall Study|Withdrawal by Subject|4|||
42022508|NCT01061151|75829822|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
42022509|NCT01061151|75829823|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
42022510|NCT01061151|75829824|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
42022511|NCT01061151|75829825|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
42022512|NCT01061151|75829822|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
42022513|NCT01061151|75829823|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
42022514|NCT01061151|75829824|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
42022515|NCT01061151|75829825|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
42022516|NCT01061151|75829822|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
41936684|NCT02409732|75647558|FG000|Overall Study|Lost to Follow-up|2|||
41936685|NCT01650636|75647569|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
41936686|NCT01650636|75647570|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
41936687|NCT01650636|75647569|FG000|Washout up to 5 Months|Physician Decision|2|||
41936688|NCT01650636|75647570|FG001|Washout up to 5 Months|Physician Decision|2|||
42022517|NCT01061151|75829823|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
42022518|NCT01061151|75829824|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
41936689|NCT01650636|75647569|FG000|Washout up to 5 Months|Death|1|||
41936690|NCT01650636|75647570|FG001|Washout up to 5 Months|Death|0|||
41936691|NCT01650636|75647569|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
41936692|NCT01650636|75647570|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
41936693|NCT01650636|75647569|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
41936694|NCT01650636|75647570|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
41936695|NCT01650636|75647569|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
41936696|NCT01650636|75647570|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
41936697|NCT02436876|75647580|FG000|Overall Study|Lost to Follow-up|0|||
41936698|NCT02436876|75647581|FG001|Overall Study|Lost to Follow-up|1|||
41936699|NCT02436876|75647582|FG002|Overall Study|Lost to Follow-up|1|||
41936700|NCT02436876|75647583|FG003|Overall Study|Lost to Follow-up|1|||
41936701|NCT02436876|75647580|FG000|Overall Study|Withdrawal by Subject|1|||
41936702|NCT02436876|75647581|FG001|Overall Study|Withdrawal by Subject|0|||
41936703|NCT02436876|75647582|FG002|Overall Study|Withdrawal by Subject|0|||
41936704|NCT02436876|75647583|FG003|Overall Study|Withdrawal by Subject|1|||
41936705|NCT02436876|75647580|FG000|Overall Study|Physician Decision|0|||
41936706|NCT02436876|75647581|FG001|Overall Study|Physician Decision|2|||
41936707|NCT02436876|75647582|FG002|Overall Study|Physician Decision|1|||
41936708|NCT02436876|75647583|FG003|Overall Study|Physician Decision|0|||
41936709|NCT02436876|75647580|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
41936710|NCT02436876|75647581|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
41936711|NCT02436876|75647582|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
41936712|NCT02436876|75647583|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
41936713|NCT02382276|75647612|FG000|Overall Study|Withdrawal by Subject|4|||
41936714|NCT02382276|75647613|FG001|Overall Study|Withdrawal by Subject|8|||
41936715|NCT02382276|75647614|FG002|Overall Study|Withdrawal by Subject|5|||
41936716|NCT02382276|75647612|FG000|Overall Study|Adverse Event|7|||
41936717|NCT02382276|75647613|FG001|Overall Study|Adverse Event|2|||
41936718|NCT02382276|75647614|FG002|Overall Study|Adverse Event|32|||
41936719|NCT02382276|75647612|FG000|Overall Study|Physician Decision|0|||
41936720|NCT02382276|75647613|FG001|Overall Study|Physician Decision|0|||
41936721|NCT02382276|75647614|FG002|Overall Study|Physician Decision|2|||
41936722|NCT02436408|75647655|FG000|Overall Study|Death|1|||
41936723|NCT02436330|75647678|FG000|Cohort 1|Lost to Follow-up|5|||
41936724|NCT02436330|75647679|FG001|Cohort 1|Lost to Follow-up|2|||
41936725|NCT02436330|75647678|FG000|Cohort 1|Withdrawal by Subject|0|||
41936726|NCT02436330|75647679|FG001|Cohort 1|Withdrawal by Subject|1|||
41936727|NCT02436330|75647678|FG000|Cohort 2|Lost to Follow-up|2|||
41936728|NCT02436330|75647679|FG001|Cohort 2|Lost to Follow-up|0|||
41936729|NCT02436330|75647678|FG000|Cohort 2|Withdrawal by Subject|2|||
41936730|NCT02436330|75647679|FG001|Cohort 2|Withdrawal by Subject|3|||
41936731|NCT02436330|75647678|FG000|Cohort 3|Lost to Follow-up|1|||
41936732|NCT02436330|75647679|FG001|Cohort 3|Lost to Follow-up|0|||
41936733|NCT02436330|75647678|FG000|Cohort 3|Withdrawal by Subject|4|||
41936734|NCT02436330|75647679|FG001|Cohort 3|Withdrawal by Subject|0|||
41936735|NCT02436330|75647678|FG000|Cohort 4|Lost to Follow-up|1|||
41936736|NCT02436330|75647679|FG001|Cohort 4|Lost to Follow-up|0|||
41936737|NCT02436330|75647678|FG000|Cohort 4|Withdrawal by Subject|1|||
41936738|NCT02436330|75647679|FG001|Cohort 4|Withdrawal by Subject|0|||
41936739|NCT02436330|75647678|FG000|Cohort 5|Lost to Follow-up|3|||
41936740|NCT02436330|75647679|FG001|Cohort 5|Lost to Follow-up|2|||
41936741|NCT02436330|75647678|FG000|Cohort 5|Withdrawal by Subject|3|||
41936742|NCT02436330|75647679|FG001|Cohort 5|Withdrawal by Subject|2|||
41936743|NCT02436330|75647678|FG000|Cohort 6|Lost to Follow-up|2|||
41936744|NCT02436330|75647679|FG001|Cohort 6|Lost to Follow-up|0|||
41936745|NCT02436330|75647678|FG000|Cohort 6|Withdrawal by Subject|1|||
41936746|NCT02436330|75647679|FG001|Cohort 6|Withdrawal by Subject|1|||
41936747|NCT01650558|75647716|FG000|Overall Study|Migration out of study area|61|||
41936748|NCT01650558|75647717|FG001|Overall Study|Migration out of study area|71|||
41936749|NCT01650558|75647718|FG002|Overall Study|Migration out of study area|56|||
41936750|NCT01650558|75647716|FG000|Overall Study|Lost to Follow-up|10|||
41936751|NCT01650558|75647717|FG001|Overall Study|Lost to Follow-up|13|||
41936752|NCT01650558|75647718|FG002|Overall Study|Lost to Follow-up|6|||
41936753|NCT01650558|75647716|FG000|Overall Study|Death|10|||
41936754|NCT01650558|75647717|FG001|Overall Study|Death|6|||
41936755|NCT01650558|75647718|FG002|Overall Study|Death|8|||
41936756|NCT01650558|75647716|FG000|Overall Study|Withdrawal by Subject|1|||
41936757|NCT01650558|75647717|FG001|Overall Study|Withdrawal by Subject|1|||
42210251|NCT03297294|76024984|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
41936758|NCT01650558|75647718|FG002|Overall Study|Withdrawal by Subject|3|||
41936759|NCT01650558|75647716|FG000|Overall Study|Non-compliant participant|1|||
41936760|NCT01650558|75647717|FG001|Overall Study|Non-compliant participant|0|||
41936761|NCT01650558|75647718|FG002|Overall Study|Non-compliant participant|2|||
41936762|NCT01650558|75647716|FG000|Overall Study|Physician Decision|0|||
41936763|NCT01650558|75647717|FG001|Overall Study|Physician Decision|1|||
41936764|NCT01650558|75647718|FG002|Overall Study|Physician Decision|0|||
41936765|NCT02408484|75647757|FG000|Overall Study|Withdrawal by Subject|3|||
41936766|NCT02408484|75647757|FG000|Overall Study|Not treated during study period|1|||
41936767|NCT02380248|75647785|FG000|Overall Study|Lost to Follow-up|11|||
41936768|NCT02380248|75647785|FG000|Overall Study|Withdrawal by Subject|3|||
41936769|NCT02408016|75647832|FG000|Overall Study|Death|6|||
41936770|NCT02408016|75647833|FG001|Overall Study|Death|1|||
41936771|NCT02408016|75647834|FG002|Overall Study|Death|0|||
41936772|NCT02408016|75647832|FG000|Overall Study|Physician Decision|0|||
41936773|NCT02408016|75647833|FG001|Overall Study|Physician Decision|2|||
41936774|NCT02408016|75647834|FG002|Overall Study|Physician Decision|0|||
41936775|NCT02407704|75647898|FG000|Overall Study|Lost to Follow-up|0|||
41936776|NCT02407704|75647899|FG001|Overall Study|Lost to Follow-up|0|||
41936777|NCT02407704|75647900|FG002|Overall Study|Lost to Follow-up|0|||
41936778|NCT02407704|75647901|FG003|Overall Study|Lost to Follow-up|2|||
41936779|NCT02407704|75647898|FG000|Overall Study|Protocol Violation|0|||
41936780|NCT02407704|75647899|FG001|Overall Study|Protocol Violation|0|||
41936781|NCT02407704|75647900|FG002|Overall Study|Protocol Violation|0|||
41936782|NCT02407704|75647901|FG003|Overall Study|Protocol Violation|1|||
41936783|NCT02407704|75647898|FG000|Overall Study|Withdrawal by Subject|0|||
41936784|NCT02407704|75647899|FG001|Overall Study|Withdrawal by Subject|0|||
41936785|NCT02407704|75647900|FG002|Overall Study|Withdrawal by Subject|1|||
41936786|NCT02407704|75647901|FG003|Overall Study|Withdrawal by Subject|0|||
41936787|NCT02406612|75647922|FG000|Overall Study|Screening Failure|3|||
41936788|NCT02406612|75647923|FG001|Overall Study|Screening Failure|0|||
41936789|NCT02406612|75647922|FG000|Overall Study|Intra-procedural Exclusion|1|||
41936790|NCT02406612|75647923|FG001|Overall Study|Intra-procedural Exclusion|3|||
41936791|NCT02406612|75647922|FG000|Overall Study|Guidewire Failure|0|||
41936792|NCT02406612|75647923|FG001|Overall Study|Guidewire Failure|1|||
41936793|NCT02405442|75648067|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
41936794|NCT02405442|75648068|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
41936795|NCT02405442|75648069|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
41936796|NCT02405442|75648070|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
41936797|NCT02405442|75648067|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
41936798|NCT02405442|75648068|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
41936799|NCT02405442|75648069|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
41936800|NCT02405442|75648070|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
41936801|NCT02405442|75648067|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
41936802|NCT02405442|75648068|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
41936803|NCT02405442|75648069|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
41936804|NCT02405442|75648070|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
41936805|NCT02405442|75648067|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
41936806|NCT02405442|75648068|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
41936807|NCT02405442|75648069|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
41936808|NCT02405442|75648070|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
41936809|NCT02405442|75648067|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
41936810|NCT02405442|75648068|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
41936811|NCT02405442|75648069|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
41936812|NCT02405442|75648070|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
41936813|NCT02405442|75648067|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
41936814|NCT02405442|75648068|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
41936815|NCT02405442|75648069|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
41936816|NCT02405442|75648070|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
41936817|NCT02405442|75648067|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
41936818|NCT02405442|75648068|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
41936819|NCT02405442|75648069|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
41936820|NCT02405442|75648070|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
41936821|NCT02405442|75648067|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
41936822|NCT02405442|75648068|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
42022519|NCT01061151|75829825|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
42022520|NCT01061151|75829822|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
42022521|NCT01061151|75829823|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
42022522|NCT01061151|75829824|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
42022523|NCT01061151|75829825|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
42022524|NCT01061151|75829822|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
42022525|NCT01061151|75829823|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
42022526|NCT01061151|75829824|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
42022527|NCT01061151|75829825|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
42022528|NCT01241552|75829849|FG000|Overall Study|Lack of Efficacy|1|||
42022529|NCT01241552|75829850|FG001|Overall Study|Lack of Efficacy|0|||
42022530|NCT01241552|75829851|FG002|Overall Study|Lack of Efficacy|0|||
42022531|NCT01241552|75829852|FG003|Overall Study|Lack of Efficacy|0|||
42022532|NCT01241552|75829849|FG000|Overall Study|Death|26|||
42210252|NCT03297294|76024985|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
41936823|NCT02405442|75648069|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
41936824|NCT02405442|75648070|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
41936825|NCT02405442|75648067|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
41936826|NCT02405442|75648068|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
41936827|NCT02405442|75648069|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
41936828|NCT02405442|75648070|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
41936829|NCT02405442|75648067|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
41936830|NCT02405442|75648068|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
41936831|NCT02405442|75648069|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
41936832|NCT02405442|75648070|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
41936833|NCT02405442|75648067|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
41936834|NCT02405442|75648068|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
41936835|NCT02405442|75648069|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
41936836|NCT02405442|75648070|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
41936837|NCT02405442|75648067|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
41936838|NCT02405442|75648068|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
41936839|NCT02405442|75648069|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
41936840|NCT02405442|75648070|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
41936841|NCT02405442|75648067|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
41936842|NCT02405442|75648068|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
41936843|NCT02405442|75648069|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
41936844|NCT02405442|75648070|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
41936845|NCT02405442|75648067|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
41936846|NCT02405442|75648068|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
41936847|NCT02405442|75648069|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
41936848|NCT02405442|75648070|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
41936849|NCT02404350|75648186|FG000|Overall Study|Adverse Event|2|||
41936850|NCT02404350|75648187|FG001|Overall Study|Adverse Event|2|||
41936851|NCT02404350|75648188|FG002|Overall Study|Adverse Event|3|||
41936852|NCT02404350|75648189|FG003|Overall Study|Adverse Event|9|||
41936853|NCT02404350|75648186|FG000|Overall Study|Lack of Efficacy|3|||
41936854|NCT02404350|75648187|FG001|Overall Study|Lack of Efficacy|1|||
41936855|NCT02404350|75648188|FG002|Overall Study|Lack of Efficacy|0|||
41936856|NCT02404350|75648189|FG003|Overall Study|Lack of Efficacy|3|||
41936857|NCT02404350|75648186|FG000|Overall Study|Lost to Follow-up|2|||
41936858|NCT02404350|75648187|FG001|Overall Study|Lost to Follow-up|0|||
41936859|NCT02404350|75648188|FG002|Overall Study|Lost to Follow-up|0|||
41936860|NCT02404350|75648189|FG003|Overall Study|Lost to Follow-up|1|||
41936861|NCT02404350|75648186|FG000|Overall Study|Physician Decision|1|||
41936862|NCT02404350|75648187|FG001|Overall Study|Physician Decision|0|||
41936863|NCT02404350|75648188|FG002|Overall Study|Physician Decision|0|||
41936864|NCT02404350|75648189|FG003|Overall Study|Physician Decision|2|||
41936865|NCT02404350|75648186|FG000|Overall Study|Pregnancy|0|||
41936866|NCT02404350|75648187|FG001|Overall Study|Pregnancy|0|||
41936867|NCT02404350|75648188|FG002|Overall Study|Pregnancy|0|||
41936868|NCT02404350|75648189|FG003|Overall Study|Pregnancy|1|||
41936869|NCT02404350|75648186|FG000|Overall Study|Withdrawal by Subject|7|||
41936870|NCT02404350|75648187|FG001|Overall Study|Withdrawal by Subject|3|||
41936871|NCT02404350|75648188|FG002|Overall Study|Withdrawal by Subject|3|||
41936872|NCT02404350|75648189|FG003|Overall Study|Withdrawal by Subject|19|||
42022533|NCT01241552|75829850|FG001|Overall Study|Death|30|||
41936873|NCT02404350|75648186|FG000|Overall Study|Due to Non-compliance with treatment|0|||
41936874|NCT02404350|75648187|FG001|Overall Study|Due to Non-compliance with treatment|0|||
41936875|NCT02404350|75648188|FG002|Overall Study|Due to Non-compliance with treatment|0|||
41936876|NCT02404350|75648189|FG003|Overall Study|Due to Non-compliance with treatment|1|||
41936877|NCT02404350|75648186|FG000|Overall Study|Due to Technical problems|0|||
41936878|NCT02404350|75648187|FG001|Overall Study|Due to Technical problems|0|||
41936879|NCT02404350|75648188|FG002|Overall Study|Due to Technical problems|0|||
41936880|NCT02404350|75648189|FG003|Overall Study|Due to Technical problems|1|||
41936881|NCT02434770|75648488|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
41936882|NCT02434770|75648489|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
41936883|NCT02434770|75648490|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
41936884|NCT02434770|75648488|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
41936885|NCT02434770|75648489|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
41936886|NCT02434770|75648490|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
41936887|NCT02434770|75648488|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
41936888|NCT02434770|75648489|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
41936889|NCT02434770|75648490|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
41936890|NCT02434770|75648488|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
41936891|NCT02434770|75648489|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
41936892|NCT02434770|75648490|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
41936893|NCT02434770|75648488|FG000|Week 1 to Week 18|Death|1|||
41936894|NCT02434770|75648489|FG001|Week 1 to Week 18|Death|0|||
41936895|NCT02434770|75648490|FG002|Week 1 to Week 18|Death|0|||
41936896|NCT02434770|75648488|FG000|Week 18 to Week|Lost to Follow-up|2|||
41936897|NCT02434770|75648489|FG001|Week 18 to Week|Lost to Follow-up|2|||
41936898|NCT02434770|75648490|FG002|Week 18 to Week|Lost to Follow-up|1|||
41936899|NCT02434770|75648488|FG000|Week 18 to Week|Withdrawal by Subject|0|||
41936900|NCT02434770|75648489|FG001|Week 18 to Week|Withdrawal by Subject|0|||
41936901|NCT02434770|75648490|FG002|Week 18 to Week|Withdrawal by Subject|2|||
41936902|NCT02434770|75648488|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
41936903|NCT02434770|75648489|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
41936904|NCT02434770|75648490|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
41936905|NCT02433834|75648521|FG000|Overall Study|Protocol-specified criteria|7|||
41936906|NCT02433834|75648521|FG000|Overall Study|Protocol Violation|3|||
41936907|NCT02433834|75648521|FG000|Overall Study|Lost to Follow-up|6|||
41936908|NCT02433834|75648521|FG000|Overall Study|Withdrawal by Subject|14|||
41936909|NCT02433834|75648521|FG000|Overall Study|Adverse Event|6|||
41936910|NCT02433834|75648521|FG000|Overall Study|Physician Decision|1|||
41936911|NCT02433678|75648565|FG000|Overall Study|Lost to Follow-up|1|||
41936912|NCT02433678|75648566|FG001|Overall Study|Lost to Follow-up|2|||
41936913|NCT02433288|75648579|FG000|Overall Study|Severe non-compliance to protocol|13|||
41936914|NCT02433288|75648580|FG001|Overall Study|Severe non-compliance to protocol|7|||
41936915|NCT02433288|75648579|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
41936916|NCT02433288|75648580|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
41936917|NCT02433288|75648579|FG000|Overall Study|Withdrawal by Subject|101|||
41936918|NCT02433288|75648580|FG001|Overall Study|Withdrawal by Subject|99|||
41936919|NCT02433288|75648579|FG000|Overall Study|Lost to Follow-up|2|||
41936920|NCT02433288|75648580|FG001|Overall Study|Lost to Follow-up|14|||
41936921|NCT02433288|75648579|FG000|Overall Study|Death|0|||
41936922|NCT02433288|75648580|FG001|Overall Study|Death|3|||
42022534|NCT01241552|75829851|FG002|Overall Study|Death|20|||
42022535|NCT01241552|75829852|FG003|Overall Study|Death|25|||
42022536|NCT01241552|75829849|FG000|Overall Study|Adverse Event|1|||
41936923|NCT02433210|75648600|FG000|Overall Study|Physician Decision|1|||
41936924|NCT02433210|75648601|FG001|Overall Study|Physician Decision|0|||
41936925|NCT02433210|75648602|FG002|Overall Study|Physician Decision|0|||
41936926|NCT02432040|75648737|FG000|Overall Study|Lack of Efficacy|3|||
41936927|NCT02432040|75648738|FG001|Overall Study|Lack of Efficacy|0|||
41936928|NCT02432040|75648737|FG000|Overall Study|Lost to Follow-up|4|||
41936929|NCT02432040|75648738|FG001|Overall Study|Lost to Follow-up|5|||
41936930|NCT02432040|75648737|FG000|Overall Study|Physician Decision|1|||
41936931|NCT02432040|75648738|FG001|Overall Study|Physician Decision|1|||
41936932|NCT04418076|75648784|FG000|Overall Study|Death|1|||
41936933|NCT04418076|75648785|FG001|Overall Study|Death|0|||
41936934|NCT04418076|75648786|FG002|Overall Study|Death|0|||
41936935|NCT04418076|75648787|FG003|Overall Study|Death|0|||
41936936|NCT04418076|75648784|FG000|Overall Study|Lost to Follow-up|2|||
41936937|NCT04418076|75648785|FG001|Overall Study|Lost to Follow-up|5|||
41936938|NCT04418076|75648786|FG002|Overall Study|Lost to Follow-up|1|||
41936939|NCT04418076|75648787|FG003|Overall Study|Lost to Follow-up|2|||
41936940|NCT04418076|75648784|FG000|Overall Study|Withdrawal by Subject|1|||
41936941|NCT04418076|75648785|FG001|Overall Study|Withdrawal by Subject|0|||
41936942|NCT04418076|75648786|FG002|Overall Study|Withdrawal by Subject|1|||
41936943|NCT04418076|75648787|FG003|Overall Study|Withdrawal by Subject|1|||
41936944|NCT04418076|75648784|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
41936945|NCT04418076|75648785|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
41936946|NCT04418076|75648786|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
41936947|NCT04418076|75648787|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
41936948|NCT04165824|75648797|FG000|Overall Study|Adverse Event|23|||
41936949|NCT04165824|75648797|FG000|Overall Study|Physician Decision|1|||
41936950|NCT04165824|75648797|FG000|Overall Study|Withdrawal by Subject|17|||
41936951|NCT04165824|75648797|FG000|Overall Study|Other|5|||
41936952|NCT03809039|75648810|FG000|Part 1|Withdrawal by Subject|1|||
41936953|NCT03809039|75648811|FG001|Part 1|Withdrawal by Subject|0|||
41936954|NCT03809039|75648812|FG002|Part 1|Withdrawal by Subject|0|||
41936955|NCT03809039|75648813|FG003|Part 1|Withdrawal by Subject|1|||
41936956|NCT03809039|75648814|FG004|Part 1|Withdrawal by Subject|0|||
41936957|NCT03809039|75648815|FG005|Part 1|Withdrawal by Subject|0|||
41936958|NCT03809039|75648816|FG006|Part 1|Withdrawal by Subject|0|||
41936959|NCT03809039|75648817|FG007|Part 1|Withdrawal by Subject|0|||
41936960|NCT03809039|75648818|FG008|Part 1|Withdrawal by Subject|0|||
41936961|NCT03809039|75648810|FG000|Part 3|Withdrawn by study termination|0|||
41936962|NCT03809039|75648811|FG001|Part 3|Withdrawn by study termination|0|||
41936963|NCT03809039|75648812|FG002|Part 3|Withdrawn by study termination|0|||
41936964|NCT03809039|75648813|FG003|Part 3|Withdrawn by study termination|0|||
41936965|NCT03809039|75648814|FG004|Part 3|Withdrawn by study termination|0|||
41936966|NCT03809039|75648815|FG005|Part 3|Withdrawn by study termination|0|||
41936967|NCT03809039|75648816|FG006|Part 3|Withdrawn by study termination|0|||
41936968|NCT03809039|75648817|FG007|Part 3|Withdrawn by study termination|2|||
41936969|NCT03809039|75648818|FG008|Part 3|Withdrawn by study termination|6|||
41936970|NCT03541200|75648851|FG000|Overall Study|Adverse Event|19|||
41936971|NCT03541200|75648851|FG000|Overall Study|Death|1|||
41936972|NCT03541200|75648851|FG000|Overall Study|Lost to Follow-up|10|||
41936973|NCT03541200|75648851|FG000|Overall Study|Physician Decision|1|||
41936974|NCT03541200|75648851|FG000|Overall Study|Protocol Violation|51|||
41936975|NCT03541200|75648851|FG000|Overall Study|Withdrawal by Subject|23|||
41936976|NCT03541200|75648851|FG000|Overall Study|other|8|||
41936977|NCT03520036|75648858|FG000|Overall Study|Adverse Event|1|||
41936978|NCT03520036|75648859|FG001|Overall Study|Adverse Event|2|||
41936979|NCT03520036|75648860|FG002|Overall Study|Adverse Event|0|||
41936980|NCT03520036|75648858|FG000|Overall Study|Protocol Violation|1|||
41936981|NCT03520036|75648859|FG001|Overall Study|Protocol Violation|0|||
41936982|NCT03520036|75648860|FG002|Overall Study|Protocol Violation|0|||
41936983|NCT03520036|75648858|FG000|Overall Study|Withdrawal by Subject|0|||
41936984|NCT03520036|75648859|FG001|Overall Study|Withdrawal by Subject|1|||
41936985|NCT03520036|75648860|FG002|Overall Study|Withdrawal by Subject|4|||
41936986|NCT03520036|75648858|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
41936987|NCT03520036|75648859|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
41936988|NCT03520036|75648860|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
41936989|NCT03505710|75648871|FG000|Overall Study|Progressive Disease|22|||
41936990|NCT03505710|75648872|FG001|Overall Study|Progressive Disease|9|||
42022537|NCT01241552|75829850|FG001|Overall Study|Adverse Event|1|||
41936991|NCT03505710|75648873|FG002|Overall Study|Progressive Disease|34|||
41936992|NCT03505710|75648871|FG000|Overall Study|Clinical Progression|6|||
41936993|NCT03505710|75648872|FG001|Overall Study|Clinical Progression|6|||
41936994|NCT03505710|75648873|FG002|Overall Study|Clinical Progression|3|||
41936995|NCT03505710|75648871|FG000|Overall Study|Adverse Event|12|||
42117973|NCT00688259|75928815|FG001|Overall Study|Declined Interview|3|||
41936996|NCT03505710|75648872|FG001|Overall Study|Adverse Event|5|||
41936997|NCT03505710|75648873|FG002|Overall Study|Adverse Event|27|||
41936998|NCT03505710|75648871|FG000|Overall Study|Withdrawal by Subject|1|||
42022538|NCT01241552|75829851|FG002|Overall Study|Adverse Event|0|||
42210253|NCT03297294|76024986|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
41936999|NCT03505710|75648872|FG001|Overall Study|Withdrawal by Subject|3|||
41937000|NCT03505710|75648873|FG002|Overall Study|Withdrawal by Subject|3|||
41937001|NCT03505710|75648871|FG000|Overall Study|Physician Decision|1|||
41937002|NCT03505710|75648872|FG001|Overall Study|Physician Decision|0|||
41937003|NCT03505710|75648873|FG002|Overall Study|Physician Decision|2|||
41937004|NCT03505710|75648871|FG000|Overall Study|Death|4|||
41937005|NCT03505710|75648872|FG001|Overall Study|Death|3|||
41937006|NCT03505710|75648873|FG002|Overall Study|Death|6|||
41937007|NCT03505710|75648871|FG000|Overall Study|Other Reasons|1|||
41937008|NCT03505710|75648872|FG001|Overall Study|Other Reasons|1|||
41937009|NCT03505710|75648873|FG002|Overall Study|Other Reasons|1|||
41937010|NCT03459729|75648881|FG000|Overall Study|Physician Decision|2|||
41937011|NCT03291067|75648889|FG000|Overall Study|Adverse Event|0|||
41937012|NCT03291067|75648890|FG001|Overall Study|Adverse Event|2|||
41937013|NCT03291067|75648891|FG002|Overall Study|Adverse Event|17|||
41937014|NCT03291067|75648892|FG003|Overall Study|Adverse Event|3|||
41937015|NCT03291067|75648889|FG000|Overall Study|Lost to Follow-up|2|||
41937016|NCT03291067|75648890|FG001|Overall Study|Lost to Follow-up|1|||
41937017|NCT03291067|75648891|FG002|Overall Study|Lost to Follow-up|0|||
41937018|NCT03291067|75648892|FG003|Overall Study|Lost to Follow-up|1|||
41937019|NCT03291067|75648889|FG000|Overall Study|Physician Decision|0|||
41937020|NCT03291067|75648890|FG001|Overall Study|Physician Decision|0|||
41937021|NCT03291067|75648891|FG002|Overall Study|Physician Decision|1|||
41937022|NCT03291067|75648892|FG003|Overall Study|Physician Decision|0|||
41937023|NCT03291067|75648889|FG000|Overall Study|Protocol Violation|5|||
41937024|NCT03291067|75648890|FG001|Overall Study|Protocol Violation|3|||
41937025|NCT03291067|75648891|FG002|Overall Study|Protocol Violation|4|||
41937026|NCT03291067|75648892|FG003|Overall Study|Protocol Violation|2|||
41937027|NCT03291067|75648889|FG000|Overall Study|Withdrawal by Subject|3|||
41937028|NCT03291067|75648890|FG001|Overall Study|Withdrawal by Subject|4|||
41937029|NCT03291067|75648891|FG002|Overall Study|Withdrawal by Subject|7|||
41937030|NCT03291067|75648892|FG003|Overall Study|Withdrawal by Subject|5|||
41937031|NCT03291067|75648889|FG000|Overall Study|Other|0|||
41937032|NCT03291067|75648890|FG001|Overall Study|Other|4|||
41937033|NCT03291067|75648891|FG002|Overall Study|Other|4|||
41937034|NCT03291067|75648892|FG003|Overall Study|Other|6|||
41937035|NCT02841280|75648904|FG000|Overall Study|Adverse Event|2|||
41937036|NCT02841280|75648905|FG001|Overall Study|Adverse Event|1|||
41937037|NCT02841280|75648904|FG000|Overall Study|Death|1|||
41937038|NCT02841280|75648905|FG001|Overall Study|Death|0|||
41937039|NCT02841280|75648904|FG000|Overall Study|Lost to Follow-up|2|||
41937040|NCT02841280|75648905|FG001|Overall Study|Lost to Follow-up|2|||
41937041|NCT02841280|75648904|FG000|Overall Study|Withdrawal by Subject|7|||
41937042|NCT02841280|75648905|FG001|Overall Study|Withdrawal by Subject|3|||
41937043|NCT02841280|75648904|FG000|Overall Study|Stop Point: BP above threshold|2|||
41937044|NCT02841280|75648905|FG001|Overall Study|Stop Point: BP above threshold|0|||
41937045|NCT02345330|75648919|FG000|Overall Study|Death|1|||
41937046|NCT02345330|75648919|FG000|Overall Study|Progressive Disease|2|||
41937047|NCT01513343|75648934|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
41937048|NCT01513343|75648935|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
41937049|NCT01513343|75648934|FG000|Post Data Collection|Dropped/withdrew from study|7|||
41937050|NCT01513343|75648935|FG001|Post Data Collection|Dropped/withdrew from study|1|||
41937051|NCT01513343|75648934|FG000|Post Data Collection|Lost to Follow-up|10|||
41937052|NCT01513343|75648935|FG001|Post Data Collection|Lost to Follow-up|23|||
41937053|NCT01513343|75648934|FG000|6-month Follow-up|Lost to Follow-up|28|||
41937054|NCT01513343|75648935|FG001|6-month Follow-up|Lost to Follow-up|17|||
41937055|NCT01513343|75648934|FG000|12-month Follow-up|Lost to Follow-up|10|||
41937056|NCT01513343|75648935|FG001|12-month Follow-up|Lost to Follow-up|3|||
41937057|NCT01440816|75648962|FG000|Overall Study|Disease Progression|0|||
41937058|NCT01440816|75648963|FG001|Overall Study|Disease Progression|9|||
41937059|NCT01440816|75648962|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
41937060|NCT01440816|75648963|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
41937061|NCT01348919|75648974|FG000|Overall Study|Adverse Event|3|||
41937062|NCT01348919|75648975|FG001|Overall Study|Adverse Event|1|||
41937063|NCT01348919|75648976|FG002|Overall Study|Adverse Event|0|||
41937064|NCT01348919|75648974|FG000|Overall Study|Withdrawal by Subject|0|||
41937065|NCT01348919|75648975|FG001|Overall Study|Withdrawal by Subject|1|||
41937066|NCT01348919|75648976|FG002|Overall Study|Withdrawal by Subject|0|||
41937067|NCT01348919|75648974|FG000|Overall Study|Disease progression|0|||
41937068|NCT01348919|75648975|FG001|Overall Study|Disease progression|1|||
41937069|NCT01348919|75648976|FG002|Overall Study|Disease progression|1|||
41937070|NCT00966381|75648988|FG000|Overall Study|Withdrawal by Subject|2|||
41937071|NCT00966381|75648989|FG001|Overall Study|Withdrawal by Subject|2|||
41937072|NCT02431806|75649001|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
41937073|NCT02431806|75649002|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
41937074|NCT02431806|75649003|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
41937075|NCT02431806|75649004|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
41937076|NCT02431806|75649001|FG000|Double-blind Treatment Period|Adverse Event|4|||
41937077|NCT02431806|75649002|FG001|Double-blind Treatment Period|Adverse Event|7|||
42022539|NCT01241552|75829852|FG003|Overall Study|Adverse Event|0|||
41937078|NCT02431806|75649003|FG002|Double-blind Treatment Period|Adverse Event|11|||
41937079|NCT02431806|75649004|FG003|Double-blind Treatment Period|Adverse Event|7|||
41937080|NCT02431806|75649001|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
41937081|NCT02431806|75649002|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
41937082|NCT02431806|75649003|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
41937083|NCT02431806|75649004|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
41937084|NCT02431806|75649001|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
41937085|NCT02431806|75649002|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
41937086|NCT02431806|75649003|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
41937087|NCT02431806|75649004|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
41937088|NCT02431806|75649001|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
41937089|NCT02431806|75649002|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
41937090|NCT02431806|75649003|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
41937091|NCT02431806|75649004|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
41937092|NCT02431806|75649001|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
41937093|NCT02431806|75649002|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
41937094|NCT02431806|75649003|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
41937095|NCT02431806|75649004|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
41937096|NCT02431806|75649001|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
41937097|NCT02431806|75649002|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
41937098|NCT02431806|75649003|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
41937099|NCT02431806|75649004|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
41937100|NCT01650246|75649045|FG000|Overall Study|Adverse Event|23|||
41937101|NCT01650246|75649045|FG000|Overall Study|Protocol Violation|5|||
41937102|NCT01650246|75649045|FG000|Overall Study|Sponsor terminated study|53|||
41937103|NCT01650246|75649045|FG000|Overall Study|Lost to Follow-up|5|||
41937104|NCT01650246|75649045|FG000|Overall Study|Withdrawal by Subject|26|||
41937105|NCT01650246|75649045|FG000|Overall Study|Death|1|||
41937106|NCT01650246|75649045|FG000|Overall Study|Lack of Efficacy|30|||
41937107|NCT01652664|75649064|FG000|Overall Study|Treatment Failure|5|||
41937108|NCT01652664|75649065|FG001|Overall Study|Treatment Failure|1|||
41937109|NCT01652664|75649064|FG000|Overall Study|Inadequate IOP control|1|||
41937110|NCT01652664|75649065|FG001|Overall Study|Inadequate IOP control|0|||
41937111|NCT02379390|75649105|FG000|Overall Study|Adverse Event|1|||
41937112|NCT02379390|75649106|FG001|Overall Study|Adverse Event|1|||
41937113|NCT02379390|75649105|FG000|Overall Study|Investigator's decision|1|||
41937114|NCT02379390|75649106|FG001|Overall Study|Investigator's decision|0|||
41937115|NCT02379390|75649105|FG000|Overall Study|Study Termination|0|||
41937116|NCT02379390|75649106|FG001|Overall Study|Study Termination|1|||
41937117|NCT02379078|75649117|FG000|Overall Study|Lost to Follow-up|33|||
41937118|NCT02379078|75649118|FG001|Overall Study|Lost to Follow-up|30|||
41937119|NCT02379078|75649117|FG000|Overall Study|Withdrawal by Subject|6|||
41937120|NCT02379078|75649118|FG001|Overall Study|Withdrawal by Subject|5|||
41937121|NCT01714739|75649211|FG000|Overall Study|Disease progression|3|||
41937122|NCT01714739|75649212|FG001|Overall Study|Disease progression|5|||
41937123|NCT01714739|75649213|FG002|Overall Study|Disease progression|5|||
41937124|NCT01714739|75649214|FG003|Overall Study|Disease progression|204|||
41937125|NCT01714739|75649215|FG004|Overall Study|Disease progression|1|||
41937126|NCT01714739|75649216|FG005|Overall Study|Disease progression|3|||
41937127|NCT01714739|75649217|FG006|Overall Study|Disease progression|5|||
41937128|NCT01714739|75649211|FG000|Overall Study|Study drug toxicity|1|||
41937129|NCT01714739|75649212|FG001|Overall Study|Study drug toxicity|1|||
41937130|NCT01714739|75649213|FG002|Overall Study|Study drug toxicity|1|||
41937131|NCT01714739|75649214|FG003|Overall Study|Study drug toxicity|15|||
41937132|NCT01714739|75649215|FG004|Overall Study|Study drug toxicity|0|||
41937133|NCT01714739|75649216|FG005|Overall Study|Study drug toxicity|0|||
41937134|NCT01714739|75649217|FG006|Overall Study|Study drug toxicity|5|||
41937135|NCT01714739|75649211|FG000|Overall Study|Death|0|||
41937136|NCT01714739|75649212|FG001|Overall Study|Death|0|||
41937137|NCT01714739|75649213|FG002|Overall Study|Death|0|||
41937138|NCT01714739|75649214|FG003|Overall Study|Death|1|||
41937139|NCT01714739|75649215|FG004|Overall Study|Death|0|||
41937140|NCT01714739|75649216|FG005|Overall Study|Death|0|||
41937141|NCT01714739|75649217|FG006|Overall Study|Death|0|||
41937142|NCT01714739|75649211|FG000|Overall Study|Adverse Event unrelated to drug|0|||
41937143|NCT01714739|75649212|FG001|Overall Study|Adverse Event unrelated to drug|0|||
41937144|NCT01714739|75649213|FG002|Overall Study|Adverse Event unrelated to drug|3|||
41937145|NCT01714739|75649214|FG003|Overall Study|Adverse Event unrelated to drug|21|||
41937146|NCT01714739|75649215|FG004|Overall Study|Adverse Event unrelated to drug|0|||
41937147|NCT01714739|75649216|FG005|Overall Study|Adverse Event unrelated to drug|0|||
41937148|NCT01714739|75649217|FG006|Overall Study|Adverse Event unrelated to drug|0|||
41937149|NCT01714739|75649211|FG000|Overall Study|Participant request to stop therapy|0|||
41937150|NCT01714739|75649212|FG001|Overall Study|Participant request to stop therapy|1|||
41937151|NCT01714739|75649213|FG002|Overall Study|Participant request to stop therapy|0|||
41937152|NCT01714739|75649214|FG003|Overall Study|Participant request to stop therapy|6|||
41937153|NCT01714739|75649215|FG004|Overall Study|Participant request to stop therapy|0|||
41937154|NCT01714739|75649216|FG005|Overall Study|Participant request to stop therapy|0|||
41937155|NCT01714739|75649217|FG006|Overall Study|Participant request to stop therapy|0|||
41937156|NCT01714739|75649211|FG000|Overall Study|Participant withdrew consent|0|||
42022540|NCT01241552|75829849|FG000|Overall Study|Technical Problems|2|||
42117974|NCT00688259|75928814|FG000|Overall Study|Hospitalized at Follow-up|0|||
41937157|NCT01714739|75649212|FG001|Overall Study|Participant withdrew consent|1|||
41937158|NCT01714739|75649213|FG002|Overall Study|Participant withdrew consent|0|||
41937159|NCT01714739|75649214|FG003|Overall Study|Participant withdrew consent|8|||
41937160|NCT01714739|75649215|FG004|Overall Study|Participant withdrew consent|0|||
41937161|NCT01714739|75649216|FG005|Overall Study|Participant withdrew consent|0|||
41937162|NCT01714739|75649217|FG006|Overall Study|Participant withdrew consent|0|||
41937163|NCT01714739|75649211|FG000|Overall Study|Lost to Follow-up|0|||
41937164|NCT01714739|75649212|FG001|Overall Study|Lost to Follow-up|0|||
41937165|NCT01714739|75649213|FG002|Overall Study|Lost to Follow-up|0|||
41937166|NCT01714739|75649214|FG003|Overall Study|Lost to Follow-up|1|||
41937167|NCT01714739|75649215|FG004|Overall Study|Lost to Follow-up|0|||
41937168|NCT01714739|75649216|FG005|Overall Study|Lost to Follow-up|0|||
41937169|NCT01714739|75649217|FG006|Overall Study|Lost to Follow-up|0|||
41937170|NCT01714739|75649211|FG000|Overall Study|Maximum clinical benefit|0|||
41937171|NCT01714739|75649212|FG001|Overall Study|Maximum clinical benefit|1|||
41937172|NCT01714739|75649213|FG002|Overall Study|Maximum clinical benefit|1|||
41937173|NCT01714739|75649214|FG003|Overall Study|Maximum clinical benefit|3|||
41937174|NCT01714739|75649215|FG004|Overall Study|Maximum clinical benefit|0|||
41937175|NCT01714739|75649216|FG005|Overall Study|Maximum clinical benefit|0|||
41937176|NCT01714739|75649217|FG006|Overall Study|Maximum clinical benefit|0|||
41937177|NCT01714739|75649211|FG000|Overall Study|Poor/non-comliance|0|||
41937178|NCT01714739|75649212|FG001|Overall Study|Poor/non-comliance|1|||
41937179|NCT01714739|75649213|FG002|Overall Study|Poor/non-comliance|0|||
41937180|NCT01714739|75649214|FG003|Overall Study|Poor/non-comliance|1|||
41937181|NCT01714739|75649215|FG004|Overall Study|Poor/non-comliance|0|||
41937182|NCT01714739|75649216|FG005|Overall Study|Poor/non-comliance|0|||
41937183|NCT01714739|75649217|FG006|Overall Study|Poor/non-comliance|0|||
41937184|NCT01714739|75649211|FG000|Overall Study|No longer meets study criteria|0|||
41937185|NCT01714739|75649212|FG001|Overall Study|No longer meets study criteria|0|||
41937186|NCT01714739|75649213|FG002|Overall Study|No longer meets study criteria|0|||
41937187|NCT01714739|75649214|FG003|Overall Study|No longer meets study criteria|1|||
41937188|NCT01714739|75649215|FG004|Overall Study|No longer meets study criteria|0|||
41937189|NCT01714739|75649216|FG005|Overall Study|No longer meets study criteria|0|||
41937190|NCT01714739|75649217|FG006|Overall Study|No longer meets study criteria|0|||
41937191|NCT01714739|75649211|FG000|Overall Study|Other reason|0|||
41937192|NCT01714739|75649212|FG001|Overall Study|Other reason|0|||
41937193|NCT01714739|75649213|FG002|Overall Study|Other reason|0|||
41937194|NCT01714739|75649214|FG003|Overall Study|Other reason|3|||
41937195|NCT01714739|75649215|FG004|Overall Study|Other reason|1|||
41937196|NCT01714739|75649216|FG005|Overall Study|Other reason|0|||
41937197|NCT01714739|75649217|FG006|Overall Study|Other reason|0|||
41937198|NCT03823287|75651198|FG000|Overall Study|Withdrawal by Subject|25|||
41937199|NCT03823287|75651199|FG001|Overall Study|Withdrawal by Subject|17|||
41937200|NCT03823287|75651198|FG000|Overall Study|Death|13|||
41937201|NCT03823287|75651199|FG001|Overall Study|Death|7|||
41937202|NCT03823287|75651198|FG000|Overall Study|Lost to Follow-up|7|||
41937203|NCT03823287|75651199|FG001|Overall Study|Lost to Follow-up|8|||
41937204|NCT03823287|75651198|FG000|Overall Study|Adverse Event|6|||
41937205|NCT03823287|75651199|FG001|Overall Study|Adverse Event|8|||
41937206|NCT03823287|75651198|FG000|Overall Study|Physician Decision|5|||
41937207|NCT03823287|75651199|FG001|Overall Study|Physician Decision|2|||
41937208|NCT03823287|75651198|FG000|Overall Study|Lack of Efficacy|2|||
41937209|NCT03823287|75651199|FG001|Overall Study|Lack of Efficacy|0|||
41937210|NCT03823287|75651198|FG000|Overall Study|Other|2|||
41937211|NCT03823287|75651199|FG001|Overall Study|Other|4|||
41937212|NCT03707925|75651360|FG000|Overall Study|Inevaluable|1|||
41937213|NCT03461757|75651420|FG000|Overall Study|Adverse Event|1|||
41937214|NCT03461757|75651421|FG001|Overall Study|Adverse Event|0|||
41937215|NCT03461757|75651420|FG000|Overall Study|Lost to Follow-up|13|||
41937216|NCT03461757|75651421|FG001|Overall Study|Lost to Follow-up|7|||
41937217|NCT03461757|75651420|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
42022541|NCT01241552|75829850|FG001|Overall Study|Technical Problems|0|||
41937218|NCT03461757|75651421|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
41937219|NCT03461757|75651420|FG000|Overall Study|Non-compliance with study treatment|0|||
41937220|NCT03461757|75651421|FG001|Overall Study|Non-compliance with study treatment|1|||
41937221|NCT03461757|75651420|FG000|Overall Study|Pregnancy|2|||
41937222|NCT03461757|75651421|FG001|Overall Study|Pregnancy|0|||
41937223|NCT03461757|75651420|FG000|Overall Study|Protocol Violation|1|||
41937224|NCT03461757|75651421|FG001|Overall Study|Protocol Violation|1|||
41937225|NCT03461757|75651420|FG000|Overall Study|Withdrawal by Subject|7|||
41937226|NCT03461757|75651421|FG001|Overall Study|Withdrawal by Subject|7|||
41937227|NCT03461757|75651420|FG000|Overall Study|Other Reasons|1|||
41937228|NCT03461757|75651421|FG001|Overall Study|Other Reasons|4|||
41937229|NCT03235479|75651909|FG000|Overall Study|Lost to Follow-up|8|||
41937230|NCT03235479|75651910|FG001|Overall Study|Lost to Follow-up|11|||
41937231|NCT03235479|75651909|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
41937232|NCT03235479|75651910|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
41937233|NCT03235479|75651909|FG000|Overall Study|Pregnancy|1|||
41937234|NCT03235479|75651910|FG001|Overall Study|Pregnancy|0|||
41937235|NCT03235479|75651909|FG000|Overall Study|Protocol Deviation|1|||
41937236|NCT03235479|75651910|FG001|Overall Study|Protocol Deviation|3|||
41937237|NCT03235479|75651909|FG000|Overall Study|Technical Problems|3|||
41937238|NCT03235479|75651910|FG001|Overall Study|Technical Problems|2|||
41937239|NCT03235479|75651909|FG000|Overall Study|Withdrawal by Subject|2|||
41937240|NCT03235479|75651910|FG001|Overall Study|Withdrawal by Subject|2|||
41937241|NCT03235479|75651909|FG000|Overall Study|Other Reasons|3|||
41937242|NCT03235479|75651910|FG001|Overall Study|Other Reasons|5|||
41937243|NCT03193437|75651966|FG000|Overall Study|Adverse Event|4|||
41937244|NCT03193437|75651966|FG000|Overall Study|Withdrawal by Subject|2|||
41937245|NCT03193437|75651966|FG000|Overall Study|Disease Progression|2|||
41937246|NCT02906787|75652008|FG000|Overall Study|Withdrawal by Subject|12|||
41937247|NCT02906787|75652009|FG001|Overall Study|Withdrawal by Subject|10|||
41937248|NCT02906787|75652008|FG000|Overall Study|Missed|24|||
41937249|NCT02906787|75652009|FG001|Overall Study|Missed|22|||
41937250|NCT02107443|75652582|FG000|Overall Study|Death|42|||
41937251|NCT02107443|75652583|FG001|Overall Study|Death|30|||
41937252|NCT02107443|75652582|FG000|Overall Study|Study Protocol Violation|3|||
41937253|NCT02107443|75652583|FG001|Overall Study|Study Protocol Violation|1|||
41937254|NCT02107443|75652582|FG000|Overall Study|Registered but Not Eligible|0|||
41937255|NCT02107443|75652583|FG001|Overall Study|Registered but Not Eligible|1|||
41937256|NCT02107443|75652582|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
41937257|NCT02107443|75652583|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
41937258|NCT02107443|75652582|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
41937259|NCT02107443|75652583|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
42210254|NCT03297294|76024987|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
42210255|NCT03297294|76024988|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
42210256|NCT03238911|76025002|FG000|Overall Study|Withdrawal by Subject|1|||
41937260|NCT02107443|75652582|FG000|Overall Study|Withdrawal: Changed Mind|2|||
41937261|NCT02107443|75652583|FG001|Overall Study|Withdrawal: Changed Mind|0|||
41937262|NCT02107443|75652582|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
41937263|NCT02107443|75652583|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
41937264|NCT02107443|75652582|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
41937265|NCT02107443|75652583|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
41937266|NCT02107443|75652582|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
41937267|NCT02107443|75652583|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
41937268|NCT02107443|75652582|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
41937269|NCT02107443|75652583|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
41937270|NCT02107443|75652582|FG000|Overall Study|Withdrawal: Other Medical|9|||
41937271|NCT02107443|75652583|FG001|Overall Study|Withdrawal: Other Medical|5|||
41937272|NCT02107443|75652582|FG000|Overall Study|Withdrawal: Disease Progression|4|||
41937273|NCT02107443|75652583|FG001|Overall Study|Withdrawal: Disease Progression|2|||
41937274|NCT02107443|75652582|FG000|Overall Study|Withdrawal: Personal Issues|0|||
41937275|NCT02107443|75652583|FG001|Overall Study|Withdrawal: Personal Issues|3|||
41937276|NCT00559949|75653478|FG000|Overall Study|Progressive Disease during cycle 1|1|||
41937277|NCT00559949|75653478|FG000|Overall Study|Adverse Event|1|||
41937278|NCT00559949|75653478|FG000|Overall Study|Withdrawal by Subject|4|||
41937279|NCT00559949|75653478|FG000|Overall Study|No disease evaluation per protocol|1|||
41937280|NCT00559637|75653530|FG000|Overall Study|Adverse Event|22|||
41937281|NCT00559637|75653530|FG000|Overall Study|Withdrawal by Subject|4|||
41937282|NCT00559637|75653530|FG000|Overall Study|Protocol Violation|6|||
41937283|NCT00559637|75653530|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
41937284|NCT00559637|75653530|FG000|Overall Study|Failure to return|6|||
41937285|NCT00559637|75653530|FG000|Overall Study|Insufficient response|3|||
41937286|NCT00559637|75653530|FG000|Overall Study|Started requiring dialysis after month 7|2|||
41937287|NCT00559637|75653530|FG000|Overall Study|Suspected lung cancer|1|||
41937288|NCT00559637|75653530|FG000|Overall Study|Participation in another study|1|||
41937289|NCT00559637|75653530|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
41937290|NCT00559637|75653530|FG000|Overall Study|Change of center|1|||
41937291|NCT00559637|75653530|FG000|Overall Study|Change of home|1|||
41937292|NCT00559637|75653530|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
41937293|NCT02578641|75653603|FG000|Overall Study|Adverse Event|5|||
41937294|NCT02578641|75653604|FG001|Overall Study|Adverse Event|15|||
41937295|NCT02578641|75653603|FG000|Overall Study|Death|16|||
41937296|NCT02578641|75653604|FG001|Overall Study|Death|8|||
41937297|NCT02578641|75653603|FG000|Overall Study|Lost to Follow-up|0|||
41937298|NCT02578641|75653604|FG001|Overall Study|Lost to Follow-up|1|||
41937299|NCT02578641|75653603|FG000|Overall Study|Withdrawal by Subject|14|||
41937300|NCT02578641|75653604|FG001|Overall Study|Withdrawal by Subject|7|||
41937301|NCT02578641|75653603|FG000|Overall Study|Progressive Disease|69|||
41937302|NCT02578641|75653604|FG001|Overall Study|Progressive Disease|21|||
41937303|NCT02578641|75653603|FG000|Overall Study|No Study Drug|2|||
41937304|NCT02578641|75653604|FG001|Overall Study|No Study Drug|0|||
41937305|NCT02578641|75653603|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
41937306|NCT02578641|75653604|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
41937307|NCT02578641|75653603|FG000|Overall Study|Non-compliance with Study Schedule|1|||
41937308|NCT02578641|75653604|FG001|Overall Study|Non-compliance with Study Schedule|0|||
41937309|NCT02578641|75653603|FG000|Overall Study|Other|1|||
41937310|NCT02578641|75653604|FG001|Overall Study|Other|10|||
41937311|NCT02578641|75653603|FG000|Overall Study|Not treated|1|||
41937312|NCT02578641|75653604|FG001|Overall Study|Not treated|4|||
41937313|NCT02431260|75653632|FG000|Overall Study|Subject Decision|0|||
41937314|NCT02431260|75653633|FG001|Overall Study|Subject Decision|1|||
41937315|NCT02431260|75653634|FG002|Overall Study|Subject Decision|1|||
41937316|NCT02431260|75653635|FG003|Overall Study|Subject Decision|0|||
41937317|NCT02431260|75653636|FG004|Overall Study|Subject Decision|0|||
41937318|NCT02431260|75653637|FG005|Overall Study|Subject Decision|0|||
41937319|NCT02431260|75653638|FG006|Overall Study|Subject Decision|0|||
41937320|NCT02431260|75653639|FG007|Overall Study|Subject Decision|0|||
41937321|NCT02431260|75653640|FG008|Overall Study|Subject Decision|1|||
41937322|NCT02431260|75653641|FG009|Overall Study|Subject Decision|1|||
41937323|NCT02431260|75653642|FG010|Overall Study|Subject Decision|0|||
41937324|NCT02431260|75653643|FG011|Overall Study|Subject Decision|1|||
41937325|NCT02431260|75653644|FG012|Overall Study|Subject Decision|0|||
41937326|NCT02431260|75653645|FG013|Overall Study|Subject Decision|0|||
41937327|NCT02431260|75653632|FG000|Overall Study|Death|4|||
41937328|NCT02431260|75653633|FG001|Overall Study|Death|4|||
41937329|NCT02431260|75653634|FG002|Overall Study|Death|3|||
41937330|NCT02431260|75653635|FG003|Overall Study|Death|4|||
41937331|NCT02431260|75653636|FG004|Overall Study|Death|2|||
41937332|NCT02431260|75653637|FG005|Overall Study|Death|2|||
41937333|NCT02431260|75653638|FG006|Overall Study|Death|3|||
41937334|NCT02431260|75653639|FG007|Overall Study|Death|1|||
41937335|NCT02431260|75653640|FG008|Overall Study|Death|6|||
41937336|NCT02431260|75653641|FG009|Overall Study|Death|6|||
41937337|NCT02431260|75653642|FG010|Overall Study|Death|3|||
41937338|NCT02431260|75653643|FG011|Overall Study|Death|2|||
41937339|NCT02431260|75653644|FG012|Overall Study|Death|5|||
41937340|NCT02431260|75653645|FG013|Overall Study|Death|1|||
41937341|NCT02431260|75653632|FG000|Overall Study|Lost to Follow-up|0|||
41937342|NCT02431260|75653633|FG001|Overall Study|Lost to Follow-up|0|||
41937343|NCT02431260|75653634|FG002|Overall Study|Lost to Follow-up|0|||
41937344|NCT02431260|75653635|FG003|Overall Study|Lost to Follow-up|0|||
41937345|NCT02431260|75653636|FG004|Overall Study|Lost to Follow-up|0|||
41937346|NCT02431260|75653637|FG005|Overall Study|Lost to Follow-up|1|||
41937347|NCT02431260|75653638|FG006|Overall Study|Lost to Follow-up|0|||
41937348|NCT02431260|75653639|FG007|Overall Study|Lost to Follow-up|0|||
41937349|NCT02431260|75653640|FG008|Overall Study|Lost to Follow-up|0|||
41937350|NCT02431260|75653641|FG009|Overall Study|Lost to Follow-up|0|||
41937351|NCT02431260|75653642|FG010|Overall Study|Lost to Follow-up|0|||
41937352|NCT02431260|75653643|FG011|Overall Study|Lost to Follow-up|0|||
41937353|NCT02431260|75653644|FG012|Overall Study|Lost to Follow-up|0|||
41937354|NCT02431260|75653645|FG013|Overall Study|Lost to Follow-up|0|||
41937355|NCT02431260|75653632|FG000|Overall Study|Study Terminated by the Sponsor|0|||
41937356|NCT02431260|75653633|FG001|Overall Study|Study Terminated by the Sponsor|0|||
41937357|NCT02431260|75653634|FG002|Overall Study|Study Terminated by the Sponsor|2|||
41937358|NCT02431260|75653635|FG003|Overall Study|Study Terminated by the Sponsor|1|||
41937359|NCT02431260|75653636|FG004|Overall Study|Study Terminated by the Sponsor|1|||
41937360|NCT02431260|75653637|FG005|Overall Study|Study Terminated by the Sponsor|0|||
41937361|NCT02431260|75653638|FG006|Overall Study|Study Terminated by the Sponsor|1|||
41937362|NCT02431260|75653639|FG007|Overall Study|Study Terminated by the Sponsor|2|||
41937363|NCT02431260|75653640|FG008|Overall Study|Study Terminated by the Sponsor|1|||
41937364|NCT02431260|75653641|FG009|Overall Study|Study Terminated by the Sponsor|1|||
41937365|NCT02431260|75653642|FG010|Overall Study|Study Terminated by the Sponsor|1|||
41937366|NCT02431260|75653643|FG011|Overall Study|Study Terminated by the Sponsor|0|||
41937367|NCT02431260|75653644|FG012|Overall Study|Study Terminated by the Sponsor|4|||
41937368|NCT02431260|75653645|FG013|Overall Study|Study Terminated by the Sponsor|0|||
41937369|NCT02431260|75653632|FG000|Overall Study|Physician Decision|0|||
41937370|NCT02431260|75653633|FG001|Overall Study|Physician Decision|0|||
41937371|NCT02431260|75653634|FG002|Overall Study|Physician Decision|0|||
41937372|NCT02431260|75653635|FG003|Overall Study|Physician Decision|0|||
41937373|NCT02431260|75653636|FG004|Overall Study|Physician Decision|0|||
41937374|NCT02431260|75653637|FG005|Overall Study|Physician Decision|1|||
41937375|NCT02431260|75653638|FG006|Overall Study|Physician Decision|0|||
41937376|NCT02431260|75653639|FG007|Overall Study|Physician Decision|0|||
41937377|NCT02431260|75653640|FG008|Overall Study|Physician Decision|0|||
41937378|NCT02431260|75653641|FG009|Overall Study|Physician Decision|0|||
41937379|NCT02431260|75653642|FG010|Overall Study|Physician Decision|0|||
41937380|NCT02431260|75653643|FG011|Overall Study|Physician Decision|0|||
41937381|NCT02431260|75653644|FG012|Overall Study|Physician Decision|0|||
41937382|NCT02431260|75653645|FG013|Overall Study|Physician Decision|0|||
41937383|NCT02431260|75653632|FG000|Overall Study|Other Unspecified|0|||
41937384|NCT02431260|75653633|FG001|Overall Study|Other Unspecified|0|||
41937385|NCT02431260|75653634|FG002|Overall Study|Other Unspecified|0|||
41937386|NCT02431260|75653635|FG003|Overall Study|Other Unspecified|0|||
41937387|NCT02431260|75653636|FG004|Overall Study|Other Unspecified|0|||
41937388|NCT02431260|75653637|FG005|Overall Study|Other Unspecified|0|||
41937389|NCT02431260|75653638|FG006|Overall Study|Other Unspecified|0|||
41937390|NCT02431260|75653639|FG007|Overall Study|Other Unspecified|0|||
41937391|NCT02431260|75653640|FG008|Overall Study|Other Unspecified|0|||
41937392|NCT02431260|75653641|FG009|Overall Study|Other Unspecified|0|||
41937393|NCT02431260|75653642|FG010|Overall Study|Other Unspecified|0|||
41937394|NCT02431260|75653643|FG011|Overall Study|Other Unspecified|1|||
41937395|NCT02431260|75653644|FG012|Overall Study|Other Unspecified|1|||
41937396|NCT02431260|75653645|FG013|Overall Study|Other Unspecified|0|||
41937397|NCT02430870|75653840|FG000|Part 2|Voluntary Withdrawal|0|||
41937398|NCT02430870|75653841|FG001|Part 2|Voluntary Withdrawal|0|||
41937399|NCT02430870|75653842|FG002|Part 2|Voluntary Withdrawal|0|||
41937400|NCT02430870|75653843|FG003|Part 2|Voluntary Withdrawal|0|||
41937401|NCT02430870|75653844|FG004|Part 2|Voluntary Withdrawal|0|||
41937402|NCT02430870|75653845|FG005|Part 2|Voluntary Withdrawal|0|||
41937403|NCT02430870|75653846|FG006|Part 2|Voluntary Withdrawal|1|||
41937404|NCT02430870|75653847|FG007|Part 2|Voluntary Withdrawal|0|||
41937405|NCT02430870|75653840|FG000|Part 2|Other Reason Not Specified|0|||
41937406|NCT02430870|75653841|FG001|Part 2|Other Reason Not Specified|0|||
41937407|NCT02430870|75653842|FG002|Part 2|Other Reason Not Specified|0|||
41937408|NCT02430870|75653843|FG003|Part 2|Other Reason Not Specified|0|||
41937409|NCT02430870|75653844|FG004|Part 2|Other Reason Not Specified|0|||
41937410|NCT02430870|75653845|FG005|Part 2|Other Reason Not Specified|0|||
41937411|NCT02430870|75653846|FG006|Part 2|Other Reason Not Specified|0|||
41937412|NCT02430870|75653847|FG007|Part 2|Other Reason Not Specified|1|||
41937413|NCT02429934|75653913|FG000|Overall Study|Withdrawal by Subject|0|||
41937414|NCT02429934|75653914|FG001|Overall Study|Withdrawal by Subject|2|||
41937415|NCT02429934|75653913|FG000|Overall Study|Adverse Event|2|||
41937416|NCT02429934|75653914|FG001|Overall Study|Adverse Event|0|||
41937417|NCT02429934|75653913|FG000|Overall Study|Lost to Follow-up|1|||
41937418|NCT02429934|75653914|FG001|Overall Study|Lost to Follow-up|1|||
41937419|NCT02429934|75653913|FG000|Overall Study|Physician Decision|1|||
41937420|NCT02429934|75653914|FG001|Overall Study|Physician Decision|0|||
41937421|NCT02429856|75653928|FG000|Overall Study|Death|12|||
41937422|NCT02429856|75653929|FG001|Overall Study|Death|13|||
41937423|NCT02429856|75653928|FG000|Overall Study|Lost to Follow-up|6|||
41937424|NCT02429856|75653929|FG001|Overall Study|Lost to Follow-up|5|||
41937425|NCT02429856|75653928|FG000|Overall Study|Withdrawal by Subject|1|||
41937426|NCT02429856|75653929|FG001|Overall Study|Withdrawal by Subject|1|||
41937427|NCT02429778|75653939|FG000|Overall Study|Lost to Follow-up|2|||
41937428|NCT02429778|75653940|FG001|Overall Study|Lost to Follow-up|0|||
41937429|NCT02429778|75653939|FG000|Overall Study|Withdrawal by Subject|5|||
41937430|NCT02429778|75653940|FG001|Overall Study|Withdrawal by Subject|0|||
41937431|NCT02403180|75653948|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
41937432|NCT02403180|75653949|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
41937433|NCT02403180|75653948|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
41937434|NCT02403180|75653949|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
41937435|NCT00558467|75653983|FG000|Overall Study|Adverse Event|1|||
41937436|NCT00558467|75653984|FG001|Overall Study|Adverse Event|2|||
41937437|NCT00558467|75653983|FG000|Overall Study|Lack of Efficacy|0|||
41937438|NCT00558467|75653984|FG001|Overall Study|Lack of Efficacy|1|||
41937439|NCT00558467|75653983|FG000|Overall Study|Patient moving out of state|0|||
41937440|NCT00558467|75653984|FG001|Overall Study|Patient moving out of state|1|||
41937441|NCT02402166|75653990|FG000|Overall Study|Adverse Event|2|||
41937442|NCT02402166|75653990|FG000|Overall Study|Withdrawal by Subject|2|||
41937443|NCT02402166|75653990|FG000|Overall Study|Lost to Follow-up|1|||
41937444|NCT02378220|75654010|FG000|Overall Study|Death|6|||
41937445|NCT02378220|75654011|FG001|Overall Study|Death|1|||
41937446|NCT02401308|75654020|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
41937447|NCT02401308|75654021|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
41937448|NCT02401230|75654030|FG000|Overall Study|Adverse Event|3|||
41937449|NCT02401230|75654031|FG001|Overall Study|Adverse Event|2|||
41937450|NCT02401230|75654032|FG002|Overall Study|Adverse Event|0|||
41937451|NCT02401230|75654030|FG000|Overall Study|Withdrawal by Subject|2|||
41937452|NCT02401230|75654031|FG001|Overall Study|Withdrawal by Subject|1|||
41937453|NCT02401230|75654032|FG002|Overall Study|Withdrawal by Subject|1|||
41937454|NCT02401230|75654030|FG000|Overall Study|Lost to Follow-up|1|||
41937455|NCT02401230|75654031|FG001|Overall Study|Lost to Follow-up|3|||
41937456|NCT02401230|75654032|FG002|Overall Study|Lost to Follow-up|3|||
41937457|NCT02429310|75654073|FG000|Overall Study|Lost to Follow-up|1|||
41937458|NCT02429310|75654074|FG001|Overall Study|Lost to Follow-up|2|||
41937459|NCT02429310|75654073|FG000|Overall Study|Protocol Violation|1|||
41937460|NCT02429310|75654074|FG001|Overall Study|Protocol Violation|1|||
41937461|NCT02428608|75654100|FG000|Overall Study|Pregnancy|2|||
41937462|NCT02428608|75654100|FG000|Overall Study|Lost to Follow-up|37|||
41937463|NCT02428608|75654100|FG000|Overall Study|Withdrawal by Subject|2|||
41937464|NCT02428608|75654100|FG000|Overall Study|scheduling conflicts|15|||
41937465|NCT02428608|75654100|FG000|Overall Study|moved away|10|||
41937466|NCT02428608|75654100|FG000|Overall Study|Death|1|||
41937467|NCT02428608|75654100|FG000|Overall Study|various|16|||
41937468|NCT02428296|75654120|FG000|Overall Study|Adverse Event|7|||
41937469|NCT02428296|75654120|FG000|Overall Study|Withdrawal by Subject|2|||
41937470|NCT02427984|75654134|FG000|Overall Study|Lost to Follow-up|13|||
41937471|NCT02427984|75654135|FG001|Overall Study|Lost to Follow-up|5|||
41937472|NCT02427984|75654136|FG002|Overall Study|Lost to Follow-up|18|||
41937473|NCT00556673|75654354|FG000|Overall Study|Protocol deviation|3|||
41937474|NCT00556673|75654355|FG001|Overall Study|Protocol deviation|2|||
41937475|NCT02402322|75654379|FG000|Pretreatment|Withdrawal by Subject|3|||
41937476|NCT02402322|75654380|FG001|Pretreatment|Withdrawal by Subject|1|||
41937477|NCT02402322|75654381|FG002|Pretreatment|Withdrawal by Subject|1|||
41937478|NCT02402322|75654379|FG000|Follow-up|Withdrawal by Subject|6|||
41937479|NCT02402322|75654380|FG001|Follow-up|Withdrawal by Subject|3|||
41937480|NCT02402322|75654381|FG002|Follow-up|Withdrawal by Subject|24|||
41937481|NCT00555425|75654497|FG000|Overall Study|Missed Medication > 1 wk|34|||
41937482|NCT00555425|75654498|FG001|Overall Study|Missed Medication > 1 wk|15|||
41937483|NCT00555425|75654497|FG000|Overall Study|Missed 3 physician management visits|1|||
41937484|NCT00555425|75654498|FG001|Overall Study|Missed 3 physician management visits|0|||
41937485|NCT00555425|75654497|FG000|Overall Study|Met criteria for protective transfer|16|||
41937486|NCT00555425|75654498|FG001|Overall Study|Met criteria for protective transfer|3|||
41937487|NCT00555425|75654497|FG000|Overall Study|Became pregnant and transferred care|0|||
41937488|NCT00555425|75654498|FG001|Overall Study|Became pregnant and transferred care|1|||
41937489|NCT00554099|75654679|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
41937490|NCT00554099|75654680|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
41937491|NCT00554099|75654681|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
41937492|NCT00554099|75654679|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
41937493|NCT00554099|75654680|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
41937494|NCT00554099|75654681|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
41937495|NCT00554099|75654679|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
42022542|NCT01241552|75829851|FG002|Overall Study|Technical Problems|2|||
41937496|NCT00554099|75654680|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
41937497|NCT00554099|75654681|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
41937498|NCT00554099|75654679|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
41937499|NCT00554099|75654680|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
41937500|NCT00554099|75654681|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
41937501|NCT00554099|75654679|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
41937502|NCT00554099|75654680|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
41937503|NCT00554099|75654681|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
41937504|NCT00554099|75654679|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
41937505|NCT00554099|75654680|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
41937506|NCT00554099|75654681|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
41937507|NCT00554099|75654679|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
41937508|NCT00554099|75654680|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
41937509|NCT00554099|75654681|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
41937510|NCT00554099|75654679|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
41937511|NCT00554099|75654680|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
41937512|NCT00554099|75654681|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
41937513|NCT00554099|75654679|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
41937514|NCT00554099|75654680|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
41937515|NCT00554099|75654681|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
41937516|NCT02377362|75654715|FG000|Part A Second Treatment|Protocol Violation|0|||
41937517|NCT02377362|75654716|FG001|Part A Second Treatment|Protocol Violation|0|||
41937518|NCT02377362|75654717|FG002|Part A Second Treatment|Protocol Violation|0|||
41937519|NCT02377362|75654718|FG003|Part A Second Treatment|Protocol Violation|0|||
41937520|NCT02377362|75654719|FG004|Part A Second Treatment|Protocol Violation|1|||
41937521|NCT02377362|75654720|FG005|Part A Second Treatment|Protocol Violation|0|||
41937522|NCT02377362|75654721|FG006|Part A Second Treatment|Protocol Violation|0|||
41937523|NCT02377362|75654722|FG007|Part A Second Treatment|Protocol Violation|0|||
41937524|NCT02377362|75654723|FG008|Part A Second Treatment|Protocol Violation|0|||
41937525|NCT02377362|75654724|FG009|Part A Second Treatment|Protocol Violation|0|||
41937526|NCT02377362|75654725|FG010|Part A Second Treatment|Protocol Violation|0|||
41937527|NCT02377362|75654726|FG011|Part A Second Treatment|Protocol Violation|0|||
41937528|NCT02377362|75654727|FG012|Part A Second Treatment|Protocol Violation|0|||
41937529|NCT02377362|75654715|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
41937530|NCT02377362|75654716|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
41937531|NCT02377362|75654717|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
41937532|NCT02377362|75654718|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
41937533|NCT02377362|75654719|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
41937534|NCT02377362|75654720|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
41937535|NCT02377362|75654721|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
41937536|NCT02377362|75654722|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
41937537|NCT02377362|75654723|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
41937538|NCT02377362|75654724|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
41937539|NCT02377362|75654725|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
41937540|NCT02377362|75654726|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
41937541|NCT02377362|75654727|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
41937542|NCT02377362|75654715|FG000|Part B Overall|Protocol Violation|0|||
41937543|NCT02377362|75654716|FG001|Part B Overall|Protocol Violation|0|||
41937544|NCT02377362|75654717|FG002|Part B Overall|Protocol Violation|0|||
41937545|NCT02377362|75654718|FG003|Part B Overall|Protocol Violation|0|||
41937546|NCT02377362|75654719|FG004|Part B Overall|Protocol Violation|0|||
41937547|NCT02377362|75654720|FG005|Part B Overall|Protocol Violation|0|||
41937548|NCT02377362|75654721|FG006|Part B Overall|Protocol Violation|0|||
41937549|NCT02377362|75654722|FG007|Part B Overall|Protocol Violation|0|||
41937550|NCT02377362|75654723|FG008|Part B Overall|Protocol Violation|0|||
41937551|NCT02377362|75654724|FG009|Part B Overall|Protocol Violation|1|||
41937552|NCT02377362|75654725|FG010|Part B Overall|Protocol Violation|0|||
41937553|NCT02377362|75654726|FG011|Part B Overall|Protocol Violation|0|||
41937554|NCT02377362|75654727|FG012|Part B Overall|Protocol Violation|0|||
41937555|NCT02377362|75654715|FG000|Part B Overall|Adverse Event|0|||
41937556|NCT02377362|75654716|FG001|Part B Overall|Adverse Event|0|||
41937557|NCT02377362|75654717|FG002|Part B Overall|Adverse Event|0|||
41937558|NCT02377362|75654718|FG003|Part B Overall|Adverse Event|0|||
41937559|NCT02377362|75654719|FG004|Part B Overall|Adverse Event|0|||
41937560|NCT02377362|75654720|FG005|Part B Overall|Adverse Event|0|||
41937561|NCT02377362|75654721|FG006|Part B Overall|Adverse Event|1|||
41937562|NCT02377362|75654722|FG007|Part B Overall|Adverse Event|1|||
41937563|NCT02377362|75654723|FG008|Part B Overall|Adverse Event|0|||
41937564|NCT02377362|75654724|FG009|Part B Overall|Adverse Event|0|||
42117975|NCT00688259|75928815|FG001|Overall Study|Hospitalized at Follow-up|1|||
41937565|NCT02377362|75654725|FG010|Part B Overall|Adverse Event|0|||
41937566|NCT02377362|75654726|FG011|Part B Overall|Adverse Event|0|||
42210257|NCT03238911|76025003|FG001|Overall Study|Withdrawal by Subject|2|||
42210258|NCT03238911|76025002|FG000|Overall Study|Lost to Follow-up|2|||
42210259|NCT03238911|76025003|FG001|Overall Study|Lost to Follow-up|1|||
42210260|NCT00418834|76025012|FG000|Overall Study|Adverse Event|16|||
42300165|NCT02327169|76135335|FG013|Overall Study|Symptomatic Deterioration|2|||
42300166|NCT02327169|76135336|FG014|Overall Study|Symptomatic Deterioration|1|||
42300167|NCT02327169|76135322|FG000|Overall Study|Reason Not Specified|0|||
42300168|NCT02327169|76135323|FG001|Overall Study|Reason Not Specified|0|||
42300169|NCT02327169|76135324|FG002|Overall Study|Reason Not Specified|1|||
42300170|NCT02327169|76135325|FG003|Overall Study|Reason Not Specified|0|||
42300171|NCT02327169|76135326|FG004|Overall Study|Reason Not Specified|0|||
42300172|NCT02327169|76135327|FG005|Overall Study|Reason Not Specified|0|||
42300173|NCT02327169|76135328|FG006|Overall Study|Reason Not Specified|0|||
42300174|NCT02327169|76135329|FG007|Overall Study|Reason Not Specified|0|||
42300175|NCT02327169|76135330|FG008|Overall Study|Reason Not Specified|0|||
42300176|NCT02327169|76135331|FG009|Overall Study|Reason Not Specified|1|||
42300177|NCT02327169|76135332|FG010|Overall Study|Reason Not Specified|2|||
42210261|NCT00418834|76025013|FG001|Overall Study|Adverse Event|9|||
42210262|NCT00418834|76025012|FG000|Overall Study|Lost to Follow-up|0|||
42210263|NCT00418834|76025013|FG001|Overall Study|Lost to Follow-up|1|||
42210264|NCT00418834|76025012|FG000|Overall Study|Protocol Violation|4|||
42210265|NCT00418834|76025013|FG001|Overall Study|Protocol Violation|3|||
42300178|NCT02327169|76135333|FG011|Overall Study|Reason Not Specified|1|||
42300179|NCT02327169|76135334|FG012|Overall Study|Reason Not Specified|0|||
41937567|NCT02377362|75654727|FG012|Part B Overall|Adverse Event|0|||
41937568|NCT02377362|75654715|FG000|Part B Overall|Withdrawal by Subject|0|||
41937569|NCT02377362|75654716|FG001|Part B Overall|Withdrawal by Subject|0|||
41937570|NCT02377362|75654717|FG002|Part B Overall|Withdrawal by Subject|0|||
41937571|NCT02377362|75654718|FG003|Part B Overall|Withdrawal by Subject|0|||
41937572|NCT02377362|75654719|FG004|Part B Overall|Withdrawal by Subject|0|||
41937573|NCT02377362|75654720|FG005|Part B Overall|Withdrawal by Subject|0|||
41937574|NCT02377362|75654721|FG006|Part B Overall|Withdrawal by Subject|1|||
41937575|NCT02377362|75654722|FG007|Part B Overall|Withdrawal by Subject|0|||
41937576|NCT02377362|75654723|FG008|Part B Overall|Withdrawal by Subject|0|||
41937577|NCT02377362|75654724|FG009|Part B Overall|Withdrawal by Subject|0|||
41937578|NCT02377362|75654725|FG010|Part B Overall|Withdrawal by Subject|0|||
41937579|NCT02377362|75654726|FG011|Part B Overall|Withdrawal by Subject|1|||
41937580|NCT02377362|75654727|FG012|Part B Overall|Withdrawal by Subject|0|||
41937581|NCT00553631|75654767|FG000|Overall Study|Withdrawal by Subject|0|||
41937582|NCT00553631|75654768|FG001|Overall Study|Withdrawal by Subject|1|||
41937583|NCT00553631|75654767|FG000|Overall Study|Lost to Follow-up|1|||
41937584|NCT00553631|75654768|FG001|Overall Study|Lost to Follow-up|0|||
41937585|NCT00553319|75654777|FG000|Overall Study|Lost to Follow-up|10|||
41937586|NCT00553319|75654778|FG001|Overall Study|Lost to Follow-up|9|||
41937587|NCT00553319|75654779|FG002|Overall Study|Lost to Follow-up|5|||
41937588|NCT00553319|75654777|FG000|Overall Study|wanted treatment elsewhere|2|||
41937589|NCT00553319|75654778|FG001|Overall Study|wanted treatment elsewhere|1|||
41937590|NCT00553319|75654779|FG002|Overall Study|wanted treatment elsewhere|1|||
41937591|NCT00553319|75654777|FG000|Overall Study|non-compliance|0|||
41937592|NCT00553319|75654778|FG001|Overall Study|non-compliance|0|||
41937593|NCT00553319|75654779|FG002|Overall Study|non-compliance|2|||
41937594|NCT00553319|75654777|FG000|Overall Study|incarceration|1|||
41937595|NCT00553319|75654778|FG001|Overall Study|incarceration|0|||
41937596|NCT00553319|75654779|FG002|Overall Study|incarceration|0|||
41937597|NCT00553319|75654777|FG000|Overall Study|moved|1|||
41937598|NCT00553319|75654778|FG001|Overall Study|moved|0|||
41937599|NCT00553319|75654779|FG002|Overall Study|moved|1|||
41937600|NCT01649856|75654965|FG000|Overall Study|Withdrawal by Subject|14|||
42022543|NCT01241552|75829852|FG003|Overall Study|Technical Problems|2|||
42022544|NCT01241552|75829849|FG000|Overall Study|Progressive Disease|0|||
42022545|NCT01241552|75829850|FG001|Overall Study|Progressive Disease|0|||
42022546|NCT01241552|75829851|FG002|Overall Study|Progressive Disease|1|||
42022547|NCT01241552|75829852|FG003|Overall Study|Progressive Disease|2|||
42022548|NCT01241552|75829849|FG000|Overall Study|Protocol Violation|0|||
42022549|NCT01241552|75829850|FG001|Overall Study|Protocol Violation|2|||
42022550|NCT01241552|75829851|FG002|Overall Study|Protocol Violation|6|||
42022551|NCT01241552|75829852|FG003|Overall Study|Protocol Violation|1|||
41937601|NCT01649856|75654966|FG001|Overall Study|Withdrawal by Subject|14|||
41937602|NCT01649856|75654965|FG000|Overall Study|Protocol Violation|4|||
41937603|NCT01649856|75654966|FG001|Overall Study|Protocol Violation|4|||
41937604|NCT01649856|75654965|FG000|Overall Study|Treatment Failure|1|||
42117976|NCT00688181|75928821|FG000|Overall Study|Lost to Follow-up|17|||
41937605|NCT01649856|75654966|FG001|Overall Study|Treatment Failure|1|||
41937606|NCT01649856|75654965|FG000|Overall Study|Death|69|||
42022552|NCT01241552|75829849|FG000|Overall Study|Withdrawal by Subject|7|||
42022553|NCT01241552|75829850|FG001|Overall Study|Withdrawal by Subject|15|||
42022554|NCT01241552|75829851|FG002|Overall Study|Withdrawal by Subject|14|||
42022555|NCT01241552|75829852|FG003|Overall Study|Withdrawal by Subject|15|||
42022556|NCT01241552|75829849|FG000|Overall Study|Physician Decision|2|||
41937607|NCT01649856|75654966|FG001|Overall Study|Death|34|||
41937608|NCT01649856|75654965|FG000|Overall Study|Stable or Progressed Disease|5|||
41937609|NCT01649856|75654966|FG001|Overall Study|Stable or Progressed Disease|3|||
41937610|NCT01649856|75654965|FG000|Overall Study|Lost to Follow-up|20|||
41937611|NCT01649856|75654966|FG001|Overall Study|Lost to Follow-up|16|||
41937612|NCT01649856|75654965|FG000|Overall Study|Lack of Compliance|6|||
41937613|NCT01649856|75654966|FG001|Overall Study|Lack of Compliance|1|||
41937614|NCT01649856|75654965|FG000|Overall Study|Other|20|||
41937615|NCT01649856|75654966|FG001|Overall Study|Other|5|||
41937616|NCT02375724|75654987|FG000|Overall Study|Lack of Efficacy|1|||
41937617|NCT02375724|75654988|FG001|Overall Study|Lack of Efficacy|1|||
41937618|NCT02375724|75654987|FG000|Overall Study|Withdrawal by Subject|1|||
41937619|NCT02375724|75654988|FG001|Overall Study|Withdrawal by Subject|1|||
41937620|NCT02375724|75654987|FG000|Overall Study|Lost to Follow-up|1|||
41937621|NCT02375724|75654988|FG001|Overall Study|Lost to Follow-up|0|||
41937622|NCT02375724|75654987|FG000|Overall Study|Protocol Violation|1|||
41937623|NCT02375724|75654988|FG001|Overall Study|Protocol Violation|0|||
41937624|NCT02375724|75654987|FG000|Overall Study|Adverse Event|2|||
41937625|NCT02375724|75654988|FG001|Overall Study|Adverse Event|4|||
41937626|NCT02398188|75654996|FG000|Overall Study|Adverse Event|2|||
41937627|NCT02398188|75654997|FG001|Overall Study|Adverse Event|3|||
41937628|NCT02398188|75654996|FG000|Overall Study|Lost to Follow-up|5|||
41937629|NCT02398188|75654997|FG001|Overall Study|Lost to Follow-up|0|||
41937630|NCT02398188|75654996|FG000|Overall Study|Non-compliance|4|||
41937631|NCT02398188|75654997|FG001|Overall Study|Non-compliance|4|||
41937632|NCT02398188|75654996|FG000|Overall Study|Protocol Violation|6|||
41937633|NCT02398188|75654997|FG001|Overall Study|Protocol Violation|10|||
41937634|NCT02398188|75654996|FG000|Overall Study|Sponsor Decision|2|||
41937635|NCT02398188|75654997|FG001|Overall Study|Sponsor Decision|1|||
41937636|NCT02398188|75654996|FG000|Overall Study|Pregnancy|1|||
41937637|NCT02398188|75654997|FG001|Overall Study|Pregnancy|0|||
41937638|NCT02398188|75654996|FG000|Overall Study|Withdrawal by Subject|7|||
41937639|NCT02398188|75654997|FG001|Overall Study|Withdrawal by Subject|16|||
42022557|NCT01241552|75829850|FG001|Overall Study|Physician Decision|4|||
42022558|NCT01241552|75829851|FG002|Overall Study|Physician Decision|2|||
42022559|NCT01241552|75829852|FG003|Overall Study|Physician Decision|3|||
42022560|NCT01241552|75829849|FG000|Overall Study|Lost to Follow-up|2|||
42022561|NCT01241552|75829850|FG001|Overall Study|Lost to Follow-up|11|||
42022562|NCT01241552|75829851|FG002|Overall Study|Lost to Follow-up|15|||
42022563|NCT01241552|75829852|FG003|Overall Study|Lost to Follow-up|16|||
41937640|NCT02426580|75655005|FG000|Overall Study|Death|2|||
41937641|NCT02426580|75655006|FG001|Overall Study|Death|2|||
41937642|NCT02426580|75655005|FG000|Overall Study|Lost to Follow-up|0|||
41937643|NCT02426580|75655006|FG001|Overall Study|Lost to Follow-up|9|||
42022564|NCT00948922|75829865|FG000|Overall Study|Did not start study treatment|2|||
42022565|NCT00948922|75829866|FG001|Overall Study|Did not start study treatment|5|||
42022566|NCT00948922|75829867|FG002|Overall Study|Did not start study treatment|0|||
42022567|NCT00948922|75829865|FG000|Overall Study|Withdrawal by Subject|0|||
42022568|NCT00948922|75829866|FG001|Overall Study|Withdrawal by Subject|2|||
41937644|NCT02426580|75655005|FG000|Overall Study|transfer to hemodialysis|5|||
41937645|NCT02426580|75655006|FG001|Overall Study|transfer to hemodialysis|5|||
41937646|NCT02426580|75655005|FG000|Overall Study|Kidney transplant|3|||
42022569|NCT00948922|75829867|FG002|Overall Study|Withdrawal by Subject|1|||
41937647|NCT02426580|75655006|FG001|Overall Study|Kidney transplant|0|||
41937648|NCT02426580|75655005|FG000|Overall Study|Allergic to egg white|1|||
41937649|NCT02426580|75655006|FG001|Overall Study|Allergic to egg white|0|||
41937650|NCT01651260|75655012|FG000|Overall Study|unable to apply product|3|||
41937651|NCT02425098|75655032|FG000|Overall Study|Lost to Follow-up|7|||
42022570|NCT00948922|75829865|FG000|Overall Study|Death|3|||
41937652|NCT02425098|75655033|FG001|Overall Study|Lost to Follow-up|7|||
41937653|NCT02425098|75655032|FG000|Overall Study|Withdrawal by Subject|4|||
41937654|NCT02425098|75655033|FG001|Overall Study|Withdrawal by Subject|8|||
41937655|NCT02425098|75655032|FG000|Overall Study|Pregnancy|2|||
41937656|NCT02425098|75655033|FG001|Overall Study|Pregnancy|0|||
41937657|NCT02425098|75655032|FG000|Overall Study|Reason not Specified|0|||
41937658|NCT02425098|75655033|FG001|Overall Study|Reason not Specified|1|||
41937659|NCT02424630|75655041|FG000|Overall Study|No rotator cuff tear|1|||
41937660|NCT02424630|75655042|FG001|Overall Study|No rotator cuff tear|2|||
41937661|NCT02424630|75655041|FG000|Overall Study|Open procedure|0|||
41937662|NCT02424630|75655042|FG001|Overall Study|Open procedure|1|||
41937663|NCT02397408|75655048|FG000|Overall Study|Physician Decision|4|||
41937664|NCT02397408|75655048|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
41937665|NCT02397096|75655054|FG000|Day 1 to Week 24|Adverse Event|7|||
41937666|NCT02397096|75655055|FG001|Day 1 to Week 24|Adverse Event|1|||
41937667|NCT02397096|75655054|FG000|Day 1 to Week 24|Death|1|||
41937668|NCT02397096|75655055|FG001|Day 1 to Week 24|Death|0|||
41937669|NCT02397096|75655054|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
41937670|NCT02397096|75655055|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
41937671|NCT02397096|75655054|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
41937672|NCT02397096|75655055|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
41937673|NCT02397096|75655054|FG000|Day 1 to Week 24|Physician Decision|2|||
41937674|NCT02397096|75655055|FG001|Day 1 to Week 24|Physician Decision|3|||
41937675|NCT02397096|75655054|FG000|Day 1 to Week 24|Protocol Violation|1|||
41937676|NCT02397096|75655055|FG001|Day 1 to Week 24|Protocol Violation|4|||
41937677|NCT02397096|75655054|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
41937678|NCT02397096|75655055|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
41937679|NCT02397096|75655054|FG000|Week 24 to Week 48|Adverse Event|6|||
41937680|NCT02397096|75655055|FG001|Week 24 to Week 48|Adverse Event|2|||
41937681|NCT02397096|75655054|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
41937682|NCT02397096|75655055|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
41937683|NCT02397096|75655054|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
41937684|NCT02397096|75655055|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
41937685|NCT02397096|75655054|FG000|Week 24 to Week 48|Physician Decision|2|||
41937686|NCT02397096|75655055|FG001|Week 24 to Week 48|Physician Decision|1|||
41937687|NCT02397096|75655054|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
41937688|NCT02397096|75655055|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
41937689|NCT02397096|75655054|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
41937690|NCT02397096|75655055|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
41937691|NCT02397096|75655054|FG000|Study Extensions|Ongoing|399|||
41937692|NCT02397096|75655055|FG001|Study Extensions|Ongoing|202|||
41937693|NCT02372058|75655065|FG000|Overall Study|Withdrawal by Subject|3|||
41937694|NCT02396316|75655073|FG000|Overall Study|Physician Decision|1|||
41937695|NCT02396316|75655074|FG001|Overall Study|Physician Decision|0|||
41937696|NCT02396316|75655073|FG000|Overall Study|Progressive disease|6|||
41937697|NCT02396316|75655074|FG001|Overall Study|Progressive disease|3|||
41937698|NCT02396316|75655073|FG000|Overall Study|Protocol Violation|0|||
41937699|NCT02396316|75655074|FG001|Overall Study|Protocol Violation|1|||
41937700|NCT02396316|75655073|FG000|Overall Study|Treatment unblinded|0|||
41937701|NCT02396316|75655074|FG001|Overall Study|Treatment unblinded|1|||
41937702|NCT02395536|75655084|FG000|Overall Study|Lost to Follow-up|4|||
41937703|NCT02395536|75655085|FG001|Overall Study|Lost to Follow-up|4|||
41937704|NCT02395536|75655084|FG000|Overall Study|Death|2|||
41937705|NCT02395536|75655085|FG001|Overall Study|Death|0|||
41937706|NCT02395536|75655084|FG000|Overall Study|Physician Decision|4|||
41937707|NCT02395536|75655085|FG001|Overall Study|Physician Decision|6|||
41937708|NCT02395536|75655084|FG000|Overall Study|Withdrawal by Subject|9|||
41937709|NCT02395536|75655085|FG001|Overall Study|Withdrawal by Subject|17|||
41937710|NCT02395536|75655084|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
41937711|NCT02395536|75655085|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
41937712|NCT02395536|75655084|FG000|Overall Study|Insurance issue|0|||
41937713|NCT02395536|75655085|FG001|Overall Study|Insurance issue|1|||
41937714|NCT00552929|75655101|FG000|Overall Study|Lost to Follow-up|0|||
41937715|NCT00552929|75655102|FG001|Overall Study|Lost to Follow-up|0|||
41937716|NCT00552929|75655103|FG002|Overall Study|Lost to Follow-up|0|||
41937717|NCT00552929|75655104|FG003|Overall Study|Lost to Follow-up|0|||
41937718|NCT00552929|75655105|FG004|Overall Study|Lost to Follow-up|0|||
41937719|NCT00552929|75655106|FG005|Overall Study|Lost to Follow-up|0|||
41937720|NCT00552929|75655107|FG006|Overall Study|Lost to Follow-up|0|||
41937721|NCT00552929|75655108|FG007|Overall Study|Lost to Follow-up|0|||
41937722|NCT00552929|75655109|FG008|Overall Study|Lost to Follow-up|1|||
41937723|NCT00552929|75655110|FG009|Overall Study|Lost to Follow-up|0|||
41937724|NCT00552929|75655101|FG000|Overall Study|Not Eligible|0|||
41937725|NCT00552929|75655102|FG001|Overall Study|Not Eligible|0|||
41937726|NCT00552929|75655103|FG002|Overall Study|Not Eligible|0|||
41937727|NCT00552929|75655104|FG003|Overall Study|Not Eligible|0|||
41937728|NCT00552929|75655105|FG004|Overall Study|Not Eligible|0|||
41937729|NCT00552929|75655106|FG005|Overall Study|Not Eligible|1|||
41937730|NCT00552929|75655107|FG006|Overall Study|Not Eligible|0|||
41937731|NCT00552929|75655108|FG007|Overall Study|Not Eligible|0|||
42022571|NCT00948922|75829866|FG001|Overall Study|Death|0|||
41937732|NCT00552929|75655109|FG008|Overall Study|Not Eligible|0|||
41937733|NCT00552929|75655110|FG009|Overall Study|Not Eligible|0|||
41937734|NCT02395302|75655132|FG000|Overall Study|Screen Failure|3|||
41937735|NCT02395302|75655132|FG000|Overall Study|Run In Failure|7|||
41937736|NCT02395302|75655132|FG000|Overall Study|Withdrawal by Subject|2|||
41937737|NCT02395302|75655132|FG000|Overall Study|Physician Decision|2|||
41937738|NCT02371980|75655166|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
41937739|NCT02371980|75655167|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
41937740|NCT02371980|75655168|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
41937741|NCT02371980|75655169|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
41937742|NCT02371980|75655170|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
41937743|NCT02371980|75655166|FG000|Open-label Period|Significant Protocol Deviation|19|||
41937744|NCT02371980|75655167|FG001|Open-label Period|Significant Protocol Deviation|0|||
41937745|NCT02371980|75655168|FG002|Open-label Period|Significant Protocol Deviation|0|||
41937746|NCT02371980|75655169|FG003|Open-label Period|Significant Protocol Deviation|0|||
41937747|NCT02371980|75655170|FG004|Open-label Period|Significant Protocol Deviation|0|||
41937748|NCT02371980|75655166|FG000|Open-label Period|Noncompliance with Study Drug|10|||
41937749|NCT02371980|75655167|FG001|Open-label Period|Noncompliance with Study Drug|0|||
41937750|NCT02371980|75655168|FG002|Open-label Period|Noncompliance with Study Drug|0|||
41937751|NCT02371980|75655169|FG003|Open-label Period|Noncompliance with Study Drug|0|||
41937752|NCT02371980|75655170|FG004|Open-label Period|Noncompliance with Study Drug|0|||
41937753|NCT02371980|75655166|FG000|Open-label Period|Lost to Follow-up|55|||
41937754|NCT02371980|75655167|FG001|Open-label Period|Lost to Follow-up|0|||
41937755|NCT02371980|75655168|FG002|Open-label Period|Lost to Follow-up|0|||
41937756|NCT02371980|75655169|FG003|Open-label Period|Lost to Follow-up|0|||
41937757|NCT02371980|75655170|FG004|Open-label Period|Lost to Follow-up|0|||
41937758|NCT02371980|75655166|FG000|Open-label Period|Voluntary Withdrawal|91|||
41937759|NCT02371980|75655167|FG001|Open-label Period|Voluntary Withdrawal|0|||
41937760|NCT02371980|75655168|FG002|Open-label Period|Voluntary Withdrawal|0|||
41937761|NCT02371980|75655169|FG003|Open-label Period|Voluntary Withdrawal|0|||
41937762|NCT02371980|75655170|FG004|Open-label Period|Voluntary Withdrawal|0|||
41937763|NCT02371980|75655166|FG000|Open-label Period|Pregnancy|1|||
41937764|NCT02371980|75655167|FG001|Open-label Period|Pregnancy|0|||
41937765|NCT02371980|75655168|FG002|Open-label Period|Pregnancy|0|||
41937766|NCT02371980|75655169|FG003|Open-label Period|Pregnancy|0|||
41937767|NCT02371980|75655170|FG004|Open-label Period|Pregnancy|0|||
41937768|NCT02371980|75655166|FG000|Open-label Period|Lack of Efficacy|116|||
41937769|NCT02371980|75655167|FG001|Open-label Period|Lack of Efficacy|0|||
41937770|NCT02371980|75655168|FG002|Open-label Period|Lack of Efficacy|0|||
41937771|NCT02371980|75655169|FG003|Open-label Period|Lack of Efficacy|0|||
41937772|NCT02371980|75655170|FG004|Open-label Period|Lack of Efficacy|0|||
41937773|NCT02371980|75655166|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
41937774|NCT02371980|75655167|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
41937775|NCT02371980|75655168|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
41937776|NCT02371980|75655169|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
41937777|NCT02371980|75655170|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
41937778|NCT02371980|75655166|FG000|Open-label Period|Reason not Specified|9|||
42022572|NCT00948922|75829867|FG002|Overall Study|Death|0|||
42022573|NCT00948922|75829865|FG000|Overall Study|Disease progression|0|||
42022574|NCT00948922|75829866|FG001|Overall Study|Disease progression|1|||
41937779|NCT02371980|75655167|FG001|Open-label Period|Reason not Specified|0|||
41937780|NCT02371980|75655168|FG002|Open-label Period|Reason not Specified|0|||
42022575|NCT00948922|75829867|FG002|Overall Study|Disease progression|0|||
41937781|NCT02371980|75655169|FG003|Open-label Period|Reason not Specified|0|||
41937782|NCT02371980|75655170|FG004|Open-label Period|Reason not Specified|0|||
41937783|NCT02371980|75655166|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
41937784|NCT02371980|75655167|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
41937785|NCT02371980|75655168|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
41937786|NCT02371980|75655169|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
41937787|NCT02371980|75655170|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
41937788|NCT02371980|75655166|FG000|Double-blind Period|Significant Protocol Deviation|0|||
41937789|NCT02371980|75655167|FG001|Double-blind Period|Significant Protocol Deviation|2|||
41937790|NCT02371980|75655168|FG002|Double-blind Period|Significant Protocol Deviation|7|||
41937791|NCT02371980|75655169|FG003|Double-blind Period|Significant Protocol Deviation|3|||
41937792|NCT02371980|75655170|FG004|Double-blind Period|Significant Protocol Deviation|3|||
41937793|NCT02371980|75655166|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
41937794|NCT02371980|75655167|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
41937795|NCT02371980|75655168|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
41937796|NCT02371980|75655169|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
41937797|NCT02371980|75655170|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
41937798|NCT02371980|75655166|FG000|Double-blind Period|Lost to Follow-up|0|||
41937799|NCT02371980|75655167|FG001|Double-blind Period|Lost to Follow-up|8|||
41937800|NCT02371980|75655168|FG002|Double-blind Period|Lost to Follow-up|8|||
41937801|NCT02371980|75655169|FG003|Double-blind Period|Lost to Follow-up|6|||
41937802|NCT02371980|75655170|FG004|Double-blind Period|Lost to Follow-up|5|||
41937803|NCT02371980|75655166|FG000|Double-blind Period|Voluntary Withdrawal|0|||
41937804|NCT02371980|75655167|FG001|Double-blind Period|Voluntary Withdrawal|12|||
41937805|NCT02371980|75655168|FG002|Double-blind Period|Voluntary Withdrawal|8|||
41937806|NCT02371980|75655169|FG003|Double-blind Period|Voluntary Withdrawal|9|||
41937807|NCT02371980|75655170|FG004|Double-blind Period|Voluntary Withdrawal|11|||
41937808|NCT02371980|75655166|FG000|Double-blind Period|Relapse|0|||
41937809|NCT02371980|75655167|FG001|Double-blind Period|Relapse|50|||
41937810|NCT02371980|75655168|FG002|Double-blind Period|Relapse|25|||
41937811|NCT02371980|75655169|FG003|Double-blind Period|Relapse|25|||
41937812|NCT02371980|75655170|FG004|Double-blind Period|Relapse|26|||
41937813|NCT02371980|75655166|FG000|Double-blind Period|Reason not Specified|0|||
41937814|NCT02371980|75655167|FG001|Double-blind Period|Reason not Specified|3|||
41937815|NCT02371980|75655168|FG002|Double-blind Period|Reason not Specified|3|||
41937816|NCT02371980|75655169|FG003|Double-blind Period|Reason not Specified|2|||
41937817|NCT02371980|75655170|FG004|Double-blind Period|Reason not Specified|1|||
41937818|NCT02371980|75655166|FG000|Double-blind Period|Missing|0|||
41937819|NCT02371980|75655167|FG001|Double-blind Period|Missing|1|||
41937820|NCT02371980|75655168|FG002|Double-blind Period|Missing|0|||
41937821|NCT02371980|75655169|FG003|Double-blind Period|Missing|0|||
41937822|NCT02371980|75655170|FG004|Double-blind Period|Missing|0|||
41937823|NCT02371746|75655310|FG000|Overall Study|Consent withdrawn|0|||
41937824|NCT02371746|75655311|FG001|Overall Study|Consent withdrawn|0|||
41937825|NCT02371746|75655312|FG002|Overall Study|Consent withdrawn|0|||
41937826|NCT02371746|75655313|FG003|Overall Study|Consent withdrawn|0|||
41937827|NCT02371746|75655314|FG004|Overall Study|Consent withdrawn|0|||
41937828|NCT02371746|75655315|FG005|Overall Study|Consent withdrawn|0|||
41937829|NCT02371746|75655316|FG006|Overall Study|Consent withdrawn|1|||
41937830|NCT02421666|75655364|FG000|6-month Follow-up|Lost to Follow-up|8|||
41937831|NCT02421666|75655365|FG001|6-month Follow-up|Lost to Follow-up|7|||
41937832|NCT02421666|75655364|FG000|6-month Follow-up|Withdrawal by Subject|5|||
41937833|NCT02421666|75655365|FG001|6-month Follow-up|Withdrawal by Subject|6|||
41937834|NCT02421666|75655364|FG000|12-month Follow-up|Lost to Follow-up|5|||
41937835|NCT02421666|75655365|FG001|12-month Follow-up|Lost to Follow-up|5|||
41937836|NCT02421666|75655364|FG000|12-month Follow-up|Withdrawal by Subject|6|||
41937837|NCT02421666|75655365|FG001|12-month Follow-up|Withdrawal by Subject|11|||
41937838|NCT02394756|75655375|FG000|Period 1|Lens Discomfort|0|||
41937839|NCT02394756|75655376|FG001|Period 1|Lens Discomfort|0|||
41937840|NCT02394756|75655377|FG002|Period 1|Lens Discomfort|0|||
41937841|NCT02394756|75655378|FG003|Period 1|Lens Discomfort|0|||
41937842|NCT02394756|75655379|FG004|Period 1|Lens Discomfort|0|||
41937843|NCT02394756|75655380|FG005|Period 1|Lens Discomfort|1|||
42022576|NCT00948922|75829865|FG000|Overall Study|Insurance issues|1|||
42022577|NCT00948922|75829866|FG001|Overall Study|Insurance issues|0|||
41937844|NCT02394756|75655375|FG000|Period 1|Withdrawal by Subject|0|||
41937845|NCT02394756|75655376|FG001|Period 1|Withdrawal by Subject|1|||
41937846|NCT02394756|75655377|FG002|Period 1|Withdrawal by Subject|1|||
42022578|NCT00948922|75829867|FG002|Overall Study|Insurance issues|0|||
42022579|NCT00948922|75829865|FG000|Overall Study|Transplant eligibility issues|2|||
41937847|NCT02394756|75655378|FG003|Period 1|Withdrawal by Subject|1|||
41937848|NCT02394756|75655379|FG004|Period 1|Withdrawal by Subject|0|||
41937849|NCT02394756|75655380|FG005|Period 1|Withdrawal by Subject|0|||
41937850|NCT02394756|75655375|FG000|Period 2|Unsatisfactory Visual Response|0|||
41937851|NCT02394756|75655376|FG001|Period 2|Unsatisfactory Visual Response|0|||
41937852|NCT02394756|75655377|FG002|Period 2|Unsatisfactory Visual Response|0|||
41937853|NCT02394756|75655378|FG003|Period 2|Unsatisfactory Visual Response|0|||
41937854|NCT02394756|75655379|FG004|Period 2|Unsatisfactory Visual Response|1|||
41937855|NCT02394756|75655380|FG005|Period 2|Unsatisfactory Visual Response|0|||
41937856|NCT02370888|75655401|FG000|Overall Study|disease progression|2|||
41937857|NCT02370888|75655401|FG000|Overall Study|did not meet chimerism criteria|6|||
41937858|NCT02394600|75655425|FG000|Overall Study|Adverse Event|3|||
41937859|NCT02394600|75655426|FG001|Overall Study|Adverse Event|0|||
41937860|NCT02394600|75655425|FG000|Overall Study|Lost to Follow-up|0|||
41937861|NCT02394600|75655426|FG001|Overall Study|Lost to Follow-up|1|||
41937862|NCT02394600|75655425|FG000|Overall Study|Withdrawal by Subject|0|||
41937863|NCT02394600|75655426|FG001|Overall Study|Withdrawal by Subject|1|||
41937864|NCT02394600|75655425|FG000|Overall Study|Protocol Violation|1|||
41937865|NCT02394600|75655426|FG001|Overall Study|Protocol Violation|0|||
41937866|NCT04685499|75655442|FG000|Overall Study|Study Terminated Early|1|||
41937867|NCT02421588|75655518|FG000|Overall Study|Non-treatment-related AE|8|||
41937868|NCT02421588|75655519|FG001|Overall Study|Non-treatment-related AE|8|||
41937869|NCT02421588|75655518|FG000|Overall Study|Progressive disease|152|||
41937870|NCT02421588|75655519|FG001|Overall Study|Progressive disease|135|||
41937871|NCT02421588|75655518|FG000|Overall Study|Death|11|||
41937872|NCT02421588|75655519|FG001|Overall Study|Death|3|||
41937873|NCT02421588|75655518|FG000|Overall Study|Physician Decision|8|||
41937874|NCT02421588|75655519|FG001|Overall Study|Physician Decision|17|||
41937875|NCT02421588|75655518|FG000|Overall Study|Other reason not specified|3|||
41937876|NCT02421588|75655519|FG001|Overall Study|Other reason not specified|1|||
41937877|NCT02421588|75655518|FG000|Overall Study|Symptomatic deterioration|13|||
41937878|NCT02421588|75655519|FG001|Overall Study|Symptomatic deterioration|19|||
41937879|NCT02421588|75655518|FG000|Overall Study|Treatment-related AE|10|||
41937880|NCT02421588|75655519|FG001|Overall Study|Treatment-related AE|14|||
41937881|NCT02421588|75655518|FG000|Overall Study|Withdrawal by Subject|14|||
41937882|NCT02421588|75655519|FG001|Overall Study|Withdrawal by Subject|16|||
41937883|NCT02421588|75655518|FG000|Overall Study|Not treated|2|||
41937884|NCT02421588|75655519|FG001|Overall Study|Not treated|8|||
41937885|NCT02421510|75655528|FG000|Overall Study|Other|4|||
41937886|NCT02421510|75655529|FG001|Overall Study|Other|2|||
41937887|NCT02421510|75655530|FG002|Overall Study|Other|3|||
41937888|NCT02421510|75655528|FG000|Overall Study|Protocol Violation|1|||
41937889|NCT02421510|75655529|FG001|Overall Study|Protocol Violation|2|||
41937890|NCT02421510|75655530|FG002|Overall Study|Protocol Violation|0|||
41937891|NCT02421510|75655528|FG000|Overall Study|Death|1|||
41937892|NCT02421510|75655529|FG001|Overall Study|Death|0|||
41937893|NCT02421510|75655530|FG002|Overall Study|Death|0|||
41937894|NCT02421510|75655528|FG000|Overall Study|Noncompliance with study drug|1|||
41937895|NCT02421510|75655529|FG001|Overall Study|Noncompliance with study drug|0|||
41937896|NCT02421510|75655530|FG002|Overall Study|Noncompliance with study drug|0|||
41937897|NCT02421510|75655528|FG000|Overall Study|Physician Decision|1|||
41937898|NCT02421510|75655529|FG001|Overall Study|Physician Decision|1|||
41937899|NCT02421510|75655530|FG002|Overall Study|Physician Decision|3|||
41937900|NCT02421510|75655528|FG000|Overall Study|Adverse Event|9|||
41937901|NCT02421510|75655529|FG001|Overall Study|Adverse Event|10|||
41937902|NCT02421510|75655530|FG002|Overall Study|Adverse Event|18|||
41937903|NCT02421510|75655528|FG000|Overall Study|Pregnancy|1|||
41937904|NCT02421510|75655529|FG001|Overall Study|Pregnancy|1|||
41937905|NCT02421510|75655530|FG002|Overall Study|Pregnancy|0|||
41937906|NCT02421510|75655528|FG000|Overall Study|Withdrawal by Subject|14|||
41937907|NCT02421510|75655529|FG001|Overall Study|Withdrawal by Subject|18|||
41937908|NCT02421510|75655530|FG002|Overall Study|Withdrawal by Subject|12|||
41937909|NCT02421510|75655528|FG000|Overall Study|Lost to Follow-up|1|||
41937910|NCT02421510|75655529|FG001|Overall Study|Lost to Follow-up|1|||
41937911|NCT02421510|75655530|FG002|Overall Study|Lost to Follow-up|0|||
41937912|NCT00552617|75655548|FG000|Overall Study|Not Treated|0|||
41937913|NCT00552617|75655549|FG001|Overall Study|Not Treated|0|||
41937914|NCT00552617|75655550|FG002|Overall Study|Not Treated|1|||
41937915|NCT00552617|75655551|FG003|Overall Study|Not Treated|0|||
41937916|NCT00552617|75655552|FG004|Overall Study|Not Treated|0|||
41937917|NCT00552617|75655553|FG005|Overall Study|Not Treated|0|||
41937918|NCT00552617|75655554|FG006|Overall Study|Not Treated|0|||
41937919|NCT00552617|75655555|FG007|Overall Study|Not Treated|0|||
41937920|NCT00552617|75655556|FG008|Overall Study|Not Treated|0|||
41937921|NCT00552617|75655557|FG009|Overall Study|Not Treated|1|||
41937922|NCT00552617|75655548|FG000|Overall Study|Lost to Follow-up|0|||
41937923|NCT00552617|75655549|FG001|Overall Study|Lost to Follow-up|0|||
41937924|NCT00552617|75655550|FG002|Overall Study|Lost to Follow-up|0|||
41937925|NCT00552617|75655551|FG003|Overall Study|Lost to Follow-up|1|||
41937926|NCT00552617|75655552|FG004|Overall Study|Lost to Follow-up|0|||
41937927|NCT00552617|75655553|FG005|Overall Study|Lost to Follow-up|2|||
41937928|NCT00552617|75655554|FG006|Overall Study|Lost to Follow-up|0|||
41937929|NCT00552617|75655555|FG007|Overall Study|Lost to Follow-up|0|||
41937930|NCT00552617|75655556|FG008|Overall Study|Lost to Follow-up|2|||
41937931|NCT00552617|75655557|FG009|Overall Study|Lost to Follow-up|0|||
41937932|NCT02421120|75655579|FG000|Overall Study|Adverse Event|1|||
41937933|NCT02420262|75655585|FG000|Overall Study|Adverse Event|1|||
41937934|NCT02420262|75655586|FG001|Overall Study|Adverse Event|0|||
41937935|NCT02420262|75655585|FG000|Overall Study|Withdrawal by Subject|1|||
41937936|NCT02420262|75655586|FG001|Overall Study|Withdrawal by Subject|4|||
41937937|NCT02420262|75655585|FG000|Overall Study|Unclassified|0|||
41937938|NCT02420262|75655586|FG001|Overall Study|Unclassified|1|||
41937939|NCT00552305|75655592|FG000|Overall Study|Adverse Event|43|||
41937940|NCT00552305|75655592|FG000|Overall Study|Lack of Efficacy|120|||
41937941|NCT00552305|75655592|FG000|Overall Study|Lost to Follow-up|4|||
41937942|NCT00552305|75655592|FG000|Overall Study|Protocol Violation|3|||
41937943|NCT00552305|75655592|FG000|Overall Study|Withdrawal by Subject|44|||
41937944|NCT00552305|75655592|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
41937945|NCT00552305|75655592|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
41937946|NCT00552305|75655592|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
41937947|NCT00552305|75655592|FG000|Overall Study|Unsatisfactory compliance|11|||
41937948|NCT00552305|75655592|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
41937949|NCT00552305|75655592|FG000|Overall Study|AE/Other: prohibited drug required|1|||
41937950|NCT00552305|75655592|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
41937951|NCT00552305|75655592|FG000|Overall Study|Other: Site closed|4|||
41937952|NCT00552305|75655592|FG000|Overall Study|Other: Personal problems|1|||
41937953|NCT00552305|75655592|FG000|Overall Study|Other: Unable to attend visits|1|||
41937954|NCT00552305|75655592|FG000|Overall Study|Other: Subject underwent surgery|4|||
41937955|NCT00552305|75655592|FG000|Overall Study|Other: Subject became pregnant|1|||
41937956|NCT00552305|75655592|FG000|Overall Study|Other: Health problems, not drug related|1|||
41937957|NCT00552305|75655592|FG000|Overall Study|Other: Subject moved from area|2|||
41937958|NCT00552305|75655592|FG000|Overall Study|Other: Subject incarcerated|1|||
41937959|NCT00552305|75655592|FG000|Overall Study|Other: Subject went to rehab|1|||
41937960|NCT00552071|75655618|FG000|Overall Study|Adverse Event|1|||
41937961|NCT00552071|75655619|FG001|Overall Study|Adverse Event|0|||
41937962|NCT00552071|75655618|FG000|Overall Study|Lack of Efficacy|1|||
41937963|NCT00552071|75655619|FG001|Overall Study|Lack of Efficacy|0|||
41937964|NCT00552071|75655618|FG000|Overall Study|Physician Decision|1|||
41937965|NCT00552071|75655619|FG001|Overall Study|Physician Decision|0|||
41937966|NCT00552071|75655618|FG000|Overall Study|Pregnancy|1|||
41937967|NCT00552071|75655619|FG001|Overall Study|Pregnancy|0|||
41937968|NCT00552071|75655618|FG000|Overall Study|Death|0|||
41937969|NCT00552071|75655619|FG001|Overall Study|Death|1|||
41937970|NCT00552071|75655618|FG000|Overall Study|Withdrawal by Subject|0|||
41937971|NCT00552071|75655619|FG001|Overall Study|Withdrawal by Subject|1|||
41937972|NCT00551525|75655627|FG000|Overall Study|Protocol Violation|5|||
41937973|NCT02370498|75655654|FG000|Overall Study|Adverse Event|10|||
41937974|NCT02370498|75655655|FG001|Overall Study|Adverse Event|8|||
41937975|NCT02370498|75655654|FG000|Overall Study|Death|263|||
41937976|NCT02370498|75655655|FG001|Overall Study|Death|265|||
41937977|NCT02370498|75655654|FG000|Overall Study|Protocol Violation|1|||
41937978|NCT02370498|75655655|FG001|Overall Study|Protocol Violation|2|||
41937979|NCT02370498|75655654|FG000|Overall Study|Withdrawal by Subject|7|||
41937980|NCT02370498|75655655|FG001|Overall Study|Withdrawal by Subject|12|||
41937981|NCT02370498|75655654|FG000|Overall Study|Sponsor's decision|15|||
41937982|NCT02370498|75655655|FG001|Overall Study|Sponsor's decision|9|||
41937983|NCT02347332|75655680|FG000|Overall Study|Not treated|5|||
41937984|NCT02347332|75655681|FG001|Overall Study|Not treated|2|||
41937985|NCT02347332|75655680|FG000|Overall Study|Progressive disease|141|||
41937986|NCT02347332|75655681|FG001|Overall Study|Progressive disease|159|||
41937987|NCT02347332|75655680|FG000|Overall Study|Adverse Event|50|||
41937988|NCT02347332|75655681|FG001|Overall Study|Adverse Event|41|||
41937989|NCT02347332|75655680|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
41937990|NCT02347332|75655681|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
41937991|NCT02347332|75655680|FG000|Overall Study|Protocol Violation|1|||
42022580|NCT00948922|75829866|FG001|Overall Study|Transplant eligibility issues|3|||
42022581|NCT00948922|75829867|FG002|Overall Study|Transplant eligibility issues|0|||
42022582|NCT00948922|75829865|FG000|Overall Study|Not evaluable at time of analysis|0|||
42022583|NCT00948922|75829866|FG001|Overall Study|Not evaluable at time of analysis|3|||
42022584|NCT00948922|75829867|FG002|Overall Study|Not evaluable at time of analysis|0|||
41937992|NCT02347332|75655681|FG001|Overall Study|Protocol Violation|1|||
41937993|NCT02347332|75655680|FG000|Overall Study|Lost to Follow-up|2|||
41937994|NCT02347332|75655681|FG001|Overall Study|Lost to Follow-up|1|||
41937995|NCT02347332|75655680|FG000|Overall Study|Physician Decision|4|||
41937996|NCT02347332|75655681|FG001|Overall Study|Physician Decision|3|||
41937997|NCT02347332|75655680|FG000|Overall Study|Withdrawal by Subject|20|||
42117977|NCT00688181|75928821|FG000|Overall Study|Unknown Reason|4|||
42300180|NCT02327169|76135335|FG013|Overall Study|Reason Not Specified|0|||
41937998|NCT02347332|75655681|FG001|Overall Study|Withdrawal by Subject|14|||
41937999|NCT02347332|75655680|FG000|Overall Study|Protocol requirement|1|||
41938000|NCT02347332|75655681|FG001|Overall Study|Protocol requirement|1|||
41938001|NCT02347332|75655680|FG000|Overall Study|Switch Post-Trial program|0|||
41938002|NCT02347332|75655681|FG001|Overall Study|Switch Post-Trial program|1|||
41938003|NCT02347176|75655704|FG000|Overall Study|Lost to Follow-up|2|||
41938004|NCT02347176|75655705|FG001|Overall Study|Lost to Follow-up|3|||
41938005|NCT02347176|75655706|FG002|Overall Study|Lost to Follow-up|1|||
41938006|NCT02347176|75655707|FG003|Overall Study|Lost to Follow-up|1|||
41938007|NCT02347176|75655704|FG000|Overall Study|Withdrawal by Subject|9|||
41938008|NCT02347176|75655705|FG001|Overall Study|Withdrawal by Subject|5|||
41938009|NCT02347176|75655706|FG002|Overall Study|Withdrawal by Subject|5|||
41938010|NCT02347176|75655707|FG003|Overall Study|Withdrawal by Subject|3|||
41938011|NCT02347176|75655704|FG000|Overall Study|Other|1|||
41938012|NCT02347176|75655705|FG001|Overall Study|Other|2|||
41938013|NCT02347176|75655706|FG002|Overall Study|Other|2|||
41938014|NCT02347176|75655707|FG003|Overall Study|Other|0|||
41938015|NCT02370420|75655719|FG000|Overall Study|Physician Decision|3|||
41938016|NCT02370420|75655720|FG001|Overall Study|Physician Decision|3|||
41938017|NCT02370420|75655719|FG000|Overall Study|Lost to Follow-up|11|||
41938018|NCT02370420|75655720|FG001|Overall Study|Lost to Follow-up|9|||
41938019|NCT02347098|75655742|FG000|Overall Study|Death|1|||
41938020|NCT02347098|75655743|FG001|Overall Study|Death|0|||
41938021|NCT02347098|75655742|FG000|Overall Study|Withdrawal by Subject|1|||
41938022|NCT02347098|75655743|FG001|Overall Study|Withdrawal by Subject|0|||
41938023|NCT02347098|75655742|FG000|Overall Study|Lost to Follow-up|2|||
41938024|NCT02347098|75655743|FG001|Overall Study|Lost to Follow-up|2|||
41938025|NCT02347098|75655742|FG000|Overall Study|Refuse Follow-up Visit|1|||
41938026|NCT02347098|75655743|FG001|Overall Study|Refuse Follow-up Visit|5|||
41938027|NCT02347098|75655742|FG000|Overall Study|no visit due to illness|2|||
41938028|NCT02347098|75655743|FG001|Overall Study|no visit due to illness|1|||
41938029|NCT02346708|75655760|FG000|Overall Study|Adverse Event|2|||
41938030|NCT02346708|75655761|FG001|Overall Study|Adverse Event|0|||
41938031|NCT02346708|75655760|FG000|Overall Study|Protocol Violation|0|||
41938032|NCT02346708|75655761|FG001|Overall Study|Protocol Violation|1|||
41938033|NCT02346240|75656251|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938034|NCT02346240|75656252|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
41938035|NCT02346240|75656253|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
41938036|NCT02346240|75656254|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
41938037|NCT02346240|75656255|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938038|NCT02346240|75656256|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938039|NCT02346240|75656257|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938040|NCT02346240|75656258|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938041|NCT02346240|75656259|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938042|NCT02346240|75656260|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938043|NCT02346240|75656261|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938044|NCT02346240|75656262|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938045|NCT02346240|75656263|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938046|NCT02346240|75656264|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938047|NCT02346240|75656265|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938048|NCT02346240|75656266|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938049|NCT02346240|75656267|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938050|NCT02346240|75656268|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938051|NCT02346240|75656269|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938052|NCT02346240|75656270|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938053|NCT02346240|75656271|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938054|NCT02346240|75656272|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938055|NCT02346240|75656273|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938056|NCT02346240|75656274|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
41938057|NCT02346240|75656251|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938058|NCT02346240|75656252|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
41938059|NCT02346240|75656253|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938060|NCT02346240|75656254|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938061|NCT02346240|75656255|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938062|NCT02346240|75656256|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938063|NCT02346240|75656257|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938064|NCT02346240|75656258|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938065|NCT02346240|75656259|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938066|NCT02346240|75656260|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938067|NCT02346240|75656261|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938068|NCT02346240|75656262|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938069|NCT02346240|75656263|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938070|NCT02346240|75656264|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
42022585|NCT01239992|75829879|FG000|Overall Study|Withdrawal by Subject|2|||
41938071|NCT02346240|75656265|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938072|NCT02346240|75656266|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938073|NCT02346240|75656267|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
42022586|NCT01239680|75829885|FG000|Overall Study|Withdrawal by Subject|2|||
42117978|NCT00688181|75928821|FG000|Overall Study|Non-clinical Reason|2|||
41938074|NCT02346240|75656268|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938075|NCT02346240|75656269|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938076|NCT02346240|75656270|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938077|NCT02346240|75656271|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938078|NCT02346240|75656272|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938079|NCT02346240|75656273|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938080|NCT02346240|75656274|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
41938081|NCT02346240|75656251|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938082|NCT02346240|75656252|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
41938083|NCT02346240|75656253|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938084|NCT02346240|75656254|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938085|NCT02346240|75656255|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938086|NCT02346240|75656256|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938087|NCT02346240|75656257|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938088|NCT02346240|75656258|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938089|NCT02346240|75656259|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938090|NCT02346240|75656260|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938091|NCT02346240|75656261|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938092|NCT02346240|75656262|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938093|NCT02346240|75656263|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938094|NCT02346240|75656264|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938095|NCT02346240|75656265|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938096|NCT02346240|75656266|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938097|NCT02346240|75656267|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938098|NCT02346240|75656268|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938099|NCT02346240|75656269|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938100|NCT02346240|75656270|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938101|NCT02346240|75656271|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938102|NCT02346240|75656272|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938103|NCT02346240|75656273|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938104|NCT02346240|75656274|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
41938105|NCT02346240|75656251|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
41938106|NCT02346240|75656252|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
41938107|NCT02346240|75656253|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
41938108|NCT02346240|75656254|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
41938109|NCT02346240|75656255|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938110|NCT02346240|75656256|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938111|NCT02346240|75656257|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938112|NCT02346240|75656258|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938113|NCT02346240|75656259|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938114|NCT02346240|75656260|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938115|NCT02346240|75656261|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938116|NCT02346240|75656262|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938117|NCT02346240|75656263|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938118|NCT02346240|75656264|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938119|NCT02346240|75656265|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938120|NCT02346240|75656266|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938121|NCT02346240|75656267|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938122|NCT02346240|75656268|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938123|NCT02346240|75656269|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938124|NCT02346240|75656270|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938125|NCT02346240|75656271|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938126|NCT02346240|75656272|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938127|NCT02346240|75656273|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938128|NCT02346240|75656274|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
41938129|NCT02346240|75656251|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
41938130|NCT02346240|75656252|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
41938131|NCT02346240|75656253|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
41938132|NCT02346240|75656254|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
41938133|NCT02346240|75656255|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938134|NCT02346240|75656256|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938135|NCT02346240|75656257|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938136|NCT02346240|75656258|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
42022587|NCT01239680|75829886|FG001|Overall Study|Withdrawal by Subject|0|||
42022588|NCT01238900|75829892|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
42022589|NCT01238900|75829892|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
42022590|NCT01238822|75829897|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
42117979|NCT00689117|75928840|FG000|Overall Study|Adverse Event|6|||
42117980|NCT00689117|75928841|FG001|Overall Study|Adverse Event|0|||
41938137|NCT02346240|75656259|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938138|NCT02346240|75656260|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938139|NCT02346240|75656261|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938140|NCT02346240|75656262|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938141|NCT02346240|75656263|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938142|NCT02346240|75656264|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938143|NCT02346240|75656265|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938144|NCT02346240|75656266|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938145|NCT02346240|75656267|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938146|NCT02346240|75656268|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938147|NCT02346240|75656269|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938148|NCT02346240|75656270|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938149|NCT02346240|75656271|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938150|NCT02346240|75656272|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938151|NCT02346240|75656273|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938152|NCT02346240|75656274|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
41938153|NCT02346240|75656251|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938154|NCT02346240|75656252|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
41938155|NCT02346240|75656253|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938156|NCT02346240|75656254|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
41938157|NCT02346240|75656255|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938158|NCT02346240|75656256|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938159|NCT02346240|75656257|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938160|NCT02346240|75656258|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938161|NCT02346240|75656259|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938162|NCT02346240|75656260|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938163|NCT02346240|75656261|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938164|NCT02346240|75656262|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938165|NCT02346240|75656263|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938166|NCT02346240|75656264|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938167|NCT02346240|75656265|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938168|NCT02346240|75656266|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938169|NCT02346240|75656267|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938170|NCT02346240|75656268|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938171|NCT02346240|75656269|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938172|NCT02346240|75656270|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938173|NCT02346240|75656271|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938174|NCT02346240|75656272|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938175|NCT02346240|75656273|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938176|NCT02346240|75656274|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
41938177|NCT02346240|75656251|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938178|NCT02346240|75656252|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938179|NCT02346240|75656253|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
41938180|NCT02346240|75656254|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938181|NCT02346240|75656255|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938182|NCT02346240|75656256|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938183|NCT02346240|75656257|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
42300181|NCT02327169|76135336|FG014|Overall Study|Reason Not Specified|2|||
42300182|NCT02327169|76135322|FG000|Overall Study|Withdrawal by Subject|1|||
41938184|NCT02346240|75656258|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938185|NCT02346240|75656259|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938186|NCT02346240|75656260|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938187|NCT02346240|75656261|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938188|NCT02346240|75656262|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938189|NCT02346240|75656263|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938190|NCT02346240|75656264|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938191|NCT02346240|75656265|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938192|NCT02346240|75656266|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938193|NCT02346240|75656267|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938194|NCT02346240|75656268|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938195|NCT02346240|75656269|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938196|NCT02346240|75656270|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
42300183|NCT02327169|76135323|FG001|Overall Study|Withdrawal by Subject|0|||
42300184|NCT02327169|76135324|FG002|Overall Study|Withdrawal by Subject|0|||
41938197|NCT02346240|75656271|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938198|NCT02346240|75656272|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938199|NCT02346240|75656273|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938200|NCT02346240|75656274|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
41938201|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938202|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938203|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938204|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938205|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938206|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938207|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938208|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
41938209|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
41938210|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938211|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938212|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938213|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938214|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
41938215|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
41938216|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
41938217|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
41938218|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938219|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938220|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938221|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938222|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938223|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938224|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41938225|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938226|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938227|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938228|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938229|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938230|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938231|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938232|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938233|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938234|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938235|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938236|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938237|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938238|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
41938239|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938240|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
41938241|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938242|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938243|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938244|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938245|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938246|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938247|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938248|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41938249|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938250|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938251|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938252|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938253|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938254|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938255|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938256|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938257|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938258|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938259|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42117981|NCT00689117|75928842|FG002|Overall Study|Adverse Event|5|||
42117982|NCT00689117|75928843|FG003|Overall Study|Adverse Event|0|||
42117983|NCT00689117|75928840|FG000|Overall Study|Lost to Follow-up|26|||
41938260|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938261|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938262|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938263|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
41938264|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938265|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938266|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938267|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938268|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938269|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938270|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938271|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938272|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41938273|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
42022591|NCT01238588|75829907|FG000|Overall Study|Withdrawal by Subject|1|||
42022592|NCT01238588|75829907|FG000|Overall Study|Physician Decision|2|||
42022593|NCT01047501|75829914|FG000|Overall Study|Adverse Event|7|||
42022594|NCT01047501|75829915|FG001|Overall Study|Adverse Event|8|||
42022595|NCT01047501|75829916|FG002|Overall Study|Adverse Event|5|||
42022596|NCT01047501|75829914|FG000|Overall Study|Withdrew Consent|6|||
42022597|NCT01047501|75829915|FG001|Overall Study|Withdrew Consent|2|||
41938274|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938275|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938276|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938277|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938278|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
41938279|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
41938280|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
41938281|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
41938282|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938283|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
41938284|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
41938285|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938286|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
41938287|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
41938288|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
41938289|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
41938290|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938291|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938292|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938293|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938294|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938295|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938296|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41938297|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938298|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938299|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938300|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938301|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938302|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
42022598|NCT01047501|75829916|FG002|Overall Study|Withdrew Consent|4|||
42022599|NCT01047501|75829914|FG000|Overall Study|Lost to Follow-up|0|||
42022600|NCT01047501|75829915|FG001|Overall Study|Lost to Follow-up|1|||
42022601|NCT01047501|75829916|FG002|Overall Study|Lost to Follow-up|1|||
41938303|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938304|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938305|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938306|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938307|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938308|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938309|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938310|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
41938311|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
41938312|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
41938313|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
41938314|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938315|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938316|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938317|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938318|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938319|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938320|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41938321|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938322|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938323|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938324|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938325|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938326|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938327|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
41938328|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938329|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938330|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938331|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938332|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938333|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938334|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938335|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938336|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938337|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938338|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938339|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938340|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938341|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938342|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938343|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938344|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
41938345|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938346|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938347|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938348|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938349|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938350|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938351|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938352|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938353|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
41938354|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938355|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938356|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
41938357|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
42022602|NCT01047501|75829914|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
42022603|NCT01047501|75829915|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
42022604|NCT01047501|75829916|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
42022605|NCT01047501|75829914|FG000|Overall Study|Death|1|||
42210266|NCT00418834|76025012|FG000|Overall Study|Withdrawal by Subject|3|||
42210267|NCT00418834|76025013|FG001|Overall Study|Withdrawal by Subject|7|||
41938358|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
41938359|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
41938360|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938361|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938362|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938363|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938364|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938365|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938366|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938367|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938368|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
41938369|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938370|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938371|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938372|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938373|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938374|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938375|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938376|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938377|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938378|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
41938379|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938380|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938381|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938382|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938383|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938384|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938385|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938386|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938387|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938388|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938389|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938390|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938391|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938392|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
41938393|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938394|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938395|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938396|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938397|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938398|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938399|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938400|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938401|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938402|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938403|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
41938404|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938405|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938406|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938407|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938408|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938409|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938410|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938411|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938412|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938413|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938414|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
42022606|NCT01047501|75829915|FG001|Overall Study|Death|0|||
42022607|NCT01047501|75829916|FG002|Overall Study|Death|0|||
42022608|NCT01047501|75829914|FG000|Overall Study|Other discontinuation|1|||
42022609|NCT01047501|75829915|FG001|Overall Study|Other discontinuation|0|||
42022610|NCT01047501|75829916|FG002|Overall Study|Other discontinuation|1|||
42022611|NCT01047501|75829914|FG000|Overall Study|Investigator judgement|0|||
42022612|NCT01047501|75829915|FG001|Overall Study|Investigator judgement|0|||
42022613|NCT01047501|75829916|FG002|Overall Study|Investigator judgement|1|||
42022614|NCT01238120|75829928|FG000|Overall Study|Withdrawal by Subject|4|||
42022615|NCT01238120|75829929|FG001|Overall Study|Withdrawal by Subject|1|||
42022616|NCT01238120|75829930|FG002|Overall Study|Withdrawal by Subject|2|||
42022617|NCT01238120|75829931|FG003|Overall Study|Withdrawal by Subject|5|||
42022618|NCT01238120|75829928|FG000|Overall Study|Lost to Follow-up|2|||
42022619|NCT01238120|75829929|FG001|Overall Study|Lost to Follow-up|0|||
42022620|NCT01238120|75829930|FG002|Overall Study|Lost to Follow-up|1|||
42022621|NCT01238120|75829931|FG003|Overall Study|Lost to Follow-up|1|||
42022622|NCT01238120|75829928|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
42022623|NCT01238120|75829929|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
42022624|NCT01238120|75829930|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
42022625|NCT01238120|75829931|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
42022626|NCT01237340|75829941|FG000|Overall Study|Adverse Event|3|||
42022627|NCT01237340|75829941|FG000|Overall Study|Withdrawal by Subject|1|||
42022628|NCT01237340|75829941|FG000|Overall Study|Early termination of the trial|36|||
42022629|NCT01045707|75829950|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
42022630|NCT01045707|75829951|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
42022631|NCT01045707|75829950|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
42022632|NCT01045707|75829951|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
42022633|NCT01045707|75829950|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
42022634|NCT01045707|75829951|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
42022635|NCT01045707|75829950|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
42022636|NCT01045707|75829951|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
42022637|NCT01045707|75829950|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
42022638|NCT01045707|75829951|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
42022639|NCT01045707|75829950|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
42022640|NCT01045707|75829951|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
42022641|NCT01045707|75829950|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
42022642|NCT01045707|75829951|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
42022643|NCT01045707|75829950|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
42022644|NCT01045707|75829951|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
42022645|NCT01045707|75829950|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
42022646|NCT01045707|75829951|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
42022647|NCT01054599|75829959|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
42022648|NCT01054599|75829960|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
42022649|NCT01054599|75829959|FG000|Overall Study|Protocol Violation|1|||
42022650|NCT01054599|75829960|FG001|Overall Study|Protocol Violation|0|||
42022651|NCT01054599|75829959|FG000|Overall Study|Spells/seizure-like episodes|1|||
42022652|NCT01054599|75829960|FG001|Overall Study|Spells/seizure-like episodes|1|||
42022653|NCT01054599|75829959|FG000|Overall Study|Timing/scheduling difficulties|1|||
42022654|NCT01054599|75829960|FG001|Overall Study|Timing/scheduling difficulties|1|||
42022655|NCT01054599|75829959|FG000|Overall Study|Visual impairment, WTAR <80|0|||
42022656|NCT01054599|75829960|FG001|Overall Study|Visual impairment, WTAR <80|1|||
42022657|NCT01054599|75829959|FG000|Overall Study|Lost to Follow-up|0|||
42022658|NCT01054599|75829960|FG001|Overall Study|Lost to Follow-up|2|||
42022659|NCT01054599|75829959|FG000|Overall Study|Adverse Event|0|||
42022660|NCT01054599|75829960|FG001|Overall Study|Adverse Event|1|||
42022661|NCT01054599|75829959|FG000|Overall Study|Withdrawal by Subject|0|||
42022662|NCT01054599|75829960|FG001|Overall Study|Withdrawal by Subject|1|||
42022663|NCT00948766|75829968|FG000|Core Study|Adverse Event|73|||
42022664|NCT00948766|75829969|FG001|Core Study|Adverse Event|51|||
42022665|NCT00948766|75829968|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
42022666|NCT00948766|75829969|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
42022667|NCT00948766|75829968|FG000|Core Study|Patient Withdrew Consent|27|||
42022668|NCT00948766|75829969|FG001|Core Study|Patient Withdrew Consent|46|||
42022669|NCT00948766|75829968|FG000|Core Study|Lost to Follow-up|3|||
42022670|NCT00948766|75829969|FG001|Core Study|Lost to Follow-up|2|||
42022671|NCT00948766|75829968|FG000|Core Study|Administrative Problems|2|||
42022672|NCT00948766|75829969|FG001|Core Study|Administrative Problems|2|||
42022673|NCT00948766|75829968|FG000|Core Study|Death|1|||
42022674|NCT00948766|75829969|FG001|Core Study|Death|1|||
42022675|NCT00948766|75829968|FG000|Core Study|Protocol Deviation|8|||
42022676|NCT00948766|75829969|FG001|Core Study|Protocol Deviation|10|||
42022677|NCT00948766|75829968|FG000|Extension Study|Adverse Event|43|||
42022678|NCT00948766|75829969|FG001|Extension Study|Adverse Event|0|||
42022679|NCT00948766|75829968|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
42022680|NCT00948766|75829969|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
42022681|NCT00948766|75829968|FG000|Extension Study|Study Drug No Longer Required|1|||
42022682|NCT00948766|75829969|FG001|Extension Study|Study Drug No Longer Required|0|||
41938415|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938416|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
41938417|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938418|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938419|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938420|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938421|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938422|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938423|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938424|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
42022683|NCT00948766|75829968|FG000|Extension Study|Patient Withdrew Consent|32|||
42022684|NCT00948766|75829969|FG001|Extension Study|Patient Withdrew Consent|0|||
42022685|NCT00948766|75829968|FG000|Extension Study|Lost to Follow-up|8|||
42022686|NCT00948766|75829969|FG001|Extension Study|Lost to Follow-up|0|||
42022687|NCT00948766|75829968|FG000|Extension Study|Administrative Problems|1|||
42022688|NCT00948766|75829969|FG001|Extension Study|Administrative Problems|0|||
42022689|NCT00948766|75829968|FG000|Extension Study|Death|4|||
42022690|NCT00948766|75829969|FG001|Extension Study|Death|0|||
42022691|NCT01053663|75829979|FG000|Overall Study|Death|2|||
42022692|NCT01053663|75829979|FG000|Overall Study|Lost to Follow-up|1|||
42022693|NCT01053663|75829979|FG000|Overall Study|Poor IV Access|1|||
42022694|NCT01053663|75829979|FG000|Overall Study|Transferred to Another Hospital|1|||
41938425|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938426|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938427|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938428|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938429|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938430|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938431|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
41938432|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938433|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
42022695|NCT01053663|75829979|FG000|Overall Study|Negative Influenza Diagnosis|1|||
42022696|NCT01235546|75829991|FG000|Overall Study|Staff error, medication not administered|1|||
42022697|NCT01235546|75829992|FG001|Overall Study|Staff error, medication not administered|0|||
42022698|NCT01235546|75829991|FG000|Overall Study|Protocol Violation|1|||
42022699|NCT01235546|75829992|FG001|Overall Study|Protocol Violation|1|||
42022700|NCT01053429|75830007|FG000|Overall Study|Adverse Event|64|||
42022701|NCT01053429|75830007|FG000|Overall Study|Other|309|||
42022702|NCT01233284|75830011|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
42022703|NCT01233284|75830012|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
42022704|NCT01233284|75830013|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
42022705|NCT01233284|75830014|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
42022706|NCT01233284|75830015|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
42022707|NCT01233284|75830011|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
41938434|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938435|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938436|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938437|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938438|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938439|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938440|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
41938441|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938442|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938443|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938444|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938445|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
42022708|NCT01233284|75830012|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
42022709|NCT01233284|75830013|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
42022710|NCT01233284|75830014|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
42022711|NCT01233284|75830015|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
42022712|NCT01233284|75830011|FG000|Period 1 (4 Weeks)|Other|0|||
42022713|NCT01233284|75830012|FG001|Period 1 (4 Weeks)|Other|0|||
42022714|NCT01233284|75830013|FG002|Period 1 (4 Weeks)|Other|1|||
42022715|NCT01233284|75830014|FG003|Period 1 (4 Weeks)|Other|0|||
42022716|NCT01233284|75830015|FG004|Period 1 (4 Weeks)|Other|0|||
42022717|NCT01233284|75830011|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42022718|NCT01233284|75830012|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42022719|NCT01233284|75830013|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
42022720|NCT01233284|75830014|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42022721|NCT01233284|75830015|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42022722|NCT01233284|75830011|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
42022723|NCT01233284|75830012|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
42022724|NCT01233284|75830013|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
42022725|NCT01233284|75830014|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
42022726|NCT01233284|75830015|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
42022727|NCT01233284|75830011|FG000|Period 3 (4 Weeks)|Other|0|||
42022728|NCT01233284|75830012|FG001|Period 3 (4 Weeks)|Other|0|||
42117984|NCT00689117|75928841|FG001|Overall Study|Lost to Follow-up|19|||
42022729|NCT01233284|75830013|FG002|Period 3 (4 Weeks)|Other|0|||
42022730|NCT01233284|75830014|FG003|Period 3 (4 Weeks)|Other|1|||
42022731|NCT01233284|75830015|FG004|Period 3 (4 Weeks)|Other|0|||
42022732|NCT01233284|75830011|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
42022733|NCT01233284|75830012|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
42022734|NCT01233284|75830013|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
42022735|NCT01233284|75830014|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
42022736|NCT01233284|75830015|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
42022737|NCT01233284|75830011|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
42022738|NCT01233284|75830012|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
42022739|NCT01233284|75830013|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
42022740|NCT01233284|75830014|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
42022741|NCT01233284|75830015|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
42022742|NCT00948688|75830025|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
42022743|NCT00948688|75830026|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
42022744|NCT00948688|75830025|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
42022745|NCT00948688|75830026|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
42022746|NCT00948688|75830025|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
42022747|NCT00948688|75830026|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
42022748|NCT01233050|75830035|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
42022749|NCT01233050|75830036|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
42022750|NCT01232894|75830044|FG000|Overall Study|Lost to Follow-up|0|||
42022751|NCT01232894|75830045|FG001|Overall Study|Lost to Follow-up|1|||
42022752|NCT01232894|75830044|FG000|Overall Study|Death|1|||
41938446|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938447|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938448|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938449|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938450|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938451|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938452|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938453|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938454|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938455|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
41938456|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938457|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938458|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938459|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
42022753|NCT01232894|75830045|FG001|Overall Study|Death|0|||
42022754|NCT01232894|75830044|FG000|Overall Study|Protocol Violation|1|||
42022755|NCT01232894|75830045|FG001|Overall Study|Protocol Violation|1|||
42022756|NCT01232894|75830044|FG000|Overall Study|Withdrawal by Subject|8|||
42022757|NCT01232894|75830045|FG001|Overall Study|Withdrawal by Subject|5|||
42022758|NCT01232894|75830044|FG000|Overall Study|Physician Decision|2|||
42022759|NCT01232894|75830045|FG001|Overall Study|Physician Decision|1|||
42117985|NCT00689117|75928842|FG002|Overall Study|Lost to Follow-up|17|||
42022760|NCT01049217|75830053|FG000|Overall Study|Adverse Event|2|||
42022761|NCT01049217|75830054|FG001|Overall Study|Adverse Event|1|||
42022762|NCT01049217|75830053|FG000|Overall Study|Lack of Efficacy|1|||
41938460|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938461|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938462|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938463|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938464|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
41938465|NCT02346240|75656251|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938466|NCT02346240|75656252|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938467|NCT02346240|75656253|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938468|NCT02346240|75656254|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938469|NCT02346240|75656255|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938470|NCT02346240|75656256|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938471|NCT02346240|75656257|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938472|NCT02346240|75656258|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938473|NCT02346240|75656259|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938474|NCT02346240|75656260|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938475|NCT02346240|75656261|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938476|NCT02346240|75656262|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938477|NCT02346240|75656263|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938478|NCT02346240|75656264|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938479|NCT02346240|75656265|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
41938480|NCT02346240|75656266|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938481|NCT02346240|75656267|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938482|NCT02346240|75656268|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938483|NCT02346240|75656269|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938484|NCT02346240|75656270|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938485|NCT02346240|75656271|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938486|NCT02346240|75656272|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938487|NCT02346240|75656273|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938488|NCT02346240|75656274|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
41938489|NCT02346240|75656251|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938490|NCT02346240|75656252|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938491|NCT02346240|75656253|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938492|NCT02346240|75656254|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938493|NCT02346240|75656255|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938494|NCT02346240|75656256|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938495|NCT02346240|75656257|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938496|NCT02346240|75656258|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938497|NCT02346240|75656259|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938498|NCT02346240|75656260|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938499|NCT02346240|75656261|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938500|NCT02346240|75656262|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938501|NCT02346240|75656263|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938502|NCT02346240|75656264|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938503|NCT02346240|75656265|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938504|NCT02346240|75656266|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938505|NCT02346240|75656267|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
41938506|NCT02346240|75656268|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
41938507|NCT02346240|75656269|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
41938508|NCT02346240|75656270|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
41938509|NCT02346240|75656271|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
41938510|NCT02346240|75656272|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
41938511|NCT02346240|75656273|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
41938512|NCT02346240|75656274|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
41938513|NCT02346240|75656251|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938514|NCT02346240|75656252|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938515|NCT02346240|75656253|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
42022763|NCT01049217|75830054|FG001|Overall Study|Lack of Efficacy|1|||
42022764|NCT01049217|75830053|FG000|Overall Study|Lost to Follow-up|3|||
42022765|NCT01049217|75830054|FG001|Overall Study|Lost to Follow-up|8|||
42022766|NCT01049217|75830053|FG000|Overall Study|Withdrawal by Subject|4|||
42022767|NCT01049217|75830054|FG001|Overall Study|Withdrawal by Subject|3|||
42022768|NCT01049217|75830053|FG000|Overall Study|Protocol Violation|1|||
41938516|NCT02346240|75656254|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938517|NCT02346240|75656255|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938518|NCT02346240|75656256|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938519|NCT02346240|75656257|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938520|NCT02346240|75656258|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938521|NCT02346240|75656259|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938522|NCT02346240|75656260|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938523|NCT02346240|75656261|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938524|NCT02346240|75656262|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938525|NCT02346240|75656263|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938526|NCT02346240|75656264|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938527|NCT02346240|75656265|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938528|NCT02346240|75656266|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938529|NCT02346240|75656267|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938530|NCT02346240|75656268|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938531|NCT02346240|75656269|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
41938532|NCT02346240|75656270|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
41938533|NCT02346240|75656271|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938534|NCT02346240|75656272|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
41938535|NCT02346240|75656273|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938536|NCT02346240|75656274|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
41938537|NCT02346240|75656251|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938538|NCT02346240|75656252|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938539|NCT02346240|75656253|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938540|NCT02346240|75656254|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938541|NCT02346240|75656255|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938542|NCT02346240|75656256|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938543|NCT02346240|75656257|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938544|NCT02346240|75656258|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938545|NCT02346240|75656259|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938546|NCT02346240|75656260|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938547|NCT02346240|75656261|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938548|NCT02346240|75656262|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938549|NCT02346240|75656263|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938550|NCT02346240|75656264|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938551|NCT02346240|75656265|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938552|NCT02346240|75656266|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938553|NCT02346240|75656267|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938554|NCT02346240|75656268|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938555|NCT02346240|75656269|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
41938556|NCT02346240|75656270|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938557|NCT02346240|75656271|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938558|NCT02346240|75656272|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
41938559|NCT02346240|75656273|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938560|NCT02346240|75656274|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41938561|NCT02346240|75656251|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938562|NCT02346240|75656252|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938563|NCT02346240|75656253|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938564|NCT02346240|75656254|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938565|NCT02346240|75656255|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938566|NCT02346240|75656256|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938567|NCT02346240|75656257|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938568|NCT02346240|75656258|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938569|NCT02346240|75656259|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938570|NCT02346240|75656260|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938571|NCT02346240|75656261|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938572|NCT02346240|75656262|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938573|NCT02346240|75656263|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938574|NCT02346240|75656264|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938575|NCT02346240|75656265|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938576|NCT02346240|75656266|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938577|NCT02346240|75656267|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938578|NCT02346240|75656268|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
42117986|NCT00689117|75928843|FG003|Overall Study|Lost to Follow-up|11|||
42300185|NCT02327169|76135325|FG003|Overall Study|Withdrawal by Subject|0|||
42300186|NCT02327169|76135326|FG004|Overall Study|Withdrawal by Subject|1|||
41938579|NCT02346240|75656269|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938580|NCT02346240|75656270|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938581|NCT02346240|75656271|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938582|NCT02346240|75656272|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
41938583|NCT02346240|75656273|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938584|NCT02346240|75656274|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
41938585|NCT02346240|75656251|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938586|NCT02346240|75656252|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938587|NCT02346240|75656253|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938588|NCT02346240|75656254|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938589|NCT02346240|75656255|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938590|NCT02346240|75656256|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938591|NCT02346240|75656257|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938592|NCT02346240|75656258|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938593|NCT02346240|75656259|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938594|NCT02346240|75656260|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938595|NCT02346240|75656261|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938596|NCT02346240|75656262|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938597|NCT02346240|75656263|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938598|NCT02346240|75656264|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938599|NCT02346240|75656265|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938600|NCT02346240|75656266|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938601|NCT02346240|75656267|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938602|NCT02346240|75656268|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
41938603|NCT02346240|75656269|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
41938604|NCT02346240|75656270|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
41938605|NCT02346240|75656271|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41938606|NCT02346240|75656272|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
41938607|NCT02346240|75656273|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
41938608|NCT02346240|75656274|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
41938609|NCT02346240|75656251|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938610|NCT02346240|75656252|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938611|NCT02346240|75656253|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938612|NCT02346240|75656254|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938613|NCT02346240|75656255|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938614|NCT02346240|75656256|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938615|NCT02346240|75656257|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938616|NCT02346240|75656258|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938617|NCT02346240|75656259|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938618|NCT02346240|75656260|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938619|NCT02346240|75656261|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938620|NCT02346240|75656262|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938621|NCT02346240|75656263|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42022769|NCT01049217|75830054|FG001|Overall Study|Protocol Violation|3|||
42117987|NCT00689117|75928840|FG000|Overall Study|Lack of Efficacy|1|||
41938622|NCT02346240|75656264|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938623|NCT02346240|75656265|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938624|NCT02346240|75656266|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938625|NCT02346240|75656267|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938626|NCT02346240|75656268|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938627|NCT02346240|75656269|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
41938628|NCT02346240|75656270|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
41938629|NCT02346240|75656271|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41938630|NCT02346240|75656272|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
41938631|NCT02346240|75656273|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
41938632|NCT02346240|75656274|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
41938633|NCT02346240|75656251|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938634|NCT02346240|75656252|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938635|NCT02346240|75656253|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938636|NCT02346240|75656254|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938637|NCT02346240|75656255|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938638|NCT02346240|75656256|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938639|NCT02346240|75656257|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938640|NCT02346240|75656258|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938641|NCT02346240|75656259|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938642|NCT02346240|75656260|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938643|NCT02346240|75656261|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938644|NCT02346240|75656262|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938645|NCT02346240|75656263|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938646|NCT02346240|75656264|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938647|NCT02346240|75656265|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938648|NCT02346240|75656266|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938649|NCT02346240|75656267|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938650|NCT02346240|75656268|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938651|NCT02346240|75656269|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
41938652|NCT02346240|75656270|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938653|NCT02346240|75656271|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
41938654|NCT02346240|75656272|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
41938655|NCT02346240|75656273|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
41938656|NCT02346240|75656274|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
41938657|NCT02346240|75656251|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938658|NCT02346240|75656252|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938659|NCT02346240|75656253|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938660|NCT02346240|75656254|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938661|NCT02346240|75656255|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938662|NCT02346240|75656256|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938663|NCT02346240|75656257|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938664|NCT02346240|75656258|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938665|NCT02346240|75656259|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938666|NCT02346240|75656260|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938667|NCT02346240|75656261|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938668|NCT02346240|75656262|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938669|NCT02346240|75656263|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938670|NCT02346240|75656264|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938671|NCT02346240|75656265|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938672|NCT02346240|75656266|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938673|NCT02346240|75656267|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938674|NCT02346240|75656268|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938675|NCT02346240|75656269|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
41938676|NCT02346240|75656270|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938677|NCT02346240|75656271|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938678|NCT02346240|75656272|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938679|NCT02346240|75656273|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938680|NCT02346240|75656274|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
41938681|NCT02392104|75656325|FG000|Overall Study|discontinuation of warfarin|3|||
41938682|NCT02392104|75656325|FG000|Overall Study|bleeding event|1|||
41938683|NCT02392104|75656325|FG000|Overall Study|transferred care to another doctor|2|||
41938684|NCT02392104|75656325|FG000|Overall Study|INR goal range changed|1|||
41938685|NCT02392104|75656325|FG000|Overall Study|admitted to skilled nursing facility|3|||
41938686|NCT02392104|75656325|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
41938687|NCT02391948|75656343|FG000|6-month Assessment|Death|0|||
41938688|NCT02391948|75656344|FG001|6-month Assessment|Death|0|||
41938689|NCT02391948|75656345|FG002|6-month Assessment|Death|0|||
41938690|NCT02391948|75656346|FG003|6-month Assessment|Death|0|||
41938691|NCT02391948|75656347|FG004|6-month Assessment|Death|1|||
41938692|NCT02391948|75656343|FG000|6-month Assessment|Withdrawal by Subject|0|||
41938693|NCT02391948|75656344|FG001|6-month Assessment|Withdrawal by Subject|0|||
41938694|NCT02391948|75656345|FG002|6-month Assessment|Withdrawal by Subject|1|||
41938695|NCT02391948|75656346|FG003|6-month Assessment|Withdrawal by Subject|2|||
41938696|NCT02391948|75656347|FG004|6-month Assessment|Withdrawal by Subject|0|||
41938697|NCT02391948|75656343|FG000|6-month Assessment|Lost to Follow-up|4|||
41938698|NCT02391948|75656344|FG001|6-month Assessment|Lost to Follow-up|5|||
41938699|NCT02391948|75656345|FG002|6-month Assessment|Lost to Follow-up|2|||
41938700|NCT02391948|75656346|FG003|6-month Assessment|Lost to Follow-up|3|||
41938701|NCT02391948|75656347|FG004|6-month Assessment|Lost to Follow-up|1|||
41938702|NCT02391948|75656343|FG000|6-month Assessment|Medical issue/illness|1|||
41938703|NCT02391948|75656344|FG001|6-month Assessment|Medical issue/illness|1|||
41938704|NCT02391948|75656345|FG002|6-month Assessment|Medical issue/illness|0|||
41938705|NCT02391948|75656346|FG003|6-month Assessment|Medical issue/illness|0|||
41938706|NCT02391948|75656347|FG004|6-month Assessment|Medical issue/illness|0|||
41938707|NCT02391948|75656343|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
41938708|NCT02391948|75656344|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
41938709|NCT02391948|75656345|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
41938710|NCT02391948|75656346|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
41938711|NCT02391948|75656347|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
41938712|NCT02391948|75656343|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
41938713|NCT02391948|75656344|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
41938714|NCT02391948|75656345|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
41938715|NCT02391948|75656346|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
41938716|NCT02391948|75656347|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
41938717|NCT02391948|75656343|FG000|12-month Assessment|Death|0|||
41938718|NCT02391948|75656344|FG001|12-month Assessment|Death|0|||
41938719|NCT02391948|75656345|FG002|12-month Assessment|Death|0|||
41938720|NCT02391948|75656346|FG003|12-month Assessment|Death|1|||
41938721|NCT02391948|75656347|FG004|12-month Assessment|Death|0|||
41938722|NCT02391948|75656343|FG000|12-month Assessment|Withdrawal by Subject|1|||
41938723|NCT02391948|75656344|FG001|12-month Assessment|Withdrawal by Subject|0|||
41938724|NCT02391948|75656345|FG002|12-month Assessment|Withdrawal by Subject|0|||
41938725|NCT02391948|75656346|FG003|12-month Assessment|Withdrawal by Subject|1|||
41938726|NCT02391948|75656347|FG004|12-month Assessment|Withdrawal by Subject|0|||
41938727|NCT02391948|75656343|FG000|12-month Assessment|Lost to Follow-up|5|||
41938728|NCT02391948|75656344|FG001|12-month Assessment|Lost to Follow-up|4|||
41938729|NCT02391948|75656345|FG002|12-month Assessment|Lost to Follow-up|4|||
41938730|NCT02391948|75656346|FG003|12-month Assessment|Lost to Follow-up|4|||
41938731|NCT02391948|75656347|FG004|12-month Assessment|Lost to Follow-up|5|||
41938732|NCT02391948|75656343|FG000|12-month Assessment|Medical issue/illness|0|||
41938733|NCT02391948|75656344|FG001|12-month Assessment|Medical issue/illness|1|||
41938734|NCT02391948|75656345|FG002|12-month Assessment|Medical issue/illness|0|||
41938735|NCT02391948|75656346|FG003|12-month Assessment|Medical issue/illness|1|||
41938736|NCT02391948|75656347|FG004|12-month Assessment|Medical issue/illness|0|||
41938737|NCT02391948|75656343|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
41938738|NCT02391948|75656344|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
41938739|NCT02391948|75656345|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
41938740|NCT02391948|75656346|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
41938741|NCT02391948|75656347|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
41938742|NCT02391948|75656343|FG000|18-month Assessment|Death|0|||
41938743|NCT02391948|75656344|FG001|18-month Assessment|Death|0|||
41938744|NCT02391948|75656345|FG002|18-month Assessment|Death|0|||
42022770|NCT01049217|75830053|FG000|Overall Study|Pregnancy|1|||
42022771|NCT01049217|75830054|FG001|Overall Study|Pregnancy|0|||
41938745|NCT02391948|75656346|FG003|18-month Assessment|Death|1|||
41938746|NCT02391948|75656347|FG004|18-month Assessment|Death|1|||
41938747|NCT02391948|75656343|FG000|18-month Assessment|Withdrawal by Subject|1|||
41938748|NCT02391948|75656344|FG001|18-month Assessment|Withdrawal by Subject|0|||
41938749|NCT02391948|75656345|FG002|18-month Assessment|Withdrawal by Subject|0|||
41938750|NCT02391948|75656346|FG003|18-month Assessment|Withdrawal by Subject|1|||
41938751|NCT02391948|75656347|FG004|18-month Assessment|Withdrawal by Subject|0|||
41938752|NCT02391948|75656343|FG000|18-month Assessment|Lost to Follow-up|2|||
42022772|NCT01049217|75830053|FG000|Overall Study|Study Terminated by Sponsor|43|||
42022773|NCT01049217|75830054|FG001|Overall Study|Study Terminated by Sponsor|43|||
41938753|NCT02391948|75656344|FG001|18-month Assessment|Lost to Follow-up|6|||
41938754|NCT02391948|75656345|FG002|18-month Assessment|Lost to Follow-up|2|||
41938755|NCT02391948|75656346|FG003|18-month Assessment|Lost to Follow-up|2|||
41938756|NCT02391948|75656347|FG004|18-month Assessment|Lost to Follow-up|3|||
41938757|NCT02391948|75656343|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
41938758|NCT02391948|75656344|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
41938759|NCT02391948|75656345|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
41938760|NCT02391948|75656346|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
41938761|NCT02391948|75656347|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
41938762|NCT02391948|75656343|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
41938763|NCT02391948|75656344|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
41938764|NCT02391948|75656345|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
41938765|NCT02391948|75656346|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
41938766|NCT02391948|75656347|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
41938767|NCT02391948|75656343|FG000|24-month Assessment|Death|0|||
41938768|NCT02391948|75656344|FG001|24-month Assessment|Death|0|||
41938769|NCT02391948|75656345|FG002|24-month Assessment|Death|0|||
41938770|NCT02391948|75656346|FG003|24-month Assessment|Death|0|||
41938771|NCT02391948|75656347|FG004|24-month Assessment|Death|1|||
41938772|NCT02391948|75656343|FG000|24-month Assessment|Withdrawal by Subject|1|||
41938773|NCT02391948|75656344|FG001|24-month Assessment|Withdrawal by Subject|1|||
41938774|NCT02391948|75656345|FG002|24-month Assessment|Withdrawal by Subject|0|||
41938775|NCT02391948|75656346|FG003|24-month Assessment|Withdrawal by Subject|0|||
41938776|NCT02391948|75656347|FG004|24-month Assessment|Withdrawal by Subject|1|||
41938777|NCT02391948|75656343|FG000|24-month Assessment|Lost to Follow-up|5|||
41938778|NCT02391948|75656344|FG001|24-month Assessment|Lost to Follow-up|4|||
41938779|NCT02391948|75656345|FG002|24-month Assessment|Lost to Follow-up|0|||
41938780|NCT02391948|75656346|FG003|24-month Assessment|Lost to Follow-up|0|||
41938781|NCT02391948|75656347|FG004|24-month Assessment|Lost to Follow-up|0|||
41938782|NCT02391948|75656343|FG000|24-month Assessment|Medical issue/illness|0|||
41938783|NCT02391948|75656344|FG001|24-month Assessment|Medical issue/illness|0|||
41938784|NCT02391948|75656345|FG002|24-month Assessment|Medical issue/illness|1|||
41938785|NCT02391948|75656346|FG003|24-month Assessment|Medical issue/illness|0|||
41938786|NCT02391948|75656347|FG004|24-month Assessment|Medical issue/illness|0|||
41938787|NCT02391948|75656343|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
41938788|NCT02391948|75656344|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
41938789|NCT02391948|75656345|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
41938790|NCT02391948|75656346|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
41938791|NCT02391948|75656347|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
41938792|NCT02369874|75656590|FG000|Overall Study|Lost to Follow-up|2|||
41938793|NCT02369874|75656591|FG001|Overall Study|Lost to Follow-up|2|||
41938794|NCT02369874|75656592|FG002|Overall Study|Lost to Follow-up|2|||
41938795|NCT02369874|75656590|FG000|Overall Study|Withdrawal by Subject|7|||
41938796|NCT02369874|75656591|FG001|Overall Study|Withdrawal by Subject|9|||
41938797|NCT02369874|75656592|FG002|Overall Study|Withdrawal by Subject|27|||
41938798|NCT02369874|75656590|FG000|Overall Study|Miscellaneous|1|||
41938799|NCT02369874|75656591|FG001|Overall Study|Miscellaneous|1|||
41938800|NCT02369874|75656592|FG002|Overall Study|Miscellaneous|0|||
41938801|NCT02369874|75656590|FG000|Overall Study|On Treatment/Off Study|34|||
41938802|NCT02369874|75656591|FG001|Overall Study|On Treatment/Off Study|45|||
41938803|NCT02369874|75656592|FG002|Overall Study|On Treatment/Off Study|32|||
41938804|NCT02368314|75656735|FG000|Overall Study|Withdrawal by Subject|2|||
41938805|NCT02368314|75656736|FG001|Overall Study|Withdrawal by Subject|1|||
41938806|NCT02368314|75656735|FG000|Overall Study|Adverse Event|1|||
41938807|NCT02368314|75656736|FG001|Overall Study|Adverse Event|2|||
41938808|NCT02366910|75656746|FG000|Overall Study|Withdrawal by Subject|2|||
41938809|NCT02366910|75656746|FG000|Overall Study|Screen Failure|3|||
41938810|NCT05608629|75656857|FG000|Overall Study|Lost to Follow-up|2|||
41938811|NCT05180500|75656863|FG000|Overall Study|Adverse Event|1|||
41938812|NCT05180500|75656864|FG001|Overall Study|Adverse Event|0|||
41938813|NCT05180500|75656863|FG000|Overall Study|Withdrawal by Subject|2|||
41938814|NCT05180500|75656864|FG001|Overall Study|Withdrawal by Subject|0|||
42022774|NCT01049217|75830053|FG000|Overall Study|Other|1|||
42022775|NCT01049217|75830054|FG001|Overall Study|Other|2|||
42022776|NCT01049217|75830053|FG000|Overall Study|Randomized but not Treated|0|||
42022777|NCT01049217|75830054|FG001|Overall Study|Randomized but not Treated|2|||
42022778|NCT01232738|75830060|FG000|Overall Study|Death|3|||
41938815|NCT05001945|75656878|FG000|Overall Study|Adverse Event|0|||
41938816|NCT05001945|75656879|FG001|Overall Study|Adverse Event|0|||
41938817|NCT05001945|75656880|FG002|Overall Study|Adverse Event|0|||
41938818|NCT05001945|75656881|FG003|Overall Study|Adverse Event|1|||
41938819|NCT05001945|75656882|FG004|Overall Study|Adverse Event|0|||
42022779|NCT01232738|75830060|FG000|Overall Study|Physician Decision|2|||
41938820|NCT05001945|75656883|FG005|Overall Study|Adverse Event|0|||
41938821|NCT05001945|75656884|FG006|Overall Study|Adverse Event|0|||
41938822|NCT05001945|75656885|FG007|Overall Study|Adverse Event|0|||
41938823|NCT05001945|75656878|FG000|Overall Study|Lost to Follow-up|0|||
41938824|NCT05001945|75656879|FG001|Overall Study|Lost to Follow-up|1|||
41938825|NCT05001945|75656880|FG002|Overall Study|Lost to Follow-up|1|||
41938826|NCT05001945|75656881|FG003|Overall Study|Lost to Follow-up|2|||
41938827|NCT05001945|75656882|FG004|Overall Study|Lost to Follow-up|0|||
41938828|NCT05001945|75656883|FG005|Overall Study|Lost to Follow-up|1|||
41938829|NCT05001945|75656884|FG006|Overall Study|Lost to Follow-up|0|||
41938830|NCT05001945|75656885|FG007|Overall Study|Lost to Follow-up|0|||
41938831|NCT05001945|75656878|FG000|Overall Study|Protocol Violation|1|||
41938832|NCT05001945|75656879|FG001|Overall Study|Protocol Violation|0|||
41938833|NCT05001945|75656880|FG002|Overall Study|Protocol Violation|1|||
41938834|NCT05001945|75656881|FG003|Overall Study|Protocol Violation|1|||
41938835|NCT05001945|75656882|FG004|Overall Study|Protocol Violation|0|||
41938836|NCT05001945|75656883|FG005|Overall Study|Protocol Violation|1|||
41938837|NCT05001945|75656884|FG006|Overall Study|Protocol Violation|0|||
41938838|NCT05001945|75656885|FG007|Overall Study|Protocol Violation|0|||
41938839|NCT05001945|75656878|FG000|Overall Study|Withdrawal by Subject|0|||
41938840|NCT05001945|75656879|FG001|Overall Study|Withdrawal by Subject|0|||
41938841|NCT05001945|75656880|FG002|Overall Study|Withdrawal by Subject|0|||
41938842|NCT05001945|75656881|FG003|Overall Study|Withdrawal by Subject|1|||
41938843|NCT05001945|75656882|FG004|Overall Study|Withdrawal by Subject|1|||
41938844|NCT05001945|75656883|FG005|Overall Study|Withdrawal by Subject|1|||
41938845|NCT05001945|75656884|FG006|Overall Study|Withdrawal by Subject|0|||
41938846|NCT05001945|75656885|FG007|Overall Study|Withdrawal by Subject|1|||
41938847|NCT05001945|75656878|FG000|Overall Study|Not specified by Investigator|0|||
41938848|NCT05001945|75656879|FG001|Overall Study|Not specified by Investigator|3|||
41938849|NCT05001945|75656880|FG002|Overall Study|Not specified by Investigator|0|||
41938850|NCT05001945|75656881|FG003|Overall Study|Not specified by Investigator|0|||
41938851|NCT05001945|75656882|FG004|Overall Study|Not specified by Investigator|1|||
41938852|NCT05001945|75656883|FG005|Overall Study|Not specified by Investigator|0|||
41938853|NCT05001945|75656884|FG006|Overall Study|Not specified by Investigator|0|||
41938854|NCT05001945|75656885|FG007|Overall Study|Not specified by Investigator|0|||
41938855|NCT04995419|75656904|FG000|Overall Study|Withdrawal by Subject|3|||
41938856|NCT04995419|75656904|FG000|Overall Study|Progressive Disease|19|||
41938857|NCT04995419|75656904|FG000|Overall Study|Adverse Event|2|||
41938858|NCT04995419|75656904|FG000|Overall Study|Ongoing|16|||
41938859|NCT04955639|75656910|FG000|Overall Study|Withdrawal by Subject|2|||
41938860|NCT04955639|75656911|FG001|Overall Study|Withdrawal by Subject|2|||
41938861|NCT04955639|75656910|FG000|Overall Study|Week 26 survey not completed|2|||
41938862|NCT04955639|75656911|FG001|Overall Study|Week 26 survey not completed|2|||
41938863|NCT04919564|75656919|FG000|Overall Study|Lost to Follow-up|1|||
41938864|NCT04919564|75656920|FG001|Overall Study|Lost to Follow-up|0|||
41938865|NCT04919564|75656919|FG000|Overall Study|Physician Decision|1|||
41938866|NCT04919564|75656920|FG001|Overall Study|Physician Decision|1|||
41938867|NCT04908800|75656939|FG000|Overall Study|Adverse Event|0|||
41938868|NCT04908800|75656940|FG001|Overall Study|Adverse Event|0|||
41938869|NCT04908800|75656941|FG002|Overall Study|Adverse Event|0|||
41938870|NCT04908800|75656942|FG003|Overall Study|Adverse Event|0|||
41938871|NCT04908800|75656943|FG004|Overall Study|Adverse Event|0|||
41938872|NCT04908800|75656944|FG005|Overall Study|Adverse Event|0|||
41938873|NCT04908800|75656945|FG006|Overall Study|Adverse Event|0|||
41938874|NCT04908800|75656946|FG007|Overall Study|Adverse Event|0|||
41938875|NCT04908800|75656947|FG008|Overall Study|Adverse Event|0|||
41938876|NCT04908800|75656948|FG009|Overall Study|Adverse Event|0|||
41938877|NCT04908800|75656949|FG010|Overall Study|Adverse Event|1|||
41938878|NCT04908800|75656950|FG011|Overall Study|Adverse Event|0|||
41938879|NCT04908800|75656951|FG012|Overall Study|Adverse Event|0|||
41938880|NCT04889040|75656999|FG000|Overall Study|Withdrawal by Subject|3|||
41938881|NCT04889040|75657000|FG001|Overall Study|Withdrawal by Subject|3|||
41938882|NCT04889040|75656999|FG000|Overall Study|Lost to Follow-up|0|||
41938883|NCT04889040|75657000|FG001|Overall Study|Lost to Follow-up|1|||
41938884|NCT04889040|75656999|FG000|Overall Study|Adverse Event|2|||
41938885|NCT04889040|75657000|FG001|Overall Study|Adverse Event|1|||
41938886|NCT04794803|75657009|FG000|Overall Study|Death|1|||
41938887|NCT04794803|75657010|FG001|Overall Study|Death|3|||
41938888|NCT04794803|75657009|FG000|Overall Study|Lost to Follow-up|2|||
41938889|NCT04794803|75657010|FG001|Overall Study|Lost to Follow-up|2|||
41938890|NCT04794803|75657009|FG000|Overall Study|Withdrawal by Subject|1|||
41938891|NCT04794803|75657010|FG001|Overall Study|Withdrawal by Subject|0|||
41938892|NCT04794803|75657009|FG000|Overall Study|Physician Decision|1|||
41938893|NCT04794803|75657010|FG001|Overall Study|Physician Decision|1|||
41938894|NCT04794803|75657009|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
41938895|NCT04794803|75657010|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
41938896|NCT04794803|75657009|FG000|Overall Study|Refused to continue the treatment|1|||
41938897|NCT04794803|75657010|FG001|Overall Study|Refused to continue the treatment|0|||
41938898|NCT04794803|75657009|FG000|Overall Study|Patient admitted to ICU|0|||
41938899|NCT04794803|75657010|FG001|Overall Study|Patient admitted to ICU|1|||
41938900|NCT04676152|75657029|FG000|Overall Study|screen fail|9|||
42010376|NCT00998881|75817500|FG000|Overall Study|Withdrawal by Subject|1|||
42010377|NCT00998881|75817501|FG001|Overall Study|Withdrawal by Subject|0|||
42010378|NCT00998881|75817500|FG000|Overall Study|Personal matter|1|||
42010379|NCT00998881|75817501|FG001|Overall Study|Personal matter|0|||
42010380|NCT01222767|75817507|FG000|Overall Study|Progressive disease|13|||
42010381|NCT01222767|75817507|FG000|Overall Study|Adverse Event|2|||
42010382|NCT01222767|75817507|FG000|Overall Study|Surgical resection|1|||
42010383|NCT01222767|75817507|FG000|Overall Study|Never treated|1|||
42010384|NCT00993967|75817511|FG000|Overall Study|Adverse Event|8|||
42010385|NCT00993967|75817511|FG000|Overall Study|Death|1|||
42010386|NCT00993967|75817511|FG000|Overall Study|Lost to Follow-up|14|||
42010387|NCT00993967|75817511|FG000|Overall Study|Withdrawal by Subject|36|||
42010388|NCT00993967|75817511|FG000|Overall Study|Protocol Violation|2|||
42010389|NCT01222533|75817515|FG000|Overall Study|Adverse Event|5|||
42010390|NCT01222533|75817515|FG000|Overall Study|Withdrawal by Subject|5|||
42010391|NCT01222533|75817515|FG000|Overall Study|Other|4|||
42010392|NCT01221753|75817527|FG000|Overall Study|Adverse Event|1|||
42010393|NCT01221597|75817533|FG000|Overall Study|Adverse Event|4|||
42010394|NCT01221597|75817534|FG001|Overall Study|Adverse Event|1|||
42010395|NCT01221597|75817533|FG000|Overall Study|Withdrawal by Subject|20|||
42010396|NCT01221597|75817534|FG001|Overall Study|Withdrawal by Subject|6|||
42010397|NCT01221597|75817533|FG000|Overall Study|Lost to Follow-up|6|||
42010398|NCT01221597|75817534|FG001|Overall Study|Lost to Follow-up|5|||
42010399|NCT01221597|75817533|FG000|Overall Study|Protocol Violation|1|||
42010400|NCT01221597|75817534|FG001|Overall Study|Protocol Violation|0|||
42010401|NCT01221597|75817533|FG000|Overall Study|Other|3|||
42010402|NCT01221597|75817534|FG001|Overall Study|Other|4|||
42010403|NCT01221597|75817533|FG000|Overall Study|Death|2|||
42010404|NCT01221597|75817534|FG001|Overall Study|Death|0|||
42010405|NCT01221363|75817543|FG000|Overall Study|Pregnancy|1|||
42010406|NCT01221363|75817544|FG001|Overall Study|Pregnancy|0|||
42010407|NCT01221363|75817543|FG000|Overall Study|Withdrawal by Subject|11|||
42010408|NCT01221363|75817544|FG001|Overall Study|Withdrawal by Subject|5|||
42010409|NCT01221285|75817550|FG000|Overall Study|Withdrawal by Subject|1|||
42010410|NCT01014988|75817560|FG000|Overall Study|Adverse Event|20|||
42010411|NCT01014988|75817561|FG001|Overall Study|Adverse Event|0|||
42010412|NCT01014988|75817562|FG002|Overall Study|Adverse Event|1|||
42010413|NCT01014988|75817563|FG003|Overall Study|Adverse Event|0|||
42010414|NCT01014988|75817564|FG004|Overall Study|Adverse Event|1|||
42010415|NCT01014988|75817565|FG005|Overall Study|Adverse Event|3|||
42010416|NCT01014988|75817560|FG000|Overall Study|Lost to Follow-up|1|||
42010417|NCT01014988|75817561|FG001|Overall Study|Lost to Follow-up|0|||
42010418|NCT01014988|75817562|FG002|Overall Study|Lost to Follow-up|1|||
42010419|NCT01014988|75817563|FG003|Overall Study|Lost to Follow-up|0|||
42010420|NCT01014988|75817564|FG004|Overall Study|Lost to Follow-up|0|||
42117988|NCT00689117|75928841|FG001|Overall Study|Lack of Efficacy|2|||
42010421|NCT01014988|75817565|FG005|Overall Study|Lost to Follow-up|0|||
42010422|NCT01014988|75817560|FG000|Overall Study|Physician Decision|1|||
42010423|NCT01014988|75817561|FG001|Overall Study|Physician Decision|0|||
42010424|NCT01014988|75817562|FG002|Overall Study|Physician Decision|0|||
42010425|NCT01014988|75817563|FG003|Overall Study|Physician Decision|0|||
42010426|NCT01014988|75817564|FG004|Overall Study|Physician Decision|0|||
42010427|NCT01014988|75817565|FG005|Overall Study|Physician Decision|0|||
42010428|NCT01014988|75817560|FG000|Overall Study|Withdrawal by Subject|1|||
42010429|NCT01014988|75817561|FG001|Overall Study|Withdrawal by Subject|0|||
42010430|NCT01014988|75817562|FG002|Overall Study|Withdrawal by Subject|0|||
42010431|NCT01014988|75817563|FG003|Overall Study|Withdrawal by Subject|0|||
42010432|NCT01014988|75817564|FG004|Overall Study|Withdrawal by Subject|0|||
42010433|NCT01014988|75817565|FG005|Overall Study|Withdrawal by Subject|0|||
42010434|NCT01014910|75817589|FG000|Overall Study|Withdrawal by Subject|0|||
41938901|NCT04618471|75657037|FG000|Overall Study|Screen Failure|62|||
41938902|NCT04618471|75657037|FG000|Overall Study|Withdrawal by Subject|6|||
41938903|NCT04618471|75657037|FG000|Overall Study|Physician Decision|2|||
41938904|NCT04618471|75657037|FG000|Overall Study|Lost to Follow-up|1|||
41938905|NCT04618471|75657037|FG000|Overall Study|Various other reasons|2|||
41938906|NCT04618471|75657037|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
41938907|NCT04546425|75657045|FG000|Overall Study|Protocol Violation|1|||
41938908|NCT04546425|75657046|FG001|Overall Study|Protocol Violation|1|||
41938909|NCT04546425|75657047|FG002|Overall Study|Protocol Violation|0|||
41938910|NCT04546425|75657048|FG003|Overall Study|Protocol Violation|0|||
41938911|NCT04546425|75657045|FG000|Overall Study|Adverse Event|3|||
41938912|NCT04546425|75657046|FG001|Overall Study|Adverse Event|0|||
41938913|NCT04546425|75657047|FG002|Overall Study|Adverse Event|0|||
41938914|NCT04546425|75657048|FG003|Overall Study|Adverse Event|0|||
41938915|NCT04546425|75657045|FG000|Overall Study|Lost to Follow-up|5|||
41938916|NCT04546425|75657046|FG001|Overall Study|Lost to Follow-up|4|||
41938917|NCT04546425|75657047|FG002|Overall Study|Lost to Follow-up|0|||
41938918|NCT04546425|75657048|FG003|Overall Study|Lost to Follow-up|0|||
41938919|NCT04546425|75657045|FG000|Overall Study|No Longer met eligibility criteria|3|||
41938920|NCT04546425|75657046|FG001|Overall Study|No Longer met eligibility criteria|3|||
41938921|NCT04546425|75657047|FG002|Overall Study|No Longer met eligibility criteria|1|||
41938922|NCT04546425|75657048|FG003|Overall Study|No Longer met eligibility criteria|1|||
41938923|NCT04546425|75657045|FG000|Overall Study|Withdrawal by parent/guardian|6|||
41938924|NCT04546425|75657046|FG001|Overall Study|Withdrawal by parent/guardian|5|||
41938925|NCT04546425|75657047|FG002|Overall Study|Withdrawal by parent/guardian|1|||
41938926|NCT04546425|75657048|FG003|Overall Study|Withdrawal by parent/guardian|1|||
41938927|NCT04537949|75657066|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
41938928|NCT04537949|75657067|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
41938929|NCT04537949|75657068|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
41938930|NCT04537949|75657069|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
41938931|NCT04537949|75657070|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
41938932|NCT04537949|75657071|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
41938933|NCT04537949|75657072|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
41938934|NCT04537949|75657073|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
41938935|NCT04537949|75657066|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
41938936|NCT04537949|75657067|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
41938937|NCT04537949|75657068|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
41938938|NCT04537949|75657069|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
41938939|NCT04537949|75657070|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
41938940|NCT04537949|75657071|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
41938941|NCT04537949|75657072|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
41938942|NCT04537949|75657073|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
41938943|NCT04537949|75657066|FG000|Follow-up Phase|Lost to Follow-up|0|||
41938944|NCT04537949|75657067|FG001|Follow-up Phase|Lost to Follow-up|3|||
41938945|NCT04537949|75657068|FG002|Follow-up Phase|Lost to Follow-up|0|||
41938946|NCT04537949|75657069|FG003|Follow-up Phase|Lost to Follow-up|0|||
41938947|NCT04537949|75657070|FG004|Follow-up Phase|Lost to Follow-up|0|||
41938948|NCT04537949|75657071|FG005|Follow-up Phase|Lost to Follow-up|0|||
41938949|NCT04537949|75657072|FG006|Follow-up Phase|Lost to Follow-up|0|||
41938950|NCT04537949|75657073|FG007|Follow-up Phase|Lost to Follow-up|0|||
41938951|NCT04537949|75657066|FG000|Follow-up Phase|personal reasons|0|||
41938952|NCT04537949|75657067|FG001|Follow-up Phase|personal reasons|0|||
41938953|NCT04537949|75657068|FG002|Follow-up Phase|personal reasons|0|||
41938954|NCT04537949|75657069|FG003|Follow-up Phase|personal reasons|1|||
41938955|NCT04537949|75657070|FG004|Follow-up Phase|personal reasons|1|||
41938956|NCT04537949|75657071|FG005|Follow-up Phase|personal reasons|0|||
41938957|NCT04537949|75657072|FG006|Follow-up Phase|personal reasons|0|||
41938958|NCT04537949|75657073|FG007|Follow-up Phase|personal reasons|0|||
41938959|NCT04537949|75657066|FG000|Follow-up Phase|Withdrawal by Subject|0|||
41938960|NCT04537949|75657067|FG001|Follow-up Phase|Withdrawal by Subject|0|||
41938961|NCT04537949|75657068|FG002|Follow-up Phase|Withdrawal by Subject|0|||
41938962|NCT04537949|75657069|FG003|Follow-up Phase|Withdrawal by Subject|0|||
41938963|NCT04537949|75657070|FG004|Follow-up Phase|Withdrawal by Subject|1|||
41938964|NCT04537949|75657071|FG005|Follow-up Phase|Withdrawal by Subject|0|||
41938965|NCT04537949|75657072|FG006|Follow-up Phase|Withdrawal by Subject|0|||
41938966|NCT04537949|75657073|FG007|Follow-up Phase|Withdrawal by Subject|0|||
41938967|NCT04439201|75657091|FG000|Overall Study|Ineligible|2|||
41938968|NCT04439201|75657091|FG000|Overall Study|Never start protocol therapy|1|||
41938969|NCT04439201|75657091|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
41938970|NCT04439201|75657091|FG000|Overall Study|Mutation status not confirmed|4|||
41938971|NCT04439201|75657091|FG000|Overall Study|Adverse Event|1|||
41938972|NCT04439201|75657091|FG000|Overall Study|Death|7|||
41938973|NCT04439201|75657091|FG000|Overall Study|Withdrawal by Subject|2|||
41938974|NCT04439201|75657091|FG000|Overall Study|Disease progression|20|||
41938975|NCT04439201|75657091|FG000|Overall Study|Alternative therapy|1|||
41938976|NCT04439201|75657091|FG000|Overall Study|Physician Decision|1|||
41938977|NCT04425902|75657095|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
41938978|NCT04421586|75657108|FG000|Overall Study|Death|0|||
41938979|NCT04421586|75657109|FG001|Overall Study|Death|1|||
41938980|NCT04421586|75657108|FG000|Overall Study|Lost to Follow-up|2|||
41938981|NCT04421586|75657109|FG001|Overall Study|Lost to Follow-up|2|||
41938982|NCT04421586|75657108|FG000|Overall Study|Withdrawn by PI|1|||
41938983|NCT04421586|75657109|FG001|Overall Study|Withdrawn by PI|0|||
41938984|NCT04421586|75657108|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
41938985|NCT04421586|75657109|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
41938986|NCT04407234|75657117|FG000|Overall Study|Adverse Event|3|||
41938987|NCT04407234|75657118|FG001|Overall Study|Adverse Event|3|||
41938988|NCT04337931|75657137|FG000|Overall Study|Death|4|||
41938989|NCT04337931|75657138|FG001|Overall Study|Death|1|||
41938990|NCT04337931|75657139|FG002|Overall Study|Death|7|||
41938991|NCT04337931|75657137|FG000|Overall Study|Withdrawal by Subject|0|||
41938992|NCT04337931|75657138|FG001|Overall Study|Withdrawal by Subject|1|||
41938993|NCT04337931|75657139|FG002|Overall Study|Withdrawal by Subject|0|||
41938994|NCT04337931|75657137|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
41938995|NCT04337931|75657138|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
41938996|NCT04337931|75657139|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
41938997|NCT04337931|75657137|FG000|Overall Study|Study terminated by sponsor|3|||
41938998|NCT04337931|75657138|FG001|Overall Study|Study terminated by sponsor|6|||
41938999|NCT04337931|75657139|FG002|Overall Study|Study terminated by sponsor|2|||
41939000|NCT04337931|75657137|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
41939001|NCT04337931|75657138|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
41939002|NCT04337931|75657139|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
41939003|NCT04337931|75657137|FG000|Overall Study|Colorectal cancer treatment|1|||
41939004|NCT04337931|75657138|FG001|Overall Study|Colorectal cancer treatment|0|||
41939005|NCT04337931|75657139|FG002|Overall Study|Colorectal cancer treatment|0|||
41939006|NCT04337931|75657137|FG000|Overall Study|Participant decision|0|||
41939007|NCT04337931|75657138|FG001|Overall Study|Participant decision|1|||
41939008|NCT04337931|75657139|FG002|Overall Study|Participant decision|0|||
41939009|NCT04270747|75657150|FG000|Through Week 16|Adverse Event|1|||
41939010|NCT04270747|75657151|FG001|Through Week 16|Adverse Event|2|||
41939011|NCT04270747|75657152|FG002|Through Week 16|Adverse Event|0|||
41939012|NCT04270747|75657150|FG000|Through Week 16|Death|0|||
41939013|NCT04270747|75657151|FG001|Through Week 16|Death|2|||
41939014|NCT04270747|75657152|FG002|Through Week 16|Death|0|||
41939015|NCT04270747|75657150|FG000|Through Week 16|Consent Withdrawn|3|||
41939016|NCT04270747|75657151|FG001|Through Week 16|Consent Withdrawn|3|||
41939017|NCT04270747|75657152|FG002|Through Week 16|Consent Withdrawn|0|||
41939018|NCT04270747|75657150|FG000|Through Week 16|Physician Decision|1|||
41939019|NCT04270747|75657151|FG001|Through Week 16|Physician Decision|1|||
41939020|NCT04270747|75657152|FG002|Through Week 16|Physician Decision|0|||
41939021|NCT04270747|75657150|FG000|Through Week 16|Lost to Follow-up|2|||
41939022|NCT04270747|75657151|FG001|Through Week 16|Lost to Follow-up|0|||
41939023|NCT04270747|75657152|FG002|Through Week 16|Lost to Follow-up|0|||
41939024|NCT04270747|75657150|FG000|Through Week 16|Protocol Violation|1|||
41939025|NCT04270747|75657151|FG001|Through Week 16|Protocol Violation|2|||
41939026|NCT04270747|75657152|FG002|Through Week 16|Protocol Violation|0|||
41939027|NCT04270747|75657150|FG000|Through Week 16|Protocol Specified Criteria|6|||
41939028|NCT04270747|75657151|FG001|Through Week 16|Protocol Specified Criteria|7|||
41939029|NCT04270747|75657152|FG002|Through Week 16|Protocol Specified Criteria|0|||
41939030|NCT04270747|75657150|FG000|Through Week 16|Miscellaneous|1|||
41939031|NCT04270747|75657151|FG001|Through Week 16|Miscellaneous|1|||
41939032|NCT04270747|75657152|FG002|Through Week 16|Miscellaneous|0|||
41939033|NCT04270747|75657150|FG000|Post Week 16|Adverse Event|7|||
41939034|NCT04270747|75657151|FG001|Post Week 16|Adverse Event|5|||
41939035|NCT04270747|75657152|FG002|Post Week 16|Adverse Event|1|||
41939036|NCT04270747|75657150|FG000|Post Week 16|Death|2|||
41939037|NCT04270747|75657151|FG001|Post Week 16|Death|0|||
41939038|NCT04270747|75657152|FG002|Post Week 16|Death|2|||
41939039|NCT04270747|75657150|FG000|Post Week 16|Consent Withdrawn|4|||
41939040|NCT04270747|75657151|FG001|Post Week 16|Consent Withdrawn|3|||
41939041|NCT04270747|75657152|FG002|Post Week 16|Consent Withdrawn|6|||
41939042|NCT04270747|75657150|FG000|Post Week 16|Physician Decision|3|||
41939043|NCT04270747|75657151|FG001|Post Week 16|Physician Decision|1|||
41939044|NCT04270747|75657152|FG002|Post Week 16|Physician Decision|1|||
41939045|NCT04270747|75657150|FG000|Post Week 16|Lost to Follow-up|2|||
41939046|NCT04270747|75657151|FG001|Post Week 16|Lost to Follow-up|1|||
42022780|NCT01232738|75830060|FG000|Overall Study|Lost to Follow-up|1|||
42022781|NCT01232738|75830060|FG000|Overall Study|Withdrawal by Subject|2|||
41939047|NCT04270747|75657152|FG002|Post Week 16|Lost to Follow-up|0|||
41939048|NCT04270747|75657150|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
41939049|NCT04270747|75657151|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
41939050|NCT04270747|75657152|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
41939051|NCT04270747|75657150|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
41939052|NCT04270747|75657151|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
41939053|NCT04270747|75657152|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
41939054|NCT04270747|75657150|FG000|Post Week 16|Miscellaneous|1|||
41939055|NCT04270747|75657151|FG001|Post Week 16|Miscellaneous|0|||
41939056|NCT04270747|75657152|FG002|Post Week 16|Miscellaneous|1|||
41939057|NCT04238728|75657183|FG000|Overall Study|Withdrawal by Subject|1|||
41939058|NCT04238728|75657183|FG000|Overall Study|Lost to Follow-up|2|||
41939059|NCT04106557|75657199|FG000|Overall Study|Physician Decision|0|||
41939060|NCT04106557|75657200|FG001|Overall Study|Physician Decision|1|||
41939061|NCT04106557|75657201|FG002|Overall Study|Physician Decision|0|||
41939062|NCT04106557|75657199|FG000|Overall Study|Protocol Violation|0|||
41939063|NCT04106557|75657200|FG001|Overall Study|Protocol Violation|1|||
41939064|NCT04106557|75657201|FG002|Overall Study|Protocol Violation|0|||
41939065|NCT04085614|75657210|FG000|Overall Study|Protocol Violation|9|||
41939066|NCT04085614|75657211|FG001|Overall Study|Protocol Violation|6|||
41939067|NCT04056455|75657219|FG000|Overall Study|Adverse Event|1|||
41939068|NCT04056455|75657220|FG001|Overall Study|Adverse Event|0|||
41939069|NCT03980184|75657228|FG000|Overall Study|Dropped out before treatment|2|||
41939070|NCT03980184|75657229|FG001|Overall Study|Dropped out before treatment|2|||
41939071|NCT03980184|75657228|FG000|Overall Study|Lost to Follow-up|11|||
41939072|NCT03980184|75657229|FG001|Overall Study|Lost to Follow-up|13|||
41939073|NCT03917459|75657237|FG000|Overall Study|Adverse Event|1|||
41939074|NCT03917459|75657238|FG001|Overall Study|Adverse Event|0|||
41939075|NCT03917459|75657237|FG000|Overall Study|Withdrawal by Subject|0|||
41939076|NCT03917459|75657238|FG001|Overall Study|Withdrawal by Subject|1|||
41939077|NCT03904693|75657248|FG000|Overall Study|Death|0|||
41939078|NCT03904693|75657249|FG001|Overall Study|Death|0|||
41939079|NCT03904693|75657250|FG002|Overall Study|Death|3|||
41939080|NCT03904693|75657248|FG000|Overall Study|Physician Decision|0|||
41939081|NCT03904693|75657249|FG001|Overall Study|Physician Decision|0|||
41939082|NCT03904693|75657250|FG002|Overall Study|Physician Decision|2|||
41939083|NCT03904693|75657248|FG000|Overall Study|Withdrawal by Subject|0|||
41939084|NCT03904693|75657249|FG001|Overall Study|Withdrawal by Subject|1|||
41939085|NCT03904693|75657250|FG002|Overall Study|Withdrawal by Subject|4|||
41939086|NCT03807778|75657264|FG000|Overall Study|Adverse Event|0|||
41939087|NCT03807778|75657265|FG001|Overall Study|Adverse Event|0|||
41939088|NCT03807778|75657266|FG002|Overall Study|Adverse Event|3|||
41939089|NCT03807778|75657267|FG003|Overall Study|Adverse Event|5|||
41939090|NCT03807778|75657264|FG000|Overall Study|Progressive Disease|4|||
41939091|NCT03807778|75657265|FG001|Overall Study|Progressive Disease|2|||
41939092|NCT03807778|75657266|FG002|Overall Study|Progressive Disease|8|||
41939093|NCT03807778|75657267|FG003|Overall Study|Progressive Disease|15|||
41939094|NCT03807778|75657264|FG000|Overall Study|Symptomatic Deterioration|0|||
41939095|NCT03807778|75657265|FG001|Overall Study|Symptomatic Deterioration|1|||
41939096|NCT03807778|75657266|FG002|Overall Study|Symptomatic Deterioration|0|||
41939097|NCT03807778|75657267|FG003|Overall Study|Symptomatic Deterioration|1|||
41939098|NCT03807778|75657264|FG000|Overall Study|Withdrawal by Subject|0|||
41939099|NCT03807778|75657265|FG001|Overall Study|Withdrawal by Subject|1|||
41939100|NCT03807778|75657266|FG002|Overall Study|Withdrawal by Subject|0|||
41939101|NCT03807778|75657267|FG003|Overall Study|Withdrawal by Subject|1|||
41939102|NCT03807778|75657264|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
41939103|NCT03807778|75657265|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
41939104|NCT03807778|75657266|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
41939105|NCT03807778|75657267|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
41939106|NCT03747939|75657282|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
41939107|NCT03747939|75657283|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
41939108|NCT03747939|75657284|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
41939109|NCT03747939|75657285|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
41939110|NCT03747939|75657282|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
41939111|NCT03747939|75657283|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
41939112|NCT03747939|75657284|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
41939113|NCT03747939|75657285|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
41939114|NCT03747939|75657282|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
41939115|NCT03747939|75657283|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
41939116|NCT03747939|75657284|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
41939117|NCT03747939|75657285|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
41939118|NCT03747939|75657282|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
42210268|NCT03276975|76025021|FG000|Overall Study|Withdrawal by Subject|1|||
41939119|NCT03747939|75657283|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
41939120|NCT03747939|75657284|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
41939121|NCT03747939|75657285|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
41939122|NCT03747939|75657282|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
41939123|NCT03747939|75657283|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
41939124|NCT03747939|75657284|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
41939125|NCT03747939|75657285|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
41939126|NCT03747939|75657282|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
41939127|NCT03747939|75657283|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
41939128|NCT03747939|75657284|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
41939129|NCT03747939|75657285|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
41939130|NCT03747939|75657282|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
41939131|NCT03747939|75657283|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
41939132|NCT03747939|75657284|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
41939133|NCT03747939|75657285|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
41939134|NCT03747939|75657282|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
41939135|NCT03747939|75657283|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
41939136|NCT03747939|75657284|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
41939137|NCT03747939|75657285|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
41939138|NCT03747939|75657282|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
41939139|NCT03747939|75657283|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
41939140|NCT03747939|75657284|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
41939141|NCT03747939|75657285|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
41939142|NCT03747939|75657282|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
41939143|NCT03747939|75657283|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
41939144|NCT03747939|75657284|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
41939145|NCT03747939|75657285|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
41939146|NCT03747939|75657282|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
41939147|NCT03747939|75657283|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
41939148|NCT03747939|75657284|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
41939149|NCT03747939|75657285|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
41939150|NCT03747939|75657282|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
41939151|NCT03747939|75657283|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
41939152|NCT03747939|75657284|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
41939153|NCT03747939|75657285|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
41939154|NCT03747939|75657282|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
41939155|NCT03747939|75657283|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
41939156|NCT03747939|75657284|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
41939157|NCT03747939|75657285|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
41939158|NCT03747939|75657282|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
41939159|NCT03747939|75657283|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
41939160|NCT03747939|75657284|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
41939161|NCT03747939|75657285|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
41939162|NCT03688620|75657304|FG000|Overall Study|Other|0|||
41939163|NCT03688620|75657305|FG001|Overall Study|Other|0|||
41939164|NCT03688620|75657306|FG002|Overall Study|Other|1|||
41939165|NCT03688620|75657304|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
41939166|NCT03688620|75657305|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
41939167|NCT03688620|75657306|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
41939168|NCT03688620|75657304|FG000|Overall Study|Lost to Follow-up|16|||
41939169|NCT03688620|75657305|FG001|Overall Study|Lost to Follow-up|0|||
41939170|NCT03688620|75657306|FG002|Overall Study|Lost to Follow-up|1|||
41939171|NCT03688620|75657304|FG000|Overall Study|Withdrawal by Subject|0|||
41939172|NCT03688620|75657305|FG001|Overall Study|Withdrawal by Subject|0|||
41939173|NCT03688620|75657306|FG002|Overall Study|Withdrawal by Subject|6|||
41939174|NCT03683173|75657318|FG000|Completed Follow-up|Unavailable|235|||
41939175|NCT03683173|75657319|FG001|Completed Follow-up|Unavailable|217|||
41939176|NCT03683173|75657318|FG000|Completed Follow-up|Refused|69|||
41939177|NCT03683173|75657319|FG001|Completed Follow-up|Refused|59|||
41939178|NCT03683173|75657318|FG000|Completed Follow-up|Disconnected phone|65|||
41939179|NCT03683173|75657319|FG001|Completed Follow-up|Disconnected phone|95|||
41939180|NCT03683173|75657318|FG000|Completed Follow-up|Health issue/deceased|10|||
41939181|NCT03683173|75657319|FG001|Completed Follow-up|Health issue/deceased|4|||
41939182|NCT03683173|75657318|FG000|Completed Follow-up|Moved away|8|||
41939183|NCT03683173|75657319|FG001|Completed Follow-up|Moved away|1|||
41939184|NCT03652961|75657338|FG000|Overall Study|Lost to Follow-up|3|||
41939185|NCT03652961|75657338|FG000|Overall Study|Screen Failure|1|||
41939186|NCT03492177|75657381|FG000|Overall Study|Adverse Event|1|||
41939187|NCT03492177|75657382|FG001|Overall Study|Adverse Event|0|||
41939188|NCT03492177|75657383|FG002|Overall Study|Adverse Event|0|||
41939189|NCT03492177|75657381|FG000|Overall Study|Death|3|||
41939190|NCT03492177|75657382|FG001|Overall Study|Death|0|||
41939191|NCT03492177|75657383|FG002|Overall Study|Death|3|||
41939192|NCT03492177|75657381|FG000|Overall Study|Lack of Efficacy|1|||
41939193|NCT03492177|75657382|FG001|Overall Study|Lack of Efficacy|2|||
41939194|NCT03492177|75657383|FG002|Overall Study|Lack of Efficacy|0|||
41939195|NCT03492177|75657381|FG000|Overall Study|Other|1|||
41939196|NCT03492177|75657382|FG001|Overall Study|Other|0|||
41939197|NCT03492177|75657383|FG002|Overall Study|Other|0|||
41939198|NCT03492177|75657381|FG000|Overall Study|Ongoing|16|||
41939199|NCT03492177|75657382|FG001|Overall Study|Ongoing|19|||
41939200|NCT03492177|75657383|FG002|Overall Study|Ongoing|17|||
41939201|NCT03484403|75657393|FG000|Overall Study|Withdrawal by Subject|6|||
41939202|NCT03484403|75657394|FG001|Overall Study|Withdrawal by Subject|4|||
41939203|NCT03462719|75657402|FG000|Overall Study|Withdrawal by Subject|4|||
41939204|NCT03462719|75657403|FG001|Overall Study|Withdrawal by Subject|3|||
41939205|NCT03462719|75657402|FG000|Overall Study|Ongoing|87|||
41939206|NCT03462719|75657403|FG001|Overall Study|Ongoing|72|||
41939207|NCT03431350|75657421|FG000|Overall Study|ONGOING|0|||
41939208|NCT03431350|75657422|FG001|Overall Study|ONGOING|0|||
41939209|NCT03431350|75657423|FG002|Overall Study|ONGOING|2|||
41939210|NCT03431350|75657424|FG003|Overall Study|ONGOING|0|||
41939211|NCT03431350|75657425|FG004|Overall Study|ONGOING|1|||
41939212|NCT03431350|75657426|FG005|Overall Study|ONGOING|3|||
41939213|NCT03431350|75657427|FG006|Overall Study|ONGOING|0|||
41939214|NCT03431350|75657428|FG007|Overall Study|ONGOING|1|||
41939215|NCT03431350|75657429|FG008|Overall Study|ONGOING|3|||
41939216|NCT03431350|75657430|FG009|Overall Study|ONGOING|4|||
41939217|NCT03431350|75657431|FG010|Overall Study|ONGOING|2|||
41939218|NCT03431350|75657432|FG011|Overall Study|ONGOING|1|||
41939219|NCT03431350|75657421|FG000|Overall Study|Death|6|||
41939220|NCT03431350|75657422|FG001|Overall Study|Death|5|||
41939221|NCT03431350|75657423|FG002|Overall Study|Death|18|||
41939222|NCT03431350|75657424|FG003|Overall Study|Death|7|||
41939223|NCT03431350|75657425|FG004|Overall Study|Death|4|||
41939224|NCT03431350|75657426|FG005|Overall Study|Death|3|||
41939225|NCT03431350|75657427|FG006|Overall Study|Death|2|||
41939226|NCT03431350|75657428|FG007|Overall Study|Death|0|||
41939227|NCT03431350|75657429|FG008|Overall Study|Death|0|||
41939228|NCT03431350|75657430|FG009|Overall Study|Death|0|||
41939229|NCT03431350|75657431|FG010|Overall Study|Death|4|||
41939230|NCT03431350|75657432|FG011|Overall Study|Death|0|||
42022782|NCT01232738|75830060|FG000|Overall Study|Adverse Event|5|||
42022783|NCT00957268|75830073|FG000|Overall Study|Voluntary Withdrawal|0|||
42300187|NCT02327169|76135327|FG005|Overall Study|Withdrawal by Subject|0|||
42300188|NCT02327169|76135328|FG006|Overall Study|Withdrawal by Subject|0|||
42300189|NCT02327169|76135329|FG007|Overall Study|Withdrawal by Subject|1|||
42300190|NCT02327169|76135330|FG008|Overall Study|Withdrawal by Subject|0|||
42300191|NCT02327169|76135331|FG009|Overall Study|Withdrawal by Subject|0|||
42300192|NCT02327169|76135332|FG010|Overall Study|Withdrawal by Subject|0|||
42300193|NCT02327169|76135333|FG011|Overall Study|Withdrawal by Subject|0|||
42300194|NCT02327169|76135334|FG012|Overall Study|Withdrawal by Subject|0|||
42300195|NCT02327169|76135335|FG013|Overall Study|Withdrawal by Subject|0|||
42300196|NCT02327169|76135336|FG014|Overall Study|Withdrawal by Subject|3|||
42300197|NCT02327169|76135322|FG000|Overall Study|Lost to Follow-up|0|||
42300198|NCT02327169|76135323|FG001|Overall Study|Lost to Follow-up|0|||
42300199|NCT02327169|76135324|FG002|Overall Study|Lost to Follow-up|0|||
42300200|NCT02327169|76135325|FG003|Overall Study|Lost to Follow-up|0|||
42300201|NCT02327169|76135326|FG004|Overall Study|Lost to Follow-up|1|||
41939231|NCT03431350|75657421|FG000|Overall Study|Lost to Follow-up|0|||
42117989|NCT00689117|75928842|FG002|Overall Study|Lack of Efficacy|2|||
42300202|NCT02327169|76135327|FG005|Overall Study|Lost to Follow-up|0|||
41939232|NCT03431350|75657422|FG001|Overall Study|Lost to Follow-up|1|||
41939233|NCT03431350|75657423|FG002|Overall Study|Lost to Follow-up|0|||
41939234|NCT03431350|75657424|FG003|Overall Study|Lost to Follow-up|0|||
41939235|NCT03431350|75657425|FG004|Overall Study|Lost to Follow-up|0|||
41939236|NCT03431350|75657426|FG005|Overall Study|Lost to Follow-up|0|||
41939237|NCT03431350|75657427|FG006|Overall Study|Lost to Follow-up|0|||
41939238|NCT03431350|75657428|FG007|Overall Study|Lost to Follow-up|0|||
41939239|NCT03431350|75657429|FG008|Overall Study|Lost to Follow-up|0|||
41939240|NCT03431350|75657430|FG009|Overall Study|Lost to Follow-up|0|||
42300203|NCT02327169|76135328|FG006|Overall Study|Lost to Follow-up|0|||
41939241|NCT03431350|75657431|FG010|Overall Study|Lost to Follow-up|0|||
41939242|NCT03431350|75657432|FG011|Overall Study|Lost to Follow-up|0|||
41939243|NCT03431350|75657421|FG000|Overall Study|Withdrawal by Subject|0|||
41939244|NCT03431350|75657422|FG001|Overall Study|Withdrawal by Subject|0|||
41939245|NCT03431350|75657423|FG002|Overall Study|Withdrawal by Subject|0|||
41939246|NCT03431350|75657424|FG003|Overall Study|Withdrawal by Subject|1|||
41939247|NCT03431350|75657425|FG004|Overall Study|Withdrawal by Subject|1|||
41939248|NCT03431350|75657426|FG005|Overall Study|Withdrawal by Subject|1|||
41939249|NCT03431350|75657427|FG006|Overall Study|Withdrawal by Subject|0|||
41939250|NCT03431350|75657428|FG007|Overall Study|Withdrawal by Subject|0|||
41939251|NCT03431350|75657429|FG008|Overall Study|Withdrawal by Subject|0|||
41939252|NCT03431350|75657430|FG009|Overall Study|Withdrawal by Subject|2|||
41939253|NCT03431350|75657431|FG010|Overall Study|Withdrawal by Subject|0|||
41939254|NCT03431350|75657432|FG011|Overall Study|Withdrawal by Subject|1|||
41939255|NCT03431350|75657421|FG000|Overall Study|Other|0|||
41939256|NCT03431350|75657422|FG001|Overall Study|Other|0|||
41939257|NCT03431350|75657423|FG002|Overall Study|Other|1|||
41939258|NCT03431350|75657424|FG003|Overall Study|Other|3|||
41939259|NCT03431350|75657425|FG004|Overall Study|Other|2|||
41939260|NCT03431350|75657426|FG005|Overall Study|Other|2|||
41939261|NCT03431350|75657427|FG006|Overall Study|Other|4|||
41939262|NCT03431350|75657428|FG007|Overall Study|Other|0|||
41939263|NCT03431350|75657429|FG008|Overall Study|Other|14|||
41939264|NCT03431350|75657430|FG009|Overall Study|Other|11|||
41939265|NCT03431350|75657431|FG010|Overall Study|Other|11|||
41939266|NCT03431350|75657432|FG011|Overall Study|Other|15|||
41939267|NCT03299049|75657468|FG000|Overall Study|On-going|486|||
41939268|NCT03299049|75657469|FG001|Overall Study|On-going|481|||
41939269|NCT03299049|75657468|FG000|Overall Study|Withdrawal by Subject|6|||
41939270|NCT03299049|75657469|FG001|Overall Study|Withdrawal by Subject|21|||
41939271|NCT03299049|75657468|FG000|Overall Study|Physician Decision|5|||
41939272|NCT03299049|75657469|FG001|Overall Study|Physician Decision|1|||
41939273|NCT03299049|75657468|FG000|Overall Study|Lost to Follow-up|2|||
41939274|NCT03299049|75657469|FG001|Overall Study|Lost to Follow-up|0|||
41939275|NCT03299049|75657468|FG000|Overall Study|Pregnancy|1|||
41939276|NCT03299049|75657469|FG001|Overall Study|Pregnancy|3|||
41939277|NCT03299049|75657468|FG000|Overall Study|Protocol Violation|1|||
41939278|NCT03299049|75657469|FG001|Overall Study|Protocol Violation|1|||
41939279|NCT03299049|75657468|FG000|Overall Study|Lack of Efficacy|9|||
41939280|NCT03299049|75657469|FG001|Overall Study|Lack of Efficacy|3|||
41939281|NCT03299049|75657468|FG000|Overall Study|Adverse Event|12|||
41939282|NCT03299049|75657469|FG001|Overall Study|Adverse Event|13|||
41939283|NCT03298022|75657482|FG000|Overall Study|Lack of Efficacy|4|||
41939284|NCT03298022|75657482|FG000|Overall Study|Withdrawal by Subject|7|||
41939285|NCT03298022|75657482|FG000|Overall Study|Adverse Event|1|||
41939286|NCT03298022|75657482|FG000|Overall Study|disease relapse|1|||
41939287|NCT03277105|75657494|FG000|Overall Study|Death|129|||
41939288|NCT03277105|75657495|FG001|Overall Study|Death|124|||
41939289|NCT03277105|75657494|FG000|Overall Study|Lost to Follow-up|2|||
41939290|NCT03277105|75657495|FG001|Overall Study|Lost to Follow-up|4|||
41939291|NCT03277105|75657494|FG000|Overall Study|Withdrawal by Subject|10|||
41939292|NCT03277105|75657495|FG001|Overall Study|Withdrawal by Subject|10|||
41939293|NCT03277105|75657494|FG000|Overall Study|Other|118|||
41939294|NCT03277105|75657495|FG001|Overall Study|Other|125|||
41939295|NCT03247413|75657501|FG000|Overall Study|Lost to Follow-up|28|||
41939296|NCT03206203|75657509|FG000|Treatment|Death|38|||
41939297|NCT03206203|75657510|FG001|Treatment|Death|26|||
41939298|NCT03206203|75657511|FG002|Treatment|Death|0|||
41939299|NCT03206203|75657509|FG000|Treatment|Withdrawal by Subject|1|||
41939300|NCT03206203|75657510|FG001|Treatment|Withdrawal by Subject|0|||
41939301|NCT03206203|75657511|FG002|Treatment|Withdrawal by Subject|0|||
41939302|NCT03206203|75657509|FG000|Treatment|Lost to Follow-up|4|||
41939303|NCT03206203|75657510|FG001|Treatment|Lost to Follow-up|0|||
42117990|NCT00689117|75928843|FG003|Overall Study|Lack of Efficacy|2|||
41939304|NCT03206203|75657511|FG002|Treatment|Lost to Follow-up|0|||
41939305|NCT03206203|75657509|FG000|Treatment|N/A in Follow-Up|8|||
41939306|NCT03206203|75657510|FG001|Treatment|N/A in Follow-Up|1|||
41939307|NCT03206203|75657511|FG002|Treatment|N/A in Follow-Up|0|||
41939308|NCT03206203|75657509|FG000|Treatment|Disease progression|0|||
41939309|NCT03206203|75657510|FG001|Treatment|Disease progression|1|||
41939310|NCT03206203|75657511|FG002|Treatment|Disease progression|0|||
41939311|NCT03206203|75657509|FG000|Treatment|Refused follow-up|0|||
41939312|NCT03206203|75657510|FG001|Treatment|Refused follow-up|1|||
41939313|NCT03206203|75657511|FG002|Treatment|Refused follow-up|0|||
41939314|NCT03206203|75657509|FG000|Treatment|Cross over to Arm 1|0|||
41939315|NCT03206203|75657510|FG001|Treatment|Cross over to Arm 1|19|||
41939316|NCT03206203|75657511|FG002|Treatment|Cross over to Arm 1|0|||
41939317|NCT03206203|75657509|FG000|Optional Cross-Over|Death|0|||
41939318|NCT03206203|75657510|FG001|Optional Cross-Over|Death|0|||
41939319|NCT03206203|75657511|FG002|Optional Cross-Over|Death|14|||
41939320|NCT03206203|75657509|FG000|Optional Cross-Over|Refused follow-up|0|||
41939321|NCT03206203|75657510|FG001|Optional Cross-Over|Refused follow-up|0|||
41939322|NCT03206203|75657511|FG002|Optional Cross-Over|Refused follow-up|2|||
41939323|NCT03201965|75657521|FG000|Overall Study|Death|5|||
41939324|NCT03201965|75657522|FG001|Overall Study|Death|27|||
41939325|NCT03201965|75657523|FG002|Overall Study|Death|27|||
41939326|NCT03201965|75657521|FG000|Overall Study|Lost to Follow-up|0|||
41939327|NCT03201965|75657522|FG001|Overall Study|Lost to Follow-up|1|||
41939328|NCT03201965|75657523|FG002|Overall Study|Lost to Follow-up|0|||
41939329|NCT03201965|75657521|FG000|Overall Study|Withdrawal by Subject|3|||
41939330|NCT03201965|75657522|FG001|Overall Study|Withdrawal by Subject|13|||
41939331|NCT03201965|75657523|FG002|Overall Study|Withdrawal by Subject|4|||
41939332|NCT03201965|75657521|FG000|Overall Study|Ongoing|20|||
41939333|NCT03201965|75657522|FG001|Overall Study|Ongoing|152|||
41939334|NCT03201965|75657523|FG002|Overall Study|Ongoing|164|||
41939335|NCT03126019|75657532|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
41939336|NCT03126019|75657533|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
41939337|NCT03126019|75657532|FG000|Overall Study|Death|2|||
41939338|NCT03126019|75657533|FG001|Overall Study|Death|7|||
41939339|NCT03126019|75657532|FG000|Overall Study|Lost to Follow-up|2|||
41939340|NCT03126019|75657533|FG001|Overall Study|Lost to Follow-up|3|||
41939341|NCT03126019|75657532|FG000|Overall Study|Withdrawal by Participant|1|||
41939342|NCT03126019|75657533|FG001|Overall Study|Withdrawal by Participant|3|||
41939343|NCT03126019|75657532|FG000|Overall Study|Reason not Specified|1|||
41939344|NCT03126019|75657533|FG001|Overall Study|Reason not Specified|3|||
41939345|NCT03072862|75657540|FG000|Overall Study|Withdrawal by Subject|4|||
41939346|NCT03072862|75657540|FG000|Overall Study|Lost to Follow-up|6|||
41939347|NCT03072862|75657540|FG000|Overall Study|Protocol Violation|4|||
41939348|NCT03072862|75657540|FG000|Overall Study|Physician Decision|2|||
41939349|NCT03072862|75657540|FG000|Overall Study|Death|1|||
41939350|NCT03072862|75657540|FG000|Overall Study|Adverse Event|1|||
41939351|NCT03055221|75657544|FG000|Overall Study|Adverse Event|2|||
41939352|NCT03055221|75657544|FG000|Overall Study|Withdrawal by Subject|4|||
41939353|NCT03055221|75657544|FG000|Overall Study|Death|6|||
41939354|NCT03055221|75657544|FG000|Overall Study|Physician Decision|1|||
41939355|NCT03055221|75657544|FG000|Overall Study|Study terminated by Sponsor|3|||
41939356|NCT03055221|75657544|FG000|Overall Study|Lost to Follow-up|4|||
41939357|NCT02913482|75657552|FG000|Overall Study|Death|0|||
41939358|NCT02913482|75657553|FG001|Overall Study|Death|2|||
41939359|NCT02913482|75657554|FG002|Overall Study|Death|2|||
41939360|NCT02913482|75657552|FG000|Overall Study|Progressive Disease|1|||
41939361|NCT02913482|75657553|FG001|Overall Study|Progressive Disease|1|||
41939362|NCT02913482|75657554|FG002|Overall Study|Progressive Disease|1|||
41939363|NCT02838420|75657566|FG000|Overall Study|Ongoing in Study|113|||
41939364|NCT02838420|75657567|FG001|Overall Study|Ongoing in Study|45|||
42300204|NCT02327169|76135329|FG007|Overall Study|Lost to Follow-up|0|||
41939365|NCT02838420|75657566|FG000|Overall Study|Lost to Follow-up|1|||
41939366|NCT02838420|75657567|FG001|Overall Study|Lost to Follow-up|0|||
41939367|NCT02838420|75657566|FG000|Overall Study|Withdrawal by Subject|3|||
41939368|NCT02838420|75657567|FG001|Overall Study|Withdrawal by Subject|4|||
41939369|NCT02838420|75657566|FG000|Overall Study|Death|8|||
41939370|NCT02838420|75657567|FG001|Overall Study|Death|13|||
41939371|NCT02728076|75657573|FG000|Overall Study|Physician Decision|4|||
41939372|NCT02632409|75657579|FG000|Randomized|AE unrelated to study Drug|0|||
41939373|NCT02632409|75657580|FG001|Randomized|AE unrelated to study Drug|1|||
41939374|NCT02632409|75657579|FG000|Randomized|Participant withdrew consent|2|||
41939375|NCT02632409|75657580|FG001|Randomized|Participant withdrew consent|1|||
41939376|NCT02632409|75657579|FG000|Randomized|No Longer meets study criteria|5|||
41939377|NCT02632409|75657580|FG001|Randomized|No Longer meets study criteria|0|||
41939378|NCT02632409|75657579|FG000|Randomized|other reasons|1|||
41939379|NCT02632409|75657580|FG001|Randomized|other reasons|0|||
41939380|NCT02632409|75657579|FG000|Treatment Period|Ongoing Treatment|20|||
41939381|NCT02632409|75657580|FG001|Treatment Period|Ongoing Treatment|21|||
41939382|NCT02632409|75657579|FG000|Treatment Period|Disease Recurrence|147|||
42300205|NCT02327169|76135330|FG008|Overall Study|Lost to Follow-up|0|||
42300206|NCT02327169|76135331|FG009|Overall Study|Lost to Follow-up|0|||
42300207|NCT02327169|76135332|FG010|Overall Study|Lost to Follow-up|0|||
42300208|NCT02327169|76135333|FG011|Overall Study|Lost to Follow-up|0|||
42300209|NCT02327169|76135334|FG012|Overall Study|Lost to Follow-up|0|||
42300210|NCT02327169|76135335|FG013|Overall Study|Lost to Follow-up|0|||
42300211|NCT02327169|76135336|FG014|Overall Study|Lost to Follow-up|0|||
42300212|NCT02327013|76135381|FG000|Overall Study|Adverse Event|4|||
42300213|NCT02327013|76135382|FG001|Overall Study|Adverse Event|4|||
42300214|NCT02327013|76135383|FG002|Overall Study|Adverse Event|3|||
42300215|NCT02327013|76135384|FG003|Overall Study|Adverse Event|0|||
42300216|NCT02327013|76135385|FG004|Overall Study|Adverse Event|1|||
42300217|NCT02327013|76135381|FG000|Overall Study|Lack of Efficacy|2|||
42300218|NCT02327013|76135382|FG001|Overall Study|Lack of Efficacy|0|||
42300219|NCT02327013|76135383|FG002|Overall Study|Lack of Efficacy|5|||
42300220|NCT02327013|76135384|FG003|Overall Study|Lack of Efficacy|0|||
42300221|NCT02327013|76135385|FG004|Overall Study|Lack of Efficacy|1|||
42300222|NCT02327013|76135381|FG000|Overall Study|Non-compliance with IMP|1|||
42300223|NCT02327013|76135382|FG001|Overall Study|Non-compliance with IMP|2|||
42300224|NCT02327013|76135383|FG002|Overall Study|Non-compliance with IMP|7|||
42300225|NCT02327013|76135384|FG003|Overall Study|Non-compliance with IMP|0|||
42300226|NCT02327013|76135385|FG004|Overall Study|Non-compliance with IMP|0|||
42300227|NCT02327013|76135381|FG000|Overall Study|Withdrawal of Consent|1|||
42300228|NCT02327013|76135382|FG001|Overall Study|Withdrawal of Consent|0|||
42300229|NCT02327013|76135383|FG002|Overall Study|Withdrawal of Consent|3|||
42300230|NCT02327013|76135384|FG003|Overall Study|Withdrawal of Consent|0|||
41939383|NCT02632409|75657580|FG001|Treatment Period|Disease Recurrence|90|||
41939384|NCT02632409|75657579|FG000|Treatment Period|Study Drug Toxicity|8|||
41939385|NCT02632409|75657580|FG001|Treatment Period|Study Drug Toxicity|49|||
41939386|NCT02632409|75657579|FG000|Treatment Period|Death|1|||
41939387|NCT02632409|75657580|FG001|Treatment Period|Death|0|||
41939388|NCT02632409|75657579|FG000|Treatment Period|AE unrelated to study drug|15|||
41939389|NCT02632409|75657580|FG001|Treatment Period|AE unrelated to study drug|16|||
41939390|NCT02632409|75657579|FG000|Treatment Period|Request to discontinue treatment|4|||
41939391|NCT02632409|75657580|FG001|Treatment Period|Request to discontinue treatment|19|||
41939392|NCT02632409|75657579|FG000|Treatment Period|Participant withdrew consent|7|||
41939393|NCT02632409|75657580|FG001|Treatment Period|Participant withdrew consent|5|||
41939394|NCT02632409|75657579|FG000|Treatment Period|Lost to Follow-up|0|||
41939395|NCT02632409|75657580|FG001|Treatment Period|Lost to Follow-up|1|||
41939396|NCT02632409|75657579|FG000|Treatment Period|Maximum clinical benefit|1|||
41939397|NCT02632409|75657580|FG001|Treatment Period|Maximum clinical benefit|0|||
41939398|NCT02632409|75657579|FG000|Treatment Period|No longer meets study criteria|3|||
42300231|NCT02327013|76135385|FG004|Overall Study|Withdrawal of Consent|0|||
42300232|NCT02327013|76135381|FG000|Overall Study|Lost to Follow-up|2|||
42300233|NCT02327013|76135382|FG001|Overall Study|Lost to Follow-up|4|||
42300234|NCT02327013|76135383|FG002|Overall Study|Lost to Follow-up|5|||
41939399|NCT02632409|75657580|FG001|Treatment Period|No longer meets study criteria|0|||
41939400|NCT02632409|75657579|FG000|Treatment Period|Administrative Reason by sponsor|0|||
41939401|NCT02632409|75657580|FG001|Treatment Period|Administrative Reason by sponsor|1|||
41939402|NCT02632409|75657579|FG000|Treatment Period|Other Reasons|10|||
41939403|NCT02632409|75657580|FG001|Treatment Period|Other Reasons|6|||
41939404|NCT02489318|75657588|FG000|Randomized|Withdrawal by Subject|0|||
41939405|NCT02489318|75657589|FG001|Randomized|Withdrawal by Subject|1|||
41939406|NCT02489318|75657588|FG000|Treated|Adverse Event|19|||
41939407|NCT02489318|75657589|FG001|Treated|Adverse Event|62|||
41939408|NCT02489318|75657588|FG000|Treated|Death|13|||
41939409|NCT02489318|75657589|FG001|Treated|Death|11|||
41939410|NCT02489318|75657588|FG000|Treated|Physician Decision|4|||
41939411|NCT02489318|75657589|FG001|Treated|Physician Decision|6|||
41939412|NCT02489318|75657588|FG000|Treated|Protocol Violation|1|||
41939413|NCT02489318|75657589|FG001|Treated|Protocol Violation|2|||
41939414|NCT02489318|75657588|FG000|Treated|Withdrawal by Subject|37|||
41939415|NCT02489318|75657589|FG001|Treated|Withdrawal by Subject|36|||
41939416|NCT02489318|75657588|FG000|Treated|Other: Progressive Disease|245|||
41939417|NCT02489318|75657589|FG001|Treated|Other: Progressive Disease|138|||
41939418|NCT02489318|75657588|FG000|Treated|Other|0|||
41939419|NCT02489318|75657589|FG001|Treated|Other|2|||
41939420|NCT02489318|75657588|FG000|Treated|Ongoing|0|||
41939421|NCT02489318|75657589|FG001|Treated|Ongoing|267|||
41939422|NCT02333227|75657607|FG000|Overall Study|Lost to Follow-up|137|||
41939423|NCT02333227|75657608|FG001|Overall Study|Lost to Follow-up|106|||
41939424|NCT02333227|75657607|FG000|Overall Study|Pregnancy Interrupted|42|||
41939425|NCT02333227|75657608|FG001|Overall Study|Pregnancy Interrupted|89|||
41939426|NCT02333227|75657607|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
41939427|NCT02333227|75657608|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
41939428|NCT02277444|75657614|FG000|Overall Study|Adverse Event|10|||
41939429|NCT02277444|75657614|FG000|Overall Study|Withdrawal by Subject|3|||
41939430|NCT02277444|75657614|FG000|Overall Study|Other|1|||
41939431|NCT02277444|75657614|FG000|Overall Study|Enrolled and not Treated|3|||
41939432|NCT02277444|75657614|FG000|Overall Study|Ongoing|113|||
41939433|NCT02257736|75657620|FG000|Overall Study|Progressive disease|365|||
41939434|NCT02257736|75657621|FG001|Overall Study|Progressive disease|327|||
41939435|NCT02257736|75657620|FG000|Overall Study|Adverse Event|45|||
41939436|NCT02257736|75657621|FG001|Overall Study|Adverse Event|56|||
41939437|NCT02257736|75657620|FG000|Overall Study|Withdrawal by Subject|21|||
41939438|NCT02257736|75657621|FG001|Overall Study|Withdrawal by Subject|38|||
41939439|NCT02257736|75657620|FG000|Overall Study|Death|11|||
41939440|NCT02257736|75657621|FG001|Overall Study|Death|6|||
41939441|NCT02257736|75657620|FG000|Overall Study|Physician Decision|5|||
41939442|NCT02257736|75657621|FG001|Overall Study|Physician Decision|9|||
41939443|NCT02257736|75657620|FG000|Overall Study|Non-Compliance with study drug|1|||
41939444|NCT02257736|75657621|FG001|Overall Study|Non-Compliance with study drug|2|||
41939445|NCT02257736|75657620|FG000|Overall Study|Protocol Violation|1|||
41939446|NCT02257736|75657621|FG001|Overall Study|Protocol Violation|0|||
41939447|NCT02257736|75657620|FG000|Overall Study|Other|1|||
41939448|NCT02257736|75657621|FG001|Overall Study|Other|7|||
41939449|NCT02257736|75657620|FG000|Overall Study|Randomized, not treated|1|||
41939450|NCT02257736|75657621|FG001|Overall Study|Randomized, not treated|2|||
41939451|NCT02252172|75657629|FG000|Overall Study|Lost to Follow-up|3|||
41939452|NCT02252172|75657630|FG001|Overall Study|Lost to Follow-up|1|||
41939453|NCT02252172|75657629|FG000|Overall Study|Ongoing|276|||
41939454|NCT02252172|75657630|FG001|Overall Study|Ongoing|298|||
41939455|NCT02195479|75657638|FG000|Overall Study|Lost to Follow-up|3|||
41939456|NCT02195479|75657639|FG001|Overall Study|Lost to Follow-up|0|||
41939457|NCT02195479|75657638|FG000|Overall Study|Death|48|||
41939458|NCT02195479|75657639|FG001|Overall Study|Death|45|||
41939459|NCT02195479|75657638|FG000|Overall Study|Physician Decision|1|||
41939460|NCT02195479|75657639|FG001|Overall Study|Physician Decision|0|||
41939461|NCT02195479|75657638|FG000|Overall Study|Withdrawal by Subject|11|||
41939462|NCT02195479|75657639|FG001|Overall Study|Withdrawal by Subject|6|||
41939463|NCT02195479|75657638|FG000|Overall Study|Other|2|||
41939464|NCT02195479|75657639|FG001|Overall Study|Other|2|||
41939465|NCT02195479|75657638|FG000|Overall Study|Ongoing|291|||
41939466|NCT02195479|75657639|FG001|Overall Study|Ongoing|297|||
41939467|NCT02076009|75657647|FG000|Overall Study|Death|172|||
41939468|NCT02076009|75657648|FG001|Overall Study|Death|153|||
41939469|NCT02076009|75657647|FG000|Overall Study|Withdrawal by Subject|16|||
41939470|NCT02076009|75657648|FG001|Overall Study|Withdrawal by Subject|12|||
41939471|NCT02076009|75657647|FG000|Overall Study|Lost to Follow-up|4|||
41939472|NCT02076009|75657648|FG001|Overall Study|Lost to Follow-up|2|||
41939473|NCT02076009|75657647|FG000|Overall Study|Progressive Disease|1|||
41939474|NCT02076009|75657648|FG001|Overall Study|Progressive Disease|0|||
41939475|NCT02076009|75657647|FG000|Overall Study|Physician Decision|0|||
41939476|NCT02076009|75657648|FG001|Overall Study|Physician Decision|1|||
41939477|NCT02076009|75657647|FG000|Overall Study|End of data collection|90|||
41939478|NCT02076009|75657648|FG001|Overall Study|End of data collection|118|||
41939479|NCT01946204|75657656|FG000|Overall Study|Death|38|||
41939480|NCT01946204|75657657|FG001|Overall Study|Death|59|||
41939481|NCT01946204|75657656|FG000|Overall Study|Withdrawal by Subject|37|||
41939482|NCT01946204|75657657|FG001|Overall Study|Withdrawal by Subject|50|||
41939483|NCT01946204|75657656|FG000|Overall Study|Lost to Follow-up|3|||
41939484|NCT01946204|75657657|FG001|Overall Study|Lost to Follow-up|7|||
41939485|NCT01946204|75657656|FG000|Overall Study|Ongoing|316|||
41939486|NCT01946204|75657657|FG001|Overall Study|Ongoing|687|||
41939487|NCT01946204|75657656|FG000|Overall Study|Other|7|||
41939488|NCT01946204|75657657|FG001|Overall Study|Other|3|||
41939489|NCT01831635|75657666|FG000|Overall Study|Withdrawal by Subject|0|||
41939490|NCT01831635|75657667|FG001|Overall Study|Withdrawal by Subject|2|||
41939491|NCT01831635|75657668|FG002|Overall Study|Withdrawal by Subject|0|||
41939492|NCT01776840|75657678|FG000|Overall Study|Lost to Follow-up|4|||
41939493|NCT01776840|75657679|FG001|Overall Study|Lost to Follow-up|4|||
41939494|NCT01776840|75657678|FG000|Overall Study|Withdrawal by Subject|42|||
41939495|NCT01776840|75657679|FG001|Overall Study|Withdrawal by Subject|22|||
41939496|NCT01776840|75657678|FG000|Overall Study|Ongoing|112|||
41939497|NCT01776840|75657679|FG001|Overall Study|Ongoing|129|||
41939498|NCT01615029|75657690|FG000|Overall Study|Adverse Event|0|||
41939499|NCT01615029|75657691|FG001|Overall Study|Adverse Event|0|||
41939500|NCT01615029|75657692|FG002|Overall Study|Adverse Event|0|||
41939501|NCT01615029|75657693|FG003|Overall Study|Adverse Event|0|||
41939502|NCT01615029|75657694|FG004|Overall Study|Adverse Event|1|||
41939503|NCT01615029|75657690|FG000|Overall Study|Death|0|||
41939504|NCT01615029|75657691|FG001|Overall Study|Death|0|||
41939505|NCT01615029|75657692|FG002|Overall Study|Death|0|||
41939506|NCT01615029|75657693|FG003|Overall Study|Death|0|||
41939507|NCT01615029|75657694|FG004|Overall Study|Death|1|||
41939508|NCT01615029|75657690|FG000|Overall Study|Lost to Follow-up|0|||
41939509|NCT01615029|75657691|FG001|Overall Study|Lost to Follow-up|0|||
41939510|NCT01615029|75657692|FG002|Overall Study|Lost to Follow-up|0|||
41939511|NCT01615029|75657693|FG003|Overall Study|Lost to Follow-up|0|||
41939512|NCT01615029|75657694|FG004|Overall Study|Lost to Follow-up|1|||
41939513|NCT01615029|75657690|FG000|Overall Study|Progressive disease|2|||
41939514|NCT01615029|75657691|FG001|Overall Study|Progressive disease|1|||
41939515|NCT01615029|75657692|FG002|Overall Study|Progressive disease|1|||
41939516|NCT01615029|75657693|FG003|Overall Study|Progressive disease|1|||
41939517|NCT01615029|75657694|FG004|Overall Study|Progressive disease|5|||
41939518|NCT01615029|75657690|FG000|Overall Study|Physician Decision|0|||
41939519|NCT01615029|75657691|FG001|Overall Study|Physician Decision|0|||
41939520|NCT01615029|75657692|FG002|Overall Study|Physician Decision|0|||
41939521|NCT01615029|75657693|FG003|Overall Study|Physician Decision|0|||
41939522|NCT01615029|75657694|FG004|Overall Study|Physician Decision|1|||
41939523|NCT01615029|75657690|FG000|Overall Study|Ongoing|1|||
41939524|NCT01615029|75657691|FG001|Overall Study|Ongoing|2|||
41939525|NCT01615029|75657692|FG002|Overall Study|Ongoing|3|||
41939526|NCT01615029|75657693|FG003|Overall Study|Ongoing|2|||
41939527|NCT01615029|75657694|FG004|Overall Study|Ongoing|23|||
41939528|NCT01606878|75657717|FG000|Overall Study|Adverse Event|1|||
41939529|NCT01606878|75657718|FG001|Overall Study|Adverse Event|1|||
41939530|NCT01606878|75657719|FG002|Overall Study|Adverse Event|0|||
41939531|NCT01606878|75657720|FG003|Overall Study|Adverse Event|0|||
41939532|NCT01606878|75657721|FG004|Overall Study|Adverse Event|0|||
42210269|NCT03276975|76025022|FG001|Overall Study|Withdrawal by Subject|0|||
41939533|NCT01606878|75657722|FG005|Overall Study|Adverse Event|0|||
41939534|NCT01606878|75657723|FG006|Overall Study|Adverse Event|1|||
41939535|NCT01606878|75657724|FG007|Overall Study|Adverse Event|0|||
41939536|NCT01606878|75657725|FG008|Overall Study|Adverse Event|1|||
41939537|NCT01606878|75657726|FG009|Overall Study|Adverse Event|3|||
41939538|NCT01606878|75657727|FG010|Overall Study|Adverse Event|0|||
41939539|NCT01606878|75657717|FG000|Overall Study|Lack of Efficacy|1|||
41939540|NCT01606878|75657718|FG001|Overall Study|Lack of Efficacy|1|||
41939541|NCT01606878|75657719|FG002|Overall Study|Lack of Efficacy|1|||
41939542|NCT01606878|75657720|FG003|Overall Study|Lack of Efficacy|2|||
41939543|NCT01606878|75657721|FG004|Overall Study|Lack of Efficacy|1|||
41939544|NCT01606878|75657722|FG005|Overall Study|Lack of Efficacy|2|||
41939545|NCT01606878|75657723|FG006|Overall Study|Lack of Efficacy|1|||
41939546|NCT01606878|75657724|FG007|Overall Study|Lack of Efficacy|2|||
41939547|NCT01606878|75657725|FG008|Overall Study|Lack of Efficacy|2|||
41939548|NCT01606878|75657726|FG009|Overall Study|Lack of Efficacy|0|||
41939549|NCT01606878|75657727|FG010|Overall Study|Lack of Efficacy|1|||
41939550|NCT01606878|75657717|FG000|Overall Study|Physician Decision|1|||
41939551|NCT01606878|75657718|FG001|Overall Study|Physician Decision|0|||
41939552|NCT01606878|75657719|FG002|Overall Study|Physician Decision|2|||
41939553|NCT01606878|75657720|FG003|Overall Study|Physician Decision|1|||
41939554|NCT01606878|75657721|FG004|Overall Study|Physician Decision|1|||
41939555|NCT01606878|75657722|FG005|Overall Study|Physician Decision|1|||
41939556|NCT01606878|75657723|FG006|Overall Study|Physician Decision|2|||
41939557|NCT01606878|75657724|FG007|Overall Study|Physician Decision|0|||
41939558|NCT01606878|75657725|FG008|Overall Study|Physician Decision|1|||
41939559|NCT01606878|75657726|FG009|Overall Study|Physician Decision|0|||
41939560|NCT01606878|75657727|FG010|Overall Study|Physician Decision|0|||
41939561|NCT01606878|75657717|FG000|Overall Study|Withdrawal by Subject|3|||
41939562|NCT01606878|75657718|FG001|Overall Study|Withdrawal by Subject|2|||
41939563|NCT01606878|75657719|FG002|Overall Study|Withdrawal by Subject|2|||
41939564|NCT01606878|75657720|FG003|Overall Study|Withdrawal by Subject|0|||
41939565|NCT01606878|75657721|FG004|Overall Study|Withdrawal by Subject|1|||
41939566|NCT01606878|75657722|FG005|Overall Study|Withdrawal by Subject|1|||
41939567|NCT01606878|75657723|FG006|Overall Study|Withdrawal by Subject|2|||
41939568|NCT01606878|75657724|FG007|Overall Study|Withdrawal by Subject|1|||
41939569|NCT01606878|75657725|FG008|Overall Study|Withdrawal by Subject|2|||
41939570|NCT01606878|75657726|FG009|Overall Study|Withdrawal by Subject|0|||
41939571|NCT01606878|75657727|FG010|Overall Study|Withdrawal by Subject|2|||
41939572|NCT01467427|75657761|FG000|Overall Study|Withdrawal by Subject|1|||
41939573|NCT01467427|75657762|FG001|Overall Study|Withdrawal by Subject|0|||
41939574|NCT01467427|75657761|FG000|Overall Study|Entered extension phase|11|||
41939575|NCT01467427|75657762|FG001|Overall Study|Entered extension phase|11|||
41939576|NCT01467427|75657761|FG000|Overall Study|Not continuing in extension phase|0|||
41939577|NCT01467427|75657762|FG001|Overall Study|Not continuing in extension phase|2|||
41939578|NCT01314118|75657768|FG000|Overall Study|Adverse Event|9|||
41939579|NCT01314118|75657768|FG000|Overall Study|Progressive disease|27|||
41939580|NCT01314118|75657768|FG000|Overall Study|Physician Decision|11|||
41939581|NCT01314118|75657768|FG000|Overall Study|Death|4|||
41939582|NCT01314118|75657768|FG000|Overall Study|Protocol Violation|5|||
41939583|NCT01314118|75657768|FG000|Overall Study|Withdrawal by Subject|11|||
41939584|NCT01314118|75657768|FG000|Overall Study|Other|2|||
41939585|NCT01314118|75657768|FG000|Overall Study|Ongoing|62|||
41939586|NCT01175356|75657772|FG000|Overall Study|Death|1|||
41939587|NCT01175356|75657772|FG000|Overall Study|Lack of Efficacy|12|||
41939588|NCT01175356|75657772|FG000|Overall Study|Lost to Follow-up|1|||
41939589|NCT01175356|75657772|FG000|Overall Study|Physician Decision|23|||
41939590|NCT01175356|75657772|FG000|Overall Study|Ineligible|1|||
41939591|NCT01175356|75657772|FG000|Overall Study|Treatment Slot Not Available|18|||
42022784|NCT00957268|75830074|FG001|Overall Study|Voluntary Withdrawal|0|||
42300235|NCT02327013|76135384|FG003|Overall Study|Lost to Follow-up|0|||
41939592|NCT01175356|75657772|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
41939593|NCT01175356|75657772|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
41939594|NCT01175356|75657772|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
41939595|NCT01175356|75657772|FG000|Overall Study|Inadequate stem cell for transplant|1|||
41939596|NCT01175356|75657772|FG000|Overall Study|Initiation other tx prior to completion|9|||
41939597|NCT01171898|75657780|FG000|Overall Study|Death|0|||
41939598|NCT01171898|75657781|FG001|Overall Study|Death|0|||
41939599|NCT01171898|75657782|FG002|Overall Study|Death|2|||
41939600|NCT01171898|75657783|FG003|Overall Study|Death|0|||
41939601|NCT01171898|75657780|FG000|Overall Study|Lost to Follow-up|0|||
41939602|NCT01171898|75657781|FG001|Overall Study|Lost to Follow-up|1|||
41939603|NCT01171898|75657782|FG002|Overall Study|Lost to Follow-up|1|||
41939604|NCT01171898|75657783|FG003|Overall Study|Lost to Follow-up|1|||
41939605|NCT01171898|75657780|FG000|Overall Study|Withdrawal by Subject|1|||
42022785|NCT00957268|75830075|FG002|Overall Study|Voluntary Withdrawal|1|||
42022786|NCT00957268|75830076|FG003|Overall Study|Voluntary Withdrawal|0|||
41939606|NCT01171898|75657781|FG001|Overall Study|Withdrawal by Subject|4|||
41939607|NCT01171898|75657782|FG002|Overall Study|Withdrawal by Subject|6|||
41939608|NCT01171898|75657783|FG003|Overall Study|Withdrawal by Subject|3|||
41939609|NCT01171898|75657780|FG000|Overall Study|Terminated by Sponsor|1|||
41939610|NCT01171898|75657781|FG001|Overall Study|Terminated by Sponsor|0|||
41939611|NCT01171898|75657782|FG002|Overall Study|Terminated by Sponsor|0|||
41939612|NCT01171898|75657783|FG003|Overall Study|Terminated by Sponsor|0|||
41939613|NCT01171898|75657780|FG000|Overall Study|Ongoing|1|||
41939614|NCT01171898|75657781|FG001|Overall Study|Ongoing|9|||
41939615|NCT01171898|75657782|FG002|Overall Study|Ongoing|3|||
41939616|NCT01171898|75657783|FG003|Overall Study|Ongoing|0|||
41939617|NCT01171898|75657780|FG000|Overall Study|Other|1|||
41939618|NCT01171898|75657781|FG001|Overall Study|Other|5|||
41939619|NCT01171898|75657782|FG002|Overall Study|Other|0|||
41939620|NCT01171898|75657783|FG003|Overall Study|Other|2|||
41939621|NCT01005745|75657796|FG000|Overall Study|No TIL growth|1|||
41939622|NCT01005745|75657796|FG000|Overall Study|Disease progressed during TIL growth|3|||
41939623|NCT01005745|75657796|FG000|Overall Study|Death prior to treatment|1|||
41939624|NCT01005745|75657796|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
41939625|NCT00980538|75657800|FG000|Overall Study|Lost to Follow-up|20|||
41939626|NCT00980538|75657800|FG000|Overall Study|Sponsor's Decision|4|||
41939627|NCT00980538|75657800|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
41939628|NCT00980538|75657800|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
41939629|NCT00980538|75657800|FG000|Overall Study|Switch to Commercially Available Medication|25|||
41939630|NCT00980538|75657800|FG000|Overall Study|Participant Non-Compliant|9|||
41939631|NCT00980538|75657800|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
41939632|NCT00980538|75657800|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
41939633|NCT00980538|75657800|FG000|Overall Study|Other|60|||
41939634|NCT00980538|75657800|FG000|Overall Study|Other|1|||
41939635|NCT00676715|75657808|FG000|Overall Study|Withdrawal by Subject|7|||
41939636|NCT00676715|75657809|FG001|Overall Study|Withdrawal by Subject|9|||
41939637|NCT00676715|75657810|FG002|Overall Study|Withdrawal by Subject|10|||
41939638|NCT00676715|75657811|FG003|Overall Study|Withdrawal by Subject|10|||
41939639|NCT00676715|75657808|FG000|Overall Study|Other|2|||
41939640|NCT00676715|75657809|FG001|Overall Study|Other|6|||
41939641|NCT00676715|75657810|FG002|Overall Study|Other|4|||
41939642|NCT00676715|75657811|FG003|Overall Study|Other|3|||
41939643|NCT00676715|75657808|FG000|Overall Study|Lost to Follow-up|1|||
41939644|NCT00676715|75657809|FG001|Overall Study|Lost to Follow-up|1|||
41939645|NCT00676715|75657810|FG002|Overall Study|Lost to Follow-up|7|||
41939646|NCT00676715|75657811|FG003|Overall Study|Lost to Follow-up|3|||
41939647|NCT00676715|75657808|FG000|Overall Study|Death|1|||
41939648|NCT00676715|75657809|FG001|Overall Study|Death|1|||
41939649|NCT00676715|75657810|FG002|Overall Study|Death|1|||
41939650|NCT00676715|75657811|FG003|Overall Study|Death|0|||
41939651|NCT00676715|75657808|FG000|Overall Study|Adverse Event|0|||
41939652|NCT00676715|75657809|FG001|Overall Study|Adverse Event|1|||
41939653|NCT00676715|75657810|FG002|Overall Study|Adverse Event|2|||
41939654|NCT00676715|75657811|FG003|Overall Study|Adverse Event|0|||
41939655|NCT00676715|75657808|FG000|Overall Study|Participants Ongoing|29|||
41939656|NCT00676715|75657809|FG001|Overall Study|Participants Ongoing|29|||
41939657|NCT00676715|75657810|FG002|Overall Study|Participants Ongoing|17|||
41939658|NCT00676715|75657811|FG003|Overall Study|Participants Ongoing|24|||
41939659|NCT02345226|75658027|FG000|Double-Blind Phase|Adverse Event|5|||
41939660|NCT02345226|75658028|FG001|Double-Blind Phase|Adverse Event|6|||
41939661|NCT02345226|75658027|FG000|Double-Blind Phase|Death|3|||
41939662|NCT02345226|75658028|FG001|Double-Blind Phase|Death|0|||
41939663|NCT02345226|75658027|FG000|Double-Blind Phase|Pregnancy|0|||
41939664|NCT02345226|75658028|FG001|Double-Blind Phase|Pregnancy|1|||
41939665|NCT02345226|75658027|FG000|Double-Blind Phase|Lack of Efficacy|1|||
41939666|NCT02345226|75658028|FG001|Double-Blind Phase|Lack of Efficacy|0|||
41939667|NCT02345226|75658027|FG000|Double-Blind Phase|Investigator's Discretion|4|||
41939668|NCT02345226|75658028|FG001|Double-Blind Phase|Investigator's Discretion|3|||
41939669|NCT02345226|75658027|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
41939670|NCT02345226|75658028|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
41939671|NCT02345226|75658027|FG000|Double-Blind Phase|Withdrew Consent|41|||
41939672|NCT02345226|75658028|FG001|Double-Blind Phase|Withdrew Consent|39|||
41939673|NCT02345226|75658027|FG000|Double-Blind Phase|Lost to Follow-up|12|||
41939674|NCT02345226|75658028|FG001|Double-Blind Phase|Lost to Follow-up|16|||
41939675|NCT02345226|75658027|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
41939676|NCT02345226|75658028|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
41939677|NCT02345226|75658027|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
41939678|NCT02345226|75658028|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
41939679|NCT00551369|75658599|FG000|Overall Study|Protocol Violation|5|||
41939680|NCT00551369|75658599|FG000|Overall Study|Withdrawal by Subject|1|||
41939681|NCT00551369|75658599|FG000|Overall Study|Not treated per protocol and re|1|||
41939682|NCT00551291|75658612|FG000|Overall Study|Physician Decision|1|||
41939683|NCT00551213|75658718|FG000|Overall Study|Adverse Event|6|||
41939684|NCT00551213|75658719|FG001|Overall Study|Adverse Event|3|||
41939685|NCT00551213|75658718|FG000|Overall Study|Progressive Disease|41|||
42022787|NCT00957268|75830077|FG004|Overall Study|Voluntary Withdrawal|0|||
42022788|NCT01230788|75830089|FG000|Overall Study|Prescribed exclusion drug|1|||
42022789|NCT01230710|75830093|FG000|Overall Study|Disease Progression|41|||
41939686|NCT00551213|75658719|FG001|Overall Study|Progressive Disease|12|||
41939687|NCT00551213|75658718|FG000|Overall Study|Withdrawal by Subject|2|||
41939688|NCT00551213|75658719|FG001|Overall Study|Withdrawal by Subject|0|||
41939689|NCT00551213|75658718|FG000|Overall Study|Not Treated|1|||
41939690|NCT00551213|75658719|FG001|Overall Study|Not Treated|2|||
41939691|NCT00550043|75658856|FG000|Overall Study|Adverse Event|0|||
41939692|NCT00550043|75658857|FG001|Overall Study|Adverse Event|0|||
41939693|NCT00550043|75658858|FG002|Overall Study|Adverse Event|0|||
41939694|NCT00550043|75658859|FG003|Overall Study|Adverse Event|1|||
41939695|NCT00550043|75658860|FG004|Overall Study|Adverse Event|1|||
41939696|NCT00550043|75658856|FG000|Overall Study|Subject Withdrew Consent|0|||
41939697|NCT00550043|75658857|FG001|Overall Study|Subject Withdrew Consent|2|||
42022790|NCT01230710|75830093|FG000|Overall Study|Lost to Follow-up|3|||
41939698|NCT00550043|75658858|FG002|Overall Study|Subject Withdrew Consent|1|||
41939699|NCT00550043|75658859|FG003|Overall Study|Subject Withdrew Consent|0|||
41939700|NCT00550043|75658860|FG004|Overall Study|Subject Withdrew Consent|0|||
41939701|NCT00550043|75658856|FG000|Overall Study|Other Reasons- Unspecified|0|||
41939702|NCT00550043|75658857|FG001|Overall Study|Other Reasons- Unspecified|1|||
41939703|NCT00550043|75658858|FG002|Overall Study|Other Reasons- Unspecified|0|||
41939704|NCT00550043|75658859|FG003|Overall Study|Other Reasons- Unspecified|1|||
41939705|NCT00550043|75658860|FG004|Overall Study|Other Reasons- Unspecified|0|||
41939706|NCT03188822|75659579|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
41939707|NCT03188822|75659579|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
41939708|NCT04976777|75659713|FG000|Overall Study|COVID-19 Infection|1|||
41939709|NCT04976777|75659714|FG001|Overall Study|COVID-19 Infection|0|||
41939710|NCT00555971|75659888|FG000|Overall Study|Adverse Event|1|||
41939711|NCT00555971|75659889|FG001|Overall Study|Adverse Event|1|||
41939712|NCT02343120|75660756|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
41939713|NCT02343120|75660757|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
41939714|NCT02343120|75660758|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
41939715|NCT02343120|75660759|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
41939716|NCT02343120|75660760|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
41939717|NCT02343120|75660756|FG000|Part 1: Dose Escalation|Death|1|||
41939718|NCT02343120|75660757|FG001|Part 1: Dose Escalation|Death|2|||
41939719|NCT02343120|75660758|FG002|Part 1: Dose Escalation|Death|2|||
41939720|NCT02343120|75660759|FG003|Part 1: Dose Escalation|Death|2|||
41939721|NCT02343120|75660760|FG004|Part 1: Dose Escalation|Death|1|||
41939722|NCT02343120|75660756|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
41939723|NCT02343120|75660757|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
41939724|NCT02343120|75660758|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
41939725|NCT02343120|75660759|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
41939726|NCT02343120|75660760|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
41939727|NCT02343120|75660756|FG000|Part 2: Expansion|Sponsor decision|0|||
41939728|NCT02343120|75660757|FG001|Part 2: Expansion|Sponsor decision|0|||
41939729|NCT02343120|75660758|FG002|Part 2: Expansion|Sponsor decision|0|||
41939730|NCT02343120|75660759|FG003|Part 2: Expansion|Sponsor decision|165|||
41939731|NCT02343120|75660760|FG004|Part 2: Expansion|Sponsor decision|67|||
41939732|NCT02343120|75660756|FG000|Part 2: Expansion|Death|0|||
41939733|NCT02343120|75660757|FG001|Part 2: Expansion|Death|0|||
41939734|NCT02343120|75660758|FG002|Part 2: Expansion|Death|0|||
41939735|NCT02343120|75660759|FG003|Part 2: Expansion|Death|74|||
41939736|NCT02343120|75660760|FG004|Part 2: Expansion|Death|17|||
41939737|NCT02343120|75660756|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
41939738|NCT02343120|75660757|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
41939739|NCT02343120|75660758|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
41939740|NCT02343120|75660759|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
41939741|NCT02343120|75660760|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
41939742|NCT02343120|75660756|FG000|Part 2: Expansion|Lost to Follow-up|0|||
41939743|NCT02343120|75660757|FG001|Part 2: Expansion|Lost to Follow-up|0|||
41939744|NCT02343120|75660758|FG002|Part 2: Expansion|Lost to Follow-up|0|||
41939745|NCT02343120|75660759|FG003|Part 2: Expansion|Lost to Follow-up|5|||
41939746|NCT02343120|75660760|FG004|Part 2: Expansion|Lost to Follow-up|2|||
41939747|NCT02343120|75660756|FG000|Part 2: Expansion|Other|0|||
41939748|NCT02343120|75660757|FG001|Part 2: Expansion|Other|0|||
41939749|NCT02343120|75660758|FG002|Part 2: Expansion|Other|0|||
41939750|NCT02343120|75660759|FG003|Part 2: Expansion|Other|1|||
41939751|NCT02343120|75660760|FG004|Part 2: Expansion|Other|5|||
41939752|NCT02343120|75660756|FG000|Part 2: Expansion|Adverse Event|0|||
41939753|NCT02343120|75660757|FG001|Part 2: Expansion|Adverse Event|0|||
41939754|NCT02343120|75660758|FG002|Part 2: Expansion|Adverse Event|0|||
41939755|NCT02343120|75660759|FG003|Part 2: Expansion|Adverse Event|1|||
41939756|NCT02343120|75660760|FG004|Part 2: Expansion|Adverse Event|1|||
41939757|NCT02342886|75661017|FG000|Overall Study|Treatment non-compliance|1|||
41939758|NCT02342886|75661018|FG001|Overall Study|Treatment non-compliance|0|||
41939759|NCT02342886|75661019|FG002|Overall Study|Treatment non-compliance|0|||
41939760|NCT02342886|75661020|FG003|Overall Study|Treatment non-compliance|1|||
41939761|NCT02342886|75661021|FG004|Overall Study|Treatment non-compliance|0|||
41939762|NCT02342886|75661017|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
42022791|NCT01230710|75830093|FG000|Overall Study|Death|4|||
42210270|NCT03297216|76025030|FG000|Overall Study|Death|0|||
42300236|NCT02327013|76135385|FG004|Overall Study|Lost to Follow-up|0|||
41939763|NCT02342886|75661018|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
41939764|NCT02342886|75661019|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
41939765|NCT02342886|75661020|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
41939766|NCT02342886|75661021|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
41939767|NCT02342886|75661017|FG000|Overall Study|Adverse event/specific toxicity|4|||
41939768|NCT02342886|75661018|FG001|Overall Study|Adverse event/specific toxicity|3|||
41939769|NCT02342886|75661019|FG002|Overall Study|Adverse event/specific toxicity|11|||
41939770|NCT02342886|75661020|FG003|Overall Study|Adverse event/specific toxicity|2|||
41939771|NCT02342886|75661021|FG004|Overall Study|Adverse event/specific toxicity|1|||
41939772|NCT02342886|75661017|FG000|Overall Study|Lost to Follow-up|1|||
41939773|NCT02342886|75661018|FG001|Overall Study|Lost to Follow-up|0|||
41939774|NCT02342886|75661019|FG002|Overall Study|Lost to Follow-up|0|||
41939775|NCT02342886|75661020|FG003|Overall Study|Lost to Follow-up|0|||
41939776|NCT02342886|75661021|FG004|Overall Study|Lost to Follow-up|0|||
41939777|NCT02342886|75661017|FG000|Overall Study|Death|1|||
41939778|NCT02342886|75661018|FG001|Overall Study|Death|2|||
41939779|NCT02342886|75661019|FG002|Overall Study|Death|1|||
41939780|NCT02342886|75661020|FG003|Overall Study|Death|0|||
42210271|NCT03297216|76025031|FG001|Overall Study|Death|1|||
41939781|NCT02342886|75661021|FG004|Overall Study|Death|1|||
41939782|NCT02342886|75661017|FG000|Overall Study|Withdrawal by Subject|0|||
41939783|NCT02342886|75661018|FG001|Overall Study|Withdrawal by Subject|1|||
41939784|NCT02342886|75661019|FG002|Overall Study|Withdrawal by Subject|0|||
41939785|NCT02342886|75661020|FG003|Overall Study|Withdrawal by Subject|1|||
41939786|NCT02342886|75661021|FG004|Overall Study|Withdrawal by Subject|0|||
41939787|NCT02342886|75661017|FG000|Overall Study|Investigator/sponsor decision|0|||
41939788|NCT02342886|75661018|FG001|Overall Study|Investigator/sponsor decision|2|||
41939789|NCT02342886|75661019|FG002|Overall Study|Investigator/sponsor decision|0|||
41939790|NCT02342886|75661020|FG003|Overall Study|Investigator/sponsor decision|3|||
41939791|NCT02342886|75661021|FG004|Overall Study|Investigator/sponsor decision|1|||
41939792|NCT02342886|75661017|FG000|Overall Study|Pregnancy|0|||
41939793|NCT02342886|75661018|FG001|Overall Study|Pregnancy|0|||
41939794|NCT02342886|75661019|FG002|Overall Study|Pregnancy|2|||
41939795|NCT02342886|75661020|FG003|Overall Study|Pregnancy|0|||
41939796|NCT02342886|75661021|FG004|Overall Study|Pregnancy|0|||
41939797|NCT02342886|75661017|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
41939798|NCT02342886|75661018|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
41939799|NCT02342886|75661019|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
41939800|NCT02342886|75661020|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
41939801|NCT02342886|75661021|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
41939802|NCT02342886|75661017|FG000|Overall Study|Protocol Violation|0|||
41939803|NCT02342886|75661018|FG001|Overall Study|Protocol Violation|0|||
41939804|NCT02342886|75661019|FG002|Overall Study|Protocol Violation|0|||
41939805|NCT02342886|75661020|FG003|Overall Study|Protocol Violation|2|||
41939806|NCT02342886|75661021|FG004|Overall Study|Protocol Violation|0|||
41939807|NCT02390076|75661057|FG000|Overall Study|Lost to Follow-up|2|||
41939808|NCT02390076|75661058|FG001|Overall Study|Lost to Follow-up|1|||
41939809|NCT02390076|75661059|FG002|Overall Study|Lost to Follow-up|4|||
41939810|NCT02389998|75661078|FG000|Overall Study|car accident|1|||
41939811|NCT02389998|75661079|FG001|Overall Study|car accident|0|||
41939812|NCT02389764|75661105|FG000|Overall Study|Lack of Efficacy|9|||
41939813|NCT02366130|75661176|FG000|Overall Study|Withdrawal by Subject|3|||
41939814|NCT02366130|75661176|FG000|Overall Study|Ineligible|6|||
41939815|NCT02389452|75661238|FG000|Overall Study|Lost to Follow-up|13|||
41939816|NCT02389452|75661238|FG000|Overall Study|Adverse Event|1|||
41939817|NCT02389452|75661238|FG000|Overall Study|Withdrawal by Subject|5|||
41939818|NCT02389452|75661238|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
41939819|NCT02365584|75661276|FG000|Overall Study|Adverse Event|2|||
41939820|NCT02365584|75661277|FG001|Overall Study|Adverse Event|2|||
41939821|NCT02365584|75661276|FG000|Overall Study|Withdrawal by Subject|1|||
41939822|NCT02365584|75661277|FG001|Overall Study|Withdrawal by Subject|0|||
41939823|NCT02365584|75661276|FG000|Overall Study|Disease Progression|9|||
41939824|NCT02365584|75661277|FG001|Overall Study|Disease Progression|12|||
41939825|NCT02342418|75661289|FG000|Overall Study|Adverse Event|0|||
41939826|NCT02342418|75661290|FG001|Overall Study|Adverse Event|1|||
41939827|NCT02365506|75661331|FG000|Overall Study|Investigator's Discretion|0|||
41939828|NCT02365506|75661332|FG001|Overall Study|Investigator's Discretion|0|||
41939829|NCT02365506|75661333|FG002|Overall Study|Investigator's Discretion|1|||
41939830|NCT02312934|75661370|FG000|Overall Study|Lost to Follow-up|1|||
41939831|NCT02312934|75661371|FG001|Overall Study|Lost to Follow-up|0|||
41939832|NCT02312934|75661370|FG000|Overall Study|Physician Decision|1|||
41939833|NCT02312934|75661371|FG001|Overall Study|Physician Decision|0|||
41939834|NCT02341482|75661405|FG000|Overall Study|Adverse Event|1|||
41939835|NCT02312856|75661445|FG000|Overall Study|Death|1|||
41939836|NCT02312856|75661445|FG000|Overall Study|Lost to Follow-up|3|||
41939837|NCT01602120|75661910|FG000|Overall Study|Adverse Event|3|||
41939838|NCT01602120|75661911|FG001|Overall Study|Adverse Event|6|||
42022792|NCT01230710|75830093|FG000|Overall Study|Withdrawal of Consent|1|||
42022793|NCT01230554|75830097|FG000|Overall Study|Lost to Follow-up|2|||
41939839|NCT01602120|75661912|FG002|Overall Study|Adverse Event|0|||
41939840|NCT01602120|75661913|FG003|Overall Study|Adverse Event|2|||
41939841|NCT01602120|75661910|FG000|Overall Study|Death|0|||
41939842|NCT01602120|75661911|FG001|Overall Study|Death|4|||
41939843|NCT01602120|75661912|FG002|Overall Study|Death|0|||
41939844|NCT01602120|75661913|FG003|Overall Study|Death|0|||
41939845|NCT01602120|75661910|FG000|Overall Study|Lost to Follow-up|0|||
41939846|NCT01602120|75661911|FG001|Overall Study|Lost to Follow-up|1|||
41939847|NCT01602120|75661912|FG002|Overall Study|Lost to Follow-up|0|||
41939848|NCT01602120|75661913|FG003|Overall Study|Lost to Follow-up|1|||
41939849|NCT01602120|75661910|FG000|Overall Study|Protocol Violation|1|||
41939850|NCT01602120|75661911|FG001|Overall Study|Protocol Violation|1|||
41939851|NCT01602120|75661912|FG002|Overall Study|Protocol Violation|0|||
41939852|NCT01602120|75661913|FG003|Overall Study|Protocol Violation|0|||
41939853|NCT01602120|75661910|FG000|Overall Study|Non-compliance|0|||
41939854|NCT01602120|75661911|FG001|Overall Study|Non-compliance|3|||
41939855|NCT01602120|75661912|FG002|Overall Study|Non-compliance|0|||
41939856|NCT01602120|75661913|FG003|Overall Study|Non-compliance|1|||
41939857|NCT01602120|75661910|FG000|Overall Study|Withdrawal by Subject|8|||
41939858|NCT01602120|75661911|FG001|Overall Study|Withdrawal by Subject|17|||
41939859|NCT01602120|75661912|FG002|Overall Study|Withdrawal by Subject|0|||
41939860|NCT01602120|75661913|FG003|Overall Study|Withdrawal by Subject|3|||
41939861|NCT01602120|75661910|FG000|Overall Study|Study Terminated by Sponsor|12|||
41939862|NCT01602120|75661911|FG001|Overall Study|Study Terminated by Sponsor|24|||
41939863|NCT01602120|75661912|FG002|Overall Study|Study Terminated by Sponsor|17|||
41939864|NCT01602120|75661913|FG003|Overall Study|Study Terminated by Sponsor|44|||
41939865|NCT01602120|75661910|FG000|Overall Study|Physician Decision|2|||
41939866|NCT01602120|75661911|FG001|Overall Study|Physician Decision|3|||
41939867|NCT01602120|75661912|FG002|Overall Study|Physician Decision|0|||
41939868|NCT01602120|75661913|FG003|Overall Study|Physician Decision|0|||
41939869|NCT01602120|75661910|FG000|Overall Study|Unspecified Reason|3|||
41939870|NCT01602120|75661911|FG001|Overall Study|Unspecified Reason|1|||
41939871|NCT01602120|75661912|FG002|Overall Study|Unspecified Reason|0|||
41939872|NCT01602120|75661913|FG003|Overall Study|Unspecified Reason|2|||
41939873|NCT04543955|75662720|FG000|Overall Study|Company cancelled study|1|||
41939874|NCT04543955|75662721|FG001|Overall Study|Company cancelled study|0|||
41939875|NCT04436744|75663271|FG000|Overall Study|Adverse Event|1|||
41939876|NCT04436744|75663272|FG001|Overall Study|Adverse Event|1|||
41939877|NCT04436744|75663271|FG000|Overall Study|Death|1|||
41939878|NCT04436744|75663272|FG001|Overall Study|Death|0|||
41939879|NCT04436744|75663271|FG000|Overall Study|Lost to Follow-up|0|||
41939880|NCT04436744|75663272|FG001|Overall Study|Lost to Follow-up|2|||
41939881|NCT04436744|75663271|FG000|Overall Study|Physician Decision|0|||
41939882|NCT04436744|75663272|FG001|Overall Study|Physician Decision|1|||
41939883|NCT04436744|75663271|FG000|Overall Study|Progressive Disease|0|||
41939884|NCT04436744|75663272|FG001|Overall Study|Progressive Disease|4|||
41939885|NCT04436744|75663271|FG000|Overall Study|Protocol Deviation|1|||
41939886|NCT04436744|75663272|FG001|Overall Study|Protocol Deviation|1|||
41939887|NCT04436744|75663271|FG000|Overall Study|Withdrawal by Subject|1|||
41939888|NCT04436744|75663272|FG001|Overall Study|Withdrawal by Subject|2|||
41939889|NCT02243306|75663419|FG000|Overall Study|Adverse Event|0|||
41939890|NCT02243306|75663420|FG001|Overall Study|Adverse Event|1|||
41939891|NCT02243306|75663419|FG000|Overall Study|Other: Reached stopping criteria|0|||
41939892|NCT02243306|75663420|FG001|Overall Study|Other: Reached stopping criteria|1|||
41939893|NCT02243306|75663419|FG000|Overall Study|Physician Decision|0|||
41939894|NCT02243306|75663420|FG001|Overall Study|Physician Decision|1|||
41939895|NCT03214679|75663576|FG000|Overall Study|Lost to Follow-up|12|||
41939896|NCT03214679|75663577|FG001|Overall Study|Lost to Follow-up|14|||
41939897|NCT03214679|75663576|FG000|Overall Study|not eligible|2|||
41939898|NCT03214679|75663577|FG001|Overall Study|not eligible|0|||
41939899|NCT01602380|75663924|FG000|Overall Study|Death|63|||
41939900|NCT01602380|75663925|FG001|Overall Study|Death|68|||
42022794|NCT01230554|75830097|FG000|Overall Study|Inability to maintain visit schedule|1|||
42022795|NCT01040793|75830101|FG000|Overall Study|Adverse Event|5|||
42022796|NCT01040793|75830102|FG001|Overall Study|Adverse Event|3|||
41939901|NCT01602380|75663924|FG000|Overall Study|Withdrawal by Subject|22|||
41939902|NCT01602380|75663925|FG001|Overall Study|Withdrawal by Subject|29|||
41939903|NCT01602380|75663924|FG000|Overall Study|Lost to Follow-up|6|||
41939904|NCT01602380|75663925|FG001|Overall Study|Lost to Follow-up|1|||
41939905|NCT01602380|75663924|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
41939906|NCT01602380|75663925|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
41939907|NCT01349465|75664859|FG000|Overall Study|Adverse Event|1|||
41939908|NCT01349465|75664860|FG001|Overall Study|Adverse Event|0|||
41939909|NCT01349465|75664859|FG000|Overall Study|Death|3|||
41939910|NCT01349465|75664860|FG001|Overall Study|Death|0|||
41939911|NCT01349465|75664859|FG000|Overall Study|Lost to Follow-up|10|||
41939912|NCT01349465|75664860|FG001|Overall Study|Lost to Follow-up|1|||
41939913|NCT01349465|75664859|FG000|Overall Study|Withdrawal by Subject|4|||
42022797|NCT01040793|75830103|FG002|Overall Study|Adverse Event|0|||
41939914|NCT01349465|75664860|FG001|Overall Study|Withdrawal by Subject|2|||
41939915|NCT01349465|75664859|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
41939916|NCT01349465|75664860|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
41939917|NCT01648764|75665970|FG000|Overall Study|Progressive Disease|0|||
41939918|NCT01648764|75665971|FG001|Overall Study|Progressive Disease|1|||
41939919|NCT01648764|75665972|FG002|Overall Study|Progressive Disease|0|||
41939920|NCT01648764|75665973|FG003|Overall Study|Progressive Disease|0|||
41939921|NCT01648764|75665974|FG004|Overall Study|Progressive Disease|0|||
41939922|NCT01648764|75665975|FG005|Overall Study|Progressive Disease|1|||
41939923|NCT01648764|75665976|FG006|Overall Study|Progressive Disease|1|||
41939924|NCT01648764|75665977|FG007|Overall Study|Progressive Disease|0|||
41939925|NCT01648764|75665978|FG008|Overall Study|Progressive Disease|0|||
41939926|NCT01648764|75665979|FG009|Overall Study|Progressive Disease|2|||
41939927|NCT01648764|75665980|FG010|Overall Study|Progressive Disease|0|||
41939928|NCT01648764|75665981|FG011|Overall Study|Progressive Disease|1|||
41939929|NCT01648764|75665982|FG012|Overall Study|Progressive Disease|2|||
41939930|NCT01648764|75665983|FG013|Overall Study|Progressive Disease|1|||
41939931|NCT01648764|75665970|FG000|Overall Study|Adverse Event|0|||
41939932|NCT01648764|75665971|FG001|Overall Study|Adverse Event|0|||
41939933|NCT01648764|75665972|FG002|Overall Study|Adverse Event|0|||
41939934|NCT01648764|75665973|FG003|Overall Study|Adverse Event|0|||
41939935|NCT01648764|75665974|FG004|Overall Study|Adverse Event|0|||
41939936|NCT01648764|75665975|FG005|Overall Study|Adverse Event|1|||
41939937|NCT01648764|75665976|FG006|Overall Study|Adverse Event|0|||
41939938|NCT01648764|75665977|FG007|Overall Study|Adverse Event|0|||
41939939|NCT01648764|75665978|FG008|Overall Study|Adverse Event|0|||
41939940|NCT01648764|75665979|FG009|Overall Study|Adverse Event|1|||
41939941|NCT01648764|75665980|FG010|Overall Study|Adverse Event|0|||
41939942|NCT01648764|75665981|FG011|Overall Study|Adverse Event|3|||
41939943|NCT01648764|75665982|FG012|Overall Study|Adverse Event|1|||
41939944|NCT01648764|75665983|FG013|Overall Study|Adverse Event|1|||
41939945|NCT01648764|75665970|FG000|Overall Study|Death|0|||
41939946|NCT01648764|75665971|FG001|Overall Study|Death|0|||
41939947|NCT01648764|75665972|FG002|Overall Study|Death|0|||
41939948|NCT01648764|75665973|FG003|Overall Study|Death|0|||
41939949|NCT01648764|75665974|FG004|Overall Study|Death|0|||
41939950|NCT01648764|75665975|FG005|Overall Study|Death|0|||
41939951|NCT01648764|75665976|FG006|Overall Study|Death|1|||
41939952|NCT01648764|75665977|FG007|Overall Study|Death|0|||
41939953|NCT01648764|75665978|FG008|Overall Study|Death|0|||
41939954|NCT01648764|75665979|FG009|Overall Study|Death|0|||
41939955|NCT01648764|75665980|FG010|Overall Study|Death|0|||
41939956|NCT01648764|75665981|FG011|Overall Study|Death|0|||
41939957|NCT01648764|75665982|FG012|Overall Study|Death|0|||
41939958|NCT01648764|75665983|FG013|Overall Study|Death|1|||
41939959|NCT01648764|75665970|FG000|Overall Study|Withdrawal by Subject|0|||
41939960|NCT01648764|75665971|FG001|Overall Study|Withdrawal by Subject|0|||
41939961|NCT01648764|75665972|FG002|Overall Study|Withdrawal by Subject|0|||
41939962|NCT01648764|75665973|FG003|Overall Study|Withdrawal by Subject|0|||
41939963|NCT01648764|75665974|FG004|Overall Study|Withdrawal by Subject|0|||
41939964|NCT01648764|75665975|FG005|Overall Study|Withdrawal by Subject|0|||
41939965|NCT01648764|75665976|FG006|Overall Study|Withdrawal by Subject|2|||
41939966|NCT01648764|75665977|FG007|Overall Study|Withdrawal by Subject|0|||
41939967|NCT01648764|75665978|FG008|Overall Study|Withdrawal by Subject|0|||
41939968|NCT01648764|75665979|FG009|Overall Study|Withdrawal by Subject|0|||
41939969|NCT01648764|75665980|FG010|Overall Study|Withdrawal by Subject|0|||
41939970|NCT01648764|75665981|FG011|Overall Study|Withdrawal by Subject|0|||
41939971|NCT01648764|75665982|FG012|Overall Study|Withdrawal by Subject|1|||
41939972|NCT01648764|75665983|FG013|Overall Study|Withdrawal by Subject|0|||
41939973|NCT01648764|75665970|FG000|Overall Study|Investigator Decision|0|||
41939974|NCT01648764|75665971|FG001|Overall Study|Investigator Decision|0|||
41939975|NCT01648764|75665972|FG002|Overall Study|Investigator Decision|0|||
41939976|NCT01648764|75665973|FG003|Overall Study|Investigator Decision|0|||
41939977|NCT01648764|75665974|FG004|Overall Study|Investigator Decision|0|||
41939978|NCT01648764|75665975|FG005|Overall Study|Investigator Decision|0|||
41939979|NCT01648764|75665976|FG006|Overall Study|Investigator Decision|1|||
41939980|NCT01648764|75665977|FG007|Overall Study|Investigator Decision|0|||
41939981|NCT01648764|75665978|FG008|Overall Study|Investigator Decision|0|||
41939982|NCT01648764|75665979|FG009|Overall Study|Investigator Decision|0|||
41939983|NCT01648764|75665980|FG010|Overall Study|Investigator Decision|0|||
41939984|NCT01648764|75665981|FG011|Overall Study|Investigator Decision|1|||
41939985|NCT01648764|75665982|FG012|Overall Study|Investigator Decision|0|||
41939986|NCT01648764|75665983|FG013|Overall Study|Investigator Decision|0|||
41939987|NCT02364336|75666019|FG000|Overall Study|Adverse Event|0|||
41939988|NCT02364336|75666020|FG001|Overall Study|Adverse Event|1|||
41939989|NCT02810951|75666251|FG000|Overall Study|Adverse Event|1|||
41939990|NCT02310906|75666347|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
41939991|NCT02310906|75666348|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
41939992|NCT02310906|75666349|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
41939993|NCT02310906|75666350|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
41939994|NCT02310906|75666347|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
41939995|NCT02310906|75666348|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
41939996|NCT02310906|75666349|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
41939997|NCT02310906|75666350|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
41939998|NCT02310906|75666347|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
41939999|NCT02310906|75666348|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
41940000|NCT02310906|75666349|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
41940001|NCT02310906|75666350|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
41940002|NCT02310906|75666347|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
41940003|NCT02310906|75666348|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
41940004|NCT02310906|75666349|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
41940005|NCT02310906|75666350|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
41940006|NCT02340078|75666400|FG000|Overall Study|Protocol Violation|1|||
41940007|NCT02340000|75666416|FG000|Time Period 1|Withdrawal by Subject|6|||
41940008|NCT02340000|75666417|FG001|Time Period 1|Withdrawal by Subject|8|||
41940009|NCT02340000|75666416|FG000|Time Period 1|Lost to Follow-up|6|||
41940010|NCT02340000|75666417|FG001|Time Period 1|Lost to Follow-up|7|||
41940011|NCT02340000|75666416|FG000|Time Period 2|Withdrawal by Subject|9|||
41940012|NCT02340000|75666417|FG001|Time Period 2|Withdrawal by Subject|7|||
41940013|NCT02340000|75666416|FG000|Time Period 2|Lost to Follow-up|10|||
41940014|NCT02340000|75666417|FG001|Time Period 2|Lost to Follow-up|8|||
41940015|NCT02364180|75666448|FG000|Overall Study|Screen Fail|1|||
41940016|NCT02310750|75667086|FG000|HP Period 1|Lost to Follow-up|0|||
41940017|NCT02310750|75667087|FG001|HP Period 1|Lost to Follow-up|0|||
41940018|NCT02310750|75667088|FG002|HP Period 1|Lost to Follow-up|0|||
41940019|NCT02310750|75667089|FG003|HP Period 1|Lost to Follow-up|0|||
41940020|NCT02310750|75667090|FG004|HP Period 1|Lost to Follow-up|0|||
41940021|NCT02310750|75667091|FG005|HP Period 1|Lost to Follow-up|0|||
41940022|NCT02310750|75667092|FG006|HP Period 1|Lost to Follow-up|1|||
41940023|NCT02310750|75667093|FG007|HP Period 1|Lost to Follow-up|0|||
41940024|NCT02310750|75667094|FG008|HP Period 1|Lost to Follow-up|0|||
41940025|NCT02310750|75667095|FG009|HP Period 1|Lost to Follow-up|0|||
41940026|NCT02310750|75667096|FG010|HP Period 1|Lost to Follow-up|0|||
41940027|NCT02310750|75667097|FG011|HP Period 1|Lost to Follow-up|0|||
41940028|NCT02310750|75667098|FG012|HP Period 1|Lost to Follow-up|0|||
41940029|NCT02310750|75667099|FG013|HP Period 1|Lost to Follow-up|0|||
41940030|NCT02310750|75667100|FG014|HP Period 1|Lost to Follow-up|0|||
41940031|NCT02310750|75667101|FG015|HP Period 1|Lost to Follow-up|0|||
41940032|NCT02310750|75667086|FG000|HP Period 1|Withdrawal by Subject|1|||
41940033|NCT02310750|75667087|FG001|HP Period 1|Withdrawal by Subject|0|||
41940034|NCT02310750|75667088|FG002|HP Period 1|Withdrawal by Subject|0|||
41940035|NCT02310750|75667089|FG003|HP Period 1|Withdrawal by Subject|1|||
41940036|NCT02310750|75667090|FG004|HP Period 1|Withdrawal by Subject|0|||
41940037|NCT02310750|75667091|FG005|HP Period 1|Withdrawal by Subject|0|||
41940038|NCT02310750|75667092|FG006|HP Period 1|Withdrawal by Subject|0|||
41940039|NCT02310750|75667093|FG007|HP Period 1|Withdrawal by Subject|0|||
41940040|NCT02310750|75667094|FG008|HP Period 1|Withdrawal by Subject|0|||
41940041|NCT02310750|75667095|FG009|HP Period 1|Withdrawal by Subject|0|||
41940042|NCT02310750|75667096|FG010|HP Period 1|Withdrawal by Subject|0|||
41940043|NCT02310750|75667097|FG011|HP Period 1|Withdrawal by Subject|0|||
41940044|NCT02310750|75667098|FG012|HP Period 1|Withdrawal by Subject|0|||
41940045|NCT02310750|75667099|FG013|HP Period 1|Withdrawal by Subject|0|||
41940046|NCT02310750|75667100|FG014|HP Period 1|Withdrawal by Subject|0|||
41940047|NCT02310750|75667101|FG015|HP Period 1|Withdrawal by Subject|0|||
41940048|NCT02310750|75667086|FG000|HP Washout 1|Lost to Follow-up|0|||
41940049|NCT02310750|75667087|FG001|HP Washout 1|Lost to Follow-up|0|||
41940050|NCT02310750|75667088|FG002|HP Washout 1|Lost to Follow-up|1|||
41940051|NCT02310750|75667089|FG003|HP Washout 1|Lost to Follow-up|1|||
41940052|NCT02310750|75667090|FG004|HP Washout 1|Lost to Follow-up|2|||
41940053|NCT02310750|75667091|FG005|HP Washout 1|Lost to Follow-up|2|||
41940054|NCT02310750|75667092|FG006|HP Washout 1|Lost to Follow-up|3|||
41940055|NCT02310750|75667093|FG007|HP Washout 1|Lost to Follow-up|0|||
41940056|NCT02310750|75667094|FG008|HP Washout 1|Lost to Follow-up|0|||
41940057|NCT02310750|75667095|FG009|HP Washout 1|Lost to Follow-up|0|||
41940058|NCT02310750|75667096|FG010|HP Washout 1|Lost to Follow-up|0|||
41940059|NCT02310750|75667097|FG011|HP Washout 1|Lost to Follow-up|0|||
41940060|NCT02310750|75667098|FG012|HP Washout 1|Lost to Follow-up|0|||
41940061|NCT02310750|75667099|FG013|HP Washout 1|Lost to Follow-up|0|||
41940062|NCT02310750|75667100|FG014|HP Washout 1|Lost to Follow-up|0|||
41940063|NCT02310750|75667101|FG015|HP Washout 1|Lost to Follow-up|0|||
41940064|NCT02310750|75667086|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940065|NCT02310750|75667087|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940066|NCT02310750|75667088|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940067|NCT02310750|75667089|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
41940068|NCT02310750|75667090|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940069|NCT02310750|75667091|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
41940070|NCT02310750|75667092|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940071|NCT02310750|75667093|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940072|NCT02310750|75667094|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
41940073|NCT02310750|75667095|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
41940074|NCT02310750|75667096|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940075|NCT02310750|75667097|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940076|NCT02310750|75667098|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940077|NCT02310750|75667099|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940078|NCT02310750|75667100|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940079|NCT02310750|75667101|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
41940080|NCT02310750|75667086|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940081|NCT02310750|75667087|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940082|NCT02310750|75667088|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940083|NCT02310750|75667089|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940084|NCT02310750|75667090|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940085|NCT02310750|75667091|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940086|NCT02310750|75667092|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940087|NCT02310750|75667093|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940088|NCT02310750|75667094|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940089|NCT02310750|75667095|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
41940090|NCT02310750|75667096|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940091|NCT02310750|75667097|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940092|NCT02310750|75667098|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940093|NCT02310750|75667099|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940094|NCT02310750|75667100|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940095|NCT02310750|75667101|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
41940096|NCT02310750|75667086|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940097|NCT02310750|75667087|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940098|NCT02310750|75667088|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940099|NCT02310750|75667089|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940100|NCT02310750|75667090|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940101|NCT02310750|75667091|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940102|NCT02310750|75667092|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940103|NCT02310750|75667093|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
41940104|NCT02310750|75667094|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
41940105|NCT02310750|75667095|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
41940106|NCT02310750|75667096|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940107|NCT02310750|75667097|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940108|NCT02310750|75667098|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940109|NCT02310750|75667099|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940110|NCT02310750|75667100|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940111|NCT02310750|75667101|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
41940112|NCT02310750|75667086|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940113|NCT02310750|75667087|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940114|NCT02310750|75667088|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940115|NCT02310750|75667089|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940116|NCT02310750|75667090|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940117|NCT02310750|75667091|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940118|NCT02310750|75667092|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940119|NCT02310750|75667093|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
41940120|NCT02310750|75667094|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
41940121|NCT02310750|75667095|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940122|NCT02310750|75667096|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940123|NCT02310750|75667097|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940124|NCT02310750|75667098|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940125|NCT02310750|75667099|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940126|NCT02310750|75667100|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940127|NCT02310750|75667101|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
41940128|NCT02310750|75667086|FG000|HP Washout 2|Lost to Follow-up|0|||
41940129|NCT02310750|75667087|FG001|HP Washout 2|Lost to Follow-up|0|||
41940130|NCT02310750|75667088|FG002|HP Washout 2|Lost to Follow-up|0|||
41940131|NCT02310750|75667089|FG003|HP Washout 2|Lost to Follow-up|0|||
41940132|NCT02310750|75667090|FG004|HP Washout 2|Lost to Follow-up|1|||
41940133|NCT02310750|75667091|FG005|HP Washout 2|Lost to Follow-up|0|||
41940134|NCT02310750|75667092|FG006|HP Washout 2|Lost to Follow-up|7|||
41940135|NCT02310750|75667093|FG007|HP Washout 2|Lost to Follow-up|0|||
41940136|NCT02310750|75667094|FG008|HP Washout 2|Lost to Follow-up|0|||
41940137|NCT02310750|75667095|FG009|HP Washout 2|Lost to Follow-up|0|||
41940138|NCT02310750|75667096|FG010|HP Washout 2|Lost to Follow-up|0|||
41940139|NCT02310750|75667097|FG011|HP Washout 2|Lost to Follow-up|0|||
41940140|NCT02310750|75667098|FG012|HP Washout 2|Lost to Follow-up|0|||
41940141|NCT02310750|75667099|FG013|HP Washout 2|Lost to Follow-up|0|||
41940142|NCT02310750|75667100|FG014|HP Washout 2|Lost to Follow-up|0|||
41940143|NCT02310750|75667101|FG015|HP Washout 2|Lost to Follow-up|0|||
41940144|NCT02310672|75667206|FG000|Overall Study|Death|1|||
41940145|NCT02310672|75667206|FG000|Overall Study|Lost to Follow-up|1|||
41940146|NCT02310672|75667206|FG000|Overall Study|Withdrawal by Subject|1|||
41940147|NCT02310672|75667206|FG000|Overall Study|Sponsor's decision|12|||
41940148|NCT02363946|75667352|FG000|Overall Study|Lost to Follow-up|0|||
41940149|NCT02363946|75667353|FG001|Overall Study|Lost to Follow-up|0|||
41940150|NCT02363946|75667354|FG002|Overall Study|Lost to Follow-up|0|||
41940151|NCT02363946|75667355|FG003|Overall Study|Lost to Follow-up|0|||
41940152|NCT02363946|75667356|FG004|Overall Study|Lost to Follow-up|0|||
41940153|NCT02363946|75667357|FG005|Overall Study|Lost to Follow-up|0|||
41940154|NCT02363946|75667358|FG006|Overall Study|Lost to Follow-up|0|||
41940155|NCT02363946|75667359|FG007|Overall Study|Lost to Follow-up|1|||
41940156|NCT02363946|75667360|FG008|Overall Study|Lost to Follow-up|0|||
41940157|NCT02363946|75667361|FG009|Overall Study|Lost to Follow-up|0|||
41940158|NCT02363946|75667362|FG010|Overall Study|Lost to Follow-up|0|||
41940159|NCT02363946|75667363|FG011|Overall Study|Lost to Follow-up|0|||
41940160|NCT02363946|75667364|FG012|Overall Study|Lost to Follow-up|0|||
41940161|NCT02363478|75667392|FG000|Overall Study|Lost to Follow-up|4|||
41940162|NCT02363478|75667392|FG000|Overall Study|Adverse Event|4|||
41940163|NCT02310126|75667399|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
41940164|NCT02310126|75667400|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
41940165|NCT02310126|75667399|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
41940166|NCT02310126|75667400|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
41940167|NCT02338362|75667408|FG000|Overall Study|Withdrawal by Subject|1|||
41940168|NCT02338362|75667409|FG001|Overall Study|Withdrawal by Subject|1|||
41940169|NCT02363322|75667417|FG000|Overall Study|Lost to Follow-up|1|||
41940170|NCT02363322|75667418|FG001|Overall Study|Lost to Follow-up|0|||
41940171|NCT02361762|75667426|FG000|Overall Study|Withdrawal by Subject|0|||
41940172|NCT02361762|75667427|FG001|Overall Study|Withdrawal by Subject|1|||
41940173|NCT02361762|75667426|FG000|Overall Study|Lost to Follow-up|0|||
41940174|NCT02361762|75667427|FG001|Overall Study|Lost to Follow-up|1|||
41940175|NCT02337738|75667436|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
41940176|NCT02337738|75667437|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
41940177|NCT02337738|75667438|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
41940178|NCT02337738|75667436|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
41940179|NCT02337738|75667437|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
41940180|NCT02337738|75667438|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
41940181|NCT02337738|75667436|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
41940182|NCT02337738|75667437|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
41940183|NCT02337738|75667438|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
41940184|NCT02337738|75667436|FG000|Overall Study|Voluntary Withdrawal|10|||
41940185|NCT02337738|75667437|FG001|Overall Study|Voluntary Withdrawal|5|||
41940186|NCT02337738|75667438|FG002|Overall Study|Voluntary Withdrawal|2|||
41940187|NCT02337738|75667436|FG000|Overall Study|Lack of Efficacy|2|||
41940188|NCT02337738|75667437|FG001|Overall Study|Lack of Efficacy|4|||
41940189|NCT02337738|75667438|FG002|Overall Study|Lack of Efficacy|0|||
41940190|NCT02337738|75667436|FG000|Overall Study|Investigator's Judgment|1|||
41940191|NCT02337738|75667437|FG001|Overall Study|Investigator's Judgment|1|||
41940192|NCT02337738|75667438|FG002|Overall Study|Investigator's Judgment|3|||
41940193|NCT02309112|75667449|FG000|Overall Study|Withdrawal by Subject|1|||
41940194|NCT02309112|75667450|FG001|Overall Study|Withdrawal by Subject|0|||
41940195|NCT02309112|75667451|FG002|Overall Study|Withdrawal by Subject|1|||
41940196|NCT02309112|75667449|FG000|Overall Study|Lost to Follow-up|0|||
41940197|NCT02309112|75667450|FG001|Overall Study|Lost to Follow-up|1|||
41940198|NCT02309112|75667451|FG002|Overall Study|Lost to Follow-up|0|||
41940199|NCT02361216|75667463|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
41940200|NCT02361216|75667464|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
41940201|NCT02361216|75667463|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
41940202|NCT02361216|75667464|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
41940203|NCT02361216|75667463|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
41940204|NCT02361216|75667464|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
41940205|NCT02361216|75667463|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
41940206|NCT02361216|75667464|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
41940207|NCT02361216|75667463|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
41940208|NCT02361216|75667464|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
41940209|NCT02361216|75667463|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
41940210|NCT02361216|75667464|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
41940211|NCT00559988|75667897|FG000|Overall Study|Death|147|||
41940212|NCT00559988|75667898|FG001|Overall Study|Death|140|||
41940213|NCT00559988|75667897|FG000|Overall Study|Withdrawal by Subject|152|||
41940214|NCT00559988|75667898|FG001|Overall Study|Withdrawal by Subject|139|||
41940215|NCT00559988|75667897|FG000|Overall Study|Lost to Follow-up|42|||
41940216|NCT00559988|75667898|FG001|Overall Study|Lost to Follow-up|56|||
41940217|NCT00559988|75667897|FG000|Overall Study|ICD device explanted|10|||
41940218|NCT00559988|75667898|FG001|Overall Study|ICD device explanted|17|||
41940219|NCT00559754|75667960|FG000|Overall Study|Disease progression|1|||
41940220|NCT00559754|75667960|FG000|Overall Study|Adverse Event|5|||
41940221|NCT00559754|75667960|FG000|Overall Study|Protocol Violation|1|||
41940222|NCT00559754|75667960|FG000|Overall Study|Investigator criteria|2|||
41940223|NCT00559754|75667960|FG000|Overall Study|Withdrawal by Subject|2|||
41940224|NCT00559364|75668074|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
41940225|NCT00559364|75668075|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
41940226|NCT02308020|75668138|FG000|Overall Study|Lost to Follow-up|1|||
41940227|NCT02308020|75668139|FG001|Overall Study|Lost to Follow-up|7|||
41940228|NCT02308020|75668140|FG002|Overall Study|Lost to Follow-up|0|||
41940229|NCT02308020|75668141|FG003|Overall Study|Lost to Follow-up|0|||
41940230|NCT02308020|75668142|FG004|Overall Study|Lost to Follow-up|1|||
41940231|NCT02308020|75668143|FG005|Overall Study|Lost to Follow-up|2|||
41940232|NCT02308020|75668138|FG000|Overall Study|Sponsor Decision|0|||
41940233|NCT02308020|75668139|FG001|Overall Study|Sponsor Decision|8|||
41940234|NCT02308020|75668140|FG002|Overall Study|Sponsor Decision|0|||
41940235|NCT02308020|75668141|FG003|Overall Study|Sponsor Decision|2|||
41940236|NCT02308020|75668142|FG004|Overall Study|Sponsor Decision|2|||
41940237|NCT02308020|75668143|FG005|Overall Study|Sponsor Decision|1|||
41940238|NCT02308020|75668138|FG000|Overall Study|Withdrawal by Subject|3|||
41940239|NCT02308020|75668139|FG001|Overall Study|Withdrawal by Subject|5|||
41940240|NCT02308020|75668140|FG002|Overall Study|Withdrawal by Subject|3|||
41940241|NCT02308020|75668141|FG003|Overall Study|Withdrawal by Subject|2|||
41940242|NCT02308020|75668142|FG004|Overall Study|Withdrawal by Subject|1|||
41940243|NCT02308020|75668143|FG005|Overall Study|Withdrawal by Subject|2|||
41940244|NCT02359890|75668163|FG000|Overall Study|Not meeting eligibility|4|||
41940245|NCT02359890|75668163|FG000|Overall Study|Never treated with study catheter|6|||
41940246|NCT02306850|75668167|FG000|Overall Study|Lack of Efficacy|2|||
41940247|NCT02306694|75668172|FG000|Overall Study|Withdrawal by Subject|3|||
41940248|NCT02306694|75668172|FG000|Overall Study|Lost to Follow-up|1|||
41940249|NCT01648140|75668184|FG000|Overall Study|Physician Decision|1|||
41940250|NCT01648140|75668185|FG001|Overall Study|Physician Decision|0|||
41940251|NCT01648140|75668186|FG002|Overall Study|Physician Decision|0|||
41940252|NCT01648140|75668187|FG003|Overall Study|Physician Decision|0|||
41940253|NCT01648140|75668184|FG000|Overall Study|Lack of Efficacy|4|||
41940254|NCT01648140|75668185|FG001|Overall Study|Lack of Efficacy|7|||
41940255|NCT01648140|75668186|FG002|Overall Study|Lack of Efficacy|1|||
41940256|NCT01648140|75668187|FG003|Overall Study|Lack of Efficacy|0|||
41940257|NCT01648140|75668184|FG000|Overall Study|Adverse Event|3|||
41940258|NCT01648140|75668185|FG001|Overall Study|Adverse Event|1|||
41940259|NCT01648140|75668186|FG002|Overall Study|Adverse Event|2|||
41940260|NCT01648140|75668187|FG003|Overall Study|Adverse Event|0|||
41940261|NCT01648140|75668184|FG000|Overall Study|Withdrawal by Subject|2|||
41940262|NCT01648140|75668185|FG001|Overall Study|Withdrawal by Subject|3|||
41940263|NCT01648140|75668186|FG002|Overall Study|Withdrawal by Subject|3|||
41940264|NCT01648140|75668187|FG003|Overall Study|Withdrawal by Subject|2|||
41940265|NCT01648140|75668184|FG000|Overall Study|Lost to Follow-up|2|||
41940266|NCT01648140|75668185|FG001|Overall Study|Lost to Follow-up|1|||
41940267|NCT01648140|75668186|FG002|Overall Study|Lost to Follow-up|2|||
41940268|NCT01648140|75668187|FG003|Overall Study|Lost to Follow-up|0|||
41940269|NCT02336178|75668206|FG000|Overall Study|Lost to Follow-up|1|||
41940270|NCT02336178|75668206|FG000|Overall Study|Protocol Violation|1|||
41940271|NCT02336178|75668206|FG000|Overall Study|Withdrawal by Subject|1|||
41940272|NCT02336178|75668206|FG000|Overall Study|Other|1|||
41940273|NCT02357940|75668220|FG000|Overall Study|Adverse Event|0|||
41940274|NCT02357940|75668221|FG001|Overall Study|Adverse Event|1|||
41940275|NCT02357940|75668220|FG000|Overall Study|Investigator's judgement|0|||
41940276|NCT02357940|75668221|FG001|Overall Study|Investigator's judgement|1|||
41940277|NCT02335242|75668229|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
41940278|NCT02335242|75668230|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
41940279|NCT02335242|75668229|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
41940280|NCT02335242|75668230|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
41940281|NCT02335242|75668229|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
41940282|NCT02335242|75668230|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
41940283|NCT02334384|75668242|FG000|Overall Study|Lost to Follow-up|1|||
41940284|NCT02334384|75668243|FG001|Overall Study|Lost to Follow-up|1|||
41940285|NCT02334306|75668251|FG000|Double-blind Period|Adverse Event|0|||
41940286|NCT02334306|75668252|FG001|Double-blind Period|Adverse Event|1|||
41940287|NCT02334306|75668251|FG000|Double-blind Period|Withdrawal by Subject|1|||
41940288|NCT02334306|75668252|FG001|Double-blind Period|Withdrawal by Subject|1|||
41940289|NCT02305758|75668261|FG000|Overall Study|Death|27|||
41940290|NCT02305758|75668262|FG001|Overall Study|Death|27|||
41940291|NCT02305758|75668261|FG000|Overall Study|Withdrew consent|9|||
41940292|NCT02305758|75668262|FG001|Overall Study|Withdrew consent|2|||
41940293|NCT02305758|75668261|FG000|Overall Study|Lost to Follow-up|6|||
41940294|NCT02305758|75668262|FG001|Overall Study|Lost to Follow-up|1|||
41940295|NCT02305758|75668261|FG000|Overall Study|Study Terminated by Sponsor|21|||
41940296|NCT02305758|75668262|FG001|Overall Study|Study Terminated by Sponsor|34|||
41940297|NCT02305758|75668261|FG000|Overall Study|Other, not specified|2|||
41940298|NCT02305758|75668262|FG001|Overall Study|Other, not specified|1|||
41940299|NCT02305446|75668268|FG000|Overall Study|Adverse Event|1|||
41940300|NCT02303574|75668405|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
41940301|NCT02303574|75668406|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
41940302|NCT02303574|75668407|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
41940303|NCT02303574|75668408|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
41940304|NCT02303574|75668409|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
41940305|NCT02303574|75668410|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
42300237|NCT02327013|76135381|FG000|Overall Study|Administrative or other reason(s)|1|||
42300238|NCT02327013|76135382|FG001|Overall Study|Administrative or other reason(s)|5|||
42300239|NCT02327013|76135383|FG002|Overall Study|Administrative or other reason(s)|11|||
42300240|NCT02327013|76135384|FG003|Overall Study|Administrative or other reason(s)|1|||
42300241|NCT02327013|76135385|FG004|Overall Study|Administrative or other reason(s)|1|||
42300242|NCT02327013|76135381|FG000|Overall Study|Protocol Violation|0|||
42300243|NCT02327013|76135382|FG001|Overall Study|Protocol Violation|0|||
42300244|NCT02327013|76135383|FG002|Overall Study|Protocol Violation|3|||
42300245|NCT02327013|76135384|FG003|Overall Study|Protocol Violation|0|||
41940306|NCT02303574|75668411|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
41940307|NCT02303574|75668412|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
41940308|NCT02303574|75668413|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
41940309|NCT02303574|75668414|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
41940310|NCT02303574|75668405|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
41940311|NCT02303574|75668406|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
41940312|NCT02303574|75668407|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
41940313|NCT02303574|75668408|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
41940314|NCT02303574|75668409|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
41940315|NCT02303574|75668410|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
41940316|NCT02303574|75668411|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
41940317|NCT02303574|75668412|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
41940318|NCT02303574|75668413|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
41940319|NCT02303574|75668414|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
41940320|NCT02354976|75668450|FG000|Overall Study|Other - reason not specified|1|||
41940321|NCT02354976|75668451|FG001|Overall Study|Other - reason not specified|0|||
41940322|NCT02354976|75668452|FG002|Overall Study|Other - reason not specified|1|||
41940323|NCT02354976|75668450|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
41940324|NCT02354976|75668451|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
41940325|NCT02354976|75668452|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
41940326|NCT02354976|75668450|FG000|Overall Study|Adverse Event|1|||
41940327|NCT02354976|75668451|FG001|Overall Study|Adverse Event|0|||
41940328|NCT02354976|75668452|FG002|Overall Study|Adverse Event|2|||
41940329|NCT02303262|75668460|FG000|Overall Study|Withdrawal by Subject|2|||
41940330|NCT00558896|75668471|FG000|Overall Study|Adverse Event|1|||
41940331|NCT00558896|75668472|FG001|Overall Study|Adverse Event|1|||
41940332|NCT00558896|75668473|FG002|Overall Study|Adverse Event|1|||
41940333|NCT00558896|75668474|FG003|Overall Study|Adverse Event|3|||
41940334|NCT00558896|75668475|FG004|Overall Study|Adverse Event|4|||
41940335|NCT00558896|75668476|FG005|Overall Study|Adverse Event|10|||
41940336|NCT00558896|75668477|FG006|Overall Study|Adverse Event|3|||
41940337|NCT00558896|75668471|FG000|Overall Study|Death|3|||
41940338|NCT00558896|75668472|FG001|Overall Study|Death|0|||
41940339|NCT00558896|75668473|FG002|Overall Study|Death|2|||
41940340|NCT00558896|75668474|FG003|Overall Study|Death|3|||
41940341|NCT00558896|75668475|FG004|Overall Study|Death|2|||
41940342|NCT00558896|75668476|FG005|Overall Study|Death|2|||
41940343|NCT00558896|75668477|FG006|Overall Study|Death|6|||
41940344|NCT00558896|75668471|FG000|Overall Study|Withdrawal by Subject|2|||
41940345|NCT00558896|75668472|FG001|Overall Study|Withdrawal by Subject|1|||
41940346|NCT00558896|75668473|FG002|Overall Study|Withdrawal by Subject|1|||
41940347|NCT00558896|75668474|FG003|Overall Study|Withdrawal by Subject|1|||
42300246|NCT02327013|76135385|FG004|Overall Study|Protocol Violation|1|||
42300247|NCT02327013|76135381|FG000|Overall Study|Withdrawal before treatment|2|||
41940348|NCT00558896|75668475|FG004|Overall Study|Withdrawal by Subject|1|||
41940349|NCT00558896|75668476|FG005|Overall Study|Withdrawal by Subject|5|||
41940350|NCT00558896|75668477|FG006|Overall Study|Withdrawal by Subject|5|||
41940351|NCT00558896|75668471|FG000|Overall Study|Alternative Treatment|2|||
41940352|NCT00558896|75668472|FG001|Overall Study|Alternative Treatment|2|||
41940353|NCT00558896|75668473|FG002|Overall Study|Alternative Treatment|0|||
41940354|NCT00558896|75668474|FG003|Overall Study|Alternative Treatment|2|||
41940355|NCT00558896|75668475|FG004|Overall Study|Alternative Treatment|6|||
41940356|NCT00558896|75668476|FG005|Overall Study|Alternative Treatment|7|||
41940357|NCT00558896|75668477|FG006|Overall Study|Alternative Treatment|1|||
41940358|NCT00558896|75668471|FG000|Overall Study|Physician discretion|3|||
41940359|NCT00558896|75668472|FG001|Overall Study|Physician discretion|2|||
41940360|NCT00558896|75668473|FG002|Overall Study|Physician discretion|1|||
41940361|NCT00558896|75668474|FG003|Overall Study|Physician discretion|2|||
41940362|NCT00558896|75668475|FG004|Overall Study|Physician discretion|1|||
41940363|NCT00558896|75668476|FG005|Overall Study|Physician discretion|3|||
41940364|NCT00558896|75668477|FG006|Overall Study|Physician discretion|3|||
41940365|NCT00558896|75668471|FG000|Overall Study|Continues on treatment|10|||
41940366|NCT00558896|75668472|FG001|Overall Study|Continues on treatment|1|||
41940367|NCT00558896|75668473|FG002|Overall Study|Continues on treatment|0|||
41940368|NCT00558896|75668474|FG003|Overall Study|Continues on treatment|1|||
41940369|NCT00558896|75668475|FG004|Overall Study|Continues on treatment|9|||
41940370|NCT00558896|75668476|FG005|Overall Study|Continues on treatment|25|||
41940371|NCT00558896|75668477|FG006|Overall Study|Continues on treatment|6|||
41940372|NCT00558428|75668611|FG000|Overall Study|Adverse Event|6|||
41940373|NCT00558428|75668612|FG001|Overall Study|Adverse Event|22|||
41940374|NCT00558428|75668613|FG002|Overall Study|Adverse Event|3|||
41940375|NCT00558428|75668614|FG003|Overall Study|Adverse Event|4|||
41940376|NCT00558428|75668611|FG000|Overall Study|Lost to Follow-up|0|||
41940377|NCT00558428|75668612|FG001|Overall Study|Lost to Follow-up|1|||
41940378|NCT00558428|75668613|FG002|Overall Study|Lost to Follow-up|0|||
41940379|NCT00558428|75668614|FG003|Overall Study|Lost to Follow-up|0|||
41940380|NCT00558428|75668611|FG000|Overall Study|Lack of Efficacy|0|||
41940381|NCT00558428|75668612|FG001|Overall Study|Lack of Efficacy|0|||
41940382|NCT00558428|75668613|FG002|Overall Study|Lack of Efficacy|1|||
41940383|NCT00558428|75668614|FG003|Overall Study|Lack of Efficacy|2|||
41940384|NCT00558428|75668611|FG000|Overall Study|Non compliant with protocol|1|||
41940385|NCT00558428|75668612|FG001|Overall Study|Non compliant with protocol|0|||
41940386|NCT00558428|75668613|FG002|Overall Study|Non compliant with protocol|0|||
41940387|NCT00558428|75668614|FG003|Overall Study|Non compliant with protocol|3|||
41940388|NCT00558428|75668611|FG000|Overall Study|Consent withdrawn|2|||
41940389|NCT00558428|75668612|FG001|Overall Study|Consent withdrawn|1|||
41940390|NCT00558428|75668613|FG002|Overall Study|Consent withdrawn|0|||
41940391|NCT00558428|75668614|FG003|Overall Study|Consent withdrawn|1|||
41940392|NCT00558428|75668611|FG000|Overall Study|Other|3|||
41940393|NCT00558428|75668612|FG001|Overall Study|Other|0|||
41940394|NCT00558428|75668613|FG002|Overall Study|Other|0|||
41940395|NCT00558428|75668614|FG003|Overall Study|Other|1|||
41940396|NCT00558272|75668653|FG000|Overall Study|Adverse Event|10|||
41940397|NCT00558272|75668654|FG001|Overall Study|Adverse Event|0|||
41940398|NCT00558272|75668653|FG000|Overall Study|Death|1|||
41940399|NCT00558272|75668654|FG001|Overall Study|Death|0|||
41940400|NCT00558272|75668653|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
41940401|NCT00558272|75668654|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
41940402|NCT00558272|75668653|FG000|Overall Study|AZ study team decision|0|||
41940403|NCT00558272|75668654|FG001|Overall Study|AZ study team decision|1|||
41940404|NCT00558272|75668653|FG000|Overall Study|Incorrectly enrolled|1|||
41940405|NCT00558272|75668654|FG001|Overall Study|Incorrectly enrolled|0|||
41940406|NCT00558272|75668653|FG000|Overall Study|Withdrawal by Subject|0|||
41940407|NCT00558272|75668654|FG001|Overall Study|Withdrawal by Subject|1|||
41940408|NCT00557492|75668799|FG000|Overall Study|Change in health insurance|1|||
41940409|NCT02354586|75668902|FG000|Overall Study|Death|230|||
41940410|NCT02354586|75668902|FG000|Overall Study|Withdrawal by Subject|59|||
41940411|NCT02354586|75668902|FG000|Overall Study|Lost to Follow-up|11|||
41940412|NCT02354586|75668902|FG000|Overall Study|Sponsor decision|51|||
41940413|NCT02354586|75668902|FG000|Overall Study|Site closure|2|||
41940414|NCT02354586|75668902|FG000|Overall Study|Intercurrent illness|1|||
41940415|NCT02354586|75668902|FG000|Overall Study|Protocol Violation|3|||
41940416|NCT02354586|75668902|FG000|Overall Study|Physician Decision|13|||
41940417|NCT02354586|75668902|FG000|Overall Study|Lack of Efficacy|86|||
41940418|NCT02354586|75668902|FG000|Overall Study|Adverse Event|7|||
41940419|NCT02332824|75668927|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
41940420|NCT02332824|75668928|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
41940421|NCT02332824|75668929|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
41940422|NCT02332824|75668930|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
41940423|NCT02332824|75668931|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
41940424|NCT02332824|75668932|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
41940425|NCT02332824|75668927|FG000|Overall Study|Voluntary Withdrawal|1|||
41940426|NCT02332824|75668928|FG001|Overall Study|Voluntary Withdrawal|0|||
41940427|NCT02332824|75668929|FG002|Overall Study|Voluntary Withdrawal|0|||
41940428|NCT02332824|75668930|FG003|Overall Study|Voluntary Withdrawal|0|||
41940429|NCT02332824|75668931|FG004|Overall Study|Voluntary Withdrawal|0|||
42210272|NCT03297216|76025030|FG000|Overall Study|Miscarriage|0|||
41940430|NCT02332824|75668932|FG005|Overall Study|Voluntary Withdrawal|0|||
41940431|NCT02332824|75668927|FG000|Overall Study|Inconvenient schedule|1|||
41940432|NCT02332824|75668928|FG001|Overall Study|Inconvenient schedule|1|||
41940433|NCT02332824|75668929|FG002|Overall Study|Inconvenient schedule|0|||
41940434|NCT02332824|75668930|FG003|Overall Study|Inconvenient schedule|0|||
41940435|NCT02332824|75668931|FG004|Overall Study|Inconvenient schedule|0|||
41940436|NCT02332824|75668932|FG005|Overall Study|Inconvenient schedule|0|||
41940437|NCT02332824|75668927|FG000|Overall Study|Transfer|0|||
41940438|NCT02332824|75668928|FG001|Overall Study|Transfer|0|||
41940439|NCT02332824|75668929|FG002|Overall Study|Transfer|1|||
41940440|NCT02332824|75668930|FG003|Overall Study|Transfer|1|||
41940441|NCT02332824|75668931|FG004|Overall Study|Transfer|0|||
41940442|NCT02332824|75668932|FG005|Overall Study|Transfer|0|||
41940443|NCT00556712|75669079|FG000|Overall Study|Adverse Event|7|||
41940444|NCT00556712|75669080|FG001|Overall Study|Adverse Event|19|||
41940445|NCT00556712|75669079|FG000|Overall Study|Death|5|||
41940446|NCT00556712|75669080|FG001|Overall Study|Death|10|||
41940447|NCT00556712|75669079|FG000|Overall Study|Progressive Disease|383|||
41940448|NCT00556712|75669080|FG001|Overall Study|Progressive Disease|320|||
41940449|NCT00556712|75669079|FG000|Overall Study|Protocol Violation|3|||
41940450|NCT00556712|75669080|FG001|Overall Study|Protocol Violation|2|||
41940451|NCT00556712|75669079|FG000|Overall Study|Refused Treatment|17|||
41940452|NCT00556712|75669080|FG001|Overall Study|Refused Treatment|16|||
41940453|NCT00556712|75669079|FG000|Overall Study|Failure to Return|2|||
41940454|NCT00556712|75669080|FG001|Overall Study|Failure to Return|3|||
41940455|NCT00556712|75669079|FG000|Overall Study|Other|2|||
41940456|NCT00556712|75669080|FG001|Overall Study|Other|2|||
41940457|NCT00556712|75669079|FG000|Overall Study|Ongoing at Data Cutoff|32|||
41940458|NCT00556712|75669080|FG001|Overall Study|Ongoing at Data Cutoff|66|||
41940459|NCT00556322|75669154|FG000|Overall Study|Insufficient therapeutic response|158|||
41940460|NCT00556322|75669155|FG001|Overall Study|Insufficient therapeutic response|168|||
41940461|NCT00556322|75669154|FG000|Overall Study|Adverse Event|7|||
41940462|NCT00556322|75669155|FG001|Overall Study|Adverse Event|4|||
41940463|NCT00556322|75669154|FG000|Overall Study|Other|4|||
41940464|NCT00556322|75669155|FG001|Overall Study|Other|1|||
41940465|NCT00556322|75669154|FG000|Overall Study|Lost to Follow-up|5|||
41940466|NCT00556322|75669155|FG001|Overall Study|Lost to Follow-up|3|||
41940467|NCT00556322|75669154|FG000|Overall Study|Withdrawal by Subject|19|||
41940468|NCT00556322|75669155|FG001|Overall Study|Withdrawal by Subject|7|||
41940469|NCT00556322|75669154|FG000|Overall Study|Protocol Violation|5|||
41940470|NCT00556322|75669155|FG001|Overall Study|Protocol Violation|1|||
41940471|NCT00556322|75669154|FG000|Overall Study|Ongoing at data cutoff|3|||
41940472|NCT00556322|75669155|FG001|Overall Study|Ongoing at data cutoff|5|||
42300248|NCT02327013|76135382|FG001|Overall Study|Withdrawal before treatment|1|||
41940473|NCT00556322|75669154|FG000|Overall Study|Death|20|||
42210273|NCT03297216|76025031|FG001|Overall Study|Miscarriage|2|||
41940474|NCT00556322|75669155|FG001|Overall Study|Death|14|||
41940475|NCT00556166|75669173|FG000|Overall Study|Withdrawal by Subject|1|||
41940476|NCT02332590|75669333|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
41940477|NCT02332590|75669334|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
42210274|NCT03297216|76025030|FG000|Overall Study|Lost to Follow-up|3|||
41940478|NCT02332590|75669333|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
41940479|NCT02332590|75669334|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
41940480|NCT02332590|75669333|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
41940481|NCT02332590|75669334|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
41940482|NCT02332590|75669333|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
42300249|NCT02327013|76135383|FG002|Overall Study|Withdrawal before treatment|5|||
42300250|NCT02327013|76135384|FG003|Overall Study|Withdrawal before treatment|0|||
42300251|NCT02327013|76135385|FG004|Overall Study|Withdrawal before treatment|0|||
42300252|NCT02301975|76135408|FG000|Overall Study|Adverse Event|8|||
42300253|NCT02301975|76135409|FG001|Overall Study|Adverse Event|3|||
42300254|NCT02301975|76135410|FG002|Overall Study|Adverse Event|2|||
41940483|NCT02332590|75669334|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
41940484|NCT02332590|75669333|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
41940485|NCT02332590|75669334|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
41940486|NCT02332590|75669333|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
41940487|NCT02332590|75669334|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
41940488|NCT02332590|75669333|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
41940489|NCT02332590|75669334|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
41940490|NCT02332590|75669333|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
41940491|NCT02332590|75669334|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
41940492|NCT02332590|75669333|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
41940493|NCT02332590|75669334|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
41940494|NCT00554840|75669405|FG000|Overall Study|Physician Decision|0|||
41940495|NCT00554840|75669406|FG001|Overall Study|Physician Decision|1|||
41940496|NCT02302716|75669431|FG000|Overall Study|Adverse Event|1|||
41940497|NCT02302716|75669432|FG001|Overall Study|Adverse Event|1|||
41940498|NCT02302716|75669431|FG000|Overall Study|Death|0|||
41940499|NCT02302716|75669432|FG001|Overall Study|Death|1|||
41940500|NCT02302716|75669431|FG000|Overall Study|Lack of Efficacy|0|||
41940501|NCT02302716|75669432|FG001|Overall Study|Lack of Efficacy|1|||
41940502|NCT02302716|75669431|FG000|Overall Study|Lost to Follow-up|2|||
41940503|NCT02302716|75669432|FG001|Overall Study|Lost to Follow-up|4|||
41940504|NCT02302716|75669431|FG000|Overall Study|Physician Decision|3|||
41940505|NCT02302716|75669432|FG001|Overall Study|Physician Decision|4|||
41940506|NCT02302716|75669431|FG000|Overall Study|Withdrawal by Subject|13|||
41940507|NCT02302716|75669432|FG001|Overall Study|Withdrawal by Subject|7|||
41940508|NCT02302716|75669431|FG000|Overall Study|Protocol Violation|0|||
41940509|NCT02302716|75669432|FG001|Overall Study|Protocol Violation|1|||
41940510|NCT00554606|75669461|FG000|Overall Study|Adverse Event|3|||
41940511|NCT00554606|75669461|FG000|Overall Study|Abnormal laboratory values|1|||
41940512|NCT00554606|75669461|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
41940513|NCT00554606|75669461|FG000|Overall Study|Subject withdrew consent|2|||
41940514|NCT00554606|75669461|FG000|Overall Study|Lost to Follow-up|2|||
41940515|NCT00554606|75669461|FG000|Overall Study|Administrative problems|60|||
41940516|NCT00554606|75669461|FG000|Overall Study|Death|1|||
41940517|NCT00554606|75669461|FG000|Overall Study|Protocol deviation|2|||
41940518|NCT02354508|75669497|FG000|Period 1: Core Phase|Adverse Event|1|||
41940519|NCT02354508|75669498|FG001|Period 1: Core Phase|Adverse Event|1|||
41940520|NCT02354508|75669499|FG002|Period 1: Core Phase|Adverse Event|2|||
41940521|NCT02354508|75669497|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
41940522|NCT02354508|75669498|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
41940523|NCT02354508|75669499|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
41940524|NCT02354508|75669497|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
41940525|NCT02354508|75669498|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
41940526|NCT02354508|75669499|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
41940527|NCT02354508|75669497|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
41940528|NCT02354508|75669498|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
41940529|NCT02354508|75669499|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
41940530|NCT02354508|75669497|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
41940531|NCT02354508|75669498|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
41940532|NCT02354508|75669499|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
41940533|NCT02354508|75669497|FG000|Period 2: Extension Phase|Physician Decision|5|||
41940534|NCT02354508|75669498|FG001|Period 2: Extension Phase|Physician Decision|0|||
41940535|NCT02354508|75669499|FG002|Period 2: Extension Phase|Physician Decision|1|||
41940536|NCT02354508|75669497|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
41940537|NCT02354508|75669498|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
42300255|NCT02301975|76135408|FG000|Overall Study|Lack of Efficacy|1|||
41940538|NCT02354508|75669499|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
41940539|NCT02354508|75669497|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
41940540|NCT02354508|75669498|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
41940541|NCT02354508|75669499|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
41940542|NCT02354508|75669497|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
41940543|NCT02354508|75669498|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
41940544|NCT02354508|75669499|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
41940545|NCT00554216|75669551|FG000|Overall Study|Lost to Follow-up|92|||
41940546|NCT00554216|75669552|FG001|Overall Study|Lost to Follow-up|31|||
41940547|NCT00554216|75669553|FG002|Overall Study|Lost to Follow-up|63|||
41940548|NCT00554216|75669551|FG000|Overall Study|Adverse Event|16|||
41940549|NCT00554216|75669552|FG001|Overall Study|Adverse Event|16|||
41940550|NCT00554216|75669553|FG002|Overall Study|Adverse Event|36|||
41940551|NCT00554216|75669551|FG000|Overall Study|Withdrawal by Subject|92|||
41940552|NCT00554216|75669552|FG001|Overall Study|Withdrawal by Subject|31|||
41940553|NCT00554216|75669553|FG002|Overall Study|Withdrawal by Subject|43|||
41940554|NCT00554216|75669551|FG000|Overall Study|Non compliance|10|||
41940555|NCT00554216|75669552|FG001|Overall Study|Non compliance|4|||
41940556|NCT00554216|75669553|FG002|Overall Study|Non compliance|5|||
41940557|NCT00554216|75669551|FG000|Overall Study|Pregnancy|2|||
41940558|NCT00554216|75669552|FG001|Overall Study|Pregnancy|1|||
41940559|NCT00554216|75669553|FG002|Overall Study|Pregnancy|14|||
41940560|NCT00554216|75669551|FG000|Overall Study|Restricted med|3|||
41940561|NCT00554216|75669552|FG001|Overall Study|Restricted med|1|||
41940562|NCT00554216|75669553|FG002|Overall Study|Restricted med|1|||
41940563|NCT00554216|75669551|FG000|Overall Study|Other|12|||
41940564|NCT00554216|75669552|FG001|Overall Study|Other|7|||
41940565|NCT00554216|75669553|FG002|Overall Study|Other|10|||
41940566|NCT00554216|75669551|FG000|Overall Study|Lack of Efficacy|15|||
41940567|NCT00554216|75669552|FG001|Overall Study|Lack of Efficacy|3|||
41940568|NCT00554216|75669553|FG002|Overall Study|Lack of Efficacy|0|||
41940569|NCT02353572|75669578|FG000|Overall Study|Withdrawal by Subject|1|||
41940570|NCT02353572|75669578|FG000|Overall Study|Study terminated|2|||
41940571|NCT00552578|75669590|FG000|Overall Study|Lost to Follow-up|1|||
41940572|NCT00552578|75669591|FG001|Overall Study|Lost to Follow-up|1|||
41940573|NCT02301936|75669599|FG000|Overall Study|Lost to Follow-up|1|||
41940574|NCT02301936|75669600|FG001|Overall Study|Lost to Follow-up|0|||
41940575|NCT00552344|75669639|FG000|Overall Study|Lack of Efficacy|55|||
41940576|NCT00552344|75669639|FG000|Overall Study|Loss of efficacy|75|||
41940577|NCT00552344|75669639|FG000|Overall Study|Lost to Follow-up|8|||
41940578|NCT00552344|75669639|FG000|Overall Study|Withdrawal by Subject|48|||
41940579|NCT00552344|75669639|FG000|Overall Study|SAE, non-fatal|6|||
41940580|NCT00552344|75669639|FG000|Overall Study|AE, non-serious non-fatal|38|||
41940581|NCT00552344|75669639|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
41940582|NCT00552344|75669639|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
41940583|NCT00552344|75669639|FG000|Overall Study|Other Reason|22|||
41940584|NCT00553514|75669676|FG000|Overall Study|Protocol deviation|0|||
41940585|NCT00553514|75669677|FG001|Overall Study|Protocol deviation|0|||
41940586|NCT00553514|75669678|FG002|Overall Study|Protocol deviation|0|||
41940587|NCT00553514|75669679|FG003|Overall Study|Protocol deviation|1|||
41940588|NCT00553514|75669680|FG004|Overall Study|Protocol deviation|0|||
41940589|NCT00553514|75669676|FG000|Overall Study|Lack of ovarian response|4|||
41940590|NCT00553514|75669677|FG001|Overall Study|Lack of ovarian response|5|||
42117991|NCT00689117|75928840|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
42117992|NCT00689117|75928841|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
42117993|NCT00689117|75928842|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
42117994|NCT00689117|75928843|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
42117995|NCT00689117|75928840|FG000|Overall Study|Withdrawal by Subject|19|||
42300256|NCT02301975|76135409|FG001|Overall Study|Lack of Efficacy|1|||
41940591|NCT00553514|75669678|FG002|Overall Study|Lack of ovarian response|5|||
41940592|NCT00553514|75669679|FG003|Overall Study|Lack of ovarian response|5|||
41940593|NCT00553514|75669680|FG004|Overall Study|Lack of ovarian response|6|||
41940594|NCT00553514|75669676|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
41940595|NCT00553514|75669677|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
41940596|NCT00553514|75669678|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
41940597|NCT00553514|75669679|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
41940598|NCT00553514|75669680|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
41940599|NCT00553514|75669676|FG000|Overall Study|Risk of multiple pregnancy|0|||
41940600|NCT00553514|75669677|FG001|Overall Study|Risk of multiple pregnancy|2|||
41940601|NCT00553514|75669678|FG002|Overall Study|Risk of multiple pregnancy|0|||
42300257|NCT02301975|76135410|FG002|Overall Study|Lack of Efficacy|1|||
41940602|NCT00553514|75669679|FG003|Overall Study|Risk of multiple pregnancy|1|||
41940603|NCT00553514|75669680|FG004|Overall Study|Risk of multiple pregnancy|0|||
41940604|NCT00553514|75669676|FG000|Overall Study|Other|1|||
41940605|NCT00553514|75669677|FG001|Overall Study|Other|1|||
42022798|NCT01040793|75830104|FG003|Overall Study|Adverse Event|2|||
41940606|NCT00553514|75669678|FG002|Overall Study|Other|0|||
41940607|NCT00553514|75669679|FG003|Overall Study|Other|0|||
41940608|NCT00553514|75669680|FG004|Overall Study|Other|1|||
41940609|NCT00553436|75669704|FG000|Overall Study|Conversion to another procedure|1|||
41940610|NCT00553202|75669735|FG000|Overall Study|Death|16|||
41940611|NCT00553202|75669735|FG000|Overall Study|Lost to Follow-up|1|||
41940612|NCT00553202|75669735|FG000|Overall Study|Physician Decision|28|||
41940613|NCT00553202|75669735|FG000|Overall Study|Withdrawal by Subject|1|||
41940614|NCT00553202|75669735|FG000|Overall Study|No donor identified|16|||
41940615|NCT00553202|75669735|FG000|Overall Study|Fails to meet organ function|6|||
41940616|NCT00552188|75669759|FG000|Overall Study|Adverse Event|0|||
41940617|NCT00552188|75669760|FG001|Overall Study|Adverse Event|2|||
41940618|NCT00552188|75669759|FG000|Overall Study|Lost to Follow-up|2|||
41940619|NCT00552188|75669760|FG001|Overall Study|Lost to Follow-up|1|||
41940620|NCT00552188|75669759|FG000|Overall Study|Withdrawal of consent|0|||
41940621|NCT00552188|75669760|FG001|Overall Study|Withdrawal of consent|1|||
41940622|NCT00552188|75669759|FG000|Overall Study|Subject returned to home country|0|||
41940623|NCT00552188|75669760|FG001|Overall Study|Subject returned to home country|1|||
41940624|NCT00552110|75669780|FG000|Overall Study|Serious or Life-Threatening AE|0|||
41940625|NCT00552110|75669781|FG001|Overall Study|Serious or Life-Threatening AE|0|||
41940626|NCT00552110|75669782|FG002|Overall Study|Serious or Life-Threatening AE|1|||
41940627|NCT00552110|75669783|FG003|Overall Study|Serious or Life-Threatening AE|0|||
41940628|NCT00552110|75669784|FG004|Overall Study|Serious or Life-Threatening AE|0|||
41940629|NCT00552110|75669780|FG000|Overall Study|Lack of Efficacy|1|||
41940630|NCT00552110|75669781|FG001|Overall Study|Lack of Efficacy|0|||
41940631|NCT00552110|75669782|FG002|Overall Study|Lack of Efficacy|0|||
41940632|NCT00552110|75669783|FG003|Overall Study|Lack of Efficacy|1|||
41940633|NCT00552110|75669784|FG004|Overall Study|Lack of Efficacy|4|||
41940634|NCT00552110|75669780|FG000|Overall Study|Withdrawal by Subject|0|||
41940635|NCT00552110|75669781|FG001|Overall Study|Withdrawal by Subject|2|||
41940636|NCT00552110|75669782|FG002|Overall Study|Withdrawal by Subject|0|||
41940637|NCT00552110|75669783|FG003|Overall Study|Withdrawal by Subject|3|||
41940638|NCT00552110|75669784|FG004|Overall Study|Withdrawal by Subject|2|||
41940639|NCT00552110|75669780|FG000|Overall Study|Lost to Follow-up|0|||
41940640|NCT00552110|75669781|FG001|Overall Study|Lost to Follow-up|0|||
41940641|NCT00552110|75669782|FG002|Overall Study|Lost to Follow-up|0|||
41940642|NCT00552110|75669783|FG003|Overall Study|Lost to Follow-up|1|||
41940643|NCT00552110|75669784|FG004|Overall Study|Lost to Follow-up|1|||
41940644|NCT00552110|75669780|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
41940645|NCT00552110|75669781|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
41940646|NCT00552110|75669782|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
41940647|NCT00552110|75669783|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
41940648|NCT00552110|75669784|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
41940649|NCT00552110|75669780|FG000|Overall Study|Withdrawn per Sponsor|0|||
41940650|NCT00552110|75669781|FG001|Overall Study|Withdrawn per Sponsor|1|||
41940651|NCT00552110|75669782|FG002|Overall Study|Withdrawn per Sponsor|0|||
41940652|NCT00552110|75669783|FG003|Overall Study|Withdrawn per Sponsor|0|||
41940653|NCT00552110|75669784|FG004|Overall Study|Withdrawn per Sponsor|1|||
41940654|NCT00552110|75669780|FG000|Overall Study|Use of Prohibited Medication|1|||
41940655|NCT00552110|75669781|FG001|Overall Study|Use of Prohibited Medication|1|||
41940656|NCT00552110|75669782|FG002|Overall Study|Use of Prohibited Medication|0|||
41940657|NCT00552110|75669783|FG003|Overall Study|Use of Prohibited Medication|0|||
41940658|NCT00552110|75669784|FG004|Overall Study|Use of Prohibited Medication|0|||
41940659|NCT00552110|75669780|FG000|Overall Study|Delay of Study due to Relabeling|0|||
41940660|NCT00552110|75669781|FG001|Overall Study|Delay of Study due to Relabeling|0|||
42022799|NCT01040793|75830105|FG004|Overall Study|Adverse Event|2|||
41940661|NCT00552110|75669782|FG002|Overall Study|Delay of Study due to Relabeling|0|||
41940662|NCT00552110|75669783|FG003|Overall Study|Delay of Study due to Relabeling|1|||
41940663|NCT00552110|75669784|FG004|Overall Study|Delay of Study due to Relabeling|0|||
41940664|NCT00552110|75669780|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
41940665|NCT00552110|75669781|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
41940666|NCT00552110|75669782|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
41940667|NCT00552110|75669783|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
41940668|NCT00552110|75669784|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
41940669|NCT00552110|75669780|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
41940670|NCT00552110|75669781|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
41940671|NCT00552110|75669782|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
42022800|NCT01040793|75830106|FG005|Overall Study|Adverse Event|1|||
41940672|NCT00552110|75669783|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
41940673|NCT00552110|75669784|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
41940674|NCT02301624|75669807|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
41940675|NCT02301624|75669808|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
41940676|NCT02301624|75669807|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
41940677|NCT02301624|75669808|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
41940678|NCT02301624|75669807|FG000|Open-label Maintenance Phase|Adverse Event|2|||
41940679|NCT02301624|75669808|FG001|Open-label Maintenance Phase|Adverse Event|5|||
41940680|NCT02301624|75669807|FG000|Open-label Maintenance Phase|Physician Decision|3|||
41940681|NCT02301624|75669808|FG001|Open-label Maintenance Phase|Physician Decision|3|||
41940682|NCT02301624|75669807|FG000|Open-label Maintenance Phase|Death|2|||
41940683|NCT02301624|75669808|FG001|Open-label Maintenance Phase|Death|1|||
41940684|NCT02301624|75669807|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
41940685|NCT02301624|75669808|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
41940686|NCT02301546|75669849|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
41940687|NCT02301546|75669850|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
41940688|NCT02301546|75669849|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
41940689|NCT02301546|75669850|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
41940690|NCT02301546|75669849|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
41940691|NCT02301546|75669850|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
41940692|NCT02301546|75669849|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
41940693|NCT02301546|75669850|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
41940694|NCT02301546|75669849|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
41940695|NCT02301546|75669850|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
41940696|NCT02301546|75669849|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
41940697|NCT02301546|75669850|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
41940698|NCT02301546|75669849|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
41940699|NCT02301546|75669850|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
41940700|NCT02351934|75669874|FG000|Allocation|POD weight<pre-op weight|3|||
41940701|NCT02351934|75669875|FG001|Allocation|POD weight<pre-op weight|0|||
41940702|NCT02351934|75669874|FG000|Allocation|Hypotension preventing administration|2|||
41940703|NCT02351934|75669875|FG001|Allocation|Hypotension preventing administration|0|||
41940704|NCT02351934|75669874|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
41940705|NCT02351934|75669875|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
41940706|NCT02351934|75669874|FG000|Follow-Up|POD weight<pre-op weight|3|||
41940707|NCT02351934|75669875|FG001|Follow-Up|POD weight<pre-op weight|0|||
41940708|NCT02351934|75669874|FG000|Follow-Up|Acute Kidney Injury|1|||
41940709|NCT02351934|75669875|FG001|Follow-Up|Acute Kidney Injury|0|||
41940710|NCT02351934|75669874|FG000|Follow-Up|Early dismissal|3|||
41940711|NCT02351934|75669875|FG001|Follow-Up|Early dismissal|0|||
41940712|NCT02351934|75669874|FG000|Follow-Up|Hypotension|3|||
41940713|NCT02351934|75669875|FG001|Follow-Up|Hypotension|0|||
41940714|NCT02351934|75669874|FG000|Follow-Up|No documentation|2|||
41940715|NCT02351934|75669875|FG001|Follow-Up|No documentation|0|||
41940716|NCT02351934|75669874|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
41940717|NCT02351934|75669875|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
41940718|NCT02351934|75669874|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
41940719|NCT02351934|75669875|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
41940720|NCT02351856|75669915|FG000|Overall Study|Adverse Event|2|||
41940721|NCT02351856|75669915|FG000|Overall Study|Physician Decision|5|||
41940722|NCT02351856|75669915|FG000|Overall Study|Study terminated by sponsor|1|||
41940723|NCT02349360|75669955|FG000|Overall Study|Withdrawal by Subject|0|||
41940724|NCT02349360|75669956|FG001|Overall Study|Withdrawal by Subject|1|||
41940725|NCT00551642|75669981|FG000|Treatment Period|Protocol Deviation|6|||
41940726|NCT00551642|75669982|FG001|Treatment Period|Protocol Deviation|11|||
41940727|NCT00551642|75669981|FG000|Treatment Period|Delivery device failure|1|||
41940728|NCT00551642|75669982|FG001|Treatment Period|Delivery device failure|3|||
41940729|NCT00551642|75669981|FG000|Treatment Period|Physician Decision|0|||
41940730|NCT00551642|75669982|FG001|Treatment Period|Physician Decision|1|||
42117996|NCT00689117|75928841|FG001|Overall Study|Withdrawal by Subject|18|||
42117997|NCT00689117|75928842|FG002|Overall Study|Withdrawal by Subject|26|||
41940731|NCT00551642|75669981|FG000|Treatment Period|Death|33|||
41940732|NCT00551642|75669982|FG001|Treatment Period|Death|31|||
41940733|NCT00551642|75669981|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
41940734|NCT00551642|75669982|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
41940735|NCT00551642|75669981|FG000|Treatment Period|Adverse Event|15|||
41940736|NCT00551642|75669982|FG001|Treatment Period|Adverse Event|12|||
41940737|NCT00551642|75669981|FG000|Treatment Period|Withdrawal by Subject|2|||
41940738|NCT00551642|75669982|FG001|Treatment Period|Withdrawal by Subject|1|||
41940739|NCT00550550|75670067|FG000|Overall Study|Adverse Event|13|||
41940740|NCT00550550|75670068|FG001|Overall Study|Adverse Event|5|||
41940741|NCT00550550|75670067|FG000|Overall Study|Treatment Failure|0|||
41940742|NCT00550550|75670068|FG001|Overall Study|Treatment Failure|1|||
41940743|NCT00550550|75670067|FG000|Overall Study|Lost to Follow-up|4|||
41940744|NCT00550550|75670068|FG001|Overall Study|Lost to Follow-up|0|||
41940745|NCT00550550|75670067|FG000|Overall Study|Withdrawal by Subject|10|||
42117998|NCT00689117|75928843|FG003|Overall Study|Withdrawal by Subject|13|||
42117999|NCT00689117|75928840|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
41940746|NCT00550550|75670068|FG001|Overall Study|Withdrawal by Subject|8|||
41940747|NCT00550550|75670067|FG000|Overall Study|Protocol Violation|5|||
41940748|NCT00550550|75670068|FG001|Overall Study|Protocol Violation|14|||
41940749|NCT00550550|75670067|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
41940750|NCT00550550|75670068|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
41940751|NCT00550550|75670067|FG000|Overall Study|Randomized But Not Treated|1|||
41940752|NCT00550550|75670068|FG001|Overall Study|Randomized But Not Treated|0|||
41940753|NCT02301156|75670119|FG000|Overall Study|Adverse Event|13|||
41940754|NCT02301156|75670120|FG001|Overall Study|Adverse Event|14|||
41940755|NCT02301156|75670119|FG000|Overall Study|Death|1|||
41940756|NCT02301156|75670120|FG001|Overall Study|Death|5|||
41940757|NCT02301156|75670119|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
42210275|NCT03297216|76025031|FG001|Overall Study|Lost to Follow-up|2|||
42210276|NCT03260868|76025046|FG000|Overall Study|Poor Compliance to Protocol|0|||
42210277|NCT03260868|76025047|FG001|Overall Study|Poor Compliance to Protocol|2|||
42210278|NCT03260868|76025046|FG000|Overall Study|Study Terminated By Sponsor|2|||
42210279|NCT03260868|76025047|FG001|Overall Study|Study Terminated By Sponsor|1|||
42210280|NCT03260868|76025046|FG000|Overall Study|Other than specified above|1|||
42210281|NCT03260868|76025047|FG001|Overall Study|Other than specified above|0|||
42210282|NCT03293394|76025055|FG000|Follow-up (6 Months)|Adverse Event|4|||
42210283|NCT03293394|76025056|FG001|Follow-up (6 Months)|Adverse Event|2|||
42210284|NCT03259308|76025065|FG000|Overall Study|Adverse Event|5|||
41940758|NCT02301156|75670120|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
41940759|NCT02301156|75670119|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
41940760|NCT02301156|75670120|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
41940761|NCT02301156|75670119|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
41940762|NCT02301156|75670120|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
41940763|NCT02301156|75670119|FG000|Overall Study|Reason not Specified|6|||
41940764|NCT02301156|75670120|FG001|Overall Study|Reason not Specified|3|||
41940765|NCT02301390|75670201|FG000|Overall Study|Withdrawal by Subject|3|||
42210285|NCT03259308|76025066|FG001|Overall Study|Adverse Event|4|||
42022801|NCT01040793|75830101|FG000|Overall Study|Protocol Violation|1|||
42210286|NCT03259308|76025067|FG002|Overall Study|Adverse Event|1|||
41940766|NCT02301390|75670202|FG001|Overall Study|Withdrawal by Subject|5|||
41940767|NCT02301390|75670201|FG000|Overall Study|Protocol Violation|1|||
41940768|NCT02301390|75670202|FG001|Overall Study|Protocol Violation|0|||
41940769|NCT02301390|75670201|FG000|Overall Study|Physician Decision|1|||
41940770|NCT02301390|75670202|FG001|Overall Study|Physician Decision|0|||
41940771|NCT02301390|75670201|FG000|Overall Study|Lost to Follow-up|0|||
41940772|NCT02301390|75670202|FG001|Overall Study|Lost to Follow-up|1|||
41940773|NCT02301390|75670201|FG000|Overall Study|Death|2|||
41940774|NCT02301390|75670202|FG001|Overall Study|Death|2|||
41940775|NCT02301390|75670201|FG000|Overall Study|Procedure not completed|0|||
41940776|NCT02301390|75670202|FG001|Overall Study|Procedure not completed|4|||
41940777|NCT02301390|75670201|FG000|Overall Study|Missed multiple visits|1|||
41940778|NCT02301390|75670202|FG001|Overall Study|Missed multiple visits|1|||
41940779|NCT02301390|75670201|FG000|Overall Study|study terminated|2|||
41940780|NCT02301390|75670202|FG001|Overall Study|study terminated|0|||
41940781|NCT02300610|75670319|FG000|Overall Study|Withdrawal by Subject|1|||
41940782|NCT02300610|75670320|FG001|Overall Study|Withdrawal by Subject|0|||
41940783|NCT02300610|75670321|FG002|Overall Study|Withdrawal by Subject|1|||
41940784|NCT02300298|75670366|FG000|Disposition for Nintedanib|Progressive disease|10|||
41940785|NCT02300298|75670367|FG001|Disposition for Nintedanib|Progressive disease|0|||
41940786|NCT02300298|75670366|FG000|Disposition for Docetaxel|Progressive disease|0|||
41940787|NCT02300298|75670367|FG001|Disposition for Docetaxel|Progressive disease|6|||
41940788|NCT02300298|75670366|FG000|Disposition for Docetaxel|other adverse event|0|||
41940789|NCT02300298|75670367|FG001|Disposition for Docetaxel|other adverse event|4|||
41940790|NCT02300220|75670373|FG000|Overall Study|Lost to Follow-up|1|||
41940791|NCT02300220|75670374|FG001|Overall Study|Lost to Follow-up|2|||
41940792|NCT02300220|75670373|FG000|Overall Study|Death|1|||
41940793|NCT02300220|75670374|FG001|Overall Study|Death|1|||
41940794|NCT02300220|75670373|FG000|Overall Study|Adverse Event|1|||
41940795|NCT02300220|75670374|FG001|Overall Study|Adverse Event|1|||
41940796|NCT02300220|75670373|FG000|Overall Study|Protocol Violation|1|||
41940797|NCT02300220|75670374|FG001|Overall Study|Protocol Violation|0|||
41940798|NCT02300220|75670373|FG000|Overall Study|Withdrawal by Subject|0|||
41940799|NCT02300220|75670374|FG001|Overall Study|Withdrawal by Subject|2|||
41940800|NCT02300220|75670373|FG000|Overall Study|Did not tolerate IMP|0|||
41940801|NCT02300220|75670374|FG001|Overall Study|Did not tolerate IMP|1|||
41940802|NCT02327130|75670398|FG000|Overall Study|Discharged in less than 5 days|5|||
41940803|NCT02327130|75670398|FG000|Overall Study|Physician Decision|2|||
41940804|NCT02327130|75670398|FG000|Overall Study|Unable to provide breath sample|1|||
41940805|NCT02327130|75670398|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
41940806|NCT02327130|75670398|FG000|Overall Study|Met exclusion criteria|3|||
41940807|NCT02326272|75670453|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940808|NCT02326272|75670454|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
41940809|NCT02326272|75670455|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
41940810|NCT02326272|75670456|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940811|NCT02326272|75670457|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940812|NCT02326272|75670458|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940813|NCT02326272|75670459|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940814|NCT02326272|75670460|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940815|NCT02326272|75670461|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940816|NCT02326272|75670462|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940817|NCT02326272|75670463|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940818|NCT02326272|75670464|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940819|NCT02326272|75670465|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940820|NCT02326272|75670466|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940821|NCT02326272|75670467|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41940822|NCT02326272|75670453|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
41940823|NCT02326272|75670454|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
41940824|NCT02326272|75670455|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41940825|NCT02326272|75670456|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41940826|NCT02326272|75670457|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41940827|NCT02326272|75670458|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42210287|NCT03259308|76025065|FG000|Overall Study|Withdrawal by Subject|2|||
41940828|NCT02326272|75670459|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41940829|NCT02326272|75670460|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41940830|NCT02326272|75670461|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41940831|NCT02326272|75670462|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41940832|NCT02326272|75670463|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41940833|NCT02326272|75670464|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41940834|NCT02326272|75670465|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41940835|NCT02326272|75670466|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42022802|NCT01040793|75830102|FG001|Overall Study|Protocol Violation|1|||
42022803|NCT01040793|75830103|FG002|Overall Study|Protocol Violation|1|||
41940836|NCT02326272|75670467|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41940837|NCT02326272|75670453|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
41940838|NCT02326272|75670454|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
41940839|NCT02326272|75670455|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
41940840|NCT02326272|75670456|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940841|NCT02326272|75670457|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940842|NCT02326272|75670458|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940843|NCT02326272|75670459|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940844|NCT02326272|75670460|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940845|NCT02326272|75670461|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940846|NCT02326272|75670462|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940847|NCT02326272|75670463|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940848|NCT02326272|75670464|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940849|NCT02326272|75670465|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940850|NCT02326272|75670466|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940851|NCT02326272|75670467|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
41940852|NCT02326272|75670453|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940853|NCT02326272|75670454|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940854|NCT02326272|75670455|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
41940855|NCT02326272|75670456|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940856|NCT02326272|75670457|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940857|NCT02326272|75670458|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940858|NCT02326272|75670459|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940859|NCT02326272|75670460|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940860|NCT02326272|75670461|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940861|NCT02326272|75670462|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940862|NCT02326272|75670463|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940863|NCT02326272|75670464|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940864|NCT02326272|75670465|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940865|NCT02326272|75670466|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940866|NCT02326272|75670467|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
41940867|NCT02326272|75670453|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940868|NCT02326272|75670454|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940869|NCT02326272|75670455|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
41940870|NCT02326272|75670456|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940871|NCT02326272|75670457|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940872|NCT02326272|75670458|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940873|NCT02326272|75670459|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940874|NCT02326272|75670460|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940875|NCT02326272|75670461|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940876|NCT02326272|75670462|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940877|NCT02326272|75670463|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940878|NCT02326272|75670464|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940879|NCT02326272|75670465|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940880|NCT02326272|75670466|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940881|NCT02326272|75670467|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
41940882|NCT02326272|75670453|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940883|NCT02326272|75670454|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940884|NCT02326272|75670455|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
41940885|NCT02326272|75670456|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940886|NCT02326272|75670457|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940887|NCT02326272|75670458|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940888|NCT02326272|75670459|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940889|NCT02326272|75670460|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940890|NCT02326272|75670461|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940891|NCT02326272|75670462|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940892|NCT02326272|75670463|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940893|NCT02326272|75670464|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940894|NCT02326272|75670465|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940895|NCT02326272|75670466|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
41940896|NCT02326272|75670467|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
42022804|NCT01040793|75830104|FG003|Overall Study|Protocol Violation|0|||
41940897|NCT02326272|75670453|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940898|NCT02326272|75670454|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940899|NCT02326272|75670455|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
41940900|NCT02326272|75670456|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940901|NCT02326272|75670457|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940902|NCT02326272|75670458|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940903|NCT02326272|75670459|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940904|NCT02326272|75670460|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940905|NCT02326272|75670461|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940906|NCT02326272|75670462|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940907|NCT02326272|75670463|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940908|NCT02326272|75670464|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940909|NCT02326272|75670465|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940910|NCT02326272|75670466|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940911|NCT02326272|75670467|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
41940912|NCT02326272|75670453|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41940913|NCT02326272|75670454|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41940914|NCT02326272|75670455|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41940915|NCT02326272|75670456|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41940916|NCT02326272|75670457|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
41940917|NCT02326272|75670458|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
41940918|NCT02326272|75670459|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
41940919|NCT02326272|75670460|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
41940920|NCT02326272|75670461|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
41940921|NCT02326272|75670462|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41940922|NCT02326272|75670463|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41940923|NCT02326272|75670464|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41940924|NCT02326272|75670465|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41940925|NCT02326272|75670466|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41940926|NCT02326272|75670467|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
41940927|NCT02326272|75670453|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41940928|NCT02326272|75670454|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41940929|NCT02326272|75670455|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41940930|NCT02326272|75670456|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41940931|NCT02326272|75670457|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41940932|NCT02326272|75670458|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
41940933|NCT02326272|75670459|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
41940934|NCT02326272|75670460|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41940935|NCT02326272|75670461|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
41940936|NCT02326272|75670462|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
41940937|NCT02326272|75670463|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41940938|NCT02326272|75670464|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41940939|NCT02326272|75670465|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41940940|NCT02326272|75670466|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41940941|NCT02326272|75670467|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
41940942|NCT02326272|75670453|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940943|NCT02326272|75670454|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940944|NCT02326272|75670455|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940945|NCT02326272|75670456|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940946|NCT02326272|75670457|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940947|NCT02326272|75670458|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
41940948|NCT02326272|75670459|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940949|NCT02326272|75670460|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
41940950|NCT02326272|75670461|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940951|NCT02326272|75670462|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940952|NCT02326272|75670463|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940953|NCT02326272|75670464|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940954|NCT02326272|75670465|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42022805|NCT01040793|75830105|FG004|Overall Study|Protocol Violation|1|||
42022806|NCT01040793|75830106|FG005|Overall Study|Protocol Violation|0|||
42022807|NCT01040793|75830101|FG000|Overall Study|Lost to Follow-up|0|||
42022808|NCT01040793|75830102|FG001|Overall Study|Lost to Follow-up|1|||
41940955|NCT02326272|75670466|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940956|NCT02326272|75670467|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
41940957|NCT02326272|75670453|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41940958|NCT02326272|75670454|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41940959|NCT02326272|75670455|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41940960|NCT02326272|75670456|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
41940961|NCT02326272|75670457|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41940962|NCT02326272|75670458|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
41940963|NCT02326272|75670459|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
41940964|NCT02326272|75670460|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
41940965|NCT02326272|75670461|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41940966|NCT02326272|75670462|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
41940967|NCT02326272|75670463|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41940968|NCT02326272|75670464|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41940969|NCT02326272|75670465|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41940970|NCT02326272|75670466|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41940971|NCT02326272|75670467|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
41940972|NCT02326272|75670453|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940973|NCT02326272|75670454|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940974|NCT02326272|75670455|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940975|NCT02326272|75670456|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940976|NCT02326272|75670457|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940977|NCT02326272|75670458|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940978|NCT02326272|75670459|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940979|NCT02326272|75670460|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
41940980|NCT02326272|75670461|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940981|NCT02326272|75670462|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940982|NCT02326272|75670463|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940983|NCT02326272|75670464|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940984|NCT02326272|75670465|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940985|NCT02326272|75670466|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940986|NCT02326272|75670467|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
41940987|NCT02326272|75670453|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41940988|NCT02326272|75670454|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41940989|NCT02326272|75670455|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41940990|NCT02326272|75670456|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41940991|NCT02326272|75670457|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41940992|NCT02326272|75670458|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41940993|NCT02326272|75670459|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
41940994|NCT02326272|75670460|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41940995|NCT02326272|75670461|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41940996|NCT02326272|75670462|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41940997|NCT02326272|75670463|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41940998|NCT02326272|75670464|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41940999|NCT02326272|75670465|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41941000|NCT02326272|75670466|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41941001|NCT02326272|75670467|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
41941002|NCT02326272|75670453|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941003|NCT02326272|75670454|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941004|NCT02326272|75670455|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941005|NCT02326272|75670456|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941006|NCT02326272|75670457|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941007|NCT02326272|75670458|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941008|NCT02326272|75670459|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941009|NCT02326272|75670460|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941010|NCT02326272|75670461|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
41941011|NCT02326272|75670462|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941012|NCT02326272|75670463|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941013|NCT02326272|75670464|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941014|NCT02326272|75670465|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941015|NCT02326272|75670466|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941016|NCT02326272|75670467|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
41941017|NCT02326272|75670453|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
42022809|NCT01040793|75830103|FG002|Overall Study|Lost to Follow-up|1|||
41941018|NCT02326272|75670454|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41941019|NCT02326272|75670455|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41941020|NCT02326272|75670456|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41941021|NCT02326272|75670457|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41941022|NCT02326272|75670458|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
41941023|NCT02326272|75670459|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
41941024|NCT02326272|75670460|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
41941025|NCT02326272|75670461|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
41941026|NCT02326272|75670462|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41941027|NCT02326272|75670463|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41941028|NCT02326272|75670464|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41941029|NCT02326272|75670465|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41941030|NCT02326272|75670466|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41941031|NCT02326272|75670467|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
41941032|NCT02326272|75670453|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941033|NCT02326272|75670454|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941034|NCT02326272|75670455|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941035|NCT02326272|75670456|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941036|NCT02326272|75670457|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941037|NCT02326272|75670458|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
41941038|NCT02326272|75670459|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941039|NCT02326272|75670460|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941040|NCT02326272|75670461|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941041|NCT02326272|75670462|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941042|NCT02326272|75670463|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941043|NCT02326272|75670464|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941044|NCT02326272|75670465|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941045|NCT02326272|75670466|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941046|NCT02326272|75670467|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
41941047|NCT02326272|75670453|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941048|NCT02326272|75670454|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941049|NCT02326272|75670455|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941050|NCT02326272|75670456|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941051|NCT02326272|75670457|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941052|NCT02326272|75670458|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941053|NCT02326272|75670459|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
41941054|NCT02326272|75670460|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941055|NCT02326272|75670461|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941056|NCT02326272|75670462|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941057|NCT02326272|75670463|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941058|NCT02326272|75670464|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941059|NCT02326272|75670465|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941060|NCT02326272|75670466|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941061|NCT02326272|75670467|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
41941062|NCT02326272|75670453|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
41941063|NCT02326272|75670454|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
41941064|NCT02326272|75670455|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
41941065|NCT02326272|75670456|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
41941066|NCT02326272|75670457|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
41941067|NCT02326272|75670458|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
41941068|NCT02326272|75670459|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
41941069|NCT02326272|75670460|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
41941070|NCT02326272|75670461|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
41941071|NCT02326272|75670462|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
41941072|NCT02326272|75670463|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
41941073|NCT02326272|75670464|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
41941074|NCT02326272|75670465|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
41941075|NCT02326272|75670466|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
41941076|NCT02326272|75670467|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
41941077|NCT02326272|75670453|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42118000|NCT00689117|75928841|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
41941078|NCT02326272|75670454|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
41941079|NCT02326272|75670455|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
41941080|NCT02326272|75670456|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
41941081|NCT02326272|75670457|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
41941082|NCT02326272|75670458|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
41941083|NCT02326272|75670459|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
41941084|NCT02326272|75670460|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
41941085|NCT02326272|75670461|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
41941086|NCT02326272|75670462|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
41941087|NCT02326272|75670463|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
41941088|NCT02326272|75670464|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
41941089|NCT02326272|75670465|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
41941090|NCT02326272|75670466|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
41941091|NCT02326272|75670467|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
41941092|NCT02326272|75670453|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941093|NCT02326272|75670454|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941094|NCT02326272|75670455|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941095|NCT02326272|75670456|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941096|NCT02326272|75670457|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941097|NCT02326272|75670458|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941098|NCT02326272|75670459|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941099|NCT02326272|75670460|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941100|NCT02326272|75670461|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941101|NCT02326272|75670462|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941102|NCT02326272|75670463|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
41941103|NCT02326272|75670464|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941104|NCT02326272|75670465|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
41941105|NCT02326272|75670466|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941106|NCT02326272|75670467|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41941107|NCT02326272|75670453|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941108|NCT02326272|75670454|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941109|NCT02326272|75670455|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941110|NCT02326272|75670456|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941111|NCT02326272|75670457|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941112|NCT02326272|75670458|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941113|NCT02326272|75670459|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941114|NCT02326272|75670460|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941115|NCT02326272|75670461|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941116|NCT02326272|75670462|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941117|NCT02326272|75670463|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941118|NCT02326272|75670464|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
41941119|NCT02326272|75670465|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941120|NCT02326272|75670466|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941121|NCT02326272|75670467|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41941122|NCT02326272|75670453|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941123|NCT02326272|75670454|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941124|NCT02326272|75670455|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941125|NCT02326272|75670456|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941126|NCT02326272|75670457|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941127|NCT02326272|75670458|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941128|NCT02326272|75670459|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941129|NCT02326272|75670460|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941130|NCT02326272|75670461|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941131|NCT02326272|75670462|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941132|NCT02326272|75670463|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
41941133|NCT02326272|75670464|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941134|NCT02326272|75670465|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
41941135|NCT02326272|75670466|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41941136|NCT02326272|75670467|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
41941137|NCT02326272|75670453|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941138|NCT02326272|75670454|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941139|NCT02326272|75670455|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42118001|NCT00689117|75928842|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
41941140|NCT02326272|75670456|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941141|NCT02326272|75670457|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941142|NCT02326272|75670458|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941143|NCT02326272|75670459|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941144|NCT02326272|75670460|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941145|NCT02326272|75670461|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941146|NCT02326272|75670462|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941147|NCT02326272|75670463|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941148|NCT02326272|75670464|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
41941149|NCT02326272|75670465|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941150|NCT02326272|75670466|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
41941151|NCT02326272|75670467|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
41941152|NCT02326272|75670453|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941153|NCT02326272|75670454|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941154|NCT02326272|75670455|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941155|NCT02326272|75670456|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941156|NCT02326272|75670457|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941157|NCT02326272|75670458|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941158|NCT02326272|75670459|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941159|NCT02326272|75670460|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941160|NCT02326272|75670461|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941161|NCT02326272|75670462|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941162|NCT02326272|75670463|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941163|NCT02326272|75670464|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
41941164|NCT02326272|75670465|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
41941165|NCT02326272|75670466|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
41941166|NCT02326272|75670467|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
41941167|NCT02326272|75670453|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941168|NCT02326272|75670454|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941169|NCT02326272|75670455|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941170|NCT02326272|75670456|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941171|NCT02326272|75670457|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941172|NCT02326272|75670458|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941173|NCT02326272|75670459|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941174|NCT02326272|75670460|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941175|NCT02326272|75670461|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941176|NCT02326272|75670462|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941177|NCT02326272|75670463|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941178|NCT02326272|75670464|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
41941179|NCT02326272|75670465|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941180|NCT02326272|75670466|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941181|NCT02326272|75670467|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
41941182|NCT02326272|75670453|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941183|NCT02326272|75670454|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941184|NCT02326272|75670455|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941185|NCT02326272|75670456|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941186|NCT02326272|75670457|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941187|NCT02326272|75670458|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941188|NCT02326272|75670459|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941189|NCT02326272|75670460|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941190|NCT02326272|75670461|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941191|NCT02326272|75670462|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941192|NCT02326272|75670463|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941193|NCT02326272|75670464|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941194|NCT02326272|75670465|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
41941195|NCT02326272|75670466|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941196|NCT02326272|75670467|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
41941197|NCT02325414|75670504|FG000|Overall Study|Withdrawal by Subject|3|||
41941198|NCT02325414|75670505|FG001|Overall Study|Withdrawal by Subject|1|||
41941199|NCT02325414|75670504|FG000|Overall Study|Lost to Follow-up|5|||
41941200|NCT02325414|75670505|FG001|Overall Study|Lost to Follow-up|5|||
41941201|NCT02349048|75670523|FG000|Overall Study|Withdrawal by Subject|4|||
41941202|NCT02349048|75670524|FG001|Overall Study|Withdrawal by Subject|0|||
41941203|NCT02349048|75670523|FG000|Overall Study|Lost to Follow-up|1|||
41941204|NCT02349048|75670524|FG001|Overall Study|Lost to Follow-up|0|||
41941205|NCT02299206|75670571|FG000|Overall Study|Lost to Follow-up|1|||
41941206|NCT02299206|75670571|FG000|Overall Study|Withdrawal by Subject|1|||
41941207|NCT02298192|75670590|FG000|Overall Study|Unclassified|3|||
41941208|NCT02298192|75670591|FG001|Overall Study|Unclassified|2|||
41941209|NCT02298192|75670590|FG000|Overall Study|Withdrawal criteria|2|||
41941210|NCT02298192|75670591|FG001|Overall Study|Withdrawal criteria|0|||
41941211|NCT02298192|75670590|FG000|Overall Study|Withdrawal by Subject|6|||
41941212|NCT02298192|75670591|FG001|Overall Study|Withdrawal by Subject|1|||
41941213|NCT02298192|75670590|FG000|Overall Study|Lost to Follow-up|2|||
41941214|NCT02298192|75670591|FG001|Overall Study|Lost to Follow-up|1|||
41941215|NCT02298192|75670590|FG000|Overall Study|Adverse Event|6|||
41941216|NCT02298192|75670591|FG001|Overall Study|Adverse Event|2|||
41941217|NCT02280408|75670717|FG000|Overall Study|Lost to Follow-up|0|||
41941218|NCT02280408|75670718|FG001|Overall Study|Lost to Follow-up|2|||
41941219|NCT02280408|75670719|FG002|Overall Study|Lost to Follow-up|0|||
41941220|NCT02280408|75670720|FG003|Overall Study|Lost to Follow-up|0|||
41941221|NCT02296476|75670787|FG000|Overall Study|Disease Progression|6|||
41941222|NCT02296476|75670788|FG001|Overall Study|Disease Progression|4|||
41941223|NCT02296476|75670789|FG002|Overall Study|Disease Progression|2|||
41941224|NCT00552032|75670830|FG000|Overall Study|Withdrawal by Subject|2|||
41941225|NCT00552032|75670831|FG001|Overall Study|Withdrawal by Subject|2|||
41941226|NCT00552032|75670830|FG000|Overall Study|Protocol Violation|7|||
41941227|NCT00552032|75670831|FG001|Overall Study|Protocol Violation|12|||
41941228|NCT00552032|75670830|FG000|Overall Study|Lost to Follow-up|8|||
41941229|NCT00552032|75670831|FG001|Overall Study|Lost to Follow-up|5|||
41941230|NCT03312530|75671617|FG000|Overall Study|Death|5|||
41941231|NCT03312530|75671618|FG001|Overall Study|Death|5|||
41941232|NCT03312530|75671619|FG002|Overall Study|Death|4|||
41941233|NCT03312530|75671620|FG003|Overall Study|Death|10|||
41941234|NCT03312530|75671621|FG004|Overall Study|Death|8|||
41941235|NCT03312530|75671617|FG000|Overall Study|Lost to Follow-up|0|||
41941236|NCT03312530|75671618|FG001|Overall Study|Lost to Follow-up|0|||
41941237|NCT03312530|75671619|FG002|Overall Study|Lost to Follow-up|0|||
41941238|NCT03312530|75671620|FG003|Overall Study|Lost to Follow-up|1|||
41941239|NCT03312530|75671621|FG004|Overall Study|Lost to Follow-up|0|||
41941240|NCT03312530|75671617|FG000|Overall Study|Participant in another sponsor study.|0|||
41941241|NCT03312530|75671618|FG001|Overall Study|Participant in another sponsor study.|0|||
41941242|NCT03312530|75671619|FG002|Overall Study|Participant in another sponsor study.|0|||
41941243|NCT03312530|75671620|FG003|Overall Study|Participant in another sponsor study.|1|||
41941244|NCT03312530|75671621|FG004|Overall Study|Participant in another sponsor study.|0|||
41941245|NCT03312530|75671617|FG000|Overall Study|Study terminated by sponsor|1|||
41941246|NCT03312530|75671618|FG001|Overall Study|Study terminated by sponsor|0|||
41941247|NCT03312530|75671619|FG002|Overall Study|Study terminated by sponsor|2|||
41941248|NCT03312530|75671620|FG003|Overall Study|Study terminated by sponsor|3|||
41941249|NCT03312530|75671621|FG004|Overall Study|Study terminated by sponsor|7|||
41941250|NCT03312530|75671617|FG000|Overall Study|Withdrawal by Subject|0|||
41941251|NCT03312530|75671618|FG001|Overall Study|Withdrawal by Subject|1|||
41941252|NCT03312530|75671619|FG002|Overall Study|Withdrawal by Subject|0|||
41941253|NCT03312530|75671620|FG003|Overall Study|Withdrawal by Subject|0|||
41941254|NCT03312530|75671621|FG004|Overall Study|Withdrawal by Subject|0|||
41941255|NCT03312530|75671617|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
41941256|NCT03312530|75671618|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
41941257|NCT03312530|75671619|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
41941258|NCT03312530|75671620|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
41941259|NCT03312530|75671621|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
41941260|NCT02296320|75671739|FG000|Overall Study|Withdrawal by Subject|4|||
41941261|NCT02296320|75671740|FG001|Overall Study|Withdrawal by Subject|0|||
41941262|NCT02296320|75671741|FG002|Overall Study|Withdrawal by Subject|2|||
41941263|NCT02296320|75671739|FG000|Overall Study|Death|24|||
41941264|NCT02296320|75671740|FG001|Overall Study|Death|3|||
41941265|NCT02296320|75671741|FG002|Overall Study|Death|27|||
41941266|NCT02296320|75671739|FG000|Overall Study|Lost to Follow-up|5|||
41941267|NCT02296320|75671740|FG001|Overall Study|Lost to Follow-up|2|||
41941268|NCT02296320|75671741|FG002|Overall Study|Lost to Follow-up|7|||
41941269|NCT02296320|75671739|FG000|Overall Study|Not treated|2|||
41941270|NCT02296320|75671740|FG001|Overall Study|Not treated|0|||
41941271|NCT02296320|75671741|FG002|Overall Study|Not treated|0|||
41941272|NCT02296320|75671739|FG000|Overall Study|Not - specified|0|||
41941273|NCT02296320|75671740|FG001|Overall Study|Not - specified|0|||
41941274|NCT02296320|75671741|FG002|Overall Study|Not - specified|1|||
41941275|NCT02296242|75671780|FG000|Overall Study|Death|1|||
41941276|NCT02296242|75671781|FG001|Overall Study|Death|1|||
41941277|NCT02296242|75671782|FG002|Overall Study|Death|1|||
41941278|NCT02296242|75671783|FG003|Overall Study|Death|1|||
41941279|NCT02296242|75671784|FG004|Overall Study|Death|1|||
41941280|NCT02296242|75671780|FG000|Overall Study|Withdrawal by Subject|0|||
41941281|NCT02296242|75671781|FG001|Overall Study|Withdrawal by Subject|0|||
41941282|NCT02296242|75671782|FG002|Overall Study|Withdrawal by Subject|1|||
41941283|NCT02296242|75671783|FG003|Overall Study|Withdrawal by Subject|1|||
41941284|NCT02296242|75671784|FG004|Overall Study|Withdrawal by Subject|3|||
41941285|NCT02296242|75671780|FG000|Overall Study|Disease Progression|1|||
41941286|NCT02296242|75671781|FG001|Overall Study|Disease Progression|3|||
41941287|NCT02296242|75671782|FG002|Overall Study|Disease Progression|2|||
41941288|NCT02296242|75671783|FG003|Overall Study|Disease Progression|8|||
41941289|NCT02296242|75671784|FG004|Overall Study|Disease Progression|11|||
41941290|NCT02296242|75671780|FG000|Overall Study|Unacceptable Toxicity|0|||
41941291|NCT02296242|75671781|FG001|Overall Study|Unacceptable Toxicity|0|||
41941292|NCT02296242|75671782|FG002|Overall Study|Unacceptable Toxicity|0|||
41941293|NCT02296242|75671783|FG003|Overall Study|Unacceptable Toxicity|0|||
41941294|NCT02296242|75671784|FG004|Overall Study|Unacceptable Toxicity|1|||
41941295|NCT02296242|75671780|FG000|Overall Study|Patient Condition Changed|0|||
41941296|NCT02296242|75671781|FG001|Overall Study|Patient Condition Changed|0|||
41941297|NCT02296242|75671782|FG002|Overall Study|Patient Condition Changed|2|||
41941298|NCT02296242|75671783|FG003|Overall Study|Patient Condition Changed|0|||
41941299|NCT02296242|75671784|FG004|Overall Study|Patient Condition Changed|1|||
41941300|NCT02296242|75671780|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
41941301|NCT02296242|75671781|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
41941302|NCT02296242|75671782|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
41941303|NCT02296242|75671783|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
41941304|NCT02296242|75671784|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
42022810|NCT01040793|75830104|FG003|Overall Study|Lost to Follow-up|0|||
42022811|NCT01040793|75830105|FG004|Overall Study|Lost to Follow-up|0|||
42210288|NCT03259308|76025066|FG001|Overall Study|Withdrawal by Subject|1|||
41941305|NCT02296242|75671780|FG000|Overall Study|Lost to Follow-up|1|||
41941306|NCT02296242|75671781|FG001|Overall Study|Lost to Follow-up|0|||
41941307|NCT02296242|75671782|FG002|Overall Study|Lost to Follow-up|0|||
41941308|NCT02296242|75671783|FG003|Overall Study|Lost to Follow-up|0|||
41941309|NCT02296242|75671784|FG004|Overall Study|Lost to Follow-up|0|||
41941310|NCT02296242|75671780|FG000|Overall Study|Need for Hydroxyurea|2|||
41941311|NCT02296242|75671781|FG001|Overall Study|Need for Hydroxyurea|0|||
41941312|NCT02296242|75671782|FG002|Overall Study|Need for Hydroxyurea|0|||
41941313|NCT02296242|75671783|FG003|Overall Study|Need for Hydroxyurea|0|||
41941314|NCT02296242|75671784|FG004|Overall Study|Need for Hydroxyurea|0|||
41941315|NCT02296242|75671780|FG000|Overall Study|Screened for Other Protocol|0|||
41941316|NCT02296242|75671781|FG001|Overall Study|Screened for Other Protocol|1|||
41941317|NCT02296242|75671782|FG002|Overall Study|Screened for Other Protocol|0|||
41941318|NCT02296242|75671783|FG003|Overall Study|Screened for Other Protocol|0|||
41941319|NCT02296242|75671784|FG004|Overall Study|Screened for Other Protocol|0|||
41941320|NCT02296242|75671780|FG000|Overall Study|Physician Decision|0|||
41941321|NCT02296242|75671781|FG001|Overall Study|Physician Decision|1|||
41941322|NCT02296242|75671782|FG002|Overall Study|Physician Decision|0|||
41941323|NCT02296242|75671783|FG003|Overall Study|Physician Decision|1|||
41941324|NCT02296242|75671784|FG004|Overall Study|Physician Decision|0|||
41941325|NCT02296242|75671780|FG000|Overall Study|Alternative Treatment|0|||
41941326|NCT02296242|75671781|FG001|Overall Study|Alternative Treatment|0|||
41941327|NCT02296242|75671782|FG002|Overall Study|Alternative Treatment|0|||
41941328|NCT02296242|75671783|FG003|Overall Study|Alternative Treatment|1|||
41941329|NCT02296242|75671784|FG004|Overall Study|Alternative Treatment|0|||
41941330|NCT02296242|75671780|FG000|Overall Study|Adverse Event|0|||
41941331|NCT02296242|75671781|FG001|Overall Study|Adverse Event|0|||
41941332|NCT02296242|75671782|FG002|Overall Study|Adverse Event|0|||
41941333|NCT02296242|75671783|FG003|Overall Study|Adverse Event|1|||
41941334|NCT02296242|75671784|FG004|Overall Study|Adverse Event|0|||
41941335|NCT02296242|75671780|FG000|Overall Study|Lack of Efficacy|0|||
41941336|NCT02296242|75671781|FG001|Overall Study|Lack of Efficacy|0|||
41941337|NCT02296242|75671782|FG002|Overall Study|Lack of Efficacy|0|||
41941338|NCT02296242|75671783|FG003|Overall Study|Lack of Efficacy|0|||
41941339|NCT02296242|75671784|FG004|Overall Study|Lack of Efficacy|3|||
41941340|NCT02295774|75671804|FG000|Overall Study|Physician Decision|1|||
41941341|NCT02295774|75671804|FG000|Overall Study|Withdrawal by Subject|2|||
41941342|NCT02294682|75671819|FG000|Overall Study|Could not swallow pills|1|||
41941343|NCT02294682|75671820|FG001|Overall Study|Could not swallow pills|0|||
41941344|NCT02294604|75671829|FG000|Overall Study|Did not provide samples for culture|0|||
41941345|NCT02294604|75671830|FG001|Overall Study|Did not provide samples for culture|1|||
41941346|NCT02294604|75671831|FG002|Overall Study|Did not provide samples for culture|0|||
41941347|NCT02294604|75671829|FG000|Overall Study|Culture contamination|1|||
41941348|NCT02294604|75671830|FG001|Overall Study|Culture contamination|2|||
41941349|NCT02294604|75671831|FG002|Overall Study|Culture contamination|0|||
41941350|NCT01645176|75671850|FG000|Overall Study|Lack of Efficacy|4|||
41941351|NCT01645176|75671850|FG000|Overall Study|did not complete final MRI|1|||
41941352|NCT02322216|75671865|FG000|Overall Study|Adverse Event|1|||
41941353|NCT02322216|75671866|FG001|Overall Study|Adverse Event|0|||
41941354|NCT02322216|75671865|FG000|Overall Study|Withdrawal by Subject|1|||
41941355|NCT02322216|75671866|FG001|Overall Study|Withdrawal by Subject|4|||
41941356|NCT01647516|75671907|FG000|Induction Period (IP)|Physician Decision|2|||
41941357|NCT01647516|75671908|FG001|Induction Period (IP)|Physician Decision|0|||
41941358|NCT01647516|75671909|FG002|Induction Period (IP)|Physician Decision|0|||
41941359|NCT01647516|75671910|FG003|Induction Period (IP)|Physician Decision|0|||
41941360|NCT01647516|75671911|FG004|Induction Period (IP)|Physician Decision|0|||
41941361|NCT01647516|75671912|FG005|Induction Period (IP)|Physician Decision|0|||
41941362|NCT01647516|75671907|FG000|Induction Period (IP)|Adverse Event|1|||
41941363|NCT01647516|75671908|FG001|Induction Period (IP)|Adverse Event|2|||
41941364|NCT01647516|75671909|FG002|Induction Period (IP)|Adverse Event|0|||
41941365|NCT01647516|75671910|FG003|Induction Period (IP)|Adverse Event|0|||
41941366|NCT01647516|75671911|FG004|Induction Period (IP)|Adverse Event|0|||
41941367|NCT01647516|75671912|FG005|Induction Period (IP)|Adverse Event|0|||
41941368|NCT01647516|75671907|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
41941369|NCT01647516|75671908|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
41941370|NCT01647516|75671909|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
41941371|NCT01647516|75671910|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
41941372|NCT01647516|75671911|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
41941373|NCT01647516|75671912|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
41941374|NCT01647516|75671907|FG000|Induction Period (IP)|Participant Choice|0|||
41941375|NCT01647516|75671908|FG001|Induction Period (IP)|Participant Choice|0|||
41941376|NCT01647516|75671909|FG002|Induction Period (IP)|Participant Choice|1|||
42118002|NCT00689117|75928843|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
41941377|NCT01647516|75671910|FG003|Induction Period (IP)|Participant Choice|0|||
42118003|NCT00689117|75928840|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
41941378|NCT01647516|75671911|FG004|Induction Period (IP)|Participant Choice|0|||
41941379|NCT01647516|75671912|FG005|Induction Period (IP)|Participant Choice|0|||
41941380|NCT01647516|75671907|FG000|Induction Period (IP)|Lack of Efficacy|1|||
41941381|NCT01647516|75671908|FG001|Induction Period (IP)|Lack of Efficacy|0|||
41941382|NCT01647516|75671909|FG002|Induction Period (IP)|Lack of Efficacy|0|||
41941383|NCT01647516|75671910|FG003|Induction Period (IP)|Lack of Efficacy|0|||
41941384|NCT01647516|75671911|FG004|Induction Period (IP)|Lack of Efficacy|0|||
41941385|NCT01647516|75671912|FG005|Induction Period (IP)|Lack of Efficacy|0|||
41941386|NCT01647516|75671907|FG000|Induction Period (IP)|No study drug received|1|||
41941387|NCT01647516|75671908|FG001|Induction Period (IP)|No study drug received|1|||
41941388|NCT01647516|75671909|FG002|Induction Period (IP)|No study drug received|0|||
41941389|NCT01647516|75671910|FG003|Induction Period (IP)|No study drug received|0|||
41941390|NCT01647516|75671911|FG004|Induction Period (IP)|No study drug received|0|||
41941391|NCT01647516|75671912|FG005|Induction Period (IP)|No study drug received|0|||
41941392|NCT01647516|75671907|FG000|Maintenance Period (MP)|Adverse Event|2|||
41941393|NCT01647516|75671908|FG001|Maintenance Period (MP)|Adverse Event|1|||
41941394|NCT01647516|75671909|FG002|Maintenance Period (MP)|Adverse Event|0|||
41941395|NCT01647516|75671910|FG003|Maintenance Period (MP)|Adverse Event|0|||
41941396|NCT01647516|75671911|FG004|Maintenance Period (MP)|Adverse Event|0|||
41941397|NCT01647516|75671912|FG005|Maintenance Period (MP)|Adverse Event|0|||
41941398|NCT01647516|75671907|FG000|Maintenance Period (MP)|Non-compliance|1|||
41941399|NCT01647516|75671908|FG001|Maintenance Period (MP)|Non-compliance|0|||
41941400|NCT01647516|75671909|FG002|Maintenance Period (MP)|Non-compliance|0|||
41941401|NCT01647516|75671910|FG003|Maintenance Period (MP)|Non-compliance|0|||
41941402|NCT01647516|75671911|FG004|Maintenance Period (MP)|Non-compliance|0|||
41941403|NCT01647516|75671912|FG005|Maintenance Period (MP)|Non-compliance|0|||
41941404|NCT01647516|75671907|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
41941405|NCT01647516|75671908|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
41941406|NCT01647516|75671909|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
41941407|NCT01647516|75671910|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
41941408|NCT01647516|75671911|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
41941409|NCT01647516|75671912|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
41941410|NCT01647516|75671907|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
41941411|NCT01647516|75671908|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
41941412|NCT01647516|75671909|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
41941413|NCT01647516|75671910|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
41941414|NCT01647516|75671911|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
41941415|NCT01647516|75671912|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
41941416|NCT01647516|75671907|FG000|Open-Label Period|Adverse Event|0|||
41941417|NCT01647516|75671908|FG001|Open-Label Period|Adverse Event|0|||
41941418|NCT01647516|75671909|FG002|Open-Label Period|Adverse Event|0|||
41941419|NCT01647516|75671910|FG003|Open-Label Period|Adverse Event|5|||
41941420|NCT01647516|75671911|FG004|Open-Label Period|Adverse Event|6|||
41941421|NCT01647516|75671912|FG005|Open-Label Period|Adverse Event|3|||
41941422|NCT01647516|75671907|FG000|Open-Label Period|Pregnancy|0|||
41941423|NCT01647516|75671908|FG001|Open-Label Period|Pregnancy|0|||
41941424|NCT01647516|75671909|FG002|Open-Label Period|Pregnancy|0|||
41941425|NCT01647516|75671910|FG003|Open-Label Period|Pregnancy|0|||
41941426|NCT01647516|75671911|FG004|Open-Label Period|Pregnancy|0|||
41941427|NCT01647516|75671912|FG005|Open-Label Period|Pregnancy|1|||
41941428|NCT01647516|75671907|FG000|Open-Label Period|Non-compliance|0|||
41941429|NCT01647516|75671908|FG001|Open-Label Period|Non-compliance|0|||
41941430|NCT01647516|75671909|FG002|Open-Label Period|Non-compliance|0|||
41941431|NCT01647516|75671910|FG003|Open-Label Period|Non-compliance|1|||
41941432|NCT01647516|75671911|FG004|Open-Label Period|Non-compliance|0|||
41941433|NCT01647516|75671912|FG005|Open-Label Period|Non-compliance|1|||
41941434|NCT01647516|75671907|FG000|Open-Label Period|Physician Decision|0|||
41941435|NCT01647516|75671908|FG001|Open-Label Period|Physician Decision|0|||
41941436|NCT01647516|75671909|FG002|Open-Label Period|Physician Decision|0|||
41941437|NCT01647516|75671910|FG003|Open-Label Period|Physician Decision|1|||
41941438|NCT01647516|75671911|FG004|Open-Label Period|Physician Decision|1|||
41941439|NCT01647516|75671912|FG005|Open-Label Period|Physician Decision|0|||
41941440|NCT01647516|75671907|FG000|Open-Label Period|Withdrawal by Subject|0|||
41941441|NCT01647516|75671908|FG001|Open-Label Period|Withdrawal by Subject|0|||
41941442|NCT01647516|75671909|FG002|Open-Label Period|Withdrawal by Subject|0|||
41941443|NCT01647516|75671910|FG003|Open-Label Period|Withdrawal by Subject|9|||
41941444|NCT01647516|75671911|FG004|Open-Label Period|Withdrawal by Subject|11|||
41941445|NCT01647516|75671912|FG005|Open-Label Period|Withdrawal by Subject|6|||
41941446|NCT01647516|75671907|FG000|Open-Label Period|Lost to Follow-up|0|||
41941447|NCT01647516|75671908|FG001|Open-Label Period|Lost to Follow-up|0|||
41941448|NCT01647516|75671909|FG002|Open-Label Period|Lost to Follow-up|0|||
41941449|NCT01647516|75671910|FG003|Open-Label Period|Lost to Follow-up|1|||
41941450|NCT01647516|75671911|FG004|Open-Label Period|Lost to Follow-up|0|||
41941451|NCT01647516|75671912|FG005|Open-Label Period|Lost to Follow-up|1|||
41941452|NCT01647516|75671907|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
41941453|NCT01647516|75671908|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
41941454|NCT01647516|75671909|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
41941455|NCT01647516|75671910|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
41941456|NCT01647516|75671911|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
41941457|NCT01647516|75671912|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
41941458|NCT01647516|75671907|FG000|Open-Label Period|Lack of Efficacy|0|||
41941459|NCT01647516|75671908|FG001|Open-Label Period|Lack of Efficacy|0|||
41941460|NCT01647516|75671909|FG002|Open-Label Period|Lack of Efficacy|0|||
41941461|NCT01647516|75671910|FG003|Open-Label Period|Lack of Efficacy|7|||
41941462|NCT01647516|75671911|FG004|Open-Label Period|Lack of Efficacy|9|||
41941463|NCT01647516|75671912|FG005|Open-Label Period|Lack of Efficacy|10|||
41941464|NCT01647516|75671907|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
41941465|NCT01647516|75671908|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
41941466|NCT01647516|75671909|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
41941467|NCT01647516|75671910|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
41941468|NCT01647516|75671911|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
41941469|NCT01647516|75671912|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
41941470|NCT01647516|75671907|FG000|Open-Label Period|No completion / discontinuation visit|0|||
41941471|NCT01647516|75671908|FG001|Open-Label Period|No completion / discontinuation visit|0|||
41941472|NCT01647516|75671909|FG002|Open-Label Period|No completion / discontinuation visit|0|||
41941473|NCT01647516|75671910|FG003|Open-Label Period|No completion / discontinuation visit|0|||
41941474|NCT01647516|75671911|FG004|Open-Label Period|No completion / discontinuation visit|2|||
41941475|NCT01647516|75671912|FG005|Open-Label Period|No completion / discontinuation visit|1|||
41941476|NCT01647282|75671929|FG000|Overall Study|Physician Decision|7|||
41941477|NCT01647282|75671930|FG001|Overall Study|Physician Decision|5|||
41941478|NCT02321436|75671938|FG000|Overall Study|Withdrawal by Subject|1|||
41941479|NCT02321436|75671939|FG001|Overall Study|Withdrawal by Subject|0|||
41941480|NCT02321436|75671938|FG000|Overall Study|Lost to Follow-up|0|||
41941481|NCT02321436|75671939|FG001|Overall Study|Lost to Follow-up|1|||
41941482|NCT02319642|75671948|FG000|Overall Study|Adverse Event|2|||
41941483|NCT02319642|75671949|FG001|Overall Study|Adverse Event|4|||
41941484|NCT02319642|75671948|FG000|Overall Study|Lack of Efficacy|1|||
41941485|NCT02319642|75671949|FG001|Overall Study|Lack of Efficacy|1|||
41941486|NCT02319642|75671948|FG000|Overall Study|Withdrawal by Subject|1|||
41941487|NCT02319642|75671949|FG001|Overall Study|Withdrawal by Subject|1|||
41941488|NCT02280096|75671959|FG000|Overall Study|Pregnancy|1|||
41941489|NCT02280096|75671960|FG001|Overall Study|Pregnancy|0|||
41941490|NCT02280096|75671959|FG000|Overall Study|Functional neurological disorder|1|||
41941491|NCT02280096|75671960|FG001|Overall Study|Functional neurological disorder|0|||
41941492|NCT02280096|75671959|FG000|Overall Study|Lack of attachment|0|||
41941493|NCT02280096|75671960|FG001|Overall Study|Lack of attachment|1|||
41941494|NCT02279862|75671977|FG000|Overall Study|Study drug toxicity|3|||
41941495|NCT02279862|75671978|FG001|Overall Study|Study drug toxicity|6|||
41941496|NCT02279862|75671977|FG000|Overall Study|No longer meets criteria|0|||
41941497|NCT02279862|75671978|FG001|Overall Study|No longer meets criteria|1|||
41941498|NCT02279862|75671977|FG000|Overall Study|Administrative reason by sponsor|0|||
41941499|NCT02279862|75671978|FG001|Overall Study|Administrative reason by sponsor|1|||
41941500|NCT02279862|75671977|FG000|Overall Study|Disease progression|5|||
41941501|NCT02279862|75671978|FG001|Overall Study|Disease progression|2|||
41941502|NCT02279862|75671977|FG000|Overall Study|Study closed by sponsor|16|||
41941503|NCT02279862|75671978|FG001|Overall Study|Study closed by sponsor|13|||
41941504|NCT02279862|75671977|FG000|Overall Study|Other|1|||
41941505|NCT02279862|75671978|FG001|Overall Study|Other|2|||
41941506|NCT02279862|75671977|FG000|Overall Study|Withdrawal by Subject|1|||
41941507|NCT02279862|75671978|FG001|Overall Study|Withdrawal by Subject|0|||
42300258|NCT02301975|76135408|FG000|Overall Study|Protocol Violation|3|||
42300259|NCT02301975|76135409|FG001|Overall Study|Protocol Violation|5|||
41941508|NCT02318940|75671986|FG000|Overall Study|lost the record|1|||
41941509|NCT02318940|75671987|FG001|Overall Study|lost the record|0|||
41941510|NCT02294058|75671996|FG000|Overall Study|Adverse Event|16|||
41941511|NCT02294058|75671997|FG001|Overall Study|Adverse Event|7|||
41941512|NCT02294058|75671998|FG002|Overall Study|Adverse Event|13|||
41941513|NCT02294058|75671996|FG000|Overall Study|Lack of Efficacy|3|||
41941514|NCT02294058|75671997|FG001|Overall Study|Lack of Efficacy|3|||
41941515|NCT02294058|75671998|FG002|Overall Study|Lack of Efficacy|0|||
41941516|NCT02294058|75671996|FG000|Overall Study|Lost to Follow-up|1|||
41941517|NCT02294058|75671997|FG001|Overall Study|Lost to Follow-up|0|||
41941518|NCT02294058|75671998|FG002|Overall Study|Lost to Follow-up|2|||
41941519|NCT02294058|75671996|FG000|Overall Study|Withdrawal by Subject|10|||
41941520|NCT02294058|75671997|FG001|Overall Study|Withdrawal by Subject|14|||
41941521|NCT02294058|75671998|FG002|Overall Study|Withdrawal by Subject|13|||
41941522|NCT02294058|75671996|FG000|Overall Study|Physician Decision|2|||
42300260|NCT02301975|76135410|FG002|Overall Study|Protocol Violation|3|||
41941523|NCT02294058|75671997|FG001|Overall Study|Physician Decision|1|||
41941524|NCT02294058|75671998|FG002|Overall Study|Physician Decision|0|||
41941525|NCT02294058|75671996|FG000|Overall Study|Miscellaneous|4|||
41941526|NCT02294058|75671997|FG001|Overall Study|Miscellaneous|1|||
41941527|NCT02294058|75671998|FG002|Overall Study|Miscellaneous|1|||
41941528|NCT02293902|75672010|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
41941529|NCT02293902|75672011|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
41941530|NCT02293902|75672012|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
41941531|NCT02293902|75672013|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
41941532|NCT02293902|75672014|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
41941533|NCT02293902|75672010|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
41941534|NCT02293902|75672011|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
41941535|NCT02293902|75672012|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
41941536|NCT02293902|75672013|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
41941537|NCT02293902|75672014|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
41941538|NCT02293902|75672010|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
41941539|NCT02293902|75672011|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
41941540|NCT02293902|75672012|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
41941541|NCT02293902|75672013|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
41941542|NCT02293902|75672014|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
41941543|NCT02293902|75672010|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
41941544|NCT02293902|75672011|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
41941545|NCT02293902|75672012|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
41941546|NCT02293902|75672013|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
41941547|NCT02293902|75672014|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
41941548|NCT02293902|75672010|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
41941549|NCT02293902|75672011|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
41941550|NCT02293902|75672012|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
41941551|NCT02293902|75672013|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
41941552|NCT02293902|75672014|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
41941553|NCT02278614|75672034|FG000|Overall Study|Withdrawal by Subject|3|||
41941554|NCT02278614|75672035|FG001|Overall Study|Withdrawal by Subject|5|||
41941555|NCT02278614|75672034|FG000|Overall Study|Adverse Event|1|||
41941556|NCT02278614|75672035|FG001|Overall Study|Adverse Event|0|||
41941557|NCT02278614|75672034|FG000|Overall Study|left eye was not eligible|1|||
41941558|NCT02278614|75672035|FG001|Overall Study|left eye was not eligible|0|||
41941559|NCT02318706|75672045|FG000|Double-blind Phase|Adverse Event|7|||
41941560|NCT02318706|75672046|FG001|Double-blind Phase|Adverse Event|4|||
41941561|NCT02318706|75672047|FG002|Double-blind Phase|Adverse Event|3|||
41941562|NCT02318706|75672048|FG003|Double-blind Phase|Adverse Event|10|||
41941563|NCT02318706|75672049|FG004|Double-blind Phase|Adverse Event|0|||
41941564|NCT02318706|75672045|FG000|Double-blind Phase|Lost to Follow-up|1|||
41941565|NCT02318706|75672046|FG001|Double-blind Phase|Lost to Follow-up|0|||
41941566|NCT02318706|75672047|FG002|Double-blind Phase|Lost to Follow-up|0|||
41941567|NCT02318706|75672048|FG003|Double-blind Phase|Lost to Follow-up|0|||
41941568|NCT02318706|75672049|FG004|Double-blind Phase|Lost to Follow-up|0|||
41941569|NCT02318706|75672045|FG000|Double-blind Phase|Protocol Violation|4|||
41941570|NCT02318706|75672046|FG001|Double-blind Phase|Protocol Violation|2|||
41941571|NCT02318706|75672047|FG002|Double-blind Phase|Protocol Violation|4|||
41941572|NCT02318706|75672048|FG003|Double-blind Phase|Protocol Violation|3|||
41941573|NCT02318706|75672049|FG004|Double-blind Phase|Protocol Violation|0|||
41941574|NCT02318706|75672045|FG000|Double-blind Phase|Withdrawal by Subject|9|||
41941575|NCT02318706|75672046|FG001|Double-blind Phase|Withdrawal by Subject|5|||
41941576|NCT02318706|75672047|FG002|Double-blind Phase|Withdrawal by Subject|7|||
41941577|NCT02318706|75672048|FG003|Double-blind Phase|Withdrawal by Subject|10|||
41941578|NCT02318706|75672049|FG004|Double-blind Phase|Withdrawal by Subject|0|||
41941579|NCT02318706|75672045|FG000|Double-blind Phase|Other|4|||
41941580|NCT02318706|75672046|FG001|Double-blind Phase|Other|1|||
41941581|NCT02318706|75672047|FG002|Double-blind Phase|Other|2|||
41941582|NCT02318706|75672048|FG003|Double-blind Phase|Other|1|||
41941583|NCT02318706|75672049|FG004|Double-blind Phase|Other|0|||
41941584|NCT02318706|75672045|FG000|Double-blind Phase|Death|0|||
41941585|NCT02318706|75672046|FG001|Double-blind Phase|Death|0|||
41941586|NCT02318706|75672047|FG002|Double-blind Phase|Death|2|||
41941587|NCT02318706|75672048|FG003|Double-blind Phase|Death|0|||
41941588|NCT02318706|75672049|FG004|Double-blind Phase|Death|0|||
41941589|NCT02318706|75672045|FG000|Open-label Extension Phase|Adverse Event|0|||
41941590|NCT02318706|75672046|FG001|Open-label Extension Phase|Adverse Event|0|||
41941591|NCT02318706|75672047|FG002|Open-label Extension Phase|Adverse Event|0|||
41941592|NCT02318706|75672048|FG003|Open-label Extension Phase|Adverse Event|0|||
41941593|NCT02318706|75672049|FG004|Open-label Extension Phase|Adverse Event|21|||
41941594|NCT02318706|75672045|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
41941595|NCT02318706|75672046|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
41941596|NCT02318706|75672047|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
41941597|NCT02318706|75672048|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
41941598|NCT02318706|75672049|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
41941599|NCT02318706|75672045|FG000|Open-label Extension Phase|Death|0|||
41941600|NCT02318706|75672046|FG001|Open-label Extension Phase|Death|0|||
41941601|NCT02318706|75672047|FG002|Open-label Extension Phase|Death|0|||
41941602|NCT02318706|75672048|FG003|Open-label Extension Phase|Death|0|||
41941603|NCT02318706|75672049|FG004|Open-label Extension Phase|Death|1|||
41941604|NCT02318706|75672045|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
41941605|NCT02318706|75672046|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
41941606|NCT02318706|75672047|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
41941607|NCT02318706|75672048|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
41941608|NCT02318706|75672049|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
41941609|NCT04583280|75672100|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
41941610|NCT04583280|75672101|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
41941611|NCT04489940|75672120|FG000|Overall Study|Other|2|||
41941612|NCT04489940|75672120|FG000|Overall Study|Withdrawal by Subject|2|||
41941613|NCT04489940|75672120|FG000|Overall Study|Death|5|||
41941614|NCT04489940|75672120|FG000|Overall Study|Lost to Follow-up|1|||
41941615|NCT04365257|75672126|FG000|Overall Study|Physician Decision|1|||
41941616|NCT04365257|75672127|FG001|Overall Study|Physician Decision|0|||
41941617|NCT04365257|75672126|FG000|Overall Study|Patient Noncompliance|1|||
41941618|NCT04365257|75672127|FG001|Overall Study|Patient Noncompliance|0|||
41941619|NCT04365257|75672126|FG000|Overall Study|Withdrawal by Subject|0|||
41941620|NCT04365257|75672127|FG001|Overall Study|Withdrawal by Subject|1|||
41941621|NCT03395223|75672159|FG000|Overall Study|Lost to Follow-up|3|||
41941622|NCT03395223|75672159|FG000|Overall Study|Other|1|||
41941623|NCT02864940|75672189|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
41941624|NCT02864940|75672190|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
41941625|NCT02756611|75672209|FG000|Overall Study|Death|70|||
41941626|NCT02756611|75672209|FG000|Overall Study|Withdrawal by Subject|2|||
41941627|NCT02756611|75672209|FG000|Overall Study|Lost to Follow-up|3|||
41941628|NCT02756611|75672209|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
41941629|NCT02756611|75672209|FG000|Overall Study|Other|10|||
41941630|NCT02624518|75672213|FG000|Overall Study|Physician Decision|1|||
41941631|NCT02287623|75672219|FG000|Overall Study|Protocol Violation|0|||
41941632|NCT02287623|75672220|FG001|Overall Study|Protocol Violation|1|||
41941633|NCT01794520|75672242|FG000|Overall Study|Adverse events- related to progression|0|||
41941634|NCT01794520|75672243|FG001|Overall Study|Adverse events- related to progression|0|||
41941635|NCT01794520|75672244|FG002|Overall Study|Adverse events- related to progression|1|||
41941636|NCT01794520|75672245|FG003|Overall Study|Adverse events- related to progression|2|||
41941637|NCT01794520|75672246|FG004|Overall Study|Adverse events- related to progression|0|||
41941638|NCT01794520|75672247|FG005|Overall Study|Adverse events- related to progression|1|||
41941639|NCT01794520|75672248|FG006|Overall Study|Adverse events- related to progression|0|||
41941640|NCT01794520|75672242|FG000|Overall Study|Adverse event- not related to progression|1|||
41941641|NCT01794520|75672243|FG001|Overall Study|Adverse event- not related to progression|1|||
41941642|NCT01794520|75672244|FG002|Overall Study|Adverse event- not related to progression|0|||
41941643|NCT01794520|75672245|FG003|Overall Study|Adverse event- not related to progression|0|||
41941644|NCT01794520|75672246|FG004|Overall Study|Adverse event- not related to progression|2|||
41941645|NCT01794520|75672247|FG005|Overall Study|Adverse event- not related to progression|0|||
42118004|NCT00689117|75928841|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
41941646|NCT01794520|75672248|FG006|Overall Study|Adverse event- not related to progression|0|||
41941647|NCT01794520|75672242|FG000|Overall Study|Progressive disease|5|||
41941648|NCT01794520|75672243|FG001|Overall Study|Progressive disease|6|||
41941649|NCT01794520|75672244|FG002|Overall Study|Progressive disease|2|||
41941650|NCT01794520|75672245|FG003|Overall Study|Progressive disease|5|||
41941651|NCT01794520|75672246|FG004|Overall Study|Progressive disease|27|||
41941652|NCT01794520|75672247|FG005|Overall Study|Progressive disease|18|||
41941653|NCT01794520|75672248|FG006|Overall Study|Progressive disease|0|||
41941654|NCT01794520|75672242|FG000|Overall Study|Withdrew consent|0|||
41941655|NCT01794520|75672243|FG001|Overall Study|Withdrew consent|0|||
41941656|NCT01794520|75672244|FG002|Overall Study|Withdrew consent|1|||
41941657|NCT01794520|75672245|FG003|Overall Study|Withdrew consent|1|||
41941658|NCT01794520|75672246|FG004|Overall Study|Withdrew consent|0|||
41941659|NCT01794520|75672247|FG005|Overall Study|Withdrew consent|0|||
41941660|NCT01794520|75672248|FG006|Overall Study|Withdrew consent|0|||
41941661|NCT01794520|75672242|FG000|Overall Study|Lost to Follow-up|0|||
41941662|NCT01794520|75672243|FG001|Overall Study|Lost to Follow-up|0|||
41941663|NCT01794520|75672244|FG002|Overall Study|Lost to Follow-up|0|||
41941664|NCT01794520|75672245|FG003|Overall Study|Lost to Follow-up|0|||
41941665|NCT01794520|75672246|FG004|Overall Study|Lost to Follow-up|1|||
41941666|NCT01794520|75672247|FG005|Overall Study|Lost to Follow-up|0|||
41941667|NCT01794520|75672248|FG006|Overall Study|Lost to Follow-up|0|||
41941668|NCT01794520|75672242|FG000|Overall Study|Toxicity|0|||
41941669|NCT01794520|75672243|FG001|Overall Study|Toxicity|2|||
41941670|NCT01794520|75672244|FG002|Overall Study|Toxicity|0|||
41941671|NCT01794520|75672245|FG003|Overall Study|Toxicity|0|||
41941672|NCT01794520|75672246|FG004|Overall Study|Toxicity|0|||
41941673|NCT01794520|75672247|FG005|Overall Study|Toxicity|0|||
41941674|NCT01794520|75672248|FG006|Overall Study|Toxicity|0|||
41941675|NCT01794520|75672242|FG000|Overall Study|Study terminated by sponsor|0|||
41941676|NCT01794520|75672243|FG001|Overall Study|Study terminated by sponsor|0|||
41941677|NCT01794520|75672244|FG002|Overall Study|Study terminated by sponsor|1|||
41941678|NCT01794520|75672245|FG003|Overall Study|Study terminated by sponsor|0|||
41941679|NCT01794520|75672246|FG004|Overall Study|Study terminated by sponsor|1|||
41941680|NCT01794520|75672247|FG005|Overall Study|Study terminated by sponsor|0|||
41941681|NCT01794520|75672248|FG006|Overall Study|Study terminated by sponsor|7|||
41941682|NCT01794520|75672242|FG000|Overall Study|Death|0|||
41941683|NCT01794520|75672243|FG001|Overall Study|Death|0|||
41941684|NCT01794520|75672244|FG002|Overall Study|Death|0|||
41941685|NCT01794520|75672245|FG003|Overall Study|Death|0|||
41941686|NCT01794520|75672246|FG004|Overall Study|Death|1|||
41941687|NCT01794520|75672247|FG005|Overall Study|Death|0|||
41941688|NCT01794520|75672248|FG006|Overall Study|Death|22|||
41941689|NCT01794520|75672242|FG000|Overall Study|Other, not specified|0|||
42022812|NCT01040793|75830106|FG005|Overall Study|Lost to Follow-up|0|||
42022813|NCT01040793|75830101|FG000|Overall Study|Withdrawal by Subject|0|||
42022814|NCT01040793|75830102|FG001|Overall Study|Withdrawal by Subject|0|||
42022815|NCT01040793|75830103|FG002|Overall Study|Withdrawal by Subject|0|||
41941690|NCT01794520|75672243|FG001|Overall Study|Other, not specified|0|||
41941691|NCT01794520|75672244|FG002|Overall Study|Other, not specified|1|||
41941692|NCT01794520|75672245|FG003|Overall Study|Other, not specified|1|||
41941693|NCT01794520|75672246|FG004|Overall Study|Other, not specified|4|||
41941694|NCT01794520|75672247|FG005|Overall Study|Other, not specified|1|||
41941695|NCT01794520|75672248|FG006|Overall Study|Other, not specified|2|||
41941696|NCT01774019|75672271|FG000|Overall Study|No longer meets protocol criteria|2|||
41941697|NCT01774019|75672272|FG001|Overall Study|No longer meets protocol criteria|0|||
41941698|NCT01774019|75672271|FG000|Overall Study|Withdrawal by Subject|1|||
41941699|NCT01774019|75672272|FG001|Overall Study|Withdrawal by Subject|0|||
41941700|NCT01774019|75672271|FG000|Overall Study|Surgery delayed > 120 days|1|||
41941701|NCT01774019|75672272|FG001|Overall Study|Surgery delayed > 120 days|0|||
41941702|NCT01774019|75672271|FG000|Overall Study|Patient refused surgery|1|||
41941703|NCT01774019|75672272|FG001|Overall Study|Patient refused surgery|1|||
41941704|NCT01774019|75672271|FG000|Overall Study|Unable to implant study device|1|||
41941705|NCT01774019|75672272|FG001|Overall Study|Unable to implant study device|0|||
41941706|NCT01774019|75672271|FG000|Overall Study|Lost to Follow-up|0|||
41941707|NCT01774019|75672272|FG001|Overall Study|Lost to Follow-up|3|||
41941708|NCT03251924|75672625|FG000|Overall Study|Disease Progression|6|||
41941709|NCT03251924|75672626|FG001|Overall Study|Disease Progression|6|||
41941710|NCT03251924|75672627|FG002|Overall Study|Disease Progression|7|||
41941711|NCT03251924|75672628|FG003|Overall Study|Disease Progression|8|||
41941712|NCT03251924|75672629|FG004|Overall Study|Disease Progression|8|||
41941713|NCT03251924|75672630|FG005|Overall Study|Disease Progression|7|||
42022816|NCT01040793|75830104|FG003|Overall Study|Withdrawal by Subject|2|||
42022817|NCT01040793|75830105|FG004|Overall Study|Withdrawal by Subject|0|||
41941714|NCT03251924|75672631|FG006|Overall Study|Disease Progression|6|||
41941715|NCT03251924|75672632|FG007|Overall Study|Disease Progression|10|||
41941716|NCT03251924|75672633|FG008|Overall Study|Disease Progression|6|||
41941717|NCT03251924|75672625|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
41941718|NCT03251924|75672626|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
41941719|NCT03251924|75672627|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
41941720|NCT03251924|75672628|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
41941721|NCT03251924|75672629|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
41941722|NCT03251924|75672630|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
41941723|NCT03251924|75672631|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
41941724|NCT03251924|75672632|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
41941725|NCT03251924|75672633|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
41941726|NCT03251924|75672625|FG000|Overall Study|Death|0|||
41941727|NCT03251924|75672626|FG001|Overall Study|Death|1|||
41941728|NCT03251924|75672627|FG002|Overall Study|Death|0|||
41941729|NCT03251924|75672628|FG003|Overall Study|Death|1|||
41941730|NCT03251924|75672629|FG004|Overall Study|Death|1|||
41941731|NCT03251924|75672630|FG005|Overall Study|Death|1|||
41941732|NCT03251924|75672631|FG006|Overall Study|Death|0|||
41941733|NCT03251924|75672632|FG007|Overall Study|Death|0|||
41941734|NCT03251924|75672633|FG008|Overall Study|Death|0|||
41941735|NCT03251924|75672625|FG000|Overall Study|Study Drug Toxicity|0|||
41941736|NCT03251924|75672626|FG001|Overall Study|Study Drug Toxicity|0|||
41941737|NCT03251924|75672627|FG002|Overall Study|Study Drug Toxicity|0|||
41941738|NCT03251924|75672628|FG003|Overall Study|Study Drug Toxicity|1|||
41941739|NCT03251924|75672629|FG004|Overall Study|Study Drug Toxicity|0|||
41941740|NCT03251924|75672630|FG005|Overall Study|Study Drug Toxicity|0|||
41941741|NCT03251924|75672631|FG006|Overall Study|Study Drug Toxicity|0|||
41941742|NCT03251924|75672632|FG007|Overall Study|Study Drug Toxicity|0|||
41941743|NCT03251924|75672633|FG008|Overall Study|Study Drug Toxicity|1|||
41941744|NCT03251924|75672625|FG000|Overall Study|Other Reasons|0|||
41941745|NCT03251924|75672626|FG001|Overall Study|Other Reasons|0|||
41941746|NCT03251924|75672627|FG002|Overall Study|Other Reasons|0|||
41941747|NCT03251924|75672628|FG003|Overall Study|Other Reasons|0|||
41941748|NCT03251924|75672629|FG004|Overall Study|Other Reasons|0|||
41941749|NCT03251924|75672630|FG005|Overall Study|Other Reasons|0|||
41941750|NCT03251924|75672631|FG006|Overall Study|Other Reasons|0|||
41941751|NCT03251924|75672632|FG007|Overall Study|Other Reasons|0|||
41941752|NCT03251924|75672633|FG008|Overall Study|Other Reasons|1|||
41941753|NCT03251924|75672625|FG000|Overall Study|Participant request to discontinue study treatment|0|||
41941754|NCT03251924|75672626|FG001|Overall Study|Participant request to discontinue study treatment|0|||
41941755|NCT03251924|75672627|FG002|Overall Study|Participant request to discontinue study treatment|0|||
41941756|NCT03251924|75672628|FG003|Overall Study|Participant request to discontinue study treatment|0|||
41941757|NCT03251924|75672629|FG004|Overall Study|Participant request to discontinue study treatment|0|||
41941758|NCT03251924|75672630|FG005|Overall Study|Participant request to discontinue study treatment|0|||
41941759|NCT03251924|75672631|FG006|Overall Study|Participant request to discontinue study treatment|0|||
41941760|NCT03251924|75672632|FG007|Overall Study|Participant request to discontinue study treatment|1|||
41941761|NCT03251924|75672633|FG008|Overall Study|Participant request to discontinue study treatment|0|||
41941762|NCT03723707|75672721|FG000|Overall Study|Death|32|||
41941763|NCT03723707|75672722|FG001|Overall Study|Death|32|||
41941764|NCT03723707|75672721|FG000|Overall Study|Admitted to long term care|12|||
41941765|NCT03723707|75672722|FG001|Overall Study|Admitted to long term care|12|||
41941766|NCT03723707|75672721|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
41941767|NCT03723707|75672722|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
41941768|NCT03723707|75672721|FG000|Overall Study|Lost to Follow-up|40|||
41941769|NCT03723707|75672722|FG001|Overall Study|Lost to Follow-up|22|||
41941770|NCT03723707|75672721|FG000|Overall Study|Discontinued after study closure|24|||
41941771|NCT03723707|75672722|FG001|Overall Study|Discontinued after study closure|12|||
41941772|NCT01350141|75672832|FG000|Overall Study|Lost to Follow-up|1|||
41941773|NCT01350141|75672833|FG001|Overall Study|Lost to Follow-up|0|||
41941774|NCT01350141|75672834|FG002|Overall Study|Lost to Follow-up|1|||
41941775|NCT01350141|75672832|FG000|Overall Study|Withdrawal by Subject|1|||
41941776|NCT01350141|75672833|FG001|Overall Study|Withdrawal by Subject|0|||
41941777|NCT01350141|75672834|FG002|Overall Study|Withdrawal by Subject|0|||
41941778|NCT01350141|75672832|FG000|Overall Study|Randomized but not treated|1|||
41941779|NCT01350141|75672833|FG001|Overall Study|Randomized but not treated|0|||
41941780|NCT01350141|75672834|FG002|Overall Study|Randomized but not treated|0|||
41941781|NCT05045625|75673373|FG000|Overall Study|Lost to Follow-up|3|||
41941782|NCT04830969|75673755|FG000|Overall Study|Withdrawal by Subject|6|||
41941783|NCT04830969|75673756|FG001|Overall Study|Withdrawal by Subject|2|||
41941784|NCT04830969|75673755|FG000|Overall Study|Protocol Violation|3|||
41941785|NCT04830969|75673756|FG001|Overall Study|Protocol Violation|9|||
41941786|NCT04830969|75673755|FG000|Overall Study|Lost to Follow-up|4|||
41941787|NCT04830969|75673756|FG001|Overall Study|Lost to Follow-up|4|||
41941788|NCT02384993|75674067|FG000|Overall Study|Adverse Event|0|||
41941789|NCT02384993|75674068|FG001|Overall Study|Adverse Event|1|||
41941790|NCT01352117|75674112|FG000|Overall Study|Death|15|||
41941791|NCT01352117|75674113|FG001|Overall Study|Death|16|||
41941792|NCT01352117|75674112|FG000|Overall Study|Withdrawal by Subject|1|||
41941793|NCT01352117|75674113|FG001|Overall Study|Withdrawal by Subject|0|||
41941794|NCT01352117|75674112|FG000|Overall Study|Lost to Follow-up|2|||
41941795|NCT01352117|75674113|FG001|Overall Study|Lost to Follow-up|7|||
41941796|NCT01352117|75674112|FG000|Overall Study|Non-adherent to study requirements|1|||
41941797|NCT01352117|75674113|FG001|Overall Study|Non-adherent to study requirements|1|||
41941798|NCT01352117|75674112|FG000|Overall Study|Did not initiate study treatment|1|||
41941799|NCT01352117|75674113|FG001|Overall Study|Did not initiate study treatment|0|||
41941800|NCT01352117|75674112|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
41941801|NCT01352117|75674113|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
41941802|NCT03578237|75674184|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
41941803|NCT03578237|75674185|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
41941804|NCT02220725|75674268|FG000|Overall Study|Lost to Follow-up|0|||
41941805|NCT02220725|75674269|FG001|Overall Study|Lost to Follow-up|0|||
41941806|NCT02220725|75674270|FG002|Overall Study|Lost to Follow-up|0|||
41941807|NCT02220725|75674271|FG003|Overall Study|Lost to Follow-up|1|||
41941808|NCT02220725|75674268|FG000|Overall Study|Withdrawal by Subject|0|||
41941809|NCT02220725|75674269|FG001|Overall Study|Withdrawal by Subject|0|||
41941810|NCT02220725|75674270|FG002|Overall Study|Withdrawal by Subject|0|||
41941811|NCT02220725|75674271|FG003|Overall Study|Withdrawal by Subject|1|||
41941812|NCT02259517|75674313|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
41941813|NCT02259517|75674314|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
41941814|NCT02259517|75674315|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
41941815|NCT02259517|75674313|FG000|Overall Study|Withdrawal by Subject|0|||
41941816|NCT02259517|75674314|FG001|Overall Study|Withdrawal by Subject|0|||
41941817|NCT02259517|75674315|FG002|Overall Study|Withdrawal by Subject|3|||
41941818|NCT02277990|75674358|FG000|Overall Study|Death|170|||
41941819|NCT02277990|75674359|FG001|Overall Study|Death|188|||
41941820|NCT02277990|75674358|FG000|Overall Study|Withdrawal by Subject|64|||
41941821|NCT02277990|75674359|FG001|Overall Study|Withdrawal by Subject|53|||
41941822|NCT02277990|75674358|FG000|Overall Study|Physician Decision|40|||
41941823|NCT02277990|75674359|FG001|Overall Study|Physician Decision|34|||
41941824|NCT02277990|75674358|FG000|Overall Study|Lost to Follow-up|66|||
41941825|NCT02277990|75674359|FG001|Overall Study|Lost to Follow-up|69|||
41941826|NCT02277990|75674358|FG000|Overall Study|Had other reason|26|||
41941827|NCT02277990|75674359|FG001|Overall Study|Had other reason|32|||
41941828|NCT02317614|75674381|FG000|Overall Study|Lost to Follow-up|1|||
41941829|NCT02317614|75674382|FG001|Overall Study|Lost to Follow-up|1|||
42300261|NCT02301975|76135408|FG000|Overall Study|Lost to Follow-up|0|||
42300262|NCT02301975|76135409|FG001|Overall Study|Lost to Follow-up|2|||
42300263|NCT02301975|76135410|FG002|Overall Study|Lost to Follow-up|2|||
41941830|NCT02317614|75674381|FG000|Overall Study|Withdrawal by Subject|1|||
41941831|NCT02317614|75674382|FG001|Overall Study|Withdrawal by Subject|0|||
41941832|NCT02317614|75674381|FG000|Overall Study|Death|1|||
41941833|NCT02317614|75674382|FG001|Overall Study|Death|1|||
41941834|NCT02276040|75674395|FG000|Overall Study|Physician Decision|15|||
41941835|NCT02315664|75674401|FG000|Overall Study|Lost to Follow-up|1|||
41941836|NCT02315664|75674402|FG001|Overall Study|Lost to Follow-up|1|||
41941837|NCT02315664|75674401|FG000|Overall Study|Withdrawal by Subject|0|||
41941838|NCT02315664|75674402|FG001|Overall Study|Withdrawal by Subject|3|||
41941839|NCT02314728|75674430|FG000|Overall Study|Protocol Violation|1|||
41941840|NCT02314728|75674431|FG001|Overall Study|Protocol Violation|0|||
41941841|NCT02314728|75674430|FG000|Overall Study|Lost to Follow-up|0|||
41941842|NCT02314728|75674431|FG001|Overall Study|Lost to Follow-up|1|||
41941843|NCT02275338|75674450|FG000|Overall Study|Adverse Event|15|||
41941844|NCT02275338|75674450|FG000|Overall Study|Lack of Efficacy|3|||
41941845|NCT02275338|75674450|FG000|Overall Study|Withdrawal by Subject|4|||
42022818|NCT01040793|75830106|FG005|Overall Study|Withdrawal by Subject|0|||
42022819|NCT01040793|75830101|FG000|Overall Study|Other reasons not listed above|0|||
42022820|NCT01040793|75830102|FG001|Overall Study|Other reasons not listed above|0|||
42022821|NCT01040793|75830103|FG002|Overall Study|Other reasons not listed above|1|||
42022822|NCT01040793|75830104|FG003|Overall Study|Other reasons not listed above|0|||
41941846|NCT02275338|75674450|FG000|Overall Study|Disease progression (death)|1|||
41941847|NCT02275338|75674450|FG000|Overall Study|Ineligible to start Phase 2|4|||
41941848|NCT02275338|75674450|FG000|Overall Study|Reason not specified|5|||
41941849|NCT02275338|75674450|FG000|Overall Study|Does not meet entry criteria|1|||
41941850|NCT02313558|75674457|FG000|Overall Study|Withdrawal by Subject|2|||
41941851|NCT02313558|75674458|FG001|Overall Study|Withdrawal by Subject|0|||
41941852|NCT02313558|75674457|FG000|Overall Study|Lost to Follow-up|4|||
41941853|NCT02313558|75674458|FG001|Overall Study|Lost to Follow-up|4|||
41941854|NCT01646268|75674486|FG000|Overall Study|Adverse Event|6|||
41941855|NCT01646268|75674487|FG001|Overall Study|Adverse Event|7|||
41941856|NCT01646268|75674486|FG000|Overall Study|Lack of Efficacy|1|||
41941857|NCT01646268|75674487|FG001|Overall Study|Lack of Efficacy|3|||
42022823|NCT01040793|75830105|FG004|Overall Study|Other reasons not listed above|1|||
42022824|NCT01040793|75830106|FG005|Overall Study|Other reasons not listed above|0|||
41941858|NCT01646268|75674486|FG000|Overall Study|Protocol Violation|0|||
41941859|NCT01646268|75674487|FG001|Overall Study|Protocol Violation|1|||
41941860|NCT01646268|75674486|FG000|Overall Study|Withdrawal by Subject|2|||
41941861|NCT01646268|75674487|FG001|Overall Study|Withdrawal by Subject|5|||
41941862|NCT01646268|75674486|FG000|Overall Study|Other|2|||
41941863|NCT01646268|75674487|FG001|Overall Study|Other|0|||
41941864|NCT02275026|75674493|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
41941865|NCT02275026|75674493|FG000|Overall Study|Withdrawal by Subject|4|||
41941866|NCT02275026|75674493|FG000|Overall Study|Ineligible due to medical history|13|||
41941867|NCT02275026|75674493|FG000|Overall Study|MRI malfunction precluded testing|1|||
41941868|NCT02275026|75674493|FG000|Overall Study|Ineligible after MRI findings|1|||
41941869|NCT02275026|75674493|FG000|Overall Study|Lost to Follow-up|2|||
41941870|NCT02275026|75674493|FG000|Overall Study|Scanner failure|1|||
41941871|NCT04579250|75674596|FG000|Overall Study|Withdrawal by Subject|1|||
41941872|NCT04579250|75674597|FG001|Overall Study|Withdrawal by Subject|1|||
41941873|NCT04579250|75674598|FG002|Overall Study|Withdrawal by Subject|0|||
41941874|NCT04579250|75674596|FG000|Overall Study|Lost to Follow-up|1|||
41941875|NCT04579250|75674597|FG001|Overall Study|Lost to Follow-up|1|||
41941876|NCT04579250|75674598|FG002|Overall Study|Lost to Follow-up|0|||
41941877|NCT04579250|75674596|FG000|Overall Study|Moved from area|0|||
41941878|NCT04579250|75674597|FG001|Overall Study|Moved from area|1|||
41941879|NCT04579250|75674598|FG002|Overall Study|Moved from area|2|||
41941880|NCT03175367|75674625|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
41941881|NCT03175367|75674626|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
41941882|NCT03175367|75674627|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
41941883|NCT03175367|75674628|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
41941884|NCT03175367|75674629|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
41941885|NCT03175367|75674630|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
41941886|NCT03175367|75674631|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
41941887|NCT03175367|75674625|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
41941888|NCT03175367|75674626|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
41941889|NCT03175367|75674627|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
41941890|NCT03175367|75674628|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
41941891|NCT03175367|75674629|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
41941892|NCT03175367|75674630|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
41941893|NCT03175367|75674631|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
41941894|NCT03175367|75674625|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
41941895|NCT03175367|75674626|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
41941896|NCT03175367|75674627|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
41941897|NCT03175367|75674628|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
41941898|NCT03175367|75674629|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
41941899|NCT03175367|75674630|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
41941900|NCT03175367|75674631|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
41941901|NCT03175367|75674625|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
41941902|NCT03175367|75674626|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
41941903|NCT03175367|75674627|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
41941904|NCT03175367|75674628|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
41941905|NCT03175367|75674629|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
41941906|NCT03175367|75674630|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
41941907|NCT03175367|75674631|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
41941908|NCT03175367|75674625|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
41941909|NCT03175367|75674626|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
41941910|NCT03175367|75674627|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
41941911|NCT03175367|75674628|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
41941912|NCT03175367|75674629|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
41941913|NCT03175367|75674630|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
41941914|NCT03175367|75674631|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
41941915|NCT03175367|75674625|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
41941916|NCT03175367|75674626|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
41941917|NCT03175367|75674627|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
41941918|NCT03175367|75674628|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
41941919|NCT03175367|75674629|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
41941920|NCT03175367|75674630|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
41941921|NCT03175367|75674631|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
41941922|NCT03175367|75674625|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
41941923|NCT03175367|75674626|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
41941924|NCT03175367|75674627|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
41941925|NCT03175367|75674628|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
41941926|NCT03175367|75674629|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
41941927|NCT03175367|75674630|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
41941928|NCT03175367|75674631|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
41941929|NCT03174275|75674672|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
41941930|NCT03174275|75674672|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
41941931|NCT03174275|75674672|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
41941932|NCT03174275|75674672|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
41941933|NCT03174275|75674672|FG000|Adjuvant Chemotherapy|Progression|1|||
41941934|NCT03174275|75674672|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
41941935|NCT03174275|75674672|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
41941936|NCT03174275|75674672|FG000|Adjuvant Durvalumab|Progression|1|||
41941937|NCT03174275|75674672|FG000|Adjuvant Durvalumab|Adverse Event|3|||
41941938|NCT03174275|75674672|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
41941939|NCT03174275|75674672|FG000|Adjuvant Radiotherapy|Progression|1|||
41941940|NCT03174275|75674672|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
41941941|NCT03990363|75674764|FG000|Overall Study|Withdrawal by Subject|10|||
41941942|NCT03990363|75674765|FG001|Overall Study|Withdrawal by Subject|9|||
41941943|NCT03990363|75674766|FG002|Overall Study|Withdrawal by Subject|18|||
41941944|NCT03990363|75674767|FG003|Overall Study|Withdrawal by Subject|11|||
41941945|NCT03990363|75674768|FG004|Overall Study|Withdrawal by Subject|9|||
41941946|NCT03990363|75674764|FG000|Overall Study|Physician Decision|1|||
41941947|NCT03990363|75674765|FG001|Overall Study|Physician Decision|0|||
41941948|NCT03990363|75674766|FG002|Overall Study|Physician Decision|0|||
41941949|NCT03990363|75674767|FG003|Overall Study|Physician Decision|0|||
41941950|NCT03990363|75674768|FG004|Overall Study|Physician Decision|0|||
41941951|NCT03990363|75674764|FG000|Overall Study|Adverse Event|1|||
41941952|NCT03990363|75674765|FG001|Overall Study|Adverse Event|3|||
41941953|NCT03990363|75674766|FG002|Overall Study|Adverse Event|2|||
41941954|NCT03990363|75674767|FG003|Overall Study|Adverse Event|2|||
41941955|NCT03990363|75674768|FG004|Overall Study|Adverse Event|0|||
41941956|NCT03990363|75674764|FG000|Overall Study|Death|14|||
41941957|NCT03990363|75674765|FG001|Overall Study|Death|8|||
41941958|NCT03990363|75674766|FG002|Overall Study|Death|14|||
41941959|NCT03990363|75674767|FG003|Overall Study|Death|10|||
41941960|NCT03990363|75674768|FG004|Overall Study|Death|11|||
41941961|NCT03990363|75674764|FG000|Overall Study|Failure to meet randomization criteria|0|||
41941962|NCT03990363|75674765|FG001|Overall Study|Failure to meet randomization criteria|1|||
41941963|NCT03990363|75674766|FG002|Overall Study|Failure to meet randomization criteria|1|||
41941964|NCT03990363|75674767|FG003|Overall Study|Failure to meet randomization criteria|0|||
41941965|NCT03990363|75674768|FG004|Overall Study|Failure to meet randomization criteria|0|||
41941966|NCT03990363|75674764|FG000|Overall Study|Lost to Follow-up|0|||
41941967|NCT03990363|75674765|FG001|Overall Study|Lost to Follow-up|0|||
41941968|NCT03990363|75674766|FG002|Overall Study|Lost to Follow-up|0|||
41941969|NCT03990363|75674767|FG003|Overall Study|Lost to Follow-up|1|||
41941970|NCT03990363|75674768|FG004|Overall Study|Lost to Follow-up|2|||
41941971|NCT03990363|75674764|FG000|Overall Study|Non-compliance with study drug|2|||
41941972|NCT03990363|75674765|FG001|Overall Study|Non-compliance with study drug|1|||
41941973|NCT03990363|75674766|FG002|Overall Study|Non-compliance with study drug|2|||
41941974|NCT03990363|75674767|FG003|Overall Study|Non-compliance with study drug|0|||
41941975|NCT03990363|75674768|FG004|Overall Study|Non-compliance with study drug|0|||
41941976|NCT03990363|75674764|FG000|Overall Study|Study terminated by sponsor|0|||
41941977|NCT03990363|75674765|FG001|Overall Study|Study terminated by sponsor|1|||
41941978|NCT03990363|75674766|FG002|Overall Study|Study terminated by sponsor|0|||
41941979|NCT03990363|75674767|FG003|Overall Study|Study terminated by sponsor|0|||
41941980|NCT03990363|75674768|FG004|Overall Study|Study terminated by sponsor|0|||
41941981|NCT03990363|75674764|FG000|Overall Study|Site terminated by sponsor|2|||
41941982|NCT03990363|75674765|FG001|Overall Study|Site terminated by sponsor|1|||
41941983|NCT03990363|75674766|FG002|Overall Study|Site terminated by sponsor|2|||
41941984|NCT03990363|75674767|FG003|Overall Study|Site terminated by sponsor|0|||
41941985|NCT03990363|75674768|FG004|Overall Study|Site terminated by sponsor|2|||
41941986|NCT03990363|75674764|FG000|Overall Study|Not categorized|5|||
41941987|NCT03990363|75674765|FG001|Overall Study|Not categorized|5|||
41941988|NCT03990363|75674766|FG002|Overall Study|Not categorized|3|||
41941989|NCT03990363|75674767|FG003|Overall Study|Not categorized|2|||
41941990|NCT03990363|75674768|FG004|Overall Study|Not categorized|2|||
41941991|NCT04661839|75674838|FG000|Overall Study|Not Treated|0|||
41941992|NCT04661839|75674839|FG001|Overall Study|Not Treated|0|||
42022825|NCT00948064|75830119|FG000|Phase I|No treatment received|1|||
41941993|NCT04661839|75674840|FG002|Overall Study|Not Treated|1|||
41941994|NCT04661839|75674841|FG003|Overall Study|Not Treated|0|||
41941995|NCT04661839|75674838|FG000|Overall Study|Lost to Follow-up|1|||
41941996|NCT04661839|75674839|FG001|Overall Study|Lost to Follow-up|0|||
42022826|NCT00948064|75830120|FG001|Phase I|No treatment received|0|||
41941997|NCT04661839|75674840|FG002|Overall Study|Lost to Follow-up|0|||
41941998|NCT04661839|75674841|FG003|Overall Study|Lost to Follow-up|1|||
41941999|NCT02240485|75674942|FG000|3 Months Post-admission|Lost to Follow-up|1|||
42022827|NCT00948064|75830121|FG002|Phase I|No treatment received|0|||
41942000|NCT02240485|75674943|FG001|3 Months Post-admission|Lost to Follow-up|5|||
41942001|NCT02240485|75674942|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
41942002|NCT02240485|75674943|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
41942003|NCT02240485|75674942|FG000|9 Months Post-admission|Lost to Follow-up|3|||
41942004|NCT02240485|75674943|FG001|9 Months Post-admission|Lost to Follow-up|1|||
41942005|NCT02240485|75674942|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
41942006|NCT02240485|75674943|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
41942007|NCT02240485|75674942|FG000|18 Months Post-admission|Lost to Follow-up|1|||
41942008|NCT02240485|75674943|FG001|18 Months Post-admission|Lost to Follow-up|1|||
42022828|NCT00948064|75830119|FG000|Phase II|Physician Decision|0|||
42022829|NCT00948064|75830120|FG001|Phase II|Physician Decision|0|||
42022830|NCT00948064|75830121|FG002|Phase II|Physician Decision|1|||
42022831|NCT00948064|75830119|FG000|Phase II|Withdrawal by Subject|0|||
42022832|NCT00948064|75830120|FG001|Phase II|Withdrawal by Subject|1|||
42022833|NCT00948064|75830121|FG002|Phase II|Withdrawal by Subject|0|||
42022834|NCT00953524|75830135|FG000|Overall Study|Adverse Event|2|||
42022835|NCT00953524|75830136|FG001|Overall Study|Adverse Event|0|||
42022836|NCT00953524|75830137|FG002|Overall Study|Adverse Event|1|||
42022837|NCT00953524|75830138|FG003|Overall Study|Adverse Event|2|||
42118005|NCT00689117|75928842|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42300264|NCT02301975|76135408|FG000|Overall Study|Physician Decision|4|||
41942009|NCT02240485|75674942|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
41942010|NCT02240485|75674943|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
41942011|NCT04149535|75674966|FG000|Overall Study|Death|11|||
41942012|NCT04149535|75674967|FG001|Overall Study|Death|7|||
41942013|NCT04149535|75674966|FG000|Overall Study|Physician Decision|10|||
41942014|NCT04149535|75674967|FG001|Overall Study|Physician Decision|4|||
41942015|NCT04149535|75674966|FG000|Overall Study|Withdrawal by Subject|6|||
41942016|NCT04149535|75674967|FG001|Overall Study|Withdrawal by Subject|7|||
42300265|NCT02301975|76135409|FG001|Overall Study|Physician Decision|2|||
42300266|NCT02301975|76135410|FG002|Overall Study|Physician Decision|3|||
41942017|NCT04149535|75674966|FG000|Overall Study|Not described|2|||
41942018|NCT04149535|75674967|FG001|Overall Study|Not described|0|||
41942019|NCT02210559|75674985|FG000|Overall Study|Progressive Disease|3|||
41942020|NCT02210559|75674986|FG001|Overall Study|Progressive Disease|2|||
41942021|NCT02210559|75674985|FG000|Overall Study|Adverse Event|2|||
41942022|NCT02210559|75674986|FG001|Overall Study|Adverse Event|2|||
41942023|NCT02210559|75674985|FG000|Overall Study|Physician Decision|1|||
41942024|NCT02210559|75674986|FG001|Overall Study|Physician Decision|0|||
41942025|NCT02210559|75674985|FG000|Overall Study|Withdrawal by Subject|0|||
41942026|NCT02210559|75674986|FG001|Overall Study|Withdrawal by Subject|1|||
41942027|NCT02210559|75674985|FG000|Overall Study|Other than specified|0|||
41942028|NCT02210559|75674986|FG001|Overall Study|Other than specified|1|||
41942029|NCT02073279|75675143|FG000|Double-blind Period|Adverse Event|1|||
41942030|NCT02073279|75675144|FG001|Double-blind Period|Adverse Event|1|||
41942031|NCT02073279|75675143|FG000|Double-blind Period|Switched to another treatment|1|||
41942032|NCT02073279|75675144|FG001|Double-blind Period|Switched to another treatment|2|||
41942033|NCT02073279|75675143|FG000|Double-blind Period|Protocol Violation|0|||
41942034|NCT02073279|75675144|FG001|Double-blind Period|Protocol Violation|1|||
41942035|NCT02073279|75675143|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
41942036|NCT02073279|75675144|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
41942037|NCT02073279|75675143|FG000|Double-blind Period|Withdrawal by Subject|2|||
41942038|NCT02073279|75675144|FG001|Double-blind Period|Withdrawal by Subject|2|||
41942039|NCT02073279|75675143|FG000|Open-label Extension Period|Adverse Event|1|||
41942040|NCT02073279|75675144|FG001|Open-label Extension Period|Adverse Event|0|||
41942041|NCT02073279|75675143|FG000|Open-label Extension Period|Lack of Efficacy|1|||
41942042|NCT02073279|75675144|FG001|Open-label Extension Period|Lack of Efficacy|0|||
41942043|NCT02073279|75675143|FG000|Open-label Extension Period|Lost to Follow-up|0|||
41942044|NCT02073279|75675144|FG001|Open-label Extension Period|Lost to Follow-up|4|||
41942045|NCT02073279|75675143|FG000|Open-label Extension Period|Switched to another treatment|1|||
41942046|NCT02073279|75675144|FG001|Open-label Extension Period|Switched to another treatment|4|||
41942047|NCT02073279|75675143|FG000|Open-label Extension Period|Protocol Violation|0|||
41942048|NCT02073279|75675144|FG001|Open-label Extension Period|Protocol Violation|1|||
41942049|NCT02073279|75675143|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
41942050|NCT02073279|75675144|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
42022838|NCT00953524|75830135|FG000|Overall Study|Protocol Violation|18|||
42118006|NCT00689117|75928843|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
41942051|NCT02073279|75675143|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
41942052|NCT02073279|75675144|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
41942053|NCT01673867|75675400|FG000|Randomization|Adverse event unrelated to study drug|1|||
41942054|NCT01673867|75675401|FG001|Randomization|Adverse event unrelated to study drug|0|||
42022839|NCT00953524|75830136|FG001|Overall Study|Protocol Violation|10|||
42022840|NCT00953524|75830137|FG002|Overall Study|Protocol Violation|11|||
42300267|NCT02301975|76135408|FG000|Overall Study|Withdrawal by Subject|15|||
41942055|NCT01673867|75675400|FG000|Randomization|Participant request to discontinue study treatment|0|||
41942056|NCT01673867|75675401|FG001|Randomization|Participant request to discontinue study treatment|4|||
41942057|NCT01673867|75675400|FG000|Randomization|Withdrawal by participant|0|||
41942058|NCT01673867|75675401|FG001|Randomization|Withdrawal by participant|12|||
41942059|NCT01673867|75675400|FG000|Randomization|Lost to Follow-up|0|||
41942060|NCT01673867|75675401|FG001|Randomization|Lost to Follow-up|1|||
41942061|NCT01673867|75675400|FG000|Randomization|Participant no longer meets study criteria|4|||
41942062|NCT01673867|75675401|FG001|Randomization|Participant no longer meets study criteria|5|||
41942063|NCT01673867|75675400|FG000|Treatment|Disease Progression|208|||
41942064|NCT01673867|75675401|FG001|Treatment|Disease Progression|178|||
41942065|NCT01673867|75675400|FG000|Treatment|Study Drug Toxicity|23|||
41942066|NCT01673867|75675401|FG001|Treatment|Study Drug Toxicity|43|||
41942067|NCT01673867|75675400|FG000|Treatment|Death|2|||
41942068|NCT01673867|75675401|FG001|Treatment|Death|3|||
41942069|NCT01673867|75675400|FG000|Treatment|Adverse event unrelated to study drug|23|||
41942070|NCT01673867|75675401|FG001|Treatment|Adverse event unrelated to study drug|10|||
41942071|NCT01673867|75675400|FG000|Treatment|Participant request to discontinue study treatment|7|||
41942072|NCT01673867|75675401|FG001|Treatment|Participant request to discontinue study treatment|17|||
41942073|NCT01673867|75675400|FG000|Treatment|Withdrawal by participant|5|||
41942074|NCT01673867|75675401|FG001|Treatment|Withdrawal by participant|5|||
41942075|NCT01673867|75675400|FG000|Treatment|Maximum clinical benefit|1|||
41942076|NCT01673867|75675401|FG001|Treatment|Maximum clinical benefit|10|||
41942077|NCT01673867|75675400|FG000|Treatment|Participant no longer meets study criteria|2|||
41942078|NCT01673867|75675401|FG001|Treatment|Participant no longer meets study criteria|0|||
41942079|NCT01673867|75675400|FG000|Treatment|Administrative reason by sponsor|3|||
41942080|NCT01673867|75675401|FG001|Treatment|Administrative reason by sponsor|0|||
41942081|NCT01673867|75675400|FG000|Treatment|Other reason|11|||
41942082|NCT01673867|75675401|FG001|Treatment|Other reason|2|||
41942083|NCT02041533|75675497|FG000|Pre-Treatment Period|Disease Progression|1|||
41942084|NCT02041533|75675498|FG001|Pre-Treatment Period|Disease Progression|1|||
41942085|NCT02041533|75675497|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
41942086|NCT02041533|75675498|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
41942087|NCT02041533|75675497|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
41942088|NCT02041533|75675498|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
41942089|NCT02041533|75675497|FG000|Treatment Period|Disease progression|189|||
41942090|NCT02041533|75675498|FG001|Treatment Period|Disease progression|146|||
41942091|NCT02041533|75675497|FG000|Treatment Period|Study drug toxicity|30|||
41942092|NCT02041533|75675498|FG001|Treatment Period|Study drug toxicity|34|||
41942093|NCT02041533|75675497|FG000|Treatment Period|Death|1|||
41942094|NCT02041533|75675498|FG001|Treatment Period|Death|0|||
41942095|NCT02041533|75675497|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
41942096|NCT02041533|75675498|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
41942097|NCT02041533|75675497|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
41942098|NCT02041533|75675498|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
41942099|NCT02041533|75675497|FG000|Treatment Period|Participant withdrew consent|2|||
41942100|NCT02041533|75675498|FG001|Treatment Period|Participant withdrew consent|2|||
41942101|NCT02041533|75675497|FG000|Treatment Period|Maximum clinical benefit|0|||
41942102|NCT02041533|75675498|FG001|Treatment Period|Maximum clinical benefit|18|||
41942103|NCT02041533|75675497|FG000|Treatment Period|Poor/Non-compliance|1|||
41942104|NCT02041533|75675498|FG001|Treatment Period|Poor/Non-compliance|0|||
41942105|NCT02041533|75675497|FG000|Treatment Period|Administrative reason by sponsor|1|||
41942106|NCT02041533|75675498|FG001|Treatment Period|Administrative reason by sponsor|0|||
41942107|NCT02041533|75675497|FG000|Treatment Period|Other reasons|9|||
41942108|NCT02041533|75675498|FG001|Treatment Period|Other reasons|2|||
41942109|NCT02041533|75675497|FG000|Treatment Period|Not Reported|0|||
41942110|NCT02041533|75675498|FG001|Treatment Period|Not Reported|1|||
41942111|NCT02907203|75675505|FG000|Overall Study|Death|1|||
41942112|NCT02907203|75675505|FG000|Overall Study|Lost to Follow-up|3|||
41942113|NCT02907203|75675505|FG000|Overall Study|Withdrawal by Subject|3|||
41942114|NCT02907203|75675505|FG000|Overall Study|Surgical bypass|1|||
41942115|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
42118007|NCT00689117|75928840|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
41942116|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
41942117|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
41942118|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
41942119|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
41942120|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
41942121|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
42010435|NCT01014910|75817590|FG001|Overall Study|Withdrawal by Subject|2|||
42010436|NCT01019980|75817598|FG000|Overall Study|Drug not available.|2|||
42010437|NCT01019980|75817599|FG001|Overall Study|Drug not available.|0|||
42010438|NCT00993499|75817611|FG000|Run-in Period (8 Days)|Adverse Event|0|||
41942122|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
41942123|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Death|1|||
41942124|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Death|1|||
41942125|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
41942126|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
41942127|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
41942128|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
41942129|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
41942130|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
41942131|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
41942132|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
41942133|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
41942134|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
41942135|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
41942136|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
41942137|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
41942138|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
41942139|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
41942140|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
41942141|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
41942142|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
41942143|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
41942144|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
41942145|NCT00559585|75676601|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
41942146|NCT00559585|75676602|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
41942147|NCT00559585|75676601|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
41942148|NCT00559585|75676602|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
41942149|NCT00559585|75676601|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
41942150|NCT00559585|75676602|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
41942151|NCT00559585|75676601|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
41942152|NCT00559585|75676602|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
41942153|NCT00559585|75676601|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
41942154|NCT00559585|75676602|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
41942155|NCT00559585|75676601|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
41942156|NCT00559585|75676602|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
41942157|NCT00559585|75676601|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
41942158|NCT00559585|75676602|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
41942159|NCT00559585|75676601|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
41942160|NCT00559585|75676602|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
41942161|NCT00559585|75676601|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
41942162|NCT00559585|75676602|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
41942163|NCT00559585|75676601|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
41942164|NCT00559585|75676602|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
41942165|NCT00559585|75676601|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
41942166|NCT00559585|75676602|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
41942167|NCT00559585|75676601|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
41942168|NCT00559585|75676602|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
41942169|NCT00559585|75676601|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
41942170|NCT00559585|75676602|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
41942171|NCT00559507|75676642|FG000|Overall Study|Not treated, patient ineligible|3|||
42022841|NCT00953524|75830138|FG003|Overall Study|Protocol Violation|6|||
42022842|NCT00953524|75830135|FG000|Overall Study|Lost to Follow-up|0|||
42022843|NCT00953524|75830136|FG001|Overall Study|Lost to Follow-up|1|||
42022844|NCT00953524|75830137|FG002|Overall Study|Lost to Follow-up|1|||
42022845|NCT00953524|75830138|FG003|Overall Study|Lost to Follow-up|0|||
42022846|NCT00953524|75830135|FG000|Overall Study|Withdrawal by Subject|2|||
42022847|NCT00953524|75830136|FG001|Overall Study|Withdrawal by Subject|4|||
42022848|NCT00953524|75830137|FG002|Overall Study|Withdrawal by Subject|1|||
42022849|NCT00953524|75830138|FG003|Overall Study|Withdrawal by Subject|0|||
41942172|NCT00559273|75676898|FG000|Correction Period (20 Weeks)|Death|3|||
41942173|NCT00559273|75676899|FG001|Correction Period (20 Weeks)|Death|4|||
41942174|NCT00559273|75676898|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
42022850|NCT01040403|75830157|FG000|Overall Study|Adverse Event|10|||
42022851|NCT01040403|75830157|FG000|Overall Study|Protocol Violation|2|||
42022852|NCT01040403|75830157|FG000|Overall Study|Lost to Follow-up|1|||
41942175|NCT00559273|75676899|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
41942176|NCT00559273|75676898|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
41942177|NCT00559273|75676899|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
41942178|NCT00559273|75676898|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
41942179|NCT00559273|75676899|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
41942180|NCT00559273|75676898|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
41942181|NCT00559273|75676899|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
41942182|NCT00559273|75676898|FG000|Evaluation Period (8 Weeks)|Death|1|||
41942183|NCT00559273|75676899|FG001|Evaluation Period (8 Weeks)|Death|3|||
41942184|NCT00559273|75676898|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
41942185|NCT00559273|75676899|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
42300268|NCT02301975|76135409|FG001|Overall Study|Withdrawal by Subject|12|||
41942186|NCT00559273|75676898|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
41942187|NCT00559273|75676899|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
41942188|NCT00559273|75676898|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
41942189|NCT00559273|75676899|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
41942190|NCT00558259|75676954|FG000|Overall Study|Adverse Event|50|||
41942191|NCT00558259|75676955|FG001|Overall Study|Adverse Event|81|||
41942192|NCT00558259|75676954|FG000|Overall Study|Protocol Violation|9|||
41942193|NCT00558259|75676955|FG001|Overall Study|Protocol Violation|5|||
41942194|NCT00558259|75676954|FG000|Overall Study|Withdrawal by Subject|12|||
41942195|NCT00558259|75676955|FG001|Overall Study|Withdrawal by Subject|13|||
41942196|NCT00558103|75677102|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
41942197|NCT00558103|75677103|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
41942198|NCT00558103|75677104|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
41942199|NCT00558103|75677105|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
41942200|NCT00558103|75677106|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
41942201|NCT00558103|75677107|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
41942202|NCT00558103|75677102|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
41942203|NCT00558103|75677103|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
41942204|NCT00558103|75677104|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
41942205|NCT00558103|75677105|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
41942206|NCT00558103|75677106|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
41942207|NCT00558103|75677107|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
41942208|NCT00558103|75677102|FG000|Randomized Treatment Phase|Disease Progression|1|||
41942209|NCT00558103|75677103|FG001|Randomized Treatment Phase|Disease Progression|0|||
41942210|NCT00558103|75677104|FG002|Randomized Treatment Phase|Disease Progression|1|||
41942211|NCT00558103|75677105|FG003|Randomized Treatment Phase|Disease Progression|0|||
41942212|NCT00558103|75677106|FG004|Randomized Treatment Phase|Disease Progression|0|||
41942213|NCT00558103|75677107|FG005|Randomized Treatment Phase|Disease Progression|0|||
41942214|NCT00558103|75677102|FG000|Randomized Treatment Phase|Adverse Event|0|||
41942215|NCT00558103|75677103|FG001|Randomized Treatment Phase|Adverse Event|0|||
41942216|NCT00558103|75677104|FG002|Randomized Treatment Phase|Adverse Event|0|||
41942217|NCT00558103|75677105|FG003|Randomized Treatment Phase|Adverse Event|1|||
41942218|NCT00558103|75677106|FG004|Randomized Treatment Phase|Adverse Event|1|||
41942219|NCT00558103|75677107|FG005|Randomized Treatment Phase|Adverse Event|0|||
41942220|NCT00558103|75677102|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
41942221|NCT00558103|75677103|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
41942222|NCT00558103|75677104|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
41942223|NCT00558103|75677105|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
41942224|NCT00558103|75677106|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
41942225|NCT00558103|75677107|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
41942226|NCT00558103|75677102|FG000|Monotherapy Extension Phase|Disease Progression|0|||
41942227|NCT00558103|75677103|FG001|Monotherapy Extension Phase|Disease Progression|0|||
41942228|NCT00558103|75677104|FG002|Monotherapy Extension Phase|Disease Progression|0|||
41942229|NCT00558103|75677105|FG003|Monotherapy Extension Phase|Disease Progression|0|||
42300269|NCT02301975|76135410|FG002|Overall Study|Withdrawal by Subject|11|||
42300270|NCT02301897|76135421|FG000|Treatment Course 1|Non-Compliance|0|||
41942230|NCT00558103|75677106|FG004|Monotherapy Extension Phase|Disease Progression|0|||
41942231|NCT00558103|75677107|FG005|Monotherapy Extension Phase|Disease Progression|8|||
41942232|NCT00558025|75677144|FG000|Overall Study|Adverse Event|1|||
41942233|NCT00558025|75677145|FG001|Overall Study|Adverse Event|1|||
41942234|NCT00558025|75677144|FG000|Overall Study|Withdrawal by Subject|2|||
41942235|NCT00558025|75677145|FG001|Overall Study|Withdrawal by Subject|2|||
41942236|NCT00558025|75677144|FG000|Overall Study|Protocol Violation|1|||
41942237|NCT00558025|75677145|FG001|Overall Study|Protocol Violation|0|||
41942238|NCT00557323|75677198|FG000|Overall Study|Death|3|||
41942239|NCT00557323|75677198|FG000|Overall Study|Withdrawal by Subject|2|||
41942240|NCT00557323|75677198|FG000|Overall Study|Administrative change|2|||
41942241|NCT00557245|75677232|FG000|Overall Study|Lost to Follow-up|7|||
41942242|NCT00557245|75677233|FG001|Overall Study|Lost to Follow-up|8|||
42300271|NCT02301897|76135422|FG001|Treatment Course 1|Non-Compliance|0|||
41942243|NCT00557245|75677234|FG002|Overall Study|Lost to Follow-up|10|||
41942244|NCT00557245|75677232|FG000|Overall Study|Ineligible|5|||
41942245|NCT00557245|75677233|FG001|Overall Study|Ineligible|4|||
41942246|NCT00557245|75677234|FG002|Overall Study|Ineligible|2|||
41942247|NCT00556075|75677295|FG000|Overall Study|Lost to Follow-up|3|||
41942248|NCT00556075|75677296|FG001|Overall Study|Lost to Follow-up|0|||
41942249|NCT00556075|75677297|FG002|Overall Study|Lost to Follow-up|3|||
41942250|NCT00556075|75677295|FG000|Overall Study|Withdrawal by Subject|3|||
41942251|NCT00556075|75677296|FG001|Overall Study|Withdrawal by Subject|3|||
41942252|NCT00556075|75677297|FG002|Overall Study|Withdrawal by Subject|0|||
41942253|NCT00556075|75677295|FG000|Overall Study|Protocol Violation|1|||
41942254|NCT00556075|75677296|FG001|Overall Study|Protocol Violation|1|||
41942255|NCT00556075|75677297|FG002|Overall Study|Protocol Violation|3|||
41942256|NCT00556075|75677295|FG000|Overall Study|Not eligible|1|||
41942257|NCT00556075|75677296|FG001|Overall Study|Not eligible|1|||
41942258|NCT00556075|75677297|FG002|Overall Study|Not eligible|2|||
41942259|NCT00556075|75677295|FG000|Overall Study|Adverse Event|1|||
41942260|NCT00556075|75677296|FG001|Overall Study|Adverse Event|2|||
41942261|NCT00556075|75677297|FG002|Overall Study|Adverse Event|0|||
41942262|NCT00556075|75677295|FG000|Overall Study|Personal issues|4|||
41942263|NCT00556075|75677296|FG001|Overall Study|Personal issues|1|||
41942264|NCT00556075|75677297|FG002|Overall Study|Personal issues|0|||
41942265|NCT00556075|75677295|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
41942266|NCT00556075|75677296|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
41942267|NCT00556075|75677297|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
41942268|NCT02289690|75677328|FG000|Overall Study|Adverse Event Related to Progression|0|||
41942269|NCT02289690|75677329|FG001|Overall Study|Adverse Event Related to Progression|1|||
41942270|NCT02289690|75677330|FG002|Overall Study|Adverse Event Related to Progression|1|||
41942271|NCT02289690|75677331|FG003|Overall Study|Adverse Event Related to Progression|0|||
41942272|NCT02289690|75677332|FG004|Overall Study|Adverse Event Related to Progression|1|||
41942273|NCT02289690|75677333|FG005|Overall Study|Adverse Event Related to Progression|0|||
41942274|NCT02289690|75677334|FG006|Overall Study|Adverse Event Related to Progression|1|||
41942275|NCT02289690|75677335|FG007|Overall Study|Adverse Event Related to Progression|0|||
41942276|NCT02289690|75677336|FG008|Overall Study|Adverse Event Related to Progression|0|||
41942277|NCT02289690|75677337|FG009|Overall Study|Adverse Event Related to Progression|0|||
41942278|NCT02289690|75677328|FG000|Overall Study|Withdrawal by Subject|1|||
41942279|NCT02289690|75677329|FG001|Overall Study|Withdrawal by Subject|0|||
41942280|NCT02289690|75677330|FG002|Overall Study|Withdrawal by Subject|0|||
41942281|NCT02289690|75677331|FG003|Overall Study|Withdrawal by Subject|0|||
41942282|NCT02289690|75677332|FG004|Overall Study|Withdrawal by Subject|1|||
41942283|NCT02289690|75677333|FG005|Overall Study|Withdrawal by Subject|1|||
41942284|NCT02289690|75677334|FG006|Overall Study|Withdrawal by Subject|0|||
41942285|NCT02289690|75677335|FG007|Overall Study|Withdrawal by Subject|0|||
41942286|NCT02289690|75677336|FG008|Overall Study|Withdrawal by Subject|4|||
41942287|NCT02289690|75677337|FG009|Overall Study|Withdrawal by Subject|2|||
41942288|NCT02289690|75677328|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
41942289|NCT02289690|75677329|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
41942290|NCT02289690|75677330|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
41942291|NCT02289690|75677331|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
41942292|NCT02289690|75677332|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
41942293|NCT02289690|75677333|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
41942294|NCT02289690|75677334|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
41942295|NCT02289690|75677335|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
41942296|NCT02289690|75677336|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
41942297|NCT02289690|75677337|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
41942298|NCT02289690|75677328|FG000|Overall Study|Lost to Follow-up|0|||
41942299|NCT02289690|75677329|FG001|Overall Study|Lost to Follow-up|0|||
41942300|NCT02289690|75677330|FG002|Overall Study|Lost to Follow-up|0|||
41942301|NCT02289690|75677331|FG003|Overall Study|Lost to Follow-up|0|||
41942302|NCT02289690|75677332|FG004|Overall Study|Lost to Follow-up|0|||
41942303|NCT02289690|75677333|FG005|Overall Study|Lost to Follow-up|0|||
41942304|NCT02289690|75677334|FG006|Overall Study|Lost to Follow-up|0|||
42022853|NCT01040403|75830157|FG000|Overall Study|Not treated|1|||
41942305|NCT02289690|75677335|FG007|Overall Study|Lost to Follow-up|1|||
41942306|NCT02289690|75677336|FG008|Overall Study|Lost to Follow-up|0|||
41942307|NCT02289690|75677337|FG009|Overall Study|Lost to Follow-up|2|||
41942308|NCT02289690|75677328|FG000|Overall Study|Death|0|||
41942309|NCT02289690|75677329|FG001|Overall Study|Death|0|||
41942310|NCT02289690|75677330|FG002|Overall Study|Death|0|||
41942311|NCT02289690|75677331|FG003|Overall Study|Death|0|||
41942312|NCT02289690|75677332|FG004|Overall Study|Death|0|||
41942313|NCT02289690|75677333|FG005|Overall Study|Death|0|||
41942314|NCT02289690|75677334|FG006|Overall Study|Death|0|||
41942315|NCT02289690|75677335|FG007|Overall Study|Death|49|||
41942316|NCT02289690|75677336|FG008|Overall Study|Death|45|||
41942317|NCT02289690|75677337|FG009|Overall Study|Death|41|||
42300272|NCT02301897|76135423|FG002|Treatment Course 1|Non-Compliance|1|||
41942318|NCT02289690|75677328|FG000|Overall Study|Sponsor Discontinued Study|0|||
41942319|NCT02289690|75677329|FG001|Overall Study|Sponsor Discontinued Study|0|||
41942320|NCT02289690|75677330|FG002|Overall Study|Sponsor Discontinued Study|0|||
41942321|NCT02289690|75677331|FG003|Overall Study|Sponsor Discontinued Study|0|||
41942322|NCT02289690|75677332|FG004|Overall Study|Sponsor Discontinued Study|0|||
41942323|NCT02289690|75677333|FG005|Overall Study|Sponsor Discontinued Study|0|||
41942324|NCT02289690|75677334|FG006|Overall Study|Sponsor Discontinued Study|0|||
41942325|NCT02289690|75677335|FG007|Overall Study|Sponsor Discontinued Study|9|||
41942326|NCT02289690|75677336|FG008|Overall Study|Sponsor Discontinued Study|7|||
41942327|NCT02289690|75677337|FG009|Overall Study|Sponsor Discontinued Study|15|||
41942328|NCT02289690|75677328|FG000|Overall Study|Other|0|||
41942329|NCT02289690|75677329|FG001|Overall Study|Other|0|||
41942330|NCT02289690|75677330|FG002|Overall Study|Other|0|||
41942331|NCT02289690|75677331|FG003|Overall Study|Other|1|||
41942332|NCT02289690|75677332|FG004|Overall Study|Other|1|||
41942333|NCT02289690|75677333|FG005|Overall Study|Other|0|||
41942334|NCT02289690|75677334|FG006|Overall Study|Other|1|||
41942335|NCT02289690|75677335|FG007|Overall Study|Other|2|||
41942336|NCT02289690|75677336|FG008|Overall Study|Other|3|||
41942337|NCT02289690|75677337|FG009|Overall Study|Other|1|||
41942338|NCT02289456|75677440|FG000|Induction Period|Death|2|||
41942339|NCT02289456|75677440|FG000|Induction Period|Adverse Event|11|||
41942340|NCT02289456|75677440|FG000|Induction Period|Progressive Disease (PD)|4|||
41942341|NCT02289456|75677440|FG000|Induction Period|Symptomatic Deterioration|4|||
41942342|NCT02289456|75677440|FG000|Induction Period|Withdrawal by Subject|2|||
41942343|NCT02289456|75677440|FG000|Induction Period|Miscellaneous|1|||
41942344|NCT02289456|75677440|FG000|Monotherapy Period|Death|1|||
41942345|NCT02289456|75677440|FG000|Monotherapy Period|Adverse Event|1|||
41942346|NCT02289456|75677440|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
41942347|NCT02289456|75677440|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
41942348|NCT02289456|75677440|FG000|Monotherapy Period|Withdrawal by Subject|2|||
41942349|NCT02289456|75677440|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
41942350|NCT02289456|75677440|FG000|Monotherapy Period|Miscellaneous|1|||
41942351|NCT02274948|75677489|FG000|Overall Study|Lost to Follow-up|28|||
41942352|NCT02274948|75677490|FG001|Overall Study|Lost to Follow-up|25|||
41942353|NCT02274948|75677489|FG000|Overall Study|Withdrawal by Subject|64|||
41942354|NCT02274948|75677490|FG001|Overall Study|Withdrawal by Subject|58|||
41942355|NCT02274948|75677489|FG000|Overall Study|Stopped on family Practitioner advice|2|||
41942356|NCT02274948|75677490|FG001|Overall Study|Stopped on family Practitioner advice|5|||
41942357|NCT02274948|75677489|FG000|Overall Study|Left the area|4|||
41942358|NCT02274948|75677490|FG001|Overall Study|Left the area|3|||
41942359|NCT02274792|75677506|FG000|Overall Study|Withdrawal by Subject|13|||
41942360|NCT02274792|75677506|FG000|Overall Study|Lost to Follow-up|8|||
41942361|NCT02274792|75677506|FG000|Overall Study|Protocol Specified Criteria|2|||
41942362|NCT02274792|75677506|FG000|Overall Study|Sponsor Decision|2|||
41942363|NCT02274558|75677536|FG000|Overall Study|Adverse Event|2|||
41942364|NCT02274558|75677537|FG001|Overall Study|Adverse Event|4|||
41942365|NCT02274558|75677538|FG002|Overall Study|Adverse Event|2|||
41942366|NCT02274558|75677536|FG000|Overall Study|Non-compliance|2|||
41942367|NCT02274558|75677537|FG001|Overall Study|Non-compliance|1|||
41942368|NCT02274558|75677538|FG002|Overall Study|Non-compliance|0|||
41942369|NCT02274558|75677536|FG000|Overall Study|Withdrawal by Subject|1|||
41942370|NCT02274558|75677537|FG001|Overall Study|Withdrawal by Subject|5|||
41942371|NCT02274558|75677538|FG002|Overall Study|Withdrawal by Subject|4|||
41942372|NCT02274558|75677536|FG000|Overall Study|Death|0|||
41942373|NCT02274558|75677537|FG001|Overall Study|Death|0|||
41942374|NCT02274558|75677538|FG002|Overall Study|Death|1|||
41942375|NCT02274558|75677536|FG000|Overall Study|Lost to Follow-up|2|||
41942376|NCT02274558|75677537|FG001|Overall Study|Lost to Follow-up|1|||
41942377|NCT02274558|75677538|FG002|Overall Study|Lost to Follow-up|1|||
41942378|NCT02274558|75677536|FG000|Overall Study|Physician Decision|0|||
41942379|NCT02274558|75677537|FG001|Overall Study|Physician Decision|2|||
41942380|NCT02274558|75677538|FG002|Overall Study|Physician Decision|1|||
41942381|NCT02287896|75677555|FG000|Second Injection Visit|Withdrawal by Subject|0|||
41942382|NCT02287896|75677556|FG001|Second Injection Visit|Withdrawal by Subject|1|||
41942383|NCT00553501|75677614|FG000|Overall Study|Adverse Event|2|||
41942384|NCT00553501|75677614|FG000|Overall Study|Death|1|||
41942385|NCT00553501|75677614|FG000|Overall Study|Progression|1|||
41942386|NCT02287584|75677642|FG000|the Double-blind Phase|Adverse Event|17|||
41942387|NCT02287584|75677643|FG001|the Double-blind Phase|Adverse Event|17|||
41942388|NCT02287584|75677644|FG002|the Double-blind Phase|Adverse Event|12|||
41942389|NCT02287584|75677645|FG003|the Double-blind Phase|Adverse Event|0|||
41942390|NCT02287584|75677646|FG004|the Double-blind Phase|Adverse Event|0|||
41942391|NCT02287584|75677647|FG005|the Double-blind Phase|Adverse Event|0|||
41942392|NCT02287584|75677642|FG000|the Double-blind Phase|Lack of Efficacy|18|||
41942393|NCT02287584|75677643|FG001|the Double-blind Phase|Lack of Efficacy|8|||
41942394|NCT02287584|75677644|FG002|the Double-blind Phase|Lack of Efficacy|8|||
41942395|NCT02287584|75677645|FG003|the Double-blind Phase|Lack of Efficacy|0|||
41942396|NCT02287584|75677646|FG004|the Double-blind Phase|Lack of Efficacy|0|||
41942397|NCT02287584|75677647|FG005|the Double-blind Phase|Lack of Efficacy|0|||
41942398|NCT02287584|75677642|FG000|the Double-blind Phase|Lost to Follow-up|0|||
41942399|NCT02287584|75677643|FG001|the Double-blind Phase|Lost to Follow-up|1|||
41942400|NCT02287584|75677644|FG002|the Double-blind Phase|Lost to Follow-up|1|||
41942401|NCT02287584|75677645|FG003|the Double-blind Phase|Lost to Follow-up|0|||
41942402|NCT02287584|75677646|FG004|the Double-blind Phase|Lost to Follow-up|0|||
41942403|NCT02287584|75677647|FG005|the Double-blind Phase|Lost to Follow-up|0|||
41942404|NCT02287584|75677642|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
41942405|NCT02287584|75677643|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
41942406|NCT02287584|75677644|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
41942407|NCT02287584|75677645|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
41942408|NCT02287584|75677646|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
41942409|NCT02287584|75677647|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
41942410|NCT02287584|75677642|FG000|the Double-blind Phase|Pregnancy|0|||
41942411|NCT02287584|75677643|FG001|the Double-blind Phase|Pregnancy|1|||
41942412|NCT02287584|75677644|FG002|the Double-blind Phase|Pregnancy|0|||
41942413|NCT02287584|75677645|FG003|the Double-blind Phase|Pregnancy|0|||
41942414|NCT02287584|75677646|FG004|the Double-blind Phase|Pregnancy|0|||
41942415|NCT02287584|75677647|FG005|the Double-blind Phase|Pregnancy|0|||
41942416|NCT02287584|75677642|FG000|the Double-blind Phase|Protocol Violation|0|||
41942417|NCT02287584|75677643|FG001|the Double-blind Phase|Protocol Violation|3|||
41942418|NCT02287584|75677644|FG002|the Double-blind Phase|Protocol Violation|0|||
41942419|NCT02287584|75677645|FG003|the Double-blind Phase|Protocol Violation|0|||
41942420|NCT02287584|75677646|FG004|the Double-blind Phase|Protocol Violation|0|||
41942421|NCT02287584|75677647|FG005|the Double-blind Phase|Protocol Violation|0|||
41942422|NCT02287584|75677642|FG000|the Double-blind Phase|other reasons|0|||
41942423|NCT02287584|75677643|FG001|the Double-blind Phase|other reasons|0|||
41942424|NCT02287584|75677644|FG002|the Double-blind Phase|other reasons|1|||
41942425|NCT02287584|75677645|FG003|the Double-blind Phase|other reasons|0|||
41942426|NCT02287584|75677646|FG004|the Double-blind Phase|other reasons|0|||
41942427|NCT02287584|75677647|FG005|the Double-blind Phase|other reasons|0|||
41942428|NCT02287584|75677642|FG000|the Open-label Phase|Did not receive drug|0|||
41942429|NCT02287584|75677643|FG001|the Open-label Phase|Did not receive drug|0|||
41942430|NCT02287584|75677644|FG002|the Open-label Phase|Did not receive drug|0|||
41942431|NCT02287584|75677645|FG003|the Open-label Phase|Did not receive drug|7|||
41942432|NCT02287584|75677646|FG004|the Open-label Phase|Did not receive drug|6|||
41942433|NCT02287584|75677647|FG005|the Open-label Phase|Did not receive drug|4|||
41942434|NCT02287584|75677642|FG000|the Open-label Phase|Adverse Event|0|||
41942435|NCT02287584|75677643|FG001|the Open-label Phase|Adverse Event|0|||
41942436|NCT02287584|75677644|FG002|the Open-label Phase|Adverse Event|0|||
41942437|NCT02287584|75677645|FG003|the Open-label Phase|Adverse Event|15|||
41942438|NCT02287584|75677646|FG004|the Open-label Phase|Adverse Event|12|||
41942439|NCT02287584|75677647|FG005|the Open-label Phase|Adverse Event|16|||
41942440|NCT02287584|75677642|FG000|the Open-label Phase|Lack of Efficacy|0|||
41942441|NCT02287584|75677643|FG001|the Open-label Phase|Lack of Efficacy|0|||
41942442|NCT02287584|75677644|FG002|the Open-label Phase|Lack of Efficacy|0|||
41942443|NCT02287584|75677645|FG003|the Open-label Phase|Lack of Efficacy|8|||
42300273|NCT02301897|76135421|FG000|Treatment Course 1|Adverse Event|1|||
41942444|NCT02287584|75677646|FG004|the Open-label Phase|Lack of Efficacy|3|||
41942445|NCT02287584|75677647|FG005|the Open-label Phase|Lack of Efficacy|7|||
41942446|NCT02287584|75677642|FG000|the Open-label Phase|Lost to Follow-up|0|||
41942447|NCT02287584|75677643|FG001|the Open-label Phase|Lost to Follow-up|0|||
41942448|NCT02287584|75677644|FG002|the Open-label Phase|Lost to Follow-up|0|||
41942449|NCT02287584|75677645|FG003|the Open-label Phase|Lost to Follow-up|4|||
41942450|NCT02287584|75677646|FG004|the Open-label Phase|Lost to Follow-up|1|||
41942451|NCT02287584|75677647|FG005|the Open-label Phase|Lost to Follow-up|2|||
41942452|NCT02287584|75677642|FG000|the Open-label Phase|Withdrawal by Subject|0|||
41942453|NCT02287584|75677643|FG001|the Open-label Phase|Withdrawal by Subject|0|||
41942454|NCT02287584|75677644|FG002|the Open-label Phase|Withdrawal by Subject|0|||
41942455|NCT02287584|75677645|FG003|the Open-label Phase|Withdrawal by Subject|18|||
41942456|NCT02287584|75677646|FG004|the Open-label Phase|Withdrawal by Subject|29|||
41942457|NCT02287584|75677647|FG005|the Open-label Phase|Withdrawal by Subject|21|||
41942458|NCT02287584|75677642|FG000|the Open-label Phase|non-compliance|0|||
41942459|NCT02287584|75677643|FG001|the Open-label Phase|non-compliance|0|||
41942460|NCT02287584|75677644|FG002|the Open-label Phase|non-compliance|0|||
41942461|NCT02287584|75677645|FG003|the Open-label Phase|non-compliance|2|||
41942462|NCT02287584|75677646|FG004|the Open-label Phase|non-compliance|5|||
41942463|NCT02287584|75677647|FG005|the Open-label Phase|non-compliance|1|||
41942464|NCT02287584|75677642|FG000|the Open-label Phase|other reasons|0|||
41942465|NCT02287584|75677643|FG001|the Open-label Phase|other reasons|0|||
41942466|NCT02287584|75677644|FG002|the Open-label Phase|other reasons|0|||
41942467|NCT02287584|75677645|FG003|the Open-label Phase|other reasons|3|||
41942468|NCT02287584|75677646|FG004|the Open-label Phase|other reasons|6|||
41942469|NCT02287584|75677647|FG005|the Open-label Phase|other reasons|6|||
41942470|NCT00553267|75677680|FG000|Overall Study|Adverse Event|8|||
41942471|NCT00553267|75677681|FG001|Overall Study|Adverse Event|10|||
41942472|NCT00553267|75677682|FG002|Overall Study|Adverse Event|5|||
41942473|NCT00553267|75677680|FG000|Overall Study|Non compliant with protocol|3|||
41942474|NCT00553267|75677681|FG001|Overall Study|Non compliant with protocol|3|||
41942475|NCT00553267|75677682|FG002|Overall Study|Non compliant with protocol|2|||
41942476|NCT00553267|75677680|FG000|Overall Study|Lost to Follow-up|0|||
41942477|NCT00553267|75677681|FG001|Overall Study|Lost to Follow-up|0|||
41942478|NCT00553267|75677682|FG002|Overall Study|Lost to Follow-up|1|||
41942479|NCT00553267|75677680|FG000|Overall Study|Consent withdrawn|2|||
41942480|NCT00553267|75677681|FG001|Overall Study|Consent withdrawn|3|||
41942481|NCT00553267|75677682|FG002|Overall Study|Consent withdrawn|1|||
41942482|NCT00553267|75677680|FG000|Overall Study|Specified category|1|||
41942483|NCT00553267|75677681|FG001|Overall Study|Specified category|2|||
41942484|NCT00553267|75677682|FG002|Overall Study|Specified category|1|||
41942485|NCT02271984|75677696|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
41942486|NCT02271984|75677697|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
41942487|NCT02271984|75677698|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
41942488|NCT02271984|75677699|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
41942489|NCT02271984|75677700|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
41942490|NCT02271984|75677701|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
41942491|NCT02271984|75677702|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
41942492|NCT02271984|75677703|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
41942493|NCT02271984|75677704|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
41942494|NCT02271984|75677705|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
41942495|NCT02271984|75677706|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
41942496|NCT02271984|75677707|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
41942497|NCT02287038|75677758|FG000|Overall Study|Stopped attending appointments|3|||
41942498|NCT02287038|75677759|FG001|Overall Study|Stopped attending appointments|2|||
41942499|NCT02287038|75677758|FG000|Overall Study|Anxiety after starting medication|0|||
41942500|NCT02287038|75677759|FG001|Overall Study|Anxiety after starting medication|1|||
41942501|NCT02287038|75677758|FG000|Overall Study|Nausea after starting medication|1|||
41942502|NCT02287038|75677759|FG001|Overall Study|Nausea after starting medication|0|||
41942503|NCT02287038|75677758|FG000|Overall Study|Abnormal ECG after starting medication|1|||
41942504|NCT02287038|75677759|FG001|Overall Study|Abnormal ECG after starting medication|0|||
41942505|NCT02286960|75677769|FG000|Overall Study|Lost to Follow-up|3|||
41942506|NCT02286960|75677770|FG001|Overall Study|Lost to Follow-up|3|||
41942507|NCT02286102|75677787|FG000|Overall Study|Screen Failure|1|||
41942508|NCT02286102|75677788|FG001|Overall Study|Screen Failure|1|||
41942509|NCT02285166|75677794|FG000|Overall Study|Case Report Forms Uncollected|564|||
41942510|NCT02285166|75677794|FG000|Overall Study|Protocol Deviation|402|||
41942511|NCT00555061|75677857|FG000|Overall Study|Adverse Event|3|||
41942512|NCT00555061|75677857|FG000|Overall Study|Protocol Violation|1|||
41942513|NCT00555061|75677857|FG000|Overall Study|Lost to Follow-up|2|||
41942514|NCT00555061|75677857|FG000|Overall Study|Withdrawal by Subject|2|||
42022854|NCT01040403|75830157|FG000|Overall Study|Other reason not defined above|6|||
42022855|NCT00957034|75830179|FG000|Overall Study|Adverse Event|0|||
41942515|NCT00555061|75677857|FG000|Overall Study|Participant enrolled, but never treated|1|||
41942516|NCT01642212|75677875|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
41942517|NCT01642212|75677876|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
41942518|NCT01642212|75677877|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
41942519|NCT01642212|75677878|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
41942520|NCT01642212|75677879|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
41942521|NCT01642212|75677875|FG000|Double-blind Treatment|Other|0|||
41942522|NCT01642212|75677876|FG001|Double-blind Treatment|Other|2|||
41942523|NCT01642212|75677877|FG002|Double-blind Treatment|Other|1|||
41942524|NCT01642212|75677878|FG003|Double-blind Treatment|Other|0|||
41942525|NCT01642212|75677879|FG004|Double-blind Treatment|Other|0|||
41942526|NCT01642212|75677875|FG000|Double-blind Treatment|Non-compliance|0|||
41942527|NCT01642212|75677876|FG001|Double-blind Treatment|Non-compliance|1|||
41942528|NCT01642212|75677877|FG002|Double-blind Treatment|Non-compliance|0|||
41942529|NCT01642212|75677878|FG003|Double-blind Treatment|Non-compliance|0|||
41942530|NCT01642212|75677879|FG004|Double-blind Treatment|Non-compliance|0|||
41942531|NCT01642212|75677875|FG000|Double-blind Treatment|Adverse Event|0|||
41942532|NCT01642212|75677876|FG001|Double-blind Treatment|Adverse Event|0|||
41942533|NCT01642212|75677877|FG002|Double-blind Treatment|Adverse Event|1|||
41942534|NCT01642212|75677878|FG003|Double-blind Treatment|Adverse Event|0|||
41942535|NCT01642212|75677879|FG004|Double-blind Treatment|Adverse Event|0|||
41942536|NCT01642212|75677875|FG000|Open-label Extension|Adverse Event|0|||
41942537|NCT01642212|75677876|FG001|Open-label Extension|Adverse Event|0|||
41942538|NCT01642212|75677877|FG002|Open-label Extension|Adverse Event|0|||
41942539|NCT01642212|75677878|FG003|Open-label Extension|Adverse Event|3|||
41942540|NCT01642212|75677879|FG004|Open-label Extension|Adverse Event|0|||
41942541|NCT01642212|75677875|FG000|Open-label Extension|Sponsor Decision|0|||
41942542|NCT01642212|75677876|FG001|Open-label Extension|Sponsor Decision|0|||
41942543|NCT01642212|75677877|FG002|Open-label Extension|Sponsor Decision|0|||
41942544|NCT01642212|75677878|FG003|Open-label Extension|Sponsor Decision|7|||
41942545|NCT01642212|75677879|FG004|Open-label Extension|Sponsor Decision|4|||
41942546|NCT01642212|75677875|FG000|Open-label Extension|Consent Withdrawn|0|||
41942547|NCT01642212|75677876|FG001|Open-label Extension|Consent Withdrawn|0|||
41942548|NCT01642212|75677877|FG002|Open-label Extension|Consent Withdrawn|0|||
41942549|NCT01642212|75677878|FG003|Open-label Extension|Consent Withdrawn|0|||
41942550|NCT01642212|75677879|FG004|Open-label Extension|Consent Withdrawn|2|||
41942551|NCT01642212|75677875|FG000|Open-label Extension|Lost to Follow-up|0|||
41942552|NCT01642212|75677876|FG001|Open-label Extension|Lost to Follow-up|0|||
41942553|NCT01642212|75677877|FG002|Open-label Extension|Lost to Follow-up|0|||
41942554|NCT01642212|75677878|FG003|Open-label Extension|Lost to Follow-up|0|||
41942555|NCT01642212|75677879|FG004|Open-label Extension|Lost to Follow-up|1|||
41942556|NCT01642212|75677875|FG000|Open-label Extension|Other|0|||
41942557|NCT01642212|75677876|FG001|Open-label Extension|Other|0|||
41942558|NCT01642212|75677877|FG002|Open-label Extension|Other|0|||
41942559|NCT01642212|75677878|FG003|Open-label Extension|Other|0|||
41942560|NCT01642212|75677879|FG004|Open-label Extension|Other|1|||
41942561|NCT00552175|75677904|FG000|Overall Study|Lack of Efficacy|2|||
41942562|NCT00552175|75677905|FG001|Overall Study|Lack of Efficacy|0|||
41942563|NCT00552175|75677906|FG002|Overall Study|Lack of Efficacy|1|||
41942564|NCT00552175|75677904|FG000|Overall Study|Adverse Event|9|||
41942565|NCT00552175|75677905|FG001|Overall Study|Adverse Event|9|||
41942566|NCT00552175|75677906|FG002|Overall Study|Adverse Event|10|||
41942567|NCT00552175|75677904|FG000|Overall Study|Withdrawal by Subject|2|||
41942568|NCT00552175|75677905|FG001|Overall Study|Withdrawal by Subject|2|||
41942569|NCT00552175|75677906|FG002|Overall Study|Withdrawal by Subject|1|||
41942570|NCT00552175|75677904|FG000|Overall Study|Lost to Follow-up|0|||
41942571|NCT00552175|75677905|FG001|Overall Study|Lost to Follow-up|0|||
41942572|NCT00552175|75677906|FG002|Overall Study|Lost to Follow-up|1|||
41942573|NCT00552175|75677904|FG000|Overall Study|Entry Criteria Not Met|1|||
41942574|NCT00552175|75677905|FG001|Overall Study|Entry Criteria Not Met|1|||
41942575|NCT00552175|75677906|FG002|Overall Study|Entry Criteria Not Met|0|||
41942576|NCT00552175|75677904|FG000|Overall Study|Reason Not Specified|3|||
41942577|NCT00552175|75677905|FG001|Overall Study|Reason Not Specified|1|||
41942578|NCT00552175|75677906|FG002|Overall Study|Reason Not Specified|1|||
41942579|NCT01644474|75677917|FG000|Overall Study|Poor compliance to protocol|1|||
41942580|NCT01644474|75677918|FG001|Overall Study|Poor compliance to protocol|0|||
41942581|NCT01644474|75677917|FG000|Overall Study|Consent withdrawn by participant|0|||
41942582|NCT01644474|75677918|FG001|Overall Study|Consent withdrawn by participant|1|||
41942583|NCT01644474|75677917|FG000|Overall Study|Participant moved|0|||
41942584|NCT01644474|75677918|FG001|Overall Study|Participant moved|1|||
41942585|NCT01644474|75677917|FG000|Overall Study|Adverse Event|4|||
41942586|NCT01644474|75677918|FG001|Overall Study|Adverse Event|5|||
41942587|NCT01644474|75677917|FG000|Overall Study|Site scheduling error|1|||
41942588|NCT01644474|75677918|FG001|Overall Study|Site scheduling error|1|||
41942589|NCT01644474|75677917|FG000|Overall Study|Protocol Violation|1|||
41942590|NCT01644474|75677918|FG001|Overall Study|Protocol Violation|0|||
41942591|NCT02285010|75677953|FG000|Overall Study|not abdominal hysterectomy|2|||
41942592|NCT02285010|75677954|FG001|Overall Study|not abdominal hysterectomy|0|||
41942593|NCT02285010|75677953|FG000|Overall Study|Not spinal anesthesia|3|||
41942594|NCT02285010|75677954|FG001|Overall Study|Not spinal anesthesia|1|||
41942595|NCT00551161|75677998|FG000|Overall Study|Withdrawal by Subject|1|||
42300274|NCT02301897|76135422|FG001|Treatment Course 1|Adverse Event|1|||
41942596|NCT00550771|75678034|FG000|Overall Study|Adverse Event|11|||
41942597|NCT00550771|75678035|FG001|Overall Study|Adverse Event|3|||
41942598|NCT00550771|75678034|FG000|Overall Study|Discontinued for study-related reasons|0|||
41942599|NCT00550771|75678035|FG001|Overall Study|Discontinued for study-related reasons|1|||
41942600|NCT00550771|75678034|FG000|Overall Study|Physician Decision|2|||
42300275|NCT02301897|76135423|FG002|Treatment Course 1|Adverse Event|0|||
41942601|NCT00550771|75678035|FG001|Overall Study|Physician Decision|0|||
41942602|NCT00550771|75678034|FG000|Overall Study|Withdrawal by Subject|0|||
41942603|NCT00550771|75678035|FG001|Overall Study|Withdrawal by Subject|1|||
41942604|NCT00550771|75678034|FG000|Overall Study|Protocol Violation|4|||
41942605|NCT00550771|75678035|FG001|Overall Study|Protocol Violation|5|||
41942606|NCT00550537|75678068|FG000|Overall Study|Death|18|||
41942607|NCT00550537|75678068|FG000|Overall Study|Adverse Event|20|||
41942608|NCT00550537|75678068|FG000|Overall Study|Disease progression before|46|||
41942609|NCT00550537|75678068|FG000|Overall Study|Withdrawal by Subject|7|||
41942610|NCT00550537|75678068|FG000|Overall Study|Change in treatment plan|4|||
41942611|NCT00550537|75678068|FG000|Overall Study|Other complicating ilness|3|||
41942612|NCT00550537|75678068|FG000|Overall Study|Declining performance status|2|||
41942613|NCT00550537|75678068|FG000|Overall Study|Treated closer to home|4|||
41942614|NCT00550147|75678086|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
41942615|NCT00550147|75678086|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
41942616|NCT00550147|75678086|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
41942617|NCT00550147|75678086|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
41942618|NCT00550147|75678086|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
41942619|NCT00550459|75678297|FG000|Overall Study|Adverse Event|0|||
41942620|NCT00550459|75678298|FG001|Overall Study|Adverse Event|2|||
41942621|NCT00550459|75678297|FG000|Overall Study|Withdrawal by Subject|1|||
41942622|NCT00550459|75678298|FG001|Overall Study|Withdrawal by Subject|1|||
41942623|NCT02823145|75678333|FG000|Enrollment|Other|1|||
41942624|NCT02823145|75678334|FG001|Enrollment|Other|0|||
41942625|NCT02823145|75678333|FG000|Treatment|Adverse Event|0|||
41942626|NCT02823145|75678334|FG001|Treatment|Adverse Event|11|||
41942627|NCT02823145|75678333|FG000|Treatment|Death|0|||
41942628|NCT02823145|75678334|FG001|Treatment|Death|3|||
41942629|NCT02823145|75678333|FG000|Treatment|Family Decision|0|||
41942630|NCT02823145|75678334|FG001|Treatment|Family Decision|1|||
41942631|NCT02823145|75678333|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
41942632|NCT02823145|75678334|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
41942633|NCT02823145|75678333|FG000|Treatment|Lack of Efficacy|0|||
42022856|NCT00957034|75830180|FG001|Overall Study|Adverse Event|1|||
41942634|NCT02823145|75678334|FG001|Treatment|Lack of Efficacy|48|||
41942635|NCT02823145|75678333|FG000|Treatment|Non-Compliance With E-Diary|0|||
41942636|NCT02823145|75678334|FG001|Treatment|Non-Compliance With E-Diary|1|||
41942637|NCT02823145|75678333|FG000|Treatment|Physician Decision|0|||
41942638|NCT02823145|75678334|FG001|Treatment|Physician Decision|2|||
41942639|NCT02823145|75678333|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
42118008|NCT00689117|75928841|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
41942640|NCT02823145|75678334|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
41942641|NCT02823145|75678333|FG000|Treatment|Subject needed to take prohibited medication|0|||
41942642|NCT02823145|75678334|FG001|Treatment|Subject needed to take prohibited medication|1|||
41942643|NCT02823145|75678333|FG000|Treatment|Subject transferred to direct access programme|0|||
41942644|NCT02823145|75678334|FG001|Treatment|Subject transferred to direct access programme|1|||
41942645|NCT02823145|75678333|FG000|Treatment|Switching to commercially available drug|0|||
41942646|NCT02823145|75678334|FG001|Treatment|Switching to commercially available drug|11|||
41942647|NCT02823145|75678333|FG000|Treatment|Transitioned to commercial supply of medication|0|||
41942648|NCT02823145|75678334|FG001|Treatment|Transitioned to commercial supply of medication|1|||
41942649|NCT02823145|75678333|FG000|Treatment|Withdrawal By Caregiver|0|||
42022857|NCT00957034|75830181|FG002|Overall Study|Adverse Event|1|||
42022858|NCT00957034|75830179|FG000|Overall Study|Sponsor Terminated Study|6|||
42022859|NCT00957034|75830180|FG001|Overall Study|Sponsor Terminated Study|1|||
42022860|NCT00957034|75830181|FG002|Overall Study|Sponsor Terminated Study|5|||
42022861|NCT00957034|75830179|FG000|Overall Study|Withdrawal by Subject|0|||
42022862|NCT00957034|75830180|FG001|Overall Study|Withdrawal by Subject|2|||
42022863|NCT00957034|75830181|FG002|Overall Study|Withdrawal by Subject|0|||
42022864|NCT00953056|75830195|FG000|Overall Study|Withdrew Consent|0|||
42022865|NCT00953056|75830196|FG001|Overall Study|Withdrew Consent|0|||
42022866|NCT00953056|75830197|FG002|Overall Study|Withdrew Consent|0|||
42022867|NCT00953056|75830198|FG003|Overall Study|Withdrew Consent|0|||
42022868|NCT00953056|75830199|FG004|Overall Study|Withdrew Consent|2|||
42022869|NCT00953056|75830200|FG005|Overall Study|Withdrew Consent|3|||
42022870|NCT00953056|75830195|FG000|Overall Study|Serious Adverse Event|0|||
42022871|NCT00953056|75830196|FG001|Overall Study|Serious Adverse Event|0|||
42022872|NCT00953056|75830197|FG002|Overall Study|Serious Adverse Event|0|||
42022873|NCT00953056|75830198|FG003|Overall Study|Serious Adverse Event|0|||
42022874|NCT00953056|75830199|FG004|Overall Study|Serious Adverse Event|0|||
42022875|NCT00953056|75830200|FG005|Overall Study|Serious Adverse Event|1|||
42022876|NCT00952822|75830225|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
42022877|NCT00952822|75830226|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
42022878|NCT00952822|75830227|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
42022879|NCT00952822|75830228|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
42022880|NCT00952822|75830225|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
42022881|NCT00952822|75830226|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
42022882|NCT00952822|75830227|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
42022883|NCT00952822|75830228|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
42022884|NCT01038297|75830242|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
42022885|NCT01038297|75830243|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
42022886|NCT01038297|75830244|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
42022887|NCT00955708|75830261|FG000|Overall Study|Death|269|||
42022888|NCT00955708|75830261|FG000|Overall Study|Lost to Follow-up|72|||
42022889|NCT00955708|75830261|FG000|Overall Study|Physician Decision|36|||
42022890|NCT00955708|75830261|FG000|Overall Study|Protocol Violation|134|||
42022891|NCT00955708|75830261|FG000|Overall Study|Registry Conclusion|186|||
42022892|NCT00955708|75830261|FG000|Overall Study|Product removed from service|94|||
42022893|NCT00955708|75830261|FG000|Overall Study|Patient Refused to participate further|116|||
42022894|NCT00955708|75830261|FG000|Overall Study|Closure of study location|60|||
42022895|NCT00955708|75830261|FG000|Overall Study|Patient changed care provider/moved|91|||
42022896|NCT01037985|75830265|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
42022897|NCT01037985|75830266|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
42022898|NCT01037985|75830265|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
42022899|NCT01037985|75830266|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
42022900|NCT01037985|75830265|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
42022901|NCT01037985|75830266|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
42022902|NCT01037985|75830265|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
42022903|NCT01037985|75830266|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
42022904|NCT00955474|75830278|FG000|Overall Study|Physician Decision|7|||
42022905|NCT00955474|75830279|FG001|Overall Study|Physician Decision|5|||
42022906|NCT01229150|75830291|FG000|Overall Study|Toxicity|2|||
42022907|NCT01229150|75830292|FG001|Overall Study|Toxicity|2|||
42022908|NCT01229150|75830293|FG002|Overall Study|Toxicity|0|||
42022909|NCT01229150|75830294|FG003|Overall Study|Toxicity|0|||
42022910|NCT00952588|75830310|FG000|Overall Study|Death|28|||
42022911|NCT00952588|75830311|FG001|Overall Study|Death|13|||
41942650|NCT02823145|75678334|FG001|Treatment|Withdrawal By Caregiver|1|||
42022912|NCT00952588|75830310|FG000|Overall Study|Withdrawal by Subject|2|||
42022913|NCT00952588|75830311|FG001|Overall Study|Withdrawal by Subject|5|||
42022914|NCT00952588|75830310|FG000|Overall Study|Adverse Event|2|||
42022915|NCT00952588|75830311|FG001|Overall Study|Adverse Event|3|||
42022916|NCT00952588|75830310|FG000|Overall Study|Lost to Follow-up|2|||
42022917|NCT00952588|75830311|FG001|Overall Study|Lost to Follow-up|0|||
42022918|NCT00952588|75830310|FG000|Overall Study|Physician Decision|0|||
42300276|NCT02301897|76135421|FG000|Treatment Course 1|Lost to Follow-up|1|||
42300277|NCT02301897|76135422|FG001|Treatment Course 1|Lost to Follow-up|2|||
41942651|NCT02823145|75678333|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
41942652|NCT02823145|75678334|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
41942653|NCT02823145|75678333|FG000|Treatment|Withdrawal by Subject|0|||
41942654|NCT02823145|75678334|FG001|Treatment|Withdrawal by Subject|16|||
41942655|NCT02823145|75678333|FG000|Treatment|Reason unknown|0|||
41942656|NCT02823145|75678334|FG001|Treatment|Reason unknown|1|||
42022919|NCT00952588|75830311|FG001|Overall Study|Physician Decision|1|||
42022920|NCT00952588|75830310|FG000|Overall Study|Lack of Efficacy|2|||
41942657|NCT01643928|75678598|FG000|Overall Study|Lost to Follow-up|1|||
41942658|NCT01643928|75678599|FG001|Overall Study|Lost to Follow-up|0|||
41942659|NCT01643928|75678600|FG002|Overall Study|Lost to Follow-up|2|||
41942660|NCT01643928|75678601|FG003|Overall Study|Lost to Follow-up|0|||
42022921|NCT00952588|75830311|FG001|Overall Study|Lack of Efficacy|2|||
42022922|NCT01227902|75830321|FG000|Overall Study|Adverse Event|12|||
42022923|NCT01227902|75830322|FG001|Overall Study|Adverse Event|8|||
42022924|NCT01227902|75830323|FG002|Overall Study|Adverse Event|11|||
41942661|NCT01643928|75678602|FG004|Overall Study|Lost to Follow-up|0|||
41942662|NCT01643928|75678598|FG000|Overall Study|Withdrawal by Subject|2|||
41942663|NCT01643928|75678599|FG001|Overall Study|Withdrawal by Subject|0|||
41942664|NCT01643928|75678600|FG002|Overall Study|Withdrawal by Subject|0|||
41942665|NCT01643928|75678601|FG003|Overall Study|Withdrawal by Subject|1|||
41942666|NCT01643928|75678602|FG004|Overall Study|Withdrawal by Subject|0|||
41942667|NCT01643928|75678598|FG000|Overall Study|Pregnancy|0|||
41942668|NCT01643928|75678599|FG001|Overall Study|Pregnancy|0|||
41942669|NCT01643928|75678600|FG002|Overall Study|Pregnancy|0|||
41942670|NCT01643928|75678601|FG003|Overall Study|Pregnancy|1|||
41942671|NCT01643928|75678602|FG004|Overall Study|Pregnancy|0|||
41942672|NCT01643928|75678598|FG000|Overall Study|Other|5|||
41942673|NCT01643928|75678599|FG001|Overall Study|Other|1|||
41942674|NCT01643928|75678600|FG002|Overall Study|Other|1|||
41942675|NCT01643928|75678601|FG003|Overall Study|Other|0|||
41942676|NCT01643928|75678602|FG004|Overall Study|Other|0|||
41942677|NCT01643928|75678598|FG000|Overall Study|Adverse Event|2|||
41942678|NCT01643928|75678599|FG001|Overall Study|Adverse Event|1|||
41942679|NCT01643928|75678600|FG002|Overall Study|Adverse Event|0|||
41942680|NCT01643928|75678601|FG003|Overall Study|Adverse Event|1|||
41942681|NCT01643928|75678602|FG004|Overall Study|Adverse Event|2|||
41942682|NCT03237845|75678813|FG000|Overall Study|Adverse Event|0|||
41942683|NCT03237845|75678814|FG001|Overall Study|Adverse Event|1|||
41942684|NCT03237845|75678813|FG000|Overall Study|Lost to Follow-up|13|||
41942685|NCT03237845|75678814|FG001|Overall Study|Lost to Follow-up|10|||
41942686|NCT03237845|75678813|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
41942687|NCT03237845|75678814|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
41942688|NCT03237845|75678813|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
41942689|NCT03237845|75678814|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
41942690|NCT03237845|75678813|FG000|Overall Study|Physician Decision|1|||
41942691|NCT03237845|75678814|FG001|Overall Study|Physician Decision|2|||
41942692|NCT03237845|75678813|FG000|Overall Study|Pregnancy|1|||
41942693|NCT03237845|75678814|FG001|Overall Study|Pregnancy|0|||
41942694|NCT03237845|75678813|FG000|Overall Study|Protocol Deviation|0|||
41942695|NCT03237845|75678814|FG001|Overall Study|Protocol Deviation|1|||
41942696|NCT03237845|75678813|FG000|Overall Study|Technical Problems|8|||
41942697|NCT03237845|75678814|FG001|Overall Study|Technical Problems|1|||
41942698|NCT03237845|75678813|FG000|Overall Study|Withdrawal by Subject|3|||
41942699|NCT03237845|75678814|FG001|Overall Study|Withdrawal by Subject|3|||
41942700|NCT03237845|75678813|FG000|Overall Study|Other Reasons|4|||
41942701|NCT03237845|75678814|FG001|Overall Study|Other Reasons|0|||
41942702|NCT01643850|75678901|FG000|Overall Study|Withdrawal by Subject|0|||
41942703|NCT01643850|75678902|FG001|Overall Study|Withdrawal by Subject|0|||
41942704|NCT01643850|75678903|FG002|Overall Study|Withdrawal by Subject|0|||
41942705|NCT01643850|75678904|FG003|Overall Study|Withdrawal by Subject|0|||
41942706|NCT01643850|75678905|FG004|Overall Study|Withdrawal by Subject|1|||
41942707|NCT01643850|75678906|FG005|Overall Study|Withdrawal by Subject|0|||
41942708|NCT01643850|75678907|FG006|Overall Study|Withdrawal by Subject|0|||
41942709|NCT01643850|75678908|FG007|Overall Study|Withdrawal by Subject|0|||
41942710|NCT01643850|75678909|FG008|Overall Study|Withdrawal by Subject|0|||
41942711|NCT01643850|75678901|FG000|Overall Study|Lost to Follow-up|0|||
41942712|NCT01643850|75678902|FG001|Overall Study|Lost to Follow-up|0|||
41942713|NCT01643850|75678903|FG002|Overall Study|Lost to Follow-up|0|||
41942714|NCT01643850|75678904|FG003|Overall Study|Lost to Follow-up|0|||
41942715|NCT01643850|75678905|FG004|Overall Study|Lost to Follow-up|0|||
41942716|NCT01643850|75678906|FG005|Overall Study|Lost to Follow-up|0|||
41942717|NCT01643850|75678907|FG006|Overall Study|Lost to Follow-up|1|||
41942718|NCT01643850|75678908|FG007|Overall Study|Lost to Follow-up|0|||
41942719|NCT01643850|75678909|FG008|Overall Study|Lost to Follow-up|1|||
41942720|NCT01643850|75678901|FG000|Overall Study|Adverse Event|0|||
41942721|NCT01643850|75678902|FG001|Overall Study|Adverse Event|0|||
41942722|NCT01643850|75678903|FG002|Overall Study|Adverse Event|0|||
41942723|NCT01643850|75678904|FG003|Overall Study|Adverse Event|0|||
41942724|NCT01643850|75678905|FG004|Overall Study|Adverse Event|1|||
41942725|NCT01643850|75678906|FG005|Overall Study|Adverse Event|0|||
41942726|NCT01643850|75678907|FG006|Overall Study|Adverse Event|0|||
41942727|NCT01643850|75678908|FG007|Overall Study|Adverse Event|0|||
41942728|NCT01643850|75678909|FG008|Overall Study|Adverse Event|0|||
41942729|NCT01643850|75678901|FG000|Overall Study|Administrative Problems|0|||
41942730|NCT01643850|75678902|FG001|Overall Study|Administrative Problems|0|||
41942731|NCT01643850|75678903|FG002|Overall Study|Administrative Problems|1|||
41942732|NCT01643850|75678904|FG003|Overall Study|Administrative Problems|0|||
41942733|NCT01643850|75678905|FG004|Overall Study|Administrative Problems|1|||
41942734|NCT01643850|75678906|FG005|Overall Study|Administrative Problems|0|||
41942735|NCT01643850|75678907|FG006|Overall Study|Administrative Problems|0|||
41942736|NCT01643850|75678908|FG007|Overall Study|Administrative Problems|0|||
41942737|NCT01643850|75678909|FG008|Overall Study|Administrative Problems|0|||
41942738|NCT02271594|75678977|FG000|Overall Study|Study closed; recruiting failure|19|||
41942739|NCT02271594|75678978|FG001|Overall Study|Study closed; recruiting failure|12|||
41942740|NCT02535923|75678997|FG000|Overall Study|Lost to Follow-up|5|||
41942741|NCT02535923|75678998|FG001|Overall Study|Lost to Follow-up|5|||
41942742|NCT02535923|75678997|FG000|Overall Study|Withdrawal by Subject|4|||
41942743|NCT02535923|75678998|FG001|Overall Study|Withdrawal by Subject|3|||
41942744|NCT02270736|75679007|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
41942745|NCT02270736|75679008|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
41942746|NCT02270736|75679009|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
41942747|NCT02270736|75679010|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
41942748|NCT02270736|75679011|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
41942749|NCT02270736|75679007|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
41942750|NCT02270736|75679008|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
41942751|NCT02270736|75679009|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
41942752|NCT02270736|75679010|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
41942753|NCT02270736|75679011|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
41942754|NCT02270736|75679007|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
41942755|NCT02270736|75679008|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
41942756|NCT02270736|75679009|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
41942757|NCT02270736|75679010|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
41942758|NCT02270736|75679011|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
41942759|NCT02270736|75679007|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
41942760|NCT02270736|75679008|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
41942761|NCT02270736|75679009|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
41942762|NCT02270736|75679010|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
41942763|NCT02270736|75679011|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
41942764|NCT02270736|75679007|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
41942765|NCT02270736|75679008|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
41942766|NCT02270736|75679009|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
41942767|NCT02270736|75679010|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
41942768|NCT02270736|75679011|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
41942769|NCT02270736|75679007|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
41942770|NCT02270736|75679008|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
41942771|NCT02270736|75679009|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
41942772|NCT02270736|75679010|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
41942773|NCT02270736|75679011|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
41942774|NCT02270736|75679007|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
41942775|NCT02270736|75679008|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
41942776|NCT02270736|75679009|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
41942777|NCT02270736|75679010|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
41942778|NCT02270736|75679011|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
41942779|NCT02270736|75679007|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
41942780|NCT02270736|75679008|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
41942781|NCT02270736|75679009|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
41942782|NCT02270736|75679010|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
41942783|NCT02270736|75679011|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
41942784|NCT02270736|75679007|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
41942785|NCT02270736|75679008|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
41942786|NCT02270736|75679009|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
41942787|NCT02270736|75679010|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
41942788|NCT02270736|75679011|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
41942789|NCT02269098|75679026|FG000|Overall Study|Lost to Follow-up|14|||
41942790|NCT02269098|75679027|FG001|Overall Study|Lost to Follow-up|9|||
41942791|NCT02283762|75679160|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
41942792|NCT02283762|75679161|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
41942793|NCT02283762|75679160|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
41942794|NCT02283762|75679161|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
41942795|NCT02283762|75679160|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
41942796|NCT02283762|75679161|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
41942797|NCT02283762|75679160|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
41942798|NCT02283762|75679161|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
41942799|NCT02283762|75679160|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
42022925|NCT01227902|75830324|FG003|Overall Study|Adverse Event|4|||
41942800|NCT02283762|75679161|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
41942801|NCT02283762|75679160|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
42022926|NCT01227902|75830321|FG000|Overall Study|Lack of Efficacy|1|||
41942802|NCT02283762|75679161|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
41942803|NCT02283762|75679160|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
41942804|NCT02283762|75679161|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
41942805|NCT02283762|75679160|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
42022927|NCT01227902|75830322|FG001|Overall Study|Lack of Efficacy|2|||
42022928|NCT01227902|75830323|FG002|Overall Study|Lack of Efficacy|2|||
41942806|NCT02283762|75679161|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
41942807|NCT02283762|75679160|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
41942808|NCT02283762|75679161|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
41942809|NCT02283762|75679160|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
41942810|NCT02283762|75679161|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
41942811|NCT02283762|75679160|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
41942812|NCT02283762|75679161|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
41942813|NCT02283762|75679160|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
41942814|NCT02283762|75679161|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
41942815|NCT02283294|75679261|FG000|Overall Study|Lost to Follow-up|1|||
41942816|NCT02283294|75679262|FG001|Overall Study|Lost to Follow-up|1|||
41942817|NCT02283294|75679261|FG000|Overall Study|Withdrawal by Subject|1|||
41942818|NCT02283294|75679262|FG001|Overall Study|Withdrawal by Subject|6|||
41942819|NCT02283294|75679261|FG000|Overall Study|Protocol Violation|1|||
41942820|NCT02283294|75679262|FG001|Overall Study|Protocol Violation|0|||
41942821|NCT02283294|75679261|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
41942822|NCT02283294|75679262|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
41942823|NCT02282982|75679278|FG000|Overall Study|Lost to Follow-up|15|||
41942824|NCT02282982|75679278|FG000|Overall Study|Withdrew consent|2|||
41942825|NCT02282982|75679278|FG000|Overall Study|Death|4|||
41942826|NCT02282982|75679278|FG000|Overall Study|Lack of product|156|||
41942827|NCT02282982|75679278|FG000|Overall Study|Palivizumab is ended|11|||
41942828|NCT02282982|75679278|FG000|Overall Study|Other, not specified|18|||
41942829|NCT02268864|75679320|FG000|Overall Study|Withdrawal by Subject|2|||
41942830|NCT02268864|75679321|FG001|Overall Study|Withdrawal by Subject|0|||
41942831|NCT02268864|75679322|FG002|Overall Study|Withdrawal by Subject|0|||
41942832|NCT02268864|75679320|FG000|Overall Study|Death|0|||
41942833|NCT02268864|75679321|FG001|Overall Study|Death|1|||
41942834|NCT02268864|75679322|FG002|Overall Study|Death|0|||
41942835|NCT02268786|75679351|FG000|Overall Study|No Euploid Embryos available|42|||
41942836|NCT02268786|75679352|FG001|Overall Study|No Euploid Embryos available|0|||
41942837|NCT02268786|75679351|FG000|Overall Study|Withdrawal by Subject|7|||
41942838|NCT02268786|75679352|FG001|Overall Study|Withdrawal by Subject|14|||
41942839|NCT02268786|75679351|FG000|Overall Study|Thaw Failure|6|||
41942840|NCT02268786|75679352|FG001|Overall Study|Thaw Failure|4|||
41942841|NCT02268786|75679351|FG000|Overall Study|Protocol Violation|1|||
41942842|NCT02268786|75679352|FG001|Overall Study|Protocol Violation|0|||
41942843|NCT02268396|75679367|FG000|Overall Study|Adverse Event|3|||
41942844|NCT02268396|75679367|FG000|Overall Study|Administrative|2|||
41942845|NCT02268396|75679367|FG000|Overall Study|Withdrawal by Subject|1|||
41942846|NCT02268396|75679367|FG000|Overall Study|Lost to Follow-up|2|||
41942847|NCT02268396|75679367|FG000|Overall Study|Protocol-Specified Criteria|2|||
41942848|NCT02268396|75679367|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
41942849|NCT02268084|75679373|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
41942850|NCT02268084|75679374|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
41942851|NCT02268084|75679373|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
41942852|NCT02268084|75679374|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
41942853|NCT01643772|75679403|FG000|Overall Study|Protocol Violation|0|||
41942854|NCT01643772|75679404|FG001|Overall Study|Protocol Violation|0|||
41942855|NCT01643772|75679405|FG002|Overall Study|Protocol Violation|0|||
41942856|NCT01643772|75679406|FG003|Overall Study|Protocol Violation|1|||
41942857|NCT01643772|75679403|FG000|Overall Study|Adverse Event|0|||
41942858|NCT01643772|75679404|FG001|Overall Study|Adverse Event|0|||
41942859|NCT01643772|75679405|FG002|Overall Study|Adverse Event|0|||
41942860|NCT01643772|75679406|FG003|Overall Study|Adverse Event|1|||
41942861|NCT02265744|75679509|FG000|Overall Study|Poor/Non-compliance|1|||
41942862|NCT02265744|75679510|FG001|Overall Study|Poor/Non-compliance|1|||
41942863|NCT02265744|75679511|FG002|Overall Study|Poor/Non-compliance|0|||
41942864|NCT02265744|75679512|FG003|Overall Study|Poor/Non-compliance|0|||
41942865|NCT02265744|75679513|FG004|Overall Study|Poor/Non-compliance|2|||
41942866|NCT02265744|75679509|FG000|Overall Study|Lost to Follow-up|0|||
41942867|NCT02265744|75679510|FG001|Overall Study|Lost to Follow-up|0|||
41942868|NCT02265744|75679511|FG002|Overall Study|Lost to Follow-up|0|||
41942869|NCT02265744|75679512|FG003|Overall Study|Lost to Follow-up|1|||
41942870|NCT02265744|75679513|FG004|Overall Study|Lost to Follow-up|0|||
41942871|NCT02265744|75679509|FG000|Overall Study|Death|0|||
41942872|NCT02265744|75679510|FG001|Overall Study|Death|0|||
41942873|NCT02265744|75679511|FG002|Overall Study|Death|0|||
41942874|NCT02265744|75679512|FG003|Overall Study|Death|2|||
42300278|NCT02301897|76135423|FG002|Treatment Course 1|Lost to Follow-up|1|||
42300279|NCT02301897|76135421|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
41942875|NCT02265744|75679513|FG004|Overall Study|Death|0|||
41942876|NCT02265744|75679509|FG000|Overall Study|Withdrawal by Subject|2|||
41942877|NCT02265744|75679510|FG001|Overall Study|Withdrawal by Subject|0|||
42022929|NCT01227902|75830324|FG003|Overall Study|Lack of Efficacy|1|||
41942878|NCT02265744|75679511|FG002|Overall Study|Withdrawal by Subject|0|||
41942879|NCT02265744|75679512|FG003|Overall Study|Withdrawal by Subject|2|||
41942880|NCT02265744|75679513|FG004|Overall Study|Withdrawal by Subject|0|||
41942881|NCT02265744|75679509|FG000|Overall Study|Participant request to discontinue|2|||
41942882|NCT02265744|75679510|FG001|Overall Study|Participant request to discontinue|2|||
41942883|NCT02265744|75679511|FG002|Overall Study|Participant request to discontinue|2|||
41942884|NCT02265744|75679512|FG003|Overall Study|Participant request to discontinue|0|||
41942885|NCT02265744|75679513|FG004|Overall Study|Participant request to discontinue|0|||
41942886|NCT02265744|75679509|FG000|Overall Study|Adverse Event|8|||
41942887|NCT02265744|75679510|FG001|Overall Study|Adverse Event|4|||
41942888|NCT02265744|75679511|FG002|Overall Study|Adverse Event|9|||
41942889|NCT02265744|75679512|FG003|Overall Study|Adverse Event|8|||
41942890|NCT02265744|75679513|FG004|Overall Study|Adverse Event|2|||
41942891|NCT02265744|75679509|FG000|Overall Study|Lack of Efficacy|2|||
42300280|NCT02301897|76135422|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
42300281|NCT02301897|76135423|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
42300282|NCT02301897|76135421|FG000|Treatment Course 1|Withdrawal by Subject|0|||
41942892|NCT02265744|75679510|FG001|Overall Study|Lack of Efficacy|4|||
41942893|NCT02265744|75679511|FG002|Overall Study|Lack of Efficacy|3|||
41942894|NCT02265744|75679512|FG003|Overall Study|Lack of Efficacy|4|||
41942895|NCT02265744|75679513|FG004|Overall Study|Lack of Efficacy|5|||
41942896|NCT02265744|75679509|FG000|Overall Study|Reason not provided by Investigator|1|||
41942897|NCT02265744|75679510|FG001|Overall Study|Reason not provided by Investigator|0|||
41942898|NCT02265744|75679511|FG002|Overall Study|Reason not provided by Investigator|0|||
41942899|NCT02265744|75679512|FG003|Overall Study|Reason not provided by Investigator|2|||
41942900|NCT02265744|75679513|FG004|Overall Study|Reason not provided by Investigator|0|||
41942901|NCT02265744|75679509|FG000|Overall Study|Administrative reason by sponsor|3|||
41942902|NCT02265744|75679510|FG001|Overall Study|Administrative reason by sponsor|2|||
41942903|NCT02265744|75679511|FG002|Overall Study|Administrative reason by sponsor|2|||
41942904|NCT02265744|75679512|FG003|Overall Study|Administrative reason by sponsor|3|||
41942905|NCT02265744|75679513|FG004|Overall Study|Administrative reason by sponsor|3|||
41942906|NCT02265744|75679509|FG000|Overall Study|Subject no longer meets study criteria|0|||
41942907|NCT02265744|75679510|FG001|Overall Study|Subject no longer meets study criteria|0|||
41942908|NCT02265744|75679511|FG002|Overall Study|Subject no longer meets study criteria|0|||
41942909|NCT02265744|75679512|FG003|Overall Study|Subject no longer meets study criteria|0|||
41942910|NCT02265744|75679513|FG004|Overall Study|Subject no longer meets study criteria|1|||
41942911|NCT02265744|75679509|FG000|Overall Study|Pregnancy|1|||
41942912|NCT02265744|75679510|FG001|Overall Study|Pregnancy|2|||
41942913|NCT02265744|75679511|FG002|Overall Study|Pregnancy|1|||
41942914|NCT02265744|75679512|FG003|Overall Study|Pregnancy|1|||
41942915|NCT02265744|75679513|FG004|Overall Study|Pregnancy|0|||
41942916|NCT00085735|75679542|FG000|Overall Study|Adverse Event|1|||
41942917|NCT00085735|75679543|FG001|Overall Study|Adverse Event|0|||
41942918|NCT00085735|75679544|FG002|Overall Study|Adverse Event|0|||
41942919|NCT00085735|75679545|FG003|Overall Study|Adverse Event|0|||
41942920|NCT00085735|75679546|FG004|Overall Study|Adverse Event|0|||
41942921|NCT00085735|75679547|FG005|Overall Study|Adverse Event|0|||
41942922|NCT00085735|75679542|FG000|Overall Study|Lack of Efficacy|2|||
41942923|NCT00085735|75679543|FG001|Overall Study|Lack of Efficacy|4|||
41942924|NCT00085735|75679544|FG002|Overall Study|Lack of Efficacy|6|||
41942925|NCT00085735|75679545|FG003|Overall Study|Lack of Efficacy|3|||
41942926|NCT00085735|75679546|FG004|Overall Study|Lack of Efficacy|4|||
41942927|NCT00085735|75679547|FG005|Overall Study|Lack of Efficacy|3|||
41942928|NCT00085735|75679542|FG000|Overall Study|Lost to Follow-up|0|||
41942929|NCT00085735|75679543|FG001|Overall Study|Lost to Follow-up|1|||
41942930|NCT00085735|75679544|FG002|Overall Study|Lost to Follow-up|0|||
41942931|NCT00085735|75679545|FG003|Overall Study|Lost to Follow-up|0|||
41942932|NCT00085735|75679546|FG004|Overall Study|Lost to Follow-up|1|||
41942933|NCT00085735|75679547|FG005|Overall Study|Lost to Follow-up|0|||
41942934|NCT00085735|75679542|FG000|Overall Study|Physician Decision|2|||
41942935|NCT00085735|75679543|FG001|Overall Study|Physician Decision|3|||
41942936|NCT00085735|75679544|FG002|Overall Study|Physician Decision|2|||
41942937|NCT00085735|75679545|FG003|Overall Study|Physician Decision|3|||
41942938|NCT00085735|75679546|FG004|Overall Study|Physician Decision|11|||
41942939|NCT00085735|75679547|FG005|Overall Study|Physician Decision|8|||
41942940|NCT00085735|75679542|FG000|Overall Study|Protocol Violation|1|||
41942941|NCT00085735|75679543|FG001|Overall Study|Protocol Violation|0|||
41942942|NCT00085735|75679544|FG002|Overall Study|Protocol Violation|0|||
41942943|NCT00085735|75679545|FG003|Overall Study|Protocol Violation|0|||
41942944|NCT00085735|75679546|FG004|Overall Study|Protocol Violation|0|||
41942945|NCT00085735|75679547|FG005|Overall Study|Protocol Violation|0|||
41942946|NCT00085735|75679542|FG000|Overall Study|Withdrawal by Subject|1|||
41942947|NCT00085735|75679543|FG001|Overall Study|Withdrawal by Subject|0|||
42300283|NCT02301897|76135422|FG001|Treatment Course 1|Withdrawal by Subject|0|||
41942948|NCT00085735|75679544|FG002|Overall Study|Withdrawal by Subject|4|||
41942949|NCT00085735|75679545|FG003|Overall Study|Withdrawal by Subject|5|||
41942950|NCT00085735|75679546|FG004|Overall Study|Withdrawal by Subject|7|||
41942951|NCT00085735|75679547|FG005|Overall Study|Withdrawal by Subject|8|||
41942952|NCT00085735|75679542|FG000|Overall Study|Patient ineligible|1|||
41942953|NCT00085735|75679543|FG001|Overall Study|Patient ineligible|0|||
41942954|NCT00085735|75679544|FG002|Overall Study|Patient ineligible|3|||
41942955|NCT00085735|75679545|FG003|Overall Study|Patient ineligible|7|||
41942956|NCT00085735|75679546|FG004|Overall Study|Patient ineligible|17|||
41942957|NCT00085735|75679547|FG005|Overall Study|Patient ineligible|8|||
41942958|NCT00085735|75679542|FG000|Overall Study|Excess residual disease|2|||
41942959|NCT00085735|75679543|FG001|Overall Study|Excess residual disease|2|||
41942960|NCT00085735|75679544|FG002|Overall Study|Excess residual disease|1|||
41942961|NCT00085735|75679545|FG003|Overall Study|Excess residual disease|1|||
41942962|NCT00085735|75679546|FG004|Overall Study|Excess residual disease|1|||
41942963|NCT00085735|75679547|FG005|Overall Study|Excess residual disease|4|||
41942964|NCT00085735|75679542|FG000|Overall Study|Reason not documented|1|||
41942965|NCT00085735|75679543|FG001|Overall Study|Reason not documented|0|||
41942966|NCT00085735|75679544|FG002|Overall Study|Reason not documented|1|||
41942967|NCT00085735|75679545|FG003|Overall Study|Reason not documented|0|||
41942968|NCT00085735|75679546|FG004|Overall Study|Reason not documented|1|||
41942969|NCT00085735|75679547|FG005|Overall Study|Reason not documented|0|||
41942970|NCT00085735|75679542|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
41942971|NCT00085735|75679543|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
41942972|NCT00085735|75679544|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
41942973|NCT00085735|75679545|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
41942974|NCT00085735|75679546|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
41942975|NCT00085735|75679547|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
41942976|NCT04537793|75679849|FG000|Part B (24 Weeks)|Adverse Event|0|||
41942977|NCT04537793|75679850|FG001|Part B (24 Weeks)|Adverse Event|1|||
41942978|NCT01938001|75681099|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
41942979|NCT01938001|75681100|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
41942980|NCT01938001|75681099|FG000|Pre-Treatment|Death|1|||
41942981|NCT01938001|75681100|FG001|Pre-Treatment|Death|0|||
41942982|NCT01938001|75681099|FG000|Treatment|Death|2|||
41942983|NCT01938001|75681100|FG001|Treatment|Death|0|||
41942984|NCT01938001|75681099|FG000|Treatment|Adverse Event|14|||
41942985|NCT01938001|75681100|FG001|Treatment|Adverse Event|8|||
41942986|NCT01938001|75681099|FG000|Treatment|Progressive Disease|21|||
41942987|NCT01938001|75681100|FG001|Treatment|Progressive Disease|54|||
41942988|NCT01938001|75681099|FG000|Treatment|Withdrawal by Subject|13|||
41942989|NCT01938001|75681100|FG001|Treatment|Withdrawal by Subject|7|||
41942990|NCT01938001|75681099|FG000|Treatment|Other reasons|2|||
41942991|NCT01938001|75681100|FG001|Treatment|Other reasons|1|||
41942992|NCT01066663|75681261|FG000|Overall Study|Adverse Event|0|||
41942993|NCT01066663|75681262|FG001|Overall Study|Adverse Event|0|||
41942994|NCT01066663|75681263|FG002|Overall Study|Adverse Event|1|||
41942995|NCT03930745|75683469|FG000|Overall Study|Lost to Follow-up|10|||
41942996|NCT03930745|75683470|FG001|Overall Study|Lost to Follow-up|5|||
41942997|NCT03930745|75683469|FG000|Overall Study|Withdrawal by Subject|1|||
41942998|NCT03930745|75683470|FG001|Overall Study|Withdrawal by Subject|2|||
41942999|NCT03930745|75683469|FG000|Overall Study|Protocol Violation|2|||
41943000|NCT03930745|75683470|FG001|Overall Study|Protocol Violation|2|||
41943001|NCT03930745|75683469|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
41943002|NCT03930745|75683470|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
41943003|NCT03930745|75683469|FG000|Overall Study|Adverse Event|0|||
41943004|NCT03930745|75683470|FG001|Overall Study|Adverse Event|1|||
41943005|NCT03930745|75683469|FG000|Overall Study|Pregnancy|0|||
41943006|NCT03930745|75683470|FG001|Overall Study|Pregnancy|1|||
41943007|NCT04473326|75686215|FG000|Overall Study|Death|0|||
41943008|NCT04473326|75686216|FG001|Overall Study|Death|1|||
41943009|NCT04473326|75686215|FG000|Overall Study|Withdrawal by Subject|1|||
42022930|NCT01227902|75830321|FG000|Overall Study|Protocol Violation|1|||
42022931|NCT01227902|75830322|FG001|Overall Study|Protocol Violation|0|||
41943010|NCT04473326|75686216|FG001|Overall Study|Withdrawal by Subject|2|||
41943011|NCT05993299|75686567|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
41943012|NCT05993299|75686567|FG000|Overall Study|Ongoing|4|||
41943013|NCT05239598|75686624|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
41943014|NCT05239598|75686625|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
41943015|NCT05239598|75686624|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
41943016|NCT05239598|75686625|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
42022932|NCT01227902|75830323|FG002|Overall Study|Protocol Violation|0|||
42022933|NCT01227902|75830324|FG003|Overall Study|Protocol Violation|0|||
41943017|NCT05010070|75686668|FG000|Overall Study|Lost to Follow-up|1|||
41943018|NCT05010070|75686668|FG000|Overall Study|Withdrawal by Subject|1|||
41943019|NCT04523480|75686693|FG000|Overall Study|Lost to Follow-up|30|||
41943020|NCT04523480|75686694|FG001|Overall Study|Lost to Follow-up|35|||
41943021|NCT04523480|75686695|FG002|Overall Study|Lost to Follow-up|0|||
41943022|NCT04454125|75686705|FG000|Overall Study|Lost to Follow-up|0|||
41943023|NCT04454125|75686706|FG001|Overall Study|Lost to Follow-up|1|||
41943024|NCT04307446|75686718|FG000|Overall Study|Lost to Follow-up|2|||
41943025|NCT04307446|75686719|FG001|Overall Study|Lost to Follow-up|0|||
41943026|NCT04143009|75686741|FG000|Pilot Trial|Lost to Follow-up|0|||
41943027|NCT04143009|75686742|FG001|Pilot Trial|Lost to Follow-up|1|||
41943028|NCT04143009|75686743|FG002|Pilot Trial|Lost to Follow-up|1|||
41943029|NCT04126317|75686753|FG000|Overall Study|Adverse Event|0|||
41943030|NCT04126317|75686754|FG001|Overall Study|Adverse Event|1|||
41943031|NCT04126317|75686753|FG000|Overall Study|Withdrawal by Subject|4|||
41943032|NCT04126317|75686754|FG001|Overall Study|Withdrawal by Subject|1|||
41943033|NCT04066894|75686760|FG000|Overall Study|Lack of Efficacy|1|||
41943034|NCT04066894|75686760|FG000|Overall Study|Screen Failure|1|||
41943035|NCT03929913|75686786|FG000|Overall Study|Death|4|||
41943036|NCT03929913|75686786|FG000|Overall Study|Lost to Follow-up|1|||
41943037|NCT03929913|75686786|FG000|Overall Study|Failed Procedure|2|||
41943038|NCT03832192|75686801|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
41943039|NCT03832192|75686802|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
41943040|NCT03738800|75686818|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
41943041|NCT03738800|75686819|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
41943042|NCT03738800|75686820|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
41943043|NCT03738800|75686818|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
41943044|NCT03738800|75686819|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
41943045|NCT03738800|75686820|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
41943046|NCT03738800|75686818|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
41943047|NCT03738800|75686819|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
41943048|NCT03738800|75686820|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
41943049|NCT03682055|75686839|FG000|Overall Study|Lack of Efficacy|1|||
41943050|NCT03682055|75686840|FG001|Overall Study|Lack of Efficacy|2|||
41943051|NCT03682055|75686841|FG002|Overall Study|Lack of Efficacy|1|||
41943052|NCT03682055|75686842|FG003|Overall Study|Lack of Efficacy|2|||
41943053|NCT03682055|75686843|FG004|Overall Study|Lack of Efficacy|1|||
41943054|NCT03682055|75686844|FG005|Overall Study|Lack of Efficacy|3|||
41943055|NCT03682055|75686839|FG000|Overall Study|Withdrawal by Subject|0|||
41943056|NCT03682055|75686840|FG001|Overall Study|Withdrawal by Subject|0|||
41943057|NCT03682055|75686841|FG002|Overall Study|Withdrawal by Subject|0|||
41943058|NCT03682055|75686842|FG003|Overall Study|Withdrawal by Subject|0|||
41943059|NCT03682055|75686843|FG004|Overall Study|Withdrawal by Subject|0|||
41943060|NCT03682055|75686844|FG005|Overall Study|Withdrawal by Subject|1|||
41943061|NCT03682055|75686839|FG000|Overall Study|Termination of Study by Sponsor|0|||
41943062|NCT03682055|75686840|FG001|Overall Study|Termination of Study by Sponsor|0|||
41943063|NCT03682055|75686841|FG002|Overall Study|Termination of Study by Sponsor|0|||
41943064|NCT03682055|75686842|FG003|Overall Study|Termination of Study by Sponsor|0|||
41943065|NCT03682055|75686843|FG004|Overall Study|Termination of Study by Sponsor|0|||
41943066|NCT03682055|75686844|FG005|Overall Study|Termination of Study by Sponsor|3|||
41943067|NCT03547518|75686860|FG000|Overall Study|Lost to Follow-up|2|||
41943068|NCT03547518|75686861|FG001|Overall Study|Lost to Follow-up|0|||
41943069|NCT03519347|75686872|FG000|Interventional Crossover Period 1|Death|0|||
41943070|NCT03519347|75686873|FG001|Interventional Crossover Period 1|Death|0|||
41943071|NCT03519347|75686874|FG002|Interventional Crossover Period 1|Death|0|||
41943072|NCT03519347|75686875|FG003|Interventional Crossover Period 1|Death|1|||
41943073|NCT03199638|75686913|FG000|Overall Study|inability to drink glutamine during regularly|0|||
41943074|NCT03199638|75686914|FG001|Overall Study|inability to drink glutamine during regularly|2|||
41943075|NCT03015194|75686933|FG000|Overall Study|Death|10|||
41943076|NCT03015194|75686933|FG000|Overall Study|Withdrawal by Subject|2|||
41943077|NCT02873715|75686944|FG000|Overall Study|Lost to Follow-up|84|||
41943078|NCT02873715|75686945|FG001|Overall Study|Lost to Follow-up|94|||
41943079|NCT02873715|75686944|FG000|Overall Study|Withdrawal by Subject|7|||
41943080|NCT02873715|75686945|FG001|Overall Study|Withdrawal by Subject|26|||
41943081|NCT02536300|75686963|FG000|Overall Study|Investigator's Discretion|17|||
41943082|NCT02536300|75686964|FG001|Overall Study|Investigator's Discretion|11|||
41943083|NCT02536300|75686965|FG002|Overall Study|Investigator's Discretion|2|||
41943084|NCT02536300|75686963|FG000|Overall Study|Progressive Disease|11|||
41943085|NCT02536300|75686964|FG001|Overall Study|Progressive Disease|7|||
41943086|NCT02536300|75686965|FG002|Overall Study|Progressive Disease|6|||
41943087|NCT02536300|75686963|FG000|Overall Study|Study Terminated by Sponsor|6|||
41943088|NCT02536300|75686964|FG001|Overall Study|Study Terminated by Sponsor|4|||
41943089|NCT02536300|75686965|FG002|Overall Study|Study Terminated by Sponsor|7|||
41943090|NCT02536300|75686963|FG000|Overall Study|Death|7|||
41943091|NCT02536300|75686964|FG001|Overall Study|Death|0|||
41943092|NCT02536300|75686965|FG002|Overall Study|Death|5|||
41943093|NCT02536300|75686963|FG000|Overall Study|Withdrew Consent|4|||
41943094|NCT02536300|75686964|FG001|Overall Study|Withdrew Consent|2|||
41943095|NCT02536300|75686965|FG002|Overall Study|Withdrew Consent|0|||
41943096|NCT02536300|75686963|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
41943097|NCT02536300|75686964|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
42010439|NCT00993499|75817612|FG001|Run-in Period (8 Days)|Adverse Event|1|||
41943098|NCT02536300|75686965|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
41943099|NCT02536300|75686963|FG000|Overall Study|Enrolled but Never Treated|0|||
41943100|NCT02536300|75686964|FG001|Overall Study|Enrolled but Never Treated|0|||
41943101|NCT02536300|75686965|FG002|Overall Study|Enrolled but Never Treated|1|||
41943102|NCT02536300|75686963|FG000|Overall Study|Non-compliance With Study Drug|1|||
41943103|NCT02536300|75686964|FG001|Overall Study|Non-compliance With Study Drug|0|||
41943104|NCT02536300|75686965|FG002|Overall Study|Non-compliance With Study Drug|0|||
41943105|NCT02536300|75686963|FG000|Overall Study|Protocol Violation|0|||
41943106|NCT02536300|75686964|FG001|Overall Study|Protocol Violation|1|||
41943107|NCT02536300|75686965|FG002|Overall Study|Protocol Violation|0|||
41943110|NCT01949662|75686993|FG000|Overall Study|Death|9|||
41943111|NCT01949662|75686994|FG001|Overall Study|Death|7|||
41943112|NCT01949662|75686993|FG000|Overall Study|Discharged before an agitation event|8|||
41943113|NCT01949662|75686994|FG001|Overall Study|Discharged before an agitation event|3|||
41943114|NCT01949662|75686993|FG000|Overall Study|Dropped out|1|||
41943115|NCT01949662|75686994|FG001|Overall Study|Dropped out|3|||
41943116|NCT01949662|75686993|FG000|Overall Study|Ineligible|0|||
41943117|NCT01949662|75686994|FG001|Overall Study|Ineligible|1|||
41943118|NCT01856686|75687002|FG000|Overall Study|Lost to Follow-up|5|||
41943119|NCT01856686|75687003|FG001|Overall Study|Lost to Follow-up|11|||
41943120|NCT01770145|75687009|FG000|Baseline|Adverse Event|20|||
41943121|NCT01770145|75687009|FG000|Baseline|Withdrawal by Subject|1|||
41943122|NCT01770145|75687009|FG000|Baseline|Lost to Follow-up|1|||
41943123|NCT01770145|75687009|FG000|Baseline|Unable to define optimal dose|4|||
41943124|NCT01770145|75687009|FG000|Treatment|Adverse Event|3|||
41943125|NCT01770145|75687009|FG000|Treatment|Withdrawal by Subject|1|||
41943126|NCT01749137|75687015|FG000|Overall Study|Adverse Event|4|||
41943127|NCT01749137|75687016|FG001|Overall Study|Adverse Event|4|||
41943128|NCT01749137|75687015|FG000|Overall Study|Lost to Follow-up|2|||
41943129|NCT01749137|75687016|FG001|Overall Study|Lost to Follow-up|3|||
41943130|NCT01749137|75687015|FG000|Overall Study|Physician Decision|1|||
41943131|NCT01749137|75687016|FG001|Overall Study|Physician Decision|0|||
41943132|NCT01749137|75687015|FG000|Overall Study|Withdrawal by Subject|8|||
41943133|NCT01749137|75687016|FG001|Overall Study|Withdrawal by Subject|4|||
41943134|NCT01726582|75687022|FG000|Overall Study|Physician Decision|99|||
41943135|NCT01726582|75687022|FG000|Overall Study|Death|85|||
41943136|NCT00794339|75687037|FG000|Overall Study|Withdrawal by Subject|3|||
41943137|NCT00794339|75687037|FG000|Overall Study|Ineligible|4|||
41943138|NCT00794339|75687037|FG000|Overall Study|Tx prior to ATSM|3|||
41943139|NCT00794339|75687037|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
41943140|NCT00794339|75687037|FG000|Overall Study|Tx not per protocol|1|||
41943141|NCT00506662|75687064|FG000|Overall Study|Adverse Event|0|||
41943142|NCT00506662|75687065|FG001|Overall Study|Adverse Event|2|||
41943143|NCT00506662|75687064|FG000|Overall Study|Lack of Efficacy|1|||
41943144|NCT00506662|75687065|FG001|Overall Study|Lack of Efficacy|0|||
41943145|NCT00506662|75687064|FG000|Overall Study|Protocol Violation|2|||
41943146|NCT00506662|75687065|FG001|Overall Study|Protocol Violation|4|||
41943147|NCT00506662|75687064|FG000|Overall Study|Trial terminated|10|||
41943148|NCT00506662|75687065|FG001|Overall Study|Trial terminated|16|||
41943149|NCT00506662|75687064|FG000|Overall Study|Not recorded|4|||
41943150|NCT00506662|75687065|FG001|Overall Study|Not recorded|6|||
41943151|NCT00161213|75687071|FG000|Overall Study|Withdrawal by Subject|1|||
41943152|NCT00161213|75687071|FG000|Overall Study|Evaluable for toxicity but not response|1|||
41943153|NCT00006436|75687079|FG000|Overall Study|Refused further treatment|2|||
41943154|NCT00006436|75687079|FG000|Overall Study|Declined to participate (before treatment started)|1|||
41943155|NCT03838484|75687302|FG000|Overall Study|Lost to Follow-up|0|||
41943156|NCT03838484|75687303|FG001|Overall Study|Lost to Follow-up|1|||
41943157|NCT03838484|75687304|FG002|Overall Study|Lost to Follow-up|0|||
42022934|NCT01227902|75830321|FG000|Overall Study|Lost to Follow-up|0|||
42300284|NCT02301897|76135423|FG002|Treatment Course 1|Withdrawal by Subject|2|||
42300285|NCT02301897|76135421|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
42022935|NCT01227902|75830322|FG001|Overall Study|Lost to Follow-up|0|||
42300286|NCT02301897|76135422|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
42300287|NCT02301897|76135423|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
41943158|NCT03838484|75687305|FG003|Overall Study|Lost to Follow-up|0|||
41943159|NCT01349192|75687537|FG000|Overall Study|Protocol Violation|0|||
41943160|NCT01349192|75687538|FG001|Overall Study|Protocol Violation|1|||
41943161|NCT01349192|75687537|FG000|Overall Study|Withdrawal by Subject|0|||
41943162|NCT01349192|75687538|FG001|Overall Study|Withdrawal by Subject|2|||
41943163|NCT01349192|75687537|FG000|Overall Study|Lost to Follow-up|1|||
41943164|NCT01349192|75687538|FG001|Overall Study|Lost to Follow-up|3|||
41943165|NCT01349192|75687537|FG000|Overall Study|Failure to adhere to Protocol|2|||
41943166|NCT01349192|75687538|FG001|Overall Study|Failure to adhere to Protocol|0|||
41943167|NCT01721876|75687893|FG000|Overall Study|Not treated|1|||
41943168|NCT01721876|75687894|FG001|Overall Study|Not treated|4|||
41943169|NCT01721876|75687893|FG000|Overall Study|Disease progression / relapse|123|||
41943170|NCT01721876|75687894|FG001|Overall Study|Disease progression / relapse|156|||
41943171|NCT01721876|75687893|FG000|Overall Study|Death|6|||
41943172|NCT01721876|75687894|FG001|Overall Study|Death|13|||
41943173|NCT01721876|75687893|FG000|Overall Study|Adverse Event|41|||
41943174|NCT01721876|75687894|FG001|Overall Study|Adverse Event|165|||
41943175|NCT01721876|75687893|FG000|Overall Study|Protocol Violation|2|||
41943176|NCT01721876|75687894|FG001|Overall Study|Protocol Violation|1|||
41943177|NCT01721876|75687893|FG000|Overall Study|Withdrawal by Subject|15|||
41943178|NCT01721876|75687894|FG001|Overall Study|Withdrawal by Subject|38|||
41943179|NCT01721876|75687893|FG000|Overall Study|Reason not listed|34|||
41943180|NCT01721876|75687894|FG001|Overall Study|Reason not listed|63|||
41943181|NCT01721876|75687893|FG000|Overall Study|Sponsor terminated trial|0|||
41943182|NCT01721876|75687894|FG001|Overall Study|Sponsor terminated trial|4|||
42300288|NCT02301897|76135421|FG000|Treatment Course 2|Lost to Follow-up|0|||
42300289|NCT02301897|76135422|FG001|Treatment Course 2|Lost to Follow-up|2|||
42300290|NCT02301897|76135423|FG002|Treatment Course 2|Lost to Follow-up|0|||
42300291|NCT02301897|76135421|FG000|Treatment Course 2|Pregnancy|0|||
42300292|NCT02301897|76135422|FG001|Treatment Course 2|Pregnancy|1|||
42300293|NCT02301897|76135423|FG002|Treatment Course 2|Pregnancy|1|||
42300294|NCT02301897|76135421|FG000|Treatment Course 2|Withdrawal by Subject|0|||
42300295|NCT02301897|76135422|FG001|Treatment Course 2|Withdrawal by Subject|2|||
41943183|NCT02265510|75688125|FG000|Overall Study|Withdrawal by Subject|1|||
41943184|NCT02265510|75688126|FG001|Overall Study|Withdrawal by Subject|1|||
41943185|NCT02265510|75688127|FG002|Overall Study|Withdrawal by Subject|2|||
41943186|NCT02265510|75688128|FG003|Overall Study|Withdrawal by Subject|1|||
41943187|NCT02265510|75688129|FG004|Overall Study|Withdrawal by Subject|0|||
41943188|NCT02265510|75688130|FG005|Overall Study|Withdrawal by Subject|2|||
41943189|NCT02265510|75688131|FG006|Overall Study|Withdrawal by Subject|0|||
41943190|NCT02265510|75688132|FG007|Overall Study|Withdrawal by Subject|2|||
41943191|NCT02265510|75688133|FG008|Overall Study|Withdrawal by Subject|0|||
41943192|NCT02265510|75688134|FG009|Overall Study|Withdrawal by Subject|0|||
41943193|NCT02265510|75688135|FG010|Overall Study|Withdrawal by Subject|0|||
41943194|NCT02265510|75688136|FG011|Overall Study|Withdrawal by Subject|0|||
41943195|NCT02265510|75688137|FG012|Overall Study|Withdrawal by Subject|1|||
41943196|NCT02265510|75688138|FG013|Overall Study|Withdrawal by Subject|0|||
41943197|NCT02265510|75688125|FG000|Overall Study|Disease Progression|0|||
41943198|NCT02265510|75688126|FG001|Overall Study|Disease Progression|1|||
41943199|NCT02265510|75688127|FG002|Overall Study|Disease Progression|2|||
41943200|NCT02265510|75688128|FG003|Overall Study|Disease Progression|1|||
41943201|NCT02265510|75688129|FG004|Overall Study|Disease Progression|1|||
41943202|NCT02265510|75688130|FG005|Overall Study|Disease Progression|0|||
41943203|NCT02265510|75688131|FG006|Overall Study|Disease Progression|0|||
41943204|NCT02265510|75688132|FG007|Overall Study|Disease Progression|0|||
41943205|NCT02265510|75688133|FG008|Overall Study|Disease Progression|0|||
41943206|NCT02265510|75688134|FG009|Overall Study|Disease Progression|0|||
41943207|NCT02265510|75688135|FG010|Overall Study|Disease Progression|0|||
41943208|NCT02265510|75688136|FG011|Overall Study|Disease Progression|0|||
41943209|NCT02265510|75688137|FG012|Overall Study|Disease Progression|0|||
41943210|NCT02265510|75688138|FG013|Overall Study|Disease Progression|0|||
41943211|NCT02265510|75688125|FG000|Overall Study|Death|2|||
41943212|NCT02265510|75688126|FG001|Overall Study|Death|0|||
41943213|NCT02265510|75688127|FG002|Overall Study|Death|2|||
41943214|NCT02265510|75688128|FG003|Overall Study|Death|2|||
41943215|NCT02265510|75688129|FG004|Overall Study|Death|1|||
41943216|NCT02265510|75688130|FG005|Overall Study|Death|3|||
41943217|NCT02265510|75688131|FG006|Overall Study|Death|2|||
41943218|NCT02265510|75688132|FG007|Overall Study|Death|1|||
41943219|NCT02265510|75688133|FG008|Overall Study|Death|3|||
41943220|NCT02265510|75688134|FG009|Overall Study|Death|3|||
41943221|NCT02265510|75688135|FG010|Overall Study|Death|4|||
41943222|NCT02265510|75688136|FG011|Overall Study|Death|12|||
41943223|NCT02265510|75688137|FG012|Overall Study|Death|7|||
42300296|NCT02301897|76135423|FG002|Treatment Course 2|Withdrawal by Subject|0|||
41943224|NCT02265510|75688138|FG013|Overall Study|Death|6|||
41943225|NCT02265510|75688125|FG000|Overall Study|Lost to Follow-up|0|||
41943226|NCT02265510|75688126|FG001|Overall Study|Lost to Follow-up|0|||
41943227|NCT02265510|75688127|FG002|Overall Study|Lost to Follow-up|0|||
41943228|NCT02265510|75688128|FG003|Overall Study|Lost to Follow-up|0|||
41943229|NCT02265510|75688129|FG004|Overall Study|Lost to Follow-up|1|||
41943230|NCT02265510|75688130|FG005|Overall Study|Lost to Follow-up|0|||
42300297|NCT02301897|76135421|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
42300298|NCT02301897|76135422|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
41943231|NCT02265510|75688131|FG006|Overall Study|Lost to Follow-up|0|||
41943232|NCT02265510|75688132|FG007|Overall Study|Lost to Follow-up|0|||
41943233|NCT02265510|75688133|FG008|Overall Study|Lost to Follow-up|0|||
41943234|NCT02265510|75688134|FG009|Overall Study|Lost to Follow-up|2|||
41943235|NCT02265510|75688135|FG010|Overall Study|Lost to Follow-up|0|||
41943236|NCT02265510|75688136|FG011|Overall Study|Lost to Follow-up|0|||
41943237|NCT02265510|75688137|FG012|Overall Study|Lost to Follow-up|0|||
41943238|NCT02265510|75688138|FG013|Overall Study|Lost to Follow-up|2|||
41943239|NCT02265510|75688125|FG000|Overall Study|Other|0|||
41943240|NCT02265510|75688126|FG001|Overall Study|Other|1|||
41943241|NCT02265510|75688127|FG002|Overall Study|Other|0|||
41943242|NCT02265510|75688128|FG003|Overall Study|Other|0|||
41943243|NCT02265510|75688129|FG004|Overall Study|Other|0|||
41943244|NCT02265510|75688130|FG005|Overall Study|Other|0|||
41943245|NCT02265510|75688131|FG006|Overall Study|Other|0|||
41943246|NCT02265510|75688132|FG007|Overall Study|Other|0|||
41943247|NCT02265510|75688133|FG008|Overall Study|Other|0|||
41943248|NCT02265510|75688134|FG009|Overall Study|Other|0|||
41943249|NCT02265510|75688135|FG010|Overall Study|Other|0|||
41943250|NCT02265510|75688136|FG011|Overall Study|Other|0|||
41943251|NCT02265510|75688137|FG012|Overall Study|Other|0|||
41943252|NCT02265510|75688138|FG013|Overall Study|Other|0|||
41943253|NCT02265510|75688125|FG000|Overall Study|Study Terminated by Sponsor|0|||
41943254|NCT02265510|75688126|FG001|Overall Study|Study Terminated by Sponsor|0|||
41943255|NCT02265510|75688127|FG002|Overall Study|Study Terminated by Sponsor|0|||
41943256|NCT02265510|75688128|FG003|Overall Study|Study Terminated by Sponsor|0|||
41943257|NCT02265510|75688129|FG004|Overall Study|Study Terminated by Sponsor|0|||
41943258|NCT02265510|75688130|FG005|Overall Study|Study Terminated by Sponsor|1|||
41943259|NCT02265510|75688131|FG006|Overall Study|Study Terminated by Sponsor|1|||
41943260|NCT02265510|75688132|FG007|Overall Study|Study Terminated by Sponsor|1|||
41943261|NCT02265510|75688133|FG008|Overall Study|Study Terminated by Sponsor|1|||
41943262|NCT02265510|75688134|FG009|Overall Study|Study Terminated by Sponsor|2|||
41943263|NCT02265510|75688135|FG010|Overall Study|Study Terminated by Sponsor|1|||
41943264|NCT02265510|75688136|FG011|Overall Study|Study Terminated by Sponsor|4|||
41943265|NCT02265510|75688137|FG012|Overall Study|Study Terminated by Sponsor|1|||
41943266|NCT02265510|75688138|FG013|Overall Study|Study Terminated by Sponsor|2|||
41943267|NCT01238211|75688239|FG000|Overall Study|Continues active treatment|31|||
41943268|NCT01238211|75688239|FG000|Overall Study|Adverse Event|7|||
41943269|NCT01238211|75688239|FG000|Overall Study|Death|4|||
41943270|NCT01238211|75688239|FG000|Overall Study|Relapse/Progression|2|||
41943271|NCT01238211|75688239|FG000|Overall Study|Withdrawal by Subject|7|||
41943272|NCT01238211|75688239|FG000|Overall Study|Non-protocol treatment|4|||
41943273|NCT01238211|75688239|FG000|Overall Study|Investigator/Patient Decision|3|||
41943274|NCT02264574|75688415|FG000|Overall Study|Death|21|||
41943275|NCT02264574|75688416|FG001|Overall Study|Death|21|||
41943276|NCT02264574|75688415|FG000|Overall Study|Withdrawal by Subject|8|||
41943277|NCT02264574|75688416|FG001|Overall Study|Withdrawal by Subject|6|||
41943278|NCT02264574|75688415|FG000|Overall Study|Other, Not Specified|0|||
41943279|NCT02264574|75688416|FG001|Overall Study|Other, Not Specified|3|||
41943280|NCT01641900|75688456|FG000|Overall Study|Withdrawal by Subject|2|||
41943281|NCT01641900|75688457|FG001|Overall Study|Withdrawal by Subject|2|||
41943282|NCT01640808|75688522|FG000|Overall Study|Unable to continue dynamic CT|14|||
41943283|NCT01640808|75688523|FG001|Overall Study|Unable to continue dynamic CT|4|||
41943284|NCT01640808|75688522|FG000|Overall Study|Withdrawal by Subject|12|||
41943285|NCT01640808|75688523|FG001|Overall Study|Withdrawal by Subject|4|||
41943286|NCT01640808|75688522|FG000|Overall Study|Lost to Follow-up|4|||
41943287|NCT01640808|75688523|FG001|Overall Study|Lost to Follow-up|0|||
41943288|NCT01640808|75688522|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
41943289|NCT01640808|75688523|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
41943290|NCT01640808|75688522|FG000|Overall Study|Administration of anticancer drugs|2|||
42022936|NCT01227902|75830323|FG002|Overall Study|Lost to Follow-up|1|||
42022937|NCT01227902|75830324|FG003|Overall Study|Lost to Follow-up|2|||
42022938|NCT01227902|75830321|FG000|Overall Study|Physician Decision|0|||
42022939|NCT01227902|75830322|FG001|Overall Study|Physician Decision|1|||
42022940|NCT01227902|75830323|FG002|Overall Study|Physician Decision|1|||
41943291|NCT01640808|75688523|FG001|Overall Study|Administration of anticancer drugs|1|||
41943292|NCT01640808|75688522|FG000|Overall Study|Physician Decision|19|||
41943293|NCT01640808|75688523|FG001|Overall Study|Physician Decision|5|||
41943294|NCT01640808|75688522|FG000|Overall Study|Randomized but not treated|4|||
41943295|NCT01640808|75688523|FG001|Overall Study|Randomized but not treated|2|||
41943296|NCT02263326|75688544|FG000|Overall Study|Lost to Follow-up|1|||
41943297|NCT02263326|75688545|FG001|Overall Study|Lost to Follow-up|1|||
41943298|NCT02260986|75688651|FG000|Overall Study|Adverse Event|24|||
42022941|NCT01227902|75830324|FG003|Overall Study|Physician Decision|0|||
42022942|NCT01227902|75830321|FG000|Overall Study|Withdrawal by Subject|4|||
41943299|NCT02260986|75688652|FG001|Overall Study|Adverse Event|0|||
41943300|NCT02260986|75688653|FG002|Overall Study|Adverse Event|11|||
41943301|NCT02260986|75688651|FG000|Overall Study|Lack of Efficacy|27|||
41943302|NCT02260986|75688652|FG001|Overall Study|Lack of Efficacy|3|||
41943303|NCT02260986|75688653|FG002|Overall Study|Lack of Efficacy|0|||
41943304|NCT02260986|75688651|FG000|Overall Study|Protocol Violation|14|||
41943305|NCT02260986|75688652|FG001|Overall Study|Protocol Violation|5|||
41943306|NCT02260986|75688653|FG002|Overall Study|Protocol Violation|16|||
41943307|NCT02260986|75688651|FG000|Overall Study|Car accident|0|||
41943308|NCT02260986|75688652|FG001|Overall Study|Car accident|0|||
42022943|NCT01227902|75830322|FG001|Overall Study|Withdrawal by Subject|2|||
41943309|NCT02260986|75688653|FG002|Overall Study|Car accident|1|||
41943310|NCT02260986|75688651|FG000|Overall Study|Withdrawal by Subject|17|||
41943311|NCT02260986|75688652|FG001|Overall Study|Withdrawal by Subject|4|||
41943312|NCT02260986|75688653|FG002|Overall Study|Withdrawal by Subject|9|||
41943313|NCT02260986|75688651|FG000|Overall Study|Incorrect randomization|0|||
41943314|NCT02260986|75688652|FG001|Overall Study|Incorrect randomization|1|||
41943315|NCT02260986|75688653|FG002|Overall Study|Incorrect randomization|0|||
41943316|NCT02260986|75688651|FG000|Overall Study|Lack of investigation product supply|2|||
41943317|NCT02260986|75688652|FG001|Overall Study|Lack of investigation product supply|0|||
41943318|NCT02260986|75688653|FG002|Overall Study|Lack of investigation product supply|1|||
41943319|NCT02260986|75688651|FG000|Overall Study|Lost to Follow-up|4|||
41943320|NCT02260986|75688652|FG001|Overall Study|Lost to Follow-up|0|||
41943321|NCT02260986|75688653|FG002|Overall Study|Lost to Follow-up|3|||
41943322|NCT02260986|75688651|FG000|Overall Study|Pregnancy|2|||
41943323|NCT02260986|75688652|FG001|Overall Study|Pregnancy|0|||
41943324|NCT02260986|75688653|FG002|Overall Study|Pregnancy|0|||
41943325|NCT02259582|75688669|FG000|Overall Study|Physician Decision|0|||
41943326|NCT02259582|75688670|FG001|Overall Study|Physician Decision|1|||
41943327|NCT02259582|75688671|FG002|Overall Study|Physician Decision|0|||
41943328|NCT02259582|75688669|FG000|Overall Study|Death|0|||
41943329|NCT02259582|75688670|FG001|Overall Study|Death|0|||
41943330|NCT02259582|75688671|FG002|Overall Study|Death|1|||
41943331|NCT02259582|75688669|FG000|Overall Study|Adverse Event|1|||
41943332|NCT02259582|75688670|FG001|Overall Study|Adverse Event|0|||
41943333|NCT02259582|75688671|FG002|Overall Study|Adverse Event|1|||
41943334|NCT02259582|75688669|FG000|Overall Study|Withdrawal by Subject|0|||
41943335|NCT02259582|75688670|FG001|Overall Study|Withdrawal by Subject|0|||
41943336|NCT02259582|75688671|FG002|Overall Study|Withdrawal by Subject|1|||
41943337|NCT02259582|75688669|FG000|Overall Study|Disease progression|14|||
41943338|NCT02259582|75688670|FG001|Overall Study|Disease progression|15|||
41943339|NCT02259582|75688671|FG002|Overall Study|Disease progression|17|||
41943340|NCT02259582|75688669|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
41943341|NCT02259582|75688670|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
41943342|NCT02259582|75688671|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
41943343|NCT03238651|75688684|FG000|Overall Study|Other|0|||
41943344|NCT03238651|75688685|FG001|Overall Study|Other|0|||
41943345|NCT03238651|75688686|FG002|Overall Study|Other|0|||
41943346|NCT03238651|75688687|FG003|Overall Study|Other|0|||
41943347|NCT03238651|75688688|FG004|Overall Study|Other|1|||
41943348|NCT03238651|75688684|FG000|Overall Study|Progressive Disease|2|||
41943349|NCT03238651|75688685|FG001|Overall Study|Progressive Disease|2|||
41943350|NCT03238651|75688686|FG002|Overall Study|Progressive Disease|2|||
41943351|NCT03238651|75688687|FG003|Overall Study|Progressive Disease|2|||
41943352|NCT03238651|75688688|FG004|Overall Study|Progressive Disease|0|||
41943353|NCT03238651|75688684|FG000|Overall Study|Withdrawal by Subject|0|||
41943354|NCT03238651|75688685|FG001|Overall Study|Withdrawal by Subject|1|||
41943355|NCT03238651|75688686|FG002|Overall Study|Withdrawal by Subject|0|||
41943356|NCT03238651|75688687|FG003|Overall Study|Withdrawal by Subject|1|||
41943357|NCT03238651|75688688|FG004|Overall Study|Withdrawal by Subject|0|||
41943358|NCT03238651|75688684|FG000|Overall Study|Adverse Event|1|||
41943359|NCT03238651|75688685|FG001|Overall Study|Adverse Event|3|||
41943360|NCT03238651|75688686|FG002|Overall Study|Adverse Event|2|||
41943361|NCT03238651|75688687|FG003|Overall Study|Adverse Event|0|||
41943362|NCT03238651|75688688|FG004|Overall Study|Adverse Event|0|||
42022944|NCT01227902|75830323|FG002|Overall Study|Withdrawal by Subject|4|||
42022945|NCT01227902|75830324|FG003|Overall Study|Withdrawal by Subject|3|||
42022946|NCT00946192|75830338|FG000|Overall Study|Lost to Follow-up|6|||
41943363|NCT05346055|75688712|FG000|Overall Study|Withdrawal by Subject|1|||
41943364|NCT05346055|75688712|FG000|Overall Study|Protocol Violation|1|||
41943365|NCT05346055|75688712|FG000|Overall Study|Therapist decision|1|||
41943366|NCT05211739|75688722|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
41943367|NCT05211739|75688723|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
41943368|NCT05211739|75688722|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
41943369|NCT05211739|75688723|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
41943370|NCT05211739|75688722|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
41943371|NCT05211739|75688723|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
41943372|NCT05211739|75688722|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
41943373|NCT05211739|75688723|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
41943374|NCT05085405|75688751|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
41943375|NCT05085405|75688752|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
42022947|NCT00946192|75830339|FG001|Overall Study|Lost to Follow-up|11|||
41943376|NCT05085405|75688753|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
41943377|NCT05085405|75688754|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
42022948|NCT00946192|75830340|FG002|Overall Study|Lost to Follow-up|9|||
42022949|NCT00946192|75830338|FG000|Overall Study|Withdrawal by Subject|10|||
42022950|NCT00946192|75830339|FG001|Overall Study|Withdrawal by Subject|7|||
41943378|NCT05085405|75688755|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
41943379|NCT05085405|75688756|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
41943380|NCT05085405|75688751|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
41943381|NCT05085405|75688752|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
41943382|NCT05085405|75688753|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
41943383|NCT05085405|75688754|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
41943384|NCT05085405|75688755|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
41943385|NCT05085405|75688756|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
41943386|NCT04932941|75688768|FG000|Overall Study|Lost to Follow-up|3|||
41943387|NCT04932941|75688769|FG001|Overall Study|Lost to Follow-up|1|||
41943388|NCT04932941|75688768|FG000|Overall Study|Withdrawal by Subject|7|||
41943389|NCT04932941|75688769|FG001|Overall Study|Withdrawal by Subject|4|||
42300299|NCT02301897|76135423|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
42300300|NCT02301429|76135431|FG000|Overall Study|not acceptable vascular anatomy|3|||
42300301|NCT02300259|76135438|FG000|Period 1|Adverse Event|0|||
42300302|NCT02300259|76135439|FG001|Period 1|Adverse Event|0|||
42300303|NCT02300259|76135440|FG002|Period 1|Adverse Event|1|||
42300304|NCT02300259|76135438|FG000|Period 1|Withdrawal by Subject|0|||
42300305|NCT02300259|76135439|FG001|Period 1|Withdrawal by Subject|0|||
42300306|NCT02300259|76135440|FG002|Period 1|Withdrawal by Subject|1|||
42300307|NCT02300259|76135438|FG000|Period 2|Adverse Event|1|||
42300308|NCT02300259|76135439|FG001|Period 2|Adverse Event|0|||
42300309|NCT02300259|76135440|FG002|Period 2|Adverse Event|0|||
42300310|NCT02300259|76135438|FG000|Period 2|Withdrawal by Subject|0|||
42300311|NCT02300259|76135439|FG001|Period 2|Withdrawal by Subject|0|||
42300312|NCT02300259|76135440|FG002|Period 2|Withdrawal by Subject|1|||
42300313|NCT02367885|76135462|FG000|Overall Study|Lost to Follow-up|1|||
42300314|NCT02367885|76135463|FG001|Overall Study|Lost to Follow-up|0|||
42300315|NCT02367885|76135464|FG002|Overall Study|Lost to Follow-up|0|||
42300316|NCT02367885|76135462|FG000|Overall Study|Withdrawal by Subject|1|||
42300317|NCT02367885|76135463|FG001|Overall Study|Withdrawal by Subject|0|||
42300318|NCT02367885|76135464|FG002|Overall Study|Withdrawal by Subject|0|||
42300319|NCT02367729|76135477|FG000|Overall Study|Organic disorder diagnosed|2|||
41943390|NCT04932941|75688768|FG000|Overall Study|Other|4|||
41943391|NCT04932941|75688769|FG001|Overall Study|Other|2|||
41943392|NCT04662073|75688829|FG000|Overall Study|Withdrawal by Subject|1|||
41943393|NCT04662073|75688830|FG001|Overall Study|Withdrawal by Subject|0|||
41943394|NCT04656418|75688838|FG000|Overall Study|Withdrawal by Subject|1|||
41943395|NCT04656418|75688839|FG001|Overall Study|Withdrawal by Subject|3|||
41943396|NCT04622306|75688846|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
41943397|NCT04622306|75688847|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
41943398|NCT04622306|75688848|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
41943399|NCT04622306|75688849|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
41943400|NCT04622306|75688850|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
41943401|NCT04622306|75688851|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
41943402|NCT04622306|75688846|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
41943403|NCT04622306|75688847|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
41943404|NCT04622306|75688848|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
41943405|NCT04622306|75688849|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
41943406|NCT04622306|75688850|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
41943407|NCT04622306|75688851|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
41943408|NCT04601103|75688863|FG000|Overall Study|Needed crown & cleaning|0|||
41943409|NCT04601103|75688864|FG001|Overall Study|Needed crown & cleaning|0|||
41943410|NCT04601103|75688865|FG002|Overall Study|Needed crown & cleaning|1|||
41943411|NCT04601103|75688863|FG000|Overall Study|study was terminated|18|||
41943412|NCT04601103|75688864|FG001|Overall Study|study was terminated|18|||
41943413|NCT04601103|75688865|FG002|Overall Study|study was terminated|16|||
41943414|NCT04575597|75688879|FG000|Overall Study|Death|0|||
41943415|NCT04575597|75688880|FG001|Overall Study|Death|0|||
41943416|NCT04575597|75688881|FG002|Overall Study|Death|0|||
41943417|NCT04575597|75688882|FG003|Overall Study|Death|1|||
41943418|NCT04575597|75688883|FG004|Overall Study|Death|3|||
41943419|NCT04575597|75688884|FG005|Overall Study|Death|14|||
41943420|NCT04575597|75688879|FG000|Overall Study|Lost to Follow-up|2|||
41943421|NCT04575597|75688880|FG001|Overall Study|Lost to Follow-up|1|||
41943422|NCT04575597|75688881|FG002|Overall Study|Lost to Follow-up|1|||
41943423|NCT04575597|75688882|FG003|Overall Study|Lost to Follow-up|2|||
41943424|NCT04575597|75688883|FG004|Overall Study|Lost to Follow-up|10|||
41943425|NCT04575597|75688884|FG005|Overall Study|Lost to Follow-up|8|||
42022951|NCT00946192|75830340|FG002|Overall Study|Withdrawal by Subject|3|||
42022952|NCT00946192|75830338|FG000|Overall Study|Did not start medication|2|||
42300320|NCT02367729|76135478|FG001|Overall Study|Organic disorder diagnosed|1|||
42300321|NCT02367729|76135477|FG000|Overall Study|Adverse Event|1|||
42300322|NCT02367729|76135478|FG001|Overall Study|Adverse Event|2|||
41943426|NCT04575597|75688879|FG000|Overall Study|Withdrawal by Subject|2|||
41943427|NCT04575597|75688880|FG001|Overall Study|Withdrawal by Subject|2|||
41943428|NCT04575597|75688881|FG002|Overall Study|Withdrawal by Subject|4|||
41943429|NCT04575597|75688882|FG003|Overall Study|Withdrawal by Subject|2|||
41943430|NCT04575597|75688883|FG004|Overall Study|Withdrawal by Subject|25|||
41943431|NCT04575597|75688884|FG005|Overall Study|Withdrawal by Subject|28|||
41943432|NCT04575597|75688879|FG000|Overall Study|Not Recorded|0|||
41943433|NCT04575597|75688880|FG001|Overall Study|Not Recorded|0|||
41943434|NCT04575597|75688881|FG002|Overall Study|Not Recorded|0|||
41943435|NCT04575597|75688882|FG003|Overall Study|Not Recorded|0|||
41943436|NCT04575597|75688883|FG004|Overall Study|Not Recorded|0|||
41943437|NCT04575597|75688884|FG005|Overall Study|Not Recorded|2|||
41943438|NCT04575597|75688879|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
41943439|NCT04575597|75688880|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
41943440|NCT04575597|75688881|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
41943441|NCT04575597|75688882|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
41943442|NCT04575597|75688883|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
41943443|NCT04575597|75688884|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
41943444|NCT04546724|75688906|FG000|Overall Study|Withdrawal by Subject|145|||
41943445|NCT04546724|75688907|FG001|Overall Study|Withdrawal by Subject|41|||
41943446|NCT04546724|75688906|FG000|Overall Study|Adverse Event|1|||
41943447|NCT04546724|75688907|FG001|Overall Study|Adverse Event|1|||
41943448|NCT04546724|75688906|FG000|Overall Study|Lost to Follow-up|186|||
41943449|NCT04546724|75688907|FG001|Overall Study|Lost to Follow-up|63|||
41943450|NCT04546724|75688906|FG000|Overall Study|Physician Decision|8|||
41943451|NCT04546724|75688907|FG001|Overall Study|Physician Decision|2|||
41943452|NCT04546724|75688906|FG000|Overall Study|Death|2|||
41943453|NCT04546724|75688907|FG001|Overall Study|Death|1|||
41943454|NCT04546724|75688906|FG000|Overall Study|subject has been out of town|1|||
41943455|NCT04546724|75688907|FG001|Overall Study|subject has been out of town|0|||
41943456|NCT04546724|75688906|FG000|Overall Study|subject is incarcerated|2|||
41943457|NCT04546724|75688907|FG001|Overall Study|subject is incarcerated|0|||
41943458|NCT04546724|75688906|FG000|Overall Study|subject is relocating|12|||
41943459|NCT04546724|75688907|FG001|Overall Study|subject is relocating|4|||
41943460|NCT04546724|75688906|FG000|Overall Study|Subject in another study|1|||
41943461|NCT04546724|75688907|FG001|Overall Study|Subject in another study|1|||
41943462|NCT04391842|75688923|FG000|Overall Study|Withdrawal by Subject|2|||
41943463|NCT04327024|75688946|FG000|Overall Study|Death|1|||
41943464|NCT04327024|75688947|FG001|Overall Study|Death|2|||
41943465|NCT04327024|75688948|FG002|Overall Study|Death|1|||
41943466|NCT04327024|75688946|FG000|Overall Study|Non-compliance with study drug|0|||
41943467|NCT04327024|75688947|FG001|Overall Study|Non-compliance with study drug|1|||
41943468|NCT04327024|75688948|FG002|Overall Study|Non-compliance with study drug|0|||
41943469|NCT04327024|75688946|FG000|Overall Study|Withdrawal by Subject|1|||
41943470|NCT04327024|75688947|FG001|Overall Study|Withdrawal by Subject|1|||
41943471|NCT04327024|75688948|FG002|Overall Study|Withdrawal by Subject|2|||
41943472|NCT04322149|75688961|FG000|Overall Study|Adverse Event|1|||
41943473|NCT04322149|75688962|FG001|Overall Study|Adverse Event|1|||
41943474|NCT04322149|75688963|FG002|Overall Study|Adverse Event|0|||
41943475|NCT04322149|75688964|FG003|Overall Study|Adverse Event|0|||
41943476|NCT04322149|75688961|FG000|Overall Study|Withdrawal by Subject|0|||
41943477|NCT04322149|75688962|FG001|Overall Study|Withdrawal by Subject|0|||
41943478|NCT04322149|75688963|FG002|Overall Study|Withdrawal by Subject|0|||
41943479|NCT04322149|75688964|FG003|Overall Study|Withdrawal by Subject|2|||
41943480|NCT04322149|75688961|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
41943481|NCT04322149|75688962|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
41943482|NCT04322149|75688963|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
41943483|NCT04322149|75688964|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
41943484|NCT04294459|75688985|FG000|Overall Study|Adverse Event|0|||
41943485|NCT04294459|75688986|FG001|Overall Study|Adverse Event|1|||
41943486|NCT04226742|75688995|FG000|Overall Study|Lost to Follow-up|16|||
41943487|NCT04226742|75688996|FG001|Overall Study|Lost to Follow-up|13|||
41943488|NCT04226742|75688995|FG000|Overall Study|Withdrawal by Subject|5|||
42022953|NCT00946192|75830339|FG001|Overall Study|Did not start medication|0|||
41943489|NCT04226742|75688996|FG001|Overall Study|Withdrawal by Subject|3|||
41943490|NCT04194528|75689002|FG000|Overall Study|Adverse Event|1|||
41943491|NCT04146012|75689034|FG000|Overall Study|Study Terminated|30|||
42022954|NCT00946192|75830340|FG002|Overall Study|Did not start medication|0|||
42022955|NCT01037127|75830350|FG000|Overall Study|Lost to Follow-up|2|||
41943492|NCT04146012|75689035|FG001|Overall Study|Study Terminated|15|||
41943493|NCT04085458|75689041|FG000|Overall Study|Other|1|||
41943494|NCT04085458|75689041|FG000|Overall Study|Withdrawal by Subject|2|||
41943495|NCT04085458|75689041|FG000|Overall Study|Adverse Event|2|||
41943496|NCT04033159|75689047|FG000|Washout Period|Physician Decision|0|||
41943497|NCT04033159|75689048|FG001|Washout Period|Physician Decision|1|||
41943498|NCT04033159|75689049|FG002|Washout Period|Physician Decision|0|||
41943499|NCT04033159|75689047|FG000|Washout Period|Study terminated by Sponsor|0|||
41943500|NCT04033159|75689048|FG001|Washout Period|Study terminated by Sponsor|7|||
41943501|NCT04033159|75689049|FG002|Washout Period|Study terminated by Sponsor|0|||
41943502|NCT04033159|75689047|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
41943503|NCT04033159|75689048|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
41943504|NCT04033159|75689049|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
41943505|NCT03969888|75689065|FG000|Overall Study|Never Received Study Drug|0|||
41943506|NCT03969888|75689066|FG001|Overall Study|Never Received Study Drug|0|||
41943507|NCT03969888|75689067|FG002|Overall Study|Never Received Study Drug|1|||
41943508|NCT03969888|75689068|FG003|Overall Study|Never Received Study Drug|0|||
41943509|NCT03969888|75689069|FG004|Overall Study|Never Received Study Drug|0|||
41943510|NCT03969888|75689070|FG005|Overall Study|Never Received Study Drug|0|||
41943511|NCT03969888|75689071|FG006|Overall Study|Never Received Study Drug|1|||
41943512|NCT03969888|75689072|FG007|Overall Study|Never Received Study Drug|0|||
41943513|NCT03969888|75689065|FG000|Overall Study|Reason Not Specified|0|||
41943514|NCT03969888|75689066|FG001|Overall Study|Reason Not Specified|0|||
41943515|NCT03969888|75689067|FG002|Overall Study|Reason Not Specified|0|||
41943516|NCT03969888|75689068|FG003|Overall Study|Reason Not Specified|0|||
41943517|NCT03969888|75689069|FG004|Overall Study|Reason Not Specified|0|||
41943518|NCT03969888|75689070|FG005|Overall Study|Reason Not Specified|0|||
41943519|NCT03969888|75689071|FG006|Overall Study|Reason Not Specified|0|||
41943520|NCT03969888|75689072|FG007|Overall Study|Reason Not Specified|1|||
41943521|NCT03952559|75689096|FG000|Double Blind Treatment Period|Adverse Event|0|||
41943522|NCT03952559|75689097|FG001|Double Blind Treatment Period|Adverse Event|2|||
41943523|NCT03952559|75689098|FG002|Double Blind Treatment Period|Adverse Event|1|||
41943524|NCT03952559|75689099|FG003|Double Blind Treatment Period|Adverse Event|0|||
41943525|NCT03952559|75689100|FG004|Double Blind Treatment Period|Adverse Event|1|||
41943526|NCT03952559|75689096|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
41943527|NCT03952559|75689097|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
41943528|NCT03952559|75689098|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
41943529|NCT03952559|75689099|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
41943530|NCT03952559|75689100|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
41943531|NCT03952559|75689096|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
41943532|NCT03952559|75689097|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
41943533|NCT03952559|75689098|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
41943534|NCT03952559|75689099|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
41943535|NCT03952559|75689100|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
41943536|NCT03952559|75689096|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
41943537|NCT03952559|75689097|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
41943538|NCT03952559|75689098|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
41943539|NCT03952559|75689099|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
41943540|NCT03952559|75689100|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
41943541|NCT03945175|75689136|FG000|Overall Study|Did not meet inclusion criteria|31|||
41943542|NCT03945175|75689136|FG000|Overall Study|Withdrew consent|2|||
41943543|NCT03945175|75689136|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
41943544|NCT03945175|75689136|FG000|Overall Study|Early termination during Mydayis treatment|1|||
41943545|NCT03942406|75689147|FG000|Overall Study|Lost to Follow-up|4|||
41943546|NCT03942406|75689148|FG001|Overall Study|Lost to Follow-up|5|||
41943547|NCT03942406|75689149|FG002|Overall Study|Lost to Follow-up|3|||
41943548|NCT03942406|75689150|FG003|Overall Study|Lost to Follow-up|7|||
41943549|NCT03942406|75689151|FG004|Overall Study|Lost to Follow-up|1|||
41943550|NCT03942406|75689152|FG005|Overall Study|Lost to Follow-up|0|||
41943551|NCT03942406|75689153|FG006|Overall Study|Lost to Follow-up|0|||
41943552|NCT03942406|75689147|FG000|Overall Study|Withdrawal by Subject|3|||
41943553|NCT03942406|75689148|FG001|Overall Study|Withdrawal by Subject|1|||
41943554|NCT03942406|75689149|FG002|Overall Study|Withdrawal by Subject|1|||
41943555|NCT03942406|75689150|FG003|Overall Study|Withdrawal by Subject|3|||
41943556|NCT03942406|75689151|FG004|Overall Study|Withdrawal by Subject|0|||
41943557|NCT03942406|75689152|FG005|Overall Study|Withdrawal by Subject|0|||
42022956|NCT01037127|75830351|FG001|Overall Study|Lost to Follow-up|4|||
41943558|NCT03942406|75689153|FG006|Overall Study|Withdrawal by Subject|0|||
41943559|NCT03942406|75689147|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
41943560|NCT03942406|75689148|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
41943561|NCT03942406|75689149|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
41943562|NCT03942406|75689150|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
41943563|NCT03942406|75689151|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
41943564|NCT03942406|75689152|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
41943565|NCT03942406|75689153|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
42022957|NCT01037127|75830350|FG000|Overall Study|Physician Decision|1|||
41943566|NCT03909100|75689187|FG000|Overall Study|Protocol Deviation|2|||
41943567|NCT03909100|75689187|FG000|Overall Study|Technical Problems|4|||
41943568|NCT03909100|75689187|FG000|Overall Study|Withdrawal by Subject|4|||
41943569|NCT03909100|75689187|FG000|Overall Study|Lost to Follow-up|1|||
41943570|NCT03909100|75689187|FG000|Overall Study|Reason not Specified|4|||
41943571|NCT03896295|75689209|FG000|Overall Study|Adverse Event|0|||
41943572|NCT03896295|75689210|FG001|Overall Study|Adverse Event|1|||
41943573|NCT03896295|75689209|FG000|Overall Study|COVID-19|7|||
41943574|NCT03896295|75689210|FG001|Overall Study|COVID-19|29|||
41943575|NCT03734666|75689251|FG000|Overall Study|Other|7|||
41943576|NCT03734666|75689252|FG001|Overall Study|Other|4|||
41943577|NCT03734666|75689251|FG000|Overall Study|Lost to Follow-up|12|||
41943578|NCT03734666|75689252|FG001|Overall Study|Lost to Follow-up|12|||
41943579|NCT03635489|75689265|FG000|Overall Study|Death|6|||
41943580|NCT03635489|75689266|FG001|Overall Study|Death|3|||
41943581|NCT03635489|75689265|FG000|Overall Study|Lost to Follow-up|0|||
41943582|NCT03635489|75689266|FG001|Overall Study|Lost to Follow-up|1|||
41943583|NCT03635489|75689265|FG000|Overall Study|Withdrawal by Subject|1|||
41943584|NCT03635489|75689266|FG001|Overall Study|Withdrawal by Subject|2|||
41943585|NCT03633617|75689277|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
41943586|NCT03633617|75689278|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
41943587|NCT03633617|75689279|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
41943588|NCT03633617|75689280|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
41943589|NCT03633617|75689281|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
41943590|NCT03633617|75689282|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
41943591|NCT03633617|75689283|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
41943592|NCT03633617|75689284|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
41943593|NCT03633617|75689285|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
41943594|NCT03633617|75689286|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
41943595|NCT03633617|75689287|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
41943596|NCT03633617|75689277|FG000|Part A|Unconfirmed early termination visit|1|||
41943597|NCT03633617|75689278|FG001|Part A|Unconfirmed early termination visit|0|||
41943598|NCT03633617|75689279|FG002|Part A|Unconfirmed early termination visit|0|||
41943599|NCT03633617|75689280|FG003|Part A|Unconfirmed early termination visit|0|||
41943600|NCT03633617|75689281|FG004|Part A|Unconfirmed early termination visit|0|||
41943601|NCT03633617|75689282|FG005|Part A|Unconfirmed early termination visit|0|||
41943602|NCT03633617|75689283|FG006|Part A|Unconfirmed early termination visit|0|||
41943603|NCT03633617|75689284|FG007|Part A|Unconfirmed early termination visit|0|||
41943604|NCT03633617|75689285|FG008|Part A|Unconfirmed early termination visit|0|||
41943605|NCT03633617|75689286|FG009|Part A|Unconfirmed early termination visit|0|||
41943606|NCT03633617|75689287|FG010|Part A|Unconfirmed early termination visit|0|||
41943607|NCT03633617|75689277|FG000|Part A|Adverse Event|0|||
41943608|NCT03633617|75689278|FG001|Part A|Adverse Event|1|||
41943609|NCT03633617|75689279|FG002|Part A|Adverse Event|0|||
41943610|NCT03633617|75689280|FG003|Part A|Adverse Event|0|||
41943611|NCT03633617|75689281|FG004|Part A|Adverse Event|0|||
41943612|NCT03633617|75689282|FG005|Part A|Adverse Event|0|||
41943613|NCT03633617|75689283|FG006|Part A|Adverse Event|0|||
41943614|NCT03633617|75689284|FG007|Part A|Adverse Event|0|||
42022958|NCT01037127|75830351|FG001|Overall Study|Physician Decision|0|||
42022959|NCT01037127|75830350|FG000|Overall Study|Study Closed Terminated|2|||
42022960|NCT01037127|75830351|FG001|Overall Study|Study Closed Terminated|17|||
42022961|NCT00946114|75830369|FG000|Overall Study|Death|5|||
42022962|NCT00946114|75830370|FG001|Overall Study|Death|2|||
42022963|NCT00946114|75830369|FG000|Overall Study|Other|1|||
42022964|NCT00946114|75830370|FG001|Overall Study|Other|0|||
42022965|NCT00946114|75830369|FG000|Overall Study|Withdrawal by Subject|2|||
41943615|NCT03633617|75689285|FG008|Part A|Adverse Event|0|||
41943616|NCT03633617|75689286|FG009|Part A|Adverse Event|0|||
42022966|NCT00946114|75830370|FG001|Overall Study|Withdrawal by Subject|0|||
42300323|NCT02367729|76135477|FG000|Overall Study|Withdrawal by Subject|0|||
42022967|NCT01038921|75830378|FG000|Overall Study|Withdrawal by Subject|1|||
41943617|NCT03633617|75689287|FG010|Part A|Adverse Event|0|||
41943618|NCT03633617|75689277|FG000|Part A|Pregnancy|1|||
41943619|NCT03633617|75689278|FG001|Part A|Pregnancy|0|||
41943620|NCT03633617|75689279|FG002|Part A|Pregnancy|0|||
41943621|NCT03633617|75689280|FG003|Part A|Pregnancy|0|||
41943622|NCT03633617|75689281|FG004|Part A|Pregnancy|0|||
41943623|NCT03633617|75689282|FG005|Part A|Pregnancy|0|||
41943624|NCT03633617|75689283|FG006|Part A|Pregnancy|0|||
41943625|NCT03633617|75689284|FG007|Part A|Pregnancy|0|||
41943626|NCT03633617|75689285|FG008|Part A|Pregnancy|0|||
41943627|NCT03633617|75689286|FG009|Part A|Pregnancy|0|||
42022968|NCT01038921|75830379|FG001|Overall Study|Withdrawal by Subject|0|||
42022969|NCT01038921|75830378|FG000|Overall Study|Physician Decision|1|||
41943628|NCT03633617|75689287|FG010|Part A|Pregnancy|0|||
42022970|NCT01038921|75830379|FG001|Overall Study|Physician Decision|0|||
42022971|NCT01038687|75830388|FG000|Overall Study|Adverse Event|0|||
42022972|NCT01038687|75830389|FG001|Overall Study|Adverse Event|2|||
42022973|NCT01038687|75830390|FG002|Overall Study|Adverse Event|1|||
42022974|NCT01081912|75830398|FG000|Conversion/Titration|Adverse Event|47|||
42022975|NCT01081912|75830399|FG001|Conversion/Titration|Adverse Event|0|||
42022976|NCT01081912|75830400|FG002|Conversion/Titration|Adverse Event|0|||
42022977|NCT01081912|75830398|FG000|Conversion/Titration|Lack of Efficacy|17|||
42022978|NCT01081912|75830399|FG001|Conversion/Titration|Lack of Efficacy|0|||
42022979|NCT01081912|75830400|FG002|Conversion/Titration|Lack of Efficacy|0|||
42022980|NCT01081912|75830398|FG000|Conversion/Titration|Lost to Follow-up|5|||
42022981|NCT01081912|75830399|FG001|Conversion/Titration|Lost to Follow-up|0|||
42022982|NCT01081912|75830400|FG002|Conversion/Titration|Lost to Follow-up|0|||
42022983|NCT01081912|75830398|FG000|Conversion/Titration|Physician Decision|2|||
42022984|NCT01081912|75830399|FG001|Conversion/Titration|Physician Decision|0|||
42022985|NCT01081912|75830400|FG002|Conversion/Titration|Physician Decision|0|||
42022986|NCT01081912|75830398|FG000|Conversion/Titration|Protocol Violation|67|||
42022987|NCT01081912|75830399|FG001|Conversion/Titration|Protocol Violation|0|||
42022988|NCT01081912|75830400|FG002|Conversion/Titration|Protocol Violation|0|||
42022989|NCT01081912|75830398|FG000|Conversion/Titration|Withdrawal by Subject|23|||
42022990|NCT01081912|75830399|FG001|Conversion/Titration|Withdrawal by Subject|0|||
42022991|NCT01081912|75830400|FG002|Conversion/Titration|Withdrawal by Subject|0|||
42022992|NCT01081912|75830398|FG000|Conversion/Titration|Non-Compliance|47|||
42022993|NCT01081912|75830399|FG001|Conversion/Titration|Non-Compliance|0|||
42022994|NCT01081912|75830400|FG002|Conversion/Titration|Non-Compliance|0|||
42022995|NCT01081912|75830398|FG000|Maintenance Treatment|Adverse Event|0|||
42022996|NCT01081912|75830399|FG001|Maintenance Treatment|Adverse Event|2|||
42022997|NCT01081912|75830400|FG002|Maintenance Treatment|Adverse Event|12|||
42022998|NCT01081912|75830398|FG000|Maintenance Treatment|Lack of Efficacy|0|||
42022999|NCT01081912|75830399|FG001|Maintenance Treatment|Lack of Efficacy|14|||
42023000|NCT01081912|75830400|FG002|Maintenance Treatment|Lack of Efficacy|64|||
42023001|NCT01081912|75830398|FG000|Maintenance Treatment|Lost to Follow-up|0|||
42023002|NCT01081912|75830399|FG001|Maintenance Treatment|Lost to Follow-up|1|||
42023003|NCT01081912|75830400|FG002|Maintenance Treatment|Lost to Follow-up|0|||
42023004|NCT01081912|75830398|FG000|Maintenance Treatment|Physician Decision|0|||
42023005|NCT01081912|75830399|FG001|Maintenance Treatment|Physician Decision|0|||
42023006|NCT01081912|75830400|FG002|Maintenance Treatment|Physician Decision|1|||
42023007|NCT01081912|75830398|FG000|Maintenance Treatment|Protocol Violation|0|||
42023008|NCT01081912|75830399|FG001|Maintenance Treatment|Protocol Violation|1|||
42023009|NCT01081912|75830400|FG002|Maintenance Treatment|Protocol Violation|2|||
42023010|NCT01081912|75830398|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
42023011|NCT01081912|75830399|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
42023012|NCT01081912|75830400|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
42023013|NCT01081912|75830398|FG000|Maintenance Treatment|Non-Compliance|0|||
42023014|NCT01081912|75830399|FG001|Maintenance Treatment|Non-Compliance|4|||
42023015|NCT01081912|75830400|FG002|Maintenance Treatment|Non-Compliance|7|||
42023016|NCT01081912|75830398|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
41943629|NCT03633617|75689277|FG000|Part A|Withdrawal by Subject|0|||
41943630|NCT03633617|75689278|FG001|Part A|Withdrawal by Subject|1|||
41943631|NCT03633617|75689279|FG002|Part A|Withdrawal by Subject|0|||
41943632|NCT03633617|75689280|FG003|Part A|Withdrawal by Subject|0|||
41943633|NCT03633617|75689281|FG004|Part A|Withdrawal by Subject|0|||
41943634|NCT03633617|75689282|FG005|Part A|Withdrawal by Subject|0|||
41943635|NCT03633617|75689283|FG006|Part A|Withdrawal by Subject|0|||
41943636|NCT03633617|75689284|FG007|Part A|Withdrawal by Subject|0|||
41943637|NCT03633617|75689285|FG008|Part A|Withdrawal by Subject|0|||
41943638|NCT03633617|75689286|FG009|Part A|Withdrawal by Subject|0|||
41943639|NCT03633617|75689287|FG010|Part A|Withdrawal by Subject|0|||
41943640|NCT03633617|75689277|FG000|Part B|Adverse Event|0|||
41943641|NCT03633617|75689278|FG001|Part B|Adverse Event|0|||
41943642|NCT03633617|75689279|FG002|Part B|Adverse Event|2|||
41943643|NCT03633617|75689280|FG003|Part B|Adverse Event|2|||
41943644|NCT03633617|75689281|FG004|Part B|Adverse Event|1|||
41943645|NCT03633617|75689282|FG005|Part B|Adverse Event|0|||
41943646|NCT03633617|75689283|FG006|Part B|Adverse Event|0|||
41943647|NCT03633617|75689284|FG007|Part B|Adverse Event|0|||
41943648|NCT03633617|75689285|FG008|Part B|Adverse Event|0|||
41943649|NCT03633617|75689286|FG009|Part B|Adverse Event|0|||
41943650|NCT03633617|75689287|FG010|Part B|Adverse Event|0|||
41943651|NCT03633617|75689277|FG000|Part B|Withdrawal by Subject|0|||
41943652|NCT03633617|75689278|FG001|Part B|Withdrawal by Subject|0|||
42023017|NCT01081912|75830399|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
42023018|NCT01081912|75830400|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
42023019|NCT01038609|75830412|FG000|Overall Study|Adverse Event|0|||
42023020|NCT01038609|75830413|FG001|Overall Study|Adverse Event|0|||
42023021|NCT01038609|75830414|FG002|Overall Study|Adverse Event|1|||
42023022|NCT01038609|75830415|FG003|Overall Study|Adverse Event|0|||
42023023|NCT01038609|75830416|FG004|Overall Study|Adverse Event|0|||
42023024|NCT01038609|75830412|FG000|Overall Study|Dosing Error|0|||
42023025|NCT01038609|75830413|FG001|Overall Study|Dosing Error|0|||
42023026|NCT01038609|75830414|FG002|Overall Study|Dosing Error|0|||
42023027|NCT01038609|75830415|FG003|Overall Study|Dosing Error|1|||
42023028|NCT01038609|75830416|FG004|Overall Study|Dosing Error|1|||
42023029|NCT01038609|75830412|FG000|Overall Study|Death in the Family|1|||
42023030|NCT01038609|75830413|FG001|Overall Study|Death in the Family|0|||
42023031|NCT01038609|75830414|FG002|Overall Study|Death in the Family|0|||
42023032|NCT01038609|75830415|FG003|Overall Study|Death in the Family|0|||
42023033|NCT01038609|75830416|FG004|Overall Study|Death in the Family|0|||
42023034|NCT01038609|75830412|FG000|Overall Study|Refusal of Blood Draws|0|||
42023035|NCT01038609|75830413|FG001|Overall Study|Refusal of Blood Draws|1|||
42023036|NCT01038609|75830414|FG002|Overall Study|Refusal of Blood Draws|0|||
42023037|NCT01038609|75830415|FG003|Overall Study|Refusal of Blood Draws|0|||
42023038|NCT01038609|75830416|FG004|Overall Study|Refusal of Blood Draws|0|||
42023039|NCT02357134|75830432|FG000|Overall Study|Lost to Follow-up|1|||
42023040|NCT02357134|75830433|FG001|Overall Study|Lost to Follow-up|0|||
42023041|NCT02357134|75830434|FG002|Overall Study|Lost to Follow-up|0|||
42023042|NCT02357134|75830435|FG003|Overall Study|Lost to Follow-up|0|||
42023043|NCT00745420|75830445|FG000|Overall Study|Ineligible|1|||
42023044|NCT02853370|75830449|FG000|Overall Study|Physician Decision|1|||
42023045|NCT02853370|75830449|FG000|Overall Study|Lack of Efficacy|2|||
42023046|NCT02853370|75830449|FG000|Overall Study|Death|1|||
42023047|NCT02853370|75830449|FG000|Overall Study|Adverse Event|4|||
42023048|NCT02853370|75830449|FG000|Overall Study|Withdrawal by Subject|3|||
42023049|NCT01879072|75830454|FG000|Overall Study|Withdrawal by Subject|121|||
42023050|NCT01879072|75830454|FG000|Overall Study|Not Transplanted|30|||
42023051|NCT00954538|75830460|FG000|Part III|Withdrawal by Subject|0|||
42023052|NCT00954538|75830461|FG001|Part III|Withdrawal by Subject|0|||
42023053|NCT00954538|75830462|FG002|Part III|Withdrawal by Subject|0|||
42023054|NCT00954538|75830463|FG003|Part III|Withdrawal by Subject|0|||
42023055|NCT00954538|75830464|FG004|Part III|Withdrawal by Subject|1|||
42023056|NCT00954538|75830465|FG005|Part III|Withdrawal by Subject|0|||
42023057|NCT00943852|75830474|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
42023058|NCT00943852|75830475|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
42023059|NCT00943852|75830476|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
42023060|NCT00943852|75830477|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
42023061|NCT00943852|75830478|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
42023062|NCT00943852|75830479|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
42023063|NCT00943852|75830480|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
42023064|NCT00943852|75830481|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
42023065|NCT00943852|75830482|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
42023066|NCT00943852|75830483|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
42023067|NCT00943852|75830474|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
41943653|NCT03633617|75689279|FG002|Part B|Withdrawal by Subject|1|||
41943654|NCT03633617|75689280|FG003|Part B|Withdrawal by Subject|0|||
41943655|NCT03633617|75689281|FG004|Part B|Withdrawal by Subject|2|||
41943656|NCT03633617|75689282|FG005|Part B|Withdrawal by Subject|0|||
41943657|NCT03633617|75689283|FG006|Part B|Withdrawal by Subject|0|||
41943658|NCT03633617|75689284|FG007|Part B|Withdrawal by Subject|0|||
41943659|NCT03633617|75689285|FG008|Part B|Withdrawal by Subject|0|||
41943660|NCT03633617|75689286|FG009|Part B|Withdrawal by Subject|0|||
41943661|NCT03633617|75689287|FG010|Part B|Withdrawal by Subject|0|||
41943662|NCT03633617|75689277|FG000|Part B|Lost to Follow-up|0|||
41943663|NCT03633617|75689278|FG001|Part B|Lost to Follow-up|0|||
41943664|NCT03633617|75689279|FG002|Part B|Lost to Follow-up|0|||
41943665|NCT03633617|75689280|FG003|Part B|Lost to Follow-up|0|||
41943666|NCT03633617|75689281|FG004|Part B|Lost to Follow-up|1|||
41943667|NCT03633617|75689282|FG005|Part B|Lost to Follow-up|0|||
41943668|NCT03633617|75689283|FG006|Part B|Lost to Follow-up|0|||
41943669|NCT03633617|75689284|FG007|Part B|Lost to Follow-up|0|||
41943670|NCT03633617|75689285|FG008|Part B|Lost to Follow-up|0|||
41943671|NCT03633617|75689286|FG009|Part B|Lost to Follow-up|0|||
41943672|NCT03633617|75689287|FG010|Part B|Lost to Follow-up|0|||
41943673|NCT03633617|75689277|FG000|Part B|Physician Decision|0|||
41943674|NCT03633617|75689278|FG001|Part B|Physician Decision|0|||
41943675|NCT03633617|75689279|FG002|Part B|Physician Decision|0|||
41943676|NCT03633617|75689280|FG003|Part B|Physician Decision|0|||
41943677|NCT03633617|75689281|FG004|Part B|Physician Decision|1|||
41943678|NCT03633617|75689282|FG005|Part B|Physician Decision|0|||
42023068|NCT00943852|75830475|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
42023069|NCT00943852|75830476|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
41943679|NCT03633617|75689283|FG006|Part B|Physician Decision|0|||
41943680|NCT03633617|75689284|FG007|Part B|Physician Decision|0|||
41943681|NCT03633617|75689285|FG008|Part B|Physician Decision|0|||
41943682|NCT03633617|75689286|FG009|Part B|Physician Decision|0|||
41943683|NCT03633617|75689287|FG010|Part B|Physician Decision|0|||
42023070|NCT00943852|75830477|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
42023071|NCT00943852|75830478|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
42023072|NCT00943852|75830479|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
42023073|NCT00943852|75830480|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
42023074|NCT00943852|75830481|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
42023075|NCT00943852|75830482|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
42023076|NCT00943852|75830483|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
42023077|NCT00943852|75830474|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
42023078|NCT00943852|75830475|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
42023079|NCT00943852|75830476|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
42023080|NCT00943852|75830477|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
42023081|NCT00943852|75830478|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
42023082|NCT00943852|75830479|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
42023083|NCT00943852|75830480|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
42023084|NCT00943852|75830481|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
42023085|NCT00943852|75830482|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
42023086|NCT00943852|75830483|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
42023087|NCT00943852|75830474|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
42023088|NCT00943852|75830475|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
42023089|NCT00943852|75830476|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
42023090|NCT00943852|75830477|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
42023091|NCT00943852|75830478|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
42023092|NCT00943852|75830479|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
42023093|NCT00943852|75830480|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
42023094|NCT00943852|75830481|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
42023095|NCT00943852|75830482|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
42023096|NCT00943852|75830483|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
42023097|NCT00943852|75830474|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
42023098|NCT00943852|75830475|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
42023099|NCT00943852|75830476|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
42023100|NCT00943852|75830477|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
42023101|NCT00943852|75830478|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
42023102|NCT00943852|75830479|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
42023103|NCT00943852|75830480|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
42023104|NCT00943852|75830481|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
42023105|NCT00943852|75830482|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
42023106|NCT00943852|75830483|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
42023107|NCT00952276|75830498|FG000|Overall Study|Withdrawal by Subject|1|||
42023108|NCT00952276|75830499|FG001|Overall Study|Withdrawal by Subject|0|||
42023109|NCT00952276|75830500|FG002|Overall Study|Withdrawal by Subject|0|||
42023110|NCT00952276|75830501|FG003|Overall Study|Withdrawal by Subject|1|||
42023111|NCT00952276|75830502|FG004|Overall Study|Withdrawal by Subject|0|||
42023112|NCT00943384|75830514|FG000|Overall Study|Dispositioned prior to treatment|23|||
42023113|NCT00943384|75830514|FG000|Overall Study|Treated off protocol-protocol violation|5|||
42023114|NCT00943384|75830514|FG000|Overall Study|Lost to Follow-up|16|||
42023115|NCT00943384|75830514|FG000|Overall Study|Withdrawal by Subject|5|||
42023116|NCT00943306|75830518|FG000|Overall Study|Physician Decision|1|||
42023117|NCT00943306|75830518|FG000|Overall Study|Death|1|||
42023118|NCT00943306|75830518|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
42023119|NCT01198002|75830525|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
42023120|NCT01198002|75830526|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
42023121|NCT01198002|75830527|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
42023122|NCT01198002|75830525|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
41943684|NCT03633617|75689277|FG000|Part B|COVID-19 Restrictions|0|||
41943685|NCT03633617|75689278|FG001|Part B|COVID-19 Restrictions|0|||
41943686|NCT03633617|75689279|FG002|Part B|COVID-19 Restrictions|1|||
41943687|NCT03633617|75689280|FG003|Part B|COVID-19 Restrictions|0|||
41943688|NCT03633617|75689281|FG004|Part B|COVID-19 Restrictions|0|||
41943689|NCT03633617|75689282|FG005|Part B|COVID-19 Restrictions|0|||
41943690|NCT03633617|75689283|FG006|Part B|COVID-19 Restrictions|0|||
41943691|NCT03633617|75689284|FG007|Part B|COVID-19 Restrictions|0|||
41943692|NCT03633617|75689285|FG008|Part B|COVID-19 Restrictions|0|||
41943693|NCT03633617|75689286|FG009|Part B|COVID-19 Restrictions|0|||
41943694|NCT03633617|75689287|FG010|Part B|COVID-19 Restrictions|0|||
42023123|NCT01198002|75830526|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
42023124|NCT01198002|75830527|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
42023125|NCT01198002|75830525|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
42023126|NCT01198002|75830526|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
42023127|NCT01198002|75830527|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
42023128|NCT01198002|75830525|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
42023129|NCT01198002|75830526|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
42023130|NCT01198002|75830527|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
42023131|NCT01198002|75830525|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
42023132|NCT01198002|75830526|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
42023133|NCT01198002|75830527|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
42023134|NCT01198002|75830525|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
42023135|NCT01198002|75830526|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
42023136|NCT01198002|75830527|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
42023137|NCT01198002|75830525|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
42023138|NCT01198002|75830526|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
42023139|NCT01198002|75830527|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
42023140|NCT01198002|75830525|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
42023141|NCT01198002|75830526|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
42023142|NCT01198002|75830527|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
42023143|NCT01198002|75830525|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
42023144|NCT01198002|75830526|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
42023145|NCT01198002|75830527|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
42023146|NCT01198002|75830525|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
42023147|NCT01198002|75830526|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
42023148|NCT01198002|75830527|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
42023149|NCT01198002|75830525|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
42023150|NCT01198002|75830526|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
42023151|NCT01198002|75830527|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
42023152|NCT01198002|75830525|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
42023153|NCT01198002|75830526|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
42023154|NCT01198002|75830527|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
42023155|NCT01198002|75830525|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
42023156|NCT01198002|75830526|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
42023157|NCT01198002|75830527|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
42023158|NCT01198002|75830525|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
42023159|NCT01198002|75830526|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
42023160|NCT01198002|75830527|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
42023161|NCT01198002|75830525|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
42023162|NCT01198002|75830526|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
42023163|NCT01198002|75830527|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
42023164|NCT01197534|75830560|FG000|Overall Study|Not reported|16|||
42023165|NCT01197534|75830561|FG001|Overall Study|Not reported|10|||
42023166|NCT01197534|75830562|FG002|Overall Study|Not reported|16|||
42023167|NCT01197534|75830560|FG000|Overall Study|Enrolment in long term extension|57|||
42023168|NCT01197534|75830561|FG001|Overall Study|Enrolment in long term extension|66|||
42023169|NCT01197534|75830562|FG002|Overall Study|Enrolment in long term extension|119|||
42023170|NCT01197534|75830560|FG000|Overall Study|Severe non-compliance to protocol|3|||
42023171|NCT01197534|75830561|FG001|Overall Study|Severe non-compliance to protocol|4|||
42023172|NCT01197534|75830562|FG002|Overall Study|Severe non-compliance to protocol|1|||
42023173|NCT01197534|75830560|FG000|Overall Study|Lack of therapeutic response|9|||
42023174|NCT01197534|75830561|FG001|Overall Study|Lack of therapeutic response|4|||
42023175|NCT01197534|75830562|FG002|Overall Study|Lack of therapeutic response|9|||
42023176|NCT01197534|75830560|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
42023177|NCT01197534|75830561|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
42023178|NCT01197534|75830562|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
42023179|NCT01197534|75830560|FG000|Overall Study|Lost to Follow-up|1|||
42023180|NCT01197534|75830561|FG001|Overall Study|Lost to Follow-up|4|||
42023181|NCT01197534|75830562|FG002|Overall Study|Lost to Follow-up|2|||
42023182|NCT01197534|75830560|FG000|Overall Study|Adverse Event|35|||
42023183|NCT01197534|75830561|FG001|Overall Study|Adverse Event|36|||
42023184|NCT01197534|75830562|FG002|Overall Study|Adverse Event|24|||
42023185|NCT01197378|75830573|FG000|Overall Study|Adverse Event|3|||
42023186|NCT01197378|75830573|FG000|Overall Study|Withdrawal by Subject|1|||
42300324|NCT02367729|76135478|FG001|Overall Study|Withdrawal by Subject|5|||
42300325|NCT02366637|76135485|FG000|First Intervention Period|Adverse Event|0|||
42300326|NCT02366637|76135486|FG001|First Intervention Period|Adverse Event|1|||
42300327|NCT02366637|76135485|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
42300328|NCT02366637|76135486|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
42023187|NCT01197378|75830573|FG000|Overall Study|Physician Decision|1|||
42023188|NCT01197378|75830573|FG000|Overall Study|Other|2|||
42023189|NCT01197300|75830579|FG000|Overall Study|Lost to Follow-up|0|||
42023190|NCT01197300|75830580|FG001|Overall Study|Lost to Follow-up|1|||
42023191|NCT01197300|75830579|FG000|Overall Study|Protocol Violation|0|||
42023192|NCT01197300|75830580|FG001|Overall Study|Protocol Violation|1|||
42023193|NCT01196988|75830595|FG000|Overall Study|Adverse Event|1|||
42023194|NCT01196988|75830596|FG001|Overall Study|Adverse Event|2|||
42023195|NCT01196988|75830597|FG002|Overall Study|Adverse Event|0|||
42023196|NCT01196988|75830598|FG003|Overall Study|Adverse Event|0|||
42023197|NCT01196988|75830595|FG000|Overall Study|Withdrawal by Subject|5|||
42023198|NCT01196988|75830596|FG001|Overall Study|Withdrawal by Subject|1|||
42023199|NCT01196988|75830597|FG002|Overall Study|Withdrawal by Subject|4|||
42023200|NCT01196988|75830598|FG003|Overall Study|Withdrawal by Subject|0|||
42023201|NCT01196988|75830595|FG000|Overall Study|Lost to Follow-up|16|||
42023202|NCT01196988|75830596|FG001|Overall Study|Lost to Follow-up|29|||
42023203|NCT01196988|75830597|FG002|Overall Study|Lost to Follow-up|21|||
42023204|NCT01196988|75830598|FG003|Overall Study|Lost to Follow-up|1|||
42023205|NCT01196988|75830595|FG000|Overall Study|Other|2|||
42023206|NCT01196988|75830596|FG001|Overall Study|Other|0|||
42023207|NCT01196988|75830597|FG002|Overall Study|Other|0|||
42023208|NCT01196988|75830598|FG003|Overall Study|Other|0|||
42023209|NCT01196052|75830609|FG000|Overall Study|Adverse Event|9|||
42023210|NCT01196052|75830609|FG000|Overall Study|Lost to Follow-up|1|||
42023211|NCT01196052|75830609|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
42023212|NCT01196052|75830609|FG000|Overall Study|Reason not Specified|5|||
42023213|NCT01196052|75830609|FG000|Overall Study|Withdrawal by Subject|6|||
42023214|NCT01195662|75830616|FG000|Double Blind Treatment Period|Adverse Event|4|||
42023215|NCT01195662|75830617|FG001|Double Blind Treatment Period|Adverse Event|1|||
42023216|NCT01195662|75830618|FG002|Double Blind Treatment Period|Adverse Event|2|||
42023217|NCT01195662|75830616|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
42023218|NCT01195662|75830617|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
42023219|NCT01195662|75830618|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
42023220|NCT01195662|75830616|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
42023221|NCT01195662|75830617|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
42023222|NCT01195662|75830618|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
42023223|NCT01195662|75830616|FG000|Double Blind Treatment Period|Administrative reason|2|||
41943695|NCT03633617|75689277|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
41943696|NCT03633617|75689278|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
41943697|NCT03633617|75689279|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
41943698|NCT03633617|75689280|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
41943699|NCT03633617|75689281|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
41943700|NCT03633617|75689282|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
41943701|NCT03633617|75689283|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
41943702|NCT03633617|75689284|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
41943703|NCT03633617|75689285|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
41943704|NCT03633617|75689286|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
41943705|NCT03633617|75689287|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
41943706|NCT03633617|75689277|FG000|Part C (& Follow-up)|Adverse Event|0|||
41943707|NCT03633617|75689278|FG001|Part C (& Follow-up)|Adverse Event|0|||
41943708|NCT03633617|75689279|FG002|Part C (& Follow-up)|Adverse Event|0|||
41943709|NCT03633617|75689280|FG003|Part C (& Follow-up)|Adverse Event|0|||
41943710|NCT03633617|75689281|FG004|Part C (& Follow-up)|Adverse Event|0|||
41943711|NCT03633617|75689282|FG005|Part C (& Follow-up)|Adverse Event|1|||
41943712|NCT03633617|75689283|FG006|Part C (& Follow-up)|Adverse Event|0|||
41943713|NCT03633617|75689284|FG007|Part C (& Follow-up)|Adverse Event|1|||
41943714|NCT03633617|75689285|FG008|Part C (& Follow-up)|Adverse Event|0|||
41943715|NCT03633617|75689286|FG009|Part C (& Follow-up)|Adverse Event|0|||
41943716|NCT03633617|75689287|FG010|Part C (& Follow-up)|Adverse Event|0|||
41943717|NCT03633617|75689277|FG000|Part C (& Follow-up)|Pregnancy|0|||
41943718|NCT03633617|75689278|FG001|Part C (& Follow-up)|Pregnancy|0|||
41943719|NCT03633617|75689279|FG002|Part C (& Follow-up)|Pregnancy|0|||
41943720|NCT03633617|75689280|FG003|Part C (& Follow-up)|Pregnancy|0|||
41943721|NCT03633617|75689281|FG004|Part C (& Follow-up)|Pregnancy|0|||
41943722|NCT03633617|75689282|FG005|Part C (& Follow-up)|Pregnancy|0|||
41943723|NCT03633617|75689283|FG006|Part C (& Follow-up)|Pregnancy|0|||
42023224|NCT01195662|75830617|FG001|Double Blind Treatment Period|Administrative reason|1|||
42023225|NCT01195662|75830618|FG002|Double Blind Treatment Period|Administrative reason|1|||
41943724|NCT03633617|75689284|FG007|Part C (& Follow-up)|Pregnancy|0|||
42023226|NCT01195662|75830616|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
42023227|NCT01195662|75830617|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
42023228|NCT01195662|75830618|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
42023229|NCT01195662|75830616|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
42023230|NCT01195662|75830617|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
42023231|NCT01195662|75830618|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
42023232|NCT01195662|75830616|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
42023233|NCT01195662|75830617|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
42023234|NCT01195662|75830618|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
42023235|NCT01195662|75830616|FG000|Double Blind Treatment Period|Non-specified|3|||
42023236|NCT01195662|75830617|FG001|Double Blind Treatment Period|Non-specified|0|||
42023237|NCT01195662|75830618|FG002|Double Blind Treatment Period|Non-specified|0|||
42023238|NCT01195662|75830616|FG000|Double Blind Treatment Period|Missing disposition information|0|||
42023239|NCT01195662|75830617|FG001|Double Blind Treatment Period|Missing disposition information|1|||
42023240|NCT01195662|75830618|FG002|Double Blind Treatment Period|Missing disposition information|1|||
42023241|NCT01195662|75830616|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
42023242|NCT01195662|75830617|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
42023243|NCT01195662|75830618|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
42023244|NCT01195662|75830616|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
42023245|NCT01195662|75830617|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
42023246|NCT01195662|75830618|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
42023247|NCT01195272|75830627|FG000|Overall Study|Adverse Event|1|||
42023248|NCT01195272|75830627|FG000|Overall Study|Lack of Efficacy|3|||
42023249|NCT01194804|75830631|FG000|Overall Study|Withdrawal by Subject|1|||
42023250|NCT01194414|75830655|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
42023251|NCT01194414|75830656|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
42023252|NCT01194414|75830657|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
42023253|NCT01194414|75830658|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
42023254|NCT01194414|75830655|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
42023255|NCT01194414|75830656|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
42023256|NCT01194414|75830657|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
42023257|NCT01194414|75830658|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
42023258|NCT01194414|75830655|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
42023259|NCT01194414|75830656|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
42023260|NCT01194414|75830657|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
42023261|NCT01194414|75830658|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
42023262|NCT01194414|75830655|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
41943725|NCT03633617|75689285|FG008|Part C (& Follow-up)|Pregnancy|0|||
41943726|NCT03633617|75689286|FG009|Part C (& Follow-up)|Pregnancy|1|||
41943727|NCT03633617|75689287|FG010|Part C (& Follow-up)|Pregnancy|0|||
41943728|NCT03633617|75689277|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
41943729|NCT03633617|75689278|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
41943730|NCT03633617|75689279|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
41943731|NCT03633617|75689280|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
41943732|NCT03633617|75689281|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
41943733|NCT03633617|75689282|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
41943734|NCT03633617|75689283|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
41943735|NCT03633617|75689284|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
41943736|NCT03633617|75689285|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
41943737|NCT03633617|75689286|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
41943738|NCT03633617|75689287|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
41943739|NCT03633617|75689277|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
41943740|NCT03633617|75689278|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
41943741|NCT03633617|75689279|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
41943742|NCT03633617|75689280|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
41943743|NCT03633617|75689281|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
41943744|NCT03633617|75689282|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
41943745|NCT03633617|75689283|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
41943746|NCT03633617|75689284|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
41943747|NCT03633617|75689285|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
41943748|NCT03633617|75689286|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
41943749|NCT03633617|75689287|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
41943750|NCT03633617|75689277|FG000|Part C (& Follow-up)|Physician Decision|0|||
41943751|NCT03633617|75689278|FG001|Part C (& Follow-up)|Physician Decision|0|||
41943752|NCT03633617|75689279|FG002|Part C (& Follow-up)|Physician Decision|0|||
41943753|NCT03633617|75689280|FG003|Part C (& Follow-up)|Physician Decision|0|||
41943754|NCT03633617|75689281|FG004|Part C (& Follow-up)|Physician Decision|0|||
41943755|NCT03633617|75689282|FG005|Part C (& Follow-up)|Physician Decision|0|||
41943756|NCT03633617|75689283|FG006|Part C (& Follow-up)|Physician Decision|0|||
41943757|NCT03633617|75689284|FG007|Part C (& Follow-up)|Physician Decision|1|||
41943758|NCT03633617|75689285|FG008|Part C (& Follow-up)|Physician Decision|0|||
42023263|NCT01194414|75830656|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
42023264|NCT01194414|75830657|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
41943759|NCT03633617|75689286|FG009|Part C (& Follow-up)|Physician Decision|0|||
41943760|NCT03633617|75689287|FG010|Part C (& Follow-up)|Physician Decision|1|||
41943761|NCT03633617|75689277|FG000|Part C (& Follow-up)|COVID-19 related|0|||
41943762|NCT03633617|75689278|FG001|Part C (& Follow-up)|COVID-19 related|0|||
41943763|NCT03633617|75689279|FG002|Part C (& Follow-up)|COVID-19 related|0|||
41943764|NCT03633617|75689280|FG003|Part C (& Follow-up)|COVID-19 related|0|||
41943765|NCT03633617|75689281|FG004|Part C (& Follow-up)|COVID-19 related|0|||
41943766|NCT03633617|75689282|FG005|Part C (& Follow-up)|COVID-19 related|1|||
41943767|NCT03633617|75689283|FG006|Part C (& Follow-up)|COVID-19 related|0|||
41943768|NCT03633617|75689284|FG007|Part C (& Follow-up)|COVID-19 related|0|||
41943769|NCT03633617|75689285|FG008|Part C (& Follow-up)|COVID-19 related|0|||
41943770|NCT03633617|75689286|FG009|Part C (& Follow-up)|COVID-19 related|0|||
41943771|NCT03633617|75689287|FG010|Part C (& Follow-up)|COVID-19 related|0|||
41943772|NCT03633617|75689277|FG000|Part C (& Follow-up)|Protocol Violation|0|||
41943773|NCT03633617|75689278|FG001|Part C (& Follow-up)|Protocol Violation|0|||
41943774|NCT03633617|75689279|FG002|Part C (& Follow-up)|Protocol Violation|0|||
41943775|NCT03633617|75689280|FG003|Part C (& Follow-up)|Protocol Violation|0|||
41943776|NCT03633617|75689281|FG004|Part C (& Follow-up)|Protocol Violation|0|||
41943777|NCT03633617|75689282|FG005|Part C (& Follow-up)|Protocol Violation|0|||
41943778|NCT03633617|75689283|FG006|Part C (& Follow-up)|Protocol Violation|0|||
41943779|NCT03633617|75689284|FG007|Part C (& Follow-up)|Protocol Violation|0|||
41943780|NCT03633617|75689285|FG008|Part C (& Follow-up)|Protocol Violation|0|||
41943781|NCT03633617|75689286|FG009|Part C (& Follow-up)|Protocol Violation|3|||
41943782|NCT03633617|75689287|FG010|Part C (& Follow-up)|Protocol Violation|1|||
41943783|NCT03633617|75689277|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
41943784|NCT03633617|75689278|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
41943785|NCT03633617|75689279|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
41943786|NCT03633617|75689280|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
41943787|NCT03633617|75689281|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
41943788|NCT03633617|75689282|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
41943789|NCT03633617|75689283|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
41943790|NCT03633617|75689284|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
41943791|NCT03633617|75689285|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
41943792|NCT03633617|75689286|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
41943793|NCT03633617|75689287|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
41943794|NCT03631784|75689317|FG000|Overall Study|Death|48|||
41943795|NCT03631784|75689318|FG001|Overall Study|Death|28|||
41943796|NCT03631784|75689317|FG000|Overall Study|Lost to Follow-up|1|||
41943797|NCT03631784|75689318|FG001|Overall Study|Lost to Follow-up|0|||
41943798|NCT03631784|75689317|FG000|Overall Study|Withdrawal by Subject|0|||
41943799|NCT03631784|75689318|FG001|Overall Study|Withdrawal by Subject|3|||
41943800|NCT03631784|75689317|FG000|Overall Study|Participants Ongoing|63|||
41943801|NCT03631784|75689318|FG001|Overall Study|Participants Ongoing|71|||
41943802|NCT03617705|75689324|FG000|Overall Study|Withdrawal by Subject|2|||
41943803|NCT03617705|75689324|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
41943804|NCT03617705|75689324|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
41943805|NCT03607422|75689334|FG000|Overall Study|Adverse Event|7|||
41943806|NCT03607422|75689335|FG001|Overall Study|Adverse Event|3|||
41943807|NCT03607422|75689336|FG002|Overall Study|Adverse Event|2|||
41943808|NCT03607422|75689337|FG003|Overall Study|Adverse Event|0|||
41943809|NCT03607422|75689338|FG004|Overall Study|Adverse Event|2|||
41943810|NCT03607422|75689339|FG005|Overall Study|Adverse Event|0|||
41943811|NCT03607422|75689334|FG000|Overall Study|Withdrawal by Subject|11|||
41943812|NCT03607422|75689335|FG001|Overall Study|Withdrawal by Subject|3|||
41943813|NCT03607422|75689336|FG002|Overall Study|Withdrawal by Subject|6|||
42023265|NCT01194414|75830658|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
42118009|NCT00689117|75928842|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
42300329|NCT02366637|76135485|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
42300330|NCT02366637|76135486|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
42300331|NCT02300103|76135492|FG000|Overall Study|Lack of Efficacy|3|||
42300332|NCT02300103|76135492|FG000|Overall Study|Protocol Violation|1|||
42300333|NCT02300103|76135492|FG000|Overall Study|Withdrew Consent|2|||
42300334|NCT02326467|76135496|FG000|Overall Study|Withdrawal by Subject|1|||
41943814|NCT03607422|75689337|FG003|Overall Study|Withdrawal by Subject|2|||
41943815|NCT03607422|75689338|FG004|Overall Study|Withdrawal by Subject|0|||
41943816|NCT03607422|75689339|FG005|Overall Study|Withdrawal by Subject|0|||
41943817|NCT03607422|75689334|FG000|Overall Study|Lost to Follow-up|0|||
41943818|NCT03607422|75689335|FG001|Overall Study|Lost to Follow-up|0|||
41943819|NCT03607422|75689336|FG002|Overall Study|Lost to Follow-up|1|||
41943820|NCT03607422|75689337|FG003|Overall Study|Lost to Follow-up|0|||
41943821|NCT03607422|75689338|FG004|Overall Study|Lost to Follow-up|0|||
41943822|NCT03607422|75689339|FG005|Overall Study|Lost to Follow-up|0|||
41943823|NCT03607422|75689334|FG000|Overall Study|Other|12|||
41943824|NCT03607422|75689335|FG001|Overall Study|Other|4|||
41943825|NCT03607422|75689336|FG002|Overall Study|Other|1|||
41943826|NCT03607422|75689337|FG003|Overall Study|Other|2|||
41943827|NCT03607422|75689338|FG004|Overall Study|Other|0|||
41943828|NCT03607422|75689339|FG005|Overall Study|Other|2|||
41943829|NCT03607422|75689334|FG000|Overall Study|Ongoing at Time of Analysis|8|||
41943830|NCT03607422|75689335|FG001|Overall Study|Ongoing at Time of Analysis|0|||
41943831|NCT03607422|75689336|FG002|Overall Study|Ongoing at Time of Analysis|2|||
41943832|NCT03607422|75689337|FG003|Overall Study|Ongoing at Time of Analysis|1|||
41943833|NCT03607422|75689338|FG004|Overall Study|Ongoing at Time of Analysis|1|||
41943834|NCT03607422|75689339|FG005|Overall Study|Ongoing at Time of Analysis|1|||
41943835|NCT03568318|75689377|FG000|Overall Study|Adverse Event|3|||
41943836|NCT03568318|75689378|FG001|Overall Study|Adverse Event|1|||
41943837|NCT03568318|75689379|FG002|Overall Study|Adverse Event|1|||
41943838|NCT03568318|75689380|FG003|Overall Study|Adverse Event|0|||
41943839|NCT03568318|75689381|FG004|Overall Study|Adverse Event|1|||
41943840|NCT03568318|75689382|FG005|Overall Study|Adverse Event|0|||
41943841|NCT03568318|75689377|FG000|Overall Study|Withdrawal by Subject|6|||
41943842|NCT03568318|75689378|FG001|Overall Study|Withdrawal by Subject|5|||
41943843|NCT03568318|75689379|FG002|Overall Study|Withdrawal by Subject|2|||
41943844|NCT03568318|75689380|FG003|Overall Study|Withdrawal by Subject|1|||
41943845|NCT03568318|75689381|FG004|Overall Study|Withdrawal by Subject|0|||
41943846|NCT03568318|75689382|FG005|Overall Study|Withdrawal by Subject|0|||
41943847|NCT03568318|75689377|FG000|Overall Study|Lost to Follow-up|3|||
41943848|NCT03568318|75689378|FG001|Overall Study|Lost to Follow-up|2|||
41943849|NCT03568318|75689379|FG002|Overall Study|Lost to Follow-up|2|||
41943850|NCT03568318|75689380|FG003|Overall Study|Lost to Follow-up|2|||
41943851|NCT03568318|75689381|FG004|Overall Study|Lost to Follow-up|1|||
41943852|NCT03568318|75689382|FG005|Overall Study|Lost to Follow-up|0|||
41943853|NCT03568318|75689377|FG000|Overall Study|Other|3|||
41943854|NCT03568318|75689378|FG001|Overall Study|Other|1|||
41943855|NCT03568318|75689379|FG002|Overall Study|Other|3|||
41943856|NCT03568318|75689380|FG003|Overall Study|Other|0|||
41943857|NCT03568318|75689381|FG004|Overall Study|Other|0|||
41943858|NCT03568318|75689382|FG005|Overall Study|Other|0|||
41943859|NCT03568318|75689377|FG000|Overall Study|Ongoing at Time of Analysis|5|||
41943860|NCT03568318|75689378|FG001|Overall Study|Ongoing at Time of Analysis|3|||
41943861|NCT03568318|75689379|FG002|Overall Study|Ongoing at Time of Analysis|2|||
41943862|NCT03568318|75689380|FG003|Overall Study|Ongoing at Time of Analysis|1|||
41943863|NCT03568318|75689381|FG004|Overall Study|Ongoing at Time of Analysis|0|||
41943864|NCT03568318|75689382|FG005|Overall Study|Ongoing at Time of Analysis|0|||
41943865|NCT03550794|75689398|FG000|Overall Study|No longer met inclusion criteria|1|||
41943866|NCT03550794|75689399|FG001|Overall Study|No longer met inclusion criteria|2|||
41943867|NCT03550794|75689398|FG000|Overall Study|Goals of care changed|1|||
41943868|NCT03550794|75689399|FG001|Overall Study|Goals of care changed|0|||
41943869|NCT03550794|75689398|FG000|Overall Study|Withdrawal by Subject|2|||
41943870|NCT03550794|75689399|FG001|Overall Study|Withdrawal by Subject|0|||
41943871|NCT03550794|75689398|FG000|Overall Study|Death|0|||
41943872|NCT03550794|75689399|FG001|Overall Study|Death|1|||
41943873|NCT03427125|75689438|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
41943874|NCT03427125|75689439|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
41943875|NCT03427125|75689440|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
41943876|NCT03341273|75689455|FG000|Overall Study|Lost to Follow-up|7|||
41943877|NCT03341273|75689456|FG001|Overall Study|Lost to Follow-up|7|||
41943878|NCT03341273|75689455|FG000|Overall Study|Withdrawal by Subject|4|||
41943879|NCT03341273|75689456|FG001|Overall Study|Withdrawal by Subject|2|||
41943880|NCT03341273|75689455|FG000|Overall Study|Physician Decision|1|||
41943881|NCT03341273|75689456|FG001|Overall Study|Physician Decision|0|||
41943882|NCT03341273|75689455|FG000|Overall Study|Protocol Violation|0|||
41943883|NCT03341273|75689456|FG001|Overall Study|Protocol Violation|1|||
41943884|NCT03341273|75689455|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
41943885|NCT03341273|75689456|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
41943886|NCT03341273|75689455|FG000|Overall Study|Became ineligible after enrollment|1|||
41943887|NCT03341273|75689456|FG001|Overall Study|Became ineligible after enrollment|0|||
41943888|NCT03341273|75689455|FG000|Overall Study|Not Eligible at Enrollment|0|||
41943889|NCT03341273|75689456|FG001|Overall Study|Not Eligible at Enrollment|1|||
41943890|NCT03341273|75689455|FG000|Overall Study|Participant incarcerated|1|||
41943891|NCT03341273|75689456|FG001|Overall Study|Participant incarcerated|0|||
41943892|NCT03284710|75689466|FG000|Overall Study|Withdrawal by Subject|1|||
41943893|NCT03284710|75689467|FG001|Overall Study|Withdrawal by Subject|0|||
41943894|NCT03284710|75689468|FG002|Overall Study|Withdrawal by Subject|1|||
41943895|NCT03284710|75689469|FG003|Overall Study|Withdrawal by Subject|6|||
41943896|NCT03284710|75689466|FG000|Overall Study|Lost to Follow-up|3|||
41943897|NCT03284710|75689467|FG001|Overall Study|Lost to Follow-up|3|||
41943898|NCT03284710|75689468|FG002|Overall Study|Lost to Follow-up|1|||
41943899|NCT03284710|75689469|FG003|Overall Study|Lost to Follow-up|0|||
41943900|NCT03284710|75689466|FG000|Overall Study|Physician Decision|1|||
41943901|NCT03284710|75689467|FG001|Overall Study|Physician Decision|0|||
41943902|NCT03284710|75689468|FG002|Overall Study|Physician Decision|0|||
41943903|NCT03284710|75689469|FG003|Overall Study|Physician Decision|0|||
41943904|NCT03284710|75689466|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
41943905|NCT03284710|75689467|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
41943906|NCT03284710|75689468|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
41943907|NCT03284710|75689469|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
41943908|NCT03284710|75689466|FG000|Overall Study|HIV Infection|0|||
41943909|NCT03284710|75689467|FG001|Overall Study|HIV Infection|2|||
41943910|NCT03284710|75689468|FG002|Overall Study|HIV Infection|2|||
41943911|NCT03284710|75689469|FG003|Overall Study|HIV Infection|1|||
41943912|NCT03248167|75689488|FG000|Overall Study|Withdrawal by Subject|2|||
41943913|NCT03248167|75689489|FG001|Overall Study|Withdrawal by Subject|2|||
41943914|NCT03248167|75689488|FG000|Overall Study|Physician Decision|0|||
41943915|NCT03248167|75689489|FG001|Overall Study|Physician Decision|1|||
41943916|NCT03248167|75689488|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
41943917|NCT03248167|75689489|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
41943918|NCT03248167|75689488|FG000|Overall Study|Lost to Follow-up|1|||
41943919|NCT03248167|75689489|FG001|Overall Study|Lost to Follow-up|0|||
41943920|NCT03220737|75689503|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
41943921|NCT03220737|75689504|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
41943922|NCT03220737|75689505|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
41943923|NCT03220737|75689506|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
41943924|NCT03220737|75689507|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
41943925|NCT03220737|75689508|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
41943926|NCT03220737|75689509|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
41943927|NCT03220737|75689503|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
41943928|NCT03220737|75689504|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
41943929|NCT03220737|75689505|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
41943930|NCT03220737|75689506|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
41943931|NCT03220737|75689507|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
41943932|NCT03220737|75689508|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
41943933|NCT03220737|75689509|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
41943934|NCT03220737|75689503|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
41943935|NCT03220737|75689504|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
41943936|NCT03220737|75689505|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
41943937|NCT03220737|75689506|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
41943938|NCT03220737|75689507|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
41943939|NCT03220737|75689508|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
41943940|NCT03220737|75689509|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
41943941|NCT03220737|75689503|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
41943942|NCT03220737|75689504|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
41943943|NCT03220737|75689505|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
41943944|NCT03220737|75689506|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
41943945|NCT03220737|75689507|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
41943946|NCT03220737|75689508|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
41943947|NCT03220737|75689509|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
41943948|NCT03220737|75689503|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
41943949|NCT03220737|75689504|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
41943950|NCT03220737|75689505|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
41943951|NCT03220737|75689506|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
41943952|NCT03220737|75689507|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
41943953|NCT03220737|75689508|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
41943954|NCT03220737|75689509|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
41943955|NCT03220737|75689503|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
41943956|NCT03220737|75689504|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
41943957|NCT03220737|75689505|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
41943958|NCT03220737|75689506|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
41943959|NCT03220737|75689507|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
41943960|NCT03220737|75689508|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
41943961|NCT03220737|75689509|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
41943962|NCT03220737|75689503|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
41943963|NCT03220737|75689504|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
41943964|NCT03220737|75689505|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
41943965|NCT03220737|75689506|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
41943966|NCT03220737|75689507|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
41943967|NCT03220737|75689508|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
41943968|NCT03220737|75689509|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
41943969|NCT03220737|75689503|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
41943970|NCT03220737|75689504|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
41943971|NCT03220737|75689505|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
41943972|NCT03220737|75689506|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
41943973|NCT03220737|75689507|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
41943974|NCT03220737|75689508|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
41943975|NCT03220737|75689509|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
41943976|NCT03198728|75689533|FG000|Overall Study|Adverse Event|10|||
41943977|NCT03198728|75689534|FG001|Overall Study|Adverse Event|5|||
41943978|NCT03198728|75689533|FG000|Overall Study|Lost to Follow-up|21|||
41943979|NCT03198728|75689534|FG001|Overall Study|Lost to Follow-up|7|||
41943980|NCT03198728|75689533|FG000|Overall Study|Physician Decision|7|||
41943981|NCT03198728|75689534|FG001|Overall Study|Physician Decision|2|||
41943982|NCT03198728|75689533|FG000|Overall Study|Withdrawal by Subject|14|||
41943983|NCT03198728|75689534|FG001|Overall Study|Withdrawal by Subject|10|||
41943984|NCT03144804|75689566|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
41943985|NCT03142334|75689572|FG000|Overall Study|Death|18|||
41943986|NCT03142334|75689573|FG001|Overall Study|Death|33|||
41943987|NCT03142334|75689572|FG000|Overall Study|Withdrawal by Subject|15|||
41943988|NCT03142334|75689573|FG001|Overall Study|Withdrawal by Subject|11|||
41943989|NCT03142334|75689572|FG000|Overall Study|Ongoing on trial follow up|463|||
41943990|NCT03142334|75689573|FG001|Overall Study|Ongoing on trial follow up|454|||
41943991|NCT03126539|75689581|FG000|Overall Study|Lost to Follow-up|1|||
41943992|NCT03126539|75689582|FG001|Overall Study|Lost to Follow-up|1|||
41943993|NCT03126539|75689583|FG002|Overall Study|Lost to Follow-up|1|||
41943994|NCT03126539|75689584|FG003|Overall Study|Lost to Follow-up|0|||
41943995|NCT03126539|75689585|FG004|Overall Study|Lost to Follow-up|0|||
41943996|NCT03123250|75689598|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
41943997|NCT03099096|75689602|FG000|Overall Study|Adverse Event|1|||
41943998|NCT03099096|75689602|FG000|Overall Study|Physician Decision|1|||
41943999|NCT03043664|75689606|FG000|Overall Study|Lost to Follow-up|1|||
41944000|NCT03041467|75689612|FG000|Overall Study|Death|40|||
41944001|NCT03041467|75689613|FG001|Overall Study|Death|36|||
41944002|NCT03041467|75689612|FG000|Overall Study|Withdrawal by Subject|36|||
41944003|NCT03041467|75689613|FG001|Overall Study|Withdrawal by Subject|37|||
41944004|NCT03041467|75689612|FG000|Overall Study|Lost to Follow-up|6|||
41944005|NCT03041467|75689613|FG001|Overall Study|Lost to Follow-up|7|||
41944006|NCT03041467|75689612|FG000|Overall Study|Declined consent for study extension|21|||
41944007|NCT03041467|75689613|FG001|Overall Study|Declined consent for study extension|33|||
41944008|NCT03041467|75689612|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
41944009|NCT03041467|75689613|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
41944010|NCT03041467|75689612|FG000|Overall Study|48 Month visit not completed|9|||
41944011|NCT03041467|75689613|FG001|Overall Study|48 Month visit not completed|4|||
41944012|NCT03019406|75689625|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
41944013|NCT03019406|75689626|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
41944014|NCT03019406|75689627|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
41944015|NCT03019406|75689628|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
41944016|NCT02972593|75689643|FG000|Overall Study|Lost to Follow-up|19|||
41944017|NCT02972593|75689644|FG001|Overall Study|Lost to Follow-up|15|||
41944018|NCT02972593|75689643|FG000|Overall Study|Protocol Violation|1|||
41944019|NCT02972593|75689644|FG001|Overall Study|Protocol Violation|0|||
41944020|NCT02949700|75689656|FG000|Phase I|Withdrawal by Subject|1|||
41944021|NCT02949700|75689657|FG001|Phase I|Withdrawal by Subject|1|||
41944022|NCT02949700|75689658|FG002|Phase I|Withdrawal by Subject|0|||
41944023|NCT02949700|75689659|FG003|Phase I|Withdrawal by Subject|0|||
41944024|NCT02949700|75689656|FG000|Phase I|Protocol Violation|1|||
41944025|NCT02949700|75689657|FG001|Phase I|Protocol Violation|0|||
41944026|NCT02949700|75689658|FG002|Phase I|Protocol Violation|0|||
41944027|NCT02949700|75689659|FG003|Phase I|Protocol Violation|0|||
41944028|NCT02949700|75689656|FG000|Phase II|Withdrawal by Subject|0|||
41944029|NCT02949700|75689657|FG001|Phase II|Withdrawal by Subject|0|||
41944030|NCT02949700|75689658|FG002|Phase II|Withdrawal by Subject|0|||
41944031|NCT02949700|75689659|FG003|Phase II|Withdrawal by Subject|2|||
41944032|NCT02949700|75689656|FG000|Phase II|Protocol Violation|0|||
41944033|NCT02949700|75689657|FG001|Phase II|Protocol Violation|0|||
41944034|NCT02949700|75689658|FG002|Phase II|Protocol Violation|1|||
41944035|NCT02949700|75689659|FG003|Phase II|Protocol Violation|3|||
41944036|NCT02947087|75689670|FG000|Overall Study|Withdrawal by Subject|3|||
41944037|NCT02947087|75689671|FG001|Overall Study|Withdrawal by Subject|2|||
41944038|NCT02868216|75689679|FG000|Overall Study|Death|0|||
41944039|NCT02868216|75689680|FG001|Overall Study|Death|1|||
41944040|NCT02868216|75689679|FG000|Overall Study|coronary artery bypass|1|||
41944041|NCT02868216|75689680|FG001|Overall Study|coronary artery bypass|0|||
41944042|NCT02868216|75689679|FG000|Overall Study|Withdrawal by Subject|7|||
41944043|NCT02868216|75689680|FG001|Overall Study|Withdrawal by Subject|5|||
41944044|NCT02841995|75689689|FG000|Overall Study|Disease progression|5|||
41944045|NCT02841995|75689690|FG001|Overall Study|Disease progression|11|||
41944046|NCT02841995|75689691|FG002|Overall Study|Disease progression|8|||
41944047|NCT02841995|75689689|FG000|Overall Study|Withdrawal by Subject|2|||
41944048|NCT02841995|75689690|FG001|Overall Study|Withdrawal by Subject|4|||
41944049|NCT02841995|75689691|FG002|Overall Study|Withdrawal by Subject|4|||
41944050|NCT02841995|75689689|FG000|Overall Study|Adverse Event|2|||
41944051|NCT02841995|75689690|FG001|Overall Study|Adverse Event|0|||
41944052|NCT02841995|75689691|FG002|Overall Study|Adverse Event|1|||
41944053|NCT02841995|75689689|FG000|Overall Study|Investigator decision|2|||
41944054|NCT02841995|75689690|FG001|Overall Study|Investigator decision|0|||
41944055|NCT02841995|75689691|FG002|Overall Study|Investigator decision|1|||
41944056|NCT02841995|75689689|FG000|Overall Study|Death|0|||
41944057|NCT02841995|75689690|FG001|Overall Study|Death|0|||
41944058|NCT02841995|75689691|FG002|Overall Study|Death|2|||
41944059|NCT02841995|75689689|FG000|Overall Study|Noncompliance to protocol|1|||
41944060|NCT02841995|75689690|FG001|Overall Study|Noncompliance to protocol|0|||
41944061|NCT02841995|75689691|FG002|Overall Study|Noncompliance to protocol|0|||
41944062|NCT02841995|75689689|FG000|Overall Study|Sponsor decision|1|||
41944063|NCT02841995|75689690|FG001|Overall Study|Sponsor decision|0|||
41944064|NCT02841995|75689691|FG002|Overall Study|Sponsor decision|0|||
41944065|NCT02841995|75689689|FG000|Overall Study|Other|4|||
41944066|NCT02841995|75689690|FG001|Overall Study|Other|1|||
41944067|NCT02841995|75689691|FG002|Overall Study|Other|5|||
41944068|NCT02643966|75689708|FG000|First Screening Round|ineligible|1|||
41944069|NCT02643966|75689708|FG000|First Screening Round|excluded from analysis|2|||
41944070|NCT02643966|75689708|FG000|First Screening Round|Lost to Follow-up|56|||
41944071|NCT02643966|75689708|FG000|First Screening Round|Withdrawal by Subject|28|||
41944072|NCT02643966|75689708|FG000|First Screening Round|Death|1|||
41944073|NCT02643966|75689708|FG000|Between First and Second Screening|Lost to Follow-up|65|||
41944074|NCT02643966|75689708|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
41944075|NCT02643966|75689708|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
41944076|NCT02643966|75689708|FG000|Second Screening Round|Withdrawal by Subject|20|||
41944077|NCT02643966|75689708|FG000|Second Screening Round|Lost to Follow-up|57|||
41944078|NCT02643966|75689708|FG000|Second Screening Round|Physician Decision|2|||
41944079|NCT02643966|75689708|FG000|Second Screening Round|Death|4|||
41944080|NCT02643966|75689708|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
41944081|NCT02643966|75689708|FG000|Between Second and Third Screening|Death|1|||
41944082|NCT02643966|75689708|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
41944083|NCT02643966|75689708|FG000|Third Screening Round|PI excluded|2|||
41944084|NCT02643966|75689708|FG000|Third Screening Round|Lost to Follow-up|241|||
41944085|NCT02554383|75689737|FG000|Overall Study|Ineligible|3|||
41944086|NCT02554383|75689738|FG001|Overall Study|Ineligible|2|||
41944087|NCT02554383|75689737|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
41944088|NCT02554383|75689738|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
41944089|NCT02554383|75689737|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
41944090|NCT02554383|75689738|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
41944091|NCT02554383|75689737|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
41944092|NCT02554383|75689738|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
41944093|NCT02522871|75689746|FG000|Overall Study|Protocol Violation|1|||
41944094|NCT02522871|75689747|FG001|Overall Study|Protocol Violation|4|||
41944095|NCT02522871|75689746|FG000|Overall Study|Treated without randomization|1|||
41944096|NCT02522871|75689747|FG001|Overall Study|Treated without randomization|0|||
41944097|NCT02522871|75689746|FG000|Overall Study|Death|9|||
41944098|NCT02522871|75689747|FG001|Overall Study|Death|9|||
41944099|NCT02522871|75689746|FG000|Overall Study|Died in operating room prior to transplant|0|||
41944100|NCT02522871|75689747|FG001|Overall Study|Died in operating room prior to transplant|1|||
41944101|NCT02519439|75689762|FG000|Overall Study|Study Termination|19|||
41944102|NCT02519439|75689762|FG000|Overall Study|Withdrawal by Subject|1|||
41944103|NCT02519439|75689762|FG000|Overall Study|Adverse Event|1|||
41944104|NCT02147184|75689772|FG000|Overall Study|Lost to Follow-up|28|||
41944105|NCT02147184|75689773|FG001|Overall Study|Lost to Follow-up|15|||
41944106|NCT02147184|75689772|FG000|Overall Study|Study Burden|11|||
41944107|NCT02147184|75689773|FG001|Overall Study|Study Burden|7|||
41944108|NCT02147184|75689772|FG000|Overall Study|Pregnancy|6|||
41944109|NCT02147184|75689773|FG001|Overall Study|Pregnancy|0|||
41944110|NCT02147184|75689772|FG000|Overall Study|Moved out of state|3|||
41944111|NCT02147184|75689773|FG001|Overall Study|Moved out of state|3|||
41944112|NCT02147184|75689772|FG000|Overall Study|Physician Decision|0|||
41944113|NCT02147184|75689773|FG001|Overall Study|Physician Decision|2|||
41944114|NCT02147184|75689772|FG000|Overall Study|Other|1|||
41944115|NCT02147184|75689773|FG001|Overall Study|Other|0|||
41944116|NCT02101021|75689784|FG000|Overall Study|Death|4|||
41944117|NCT02101021|75689785|FG001|Overall Study|Death|3|||
41944118|NCT02101021|75689786|FG002|Overall Study|Death|6|||
41944119|NCT02101021|75689787|FG003|Overall Study|Death|0|||
41944120|NCT02101021|75689788|FG004|Overall Study|Death|3|||
41944121|NCT02101021|75689784|FG000|Overall Study|Withdrew Consent from study|1|||
41944122|NCT02101021|75689785|FG001|Overall Study|Withdrew Consent from study|1|||
41944123|NCT02101021|75689786|FG002|Overall Study|Withdrew Consent from study|0|||
41944124|NCT02101021|75689787|FG003|Overall Study|Withdrew Consent from study|2|||
41944125|NCT02101021|75689788|FG004|Overall Study|Withdrew Consent from study|0|||
41944126|NCT02101021|75689784|FG000|Overall Study|Lost to Follow-up|1|||
41944127|NCT02101021|75689785|FG001|Overall Study|Lost to Follow-up|0|||
41944128|NCT02101021|75689786|FG002|Overall Study|Lost to Follow-up|0|||
41944129|NCT02101021|75689787|FG003|Overall Study|Lost to Follow-up|0|||
41944130|NCT02101021|75689788|FG004|Overall Study|Lost to Follow-up|0|||
41944131|NCT02101021|75689784|FG000|Overall Study|Study Terminated by Sponsor|1|||
41944132|NCT02101021|75689785|FG001|Overall Study|Study Terminated by Sponsor|0|||
41944133|NCT02101021|75689786|FG002|Overall Study|Study Terminated by Sponsor|1|||
41944134|NCT02101021|75689787|FG003|Overall Study|Study Terminated by Sponsor|1|||
41944135|NCT02101021|75689788|FG004|Overall Study|Study Terminated by Sponsor|1|||
41944136|NCT02031536|75689813|FG000|Overall Study|ineligible|1|||
41944137|NCT02031536|75689814|FG001|Overall Study|ineligible|0|||
41944138|NCT02028455|75689828|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
41944139|NCT02028455|75689829|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
41944140|NCT02028455|75689830|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
41944141|NCT02028455|75689831|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
41944142|NCT02028455|75689832|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
41944143|NCT02028455|75689833|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
41944144|NCT02028455|75689834|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
41944145|NCT02028455|75689835|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
41944146|NCT02028455|75689828|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
41944147|NCT02028455|75689829|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
41944148|NCT02028455|75689830|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
41944149|NCT02028455|75689831|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
41944150|NCT02028455|75689832|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
41944151|NCT02028455|75689833|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
41944152|NCT02028455|75689834|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
41944153|NCT02028455|75689835|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
41944154|NCT02028455|75689828|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
41944155|NCT02028455|75689829|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
41944156|NCT02028455|75689830|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
41944157|NCT02028455|75689831|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
41944158|NCT02028455|75689832|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
41944159|NCT02028455|75689833|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
41944160|NCT02028455|75689834|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
41944161|NCT02028455|75689835|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
41944162|NCT02028455|75689828|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
41944163|NCT02028455|75689829|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
41944164|NCT02028455|75689830|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
41944165|NCT02028455|75689831|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
41944166|NCT02028455|75689832|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
41944167|NCT02028455|75689833|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
41944168|NCT02028455|75689834|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
41944169|NCT02028455|75689835|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
41944170|NCT02019641|75689859|FG000|10-Week Follow up|Withdrawal by investigator|2|||
41944171|NCT02019641|75689860|FG001|10-Week Follow up|Withdrawal by investigator|0|||
41944172|NCT02019641|75689861|FG002|10-Week Follow up|Withdrawal by investigator|0|||
41944173|NCT02019641|75689859|FG000|10-Week Follow up|Withdrawal by Subject|1|||
41944174|NCT02019641|75689860|FG001|10-Week Follow up|Withdrawal by Subject|1|||
41944175|NCT02019641|75689861|FG002|10-Week Follow up|Withdrawal by Subject|0|||
41944176|NCT02019641|75689859|FG000|20-Week Follow up|Withdrawal by investigator|0|||
41944177|NCT02019641|75689860|FG001|20-Week Follow up|Withdrawal by investigator|0|||
41944178|NCT02019641|75689861|FG002|20-Week Follow up|Withdrawal by investigator|1|||
41944179|NCT01964430|75689870|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
41944180|NCT01964430|75689871|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
41944181|NCT01964430|75689870|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
41944182|NCT01964430|75689871|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
42300335|NCT02299635|76135501|FG000|Overall Study|Adverse Event|2|||
41944183|NCT01964430|75689870|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
41944184|NCT01964430|75689871|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
41944185|NCT01964430|75689870|FG000|Treatment Period|Adverse Event|71|||
41944186|NCT01964430|75689871|FG001|Treatment Period|Adverse Event|37|||
41944187|NCT01964430|75689870|FG000|Treatment Period|Withdrawal by Subject|36|||
41944188|NCT01964430|75689871|FG001|Treatment Period|Withdrawal by Subject|27|||
41944189|NCT01964430|75689870|FG000|Treatment Period|Death|1|||
41944190|NCT01964430|75689871|FG001|Treatment Period|Death|3|||
41944191|NCT01964430|75689870|FG000|Treatment Period|Protocol Deviation|0|||
41944192|NCT01964430|75689871|FG001|Treatment Period|Protocol Deviation|1|||
41944193|NCT01964430|75689870|FG000|Treatment Period|Physician Decision|5|||
41944194|NCT01964430|75689871|FG001|Treatment Period|Physician Decision|4|||
41944195|NCT01964430|75689870|FG000|Treatment Period|Disease Relapse|28|||
41944196|NCT01964430|75689871|FG001|Treatment Period|Disease Relapse|38|||
41944197|NCT01964430|75689870|FG000|Treatment Period|Other reasons|1|||
41944198|NCT01964430|75689871|FG001|Treatment Period|Other reasons|3|||
41944199|NCT01898494|75689881|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
41944200|NCT01898494|75689882|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
41944201|NCT01898494|75689883|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
41944202|NCT01898494|75689884|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
41944203|NCT01898494|75689885|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
41944204|NCT01898494|75689881|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
41944205|NCT01898494|75689882|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
41944206|NCT01898494|75689883|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
41944207|NCT01898494|75689884|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
41944208|NCT01898494|75689885|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
41944209|NCT01898494|75689881|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
41944210|NCT01898494|75689882|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
41944211|NCT01898494|75689883|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
41944212|NCT01898494|75689884|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
41944213|NCT01898494|75689885|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
41944214|NCT01898494|75689881|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
41944215|NCT01898494|75689882|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
41944216|NCT01898494|75689883|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
41944217|NCT01898494|75689884|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
41944218|NCT01898494|75689885|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
41944219|NCT01898494|75689881|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
41944220|NCT01898494|75689882|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
41944221|NCT01898494|75689883|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
41944222|NCT01898494|75689884|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
41944223|NCT01898494|75689885|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
41944224|NCT01898494|75689881|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
41944225|NCT01898494|75689882|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
41944226|NCT01898494|75689883|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
41944227|NCT01898494|75689884|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
41944228|NCT01898494|75689885|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
41944229|NCT01898494|75689881|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
41944230|NCT01898494|75689882|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
41944231|NCT01898494|75689883|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
41944232|NCT01898494|75689884|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
41944233|NCT01898494|75689885|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
41944234|NCT01898494|75689881|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
41944235|NCT01898494|75689882|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
41944236|NCT01898494|75689883|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
41944237|NCT01898494|75689884|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
41944238|NCT01898494|75689885|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
41944239|NCT01898494|75689881|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
41944240|NCT01898494|75689882|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
41944241|NCT01898494|75689883|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
41944242|NCT01898494|75689884|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
41944243|NCT01898494|75689885|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
41944244|NCT01898494|75689881|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
41944245|NCT01898494|75689882|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
41944246|NCT01898494|75689883|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
41944247|NCT01898494|75689884|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
41944248|NCT01898494|75689885|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
41944249|NCT01898494|75689881|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
41944250|NCT01898494|75689882|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
41944251|NCT01898494|75689883|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
41944252|NCT01898494|75689884|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
41944253|NCT01898494|75689885|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
41944254|NCT01898494|75689881|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
41944255|NCT01898494|75689882|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
41944256|NCT01898494|75689883|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
41944257|NCT01898494|75689884|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
41944258|NCT01898494|75689885|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
41944259|NCT01898494|75689881|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
41944260|NCT01898494|75689882|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
41944261|NCT01898494|75689883|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
41944262|NCT01898494|75689884|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
41944263|NCT01898494|75689885|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
41944264|NCT01898494|75689881|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
41944265|NCT01898494|75689882|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
41944266|NCT01898494|75689883|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
41944267|NCT01898494|75689884|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
41944268|NCT01898494|75689885|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
41944269|NCT01863043|75689899|FG000|Overall Study|Death|6|||
41944270|NCT01863043|75689900|FG001|Overall Study|Death|1|||
41944271|NCT01863043|75689899|FG000|Overall Study|Withdrawal by Subject|0|||
41944272|NCT01863043|75689900|FG001|Overall Study|Withdrawal by Subject|2|||
41944273|NCT01863043|75689899|FG000|Overall Study|Adverse Event|7|||
41944274|NCT01863043|75689900|FG001|Overall Study|Adverse Event|8|||
41944275|NCT01863043|75689899|FG000|Overall Study|exclusion criteria found after enrollment|0|||
41944276|NCT01863043|75689900|FG001|Overall Study|exclusion criteria found after enrollment|1|||
41944277|NCT01841359|75689906|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
41944278|NCT01841359|75689906|FG000|Overall Study|Concommitant medical issues|2|||
41944279|NCT01841359|75689906|FG000|Overall Study|Adverse Event|3|||
41944280|NCT01841359|75689906|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
41944281|NCT01660451|75689916|FG000|Overall Study|Protocol Violation|0|||
41944282|NCT01660451|75689917|FG001|Overall Study|Protocol Violation|1|||
41944283|NCT01660451|75689918|FG002|Overall Study|Protocol Violation|1|||
41944284|NCT01660451|75689916|FG000|Overall Study|Adverse Event (AE) without Clinical PD|11|||
41944285|NCT01660451|75689917|FG001|Overall Study|Adverse Event (AE) without Clinical PD|8|||
41944286|NCT01660451|75689918|FG002|Overall Study|Adverse Event (AE) without Clinical PD|26|||
41944287|NCT01660451|75689916|FG000|Overall Study|AE with Clinical PD|1|||
41944288|NCT01660451|75689917|FG001|Overall Study|AE with Clinical PD|3|||
41944289|NCT01660451|75689918|FG002|Overall Study|AE with Clinical PD|9|||
41944290|NCT01660451|75689916|FG000|Overall Study|Sponsor Decision|0|||
41944291|NCT01660451|75689917|FG001|Overall Study|Sponsor Decision|0|||
41944292|NCT01660451|75689918|FG002|Overall Study|Sponsor Decision|1|||
41944293|NCT01660451|75689916|FG000|Overall Study|Protocol Deviation|0|||
41944294|NCT01660451|75689917|FG001|Overall Study|Protocol Deviation|0|||
41944295|NCT01660451|75689918|FG002|Overall Study|Protocol Deviation|1|||
41944296|NCT01660451|75689916|FG000|Overall Study|Physician Decision|1|||
41944297|NCT01660451|75689917|FG001|Overall Study|Physician Decision|2|||
41944298|NCT01660451|75689918|FG002|Overall Study|Physician Decision|5|||
41944299|NCT01660451|75689916|FG000|Overall Study|Withdrawal by Subject|1|||
41944300|NCT01660451|75689917|FG001|Overall Study|Withdrawal by Subject|0|||
41944301|NCT01660451|75689918|FG002|Overall Study|Withdrawal by Subject|16|||
41944302|NCT01660451|75689916|FG000|Overall Study|Ongoing with treatment|3|||
41944303|NCT01660451|75689917|FG001|Overall Study|Ongoing with treatment|3|||
41944304|NCT01660451|75689918|FG002|Overall Study|Ongoing with treatment|46|||
41944305|NCT01390584|75689937|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
41944306|NCT01390584|75689938|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
41944307|NCT01390584|75689939|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
41944308|NCT01242800|75689950|FG000|Overall Study|Patient refusal|0|||
41944309|NCT01242800|75689951|FG001|Overall Study|Patient refusal|10|||
41944310|NCT01242800|75689950|FG000|Overall Study|Physician Decision|0|||
41944311|NCT01242800|75689951|FG001|Overall Study|Physician Decision|1|||
41944312|NCT01242800|75689950|FG000|Overall Study|Disease progression|0|||
41944313|NCT01242800|75689951|FG001|Overall Study|Disease progression|3|||
41944314|NCT01242800|75689950|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
41944315|NCT01242800|75689951|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
41944316|NCT01242800|75689950|FG000|Overall Study|Reasons not reported|0|||
41944317|NCT01242800|75689951|FG001|Overall Study|Reasons not reported|4|||
41944318|NCT01216683|75689960|FG000|Induction|Never started treatment|0|||
41944319|NCT01216683|75689961|FG001|Induction|Never started treatment|6|||
42023266|NCT01194414|75830655|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
42023267|NCT01194414|75830656|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
41944320|NCT01216683|75689962|FG002|Induction|Never started treatment|3|||
41944321|NCT01216683|75689960|FG000|Induction|Lack of Efficacy|4|||
41944322|NCT01216683|75689961|FG001|Induction|Lack of Efficacy|3|||
41944323|NCT01216683|75689962|FG002|Induction|Lack of Efficacy|7|||
41944324|NCT01216683|75689960|FG000|Induction|Adverse Event|0|||
41944325|NCT01216683|75689961|FG001|Induction|Adverse Event|5|||
41944326|NCT01216683|75689962|FG002|Induction|Adverse Event|5|||
41944327|NCT01216683|75689960|FG000|Induction|Death|0|||
41944328|NCT01216683|75689961|FG001|Induction|Death|0|||
42023268|NCT01194414|75830657|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
41944329|NCT01216683|75689962|FG002|Induction|Death|2|||
41944330|NCT01216683|75689960|FG000|Induction|Withdrawal by Subject|0|||
41944331|NCT01216683|75689961|FG001|Induction|Withdrawal by Subject|4|||
41944332|NCT01216683|75689962|FG002|Induction|Withdrawal by Subject|2|||
41944333|NCT01216683|75689960|FG000|Induction|Other disease|0|||
41944334|NCT01216683|75689961|FG001|Induction|Other disease|1|||
41944335|NCT01216683|75689962|FG002|Induction|Other disease|2|||
41944336|NCT01216683|75689960|FG000|Continuation|Lack of Efficacy|3|||
41944337|NCT01216683|75689961|FG001|Continuation|Lack of Efficacy|2|||
41944338|NCT01216683|75689962|FG002|Continuation|Lack of Efficacy|7|||
41944339|NCT01216683|75689960|FG000|Continuation|Adverse Event|5|||
41944340|NCT01216683|75689961|FG001|Continuation|Adverse Event|3|||
41944341|NCT01216683|75689962|FG002|Continuation|Adverse Event|16|||
41944342|NCT01216683|75689960|FG000|Continuation|Death|1|||
41944343|NCT01216683|75689961|FG001|Continuation|Death|0|||
41944344|NCT01216683|75689962|FG002|Continuation|Death|2|||
41944345|NCT01216683|75689960|FG000|Continuation|Withdrawal by Subject|4|||
41944346|NCT01216683|75689961|FG001|Continuation|Withdrawal by Subject|5|||
41944347|NCT01216683|75689962|FG002|Continuation|Withdrawal by Subject|9|||
41944348|NCT01216683|75689960|FG000|Continuation|Other diseases|0|||
41944349|NCT01216683|75689961|FG001|Continuation|Other diseases|2|||
41944350|NCT01216683|75689962|FG002|Continuation|Other diseases|1|||
41944351|NCT01216683|75689960|FG000|Continuation|Physician Decision|1|||
41944352|NCT01216683|75689961|FG001|Continuation|Physician Decision|0|||
41944353|NCT01216683|75689962|FG002|Continuation|Physician Decision|1|||
41944354|NCT01216683|75689960|FG000|Continuation|Non-compliance|1|||
41944355|NCT01216683|75689961|FG001|Continuation|Non-compliance|0|||
41944356|NCT01216683|75689962|FG002|Continuation|Non-compliance|1|||
41944357|NCT01216683|75689960|FG000|Continuation|Insurance change|0|||
41944358|NCT01216683|75689961|FG001|Continuation|Insurance change|1|||
41944359|NCT01216683|75689962|FG002|Continuation|Insurance change|0|||
41944360|NCT01216683|75689960|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
41944361|NCT01216683|75689961|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
41944362|NCT01216683|75689962|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
41944363|NCT01216683|75689960|FG000|Continuation|Not reported|0|||
41944364|NCT01216683|75689961|FG001|Continuation|Not reported|0|||
41944365|NCT01216683|75689962|FG002|Continuation|Not reported|1|||
41944366|NCT01216683|75689960|FG000|Continuation|Never started treatment|0|||
41944367|NCT01216683|75689961|FG001|Continuation|Never started treatment|1|||
41944368|NCT01216683|75689962|FG002|Continuation|Never started treatment|5|||
41944369|NCT01145495|75689983|FG000|Overall Study|Adverse Event|6|||
41944370|NCT01145495|75689983|FG000|Overall Study|Withdrawal by Subject|6|||
41944371|NCT01145495|75689983|FG000|Overall Study|Disease progression after respone|2|||
41944372|NCT01124695|75689989|FG000|Overall Study|Disease progression|77|||
41944373|NCT01124695|75689989|FG000|Overall Study|Adverse Event|11|||
41944374|NCT01124695|75689989|FG000|Overall Study|Death|1|||
41944375|NCT01124695|75689989|FG000|Overall Study|Withdrawal by Subject|7|||
41944376|NCT01124695|75689989|FG000|Overall Study|Physician Decision|3|||
41944377|NCT01124695|75689989|FG000|Overall Study|Alternative therapy|9|||
41944378|NCT01124695|75689989|FG000|Overall Study|No documentation that patient went off treatment|4|||
41944379|NCT01124695|75689989|FG000|Overall Study|Ineligible|9|||
41944380|NCT01124695|75689989|FG000|Overall Study|Ineligible and never start treatment|2|||
41944381|NCT01084083|75690000|FG000|Overall Study|Adverse Event|5|||
42023269|NCT01194414|75830658|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
42023270|NCT01194414|75830655|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
42023271|NCT01194414|75830656|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
42023272|NCT01194414|75830657|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
42023273|NCT01194414|75830658|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
42023274|NCT01194414|75830655|FG000|24 Weeks Double Blind Period|Other|0|||
42023275|NCT01194414|75830656|FG001|24 Weeks Double Blind Period|Other|1|||
42023276|NCT01194414|75830657|FG002|24 Weeks Double Blind Period|Other|0|||
42023277|NCT01194414|75830658|FG003|24 Weeks Double Blind Period|Other|0|||
42023278|NCT01194414|75830655|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
42023279|NCT01194414|75830656|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
42023280|NCT01194414|75830657|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
42023281|NCT01194414|75830658|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
41944382|NCT01084083|75690000|FG000|Overall Study|Death|1|||
41944383|NCT01084083|75690000|FG000|Overall Study|Withdrawal by Subject|2|||
41944384|NCT01084083|75690000|FG000|Overall Study|Complicating disease|1|||
41944385|NCT01084083|75690000|FG000|Overall Study|Other|2|||
41944386|NCT01084083|75690000|FG000|Overall Study|Never started assigned therapy|1|||
41944387|NCT01079780|75690008|FG000|Overall Study|Disease progression|43|||
41944388|NCT01079780|75690009|FG001|Overall Study|Disease progression|7|||
41944389|NCT01079780|75690010|FG002|Overall Study|Disease progression|31|||
41944390|NCT01079780|75690008|FG000|Overall Study|Adverse Event|13|||
42023282|NCT01194414|75830655|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
41944391|NCT01079780|75690009|FG001|Overall Study|Adverse Event|5|||
41944392|NCT01079780|75690010|FG002|Overall Study|Adverse Event|7|||
41944393|NCT01079780|75690008|FG000|Overall Study|Death|2|||
41944394|NCT01079780|75690009|FG001|Overall Study|Death|0|||
41944395|NCT01079780|75690010|FG002|Overall Study|Death|2|||
41944396|NCT01079780|75690008|FG000|Overall Study|Withdrawal by Subject|6|||
41944397|NCT01079780|75690009|FG001|Overall Study|Withdrawal by Subject|4|||
41944398|NCT01079780|75690010|FG002|Overall Study|Withdrawal by Subject|4|||
41944399|NCT01079780|75690008|FG000|Overall Study|Alternative therapy|2|||
41944400|NCT01079780|75690009|FG001|Overall Study|Alternative therapy|0|||
41944401|NCT01079780|75690010|FG002|Overall Study|Alternative therapy|2|||
41944402|NCT01079780|75690008|FG000|Overall Study|Physician Decision|1|||
41944403|NCT01079780|75690009|FG001|Overall Study|Physician Decision|0|||
41944404|NCT01079780|75690010|FG002|Overall Study|Physician Decision|1|||
41944405|NCT01079780|75690008|FG000|Overall Study|Error made in lesion measurement|1|||
41944406|NCT01079780|75690009|FG001|Overall Study|Error made in lesion measurement|0|||
41944407|NCT01079780|75690010|FG002|Overall Study|Error made in lesion measurement|0|||
41944408|NCT01079780|75690008|FG000|Overall Study|Patient had surgery|1|||
41944409|NCT01079780|75690009|FG001|Overall Study|Patient had surgery|0|||
41944410|NCT01079780|75690010|FG002|Overall Study|Patient had surgery|0|||
41944411|NCT01079780|75690008|FG000|Overall Study|Treatment cycle delay|0|||
41944412|NCT01079780|75690009|FG001|Overall Study|Treatment cycle delay|0|||
41944413|NCT01079780|75690010|FG002|Overall Study|Treatment cycle delay|1|||
41944414|NCT01079780|75690008|FG000|Overall Study|Never started treatment|1|||
41944415|NCT01079780|75690009|FG001|Overall Study|Never started treatment|0|||
41944416|NCT01079780|75690010|FG002|Overall Study|Never started treatment|2|||
41944417|NCT01013961|75690020|FG000|Overall Study|Adverse Event|2|||
41944418|NCT01013961|75690021|FG001|Overall Study|Adverse Event|2|||
41944419|NCT01013961|75690020|FG000|Overall Study|Withdrawal by Subject|1|||
41944420|NCT01013961|75690021|FG001|Overall Study|Withdrawal by Subject|0|||
41944421|NCT01013961|75690020|FG000|Overall Study|Physician Decision|0|||
41944422|NCT01013961|75690021|FG001|Overall Study|Physician Decision|1|||
41944423|NCT00834093|75690036|FG000|Overall Study|Progressive Disease|3|||
41944424|NCT00834093|75690036|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
41944425|NCT00606294|75690042|FG000|Overall Study|Withdrawal by Subject|36|||
41944426|NCT00606294|75690043|FG001|Overall Study|Withdrawal by Subject|0|||
41944427|NCT00583596|75690049|FG000|Overall Study|Lost to Follow-up|110|||
41944428|NCT00583596|75690049|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
41944429|NCT00583596|75690049|FG000|Overall Study|Death|2|||
41944430|NCT00583596|75690049|FG000|Overall Study|Withdrawal by Subject|6|||
41944431|NCT00583596|75690049|FG000|Overall Study|Lost to Follow-up|94|||
41944432|NCT00583596|75690049|FG000|Overall Study|Data not complete|1|||
41944433|NCT00583596|75690049|FG000|Overall Study|Not consented|15|||
41944434|NCT00583596|75690049|FG000|Overall Study|Outside f-up window|26|||
41944435|NCT00316888|75690060|FG000|Overall Study|Adverse Event|4|||
41944436|NCT00316888|75690061|FG001|Overall Study|Adverse Event|5|||
41944437|NCT00316888|75690060|FG000|Overall Study|Withdrawal by Subject|2|||
41944438|NCT00316888|75690061|FG001|Overall Study|Withdrawal by Subject|2|||
41944439|NCT00316888|75690060|FG000|Overall Study|Not start protocol therapy|0|||
41944440|NCT00316888|75690061|FG001|Overall Study|Not start protocol therapy|1|||
41944441|NCT00274924|75690070|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
41944442|NCT00274924|75690071|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
41944443|NCT00274924|75690072|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
41944444|NCT00274924|75690070|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
41944445|NCT00274924|75690071|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
41944446|NCT00274924|75690072|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
41944447|NCT00274924|75690070|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
41944448|NCT00274924|75690071|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
41944449|NCT00274924|75690072|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
41944450|NCT00274924|75690070|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
41944451|NCT00274924|75690071|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
41944452|NCT00274924|75690072|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
41944453|NCT00274924|75690070|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
41944454|NCT00274924|75690071|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
41944455|NCT00274924|75690072|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
41944456|NCT00274924|75690070|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
41944457|NCT00274924|75690071|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
41944458|NCT00274924|75690072|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
41944459|NCT00274924|75690070|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
41944460|NCT00274924|75690071|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
41944461|NCT00274924|75690072|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
41944462|NCT00274924|75690070|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
41944463|NCT00274924|75690071|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
41944464|NCT00274924|75690072|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
41944465|NCT00274924|75690070|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
41944466|NCT00274924|75690071|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
41944467|NCT00274924|75690072|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
41944468|NCT00274924|75690070|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
41944469|NCT00274924|75690071|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
41944470|NCT00274924|75690072|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
41944471|NCT00274924|75690070|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
41944472|NCT00274924|75690071|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
41944473|NCT00274924|75690072|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
41944474|NCT00274924|75690070|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
41944475|NCT00274924|75690071|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
41944476|NCT00274924|75690072|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
41944477|NCT00274924|75690070|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
41944478|NCT00274924|75690071|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
41944479|NCT00274924|75690072|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
41944480|NCT00104884|75690079|FG000|Overall Study|Disease progression|4|||
41944481|NCT00096174|75690083|FG000|Overall Study|Lack of Efficacy|9|||
41944482|NCT00096174|75690083|FG000|Overall Study|Adverse Event|15|||
41944483|NCT00096174|75690083|FG000|Overall Study|Death|6|||
41944484|NCT00096174|75690083|FG000|Overall Study|Withdrawal by Subject|15|||
41944485|NCT00096174|75690083|FG000|Overall Study|Not started protocol therapy|3|||
41944486|NCT00096174|75690083|FG000|Overall Study|Ineligible|6|||
41944487|NCT00096174|75690083|FG000|Overall Study|other reason|8|||
41944488|NCT00080938|75690087|FG000|Overall Study|Adverse Event|3|||
41944489|NCT00080938|75690087|FG000|Overall Study|Withdrawal by Subject|6|||
41944490|NCT00080938|75690087|FG000|Overall Study|Death|2|||
41944491|NCT00080938|75690087|FG000|Overall Study|Lack of Efficacy|7|||
41944492|NCT00080938|75690087|FG000|Overall Study|other disease|1|||
41944493|NCT00080938|75690087|FG000|Overall Study|Not started protocol therapy|1|||
41944494|NCT00080938|75690087|FG000|Overall Study|Ineligible|4|||
41944495|NCT00074282|75690091|FG000|Step 1|Adverse Event|32|||
41944496|NCT00074282|75690092|FG001|Step 1|Adverse Event|0|||
41944497|NCT00074282|75690093|FG002|Step 1|Adverse Event|0|||
41944498|NCT00074282|75690091|FG000|Step 1|Death|6|||
41944499|NCT00074282|75690092|FG001|Step 1|Death|0|||
41944500|NCT00074282|75690093|FG002|Step 1|Death|0|||
41944501|NCT00074282|75690091|FG000|Step 1|Withdrawal by Subject|7|||
41944502|NCT00074282|75690092|FG001|Step 1|Withdrawal by Subject|0|||
41944503|NCT00074282|75690093|FG002|Step 1|Withdrawal by Subject|0|||
41944504|NCT00074282|75690091|FG000|Step 1|Disease progression|2|||
41944505|NCT00074282|75690092|FG001|Step 1|Disease progression|0|||
41944506|NCT00074282|75690093|FG002|Step 1|Disease progression|0|||
41944507|NCT00074282|75690091|FG000|Step 1|Alternative therapy|2|||
41944508|NCT00074282|75690092|FG001|Step 1|Alternative therapy|0|||
41944509|NCT00074282|75690093|FG002|Step 1|Alternative therapy|0|||
41944510|NCT00074282|75690091|FG000|Step 1|Other complicating disease|2|||
41944511|NCT00074282|75690092|FG001|Step 1|Other complicating disease|0|||
41944512|NCT00074282|75690093|FG002|Step 1|Other complicating disease|0|||
41944513|NCT00074282|75690091|FG000|Step 1|Physician Decision|1|||
41944514|NCT00074282|75690092|FG001|Step 1|Physician Decision|0|||
41944515|NCT00074282|75690093|FG002|Step 1|Physician Decision|0|||
41944516|NCT00074282|75690091|FG000|Step 1|Ineligible|4|||
41944517|NCT00074282|75690092|FG001|Step 1|Ineligible|0|||
41944518|NCT00074282|75690093|FG002|Step 1|Ineligible|0|||
41944519|NCT00074282|75690091|FG000|Step 1|Never started treatment|2|||
41944520|NCT00074282|75690092|FG001|Step 1|Never started treatment|0|||
41944521|NCT00074282|75690093|FG002|Step 1|Never started treatment|0|||
41944522|NCT00074282|75690091|FG000|Step 2|Adverse Event|0|||
41944523|NCT00074282|75690092|FG001|Step 2|Adverse Event|2|||
41944524|NCT00074282|75690093|FG002|Step 2|Adverse Event|12|||
41944525|NCT00074282|75690091|FG000|Step 2|Disease progression|0|||
41944526|NCT00074282|75690092|FG001|Step 2|Disease progression|0|||
41944527|NCT00074282|75690093|FG002|Step 2|Disease progression|5|||
42023283|NCT01194414|75830656|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
42023284|NCT01194414|75830657|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
42023285|NCT01194414|75830658|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
41944528|NCT00074282|75690091|FG000|Step 2|Death|0|||
41944529|NCT00074282|75690092|FG001|Step 2|Death|0|||
41944530|NCT00074282|75690093|FG002|Step 2|Death|3|||
41944531|NCT00074282|75690091|FG000|Step 2|Withdrawal by Subject|0|||
41944532|NCT00074282|75690092|FG001|Step 2|Withdrawal by Subject|0|||
41944533|NCT00074282|75690093|FG002|Step 2|Withdrawal by Subject|2|||
41944534|NCT00074282|75690091|FG000|Step 2|Physician Decision|0|||
41944535|NCT00074282|75690092|FG001|Step 2|Physician Decision|0|||
41944536|NCT00074282|75690093|FG002|Step 2|Physician Decision|1|||
41944537|NCT00074282|75690091|FG000|Step 2|Ineligible|0|||
41944538|NCT00074282|75690092|FG001|Step 2|Ineligible|0|||
41944539|NCT00074282|75690093|FG002|Step 2|Ineligible|1|||
41944540|NCT00071981|75690105|FG000|Overall Study|Lack of Efficacy|37|||
41944541|NCT00071981|75690106|FG001|Overall Study|Lack of Efficacy|29|||
41944542|NCT00071981|75690107|FG002|Overall Study|Lack of Efficacy|30|||
41944543|NCT00071981|75690108|FG003|Overall Study|Lack of Efficacy|43|||
41944544|NCT00071981|75690105|FG000|Overall Study|Adverse Event|4|||
41944545|NCT00071981|75690106|FG001|Overall Study|Adverse Event|4|||
41944546|NCT00071981|75690107|FG002|Overall Study|Adverse Event|3|||
41944547|NCT00071981|75690108|FG003|Overall Study|Adverse Event|1|||
41944548|NCT00071981|75690105|FG000|Overall Study|Death|0|||
41944549|NCT00071981|75690106|FG001|Overall Study|Death|0|||
41944550|NCT00071981|75690107|FG002|Overall Study|Death|1|||
41944551|NCT00071981|75690108|FG003|Overall Study|Death|1|||
41944552|NCT00071981|75690105|FG000|Overall Study|Withdrawal by Subject|3|||
41944553|NCT00071981|75690106|FG001|Overall Study|Withdrawal by Subject|1|||
41944554|NCT00071981|75690107|FG002|Overall Study|Withdrawal by Subject|0|||
41944555|NCT00071981|75690108|FG003|Overall Study|Withdrawal by Subject|0|||
41944556|NCT00071981|75690105|FG000|Overall Study|No protocol therapy|2|||
41944557|NCT00071981|75690106|FG001|Overall Study|No protocol therapy|5|||
41944558|NCT00071981|75690107|FG002|Overall Study|No protocol therapy|1|||
41944559|NCT00071981|75690108|FG003|Overall Study|No protocol therapy|0|||
41944560|NCT00071981|75690105|FG000|Overall Study|others (not specified in the study)|0|||
41944561|NCT00071981|75690106|FG001|Overall Study|others (not specified in the study)|2|||
41944562|NCT00071981|75690107|FG002|Overall Study|others (not specified in the study)|2|||
41944563|NCT00071981|75690108|FG003|Overall Study|others (not specified in the study)|0|||
41944564|NCT00070291|75690118|FG000|Step 1|Withdrawal by Subject|1|||
41944565|NCT00070291|75690118|FG000|Step 1|Adverse Event|1|||
41944566|NCT00070291|75690118|FG000|Step 2|Adverse Event|1|||
41944567|NCT00064350|75690125|FG000|Induction Treatment|Disease Progression|5|||
41944568|NCT00064350|75690126|FG001|Induction Treatment|Disease Progression|1|||
41944569|NCT00064350|75690127|FG002|Induction Treatment|Disease Progression|110|||
41944570|NCT00064350|75690125|FG000|Induction Treatment|Adverse Event|0|||
41944571|NCT00064350|75690126|FG001|Induction Treatment|Adverse Event|2|||
41944572|NCT00064350|75690127|FG002|Induction Treatment|Adverse Event|49|||
41944573|NCT00064350|75690125|FG000|Induction Treatment|Death|0|||
41944574|NCT00064350|75690126|FG001|Induction Treatment|Death|0|||
41944575|NCT00064350|75690127|FG002|Induction Treatment|Death|9|||
41944576|NCT00064350|75690125|FG000|Induction Treatment|Withdrawal by Subject|0|||
41944577|NCT00064350|75690126|FG001|Induction Treatment|Withdrawal by Subject|0|||
41944578|NCT00064350|75690127|FG002|Induction Treatment|Withdrawal by Subject|21|||
41944579|NCT00064350|75690125|FG000|Induction Treatment|Ineligible or never started treatment|3|||
41944580|NCT00064350|75690126|FG001|Induction Treatment|Ineligible or never started treatment|6|||
41944581|NCT00064350|75690127|FG002|Induction Treatment|Ineligible or never started treatment|34|||
41944582|NCT00064350|75690125|FG000|Induction Treatment|Other|0|||
41944583|NCT00064350|75690126|FG001|Induction Treatment|Other|0|||
41944584|NCT00064350|75690127|FG002|Induction Treatment|Other|13|||
41944585|NCT00064350|75690125|FG000|Randomization|Adverse Event|8|||
41944586|NCT00064350|75690126|FG001|Randomization|Adverse Event|3|||
41944587|NCT00064350|75690127|FG002|Randomization|Adverse Event|0|||
41944588|NCT00064350|75690125|FG000|Randomization|Death|3|||
41944589|NCT00064350|75690126|FG001|Randomization|Death|0|||
41944590|NCT00064350|75690127|FG002|Randomization|Death|0|||
41944591|NCT00064350|75690125|FG000|Randomization|Withdrawal by Subject|1|||
41944592|NCT00064350|75690126|FG001|Randomization|Withdrawal by Subject|0|||
41944593|NCT00064350|75690127|FG002|Randomization|Withdrawal by Subject|0|||
41944594|NCT00064350|75690125|FG000|Randomization|Ineligible or never started treatment|9|||
41944595|NCT00064350|75690126|FG001|Randomization|Ineligible or never started treatment|15|||
41944596|NCT00064350|75690127|FG002|Randomization|Ineligible or never started treatment|0|||
41944597|NCT00064350|75690125|FG000|Randomization|Other|5|||
41944598|NCT00064350|75690126|FG001|Randomization|Other|0|||
41944599|NCT00064350|75690127|FG002|Randomization|Other|0|||
41944600|NCT00064350|75690125|FG000|Cross-Over|Adverse Event|0|||
41944601|NCT00064350|75690126|FG001|Cross-Over|Adverse Event|1|||
41944602|NCT00064350|75690127|FG002|Cross-Over|Adverse Event|0|||
42023286|NCT01194414|75830655|FG000|24 Weeks Double Blind Period|Death|0|||
42023287|NCT01194414|75830656|FG001|24 Weeks Double Blind Period|Death|1|||
42023288|NCT01194414|75830657|FG002|24 Weeks Double Blind Period|Death|0|||
42023289|NCT01194414|75830658|FG003|24 Weeks Double Blind Period|Death|0|||
42023290|NCT01194414|75830655|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
42023291|NCT01194414|75830656|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
41944603|NCT00064350|75690125|FG000|Cross-Over|Death|1|||
41944604|NCT00064350|75690126|FG001|Cross-Over|Death|3|||
41944605|NCT00064350|75690127|FG002|Cross-Over|Death|0|||
41944606|NCT00064350|75690125|FG000|Cross-Over|Withdrawal by Subject|2|||
41944607|NCT00064350|75690126|FG001|Cross-Over|Withdrawal by Subject|2|||
41944608|NCT00064350|75690127|FG002|Cross-Over|Withdrawal by Subject|0|||
41944609|NCT00064350|75690125|FG000|Cross-Over|Ineligible or never started treatment|3|||
41944610|NCT00064350|75690126|FG001|Cross-Over|Ineligible or never started treatment|6|||
41944611|NCT00064350|75690127|FG002|Cross-Over|Ineligible or never started treatment|0|||
41944612|NCT00064350|75690125|FG000|Cross-Over|Other|0|||
41944613|NCT00064350|75690126|FG001|Cross-Over|Other|2|||
41944614|NCT00064350|75690127|FG002|Cross-Over|Other|0|||
41944615|NCT00063986|75690136|FG000|Overall Study|Withdrawal by Subject|1|||
41944616|NCT00063986|75690136|FG000|Overall Study|Ineligible|1|||
41944617|NCT00063986|75690136|FG000|Overall Study|Intra-operatively ineligible|4|||
41944618|NCT00057954|75690144|FG000|Overall Study|Death|1|||
41944619|NCT00057954|75690144|FG000|Overall Study|Disease progression|1|||
41944620|NCT00049530|75690148|FG000|Overall Study|Lack of Efficacy|25|||
41944621|NCT00049530|75690148|FG000|Overall Study|Adverse Event|2|||
41944622|NCT00049530|75690148|FG000|Overall Study|Death|1|||
41944623|NCT00049530|75690148|FG000|Overall Study|symptomatic deterioration|1|||
41944624|NCT00049530|75690148|FG000|Overall Study|ineligible|3|||
41944625|NCT00045305|75690152|FG000|Overall Study|Lack of Efficacy|6|||
41944626|NCT00045305|75690152|FG000|Overall Study|Adverse Event|3|||
41944627|NCT00045305|75690152|FG000|Overall Study|Death|3|||
41944628|NCT00045305|75690152|FG000|Overall Study|site error|2|||
41944629|NCT00033657|75690158|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
41944630|NCT00033657|75690159|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
41944631|NCT00033657|75690158|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
41944632|NCT00033657|75690159|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
41944633|NCT00033657|75690158|FG000|Neoadjuvant Chemotherapy|Death|1|||
41944634|NCT00033657|75690159|FG001|Neoadjuvant Chemotherapy|Death|1|||
41944635|NCT00033657|75690158|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
41944636|NCT00033657|75690159|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
41944637|NCT00033657|75690158|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
41944638|NCT00033657|75690159|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
41944639|NCT00033657|75690158|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
41944640|NCT00033657|75690159|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
41944641|NCT00033657|75690158|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
41944642|NCT00033657|75690159|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
41944643|NCT00033657|75690158|FG000|Surgical Resection|not complete resection|0|||
41944644|NCT00033657|75690159|FG001|Surgical Resection|not complete resection|3|||
41944645|NCT00033657|75690158|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
41944646|NCT00033657|75690159|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
41944647|NCT00033657|75690158|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
41944648|NCT00033657|75690159|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
41944649|NCT00033657|75690158|FG000|Adjuvant Chemotherapy|Death|2|||
41944650|NCT00033657|75690159|FG001|Adjuvant Chemotherapy|Death|1|||
41944651|NCT00033657|75690158|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
41944652|NCT00033657|75690159|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
41944653|NCT00033657|75690158|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
41944654|NCT00033657|75690159|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
41944655|NCT00033657|75690158|FG000|Adjuvant Chemotherapy|Other|0|||
41944656|NCT00033657|75690159|FG001|Adjuvant Chemotherapy|Other|2|||
41944657|NCT00003389|75690169|FG000|Overall Study|Disease progression|6|||
41944658|NCT00003389|75690170|FG001|Overall Study|Disease progression|1|||
41944659|NCT00003389|75690169|FG000|Overall Study|Adverse Event|13|||
41944660|NCT00003389|75690170|FG001|Overall Study|Adverse Event|2|||
41944661|NCT00003389|75690169|FG000|Overall Study|Death|0|||
41944662|NCT00003389|75690170|FG001|Overall Study|Death|3|||
41944663|NCT00003389|75690169|FG000|Overall Study|Withdrawal by Subject|12|||
41944664|NCT00003389|75690170|FG001|Overall Study|Withdrawal by Subject|5|||
41944665|NCT00003389|75690169|FG000|Overall Study|Alternative therapy|2|||
41944666|NCT00003389|75690170|FG001|Overall Study|Alternative therapy|1|||
41944667|NCT00003389|75690169|FG000|Overall Study|Complicating disease|1|||
41944668|NCT00003389|75690170|FG001|Overall Study|Complicating disease|0|||
41944669|NCT00003389|75690169|FG000|Overall Study|Off-treatment reason missing|31|||
41944670|NCT00003389|75690170|FG001|Overall Study|Off-treatment reason missing|21|||
41944671|NCT00003389|75690169|FG000|Overall Study|Ineligible|33|||
41944672|NCT00003389|75690170|FG001|Overall Study|Ineligible|27|||
41944673|NCT00003138|75690178|FG000|Step 1|Reasons off treatment not documented|60|||
41944674|NCT00003138|75690179|FG001|Step 1|Reasons off treatment not documented|57|||
41944675|NCT00003138|75690178|FG000|Step 1|Never started treatment|1|||
41944676|NCT00003138|75690179|FG001|Step 1|Never started treatment|0|||
41944677|NCT00003138|75690178|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
41944678|NCT00003138|75690179|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
41944679|NCT00003138|75690178|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
41944680|NCT00003138|75690179|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
42023292|NCT01194414|75830657|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
41944681|NCT00003138|75690178|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
42023293|NCT01194414|75830658|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
42300336|NCT02299635|76135501|FG000|Overall Study|Death|1|||
41944682|NCT00003138|75690179|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
41944683|NCT00003138|75690178|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
41944684|NCT00003138|75690179|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
41944685|NCT00002525|75690190|FG000|Overall Study|Adverse Event|36|||
41944686|NCT00002525|75690191|FG001|Overall Study|Adverse Event|0|||
41944687|NCT00002525|75690190|FG000|Overall Study|Death|5|||
41944688|NCT00002525|75690191|FG001|Overall Study|Death|0|||
41944689|NCT00002525|75690190|FG000|Overall Study|Withdrawal by Subject|11|||
41944690|NCT00002525|75690191|FG001|Overall Study|Withdrawal by Subject|0|||
41944691|NCT00002525|75690190|FG000|Overall Study|Start non-protocol therapy|1|||
41944692|NCT00002525|75690191|FG001|Overall Study|Start non-protocol therapy|0|||
41944693|NCT00002525|75690190|FG000|Overall Study|Other complicating disease|1|||
41944694|NCT00002525|75690191|FG001|Overall Study|Other complicating disease|0|||
41944695|NCT00002525|75690190|FG000|Overall Study|Duke's A, B1, D disease|92|||
41944696|NCT00002525|75690191|FG001|Overall Study|Duke's A, B1, D disease|0|||
41944697|NCT00002525|75690190|FG000|Overall Study|Error|6|||
41944698|NCT00002525|75690191|FG001|Overall Study|Error|0|||
41944699|NCT00002525|75690190|FG000|Overall Study|Other|26|||
41944700|NCT00002525|75690191|FG001|Overall Study|Other|0|||
41944701|NCT00002525|75690190|FG000|Overall Study|Never start protocol therapy|8|||
41944702|NCT00002525|75690191|FG001|Overall Study|Never start protocol therapy|0|||
41944703|NCT02259348|75690199|FG000|Overall Study|Donors|6|||
41944704|NCT02259348|75690199|FG000|Overall Study|Death|4|||
41944705|NCT02259114|75690456|FG000|Overall Study|Progressive Disease|14|||
41944706|NCT02259114|75690457|FG001|Overall Study|Progressive Disease|2|||
41944707|NCT02259114|75690458|FG002|Overall Study|Progressive Disease|10|||
41944708|NCT02259114|75690459|FG003|Overall Study|Progressive Disease|2|||
41944709|NCT02259114|75690460|FG004|Overall Study|Progressive Disease|5|||
41944710|NCT02259114|75690456|FG000|Overall Study|Adverse Event|2|||
41944711|NCT02259114|75690457|FG001|Overall Study|Adverse Event|1|||
41944712|NCT02259114|75690458|FG002|Overall Study|Adverse Event|0|||
41944713|NCT02259114|75690459|FG003|Overall Study|Adverse Event|0|||
41944714|NCT02259114|75690460|FG004|Overall Study|Adverse Event|1|||
41944715|NCT02259114|75690456|FG000|Overall Study|Death|3|||
41944716|NCT02259114|75690457|FG001|Overall Study|Death|0|||
41944717|NCT02259114|75690458|FG002|Overall Study|Death|1|||
41944718|NCT02259114|75690459|FG003|Overall Study|Death|0|||
41944719|NCT02259114|75690460|FG004|Overall Study|Death|0|||
41944720|NCT02259114|75690456|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
41944721|NCT02259114|75690457|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
41944722|NCT02259114|75690458|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
41944723|NCT02259114|75690459|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
41944724|NCT02259114|75690460|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
41944725|NCT02259114|75690456|FG000|Overall Study|Withdrawal by Subject|0|||
41944726|NCT02259114|75690457|FG001|Overall Study|Withdrawal by Subject|0|||
41944727|NCT02259114|75690458|FG002|Overall Study|Withdrawal by Subject|1|||
41944728|NCT02259114|75690459|FG003|Overall Study|Withdrawal by Subject|1|||
41944729|NCT02259114|75690460|FG004|Overall Study|Withdrawal by Subject|0|||
41944730|NCT02259114|75690456|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
41944731|NCT02259114|75690457|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
41944732|NCT02259114|75690458|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
41944733|NCT02259114|75690459|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
41944734|NCT02259114|75690460|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
41944735|NCT02259114|75690456|FG000|Overall Study|Not Treated|1|||
41944736|NCT02259114|75690457|FG001|Overall Study|Not Treated|0|||
41944737|NCT02259114|75690458|FG002|Overall Study|Not Treated|0|||
41944738|NCT02259114|75690459|FG003|Overall Study|Not Treated|0|||
41944739|NCT02259114|75690460|FG004|Overall Study|Not Treated|0|||
41944740|NCT02258334|75690515|FG000|Overall Study|Adverse Event|1|||
41944741|NCT02258334|75690516|FG001|Overall Study|Adverse Event|0|||
41944742|NCT02258334|75690517|FG002|Overall Study|Adverse Event|0|||
41944743|NCT02258334|75690518|FG003|Overall Study|Adverse Event|0|||
41944744|NCT04960202|75690555|FG000|Overall Study|Other|12|||
41944745|NCT04960202|75690556|FG001|Overall Study|Other|10|||
41944746|NCT04960202|75690555|FG000|Overall Study|Withdrawal by Subject|43|||
41944747|NCT04960202|75690556|FG001|Overall Study|Withdrawal by Subject|45|||
41944748|NCT04960202|75690555|FG000|Overall Study|Lost to Follow-up|20|||
41944749|NCT04960202|75690556|FG001|Overall Study|Lost to Follow-up|17|||
41944750|NCT04960202|75690555|FG000|Overall Study|Death|0|||
41944751|NCT04960202|75690556|FG001|Overall Study|Death|15|||
41944752|NCT02257632|75690626|FG000|Overall Study|Withdrawal by Subject|0|||
41944753|NCT02257632|75690627|FG001|Overall Study|Withdrawal by Subject|1|||
41944754|NCT02257632|75690626|FG000|Overall Study|Adverse Event|1|||
41944755|NCT02257632|75690627|FG001|Overall Study|Adverse Event|2|||
41944756|NCT01642914|75690661|FG000|Overall Study|Adverse Event|11|||
41944757|NCT01642914|75690662|FG001|Overall Study|Adverse Event|7|||
41944758|NCT01642914|75690663|FG002|Overall Study|Adverse Event|15|||
41944759|NCT01642914|75690661|FG000|Overall Study|Lack of Efficacy|9|||
41944760|NCT01642914|75690662|FG001|Overall Study|Lack of Efficacy|4|||
41944761|NCT01642914|75690663|FG002|Overall Study|Lack of Efficacy|2|||
41944762|NCT01642914|75690661|FG000|Overall Study|Protocol Violation|15|||
41944763|NCT01642914|75690662|FG001|Overall Study|Protocol Violation|13|||
41944764|NCT01642914|75690663|FG002|Overall Study|Protocol Violation|6|||
41944765|NCT01642914|75690661|FG000|Overall Study|Withdrawal by Subject|5|||
41944766|NCT01642914|75690662|FG001|Overall Study|Withdrawal by Subject|5|||
41944767|NCT01642914|75690663|FG002|Overall Study|Withdrawal by Subject|10|||
41944768|NCT01642914|75690661|FG000|Overall Study|Lost to Follow-up|5|||
41944769|NCT01642914|75690662|FG001|Overall Study|Lost to Follow-up|3|||
41944770|NCT01642914|75690663|FG002|Overall Study|Lost to Follow-up|7|||
41944771|NCT01642914|75690661|FG000|Overall Study|Other Reason|1|||
41944772|NCT01642914|75690662|FG001|Overall Study|Other Reason|0|||
41944773|NCT01642914|75690663|FG002|Overall Study|Other Reason|0|||
41944774|NCT01642602|75690722|FG000|Overall Study|Adverse Event|2|||
41944775|NCT02256540|75690788|FG000|Overall Study|Withdrawal by Subject|0|||
41944776|NCT02256540|75690789|FG001|Overall Study|Withdrawal by Subject|1|||
41944777|NCT02256540|75690790|FG002|Overall Study|Withdrawal by Subject|1|||
41944778|NCT02256540|75690788|FG000|Overall Study|Back pain preventing exercise|0|||
41944779|NCT02256540|75690789|FG001|Overall Study|Back pain preventing exercise|0|||
41944780|NCT02256540|75690790|FG002|Overall Study|Back pain preventing exercise|1|||
41944781|NCT01640184|75690814|FG000|Overall Study|Death|1|||
41944782|NCT01640184|75690815|FG001|Overall Study|Death|0|||
41944783|NCT01640184|75690816|FG002|Overall Study|Death|0|||
41944784|NCT01640184|75690814|FG000|Overall Study|Lost to Follow-up|4|||
41944785|NCT01640184|75690815|FG001|Overall Study|Lost to Follow-up|1|||
41944786|NCT01640184|75690816|FG002|Overall Study|Lost to Follow-up|0|||
41944787|NCT01640184|75690814|FG000|Overall Study|Physician Decision|3|||
41944788|NCT01640184|75690815|FG001|Overall Study|Physician Decision|0|||
41944789|NCT01640184|75690816|FG002|Overall Study|Physician Decision|0|||
41944790|NCT01640184|75690814|FG000|Overall Study|Withdrawal by Subject|0|||
41944791|NCT01640184|75690815|FG001|Overall Study|Withdrawal by Subject|1|||
41944792|NCT01640184|75690816|FG002|Overall Study|Withdrawal by Subject|1|||
41944793|NCT01640184|75690814|FG000|Overall Study|Protocol Violation|0|||
41944794|NCT01640184|75690815|FG001|Overall Study|Protocol Violation|0|||
41944795|NCT01640184|75690816|FG002|Overall Study|Protocol Violation|1|||
41944796|NCT02256384|75690836|FG000|Overall Study|Withdrawal by Subject|12|||
41944797|NCT02256384|75690836|FG000|Overall Study|Equipment not capturing data|2|||
41944798|NCT02255760|75690879|FG000|Overall Study|Lost to Follow-up|0|||
41944799|NCT02255760|75690880|FG001|Overall Study|Lost to Follow-up|1|||
41944800|NCT02255760|75690881|FG002|Overall Study|Lost to Follow-up|0|||
41944801|NCT02255760|75690882|FG003|Overall Study|Lost to Follow-up|0|||
41944802|NCT02255760|75690883|FG004|Overall Study|Lost to Follow-up|0|||
41944803|NCT01641822|75690979|FG000|Run-in Phase|Noncompliance with study drug|1|||
41944804|NCT01641822|75690980|FG001|Run-in Phase|Noncompliance with study drug|0|||
41944805|NCT01641822|75690981|FG002|Run-in Phase|Noncompliance with study drug|0|||
41944806|NCT01641822|75690979|FG000|Run-in Phase|Adverse Event|3|||
41944807|NCT01641822|75690980|FG001|Run-in Phase|Adverse Event|0|||
41944808|NCT01641822|75690981|FG002|Run-in Phase|Adverse Event|0|||
41944809|NCT01641822|75690979|FG000|Run-in Phase|Withdrew consent|1|||
41944810|NCT01641822|75690980|FG001|Run-in Phase|Withdrew consent|0|||
41944811|NCT01641822|75690981|FG002|Run-in Phase|Withdrew consent|0|||
41944812|NCT01641822|75690979|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
41944813|NCT01641822|75690980|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
41944814|NCT01641822|75690981|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
41944815|NCT01641822|75690979|FG000|Comparative Phase|Noncompliance with study drug|0|||
41944816|NCT01641822|75690980|FG001|Comparative Phase|Noncompliance with study drug|1|||
41944817|NCT01641822|75690981|FG002|Comparative Phase|Noncompliance with study drug|0|||
41944818|NCT01641822|75690979|FG000|Comparative Phase|Investigator's discretion|0|||
41944819|NCT01641822|75690980|FG001|Comparative Phase|Investigator's discretion|0|||
41944820|NCT01641822|75690981|FG002|Comparative Phase|Investigator's discretion|1|||
41944821|NCT01641822|75690979|FG000|Comparative Phase|Pregnancy|0|||
42023294|NCT01194414|75830655|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
42023295|NCT01194414|75830656|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
42023296|NCT01194414|75830657|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
42023297|NCT01194414|75830658|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
42023298|NCT01194414|75830655|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
42023299|NCT01194414|75830656|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
42300337|NCT02299635|76135501|FG000|Overall Study|Global deterioration of health status|1|||
42300338|NCT02299635|76135501|FG000|Overall Study|Objective progression or relapse|10|||
41944822|NCT01641822|75690980|FG001|Comparative Phase|Pregnancy|0|||
41944823|NCT01641822|75690981|FG002|Comparative Phase|Pregnancy|1|||
41944824|NCT01641822|75690979|FG000|Comparative Phase|Adverse event, serious fatal|0|||
41944825|NCT01641822|75690980|FG001|Comparative Phase|Adverse event, serious fatal|1|||
41944826|NCT01641822|75690981|FG002|Comparative Phase|Adverse event, serious fatal|0|||
41944827|NCT01641822|75690979|FG000|Comparative Phase|Withdrew consent|0|||
41944828|NCT01641822|75690980|FG001|Comparative Phase|Withdrew consent|3|||
41944829|NCT01641822|75690981|FG002|Comparative Phase|Withdrew consent|7|||
41944830|NCT01641822|75690979|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
41944831|NCT01641822|75690980|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
41944832|NCT01641822|75690981|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
41944833|NCT01641198|75691061|FG000|After 12 Months of Function|Lost to Follow-up|3|||
41944834|NCT01641198|75691062|FG001|After 12 Months of Function|Lost to Follow-up|2|||
41944835|NCT01641198|75691063|FG002|After 12 Months of Function|Lost to Follow-up|2|||
41944836|NCT01641198|75691061|FG000|After 12 Months of Function|Protocol Violation|1|||
41944837|NCT01641198|75691062|FG001|After 12 Months of Function|Protocol Violation|0|||
41944838|NCT01641198|75691063|FG002|After 12 Months of Function|Protocol Violation|0|||
41944839|NCT01641198|75691061|FG000|After 12 Months of Function|Adverse Event|0|||
41944840|NCT01641198|75691062|FG001|After 12 Months of Function|Adverse Event|1|||
41944841|NCT01641198|75691063|FG002|After 12 Months of Function|Adverse Event|0|||
41944842|NCT01641198|75691061|FG000|After 24 Months of Function|Lost to Follow-up|4|||
41944843|NCT01641198|75691062|FG001|After 24 Months of Function|Lost to Follow-up|9|||
41944844|NCT01641198|75691063|FG002|After 24 Months of Function|Lost to Follow-up|6|||
41944845|NCT01641198|75691061|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
41944846|NCT01641198|75691062|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
41944847|NCT01641198|75691063|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
41944848|NCT01641198|75691061|FG000|At 15-20 Years of Function|Death|1|||
41944849|NCT01641198|75691062|FG001|At 15-20 Years of Function|Death|0|||
41944850|NCT01641198|75691063|FG002|At 15-20 Years of Function|Death|1|||
41944851|NCT01639560|75691148|FG000|Overall Study|Withdrawal by Subject|9|||
41944852|NCT01639560|75691149|FG001|Overall Study|Withdrawal by Subject|14|||
41944853|NCT01639560|75691148|FG000|Overall Study|Lack of Efficacy|1|||
41944854|NCT01639560|75691149|FG001|Overall Study|Lack of Efficacy|2|||
41944855|NCT01639560|75691148|FG000|Overall Study|Lost to Follow-up|9|||
41944856|NCT01639560|75691149|FG001|Overall Study|Lost to Follow-up|11|||
41944857|NCT01639560|75691148|FG000|Overall Study|Adverse Event|0|||
41944858|NCT01639560|75691149|FG001|Overall Study|Adverse Event|2|||
41944859|NCT01601652|75691171|FG000|Overall Study|Death|1|||
41944860|NCT03952130|75691209|FG000|Overall Study|Adverse Event|0|||
41944861|NCT03952130|75691210|FG001|Overall Study|Adverse Event|1|||
41944862|NCT03952130|75691209|FG000|Overall Study|Lost to Follow-up|1|||
41944863|NCT03952130|75691210|FG001|Overall Study|Lost to Follow-up|0|||
41944864|NCT03952130|75691209|FG000|Overall Study|Withdrawal by Subject|1|||
41944865|NCT03952130|75691210|FG001|Overall Study|Withdrawal by Subject|5|||
41944866|NCT01640964|75691254|FG000|Overall Study|Lost to Follow-up|0|||
41944867|NCT01640964|75691255|FG001|Overall Study|Lost to Follow-up|0|||
41944868|NCT01640964|75691256|FG002|Overall Study|Lost to Follow-up|1|||
41944869|NCT01640964|75691254|FG000|Overall Study|Protocol Deviation|1|||
41944870|NCT01640964|75691255|FG001|Overall Study|Protocol Deviation|1|||
41944871|NCT01640964|75691256|FG002|Overall Study|Protocol Deviation|2|||
41944872|NCT01638390|75691367|FG000|Overall Study|screening failures|21|||
41944873|NCT01600716|75691398|FG000|Overall Study|Other Reasons|3|||
41944874|NCT01600716|75691399|FG001|Overall Study|Other Reasons|1|||
41944875|NCT01600716|75691398|FG000|Overall Study|Personal Reasons|0|||
41944876|NCT01600716|75691399|FG001|Overall Study|Personal Reasons|2|||
41944877|NCT01600716|75691398|FG000|Overall Study|Lost to Follow-up|0|||
41944878|NCT01600716|75691399|FG001|Overall Study|Lost to Follow-up|2|||
41944879|NCT01600716|75691398|FG000|Overall Study|Pregnancy|1|||
41944880|NCT01600716|75691399|FG001|Overall Study|Pregnancy|0|||
41944881|NCT01600716|75691398|FG000|Overall Study|Lack of Efficacy|2|||
42023300|NCT01194414|75830657|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
42023301|NCT01194414|75830658|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
42023302|NCT01194414|75830655|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
42023303|NCT01194414|75830656|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
42023304|NCT01194414|75830657|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
41944882|NCT01600716|75691399|FG001|Overall Study|Lack of Efficacy|1|||
41944883|NCT01600716|75691398|FG000|Overall Study|Adverse Event|1|||
41944884|NCT01600716|75691399|FG001|Overall Study|Adverse Event|1|||
41944885|NCT01600326|75691511|FG000|Overall Study|Lost to Follow-up|1|||
41944886|NCT01600326|75691512|FG001|Overall Study|Lost to Follow-up|1|||
41944887|NCT01637142|75691648|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
41944888|NCT01636986|75691666|FG000|Overall Study|Withdrawal by Subject|0|||
41944889|NCT01636986|75691667|FG001|Overall Study|Withdrawal by Subject|1|||
41944890|NCT01636986|75691666|FG000|Overall Study|Corneal Staining|0|||
41944891|NCT01636986|75691667|FG001|Overall Study|Corneal Staining|1|||
41944892|NCT01601496|75691757|FG000|Overall Study|Physician Decision|1|||
41944893|NCT01601496|75691757|FG000|Overall Study|Withdrawal by Subject|1|||
41944894|NCT01601496|75691757|FG000|Overall Study|Lost to Follow-up|6|||
41944895|NCT01601496|75691757|FG000|Overall Study|Death|4|||
41944896|NCT01601496|75691757|FG000|Overall Study|Other: patient refusal to continue|3|||
41944897|NCT03211832|75691763|FG000|Overall Study|No longer with agency|32|||
41944898|NCT03211832|75691764|FG001|Overall Study|No longer with agency|49|||
41944899|NCT03211832|75691765|FG002|Overall Study|No longer with agency|30|||
41944900|NCT03211832|75691763|FG000|Overall Study|Declined survey|3|||
41944901|NCT03211832|75691764|FG001|Overall Study|Declined survey|3|||
41944902|NCT03211832|75691765|FG002|Overall Study|Declined survey|2|||
42023305|NCT01194414|75830658|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
42023306|NCT01194414|75830655|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
42023307|NCT01194414|75830656|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
42023308|NCT01194414|75830657|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
42023309|NCT01194414|75830658|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
42023310|NCT01194414|75830655|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
42023311|NCT01194414|75830656|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
42023312|NCT01194414|75830657|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
42023313|NCT01194414|75830658|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
42023314|NCT01194414|75830655|FG000|72 Weeks Open Label Extension|Other|2|||
42023315|NCT01194414|75830656|FG001|72 Weeks Open Label Extension|Other|1|||
42023316|NCT01194414|75830657|FG002|72 Weeks Open Label Extension|Other|0|||
42023317|NCT01194414|75830658|FG003|72 Weeks Open Label Extension|Other|0|||
42023318|NCT01194414|75830655|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
42023319|NCT01194414|75830656|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
42023320|NCT01194414|75830657|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
42023321|NCT01194414|75830658|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
42023322|NCT01194414|75830655|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
42023323|NCT01194414|75830656|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
42023324|NCT01194414|75830657|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
42023325|NCT01194414|75830658|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
42023326|NCT01194414|75830655|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
42023327|NCT01194414|75830656|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
42023328|NCT01194414|75830657|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
42023329|NCT01194414|75830658|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
42023330|NCT01194414|75830655|FG000|72 Weeks Open Label Extension|Death|1|||
42023331|NCT01194414|75830656|FG001|72 Weeks Open Label Extension|Death|2|||
42023332|NCT01194414|75830657|FG002|72 Weeks Open Label Extension|Death|0|||
42023333|NCT01194414|75830658|FG003|72 Weeks Open Label Extension|Death|2|||
42023334|NCT01194258|75830670|FG000|Titration Period|Withdrawal by Subject|6|||
41944903|NCT03211832|75691763|FG000|Overall Study|Not available during data collection|1|||
41944904|NCT03211832|75691764|FG001|Overall Study|Not available during data collection|0|||
41944905|NCT03211832|75691765|FG002|Overall Study|Not available during data collection|2|||
41944906|NCT04887948|75691774|FG000|Overall Study|Death|1|||
41944907|NCT04887948|75691775|FG001|Overall Study|Death|0|||
41944908|NCT04887948|75691776|FG002|Overall Study|Death|0|||
41944909|NCT04887948|75691774|FG000|Overall Study|Lost to Follow-up|1|||
41944910|NCT04887948|75691775|FG001|Overall Study|Lost to Follow-up|0|||
41944911|NCT04887948|75691776|FG002|Overall Study|Lost to Follow-up|3|||
41944912|NCT04887948|75691774|FG000|Overall Study|Physician Decision|0|||
41944913|NCT04887948|75691775|FG001|Overall Study|Physician Decision|4|||
41944914|NCT04887948|75691776|FG002|Overall Study|Physician Decision|1|||
41944915|NCT04887948|75691774|FG000|Overall Study|Protocol Violation|1|||
41944916|NCT04887948|75691775|FG001|Overall Study|Protocol Violation|1|||
41944917|NCT04887948|75691776|FG002|Overall Study|Protocol Violation|0|||
41944918|NCT04887948|75691774|FG000|Overall Study|Withdrawal by Subject|0|||
41944919|NCT04887948|75691775|FG001|Overall Study|Withdrawal by Subject|6|||
41944920|NCT04887948|75691776|FG002|Overall Study|Withdrawal by Subject|1|||
41944921|NCT04887948|75691774|FG000|Overall Study|No longer met eligibility criteria|1|||
41944922|NCT04887948|75691775|FG001|Overall Study|No longer met eligibility criteria|2|||
41944923|NCT04887948|75691776|FG002|Overall Study|No longer met eligibility criteria|1|||
41944924|NCT04887948|75691774|FG000|Overall Study|Other|2|||
41944925|NCT04887948|75691775|FG001|Overall Study|Other|1|||
41944926|NCT04887948|75691776|FG002|Overall Study|Other|1|||
41944927|NCT01638000|75691914|FG000|Overall Study|Randomized but Never Received Drug|7|||
41944928|NCT01638000|75691915|FG001|Overall Study|Randomized but Never Received Drug|10|||
41944929|NCT01638000|75691914|FG000|Overall Study|Adverse Event|14|||
42023335|NCT01194258|75830671|FG001|Titration Period|Withdrawal by Subject|0|||
42023336|NCT01194258|75830672|FG002|Titration Period|Withdrawal by Subject|0|||
42023337|NCT01194258|75830673|FG003|Titration Period|Withdrawal by Subject|0|||
42023338|NCT01194258|75830674|FG004|Titration Period|Withdrawal by Subject|0|||
42023339|NCT01194258|75830670|FG000|Titration Period|Lost to Follow-up|2|||
42023340|NCT01194258|75830671|FG001|Titration Period|Lost to Follow-up|0|||
42023341|NCT01194258|75830672|FG002|Titration Period|Lost to Follow-up|0|||
41944930|NCT01638000|75691915|FG001|Overall Study|Adverse Event|16|||
41944931|NCT01638000|75691914|FG000|Overall Study|Lack of Efficacy|5|||
41944932|NCT01638000|75691915|FG001|Overall Study|Lack of Efficacy|6|||
41944933|NCT01638000|75691914|FG000|Overall Study|Protocol Violation|11|||
42023342|NCT01194258|75830673|FG003|Titration Period|Lost to Follow-up|0|||
42023343|NCT01194258|75830674|FG004|Titration Period|Lost to Follow-up|0|||
42023344|NCT01194258|75830670|FG000|Titration Period|Titration failure|3|||
42300339|NCT02299635|76135501|FG000|Overall Study|Withdrawal by Subject|2|||
41944934|NCT01638000|75691915|FG001|Overall Study|Protocol Violation|13|||
42023345|NCT01194258|75830671|FG001|Titration Period|Titration failure|0|||
42023346|NCT01194258|75830672|FG002|Titration Period|Titration failure|0|||
42023347|NCT01194258|75830673|FG003|Titration Period|Titration failure|0|||
42023348|NCT01194258|75830674|FG004|Titration Period|Titration failure|0|||
42023349|NCT01194258|75830670|FG000|Period 1 (12 Weeks)|Death|0|||
41944935|NCT01638000|75691914|FG000|Overall Study|Withdrawal by Subject|21|||
41944936|NCT01638000|75691915|FG001|Overall Study|Withdrawal by Subject|24|||
41944937|NCT01638000|75691914|FG000|Overall Study|Miscellaneous|2|||
41944938|NCT01638000|75691915|FG001|Overall Study|Miscellaneous|2|||
41944939|NCT01637922|75691974|FG000|Overall Study|Adverse Event|0|||
41944940|NCT01637922|75691975|FG001|Overall Study|Adverse Event|1|||
41944941|NCT01637922|75691974|FG000|Overall Study|Protocol Violation|0|||
41944942|NCT01637922|75691975|FG001|Overall Study|Protocol Violation|1|||
41944943|NCT01637922|75691974|FG000|Overall Study|Withdrawal by Subject|0|||
41944944|NCT01637922|75691975|FG001|Overall Study|Withdrawal by Subject|3|||
41944945|NCT01637922|75691974|FG000|Overall Study|Lost to Follow-up|2|||
41944946|NCT01637922|75691975|FG001|Overall Study|Lost to Follow-up|0|||
41944947|NCT01638546|75692179|FG000|Overall Study|Adverse Event|1|||
41944948|NCT01638546|75692180|FG001|Overall Study|Adverse Event|3|||
41944949|NCT03172494|75692200|FG000|Overall Study|Adverse Event|5|||
41944950|NCT03172494|75692201|FG001|Overall Study|Adverse Event|1|||
41944951|NCT03172494|75692202|FG002|Overall Study|Adverse Event|15|||
41944952|NCT03172494|75692200|FG000|Overall Study|Protocol Violation|3|||
41944953|NCT03172494|75692201|FG001|Overall Study|Protocol Violation|2|||
41944954|NCT03172494|75692202|FG002|Overall Study|Protocol Violation|1|||
41944955|NCT03172494|75692200|FG000|Overall Study|Lack of Efficacy|0|||
41944956|NCT03172494|75692201|FG001|Overall Study|Lack of Efficacy|0|||
41944957|NCT03172494|75692202|FG002|Overall Study|Lack of Efficacy|4|||
41944958|NCT03172494|75692200|FG000|Overall Study|Pregnancy|0|||
41944959|NCT03172494|75692201|FG001|Overall Study|Pregnancy|1|||
41944960|NCT03172494|75692202|FG002|Overall Study|Pregnancy|0|||
41944961|NCT03172494|75692200|FG000|Overall Study|Withdrawal by Subject|10|||
41944962|NCT03172494|75692201|FG001|Overall Study|Withdrawal by Subject|8|||
41944963|NCT03172494|75692202|FG002|Overall Study|Withdrawal by Subject|8|||
41944964|NCT03172494|75692200|FG000|Overall Study|Severe hypoglycaemic episode|0|||
41944965|NCT03172494|75692201|FG001|Overall Study|Severe hypoglycaemic episode|0|||
41944966|NCT03172494|75692202|FG002|Overall Study|Severe hypoglycaemic episode|1|||
41944967|NCT03172494|75692200|FG000|Overall Study|Non-compliance towards treatment|2|||
41944968|NCT03172494|75692201|FG001|Overall Study|Non-compliance towards treatment|0|||
41944969|NCT03172494|75692202|FG002|Overall Study|Non-compliance towards treatment|0|||
41944970|NCT01636362|75692303|FG000|Overall Study|Physician Decision|6|||
41944971|NCT01636362|75692303|FG000|Overall Study|Subject healed, not returning|1|||
41944972|NCT01636362|75692303|FG000|Overall Study|Withdrawal by Subject|1|||
41944973|NCT02797184|75692332|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
41944974|NCT02797184|75692333|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
41944975|NCT03042468|75692375|FG000|Overall Study|Death|0|||
41944976|NCT03042468|75692376|FG001|Overall Study|Death|1|||
41944977|NCT03042468|75692377|FG002|Overall Study|Death|1|||
41944978|NCT03042468|75692378|FG003|Overall Study|Death|0|||
41944979|NCT03042468|75692379|FG004|Overall Study|Death|0|||
41944980|NCT03042468|75692380|FG005|Overall Study|Death|0|||
41944981|NCT03042468|75692375|FG000|Overall Study|Withdrawal by Subject|0|||
41944982|NCT03042468|75692376|FG001|Overall Study|Withdrawal by Subject|0|||
41944983|NCT03042468|75692377|FG002|Overall Study|Withdrawal by Subject|0|||
41944984|NCT03042468|75692378|FG003|Overall Study|Withdrawal by Subject|0|||
41944985|NCT03042468|75692379|FG004|Overall Study|Withdrawal by Subject|0|||
41944986|NCT03042468|75692380|FG005|Overall Study|Withdrawal by Subject|1|||
42023350|NCT01194258|75830671|FG001|Period 1 (12 Weeks)|Death|0|||
42023351|NCT01194258|75830672|FG002|Period 1 (12 Weeks)|Death|0|||
41944987|NCT03042468|75692375|FG000|Overall Study|Lost to Follow-up|0|||
41944988|NCT03042468|75692376|FG001|Overall Study|Lost to Follow-up|0|||
41944989|NCT03042468|75692377|FG002|Overall Study|Lost to Follow-up|0|||
41944990|NCT03042468|75692378|FG003|Overall Study|Lost to Follow-up|0|||
41944991|NCT03042468|75692379|FG004|Overall Study|Lost to Follow-up|1|||
41944992|NCT03042468|75692380|FG005|Overall Study|Lost to Follow-up|1|||
41944993|NCT01634178|75692398|FG000|Treatment Period 1|Adverse Event|0|||
41944994|NCT01634178|75692399|FG001|Treatment Period 1|Adverse Event|1|||
41944995|NCT01634178|75692398|FG000|Treatment Period 2|Adverse Event|1|||
41944996|NCT01634178|75692399|FG001|Treatment Period 2|Adverse Event|0|||
41944997|NCT02412306|75692441|FG000|Overall Study|Lost to Follow-up|0|||
41944998|NCT02412306|75692442|FG001|Overall Study|Lost to Follow-up|1|||
41944999|NCT02412306|75692443|FG002|Overall Study|Lost to Follow-up|0|||
41945000|NCT02412306|75692444|FG003|Overall Study|Lost to Follow-up|0|||
41945001|NCT02412306|75692445|FG004|Overall Study|Lost to Follow-up|0|||
41945002|NCT02412306|75692441|FG000|Overall Study|Withdrawal by Subject|0|||
41945003|NCT02412306|75692442|FG001|Overall Study|Withdrawal by Subject|0|||
41945004|NCT02412306|75692443|FG002|Overall Study|Withdrawal by Subject|1|||
41945005|NCT02412306|75692444|FG003|Overall Study|Withdrawal by Subject|0|||
41945006|NCT02412306|75692445|FG004|Overall Study|Withdrawal by Subject|0|||
41945007|NCT02412306|75692441|FG000|Overall Study|Death|5|||
41945008|NCT02412306|75692442|FG001|Overall Study|Death|7|||
41945009|NCT02412306|75692443|FG002|Overall Study|Death|15|||
41945010|NCT02412306|75692444|FG003|Overall Study|Death|0|||
41945011|NCT02412306|75692445|FG004|Overall Study|Death|2|||
41945012|NCT04285723|75692468|FG000|Overall Study|Subject decision|1|||
41945013|NCT04285723|75692469|FG001|Overall Study|Subject decision|2|||
41945014|NCT04285723|75692468|FG000|Overall Study|Physician Decision|1|||
41945015|NCT04285723|75692469|FG001|Overall Study|Physician Decision|0|||
41945016|NCT04285723|75692468|FG000|Overall Study|No efficiency|1|||
41945017|NCT04285723|75692469|FG001|Overall Study|No efficiency|0|||
41945018|NCT01352221|75692483|FG000|Double-blind Phase|Adverse Event|6|||
41945019|NCT01352221|75692484|FG001|Double-blind Phase|Adverse Event|4|||
41945020|NCT01352221|75692485|FG002|Double-blind Phase|Adverse Event|0|||
41945021|NCT01352221|75692486|FG003|Double-blind Phase|Adverse Event|0|||
41945022|NCT01352221|75692483|FG000|Double-blind Phase|Withdrawal by Subject|3|||
41945023|NCT01352221|75692484|FG001|Double-blind Phase|Withdrawal by Subject|5|||
41945024|NCT01352221|75692485|FG002|Double-blind Phase|Withdrawal by Subject|0|||
41945025|NCT01352221|75692486|FG003|Double-blind Phase|Withdrawal by Subject|0|||
41945026|NCT01352221|75692483|FG000|Double-blind Phase|Lost to Follow-up|0|||
41945027|NCT01352221|75692484|FG001|Double-blind Phase|Lost to Follow-up|1|||
41945028|NCT01352221|75692485|FG002|Double-blind Phase|Lost to Follow-up|0|||
41945029|NCT01352221|75692486|FG003|Double-blind Phase|Lost to Follow-up|0|||
41945030|NCT01352221|75692483|FG000|Double-blind Phase|Protocol Violation|0|||
41945031|NCT01352221|75692484|FG001|Double-blind Phase|Protocol Violation|1|||
41945032|NCT01352221|75692485|FG002|Double-blind Phase|Protocol Violation|0|||
41945033|NCT01352221|75692486|FG003|Double-blind Phase|Protocol Violation|0|||
41945034|NCT01352221|75692483|FG000|Open-label Phase|Physician Decision|0|||
41945035|NCT01352221|75692484|FG001|Open-label Phase|Physician Decision|0|||
41945036|NCT01352221|75692485|FG002|Open-label Phase|Physician Decision|2|||
41945037|NCT01352221|75692486|FG003|Open-label Phase|Physician Decision|1|||
41945038|NCT01352221|75692483|FG000|Open-label Phase|Pregnancy|0|||
41945039|NCT01352221|75692484|FG001|Open-label Phase|Pregnancy|0|||
41945040|NCT01352221|75692485|FG002|Open-label Phase|Pregnancy|1|||
41945041|NCT01352221|75692486|FG003|Open-label Phase|Pregnancy|0|||
41945042|NCT01352221|75692483|FG000|Open-label Phase|Adverse Event|0|||
41945043|NCT01352221|75692484|FG001|Open-label Phase|Adverse Event|0|||
41945044|NCT01352221|75692485|FG002|Open-label Phase|Adverse Event|8|||
41945045|NCT01352221|75692486|FG003|Open-label Phase|Adverse Event|4|||
41945046|NCT01352221|75692483|FG000|Open-label Phase|Withdrawal by Subject|0|||
42023352|NCT01194258|75830673|FG003|Period 1 (12 Weeks)|Death|0|||
42023353|NCT01194258|75830674|FG004|Period 1 (12 Weeks)|Death|1|||
42023354|NCT01194258|75830670|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
42023355|NCT01194258|75830671|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
41945047|NCT01352221|75692484|FG001|Open-label Phase|Withdrawal by Subject|0|||
41945048|NCT01352221|75692485|FG002|Open-label Phase|Withdrawal by Subject|1|||
41945049|NCT01352221|75692486|FG003|Open-label Phase|Withdrawal by Subject|6|||
41945050|NCT01352221|75692483|FG000|Open-label Phase|Worsening of IBD|0|||
41945051|NCT01352221|75692484|FG001|Open-label Phase|Worsening of IBD|0|||
41945052|NCT01352221|75692485|FG002|Open-label Phase|Worsening of IBD|1|||
41945053|NCT01352221|75692486|FG003|Open-label Phase|Worsening of IBD|0|||
41945054|NCT01634100|75692512|FG000|Overall Study|Withdrawal by Subject|1|||
42023356|NCT01194258|75830672|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
41945055|NCT01634100|75692513|FG001|Overall Study|Withdrawal by Subject|0|||
41945056|NCT01634100|75692514|FG002|Overall Study|Withdrawal by Subject|1|||
42023357|NCT01194258|75830673|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
41945057|NCT01634100|75692515|FG003|Overall Study|Withdrawal by Subject|0|||
42300340|NCT02299635|76135501|FG000|Overall Study|Other|3|||
41945058|NCT01634100|75692516|FG004|Overall Study|Withdrawal by Subject|0|||
41945059|NCT01634100|75692517|FG005|Overall Study|Withdrawal by Subject|0|||
41945060|NCT01633944|75692527|FG000|Open-label Titration Phase|Adverse Event|109|||
41945061|NCT01633944|75692528|FG001|Open-label Titration Phase|Adverse Event|0|||
41945062|NCT01633944|75692529|FG002|Open-label Titration Phase|Adverse Event|0|||
41945063|NCT01633944|75692527|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
41945064|NCT01633944|75692528|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
41945065|NCT01633944|75692529|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
41945066|NCT01633944|75692527|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
41945067|NCT01633944|75692528|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
41945068|NCT01633944|75692529|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
41945069|NCT01633944|75692527|FG000|Open-label Titration Phase|Protocol Violation|24|||
41945070|NCT01633944|75692528|FG001|Open-label Titration Phase|Protocol Violation|0|||
41945071|NCT01633944|75692529|FG002|Open-label Titration Phase|Protocol Violation|0|||
41945072|NCT01633944|75692527|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
41945073|NCT01633944|75692528|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
41945074|NCT01633944|75692529|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
41945075|NCT01633944|75692527|FG000|Open-label Titration Phase|Other|68|||
41945076|NCT01633944|75692528|FG001|Open-label Titration Phase|Other|0|||
41945077|NCT01633944|75692529|FG002|Open-label Titration Phase|Other|0|||
41945078|NCT01633944|75692527|FG000|Double-blind Treatment Phase|Adverse Event|0|||
41945079|NCT01633944|75692528|FG001|Double-blind Treatment Phase|Adverse Event|13|||
41945080|NCT01633944|75692529|FG002|Double-blind Treatment Phase|Adverse Event|7|||
41945081|NCT01633944|75692527|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
41945082|NCT01633944|75692528|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
41945083|NCT01633944|75692529|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
41945084|NCT01633944|75692527|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
41945085|NCT01633944|75692528|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
41945086|NCT01633944|75692529|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
41945087|NCT01633944|75692527|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
41945088|NCT01633944|75692528|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
41945089|NCT01633944|75692529|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
41945090|NCT01633944|75692527|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
41945091|NCT01633944|75692528|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
41945092|NCT01633944|75692529|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
41945093|NCT01633944|75692527|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
41945094|NCT01633944|75692528|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
41945095|NCT01633944|75692529|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
41945096|NCT01633944|75692527|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
41945097|NCT01633944|75692528|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
41945098|NCT01633944|75692529|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
41945099|NCT01633944|75692527|FG000|Double-blind Treatment Phase|Other|0|||
41945100|NCT01633944|75692528|FG001|Double-blind Treatment Phase|Other|7|||
41945101|NCT01633944|75692529|FG002|Double-blind Treatment Phase|Other|0|||
41945102|NCT01633788|75692574|FG000|Overall Study|Adverse Event|1|||
41945103|NCT01633788|75692575|FG001|Overall Study|Adverse Event|3|||
41945104|NCT01633788|75692576|FG002|Overall Study|Adverse Event|3|||
41945105|NCT01633788|75692577|FG003|Overall Study|Adverse Event|3|||
41945106|NCT01633788|75692574|FG000|Overall Study|Lost to Follow-up|2|||
41945107|NCT01633788|75692575|FG001|Overall Study|Lost to Follow-up|2|||
41945108|NCT01633788|75692576|FG002|Overall Study|Lost to Follow-up|2|||
41945109|NCT01633788|75692577|FG003|Overall Study|Lost to Follow-up|0|||
41945110|NCT01633788|75692574|FG000|Overall Study|Personal Reasons|3|||
41945111|NCT01633788|75692575|FG001|Overall Study|Personal Reasons|1|||
41945112|NCT01633788|75692576|FG002|Overall Study|Personal Reasons|1|||
41945113|NCT01633788|75692577|FG003|Overall Study|Personal Reasons|3|||
41945114|NCT01633788|75692574|FG000|Overall Study|Protocol Violation|1|||
41945115|NCT01633788|75692575|FG001|Overall Study|Protocol Violation|0|||
41945116|NCT01633788|75692576|FG002|Overall Study|Protocol Violation|1|||
41945117|NCT01633788|75692577|FG003|Overall Study|Protocol Violation|0|||
41945118|NCT01633788|75692574|FG000|Overall Study|Other Reasons|0|||
41945119|NCT01633788|75692575|FG001|Overall Study|Other Reasons|2|||
41945120|NCT01633788|75692576|FG002|Overall Study|Other Reasons|3|||
41945121|NCT01633788|75692577|FG003|Overall Study|Other Reasons|7|||
41945122|NCT04154943|75692587|FG000|Overall Study|Study Ongoing|68|||
41945123|NCT04154943|75692587|FG000|Overall Study|Lost to Follow-up|1|||
41945124|NCT04154943|75692587|FG000|Overall Study|Decision by the Investigator|1|||
41945125|NCT04154943|75692587|FG000|Overall Study|Death|5|||
41945126|NCT04154943|75692587|FG000|Overall Study|Withdrawal by Subject|4|||
41945127|NCT03476239|75692608|FG000|Overall Study|Withdrawal by Subject|10|||
41945128|NCT03476239|75692608|FG000|Overall Study|Death|80|||
41945129|NCT03476239|75692608|FG000|Overall Study|Lost to Follow-up|8|||
41945130|NCT02678312|75692617|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
41945131|NCT02678312|75692618|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
41945132|NCT02678312|75692619|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
41945133|NCT02678312|75692620|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
41945134|NCT02678312|75692621|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
41945135|NCT02678312|75692617|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
41945136|NCT02678312|75692618|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
41945137|NCT02678312|75692619|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
41945138|NCT02678312|75692620|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
41945139|NCT02678312|75692621|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
41945140|NCT02678312|75692617|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
41945141|NCT02678312|75692618|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
41945142|NCT02678312|75692619|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
41945143|NCT02678312|75692620|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
41945144|NCT02678312|75692621|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
41945145|NCT02678312|75692617|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
41945146|NCT02678312|75692618|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
41945147|NCT02678312|75692619|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
41945148|NCT02678312|75692620|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
41945149|NCT02678312|75692621|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
41945150|NCT02678312|75692617|FG000|Part 2 Double Blind Epoch|Death|0|||
41945151|NCT02678312|75692618|FG001|Part 2 Double Blind Epoch|Death|0|||
41945152|NCT02678312|75692619|FG002|Part 2 Double Blind Epoch|Death|0|||
41945153|NCT02678312|75692620|FG003|Part 2 Double Blind Epoch|Death|8|||
41945154|NCT02678312|75692621|FG004|Part 2 Double Blind Epoch|Death|12|||
41945155|NCT02678312|75692617|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
41945156|NCT02678312|75692618|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
41945157|NCT02678312|75692619|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
41945158|NCT02678312|75692620|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
41945159|NCT02678312|75692621|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
41945160|NCT02678312|75692617|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
41945161|NCT02678312|75692618|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
41945162|NCT02678312|75692619|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
41945163|NCT02678312|75692620|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
41945164|NCT02678312|75692621|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
41945165|NCT02678312|75692617|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
41945166|NCT02678312|75692618|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
41945167|NCT02678312|75692619|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
41945168|NCT02678312|75692620|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
41945169|NCT02678312|75692621|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
41945170|NCT02256631|75692859|FG000|Overall Study|Lost to Follow-up|1|||
41945171|NCT02256631|75692860|FG001|Overall Study|Lost to Follow-up|1|||
41945172|NCT02256631|75692861|FG002|Overall Study|Lost to Follow-up|0|||
41945173|NCT02256631|75692862|FG003|Overall Study|Lost to Follow-up|2|||
41945174|NCT02256631|75692863|FG004|Overall Study|Lost to Follow-up|0|||
41945175|NCT02256631|75692864|FG005|Overall Study|Lost to Follow-up|4|||
41945176|NCT02256631|75692865|FG006|Overall Study|Lost to Follow-up|1|||
41945177|NCT02256631|75692859|FG000|Overall Study|Withdrawal by Subject|0|||
41945178|NCT02256631|75692860|FG001|Overall Study|Withdrawal by Subject|0|||
41945179|NCT02256631|75692861|FG002|Overall Study|Withdrawal by Subject|0|||
41945180|NCT02256631|75692862|FG003|Overall Study|Withdrawal by Subject|1|||
41945181|NCT02256631|75692863|FG004|Overall Study|Withdrawal by Subject|1|||
41945182|NCT02256631|75692864|FG005|Overall Study|Withdrawal by Subject|0|||
41945183|NCT02256631|75692865|FG006|Overall Study|Withdrawal by Subject|1|||
41945184|NCT02256631|75692859|FG000|Overall Study|Unable to get to clinic|0|||
41945185|NCT02256631|75692860|FG001|Overall Study|Unable to get to clinic|2|||
41945186|NCT02256631|75692861|FG002|Overall Study|Unable to get to clinic|0|||
41945187|NCT02256631|75692862|FG003|Overall Study|Unable to get to clinic|1|||
41945188|NCT02256631|75692863|FG004|Overall Study|Unable to get to clinic|0|||
41945189|NCT02256631|75692864|FG005|Overall Study|Unable to get to clinic|1|||
41945190|NCT02256631|75692865|FG006|Overall Study|Unable to get to clinic|2|||
41945191|NCT02279745|75692975|FG000|Overall Study|Adverse Event|7|||
41945192|NCT02279745|75692975|FG000|Overall Study|Death|6|||
41945193|NCT02279745|75692975|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
41945194|NCT02279745|75692975|FG000|Overall Study|Withdrawal by Subject|2|||
41945195|NCT02279745|75692975|FG000|Overall Study|Pregnancy|1|||
41945196|NCT02279745|75692975|FG000|Overall Study|Study Non-compliance|1|||
41945197|NCT02279745|75692975|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
41945198|NCT01761877|75693014|FG000|Overall Study|Adverse Event|7|||
41945199|NCT01761877|75693015|FG001|Overall Study|Adverse Event|0|||
41945200|NCT01761877|75693014|FG000|Overall Study|Withdrawal by Subject|6|||
41945201|NCT01761877|75693015|FG001|Overall Study|Withdrawal by Subject|4|||
41945202|NCT01761877|75693014|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
41945203|NCT01761877|75693015|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
41945204|NCT01761877|75693014|FG000|Overall Study|Death|0|||
41945205|NCT01761877|75693015|FG001|Overall Study|Death|1|||
41945206|NCT01761877|75693014|FG000|Overall Study|MRI intolerant|1|||
41945207|NCT01761877|75693015|FG001|Overall Study|MRI intolerant|6|||
41945208|NCT00588523|75693095|FG000|Overall Study|Not treated|3|||
41945209|NCT03093259|75693269|FG000|Overall Study|Adverse Event|1|||
41945210|NCT03093259|75693270|FG001|Overall Study|Adverse Event|0|||
41945211|NCT03093259|75693269|FG000|Overall Study|Withdrawal by Subject|1|||
41945212|NCT03093259|75693270|FG001|Overall Study|Withdrawal by Subject|0|||
41945213|NCT02997865|75693562|FG000|Overall Study|Death|2|||
41945214|NCT02997865|75693563|FG001|Overall Study|Death|1|||
41945215|NCT02997865|75693562|FG000|Overall Study|Lost to Follow-up|6|||
41945216|NCT02997865|75693563|FG001|Overall Study|Lost to Follow-up|3|||
41945217|NCT02997865|75693562|FG000|Overall Study|Withdrawal by Subject|5|||
41945218|NCT02997865|75693563|FG001|Overall Study|Withdrawal by Subject|0|||
41945219|NCT01575834|75694792|FG000|Overall Study|Withdrawal by Subject|352|||
41945220|NCT01575834|75694793|FG001|Overall Study|Withdrawal by Subject|390|||
41945221|NCT01575834|75694792|FG000|Overall Study|Death|81|||
41945222|NCT01575834|75694793|FG001|Overall Study|Death|74|||
41945223|NCT01575834|75694792|FG000|Overall Study|Other|70|||
41945224|NCT01575834|75694793|FG001|Overall Study|Other|70|||
41945225|NCT01575834|75694792|FG000|Overall Study|Adverse Event|63|||
41945226|NCT01575834|75694793|FG001|Overall Study|Adverse Event|61|||
41945227|NCT01575834|75694792|FG000|Overall Study|Lost to Follow-up|55|||
41945228|NCT01575834|75694793|FG001|Overall Study|Lost to Follow-up|68|||
41945229|NCT01575834|75694792|FG000|Overall Study|Noncompliance|52|||
41945230|NCT01575834|75694793|FG001|Overall Study|Noncompliance|27|||
41945231|NCT01575834|75694792|FG000|Overall Study|Administrative decision|15|||
41945232|NCT01575834|75694793|FG001|Overall Study|Administrative decision|33|||
41945233|NCT01575834|75694792|FG000|Overall Study|Ineligibility Determined|5|||
41945234|NCT01575834|75694793|FG001|Overall Study|Ineligibility Determined|8|||
41945235|NCT01575834|75694792|FG000|Overall Study|Protocol Deviation|4|||
41945236|NCT01575834|75694793|FG001|Overall Study|Protocol Deviation|3|||
41945237|NCT01575834|75694792|FG000|Overall Study|Requirement for Alternative Therapy|2|||
41945238|NCT01575834|75694793|FG001|Overall Study|Requirement for Alternative Therapy|4|||
41945239|NCT02253654|75694905|FG000|Overall Study|Withdrawal by Subject|12|||
41945240|NCT02253654|75694906|FG001|Overall Study|Withdrawal by Subject|4|||
41945241|NCT02253654|75694905|FG000|Overall Study|Decision by Sponsor|1|||
41945242|NCT02253654|75694906|FG001|Overall Study|Decision by Sponsor|1|||
41945243|NCT02253654|75694905|FG000|Overall Study|Lost to Follow-up|2|||
41945244|NCT02253654|75694906|FG001|Overall Study|Lost to Follow-up|5|||
41945245|NCT02253654|75694905|FG000|Overall Study|Death|4|||
41945246|NCT02253654|75694906|FG001|Overall Study|Death|7|||
41945247|NCT02253654|75694905|FG000|Overall Study|Did Not Receive Study Treatment|4|||
41945248|NCT02253654|75694906|FG001|Overall Study|Did Not Receive Study Treatment|1|||
41945249|NCT02252406|75694914|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
41945250|NCT02252406|75694915|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
41945251|NCT02252406|75694914|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
41945252|NCT02252406|75694915|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
41945253|NCT02252406|75694914|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
41945254|NCT02252406|75694915|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
41945255|NCT02252406|75694914|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
41945256|NCT02252406|75694915|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
41945257|NCT02252406|75694914|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
41945258|NCT02252406|75694915|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
41945259|NCT02246478|75694925|FG000|Multiple-dose Phase|Protocol Violation|1|||
41945260|NCT02246478|75694926|FG001|Multiple-dose Phase|Protocol Violation|0|||
41945261|NCT02246478|75694927|FG002|Multiple-dose Phase|Protocol Violation|0|||
41945262|NCT02246478|75694928|FG003|Multiple-dose Phase|Protocol Violation|1|||
42023358|NCT01194258|75830674|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
42023359|NCT01194258|75830670|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
41945263|NCT02252016|75694947|FG000|Overall Study|Lost to Follow-up|2|||
41945264|NCT02252016|75694948|FG001|Overall Study|Lost to Follow-up|1|||
41945265|NCT02252016|75694947|FG000|Overall Study|Physician Decision|1|||
41945266|NCT02252016|75694948|FG001|Overall Study|Physician Decision|0|||
41945267|NCT02252016|75694947|FG000|Overall Study|Withdrawal by Subject|0|||
41945268|NCT02252016|75694948|FG001|Overall Study|Withdrawal by Subject|2|||
41945269|NCT02249832|75694954|FG000|Overall Study|Withdrawal by Subject|3|||
41945270|NCT02249832|75694954|FG000|Overall Study|Lost to Follow-up|10|||
42023360|NCT01194258|75830671|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
41945271|NCT02248974|75694965|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
41945272|NCT02248974|75694966|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
41945273|NCT02248974|75694965|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
41945274|NCT02248974|75694966|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
41945275|NCT02248974|75694965|FG000|1-Day Follow-Up|Enrolled in another study|1|||
41945276|NCT02248974|75694966|FG001|1-Day Follow-Up|Enrolled in another study|0|||
41945277|NCT02248974|75694965|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
41945278|NCT02248974|75694966|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
42023361|NCT01194258|75830672|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
41945279|NCT02248974|75694965|FG000|1-Week Follow-Up|Enrolled in another study|1|||
41945280|NCT02248974|75694966|FG001|1-Week Follow-Up|Enrolled in another study|1|||
41945281|NCT02248974|75694965|FG000|1-Week Follow-Up|Transferred to another facility|1|||
41945282|NCT02248974|75694966|FG001|1-Week Follow-Up|Transferred to another facility|0|||
41945283|NCT02248974|75694965|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
41945284|NCT02248974|75694966|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
41945285|NCT02248974|75694965|FG000|1-Week Follow-Up|Death|1|||
41945286|NCT02248974|75694966|FG001|1-Week Follow-Up|Death|1|||
41945287|NCT02248974|75694965|FG000|1-Week Follow-Up|Excluded because of age|0|||
41945288|NCT02248974|75694966|FG001|1-Week Follow-Up|Excluded because of age|1|||
41945289|NCT02248974|75694965|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
41945290|NCT02248974|75694966|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
41945291|NCT02248974|75694965|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
41945292|NCT02248974|75694966|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
41945293|NCT02248974|75694965|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
41945294|NCT02248974|75694966|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
41945295|NCT02248974|75694965|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
41945296|NCT02248974|75694966|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
41945297|NCT02248974|75694965|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
41945298|NCT02248974|75694966|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
41945299|NCT02246166|75694974|FG000|Overall Study|Protocol Violation|1|||
41945300|NCT02246166|75694975|FG001|Overall Study|Protocol Violation|0|||
41945301|NCT02706847|75694984|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
41945302|NCT02706847|75694985|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
41945303|NCT02706847|75694986|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
41945304|NCT02706847|75694987|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
41945305|NCT02706847|75694984|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
41945306|NCT02706847|75694985|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
41945307|NCT02706847|75694986|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
41945308|NCT02706847|75694987|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
41945309|NCT02706847|75694984|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
41945310|NCT02706847|75694985|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
41945311|NCT02706847|75694986|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
41945312|NCT02706847|75694987|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
41945313|NCT02706847|75694984|FG000|Period 1: Day 1 to Week 12|Other|4|||
41945314|NCT02706847|75694985|FG001|Period 1: Day 1 to Week 12|Other|4|||
41945315|NCT02706847|75694986|FG002|Period 1: Day 1 to Week 12|Other|2|||
41945316|NCT02706847|75694987|FG003|Period 1: Day 1 to Week 12|Other|2|||
41945317|NCT02706847|75694984|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
41945318|NCT02706847|75694985|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
41945319|NCT02706847|75694986|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
41945320|NCT02706847|75694987|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
41945321|NCT02706847|75694984|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
41945322|NCT02706847|75694985|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
41945323|NCT02706847|75694986|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
41945324|NCT02706847|75694987|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
41945325|NCT02706847|75694984|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
41945326|NCT02706847|75694985|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
41945327|NCT02706847|75694986|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
41945328|NCT02706847|75694987|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
41945329|NCT02706847|75694984|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
41945330|NCT02706847|75694985|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
41945331|NCT02706847|75694986|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
41945332|NCT02706847|75694987|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
41945333|NCT02706847|75694984|FG000|Period 1: Week 12 to Week 24|Other|1|||
41945334|NCT02706847|75694985|FG001|Period 1: Week 12 to Week 24|Other|0|||
41945335|NCT02706847|75694986|FG002|Period 1: Week 12 to Week 24|Other|1|||
41945336|NCT02706847|75694987|FG003|Period 1: Week 12 to Week 24|Other|4|||
41945337|NCT02706847|75694984|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
41945338|NCT02706847|75694985|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
41945339|NCT02706847|75694986|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
41945340|NCT02706847|75694987|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
41945341|NCT02706847|75694984|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
42300341|NCT02366091|76135509|FG000|Overall Study|Withdrawal by Subject|3|||
42300342|NCT02366091|76135510|FG001|Overall Study|Withdrawal by Subject|7|||
42300343|NCT02366091|76135511|FG002|Overall Study|Withdrawal by Subject|3|||
41945342|NCT02706847|75694985|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
41945343|NCT02706847|75694986|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
41945344|NCT02706847|75694987|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
41945345|NCT02706847|75694984|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
41945346|NCT02706847|75694985|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
41945347|NCT02706847|75694986|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
41945348|NCT02706847|75694987|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
41945349|NCT02706847|75694984|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
41945350|NCT02706847|75694985|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
41945351|NCT02706847|75694986|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
41945352|NCT02706847|75694987|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
41945353|NCT02706847|75694984|FG000|Period 2: Week 24 to Week 260|Other|8|||
41945354|NCT02706847|75694985|FG001|Period 2: Week 24 to Week 260|Other|5|||
41945355|NCT02706847|75694986|FG002|Period 2: Week 24 to Week 260|Other|15|||
41945356|NCT02706847|75694987|FG003|Period 2: Week 24 to Week 260|Other|15|||
41945357|NCT02245620|75695000|FG000|Overall Study|Physician Decision|1|||
41945358|NCT02245620|75695001|FG001|Overall Study|Physician Decision|1|||
41945359|NCT02244996|75695009|FG000|Overall Study|Lack of Efficacy|2|||
41945360|NCT02244996|75695010|FG001|Overall Study|Lack of Efficacy|6|||
41945361|NCT02243280|75695045|FG000|Treated|Adverse Event|1|||
41945362|NCT02243280|75695046|FG001|Treated|Adverse Event|0|||
41945363|NCT02243280|75695047|FG002|Treated|Adverse Event|0|||
41945364|NCT02243280|75695048|FG003|Treated|Adverse Event|0|||
41945365|NCT02243280|75695049|FG004|Treated|Adverse Event|0|||
41945366|NCT02243280|75695050|FG005|Treated|Adverse Event|0|||
41945367|NCT02243280|75695051|FG006|Treated|Adverse Event|0|||
41945368|NCT02243280|75695052|FG007|Treated|Adverse Event|0|||
41945369|NCT02243280|75695053|FG008|Treated|Adverse Event|0|||
41945370|NCT02243280|75695054|FG009|Treated|Adverse Event|0|||
41945371|NCT02243280|75695055|FG010|Treated|Adverse Event|1|||
41945372|NCT02243280|75695045|FG000|Treated|Lost to Follow-up|0|||
41945373|NCT02243280|75695046|FG001|Treated|Lost to Follow-up|0|||
41945374|NCT02243280|75695047|FG002|Treated|Lost to Follow-up|0|||
41945375|NCT02243280|75695048|FG003|Treated|Lost to Follow-up|0|||
41945376|NCT02243280|75695049|FG004|Treated|Lost to Follow-up|0|||
41945377|NCT02243280|75695050|FG005|Treated|Lost to Follow-up|0|||
41945378|NCT02243280|75695051|FG006|Treated|Lost to Follow-up|0|||
41945379|NCT02243280|75695052|FG007|Treated|Lost to Follow-up|0|||
41945380|NCT02243280|75695053|FG008|Treated|Lost to Follow-up|1|||
41945381|NCT02243280|75695054|FG009|Treated|Lost to Follow-up|0|||
41945382|NCT02243280|75695055|FG010|Treated|Lost to Follow-up|2|||
41945383|NCT02248818|75695113|FG000|Screening|Protocol Violation|0|||
41945384|NCT02248818|75695114|FG001|Screening|Protocol Violation|0|||
41945385|NCT02248818|75695115|FG002|Screening|Protocol Violation|0|||
41945386|NCT02248818|75695116|FG003|Screening|Protocol Violation|0|||
41945387|NCT02248818|75695117|FG004|Screening|Protocol Violation|0|||
41945388|NCT02248818|75695118|FG005|Screening|Protocol Violation|0|||
41945389|NCT02248818|75695119|FG006|Screening|Protocol Violation|0|||
41945390|NCT02248818|75695120|FG007|Screening|Protocol Violation|0|||
41945391|NCT02248818|75695121|FG008|Screening|Protocol Violation|7|||
41945392|NCT02248818|75695113|FG000|Screening|Study fully enrolled|0|||
41945393|NCT02248818|75695114|FG001|Screening|Study fully enrolled|0|||
41945394|NCT02248818|75695115|FG002|Screening|Study fully enrolled|0|||
41945395|NCT02248818|75695116|FG003|Screening|Study fully enrolled|0|||
41945396|NCT02248818|75695117|FG004|Screening|Study fully enrolled|0|||
41945397|NCT02248818|75695118|FG005|Screening|Study fully enrolled|0|||
41945398|NCT02248818|75695119|FG006|Screening|Study fully enrolled|0|||
41945399|NCT02248818|75695120|FG007|Screening|Study fully enrolled|0|||
41945400|NCT02248818|75695121|FG008|Screening|Study fully enrolled|14|||
41945401|NCT02248818|75695113|FG000|Screening|Physician Decision|0|||
41945402|NCT02248818|75695114|FG001|Screening|Physician Decision|0|||
41945403|NCT02248818|75695115|FG002|Screening|Physician Decision|0|||
41945404|NCT02248818|75695116|FG003|Screening|Physician Decision|0|||
41945405|NCT02248818|75695117|FG004|Screening|Physician Decision|0|||
41945406|NCT02248818|75695118|FG005|Screening|Physician Decision|0|||
41945407|NCT02248818|75695119|FG006|Screening|Physician Decision|0|||
41945408|NCT02248818|75695120|FG007|Screening|Physician Decision|0|||
42023362|NCT01194258|75830673|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
42023363|NCT01194258|75830674|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
42023364|NCT01194258|75830670|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
41945409|NCT02248818|75695121|FG008|Screening|Physician Decision|73|||
41945410|NCT02248818|75695113|FG000|Screening|Withdrawal by Subject|0|||
42023365|NCT01194258|75830671|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
41945411|NCT02248818|75695114|FG001|Screening|Withdrawal by Subject|0|||
41945412|NCT02248818|75695115|FG002|Screening|Withdrawal by Subject|0|||
41945413|NCT02248818|75695116|FG003|Screening|Withdrawal by Subject|0|||
42023366|NCT01194258|75830672|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
42300344|NCT02366091|76135512|FG003|Overall Study|Withdrawal by Subject|1|||
41945414|NCT02248818|75695117|FG004|Screening|Withdrawal by Subject|0|||
41945415|NCT02248818|75695118|FG005|Screening|Withdrawal by Subject|0|||
41945416|NCT02248818|75695119|FG006|Screening|Withdrawal by Subject|0|||
41945417|NCT02248818|75695120|FG007|Screening|Withdrawal by Subject|0|||
41945418|NCT02248818|75695121|FG008|Screening|Withdrawal by Subject|6|||
41945419|NCT02248818|75695113|FG000|Screening|Lost to Follow-up|0|||
41945420|NCT02248818|75695114|FG001|Screening|Lost to Follow-up|0|||
41945421|NCT02248818|75695115|FG002|Screening|Lost to Follow-up|0|||
42023367|NCT01194258|75830673|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
41945422|NCT02248818|75695116|FG003|Screening|Lost to Follow-up|0|||
41945423|NCT02248818|75695117|FG004|Screening|Lost to Follow-up|0|||
41945424|NCT02248818|75695118|FG005|Screening|Lost to Follow-up|0|||
41945425|NCT02248818|75695119|FG006|Screening|Lost to Follow-up|0|||
41945426|NCT02248818|75695120|FG007|Screening|Lost to Follow-up|0|||
41945427|NCT02248818|75695121|FG008|Screening|Lost to Follow-up|7|||
41945428|NCT02248818|75695113|FG000|Randomised Study|Administrative - randomization error|0|||
41945429|NCT02248818|75695114|FG001|Randomised Study|Administrative - randomization error|0|||
41945430|NCT02248818|75695115|FG002|Randomised Study|Administrative - randomization error|0|||
41945431|NCT02248818|75695116|FG003|Randomised Study|Administrative - randomization error|0|||
41945432|NCT02248818|75695117|FG004|Randomised Study|Administrative - randomization error|0|||
41945433|NCT02248818|75695118|FG005|Randomised Study|Administrative - randomization error|8|||
41945434|NCT02248818|75695119|FG006|Randomised Study|Administrative - randomization error|0|||
41945435|NCT02248818|75695120|FG007|Randomised Study|Administrative - randomization error|0|||
41945436|NCT02248818|75695121|FG008|Randomised Study|Administrative - randomization error|0|||
41945437|NCT02247960|75695150|FG000|Patient Consent and Randomization|Physician Decision|2|||
41945438|NCT02247960|75695151|FG001|Patient Consent and Randomization|Physician Decision|2|||
41945439|NCT02247960|75695150|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
41945440|NCT02247960|75695151|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
41945441|NCT02247960|75695150|FG000|Catheter Removed|Lost to Follow-up|7|||
41945442|NCT02247960|75695151|FG001|Catheter Removed|Lost to Follow-up|10|||
41945443|NCT02247804|75695240|FG000|Treatment Period 1|Adverse Event|9|||
41945444|NCT02247804|75695241|FG001|Treatment Period 1|Adverse Event|2|||
41945445|NCT02247804|75695242|FG002|Treatment Period 1|Adverse Event|0|||
41945446|NCT02247804|75695240|FG000|Treatment Period 1|Lack of Efficacy|0|||
41945447|NCT02247804|75695241|FG001|Treatment Period 1|Lack of Efficacy|0|||
41945448|NCT02247804|75695242|FG002|Treatment Period 1|Lack of Efficacy|2|||
41945449|NCT02247804|75695240|FG000|Treatment Period 1|Lost to Follow-up|1|||
41945450|NCT02247804|75695241|FG001|Treatment Period 1|Lost to Follow-up|0|||
41945451|NCT02247804|75695242|FG002|Treatment Period 1|Lost to Follow-up|2|||
41945452|NCT02247804|75695240|FG000|Treatment Period 1|Personal Reasons|7|||
41945453|NCT02247804|75695241|FG001|Treatment Period 1|Personal Reasons|1|||
41945454|NCT02247804|75695242|FG002|Treatment Period 1|Personal Reasons|2|||
41945455|NCT02247804|75695240|FG000|Treatment Period 1|Protocol Deviation|0|||
41945456|NCT02247804|75695241|FG001|Treatment Period 1|Protocol Deviation|0|||
41945457|NCT02247804|75695242|FG002|Treatment Period 1|Protocol Deviation|1|||
41945458|NCT02247804|75695240|FG000|Treatment Period 1|Randomized but not Treated|5|||
41945459|NCT02247804|75695241|FG001|Treatment Period 1|Randomized but not Treated|1|||
41945460|NCT02247804|75695242|FG002|Treatment Period 1|Randomized but not Treated|1|||
41945461|NCT02247804|75695240|FG000|Treatment Period 2|Adverse Event|6|||
41945462|NCT02247804|75695241|FG001|Treatment Period 2|Adverse Event|3|||
41945463|NCT02247804|75695242|FG002|Treatment Period 2|Adverse Event|3|||
41945464|NCT02247804|75695240|FG000|Treatment Period 2|Lack of Efficacy|0|||
41945465|NCT02247804|75695241|FG001|Treatment Period 2|Lack of Efficacy|0|||
41945466|NCT02247804|75695242|FG002|Treatment Period 2|Lack of Efficacy|1|||
41945467|NCT02247804|75695240|FG000|Treatment Period 2|Lost to Follow-up|0|||
41945468|NCT02247804|75695241|FG001|Treatment Period 2|Lost to Follow-up|1|||
41945469|NCT02247804|75695242|FG002|Treatment Period 2|Lost to Follow-up|1|||
41945470|NCT02247804|75695240|FG000|Treatment Period 2|Personal Reasons|2|||
41945471|NCT02247804|75695241|FG001|Treatment Period 2|Personal Reasons|1|||
41945472|NCT02247804|75695242|FG002|Treatment Period 2|Personal Reasons|1|||
41945473|NCT02247804|75695240|FG000|Treatment Period 2|Reason not Specified|0|||
41945474|NCT02247804|75695241|FG001|Treatment Period 2|Reason not Specified|0|||
41945475|NCT02247804|75695242|FG002|Treatment Period 2|Reason not Specified|2|||
41945476|NCT02247804|75695240|FG000|Treatment Period 3|Adverse Event|4|||
41945477|NCT02247804|75695241|FG001|Treatment Period 3|Adverse Event|3|||
41945478|NCT02247804|75695242|FG002|Treatment Period 3|Adverse Event|3|||
41945479|NCT02247804|75695240|FG000|Treatment Period 3|Lack of Efficacy|0|||
41945480|NCT02247804|75695241|FG001|Treatment Period 3|Lack of Efficacy|1|||
41945481|NCT02247804|75695242|FG002|Treatment Period 3|Lack of Efficacy|0|||
41945482|NCT02247804|75695240|FG000|Treatment Period 3|Lost to Follow-up|1|||
41945483|NCT02247804|75695241|FG001|Treatment Period 3|Lost to Follow-up|2|||
41945484|NCT02247804|75695242|FG002|Treatment Period 3|Lost to Follow-up|2|||
41945485|NCT02247804|75695240|FG000|Treatment Period 3|Personal Reasons|4|||
41945486|NCT02247804|75695241|FG001|Treatment Period 3|Personal Reasons|3|||
41945487|NCT02247804|75695242|FG002|Treatment Period 3|Personal Reasons|2|||
41945488|NCT02247804|75695240|FG000|Treatment Period 3|Reason not Specified|2|||
41945489|NCT02247804|75695241|FG001|Treatment Period 3|Reason not Specified|1|||
41945490|NCT02247804|75695242|FG002|Treatment Period 3|Reason not Specified|3|||
41945491|NCT02243202|75695267|FG000|Overall Study|Adverse Event|5|||
41945492|NCT02243202|75695268|FG001|Overall Study|Adverse Event|6|||
41945493|NCT02243202|75695269|FG002|Overall Study|Adverse Event|10|||
41945494|NCT02243202|75695270|FG003|Overall Study|Adverse Event|4|||
41945495|NCT02243202|75695267|FG000|Overall Study|Lost to Follow-up|9|||
41945496|NCT02243202|75695268|FG001|Overall Study|Lost to Follow-up|9|||
41945497|NCT02243202|75695269|FG002|Overall Study|Lost to Follow-up|14|||
41945498|NCT02243202|75695270|FG003|Overall Study|Lost to Follow-up|11|||
41945499|NCT02243202|75695267|FG000|Overall Study|Protocol Violation|3|||
41945500|NCT02243202|75695268|FG001|Overall Study|Protocol Violation|1|||
41945501|NCT02243202|75695269|FG002|Overall Study|Protocol Violation|2|||
41945502|NCT02243202|75695270|FG003|Overall Study|Protocol Violation|1|||
41945503|NCT02243202|75695267|FG000|Overall Study|Withdrawal by Subject|7|||
41945504|NCT02243202|75695268|FG001|Overall Study|Withdrawal by Subject|6|||
41945505|NCT02243202|75695269|FG002|Overall Study|Withdrawal by Subject|4|||
41945506|NCT02243202|75695270|FG003|Overall Study|Withdrawal by Subject|4|||
41945507|NCT02243202|75695267|FG000|Overall Study|Other|1|||
41945508|NCT02243202|75695268|FG001|Overall Study|Other|3|||
41945509|NCT02243202|75695269|FG002|Overall Study|Other|1|||
41945510|NCT02243202|75695270|FG003|Overall Study|Other|2|||
41945511|NCT02243202|75695267|FG000|Overall Study|Randomized but not received treatment|0|||
41945512|NCT02243202|75695268|FG001|Overall Study|Randomized but not received treatment|0|||
41945513|NCT02243202|75695269|FG002|Overall Study|Randomized but not received treatment|0|||
41945514|NCT02243202|75695270|FG003|Overall Study|Randomized but not received treatment|1|||
41945515|NCT02243046|75695283|FG000|Overall Study|Lost to Follow-up|1|||
41945516|NCT02243046|75695284|FG001|Overall Study|Lost to Follow-up|1|||
41945517|NCT02243046|75695285|FG002|Overall Study|Lost to Follow-up|4|||
41945518|NCT02207946|75695295|FG000|Overall Study|Lost to Follow-up|1|||
41945519|NCT02207946|75695296|FG001|Overall Study|Lost to Follow-up|0|||
41945520|NCT02207946|75695295|FG000|Overall Study|Adverse Event|0|||
41945521|NCT02207946|75695296|FG001|Overall Study|Adverse Event|1|||
41945522|NCT03976076|75695303|FG000|Overall Study|Withdrawal by Subject|2|||
41945523|NCT03551210|75695502|FG000|Overall Study|Adverse Event|5|||
41945524|NCT03551210|75695503|FG001|Overall Study|Adverse Event|6|||
41945525|NCT03551210|75695502|FG000|Overall Study|Withdrawal by Subject|1|||
41945526|NCT03551210|75695503|FG001|Overall Study|Withdrawal by Subject|7|||
41945527|NCT03551210|75695502|FG000|Overall Study|Needed in other antibiotic treatment|2|||
41945528|NCT03551210|75695503|FG001|Overall Study|Needed in other antibiotic treatment|5|||
41945529|NCT03551210|75695502|FG000|Overall Study|Lost to Follow-up|1|||
41945530|NCT03551210|75695503|FG001|Overall Study|Lost to Follow-up|1|||
41945531|NCT03551210|75695502|FG000|Overall Study|Absence of visit 4 and 5|1|||
41945532|NCT03551210|75695503|FG001|Overall Study|Absence of visit 4 and 5|0|||
41945533|NCT03551210|75695502|FG000|Overall Study|No drug for dispensing|0|||
41945534|NCT03551210|75695503|FG001|Overall Study|No drug for dispensing|1|||
41945535|NCT02207634|75695640|FG000|Overall Study|Withdrawal by Subject|21|||
41945536|NCT02207634|75695641|FG001|Overall Study|Withdrawal by Subject|31|||
41945537|NCT02207634|75695640|FG000|Overall Study|Lost to Follow-up|1|||
41945538|NCT02207634|75695641|FG001|Overall Study|Lost to Follow-up|0|||
41945539|NCT03452228|75695673|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
41945540|NCT03452228|75695674|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
41945541|NCT03452228|75695675|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
41945542|NCT03452228|75695673|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
41945543|NCT03452228|75695674|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
41945544|NCT03452228|75695675|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
41945545|NCT03452228|75695673|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
41945546|NCT03452228|75695674|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
41945547|NCT03452228|75695675|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
41945548|NCT03452228|75695673|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
41945549|NCT03452228|75695674|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
41945550|NCT03452228|75695675|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
42023368|NCT01194258|75830674|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42023369|NCT01193556|75830687|FG000|Overall Study|Study termination|26|||
42023370|NCT01193556|75830688|FG001|Overall Study|Study termination|25|||
42023371|NCT00951496|75830701|FG000|Overall Study|Did not initiate study treatment|10|||
41945551|NCT02207556|75695738|FG000|Overall Study|Physician Decision|1|||
41945552|NCT02207556|75695739|FG001|Overall Study|Physician Decision|0|||
41945553|NCT02207556|75695738|FG000|Overall Study|Withdrawal by Subject|1|||
41945554|NCT02207556|75695739|FG001|Overall Study|Withdrawal by Subject|0|||
41945555|NCT02207556|75695738|FG000|Overall Study|Death|0|||
41945556|NCT02207556|75695739|FG001|Overall Study|Death|5|||
41945557|NCT03732638|75695754|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
41945558|NCT03732638|75695755|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
42023372|NCT00951496|75830702|FG001|Overall Study|Did not initiate study treatment|8|||
41945559|NCT03732638|75695754|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
41945560|NCT03732638|75695755|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
41945561|NCT03732638|75695754|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
41945562|NCT03732638|75695755|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
41945563|NCT03732638|75695754|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
41945564|NCT03732638|75695755|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
41945565|NCT03732638|75695754|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
41945566|NCT03732638|75695755|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
41945567|NCT03732638|75695754|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
41945568|NCT03732638|75695755|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
41945569|NCT03732638|75695754|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
41945570|NCT03732638|75695755|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
41945571|NCT03732638|75695754|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
41945572|NCT03732638|75695755|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
41945573|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
41945574|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
41945575|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
41945576|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
41945577|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
41945578|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
41945579|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
41945580|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
41945581|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
41945582|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
41945583|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
41945584|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
41945585|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
41945586|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
41945587|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
41945588|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
41945589|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
41945590|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
41945591|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
41945592|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
41945593|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
41945594|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
41945595|NCT03732638|75695754|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
41945596|NCT03732638|75695755|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
41945597|NCT03732638|75695754|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
41945598|NCT03732638|75695755|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
41945599|NCT03732638|75695754|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
41945600|NCT03732638|75695755|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
41945601|NCT03732638|75695754|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
41945602|NCT03732638|75695755|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
41945603|NCT03732638|75695754|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
41945604|NCT03732638|75695755|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
41945605|NCT03266588|75695794|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
41945606|NCT03266588|75695795|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
41945607|NCT03266588|75695796|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
41945608|NCT03266588|75695794|FG000|Observational Period|Withdrawal by Subject|44|||
41945609|NCT03266588|75695795|FG001|Observational Period|Withdrawal by Subject|22|||
41945610|NCT03266588|75695796|FG002|Observational Period|Withdrawal by Subject|13|||
41945611|NCT03266588|75695794|FG000|Observational Period|Non-compliance|18|||
41945612|NCT03266588|75695795|FG001|Observational Period|Non-compliance|12|||
41945613|NCT03266588|75695796|FG002|Observational Period|Non-compliance|10|||
41945614|NCT03266588|75695794|FG000|Observational Period|Lost to Follow-up|8|||
41945615|NCT03266588|75695795|FG001|Observational Period|Lost to Follow-up|12|||
41945616|NCT03266588|75695796|FG002|Observational Period|Lost to Follow-up|4|||
41945617|NCT03266588|75695794|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
41945618|NCT03266588|75695795|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
41945619|NCT03266588|75695796|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
41945620|NCT03266588|75695794|FG000|Observational Period|Protocol Deviation|1|||
41945621|NCT03266588|75695795|FG001|Observational Period|Protocol Deviation|0|||
41945622|NCT03266588|75695796|FG002|Observational Period|Protocol Deviation|0|||
41945623|NCT03266588|75695794|FG000|Observational Period|Other Reasons|3|||
41945624|NCT03266588|75695795|FG001|Observational Period|Other Reasons|0|||
41945625|NCT03266588|75695796|FG002|Observational Period|Other Reasons|1|||
41945626|NCT03266588|75695794|FG000|Long-term Treatment Period|Adverse Event|33|||
41945627|NCT03266588|75695795|FG001|Long-term Treatment Period|Adverse Event|17|||
41945628|NCT03266588|75695796|FG002|Long-term Treatment Period|Adverse Event|8|||
41945629|NCT03266588|75695794|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
41945630|NCT03266588|75695795|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
41945631|NCT03266588|75695796|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
41945632|NCT03266588|75695794|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
41945633|NCT03266588|75695795|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
41945634|NCT03266588|75695796|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
41945635|NCT03266588|75695794|FG000|Long-term Treatment Period|Non-Compliance|126|||
41945636|NCT03266588|75695795|FG001|Long-term Treatment Period|Non-Compliance|57|||
41945637|NCT03266588|75695796|FG002|Long-term Treatment Period|Non-Compliance|7|||
41945638|NCT03266588|75695794|FG000|Long-term Treatment Period|Pregnancy|11|||
41945639|NCT03266588|75695795|FG001|Long-term Treatment Period|Pregnancy|5|||
41945640|NCT03266588|75695796|FG002|Long-term Treatment Period|Pregnancy|0|||
41945641|NCT03266588|75695794|FG000|Long-term Treatment Period|Protocol Deviation|17|||
41945642|NCT03266588|75695795|FG001|Long-term Treatment Period|Protocol Deviation|10|||
41945643|NCT03266588|75695796|FG002|Long-term Treatment Period|Protocol Deviation|4|||
41945644|NCT03266588|75695794|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
41945645|NCT03266588|75695795|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
41945646|NCT03266588|75695796|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
41945647|NCT03266588|75695794|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
41945648|NCT03266588|75695795|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
41945649|NCT03266588|75695796|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
41945650|NCT03266588|75695794|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
41945651|NCT03266588|75695795|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
41945652|NCT03266588|75695796|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
41945653|NCT03266588|75695794|FG000|Long-term Treatment Period|Other Reasons|5|||
41945654|NCT03266588|75695795|FG001|Long-term Treatment Period|Other Reasons|0|||
41945655|NCT03266588|75695796|FG002|Long-term Treatment Period|Other Reasons|0|||
41945656|NCT03266588|75695794|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
41945657|NCT03266588|75695795|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
41945658|NCT03266588|75695796|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
41945659|NCT03238196|75695860|FG000|Overall Study|Adverse Event|3|||
41945660|NCT03238196|75695861|FG001|Overall Study|Adverse Event|0|||
41945661|NCT03238196|75695862|FG002|Overall Study|Adverse Event|2|||
41945662|NCT03238196|75695863|FG003|Overall Study|Adverse Event|2|||
41945663|NCT03238196|75695860|FG000|Overall Study|Withdrawal by Subject|4|||
41945664|NCT03238196|75695861|FG001|Overall Study|Withdrawal by Subject|1|||
41945665|NCT03238196|75695862|FG002|Overall Study|Withdrawal by Subject|1|||
41945666|NCT03238196|75695863|FG003|Overall Study|Withdrawal by Subject|0|||
41945667|NCT03238196|75695860|FG000|Overall Study|Disease progression|14|||
41945668|NCT03238196|75695861|FG001|Overall Study|Disease progression|2|||
41945669|NCT03238196|75695862|FG002|Overall Study|Disease progression|3|||
41945670|NCT03238196|75695863|FG003|Overall Study|Disease progression|2|||
41945671|NCT03238196|75695860|FG000|Overall Study|Still on treatment|1|||
41945672|NCT03238196|75695861|FG001|Overall Study|Still on treatment|0|||
41945673|NCT03238196|75695862|FG002|Overall Study|Still on treatment|0|||
41945674|NCT03238196|75695863|FG003|Overall Study|Still on treatment|0|||
41945675|NCT03019640|75695882|FG000|Overall Study|Screen Failures|4|||
41945676|NCT03019640|75695882|FG000|Overall Study|Adverse Event|3|||
41945677|NCT03019640|75695882|FG000|Overall Study|Participant Relapsed|1|||
41945678|NCT02240706|75695950|FG000|Overall Study|Lack of Efficacy|2|||
41945679|NCT02240706|75695951|FG001|Overall Study|Lack of Efficacy|2|||
41945680|NCT02240706|75695952|FG002|Overall Study|Lack of Efficacy|2|||
41945681|NCT02240706|75695953|FG003|Overall Study|Lack of Efficacy|2|||
41945682|NCT02240706|75695954|FG004|Overall Study|Lack of Efficacy|5|||
41945683|NCT02240706|75695955|FG005|Overall Study|Lack of Efficacy|0|||
41945684|NCT02240706|75695956|FG006|Overall Study|Lack of Efficacy|0|||
41945685|NCT02240706|75695950|FG000|Overall Study|Adverse Event|1|||
41945686|NCT02240706|75695951|FG001|Overall Study|Adverse Event|0|||
41945687|NCT02240706|75695952|FG002|Overall Study|Adverse Event|1|||
41945688|NCT02240706|75695953|FG003|Overall Study|Adverse Event|0|||
41945689|NCT02240706|75695954|FG004|Overall Study|Adverse Event|2|||
41945690|NCT02240706|75695955|FG005|Overall Study|Adverse Event|0|||
41945691|NCT02240706|75695956|FG006|Overall Study|Adverse Event|0|||
42023373|NCT00951496|75830703|FG002|Overall Study|Did not initiate study treatment|13|||
42023374|NCT01193244|75830716|FG000|Overall Study|Withdrawal by Subject|79|||
42023375|NCT01193244|75830717|FG001|Overall Study|Withdrawal by Subject|97|||
42023376|NCT01193244|75830716|FG000|Overall Study|Other|303|||
42023377|NCT01193244|75830717|FG001|Overall Study|Other|278|||
42300345|NCT02326155|76135524|FG000|Overall Study|Adverse Event|21|||
42300346|NCT02326155|76135525|FG001|Overall Study|Adverse Event|5|||
41945692|NCT02240706|75695950|FG000|Overall Study|Progressive disease|0|||
42023378|NCT01193244|75830716|FG000|Overall Study|Lost to Follow-up|6|||
42023379|NCT01193244|75830717|FG001|Overall Study|Lost to Follow-up|15|||
42023380|NCT01192152|75830723|FG000|Period 1|left prematurely (while on treatment B)|0|||
41945693|NCT02240706|75695951|FG001|Overall Study|Progressive disease|0|||
41945694|NCT02240706|75695952|FG002|Overall Study|Progressive disease|0|||
41945695|NCT02240706|75695953|FG003|Overall Study|Progressive disease|0|||
41945696|NCT02240706|75695954|FG004|Overall Study|Progressive disease|1|||
41945697|NCT02240706|75695955|FG005|Overall Study|Progressive disease|0|||
42023381|NCT01192152|75830724|FG001|Period 1|left prematurely (while on treatment B)|1|||
42023382|NCT01192152|75830723|FG000|Period 3|family emergency|1|||
42300347|NCT02326155|76135524|FG000|Overall Study|Death|3|||
42023383|NCT01192152|75830724|FG001|Period 3|family emergency|0|||
42023384|NCT01191840|75830734|FG000|Overall Study|withdrew consent|2|||
42023385|NCT01191840|75830735|FG001|Overall Study|withdrew consent|1|||
42023386|NCT01191840|75830734|FG000|Overall Study|Subject discontinued treatment|1|||
42023387|NCT01191840|75830735|FG001|Overall Study|Subject discontinued treatment|2|||
42023388|NCT01191840|75830734|FG000|Overall Study|Lost to Follow-up|4|||
42023389|NCT01191840|75830735|FG001|Overall Study|Lost to Follow-up|6|||
42023390|NCT01191840|75830734|FG000|Overall Study|Non Staph Infection|4|||
42023391|NCT01191840|75830735|FG001|Overall Study|Non Staph Infection|3|||
42023392|NCT01191840|75830734|FG000|Overall Study|ineligible at enrollment|1|||
42023393|NCT01191840|75830735|FG001|Overall Study|ineligible at enrollment|0|||
42023394|NCT01191840|75830734|FG000|Overall Study|IRB approval lapse|0|||
41945698|NCT02240706|75695956|FG006|Overall Study|Progressive disease|0|||
41945699|NCT02240706|75695950|FG000|Overall Study|Dose limiting toxicity|0|||
41945700|NCT02240706|75695951|FG001|Overall Study|Dose limiting toxicity|0|||
41945701|NCT02240706|75695952|FG002|Overall Study|Dose limiting toxicity|0|||
41945702|NCT02240706|75695953|FG003|Overall Study|Dose limiting toxicity|0|||
41945703|NCT02240706|75695954|FG004|Overall Study|Dose limiting toxicity|1|||
41945704|NCT02240706|75695955|FG005|Overall Study|Dose limiting toxicity|0|||
41945705|NCT02240706|75695956|FG006|Overall Study|Dose limiting toxicity|0|||
41945706|NCT02240706|75695950|FG000|Overall Study|Refused to continue taking medication|0|||
41945707|NCT02240706|75695951|FG001|Overall Study|Refused to continue taking medication|1|||
41945708|NCT02240706|75695952|FG002|Overall Study|Refused to continue taking medication|3|||
41945709|NCT02240706|75695953|FG003|Overall Study|Refused to continue taking medication|1|||
41945710|NCT02240706|75695954|FG004|Overall Study|Refused to continue taking medication|2|||
41945711|NCT02240706|75695955|FG005|Overall Study|Refused to continue taking medication|0|||
41945712|NCT02240706|75695956|FG006|Overall Study|Refused to continue taking medication|0|||
41945713|NCT02240706|75695950|FG000|Overall Study|Insurance billing concerns|0|||
41945714|NCT02240706|75695951|FG001|Overall Study|Insurance billing concerns|0|||
41945715|NCT02240706|75695952|FG002|Overall Study|Insurance billing concerns|0|||
41945716|NCT02240706|75695953|FG003|Overall Study|Insurance billing concerns|1|||
41945717|NCT02240706|75695954|FG004|Overall Study|Insurance billing concerns|0|||
41945718|NCT02240706|75695955|FG005|Overall Study|Insurance billing concerns|0|||
41945719|NCT02240706|75695956|FG006|Overall Study|Insurance billing concerns|0|||
41945720|NCT01600092|75695981|FG000|Overall Study|Adverse Event|2|||
41945721|NCT01600092|75695982|FG001|Overall Study|Adverse Event|0|||
41945722|NCT01600092|75695981|FG000|Overall Study|Lost to Follow-up|4|||
41945723|NCT01600092|75695982|FG001|Overall Study|Lost to Follow-up|6|||
41945724|NCT01600092|75695981|FG000|Overall Study|Withdrawal by parent/guardian|8|||
41945725|NCT01600092|75695982|FG001|Overall Study|Withdrawal by parent/guardian|6|||
41945726|NCT01600092|75695981|FG000|Overall Study|Physician Decision|1|||
41945727|NCT01600092|75695982|FG001|Overall Study|Physician Decision|1|||
41945728|NCT01600092|75695981|FG000|Overall Study|Randomized but not vaccinated|3|||
41945729|NCT01600092|75695982|FG001|Overall Study|Randomized but not vaccinated|3|||
41945730|NCT02240628|75695994|FG000|Overall Study|Physician Decision|6|||
41945731|NCT02240628|75695995|FG001|Overall Study|Physician Decision|5|||
41945732|NCT02207400|75696017|FG000|Overall Study|Adverse Event|1|||
41945733|NCT02207400|75696018|FG001|Overall Study|Adverse Event|1|||
41945734|NCT02207400|75696017|FG000|Overall Study|Lost to Follow-up|6|||
41945735|NCT02207400|75696018|FG001|Overall Study|Lost to Follow-up|7|||
41945736|NCT02207400|75696017|FG000|Overall Study|Protocol Violation|1|||
41945737|NCT02207400|75696018|FG001|Overall Study|Protocol Violation|1|||
41945738|NCT02207400|75696017|FG000|Overall Study|Withdrawal by Subject|8|||
41945739|NCT02207400|75696018|FG001|Overall Study|Withdrawal by Subject|4|||
41945740|NCT02207400|75696017|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
41945741|NCT02207400|75696018|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
41945742|NCT02207244|75696377|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
41945743|NCT02207244|75696378|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
42023395|NCT01191840|75830735|FG001|Overall Study|IRB approval lapse|2|||
41945744|NCT02207244|75696379|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
41945745|NCT02207244|75696380|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
41945746|NCT02207244|75696381|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
41945747|NCT02207244|75696382|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
41945748|NCT02207244|75696383|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
41945749|NCT02207244|75696384|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
41945750|NCT02207244|75696385|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
42023396|NCT01191840|75830734|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
42023397|NCT01191840|75830735|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
41945751|NCT02207244|75696386|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
41945752|NCT02207244|75696387|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
41945753|NCT02207244|75696377|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
41945754|NCT02207244|75696378|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
41945755|NCT02207244|75696379|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
41945756|NCT02207244|75696380|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
41945757|NCT02207244|75696381|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
41945758|NCT02207244|75696382|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
41945759|NCT02207244|75696383|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
41945760|NCT02207244|75696384|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
41945761|NCT02207244|75696385|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
41945762|NCT02207244|75696386|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
41945763|NCT02207244|75696387|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
41945764|NCT02207244|75696377|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
41945765|NCT02207244|75696378|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
41945766|NCT02207244|75696379|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
41945767|NCT02207244|75696380|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
41945768|NCT02207244|75696381|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
41945769|NCT02207244|75696382|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
41945770|NCT02207244|75696383|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
41945771|NCT02207244|75696384|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
41945772|NCT02207244|75696385|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
41945773|NCT02207244|75696386|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
41945774|NCT02207244|75696387|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
41945775|NCT02207244|75696377|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
41945776|NCT02207244|75696378|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
41945777|NCT02207244|75696379|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
41945778|NCT02207244|75696380|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
41945779|NCT02207244|75696381|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
41945780|NCT02207244|75696382|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
41945781|NCT02207244|75696383|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
41945782|NCT02207244|75696384|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
41945783|NCT02207244|75696385|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
41945784|NCT02207244|75696386|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
41945785|NCT02207244|75696387|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
41945786|NCT02207244|75696377|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
41945787|NCT02207244|75696378|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
41945788|NCT02207244|75696379|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
41945789|NCT02207244|75696380|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
41945790|NCT02207244|75696381|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
41945791|NCT02207244|75696382|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
41945792|NCT02207244|75696383|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
41945793|NCT02207244|75696384|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
41945794|NCT02207244|75696385|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
41945795|NCT02207244|75696386|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
41945796|NCT02207244|75696387|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
41945797|NCT02207244|75696377|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
41945798|NCT02207244|75696378|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
41945799|NCT02207244|75696379|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
41945800|NCT02207244|75696380|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
41945801|NCT02207244|75696381|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
41945802|NCT02207244|75696382|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
41945803|NCT02207244|75696383|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
41945804|NCT02207244|75696384|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
41945805|NCT02207244|75696385|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
41945806|NCT02207244|75696386|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
41945807|NCT02207244|75696387|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
41945808|NCT02207244|75696377|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
41945809|NCT02207244|75696378|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
41945810|NCT02207244|75696379|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
41945811|NCT02207244|75696380|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
41945812|NCT02207244|75696381|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
42023398|NCT01191840|75830734|FG000|Overall Study|Withdrawal by Subject|2|||
42023399|NCT01191840|75830735|FG001|Overall Study|Withdrawal by Subject|0|||
42023400|NCT00943072|75830747|FG000|Overall Study|Adverse Event|0|||
42023401|NCT00943072|75830748|FG001|Overall Study|Adverse Event|3|||
42023402|NCT00943072|75830747|FG000|Overall Study|Death|0|||
42023403|NCT00943072|75830748|FG001|Overall Study|Death|2|||
42023404|NCT00943072|75830747|FG000|Overall Study|Withdrawal by Subject|3|||
42023405|NCT00943072|75830748|FG001|Overall Study|Withdrawal by Subject|1|||
42023406|NCT00943072|75830747|FG000|Overall Study|Protocol Violation|0|||
42023407|NCT00943072|75830748|FG001|Overall Study|Protocol Violation|1|||
41945813|NCT02207244|75696382|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
41945814|NCT02207244|75696383|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
41945815|NCT02207244|75696384|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
41945816|NCT02207244|75696385|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
41945817|NCT02207244|75696386|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
41945818|NCT02207244|75696387|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
41945819|NCT02207244|75696377|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
41945820|NCT02207244|75696378|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
41945821|NCT02207244|75696379|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
41945822|NCT02207244|75696380|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
41945823|NCT02207244|75696381|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
41945824|NCT02207244|75696382|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
41945825|NCT02207244|75696383|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
41945826|NCT02207244|75696384|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
41945827|NCT02207244|75696385|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
41945828|NCT02207244|75696386|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
41945829|NCT02207244|75696387|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
41945830|NCT02207244|75696377|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
41945831|NCT02207244|75696378|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
41945832|NCT02207244|75696379|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
41945833|NCT02207244|75696380|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
41945834|NCT02207244|75696381|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
41945835|NCT02207244|75696382|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
41945836|NCT02207244|75696383|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
41945837|NCT02207244|75696384|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
41945838|NCT02207244|75696385|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
41945839|NCT02207244|75696386|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
41945840|NCT02207244|75696387|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
41945841|NCT02207244|75696377|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
41945842|NCT02207244|75696378|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
41945843|NCT02207244|75696379|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
41945844|NCT02207244|75696380|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
41945845|NCT02207244|75696381|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
41945846|NCT02207244|75696382|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
41945847|NCT02207244|75696383|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
41945848|NCT02207244|75696384|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
41945849|NCT02207244|75696385|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
41945850|NCT02207244|75696386|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
41945851|NCT02207244|75696387|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
41945852|NCT02207244|75696377|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
41945853|NCT02207244|75696378|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
41945854|NCT02207244|75696379|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
41945855|NCT02207244|75696380|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
41945856|NCT02207244|75696381|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
41945857|NCT02207244|75696382|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
41945858|NCT02207244|75696383|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
41945859|NCT02207244|75696384|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
41945860|NCT02207244|75696385|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
41945861|NCT02207244|75696386|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
41945862|NCT02207244|75696387|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
41945863|NCT02207244|75696377|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
41945864|NCT02207244|75696378|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
41945865|NCT02207244|75696379|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
41945866|NCT02207244|75696380|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
41945867|NCT02207244|75696381|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
41945868|NCT02207244|75696382|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
41945869|NCT02207244|75696383|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
41945870|NCT02207244|75696384|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
41945871|NCT02207244|75696385|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
41945872|NCT02207244|75696386|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
41945873|NCT02207244|75696387|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
41945874|NCT02207244|75696377|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
41945875|NCT02207244|75696378|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
41945876|NCT02207244|75696379|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
41945877|NCT02207244|75696380|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
42023408|NCT00943072|75830747|FG000|Overall Study|Lost to Follow-up|1|||
41945878|NCT02207244|75696381|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
41945879|NCT02207244|75696382|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
41945880|NCT02207244|75696383|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
41945881|NCT02207244|75696384|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
41945882|NCT02207244|75696385|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
41945883|NCT02207244|75696386|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
41945884|NCT02207244|75696387|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
41945885|NCT02207244|75696377|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
41945886|NCT02207244|75696378|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
41945887|NCT02207244|75696379|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
41945888|NCT02207244|75696380|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
41945889|NCT02207244|75696381|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
41945890|NCT02207244|75696382|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
41945891|NCT02207244|75696383|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
41945892|NCT02207244|75696384|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
41945893|NCT02207244|75696385|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
41945894|NCT02207244|75696386|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
41945895|NCT02207244|75696387|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
41945896|NCT02207244|75696377|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
41945897|NCT02207244|75696378|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
41945898|NCT02207244|75696379|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
41945899|NCT02207244|75696380|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
41945900|NCT02207244|75696381|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
41945901|NCT02207244|75696382|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
41945902|NCT02207244|75696383|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
41945903|NCT02207244|75696384|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
41945904|NCT02207244|75696385|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
41945905|NCT02207244|75696386|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
41945906|NCT02207244|75696387|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
41945907|NCT02207244|75696377|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
41945908|NCT02207244|75696378|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
41945909|NCT02207244|75696379|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
41945910|NCT02207244|75696380|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
41945911|NCT02207244|75696381|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
41945912|NCT02207244|75696382|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
41945913|NCT02207244|75696383|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
41945914|NCT02207244|75696384|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
41945915|NCT02207244|75696385|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
41945916|NCT02207244|75696386|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
41945917|NCT02207244|75696387|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
41945918|NCT02207244|75696377|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
41945919|NCT02207244|75696378|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
41945920|NCT02207244|75696379|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
41945921|NCT02207244|75696380|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
41945922|NCT02207244|75696381|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
41945923|NCT02207244|75696382|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
41945924|NCT02207244|75696383|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
41945925|NCT02207244|75696384|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
41945926|NCT02207244|75696385|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
41945927|NCT02207244|75696386|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
41945928|NCT02207244|75696387|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
41945929|NCT02207244|75696377|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
41945930|NCT02207244|75696378|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
41945931|NCT02207244|75696379|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
41945932|NCT02207244|75696380|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
41945933|NCT02207244|75696381|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
41945934|NCT02207244|75696382|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
41945935|NCT02207244|75696383|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
42023409|NCT00943072|75830748|FG001|Overall Study|Lost to Follow-up|2|||
42023410|NCT00943072|75830747|FG000|Overall Study|Lack of Efficacy|0|||
41945936|NCT02207244|75696384|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
41945937|NCT02207244|75696385|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
41945938|NCT02207244|75696386|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
41945939|NCT02207244|75696387|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
42023411|NCT00943072|75830748|FG001|Overall Study|Lack of Efficacy|4|||
42023412|NCT00943072|75830747|FG000|Overall Study|Other|1|||
42023413|NCT00943072|75830748|FG001|Overall Study|Other|1|||
41945940|NCT02207244|75696377|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
41945941|NCT02207244|75696378|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
41945942|NCT02207244|75696379|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
41945943|NCT02207244|75696380|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
41945944|NCT02207244|75696381|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
41945945|NCT02207244|75696382|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
41945946|NCT02207244|75696383|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
41945947|NCT02207244|75696384|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
41945948|NCT02207244|75696385|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
41945949|NCT02207244|75696386|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
41945950|NCT02207244|75696387|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
41945951|NCT02207244|75696377|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
41945952|NCT02207244|75696378|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
41945953|NCT02207244|75696379|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
41945954|NCT02207244|75696380|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
41945955|NCT02207244|75696381|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
41945956|NCT02207244|75696382|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
41945957|NCT02207244|75696383|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
41945958|NCT02207244|75696384|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
41945959|NCT02207244|75696385|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
41945960|NCT02207244|75696386|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
41945961|NCT02207244|75696387|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
41945962|NCT02207244|75696377|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
41945963|NCT02207244|75696378|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
41945964|NCT02207244|75696379|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
41945965|NCT02207244|75696380|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
41945966|NCT02207244|75696381|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
41945967|NCT02207244|75696382|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
41945968|NCT02207244|75696383|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
41945969|NCT02207244|75696384|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
41945970|NCT02207244|75696385|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
41945971|NCT02207244|75696386|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
41945972|NCT02207244|75696387|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
41945973|NCT02207244|75696377|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
41945974|NCT02207244|75696378|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
41945975|NCT02207244|75696379|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
42023414|NCT00942994|75830758|FG000|Overall Study|Adverse Event|7|||
42023415|NCT00942994|75830759|FG001|Overall Study|Adverse Event|4|||
42023416|NCT00942994|75830758|FG000|Overall Study|Abnormal laboratory value(s)|1|||
41945976|NCT02207244|75696380|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
41945977|NCT02207244|75696381|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
41945978|NCT02207244|75696382|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
42023417|NCT00942994|75830759|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42023418|NCT00942994|75830758|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42023419|NCT00942994|75830759|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
42300348|NCT02326155|76135525|FG001|Overall Study|Death|0|||
41945979|NCT02207244|75696383|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
41945980|NCT02207244|75696384|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
41945981|NCT02207244|75696385|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
41945982|NCT02207244|75696386|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
41945983|NCT02207244|75696387|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
41945984|NCT02207244|75696377|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
41945985|NCT02207244|75696378|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
41945986|NCT02207244|75696379|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
41945987|NCT02207244|75696380|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
41945988|NCT02207244|75696381|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
41945989|NCT02207244|75696382|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
41945990|NCT02207244|75696383|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
41945991|NCT02207244|75696384|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
41945992|NCT02207244|75696385|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
41945993|NCT02207244|75696386|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
41945994|NCT02207244|75696387|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
41945995|NCT02207244|75696377|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
41945996|NCT02207244|75696378|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
41945997|NCT02207244|75696379|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
41945998|NCT02207244|75696380|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
41945999|NCT02207244|75696381|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
41946000|NCT02207244|75696382|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
41946001|NCT02207244|75696383|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
41946002|NCT02207244|75696384|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
41946003|NCT02207244|75696385|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
41946004|NCT02207244|75696386|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
41946005|NCT02207244|75696387|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
41946006|NCT02207244|75696377|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
41946007|NCT02207244|75696378|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
41946008|NCT02207244|75696379|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
41946009|NCT02207244|75696380|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
41946010|NCT02207244|75696381|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
41946011|NCT02207244|75696382|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
41946012|NCT02207244|75696383|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
41946013|NCT02207244|75696384|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
41946014|NCT02207244|75696385|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
41946015|NCT02207244|75696386|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
41946016|NCT02207244|75696387|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
41946017|NCT02207244|75696377|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
41946018|NCT02207244|75696378|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
41946019|NCT02207244|75696379|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
41946020|NCT02207244|75696380|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
41946021|NCT02207244|75696381|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
41946022|NCT02207244|75696382|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
41946023|NCT02207244|75696383|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
41946024|NCT02207244|75696384|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
41946025|NCT02207244|75696385|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
41946026|NCT02207244|75696386|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
41946027|NCT02207244|75696387|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
41946028|NCT02207244|75696377|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
41946029|NCT02207244|75696378|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
41946030|NCT02207244|75696379|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
41946031|NCT02207244|75696380|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
41946032|NCT02207244|75696381|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
41946033|NCT02207244|75696382|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
42023420|NCT00942994|75830758|FG000|Overall Study|Patient withdrew consent|5|||
42023421|NCT00942994|75830759|FG001|Overall Study|Patient withdrew consent|8|||
42023422|NCT00942994|75830758|FG000|Overall Study|Lost to Follow-up|1|||
42023423|NCT00942994|75830759|FG001|Overall Study|Lost to Follow-up|4|||
42023424|NCT00942994|75830758|FG000|Overall Study|Protocol deviation|1|||
41946034|NCT02207244|75696383|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
41946035|NCT02207244|75696384|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
41946036|NCT02207244|75696385|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
41946037|NCT02207244|75696386|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
41946038|NCT02207244|75696387|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
42023425|NCT00942994|75830759|FG001|Overall Study|Protocol deviation|2|||
42023426|NCT00942604|75830767|FG000|Overall Study|Protocol Violation|1|||
42023427|NCT00942604|75830768|FG001|Overall Study|Protocol Violation|1|||
41946039|NCT02207244|75696377|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
41946040|NCT02207244|75696378|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
41946041|NCT02207244|75696379|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
41946042|NCT02207244|75696380|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
41946043|NCT02207244|75696381|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
41946044|NCT02207244|75696382|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
41946045|NCT02207244|75696383|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
41946046|NCT02207244|75696384|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
41946047|NCT02207244|75696385|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
41946048|NCT02207244|75696386|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
41946049|NCT02207244|75696387|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
41946050|NCT02207244|75696377|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
41946051|NCT02207244|75696378|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
41946052|NCT02207244|75696379|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
41946053|NCT02207244|75696380|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
41946054|NCT02207244|75696381|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
41946055|NCT02207244|75696382|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
41946056|NCT02207244|75696383|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
41946057|NCT02207244|75696384|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
41946058|NCT02207244|75696385|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
41946059|NCT02207244|75696386|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
41946060|NCT02207244|75696387|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
41946061|NCT02207088|75696440|FG000|Overall Study|Adverse Event|2|||
41946062|NCT02206620|75696455|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
41946063|NCT02206620|75696456|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
41946064|NCT02206620|75696455|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
41946065|NCT02206620|75696456|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
41946066|NCT02239926|75696470|FG000|Overall Study|Withdrawal by Subject|0|||
41946067|NCT02239926|75696471|FG001|Overall Study|Withdrawal by Subject|1|||
41946068|NCT02239692|75696479|FG000|Overall Study|Incomplete colonoscopy|1|||
41946069|NCT02239692|75696480|FG001|Overall Study|Incomplete colonoscopy|2|||
41946070|NCT02239692|75696479|FG000|Overall Study|Adverse Event|0|||
41946071|NCT02239692|75696480|FG001|Overall Study|Adverse Event|1|||
41946072|NCT02239692|75696479|FG000|Overall Study|Physician Decision|0|||
41946073|NCT02239692|75696480|FG001|Overall Study|Physician Decision|1|||
41946074|NCT02239692|75696479|FG000|Overall Study|Lost to Follow-up|1|||
41946075|NCT02239692|75696480|FG001|Overall Study|Lost to Follow-up|4|||
41946076|NCT02239692|75696479|FG000|Overall Study|Withdrawal by Subject|3|||
41946077|NCT02239692|75696480|FG001|Overall Study|Withdrawal by Subject|5|||
41946078|NCT02239692|75696479|FG000|Overall Study|Other reason|1|||
41946079|NCT02239692|75696480|FG001|Overall Study|Other reason|0|||
41946080|NCT02206152|75696508|FG000|Pre-Randomization|Withdrawal by Subject|2|||
41946081|NCT02239536|75696516|FG000|Overall Study|Non-neoplastic polyp|23|||
41946082|NCT02239536|75696517|FG001|Overall Study|Non-neoplastic polyp|17|||
41946083|NCT02239224|75696527|FG000|Overall Study|Administrative|0|||
41946084|NCT02239224|75696528|FG001|Overall Study|Administrative|0|||
41946085|NCT02239224|75696529|FG002|Overall Study|Administrative|3|||
41946086|NCT02239224|75696530|FG003|Overall Study|Administrative|1|||
41946087|NCT01600014|75696540|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
41946088|NCT01600014|75696541|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
41946089|NCT01600014|75696540|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
41946090|NCT01600014|75696541|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
41946091|NCT01600014|75696540|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
41946092|NCT01600014|75696541|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
41946093|NCT01600014|75696540|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
41946094|NCT01600014|75696541|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
41946095|NCT01600014|75696540|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
41946096|NCT01600014|75696541|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
41946097|NCT01600014|75696540|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
41946098|NCT01600014|75696541|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
41946099|NCT01600014|75696540|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
41946100|NCT01600014|75696541|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
41946101|NCT01600014|75696540|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
41946102|NCT01600014|75696541|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
41946103|NCT01600014|75696540|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
41946104|NCT01600014|75696541|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
41946105|NCT01600014|75696540|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
41946106|NCT01600014|75696541|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
41946107|NCT01600014|75696540|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
41946108|NCT01600014|75696541|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
42023428|NCT00942604|75830767|FG000|Overall Study|Adverse Event|0|||
41946109|NCT01600014|75696540|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
41946110|NCT01600014|75696541|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
41946111|NCT01600014|75696540|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
41946112|NCT01600014|75696541|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
41946113|NCT01600014|75696540|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
41946114|NCT01600014|75696541|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
41946115|NCT01600014|75696540|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
41946116|NCT01600014|75696541|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
41946117|NCT01600014|75696540|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
41946118|NCT01600014|75696541|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
41946119|NCT01600014|75696540|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
41946120|NCT01600014|75696541|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
41946121|NCT02237196|75696563|FG000|Overall Study|Adverse Event|0|||
41946122|NCT02237196|75696564|FG001|Overall Study|Adverse Event|1|||
41946123|NCT02237196|75696565|FG002|Overall Study|Adverse Event|1|||
41946124|NCT02237196|75696566|FG003|Overall Study|Adverse Event|0|||
41946125|NCT02237196|75696563|FG000|Overall Study|Lost to Follow-up|4|||
41946126|NCT02237196|75696564|FG001|Overall Study|Lost to Follow-up|2|||
41946127|NCT02237196|75696565|FG002|Overall Study|Lost to Follow-up|4|||
41946128|NCT02237196|75696566|FG003|Overall Study|Lost to Follow-up|6|||
41946129|NCT02237196|75696563|FG000|Overall Study|Physician Decision|2|||
41946130|NCT02237196|75696564|FG001|Overall Study|Physician Decision|0|||
41946131|NCT02237196|75696565|FG002|Overall Study|Physician Decision|0|||
41946132|NCT02237196|75696566|FG003|Overall Study|Physician Decision|1|||
41946133|NCT02237196|75696563|FG000|Overall Study|Pregnancy|0|||
41946134|NCT02237196|75696564|FG001|Overall Study|Pregnancy|0|||
41946135|NCT02237196|75696565|FG002|Overall Study|Pregnancy|1|||
41946136|NCT02237196|75696566|FG003|Overall Study|Pregnancy|1|||
41946137|NCT02237196|75696563|FG000|Overall Study|Withdrawal by Subject|1|||
41946138|NCT02237196|75696564|FG001|Overall Study|Withdrawal by Subject|1|||
41946139|NCT02237196|75696565|FG002|Overall Study|Withdrawal by Subject|4|||
41946140|NCT02237196|75696566|FG003|Overall Study|Withdrawal by Subject|1|||
41946141|NCT02237196|75696563|FG000|Overall Study|Site Error|1|||
41946142|NCT02237196|75696564|FG001|Overall Study|Site Error|2|||
41946143|NCT02237196|75696565|FG002|Overall Study|Site Error|0|||
41946144|NCT02237196|75696566|FG003|Overall Study|Site Error|2|||
41946145|NCT02237118|75696582|FG000|Overall Study|Protocol Violation|0|||
41946146|NCT02237118|75696583|FG001|Overall Study|Protocol Violation|1|||
41946147|NCT02237118|75696582|FG000|Overall Study|consent withdrawn|1|||
41946148|NCT02237118|75696583|FG001|Overall Study|consent withdrawn|0|||
41946149|NCT02234622|75696599|FG000|Overall Study|Withdrawal by Subject|16|||
41946150|NCT02234622|75696600|FG001|Overall Study|Withdrawal by Subject|22|||
41946151|NCT02234622|75696599|FG000|Overall Study|Lost to Follow-up|27|||
41946152|NCT02234622|75696600|FG001|Overall Study|Lost to Follow-up|14|||
41946153|NCT02203032|75696608|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
41946154|NCT02203032|75696609|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
41946155|NCT02203032|75696610|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
41946156|NCT02203032|75696611|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
41946157|NCT02203032|75696608|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
41946158|NCT02203032|75696609|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
41946159|NCT02203032|75696610|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
41946160|NCT02203032|75696611|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
41946161|NCT02203032|75696608|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
41946162|NCT02203032|75696609|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
41946163|NCT02203032|75696610|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
41946164|NCT02203032|75696611|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
41946165|NCT02203032|75696608|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
41946166|NCT02203032|75696609|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
41946167|NCT02203032|75696610|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
41946168|NCT02203032|75696611|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
41946169|NCT02203032|75696608|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
41946170|NCT02203032|75696609|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
42023429|NCT00942604|75830768|FG001|Overall Study|Adverse Event|1|||
42023430|NCT00942604|75830767|FG000|Overall Study|Withdrawal by Subject|0|||
41946171|NCT02203032|75696610|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
41946172|NCT02203032|75696611|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
41946173|NCT02203032|75696608|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
41946174|NCT02203032|75696609|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
41946175|NCT02203032|75696610|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
41946176|NCT02203032|75696611|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
42023431|NCT00942604|75830768|FG001|Overall Study|Withdrawal by Subject|1|||
41946177|NCT02203032|75696608|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
41946178|NCT02203032|75696609|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
41946179|NCT02203032|75696610|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
41946180|NCT02203032|75696611|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
41946181|NCT02203032|75696608|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
41946182|NCT02203032|75696609|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
41946183|NCT02203032|75696610|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
41946184|NCT02203032|75696611|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
41946185|NCT02203032|75696608|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
41946186|NCT02203032|75696609|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
41946187|NCT02203032|75696610|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
41946188|NCT02203032|75696611|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
41946189|NCT02203032|75696608|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
41946190|NCT02203032|75696609|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
41946191|NCT02203032|75696610|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
41946192|NCT02203032|75696611|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
41946193|NCT02203032|75696608|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
41946194|NCT02203032|75696609|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
41946195|NCT02203032|75696610|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
41946196|NCT02203032|75696611|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
41946197|NCT02203032|75696608|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
41946198|NCT02203032|75696609|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
41946199|NCT02203032|75696610|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
41946200|NCT02203032|75696611|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
41946201|NCT02169414|75696623|FG000|Overall Study|Withdrawal by Subject|1|||
41946202|NCT02169414|75696624|FG001|Overall Study|Withdrawal by Subject|0|||
41946203|NCT02169414|75696625|FG002|Overall Study|Withdrawal by Subject|0|||
41946204|NCT02169414|75696626|FG003|Overall Study|Withdrawal by Subject|0|||
41946205|NCT02169414|75696623|FG000|Overall Study|Adverse Event|0|||
41946206|NCT02169414|75696624|FG001|Overall Study|Adverse Event|1|||
41946207|NCT02169414|75696625|FG002|Overall Study|Adverse Event|0|||
41946208|NCT02169414|75696626|FG003|Overall Study|Adverse Event|0|||
41946209|NCT02201940|75696642|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
41946210|NCT02201940|75696643|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
41946211|NCT02201940|75696642|FG000|Overall Study|Lack of Efficacy|2|||
41946212|NCT02201940|75696643|FG001|Overall Study|Lack of Efficacy|113|||
41946213|NCT02201940|75696642|FG000|Overall Study|Lost to Follow-up|5|||
41946214|NCT02201940|75696643|FG001|Overall Study|Lost to Follow-up|0|||
41946215|NCT02201940|75696642|FG000|Overall Study|Withdrew Consent|2|||
41946216|NCT02201940|75696643|FG001|Overall Study|Withdrew Consent|1|||
41946217|NCT02201940|75696642|FG000|Overall Study|Investigator's Discretion|1|||
41946218|NCT02201940|75696643|FG001|Overall Study|Investigator's Discretion|1|||
41946219|NCT02201940|75696642|FG000|Overall Study|Death|1|||
41946220|NCT02201940|75696643|FG001|Overall Study|Death|0|||
41946221|NCT02201940|75696642|FG000|Overall Study|Adverse Event|0|||
41946222|NCT02201940|75696643|FG001|Overall Study|Adverse Event|1|||
41946223|NCT02232984|75696649|FG000|Overall Study|Withdrawal by Subject|5|||
41946224|NCT02232984|75696649|FG000|Overall Study|Death|1|||
41946225|NCT02232984|75696649|FG000|Overall Study|Investigator withdrawal|10|||
41946226|NCT02232984|75696649|FG000|Overall Study|Device implant unsuccessful|53|||
41946227|NCT02232984|75696649|FG000|Overall Study|not disclosed by site|7|||
41946228|NCT02232984|75696649|FG000|Overall Study|Protocol Violation|1|||
41946229|NCT02169336|75696659|FG000|Overall Study|Lack of Efficacy|1|||
41946230|NCT02169336|75696660|FG001|Overall Study|Lack of Efficacy|1|||
41946231|NCT02169336|75696661|FG002|Overall Study|Lack of Efficacy|0|||
41946232|NCT02169336|75696659|FG000|Overall Study|Adverse Event|2|||
41946233|NCT02169336|75696660|FG001|Overall Study|Adverse Event|3|||
41946234|NCT02169336|75696661|FG002|Overall Study|Adverse Event|1|||
41946235|NCT02169336|75696659|FG000|Overall Study|Withdrawal by Subject|1|||
41946236|NCT02169336|75696660|FG001|Overall Study|Withdrawal by Subject|0|||
41946237|NCT02169336|75696661|FG002|Overall Study|Withdrawal by Subject|0|||
41946238|NCT02169336|75696659|FG000|Overall Study|Physician Decision|0|||
41946239|NCT02169336|75696660|FG001|Overall Study|Physician Decision|0|||
41946240|NCT02169336|75696661|FG002|Overall Study|Physician Decision|1|||
41946241|NCT02169336|75696659|FG000|Overall Study|Subject declined to continue dosing|0|||
41946242|NCT02169336|75696660|FG001|Overall Study|Subject declined to continue dosing|0|||
41946243|NCT02169336|75696661|FG002|Overall Study|Subject declined to continue dosing|1|||
41946244|NCT02609828|75696677|FG000|Overall Study|Adverse Event|8|||
41946245|NCT02609828|75696678|FG001|Overall Study|Adverse Event|1|||
41946246|NCT02609828|75696679|FG002|Overall Study|Adverse Event|0|||
41946247|NCT02609828|75696680|FG003|Overall Study|Adverse Event|6|||
41946248|NCT02609828|75696677|FG000|Overall Study|Death|15|||
41946249|NCT02609828|75696678|FG001|Overall Study|Death|1|||
41946250|NCT02609828|75696679|FG002|Overall Study|Death|1|||
41946251|NCT02609828|75696680|FG003|Overall Study|Death|19|||
41946252|NCT02609828|75696677|FG000|Overall Study|Insufficient clinical response|2|||
41946253|NCT02609828|75696678|FG001|Overall Study|Insufficient clinical response|1|||
41946254|NCT02609828|75696679|FG002|Overall Study|Insufficient clinical response|0|||
41946255|NCT02609828|75696680|FG003|Overall Study|Insufficient clinical response|0|||
41946256|NCT02609828|75696677|FG000|Overall Study|Lost to Follow-up|0|||
41946257|NCT02609828|75696678|FG001|Overall Study|Lost to Follow-up|0|||
41946258|NCT02609828|75696679|FG002|Overall Study|Lost to Follow-up|0|||
41946259|NCT02609828|75696680|FG003|Overall Study|Lost to Follow-up|1|||
41946260|NCT02609828|75696677|FG000|Overall Study|Protocol Violation|2|||
41946261|NCT02609828|75696678|FG001|Overall Study|Protocol Violation|0|||
41946262|NCT02609828|75696679|FG002|Overall Study|Protocol Violation|0|||
41946263|NCT02609828|75696680|FG003|Overall Study|Protocol Violation|1|||
41946264|NCT02609828|75696677|FG000|Overall Study|Withdrawal by Subject|12|||
41946265|NCT02609828|75696678|FG001|Overall Study|Withdrawal by Subject|1|||
41946266|NCT02609828|75696679|FG002|Overall Study|Withdrawal by Subject|0|||
41946267|NCT02609828|75696680|FG003|Overall Study|Withdrawal by Subject|10|||
41946268|NCT02609828|75696677|FG000|Overall Study|Other|3|||
41946269|NCT02609828|75696678|FG001|Overall Study|Other|0|||
41946270|NCT02609828|75696679|FG002|Overall Study|Other|0|||
41946271|NCT02609828|75696680|FG003|Overall Study|Other|6|||
41946272|NCT02609828|75696677|FG000|Overall Study|Randomized but not treated|1|||
41946273|NCT02609828|75696678|FG001|Overall Study|Randomized but not treated|0|||
41946274|NCT02609828|75696679|FG002|Overall Study|Randomized but not treated|0|||
41946275|NCT02609828|75696680|FG003|Overall Study|Randomized but not treated|0|||
41946276|NCT01632306|75696696|FG000|Overall Study|Protocol Violation|1|||
41946277|NCT01632306|75696697|FG001|Overall Study|Protocol Violation|0|||
41946278|NCT01632306|75696698|FG002|Overall Study|Protocol Violation|0|||
41946279|NCT02201784|75696706|FG000|Overall Study|Failure to achieve adequate block|2|||
41946280|NCT02201784|75696707|FG001|Overall Study|Failure to achieve adequate block|0|||
41946281|NCT02201472|75696713|FG000|Overall Study|Lack of Efficacy|2|||
41946282|NCT02168946|75696758|FG000|Overall Study|Adverse Event|8|||
41946283|NCT02168946|75696759|FG001|Overall Study|Adverse Event|5|||
41946284|NCT02168946|75696758|FG000|Overall Study|Lost to Follow-up|3|||
41946285|NCT02168946|75696759|FG001|Overall Study|Lost to Follow-up|0|||
41946286|NCT02168946|75696758|FG000|Overall Study|Subject unable to come back for visits|1|||
41946287|NCT02168946|75696759|FG001|Overall Study|Subject unable to come back for visits|0|||
41946288|NCT02168478|75696780|FG000|Overall Study|Withdrawal by Subject|1|||
41946289|NCT02168478|75696780|FG000|Overall Study|Did Not Consent to Participation|2|||
41946290|NCT02168478|75696780|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
41946291|NCT02200614|75697931|FG000|Double Blind Treatment|Adverse Event|86|||
41946292|NCT02200614|75697932|FG001|Double Blind Treatment|Adverse Event|48|||
41946293|NCT02200614|75697931|FG000|Double Blind Treatment|Confirmed metastasis|120|||
41946294|NCT02200614|75697932|FG001|Double Blind Treatment|Confirmed metastasis|140|||
41946295|NCT02200614|75697931|FG000|Double Blind Treatment|Judgment of the investigator|59|||
41946296|NCT02200614|75697932|FG001|Double Blind Treatment|Judgment of the investigator|99|||
41946297|NCT02200614|75697931|FG000|Double Blind Treatment|Metastasis by local reading|1|||
41946298|NCT02200614|75697932|FG001|Double Blind Treatment|Metastasis by local reading|3|||
41946299|NCT02200614|75697931|FG000|Double Blind Treatment|Other reason|6|||
41946300|NCT02200614|75697932|FG001|Double Blind Treatment|Other reason|2|||
41946301|NCT02200614|75697931|FG000|Double Blind Treatment|Personal reason|77|||
41946302|NCT02200614|75697932|FG001|Double Blind Treatment|Personal reason|85|||
41946303|NCT02200614|75697931|FG000|Double Blind Treatment|Protocol deviation|14|||
41946304|NCT02200614|75697932|FG001|Double Blind Treatment|Protocol deviation|7|||
41946305|NCT02200614|75697931|FG000|Double Blind Treatment|Not treated|1|||
41946306|NCT02200614|75697932|FG001|Double Blind Treatment|Not treated|0|||
41946307|NCT02200614|75697931|FG000|Open Label|Adverse Event|41|||
41946308|NCT02200614|75697932|FG001|Open Label|Adverse Event|11|||
41946309|NCT02200614|75697931|FG000|Open Label|Confirmed metastasis|1|||
41946310|NCT02200614|75697932|FG001|Open Label|Confirmed metastasis|0|||
41946311|NCT02200614|75697931|FG000|Open Label|Judgment of the investigator|29|||
41946312|NCT02200614|75697932|FG001|Open Label|Judgment of the investigator|2|||
41946313|NCT02200614|75697931|FG000|Open Label|Metastasis by local reading|138|||
41946314|NCT02200614|75697932|FG001|Open Label|Metastasis by local reading|27|||
41946315|NCT02200614|75697931|FG000|Open Label|Other reason|22|||
41946316|NCT02200614|75697932|FG001|Open Label|Other reason|4|||
41946317|NCT02200614|75697931|FG000|Open Label|Personal reason|60|||
41946318|NCT02200614|75697932|FG001|Open Label|Personal reason|8|||
41946319|NCT02200614|75697931|FG000|Open Label|Protocol deviation|3|||
41946320|NCT02200614|75697932|FG001|Open Label|Protocol deviation|2|||
41946321|NCT02200614|75697931|FG000|Open Label|Missing|2|||
41946322|NCT02200614|75697932|FG001|Open Label|Missing|2|||
41946323|NCT02231892|75697943|FG000|Overall Study|Lost to Follow-up|1|||
41946324|NCT02231892|75697944|FG001|Overall Study|Lost to Follow-up|0|||
41946325|NCT02231892|75697945|FG002|Overall Study|Lost to Follow-up|3|||
41946326|NCT02231892|75697943|FG000|Overall Study|Withdrawal by Subject|4|||
41946327|NCT02231892|75697944|FG001|Overall Study|Withdrawal by Subject|3|||
41946328|NCT02231892|75697945|FG002|Overall Study|Withdrawal by Subject|15|||
41946329|NCT02231892|75697943|FG000|Overall Study|Physician Decision|0|||
41946330|NCT02231892|75697944|FG001|Overall Study|Physician Decision|2|||
41946331|NCT02231892|75697945|FG002|Overall Study|Physician Decision|4|||
41946332|NCT02231892|75697943|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
41946333|NCT02231892|75697944|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
41946334|NCT02231892|75697945|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
41946335|NCT02231892|75697943|FG000|Overall Study|Participant motor threshold was >83%|0|||
41946336|NCT02231892|75697944|FG001|Overall Study|Participant motor threshold was >83%|0|||
41946337|NCT02231892|75697945|FG002|Overall Study|Participant motor threshold was >83%|9|||
41946338|NCT02231892|75697943|FG000|Overall Study|Could not find motor threshold|2|||
41946339|NCT02231892|75697944|FG001|Overall Study|Could not find motor threshold|0|||
41946340|NCT02231892|75697945|FG002|Overall Study|Could not find motor threshold|1|||
41946341|NCT02231892|75697943|FG000|Overall Study|Could not find reliable motor hotspot|0|||
41946342|NCT02231892|75697944|FG001|Overall Study|Could not find reliable motor hotspot|0|||
41946343|NCT02231892|75697945|FG002|Overall Study|Could not find reliable motor hotspot|1|||
41946344|NCT02231580|75697961|FG000|Overall Study|Adverse Event|5|||
41946345|NCT02231580|75697962|FG001|Overall Study|Adverse Event|0|||
41946346|NCT02166606|75697970|FG000|Overall Study|Adverse Event|3|||
41946347|NCT02166606|75697970|FG000|Overall Study|Death|31|||
41946348|NCT02166606|75697970|FG000|Overall Study|Protocol Violation|7|||
41946349|NCT02166606|75697970|FG000|Overall Study|Lost to Follow-up|30|||
41946350|NCT02166606|75697970|FG000|Overall Study|Withdrawal by Subject|1|||
41946351|NCT02166606|75697970|FG000|Overall Study|Physician Decision|1|||
41946352|NCT02166606|75697970|FG000|Overall Study|Device upgrade|1|||
41946353|NCT02166606|75697970|FG000|Overall Study|Enrolled after End of Enrollment|4|||
41946354|NCT02230956|75697977|FG000|Overall Study|Adverse Event|1|||
41946355|NCT02230956|75697978|FG001|Overall Study|Adverse Event|1|||
41946356|NCT02230956|75697979|FG002|Overall Study|Adverse Event|0|||
41946357|NCT02230956|75697977|FG000|Overall Study|Lack of Efficacy|1|||
41946358|NCT02230956|75697978|FG001|Overall Study|Lack of Efficacy|1|||
41946359|NCT02230956|75697979|FG002|Overall Study|Lack of Efficacy|1|||
41946360|NCT02230956|75697977|FG000|Overall Study|Lost to Follow-up|1|||
41946361|NCT02230956|75697978|FG001|Overall Study|Lost to Follow-up|1|||
41946362|NCT02230956|75697979|FG002|Overall Study|Lost to Follow-up|2|||
41946363|NCT02230956|75697977|FG000|Overall Study|Personal Reasons|2|||
41946364|NCT02230956|75697978|FG001|Overall Study|Personal Reasons|1|||
41946365|NCT02230956|75697979|FG002|Overall Study|Personal Reasons|1|||
41946366|NCT02230956|75697977|FG000|Overall Study|Protocol Violation|0|||
41946367|NCT02230956|75697978|FG001|Overall Study|Protocol Violation|1|||
41946368|NCT02230956|75697979|FG002|Overall Study|Protocol Violation|1|||
41946369|NCT02230956|75697977|FG000|Overall Study|Other Miscellaneous Reason|0|||
41946370|NCT02230956|75697978|FG001|Overall Study|Other Miscellaneous Reason|1|||
41946371|NCT02230956|75697979|FG002|Overall Study|Other Miscellaneous Reason|2|||
41946372|NCT02230410|75697987|FG000|Overall Study|Screen Failure|3|||
41946373|NCT02230332|75697993|FG000|Overall Study|Adverse Event|2|||
41946374|NCT02230332|75697994|FG001|Overall Study|Adverse Event|1|||
41946375|NCT02230332|75697993|FG000|Overall Study|Lost to Follow-up|1|||
41946376|NCT02230332|75697994|FG001|Overall Study|Lost to Follow-up|0|||
41946377|NCT02230332|75697993|FG000|Overall Study|Protocol Violation|1|||
41946378|NCT02230332|75697994|FG001|Overall Study|Protocol Violation|0|||
41946379|NCT02230254|75698000|FG000|Overall Study|Lost to Follow-up|3|||
41946380|NCT02198664|75698006|FG000|Overall Study|Adverse Event|2|||
41946381|NCT02198664|75698007|FG001|Overall Study|Adverse Event|0|||
41946382|NCT02198664|75698006|FG000|Overall Study|Withdrawal by Subject|11|||
41946383|NCT02198664|75698007|FG001|Overall Study|Withdrawal by Subject|8|||
41946384|NCT02198664|75698006|FG000|Overall Study|Failure to tolerate|2|||
41946385|NCT02198664|75698007|FG001|Overall Study|Failure to tolerate|0|||
41946386|NCT02198664|75698006|FG000|Overall Study|Not stated|1|||
41946387|NCT02198664|75698007|FG001|Overall Study|Not stated|0|||
41946388|NCT02165826|75698018|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
41946389|NCT02165826|75698019|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
41946390|NCT02165826|75698020|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
41946391|NCT02165826|75698018|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
41946392|NCT02165826|75698019|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
42023432|NCT00942604|75830767|FG000|Overall Study|Patient relocation|1|||
41946393|NCT02165826|75698020|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
41946394|NCT02165826|75698018|FG000|Main Treatment Period|Lost to Follow-up|4|||
41946395|NCT02165826|75698019|FG001|Main Treatment Period|Lost to Follow-up|2|||
41946396|NCT02165826|75698020|FG002|Main Treatment Period|Lost to Follow-up|1|||
41946397|NCT02165826|75698018|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
41946398|NCT02165826|75698019|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
41946399|NCT02165826|75698020|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
41946400|NCT02165826|75698018|FG000|Main Treatment Period|Lack of Efficacy|2|||
41946401|NCT02165826|75698019|FG001|Main Treatment Period|Lack of Efficacy|0|||
41946402|NCT02165826|75698020|FG002|Main Treatment Period|Lack of Efficacy|0|||
42023433|NCT00942604|75830768|FG001|Overall Study|Patient relocation|1|||
41946403|NCT02165826|75698018|FG000|Main Treatment Period|Reason Not Specified|8|||
41946404|NCT02165826|75698019|FG001|Main Treatment Period|Reason Not Specified|5|||
41946405|NCT02165826|75698020|FG002|Main Treatment Period|Reason Not Specified|16|||
41946406|NCT02165826|75698018|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
41946407|NCT02165826|75698019|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
41946408|NCT02165826|75698020|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
41946409|NCT02165826|75698018|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
41946410|NCT02165826|75698019|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
41946411|NCT02165826|75698020|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
41946412|NCT02165826|75698018|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
41946413|NCT02165826|75698019|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
41946414|NCT02165826|75698020|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
41946415|NCT02165826|75698018|FG000|Down-Titration Period|Reason Not Specified|1|||
41946416|NCT02165826|75698019|FG001|Down-Titration Period|Reason Not Specified|0|||
41946417|NCT02165826|75698020|FG002|Down-Titration Period|Reason Not Specified|2|||
41946418|NCT02198040|75698057|FG000|Overall Study|Work reasons|0|||
41946419|NCT02198040|75698058|FG001|Overall Study|Work reasons|1|||
41946420|NCT02198040|75698059|FG002|Overall Study|Work reasons|0|||
41946421|NCT02198040|75698057|FG000|Overall Study|Withdrawal by Subject|0|||
41946422|NCT02198040|75698058|FG001|Overall Study|Withdrawal by Subject|0|||
41946423|NCT02198040|75698059|FG002|Overall Study|Withdrawal by Subject|1|||
41946424|NCT02197806|75698073|FG000|Overall Study|Adverse Event|0|||
41946425|NCT02197806|75698074|FG001|Overall Study|Adverse Event|1|||
41946426|NCT02197806|75698075|FG002|Overall Study|Adverse Event|0|||
41946427|NCT02197806|75698076|FG003|Overall Study|Adverse Event|1|||
41946428|NCT02229864|75698123|FG000|Overall Study|Death|2|||
41946429|NCT02229864|75698123|FG000|Overall Study|Lost to Follow-up|1|||
41946430|NCT02229552|75698127|FG000|Baseline|Withdrawal by Subject|6|||
41946431|NCT02229552|75698127|FG000|1-year Follow up|Withdrawal by Subject|7|||
41946432|NCT02229552|75698127|FG000|1-year Follow up|Lost to Follow-up|18|||
41946433|NCT02229552|75698127|FG000|2-Year Follow up|Withdrawal by Subject|9|||
41946434|NCT02229552|75698127|FG000|2-Year Follow up|Lost to Follow-up|17|||
41946435|NCT02229396|75698134|FG000|Overall Study|Adverse Event|6|||
41946436|NCT02229396|75698135|FG001|Overall Study|Adverse Event|12|||
41946437|NCT02229396|75698136|FG002|Overall Study|Adverse Event|12|||
41946438|NCT02229396|75698134|FG000|Overall Study|Death|2|||
41946439|NCT02229396|75698135|FG001|Overall Study|Death|3|||
41946440|NCT02229396|75698136|FG002|Overall Study|Death|1|||
41946441|NCT02229396|75698134|FG000|Overall Study|Lost to Follow-up|14|||
41946442|NCT02229396|75698135|FG001|Overall Study|Lost to Follow-up|14|||
41946443|NCT02229396|75698136|FG002|Overall Study|Lost to Follow-up|21|||
41946444|NCT02229396|75698134|FG000|Overall Study|Protocol Violation|2|||
41946445|NCT02229396|75698135|FG001|Overall Study|Protocol Violation|1|||
41946446|NCT02229396|75698136|FG002|Overall Study|Protocol Violation|0|||
41946447|NCT02229396|75698134|FG000|Overall Study|Patient Incorrectly Randomized|0|||
41946448|NCT02229396|75698135|FG001|Overall Study|Patient Incorrectly Randomized|0|||
41946449|NCT02229396|75698136|FG002|Overall Study|Patient Incorrectly Randomized|1|||
41946450|NCT02229396|75698134|FG000|Overall Study|Other|10|||
41946451|NCT02229396|75698135|FG001|Overall Study|Other|18|||
41946452|NCT02229396|75698136|FG002|Overall Study|Other|15|||
41946453|NCT02229396|75698134|FG000|Overall Study|Withdrawal by Subject|42|||
41946454|NCT02229396|75698135|FG001|Overall Study|Withdrawal by Subject|28|||
41946455|NCT02229396|75698136|FG002|Overall Study|Withdrawal by Subject|41|||
41946456|NCT02229396|75698134|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
41946457|NCT02229396|75698135|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
41946458|NCT02229396|75698136|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
41946459|NCT02229396|75698134|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
41946460|NCT02229396|75698135|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
41946461|NCT02229396|75698136|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
41946462|NCT02197416|75698151|FG000|Overall Study|Other reasons|0|||
41946463|NCT02197416|75698152|FG001|Overall Study|Other reasons|2|||
41946464|NCT02197416|75698153|FG002|Overall Study|Other reasons|5|||
41946465|NCT02197416|75698151|FG000|Overall Study|Withdrawal by Subject|0|||
41946466|NCT02197416|75698152|FG001|Overall Study|Withdrawal by Subject|2|||
42300349|NCT02326155|76135524|FG000|Overall Study|Lack of Efficacy|49|||
42300350|NCT02326155|76135525|FG001|Overall Study|Lack of Efficacy|5|||
41946467|NCT02197416|75698153|FG002|Overall Study|Withdrawal by Subject|1|||
41946468|NCT02197416|75698151|FG000|Overall Study|Protocol Violation|1|||
41946469|NCT02197416|75698152|FG001|Overall Study|Protocol Violation|0|||
41946470|NCT02197416|75698153|FG002|Overall Study|Protocol Violation|1|||
41946471|NCT02197416|75698151|FG000|Overall Study|Adverse Event|0|||
41946472|NCT02197416|75698152|FG001|Overall Study|Adverse Event|0|||
41946473|NCT02197416|75698153|FG002|Overall Study|Adverse Event|1|||
41946474|NCT02165202|75698161|FG000|Oral Phase|Refused further participation|5|||
41946475|NCT02165202|75698162|FG001|Oral Phase|Refused further participation|1|||
41946476|NCT02165202|75698161|FG000|Oral Phase|Study product Related Toxicity|1|||
41946477|NCT02165202|75698162|FG001|Oral Phase|Study product Related Toxicity|0|||
41946478|NCT02165202|75698161|FG000|Oral Phase|Unable to contact Participant|1|||
41946479|NCT02165202|75698162|FG001|Oral Phase|Unable to contact Participant|1|||
41946480|NCT02165202|75698161|FG000|Oral Phase|Clinical reasons|1|||
41946481|NCT02165202|75698162|FG001|Oral Phase|Clinical reasons|0|||
41946482|NCT02165202|75698161|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
41946483|NCT02165202|75698162|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
41946484|NCT02165202|75698161|FG000|Oral Phase|CMC advised termination|1|||
41946485|NCT02165202|75698162|FG001|Oral Phase|CMC advised termination|0|||
41946486|NCT02165202|75698161|FG000|Oral Phase|Relocated, no follow-up planned|1|||
41946487|NCT02165202|75698162|FG001|Oral Phase|Relocated, no follow-up planned|0|||
41946488|NCT02165202|75698161|FG000|Oral Phase|Abnormal EKG|0|||
41946489|NCT02165202|75698162|FG001|Oral Phase|Abnormal EKG|1|||
41946490|NCT02165202|75698161|FG000|Injection Phase|Abnormal Lab Value|5|||
41946491|NCT02165202|75698162|FG001|Injection Phase|Abnormal Lab Value|1|||
41946492|NCT02165202|75698161|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
41946493|NCT02165202|75698162|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
41946494|NCT02165202|75698161|FG000|Injection Phase|Unable to attend within Visit Window|1|||
41946495|NCT02165202|75698162|FG001|Injection Phase|Unable to attend within Visit Window|0|||
41946496|NCT02165202|75698161|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
41946497|NCT02165202|75698162|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
41946498|NCT02165202|75698161|FG000|Injection Phase|End of Study|2|||
41946499|NCT02165202|75698162|FG001|Injection Phase|End of Study|1|||
41946500|NCT02165202|75698161|FG000|Injection Phase|Study Product related Toxicity|1|||
41946501|NCT02165202|75698162|FG001|Injection Phase|Study Product related Toxicity|0|||
41946502|NCT02165202|75698161|FG000|Injection Phase|No longer interested|0|||
41946503|NCT02165202|75698162|FG001|Injection Phase|No longer interested|1|||
41946504|NCT02165202|75698161|FG000|Injection Phase|Participant unwilling to comply|1|||
41946505|NCT02165202|75698162|FG001|Injection Phase|Participant unwilling to comply|0|||
41946506|NCT01628874|75698170|FG000|Overall Study|Physician Decision|1|||
41946507|NCT01628874|75698171|FG001|Overall Study|Physician Decision|1|||
41946508|NCT01628874|75698170|FG000|Overall Study|Age >4 months|4|||
41946509|NCT01628874|75698171|FG001|Overall Study|Age >4 months|2|||
41946510|NCT02196714|75698196|FG000|Overall Study|Protocol Violation|0|||
41946511|NCT02196714|75698197|FG001|Overall Study|Protocol Violation|0|||
41946512|NCT02196714|75698198|FG002|Overall Study|Protocol Violation|1|||
41946513|NCT02196714|75698199|FG003|Overall Study|Protocol Violation|0|||
41946514|NCT02196558|75698223|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
41946515|NCT02196558|75698224|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
41946516|NCT02196558|75698225|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
41946517|NCT02196558|75698223|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
41946518|NCT02196558|75698224|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
41946519|NCT02196558|75698225|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
41946520|NCT02196558|75698223|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
41946521|NCT02196558|75698224|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
41946522|NCT02196558|75698225|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
41946523|NCT02196558|75698223|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
41946524|NCT02196558|75698224|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
41946525|NCT02196558|75698225|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
41946526|NCT02196558|75698223|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
41946527|NCT02196558|75698224|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
41946528|NCT02196558|75698225|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
41946529|NCT02196324|75698246|FG000|Overall Study|Withdrawal by Subject|8|||
41946530|NCT02196324|75698247|FG001|Overall Study|Withdrawal by Subject|4|||
41946531|NCT02196324|75698246|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
41946532|NCT02196324|75698247|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
41946533|NCT02196324|75698246|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
41946534|NCT02196324|75698247|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
41946535|NCT02196324|75698246|FG000|Overall Study|Other|1|||
41946536|NCT02196324|75698247|FG001|Overall Study|Other|0|||
41946537|NCT02195700|75698255|FG000|Overall Study|Protocol Violation|0|||
41946538|NCT02195700|75698256|FG001|Overall Study|Protocol Violation|2|||
41946539|NCT02195700|75698255|FG000|Overall Study|Noncompliance|1|||
41946540|NCT02195700|75698256|FG001|Overall Study|Noncompliance|0|||
42023434|NCT01188564|75830776|FG000|Double-blind Phase|randomized not treated|1|||
41946541|NCT02195700|75698255|FG000|Overall Study|Adverse Event|1|||
41946542|NCT02195700|75698256|FG001|Overall Study|Adverse Event|2|||
41946543|NCT02195700|75698255|FG000|Overall Study|Withdrawal by Subject|3|||
41946544|NCT02195700|75698256|FG001|Overall Study|Withdrawal by Subject|2|||
41946545|NCT02195700|75698255|FG000|Overall Study|Lost to Follow-up|1|||
41946546|NCT02195700|75698256|FG001|Overall Study|Lost to Follow-up|1|||
42023435|NCT01188564|75830777|FG001|Double-blind Phase|randomized not treated|0|||
42023436|NCT01187550|75830785|FG000|Overall Study|Protocol Violation|3|||
41946547|NCT02228460|75698271|FG000|Overall Study|Adverse Event|1|||
41946548|NCT02228460|75698271|FG000|Overall Study|Lost to Follow-up|1|||
41946549|NCT02227446|75698287|FG000|Overall Study|not eligible post randomization|18|||
41946550|NCT02227446|75698288|FG001|Overall Study|not eligible post randomization|29|||
41946551|NCT02227446|75698287|FG000|Overall Study|Withdrawal by Subject|4|||
41946552|NCT02227446|75698288|FG001|Overall Study|Withdrawal by Subject|5|||
41946553|NCT02227368|75698296|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
41946554|NCT02227368|75698297|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
41946555|NCT02227368|75698296|FG000|Overall Study|Lost to Follow-up|1|||
41946556|NCT02227368|75698297|FG001|Overall Study|Lost to Follow-up|0|||
41946557|NCT02227368|75698296|FG000|Overall Study|Adverse Event|1|||
41946558|NCT02227368|75698297|FG001|Overall Study|Adverse Event|0|||
41946559|NCT02162862|75698306|FG000|Overall Study|Lost to Follow-up|0|||
41946560|NCT02162862|75698307|FG001|Overall Study|Lost to Follow-up|11|||
41946561|NCT02162862|75698308|FG002|Overall Study|Lost to Follow-up|0|||
41946562|NCT02162862|75698306|FG000|Overall Study|Subject did not feel the med was needed|0|||
41946563|NCT02162862|75698307|FG001|Overall Study|Subject did not feel the med was needed|0|||
41946564|NCT02162862|75698308|FG002|Overall Study|Subject did not feel the med was needed|4|||
41946565|NCT02226198|75698346|FG000|Lead-in Phase|Protocol Violation|1|||
41946566|NCT02226198|75698347|FG001|Lead-in Phase|Protocol Violation|0|||
41946567|NCT02226198|75698348|FG002|Lead-in Phase|Protocol Violation|0|||
41946568|NCT02226198|75698346|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
41946569|NCT02226198|75698347|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
41946570|NCT02226198|75698348|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
41946571|NCT02226120|75698519|FG000|Overall Study|Adverse Event|60|||
41946572|NCT02226120|75698519|FG000|Overall Study|Death|172|||
41946573|NCT02226120|75698519|FG000|Overall Study|Study terminated by sponsor|1|||
41946574|NCT02226120|75698519|FG000|Overall Study|Technical problems|4|||
41946575|NCT02226120|75698519|FG000|Overall Study|Lost to Follow-up|13|||
41946576|NCT02226120|75698519|FG000|Overall Study|Physician Decision|21|||
41946577|NCT02226120|75698519|FG000|Overall Study|Withdrawal by parent/guardian|36|||
41946578|NCT02226120|75698519|FG000|Overall Study|Non-compliance with study drug|10|||
41946579|NCT02226120|75698519|FG000|Overall Study|Protocol deviation|1|||
41946580|NCT02226120|75698519|FG000|Overall Study|missing treatment disposition pages|2|||
41946581|NCT02194998|75698684|FG000|On-HCV Treatment|Did not pick up study medication|0|||
41946582|NCT02194998|75698685|FG001|On-HCV Treatment|Did not pick up study medication|1|||
41946583|NCT02194998|75698686|FG002|On-HCV Treatment|Did not pick up study medication|0|||
41946584|NCT02194998|75698687|FG003|On-HCV Treatment|Did not pick up study medication|0|||
41946585|NCT02194998|75698684|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
41946586|NCT02194998|75698685|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
41946587|NCT02194998|75698686|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
41946588|NCT02194998|75698687|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
41946589|NCT02194062|75698700|FG000|Overall Study|Lost to Follow-up|2|||
41946590|NCT02194062|75698701|FG001|Overall Study|Lost to Follow-up|2|||
41946591|NCT02194062|75698702|FG002|Overall Study|Lost to Follow-up|5|||
41946592|NCT02193828|75698723|FG000|Overall Study|Withdrawal by Subject|0|||
41946593|NCT02193828|75698724|FG001|Overall Study|Withdrawal by Subject|0|||
41946594|NCT02193828|75698725|FG002|Overall Study|Withdrawal by Subject|1|||
41946595|NCT02193828|75698726|FG003|Overall Study|Withdrawal by Subject|1|||
41946596|NCT02192970|75698747|FG000|Overall Study|Lost to Follow-up|6|||
41946597|NCT02192970|75698748|FG001|Overall Study|Lost to Follow-up|0|||
41946598|NCT02192190|75698932|FG000|Overall Study|Adverse Event|1|||
41946599|NCT02192190|75698933|FG001|Overall Study|Adverse Event|1|||
41946600|NCT02192190|75698934|FG002|Overall Study|Adverse Event|0|||
41946601|NCT02192190|75698935|FG003|Overall Study|Adverse Event|0|||
41946602|NCT02192190|75698936|FG004|Overall Study|Adverse Event|0|||
41946603|NCT02192190|75698937|FG005|Overall Study|Adverse Event|0|||
41946604|NCT02192190|75698932|FG000|Overall Study|Lost to Follow-up|3|||
41946605|NCT02192190|75698933|FG001|Overall Study|Lost to Follow-up|3|||
41946606|NCT02192190|75698934|FG002|Overall Study|Lost to Follow-up|2|||
41946607|NCT02192190|75698935|FG003|Overall Study|Lost to Follow-up|1|||
41946608|NCT02192190|75698936|FG004|Overall Study|Lost to Follow-up|4|||
41946609|NCT02192190|75698937|FG005|Overall Study|Lost to Follow-up|3|||
41946610|NCT02192190|75698932|FG000|Overall Study|Physician Decision|2|||
41946611|NCT02192190|75698933|FG001|Overall Study|Physician Decision|0|||
41946612|NCT02192190|75698934|FG002|Overall Study|Physician Decision|0|||
41946613|NCT02192190|75698935|FG003|Overall Study|Physician Decision|0|||
41946614|NCT02192190|75698936|FG004|Overall Study|Physician Decision|0|||
41946615|NCT02192190|75698937|FG005|Overall Study|Physician Decision|0|||
41946616|NCT02192190|75698932|FG000|Overall Study|Terminated by Sponsor|43|||
41946617|NCT02192190|75698933|FG001|Overall Study|Terminated by Sponsor|23|||
41946618|NCT02192190|75698934|FG002|Overall Study|Terminated by Sponsor|20|||
41946619|NCT02192190|75698935|FG003|Overall Study|Terminated by Sponsor|23|||
41946620|NCT02192190|75698936|FG004|Overall Study|Terminated by Sponsor|21|||
41946621|NCT02192190|75698937|FG005|Overall Study|Terminated by Sponsor|23|||
41946622|NCT02192190|75698932|FG000|Overall Study|Withdrawal by Subject|4|||
41946623|NCT02192190|75698933|FG001|Overall Study|Withdrawal by Subject|1|||
41946624|NCT02192190|75698934|FG002|Overall Study|Withdrawal by Subject|2|||
41946625|NCT02192190|75698935|FG003|Overall Study|Withdrawal by Subject|1|||
41946626|NCT02192190|75698936|FG004|Overall Study|Withdrawal by Subject|5|||
41946627|NCT02192190|75698937|FG005|Overall Study|Withdrawal by Subject|3|||
41946628|NCT02192190|75698932|FG000|Overall Study|Could not Keep Visit Schedule|1|||
41946629|NCT02192190|75698933|FG001|Overall Study|Could not Keep Visit Schedule|0|||
41946630|NCT02192190|75698934|FG002|Overall Study|Could not Keep Visit Schedule|0|||
41946631|NCT02192190|75698935|FG003|Overall Study|Could not Keep Visit Schedule|0|||
41946632|NCT02192190|75698936|FG004|Overall Study|Could not Keep Visit Schedule|0|||
41946633|NCT02192190|75698937|FG005|Overall Study|Could not Keep Visit Schedule|0|||
41946634|NCT02192190|75698932|FG000|Overall Study|Positive Drug Screen|0|||
41946635|NCT02192190|75698933|FG001|Overall Study|Positive Drug Screen|0|||
41946636|NCT02192190|75698934|FG002|Overall Study|Positive Drug Screen|0|||
41946637|NCT02192190|75698935|FG003|Overall Study|Positive Drug Screen|1|||
41946638|NCT02192190|75698936|FG004|Overall Study|Positive Drug Screen|0|||
41946639|NCT02192190|75698937|FG005|Overall Study|Positive Drug Screen|0|||
41946640|NCT02192190|75698932|FG000|Overall Study|Inadequate Pain Relief|0|||
41946641|NCT02192190|75698933|FG001|Overall Study|Inadequate Pain Relief|1|||
41946642|NCT02192190|75698934|FG002|Overall Study|Inadequate Pain Relief|1|||
41946643|NCT02192190|75698935|FG003|Overall Study|Inadequate Pain Relief|0|||
41946644|NCT02192190|75698936|FG004|Overall Study|Inadequate Pain Relief|0|||
41946645|NCT02192190|75698937|FG005|Overall Study|Inadequate Pain Relief|0|||
41946646|NCT02224638|75698965|FG000|Overall Study|Adverse Event|1|||
41946647|NCT02224638|75698966|FG001|Overall Study|Adverse Event|1|||
41946648|NCT02224560|75698981|FG000|Overall Study|Protocol Deviation|1|||
41946649|NCT02224560|75698982|FG001|Overall Study|Protocol Deviation|0|||
41946650|NCT02224560|75698983|FG002|Overall Study|Protocol Deviation|0|||
41946651|NCT02224560|75698981|FG000|Overall Study|Withdrawal by Subject|2|||
41946652|NCT02224560|75698982|FG001|Overall Study|Withdrawal by Subject|0|||
41946653|NCT02224560|75698983|FG002|Overall Study|Withdrawal by Subject|1|||
41946654|NCT02224560|75698981|FG000|Overall Study|Met Withdrawal Criteria|1|||
41946655|NCT02224560|75698982|FG001|Overall Study|Met Withdrawal Criteria|0|||
41946656|NCT02224560|75698983|FG002|Overall Study|Met Withdrawal Criteria|0|||
41946657|NCT02224560|75698981|FG000|Overall Study|Adverse Event|4|||
41946658|NCT02224560|75698982|FG001|Overall Study|Adverse Event|1|||
41946659|NCT02224560|75698983|FG002|Overall Study|Adverse Event|1|||
41946660|NCT02224560|75698981|FG000|Overall Study|Withdrawn by Investigator|1|||
41946661|NCT02224560|75698982|FG001|Overall Study|Withdrawn by Investigator|1|||
41946662|NCT02224560|75698983|FG002|Overall Study|Withdrawn by Investigator|0|||
41946663|NCT02161458|75698995|FG000|Overall Study|Withdrawal by Subject|0|||
41946664|NCT02161458|75698996|FG001|Overall Study|Withdrawal by Subject|4|||
41946665|NCT02161458|75698997|FG002|Overall Study|Withdrawal by Subject|4|||
41946666|NCT02161458|75698998|FG003|Overall Study|Withdrawal by Subject|0|||
41946667|NCT02161458|75698995|FG000|Overall Study|Lost to Follow-up|0|||
41946668|NCT02161458|75698996|FG001|Overall Study|Lost to Follow-up|2|||
41946669|NCT02161458|75698997|FG002|Overall Study|Lost to Follow-up|1|||
41946670|NCT02161458|75698998|FG003|Overall Study|Lost to Follow-up|0|||
41946671|NCT02223858|75699010|FG000|Overall Study|Death|1|||
41946672|NCT02223858|75699011|FG001|Overall Study|Death|1|||
41946673|NCT02223858|75699010|FG000|Overall Study|Lost to Follow-up|6|||
41946674|NCT02223858|75699011|FG001|Overall Study|Lost to Follow-up|11|||
41946675|NCT02223858|75699010|FG000|Overall Study|Withdrawal by Subject|8|||
41946676|NCT02223858|75699011|FG001|Overall Study|Withdrawal by Subject|5|||
41946677|NCT02223858|75699010|FG000|Overall Study|Refused|9|||
41946678|NCT02223858|75699011|FG001|Overall Study|Refused|9|||
41946679|NCT02223390|75699019|FG000|Overall Study|Lost to Follow-up|9|||
41946680|NCT02223390|75699020|FG001|Overall Study|Lost to Follow-up|4|||
41946681|NCT04914000|75700887|FG000|Overall Study|Lost to Follow-up|8|||
41946682|NCT04914000|75700887|FG000|Overall Study|Withdrawal by Subject|1|||
41946683|NCT04530825|75700904|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
41946684|NCT04530825|75700905|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
41946685|NCT04530825|75700906|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
41946686|NCT04530825|75700907|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
41946687|NCT04530825|75700904|FG000|Overall Study|Did not complete follow-up|3|||
41946688|NCT04530825|75700905|FG001|Overall Study|Did not complete follow-up|0|||
41946689|NCT04530825|75700906|FG002|Overall Study|Did not complete follow-up|0|||
41946690|NCT04530825|75700907|FG003|Overall Study|Did not complete follow-up|0|||
41946691|NCT04169373|75700921|FG000|Week 1 to Week 14|Adverse Event|1|||
41946692|NCT04169373|75700922|FG001|Week 1 to Week 14|Adverse Event|0|||
41946693|NCT04169373|75700923|FG002|Week 1 to Week 14|Adverse Event|1|||
41946694|NCT04169373|75700924|FG003|Week 1 to Week 14|Adverse Event|2|||
41946695|NCT04169373|75700921|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
41946696|NCT04169373|75700922|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
41946697|NCT04169373|75700923|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
41946698|NCT04169373|75700924|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
41946699|NCT04169373|75700921|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
41946700|NCT04169373|75700922|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
41946701|NCT04169373|75700923|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
41946702|NCT04169373|75700924|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
41946703|NCT04169373|75700921|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
41946704|NCT04169373|75700922|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
41946705|NCT04169373|75700923|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
41946706|NCT04169373|75700924|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
41946707|NCT04169373|75700921|FG000|Week 1 to Week 14|Other|1|||
41946708|NCT04169373|75700922|FG001|Week 1 to Week 14|Other|3|||
41946709|NCT04169373|75700923|FG002|Week 1 to Week 14|Other|3|||
41946710|NCT04169373|75700924|FG003|Week 1 to Week 14|Other|5|||
41946711|NCT04169373|75700921|FG000|Week 14 to Week 52|Adverse Event|1|||
41946712|NCT04169373|75700922|FG001|Week 14 to Week 52|Adverse Event|0|||
41946713|NCT04169373|75700923|FG002|Week 14 to Week 52|Adverse Event|0|||
41946714|NCT04169373|75700924|FG003|Week 14 to Week 52|Adverse Event|1|||
41946715|NCT04169373|75700921|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
41946716|NCT04169373|75700922|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
41946717|NCT04169373|75700923|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
41946718|NCT04169373|75700924|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
41946719|NCT04169373|75700921|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
41946720|NCT04169373|75700922|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
41946721|NCT04169373|75700923|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
41946722|NCT04169373|75700924|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
41946723|NCT04169373|75700921|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
41946724|NCT04169373|75700922|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
41946725|NCT04169373|75700923|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
41946726|NCT04169373|75700924|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
41946727|NCT04169373|75700921|FG000|Week 14 to Week 52|Other|4|||
41946728|NCT04169373|75700922|FG001|Week 14 to Week 52|Other|5|||
41946729|NCT04169373|75700923|FG002|Week 14 to Week 52|Other|4|||
41946730|NCT04169373|75700924|FG003|Week 14 to Week 52|Other|5|||
41946731|NCT04169373|75700921|FG000|Week 14 to Week 52|Ongoing|0|||
41946732|NCT04169373|75700922|FG001|Week 14 to Week 52|Ongoing|1|||
41946733|NCT04169373|75700923|FG002|Week 14 to Week 52|Ongoing|0|||
41946734|NCT04169373|75700924|FG003|Week 14 to Week 52|Ongoing|0|||
41946735|NCT04154930|75700939|FG000|Overall Study|Withdrawal by Subject|15|||
41946736|NCT04154930|75700940|FG001|Overall Study|Withdrawal by Subject|6|||
41946737|NCT04154930|75700939|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
41946738|NCT04154930|75700940|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
41946739|NCT04154930|75700939|FG000|Overall Study|Lost to Follow-up|14|||
41946740|NCT04154930|75700940|FG001|Overall Study|Lost to Follow-up|6|||
41946741|NCT04154930|75700939|FG000|Overall Study|Other|6|||
41946742|NCT04154930|75700940|FG001|Overall Study|Other|0|||
41946743|NCT04124471|75700946|FG000|Overall Study|screen failure|1|||
41946744|NCT04093024|75700952|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
41946745|NCT04093024|75700953|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
41946746|NCT04093024|75700952|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
41946747|NCT04093024|75700953|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
41946748|NCT04093024|75700952|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
41946749|NCT04093024|75700953|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
41946750|NCT04093024|75700952|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
41946751|NCT04093024|75700953|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
41946752|NCT03633929|75700987|FG000|Overall Study|Lost to Follow-up|1|||
41946753|NCT03633929|75700987|FG000|Overall Study|Did not login to software. Did not participate|3|||
41946754|NCT03625687|75700991|FG000|Overall Study|Death|1|||
41946755|NCT02785952|75701014|FG000|Overall Study|Adverse Event|31|||
41946756|NCT02785952|75701015|FG001|Overall Study|Adverse Event|19|||
41946757|NCT02785952|75701014|FG000|Overall Study|Refusal unrelated to adverse events|10|||
41946758|NCT02785952|75701015|FG001|Overall Study|Refusal unrelated to adverse events|5|||
41946759|NCT02785952|75701014|FG000|Overall Study|Disease progression/relapse|61|||
41946760|NCT02785952|75701015|FG001|Overall Study|Disease progression/relapse|89|||
41946761|NCT02785952|75701014|FG000|Overall Study|Death|11|||
41946762|NCT02785952|75701015|FG001|Overall Study|Death|7|||
41946763|NCT02785952|75701014|FG000|Overall Study|Other- not protocol specified|6|||
41946764|NCT02785952|75701015|FG001|Overall Study|Other- not protocol specified|4|||
41946765|NCT02785952|75701014|FG000|Overall Study|On protocol treatment|6|||
41946766|NCT02785952|75701015|FG001|Overall Study|On protocol treatment|3|||
41946767|NCT02674685|75701023|FG000|Overall Study|Withdrawal by Subject|4|||
41946768|NCT02654236|75701030|FG000|Overall Study|Withdrawal by Subject|0|||
41946769|NCT02654236|75701031|FG001|Overall Study|Withdrawal by Subject|0|||
41946770|NCT02654236|75701032|FG002|Overall Study|Withdrawal by Subject|2|||
41946771|NCT02372136|75701042|FG000|Overall Study|Death|3|||
41946772|NCT02372136|75701043|FG001|Overall Study|Death|1|||
41946773|NCT02194829|75701053|FG000|Overall Study|Adverse Event|2|||
41946774|NCT02194829|75701054|FG001|Overall Study|Adverse Event|2|||
41946775|NCT02194829|75701053|FG000|Overall Study|Death|0|||
41946776|NCT02194829|75701054|FG001|Overall Study|Death|1|||
41946777|NCT02194829|75701053|FG000|Overall Study|Disease progression|0|||
41946778|NCT02194829|75701054|FG001|Overall Study|Disease progression|1|||
41946779|NCT02194829|75701053|FG000|Overall Study|Withdrawal by Subject|0|||
41946780|NCT02194829|75701054|FG001|Overall Study|Withdrawal by Subject|1|||
41946781|NCT02194829|75701053|FG000|Overall Study|Never started protocol therapy|0|||
41946782|NCT02194829|75701054|FG001|Overall Study|Never started protocol therapy|1|||
41946783|NCT02087046|75701061|FG000|Overall Study|Adverse Event|4|||
41946784|NCT02087046|75701061|FG000|Overall Study|Death|1|||
41946785|NCT02087046|75701061|FG000|Overall Study|Lost to Follow-up|3|||
41946786|NCT02087046|75701061|FG000|Overall Study|Withdrawal by Subject|2|||
41946787|NCT02087046|75701061|FG000|Overall Study|Physician Decision|1|||
41946788|NCT01390038|75701070|FG000|Overall Study|Death|1|||
41946789|NCT01390038|75701070|FG000|Overall Study|Lost to Follow-up|1|||
41946790|NCT01390038|75701070|FG000|Overall Study|Withdrawal by Subject|4|||
41946791|NCT01390038|75701070|FG000|Overall Study|Simpliciti System Removal|2|||
41946792|NCT00621192|75701088|FG000|Overall Study|Withdrawal by Subject|0|||
41946793|NCT00621192|75701089|FG001|Overall Study|Withdrawal by Subject|0|||
41946794|NCT00621192|75701090|FG002|Overall Study|Withdrawal by Subject|2|||
41946795|NCT00621192|75701091|FG003|Overall Study|Withdrawal by Subject|0|||
41946796|NCT00621192|75701088|FG000|Overall Study|Physician Decision|1|||
41946797|NCT00621192|75701089|FG001|Overall Study|Physician Decision|3|||
41946798|NCT00621192|75701090|FG002|Overall Study|Physician Decision|0|||
41946799|NCT00621192|75701091|FG003|Overall Study|Physician Decision|0|||
41946800|NCT00621192|75701088|FG000|Overall Study|Protocol Violation|1|||
41946801|NCT00621192|75701089|FG001|Overall Study|Protocol Violation|0|||
41946802|NCT00621192|75701090|FG002|Overall Study|Protocol Violation|0|||
41946803|NCT00621192|75701091|FG003|Overall Study|Protocol Violation|1|||
41946804|NCT00621192|75701088|FG000|Overall Study|Adverse Event|0|||
41946805|NCT00621192|75701089|FG001|Overall Study|Adverse Event|1|||
41946806|NCT00621192|75701090|FG002|Overall Study|Adverse Event|0|||
41946807|NCT00621192|75701091|FG003|Overall Study|Adverse Event|1|||
41946808|NCT00621192|75701088|FG000|Overall Study|Death|2|||
41946809|NCT00621192|75701089|FG001|Overall Study|Death|5|||
41946810|NCT00621192|75701090|FG002|Overall Study|Death|0|||
41946811|NCT00621192|75701091|FG003|Overall Study|Death|0|||
41946812|NCT00621192|75701088|FG000|Overall Study|Final Assessments not Completed|0|||
41946813|NCT00621192|75701089|FG001|Overall Study|Final Assessments not Completed|0|||
41946814|NCT00621192|75701090|FG002|Overall Study|Final Assessments not Completed|3|||
41946815|NCT00621192|75701091|FG003|Overall Study|Final Assessments not Completed|1|||
41946816|NCT00278200|75701103|FG000|Overall Study|Death|1|||
41946817|NCT00278200|75701104|FG001|Overall Study|Death|3|||
41946818|NCT00278200|75701103|FG000|Overall Study|Physician Decision|0|||
41946819|NCT00278200|75701104|FG001|Overall Study|Physician Decision|1|||
41946820|NCT00255346|75701115|FG000|Overall Study|Adverse Event|1|||
41946821|NCT00255346|75701116|FG001|Overall Study|Adverse Event|0|||
41946822|NCT00255346|75701117|FG002|Overall Study|Adverse Event|0|||
41946823|NCT00255346|75701118|FG003|Overall Study|Adverse Event|0|||
41946824|NCT00255346|75701119|FG004|Overall Study|Adverse Event|0|||
41946825|NCT02222922|75703260|FG000|Overall Study|Death|0|||
41946826|NCT02222922|75703261|FG001|Overall Study|Death|0|||
41946827|NCT02222922|75703262|FG002|Overall Study|Death|0|||
41946828|NCT02222922|75703263|FG003|Overall Study|Death|0|||
41946829|NCT02222922|75703264|FG004|Overall Study|Death|13|||
41946830|NCT02222922|75703265|FG005|Overall Study|Death|0|||
41946831|NCT02222922|75703266|FG006|Overall Study|Death|0|||
41946832|NCT02222922|75703267|FG007|Overall Study|Death|0|||
41946833|NCT02222922|75703268|FG008|Overall Study|Death|2|||
41946834|NCT02222922|75703260|FG000|Overall Study|Lost to Follow-up|0|||
41946835|NCT02222922|75703261|FG001|Overall Study|Lost to Follow-up|0|||
42023437|NCT01187550|75830786|FG001|Overall Study|Protocol Violation|1|||
41946836|NCT02222922|75703262|FG002|Overall Study|Lost to Follow-up|1|||
41946837|NCT02222922|75703263|FG003|Overall Study|Lost to Follow-up|0|||
41946838|NCT02222922|75703264|FG004|Overall Study|Lost to Follow-up|9|||
41946839|NCT02222922|75703265|FG005|Overall Study|Lost to Follow-up|1|||
42023438|NCT01187550|75830785|FG000|Overall Study|Other|3|||
41946840|NCT02222922|75703266|FG006|Overall Study|Lost to Follow-up|0|||
41946841|NCT02222922|75703267|FG007|Overall Study|Lost to Follow-up|0|||
41946842|NCT02222922|75703268|FG008|Overall Study|Lost to Follow-up|0|||
41946843|NCT02222922|75703260|FG000|Overall Study|Other|0|||
41946844|NCT02222922|75703261|FG001|Overall Study|Other|0|||
41946845|NCT02222922|75703262|FG002|Overall Study|Other|0|||
41946846|NCT02222922|75703263|FG003|Overall Study|Other|2|||
41946847|NCT02222922|75703264|FG004|Overall Study|Other|10|||
41946848|NCT02222922|75703265|FG005|Overall Study|Other|2|||
41946849|NCT02222922|75703266|FG006|Overall Study|Other|2|||
41946850|NCT02222922|75703267|FG007|Overall Study|Other|4|||
42023439|NCT01187550|75830786|FG001|Overall Study|Other|0|||
41946851|NCT02222922|75703268|FG008|Overall Study|Other|1|||
41946852|NCT02222922|75703260|FG000|Overall Study|Participant refused further follow-up|1|||
41946853|NCT02222922|75703261|FG001|Overall Study|Participant refused further follow-up|0|||
41946854|NCT02222922|75703262|FG002|Overall Study|Participant refused further follow-up|0|||
41946855|NCT02222922|75703263|FG003|Overall Study|Participant refused further follow-up|1|||
41946856|NCT02222922|75703264|FG004|Overall Study|Participant refused further follow-up|6|||
41946857|NCT02222922|75703265|FG005|Overall Study|Participant refused further follow-up|0|||
41946858|NCT02222922|75703266|FG006|Overall Study|Participant refused further follow-up|0|||
42023440|NCT01187550|75830785|FG000|Overall Study|Randomized but not treated|8|||
42023441|NCT01187550|75830786|FG001|Overall Study|Randomized but not treated|0|||
42023442|NCT01186770|75830796|FG000|Overall Study|Ineligibility|0|||
42023443|NCT01186770|75830797|FG001|Overall Study|Ineligibility|0|||
42023444|NCT01186770|75830798|FG002|Overall Study|Ineligibility|2|||
42023445|NCT01186770|75830799|FG003|Overall Study|Ineligibility|0|||
42023446|NCT01186770|75830796|FG000|Overall Study|Protocol Violation|7|||
42023447|NCT01186770|75830797|FG001|Overall Study|Protocol Violation|9|||
42023448|NCT01186770|75830798|FG002|Overall Study|Protocol Violation|12|||
42023449|NCT01186770|75830799|FG003|Overall Study|Protocol Violation|14|||
42023450|NCT01186770|75830796|FG000|Overall Study|Adverse Event|2|||
42023451|NCT01186770|75830797|FG001|Overall Study|Adverse Event|9|||
42023452|NCT01186770|75830798|FG002|Overall Study|Adverse Event|7|||
42023453|NCT01186770|75830799|FG003|Overall Study|Adverse Event|9|||
42023454|NCT01186770|75830796|FG000|Overall Study|Withdrawal by Subject|15|||
42023455|NCT01186770|75830797|FG001|Overall Study|Withdrawal by Subject|13|||
42023456|NCT01186770|75830798|FG002|Overall Study|Withdrawal by Subject|11|||
42023457|NCT01186770|75830799|FG003|Overall Study|Withdrawal by Subject|17|||
42023458|NCT01186770|75830796|FG000|Overall Study|Lost to Follow-up|10|||
42023459|NCT01186770|75830797|FG001|Overall Study|Lost to Follow-up|6|||
42023460|NCT01186770|75830798|FG002|Overall Study|Lost to Follow-up|14|||
42023461|NCT01186770|75830799|FG003|Overall Study|Lost to Follow-up|9|||
42023462|NCT01186770|75830796|FG000|Overall Study|Insufficient response to treatment|7|||
42023463|NCT01186770|75830797|FG001|Overall Study|Insufficient response to treatment|8|||
42023464|NCT01186770|75830798|FG002|Overall Study|Insufficient response to treatment|5|||
42023465|NCT01186770|75830799|FG003|Overall Study|Insufficient response to treatment|7|||
42023466|NCT01186770|75830796|FG000|Overall Study|Other than specified|0|||
42023467|NCT01186770|75830797|FG001|Overall Study|Other than specified|1|||
42023468|NCT01186770|75830798|FG002|Overall Study|Other than specified|1|||
42023469|NCT01186770|75830799|FG003|Overall Study|Other than specified|2|||
42023470|NCT01186692|75830809|FG000|Overall Study|Not Catheterized|11|||
42023471|NCT01186692|75830809|FG000|Overall Study|Futher testing contraindicated implant|19|||
42023472|NCT01186692|75830809|FG000|Overall Study|Adverse Event|2|||
42023473|NCT01186458|75830817|FG000|Overall Study|Adverse Event|1|||
42023474|NCT01185834|75830821|FG000|Overall Study|Lost to Follow-up|2|||
42023475|NCT01185834|75830821|FG000|Overall Study|Discomfort|4|||
42023476|NCT01185834|75830821|FG000|Overall Study|Biomicroscopy|4|||
42023477|NCT01185834|75830821|FG000|Overall Study|Time/Job Conflict|2|||
42023478|NCT01185834|75830821|FG000|Overall Study|Early exit - Site error|2|||
42023479|NCT01185600|75830827|FG000|Overall Study|Adverse Event|1|||
42023480|NCT01185600|75830828|FG001|Overall Study|Adverse Event|1|||
41946859|NCT02222922|75703267|FG007|Overall Study|Participant refused further follow-up|0|||
41946860|NCT02222922|75703268|FG008|Overall Study|Participant refused further follow-up|3|||
42023481|NCT01185600|75830827|FG000|Overall Study|Death|0|||
42023482|NCT01185600|75830828|FG001|Overall Study|Death|1|||
42023483|NCT01185600|75830827|FG000|Overall Study|Lost to Follow-up|0|||
42023484|NCT01185600|75830828|FG001|Overall Study|Lost to Follow-up|5|||
42023485|NCT01185600|75830827|FG000|Overall Study|Physician Decision|29|||
42023486|NCT01185600|75830828|FG001|Overall Study|Physician Decision|35|||
42023487|NCT01185600|75830827|FG000|Overall Study|Withdrawal by Subject|1|||
42023488|NCT01185600|75830828|FG001|Overall Study|Withdrawal by Subject|1|||
42023489|NCT01185600|75830827|FG000|Overall Study|Hold by DSMB|1|||
42023490|NCT01185600|75830828|FG001|Overall Study|Hold by DSMB|2|||
42023491|NCT01185522|75830837|FG000|Overall Study|Lack of Efficacy|28|||
42023492|NCT01185522|75830837|FG000|Overall Study|Lost to Follow-up|19|||
42023493|NCT01185522|75830837|FG000|Overall Study|Withdrawal by Subject|10|||
41946861|NCT02161146|75703320|FG000|Overall Study|Adverse Event|1|||
41946862|NCT02161146|75703321|FG001|Overall Study|Adverse Event|1|||
41946863|NCT02161146|75703322|FG002|Overall Study|Adverse Event|0|||
41946864|NCT02161146|75703323|FG003|Overall Study|Adverse Event|1|||
41946865|NCT02161146|75703324|FG004|Overall Study|Adverse Event|0|||
41946866|NCT02161146|75703320|FG000|Overall Study|Lost to Follow-up|0|||
41946867|NCT02161146|75703321|FG001|Overall Study|Lost to Follow-up|1|||
41946868|NCT02161146|75703322|FG002|Overall Study|Lost to Follow-up|0|||
42023494|NCT01185522|75830837|FG000|Overall Study|Poor tolerance|39|||
42023495|NCT01185522|75830837|FG000|Overall Study|Other reasons|12|||
42023496|NCT01185366|75830844|FG000|First Line Therapy|Insurance Coverage Denied|1|||
42023497|NCT01185366|75830845|FG001|First Line Therapy|Insurance Coverage Denied|1|||
42023498|NCT01185366|75830844|FG000|First Line Therapy|Withdrawal by Subject|1|||
42023499|NCT01185366|75830845|FG001|First Line Therapy|Withdrawal by Subject|0|||
41946869|NCT02161146|75703323|FG003|Overall Study|Lost to Follow-up|0|||
42023500|NCT01185366|75830844|FG000|First Line Therapy|Lack of Metastatic Site|1|||
42023501|NCT01185366|75830845|FG001|First Line Therapy|Lack of Metastatic Site|0|||
42023502|NCT01185366|75830844|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
42023503|NCT01185366|75830845|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
42023504|NCT01185366|75830844|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
42023505|NCT01185366|75830845|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
42023506|NCT01185366|75830844|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
42023507|NCT01185366|75830845|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
42023508|NCT01185366|75830844|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
42023509|NCT01185366|75830845|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
42023510|NCT01185288|75830855|FG000|Overall Study|Adverse Event|7|||
42023511|NCT01185288|75830856|FG001|Overall Study|Adverse Event|6|||
42023512|NCT01185288|75830855|FG000|Overall Study|Withdrawal by Subject|6|||
42023513|NCT01185288|75830856|FG001|Overall Study|Withdrawal by Subject|4|||
42023514|NCT01185288|75830855|FG000|Overall Study|Lost to Follow-up|2|||
42023515|NCT01185288|75830856|FG001|Overall Study|Lost to Follow-up|5|||
42023516|NCT01185288|75830855|FG000|Overall Study|Lack of Efficacy|2|||
42023517|NCT01185288|75830856|FG001|Overall Study|Lack of Efficacy|0|||
42023518|NCT01185288|75830855|FG000|Overall Study|Investigator discretion|1|||
42023519|NCT01185288|75830856|FG001|Overall Study|Investigator discretion|0|||
42023520|NCT01185288|75830855|FG000|Overall Study|Did not meet inclusion criteria|1|||
42023521|NCT01185288|75830856|FG001|Overall Study|Did not meet inclusion criteria|0|||
42023522|NCT01185288|75830855|FG000|Overall Study|Noncompliance|0|||
42023523|NCT01185288|75830856|FG001|Overall Study|Noncompliance|1|||
42023524|NCT01184508|75830864|FG000|Overall Study|Adverse Event|4|||
42023525|NCT01184508|75830865|FG001|Overall Study|Adverse Event|6|||
42023526|NCT01184508|75830864|FG000|Overall Study|Lack of Efficacy|1|||
42023527|NCT01184508|75830865|FG001|Overall Study|Lack of Efficacy|1|||
42023528|NCT01184508|75830864|FG000|Overall Study|Lost to Follow-up|1|||
42023529|NCT01184508|75830865|FG001|Overall Study|Lost to Follow-up|1|||
42023530|NCT01184508|75830864|FG000|Overall Study|Physician Decision|1|||
42023531|NCT01184508|75830865|FG001|Overall Study|Physician Decision|0|||
42023532|NCT01184508|75830864|FG000|Overall Study|Protocol Violation|3|||
42023533|NCT01184508|75830865|FG001|Overall Study|Protocol Violation|1|||
42023534|NCT01184508|75830864|FG000|Overall Study|Sponsor Decision|5|||
42023535|NCT01184508|75830865|FG001|Overall Study|Sponsor Decision|2|||
42023536|NCT01184508|75830864|FG000|Overall Study|Withdrawal by Subject|1|||
42023537|NCT01184508|75830865|FG001|Overall Study|Withdrawal by Subject|3|||
42023538|NCT01184508|75830864|FG000|Overall Study|Randomized, Not Treated|0|||
42023539|NCT01184508|75830865|FG001|Overall Study|Randomized, Not Treated|1|||
42023540|NCT01184118|75830872|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
42023541|NCT01184118|75830872|FG000|Overall Study|No physiologic confirmation of asthma|8|||
42023542|NCT01184118|75830872|FG000|Overall Study|FEV1 <60% predicted|2|||
42023543|NCT01184118|75830872|FG000|Overall Study|Exclusionary medical condition|2|||
42023544|NCT01184118|75830872|FG000|Overall Study|Withdrawal by Subject|5|||
42023545|NCT01183884|75830876|FG000|Overall Study|Progressive Disease|26|||
42023546|NCT01183884|75830876|FG000|Overall Study|Adverse Event|3|||
42023547|NCT01183884|75830876|FG000|Overall Study|Withdrawal by Subject|1|||
42023548|NCT01183884|75830876|FG000|Overall Study|Other Complicating Disease|3|||
42023549|NCT01183884|75830876|FG000|Overall Study|Not Treated|1|||
42023550|NCT01183884|75830876|FG000|Overall Study|Other|4|||
42023551|NCT01183260|75830882|FG000|Overall Study|Intraop screen failure|2|||
42023552|NCT01183260|75830883|FG001|Overall Study|Intraop screen failure|0|||
42023553|NCT01183260|75830882|FG000|Overall Study|Withdrawal by Subject|1|||
42023554|NCT01183260|75830883|FG001|Overall Study|Withdrawal by Subject|1|||
42023555|NCT01183260|75830882|FG000|Overall Study|Revised within 30 days|0|||
42023556|NCT01183260|75830883|FG001|Overall Study|Revised within 30 days|1|||
42023557|NCT01183260|75830882|FG000|Overall Study|Death|1|||
42023558|NCT01183260|75830883|FG001|Overall Study|Death|0|||
42023559|NCT01191762|75830891|FG000|Overall Study|Adverse Event|1|||
41946870|NCT02161146|75703324|FG004|Overall Study|Lost to Follow-up|0|||
41946871|NCT02161146|75703320|FG000|Overall Study|Personal Reasons|0|||
41946872|NCT02161146|75703321|FG001|Overall Study|Personal Reasons|1|||
41946873|NCT02161146|75703322|FG002|Overall Study|Personal Reasons|0|||
41946874|NCT02161146|75703323|FG003|Overall Study|Personal Reasons|2|||
41946875|NCT02161146|75703324|FG004|Overall Study|Personal Reasons|1|||
41946876|NCT02161146|75703320|FG000|Overall Study|Other Miscellaneous Reasons|0|||
41946877|NCT02161146|75703321|FG001|Overall Study|Other Miscellaneous Reasons|1|||
41946878|NCT02161146|75703322|FG002|Overall Study|Other Miscellaneous Reasons|0|||
41946879|NCT02161146|75703323|FG003|Overall Study|Other Miscellaneous Reasons|0|||
42023560|NCT01191762|75830892|FG001|Overall Study|Adverse Event|0|||
42023561|NCT01190514|75830898|FG000|First Intervention (Period 1)|Adverse Event|1|||
42023562|NCT01190514|75830899|FG001|First Intervention (Period 1)|Adverse Event|0|||
42023563|NCT01190514|75830900|FG002|First Intervention (Period 1)|Adverse Event|0|||
42023564|NCT01190514|75830901|FG003|First Intervention (Period 1)|Adverse Event|0|||
41946880|NCT02161146|75703324|FG004|Overall Study|Other Miscellaneous Reasons|0|||
42023565|NCT01190514|75830898|FG000|Third Intervention (Period 3)|Adverse Event|1|||
42023566|NCT01190514|75830899|FG001|Third Intervention (Period 3)|Adverse Event|0|||
42023567|NCT01190514|75830900|FG002|Third Intervention (Period 3)|Adverse Event|0|||
42023568|NCT01190514|75830901|FG003|Third Intervention (Period 3)|Adverse Event|0|||
42023569|NCT01190436|75830911|FG000|Overall Study|Lost to Follow-up|35|||
42023570|NCT01190436|75830911|FG000|Overall Study|Other|4|||
42023571|NCT01035255|75830918|FG000|Overall Study|Death|724|||
42023572|NCT01035255|75830919|FG001|Overall Study|Death|844|||
41946881|NCT02222688|75703559|FG000|Overall Study|Withdrawal by Subject|0|||
41946882|NCT02222688|75703560|FG001|Overall Study|Withdrawal by Subject|0|||
41946883|NCT02222688|75703561|FG002|Overall Study|Withdrawal by Subject|0|||
41946884|NCT02222688|75703562|FG003|Overall Study|Withdrawal by Subject|2|||
41946885|NCT02222688|75703563|FG004|Overall Study|Withdrawal by Subject|1|||
41946886|NCT02222688|75703564|FG005|Overall Study|Withdrawal by Subject|0|||
41946887|NCT02222688|75703565|FG006|Overall Study|Withdrawal by Subject|1|||
41946888|NCT02222688|75703559|FG000|Overall Study|Disease progression|1|||
41946889|NCT02222688|75703560|FG001|Overall Study|Disease progression|0|||
41946890|NCT02222688|75703561|FG002|Overall Study|Disease progression|0|||
41946891|NCT02222688|75703562|FG003|Overall Study|Disease progression|0|||
41946892|NCT02222688|75703563|FG004|Overall Study|Disease progression|0|||
41946893|NCT02222688|75703564|FG005|Overall Study|Disease progression|0|||
41946894|NCT02222688|75703565|FG006|Overall Study|Disease progression|0|||
41946895|NCT02159352|75703617|FG000|Overall Study|Adverse Event|3|||
41946896|NCT02159352|75703618|FG001|Overall Study|Adverse Event|1|||
41946897|NCT02159352|75703617|FG000|Overall Study|Withdrawal by Subject|0|||
41946898|NCT02159352|75703618|FG001|Overall Study|Withdrawal by Subject|1|||
41946899|NCT02187744|75703655|FG000|Study|Participant refused further follow-up|1|||
41946900|NCT02187744|75703656|FG001|Study|Participant refused further follow-up|0|||
41946901|NCT02187744|75703655|FG000|Study|Other|2|||
41946902|NCT02187744|75703656|FG001|Study|Other|1|||
41946903|NCT02187744|75703655|FG000|Study|Lost to Follow-up|0|||
41946904|NCT02187744|75703656|FG001|Study|Lost to Follow-up|2|||
41946905|NCT02187744|75703655|FG000|Study|Related adverse event, not serious|0|||
41946906|NCT02187744|75703656|FG001|Study|Related adverse event, not serious|2|||
41946907|NCT02187744|75703655|FG000|Study|Death|1|||
41946908|NCT02187744|75703656|FG001|Study|Death|0|||
41946909|NCT02187744|75703655|FG000|Study|Related adverse event, serious non-fatal|0|||
41946910|NCT02187744|75703656|FG001|Study|Related adverse event, serious non-fatal|1|||
41946911|NCT02187744|75703655|FG000|Treatment|Death|1|||
41946912|NCT02187744|75703656|FG001|Treatment|Death|0|||
41946913|NCT02187744|75703655|FG000|Treatment|Related adverse event, serious non-fatal|0|||
41946914|NCT02187744|75703656|FG001|Treatment|Related adverse event, serious non-fatal|1|||
41946915|NCT02187744|75703655|FG000|Treatment|Related adverse event, not serious|0|||
41946916|NCT02187744|75703656|FG001|Treatment|Related adverse event, not serious|2|||
41946917|NCT02187744|75703655|FG000|Treatment|Lost to Follow-up|0|||
41946918|NCT02187744|75703656|FG001|Treatment|Lost to Follow-up|1|||
41946919|NCT02187744|75703655|FG000|Treatment|Other|2|||
41946920|NCT02187744|75703656|FG001|Treatment|Other|0|||
41946921|NCT02187744|75703655|FG000|Treatment|Participant refused continued treatment|1|||
41946922|NCT02187744|75703656|FG001|Treatment|Participant refused continued treatment|1|||
41946923|NCT02186652|75703837|FG000|Overall Study|Lost to Follow-up|2|||
41946924|NCT02186652|75703838|FG001|Overall Study|Lost to Follow-up|0|||
41946925|NCT02185794|75703874|FG000|Overall Study|Enrolled but Never Dosed|1|||
41946926|NCT02185794|75703875|FG001|Overall Study|Enrolled but Never Dosed|6|||
41946927|NCT02185794|75703876|FG002|Overall Study|Enrolled but Never Dosed|3|||
41946928|NCT02185794|75703877|FG003|Overall Study|Enrolled but Never Dosed|1|||
41946929|NCT02185794|75703878|FG004|Overall Study|Enrolled but Never Dosed|1|||
41946930|NCT02185794|75703879|FG005|Overall Study|Enrolled but Never Dosed|0|||
41946931|NCT02185794|75703874|FG000|Overall Study|Investigator's Discretion|1|||
41946932|NCT02185794|75703875|FG001|Overall Study|Investigator's Discretion|0|||
41946933|NCT02185794|75703876|FG002|Overall Study|Investigator's Discretion|1|||
41946934|NCT02185794|75703877|FG003|Overall Study|Investigator's Discretion|2|||
41946935|NCT02185794|75703878|FG004|Overall Study|Investigator's Discretion|2|||
41946936|NCT02185794|75703879|FG005|Overall Study|Investigator's Discretion|15|||
42023573|NCT01035255|75830918|FG000|Overall Study|Lost to Follow-up|2|||
41946937|NCT02185794|75703874|FG000|Overall Study|Withdrew Consent|2|||
41946938|NCT02185794|75703875|FG001|Overall Study|Withdrew Consent|5|||
41946939|NCT02185794|75703876|FG002|Overall Study|Withdrew Consent|10|||
41946940|NCT02185794|75703877|FG003|Overall Study|Withdrew Consent|2|||
41946941|NCT02185794|75703878|FG004|Overall Study|Withdrew Consent|0|||
41946942|NCT02185794|75703879|FG005|Overall Study|Withdrew Consent|0|||
41946943|NCT02185794|75703874|FG000|Overall Study|Lost to Follow-up|1|||
41946944|NCT02185794|75703875|FG001|Overall Study|Lost to Follow-up|2|||
41946945|NCT02185794|75703876|FG002|Overall Study|Lost to Follow-up|2|||
41946946|NCT02185794|75703877|FG003|Overall Study|Lost to Follow-up|3|||
41946947|NCT02185794|75703878|FG004|Overall Study|Lost to Follow-up|0|||
42023574|NCT01035255|75830919|FG001|Overall Study|Lost to Follow-up|5|||
41946948|NCT02185794|75703879|FG005|Overall Study|Lost to Follow-up|1|||
41946949|NCT02221674|75703910|FG000|Overall Study|Lost to Follow-up|1|||
41946950|NCT02221674|75703911|FG001|Overall Study|Lost to Follow-up|0|||
41946951|NCT02221674|75703912|FG002|Overall Study|Lost to Follow-up|0|||
41946952|NCT02221284|75703927|FG000|Overall Study|Case Report Forms Uncollected|56|||
41946953|NCT02221284|75703927|FG000|Overall Study|Protocol Deviation|5|||
41946954|NCT02187042|75704084|FG000|Overall Study|Death|1|||
41946955|NCT02187042|75704085|FG001|Overall Study|Death|1|||
41946956|NCT02187042|75704084|FG000|Overall Study|Toxicity|6|||
41946957|NCT02187042|75704085|FG001|Overall Study|Toxicity|5|||
41946958|NCT02187042|75704084|FG000|Overall Study|Participant choice|1|||
41946959|NCT02187042|75704085|FG001|Overall Study|Participant choice|0|||
41946960|NCT02187042|75704084|FG000|Overall Study|Doctor choice|1|||
41946961|NCT02187042|75704085|FG001|Overall Study|Doctor choice|0|||
41946962|NCT02187042|75704084|FG000|Overall Study|Progressive disease|4|||
41946963|NCT02187042|75704085|FG001|Overall Study|Progressive disease|8|||
41946964|NCT02219334|75704268|FG000|Overall Study|Withdrawal by Subject|1|||
41946965|NCT02219334|75704269|FG001|Overall Study|Withdrawal by Subject|0|||
41946966|NCT02219334|75704268|FG000|Overall Study|Protocol Violation|7|||
41946967|NCT02219334|75704269|FG001|Overall Study|Protocol Violation|3|||
41946968|NCT02159040|75704287|FG000|Overall Study|Death|1|||
41946969|NCT02218008|75704312|FG000|Stage 1 (S1)|Adverse Event|6|||
41946970|NCT02218008|75704313|FG001|Stage 1 (S1)|Adverse Event|5|||
41946971|NCT02218008|75704314|FG002|Stage 1 (S1)|Adverse Event|11|||
41946972|NCT02218008|75704315|FG003|Stage 1 (S1)|Adverse Event|0|||
41946973|NCT02218008|75704316|FG004|Stage 1 (S1)|Adverse Event|0|||
41946974|NCT02218008|75704317|FG005|Stage 1 (S1)|Adverse Event|0|||
41946975|NCT02218008|75704312|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
41946976|NCT02218008|75704313|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
41946977|NCT02218008|75704314|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
41946978|NCT02218008|75704315|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
41946979|NCT02218008|75704316|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
41946980|NCT02218008|75704317|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
41946981|NCT02218008|75704312|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
41946982|NCT02218008|75704313|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
41946983|NCT02218008|75704314|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
41946984|NCT02218008|75704315|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
41946985|NCT02218008|75704316|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
41946986|NCT02218008|75704317|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
41946987|NCT02218008|75704312|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
41946988|NCT02218008|75704313|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
41946989|NCT02218008|75704314|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
41946990|NCT02218008|75704315|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
41946991|NCT02218008|75704316|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
41946992|NCT02218008|75704317|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
41946993|NCT02218008|75704312|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
41946994|NCT02218008|75704313|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
41946995|NCT02218008|75704314|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
41946996|NCT02218008|75704315|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
41946997|NCT02218008|75704316|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
41946998|NCT02218008|75704317|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
41946999|NCT02218008|75704312|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
41947000|NCT02218008|75704313|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
41947001|NCT02218008|75704314|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
41947002|NCT02218008|75704315|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
41947003|NCT02218008|75704316|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
41947004|NCT02218008|75704317|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
41947005|NCT02218008|75704312|FG000|Stage 1 (S1)|Pregnancy|0|||
41947006|NCT02218008|75704313|FG001|Stage 1 (S1)|Pregnancy|0|||
41947007|NCT02218008|75704314|FG002|Stage 1 (S1)|Pregnancy|1|||
41947008|NCT02218008|75704315|FG003|Stage 1 (S1)|Pregnancy|0|||
41947009|NCT02218008|75704316|FG004|Stage 1 (S1)|Pregnancy|0|||
41947010|NCT02218008|75704317|FG005|Stage 1 (S1)|Pregnancy|0|||
41947011|NCT02218008|75704312|FG000|Stage 1 (S1)|Protocol Violation|0|||
41947012|NCT02218008|75704313|FG001|Stage 1 (S1)|Protocol Violation|0|||
41947013|NCT02218008|75704314|FG002|Stage 1 (S1)|Protocol Violation|1|||
41947014|NCT02218008|75704315|FG003|Stage 1 (S1)|Protocol Violation|0|||
41947015|NCT02218008|75704316|FG004|Stage 1 (S1)|Protocol Violation|0|||
41947016|NCT02218008|75704317|FG005|Stage 1 (S1)|Protocol Violation|0|||
41947017|NCT02218008|75704312|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
41947018|NCT02218008|75704313|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
41947019|NCT02218008|75704314|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
41947020|NCT02218008|75704315|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
41947021|NCT02218008|75704316|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
41947022|NCT02218008|75704317|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
41947023|NCT02218008|75704312|FG000|Stage 2 (S2)|Adverse Event|0|||
41947024|NCT02218008|75704313|FG001|Stage 2 (S2)|Adverse Event|0|||
41947025|NCT02218008|75704314|FG002|Stage 2 (S2)|Adverse Event|0|||
41947026|NCT02218008|75704315|FG003|Stage 2 (S2)|Adverse Event|2|||
41947027|NCT02218008|75704316|FG004|Stage 2 (S2)|Adverse Event|3|||
41947028|NCT02218008|75704317|FG005|Stage 2 (S2)|Adverse Event|3|||
41947029|NCT02218008|75704312|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
41947030|NCT02218008|75704313|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
41947031|NCT02218008|75704314|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
41947032|NCT02218008|75704315|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
41947033|NCT02218008|75704316|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
41947034|NCT02218008|75704317|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
41947035|NCT02218008|75704312|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
41947036|NCT02218008|75704313|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
41947037|NCT02218008|75704314|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
41947038|NCT02218008|75704315|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
41947039|NCT02218008|75704316|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
41947040|NCT02218008|75704317|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
41947041|NCT02218008|75704312|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
41947042|NCT02218008|75704313|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
41947043|NCT02218008|75704314|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
41947044|NCT02218008|75704315|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
41947045|NCT02218008|75704316|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
41947046|NCT02218008|75704317|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
41947047|NCT02218008|75704312|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
41947048|NCT02218008|75704313|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
42023575|NCT01035255|75830918|FG000|Overall Study|patient's request|15|||
42023576|NCT01035255|75830919|FG001|Overall Study|patient's request|13|||
42023577|NCT01190124|75830928|FG000|Overall Study|Death|3|||
42300351|NCT02326155|76135524|FG000|Overall Study|Lost to Follow-up|14|||
41947049|NCT02218008|75704314|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
41947050|NCT02218008|75704315|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
41947051|NCT02218008|75704316|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
41947052|NCT02218008|75704317|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
41947053|NCT01632150|75704414|FG000|Overall Study|Disease progression|27|||
41947054|NCT01632150|75704414|FG000|Overall Study|Study drug toxicity|1|||
41947055|NCT01632150|75704414|FG000|Overall Study|Unrelated adverse event|7|||
41947056|NCT01632150|75704414|FG000|Overall Study|Withdrawal by Subject|2|||
41947057|NCT01632150|75704414|FG000|Overall Study|Patient underwent autologous transplant|1|||
41947058|NCT01632150|75704414|FG000|Overall Study|Moved to compassionate program|2|||
41947059|NCT02185014|75704439|FG000|Overall Study|Adverse Event|18|||
41947060|NCT02185014|75704439|FG000|Overall Study|Withdrew Consent|8|||
41947061|NCT02185014|75704439|FG000|Overall Study|Lost to Follow-up|4|||
41947062|NCT02185014|75704439|FG000|Overall Study|Lack of Efficacy|14|||
41947063|NCT02185014|75704439|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
41947064|NCT02185014|75704439|FG000|Overall Study|Subject Noncompliance|1|||
41947065|NCT02185014|75704439|FG000|Overall Study|Other|4|||
41947066|NCT02184156|75704489|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
41947067|NCT02184156|75704490|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
41947068|NCT02184156|75704489|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
41947069|NCT02184156|75704490|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
41947070|NCT02158884|75704513|FG000|Baseline Assessment|Missed performance assessment|3|||
41947071|NCT02158884|75704513|FG000|Baseline Assessment|Missed SMFA|1|||
41947072|NCT02158884|75704513|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
41947073|NCT02158884|75704513|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
41947074|NCT02158884|75704513|FG000|6 Month Assessment|Missed SMFA|20|||
41947075|NCT02158884|75704513|FG000|12 Month Assessment|Missed SMFA|17|||
41947076|NCT02158806|75704556|FG000|Overall Study|Death|2|||
41947077|NCT02158806|75704557|FG001|Overall Study|Death|0|||
41947078|NCT02158806|75704556|FG000|Overall Study|Withdrawal by Subject|2|||
41947079|NCT02158806|75704557|FG001|Overall Study|Withdrawal by Subject|0|||
41947080|NCT02158806|75704556|FG000|Overall Study|Lost to Follow-up|0|||
41947081|NCT02158806|75704557|FG001|Overall Study|Lost to Follow-up|3|||
41947082|NCT02158806|75704556|FG000|Overall Study|Moved out of area|0|||
41947083|NCT02158806|75704557|FG001|Overall Study|Moved out of area|1|||
41947084|NCT02158806|75704556|FG000|Overall Study|Transferred to palliative care|0|||
41947085|NCT02158806|75704557|FG001|Overall Study|Transferred to palliative care|1|||
41947086|NCT02158728|75704588|FG000|Overall Study|no procedure according to CIP done|3|||
41947087|NCT02158728|75704588|FG000|Overall Study|no qualified dataset|24|||
41947088|NCT02157948|75704633|FG000|Overall Study|Withdrawal by Subject|4|||
41947089|NCT02157948|75704634|FG001|Overall Study|Withdrawal by Subject|5|||
41947090|NCT02157948|75704633|FG000|Overall Study|Lost to Follow-up|3|||
41947091|NCT02157948|75704634|FG001|Overall Study|Lost to Follow-up|2|||
41947092|NCT02157948|75704633|FG000|Overall Study|Protocol Specified Criteria|2|||
41947093|NCT02157948|75704634|FG001|Overall Study|Protocol Specified Criteria|1|||
41947094|NCT02157948|75704633|FG000|Overall Study|Decision by Sponsor|0|||
41947095|NCT02157948|75704634|FG001|Overall Study|Decision by Sponsor|1|||
41947096|NCT02182830|75704675|FG000|Overall Study|Not Treated|1|||
41947097|NCT02182830|75704676|FG001|Overall Study|Not Treated|1|||
41947098|NCT02182830|75704675|FG000|Overall Study|Trial stopped, reason missing|3|||
41947099|NCT02182830|75704676|FG001|Overall Study|Trial stopped, reason missing|3|||
41947100|NCT02182830|75704675|FG000|Overall Study|Consent withdrawn|8|||
41947101|NCT02182830|75704676|FG001|Overall Study|Consent withdrawn|8|||
41947102|NCT02182830|75704675|FG000|Overall Study|Lost to Follow-up|3|||
41947103|NCT02182830|75704676|FG001|Overall Study|Lost to Follow-up|3|||
41947104|NCT02182440|75705250|FG000|Overall Study|Adverse Event|0|||
41947105|NCT02182440|75705251|FG001|Overall Study|Adverse Event|1|||
41947106|NCT02182440|75705252|FG002|Overall Study|Adverse Event|0|||
41947107|NCT02182440|75705253|FG003|Overall Study|Adverse Event|0|||
41947108|NCT02182440|75705250|FG000|Overall Study|Death|31|||
41947109|NCT02182440|75705251|FG001|Overall Study|Death|8|||
41947110|NCT02182440|75705252|FG002|Overall Study|Death|5|||
41947111|NCT02182440|75705253|FG003|Overall Study|Death|16|||
41947112|NCT02182440|75705250|FG000|Overall Study|Protocol Violation|0|||
41947113|NCT02182440|75705251|FG001|Overall Study|Protocol Violation|1|||
41947114|NCT02182440|75705252|FG002|Overall Study|Protocol Violation|0|||
41947115|NCT02182440|75705253|FG003|Overall Study|Protocol Violation|0|||
41947116|NCT02182440|75705250|FG000|Overall Study|Physician Decision|1|||
41947117|NCT02182440|75705251|FG001|Overall Study|Physician Decision|0|||
41947118|NCT02182440|75705252|FG002|Overall Study|Physician Decision|0|||
41947119|NCT02182440|75705253|FG003|Overall Study|Physician Decision|0|||
41947120|NCT02182440|75705250|FG000|Overall Study|Withdrawal by Subject|1|||
41947121|NCT02182440|75705251|FG001|Overall Study|Withdrawal by Subject|1|||
41947122|NCT02182440|75705252|FG002|Overall Study|Withdrawal by Subject|3|||
41947123|NCT02182440|75705253|FG003|Overall Study|Withdrawal by Subject|4|||
41947124|NCT02182440|75705250|FG000|Overall Study|different, e.g adm other hospital|12|||
41947125|NCT02182440|75705251|FG001|Overall Study|different, e.g adm other hospital|3|||
41947126|NCT02182440|75705252|FG002|Overall Study|different, e.g adm other hospital|3|||
41947127|NCT02182440|75705253|FG003|Overall Study|different, e.g adm other hospital|10|||
41947128|NCT02181816|75705295|FG000|Overall Study|Case Report Forms Uncollected|38|||
41947129|NCT02181816|75705295|FG000|Overall Study|Protocol Deviation|21|||
41947130|NCT02156466|75705451|FG000|Overall Study|Adverse Event|0|||
41947131|NCT02156466|75705452|FG001|Overall Study|Adverse Event|0|||
41947132|NCT02156466|75705453|FG002|Overall Study|Adverse Event|1|||
41947133|NCT02156466|75705454|FG003|Overall Study|Adverse Event|1|||
41947134|NCT02156466|75705455|FG004|Overall Study|Adverse Event|0|||
41947135|NCT02156466|75705451|FG000|Overall Study|Quantiferon Positivity|0|||
41947136|NCT02156466|75705452|FG001|Overall Study|Quantiferon Positivity|0|||
41947137|NCT02156466|75705453|FG002|Overall Study|Quantiferon Positivity|0|||
41947138|NCT02156466|75705454|FG003|Overall Study|Quantiferon Positivity|1|||
41947139|NCT02156466|75705455|FG004|Overall Study|Quantiferon Positivity|0|||
41947140|NCT02216526|75705494|FG000|Overall Study|Adverse Event|1|||
41947141|NCT02216526|75705495|FG001|Overall Study|Adverse Event|1|||
41947142|NCT02216526|75705496|FG002|Overall Study|Adverse Event|0|||
41947143|NCT02216526|75705494|FG000|Overall Study|Death|0|||
41947144|NCT02216526|75705495|FG001|Overall Study|Death|1|||
41947145|NCT02216526|75705496|FG002|Overall Study|Death|3|||
41947146|NCT02216526|75705494|FG000|Overall Study|Protocol Violation|2|||
41947147|NCT02216526|75705495|FG001|Overall Study|Protocol Violation|0|||
41947148|NCT02216526|75705496|FG002|Overall Study|Protocol Violation|2|||
41947149|NCT02216526|75705494|FG000|Overall Study|Hospitalization|2|||
41947150|NCT02216526|75705495|FG001|Overall Study|Hospitalization|1|||
41947151|NCT02216526|75705496|FG002|Overall Study|Hospitalization|3|||
41947152|NCT02216214|75705536|FG000|Overall Study|Randomized Never Received Study Drug|1|||
41947153|NCT02216214|75705537|FG001|Overall Study|Randomized Never Received Study Drug|0|||
41947154|NCT02216214|75705536|FG000|Overall Study|Adverse Event|10|||
41947155|NCT02216214|75705537|FG001|Overall Study|Adverse Event|8|||
41947156|NCT02216214|75705536|FG000|Overall Study|Lack of Efficacy|2|||
41947157|NCT02216214|75705537|FG001|Overall Study|Lack of Efficacy|2|||
41947158|NCT02216214|75705536|FG000|Overall Study|Lost to Follow-up|3|||
41947159|NCT02216214|75705537|FG001|Overall Study|Lost to Follow-up|2|||
41947160|NCT02216214|75705536|FG000|Overall Study|Protocol Violation|4|||
41947161|NCT02216214|75705537|FG001|Overall Study|Protocol Violation|2|||
41947162|NCT02216214|75705536|FG000|Overall Study|Withdrawal by Subject|22|||
41947163|NCT02216214|75705537|FG001|Overall Study|Withdrawal by Subject|20|||
41947164|NCT02216214|75705536|FG000|Overall Study|Study Terminated By Sponsor|0|||
41947165|NCT02216214|75705537|FG001|Overall Study|Study Terminated By Sponsor|1|||
41947166|NCT02216214|75705536|FG000|Overall Study|Miscellaneous|1|||
41947167|NCT02216214|75705537|FG001|Overall Study|Miscellaneous|1|||
41947168|NCT02214186|75705568|FG000|Overall Study|Lost to Follow-up|1|||
41947169|NCT02214186|75705569|FG001|Overall Study|Lost to Follow-up|1|||
41947170|NCT02214186|75705568|FG000|Overall Study|Protocol Violation|1|||
41947171|NCT02214186|75705569|FG001|Overall Study|Protocol Violation|1|||
41947172|NCT02181504|75705625|FG000|Overall Study|Adverse Event|1|||
41947173|NCT02181504|75705626|FG001|Overall Study|Adverse Event|1|||
41947174|NCT02181504|75705627|FG002|Overall Study|Adverse Event|1|||
41947175|NCT02179398|75705657|FG000|Overall Study|Lack of obligatory data|3|||
41947176|NCT02179398|75705658|FG001|Overall Study|Lack of obligatory data|3|||
41947177|NCT02179398|75705657|FG000|Overall Study|Lost to Follow-up|0|||
41947178|NCT02179398|75705658|FG001|Overall Study|Lost to Follow-up|1|||
41947179|NCT02156076|75705672|FG000|Treatment Period|no longer meets study criteria|0|||
41947180|NCT02156076|75705673|FG001|Treatment Period|no longer meets study criteria|0|||
41947181|NCT02156076|75705674|FG002|Treatment Period|no longer meets study criteria|1|||
41947182|NCT02156076|75705675|FG003|Treatment Period|no longer meets study criteria|0|||
41947183|NCT02156076|75705672|FG000|Treatment Period|Poor/non-compliance|0|||
41947184|NCT02156076|75705673|FG001|Treatment Period|Poor/non-compliance|1|||
41947185|NCT02156076|75705674|FG002|Treatment Period|Poor/non-compliance|0|||
41947186|NCT02156076|75705675|FG003|Treatment Period|Poor/non-compliance|0|||
41947187|NCT02156076|75705672|FG000|Treatment Period|Lost to Follow-up|0|||
41947188|NCT02156076|75705673|FG001|Treatment Period|Lost to Follow-up|0|||
41947189|NCT02156076|75705674|FG002|Treatment Period|Lost to Follow-up|0|||
41947190|NCT02156076|75705675|FG003|Treatment Period|Lost to Follow-up|1|||
41947191|NCT02156076|75705672|FG000|Treatment Period|Withdrawal by Subject|0|||
41947192|NCT02156076|75705673|FG001|Treatment Period|Withdrawal by Subject|0|||
41947193|NCT02156076|75705674|FG002|Treatment Period|Withdrawal by Subject|1|||
41947194|NCT02156076|75705675|FG003|Treatment Period|Withdrawal by Subject|0|||
41947195|NCT02156076|75705672|FG000|Treatment Period|Subject request to discontinue treatment|0|||
41947196|NCT02156076|75705673|FG001|Treatment Period|Subject request to discontinue treatment|1|||
41947197|NCT02156076|75705674|FG002|Treatment Period|Subject request to discontinue treatment|0|||
41947198|NCT02156076|75705675|FG003|Treatment Period|Subject request to discontinue treatment|0|||
41947199|NCT02156076|75705672|FG000|Treatment Period|Adverse Event|0|||
41947200|NCT02156076|75705673|FG001|Treatment Period|Adverse Event|0|||
42118010|NCT00689117|75928843|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
42118011|NCT00689117|75928840|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
41947201|NCT02156076|75705674|FG002|Treatment Period|Adverse Event|0|||
41947202|NCT02156076|75705675|FG003|Treatment Period|Adverse Event|1|||
41947203|NCT02156076|75705672|FG000|Follow-up Period|Withdrawal by Subject|1|||
41947204|NCT02156076|75705673|FG001|Follow-up Period|Withdrawal by Subject|0|||
41947205|NCT02156076|75705674|FG002|Follow-up Period|Withdrawal by Subject|0|||
41947206|NCT02156076|75705675|FG003|Follow-up Period|Withdrawal by Subject|0|||
41947207|NCT02213094|75705687|FG000|Overall Study|Adverse Event|1|||
41947208|NCT02213094|75705688|FG001|Overall Study|Adverse Event|0|||
42023578|NCT01190124|75830929|FG001|Overall Study|Death|0|||
41947209|NCT02155608|75705696|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
41947210|NCT02155608|75705697|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
42023579|NCT01190124|75830930|FG002|Overall Study|Death|0|||
41947211|NCT02155608|75705696|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
41947212|NCT02155608|75705697|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
41947213|NCT01629966|75705712|FG000|Overall Study|Pregnancy|0|||
41947214|NCT01629966|75705713|FG001|Overall Study|Pregnancy|1|||
41947215|NCT01629966|75705714|FG002|Overall Study|Pregnancy|0|||
41947216|NCT01629966|75705712|FG000|Overall Study|Lost to Follow-up|10|||
41947217|NCT01629966|75705713|FG001|Overall Study|Lost to Follow-up|13|||
41947218|NCT01629966|75705714|FG002|Overall Study|Lost to Follow-up|9|||
41947219|NCT01629966|75705712|FG000|Overall Study|Withdrawal by Subject|8|||
41947220|NCT01629966|75705713|FG001|Overall Study|Withdrawal by Subject|9|||
41947221|NCT01629966|75705714|FG002|Overall Study|Withdrawal by Subject|16|||
41947222|NCT01629966|75705712|FG000|Overall Study|Protocol Violation|7|||
41947223|NCT01629966|75705713|FG001|Overall Study|Protocol Violation|9|||
41947224|NCT01629966|75705714|FG002|Overall Study|Protocol Violation|7|||
41947225|NCT01629966|75705712|FG000|Overall Study|Lack of Efficacy|5|||
41947226|NCT01629966|75705713|FG001|Overall Study|Lack of Efficacy|2|||
41947227|NCT01629966|75705714|FG002|Overall Study|Lack of Efficacy|4|||
41947228|NCT01629966|75705712|FG000|Overall Study|Adverse Event|11|||
41947229|NCT01629966|75705713|FG001|Overall Study|Adverse Event|18|||
41947230|NCT01629966|75705714|FG002|Overall Study|Adverse Event|30|||
41947231|NCT02177838|75705754|FG000|Overall Study|Withdrawal by Subject|1|||
41947232|NCT02177838|75705754|FG000|Overall Study|Physician Decision|1|||
41947233|NCT02177838|75705754|FG000|Overall Study|Death|1|||
41947234|NCT02177136|75705851|FG000|DB Phase|Withdrawal by Subject|2|||
41947235|NCT02177136|75705852|FG001|DB Phase|Withdrawal by Subject|0|||
41947236|NCT02177136|75705853|FG002|DB Phase|Withdrawal by Subject|0|||
41947237|NCT02177136|75705854|FG003|DB Phase|Withdrawal by Subject|0|||
41947238|NCT02177136|75705851|FG000|DB Phase|Discontinued Due to Pruritus|1|||
41947239|NCT02177136|75705852|FG001|DB Phase|Discontinued Due to Pruritus|3|||
41947240|NCT02177136|75705853|FG002|DB Phase|Discontinued Due to Pruritus|0|||
41947241|NCT02177136|75705854|FG003|DB Phase|Discontinued Due to Pruritus|0|||
41947242|NCT02177136|75705851|FG000|DB Phase|Adverse Event|3|||
41947243|NCT02177136|75705852|FG001|DB Phase|Adverse Event|2|||
41947244|NCT02177136|75705853|FG002|DB Phase|Adverse Event|3|||
41947245|NCT02177136|75705854|FG003|DB Phase|Adverse Event|0|||
41947246|NCT02177136|75705851|FG000|DB Phase|Protocol Violation|0|||
41947247|NCT02177136|75705852|FG001|DB Phase|Protocol Violation|0|||
41947248|NCT02177136|75705853|FG002|DB Phase|Protocol Violation|1|||
41947249|NCT02177136|75705854|FG003|DB Phase|Protocol Violation|0|||
41947250|NCT02177136|75705851|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
41947251|NCT02177136|75705852|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
41947252|NCT02177136|75705853|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
41947253|NCT02177136|75705854|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
41947254|NCT02177136|75705851|FG000|LTSE Phase|Withdrawal by Subject|0|||
41947255|NCT02177136|75705852|FG001|LTSE Phase|Withdrawal by Subject|0|||
41947256|NCT02177136|75705853|FG002|LTSE Phase|Withdrawal by Subject|0|||
41947257|NCT02177136|75705854|FG003|LTSE Phase|Withdrawal by Subject|6|||
41947258|NCT02177136|75705851|FG000|LTSE Phase|Adverse Event|0|||
41947259|NCT02177136|75705852|FG001|LTSE Phase|Adverse Event|0|||
41947260|NCT02177136|75705853|FG002|LTSE Phase|Adverse Event|0|||
41947261|NCT02177136|75705854|FG003|LTSE Phase|Adverse Event|10|||
42023580|NCT01190124|75830928|FG000|Overall Study|Therapeutic Failure|12|||
42023581|NCT01190124|75830929|FG001|Overall Study|Therapeutic Failure|0|||
42023582|NCT01190124|75830930|FG002|Overall Study|Therapeutic Failure|1|||
42023583|NCT01190124|75830928|FG000|Overall Study|Lost to Follow-up|2|||
42023584|NCT01190124|75830929|FG001|Overall Study|Lost to Follow-up|0|||
42023585|NCT01190124|75830930|FG002|Overall Study|Lost to Follow-up|0|||
42023586|NCT01189890|75830943|FG000|Overall Study|Adverse Event|3|||
42023587|NCT01189890|75830944|FG001|Overall Study|Adverse Event|4|||
42023588|NCT01189890|75830943|FG000|Overall Study|Lack of Efficacy|7|||
42023589|NCT01189890|75830944|FG001|Overall Study|Lack of Efficacy|2|||
42023590|NCT01189890|75830943|FG000|Overall Study|Lost to Follow-up|1|||
42023591|NCT01189890|75830944|FG001|Overall Study|Lost to Follow-up|7|||
42023592|NCT01189890|75830943|FG000|Overall Study|Protocol Violation|1|||
42023593|NCT01189890|75830944|FG001|Overall Study|Protocol Violation|5|||
41947262|NCT02177136|75705851|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
42118012|NCT00689117|75928841|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
42118013|NCT00689117|75928842|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
41947263|NCT02177136|75705852|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
41947264|NCT02177136|75705853|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
41947265|NCT02177136|75705854|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
42023594|NCT01189890|75830943|FG000|Overall Study|Withdrawal by Subject|15|||
42023595|NCT01189890|75830944|FG001|Overall Study|Withdrawal by Subject|11|||
41947266|NCT02177136|75705851|FG000|LTSE Phase|Physician Decision|0|||
41947267|NCT02177136|75705852|FG001|LTSE Phase|Physician Decision|0|||
41947268|NCT02177136|75705853|FG002|LTSE Phase|Physician Decision|0|||
41947269|NCT02177136|75705854|FG003|LTSE Phase|Physician Decision|2|||
41947270|NCT02177136|75705851|FG000|LTSE Phase|Lost to Follow-up|0|||
41947271|NCT02177136|75705852|FG001|LTSE Phase|Lost to Follow-up|0|||
41947272|NCT02177136|75705853|FG002|LTSE Phase|Lost to Follow-up|0|||
41947273|NCT02177136|75705854|FG003|LTSE Phase|Lost to Follow-up|1|||
41947274|NCT02177136|75705851|FG000|LTSE Phase|Participant Moved|0|||
41947275|NCT02177136|75705852|FG001|LTSE Phase|Participant Moved|0|||
41947276|NCT02177136|75705853|FG002|LTSE Phase|Participant Moved|0|||
41947277|NCT02177136|75705854|FG003|LTSE Phase|Participant Moved|1|||
41947278|NCT02176356|75705882|FG000|Overall Study|Screen Failure|14|||
41947279|NCT02176356|75705882|FG000|Overall Study|Lost to Follow-up|4|||
41947280|NCT02176356|75705882|FG000|Overall Study|Personal Reasons|3|||
41947281|NCT02176356|75705882|FG000|Overall Study|Other Miscellaneous Reasons|2|||
41947282|NCT02210208|75705892|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
41947283|NCT02210208|75705892|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
41947284|NCT02210208|75705892|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
41947285|NCT02209506|75705912|FG000|Overall Study|Withdrawal by Subject|0|||
41947286|NCT02209506|75705913|FG001|Overall Study|Withdrawal by Subject|0|||
41947287|NCT02209506|75705914|FG002|Overall Study|Withdrawal by Subject|0|||
41947288|NCT02209506|75705915|FG003|Overall Study|Withdrawal by Subject|0|||
41947289|NCT02209506|75705916|FG004|Overall Study|Withdrawal by Subject|1|||
41947290|NCT02153736|75705933|FG000|Overall Study|Lost to Follow-up|1|||
41947291|NCT02153736|75705934|FG001|Overall Study|Lost to Follow-up|0|||
41947292|NCT02153736|75705933|FG000|Overall Study|Medical status change made ineligible|1|||
41947293|NCT02153736|75705934|FG001|Overall Study|Medical status change made ineligible|0|||
41947294|NCT02153736|75705933|FG000|Overall Study|Death|0|||
41947295|NCT02153736|75705934|FG001|Overall Study|Death|1|||
41947296|NCT02153736|75705933|FG000|Overall Study|Withdrawal by Subject|0|||
41947297|NCT02153736|75705934|FG001|Overall Study|Withdrawal by Subject|1|||
41947298|NCT02175966|75705942|FG000|Follow-up Period|Lack of Efficacy|10|||
41947299|NCT02175966|75705943|FG001|Follow-up Period|Lack of Efficacy|6|||
41947300|NCT02153346|75705949|FG000|Overall Study|Lost to Follow-up|11|||
41947301|NCT02174562|75705956|FG000|Overall Study|Withdrawal by Subject|7|||
41947302|NCT02174562|75705957|FG001|Overall Study|Withdrawal by Subject|2|||
41947303|NCT02174562|75705956|FG000|Overall Study|Death|2|||
41947304|NCT02174562|75705957|FG001|Overall Study|Death|0|||
41947305|NCT02174562|75705956|FG000|Overall Study|Lost to Follow-up|0|||
41947306|NCT02174562|75705957|FG001|Overall Study|Lost to Follow-up|3|||
41947307|NCT02136576|75705966|FG000|Overall Study|Lost to Follow-up|2|||
41947308|NCT02136576|75705967|FG001|Overall Study|Lost to Follow-up|0|||
41947309|NCT02136576|75705968|FG002|Overall Study|Lost to Follow-up|0|||
41947310|NCT02153112|75706225|FG000|Overall Study|Adverse Event|0|||
41947311|NCT02153112|75706226|FG001|Overall Study|Adverse Event|0|||
41947312|NCT02153112|75706227|FG002|Overall Study|Adverse Event|1|||
41947313|NCT02153112|75706228|FG003|Overall Study|Adverse Event|0|||
41947314|NCT02153112|75706229|FG004|Overall Study|Adverse Event|0|||
41947315|NCT02153112|75706230|FG005|Overall Study|Adverse Event|0|||
41947316|NCT02153112|75706231|FG006|Overall Study|Adverse Event|0|||
41947317|NCT02153112|75706232|FG007|Overall Study|Adverse Event|0|||
41947318|NCT02153112|75706233|FG008|Overall Study|Adverse Event|0|||
41947319|NCT02153112|75706234|FG009|Overall Study|Adverse Event|0|||
41947320|NCT02153112|75706225|FG000|Overall Study|Lost to Follow-up|1|||
41947321|NCT02153112|75706226|FG001|Overall Study|Lost to Follow-up|1|||
41947322|NCT02153112|75706227|FG002|Overall Study|Lost to Follow-up|0|||
41947323|NCT02153112|75706228|FG003|Overall Study|Lost to Follow-up|0|||
41947324|NCT02153112|75706229|FG004|Overall Study|Lost to Follow-up|2|||
41947325|NCT02153112|75706230|FG005|Overall Study|Lost to Follow-up|1|||
41947326|NCT02153112|75706231|FG006|Overall Study|Lost to Follow-up|1|||
41947327|NCT02153112|75706232|FG007|Overall Study|Lost to Follow-up|0|||
41947328|NCT02153112|75706233|FG008|Overall Study|Lost to Follow-up|1|||
41947329|NCT02153112|75706234|FG009|Overall Study|Lost to Follow-up|1|||
41947330|NCT02153112|75706225|FG000|Overall Study|Withdrawal by Subject|3|||
41947331|NCT02153112|75706226|FG001|Overall Study|Withdrawal by Subject|1|||
41947332|NCT02153112|75706227|FG002|Overall Study|Withdrawal by Subject|2|||
41947333|NCT02153112|75706228|FG003|Overall Study|Withdrawal by Subject|2|||
41947334|NCT02153112|75706229|FG004|Overall Study|Withdrawal by Subject|1|||
41947335|NCT02153112|75706230|FG005|Overall Study|Withdrawal by Subject|1|||
42023596|NCT01189890|75830943|FG000|Overall Study|Non Compliance|0|||
42023597|NCT01189890|75830944|FG001|Overall Study|Non Compliance|1|||
42023598|NCT01189890|75830943|FG000|Overall Study|Physician Decision|5|||
41947336|NCT02153112|75706231|FG006|Overall Study|Withdrawal by Subject|7|||
41947337|NCT02153112|75706232|FG007|Overall Study|Withdrawal by Subject|2|||
41947338|NCT02153112|75706233|FG008|Overall Study|Withdrawal by Subject|13|||
41947339|NCT02153112|75706234|FG009|Overall Study|Withdrawal by Subject|12|||
41947340|NCT02153112|75706225|FG000|Overall Study|Reason not Specified|0|||
41947341|NCT02153112|75706226|FG001|Overall Study|Reason not Specified|0|||
41947342|NCT02153112|75706227|FG002|Overall Study|Reason not Specified|0|||
41947343|NCT02153112|75706228|FG003|Overall Study|Reason not Specified|0|||
41947344|NCT02153112|75706229|FG004|Overall Study|Reason not Specified|0|||
41947345|NCT02153112|75706230|FG005|Overall Study|Reason not Specified|0|||
41947346|NCT02153112|75706231|FG006|Overall Study|Reason not Specified|0|||
41947347|NCT02153112|75706232|FG007|Overall Study|Reason not Specified|0|||
41947348|NCT02153112|75706233|FG008|Overall Study|Reason not Specified|1|||
41947349|NCT02153112|75706234|FG009|Overall Study|Reason not Specified|1|||
41947350|NCT02133924|75706284|FG000|Overall Study|Death|38|||
41947351|NCT02133924|75706284|FG000|Overall Study|Physician Decision|1|||
41947352|NCT02133924|75706284|FG000|Overall Study|Withdrawal by Subject|3|||
41947353|NCT02173704|75706375|FG000|Overall Study|Adverse Event|1|||
41947354|NCT02173704|75706376|FG001|Overall Study|Adverse Event|0|||
41947355|NCT02173704|75706375|FG000|Overall Study|Lost to Follow-up|1|||
41947356|NCT02173704|75706376|FG001|Overall Study|Lost to Follow-up|0|||
41947357|NCT02173704|75706375|FG000|Overall Study|Other|1|||
41947358|NCT02173704|75706376|FG001|Overall Study|Other|0|||
41947359|NCT02173704|75706375|FG000|Overall Study|Protocol Violation|1|||
41947360|NCT02173704|75706376|FG001|Overall Study|Protocol Violation|0|||
41947361|NCT02173704|75706375|FG000|Overall Study|Withdrawal by Subject|9|||
41947362|NCT02173704|75706376|FG001|Overall Study|Withdrawal by Subject|4|||
41947363|NCT02173548|75706397|FG000|Overall Study|Lost to Follow-up|0|||
41947364|NCT02173548|75706398|FG001|Overall Study|Lost to Follow-up|2|||
41947365|NCT02173548|75706397|FG000|Overall Study|Withdrawal by Subject|1|||
41947366|NCT02173548|75706398|FG001|Overall Study|Withdrawal by Subject|0|||
41947367|NCT02173158|75706414|FG000|Efficacy Phase|Adverse Event|1|||
41947368|NCT02152566|75706436|FG000|Overall Study|Lost to Follow-up|1|||
41947369|NCT02152566|75706436|FG000|Overall Study|Withdrawal by Subject|2|||
41947370|NCT02171130|75706465|FG000|Overall Study|Death|1|||
41947371|NCT02171130|75706465|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
41947372|NCT02171130|75706465|FG000|Overall Study|Discontinued; Site Termination|5|||
41947373|NCT02171130|75706465|FG000|Overall Study|Withdrawal by Subject|3|||
41947374|NCT02171130|75706465|FG000|Overall Study|Physician Decision|1|||
41947375|NCT02171130|75706465|FG000|Overall Study|Lost to Follow-up|1|||
41947376|NCT02171130|75706465|FG000|Overall Study|Met Exclusion Criteria|1|||
41947377|NCT03603314|75712290|FG000|Overall Study|Lost to Follow-up|0|||
41947378|NCT03603314|75712291|FG001|Overall Study|Lost to Follow-up|3|||
41947379|NCT03603314|75712292|FG002|Overall Study|Lost to Follow-up|0|||
41947380|NCT03603314|75712290|FG000|Overall Study|Protocol Violation|0|||
41947381|NCT03603314|75712291|FG001|Overall Study|Protocol Violation|1|||
41947382|NCT03603314|75712292|FG002|Overall Study|Protocol Violation|0|||
41947383|NCT03603314|75712290|FG000|Overall Study|Adverse Event|2|||
41947384|NCT03603314|75712291|FG001|Overall Study|Adverse Event|0|||
41947385|NCT03603314|75712292|FG002|Overall Study|Adverse Event|0|||
41947386|NCT03603314|75712290|FG000|Overall Study|Physician Decision|1|||
41947387|NCT03603314|75712291|FG001|Overall Study|Physician Decision|1|||
41947388|NCT03603314|75712292|FG002|Overall Study|Physician Decision|0|||
41947389|NCT03603314|75712290|FG000|Overall Study|Withdrawal by Subject|4|||
41947390|NCT03603314|75712291|FG001|Overall Study|Withdrawal by Subject|5|||
41947391|NCT03603314|75712292|FG002|Overall Study|Withdrawal by Subject|3|||
41947392|NCT03603314|75712290|FG000|Overall Study|Other|0|||
41947393|NCT03603314|75712291|FG001|Overall Study|Other|1|||
41947394|NCT03603314|75712292|FG002|Overall Study|Other|0|||
41947395|NCT04302350|75712307|FG000|Overall Study|Physician Decision|1|||
41947396|NCT04302350|75712308|FG001|Overall Study|Physician Decision|1|||
41947397|NCT04302350|75712309|FG002|Overall Study|Physician Decision|2|||
41947398|NCT04302350|75712307|FG000|Overall Study|Lack of Efficacy|1|||
41947399|NCT04302350|75712308|FG001|Overall Study|Lack of Efficacy|1|||
41947400|NCT04302350|75712309|FG002|Overall Study|Lack of Efficacy|4|||
41947401|NCT04302350|75712307|FG000|Overall Study|Adverse Event|0|||
41947402|NCT04302350|75712308|FG001|Overall Study|Adverse Event|1|||
41947403|NCT04302350|75712309|FG002|Overall Study|Adverse Event|2|||
41947404|NCT02335424|75712344|FG000|Overall Study|Withdrawal by Subject|19|||
41947405|NCT02335424|75712344|FG000|Overall Study|Adverse Event|25|||
41947406|NCT02335424|75712344|FG000|Overall Study|Death|273|||
42023599|NCT01189890|75830944|FG001|Overall Study|Physician Decision|4|||
42023600|NCT01189890|75830943|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
42023601|NCT01189890|75830944|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
41947407|NCT02335424|75712344|FG000|Overall Study|Lost to Follow-up|3|||
41947408|NCT02335424|75712344|FG000|Overall Study|Physician Decision|13|||
41947409|NCT02335424|75712344|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
41947410|NCT02335424|75712344|FG000|Overall Study|Protocol Violation|1|||
41947411|NCT02335424|75712344|FG000|Overall Study|Screen failure|1|||
41947412|NCT03805412|75712351|FG000|Overall Study|Lost to Follow-up|0|||
41947413|NCT03805412|75712352|FG001|Overall Study|Lost to Follow-up|1|||
41947414|NCT04791319|75712372|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
41947415|NCT04791319|75712373|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
41947416|NCT04791319|75712374|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
41947417|NCT04791319|75712375|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
41947418|NCT04791319|75712376|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
41947419|NCT04791319|75712377|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
41947420|NCT04791319|75712378|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
41947421|NCT04791319|75712379|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
41947422|NCT04791319|75712380|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
41947423|NCT04791319|75712381|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
41947424|NCT04791319|75712382|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
41947425|NCT04791319|75712372|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
41947426|NCT04791319|75712373|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
41947427|NCT04791319|75712374|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
41947428|NCT04791319|75712375|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
41947429|NCT04791319|75712376|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
41947430|NCT04791319|75712377|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
41947431|NCT04791319|75712378|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
41947432|NCT04791319|75712379|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
41947433|NCT04791319|75712380|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
41947434|NCT04791319|75712381|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
41947435|NCT04791319|75712382|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
41947436|NCT04791319|75712372|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
41947437|NCT04791319|75712373|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
41947438|NCT04791319|75712374|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
41947439|NCT04791319|75712375|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
41947440|NCT04791319|75712376|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
41947441|NCT04791319|75712377|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
41947442|NCT04791319|75712378|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
41947443|NCT04791319|75712379|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
41947444|NCT04791319|75712380|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
41947445|NCT04791319|75712381|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
41947446|NCT04791319|75712382|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
41947447|NCT04791319|75712372|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
41947448|NCT04791319|75712373|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
41947449|NCT04791319|75712374|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
41947450|NCT04791319|75712375|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
41947451|NCT04791319|75712376|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
41947452|NCT04791319|75712377|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
41947453|NCT04791319|75712378|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
41947454|NCT04791319|75712379|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
41947455|NCT04791319|75712380|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
41947456|NCT04791319|75712381|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
41947457|NCT04791319|75712382|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
41947458|NCT04791319|75712372|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
41947459|NCT04791319|75712373|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
41947460|NCT04791319|75712374|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
41947461|NCT04791319|75712375|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
41947462|NCT04791319|75712376|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
41947463|NCT04791319|75712377|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
41947464|NCT04791319|75712378|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
41947465|NCT04791319|75712379|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
41947466|NCT04791319|75712380|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
41947467|NCT04791319|75712381|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
41947468|NCT04791319|75712382|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
41947469|NCT04791319|75712372|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
41947470|NCT04791319|75712373|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
41947471|NCT04791319|75712374|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
41947472|NCT04791319|75712375|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
41947473|NCT04791319|75712376|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
41947474|NCT04791319|75712377|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
41947475|NCT04791319|75712378|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
41947476|NCT04791319|75712379|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
42023602|NCT01189812|75830952|FG000|Overall Study|Withdrawal by Subject|2|||
42023603|NCT01189812|75830953|FG001|Overall Study|Withdrawal by Subject|3|||
42023604|NCT01189812|75830952|FG000|Overall Study|Adverse Event|1|||
42023605|NCT01189812|75830953|FG001|Overall Study|Adverse Event|0|||
42023606|NCT01189812|75830952|FG000|Overall Study|Out of Window|4|||
42023607|NCT01189812|75830953|FG001|Overall Study|Out of Window|3|||
42023608|NCT01189812|75830952|FG000|Overall Study|Moved out of State|1|||
42023609|NCT01189812|75830953|FG001|Overall Study|Moved out of State|2|||
42023610|NCT00950950|75830961|FG000|Overall Study|Adverse Event|1|||
41947477|NCT04791319|75712380|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
41947478|NCT04791319|75712381|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
41947479|NCT04791319|75712382|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
41947480|NCT04791319|75712372|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
41947481|NCT04791319|75712373|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
41947482|NCT04791319|75712374|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
41947483|NCT04791319|75712375|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
41947484|NCT04791319|75712376|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
41947485|NCT04791319|75712377|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
41947486|NCT04791319|75712378|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
41947487|NCT04791319|75712379|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
41947488|NCT04791319|75712380|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
41947489|NCT04791319|75712381|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
41947490|NCT04791319|75712382|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
41947491|NCT04791319|75712372|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
41947492|NCT04791319|75712373|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
41947493|NCT04791319|75712374|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
41947494|NCT04791319|75712375|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
41947495|NCT04791319|75712376|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
41947496|NCT04791319|75712377|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
41947497|NCT04791319|75712378|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
41947498|NCT04791319|75712379|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
41947499|NCT04791319|75712380|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
41947500|NCT04791319|75712381|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
41947501|NCT04791319|75712382|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
41947502|NCT04791319|75712372|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
41947503|NCT04791319|75712373|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
41947504|NCT04791319|75712374|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
41947505|NCT04791319|75712375|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
41947506|NCT04791319|75712376|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
41947507|NCT04791319|75712377|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
41947508|NCT04791319|75712378|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
41947509|NCT04791319|75712379|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
41947510|NCT04791319|75712380|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
41947511|NCT04791319|75712381|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
41947512|NCT04791319|75712382|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
41947513|NCT03472495|75712439|FG000|Overall Study|Treatment no longer indicated|1|||
41947514|NCT03472495|75712440|FG001|Overall Study|Treatment no longer indicated|2|||
41947515|NCT03472495|75712439|FG000|Overall Study|Physician Decision|0|||
41947516|NCT03472495|75712440|FG001|Overall Study|Physician Decision|2|||
41947517|NCT03234907|75712448|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
41947518|NCT03234907|75712449|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
41947519|NCT03234907|75712450|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
41947520|NCT03234907|75712451|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
41947521|NCT03234907|75712452|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
41947522|NCT03234907|75712453|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
41947523|NCT03234907|75712448|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
41947524|NCT03234907|75712449|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
41947525|NCT03234907|75712450|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
41947526|NCT03234907|75712451|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
41947527|NCT03234907|75712452|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
41947528|NCT03234907|75712453|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
41947529|NCT03234907|75712448|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
41947530|NCT03234907|75712449|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
41947531|NCT03234907|75712450|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
41947532|NCT03234907|75712451|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
41947533|NCT03234907|75712452|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
42023611|NCT00950950|75830962|FG001|Overall Study|Adverse Event|0|||
42023612|NCT00950950|75830961|FG000|Overall Study|Withdrawal by Subject|0|||
42023613|NCT00950950|75830962|FG001|Overall Study|Withdrawal by Subject|1|||
42023614|NCT00950872|75830969|FG000|Overall Study|Withdrawal by Subject|1|||
42300352|NCT02326155|76135525|FG001|Overall Study|Lost to Follow-up|3|||
41947534|NCT03234907|75712453|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
41947535|NCT03234907|75712448|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
41947536|NCT03234907|75712449|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
41947537|NCT03234907|75712450|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
41947538|NCT03234907|75712451|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
41947539|NCT03234907|75712452|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
41947540|NCT03234907|75712453|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
41947541|NCT03234907|75712448|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
41947542|NCT03234907|75712449|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
41947543|NCT03234907|75712450|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
41947544|NCT03234907|75712451|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
41947545|NCT03234907|75712452|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
41947546|NCT03234907|75712453|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
41947547|NCT03234907|75712448|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
41947548|NCT03234907|75712449|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
41947549|NCT03234907|75712450|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
41947550|NCT03234907|75712451|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
41947551|NCT03234907|75712452|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
41947552|NCT03234907|75712453|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
41947553|NCT03234907|75712448|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
41947554|NCT03234907|75712449|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
41947555|NCT03234907|75712450|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
41947556|NCT03234907|75712451|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
41947557|NCT03234907|75712452|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
41947558|NCT03234907|75712453|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
41947559|NCT03818581|75712467|FG000|Overall Study|Adverse Event|1|||
41947560|NCT03818581|75712468|FG001|Overall Study|Adverse Event|0|||
41947561|NCT03818581|75712469|FG002|Overall Study|Adverse Event|0|||
41947562|NCT03818581|75712470|FG003|Overall Study|Adverse Event|0|||
41947563|NCT03818581|75712471|FG004|Overall Study|Adverse Event|0|||
41947564|NCT03818581|75712467|FG000|Overall Study|Covid-19|2|||
41947565|NCT03818581|75712468|FG001|Overall Study|Covid-19|0|||
41947566|NCT03818581|75712469|FG002|Overall Study|Covid-19|0|||
41947567|NCT03818581|75712470|FG003|Overall Study|Covid-19|0|||
41947568|NCT03818581|75712471|FG004|Overall Study|Covid-19|1|||
41947569|NCT03818581|75712467|FG000|Overall Study|Withdrawal by Subject|0|||
41947570|NCT03818581|75712468|FG001|Overall Study|Withdrawal by Subject|0|||
41947571|NCT03818581|75712469|FG002|Overall Study|Withdrawal by Subject|0|||
41947572|NCT03818581|75712470|FG003|Overall Study|Withdrawal by Subject|0|||
41947573|NCT03818581|75712471|FG004|Overall Study|Withdrawal by Subject|1|||
41947574|NCT03818581|75712467|FG000|Overall Study|No longer met study criteria|1|||
41947575|NCT03818581|75712468|FG001|Overall Study|No longer met study criteria|0|||
41947576|NCT03818581|75712469|FG002|Overall Study|No longer met study criteria|0|||
41947577|NCT03818581|75712470|FG003|Overall Study|No longer met study criteria|0|||
41947578|NCT03818581|75712471|FG004|Overall Study|No longer met study criteria|2|||
41947579|NCT03736447|75712485|FG000|Overall Study|Adverse Event|5|||
41947580|NCT03736447|75712486|FG001|Overall Study|Adverse Event|1|||
41947581|NCT03736447|75712485|FG000|Overall Study|Withdrawal by Subject|5|||
41947582|NCT03736447|75712486|FG001|Overall Study|Withdrawal by Subject|1|||
41947583|NCT03736447|75712485|FG000|Overall Study|Lost to Follow-up|1|||
41947584|NCT03736447|75712486|FG001|Overall Study|Lost to Follow-up|0|||
41947585|NCT03736447|75712485|FG000|Overall Study|Physician Decision|1|||
41947586|NCT03736447|75712486|FG001|Overall Study|Physician Decision|0|||
41947587|NCT03736447|75712485|FG000|Overall Study|Continued commitment to study treatment|3|||
41947588|NCT03736447|75712486|FG001|Overall Study|Continued commitment to study treatment|0|||
41947589|NCT03736447|75712485|FG000|Overall Study|Taste aversion to study product|0|||
41947590|NCT03736447|75712486|FG001|Overall Study|Taste aversion to study product|1|||
41947591|NCT02132754|75712535|FG000|Overall Study|Adverse Event|0|||
41947592|NCT02132754|75712536|FG001|Overall Study|Adverse Event|0|||
41947593|NCT02132754|75712537|FG002|Overall Study|Adverse Event|0|||
41947594|NCT02132754|75712538|FG003|Overall Study|Adverse Event|0|||
41947595|NCT02132754|75712539|FG004|Overall Study|Adverse Event|0|||
41947596|NCT02132754|75712540|FG005|Overall Study|Adverse Event|0|||
41947597|NCT02132754|75712541|FG006|Overall Study|Adverse Event|0|||
41947598|NCT02132754|75712542|FG007|Overall Study|Adverse Event|0|||
41947599|NCT02132754|75712543|FG008|Overall Study|Adverse Event|0|||
41947600|NCT02132754|75712544|FG009|Overall Study|Adverse Event|0|||
41947601|NCT02132754|75712545|FG010|Overall Study|Adverse Event|0|||
41947602|NCT02132754|75712546|FG011|Overall Study|Adverse Event|0|||
41947603|NCT02132754|75712547|FG012|Overall Study|Adverse Event|0|||
41947604|NCT02132754|75712548|FG013|Overall Study|Adverse Event|0|||
41947605|NCT02132754|75712549|FG014|Overall Study|Adverse Event|0|||
41947606|NCT02132754|75712550|FG015|Overall Study|Adverse Event|0|||
41947607|NCT02132754|75712551|FG016|Overall Study|Adverse Event|0|||
41947608|NCT02132754|75712552|FG017|Overall Study|Adverse Event|1|||
41947609|NCT02132754|75712553|FG018|Overall Study|Adverse Event|0|||
41947610|NCT02132754|75712554|FG019|Overall Study|Adverse Event|0|||
41947611|NCT02132754|75712555|FG020|Overall Study|Adverse Event|0|||
41947612|NCT02132754|75712556|FG021|Overall Study|Adverse Event|0|||
41947613|NCT02132754|75712557|FG022|Overall Study|Adverse Event|0|||
41947614|NCT02132754|75712558|FG023|Overall Study|Adverse Event|0|||
41947615|NCT02132754|75712559|FG024|Overall Study|Adverse Event|0|||
41947616|NCT02132754|75712560|FG025|Overall Study|Adverse Event|1|||
41947617|NCT02132754|75712561|FG026|Overall Study|Adverse Event|1|||
41947618|NCT02132754|75712562|FG027|Overall Study|Adverse Event|0|||
41947619|NCT02132754|75712563|FG028|Overall Study|Adverse Event|0|||
41947620|NCT02132754|75712564|FG029|Overall Study|Adverse Event|0|||
41947621|NCT02132754|75712565|FG030|Overall Study|Adverse Event|1|||
41947622|NCT02132754|75712566|FG031|Overall Study|Adverse Event|0|||
41947623|NCT02132754|75712567|FG032|Overall Study|Adverse Event|1|||
41947624|NCT02132754|75712568|FG033|Overall Study|Adverse Event|1|||
41947625|NCT02132754|75712535|FG000|Overall Study|Clinical Progression|0|||
41947626|NCT02132754|75712536|FG001|Overall Study|Clinical Progression|0|||
41947627|NCT02132754|75712537|FG002|Overall Study|Clinical Progression|0|||
42023615|NCT00950872|75830969|FG000|Overall Study|Did not have surgery|2|||
42023616|NCT01189500|75830973|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
42023617|NCT01189500|75830973|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
42023618|NCT00938860|75830982|FG000|Overall Study|Adverse Event|2|||
42023619|NCT00938860|75830983|FG001|Overall Study|Adverse Event|1|||
42023620|NCT00938860|75830982|FG000|Overall Study|Abnormal laboratory values|2|||
42023621|NCT00938860|75830983|FG001|Overall Study|Abnormal laboratory values|2|||
42023622|NCT00938860|75830982|FG000|Overall Study|Withdrawal by Subject|11|||
42023623|NCT00938860|75830983|FG001|Overall Study|Withdrawal by Subject|8|||
42023624|NCT00938860|75830982|FG000|Overall Study|Lost to Follow-up|4|||
42023625|NCT00938860|75830983|FG001|Overall Study|Lost to Follow-up|4|||
42023626|NCT00938860|75830982|FG000|Overall Study|Administration problems|2|||
42023627|NCT00938860|75830983|FG001|Overall Study|Administration problems|0|||
42023628|NCT00938860|75830982|FG000|Overall Study|Death|1|||
42023629|NCT00938860|75830983|FG001|Overall Study|Death|1|||
42023630|NCT00938860|75830982|FG000|Overall Study|Protocol Violation|3|||
42023631|NCT00938860|75830983|FG001|Overall Study|Protocol Violation|1|||
42023632|NCT00938470|75830991|FG000|Overall Study|Disease Progression|3|||
42023633|NCT00938470|75830992|FG001|Overall Study|Disease Progression|0|||
42023634|NCT00938470|75830991|FG000|Overall Study|Alternate Treatment|1|||
42023635|NCT00938470|75830992|FG001|Overall Study|Alternate Treatment|0|||
42023636|NCT00938470|75830991|FG000|Overall Study|Death|3|||
42023637|NCT00938470|75830992|FG001|Overall Study|Death|2|||
42023638|NCT00938470|75830991|FG000|Overall Study|Other Reason|0|||
42023639|NCT00938470|75830992|FG001|Overall Study|Other Reason|1|||
42023640|NCT00938392|75831000|FG000|Overall Study|Adverse Event|0|||
42023641|NCT00938392|75831001|FG001|Overall Study|Adverse Event|1|||
42023642|NCT00938392|75831000|FG000|Overall Study|Withdrawal by Subject|0|||
42023643|NCT00938392|75831001|FG001|Overall Study|Withdrawal by Subject|1|||
42023644|NCT00938392|75831000|FG000|Overall Study|Lost to Follow-up|2|||
42023645|NCT00938392|75831001|FG001|Overall Study|Lost to Follow-up|2|||
42023646|NCT01022853|75831012|FG000|Overall Study|Progressive disease|2|||
42023647|NCT01022853|75831013|FG001|Overall Study|Progressive disease|3|||
42023648|NCT01022853|75831014|FG002|Overall Study|Progressive disease|11|||
42023649|NCT01022853|75831015|FG003|Overall Study|Progressive disease|7|||
42023650|NCT01022853|75831016|FG004|Overall Study|Progressive disease|1|||
42023651|NCT01022853|75831012|FG000|Overall Study|Dose-limiting toxicity|0|||
41947628|NCT02132754|75712538|FG003|Overall Study|Clinical Progression|0|||
42023652|NCT01022853|75831013|FG001|Overall Study|Dose-limiting toxicity|0|||
41947629|NCT02132754|75712539|FG004|Overall Study|Clinical Progression|0|||
42023653|NCT01022853|75831014|FG002|Overall Study|Dose-limiting toxicity|0|||
42023654|NCT01022853|75831015|FG003|Overall Study|Dose-limiting toxicity|0|||
41947630|NCT02132754|75712540|FG005|Overall Study|Clinical Progression|0|||
42023655|NCT01022853|75831016|FG004|Overall Study|Dose-limiting toxicity|1|||
41947631|NCT02132754|75712541|FG006|Overall Study|Clinical Progression|0|||
41947632|NCT02132754|75712542|FG007|Overall Study|Clinical Progression|0|||
41947633|NCT02132754|75712543|FG008|Overall Study|Clinical Progression|0|||
41947634|NCT02132754|75712544|FG009|Overall Study|Clinical Progression|1|||
41947635|NCT02132754|75712545|FG010|Overall Study|Clinical Progression|0|||
41947636|NCT02132754|75712546|FG011|Overall Study|Clinical Progression|0|||
41947637|NCT02132754|75712547|FG012|Overall Study|Clinical Progression|0|||
41947638|NCT02132754|75712548|FG013|Overall Study|Clinical Progression|0|||
41947639|NCT02132754|75712549|FG014|Overall Study|Clinical Progression|0|||
41947640|NCT02132754|75712550|FG015|Overall Study|Clinical Progression|0|||
41947641|NCT02132754|75712551|FG016|Overall Study|Clinical Progression|1|||
41947642|NCT02132754|75712552|FG017|Overall Study|Clinical Progression|1|||
41947643|NCT02132754|75712553|FG018|Overall Study|Clinical Progression|0|||
41947644|NCT02132754|75712554|FG019|Overall Study|Clinical Progression|1|||
41947645|NCT02132754|75712555|FG020|Overall Study|Clinical Progression|0|||
41947646|NCT02132754|75712556|FG021|Overall Study|Clinical Progression|0|||
41947647|NCT02132754|75712557|FG022|Overall Study|Clinical Progression|1|||
41947648|NCT02132754|75712558|FG023|Overall Study|Clinical Progression|0|||
41947649|NCT02132754|75712559|FG024|Overall Study|Clinical Progression|1|||
41947650|NCT02132754|75712560|FG025|Overall Study|Clinical Progression|1|||
41947651|NCT02132754|75712561|FG026|Overall Study|Clinical Progression|0|||
41947652|NCT02132754|75712562|FG027|Overall Study|Clinical Progression|1|||
41947653|NCT02132754|75712563|FG028|Overall Study|Clinical Progression|1|||
41947654|NCT02132754|75712564|FG029|Overall Study|Clinical Progression|0|||
41947655|NCT02132754|75712565|FG030|Overall Study|Clinical Progression|1|||
41947656|NCT02132754|75712566|FG031|Overall Study|Clinical Progression|0|||
41947657|NCT02132754|75712567|FG032|Overall Study|Clinical Progression|0|||
41947658|NCT02132754|75712568|FG033|Overall Study|Clinical Progression|2|||
41947659|NCT02132754|75712535|FG000|Overall Study|Death|0|||
41947660|NCT02132754|75712536|FG001|Overall Study|Death|0|||
41947661|NCT02132754|75712537|FG002|Overall Study|Death|0|||
41947662|NCT02132754|75712538|FG003|Overall Study|Death|0|||
41947663|NCT02132754|75712539|FG004|Overall Study|Death|0|||
41947664|NCT02132754|75712540|FG005|Overall Study|Death|0|||
41947665|NCT02132754|75712541|FG006|Overall Study|Death|0|||
41947666|NCT02132754|75712542|FG007|Overall Study|Death|0|||
41947667|NCT02132754|75712543|FG008|Overall Study|Death|0|||
41947668|NCT02132754|75712544|FG009|Overall Study|Death|0|||
41947669|NCT02132754|75712545|FG010|Overall Study|Death|0|||
41947670|NCT02132754|75712546|FG011|Overall Study|Death|0|||
41947671|NCT02132754|75712547|FG012|Overall Study|Death|0|||
41947672|NCT02132754|75712548|FG013|Overall Study|Death|0|||
41947673|NCT02132754|75712549|FG014|Overall Study|Death|0|||
41947674|NCT02132754|75712550|FG015|Overall Study|Death|1|||
41947675|NCT02132754|75712551|FG016|Overall Study|Death|0|||
41947676|NCT02132754|75712552|FG017|Overall Study|Death|0|||
41947677|NCT02132754|75712553|FG018|Overall Study|Death|0|||
41947678|NCT02132754|75712554|FG019|Overall Study|Death|1|||
41947679|NCT02132754|75712555|FG020|Overall Study|Death|0|||
41947680|NCT02132754|75712556|FG021|Overall Study|Death|1|||
41947681|NCT02132754|75712557|FG022|Overall Study|Death|0|||
41947682|NCT02132754|75712558|FG023|Overall Study|Death|0|||
41947683|NCT02132754|75712559|FG024|Overall Study|Death|0|||
41947684|NCT02132754|75712560|FG025|Overall Study|Death|0|||
41947685|NCT02132754|75712561|FG026|Overall Study|Death|1|||
41947686|NCT02132754|75712562|FG027|Overall Study|Death|0|||
41947687|NCT02132754|75712563|FG028|Overall Study|Death|0|||
41947688|NCT02132754|75712564|FG029|Overall Study|Death|0|||
41947689|NCT02132754|75712565|FG030|Overall Study|Death|0|||
41947690|NCT02132754|75712566|FG031|Overall Study|Death|0|||
41947691|NCT02132754|75712567|FG032|Overall Study|Death|0|||
41947692|NCT02132754|75712568|FG033|Overall Study|Death|2|||
41947693|NCT02132754|75712535|FG000|Overall Study|Excluded Medication|0|||
41947694|NCT02132754|75712536|FG001|Overall Study|Excluded Medication|0|||
41947695|NCT02132754|75712537|FG002|Overall Study|Excluded Medication|0|||
41947696|NCT02132754|75712538|FG003|Overall Study|Excluded Medication|0|||
41947697|NCT02132754|75712539|FG004|Overall Study|Excluded Medication|0|||
41947698|NCT02132754|75712540|FG005|Overall Study|Excluded Medication|0|||
41947699|NCT02132754|75712541|FG006|Overall Study|Excluded Medication|0|||
41947700|NCT02132754|75712542|FG007|Overall Study|Excluded Medication|0|||
41947701|NCT02132754|75712543|FG008|Overall Study|Excluded Medication|0|||
41947702|NCT02132754|75712544|FG009|Overall Study|Excluded Medication|0|||
41947703|NCT02132754|75712545|FG010|Overall Study|Excluded Medication|0|||
41947704|NCT02132754|75712546|FG011|Overall Study|Excluded Medication|0|||
41947705|NCT02132754|75712547|FG012|Overall Study|Excluded Medication|0|||
41947706|NCT02132754|75712548|FG013|Overall Study|Excluded Medication|0|||
41947707|NCT02132754|75712549|FG014|Overall Study|Excluded Medication|0|||
41947708|NCT02132754|75712550|FG015|Overall Study|Excluded Medication|0|||
41947709|NCT02132754|75712551|FG016|Overall Study|Excluded Medication|0|||
41947710|NCT02132754|75712552|FG017|Overall Study|Excluded Medication|0|||
41947711|NCT02132754|75712553|FG018|Overall Study|Excluded Medication|0|||
41947712|NCT02132754|75712554|FG019|Overall Study|Excluded Medication|0|||
41947713|NCT02132754|75712555|FG020|Overall Study|Excluded Medication|1|||
41947714|NCT02132754|75712556|FG021|Overall Study|Excluded Medication|0|||
41947715|NCT02132754|75712557|FG022|Overall Study|Excluded Medication|0|||
41947716|NCT02132754|75712558|FG023|Overall Study|Excluded Medication|0|||
41947717|NCT02132754|75712559|FG024|Overall Study|Excluded Medication|0|||
41947718|NCT02132754|75712560|FG025|Overall Study|Excluded Medication|0|||
41947719|NCT02132754|75712561|FG026|Overall Study|Excluded Medication|0|||
41947720|NCT02132754|75712562|FG027|Overall Study|Excluded Medication|0|||
41947721|NCT02132754|75712563|FG028|Overall Study|Excluded Medication|0|||
41947722|NCT02132754|75712564|FG029|Overall Study|Excluded Medication|0|||
41947723|NCT02132754|75712565|FG030|Overall Study|Excluded Medication|0|||
41947724|NCT02132754|75712566|FG031|Overall Study|Excluded Medication|0|||
41947725|NCT02132754|75712567|FG032|Overall Study|Excluded Medication|0|||
41947726|NCT02132754|75712568|FG033|Overall Study|Excluded Medication|1|||
41947727|NCT02132754|75712535|FG000|Overall Study|Physician Decision|0|||
41947728|NCT02132754|75712536|FG001|Overall Study|Physician Decision|0|||
41947729|NCT02132754|75712537|FG002|Overall Study|Physician Decision|0|||
41947730|NCT02132754|75712538|FG003|Overall Study|Physician Decision|0|||
41947731|NCT02132754|75712539|FG004|Overall Study|Physician Decision|0|||
41947732|NCT02132754|75712540|FG005|Overall Study|Physician Decision|0|||
41947733|NCT02132754|75712541|FG006|Overall Study|Physician Decision|0|||
41947734|NCT02132754|75712542|FG007|Overall Study|Physician Decision|0|||
41947735|NCT02132754|75712543|FG008|Overall Study|Physician Decision|0|||
41947736|NCT02132754|75712544|FG009|Overall Study|Physician Decision|1|||
41947737|NCT02132754|75712545|FG010|Overall Study|Physician Decision|0|||
41947738|NCT02132754|75712546|FG011|Overall Study|Physician Decision|1|||
41947739|NCT02132754|75712547|FG012|Overall Study|Physician Decision|1|||
41947740|NCT02132754|75712548|FG013|Overall Study|Physician Decision|0|||
41947741|NCT02132754|75712549|FG014|Overall Study|Physician Decision|0|||
41947742|NCT02132754|75712550|FG015|Overall Study|Physician Decision|1|||
41947743|NCT02132754|75712551|FG016|Overall Study|Physician Decision|0|||
41947744|NCT02132754|75712552|FG017|Overall Study|Physician Decision|0|||
41947745|NCT02132754|75712553|FG018|Overall Study|Physician Decision|0|||
41947746|NCT02132754|75712554|FG019|Overall Study|Physician Decision|0|||
41947747|NCT02132754|75712555|FG020|Overall Study|Physician Decision|0|||
41947748|NCT02132754|75712556|FG021|Overall Study|Physician Decision|0|||
41947749|NCT02132754|75712557|FG022|Overall Study|Physician Decision|0|||
41947750|NCT02132754|75712558|FG023|Overall Study|Physician Decision|0|||
41947751|NCT02132754|75712559|FG024|Overall Study|Physician Decision|1|||
41947752|NCT02132754|75712560|FG025|Overall Study|Physician Decision|0|||
41947753|NCT02132754|75712561|FG026|Overall Study|Physician Decision|0|||
41947754|NCT02132754|75712562|FG027|Overall Study|Physician Decision|0|||
41947755|NCT02132754|75712563|FG028|Overall Study|Physician Decision|0|||
41947756|NCT02132754|75712564|FG029|Overall Study|Physician Decision|0|||
41947757|NCT02132754|75712565|FG030|Overall Study|Physician Decision|0|||
41947758|NCT02132754|75712566|FG031|Overall Study|Physician Decision|1|||
41947759|NCT02132754|75712567|FG032|Overall Study|Physician Decision|0|||
41947760|NCT02132754|75712568|FG033|Overall Study|Physician Decision|3|||
41947761|NCT02132754|75712535|FG000|Overall Study|Progressive Disease|1|||
41947762|NCT02132754|75712536|FG001|Overall Study|Progressive Disease|1|||
41947763|NCT02132754|75712537|FG002|Overall Study|Progressive Disease|1|||
41947764|NCT02132754|75712538|FG003|Overall Study|Progressive Disease|1|||
41947765|NCT02132754|75712539|FG004|Overall Study|Progressive Disease|1|||
41947766|NCT02132754|75712540|FG005|Overall Study|Progressive Disease|1|||
41947767|NCT02132754|75712541|FG006|Overall Study|Progressive Disease|1|||
41947768|NCT02132754|75712542|FG007|Overall Study|Progressive Disease|1|||
41947769|NCT02132754|75712543|FG008|Overall Study|Progressive Disease|1|||
41947770|NCT02132754|75712544|FG009|Overall Study|Progressive Disease|3|||
41947771|NCT02132754|75712545|FG010|Overall Study|Progressive Disease|3|||
41947772|NCT02132754|75712546|FG011|Overall Study|Progressive Disease|2|||
41947773|NCT02132754|75712547|FG012|Overall Study|Progressive Disease|2|||
41947774|NCT02132754|75712548|FG013|Overall Study|Progressive Disease|3|||
41947775|NCT02132754|75712549|FG014|Overall Study|Progressive Disease|2|||
41947776|NCT02132754|75712550|FG015|Overall Study|Progressive Disease|1|||
41947777|NCT02132754|75712551|FG016|Overall Study|Progressive Disease|2|||
41947778|NCT02132754|75712552|FG017|Overall Study|Progressive Disease|1|||
41947779|NCT02132754|75712553|FG018|Overall Study|Progressive Disease|3|||
41947780|NCT02132754|75712554|FG019|Overall Study|Progressive Disease|1|||
41947781|NCT02132754|75712555|FG020|Overall Study|Progressive Disease|1|||
41947782|NCT02132754|75712556|FG021|Overall Study|Progressive Disease|3|||
41947783|NCT02132754|75712557|FG022|Overall Study|Progressive Disease|2|||
41947784|NCT02132754|75712558|FG023|Overall Study|Progressive Disease|3|||
41947785|NCT02132754|75712559|FG024|Overall Study|Progressive Disease|0|||
41947786|NCT02132754|75712560|FG025|Overall Study|Progressive Disease|1|||
41947787|NCT02132754|75712561|FG026|Overall Study|Progressive Disease|2|||
41947788|NCT02132754|75712562|FG027|Overall Study|Progressive Disease|1|||
41947789|NCT02132754|75712563|FG028|Overall Study|Progressive Disease|2|||
41947790|NCT02132754|75712564|FG029|Overall Study|Progressive Disease|3|||
41947791|NCT02132754|75712565|FG030|Overall Study|Progressive Disease|1|||
41947792|NCT02132754|75712566|FG031|Overall Study|Progressive Disease|1|||
41947793|NCT02132754|75712567|FG032|Overall Study|Progressive Disease|3|||
41947794|NCT02132754|75712568|FG033|Overall Study|Progressive Disease|6|||
41947795|NCT02132754|75712535|FG000|Overall Study|Screen Failure|0|||
41947796|NCT02132754|75712536|FG001|Overall Study|Screen Failure|0|||
41947797|NCT02132754|75712537|FG002|Overall Study|Screen Failure|0|||
41947798|NCT02132754|75712538|FG003|Overall Study|Screen Failure|0|||
41947799|NCT02132754|75712539|FG004|Overall Study|Screen Failure|0|||
41947800|NCT02132754|75712540|FG005|Overall Study|Screen Failure|0|||
41947801|NCT02132754|75712541|FG006|Overall Study|Screen Failure|0|||
41947802|NCT02132754|75712542|FG007|Overall Study|Screen Failure|0|||
41947803|NCT02132754|75712543|FG008|Overall Study|Screen Failure|0|||
41947804|NCT02132754|75712544|FG009|Overall Study|Screen Failure|0|||
41947805|NCT02132754|75712545|FG010|Overall Study|Screen Failure|0|||
41947806|NCT02132754|75712546|FG011|Overall Study|Screen Failure|0|||
41947807|NCT02132754|75712547|FG012|Overall Study|Screen Failure|0|||
41947808|NCT02132754|75712548|FG013|Overall Study|Screen Failure|0|||
41947809|NCT02132754|75712549|FG014|Overall Study|Screen Failure|0|||
41947810|NCT02132754|75712550|FG015|Overall Study|Screen Failure|0|||
41947811|NCT02132754|75712551|FG016|Overall Study|Screen Failure|0|||
41947812|NCT02132754|75712552|FG017|Overall Study|Screen Failure|0|||
41947813|NCT02132754|75712553|FG018|Overall Study|Screen Failure|0|||
41947814|NCT02132754|75712554|FG019|Overall Study|Screen Failure|1|||
41947815|NCT02132754|75712555|FG020|Overall Study|Screen Failure|0|||
41947816|NCT02132754|75712556|FG021|Overall Study|Screen Failure|1|||
41947817|NCT02132754|75712557|FG022|Overall Study|Screen Failure|0|||
41947818|NCT02132754|75712558|FG023|Overall Study|Screen Failure|0|||
41947819|NCT02132754|75712559|FG024|Overall Study|Screen Failure|0|||
41947820|NCT02132754|75712560|FG025|Overall Study|Screen Failure|0|||
41947821|NCT02132754|75712561|FG026|Overall Study|Screen Failure|0|||
41947822|NCT02132754|75712562|FG027|Overall Study|Screen Failure|0|||
41947823|NCT02132754|75712563|FG028|Overall Study|Screen Failure|0|||
41947824|NCT02132754|75712564|FG029|Overall Study|Screen Failure|0|||
41947825|NCT02132754|75712565|FG030|Overall Study|Screen Failure|0|||
41947826|NCT02132754|75712566|FG031|Overall Study|Screen Failure|0|||
41947827|NCT02132754|75712567|FG032|Overall Study|Screen Failure|0|||
41947828|NCT02132754|75712568|FG033|Overall Study|Screen Failure|0|||
42023656|NCT01022853|75831012|FG000|Overall Study|Withdrawal by Subject|0|||
42023657|NCT01022853|75831013|FG001|Overall Study|Withdrawal by Subject|1|||
42023658|NCT01022853|75831014|FG002|Overall Study|Withdrawal by Subject|1|||
42023659|NCT01022853|75831015|FG003|Overall Study|Withdrawal by Subject|1|||
42023660|NCT01022853|75831016|FG004|Overall Study|Withdrawal by Subject|0|||
42023661|NCT01022853|75831012|FG000|Overall Study|Other not stated above|1|||
42023662|NCT01022853|75831013|FG001|Overall Study|Other not stated above|0|||
41947829|NCT02132754|75712535|FG000|Overall Study|Transferred to Extension Study|0|||
41947830|NCT02132754|75712536|FG001|Overall Study|Transferred to Extension Study|0|||
41947831|NCT02132754|75712537|FG002|Overall Study|Transferred to Extension Study|0|||
41947832|NCT02132754|75712538|FG003|Overall Study|Transferred to Extension Study|0|||
41947833|NCT02132754|75712539|FG004|Overall Study|Transferred to Extension Study|0|||
41947834|NCT02132754|75712540|FG005|Overall Study|Transferred to Extension Study|0|||
41947835|NCT02132754|75712541|FG006|Overall Study|Transferred to Extension Study|0|||
41947836|NCT02132754|75712542|FG007|Overall Study|Transferred to Extension Study|0|||
41947837|NCT02132754|75712543|FG008|Overall Study|Transferred to Extension Study|0|||
41947838|NCT02132754|75712544|FG009|Overall Study|Transferred to Extension Study|0|||
41947839|NCT02132754|75712545|FG010|Overall Study|Transferred to Extension Study|0|||
41947840|NCT02132754|75712546|FG011|Overall Study|Transferred to Extension Study|0|||
41947841|NCT02132754|75712547|FG012|Overall Study|Transferred to Extension Study|0|||
41947842|NCT02132754|75712548|FG013|Overall Study|Transferred to Extension Study|0|||
41947843|NCT02132754|75712549|FG014|Overall Study|Transferred to Extension Study|0|||
41947844|NCT02132754|75712550|FG015|Overall Study|Transferred to Extension Study|0|||
41947845|NCT02132754|75712551|FG016|Overall Study|Transferred to Extension Study|0|||
41947846|NCT02132754|75712552|FG017|Overall Study|Transferred to Extension Study|0|||
41947847|NCT02132754|75712553|FG018|Overall Study|Transferred to Extension Study|0|||
41947848|NCT02132754|75712554|FG019|Overall Study|Transferred to Extension Study|0|||
41947849|NCT02132754|75712555|FG020|Overall Study|Transferred to Extension Study|0|||
41947850|NCT02132754|75712556|FG021|Overall Study|Transferred to Extension Study|0|||
42023663|NCT01022853|75831014|FG002|Overall Study|Other not stated above|1|||
42300353|NCT02326155|76135524|FG000|Overall Study|Protocol Violation|2|||
41947851|NCT02132754|75712557|FG022|Overall Study|Transferred to Extension Study|0|||
41947852|NCT02132754|75712558|FG023|Overall Study|Transferred to Extension Study|0|||
41947853|NCT02132754|75712559|FG024|Overall Study|Transferred to Extension Study|0|||
41947854|NCT02132754|75712560|FG025|Overall Study|Transferred to Extension Study|0|||
41947855|NCT02132754|75712561|FG026|Overall Study|Transferred to Extension Study|0|||
41947856|NCT02132754|75712562|FG027|Overall Study|Transferred to Extension Study|0|||
41947857|NCT02132754|75712563|FG028|Overall Study|Transferred to Extension Study|0|||
41947858|NCT02132754|75712564|FG029|Overall Study|Transferred to Extension Study|0|||
41947859|NCT02132754|75712565|FG030|Overall Study|Transferred to Extension Study|0|||
42300354|NCT02326155|76135525|FG001|Overall Study|Protocol Violation|0|||
41947860|NCT02132754|75712566|FG031|Overall Study|Transferred to Extension Study|0|||
41947861|NCT02132754|75712567|FG032|Overall Study|Transferred to Extension Study|0|||
41947862|NCT02132754|75712568|FG033|Overall Study|Transferred to Extension Study|6|||
41947863|NCT02132754|75712535|FG000|Overall Study|Withdrawal by Subject|0|||
41947864|NCT02132754|75712536|FG001|Overall Study|Withdrawal by Subject|0|||
41947865|NCT02132754|75712537|FG002|Overall Study|Withdrawal by Subject|0|||
41947866|NCT02132754|75712538|FG003|Overall Study|Withdrawal by Subject|0|||
41947867|NCT02132754|75712539|FG004|Overall Study|Withdrawal by Subject|0|||
41947868|NCT02132754|75712540|FG005|Overall Study|Withdrawal by Subject|0|||
41947869|NCT02132754|75712541|FG006|Overall Study|Withdrawal by Subject|0|||
41947870|NCT02132754|75712542|FG007|Overall Study|Withdrawal by Subject|0|||
41947871|NCT02132754|75712543|FG008|Overall Study|Withdrawal by Subject|0|||
41947872|NCT02132754|75712544|FG009|Overall Study|Withdrawal by Subject|1|||
41947873|NCT02132754|75712545|FG010|Overall Study|Withdrawal by Subject|0|||
41947874|NCT02132754|75712546|FG011|Overall Study|Withdrawal by Subject|0|||
41947875|NCT02132754|75712547|FG012|Overall Study|Withdrawal by Subject|1|||
41947876|NCT02132754|75712548|FG013|Overall Study|Withdrawal by Subject|0|||
41947877|NCT02132754|75712549|FG014|Overall Study|Withdrawal by Subject|1|||
41947878|NCT02132754|75712550|FG015|Overall Study|Withdrawal by Subject|2|||
41947879|NCT02132754|75712551|FG016|Overall Study|Withdrawal by Subject|1|||
41947880|NCT02132754|75712552|FG017|Overall Study|Withdrawal by Subject|0|||
41947881|NCT02132754|75712553|FG018|Overall Study|Withdrawal by Subject|0|||
41947882|NCT02132754|75712554|FG019|Overall Study|Withdrawal by Subject|0|||
41947883|NCT02132754|75712555|FG020|Overall Study|Withdrawal by Subject|1|||
41947884|NCT02132754|75712556|FG021|Overall Study|Withdrawal by Subject|0|||
41947885|NCT02132754|75712557|FG022|Overall Study|Withdrawal by Subject|0|||
41947886|NCT02132754|75712558|FG023|Overall Study|Withdrawal by Subject|0|||
41947887|NCT02132754|75712559|FG024|Overall Study|Withdrawal by Subject|1|||
41947888|NCT02132754|75712560|FG025|Overall Study|Withdrawal by Subject|0|||
41947889|NCT02132754|75712561|FG026|Overall Study|Withdrawal by Subject|0|||
41947890|NCT02132754|75712562|FG027|Overall Study|Withdrawal by Subject|1|||
41947891|NCT02132754|75712563|FG028|Overall Study|Withdrawal by Subject|0|||
41947892|NCT02132754|75712564|FG029|Overall Study|Withdrawal by Subject|0|||
41947893|NCT02132754|75712565|FG030|Overall Study|Withdrawal by Subject|0|||
41947894|NCT02132754|75712566|FG031|Overall Study|Withdrawal by Subject|1|||
41947895|NCT02132754|75712567|FG032|Overall Study|Withdrawal by Subject|0|||
41947896|NCT02132754|75712568|FG033|Overall Study|Withdrawal by Subject|2|||
41947897|NCT02151786|75712678|FG000|Overall Study|Unavailability of Case Report Form|26|||
41947898|NCT02151786|75712678|FG000|Overall Study|Outside the Contract Period|1|||
41947899|NCT02151786|75712678|FG000|Overall Study|Randomized, not Treated|1|||
41947900|NCT02151786|75712678|FG000|Overall Study|Unavailability of Information|8|||
41947901|NCT02132130|75712686|FG000|Overall Study|Lost to Follow-up|0|||
41947902|NCT02132130|75712687|FG001|Overall Study|Lost to Follow-up|2|||
41947903|NCT02132130|75712688|FG002|Overall Study|Lost to Follow-up|0|||
41947904|NCT02132130|75712689|FG003|Overall Study|Lost to Follow-up|0|||
41947905|NCT02132130|75712686|FG000|Overall Study|Withdrawal by Subject|0|||
41947906|NCT02132130|75712687|FG001|Overall Study|Withdrawal by Subject|0|||
41947907|NCT02132130|75712688|FG002|Overall Study|Withdrawal by Subject|0|||
41947908|NCT02132130|75712689|FG003|Overall Study|Withdrawal by Subject|1|||
41947909|NCT02131662|75712708|FG000|Overall Study|Protocol Violation|1|||
41947910|NCT02131662|75712709|FG001|Overall Study|Protocol Violation|0|||
41947911|NCT02131662|75712710|FG002|Overall Study|Protocol Violation|0|||
41947912|NCT02131662|75712711|FG003|Overall Study|Protocol Violation|0|||
41947913|NCT02131662|75712712|FG004|Overall Study|Protocol Violation|0|||
41947914|NCT02131662|75712708|FG000|Overall Study|Other|2|||
41947915|NCT02131662|75712709|FG001|Overall Study|Other|4|||
41947916|NCT02131662|75712710|FG002|Overall Study|Other|3|||
41947917|NCT02131662|75712711|FG003|Overall Study|Other|3|||
41947918|NCT02131662|75712712|FG004|Overall Study|Other|4|||
41947919|NCT02131662|75712708|FG000|Overall Study|Adverse Event|0|||
41947920|NCT02131662|75712709|FG001|Overall Study|Adverse Event|1|||
41947921|NCT02131662|75712710|FG002|Overall Study|Adverse Event|1|||
41947922|NCT02131662|75712711|FG003|Overall Study|Adverse Event|1|||
41947923|NCT02131662|75712712|FG004|Overall Study|Adverse Event|3|||
41947924|NCT02131662|75712708|FG000|Overall Study|Pregnancy|0|||
41947925|NCT02131662|75712709|FG001|Overall Study|Pregnancy|1|||
42023664|NCT01022853|75831015|FG003|Overall Study|Other not stated above|0|||
42023665|NCT01022853|75831016|FG004|Overall Study|Other not stated above|0|||
41947926|NCT02131662|75712710|FG002|Overall Study|Pregnancy|0|||
41947927|NCT02131662|75712711|FG003|Overall Study|Pregnancy|1|||
41947928|NCT02131662|75712712|FG004|Overall Study|Pregnancy|0|||
41947929|NCT02131662|75712708|FG000|Overall Study|Wish for pregnancy|0|||
42023666|NCT01034709|75831033|FG000|Overall Study|Protocol Violation|9|||
41947930|NCT02131662|75712709|FG001|Overall Study|Wish for pregnancy|0|||
41947931|NCT02131662|75712710|FG002|Overall Study|Wish for pregnancy|0|||
41947932|NCT02131662|75712711|FG003|Overall Study|Wish for pregnancy|0|||
41947933|NCT02131662|75712712|FG004|Overall Study|Wish for pregnancy|1|||
41947934|NCT02131662|75712708|FG000|Overall Study|Lack of Efficacy|1|||
41947935|NCT02131662|75712709|FG001|Overall Study|Lack of Efficacy|0|||
41947936|NCT02131662|75712710|FG002|Overall Study|Lack of Efficacy|0|||
41947937|NCT02131662|75712711|FG003|Overall Study|Lack of Efficacy|0|||
41947938|NCT02131662|75712712|FG004|Overall Study|Lack of Efficacy|1|||
41947939|NCT02131662|75712708|FG000|Overall Study|Withdrawal by Subject|1|||
41947940|NCT02131662|75712709|FG001|Overall Study|Withdrawal by Subject|5|||
41947941|NCT02131662|75712710|FG002|Overall Study|Withdrawal by Subject|1|||
41947942|NCT02131662|75712711|FG003|Overall Study|Withdrawal by Subject|5|||
41947943|NCT02131662|75712712|FG004|Overall Study|Withdrawal by Subject|6|||
41947944|NCT02131662|75712708|FG000|Overall Study|Lost to Follow-up|1|||
41947945|NCT02131662|75712709|FG001|Overall Study|Lost to Follow-up|3|||
41947946|NCT02131662|75712710|FG002|Overall Study|Lost to Follow-up|0|||
41947947|NCT02131662|75712711|FG003|Overall Study|Lost to Follow-up|9|||
41947948|NCT02131662|75712712|FG004|Overall Study|Lost to Follow-up|0|||
41947949|NCT02131662|75712708|FG000|Overall Study|Not treated|2|||
41947950|NCT02131662|75712709|FG001|Overall Study|Not treated|0|||
41947951|NCT02131662|75712710|FG002|Overall Study|Not treated|2|||
41947952|NCT02131662|75712711|FG003|Overall Study|Not treated|2|||
41947953|NCT02131662|75712712|FG004|Overall Study|Not treated|3|||
41947954|NCT02106156|75712731|FG000|Overall Study|Patient Died|19|||
41947955|NCT02106156|75712732|FG001|Overall Study|Patient Died|0|||
41947956|NCT02106156|75712733|FG002|Overall Study|Patient Died|0|||
41947957|NCT02106156|75712731|FG000|Overall Study|Lack of Tolerability|305|||
41947958|NCT02106156|75712732|FG001|Overall Study|Lack of Tolerability|3|||
41947959|NCT02106156|75712733|FG002|Overall Study|Lack of Tolerability|0|||
41947960|NCT02106156|75712731|FG000|Overall Study|Lack of Virological Response|1044|||
41947961|NCT02106156|75712732|FG001|Overall Study|Lack of Virological Response|8|||
41947962|NCT02106156|75712733|FG002|Overall Study|Lack of Virological Response|0|||
41947963|NCT02106156|75712731|FG000|Overall Study|Concomitant Disease|74|||
41947964|NCT02106156|75712732|FG001|Overall Study|Concomitant Disease|2|||
41947965|NCT02106156|75712733|FG002|Overall Study|Concomitant Disease|0|||
41947966|NCT02106156|75712731|FG000|Overall Study|Lack of Compliance|211|||
41947967|NCT02106156|75712732|FG001|Overall Study|Lack of Compliance|7|||
41947968|NCT02106156|75712733|FG002|Overall Study|Lack of Compliance|0|||
41947969|NCT02106156|75712731|FG000|Overall Study|Patients Request|307|||
41947970|NCT02106156|75712732|FG001|Overall Study|Patients Request|9|||
41947971|NCT02106156|75712733|FG002|Overall Study|Patients Request|0|||
41947972|NCT02106156|75712731|FG000|Overall Study|Lost to Follow-up|451|||
41947973|NCT02106156|75712732|FG001|Overall Study|Lost to Follow-up|8|||
41947974|NCT02106156|75712733|FG002|Overall Study|Lost to Follow-up|0|||
41947975|NCT02106156|75712731|FG000|Overall Study|Unplanned Event|82|||
41947976|NCT02106156|75712732|FG001|Overall Study|Unplanned Event|2|||
41947977|NCT02106156|75712733|FG002|Overall Study|Unplanned Event|0|||
41947978|NCT02106156|75712731|FG000|Overall Study|Change of Laboratory Parameter|10|||
41947979|NCT02106156|75712732|FG001|Overall Study|Change of Laboratory Parameter|0|||
41947980|NCT02106156|75712733|FG002|Overall Study|Change of Laboratory Parameter|0|||
41947981|NCT02106156|75712731|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
41947982|NCT02106156|75712732|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
41947983|NCT02106156|75712733|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
41947984|NCT02106156|75712731|FG000|Overall Study|Relocation/Change of Physician|40|||
41947985|NCT02106156|75712732|FG001|Overall Study|Relocation/Change of Physician|1|||
41947986|NCT02106156|75712733|FG002|Overall Study|Relocation/Change of Physician|0|||
41947987|NCT01598610|75712759|FG000|Overall Study|Adverse Event|1|||
41947988|NCT01625988|75712765|FG000|Overall Study|Lost to Follow-up|5|||
41947989|NCT01625988|75712766|FG001|Overall Study|Lost to Follow-up|6|||
41947990|NCT01625988|75712765|FG000|Overall Study|Withdrawal by Subject|8|||
41947991|NCT01625988|75712766|FG001|Overall Study|Withdrawal by Subject|3|||
41947992|NCT01625988|75712765|FG000|Overall Study|Adverse Event|0|||
41947993|NCT01625988|75712766|FG001|Overall Study|Adverse Event|1|||
41947994|NCT01625988|75712765|FG000|Overall Study|Lack of Efficacy|0|||
41947995|NCT01625988|75712766|FG001|Overall Study|Lack of Efficacy|1|||
42023667|NCT01034709|75831034|FG001|Overall Study|Protocol Violation|16|||
42023668|NCT00937768|75831042|FG000|Overall Study|Refused Further Treatment|3|||
42023669|NCT00937768|75831043|FG001|Overall Study|Refused Further Treatment|2|||
41947996|NCT01625988|75712765|FG000|Overall Study|Randomized Inappropriately|1|||
41947997|NCT01625988|75712766|FG001|Overall Study|Randomized Inappropriately|0|||
41947998|NCT01625988|75712765|FG000|Overall Study|Protocol Violation|0|||
41947999|NCT01625988|75712766|FG001|Overall Study|Protocol Violation|2|||
41948000|NCT02131272|75712777|FG000|Overall Study|Withdrawal by parent|0|||
41948001|NCT02131272|75712778|FG001|Overall Study|Withdrawal by parent|1|||
42023670|NCT00937768|75831042|FG000|Overall Study|Disease Progression|1|||
41948002|NCT02131272|75712777|FG000|Overall Study|Withdrawal by Subject|0|||
41948003|NCT02131272|75712778|FG001|Overall Study|Withdrawal by Subject|1|||
41948004|NCT02131272|75712777|FG000|Overall Study|Withdrawal Criteria|1|||
41948005|NCT02131272|75712778|FG001|Overall Study|Withdrawal Criteria|0|||
41948006|NCT02130882|75712786|FG000|Overall Study|Withdrawal by Subject|0|||
41948007|NCT02130882|75712787|FG001|Overall Study|Withdrawal by Subject|1|||
41948008|NCT02130570|75712795|FG000|Overall Study|Death|3|||
41948009|NCT02130570|75712796|FG001|Overall Study|Death|5|||
41948010|NCT02130570|75712795|FG000|Overall Study|Withdrawal by Subject|6|||
41948011|NCT02130570|75712796|FG001|Overall Study|Withdrawal by Subject|3|||
41948012|NCT02130570|75712795|FG000|Overall Study|Part of practice that discontinued study|0|||
41948013|NCT02130570|75712796|FG001|Overall Study|Part of practice that discontinued study|5|||
41948014|NCT02149836|75712803|FG000|Overall Study|Withdrawal by Subject|1|||
41948015|NCT02130024|75712809|FG000|Overall Study|Adverse Event|10|||
41948016|NCT02130024|75712810|FG001|Overall Study|Adverse Event|11|||
41948017|NCT02130024|75712809|FG000|Overall Study|Death|2|||
41948018|NCT02130024|75712810|FG001|Overall Study|Death|2|||
41948019|NCT02130024|75712809|FG000|Overall Study|Lost to Follow-up|1|||
41948020|NCT02130024|75712810|FG001|Overall Study|Lost to Follow-up|1|||
41948021|NCT02130024|75712809|FG000|Overall Study|Physician Decision|1|||
41948022|NCT02130024|75712810|FG001|Overall Study|Physician Decision|3|||
41948023|NCT02130024|75712809|FG000|Overall Study|Protocol Deviation|4|||
41948024|NCT02130024|75712810|FG001|Overall Study|Protocol Deviation|0|||
41948025|NCT02130024|75712809|FG000|Overall Study|Site Administration Problems|1|||
41948026|NCT02130024|75712810|FG001|Overall Study|Site Administration Problems|0|||
41948027|NCT02130024|75712809|FG000|Overall Study|Subject Withdrew Consent|6|||
41948028|NCT02130024|75712810|FG001|Overall Study|Subject Withdrew Consent|14|||
41948029|NCT02105688|75712818|FG000|Part A: Double-Blind|Adverse Event|1|||
41948030|NCT02105688|75712819|FG001|Part A: Double-Blind|Adverse Event|0|||
41948031|NCT02105688|75712818|FG000|Part A: Double-Blind|Death|0|||
41948032|NCT02105688|75712819|FG001|Part A: Double-Blind|Death|1|||
41948033|NCT02105688|75712818|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
41948034|NCT02105688|75712819|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
41948035|NCT02105688|75712818|FG000|Part A: Double-Blind|Physician Decision|0|||
41948036|NCT02105688|75712819|FG001|Part A: Double-Blind|Physician Decision|1|||
41948037|NCT02105688|75712818|FG000|Part A: Double-Blind|Status Unknown|0|||
41948038|NCT02105688|75712819|FG001|Part A: Double-Blind|Status Unknown|2|||
41948039|NCT02105688|75712818|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
41948040|NCT02105688|75712819|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
41948041|NCT02105688|75712818|FG000|Part B: Observational Follow-up|Death|2|||
41948042|NCT02105688|75712819|FG001|Part B: Observational Follow-up|Death|1|||
41948043|NCT02105688|75712818|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
41948044|NCT02105688|75712819|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
41948045|NCT02105688|75712818|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
41948046|NCT02105688|75712819|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
41948047|NCT02105688|75712818|FG000|Part B: Observational Follow-up|Physician Decision|3|||
41948048|NCT02105688|75712819|FG001|Part B: Observational Follow-up|Physician Decision|1|||
41948049|NCT02105454|75712826|FG000|Overall Study|Withdrawal by Subject|1|||
41948050|NCT01625910|75712832|FG000|Overall Study|Lost to Follow-up|3|||
41948051|NCT01625910|75712833|FG001|Overall Study|Lost to Follow-up|4|||
41948052|NCT02104752|75712843|FG000|Overall Study|Withdrawal by Subject|1|||
41948053|NCT02104752|75712844|FG001|Overall Study|Withdrawal by Subject|0|||
41948054|NCT02104752|75712843|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
41948055|NCT02104752|75712844|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
41948056|NCT02102724|75712852|FG000|Overall Study|Lost to Follow-up|1|||
41948057|NCT02102724|75712853|FG001|Overall Study|Lost to Follow-up|0|||
41948058|NCT02102724|75712852|FG000|Overall Study|surgery for brain aneurysm|1|||
41948059|NCT02102724|75712853|FG001|Overall Study|surgery for brain aneurysm|1|||
41948060|NCT02102490|75712859|FG000|Overall Study|Death|6|||
41948061|NCT02102490|75712859|FG000|Overall Study|Lost to Follow-up|1|||
41948062|NCT02101554|75712866|FG000|Overall Study|Protocol Violation|0|||
41948063|NCT02101554|75712867|FG001|Overall Study|Protocol Violation|1|||
41948064|NCT02101554|75712868|FG002|Overall Study|Protocol Violation|0|||
41948065|NCT02101554|75712866|FG000|Overall Study|Insufficient Clinical Response|0|||
41948066|NCT02101554|75712867|FG001|Overall Study|Insufficient Clinical Response|2|||
41948067|NCT02101554|75712868|FG002|Overall Study|Insufficient Clinical Response|0|||
41948068|NCT02101554|75712866|FG000|Overall Study|Adverse Event|2|||
41948069|NCT02101554|75712867|FG001|Overall Study|Adverse Event|1|||
41948070|NCT02101554|75712868|FG002|Overall Study|Adverse Event|1|||
41948071|NCT02101554|75712866|FG000|Overall Study|Lost to Follow-up|0|||
41948072|NCT02101554|75712867|FG001|Overall Study|Lost to Follow-up|1|||
41948073|NCT02101554|75712868|FG002|Overall Study|Lost to Follow-up|0|||
41948074|NCT02101554|75712866|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
41948075|NCT02101554|75712867|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
41948076|NCT02101554|75712868|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
41948077|NCT02128932|75712879|FG000|Overall Study|Withdrawal by Subject|11|||
41948078|NCT02128932|75712880|FG001|Overall Study|Withdrawal by Subject|7|||
41948079|NCT02128932|75712881|FG002|Overall Study|Withdrawal by Subject|8|||
41948080|NCT02128932|75712879|FG000|Overall Study|Death|2|||
41948081|NCT02128932|75712880|FG001|Overall Study|Death|0|||
41948082|NCT02128932|75712881|FG002|Overall Study|Death|2|||
41948083|NCT02128932|75712879|FG000|Overall Study|Lost to Follow-up|2|||
41948084|NCT02128932|75712880|FG001|Overall Study|Lost to Follow-up|1|||
41948085|NCT02128932|75712881|FG002|Overall Study|Lost to Follow-up|1|||
41948086|NCT02128932|75712879|FG000|Overall Study|No reason for withdrawal|12|||
41948087|NCT02128932|75712880|FG001|Overall Study|No reason for withdrawal|11|||
41948088|NCT02128932|75712881|FG002|Overall Study|No reason for withdrawal|7|||
41948089|NCT02128542|75712891|FG000|Overall Study|Lost to Follow-up|3|||
41948090|NCT02128542|75712892|FG001|Overall Study|Lost to Follow-up|0|||
41948091|NCT02128542|75712891|FG000|Overall Study|Withdrew Consent|1|||
41948092|NCT02128542|75712892|FG001|Overall Study|Withdrew Consent|0|||
41948093|NCT02127372|75712902|FG000|Overall Study|Withdrawal by Subject|1|||
41948094|NCT02127372|75712903|FG001|Overall Study|Withdrawal by Subject|0|||
41948095|NCT02126826|75712917|FG000|Overall Study|Withdrawal by Subject|0|||
41948096|NCT02126826|75712918|FG001|Overall Study|Withdrawal by Subject|0|||
41948097|NCT02126826|75712919|FG002|Overall Study|Withdrawal by Subject|0|||
41948098|NCT02126826|75712920|FG003|Overall Study|Withdrawal by Subject|1|||
42023671|NCT00937768|75831043|FG001|Overall Study|Disease Progression|1|||
42023672|NCT00937768|75831042|FG000|Overall Study|Alternate Treatment|0|||
42023673|NCT00937768|75831043|FG001|Overall Study|Alternate Treatment|1|||
42023674|NCT00937768|75831042|FG000|Overall Study|No Further Funding|4|||
42023675|NCT00937768|75831043|FG001|Overall Study|No Further Funding|4|||
41948099|NCT02126826|75712921|FG004|Overall Study|Withdrawal by Subject|0|||
41948100|NCT02126826|75712922|FG005|Overall Study|Withdrawal by Subject|0|||
41948101|NCT02126826|75712923|FG006|Overall Study|Withdrawal by Subject|0|||
41948102|NCT02126670|75712948|FG000|Overall Study|Withdrawal by Subject|1|||
41948103|NCT02126670|75712949|FG001|Overall Study|Withdrawal by Subject|0|||
41948104|NCT02126670|75712950|FG002|Overall Study|Withdrawal by Subject|0|||
41948105|NCT02126670|75712951|FG003|Overall Study|Withdrawal by Subject|1|||
41948106|NCT02125734|75712963|FG000|Period 2|Adverse Event|0|||
41948107|NCT02125734|75712964|FG001|Period 2|Adverse Event|1|||
41948108|NCT02124798|75712970|FG000|Overall Study|Adverse Event|3|||
41948109|NCT02124798|75712970|FG000|Overall Study|Lost to Follow-up|1|||
41948110|NCT02146326|75712978|FG000|Overall Study|Lost to Follow-up|3|||
41948111|NCT02146326|75712979|FG001|Overall Study|Lost to Follow-up|3|||
41948112|NCT02146326|75712980|FG002|Overall Study|Lost to Follow-up|11|||
41948113|NCT02146326|75712981|FG003|Overall Study|Lost to Follow-up|19|||
41948114|NCT02146326|75712978|FG000|Overall Study|Withdrawal by Subject|2|||
41948115|NCT02146326|75712979|FG001|Overall Study|Withdrawal by Subject|1|||
41948116|NCT02146326|75712980|FG002|Overall Study|Withdrawal by Subject|15|||
41948117|NCT02146326|75712981|FG003|Overall Study|Withdrawal by Subject|11|||
41948118|NCT02146326|75712978|FG000|Overall Study|Separated from mental health center|23|||
41948119|NCT02146326|75712979|FG001|Overall Study|Separated from mental health center|33|||
41948120|NCT02146326|75712980|FG002|Overall Study|Separated from mental health center|0|||
41948121|NCT02146326|75712981|FG003|Overall Study|Separated from mental health center|0|||
41948122|NCT02146326|75712978|FG000|Overall Study|Incarcerated|0|||
41948123|NCT02146326|75712979|FG001|Overall Study|Incarcerated|0|||
41948124|NCT02146326|75712980|FG002|Overall Study|Incarcerated|3|||
41948125|NCT02146326|75712981|FG003|Overall Study|Incarcerated|8|||
41948126|NCT02146326|75712978|FG000|Overall Study|Death|0|||
41948127|NCT02146326|75712979|FG001|Overall Study|Death|0|||
41948128|NCT02146326|75712980|FG002|Overall Study|Death|4|||
41948129|NCT02146326|75712981|FG003|Overall Study|Death|4|||
41948130|NCT02146326|75712978|FG000|Overall Study|Unable to complete interview|0|||
41948131|NCT02146326|75712979|FG001|Overall Study|Unable to complete interview|0|||
41948132|NCT02146326|75712980|FG002|Overall Study|Unable to complete interview|10|||
41948133|NCT02146326|75712981|FG003|Overall Study|Unable to complete interview|6|||
41948134|NCT02146248|75712997|FG000|Overall Study|Withdrawal by Subject|2|||
41948135|NCT02145468|75713007|FG000|Overall Study|Withdrawal by Subject|5|||
41948136|NCT02145468|75713008|FG001|Overall Study|Withdrawal by Subject|8|||
41948137|NCT02124564|75713014|FG000|Treatment Period|Adverse Event|2|||
41948138|NCT02124564|75713014|FG000|Treatment Period|Lack of Efficacy|3|||
41948139|NCT02124564|75713014|FG000|Treatment Period|Withdrawal by Subject|2|||
41948140|NCT02145390|75713019|FG000|Overall Study|Withdrawal by Subject|1|||
41948141|NCT02100696|75713029|FG000|Induction Phase|Adverse Event|0|||
41948142|NCT02100696|75713030|FG001|Induction Phase|Adverse Event|0|||
41948143|NCT02100696|75713031|FG002|Induction Phase|Adverse Event|1|||
41948144|NCT02100696|75713032|FG003|Induction Phase|Adverse Event|0|||
41948145|NCT02100696|75713033|FG004|Induction Phase|Adverse Event|0|||
42023676|NCT00940888|75831049|FG000|Overall Study|Unsuccessful Implant|4|||
42023677|NCT00940888|75831049|FG000|Overall Study|Death|461|||
42023678|NCT00940888|75831049|FG000|Overall Study|Withdrawn - Non-Death|364|||
41948146|NCT02100696|75713034|FG005|Induction Phase|Adverse Event|0|||
41948147|NCT02100696|75713029|FG000|Induction Phase|Lost to Follow-up|1|||
41948148|NCT02100696|75713030|FG001|Induction Phase|Lost to Follow-up|0|||
42023679|NCT00940888|75831049|FG000|Overall Study|Lost to Follow-up|6|||
41948149|NCT02100696|75713031|FG002|Induction Phase|Lost to Follow-up|1|||
41948150|NCT02100696|75713032|FG003|Induction Phase|Lost to Follow-up|0|||
41948151|NCT02100696|75713033|FG004|Induction Phase|Lost to Follow-up|0|||
41948152|NCT02100696|75713034|FG005|Induction Phase|Lost to Follow-up|0|||
41948153|NCT02100696|75713029|FG000|Induction Phase|Protocol Violation|0|||
41948154|NCT02100696|75713030|FG001|Induction Phase|Protocol Violation|1|||
41948155|NCT02100696|75713031|FG002|Induction Phase|Protocol Violation|1|||
41948156|NCT02100696|75713032|FG003|Induction Phase|Protocol Violation|0|||
41948157|NCT02100696|75713033|FG004|Induction Phase|Protocol Violation|0|||
41948158|NCT02100696|75713034|FG005|Induction Phase|Protocol Violation|0|||
41948159|NCT02100696|75713029|FG000|Induction Phase|Withdrawal by Subject|8|||
41948160|NCT02100696|75713030|FG001|Induction Phase|Withdrawal by Subject|2|||
41948161|NCT02100696|75713031|FG002|Induction Phase|Withdrawal by Subject|13|||
41948162|NCT02100696|75713032|FG003|Induction Phase|Withdrawal by Subject|0|||
41948163|NCT02100696|75713033|FG004|Induction Phase|Withdrawal by Subject|0|||
41948164|NCT02100696|75713034|FG005|Induction Phase|Withdrawal by Subject|0|||
41948165|NCT02100696|75713029|FG000|Induction Phase|Physician Decision|1|||
41948166|NCT02100696|75713030|FG001|Induction Phase|Physician Decision|0|||
41948167|NCT02100696|75713031|FG002|Induction Phase|Physician Decision|2|||
41948168|NCT02100696|75713032|FG003|Induction Phase|Physician Decision|0|||
41948169|NCT02100696|75713033|FG004|Induction Phase|Physician Decision|0|||
41948170|NCT02100696|75713034|FG005|Induction Phase|Physician Decision|0|||
41948171|NCT02100696|75713029|FG000|Induction Phase|Multiple Reasons|5|||
41948172|NCT02100696|75713030|FG001|Induction Phase|Multiple Reasons|2|||
41948173|NCT02100696|75713031|FG002|Induction Phase|Multiple Reasons|8|||
41948174|NCT02100696|75713032|FG003|Induction Phase|Multiple Reasons|0|||
41948175|NCT02100696|75713033|FG004|Induction Phase|Multiple Reasons|0|||
41948176|NCT02100696|75713034|FG005|Induction Phase|Multiple Reasons|0|||
41948177|NCT02100696|75713029|FG000|Maintenance Phase|Adverse Event|0|||
41948178|NCT02100696|75713030|FG001|Maintenance Phase|Adverse Event|0|||
41948179|NCT02100696|75713031|FG002|Maintenance Phase|Adverse Event|0|||
41948180|NCT02100696|75713032|FG003|Maintenance Phase|Adverse Event|0|||
41948181|NCT02100696|75713033|FG004|Maintenance Phase|Adverse Event|0|||
41948182|NCT02100696|75713034|FG005|Maintenance Phase|Adverse Event|2|||
41948183|NCT02100696|75713029|FG000|Maintenance Phase|Lost to Follow-up|0|||
41948184|NCT02100696|75713030|FG001|Maintenance Phase|Lost to Follow-up|0|||
41948185|NCT02100696|75713031|FG002|Maintenance Phase|Lost to Follow-up|0|||
41948186|NCT02100696|75713032|FG003|Maintenance Phase|Lost to Follow-up|0|||
41948187|NCT02100696|75713033|FG004|Maintenance Phase|Lost to Follow-up|1|||
41948188|NCT02100696|75713034|FG005|Maintenance Phase|Lost to Follow-up|0|||
41948189|NCT02100696|75713029|FG000|Maintenance Phase|Protocol Violation|0|||
41948190|NCT02100696|75713030|FG001|Maintenance Phase|Protocol Violation|0|||
41948191|NCT02100696|75713031|FG002|Maintenance Phase|Protocol Violation|0|||
41948192|NCT02100696|75713032|FG003|Maintenance Phase|Protocol Violation|0|||
41948193|NCT02100696|75713033|FG004|Maintenance Phase|Protocol Violation|1|||
41948194|NCT02100696|75713034|FG005|Maintenance Phase|Protocol Violation|0|||
41948195|NCT02100696|75713029|FG000|Maintenance Phase|Withdrawal by Subject|0|||
41948196|NCT02100696|75713030|FG001|Maintenance Phase|Withdrawal by Subject|0|||
41948197|NCT02100696|75713031|FG002|Maintenance Phase|Withdrawal by Subject|0|||
41948198|NCT02100696|75713032|FG003|Maintenance Phase|Withdrawal by Subject|1|||
41948199|NCT02100696|75713033|FG004|Maintenance Phase|Withdrawal by Subject|4|||
41948200|NCT02100696|75713034|FG005|Maintenance Phase|Withdrawal by Subject|2|||
41948201|NCT02100696|75713029|FG000|Maintenance Phase|Physician Decision|0|||
41948202|NCT02100696|75713030|FG001|Maintenance Phase|Physician Decision|0|||
41948203|NCT02100696|75713031|FG002|Maintenance Phase|Physician Decision|0|||
41948204|NCT02100696|75713032|FG003|Maintenance Phase|Physician Decision|0|||
41948205|NCT02100696|75713033|FG004|Maintenance Phase|Physician Decision|1|||
41948206|NCT02100696|75713034|FG005|Maintenance Phase|Physician Decision|0|||
41948207|NCT02100696|75713029|FG000|Maintenance Phase|Multiple Reasons|0|||
41948208|NCT02100696|75713030|FG001|Maintenance Phase|Multiple Reasons|0|||
41948209|NCT02100696|75713031|FG002|Maintenance Phase|Multiple Reasons|0|||
41948210|NCT02100696|75713032|FG003|Maintenance Phase|Multiple Reasons|0|||
41948211|NCT02100696|75713033|FG004|Maintenance Phase|Multiple Reasons|2|||
41948212|NCT02100696|75713034|FG005|Maintenance Phase|Multiple Reasons|1|||
41948213|NCT02145156|75713058|FG000|Overall Study|No match to vaccination records|60|||
41948214|NCT02145156|75713059|FG001|Overall Study|No match to vaccination records|52|||
41948215|NCT02145156|75713060|FG002|Overall Study|No match to vaccination records|41|||
42023680|NCT01189266|75831056|FG000|Overall Study|Adverse Event|1|||
41948216|NCT02123472|75713068|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
41948217|NCT02123472|75713069|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
41948218|NCT02145078|75713075|FG000|Overall Study|Death|1|||
41948219|NCT02145078|75713075|FG000|Overall Study|Reason not given|3|||
41948220|NCT02144610|75713081|FG000|Overall Study|Physician Decision|1|||
41948221|NCT02144610|75713082|FG001|Overall Study|Physician Decision|0|||
41948222|NCT02144610|75713081|FG000|Overall Study|Withdrawal by Subject|1|||
41948223|NCT02144610|75713082|FG001|Overall Study|Withdrawal by Subject|5|||
41948224|NCT02144610|75713081|FG000|Overall Study|Death|2|||
41948225|NCT02144610|75713082|FG001|Overall Study|Death|2|||
41948226|NCT02144610|75713081|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
41948227|NCT02144610|75713082|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
41948228|NCT02144610|75713081|FG000|Overall Study|Other|0|||
41948229|NCT02144610|75713082|FG001|Overall Study|Other|1|||
41948230|NCT02100228|75713090|FG000|Overall Study|Other|19|||
41948231|NCT02100228|75713091|FG001|Overall Study|Other|19|||
41948232|NCT02100228|75713090|FG000|Overall Study|Administrative reason|0|||
41948233|NCT02100228|75713091|FG001|Overall Study|Administrative reason|1|||
41948234|NCT02100228|75713090|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
41948235|NCT02100228|75713091|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
41948236|NCT02100228|75713090|FG000|Overall Study|Non-compliance|0|||
41948237|NCT02100228|75713091|FG001|Overall Study|Non-compliance|3|||
41948238|NCT02100228|75713090|FG000|Overall Study|Lost to Follow-up|0|||
41948239|NCT02100228|75713091|FG001|Overall Study|Lost to Follow-up|1|||
41948240|NCT02100228|75713090|FG000|Overall Study|Withdrawal by Subject|27|||
41948241|NCT02100228|75713091|FG001|Overall Study|Withdrawal by Subject|37|||
41948242|NCT02100228|75713090|FG000|Overall Study|Adverse Event|16|||
41948243|NCT02100228|75713091|FG001|Overall Study|Adverse Event|12|||
41948244|NCT02100228|75713090|FG000|Overall Study|Death|1|||
41948245|NCT02100228|75713091|FG001|Overall Study|Death|1|||
41948246|NCT02099838|75713099|FG000|Overall Study|Death|1|||
41948247|NCT02099838|75713100|FG001|Overall Study|Death|0|||
41948248|NCT02099838|75713099|FG000|Overall Study|Lost to Follow-up|3|||
41948249|NCT02099838|75713100|FG001|Overall Study|Lost to Follow-up|1|||
41948250|NCT02099838|75713099|FG000|Overall Study|Withdrawal by Subject|0|||
41948251|NCT02099838|75713100|FG001|Overall Study|Withdrawal by Subject|1|||
41948252|NCT02144220|75713106|FG000|Overall Study|technology incompatibility|9|||
41948253|NCT02144220|75713106|FG000|Overall Study|Lack of Efficacy|4|||
41948254|NCT02144220|75713106|FG000|Overall Study|Physician Decision|3|||
41948255|NCT02144220|75713106|FG000|Overall Study|Withdrawal by Subject|2|||
41948256|NCT02144220|75713106|FG000|Overall Study|Protocol Violation|1|||
41948257|NCT02099682|75713110|FG000|Overall Study|Data Not Available|51|||
41948258|NCT02099682|75713110|FG000|Overall Study|Lost to Follow-up|31|||
42023681|NCT01189266|75831057|FG001|Overall Study|Adverse Event|0|||
41948259|NCT02099682|75713110|FG000|Overall Study|Other|29|||
41948260|NCT02142894|75713114|FG000|Overall Study|Protocol Violation|8|||
41948261|NCT02098746|75713118|FG000|Overall Study|Changes of Investigator|2|||
41948262|NCT02098746|75713118|FG000|Overall Study|Other Miscellaneous Reasons|1|||
41948263|NCT02098746|75713118|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
41948264|NCT02098746|75713118|FG000|Overall Study|Data Not Available After Treatment|1|||
41948265|NCT02122770|75713126|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
41948266|NCT02122770|75713127|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
41948267|NCT02122770|75713128|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
41948268|NCT02122770|75713129|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
41948269|NCT02122770|75713130|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
41948270|NCT02122770|75713131|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
41948271|NCT02122770|75713126|FG000|Part A: Drug-drug Interaction 2|Other|0|||
41948272|NCT02122770|75713127|FG001|Part A: Drug-drug Interaction 2|Other|0|||
41948273|NCT02122770|75713128|FG002|Part A: Drug-drug Interaction 2|Other|1|||
41948274|NCT02122770|75713129|FG003|Part A: Drug-drug Interaction 2|Other|0|||
41948275|NCT02122770|75713130|FG004|Part A: Drug-drug Interaction 2|Other|0|||
41948276|NCT02122770|75713131|FG005|Part A: Drug-drug Interaction 2|Other|0|||
41948277|NCT02122770|75713126|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
41948278|NCT02122770|75713127|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
41948279|NCT02122770|75713128|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
41948280|NCT02122770|75713129|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
41948281|NCT02122770|75713130|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
41948282|NCT02122770|75713131|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
41948283|NCT02122770|75713126|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
41948284|NCT02122770|75713127|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
41948285|NCT02122770|75713128|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
41948286|NCT02122770|75713129|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
41948287|NCT02122770|75713130|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
41948288|NCT02122770|75713131|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
41948289|NCT02122770|75713126|FG000|Part B: Standard of Care|Adverse Event|0|||
41948290|NCT02122770|75713127|FG001|Part B: Standard of Care|Adverse Event|0|||
41948291|NCT02122770|75713128|FG002|Part B: Standard of Care|Adverse Event|0|||
41948292|NCT02122770|75713129|FG003|Part B: Standard of Care|Adverse Event|0|||
41948293|NCT02122770|75713130|FG004|Part B: Standard of Care|Adverse Event|4|||
41948294|NCT02122770|75713131|FG005|Part B: Standard of Care|Adverse Event|1|||
41948295|NCT02122770|75713126|FG000|Part B: Standard of Care|Other|0|||
41948296|NCT02122770|75713127|FG001|Part B: Standard of Care|Other|0|||
41948297|NCT02122770|75713128|FG002|Part B: Standard of Care|Other|0|||
41948298|NCT02122770|75713129|FG003|Part B: Standard of Care|Other|0|||
41948299|NCT02122770|75713130|FG004|Part B: Standard of Care|Other|0|||
41948300|NCT02122770|75713131|FG005|Part B: Standard of Care|Other|2|||
41948301|NCT02122770|75713126|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
41948302|NCT02122770|75713127|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
41948303|NCT02122770|75713128|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
41948304|NCT02122770|75713129|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
41948305|NCT02122770|75713130|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
41948306|NCT02122770|75713131|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
41948307|NCT02122770|75713126|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
41948308|NCT02122770|75713127|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
41948309|NCT02122770|75713128|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
41948310|NCT02122770|75713129|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
41948311|NCT02122770|75713130|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
41948312|NCT02122770|75713131|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
41948313|NCT02122770|75713126|FG000|Part B: Standard of Care|Progressive Disease|0|||
41948314|NCT02122770|75713127|FG001|Part B: Standard of Care|Progressive Disease|0|||
41948315|NCT02122770|75713128|FG002|Part B: Standard of Care|Progressive Disease|0|||
41948316|NCT02122770|75713129|FG003|Part B: Standard of Care|Progressive Disease|0|||
41948317|NCT02122770|75713130|FG004|Part B: Standard of Care|Progressive Disease|10|||
41948318|NCT02122770|75713131|FG005|Part B: Standard of Care|Progressive Disease|8|||
41948319|NCT02122380|75713156|FG000|First Intervention (30 Days)|Adverse Event|1|||
41948320|NCT02122380|75713157|FG001|First Intervention (30 Days)|Adverse Event|0|||
41948321|NCT02122380|75713156|FG000|First Intervention (30 Days)|Physician Decision|0|||
41948322|NCT02122380|75713157|FG001|First Intervention (30 Days)|Physician Decision|1|||
41948323|NCT02122380|75713156|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
41948324|NCT02122380|75713157|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
41948325|NCT02122380|75713156|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
41948326|NCT02122380|75713157|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
41948327|NCT02122380|75713156|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
41948328|NCT02122380|75713157|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
41948329|NCT02122146|75713172|FG000|Part 1: Dose Escalation|Death|0|||
41948330|NCT02122146|75713173|FG001|Part 1: Dose Escalation|Death|1|||
41948331|NCT02122146|75713174|FG002|Part 1: Dose Escalation|Death|1|||
41948332|NCT02122146|75713175|FG003|Part 1: Dose Escalation|Death|0|||
41948333|NCT02122146|75713176|FG004|Part 1: Dose Escalation|Death|0|||
41948334|NCT02122146|75713177|FG005|Part 1: Dose Escalation|Death|0|||
41948335|NCT02122146|75713178|FG006|Part 1: Dose Escalation|Death|0|||
41948336|NCT02122146|75713179|FG007|Part 1: Dose Escalation|Death|0|||
41948337|NCT02122146|75713172|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
41948338|NCT02122146|75713173|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
41948339|NCT02122146|75713174|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
41948340|NCT02122146|75713175|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
41948341|NCT02122146|75713176|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
41948342|NCT02122146|75713177|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
41948343|NCT02122146|75713178|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
41948344|NCT02122146|75713179|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
41948345|NCT02122146|75713172|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
41948346|NCT02122146|75713173|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
41948347|NCT02122146|75713174|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
41948348|NCT02122146|75713175|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
41948349|NCT02122146|75713176|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
41948350|NCT02122146|75713177|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
41948351|NCT02122146|75713178|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
41948352|NCT02122146|75713179|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
42023682|NCT01189266|75831058|FG002|Overall Study|Adverse Event|5|||
42023683|NCT01189266|75831056|FG000|Overall Study|Death|0|||
42023684|NCT01189266|75831057|FG001|Overall Study|Death|0|||
41948353|NCT02122146|75713172|FG000|Part 1: Dose Escalation|Other|1|||
41948354|NCT02122146|75713173|FG001|Part 1: Dose Escalation|Other|0|||
42300355|NCT02326155|76135524|FG000|Overall Study|Withdrawal by Subject|34|||
41948355|NCT02122146|75713174|FG002|Part 1: Dose Escalation|Other|0|||
41948356|NCT02122146|75713175|FG003|Part 1: Dose Escalation|Other|0|||
41948357|NCT02122146|75713176|FG004|Part 1: Dose Escalation|Other|0|||
41948358|NCT02122146|75713177|FG005|Part 1: Dose Escalation|Other|1|||
41948359|NCT02122146|75713178|FG006|Part 1: Dose Escalation|Other|1|||
41948360|NCT02122146|75713179|FG007|Part 1: Dose Escalation|Other|2|||
41948361|NCT02121834|75713205|FG000|Overall Study|Protocol Violation|0|||
41948362|NCT02121834|75713206|FG001|Overall Study|Protocol Violation|1|||
41948363|NCT02121834|75713207|FG002|Overall Study|Protocol Violation|0|||
41948364|NCT02121834|75713208|FG003|Overall Study|Protocol Violation|0|||
41948365|NCT02121834|75713209|FG004|Overall Study|Protocol Violation|0|||
41948366|NCT02121834|75713210|FG005|Overall Study|Protocol Violation|0|||
41948367|NCT02121834|75713211|FG006|Overall Study|Protocol Violation|0|||
41948368|NCT02121834|75713205|FG000|Overall Study|Withdrawal by Subject|0|||
41948369|NCT02121834|75713206|FG001|Overall Study|Withdrawal by Subject|1|||
41948370|NCT02121834|75713207|FG002|Overall Study|Withdrawal by Subject|1|||
41948371|NCT02121834|75713208|FG003|Overall Study|Withdrawal by Subject|0|||
41948372|NCT02121834|75713209|FG004|Overall Study|Withdrawal by Subject|0|||
41948373|NCT02121834|75713210|FG005|Overall Study|Withdrawal by Subject|0|||
41948374|NCT02121834|75713211|FG006|Overall Study|Withdrawal by Subject|0|||
41948375|NCT02121834|75713205|FG000|Overall Study|Lost to Follow-up|0|||
41948376|NCT02121834|75713206|FG001|Overall Study|Lost to Follow-up|0|||
41948377|NCT02121834|75713207|FG002|Overall Study|Lost to Follow-up|1|||
41948378|NCT02121834|75713208|FG003|Overall Study|Lost to Follow-up|0|||
41948379|NCT02121834|75713209|FG004|Overall Study|Lost to Follow-up|0|||
41948380|NCT02121834|75713210|FG005|Overall Study|Lost to Follow-up|0|||
41948381|NCT02121834|75713211|FG006|Overall Study|Lost to Follow-up|0|||
41948382|NCT02121756|75713239|FG000|Overall Study|Adverse Event|3|||
41948383|NCT02121756|75713240|FG001|Overall Study|Adverse Event|0|||
41948384|NCT02121756|75713239|FG000|Overall Study|Protocol Violation|1|||
41948385|NCT02121756|75713240|FG001|Overall Study|Protocol Violation|1|||
41948386|NCT02121756|75713239|FG000|Overall Study|Physician Decision|2|||
41948387|NCT02121756|75713240|FG001|Overall Study|Physician Decision|1|||
41948388|NCT02142504|75713252|FG000|Overall Study|Protocol Violation|2|||
41948389|NCT02142504|75713253|FG001|Overall Study|Protocol Violation|1|||
41948390|NCT02142504|75713254|FG002|Overall Study|Protocol Violation|2|||
41948391|NCT02142504|75713252|FG000|Overall Study|Adverse Event|2|||
41948392|NCT02142504|75713253|FG001|Overall Study|Adverse Event|3|||
41948393|NCT02142504|75713254|FG002|Overall Study|Adverse Event|4|||
41948394|NCT02142504|75713252|FG000|Overall Study|Lost to Follow-up|12|||
41948395|NCT02142504|75713253|FG001|Overall Study|Lost to Follow-up|19|||
41948396|NCT02142504|75713254|FG002|Overall Study|Lost to Follow-up|17|||
41948397|NCT02142504|75713252|FG000|Overall Study|Withdrawal by Subject|7|||
41948398|NCT02142504|75713253|FG001|Overall Study|Withdrawal by Subject|9|||
41948399|NCT02142504|75713254|FG002|Overall Study|Withdrawal by Subject|11|||
41948400|NCT02142504|75713252|FG000|Overall Study|Pregnancy|4|||
41948401|NCT02142504|75713253|FG001|Overall Study|Pregnancy|4|||
41948402|NCT02142504|75713254|FG002|Overall Study|Pregnancy|2|||
41948403|NCT02142504|75713252|FG000|Overall Study|Physician Decision|0|||
41948404|NCT02142504|75713253|FG001|Overall Study|Physician Decision|1|||
41948405|NCT02142504|75713254|FG002|Overall Study|Physician Decision|3|||
41948406|NCT02142504|75713252|FG000|Overall Study|Reason Not Specified|4|||
41948407|NCT02142504|75713253|FG001|Overall Study|Reason Not Specified|5|||
41948408|NCT02142504|75713254|FG002|Overall Study|Reason Not Specified|4|||
41948409|NCT02121522|75713262|FG000|Overall Study|Adverse Event|1|||
41948410|NCT02121210|75713268|FG000|Overall Study|Adverse Event|5|||
41948411|NCT02121210|75713269|FG001|Overall Study|Adverse Event|7|||
41948412|NCT02121210|75713268|FG000|Overall Study|Lack of Efficacy|2|||
41948413|NCT02121210|75713269|FG001|Overall Study|Lack of Efficacy|0|||
41948414|NCT02121210|75713268|FG000|Overall Study|Other than specified above|0|||
41948415|NCT02121210|75713269|FG001|Overall Study|Other than specified above|2|||
41948416|NCT02141490|75713278|FG000|Overall Study|Screening failures|4|||
41948417|NCT02141490|75713279|FG001|Overall Study|Screening failures|0|||
41948418|NCT02141490|75713280|FG002|Overall Study|Screening failures|0|||
41948419|NCT02097108|75713290|FG000|Overall Study|Adverse Event|1|||
41948420|NCT02097108|75713290|FG000|Overall Study|patient was abroad for 6 months|1|||
41948421|NCT02097030|75713296|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
41948422|NCT02097030|75713297|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
41948423|NCT02097030|75713296|FG000|First Intervention (3 Days)|Visual Acuity|0|||
42023685|NCT01189266|75831058|FG002|Overall Study|Death|5|||
41948424|NCT02097030|75713297|FG001|First Intervention (3 Days)|Visual Acuity|1|||
41948425|NCT02096952|75713307|FG000|Overall Study|Adverse Event|1|||
41948426|NCT02120898|75713314|FG000|Overall Study|Withdrawal by Subject|4|||
41948427|NCT02120898|75713315|FG001|Overall Study|Withdrawal by Subject|2|||
41948428|NCT02120898|75713316|FG002|Overall Study|Withdrawal by Subject|2|||
41948429|NCT02120898|75713314|FG000|Overall Study|Non-compliance with study drug|3|||
41948430|NCT02120898|75713315|FG001|Overall Study|Non-compliance with study drug|0|||
42023686|NCT01189266|75831056|FG000|Overall Study|Lack of Efficacy|4|||
42023687|NCT01189266|75831057|FG001|Overall Study|Lack of Efficacy|5|||
41948431|NCT02120898|75713316|FG002|Overall Study|Non-compliance with study drug|0|||
41948432|NCT02120898|75713314|FG000|Overall Study|Adverse Event|1|||
41948433|NCT02120898|75713315|FG001|Overall Study|Adverse Event|2|||
41948434|NCT02120898|75713316|FG002|Overall Study|Adverse Event|1|||
41948435|NCT02120898|75713314|FG000|Overall Study|Protocol Violation|1|||
41948436|NCT02120898|75713315|FG001|Overall Study|Protocol Violation|2|||
41948437|NCT02120898|75713316|FG002|Overall Study|Protocol Violation|0|||
41948438|NCT02120898|75713314|FG000|Overall Study|Lost to Follow-up|0|||
41948439|NCT02120898|75713315|FG001|Overall Study|Lost to Follow-up|0|||
41948440|NCT02120898|75713316|FG002|Overall Study|Lost to Follow-up|1|||
41948441|NCT02120664|75713329|FG000|Overall Study|Withdrawal by Subject|0|||
41948442|NCT02120664|75713330|FG001|Overall Study|Withdrawal by Subject|0|||
41948443|NCT02120664|75713331|FG002|Overall Study|Withdrawal by Subject|0|||
41948444|NCT02120664|75713332|FG003|Overall Study|Withdrawal by Subject|1|||
41948445|NCT02120664|75713333|FG004|Overall Study|Withdrawal by Subject|0|||
41948446|NCT01627860|75713348|FG000|Overall Study|Adverse Event|9|||
41948447|NCT01627860|75713349|FG001|Overall Study|Adverse Event|4|||
41948448|NCT01627860|75713348|FG000|Overall Study|Withdrawal by Subject|2|||
41948449|NCT01627860|75713349|FG001|Overall Study|Withdrawal by Subject|1|||
41948450|NCT01627860|75713348|FG000|Overall Study|Seizure frequency doubled|0|||
41948451|NCT01627860|75713349|FG001|Overall Study|Seizure frequency doubled|1|||
41948452|NCT01627860|75713348|FG000|Overall Study|Protocol Violation|1|||
41948453|NCT01627860|75713349|FG001|Overall Study|Protocol Violation|0|||
41948454|NCT01627782|75713359|FG000|Overall Study|Adverse Event|1|||
41948455|NCT01627782|75713360|FG001|Overall Study|Adverse Event|2|||
41948456|NCT01627782|75713361|FG002|Overall Study|Adverse Event|0|||
41948457|NCT01627782|75713362|FG003|Overall Study|Adverse Event|1|||
41948458|NCT01627782|75713359|FG000|Overall Study|Lack of Efficacy|11|||
41948459|NCT01627782|75713360|FG001|Overall Study|Lack of Efficacy|1|||
41948460|NCT01627782|75713361|FG002|Overall Study|Lack of Efficacy|15|||
41948461|NCT01627782|75713362|FG003|Overall Study|Lack of Efficacy|2|||
41948462|NCT01627782|75713359|FG000|Overall Study|Protocol Violation|1|||
41948463|NCT01627782|75713360|FG001|Overall Study|Protocol Violation|0|||
41948464|NCT01627782|75713361|FG002|Overall Study|Protocol Violation|0|||
41948465|NCT01627782|75713362|FG003|Overall Study|Protocol Violation|0|||
41948466|NCT01627782|75713359|FG000|Overall Study|Withdrawal by Subject|2|||
41948467|NCT01627782|75713360|FG001|Overall Study|Withdrawal by Subject|1|||
41948468|NCT01627782|75713361|FG002|Overall Study|Withdrawal by Subject|0|||
41948469|NCT01627782|75713362|FG003|Overall Study|Withdrawal by Subject|0|||
41948470|NCT01627782|75713359|FG000|Overall Study|Other|0|||
41948471|NCT01627782|75713360|FG001|Overall Study|Other|2|||
41948472|NCT01627782|75713361|FG002|Overall Study|Other|0|||
41948473|NCT01627782|75713362|FG003|Overall Study|Other|3|||
41948474|NCT01627782|75713359|FG000|Overall Study|Randomized But Not Treated|1|||
41948475|NCT01627782|75713360|FG001|Overall Study|Randomized But Not Treated|0|||
41948476|NCT01627782|75713361|FG002|Overall Study|Randomized But Not Treated|0|||
41948477|NCT01627782|75713362|FG003|Overall Study|Randomized But Not Treated|0|||
41948478|NCT01598532|75713374|FG000|Overall Study|Lost to Follow-up|3|||
41948479|NCT01598532|75713374|FG000|Overall Study|Did not meet inclusion criteria|8|||
41948480|NCT02119650|75713383|FG000|Overall Study|Adverse Event|3|||
41948481|NCT02119650|75713384|FG001|Overall Study|Adverse Event|4|||
41948482|NCT02119650|75713383|FG000|Overall Study|Subject decision|2|||
41948483|NCT02119650|75713384|FG001|Overall Study|Subject decision|3|||
41948484|NCT02119650|75713383|FG000|Overall Study|Disease progression|11|||
41948485|NCT02119650|75713384|FG001|Overall Study|Disease progression|14|||
41948486|NCT02119650|75713383|FG000|Overall Study|Death|5|||
41948487|NCT02119650|75713384|FG001|Overall Study|Death|1|||
41948488|NCT02119650|75713383|FG000|Overall Study|Noncompliance with study treatment|1|||
41948489|NCT02119650|75713384|FG001|Overall Study|Noncompliance with study treatment|1|||
41948490|NCT02119650|75713383|FG000|Overall Study|Study terminated by the sponsor|1|||
41948491|NCT02119650|75713384|FG001|Overall Study|Study terminated by the sponsor|0|||
41948492|NCT02119650|75713383|FG000|Overall Study|Physician Decision|0|||
41948493|NCT02119650|75713384|FG001|Overall Study|Physician Decision|2|||
41948494|NCT02119650|75713383|FG000|Overall Study|Multiple reasons for termination|2|||
41948495|NCT02119650|75713384|FG001|Overall Study|Multiple reasons for termination|1|||
41948496|NCT02119416|75713393|FG000|Overall Study|Protocol Violation|1|||
41948497|NCT02119416|75713394|FG001|Overall Study|Protocol Violation|1|||
41948498|NCT02119416|75713395|FG002|Overall Study|Protocol Violation|1|||
41948499|NCT02119416|75713393|FG000|Overall Study|wrong pubertal stage|1|||
41948500|NCT02119416|75713394|FG001|Overall Study|wrong pubertal stage|0|||
41948501|NCT02119416|75713395|FG002|Overall Study|wrong pubertal stage|1|||
41948502|NCT02140164|75713406|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
41948503|NCT02119260|75713417|FG000|Overall Study|Adverse Event|1|||
41948504|NCT02119260|75713418|FG001|Overall Study|Adverse Event|0|||
41948505|NCT02119260|75713419|FG002|Overall Study|Adverse Event|0|||
41948506|NCT02119260|75713420|FG003|Overall Study|Adverse Event|0|||
41948507|NCT02119260|75713421|FG004|Overall Study|Adverse Event|0|||
41948508|NCT02119260|75713422|FG005|Overall Study|Adverse Event|0|||
41948509|NCT02119260|75713423|FG006|Overall Study|Adverse Event|0|||
41948510|NCT02119260|75713417|FG000|Overall Study|Withdrew consent|0|||
41948511|NCT02119260|75713418|FG001|Overall Study|Withdrew consent|1|||
41948512|NCT02119260|75713419|FG002|Overall Study|Withdrew consent|1|||
41948513|NCT02119260|75713420|FG003|Overall Study|Withdrew consent|0|||
41948514|NCT02119260|75713421|FG004|Overall Study|Withdrew consent|0|||
41948515|NCT02119260|75713422|FG005|Overall Study|Withdrew consent|0|||
41948516|NCT02119260|75713423|FG006|Overall Study|Withdrew consent|0|||
41948517|NCT02119104|75713448|FG000|Overall Study|Protocol Violation|16|||
41948518|NCT02119026|75713454|FG000|1st-line Treatment|Adverse Event|9|||
41948519|NCT02119026|75713455|FG001|1st-line Treatment|Adverse Event|14|||
41948520|NCT02119026|75713454|FG000|1st-line Treatment|Physician Decision|3|||
41948521|NCT02119026|75713455|FG001|1st-line Treatment|Physician Decision|8|||
41948522|NCT02119026|75713454|FG000|1st-line Treatment|Withdrawal by Subject|4|||
41948523|NCT02119026|75713455|FG001|1st-line Treatment|Withdrawal by Subject|10|||
41948524|NCT02119026|75713454|FG000|1st-line Treatment|Patient condition or compliance|6|||
41948525|NCT02119026|75713455|FG001|1st-line Treatment|Patient condition or compliance|4|||
41948526|NCT02119026|75713454|FG000|1st-line Treatment|Surgery of metastases|2|||
41948527|NCT02119026|75713455|FG001|1st-line Treatment|Surgery of metastases|1|||
41948528|NCT02119026|75713454|FG000|1st-line Treatment|Death|2|||
41948529|NCT02119026|75713455|FG001|1st-line Treatment|Death|1|||
41948530|NCT02119026|75713454|FG000|2nd-line Treatment|Lost to Follow-up|2|||
41948531|NCT02119026|75713455|FG001|2nd-line Treatment|Lost to Follow-up|0|||
41948532|NCT02119026|75713454|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
41948533|NCT02119026|75713455|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
41948534|NCT02119026|75713454|FG000|2nd-line Treatment|Adverse Event|4|||
41948535|NCT02119026|75713455|FG001|2nd-line Treatment|Adverse Event|1|||
41948536|NCT02095158|75713461|FG000|Overall Study|Adverse Event|14|||
41948537|NCT02095158|75713461|FG000|Overall Study|Lack of Efficacy|3|||
41948538|NCT02095158|75713461|FG000|Overall Study|Pregnancy|1|||
41948539|NCT02095158|75713461|FG000|Overall Study|Lost to Follow-up|20|||
41948540|NCT02095158|75713461|FG000|Overall Study|Personal Reasons|35|||
41948541|NCT02095158|75713461|FG000|Overall Study|Protocol Violation|1|||
41948542|NCT02095158|75713461|FG000|Overall Study|Other Miscellaneous Reasons|1|||
41948543|NCT02094612|75713467|FG000|Overall Study|Lost to Follow-up|47|||
41948544|NCT02094612|75713468|FG001|Overall Study|Lost to Follow-up|47|||
41948545|NCT02094612|75713467|FG000|Overall Study|Never started ADHD medication|32|||
41948546|NCT02094612|75713468|FG001|Overall Study|Never started ADHD medication|23|||
41948547|NCT02139306|75713476|FG000|Overall Study|Withdrawal by Subject|4|||
41948548|NCT02139306|75713477|FG001|Overall Study|Withdrawal by Subject|6|||
41948549|NCT02139306|75713476|FG000|Overall Study|Adverse Event|3|||
41948550|NCT02139306|75713477|FG001|Overall Study|Adverse Event|4|||
41948551|NCT02139306|75713476|FG000|Overall Study|Physician Decision|0|||
41948552|NCT02139306|75713477|FG001|Overall Study|Physician Decision|1|||
41948553|NCT02139306|75713476|FG000|Overall Study|Other Unspecified|2|||
41948554|NCT02139306|75713477|FG001|Overall Study|Other Unspecified|3|||
41948555|NCT02139306|75713476|FG000|Overall Study|Protocol Violation|4|||
41948556|NCT02139306|75713477|FG001|Overall Study|Protocol Violation|0|||
41948557|NCT02094300|75713484|FG000|Overall Study|Death|7|||
41948558|NCT02094300|75713484|FG000|Overall Study|Lost to Follow-up|10|||
41948559|NCT02094300|75713484|FG000|Overall Study|Still be eligible for follow-up|3|||
41948560|NCT02118792|75713490|FG000|Overall Study|Withdrawal by Subject|6|||
41948561|NCT02118792|75713491|FG001|Overall Study|Withdrawal by Subject|3|||
41948562|NCT02118792|75713490|FG000|Overall Study|Lost to Follow-up|4|||
41948563|NCT02118792|75713491|FG001|Overall Study|Lost to Follow-up|4|||
41948564|NCT02118792|75713490|FG000|Overall Study|Adverse Event|5|||
41948565|NCT02118792|75713491|FG001|Overall Study|Adverse Event|4|||
41948566|NCT02118792|75713490|FG000|Overall Study|Withdrawal by parent/guardian|14|||
41948567|NCT02118792|75713491|FG001|Overall Study|Withdrawal by parent/guardian|20|||
41948568|NCT02118792|75713490|FG000|Overall Study|Other|1|||
41948569|NCT02118792|75713491|FG001|Overall Study|Other|6|||
41948570|NCT02118792|75713490|FG000|Overall Study|Randomised but not treated|1|||
41948571|NCT02118792|75713491|FG001|Overall Study|Randomised but not treated|0|||
41948572|NCT02118714|75713499|FG000|Overall Study|Lost to Follow-up|2|||
41948573|NCT02118714|75713499|FG000|Overall Study|Protocol Violation|1|||
41948574|NCT02138916|75713506|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
41948575|NCT02138916|75713507|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
41948576|NCT02138916|75713508|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
41948577|NCT02138916|75713506|FG000|Overall Study|Death|14|||
41948578|NCT02138916|75713507|FG001|Overall Study|Death|11|||
41948579|NCT02138916|75713508|FG002|Overall Study|Death|12|||
41948580|NCT02138916|75713506|FG000|Overall Study|Withdrawal by Subject|27|||
41948581|NCT02138916|75713507|FG001|Overall Study|Withdrawal by Subject|31|||
41948582|NCT02138916|75713508|FG002|Overall Study|Withdrawal by Subject|32|||
41948583|NCT02138916|75713506|FG000|Overall Study|Study specific withdrawal criteria|0|||
41948584|NCT02138916|75713507|FG001|Overall Study|Study specific withdrawal criteria|0|||
41948585|NCT02138916|75713508|FG002|Overall Study|Study specific withdrawal criteria|1|||
41948586|NCT02138916|75713506|FG000|Overall Study|incorrect enrolment|1|||
41948587|NCT02138916|75713507|FG001|Overall Study|incorrect enrolment|1|||
41948588|NCT02138916|75713508|FG002|Overall Study|incorrect enrolment|0|||
41948589|NCT02138916|75713506|FG000|Overall Study|Severe non-compliance|1|||
41948590|NCT02138916|75713507|FG001|Overall Study|Severe non-compliance|2|||
41948591|NCT02138916|75713508|FG002|Overall Study|Severe non-compliance|1|||
41948592|NCT02138916|75713506|FG000|Overall Study|Lost to Follow-up|4|||
41948593|NCT02138916|75713507|FG001|Overall Study|Lost to Follow-up|2|||
41948594|NCT02138916|75713508|FG002|Overall Study|Lost to Follow-up|3|||
41948595|NCT02138916|75713506|FG000|Overall Study|Adverse Event|4|||
41948596|NCT02138916|75713507|FG001|Overall Study|Adverse Event|4|||
41948597|NCT02138916|75713508|FG002|Overall Study|Adverse Event|3|||
41948598|NCT02118012|75713518|FG000|Overall Study|Adverse Event|0|||
41948599|NCT02118012|75713519|FG001|Overall Study|Adverse Event|1|||
41948600|NCT02118012|75713518|FG000|Overall Study|Physician Decision|0|||
41948601|NCT02118012|75713519|FG001|Overall Study|Physician Decision|1|||
41948602|NCT02093520|75713527|FG000|Overall Study|Not treated|6|||
41948603|NCT02093520|75713528|FG001|Overall Study|Not treated|22|||
41948604|NCT02138838|75713536|FG000|Overall Study|Study Closure|7|||
41948605|NCT02138838|75713537|FG001|Overall Study|Study Closure|6|||
41948606|NCT02138838|75713536|FG000|Overall Study|Withdrawal by Subject|1|||
41948607|NCT02138838|75713537|FG001|Overall Study|Withdrawal by Subject|5|||
41948608|NCT02138214|75713546|FG000|Overall Study|Withdrawal by Subject|0|||
41948609|NCT02138214|75713547|FG001|Overall Study|Withdrawal by Subject|1|||
41948610|NCT02138214|75713548|FG002|Overall Study|Withdrawal by Subject|0|||
41948611|NCT02138214|75713546|FG000|Overall Study|Lost to Follow-up|0|||
41948612|NCT02138214|75713547|FG001|Overall Study|Lost to Follow-up|2|||
41948613|NCT02138214|75713548|FG002|Overall Study|Lost to Follow-up|4|||
41948614|NCT02138214|75713546|FG000|Overall Study|Screen Failure|0|||
41948615|NCT02138214|75713547|FG001|Overall Study|Screen Failure|1|||
41948616|NCT02138214|75713548|FG002|Overall Study|Screen Failure|0|||
41948617|NCT02092662|75713557|FG000|Overall Study|Lost to Follow-up|13|||
41948618|NCT02092662|75713558|FG001|Overall Study|Lost to Follow-up|0|||
41948619|NCT02092350|75713567|FG000|Overall Study|Adverse Event|0|||
41948620|NCT02092350|75713568|FG001|Overall Study|Adverse Event|3|||
41948621|NCT02092350|75713567|FG000|Overall Study|Death|2|||
41948622|NCT02092350|75713568|FG001|Overall Study|Death|5|||
41948623|NCT02092350|75713567|FG000|Overall Study|Lost to Follow-up|3|||
41948624|NCT02092350|75713568|FG001|Overall Study|Lost to Follow-up|1|||
41948625|NCT02092350|75713567|FG000|Overall Study|Protocol Violation|1|||
41948626|NCT02092350|75713568|FG001|Overall Study|Protocol Violation|0|||
41948627|NCT02092350|75713567|FG000|Overall Study|Physician Decision|1|||
41948628|NCT02092350|75713568|FG001|Overall Study|Physician Decision|1|||
41948629|NCT02092350|75713567|FG000|Overall Study|Screen Failure|1|||
41948630|NCT02092350|75713568|FG001|Overall Study|Screen Failure|0|||
41948631|NCT02092350|75713567|FG000|Overall Study|Withdrawal by Subject|2|||
41948632|NCT02092350|75713568|FG001|Overall Study|Withdrawal by Subject|2|||
41948633|NCT02117544|75713576|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
41948634|NCT02117544|75713577|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
41948635|NCT02138136|75713584|FG000|Overall Study|Protocol Violation|4|||
41948636|NCT02138136|75713584|FG000|Overall Study|Physician Decision|7|||
41948637|NCT02138136|75713584|FG000|Overall Study|Lack of Efficacy|35|||
41948638|NCT02138136|75713584|FG000|Overall Study|Pregnancy|2|||
41948639|NCT02138136|75713584|FG000|Overall Study|Adverse Event|18|||
41948640|NCT02138136|75713584|FG000|Overall Study|Withdrawal by Subject|36|||
41948641|NCT02138136|75713584|FG000|Overall Study|Lost to Follow-up|32|||
41948642|NCT02138136|75713584|FG000|Overall Study|Withdrawn by Sponsor|5|||
41948643|NCT01626690|75713591|FG000|Overall Study|Protocol Violation|1|||
41948644|NCT01626690|75713592|FG001|Overall Study|Protocol Violation|0|||
41948645|NCT01626690|75713591|FG000|Overall Study|Adverse Event|1|||
41948646|NCT01626690|75713592|FG001|Overall Study|Adverse Event|0|||
41948647|NCT01626456|75713602|FG000|Overall Study|Withdrawal by Subject|21|||
41948648|NCT01626456|75713603|FG001|Overall Study|Withdrawal by Subject|46|||
41948649|NCT01626456|75713602|FG000|Overall Study|Adverse Event|2|||
41948650|NCT01626456|75713603|FG001|Overall Study|Adverse Event|27|||
41948651|NCT01626456|75713602|FG000|Overall Study|Lost to Follow-up|2|||
41948652|NCT01626456|75713603|FG001|Overall Study|Lost to Follow-up|27|||
42023688|NCT01189266|75831058|FG002|Overall Study|Lack of Efficacy|44|||
41948653|NCT01626456|75713602|FG000|Overall Study|Lack of Efficacy|6|||
41948654|NCT01626456|75713603|FG001|Overall Study|Lack of Efficacy|7|||
41948655|NCT01626456|75713602|FG000|Overall Study|Physician Decision|1|||
41948656|NCT01626456|75713603|FG001|Overall Study|Physician Decision|4|||
42023689|NCT01189266|75831056|FG000|Overall Study|Physician Decision|0|||
42023690|NCT01189266|75831057|FG001|Overall Study|Physician Decision|0|||
41948657|NCT01626456|75713602|FG000|Overall Study|Protocol Violation|1|||
41948658|NCT01626456|75713603|FG001|Overall Study|Protocol Violation|1|||
41948659|NCT01626456|75713602|FG000|Overall Study|Site Closure|2|||
42023691|NCT01189266|75831058|FG002|Overall Study|Physician Decision|1|||
41948660|NCT01626456|75713603|FG001|Overall Study|Site Closure|3|||
42023692|NCT01189266|75831056|FG000|Overall Study|Protocol Violation|0|||
42023693|NCT01189266|75831057|FG001|Overall Study|Protocol Violation|1|||
42023694|NCT01189266|75831058|FG002|Overall Study|Protocol Violation|1|||
41948661|NCT01626456|75713602|FG000|Overall Study|Incarceration|0|||
41948662|NCT01626456|75713603|FG001|Overall Study|Incarceration|2|||
41948663|NCT02116608|75713621|FG000|Overall Study|Lost to Follow-up|0|||
41948664|NCT02116608|75713622|FG001|Overall Study|Lost to Follow-up|0|||
41948665|NCT02116608|75713623|FG002|Overall Study|Lost to Follow-up|1|||
41948666|NCT02116608|75713621|FG000|Overall Study|Physician Decision|0|||
41948667|NCT02116608|75713622|FG001|Overall Study|Physician Decision|1|||
41948668|NCT02116608|75713623|FG002|Overall Study|Physician Decision|0|||
41948669|NCT02116608|75713621|FG000|Overall Study|Death|0|||
41948670|NCT02116608|75713622|FG001|Overall Study|Death|1|||
41948671|NCT02116608|75713623|FG002|Overall Study|Death|0|||
41948672|NCT02092116|75713633|FG000|Overall Study|Withdrawal by Subject|0|||
41948673|NCT02092116|75713634|FG001|Overall Study|Withdrawal by Subject|3|||
41948674|NCT02092116|75713633|FG000|Overall Study|Adverse Event|0|||
41948675|NCT02092116|75713634|FG001|Overall Study|Adverse Event|1|||
41948676|NCT02091726|75713640|FG000|Overall Study|Lost to Follow-up|6|||
41948677|NCT02091414|75713644|FG000|Overall Study|Withdrawal by Subject|2|||
41948678|NCT02091414|75713644|FG000|Overall Study|Death|2|||
41948679|NCT02116530|75713650|FG000|Overall Study|Withdrawal by Subject|1|||
41948680|NCT02116530|75713651|FG001|Overall Study|Withdrawal by Subject|2|||
41948681|NCT02116530|75713650|FG000|Overall Study|Adverse Event|4|||
41948682|NCT02116530|75713651|FG001|Overall Study|Adverse Event|0|||
41948683|NCT02116530|75713650|FG000|Overall Study|Physician Decision|1|||
41948684|NCT02116530|75713651|FG001|Overall Study|Physician Decision|0|||
41948685|NCT02116530|75713650|FG000|Overall Study|Lost to Follow-up|1|||
41948686|NCT02116530|75713651|FG001|Overall Study|Lost to Follow-up|0|||
41948687|NCT02116530|75713650|FG000|Overall Study|Other Medical Problems|2|||
41948688|NCT02116530|75713651|FG001|Overall Study|Other Medical Problems|2|||
41948689|NCT02072226|75713659|FG000|Overall Study|Lost to Follow-up|11|||
41948690|NCT02072226|75713660|FG001|Overall Study|Lost to Follow-up|7|||
41948691|NCT02072226|75713659|FG000|Overall Study|Patient Non-compliance|2|||
41948692|NCT02072226|75713660|FG001|Overall Study|Patient Non-compliance|3|||
41948693|NCT02072226|75713659|FG000|Overall Study|Death|1|||
41948694|NCT02072226|75713660|FG001|Overall Study|Death|0|||
41948695|NCT02072226|75713659|FG000|Overall Study|Patient Withdrawal of Consent|1|||
41948696|NCT02072226|75713660|FG001|Overall Study|Patient Withdrawal of Consent|0|||
41948697|NCT02090634|75713668|FG000|Overall Study|Lost to Follow-up|0|||
41948698|NCT02090634|75713669|FG001|Overall Study|Lost to Follow-up|1|||
41948699|NCT02090634|75713668|FG000|Overall Study|Death|0|||
41948700|NCT02090634|75713669|FG001|Overall Study|Death|1|||
41948701|NCT02090634|75713668|FG000|Overall Study|Protocol Violation|3|||
41948702|NCT02090634|75713669|FG001|Overall Study|Protocol Violation|1|||
41948703|NCT02090634|75713668|FG000|Overall Study|Adverse Event|2|||
41948704|NCT02090634|75713669|FG001|Overall Study|Adverse Event|0|||
41948705|NCT02114892|75713677|FG000|Overall Study|Lost to Follow-up|1|||
41948706|NCT02114892|75713678|FG001|Overall Study|Lost to Follow-up|2|||
41948707|NCT02070978|75713687|FG000|Overall Study|Adverse Event|6|||
41948708|NCT02070978|75713688|FG001|Overall Study|Adverse Event|2|||
41948709|NCT02070978|75713689|FG002|Overall Study|Adverse Event|0|||
41948710|NCT02070978|75713687|FG000|Overall Study|Lost to Follow-up|1|||
41948711|NCT02070978|75713688|FG001|Overall Study|Lost to Follow-up|3|||
41948712|NCT02070978|75713689|FG002|Overall Study|Lost to Follow-up|4|||
41948713|NCT02070978|75713687|FG000|Overall Study|Withdrawal by Subject|3|||
41948714|NCT02070978|75713688|FG001|Overall Study|Withdrawal by Subject|5|||
41948715|NCT02070978|75713689|FG002|Overall Study|Withdrawal by Subject|3|||
41948716|NCT02070978|75713687|FG000|Overall Study|Protocol Violation|1|||
41948717|NCT02070978|75713688|FG001|Overall Study|Protocol Violation|0|||
41948718|NCT02070978|75713689|FG002|Overall Study|Protocol Violation|3|||
41948719|NCT02070978|75713687|FG000|Overall Study|Lack of Efficacy|0|||
41948720|NCT02070978|75713688|FG001|Overall Study|Lack of Efficacy|1|||
41948721|NCT02070978|75713689|FG002|Overall Study|Lack of Efficacy|0|||
41948722|NCT02070978|75713687|FG000|Overall Study|Death|0|||
41948723|NCT02070978|75713688|FG001|Overall Study|Death|0|||
41948724|NCT02070978|75713689|FG002|Overall Study|Death|2|||
41948725|NCT02070978|75713687|FG000|Overall Study|Un-specified|3|||
41948726|NCT02070978|75713688|FG001|Overall Study|Un-specified|2|||
41948727|NCT02070978|75713689|FG002|Overall Study|Un-specified|2|||
41948728|NCT02070978|75713687|FG000|Overall Study|Terminated by Sponsor|33|||
41948729|NCT02070978|75713688|FG001|Overall Study|Terminated by Sponsor|40|||
41948730|NCT02070978|75713689|FG002|Overall Study|Terminated by Sponsor|39|||
41948731|NCT02114268|75713703|FG000|Overall Study|Lost to Follow-up|4|||
41948732|NCT02114268|75713704|FG001|Overall Study|Lost to Follow-up|1|||
41948733|NCT02114268|75713705|FG002|Overall Study|Lost to Follow-up|1|||
41948734|NCT02114268|75713706|FG003|Overall Study|Lost to Follow-up|0|||
41948735|NCT02114268|75713707|FG004|Overall Study|Lost to Follow-up|0|||
41948736|NCT02114268|75713708|FG005|Overall Study|Lost to Follow-up|2|||
41948737|NCT02114268|75713703|FG000|Overall Study|Withdrawal by Subject|1|||
41948738|NCT02114268|75713704|FG001|Overall Study|Withdrawal by Subject|0|||
41948739|NCT02114268|75713705|FG002|Overall Study|Withdrawal by Subject|0|||
41948740|NCT02114268|75713706|FG003|Overall Study|Withdrawal by Subject|0|||
41948741|NCT02114268|75713707|FG004|Overall Study|Withdrawal by Subject|0|||
41948742|NCT02114268|75713708|FG005|Overall Study|Withdrawal by Subject|1|||
41948743|NCT02114268|75713703|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
41948744|NCT02114268|75713704|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
41948745|NCT02114268|75713705|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
41948746|NCT02114268|75713706|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
41948747|NCT02114268|75713707|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
41948748|NCT02114268|75713708|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
41948749|NCT02089230|75713730|FG000|Overall Study|Death|0|||
41948750|NCT02089230|75713731|FG001|Overall Study|Death|0|||
41948751|NCT02089230|75713732|FG002|Overall Study|Death|2|||
41948752|NCT02089230|75713730|FG000|Overall Study|Seeking Alternative Therapy|0|||
41948753|NCT02089230|75713731|FG001|Overall Study|Seeking Alternative Therapy|0|||
41948754|NCT02089230|75713732|FG002|Overall Study|Seeking Alternative Therapy|4|||
41948755|NCT02070744|75713744|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
41948756|NCT02070744|75713745|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
41948757|NCT02070744|75713746|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
41948758|NCT02070744|75713747|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
41948759|NCT02070744|75713748|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
41948760|NCT02070744|75713744|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
41948761|NCT02070744|75713745|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
41948762|NCT02070744|75713746|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
41948763|NCT02070744|75713747|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
41948764|NCT02070744|75713748|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
41948765|NCT02070744|75713744|FG000|OLE Phase (48 Weeks)|Other|0|||
41948766|NCT02070744|75713745|FG001|OLE Phase (48 Weeks)|Other|0|||
41948767|NCT02070744|75713746|FG002|OLE Phase (48 Weeks)|Other|0|||
41948768|NCT02070744|75713747|FG003|OLE Phase (48 Weeks)|Other|0|||
41948769|NCT02070744|75713748|FG004|OLE Phase (48 Weeks)|Other|1|||
41948770|NCT02113956|75713765|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
41948771|NCT02113956|75713766|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
41948772|NCT02113956|75713765|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
41948773|NCT02113956|75713766|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
41948774|NCT02113956|75713765|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
41948775|NCT02113956|75713766|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
41948776|NCT02070588|75713775|FG000|Overall Study|Withdrawal by Subject|29|||
41948777|NCT02070588|75713776|FG001|Overall Study|Withdrawal by Subject|1|||
41948778|NCT02070588|75713777|FG002|Overall Study|Withdrawal by Subject|0|||
41948779|NCT02070588|75713775|FG000|Overall Study|Writhdrawal due to early termination|9|||
41948780|NCT02070588|75713776|FG001|Overall Study|Writhdrawal due to early termination|0|||
41948781|NCT02070588|75713777|FG002|Overall Study|Writhdrawal due to early termination|0|||
41948782|NCT02070588|75713775|FG000|Overall Study|Adverse Event|1|||
41948783|NCT02070588|75713776|FG001|Overall Study|Adverse Event|0|||
41948784|NCT02070588|75713777|FG002|Overall Study|Adverse Event|0|||
41948785|NCT02111850|75713796|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
41948786|NCT02111850|75713797|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
41948787|NCT02111850|75713798|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
41948788|NCT02111850|75713799|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
41948789|NCT02111850|75713800|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
41948790|NCT02111850|75713801|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
41948791|NCT02111850|75713802|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
41948792|NCT02111850|75713803|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
41948793|NCT02111850|75713804|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
41948794|NCT02111850|75713805|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
41948795|NCT02111850|75713806|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
41948796|NCT02087904|75713836|FG000|Overall Study|Did Not Receive Study Drug|0|||
41948797|NCT02087904|75713837|FG001|Overall Study|Did Not Receive Study Drug|0|||
41948798|NCT02087904|75713838|FG002|Overall Study|Did Not Receive Study Drug|2|||
41948799|NCT02087904|75713839|FG003|Overall Study|Did Not Receive Study Drug|1|||
41948800|NCT02087904|75713836|FG000|Overall Study|Adverse Event|8|||
41948801|NCT02087904|75713837|FG001|Overall Study|Adverse Event|4|||
41948802|NCT02087904|75713838|FG002|Overall Study|Adverse Event|4|||
41948803|NCT02087904|75713839|FG003|Overall Study|Adverse Event|12|||
41948804|NCT02087904|75713836|FG000|Overall Study|Lack of Efficacy|3|||
41948805|NCT02087904|75713837|FG001|Overall Study|Lack of Efficacy|6|||
41948806|NCT02087904|75713838|FG002|Overall Study|Lack of Efficacy|3|||
41948807|NCT02087904|75713839|FG003|Overall Study|Lack of Efficacy|2|||
41948808|NCT02087904|75713836|FG000|Overall Study|Other|6|||
41948809|NCT02087904|75713837|FG001|Overall Study|Other|2|||
41948810|NCT02087904|75713838|FG002|Overall Study|Other|4|||
41948811|NCT02087904|75713839|FG003|Overall Study|Other|4|||
41948812|NCT02087904|75713836|FG000|Overall Study|Withdrawal by Subject|8|||
41948813|NCT02087904|75713837|FG001|Overall Study|Withdrawal by Subject|3|||
41948814|NCT02087904|75713838|FG002|Overall Study|Withdrawal by Subject|7|||
41948815|NCT02087904|75713839|FG003|Overall Study|Withdrawal by Subject|4|||
41948816|NCT02087904|75713836|FG000|Overall Study|Lost to Follow-up|0|||
41948817|NCT02087904|75713837|FG001|Overall Study|Lost to Follow-up|4|||
41948818|NCT02087904|75713838|FG002|Overall Study|Lost to Follow-up|2|||
41948819|NCT02087904|75713839|FG003|Overall Study|Lost to Follow-up|2|||
41948820|NCT02087670|75713851|FG000|Overall Study|Withdrawal by Subject|3|||
41948821|NCT02087670|75713852|FG001|Overall Study|Withdrawal by Subject|2|||
41948822|NCT02086968|75713860|FG000|Overall Study|Adverse Event|1|||
41948823|NCT02086968|75713861|FG001|Overall Study|Adverse Event|5|||
41948824|NCT02086968|75713860|FG000|Overall Study|Lost to Follow-up|2|||
41948825|NCT02086968|75713861|FG001|Overall Study|Lost to Follow-up|3|||
41948826|NCT02086968|75713860|FG000|Overall Study|Study drug received outside protocol|0|||
41948827|NCT02086968|75713861|FG001|Overall Study|Study drug received outside protocol|1|||
41948828|NCT02086968|75713860|FG000|Overall Study|Physician Decision|4|||
41948829|NCT02086968|75713861|FG001|Overall Study|Physician Decision|0|||
41948830|NCT02086968|75713860|FG000|Overall Study|Withdrawal by Subject|1|||
41948831|NCT02086968|75713861|FG001|Overall Study|Withdrawal by Subject|4|||
41948832|NCT02086110|75713869|FG000|Overall Study|Withdrawal by Subject|1|||
41948833|NCT02086110|75713870|FG001|Overall Study|Withdrawal by Subject|1|||
41948834|NCT02085252|75713879|FG000|Overall Study|Withdrawal of Consent|1|||
41948835|NCT02085252|75713880|FG001|Overall Study|Withdrawal of Consent|0|||
41948836|NCT02085252|75713879|FG000|Overall Study|Adverse Event|0|||
41948837|NCT02085252|75713880|FG001|Overall Study|Adverse Event|1|||
41948838|NCT02085252|75713879|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
41948839|NCT02085252|75713880|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
41948840|NCT02085252|75713879|FG000|Overall Study|Reason Not Specified|0|||
41948841|NCT02085252|75713880|FG001|Overall Study|Reason Not Specified|1|||
41948842|NCT02085252|75713879|FG000|Overall Study|Reason Unknown|0|||
41948843|NCT02085252|75713880|FG001|Overall Study|Reason Unknown|1|||
41948844|NCT02084238|75713886|FG000|Overall Study|Lost to Follow-up|2|||
41948845|NCT02084082|75713899|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
41948846|NCT02084082|75713900|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
41948847|NCT02084082|75713901|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
41948848|NCT02084082|75713902|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
41948849|NCT02084082|75713899|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
41948850|NCT02084082|75713900|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
41948851|NCT02084082|75713901|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
41948852|NCT02084082|75713902|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
41948853|NCT02083926|75713914|FG000|Overall Study|Withdrawal by Subject|1|||
41948854|NCT02083926|75713915|FG001|Overall Study|Withdrawal by Subject|0|||
41948855|NCT02083380|75713925|FG000|Overall Study|Lack of Efficacy|68|||
41948856|NCT02083380|75713926|FG001|Overall Study|Lack of Efficacy|79|||
41948857|NCT02083380|75713927|FG002|Overall Study|Lack of Efficacy|64|||
41948858|NCT02083380|75713925|FG000|Overall Study|Withdrawal by Subject|9|||
41948859|NCT02083380|75713926|FG001|Overall Study|Withdrawal by Subject|3|||
41948860|NCT02083380|75713927|FG002|Overall Study|Withdrawal by Subject|7|||
41948861|NCT02083380|75713925|FG000|Overall Study|Physician Decision|1|||
41948862|NCT02083380|75713926|FG001|Overall Study|Physician Decision|6|||
41948863|NCT02083380|75713927|FG002|Overall Study|Physician Decision|3|||
41948864|NCT02083380|75713925|FG000|Overall Study|Adverse Event|0|||
41948865|NCT02083380|75713926|FG001|Overall Study|Adverse Event|0|||
41948866|NCT02083380|75713927|FG002|Overall Study|Adverse Event|1|||
41948867|NCT02083380|75713925|FG000|Overall Study|Lost to Follow-up|5|||
41948868|NCT02083380|75713926|FG001|Overall Study|Lost to Follow-up|3|||
41948869|NCT02083380|75713927|FG002|Overall Study|Lost to Follow-up|3|||
41948870|NCT02083380|75713925|FG000|Overall Study|Other|8|||
42023695|NCT01189266|75831056|FG000|Overall Study|Withdrawal by Subject|0|||
42023696|NCT01189266|75831057|FG001|Overall Study|Withdrawal by Subject|0|||
42023697|NCT01189266|75831058|FG002|Overall Study|Withdrawal by Subject|1|||
42023698|NCT01189266|75831056|FG000|Overall Study|Patient refuses further therapy|1|||
42023699|NCT01189266|75831057|FG001|Overall Study|Patient refuses further therapy|0|||
42023700|NCT01189266|75831058|FG002|Overall Study|Patient refuses further therapy|7|||
41948871|NCT02083380|75713926|FG001|Overall Study|Other|4|||
41948872|NCT02083380|75713927|FG002|Overall Study|Other|6|||
41948873|NCT02109744|75713942|FG000|Overall Study|Death|1|||
41948874|NCT02109744|75713943|FG001|Overall Study|Death|1|||
41948875|NCT02109744|75713942|FG000|Overall Study|no marrow exam|1|||
41948876|NCT02109744|75713943|FG001|Overall Study|no marrow exam|0|||
41948877|NCT02109432|75713949|FG000|Overall Study|Withdrawal by Subject|1|||
41948878|NCT02109042|75713953|FG000|Overall Study|Sponsor Decision|15|||
41948879|NCT02066922|75713958|FG000|Overall Study|Adverse Event|1|||
41948880|NCT02108262|75713969|FG000|Overall Study|Non-compliance|0|||
41948881|NCT02108262|75713970|FG001|Overall Study|Non-compliance|2|||
41948882|NCT02108262|75713971|FG002|Overall Study|Non-compliance|1|||
41948883|NCT02108262|75713972|FG003|Overall Study|Non-compliance|1|||
41948884|NCT02108262|75713969|FG000|Overall Study|Randomized by error/screen failure|0|||
41948885|NCT02108262|75713970|FG001|Overall Study|Randomized by error/screen failure|0|||
41948886|NCT02108262|75713971|FG002|Overall Study|Randomized by error/screen failure|1|||
41948887|NCT02108262|75713972|FG003|Overall Study|Randomized by error/screen failure|0|||
41948888|NCT02108262|75713969|FG000|Overall Study|Distance to center|0|||
41948889|NCT02108262|75713970|FG001|Overall Study|Distance to center|1|||
41948890|NCT02108262|75713971|FG002|Overall Study|Distance to center|1|||
41948891|NCT02108262|75713972|FG003|Overall Study|Distance to center|0|||
41948892|NCT02108262|75713969|FG000|Overall Study|Adverse Event|0|||
41948893|NCT02108262|75713970|FG001|Overall Study|Adverse Event|11|||
41948894|NCT02108262|75713971|FG002|Overall Study|Adverse Event|6|||
41948895|NCT02108262|75713972|FG003|Overall Study|Adverse Event|12|||
41948896|NCT02108262|75713969|FG000|Overall Study|Death|0|||
41948897|NCT02108262|75713970|FG001|Overall Study|Death|2|||
41948898|NCT02108262|75713971|FG002|Overall Study|Death|2|||
41948899|NCT02108262|75713972|FG003|Overall Study|Death|1|||
41948900|NCT02108262|75713969|FG000|Overall Study|Lost to Follow-up|0|||
41948901|NCT02108262|75713970|FG001|Overall Study|Lost to Follow-up|0|||
41948902|NCT02108262|75713971|FG002|Overall Study|Lost to Follow-up|1|||
41948903|NCT02108262|75713972|FG003|Overall Study|Lost to Follow-up|0|||
41948904|NCT02108262|75713969|FG000|Overall Study|Physician Decision|0|||
41948905|NCT02108262|75713970|FG001|Overall Study|Physician Decision|0|||
41948906|NCT02108262|75713971|FG002|Overall Study|Physician Decision|2|||
41948907|NCT02108262|75713972|FG003|Overall Study|Physician Decision|0|||
41948908|NCT02108262|75713969|FG000|Overall Study|Withdrawal by Subject|0|||
41948909|NCT02108262|75713970|FG001|Overall Study|Withdrawal by Subject|7|||
41948910|NCT02108262|75713971|FG002|Overall Study|Withdrawal by Subject|3|||
41948911|NCT02108262|75713972|FG003|Overall Study|Withdrawal by Subject|4|||
41948912|NCT02108262|75713969|FG000|Overall Study|Due to key hepatic values|0|||
41948913|NCT02108262|75713970|FG001|Overall Study|Due to key hepatic values|1|||
41948914|NCT02108262|75713971|FG002|Overall Study|Due to key hepatic values|0|||
41948915|NCT02108262|75713972|FG003|Overall Study|Due to key hepatic values|0|||
41948916|NCT02108262|75713969|FG000|Overall Study|Unable to contact patient|0|||
41948917|NCT02108262|75713970|FG001|Overall Study|Unable to contact patient|3|||
41948918|NCT02108262|75713971|FG002|Overall Study|Unable to contact patient|1|||
41948919|NCT02108262|75713972|FG003|Overall Study|Unable to contact patient|2|||
41948920|NCT02108262|75713969|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
41948921|NCT02108262|75713970|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
41948922|NCT02108262|75713971|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
41948923|NCT02108262|75713972|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
41948924|NCT02108262|75713969|FG000|Overall Study|Patient did not want another infusion|0|||
41948925|NCT02108262|75713970|FG001|Overall Study|Patient did not want another infusion|3|||
41948926|NCT02108262|75713971|FG002|Overall Study|Patient did not want another infusion|3|||
41948927|NCT02108262|75713972|FG003|Overall Study|Patient did not want another infusion|2|||
41948928|NCT02108262|75713969|FG000|Overall Study|Vacation|0|||
41948929|NCT02108262|75713970|FG001|Overall Study|Vacation|1|||
41948930|NCT02108262|75713971|FG002|Overall Study|Vacation|0|||
41948931|NCT02108262|75713972|FG003|Overall Study|Vacation|0|||
41948932|NCT02108262|75713969|FG000|Overall Study|Patient decision|0|||
41948933|NCT02108262|75713970|FG001|Overall Study|Patient decision|7|||
41948934|NCT02108262|75713971|FG002|Overall Study|Patient decision|9|||
41948935|NCT02108262|75713972|FG003|Overall Study|Patient decision|14|||
42023701|NCT01189266|75831056|FG000|Overall Study|No treatment|0|||
42023702|NCT01189266|75831057|FG001|Overall Study|No treatment|0|||
42023703|NCT01189266|75831058|FG002|Overall Study|No treatment|1|||
42023704|NCT01189032|75831070|FG000|Overall Study|Adverse Event|1|||
42023705|NCT01189032|75831071|FG001|Overall Study|Adverse Event|3|||
42023706|NCT01189032|75831072|FG002|Overall Study|Adverse Event|4|||
42023707|NCT01189032|75831070|FG000|Overall Study|Lack of Efficacy|2|||
42023708|NCT01189032|75831071|FG001|Overall Study|Lack of Efficacy|3|||
42023709|NCT01189032|75831072|FG002|Overall Study|Lack of Efficacy|0|||
42023710|NCT01189032|75831070|FG000|Overall Study|Withdrawal by Subject|1|||
41948936|NCT02108262|75713969|FG000|Overall Study|Missed IV due to pharmacy error|0|||
41948937|NCT02108262|75713970|FG001|Overall Study|Missed IV due to pharmacy error|0|||
42023711|NCT01189032|75831071|FG001|Overall Study|Withdrawal by Subject|0|||
41948938|NCT02108262|75713971|FG002|Overall Study|Missed IV due to pharmacy error|1|||
41948939|NCT02108262|75713972|FG003|Overall Study|Missed IV due to pharmacy error|0|||
41948940|NCT02107482|75713981|FG000|Overall Study|inconveinence|2|||
41948941|NCT02107482|75713981|FG000|Overall Study|Lost to Follow-up|1|||
41948942|NCT02107482|75713981|FG000|Overall Study|Lack of Efficacy|1|||
41948943|NCT02066298|75713991|FG000|Overall Study|Lost to Follow-up|3|||
41948944|NCT02066298|75713992|FG001|Overall Study|Lost to Follow-up|2|||
41948945|NCT02066298|75713993|FG002|Overall Study|Lost to Follow-up|3|||
41948946|NCT02066298|75713994|FG003|Overall Study|Lost to Follow-up|2|||
41948947|NCT02066298|75713995|FG004|Overall Study|Lost to Follow-up|3|||
42023712|NCT01189032|75831072|FG002|Overall Study|Withdrawal by Subject|1|||
42023713|NCT01189032|75831070|FG000|Overall Study|Protocol Violation|1|||
42023714|NCT01189032|75831071|FG001|Overall Study|Protocol Violation|1|||
42023715|NCT01189032|75831072|FG002|Overall Study|Protocol Violation|1|||
42023716|NCT01188798|75831082|FG000|Overall Study|Death|0|||
41948948|NCT02066298|75713996|FG005|Overall Study|Lost to Follow-up|4|||
41948949|NCT02066298|75713991|FG000|Overall Study|Withdrawal by Subject|6|||
41948950|NCT02066298|75713992|FG001|Overall Study|Withdrawal by Subject|6|||
41948951|NCT02066298|75713993|FG002|Overall Study|Withdrawal by Subject|6|||
41948952|NCT02066298|75713994|FG003|Overall Study|Withdrawal by Subject|4|||
41948953|NCT02066298|75713995|FG004|Overall Study|Withdrawal by Subject|5|||
41948954|NCT02066298|75713996|FG005|Overall Study|Withdrawal by Subject|8|||
41948955|NCT02066298|75713991|FG000|Overall Study|Physician Decision|0|||
41948956|NCT02066298|75713992|FG001|Overall Study|Physician Decision|0|||
41948957|NCT02066298|75713993|FG002|Overall Study|Physician Decision|1|||
41948958|NCT02066298|75713994|FG003|Overall Study|Physician Decision|0|||
41948959|NCT02066298|75713995|FG004|Overall Study|Physician Decision|1|||
41948960|NCT02066298|75713996|FG005|Overall Study|Physician Decision|0|||
41948961|NCT02082912|75714010|FG000|Overall Study|Physician Decision|0|||
42023717|NCT01188798|75831083|FG001|Overall Study|Death|1|||
42023718|NCT01188798|75831082|FG000|Overall Study|Required additional transplant|1|||
42023719|NCT01188798|75831083|FG001|Overall Study|Required additional transplant|1|||
42023720|NCT01188798|75831082|FG000|Overall Study|Protocol closure|1|||
42023721|NCT01188798|75831083|FG001|Overall Study|Protocol closure|1|||
42023722|NCT01183104|75831092|FG000|Overall Study|Adverse Event|8|||
42023723|NCT01183104|75831093|FG001|Overall Study|Adverse Event|6|||
42023724|NCT01183104|75831092|FG000|Overall Study|Death|0|||
41948962|NCT02082912|75714011|FG001|Overall Study|Physician Decision|1|||
41948963|NCT02082522|75714019|FG000|Overall Study|Sponsor termination|5|||
41948964|NCT02082522|75714020|FG001|Overall Study|Sponsor termination|3|||
41948965|NCT02082522|75714019|FG000|Overall Study|Withdrawal by Subject|2|||
41948966|NCT02082522|75714020|FG001|Overall Study|Withdrawal by Subject|4|||
41948967|NCT02082522|75714019|FG000|Overall Study|Death|1|||
41948968|NCT02082522|75714020|FG001|Overall Study|Death|0|||
41948969|NCT02082522|75714019|FG000|Overall Study|Lost to Follow-up|1|||
41948970|NCT02082522|75714020|FG001|Overall Study|Lost to Follow-up|0|||
41948971|NCT02082522|75714019|FG000|Overall Study|Physician Decision|3|||
41948972|NCT02082522|75714020|FG001|Overall Study|Physician Decision|1|||
41948973|NCT02082522|75714019|FG000|Overall Study|Disease progression|2|||
41948974|NCT02082522|75714020|FG001|Overall Study|Disease progression|2|||
41948975|NCT02082522|75714019|FG000|Overall Study|Chemotherapy change|1|||
41948976|NCT02082522|75714020|FG001|Overall Study|Chemotherapy change|3|||
41948977|NCT02082210|75714032|FG000|Overall Study|Death|0|||
41948978|NCT02082210|75714033|FG001|Overall Study|Death|0|||
41948979|NCT02082210|75714034|FG002|Overall Study|Death|1|||
41948980|NCT02082210|75714035|FG003|Overall Study|Death|1|||
41948981|NCT02082210|75714036|FG004|Overall Study|Death|1|||
41948982|NCT02082210|75714037|FG005|Overall Study|Death|0|||
41948983|NCT02082210|75714032|FG000|Overall Study|Withdrawal by Subject|0|||
41948984|NCT02082210|75714033|FG001|Overall Study|Withdrawal by Subject|0|||
41948985|NCT02082210|75714034|FG002|Overall Study|Withdrawal by Subject|0|||
41948986|NCT02082210|75714035|FG003|Overall Study|Withdrawal by Subject|1|||
41948987|NCT02082210|75714036|FG004|Overall Study|Withdrawal by Subject|2|||
41948988|NCT02082210|75714037|FG005|Overall Study|Withdrawal by Subject|2|||
41948989|NCT02082210|75714032|FG000|Overall Study|Clinical Progression|0|||
41948990|NCT02082210|75714033|FG001|Overall Study|Clinical Progression|0|||
41948991|NCT02082210|75714034|FG002|Overall Study|Clinical Progression|0|||
42023725|NCT01183104|75831093|FG001|Overall Study|Death|1|||
42023726|NCT01183104|75831092|FG000|Overall Study|Lost to Follow-up|14|||
42118014|NCT00689117|75928843|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
42118015|NCT00689117|75928840|FG000|Overall Study|Use of Prohibitive Medication|2|||
42023727|NCT01183104|75831093|FG001|Overall Study|Lost to Follow-up|7|||
42023728|NCT01183104|75831092|FG000|Overall Study|Physician Decision|5|||
42023729|NCT01183104|75831093|FG001|Overall Study|Physician Decision|8|||
41948992|NCT02082210|75714035|FG003|Overall Study|Clinical Progression|1|||
41948993|NCT02082210|75714036|FG004|Overall Study|Clinical Progression|0|||
41948994|NCT02082210|75714037|FG005|Overall Study|Clinical Progression|0|||
41948995|NCT02082210|75714032|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
41948996|NCT02082210|75714033|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
41948997|NCT02082210|75714034|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
41948998|NCT02082210|75714035|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
41948999|NCT02082210|75714036|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
41949000|NCT02082210|75714037|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
41949001|NCT02082210|75714032|FG000|Overall Study|Physician Decision|0|||
41949002|NCT02082210|75714033|FG001|Overall Study|Physician Decision|0|||
41949003|NCT02082210|75714034|FG002|Overall Study|Physician Decision|1|||
42023730|NCT01183104|75831092|FG000|Overall Study|Withdrawal by Subject|6|||
41949004|NCT02082210|75714035|FG003|Overall Study|Physician Decision|1|||
41949005|NCT02082210|75714036|FG004|Overall Study|Physician Decision|0|||
41949006|NCT02082210|75714037|FG005|Overall Study|Physician Decision|0|||
41949007|NCT02107092|75714063|FG000|Overall Study|Miscellaneous|3|||
41949008|NCT02107092|75714063|FG000|Overall Study|Subject compliance|3|||
41949009|NCT02107092|75714063|FG000|Overall Study|Hypo-or hyperkalemia|2|||
41949010|NCT02107092|75714063|FG000|Overall Study|Met ECG withdrawal criteria|3|||
41949011|NCT02107092|75714063|FG000|Overall Study|Physician Decision|3|||
41949012|NCT02107092|75714063|FG000|Overall Study|Lost to Follow-up|2|||
41949013|NCT02107092|75714063|FG000|Overall Study|Withdrawal by Subject|9|||
41949014|NCT02107092|75714063|FG000|Overall Study|Adverse Event|7|||
41949015|NCT02107092|75714063|FG000|Overall Study|Expected progression of CKD|12|||
41949016|NCT02107014|75714067|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
42023731|NCT01183104|75831093|FG001|Overall Study|Withdrawal by Subject|11|||
42023732|NCT01183104|75831092|FG000|Overall Study|Nonparticipation in Extension Study|39|||
42023733|NCT01183104|75831093|FG001|Overall Study|Nonparticipation in Extension Study|50|||
42023734|NCT01183104|75831092|FG000|Overall Study|Did not receive study drug|5|||
42023735|NCT01183104|75831093|FG001|Overall Study|Did not receive study drug|9|||
42023736|NCT01163292|75831101|FG000|Overall Study|Lack of Efficacy|9|||
42023737|NCT01163292|75831102|FG001|Overall Study|Lack of Efficacy|0|||
42023738|NCT01163292|75831101|FG000|Overall Study|Adverse Event|6|||
42023739|NCT01163292|75831102|FG001|Overall Study|Adverse Event|0|||
42023740|NCT01163292|75831101|FG000|Overall Study|Initiation of biological therapy|0|||
42023741|NCT01163292|75831102|FG001|Overall Study|Initiation of biological therapy|15|||
41949017|NCT01624974|75714073|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
41949018|NCT01624974|75714074|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
41949019|NCT01624974|75714073|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
41949020|NCT01624974|75714074|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
41949021|NCT01624974|75714073|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
41949022|NCT01624974|75714074|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
41949023|NCT01624974|75714073|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
41949024|NCT01624974|75714074|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
41949025|NCT01624974|75714073|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
41949026|NCT01624974|75714074|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
41949027|NCT01624974|75714073|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
41949028|NCT01624974|75714074|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
41949029|NCT01624974|75714073|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
41949030|NCT01624974|75714074|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
41949031|NCT01624974|75714073|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
41949032|NCT01624974|75714074|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
41949033|NCT01624974|75714073|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
41949034|NCT01624974|75714074|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
41949035|NCT01624974|75714073|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
41949036|NCT01624974|75714074|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
41949037|NCT01624974|75714073|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
41949038|NCT01624974|75714074|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
41949039|NCT01624974|75714073|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
41949040|NCT01624974|75714074|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
41949041|NCT02065518|75714085|FG000|Overall Study|Lost to Follow-up|3|||
41949042|NCT02065518|75714086|FG001|Overall Study|Lost to Follow-up|4|||
41949043|NCT02065518|75714087|FG002|Overall Study|Lost to Follow-up|0|||
41949044|NCT02065518|75714088|FG003|Overall Study|Lost to Follow-up|3|||
41949045|NCT02065518|75714085|FG000|Overall Study|Withdrawal by Subject|3|||
41949046|NCT02065518|75714086|FG001|Overall Study|Withdrawal by Subject|4|||
41949047|NCT02065518|75714087|FG002|Overall Study|Withdrawal by Subject|9|||
41949048|NCT02065518|75714088|FG003|Overall Study|Withdrawal by Subject|2|||
42023742|NCT01163292|75831101|FG000|Overall Study|Sufficient response to adalimumab|8|||
42023743|NCT01163292|75831102|FG001|Overall Study|Sufficient response to adalimumab|0|||
42023744|NCT01163292|75831101|FG000|Overall Study|Refusal to receive adalimumab|7|||
42023745|NCT01163292|75831102|FG001|Overall Study|Refusal to receive adalimumab|0|||
42023746|NCT01163292|75831101|FG000|Overall Study|Economic reasons|6|||
42023747|NCT01163292|75831102|FG001|Overall Study|Economic reasons|0|||
42023748|NCT01163292|75831101|FG000|Overall Study|No further visits|5|||
42023749|NCT01163292|75831102|FG001|Overall Study|No further visits|7|||
41949049|NCT01624662|75714102|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
42023750|NCT00950248|75831110|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
42023751|NCT00950248|75831111|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
42118016|NCT00689117|75928841|FG001|Overall Study|Use of Prohibitive Medication|1|||
41949050|NCT01624662|75714103|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
41949051|NCT01624662|75714104|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
41949052|NCT01624662|75714105|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
41949053|NCT01624662|75714102|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
41949054|NCT01624662|75714103|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
41949055|NCT01624662|75714104|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
41949056|NCT01624662|75714105|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
41949057|NCT01624662|75714102|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
41949058|NCT01624662|75714103|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
41949059|NCT01624662|75714104|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
41949060|NCT01624662|75714105|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
41949061|NCT01624662|75714102|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
41949062|NCT01624662|75714103|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
41949063|NCT01624662|75714104|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
41949064|NCT01624662|75714105|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
41949065|NCT01624662|75714102|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
41949066|NCT01624662|75714103|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
41949067|NCT01624662|75714104|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
41949068|NCT01624662|75714105|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
41949069|NCT01624662|75714102|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
41949070|NCT01624662|75714103|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
41949071|NCT01624662|75714104|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
41949072|NCT01624662|75714105|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
41949073|NCT01624662|75714102|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
41949074|NCT01624662|75714103|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
41949075|NCT01624662|75714104|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
41949076|NCT01624662|75714105|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
42023752|NCT00950248|75831112|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
42023753|NCT00950248|75831110|FG000|Year 1: Baseline|worsening of symptoms|2|||
42118017|NCT00689117|75928842|FG002|Overall Study|Use of Prohibitive Medication|3|||
42118018|NCT00689117|75928843|FG003|Overall Study|Use of Prohibitive Medication|0|||
41949077|NCT01624506|75714128|FG000|Overall Study|Lost to Follow-up|29|||
41949078|NCT01624506|75714129|FG001|Overall Study|Lost to Follow-up|15|||
41949079|NCT01624506|75714128|FG000|Overall Study|Withdrawal by Subject|9|||
41949080|NCT01624506|75714129|FG001|Overall Study|Withdrawal by Subject|2|||
41949081|NCT01624506|75714128|FG000|Overall Study|Death|1|||
41949082|NCT01624506|75714129|FG001|Overall Study|Death|0|||
41949083|NCT01624506|75714128|FG000|Overall Study|LINX explants|23|||
41949084|NCT01624506|75714129|FG001|Overall Study|LINX explants|0|||
41949085|NCT01624506|75714128|FG000|Overall Study|Adverse Event|3|||
41949086|NCT01624506|75714129|FG001|Overall Study|Adverse Event|0|||
41949087|NCT02106390|75714138|FG000|Overall Study|Withdrawal by Subject|15|||
41949088|NCT02106390|75714139|FG001|Overall Study|Withdrawal by Subject|16|||
41949089|NCT02106390|75714140|FG002|Overall Study|Withdrawal by Subject|15|||
41949090|NCT02106390|75714138|FG000|Overall Study|Lost to Follow-up|25|||
41949091|NCT02106390|75714139|FG001|Overall Study|Lost to Follow-up|20|||
41949092|NCT02106390|75714140|FG002|Overall Study|Lost to Follow-up|13|||
41949093|NCT02106390|75714138|FG000|Overall Study|Other: Administrative Reason|8|||
41949094|NCT02106390|75714139|FG001|Overall Study|Other: Administrative Reason|5|||
41949095|NCT02106390|75714140|FG002|Overall Study|Other: Administrative Reason|12|||
41949096|NCT02106390|75714138|FG000|Overall Study|Other: Unspecified|1|||
41949097|NCT02106390|75714139|FG001|Overall Study|Other: Unspecified|4|||
41949098|NCT02106390|75714140|FG002|Overall Study|Other: Unspecified|2|||
41949099|NCT02106390|75714138|FG000|Overall Study|Adverse Event|0|||
41949100|NCT02106390|75714139|FG001|Overall Study|Adverse Event|2|||
41949101|NCT02106390|75714140|FG002|Overall Study|Adverse Event|1|||
41949102|NCT02106390|75714138|FG000|Overall Study|Protocol Violation|0|||
41949103|NCT02106390|75714139|FG001|Overall Study|Protocol Violation|1|||
41949104|NCT02106390|75714140|FG002|Overall Study|Protocol Violation|0|||
41949105|NCT02064894|75714154|FG000|Overall Study|Withdrawal by Subject|43|||
41949106|NCT02064894|75714155|FG001|Overall Study|Withdrawal by Subject|102|||
41949107|NCT02064894|75714156|FG002|Overall Study|Withdrawal by Subject|115|||
41949108|NCT02081586|75714168|FG000|Overall Study|Lost to Follow-up|0|||
41949109|NCT02081586|75714169|FG001|Overall Study|Lost to Follow-up|1|||
41949110|NCT02081586|75714170|FG002|Overall Study|Lost to Follow-up|0|||
41949111|NCT02081586|75714171|FG003|Overall Study|Lost to Follow-up|1|||
41949112|NCT02081586|75714168|FG000|Overall Study|Head injury not related to study|0|||
41949113|NCT02081586|75714169|FG001|Overall Study|Head injury not related to study|0|||
41949114|NCT02081586|75714170|FG002|Overall Study|Head injury not related to study|1|||
41949115|NCT02081586|75714171|FG003|Overall Study|Head injury not related to study|0|||
41949116|NCT02081196|75714183|FG000|Overall Study|Lost to Follow-up|1|||
41949117|NCT02064816|75714191|FG000|Overall Study|Adverse Event|3|||
41949118|NCT02064816|75714192|FG001|Overall Study|Adverse Event|2|||
41949119|NCT02064816|75714191|FG000|Overall Study|Withdrawal by Subject|2|||
41949120|NCT02064816|75714192|FG001|Overall Study|Withdrawal by Subject|1|||
41949121|NCT02064816|75714191|FG000|Overall Study|Lost to Follow-up|2|||
41949122|NCT02064816|75714192|FG001|Overall Study|Lost to Follow-up|1|||
41949123|NCT02064816|75714191|FG000|Overall Study|Therapeutic failure|0|||
41949124|NCT02064816|75714192|FG001|Overall Study|Therapeutic failure|1|||
41949125|NCT02064816|75714191|FG000|Overall Study|Other|1|||
41949126|NCT02064816|75714192|FG001|Overall Study|Other|3|||
41949127|NCT02080260|75714198|FG000|Overall Study|Death|18|||
41949128|NCT02080260|75714198|FG000|Overall Study|Withdrawal by Subject|1|||
41949129|NCT01624194|75714204|FG000|Overall Study|Lost to Follow-up|1|||
41949130|NCT01624194|75714205|FG001|Overall Study|Lost to Follow-up|0|||
41949131|NCT01624194|75714204|FG000|Overall Study|Withdrawal by Subject|1|||
41949132|NCT01624194|75714205|FG001|Overall Study|Withdrawal by Subject|0|||
41949133|NCT02079636|75714227|FG000|Overall Study|Death|2|||
41949134|NCT02079636|75714228|FG001|Overall Study|Death|1|||
41949135|NCT02079636|75714229|FG002|Overall Study|Death|0|||
41949136|NCT02079636|75714230|FG003|Overall Study|Death|5|||
41949137|NCT02079636|75714231|FG004|Overall Study|Death|1|||
41949138|NCT02079636|75714232|FG005|Overall Study|Death|2|||
41949139|NCT02079636|75714233|FG006|Overall Study|Death|1|||
41949140|NCT02079636|75714234|FG007|Overall Study|Death|0|||
41949141|NCT02079636|75714235|FG008|Overall Study|Death|0|||
41949142|NCT02079636|75714236|FG009|Overall Study|Death|0|||
41949143|NCT02079636|75714237|FG010|Overall Study|Death|0|||
41949144|NCT02079636|75714238|FG011|Overall Study|Death|1|||
41949145|NCT02079636|75714239|FG012|Overall Study|Death|1|||
41949146|NCT02079636|75714240|FG013|Overall Study|Death|0|||
41949147|NCT02079636|75714241|FG014|Overall Study|Death|2|||
41949148|NCT02079636|75714227|FG000|Overall Study|Adverse Event|1|||
41949149|NCT02079636|75714228|FG001|Overall Study|Adverse Event|1|||
41949150|NCT02079636|75714229|FG002|Overall Study|Adverse Event|0|||
41949151|NCT02079636|75714230|FG003|Overall Study|Adverse Event|1|||
41949152|NCT02079636|75714231|FG004|Overall Study|Adverse Event|1|||
41949153|NCT02079636|75714232|FG005|Overall Study|Adverse Event|2|||
41949154|NCT02079636|75714233|FG006|Overall Study|Adverse Event|0|||
41949155|NCT02079636|75714234|FG007|Overall Study|Adverse Event|0|||
41949156|NCT02079636|75714235|FG008|Overall Study|Adverse Event|0|||
41949157|NCT02079636|75714236|FG009|Overall Study|Adverse Event|0|||
41949158|NCT02079636|75714237|FG010|Overall Study|Adverse Event|0|||
41949159|NCT02079636|75714238|FG011|Overall Study|Adverse Event|0|||
41949160|NCT02079636|75714239|FG012|Overall Study|Adverse Event|0|||
41949161|NCT02079636|75714240|FG013|Overall Study|Adverse Event|0|||
41949162|NCT02079636|75714241|FG014|Overall Study|Adverse Event|0|||
41949163|NCT02079636|75714227|FG000|Overall Study|Progressive disease|0|||
42023754|NCT00950248|75831111|FG001|Year 1: Baseline|worsening of symptoms|0|||
42023755|NCT00950248|75831112|FG002|Year 1: Baseline|worsening of symptoms|0|||
42023756|NCT00950248|75831110|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
42023757|NCT00950248|75831111|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
42023758|NCT00950248|75831112|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
42023759|NCT00950248|75831110|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
42023760|NCT00950248|75831111|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
42023761|NCT00950248|75831112|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
42023762|NCT00950248|75831110|FG000|Year 2&3 Treatment Randomization|Death|0|||
42023763|NCT00950248|75831111|FG001|Year 2&3 Treatment Randomization|Death|0|||
42023764|NCT00950248|75831112|FG002|Year 2&3 Treatment Randomization|Death|1|||
42023765|NCT00950248|75831110|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
42023766|NCT00950248|75831111|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
42023767|NCT00950248|75831112|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
42023768|NCT00950170|75831119|FG000|Overall Study|Parent/Legal Guardian Request|1|||
42023769|NCT00950170|75831119|FG000|Overall Study|Adverse Event|2|||
42023770|NCT00950170|75831119|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
42023771|NCT01227824|75831143|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
42023772|NCT01227824|75831144|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
42023773|NCT01227824|75831145|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
42023774|NCT01227824|75831143|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
42023775|NCT01227824|75831144|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
42023776|NCT01227824|75831145|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
42023777|NCT01227824|75831143|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
42118019|NCT00689117|75928840|FG000|Overall Study|Pregnancy|0|||
42300356|NCT02326155|76135525|FG001|Overall Study|Withdrawal by Subject|11|||
42300357|NCT02326155|76135524|FG000|Overall Study|Disease progression|37|||
42300358|NCT02326155|76135525|FG001|Overall Study|Disease progression|4|||
42300359|NCT02326155|76135524|FG000|Overall Study|Study close|188|||
42300360|NCT02326155|76135525|FG001|Overall Study|Study close|21|||
42300361|NCT02326155|76135524|FG000|Overall Study|except for study close|46|||
42300362|NCT02326155|76135525|FG001|Overall Study|except for study close|13|||
42300363|NCT02299167|76135531|FG000|Overall Study|patients were excluded from the study|11|||
42300364|NCT01647711|76135540|FG000|Overall Study|Progressive disease|6|||
42300365|NCT01647711|76135541|FG001|Overall Study|Progressive disease|2|||
42300366|NCT01647711|76135542|FG002|Overall Study|Progressive disease|6|||
42300367|NCT01647711|76135543|FG003|Overall Study|Progressive disease|8|||
42300368|NCT01647711|76135544|FG004|Overall Study|Progressive disease|2|||
42300369|NCT01647711|76135540|FG000|Overall Study|Other adverse event|0|||
42300370|NCT01647711|76135541|FG001|Overall Study|Other adverse event|0|||
42300371|NCT01647711|76135542|FG002|Overall Study|Other adverse event|2|||
42300372|NCT01647711|76135543|FG003|Overall Study|Other adverse event|0|||
42300373|NCT01647711|76135544|FG004|Overall Study|Other adverse event|2|||
42300374|NCT01647711|76135540|FG000|Overall Study|Protocol Violation|0|||
42300375|NCT01647711|76135541|FG001|Overall Study|Protocol Violation|0|||
42300376|NCT01647711|76135542|FG002|Overall Study|Protocol Violation|0|||
42300377|NCT01647711|76135543|FG003|Overall Study|Protocol Violation|0|||
42300378|NCT01647711|76135544|FG004|Overall Study|Protocol Violation|1|||
41949164|NCT02079636|75714228|FG001|Overall Study|Progressive disease|0|||
41949165|NCT02079636|75714229|FG002|Overall Study|Progressive disease|0|||
41949166|NCT02079636|75714230|FG003|Overall Study|Progressive disease|2|||
42300379|NCT01647711|76135540|FG000|Overall Study|Refused to continue taking medication|0|||
42300380|NCT01647711|76135541|FG001|Overall Study|Refused to continue taking medication|0|||
42300381|NCT01647711|76135542|FG002|Overall Study|Refused to continue taking medication|0|||
42300382|NCT01647711|76135543|FG003|Overall Study|Refused to continue taking medication|2|||
41949167|NCT02079636|75714231|FG004|Overall Study|Progressive disease|0|||
42023778|NCT01227824|75831144|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
42300383|NCT01647711|76135544|FG004|Overall Study|Refused to continue taking medication|1|||
42300384|NCT01647711|76135540|FG000|Overall Study|Other reason not defined|0|||
42300385|NCT01647711|76135541|FG001|Overall Study|Other reason not defined|1|||
42300386|NCT01647711|76135542|FG002|Overall Study|Other reason not defined|1|||
42300387|NCT01647711|76135543|FG003|Overall Study|Other reason not defined|1|||
42300388|NCT01647711|76135544|FG004|Overall Study|Other reason not defined|0|||
42300389|NCT02547233|76135560|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
41949168|NCT02079636|75714232|FG005|Overall Study|Progressive disease|0|||
41949169|NCT02079636|75714233|FG006|Overall Study|Progressive disease|0|||
41949170|NCT02079636|75714234|FG007|Overall Study|Progressive disease|0|||
41949171|NCT02079636|75714235|FG008|Overall Study|Progressive disease|0|||
41949172|NCT02079636|75714236|FG009|Overall Study|Progressive disease|0|||
41949173|NCT02079636|75714237|FG010|Overall Study|Progressive disease|0|||
41949174|NCT02079636|75714238|FG011|Overall Study|Progressive disease|0|||
41949175|NCT02079636|75714239|FG012|Overall Study|Progressive disease|1|||
41949176|NCT02079636|75714240|FG013|Overall Study|Progressive disease|0|||
41949177|NCT02079636|75714241|FG014|Overall Study|Progressive disease|0|||
41949178|NCT02079636|75714227|FG000|Overall Study|Withdrawal by Subject|0|||
41949179|NCT02079636|75714228|FG001|Overall Study|Withdrawal by Subject|0|||
41949180|NCT02079636|75714229|FG002|Overall Study|Withdrawal by Subject|0|||
41949181|NCT02079636|75714230|FG003|Overall Study|Withdrawal by Subject|4|||
42300390|NCT02547233|76135561|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
42300391|NCT02547233|76135560|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
41949182|NCT02079636|75714231|FG004|Overall Study|Withdrawal by Subject|0|||
41949183|NCT02079636|75714232|FG005|Overall Study|Withdrawal by Subject|1|||
41949184|NCT02079636|75714233|FG006|Overall Study|Withdrawal by Subject|0|||
41949185|NCT02079636|75714234|FG007|Overall Study|Withdrawal by Subject|0|||
41949186|NCT02079636|75714235|FG008|Overall Study|Withdrawal by Subject|0|||
41949187|NCT02079636|75714236|FG009|Overall Study|Withdrawal by Subject|2|||
41949188|NCT02079636|75714237|FG010|Overall Study|Withdrawal by Subject|1|||
41949189|NCT02079636|75714238|FG011|Overall Study|Withdrawal by Subject|1|||
41949190|NCT02079636|75714239|FG012|Overall Study|Withdrawal by Subject|1|||
41949191|NCT02079636|75714240|FG013|Overall Study|Withdrawal by Subject|0|||
41949192|NCT02079636|75714241|FG014|Overall Study|Withdrawal by Subject|2|||
41949193|NCT02079636|75714227|FG000|Overall Study|Physician Decision|0|||
41949194|NCT02079636|75714228|FG001|Overall Study|Physician Decision|0|||
41949195|NCT02079636|75714229|FG002|Overall Study|Physician Decision|0|||
41949196|NCT02079636|75714230|FG003|Overall Study|Physician Decision|0|||
41949197|NCT02079636|75714231|FG004|Overall Study|Physician Decision|0|||
41949198|NCT02079636|75714232|FG005|Overall Study|Physician Decision|1|||
41949199|NCT02079636|75714233|FG006|Overall Study|Physician Decision|0|||
41949200|NCT02079636|75714234|FG007|Overall Study|Physician Decision|0|||
41949201|NCT02079636|75714235|FG008|Overall Study|Physician Decision|0|||
41949202|NCT02079636|75714236|FG009|Overall Study|Physician Decision|1|||
41949203|NCT02079636|75714237|FG010|Overall Study|Physician Decision|1|||
41949204|NCT02079636|75714238|FG011|Overall Study|Physician Decision|0|||
41949205|NCT02079636|75714239|FG012|Overall Study|Physician Decision|0|||
41949206|NCT02079636|75714240|FG013|Overall Study|Physician Decision|0|||
41949207|NCT02079636|75714241|FG014|Overall Study|Physician Decision|1|||
41949208|NCT02079636|75714227|FG000|Overall Study|Lost to Follow-up|0|||
41949209|NCT02079636|75714228|FG001|Overall Study|Lost to Follow-up|0|||
41949210|NCT02079636|75714229|FG002|Overall Study|Lost to Follow-up|0|||
41949211|NCT02079636|75714230|FG003|Overall Study|Lost to Follow-up|0|||
41949212|NCT02079636|75714231|FG004|Overall Study|Lost to Follow-up|0|||
41949213|NCT02079636|75714232|FG005|Overall Study|Lost to Follow-up|0|||
41949214|NCT02079636|75714233|FG006|Overall Study|Lost to Follow-up|0|||
41949215|NCT02079636|75714234|FG007|Overall Study|Lost to Follow-up|1|||
41949216|NCT02079636|75714235|FG008|Overall Study|Lost to Follow-up|0|||
41949217|NCT02079636|75714236|FG009|Overall Study|Lost to Follow-up|0|||
41949218|NCT02079636|75714237|FG010|Overall Study|Lost to Follow-up|0|||
41949219|NCT02079636|75714238|FG011|Overall Study|Lost to Follow-up|0|||
41949220|NCT02079636|75714239|FG012|Overall Study|Lost to Follow-up|0|||
41949221|NCT02079636|75714240|FG013|Overall Study|Lost to Follow-up|0|||
41949222|NCT02079636|75714241|FG014|Overall Study|Lost to Follow-up|0|||
41949223|NCT02079246|75714305|FG000|OLEX|Withdrawal before treatment|1|||
41949224|NCT02079246|75714306|FG001|OLEX|Withdrawal before treatment|0|||
41949225|NCT02079246|75714305|FG000|OLEX|Death|11|||
41949226|NCT02079246|75714306|FG001|OLEX|Death|0|||
41949227|NCT02079246|75714305|FG000|OLEX|Adverse Event|66|||
41949228|NCT02079246|75714306|FG001|OLEX|Adverse Event|0|||
41949229|NCT02079246|75714305|FG000|OLEX|Withdrawal by Subject|60|||
41949230|NCT02079246|75714306|FG001|OLEX|Withdrawal by Subject|0|||
41949231|NCT02079246|75714305|FG000|OLEX|Lost to Follow-up|6|||
41949232|NCT02079246|75714306|FG001|OLEX|Lost to Follow-up|0|||
41949233|NCT02079246|75714305|FG000|OLEX|Protocol Violation|6|||
41949234|NCT02079246|75714306|FG001|OLEX|Protocol Violation|0|||
41949235|NCT02079246|75714305|FG000|OLEX|Lack of Efficacy|3|||
42300392|NCT02547233|76135561|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
41949236|NCT02079246|75714306|FG001|OLEX|Lack of Efficacy|0|||
41949237|NCT02079246|75714305|FG000|OLEX|Results of the lead-in studies|58|||
41949238|NCT02079246|75714306|FG001|OLEX|Results of the lead-in studies|0|||
41949239|NCT02079246|75714305|FG000|OLEX|Other: Disallowed medication|8|||
41949240|NCT02079246|75714306|FG001|OLEX|Other: Disallowed medication|0|||
41949241|NCT02079246|75714305|FG000|OLEX|Other: Insufficient compliance|2|||
41949242|NCT02079246|75714306|FG001|OLEX|Other: Insufficient compliance|0|||
41949243|NCT02079246|75714305|FG000|OLEX|Other: Caregiver unavailable|3|||
41949244|NCT02079246|75714306|FG001|OLEX|Other: Caregiver unavailable|0|||
41949245|NCT02079246|75714305|FG000|OLEX|Other: Coordinator decision|1|||
41949246|NCT02079246|75714306|FG001|OLEX|Other: Coordinator decision|0|||
41949247|NCT02079246|75714305|FG000|OLEX|Other: Worsening of condition|1|||
41949248|NCT02079246|75714306|FG001|OLEX|Other: Worsening of condition|0|||
41949249|NCT02079246|75714305|FG000|OLEX|Other: Moved to nursing home|1|||
41949250|NCT02079246|75714306|FG001|OLEX|Other: Moved to nursing home|0|||
41949251|NCT02079246|75714305|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
41949252|NCT02079246|75714306|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
41949253|NCT02079246|75714305|FG000|OLEX-MEM|Adverse Event|0|||
41949254|NCT02079246|75714306|FG001|OLEX-MEM|Adverse Event|6|||
41949255|NCT02079246|75714305|FG000|OLEX-MEM|Withdrawal by Subject|0|||
41949256|NCT02079246|75714306|FG001|OLEX-MEM|Withdrawal by Subject|7|||
41949257|NCT02079246|75714305|FG000|OLEX-MEM|Protocol Violation|0|||
41949258|NCT02079246|75714306|FG001|OLEX-MEM|Protocol Violation|2|||
41949259|NCT02079246|75714305|FG000|OLEX-MEM|Lost to Follow-up|0|||
41949260|NCT02079246|75714306|FG001|OLEX-MEM|Lost to Follow-up|1|||
41949261|NCT02079246|75714305|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
41949262|NCT02079246|75714306|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
41949263|NCT02077374|75714317|FG000|Overall Study|Withdrawal by Subject|0|||
41949264|NCT02077374|75714318|FG001|Overall Study|Withdrawal by Subject|1|||
41949265|NCT02077374|75714317|FG000|Overall Study|Protocol Violation|0|||
41949266|NCT02077374|75714318|FG001|Overall Study|Protocol Violation|1|||
41949267|NCT02077140|75714332|FG000|Overall Study|Lost to Follow-up|4|||
41949268|NCT02077140|75714333|FG001|Overall Study|Lost to Follow-up|1|||
41949269|NCT02077140|75714334|FG002|Overall Study|Lost to Follow-up|2|||
41949270|NCT02077140|75714335|FG003|Overall Study|Lost to Follow-up|2|||
41949271|NCT02077140|75714336|FG004|Overall Study|Lost to Follow-up|3|||
41949272|NCT02077140|75714332|FG000|Overall Study|Withdrawal by Subject|0|||
41949273|NCT02077140|75714333|FG001|Overall Study|Withdrawal by Subject|1|||
41949274|NCT02077140|75714334|FG002|Overall Study|Withdrawal by Subject|0|||
41949275|NCT02077140|75714335|FG003|Overall Study|Withdrawal by Subject|2|||
41949276|NCT02077140|75714336|FG004|Overall Study|Withdrawal by Subject|2|||
41949277|NCT02047110|75714355|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
41949278|NCT02047110|75714356|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
41949279|NCT02047110|75714357|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
41949280|NCT02047110|75714358|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
41949281|NCT02047110|75714355|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
41949282|NCT02047110|75714356|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
41949283|NCT02047110|75714357|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
41949284|NCT02047110|75714358|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
41949285|NCT02047110|75714355|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
41949286|NCT02047110|75714356|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
41949287|NCT02047110|75714357|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
41949288|NCT02047110|75714358|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
41949289|NCT02047110|75714355|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
41949290|NCT02047110|75714356|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
41949291|NCT02047110|75714357|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
41949292|NCT02047110|75714358|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
41949293|NCT02047110|75714355|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
41949294|NCT02047110|75714356|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
41949295|NCT02047110|75714357|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
41949296|NCT02047110|75714358|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
41949297|NCT02047110|75714355|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
41949298|NCT02047110|75714356|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
41949299|NCT02047110|75714357|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
41949300|NCT02047110|75714358|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
41949301|NCT02047110|75714355|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
41949302|NCT02047110|75714356|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
41949303|NCT02047110|75714357|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
41949304|NCT02047110|75714358|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
41949305|NCT02047110|75714355|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
41949306|NCT02047110|75714356|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
41949307|NCT02047110|75714357|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
41949308|NCT02047110|75714358|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
41949309|NCT02047110|75714355|FG000|Escape Treatment Period|Adverse Event|1|||
41949310|NCT02047110|75714356|FG001|Escape Treatment Period|Adverse Event|2|||
41949311|NCT02047110|75714357|FG002|Escape Treatment Period|Adverse Event|2|||
41949312|NCT02047110|75714358|FG003|Escape Treatment Period|Adverse Event|0|||
41949313|NCT02047110|75714355|FG000|Escape Treatment Period|Other than specified|1|||
41949314|NCT02047110|75714356|FG001|Escape Treatment Period|Other than specified|2|||
41949315|NCT02047110|75714357|FG002|Escape Treatment Period|Other than specified|0|||
41949316|NCT02047110|75714358|FG003|Escape Treatment Period|Other than specified|1|||
41949317|NCT02047110|75714355|FG000|OLE Treatment Period|Other than specified|0|||
41949318|NCT02047110|75714356|FG001|OLE Treatment Period|Other than specified|0|||
41949319|NCT02047110|75714357|FG002|OLE Treatment Period|Other than specified|1|||
41949320|NCT02047110|75714358|FG003|OLE Treatment Period|Other than specified|0|||
41949321|NCT02046564|75714377|FG000|Overall Study|Adverse Event|6|||
41949322|NCT02046564|75714378|FG001|Overall Study|Adverse Event|3|||
41949323|NCT02046564|75714377|FG000|Overall Study|Physician Decision|0|||
41949324|NCT02046564|75714378|FG001|Overall Study|Physician Decision|1|||
41949325|NCT02046564|75714377|FG000|Overall Study|Protocol Violation|3|||
41949326|NCT02046564|75714378|FG001|Overall Study|Protocol Violation|1|||
41949327|NCT02046564|75714377|FG000|Overall Study|Withdrawal by Subject|4|||
41949328|NCT02046564|75714378|FG001|Overall Study|Withdrawal by Subject|10|||
41949329|NCT02046564|75714377|FG000|Overall Study|Subject met withdrawal criteria|2|||
41949330|NCT02046564|75714378|FG001|Overall Study|Subject met withdrawal criteria|5|||
41949331|NCT02046174|75714384|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
41949332|NCT02046174|75714385|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
41949333|NCT02045862|75714473|FG000|Overall Study|Death|0|||
41949334|NCT02045862|75714474|FG001|Overall Study|Death|0|||
41949335|NCT02045862|75714475|FG002|Overall Study|Death|1|||
41949336|NCT02045862|75714473|FG000|Overall Study|Miscellaneous|5|||
41949337|NCT02045862|75714474|FG001|Overall Study|Miscellaneous|0|||
41949338|NCT02045862|75714475|FG002|Overall Study|Miscellaneous|8|||
41949339|NCT02045862|75714473|FG000|Overall Study|Withdrawal by Patient|18|||
41949340|NCT02045862|75714474|FG001|Overall Study|Withdrawal by Patient|27|||
41949341|NCT02045862|75714475|FG002|Overall Study|Withdrawal by Patient|57|||
41949342|NCT02045862|75714473|FG000|Overall Study|Protocol Violation|0|||
41949343|NCT02045862|75714474|FG001|Overall Study|Protocol Violation|0|||
41949344|NCT02045862|75714475|FG002|Overall Study|Protocol Violation|6|||
41949345|NCT02045862|75714473|FG000|Overall Study|Lack of Efficacy|8|||
41949346|NCT02045862|75714474|FG001|Overall Study|Lack of Efficacy|4|||
41949347|NCT02045862|75714475|FG002|Overall Study|Lack of Efficacy|13|||
41949348|NCT02045862|75714473|FG000|Overall Study|Randomized but not Received Study Drug|0|||
41949349|NCT02045862|75714474|FG001|Overall Study|Randomized but not Received Study Drug|2|||
41949350|NCT02045862|75714475|FG002|Overall Study|Randomized but not Received Study Drug|8|||
41949351|NCT02045862|75714473|FG000|Overall Study|Adverse Event|7|||
41949352|NCT02045862|75714474|FG001|Overall Study|Adverse Event|5|||
41949353|NCT02045862|75714475|FG002|Overall Study|Adverse Event|27|||
41949354|NCT02045862|75714473|FG000|Overall Study|Lost to Follow-up|1|||
41949355|NCT02045862|75714474|FG001|Overall Study|Lost to Follow-up|2|||
41949356|NCT02045862|75714475|FG002|Overall Study|Lost to Follow-up|6|||
42300393|NCT02547233|76135560|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
42300394|NCT02547233|76135561|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
41949357|NCT02075658|75714485|FG000|Overall Study|Physician Decision|2|||
41949358|NCT02075658|75714486|FG001|Overall Study|Physician Decision|2|||
41949359|NCT02063880|75714494|FG000|Overall Study|Death|21|||
41949360|NCT02063880|75714495|FG001|Overall Study|Death|18|||
41949361|NCT02063880|75714494|FG000|Overall Study|Lost to Follow-up|7|||
41949362|NCT02063880|75714495|FG001|Overall Study|Lost to Follow-up|7|||
41949363|NCT02063880|75714494|FG000|Overall Study|Ineligible|0|||
41949364|NCT02063880|75714495|FG001|Overall Study|Ineligible|2|||
41949365|NCT02044848|75714503|FG000|Overall Study|Administrative Problems|2|||
41949366|NCT02044848|75714504|FG001|Overall Study|Administrative Problems|3|||
41949367|NCT02044458|75714512|FG000|Overall Study|Protocol Violation|3|||
41949368|NCT02044458|75714513|FG001|Overall Study|Protocol Violation|8|||
42118020|NCT00689117|75928841|FG001|Overall Study|Pregnancy|2|||
41949369|NCT02044302|75714521|FG000|Overall Study|study terminated|2|||
41949370|NCT02044302|75714522|FG001|Overall Study|study terminated|0|||
41949371|NCT02062944|75714526|FG000|Overall Study|Lost to Follow-up|1|||
41949372|NCT02062944|75714526|FG000|Overall Study|New hemotological disorder identified|1|||
41949373|NCT02062944|75714526|FG000|Overall Study|Uncontrolled Hypertension|1|||
41949374|NCT02062944|75714526|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
41949375|NCT02062632|75714531|FG000|Overall Study|No treatment data|1|||
41949376|NCT02062398|75714535|FG000|Overall Study|Implant removal|1|||
41949377|NCT02061540|75714539|FG000|Overall Study|Adverse Event|2|||
41949378|NCT02061540|75714539|FG000|Overall Study|Withdrawal by Subject|2|||
41949379|NCT02043366|75714554|FG000|Overall Study|Lost to Follow-up|2|||
41949380|NCT02043366|75714555|FG001|Overall Study|Lost to Follow-up|2|||
41949381|NCT02043366|75714556|FG002|Overall Study|Lost to Follow-up|2|||
41949382|NCT02043366|75714557|FG003|Overall Study|Lost to Follow-up|2|||
41949383|NCT02043366|75714558|FG004|Overall Study|Lost to Follow-up|2|||
41949384|NCT02043366|75714559|FG005|Overall Study|Lost to Follow-up|2|||
41949385|NCT02060370|75714575|FG000|Overall Study|Physician Decision|1|||
41949386|NCT01622088|75714579|FG000|Overall Study|Adverse Event|20|||
41949387|NCT01622088|75714579|FG000|Overall Study|Lost to Follow-up|1|||
41949388|NCT01622088|75714579|FG000|Overall Study|Withdrawal by Subject|20|||
41949389|NCT01622088|75714579|FG000|Overall Study|Investigator Decision|1|||
41949390|NCT01622088|75714579|FG000|Overall Study|Death|53|||
41949391|NCT01622088|75714579|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
41949392|NCT01621542|75714590|FG000|Overall Study|Adverse Event|0|||
41949393|NCT01621542|75714591|FG001|Overall Study|Adverse Event|0|||
41949394|NCT01621542|75714592|FG002|Overall Study|Adverse Event|1|||
41949395|NCT01621542|75714593|FG003|Overall Study|Adverse Event|3|||
41949396|NCT01621542|75714594|FG004|Overall Study|Adverse Event|0|||
41949397|NCT01621542|75714595|FG005|Overall Study|Adverse Event|0|||
41949398|NCT01621542|75714590|FG000|Overall Study|Death|0|||
41949399|NCT01621542|75714591|FG001|Overall Study|Death|1|||
41949400|NCT01621542|75714592|FG002|Overall Study|Death|0|||
41949401|NCT01621542|75714593|FG003|Overall Study|Death|0|||
41949402|NCT01621542|75714594|FG004|Overall Study|Death|0|||
41949403|NCT01621542|75714595|FG005|Overall Study|Death|0|||
41949404|NCT01621542|75714590|FG000|Overall Study|Physician Decision|1|||
41949405|NCT01621542|75714591|FG001|Overall Study|Physician Decision|0|||
41949406|NCT01621542|75714592|FG002|Overall Study|Physician Decision|1|||
41949407|NCT01621542|75714593|FG003|Overall Study|Physician Decision|13|||
41949408|NCT01621542|75714594|FG004|Overall Study|Physician Decision|3|||
41949409|NCT01621542|75714595|FG005|Overall Study|Physician Decision|1|||
41949410|NCT01621542|75714590|FG000|Overall Study|Withdrawal by Subject|2|||
41949411|NCT01621542|75714591|FG001|Overall Study|Withdrawal by Subject|0|||
41949412|NCT01621542|75714592|FG002|Overall Study|Withdrawal by Subject|1|||
41949413|NCT01621542|75714593|FG003|Overall Study|Withdrawal by Subject|3|||
41949414|NCT01621542|75714594|FG004|Overall Study|Withdrawal by Subject|3|||
41949415|NCT01621542|75714595|FG005|Overall Study|Withdrawal by Subject|3|||
41949416|NCT01621542|75714590|FG000|Overall Study|progression/treatment failure|2|||
41949417|NCT01621542|75714591|FG001|Overall Study|progression/treatment failure|4|||
41949418|NCT01621542|75714592|FG002|Overall Study|progression/treatment failure|3|||
41949419|NCT01621542|75714593|FG003|Overall Study|progression/treatment failure|7|||
41949420|NCT01621542|75714594|FG004|Overall Study|progression/treatment failure|3|||
41949421|NCT01621542|75714595|FG005|Overall Study|progression/treatment failure|5|||
41949422|NCT01621542|75714590|FG000|Overall Study|Protocol Violation|0|||
41949423|NCT01621542|75714591|FG001|Overall Study|Protocol Violation|0|||
41949424|NCT01621542|75714592|FG002|Overall Study|Protocol Violation|0|||
41949425|NCT01621542|75714593|FG003|Overall Study|Protocol Violation|1|||
41949426|NCT01621542|75714594|FG004|Overall Study|Protocol Violation|0|||
41949427|NCT01621542|75714595|FG005|Overall Study|Protocol Violation|0|||
41949428|NCT01621542|75714590|FG000|Overall Study|study stopped by sponsor|0|||
41949429|NCT01621542|75714591|FG001|Overall Study|study stopped by sponsor|0|||
41949430|NCT01621542|75714592|FG002|Overall Study|study stopped by sponsor|0|||
41949431|NCT01621542|75714593|FG003|Overall Study|study stopped by sponsor|1|||
41949432|NCT01621542|75714594|FG004|Overall Study|study stopped by sponsor|0|||
41949433|NCT01621542|75714595|FG005|Overall Study|study stopped by sponsor|0|||
41949434|NCT02021292|75714611|FG000|Overall Study|Physician Decision|0|||
41949435|NCT02021292|75714612|FG001|Overall Study|Physician Decision|1|||
41949436|NCT02021292|75714611|FG000|Overall Study|Lost to Follow-up|0|||
41949437|NCT02021292|75714612|FG001|Overall Study|Lost to Follow-up|1|||
41949438|NCT02021292|75714611|FG000|Overall Study|Death|0|||
41949439|NCT02021292|75714612|FG001|Overall Study|Death|1|||
41949440|NCT02059980|75714622|FG000|Overall Study|Lost to Follow-up|2|||
41949441|NCT02059980|75714623|FG001|Overall Study|Lost to Follow-up|1|||
41949442|NCT02043132|75714631|FG000|Overall Study|Lost to Follow-up|1|||
41949443|NCT02043132|75714632|FG001|Overall Study|Lost to Follow-up|1|||
41949444|NCT02043132|75714631|FG000|Overall Study|screen failures|4|||
41949445|NCT02043132|75714632|FG001|Overall Study|screen failures|8|||
41949446|NCT02059434|75714647|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
41949447|NCT02059434|75714648|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
41949448|NCT02059434|75714649|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
41949449|NCT02059434|75714650|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
41949450|NCT02059434|75714651|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
41949451|NCT02059434|75714652|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
41949452|NCT02059434|75714653|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
41949453|NCT02059434|75714654|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
41949454|NCT02059434|75714655|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
41949455|NCT02059434|75714647|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
41949456|NCT02059434|75714648|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
41949457|NCT02059434|75714649|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
41949458|NCT02059434|75714650|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
41949459|NCT02059434|75714651|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
41949460|NCT02059434|75714652|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
41949461|NCT02059434|75714653|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
41949462|NCT02059434|75714654|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
41949463|NCT02059434|75714655|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
41949464|NCT02059434|75714647|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
41949465|NCT02059434|75714648|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
41949466|NCT02059434|75714649|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
41949467|NCT02059434|75714650|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
41949468|NCT02059434|75714651|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
41949469|NCT02059434|75714652|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
41949470|NCT02059434|75714653|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
41949471|NCT02059434|75714654|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
41949472|NCT02059434|75714655|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
41949473|NCT02059434|75714647|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
41949474|NCT02059434|75714648|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
41949475|NCT02059434|75714649|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
41949476|NCT02059434|75714650|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
41949477|NCT02059434|75714651|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
41949478|NCT02059434|75714652|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
41949479|NCT02059434|75714653|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
41949480|NCT02059434|75714654|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
41949481|NCT02059434|75714655|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
41949482|NCT02059434|75714647|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
41949483|NCT02059434|75714648|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
41949484|NCT02059434|75714649|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
41949485|NCT02059434|75714650|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
41949486|NCT02059434|75714651|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
41949487|NCT02059434|75714652|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
41949488|NCT02059434|75714653|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
41949489|NCT02059434|75714654|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
41949490|NCT02059434|75714655|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
41949491|NCT02059278|75714685|FG000|Overall Study|Adverse Event|1|||
41949492|NCT02059278|75714686|FG001|Overall Study|Adverse Event|1|||
41949493|NCT02059278|75714685|FG000|Overall Study|Lost to Follow-up|1|||
41949494|NCT02059278|75714686|FG001|Overall Study|Lost to Follow-up|0|||
41949495|NCT02059278|75714685|FG000|Overall Study|Withdrawal by Subject|0|||
41949496|NCT02059278|75714686|FG001|Overall Study|Withdrawal by Subject|3|||
41949497|NCT02059278|75714685|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
41949498|NCT02059278|75714686|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
41949499|NCT02020512|75714692|FG000|Overall Study|Adverse Event|1|||
41949500|NCT02020512|75714692|FG000|Overall Study|Lost to Follow-up|3|||
41949501|NCT02020512|75714692|FG000|Overall Study|Protocol Violation|4|||
41949502|NCT02041962|75714698|FG000|Overall Study|Lost Aetna Coverage|43|||
41949503|NCT02041962|75714699|FG001|Overall Study|Lost Aetna Coverage|40|||
41949504|NCT02041962|75714698|FG000|Overall Study|Death|1|||
41949505|NCT02041962|75714699|FG001|Overall Study|Death|1|||
41949506|NCT02041962|75714698|FG000|Overall Study|Lost to Follow-up|37|||
41949507|NCT02041962|75714699|FG001|Overall Study|Lost to Follow-up|32|||
41949508|NCT02041962|75714698|FG000|Overall Study|Withdrawal by Subject|0|||
41949509|NCT02041962|75714699|FG001|Overall Study|Withdrawal by Subject|11|||
41949510|NCT02041494|75714707|FG000|Overall Study|Death|1|||
41949511|NCT02041494|75714708|FG001|Overall Study|Death|3|||
41949512|NCT02041494|75714707|FG000|Overall Study|Lost to Follow-up|2|||
41949513|NCT02041494|75714708|FG001|Overall Study|Lost to Follow-up|6|||
41949514|NCT02041494|75714707|FG000|Overall Study|study terminated|16|||
41949515|NCT02041494|75714708|FG001|Overall Study|study terminated|11|||
41949516|NCT02041104|75714739|FG000|Overall Study|Lost to Follow-up|1|||
41949517|NCT02041104|75714740|FG001|Overall Study|Lost to Follow-up|4|||
41949518|NCT02041104|75714739|FG000|Overall Study|discomfort during OGTT|0|||
42118021|NCT00689117|75928842|FG002|Overall Study|Pregnancy|0|||
42118022|NCT00689117|75928843|FG003|Overall Study|Pregnancy|2|||
41949519|NCT02041104|75714740|FG001|Overall Study|discomfort during OGTT|3|||
41949520|NCT02019420|75714750|FG000|Overall Study|Did not receive study drug|2|||
41949521|NCT02019420|75714751|FG001|Overall Study|Did not receive study drug|2|||
41949522|NCT02019420|75714750|FG000|Overall Study|Withdrawal by Subject|1|||
41949523|NCT02019420|75714751|FG001|Overall Study|Withdrawal by Subject|3|||
41949524|NCT02019420|75714750|FG000|Overall Study|At request of sponsor or investigator|0|||
41949525|NCT02019420|75714751|FG001|Overall Study|At request of sponsor or investigator|1|||
41949526|NCT02019420|75714750|FG000|Overall Study|Death|104|||
41949527|NCT02019420|75714751|FG001|Overall Study|Death|99|||
41949528|NCT02019420|75714750|FG000|Overall Study|Transferred to other care facility|1|||
41949529|NCT02019420|75714751|FG001|Overall Study|Transferred to other care facility|1|||
41949530|NCT02019264|75714759|FG000|Overall Study|Not treated|6|||
41949531|NCT02019264|75714760|FG001|Overall Study|Not treated|4|||
41949532|NCT02019264|75714759|FG000|Overall Study|Lost to Follow-up|50|||
41949533|NCT02019264|75714760|FG001|Overall Study|Lost to Follow-up|47|||
41949534|NCT02019264|75714759|FG000|Overall Study|Withdrawal by Subject|142|||
41949535|NCT02019264|75714760|FG001|Overall Study|Withdrawal by Subject|117|||
41949536|NCT02019264|75714759|FG000|Overall Study|Administrative reason|36|||
41949537|NCT02019264|75714760|FG001|Overall Study|Administrative reason|28|||
41949538|NCT02019264|75714759|FG000|Overall Study|Missing|14|||
41949539|NCT02019264|75714760|FG001|Overall Study|Missing|11|||
41949540|NCT02019108|75714768|FG000|Overall Study|Lost to Follow-up|5|||
41949541|NCT02019108|75714769|FG001|Overall Study|Lost to Follow-up|7|||
41949542|NCT02018562|75714777|FG000|Overall Study|Withdrawal by Subject|2|||
41949543|NCT02018562|75714778|FG001|Overall Study|Withdrawal by Subject|0|||
41949544|NCT02018562|75714777|FG000|Overall Study|Discharged prior to study completion|1|||
41949545|NCT02018562|75714778|FG001|Overall Study|Discharged prior to study completion|0|||
41949546|NCT02058966|75714784|FG000|Open-Label Methamphetamine|Adverse Event|1|||
41949547|NCT02058966|75714784|FG000|First Intervention|Withdrawal by Subject|1|||
41949548|NCT02017860|75714796|FG000|Overall Study|Adverse Event|1|||
41949549|NCT02017860|75714796|FG000|Overall Study|Withdrawal by Subject|1|||
41949550|NCT02040870|75714800|FG000|Overall Study|Completed treatment phase|6|||
41949551|NCT02040870|75714800|FG000|Overall Study|Adverse Event|7|||
41949552|NCT02040870|75714800|FG000|Overall Study|Progressive disease|58|||
41949553|NCT02040870|75714800|FG000|Overall Study|Physician Decision|6|||
41949554|NCT02040870|75714800|FG000|Overall Study|Subject/guardian decision|10|||
41949555|NCT02040870|75714800|FG000|Overall Study|Lost to Follow-up|3|||
41949556|NCT02040870|75714800|FG000|Overall Study|Death|13|||
41949557|NCT02016690|75714804|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
41949558|NCT02016690|75714804|FG000|Overall Study|Excluded from SAS: Duplication|2|||
41949559|NCT02016690|75714804|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
41949560|NCT02016690|75714804|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
41949561|NCT02016690|75714804|FG000|Overall Study|Did not meet inclusion criteria|13|||
41949562|NCT02016690|75714804|FG000|Overall Study|Hospitalized for RSV at study start|3|||
41949563|NCT02016300|75714810|FG000|Overall Study|Lost to Follow-up|0|||
41949564|NCT02016300|75714811|FG001|Overall Study|Lost to Follow-up|3|||
41949565|NCT02040090|75714819|FG000|Overall Study|Adverse Event|2|||
41949566|NCT02040090|75714820|FG001|Overall Study|Adverse Event|0|||
41949567|NCT02040090|75714819|FG000|Overall Study|Physician Decision|1|||
41949568|NCT02040090|75714820|FG001|Overall Study|Physician Decision|0|||
41949569|NCT02040090|75714819|FG000|Overall Study|Withdrawal by Subject|0|||
41949570|NCT02040090|75714820|FG001|Overall Study|Withdrawal by Subject|1|||
41949571|NCT02040090|75714819|FG000|Overall Study|Lost to Follow-up|0|||
41949572|NCT02040090|75714820|FG001|Overall Study|Lost to Follow-up|1|||
41949573|NCT02058498|75714826|FG000|Overall Study|Withdrawal by Subject|4|||
41949574|NCT02039778|75714830|FG000|Overall Study|Death|2|||
41949575|NCT02039778|75714830|FG000|Overall Study|Withdrawal by Subject|1|||
42300395|NCT02547233|76135560|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
42300396|NCT02547233|76135561|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
42023779|NCT01227824|75831145|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
41949576|NCT02039778|75714830|FG000|Overall Study|Never started the protocol treatment|1|||
42023780|NCT01227824|75831143|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
41949577|NCT02015754|75714834|FG000|Overall Study|Disease progression|5|||
41949578|NCT02015754|75714834|FG000|Overall Study|Change in treatment modality|5|||
41949579|NCT02015754|75714834|FG000|Overall Study|Lost to Follow-up|1|||
41949580|NCT02015676|75714841|FG000|Overall Study|Adverse Event|2|||
41949581|NCT02015676|75714842|FG001|Overall Study|Adverse Event|18|||
41949582|NCT02015676|75714843|FG002|Overall Study|Adverse Event|0|||
41949583|NCT02015676|75714841|FG000|Overall Study|Lack of Efficacy|2|||
41949584|NCT02015676|75714842|FG001|Overall Study|Lack of Efficacy|4|||
41949585|NCT02015676|75714843|FG002|Overall Study|Lack of Efficacy|0|||
41949586|NCT02015676|75714841|FG000|Overall Study|Protocol Violation|1|||
41949587|NCT02015676|75714842|FG001|Overall Study|Protocol Violation|0|||
41949588|NCT02015676|75714843|FG002|Overall Study|Protocol Violation|0|||
41949589|NCT02015676|75714841|FG000|Overall Study|Withdrawal by Subject|1|||
41949590|NCT02015676|75714842|FG001|Overall Study|Withdrawal by Subject|7|||
41949591|NCT02015676|75714843|FG002|Overall Study|Withdrawal by Subject|1|||
41949592|NCT02015676|75714841|FG000|Overall Study|Administrative reasons|0|||
41949593|NCT02015676|75714842|FG001|Overall Study|Administrative reasons|3|||
41949594|NCT02015676|75714843|FG002|Overall Study|Administrative reasons|1|||
41949595|NCT02015676|75714841|FG000|Overall Study|Death|0|||
41949596|NCT02015676|75714842|FG001|Overall Study|Death|1|||
41949597|NCT02015676|75714843|FG002|Overall Study|Death|0|||
41949598|NCT02015676|75714841|FG000|Overall Study|Disease progression|3|||
41949599|NCT02015676|75714842|FG001|Overall Study|Disease progression|1|||
41949600|NCT02015676|75714843|FG002|Overall Study|Disease progression|1|||
41949601|NCT02015520|75714851|FG000|Overall Study|Lack of Efficacy|1|||
41949602|NCT02015520|75714852|FG001|Overall Study|Lack of Efficacy|0|||
41949603|NCT02015520|75714853|FG002|Overall Study|Lack of Efficacy|3|||
41949604|NCT02015520|75714854|FG003|Overall Study|Lack of Efficacy|2|||
41949605|NCT02015520|75714851|FG000|Overall Study|Adverse Event|0|||
41949606|NCT02015520|75714852|FG001|Overall Study|Adverse Event|0|||
41949607|NCT02015520|75714853|FG002|Overall Study|Adverse Event|0|||
41949608|NCT02015520|75714854|FG003|Overall Study|Adverse Event|1|||
41949609|NCT02015520|75714851|FG000|Overall Study|Withdrawal by Subject|2|||
41949610|NCT02015520|75714852|FG001|Overall Study|Withdrawal by Subject|2|||
41949611|NCT02015520|75714853|FG002|Overall Study|Withdrawal by Subject|1|||
41949612|NCT02015520|75714854|FG003|Overall Study|Withdrawal by Subject|0|||
41949613|NCT02015520|75714851|FG000|Overall Study|Death|1|||
41949614|NCT02015520|75714852|FG001|Overall Study|Death|0|||
41949615|NCT02015520|75714853|FG002|Overall Study|Death|0|||
41949616|NCT02015520|75714854|FG003|Overall Study|Death|0|||
41949617|NCT02015520|75714851|FG000|Overall Study|Lost to Follow-up|0|||
41949618|NCT02015520|75714852|FG001|Overall Study|Lost to Follow-up|0|||
41949619|NCT02015520|75714853|FG002|Overall Study|Lost to Follow-up|1|||
41949620|NCT02015520|75714854|FG003|Overall Study|Lost to Follow-up|0|||
41949621|NCT02015520|75714851|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
41949622|NCT02015520|75714852|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
41949623|NCT02015520|75714853|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
41949624|NCT02015520|75714854|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
41949625|NCT02015520|75714851|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
41949626|NCT02015520|75714852|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
41949627|NCT02015520|75714853|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
41949628|NCT02015520|75714854|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
41949629|NCT02058108|75714866|FG000|Overall Study|Abnormal Laboratory Values|0|||
42023781|NCT01227824|75831144|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
42023782|NCT01227824|75831145|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
42023783|NCT01227824|75831143|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
42023784|NCT01227824|75831144|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
42023785|NCT01227824|75831145|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
42023786|NCT01227824|75831143|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
41949630|NCT02058108|75714867|FG001|Overall Study|Abnormal Laboratory Values|1|||
42023787|NCT01227824|75831144|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
42023788|NCT01227824|75831145|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
42023789|NCT01227824|75831143|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
42023790|NCT01227824|75831144|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
42023791|NCT01227824|75831145|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
42023792|NCT01227824|75831143|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
42023793|NCT01227824|75831144|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
42023794|NCT01227824|75831145|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
42023795|NCT01227824|75831143|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
42023796|NCT01227824|75831144|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
42023797|NCT01227824|75831145|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
42023798|NCT01227824|75831143|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
42023799|NCT01227824|75831144|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
42023800|NCT01227824|75831145|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
42023801|NCT01227824|75831143|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
42023802|NCT01227824|75831144|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
41949631|NCT02058108|75714866|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
41949632|NCT02058108|75714867|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
41949633|NCT02058108|75714866|FG000|Overall Study|No longer requires study drug|0|||
41949634|NCT02058108|75714867|FG001|Overall Study|No longer requires study drug|1|||
41949635|NCT02058108|75714866|FG000|Overall Study|Withdrawal by Subject|1|||
41949636|NCT02058108|75714867|FG001|Overall Study|Withdrawal by Subject|0|||
42023803|NCT01227824|75831145|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
42023804|NCT01227824|75831143|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
42023805|NCT01227824|75831144|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
42023806|NCT01227824|75831145|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
42023807|NCT01227824|75831143|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
42023808|NCT01227824|75831144|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
41949637|NCT02058108|75714866|FG000|Overall Study|Administrative problems|3|||
41949638|NCT02058108|75714867|FG001|Overall Study|Administrative problems|3|||
41949639|NCT02058108|75714866|FG000|Overall Study|Protocol Violation|0|||
41949640|NCT02058108|75714867|FG001|Overall Study|Protocol Violation|1|||
41949641|NCT02057874|75714875|FG000|Overall Study|participant did not return for scan|1|||
41949642|NCT02038920|75714882|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
41949643|NCT02038920|75714883|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
41949644|NCT02038920|75714884|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
41949645|NCT02038920|75714885|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
41949646|NCT02038920|75714886|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
41949647|NCT02038920|75714887|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
41949648|NCT02038920|75714882|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
41949649|NCT02038920|75714883|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
41949650|NCT02038920|75714884|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
41949651|NCT02038920|75714885|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
41949652|NCT02038920|75714886|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
41949653|NCT02038920|75714887|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
41949654|NCT02038920|75714882|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
41949655|NCT02038920|75714883|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
41949656|NCT02038920|75714884|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
41949657|NCT02038920|75714885|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
41949658|NCT02038920|75714886|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
41949659|NCT02038920|75714887|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
41949660|NCT02038920|75714882|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
41949661|NCT02038920|75714883|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
41949662|NCT02038920|75714884|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
41949663|NCT02038920|75714885|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
41949664|NCT02038920|75714886|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
41949665|NCT02038920|75714887|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
41949666|NCT02038920|75714882|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
41949667|NCT02038920|75714883|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
41949668|NCT02038920|75714884|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
41949669|NCT02038920|75714885|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
41949670|NCT02038920|75714886|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
41949671|NCT02038920|75714887|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
41949672|NCT02038920|75714882|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
41949673|NCT02038920|75714883|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
41949674|NCT02038920|75714884|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
41949675|NCT02038920|75714885|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
42023809|NCT01227824|75831145|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
42023810|NCT01227824|75831143|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
42023811|NCT01227824|75831144|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
42023812|NCT01227824|75831145|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
42023813|NCT01227824|75831143|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
42023814|NCT01227824|75831144|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
42023815|NCT01227824|75831145|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
42023816|NCT00949702|75831152|FG000|Overall Study|Death|40|||
42023817|NCT00949702|75831152|FG000|Overall Study|Disease progression|7|||
42023818|NCT00949702|75831152|FG000|Overall Study|Withdrawal of consent|1|||
42023819|NCT01034631|75831159|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
42023820|NCT01034631|75831160|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
42023821|NCT01034631|75831161|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
42023822|NCT01034631|75831159|FG000|Phase II|Not Evaluable per protocol|0|||
42023823|NCT01034631|75831160|FG001|Phase II|Not Evaluable per protocol|0|||
42023824|NCT01034631|75831161|FG002|Phase II|Not Evaluable per protocol|2|||
42023825|NCT01034631|75831159|FG000|Phase II|Determined Ineligible per protocol|0|||
41949676|NCT02038920|75714886|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
41949677|NCT02038920|75714887|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
42023826|NCT01034631|75831160|FG001|Phase II|Determined Ineligible per protocol|1|||
42023827|NCT01034631|75831161|FG002|Phase II|Determined Ineligible per protocol|0|||
41949678|NCT02038920|75714882|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
41949679|NCT02038920|75714883|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
41949680|NCT02038920|75714884|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
41949681|NCT02038920|75714885|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
41949682|NCT02038920|75714886|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
41949683|NCT02038920|75714887|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
41949684|NCT02038920|75714882|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
41949685|NCT02038920|75714883|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
41949686|NCT02038920|75714884|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
41949687|NCT02038920|75714885|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
41949688|NCT02038920|75714886|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
41949689|NCT02038920|75714887|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
41949690|NCT02038920|75714882|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
41949691|NCT02038920|75714883|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
41949692|NCT02038920|75714884|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
41949693|NCT02038920|75714885|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
41949694|NCT02038920|75714886|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
41949695|NCT02038920|75714887|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
41949696|NCT02038920|75714882|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
41949697|NCT02038920|75714883|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
41949698|NCT02038920|75714884|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
41949699|NCT02038920|75714885|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
41949700|NCT02038920|75714886|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
41949701|NCT02038920|75714887|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
41949702|NCT02038920|75714882|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
41949703|NCT02038920|75714883|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
41949704|NCT02038920|75714884|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
41949705|NCT02038920|75714885|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
41949706|NCT02038920|75714886|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
41949707|NCT02038920|75714887|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
41949708|NCT02038920|75714882|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
41949709|NCT02038920|75714883|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
41949710|NCT02038920|75714884|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
41949711|NCT02038920|75714885|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
41949712|NCT02038920|75714886|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
41949713|NCT02038920|75714887|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
41949714|NCT02038764|75714909|FG000|Overall Study|Adverse Event|0|||
41949715|NCT02038764|75714910|FG001|Overall Study|Adverse Event|0|||
41949716|NCT02038764|75714911|FG002|Overall Study|Adverse Event|1|||
41949717|NCT02038764|75714912|FG003|Overall Study|Adverse Event|0|||
41949718|NCT02038764|75714913|FG004|Overall Study|Adverse Event|0|||
41949719|NCT02038764|75714909|FG000|Overall Study|Lost to Follow-up|0|||
41949720|NCT02038764|75714910|FG001|Overall Study|Lost to Follow-up|1|||
41949721|NCT02038764|75714911|FG002|Overall Study|Lost to Follow-up|0|||
41949722|NCT02038764|75714912|FG003|Overall Study|Lost to Follow-up|0|||
42300397|NCT02547233|76135560|FG000|12-month Follow-up|Withdrawal by Subject|10|||
41949723|NCT02038764|75714913|FG004|Overall Study|Lost to Follow-up|0|||
41949724|NCT02038764|75714909|FG000|Overall Study|Withdrawal by Subject|0|||
41949725|NCT02038764|75714910|FG001|Overall Study|Withdrawal by Subject|0|||
41949726|NCT02038764|75714911|FG002|Overall Study|Withdrawal by Subject|0|||
41949727|NCT02038764|75714912|FG003|Overall Study|Withdrawal by Subject|0|||
41949728|NCT02038764|75714913|FG004|Overall Study|Withdrawal by Subject|1|||
41949729|NCT02038764|75714909|FG000|Overall Study|Other|1|||
41949730|NCT02038764|75714910|FG001|Overall Study|Other|0|||
41949731|NCT02038764|75714911|FG002|Overall Study|Other|1|||
41949732|NCT02038764|75714912|FG003|Overall Study|Other|0|||
41949733|NCT02038764|75714913|FG004|Overall Study|Other|0|||
41949734|NCT02014740|75714931|FG000|Overall Study|Lost to Follow-up|4|||
41949735|NCT02014740|75714932|FG001|Overall Study|Lost to Follow-up|4|||
41949736|NCT02014740|75714931|FG000|Overall Study|Withdrawal by Subject|2|||
41949737|NCT02014740|75714932|FG001|Overall Study|Withdrawal by Subject|1|||
41949738|NCT02014584|75714940|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
41949739|NCT02014584|75714941|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
41949740|NCT02014584|75714942|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
41949741|NCT02014584|75714943|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
41949742|NCT02014584|75714944|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
41949743|NCT02014584|75714945|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
41949744|NCT02014584|75714940|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
41949745|NCT02014584|75714941|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
41949746|NCT02014584|75714942|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
41949747|NCT02014584|75714943|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
41949748|NCT02014584|75714944|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
41949749|NCT02014584|75714945|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
41949750|NCT02014584|75714940|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
41949751|NCT02014584|75714941|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
41949752|NCT02014584|75714942|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
41949753|NCT02014584|75714943|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
41949754|NCT02014584|75714944|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
41949755|NCT02014584|75714945|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
41949756|NCT02014584|75714940|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
41949757|NCT02014584|75714941|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
41949758|NCT02014584|75714942|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
41949759|NCT02014584|75714943|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
41949760|NCT02014584|75714944|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
41949761|NCT02014584|75714945|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
41949762|NCT02014584|75714940|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
41949763|NCT02014584|75714941|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
41949764|NCT02014584|75714942|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
41949765|NCT02014584|75714943|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
41949766|NCT02014584|75714944|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
41949767|NCT02014584|75714945|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
41949768|NCT02014272|75714957|FG000|Intervention Period 1|Withdrawal by Subject|1|||
41949769|NCT02014272|75714958|FG001|Intervention Period 1|Withdrawal by Subject|0|||
41949770|NCT02014272|75714957|FG000|Intervention Period 1|Adverse Event|0|||
41949771|NCT02014272|75714958|FG001|Intervention Period 1|Adverse Event|1|||
41949772|NCT02037984|75714972|FG000|Overall Study|Lack of Efficacy|0|||
41949773|NCT02037984|75714973|FG001|Overall Study|Lack of Efficacy|0|||
41949774|NCT02037984|75714974|FG002|Overall Study|Lack of Efficacy|3|||
41949775|NCT02037984|75714975|FG003|Overall Study|Lack of Efficacy|10|||
41949776|NCT02037984|75714976|FG004|Overall Study|Lack of Efficacy|2|||
41949777|NCT02037984|75714977|FG005|Overall Study|Lack of Efficacy|2|||
41949778|NCT02037984|75714978|FG006|Overall Study|Lack of Efficacy|4|||
41949779|NCT02037984|75714979|FG007|Overall Study|Lack of Efficacy|3|||
41949780|NCT02037984|75714972|FG000|Overall Study|Lost to Follow-up|1|||
41949781|NCT02037984|75714973|FG001|Overall Study|Lost to Follow-up|0|||
41949782|NCT02037984|75714974|FG002|Overall Study|Lost to Follow-up|3|||
41949783|NCT02037984|75714975|FG003|Overall Study|Lost to Follow-up|5|||
41949784|NCT02037984|75714976|FG004|Overall Study|Lost to Follow-up|2|||
41949785|NCT02037984|75714977|FG005|Overall Study|Lost to Follow-up|2|||
41949786|NCT02037984|75714978|FG006|Overall Study|Lost to Follow-up|2|||
41949787|NCT02037984|75714979|FG007|Overall Study|Lost to Follow-up|4|||
41949788|NCT02037984|75714972|FG000|Overall Study|Physician Decision|0|||
41949789|NCT02037984|75714973|FG001|Overall Study|Physician Decision|0|||
41949790|NCT02037984|75714974|FG002|Overall Study|Physician Decision|0|||
41949791|NCT02037984|75714975|FG003|Overall Study|Physician Decision|0|||
41949792|NCT02037984|75714976|FG004|Overall Study|Physician Decision|0|||
41949793|NCT02037984|75714977|FG005|Overall Study|Physician Decision|0|||
41949794|NCT02037984|75714978|FG006|Overall Study|Physician Decision|1|||
41949795|NCT02037984|75714979|FG007|Overall Study|Physician Decision|0|||
41949796|NCT02037984|75714972|FG000|Overall Study|Protocol Violation|0|||
41949797|NCT02037984|75714973|FG001|Overall Study|Protocol Violation|0|||
41949798|NCT02037984|75714974|FG002|Overall Study|Protocol Violation|0|||
41949799|NCT02037984|75714975|FG003|Overall Study|Protocol Violation|0|||
41949800|NCT02037984|75714976|FG004|Overall Study|Protocol Violation|0|||
41949801|NCT02037984|75714977|FG005|Overall Study|Protocol Violation|1|||
41949802|NCT02037984|75714978|FG006|Overall Study|Protocol Violation|2|||
41949803|NCT02037984|75714979|FG007|Overall Study|Protocol Violation|0|||
41949804|NCT02037984|75714972|FG000|Overall Study|Technical Problems|0|||
41949805|NCT02037984|75714973|FG001|Overall Study|Technical Problems|0|||
41949806|NCT02037984|75714974|FG002|Overall Study|Technical Problems|3|||
41949807|NCT02037984|75714975|FG003|Overall Study|Technical Problems|3|||
41949808|NCT02037984|75714976|FG004|Overall Study|Technical Problems|2|||
41949809|NCT02037984|75714977|FG005|Overall Study|Technical Problems|3|||
41949810|NCT02037984|75714978|FG006|Overall Study|Technical Problems|4|||
41949811|NCT02037984|75714979|FG007|Overall Study|Technical Problems|2|||
41949812|NCT02037984|75714972|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42118023|NCT00689117|75928840|FG000|Overall Study|Incarceration|2|||
41949813|NCT02037984|75714973|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
41949814|NCT02037984|75714974|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
41949815|NCT02037984|75714975|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
41949816|NCT02037984|75714976|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
41949817|NCT02037984|75714977|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
41949818|NCT02037984|75714978|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
41949819|NCT02037984|75714979|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
41949820|NCT02037984|75714972|FG000|Overall Study|Withdrawal by Subject|0|||
41949821|NCT02037984|75714973|FG001|Overall Study|Withdrawal by Subject|0|||
41949822|NCT02037984|75714974|FG002|Overall Study|Withdrawal by Subject|0|||
41949823|NCT02037984|75714975|FG003|Overall Study|Withdrawal by Subject|1|||
41949824|NCT02037984|75714976|FG004|Overall Study|Withdrawal by Subject|1|||
41949825|NCT02037984|75714977|FG005|Overall Study|Withdrawal by Subject|3|||
41949826|NCT02037984|75714978|FG006|Overall Study|Withdrawal by Subject|0|||
41949827|NCT02037984|75714979|FG007|Overall Study|Withdrawal by Subject|1|||
41949828|NCT02057406|75715010|FG000|Overall Study|Physician Decision|0|||
41949829|NCT02057406|75715011|FG001|Overall Study|Physician Decision|0|||
41949830|NCT02057406|75715012|FG002|Overall Study|Physician Decision|2|||
41949831|NCT02057406|75715010|FG000|Overall Study|Withdrawal by Subject|0|||
41949832|NCT02057406|75715011|FG001|Overall Study|Withdrawal by Subject|2|||
41949833|NCT02057406|75715012|FG002|Overall Study|Withdrawal by Subject|0|||
41949834|NCT02057406|75715010|FG000|Overall Study|Lost to Follow-up|0|||
41949835|NCT02057406|75715011|FG001|Overall Study|Lost to Follow-up|0|||
41949836|NCT02057406|75715012|FG002|Overall Study|Lost to Follow-up|1|||
41949837|NCT02057406|75715010|FG000|Overall Study|Death|1|||
41949838|NCT02057406|75715011|FG001|Overall Study|Death|0|||
41949839|NCT02057406|75715012|FG002|Overall Study|Death|0|||
41949840|NCT02057406|75715010|FG000|Overall Study|Protocol Violation|0|||
41949841|NCT02057406|75715011|FG001|Overall Study|Protocol Violation|1|||
41949842|NCT02057406|75715012|FG002|Overall Study|Protocol Violation|0|||
41949843|NCT02057406|75715010|FG000|Overall Study|Patient transportation issues|0|||
41949844|NCT02057406|75715011|FG001|Overall Study|Patient transportation issues|0|||
41949845|NCT02057406|75715012|FG002|Overall Study|Patient transportation issues|1|||
41949846|NCT02036580|75715023|FG000|Overall Study|Withdrawal by Subject|0|||
41949847|NCT02036580|75715024|FG001|Overall Study|Withdrawal by Subject|1|||
41949848|NCT02036580|75715025|FG002|Overall Study|Withdrawal by Subject|0|||
41949849|NCT02036580|75715023|FG000|Overall Study|Adverse Event|1|||
41949850|NCT02036580|75715024|FG001|Overall Study|Adverse Event|0|||
41949851|NCT02036580|75715025|FG002|Overall Study|Adverse Event|0|||
41949852|NCT02014116|75715042|FG000|Overall Study|Progressive Disease|3|||
41949853|NCT02014116|75715043|FG001|Overall Study|Progressive Disease|4|||
41949854|NCT02014116|75715044|FG002|Overall Study|Progressive Disease|2|||
41949855|NCT02014116|75715045|FG003|Overall Study|Progressive Disease|6|||
41949856|NCT02014116|75715046|FG004|Overall Study|Progressive Disease|1|||
41949857|NCT02014116|75715047|FG005|Overall Study|Progressive Disease|13|||
41949858|NCT02014116|75715048|FG006|Overall Study|Progressive Disease|1|||
41949859|NCT02014116|75715049|FG007|Overall Study|Progressive Disease|3|||
41949860|NCT02014116|75715050|FG008|Overall Study|Progressive Disease|7|||
41949861|NCT02014116|75715042|FG000|Overall Study|Adverse Event|0|||
41949862|NCT02014116|75715043|FG001|Overall Study|Adverse Event|0|||
41949863|NCT02014116|75715044|FG002|Overall Study|Adverse Event|0|||
41949864|NCT02014116|75715045|FG003|Overall Study|Adverse Event|0|||
41949865|NCT02014116|75715046|FG004|Overall Study|Adverse Event|1|||
41949866|NCT02014116|75715047|FG005|Overall Study|Adverse Event|0|||
41949867|NCT02014116|75715048|FG006|Overall Study|Adverse Event|0|||
41949868|NCT02014116|75715049|FG007|Overall Study|Adverse Event|1|||
41949869|NCT02014116|75715050|FG008|Overall Study|Adverse Event|0|||
41949870|NCT02014116|75715042|FG000|Overall Study|Lost to Follow-up|0|||
41949871|NCT02014116|75715043|FG001|Overall Study|Lost to Follow-up|0|||
41949872|NCT02014116|75715044|FG002|Overall Study|Lost to Follow-up|0|||
41949873|NCT02014116|75715045|FG003|Overall Study|Lost to Follow-up|0|||
41949874|NCT02014116|75715046|FG004|Overall Study|Lost to Follow-up|0|||
41949875|NCT02014116|75715047|FG005|Overall Study|Lost to Follow-up|1|||
41949876|NCT02014116|75715048|FG006|Overall Study|Lost to Follow-up|0|||
41949877|NCT02014116|75715049|FG007|Overall Study|Lost to Follow-up|0|||
41949878|NCT02014116|75715050|FG008|Overall Study|Lost to Follow-up|1|||
41949879|NCT02014116|75715042|FG000|Overall Study|Death|0|||
41949880|NCT02014116|75715043|FG001|Overall Study|Death|0|||
41949881|NCT02014116|75715044|FG002|Overall Study|Death|0|||
42023828|NCT01227668|75831173|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
41949882|NCT02014116|75715045|FG003|Overall Study|Death|0|||
41949883|NCT02014116|75715046|FG004|Overall Study|Death|0|||
41949884|NCT02014116|75715047|FG005|Overall Study|Death|0|||
41949885|NCT02014116|75715048|FG006|Overall Study|Death|0|||
41949886|NCT02014116|75715049|FG007|Overall Study|Death|1|||
41949887|NCT02014116|75715050|FG008|Overall Study|Death|1|||
41949888|NCT02014116|75715042|FG000|Overall Study|Withdrawal by Subject|0|||
41949889|NCT02014116|75715043|FG001|Overall Study|Withdrawal by Subject|0|||
41949890|NCT02014116|75715044|FG002|Overall Study|Withdrawal by Subject|1|||
41949891|NCT02014116|75715045|FG003|Overall Study|Withdrawal by Subject|1|||
41949892|NCT02014116|75715046|FG004|Overall Study|Withdrawal by Subject|0|||
41949893|NCT02014116|75715047|FG005|Overall Study|Withdrawal by Subject|1|||
41949894|NCT02014116|75715048|FG006|Overall Study|Withdrawal by Subject|0|||
41949895|NCT02014116|75715049|FG007|Overall Study|Withdrawal by Subject|0|||
41949896|NCT02014116|75715050|FG008|Overall Study|Withdrawal by Subject|0|||
42118024|NCT00689117|75928841|FG001|Overall Study|Incarceration|0|||
41949897|NCT02014116|75715042|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
41949898|NCT02014116|75715043|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
41949899|NCT02014116|75715044|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
41949900|NCT02014116|75715045|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
41949901|NCT02014116|75715046|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
41949902|NCT02014116|75715047|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
41949903|NCT02014116|75715048|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
41949904|NCT02014116|75715049|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
41949905|NCT02014116|75715050|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
41949906|NCT02014116|75715042|FG000|Overall Study|Physician Decision|0|||
41949907|NCT02014116|75715043|FG001|Overall Study|Physician Decision|0|||
41949908|NCT02014116|75715044|FG002|Overall Study|Physician Decision|0|||
41949909|NCT02014116|75715045|FG003|Overall Study|Physician Decision|0|||
41949910|NCT02014116|75715046|FG004|Overall Study|Physician Decision|0|||
41949911|NCT02014116|75715047|FG005|Overall Study|Physician Decision|0|||
41949912|NCT02014116|75715048|FG006|Overall Study|Physician Decision|0|||
41949913|NCT02014116|75715049|FG007|Overall Study|Physician Decision|0|||
41949914|NCT02014116|75715050|FG008|Overall Study|Physician Decision|1|||
41949915|NCT02057250|75715077|FG000|AID Assessment Phase|Adverse Event|3|||
41949916|NCT02057250|75715078|FG001|AID Assessment Phase|Adverse Event|2|||
41949917|NCT02057250|75715079|FG002|AID Assessment Phase|Adverse Event|6|||
41949918|NCT02057250|75715080|FG003|AID Assessment Phase|Adverse Event|1|||
41949919|NCT02057250|75715081|FG004|AID Assessment Phase|Adverse Event|0|||
41949920|NCT02057250|75715077|FG000|AID Assessment Phase|Other than specified above|1|||
41949921|NCT02057250|75715078|FG001|AID Assessment Phase|Other than specified above|1|||
41949922|NCT02057250|75715079|FG002|AID Assessment Phase|Other than specified above|1|||
41949923|NCT02057250|75715080|FG003|AID Assessment Phase|Other than specified above|1|||
41949924|NCT02057250|75715081|FG004|AID Assessment Phase|Other than specified above|0|||
41949925|NCT02057250|75715077|FG000|Extension Phase|Adverse Event|0|||
41949926|NCT02057250|75715078|FG001|Extension Phase|Adverse Event|0|||
41949927|NCT02057250|75715079|FG002|Extension Phase|Adverse Event|0|||
41949928|NCT02057250|75715080|FG003|Extension Phase|Adverse Event|0|||
41949929|NCT02057250|75715081|FG004|Extension Phase|Adverse Event|15|||
41949930|NCT02057250|75715077|FG000|Extension Phase|Lack of Efficacy|0|||
41949931|NCT02057250|75715078|FG001|Extension Phase|Lack of Efficacy|0|||
41949932|NCT02057250|75715079|FG002|Extension Phase|Lack of Efficacy|0|||
41949933|NCT02057250|75715080|FG003|Extension Phase|Lack of Efficacy|0|||
41949934|NCT02057250|75715081|FG004|Extension Phase|Lack of Efficacy|10|||
41949935|NCT02057250|75715077|FG000|Extension Phase|Entered in this period but not treated|0|||
41949936|NCT02057250|75715078|FG001|Extension Phase|Entered in this period but not treated|0|||
41949937|NCT02057250|75715079|FG002|Extension Phase|Entered in this period but not treated|0|||
41949938|NCT02057250|75715080|FG003|Extension Phase|Entered in this period but not treated|0|||
41949939|NCT02057250|75715081|FG004|Extension Phase|Entered in this period but not treated|4|||
41949940|NCT02057250|75715077|FG000|Extension Phase|Other than specified above|0|||
41949941|NCT02057250|75715078|FG001|Extension Phase|Other than specified above|0|||
41949942|NCT02057250|75715079|FG002|Extension Phase|Other than specified above|0|||
41949943|NCT02057250|75715080|FG003|Extension Phase|Other than specified above|0|||
41949944|NCT02057250|75715081|FG004|Extension Phase|Other than specified above|7|||
41949945|NCT02036502|75715101|FG000|Part 1:Dose Determination/Escalation|Death|3|||
41949946|NCT02036502|75715102|FG001|Part 1:Dose Determination/Escalation|Death|2|||
41949947|NCT02036502|75715103|FG002|Part 1:Dose Determination/Escalation|Death|0|||
41949948|NCT02036502|75715104|FG003|Part 1:Dose Determination/Escalation|Death|0|||
41949949|NCT02036502|75715105|FG004|Part 1:Dose Determination/Escalation|Death|0|||
41949950|NCT02036502|75715106|FG005|Part 1:Dose Determination/Escalation|Death|0|||
41949951|NCT02036502|75715107|FG006|Part 1:Dose Determination/Escalation|Death|0|||
41949952|NCT02036502|75715108|FG007|Part 1:Dose Determination/Escalation|Death|0|||
41949953|NCT02036502|75715101|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
41949954|NCT02036502|75715102|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
41949955|NCT02036502|75715103|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
41949956|NCT02036502|75715104|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
41949957|NCT02036502|75715105|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
41949958|NCT02036502|75715106|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
41949959|NCT02036502|75715107|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
41949960|NCT02036502|75715108|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
41949961|NCT02036502|75715101|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
41949962|NCT02036502|75715102|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
41949963|NCT02036502|75715103|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
42023829|NCT01227668|75831174|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
41949964|NCT02036502|75715104|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
41949965|NCT02036502|75715105|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
41949966|NCT02036502|75715106|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
41949967|NCT02036502|75715107|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
41949968|NCT02036502|75715108|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
41949969|NCT02036502|75715101|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
41949970|NCT02036502|75715102|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
41949971|NCT02036502|75715103|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
41949972|NCT02036502|75715104|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
41949973|NCT02036502|75715105|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
41949974|NCT02036502|75715106|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
41949975|NCT02036502|75715107|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
41949976|NCT02036502|75715108|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
41949977|NCT02036502|75715101|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
41949978|NCT02036502|75715102|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
41949979|NCT02036502|75715103|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
41949980|NCT02036502|75715104|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
41949981|NCT02036502|75715105|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
41949982|NCT02036502|75715106|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
41949983|NCT02036502|75715107|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
41949984|NCT02036502|75715108|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
41949985|NCT02036502|75715101|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
41949986|NCT02036502|75715102|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
41949987|NCT02036502|75715103|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
41949988|NCT02036502|75715104|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
41949989|NCT02036502|75715105|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
41949990|NCT02036502|75715106|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
41949991|NCT02036502|75715107|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
41949992|NCT02036502|75715108|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
41949993|NCT02036502|75715101|FG000|Part 2:Dose Confirmation|Death|0|||
41949994|NCT02036502|75715102|FG001|Part 2:Dose Confirmation|Death|0|||
41949995|NCT02036502|75715103|FG002|Part 2:Dose Confirmation|Death|1|||
41949996|NCT02036502|75715104|FG003|Part 2:Dose Confirmation|Death|0|||
41949997|NCT02036502|75715105|FG004|Part 2:Dose Confirmation|Death|0|||
41949998|NCT02036502|75715106|FG005|Part 2:Dose Confirmation|Death|0|||
41949999|NCT02036502|75715107|FG006|Part 2:Dose Confirmation|Death|0|||
41950000|NCT02036502|75715108|FG007|Part 2:Dose Confirmation|Death|0|||
41950001|NCT02036502|75715101|FG000|Part 2:Dose Confirmation|Not treated|0|||
41950002|NCT02036502|75715102|FG001|Part 2:Dose Confirmation|Not treated|0|||
41950003|NCT02036502|75715103|FG002|Part 2:Dose Confirmation|Not treated|0|||
41950004|NCT02036502|75715104|FG003|Part 2:Dose Confirmation|Not treated|1|||
41950005|NCT02036502|75715105|FG004|Part 2:Dose Confirmation|Not treated|0|||
41950006|NCT02036502|75715106|FG005|Part 2:Dose Confirmation|Not treated|0|||
41950007|NCT02036502|75715107|FG006|Part 2:Dose Confirmation|Not treated|0|||
41950008|NCT02036502|75715108|FG007|Part 2:Dose Confirmation|Not treated|0|||
41950009|NCT02036502|75715101|FG000|Part 3:Dose Expansion|Adverse Event|0|||
41950010|NCT02036502|75715102|FG001|Part 3:Dose Expansion|Adverse Event|0|||
41950011|NCT02036502|75715103|FG002|Part 3:Dose Expansion|Adverse Event|0|||
41950012|NCT02036502|75715104|FG003|Part 3:Dose Expansion|Adverse Event|0|||
41950013|NCT02036502|75715105|FG004|Part 3:Dose Expansion|Adverse Event|0|||
41950014|NCT02036502|75715106|FG005|Part 3:Dose Expansion|Adverse Event|4|||
41950015|NCT02036502|75715107|FG006|Part 3:Dose Expansion|Adverse Event|0|||
41950016|NCT02036502|75715108|FG007|Part 3:Dose Expansion|Adverse Event|2|||
41950017|NCT02036502|75715101|FG000|Part 3:Dose Expansion|Death|0|||
41950018|NCT02036502|75715102|FG001|Part 3:Dose Expansion|Death|0|||
41950019|NCT02036502|75715103|FG002|Part 3:Dose Expansion|Death|0|||
41950020|NCT02036502|75715104|FG003|Part 3:Dose Expansion|Death|0|||
41950021|NCT02036502|75715105|FG004|Part 3:Dose Expansion|Death|0|||
41950022|NCT02036502|75715106|FG005|Part 3:Dose Expansion|Death|24|||
41950023|NCT02036502|75715107|FG006|Part 3:Dose Expansion|Death|0|||
41950024|NCT02036502|75715108|FG007|Part 3:Dose Expansion|Death|3|||
41950025|NCT02036502|75715101|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
41950026|NCT02036502|75715102|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
41950027|NCT02036502|75715103|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
41950028|NCT02036502|75715104|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
41950029|NCT02036502|75715105|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
41950030|NCT02036502|75715106|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
42300398|NCT02547233|76135561|FG001|12-month Follow-up|Withdrawal by Subject|10|||
41950031|NCT02036502|75715107|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
41950032|NCT02036502|75715108|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
41950033|NCT02036502|75715101|FG000|Part 3:Dose Expansion|Physician Decision|0|||
41950034|NCT02036502|75715102|FG001|Part 3:Dose Expansion|Physician Decision|0|||
41950035|NCT02036502|75715103|FG002|Part 3:Dose Expansion|Physician Decision|0|||
41950036|NCT02036502|75715104|FG003|Part 3:Dose Expansion|Physician Decision|0|||
41950037|NCT02036502|75715105|FG004|Part 3:Dose Expansion|Physician Decision|0|||
42300399|NCT02547233|76135560|FG000|12-month Follow-up|Lost to Follow-up|3|||
42300400|NCT02547233|76135561|FG001|12-month Follow-up|Lost to Follow-up|3|||
41950038|NCT02036502|75715106|FG005|Part 3:Dose Expansion|Physician Decision|1|||
41950039|NCT02036502|75715107|FG006|Part 3:Dose Expansion|Physician Decision|0|||
41950040|NCT02036502|75715108|FG007|Part 3:Dose Expansion|Physician Decision|0|||
41950041|NCT02036502|75715101|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
41950042|NCT02036502|75715102|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
41950043|NCT02036502|75715103|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
41950044|NCT02036502|75715104|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
41950045|NCT02036502|75715105|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
41950046|NCT02036502|75715106|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
41950047|NCT02036502|75715107|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
41950048|NCT02036502|75715108|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
41950049|NCT02036502|75715101|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
41950050|NCT02036502|75715102|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
41950051|NCT02036502|75715103|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
41950052|NCT02036502|75715104|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
41950053|NCT02036502|75715105|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
41950054|NCT02036502|75715106|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
41950055|NCT02036502|75715107|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
41950056|NCT02036502|75715108|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
41950057|NCT02036502|75715101|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
41950058|NCT02036502|75715102|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
41950059|NCT02036502|75715103|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
41950060|NCT02036502|75715104|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
41950061|NCT02036502|75715105|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
41950062|NCT02036502|75715106|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
41950063|NCT02036502|75715107|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
41950064|NCT02036502|75715108|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
41950065|NCT02036502|75715101|FG000|Part 3:Dose Expansion|Not Treated|0|||
41950066|NCT02036502|75715102|FG001|Part 3:Dose Expansion|Not Treated|0|||
41950067|NCT02036502|75715103|FG002|Part 3:Dose Expansion|Not Treated|0|||
41950068|NCT02036502|75715104|FG003|Part 3:Dose Expansion|Not Treated|0|||
41950069|NCT02036502|75715105|FG004|Part 3:Dose Expansion|Not Treated|0|||
41950070|NCT02036502|75715106|FG005|Part 3:Dose Expansion|Not Treated|2|||
41950071|NCT02036502|75715107|FG006|Part 3:Dose Expansion|Not Treated|0|||
41950072|NCT02036502|75715108|FG007|Part 3:Dose Expansion|Not Treated|0|||
41950073|NCT02056626|75715132|FG000|Overall Study|patient did not follow directions|3|||
41950074|NCT02056626|75715133|FG001|Overall Study|patient did not follow directions|1|||
41950075|NCT02056626|75715134|FG002|Overall Study|patient did not follow directions|0|||
41950076|NCT02056626|75715135|FG003|Overall Study|patient did not follow directions|0|||
41950077|NCT02035332|75715145|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
41950078|NCT02056392|75715155|FG000|Overall Study|Lost to Follow-up|0|||
41950079|NCT02056392|75715156|FG001|Overall Study|Lost to Follow-up|1|||
41950080|NCT02056392|75715157|FG002|Overall Study|Lost to Follow-up|2|||
41950081|NCT02056392|75715158|FG003|Overall Study|Lost to Follow-up|0|||
41950082|NCT02056392|75715159|FG004|Overall Study|Lost to Follow-up|0|||
41950083|NCT02056392|75715160|FG005|Overall Study|Lost to Follow-up|0|||
41950084|NCT02056392|75715155|FG000|Overall Study|Protocol Violation|1|||
41950085|NCT02056392|75715156|FG001|Overall Study|Protocol Violation|0|||
41950086|NCT02056392|75715157|FG002|Overall Study|Protocol Violation|1|||
41950087|NCT02056392|75715158|FG003|Overall Study|Protocol Violation|0|||
41950088|NCT02056392|75715159|FG004|Overall Study|Protocol Violation|0|||
41950089|NCT02056392|75715160|FG005|Overall Study|Protocol Violation|0|||
41950090|NCT02056392|75715155|FG000|Overall Study|Withdrawal by Subject|1|||
41950091|NCT02056392|75715156|FG001|Overall Study|Withdrawal by Subject|0|||
41950092|NCT02056392|75715157|FG002|Overall Study|Withdrawal by Subject|0|||
41950093|NCT02056392|75715158|FG003|Overall Study|Withdrawal by Subject|0|||
41950094|NCT02056392|75715159|FG004|Overall Study|Withdrawal by Subject|1|||
41950095|NCT02056392|75715160|FG005|Overall Study|Withdrawal by Subject|0|||
41950096|NCT02034708|75715170|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
41950097|NCT02034708|75715171|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
41950098|NCT02034708|75715170|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
41950099|NCT02034708|75715171|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
41950100|NCT02034708|75715170|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
41950101|NCT02034708|75715171|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
41950102|NCT02034708|75715170|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
41950103|NCT02034708|75715171|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
41950104|NCT02034552|75715185|FG000|Overall Study|Never treated|3|||
42023830|NCT01227668|75831173|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
41950105|NCT02034552|75715186|FG001|Overall Study|Never treated|2|||
41950106|NCT02034552|75715187|FG002|Overall Study|Never treated|0|||
41950107|NCT02034552|75715185|FG000|Overall Study|Radiological progression|3|||
41950108|NCT02034552|75715186|FG001|Overall Study|Radiological progression|5|||
41950109|NCT02034552|75715187|FG002|Overall Study|Radiological progression|4|||
41950110|NCT02034552|75715185|FG000|Overall Study|AE not assoc. with disease progression|1|||
41950111|NCT02034552|75715186|FG001|Overall Study|AE not assoc. with disease progression|4|||
41950112|NCT02034552|75715187|FG002|Overall Study|AE not assoc. with disease progression|2|||
41950113|NCT02034552|75715185|FG000|Overall Study|AE associated with disease progression|0|||
41950114|NCT02034552|75715186|FG001|Overall Study|AE associated with disease progression|1|||
41950115|NCT02034552|75715187|FG002|Overall Study|AE associated with disease progression|0|||
41950116|NCT02034552|75715185|FG000|Overall Study|Withdrawal by Subject|2|||
41950117|NCT02034552|75715186|FG001|Overall Study|Withdrawal by Subject|1|||
41950118|NCT02034552|75715187|FG002|Overall Study|Withdrawal by Subject|1|||
41950119|NCT02034552|75715185|FG000|Overall Study|Non-compliance with study drug|0|||
41950120|NCT02034552|75715186|FG001|Overall Study|Non-compliance with study drug|0|||
41950121|NCT02034552|75715187|FG002|Overall Study|Non-compliance with study drug|1|||
41950122|NCT02034552|75715185|FG000|Overall Study|Clinical progression|5|||
41950123|NCT02034552|75715186|FG001|Overall Study|Clinical progression|7|||
41950124|NCT02034552|75715187|FG002|Overall Study|Clinical progression|9|||
41950125|NCT02034474|75715197|FG000|Overall Study|Adverse Event|3|||
42023831|NCT01227668|75831174|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
42023832|NCT01227668|75831173|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
41950126|NCT02034474|75715198|FG001|Overall Study|Adverse Event|2|||
41950127|NCT02034474|75715197|FG000|Overall Study|Withdrawal by Subject|1|||
41950128|NCT02034474|75715198|FG001|Overall Study|Withdrawal by Subject|2|||
41950129|NCT02011542|75715206|FG000|Overall Study|Physician Decision|1|||
41950130|NCT02011386|75715210|FG000|Overall Study|Non-compliance|2|||
41950131|NCT02011386|75715210|FG000|Overall Study|Lack of Efficacy|3|||
41950132|NCT02010684|75715216|FG000|Overall Study|Lost to Follow-up|8|||
41950133|NCT02010684|75715217|FG001|Overall Study|Lost to Follow-up|18|||
41950134|NCT02010684|75715216|FG000|Overall Study|Withdrawal by Subject|4|||
41950135|NCT02010684|75715217|FG001|Overall Study|Withdrawal by Subject|5|||
41950136|NCT02034162|75715225|FG000|Double-blind|Lost to Follow-up|3|||
41950137|NCT02034162|75715226|FG001|Double-blind|Lost to Follow-up|0|||
41950138|NCT02034162|75715227|FG002|Double-blind|Lost to Follow-up|0|||
41950139|NCT02034162|75715225|FG000|Double-blind|Physician Decision|1|||
41950140|NCT02034162|75715226|FG001|Double-blind|Physician Decision|0|||
41950141|NCT02034162|75715227|FG002|Double-blind|Physician Decision|0|||
41950142|NCT02034162|75715225|FG000|Double-blind|Protocol Violation|0|||
41950143|NCT02034162|75715226|FG001|Double-blind|Protocol Violation|1|||
41950144|NCT02034162|75715227|FG002|Double-blind|Protocol Violation|0|||
41950145|NCT02034162|75715225|FG000|Double-blind|Withdrawal by Subject|5|||
41950146|NCT02034162|75715226|FG001|Double-blind|Withdrawal by Subject|7|||
41950147|NCT02034162|75715227|FG002|Double-blind|Withdrawal by Subject|0|||
41950148|NCT02034006|75715240|FG000|Overall Study|Withdrawal by Subject|7|||
41950149|NCT02034006|75715240|FG000|Overall Study|Lost to Follow-up|5|||
41950150|NCT02034006|75715240|FG000|Overall Study|Death|1|||
41950151|NCT02034006|75715240|FG000|Overall Study|Pregnancy|1|||
41950152|NCT02054910|75715249|FG000|Overall Study|Lost to Follow-up|4|||
41950153|NCT02054910|75715250|FG001|Overall Study|Lost to Follow-up|1|||
41950154|NCT02033850|75715260|FG000|Overall Study|Death|1|||
41950155|NCT02033850|75715261|FG001|Overall Study|Death|0|||
41950156|NCT02033850|75715260|FG000|Overall Study|unrelated medical reason|1|||
42300401|NCT02547233|76135560|FG000|12-month Follow-up|Lack of Efficacy|1|||
42300402|NCT02547233|76135561|FG001|12-month Follow-up|Lack of Efficacy|2|||
42300403|NCT02547233|76135560|FG000|12-month Follow-up|Protocol Violation|0|||
42300404|NCT02547233|76135561|FG001|12-month Follow-up|Protocol Violation|1|||
42300405|NCT02547233|76135560|FG000|12-month Follow-up|Other|0|||
41950157|NCT02033850|75715261|FG001|Overall Study|unrelated medical reason|1|||
41950158|NCT02054130|75715271|FG000|Overall Study|Withdrawal by Subject|4|||
41950159|NCT02054130|75715272|FG001|Overall Study|Withdrawal by Subject|4|||
41950160|NCT02054130|75715273|FG002|Overall Study|Withdrawal by Subject|7|||
41950161|NCT02054130|75715274|FG003|Overall Study|Withdrawal by Subject|10|||
42118025|NCT00689117|75928842|FG002|Overall Study|Incarceration|0|||
41950162|NCT02054130|75715271|FG000|Overall Study|Death|0|||
41950163|NCT02054130|75715272|FG001|Overall Study|Death|1|||
42300406|NCT02547233|76135561|FG001|12-month Follow-up|Other|1|||
41950164|NCT02054130|75715273|FG002|Overall Study|Death|0|||
41950165|NCT02054130|75715274|FG003|Overall Study|Death|0|||
41950166|NCT02054130|75715271|FG000|Overall Study|Lost to Follow-up|0|||
41950167|NCT02054130|75715272|FG001|Overall Study|Lost to Follow-up|0|||
41950168|NCT02054130|75715273|FG002|Overall Study|Lost to Follow-up|1|||
41950169|NCT02054130|75715274|FG003|Overall Study|Lost to Follow-up|2|||
41950170|NCT02054130|75715271|FG000|Overall Study|Missed dose|4|||
41950171|NCT02054130|75715272|FG001|Overall Study|Missed dose|6|||
41950172|NCT02054130|75715273|FG002|Overall Study|Missed dose|7|||
41950173|NCT02054130|75715274|FG003|Overall Study|Missed dose|10|||
41950174|NCT02009046|75715289|FG000|Overall Study|Lost to Follow-up|256|||
41950175|NCT02009046|75715290|FG001|Overall Study|Lost to Follow-up|206|||
41950176|NCT02052960|75715306|FG000|Overall Study|Adverse Event|19|||
41950177|NCT02052960|75715307|FG001|Overall Study|Adverse Event|17|||
41950178|NCT02052960|75715306|FG000|Overall Study|Protocol Violation|4|||
41950179|NCT02052960|75715307|FG001|Overall Study|Protocol Violation|3|||
41950180|NCT02052960|75715306|FG000|Overall Study|Withdrawal by Subject|6|||
41950181|NCT02052960|75715307|FG001|Overall Study|Withdrawal by Subject|11|||
41950182|NCT02052960|75715306|FG000|Overall Study|Other|25|||
41950183|NCT02052960|75715307|FG001|Overall Study|Other|15|||
41950184|NCT02008890|75715319|FG000|Period 1|Withdrawal by Subject|7|||
41950185|NCT02008890|75715320|FG001|Period 1|Withdrawal by Subject|7|||
41950186|NCT02008890|75715321|FG002|Period 1|Withdrawal by Subject|5|||
41950187|NCT02008890|75715322|FG003|Period 1|Withdrawal by Subject|0|||
41950188|NCT02008890|75715323|FG004|Period 1|Withdrawal by Subject|0|||
41950189|NCT02008890|75715319|FG000|Period 1|Pregnancy|1|||
41950190|NCT02008890|75715320|FG001|Period 1|Pregnancy|0|||
41950191|NCT02008890|75715321|FG002|Period 1|Pregnancy|0|||
41950192|NCT02008890|75715322|FG003|Period 1|Pregnancy|0|||
41950193|NCT02008890|75715323|FG004|Period 1|Pregnancy|0|||
41950194|NCT02008890|75715319|FG000|Period 1|Physician Decision|1|||
41950195|NCT02008890|75715320|FG001|Period 1|Physician Decision|0|||
41950196|NCT02008890|75715321|FG002|Period 1|Physician Decision|1|||
41950197|NCT02008890|75715322|FG003|Period 1|Physician Decision|0|||
41950198|NCT02008890|75715323|FG004|Period 1|Physician Decision|0|||
41950199|NCT02008890|75715319|FG000|Period 1|Adverse Event|6|||
41950200|NCT02008890|75715320|FG001|Period 1|Adverse Event|8|||
41950201|NCT02008890|75715321|FG002|Period 1|Adverse Event|6|||
41950202|NCT02008890|75715322|FG003|Period 1|Adverse Event|0|||
41950203|NCT02008890|75715323|FG004|Period 1|Adverse Event|0|||
41950204|NCT02008890|75715319|FG000|Period 2|Adverse Event|12|||
41950205|NCT02008890|75715320|FG001|Period 2|Adverse Event|7|||
41950206|NCT02008890|75715321|FG002|Period 2|Adverse Event|0|||
41950207|NCT02008890|75715322|FG003|Period 2|Adverse Event|5|||
41950208|NCT02008890|75715323|FG004|Period 2|Adverse Event|5|||
41950209|NCT02008890|75715319|FG000|Period 2|Withdrawal by Subject|11|||
41950210|NCT02008890|75715320|FG001|Period 2|Withdrawal by Subject|8|||
41950211|NCT02008890|75715321|FG002|Period 2|Withdrawal by Subject|0|||
41950212|NCT02008890|75715322|FG003|Period 2|Withdrawal by Subject|7|||
41950213|NCT02008890|75715323|FG004|Period 2|Withdrawal by Subject|2|||
41950214|NCT02008890|75715319|FG000|Period 2|Physician Decision|4|||
41950215|NCT02008890|75715320|FG001|Period 2|Physician Decision|0|||
41950216|NCT02008890|75715321|FG002|Period 2|Physician Decision|0|||
41950217|NCT02008890|75715322|FG003|Period 2|Physician Decision|2|||
41950218|NCT02008890|75715323|FG004|Period 2|Physician Decision|1|||
41950219|NCT02008890|75715319|FG000|Period 2|Lost to Follow-up|0|||
41950220|NCT02008890|75715320|FG001|Period 2|Lost to Follow-up|0|||
41950221|NCT02008890|75715321|FG002|Period 2|Lost to Follow-up|1|||
41950222|NCT02008890|75715322|FG003|Period 2|Lost to Follow-up|0|||
41950223|NCT02008890|75715323|FG004|Period 2|Lost to Follow-up|0|||
41950224|NCT02008890|75715319|FG000|Extension Period|Withdrawal by Subject|3|||
41950225|NCT02008890|75715320|FG001|Extension Period|Withdrawal by Subject|2|||
41950226|NCT02008890|75715321|FG002|Extension Period|Withdrawal by Subject|0|||
41950227|NCT02008890|75715322|FG003|Extension Period|Withdrawal by Subject|4|||
41950228|NCT02008890|75715323|FG004|Extension Period|Withdrawal by Subject|2|||
41950229|NCT02008890|75715319|FG000|Extension Period|Lost to Follow-up|1|||
42300407|NCT05476679|76135574|FG000|Overall Study|Withdrawal by Subject|0|||
42300408|NCT05476679|76135575|FG001|Overall Study|Withdrawal by Subject|0|||
41950230|NCT02008890|75715320|FG001|Extension Period|Lost to Follow-up|0|||
41950231|NCT02008890|75715321|FG002|Extension Period|Lost to Follow-up|0|||
41950232|NCT02008890|75715322|FG003|Extension Period|Lost to Follow-up|0|||
41950233|NCT02008890|75715323|FG004|Extension Period|Lost to Follow-up|0|||
41950234|NCT02008890|75715319|FG000|Extension Period|Adverse Event|1|||
41950235|NCT02008890|75715320|FG001|Extension Period|Adverse Event|3|||
41950236|NCT02008890|75715321|FG002|Extension Period|Adverse Event|0|||
41950237|NCT02008890|75715322|FG003|Extension Period|Adverse Event|0|||
41950238|NCT02008890|75715323|FG004|Extension Period|Adverse Event|2|||
41950239|NCT02052414|75715338|FG000|Overall Study|Adverse Event|12|||
41950240|NCT02052414|75715338|FG000|Overall Study|Lack of Efficacy|2|||
41950241|NCT02052414|75715338|FG000|Overall Study|Withdrawal by Subject|3|||
42300409|NCT05476679|76135576|FG002|Overall Study|Withdrawal by Subject|0|||
41950242|NCT02007954|75715343|FG000|Overall Study|Received liver transplant|3|||
41950243|NCT02007954|75715343|FG000|Overall Study|Switch in treatment modality|2|||
41950244|NCT02007954|75715343|FG000|Overall Study|Disease progression and unrelated AE|1|||
41950245|NCT02007954|75715343|FG000|Overall Study|Death|1|||
41950246|NCT02049450|75715347|FG000|Overall Study|Adverse Event|2|||
41950247|NCT02049450|75715347|FG000|Overall Study|Withdrawal by Subject|1|||
41950248|NCT02049450|75715347|FG000|Overall Study|Patients/guardian decision|1|||
41950249|NCT02031432|75715358|FG000|Overall Study|Protocol Violation|1|||
41950250|NCT02031432|75715358|FG000|Overall Study|Lack of Efficacy|5|||
41950251|NCT02031432|75715358|FG000|Overall Study|Cancer Progression|2|||
41950252|NCT02031432|75715358|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
41950253|NCT02031432|75715358|FG000|Overall Study|Adverse Event|8|||
41950254|NCT02031432|75715358|FG000|Overall Study|Withdrawal by Subject|5|||
41950255|NCT02031432|75715358|FG000|Overall Study|Lost to Follow-up|1|||
41950256|NCT02031432|75715358|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
41950257|NCT02031432|75715358|FG000|Overall Study|Death|10|||
41950258|NCT02031276|75715365|FG000|Period 1 Double-blind IV|Adverse Event|6|||
41950259|NCT02031276|75715366|FG001|Period 1 Double-blind IV|Adverse Event|5|||
41950260|NCT02031276|75715367|FG002|Period 1 Double-blind IV|Adverse Event|1|||
41950261|NCT02031276|75715365|FG000|Period 1 Double-blind IV|Other|0|||
41950262|NCT02031276|75715366|FG001|Period 1 Double-blind IV|Other|1|||
41950263|NCT02031276|75715367|FG002|Period 1 Double-blind IV|Other|0|||
41950264|NCT02031276|75715365|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
41950265|NCT02031276|75715366|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
41950266|NCT02031276|75715367|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
41950267|NCT02031276|75715365|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
41950268|NCT02031276|75715366|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
41950269|NCT02031276|75715367|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
41950270|NCT02031276|75715365|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
41950271|NCT02031276|75715366|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
41950272|NCT02031276|75715367|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
41950273|NCT02031276|75715365|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
41950274|NCT02031276|75715366|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
41950275|NCT02031276|75715367|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
41950276|NCT02031276|75715365|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
41950277|NCT02031276|75715366|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
41950278|NCT02031276|75715367|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
41950279|NCT02031276|75715365|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
41950280|NCT02031276|75715366|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
41950281|NCT02031276|75715367|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
41950282|NCT02031276|75715365|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
41950283|NCT02031276|75715366|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
41950284|NCT02031276|75715367|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
41950285|NCT02007720|75715381|FG000|Overall Study|Withdrawal by Subject|9|||
41950286|NCT02007720|75715382|FG001|Overall Study|Withdrawal by Subject|11|||
41950287|NCT02007720|75715381|FG000|Overall Study|study terminated by sponsor|58|||
41950288|NCT02007720|75715382|FG001|Overall Study|study terminated by sponsor|54|||
41950289|NCT02007720|75715381|FG000|Overall Study|technical problem|4|||
41950290|NCT02007720|75715382|FG001|Overall Study|technical problem|2|||
41950291|NCT02007720|75715381|FG000|Overall Study|patient followd less than 165 days|11|||
41950292|NCT02007720|75715382|FG001|Overall Study|patient followd less than 165 days|5|||
41950293|NCT01363440|75715392|FG000|Overall Study|Adverse Event|5|||
41950294|NCT01363440|75715393|FG001|Overall Study|Adverse Event|4|||
41950295|NCT01363440|75715394|FG002|Overall Study|Adverse Event|4|||
41950296|NCT01363440|75715392|FG000|Overall Study|Death|3|||
41950297|NCT01363440|75715393|FG001|Overall Study|Death|7|||
41950298|NCT01363440|75715394|FG002|Overall Study|Death|5|||
41950299|NCT01363440|75715392|FG000|Overall Study|Withdrawal by Subject|9|||
41950300|NCT01363440|75715393|FG001|Overall Study|Withdrawal by Subject|11|||
41950301|NCT01363440|75715394|FG002|Overall Study|Withdrawal by Subject|11|||
41950302|NCT01363440|75715392|FG000|Overall Study|Lost to Follow-up|2|||
41950303|NCT01363440|75715393|FG001|Overall Study|Lost to Follow-up|4|||
41950304|NCT01363440|75715394|FG002|Overall Study|Lost to Follow-up|5|||
41950305|NCT01363440|75715392|FG000|Overall Study|Other|4|||
42300410|NCT05476679|76135577|FG003|Overall Study|Withdrawal by Subject|1|||
42300411|NCT05476679|76135578|FG004|Overall Study|Withdrawal by Subject|0|||
42300412|NCT05476679|76135574|FG000|Overall Study|Lost to Follow-up|0|||
41950306|NCT01363440|75715393|FG001|Overall Study|Other|5|||
41950307|NCT01363440|75715394|FG002|Overall Study|Other|2|||
41950308|NCT02007252|75715407|FG000|Overall Study|Administrative problems|3|||
41950309|NCT02007252|75715408|FG001|Overall Study|Administrative problems|7|||
41950310|NCT02007252|75715407|FG000|Overall Study|Abnormal laboratory value(s)|1|||
41950311|NCT02007252|75715408|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42300413|NCT05476679|76135575|FG001|Overall Study|Lost to Follow-up|0|||
41950312|NCT02007252|75715407|FG000|Overall Study|Adverse Event|7|||
41950313|NCT02007252|75715408|FG001|Overall Study|Adverse Event|4|||
41950314|NCT02007096|75715416|FG000|Overall Study|medication not available|2|||
41950315|NCT02007096|75715417|FG001|Overall Study|medication not available|0|||
41950316|NCT02007096|75715416|FG000|Overall Study|did not inject saline|0|||
41950317|NCT02007096|75715417|FG001|Overall Study|did not inject saline|3|||
41950318|NCT02007096|75715416|FG000|Overall Study|did not follow postoperative protocol|8|||
41950319|NCT02007096|75715417|FG001|Overall Study|did not follow postoperative protocol|11|||
41950320|NCT02007096|75715416|FG000|Overall Study|converted to open surgery|1|||
41950321|NCT02007096|75715417|FG001|Overall Study|converted to open surgery|1|||
41950322|NCT02007096|75715416|FG000|Overall Study|no mesh placed|0|||
41950323|NCT02007096|75715417|FG001|Overall Study|no mesh placed|1|||
41950324|NCT02006706|75715423|FG000|Overall Study|Lost to Follow-up|1|||
41950325|NCT02049138|75715430|FG000|Overall Study|Adverse Event|46|||
41950326|NCT02049138|75715431|FG001|Overall Study|Adverse Event|25|||
41950327|NCT02049138|75715432|FG002|Overall Study|Adverse Event|1|||
41950328|NCT02049138|75715430|FG000|Overall Study|Withdrawal by Subject|57|||
41950329|NCT02049138|75715431|FG001|Overall Study|Withdrawal by Subject|21|||
41950330|NCT02049138|75715432|FG002|Overall Study|Withdrawal by Subject|5|||
41950331|NCT02049138|75715430|FG000|Overall Study|Lost to Follow-up|18|||
41950332|NCT02049138|75715431|FG001|Overall Study|Lost to Follow-up|5|||
41950333|NCT02049138|75715432|FG002|Overall Study|Lost to Follow-up|1|||
41950334|NCT02049138|75715430|FG000|Overall Study|Lack of Efficacy|10|||
41950335|NCT02049138|75715431|FG001|Overall Study|Lack of Efficacy|26|||
41950336|NCT02049138|75715432|FG002|Overall Study|Lack of Efficacy|1|||
41950337|NCT02049138|75715430|FG000|Overall Study|Non-Compliance|15|||
41950338|NCT02049138|75715431|FG001|Overall Study|Non-Compliance|6|||
41950339|NCT02049138|75715432|FG002|Overall Study|Non-Compliance|0|||
41950340|NCT02049138|75715430|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
41950341|NCT02049138|75715431|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
41950342|NCT02049138|75715432|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
41950343|NCT02049138|75715430|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
41950344|NCT02049138|75715431|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
41950345|NCT02049138|75715432|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
41950346|NCT02049138|75715430|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
41950347|NCT02049138|75715431|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
41950348|NCT02049138|75715432|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
41950349|NCT02049138|75715430|FG000|Overall Study|Other|15|||
41950350|NCT02049138|75715431|FG001|Overall Study|Other|13|||
41950351|NCT02049138|75715432|FG002|Overall Study|Other|0|||
41950352|NCT02049138|75715430|FG000|Overall Study|Missing|0|||
41950353|NCT02049138|75715431|FG001|Overall Study|Missing|1|||
41950354|NCT02049138|75715432|FG002|Overall Study|Missing|0|||
41950355|NCT02048904|75715443|FG000|Overall Study|Withdrawal by Subject|7|||
41950356|NCT02048904|75715443|FG000|Overall Study|Physician Decision|70|||
41950357|NCT02006628|75715449|FG000|Overall Study|Adverse Event|1|||
41950358|NCT02006628|75715450|FG001|Overall Study|Adverse Event|1|||
41950359|NCT02006628|75715449|FG000|Overall Study|Withdrawal by Subject|2|||
41950360|NCT02006628|75715450|FG001|Overall Study|Withdrawal by Subject|1|||
41950361|NCT02048826|75715458|FG000|Overall Study|Withdrawal by Subject|1|||
41950362|NCT02048826|75715459|FG001|Overall Study|Withdrawal by Subject|0|||
41950363|NCT02006472|75715470|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
41950364|NCT02006472|75715471|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
41950365|NCT02006472|75715472|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
41950366|NCT02006472|75715473|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
41950367|NCT02006472|75715474|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
41950368|NCT02006472|75715470|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
41950369|NCT02006472|75715471|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
41950370|NCT02006472|75715472|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
41950371|NCT02006472|75715473|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
41950372|NCT02006472|75715474|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
41950373|NCT02006472|75715470|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
41950374|NCT02006472|75715471|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
41950375|NCT02006472|75715472|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
41950376|NCT02006472|75715473|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
41950377|NCT02006472|75715474|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
41950378|NCT02006472|75715470|FG000|Period 1 (Through Week 26)|Other|1|||
41950379|NCT02006472|75715471|FG001|Period 1 (Through Week 26)|Other|5|||
41950380|NCT02006472|75715472|FG002|Period 1 (Through Week 26)|Other|0|||
41950381|NCT02006472|75715473|FG003|Period 1 (Through Week 26)|Other|2|||
41950382|NCT02006472|75715474|FG004|Period 1 (Through Week 26)|Other|3|||
41950383|NCT02006472|75715470|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
41950384|NCT02006472|75715471|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
41950385|NCT02006472|75715472|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
41950386|NCT02006472|75715473|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
41950387|NCT02006472|75715474|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
41950388|NCT02006472|75715470|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
41950389|NCT02006472|75715471|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
41950390|NCT02006472|75715472|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
41950391|NCT02006472|75715473|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
41950392|NCT02006472|75715474|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
41950393|NCT02006472|75715470|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
41950394|NCT02006472|75715471|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
41950395|NCT02006472|75715472|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
41950396|NCT02006472|75715473|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
41950397|NCT02006472|75715474|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
41950398|NCT02006472|75715470|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
41950399|NCT02006472|75715471|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
41950400|NCT02006472|75715472|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
41950401|NCT02006472|75715473|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
41950402|NCT02006472|75715474|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
41950403|NCT02006472|75715470|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
41950404|NCT02006472|75715471|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
41950405|NCT02006472|75715472|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
41950406|NCT02006472|75715473|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
41950407|NCT02006472|75715474|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
41950408|NCT02006472|75715470|FG000|Period 2 (Through Week 52)|Other|0|||
41950409|NCT02006472|75715471|FG001|Period 2 (Through Week 52)|Other|1|||
41950410|NCT02006472|75715472|FG002|Period 2 (Through Week 52)|Other|0|||
41950411|NCT02006472|75715473|FG003|Period 2 (Through Week 52)|Other|1|||
41950412|NCT02006472|75715474|FG004|Period 2 (Through Week 52)|Other|0|||
41950413|NCT02006472|75715470|FG000|Period 2 (Through Week 52)|Not treated|0|||
41950414|NCT02006472|75715471|FG001|Period 2 (Through Week 52)|Not treated|0|||
41950415|NCT02006472|75715472|FG002|Period 2 (Through Week 52)|Not treated|2|||
41950416|NCT02006472|75715473|FG003|Period 2 (Through Week 52)|Not treated|0|||
41950417|NCT02006472|75715474|FG004|Period 2 (Through Week 52)|Not treated|0|||
41950418|NCT02006472|75715470|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
41950419|NCT02006472|75715471|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
41950420|NCT02006472|75715472|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
41950421|NCT02006472|75715473|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
41950422|NCT02006472|75715474|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
41950423|NCT02006472|75715470|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
41950424|NCT02006472|75715471|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
41950425|NCT02006472|75715472|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
41950426|NCT02006472|75715473|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
41950427|NCT02006472|75715474|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
41950428|NCT02005692|75715491|FG000|Overall Study|Protocol Violation|1|||
41950429|NCT02005692|75715491|FG000|Overall Study|Withdrawal by Subject|1|||
41950430|NCT02005692|75715491|FG000|Overall Study|Discharged earlier than anticipated|5|||
41950431|NCT02029638|75715499|FG000|Overall Study|Death|0|||
41950432|NCT02029638|75715500|FG001|Overall Study|Death|0|||
41950433|NCT02029638|75715501|FG002|Overall Study|Death|1|||
41950434|NCT02029638|75715499|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
41950435|NCT02029638|75715500|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
41950436|NCT02029638|75715501|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
41950437|NCT02047734|75715512|FG000|Overall Study|Adverse Event|18|||
41950438|NCT02047734|75715513|FG001|Overall Study|Adverse Event|13|||
41950439|NCT02047734|75715514|FG002|Overall Study|Adverse Event|13|||
41950440|NCT02047734|75715512|FG000|Overall Study|Lack of Efficacy|4|||
41950441|NCT02047734|75715513|FG001|Overall Study|Lack of Efficacy|5|||
41950442|NCT02047734|75715514|FG002|Overall Study|Lack of Efficacy|1|||
41950443|NCT02047734|75715512|FG000|Overall Study|Protocol Violation|3|||
41950444|NCT02047734|75715513|FG001|Overall Study|Protocol Violation|1|||
41950445|NCT02047734|75715514|FG002|Overall Study|Protocol Violation|1|||
41950446|NCT02047734|75715512|FG000|Overall Study|Lost to Follow-up|1|||
41950447|NCT02047734|75715513|FG001|Overall Study|Lost to Follow-up|4|||
41950448|NCT02047734|75715514|FG002|Overall Study|Lost to Follow-up|0|||
41950449|NCT02047734|75715512|FG000|Overall Study|Death|0|||
41950450|NCT02047734|75715513|FG001|Overall Study|Death|1|||
41950451|NCT02047734|75715514|FG002|Overall Study|Death|0|||
41950452|NCT02047734|75715512|FG000|Overall Study|Withdrawal by Subject|30|||
41950453|NCT02047734|75715513|FG001|Overall Study|Withdrawal by Subject|31|||
41950454|NCT02047734|75715514|FG002|Overall Study|Withdrawal by Subject|19|||
41950455|NCT02047734|75715512|FG000|Overall Study|Physician Decision|7|||
41950456|NCT02047734|75715513|FG001|Overall Study|Physician Decision|6|||
41950457|NCT02047734|75715514|FG002|Overall Study|Physician Decision|5|||
41950458|NCT02047734|75715512|FG000|Overall Study|Miscellaneous|2|||
42023833|NCT01227668|75831174|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
42118026|NCT00689117|75928843|FG003|Overall Study|Incarceration|0|||
41950459|NCT02047734|75715513|FG001|Overall Study|Miscellaneous|4|||
41950460|NCT02047734|75715514|FG002|Overall Study|Miscellaneous|6|||
41950461|NCT02047734|75715512|FG000|Overall Study|Did Not Receive Study Drug|2|||
41950462|NCT02047734|75715513|FG001|Overall Study|Did Not Receive Study Drug|4|||
41950463|NCT02047734|75715514|FG002|Overall Study|Did Not Receive Study Drug|1|||
41950464|NCT02053350|75715522|FG000|Overall Study|Withdrawal by Subject|1|||
41950465|NCT02053350|75715522|FG000|Overall Study|Adverse Event|4|||
41950466|NCT01994850|75715526|FG000|Overall Study|Physician Decision|1|||
41950467|NCT01994850|75715526|FG000|Overall Study|Withdrawal by Subject|1|||
41950468|NCT02027844|75715533|FG000|Overall Study|Withdrawal by Subject|3|||
41950469|NCT02027844|75715534|FG001|Overall Study|Withdrawal by Subject|2|||
41950470|NCT02027844|75715535|FG002|Overall Study|Withdrawal by Subject|1|||
41950471|NCT02027844|75715533|FG000|Overall Study|Lost to Follow-up|0|||
41950472|NCT02027844|75715534|FG001|Overall Study|Lost to Follow-up|2|||
41950473|NCT02027844|75715535|FG002|Overall Study|Lost to Follow-up|1|||
41950474|NCT02027844|75715533|FG000|Overall Study|Protocol Violation|0|||
41950475|NCT02027844|75715534|FG001|Overall Study|Protocol Violation|2|||
41950476|NCT02027844|75715535|FG002|Overall Study|Protocol Violation|0|||
41950477|NCT02027844|75715533|FG000|Overall Study|Incomlete data|2|||
41950478|NCT02027844|75715534|FG001|Overall Study|Incomlete data|0|||
41950479|NCT02027844|75715535|FG002|Overall Study|Incomlete data|0|||
41950480|NCT01994382|75715560|FG000|Overall Study|Informed consent withdrawn|0|||
41950481|NCT01994382|75715561|FG001|Overall Study|Informed consent withdrawn|0|||
41950482|NCT01994382|75715562|FG002|Overall Study|Informed consent withdrawn|0|||
41950483|NCT01994382|75715563|FG003|Overall Study|Informed consent withdrawn|0|||
41950484|NCT01994382|75715564|FG004|Overall Study|Informed consent withdrawn|0|||
41950485|NCT01994382|75715565|FG005|Overall Study|Informed consent withdrawn|0|||
41950486|NCT01994382|75715566|FG006|Overall Study|Informed consent withdrawn|1|||
41950487|NCT01994382|75715567|FG007|Overall Study|Informed consent withdrawn|0|||
41950488|NCT01994382|75715568|FG008|Overall Study|Informed consent withdrawn|0|||
41950489|NCT01994382|75715569|FG009|Overall Study|Informed consent withdrawn|0|||
41950490|NCT01994382|75715570|FG010|Overall Study|Informed consent withdrawn|0|||
41950491|NCT01994382|75715571|FG011|Overall Study|Informed consent withdrawn|0|||
41950492|NCT01994382|75715572|FG012|Overall Study|Informed consent withdrawn|0|||
41950493|NCT01994382|75715573|FG013|Overall Study|Informed consent withdrawn|0|||
41950494|NCT01994382|75715574|FG014|Overall Study|Informed consent withdrawn|0|||
41950495|NCT01994382|75715575|FG015|Overall Study|Informed consent withdrawn|0|||
41950496|NCT01994382|75715576|FG016|Overall Study|Informed consent withdrawn|0|||
41950497|NCT01994382|75715560|FG000|Overall Study|Progressive disease|3|||
41950498|NCT01994382|75715561|FG001|Overall Study|Progressive disease|4|||
41950499|NCT01994382|75715562|FG002|Overall Study|Progressive disease|4|||
41950500|NCT01994382|75715563|FG003|Overall Study|Progressive disease|3|||
41950501|NCT01994382|75715564|FG004|Overall Study|Progressive disease|2|||
41950502|NCT01994382|75715565|FG005|Overall Study|Progressive disease|3|||
41950503|NCT01994382|75715566|FG006|Overall Study|Progressive disease|3|||
41950504|NCT01994382|75715567|FG007|Overall Study|Progressive disease|6|||
41950505|NCT01994382|75715568|FG008|Overall Study|Progressive disease|2|||
41950506|NCT01994382|75715569|FG009|Overall Study|Progressive disease|2|||
41950507|NCT01994382|75715570|FG010|Overall Study|Progressive disease|13|||
41950508|NCT01994382|75715571|FG011|Overall Study|Progressive disease|8|||
41950509|NCT01994382|75715572|FG012|Overall Study|Progressive disease|7|||
41950510|NCT01994382|75715573|FG013|Overall Study|Progressive disease|3|||
41950511|NCT01994382|75715574|FG014|Overall Study|Progressive disease|6|||
42300414|NCT05476679|76135576|FG002|Overall Study|Lost to Follow-up|0|||
41950512|NCT01994382|75715575|FG015|Overall Study|Progressive disease|44|||
41950513|NCT01994382|75715576|FG016|Overall Study|Progressive disease|28|||
42023834|NCT01227668|75831173|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
42023835|NCT01227668|75831174|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
42023836|NCT01227668|75831173|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
42023837|NCT01227668|75831174|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
42023838|NCT01227668|75831173|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
42023839|NCT01227668|75831174|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
42023840|NCT01227668|75831173|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
42023841|NCT01227668|75831174|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
42023842|NCT01227668|75831173|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
42023843|NCT01227668|75831174|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
42023844|NCT01227668|75831173|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
42023845|NCT01227668|75831174|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
41950514|NCT01994382|75715560|FG000|Overall Study|Physician Decision|0|||
41950515|NCT01994382|75715561|FG001|Overall Study|Physician Decision|1|||
41950516|NCT01994382|75715562|FG002|Overall Study|Physician Decision|0|||
41950517|NCT01994382|75715563|FG003|Overall Study|Physician Decision|0|||
41950518|NCT01994382|75715564|FG004|Overall Study|Physician Decision|0|||
41950519|NCT01994382|75715565|FG005|Overall Study|Physician Decision|0|||
41950520|NCT01994382|75715566|FG006|Overall Study|Physician Decision|0|||
41950521|NCT01994382|75715567|FG007|Overall Study|Physician Decision|0|||
41950522|NCT01994382|75715568|FG008|Overall Study|Physician Decision|0|||
41950523|NCT01994382|75715569|FG009|Overall Study|Physician Decision|0|||
42023846|NCT01227668|75831173|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
42023847|NCT01227668|75831174|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
42023848|NCT01227668|75831173|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
42023849|NCT01227668|75831174|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
42023850|NCT01227668|75831173|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
41950524|NCT01994382|75715570|FG010|Overall Study|Physician Decision|3|||
41950525|NCT01994382|75715571|FG011|Overall Study|Physician Decision|1|||
41950526|NCT01994382|75715572|FG012|Overall Study|Physician Decision|1|||
41950527|NCT01994382|75715573|FG013|Overall Study|Physician Decision|0|||
41950528|NCT01994382|75715574|FG014|Overall Study|Physician Decision|1|||
41950529|NCT01994382|75715575|FG015|Overall Study|Physician Decision|4|||
41950530|NCT01994382|75715576|FG016|Overall Study|Physician Decision|2|||
41950531|NCT01994382|75715560|FG000|Overall Study|Death|0|||
41950532|NCT01994382|75715561|FG001|Overall Study|Death|0|||
41950533|NCT01994382|75715562|FG002|Overall Study|Death|0|||
41950534|NCT01994382|75715563|FG003|Overall Study|Death|0|||
41950535|NCT01994382|75715564|FG004|Overall Study|Death|1|||
41950536|NCT01994382|75715565|FG005|Overall Study|Death|0|||
41950537|NCT01994382|75715566|FG006|Overall Study|Death|0|||
41950538|NCT01994382|75715567|FG007|Overall Study|Death|0|||
41950539|NCT01994382|75715568|FG008|Overall Study|Death|1|||
41950540|NCT01994382|75715569|FG009|Overall Study|Death|1|||
41950541|NCT01994382|75715570|FG010|Overall Study|Death|0|||
41950542|NCT01994382|75715571|FG011|Overall Study|Death|0|||
41950543|NCT01994382|75715572|FG012|Overall Study|Death|0|||
41950544|NCT01994382|75715573|FG013|Overall Study|Death|0|||
41950545|NCT01994382|75715574|FG014|Overall Study|Death|0|||
41950546|NCT01994382|75715575|FG015|Overall Study|Death|1|||
41950547|NCT01994382|75715576|FG016|Overall Study|Death|0|||
41950548|NCT01994382|75715560|FG000|Overall Study|Adverse Event|0|||
41950549|NCT01994382|75715561|FG001|Overall Study|Adverse Event|1|||
41950550|NCT01994382|75715562|FG002|Overall Study|Adverse Event|2|||
41950551|NCT01994382|75715563|FG003|Overall Study|Adverse Event|0|||
41950552|NCT01994382|75715564|FG004|Overall Study|Adverse Event|0|||
41950553|NCT01994382|75715565|FG005|Overall Study|Adverse Event|0|||
41950554|NCT01994382|75715566|FG006|Overall Study|Adverse Event|0|||
41950555|NCT01994382|75715567|FG007|Overall Study|Adverse Event|0|||
41950556|NCT01994382|75715568|FG008|Overall Study|Adverse Event|0|||
41950557|NCT01994382|75715569|FG009|Overall Study|Adverse Event|0|||
41950558|NCT01994382|75715570|FG010|Overall Study|Adverse Event|15|||
41950559|NCT01994382|75715571|FG011|Overall Study|Adverse Event|2|||
41950560|NCT01994382|75715572|FG012|Overall Study|Adverse Event|7|||
41950561|NCT01994382|75715573|FG013|Overall Study|Adverse Event|3|||
41950562|NCT01994382|75715574|FG014|Overall Study|Adverse Event|17|||
41950563|NCT01994382|75715575|FG015|Overall Study|Adverse Event|6|||
41950564|NCT01994382|75715576|FG016|Overall Study|Adverse Event|3|||
41950565|NCT01994382|75715560|FG000|Overall Study|Other than specified|0|||
41950566|NCT01994382|75715561|FG001|Overall Study|Other than specified|0|||
41950567|NCT01994382|75715562|FG002|Overall Study|Other than specified|0|||
41950568|NCT01994382|75715563|FG003|Overall Study|Other than specified|0|||
41950569|NCT01994382|75715564|FG004|Overall Study|Other than specified|0|||
41950570|NCT01994382|75715565|FG005|Overall Study|Other than specified|0|||
41950571|NCT01994382|75715566|FG006|Overall Study|Other than specified|0|||
41950572|NCT01994382|75715567|FG007|Overall Study|Other than specified|0|||
41950573|NCT01994382|75715568|FG008|Overall Study|Other than specified|0|||
41950574|NCT01994382|75715569|FG009|Overall Study|Other than specified|0|||
41950575|NCT01994382|75715570|FG010|Overall Study|Other than specified|2|||
41950576|NCT01994382|75715571|FG011|Overall Study|Other than specified|0|||
41950577|NCT01994382|75715572|FG012|Overall Study|Other than specified|2|||
41950578|NCT01994382|75715573|FG013|Overall Study|Other than specified|0|||
41950579|NCT01994382|75715574|FG014|Overall Study|Other than specified|0|||
41950580|NCT01994382|75715575|FG015|Overall Study|Other than specified|4|||
41950581|NCT01994382|75715576|FG016|Overall Study|Other than specified|4|||
41950582|NCT01994382|75715560|FG000|Overall Study|Withdrawal by Subject|0|||
41950583|NCT01994382|75715561|FG001|Overall Study|Withdrawal by Subject|0|||
41950584|NCT01994382|75715562|FG002|Overall Study|Withdrawal by Subject|0|||
41950585|NCT01994382|75715563|FG003|Overall Study|Withdrawal by Subject|0|||
41950586|NCT01994382|75715564|FG004|Overall Study|Withdrawal by Subject|0|||
41950587|NCT01994382|75715565|FG005|Overall Study|Withdrawal by Subject|0|||
42023851|NCT01227668|75831174|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
42023852|NCT01227512|75831186|FG000|Overall Study|Physician Decision|6|||
41950588|NCT01994382|75715566|FG006|Overall Study|Withdrawal by Subject|0|||
41950589|NCT01994382|75715567|FG007|Overall Study|Withdrawal by Subject|0|||
41950590|NCT01994382|75715568|FG008|Overall Study|Withdrawal by Subject|0|||
41950591|NCT01994382|75715569|FG009|Overall Study|Withdrawal by Subject|0|||
41950592|NCT01994382|75715570|FG010|Overall Study|Withdrawal by Subject|6|||
41950593|NCT01994382|75715571|FG011|Overall Study|Withdrawal by Subject|0|||
41950594|NCT01994382|75715572|FG012|Overall Study|Withdrawal by Subject|2|||
41950595|NCT01994382|75715573|FG013|Overall Study|Withdrawal by Subject|0|||
41950596|NCT01994382|75715574|FG014|Overall Study|Withdrawal by Subject|4|||
41950597|NCT01994382|75715575|FG015|Overall Study|Withdrawal by Subject|3|||
41950598|NCT01994382|75715576|FG016|Overall Study|Withdrawal by Subject|0|||
41950599|NCT01994382|75715560|FG000|Overall Study|Lost to Follow-up|0|||
41950600|NCT01994382|75715561|FG001|Overall Study|Lost to Follow-up|0|||
41950601|NCT01994382|75715562|FG002|Overall Study|Lost to Follow-up|0|||
41950602|NCT01994382|75715563|FG003|Overall Study|Lost to Follow-up|0|||
41950603|NCT01994382|75715564|FG004|Overall Study|Lost to Follow-up|0|||
41950604|NCT01994382|75715565|FG005|Overall Study|Lost to Follow-up|0|||
41950605|NCT01994382|75715566|FG006|Overall Study|Lost to Follow-up|0|||
41950606|NCT01994382|75715567|FG007|Overall Study|Lost to Follow-up|0|||
41950607|NCT01994382|75715568|FG008|Overall Study|Lost to Follow-up|0|||
41950608|NCT01994382|75715569|FG009|Overall Study|Lost to Follow-up|0|||
41950609|NCT01994382|75715570|FG010|Overall Study|Lost to Follow-up|1|||
41950610|NCT01994382|75715571|FG011|Overall Study|Lost to Follow-up|0|||
41950611|NCT01994382|75715572|FG012|Overall Study|Lost to Follow-up|0|||
41950612|NCT01994382|75715573|FG013|Overall Study|Lost to Follow-up|0|||
41950613|NCT01994382|75715574|FG014|Overall Study|Lost to Follow-up|0|||
41950614|NCT01994382|75715575|FG015|Overall Study|Lost to Follow-up|0|||
41950615|NCT01994382|75715576|FG016|Overall Study|Lost to Follow-up|0|||
41950616|NCT01994382|75715560|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950617|NCT01994382|75715561|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950618|NCT01994382|75715562|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950619|NCT01994382|75715563|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950620|NCT01994382|75715564|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950621|NCT01994382|75715565|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950622|NCT01994382|75715566|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950623|NCT01994382|75715567|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950624|NCT01994382|75715568|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950625|NCT01994382|75715569|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950626|NCT01994382|75715570|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
41950627|NCT01994382|75715571|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950628|NCT01994382|75715572|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
41950629|NCT01994382|75715573|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950630|NCT01994382|75715574|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
41950631|NCT01994382|75715575|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
41950632|NCT01994382|75715576|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
41950633|NCT01994382|75715560|FG000|Overall Study|Protocol violation/noncompliance|0|||
41950634|NCT01994382|75715561|FG001|Overall Study|Protocol violation/noncompliance|0|||
41950635|NCT01994382|75715562|FG002|Overall Study|Protocol violation/noncompliance|0|||
41950636|NCT01994382|75715563|FG003|Overall Study|Protocol violation/noncompliance|0|||
41950637|NCT01994382|75715564|FG004|Overall Study|Protocol violation/noncompliance|0|||
41950638|NCT01994382|75715565|FG005|Overall Study|Protocol violation/noncompliance|0|||
41950639|NCT01994382|75715566|FG006|Overall Study|Protocol violation/noncompliance|0|||
41950640|NCT01994382|75715567|FG007|Overall Study|Protocol violation/noncompliance|0|||
41950641|NCT01994382|75715568|FG008|Overall Study|Protocol violation/noncompliance|0|||
41950642|NCT01994382|75715569|FG009|Overall Study|Protocol violation/noncompliance|0|||
41950643|NCT01994382|75715570|FG010|Overall Study|Protocol violation/noncompliance|0|||
41950644|NCT01994382|75715571|FG011|Overall Study|Protocol violation/noncompliance|1|||
41950645|NCT01994382|75715572|FG012|Overall Study|Protocol violation/noncompliance|0|||
41950646|NCT01994382|75715573|FG013|Overall Study|Protocol violation/noncompliance|0|||
41950647|NCT01994382|75715574|FG014|Overall Study|Protocol violation/noncompliance|0|||
41950648|NCT01994382|75715575|FG015|Overall Study|Protocol violation/noncompliance|0|||
41950649|NCT01994382|75715576|FG016|Overall Study|Protocol violation/noncompliance|2|||
41950650|NCT01994382|75715560|FG000|Overall Study|Rolled over to Phase 2a|0|||
41950651|NCT01994382|75715561|FG001|Overall Study|Rolled over to Phase 2a|0|||
41950652|NCT01994382|75715562|FG002|Overall Study|Rolled over to Phase 2a|1|||
41950653|NCT01994382|75715563|FG003|Overall Study|Rolled over to Phase 2a|0|||
41950654|NCT01994382|75715564|FG004|Overall Study|Rolled over to Phase 2a|0|||
41950655|NCT01994382|75715565|FG005|Overall Study|Rolled over to Phase 2a|0|||
41950656|NCT01994382|75715566|FG006|Overall Study|Rolled over to Phase 2a|0|||
41950657|NCT01994382|75715567|FG007|Overall Study|Rolled over to Phase 2a|0|||
41950658|NCT01994382|75715568|FG008|Overall Study|Rolled over to Phase 2a|0|||
41950659|NCT01994382|75715569|FG009|Overall Study|Rolled over to Phase 2a|2|||
41950660|NCT01994382|75715570|FG010|Overall Study|Rolled over to Phase 2a|0|||
41950661|NCT01994382|75715571|FG011|Overall Study|Rolled over to Phase 2a|0|||
42023853|NCT01227512|75831187|FG001|Overall Study|Physician Decision|6|||
42023854|NCT01227512|75831186|FG000|Overall Study|Adverse Event|4|||
41950662|NCT01994382|75715572|FG012|Overall Study|Rolled over to Phase 2a|0|||
42023855|NCT01227512|75831187|FG001|Overall Study|Adverse Event|3|||
41950663|NCT01994382|75715573|FG013|Overall Study|Rolled over to Phase 2a|0|||
41950664|NCT01994382|75715574|FG014|Overall Study|Rolled over to Phase 2a|0|||
41950665|NCT01994382|75715575|FG015|Overall Study|Rolled over to Phase 2a|0|||
41950666|NCT01994382|75715576|FG016|Overall Study|Rolled over to Phase 2a|0|||
41950667|NCT02003898|75715619|FG000|Overall Study|Death|3|||
41950668|NCT02003898|75715619|FG000|Overall Study|Lost to Follow-up|12|||
41950669|NCT02003898|75715619|FG000|Overall Study|Withdrawal by Subject|52|||
41950670|NCT01994226|75715625|FG000|Overall Study|Protocol Violation|13|||
41950671|NCT01994226|75715626|FG001|Overall Study|Protocol Violation|10|||
41950672|NCT01994226|75715625|FG000|Overall Study|Early Cessation of treatment|6|||
41950673|NCT01994226|75715626|FG001|Overall Study|Early Cessation of treatment|11|||
41950674|NCT02002884|75715635|FG000|Main Period (MP)|Other|0|||
41950675|NCT02002884|75715636|FG001|Main Period (MP)|Other|3|||
41950676|NCT02002884|75715637|FG002|Main Period (MP)|Other|3|||
41950677|NCT02002884|75715638|FG003|Main Period (MP)|Other|0|||
41950678|NCT02002884|75715635|FG000|Main Period (MP)|Adverse Event|0|||
41950679|NCT02002884|75715636|FG001|Main Period (MP)|Adverse Event|1|||
41950680|NCT02002884|75715637|FG002|Main Period (MP)|Adverse Event|1|||
41950681|NCT02002884|75715638|FG003|Main Period (MP)|Adverse Event|0|||
41950682|NCT02002884|75715635|FG000|Main Period (MP)|Withdrawal by Subject|6|||
41950683|NCT02002884|75715636|FG001|Main Period (MP)|Withdrawal by Subject|2|||
41950684|NCT02002884|75715637|FG002|Main Period (MP)|Withdrawal by Subject|2|||
41950685|NCT02002884|75715638|FG003|Main Period (MP)|Withdrawal by Subject|0|||
41950686|NCT02002884|75715635|FG000|Main Period (MP)|Lost to Follow-up|0|||
41950687|NCT02002884|75715636|FG001|Main Period (MP)|Lost to Follow-up|0|||
41950688|NCT02002884|75715637|FG002|Main Period (MP)|Lost to Follow-up|2|||
41950689|NCT02002884|75715638|FG003|Main Period (MP)|Lost to Follow-up|0|||
41950690|NCT02002884|75715635|FG000|Open-Label Extension Period (OLEX)|Other|0|||
41950691|NCT02002884|75715636|FG001|Open-Label Extension Period (OLEX)|Other|0|||
41950692|NCT02002884|75715637|FG002|Open-Label Extension Period (OLEX)|Other|0|||
41950693|NCT02002884|75715638|FG003|Open-Label Extension Period (OLEX)|Other|24|||
41950694|NCT02002884|75715635|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
41950695|NCT02002884|75715636|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
41950696|NCT02002884|75715637|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
41950697|NCT02002884|75715638|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
41950698|NCT02002884|75715635|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
41950699|NCT02002884|75715636|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
41950700|NCT02002884|75715637|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
41950701|NCT02002884|75715638|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
41950702|NCT02002884|75715635|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
41950703|NCT02002884|75715636|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
41950704|NCT02002884|75715637|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
41950705|NCT02002884|75715638|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
41950706|NCT02002884|75715635|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
41950707|NCT02002884|75715636|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
41950708|NCT02002884|75715637|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
41950709|NCT02002884|75715638|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
41950710|NCT02002182|75715650|FG000|Overall Study|Withdraw from study|3|||
41950711|NCT02002182|75715651|FG001|Overall Study|Withdraw from study|1|||
41950712|NCT02002182|75715650|FG000|Overall Study|Health Reasons|1|||
41950713|NCT02002182|75715651|FG001|Overall Study|Health Reasons|0|||
41950714|NCT02002182|75715650|FG000|Overall Study|Death|1|||
41950715|NCT02002182|75715651|FG001|Overall Study|Death|0|||
41950716|NCT01990950|75715657|FG000|Overall Study|Death|3|||
41950717|NCT01990950|75715657|FG000|Overall Study|Lost to Follow-up|2|||
41950718|NCT01990950|75715657|FG000|Overall Study|Withdrawal by Subject|6|||
41950719|NCT02001558|75715663|FG000|Overall Study|Lost to Follow-up|8|||
41950720|NCT02001558|75715664|FG001|Overall Study|Lost to Follow-up|14|||
41950721|NCT02023866|75715670|FG000|Overall Study|Non-compliance|2|||
41950722|NCT02023866|75715670|FG000|Overall Study|Adverse Event|3|||
41950723|NCT02023866|75715670|FG000|Overall Study|Withdrawal by Subject|1|||
41950724|NCT02023242|75715676|FG000|Overall Study|Lost to Follow-up|3|||
41950725|NCT02023242|75715677|FG001|Overall Study|Lost to Follow-up|1|||
41950726|NCT02023242|75715676|FG000|Overall Study|Death|0|||
41950727|NCT02023242|75715677|FG001|Overall Study|Death|1|||
41950728|NCT01967940|75715686|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
41950729|NCT01967940|75715687|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
41950730|NCT01967940|75715688|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
41950731|NCT01967940|75715689|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
41950732|NCT01967940|75715686|FG000|Part 2|Adverse Event|0|||
41950733|NCT01967940|75715687|FG001|Part 2|Adverse Event|0|||
41950734|NCT01967940|75715688|FG002|Part 2|Adverse Event|0|||
41950735|NCT01967940|75715689|FG003|Part 2|Adverse Event|1|||
41950736|NCT01967940|75715686|FG000|Part 2|Unknown Reason|0|||
41950737|NCT01967940|75715687|FG001|Part 2|Unknown Reason|0|||
42023856|NCT01227512|75831186|FG000|Overall Study|Withdrawal by Subject|3|||
41950738|NCT01967940|75715688|FG002|Part 2|Unknown Reason|0|||
41950739|NCT01967940|75715689|FG003|Part 2|Unknown Reason|1|||
41950740|NCT01990560|75715699|FG000|Overall Study|Withdrawal by Subject|1|||
41950741|NCT01998984|75715707|FG000|Overall Study|Adverse Event|0|||
41950742|NCT01998984|75715708|FG001|Overall Study|Adverse Event|0|||
41950743|NCT01998984|75715709|FG002|Overall Study|Adverse Event|0|||
41950744|NCT01998984|75715710|FG003|Overall Study|Adverse Event|1|||
41950745|NCT01998984|75715707|FG000|Overall Study|Lost to Follow-up|0|||
41950746|NCT01998984|75715708|FG001|Overall Study|Lost to Follow-up|1|||
41950747|NCT01998984|75715709|FG002|Overall Study|Lost to Follow-up|0|||
41950748|NCT01998984|75715710|FG003|Overall Study|Lost to Follow-up|1|||
41950749|NCT01998984|75715707|FG000|Overall Study|Withdrawal by Subject|0|||
41950750|NCT01998984|75715708|FG001|Overall Study|Withdrawal by Subject|0|||
41950751|NCT01998984|75715709|FG002|Overall Study|Withdrawal by Subject|1|||
41950752|NCT01998984|75715710|FG003|Overall Study|Withdrawal by Subject|0|||
41950753|NCT01998984|75715707|FG000|Overall Study|Other|0|||
41950754|NCT01998984|75715708|FG001|Overall Study|Other|0|||
41950755|NCT01998984|75715709|FG002|Overall Study|Other|0|||
41950756|NCT01998984|75715710|FG003|Overall Study|Other|1|||
41950757|NCT01967706|75715722|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
41950758|NCT01967706|75715723|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
41950759|NCT01967706|75715724|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
41950760|NCT01967706|75715725|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
41950761|NCT01967628|75715736|FG000|Overall Study|Withdrawal by Subject|2|||
41950762|NCT01967628|75715737|FG001|Overall Study|Withdrawal by Subject|0|||
41950763|NCT01967628|75715736|FG000|Overall Study|Unable to complete bronchoscopy|4|||
41950764|NCT01967628|75715737|FG001|Overall Study|Unable to complete bronchoscopy|6|||
41950765|NCT01967628|75715736|FG000|Overall Study|Lost to Follow-up|1|||
41950766|NCT01967628|75715737|FG001|Overall Study|Lost to Follow-up|0|||
41950767|NCT01967628|75715736|FG000|Overall Study|Low protein concentration in sample|20|||
41950768|NCT01967628|75715737|FG001|Overall Study|Low protein concentration in sample|25|||
41950769|NCT01998906|75715746|FG000|Overall Study|Participants ongoing in follow-up|77|||
41950770|NCT01998906|75715747|FG001|Overall Study|Participants ongoing in follow-up|60|||
41950771|NCT01998906|75715748|FG002|Overall Study|Participants ongoing in follow-up|58|||
41950772|NCT01998906|75715746|FG000|Overall Study|Death|21|||
41950773|NCT01998906|75715747|FG001|Overall Study|Death|30|||
41950774|NCT01998906|75715748|FG002|Overall Study|Death|17|||
41950775|NCT01998906|75715746|FG000|Overall Study|Lack of Efficacy|10|||
41950776|NCT01998906|75715747|FG001|Overall Study|Lack of Efficacy|9|||
41950777|NCT01998906|75715748|FG002|Overall Study|Lack of Efficacy|8|||
41950778|NCT01998906|75715746|FG000|Overall Study|Failure to return|0|||
41950779|NCT01998906|75715747|FG001|Overall Study|Failure to return|2|||
41950780|NCT01998906|75715748|FG002|Overall Study|Failure to return|4|||
41950781|NCT01998906|75715746|FG000|Overall Study|Violation of Selection Criteria|0|||
41950782|NCT01998906|75715747|FG001|Overall Study|Violation of Selection Criteria|0|||
41950783|NCT01998906|75715748|FG002|Overall Study|Violation of Selection Criteria|1|||
41950784|NCT01998906|75715746|FG000|Overall Study|Withdrawal by Subject|1|||
41950785|NCT01998906|75715747|FG001|Overall Study|Withdrawal by Subject|4|||
41950786|NCT01998906|75715748|FG002|Overall Study|Withdrawal by Subject|3|||
41950787|NCT01998906|75715746|FG000|Overall Study|Administrative/Other|2|||
41950788|NCT01998906|75715747|FG001|Overall Study|Administrative/Other|1|||
41950789|NCT01998906|75715748|FG002|Overall Study|Administrative/Other|3|||
41950790|NCT01998906|75715746|FG000|Overall Study|Other|3|||
41950791|NCT01998906|75715747|FG001|Overall Study|Other|8|||
41950792|NCT01998906|75715748|FG002|Overall Study|Other|4|||
41950793|NCT01967550|75715761|FG000|Overall Study|Withdrawal by Subject|1|||
41950794|NCT01967550|75715762|FG001|Overall Study|Withdrawal by Subject|0|||
41950795|NCT01967550|75715761|FG000|Overall Study|Adverse Event|2|||
41950796|NCT01967550|75715762|FG001|Overall Study|Adverse Event|0|||
41950797|NCT01967550|75715761|FG000|Overall Study|Protocol Violation|2|||
41950798|NCT01967550|75715762|FG001|Overall Study|Protocol Violation|1|||
41950799|NCT01967550|75715761|FG000|Overall Study|Non Compliance|0|||
42023857|NCT01227512|75831187|FG001|Overall Study|Withdrawal by Subject|0|||
42023858|NCT01227512|75831186|FG000|Overall Study|Participant met withdrawal criteria|0|||
42023859|NCT01227512|75831187|FG001|Overall Study|Participant met withdrawal criteria|1|||
41950800|NCT01967550|75715762|FG001|Overall Study|Non Compliance|1|||
41950801|NCT01989546|75715768|FG000|Overall Study|Clinical Progression|1|||
41950802|NCT01989546|75715768|FG000|Overall Study|Disease progression on study|8|||
41950803|NCT01997892|75715772|FG000|Overall Study|Physician Decision|2|||
41950804|NCT01997892|75715772|FG000|Overall Study|Lost to Follow-up|6|||
41950805|NCT01997892|75715772|FG000|Overall Study|Death|14|||
41950806|NCT01997892|75715772|FG000|Overall Study|Renal transplant|8|||
41950807|NCT01997892|75715772|FG000|Overall Study|Other|3|||
41950808|NCT01997892|75715772|FG000|Overall Study|Study completion data not recorded|35|||
41950809|NCT01989468|75715784|FG000|Overall Study|Adverse Event|10|||
41950810|NCT01989468|75715785|FG001|Overall Study|Adverse Event|15|||
41950811|NCT01989468|75715786|FG002|Overall Study|Adverse Event|4|||
41950812|NCT01989468|75715787|FG003|Overall Study|Adverse Event|5|||
41950813|NCT01989468|75715788|FG004|Overall Study|Adverse Event|4|||
41950814|NCT01989468|75715784|FG000|Overall Study|Lack of Efficacy|11|||
41950815|NCT01989468|75715785|FG001|Overall Study|Lack of Efficacy|11|||
41950816|NCT01989468|75715786|FG002|Overall Study|Lack of Efficacy|7|||
41950817|NCT01989468|75715787|FG003|Overall Study|Lack of Efficacy|4|||
41950818|NCT01989468|75715788|FG004|Overall Study|Lack of Efficacy|2|||
41950819|NCT01989468|75715784|FG000|Overall Study|Lost to Follow-up|5|||
41950820|NCT01989468|75715785|FG001|Overall Study|Lost to Follow-up|2|||
41950821|NCT01989468|75715786|FG002|Overall Study|Lost to Follow-up|0|||
41950822|NCT01989468|75715787|FG003|Overall Study|Lost to Follow-up|1|||
41950823|NCT01989468|75715788|FG004|Overall Study|Lost to Follow-up|1|||
41950824|NCT01989468|75715784|FG000|Overall Study|Physician Decision|4|||
41950825|NCT01989468|75715785|FG001|Overall Study|Physician Decision|1|||
41950826|NCT01989468|75715786|FG002|Overall Study|Physician Decision|0|||
41950827|NCT01989468|75715787|FG003|Overall Study|Physician Decision|1|||
41950828|NCT01989468|75715788|FG004|Overall Study|Physician Decision|0|||
41950829|NCT01989468|75715784|FG000|Overall Study|Pregnancy|0|||
41950830|NCT01989468|75715785|FG001|Overall Study|Pregnancy|1|||
41950831|NCT01989468|75715786|FG002|Overall Study|Pregnancy|0|||
41950832|NCT01989468|75715787|FG003|Overall Study|Pregnancy|0|||
41950833|NCT01989468|75715788|FG004|Overall Study|Pregnancy|0|||
41950834|NCT01989468|75715784|FG000|Overall Study|Technical Problems|3|||
41950835|NCT01989468|75715785|FG001|Overall Study|Technical Problems|1|||
41950836|NCT01989468|75715786|FG002|Overall Study|Technical Problems|3|||
41950837|NCT01989468|75715787|FG003|Overall Study|Technical Problems|1|||
41950838|NCT01989468|75715788|FG004|Overall Study|Technical Problems|0|||
41950839|NCT01989468|75715784|FG000|Overall Study|Subject Guardian Decision|11|||
41950840|NCT01989468|75715785|FG001|Overall Study|Subject Guardian Decision|6|||
41950841|NCT01989468|75715786|FG002|Overall Study|Subject Guardian Decision|4|||
41950842|NCT01989468|75715787|FG003|Overall Study|Subject Guardian Decision|4|||
41950843|NCT01989468|75715788|FG004|Overall Study|Subject Guardian Decision|1|||
41950844|NCT01989468|75715784|FG000|Overall Study|Death|3|||
41950845|NCT01989468|75715785|FG001|Overall Study|Death|0|||
41950846|NCT01989468|75715786|FG002|Overall Study|Death|1|||
41950847|NCT01989468|75715787|FG003|Overall Study|Death|0|||
41950848|NCT01989468|75715788|FG004|Overall Study|Death|0|||
41950849|NCT01989156|75715804|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
41950850|NCT01989156|75715805|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
41950851|NCT01989156|75715806|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
41950852|NCT01989156|75715804|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
41950853|NCT01989156|75715805|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
41950854|NCT01989156|75715806|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
41950855|NCT01989156|75715804|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
41950856|NCT01989156|75715805|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
41950857|NCT01989156|75715806|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
41950858|NCT01989156|75715804|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
41950859|NCT01989156|75715805|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
41950860|NCT01989156|75715806|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
41950861|NCT01989156|75715804|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
41950862|NCT01989156|75715805|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
41950863|NCT01989156|75715806|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
41950864|NCT01989156|75715804|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
41950865|NCT01989156|75715805|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
41950866|NCT01989156|75715806|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
41950867|NCT01989156|75715804|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
41950868|NCT01989156|75715805|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
41950869|NCT01989156|75715806|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
41950870|NCT01989156|75715804|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
41950871|NCT01989156|75715805|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
41950872|NCT01989156|75715806|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
41950873|NCT01620762|75715817|FG000|Overall Study|Protocol Violation|1|||
41950874|NCT01620762|75715818|FG001|Overall Study|Protocol Violation|1|||
41950875|NCT01620762|75715819|FG002|Overall Study|Protocol Violation|1|||
41950876|NCT01620762|75715817|FG000|Overall Study|Adverse Event|9|||
41950877|NCT01620762|75715818|FG001|Overall Study|Adverse Event|5|||
41950878|NCT01620762|75715819|FG002|Overall Study|Adverse Event|2|||
41950879|NCT01620762|75715817|FG000|Overall Study|Withdrawal by Subject|23|||
41950880|NCT01620762|75715818|FG001|Overall Study|Withdrawal by Subject|26|||
41950881|NCT01620762|75715819|FG002|Overall Study|Withdrawal by Subject|27|||
41950882|NCT01620762|75715817|FG000|Overall Study|Lost to Follow-up|11|||
41950883|NCT01620762|75715818|FG001|Overall Study|Lost to Follow-up|17|||
41950884|NCT01620762|75715819|FG002|Overall Study|Lost to Follow-up|10|||
41950885|NCT01620762|75715817|FG000|Overall Study|Protocol deviation|1|||
41950886|NCT01620762|75715818|FG001|Overall Study|Protocol deviation|1|||
41950887|NCT01620762|75715819|FG002|Overall Study|Protocol deviation|6|||
41950888|NCT01620762|75715817|FG000|Overall Study|Subject deterioration|0|||
41950889|NCT01620762|75715818|FG001|Overall Study|Subject deterioration|1|||
41950890|NCT01620762|75715819|FG002|Overall Study|Subject deterioration|1|||
41950891|NCT01620762|75715817|FG000|Overall Study|Non-specified|3|||
41950892|NCT01620762|75715818|FG001|Overall Study|Non-specified|6|||
41950893|NCT01620762|75715819|FG002|Overall Study|Non-specified|5|||
41950894|NCT01620762|75715817|FG000|Overall Study|Use of prohibted therapies|0|||
41950895|NCT01620762|75715818|FG001|Overall Study|Use of prohibted therapies|1|||
41950896|NCT01620762|75715819|FG002|Overall Study|Use of prohibted therapies|1|||
41950897|NCT01966068|75715829|FG000|Overall Study|Withdrawal by Subject|57|||
41950898|NCT01966068|75715829|FG000|Overall Study|Lost to Follow-up|81|||
41950899|NCT01620528|75715837|FG000|Treatment Period|Did Not Receive Study Drug|0|||
41950900|NCT01620528|75715838|FG001|Treatment Period|Did Not Receive Study Drug|0|||
41950901|NCT01620528|75715839|FG002|Treatment Period|Did Not Receive Study Drug|1|||
41950902|NCT01620528|75715837|FG000|Treatment Period|Withdrawal by Subject|35|||
41950903|NCT01620528|75715838|FG001|Treatment Period|Withdrawal by Subject|21|||
41950904|NCT01620528|75715839|FG002|Treatment Period|Withdrawal by Subject|16|||
41950905|NCT01620528|75715837|FG000|Treatment Period|Adverse Event|17|||
41950906|NCT01620528|75715838|FG001|Treatment Period|Adverse Event|13|||
41950907|NCT01620528|75715839|FG002|Treatment Period|Adverse Event|21|||
41950908|NCT01620528|75715837|FG000|Treatment Period|Lost to Follow-up|16|||
41950909|NCT01620528|75715838|FG001|Treatment Period|Lost to Follow-up|8|||
41950910|NCT01620528|75715839|FG002|Treatment Period|Lost to Follow-up|14|||
41950911|NCT01620528|75715837|FG000|Treatment Period|Other|9|||
41950912|NCT01620528|75715838|FG001|Treatment Period|Other|5|||
41950913|NCT01620528|75715839|FG002|Treatment Period|Other|7|||
41950914|NCT01620528|75715837|FG000|Treatment Period|Subject Noncompliant|11|||
41950915|NCT01620528|75715838|FG001|Treatment Period|Subject Noncompliant|2|||
41950916|NCT01620528|75715839|FG002|Treatment Period|Subject Noncompliant|2|||
41950917|NCT01620528|75715837|FG000|Treatment Period|Pregnancy|7|||
41950918|NCT01620528|75715838|FG001|Treatment Period|Pregnancy|2|||
41950919|NCT01620528|75715839|FG002|Treatment Period|Pregnancy|2|||
41950920|NCT01620528|75715837|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
41950921|NCT01620528|75715838|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
41950922|NCT01620528|75715839|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
41950923|NCT01620528|75715837|FG000|Treatment Period|Exclusionary Medication Received|0|||
41950924|NCT01620528|75715838|FG001|Treatment Period|Exclusionary Medication Received|1|||
41950925|NCT01620528|75715839|FG002|Treatment Period|Exclusionary Medication Received|0|||
41950926|NCT01620528|75715837|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
41950927|NCT01620528|75715838|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
41950928|NCT01620528|75715839|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
41950929|NCT01620528|75715837|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
41950930|NCT01620528|75715838|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
41950931|NCT01620528|75715839|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
41950932|NCT01620528|75715837|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
41950933|NCT01620528|75715838|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
41950934|NCT01620528|75715839|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
41950935|NCT01620528|75715837|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
41950936|NCT01620528|75715838|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
41950937|NCT01620528|75715839|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
41950938|NCT01620528|75715837|FG000|Post-Treatment Follow-Up Period|Other|6|||
41950939|NCT01620528|75715838|FG001|Post-Treatment Follow-Up Period|Other|4|||
41950940|NCT01620528|75715839|FG002|Post-Treatment Follow-Up Period|Other|2|||
41950941|NCT01965834|75715847|FG000|Overall Study|Lack of Efficacy|4|||
41950942|NCT01965600|75715851|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
41950943|NCT01965600|75715852|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
41950944|NCT01965600|75715853|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
41950945|NCT01965600|75715854|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
41950946|NCT01965600|75715851|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
41950947|NCT01965600|75715852|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
41950948|NCT01965600|75715853|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
41950949|NCT01965600|75715854|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
41950950|NCT01965600|75715851|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
41950951|NCT01965600|75715852|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
41950952|NCT01965600|75715853|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
41950953|NCT01965600|75715854|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
41950954|NCT01965600|75715851|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
41950955|NCT01965600|75715852|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
42023860|NCT01227278|75831197|FG000|Overall Study|Withdrawal by Subject|4|||
41950956|NCT01965600|75715853|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
41950957|NCT01965600|75715854|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
41950958|NCT01965600|75715851|FG000|Second Intervention|Study terminated by Sponsor|0|||
41950959|NCT01965600|75715852|FG001|Second Intervention|Study terminated by Sponsor|0|||
41950960|NCT01965600|75715853|FG002|Second Intervention|Study terminated by Sponsor|2|||
41950961|NCT01965600|75715854|FG003|Second Intervention|Study terminated by Sponsor|2|||
41950962|NCT01996332|75715862|FG000|Overall Study|Adverse Event|117|||
41950963|NCT01996332|75715862|FG000|Overall Study|Lack of Efficacy|1245|||
41950964|NCT01996332|75715862|FG000|Overall Study|Death|264|||
41950965|NCT01996332|75715862|FG000|Overall Study|Protocol Violation|9|||
42023861|NCT01227278|75831198|FG001|Overall Study|Withdrawal by Subject|4|||
42023862|NCT01227278|75831197|FG000|Overall Study|Death|0|||
41950966|NCT01996332|75715862|FG000|Overall Study|Withdrawal by Subject|71|||
41950967|NCT01996332|75715862|FG000|Overall Study|Other|20|||
42023863|NCT01227278|75831198|FG001|Overall Study|Death|2|||
41950968|NCT01996332|75715862|FG000|Overall Study|Clinical Deterioration|28|||
41950969|NCT01996332|75715862|FG000|Overall Study|Physician Decision|17|||
41950970|NCT01996332|75715862|FG000|Overall Study|Lost to Follow-up|34|||
41950971|NCT01996254|75715868|FG000|Overall Study|Change in Eligibility|0|||
41950972|NCT01996254|75715869|FG001|Overall Study|Change in Eligibility|2|||
41950973|NCT01996254|75715870|FG002|Overall Study|Change in Eligibility|0|||
41950974|NCT01996254|75715868|FG000|Overall Study|Withdrawal by Subject|0|||
41950975|NCT01996254|75715869|FG001|Overall Study|Withdrawal by Subject|3|||
41950976|NCT01996254|75715870|FG002|Overall Study|Withdrawal by Subject|4|||
41950977|NCT01996254|75715868|FG000|Overall Study|Lost to Follow-up|1|||
41950978|NCT01996254|75715869|FG001|Overall Study|Lost to Follow-up|0|||
41950979|NCT01996254|75715870|FG002|Overall Study|Lost to Follow-up|4|||
41950980|NCT01987986|75715884|FG000|Overall Study|Lost to Follow-up|1|||
41950981|NCT01987986|75715885|FG001|Overall Study|Lost to Follow-up|0|||
41950982|NCT01987986|75715886|FG002|Overall Study|Lost to Follow-up|0|||
41950983|NCT01987986|75715887|FG003|Overall Study|Lost to Follow-up|0|||
41950984|NCT01987986|75715884|FG000|Overall Study|Adverse Event|1|||
41950985|NCT01987986|75715885|FG001|Overall Study|Adverse Event|0|||
41950986|NCT01987986|75715886|FG002|Overall Study|Adverse Event|2|||
41950987|NCT01987986|75715887|FG003|Overall Study|Adverse Event|0|||
41950988|NCT01987908|75715897|FG000|Placebo Lead-in Period|Adverse Event|2|||
41950989|NCT01987908|75715898|FG001|Placebo Lead-in Period|Adverse Event|0|||
41950990|NCT01987908|75715899|FG002|Placebo Lead-in Period|Adverse Event|0|||
41950991|NCT01987908|75715897|FG000|Placebo Lead-in Period|Physician Decision|2|||
41950992|NCT01987908|75715898|FG001|Placebo Lead-in Period|Physician Decision|0|||
41950993|NCT01987908|75715899|FG002|Placebo Lead-in Period|Physician Decision|0|||
41950994|NCT01987908|75715897|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
42023864|NCT01227278|75831197|FG000|Overall Study|Other|1|||
42023865|NCT01227278|75831198|FG001|Overall Study|Other|2|||
42023866|NCT01034397|75831206|FG000|Overall Study|Lack of compliance|0|||
42023867|NCT01034397|75831207|FG001|Overall Study|Lack of compliance|1|||
42023868|NCT01034397|75831206|FG000|Overall Study|Lack of Efficacy|3|||
42023869|NCT01034397|75831207|FG001|Overall Study|Lack of Efficacy|0|||
42023870|NCT01034397|75831206|FG000|Overall Study|Adverse Event|4|||
42023871|NCT01034397|75831207|FG001|Overall Study|Adverse Event|0|||
42023872|NCT01034397|75831206|FG000|Overall Study|Other|0|||
42023873|NCT01034397|75831207|FG001|Overall Study|Other|1|||
42023874|NCT01227044|75831224|FG000|Overall Study|Lost to Follow-up|5|||
42023875|NCT01227044|75831225|FG001|Overall Study|Lost to Follow-up|7|||
42023876|NCT01227044|75831224|FG000|Overall Study|Discontinued Intervention|1|||
42023877|NCT01227044|75831225|FG001|Overall Study|Discontinued Intervention|2|||
41950995|NCT01987908|75715898|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
42023878|NCT01225952|75831234|FG000|Overall Study|Lost to Follow-up|1|||
42023879|NCT01225952|75831235|FG001|Overall Study|Lost to Follow-up|0|||
42023880|NCT01225952|75831236|FG002|Overall Study|Lost to Follow-up|0|||
42023881|NCT01225952|75831234|FG000|Overall Study|Study Eye Explanted|0|||
42023882|NCT01225952|75831235|FG001|Overall Study|Study Eye Explanted|0|||
41950996|NCT01987908|75715899|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
41950997|NCT01987908|75715897|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
41950998|NCT01987908|75715898|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
41950999|NCT01987908|75715899|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
41951000|NCT01987908|75715897|FG000|Treatment Period|Adverse Event|0|||
41951001|NCT01987908|75715898|FG001|Treatment Period|Adverse Event|1|||
41951002|NCT01987908|75715899|FG002|Treatment Period|Adverse Event|1|||
41951003|NCT01987908|75715897|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
41951004|NCT01987908|75715898|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
42023883|NCT01225952|75831236|FG002|Overall Study|Study Eye Explanted|1|||
42023884|NCT01225952|75831234|FG000|Overall Study|Withdrawal by Subject|4|||
42023885|NCT01225952|75831235|FG001|Overall Study|Withdrawal by Subject|4|||
42023886|NCT01225952|75831236|FG002|Overall Study|Withdrawal by Subject|5|||
42023887|NCT01225952|75831234|FG000|Overall Study|Surgical complications|1|||
41951005|NCT01987908|75715899|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
41951006|NCT01987908|75715897|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
41951007|NCT01987908|75715898|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
41951008|NCT01987908|75715899|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
41951009|NCT01995552|75715923|FG000|Overall Study|Protocol Violation|1|||
41951010|NCT01995552|75715923|FG000|Overall Study|Lack of Efficacy|15|||
41951011|NCT01995552|75715923|FG000|Overall Study|Death|1|||
41951012|NCT01987830|75715929|FG000|Overall Study|Never received baseline scan|1|||
41951013|NCT01987596|75715935|FG000|Overall Study|Physician Decision|1|||
41951014|NCT01987596|75715936|FG001|Overall Study|Physician Decision|0|||
41951015|NCT01987596|75715935|FG000|Overall Study|Progressive Disease; missing all period|0|||
41951016|NCT01987596|75715936|FG001|Overall Study|Progressive Disease; missing all period|1|||
41951017|NCT01964976|75715950|FG000|Overall Study|Protocol Violation|31|||
41951018|NCT01964898|75715959|FG000|Overall Study|ineligible post-randomization|1|||
41951019|NCT01964898|75715960|FG001|Overall Study|ineligible post-randomization|1|||
41951020|NCT01964898|75715959|FG000|Overall Study|did not receive the allocated interventi|2|||
41951021|NCT01964898|75715960|FG001|Overall Study|did not receive the allocated interventi|1|||
41951022|NCT01964898|75715959|FG000|Overall Study|Lost to Follow-up|3|||
41951023|NCT01964898|75715960|FG001|Overall Study|Lost to Follow-up|5|||
41951024|NCT01964898|75715959|FG000|Overall Study|Withdrawal by Subject|1|||
41951025|NCT01964898|75715960|FG001|Overall Study|Withdrawal by Subject|0|||
41951026|NCT01964352|75715970|FG000|Overall Study|Adverse Event|13|||
42023888|NCT01225952|75831235|FG001|Overall Study|Surgical complications|0|||
41951027|NCT01964352|75715971|FG001|Overall Study|Adverse Event|3|||
41951028|NCT01964352|75715972|FG002|Overall Study|Adverse Event|4|||
41951029|NCT01964352|75715973|FG003|Overall Study|Adverse Event|3|||
41951030|NCT01964352|75715970|FG000|Overall Study|Lack of Efficacy|6|||
41951031|NCT01964352|75715971|FG001|Overall Study|Lack of Efficacy|0|||
41951032|NCT01964352|75715972|FG002|Overall Study|Lack of Efficacy|0|||
41951033|NCT01964352|75715973|FG003|Overall Study|Lack of Efficacy|0|||
41951034|NCT01964352|75715970|FG000|Overall Study|Protocol Violation|2|||
41951035|NCT01964352|75715971|FG001|Overall Study|Protocol Violation|4|||
41951036|NCT01964352|75715972|FG002|Overall Study|Protocol Violation|0|||
41951037|NCT01964352|75715973|FG003|Overall Study|Protocol Violation|2|||
41951038|NCT01964352|75715970|FG000|Overall Study|Lost to Follow-up|1|||
41951039|NCT01964352|75715971|FG001|Overall Study|Lost to Follow-up|0|||
41951040|NCT01964352|75715972|FG002|Overall Study|Lost to Follow-up|0|||
41951041|NCT01964352|75715973|FG003|Overall Study|Lost to Follow-up|1|||
41951042|NCT01964352|75715970|FG000|Overall Study|Withdrawal by Subject|4|||
41951043|NCT01964352|75715971|FG001|Overall Study|Withdrawal by Subject|2|||
41951044|NCT01964352|75715972|FG002|Overall Study|Withdrawal by Subject|1|||
41951045|NCT01964352|75715973|FG003|Overall Study|Withdrawal by Subject|0|||
41951046|NCT01964352|75715970|FG000|Overall Study|Other than stated above|0|||
41951047|NCT01964352|75715971|FG001|Overall Study|Other than stated above|2|||
41951048|NCT01964352|75715972|FG002|Overall Study|Other than stated above|1|||
41951049|NCT01964352|75715973|FG003|Overall Study|Other than stated above|2|||
41951050|NCT01946412|75715983|FG000|Overall Study|Adverse Event|1|||
41951051|NCT01946412|75715983|FG000|Overall Study|Non-Compliance|1|||
41951052|NCT01946412|75715983|FG000|Overall Study|Continued with commercial Kalydeco|2|||
41951053|NCT01946412|75715983|FG000|Overall Study|Difficulty in swallowing|1|||
41951054|NCT01946178|75715989|FG000|Overall Study|Pregnancy|1|||
41951055|NCT01946178|75715989|FG000|Overall Study|Lost to Follow-up|1|||
41951056|NCT01945944|75715999|FG000|Overall Study|Adverse Event|0|||
41951057|NCT01945944|75716000|FG001|Overall Study|Adverse Event|2|||
41951058|NCT01945944|75715999|FG000|Overall Study|Physician Decision|1|||
41951059|NCT01945944|75716000|FG001|Overall Study|Physician Decision|0|||
42023889|NCT01225952|75831236|FG002|Overall Study|Surgical complications|0|||
42023890|NCT01034163|75831246|FG000|Overall Study|Treatment completed as per protocol|8|||
42023891|NCT01034163|75831247|FG001|Overall Study|Treatment completed as per protocol|7|||
42023892|NCT01034163|75831246|FG000|Overall Study|Withdrawal by Subject|8|||
41951060|NCT01945944|75715999|FG000|Overall Study|Withdrawal by Subject|0|||
41951061|NCT01945944|75716000|FG001|Overall Study|Withdrawal by Subject|1|||
41951062|NCT01945866|75716010|FG000|Overall Study|Eyes did not complete or were dropped|2|||
41951063|NCT01945866|75716011|FG001|Overall Study|Eyes did not complete or were dropped|0|||
41951064|NCT01986114|75716018|FG000|Overall Study|Adverse Event|59|||
41951065|NCT01986114|75716018|FG000|Overall Study|Lack of Efficacy|23|||
41951066|NCT01986114|75716018|FG000|Overall Study|Withdrawal by Subject|58|||
41951067|NCT01986114|75716018|FG000|Overall Study|Noncompliance|3|||
41951068|NCT01986114|75716018|FG000|Overall Study|Protocol Violation|1|||
41951069|NCT01986114|75716018|FG000|Overall Study|Lost to Follow-up|5|||
41951070|NCT01986114|75716018|FG000|Overall Study|Other reason|7|||
41951071|NCT01945710|75716031|FG000|Overall Study|Progressive Disease|5|||
41951072|NCT01945710|75716032|FG001|Overall Study|Progressive Disease|4|||
41951073|NCT01945710|75716033|FG002|Overall Study|Progressive Disease|3|||
42023893|NCT01034163|75831247|FG001|Overall Study|Withdrawal by Subject|2|||
42023894|NCT01034163|75831246|FG000|Overall Study|Protocol deviation|1|||
41951074|NCT01945710|75716034|FG003|Overall Study|Progressive Disease|2|||
41951075|NCT01945710|75716035|FG004|Overall Study|Progressive Disease|7|||
41951076|NCT01945710|75716036|FG005|Overall Study|Progressive Disease|3|||
41951077|NCT01945710|75716037|FG006|Overall Study|Progressive Disease|19|||
41951078|NCT01945710|75716031|FG000|Overall Study|Adverse Event|0|||
41951079|NCT01945710|75716032|FG001|Overall Study|Adverse Event|1|||
41951080|NCT01945710|75716033|FG002|Overall Study|Adverse Event|0|||
41951081|NCT01945710|75716034|FG003|Overall Study|Adverse Event|0|||
41951082|NCT01945710|75716035|FG004|Overall Study|Adverse Event|0|||
41951083|NCT01945710|75716036|FG005|Overall Study|Adverse Event|0|||
41951084|NCT01945710|75716037|FG006|Overall Study|Adverse Event|0|||
41951085|NCT01945710|75716031|FG000|Overall Study|Other|2|||
41951086|NCT01945710|75716032|FG001|Overall Study|Other|0|||
41951087|NCT01945710|75716033|FG002|Overall Study|Other|3|||
41951088|NCT01945710|75716034|FG003|Overall Study|Other|1|||
41951089|NCT01945710|75716035|FG004|Overall Study|Other|1|||
41951090|NCT01945710|75716036|FG005|Overall Study|Other|0|||
41951091|NCT01945710|75716037|FG006|Overall Study|Other|4|||
41951092|NCT01945710|75716031|FG000|Overall Study|Withdrawal by Subject|0|||
41951093|NCT01945710|75716032|FG001|Overall Study|Withdrawal by Subject|1|||
41951094|NCT01945710|75716033|FG002|Overall Study|Withdrawal by Subject|1|||
41951095|NCT01945710|75716034|FG003|Overall Study|Withdrawal by Subject|0|||
41951096|NCT01945710|75716035|FG004|Overall Study|Withdrawal by Subject|1|||
41951097|NCT01945710|75716036|FG005|Overall Study|Withdrawal by Subject|0|||
41951098|NCT01945710|75716037|FG006|Overall Study|Withdrawal by Subject|0|||
41951099|NCT01945242|75716057|FG000|Overall Study|Physician Decision|3|||
41951100|NCT01945242|75716058|FG001|Overall Study|Physician Decision|3|||
41951101|NCT01945086|75716068|FG000|Overall Study|Withdrawal by Subject|1|||
41951102|NCT01945086|75716069|FG001|Overall Study|Withdrawal by Subject|0|||
41951103|NCT01945086|75716070|FG002|Overall Study|Withdrawal by Subject|1|||
41951104|NCT01945086|75716068|FG000|Overall Study|Adverse Event|0|||
41951105|NCT01945086|75716069|FG001|Overall Study|Adverse Event|0|||
41951106|NCT01945086|75716070|FG002|Overall Study|Adverse Event|1|||
41951107|NCT01963728|75716080|FG000|Overall Study|Study terminated early|0|||
41951108|NCT01963728|75716081|FG001|Overall Study|Study terminated early|1|||
41951109|NCT01963260|75716097|FG000|Overall Study|Withdrawal by Subject|2|||
41951110|NCT01963260|75716098|FG001|Overall Study|Withdrawal by Subject|0|||
41951111|NCT01963260|75716099|FG002|Overall Study|Withdrawal by Subject|0|||
41951112|NCT01963260|75716100|FG003|Overall Study|Withdrawal by Subject|1|||
41951113|NCT01963260|75716101|FG004|Overall Study|Withdrawal by Subject|2|||
41951114|NCT01963260|75716102|FG005|Overall Study|Withdrawal by Subject|0|||
41951115|NCT01963260|75716103|FG006|Overall Study|Withdrawal by Subject|0|||
41951116|NCT01963260|75716104|FG007|Overall Study|Withdrawal by Subject|0|||
41951117|NCT01963260|75716105|FG008|Overall Study|Withdrawal by Subject|0|||
41951118|NCT01963260|75716106|FG009|Overall Study|Withdrawal by Subject|0|||
41951119|NCT01962948|75716139|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
41951120|NCT01962948|75716140|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
41951121|NCT01962948|75716141|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
41951122|NCT01962948|75716142|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
41951123|NCT01985334|75716157|FG000|Overall Study|Administrative problems|1|||
41951124|NCT01985334|75716158|FG001|Overall Study|Administrative problems|1|||
41951125|NCT01985334|75716159|FG002|Overall Study|Administrative problems|0|||
41951126|NCT01985334|75716160|FG003|Overall Study|Administrative problems|2|||
41951127|NCT01985334|75716161|FG004|Overall Study|Administrative problems|0|||
41951128|NCT01985334|75716162|FG005|Overall Study|Administrative problems|1|||
41951129|NCT01985334|75716163|FG006|Overall Study|Administrative problems|1|||
41951130|NCT01985334|75716164|FG007|Overall Study|Administrative problems|3|||
41951131|NCT01985334|75716157|FG000|Overall Study|Death|1|||
41951132|NCT01985334|75716158|FG001|Overall Study|Death|0|||
41951133|NCT01985334|75716159|FG002|Overall Study|Death|0|||
41951134|NCT01985334|75716160|FG003|Overall Study|Death|3|||
41951135|NCT01985334|75716161|FG004|Overall Study|Death|0|||
41951136|NCT01985334|75716162|FG005|Overall Study|Death|0|||
41951137|NCT01985334|75716163|FG006|Overall Study|Death|1|||
41951138|NCT01985334|75716164|FG007|Overall Study|Death|2|||
41951139|NCT01985334|75716157|FG000|Overall Study|Worsening of disease|0|||
41951140|NCT01985334|75716158|FG001|Overall Study|Worsening of disease|0|||
41951141|NCT01985334|75716159|FG002|Overall Study|Worsening of disease|0|||
41951142|NCT01985334|75716160|FG003|Overall Study|Worsening of disease|1|||
41951143|NCT01985334|75716161|FG004|Overall Study|Worsening of disease|0|||
41951144|NCT01985334|75716162|FG005|Overall Study|Worsening of disease|3|||
41951145|NCT01985334|75716163|FG006|Overall Study|Worsening of disease|0|||
41951146|NCT01985334|75716164|FG007|Overall Study|Worsening of disease|1|||
41951147|NCT01985334|75716157|FG000|Overall Study|Other|2|||
41951148|NCT01985334|75716158|FG001|Overall Study|Other|9|||
41951149|NCT01985334|75716159|FG002|Overall Study|Other|7|||
41951150|NCT01985334|75716160|FG003|Overall Study|Other|17|||
41951151|NCT01985334|75716161|FG004|Overall Study|Other|4|||
41951152|NCT01985334|75716162|FG005|Overall Study|Other|8|||
41951153|NCT01985334|75716163|FG006|Overall Study|Other|4|||
41951154|NCT01985334|75716164|FG007|Overall Study|Other|7|||
41951155|NCT01985334|75716157|FG000|Overall Study|Protocol deviation|6|||
41951156|NCT01985334|75716158|FG001|Overall Study|Protocol deviation|31|||
41951157|NCT01985334|75716159|FG002|Overall Study|Protocol deviation|25|||
41951158|NCT01985334|75716160|FG003|Overall Study|Protocol deviation|84|||
41951159|NCT01985334|75716161|FG004|Overall Study|Protocol deviation|17|||
41951160|NCT01985334|75716162|FG005|Overall Study|Protocol deviation|47|||
41951161|NCT01985334|75716163|FG006|Overall Study|Protocol deviation|15|||
41951162|NCT01985334|75716164|FG007|Overall Study|Protocol deviation|42|||
41951163|NCT01985334|75716157|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
41951164|NCT01985334|75716158|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
41951165|NCT01985334|75716159|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
41951166|NCT01985334|75716160|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
41951167|NCT01985334|75716161|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
41951168|NCT01985334|75716162|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
41951169|NCT01985334|75716163|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
41951170|NCT01985334|75716164|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
41951171|NCT01985334|75716157|FG000|Overall Study|Subject withdrawal of consent|3|||
41951172|NCT01985334|75716158|FG001|Overall Study|Subject withdrawal of consent|6|||
41951173|NCT01985334|75716159|FG002|Overall Study|Subject withdrawal of consent|2|||
41951174|NCT01985334|75716160|FG003|Overall Study|Subject withdrawal of consent|28|||
41951175|NCT01985334|75716161|FG004|Overall Study|Subject withdrawal of consent|4|||
41951176|NCT01985334|75716162|FG005|Overall Study|Subject withdrawal of consent|19|||
41951177|NCT01985334|75716163|FG006|Overall Study|Subject withdrawal of consent|0|||
41951178|NCT01985334|75716164|FG007|Overall Study|Subject withdrawal of consent|20|||
41951179|NCT01985334|75716157|FG000|Overall Study|Adverse Event|0|||
41951180|NCT01985334|75716158|FG001|Overall Study|Adverse Event|8|||
41951181|NCT01985334|75716159|FG002|Overall Study|Adverse Event|2|||
41951182|NCT01985334|75716160|FG003|Overall Study|Adverse Event|26|||
41951183|NCT01985334|75716161|FG004|Overall Study|Adverse Event|3|||
41951184|NCT01985334|75716162|FG005|Overall Study|Adverse Event|18|||
41951185|NCT01985334|75716163|FG006|Overall Study|Adverse Event|3|||
41951186|NCT01985334|75716164|FG007|Overall Study|Adverse Event|15|||
41951187|NCT01985334|75716157|FG000|Overall Study|Other|4|||
41951188|NCT01985334|75716158|FG001|Overall Study|Other|2|||
41951189|NCT01985334|75716159|FG002|Overall Study|Other|3|||
41951190|NCT01985334|75716160|FG003|Overall Study|Other|10|||
41951191|NCT01985334|75716161|FG004|Overall Study|Other|1|||
41951192|NCT01985334|75716162|FG005|Overall Study|Other|6|||
41951193|NCT01985334|75716163|FG006|Overall Study|Other|2|||
41951194|NCT01985334|75716164|FG007|Overall Study|Other|2|||
41951195|NCT01985334|75716157|FG000|Overall Study|Medication non-compliance|0|||
41951196|NCT01985334|75716158|FG001|Overall Study|Medication non-compliance|4|||
41951197|NCT01985334|75716159|FG002|Overall Study|Medication non-compliance|1|||
41951198|NCT01985334|75716160|FG003|Overall Study|Medication non-compliance|6|||
41951199|NCT01985334|75716161|FG004|Overall Study|Medication non-compliance|2|||
41951200|NCT01985334|75716162|FG005|Overall Study|Medication non-compliance|3|||
41951201|NCT01985334|75716163|FG006|Overall Study|Medication non-compliance|1|||
41951202|NCT01985334|75716164|FG007|Overall Study|Medication non-compliance|3|||
41951203|NCT01985334|75716157|FG000|Overall Study|Use of prohibited treatment|1|||
41951204|NCT01985334|75716158|FG001|Overall Study|Use of prohibited treatment|4|||
41951205|NCT01985334|75716159|FG002|Overall Study|Use of prohibited treatment|1|||
41951206|NCT01985334|75716160|FG003|Overall Study|Use of prohibited treatment|2|||
41951207|NCT01985334|75716161|FG004|Overall Study|Use of prohibited treatment|1|||
41951208|NCT01985334|75716162|FG005|Overall Study|Use of prohibited treatment|6|||
41951209|NCT01985334|75716163|FG006|Overall Study|Use of prohibited treatment|2|||
41951210|NCT01985334|75716164|FG007|Overall Study|Use of prohibited treatment|0|||
41951211|NCT01985334|75716157|FG000|Overall Study|Investigator decision|0|||
41951212|NCT01985334|75716158|FG001|Overall Study|Investigator decision|3|||
42023895|NCT01034163|75831247|FG001|Overall Study|Protocol deviation|0|||
41951213|NCT01985334|75716159|FG002|Overall Study|Investigator decision|0|||
41951214|NCT01985334|75716160|FG003|Overall Study|Investigator decision|7|||
41951215|NCT01985334|75716161|FG004|Overall Study|Investigator decision|1|||
41951216|NCT01985334|75716162|FG005|Overall Study|Investigator decision|1|||
41951217|NCT01985334|75716163|FG006|Overall Study|Investigator decision|0|||
41951218|NCT01985334|75716164|FG007|Overall Study|Investigator decision|4|||
41951219|NCT01985334|75716157|FG000|Overall Study|Lost to Follow-up|0|||
41951220|NCT01985334|75716158|FG001|Overall Study|Lost to Follow-up|2|||
41951221|NCT01985334|75716159|FG002|Overall Study|Lost to Follow-up|0|||
41951222|NCT01985334|75716160|FG003|Overall Study|Lost to Follow-up|3|||
41951223|NCT01985334|75716161|FG004|Overall Study|Lost to Follow-up|1|||
41951224|NCT01985334|75716162|FG005|Overall Study|Lost to Follow-up|4|||
41951225|NCT01985334|75716163|FG006|Overall Study|Lost to Follow-up|0|||
41951226|NCT01985334|75716164|FG007|Overall Study|Lost to Follow-up|3|||
41951227|NCT01944774|75716199|FG000|Overall Study|Withdrawal by Subject|2|||
41951228|NCT01944774|75716200|FG001|Overall Study|Withdrawal by Subject|3|||
41951229|NCT01944774|75716201|FG002|Overall Study|Withdrawal by Subject|3|||
41951230|NCT01944774|75716199|FG000|Overall Study|Adverse Event|3|||
41951231|NCT01944774|75716200|FG001|Overall Study|Adverse Event|2|||
41951232|NCT01944774|75716201|FG002|Overall Study|Adverse Event|3|||
41951233|NCT01944774|75716199|FG000|Overall Study|Lack of Efficacy|1|||
41951234|NCT01944774|75716200|FG001|Overall Study|Lack of Efficacy|2|||
41951235|NCT01944774|75716201|FG002|Overall Study|Lack of Efficacy|2|||
41951236|NCT01944774|75716199|FG000|Overall Study|Lost to Follow-up|0|||
41951237|NCT01944774|75716200|FG001|Overall Study|Lost to Follow-up|1|||
41951238|NCT01944774|75716201|FG002|Overall Study|Lost to Follow-up|0|||
41951239|NCT01944462|75716212|FG000|PPPP Educational Program|Lost to Follow-up|60|||
41951240|NCT01943292|75716220|FG000|Overall Study|Withdrawal by Subject|1|||
41951241|NCT01943292|75716221|FG001|Overall Study|Withdrawal by Subject|0|||
41951242|NCT01943292|75716222|FG002|Overall Study|Withdrawal by Subject|0|||
41951243|NCT01961544|75716230|FG000|Overall Study|Protocol Violation|1|||
41951244|NCT01961544|75716230|FG000|Overall Study|Withdrawal by Subject|7|||
41951245|NCT01961544|75716230|FG000|Overall Study|Adverse Event|1|||
41951246|NCT01961544|75716230|FG000|Overall Study|Physician Decision|2|||
41951247|NCT01961544|75716230|FG000|Overall Study|Poor Tolerance|1|||
41951248|NCT01961544|75716230|FG000|Overall Study|Aggravation of Steral Pain|1|||
41951249|NCT01942590|75716236|FG000|Overall Study|Withdrawal by Subject|0|||
41951250|NCT01942590|75716237|FG001|Overall Study|Withdrawal by Subject|1|||
41951251|NCT01942590|75716236|FG000|Overall Study|Adverse Event|1|||
41951252|NCT01942590|75716237|FG001|Overall Study|Adverse Event|0|||
41951253|NCT01984242|75716247|FG000|Overall Study|Death|52|||
41951254|NCT01984242|75716248|FG001|Overall Study|Death|50|||
41951255|NCT01984242|75716249|FG002|Overall Study|Death|52|||
41951256|NCT01984242|75716247|FG000|Overall Study|Withdrawal by Subject|5|||
41951257|NCT01984242|75716248|FG001|Overall Study|Withdrawal by Subject|3|||
41951258|NCT01984242|75716249|FG002|Overall Study|Withdrawal by Subject|10|||
41951259|NCT01984242|75716247|FG000|Overall Study|Physician Decision|0|||
41951260|NCT01984242|75716248|FG001|Overall Study|Physician Decision|0|||
41951261|NCT01984242|75716249|FG002|Overall Study|Physician Decision|1|||
41951262|NCT01984242|75716247|FG000|Overall Study|Lost to Follow-up|4|||
41951263|NCT01984242|75716248|FG001|Overall Study|Lost to Follow-up|0|||
41951264|NCT01984242|75716249|FG002|Overall Study|Lost to Follow-up|3|||
41951265|NCT01984242|75716247|FG000|Overall Study|Sponsor Decision|1|||
41951266|NCT01984242|75716248|FG001|Overall Study|Sponsor Decision|0|||
41951267|NCT01984242|75716249|FG002|Overall Study|Sponsor Decision|0|||
41951268|NCT01984242|75716247|FG000|Overall Study|Non-Compliance|1|||
41951269|NCT01984242|75716248|FG001|Overall Study|Non-Compliance|0|||
41951270|NCT01984242|75716249|FG002|Overall Study|Non-Compliance|0|||
41951271|NCT01984242|75716247|FG000|Overall Study|Study terminated by Sponsor|38|||
41951272|NCT01984242|75716248|FG001|Overall Study|Study terminated by Sponsor|50|||
41951273|NCT01984242|75716249|FG002|Overall Study|Study terminated by Sponsor|34|||
41951274|NCT01984242|75716247|FG000|Overall Study|Disease Progression|0|||
41951275|NCT01984242|75716248|FG001|Overall Study|Disease Progression|0|||
41951276|NCT01984242|75716249|FG002|Overall Study|Disease Progression|1|||
41951277|NCT01941498|75716265|FG000|Overall Study|Relocated out of state|1|||
41951278|NCT01960998|75716286|FG000|Overall Study|Lost to Follow-up|3|||
41951279|NCT01960998|75716287|FG001|Overall Study|Lost to Follow-up|7|||
41951280|NCT01960998|75716286|FG000|Overall Study|Death|0|||
41951281|NCT01960998|75716287|FG001|Overall Study|Death|1|||
41951282|NCT01960998|75716286|FG000|Overall Study|Withdrawal by Subject|8|||
41951283|NCT01960998|75716287|FG001|Overall Study|Withdrawal by Subject|2|||
41951284|NCT01960998|75716286|FG000|Overall Study|lost computer access|0|||
41951285|NCT01960998|75716287|FG001|Overall Study|lost computer access|1|||
42023896|NCT01034163|75831246|FG000|Overall Study|Disease progression|3|||
42023897|NCT01034163|75831247|FG001|Overall Study|Disease progression|4|||
42023898|NCT01034163|75831246|FG000|Overall Study|Adverse Event|6|||
42023899|NCT01034163|75831247|FG001|Overall Study|Adverse Event|0|||
42023900|NCT01034163|75831246|FG000|Overall Study|Administrative problems|0|||
41951286|NCT01941186|75716297|FG000|Follow-up|Lost to Follow-up|1|||
41951287|NCT01941186|75716298|FG001|Follow-up|Lost to Follow-up|0|||
41951288|NCT01960842|75716317|FG000|Overall Study|Adverse Event|1|||
41951289|NCT01960842|75716317|FG000|Overall Study|Withdrawal by Subject|2|||
42023901|NCT01034163|75831247|FG001|Overall Study|Administrative problems|1|||
42023902|NCT01034163|75831246|FG000|Overall Study|Abnormal laboratory value|1|||
41951290|NCT01984164|75716323|FG000|Overall Study|Withdrawal by Subject|4|||
41951291|NCT01984164|75716324|FG001|Overall Study|Withdrawal by Subject|3|||
41951292|NCT01984164|75716323|FG000|Overall Study|Adverse Event|5|||
41951293|NCT01984164|75716324|FG001|Overall Study|Adverse Event|19|||
41951294|NCT01984164|75716323|FG000|Overall Study|Lost to Follow-up|1|||
41951295|NCT01984164|75716324|FG001|Overall Study|Lost to Follow-up|3|||
41951296|NCT01983930|75716332|FG000|Overall Study|Withdrawal by Subject|9|||
41951297|NCT01983930|75716333|FG001|Overall Study|Withdrawal by Subject|8|||
41951298|NCT01983930|75716332|FG000|Overall Study|Adverse Event|0|||
41951299|NCT01983930|75716333|FG001|Overall Study|Adverse Event|1|||
41951300|NCT01983774|75716346|FG000|Overall Study|Lung Transplant|0|||
41951301|NCT01983774|75716347|FG001|Overall Study|Lung Transplant|1|||
41951302|NCT01983774|75716346|FG000|Overall Study|Lost to Follow-up|1|||
41951303|NCT01983774|75716347|FG001|Overall Study|Lost to Follow-up|0|||
41951304|NCT01982682|75716355|FG000|Overall Study|Physician Decision|1|||
41951305|NCT01940484|75716360|FG000|Overall Study|Withdrawal by Subject|3|||
41951306|NCT01940484|75716360|FG000|Overall Study|Underwent transplantation|4|||
41951307|NCT01940484|75716360|FG000|Overall Study|Death|2|||
41951308|NCT01940484|75716360|FG000|Overall Study|Adverse Event|1|||
41951309|NCT01939548|75716367|FG000|Overall Study|Non compliance|0|||
41951310|NCT01939548|75716368|FG001|Overall Study|Non compliance|2|||
41951311|NCT01939548|75716369|FG002|Overall Study|Non compliance|0|||
41951312|NCT01939548|75716367|FG000|Overall Study|Study Terminated by Sponsor|17|||
41951313|NCT01939548|75716368|FG001|Overall Study|Study Terminated by Sponsor|19|||
41951314|NCT01939548|75716369|FG002|Overall Study|Study Terminated by Sponsor|12|||
41951315|NCT01939548|75716367|FG000|Overall Study|Insufficient Clinical Response|1|||
41951316|NCT01939548|75716368|FG001|Overall Study|Insufficient Clinical Response|0|||
41951317|NCT01939548|75716369|FG002|Overall Study|Insufficient Clinical Response|0|||
41951318|NCT01939548|75716367|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
41951319|NCT01939548|75716368|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
41951320|NCT01939548|75716369|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
41951321|NCT01939548|75716367|FG000|Overall Study|Withdrawal by Subject|4|||
41951322|NCT01939548|75716368|FG001|Overall Study|Withdrawal by Subject|4|||
41951323|NCT01939548|75716369|FG002|Overall Study|Withdrawal by Subject|1|||
41951324|NCT01939548|75716367|FG000|Overall Study|Protocol Violation|7|||
41951325|NCT01939548|75716368|FG001|Overall Study|Protocol Violation|6|||
41951326|NCT01939548|75716369|FG002|Overall Study|Protocol Violation|5|||
41951327|NCT01939548|75716367|FG000|Overall Study|Lost to Follow-up|5|||
41951328|NCT01939548|75716368|FG001|Overall Study|Lost to Follow-up|5|||
41951329|NCT01939548|75716369|FG002|Overall Study|Lost to Follow-up|3|||
41951330|NCT01939548|75716367|FG000|Overall Study|Adverse Event|2|||
41951331|NCT01939548|75716368|FG001|Overall Study|Adverse Event|9|||
41951332|NCT01939548|75716369|FG002|Overall Study|Adverse Event|7|||
41951333|NCT01939548|75716367|FG000|Overall Study|Death|0|||
41951334|NCT01939548|75716368|FG001|Overall Study|Death|0|||
41951335|NCT01939548|75716369|FG002|Overall Study|Death|1|||
41951336|NCT01939548|75716367|FG000|Overall Study|Participant dropped|0|||
41951337|NCT01939548|75716368|FG001|Overall Study|Participant dropped|0|||
41951338|NCT01939548|75716369|FG002|Overall Study|Participant dropped|1|||
41951339|NCT01939548|75716367|FG000|Overall Study|Participant unwilling to continue|0|||
41951340|NCT01939548|75716368|FG001|Overall Study|Participant unwilling to continue|1|||
41951341|NCT01939548|75716369|FG002|Overall Study|Participant unwilling to continue|0|||
41951342|NCT01939548|75716367|FG000|Overall Study|Participant withdrew consent|0|||
41951343|NCT01939548|75716368|FG001|Overall Study|Participant withdrew consent|2|||
41951344|NCT01939548|75716369|FG002|Overall Study|Participant withdrew consent|0|||
41951345|NCT01939548|75716367|FG000|Overall Study|Did not complete follow-up|0|||
41951346|NCT01939548|75716368|FG001|Overall Study|Did not complete follow-up|1|||
41951347|NCT01939548|75716369|FG002|Overall Study|Did not complete follow-up|0|||
41951348|NCT01960296|75716379|FG000|Overall Study|Postponed surgery|1|||
41951349|NCT01960296|75716380|FG001|Overall Study|Postponed surgery|0|||
41951350|NCT01960296|75716379|FG000|Overall Study|Received different procedure|1|||
41951351|NCT01960296|75716380|FG001|Overall Study|Received different procedure|3|||
41951352|NCT01982292|75716388|FG000|Overall Study|Adverse Event|2|||
41951353|NCT01982292|75716389|FG001|Overall Study|Adverse Event|0|||
41951354|NCT01982292|75716388|FG000|Overall Study|Death|1|||
41951355|NCT01982292|75716389|FG001|Overall Study|Death|0|||
41951356|NCT01982292|75716388|FG000|Overall Study|Lost to Follow-up|2|||
41951357|NCT01982292|75716389|FG001|Overall Study|Lost to Follow-up|0|||
41951358|NCT01982292|75716388|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
41951359|NCT01982292|75716389|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
41951360|NCT01982292|75716388|FG000|Overall Study|Protocol Deviation|1|||
42023903|NCT01034163|75831247|FG001|Overall Study|Abnormal laboratory value|0|||
42023904|NCT01033851|75831255|FG000|Overall Study|Withdrawal by Subject|3|||
41951361|NCT01982292|75716389|FG001|Overall Study|Protocol Deviation|0|||
41951362|NCT01982292|75716388|FG000|Overall Study|Patient/Guardian Decision|3|||
41951363|NCT01982292|75716389|FG001|Overall Study|Patient/Guardian Decision|1|||
41951364|NCT01982292|75716388|FG000|Overall Study|Technical Problems|2|||
41951365|NCT01982292|75716389|FG001|Overall Study|Technical Problems|0|||
41951366|NCT01939314|75716397|FG000|Overall Study|Withdrawal by Subject|3|||
41951367|NCT01939314|75716398|FG001|Overall Study|Withdrawal by Subject|1|||
41951368|NCT01939314|75716397|FG000|Overall Study|Protocol Violation|1|||
41951369|NCT01939314|75716398|FG001|Overall Study|Protocol Violation|0|||
41951370|NCT01939314|75716397|FG000|Overall Study|Pregnancy|0|||
41951371|NCT01939314|75716398|FG001|Overall Study|Pregnancy|1|||
42118027|NCT00689117|75928840|FG000|Overall Study|Fear of Birth Defects|0|||
41951372|NCT01939314|75716397|FG000|Overall Study|Lost to Follow-up|5|||
41951373|NCT01939314|75716398|FG001|Overall Study|Lost to Follow-up|6|||
41951374|NCT01939158|75716410|FG000|Overall Study|Adverse Event|1|||
41951375|NCT01939158|75716411|FG001|Overall Study|Adverse Event|0|||
41951376|NCT01939158|75716412|FG002|Overall Study|Adverse Event|0|||
41951377|NCT01939158|75716413|FG003|Overall Study|Adverse Event|0|||
41951378|NCT01939158|75716410|FG000|Overall Study|Withdrawal by Subject|22|||
41951379|NCT01939158|75716411|FG001|Overall Study|Withdrawal by Subject|25|||
41951380|NCT01939158|75716412|FG002|Overall Study|Withdrawal by Subject|15|||
41951381|NCT01939158|75716413|FG003|Overall Study|Withdrawal by Subject|17|||
41951382|NCT01939158|75716410|FG000|Overall Study|Migrated/moved from study area|5|||
41951383|NCT01939158|75716411|FG001|Overall Study|Migrated/moved from study area|7|||
41951384|NCT01939158|75716412|FG002|Overall Study|Migrated/moved from study area|3|||
41951385|NCT01939158|75716413|FG003|Overall Study|Migrated/moved from study area|6|||
41951386|NCT01939158|75716410|FG000|Overall Study|Lost to Follow-up|18|||
41951387|NCT01939158|75716411|FG001|Overall Study|Lost to Follow-up|17|||
41951388|NCT01939158|75716412|FG002|Overall Study|Lost to Follow-up|17|||
41951389|NCT01939158|75716413|FG003|Overall Study|Lost to Follow-up|17|||
41951390|NCT01939158|75716410|FG000|Overall Study|Death|0|||
41951391|NCT01939158|75716411|FG001|Overall Study|Death|0|||
41951392|NCT01939158|75716412|FG002|Overall Study|Death|1|||
41951393|NCT01939158|75716413|FG003|Overall Study|Death|1|||
41951394|NCT01939158|75716410|FG000|Overall Study|No longer meets eligibility criteria|0|||
41951395|NCT01939158|75716411|FG001|Overall Study|No longer meets eligibility criteria|0|||
41951396|NCT01939158|75716412|FG002|Overall Study|No longer meets eligibility criteria|1|||
41951397|NCT01939158|75716413|FG003|Overall Study|No longer meets eligibility criteria|0|||
41951398|NCT01939158|75716410|FG000|Overall Study|Other|1|||
41951399|NCT01939158|75716411|FG001|Overall Study|Other|3|||
41951400|NCT01939158|75716412|FG002|Overall Study|Other|4|||
41951401|NCT01939158|75716413|FG003|Overall Study|Other|3|||
41951402|NCT01939002|75716429|FG000|Overall Study|Adverse Event|13|||
41951403|NCT01939002|75716430|FG001|Overall Study|Adverse Event|13|||
41951404|NCT01939002|75716429|FG000|Overall Study|Withdrawal by Subject|5|||
41951405|NCT01939002|75716430|FG001|Overall Study|Withdrawal by Subject|3|||
41951406|NCT01939002|75716429|FG000|Overall Study|Other|1|||
41951407|NCT01939002|75716430|FG001|Overall Study|Other|2|||
41951408|NCT01938846|75716444|FG000|Overall Study|Progressive disease|26|||
41951409|NCT01938846|75716445|FG001|Overall Study|Progressive disease|18|||
42023905|NCT01033851|75831256|FG001|Overall Study|Withdrawal by Subject|7|||
41951410|NCT01938846|75716446|FG002|Overall Study|Progressive disease|16|||
41951411|NCT01938846|75716444|FG000|Overall Study|Adverse Event|8|||
41951412|NCT01938846|75716445|FG001|Overall Study|Adverse Event|4|||
41951413|NCT01938846|75716446|FG002|Overall Study|Adverse Event|3|||
41951414|NCT01938846|75716444|FG000|Overall Study|Withdrawal by Subject|2|||
41951415|NCT01938846|75716445|FG001|Overall Study|Withdrawal by Subject|2|||
41951416|NCT01938846|75716446|FG002|Overall Study|Withdrawal by Subject|1|||
41951417|NCT01938846|75716444|FG000|Overall Study|Other than listed|5|||
41951418|NCT01938846|75716445|FG001|Overall Study|Other than listed|1|||
41951419|NCT01938846|75716446|FG002|Overall Study|Other than listed|4|||
41951420|NCT01960140|75716487|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
41951421|NCT01981356|75716497|FG000|Overall Study|Lost to Follow-up|4|||
41951422|NCT01981356|75716498|FG001|Overall Study|Lost to Follow-up|1|||
41951423|NCT01981356|75716497|FG000|Overall Study|Withdrawal by Subject|1|||
41951424|NCT01981356|75716498|FG001|Overall Study|Withdrawal by Subject|1|||
41951425|NCT01981356|75716497|FG000|Overall Study|Protocol Violation|2|||
41951426|NCT01981356|75716498|FG001|Overall Study|Protocol Violation|0|||
41951427|NCT01981122|75716507|FG000|Overall Study|Withdrawal by Subject|0|||
42023906|NCT01162122|75831264|FG000|Overall Study|Withdrawal by Subject|52|||
42023907|NCT01162122|75831265|FG001|Overall Study|Withdrawal by Subject|43|||
42023908|NCT01162122|75831264|FG000|Overall Study|Lost to Follow-up|73|||
42023909|NCT01162122|75831265|FG001|Overall Study|Lost to Follow-up|91|||
42023910|NCT01162122|75831264|FG000|Overall Study|Adverse Event|3|||
42023911|NCT01162122|75831265|FG001|Overall Study|Adverse Event|2|||
42023912|NCT01162122|75831264|FG000|Overall Study|Death|51|||
41951428|NCT01981122|75716508|FG001|Overall Study|Withdrawal by Subject|2|||
42023913|NCT01162122|75831265|FG001|Overall Study|Death|46|||
42023914|NCT01162122|75831264|FG000|Overall Study|Protocol Violation|2|||
42023915|NCT01162122|75831265|FG001|Overall Study|Protocol Violation|2|||
42023916|NCT01162122|75831264|FG000|Overall Study|Inappropriate enrollment|5|||
42023917|NCT01162122|75831265|FG001|Overall Study|Inappropriate enrollment|4|||
42023918|NCT01162122|75831264|FG000|Overall Study|Administrative reason|1|||
41951429|NCT01981122|75716507|FG000|Overall Study|Protocol Violation|0|||
41951430|NCT01981122|75716508|FG001|Overall Study|Protocol Violation|1|||
41951431|NCT01981122|75716507|FG000|Overall Study|Lost to Follow-up|0|||
42023919|NCT01162122|75831265|FG001|Overall Study|Administrative reason|1|||
42023920|NCT01162122|75831264|FG000|Overall Study|Unable to classify|3|||
41951432|NCT01981122|75716508|FG001|Overall Study|Lost to Follow-up|1|||
41951433|NCT01981122|75716507|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
41951434|NCT01981122|75716508|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
41951435|NCT01981122|75716507|FG000|Overall Study|Death|14|||
42023921|NCT01162122|75831265|FG001|Overall Study|Unable to classify|7|||
41951436|NCT01981122|75716508|FG001|Overall Study|Death|15|||
41951437|NCT01980888|75716516|FG000|Overall Study|Study Terminated by Sponsor|116|||
41951438|NCT01980888|75716517|FG001|Overall Study|Study Terminated by Sponsor|122|||
41951439|NCT01980888|75716516|FG000|Overall Study|Withdrew Consent|17|||
41951440|NCT01980888|75716517|FG001|Overall Study|Withdrew Consent|6|||
41951441|NCT01980888|75716516|FG000|Overall Study|Investigator's Discretion|8|||
41951442|NCT01980888|75716517|FG001|Overall Study|Investigator's Discretion|3|||
41951443|NCT01980888|75716516|FG000|Overall Study|Non-Compliance with Study Drug|3|||
41951444|NCT01980888|75716517|FG001|Overall Study|Non-Compliance with Study Drug|2|||
41951445|NCT01937364|75716534|FG000|Overall Study|Adverse Event|2|||
41951446|NCT01937364|75716535|FG001|Overall Study|Adverse Event|1|||
41951447|NCT01979952|75716543|FG000|Overall Study|Adverse Event|4|||
41951448|NCT01979952|75716544|FG001|Overall Study|Adverse Event|5|||
41951449|NCT01979952|75716543|FG000|Overall Study|Protocol Violation|1|||
41951450|NCT01979952|75716544|FG001|Overall Study|Protocol Violation|0|||
41951451|NCT01979952|75716543|FG000|Overall Study|Withdrawal by Subject|2|||
41951452|NCT01979952|75716544|FG001|Overall Study|Withdrawal by Subject|1|||
41951453|NCT01979952|75716543|FG000|Overall Study|Other than specified above|1|||
41951454|NCT01979952|75716544|FG001|Overall Study|Other than specified above|0|||
41951455|NCT01999218|75716553|FG000|Overall Study|Hyperglycemia|18|||
41951456|NCT01999218|75716554|FG001|Overall Study|Hyperglycemia|17|||
41951457|NCT01999218|75716555|FG002|Overall Study|Hyperglycemia|17|||
41951458|NCT01999218|75716553|FG000|Overall Study|Lack of Efficacy|1|||
41951459|NCT01999218|75716554|FG001|Overall Study|Lack of Efficacy|0|||
41951460|NCT01999218|75716555|FG002|Overall Study|Lack of Efficacy|1|||
41951461|NCT01999218|75716553|FG000|Overall Study|Lost to Follow-up|22|||
41951462|NCT01999218|75716554|FG001|Overall Study|Lost to Follow-up|17|||
41951463|NCT01999218|75716555|FG002|Overall Study|Lost to Follow-up|18|||
41951464|NCT01999218|75716553|FG000|Overall Study|Non-Compliance With Study Drug|6|||
41951465|NCT01999218|75716554|FG001|Overall Study|Non-Compliance With Study Drug|4|||
41951466|NCT01999218|75716555|FG002|Overall Study|Non-Compliance With Study Drug|1|||
41951467|NCT01999218|75716553|FG000|Overall Study|Physician Decision|1|||
41951468|NCT01999218|75716554|FG001|Overall Study|Physician Decision|4|||
41951469|NCT01999218|75716555|FG002|Overall Study|Physician Decision|6|||
41951470|NCT01999218|75716553|FG000|Overall Study|Protocol Violation|4|||
41951471|NCT01999218|75716554|FG001|Overall Study|Protocol Violation|5|||
41951472|NCT01999218|75716555|FG002|Overall Study|Protocol Violation|4|||
41951473|NCT01999218|75716553|FG000|Overall Study|Screen failure|0|||
41951474|NCT01999218|75716554|FG001|Overall Study|Screen failure|1|||
41951475|NCT01999218|75716555|FG002|Overall Study|Screen failure|0|||
41951476|NCT01999218|75716553|FG000|Overall Study|Study Terminated By Sponsor|7|||
41951477|NCT01999218|75716554|FG001|Overall Study|Study Terminated By Sponsor|5|||
41951478|NCT01999218|75716555|FG002|Overall Study|Study Terminated By Sponsor|12|||
41951479|NCT01999218|75716553|FG000|Overall Study|Participant moves|2|||
41951480|NCT01999218|75716554|FG001|Overall Study|Participant moves|5|||
41951481|NCT01999218|75716555|FG002|Overall Study|Participant moves|3|||
41951482|NCT01999218|75716553|FG000|Overall Study|Withdrawal by Subject|28|||
41951483|NCT01999218|75716554|FG001|Overall Study|Withdrawal by Subject|29|||
41951484|NCT01999218|75716555|FG002|Overall Study|Withdrawal by Subject|34|||
41951485|NCT01999218|75716553|FG000|Overall Study|Creatinine/eGFR|0|||
41951486|NCT01999218|75716554|FG001|Overall Study|Creatinine/eGFR|0|||
41951487|NCT01999218|75716555|FG002|Overall Study|Creatinine/eGFR|1|||
41951488|NCT01999218|75716553|FG000|Overall Study|Death|7|||
41951489|NCT01999218|75716554|FG001|Overall Study|Death|1|||
41951490|NCT01999218|75716555|FG002|Overall Study|Death|2|||
41951491|NCT01999218|75716553|FG000|Overall Study|Excluded Medication|1|||
41951492|NCT01999218|75716554|FG001|Overall Study|Excluded Medication|1|||
41951493|NCT01999218|75716555|FG002|Overall Study|Excluded Medication|2|||
41951494|NCT01999218|75716553|FG000|Overall Study|Adverse Event|9|||
41951495|NCT01999218|75716554|FG001|Overall Study|Adverse Event|7|||
41951496|NCT01999218|75716555|FG002|Overall Study|Adverse Event|7|||
42023922|NCT01162122|75831264|FG000|Overall Study|Missing primary reason|1|||
41951497|NCT01999218|75716553|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
41951498|NCT01999218|75716554|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
41951499|NCT01999218|75716555|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
41951500|NCT01937130|75716567|FG000|Overall Study|Withdrawal by Subject|0|||
41951501|NCT01937130|75716568|FG001|Overall Study|Withdrawal by Subject|0|||
41951502|NCT01937130|75716569|FG002|Overall Study|Withdrawal by Subject|0|||
41951503|NCT01937130|75716570|FG003|Overall Study|Withdrawal by Subject|1|||
41951504|NCT01937130|75716567|FG000|Overall Study|Adverse Event|0|||
41951505|NCT01937130|75716568|FG001|Overall Study|Adverse Event|1|||
41951506|NCT01937130|75716569|FG002|Overall Study|Adverse Event|0|||
42023923|NCT01162122|75831265|FG001|Overall Study|Missing primary reason|0|||
41951507|NCT01937130|75716570|FG003|Overall Study|Adverse Event|1|||
41951508|NCT01937130|75716567|FG000|Overall Study|Death|1|||
41951509|NCT01937130|75716568|FG001|Overall Study|Death|1|||
42023924|NCT01033071|75831277|FG000|Overall Study|Adverse Event|28|||
41951510|NCT01937130|75716569|FG002|Overall Study|Death|1|||
41951511|NCT01937130|75716570|FG003|Overall Study|Death|0|||
41951512|NCT01937130|75716567|FG000|Overall Study|Lost to Follow-up|2|||
41951513|NCT01937130|75716568|FG001|Overall Study|Lost to Follow-up|0|||
41951514|NCT01937130|75716569|FG002|Overall Study|Lost to Follow-up|2|||
41951515|NCT01937130|75716570|FG003|Overall Study|Lost to Follow-up|0|||
41951516|NCT01937130|75716567|FG000|Overall Study|Physician Decision|0|||
41951517|NCT01937130|75716568|FG001|Overall Study|Physician Decision|1|||
41951518|NCT01937130|75716569|FG002|Overall Study|Physician Decision|0|||
41951519|NCT01937130|75716570|FG003|Overall Study|Physician Decision|0|||
41951520|NCT01937130|75716567|FG000|Overall Study|Patients unable to swallow|0|||
41951521|NCT01937130|75716568|FG001|Overall Study|Patients unable to swallow|1|||
41951522|NCT01937130|75716569|FG002|Overall Study|Patients unable to swallow|0|||
41951523|NCT01937130|75716570|FG003|Overall Study|Patients unable to swallow|0|||
41951524|NCT01937130|75716567|FG000|Overall Study|Patient lost to FU due to death|2|||
41951525|NCT01937130|75716568|FG001|Overall Study|Patient lost to FU due to death|0|||
41951526|NCT01937130|75716569|FG002|Overall Study|Patient lost to FU due to death|0|||
41951527|NCT01937130|75716570|FG003|Overall Study|Patient lost to FU due to death|0|||
41951528|NCT01936974|75716582|FG000|Overall Study|Physician Decision|2|||
41951529|NCT01936974|75716583|FG001|Overall Study|Physician Decision|5|||
41951530|NCT01959516|75716589|FG000|Epoch 1|Adverse Event|4|||
41951531|NCT01959516|75716590|FG001|Epoch 1|Adverse Event|1|||
41951532|NCT01959516|75716589|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
41951533|NCT01959516|75716590|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
41951534|NCT01959516|75716589|FG000|Epoch 1|Subject withdrew consent|3|||
41951535|NCT01959516|75716590|FG001|Epoch 1|Subject withdrew consent|2|||
41951536|NCT01959516|75716589|FG000|Epoch 1|Administrative problems|1|||
41951537|NCT01959516|75716590|FG001|Epoch 1|Administrative problems|0|||
41951538|NCT01959516|75716589|FG000|Epoch 1|Use of prohibited treatment|1|||
41951539|NCT01959516|75716590|FG001|Epoch 1|Use of prohibited treatment|0|||
41951540|NCT01959516|75716589|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
41951541|NCT01959516|75716590|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
41951542|NCT01959516|75716589|FG000|Epoch 1|Protocol deviation|0|||
41951543|NCT01959516|75716590|FG001|Epoch 1|Protocol deviation|1|||
41951544|NCT01959516|75716589|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
41951545|NCT01959516|75716590|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
41951546|NCT01959516|75716589|FG000|Epoch 2|Subject withdrew consent|1|||
41951547|NCT01959516|75716590|FG001|Epoch 2|Subject withdrew consent|0|||
41951548|NCT01959516|75716589|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
41951549|NCT01959516|75716590|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
41951550|NCT01979016|75716598|FG000|Overall Study|Withdrawal by Subject|2|||
41951551|NCT01979016|75716599|FG001|Overall Study|Withdrawal by Subject|0|||
41951552|NCT01979016|75716598|FG000|Overall Study|Adverse Event|0|||
41951553|NCT01979016|75716599|FG001|Overall Study|Adverse Event|1|||
41951554|NCT01935336|75716609|FG000|Overall Study|Adverse Event|1|||
41951555|NCT01935336|75716610|FG001|Overall Study|Adverse Event|0|||
41951556|NCT01935336|75716611|FG002|Overall Study|Adverse Event|0|||
41951557|NCT01935336|75716612|FG003|Overall Study|Adverse Event|0|||
41951558|NCT01935336|75716609|FG000|Overall Study|Progressive disease|5|||
41951559|NCT01935336|75716610|FG001|Overall Study|Progressive disease|3|||
41951560|NCT01935336|75716611|FG002|Overall Study|Progressive disease|47|||
41951561|NCT01935336|75716612|FG003|Overall Study|Progressive disease|66|||
41951562|NCT01978236|75716628|FG000|Overall Study|Discontinued due to study close|2|||
41951563|NCT01977846|75716634|FG000|Total Study - Prospective|Death|0|||
41951564|NCT01977846|75716635|FG001|Total Study - Prospective|Death|1|||
41951565|NCT01977846|75716634|FG000|Total Study - Prospective|Lost to Follow-up|0|||
41951566|NCT01977846|75716635|FG001|Total Study - Prospective|Lost to Follow-up|8|||
41951567|NCT01977846|75716634|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
41951568|NCT01977846|75716635|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
41951569|NCT01977846|75716634|FG000|Total Study - Prospective|Not available at time of visit|0|||
41951570|NCT01977846|75716635|FG001|Total Study - Prospective|Not available at time of visit|5|||
41951571|NCT01977846|75716634|FG000|Total Study - Prospective|No show|0|||
41951572|NCT01977846|75716635|FG001|Total Study - Prospective|No show|1|||
41951573|NCT01977846|75716634|FG000|Total Study - Prospective|Protocol Violation|0|||
41951574|NCT01977846|75716635|FG001|Total Study - Prospective|Protocol Violation|1|||
42300415|NCT05476679|76135577|FG003|Overall Study|Lost to Follow-up|1|||
41951575|NCT01934790|75716642|FG000|Treatment|Adverse Event|3|||
41951576|NCT01934790|75716642|FG000|Treatment|Clinical progression|6|||
41951577|NCT01934790|75716642|FG000|Treatment|Radiological progression|4|||
41951578|NCT01934790|75716642|FG000|Treatment|Withdrawal by Subject|2|||
41951579|NCT01934790|75716642|FG000|Treatment|Study drug never administered|1|||
41951580|NCT01934790|75716642|FG000|Active Follow up|Death|20|||
41951581|NCT01934790|75716642|FG000|Active Follow up|Physician Decision|2|||
41951582|NCT01934790|75716642|FG000|Active Follow up|Progressive disease|1|||
41951583|NCT01934790|75716642|FG000|Active Follow up|Other reason|1|||
41951584|NCT01934556|75716649|FG000|Overall Study|Withdrawal by Subject|0|||
41951585|NCT01934556|75716650|FG001|Overall Study|Withdrawal by Subject|1|||
41951586|NCT01934556|75716651|FG002|Overall Study|Withdrawal by Subject|1|||
41951587|NCT01934556|75716649|FG000|Overall Study|Lost to Follow-up|4|||
41951588|NCT01934556|75716650|FG001|Overall Study|Lost to Follow-up|10|||
41951589|NCT01934556|75716651|FG002|Overall Study|Lost to Follow-up|7|||
41951590|NCT01934556|75716649|FG000|Overall Study|Death|1|||
41951591|NCT01934556|75716650|FG001|Overall Study|Death|5|||
41951592|NCT01934556|75716651|FG002|Overall Study|Death|2|||
41951593|NCT01977690|75716661|FG000|Overall Study|Withdrawal by Subject|0|||
41951594|NCT01977690|75716662|FG001|Overall Study|Withdrawal by Subject|4|||
41951595|NCT01934010|75716737|FG000|Overall Study|Adverse Event|1|||
41951596|NCT01934010|75716738|FG001|Overall Study|Adverse Event|1|||
41951597|NCT01934010|75716739|FG002|Overall Study|Adverse Event|0|||
41951598|NCT01934010|75716737|FG000|Overall Study|Withdrawal by Subject|15|||
41951599|NCT01934010|75716738|FG001|Overall Study|Withdrawal by Subject|6|||
41951600|NCT01934010|75716739|FG002|Overall Study|Withdrawal by Subject|2|||
42023925|NCT01033071|75831278|FG001|Overall Study|Adverse Event|51|||
42023926|NCT01033071|75831279|FG002|Overall Study|Adverse Event|26|||
42023927|NCT01033071|75831277|FG000|Overall Study|Protocol Violation|0|||
42023928|NCT01033071|75831278|FG001|Overall Study|Protocol Violation|2|||
42023929|NCT01033071|75831279|FG002|Overall Study|Protocol Violation|1|||
42023930|NCT01033071|75831277|FG000|Overall Study|Lost to Follow-up|4|||
42023931|NCT01033071|75831278|FG001|Overall Study|Lost to Follow-up|5|||
42023932|NCT01033071|75831279|FG002|Overall Study|Lost to Follow-up|5|||
42023933|NCT01033071|75831277|FG000|Overall Study|Withdrawal by Subject|17|||
42023934|NCT01033071|75831278|FG001|Overall Study|Withdrawal by Subject|14|||
42023935|NCT01033071|75831279|FG002|Overall Study|Withdrawal by Subject|11|||
42023936|NCT01033071|75831277|FG000|Overall Study|Lack of Efficacy|0|||
42023937|NCT01033071|75831278|FG001|Overall Study|Lack of Efficacy|1|||
42023938|NCT01033071|75831279|FG002|Overall Study|Lack of Efficacy|1|||
42023939|NCT01033071|75831277|FG000|Overall Study|Other|6|||
42023940|NCT01033071|75831278|FG001|Overall Study|Other|4|||
42023941|NCT01033071|75831279|FG002|Overall Study|Other|3|||
42023942|NCT01032915|75831291|FG000|Overall Study|Adverse Event|2|||
42023943|NCT01032915|75831292|FG001|Overall Study|Adverse Event|2|||
42023944|NCT01032915|75831293|FG002|Overall Study|Adverse Event|1|||
42023945|NCT01032915|75831294|FG003|Overall Study|Adverse Event|1|||
42023946|NCT01032915|75831291|FG000|Overall Study|Abnormal test procedure result|0|||
42023947|NCT01032915|75831292|FG001|Overall Study|Abnormal test procedure result|0|||
42023948|NCT01032915|75831293|FG002|Overall Study|Abnormal test procedure result|1|||
42023949|NCT01032915|75831294|FG003|Overall Study|Abnormal test procedure result|0|||
42023950|NCT01032915|75831291|FG000|Overall Study|Withdrawal by Subject|0|||
42023951|NCT01032915|75831292|FG001|Overall Study|Withdrawal by Subject|3|||
42023952|NCT01032915|75831293|FG002|Overall Study|Withdrawal by Subject|1|||
42023953|NCT01032915|75831294|FG003|Overall Study|Withdrawal by Subject|1|||
42023954|NCT01032915|75831291|FG000|Overall Study|Administrative reasons|5|||
42023955|NCT01032915|75831292|FG001|Overall Study|Administrative reasons|6|||
42023956|NCT01032915|75831293|FG002|Overall Study|Administrative reasons|4|||
42023957|NCT01032915|75831294|FG003|Overall Study|Administrative reasons|4|||
42023958|NCT01032915|75831291|FG000|Overall Study|Protocol Violation|1|||
42023959|NCT01032915|75831292|FG001|Overall Study|Protocol Violation|0|||
42023960|NCT01032915|75831293|FG002|Overall Study|Protocol Violation|0|||
42023961|NCT01032915|75831294|FG003|Overall Study|Protocol Violation|1|||
42023962|NCT01161498|75831306|FG000|Overall Study|Disease Progression|0|||
42023963|NCT01161498|75831307|FG001|Overall Study|Disease Progression|1|||
42023964|NCT01180998|75831316|FG000|Overall Study|Poor Vision|0|||
42023965|NCT01180998|75831317|FG001|Overall Study|Poor Vision|2|||
42023966|NCT01180998|75831318|FG002|Overall Study|Poor Vision|2|||
42023967|NCT01180998|75831316|FG000|Overall Study|Lost to Follow-up|0|||
42023968|NCT01180998|75831317|FG001|Overall Study|Lost to Follow-up|0|||
42023969|NCT01180998|75831318|FG002|Overall Study|Lost to Follow-up|1|||
42023970|NCT01180998|75831316|FG000|Overall Study|Protocol Violation|1|||
42023971|NCT01180998|75831317|FG001|Overall Study|Protocol Violation|2|||
42023972|NCT01180998|75831318|FG002|Overall Study|Protocol Violation|0|||
42023973|NCT01180998|75831316|FG000|Overall Study|Withdrawal by Subject|0|||
41951601|NCT01934010|75716737|FG000|Overall Study|Lost to Follow-up|7|||
41951602|NCT01934010|75716738|FG001|Overall Study|Lost to Follow-up|4|||
41951603|NCT01934010|75716739|FG002|Overall Study|Lost to Follow-up|0|||
41951604|NCT01620138|75716758|FG000|Overall Study|Withdrawal by Subject|3|||
42023974|NCT01180998|75831317|FG001|Overall Study|Withdrawal by Subject|0|||
42023975|NCT01180998|75831318|FG002|Overall Study|Withdrawal by Subject|1|||
42023976|NCT01180998|75831316|FG000|Overall Study|Poor comfort|3|||
42023977|NCT01180998|75831317|FG001|Overall Study|Poor comfort|0|||
42023978|NCT01180998|75831318|FG002|Overall Study|Poor comfort|4|||
42023979|NCT01180998|75831316|FG000|Overall Study|Poor lens handling|0|||
42023980|NCT01180998|75831317|FG001|Overall Study|Poor lens handling|0|||
42023981|NCT01180998|75831318|FG002|Overall Study|Poor lens handling|2|||
42023982|NCT01029795|75831329|FG000|Overall Study|Entry Criteria Not Met|2|||
41951605|NCT01620138|75716759|FG001|Overall Study|Withdrawal by Subject|0|||
41951606|NCT01620138|75716758|FG000|Overall Study|Lack of Efficacy|1|||
42023983|NCT01029795|75831330|FG001|Overall Study|Entry Criteria Not Met|1|||
42023984|NCT01029795|75831329|FG000|Overall Study|Physician Decision|2|||
42300416|NCT05476679|76135578|FG004|Overall Study|Lost to Follow-up|0|||
42300417|NCT02546765|76135596|FG000|Overall Study|Withdrawal by Subject|0|||
42300418|NCT02546765|76135597|FG001|Overall Study|Withdrawal by Subject|1|||
42300419|NCT02546765|76135598|FG002|Overall Study|Withdrawal by Subject|0|||
42300420|NCT02546765|76135599|FG003|Overall Study|Withdrawal by Subject|0|||
42300421|NCT02553629|76135622|FG000|Overall Study|Logistic reasons|3|||
42300422|NCT02553629|76135623|FG001|Overall Study|Logistic reasons|6|||
42300423|NCT02546609|76135632|FG000|Overall Study|Withdrawal by Subject|0|||
42300424|NCT02546609|76135633|FG001|Overall Study|Withdrawal by Subject|1|||
42300425|NCT02546609|76135634|FG002|Overall Study|Withdrawal by Subject|2|||
41951607|NCT01620138|75716759|FG001|Overall Study|Lack of Efficacy|0|||
41951608|NCT01620138|75716758|FG000|Overall Study|Adverse Event|2|||
41951609|NCT01620138|75716759|FG001|Overall Study|Adverse Event|0|||
41951610|NCT01977612|75716767|FG000|Overall Study|Lost to Follow-up|1|||
41951611|NCT01977612|75716768|FG001|Overall Study|Lost to Follow-up|1|||
41951612|NCT01932996|75716776|FG000|Overall Study|Protocol Violation|2|||
41951613|NCT01932996|75716777|FG001|Overall Study|Protocol Violation|0|||
41951614|NCT01932762|75716787|FG000|Overall Study|Withdrawal by Subject|1|||
41951615|NCT01932762|75716788|FG001|Overall Study|Withdrawal by Subject|2|||
41951616|NCT01932762|75716789|FG002|Overall Study|Withdrawal by Subject|0|||
41951617|NCT01932762|75716790|FG003|Overall Study|Withdrawal by Subject|0|||
41951618|NCT01932762|75716787|FG000|Overall Study|Lost to Follow-up|4|||
41951619|NCT01932762|75716788|FG001|Overall Study|Lost to Follow-up|0|||
41951620|NCT01932762|75716789|FG002|Overall Study|Lost to Follow-up|0|||
41951621|NCT01932762|75716790|FG003|Overall Study|Lost to Follow-up|1|||
41951622|NCT01932762|75716787|FG000|Overall Study|Physician Decision|1|||
41951623|NCT01932762|75716788|FG001|Overall Study|Physician Decision|0|||
41951624|NCT01932762|75716789|FG002|Overall Study|Physician Decision|0|||
41951625|NCT01932762|75716790|FG003|Overall Study|Physician Decision|0|||
41951626|NCT01618968|75716804|FG000|Overall Study|Adverse Event|1|||
41951627|NCT01618968|75716805|FG001|Overall Study|Adverse Event|0|||
41951628|NCT01618968|75716806|FG002|Overall Study|Adverse Event|0|||
41951629|NCT01618968|75716807|FG003|Overall Study|Adverse Event|0|||
41951630|NCT01618968|75716804|FG000|Overall Study|Death|0|||
41951631|NCT01618968|75716805|FG001|Overall Study|Death|0|||
41951632|NCT01618968|75716806|FG002|Overall Study|Death|0|||
41951633|NCT01618968|75716807|FG003|Overall Study|Death|1|||
41951634|NCT01932294|75716816|FG000|Overall Study|Death|43|||
41951635|NCT01932294|75716816|FG000|Overall Study|Lost to Follow-up|8|||
41951636|NCT01932294|75716816|FG000|Overall Study|VAD Implantation|20|||
41951637|NCT01932294|75716816|FG000|Overall Study|Heart Transplantation|16|||
41951638|NCT01932294|75716816|FG000|Overall Study|Transferred to other hospitals|12|||
41951639|NCT01931670|75716824|FG000|Treatment Period|Exclusionary Medication Received|1|||
41951640|NCT01931670|75716825|FG001|Treatment Period|Exclusionary Medication Received|1|||
41951641|NCT01931670|75716826|FG002|Treatment Period|Exclusionary Medication Received|1|||
41951642|NCT01931670|75716824|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
41951643|NCT01931670|75716825|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
41951644|NCT01931670|75716826|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
41951645|NCT01931670|75716824|FG000|Treatment Period|Subject Noncompliant|4|||
41951646|NCT01931670|75716825|FG001|Treatment Period|Subject Noncompliant|9|||
41951647|NCT01931670|75716826|FG002|Treatment Period|Subject Noncompliant|5|||
41951648|NCT01931670|75716824|FG000|Treatment Period|Adverse Event|19|||
41951649|NCT01931670|75716825|FG001|Treatment Period|Adverse Event|8|||
41951650|NCT01931670|75716826|FG002|Treatment Period|Adverse Event|21|||
41951651|NCT01931670|75716824|FG000|Treatment Period|Lack of Efficacy|11|||
41951652|NCT01931670|75716825|FG001|Treatment Period|Lack of Efficacy|2|||
41951653|NCT01931670|75716826|FG002|Treatment Period|Lack of Efficacy|2|||
41951654|NCT01931670|75716824|FG000|Treatment Period|Pregnancy|7|||
41951655|NCT01931670|75716825|FG001|Treatment Period|Pregnancy|2|||
41951656|NCT01931670|75716826|FG002|Treatment Period|Pregnancy|0|||
41951657|NCT01931670|75716824|FG000|Treatment Period|Other|8|||
41951658|NCT01931670|75716825|FG001|Treatment Period|Other|7|||
41951659|NCT01931670|75716826|FG002|Treatment Period|Other|2|||
41951660|NCT01931670|75716824|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
41951661|NCT01931670|75716825|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
41951662|NCT01931670|75716826|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
41951663|NCT01931670|75716824|FG000|Treatment Period|Lost to Follow-up|19|||
41951664|NCT01931670|75716825|FG001|Treatment Period|Lost to Follow-up|5|||
41951665|NCT01931670|75716826|FG002|Treatment Period|Lost to Follow-up|7|||
41951666|NCT01931670|75716824|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
41951667|NCT01931670|75716825|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
42023985|NCT01029795|75831330|FG001|Overall Study|Physician Decision|1|||
41951668|NCT01931670|75716826|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
41951669|NCT01931670|75716824|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
42023986|NCT01029795|75831329|FG000|Overall Study|Sponsor Decision|11|||
42300426|NCT02546609|76135632|FG000|Overall Study|Adverse Event|0|||
42300427|NCT02546609|76135633|FG001|Overall Study|Adverse Event|6|||
41951670|NCT01931670|75716825|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
41951671|NCT01931670|75716826|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
41951672|NCT01931670|75716824|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
41951673|NCT01931670|75716825|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
41951674|NCT01931670|75716826|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
41951675|NCT01931670|75716824|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
41951676|NCT01931670|75716825|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
41951677|NCT01931670|75716826|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
41951678|NCT01931670|75716824|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
41951679|NCT01931670|75716825|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
41951680|NCT01931670|75716826|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
41951681|NCT01931670|75716824|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
41951682|NCT01931670|75716825|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
41951683|NCT01931670|75716826|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
41951684|NCT01977456|75716834|FG000|Overall Study|Death|5|||
41951685|NCT01957644|75716843|FG000|Overall Study|Adverse Event|4|||
41951686|NCT01957644|75716844|FG001|Overall Study|Adverse Event|2|||
41951687|NCT01957644|75716845|FG002|Overall Study|Adverse Event|0|||
41951688|NCT01957644|75716846|FG003|Overall Study|Adverse Event|0|||
41951689|NCT01957644|75716847|FG004|Overall Study|Adverse Event|1|||
41951690|NCT01957644|75716843|FG000|Overall Study|Progressive disease / relapse|0|||
41951691|NCT01957644|75716844|FG001|Overall Study|Progressive disease / relapse|1|||
41951692|NCT01957644|75716845|FG002|Overall Study|Progressive disease / relapse|0|||
41951693|NCT01957644|75716846|FG003|Overall Study|Progressive disease / relapse|1|||
41951694|NCT01957644|75716847|FG004|Overall Study|Progressive disease / relapse|0|||
41951695|NCT01957644|75716843|FG000|Overall Study|Other reason|1|||
41951696|NCT01957644|75716844|FG001|Overall Study|Other reason|2|||
41951697|NCT01957644|75716845|FG002|Overall Study|Other reason|1|||
41951698|NCT01957644|75716846|FG003|Overall Study|Other reason|1|||
41951699|NCT01957644|75716847|FG004|Overall Study|Other reason|0|||
41951700|NCT01957644|75716843|FG000|Overall Study|Withdrawal by Subject|1|||
41951701|NCT01957644|75716844|FG001|Overall Study|Withdrawal by Subject|0|||
41951702|NCT01957644|75716845|FG002|Overall Study|Withdrawal by Subject|0|||
41951703|NCT01957644|75716846|FG003|Overall Study|Withdrawal by Subject|0|||
41951704|NCT01957644|75716847|FG004|Overall Study|Withdrawal by Subject|0|||
41951705|NCT01957644|75716843|FG000|Overall Study|Protocol Violation|0|||
41951706|NCT01957644|75716844|FG001|Overall Study|Protocol Violation|1|||
41951707|NCT01957644|75716845|FG002|Overall Study|Protocol Violation|0|||
41951708|NCT01957644|75716846|FG003|Overall Study|Protocol Violation|0|||
41951709|NCT01957644|75716847|FG004|Overall Study|Protocol Violation|0|||
41951710|NCT01931202|75716864|FG000|Overall Study|Withdrawal by Subject|0|||
41951711|NCT01931202|75716865|FG001|Overall Study|Withdrawal by Subject|0|||
41951712|NCT01931202|75716866|FG002|Overall Study|Withdrawal by Subject|2|||
41951713|NCT01931202|75716864|FG000|Overall Study|Lost to Follow-up|0|||
41951714|NCT01931202|75716865|FG001|Overall Study|Lost to Follow-up|5|||
41951715|NCT01931202|75716866|FG002|Overall Study|Lost to Follow-up|2|||
41951716|NCT01930890|75716881|FG000|Overall Study|Study Termination|14|||
41951717|NCT01930890|75716882|FG001|Overall Study|Study Termination|28|||
41951718|NCT01930890|75716883|FG002|Overall Study|Study Termination|13|||
41951719|NCT01930890|75716884|FG003|Overall Study|Study Termination|25|||
41951720|NCT01930890|75716881|FG000|Overall Study|Death|0|||
41951721|NCT01930890|75716882|FG001|Overall Study|Death|0|||
41951722|NCT01930890|75716883|FG002|Overall Study|Death|0|||
41951723|NCT01930890|75716884|FG003|Overall Study|Death|1|||
41951724|NCT01930890|75716881|FG000|Overall Study|Investigator Decision|0|||
41951725|NCT01930890|75716882|FG001|Overall Study|Investigator Decision|1|||
41951726|NCT01930890|75716883|FG002|Overall Study|Investigator Decision|0|||
41951727|NCT01930890|75716884|FG003|Overall Study|Investigator Decision|0|||
41951728|NCT01930890|75716881|FG000|Overall Study|Consent Withdrawn|0|||
41951729|NCT01930890|75716882|FG001|Overall Study|Consent Withdrawn|3|||
41951730|NCT01930890|75716883|FG002|Overall Study|Consent Withdrawn|0|||
41951731|NCT01930890|75716884|FG003|Overall Study|Consent Withdrawn|1|||
41951732|NCT01930890|75716881|FG000|Overall Study|Adverse Event|0|||
41951733|NCT01930890|75716882|FG001|Overall Study|Adverse Event|1|||
41951734|NCT01930890|75716883|FG002|Overall Study|Adverse Event|0|||
41951735|NCT01930890|75716884|FG003|Overall Study|Adverse Event|0|||
41951736|NCT01930188|75716897|FG000|Overall Study|unclassified|4|||
41951737|NCT01930188|75716898|FG001|Overall Study|unclassified|5|||
41951738|NCT01930188|75716899|FG002|Overall Study|unclassified|3|||
41951739|NCT01930188|75716897|FG000|Overall Study|Missing follow-up information|2|||
41951740|NCT01930188|75716898|FG001|Overall Study|Missing follow-up information|2|||
41951741|NCT01930188|75716899|FG002|Overall Study|Missing follow-up information|3|||
41951742|NCT01930188|75716897|FG000|Overall Study|Lost to Follow-up|5|||
41951743|NCT01930188|75716898|FG001|Overall Study|Lost to Follow-up|2|||
41951744|NCT01930188|75716899|FG002|Overall Study|Lost to Follow-up|2|||
41951745|NCT01930188|75716897|FG000|Overall Study|Death|2|||
41951746|NCT01930188|75716898|FG001|Overall Study|Death|1|||
41951747|NCT01930188|75716899|FG002|Overall Study|Death|3|||
41951748|NCT01930188|75716897|FG000|Overall Study|Withdrawal by Subject|9|||
41951749|NCT01930188|75716898|FG001|Overall Study|Withdrawal by Subject|11|||
41951750|NCT01930188|75716899|FG002|Overall Study|Withdrawal by Subject|8|||
41951751|NCT01977222|75716908|FG000|Overall Study|Withdrawal by Subject|1|||
41951752|NCT01957488|75716912|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
41951753|NCT01957488|75716913|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
41951754|NCT01957488|75716914|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
41951755|NCT01957488|75716915|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
41951756|NCT01957488|75716916|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
41951757|NCT01957488|75716917|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
41951758|NCT01957488|75716912|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
41951759|NCT01957488|75716913|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
41951760|NCT01957488|75716914|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
41951761|NCT01957488|75716915|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
41951762|NCT01957488|75716916|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
41951763|NCT01957488|75716917|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
41951764|NCT01957488|75716912|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
41951765|NCT01957488|75716913|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
41951766|NCT01957488|75716914|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
41951767|NCT01957488|75716915|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
41951768|NCT01957488|75716916|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
41951769|NCT01957488|75716917|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
41951770|NCT01957488|75716912|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
41951771|NCT01957488|75716913|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
41951772|NCT01957488|75716914|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
41951773|NCT01957488|75716915|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
41951774|NCT01957488|75716916|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
41951775|NCT01957488|75716917|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
41951776|NCT01957488|75716912|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
41951777|NCT01957488|75716913|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
41951778|NCT01957488|75716914|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
41951779|NCT01957488|75716915|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
41951780|NCT01957488|75716916|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
41951781|NCT01957488|75716917|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
41951782|NCT01957488|75716912|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
41951783|NCT01957488|75716913|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
41951784|NCT01957488|75716914|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
41951785|NCT01957488|75716915|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
41951786|NCT01957488|75716916|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
41951787|NCT01957488|75716917|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
41951788|NCT01957488|75716912|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
41951789|NCT01957488|75716913|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
41951790|NCT01957488|75716914|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
41951791|NCT01957488|75716915|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
41951792|NCT01957488|75716916|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
41951793|NCT01957488|75716917|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
41951794|NCT01957488|75716912|FG000|Test Period 2 (2 Weeks)|Other|1|||
41951795|NCT01957488|75716913|FG001|Test Period 2 (2 Weeks)|Other|0|||
41951796|NCT01957488|75716914|FG002|Test Period 2 (2 Weeks)|Other|0|||
41951797|NCT01957488|75716915|FG003|Test Period 2 (2 Weeks)|Other|0|||
41951798|NCT01957488|75716916|FG004|Test Period 2 (2 Weeks)|Other|0|||
41951799|NCT01957488|75716917|FG005|Test Period 2 (2 Weeks)|Other|0|||
41951800|NCT01957488|75716912|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
41951801|NCT01957488|75716913|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
41951802|NCT01957488|75716914|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
41951803|NCT01957488|75716915|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
41951804|NCT01957488|75716916|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
41951805|NCT01957488|75716917|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
41951806|NCT01957488|75716912|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
41951807|NCT01957488|75716913|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
41951808|NCT01957488|75716914|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
41951809|NCT01957488|75716915|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
41951810|NCT01957488|75716916|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
41951811|NCT01957488|75716917|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
41951812|NCT01957488|75716912|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
41951813|NCT01957488|75716913|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
41951814|NCT01957488|75716914|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
41951815|NCT01957488|75716915|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
42300428|NCT02546609|76135634|FG002|Overall Study|Adverse Event|1|||
41951816|NCT01957488|75716916|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
41951817|NCT01957488|75716917|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
41951818|NCT01957488|75716912|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
41951819|NCT01957488|75716913|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
41951820|NCT01957488|75716914|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
41951821|NCT01957488|75716915|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
41951822|NCT01957488|75716916|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
41951823|NCT01957488|75716917|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
41951824|NCT01957488|75716912|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
41951825|NCT01957488|75716913|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
41951826|NCT01957488|75716914|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
41951827|NCT01957488|75716915|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
41951828|NCT01957488|75716916|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
41951829|NCT01957488|75716917|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
41951830|NCT01976364|75716925|FG000|Main Study (36 Months)|Adverse Event|63|||
41951831|NCT01976364|75716926|FG001|Main Study (36 Months)|Adverse Event|0|||
41951832|NCT01976364|75716927|FG002|Main Study (36 Months)|Adverse Event|0|||
41951833|NCT01976364|75716925|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
41951834|NCT01976364|75716926|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
41951835|NCT01976364|75716927|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
41951836|NCT01976364|75716925|FG000|Main Study (36 Months)|Other|13|||
41951837|NCT01976364|75716926|FG001|Main Study (36 Months)|Other|0|||
41951838|NCT01976364|75716927|FG002|Main Study (36 Months)|Other|0|||
41951839|NCT01976364|75716925|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
41951840|NCT01976364|75716926|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
41951841|NCT01976364|75716927|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
41951842|NCT01976364|75716925|FG000|Main Study (36 Months)|Medication error|1|||
41951843|NCT01976364|75716926|FG001|Main Study (36 Months)|Medication error|0|||
41951844|NCT01976364|75716927|FG002|Main Study (36 Months)|Medication error|0|||
41951845|NCT01976364|75716925|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
41951846|NCT01976364|75716926|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
41951847|NCT01976364|75716927|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
41951848|NCT01976364|75716925|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
41951849|NCT01976364|75716926|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
41951850|NCT01976364|75716927|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
41951851|NCT01976364|75716925|FG000|Main Study (36 Months)|Protocol Violation|13|||
41951852|NCT01976364|75716926|FG001|Main Study (36 Months)|Protocol Violation|0|||
41951853|NCT01976364|75716927|FG002|Main Study (36 Months)|Protocol Violation|0|||
41951854|NCT01976364|75716925|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
41951855|NCT01976364|75716926|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
41951856|NCT01976364|75716927|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
41951857|NCT01976364|75716925|FG000|Main Study (36 Months)|Death|5|||
41951858|NCT01976364|75716926|FG001|Main Study (36 Months)|Death|0|||
41951859|NCT01976364|75716927|FG002|Main Study (36 Months)|Death|0|||
41951860|NCT01976364|75716925|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
41951861|NCT01976364|75716926|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
41951862|NCT01976364|75716927|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
41951863|NCT01976364|75716925|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
41951864|NCT01976364|75716926|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
41951865|NCT01976364|75716927|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
41951866|NCT01976364|75716925|FG000|Sub-study (12 Months)|Protocol Violation|0|||
41951867|NCT01976364|75716926|FG001|Sub-study (12 Months)|Protocol Violation|1|||
41951868|NCT01976364|75716927|FG002|Sub-study (12 Months)|Protocol Violation|1|||
41951869|NCT01976364|75716925|FG000|Sub-study (12 Months)|Adverse Event|0|||
41951870|NCT01976364|75716926|FG001|Sub-study (12 Months)|Adverse Event|4|||
41951871|NCT01976364|75716927|FG002|Sub-study (12 Months)|Adverse Event|3|||
41951872|NCT01956240|75716938|FG000|Overall Study|Lost to Follow-up|6|||
41951873|NCT01956240|75716939|FG001|Overall Study|Lost to Follow-up|20|||
41951874|NCT01956240|75716938|FG000|Overall Study|Adverse Event|17|||
41951875|NCT01956240|75716939|FG001|Overall Study|Adverse Event|4|||
41951876|NCT01929876|75716945|FG000|Period 2|Non-Compliance|1|||
41951877|NCT01929408|75716949|FG000|Overall Study|received HCT as initial treatment|8|||
41951878|NCT01929018|75716955|FG000|Overall Study|Lost to Follow-up|1|||
41951879|NCT01929018|75716956|FG001|Overall Study|Lost to Follow-up|0|||
41951880|NCT01929018|75716955|FG000|Overall Study|Hospitalization|0|||
41951881|NCT01929018|75716956|FG001|Overall Study|Hospitalization|1|||
41951882|NCT01928940|75716964|FG000|Overall Study|Adverse Event|0|||
41951883|NCT01928940|75716965|FG001|Overall Study|Adverse Event|1|||
41951884|NCT01928862|75716977|FG000|Overall Study|Lost to Follow-up|1|||
41951885|NCT01928862|75716978|FG001|Overall Study|Lost to Follow-up|0|||
41951886|NCT01928862|75716979|FG002|Overall Study|Lost to Follow-up|0|||
41951887|NCT01928862|75716980|FG003|Overall Study|Lost to Follow-up|0|||
41951888|NCT01928862|75716981|FG004|Overall Study|Lost to Follow-up|1|||
41951889|NCT01954056|75716996|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
42023987|NCT01029795|75831330|FG001|Overall Study|Sponsor Decision|17|||
41951890|NCT01954056|75716997|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
41951891|NCT01953354|75717005|FG000|Overall Study|Withdrawal by Subject|0|||
41951892|NCT01953354|75717006|FG001|Overall Study|Withdrawal by Subject|1|||
41951893|NCT01953354|75717005|FG000|Overall Study|Decision of Sponsor|0|||
41951894|NCT01953354|75717006|FG001|Overall Study|Decision of Sponsor|1|||
41951895|NCT01953354|75717005|FG000|Overall Study|Disease Exacerbation|1|||
41951896|NCT01953354|75717006|FG001|Overall Study|Disease Exacerbation|0|||
41951897|NCT01975272|75717015|FG000|Overall Study|Excluded after protocol amendment|1|||
41951898|NCT01975272|75717016|FG001|Overall Study|Excluded after protocol amendment|1|||
41951899|NCT01975272|75717017|FG002|Overall Study|Excluded after protocol amendment|2|||
41951900|NCT01951638|75717030|FG000|Treatment Period|Protocol Violation|0|||
41951901|NCT01951638|75717031|FG001|Treatment Period|Protocol Violation|0|||
41951902|NCT01951638|75717032|FG002|Treatment Period|Protocol Violation|0|||
41951903|NCT01951638|75717033|FG003|Treatment Period|Protocol Violation|2|||
41951904|NCT01951638|75717034|FG004|Treatment Period|Protocol Violation|0|||
41951905|NCT01951638|75717030|FG000|Treatment Period|Protocol-driven decision point|1|||
41951906|NCT01951638|75717031|FG001|Treatment Period|Protocol-driven decision point|3|||
41951907|NCT01951638|75717032|FG002|Treatment Period|Protocol-driven decision point|0|||
41951908|NCT01951638|75717033|FG003|Treatment Period|Protocol-driven decision point|0|||
41951909|NCT01951638|75717034|FG004|Treatment Period|Protocol-driven decision point|0|||
41951910|NCT01951638|75717030|FG000|Treatment Period|Logistical difficulties|0|||
41951911|NCT01951638|75717031|FG001|Treatment Period|Logistical difficulties|1|||
41951912|NCT01951638|75717032|FG002|Treatment Period|Logistical difficulties|1|||
41951913|NCT01951638|75717033|FG003|Treatment Period|Logistical difficulties|0|||
41951914|NCT01951638|75717034|FG004|Treatment Period|Logistical difficulties|0|||
41951915|NCT01951638|75717030|FG000|Treatment Period|Withdrawal by Subject|9|||
41951916|NCT01951638|75717031|FG001|Treatment Period|Withdrawal by Subject|6|||
41951917|NCT01951638|75717032|FG002|Treatment Period|Withdrawal by Subject|4|||
41951918|NCT01951638|75717033|FG003|Treatment Period|Withdrawal by Subject|5|||
41951919|NCT01951638|75717034|FG004|Treatment Period|Withdrawal by Subject|4|||
41951920|NCT01951638|75717030|FG000|Treatment Period|Death|0|||
41951921|NCT01951638|75717031|FG001|Treatment Period|Death|0|||
41951922|NCT01951638|75717032|FG002|Treatment Period|Death|0|||
41951923|NCT01951638|75717033|FG003|Treatment Period|Death|3|||
41951924|NCT01951638|75717034|FG004|Treatment Period|Death|1|||
41951925|NCT01951638|75717030|FG000|Treatment Period|Adverse Event|3|||
41951926|NCT01951638|75717031|FG001|Treatment Period|Adverse Event|4|||
41951927|NCT01951638|75717032|FG002|Treatment Period|Adverse Event|8|||
41951928|NCT01951638|75717033|FG003|Treatment Period|Adverse Event|6|||
41951929|NCT01951638|75717034|FG004|Treatment Period|Adverse Event|5|||
41951930|NCT01951638|75717030|FG000|Follow-up Period|Protocol Violation|0|||
41951931|NCT01951638|75717031|FG001|Follow-up Period|Protocol Violation|0|||
41951932|NCT01951638|75717032|FG002|Follow-up Period|Protocol Violation|0|||
41951933|NCT01951638|75717033|FG003|Follow-up Period|Protocol Violation|1|||
41951934|NCT01951638|75717034|FG004|Follow-up Period|Protocol Violation|0|||
41951935|NCT01951638|75717030|FG000|Follow-up Period|Logistical difficulties|0|||
41951936|NCT01951638|75717031|FG001|Follow-up Period|Logistical difficulties|2|||
41951937|NCT01951638|75717032|FG002|Follow-up Period|Logistical difficulties|0|||
41951938|NCT01951638|75717033|FG003|Follow-up Period|Logistical difficulties|0|||
41951939|NCT01951638|75717034|FG004|Follow-up Period|Logistical difficulties|1|||
41951940|NCT01951638|75717030|FG000|Follow-up Period|Withdrawal by Subject|1|||
41951941|NCT01951638|75717031|FG001|Follow-up Period|Withdrawal by Subject|5|||
41951942|NCT01951638|75717032|FG002|Follow-up Period|Withdrawal by Subject|2|||
41951943|NCT01951638|75717033|FG003|Follow-up Period|Withdrawal by Subject|1|||
41951944|NCT01951638|75717034|FG004|Follow-up Period|Withdrawal by Subject|2|||
41951945|NCT01951638|75717030|FG000|Follow-up Period|Lost to Follow-up|0|||
41951946|NCT01951638|75717031|FG001|Follow-up Period|Lost to Follow-up|1|||
41951947|NCT01951638|75717032|FG002|Follow-up Period|Lost to Follow-up|0|||
41951948|NCT01951638|75717033|FG003|Follow-up Period|Lost to Follow-up|1|||
41951949|NCT01951638|75717034|FG004|Follow-up Period|Lost to Follow-up|0|||
41951950|NCT01951638|75717030|FG000|Follow-up Period|Death|1|||
41951951|NCT01951638|75717031|FG001|Follow-up Period|Death|0|||
41951952|NCT01951638|75717032|FG002|Follow-up Period|Death|1|||
41951953|NCT01951638|75717033|FG003|Follow-up Period|Death|4|||
41951954|NCT01951638|75717034|FG004|Follow-up Period|Death|1|||
41951955|NCT01951638|75717030|FG000|Follow-up Period|Adverse Event|0|||
41951956|NCT01951638|75717031|FG001|Follow-up Period|Adverse Event|1|||
41951957|NCT01951638|75717032|FG002|Follow-up Period|Adverse Event|2|||
41951958|NCT01951638|75717033|FG003|Follow-up Period|Adverse Event|1|||
41951959|NCT01951638|75717034|FG004|Follow-up Period|Adverse Event|1|||
41951960|NCT01928472|75717050|FG000|Overall Study|Death|0|||
41951961|NCT01928472|75717051|FG001|Overall Study|Death|0|||
41951962|NCT01928472|75717052|FG002|Overall Study|Death|1|||
41951963|NCT01928472|75717053|FG003|Overall Study|Death|0|||
41951964|NCT01928472|75717050|FG000|Overall Study|Withdrawal by Subject|4|||
41951965|NCT01928472|75717051|FG001|Overall Study|Withdrawal by Subject|4|||
41951966|NCT01928472|75717052|FG002|Overall Study|Withdrawal by Subject|1|||
41951967|NCT01928472|75717053|FG003|Overall Study|Withdrawal by Subject|2|||
41951968|NCT01928472|75717050|FG000|Overall Study|Lost to Follow-up|2|||
41951969|NCT01928472|75717051|FG001|Overall Study|Lost to Follow-up|3|||
41951970|NCT01928472|75717052|FG002|Overall Study|Lost to Follow-up|4|||
41951971|NCT01928472|75717053|FG003|Overall Study|Lost to Follow-up|0|||
41951972|NCT01928472|75717050|FG000|Overall Study|Administrative Reason|2|||
41951973|NCT01928472|75717051|FG001|Overall Study|Administrative Reason|1|||
41951974|NCT01928472|75717052|FG002|Overall Study|Administrative Reason|0|||
41951975|NCT01928472|75717053|FG003|Overall Study|Administrative Reason|0|||
41951976|NCT01928472|75717050|FG000|Overall Study|Unclassified|0|||
41951977|NCT01928472|75717051|FG001|Overall Study|Unclassified|0|||
41951978|NCT01928472|75717052|FG002|Overall Study|Unclassified|1|||
41951979|NCT01928472|75717053|FG003|Overall Study|Unclassified|0|||
41951980|NCT01351415|75718906|FG000|Overall Study|Withdrawal by Subject|15|||
41951981|NCT01351415|75718907|FG001|Overall Study|Withdrawal by Subject|17|||
41951982|NCT01351415|75718906|FG000|Overall Study|Trial termination by the Sponsor|28|||
41951983|NCT01351415|75718907|FG001|Overall Study|Trial termination by the Sponsor|19|||
41951984|NCT01351415|75718906|FG000|Overall Study|Lost to Follow-up|5|||
41951985|NCT01351415|75718907|FG001|Overall Study|Lost to Follow-up|7|||
41951986|NCT01351415|75718906|FG000|Overall Study|Death|190|||
41951987|NCT01351415|75718907|FG001|Overall Study|Death|187|||
41951988|NCT01351415|75718906|FG000|Overall Study|Physician Decision|2|||
41951989|NCT01351415|75718907|FG001|Overall Study|Physician Decision|3|||
41951990|NCT01351415|75718906|FG000|Overall Study|Reason unknown|0|||
41951991|NCT01351415|75718907|FG001|Overall Study|Reason unknown|2|||
41951992|NCT01351415|75718906|FG000|Overall Study|Never Started|5|||
41951993|NCT01351415|75718907|FG001|Overall Study|Never Started|5|||
41951994|NCT04811339|75719015|FG000|Overall Study|lack of transportation not wanting to return|4|||
41951995|NCT04811339|75719016|FG001|Overall Study|lack of transportation not wanting to return|8|||
41951996|NCT04811339|75719017|FG002|Overall Study|lack of transportation not wanting to return|0|||
41951997|NCT04811339|75719015|FG000|Overall Study|Adverse Event|3|||
41951998|NCT04811339|75719016|FG001|Overall Study|Adverse Event|0|||
41951999|NCT04811339|75719017|FG002|Overall Study|Adverse Event|0|||
41952000|NCT04811339|75719015|FG000|Overall Study|Lost to Follow-up|1|||
41952001|NCT04811339|75719016|FG001|Overall Study|Lost to Follow-up|0|||
41952002|NCT04811339|75719017|FG002|Overall Study|Lost to Follow-up|0|||
41952003|NCT04811339|75719015|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
41952004|NCT04811339|75719016|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
41952005|NCT04811339|75719017|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
41952006|NCT04811339|75719015|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
41952007|NCT04811339|75719016|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
41952008|NCT04811339|75719017|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
41952009|NCT04811339|75719015|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
41952010|NCT04811339|75719016|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
41952011|NCT04811339|75719017|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
41952012|NCT04811339|75719015|FG000|Overall Study|Withdrawal by Subject|0|||
41952013|NCT04811339|75719016|FG001|Overall Study|Withdrawal by Subject|3|||
41952014|NCT04811339|75719017|FG002|Overall Study|Withdrawal by Subject|0|||
41952015|NCT04811339|75719015|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
41952016|NCT04811339|75719016|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
41952017|NCT04811339|75719017|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
41952018|NCT04811339|75719015|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
41952019|NCT04811339|75719016|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
41952020|NCT04811339|75719017|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
41952021|NCT04332107|75719029|FG000|Day 3|Lost to Follow-up|23|||
41952022|NCT04332107|75719030|FG001|Day 3|Lost to Follow-up|14|||
41952023|NCT04332107|75719029|FG000|Day 3|Missing outcome data|3|||
41952024|NCT04332107|75719030|FG001|Day 3|Missing outcome data|6|||
41952025|NCT04332107|75719029|FG000|Day 14|Lost to Follow-up|13|||
41952026|NCT04332107|75719030|FG001|Day 14|Lost to Follow-up|4|||
41952027|NCT04332107|75719029|FG000|Day 14|Missing outcome data|4|||
41952028|NCT04332107|75719030|FG001|Day 14|Missing outcome data|4|||
41952029|NCT04332107|75719029|FG000|Day 21|Lost to Follow-up|10|||
41952030|NCT04332107|75719030|FG001|Day 21|Lost to Follow-up|2|||
41952031|NCT03375203|75719045|FG000|Overall Study|Protocol Violation|0|||
41952032|NCT03375203|75719046|FG001|Overall Study|Protocol Violation|0|||
41952033|NCT03375203|75719047|FG002|Overall Study|Protocol Violation|1|||
41952034|NCT03375203|75719048|FG003|Overall Study|Protocol Violation|0|||
41952035|NCT03375203|75719049|FG004|Overall Study|Protocol Violation|0|||
41952036|NCT03375203|75719045|FG000|Overall Study|Adverse Event|2|||
41952037|NCT03375203|75719046|FG001|Overall Study|Adverse Event|3|||
41952038|NCT03375203|75719047|FG002|Overall Study|Adverse Event|0|||
42118028|NCT00689117|75928841|FG001|Overall Study|Fear of Birth Defects|0|||
41952039|NCT03375203|75719048|FG003|Overall Study|Adverse Event|2|||
41952040|NCT03375203|75719049|FG004|Overall Study|Adverse Event|2|||
41952041|NCT03375203|75719045|FG000|Overall Study|Withdrawal by Subject|3|||
41952042|NCT03375203|75719046|FG001|Overall Study|Withdrawal by Subject|0|||
41952043|NCT03375203|75719047|FG002|Overall Study|Withdrawal by Subject|1|||
41952044|NCT03375203|75719048|FG003|Overall Study|Withdrawal by Subject|0|||
41952045|NCT03375203|75719049|FG004|Overall Study|Withdrawal by Subject|2|||
41952046|NCT03375203|75719045|FG000|Overall Study|Non-compliance with study drug|1|||
41952047|NCT03375203|75719046|FG001|Overall Study|Non-compliance with study drug|0|||
41952048|NCT03375203|75719047|FG002|Overall Study|Non-compliance with study drug|0|||
41952049|NCT03375203|75719048|FG003|Overall Study|Non-compliance with study drug|0|||
41952050|NCT03375203|75719049|FG004|Overall Study|Non-compliance with study drug|0|||
41952051|NCT03375203|75719045|FG000|Overall Study|Randomized, not treated.|0|||
41952052|NCT03375203|75719046|FG001|Overall Study|Randomized, not treated.|1|||
41952053|NCT03375203|75719047|FG002|Overall Study|Randomized, not treated.|0|||
41952054|NCT03375203|75719048|FG003|Overall Study|Randomized, not treated.|0|||
41952055|NCT03375203|75719049|FG004|Overall Study|Randomized, not treated.|0|||
41952056|NCT03075839|75719071|FG000|Overall Study|Lost to Follow-up|4|||
41952057|NCT02919683|75719077|FG000|Post-Surgery Follow-Up|Death|2|||
41952058|NCT02919683|75719078|FG001|Post-Surgery Follow-Up|Death|2|||
41952059|NCT02919683|75719077|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
41952060|NCT02919683|75719078|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
41952061|NCT01928082|75719085|FG000|Overall Study|Study terminated.|1|||
41952062|NCT01972776|75719095|FG000|Part 1|Withdrawal by Subject|0|||
41952063|NCT01972776|75719096|FG001|Part 1|Withdrawal by Subject|0|||
41952064|NCT01972776|75719097|FG002|Part 1|Withdrawal by Subject|1|||
41952065|NCT01972776|75719098|FG003|Part 1|Withdrawal by Subject|0|||
41952066|NCT01972776|75719099|FG004|Part 1|Withdrawal by Subject|0|||
41952067|NCT01972776|75719100|FG005|Part 1|Withdrawal by Subject|0|||
41952068|NCT01972776|75719095|FG000|Part 1|Adverse Event|0|||
41952069|NCT01972776|75719096|FG001|Part 1|Adverse Event|0|||
41952070|NCT01972776|75719097|FG002|Part 1|Adverse Event|1|||
41952071|NCT01972776|75719098|FG003|Part 1|Adverse Event|1|||
41952072|NCT01972776|75719099|FG004|Part 1|Adverse Event|0|||
41952073|NCT01972776|75719100|FG005|Part 1|Adverse Event|0|||
41952074|NCT01972776|75719095|FG000|Part 2|Adverse Event|0|||
41952075|NCT01972776|75719096|FG001|Part 2|Adverse Event|0|||
41952076|NCT01972776|75719097|FG002|Part 2|Adverse Event|0|||
41952077|NCT01972776|75719098|FG003|Part 2|Adverse Event|0|||
41952078|NCT01972776|75719099|FG004|Part 2|Adverse Event|3|||
41952079|NCT01972776|75719100|FG005|Part 2|Adverse Event|0|||
41952080|NCT01972776|75719095|FG000|Part 2|Administrative problems|0|||
41952081|NCT01972776|75719096|FG001|Part 2|Administrative problems|0|||
41952082|NCT01972776|75719097|FG002|Part 2|Administrative problems|0|||
41952083|NCT01972776|75719098|FG003|Part 2|Administrative problems|0|||
41952084|NCT01972776|75719099|FG004|Part 2|Administrative problems|10|||
41952085|NCT01972776|75719100|FG005|Part 2|Administrative problems|7|||
41952086|NCT03763331|75719116|FG000|Overall Study|Lost to Follow-up|1|||
41952087|NCT03763331|75719117|FG001|Overall Study|Lost to Follow-up|0|||
41952088|NCT03763331|75719116|FG000|Overall Study|Withdrawal by Subject|1|||
41952089|NCT03763331|75719117|FG001|Overall Study|Withdrawal by Subject|0|||
41952090|NCT03763331|75719116|FG000|Overall Study|Non-compliance|0|||
41952091|NCT03763331|75719117|FG001|Overall Study|Non-compliance|3|||
41952092|NCT00001259|75719144|FG000|Study 2|Adverse Event|0|||
41952093|NCT00001259|75719145|FG001|Study 2|Adverse Event|0|||
41952094|NCT00001259|75719146|FG002|Study 2|Adverse Event|0|||
41952095|NCT00001259|75719147|FG003|Study 2|Adverse Event|0|||
41952096|NCT00001259|75719148|FG004|Study 2|Adverse Event|2|||
41952097|NCT00001259|75719149|FG005|Study 2|Adverse Event|0|||
41952098|NCT00001259|75719150|FG006|Study 2|Adverse Event|0|||
41952099|NCT01926444|75719164|FG000|Overall Study|Colonoscopy not performed|0|||
41952100|NCT01926444|75719165|FG001|Overall Study|Colonoscopy not performed|0|||
41952101|NCT01926444|75719166|FG002|Overall Study|Colonoscopy not performed|4|||
41952102|NCT01926444|75719167|FG003|Overall Study|Colonoscopy not performed|2|||
41952103|NCT05003167|75719177|FG000|Overall Study|Withdrawal by Subject|1|||
41952104|NCT04988035|75719183|FG000|Overall Study|Death|19|||
41952105|NCT04988035|75719184|FG001|Overall Study|Death|13|||
41952106|NCT04988035|75719183|FG000|Overall Study|Lost to Follow-up|12|||
41952107|NCT04988035|75719184|FG001|Overall Study|Lost to Follow-up|6|||
41952108|NCT04988035|75719183|FG000|Overall Study|Protocol Violation|0|||
41952109|NCT04988035|75719184|FG001|Overall Study|Protocol Violation|1|||
41952110|NCT04988035|75719183|FG000|Overall Study|Withdrawal by Subject|2|||
41952111|NCT04988035|75719184|FG001|Overall Study|Withdrawal by Subject|4|||
41952112|NCT04988035|75719183|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
41952113|NCT04988035|75719184|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
41952114|NCT04847674|75719202|FG000|Overall Study|Withdrawal by Subject|0|||
41952115|NCT04847674|75719203|FG001|Overall Study|Withdrawal by Subject|1|||
41952116|NCT04847674|75719204|FG002|Overall Study|Withdrawal by Subject|0|||
41952117|NCT04847674|75719202|FG000|Overall Study|Lost to Follow-up|0|||
41952118|NCT04847674|75719203|FG001|Overall Study|Lost to Follow-up|0|||
41952119|NCT04847674|75719204|FG002|Overall Study|Lost to Follow-up|2|||
41952120|NCT04847674|75719202|FG000|Overall Study|Other than specified|21|||
41952121|NCT04847674|75719203|FG001|Overall Study|Other than specified|20|||
41952122|NCT04847674|75719204|FG002|Overall Study|Other than specified|20|||
41952123|NCT04649060|75719216|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
41952124|NCT04649060|75719217|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
41952125|NCT04649060|75719216|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
41952126|NCT04649060|75719217|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
41952127|NCT04649060|75719216|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
41952128|NCT04649060|75719217|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
41952129|NCT04649060|75719216|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
41952130|NCT04649060|75719217|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
41952131|NCT04649060|75719216|FG000|Arm A/Arm B Treatment|Patient Request|1|||
41952132|NCT04649060|75719217|FG001|Arm A/Arm B Treatment|Patient Request|0|||
41952133|NCT04649060|75719216|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
41952134|NCT04649060|75719217|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
41952135|NCT04649060|75719216|FG000|Arm A/Arm B Treatment|Other|1|||
41952136|NCT04649060|75719217|FG001|Arm A/Arm B Treatment|Other|0|||
41952137|NCT04649060|75719216|FG000|Crossover (Arm B)|Adverse Event|0|||
41952138|NCT04649060|75719217|FG001|Crossover (Arm B)|Adverse Event|1|||
41952139|NCT04649060|75719216|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
41952140|NCT04649060|75719217|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
41952141|NCT04640272|75719224|FG000|Overall Study|Subject moved out of area|1|||
41952142|NCT04511650|75719231|FG000|Overall Study|Lost to Follow-up|1|||
41952143|NCT04511650|75719232|FG001|Overall Study|Lost to Follow-up|0|||
41952144|NCT04511650|75719233|FG002|Overall Study|Lost to Follow-up|0|||
41952145|NCT04511650|75719231|FG000|Overall Study|Withdrawal by Subject|1|||
41952146|NCT04511650|75719232|FG001|Overall Study|Withdrawal by Subject|0|||
41952147|NCT04511650|75719233|FG002|Overall Study|Withdrawal by Subject|0|||
41952148|NCT04511650|75719231|FG000|Overall Study|reason not provided|0|||
41952149|NCT04511650|75719232|FG001|Overall Study|reason not provided|0|||
41952150|NCT04511650|75719233|FG002|Overall Study|reason not provided|1|||
41952151|NCT04511650|75719231|FG000|Overall Study|Death|1|||
41952152|NCT04511650|75719232|FG001|Overall Study|Death|1|||
41952153|NCT04511650|75719233|FG002|Overall Study|Death|1|||
41952154|NCT04285580|75719252|FG000|Overall Study|Protocol Violation|0|||
41952155|NCT04285580|75719253|FG001|Overall Study|Protocol Violation|1|||
41952156|NCT04200248|75719271|FG000|Overall Study|Personal reasons|0|||
41952157|NCT04200248|75719272|FG001|Overall Study|Personal reasons|0|||
41952158|NCT04200248|75719273|FG002|Overall Study|Personal reasons|1|||
41952159|NCT04200248|75719271|FG000|Overall Study|Discontinued prior to treatment|3|||
41952160|NCT04200248|75719272|FG001|Overall Study|Discontinued prior to treatment|3|||
41952161|NCT04200248|75719273|FG002|Overall Study|Discontinued prior to treatment|2|||
41952162|NCT04137887|75719283|FG000|Overall Study|Death|102|||
41952163|NCT04137887|75719284|FG001|Overall Study|Death|92|||
41952164|NCT04137887|75719283|FG000|Overall Study|Withdrawal by Subject|2|||
41952165|NCT04137887|75719284|FG001|Overall Study|Withdrawal by Subject|3|||
41952166|NCT04137887|75719283|FG000|Overall Study|Randomized but not treated|0|||
41952167|NCT04137887|75719284|FG001|Overall Study|Randomized but not treated|1|||
41952168|NCT04074590|75719292|FG000|Overall Study|Adverse Event|1|||
41952169|NCT04074590|75719293|FG001|Overall Study|Adverse Event|0|||
41952170|NCT04074590|75719292|FG000|Overall Study|Physician Decision|1|||
41952171|NCT04074590|75719293|FG001|Overall Study|Physician Decision|0|||
41952172|NCT04074590|75719292|FG000|Overall Study|Withdrawal by Subject|2|||
41952173|NCT04074590|75719293|FG001|Overall Study|Withdrawal by Subject|0|||
41952174|NCT03557008|75719330|FG000|Overall Study|Withdrawal by Subject|2|||
41952175|NCT03557008|75719331|FG001|Overall Study|Withdrawal by Subject|2|||
41952176|NCT03557008|75719330|FG000|Overall Study|Early termination from study|3|||
41952177|NCT03557008|75719331|FG001|Overall Study|Early termination from study|1|||
41952178|NCT03040999|75719339|FG000|Overall Study|Lost to Follow-up|1|||
41952179|NCT03040999|75719340|FG001|Overall Study|Lost to Follow-up|0|||
41952180|NCT03040999|75719339|FG000|Overall Study|Withdrawal by Subject|7|||
41952181|NCT03040999|75719340|FG001|Overall Study|Withdrawal by Subject|12|||
41952182|NCT03040999|75719339|FG000|Overall Study|Death|128|||
41952183|NCT03040999|75719340|FG001|Overall Study|Death|138|||
41952184|NCT03040999|75719339|FG000|Overall Study|Participants Ongoing in Trial|266|||
41952185|NCT03040999|75719340|FG001|Overall Study|Participants Ongoing in Trial|252|||
41952186|NCT02366728|75719349|FG000|Overall Study|Death|0|||
41952187|NCT02366728|75719350|FG001|Overall Study|Death|0|||
41952188|NCT02366728|75719351|FG002|Overall Study|Death|1|||
41952189|NCT02366728|75719349|FG000|Overall Study|Adverse Event|1|||
41952190|NCT02366728|75719350|FG001|Overall Study|Adverse Event|0|||
41952191|NCT02366728|75719351|FG002|Overall Study|Adverse Event|0|||
41952192|NCT02366728|75719349|FG000|Overall Study|Screen Failure|2|||
41952193|NCT02366728|75719350|FG001|Overall Study|Screen Failure|1|||
41952194|NCT02366728|75719351|FG002|Overall Study|Screen Failure|0|||
41952195|NCT02366728|75719349|FG000|Overall Study|Only yielded 2 vaccines|1|||
41952196|NCT02366728|75719350|FG001|Overall Study|Only yielded 2 vaccines|0|||
41952197|NCT02366728|75719351|FG002|Overall Study|Only yielded 2 vaccines|0|||
41952198|NCT02355002|75719361|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
41952199|NCT02355002|75719362|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
41952200|NCT02355002|75719361|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
41952201|NCT02355002|75719362|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
41952202|NCT02355002|75719361|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
41952203|NCT02355002|75719362|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
41952204|NCT02355002|75719361|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
41952205|NCT02355002|75719362|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
41952206|NCT02355002|75719361|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
41952207|NCT02355002|75719362|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
41952208|NCT02355002|75719361|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
41952209|NCT02355002|75719362|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
41952210|NCT02355002|75719361|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
41952211|NCT02355002|75719362|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
41952212|NCT02246920|75719372|FG000|Overall Study|Adverse Event|3|||
41952213|NCT02246920|75719373|FG001|Overall Study|Adverse Event|1|||
41952214|NCT02246920|75719374|FG002|Overall Study|Adverse Event|1|||
41952215|NCT02246920|75719372|FG000|Overall Study|Lost to Follow-up|2|||
41952216|NCT02246920|75719373|FG001|Overall Study|Lost to Follow-up|1|||
41952217|NCT02246920|75719374|FG002|Overall Study|Lost to Follow-up|0|||
41952218|NCT02246920|75719372|FG000|Overall Study|Protocol Violation|2|||
41952219|NCT02246920|75719373|FG001|Overall Study|Protocol Violation|5|||
41952220|NCT02246920|75719374|FG002|Overall Study|Protocol Violation|1|||
41952221|NCT02246920|75719372|FG000|Overall Study|Withdrawal by Subject|0|||
41952222|NCT02246920|75719373|FG001|Overall Study|Withdrawal by Subject|0|||
41952223|NCT02246920|75719374|FG002|Overall Study|Withdrawal by Subject|1|||
41952224|NCT01832402|75719384|FG000|Overall Study|Lost to Follow-up|2|||
41952225|NCT01832402|75719385|FG001|Overall Study|Lost to Follow-up|0|||
41952226|NCT01832402|75719384|FG000|Overall Study|Withdrawal by Subject|3|||
41952227|NCT01832402|75719385|FG001|Overall Study|Withdrawal by Subject|3|||
41952228|NCT01832402|75719384|FG000|Overall Study|Declining Performance status|2|||
41952229|NCT01832402|75719385|FG001|Overall Study|Declining Performance status|1|||
41952230|NCT00667628|75719402|FG000|Overall Study|Lost to Follow-up|1|||
41952231|NCT00667628|75719403|FG001|Overall Study|Lost to Follow-up|0|||
41952232|NCT00667628|75719402|FG000|Overall Study|Death|6|||
41952233|NCT00667628|75719403|FG001|Overall Study|Death|6|||
41952234|NCT00667628|75719402|FG000|Overall Study|Investigator Considers in Best Interest|1|||
41952235|NCT00667628|75719403|FG001|Overall Study|Investigator Considers in Best Interest|0|||
41952236|NCT00667628|75719402|FG000|Overall Study|Sponsor Terminated Study|17|||
41952237|NCT00667628|75719403|FG001|Overall Study|Sponsor Terminated Study|21|||
41952238|NCT01597908|75719415|FG000|Randomized Phase|Death|217|||
41952239|NCT01597908|75719416|FG001|Randomized Phase|Death|238|||
41952240|NCT01597908|75719417|FG002|Randomized Phase|Death|0|||
41952241|NCT01597908|75719415|FG000|Randomized Phase|Sponsor Decision|93|||
41952242|NCT01597908|75719416|FG001|Randomized Phase|Sponsor Decision|39|||
41952243|NCT01597908|75719417|FG002|Randomized Phase|Sponsor Decision|0|||
41952244|NCT01597908|75719415|FG000|Randomized Phase|Lost to Follow-up|9|||
41952245|NCT01597908|75719416|FG001|Randomized Phase|Lost to Follow-up|16|||
41952246|NCT01597908|75719417|FG002|Randomized Phase|Lost to Follow-up|0|||
41952247|NCT01597908|75719415|FG000|Randomized Phase|Physician Decision|6|||
41952248|NCT01597908|75719416|FG001|Randomized Phase|Physician Decision|3|||
41952249|NCT01597908|75719417|FG002|Randomized Phase|Physician Decision|0|||
41952250|NCT01597908|75719415|FG000|Randomized Phase|Withdrawal by Subject|26|||
41952251|NCT01597908|75719416|FG001|Randomized Phase|Withdrawal by Subject|22|||
41952252|NCT01597908|75719417|FG002|Randomized Phase|Withdrawal by Subject|0|||
41952253|NCT01597908|75719415|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
41952254|NCT01597908|75719416|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
41952255|NCT01597908|75719417|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
41952256|NCT01597908|75719415|FG000|Crossover Phase|Death|0|||
41952257|NCT01597908|75719416|FG001|Crossover Phase|Death|0|||
41952258|NCT01597908|75719417|FG002|Crossover Phase|Death|11|||
41952259|NCT01597908|75719415|FG000|Crossover Phase|Withdrawal by Subject|0|||
41952260|NCT01597908|75719416|FG001|Crossover Phase|Withdrawal by Subject|0|||
41952261|NCT01597908|75719417|FG002|Crossover Phase|Withdrawal by Subject|3|||
41952262|NCT01597908|75719415|FG000|Crossover Phase|Sponsor Decision|0|||
41952263|NCT01597908|75719416|FG001|Crossover Phase|Sponsor Decision|0|||
41952264|NCT01597908|75719417|FG002|Crossover Phase|Sponsor Decision|20|||
41952265|NCT01951170|75719426|FG000|Overall Study|Investigator decision|1|||
41952266|NCT01951092|75719430|FG000|Overall Study|Lost to Follow-up|10|||
41952267|NCT01951092|75719430|FG000|Overall Study|Incarceration|1|||
41952268|NCT01951092|75719430|FG000|Overall Study|Transfer of Care|1|||
41952269|NCT01949532|75719436|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
41952270|NCT01949532|75719437|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
41952271|NCT01949142|75719445|FG000|Overall Study|Withdrawal of consent|1|||
41952272|NCT01949142|75719446|FG001|Overall Study|Withdrawal of consent|0|||
41952273|NCT01949142|75719445|FG000|Overall Study|Lost to Follow-up|1|||
41952274|NCT01949142|75719446|FG001|Overall Study|Lost to Follow-up|1|||
41952275|NCT01949142|75719445|FG000|Overall Study|Parent changed their mind|1|||
41952276|NCT01949142|75719446|FG001|Overall Study|Parent changed their mind|0|||
41952277|NCT01948908|75719456|FG000|Overall Study|Protocol Violation|1|||
41952278|NCT01948908|75719457|FG001|Overall Study|Protocol Violation|0|||
41952279|NCT01948908|75719458|FG002|Overall Study|Protocol Violation|2|||
41952280|NCT01925274|75719469|FG000|Overall Study|Death|1|||
41952281|NCT01925274|75719470|FG001|Overall Study|Death|0|||
41952282|NCT01925274|75719471|FG002|Overall Study|Death|0|||
41952283|NCT01925274|75719469|FG000|Overall Study|Lost to Follow-up|0|||
41952284|NCT01925274|75719470|FG001|Overall Study|Lost to Follow-up|1|||
41952285|NCT01925274|75719471|FG002|Overall Study|Lost to Follow-up|0|||
41952286|NCT01925274|75719469|FG000|Overall Study|Withdrawal by Subject|1|||
41952287|NCT01925274|75719470|FG001|Overall Study|Withdrawal by Subject|2|||
41952288|NCT01925274|75719471|FG002|Overall Study|Withdrawal by Subject|0|||
41952289|NCT01925274|75719469|FG000|Overall Study|Study terminated by sponsor|4|||
41952290|NCT01925274|75719470|FG001|Overall Study|Study terminated by sponsor|0|||
41952291|NCT01925274|75719471|FG002|Overall Study|Study terminated by sponsor|0|||
41952292|NCT01925274|75719469|FG000|Overall Study|Protocol amendment|1|||
41952293|NCT01925274|75719470|FG001|Overall Study|Protocol amendment|3|||
41952294|NCT01925274|75719471|FG002|Overall Study|Protocol amendment|6|||
41952295|NCT01948830|75719483|FG000|Overall Study|Physician Decision|1|||
41952296|NCT01948830|75719484|FG001|Overall Study|Physician Decision|3|||
41952297|NCT01948830|75719483|FG000|Overall Study|Protocol deviation|1|||
41952298|NCT01948830|75719484|FG001|Overall Study|Protocol deviation|2|||
41952299|NCT01948830|75719483|FG000|Overall Study|Lost to Follow-up|5|||
41952300|NCT01948830|75719484|FG001|Overall Study|Lost to Follow-up|4|||
41952301|NCT01948830|75719483|FG000|Overall Study|Withdrawal by Subject|14|||
41952302|NCT01948830|75719484|FG001|Overall Study|Withdrawal by Subject|17|||
41952303|NCT01948830|75719483|FG000|Overall Study|Adverse Event|9|||
41952304|NCT01948830|75719484|FG001|Overall Study|Adverse Event|2|||
41952305|NCT01948830|75719483|FG000|Overall Study|Death|3|||
41952306|NCT01948830|75719484|FG001|Overall Study|Death|4|||
41952307|NCT01972464|75719492|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
41952308|NCT01972464|75719493|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
41952309|NCT01972464|75719492|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
41952310|NCT01972464|75719493|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
41952311|NCT01972464|75719492|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
41952312|NCT01972464|75719493|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
41952313|NCT01972464|75719492|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
41952314|NCT01972464|75719493|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
41952315|NCT01948050|75719502|FG000|Overall Study|Withdrawal by Subject|0|||
41952316|NCT01948050|75719503|FG001|Overall Study|Withdrawal by Subject|1|||
41952317|NCT01947894|75719512|FG000|Overall Study|Other|3|||
41952318|NCT01947894|75719513|FG001|Overall Study|Other|4|||
41952319|NCT01947894|75719514|FG002|Overall Study|Other|3|||
41952320|NCT01947894|75719512|FG000|Overall Study|Withdrawal by Subject|12|||
41952321|NCT01947894|75719513|FG001|Overall Study|Withdrawal by Subject|4|||
41952322|NCT01947894|75719514|FG002|Overall Study|Withdrawal by Subject|1|||
41952323|NCT01947894|75719512|FG000|Overall Study|Death|12|||
41952324|NCT01947894|75719513|FG001|Overall Study|Death|1|||
41952325|NCT01947894|75719514|FG002|Overall Study|Death|0|||
41952326|NCT01947894|75719512|FG000|Overall Study|Physician Decision|2|||
41952327|NCT01947894|75719513|FG001|Overall Study|Physician Decision|0|||
41952328|NCT01947894|75719514|FG002|Overall Study|Physician Decision|0|||
41952329|NCT01947894|75719512|FG000|Overall Study|Adverse Event|5|||
41952330|NCT01947894|75719513|FG001|Overall Study|Adverse Event|1|||
41952331|NCT01947894|75719514|FG002|Overall Study|Adverse Event|0|||
41952332|NCT01947894|75719512|FG000|Overall Study|Switched to other growth hormone brand|53|||
41952333|NCT01947894|75719513|FG001|Overall Study|Switched to other growth hormone brand|8|||
42023988|NCT01029795|75831329|FG000|Overall Study|Withdrawal by Subject|1|||
42023989|NCT01029795|75831330|FG001|Overall Study|Withdrawal by Subject|3|||
42023990|NCT01032837|75831340|FG000|Overall Study|Adverse event/internal illness|0|||
42023991|NCT01032837|75831341|FG001|Overall Study|Adverse event/internal illness|1|||
41952334|NCT01947894|75719514|FG002|Overall Study|Switched to other growth hormone brand|23|||
41952335|NCT01947582|75719522|FG000|Overall Study|Withdrawal by Subject|1|||
41952336|NCT01924806|75719528|FG000|Overall Study|Physician Decision|2|||
41952337|NCT01924806|75719529|FG001|Overall Study|Physician Decision|1|||
41952338|NCT01924182|75719537|FG000|Overall Study|Withdrawal by Subject|1|||
41952339|NCT01924182|75719538|FG001|Overall Study|Withdrawal by Subject|0|||
41952340|NCT01972308|75719546|FG000|Overall Study|Withdrawal by Subject|0|||
41952341|NCT01972308|75719547|FG001|Overall Study|Withdrawal by Subject|1|||
41952342|NCT01972308|75719546|FG000|Overall Study|Lost to Follow-up|4|||
41952343|NCT01972308|75719547|FG001|Overall Study|Lost to Follow-up|6|||
41952344|NCT01972308|75719546|FG000|Overall Study|Death|4|||
41952345|NCT01972308|75719547|FG001|Overall Study|Death|1|||
41952346|NCT01946880|75719557|FG000|Overall Study|Lost to Follow-up|1|||
41952347|NCT01946880|75719558|FG001|Overall Study|Lost to Follow-up|0|||
41952348|NCT01946880|75719557|FG000|Overall Study|Physician Decision|1|||
41952349|NCT01946880|75719558|FG001|Overall Study|Physician Decision|1|||
41952350|NCT01946880|75719557|FG000|Overall Study|Withdrawal by Subject|3|||
41952351|NCT01946880|75719558|FG001|Overall Study|Withdrawal by Subject|2|||
41952352|NCT01946880|75719557|FG000|Overall Study|Met Primary Endpoint|1|||
41952353|NCT01946880|75719558|FG001|Overall Study|Met Primary Endpoint|0|||
41952354|NCT01946880|75719557|FG000|Overall Study|Personal and Family Issues|1|||
41952355|NCT01946880|75719558|FG001|Overall Study|Personal and Family Issues|0|||
41952356|NCT01972152|75719564|FG000|First Treatment Visit|Lost to Follow-up|0|||
41952357|NCT01972152|75719565|FG001|First Treatment Visit|Lost to Follow-up|1|||
41952358|NCT01972152|75719566|FG002|First Treatment Visit|Lost to Follow-up|0|||
41952359|NCT01972152|75719567|FG003|First Treatment Visit|Lost to Follow-up|0|||
41952360|NCT01972152|75719568|FG004|First Treatment Visit|Lost to Follow-up|0|||
41952361|NCT01972152|75719569|FG005|First Treatment Visit|Lost to Follow-up|0|||
41952362|NCT01972152|75719564|FG000|Second Treatment Visit|Protocol Violation|0|||
41952363|NCT01972152|75719565|FG001|Second Treatment Visit|Protocol Violation|1|||
41952364|NCT01972152|75719566|FG002|Second Treatment Visit|Protocol Violation|0|||
41952365|NCT01972152|75719567|FG003|Second Treatment Visit|Protocol Violation|0|||
41952366|NCT01972152|75719568|FG004|Second Treatment Visit|Protocol Violation|0|||
41952367|NCT01972152|75719569|FG005|Second Treatment Visit|Protocol Violation|0|||
41952368|NCT01972074|75719583|FG000|Overall Study|Adverse Event|4|||
41952369|NCT01972074|75719584|FG001|Overall Study|Adverse Event|1|||
41952370|NCT01972074|75719585|FG002|Overall Study|Adverse Event|0|||
41952371|NCT01972074|75719583|FG000|Overall Study|Lack of Efficacy|1|||
41952372|NCT01972074|75719584|FG001|Overall Study|Lack of Efficacy|1|||
41952373|NCT01972074|75719585|FG002|Overall Study|Lack of Efficacy|0|||
41952374|NCT01972074|75719583|FG000|Overall Study|Lost to Follow-up|0|||
41952375|NCT01972074|75719584|FG001|Overall Study|Lost to Follow-up|1|||
41952376|NCT01972074|75719585|FG002|Overall Study|Lost to Follow-up|1|||
41952377|NCT01972074|75719583|FG000|Overall Study|Withdrawal by Subject|1|||
41952378|NCT01972074|75719584|FG001|Overall Study|Withdrawal by Subject|1|||
41952379|NCT01972074|75719585|FG002|Overall Study|Withdrawal by Subject|1|||
41952380|NCT01972074|75719583|FG000|Overall Study|Scanner Unavailable|0|||
41952381|NCT01972074|75719584|FG001|Overall Study|Scanner Unavailable|0|||
41952382|NCT01972074|75719585|FG002|Overall Study|Scanner Unavailable|1|||
41952383|NCT01970982|75719595|FG000|Overall Study|Withdrawal by Subject|0|||
41952384|NCT01970982|75719596|FG001|Overall Study|Withdrawal by Subject|0|||
41952385|NCT01970982|75719597|FG002|Overall Study|Withdrawal by Subject|2|||
41952386|NCT01946802|75719606|FG000|Overall Study|Death|1|||
41952387|NCT01946802|75719606|FG000|Overall Study|Withdrawal by Subject|2|||
41952388|NCT01946802|75719606|FG000|Overall Study|Combined septic shock|1|||
41952389|NCT01946802|75719606|FG000|Overall Study|Protocol Violation|1|||
41952390|NCT01618266|75719610|FG000|Overall Study|Lost to Follow-up|9|||
41952391|NCT01618266|75719610|FG000|Overall Study|Treatment satisfaction|10|||
41952392|NCT01618266|75719610|FG000|Overall Study|Other reasons|11|||
41952393|NCT01618266|75719610|FG000|Overall Study|Lack of Efficacy|23|||
41952394|NCT01618266|75719610|FG000|Overall Study|Protocol Violation|43|||
41952395|NCT01919112|75719617|FG000|Secondary Analysis-day 30|Death|1|||
41952396|NCT01919112|75719618|FG001|Secondary Analysis-day 30|Death|1|||
41952397|NCT01919112|75719619|FG002|Secondary Analysis-day 30|Death|1|||
41952398|NCT01919112|75719617|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
41952399|NCT01919112|75719618|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
41952400|NCT01919112|75719619|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
42300429|NCT02546609|76135632|FG000|Overall Study|Protocol Violation|0|||
41952401|NCT01918332|75719631|FG000|Overall Study|Adverse Event|0|||
41952402|NCT01918332|75719632|FG001|Overall Study|Adverse Event|0|||
41952403|NCT01918332|75719633|FG002|Overall Study|Adverse Event|0|||
41952404|NCT01918332|75719634|FG003|Overall Study|Adverse Event|1|||
41952405|NCT01918332|75719631|FG000|Overall Study|Withdrawal by Subject|2|||
41952406|NCT01918332|75719632|FG001|Overall Study|Withdrawal by Subject|3|||
41952407|NCT01918332|75719633|FG002|Overall Study|Withdrawal by Subject|2|||
41952408|NCT01918332|75719634|FG003|Overall Study|Withdrawal by Subject|3|||
41952409|NCT01918332|75719631|FG000|Overall Study|Protocol Violation|6|||
41952410|NCT01918332|75719632|FG001|Overall Study|Protocol Violation|2|||
41952411|NCT01918332|75719633|FG002|Overall Study|Protocol Violation|6|||
41952412|NCT01918332|75719634|FG003|Overall Study|Protocol Violation|3|||
41952413|NCT01918332|75719631|FG000|Overall Study|lipid result by central lab did not meet|0|||
41952414|NCT01918332|75719632|FG001|Overall Study|lipid result by central lab did not meet|0|||
41952415|NCT01918332|75719633|FG002|Overall Study|lipid result by central lab did not meet|1|||
42300430|NCT02546609|76135633|FG001|Overall Study|Protocol Violation|1|||
41952416|NCT01918332|75719634|FG003|Overall Study|lipid result by central lab did not meet|0|||
41952417|NCT01922934|75719646|FG000|Eligible Patients|Death|0|||
41952418|NCT01922934|75719647|FG001|Eligible Patients|Death|7|||
41952419|NCT01922934|75719646|FG000|Eligible Patients|Physician Decision|17|||
41952420|NCT01922934|75719647|FG001|Eligible Patients|Physician Decision|0|||
41952421|NCT01922934|75719646|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
41952422|NCT01922934|75719647|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
41952423|NCT01922934|75719646|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
41952424|NCT01922934|75719647|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
41952425|NCT01922934|75719646|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
41952426|NCT01922934|75719647|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
41952427|NCT01922934|75719646|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
41952428|NCT01922934|75719647|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
41952429|NCT01970592|75719655|FG000|Overall Study|Withdrawal by Subject|4|||
41952430|NCT01970592|75719655|FG000|Overall Study|Physician Decision|1|||
41952431|NCT01970592|75719655|FG000|Overall Study|Adverse Event|1|||
41952432|NCT01920594|75719661|FG000|Overall Study|Adverse Event|4|||
41952433|NCT01920594|75719662|FG001|Overall Study|Adverse Event|2|||
41952434|NCT01920594|75719661|FG000|Overall Study|Lost to Follow-up|1|||
41952435|NCT01920594|75719662|FG001|Overall Study|Lost to Follow-up|0|||
41952436|NCT01920594|75719661|FG000|Overall Study|Recovery|2|||
41952437|NCT01920594|75719662|FG001|Overall Study|Recovery|0|||
41952438|NCT01920594|75719661|FG000|Overall Study|Investigator discretion|0|||
41952439|NCT01920594|75719662|FG001|Overall Study|Investigator discretion|1|||
41952440|NCT01917084|75719668|FG000|Overall Study|Withdrawal by Subject|1|||
41952441|NCT01917006|75719679|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
41952442|NCT01917006|75719680|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
41952443|NCT01917006|75719681|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
41952444|NCT01917006|75719682|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
41952445|NCT01917006|75719683|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
41952446|NCT01917006|75719684|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
41952447|NCT01917006|75719685|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
41952448|NCT01917006|75719686|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
41952449|NCT01917006|75719679|FG000|Randomized-treatment Period|Personal Reasons|0|||
41952450|NCT01917006|75719680|FG001|Randomized-treatment Period|Personal Reasons|0|||
41952451|NCT01917006|75719681|FG002|Randomized-treatment Period|Personal Reasons|0|||
41952452|NCT01917006|75719682|FG003|Randomized-treatment Period|Personal Reasons|0|||
41952453|NCT01917006|75719683|FG004|Randomized-treatment Period|Personal Reasons|0|||
41952454|NCT01917006|75719684|FG005|Randomized-treatment Period|Personal Reasons|1|||
41952455|NCT01917006|75719685|FG006|Randomized-treatment Period|Personal Reasons|0|||
41952456|NCT01917006|75719686|FG007|Randomized-treatment Period|Personal Reasons|0|||
41952457|NCT01917006|75719679|FG000|Randomized-treatment Period|Protocol Violation|1|||
41952458|NCT01917006|75719680|FG001|Randomized-treatment Period|Protocol Violation|0|||
41952459|NCT01917006|75719681|FG002|Randomized-treatment Period|Protocol Violation|0|||
41952460|NCT01917006|75719682|FG003|Randomized-treatment Period|Protocol Violation|0|||
41952461|NCT01917006|75719683|FG004|Randomized-treatment Period|Protocol Violation|0|||
41952462|NCT01917006|75719684|FG005|Randomized-treatment Period|Protocol Violation|0|||
41952463|NCT01917006|75719685|FG006|Randomized-treatment Period|Protocol Violation|0|||
41952464|NCT01917006|75719686|FG007|Randomized-treatment Period|Protocol Violation|0|||
41952465|NCT01917006|75719679|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
41952466|NCT01917006|75719680|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
41952467|NCT01917006|75719681|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
41952468|NCT01917006|75719682|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
41952469|NCT01917006|75719683|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
41952470|NCT01917006|75719684|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
41952471|NCT01917006|75719685|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
41952472|NCT01917006|75719686|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
41952473|NCT01917006|75719679|FG000|Open-label Period|Adverse Event|0|||
41952474|NCT01917006|75719680|FG001|Open-label Period|Adverse Event|0|||
41952475|NCT01917006|75719681|FG002|Open-label Period|Adverse Event|0|||
41952476|NCT01917006|75719682|FG003|Open-label Period|Adverse Event|0|||
41952477|NCT01917006|75719683|FG004|Open-label Period|Adverse Event|0|||
41952478|NCT01917006|75719684|FG005|Open-label Period|Adverse Event|0|||
41952479|NCT01917006|75719685|FG006|Open-label Period|Adverse Event|0|||
41952480|NCT01917006|75719686|FG007|Open-label Period|Adverse Event|1|||
41952481|NCT01917006|75719679|FG000|Open-label Period|Lost to Follow-up|0|||
41952482|NCT01917006|75719680|FG001|Open-label Period|Lost to Follow-up|0|||
41952483|NCT01917006|75719681|FG002|Open-label Period|Lost to Follow-up|0|||
41952484|NCT01917006|75719682|FG003|Open-label Period|Lost to Follow-up|0|||
41952485|NCT01917006|75719683|FG004|Open-label Period|Lost to Follow-up|0|||
41952486|NCT01917006|75719684|FG005|Open-label Period|Lost to Follow-up|0|||
41952487|NCT01917006|75719685|FG006|Open-label Period|Lost to Follow-up|0|||
41952488|NCT01917006|75719686|FG007|Open-label Period|Lost to Follow-up|1|||
41952489|NCT01916304|75719703|FG000|Overall Study|Screening failure|17|||
41952490|NCT01916226|75719711|FG000|Overall Study|Adverse Event|1|||
41952491|NCT01916226|75719712|FG001|Overall Study|Adverse Event|0|||
41952492|NCT01916226|75719713|FG002|Overall Study|Adverse Event|1|||
41952493|NCT01916226|75719714|FG003|Overall Study|Adverse Event|1|||
41952494|NCT01916226|75719711|FG000|Overall Study|Lack of Efficacy|0|||
41952495|NCT01916226|75719712|FG001|Overall Study|Lack of Efficacy|0|||
41952496|NCT01916226|75719713|FG002|Overall Study|Lack of Efficacy|2|||
41952497|NCT01916226|75719714|FG003|Overall Study|Lack of Efficacy|1|||
41952498|NCT01916226|75719711|FG000|Overall Study|Protocol Violation|0|||
41952499|NCT01916226|75719712|FG001|Overall Study|Protocol Violation|1|||
41952500|NCT01916226|75719713|FG002|Overall Study|Protocol Violation|0|||
41952501|NCT01916226|75719714|FG003|Overall Study|Protocol Violation|1|||
41952502|NCT01916226|75719711|FG000|Overall Study|Physician Decision|0|||
41952503|NCT01916226|75719712|FG001|Overall Study|Physician Decision|0|||
41952504|NCT01916226|75719713|FG002|Overall Study|Physician Decision|0|||
41952505|NCT01916226|75719714|FG003|Overall Study|Physician Decision|1|||
41952506|NCT01969500|75719727|FG000|Overall Study|Death|0|||
41952507|NCT01969500|75719728|FG001|Overall Study|Death|1|||
41952508|NCT01969500|75719727|FG000|Overall Study|extended hospitalization|1|||
41952509|NCT01969500|75719728|FG001|Overall Study|extended hospitalization|1|||
41952510|NCT01915914|75719734|FG000|Acute Phase|Withdrawal by Subject|4|||
41952511|NCT01915914|75719735|FG001|Acute Phase|Withdrawal by Subject|0|||
41952512|NCT01915914|75719736|FG002|Acute Phase|Withdrawal by Subject|0|||
41952513|NCT01915914|75719737|FG003|Acute Phase|Withdrawal by Subject|0|||
41952514|NCT01915914|75719734|FG000|Acute Phase|Lost to Follow-up|4|||
41952515|NCT01915914|75719735|FG001|Acute Phase|Lost to Follow-up|0|||
41952516|NCT01915914|75719736|FG002|Acute Phase|Lost to Follow-up|0|||
41952517|NCT01915914|75719737|FG003|Acute Phase|Lost to Follow-up|0|||
41952518|NCT01915914|75719734|FG000|Acute Phase|Physician Decision|1|||
41952519|NCT01915914|75719735|FG001|Acute Phase|Physician Decision|0|||
41952520|NCT01915914|75719736|FG002|Acute Phase|Physician Decision|0|||
41952521|NCT01915914|75719737|FG003|Acute Phase|Physician Decision|0|||
41952522|NCT01915914|75719734|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
41952523|NCT01915914|75719735|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
41952524|NCT01915914|75719736|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
41952525|NCT01915914|75719737|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
41952526|NCT01915914|75719734|FG000|Acute Phase|"Not Achieved treatment success"|1|||
41952527|NCT01915914|75719735|FG001|Acute Phase|"Not Achieved treatment success"|0|||
41952528|NCT01915914|75719736|FG002|Acute Phase|"Not Achieved treatment success"|0|||
41952529|NCT01915914|75719737|FG003|Acute Phase|"Not Achieved treatment success"|0|||
41952530|NCT01915914|75719734|FG000|Acute Phase|Missing|1|||
41952531|NCT01915914|75719735|FG001|Acute Phase|Missing|0|||
41952532|NCT01915914|75719736|FG002|Acute Phase|Missing|0|||
41952533|NCT01915914|75719737|FG003|Acute Phase|Missing|0|||
41952534|NCT01915914|75719734|FG000|Maintenance Phase|Withdrawal by Subject|0|||
41952535|NCT01915914|75719735|FG001|Maintenance Phase|Withdrawal by Subject|1|||
41952536|NCT01915914|75719736|FG002|Maintenance Phase|Withdrawal by Subject|1|||
41952537|NCT01915914|75719737|FG003|Maintenance Phase|Withdrawal by Subject|0|||
41952538|NCT01915914|75719734|FG000|Maintenance Phase|Lost to Follow-up|0|||
41952539|NCT01915914|75719735|FG001|Maintenance Phase|Lost to Follow-up|4|||
41952540|NCT01915914|75719736|FG002|Maintenance Phase|Lost to Follow-up|1|||
41952541|NCT01915914|75719737|FG003|Maintenance Phase|Lost to Follow-up|0|||
41952542|NCT01915914|75719734|FG000|Maintenance Phase|Missing|0|||
41952543|NCT01915914|75719735|FG001|Maintenance Phase|Missing|1|||
41952544|NCT01915914|75719736|FG002|Maintenance Phase|Missing|0|||
41952545|NCT01915914|75719737|FG003|Maintenance Phase|Missing|0|||
41952546|NCT01915914|75719734|FG000|Follow-up Phase|Withdrawal by Subject|0|||
41952547|NCT01915914|75719735|FG001|Follow-up Phase|Withdrawal by Subject|0|||
41952548|NCT01915914|75719736|FG002|Follow-up Phase|Withdrawal by Subject|0|||
41952549|NCT01915914|75719737|FG003|Follow-up Phase|Withdrawal by Subject|1|||
41952550|NCT01915914|75719734|FG000|Follow-up Phase|Physician Decision|0|||
41952551|NCT01915914|75719735|FG001|Follow-up Phase|Physician Decision|0|||
41952552|NCT01915914|75719736|FG002|Follow-up Phase|Physician Decision|0|||
41952553|NCT01915914|75719737|FG003|Follow-up Phase|Physician Decision|1|||
41952554|NCT01919970|75719757|FG000|Overall Study|Withdrawal by Subject|3|||
41952555|NCT01919970|75719758|FG001|Overall Study|Withdrawal by Subject|0|||
41952556|NCT01919814|75719764|FG000|Overall Study|Adverse Event|1|||
41952557|NCT01919814|75719765|FG001|Overall Study|Adverse Event|0|||
41952558|NCT01919814|75719764|FG000|Overall Study|Protocol Violation|1|||
41952559|NCT01919814|75719765|FG001|Overall Study|Protocol Violation|0|||
41952560|NCT01919814|75719764|FG000|Overall Study|Withdrawal by Subject|1|||
41952561|NCT01919814|75719765|FG001|Overall Study|Withdrawal by Subject|0|||
41952562|NCT01968954|75719773|FG000|Overall Study|Adverse Event|6|||
41952563|NCT01968954|75719774|FG001|Overall Study|Adverse Event|3|||
41952564|NCT01968954|75719773|FG000|Overall Study|Death|1|||
41952565|NCT01968954|75719774|FG001|Overall Study|Death|2|||
41952566|NCT01968954|75719773|FG000|Overall Study|Lost to Follow-up|6|||
41952567|NCT01968954|75719774|FG001|Overall Study|Lost to Follow-up|4|||
41952568|NCT01968954|75719773|FG000|Overall Study|Withdrawal by Subject|20|||
41952569|NCT01968954|75719774|FG001|Overall Study|Withdrawal by Subject|23|||
41952570|NCT01968954|75719773|FG000|Overall Study|Other|7|||
41952571|NCT01968954|75719774|FG001|Overall Study|Other|8|||
41952572|NCT01968954|75719773|FG000|Overall Study|Protocol Violation|0|||
41952573|NCT01968954|75719774|FG001|Overall Study|Protocol Violation|1|||
41952574|NCT01968954|75719773|FG000|Overall Study|Did not met inclusion criteria|0|||
41952575|NCT01968954|75719774|FG001|Overall Study|Did not met inclusion criteria|2|||
41952576|NCT01919190|75719783|FG000|Overall Study|Intra-op findings, etc.|3|||
41952577|NCT01919190|75719784|FG001|Overall Study|Intra-op findings, etc.|0|||
41952578|NCT01620060|75719791|FG000|Overall Study|Adverse Event|9|||
41952579|NCT01620060|75719791|FG000|Overall Study|Protocol Violation|1|||
41952580|NCT01620060|75719791|FG000|Overall Study|Withdrawal by Subject|1|||
41952581|NCT01620060|75719791|FG000|Overall Study|Did not comply with Study Produre|1|||
41952582|NCT01620060|75719791|FG000|Overall Study|Family emergency|1|||
41952583|NCT01620060|75719791|FG000|Overall Study|Per Sponsor Decision|2|||
41952584|NCT01914666|75719798|FG000|Treatment Period|Lack of Efficacy|0|||
41952585|NCT01914666|75719799|FG001|Treatment Period|Lack of Efficacy|0|||
41952586|NCT01914666|75719800|FG002|Treatment Period|Lack of Efficacy|2|||
41952587|NCT01914666|75719798|FG000|Treatment Period|Adverse Event|10|||
41952588|NCT01914666|75719799|FG001|Treatment Period|Adverse Event|4|||
41952589|NCT01914666|75719800|FG002|Treatment Period|Adverse Event|2|||
41952590|NCT01914666|75719798|FG000|Treatment Period|Withdrawal by Subject|3|||
41952591|NCT01914666|75719799|FG001|Treatment Period|Withdrawal by Subject|2|||
41952592|NCT01914666|75719800|FG002|Treatment Period|Withdrawal by Subject|2|||
41952593|NCT01914666|75719798|FG000|Treatment Period|Physician Decision|0|||
41952594|NCT01914666|75719799|FG001|Treatment Period|Physician Decision|0|||
41952595|NCT01914666|75719800|FG002|Treatment Period|Physician Decision|2|||
41952596|NCT01913340|75719808|FG000|Overall Study|Death|2|||
41952597|NCT01913340|75719809|FG001|Overall Study|Death|5|||
41952598|NCT01913340|75719808|FG000|Overall Study|Lost to Follow-up|1|||
41952599|NCT01913340|75719809|FG001|Overall Study|Lost to Follow-up|1|||
41952600|NCT01864200|75719817|FG000|Overall Study|Lost to Follow-up|1|||
41952601|NCT01864200|75719818|FG001|Overall Study|Lost to Follow-up|3|||
41952602|NCT01864200|75719817|FG000|Overall Study|Protocol Violation|1|||
41952603|NCT01864200|75719818|FG001|Overall Study|Protocol Violation|0|||
41952604|NCT01912872|75719828|FG000|Overall Study|Lost to Follow-up|2|||
41952605|NCT01912872|75719829|FG001|Overall Study|Lost to Follow-up|3|||
41952606|NCT01912872|75719830|FG002|Overall Study|Lost to Follow-up|5|||
41952607|NCT01912872|75719831|FG003|Overall Study|Lost to Follow-up|5|||
41952608|NCT01912872|75719828|FG000|Overall Study|Other unspecified|3|||
41952609|NCT01912872|75719829|FG001|Overall Study|Other unspecified|1|||
41952610|NCT01912872|75719830|FG002|Overall Study|Other unspecified|3|||
41952611|NCT01912872|75719831|FG003|Overall Study|Other unspecified|0|||
41952612|NCT01912872|75719828|FG000|Overall Study|Informed consent withdrawn|0|||
41952613|NCT01912872|75719829|FG001|Overall Study|Informed consent withdrawn|0|||
41952614|NCT01912872|75719830|FG002|Overall Study|Informed consent withdrawn|1|||
41952615|NCT01912872|75719831|FG003|Overall Study|Informed consent withdrawn|1|||
41952616|NCT01912872|75719828|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
41952617|NCT01912872|75719829|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
41952618|NCT01912872|75719830|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
41952619|NCT01912872|75719831|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
41952620|NCT01912872|75719828|FG000|Overall Study|Protocol Violation|0|||
41952621|NCT01912872|75719829|FG001|Overall Study|Protocol Violation|0|||
41952622|NCT01912872|75719830|FG002|Overall Study|Protocol Violation|1|||
41952623|NCT01912872|75719831|FG003|Overall Study|Protocol Violation|0|||
41952624|NCT01912872|75719828|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
41952625|NCT01912872|75719829|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
41952626|NCT01912872|75719830|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
41952627|NCT01912872|75719831|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
41952628|NCT01912872|75719828|FG000|Overall Study|Withdrawal of study medication|0|||
41952629|NCT01912872|75719829|FG001|Overall Study|Withdrawal of study medication|0|||
41952630|NCT01912872|75719830|FG002|Overall Study|Withdrawal of study medication|0|||
42300431|NCT02546609|76135634|FG002|Overall Study|Protocol Violation|1|||
41952631|NCT01912872|75719831|FG003|Overall Study|Withdrawal of study medication|2|||
41952632|NCT01912872|75719828|FG000|Overall Study|Missing|0|||
41952633|NCT01912872|75719829|FG001|Overall Study|Missing|0|||
41952634|NCT01912872|75719830|FG002|Overall Study|Missing|0|||
41952635|NCT01912872|75719831|FG003|Overall Study|Missing|1|||
41952636|NCT01912404|75719844|FG000|Overall Study|Due to personal reasons|1|||
41952637|NCT01912404|75719845|FG001|Overall Study|Due to personal reasons|0|||
41952638|NCT01911780|75719853|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
42300432|NCT02546609|76135632|FG000|Overall Study|Lost to Follow-up|2|||
41952639|NCT01911780|75719854|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
42300433|NCT02546609|76135633|FG001|Overall Study|Lost to Follow-up|3|||
41952640|NCT01911780|75719853|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
41952641|NCT01911780|75719854|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
41952642|NCT01911780|75719853|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
41952643|NCT01911780|75719854|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
41952644|NCT01911780|75719853|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
41952645|NCT01911780|75719854|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
41952646|NCT01911780|75719853|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
41952647|NCT01911780|75719854|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
41952648|NCT01911780|75719853|FG000|Extension Period (52 Weeks)|Personal reason|1|||
41952649|NCT01911780|75719854|FG001|Extension Period (52 Weeks)|Personal reason|1|||
41952650|NCT01911546|75719864|FG000|Overall Study|Lost to Follow-up|1|||
41952651|NCT01911546|75719864|FG000|Overall Study|Everolimus was discontinued|5|||
41952652|NCT01910298|75719870|FG000|Overall Study|Adverse Event|1|||
41952653|NCT01910298|75719871|FG001|Overall Study|Adverse Event|0|||
41952654|NCT01910298|75719870|FG000|Overall Study|Withdrawal by Subject|2|||
41952655|NCT01910298|75719871|FG001|Overall Study|Withdrawal by Subject|7|||
41952656|NCT01910298|75719870|FG000|Overall Study|Protocol Deviation|0|||
41952657|NCT01910298|75719871|FG001|Overall Study|Protocol Deviation|5|||
41952658|NCT01910298|75719870|FG000|Overall Study|Lost to Follow-up|1|||
41952659|NCT01910298|75719871|FG001|Overall Study|Lost to Follow-up|1|||
41952660|NCT01910298|75719870|FG000|Overall Study|Study Terminated by Sponsor|1|||
41952661|NCT01910298|75719871|FG001|Overall Study|Study Terminated by Sponsor|17|||
41952662|NCT01910298|75719870|FG000|Overall Study|Other Miscellaneous Reasons|0|||
41952663|NCT01910298|75719871|FG001|Overall Study|Other Miscellaneous Reasons|2|||
41952664|NCT01909674|75719879|FG000|Overall Study|Withdrawal by Subject|5|||
41952665|NCT01909674|75719880|FG001|Overall Study|Withdrawal by Subject|2|||
41952666|NCT01908816|75719890|FG000|Overall Study|Subject's no longer requires study drug|0|||
41952667|NCT01908816|75719891|FG001|Overall Study|Subject's no longer requires study drug|0|||
41952668|NCT01908816|75719892|FG002|Overall Study|Subject's no longer requires study drug|0|||
41952669|NCT01908816|75719893|FG003|Overall Study|Subject's no longer requires study drug|1|||
41952670|NCT01908816|75719890|FG000|Overall Study|Protocol deviation|1|||
41952671|NCT01908816|75719891|FG001|Overall Study|Protocol deviation|2|||
41952672|NCT01908816|75719892|FG002|Overall Study|Protocol deviation|1|||
41952673|NCT01908816|75719893|FG003|Overall Study|Protocol deviation|1|||
41952674|NCT01908816|75719890|FG000|Overall Study|Withdrawal by Subject|0|||
41952675|NCT01908816|75719891|FG001|Overall Study|Withdrawal by Subject|4|||
41952676|NCT01908816|75719892|FG002|Overall Study|Withdrawal by Subject|2|||
41952677|NCT01908816|75719893|FG003|Overall Study|Withdrawal by Subject|2|||
41952678|NCT01908816|75719890|FG000|Overall Study|Lost to Follow-up|3|||
41952679|NCT01908816|75719891|FG001|Overall Study|Lost to Follow-up|5|||
41952680|NCT01908816|75719892|FG002|Overall Study|Lost to Follow-up|4|||
41952681|NCT01908816|75719893|FG003|Overall Study|Lost to Follow-up|2|||
41952682|NCT01908816|75719890|FG000|Overall Study|Death|1|||
41952683|NCT01908816|75719891|FG001|Overall Study|Death|0|||
41952684|NCT01908816|75719892|FG002|Overall Study|Death|7|||
41952685|NCT01908816|75719893|FG003|Overall Study|Death|1|||
41952686|NCT01908816|75719890|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
41952687|NCT01908816|75719891|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
41952688|NCT01908816|75719892|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
41952689|NCT01908816|75719893|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
41952690|NCT01908816|75719890|FG000|Overall Study|Early termination|87|||
41952691|NCT01908816|75719891|FG001|Overall Study|Early termination|60|||
41952692|NCT01908816|75719892|FG002|Overall Study|Early termination|43|||
41952693|NCT01908816|75719893|FG003|Overall Study|Early termination|28|||
41952694|NCT01908582|75719906|FG000|Period 2|Physician Decision|1|||
41952695|NCT01908582|75719906|FG000|Period 2|Withdrawal by Subject|1|||
41952696|NCT01908426|75719915|FG000|Overall Study|Adverse Event|98|||
41952697|NCT01908426|75719916|FG001|Overall Study|Adverse Event|11|||
41952698|NCT01908426|75719915|FG000|Overall Study|Clinical Deterioration|72|||
41952699|NCT01908426|75719916|FG001|Overall Study|Clinical Deterioration|38|||
41952700|NCT01908426|75719915|FG000|Overall Study|Lack of Efficacy|3|||
41952701|NCT01908426|75719916|FG001|Overall Study|Lack of Efficacy|0|||
41952702|NCT01908426|75719915|FG000|Overall Study|Lost to Follow-up|0|||
41952703|NCT01908426|75719916|FG001|Overall Study|Lost to Follow-up|1|||
41952704|NCT01908426|75719915|FG000|Overall Study|Physician Decision|3|||
41952705|NCT01908426|75719916|FG001|Overall Study|Physician Decision|3|||
41952706|NCT01908426|75719915|FG000|Overall Study|Withdrawal by Subject|11|||
41952707|NCT01908426|75719916|FG001|Overall Study|Withdrawal by Subject|6|||
41952708|NCT01908426|75719915|FG000|Overall Study|Progressive Disease|206|||
41952709|NCT01908426|75719916|FG001|Overall Study|Progressive Disease|152|||
41952710|NCT01908426|75719915|FG000|Overall Study|Protocol Violation|1|||
41952711|NCT01908426|75719916|FG001|Overall Study|Protocol Violation|0|||
41952712|NCT01908426|75719915|FG000|Overall Study|No Study Treatment Given|3|||
41952713|NCT01908426|75719916|FG001|Overall Study|No Study Treatment Given|0|||
41952714|NCT01907100|75719926|FG000|Overall Study|PD based on modified RECIST criteria|31|||
41952715|NCT01907100|75719927|FG001|Overall Study|PD based on modified RECIST criteria|32|||
41952716|NCT01907100|75719928|FG002|Overall Study|PD based on modified RECIST criteria|95|||
41952717|NCT01907100|75719929|FG003|Overall Study|PD based on modified RECIST criteria|92|||
41952718|NCT01907100|75719926|FG000|Overall Study|Withdrawal by Subject|2|||
41952719|NCT01907100|75719927|FG001|Overall Study|Withdrawal by Subject|5|||
41952720|NCT01907100|75719928|FG002|Overall Study|Withdrawal by Subject|10|||
41952721|NCT01907100|75719929|FG003|Overall Study|Withdrawal by Subject|13|||
41952722|NCT01907100|75719926|FG000|Overall Study|Protocol Violation|0|||
41952723|NCT01907100|75719927|FG001|Overall Study|Protocol Violation|0|||
41952724|NCT01907100|75719928|FG002|Overall Study|Protocol Violation|1|||
41952725|NCT01907100|75719929|FG003|Overall Study|Protocol Violation|1|||
41952726|NCT01907100|75719926|FG000|Overall Study|Lost to Follow-up|0|||
41952727|NCT01907100|75719927|FG001|Overall Study|Lost to Follow-up|0|||
41952728|NCT01907100|75719928|FG002|Overall Study|Lost to Follow-up|0|||
41952729|NCT01907100|75719929|FG003|Overall Study|Lost to Follow-up|1|||
41952730|NCT01907100|75719926|FG000|Overall Study|Not treated|2|||
41952731|NCT01907100|75719927|FG001|Overall Study|Not treated|0|||
41952732|NCT01907100|75719928|FG002|Overall Study|Not treated|1|||
41952733|NCT01907100|75719929|FG003|Overall Study|Not treated|2|||
41952734|NCT01907100|75719926|FG000|Overall Study|Other than reasons specified|1|||
41952735|NCT01907100|75719927|FG001|Overall Study|Other than reasons specified|0|||
41952736|NCT01907100|75719928|FG002|Overall Study|Other than reasons specified|10|||
41952737|NCT01907100|75719929|FG003|Overall Study|Other than reasons specified|6|||
41952738|NCT01907100|75719926|FG000|Overall Study|Adverse event (AE)|6|||
41952739|NCT01907100|75719927|FG001|Overall Study|Adverse event (AE)|3|||
41952740|NCT01907100|75719928|FG002|Overall Study|Adverse event (AE)|22|||
41952741|NCT01907100|75719929|FG003|Overall Study|Adverse event (AE)|23|||
41952742|NCT01907100|75719926|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
41952743|NCT01907100|75719927|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
41952744|NCT01907100|75719928|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
41952745|NCT01907100|75719929|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
41952746|NCT01889862|75719937|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
41952747|NCT01889862|75719938|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
41952748|NCT01889862|75719939|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
41952749|NCT01889862|75719940|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
41952750|NCT01889862|75719941|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
41952751|NCT01889862|75719937|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
41952752|NCT01889862|75719938|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
41952753|NCT01889862|75719939|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
41952754|NCT01889862|75719940|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
41952755|NCT01889862|75719941|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
41952756|NCT01889862|75719937|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
41952757|NCT01889862|75719938|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
41952758|NCT01889862|75719939|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
41952759|NCT01889862|75719940|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
41952760|NCT01889862|75719941|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
41952761|NCT01889862|75719937|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
41952762|NCT01889862|75719938|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
41952763|NCT01889862|75719939|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
41952764|NCT01889862|75719940|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
41952765|NCT01889862|75719941|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
41952766|NCT01889862|75719937|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
41952767|NCT01889862|75719938|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
41952768|NCT01889862|75719939|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
41952769|NCT01889862|75719940|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
41952770|NCT01889862|75719941|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
41952771|NCT01889862|75719937|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
41952772|NCT01889862|75719938|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
41952773|NCT01889862|75719939|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
41952774|NCT01889862|75719940|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
41952775|NCT01889862|75719941|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
41952776|NCT01889862|75719937|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
41952777|NCT01889862|75719938|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
41952778|NCT01889862|75719939|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
41952779|NCT01889862|75719940|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
41952780|NCT01889862|75719941|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
41952781|NCT01889862|75719937|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
41952782|NCT01889862|75719938|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
41952783|NCT01889862|75719939|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
41952784|NCT01889862|75719940|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
41952785|NCT01889862|75719941|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
41952786|NCT01889862|75719937|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
41952787|NCT01889862|75719938|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
41952788|NCT01889862|75719939|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
41952789|NCT01889862|75719940|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
41952790|NCT01889862|75719941|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
41952791|NCT01889862|75719937|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
41952792|NCT01889862|75719938|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
41952793|NCT01889862|75719939|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
41952794|NCT01889862|75719940|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
41952795|NCT01889862|75719941|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
41952796|NCT01887912|75719968|FG000|Overall Study|Serious adverse event|400|||
41952797|NCT01887912|75719969|FG001|Overall Study|Serious adverse event|198|||
41952798|NCT01887912|75719968|FG000|Overall Study|Other Adverse Event|34|||
41952799|NCT01887912|75719969|FG001|Overall Study|Other Adverse Event|15|||
41952800|NCT01887912|75719968|FG000|Overall Study|Protocol Violation|67|||
41952801|NCT01887912|75719969|FG001|Overall Study|Protocol Violation|37|||
41952802|NCT01887912|75719968|FG000|Overall Study|Lost to Follow-up|163|||
41952803|NCT01887912|75719969|FG001|Overall Study|Lost to Follow-up|74|||
41952804|NCT01887912|75719968|FG000|Overall Study|Withdrawal by Subject|606|||
41952805|NCT01887912|75719969|FG001|Overall Study|Withdrawal by Subject|349|||
41952806|NCT01887912|75719968|FG000|Overall Study|Other|122|||
41952807|NCT01887912|75719969|FG001|Overall Study|Other|58|||
41952808|NCT01887678|75719977|FG000|Overall Study|Adverse Event|4|||
41952809|NCT01887678|75719978|FG001|Overall Study|Adverse Event|6|||
41952810|NCT01887678|75719977|FG000|Overall Study|Exceeded rescue medication dosage|4|||
41952811|NCT01887678|75719978|FG001|Overall Study|Exceeded rescue medication dosage|5|||
41952812|NCT01887678|75719977|FG000|Overall Study|Withdrawal of consent|3|||
41952813|NCT01887678|75719978|FG001|Overall Study|Withdrawal of consent|4|||
41952814|NCT01887678|75719977|FG000|Overall Study|Lost to Follow-up|4|||
41952815|NCT01887678|75719978|FG001|Overall Study|Lost to Follow-up|2|||
41952816|NCT01887678|75719977|FG000|Overall Study|Deterioration of clinical condition|0|||
41952817|NCT01887678|75719978|FG001|Overall Study|Deterioration of clinical condition|4|||
41952818|NCT01887678|75719977|FG000|Overall Study|Lack of Efficacy|1|||
41952819|NCT01887678|75719978|FG001|Overall Study|Lack of Efficacy|2|||
41952820|NCT01887678|75719977|FG000|Overall Study|Non-compliance|0|||
41952821|NCT01887678|75719978|FG001|Overall Study|Non-compliance|3|||
41952822|NCT01887678|75719977|FG000|Overall Study|Specified|1|||
41952823|NCT01887678|75719978|FG001|Overall Study|Specified|2|||
41952824|NCT01887600|75719986|FG000|Overall Study|Death|39|||
41952825|NCT01887600|75719987|FG001|Overall Study|Death|16|||
41952826|NCT01887600|75719986|FG000|Overall Study|Lack of Efficacy|3|||
41952827|NCT01887600|75719987|FG001|Overall Study|Lack of Efficacy|26|||
41952828|NCT01887600|75719986|FG000|Overall Study|Lost to Follow-up|5|||
41952829|NCT01887600|75719987|FG001|Overall Study|Lost to Follow-up|1|||
41952830|NCT01887600|75719986|FG000|Overall Study|Physician Decision|7|||
41952831|NCT01887600|75719987|FG001|Overall Study|Physician Decision|8|||
41952832|NCT01887600|75719986|FG000|Overall Study|Protocol Deviation|3|||
41952833|NCT01887600|75719987|FG001|Overall Study|Protocol Deviation|0|||
41952834|NCT01887600|75719986|FG000|Overall Study|Withdrawal by Subject|58|||
41952835|NCT01887600|75719987|FG001|Overall Study|Withdrawal by Subject|52|||
41952836|NCT01887600|75719986|FG000|Overall Study|Adverse Event|21|||
41952837|NCT01887600|75719987|FG001|Overall Study|Adverse Event|9|||
41952838|NCT01887600|75719986|FG000|Overall Study|Non-compliance with study drug|3|||
41952839|NCT01887600|75719987|FG001|Overall Study|Non-compliance with study drug|0|||
41952840|NCT01887600|75719986|FG000|Overall Study|Miscellaneous|6|||
41952841|NCT01887600|75719987|FG001|Overall Study|Miscellaneous|2|||
41952842|NCT01887600|75719986|FG000|Overall Study|Progressive Disease|1|||
41952843|NCT01887600|75719987|FG001|Overall Study|Progressive Disease|0|||
41952844|NCT01887288|75719994|FG000|Overall Study|The study was terminated and the PI has|16|||
41952845|NCT01887210|75720000|FG000|Overall Study|Withdrawal by Subject|1|||
41952846|NCT01887210|75720001|FG001|Overall Study|Withdrawal by Subject|3|||
41952847|NCT01887210|75720000|FG000|Overall Study|Lost to Follow-up|0|||
41952848|NCT01887210|75720001|FG001|Overall Study|Lost to Follow-up|1|||
41952849|NCT01885182|75720032|FG000|Overall Study|Adverse Event|11|||
41952850|NCT01885182|75720033|FG001|Overall Study|Adverse Event|13|||
41952851|NCT01885182|75720032|FG000|Overall Study|Withdrawal by Subject|13|||
41952852|NCT01885182|75720033|FG001|Overall Study|Withdrawal by Subject|6|||
41952853|NCT01885182|75720032|FG000|Overall Study|Lost to Follow-up|2|||
41952854|NCT01885182|75720033|FG001|Overall Study|Lost to Follow-up|2|||
41952855|NCT01885182|75720032|FG000|Overall Study|Lack of Efficacy|8|||
41952856|NCT01885182|75720033|FG001|Overall Study|Lack of Efficacy|1|||
41952857|NCT01885104|75720043|FG000|Overall Study|Withdrawal of Consent|1|||
41952858|NCT01885104|75720044|FG001|Overall Study|Withdrawal of Consent|0|||
41952859|NCT01885104|75720043|FG000|Overall Study|Lost to Follow-up|0|||
41952860|NCT01885104|75720044|FG001|Overall Study|Lost to Follow-up|1|||
41952861|NCT01885104|75720043|FG000|Overall Study|Physician Decision|1|||
41952862|NCT01885104|75720044|FG001|Overall Study|Physician Decision|0|||
41952863|NCT01881750|75720052|FG000|Overall Study|Changes in concomitant therapies|2|||
41952864|NCT01881750|75720053|FG001|Overall Study|Changes in concomitant therapies|3|||
41952865|NCT01881750|75720052|FG000|Overall Study|Lost to Follow-up|0|||
41952866|NCT01881750|75720053|FG001|Overall Study|Lost to Follow-up|1|||
41952867|NCT01906008|75720063|FG000|Overall Study|Lost to Follow-up|2|||
41952868|NCT01906008|75720064|FG001|Overall Study|Lost to Follow-up|0|||
41952869|NCT01906008|75720063|FG000|Overall Study|Oxaliplatin toxicity|2|||
41952870|NCT01906008|75720064|FG001|Overall Study|Oxaliplatin toxicity|0|||
41952871|NCT01906008|75720063|FG000|Overall Study|Protocol Violation|0|||
41952872|NCT01906008|75720064|FG001|Overall Study|Protocol Violation|1|||
41952873|NCT01906008|75720063|FG000|Overall Study|Withdrawal by Subject|1|||
41952874|NCT01906008|75720064|FG001|Overall Study|Withdrawal by Subject|5|||
41952875|NCT01906008|75720063|FG000|Overall Study|Did not start study med|3|||
41952876|NCT01906008|75720064|FG001|Overall Study|Did not start study med|4|||
41952877|NCT01906008|75720063|FG000|Overall Study|Oxaliplatin stops|10|||
41952878|NCT01906008|75720064|FG001|Overall Study|Oxaliplatin stops|8|||
41952879|NCT01906008|75720063|FG000|Overall Study|Hospice|1|||
41952880|NCT01906008|75720064|FG001|Overall Study|Hospice|0|||
41952881|NCT01906008|75720063|FG000|Overall Study|Physician Decision|3|||
41952882|NCT01906008|75720064|FG001|Overall Study|Physician Decision|3|||
41952883|NCT01906008|75720063|FG000|Overall Study|Lack of compliance of study med|5|||
41952884|NCT01906008|75720064|FG001|Overall Study|Lack of compliance of study med|3|||
41952885|NCT01906008|75720063|FG000|Overall Study|Adverse Event|0|||
41952886|NCT01906008|75720064|FG001|Overall Study|Adverse Event|3|||
41952887|NCT01863732|75720074|FG000|Overall Study|Adverse Event|2|||
41952888|NCT01863732|75720075|FG001|Overall Study|Adverse Event|0|||
41952889|NCT01863732|75720076|FG002|Overall Study|Adverse Event|3|||
41952890|NCT01863732|75720077|FG003|Overall Study|Adverse Event|3|||
41952891|NCT01863732|75720074|FG000|Overall Study|Lack of Efficacy|1|||
41952892|NCT01863732|75720075|FG001|Overall Study|Lack of Efficacy|0|||
41952893|NCT01863732|75720076|FG002|Overall Study|Lack of Efficacy|2|||
41952894|NCT01863732|75720077|FG003|Overall Study|Lack of Efficacy|1|||
41952895|NCT01863732|75720074|FG000|Overall Study|Lost to Follow-up|2|||
41952896|NCT01863732|75720075|FG001|Overall Study|Lost to Follow-up|2|||
41952897|NCT01863732|75720076|FG002|Overall Study|Lost to Follow-up|1|||
41952898|NCT01863732|75720077|FG003|Overall Study|Lost to Follow-up|1|||
41952899|NCT01863732|75720074|FG000|Overall Study|Physician Decision|1|||
41952900|NCT01863732|75720075|FG001|Overall Study|Physician Decision|0|||
41952901|NCT01863732|75720076|FG002|Overall Study|Physician Decision|1|||
41952902|NCT01863732|75720077|FG003|Overall Study|Physician Decision|0|||
41952903|NCT01863732|75720074|FG000|Overall Study|Pregnancy|0|||
41952904|NCT01863732|75720075|FG001|Overall Study|Pregnancy|0|||
41952905|NCT01863732|75720076|FG002|Overall Study|Pregnancy|0|||
41952906|NCT01863732|75720077|FG003|Overall Study|Pregnancy|1|||
41952907|NCT01863732|75720074|FG000|Overall Study|Technical problems|0|||
41952908|NCT01863732|75720075|FG001|Overall Study|Technical problems|1|||
41952909|NCT01863732|75720076|FG002|Overall Study|Technical problems|1|||
41952910|NCT01863732|75720077|FG003|Overall Study|Technical problems|0|||
41952911|NCT01863732|75720074|FG000|Overall Study|Subject/guardian decision|6|||
41952912|NCT01863732|75720075|FG001|Overall Study|Subject/guardian decision|9|||
41952913|NCT01863732|75720076|FG002|Overall Study|Subject/guardian decision|3|||
41952914|NCT01863732|75720077|FG003|Overall Study|Subject/guardian decision|1|||
41952915|NCT01863732|75720074|FG000|Overall Study|Death|1|||
41952916|NCT01863732|75720075|FG001|Overall Study|Death|0|||
41952917|NCT01863732|75720076|FG002|Overall Study|Death|0|||
41952918|NCT01863732|75720077|FG003|Overall Study|Death|1|||
41952919|NCT01905540|75720090|FG000|Period 3|Other|1|||
41952920|NCT01905540|75720091|FG001|Period 3|Other|0|||
41952921|NCT01905540|75720092|FG002|Period 3|Other|1|||
41952922|NCT01905540|75720093|FG003|Period 3|Other|1|||
41952923|NCT01904760|75720105|FG000|Overall Study|Protocol Violation|1|||
41952924|NCT01904760|75720106|FG001|Overall Study|Protocol Violation|0|||
41952925|NCT01904604|75720115|FG000|Overall Study|Withdrew before receiving dosing|0|||
41952926|NCT01904604|75720116|FG001|Overall Study|Withdrew before receiving dosing|1|||
41952927|NCT01904604|75720117|FG002|Overall Study|Withdrew before receiving dosing|0|||
41952928|NCT01904604|75720115|FG000|Overall Study|Non-compliance|1|||
41952929|NCT01904604|75720116|FG001|Overall Study|Non-compliance|0|||
41952930|NCT01904604|75720117|FG002|Overall Study|Non-compliance|0|||
41952931|NCT01904604|75720115|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
41952932|NCT01904604|75720116|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
41952933|NCT01904604|75720117|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
41952934|NCT01904604|75720115|FG000|Overall Study|Patch site reactions|1|||
41952935|NCT01904604|75720116|FG001|Overall Study|Patch site reactions|1|||
41952936|NCT01904604|75720117|FG002|Overall Study|Patch site reactions|0|||
41952937|NCT01904604|75720115|FG000|Overall Study|Increased syncope|0|||
41952938|NCT01904604|75720116|FG001|Overall Study|Increased syncope|1|||
41952939|NCT01904604|75720117|FG002|Overall Study|Increased syncope|0|||
41952940|NCT01904604|75720115|FG000|Overall Study|Unrelated illness|0|||
42300434|NCT02546609|76135634|FG002|Overall Study|Lost to Follow-up|1|||
41952941|NCT01904604|75720116|FG001|Overall Study|Unrelated illness|1|||
41952942|NCT01904604|75720117|FG002|Overall Study|Unrelated illness|0|||
41952943|NCT01904604|75720115|FG000|Overall Study|Passed Week 52 OFC|1|||
41952944|NCT01904604|75720116|FG001|Overall Study|Passed Week 52 OFC|0|||
41952945|NCT01904604|75720117|FG002|Overall Study|Passed Week 52 OFC|0|||
41952946|NCT01904604|75720115|FG000|Overall Study|Withdrawal by Subject|1|||
41952947|NCT01904604|75720116|FG001|Overall Study|Withdrawal by Subject|2|||
41952948|NCT01904604|75720117|FG002|Overall Study|Withdrawal by Subject|0|||
41952949|NCT01904604|75720115|FG000|Overall Study|Participant Relocated|1|||
41952950|NCT01904604|75720116|FG001|Overall Study|Participant Relocated|1|||
41952951|NCT01904604|75720117|FG002|Overall Study|Participant Relocated|1|||
41952952|NCT01904604|75720115|FG000|Overall Study|Lost to Follow-up|0|||
41952953|NCT01904604|75720116|FG001|Overall Study|Lost to Follow-up|0|||
41952954|NCT01904604|75720117|FG002|Overall Study|Lost to Follow-up|1|||
41952955|NCT01904058|75720132|FG000|Overall Study|Adverse Event|2|||
41952956|NCT01904058|75720133|FG001|Overall Study|Adverse Event|0|||
41952957|NCT01904058|75720134|FG002|Overall Study|Adverse Event|0|||
41952958|NCT01904058|75720135|FG003|Overall Study|Adverse Event|0|||
41952959|NCT01904058|75720132|FG000|Overall Study|Withdrawal by Subject|1|||
41952960|NCT01904058|75720133|FG001|Overall Study|Withdrawal by Subject|0|||
41952961|NCT01904058|75720134|FG002|Overall Study|Withdrawal by Subject|1|||
41952962|NCT01904058|75720135|FG003|Overall Study|Withdrawal by Subject|0|||
41952963|NCT01904058|75720132|FG000|Overall Study|Pregnancy|0|||
41952964|NCT01904058|75720133|FG001|Overall Study|Pregnancy|0|||
41952965|NCT01904058|75720134|FG002|Overall Study|Pregnancy|0|||
41952966|NCT01904058|75720135|FG003|Overall Study|Pregnancy|1|||
41952967|NCT01881126|75720153|FG000|Overall Study|Non-compliance|1|||
41952968|NCT01881126|75720154|FG001|Overall Study|Non-compliance|1|||
41952969|NCT01881126|75720153|FG000|Overall Study|Adverse Event|0|||
41952970|NCT01881126|75720154|FG001|Overall Study|Adverse Event|1|||
41952971|NCT01614600|75720160|FG000|Overall Study|Unacceptable fit|1|||
41952972|NCT01614600|75720160|FG000|Overall Study|Discomfort|1|||
41952973|NCT01614600|75720160|FG000|Overall Study|Unable to remove lens at the end of day|1|||
41952974|NCT01614600|75720160|FG000|Overall Study|Protocol deviation|1|||
41952975|NCT01880736|75720168|FG000|Overall Study|Adverse Event|0|||
41952976|NCT01880736|75720169|FG001|Overall Study|Adverse Event|0|||
41952977|NCT01880736|75720170|FG002|Overall Study|Adverse Event|0|||
41952978|NCT01880736|75720171|FG003|Overall Study|Adverse Event|1|||
41952979|NCT01880736|75720168|FG000|Overall Study|Withdrawal Criteria|1|||
41952980|NCT01880736|75720169|FG001|Overall Study|Withdrawal Criteria|2|||
41952981|NCT01880736|75720170|FG002|Overall Study|Withdrawal Criteria|1|||
41952982|NCT01880736|75720171|FG003|Overall Study|Withdrawal Criteria|5|||
41952983|NCT01880424|75720183|FG000|Overall Study|Adverse Event|7|||
41952984|NCT01880424|75720184|FG001|Overall Study|Adverse Event|6|||
41952985|NCT01880424|75720183|FG000|Overall Study|Lack of Efficacy|1|||
41952986|NCT01880424|75720184|FG001|Overall Study|Lack of Efficacy|4|||
41952987|NCT01880424|75720183|FG000|Overall Study|Lost to Follow-up|3|||
41952988|NCT01880424|75720184|FG001|Overall Study|Lost to Follow-up|2|||
41952989|NCT01880424|75720183|FG000|Overall Study|Protocol Violation|11|||
41952990|NCT01880424|75720184|FG001|Overall Study|Protocol Violation|13|||
41952991|NCT01880424|75720183|FG000|Overall Study|Withdrawal by Subject|10|||
41952992|NCT01880424|75720184|FG001|Overall Study|Withdrawal by Subject|30|||
41952993|NCT01880424|75720183|FG000|Overall Study|Other|1|||
41952994|NCT01880424|75720184|FG001|Overall Study|Other|0|||
41952995|NCT01862874|75720192|FG000|Overall Study|Randomized not treated|1|||
41952996|NCT01862874|75720193|FG001|Overall Study|Randomized not treated|0|||
41952997|NCT01862874|75720192|FG000|Overall Study|Adverse Event|0|||
41952998|NCT01862874|75720193|FG001|Overall Study|Adverse Event|3|||
41952999|NCT01862874|75720192|FG000|Overall Study|Lost to Follow-up|26|||
41953000|NCT01862874|75720193|FG001|Overall Study|Lost to Follow-up|29|||
41953001|NCT01862874|75720192|FG000|Overall Study|Physician Decision|5|||
41953002|NCT01862874|75720193|FG001|Overall Study|Physician Decision|3|||
41953003|NCT01862874|75720192|FG000|Overall Study|Withdrawn by parent/guardian|1|||
41953004|NCT01862874|75720193|FG001|Overall Study|Withdrawn by parent/guardian|1|||
41953005|NCT01862874|75720192|FG000|Overall Study|Withdrawal by Subject|46|||
41953006|NCT01862874|75720193|FG001|Overall Study|Withdrawal by Subject|40|||
41953007|NCT01862874|75720192|FG000|Overall Study|Death|0|||
41953008|NCT01862874|75720193|FG001|Overall Study|Death|1|||
41953009|NCT01879722|75720209|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
41953010|NCT01879722|75720210|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
41953011|NCT01879722|75720211|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
41953012|NCT01879722|75720212|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
41953013|NCT01879722|75720213|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
41953014|NCT01879722|75720214|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
41953015|NCT01879722|75720215|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
41953016|NCT01879722|75720216|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
41953017|NCT01879722|75720217|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
41953018|NCT01879722|75720218|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
41953019|NCT01879722|75720209|FG000|Overall Study|Voluntary Withdrawal|0|||
41953020|NCT01879722|75720210|FG001|Overall Study|Voluntary Withdrawal|0|||
41953021|NCT01879722|75720211|FG002|Overall Study|Voluntary Withdrawal|0|||
41953022|NCT01879722|75720212|FG003|Overall Study|Voluntary Withdrawal|0|||
41953023|NCT01879722|75720213|FG004|Overall Study|Voluntary Withdrawal|0|||
41953024|NCT01879722|75720214|FG005|Overall Study|Voluntary Withdrawal|0|||
41953025|NCT01879722|75720215|FG006|Overall Study|Voluntary Withdrawal|0|||
41953026|NCT01879722|75720216|FG007|Overall Study|Voluntary Withdrawal|0|||
41953027|NCT01879722|75720217|FG008|Overall Study|Voluntary Withdrawal|1|||
41953028|NCT01879722|75720218|FG009|Overall Study|Voluntary Withdrawal|0|||
41953029|NCT01879410|75720245|FG000|Overall Study|Adverse Event|9|||
41953030|NCT01879410|75720246|FG001|Overall Study|Adverse Event|14|||
41953031|NCT01879410|75720245|FG000|Overall Study|Lack of Efficacy|4|||
41953032|NCT01879410|75720246|FG001|Overall Study|Lack of Efficacy|6|||
41953033|NCT01879410|75720245|FG000|Overall Study|Protocol Violation|1|||
41953034|NCT01879410|75720246|FG001|Overall Study|Protocol Violation|7|||
41953035|NCT01879410|75720245|FG000|Overall Study|Lost to Follow-up|2|||
41953036|NCT01879410|75720246|FG001|Overall Study|Lost to Follow-up|1|||
41953037|NCT01879410|75720245|FG000|Overall Study|Withdrawal by Subject|7|||
41953038|NCT01879410|75720246|FG001|Overall Study|Withdrawal by Subject|8|||
41953039|NCT01879410|75720245|FG000|Overall Study|Randomised in Error|1|||
41953040|NCT01879410|75720246|FG001|Overall Study|Randomised in Error|2|||
41953041|NCT01903434|75720252|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
41953042|NCT01903434|75720253|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
41953043|NCT01903434|75720252|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
41953044|NCT01903434|75720253|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
41953045|NCT01903356|75720259|FG000|Overall Study|Lost to Follow-up|7|||
41953046|NCT01903356|75720259|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
41953047|NCT01903356|75720259|FG000|Overall Study|Violated the dosage and administration|3|||
41953048|NCT01862796|75720266|FG000|Overall Study|Prohibited medications|0|||
41953049|NCT01862796|75720267|FG001|Overall Study|Prohibited medications|0|||
41953050|NCT01862796|75720268|FG002|Overall Study|Prohibited medications|1|||
41953051|NCT01878084|75720276|FG000|Overall Study|Physician Decision|2|||
41953052|NCT01862640|75720285|FG000|Overall Study|Adverse Event|4|||
41953053|NCT01862640|75720286|FG001|Overall Study|Adverse Event|10|||
41953054|NCT01862640|75720287|FG002|Overall Study|Adverse Event|6|||
41953055|NCT01862640|75720288|FG003|Overall Study|Adverse Event|8|||
41953056|NCT01862640|75720285|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
41953057|NCT01862640|75720286|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
41953058|NCT01862640|75720287|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
41953059|NCT01862640|75720288|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
41953060|NCT01862640|75720285|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
41953061|NCT01862640|75720286|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
41953062|NCT01862640|75720287|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
41953063|NCT01862640|75720288|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
41953064|NCT01862640|75720285|FG000|Overall Study|Withdrawal by Subject|2|||
41953065|NCT01862640|75720286|FG001|Overall Study|Withdrawal by Subject|4|||
41953066|NCT01862640|75720287|FG002|Overall Study|Withdrawal by Subject|8|||
41953067|NCT01862640|75720288|FG003|Overall Study|Withdrawal by Subject|5|||
41953068|NCT01862640|75720285|FG000|Overall Study|Protocol Deviation|0|||
41953069|NCT01862640|75720286|FG001|Overall Study|Protocol Deviation|0|||
41953070|NCT01862640|75720287|FG002|Overall Study|Protocol Deviation|1|||
41953071|NCT01862640|75720288|FG003|Overall Study|Protocol Deviation|0|||
41953072|NCT01902966|75720297|FG000|Overall Study|Death|1|||
41953073|NCT01902966|75720297|FG000|Overall Study|Physician Decision|1|||
41953074|NCT01902966|75720297|FG000|Overall Study|Withdrawal by Subject|1|||
41953075|NCT01862484|75720303|FG000|Overall Study|Lack of Efficacy|1|||
41953076|NCT01862484|75720304|FG001|Overall Study|Lack of Efficacy|1|||
41953077|NCT01862484|75720303|FG000|Overall Study|Lost to Follow-up|1|||
41953078|NCT01862484|75720304|FG001|Overall Study|Lost to Follow-up|2|||
41953079|NCT01862484|75720303|FG000|Overall Study|Protocol Violation|0|||
41953080|NCT01862484|75720304|FG001|Overall Study|Protocol Violation|2|||
41953081|NCT01862484|75720303|FG000|Overall Study|Withdrawal by Subject|0|||
41953082|NCT01862484|75720304|FG001|Overall Study|Withdrawal by Subject|3|||
41953083|NCT01902888|75720310|FG000|Overall Study|Study Terminated|3|||
41953084|NCT01862328|75720321|FG000|Overall Study|Progressive Disease|3|||
41953085|NCT01862328|75720322|FG001|Overall Study|Progressive Disease|11|||
41953086|NCT01862328|75720323|FG002|Overall Study|Progressive Disease|5|||
41953087|NCT01862328|75720324|FG003|Overall Study|Progressive Disease|6|||
41953088|NCT01862328|75720325|FG004|Overall Study|Progressive Disease|7|||
41953089|NCT01862328|75720326|FG005|Overall Study|Progressive Disease|4|||
41953090|NCT01862328|75720327|FG006|Overall Study|Progressive Disease|3|||
41953091|NCT01862328|75720321|FG000|Overall Study|Adverse Event|0|||
41953092|NCT01862328|75720322|FG001|Overall Study|Adverse Event|4|||
41953093|NCT01862328|75720323|FG002|Overall Study|Adverse Event|0|||
41953094|NCT01862328|75720324|FG003|Overall Study|Adverse Event|1|||
41953095|NCT01862328|75720325|FG004|Overall Study|Adverse Event|0|||
41953096|NCT01862328|75720326|FG005|Overall Study|Adverse Event|2|||
41953097|NCT01862328|75720327|FG006|Overall Study|Adverse Event|4|||
41953098|NCT01862328|75720321|FG000|Overall Study|Other|0|||
41953099|NCT01862328|75720322|FG001|Overall Study|Other|2|||
41953100|NCT01862328|75720323|FG002|Overall Study|Other|1|||
41953101|NCT01862328|75720324|FG003|Overall Study|Other|0|||
41953102|NCT01862328|75720325|FG004|Overall Study|Other|4|||
41953103|NCT01862328|75720326|FG005|Overall Study|Other|0|||
41953104|NCT01862328|75720327|FG006|Overall Study|Other|1|||
41953105|NCT01862328|75720321|FG000|Overall Study|Withdrawal by Subject|1|||
41953106|NCT01862328|75720322|FG001|Overall Study|Withdrawal by Subject|1|||
41953107|NCT01862328|75720323|FG002|Overall Study|Withdrawal by Subject|0|||
41953108|NCT01862328|75720324|FG003|Overall Study|Withdrawal by Subject|0|||
41953109|NCT01862328|75720325|FG004|Overall Study|Withdrawal by Subject|1|||
41953110|NCT01862328|75720326|FG005|Overall Study|Withdrawal by Subject|1|||
41953111|NCT01862328|75720327|FG006|Overall Study|Withdrawal by Subject|1|||
41953112|NCT01862328|75720321|FG000|Overall Study|Symptomatic Deterioration|0|||
41953113|NCT01862328|75720322|FG001|Overall Study|Symptomatic Deterioration|0|||
41953114|NCT01862328|75720323|FG002|Overall Study|Symptomatic Deterioration|0|||
41953115|NCT01862328|75720324|FG003|Overall Study|Symptomatic Deterioration|0|||
41953116|NCT01862328|75720325|FG004|Overall Study|Symptomatic Deterioration|0|||
41953117|NCT01862328|75720326|FG005|Overall Study|Symptomatic Deterioration|0|||
41953118|NCT01862328|75720327|FG006|Overall Study|Symptomatic Deterioration|1|||
41953119|NCT01862250|75720349|FG000|Overall Study|Adverse Event|4|||
41953120|NCT01860846|75720353|FG000|Overall Study|Lost to Follow-up|33|||
41953121|NCT01901874|75720357|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
41953122|NCT01901874|75720357|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
41953123|NCT01901874|75720357|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
41953124|NCT01901874|75720357|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
41953125|NCT01901874|75720357|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
41953126|NCT01901874|75720357|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
41953127|NCT01860534|75720363|FG000|ROP #1|Needed treatment for ROP|0|||
41953128|NCT01860534|75720364|FG001|ROP #1|Needed treatment for ROP|1|||
41953129|NCT01860534|75720363|FG000|ROP #2|discharged prior to ROP #2|1|||
41953130|NCT01860534|75720364|FG001|ROP #2|discharged prior to ROP #2|0|||
41953131|NCT01901328|75720374|FG000|Overall Study|Lost to Follow-up|1|||
41953132|NCT01901328|75720375|FG001|Overall Study|Lost to Follow-up|0|||
41953133|NCT01901328|75720374|FG000|Overall Study|Physician Decision|0|||
41953134|NCT01901328|75720375|FG001|Overall Study|Physician Decision|1|||
41953135|NCT01901328|75720374|FG000|Overall Study|Protocol Violation|1|||
41953136|NCT01901328|75720375|FG001|Overall Study|Protocol Violation|1|||
41953137|NCT01901328|75720374|FG000|Overall Study|Study Terminated by Sponsor|19|||
41953138|NCT01901328|75720375|FG001|Overall Study|Study Terminated by Sponsor|16|||
41953139|NCT01901328|75720374|FG000|Overall Study|Withdrawal by Subject|1|||
41953140|NCT01901328|75720375|FG001|Overall Study|Withdrawal by Subject|2|||
41953141|NCT01901328|75720374|FG000|Overall Study|Lack of Efficacy|0|||
41953142|NCT01901328|75720375|FG001|Overall Study|Lack of Efficacy|1|||
41953143|NCT01859988|75720388|FG000|Overall Study|Withdrawal by Subject|6|||
41953144|NCT01859988|75720389|FG001|Overall Study|Withdrawal by Subject|3|||
41953145|NCT01859988|75720390|FG002|Overall Study|Withdrawal by Subject|4|||
41953146|NCT01859988|75720391|FG003|Overall Study|Withdrawal by Subject|3|||
41953147|NCT01859988|75720392|FG004|Overall Study|Withdrawal by Subject|2|||
41953148|NCT01859988|75720393|FG005|Overall Study|Withdrawal by Subject|2|||
41953149|NCT01859988|75720388|FG000|Overall Study|Lack of Efficacy|1|||
41953150|NCT01859988|75720389|FG001|Overall Study|Lack of Efficacy|1|||
41953151|NCT01859988|75720390|FG002|Overall Study|Lack of Efficacy|5|||
41953152|NCT01859988|75720391|FG003|Overall Study|Lack of Efficacy|0|||
41953153|NCT01859988|75720392|FG004|Overall Study|Lack of Efficacy|7|||
41953154|NCT01859988|75720393|FG005|Overall Study|Lack of Efficacy|9|||
41953155|NCT01859988|75720388|FG000|Overall Study|Physician Decision|1|||
41953156|NCT01859988|75720389|FG001|Overall Study|Physician Decision|3|||
41953157|NCT01859988|75720390|FG002|Overall Study|Physician Decision|1|||
41953158|NCT01859988|75720391|FG003|Overall Study|Physician Decision|3|||
41953159|NCT01859988|75720392|FG004|Overall Study|Physician Decision|4|||
41953160|NCT01859988|75720393|FG005|Overall Study|Physician Decision|1|||
41953161|NCT01859988|75720388|FG000|Overall Study|Adverse Event|2|||
41953162|NCT01859988|75720389|FG001|Overall Study|Adverse Event|1|||
41953163|NCT01859988|75720390|FG002|Overall Study|Adverse Event|3|||
41953164|NCT01859988|75720391|FG003|Overall Study|Adverse Event|1|||
41953165|NCT01859988|75720392|FG004|Overall Study|Adverse Event|2|||
41953166|NCT01859988|75720393|FG005|Overall Study|Adverse Event|2|||
41953167|NCT01859988|75720388|FG000|Overall Study|Lost to Follow-up|1|||
41953168|NCT01859988|75720389|FG001|Overall Study|Lost to Follow-up|2|||
41953169|NCT01859988|75720390|FG002|Overall Study|Lost to Follow-up|3|||
41953170|NCT01859988|75720391|FG003|Overall Study|Lost to Follow-up|0|||
41953171|NCT01859988|75720392|FG004|Overall Study|Lost to Follow-up|3|||
41953172|NCT01859988|75720393|FG005|Overall Study|Lost to Follow-up|2|||
41953173|NCT01859988|75720388|FG000|Overall Study|Protocol Violation|0|||
41953174|NCT01859988|75720389|FG001|Overall Study|Protocol Violation|0|||
41953175|NCT01859988|75720390|FG002|Overall Study|Protocol Violation|1|||
41953176|NCT01859988|75720391|FG003|Overall Study|Protocol Violation|0|||
41953177|NCT01859988|75720392|FG004|Overall Study|Protocol Violation|0|||
41953178|NCT01859988|75720393|FG005|Overall Study|Protocol Violation|0|||
41953179|NCT01859988|75720388|FG000|Overall Study|Other than specified above|0|||
41953180|NCT01859988|75720389|FG001|Overall Study|Other than specified above|2|||
41953181|NCT01859988|75720390|FG002|Overall Study|Other than specified above|11|||
41953182|NCT01859988|75720391|FG003|Overall Study|Other than specified above|3|||
41953183|NCT01859988|75720392|FG004|Overall Study|Other than specified above|5|||
41953184|NCT01859988|75720393|FG005|Overall Study|Other than specified above|3|||
41953185|NCT01859598|75720407|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
41953186|NCT01876446|75720415|FG000|Overall Study|Death|0|||
41953187|NCT01876446|75720416|FG001|Overall Study|Death|1|||
41953188|NCT01876446|75720415|FG000|Overall Study|Withdrawal by Subject|1|||
41953189|NCT01876446|75720416|FG001|Overall Study|Withdrawal by Subject|2|||
41953190|NCT01876446|75720415|FG000|Overall Study|Physician Decision|1|||
41953191|NCT01876446|75720416|FG001|Overall Study|Physician Decision|3|||
41953192|NCT01900626|75720424|FG000|Overall Study|study was closed due to low enrollment|1|||
41953193|NCT01900626|75720425|FG001|Overall Study|study was closed due to low enrollment|1|||
41953194|NCT01900314|75720435|FG000|Overall Study|Lost to Follow-up|1|||
41953195|NCT01900314|75720436|FG001|Overall Study|Lost to Follow-up|0|||
41953196|NCT01900314|75720435|FG000|Overall Study|Protocol Violation|0|||
41953197|NCT01900314|75720436|FG001|Overall Study|Protocol Violation|1|||
41953198|NCT01900314|75720435|FG000|Overall Study|Withdrawal by Subject|3|||
41953199|NCT01900314|75720436|FG001|Overall Study|Withdrawal by Subject|3|||
41953200|NCT01899768|75720443|FG000|Part A|Adverse Event|2|||
41953201|NCT01899768|75720443|FG000|Part A|Withdrawal by Subject|1|||
41953202|NCT01899768|75720443|FG000|Part B|Adverse Event|1|||
41953203|NCT01899768|75720443|FG000|Part B|Withdrawal by Subject|1|||
41953204|NCT01898598|75720453|FG000|Overall Study|Adverse Event|1|||
41953205|NCT01898598|75720454|FG001|Overall Study|Adverse Event|0|||
41953206|NCT01898598|75720453|FG000|Overall Study|Withdrawal by Subject|3|||
41953207|NCT01898598|75720454|FG001|Overall Study|Withdrawal by Subject|0|||
41953208|NCT01898598|75720453|FG000|Overall Study|Lost to Follow-up|0|||
41953209|NCT01898598|75720454|FG001|Overall Study|Lost to Follow-up|1|||
41953210|NCT01898598|75720453|FG000|Overall Study|Other|0|||
41953211|NCT01898598|75720454|FG001|Overall Study|Other|1|||
41953212|NCT01898442|75720463|FG000|Overall Study|Hemolysis/technical problems|1|||
41953213|NCT01898442|75720464|FG001|Overall Study|Hemolysis/technical problems|2|||
41953214|NCT01898442|75720465|FG002|Overall Study|Hemolysis/technical problems|2|||
41953215|NCT01898442|75720463|FG000|Overall Study|Patient vomited pills|0|||
41953216|NCT01898442|75720464|FG001|Overall Study|Patient vomited pills|0|||
41953217|NCT01898442|75720465|FG002|Overall Study|Patient vomited pills|1|||
41953218|NCT01898286|75720473|FG000|Overall Study|Withdrawal by Subject|1|||
41953219|NCT01898286|75720473|FG000|Overall Study|Protocol Violation|1|||
41953220|NCT01898286|75720473|FG000|Overall Study|Lost to Follow-up|1|||
41953221|NCT01898208|75720480|FG000|Overall Study|Positive blood culture|17|||
41953222|NCT01898208|75720481|FG001|Overall Study|Positive blood culture|23|||
41953223|NCT01898208|75720482|FG002|Overall Study|Positive blood culture|15|||
41953224|NCT01898208|75720480|FG000|Overall Study|Death/comfort care within 24 hours|10|||
41953225|NCT01898208|75720481|FG001|Overall Study|Death/comfort care within 24 hours|9|||
41953226|NCT01898208|75720482|FG002|Overall Study|Death/comfort care within 24 hours|8|||
41953227|NCT01898208|75720480|FG000|Overall Study|Negative Gram Stain|6|||
41953228|NCT01898208|75720481|FG001|Overall Study|Negative Gram Stain|9|||
41953229|NCT01898208|75720482|FG002|Overall Study|Negative Gram Stain|6|||
41953230|NCT01898208|75720480|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
41953231|NCT01898208|75720481|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
41953232|NCT01898208|75720482|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
41953233|NCT01898208|75720480|FG000|Overall Study|System/Technical Error|1|||
41953234|NCT01898208|75720481|FG001|Overall Study|System/Technical Error|2|||
41953235|NCT01898208|75720482|FG002|Overall Study|System/Technical Error|3|||
41953236|NCT01898208|75720480|FG000|Overall Study|Lost to Follow-up|3|||
41953237|NCT01898208|75720481|FG001|Overall Study|Lost to Follow-up|1|||
41953238|NCT01898208|75720482|FG002|Overall Study|Lost to Follow-up|1|||
41953239|NCT01898130|75720490|FG000|Treatment|Withdrawal by Subject|2|||
41953240|NCT01898130|75720490|FG000|Treatment|Progressive Disease|4|||
41953241|NCT01898130|75720490|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
41953242|NCT01876368|75720496|FG000|Overall Study|Adverse Event|2|||
41953243|NCT01876368|75720497|FG001|Overall Study|Adverse Event|5|||
41953244|NCT01876368|75720496|FG000|Overall Study|Lack of Efficacy|1|||
42023992|NCT01032837|75831342|FG002|Overall Study|Adverse event/internal illness|0|||
42023993|NCT01032837|75831343|FG003|Overall Study|Adverse event/internal illness|1|||
41953245|NCT01876368|75720497|FG001|Overall Study|Lack of Efficacy|0|||
41953246|NCT01876368|75720496|FG000|Overall Study|Lost to Follow-up|0|||
41953247|NCT01876368|75720497|FG001|Overall Study|Lost to Follow-up|1|||
41953248|NCT01876368|75720496|FG000|Overall Study|Non-compliance with study treatment|0|||
41953249|NCT01876368|75720497|FG001|Overall Study|Non-compliance with study treatment|1|||
41953250|NCT01876368|75720496|FG000|Overall Study|Physician Decision|0|||
41953251|NCT01876368|75720497|FG001|Overall Study|Physician Decision|2|||
41953252|NCT01876368|75720496|FG000|Overall Study|Protocol deviation|3|||
41953253|NCT01876368|75720497|FG001|Overall Study|Protocol deviation|3|||
41953254|NCT01876368|75720496|FG000|Overall Study|Subject/guardian decision|3|||
41953255|NCT01876368|75720497|FG001|Overall Study|Subject/guardian decision|1|||
41953256|NCT01874340|75720507|FG000|Overall Study|Study terminated by Sponsor|6|||
41953257|NCT01874340|75720508|FG001|Overall Study|Study terminated by Sponsor|8|||
41953258|NCT01874340|75720509|FG002|Overall Study|Study terminated by Sponsor|8|||
41953259|NCT01874340|75720510|FG003|Overall Study|Study terminated by Sponsor|4|||
41953260|NCT01874340|75720507|FG000|Overall Study|Withdrawal by Subject|0|||
41953261|NCT01874340|75720508|FG001|Overall Study|Withdrawal by Subject|0|||
41953262|NCT01874340|75720509|FG002|Overall Study|Withdrawal by Subject|0|||
41953263|NCT01874340|75720510|FG003|Overall Study|Withdrawal by Subject|1|||
41953264|NCT01897896|75720522|FG000|Overall Study|Death|1|||
41953265|NCT01897896|75720523|FG001|Overall Study|Death|0|||
41953266|NCT01897896|75720522|FG000|Overall Study|Adverse Event|11|||
41953267|NCT01897896|75720523|FG001|Overall Study|Adverse Event|1|||
41953268|NCT01897896|75720522|FG000|Overall Study|Lost to Follow-up|1|||
41953269|NCT01897896|75720523|FG001|Overall Study|Lost to Follow-up|0|||
41953270|NCT01897896|75720522|FG000|Overall Study|Non-compliance with study drug dosing|1|||
41953271|NCT01897896|75720523|FG001|Overall Study|Non-compliance with study drug dosing|1|||
41953272|NCT01897896|75720522|FG000|Overall Study|Withdrawal by Subject|7|||
41953273|NCT01897896|75720523|FG001|Overall Study|Withdrawal by Subject|1|||
41953274|NCT01897896|75720522|FG000|Overall Study|Require drug that interfere with study|1|||
41953275|NCT01897896|75720523|FG001|Overall Study|Require drug that interfere with study|4|||
41953276|NCT01897896|75720522|FG000|Overall Study|Protocol Violation|1|||
41953277|NCT01897896|75720523|FG001|Overall Study|Protocol Violation|1|||
41953278|NCT01897896|75720522|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
41953279|NCT01897896|75720523|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
41953280|NCT01897896|75720522|FG000|Overall Study|Caregiver can no longer participate|0|||
41953281|NCT01897896|75720523|FG001|Overall Study|Caregiver can no longer participate|2|||
41953282|NCT01897896|75720522|FG000|Overall Study|Other than specified|2|||
41953283|NCT01897896|75720523|FG001|Overall Study|Other than specified|1|||
41953284|NCT01858194|75720533|FG000|Overall Study|Total Artificial Heart Implant|0|||
41953285|NCT01858194|75720534|FG001|Overall Study|Total Artificial Heart Implant|1|||
41953286|NCT01858194|75720533|FG000|Overall Study|Lost to Follow-up|0|||
41953287|NCT01858194|75720534|FG001|Overall Study|Lost to Follow-up|1|||
41953288|NCT01873950|75720542|FG000|Period 5|Withdrawal by Subject|0|||
41953289|NCT01873950|75720543|FG001|Period 5|Withdrawal by Subject|0|||
41953290|NCT01873950|75720544|FG002|Period 5|Withdrawal by Subject|0|||
41953291|NCT01873950|75720545|FG003|Period 5|Withdrawal by Subject|1|||
41953292|NCT01873950|75720546|FG004|Period 5|Withdrawal by Subject|0|||
41953293|NCT01857102|75720560|FG000|Period 1|No longer meets Eligibility Criteria|0|||
41953294|NCT01857102|75720561|FG001|Period 1|No longer meets Eligibility Criteria|2|||
41953295|NCT01857102|75720560|FG000|Period 1|Lost to Follow-up|0|||
41953296|NCT01857102|75720561|FG001|Period 1|Lost to Follow-up|3|||
41953297|NCT01857102|75720560|FG000|Period 1|Unsatisfactory Lens Fit|1|||
41953298|NCT01857102|75720561|FG001|Period 1|Unsatisfactory Lens Fit|0|||
41953299|NCT01857102|75720560|FG000|Period 1|Unsatisfactory Visual Response|1|||
41953300|NCT01857102|75720561|FG001|Period 1|Unsatisfactory Visual Response|0|||
41953301|NCT01857102|75720560|FG000|Period 1|Physician Decision|1|||
41953302|NCT01857102|75720561|FG001|Period 1|Physician Decision|0|||
41953303|NCT01857102|75720560|FG000|Period 2|Lens Discomfort|1|||
41953304|NCT01857102|75720561|FG001|Period 2|Lens Discomfort|0|||
41953305|NCT01857102|75720560|FG000|Period 2|Unsatisfactory Lens Fit|1|||
41953306|NCT01857102|75720561|FG001|Period 2|Unsatisfactory Lens Fit|0|||
41953307|NCT01872078|75720573|FG000|Overall Study|Adverse Event|0|||
41953308|NCT01872078|75720574|FG001|Overall Study|Adverse Event|0|||
41953309|NCT01872078|75720575|FG002|Overall Study|Adverse Event|1|||
41953310|NCT01872078|75720576|FG003|Overall Study|Adverse Event|0|||
41953311|NCT01872078|75720573|FG000|Overall Study|Dose administration non-compliance|0|||
41953312|NCT01872078|75720574|FG001|Overall Study|Dose administration non-compliance|0|||
41953313|NCT01872078|75720575|FG002|Overall Study|Dose administration non-compliance|0|||
41953314|NCT01872078|75720576|FG003|Overall Study|Dose administration non-compliance|1|||
41953315|NCT01872078|75720573|FG000|Overall Study|Protocol Violation|0|||
41953316|NCT01872078|75720574|FG001|Overall Study|Protocol Violation|0|||
41953317|NCT01872078|75720575|FG002|Overall Study|Protocol Violation|1|||
41953318|NCT01872078|75720576|FG003|Overall Study|Protocol Violation|0|||
41953319|NCT01872078|75720573|FG000|Overall Study|Withdrawal by Subject|0|||
41953320|NCT01872078|75720574|FG001|Overall Study|Withdrawal by Subject|0|||
41953321|NCT01872078|75720575|FG002|Overall Study|Withdrawal by Subject|1|||
41953322|NCT01872078|75720576|FG003|Overall Study|Withdrawal by Subject|0|||
41953323|NCT01872078|75720573|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
41953324|NCT01872078|75720574|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
41953325|NCT01872078|75720575|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
41953326|NCT01872078|75720576|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
41953327|NCT01896726|75720586|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
41953328|NCT01896726|75720586|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
41953329|NCT01856790|75720593|FG000|Closed Loop Control|Withdrawal by Subject|2|||
41953330|NCT01856790|75720593|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
41953331|NCT01856322|75720607|FG000|Overall Study|off study due to lack of accrual|0|||
41953332|NCT01856322|75720608|FG001|Overall Study|off study due to lack of accrual|0|||
41953333|NCT01856322|75720609|FG002|Overall Study|off study due to lack of accrual|3|||
41953334|NCT01896102|75720616|FG000|Overall Study|Death|1|||
41953335|NCT01896102|75720616|FG000|Overall Study|Participant to receive allogenic transplant|2|||
41953336|NCT01871532|75720623|FG000|Overall Study|Withdrawal by Subject|1|||
41953337|NCT01871532|75720624|FG001|Overall Study|Withdrawal by Subject|2|||
41953338|NCT01855074|75720630|FG000|Overall Study|Adverse Event|1|||
41953339|NCT01855074|75720630|FG000|Overall Study|Lost to Follow-up|4|||
41953340|NCT01855074|75720630|FG000|Overall Study|Withdrawal by Subject|8|||
41953341|NCT01855074|75720630|FG000|Overall Study|Started but not treated|1|||
41953342|NCT01871142|75720634|FG000|Overall Study|Adverse Event|1|||
41953343|NCT01895322|75720648|FG000|Overall Study|Adverse Event|1|||
41953344|NCT01895322|75720648|FG000|Overall Study|Withdrawal by Subject|2|||
41953345|NCT01895322|75720648|FG000|Overall Study|Protocol Violation|10|||
41953346|NCT01894776|75720653|FG000|Overall Study|Withdrawal by Subject|1|||
41953347|NCT01894620|75720659|FG000|Overall Study|Withdrawal by Subject|0|||
41953348|NCT01894620|75720660|FG001|Overall Study|Withdrawal by Subject|1|||
41953349|NCT01854918|75720670|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
41953350|NCT01854918|75720671|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
41953351|NCT01854918|75720670|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
41953352|NCT01854918|75720671|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
41953353|NCT01854918|75720670|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
41953354|NCT01854918|75720671|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
41953355|NCT01854918|75720670|FG000|SOC-controlled Period (Year 1)|Death|5|||
41953356|NCT01854918|75720671|FG001|SOC-controlled Period (Year 1)|Death|5|||
41953357|NCT01854918|75720670|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
41953358|NCT01854918|75720671|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
41953359|NCT01854918|75720670|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
41953360|NCT01854918|75720671|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
41953361|NCT01854918|75720670|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
41953362|NCT01854918|75720671|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
41953363|NCT01854918|75720670|FG000|All-IP Period (Years 2 and 3)|Death|5|||
41953364|NCT01854918|75720671|FG001|All-IP Period (Years 2 and 3)|Death|16|||
41953365|NCT01894230|75720686|FG000|Overall Study|Lost to Follow-up|2|||
41953366|NCT01894230|75720687|FG001|Overall Study|Lost to Follow-up|2|||
41953367|NCT01894230|75720686|FG000|Overall Study|Withdrawal by Subject|4|||
41953368|NCT01894230|75720687|FG001|Overall Study|Withdrawal by Subject|4|||
41953369|NCT01894230|75720686|FG000|Overall Study|Non-adherent|0|||
41953370|NCT01894230|75720687|FG001|Overall Study|Non-adherent|1|||
41953371|NCT01894230|75720686|FG000|Overall Study|Death|1|||
41953372|NCT01894230|75720687|FG001|Overall Study|Death|0|||
41953373|NCT01894152|75720693|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
41953374|NCT01854528|75720699|FG000|Overall Study|Adverse Event|0|||
41953375|NCT01854528|75720700|FG001|Overall Study|Adverse Event|4|||
41953376|NCT01854528|75720699|FG000|Overall Study|Withdrawal by Subject|0|||
41953377|NCT01854528|75720700|FG001|Overall Study|Withdrawal by Subject|2|||
41953378|NCT01854528|75720699|FG000|Overall Study|Virologic Failure|0|||
41953379|NCT01854528|75720700|FG001|Overall Study|Virologic Failure|9|||
41953380|NCT01853982|75720708|FG000|Overall Study|Withdrawal by Subject|1|||
41953381|NCT01853982|75720709|FG001|Overall Study|Withdrawal by Subject|0|||
41953382|NCT01853982|75720708|FG000|Overall Study|Death|1|||
41953383|NCT01853982|75720709|FG001|Overall Study|Death|0|||
41953384|NCT01853982|75720708|FG000|Overall Study|Lost to Follow-up|0|||
41953385|NCT01853982|75720709|FG001|Overall Study|Lost to Follow-up|1|||
41953386|NCT01853280|75720717|FG000|Overall Study|Lack of Efficacy|2|||
41953387|NCT01853280|75720718|FG001|Overall Study|Lack of Efficacy|2|||
41953388|NCT01853280|75720717|FG000|Overall Study|Lost to Follow-up|0|||
41953389|NCT01853280|75720718|FG001|Overall Study|Lost to Follow-up|1|||
41953390|NCT01853280|75720717|FG000|Overall Study|Physician Decision|0|||
41953391|NCT01853280|75720718|FG001|Overall Study|Physician Decision|1|||
41953392|NCT01853280|75720717|FG000|Overall Study|Withdrawal by Subject|0|||
41953393|NCT01853280|75720718|FG001|Overall Study|Withdrawal by Subject|1|||
41953394|NCT01853280|75720717|FG000|Overall Study|Ineligible|0|||
41953395|NCT01853280|75720718|FG001|Overall Study|Ineligible|1|||
41953396|NCT01892436|75720728|FG000|Overall Study|Withdrawal by Subject|8|||
41953397|NCT01892436|75720729|FG001|Overall Study|Withdrawal by Subject|15|||
41953398|NCT01892436|75720730|FG002|Overall Study|Withdrawal by Subject|4|||
41953399|NCT01892436|75720731|FG003|Overall Study|Withdrawal by Subject|4|||
41953400|NCT01892436|75720728|FG000|Overall Study|Death|1|||
41953401|NCT01892436|75720729|FG001|Overall Study|Death|1|||
41953402|NCT01892436|75720730|FG002|Overall Study|Death|0|||
41953403|NCT01892436|75720731|FG003|Overall Study|Death|0|||
41953404|NCT01892436|75720728|FG000|Overall Study|Physician Decision|2|||
41953405|NCT01892436|75720729|FG001|Overall Study|Physician Decision|1|||
41953406|NCT01892436|75720730|FG002|Overall Study|Physician Decision|0|||
41953407|NCT01892436|75720731|FG003|Overall Study|Physician Decision|1|||
41953408|NCT01892436|75720728|FG000|Overall Study|Pregnancy|0|||
41953409|NCT01892436|75720729|FG001|Overall Study|Pregnancy|2|||
41953410|NCT01892436|75720730|FG002|Overall Study|Pregnancy|1|||
41953411|NCT01892436|75720731|FG003|Overall Study|Pregnancy|0|||
41953412|NCT01892436|75720728|FG000|Overall Study|Technical problems|2|||
41953413|NCT01892436|75720729|FG001|Overall Study|Technical problems|1|||
41953414|NCT01892436|75720730|FG002|Overall Study|Technical problems|1|||
41953415|NCT01892436|75720731|FG003|Overall Study|Technical problems|1|||
41953416|NCT01892436|75720728|FG000|Overall Study|Lack of Efficacy|1|||
41953417|NCT01892436|75720729|FG001|Overall Study|Lack of Efficacy|2|||
41953418|NCT01892436|75720730|FG002|Overall Study|Lack of Efficacy|2|||
41953419|NCT01892436|75720731|FG003|Overall Study|Lack of Efficacy|2|||
41953420|NCT01892436|75720728|FG000|Overall Study|Lost to Follow-up|1|||
41953421|NCT01892436|75720729|FG001|Overall Study|Lost to Follow-up|1|||
41953422|NCT01892436|75720730|FG002|Overall Study|Lost to Follow-up|1|||
41953423|NCT01892436|75720731|FG003|Overall Study|Lost to Follow-up|3|||
41953424|NCT01892436|75720728|FG000|Overall Study|non-compliance with treatment|1|||
41953425|NCT01892436|75720729|FG001|Overall Study|non-compliance with treatment|0|||
41953426|NCT01892436|75720730|FG002|Overall Study|non-compliance with treatment|0|||
41953427|NCT01892436|75720731|FG003|Overall Study|non-compliance with treatment|0|||
41953428|NCT01892436|75720728|FG000|Overall Study|Adverse Event|7|||
41953429|NCT01892436|75720729|FG001|Overall Study|Adverse Event|6|||
41953430|NCT01892436|75720730|FG002|Overall Study|Adverse Event|2|||
41953431|NCT01892436|75720731|FG003|Overall Study|Adverse Event|3|||
41953432|NCT01853046|75720743|FG000|Overall Study|Withdrawal by Subject|1|||
41953433|NCT01853046|75720744|FG001|Overall Study|Withdrawal by Subject|1|||
41953434|NCT01853046|75720743|FG000|Overall Study|Adverse Event|4|||
41953435|NCT01853046|75720744|FG001|Overall Study|Adverse Event|2|||
41953436|NCT01853046|75720743|FG000|Overall Study|Disease progression|13|||
41953437|NCT01853046|75720744|FG001|Overall Study|Disease progression|3|||
41953438|NCT01891890|75720754|FG000|Overall Study|Lost to Follow-up|0|||
41953439|NCT01891890|75720755|FG001|Overall Study|Lost to Follow-up|0|||
41953440|NCT01891890|75720756|FG002|Overall Study|Lost to Follow-up|1|||
41953441|NCT01891890|75720754|FG000|Overall Study|Study ended before endpoint reached|7|||
41953442|NCT01891890|75720755|FG001|Overall Study|Study ended before endpoint reached|3|||
41953443|NCT01891890|75720756|FG002|Overall Study|Study ended before endpoint reached|6|||
41953444|NCT01852812|75720767|FG000|Overall Study|Adverse Event|0|||
41953445|NCT01852812|75720768|FG001|Overall Study|Adverse Event|0|||
41953446|NCT01852812|75720769|FG002|Overall Study|Adverse Event|1|||
41953447|NCT01852812|75720767|FG000|Overall Study|Non-compliance With Study Drug|0|||
41953448|NCT01852812|75720768|FG001|Overall Study|Non-compliance With Study Drug|1|||
41953449|NCT01852812|75720769|FG002|Overall Study|Non-compliance With Study Drug|0|||
41953450|NCT01869348|75720779|FG000|Overall Study|Withdrawal by Subject|1|||
41953451|NCT01869348|75720780|FG001|Overall Study|Withdrawal by Subject|1|||
41953452|NCT01869192|75720788|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
41953453|NCT01869192|75720789|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
41953454|NCT01869192|75720788|FG000|Postoperative Chemotherapy|Physician Decision|0|||
41953455|NCT01869192|75720789|FG001|Postoperative Chemotherapy|Physician Decision|2|||
41953456|NCT01868646|75720797|FG000|Overall Study|Do not meet inclusion criteria|3|||
41953457|NCT01868646|75720798|FG001|Overall Study|Do not meet inclusion criteria|5|||
41953458|NCT01852110|75720806|FG000|Overall Study|Adverse Event|12|||
41953459|NCT01852110|75720807|FG001|Overall Study|Adverse Event|5|||
41953460|NCT01852110|75720808|FG002|Overall Study|Adverse Event|0|||
41953461|NCT01852110|75720809|FG003|Overall Study|Adverse Event|0|||
41953462|NCT01852110|75720810|FG004|Overall Study|Adverse Event|0|||
41953463|NCT01852110|75720811|FG005|Overall Study|Adverse Event|0|||
41953464|NCT01852110|75720806|FG000|Overall Study|Lost to Follow-up|1|||
41953465|NCT01852110|75720807|FG001|Overall Study|Lost to Follow-up|3|||
41953466|NCT01852110|75720808|FG002|Overall Study|Lost to Follow-up|0|||
41953467|NCT01852110|75720809|FG003|Overall Study|Lost to Follow-up|0|||
41953468|NCT01852110|75720810|FG004|Overall Study|Lost to Follow-up|0|||
41953469|NCT01852110|75720811|FG005|Overall Study|Lost to Follow-up|0|||
41953470|NCT01852110|75720806|FG000|Overall Study|Non-compliance with Study Drug|2|||
41953471|NCT01852110|75720807|FG001|Overall Study|Non-compliance with Study Drug|1|||
41953472|NCT01852110|75720808|FG002|Overall Study|Non-compliance with Study Drug|0|||
41953473|NCT01852110|75720809|FG003|Overall Study|Non-compliance with Study Drug|0|||
41953474|NCT01852110|75720810|FG004|Overall Study|Non-compliance with Study Drug|0|||
41953475|NCT01852110|75720811|FG005|Overall Study|Non-compliance with Study Drug|0|||
41953476|NCT01852110|75720806|FG000|Overall Study|Physician Decision|1|||
41953477|NCT01852110|75720807|FG001|Overall Study|Physician Decision|0|||
41953478|NCT01852110|75720808|FG002|Overall Study|Physician Decision|0|||
41953479|NCT01852110|75720809|FG003|Overall Study|Physician Decision|0|||
41953480|NCT01852110|75720810|FG004|Overall Study|Physician Decision|0|||
41953481|NCT01852110|75720811|FG005|Overall Study|Physician Decision|0|||
41953482|NCT01852110|75720806|FG000|Overall Study|Protocol Violation|0|||
41953483|NCT01852110|75720807|FG001|Overall Study|Protocol Violation|1|||
41953484|NCT01852110|75720808|FG002|Overall Study|Protocol Violation|0|||
41953485|NCT01852110|75720809|FG003|Overall Study|Protocol Violation|0|||
41953486|NCT01852110|75720810|FG004|Overall Study|Protocol Violation|0|||
41953487|NCT01852110|75720811|FG005|Overall Study|Protocol Violation|0|||
41953488|NCT01852110|75720806|FG000|Overall Study|Study Terminated by Sponsor|30|||
41953489|NCT01852110|75720807|FG001|Overall Study|Study Terminated by Sponsor|32|||
41953490|NCT01852110|75720808|FG002|Overall Study|Study Terminated by Sponsor|0|||
41953491|NCT01852110|75720809|FG003|Overall Study|Study Terminated by Sponsor|0|||
41953492|NCT01852110|75720810|FG004|Overall Study|Study Terminated by Sponsor|0|||
41953493|NCT01852110|75720811|FG005|Overall Study|Study Terminated by Sponsor|0|||
41953494|NCT01852110|75720806|FG000|Overall Study|Withdrawal by Subject|4|||
41953495|NCT01852110|75720807|FG001|Overall Study|Withdrawal by Subject|4|||
41953496|NCT01852110|75720808|FG002|Overall Study|Withdrawal by Subject|0|||
41953497|NCT01852110|75720809|FG003|Overall Study|Withdrawal by Subject|0|||
41953498|NCT01852110|75720810|FG004|Overall Study|Withdrawal by Subject|0|||
41953499|NCT01852110|75720811|FG005|Overall Study|Withdrawal by Subject|0|||
41953500|NCT01851720|75720827|FG000|Overall Study|Lost to Follow-up|0|||
41953501|NCT01851720|75720828|FG001|Overall Study|Lost to Follow-up|1|||
41953502|NCT01851330|75720837|FG000|Overall Study|Lack of Efficacy|10|||
41953503|NCT01851330|75720838|FG001|Overall Study|Lack of Efficacy|9|||
41953504|NCT01851330|75720839|FG002|Overall Study|Lack of Efficacy|2|||
41953505|NCT01851330|75720837|FG000|Overall Study|Lost to Follow-up|1|||
41953506|NCT01851330|75720838|FG001|Overall Study|Lost to Follow-up|6|||
41953507|NCT01851330|75720839|FG002|Overall Study|Lost to Follow-up|9|||
41953508|NCT01851330|75720837|FG000|Overall Study|Withdrew Consent|2|||
41953509|NCT01851330|75720838|FG001|Overall Study|Withdrew Consent|1|||
41953510|NCT01851330|75720839|FG002|Overall Study|Withdrew Consent|0|||
41953511|NCT01851330|75720837|FG000|Overall Study|Investigator's Discretion|0|||
41953512|NCT01851330|75720838|FG001|Overall Study|Investigator's Discretion|0|||
41953513|NCT01851330|75720839|FG002|Overall Study|Investigator's Discretion|1|||
41953514|NCT01868022|75720856|FG000|Overall Study|Withdrawal by Subject|0|||
41953515|NCT01868022|75720857|FG001|Overall Study|Withdrawal by Subject|0|||
41953516|NCT01868022|75720858|FG002|Overall Study|Withdrawal by Subject|1|||
41953517|NCT01868022|75720859|FG003|Overall Study|Withdrawal by Subject|1|||
41953518|NCT01868022|75720860|FG004|Overall Study|Withdrawal by Subject|0|||
41953519|NCT01868022|75720861|FG005|Overall Study|Withdrawal by Subject|0|||
41953520|NCT01868022|75720862|FG006|Overall Study|Withdrawal by Subject|0|||
41953521|NCT01868022|75720863|FG007|Overall Study|Withdrawal by Subject|1|||
41953522|NCT01868022|75720864|FG008|Overall Study|Withdrawal by Subject|0|||
41953523|NCT01868022|75720856|FG000|Overall Study|Adverse Event|0|||
41953524|NCT01868022|75720857|FG001|Overall Study|Adverse Event|0|||
41953525|NCT01868022|75720858|FG002|Overall Study|Adverse Event|0|||
41953526|NCT01868022|75720859|FG003|Overall Study|Adverse Event|0|||
41953527|NCT01868022|75720860|FG004|Overall Study|Adverse Event|2|||
41953528|NCT01868022|75720861|FG005|Overall Study|Adverse Event|0|||
41953529|NCT01868022|75720862|FG006|Overall Study|Adverse Event|0|||
41953530|NCT01868022|75720863|FG007|Overall Study|Adverse Event|2|||
41953531|NCT01868022|75720864|FG008|Overall Study|Adverse Event|2|||
41953532|NCT01868022|75720856|FG000|Overall Study|Physician Decision|0|||
41953533|NCT01868022|75720857|FG001|Overall Study|Physician Decision|0|||
41953534|NCT01868022|75720858|FG002|Overall Study|Physician Decision|0|||
41953535|NCT01868022|75720859|FG003|Overall Study|Physician Decision|0|||
41953536|NCT01868022|75720860|FG004|Overall Study|Physician Decision|0|||
41953537|NCT01868022|75720861|FG005|Overall Study|Physician Decision|1|||
41953538|NCT01868022|75720862|FG006|Overall Study|Physician Decision|0|||
41953539|NCT01868022|75720863|FG007|Overall Study|Physician Decision|2|||
41953540|NCT01868022|75720864|FG008|Overall Study|Physician Decision|0|||
41953541|NCT01868022|75720856|FG000|Overall Study|Study closed/terminated|0|||
41953542|NCT01868022|75720857|FG001|Overall Study|Study closed/terminated|0|||
41953543|NCT01868022|75720858|FG002|Overall Study|Study closed/terminated|0|||
41953544|NCT01868022|75720859|FG003|Overall Study|Study closed/terminated|0|||
41953545|NCT01868022|75720860|FG004|Overall Study|Study closed/terminated|0|||
41953546|NCT01868022|75720861|FG005|Overall Study|Study closed/terminated|0|||
41953547|NCT01868022|75720862|FG006|Overall Study|Study closed/terminated|0|||
41953548|NCT01868022|75720863|FG007|Overall Study|Study closed/terminated|1|||
41953549|NCT01868022|75720864|FG008|Overall Study|Study closed/terminated|0|||
41953550|NCT01868022|75720856|FG000|Overall Study|Ongoing|0|||
41953551|NCT01868022|75720857|FG001|Overall Study|Ongoing|0|||
41953552|NCT01868022|75720858|FG002|Overall Study|Ongoing|0|||
41953553|NCT01868022|75720859|FG003|Overall Study|Ongoing|0|||
41953554|NCT01868022|75720860|FG004|Overall Study|Ongoing|0|||
41953555|NCT01868022|75720861|FG005|Overall Study|Ongoing|0|||
41953556|NCT01868022|75720862|FG006|Overall Study|Ongoing|0|||
41953557|NCT01868022|75720863|FG007|Overall Study|Ongoing|3|||
41953558|NCT01868022|75720864|FG008|Overall Study|Ongoing|0|||
41953559|NCT01850004|75720890|FG000|Overall Study|Poor/Non-compliance|1|||
41953560|NCT01850004|75720890|FG000|Overall Study|Participant Withdrew Consent|9|||
41953561|NCT01850004|75720890|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
41953562|NCT01850004|75720890|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
41953563|NCT01850004|75720890|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
41953564|NCT01850004|75720890|FG000|Overall Study|Other Reasons|2|||
41953565|NCT01850004|75720890|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
41953566|NCT01850004|75720890|FG000|Overall Study|Maximum Clinical Benefit|4|||
41953567|NCT01867710|75720898|FG000|Overall Study|Death|25|||
41953568|NCT01867710|75720899|FG001|Overall Study|Death|15|||
41953569|NCT01867710|75720900|FG002|Overall Study|Death|27|||
41953570|NCT01867710|75720901|FG003|Overall Study|Death|20|||
41953571|NCT01867710|75720898|FG000|Overall Study|Lost to Follow-up|3|||
41953572|NCT01867710|75720899|FG001|Overall Study|Lost to Follow-up|4|||
41953573|NCT01867710|75720900|FG002|Overall Study|Lost to Follow-up|3|||
41953574|NCT01867710|75720901|FG003|Overall Study|Lost to Follow-up|2|||
41953575|NCT01867710|75720898|FG000|Overall Study|Withdrawal of consent|2|||
41953576|NCT01867710|75720899|FG001|Overall Study|Withdrawal of consent|5|||
41953577|NCT01867710|75720900|FG002|Overall Study|Withdrawal of consent|1|||
41953578|NCT01867710|75720901|FG003|Overall Study|Withdrawal of consent|2|||
41953579|NCT01867710|75720898|FG000|Overall Study|Study Terminated by Sponsor|9|||
41953580|NCT01867710|75720899|FG001|Overall Study|Study Terminated by Sponsor|13|||
41953581|NCT01867710|75720900|FG002|Overall Study|Study Terminated by Sponsor|8|||
41953582|NCT01867710|75720901|FG003|Overall Study|Study Terminated by Sponsor|16|||
41953583|NCT01867710|75720898|FG000|Overall Study|Biochemical progression|0|||
41953584|NCT01867710|75720899|FG001|Overall Study|Biochemical progression|1|||
41953585|NCT01867710|75720900|FG002|Overall Study|Biochemical progression|0|||
41953586|NCT01867710|75720901|FG003|Overall Study|Biochemical progression|0|||
41953587|NCT01867710|75720898|FG000|Overall Study|Clinical progression|0|||
41953588|NCT01867710|75720899|FG001|Overall Study|Clinical progression|0|||
41953589|NCT01867710|75720900|FG002|Overall Study|Clinical progression|1|||
41953590|NCT01867710|75720901|FG003|Overall Study|Clinical progression|0|||
41953591|NCT01867710|75720898|FG000|Overall Study|Disease progression|1|||
41953592|NCT01867710|75720899|FG001|Overall Study|Disease progression|0|||
41953593|NCT01867710|75720900|FG002|Overall Study|Disease progression|0|||
41953594|NCT01867710|75720901|FG003|Overall Study|Disease progression|0|||
41953595|NCT01867710|75720898|FG000|Overall Study|Patient decision|0|||
41953596|NCT01867710|75720899|FG001|Overall Study|Patient decision|0|||
41953597|NCT01867710|75720900|FG002|Overall Study|Patient decision|0|||
41953598|NCT01867710|75720901|FG003|Overall Study|Patient decision|1|||
41953599|NCT01867710|75720898|FG000|Overall Study|Patient to follow subsequent treatment|0|||
41953600|NCT01867710|75720899|FG001|Overall Study|Patient to follow subsequent treatment|1|||
41953601|NCT01867710|75720900|FG002|Overall Study|Patient to follow subsequent treatment|0|||
41953602|NCT01867710|75720901|FG003|Overall Study|Patient to follow subsequent treatment|0|||
41953603|NCT01867710|75720898|FG000|Overall Study|Progressive disease|1|||
41953604|NCT01867710|75720899|FG001|Overall Study|Progressive disease|0|||
41953605|NCT01867710|75720900|FG002|Overall Study|Progressive disease|0|||
41953606|NCT01867710|75720901|FG003|Overall Study|Progressive disease|0|||
41953607|NCT01867710|75720898|FG000|Overall Study|Protocol Violation|0|||
41953608|NCT01867710|75720899|FG001|Overall Study|Protocol Violation|0|||
41953609|NCT01867710|75720900|FG002|Overall Study|Protocol Violation|0|||
41953610|NCT01867710|75720901|FG003|Overall Study|Protocol Violation|1|||
41953611|NCT01867710|75720898|FG000|Overall Study|PSA-progression|0|||
41953612|NCT01867710|75720899|FG001|Overall Study|PSA-progression|1|||
41953613|NCT01867710|75720900|FG002|Overall Study|PSA-progression|0|||
41953614|NCT01867710|75720901|FG003|Overall Study|PSA-progression|0|||
41953615|NCT01867710|75720898|FG000|Overall Study|Study medication no longer effective|0|||
41953616|NCT01867710|75720899|FG001|Overall Study|Study medication no longer effective|1|||
42023994|NCT01032837|75831340|FG000|Overall Study|Withdrew consent|0|||
41953617|NCT01867710|75720900|FG002|Overall Study|Study medication no longer effective|0|||
41953618|NCT01867710|75720901|FG003|Overall Study|Study medication no longer effective|0|||
41953619|NCT01849848|75720911|FG000|Overall Study|Physician Decision|1|||
41953620|NCT01849848|75720911|FG000|Overall Study|Progression of the primary disease|3|||
41953621|NCT01849458|75720915|FG000|Overall Study|Lost to Follow-up|4|||
41953622|NCT01832766|75720919|FG000|Washout|Lost to Follow-up|0|||
41953623|NCT01832766|75720920|FG001|Washout|Lost to Follow-up|1|||
41953624|NCT01832532|75720928|FG000|Overall Study|Withdrawal by Subject|5|||
41953625|NCT01832532|75720929|FG001|Overall Study|Withdrawal by Subject|2|||
41953626|NCT01848990|75720938|FG000|Overall Study|Adverse Event|6|||
41953627|NCT01848990|75720939|FG001|Overall Study|Adverse Event|2|||
41953628|NCT01848990|75720940|FG002|Overall Study|Adverse Event|0|||
41953629|NCT01848990|75720938|FG000|Overall Study|Lost to Follow-up|6|||
41953630|NCT01848990|75720939|FG001|Overall Study|Lost to Follow-up|2|||
41953631|NCT01848990|75720940|FG002|Overall Study|Lost to Follow-up|2|||
41953632|NCT01848990|75720938|FG000|Overall Study|Protocol Violation|1|||
41953633|NCT01848990|75720939|FG001|Overall Study|Protocol Violation|1|||
41953634|NCT01848990|75720940|FG002|Overall Study|Protocol Violation|0|||
41953635|NCT01848990|75720938|FG000|Overall Study|Withdrawal by Subject|29|||
41953636|NCT01848990|75720939|FG001|Overall Study|Withdrawal by Subject|10|||
41953637|NCT01848990|75720940|FG002|Overall Study|Withdrawal by Subject|11|||
41953638|NCT01848990|75720938|FG000|Overall Study|Physician Decision|1|||
41953639|NCT01848990|75720939|FG001|Overall Study|Physician Decision|1|||
41953640|NCT01848990|75720940|FG002|Overall Study|Physician Decision|0|||
41953641|NCT01848990|75720938|FG000|Overall Study|Non Compliance|1|||
41953642|NCT01848990|75720939|FG001|Overall Study|Non Compliance|0|||
41953643|NCT01848990|75720940|FG002|Overall Study|Non Compliance|0|||
42023995|NCT01032837|75831341|FG001|Overall Study|Withdrew consent|2|||
42023996|NCT01032837|75831342|FG002|Overall Study|Withdrew consent|0|||
42023997|NCT01032837|75831343|FG003|Overall Study|Withdrew consent|1|||
42023998|NCT01032837|75831340|FG000|Overall Study|Failed to return|0|||
42023999|NCT01032837|75831341|FG001|Overall Study|Failed to return|0|||
42024000|NCT01032837|75831342|FG002|Overall Study|Failed to return|1|||
42024001|NCT01032837|75831343|FG003|Overall Study|Failed to return|0|||
41953644|NCT01848990|75720938|FG000|Overall Study|Death|1|||
41953645|NCT01848990|75720939|FG001|Overall Study|Death|0|||
41953646|NCT01848990|75720940|FG002|Overall Study|Death|1|||
41953647|NCT01848990|75720938|FG000|Overall Study|Other|1|||
41953648|NCT01848990|75720939|FG001|Overall Study|Other|4|||
41953649|NCT01848990|75720940|FG002|Overall Study|Other|2|||
41953650|NCT01867086|75720952|FG000|Overall Study|Disease Progression|1|||
41953651|NCT01831596|75720956|FG000|Overall Study|Other|8|||
41953652|NCT01848834|75720965|FG000|Overall Study|Adverse Event|3|||
41953653|NCT01848834|75720966|FG001|Overall Study|Adverse Event|11|||
41953654|NCT01848834|75720967|FG002|Overall Study|Adverse Event|3|||
41953655|NCT01848834|75720968|FG003|Overall Study|Adverse Event|5|||
41953656|NCT01848834|75720969|FG004|Overall Study|Adverse Event|9|||
41953657|NCT01848834|75720965|FG000|Overall Study|Death|2|||
41953658|NCT01848834|75720966|FG001|Overall Study|Death|11|||
41953659|NCT01848834|75720967|FG002|Overall Study|Death|1|||
41953660|NCT01848834|75720968|FG003|Overall Study|Death|8|||
41953661|NCT01848834|75720969|FG004|Overall Study|Death|27|||
41953662|NCT01848834|75720965|FG000|Overall Study|Excluded Medication|5|||
41953663|NCT01848834|75720966|FG001|Overall Study|Excluded Medication|4|||
41953664|NCT01848834|75720967|FG002|Overall Study|Excluded Medication|3|||
41953665|NCT01848834|75720968|FG003|Overall Study|Excluded Medication|6|||
41953666|NCT01848834|75720969|FG004|Overall Study|Excluded Medication|6|||
41953667|NCT01848834|75720965|FG000|Overall Study|Lost to Follow-up|5|||
41953668|NCT01848834|75720966|FG001|Overall Study|Lost to Follow-up|5|||
41953669|NCT01848834|75720967|FG002|Overall Study|Lost to Follow-up|3|||
41953670|NCT01848834|75720968|FG003|Overall Study|Lost to Follow-up|0|||
41953671|NCT01848834|75720969|FG004|Overall Study|Lost to Follow-up|3|||
41953672|NCT01848834|75720965|FG000|Overall Study|Physician Decision|1|||
42024002|NCT01032837|75831340|FG000|Overall Study|Refused treatment|0|||
41953673|NCT01848834|75720966|FG001|Overall Study|Physician Decision|3|||
41953674|NCT01848834|75720967|FG002|Overall Study|Physician Decision|4|||
41953675|NCT01848834|75720968|FG003|Overall Study|Physician Decision|0|||
41953676|NCT01848834|75720969|FG004|Overall Study|Physician Decision|11|||
41953677|NCT01848834|75720965|FG000|Overall Study|Protocol Violation|0|||
41953678|NCT01848834|75720966|FG001|Overall Study|Protocol Violation|0|||
41953679|NCT01848834|75720967|FG002|Overall Study|Protocol Violation|0|||
41953680|NCT01848834|75720968|FG003|Overall Study|Protocol Violation|0|||
41953681|NCT01848834|75720969|FG004|Overall Study|Protocol Violation|1|||
41953682|NCT01848834|75720965|FG000|Overall Study|Sponsor Decision|1|||
42024003|NCT01032837|75831341|FG001|Overall Study|Refused treatment|0|||
41953683|NCT01848834|75720966|FG001|Overall Study|Sponsor Decision|1|||
41953684|NCT01848834|75720967|FG002|Overall Study|Sponsor Decision|0|||
41953685|NCT01848834|75720968|FG003|Overall Study|Sponsor Decision|1|||
41953686|NCT01848834|75720969|FG004|Overall Study|Sponsor Decision|1|||
41953687|NCT01848834|75720965|FG000|Overall Study|Withdrawal by Subject|2|||
42024004|NCT01032837|75831342|FG002|Overall Study|Refused treatment|0|||
41953688|NCT01848834|75720966|FG001|Overall Study|Withdrawal by Subject|13|||
41953689|NCT01848834|75720967|FG002|Overall Study|Withdrawal by Subject|10|||
41953690|NCT01848834|75720968|FG003|Overall Study|Withdrawal by Subject|6|||
41953691|NCT01848834|75720969|FG004|Overall Study|Withdrawal by Subject|36|||
41953692|NCT01867008|75720985|FG000|Overall Study|Withdrawal by Subject|1|||
41953693|NCT01848756|75720989|FG000|Overall Study|Adverse Event|1|||
41953694|NCT01848756|75720989|FG000|Overall Study|Withdrawal by Subject|1|||
41953695|NCT01848756|75720989|FG000|Overall Study|Enrolled in Error|1|||
41953696|NCT01830972|75720996|FG000|Part II|Withdrawal by Subject|2|||
41953697|NCT01830972|75720997|FG001|Part II|Withdrawal by Subject|2|||
41953698|NCT01830972|75720996|FG000|Part III|Withdrawal by Subject|1|||
41953699|NCT01830972|75720997|FG001|Part III|Withdrawal by Subject|0|||
41953700|NCT01830972|75720996|FG000|Part III|Noncompliance|1|||
41953701|NCT01830972|75720997|FG001|Part III|Noncompliance|0|||
41953702|NCT01830972|75720996|FG000|Part IV|Withdrawal by Subject|2|||
41953703|NCT01830972|75720997|FG001|Part IV|Withdrawal by Subject|1|||
41953704|NCT01830972|75720996|FG000|Part IV|Non-Compliance|1|||
41953705|NCT01830972|75720997|FG001|Part IV|Non-Compliance|0|||
41953706|NCT01848288|75721013|FG000|Overall Study|Death|1|||
41953707|NCT01848288|75721013|FG000|Overall Study|Protocol Violation|1|||
41953708|NCT01848288|75721013|FG000|Overall Study|Withdrawal by Subject|1|||
41953709|NCT01848210|75721020|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
41953710|NCT01848210|75721021|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
41953711|NCT01848210|75721020|FG000|Overall Study|Lost to Follow-up|24|||
41953712|NCT01848210|75721021|FG001|Overall Study|Lost to Follow-up|12|||
41953713|NCT01848210|75721020|FG000|Overall Study|Protocol Violation|3|||
41953714|NCT01848210|75721021|FG001|Overall Study|Protocol Violation|5|||
41953715|NCT01848210|75721020|FG000|Overall Study|Use of Forbidden Drugs|9|||
41953716|NCT01848210|75721021|FG001|Overall Study|Use of Forbidden Drugs|10|||
41953717|NCT01848210|75721020|FG000|Overall Study|Impedition Condition|5|||
41953718|NCT01848210|75721021|FG001|Overall Study|Impedition Condition|9|||
41953719|NCT01848210|75721020|FG000|Overall Study|Adverse Event|7|||
41953720|NCT01848210|75721021|FG001|Overall Study|Adverse Event|9|||
41953721|NCT01848210|75721020|FG000|Overall Study|Discontinuation Criterion|5|||
41953722|NCT01848210|75721021|FG001|Overall Study|Discontinuation Criterion|7|||
41953723|NCT01848210|75721020|FG000|Overall Study|Hypesensitivity|1|||
41953724|NCT01848210|75721021|FG001|Overall Study|Hypesensitivity|0|||
41953725|NCT01848210|75721020|FG000|Overall Study|Hepatic Function Alteration|4|||
41953726|NCT01848210|75721021|FG001|Overall Study|Hepatic Function Alteration|0|||
41953727|NCT01848210|75721020|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
41953728|NCT01848210|75721021|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
41953729|NCT01848210|75721020|FG000|Overall Study|Administrative|1|||
41953730|NCT01848210|75721021|FG001|Overall Study|Administrative|0|||
41953731|NCT01830816|75721030|FG000|Overall Study|Progressive Disease|12|||
41953732|NCT01830816|75721031|FG001|Overall Study|Progressive Disease|7|||
41953733|NCT01830816|75721032|FG002|Overall Study|Progressive Disease|7|||
41953734|NCT01830816|75721030|FG000|Overall Study|Adverse Event|3|||
41953735|NCT01830816|75721031|FG001|Overall Study|Adverse Event|4|||
41953736|NCT01830816|75721032|FG002|Overall Study|Adverse Event|0|||
41953737|NCT01830816|75721030|FG000|Overall Study|Study Terminated by Sponsor|1|||
41953738|NCT01830816|75721031|FG001|Overall Study|Study Terminated by Sponsor|1|||
41953739|NCT01830816|75721032|FG002|Overall Study|Study Terminated by Sponsor|0|||
41953740|NCT01830816|75721030|FG000|Overall Study|Withdrawal by Subject|1|||
41953741|NCT01830816|75721031|FG001|Overall Study|Withdrawal by Subject|1|||
41953742|NCT01830816|75721032|FG002|Overall Study|Withdrawal by Subject|0|||
41953743|NCT01830816|75721030|FG000|Overall Study|Lost to Follow-up|0|||
41953744|NCT01830816|75721031|FG001|Overall Study|Lost to Follow-up|1|||
41953745|NCT01830816|75721032|FG002|Overall Study|Lost to Follow-up|0|||
41953746|NCT01830816|75721030|FG000|Overall Study|Symptomatic Deterioration|1|||
42024005|NCT01032837|75831343|FG003|Overall Study|Refused treatment|1|||
42024006|NCT01180296|75831355|FG000|Overall Study|Protocol Violation|1|||
41953747|NCT01830816|75721031|FG001|Overall Study|Symptomatic Deterioration|0|||
41953748|NCT01830816|75721032|FG002|Overall Study|Symptomatic Deterioration|0|||
41953749|NCT01830816|75721030|FG000|Overall Study|Reason not Specified|2|||
41953750|NCT01830816|75721031|FG001|Overall Study|Reason not Specified|0|||
41953751|NCT01830816|75721032|FG002|Overall Study|Reason not Specified|0|||
42024007|NCT01180296|75831356|FG001|Overall Study|Protocol Violation|2|||
42300435|NCT02546609|76135632|FG000|Overall Study|travel or work schedule restriction|0|||
41953752|NCT01846416|75721046|FG000|Treatment Phase|Death|2|||
41953753|NCT01846416|75721047|FG001|Treatment Phase|Death|9|||
42300436|NCT02546609|76135633|FG001|Overall Study|travel or work schedule restriction|0|||
41953754|NCT01846416|75721048|FG002|Treatment Phase|Death|1|||
41953755|NCT01846416|75721046|FG000|Treatment Phase|Withdrawal by Subject|2|||
42024008|NCT01160640|75831366|FG000|Overall Study|Physician Decision|3|||
41953756|NCT01846416|75721047|FG001|Treatment Phase|Withdrawal by Subject|4|||
41953757|NCT01846416|75721048|FG002|Treatment Phase|Withdrawal by Subject|2|||
41953758|NCT01846416|75721046|FG000|Treatment Phase|Other|1|||
41953759|NCT01846416|75721047|FG001|Treatment Phase|Other|5|||
41953760|NCT01846416|75721048|FG002|Treatment Phase|Other|1|||
41953761|NCT01846416|75721046|FG000|Treatment Phase|Physician Decision|1|||
41953762|NCT01846416|75721047|FG001|Treatment Phase|Physician Decision|2|||
41953763|NCT01846416|75721048|FG002|Treatment Phase|Physician Decision|0|||
41953764|NCT01846416|75721046|FG000|Treatment Phase|Adverse Event|3|||
41953765|NCT01846416|75721047|FG001|Treatment Phase|Adverse Event|4|||
41953766|NCT01846416|75721048|FG002|Treatment Phase|Adverse Event|0|||
41953767|NCT01846416|75721046|FG000|Treatment Phase|Non-compliance|0|||
41953768|NCT01846416|75721047|FG001|Treatment Phase|Non-compliance|2|||
41953769|NCT01846416|75721048|FG002|Treatment Phase|Non-compliance|0|||
41953770|NCT01846416|75721046|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
41953771|NCT01846416|75721047|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
41953772|NCT01846416|75721048|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
41953773|NCT01846416|75721046|FG000|Treatment Phase|Progressive Disease|21|||
41953774|NCT01846416|75721047|FG001|Treatment Phase|Progressive Disease|63|||
41953775|NCT01846416|75721048|FG002|Treatment Phase|Progressive Disease|9|||
41953776|NCT01846416|75721046|FG000|Survival Follow-up|Death|21|||
41953777|NCT01846416|75721047|FG001|Survival Follow-up|Death|62|||
41953778|NCT01846416|75721048|FG002|Survival Follow-up|Death|9|||
41953779|NCT01846416|75721046|FG000|Survival Follow-up|Lost to Follow-up|0|||
41953780|NCT01846416|75721047|FG001|Survival Follow-up|Lost to Follow-up|2|||
41953781|NCT01846416|75721048|FG002|Survival Follow-up|Lost to Follow-up|2|||
41953782|NCT01846416|75721046|FG000|Survival Follow-up|Withdrawal by Subject|2|||
41953783|NCT01846416|75721047|FG001|Survival Follow-up|Withdrawal by Subject|7|||
41953784|NCT01846416|75721048|FG002|Survival Follow-up|Withdrawal by Subject|0|||
41953785|NCT01846416|75721046|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
41953786|NCT01846416|75721047|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
41953787|NCT01846416|75721048|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
42024009|NCT01160640|75831367|FG001|Overall Study|Physician Decision|3|||
42024010|NCT01160640|75831366|FG000|Overall Study|Incarceration|1|||
42024011|NCT01160640|75831367|FG001|Overall Study|Incarceration|0|||
42024012|NCT01160640|75831366|FG000|Overall Study|Withdrawal by Subject|0|||
42024013|NCT01160640|75831367|FG001|Overall Study|Withdrawal by Subject|3|||
42024014|NCT01160484|75831375|FG000|Overall Study|Lack of Efficacy|9|||
42024015|NCT01160484|75831375|FG000|Overall Study|Adverse Event|6|||
41953788|NCT01846416|75721046|FG000|Survival Follow-up|Other|3|||
41953789|NCT01846416|75721047|FG001|Survival Follow-up|Other|1|||
41953790|NCT01846416|75721048|FG002|Survival Follow-up|Other|1|||
41953791|NCT01865448|75721059|FG000|Overall Study|Adverse Event|1|||
41953792|NCT01865448|75721060|FG001|Overall Study|Adverse Event|1|||
41953793|NCT01865448|75721059|FG000|Overall Study|Pregnancy|0|||
41953794|NCT01865448|75721060|FG001|Overall Study|Pregnancy|1|||
41953795|NCT01865448|75721059|FG000|Overall Study|dropout unrelated to study|1|||
41953796|NCT01865448|75721060|FG001|Overall Study|dropout unrelated to study|1|||
41953797|NCT01804140|75721067|FG000|Overall Study|No sampling or biopsy procedures done|114|||
41953798|NCT01846104|75721071|FG000|Overall Study|Withdrawal by Subject|1|||
41953799|NCT01803282|75721087|FG000|Overall Study|Progressive Disease|4|||
41953800|NCT01803282|75721088|FG001|Overall Study|Progressive Disease|3|||
41953801|NCT01803282|75721089|FG002|Overall Study|Progressive Disease|6|||
41953802|NCT01803282|75721090|FG003|Overall Study|Progressive Disease|22|||
41953803|NCT01803282|75721091|FG004|Overall Study|Progressive Disease|5|||
41953804|NCT01803282|75721092|FG005|Overall Study|Progressive Disease|8|||
41953805|NCT01803282|75721093|FG006|Overall Study|Progressive Disease|23|||
41953806|NCT01803282|75721094|FG007|Overall Study|Progressive Disease|24|||
41953807|NCT01803282|75721095|FG008|Overall Study|Progressive Disease|3|||
41953808|NCT01803282|75721096|FG009|Overall Study|Progressive Disease|29|||
41953809|NCT01803282|75721097|FG010|Overall Study|Progressive Disease|6|||
41953810|NCT01803282|75721098|FG011|Overall Study|Progressive Disease|11|||
41953811|NCT01803282|75721087|FG000|Overall Study|Death|0|||
41953812|NCT01803282|75721088|FG001|Overall Study|Death|0|||
41953813|NCT01803282|75721089|FG002|Overall Study|Death|0|||
41953814|NCT01803282|75721090|FG003|Overall Study|Death|0|||
41953815|NCT01803282|75721091|FG004|Overall Study|Death|2|||
41953816|NCT01803282|75721092|FG005|Overall Study|Death|1|||
41953817|NCT01803282|75721093|FG006|Overall Study|Death|1|||
41953818|NCT01803282|75721094|FG007|Overall Study|Death|5|||
41953819|NCT01803282|75721095|FG008|Overall Study|Death|1|||
41953820|NCT01803282|75721096|FG009|Overall Study|Death|1|||
41953821|NCT01803282|75721097|FG010|Overall Study|Death|0|||
41953822|NCT01803282|75721098|FG011|Overall Study|Death|0|||
41953823|NCT01803282|75721087|FG000|Overall Study|Withdrew Consent|0|||
41953824|NCT01803282|75721088|FG001|Overall Study|Withdrew Consent|0|||
42024016|NCT01160484|75831375|FG000|Overall Study|Withdrawal by Subject|2|||
42118029|NCT00689117|75928842|FG002|Overall Study|Fear of Birth Defects|1|||
41953825|NCT01803282|75721089|FG002|Overall Study|Withdrew Consent|0|||
41953826|NCT01803282|75721090|FG003|Overall Study|Withdrew Consent|6|||
41953827|NCT01803282|75721091|FG004|Overall Study|Withdrew Consent|1|||
41953828|NCT01803282|75721092|FG005|Overall Study|Withdrew Consent|0|||
42024017|NCT01160484|75831375|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
41953829|NCT01803282|75721093|FG006|Overall Study|Withdrew Consent|8|||
41953830|NCT01803282|75721094|FG007|Overall Study|Withdrew Consent|3|||
41953831|NCT01803282|75721095|FG008|Overall Study|Withdrew Consent|1|||
41953832|NCT01803282|75721096|FG009|Overall Study|Withdrew Consent|5|||
41953833|NCT01803282|75721097|FG010|Overall Study|Withdrew Consent|0|||
41953834|NCT01803282|75721098|FG011|Overall Study|Withdrew Consent|1|||
41953835|NCT01803282|75721087|FG000|Overall Study|Investigator's Discretion|0|||
41953836|NCT01803282|75721088|FG001|Overall Study|Investigator's Discretion|0|||
42024018|NCT01032291|75831382|FG000|Safety Lead-in|Adverse Event|1|||
42024019|NCT01032291|75831383|FG001|Safety Lead-in|Adverse Event|0|||
42024020|NCT01032291|75831384|FG002|Safety Lead-in|Adverse Event|0|||
42024021|NCT01032291|75831382|FG000|Safety Lead-in|Death|1|||
42024022|NCT01032291|75831383|FG001|Safety Lead-in|Death|0|||
42024023|NCT01032291|75831384|FG002|Safety Lead-in|Death|0|||
42024024|NCT01032291|75831382|FG000|Proof of Concept|Adverse Event|0|||
42024025|NCT01032291|75831383|FG001|Proof of Concept|Adverse Event|5|||
42024026|NCT01032291|75831384|FG002|Proof of Concept|Adverse Event|1|||
42024027|NCT01032291|75831382|FG000|Proof of Concept|Death|0|||
42024028|NCT01032291|75831383|FG001|Proof of Concept|Death|1|||
42024029|NCT01032291|75831384|FG002|Proof of Concept|Death|2|||
42024030|NCT01032291|75831382|FG000|Proof of Concept|Lack of Efficacy|0|||
42024031|NCT01032291|75831383|FG001|Proof of Concept|Lack of Efficacy|1|||
42024032|NCT01032291|75831384|FG002|Proof of Concept|Lack of Efficacy|0|||
42024033|NCT01032291|75831382|FG000|Proof of Concept|Never Received Study Drug|0|||
42024034|NCT01032291|75831383|FG001|Proof of Concept|Never Received Study Drug|1|||
42024035|NCT01032291|75831384|FG002|Proof of Concept|Never Received Study Drug|0|||
42024036|NCT01159938|75831398|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
42024037|NCT01159938|75831399|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
42024038|NCT01159938|75831400|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
42024039|NCT01159938|75831401|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
42024040|NCT01159938|75831402|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
42024041|NCT01029405|75831427|FG000|Overall Study|Withdrawal by Subject|0|||
42024042|NCT01029405|75831428|FG001|Overall Study|Withdrawal by Subject|1|||
42024043|NCT01029405|75831429|FG002|Overall Study|Withdrawal by Subject|2|||
42024044|NCT01029405|75831430|FG003|Overall Study|Withdrawal by Subject|0|||
42024045|NCT01029405|75831427|FG000|Overall Study|Protocol Violation|0|||
42024046|NCT01029405|75831428|FG001|Overall Study|Protocol Violation|0|||
41953837|NCT01803282|75721089|FG002|Overall Study|Investigator's Discretion|0|||
41953838|NCT01803282|75721090|FG003|Overall Study|Investigator's Discretion|7|||
41953839|NCT01803282|75721091|FG004|Overall Study|Investigator's Discretion|2|||
41953840|NCT01803282|75721092|FG005|Overall Study|Investigator's Discretion|1|||
41953841|NCT01803282|75721093|FG006|Overall Study|Investigator's Discretion|7|||
41953842|NCT01803282|75721094|FG007|Overall Study|Investigator's Discretion|10|||
41953843|NCT01803282|75721095|FG008|Overall Study|Investigator's Discretion|6|||
41953844|NCT01803282|75721096|FG009|Overall Study|Investigator's Discretion|7|||
41953845|NCT01803282|75721097|FG010|Overall Study|Investigator's Discretion|1|||
41953846|NCT01803282|75721098|FG011|Overall Study|Investigator's Discretion|0|||
41953847|NCT01803282|75721087|FG000|Overall Study|Adverse Event|0|||
41953848|NCT01803282|75721088|FG001|Overall Study|Adverse Event|0|||
41953849|NCT01803282|75721089|FG002|Overall Study|Adverse Event|0|||
41953850|NCT01803282|75721090|FG003|Overall Study|Adverse Event|0|||
41953851|NCT01803282|75721091|FG004|Overall Study|Adverse Event|0|||
41953852|NCT01803282|75721092|FG005|Overall Study|Adverse Event|0|||
41953853|NCT01803282|75721093|FG006|Overall Study|Adverse Event|1|||
41953854|NCT01803282|75721094|FG007|Overall Study|Adverse Event|2|||
41953855|NCT01803282|75721095|FG008|Overall Study|Adverse Event|0|||
41953856|NCT01803282|75721096|FG009|Overall Study|Adverse Event|1|||
41953857|NCT01803282|75721097|FG010|Overall Study|Adverse Event|0|||
41953858|NCT01803282|75721098|FG011|Overall Study|Adverse Event|3|||
41953859|NCT01803282|75721087|FG000|Overall Study|Non-Compliance with Study Drug|0|||
41953860|NCT01803282|75721088|FG001|Overall Study|Non-Compliance with Study Drug|0|||
41953861|NCT01803282|75721089|FG002|Overall Study|Non-Compliance with Study Drug|0|||
41953862|NCT01803282|75721090|FG003|Overall Study|Non-Compliance with Study Drug|1|||
42024047|NCT01029405|75831429|FG002|Overall Study|Protocol Violation|0|||
41953863|NCT01803282|75721091|FG004|Overall Study|Non-Compliance with Study Drug|0|||
41953864|NCT01803282|75721092|FG005|Overall Study|Non-Compliance with Study Drug|0|||
41953865|NCT01803282|75721093|FG006|Overall Study|Non-Compliance with Study Drug|0|||
41953866|NCT01803282|75721094|FG007|Overall Study|Non-Compliance with Study Drug|0|||
41953867|NCT01803282|75721095|FG008|Overall Study|Non-Compliance with Study Drug|0|||
41953868|NCT01803282|75721096|FG009|Overall Study|Non-Compliance with Study Drug|0|||
41953869|NCT01803282|75721097|FG010|Overall Study|Non-Compliance with Study Drug|0|||
42024048|NCT01029405|75831430|FG003|Overall Study|Protocol Violation|1|||
42024049|NCT01029405|75831427|FG000|Overall Study|Adverse Event|0|||
42024050|NCT01029405|75831428|FG001|Overall Study|Adverse Event|0|||
42024051|NCT01029405|75831429|FG002|Overall Study|Adverse Event|1|||
42024052|NCT01029405|75831430|FG003|Overall Study|Adverse Event|1|||
42024053|NCT01029405|75831427|FG000|Overall Study|Lost to Follow-up|2|||
41953870|NCT01803282|75721098|FG011|Overall Study|Non-Compliance with Study Drug|0|||
41953871|NCT01803282|75721087|FG000|Overall Study|Unknown Reason|0|||
41953872|NCT01803282|75721088|FG001|Overall Study|Unknown Reason|0|||
41953873|NCT01803282|75721089|FG002|Overall Study|Unknown Reason|0|||
41953874|NCT01803282|75721090|FG003|Overall Study|Unknown Reason|0|||
41953875|NCT01803282|75721091|FG004|Overall Study|Unknown Reason|0|||
41953876|NCT01803282|75721092|FG005|Overall Study|Unknown Reason|0|||
41953877|NCT01803282|75721093|FG006|Overall Study|Unknown Reason|0|||
41953878|NCT01803282|75721094|FG007|Overall Study|Unknown Reason|1|||
41953879|NCT01803282|75721095|FG008|Overall Study|Unknown Reason|0|||
41953880|NCT01803282|75721096|FG009|Overall Study|Unknown Reason|0|||
41953881|NCT01803282|75721097|FG010|Overall Study|Unknown Reason|0|||
41953882|NCT01803282|75721098|FG011|Overall Study|Unknown Reason|0|||
41953883|NCT01803282|75721087|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
41953884|NCT01803282|75721088|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
41953885|NCT01803282|75721089|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
41953886|NCT01803282|75721090|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
41953887|NCT01803282|75721091|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
41953888|NCT01803282|75721092|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
41953889|NCT01803282|75721093|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
41953890|NCT01803282|75721094|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
41953891|NCT01803282|75721095|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
41953892|NCT01803282|75721096|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
41953893|NCT01803282|75721097|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
41953894|NCT01803282|75721098|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
41953895|NCT01803282|75721087|FG000|Overall Study|Enrolled but Never Treated|0|||
41953896|NCT01803282|75721088|FG001|Overall Study|Enrolled but Never Treated|0|||
41953897|NCT01803282|75721089|FG002|Overall Study|Enrolled but Never Treated|0|||
41953898|NCT01803282|75721090|FG003|Overall Study|Enrolled but Never Treated|0|||
41953899|NCT01803282|75721091|FG004|Overall Study|Enrolled but Never Treated|1|||
41953900|NCT01803282|75721092|FG005|Overall Study|Enrolled but Never Treated|0|||
41953901|NCT01803282|75721093|FG006|Overall Study|Enrolled but Never Treated|1|||
41953902|NCT01803282|75721094|FG007|Overall Study|Enrolled but Never Treated|1|||
41953903|NCT01803282|75721095|FG008|Overall Study|Enrolled but Never Treated|0|||
41953904|NCT01803282|75721096|FG009|Overall Study|Enrolled but Never Treated|1|||
41953905|NCT01803282|75721097|FG010|Overall Study|Enrolled but Never Treated|0|||
41953906|NCT01803282|75721098|FG011|Overall Study|Enrolled but Never Treated|0|||
41953907|NCT01844778|75721127|FG000|Overall Study|Protocol deviation|0|||
41953908|NCT01844778|75721128|FG001|Overall Study|Protocol deviation|1|||
41953909|NCT01844778|75721129|FG002|Overall Study|Protocol deviation|2|||
41953910|NCT01844778|75721127|FG000|Overall Study|Withdrawal by Subject|2|||
41953911|NCT01844778|75721128|FG001|Overall Study|Withdrawal by Subject|0|||
41953912|NCT01844778|75721129|FG002|Overall Study|Withdrawal by Subject|0|||
41953913|NCT01844778|75721127|FG000|Overall Study|Adverse Event|0|||
41953914|NCT01844778|75721128|FG001|Overall Study|Adverse Event|2|||
41953915|NCT01844778|75721129|FG002|Overall Study|Adverse Event|2|||
41953916|NCT01802580|75721143|FG000|Overall Study|Physician Decision|1|||
41953917|NCT01802580|75721144|FG001|Overall Study|Physician Decision|0|||
41953918|NCT01802580|75721143|FG000|Overall Study|Protocol Violation|2|||
41953919|NCT01802580|75721144|FG001|Overall Study|Protocol Violation|0|||
41953920|NCT01802580|75721143|FG000|Overall Study|Withdrawal by Subject|5|||
41953921|NCT01802580|75721144|FG001|Overall Study|Withdrawal by Subject|6|||
41953922|NCT01802580|75721143|FG000|Overall Study|Other|1|||
41953923|NCT01802580|75721144|FG001|Overall Study|Other|3|||
41953924|NCT01802580|75721143|FG000|Overall Study|Lack of Efficacy|0|||
41953925|NCT01802580|75721144|FG001|Overall Study|Lack of Efficacy|2|||
41953926|NCT01611090|75721152|FG000|Randomized Period|Lost to Follow-up|8|||
41953927|NCT01611090|75721153|FG001|Randomized Period|Lost to Follow-up|3|||
41953928|NCT01611090|75721154|FG002|Randomized Period|Lost to Follow-up|0|||
41953929|NCT01611090|75721152|FG000|Randomized Period|Withdrawal by Subject|22|||
41953930|NCT01611090|75721153|FG001|Randomized Period|Withdrawal by Subject|26|||
41953931|NCT01611090|75721154|FG002|Randomized Period|Withdrawal by Subject|0|||
41953932|NCT01611090|75721152|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
41953933|NCT01611090|75721153|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
41953934|NCT01611090|75721154|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
41953935|NCT01611090|75721152|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
41953936|NCT01611090|75721153|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
41953937|NCT01611090|75721154|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
41953938|NCT01844700|75721163|FG000|Overall Study|Lack of Efficacy|1|||
41953939|NCT01844700|75721164|FG001|Overall Study|Lack of Efficacy|0|||
41953940|NCT01844700|75721163|FG000|Overall Study|refused medication switch|1|||
41953941|NCT01844700|75721164|FG001|Overall Study|refused medication switch|0|||
41953942|NCT01844700|75721163|FG000|Overall Study|Withdrawal by Subject|1|||
41953943|NCT01844700|75721164|FG001|Overall Study|Withdrawal by Subject|0|||
41953944|NCT01844700|75721163|FG000|Overall Study|stopped taking meds|0|||
41953945|NCT01844700|75721164|FG001|Overall Study|stopped taking meds|1|||
41953946|NCT01844076|75721174|FG000|Overall Study|Adverse Event|1|||
41953947|NCT01844076|75721175|FG001|Overall Study|Adverse Event|0|||
41953948|NCT01844076|75721176|FG002|Overall Study|Adverse Event|0|||
41953949|NCT01844076|75721177|FG003|Overall Study|Adverse Event|0|||
41953950|NCT01844076|75721174|FG000|Overall Study|Withdrawal by Subject|1|||
41953951|NCT01844076|75721175|FG001|Overall Study|Withdrawal by Subject|0|||
41953952|NCT01844076|75721176|FG002|Overall Study|Withdrawal by Subject|0|||
41953953|NCT01844076|75721177|FG003|Overall Study|Withdrawal by Subject|0|||
41953954|NCT01826604|75721189|FG000|Overall Study|Lost to Follow-up|8|||
41953955|NCT01826604|75721190|FG001|Overall Study|Lost to Follow-up|9|||
41953956|NCT01843842|75721198|FG000|Overall Study|Do not meet inclusion criteria|1|||
41953957|NCT01843842|75721199|FG001|Overall Study|Do not meet inclusion criteria|1|||
41953958|NCT01826448|75721207|FG000|Overall Study|Adverse Event|1|||
41953959|NCT01826448|75721208|FG001|Overall Study|Adverse Event|3|||
41953960|NCT01826448|75721207|FG000|Overall Study|Disease progression|2|||
41953961|NCT01826448|75721208|FG001|Overall Study|Disease progression|4|||
41953962|NCT01826448|75721207|FG000|Overall Study|Withdrawal by Subject|1|||
41953963|NCT01826448|75721208|FG001|Overall Study|Withdrawal by Subject|0|||
41953964|NCT01826448|75721207|FG000|Overall Study|Physician Decision|0|||
41953965|NCT01826448|75721208|FG001|Overall Study|Physician Decision|1|||
42300437|NCT02546609|76135634|FG002|Overall Study|travel or work schedule restriction|2|||
42300438|NCT02553317|76135644|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
42300439|NCT02553317|76135645|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
42300440|NCT02553317|76135644|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
42300441|NCT02553317|76135645|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
42300442|NCT02553317|76135644|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
42300443|NCT02553317|76135645|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
42300444|NCT02553317|76135644|FG000|Overall Treatment Period + Follow-up|Death|1|||
42300445|NCT02553317|76135645|FG001|Overall Treatment Period + Follow-up|Death|3|||
42300446|NCT02553317|76135644|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
42300447|NCT02553317|76135645|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
42300448|NCT02553317|76135644|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
42300449|NCT02553317|76135645|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
42300450|NCT02553317|76135644|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
42300451|NCT02553317|76135645|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
42300452|NCT02553317|76135644|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
42300453|NCT02553317|76135645|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
42300454|NCT02553317|76135644|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
42300455|NCT02553317|76135645|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
42300456|NCT02553317|76135644|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
42300457|NCT02553317|76135645|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
42300458|NCT02325219|76135655|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
42300459|NCT02325219|76135656|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
42300460|NCT02325219|76135657|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
42300461|NCT02325219|76135658|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
42300462|NCT02325219|76135659|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
42300463|NCT02325219|76135655|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
42300464|NCT02325219|76135656|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
42300465|NCT02325219|76135657|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
42300466|NCT02325219|76135658|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
42300467|NCT02325219|76135659|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
42300468|NCT02325219|76135655|FG000|Controlled Period (Week 0 - 16)|Other|0|||
42300469|NCT02325219|76135656|FG001|Controlled Period (Week 0 - 16)|Other|0|||
42300470|NCT02325219|76135657|FG002|Controlled Period (Week 0 - 16)|Other|1|||
42300471|NCT02325219|76135658|FG003|Controlled Period (Week 0 - 16)|Other|0|||
42300472|NCT02325219|76135659|FG004|Controlled Period (Week 0 - 16)|Other|0|||
42300473|NCT02325219|76135655|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
41953966|NCT01826448|75721207|FG000|Overall Study|2 active cancers|0|||
41953967|NCT01826448|75721208|FG001|Overall Study|2 active cancers|1|||
41953968|NCT01826370|75721214|FG000|Overall Study|Protocol Violation|6|||
41953969|NCT01826370|75721214|FG000|Overall Study|Lost to Follow-up|12|||
42118030|NCT00689117|75928843|FG003|Overall Study|Fear of Birth Defects|0|||
41953970|NCT01826370|75721214|FG000|Overall Study|Other reason not defined above|2|||
41953971|NCT01826214|75721220|FG000|Overall Study|Adverse Event|7|||
41953972|NCT01826214|75721221|FG001|Overall Study|Adverse Event|6|||
41953973|NCT01826214|75721220|FG000|Overall Study|Death|3|||
41953974|NCT01826214|75721221|FG001|Overall Study|Death|1|||
41953975|NCT01826214|75721220|FG000|Overall Study|Lost to Follow-up|1|||
41953976|NCT01826214|75721221|FG001|Overall Study|Lost to Follow-up|0|||
41953977|NCT01826214|75721220|FG000|Overall Study|Physician Decision|0|||
41953978|NCT01826214|75721221|FG001|Overall Study|Physician Decision|2|||
41953979|NCT01826214|75721220|FG000|Overall Study|Progressive disease|22|||
41953980|NCT01826214|75721221|FG001|Overall Study|Progressive disease|21|||
41953981|NCT01826214|75721220|FG000|Overall Study|Study terminated by Sponsor|0|||
41953982|NCT01826214|75721221|FG001|Overall Study|Study terminated by Sponsor|1|||
41953983|NCT01826214|75721220|FG000|Overall Study|Subject/guardian decision|2|||
41953984|NCT01826214|75721221|FG001|Overall Study|Subject/guardian decision|3|||
41953985|NCT01843062|75721229|FG000|Overall Study|Protocol Violation|1|||
41953986|NCT01843062|75721230|FG001|Overall Study|Protocol Violation|0|||
41953987|NCT01843062|75721229|FG000|Overall Study|New treatment following progression|2|||
41953988|NCT01843062|75721230|FG001|Overall Study|New treatment following progression|0|||
41953989|NCT01843062|75721229|FG000|Overall Study|Pregnancy|1|||
41953990|NCT01843062|75721230|FG001|Overall Study|Pregnancy|0|||
41953991|NCT01843062|75721229|FG000|Overall Study|Adverse Event|2|||
41953992|NCT01843062|75721230|FG001|Overall Study|Adverse Event|0|||
41953993|NCT01843062|75721229|FG000|Overall Study|Incorrect randomisation|1|||
41953994|NCT01843062|75721230|FG001|Overall Study|Incorrect randomisation|0|||
41953995|NCT01843062|75721229|FG000|Overall Study|Withdrawal by Subject|12|||
41953996|NCT01843062|75721230|FG001|Overall Study|Withdrawal by Subject|3|||
41953997|NCT01843062|75721229|FG000|Overall Study|Death|1|||
41953998|NCT01843062|75721230|FG001|Overall Study|Death|2|||
41953999|NCT01843062|75721229|FG000|Overall Study|Lost to Follow-up|2|||
41954000|NCT01843062|75721230|FG001|Overall Study|Lost to Follow-up|4|||
41954001|NCT01842438|75721238|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
41954002|NCT01842438|75721239|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
41954003|NCT01842438|75721238|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
41954004|NCT01842438|75721239|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
41954005|NCT01842438|75721238|FG000|T2: 6month Follow-up|Death|0|||
41954006|NCT01842438|75721239|FG001|T2: 6month Follow-up|Death|1|||
41954007|NCT01799226|75721251|FG000|Overall Study|Withdrawal by Subject|1|||
41954008|NCT01799226|75721252|FG001|Overall Study|Withdrawal by Subject|0|||
41954009|NCT01799226|75721251|FG000|Overall Study|Disqualified at Day 14|1|||
41954010|NCT01799226|75721252|FG001|Overall Study|Disqualified at Day 14|0|||
41954011|NCT01825200|75721260|FG000|Overall Study|Lost to Follow-up|5|||
41954012|NCT01825200|75721261|FG001|Overall Study|Lost to Follow-up|6|||
42024054|NCT01029405|75831428|FG001|Overall Study|Lost to Follow-up|1|||
42024055|NCT01029405|75831429|FG002|Overall Study|Lost to Follow-up|1|||
42024056|NCT01029405|75831430|FG003|Overall Study|Lost to Follow-up|2|||
42024057|NCT01029405|75831427|FG000|Overall Study|Other|0|||
42024058|NCT01029405|75831428|FG001|Overall Study|Other|1|||
42024059|NCT01029405|75831429|FG002|Overall Study|Other|0|||
41954013|NCT01825200|75721260|FG000|Overall Study|Withdrawal by Subject|0|||
41954014|NCT01825200|75721261|FG001|Overall Study|Withdrawal by Subject|1|||
41954015|NCT01824576|75721267|FG000|Overall Study|Device deficiency|2|||
41954016|NCT01824498|75721277|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
41954017|NCT01824498|75721278|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
41954018|NCT01824498|75721279|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
41954019|NCT01824498|75721280|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
41954020|NCT01824498|75721281|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
41954021|NCT01824498|75721282|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
41954022|NCT01798134|75721290|FG000|Overall Study|Lost to Follow-up|1|||
41954023|NCT01798134|75721290|FG000|Overall Study|Withdrawal by Subject|3|||
41954024|NCT01798134|75721290|FG000|Overall Study|Death|2|||
41954025|NCT01798134|75721290|FG000|Overall Study|Adverse Event|3|||
42024060|NCT01029405|75831430|FG003|Overall Study|Other|1|||
42024061|NCT01021683|75831440|FG000|Overall Study|Lack of Efficacy|12|||
42024062|NCT01021683|75831440|FG000|Overall Study|Recovery of neutrophil count|51|||
41954026|NCT01798134|75721290|FG000|Overall Study|Physician Decision|3|||
41954027|NCT01798134|75721290|FG000|Overall Study|Liver transplant/surgery|4|||
42024063|NCT01021683|75831440|FG000|Overall Study|Other|8|||
42024064|NCT01021293|75831446|FG000|Overall Study|Serious Adverse Event|2|||
42024065|NCT01021293|75831447|FG001|Overall Study|Serious Adverse Event|1|||
41954028|NCT01798056|75721296|FG000|Overall Study|Serious Adverse Event|13|||
41954029|NCT01798056|75721297|FG001|Overall Study|Serious Adverse Event|12|||
41954030|NCT01798056|75721296|FG000|Overall Study|Withdrawal by Subject|12|||
41954031|NCT01798056|75721297|FG001|Overall Study|Withdrawal by Subject|9|||
41954032|NCT01798056|75721296|FG000|Overall Study|Migrated/moved from study area|1|||
41954033|NCT01798056|75721297|FG001|Overall Study|Migrated/moved from study area|1|||
41954034|NCT01798056|75721296|FG000|Overall Study|Lost to Follow-up|1|||
41954035|NCT01798056|75721297|FG001|Overall Study|Lost to Follow-up|1|||
41954036|NCT01798056|75721296|FG000|Overall Study|Other|0|||
42024066|NCT01021293|75831446|FG000|Overall Study|Adverse Event|2|||
42024067|NCT01021293|75831447|FG001|Overall Study|Adverse Event|1|||
42024068|NCT01021293|75831446|FG000|Overall Study|Withdrawal by Subject|1|||
41954037|NCT01798056|75721297|FG001|Overall Study|Other|2|||
41954038|NCT01824342|75721307|FG000|Overall Study|Withdrawal by Subject|0|||
41954039|NCT01824342|75721308|FG001|Overall Study|Withdrawal by Subject|3|||
41954040|NCT01824342|75721307|FG000|Overall Study|Adverse Event|1|||
41954041|NCT01824342|75721308|FG001|Overall Study|Adverse Event|1|||
41954042|NCT01824342|75721307|FG000|Overall Study|Disease Progression|1|||
41954043|NCT01824342|75721308|FG001|Overall Study|Disease Progression|1|||
41954044|NCT01824342|75721307|FG000|Overall Study|Physician Decision|5|||
41954045|NCT01824342|75721308|FG001|Overall Study|Physician Decision|0|||
41954046|NCT01824342|75721307|FG000|Overall Study|Death|2|||
41954047|NCT01824342|75721308|FG001|Overall Study|Death|0|||
41954048|NCT01841970|75721314|FG000|Overall Study|Withdrawal by Subject|1|||
41954049|NCT01841970|75721314|FG000|Overall Study|Physician Decision|2|||
41954050|NCT01841970|75721314|FG000|Overall Study|Lost to Follow-up|8|||
41954051|NCT01823328|75721323|FG000|Overall Study|Withdrawal by Subject|8|||
41954052|NCT01823328|75721324|FG001|Overall Study|Withdrawal by Subject|6|||
41954053|NCT01840410|75721332|FG000|Overall Study|Physician Decision|1|||
41954054|NCT01840410|75721333|FG001|Overall Study|Physician Decision|2|||
41954055|NCT01840410|75721332|FG000|Overall Study|Pregnancy|1|||
41954056|NCT01840410|75721333|FG001|Overall Study|Pregnancy|0|||
41954057|NCT01840410|75721332|FG000|Overall Study|Protocol deviation|1|||
41954058|NCT01840410|75721333|FG001|Overall Study|Protocol deviation|0|||
41954059|NCT01840410|75721332|FG000|Overall Study|Lost to Follow-up|1|||
41954060|NCT01840410|75721333|FG001|Overall Study|Lost to Follow-up|0|||
41954061|NCT01840410|75721332|FG000|Overall Study|Withdrawal by Subject|2|||
41954062|NCT01840410|75721333|FG001|Overall Study|Withdrawal by Subject|1|||
41954063|NCT01840410|75721332|FG000|Overall Study|Adverse Event|1|||
41954064|NCT01840410|75721333|FG001|Overall Study|Adverse Event|1|||
41954065|NCT01797432|75721341|FG000|Overall Study|Lost to Follow-up|1|||
41954066|NCT01797432|75721341|FG000|Overall Study|Adverse Event|1|||
41954067|NCT01797432|75721341|FG000|Overall Study|Withdrawal by Subject|1|||
41954068|NCT01797432|75721341|FG000|Overall Study|lived too far from study site|1|||
41954069|NCT01797120|75721347|FG000|Overall Study|Disesae progression|37|||
41954070|NCT01797120|75721348|FG001|Overall Study|Disesae progression|49|||
41954071|NCT01797120|75721347|FG000|Overall Study|Adverse Event|13|||
41954072|NCT01797120|75721348|FG001|Overall Study|Adverse Event|5|||
41954073|NCT01797120|75721347|FG000|Overall Study|Withdrawal by Subject|6|||
41954074|NCT01797120|75721348|FG001|Overall Study|Withdrawal by Subject|6|||
41954075|NCT01797120|75721347|FG000|Overall Study|Symptomatic progression|2|||
41954076|NCT01797120|75721348|FG001|Overall Study|Symptomatic progression|1|||
41954077|NCT01797120|75721347|FG000|Overall Study|Non-compliance|1|||
41954078|NCT01797120|75721348|FG001|Overall Study|Non-compliance|0|||
41954079|NCT01797120|75721347|FG000|Overall Study|Physician Decision|3|||
41954080|NCT01797120|75721348|FG001|Overall Study|Physician Decision|0|||
41954081|NCT01797120|75721347|FG000|Overall Study|still on treatment|2|||
41954082|NCT01797120|75721348|FG001|Overall Study|still on treatment|4|||
41954083|NCT01797120|75721347|FG000|Overall Study|never start protocol therapy|2|||
41954084|NCT01797120|75721348|FG001|Overall Study|never start protocol therapy|0|||
41954085|NCT01796964|75721356|FG000|Overall Study|Adverse Event|1|||
41954086|NCT01796964|75721357|FG001|Overall Study|Adverse Event|1|||
41954087|NCT01796964|75721356|FG000|Overall Study|Death|1|||
41954088|NCT01796964|75721357|FG001|Overall Study|Death|0|||
41954089|NCT01796964|75721356|FG000|Overall Study|Protocol Violation|0|||
41954090|NCT01796964|75721357|FG001|Overall Study|Protocol Violation|1|||
41954091|NCT01796964|75721356|FG000|Overall Study|Withdrawal by Subject|1|||
41954092|NCT01796964|75721357|FG001|Overall Study|Withdrawal by Subject|1|||
41954093|NCT01838694|75721366|FG000|Overall Study|Adverse Event|0|||
41954094|NCT01838694|75721367|FG001|Overall Study|Adverse Event|1|||
41954095|NCT01795638|75721378|FG000|Overall Study|Death|0|||
41954096|NCT01795638|75721379|FG001|Overall Study|Death|3|||
41954097|NCT01795638|75721378|FG000|Overall Study|transferred to quaternary hospital|2|||
41954098|NCT01795638|75721379|FG001|Overall Study|transferred to quaternary hospital|3|||
41954099|NCT01795638|75721378|FG000|Overall Study|Protocol Violation|3|||
41954100|NCT01795638|75721379|FG001|Overall Study|Protocol Violation|0|||
41954101|NCT01795638|75721378|FG000|Overall Study|discharged from hospital|7|||
41954102|NCT01795638|75721379|FG001|Overall Study|discharged from hospital|5|||
41954103|NCT01795638|75721378|FG000|Overall Study|Withdrawal by Subject|1|||
41954104|NCT01795638|75721379|FG001|Overall Study|Withdrawal by Subject|0|||
41954105|NCT01794780|75721393|FG000|Overall Study|Adverse Event|0|||
41954106|NCT01794780|75721394|FG001|Overall Study|Adverse Event|1|||
41954107|NCT01794780|75721395|FG002|Overall Study|Adverse Event|2|||
41954108|NCT01794780|75721396|FG003|Overall Study|Adverse Event|0|||
41954109|NCT01794780|75721397|FG004|Overall Study|Adverse Event|0|||
41954110|NCT01794780|75721398|FG005|Overall Study|Adverse Event|0|||
41954111|NCT01794780|75721399|FG006|Overall Study|Adverse Event|0|||
41954112|NCT01794780|75721400|FG007|Overall Study|Adverse Event|0|||
41954113|NCT01794780|75721393|FG000|Overall Study|Death|0|||
41954114|NCT01794780|75721394|FG001|Overall Study|Death|2|||
41954115|NCT01794780|75721395|FG002|Overall Study|Death|14|||
41954116|NCT01794780|75721396|FG003|Overall Study|Death|1|||
41954117|NCT01794780|75721397|FG004|Overall Study|Death|0|||
41954118|NCT01794780|75721398|FG005|Overall Study|Death|9|||
41954119|NCT01794780|75721399|FG006|Overall Study|Death|4|||
41954120|NCT01794780|75721400|FG007|Overall Study|Death|0|||
41954121|NCT01794780|75721393|FG000|Overall Study|Lost to Follow-up|10|||
41954122|NCT01794780|75721394|FG001|Overall Study|Lost to Follow-up|64|||
41954123|NCT01794780|75721395|FG002|Overall Study|Lost to Follow-up|165|||
41954124|NCT01794780|75721396|FG003|Overall Study|Lost to Follow-up|53|||
41954125|NCT01794780|75721397|FG004|Overall Study|Lost to Follow-up|2|||
41954126|NCT01794780|75721398|FG005|Overall Study|Lost to Follow-up|99|||
41954127|NCT01794780|75721399|FG006|Overall Study|Lost to Follow-up|30|||
41954128|NCT01794780|75721400|FG007|Overall Study|Lost to Follow-up|5|||
41954129|NCT01794780|75721393|FG000|Overall Study|Withdrew informed consent|7|||
41954130|NCT01794780|75721394|FG001|Overall Study|Withdrew informed consent|17|||
41954131|NCT01794780|75721395|FG002|Overall Study|Withdrew informed consent|36|||
41954132|NCT01794780|75721396|FG003|Overall Study|Withdrew informed consent|9|||
41954133|NCT01794780|75721397|FG004|Overall Study|Withdrew informed consent|0|||
41954134|NCT01794780|75721398|FG005|Overall Study|Withdrew informed consent|48|||
41954135|NCT01794780|75721399|FG006|Overall Study|Withdrew informed consent|4|||
41954136|NCT01794780|75721400|FG007|Overall Study|Withdrew informed consent|3|||
41954137|NCT01794780|75721393|FG000|Overall Study|Other|0|||
41954138|NCT01794780|75721394|FG001|Overall Study|Other|12|||
41954139|NCT01794780|75721395|FG002|Overall Study|Other|25|||
41954140|NCT01794780|75721396|FG003|Overall Study|Other|20|||
41954141|NCT01794780|75721397|FG004|Overall Study|Other|1|||
41954142|NCT01794780|75721398|FG005|Overall Study|Other|24|||
41954143|NCT01794780|75721399|FG006|Overall Study|Other|4|||
41954144|NCT01794780|75721400|FG007|Overall Study|Other|1|||
41954145|NCT01838616|75721427|FG000|Titration Period|Adverse Event|18|||
41954146|NCT01838616|75721428|FG001|Titration Period|Adverse Event|48|||
41954147|NCT01838616|75721427|FG000|Titration Period|Lack of Efficacy|5|||
41954148|NCT01838616|75721428|FG001|Titration Period|Lack of Efficacy|12|||
41954149|NCT01838616|75721427|FG000|Titration Period|Withdrawal by Subject|5|||
41954150|NCT01838616|75721428|FG001|Titration Period|Withdrawal by Subject|5|||
41954151|NCT01838616|75721427|FG000|Titration Period|Technical problems|1|||
41954152|NCT01838616|75721428|FG001|Titration Period|Technical problems|0|||
41954153|NCT01838616|75721427|FG000|Titration Period|Other|1|||
41954154|NCT01838616|75721428|FG001|Titration Period|Other|0|||
41954155|NCT01838616|75721427|FG000|Titration Period|Protocol Violation|0|||
41954156|NCT01838616|75721428|FG001|Titration Period|Protocol Violation|1|||
41954157|NCT01838616|75721427|FG000|Continuation Period|Lack of Efficacy|3|||
41954158|NCT01838616|75721428|FG001|Continuation Period|Lack of Efficacy|5|||
41954159|NCT01838616|75721427|FG000|Continuation Period|Adverse Event|8|||
41954160|NCT01838616|75721428|FG001|Continuation Period|Adverse Event|4|||
41954161|NCT01838616|75721427|FG000|Continuation Period|Protocol Violation|2|||
41954162|NCT01838616|75721428|FG001|Continuation Period|Protocol Violation|0|||
41954163|NCT01838616|75721427|FG000|Continuation Period|Lost to Follow-up|1|||
41954164|NCT01838616|75721428|FG001|Continuation Period|Lost to Follow-up|0|||
41954165|NCT01838616|75721427|FG000|Continuation Period|Withdrawal by Subject|0|||
41954166|NCT01838616|75721428|FG001|Continuation Period|Withdrawal by Subject|4|||
41954167|NCT01838616|75721427|FG000|Continuation Period|Technical problems|0|||
41954168|NCT01838616|75721428|FG001|Continuation Period|Technical problems|1|||
41954169|NCT01838616|75721427|FG000|Pick-up Arm|Lack of Efficacy|4|||
41954170|NCT01838616|75721428|FG001|Pick-up Arm|Lack of Efficacy|0|||
41954171|NCT01838616|75721427|FG000|Pick-up Arm|Adverse Event|9|||
41954172|NCT01838616|75721428|FG001|Pick-up Arm|Adverse Event|0|||
41954173|NCT01838616|75721427|FG000|Pick-up Arm|Withdrawal by Subject|1|||
41954174|NCT01838616|75721428|FG001|Pick-up Arm|Withdrawal by Subject|0|||
41954175|NCT01838616|75721427|FG000|Pick-up Arm|Technical problems|1|||
41954176|NCT01838616|75721428|FG001|Pick-up Arm|Technical problems|0|||
41954177|NCT01611792|75721441|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
41954178|NCT01611792|75721442|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
41954179|NCT01611792|75721441|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
41954180|NCT01611792|75721442|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
41954181|NCT01820364|75721449|FG000|Part I: LGX818|Death|1|||
41954182|NCT01820364|75721450|FG001|Part I: LGX818|Death|0|||
41954183|NCT01820364|75721449|FG000|Part I: LGX818|Administrative Problems|3|||
41954184|NCT01820364|75721450|FG001|Part I: LGX818|Administrative Problems|0|||
41954185|NCT01820364|75721449|FG000|Part I: LGX818|Adverse Event|6|||
42024069|NCT01021293|75831447|FG001|Overall Study|Withdrawal by Subject|3|||
41954186|NCT01820364|75721450|FG001|Part I: LGX818|Adverse Event|0|||
42024070|NCT01021293|75831446|FG000|Overall Study|Migrated/moved from study area|6|||
42118031|NCT00689117|75928840|FG000|Overall Study|Transportation|1|||
41954187|NCT01820364|75721449|FG000|Part I: LGX818|Disease Progression|4|||
41954188|NCT01820364|75721450|FG001|Part I: LGX818|Disease Progression|0|||
41954189|NCT01820364|75721449|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
41954190|NCT01820364|75721450|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
41954191|NCT01819506|75721458|FG000|Overall Study|Physician Decision|5|||
41954192|NCT01819506|75721459|FG001|Overall Study|Physician Decision|2|||
41954193|NCT01819506|75721458|FG000|Overall Study|Withdrawal by Subject|3|||
41954194|NCT01819506|75721459|FG001|Overall Study|Withdrawal by Subject|3|||
41954195|NCT01794000|75721467|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
41954196|NCT01794000|75721468|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
41954197|NCT01794000|75721467|FG000|Double-Blind Phase (DBP)|Death|1|||
41954198|NCT01794000|75721468|FG001|Double-Blind Phase (DBP)|Death|2|||
41954199|NCT01794000|75721467|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
41954200|NCT01794000|75721468|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
41954201|NCT01794000|75721467|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
41954202|NCT01794000|75721468|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
41954203|NCT01794000|75721467|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
41954204|NCT01794000|75721468|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
41954205|NCT01794000|75721467|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
41954206|NCT01794000|75721468|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
41954207|NCT01794000|75721467|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
41954208|NCT01794000|75721468|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
41954209|NCT01794000|75721467|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
41954210|NCT01794000|75721468|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
41954211|NCT01609296|75721475|FG000|Overall Study|Death|253|||
41954212|NCT01609296|75721475|FG000|Overall Study|Withdrawal by Subject|151|||
41954213|NCT01609296|75721475|FG000|Overall Study|Lost to Follow-up|21|||
41954214|NCT01609296|75721475|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
41954215|NCT01609296|75721475|FG000|Overall Study|missed visit but known to be alive|28|||
41954216|NCT01609218|75721483|FG000|Period 1|Adverse Event|3|||
41954217|NCT01609218|75721484|FG001|Period 1|Adverse Event|5|||
41954218|NCT01609218|75721483|FG000|Period 1|Sponsor Decision|0|||
41954219|NCT01609218|75721484|FG001|Period 1|Sponsor Decision|1|||
41954220|NCT01609218|75721483|FG000|Period 2|Adverse Event|1|||
41954221|NCT01609218|75721484|FG001|Period 2|Adverse Event|0|||
41954222|NCT01609062|75721492|FG000|Extension Phase|Terminated by Sponsor|14|||
41954223|NCT01609062|75721493|FG001|Extension Phase|Terminated by Sponsor|9|||
41954224|NCT01609062|75721492|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
41954225|NCT01609062|75721493|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
41954226|NCT01609062|75721492|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
41954227|NCT01609062|75721493|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
41954228|NCT01819272|75721506|FG000|Overall Study|Adverse Event|1|||
41954229|NCT01819272|75721507|FG001|Overall Study|Adverse Event|0|||
41954230|NCT01819272|75721508|FG002|Overall Study|Adverse Event|0|||
41954231|NCT01819272|75721509|FG003|Overall Study|Adverse Event|2|||
41954232|NCT01819272|75721510|FG004|Overall Study|Adverse Event|0|||
41954233|NCT01819272|75721511|FG005|Overall Study|Adverse Event|0|||
41954234|NCT01819272|75721506|FG000|Overall Study|Lost to Follow-up|3|||
41954235|NCT01819272|75721507|FG001|Overall Study|Lost to Follow-up|0|||
41954236|NCT01819272|75721508|FG002|Overall Study|Lost to Follow-up|1|||
41954237|NCT01819272|75721509|FG003|Overall Study|Lost to Follow-up|0|||
41954238|NCT01819272|75721510|FG004|Overall Study|Lost to Follow-up|0|||
41954239|NCT01819272|75721511|FG005|Overall Study|Lost to Follow-up|3|||
41954240|NCT01819272|75721506|FG000|Overall Study|Protocol Violation|0|||
41954241|NCT01819272|75721507|FG001|Overall Study|Protocol Violation|0|||
41954242|NCT01819272|75721508|FG002|Overall Study|Protocol Violation|0|||
41954243|NCT01819272|75721509|FG003|Overall Study|Protocol Violation|1|||
41954244|NCT01819272|75721510|FG004|Overall Study|Protocol Violation|2|||
41954245|NCT01819272|75721511|FG005|Overall Study|Protocol Violation|3|||
41954246|NCT01819272|75721506|FG000|Overall Study|Physician Decision|0|||
41954247|NCT01819272|75721507|FG001|Overall Study|Physician Decision|1|||
41954248|NCT01819272|75721508|FG002|Overall Study|Physician Decision|0|||
41954249|NCT01819272|75721509|FG003|Overall Study|Physician Decision|0|||
41954250|NCT01819272|75721510|FG004|Overall Study|Physician Decision|0|||
41954251|NCT01819272|75721511|FG005|Overall Study|Physician Decision|0|||
41954252|NCT01819272|75721506|FG000|Overall Study|Withdrawal of Consent|0|||
41954253|NCT01819272|75721507|FG001|Overall Study|Withdrawal of Consent|1|||
41954254|NCT01819272|75721508|FG002|Overall Study|Withdrawal of Consent|2|||
41954255|NCT01819272|75721509|FG003|Overall Study|Withdrawal of Consent|1|||
41954256|NCT01819272|75721510|FG004|Overall Study|Withdrawal of Consent|0|||
41954257|NCT01819272|75721511|FG005|Overall Study|Withdrawal of Consent|1|||
41954258|NCT01819272|75721506|FG000|Overall Study|Loss of Glucose Control|2|||
41954259|NCT01819272|75721507|FG001|Overall Study|Loss of Glucose Control|1|||
41954260|NCT01819272|75721508|FG002|Overall Study|Loss of Glucose Control|0|||
41954261|NCT01819272|75721509|FG003|Overall Study|Loss of Glucose Control|1|||
41954262|NCT01819272|75721510|FG004|Overall Study|Loss of Glucose Control|2|||
41954263|NCT01819272|75721511|FG005|Overall Study|Loss of Glucose Control|0|||
41954264|NCT01819194|75721525|FG000|Overall Study|Loss of study articles|2|||
41954265|NCT01611558|75721529|FG000|Induction Phase|Study drug toxicity|15|||
41954266|NCT01611558|75721529|FG000|Induction Phase|Disease progression|18|||
41954267|NCT01611558|75721529|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
41954268|NCT01611558|75721529|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
41954269|NCT01611558|75721529|FG000|Induction Phase|Death|1|||
41954270|NCT01611558|75721529|FG000|Maintenance Phase|Withdrawal by Subject|1|||
41954271|NCT01611558|75721529|FG000|Maintenance Phase|Elevated Uric acid|1|||
41954272|NCT01818726|75721536|FG000|Overall Study|Administrative reasons|5|||
41954273|NCT01818726|75721537|FG001|Overall Study|Administrative reasons|1|||
41954274|NCT01818726|75721536|FG000|Overall Study|Withdrawal by Subject|0|||
41954275|NCT01818726|75721537|FG001|Overall Study|Withdrawal by Subject|1|||
41954276|NCT01818726|75721536|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
41954277|NCT01818726|75721537|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
41954278|NCT01818336|75721543|FG000|Overall Study|Declined retest visit|0|||
41954279|NCT01818336|75721544|FG001|Overall Study|Declined retest visit|11|||
41954280|NCT01818336|75721543|FG000|Overall Study|Lost to Follow-up|0|||
41954281|NCT01818336|75721544|FG001|Overall Study|Lost to Follow-up|1|||
41954282|NCT01818258|75721552|FG000|Overall Study|Death|3|||
41954283|NCT01818258|75721553|FG001|Overall Study|Death|0|||
41954284|NCT01818258|75721552|FG000|Overall Study|Withdrawal by Subject|0|||
41954285|NCT01818258|75721553|FG001|Overall Study|Withdrawal by Subject|1|||
41954286|NCT01818258|75721552|FG000|Overall Study|Lost to Follow-up|0|||
41954287|NCT01818258|75721553|FG001|Overall Study|Lost to Follow-up|1|||
41954288|NCT01818258|75721552|FG000|Overall Study|Unable to Travel to Clinic|0|||
42024071|NCT01021293|75831447|FG001|Overall Study|Migrated/moved from study area|18|||
42024072|NCT01021293|75831446|FG000|Overall Study|Lost to Follow-up|1|||
42024073|NCT01021293|75831447|FG001|Overall Study|Lost to Follow-up|1|||
42024074|NCT04625725|75831456|FG000|Overall Study|Death|4|||
42024075|NCT04625725|75831457|FG001|Overall Study|Death|4|||
42024076|NCT04625725|75831456|FG000|Overall Study|Lost to Follow-up|11|||
42024077|NCT04625725|75831457|FG001|Overall Study|Lost to Follow-up|8|||
42024078|NCT04625725|75831456|FG000|Overall Study|Physician Decision|1|||
42024079|NCT04625725|75831457|FG001|Overall Study|Physician Decision|0|||
41954289|NCT01818258|75721553|FG001|Overall Study|Unable to Travel to Clinic|1|||
41954290|NCT01817790|75721562|FG000|Overall Study|Adverse Event|0|||
41954291|NCT01817790|75721563|FG001|Overall Study|Adverse Event|2|||
41954292|NCT01817790|75721562|FG000|Overall Study|Lost to Follow-up|0|||
41954293|NCT01817790|75721563|FG001|Overall Study|Lost to Follow-up|1|||
41954294|NCT01817790|75721562|FG000|Overall Study|Protocol Violation|2|||
41954295|NCT01817790|75721563|FG001|Overall Study|Protocol Violation|1|||
41954296|NCT01817790|75721562|FG000|Overall Study|Withdrawal by Subject|1|||
41954297|NCT01817790|75721563|FG001|Overall Study|Withdrawal by Subject|3|||
41954298|NCT01817790|75721562|FG000|Overall Study|Other: Could not attend appointment|1|||
41954299|NCT01817790|75721563|FG001|Overall Study|Other: Could not attend appointment|1|||
41954300|NCT01793688|75721571|FG000|Overall Study|Protocol Violation|2|||
41954301|NCT01793142|75721575|FG000|Overall Study|Randomized not treated|7|||
41954302|NCT01792830|75721590|FG000|Overall Study|Withdrawal by Subject|22|||
41954303|NCT01792830|75721591|FG001|Overall Study|Withdrawal by Subject|0|||
41954304|NCT01792830|75721592|FG002|Overall Study|Withdrawal by Subject|0|||
41954305|NCT01792830|75721593|FG003|Overall Study|Withdrawal by Subject|2|||
41954306|NCT01792830|75721594|FG004|Overall Study|Withdrawal by Subject|1|||
41954307|NCT01792830|75721595|FG005|Overall Study|Withdrawal by Subject|1|||
41954308|NCT01792830|75721596|FG006|Overall Study|Withdrawal by Subject|1|||
41954309|NCT01792830|75721597|FG007|Overall Study|Withdrawal by Subject|1|||
41954310|NCT01792830|75721598|FG008|Overall Study|Withdrawal by Subject|7|||
41954311|NCT01792830|75721599|FG009|Overall Study|Withdrawal by Subject|0|||
41954312|NCT01792830|75721600|FG010|Overall Study|Withdrawal by Subject|2|||
41954313|NCT01792830|75721590|FG000|Overall Study|Death|3|||
41954314|NCT01792830|75721591|FG001|Overall Study|Death|0|||
41954315|NCT01792830|75721592|FG002|Overall Study|Death|0|||
41954316|NCT01792830|75721593|FG003|Overall Study|Death|1|||
41954317|NCT01792830|75721594|FG004|Overall Study|Death|0|||
41954318|NCT01792830|75721595|FG005|Overall Study|Death|0|||
41954319|NCT01792830|75721596|FG006|Overall Study|Death|1|||
42024080|NCT04625725|75831456|FG000|Overall Study|Withdrawal by Subject|56|||
41954320|NCT01792830|75721597|FG007|Overall Study|Death|0|||
42024081|NCT04625725|75831457|FG001|Overall Study|Withdrawal by Subject|32|||
42024082|NCT04625725|75831456|FG000|Overall Study|"Includes participants who discontinued early with reason other selected."|18|||
41954321|NCT01792830|75721598|FG008|Overall Study|Death|1|||
41954322|NCT01792830|75721599|FG009|Overall Study|Death|0|||
41954323|NCT01792830|75721600|FG010|Overall Study|Death|1|||
41954324|NCT01792830|75721590|FG000|Overall Study|Adverse Event|0|||
41954325|NCT01792830|75721591|FG001|Overall Study|Adverse Event|0|||
41954326|NCT01792830|75721592|FG002|Overall Study|Adverse Event|0|||
41954327|NCT01792830|75721593|FG003|Overall Study|Adverse Event|0|||
41954328|NCT01792830|75721594|FG004|Overall Study|Adverse Event|0|||
41954329|NCT01792830|75721595|FG005|Overall Study|Adverse Event|0|||
41954330|NCT01792830|75721596|FG006|Overall Study|Adverse Event|0|||
41954331|NCT01792830|75721597|FG007|Overall Study|Adverse Event|0|||
41954332|NCT01792830|75721598|FG008|Overall Study|Adverse Event|1|||
42118032|NCT00689117|75928841|FG001|Overall Study|Transportation|0|||
42118033|NCT00689117|75928842|FG002|Overall Study|Transportation|0|||
41954333|NCT01792830|75721599|FG009|Overall Study|Adverse Event|0|||
41954334|NCT01792830|75721600|FG010|Overall Study|Adverse Event|0|||
41954335|NCT01792518|75721632|FG000|Overall Study|Adverse Event|3|||
41954336|NCT01792518|75721633|FG001|Overall Study|Adverse Event|4|||
41954337|NCT01792518|75721632|FG000|Overall Study|Protocol Violation|0|||
41954338|NCT01792518|75721633|FG001|Overall Study|Protocol Violation|1|||
41954339|NCT01792518|75721632|FG000|Overall Study|Lost to Follow-up|3|||
41954340|NCT01792518|75721633|FG001|Overall Study|Lost to Follow-up|1|||
41954341|NCT01792518|75721632|FG000|Overall Study|Withdrawal by Subject|2|||
41954342|NCT01792518|75721633|FG001|Overall Study|Withdrawal by Subject|0|||
41954343|NCT01792518|75721632|FG000|Overall Study|Other Reason|0|||
41954344|NCT01792518|75721633|FG001|Overall Study|Other Reason|1|||
41954345|NCT01792284|75721639|FG000|Lead-in Period|Adverse Event|15|||
41954346|NCT01792284|75721640|FG001|Lead-in Period|Adverse Event|0|||
41954347|NCT01792284|75721641|FG002|Lead-in Period|Adverse Event|0|||
41954348|NCT01792284|75721639|FG000|Lead-in Period|Lost to Follow-up|2|||
41954349|NCT01792284|75721640|FG001|Lead-in Period|Lost to Follow-up|0|||
41954350|NCT01792284|75721641|FG002|Lead-in Period|Lost to Follow-up|0|||
41954351|NCT01792284|75721639|FG000|Lead-in Period|Protocol Violation|1|||
41954352|NCT01792284|75721640|FG001|Lead-in Period|Protocol Violation|0|||
41954353|NCT01792284|75721641|FG002|Lead-in Period|Protocol Violation|0|||
41954354|NCT01792284|75721639|FG000|Lead-in Period|Withdrawal by Subject|10|||
41954355|NCT01792284|75721640|FG001|Lead-in Period|Withdrawal by Subject|0|||
41954356|NCT01792284|75721641|FG002|Lead-in Period|Withdrawal by Subject|0|||
41954357|NCT01792284|75721639|FG000|Lead-in Period|Physician Decision|1|||
41954358|NCT01792284|75721640|FG001|Lead-in Period|Physician Decision|0|||
41954359|NCT01792284|75721641|FG002|Lead-in Period|Physician Decision|0|||
41954360|NCT01792284|75721639|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
41954361|NCT01792284|75721640|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
41954362|NCT01792284|75721641|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
41954363|NCT01792284|75721639|FG000|Randomization Period 1|Withdrawal by Subject|0|||
41954364|NCT01792284|75721640|FG001|Randomization Period 1|Withdrawal by Subject|1|||
41954365|NCT01792284|75721641|FG002|Randomization Period 1|Withdrawal by Subject|1|||
41954366|NCT01792284|75721639|FG000|Randomization Period 1|Physician Decision|0|||
41954367|NCT01792284|75721640|FG001|Randomization Period 1|Physician Decision|1|||
41954368|NCT01792284|75721641|FG002|Randomization Period 1|Physician Decision|1|||
41954369|NCT01792284|75721639|FG000|Randomization Period 1|Adverse Event|0|||
41954370|NCT01792284|75721640|FG001|Randomization Period 1|Adverse Event|0|||
41954371|NCT01792284|75721641|FG002|Randomization Period 1|Adverse Event|2|||
41954372|NCT01792284|75721639|FG000|Randomization Period 1|Lost to Follow-up|0|||
41954373|NCT01792284|75721640|FG001|Randomization Period 1|Lost to Follow-up|0|||
41954374|NCT01792284|75721641|FG002|Randomization Period 1|Lost to Follow-up|1|||
41954375|NCT01792284|75721639|FG000|Randomization Period 2|Protocol Violation|0|||
41954376|NCT01792284|75721640|FG001|Randomization Period 2|Protocol Violation|1|||
41954377|NCT01792284|75721641|FG002|Randomization Period 2|Protocol Violation|0|||
41954378|NCT01792284|75721639|FG000|Randomization Period 2|Withdrawal by Subject|0|||
41954379|NCT01792284|75721640|FG001|Randomization Period 2|Withdrawal by Subject|2|||
41954380|NCT01792284|75721641|FG002|Randomization Period 2|Withdrawal by Subject|0|||
41954381|NCT01791894|75721649|FG000|Overall Study|Adverse Event|1|||
41954382|NCT01837680|75721656|FG000|Overall Study|Lost to Follow-up|2|||
41954383|NCT01837680|75721657|FG001|Overall Study|Lost to Follow-up|2|||
41954384|NCT01837680|75721656|FG000|Overall Study|lack of insurance|0|||
41954385|NCT01837680|75721657|FG001|Overall Study|lack of insurance|2|||
41954386|NCT01837680|75721656|FG000|Overall Study|allergic reaction|6|||
41954387|NCT01837680|75721657|FG001|Overall Study|allergic reaction|0|||
41954388|NCT01837680|75721656|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
41954389|NCT01837680|75721657|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
41954390|NCT01836276|75721665|FG000|Overall Study|Lost to Follow-up|28|||
41954391|NCT01836276|75721666|FG001|Overall Study|Lost to Follow-up|51|||
41954392|NCT01790568|75721672|FG000|Overall Study|Progression prior to transplant|0|||
41954393|NCT01790568|75721673|FG001|Overall Study|Progression prior to transplant|1|||
41954394|NCT01610076|75721679|FG000|Overall Study|Technical issue with video|0|||
42118034|NCT00689117|75928843|FG003|Overall Study|Transportation|0|||
41954395|NCT01610076|75721680|FG001|Overall Study|Technical issue with video|1|||
42118035|NCT00689117|75928840|FG000|Overall Study|Patient Withdrew from Study|0|||
41954396|NCT01610076|75721679|FG000|Overall Study|Lost to Follow-up|3|||
41954397|NCT01610076|75721680|FG001|Overall Study|Lost to Follow-up|4|||
41954398|NCT01836198|75721689|FG000|Part A, Period 2|Protocol Violation|0|||
41954399|NCT01836198|75721690|FG001|Part A, Period 2|Protocol Violation|1|||
42118036|NCT00689117|75928841|FG001|Overall Study|Patient Withdrew from Study|0|||
41954400|NCT01836198|75721691|FG002|Part A, Period 2|Protocol Violation|0|||
41954401|NCT01816074|75721711|FG000|Phase 1|Time commitment issues|0|||
41954402|NCT01816074|75721712|FG001|Phase 1|Time commitment issues|0|||
41954403|NCT01816074|75721713|FG002|Phase 1|Time commitment issues|1|||
41954404|NCT01816074|75721714|FG003|Phase 1|Time commitment issues|0|||
41954405|NCT01816074|75721711|FG000|Phase 2|Time commitment Issues|0|||
41954406|NCT01816074|75721712|FG001|Phase 2|Time commitment Issues|2|||
41954407|NCT01816074|75721713|FG002|Phase 2|Time commitment Issues|0|||
41954408|NCT01816074|75721714|FG003|Phase 2|Time commitment Issues|0|||
41954409|NCT01816074|75721711|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
41954410|NCT01816074|75721712|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
41954411|NCT01816074|75721713|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
41954412|NCT01816074|75721714|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
41954413|NCT01816074|75721711|FG000|Phase 2|Physician Decision|0|||
41954414|NCT01816074|75721712|FG001|Phase 2|Physician Decision|0|||
41954415|NCT01816074|75721713|FG002|Phase 2|Physician Decision|0|||
41954416|NCT01816074|75721714|FG003|Phase 2|Physician Decision|1|||
41954417|NCT01816074|75721711|FG000|Phase 2|Withdrawal by Subject|1|||
41954418|NCT01816074|75721712|FG001|Phase 2|Withdrawal by Subject|0|||
41954419|NCT01816074|75721713|FG002|Phase 2|Withdrawal by Subject|0|||
41954420|NCT01816074|75721714|FG003|Phase 2|Withdrawal by Subject|0|||
41954421|NCT01815918|75721740|FG000|Overall Study|Patient samples not analyzable|3|||
41954422|NCT01815918|75721741|FG001|Overall Study|Patient samples not analyzable|4|||
41954423|NCT01815918|75721740|FG000|Overall Study|Lack of Efficacy|15|||
41954424|NCT01815918|75721741|FG001|Overall Study|Lack of Efficacy|15|||
41954425|NCT01789476|75721753|FG000|Overall Study|Lack of Efficacy|6|||
41954426|NCT01789476|75721754|FG001|Overall Study|Lack of Efficacy|2|||
41954427|NCT01789476|75721753|FG000|Overall Study|Adverse Event|1|||
41954428|NCT01789476|75721754|FG001|Overall Study|Adverse Event|0|||
41954429|NCT01789476|75721753|FG000|Overall Study|Unable to get IV access|1|||
41954430|NCT01789476|75721754|FG001|Overall Study|Unable to get IV access|0|||
41954431|NCT01789320|75721760|FG000|Overall Study|Re-enrolled into study|1|||
41954432|NCT01789320|75721760|FG000|Overall Study|Lost to Follow-up|1|||
41954433|NCT01815840|75721766|FG000|Overall Study|Missing|1|||
41954434|NCT01815840|75721767|FG001|Overall Study|Missing|0|||
41954435|NCT01815840|75721766|FG000|Overall Study|Withdrew Consent|31|||
41954436|NCT01815840|75721767|FG001|Overall Study|Withdrew Consent|30|||
41954437|NCT01815840|75721766|FG000|Overall Study|Administrative/Other|1|||
41954438|NCT01815840|75721767|FG001|Overall Study|Administrative/Other|3|||
41954439|NCT01815840|75721766|FG000|Overall Study|Adverse Event|10|||
41954440|NCT01815840|75721767|FG001|Overall Study|Adverse Event|16|||
41954441|NCT01815840|75721766|FG000|Overall Study|Death|2|||
41954442|NCT01815840|75721767|FG001|Overall Study|Death|2|||
41954443|NCT01815840|75721766|FG000|Overall Study|Disease progression|3|||
41954444|NCT01815840|75721767|FG001|Overall Study|Disease progression|2|||
41954445|NCT01815840|75721766|FG000|Overall Study|Investigators Decision|2|||
41954446|NCT01815840|75721767|FG001|Overall Study|Investigators Decision|3|||
41954447|NCT01815840|75721766|FG000|Overall Study|Lost to Follow-up|3|||
41954448|NCT01815840|75721767|FG001|Overall Study|Lost to Follow-up|6|||
41954449|NCT01815840|75721766|FG000|Overall Study|Refused Treatment|5|||
41954450|NCT01815840|75721767|FG001|Overall Study|Refused Treatment|1|||
41954451|NCT01815840|75721766|FG000|Overall Study|Sponsor Termination Treatment|1|||
41954452|NCT01815840|75721767|FG001|Overall Study|Sponsor Termination Treatment|0|||
41954453|NCT01774110|75721773|FG000|Overall Study|Lost to Follow-up|7|||
41954454|NCT01788228|75721780|FG000|Overall Study|Migrated/moved from study area|1|||
41954455|NCT01788228|75721781|FG001|Overall Study|Migrated/moved from study area|0|||
41954456|NCT01607346|75721790|FG000|Overall Study|Adverse Event|3|||
41954457|NCT01787838|75721794|FG000|Overall Study|refused|1413|||
41954458|NCT01787760|75721801|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
41954459|NCT01787760|75721802|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
41954460|NCT01787760|75721803|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
41954461|NCT01787760|75721801|FG000|Overall Study|Decompensated on left exotropia|0|||
41954462|NCT01787760|75721802|FG001|Overall Study|Decompensated on left exotropia|0|||
42118037|NCT00689117|75928842|FG002|Overall Study|Patient Withdrew from Study|0|||
41954463|NCT01787760|75721803|FG002|Overall Study|Decompensated on left exotropia|1|||
41954464|NCT01787760|75721801|FG000|Overall Study|Dryness|0|||
41954465|NCT01787760|75721802|FG001|Overall Study|Dryness|1|||
41954466|NCT01787760|75721803|FG002|Overall Study|Dryness|0|||
41954467|NCT01787760|75721801|FG000|Overall Study|Relocation|1|||
41954468|NCT01787760|75721802|FG001|Overall Study|Relocation|1|||
41954469|NCT01787760|75721803|FG002|Overall Study|Relocation|0|||
41954470|NCT01787760|75721801|FG000|Overall Study|Lens discomfort|3|||
41954471|NCT01787760|75721802|FG001|Overall Study|Lens discomfort|0|||
41954472|NCT01787760|75721803|FG002|Overall Study|Lens discomfort|0|||
41954473|NCT01787760|75721801|FG000|Overall Study|Lens handling difficulty|1|||
41954474|NCT01787760|75721802|FG001|Overall Study|Lens handling difficulty|2|||
41954475|NCT01787760|75721803|FG002|Overall Study|Lens handling difficulty|0|||
41954476|NCT01787760|75721801|FG000|Overall Study|Protocol Violation|6|||
41954477|NCT01787760|75721802|FG001|Overall Study|Protocol Violation|0|||
41954478|NCT01787760|75721803|FG002|Overall Study|Protocol Violation|1|||
41954479|NCT01787760|75721801|FG000|Overall Study|Withdrawal by Subject|5|||
41954480|NCT01787760|75721802|FG001|Overall Study|Withdrawal by Subject|1|||
41954481|NCT01787760|75721803|FG002|Overall Study|Withdrawal by Subject|2|||
41954482|NCT01787760|75721801|FG000|Overall Study|Lost to Follow-up|1|||
41954483|NCT01787760|75721802|FG001|Overall Study|Lost to Follow-up|0|||
41954484|NCT01787760|75721803|FG002|Overall Study|Lost to Follow-up|1|||
41954485|NCT01787760|75721801|FG000|Overall Study|Stroke|1|||
41954486|NCT01787760|75721802|FG001|Overall Study|Stroke|0|||
41954487|NCT01787760|75721803|FG002|Overall Study|Stroke|0|||
41954488|NCT01787760|75721801|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
41954489|NCT01787760|75721802|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
41954490|NCT01787760|75721803|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
41954491|NCT01787760|75721801|FG000|Overall Study|Unsatisfactory physiological response|2|||
41954492|NCT01787760|75721802|FG001|Overall Study|Unsatisfactory physiological response|4|||
41954493|NCT01787760|75721803|FG002|Overall Study|Unsatisfactory physiological response|0|||
41954494|NCT01787760|75721801|FG000|Overall Study|Unsatisfactory visual response|1|||
41954495|NCT01787760|75721802|FG001|Overall Study|Unsatisfactory visual response|1|||
41954496|NCT01787760|75721803|FG002|Overall Study|Unsatisfactory visual response|0|||
41954497|NCT01787760|75721801|FG000|Overall Study|Near vision blur|1|||
41954498|NCT01787760|75721802|FG001|Overall Study|Near vision blur|0|||
41954499|NCT01787760|75721803|FG002|Overall Study|Near vision blur|0|||
41954500|NCT01815138|75721814|FG000|Overall Study|Withdrawal by Subject|0|||
41954501|NCT01815138|75721815|FG001|Overall Study|Withdrawal by Subject|1|||
41954502|NCT01815138|75721814|FG000|Overall Study|Physician Decision|8|||
41954503|NCT01815138|75721815|FG001|Overall Study|Physician Decision|5|||
41954504|NCT01606800|75721823|FG000|Overall Study|Adverse Event|3|||
41954505|NCT01606800|75721824|FG001|Overall Study|Adverse Event|1|||
41954506|NCT01606800|75721823|FG000|Overall Study|Participant withdrew consent|0|||
41954507|NCT01606800|75721824|FG001|Overall Study|Participant withdrew consent|1|||
41954508|NCT01606800|75721823|FG000|Overall Study|Missing completion status|2|||
41954509|NCT01606800|75721824|FG001|Overall Study|Missing completion status|0|||
41954510|NCT01772550|75721833|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
41954511|NCT01772550|75721834|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
41954512|NCT01772550|75721835|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
41954513|NCT01772550|75721833|FG000|Overall Study|Adverse Event|0|||
41954514|NCT01772550|75721834|FG001|Overall Study|Adverse Event|0|||
41954515|NCT01772550|75721835|FG002|Overall Study|Adverse Event|1|||
41954516|NCT01787292|75721843|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
41954517|NCT01787292|75721844|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
41954518|NCT01787292|75721843|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
41954519|NCT01787292|75721844|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
41954520|NCT01814748|75721857|FG000|Overall Study|Lost to Follow-up|1|||
41954521|NCT01814748|75721858|FG001|Overall Study|Lost to Follow-up|2|||
41954522|NCT01814748|75721857|FG000|Overall Study|Study site terminated by sponsor|1|||
41954523|NCT01814748|75721858|FG001|Overall Study|Study site terminated by sponsor|1|||
41954524|NCT01814748|75721857|FG000|Overall Study|Withdrawal by Subject|6|||
41954525|NCT01814748|75721858|FG001|Overall Study|Withdrawal by Subject|4|||
41954526|NCT01814670|75721864|FG000|Overall Study|Protocol Violation|12|||
41954527|NCT01814046|75721870|FG000|Drug Administration|Death due to complications of RSV|1|||
41954528|NCT01814046|75721871|FG001|Drug Administration|Death due to complications of RSV|0|||
41954529|NCT01814046|75721872|FG002|Drug Administration|Death due to complications of RSV|0|||
41954530|NCT01813890|75721882|FG000|Overall Study|Adverse Event|0|||
41954531|NCT01813890|75721883|FG001|Overall Study|Adverse Event|3|||
41954532|NCT01813890|75721884|FG002|Overall Study|Adverse Event|4|||
41954533|NCT01813890|75721882|FG000|Overall Study|Lack of Efficacy|9|||
41954534|NCT01813890|75721883|FG001|Overall Study|Lack of Efficacy|1|||
41954535|NCT01813890|75721884|FG002|Overall Study|Lack of Efficacy|2|||
41954536|NCT01772316|75721892|FG000|Overall Study|Serious adverse event|1|||
41954537|NCT01772316|75721892|FG000|Overall Study|Inform consent withdrawn|1|||
41954538|NCT01772316|75721892|FG000|Overall Study|Withdrawn by sponsor decision|5|||
41954539|NCT01813422|75721898|FG000|Overall Study|Withdrawal by Subject|14|||
41954540|NCT01813422|75721899|FG001|Overall Study|Withdrawal by Subject|8|||
41954541|NCT01813422|75721898|FG000|Overall Study|Death|2|||
41954542|NCT01813422|75721899|FG001|Overall Study|Death|3|||
41954543|NCT01813422|75721898|FG000|Overall Study|Sponsor Decision|2|||
41954544|NCT01813422|75721899|FG001|Overall Study|Sponsor Decision|1|||
41954545|NCT01813422|75721898|FG000|Overall Study|Lost to Follow-up|2|||
41954546|NCT01813422|75721899|FG001|Overall Study|Lost to Follow-up|4|||
41954547|NCT01786668|75721909|FG000|Overall Study|Adverse Event|0|||
41954548|NCT01786668|75721910|FG001|Overall Study|Adverse Event|1|||
41954549|NCT01786668|75721911|FG002|Overall Study|Adverse Event|1|||
41954550|NCT01786668|75721912|FG003|Overall Study|Adverse Event|2|||
41954551|NCT01786668|75721909|FG000|Overall Study|Withdrawal by Subject|0|||
41954552|NCT01786668|75721910|FG001|Overall Study|Withdrawal by Subject|0|||
41954553|NCT01786668|75721911|FG002|Overall Study|Withdrawal by Subject|3|||
41954554|NCT01786668|75721912|FG003|Overall Study|Withdrawal by Subject|1|||
41954555|NCT01786668|75721909|FG000|Overall Study|Pregnancy|0|||
41954556|NCT01786668|75721910|FG001|Overall Study|Pregnancy|0|||
41954557|NCT01786668|75721911|FG002|Overall Study|Pregnancy|0|||
41954558|NCT01786668|75721912|FG003|Overall Study|Pregnancy|1|||
41954559|NCT01786668|75721909|FG000|Overall Study|Lost to Follow-up|1|||
41954560|NCT01786668|75721910|FG001|Overall Study|Lost to Follow-up|0|||
41954561|NCT01786668|75721911|FG002|Overall Study|Lost to Follow-up|1|||
41954562|NCT01786668|75721912|FG003|Overall Study|Lost to Follow-up|0|||
41954563|NCT01786512|75721933|FG000|Overall Study|Lost to Follow-up|0|||
41954564|NCT01786512|75721934|FG001|Overall Study|Lost to Follow-up|0|||
41954565|NCT01786512|75721935|FG002|Overall Study|Lost to Follow-up|0|||
41954566|NCT01786512|75721936|FG003|Overall Study|Lost to Follow-up|0|||
41954567|NCT01786512|75721937|FG004|Overall Study|Lost to Follow-up|0|||
41954568|NCT01786512|75721938|FG005|Overall Study|Lost to Follow-up|0|||
41954569|NCT01786512|75721939|FG006|Overall Study|Lost to Follow-up|0|||
41954570|NCT01786512|75721940|FG007|Overall Study|Lost to Follow-up|0|||
41954571|NCT01786512|75721941|FG008|Overall Study|Lost to Follow-up|0|||
41954572|NCT01786512|75721942|FG009|Overall Study|Lost to Follow-up|1|||
41954573|NCT01786512|75721943|FG010|Overall Study|Lost to Follow-up|0|||
41954574|NCT01786512|75721933|FG000|Overall Study|Decision by sponsor|0|||
41954575|NCT01786512|75721934|FG001|Overall Study|Decision by sponsor|0|||
41954576|NCT01786512|75721935|FG002|Overall Study|Decision by sponsor|0|||
41954577|NCT01786512|75721936|FG003|Overall Study|Decision by sponsor|0|||
41954578|NCT01786512|75721937|FG004|Overall Study|Decision by sponsor|0|||
41954579|NCT01786512|75721938|FG005|Overall Study|Decision by sponsor|0|||
41954580|NCT01786512|75721939|FG006|Overall Study|Decision by sponsor|0|||
41954581|NCT01786512|75721940|FG007|Overall Study|Decision by sponsor|0|||
41954582|NCT01786512|75721941|FG008|Overall Study|Decision by sponsor|0|||
41954583|NCT01786512|75721942|FG009|Overall Study|Decision by sponsor|0|||
41954584|NCT01786512|75721943|FG010|Overall Study|Decision by sponsor|2|||
41954585|NCT01786512|75721933|FG000|Overall Study|Withdrawal by Subject|0|||
41954586|NCT01786512|75721934|FG001|Overall Study|Withdrawal by Subject|1|||
41954587|NCT01786512|75721935|FG002|Overall Study|Withdrawal by Subject|0|||
41954588|NCT01786512|75721936|FG003|Overall Study|Withdrawal by Subject|0|||
41954589|NCT01786512|75721937|FG004|Overall Study|Withdrawal by Subject|0|||
41954590|NCT01786512|75721938|FG005|Overall Study|Withdrawal by Subject|0|||
41954591|NCT01786512|75721939|FG006|Overall Study|Withdrawal by Subject|1|||
41954592|NCT01786512|75721940|FG007|Overall Study|Withdrawal by Subject|0|||
41954593|NCT01786512|75721941|FG008|Overall Study|Withdrawal by Subject|0|||
41954594|NCT01786512|75721942|FG009|Overall Study|Withdrawal by Subject|3|||
41954595|NCT01786512|75721943|FG010|Overall Study|Withdrawal by Subject|7|||
41954596|NCT01786512|75721933|FG000|Overall Study|Death|0|||
41954597|NCT01786512|75721934|FG001|Overall Study|Death|0|||
41954598|NCT01786512|75721935|FG002|Overall Study|Death|0|||
41954599|NCT01786512|75721936|FG003|Overall Study|Death|0|||
41954600|NCT01786512|75721937|FG004|Overall Study|Death|0|||
41954601|NCT01786512|75721938|FG005|Overall Study|Death|0|||
41954602|NCT01786512|75721939|FG006|Overall Study|Death|0|||
41954603|NCT01786512|75721940|FG007|Overall Study|Death|0|||
41954604|NCT01786512|75721941|FG008|Overall Study|Death|4|||
41954605|NCT01786512|75721942|FG009|Overall Study|Death|1|||
41954606|NCT01786512|75721943|FG010|Overall Study|Death|3|||
41954607|NCT01772160|75721975|FG000|Overall Study|Death|3|||
41954608|NCT01772160|75721975|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
41954609|NCT01772160|75721975|FG000|Overall Study|Consent withdrawal|3|||
41954610|NCT01772160|75721975|FG000|Overall Study|Migrated / moved from the study area|4|||
41954611|NCT01772160|75721975|FG000|Overall Study|Lost to Follow-up|30|||
41954612|NCT01772160|75721975|FG000|Overall Study|Other|5|||
41954613|NCT01770912|75721981|FG000|Overall Study|Lost to Follow-up|2|||
41954614|NCT01770912|75721982|FG001|Overall Study|Lost to Follow-up|0|||
41954615|NCT01811706|75721988|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
41954616|NCT01811706|75721989|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
41954617|NCT01811472|75722000|FG000|Overall Study|Adverse Event|1|||
41954618|NCT01811472|75722001|FG001|Overall Study|Adverse Event|0|||
41954619|NCT01811472|75722002|FG002|Overall Study|Adverse Event|4|||
41954620|NCT01811472|75722000|FG000|Overall Study|Lost to Follow-up|0|||
41954621|NCT01811472|75722001|FG001|Overall Study|Lost to Follow-up|0|||
41954622|NCT01811472|75722002|FG002|Overall Study|Lost to Follow-up|1|||
41954623|NCT01811472|75722000|FG000|Overall Study|Subject/guardian decision|1|||
41954624|NCT01811472|75722001|FG001|Overall Study|Subject/guardian decision|0|||
41954625|NCT01811472|75722002|FG002|Overall Study|Subject/guardian decision|0|||
41954626|NCT01811238|75722011|FG000|Overall Study|Withdrawal by Subject|42|||
41954627|NCT01811238|75722011|FG000|Overall Study|Adverse Event|25|||
41954628|NCT01811238|75722011|FG000|Overall Study|Protocol Violation|4|||
41954629|NCT01811238|75722011|FG000|Overall Study|Lack of Efficacy|4|||
41954630|NCT01811238|75722011|FG000|Overall Study|subject refused study medication|6|||
41954631|NCT01769508|75722016|FG000|Overall Study|Death|3|||
41954632|NCT01769508|75722016|FG000|Overall Study|Withdrawal by Subject|1|||
41954633|NCT01769508|75722016|FG000|Overall Study|Adverse Event|1|||
41954634|NCT01769508|75722016|FG000|Overall Study|Lost to Follow-up|1|||
41954635|NCT01810380|75722023|FG000|Overall Study|Randomised not treated|2|||
41954636|NCT01810380|75722024|FG001|Overall Study|Randomised not treated|1|||
41954637|NCT01810380|75722025|FG002|Overall Study|Randomised not treated|1|||
41954638|NCT01810380|75722023|FG000|Overall Study|Adverse Event|11|||
41954639|NCT01810380|75722024|FG001|Overall Study|Adverse Event|14|||
41954640|NCT01810380|75722025|FG002|Overall Study|Adverse Event|4|||
41954641|NCT01810380|75722023|FG000|Overall Study|Lack of Efficacy|24|||
41954642|NCT01810380|75722024|FG001|Overall Study|Lack of Efficacy|10|||
41954643|NCT01810380|75722025|FG002|Overall Study|Lack of Efficacy|11|||
41954644|NCT01810380|75722023|FG000|Overall Study|Protocol Violation|1|||
41954645|NCT01810380|75722024|FG001|Overall Study|Protocol Violation|0|||
41954646|NCT01810380|75722025|FG002|Overall Study|Protocol Violation|1|||
41954647|NCT01810380|75722023|FG000|Overall Study|Withdrawal by Subject|6|||
41954648|NCT01810380|75722024|FG001|Overall Study|Withdrawal by Subject|0|||
41954649|NCT01810380|75722025|FG002|Overall Study|Withdrawal by Subject|6|||
41954650|NCT01810380|75722023|FG000|Overall Study|Administrative or other reasons|11|||
41954651|NCT01810380|75722024|FG001|Overall Study|Administrative or other reasons|13|||
41954652|NCT01810380|75722025|FG002|Overall Study|Administrative or other reasons|9|||
41954653|NCT01769196|75722035|FG000|Overall Study|Adverse Event|24|||
41954654|NCT01769196|75722036|FG001|Overall Study|Adverse Event|20|||
41954655|NCT01769196|75722035|FG000|Overall Study|Death|21|||
41954656|NCT01769196|75722036|FG001|Overall Study|Death|26|||
41954657|NCT01769196|75722035|FG000|Overall Study|Investigator Discretion|7|||
41954658|NCT01769196|75722036|FG001|Overall Study|Investigator Discretion|3|||
41954659|NCT01769196|75722035|FG000|Overall Study|Lack of Efficacy|3|||
41954660|NCT01769196|75722036|FG001|Overall Study|Lack of Efficacy|2|||
41954661|NCT01769196|75722035|FG000|Overall Study|Progressive disease|11|||
41954662|NCT01769196|75722036|FG001|Overall Study|Progressive disease|6|||
41954663|NCT01769196|75722035|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
41954664|NCT01769196|75722036|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
41954665|NCT01769196|75722035|FG000|Overall Study|Protocol Violation|0|||
41954666|NCT01769196|75722036|FG001|Overall Study|Protocol Violation|3|||
41954667|NCT01769196|75722035|FG000|Overall Study|Study terminated by sponsor|160|||
41954668|NCT01769196|75722036|FG001|Overall Study|Study terminated by sponsor|161|||
41954669|NCT01769196|75722035|FG000|Overall Study|Participant never dosed with study drug|1|||
41954670|NCT01769196|75722036|FG001|Overall Study|Participant never dosed with study drug|0|||
41954671|NCT01769196|75722035|FG000|Overall Study|Withdrew consent|36|||
41954672|NCT01769196|75722036|FG001|Overall Study|Withdrew consent|40|||
41954673|NCT01810302|75722044|FG000|Overall Study|Death|1|||
41954674|NCT01810302|75722045|FG001|Overall Study|Death|0|||
41954675|NCT01810302|75722044|FG000|Overall Study|Physician Decision|0|||
41954676|NCT01810302|75722045|FG001|Overall Study|Physician Decision|1|||
41954677|NCT01783938|75722053|FG000|Overall Study|Disease Progression|18|||
41954678|NCT01783938|75722054|FG001|Overall Study|Disease Progression|41|||
41954679|NCT01783938|75722053|FG000|Overall Study|Study Drug Toxicity|27|||
41954680|NCT01783938|75722054|FG001|Overall Study|Study Drug Toxicity|14|||
41954681|NCT01783938|75722053|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
41954682|NCT01783938|75722054|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
41954683|NCT01783938|75722053|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
41954684|NCT01783938|75722054|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
41954685|NCT01783938|75722053|FG000|Overall Study|Participant Withdrew Consent|2|||
41954686|NCT01783938|75722054|FG001|Overall Study|Participant Withdrew Consent|0|||
41954687|NCT01783938|75722053|FG000|Overall Study|Maximum Clinical Benefit|1|||
41954688|NCT01783938|75722054|FG001|Overall Study|Maximum Clinical Benefit|0|||
41954689|NCT01783938|75722053|FG000|Overall Study|Other Reasons|3|||
41954690|NCT01783938|75722054|FG001|Overall Study|Other Reasons|1|||
41954691|NCT01768572|75722063|FG000|Overall Study|Adverse Event|7|||
41954692|NCT01768572|75722064|FG001|Overall Study|Adverse Event|8|||
41954693|NCT01768572|75722065|FG002|Overall Study|Adverse Event|4|||
41954694|NCT01768572|75722063|FG000|Overall Study|Lack of Efficacy|1|||
41954695|NCT01768572|75722064|FG001|Overall Study|Lack of Efficacy|3|||
41954696|NCT01768572|75722065|FG002|Overall Study|Lack of Efficacy|1|||
41954697|NCT01768572|75722063|FG000|Overall Study|Other, Not due to an adverse event|1|||
41954698|NCT01768572|75722064|FG001|Overall Study|Other, Not due to an adverse event|1|||
41954699|NCT01768572|75722065|FG002|Overall Study|Other, Not due to an adverse event|1|||
41954700|NCT01783548|75722075|FG000|Overall Study|Adverse Event|8|||
41954701|NCT01783548|75722076|FG001|Overall Study|Adverse Event|4|||
41954702|NCT01783548|75722075|FG000|Overall Study|Withdrawal by Subject|11|||
41954703|NCT01783548|75722076|FG001|Overall Study|Withdrawal by Subject|8|||
41954704|NCT01783548|75722075|FG000|Overall Study|Non-compliance|4|||
41954705|NCT01783548|75722076|FG001|Overall Study|Non-compliance|0|||
41954706|NCT01783548|75722075|FG000|Overall Study|Protocol Violation|2|||
41954707|NCT01783548|75722076|FG001|Overall Study|Protocol Violation|2|||
41954708|NCT01783548|75722075|FG000|Overall Study|Lost to Follow-up|8|||
41954709|NCT01783548|75722076|FG001|Overall Study|Lost to Follow-up|3|||
41954710|NCT01783548|75722075|FG000|Overall Study|Lack of Efficacy|1|||
41954711|NCT01783548|75722076|FG001|Overall Study|Lack of Efficacy|1|||
41954712|NCT01809210|75722089|FG000|Overall Study|Withdrawal by Subject|0|||
41954713|NCT01809210|75722090|FG001|Overall Study|Withdrawal by Subject|0|||
41954714|NCT01809210|75722091|FG002|Overall Study|Withdrawal by Subject|1|||
41954715|NCT01809210|75722092|FG003|Overall Study|Withdrawal by Subject|1|||
41954716|NCT01809210|75722093|FG004|Overall Study|Withdrawal by Subject|1|||
41954717|NCT01809210|75722094|FG005|Overall Study|Withdrawal by Subject|0|||
41954718|NCT01809210|75722095|FG006|Overall Study|Withdrawal by Subject|4|||
41954719|NCT01809210|75722089|FG000|Overall Study|Death|1|||
41954720|NCT01809210|75722090|FG001|Overall Study|Death|1|||
41954721|NCT01809210|75722091|FG002|Overall Study|Death|2|||
41954722|NCT01809210|75722092|FG003|Overall Study|Death|0|||
41954723|NCT01809210|75722093|FG004|Overall Study|Death|1|||
41954724|NCT01809210|75722094|FG005|Overall Study|Death|3|||
41954725|NCT01809210|75722095|FG006|Overall Study|Death|1|||
41954726|NCT01809132|75722114|FG000|Overall Study|Withdrawal by Subject|0|||
41954727|NCT01809132|75722115|FG001|Overall Study|Withdrawal by Subject|0|||
41954728|NCT01809132|75722116|FG002|Overall Study|Withdrawal by Subject|1|||
41954729|NCT01808508|75722127|FG000|Overall Study|Lost to Follow-up|1|||
41954730|NCT01808508|75722128|FG001|Overall Study|Lost to Follow-up|0|||
41954731|NCT01808508|75722129|FG002|Overall Study|Lost to Follow-up|0|||
41954732|NCT01766778|75722139|FG000|Overall Study|Adverse Event|4|||
41954733|NCT01766778|75722140|FG001|Overall Study|Adverse Event|4|||
41954734|NCT01766778|75722139|FG000|Overall Study|Withdrawal by Subject|1|||
41954735|NCT01766778|75722140|FG001|Overall Study|Withdrawal by Subject|0|||
41954736|NCT01808196|75722146|FG000|Overall Study|Lost to Follow-up|1|||
41954737|NCT01808118|75722150|FG000|Period 1|Adverse Event|15|||
41954738|NCT01808118|75722151|FG001|Period 1|Adverse Event|0|||
41954739|NCT01808118|75722152|FG002|Period 1|Adverse Event|0|||
41954740|NCT01808118|75722150|FG000|Period 1|Withdrew consent|24|||
41954741|NCT01808118|75722151|FG001|Period 1|Withdrew consent|0|||
41954742|NCT01808118|75722152|FG002|Period 1|Withdrew consent|0|||
41954743|NCT01808118|75722150|FG000|Period 1|Lost to Follow-up|9|||
41954744|NCT01808118|75722151|FG001|Period 1|Lost to Follow-up|0|||
41954745|NCT01808118|75722152|FG002|Period 1|Lost to Follow-up|0|||
41954746|NCT01808118|75722150|FG000|Period 1|Did not meet criteria for remission|303|||
41954747|NCT01808118|75722151|FG001|Period 1|Did not meet criteria for remission|0|||
41954748|NCT01808118|75722152|FG002|Period 1|Did not meet criteria for remission|0|||
41954749|NCT01808118|75722150|FG000|Period 1|Enrolled in error|7|||
41954750|NCT01808118|75722151|FG001|Period 1|Enrolled in error|0|||
41954751|NCT01808118|75722152|FG002|Period 1|Enrolled in error|0|||
41954752|NCT01808118|75722150|FG000|Period 1|Did not meet inclusion criteria|3|||
41954753|NCT01808118|75722151|FG001|Period 1|Did not meet inclusion criteria|0|||
41954754|NCT01808118|75722152|FG002|Period 1|Did not meet inclusion criteria|0|||
41954755|NCT01808118|75722150|FG000|Period 1|Non-conformance with inclusion criteria|3|||
41954756|NCT01808118|75722151|FG001|Period 1|Non-conformance with inclusion criteria|0|||
41954757|NCT01808118|75722152|FG002|Period 1|Non-conformance with inclusion criteria|0|||
41954758|NCT01808118|75722150|FG000|Period 1|Investigator decision: site closure|2|||
41954759|NCT01808118|75722151|FG001|Period 1|Investigator decision: site closure|0|||
41954760|NCT01808118|75722152|FG002|Period 1|Investigator decision: site closure|0|||
41954761|NCT01808118|75722150|FG000|Period 1|Non-compliance per sponsor|1|||
41954762|NCT01808118|75722151|FG001|Period 1|Non-compliance per sponsor|0|||
41954763|NCT01808118|75722152|FG002|Period 1|Non-compliance per sponsor|0|||
41954764|NCT01808118|75722150|FG000|Period 1|Lack of Efficacy|1|||
41954765|NCT01808118|75722151|FG001|Period 1|Lack of Efficacy|0|||
41954766|NCT01808118|75722152|FG002|Period 1|Lack of Efficacy|0|||
41954767|NCT01808118|75722150|FG000|Period 2|Adverse Event|0|||
41954768|NCT01808118|75722151|FG001|Period 2|Adverse Event|4|||
41954769|NCT01808118|75722152|FG002|Period 2|Adverse Event|0|||
41954770|NCT01808118|75722150|FG000|Period 2|Withdrew consent|0|||
41954771|NCT01808118|75722151|FG001|Period 2|Withdrew consent|7|||
41954772|NCT01808118|75722152|FG002|Period 2|Withdrew consent|6|||
41954773|NCT01808118|75722150|FG000|Period 2|Lost to Follow-up|0|||
41954774|NCT01808118|75722151|FG001|Period 2|Lost to Follow-up|0|||
41954775|NCT01808118|75722152|FG002|Period 2|Lost to Follow-up|2|||
41954776|NCT01808118|75722150|FG000|Period 2|Investigator no longer conducting trials|0|||
41954777|NCT01808118|75722151|FG001|Period 2|Investigator no longer conducting trials|1|||
41954778|NCT01808118|75722152|FG002|Period 2|Investigator no longer conducting trials|0|||
41954779|NCT01808118|75722150|FG000|Period 2|Switched to other therapy|0|||
41954780|NCT01808118|75722151|FG001|Period 2|Switched to other therapy|1|||
41954781|NCT01808118|75722152|FG002|Period 2|Switched to other therapy|0|||
41954782|NCT01807650|75722166|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
41954783|NCT01807650|75722166|FG000|Overall Study|Adverse Event|5|||
41954784|NCT01807650|75722166|FG000|Overall Study|Other|2|||
41954785|NCT01782690|75722207|FG000|Overall Study|Not reported|7|||
41954786|NCT01782690|75722207|FG000|Overall Study|Toxicity of gemcitabine|1|||
41954787|NCT01782690|75722207|FG000|Overall Study|Toxicity of erlotinib|1|||
41954788|NCT01782690|75722207|FG000|Overall Study|Lost to Follow-up|31|||
41954789|NCT01782690|75722207|FG000|Overall Study|Withdrawal of informed consent|2|||
41954790|NCT01782690|75722207|FG000|Overall Study|Absent rash|9|||
41954791|NCT01782690|75722207|FG000|Overall Study|Physician Decision|13|||
41954792|NCT01782690|75722207|FG000|Overall Study|Patient's wish|21|||
41954793|NCT01782690|75722207|FG000|Overall Study|Tumor progression|74|||
41954794|NCT01782690|75722207|FG000|Overall Study|Death|133|||
41954795|NCT01782690|75722207|FG000|Overall Study|Study completion unknown|7|||
41954796|NCT01782378|75722213|FG000|First Series|Lost to Follow-up|7|||
41954797|NCT01782378|75722214|FG001|First Series|Lost to Follow-up|8|||
41954798|NCT01782378|75722213|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
41954799|NCT01782378|75722214|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
41954800|NCT01782378|75722213|FG000|Second Series|Lost to Follow-up|8|||
41954801|NCT01782378|75722214|FG001|Second Series|Lost to Follow-up|7|||
41954802|NCT01782378|75722213|FG000|Second Series|Did not choose to complete S2 Optional|18|||
41954803|NCT01782378|75722214|FG001|Second Series|Did not choose to complete S2 Optional|0|||
41954804|NCT01766310|75722222|FG000|Overall Study|Lost to Follow-up|1|||
41954805|NCT01766310|75722223|FG001|Overall Study|Lost to Follow-up|3|||
41954806|NCT01765920|75722231|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
41954807|NCT01765920|75722232|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
41954808|NCT01765920|75722231|FG000|Overall Study|Patient code disclosure|0|||
41954809|NCT01765920|75722232|FG001|Overall Study|Patient code disclosure|1|||
41954810|NCT01782222|75722241|FG000|Overall Study|Adverse Event|4|||
41954811|NCT01782222|75722242|FG001|Overall Study|Adverse Event|5|||
41954812|NCT01782222|75722243|FG002|Overall Study|Adverse Event|3|||
41954813|NCT01782222|75722241|FG000|Overall Study|Lack of Efficacy|2|||
41954814|NCT01782222|75722242|FG001|Overall Study|Lack of Efficacy|1|||
41954815|NCT01782222|75722243|FG002|Overall Study|Lack of Efficacy|0|||
41954816|NCT01782222|75722241|FG000|Overall Study|Protocol Violation|1|||
41954817|NCT01782222|75722242|FG001|Overall Study|Protocol Violation|0|||
41954818|NCT01782222|75722243|FG002|Overall Study|Protocol Violation|0|||
41954819|NCT01782222|75722241|FG000|Overall Study|Withdrawal by Subject|1|||
41954820|NCT01782222|75722242|FG001|Overall Study|Withdrawal by Subject|4|||
41954821|NCT01782222|75722243|FG002|Overall Study|Withdrawal by Subject|1|||
41954822|NCT01782222|75722241|FG000|Overall Study|Moved to other state|0|||
41954823|NCT01782222|75722242|FG001|Overall Study|Moved to other state|1|||
41954824|NCT01782222|75722243|FG002|Overall Study|Moved to other state|0|||
41954825|NCT01781832|75722251|FG000|Overall Study|Withdrawal by Subject|1|||
41954826|NCT01807182|75722255|FG000|Overall Study|Death|1|||
41954827|NCT01807182|75722255|FG000|Overall Study|New therapy|1|||
41954828|NCT01807182|75722255|FG000|Overall Study|Moved to hospice care|1|||
41954829|NCT01806714|75722261|FG000|Overall Study|No functioning phone number|200|||
41954830|NCT01806714|75722262|FG001|Overall Study|No functioning phone number|170|||
41954831|NCT01765764|75722271|FG000|Treatment Period|Adverse Event|1|||
41954832|NCT01765764|75722272|FG001|Treatment Period|Adverse Event|2|||
41954833|NCT01765764|75722273|FG002|Treatment Period|Adverse Event|1|||
41954834|NCT01765764|75722271|FG000|Treatment Period|Lost to Follow-up|0|||
41954835|NCT01765764|75722272|FG001|Treatment Period|Lost to Follow-up|3|||
41954836|NCT01765764|75722273|FG002|Treatment Period|Lost to Follow-up|2|||
41954837|NCT01765764|75722271|FG000|Treatment Period|Personal Reasons|1|||
41954838|NCT01765764|75722272|FG001|Treatment Period|Personal Reasons|2|||
41954839|NCT01765764|75722273|FG002|Treatment Period|Personal Reasons|1|||
41954840|NCT01765764|75722271|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
41954841|NCT01765764|75722272|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
41954842|NCT01765764|75722273|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
41954843|NCT01806168|75722284|FG000|Overall Study|Adverse Event|1|||
41954844|NCT01806168|75722285|FG001|Overall Study|Adverse Event|0|||
41954845|NCT01806168|75722286|FG002|Overall Study|Adverse Event|0|||
41954846|NCT01806168|75722284|FG000|Overall Study|Withdrawal by Subject|0|||
41954847|NCT01806168|75722285|FG001|Overall Study|Withdrawal by Subject|1|||
41954848|NCT01806168|75722286|FG002|Overall Study|Withdrawal by Subject|2|||
41954849|NCT01806168|75722284|FG000|Overall Study|Protocol Violation|0|||
41954850|NCT01806168|75722285|FG001|Overall Study|Protocol Violation|0|||
41954851|NCT01806168|75722286|FG002|Overall Study|Protocol Violation|1|||
41954852|NCT01804842|75722300|FG000|Overall Study|Adverse Event|1|||
41954853|NCT01804842|75722301|FG001|Overall Study|Adverse Event|1|||
41954854|NCT01804842|75722302|FG002|Overall Study|Adverse Event|0|||
41954855|NCT01804842|75722300|FG000|Overall Study|Lost to Follow-up|1|||
41954856|NCT01804842|75722301|FG001|Overall Study|Lost to Follow-up|0|||
41954857|NCT01804842|75722302|FG002|Overall Study|Lost to Follow-up|0|||
41954858|NCT01804842|75722300|FG000|Overall Study|Non-Compliance|1|||
41954859|NCT01804842|75722301|FG001|Overall Study|Non-Compliance|1|||
41954860|NCT01804842|75722302|FG002|Overall Study|Non-Compliance|0|||
41954861|NCT01804842|75722300|FG000|Overall Study|Personal Reason|0|||
41954862|NCT01804842|75722301|FG001|Overall Study|Personal Reason|0|||
41954863|NCT01804842|75722302|FG002|Overall Study|Personal Reason|1|||
41954864|NCT01781286|75722310|FG000|Overall Study|Lost to Follow-up|0|||
41954865|NCT01781286|75722311|FG001|Overall Study|Lost to Follow-up|0|||
41954866|NCT01781286|75722312|FG002|Overall Study|Lost to Follow-up|0|||
41954867|NCT01781286|75722313|FG003|Overall Study|Lost to Follow-up|0|||
41954868|NCT01781286|75722314|FG004|Overall Study|Lost to Follow-up|0|||
41954869|NCT01781286|75722315|FG005|Overall Study|Lost to Follow-up|1|||
41954870|NCT01781286|75722310|FG000|Overall Study|Time Constraints|2|||
41954871|NCT01781286|75722311|FG001|Overall Study|Time Constraints|0|||
41954872|NCT01781286|75722312|FG002|Overall Study|Time Constraints|2|||
41954873|NCT01781286|75722313|FG003|Overall Study|Time Constraints|0|||
41954874|NCT01781286|75722314|FG004|Overall Study|Time Constraints|0|||
41954875|NCT01781286|75722315|FG005|Overall Study|Time Constraints|0|||
41954876|NCT01781286|75722310|FG000|Overall Study|Noncompliance|0|||
41954877|NCT01781286|75722311|FG001|Overall Study|Noncompliance|0|||
41954878|NCT01781286|75722312|FG002|Overall Study|Noncompliance|0|||
41954879|NCT01781286|75722313|FG003|Overall Study|Noncompliance|1|||
41954880|NCT01781286|75722314|FG004|Overall Study|Noncompliance|0|||
41954881|NCT01781286|75722315|FG005|Overall Study|Noncompliance|0|||
41954882|NCT01780974|75722327|FG000|Overall Study|Death|1|||
41954883|NCT01780974|75722328|FG001|Overall Study|Death|0|||
41954884|NCT01780974|75722327|FG000|Overall Study|Adverse Event|1|||
41954885|NCT01780974|75722328|FG001|Overall Study|Adverse Event|3|||
41954886|NCT01780662|75722337|FG000|Overall Study|Adverse Event|1|||
41954887|NCT01780662|75722338|FG001|Overall Study|Adverse Event|0|||
41954888|NCT01780662|75722339|FG002|Overall Study|Adverse Event|2|||
41954889|NCT01780662|75722337|FG000|Overall Study|Physician Decision|0|||
41954890|NCT01780662|75722338|FG001|Overall Study|Physician Decision|5|||
41954891|NCT01780662|75722339|FG002|Overall Study|Physician Decision|7|||
41954892|NCT01780662|75722337|FG000|Overall Study|Protocol Violation|0|||
41954893|NCT01780662|75722338|FG001|Overall Study|Protocol Violation|1|||
41954894|NCT01780662|75722339|FG002|Overall Study|Protocol Violation|0|||
41954895|NCT01780662|75722337|FG000|Overall Study|Ineligible|0|||
41954896|NCT01780662|75722338|FG001|Overall Study|Ineligible|0|||
41954897|NCT01780662|75722339|FG002|Overall Study|Ineligible|1|||
41954898|NCT01780584|75722351|FG000|Overall Study|Death|1|||
41954899|NCT01780584|75722352|FG001|Overall Study|Death|0|||
41954900|NCT01780584|75722353|FG002|Overall Study|Death|1|||
41954901|NCT01780584|75722351|FG000|Overall Study|Adverse Event|0|||
41954902|NCT01780584|75722352|FG001|Overall Study|Adverse Event|1|||
41954903|NCT01780584|75722353|FG002|Overall Study|Adverse Event|0|||
41954904|NCT01780584|75722351|FG000|Overall Study|Protocol Violation|0|||
41954905|NCT01780584|75722352|FG001|Overall Study|Protocol Violation|0|||
41954906|NCT01780584|75722353|FG002|Overall Study|Protocol Violation|1|||
41954907|NCT01780506|75722363|FG000|Double-Blind Phase|Randomized but not Treated|3|||
41954908|NCT01780506|75722364|FG001|Double-Blind Phase|Randomized but not Treated|2|||
41954909|NCT01780506|75722363|FG000|Double-Blind Phase|Adverse Event|4|||
41954910|NCT01780506|75722364|FG001|Double-Blind Phase|Adverse Event|14|||
41954911|NCT01780506|75722363|FG000|Double-Blind Phase|Death|1|||
41954912|NCT01780506|75722364|FG001|Double-Blind Phase|Death|2|||
41954913|NCT01780506|75722363|FG000|Double-Blind Phase|Pregnancy|2|||
42024083|NCT04625725|75831457|FG001|Overall Study|"Includes participants who discontinued early with reason other selected."|10|||
42024084|NCT04625725|75831456|FG000|Overall Study|Ongoing in study|3409|||
42024085|NCT04625725|75831457|FG001|Overall Study|Ongoing in study|1700|||
41954914|NCT01780506|75722364|FG001|Double-Blind Phase|Pregnancy|1|||
41954915|NCT01780506|75722363|FG000|Double-Blind Phase|Lack of Efficacy|1|||
41954916|NCT01780506|75722364|FG001|Double-Blind Phase|Lack of Efficacy|1|||
41954917|NCT01780506|75722363|FG000|Double-Blind Phase|Investigator's Discretion|5|||
41954918|NCT01780506|75722364|FG001|Double-Blind Phase|Investigator's Discretion|2|||
41954919|NCT01780506|75722363|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
41954920|NCT01780506|75722364|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
41954921|NCT01780506|75722363|FG000|Double-Blind Phase|Protocol Violation|4|||
41954922|NCT01780506|75722364|FG001|Double-Blind Phase|Protocol Violation|3|||
41954923|NCT01780506|75722363|FG000|Double-Blind Phase|Withdrew Consent|23|||
41954924|NCT01780506|75722364|FG001|Double-Blind Phase|Withdrew Consent|24|||
41954925|NCT01780506|75722363|FG000|Double-Blind Phase|Lost to Follow-up|23|||
41954926|NCT01780506|75722364|FG001|Double-Blind Phase|Lost to Follow-up|26|||
41954927|NCT01780506|75722363|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
41954928|NCT01780506|75722364|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
41954929|NCT01779648|75722374|FG000|Overall Study|Protocol Violation|1|||
41954930|NCT01779648|75722375|FG001|Overall Study|Protocol Violation|0|||
41954931|NCT01762800|75722383|FG000|Overall Study|Adverse Event|8|||
41954932|NCT01762800|75722384|FG001|Overall Study|Adverse Event|13|||
41954933|NCT01762800|75722383|FG000|Overall Study|Lack of Efficacy|3|||
41954934|NCT01762800|75722384|FG001|Overall Study|Lack of Efficacy|2|||
41954935|NCT01762800|75722383|FG000|Overall Study|Study Closed/Terminated|0|||
41954936|NCT01762800|75722384|FG001|Overall Study|Study Closed/Terminated|1|||
41954937|NCT01762800|75722383|FG000|Overall Study|Physician Decision|1|||
41954938|NCT01762800|75722384|FG001|Overall Study|Physician Decision|1|||
41954939|NCT01762800|75722383|FG000|Overall Study|Withdrawal by Subject|7|||
41954940|NCT01762800|75722384|FG001|Overall Study|Withdrawal by Subject|4|||
41954941|NCT01597596|75722398|FG000|Overall Study|Study terminated by sponsor|1|||
41954942|NCT01597596|75722399|FG001|Overall Study|Study terminated by sponsor|0|||
41954943|NCT01597596|75722398|FG000|Overall Study|Physician Decision|0|||
41954944|NCT01597596|75722399|FG001|Overall Study|Physician Decision|1|||
41954945|NCT01778556|75722407|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
41954946|NCT01778556|75722408|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
41954947|NCT01778556|75722407|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
41954948|NCT01778556|75722408|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
41954949|NCT01778556|75722407|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
41954950|NCT01778556|75722408|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
41954951|NCT01778556|75722407|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
41954952|NCT01778556|75722408|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
41954953|NCT01761162|75722417|FG000|Overall Study|Withdrawal by Subject|3|||
41954954|NCT01778010|75722421|FG000|Overall Study|Withdrawal by Subject|2|||
41954955|NCT01778010|75722421|FG000|Overall Study|abnormal ECG before meds|1|||
41954956|NCT01778010|75722421|FG000|Overall Study|Arrested|1|||
41954957|NCT01778010|75722421|FG000|Overall Study|rash while on placebo|1|||
41954958|NCT01777932|75722438|FG000|Overall Study|Disease progression|136|||
41954959|NCT01777932|75722438|FG000|Overall Study|Death|3|||
41954960|NCT01777932|75722438|FG000|Overall Study|Adverse Event|34|||
41954961|NCT01777932|75722438|FG000|Overall Study|Lost to Follow-up|3|||
41954962|NCT01777932|75722438|FG000|Overall Study|Investigator decision|10|||
41954963|NCT01777932|75722438|FG000|Overall Study|Reimbursement limit|9|||
41954964|NCT01777932|75722438|FG000|Overall Study|Patient refused further treatment|10|||
41954965|NCT01777854|75722442|FG000|Overall Study|Physician Decision|3|||
41954966|NCT01777854|75722443|FG001|Overall Study|Physician Decision|3|||
41954967|NCT01777776|75722451|FG000|Overall Study|Adverse Event|2|||
41954968|NCT01777776|75722452|FG001|Overall Study|Adverse Event|4|||
41954969|NCT01777776|75722453|FG002|Overall Study|Adverse Event|0|||
41954970|NCT01777776|75722454|FG003|Overall Study|Adverse Event|0|||
41954971|NCT01777776|75722451|FG000|Overall Study|Disease Progression|4|||
41954972|NCT01777776|75722452|FG001|Overall Study|Disease Progression|8|||
41954973|NCT01777776|75722453|FG002|Overall Study|Disease Progression|6|||
41954974|NCT01777776|75722454|FG003|Overall Study|Disease Progression|3|||
41954975|NCT01777776|75722451|FG000|Overall Study|Withdrawal by Subject|0|||
41954976|NCT01777776|75722452|FG001|Overall Study|Withdrawal by Subject|0|||
41954977|NCT01777776|75722453|FG002|Overall Study|Withdrawal by Subject|0|||
41954978|NCT01777776|75722454|FG003|Overall Study|Withdrawal by Subject|1|||
41954979|NCT01777620|75722475|FG000|Overall Study|Subject Withdrawal|1|||
41954980|NCT01777620|75722476|FG001|Overall Study|Subject Withdrawal|0|||
41954981|NCT01777542|75722482|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
41954982|NCT01777542|75722483|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
41954983|NCT01736124|75722492|FG000|Post-intervention Assessment|Death|2|||
41954984|NCT01736124|75722493|FG001|Post-intervention Assessment|Death|2|||
42024086|NCT04625725|75831456|FG000|Overall Study|Protocol Deviation|1|||
42024087|NCT04625725|75831457|FG001|Overall Study|Protocol Deviation|0|||
42024088|NCT01021215|75831465|FG000|Overall Study|Lost to Follow-up|3|||
42024089|NCT01021215|75831466|FG001|Overall Study|Lost to Follow-up|0|||
42024090|NCT01021137|75831476|FG000|Overall Study|Lost to Follow-up|9|||
41954985|NCT01736124|75722492|FG000|Post-intervention Assessment|lost computer access|1|||
41954986|NCT01736124|75722493|FG001|Post-intervention Assessment|lost computer access|1|||
41954987|NCT01736124|75722492|FG000|Post-intervention Assessment|Moved away|3|||
41954988|NCT01736124|75722493|FG001|Post-intervention Assessment|Moved away|1|||
42024091|NCT01021137|75831477|FG001|Overall Study|Lost to Follow-up|4|||
41954989|NCT01736124|75722492|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
41954990|NCT01736124|75722493|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
41954991|NCT01736124|75722492|FG000|Post-intervention Assessment|Illness|3|||
41954992|NCT01736124|75722493|FG001|Post-intervention Assessment|Illness|2|||
41954993|NCT01736124|75722492|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
42024092|NCT01021137|75831478|FG002|Overall Study|Lost to Follow-up|2|||
42024093|NCT01021137|75831479|FG003|Overall Study|Lost to Follow-up|6|||
42024094|NCT01021137|75831476|FG000|Overall Study|Withdrawal by Subject|1|||
42024095|NCT01021137|75831477|FG001|Overall Study|Withdrawal by Subject|0|||
41954994|NCT01736124|75722493|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
41954995|NCT01736124|75722492|FG000|Post-intervention Assessment|Temporarily away|3|||
41954996|NCT01736124|75722493|FG001|Post-intervention Assessment|Temporarily away|1|||
41954997|NCT01736124|75722492|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
41954998|NCT01736124|75722493|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
41954999|NCT01736124|75722492|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
41955000|NCT01736124|75722493|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
41955001|NCT01736124|75722492|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
41955002|NCT01736124|75722493|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
41955003|NCT01736124|75722492|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
41955004|NCT01736124|75722493|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
41955005|NCT01736124|75722492|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
41955006|NCT01736124|75722493|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
41955007|NCT01736124|75722492|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
41955008|NCT01736124|75722493|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
41955009|NCT01736124|75722492|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
41955010|NCT01736124|75722493|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
41955011|NCT01736124|75722492|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
41955012|NCT01736124|75722493|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
41955013|NCT01736124|75722492|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
41955014|NCT01736124|75722493|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
41955015|NCT01759446|75722506|FG000|Overall Study|Protocol Violation|1|||
41955016|NCT01759446|75722507|FG001|Overall Study|Protocol Violation|0|||
41955017|NCT01759446|75722508|FG002|Overall Study|Protocol Violation|1|||
41955018|NCT01759446|75722509|FG003|Overall Study|Protocol Violation|0|||
41955019|NCT01759446|75722510|FG004|Overall Study|Protocol Violation|0|||
41955020|NCT01759446|75722506|FG000|Overall Study|Withdrawal by Subject|0|||
41955021|NCT01759446|75722507|FG001|Overall Study|Withdrawal by Subject|1|||
41955022|NCT01759446|75722508|FG002|Overall Study|Withdrawal by Subject|0|||
41955023|NCT01759446|75722509|FG003|Overall Study|Withdrawal by Subject|1|||
41955024|NCT01759446|75722510|FG004|Overall Study|Withdrawal by Subject|0|||
41955025|NCT01777308|75722524|FG000|Overall Study|Withdrawal by Subject|5|||
41955026|NCT01777308|75722525|FG001|Overall Study|Withdrawal by Subject|1|||
41955027|NCT01777308|75722524|FG000|Overall Study|Migrated/moved from study area|1|||
41955028|NCT01777308|75722525|FG001|Overall Study|Migrated/moved from study area|0|||
41955029|NCT01777308|75722524|FG000|Overall Study|Lost to Follow-up|7|||
41955030|NCT01777308|75722525|FG001|Overall Study|Lost to Follow-up|2|||
41955031|NCT01777308|75722524|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
41955032|NCT01777308|75722525|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
41955033|NCT01759368|75722534|FG000|Overall Study|Lost to Follow-up|1|||
41955034|NCT01759368|75722535|FG001|Overall Study|Lost to Follow-up|0|||
41955035|NCT01777152|75722545|FG000|Overall Study|Withdrawal by Subject|22|||
41955036|NCT01777152|75722546|FG001|Overall Study|Withdrawal by Subject|16|||
41955037|NCT01777152|75722545|FG000|Overall Study|Lost to Follow-up|3|||
41955038|NCT01777152|75722546|FG001|Overall Study|Lost to Follow-up|5|||
41955039|NCT01777152|75722545|FG000|Overall Study|Death|68|||
41955040|NCT01777152|75722546|FG001|Overall Study|Death|89|||
41955041|NCT01777152|75722545|FG000|Overall Study|Not eligible, no study drug received|1|||
41955042|NCT01777152|75722546|FG001|Overall Study|Not eligible, no study drug received|0|||
41955043|NCT01777152|75722545|FG000|Overall Study|Change of diagnosis|1|||
41955044|NCT01777152|75722546|FG001|Overall Study|Change of diagnosis|0|||
41955045|NCT01759290|75722553|FG000|Overall Study|Subjects withdrawn consent|5|||
41955046|NCT01759290|75722553|FG000|Overall Study|Physician Decision|2|||
41955047|NCT01759290|75722553|FG000|Overall Study|Death|17|||
41955048|NCT01759290|75722553|FG000|Overall Study|Lost to Follow-up|53|||
41955049|NCT01759290|75722553|FG000|Overall Study|Unknown reason|4|||
41955050|NCT01758900|75722559|FG000|Overall Study|difficulty for further intubation|7|||
41955051|NCT01758900|75722560|FG001|Overall Study|difficulty for further intubation|8|||
41955052|NCT01757184|75722568|FG000|Double-blind Period|Adverse Event|1|||
41955053|NCT01757184|75722569|FG001|Double-blind Period|Adverse Event|0|||
41955054|NCT01757184|75722570|FG002|Double-blind Period|Adverse Event|0|||
42024096|NCT01021137|75831478|FG002|Overall Study|Withdrawal by Subject|0|||
41955055|NCT01757184|75722571|FG003|Double-blind Period|Adverse Event|0|||
41955056|NCT01757184|75722568|FG000|Open-label Period|Lost to Follow-up|0|||
41955057|NCT01757184|75722569|FG001|Open-label Period|Lost to Follow-up|0|||
42024097|NCT01021137|75831479|FG003|Overall Study|Withdrawal by Subject|3|||
41955058|NCT01757184|75722570|FG002|Open-label Period|Lost to Follow-up|2|||
41955059|NCT01757184|75722571|FG003|Open-label Period|Lost to Follow-up|0|||
41955060|NCT01757184|75722568|FG000|Open-label Period|Withdrawal by Subject|0|||
41955061|NCT01757184|75722569|FG001|Open-label Period|Withdrawal by Subject|0|||
41955062|NCT01757184|75722570|FG002|Open-label Period|Withdrawal by Subject|1|||
42024098|NCT01020981|75831492|FG000|Overall Study|Did not return mailed survey|74|||
41955063|NCT01757184|75722571|FG003|Open-label Period|Withdrawal by Subject|1|||
41955064|NCT01757184|75722568|FG000|Open-label Period|Discontinued by Sponsor|0|||
41955065|NCT01757184|75722569|FG001|Open-label Period|Discontinued by Sponsor|0|||
41955066|NCT01757184|75722570|FG002|Open-label Period|Discontinued by Sponsor|1|||
41955067|NCT01757184|75722571|FG003|Open-label Period|Discontinued by Sponsor|2|||
41955068|NCT01775904|75722585|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
41955069|NCT01775904|75722585|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
41955070|NCT01775670|75722597|FG000|Overall Study|Lost to Follow-up|1|||
41955071|NCT01775670|75722598|FG001|Overall Study|Lost to Follow-up|1|||
41955072|NCT01775124|75722606|FG000|Core Period|Disease Progression|0|||
41955073|NCT01775124|75722607|FG001|Core Period|Disease Progression|1|||
41955074|NCT01775124|75722606|FG000|Core Period|Physician Decision|1|||
41955075|NCT01775124|75722607|FG001|Core Period|Physician Decision|1|||
41955076|NCT01775124|75722606|FG000|Core Period|Death|0|||
41955077|NCT01775124|75722607|FG001|Core Period|Death|1|||
41955078|NCT01775124|75722606|FG000|Core Period|Administrative problems|1|||
41955079|NCT01775124|75722607|FG001|Core Period|Administrative problems|0|||
41955080|NCT01775124|75722606|FG000|Core Period|Withdrawal by Subject|4|||
41955081|NCT01775124|75722607|FG001|Core Period|Withdrawal by Subject|2|||
41955082|NCT01775124|75722606|FG000|Core Period|Adverse Event|5|||
41955083|NCT01775124|75722607|FG001|Core Period|Adverse Event|5|||
41955084|NCT01775124|75722606|FG000|Extension Period|Adverse Event|3|||
41955085|NCT01775124|75722607|FG001|Extension Period|Adverse Event|2|||
41955086|NCT01775124|75722606|FG000|Extension Period|Physician Decision|0|||
41955087|NCT01775124|75722607|FG001|Extension Period|Physician Decision|2|||
41955088|NCT01775124|75722606|FG000|Extension Period|Administrative problems|0|||
41955089|NCT01775124|75722607|FG001|Extension Period|Administrative problems|1|||
41955090|NCT01775124|75722606|FG000|Extension Period|Lost to Follow-up|0|||
41955091|NCT01775124|75722607|FG001|Extension Period|Lost to Follow-up|1|||
41955092|NCT01775124|75722606|FG000|Extension Period|Withdrawal by Subject|9|||
41955093|NCT01775124|75722607|FG001|Extension Period|Withdrawal by Subject|12|||
41955094|NCT01733316|75722614|FG000|RP103 Phase|Non-compliance|1|||
41955095|NCT01733316|75722614|FG000|Long Term Extension Phase|Adverse Event|1|||
41955096|NCT01733316|75722614|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
41955097|NCT01733316|75722614|FG000|Long Term Extension Phase|Sponsor Decision|2|||
41955098|NCT01732926|75722627|FG000|Overall Study|Study Terminated by Sponsor|168|||
41955099|NCT01732926|75722628|FG001|Overall Study|Study Terminated by Sponsor|80|||
41955100|NCT01732926|75722627|FG000|Overall Study|Withdrawal by Subject|46|||
41955101|NCT01732926|75722628|FG001|Overall Study|Withdrawal by Subject|8|||
41955102|NCT01732926|75722627|FG000|Overall Study|Physician Decision|24|||
41955103|NCT01732926|75722628|FG001|Overall Study|Physician Decision|11|||
41955104|NCT01732926|75722627|FG000|Overall Study|Other Reason|21|||
41955105|NCT01732926|75722628|FG001|Overall Study|Other Reason|4|||
41955106|NCT01732926|75722627|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
41955107|NCT01732926|75722628|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
41955108|NCT01732926|75722627|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
41955109|NCT01732926|75722628|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
41955110|NCT01755858|75722636|FG000|Overall Study|Adverse Event|1|||
41955111|NCT01755858|75722637|FG001|Overall Study|Adverse Event|1|||
41955112|NCT01732770|75722647|FG000|Overall Study|Lost to Follow-up|2|||
41955113|NCT01732770|75722648|FG001|Overall Study|Lost to Follow-up|3|||
41955114|NCT01732770|75722647|FG000|Overall Study|Withdrawal by Subject|5|||
41955115|NCT01732770|75722648|FG001|Overall Study|Withdrawal by Subject|3|||
41955116|NCT01732770|75722647|FG000|Overall Study|Decision by Sponsor|2|||
41955117|NCT01732770|75722648|FG001|Overall Study|Decision by Sponsor|2|||
41955118|NCT01732770|75722647|FG000|Overall Study|Death|1|||
41955119|NCT01732770|75722648|FG001|Overall Study|Death|0|||
41955120|NCT01732692|75722656|FG000|Overall Study|Adverse Event|0|||
41955121|NCT01732692|75722657|FG001|Overall Study|Adverse Event|1|||
41955122|NCT01774968|75722665|FG000|Overall Study|Adverse Event|4|||
41955123|NCT01774968|75722666|FG001|Overall Study|Adverse Event|4|||
41955124|NCT01774968|75722665|FG000|Overall Study|Death|0|||
41955125|NCT01774968|75722666|FG001|Overall Study|Death|1|||
41955126|NCT01774968|75722665|FG000|Overall Study|Lost to Follow-up|1|||
41955127|NCT01774968|75722666|FG001|Overall Study|Lost to Follow-up|3|||
41955128|NCT01774968|75722665|FG000|Overall Study|Physician Decision|5|||
41955129|NCT01774968|75722666|FG001|Overall Study|Physician Decision|1|||
41955130|NCT01774968|75722665|FG000|Overall Study|Protocol Violation|14|||
41955131|NCT01774968|75722666|FG001|Overall Study|Protocol Violation|13|||
41955132|NCT01774968|75722665|FG000|Overall Study|Sponsor Decision|0|||
41955133|NCT01774968|75722666|FG001|Overall Study|Sponsor Decision|2|||
41955134|NCT01774968|75722665|FG000|Overall Study|Withdrawal by Subject|6|||
41955135|NCT01774968|75722666|FG001|Overall Study|Withdrawal by Subject|11|||
41955136|NCT01774344|75722674|FG000|Overall Study|Withdrawal by Subject|3|||
41955137|NCT01774344|75722675|FG001|Overall Study|Withdrawal by Subject|10|||
41955138|NCT01774344|75722674|FG000|Overall Study|Protocol Violation|0|||
41955139|NCT01774344|75722675|FG001|Overall Study|Protocol Violation|1|||
41955140|NCT01774344|75722674|FG000|Overall Study|Lost to Follow-up|4|||
41955141|NCT01774344|75722675|FG001|Overall Study|Lost to Follow-up|10|||
41955142|NCT01774344|75722674|FG000|Overall Study|End of survival follow-up not available|2|||
41955143|NCT01774344|75722675|FG001|Overall Study|End of survival follow-up not available|2|||
41955144|NCT01774344|75722674|FG000|Overall Study|Data collection finished|4|||
41955145|NCT01774344|75722675|FG001|Overall Study|Data collection finished|14|||
41955146|NCT01774344|75722674|FG000|Overall Study|Other|0|||
41955147|NCT01774344|75722675|FG001|Overall Study|Other|1|||
41955148|NCT01774344|75722674|FG000|Overall Study|Did not enter Survival Follow up|49|||
41955149|NCT01774344|75722675|FG001|Overall Study|Did not enter Survival Follow up|83|||
41955150|NCT01732536|75722683|FG000|Overall Study|Withdrawal by Subject|1|||
41955151|NCT01732536|75722684|FG001|Overall Study|Withdrawal by Subject|1|||
41955152|NCT01755702|75722693|FG000|Wash Out Period I|Other Reason|3|||
41955153|NCT01755702|75722693|FG000|Washout Period II|Other Reason|5|||
41955154|NCT01732458|75722707|FG000|Overall Study|Lost to Follow-up|0|||
41955155|NCT01732458|75722708|FG001|Overall Study|Lost to Follow-up|2|||
41955156|NCT01732458|75722709|FG002|Overall Study|Lost to Follow-up|0|||
41955157|NCT01732458|75722710|FG003|Overall Study|Lost to Follow-up|0|||
41955158|NCT01732458|75722707|FG000|Overall Study|Non-Compliance With Study Drug|0|||
41955159|NCT01732458|75722708|FG001|Overall Study|Non-Compliance With Study Drug|0|||
41955160|NCT01732458|75722709|FG002|Overall Study|Non-Compliance With Study Drug|1|||
41955161|NCT01732458|75722710|FG003|Overall Study|Non-Compliance With Study Drug|0|||
41955162|NCT01732458|75722707|FG000|Overall Study|Physician Decision|1|||
41955163|NCT01732458|75722708|FG001|Overall Study|Physician Decision|2|||
41955164|NCT01732458|75722709|FG002|Overall Study|Physician Decision|2|||
41955165|NCT01732458|75722710|FG003|Overall Study|Physician Decision|0|||
41955166|NCT01732458|75722707|FG000|Overall Study|Protocol Violation|2|||
41955167|NCT01732458|75722708|FG001|Overall Study|Protocol Violation|0|||
41955168|NCT01732458|75722709|FG002|Overall Study|Protocol Violation|0|||
41955169|NCT01732458|75722710|FG003|Overall Study|Protocol Violation|2|||
41955170|NCT01732458|75722707|FG000|Overall Study|Screen Failure|0|||
41955171|NCT01732458|75722708|FG001|Overall Study|Screen Failure|1|||
41955172|NCT01732458|75722709|FG002|Overall Study|Screen Failure|0|||
41955173|NCT01732458|75722710|FG003|Overall Study|Screen Failure|0|||
41955174|NCT01731990|75722734|FG000|Overall Study|Adverse Event|1|||
41955175|NCT01731990|75722735|FG001|Overall Study|Adverse Event|5|||
41955176|NCT01731990|75722734|FG000|Overall Study|Withdrawal by Subject|1|||
41955177|NCT01731990|75722735|FG001|Overall Study|Withdrawal by Subject|1|||
41955178|NCT01731990|75722734|FG000|Overall Study|Protocol deviation|1|||
41955179|NCT01731990|75722735|FG001|Overall Study|Protocol deviation|2|||
41955180|NCT01731990|75722734|FG000|Overall Study|Death|1|||
41955181|NCT01731990|75722735|FG001|Overall Study|Death|0|||
41955182|NCT01708902|75722748|FG000|Overall Study|Adverse Event|3|||
41955183|NCT01708902|75722749|FG001|Overall Study|Adverse Event|4|||
41955184|NCT01708902|75722750|FG002|Overall Study|Adverse Event|9|||
41955185|NCT01708902|75722751|FG003|Overall Study|Adverse Event|2|||
41955186|NCT01708902|75722752|FG004|Overall Study|Adverse Event|7|||
41955187|NCT01708902|75722753|FG005|Overall Study|Adverse Event|3|||
41955188|NCT01708902|75722754|FG006|Overall Study|Adverse Event|5|||
41955189|NCT01708902|75722748|FG000|Overall Study|Lack of Efficacy|3|||
41955190|NCT01708902|75722749|FG001|Overall Study|Lack of Efficacy|1|||
41955191|NCT01708902|75722750|FG002|Overall Study|Lack of Efficacy|0|||
41955192|NCT01708902|75722751|FG003|Overall Study|Lack of Efficacy|0|||
41955193|NCT01708902|75722752|FG004|Overall Study|Lack of Efficacy|0|||
41955194|NCT01708902|75722753|FG005|Overall Study|Lack of Efficacy|1|||
41955195|NCT01708902|75722754|FG006|Overall Study|Lack of Efficacy|0|||
41955196|NCT01708902|75722748|FG000|Overall Study|Non compliance with protocol|0|||
41955197|NCT01708902|75722749|FG001|Overall Study|Non compliance with protocol|2|||
41955198|NCT01708902|75722750|FG002|Overall Study|Non compliance with protocol|1|||
41955199|NCT01708902|75722751|FG003|Overall Study|Non compliance with protocol|3|||
41955200|NCT01708902|75722752|FG004|Overall Study|Non compliance with protocol|0|||
41955201|NCT01708902|75722753|FG005|Overall Study|Non compliance with protocol|0|||
41955202|NCT01708902|75722754|FG006|Overall Study|Non compliance with protocol|0|||
41955203|NCT01708902|75722748|FG000|Overall Study|Lost to Follow-up|2|||
41955204|NCT01708902|75722749|FG001|Overall Study|Lost to Follow-up|1|||
41955205|NCT01708902|75722750|FG002|Overall Study|Lost to Follow-up|2|||
41955206|NCT01708902|75722751|FG003|Overall Study|Lost to Follow-up|2|||
41955207|NCT01708902|75722752|FG004|Overall Study|Lost to Follow-up|0|||
41955208|NCT01708902|75722753|FG005|Overall Study|Lost to Follow-up|0|||
41955209|NCT01708902|75722754|FG006|Overall Study|Lost to Follow-up|1|||
41955210|NCT01708902|75722748|FG000|Overall Study|Refused to continue trial medication|8|||
41955211|NCT01708902|75722749|FG001|Overall Study|Refused to continue trial medication|0|||
41955212|NCT01708902|75722750|FG002|Overall Study|Refused to continue trial medication|4|||
41955213|NCT01708902|75722751|FG003|Overall Study|Refused to continue trial medication|2|||
41955214|NCT01708902|75722752|FG004|Overall Study|Refused to continue trial medication|8|||
41955215|NCT01708902|75722753|FG005|Overall Study|Refused to continue trial medication|1|||
41955216|NCT01708902|75722754|FG006|Overall Study|Refused to continue trial medication|1|||
41955217|NCT01708902|75722748|FG000|Overall Study|Other Reason|1|||
41955218|NCT01708902|75722749|FG001|Overall Study|Other Reason|0|||
41955219|NCT01708902|75722750|FG002|Overall Study|Other Reason|1|||
41955220|NCT01708902|75722751|FG003|Overall Study|Other Reason|1|||
41955221|NCT01708902|75722752|FG004|Overall Study|Other Reason|1|||
41955222|NCT01708902|75722753|FG005|Overall Study|Other Reason|2|||
41955223|NCT01708902|75722754|FG006|Overall Study|Other Reason|0|||
41955224|NCT01755546|75722773|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
41955225|NCT01755546|75722773|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
41955226|NCT01755546|75722773|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
41955227|NCT01755546|75722773|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
41955228|NCT01755546|75722773|FG000|Titration Phase|Adverse Event|11|||
41955229|NCT01755546|75722773|FG000|Titration Phase|Lack of Efficacy|18|||
41955230|NCT01755546|75722773|FG000|Titration Phase|Protocol Violation|9|||
41955231|NCT01755546|75722773|FG000|Titration Phase|Lost to Follow-up|2|||
41955232|NCT01755546|75722773|FG000|Titration Phase|Other and Continuing|22|||
41955233|NCT01755546|75722773|FG000|Titration Phase|Withdrawal by Subject|8|||
41955234|NCT01755546|75722773|FG000|Long Term Treatment|Adverse Event|12|||
41955235|NCT01755546|75722773|FG000|Long Term Treatment|Lack of Efficacy|6|||
41955236|NCT01755546|75722773|FG000|Long Term Treatment|Protocol Violation|10|||
41955237|NCT01755546|75722773|FG000|Long Term Treatment|Withdrawal by Subject|35|||
41955238|NCT01755546|75722773|FG000|Long Term Treatment|Lost to Follow-up|17|||
41955239|NCT01755546|75722773|FG000|Long Term Treatment|other and ongoing|41|||
41955240|NCT01755234|75722779|FG000|Overall Study|Lost to Follow-up|11|||
41955241|NCT01755234|75722780|FG001|Overall Study|Lost to Follow-up|6|||
41955242|NCT01755234|75722779|FG000|Overall Study|Change in surgical case|2|||
41955243|NCT01755234|75722780|FG001|Overall Study|Change in surgical case|1|||
41955244|NCT01755234|75722779|FG000|Overall Study|case cancelled|1|||
41955245|NCT01755234|75722780|FG001|Overall Study|case cancelled|0|||
41955246|NCT01755234|75722779|FG000|Overall Study|Withdrawal by Subject|0|||
41955247|NCT01755234|75722780|FG001|Overall Study|Withdrawal by Subject|1|||
41955248|NCT01755234|75722779|FG000|Overall Study|unblinded|1|||
41955249|NCT01755234|75722780|FG001|Overall Study|unblinded|0|||
41955250|NCT01731912|75722786|FG000|Overall Study|noncompliance|2|||
41955251|NCT01731678|75722790|FG000|Overall Study|Withdrawal by Subject|3|||
41955252|NCT01731678|75722790|FG000|Overall Study|Did not meet inclusion criteria|1|||
41955253|NCT01731678|75722790|FG000|Overall Study|RMT too high, making TMS difficult|3|||
41955254|NCT01731600|75722796|FG000|Overall Study|Adverse Event|2|||
41955255|NCT01731600|75722797|FG001|Overall Study|Adverse Event|0|||
41955256|NCT01731600|75722796|FG000|Overall Study|Withdrawal criteria|1|||
41955257|NCT01731600|75722797|FG001|Overall Study|Withdrawal criteria|0|||
41955258|NCT01731600|75722796|FG000|Overall Study|Other reasons|3|||
41955259|NCT01731600|75722797|FG001|Overall Study|Other reasons|0|||
41955260|NCT01730586|75722807|FG000|Overall Study|Progressive Disease|2|||
41955261|NCT01730586|75722807|FG000|Overall Study|Inadequate Trial|8|||
41955262|NCT01730586|75722807|FG000|Overall Study|Adverse Event|2|||
41955263|NCT01730586|75722807|FG000|Overall Study|Hospice|1|||
41955264|NCT01707030|75722815|FG000|Overall Study|Death|1|||
41955265|NCT01707030|75722816|FG001|Overall Study|Death|1|||
41955266|NCT01707030|75722815|FG000|Overall Study|Withdrawal by Subject|2|||
41955267|NCT01707030|75722816|FG001|Overall Study|Withdrawal by Subject|3|||
41955268|NCT01707030|75722815|FG000|Overall Study|Lost to Follow-up|8|||
41955269|NCT01707030|75722816|FG001|Overall Study|Lost to Follow-up|13|||
41955270|NCT01755156|75722828|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
41955271|NCT01755156|75722829|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
41955272|NCT01755156|75722828|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
41955273|NCT01755156|75722829|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
41955274|NCT01755156|75722828|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
41955275|NCT01755156|75722829|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
41955276|NCT01755156|75722828|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
41955277|NCT01755156|75722829|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
41955278|NCT01755156|75722828|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
41955279|NCT01755156|75722829|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
41955280|NCT01755156|75722828|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
41955281|NCT01755156|75722829|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
41955282|NCT01755156|75722828|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
41955283|NCT01755156|75722829|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
41955284|NCT01755156|75722828|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
41955285|NCT01755156|75722829|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
41955286|NCT01755156|75722828|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
41955287|NCT01755156|75722829|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
41955288|NCT01755156|75722828|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
41955289|NCT01755156|75722829|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
41955290|NCT01755156|75722828|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
41955291|NCT01755156|75722829|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
41955292|NCT01754922|75722841|FG000|Overall Study|Adverse Event|0|||
41955293|NCT01754922|75722842|FG001|Overall Study|Adverse Event|1|||
41955294|NCT01754766|75722852|FG000|Overall Study|Personal reasons|1|||
41955295|NCT01754766|75722853|FG001|Overall Study|Personal reasons|1|||
41955296|NCT01754766|75722854|FG002|Overall Study|Personal reasons|0|||
41955297|NCT01754376|75722862|FG000|Overall Study|Adverse Event|1|||
41955298|NCT01754376|75722862|FG000|Overall Study|Lack of Efficacy|2|||
41955299|NCT01605396|75722869|FG000|Overall Study|Adverse Event|5|||
41955300|NCT01605396|75722870|FG001|Overall Study|Adverse Event|3|||
41955301|NCT01605396|75722869|FG000|Overall Study|Lost to Follow-up|1|||
41955302|NCT01605396|75722870|FG001|Overall Study|Lost to Follow-up|0|||
41955303|NCT01605396|75722869|FG000|Overall Study|Non-Compliance With Study Drug|1|||
41955304|NCT01605396|75722870|FG001|Overall Study|Non-Compliance With Study Drug|1|||
41955305|NCT01605396|75722869|FG000|Overall Study|Physician Decision|2|||
41955306|NCT01605396|75722870|FG001|Overall Study|Physician Decision|2|||
41955307|NCT01605396|75722869|FG000|Overall Study|Progressive Disease|23|||
41955308|NCT01605396|75722870|FG001|Overall Study|Progressive Disease|27|||
41955309|NCT01605396|75722869|FG000|Overall Study|Withdrawal by Subject|4|||
41955310|NCT01605396|75722870|FG001|Overall Study|Withdrawal by Subject|2|||
41955311|NCT01605396|75722869|FG000|Overall Study|Transfer Off Study|4|||
41955312|NCT01605396|75722870|FG001|Overall Study|Transfer Off Study|5|||
41955313|NCT01730118|75722883|FG000|Dose Escalation|Death on study|5|||
41955314|NCT01730118|75722884|FG001|Dose Escalation|Death on study|7|||
41955315|NCT01730118|75722885|FG002|Dose Escalation|Death on study|2|||
41955316|NCT01730118|75722886|FG003|Dose Escalation|Death on study|6|||
41955317|NCT01730118|75722887|FG004|Dose Escalation|Death on study|0|||
41955318|NCT01730118|75722888|FG005|Dose Escalation|Death on study|0|||
41955319|NCT01730118|75722889|FG006|Dose Escalation|Death on study|0|||
41955320|NCT01730118|75722883|FG000|Dose Escalation|Died before treatment|0|||
41955321|NCT01730118|75722884|FG001|Dose Escalation|Died before treatment|0|||
41955322|NCT01730118|75722885|FG002|Dose Escalation|Died before treatment|0|||
41955323|NCT01730118|75722886|FG003|Dose Escalation|Died before treatment|0|||
41955324|NCT01730118|75722887|FG004|Dose Escalation|Died before treatment|0|||
41955325|NCT01730118|75722888|FG005|Dose Escalation|Died before treatment|0|||
41955326|NCT01730118|75722889|FG006|Dose Escalation|Died before treatment|1|||
41955327|NCT01730118|75722883|FG000|Dose Escalation|Chose to start a different treatment|1|||
41955328|NCT01730118|75722884|FG001|Dose Escalation|Chose to start a different treatment|0|||
41955329|NCT01730118|75722885|FG002|Dose Escalation|Chose to start a different treatment|0|||
41955330|NCT01730118|75722886|FG003|Dose Escalation|Chose to start a different treatment|0|||
41955331|NCT01730118|75722887|FG004|Dose Escalation|Chose to start a different treatment|0|||
41955332|NCT01730118|75722888|FG005|Dose Escalation|Chose to start a different treatment|0|||
41955333|NCT01730118|75722889|FG006|Dose Escalation|Chose to start a different treatment|0|||
41955334|NCT01730118|75722883|FG000|Dose Escalation|Withdrawal by Subject|0|||
41955335|NCT01730118|75722884|FG001|Dose Escalation|Withdrawal by Subject|0|||
41955336|NCT01730118|75722885|FG002|Dose Escalation|Withdrawal by Subject|1|||
41955337|NCT01730118|75722886|FG003|Dose Escalation|Withdrawal by Subject|0|||
41955338|NCT01730118|75722887|FG004|Dose Escalation|Withdrawal by Subject|0|||
41955339|NCT01730118|75722888|FG005|Dose Escalation|Withdrawal by Subject|0|||
41955340|NCT01730118|75722889|FG006|Dose Escalation|Withdrawal by Subject|0|||
41955341|NCT01730118|75722883|FG000|Dose Escalation|Disease progression prior to treatment|0|||
41955342|NCT01730118|75722884|FG001|Dose Escalation|Disease progression prior to treatment|0|||
41955343|NCT01730118|75722885|FG002|Dose Escalation|Disease progression prior to treatment|0|||
41955344|NCT01730118|75722886|FG003|Dose Escalation|Disease progression prior to treatment|0|||
41955345|NCT01730118|75722887|FG004|Dose Escalation|Disease progression prior to treatment|0|||
41955346|NCT01730118|75722888|FG005|Dose Escalation|Disease progression prior to treatment|0|||
41955347|NCT01730118|75722889|FG006|Dose Escalation|Disease progression prior to treatment|1|||
41955348|NCT01730118|75722883|FG000|Dose Expansion|Death|0|||
41955349|NCT01730118|75722884|FG001|Dose Expansion|Death|0|||
41955350|NCT01730118|75722885|FG002|Dose Expansion|Death|0|||
41955351|NCT01730118|75722886|FG003|Dose Expansion|Death|0|||
41955352|NCT01730118|75722887|FG004|Dose Expansion|Death|1|||
41955353|NCT01730118|75722888|FG005|Dose Expansion|Death|0|||
41955354|NCT01730118|75722889|FG006|Dose Expansion|Death|0|||
41955355|NCT01730118|75722883|FG000|Dose Expansion|Other medical condition|0|||
41955356|NCT01730118|75722884|FG001|Dose Expansion|Other medical condition|0|||
41955357|NCT01730118|75722885|FG002|Dose Expansion|Other medical condition|0|||
41955358|NCT01730118|75722886|FG003|Dose Expansion|Other medical condition|0|||
41955359|NCT01730118|75722887|FG004|Dose Expansion|Other medical condition|1|||
41955360|NCT01730118|75722888|FG005|Dose Expansion|Other medical condition|0|||
41955361|NCT01730118|75722889|FG006|Dose Expansion|Other medical condition|0|||
41955362|NCT01730118|75722883|FG000|Dose Expansion|Withdrawal by Subject|0|||
41955363|NCT01730118|75722884|FG001|Dose Expansion|Withdrawal by Subject|0|||
41955364|NCT01730118|75722885|FG002|Dose Expansion|Withdrawal by Subject|0|||
41955365|NCT01730118|75722886|FG003|Dose Expansion|Withdrawal by Subject|0|||
41955366|NCT01730118|75722887|FG004|Dose Expansion|Withdrawal by Subject|1|||
41955367|NCT01730118|75722888|FG005|Dose Expansion|Withdrawal by Subject|0|||
41955368|NCT01730118|75722889|FG006|Dose Expansion|Withdrawal by Subject|0|||
41955369|NCT01730118|75722883|FG000|Dose Expansion|Disease progression|0|||
41955370|NCT01730118|75722884|FG001|Dose Expansion|Disease progression|0|||
41955371|NCT01730118|75722885|FG002|Dose Expansion|Disease progression|0|||
41955372|NCT01730118|75722886|FG003|Dose Expansion|Disease progression|0|||
41955373|NCT01730118|75722887|FG004|Dose Expansion|Disease progression|0|||
41955374|NCT01730118|75722888|FG005|Dose Expansion|Disease progression|1|||
41955375|NCT01730118|75722889|FG006|Dose Expansion|Disease progression|0|||
41955376|NCT01730118|75722883|FG000|Dose Expansion|Inability to return|0|||
41955377|NCT01730118|75722884|FG001|Dose Expansion|Inability to return|0|||
41955378|NCT01730118|75722885|FG002|Dose Expansion|Inability to return|0|||
41955379|NCT01730118|75722886|FG003|Dose Expansion|Inability to return|0|||
41955380|NCT01730118|75722887|FG004|Dose Expansion|Inability to return|0|||
41955381|NCT01730118|75722888|FG005|Dose Expansion|Inability to return|1|||
41955382|NCT01730118|75722889|FG006|Dose Expansion|Inability to return|0|||
41955383|NCT01730118|75722883|FG000|Dose Expansion|Physician Decision|0|||
41955384|NCT01730118|75722884|FG001|Dose Expansion|Physician Decision|0|||
41955385|NCT01730118|75722885|FG002|Dose Expansion|Physician Decision|0|||
41955386|NCT01730118|75722886|FG003|Dose Expansion|Physician Decision|0|||
41955387|NCT01730118|75722887|FG004|Dose Expansion|Physician Decision|0|||
41955388|NCT01730118|75722888|FG005|Dose Expansion|Physician Decision|1|||
41955389|NCT01730118|75722889|FG006|Dose Expansion|Physician Decision|0|||
41955390|NCT01730040|75722913|FG000|Overall Study|Randomized but not treated|0|||
41955391|NCT01730040|75722914|FG001|Overall Study|Randomized but not treated|0|||
41955392|NCT01730040|75722915|FG002|Overall Study|Randomized but not treated|0|||
41955393|NCT01730040|75722916|FG003|Overall Study|Randomized but not treated|0|||
41955394|NCT01730040|75722917|FG004|Overall Study|Randomized but not treated|0|||
41955395|NCT01730040|75722918|FG005|Overall Study|Randomized but not treated|1|||
41955396|NCT01730040|75722919|FG006|Overall Study|Randomized but not treated|0|||
41955397|NCT01730040|75722913|FG000|Overall Study|Subject moved|0|||
41955398|NCT01730040|75722914|FG001|Overall Study|Subject moved|0|||
41955399|NCT01730040|75722915|FG002|Overall Study|Subject moved|1|||
41955400|NCT01730040|75722916|FG003|Overall Study|Subject moved|0|||
41955401|NCT01730040|75722917|FG004|Overall Study|Subject moved|0|||
41955402|NCT01730040|75722918|FG005|Overall Study|Subject moved|0|||
41955403|NCT01730040|75722919|FG006|Overall Study|Subject moved|1|||
41955404|NCT01730040|75722913|FG000|Overall Study|Physician Decision|0|||
41955405|NCT01730040|75722914|FG001|Overall Study|Physician Decision|0|||
41955406|NCT01730040|75722915|FG002|Overall Study|Physician Decision|0|||
41955407|NCT01730040|75722916|FG003|Overall Study|Physician Decision|0|||
41955408|NCT01730040|75722917|FG004|Overall Study|Physician Decision|0|||
41955409|NCT01730040|75722918|FG005|Overall Study|Physician Decision|1|||
41955410|NCT01730040|75722919|FG006|Overall Study|Physician Decision|1|||
41955411|NCT01730040|75722913|FG000|Overall Study|Other than specified|7|||
41955412|NCT01730040|75722914|FG001|Overall Study|Other than specified|8|||
41955413|NCT01730040|75722915|FG002|Overall Study|Other than specified|5|||
41955414|NCT01730040|75722916|FG003|Overall Study|Other than specified|5|||
41955415|NCT01730040|75722917|FG004|Overall Study|Other than specified|5|||
41955416|NCT01730040|75722918|FG005|Overall Study|Other than specified|4|||
41955417|NCT01730040|75722919|FG006|Overall Study|Other than specified|4|||
41955418|NCT01730040|75722913|FG000|Overall Study|Adverse Event|4|||
41955419|NCT01730040|75722914|FG001|Overall Study|Adverse Event|3|||
41955420|NCT01730040|75722915|FG002|Overall Study|Adverse Event|5|||
41955421|NCT01730040|75722916|FG003|Overall Study|Adverse Event|3|||
41955422|NCT01730040|75722917|FG004|Overall Study|Adverse Event|1|||
41955423|NCT01730040|75722918|FG005|Overall Study|Adverse Event|1|||
41955424|NCT01730040|75722919|FG006|Overall Study|Adverse Event|2|||
41955425|NCT01730040|75722913|FG000|Overall Study|Poor compliance to protocol|2|||
41955426|NCT01730040|75722914|FG001|Overall Study|Poor compliance to protocol|4|||
41955427|NCT01730040|75722915|FG002|Overall Study|Poor compliance to protocol|0|||
41955428|NCT01730040|75722916|FG003|Overall Study|Poor compliance to protocol|0|||
41955429|NCT01730040|75722917|FG004|Overall Study|Poor compliance to protocol|0|||
41955430|NCT01730040|75722918|FG005|Overall Study|Poor compliance to protocol|0|||
41955431|NCT01730040|75722919|FG006|Overall Study|Poor compliance to protocol|1|||
41955432|NCT01706328|75722937|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
41955433|NCT01706328|75722938|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
41955434|NCT01706328|75722939|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
41955435|NCT01706328|75722937|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
41955436|NCT01706328|75722938|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
41955437|NCT01706328|75722939|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
41955438|NCT01706328|75722937|FG000|2-week Run-in Period|Physician Decision|4|||
41955439|NCT01706328|75722938|FG001|2-week Run-in Period|Physician Decision|0|||
41955440|NCT01706328|75722939|FG002|2-week Run-in Period|Physician Decision|0|||
41955441|NCT01706328|75722937|FG000|2-week Run-in Period|Adverse Event|4|||
41955442|NCT01706328|75722938|FG001|2-week Run-in Period|Adverse Event|0|||
41955443|NCT01706328|75722939|FG002|2-week Run-in Period|Adverse Event|0|||
41955444|NCT01706328|75722937|FG000|2-week Run-in Period|Lost to Follow-up|2|||
41955445|NCT01706328|75722938|FG001|2-week Run-in Period|Lost to Follow-up|0|||
41955446|NCT01706328|75722939|FG002|2-week Run-in Period|Lost to Follow-up|0|||
41955447|NCT01706328|75722937|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
41955448|NCT01706328|75722938|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
41955449|NCT01706328|75722939|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
41955450|NCT01706328|75722937|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
41955451|NCT01706328|75722938|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
41955452|NCT01706328|75722939|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
41955453|NCT01706328|75722937|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
41955454|NCT01706328|75722938|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
41955455|NCT01706328|75722939|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
41955456|NCT01706328|75722937|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
41955457|NCT01706328|75722938|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
41955458|NCT01706328|75722939|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
41955459|NCT01706328|75722937|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
41955460|NCT01706328|75722938|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
41955461|NCT01706328|75722939|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
41955462|NCT01706328|75722937|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
41955463|NCT01706328|75722938|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
41955464|NCT01706328|75722939|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
41955465|NCT01706328|75722937|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
41955466|NCT01706328|75722938|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
41955467|NCT01706328|75722939|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
41955468|NCT01753518|75722947|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
41955469|NCT01753518|75722948|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
41955470|NCT01753518|75722947|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
41955471|NCT01753518|75722948|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
41955472|NCT01753518|75722947|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
41955473|NCT01753518|75722948|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
41955474|NCT01753518|75722947|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
41955475|NCT01753518|75722948|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
41955476|NCT01706250|75722954|FG000|Overall Study|Lost to Follow-up|2|||
41955477|NCT01729728|75722966|FG000|Overall Study|Adverse Event|0|||
41955478|NCT01729728|75722967|FG001|Overall Study|Adverse Event|6|||
41955479|NCT01729728|75722968|FG002|Overall Study|Adverse Event|0|||
41955480|NCT01729728|75722966|FG000|Overall Study|Protocol Violation|1|||
41955481|NCT01729728|75722967|FG001|Overall Study|Protocol Violation|0|||
41955482|NCT01729728|75722968|FG002|Overall Study|Protocol Violation|1|||
41955483|NCT01729026|75723101|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
41955484|NCT01729026|75723102|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
41955485|NCT01729026|75723101|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
41955486|NCT01729026|75723102|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
41955487|NCT01728792|75723116|FG000|Overall Study|Withdrawal of Consent|1|||
41955488|NCT01728792|75723117|FG001|Overall Study|Withdrawal of Consent|1|||
41955489|NCT01728792|75723118|FG002|Overall Study|Withdrawal of Consent|0|||
41955490|NCT01728792|75723119|FG003|Overall Study|Withdrawal of Consent|1|||
41955491|NCT01728792|75723120|FG004|Overall Study|Withdrawal of Consent|0|||
41955492|NCT01728792|75723116|FG000|Overall Study|Lost to Follow-up|2|||
41955493|NCT01728792|75723117|FG001|Overall Study|Lost to Follow-up|1|||
41955494|NCT01728792|75723118|FG002|Overall Study|Lost to Follow-up|4|||
41955495|NCT01728792|75723119|FG003|Overall Study|Lost to Follow-up|2|||
41955496|NCT01728792|75723120|FG004|Overall Study|Lost to Follow-up|0|||
41955497|NCT01752036|75723132|FG000|Overall Study|Death|2|||
41955498|NCT01728324|75723140|FG000|Termination of DBV|Adverse Event|14|||
41955499|NCT01728324|75723141|FG001|Termination of DBV|Adverse Event|13|||
41955500|NCT01728324|75723142|FG002|Termination of DBV|Adverse Event|4|||
41955501|NCT01728324|75723140|FG000|Termination of DBV|Lack of Efficacy|14|||
41955502|NCT01728324|75723141|FG001|Termination of DBV|Lack of Efficacy|12|||
41955503|NCT01728324|75723142|FG002|Termination of DBV|Lack of Efficacy|8|||
41955504|NCT01728324|75723140|FG000|Termination of DBV|Withdrawal by Subject|9|||
41955505|NCT01728324|75723141|FG001|Termination of DBV|Withdrawal by Subject|6|||
42024099|NCT01020981|75831493|FG001|Overall Study|Did not return mailed survey|58|||
42024100|NCT01020981|75831492|FG000|Overall Study|Survey returned undeliverable|8|||
42024101|NCT01020981|75831493|FG001|Overall Study|Survey returned undeliverable|32|||
42024102|NCT01020981|75831492|FG000|Overall Study|Participant declined to complete survey|2|||
42024103|NCT01020981|75831493|FG001|Overall Study|Participant declined to complete survey|0|||
42024104|NCT01020747|75831501|FG000|Overall Study|Withdrawal by Subject|1|||
42118038|NCT00689117|75928843|FG003|Overall Study|Patient Withdrew from Study|1|||
42024105|NCT01020435|75831508|FG000|Overall Study|Lost to Follow-up|0|||
41955506|NCT01728324|75723142|FG002|Termination of DBV|Withdrawal by Subject|2|||
41955507|NCT01728324|75723140|FG000|Termination of DBV|Other than stated|1|||
41955508|NCT01728324|75723141|FG001|Termination of DBV|Other than stated|3|||
41955509|NCT01728324|75723142|FG002|Termination of DBV|Other than stated|0|||
41955510|NCT01728324|75723140|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
41955511|NCT01728324|75723141|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
41955512|NCT01728324|75723142|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
41955513|NCT01728324|75723140|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
41955514|NCT01728324|75723141|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
41955515|NCT01728324|75723142|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
41955516|NCT01728324|75723140|FG000|Termination of FDV|Adverse Event|14|||
41955517|NCT01728324|75723141|FG001|Termination of FDV|Adverse Event|13|||
41955518|NCT01728324|75723142|FG002|Termination of FDV|Adverse Event|4|||
41955519|NCT01728324|75723140|FG000|Termination of FDV|Lack of Efficacy|14|||
41955520|NCT01728324|75723141|FG001|Termination of FDV|Lack of Efficacy|12|||
41955521|NCT01728324|75723142|FG002|Termination of FDV|Lack of Efficacy|8|||
41955522|NCT01728324|75723140|FG000|Termination of FDV|Withdrawal by Subject|9|||
41955523|NCT01728324|75723141|FG001|Termination of FDV|Withdrawal by Subject|6|||
41955524|NCT01728324|75723142|FG002|Termination of FDV|Withdrawal by Subject|2|||
41955525|NCT01728324|75723140|FG000|Termination of FDV|Other than stated|1|||
41955526|NCT01728324|75723141|FG001|Termination of FDV|Other than stated|3|||
41955527|NCT01728324|75723142|FG002|Termination of FDV|Other than stated|0|||
41955528|NCT01728324|75723140|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
41955529|NCT01728324|75723141|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
41955530|NCT01728324|75723142|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
41955531|NCT01728324|75723140|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
41955532|NCT01728324|75723141|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
41955533|NCT01728324|75723142|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
41955534|NCT01728324|75723140|FG000|Termination of RBV|Adverse Event|15|||
41955535|NCT01728324|75723141|FG001|Termination of RBV|Adverse Event|16|||
41955536|NCT01728324|75723142|FG002|Termination of RBV|Adverse Event|5|||
41955537|NCT01728324|75723140|FG000|Termination of RBV|Lack of Efficacy|14|||
41955538|NCT01728324|75723141|FG001|Termination of RBV|Lack of Efficacy|11|||
41955539|NCT01728324|75723142|FG002|Termination of RBV|Lack of Efficacy|7|||
41955540|NCT01728324|75723140|FG000|Termination of RBV|Withdrawal by Subject|9|||
41955541|NCT01728324|75723141|FG001|Termination of RBV|Withdrawal by Subject|5|||
41955542|NCT01728324|75723142|FG002|Termination of RBV|Withdrawal by Subject|2|||
41955543|NCT01728324|75723140|FG000|Termination of RBV|Other than stated|1|||
41955544|NCT01728324|75723141|FG001|Termination of RBV|Other than stated|3|||
41955545|NCT01728324|75723142|FG002|Termination of RBV|Other than stated|1|||
41955546|NCT01728324|75723140|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
41955547|NCT01728324|75723141|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
41955548|NCT01728324|75723142|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
41955549|NCT01728324|75723140|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
41955550|NCT01728324|75723141|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
41955551|NCT01728324|75723142|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
41955552|NCT01728246|75723154|FG000|Overall Study|Participant needed rescue medication|1|||
41955553|NCT01728246|75723155|FG001|Overall Study|Participant needed rescue medication|5|||
41955554|NCT01728246|75723154|FG000|Overall Study|Protocol Violation|1|||
41955555|NCT01728246|75723155|FG001|Overall Study|Protocol Violation|0|||
41955556|NCT01728246|75723154|FG000|Overall Study|Withdrawal by Subject|2|||
41955557|NCT01728246|75723155|FG001|Overall Study|Withdrawal by Subject|3|||
41955558|NCT01728246|75723154|FG000|Overall Study|Lost to Follow-up|23|||
41955559|NCT01728246|75723155|FG001|Overall Study|Lost to Follow-up|22|||
41955560|NCT01728246|75723154|FG000|Overall Study|Lack of Efficacy|1|||
41955561|NCT01728246|75723155|FG001|Overall Study|Lack of Efficacy|1|||
41955562|NCT01728246|75723154|FG000|Overall Study|Adverse Event|8|||
41955563|NCT01728246|75723155|FG001|Overall Study|Adverse Event|5|||
41955564|NCT01705236|75723161|FG000|Overall Study|Lost to Follow-up|1|||
41955565|NCT01705236|75723161|FG000|Overall Study|Administrative problems|2|||
41955566|NCT01705236|75723161|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
41955567|NCT01705236|75723161|FG000|Overall Study|Protocol Violation|3|||
41955568|NCT01705236|75723161|FG000|Overall Study|Abnormal test procedure result(s)|4|||
41955569|NCT01705236|75723161|FG000|Overall Study|Abnormal laboratory value(s)|4|||
41955570|NCT01705236|75723161|FG000|Overall Study|Withdrawal by Subject|5|||
41955571|NCT01705236|75723161|FG000|Overall Study|Adverse Event|5|||
41955572|NCT01705080|75723168|FG000|Overall Study|Missed visit|10|||
41955573|NCT01705080|75723169|FG001|Overall Study|Missed visit|4|||
41955574|NCT01705080|75723170|FG002|Overall Study|Missed visit|1|||
41955575|NCT01705080|75723168|FG000|Overall Study|Death|4|||
41955576|NCT01705080|75723169|FG001|Overall Study|Death|4|||
41955577|NCT01705080|75723170|FG002|Overall Study|Death|6|||
41955578|NCT01705080|75723168|FG000|Overall Study|Withdrawal by Subject|61|||
41955579|NCT01705080|75723169|FG001|Overall Study|Withdrawal by Subject|44|||
41955580|NCT01705080|75723170|FG002|Overall Study|Withdrawal by Subject|9|||
41955581|NCT01704846|75723180|FG000|Treatment Period 2|Withdrawal by Subject|0|||
41955582|NCT01704846|75723181|FG001|Treatment Period 2|Withdrawal by Subject|1|||
41955583|NCT01751802|75723189|FG000|Overall Study|Adverse Event|4|||
41955584|NCT01751802|75723190|FG001|Overall Study|Adverse Event|2|||
41955585|NCT01704456|75723204|FG000|Overall Study|Lost to Follow-up|8|||
41955586|NCT01704456|75723205|FG001|Overall Study|Lost to Follow-up|14|||
41955587|NCT01703988|75723215|FG000|Overall Study|Investigator Judgment|0|||
41955588|NCT01703988|75723216|FG001|Overall Study|Investigator Judgment|0|||
41955589|NCT01703988|75723217|FG002|Overall Study|Investigator Judgment|0|||
41955590|NCT01703988|75723218|FG003|Overall Study|Investigator Judgment|1|||
41955591|NCT01703832|75723231|FG000|Overall Study|Withdrawal by Subject|1|||
41955592|NCT01703832|75723232|FG001|Overall Study|Withdrawal by Subject|0|||
41955593|NCT01703286|75723238|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
41955594|NCT01703286|75723239|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
41955595|NCT01703286|75723240|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
41955596|NCT01703286|75723241|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
41955597|NCT01703286|75723242|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
41955598|NCT01703286|75723243|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
41955599|NCT01703286|75723238|FG000|Period 2 Including Washout|Adverse Event|0|||
41955600|NCT01703286|75723239|FG001|Period 2 Including Washout|Adverse Event|0|||
41955601|NCT01703286|75723240|FG002|Period 2 Including Washout|Adverse Event|0|||
41955602|NCT01703286|75723241|FG003|Period 2 Including Washout|Adverse Event|1|||
41955603|NCT01703286|75723242|FG004|Period 2 Including Washout|Adverse Event|0|||
41955604|NCT01703286|75723243|FG005|Period 2 Including Washout|Adverse Event|0|||
41955605|NCT01703208|75723256|FG000|Overall Study|Death|61|||
41955606|NCT01703208|75723257|FG001|Overall Study|Death|48|||
41955607|NCT01703208|75723256|FG000|Overall Study|Lack of Efficacy|1|||
41955608|NCT01703208|75723257|FG001|Overall Study|Lack of Efficacy|2|||
41955609|NCT01703208|75723256|FG000|Overall Study|Lost to Follow-up|68|||
41955610|NCT01703208|75723257|FG001|Overall Study|Lost to Follow-up|62|||
41955611|NCT01703208|75723256|FG000|Overall Study|Non-Compliance with Study Drug|1|||
41955612|NCT01703208|75723257|FG001|Overall Study|Non-Compliance with Study Drug|0|||
41955613|NCT01703208|75723256|FG000|Overall Study|Excluded Medication|1|||
41955614|NCT01703208|75723257|FG001|Overall Study|Excluded Medication|2|||
41955615|NCT01703208|75723256|FG000|Overall Study|Site Discontinued Study Participation|23|||
41955616|NCT01703208|75723257|FG001|Overall Study|Site Discontinued Study Participation|27|||
41955617|NCT01703208|75723256|FG000|Overall Study|Physician Decision|11|||
41955618|NCT01703208|75723257|FG001|Overall Study|Physician Decision|13|||
41955619|NCT01703208|75723256|FG000|Overall Study|Progressive disease|2|||
41955620|NCT01703208|75723257|FG001|Overall Study|Progressive disease|2|||
41955621|NCT01703208|75723256|FG000|Overall Study|Protocol Violation|1|||
41955622|NCT01703208|75723257|FG001|Overall Study|Protocol Violation|1|||
41955623|NCT01703208|75723256|FG000|Overall Study|Study Terminated by Sponsor|1710|||
41955624|NCT01703208|75723257|FG001|Overall Study|Study Terminated by Sponsor|1716|||
41955625|NCT01703208|75723256|FG000|Overall Study|Withdrawal by Subject|205|||
41955626|NCT01703208|75723257|FG001|Overall Study|Withdrawal by Subject|209|||
41955627|NCT01703208|75723256|FG000|Overall Study|Adverse Event|14|||
41955628|NCT01703208|75723257|FG001|Overall Study|Adverse Event|19|||
41955629|NCT01703208|75723256|FG000|Overall Study|Technical Problems|0|||
41955630|NCT01703208|75723257|FG001|Overall Study|Technical Problems|1|||
41955631|NCT01703208|75723256|FG000|Overall Study|Protocol Deviation|2|||
41955632|NCT01703208|75723257|FG001|Overall Study|Protocol Deviation|0|||
41955633|NCT01727700|75723266|FG000|Overall Study|Adverse Event|0|||
41955634|NCT01727700|75723267|FG001|Overall Study|Adverse Event|7|||
41955635|NCT01727700|75723268|FG002|Overall Study|Adverse Event|1|||
41955636|NCT01727700|75723266|FG000|Overall Study|Particpant withdrew consent|0|||
41955637|NCT01727700|75723267|FG001|Overall Study|Particpant withdrew consent|3|||
41955638|NCT01727700|75723268|FG002|Overall Study|Particpant withdrew consent|1|||
41955639|NCT01727700|75723266|FG000|Overall Study|Protocol Violation|2|||
41955640|NCT01727700|75723267|FG001|Overall Study|Protocol Violation|0|||
41955641|NCT01727700|75723268|FG002|Overall Study|Protocol Violation|0|||
41955642|NCT01727154|75723276|FG000|Overall Study|Death|17|||
41955643|NCT01727154|75723276|FG000|Overall Study|Withdrawal by Subject|14|||
41955644|NCT01727154|75723276|FG000|Overall Study|Subject Withdrew Consent|18|||
41955645|NCT01727154|75723276|FG000|Overall Study|Study Terminated|6|||
41955646|NCT01727154|75723276|FG000|Overall Study|No Discontinuation Documentation|4|||
41955647|NCT01725750|75723282|FG000|Overall Study|Adverse Event|1|||
41955648|NCT01725750|75723283|FG001|Overall Study|Adverse Event|0|||
41955649|NCT01725750|75723282|FG000|Overall Study|Lost to Follow-up|1|||
41955650|NCT01725750|75723283|FG001|Overall Study|Lost to Follow-up|1|||
41955651|NCT01725750|75723282|FG000|Overall Study|Withdrawal by Subject|0|||
41955652|NCT01725750|75723283|FG001|Overall Study|Withdrawal by Subject|9|||
41955653|NCT01725282|75723295|FG000|Overall Study|Adverse Event|1|||
41955654|NCT01725282|75723296|FG001|Overall Study|Adverse Event|3|||
41955655|NCT01725282|75723297|FG002|Overall Study|Adverse Event|6|||
41955656|NCT01725282|75723298|FG003|Overall Study|Adverse Event|4|||
41955657|NCT01725282|75723295|FG000|Overall Study|Exacerbation of Target Disease|1|||
41955658|NCT01725282|75723296|FG001|Overall Study|Exacerbation of Target Disease|0|||
41955659|NCT01725282|75723297|FG002|Overall Study|Exacerbation of Target Disease|0|||
41955660|NCT01725282|75723298|FG003|Overall Study|Exacerbation of Target Disease|1|||
41955661|NCT01725282|75723295|FG000|Overall Study|Met Exclusion Criteria|0|||
41955662|NCT01725282|75723296|FG001|Overall Study|Met Exclusion Criteria|0|||
41955663|NCT01725282|75723297|FG002|Overall Study|Met Exclusion Criteria|1|||
41955664|NCT01725282|75723298|FG003|Overall Study|Met Exclusion Criteria|0|||
41955665|NCT01725282|75723295|FG000|Overall Study|Study Site Withdrawal|0|||
41955666|NCT01725282|75723296|FG001|Overall Study|Study Site Withdrawal|1|||
41955667|NCT01725282|75723297|FG002|Overall Study|Study Site Withdrawal|0|||
41955668|NCT01725282|75723298|FG003|Overall Study|Study Site Withdrawal|0|||
41955669|NCT01725282|75723295|FG000|Overall Study|Withdrawal by Subject|0|||
41955670|NCT01725282|75723296|FG001|Overall Study|Withdrawal by Subject|0|||
41955671|NCT01725282|75723297|FG002|Overall Study|Withdrawal by Subject|1|||
41955672|NCT01725282|75723298|FG003|Overall Study|Withdrawal by Subject|1|||
41955673|NCT01725282|75723295|FG000|Overall Study|Lack of Efficacy|0|||
41955674|NCT01725282|75723296|FG001|Overall Study|Lack of Efficacy|1|||
41955675|NCT01725282|75723297|FG002|Overall Study|Lack of Efficacy|0|||
41955676|NCT01725282|75723298|FG003|Overall Study|Lack of Efficacy|1|||
41955677|NCT01725126|75723314|FG000|Overall Study|Protocol Violation|0|||
41955678|NCT01725126|75723315|FG001|Overall Study|Protocol Violation|1|||
41955679|NCT01725126|75723316|FG002|Overall Study|Protocol Violation|0|||
41955680|NCT01725126|75723317|FG003|Overall Study|Protocol Violation|0|||
41955681|NCT01725126|75723318|FG004|Overall Study|Protocol Violation|0|||
41955682|NCT01725126|75723319|FG005|Overall Study|Protocol Violation|0|||
41955683|NCT01725126|75723314|FG000|Overall Study|Withdrawal by Subject|0|||
41955684|NCT01725126|75723315|FG001|Overall Study|Withdrawal by Subject|0|||
41955685|NCT01725126|75723316|FG002|Overall Study|Withdrawal by Subject|0|||
41955686|NCT01725126|75723317|FG003|Overall Study|Withdrawal by Subject|1|||
41955687|NCT01725126|75723318|FG004|Overall Study|Withdrawal by Subject|0|||
41955688|NCT01725126|75723319|FG005|Overall Study|Withdrawal by Subject|0|||
41955689|NCT01751724|75723344|FG000|Overall Study|extubated bef.start assigned treatment|1|||
41955690|NCT01751724|75723345|FG001|Overall Study|extubated bef.start assigned treatment|0|||
41955691|NCT01751724|75723344|FG000|Overall Study|withdrawn by parent|0|||
41955692|NCT01751724|75723345|FG001|Overall Study|withdrawn by parent|2|||
41955693|NCT01751646|75723353|FG000|Overall Study|Lost to Follow-up|5|||
41955694|NCT01751646|75723354|FG001|Overall Study|Lost to Follow-up|1|||
41955695|NCT01751646|75723353|FG000|Overall Study|Withdrawal by Subject|0|||
41955696|NCT01751646|75723354|FG001|Overall Study|Withdrawal by Subject|4|||
41955697|NCT01751646|75723353|FG000|Overall Study|Starting hormone therapy|1|||
41955698|NCT01751646|75723354|FG001|Overall Study|Starting hormone therapy|0|||
41955699|NCT01751646|75723353|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
41955700|NCT01751646|75723354|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
41955701|NCT01751646|75723353|FG000|Overall Study|Inadvertent enrollment|1|||
41955702|NCT01751646|75723354|FG001|Overall Study|Inadvertent enrollment|1|||
41955703|NCT01751646|75723353|FG000|Overall Study|Moved out of the area|1|||
41955704|NCT01751646|75723354|FG001|Overall Study|Moved out of the area|5|||
41955705|NCT01751646|75723353|FG000|Overall Study|Inability to attend required visits|0|||
41955706|NCT01751646|75723354|FG001|Overall Study|Inability to attend required visits|1|||
41955707|NCT01751646|75723353|FG000|Overall Study|Off study due to multiple obligations|0|||
41955708|NCT01751646|75723354|FG001|Overall Study|Off study due to multiple obligations|1|||
41955709|NCT01751646|75723353|FG000|Overall Study|Fails to comply with study requirements|0|||
41955710|NCT01751646|75723354|FG001|Overall Study|Fails to comply with study requirements|1|||
41955711|NCT01751646|75723353|FG000|Overall Study|Childcare issues|1|||
41955712|NCT01751646|75723354|FG001|Overall Study|Childcare issues|1|||
41955713|NCT01751568|75723367|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
41955714|NCT01751568|75723368|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
41955715|NCT01751568|75723369|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
41955716|NCT01751412|75723377|FG000|Overall Study|Disease Progression Before Treatment|1|||
41955717|NCT01751178|75723384|FG000|Overall Study|Adverse Event|2|||
41955718|NCT01751178|75723385|FG001|Overall Study|Adverse Event|0|||
41955719|NCT01751178|75723386|FG002|Overall Study|Adverse Event|0|||
41955720|NCT01751178|75723384|FG000|Overall Study|Other Reason (unknown)|1|||
41955721|NCT01751178|75723385|FG001|Overall Study|Other Reason (unknown)|0|||
41955722|NCT01751178|75723386|FG002|Overall Study|Other Reason (unknown)|2|||
41955723|NCT01606254|75723402|FG000|Overall Study|Withdrawal by Subject|1|||
41955724|NCT01606254|75723403|FG001|Overall Study|Withdrawal by Subject|3|||
41955725|NCT01606254|75723404|FG002|Overall Study|Withdrawal by Subject|0|||
41955726|NCT01606254|75723405|FG003|Overall Study|Withdrawal by Subject|2|||
41955727|NCT01606254|75723402|FG000|Overall Study|Adverse Event|1|||
41955728|NCT01606254|75723403|FG001|Overall Study|Adverse Event|1|||
41955729|NCT01606254|75723404|FG002|Overall Study|Adverse Event|0|||
41955730|NCT01606254|75723405|FG003|Overall Study|Adverse Event|1|||
41955731|NCT01750242|75723415|FG000|Overall Study|Unreadable Images|3|||
41955732|NCT01723254|75723428|FG000|Overall Study|Conflict with work schedule|0|||
41955733|NCT01723254|75723429|FG001|Overall Study|Conflict with work schedule|0|||
41955734|NCT01723254|75723430|FG002|Overall Study|Conflict with work schedule|0|||
41955735|NCT01723254|75723431|FG003|Overall Study|Conflict with work schedule|0|||
41955736|NCT01723254|75723432|FG004|Overall Study|Conflict with work schedule|0|||
41955737|NCT01723254|75723433|FG005|Overall Study|Conflict with work schedule|0|||
41955738|NCT01723254|75723434|FG006|Overall Study|Conflict with work schedule|0|||
41955739|NCT01723254|75723435|FG007|Overall Study|Conflict with work schedule|1|||
41955740|NCT01723254|75723428|FG000|Overall Study|Personal issues|0|||
41955741|NCT01723254|75723429|FG001|Overall Study|Personal issues|0|||
41955742|NCT01723254|75723430|FG002|Overall Study|Personal issues|0|||
41955743|NCT01723254|75723431|FG003|Overall Study|Personal issues|0|||
41955744|NCT01723254|75723432|FG004|Overall Study|Personal issues|0|||
41955745|NCT01723254|75723433|FG005|Overall Study|Personal issues|1|||
41955746|NCT01723254|75723434|FG006|Overall Study|Personal issues|0|||
41955747|NCT01723254|75723435|FG007|Overall Study|Personal issues|0|||
41955748|NCT01723254|75723428|FG000|Overall Study|No longer have time to participate|0|||
41955749|NCT01723254|75723429|FG001|Overall Study|No longer have time to participate|0|||
41955750|NCT01723254|75723430|FG002|Overall Study|No longer have time to participate|0|||
41955751|NCT01723254|75723431|FG003|Overall Study|No longer have time to participate|1|||
41955752|NCT01723254|75723432|FG004|Overall Study|No longer have time to participate|0|||
41955753|NCT01723254|75723433|FG005|Overall Study|No longer have time to participate|0|||
41955754|NCT01723254|75723434|FG006|Overall Study|No longer have time to participate|0|||
41955755|NCT01723254|75723435|FG007|Overall Study|No longer have time to participate|0|||
41955756|NCT01723254|75723428|FG000|Overall Study|Move/Left to another country/city|0|||
41955757|NCT01723254|75723429|FG001|Overall Study|Move/Left to another country/city|0|||
41955758|NCT01723254|75723430|FG002|Overall Study|Move/Left to another country/city|2|||
41955759|NCT01723254|75723431|FG003|Overall Study|Move/Left to another country/city|1|||
41955760|NCT01723254|75723432|FG004|Overall Study|Move/Left to another country/city|1|||
41955761|NCT01723254|75723433|FG005|Overall Study|Move/Left to another country/city|0|||
41955762|NCT01723254|75723434|FG006|Overall Study|Move/Left to another country/city|0|||
41955763|NCT01723254|75723435|FG007|Overall Study|Move/Left to another country/city|0|||
41955764|NCT01723254|75723428|FG000|Overall Study|Protocol Violation|0|||
41955765|NCT01723254|75723429|FG001|Overall Study|Protocol Violation|1|||
41955766|NCT01723254|75723430|FG002|Overall Study|Protocol Violation|0|||
41955767|NCT01723254|75723431|FG003|Overall Study|Protocol Violation|0|||
41955768|NCT01723254|75723432|FG004|Overall Study|Protocol Violation|0|||
41955769|NCT01723254|75723433|FG005|Overall Study|Protocol Violation|0|||
41955770|NCT01723254|75723434|FG006|Overall Study|Protocol Violation|0|||
41955771|NCT01723254|75723435|FG007|Overall Study|Protocol Violation|0|||
41955772|NCT01723254|75723428|FG000|Overall Study|Withdrawal by Subject|1|||
41955773|NCT01723254|75723429|FG001|Overall Study|Withdrawal by Subject|2|||
41955774|NCT01723254|75723430|FG002|Overall Study|Withdrawal by Subject|1|||
41955775|NCT01723254|75723431|FG003|Overall Study|Withdrawal by Subject|0|||
41955776|NCT01723254|75723432|FG004|Overall Study|Withdrawal by Subject|1|||
41955777|NCT01723254|75723433|FG005|Overall Study|Withdrawal by Subject|1|||
41955778|NCT01723254|75723434|FG006|Overall Study|Withdrawal by Subject|1|||
41955779|NCT01723254|75723435|FG007|Overall Study|Withdrawal by Subject|2|||
41955780|NCT01722162|75723455|FG000|Overall Study|Withdrawal by Subject|1|||
41955781|NCT01722162|75723456|FG001|Overall Study|Withdrawal by Subject|1|||
41955782|NCT01722162|75723455|FG000|Overall Study|Found ineligible|1|||
41955783|NCT01722162|75723456|FG001|Overall Study|Found ineligible|0|||
41955784|NCT01722162|75723455|FG000|Overall Study|Unrelated to study adverse event|2|||
41955785|NCT01722162|75723456|FG001|Overall Study|Unrelated to study adverse event|2|||
41955786|NCT01722162|75723455|FG000|Overall Study|Adverse Event|1|||
41955787|NCT01722162|75723456|FG001|Overall Study|Adverse Event|1|||
41955788|NCT01722162|75723455|FG000|Overall Study|Insurance denial post enrollment|0|||
41955789|NCT01722162|75723456|FG001|Overall Study|Insurance denial post enrollment|1|||
41955790|NCT01722162|75723455|FG000|Overall Study|Noncompliance|0|||
41955791|NCT01722162|75723456|FG001|Overall Study|Noncompliance|1|||
41955792|NCT01721772|75723464|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
41955793|NCT01721772|75723465|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
41955794|NCT01721772|75723464|FG000|Pre-Treatment|Poor/non-compliance|0|||
41955795|NCT01721772|75723465|FG001|Pre-Treatment|Poor/non-compliance|1|||
41955796|NCT01721772|75723464|FG000|Pre-Treatment|Participant withdrew consent|0|||
41955797|NCT01721772|75723465|FG001|Pre-Treatment|Participant withdrew consent|1|||
41955798|NCT01721772|75723464|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
41955799|NCT01721772|75723465|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
41955800|NCT01721772|75723464|FG000|Treatment|Disease progression|119|||
41955801|NCT01721772|75723465|FG001|Treatment|Disease progression|168|||
41955802|NCT01721772|75723464|FG000|Treatment|Study drug toxicity|19|||
41955803|NCT01721772|75723465|FG001|Treatment|Study drug toxicity|10|||
41955804|NCT01721772|75723464|FG000|Treatment|Adverse event unrelated to study drug|7|||
41955805|NCT01721772|75723465|FG001|Treatment|Adverse event unrelated to study drug|7|||
41955806|NCT01721772|75723464|FG000|Treatment|Maximum clinical benefit|16|||
41955807|NCT01721772|75723465|FG001|Treatment|Maximum clinical benefit|4|||
41955808|NCT01721772|75723464|FG000|Treatment|Other|19|||
41955809|NCT01721772|75723465|FG001|Treatment|Other|2|||
41955810|NCT01721772|75723464|FG000|Treatment|Participant withdrew consent|2|||
41955811|NCT01721772|75723465|FG001|Treatment|Participant withdrew consent|5|||
41955812|NCT01721772|75723464|FG000|Treatment|Participant request to discontinue study treatment|21|||
41955813|NCT01721772|75723465|FG001|Treatment|Participant request to discontinue study treatment|8|||
41955814|NCT01721772|75723464|FG000|Treatment|Death|1|||
41955815|NCT01721772|75723465|FG001|Treatment|Death|0|||
41955816|NCT01721772|75723464|FG000|Treatment|Not reported|1|||
41955817|NCT01721772|75723465|FG001|Treatment|Not reported|0|||
41955818|NCT01721772|75723464|FG000|Treatment|Poor/non-compliance|1|||
41955819|NCT01721772|75723465|FG001|Treatment|Poor/non-compliance|0|||
41955820|NCT01721772|75723464|FG000|Treatment|Lost to Follow-up|0|||
41955821|NCT01721772|75723465|FG001|Treatment|Lost to Follow-up|1|||
41955822|NCT01702428|75723475|FG000|Overall Study|Adverse Event|2|||
41955823|NCT01702428|75723476|FG001|Overall Study|Adverse Event|0|||
41955824|NCT01702428|75723477|FG002|Overall Study|Adverse Event|0|||
41955825|NCT01702428|75723478|FG003|Overall Study|Adverse Event|0|||
41955826|NCT01702428|75723475|FG000|Overall Study|Lost to Follow-up|33|||
41955827|NCT01702428|75723476|FG001|Overall Study|Lost to Follow-up|41|||
41955828|NCT01702428|75723477|FG002|Overall Study|Lost to Follow-up|37|||
41955829|NCT01702428|75723478|FG003|Overall Study|Lost to Follow-up|44|||
41955830|NCT01702428|75723475|FG000|Overall Study|Parents cannot assist to site|1|||
41955831|NCT01702428|75723476|FG001|Overall Study|Parents cannot assist to site|0|||
41955832|NCT01702428|75723477|FG002|Overall Study|Parents cannot assist to site|1|||
41955833|NCT01702428|75723478|FG003|Overall Study|Parents cannot assist to site|0|||
41955834|NCT01702428|75723475|FG000|Overall Study|Lost Coverage|0|||
41955835|NCT01702428|75723476|FG001|Overall Study|Lost Coverage|0|||
41955836|NCT01702428|75723477|FG002|Overall Study|Lost Coverage|0|||
41955837|NCT01702428|75723478|FG003|Overall Study|Lost Coverage|1|||
41955838|NCT01702428|75723475|FG000|Overall Study|Lost Health Plan|3|||
41955839|NCT01702428|75723476|FG001|Overall Study|Lost Health Plan|5|||
41955840|NCT01702428|75723477|FG002|Overall Study|Lost Health Plan|0|||
41955841|NCT01702428|75723478|FG003|Overall Study|Lost Health Plan|2|||
41955842|NCT01702428|75723475|FG000|Overall Study|Mother transferred care|0|||
41955843|NCT01702428|75723476|FG001|Overall Study|Mother transferred care|1|||
41955844|NCT01702428|75723477|FG002|Overall Study|Mother transferred care|0|||
41955845|NCT01702428|75723478|FG003|Overall Study|Mother transferred care|0|||
41955846|NCT01702428|75723475|FG000|Overall Study|Parents too busy|1|||
41955847|NCT01702428|75723476|FG001|Overall Study|Parents too busy|0|||
41955848|NCT01702428|75723477|FG002|Overall Study|Parents too busy|0|||
41955849|NCT01702428|75723478|FG003|Overall Study|Parents too busy|0|||
41955850|NCT01702428|75723475|FG000|Overall Study|Protocol Violation|3|||
41955851|NCT01702428|75723476|FG001|Overall Study|Protocol Violation|0|||
41955852|NCT01702428|75723477|FG002|Overall Study|Protocol Violation|1|||
41955853|NCT01702428|75723478|FG003|Overall Study|Protocol Violation|0|||
41955854|NCT01702428|75723475|FG000|Overall Study|Withdrawal by Subject|21|||
41955855|NCT01702428|75723476|FG001|Overall Study|Withdrawal by Subject|23|||
41955856|NCT01702428|75723477|FG002|Overall Study|Withdrawal by Subject|14|||
41955857|NCT01702428|75723478|FG003|Overall Study|Withdrawal by Subject|10|||
41955858|NCT01701258|75723499|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
41955859|NCT01701258|75723500|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
41955860|NCT01701258|75723501|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
41955861|NCT01701258|75723502|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
41955862|NCT01701258|75723503|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
41955863|NCT01701258|75723504|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
41955864|NCT01701258|75723505|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
41955865|NCT01701258|75723506|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
41955866|NCT01701258|75723507|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
41955867|NCT01701258|75723508|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
41955868|NCT01701258|75723509|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
41955869|NCT01701258|75723510|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
41955870|NCT01701258|75723511|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
41955871|NCT01701258|75723499|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
41955872|NCT01701258|75723500|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
41955873|NCT01701258|75723501|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
41955874|NCT01701258|75723502|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
41955875|NCT01701258|75723503|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
41955876|NCT01701258|75723504|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
41955877|NCT01701258|75723505|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
41955878|NCT01701258|75723506|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
41955879|NCT01701258|75723507|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
41955880|NCT01701258|75723508|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
41955881|NCT01701258|75723509|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
41955882|NCT01701258|75723510|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
41955883|NCT01701258|75723511|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
41955884|NCT01701258|75723499|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
41955885|NCT01701258|75723500|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
41955886|NCT01701258|75723501|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
41955887|NCT01701258|75723502|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
41955888|NCT01701258|75723503|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
41955889|NCT01701258|75723504|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
41955890|NCT01701258|75723505|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
41955891|NCT01701258|75723506|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
41955892|NCT01701258|75723507|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
41955893|NCT01701258|75723508|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
41955894|NCT01701258|75723509|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
41955895|NCT01701258|75723510|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
41955896|NCT01701258|75723511|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
42024106|NCT01020435|75831509|FG001|Overall Study|Lost to Follow-up|1|||
42024107|NCT01031979|75831518|FG000|Overall Study|Lost to Follow-up|5|||
42024108|NCT01031979|75831519|FG001|Overall Study|Lost to Follow-up|4|||
42024109|NCT01020123|75831532|FG000|Main Period|Withdrawal by Subject|6|||
42024110|NCT01020123|75831533|FG001|Main Period|Withdrawal by Subject|5|||
42024111|NCT01020123|75831534|FG002|Main Period|Withdrawal by Subject|3|||
42024112|NCT01020123|75831535|FG003|Main Period|Withdrawal by Subject|1|||
42024113|NCT01020123|75831536|FG004|Main Period|Withdrawal by Subject|6|||
42024114|NCT01020123|75831537|FG005|Main Period|Withdrawal by Subject|3|||
42024115|NCT01020123|75831538|FG006|Main Period|Withdrawal by Subject|2|||
42024116|NCT01020123|75831532|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
42024117|NCT01020123|75831533|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
41955897|NCT01701258|75723499|FG000|Assessment and Scheduling|Investigator Terminated|2|||
41955898|NCT01701258|75723500|FG001|Assessment and Scheduling|Investigator Terminated|0|||
41955899|NCT01701258|75723501|FG002|Assessment and Scheduling|Investigator Terminated|0|||
42024118|NCT01020123|75831534|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
42024119|NCT01020123|75831535|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
42024120|NCT01020123|75831536|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
41955900|NCT01701258|75723502|FG003|Assessment and Scheduling|Investigator Terminated|0|||
41955901|NCT01701258|75723503|FG004|Assessment and Scheduling|Investigator Terminated|0|||
42024121|NCT01020123|75831537|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
42024122|NCT01020123|75831538|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
42024123|NCT01020123|75831532|FG000|Main Period|Adverse Event|5|||
42024124|NCT01020123|75831533|FG001|Main Period|Adverse Event|2|||
42024125|NCT01020123|75831534|FG002|Main Period|Adverse Event|2|||
42024126|NCT01020123|75831535|FG003|Main Period|Adverse Event|1|||
42024127|NCT01020123|75831536|FG004|Main Period|Adverse Event|1|||
42024128|NCT01020123|75831537|FG005|Main Period|Adverse Event|2|||
42024129|NCT01020123|75831538|FG006|Main Period|Adverse Event|1|||
42024130|NCT01020123|75831532|FG000|Main Period|Protocol Violation|4|||
42118039|NCT00689117|75928840|FG000|Overall Study|Personal Reason|0|||
41955902|NCT01701258|75723504|FG005|Assessment and Scheduling|Investigator Terminated|0|||
41955903|NCT01701258|75723505|FG006|Assessment and Scheduling|Investigator Terminated|0|||
41955904|NCT01701258|75723506|FG007|Assessment and Scheduling|Investigator Terminated|0|||
41955905|NCT01701258|75723507|FG008|Assessment and Scheduling|Investigator Terminated|0|||
41955906|NCT01701258|75723508|FG009|Assessment and Scheduling|Investigator Terminated|0|||
41955907|NCT01701258|75723509|FG010|Assessment and Scheduling|Investigator Terminated|0|||
41955908|NCT01701258|75723510|FG011|Assessment and Scheduling|Investigator Terminated|0|||
41955909|NCT01701258|75723511|FG012|Assessment and Scheduling|Investigator Terminated|0|||
41955910|NCT01700946|75723541|FG000|Overall Study|Lost to Follow-up|1|||
41955911|NCT01700946|75723542|FG001|Overall Study|Lost to Follow-up|0|||
41955912|NCT01700946|75723541|FG000|Overall Study|Physician Decision|7|||
41955913|NCT01700946|75723542|FG001|Overall Study|Physician Decision|12|||
41955914|NCT01700946|75723541|FG000|Overall Study|Withdrawal by Subject|0|||
41955915|NCT01700946|75723542|FG001|Overall Study|Withdrawal by Subject|2|||
41955916|NCT01700946|75723541|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
41955917|NCT01700946|75723542|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
41955918|NCT01700946|75723541|FG000|Overall Study|Relapse|2|||
41955919|NCT01700946|75723542|FG001|Overall Study|Relapse|1|||
41955920|NCT01700946|75723541|FG000|Overall Study|Unacceptable toxicity|1|||
41955921|NCT01700946|75723542|FG001|Overall Study|Unacceptable toxicity|0|||
41955922|NCT01748994|75723554|FG000|Overall Study|Lost to Follow-up|8|||
41955923|NCT01748994|75723555|FG001|Overall Study|Lost to Follow-up|6|||
41955924|NCT01721070|75723561|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
41955925|NCT01748760|75723570|FG000|Overall Study|Withdrawal by Subject|1|||
41955926|NCT01748760|75723571|FG001|Overall Study|Withdrawal by Subject|1|||
41955927|NCT01748760|75723570|FG000|Overall Study|Lost to Follow-up|5|||
41955928|NCT01748760|75723571|FG001|Overall Study|Lost to Follow-up|1|||
41955929|NCT01748292|75723579|FG000|Overall Study|Adverse Event|2|||
41955930|NCT01748292|75723580|FG001|Overall Study|Adverse Event|4|||
41955931|NCT01748292|75723579|FG000|Overall Study|Lost to Follow-up|0|||
41955932|NCT01748292|75723580|FG001|Overall Study|Lost to Follow-up|3|||
41955933|NCT01748292|75723579|FG000|Overall Study|Death|0|||
41955934|NCT01748292|75723580|FG001|Overall Study|Death|3|||
41955935|NCT01748292|75723579|FG000|Overall Study|Withdrawal by Subject|0|||
41955936|NCT01748292|75723580|FG001|Overall Study|Withdrawal by Subject|2|||
41955937|NCT01720602|75723586|FG000|Overall Study|Adverse Event|3|||
41955938|NCT01720602|75723586|FG000|Overall Study|Progressive disease on therapy|2|||
41955939|NCT01746732|75723590|FG000|Lead-In Period|Withdrawal by Subject|1|||
42118040|NCT00689117|75928841|FG001|Overall Study|Personal Reason|1|||
41955940|NCT01746732|75723591|FG001|Lead-In Period|Withdrawal by Subject|0|||
42024131|NCT01020123|75831533|FG001|Main Period|Protocol Violation|4|||
42024132|NCT01020123|75831534|FG002|Main Period|Protocol Violation|2|||
41955941|NCT01746732|75723592|FG002|Lead-In Period|Withdrawal by Subject|0|||
42024133|NCT01020123|75831535|FG003|Main Period|Protocol Violation|5|||
42118041|NCT00689117|75928842|FG002|Overall Study|Personal Reason|0|||
41955942|NCT01746732|75723590|FG000|Period 1|Physician Decision|0|||
41955943|NCT01746732|75723591|FG001|Period 1|Physician Decision|1|||
41955944|NCT01746732|75723592|FG002|Period 1|Physician Decision|0|||
41955945|NCT01746732|75723590|FG000|Period 2|Withdrawal by Subject|0|||
41955946|NCT01746732|75723591|FG001|Period 2|Withdrawal by Subject|0|||
41955947|NCT01746732|75723592|FG002|Period 2|Withdrawal by Subject|2|||
41955948|NCT01746732|75723590|FG000|Period 2|Adverse Event|0|||
41955949|NCT01746732|75723591|FG001|Period 2|Adverse Event|0|||
41955950|NCT01746732|75723592|FG002|Period 2|Adverse Event|1|||
41955951|NCT01746732|75723590|FG000|Period 2|Lost to Follow-up|0|||
41955952|NCT01746732|75723591|FG001|Period 2|Lost to Follow-up|0|||
41955953|NCT01746732|75723592|FG002|Period 2|Lost to Follow-up|1|||
41955954|NCT01720524|75723602|FG000|Part A|Insufficient Clinical Response|2|||
41955955|NCT01720524|75723603|FG001|Part A|Insufficient Clinical Response|4|||
41955956|NCT01720524|75723602|FG000|Part A|Adverse Event|2|||
41955957|NCT01720524|75723603|FG001|Part A|Adverse Event|2|||
41955958|NCT01720524|75723602|FG000|Part A|Death|2|||
41955959|NCT01720524|75723603|FG001|Part A|Death|1|||
41955960|NCT01720524|75723602|FG000|Part A|Lost to Follow-up|0|||
41955961|NCT01720524|75723603|FG001|Part A|Lost to Follow-up|1|||
41955962|NCT01720524|75723602|FG000|Part A|Missed 28 day follow-up visit|1|||
41955963|NCT01720524|75723603|FG001|Part A|Missed 28 day follow-up visit|1|||
41955964|NCT01720524|75723602|FG000|Part A|Withdrawal by Subject|0|||
41955965|NCT01720524|75723603|FG001|Part A|Withdrawal by Subject|1|||
41955966|NCT01720524|75723602|FG000|Part A|Other|0|||
41955967|NCT01720524|75723603|FG001|Part A|Other|1|||
41955968|NCT01720524|75723602|FG000|Part A|Lost to Follow-up|0|||
41955969|NCT01720524|75723603|FG001|Part A|Lost to Follow-up|1|||
41955970|NCT01720524|75723602|FG000|Part B|No longer willing to participate in study|1|||
41955971|NCT01720524|75723603|FG001|Part B|No longer willing to participate in study|4|||
41955972|NCT01720524|75723602|FG000|Part B|Other|2|||
41955973|NCT01720524|75723603|FG001|Part B|Other|0|||
41955974|NCT01720524|75723602|FG000|Part B|Lost to Follow-up|2|||
41955975|NCT01720524|75723603|FG001|Part B|Lost to Follow-up|3|||
41955976|NCT01720524|75723602|FG000|Part B|Death|0|||
41955977|NCT01720524|75723603|FG001|Part B|Death|2|||
41955978|NCT01720446|75723615|FG000|Overall Study|Lost to Follow-up|12|||
41955979|NCT01720446|75723616|FG001|Overall Study|Lost to Follow-up|6|||
41955980|NCT01720446|75723617|FG002|Overall Study|Lost to Follow-up|16|||
41955981|NCT01720446|75723618|FG003|Overall Study|Lost to Follow-up|16|||
41955982|NCT01720446|75723615|FG000|Overall Study|Withdrawal by Subject|2|||
41955983|NCT01720446|75723616|FG001|Overall Study|Withdrawal by Subject|5|||
41955984|NCT01720446|75723617|FG002|Overall Study|Withdrawal by Subject|4|||
41955985|NCT01720446|75723618|FG003|Overall Study|Withdrawal by Subject|4|||
41955986|NCT01746108|75723634|FG000|Overall Study|Migrated /moved from study area|0|||
41955987|NCT01746108|75723635|FG001|Overall Study|Migrated /moved from study area|1|||
41955988|NCT01746108|75723636|FG002|Overall Study|Migrated /moved from study area|0|||
41955989|NCT01746108|75723634|FG000|Overall Study|Adverse event, non-fatal|0|||
41955990|NCT01746108|75723635|FG001|Overall Study|Adverse event, non-fatal|1|||
41955991|NCT01746108|75723636|FG002|Overall Study|Adverse event, non-fatal|0|||
41955992|NCT01746108|75723634|FG000|Overall Study|Withdrawal by Subject|0|||
41955993|NCT01746108|75723635|FG001|Overall Study|Withdrawal by Subject|1|||
41955994|NCT01746108|75723636|FG002|Overall Study|Withdrawal by Subject|0|||
41955995|NCT01746108|75723634|FG000|Overall Study|Lost to Follow-up|0|||
41955996|NCT01746108|75723635|FG001|Overall Study|Lost to Follow-up|1|||
41955997|NCT01746108|75723636|FG002|Overall Study|Lost to Follow-up|0|||
41955998|NCT01717638|75723665|FG000|Overall Study|Lost to Follow-up|0|||
41955999|NCT01717638|75723666|FG001|Overall Study|Lost to Follow-up|0|||
41956000|NCT01717638|75723667|FG002|Overall Study|Lost to Follow-up|0|||
41956001|NCT01717638|75723668|FG003|Overall Study|Lost to Follow-up|0|||
41956002|NCT01717638|75723669|FG004|Overall Study|Lost to Follow-up|0|||
41956003|NCT01717638|75723670|FG005|Overall Study|Lost to Follow-up|1|||
41956004|NCT01717638|75723671|FG006|Overall Study|Lost to Follow-up|0|||
41956005|NCT01717638|75723672|FG007|Overall Study|Lost to Follow-up|0|||
41956006|NCT01717638|75723673|FG008|Overall Study|Lost to Follow-up|0|||
41956007|NCT01717638|75723674|FG009|Overall Study|Lost to Follow-up|0|||
41956008|NCT01717638|75723675|FG010|Overall Study|Lost to Follow-up|0|||
41956009|NCT01717638|75723676|FG011|Overall Study|Lost to Follow-up|0|||
41956010|NCT01717638|75723677|FG012|Overall Study|Lost to Follow-up|0|||
41956011|NCT01717638|75723665|FG000|Overall Study|Father in hospital|0|||
41956012|NCT01717638|75723666|FG001|Overall Study|Father in hospital|0|||
41956013|NCT01717638|75723667|FG002|Overall Study|Father in hospital|0|||
41956014|NCT01717638|75723668|FG003|Overall Study|Father in hospital|0|||
41956015|NCT01717638|75723669|FG004|Overall Study|Father in hospital|0|||
41956016|NCT01717638|75723670|FG005|Overall Study|Father in hospital|0|||
41956017|NCT01717638|75723671|FG006|Overall Study|Father in hospital|0|||
41956018|NCT01717638|75723672|FG007|Overall Study|Father in hospital|0|||
41956019|NCT01717638|75723673|FG008|Overall Study|Father in hospital|0|||
41956020|NCT01717638|75723674|FG009|Overall Study|Father in hospital|0|||
41956021|NCT01717638|75723675|FG010|Overall Study|Father in hospital|0|||
41956022|NCT01717638|75723676|FG011|Overall Study|Father in hospital|0|||
41956023|NCT01717638|75723677|FG012|Overall Study|Father in hospital|1|||
41956024|NCT01717638|75723665|FG000|Overall Study|Withdrawal by Subject|0|||
41956025|NCT01717638|75723666|FG001|Overall Study|Withdrawal by Subject|1|||
41956026|NCT01717638|75723667|FG002|Overall Study|Withdrawal by Subject|1|||
41956027|NCT01717638|75723668|FG003|Overall Study|Withdrawal by Subject|0|||
41956028|NCT01717638|75723669|FG004|Overall Study|Withdrawal by Subject|1|||
41956029|NCT01717638|75723670|FG005|Overall Study|Withdrawal by Subject|0|||
41956030|NCT01717638|75723671|FG006|Overall Study|Withdrawal by Subject|2|||
41956031|NCT01717638|75723672|FG007|Overall Study|Withdrawal by Subject|1|||
41956032|NCT01717638|75723673|FG008|Overall Study|Withdrawal by Subject|2|||
41956033|NCT01717638|75723674|FG009|Overall Study|Withdrawal by Subject|1|||
41956034|NCT01717638|75723675|FG010|Overall Study|Withdrawal by Subject|0|||
41956035|NCT01717638|75723676|FG011|Overall Study|Withdrawal by Subject|0|||
41956036|NCT01717638|75723677|FG012|Overall Study|Withdrawal by Subject|18|||
41956037|NCT01745094|75723715|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
41956038|NCT01745094|75723716|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
41956039|NCT01745094|75723717|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
41956040|NCT01745094|75723718|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
41956041|NCT01745094|75723715|FG000|Overall Study|Adverse Event|0|||
41956042|NCT01745094|75723716|FG001|Overall Study|Adverse Event|0|||
41956043|NCT01745094|75723717|FG002|Overall Study|Adverse Event|3|||
41956044|NCT01745094|75723718|FG003|Overall Study|Adverse Event|0|||
41956045|NCT01745094|75723715|FG000|Overall Study|Withdrawal by Subject|2|||
41956046|NCT01745094|75723716|FG001|Overall Study|Withdrawal by Subject|0|||
41956047|NCT01745094|75723717|FG002|Overall Study|Withdrawal by Subject|1|||
41956048|NCT01745094|75723718|FG003|Overall Study|Withdrawal by Subject|2|||
41956049|NCT01745094|75723715|FG000|Overall Study|Protocol Violation|1|||
41956050|NCT01745094|75723716|FG001|Overall Study|Protocol Violation|0|||
41956051|NCT01745094|75723717|FG002|Overall Study|Protocol Violation|3|||
41956052|NCT01745094|75723718|FG003|Overall Study|Protocol Violation|1|||
41956053|NCT01745094|75723715|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
41956054|NCT01745094|75723716|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
41956055|NCT01745094|75723717|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
41956056|NCT01745094|75723718|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
41956057|NCT01745094|75723715|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
41956058|NCT01745094|75723716|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
41956059|NCT01745094|75723717|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
41956060|NCT01745094|75723718|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
41956061|NCT01745094|75723715|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
41956062|NCT01745094|75723716|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
41956063|NCT01745094|75723717|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
41956064|NCT01745094|75723718|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
41956065|NCT01697748|75723733|FG000|Overall Study|ineligible skin incision|1|||
41956066|NCT01697748|75723734|FG001|Overall Study|ineligible skin incision|2|||
41956067|NCT01697748|75723733|FG000|Overall Study|ineligible uterine incision|4|||
41956068|NCT01697748|75723734|FG001|Overall Study|ineligible uterine incision|1|||
41956069|NCT01697748|75723733|FG000|Overall Study|Lost to Follow-up|53|||
41956070|NCT01697748|75723734|FG001|Overall Study|Lost to Follow-up|65|||
41956071|NCT01717326|75723760|FG000|Overall Study|Death|0|||
41956072|NCT01717326|75723761|FG001|Overall Study|Death|0|||
41956073|NCT01717326|75723762|FG002|Overall Study|Death|0|||
41956074|NCT01717326|75723763|FG003|Overall Study|Death|0|||
41956075|NCT01717326|75723764|FG004|Overall Study|Death|0|||
41956076|NCT01717326|75723765|FG005|Overall Study|Death|0|||
41956077|NCT01717326|75723766|FG006|Overall Study|Death|0|||
41956078|NCT01717326|75723767|FG007|Overall Study|Death|0|||
41956079|NCT01717326|75723768|FG008|Overall Study|Death|0|||
41956080|NCT01717326|75723769|FG009|Overall Study|Death|0|||
41956081|NCT01717326|75723770|FG010|Overall Study|Death|1|||
41956082|NCT01717326|75723771|FG011|Overall Study|Death|0|||
41956083|NCT01717326|75723772|FG012|Overall Study|Death|0|||
41956084|NCT01717326|75723773|FG013|Overall Study|Death|0|||
41956085|NCT01717326|75723774|FG014|Overall Study|Death|0|||
41956086|NCT01717326|75723775|FG015|Overall Study|Death|0|||
41956087|NCT01717326|75723776|FG016|Overall Study|Death|0|||
41956088|NCT01717326|75723777|FG017|Overall Study|Death|0|||
41956089|NCT01717326|75723778|FG018|Overall Study|Death|0|||
42024134|NCT01020123|75831536|FG004|Main Period|Protocol Violation|2|||
41956090|NCT01717326|75723779|FG019|Overall Study|Death|0|||
41956091|NCT01717326|75723760|FG000|Overall Study|Lost to Follow-up|3|||
41956092|NCT01717326|75723761|FG001|Overall Study|Lost to Follow-up|0|||
41956093|NCT01717326|75723762|FG002|Overall Study|Lost to Follow-up|0|||
41956094|NCT01717326|75723763|FG003|Overall Study|Lost to Follow-up|2|||
41956095|NCT01717326|75723764|FG004|Overall Study|Lost to Follow-up|1|||
41956096|NCT01717326|75723765|FG005|Overall Study|Lost to Follow-up|0|||
41956097|NCT01717326|75723766|FG006|Overall Study|Lost to Follow-up|1|||
41956098|NCT01717326|75723767|FG007|Overall Study|Lost to Follow-up|0|||
41956099|NCT01717326|75723768|FG008|Overall Study|Lost to Follow-up|0|||
41956100|NCT01717326|75723769|FG009|Overall Study|Lost to Follow-up|0|||
42024135|NCT01020123|75831537|FG005|Main Period|Protocol Violation|3|||
42024136|NCT01020123|75831538|FG006|Main Period|Protocol Violation|2|||
41956101|NCT01717326|75723770|FG010|Overall Study|Lost to Follow-up|1|||
41956102|NCT01717326|75723771|FG011|Overall Study|Lost to Follow-up|0|||
41956103|NCT01717326|75723772|FG012|Overall Study|Lost to Follow-up|0|||
41956104|NCT01717326|75723773|FG013|Overall Study|Lost to Follow-up|0|||
41956105|NCT01717326|75723774|FG014|Overall Study|Lost to Follow-up|0|||
41956106|NCT01717326|75723775|FG015|Overall Study|Lost to Follow-up|2|||
41956107|NCT01717326|75723776|FG016|Overall Study|Lost to Follow-up|1|||
41956108|NCT01717326|75723777|FG017|Overall Study|Lost to Follow-up|0|||
41956109|NCT01717326|75723778|FG018|Overall Study|Lost to Follow-up|2|||
41956110|NCT01717326|75723779|FG019|Overall Study|Lost to Follow-up|3|||
41956111|NCT01717326|75723760|FG000|Overall Study|Physician Decision|0|||
41956112|NCT01717326|75723761|FG001|Overall Study|Physician Decision|0|||
41956113|NCT01717326|75723762|FG002|Overall Study|Physician Decision|0|||
41956114|NCT01717326|75723763|FG003|Overall Study|Physician Decision|0|||
41956115|NCT01717326|75723764|FG004|Overall Study|Physician Decision|0|||
41956116|NCT01717326|75723765|FG005|Overall Study|Physician Decision|0|||
41956117|NCT01717326|75723766|FG006|Overall Study|Physician Decision|0|||
41956118|NCT01717326|75723767|FG007|Overall Study|Physician Decision|0|||
41956119|NCT01717326|75723768|FG008|Overall Study|Physician Decision|0|||
41956120|NCT01717326|75723769|FG009|Overall Study|Physician Decision|1|||
41956121|NCT01717326|75723770|FG010|Overall Study|Physician Decision|0|||
41956122|NCT01717326|75723771|FG011|Overall Study|Physician Decision|0|||
41956123|NCT01717326|75723772|FG012|Overall Study|Physician Decision|0|||
41956124|NCT01717326|75723773|FG013|Overall Study|Physician Decision|0|||
41956125|NCT01717326|75723774|FG014|Overall Study|Physician Decision|0|||
41956126|NCT01717326|75723775|FG015|Overall Study|Physician Decision|0|||
41956127|NCT01717326|75723776|FG016|Overall Study|Physician Decision|0|||
41956128|NCT01717326|75723777|FG017|Overall Study|Physician Decision|0|||
41956129|NCT01717326|75723778|FG018|Overall Study|Physician Decision|0|||
41956130|NCT01717326|75723779|FG019|Overall Study|Physician Decision|0|||
41956131|NCT01717326|75723760|FG000|Overall Study|Protocol Violation|0|||
41956132|NCT01717326|75723761|FG001|Overall Study|Protocol Violation|0|||
41956133|NCT01717326|75723762|FG002|Overall Study|Protocol Violation|0|||
41956134|NCT01717326|75723763|FG003|Overall Study|Protocol Violation|0|||
41956135|NCT01717326|75723764|FG004|Overall Study|Protocol Violation|1|||
41956136|NCT01717326|75723765|FG005|Overall Study|Protocol Violation|0|||
41956137|NCT01717326|75723766|FG006|Overall Study|Protocol Violation|0|||
41956138|NCT01717326|75723767|FG007|Overall Study|Protocol Violation|0|||
41956139|NCT01717326|75723768|FG008|Overall Study|Protocol Violation|0|||
41956140|NCT01717326|75723769|FG009|Overall Study|Protocol Violation|0|||
41956141|NCT01717326|75723770|FG010|Overall Study|Protocol Violation|0|||
41956142|NCT01717326|75723771|FG011|Overall Study|Protocol Violation|0|||
41956143|NCT01717326|75723772|FG012|Overall Study|Protocol Violation|0|||
41956144|NCT01717326|75723773|FG013|Overall Study|Protocol Violation|0|||
41956145|NCT01717326|75723774|FG014|Overall Study|Protocol Violation|0|||
41956146|NCT01717326|75723775|FG015|Overall Study|Protocol Violation|0|||
41956147|NCT01717326|75723776|FG016|Overall Study|Protocol Violation|0|||
41956148|NCT01717326|75723777|FG017|Overall Study|Protocol Violation|0|||
41956149|NCT01717326|75723778|FG018|Overall Study|Protocol Violation|0|||
41956150|NCT01717326|75723779|FG019|Overall Study|Protocol Violation|0|||
41956151|NCT01717326|75723760|FG000|Overall Study|Withdrawal by Subject|0|||
41956152|NCT01717326|75723761|FG001|Overall Study|Withdrawal by Subject|1|||
41956153|NCT01717326|75723762|FG002|Overall Study|Withdrawal by Subject|0|||
41956154|NCT01717326|75723763|FG003|Overall Study|Withdrawal by Subject|0|||
41956155|NCT01717326|75723764|FG004|Overall Study|Withdrawal by Subject|0|||
41956156|NCT01717326|75723765|FG005|Overall Study|Withdrawal by Subject|0|||
41956157|NCT01717326|75723766|FG006|Overall Study|Withdrawal by Subject|0|||
41956158|NCT01717326|75723767|FG007|Overall Study|Withdrawal by Subject|0|||
41956159|NCT01717326|75723768|FG008|Overall Study|Withdrawal by Subject|0|||
41956160|NCT01717326|75723769|FG009|Overall Study|Withdrawal by Subject|1|||
41956161|NCT01717326|75723770|FG010|Overall Study|Withdrawal by Subject|0|||
41956162|NCT01717326|75723771|FG011|Overall Study|Withdrawal by Subject|0|||
41956163|NCT01717326|75723772|FG012|Overall Study|Withdrawal by Subject|1|||
41956164|NCT01717326|75723773|FG013|Overall Study|Withdrawal by Subject|0|||
41956165|NCT01717326|75723774|FG014|Overall Study|Withdrawal by Subject|0|||
41956166|NCT01717326|75723775|FG015|Overall Study|Withdrawal by Subject|1|||
42024137|NCT01020123|75831532|FG000|Main Period|Lost to Follow-up|0|||
42024138|NCT01020123|75831533|FG001|Main Period|Lost to Follow-up|2|||
42024139|NCT01020123|75831534|FG002|Main Period|Lost to Follow-up|0|||
42024140|NCT01020123|75831535|FG003|Main Period|Lost to Follow-up|0|||
41956167|NCT01717326|75723776|FG016|Overall Study|Withdrawal by Subject|0|||
41956168|NCT01717326|75723777|FG017|Overall Study|Withdrawal by Subject|0|||
41956169|NCT01717326|75723778|FG018|Overall Study|Withdrawal by Subject|2|||
41956170|NCT01717326|75723779|FG019|Overall Study|Withdrawal by Subject|3|||
41956171|NCT01697592|75723831|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
41956172|NCT01697592|75723832|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
41956173|NCT01697592|75723833|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
41956174|NCT01697592|75723834|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
41956175|NCT01697592|75723835|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
41956176|NCT01697592|75723836|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
42024141|NCT01020123|75831536|FG004|Main Period|Lost to Follow-up|0|||
41956177|NCT01697592|75723837|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
41956178|NCT01697592|75723838|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
41956179|NCT01697592|75723839|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
41956180|NCT01697592|75723840|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
41956181|NCT01697592|75723831|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
41956182|NCT01697592|75723832|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
41956183|NCT01697592|75723833|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
41956184|NCT01697592|75723834|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
41956185|NCT01697592|75723835|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
41956186|NCT01697592|75723836|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
41956187|NCT01697592|75723837|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
41956188|NCT01697592|75723838|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
41956189|NCT01697592|75723839|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
41956190|NCT01697592|75723840|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
41956191|NCT01697592|75723831|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
41956192|NCT01697592|75723832|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
41956193|NCT01697592|75723833|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
41956194|NCT01697592|75723834|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
41956195|NCT01697592|75723835|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
41956196|NCT01697592|75723836|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
41956197|NCT01697592|75723837|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
41956198|NCT01697592|75723838|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
41956199|NCT01697592|75723839|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
41956200|NCT01697592|75723840|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
41956201|NCT01697592|75723831|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
41956202|NCT01697592|75723832|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
41956203|NCT01697592|75723833|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
41956204|NCT01697592|75723834|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
41956205|NCT01697592|75723835|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
41956206|NCT01697592|75723836|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
41956207|NCT01697592|75723837|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
41956208|NCT01697592|75723838|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
41956209|NCT01697592|75723839|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
41956210|NCT01697592|75723840|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
41956211|NCT01697592|75723831|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
41956212|NCT01697592|75723832|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
41956213|NCT01697592|75723833|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
41956214|NCT01697592|75723834|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
41956215|NCT01697592|75723835|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
41956216|NCT01697592|75723836|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
41956217|NCT01697592|75723837|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
41956218|NCT01697592|75723838|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
41956219|NCT01697592|75723839|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
41956220|NCT01697592|75723840|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
41956221|NCT01697592|75723831|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
41956222|NCT01697592|75723832|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
41956223|NCT01697592|75723833|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
41956224|NCT01697592|75723834|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
41956225|NCT01697592|75723835|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
41956226|NCT01697592|75723836|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
41956227|NCT01697592|75723837|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
41956228|NCT01697592|75723838|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
41956229|NCT01697592|75723839|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
41956230|NCT01697592|75723840|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
41956231|NCT01697592|75723831|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
41956232|NCT01697592|75723832|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
41956233|NCT01697592|75723833|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
41956234|NCT01697592|75723834|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
42024142|NCT01020123|75831537|FG005|Main Period|Lost to Follow-up|0|||
42024143|NCT01020123|75831538|FG006|Main Period|Lost to Follow-up|0|||
42024144|NCT01020123|75831532|FG000|Main Period|Unclasified|2|||
42024145|NCT01020123|75831533|FG001|Main Period|Unclasified|0|||
42024146|NCT01020123|75831534|FG002|Main Period|Unclasified|1|||
42024147|NCT01020123|75831535|FG003|Main Period|Unclasified|0|||
41956235|NCT01697592|75723835|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
41956236|NCT01697592|75723836|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
41956237|NCT01697592|75723837|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
41956238|NCT01697592|75723838|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
42024148|NCT01020123|75831536|FG004|Main Period|Unclasified|1|||
42024149|NCT01020123|75831537|FG005|Main Period|Unclasified|3|||
42024150|NCT01020123|75831538|FG006|Main Period|Unclasified|6|||
41956239|NCT01697592|75723839|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
41956240|NCT01697592|75723840|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
41956241|NCT01697592|75723831|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
41956242|NCT01697592|75723832|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
41956243|NCT01697592|75723833|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
41956244|NCT01697592|75723834|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
41956245|NCT01697592|75723835|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
41956246|NCT01697592|75723836|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
41956247|NCT01697592|75723837|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
41956248|NCT01697592|75723838|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
41956249|NCT01697592|75723839|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
41956250|NCT01697592|75723840|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
41956251|NCT01744782|75723876|FG000|Overall Study|Death|1|||
41956252|NCT01744392|75723880|FG000|Overall Study|Physician Decision|1|||
41956253|NCT01604850|75723887|FG000|Overall Study|Enrolled but never treated|0|||
41956254|NCT01604850|75723888|FG001|Overall Study|Enrolled but never treated|1|||
41956255|NCT01604850|75723887|FG000|Overall Study|Efficacy Failure|50|||
41956256|NCT01604850|75723888|FG001|Overall Study|Efficacy Failure|29|||
41956257|NCT01604850|75723887|FG000|Overall Study|Lost to Follow-up|1|||
41956258|NCT01604850|75723888|FG001|Overall Study|Lost to Follow-up|0|||
41956259|NCT01604850|75723887|FG000|Overall Study|Subject withdrew consent|1|||
41956260|NCT01604850|75723888|FG001|Overall Study|Subject withdrew consent|0|||
41956261|NCT01742286|75723901|FG000|Escalation Phase|Administrative problems|1|||
41956262|NCT01742286|75723902|FG001|Escalation Phase|Administrative problems|1|||
41956263|NCT01742286|75723903|FG002|Escalation Phase|Administrative problems|0|||
41956264|NCT01742286|75723904|FG003|Escalation Phase|Administrative problems|0|||
41956265|NCT01742286|75723905|FG004|Escalation Phase|Administrative problems|0|||
41956266|NCT01742286|75723906|FG005|Escalation Phase|Administrative problems|0|||
41956267|NCT01742286|75723907|FG006|Escalation Phase|Administrative problems|2|||
41956268|NCT01742286|75723901|FG000|Escalation Phase|Adverse Event|0|||
41956269|NCT01742286|75723902|FG001|Escalation Phase|Adverse Event|1|||
41956270|NCT01742286|75723903|FG002|Escalation Phase|Adverse Event|2|||
41956271|NCT01742286|75723904|FG003|Escalation Phase|Adverse Event|0|||
41956272|NCT01742286|75723905|FG004|Escalation Phase|Adverse Event|0|||
42024151|NCT01020123|75831532|FG000|Extention Period|Withdrawal by Subject|2|||
42024152|NCT01020123|75831533|FG001|Extention Period|Withdrawal by Subject|1|||
42024153|NCT01020123|75831534|FG002|Extention Period|Withdrawal by Subject|1|||
42024154|NCT01020123|75831535|FG003|Extention Period|Withdrawal by Subject|0|||
42024155|NCT01020123|75831536|FG004|Extention Period|Withdrawal by Subject|0|||
42024156|NCT01020123|75831537|FG005|Extention Period|Withdrawal by Subject|0|||
42024157|NCT01020123|75831538|FG006|Extention Period|Withdrawal by Subject|0|||
42024158|NCT01020123|75831532|FG000|Extention Period|Adverse Event|0|||
42024159|NCT01020123|75831533|FG001|Extention Period|Adverse Event|0|||
42024160|NCT01020123|75831534|FG002|Extention Period|Adverse Event|0|||
42024161|NCT01020123|75831535|FG003|Extention Period|Adverse Event|1|||
42024162|NCT01020123|75831536|FG004|Extention Period|Adverse Event|0|||
42024163|NCT01020123|75831537|FG005|Extention Period|Adverse Event|0|||
42024164|NCT01020123|75831538|FG006|Extention Period|Adverse Event|0|||
42024165|NCT01020123|75831532|FG000|Extention Period|Protocol Violation|1|||
42024166|NCT01020123|75831533|FG001|Extention Period|Protocol Violation|1|||
42024167|NCT01020123|75831534|FG002|Extention Period|Protocol Violation|1|||
42024168|NCT01020123|75831535|FG003|Extention Period|Protocol Violation|0|||
42024169|NCT01020123|75831536|FG004|Extention Period|Protocol Violation|0|||
42024170|NCT01020123|75831537|FG005|Extention Period|Protocol Violation|0|||
42024171|NCT01020123|75831538|FG006|Extention Period|Protocol Violation|1|||
42024172|NCT01020123|75831532|FG000|Extention Period|Lost to Follow-up|0|||
42024173|NCT01020123|75831533|FG001|Extention Period|Lost to Follow-up|0|||
42024174|NCT01020123|75831534|FG002|Extention Period|Lost to Follow-up|0|||
42024175|NCT01020123|75831535|FG003|Extention Period|Lost to Follow-up|0|||
42024176|NCT01020123|75831536|FG004|Extention Period|Lost to Follow-up|0|||
42024177|NCT01020123|75831537|FG005|Extention Period|Lost to Follow-up|2|||
42024178|NCT01020123|75831538|FG006|Extention Period|Lost to Follow-up|0|||
42024179|NCT01028391|75831579|FG000|Overall Study|Adverse Event|4|||
42024180|NCT01028391|75831580|FG001|Overall Study|Adverse Event|0|||
42024181|NCT01028391|75831579|FG000|Overall Study|Lack of Efficacy|0|||
42024182|NCT01028391|75831580|FG001|Overall Study|Lack of Efficacy|2|||
42024183|NCT01028391|75831579|FG000|Overall Study|Lost to Follow-up|3|||
42024184|NCT01028391|75831580|FG001|Overall Study|Lost to Follow-up|4|||
42024185|NCT01028391|75831579|FG000|Overall Study|Physician Decision|0|||
42024186|NCT01028391|75831580|FG001|Overall Study|Physician Decision|1|||
42024187|NCT01028391|75831579|FG000|Overall Study|Withdrawal by Subject|6|||
42024188|NCT01028391|75831580|FG001|Overall Study|Withdrawal by Subject|3|||
42024189|NCT01028391|75831579|FG000|Overall Study|Needed excluded medication|1|||
42024190|NCT01028391|75831580|FG001|Overall Study|Needed excluded medication|1|||
42024191|NCT01179672|75831588|FG000|Overall Study|Adverse Event|17|||
42024192|NCT01179672|75831589|FG001|Overall Study|Adverse Event|8|||
42024193|NCT01179672|75831588|FG000|Overall Study|Withdrawal by Subject|10|||
42024194|NCT01179672|75831589|FG001|Overall Study|Withdrawal by Subject|12|||
42024195|NCT01179672|75831588|FG000|Overall Study|Entry Criteria Not Met|0|||
42024196|NCT01179672|75831589|FG001|Overall Study|Entry Criteria Not Met|2|||
41956273|NCT01742286|75723906|FG005|Escalation Phase|Adverse Event|1|||
41956274|NCT01742286|75723907|FG006|Escalation Phase|Adverse Event|0|||
41956275|NCT01742286|75723901|FG000|Escalation Phase|Disease progression|3|||
41956276|NCT01742286|75723902|FG001|Escalation Phase|Disease progression|7|||
41956277|NCT01742286|75723903|FG002|Escalation Phase|Disease progression|4|||
41956278|NCT01742286|75723904|FG003|Escalation Phase|Disease progression|1|||
41956279|NCT01742286|75723905|FG004|Escalation Phase|Disease progression|4|||
41956280|NCT01742286|75723906|FG005|Escalation Phase|Disease progression|3|||
41956281|NCT01742286|75723907|FG006|Escalation Phase|Disease progression|2|||
41956282|NCT01742286|75723901|FG000|Escalation Phase|Death|0|||
41956283|NCT01742286|75723902|FG001|Escalation Phase|Death|0|||
41956284|NCT01742286|75723903|FG002|Escalation Phase|Death|0|||
41956285|NCT01742286|75723904|FG003|Escalation Phase|Death|0|||
41956286|NCT01742286|75723905|FG004|Escalation Phase|Death|0|||
41956287|NCT01742286|75723906|FG005|Escalation Phase|Death|1|||
41956288|NCT01742286|75723907|FG006|Escalation Phase|Death|0|||
41956289|NCT01742286|75723901|FG000|Escalation Phase|Physician Decision|0|||
41956290|NCT01742286|75723902|FG001|Escalation Phase|Physician Decision|3|||
41956291|NCT01742286|75723903|FG002|Escalation Phase|Physician Decision|0|||
41956292|NCT01742286|75723904|FG003|Escalation Phase|Physician Decision|1|||
41956293|NCT01742286|75723905|FG004|Escalation Phase|Physician Decision|0|||
41956294|NCT01742286|75723906|FG005|Escalation Phase|Physician Decision|0|||
41956295|NCT01742286|75723907|FG006|Escalation Phase|Physician Decision|2|||
41956296|NCT01742286|75723901|FG000|Escalation Phase|Subject/guardian decision|1|||
41956297|NCT01742286|75723902|FG001|Escalation Phase|Subject/guardian decision|0|||
41956298|NCT01742286|75723903|FG002|Escalation Phase|Subject/guardian decision|0|||
41956299|NCT01742286|75723904|FG003|Escalation Phase|Subject/guardian decision|0|||
41956300|NCT01742286|75723905|FG004|Escalation Phase|Subject/guardian decision|0|||
41956301|NCT01742286|75723906|FG005|Escalation Phase|Subject/guardian decision|0|||
41956302|NCT01742286|75723907|FG006|Escalation Phase|Subject/guardian decision|0|||
41956303|NCT01742286|75723901|FG000|Expansion Phase|Administrative problems|0|||
41956304|NCT01742286|75723902|FG001|Expansion Phase|Administrative problems|0|||
41956305|NCT01742286|75723903|FG002|Expansion Phase|Administrative problems|0|||
41956306|NCT01742286|75723904|FG003|Expansion Phase|Administrative problems|0|||
41956307|NCT01742286|75723905|FG004|Expansion Phase|Administrative problems|0|||
41956308|NCT01742286|75723906|FG005|Expansion Phase|Administrative problems|0|||
41956309|NCT01742286|75723907|FG006|Expansion Phase|Administrative problems|5|||
41956310|NCT01742286|75723901|FG000|Expansion Phase|Physician Decision|0|||
41956311|NCT01742286|75723902|FG001|Expansion Phase|Physician Decision|0|||
41956312|NCT01742286|75723903|FG002|Expansion Phase|Physician Decision|4|||
41956313|NCT01742286|75723904|FG003|Expansion Phase|Physician Decision|0|||
41956314|NCT01742286|75723905|FG004|Expansion Phase|Physician Decision|0|||
41956315|NCT01742286|75723906|FG005|Expansion Phase|Physician Decision|0|||
41956316|NCT01742286|75723907|FG006|Expansion Phase|Physician Decision|9|||
41956317|NCT01742286|75723901|FG000|Expansion Phase|Adverse Event|0|||
41956318|NCT01742286|75723902|FG001|Expansion Phase|Adverse Event|0|||
41956319|NCT01742286|75723903|FG002|Expansion Phase|Adverse Event|0|||
41956320|NCT01742286|75723904|FG003|Expansion Phase|Adverse Event|0|||
41956321|NCT01742286|75723905|FG004|Expansion Phase|Adverse Event|0|||
41956322|NCT01742286|75723906|FG005|Expansion Phase|Adverse Event|0|||
41956323|NCT01742286|75723907|FG006|Expansion Phase|Adverse Event|6|||
42118042|NCT00689117|75928843|FG003|Overall Study|Personal Reason|0|||
41956324|NCT01742286|75723901|FG000|Expansion Phase|Disease progression|0|||
42118043|NCT00689117|75928840|FG000|Overall Study|Dispensing Error|0|||
42118044|NCT00689117|75928841|FG001|Overall Study|Dispensing Error|1|||
41956325|NCT01742286|75723902|FG001|Expansion Phase|Disease progression|0|||
41956326|NCT01742286|75723903|FG002|Expansion Phase|Disease progression|3|||
41956327|NCT01742286|75723904|FG003|Expansion Phase|Disease progression|0|||
41956328|NCT01742286|75723905|FG004|Expansion Phase|Disease progression|0|||
41956329|NCT01742286|75723906|FG005|Expansion Phase|Disease progression|0|||
41956330|NCT01742286|75723907|FG006|Expansion Phase|Disease progression|15|||
41956331|NCT01742286|75723901|FG000|Expansion Phase|Withdrawal by Subject|0|||
41956332|NCT01742286|75723902|FG001|Expansion Phase|Withdrawal by Subject|0|||
41956333|NCT01742286|75723903|FG002|Expansion Phase|Withdrawal by Subject|0|||
41956334|NCT01742286|75723904|FG003|Expansion Phase|Withdrawal by Subject|0|||
41956335|NCT01742286|75723905|FG004|Expansion Phase|Withdrawal by Subject|0|||
41956336|NCT01742286|75723906|FG005|Expansion Phase|Withdrawal by Subject|0|||
41956337|NCT01742286|75723907|FG006|Expansion Phase|Withdrawal by Subject|1|||
41956338|NCT01697358|75723932|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
41956339|NCT01697358|75723933|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
41956340|NCT01697358|75723932|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
41956341|NCT01697358|75723933|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
41956342|NCT01697358|75723932|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
41956343|NCT01697358|75723933|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
41956344|NCT01697358|75723932|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
41956345|NCT01697358|75723933|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
41956346|NCT01697358|75723932|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
41956347|NCT01697358|75723933|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
41956348|NCT01697358|75723932|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
41956349|NCT01697358|75723933|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
41956350|NCT01697358|75723932|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
41956351|NCT01697358|75723933|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
41956352|NCT01697358|75723932|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
41956353|NCT01697358|75723933|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
42300474|NCT02325219|76135656|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
42300475|NCT02325219|76135657|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
42300476|NCT02325219|76135658|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
42300477|NCT02325219|76135659|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
41956354|NCT01697358|75723932|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
41956355|NCT01697358|75723933|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
42024197|NCT01179672|75831588|FG000|Overall Study|Lost to Follow-up|0|||
41956356|NCT01697358|75723932|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
41956357|NCT01697358|75723933|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
41956358|NCT01716234|75723946|FG000|Overall Study|Protocol Violation|0|||
41956359|NCT01716234|75723947|FG001|Overall Study|Protocol Violation|0|||
41956360|NCT01716234|75723948|FG002|Overall Study|Protocol Violation|0|||
41956361|NCT01716234|75723949|FG003|Overall Study|Protocol Violation|1|||
41956362|NCT01716234|75723950|FG004|Overall Study|Protocol Violation|1|||
41956363|NCT01716234|75723951|FG005|Overall Study|Protocol Violation|1|||
41956364|NCT01716234|75723952|FG006|Overall Study|Protocol Violation|0|||
41956365|NCT01716234|75723946|FG000|Overall Study|Lack of Efficacy|0|||
41956366|NCT01716234|75723947|FG001|Overall Study|Lack of Efficacy|0|||
41956367|NCT01716234|75723948|FG002|Overall Study|Lack of Efficacy|0|||
41956368|NCT01716234|75723949|FG003|Overall Study|Lack of Efficacy|1|||
41956369|NCT01716234|75723950|FG004|Overall Study|Lack of Efficacy|0|||
41956370|NCT01716234|75723951|FG005|Overall Study|Lack of Efficacy|0|||
41956371|NCT01716234|75723952|FG006|Overall Study|Lack of Efficacy|0|||
41956372|NCT01716234|75723946|FG000|Overall Study|Did not meet protocol eligibility|0|||
41956373|NCT01716234|75723947|FG001|Overall Study|Did not meet protocol eligibility|0|||
41956374|NCT01716234|75723948|FG002|Overall Study|Did not meet protocol eligibility|1|||
41956375|NCT01716234|75723949|FG003|Overall Study|Did not meet protocol eligibility|0|||
41956376|NCT01716234|75723950|FG004|Overall Study|Did not meet protocol eligibility|0|||
41956377|NCT01716234|75723951|FG005|Overall Study|Did not meet protocol eligibility|4|||
41956378|NCT01716234|75723952|FG006|Overall Study|Did not meet protocol eligibility|0|||
41956379|NCT01716234|75723946|FG000|Overall Study|Adverse Event|7|||
41956380|NCT01716234|75723947|FG001|Overall Study|Adverse Event|10|||
41956381|NCT01716234|75723948|FG002|Overall Study|Adverse Event|2|||
41956382|NCT01716234|75723949|FG003|Overall Study|Adverse Event|8|||
41956383|NCT01716234|75723950|FG004|Overall Study|Adverse Event|3|||
42024198|NCT01179672|75831589|FG001|Overall Study|Lost to Follow-up|1|||
41956384|NCT01716234|75723951|FG005|Overall Study|Adverse Event|6|||
41956385|NCT01716234|75723952|FG006|Overall Study|Adverse Event|0|||
41956386|NCT01716234|75723946|FG000|Overall Study|Withdrawal by Subject|3|||
41956387|NCT01716234|75723947|FG001|Overall Study|Withdrawal by Subject|0|||
41956388|NCT01716234|75723948|FG002|Overall Study|Withdrawal by Subject|2|||
41956389|NCT01716234|75723949|FG003|Overall Study|Withdrawal by Subject|2|||
41956390|NCT01716234|75723950|FG004|Overall Study|Withdrawal by Subject|1|||
41956391|NCT01716234|75723951|FG005|Overall Study|Withdrawal by Subject|3|||
41956392|NCT01716234|75723952|FG006|Overall Study|Withdrawal by Subject|0|||
41956393|NCT01716156|75723971|FG000|Overall Study|Protocol Violation|1|||
41956394|NCT01716156|75723972|FG001|Overall Study|Protocol Violation|0|||
41956395|NCT01716156|75723973|FG002|Overall Study|Protocol Violation|0|||
41956396|NCT01716156|75723971|FG000|Overall Study|Withdrawal by Subject|0|||
41956397|NCT01716156|75723972|FG001|Overall Study|Withdrawal by Subject|1|||
41956398|NCT01716156|75723973|FG002|Overall Study|Withdrawal by Subject|2|||
41956399|NCT01716156|75723971|FG000|Overall Study|Lost to Follow-up|1|||
41956400|NCT01716156|75723972|FG001|Overall Study|Lost to Follow-up|0|||
41956401|NCT01716156|75723973|FG002|Overall Study|Lost to Follow-up|0|||
41956402|NCT01739790|75723987|FG000|Overall Study|Early Trial Termination|2|||
41956403|NCT01739790|75723988|FG001|Overall Study|Early Trial Termination|4|||
41956404|NCT01696032|75723998|FG000|Overall Study|Withdrawal by Subject|0|||
41956405|NCT01696032|75723999|FG001|Overall Study|Withdrawal by Subject|0|||
41956406|NCT01696032|75724000|FG002|Overall Study|Withdrawal by Subject|1|||
41956407|NCT01696032|75724001|FG003|Overall Study|Withdrawal by Subject|2|||
41956408|NCT01696032|75723998|FG000|Overall Study|Death|14|||
41956409|NCT01696032|75723999|FG001|Overall Study|Death|4|||
41956410|NCT01696032|75724000|FG002|Overall Study|Death|43|||
41956411|NCT01696032|75724001|FG003|Overall Study|Death|18|||
41956412|NCT01696032|75723998|FG000|Overall Study|Lost to Follow-up|0|||
42024199|NCT01179672|75831588|FG000|Overall Study|Protocol Violation|2|||
42024200|NCT01179672|75831589|FG001|Overall Study|Protocol Violation|2|||
42024201|NCT01179672|75831588|FG000|Overall Study|Physician Decision|1|||
42024202|NCT01179672|75831589|FG001|Overall Study|Physician Decision|1|||
42024203|NCT01030965|75831603|FG000|Overall Study|Lack of Efficacy|3|||
42024204|NCT01030965|75831604|FG001|Overall Study|Lack of Efficacy|2|||
42024205|NCT01030965|75831605|FG002|Overall Study|Lack of Efficacy|0|||
41956413|NCT01696032|75723999|FG001|Overall Study|Lost to Follow-up|1|||
41956414|NCT01696032|75724000|FG002|Overall Study|Lost to Follow-up|0|||
41956415|NCT01696032|75724001|FG003|Overall Study|Lost to Follow-up|0|||
41956416|NCT01696032|75723998|FG000|Overall Study|Database lock|0|||
41956417|NCT01696032|75723999|FG001|Overall Study|Database lock|1|||
41956418|NCT01696032|75724000|FG002|Overall Study|Database lock|7|||
41956419|NCT01696032|75724001|FG003|Overall Study|Database lock|2|||
41956420|NCT01695954|75724017|FG000|Overall Study|Withdrawal by Subject|4|||
41956421|NCT01695954|75724018|FG001|Overall Study|Withdrawal by Subject|0|||
41956422|NCT01695954|75724017|FG000|Overall Study|Adverse Event|0|||
41956423|NCT01695954|75724018|FG001|Overall Study|Adverse Event|2|||
41956424|NCT01694706|75724026|FG000|Overall Study|Adverse Event|0|||
41956425|NCT01694706|75724027|FG001|Overall Study|Adverse Event|1|||
41956426|NCT01694706|75724028|FG002|Overall Study|Adverse Event|0|||
41956427|NCT01694706|75724026|FG000|Overall Study|other reason not defined above|1|||
41956428|NCT01694706|75724027|FG001|Overall Study|other reason not defined above|0|||
41956429|NCT01694706|75724028|FG002|Overall Study|other reason not defined above|0|||
41956430|NCT01693692|75724040|FG000|Overall Study|Withdrawal by Subject|12|||
41956431|NCT01693692|75724041|FG001|Overall Study|Withdrawal by Subject|10|||
41956432|NCT01693692|75724042|FG002|Overall Study|Withdrawal by Subject|11|||
41956433|NCT01693692|75724040|FG000|Overall Study|Adverse Event|7|||
41956434|NCT01693692|75724041|FG001|Overall Study|Adverse Event|14|||
41956435|NCT01693692|75724042|FG002|Overall Study|Adverse Event|9|||
41956436|NCT01693692|75724040|FG000|Overall Study|Physician Decision|0|||
41956437|NCT01693692|75724041|FG001|Overall Study|Physician Decision|0|||
41956438|NCT01693692|75724042|FG002|Overall Study|Physician Decision|1|||
41956439|NCT01693692|75724040|FG000|Overall Study|Protocol Violation|5|||
41956440|NCT01693692|75724041|FG001|Overall Study|Protocol Violation|4|||
41956441|NCT01693692|75724042|FG002|Overall Study|Protocol Violation|6|||
41956442|NCT01693692|75724040|FG000|Overall Study|Lost to Follow-up|2|||
41956443|NCT01693692|75724041|FG001|Overall Study|Lost to Follow-up|2|||
41956444|NCT01693692|75724042|FG002|Overall Study|Lost to Follow-up|3|||
41956445|NCT01693692|75724040|FG000|Overall Study|Other|4|||
41956446|NCT01693692|75724041|FG001|Overall Study|Other|4|||
41956447|NCT01693692|75724042|FG002|Overall Study|Other|6|||
41956448|NCT01693614|75724053|FG000|Overall Study|Adverse Event|7|||
41956449|NCT01693614|75724054|FG001|Overall Study|Adverse Event|11|||
41956450|NCT01693614|75724055|FG002|Overall Study|Adverse Event|5|||
41956451|NCT01693614|75724053|FG000|Overall Study|Disease progression|11|||
41956452|NCT01693614|75724054|FG001|Overall Study|Disease progression|8|||
41956453|NCT01693614|75724055|FG002|Overall Study|Disease progression|7|||
41956454|NCT01693614|75724053|FG000|Overall Study|Protocol Violation|5|||
41956455|NCT01693614|75724054|FG001|Overall Study|Protocol Violation|2|||
41956456|NCT01693614|75724055|FG002|Overall Study|Protocol Violation|1|||
41956457|NCT01693614|75724053|FG000|Overall Study|Death|1|||
41956458|NCT01693614|75724054|FG001|Overall Study|Death|0|||
41956459|NCT01693614|75724055|FG002|Overall Study|Death|0|||
41956460|NCT01693614|75724053|FG000|Overall Study|Physician Decision|1|||
41956461|NCT01693614|75724054|FG001|Overall Study|Physician Decision|1|||
41956462|NCT01693614|75724055|FG002|Overall Study|Physician Decision|4|||
41956463|NCT01693614|75724053|FG000|Overall Study|Withdrawal by subject/guardian|0|||
41956464|NCT01693614|75724054|FG001|Overall Study|Withdrawal by subject/guardian|0|||
41956465|NCT01693614|75724055|FG002|Overall Study|Withdrawal by subject/guardian|2|||
41956466|NCT01693614|75724053|FG000|Overall Study|Withdrawal by Subject|1|||
41956467|NCT01693614|75724054|FG001|Overall Study|Withdrawal by Subject|0|||
41956468|NCT01693614|75724055|FG002|Overall Study|Withdrawal by Subject|5|||
41956469|NCT01715298|75724066|FG000|Overall Study|Lost to Follow-up|0|||
41956470|NCT01715298|75724067|FG001|Overall Study|Lost to Follow-up|2|||
41956471|NCT01715298|75724066|FG000|Overall Study|Patient/guardian decision|7|||
41956472|NCT01715298|75724067|FG001|Overall Study|Patient/guardian decision|9|||
41956473|NCT01713582|75724094|FG000|Overall Study|Disease progression|3|||
41956474|NCT01713582|75724095|FG001|Overall Study|Disease progression|3|||
41956475|NCT01713582|75724096|FG002|Overall Study|Disease progression|3|||
41956476|NCT01713582|75724097|FG003|Overall Study|Disease progression|2|||
41956477|NCT01713582|75724098|FG004|Overall Study|Disease progression|3|||
41956478|NCT01713582|75724099|FG005|Overall Study|Disease progression|3|||
41956479|NCT01713582|75724100|FG006|Overall Study|Disease progression|3|||
41956480|NCT01713582|75724101|FG007|Overall Study|Disease progression|3|||
41956481|NCT01713582|75724102|FG008|Overall Study|Disease progression|3|||
41956482|NCT01713582|75724103|FG009|Overall Study|Disease progression|11|||
41956483|NCT01713582|75724104|FG010|Overall Study|Disease progression|10|||
41956484|NCT01713582|75724105|FG011|Overall Study|Disease progression|5|||
41956485|NCT01713582|75724106|FG012|Overall Study|Disease progression|3|||
41956486|NCT01713582|75724107|FG013|Overall Study|Disease progression|3|||
41956487|NCT01713582|75724108|FG014|Overall Study|Disease progression|6|||
41956488|NCT01713582|75724109|FG015|Overall Study|Disease progression|6|||
41956489|NCT01713582|75724110|FG016|Overall Study|Disease progression|5|||
41956490|NCT01713582|75724111|FG017|Overall Study|Disease progression|2|||
41956491|NCT01713582|75724112|FG018|Overall Study|Disease progression|3|||
41956492|NCT01713582|75724113|FG019|Overall Study|Disease progression|5|||
41956493|NCT01713582|75724114|FG020|Overall Study|Disease progression|15|||
41956494|NCT01713582|75724094|FG000|Overall Study|Death|0|||
41956495|NCT01713582|75724095|FG001|Overall Study|Death|0|||
41956496|NCT01713582|75724096|FG002|Overall Study|Death|0|||
41956497|NCT01713582|75724097|FG003|Overall Study|Death|1|||
41956498|NCT01713582|75724098|FG004|Overall Study|Death|1|||
41956499|NCT01713582|75724099|FG005|Overall Study|Death|3|||
41956500|NCT01713582|75724100|FG006|Overall Study|Death|3|||
41956501|NCT01713582|75724101|FG007|Overall Study|Death|2|||
41956502|NCT01713582|75724102|FG008|Overall Study|Death|3|||
41956503|NCT01713582|75724103|FG009|Overall Study|Death|4|||
41956504|NCT01713582|75724104|FG010|Overall Study|Death|3|||
41956505|NCT01713582|75724105|FG011|Overall Study|Death|0|||
41956506|NCT01713582|75724106|FG012|Overall Study|Death|0|||
41956507|NCT01713582|75724107|FG013|Overall Study|Death|0|||
41956508|NCT01713582|75724108|FG014|Overall Study|Death|0|||
41956509|NCT01713582|75724109|FG015|Overall Study|Death|0|||
41956510|NCT01713582|75724110|FG016|Overall Study|Death|0|||
41956511|NCT01713582|75724111|FG017|Overall Study|Death|0|||
41956512|NCT01713582|75724112|FG018|Overall Study|Death|0|||
41956513|NCT01713582|75724113|FG019|Overall Study|Death|0|||
41956514|NCT01713582|75724114|FG020|Overall Study|Death|0|||
41956515|NCT01713582|75724094|FG000|Overall Study|Adverse event-related|0|||
41956516|NCT01713582|75724095|FG001|Overall Study|Adverse event-related|0|||
41956517|NCT01713582|75724096|FG002|Overall Study|Adverse event-related|0|||
41956518|NCT01713582|75724097|FG003|Overall Study|Adverse event-related|0|||
41956519|NCT01713582|75724098|FG004|Overall Study|Adverse event-related|0|||
41956520|NCT01713582|75724099|FG005|Overall Study|Adverse event-related|0|||
41956521|NCT01713582|75724100|FG006|Overall Study|Adverse event-related|0|||
41956522|NCT01713582|75724101|FG007|Overall Study|Adverse event-related|0|||
41956523|NCT01713582|75724102|FG008|Overall Study|Adverse event-related|0|||
41956524|NCT01713582|75724103|FG009|Overall Study|Adverse event-related|1|||
41956525|NCT01713582|75724104|FG010|Overall Study|Adverse event-related|1|||
41956526|NCT01713582|75724105|FG011|Overall Study|Adverse event-related|0|||
41956527|NCT01713582|75724106|FG012|Overall Study|Adverse event-related|0|||
41956528|NCT01713582|75724107|FG013|Overall Study|Adverse event-related|0|||
41956529|NCT01713582|75724108|FG014|Overall Study|Adverse event-related|0|||
41956530|NCT01713582|75724109|FG015|Overall Study|Adverse event-related|0|||
41956531|NCT01713582|75724110|FG016|Overall Study|Adverse event-related|0|||
41956532|NCT01713582|75724111|FG017|Overall Study|Adverse event-related|0|||
41956533|NCT01713582|75724112|FG018|Overall Study|Adverse event-related|1|||
41956534|NCT01713582|75724113|FG019|Overall Study|Adverse event-related|0|||
41956535|NCT01713582|75724114|FG020|Overall Study|Adverse event-related|0|||
41956536|NCT01713582|75724094|FG000|Overall Study|Adverse event-unrelated|0|||
41956537|NCT01713582|75724095|FG001|Overall Study|Adverse event-unrelated|0|||
41956538|NCT01713582|75724096|FG002|Overall Study|Adverse event-unrelated|0|||
41956539|NCT01713582|75724097|FG003|Overall Study|Adverse event-unrelated|0|||
41956540|NCT01713582|75724098|FG004|Overall Study|Adverse event-unrelated|0|||
41956541|NCT01713582|75724099|FG005|Overall Study|Adverse event-unrelated|1|||
41956542|NCT01713582|75724100|FG006|Overall Study|Adverse event-unrelated|1|||
41956543|NCT01713582|75724101|FG007|Overall Study|Adverse event-unrelated|1|||
41956544|NCT01713582|75724102|FG008|Overall Study|Adverse event-unrelated|0|||
41956545|NCT01713582|75724103|FG009|Overall Study|Adverse event-unrelated|0|||
41956546|NCT01713582|75724104|FG010|Overall Study|Adverse event-unrelated|0|||
41956547|NCT01713582|75724105|FG011|Overall Study|Adverse event-unrelated|0|||
41956548|NCT01713582|75724106|FG012|Overall Study|Adverse event-unrelated|0|||
41956549|NCT01713582|75724107|FG013|Overall Study|Adverse event-unrelated|1|||
41956550|NCT01713582|75724108|FG014|Overall Study|Adverse event-unrelated|1|||
41956551|NCT01713582|75724109|FG015|Overall Study|Adverse event-unrelated|0|||
41956552|NCT01713582|75724110|FG016|Overall Study|Adverse event-unrelated|0|||
41956553|NCT01713582|75724111|FG017|Overall Study|Adverse event-unrelated|0|||
41956554|NCT01713582|75724112|FG018|Overall Study|Adverse event-unrelated|0|||
41956555|NCT01713582|75724113|FG019|Overall Study|Adverse event-unrelated|0|||
41956556|NCT01713582|75724114|FG020|Overall Study|Adverse event-unrelated|0|||
41956557|NCT01713582|75724094|FG000|Overall Study|Withdrawal of consent|0|||
41956558|NCT01713582|75724095|FG001|Overall Study|Withdrawal of consent|0|||
41956559|NCT01713582|75724096|FG002|Overall Study|Withdrawal of consent|1|||
41956560|NCT01713582|75724097|FG003|Overall Study|Withdrawal of consent|0|||
41956561|NCT01713582|75724098|FG004|Overall Study|Withdrawal of consent|0|||
41956562|NCT01713582|75724099|FG005|Overall Study|Withdrawal of consent|1|||
41956563|NCT01713582|75724100|FG006|Overall Study|Withdrawal of consent|0|||
41956564|NCT01713582|75724101|FG007|Overall Study|Withdrawal of consent|0|||
41956565|NCT01713582|75724102|FG008|Overall Study|Withdrawal of consent|0|||
41956566|NCT01713582|75724103|FG009|Overall Study|Withdrawal of consent|1|||
41956567|NCT01713582|75724104|FG010|Overall Study|Withdrawal of consent|0|||
41956568|NCT01713582|75724105|FG011|Overall Study|Withdrawal of consent|0|||
41956569|NCT01713582|75724106|FG012|Overall Study|Withdrawal of consent|0|||
41956570|NCT01713582|75724107|FG013|Overall Study|Withdrawal of consent|0|||
41956571|NCT01713582|75724108|FG014|Overall Study|Withdrawal of consent|0|||
41956572|NCT01713582|75724109|FG015|Overall Study|Withdrawal of consent|0|||
41956573|NCT01713582|75724110|FG016|Overall Study|Withdrawal of consent|0|||
41956574|NCT01713582|75724111|FG017|Overall Study|Withdrawal of consent|0|||
41956575|NCT01713582|75724112|FG018|Overall Study|Withdrawal of consent|1|||
41956576|NCT01713582|75724113|FG019|Overall Study|Withdrawal of consent|0|||
41956577|NCT01713582|75724114|FG020|Overall Study|Withdrawal of consent|0|||
41956578|NCT01713582|75724094|FG000|Overall Study|Lack of Efficacy|0|||
41956579|NCT01713582|75724095|FG001|Overall Study|Lack of Efficacy|0|||
41956580|NCT01713582|75724096|FG002|Overall Study|Lack of Efficacy|0|||
41956581|NCT01713582|75724097|FG003|Overall Study|Lack of Efficacy|0|||
42024206|NCT01030965|75831606|FG003|Overall Study|Lack of Efficacy|3|||
42024207|NCT01030965|75831603|FG000|Overall Study|Protocol Violation|1|||
42024208|NCT01030965|75831604|FG001|Overall Study|Protocol Violation|1|||
42024209|NCT01030965|75831605|FG002|Overall Study|Protocol Violation|1|||
42024210|NCT01030965|75831606|FG003|Overall Study|Protocol Violation|1|||
42024211|NCT01030965|75831603|FG000|Overall Study|Adverse Event|0|||
42024212|NCT01030965|75831604|FG001|Overall Study|Adverse Event|1|||
42024213|NCT01030965|75831605|FG002|Overall Study|Adverse Event|2|||
42024214|NCT01030965|75831606|FG003|Overall Study|Adverse Event|1|||
42024215|NCT01030965|75831603|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
42024216|NCT01030965|75831604|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
42024217|NCT01030965|75831605|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
42024218|NCT01030965|75831606|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
42024219|NCT01030965|75831603|FG000|Overall Study|Withdrawal by Subject|0|||
42024220|NCT01030965|75831604|FG001|Overall Study|Withdrawal by Subject|1|||
42024221|NCT01030965|75831605|FG002|Overall Study|Withdrawal by Subject|0|||
42024222|NCT01030965|75831606|FG003|Overall Study|Withdrawal by Subject|2|||
42024223|NCT01179516|75831619|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
42024224|NCT01179516|75831620|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
42024225|NCT01179516|75831621|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
42024226|NCT01179516|75831619|FG000|Overall Study|Lack of Efficacy|4|||
42024227|NCT01179516|75831620|FG001|Overall Study|Lack of Efficacy|2|||
42024228|NCT01179516|75831621|FG002|Overall Study|Lack of Efficacy|0|||
42024229|NCT01179516|75831619|FG000|Overall Study|Noncompliance with Study Drug|2|||
42024230|NCT01179516|75831620|FG001|Overall Study|Noncompliance with Study Drug|0|||
42024231|NCT01179516|75831621|FG002|Overall Study|Noncompliance with Study Drug|1|||
42024232|NCT01179516|75831619|FG000|Overall Study|Protocol Deviations|4|||
42024233|NCT01179516|75831620|FG001|Overall Study|Protocol Deviations|3|||
42024234|NCT01179516|75831621|FG002|Overall Study|Protocol Deviations|3|||
41956582|NCT01713582|75724098|FG004|Overall Study|Lack of Efficacy|0|||
41956583|NCT01713582|75724099|FG005|Overall Study|Lack of Efficacy|0|||
41956584|NCT01713582|75724100|FG006|Overall Study|Lack of Efficacy|0|||
41956585|NCT01713582|75724101|FG007|Overall Study|Lack of Efficacy|0|||
41956586|NCT01713582|75724102|FG008|Overall Study|Lack of Efficacy|0|||
41956587|NCT01713582|75724103|FG009|Overall Study|Lack of Efficacy|1|||
41956588|NCT01713582|75724104|FG010|Overall Study|Lack of Efficacy|2|||
41956589|NCT01713582|75724105|FG011|Overall Study|Lack of Efficacy|0|||
41956590|NCT01713582|75724106|FG012|Overall Study|Lack of Efficacy|0|||
41956591|NCT01713582|75724107|FG013|Overall Study|Lack of Efficacy|0|||
41956592|NCT01713582|75724108|FG014|Overall Study|Lack of Efficacy|0|||
41956593|NCT01713582|75724109|FG015|Overall Study|Lack of Efficacy|0|||
41956594|NCT01713582|75724110|FG016|Overall Study|Lack of Efficacy|0|||
41956595|NCT01713582|75724111|FG017|Overall Study|Lack of Efficacy|0|||
41956596|NCT01713582|75724112|FG018|Overall Study|Lack of Efficacy|0|||
41956597|NCT01713582|75724113|FG019|Overall Study|Lack of Efficacy|0|||
41956598|NCT01713582|75724114|FG020|Overall Study|Lack of Efficacy|0|||
41956599|NCT01713582|75724094|FG000|Overall Study|Withdrawal by Subject|0|||
41956600|NCT01713582|75724095|FG001|Overall Study|Withdrawal by Subject|0|||
41956601|NCT01713582|75724096|FG002|Overall Study|Withdrawal by Subject|0|||
41956602|NCT01713582|75724097|FG003|Overall Study|Withdrawal by Subject|0|||
41956603|NCT01713582|75724098|FG004|Overall Study|Withdrawal by Subject|0|||
41956604|NCT01713582|75724099|FG005|Overall Study|Withdrawal by Subject|0|||
41956605|NCT01713582|75724100|FG006|Overall Study|Withdrawal by Subject|0|||
41956606|NCT01713582|75724101|FG007|Overall Study|Withdrawal by Subject|0|||
41956607|NCT01713582|75724102|FG008|Overall Study|Withdrawal by Subject|0|||
41956608|NCT01713582|75724103|FG009|Overall Study|Withdrawal by Subject|0|||
41956609|NCT01713582|75724104|FG010|Overall Study|Withdrawal by Subject|0|||
41956610|NCT01713582|75724105|FG011|Overall Study|Withdrawal by Subject|0|||
41956611|NCT01713582|75724106|FG012|Overall Study|Withdrawal by Subject|0|||
41956612|NCT01713582|75724107|FG013|Overall Study|Withdrawal by Subject|0|||
41956613|NCT01713582|75724108|FG014|Overall Study|Withdrawal by Subject|0|||
41956614|NCT01713582|75724109|FG015|Overall Study|Withdrawal by Subject|0|||
41956615|NCT01713582|75724110|FG016|Overall Study|Withdrawal by Subject|0|||
42024235|NCT01179516|75831619|FG000|Overall Study|Withdrawal of Consent|2|||
42024236|NCT01179516|75831620|FG001|Overall Study|Withdrawal of Consent|6|||
42024237|NCT01179516|75831621|FG002|Overall Study|Withdrawal of Consent|10|||
41956616|NCT01713582|75724111|FG017|Overall Study|Withdrawal by Subject|1|||
41956617|NCT01713582|75724112|FG018|Overall Study|Withdrawal by Subject|0|||
42024238|NCT01179516|75831619|FG000|Overall Study|Lost to Follow-up|7|||
42024239|NCT01179516|75831620|FG001|Overall Study|Lost to Follow-up|7|||
42024240|NCT01179516|75831621|FG002|Overall Study|Lost to Follow-up|3|||
41956618|NCT01713582|75724113|FG019|Overall Study|Withdrawal by Subject|0|||
41956619|NCT01713582|75724114|FG020|Overall Study|Withdrawal by Subject|0|||
41956620|NCT01713582|75724094|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
41956621|NCT01713582|75724095|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
42024241|NCT01179516|75831619|FG000|Overall Study|Other|2|||
42024242|NCT01179516|75831620|FG001|Overall Study|Other|0|||
41956622|NCT01713582|75724096|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
41956623|NCT01713582|75724097|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
41956624|NCT01713582|75724098|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
41956625|NCT01713582|75724099|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
41956626|NCT01713582|75724100|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
41956627|NCT01713582|75724101|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
41956628|NCT01713582|75724102|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
41956629|NCT01713582|75724103|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
41956630|NCT01713582|75724104|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
41956631|NCT01713582|75724105|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
41956632|NCT01713582|75724106|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
41956633|NCT01713582|75724107|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
41956634|NCT01713582|75724108|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
41956635|NCT01713582|75724109|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
41956636|NCT01713582|75724110|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
41956637|NCT01713582|75724111|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
41956638|NCT01713582|75724112|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
41956639|NCT01713582|75724113|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
41956640|NCT01713582|75724114|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
41956641|NCT01713582|75724094|FG000|Overall Study|Disease progression and adverse event|0|||
41956642|NCT01713582|75724095|FG001|Overall Study|Disease progression and adverse event|0|||
41956643|NCT01713582|75724096|FG002|Overall Study|Disease progression and adverse event|0|||
41956644|NCT01713582|75724097|FG003|Overall Study|Disease progression and adverse event|0|||
41956645|NCT01713582|75724098|FG004|Overall Study|Disease progression and adverse event|0|||
41956646|NCT01713582|75724099|FG005|Overall Study|Disease progression and adverse event|0|||
41956647|NCT01713582|75724100|FG006|Overall Study|Disease progression and adverse event|0|||
41956648|NCT01713582|75724101|FG007|Overall Study|Disease progression and adverse event|0|||
41956649|NCT01713582|75724102|FG008|Overall Study|Disease progression and adverse event|0|||
41956650|NCT01713582|75724103|FG009|Overall Study|Disease progression and adverse event|0|||
41956651|NCT01713582|75724104|FG010|Overall Study|Disease progression and adverse event|0|||
41956652|NCT01713582|75724105|FG011|Overall Study|Disease progression and adverse event|0|||
41956653|NCT01713582|75724106|FG012|Overall Study|Disease progression and adverse event|0|||
41956654|NCT01713582|75724107|FG013|Overall Study|Disease progression and adverse event|0|||
41956655|NCT01713582|75724108|FG014|Overall Study|Disease progression and adverse event|0|||
41956656|NCT01713582|75724109|FG015|Overall Study|Disease progression and adverse event|0|||
41956657|NCT01713582|75724110|FG016|Overall Study|Disease progression and adverse event|1|||
41956658|NCT01713582|75724111|FG017|Overall Study|Disease progression and adverse event|0|||
41956659|NCT01713582|75724112|FG018|Overall Study|Disease progression and adverse event|0|||
41956660|NCT01713582|75724113|FG019|Overall Study|Disease progression and adverse event|0|||
41956661|NCT01713582|75724114|FG020|Overall Study|Disease progression and adverse event|0|||
41956662|NCT01739400|75724174|FG000|Overall Study|Physician Decision|3|||
41956663|NCT01739400|75724175|FG001|Overall Study|Physician Decision|0|||
41956664|NCT01739400|75724174|FG000|Overall Study|Lost to Follow-up|2|||
41956665|NCT01739400|75724175|FG001|Overall Study|Lost to Follow-up|0|||
41956666|NCT01739400|75724174|FG000|Overall Study|Death|5|||
41956667|NCT01739400|75724175|FG001|Overall Study|Death|2|||
41956668|NCT01739400|75724174|FG000|Overall Study|Withdrawal by Subject|7|||
41956669|NCT01739400|75724175|FG001|Overall Study|Withdrawal by Subject|7|||
41956670|NCT01713348|75724184|FG000|Overall Study|Withdrawal by Subject|3|||
41956671|NCT01713348|75724185|FG001|Overall Study|Withdrawal by Subject|2|||
41956672|NCT01713348|75724186|FG002|Overall Study|Withdrawal by Subject|2|||
41956673|NCT01713348|75724187|FG003|Overall Study|Withdrawal by Subject|0|||
41956674|NCT01713348|75724184|FG000|Overall Study|Lost to Follow-up|1|||
41956675|NCT01713348|75724185|FG001|Overall Study|Lost to Follow-up|0|||
41956676|NCT01713348|75724186|FG002|Overall Study|Lost to Follow-up|0|||
41956677|NCT01713348|75724187|FG003|Overall Study|Lost to Follow-up|0|||
41956678|NCT01737996|75724200|FG000|Overall Study|Adverse Event|0|||
41956679|NCT01737996|75724201|FG001|Overall Study|Adverse Event|1|||
41956680|NCT01737996|75724202|FG002|Overall Study|Adverse Event|1|||
41956681|NCT01737996|75724200|FG000|Overall Study|Withdrawal by Subject|0|||
41956682|NCT01737996|75724201|FG001|Overall Study|Withdrawal by Subject|0|||
41956683|NCT01737996|75724202|FG002|Overall Study|Withdrawal by Subject|1|||
41956684|NCT01713036|75724210|FG000|Overall Study|Death|1|||
41956685|NCT01712334|75724220|FG000|Treatment Period 1|Randomized in Error|0|||
41956686|NCT01712334|75724221|FG001|Treatment Period 1|Randomized in Error|2|||
41956687|NCT01712256|75724227|FG000|Overall Study|Lost to Follow-up|1|||
41956688|NCT01712178|75724233|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
41956689|NCT01712178|75724234|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
41956690|NCT01712178|75724233|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
41956691|NCT01712178|75724234|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
41956692|NCT01712178|75724233|FG000|Overall Study|Lost to Follow-up|0|||
41956693|NCT01712178|75724234|FG001|Overall Study|Lost to Follow-up|1|||
41956694|NCT01693068|75724242|FG000|Randomization Period|On-study|2|||
41956695|NCT01693068|75724243|FG001|Randomization Period|On-study|5|||
41956696|NCT01693068|75724244|FG002|Randomization Period|On-study|0|||
41956697|NCT01693068|75724242|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
41956698|NCT01693068|75724243|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
41956699|NCT01693068|75724244|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
41956700|NCT01691898|75724258|FG000|Overall Study|Death|34|||
41956701|NCT01691898|75724259|FG001|Overall Study|Death|32|||
41956702|NCT01691898|75724260|FG002|Overall Study|Death|6|||
41956703|NCT01691898|75724261|FG003|Overall Study|Death|3|||
41956704|NCT01691898|75724262|FG004|Overall Study|Death|8|||
41956705|NCT01691898|75724263|FG005|Overall Study|Death|31|||
41956706|NCT01691898|75724258|FG000|Overall Study|Adverse Event|0|||
41956707|NCT01691898|75724259|FG001|Overall Study|Adverse Event|1|||
41956708|NCT01691898|75724260|FG002|Overall Study|Adverse Event|0|||
41956709|NCT01691898|75724261|FG003|Overall Study|Adverse Event|1|||
41956710|NCT01691898|75724262|FG004|Overall Study|Adverse Event|1|||
41956711|NCT01691898|75724263|FG005|Overall Study|Adverse Event|0|||
41956712|NCT01691898|75724258|FG000|Overall Study|Progression of Disease|1|||
41956713|NCT01691898|75724259|FG001|Overall Study|Progression of Disease|2|||
41956714|NCT01691898|75724260|FG002|Overall Study|Progression of Disease|1|||
41956715|NCT01691898|75724261|FG003|Overall Study|Progression of Disease|0|||
41956716|NCT01691898|75724262|FG004|Overall Study|Progression of Disease|0|||
41956717|NCT01691898|75724263|FG005|Overall Study|Progression of Disease|1|||
41956718|NCT01691898|75724258|FG000|Overall Study|Lost to Follow-up|3|||
41956719|NCT01691898|75724259|FG001|Overall Study|Lost to Follow-up|1|||
41956720|NCT01691898|75724260|FG002|Overall Study|Lost to Follow-up|0|||
41956721|NCT01691898|75724261|FG003|Overall Study|Lost to Follow-up|0|||
41956722|NCT01691898|75724262|FG004|Overall Study|Lost to Follow-up|1|||
41956723|NCT01691898|75724263|FG005|Overall Study|Lost to Follow-up|0|||
41956724|NCT01691898|75724258|FG000|Overall Study|Withdrawal by Subject|9|||
41956725|NCT01691898|75724259|FG001|Overall Study|Withdrawal by Subject|8|||
41956726|NCT01691898|75724260|FG002|Overall Study|Withdrawal by Subject|2|||
41956727|NCT01691898|75724261|FG003|Overall Study|Withdrawal by Subject|1|||
41956728|NCT01691898|75724262|FG004|Overall Study|Withdrawal by Subject|3|||
41956729|NCT01691898|75724263|FG005|Overall Study|Withdrawal by Subject|3|||
41956730|NCT01691898|75724258|FG000|Overall Study|Non-Compliance|0|||
41956731|NCT01691898|75724259|FG001|Overall Study|Non-Compliance|0|||
41956732|NCT01691898|75724260|FG002|Overall Study|Non-Compliance|0|||
41956733|NCT01691898|75724261|FG003|Overall Study|Non-Compliance|0|||
41956734|NCT01691898|75724262|FG004|Overall Study|Non-Compliance|1|||
41956735|NCT01691898|75724263|FG005|Overall Study|Non-Compliance|0|||
41956736|NCT01691820|75724297|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
41956737|NCT01691820|75724298|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
41956738|NCT01691820|75724297|FG000|Overall Study|Migrated/moved from study area|7|||
41956739|NCT01691820|75724298|FG001|Overall Study|Migrated/moved from study area|4|||
41956740|NCT01691820|75724297|FG000|Overall Study|Lost to Follow-up|6|||
41956741|NCT01691820|75724298|FG001|Overall Study|Lost to Follow-up|17|||
41956742|NCT01691820|75724297|FG000|Overall Study|Other (unspecified)|4|||
41956743|NCT01691820|75724298|FG001|Overall Study|Other (unspecified)|1|||
41956744|NCT01711866|75724308|FG000|Overall Study|Noncompliant|3|||
41956745|NCT01711866|75724308|FG000|Overall Study|Withdrawal by Subject|3|||
41956746|NCT01711866|75724308|FG000|Overall Study|Adverse Event|2|||
41956747|NCT01737762|75724314|FG000|Overall Study|Adverse Event|2|||
41956748|NCT01737762|75724315|FG001|Overall Study|Adverse Event|2|||
41956749|NCT01737762|75724314|FG000|Overall Study|Lost to Follow-up|1|||
41956750|NCT01737762|75724315|FG001|Overall Study|Lost to Follow-up|0|||
41956751|NCT01737762|75724314|FG000|Overall Study|Withdrawal by Subject|2|||
41956752|NCT01737762|75724315|FG001|Overall Study|Withdrawal by Subject|2|||
41956753|NCT01737762|75724314|FG000|Overall Study|Progressive disease|1|||
41956754|NCT01737762|75724315|FG001|Overall Study|Progressive disease|2|||
41956755|NCT01737762|75724314|FG000|Overall Study|Physician Decision|1|||
41956756|NCT01737762|75724315|FG001|Overall Study|Physician Decision|1|||
41956757|NCT01737762|75724314|FG000|Overall Study|Moved from area|2|||
41956758|NCT01737762|75724315|FG001|Overall Study|Moved from area|1|||
41956759|NCT01737762|75724314|FG000|Overall Study|Trial termination|11|||
41956760|NCT01737762|75724315|FG001|Overall Study|Trial termination|9|||
41956761|NCT01691508|75724323|FG000|Overall Study|Adverse Event|3|||
41956762|NCT01691508|75724324|FG001|Overall Study|Adverse Event|3|||
41956763|NCT01691508|75724323|FG000|Overall Study|Withdrawal by Subject|1|||
41956764|NCT01691508|75724324|FG001|Overall Study|Withdrawal by Subject|0|||
41956765|NCT01682460|75724330|FG000|Overall Study|Withdrawal by Subject|2|||
41956766|NCT01682460|75724330|FG000|Overall Study|Did not meet inclusion criteria|2|||
41956767|NCT01691430|75724336|FG000|Overall Study|Death|17|||
41956768|NCT01691430|75724337|FG001|Overall Study|Death|16|||
41956769|NCT01691430|75724336|FG000|Overall Study|Withdrawal by Subject|5|||
41956770|NCT01691430|75724337|FG001|Overall Study|Withdrawal by Subject|1|||
41956771|NCT01691430|75724336|FG000|Overall Study|Lost to Follow-up|0|||
41956772|NCT01691430|75724337|FG001|Overall Study|Lost to Follow-up|3|||
41956773|NCT01709838|75724343|FG000|Overall Study|Withdrawal by Subject|21|||
41956774|NCT01709838|75724343|FG000|Overall Study|Lost to Follow-up|16|||
41956775|NCT01709838|75724343|FG000|Overall Study|Pregnancy|10|||
41956776|NCT01709838|75724343|FG000|Overall Study|Subject/guardian decision|8|||
41956777|NCT01709838|75724343|FG000|Overall Study|Adverse Event|4|||
41956778|NCT01709838|75724343|FG000|Overall Study|Physician Decision|4|||
41956779|NCT01709838|75724343|FG000|Overall Study|Death|3|||
41956780|NCT01709838|75724343|FG000|Overall Study|Protocol Violation|1|||
41956781|NCT01682226|75724349|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
41956782|NCT01682226|75724349|FG000|Overall Study|Participants did not receive treatment|2|||
41956783|NCT01682226|75724349|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
41956784|NCT04167618|75724355|FG000|Overall Study|Trial terminated by sponsor|1|||
41956785|NCT04167618|75724356|FG001|Overall Study|Trial terminated by sponsor|1|||
41956786|NCT01688466|75724364|FG000|Overall Study|Withdrawal by Subject|2|||
41956787|NCT01688466|75724365|FG001|Overall Study|Withdrawal by Subject|1|||
41956788|NCT01688466|75724364|FG000|Overall Study|Death|0|||
41956789|NCT01688466|75724365|FG001|Overall Study|Death|1|||
41956790|NCT01688466|75724364|FG000|Overall Study|Adverse Event|0|||
41956791|NCT01688466|75724365|FG001|Overall Study|Adverse Event|4|||
41956792|NCT01688466|75724364|FG000|Overall Study|Not evaluable|0|||
41956793|NCT01688466|75724365|FG001|Overall Study|Not evaluable|1|||
41956794|NCT01682148|75724373|FG000|Overall Study|Withdrawal by Subject|2|||
41956795|NCT01682148|75724374|FG001|Overall Study|Withdrawal by Subject|0|||
41956796|NCT01682148|75724373|FG000|Overall Study|Lost to Follow-up|1|||
41956797|NCT01682148|75724374|FG001|Overall Study|Lost to Follow-up|2|||
41956798|NCT01682148|75724373|FG000|Overall Study|Protocol Violation|1|||
41956799|NCT01682148|75724374|FG001|Overall Study|Protocol Violation|1|||
41956800|NCT01681992|75724388|FG000|Overall Study|Adverse Event|3|||
41956801|NCT01681992|75724389|FG001|Overall Study|Adverse Event|2|||
41956802|NCT01681992|75724390|FG002|Overall Study|Adverse Event|3|||
41956803|NCT01681992|75724388|FG000|Overall Study|Lost to Follow-up|36|||
41956804|NCT01681992|75724389|FG001|Overall Study|Lost to Follow-up|38|||
41956805|NCT01681992|75724390|FG002|Overall Study|Lost to Follow-up|53|||
41956806|NCT01681992|75724388|FG000|Overall Study|As Per Sponsor Decision|0|||
41956807|NCT01681992|75724389|FG001|Overall Study|As Per Sponsor Decision|0|||
41956808|NCT01681992|75724390|FG002|Overall Study|As Per Sponsor Decision|1|||
41956809|NCT01681992|75724388|FG000|Overall Study|Protocol Violation|0|||
41956810|NCT01681992|75724389|FG001|Overall Study|Protocol Violation|0|||
41956811|NCT01681992|75724390|FG002|Overall Study|Protocol Violation|1|||
41956812|NCT01681992|75724388|FG000|Overall Study|Withdrawal by Subject|27|||
41956813|NCT01681992|75724389|FG001|Overall Study|Withdrawal by Subject|30|||
41956814|NCT01681992|75724390|FG002|Overall Study|Withdrawal by Subject|25|||
41956815|NCT01737840|75724400|FG000|Overall Study|Diagnosed with an other pathology|2|||
41956816|NCT01737840|75724401|FG001|Overall Study|Diagnosed with an other pathology|2|||
41956817|NCT01687998|75724411|FG000|Overall Study|Withdrawal by Subject|49|||
41956818|NCT01687998|75724412|FG001|Overall Study|Withdrawal by Subject|51|||
41956819|NCT01687998|75724411|FG000|Overall Study|Known to be Alive at Study End|54|||
41956820|NCT01687998|75724412|FG001|Overall Study|Known to be Alive at Study End|62|||
41956821|NCT01687998|75724411|FG000|Overall Study|Lost to Follow-up|9|||
41956822|NCT01687998|75724412|FG001|Overall Study|Lost to Follow-up|7|||
41956823|NCT01681836|75724418|FG000|Second Intervention|Withdrawal by Subject|0|||
41956824|NCT01681836|75724419|FG001|Second Intervention|Withdrawal by Subject|1|||
41956825|NCT01681368|75724425|FG000|Overall Study|Refused further treatment|1|||
41956826|NCT01681368|75724425|FG000|Overall Study|Refused further follow up|1|||
41956827|NCT01681212|75724429|FG000|Overall Study|No longer met study criteria|5|||
41956828|NCT01681212|75724429|FG000|Overall Study|Administrative reason by sponsor|1|||
41956829|NCT01687296|75724435|FG000|Overall Study|Lack of Efficacy|1|||
41956830|NCT01687296|75724436|FG001|Overall Study|Lack of Efficacy|1|||
41956831|NCT01687296|75724435|FG000|Overall Study|Protocol Violation|0|||
41956832|NCT01687296|75724436|FG001|Overall Study|Protocol Violation|1|||
41956833|NCT01687296|75724435|FG000|Overall Study|Withdrawal by Subject|6|||
41956834|NCT01687296|75724436|FG001|Overall Study|Withdrawal by Subject|3|||
41956835|NCT01568892|75724457|FG000|Open-label Phase|Adverse Event|2|||
41956836|NCT01568892|75724458|FG001|Open-label Phase|Adverse Event|0|||
41956837|NCT01568892|75724457|FG000|Open-label Phase|Lack of Efficacy|4|||
41956838|NCT01568892|75724458|FG001|Open-label Phase|Lack of Efficacy|2|||
41956839|NCT01568892|75724457|FG000|Open-label Phase|Lost to Follow-up|0|||
41956840|NCT01568892|75724458|FG001|Open-label Phase|Lost to Follow-up|1|||
41956841|NCT01568112|75724469|FG000|Overall Study|Randomized But Not Treated|0|||
41956842|NCT01568112|75724470|FG001|Overall Study|Randomized But Not Treated|1|||
41956843|NCT01568112|75724471|FG002|Overall Study|Randomized But Not Treated|0|||
41956844|NCT01568112|75724472|FG003|Overall Study|Randomized But Not Treated|0|||
41956845|NCT01568112|75724469|FG000|Overall Study|Withdrew due to Adverse Event|2|||
41956846|NCT01568112|75724470|FG001|Overall Study|Withdrew due to Adverse Event|4|||
41956847|NCT01568112|75724471|FG002|Overall Study|Withdrew due to Adverse Event|6|||
41956848|NCT01568112|75724472|FG003|Overall Study|Withdrew due to Adverse Event|3|||
41956849|NCT01568112|75724469|FG000|Overall Study|Lost to Follow-up|0|||
41956850|NCT01568112|75724470|FG001|Overall Study|Lost to Follow-up|0|||
41956851|NCT01568112|75724471|FG002|Overall Study|Lost to Follow-up|0|||
41956852|NCT01568112|75724472|FG003|Overall Study|Lost to Follow-up|1|||
41956853|NCT01568112|75724469|FG000|Overall Study|Withdrawal by Subject|2|||
41956854|NCT01568112|75724470|FG001|Overall Study|Withdrawal by Subject|3|||
41956855|NCT01568112|75724471|FG002|Overall Study|Withdrawal by Subject|0|||
41956856|NCT01568112|75724472|FG003|Overall Study|Withdrawal by Subject|7|||
41956857|NCT01568112|75724469|FG000|Overall Study|Withdrawal by Physician|1|||
41956858|NCT01568112|75724470|FG001|Overall Study|Withdrawal by Physician|0|||
41956859|NCT01568112|75724471|FG002|Overall Study|Withdrawal by Physician|1|||
41956860|NCT01568112|75724472|FG003|Overall Study|Withdrawal by Physician|1|||
41956861|NCT01568034|75724483|FG000|Overall Study|Withdrawal by Subject|1|||
41956862|NCT01568034|75724484|FG001|Overall Study|Withdrawal by Subject|0|||
41956863|NCT01568034|75724485|FG002|Overall Study|Withdrawal by Subject|0|||
41956864|NCT01568034|75724486|FG003|Overall Study|Withdrawal by Subject|0|||
41956865|NCT01687218|75724502|FG000|Overall Study|Withdrawal by Subject|2|||
41956866|NCT01687218|75724503|FG001|Overall Study|Withdrawal by Subject|3|||
41956867|NCT01687218|75724504|FG002|Overall Study|Withdrawal by Subject|0|||
41956868|NCT01687218|75724505|FG003|Overall Study|Withdrawal by Subject|1|||
41956869|NCT01687218|75724506|FG004|Overall Study|Withdrawal by Subject|1|||
41956870|NCT01687218|75724507|FG005|Overall Study|Withdrawal by Subject|0|||
41956871|NCT01687218|75724502|FG000|Overall Study|Relocated, no follow-up planned|1|||
41956872|NCT01687218|75724503|FG001|Overall Study|Relocated, no follow-up planned|0|||
41956873|NCT01687218|75724504|FG002|Overall Study|Relocated, no follow-up planned|1|||
41956874|NCT01687218|75724505|FG003|Overall Study|Relocated, no follow-up planned|1|||
41956875|NCT01687218|75724506|FG004|Overall Study|Relocated, no follow-up planned|0|||
41956876|NCT01687218|75724507|FG005|Overall Study|Relocated, no follow-up planned|0|||
41956877|NCT01686828|75724519|FG000|Overall Study|Physician Decision|1|||
41956878|NCT01686828|75724520|FG001|Overall Study|Physician Decision|0|||
41956879|NCT01686828|75724521|FG002|Overall Study|Physician Decision|0|||
41956880|NCT01686828|75724522|FG003|Overall Study|Physician Decision|0|||
41956881|NCT01686828|75724519|FG000|Overall Study|New Job|0|||
41956882|NCT01686828|75724520|FG001|Overall Study|New Job|1|||
41956883|NCT01686828|75724521|FG002|Overall Study|New Job|0|||
41956884|NCT01686828|75724522|FG003|Overall Study|New Job|0|||
41956885|NCT01686828|75724519|FG000|Overall Study|Weight Loss|0|||
41956886|NCT01686828|75724520|FG001|Overall Study|Weight Loss|0|||
41956887|NCT01686828|75724521|FG002|Overall Study|Weight Loss|1|||
41956888|NCT01686828|75724522|FG003|Overall Study|Weight Loss|0|||
41956889|NCT01686438|75724539|FG000|Overall Study|Lost to Follow-up|8|||
41956890|NCT01686438|75724540|FG001|Overall Study|Lost to Follow-up|9|||
41956891|NCT01686438|75724541|FG002|Overall Study|Lost to Follow-up|10|||
41956892|NCT01686438|75724539|FG000|Overall Study|Adverse Event|0|||
41956893|NCT01686438|75724540|FG001|Overall Study|Adverse Event|0|||
41956894|NCT01686438|75724541|FG002|Overall Study|Adverse Event|1|||
41956895|NCT01686438|75724539|FG000|Overall Study|Protocol Violation|0|||
41956896|NCT01686438|75724540|FG001|Overall Study|Protocol Violation|0|||
41956897|NCT01686438|75724541|FG002|Overall Study|Protocol Violation|1|||
41956898|NCT01686438|75724539|FG000|Overall Study|Withdrawal by Subject|0|||
41956899|NCT01686438|75724540|FG001|Overall Study|Withdrawal by Subject|0|||
41956900|NCT01686438|75724541|FG002|Overall Study|Withdrawal by Subject|1|||
41956901|NCT01593696|75724555|FG000|Dose Escalation|Progressive Disease|2|||
41956902|NCT01593696|75724556|FG001|Dose Escalation|Progressive Disease|0|||
41956903|NCT01593696|75724557|FG002|Dose Escalation|Progressive Disease|0|||
41956904|NCT01593696|75724558|FG003|Dose Escalation|Progressive Disease|0|||
41956905|NCT01593696|75724555|FG000|Dose Expansion|Fungal infection|0|||
41956906|NCT01593696|75724556|FG001|Dose Expansion|Fungal infection|0|||
41956907|NCT01593696|75724557|FG002|Dose Expansion|Fungal infection|1|||
41956908|NCT01593696|75724558|FG003|Dose Expansion|Fungal infection|0|||
41956909|NCT01592760|75724571|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
41956910|NCT01592760|75724572|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
41956911|NCT01592760|75724573|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
41956912|NCT01696188|75724586|FG000|Overall Study|Protocol Violation|1|||
41956913|NCT01696188|75724587|FG001|Overall Study|Protocol Violation|1|||
41956914|NCT01603602|75724596|FG000|Overall Study|Adverse Event|1|||
41956915|NCT01603602|75724597|FG001|Overall Study|Adverse Event|0|||
41956916|NCT01603602|75724598|FG002|Overall Study|Adverse Event|0|||
41956917|NCT01603602|75724596|FG000|Overall Study|Personal Reasons|1|||
41956918|NCT01603602|75724597|FG001|Overall Study|Personal Reasons|0|||
41956919|NCT01603602|75724598|FG002|Overall Study|Personal Reasons|1|||
41956920|NCT01684878|75724610|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
42024243|NCT01179516|75831621|FG002|Overall Study|Other|2|||
41956921|NCT01684878|75724611|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
41956922|NCT01684878|75724612|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
41956923|NCT01684878|75724613|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
41956924|NCT01684878|75724610|FG000|Part 1: Safety Run in Phase|Death|15|||
41956925|NCT01684878|75724611|FG001|Part 1: Safety Run in Phase|Death|20|||
41956926|NCT01684878|75724612|FG002|Part 1: Safety Run in Phase|Death|0|||
41956927|NCT01684878|75724613|FG003|Part 1: Safety Run in Phase|Death|0|||
41956928|NCT01684878|75724610|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
41956929|NCT01684878|75724611|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
41956930|NCT01684878|75724612|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
41956931|NCT01684878|75724613|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
41956932|NCT01684878|75724610|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
41956933|NCT01684878|75724611|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
41956934|NCT01684878|75724612|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
41956935|NCT01684878|75724613|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
41956936|NCT01684878|75724610|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
41956937|NCT01684878|75724611|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
41956938|NCT01684878|75724612|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
41956939|NCT01684878|75724613|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
41956940|NCT01684878|75724610|FG000|Part 2: Randomized Phase|Death|0|||
41956941|NCT01684878|75724611|FG001|Part 2: Randomized Phase|Death|0|||
41956942|NCT01684878|75724612|FG002|Part 2: Randomized Phase|Death|62|||
41956943|NCT01684878|75724613|FG003|Part 2: Randomized Phase|Death|68|||
41956944|NCT01684878|75724610|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
41956945|NCT01684878|75724611|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
41956946|NCT01684878|75724612|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
41956947|NCT01684878|75724613|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
41956948|NCT01684878|75724610|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
41956949|NCT01684878|75724611|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
41956950|NCT01684878|75724612|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
41956951|NCT01684878|75724613|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
41956952|NCT01684722|75724627|FG000|Overall Study|Lost to Follow-up|78|||
41956953|NCT01684722|75724628|FG001|Overall Study|Lost to Follow-up|56|||
41956954|NCT01684722|75724629|FG002|Overall Study|Lost to Follow-up|75|||
41956955|NCT01684722|75724630|FG003|Overall Study|Lost to Follow-up|89|||
41956956|NCT01684722|75724627|FG000|Overall Study|Death|19|||
41956957|NCT01684722|75724628|FG001|Overall Study|Death|21|||
41956958|NCT01684722|75724629|FG002|Overall Study|Death|19|||
41956959|NCT01684722|75724630|FG003|Overall Study|Death|21|||
41956960|NCT01592292|75724647|FG000|Overall Study|Follow-up loss|3|||
41956961|NCT01592292|75724648|FG001|Overall Study|Follow-up loss|3|||
41956962|NCT01592292|75724649|FG002|Overall Study|Follow-up loss|1|||
41956963|NCT01592292|75724650|FG003|Overall Study|Follow-up loss|0|||
41956964|NCT01592292|75724647|FG000|Overall Study|Withdrew consent|2|||
41956965|NCT01592292|75724648|FG001|Overall Study|Withdrew consent|1|||
41956966|NCT01592292|75724649|FG002|Overall Study|Withdrew consent|0|||
41956967|NCT01592292|75724650|FG003|Overall Study|Withdrew consent|0|||
41956968|NCT01592292|75724647|FG000|Overall Study|Other|1|||
41956969|NCT01592292|75724648|FG001|Overall Study|Other|1|||
41956970|NCT01592292|75724649|FG002|Overall Study|Other|2|||
41956971|NCT01592292|75724650|FG003|Overall Study|Other|1|||
41956972|NCT01590888|75724659|FG000|Overall Study|Adverse Event|3|||
41956973|NCT01590888|75724660|FG001|Overall Study|Adverse Event|0|||
41956974|NCT01590888|75724661|FG002|Overall Study|Adverse Event|1|||
41956975|NCT01590888|75724659|FG000|Overall Study|Lost to Follow-up|1|||
41956976|NCT01590888|75724660|FG001|Overall Study|Lost to Follow-up|0|||
41956977|NCT01590888|75724661|FG002|Overall Study|Lost to Follow-up|0|||
41956978|NCT01565928|75724669|FG000|Overall Study|Adverse Event|3|||
41956979|NCT01565928|75724669|FG000|Overall Study|Other|3|||
41956980|NCT01565928|75724669|FG000|Overall Study|Progressive Disease|13|||
41956981|NCT01565928|75724669|FG000|Overall Study|Withdrawal by Subject|1|||
41956982|NCT01565928|75724669|FG000|Overall Study|Death|2|||
41956983|NCT01565850|75724678|FG000|Overall Study|Adverse Event|0|||
41956984|NCT01565850|75724679|FG001|Overall Study|Adverse Event|1|||
41956985|NCT01565850|75724678|FG000|Overall Study|Lost to Follow-up|12|||
41956986|NCT01565850|75724679|FG001|Overall Study|Lost to Follow-up|4|||
41956987|NCT01565850|75724678|FG000|Overall Study|Investigator's Discretion|2|||
41956988|NCT01565850|75724679|FG001|Overall Study|Investigator's Discretion|1|||
41956989|NCT01565850|75724678|FG000|Overall Study|Participant noncompliance|2|||
41956990|NCT01565850|75724679|FG001|Overall Study|Participant noncompliance|0|||
41956991|NCT01565850|75724678|FG000|Overall Study|Withdrew Consent|4|||
41956992|NCT01565850|75724679|FG001|Overall Study|Withdrew Consent|2|||
41956993|NCT01565694|75724685|FG000|Dose-Titration Period|Adverse Event|4|||
41956994|NCT01565694|75724685|FG000|Dose-Titration Period|Protocol Violation|10|||
41956995|NCT01565694|75724685|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
41956996|NCT01543152|75724694|FG000|Overall Study|Withdrawal by Subject|0|||
41956997|NCT01543152|75724695|FG001|Overall Study|Withdrawal by Subject|2|||
41956998|NCT01543152|75724696|FG002|Overall Study|Withdrawal by Subject|0|||
41956999|NCT01543152|75724697|FG003|Overall Study|Withdrawal by Subject|0|||
41957000|NCT01543152|75724698|FG004|Overall Study|Withdrawal by Subject|0|||
41957001|NCT01590810|75724715|FG000|Overall Study|Physician Decision|0|||
41957002|NCT01590810|75724716|FG001|Overall Study|Physician Decision|1|||
41957003|NCT01590810|75724717|FG002|Overall Study|Physician Decision|1|||
41957004|NCT01590810|75724718|FG003|Overall Study|Physician Decision|0|||
41957005|NCT01590810|75724719|FG004|Overall Study|Physician Decision|0|||
41957006|NCT01542528|75724754|FG000|Overall Study|Lost to Follow-up|2|||
41957007|NCT01542528|75724755|FG001|Overall Study|Lost to Follow-up|1|||
41957008|NCT01542528|75724754|FG000|Overall Study|Physician Decision|1|||
41957009|NCT01542528|75724755|FG001|Overall Study|Physician Decision|0|||
41957010|NCT01542528|75724754|FG000|Overall Study|Withdrawal by Subject|9|||
41957011|NCT01542528|75724755|FG001|Overall Study|Withdrawal by Subject|6|||
41957012|NCT01565148|75724765|FG000|Overall Study|Withdrawal by Subject|1|||
41957013|NCT01565148|75724766|FG001|Overall Study|Withdrawal by Subject|1|||
41957014|NCT01565148|75724767|FG002|Overall Study|Withdrawal by Subject|1|||
41957015|NCT01565148|75724768|FG003|Overall Study|Withdrawal by Subject|2|||
41957016|NCT01565148|75724765|FG000|Overall Study|Lost to Follow-up|4|||
41957017|NCT01565148|75724766|FG001|Overall Study|Lost to Follow-up|4|||
41957018|NCT01565148|75724767|FG002|Overall Study|Lost to Follow-up|0|||
41957019|NCT01565148|75724768|FG003|Overall Study|Lost to Follow-up|3|||
41957020|NCT01565148|75724765|FG000|Overall Study|Rescue Therapy|8|||
41957021|NCT01565148|75724766|FG001|Overall Study|Rescue Therapy|5|||
41957022|NCT01565148|75724767|FG002|Overall Study|Rescue Therapy|5|||
41957023|NCT01565148|75724768|FG003|Overall Study|Rescue Therapy|8|||
41957024|NCT01565148|75724765|FG000|Overall Study|Death|0|||
41957025|NCT01565148|75724766|FG001|Overall Study|Death|0|||
41957026|NCT01565148|75724767|FG002|Overall Study|Death|1|||
41957027|NCT01565148|75724768|FG003|Overall Study|Death|0|||
41957028|NCT01565148|75724765|FG000|Overall Study|Physician Decision|2|||
41957029|NCT01565148|75724766|FG001|Overall Study|Physician Decision|5|||
41957030|NCT01565148|75724767|FG002|Overall Study|Physician Decision|0|||
41957031|NCT01565148|75724768|FG003|Overall Study|Physician Decision|0|||
41957032|NCT01564758|75724782|FG000|Overall Study|Death|8|||
41957033|NCT01564758|75724782|FG000|Overall Study|Adverse Event|3|||
41957034|NCT01564758|75724782|FG000|Overall Study|Other|3|||
41957035|NCT01541826|75724789|FG000|Overall Study|Lost to Follow-up|2|||
41957036|NCT01541826|75724790|FG001|Overall Study|Lost to Follow-up|3|||
41957037|NCT01541826|75724791|FG002|Overall Study|Lost to Follow-up|0|||
41957038|NCT01541826|75724789|FG000|Overall Study|Withdrawal by Subject|2|||
41957039|NCT01541826|75724790|FG001|Overall Study|Withdrawal by Subject|0|||
41957040|NCT01541826|75724791|FG002|Overall Study|Withdrawal by Subject|0|||
41957041|NCT01541748|75724799|FG000|Overall Study|Lost to Follow-up|17|||
41957042|NCT01541748|75724799|FG000|Overall Study|Moved out of state|1|||
41957043|NCT01541748|75724799|FG000|Overall Study|Withdrawal by Subject|7|||
41957044|NCT01541748|75724799|FG000|Overall Study|Screen failure|5|||
41957045|NCT01541748|75724799|FG000|Overall Study|Did not receive study device|1|||
41957046|NCT01589094|75724812|FG000|Overall Study|Did not receive treatment|2|||
41957047|NCT01563978|75724818|FG000|Overall Study|Physician Decision|1|||
41957048|NCT01563978|75724819|FG001|Overall Study|Physician Decision|0|||
41957049|NCT01563978|75724818|FG000|Overall Study|Lost to Follow-up|1|||
41957050|NCT01563978|75724819|FG001|Overall Study|Lost to Follow-up|0|||
41957051|NCT01563978|75724818|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
41957052|NCT01563978|75724819|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
41957053|NCT01563978|75724818|FG000|Overall Study|Adverse Event|1|||
41957054|NCT01563978|75724819|FG001|Overall Study|Adverse Event|2|||
41957055|NCT01563354|75724828|FG000|Core Phase|Adverse Event|5|||
41957056|NCT01563354|75724829|FG001|Core Phase|Adverse Event|15|||
41957057|NCT01563354|75724830|FG002|Core Phase|Adverse Event|13|||
41957058|NCT01563354|75724828|FG000|Core Phase|Withdrawal by Subject|1|||
41957059|NCT01563354|75724829|FG001|Core Phase|Withdrawal by Subject|0|||
41957060|NCT01563354|75724830|FG002|Core Phase|Withdrawal by Subject|3|||
41957061|NCT01563354|75724828|FG000|Core Phase|Lost to Follow-up|1|||
41957062|NCT01563354|75724829|FG001|Core Phase|Lost to Follow-up|0|||
41957063|NCT01563354|75724830|FG002|Core Phase|Lost to Follow-up|0|||
41957064|NCT01563354|75724828|FG000|Core Phase|Death|1|||
41957065|NCT01563354|75724829|FG001|Core Phase|Death|5|||
41957066|NCT01563354|75724830|FG002|Core Phase|Death|2|||
41957067|NCT01563354|75724828|FG000|Core Phase|Diseasse progression|18|||
41957068|NCT01563354|75724829|FG001|Core Phase|Diseasse progression|7|||
41957069|NCT01563354|75724830|FG002|Core Phase|Diseasse progression|8|||
41957070|NCT01563354|75724828|FG000|Core Phase|Protocol deviation|2|||
41957071|NCT01563354|75724829|FG001|Core Phase|Protocol deviation|0|||
41957072|NCT01563354|75724830|FG002|Core Phase|Protocol deviation|0|||
41957073|NCT01563354|75724828|FG000|Core Phase|PI decision - did not enter extension|0|||
41957074|NCT01563354|75724829|FG001|Core Phase|PI decision - did not enter extension|1|||
41957075|NCT01563354|75724830|FG002|Core Phase|PI decision - did not enter extension|0|||
41957076|NCT01563354|75724828|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
41957077|NCT01563354|75724829|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
41957078|NCT01563354|75724830|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
41957079|NCT01563354|75724828|FG000|Extension Phase|Adverse Event|0|||
41957080|NCT01563354|75724829|FG001|Extension Phase|Adverse Event|3|||
41957081|NCT01563354|75724830|FG002|Extension Phase|Adverse Event|2|||
41957082|NCT01563354|75724828|FG000|Extension Phase|Withdrawal by Subject|0|||
41957083|NCT01563354|75724829|FG001|Extension Phase|Withdrawal by Subject|1|||
41957084|NCT01563354|75724830|FG002|Extension Phase|Withdrawal by Subject|0|||
41957085|NCT01563354|75724828|FG000|Extension Phase|Administration problems|3|||
41957086|NCT01563354|75724829|FG001|Extension Phase|Administration problems|2|||
41957087|NCT01563354|75724830|FG002|Extension Phase|Administration problems|3|||
41957088|NCT01563354|75724828|FG000|Extension Phase|Disease progression|9|||
41957089|NCT01563354|75724829|FG001|Extension Phase|Disease progression|8|||
41957090|NCT01563354|75724830|FG002|Extension Phase|Disease progression|10|||
41957091|NCT01588548|75724844|FG000|Overall Study|Withdrawal by Subject|0|||
41957092|NCT01588548|75724845|FG001|Overall Study|Withdrawal by Subject|1|||
41957093|NCT01588548|75724846|FG002|Overall Study|Withdrawal by Subject|1|||
41957094|NCT01588548|75724847|FG003|Overall Study|Withdrawal by Subject|1|||
41957095|NCT01588548|75724848|FG004|Overall Study|Withdrawal by Subject|2|||
41957096|NCT01588548|75724849|FG005|Overall Study|Withdrawal by Subject|3|||
41957097|NCT01588548|75724844|FG000|Overall Study|Adverse Event|0|||
41957098|NCT01588548|75724845|FG001|Overall Study|Adverse Event|0|||
41957099|NCT01588548|75724846|FG002|Overall Study|Adverse Event|1|||
41957100|NCT01588548|75724847|FG003|Overall Study|Adverse Event|2|||
41957101|NCT01588548|75724848|FG004|Overall Study|Adverse Event|1|||
41957102|NCT01588548|75724849|FG005|Overall Study|Adverse Event|0|||
41957103|NCT01588548|75724844|FG000|Overall Study|Condition Under Investigation Worsened|3|||
41957104|NCT01588548|75724845|FG001|Overall Study|Condition Under Investigation Worsened|6|||
41957105|NCT01588548|75724846|FG002|Overall Study|Condition Under Investigation Worsened|4|||
41957106|NCT01588548|75724847|FG003|Overall Study|Condition Under Investigation Worsened|4|||
41957107|NCT01588548|75724848|FG004|Overall Study|Condition Under Investigation Worsened|3|||
41957108|NCT01588548|75724849|FG005|Overall Study|Condition Under Investigation Worsened|3|||
41957109|NCT01587924|75724867|FG000|Overall Study|Adverse Event|0|||
41957110|NCT01587924|75724868|FG001|Overall Study|Adverse Event|2|||
41957111|NCT01587924|75724869|FG002|Overall Study|Adverse Event|0|||
41957112|NCT01587924|75724870|FG003|Overall Study|Adverse Event|0|||
41957113|NCT01587924|75724867|FG000|Overall Study|Protocol Violation|2|||
41957114|NCT01587924|75724868|FG001|Overall Study|Protocol Violation|1|||
41957115|NCT01587924|75724869|FG002|Overall Study|Protocol Violation|2|||
41957116|NCT01587924|75724870|FG003|Overall Study|Protocol Violation|1|||
41957117|NCT01587924|75724867|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
41957118|NCT01587924|75724868|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
41957119|NCT01587924|75724869|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
41957120|NCT01587924|75724870|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
41957121|NCT01587924|75724867|FG000|Overall Study|Withdrawal by Subject|0|||
41957122|NCT01587924|75724868|FG001|Overall Study|Withdrawal by Subject|1|||
41957123|NCT01587924|75724869|FG002|Overall Study|Withdrawal by Subject|1|||
41957124|NCT01587924|75724870|FG003|Overall Study|Withdrawal by Subject|0|||
41957125|NCT01539642|75724882|FG000|Overall Study|Lack of Efficacy|20|||
42024244|NCT01018953|75831629|FG000|Overall Study|Adverse Event|2|||
42024245|NCT01018953|75831629|FG000|Overall Study|Withdrawal by Subject|1|||
42024246|NCT01018953|75831629|FG000|Overall Study|Study termination by sponsor|5|||
42024247|NCT01158924|75831636|FG000|Overall Study|Withdrawal by Subject|1|||
41957126|NCT01539642|75724883|FG001|Overall Study|Lack of Efficacy|18|||
41957127|NCT01539642|75724882|FG000|Overall Study|Patient ready for early discharge|8|||
41957128|NCT01539642|75724883|FG001|Overall Study|Patient ready for early discharge|7|||
41957129|NCT01539642|75724882|FG000|Overall Study|Adverse Event|6|||
41957130|NCT01539642|75724883|FG001|Overall Study|Adverse Event|4|||
41957131|NCT01539642|75724882|FG000|Overall Study|Withdrawal by Subject|2|||
41957132|NCT01539642|75724883|FG001|Overall Study|Withdrawal by Subject|2|||
41957133|NCT01586364|75724889|FG000|Overall Study|Withdrawal by Subject|40|||
41957134|NCT01586364|75724889|FG000|Overall Study|Adverse Event|37|||
41957135|NCT01586364|75724889|FG000|Overall Study|Lost to Follow-up|17|||
41957136|NCT01586364|75724889|FG000|Overall Study|Protocol Violation|16|||
41957137|NCT01586364|75724889|FG000|Overall Study|Lack of Efficacy|1|||
41957138|NCT01586364|75724889|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
41957139|NCT01586364|75724889|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
42118045|NCT00689117|75928842|FG002|Overall Study|Dispensing Error|0|||
41957140|NCT01586364|75724889|FG000|Overall Study|Other-Site closure due to PI illness|1|||
41957141|NCT01586364|75724889|FG000|Overall Study|Other-PI discretion, site closing|2|||
41957142|NCT01586364|75724889|FG000|Overall Study|Other-Not specified|1|||
41957143|NCT01538628|75724895|FG000|Overall Study|Withdrawal by Subject|1|||
41957144|NCT01538628|75724896|FG001|Overall Study|Withdrawal by Subject|1|||
41957145|NCT01538628|75724895|FG000|Overall Study|Lost to Follow-up|0|||
41957146|NCT01538628|75724896|FG001|Overall Study|Lost to Follow-up|1|||
41957147|NCT01538472|75724903|FG000|Overall Study|Disease Progression|3|||
41957148|NCT01538472|75724903|FG000|Overall Study|Death|1|||
41957149|NCT01562028|75724909|FG000|Overall Study|Withdrawal by Subject|1|||
41957150|NCT01562028|75724910|FG001|Overall Study|Withdrawal by Subject|1|||
41957151|NCT01562028|75724909|FG000|Overall Study|Lost to Follow-up|2|||
41957152|NCT01562028|75724910|FG001|Overall Study|Lost to Follow-up|1|||
41957153|NCT01585584|75724916|FG000|Overall Study|Lack of Efficacy|1|||
41957154|NCT01585584|75724916|FG000|Overall Study|Withdrawal by Subject|1|||
41957155|NCT01585584|75724916|FG000|Overall Study|Physician Decision|2|||
41957156|NCT01561560|75724920|FG000|First Two Weeks of Wear|Time/job conflict|0|||
41957157|NCT01561560|75724921|FG001|First Two Weeks of Wear|Time/job conflict|1|||
41957158|NCT01561560|75724920|FG000|First Two Weeks of Wear|Adverse Event|0|||
41957159|NCT01561560|75724921|FG001|First Two Weeks of Wear|Adverse Event|1|||
41957160|NCT01561560|75724920|FG000|Second Two Weeks of Wear|Adverse Event|0|||
41957161|NCT01561560|75724921|FG001|Second Two Weeks of Wear|Adverse Event|1|||
41957162|NCT01537068|75724929|FG000|Overall Study|Lost to Follow-up|2|||
41957163|NCT01537068|75724930|FG001|Overall Study|Lost to Follow-up|1|||
41957164|NCT01537068|75724929|FG000|Overall Study|Adverse Event|0|||
41957165|NCT01537068|75724930|FG001|Overall Study|Adverse Event|1|||
41957166|NCT01537068|75724929|FG000|Overall Study|Withdrawal by Subject|1|||
41957167|NCT01537068|75724930|FG001|Overall Study|Withdrawal by Subject|1|||
41957168|NCT01537068|75724929|FG000|Overall Study|Lack of Efficacy|1|||
41957169|NCT01537068|75724930|FG001|Overall Study|Lack of Efficacy|0|||
41957170|NCT01585428|75724938|FG000|Overall Study|Death during treatment|1|||
41957171|NCT01585428|75724939|FG001|Overall Study|Death during treatment|0|||
41957172|NCT01585272|75724946|FG000|Overall Study|Adverse Event|22|||
41957173|NCT01585272|75724946|FG000|Overall Study|Protocol Violation|7|||
41957174|NCT01585272|75724946|FG000|Overall Study|Withdrawal by Subject|10|||
41957175|NCT01560780|75724952|FG000|Overall Study|Death|2|||
41957176|NCT01560780|75724953|FG001|Overall Study|Death|1|||
41957177|NCT01560780|75724952|FG000|Overall Study|Patient Preference|11|||
41957178|NCT01560780|75724953|FG001|Overall Study|Patient Preference|11|||
41957179|NCT01585038|75724961|FG000|Overall Study|Adverse Event|2|||
41957180|NCT01585038|75724962|FG001|Overall Study|Adverse Event|2|||
41957181|NCT01560234|75724976|FG000|Overall Study|Lost to Follow-up|3|||
41957182|NCT01560234|75724977|FG001|Overall Study|Lost to Follow-up|0|||
41957183|NCT01560234|75724978|FG002|Overall Study|Lost to Follow-up|1|||
41957184|NCT01560234|75724979|FG003|Overall Study|Lost to Follow-up|0|||
41957185|NCT01560234|75724980|FG004|Overall Study|Lost to Follow-up|0|||
41957186|NCT01560234|75724981|FG005|Overall Study|Lost to Follow-up|2|||
41957187|NCT01560234|75724982|FG006|Overall Study|Lost to Follow-up|0|||
41957188|NCT01560234|75724983|FG007|Overall Study|Lost to Follow-up|2|||
41957189|NCT01559844|75725001|FG000|Overall Study|Consent Withdrawn|7|||
41957190|NCT01559844|75725001|FG000|Overall Study|Death|5|||
41957191|NCT01559844|75725001|FG000|Overall Study|Efficacy Failure|10|||
41957192|NCT01559844|75725001|FG000|Overall Study|No Longer A Transplant Candidate|3|||
41957193|NCT01584648|75725007|FG000|Overall Study|Death|136|||
41957194|NCT01584648|75725008|FG001|Overall Study|Death|146|||
41957195|NCT01584648|75725007|FG000|Overall Study|Lost to Follow-up|9|||
41957196|NCT01584648|75725008|FG001|Overall Study|Lost to Follow-up|9|||
41957197|NCT01584648|75725007|FG000|Overall Study|Investigator discretion|3|||
41957198|NCT01584648|75725008|FG001|Overall Study|Investigator discretion|2|||
41957199|NCT01584648|75725007|FG000|Overall Study|Withdrew consent|13|||
41957200|NCT01584648|75725008|FG001|Overall Study|Withdrew consent|4|||
42024248|NCT01158924|75831637|FG001|Overall Study|Withdrawal by Subject|2|||
42024249|NCT01158924|75831636|FG000|Overall Study|Lost to Follow-up|0|||
41957201|NCT01584648|75725007|FG000|Overall Study|Study closed/terminated|50|||
41957202|NCT01584648|75725008|FG001|Overall Study|Study closed/terminated|23|||
41957203|NCT01584648|75725007|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
41957204|NCT01584648|75725008|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
41957205|NCT01559454|75725019|FG000|Overall Study|Lost to Follow-up|3|||
41957206|NCT01559454|75725020|FG001|Overall Study|Lost to Follow-up|2|||
42024250|NCT01158924|75831637|FG001|Overall Study|Lost to Follow-up|1|||
41957207|NCT01559454|75725019|FG000|Overall Study|Withdrawal by Subject|0|||
41957208|NCT01559454|75725020|FG001|Overall Study|Withdrawal by Subject|1|||
41957209|NCT01559454|75725019|FG000|Overall Study|Physician Decision|0|||
41957210|NCT01559454|75725020|FG001|Overall Study|Physician Decision|1|||
41957211|NCT01559454|75725019|FG000|Overall Study|Protocol Violation|0|||
41957212|NCT01559454|75725020|FG001|Overall Study|Protocol Violation|1|||
41957213|NCT01559454|75725019|FG000|Overall Study|Lack of Efficacy|0|||
41957214|NCT01559454|75725020|FG001|Overall Study|Lack of Efficacy|1|||
42024251|NCT01027845|75831645|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
41957215|NCT01584024|75725026|FG000|Overall Study|Lost to Follow-up|10|||
41957216|NCT01584024|75725026|FG000|Overall Study|Withdrawal by Subject|3|||
41957217|NCT01583166|75725033|FG000|Overall Study|Withdrawal by Subject|4|||
41957218|NCT01583166|75725034|FG001|Overall Study|Withdrawal by Subject|6|||
41957219|NCT01535274|75725042|FG000|Overall Study|Determined to be ineligible|0|||
41957220|NCT01535274|75725043|FG001|Overall Study|Determined to be ineligible|1|||
41957221|NCT01535274|75725042|FG000|Overall Study|Misallocated to propofol intervention|0|||
41957222|NCT01535274|75725043|FG001|Overall Study|Misallocated to propofol intervention|1|||
41957223|NCT01558752|75725053|FG000|Overall Study|Physician Decision|2|||
41957224|NCT01558752|75725054|FG001|Overall Study|Physician Decision|0|||
41957225|NCT01582854|75725062|FG000|Overall Study|Death|8|||
41957226|NCT01582854|75725063|FG001|Overall Study|Death|5|||
41957227|NCT01582854|75725062|FG000|Overall Study|Adverse Event|2|||
41957228|NCT01582854|75725063|FG001|Overall Study|Adverse Event|3|||
41957229|NCT01582854|75725062|FG000|Overall Study|Withdrawal by Participant|8|||
41957230|NCT01582854|75725063|FG001|Overall Study|Withdrawal by Participant|11|||
41957231|NCT01582854|75725062|FG000|Overall Study|Lost to Follow-up|1|||
41957232|NCT01582854|75725063|FG001|Overall Study|Lost to Follow-up|2|||
41957233|NCT01582854|75725062|FG000|Overall Study|Physician Decision|0|||
41957234|NCT01582854|75725063|FG001|Overall Study|Physician Decision|1|||
41957235|NCT01582854|75725062|FG000|Overall Study|Recurrent Stroke|13|||
41957236|NCT01582854|75725063|FG001|Overall Study|Recurrent Stroke|8|||
41957237|NCT01582854|75725062|FG000|Overall Study|Disallowed Concomitant Medication|3|||
41957238|NCT01582854|75725063|FG001|Overall Study|Disallowed Concomitant Medication|2|||
41957239|NCT01582854|75725062|FG000|Overall Study|Carotid or Neurosurgery|0|||
41957240|NCT01582854|75725063|FG001|Overall Study|Carotid or Neurosurgery|1|||
41957241|NCT01582854|75725062|FG000|Overall Study|General Anaesthesia|0|||
41957242|NCT01582854|75725063|FG001|Overall Study|General Anaesthesia|1|||
41957243|NCT01582854|75725062|FG000|Overall Study|Other Miscellaneous Reason|1|||
41957244|NCT01582854|75725063|FG001|Overall Study|Other Miscellaneous Reason|0|||
41957245|NCT01582308|75725069|FG000|Period 1|Withdrawal by Subject|0|||
41957246|NCT01582308|75725070|FG001|Period 1|Withdrawal by Subject|0|||
41957247|NCT01582308|75725071|FG002|Period 1|Withdrawal by Subject|0|||
41957248|NCT01582308|75725072|FG003|Period 1|Withdrawal by Subject|0|||
41957249|NCT01582308|75725073|FG004|Period 1|Withdrawal by Subject|0|||
41957250|NCT01582308|75725074|FG005|Period 1|Withdrawal by Subject|0|||
41957251|NCT01582308|75725075|FG006|Period 1|Withdrawal by Subject|1|||
41957252|NCT01582308|75725076|FG007|Period 1|Withdrawal by Subject|0|||
41957253|NCT01582308|75725077|FG008|Period 1|Withdrawal by Subject|0|||
41957254|NCT01582308|75725078|FG009|Period 1|Withdrawal by Subject|0|||
41957255|NCT01582308|75725069|FG000|10-day Washout Following Period 1|Physician Decision|0|||
41957256|NCT01582308|75725070|FG001|10-day Washout Following Period 1|Physician Decision|0|||
41957257|NCT01582308|75725071|FG002|10-day Washout Following Period 1|Physician Decision|0|||
41957258|NCT01582308|75725072|FG003|10-day Washout Following Period 1|Physician Decision|0|||
41957259|NCT01582308|75725073|FG004|10-day Washout Following Period 1|Physician Decision|1|||
41957260|NCT01582308|75725074|FG005|10-day Washout Following Period 1|Physician Decision|0|||
41957261|NCT01582308|75725075|FG006|10-day Washout Following Period 1|Physician Decision|0|||
41957262|NCT01582308|75725076|FG007|10-day Washout Following Period 1|Physician Decision|0|||
41957263|NCT01582308|75725077|FG008|10-day Washout Following Period 1|Physician Decision|0|||
41957264|NCT01582308|75725078|FG009|10-day Washout Following Period 1|Physician Decision|0|||
41957265|NCT01582308|75725069|FG000|Period 4|Physician Decision|1|||
41957266|NCT01582308|75725070|FG001|Period 4|Physician Decision|0|||
41957267|NCT01582308|75725071|FG002|Period 4|Physician Decision|0|||
41957268|NCT01582308|75725072|FG003|Period 4|Physician Decision|0|||
41957269|NCT01582308|75725073|FG004|Period 4|Physician Decision|0|||
41957270|NCT01582308|75725074|FG005|Period 4|Physician Decision|1|||
41957271|NCT01582308|75725075|FG006|Period 4|Physician Decision|0|||
41957272|NCT01582308|75725076|FG007|Period 4|Physician Decision|0|||
41957273|NCT01582308|75725077|FG008|Period 4|Physician Decision|0|||
41957274|NCT01582308|75725078|FG009|Period 4|Physician Decision|1|||
41957275|NCT01558674|75725093|FG000|Part 1|Study Terminated by Sponsor|10|||
41957276|NCT01558674|75725094|FG001|Part 1|Study Terminated by Sponsor|0|||
41957277|NCT01558674|75725093|FG000|Part 1|Withdrawal by Subject|1|||
42024252|NCT01027845|75831646|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
41957278|NCT01558674|75725094|FG001|Part 1|Withdrawal by Subject|0|||
41957279|NCT01558596|75725115|FG000|Overall Study|Withdrawal by Subject|1|||
41957280|NCT01558596|75725116|FG001|Overall Study|Withdrawal by Subject|0|||
41957281|NCT01558596|75725115|FG000|Overall Study|surgery elsewhere or cancelled|1|||
41957282|NCT01558596|75725116|FG001|Overall Study|surgery elsewhere or cancelled|1|||
41957283|NCT01558596|75725115|FG000|Overall Study|Protocol Violation|1|||
41957284|NCT01558596|75725116|FG001|Overall Study|Protocol Violation|0|||
41957285|NCT01535040|75725124|FG000|Overall Study|Physician Decision|0|||
41957286|NCT01535040|75725125|FG001|Overall Study|Physician Decision|1|||
41957287|NCT01535040|75725124|FG000|Overall Study|Withdrawal by Subject|13|||
41957288|NCT01535040|75725125|FG001|Overall Study|Withdrawal by Subject|10|||
41957289|NCT01535040|75725124|FG000|Overall Study|Never Started|9|||
41957290|NCT01535040|75725125|FG001|Overall Study|Never Started|4|||
41957291|NCT01535040|75725124|FG000|Overall Study|Toxicity|7|||
41957292|NCT01535040|75725125|FG001|Overall Study|Toxicity|5|||
41957293|NCT01535040|75725124|FG000|Overall Study|Multiple Reasons|1|||
41957294|NCT01535040|75725125|FG001|Overall Study|Multiple Reasons|1|||
41957295|NCT01534962|75725135|FG000|Overall Study|Randomized but did not start treatment|2|||
41957296|NCT01534962|75725136|FG001|Overall Study|Randomized but did not start treatment|0|||
41957297|NCT01534962|75725137|FG002|Overall Study|Randomized but did not start treatment|0|||
41957298|NCT01534962|75725138|FG003|Overall Study|Randomized but did not start treatment|1|||
41957299|NCT01534962|75725135|FG000|Overall Study|Discontinued at AF recurrence|35|||
41957300|NCT01534962|75725136|FG001|Overall Study|Discontinued at AF recurrence|26|||
41957301|NCT01534962|75725137|FG002|Overall Study|Discontinued at AF recurrence|24|||
41957302|NCT01534962|75725138|FG003|Overall Study|Discontinued at AF recurrence|31|||
41957303|NCT01582152|75725150|FG000|Overall Study|Disease Progression|4|||
41957304|NCT01582152|75725151|FG001|Overall Study|Disease Progression|5|||
41957305|NCT01582152|75725150|FG000|Overall Study|Adverse Event|2|||
41957306|NCT01582152|75725151|FG001|Overall Study|Adverse Event|1|||
41957307|NCT01581684|75725167|FG000|Overall Study|Other reason not defined|0|||
41957308|NCT01581684|75725168|FG001|Overall Study|Other reason not defined|0|||
41957309|NCT01581684|75725169|FG002|Overall Study|Other reason not defined|0|||
41957310|NCT01581684|75725170|FG003|Overall Study|Other reason not defined|0|||
41957311|NCT01581684|75725171|FG004|Overall Study|Other reason not defined|0|||
41957312|NCT01581684|75725172|FG005|Overall Study|Other reason not defined|0|||
41957313|NCT01581684|75725173|FG006|Overall Study|Other reason not defined|0|||
41957314|NCT01581684|75725174|FG007|Overall Study|Other reason not defined|0|||
41957315|NCT01581684|75725175|FG008|Overall Study|Other reason not defined|1|||
41957316|NCT01581684|75725176|FG009|Overall Study|Other reason not defined|0|||
41957317|NCT01557582|75725209|FG000|Overall Study|Protocol Violation|4|||
41957318|NCT01557582|75725209|FG000|Overall Study|Operator error|2|||
41957319|NCT01557504|75725215|FG000|Overall Study|Physician Decision|1|||
41957320|NCT01557504|75725216|FG001|Overall Study|Physician Decision|0|||
41957321|NCT01557348|75725230|FG000|Overall Study|Adverse Event|6|||
41957322|NCT01557348|75725231|FG001|Overall Study|Adverse Event|16|||
41957323|NCT01557348|75725230|FG000|Overall Study|Infusion reaction event|5|||
41957324|NCT01557348|75725231|FG001|Overall Study|Infusion reaction event|5|||
41957325|NCT01557348|75725230|FG000|Overall Study|Death|7|||
41957326|NCT01557348|75725231|FG001|Overall Study|Death|4|||
41957327|NCT01557348|75725230|FG000|Overall Study|Insufficient Therapeutic Response|13|||
41957328|NCT01557348|75725231|FG001|Overall Study|Insufficient Therapeutic Response|28|||
41957329|NCT01557348|75725230|FG000|Overall Study|Withdrawal by Subject|5|||
41957330|NCT01557348|75725231|FG001|Overall Study|Withdrawal by Subject|4|||
41957331|NCT01557348|75725230|FG000|Overall Study|Lost to Follow-up|26|||
41957332|NCT01557348|75725231|FG001|Overall Study|Lost to Follow-up|22|||
41957333|NCT01557348|75725230|FG000|Overall Study|Administrative|18|||
41957334|NCT01557348|75725231|FG001|Overall Study|Administrative|11|||
41957335|NCT01580670|75725238|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
41957336|NCT01580670|75725238|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
41957337|NCT01534260|75725244|FG000|Overall Study|Adverse Event|1|||
41957338|NCT01534260|75725245|FG001|Overall Study|Adverse Event|8|||
41957339|NCT01534260|75725244|FG000|Overall Study|Death|2|||
41957340|NCT01534260|75725245|FG001|Overall Study|Death|0|||
41957341|NCT01534260|75725244|FG000|Overall Study|Lack of Efficacy|1|||
41957342|NCT01534260|75725245|FG001|Overall Study|Lack of Efficacy|1|||
41957343|NCT01534260|75725244|FG000|Overall Study|Withdrawal by Subject|1|||
41957344|NCT01534260|75725245|FG001|Overall Study|Withdrawal by Subject|3|||
41957345|NCT01534260|75725244|FG000|Overall Study|Disease Progression|8|||
41957346|NCT01534260|75725245|FG001|Overall Study|Disease Progression|6|||
41957347|NCT01534260|75725244|FG000|Overall Study|Physician Decision|3|||
41957348|NCT01534260|75725245|FG001|Overall Study|Physician Decision|1|||
41957349|NCT01534260|75725244|FG000|Overall Study|No treatment, per protocol|0|||
41957350|NCT01534260|75725245|FG001|Overall Study|No treatment, per protocol|1|||
41957351|NCT01534182|75725253|FG000|Overall Study|Administrative problems|1|||
41957352|NCT01534182|75725254|FG001|Overall Study|Administrative problems|0|||
41957353|NCT01534182|75725253|FG000|Overall Study|Withdrawal by Subject|4|||
41957354|NCT01534182|75725254|FG001|Overall Study|Withdrawal by Subject|7|||
41957355|NCT01534182|75725253|FG000|Overall Study|Adverse Event|7|||
41957356|NCT01534182|75725254|FG001|Overall Study|Adverse Event|3|||
41957357|NCT01579812|75725261|FG000|Overall Study|Ineligible after treatment start|40|||
41957358|NCT01579812|75725261|FG000|Overall Study|Patient choice|3|||
41957359|NCT01579812|75725261|FG000|Overall Study|Noncompliance|3|||
41957360|NCT01579812|75725261|FG000|Overall Study|Withdrawal by Subject|6|||
41957361|NCT01533714|75725274|FG000|Overall Study|Adverse Event|0|||
41957362|NCT01533714|75725275|FG001|Overall Study|Adverse Event|1|||
41957363|NCT01533714|75725276|FG002|Overall Study|Adverse Event|2|||
41957364|NCT01533714|75725277|FG003|Overall Study|Adverse Event|2|||
41957365|NCT01533714|75725278|FG004|Overall Study|Adverse Event|2|||
41957366|NCT01533714|75725279|FG005|Overall Study|Adverse Event|1|||
41957367|NCT01533714|75725274|FG000|Overall Study|Lack of Efficacy|0|||
41957368|NCT01533714|75725275|FG001|Overall Study|Lack of Efficacy|0|||
41957369|NCT01533714|75725276|FG002|Overall Study|Lack of Efficacy|0|||
41957370|NCT01533714|75725277|FG003|Overall Study|Lack of Efficacy|0|||
41957371|NCT01533714|75725278|FG004|Overall Study|Lack of Efficacy|0|||
41957372|NCT01533714|75725279|FG005|Overall Study|Lack of Efficacy|1|||
41957373|NCT01533714|75725274|FG000|Overall Study|Withdrawal by Subject|0|||
41957374|NCT01533714|75725275|FG001|Overall Study|Withdrawal by Subject|1|||
41957375|NCT01533714|75725276|FG002|Overall Study|Withdrawal by Subject|0|||
41957376|NCT01533714|75725277|FG003|Overall Study|Withdrawal by Subject|1|||
41957377|NCT01533714|75725278|FG004|Overall Study|Withdrawal by Subject|1|||
41957378|NCT01533714|75725279|FG005|Overall Study|Withdrawal by Subject|0|||
41957379|NCT01533714|75725274|FG000|Overall Study|Exclusion criteria|0|||
41957380|NCT01533714|75725275|FG001|Overall Study|Exclusion criteria|1|||
41957381|NCT01533714|75725276|FG002|Overall Study|Exclusion criteria|0|||
41957382|NCT01533714|75725277|FG003|Overall Study|Exclusion criteria|0|||
41957383|NCT01533714|75725278|FG004|Overall Study|Exclusion criteria|0|||
41957384|NCT01533714|75725279|FG005|Overall Study|Exclusion criteria|0|||
41957385|NCT01533714|75725274|FG000|Overall Study|Positive for purified protein derivative|0|||
41957386|NCT01533714|75725275|FG001|Overall Study|Positive for purified protein derivative|0|||
41957387|NCT01533714|75725276|FG002|Overall Study|Positive for purified protein derivative|1|||
41957388|NCT01533714|75725277|FG003|Overall Study|Positive for purified protein derivative|0|||
41957389|NCT01533714|75725278|FG004|Overall Study|Positive for purified protein derivative|1|||
41957390|NCT01533714|75725279|FG005|Overall Study|Positive for purified protein derivative|0|||
41957391|NCT01533714|75725274|FG000|Overall Study|Withdrawal criteria|0|||
41957392|NCT01533714|75725275|FG001|Overall Study|Withdrawal criteria|0|||
41957393|NCT01533714|75725276|FG002|Overall Study|Withdrawal criteria|1|||
41957394|NCT01533714|75725277|FG003|Overall Study|Withdrawal criteria|0|||
41957395|NCT01533714|75725278|FG004|Overall Study|Withdrawal criteria|3|||
41957396|NCT01533714|75725279|FG005|Overall Study|Withdrawal criteria|1|||
41957397|NCT01533714|75725274|FG000|Overall Study|Ineligibility reason|0|||
41957398|NCT01533714|75725275|FG001|Overall Study|Ineligibility reason|0|||
41957399|NCT01533714|75725276|FG002|Overall Study|Ineligibility reason|0|||
41957400|NCT01533714|75725277|FG003|Overall Study|Ineligibility reason|1|||
41957401|NCT01533714|75725278|FG004|Overall Study|Ineligibility reason|0|||
41957402|NCT01533714|75725279|FG005|Overall Study|Ineligibility reason|0|||
41957403|NCT01533246|75725293|FG000|Overall Study|Adverse Event|1|||
41957404|NCT01533246|75725293|FG000|Overall Study|Withdrawal by Subject|1|||
41957405|NCT01579578|75725299|FG000|Overall Study|Death|4|||
41957406|NCT01579578|75725300|FG001|Overall Study|Death|1|||
41957407|NCT01579578|75725299|FG000|Overall Study|Lost to Follow-up|1|||
41957408|NCT01579578|75725300|FG001|Overall Study|Lost to Follow-up|1|||
41957409|NCT01579578|75725299|FG000|Overall Study|Withdrawal by Subject|2|||
41957410|NCT01579578|75725300|FG001|Overall Study|Withdrawal by Subject|1|||
42300478|NCT02325219|76135655|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
42300479|NCT02325219|76135656|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
41957411|NCT01579578|75725299|FG000|Overall Study|Eligibility criteria|3|||
41957412|NCT01579578|75725300|FG001|Overall Study|Eligibility criteria|9|||
41957413|NCT01579578|75725299|FG000|Overall Study|Ongoing|3|||
41957414|NCT01579578|75725300|FG001|Overall Study|Ongoing|0|||
41957415|NCT01578486|75725306|FG000|Overall Study|Physician Decision|3|||
41957416|NCT01578486|75725306|FG000|Overall Study|Withdrawal by Subject|2|||
41957417|NCT01532934|75725312|FG000|Overall Study|Lost to Follow-up|11|||
41957418|NCT01532934|75725313|FG001|Overall Study|Lost to Follow-up|11|||
41957419|NCT01532934|75725312|FG000|Overall Study|In controlled environment|3|||
41957420|NCT01532934|75725313|FG001|Overall Study|In controlled environment|2|||
41957421|NCT01555164|75725323|FG000|Overall Study|Adverse Event|5|||
41957422|NCT01555164|75725324|FG001|Overall Study|Adverse Event|7|||
41957423|NCT01555164|75725323|FG000|Overall Study|Hyperglycemia|0|||
41957424|NCT01555164|75725324|FG001|Overall Study|Hyperglycemia|1|||
42024253|NCT01027845|75831647|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
42024254|NCT01027845|75831648|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
42024255|NCT01027845|75831645|FG000|Primary Vaccination Phase|Adverse Event|1|||
42024256|NCT01027845|75831646|FG001|Primary Vaccination Phase|Adverse Event|0|||
42024257|NCT01027845|75831647|FG002|Primary Vaccination Phase|Adverse Event|0|||
42024258|NCT01027845|75831648|FG003|Primary Vaccination Phase|Adverse Event|0|||
41957425|NCT01555164|75725323|FG000|Overall Study|Investigator's Discretion|2|||
41957426|NCT01555164|75725324|FG001|Overall Study|Investigator's Discretion|2|||
42024259|NCT01027845|75831645|FG000|Primary Vaccination Phase|Protocol Violation|1|||
42024260|NCT01027845|75831646|FG001|Primary Vaccination Phase|Protocol Violation|0|||
41957427|NCT01555164|75725323|FG000|Overall Study|Lost to Follow-up|4|||
41957428|NCT01555164|75725324|FG001|Overall Study|Lost to Follow-up|3|||
41957429|NCT01555164|75725323|FG000|Overall Study|Protocol Violation|9|||
41957430|NCT01555164|75725324|FG001|Overall Study|Protocol Violation|5|||
41957431|NCT01555164|75725323|FG000|Overall Study|Subject Non-compliance|14|||
41957432|NCT01555164|75725324|FG001|Overall Study|Subject Non-compliance|6|||
41957433|NCT01555164|75725323|FG000|Overall Study|Subject Withdrew Consent|6|||
41957434|NCT01555164|75725324|FG001|Overall Study|Subject Withdrew Consent|11|||
41957435|NCT01578330|75725330|FG000|Overall Study|Adverse Event|2|||
41957436|NCT01578330|75725330|FG000|Overall Study|Protocol Violation|5|||
41957437|NCT01577160|75725334|FG000|Overall Study|Adverse Event|9|||
41957438|NCT01577160|75725334|FG000|Overall Study|Lack of Efficacy|15|||
41957439|NCT01577160|75725334|FG000|Overall Study|Lost to Follow-up|40|||
41957440|NCT01577160|75725334|FG000|Overall Study|Withdrawal by Subject|18|||
41957441|NCT01577160|75725334|FG000|Overall Study|Subject Uncooperative|7|||
41957442|NCT01577160|75725334|FG000|Overall Study|Other|9|||
41957443|NCT01554618|75725340|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
41957444|NCT01554618|75725341|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
41957445|NCT01554618|75725340|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
41957446|NCT01554618|75725341|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
41957447|NCT01554618|75725340|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
41957448|NCT01554618|75725341|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
41957449|NCT01554618|75725340|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
41957450|NCT01554618|75725341|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
41957451|NCT01554618|75725340|FG000|Open-Label Extension Period|Physician Decision|0|||
41957452|NCT01554618|75725341|FG001|Open-Label Extension Period|Physician Decision|1|||
41957453|NCT01554618|75725340|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
41957454|NCT01554618|75725341|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
41957455|NCT01531998|75725351|FG000|Overall Study|Withdrawal by Subject|3|||
41957456|NCT01576146|75725355|FG000|Extension Period 1|Adverse Event|2|||
41957457|NCT01576146|75725355|FG000|Extension Period 1|Death|2|||
41957458|NCT01576146|75725355|FG000|Extension Period 1|Physician Decision|2|||
41957459|NCT01576146|75725355|FG000|Extension Period 1|Withdrawal by Subject|1|||
41957460|NCT01576146|75725355|FG000|Extension Period 1|Lost to Follow-up|1|||
41957461|NCT01576146|75725355|FG000|Extension Period 1|Parathyroidectomy|1|||
41957462|NCT01576146|75725355|FG000|Extension Period 1|Renal Transplant|1|||
41957463|NCT01576146|75725355|FG000|Extension Period 2|Sponsor Decision|13|||
41957464|NCT01576146|75725355|FG000|Extension Period 2|Death|1|||
41957465|NCT01576146|75725355|FG000|Extension Period 2|Adverse Event|1|||
41957466|NCT01576146|75725355|FG000|Extension Period 2|Renal Transplant|1|||
41957467|NCT01576146|75725355|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
41957468|NCT01553916|75725359|FG000|Overall Study|Withdrawal by Subject|2|||
41957469|NCT01553916|75725359|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
41957470|NCT01553136|75725365|FG000|Overall Study|Adverse Event|3|||
41957471|NCT01553136|75725366|FG001|Overall Study|Adverse Event|2|||
41957472|NCT01553136|75725365|FG000|Overall Study|Withdrawal by Subject|2|||
41957473|NCT01553136|75725366|FG001|Overall Study|Withdrawal by Subject|3|||
41957474|NCT01553136|75725365|FG000|Overall Study|Lost to Follow-up|4|||
41957475|NCT01553136|75725366|FG001|Overall Study|Lost to Follow-up|10|||
41957476|NCT01553136|75725365|FG000|Overall Study|Physician Decision|2|||
41957477|NCT01553136|75725366|FG001|Overall Study|Physician Decision|3|||
41957478|NCT01553136|75725365|FG000|Overall Study|Scheduling Difficulties|5|||
41957479|NCT01553136|75725366|FG001|Overall Study|Scheduling Difficulties|4|||
41957480|NCT01552902|75725375|FG000|Overall Study|Adverse Event|1|||
41957481|NCT01552902|75725376|FG001|Overall Study|Adverse Event|15|||
41957482|NCT01552902|75725377|FG002|Overall Study|Adverse Event|14|||
41957483|NCT01552902|75725375|FG000|Overall Study|Protocol Violation|3|||
41957484|NCT01552902|75725376|FG001|Overall Study|Protocol Violation|3|||
41957485|NCT01552902|75725377|FG002|Overall Study|Protocol Violation|3|||
41957486|NCT01552902|75725375|FG000|Overall Study|Lack of Efficacy|4|||
41957487|NCT01552902|75725376|FG001|Overall Study|Lack of Efficacy|3|||
41957488|NCT01552902|75725377|FG002|Overall Study|Lack of Efficacy|1|||
41957489|NCT01552902|75725375|FG000|Overall Study|Withdrawal by Subject|1|||
42024261|NCT01027845|75831647|FG002|Primary Vaccination Phase|Protocol Violation|0|||
42024262|NCT01027845|75831648|FG003|Primary Vaccination Phase|Protocol Violation|0|||
42024263|NCT01027845|75831645|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
42024264|NCT01027845|75831646|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
42024265|NCT01027845|75831647|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
42024266|NCT01027845|75831648|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
41957490|NCT01552902|75725376|FG001|Overall Study|Withdrawal by Subject|9|||
41957491|NCT01552902|75725377|FG002|Overall Study|Withdrawal by Subject|6|||
41957492|NCT01552902|75725375|FG000|Overall Study|Lost to Follow-up|1|||
41957493|NCT01552902|75725376|FG001|Overall Study|Lost to Follow-up|3|||
41957494|NCT01552902|75725377|FG002|Overall Study|Lost to Follow-up|6|||
41957495|NCT01552902|75725375|FG000|Overall Study|Other|3|||
41957496|NCT01552902|75725376|FG001|Overall Study|Other|4|||
41957497|NCT01552902|75725377|FG002|Overall Study|Other|3|||
41957498|NCT01529346|75725403|FG000|Overall Study|Lost to Follow-up|2|||
41957499|NCT01529346|75725404|FG001|Overall Study|Lost to Follow-up|0|||
41957500|NCT01529346|75725405|FG002|Overall Study|Lost to Follow-up|1|||
41957501|NCT01529346|75725406|FG003|Overall Study|Lost to Follow-up|0|||
41957502|NCT01529346|75725407|FG004|Overall Study|Lost to Follow-up|0|||
41957503|NCT01529346|75725403|FG000|Overall Study|Other|0|||
41957504|NCT01529346|75725404|FG001|Overall Study|Other|1|||
41957505|NCT01529346|75725405|FG002|Overall Study|Other|1|||
41957506|NCT01529346|75725406|FG003|Overall Study|Other|0|||
41957507|NCT01529346|75725407|FG004|Overall Study|Other|0|||
41957508|NCT01529268|75725431|FG000|Overall Study|Lost to Follow-up|9|||
41957509|NCT01529268|75725432|FG001|Overall Study|Lost to Follow-up|3|||
41957510|NCT01529268|75725431|FG000|Overall Study|Moved|3|||
41957511|NCT01529268|75725432|FG001|Overall Study|Moved|0|||
41957512|NCT01529112|75725440|FG000|Overall Study|Adverse Event|2|||
41957513|NCT01529112|75725441|FG001|Overall Study|Adverse Event|0|||
41957514|NCT01529112|75725440|FG000|Overall Study|Death|59|||
41957515|NCT01529112|75725441|FG001|Overall Study|Death|38|||
41957516|NCT01529112|75725440|FG000|Overall Study|Protocol Violation|1|||
41957517|NCT01529112|75725441|FG001|Overall Study|Protocol Violation|0|||
41957518|NCT01529112|75725440|FG000|Overall Study|Withdrawal by Subject|7|||
41957519|NCT01529112|75725441|FG001|Overall Study|Withdrawal by Subject|3|||
41957520|NCT01551420|75725449|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
41957521|NCT01551420|75725450|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
41957522|NCT01551420|75725449|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
41957523|NCT01551420|75725450|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
41957524|NCT01551420|75725449|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
41957525|NCT01551420|75725450|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
41957526|NCT01551420|75725449|FG000|Screened for Part B Eligibility|Declined participation|8|||
41957527|NCT01551420|75725450|FG001|Screened for Part B Eligibility|Declined participation|1|||
41957528|NCT01551420|75725449|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
41957529|NCT01551420|75725450|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
41957530|NCT01551420|75725449|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
41957531|NCT01551420|75725450|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
41957532|NCT01551420|75725449|FG000|Home Use (Part B)|Withdrawal by staff|0|||
41957533|NCT01551420|75725450|FG001|Home Use (Part B)|Withdrawal by staff|1|||
41957534|NCT01575054|75725458|FG000|Overall Study|Other Reasons|5|||
41957535|NCT01575054|75725459|FG001|Overall Study|Other Reasons|3|||
41957536|NCT01575054|75725458|FG000|Overall Study|Protocol Violation|2|||
41957537|NCT01575054|75725459|FG001|Overall Study|Protocol Violation|1|||
42024267|NCT01027845|75831645|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
41957538|NCT01575054|75725458|FG000|Overall Study|Personal Reasons|10|||
41957539|NCT01575054|75725459|FG001|Overall Study|Personal Reasons|11|||
41957540|NCT01575054|75725458|FG000|Overall Study|Lost to Follow-up|3|||
41957541|NCT01575054|75725459|FG001|Overall Study|Lost to Follow-up|3|||
41957542|NCT01575054|75725458|FG000|Overall Study|Adverse Event|9|||
41957543|NCT01575054|75725459|FG001|Overall Study|Adverse Event|8|||
41957544|NCT01528254|75725467|FG000|Overall Study|Administrative problems|96|||
41957545|NCT01528254|75725468|FG001|Overall Study|Administrative problems|94|||
41957546|NCT01528254|75725467|FG000|Overall Study|Adverse Event|28|||
41957547|NCT01528254|75725468|FG001|Overall Study|Adverse Event|44|||
41957548|NCT01528254|75725467|FG000|Overall Study|Lost to Follow-up|17|||
41957549|NCT01528254|75725468|FG001|Overall Study|Lost to Follow-up|24|||
41957550|NCT01528254|75725467|FG000|Overall Study|Death|13|||
41957551|NCT01528254|75725468|FG001|Overall Study|Death|9|||
41957552|NCT01528254|75725467|FG000|Overall Study|Protocol deviation|9|||
41957553|NCT01528254|75725468|FG001|Overall Study|Protocol deviation|19|||
41957554|NCT01528254|75725467|FG000|Overall Study|New therapy for study indication|8|||
41957555|NCT01528254|75725468|FG001|Overall Study|New therapy for study indication|6|||
41957556|NCT01528254|75725467|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
41957557|NCT01528254|75725468|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
41957558|NCT01528254|75725467|FG000|Overall Study|Withdrawal by Subject|5|||
41957559|NCT01528254|75725468|FG001|Overall Study|Withdrawal by Subject|4|||
42024268|NCT01027845|75831646|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
42024269|NCT01027845|75831647|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
42024270|NCT01027845|75831648|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
42024271|NCT01027845|75831645|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
42024272|NCT01027845|75831646|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
42024273|NCT01027845|75831647|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
42024274|NCT01027845|75831648|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
42024275|NCT01017549|75831657|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
42024276|NCT01017549|75831657|FG000|One-year Follow-up|Lost to Follow-up|2|||
42024277|NCT01017549|75831657|FG000|One-year Follow-up|Withdrawal by Subject|5|||
42024278|NCT01017549|75831657|FG000|5 Year Follow-up|Lost to Follow-up|9|||
42024279|NCT01017549|75831657|FG000|5 Year Follow-up|Mastectomy|3|||
42024280|NCT01030341|75831661|FG000|Overall Study|Withdrawal by Subject|1|||
42024281|NCT01030341|75831661|FG000|Overall Study|Lost to Follow-up|2|||
42024282|NCT01026831|75831667|FG000|Overall Study|Adverse Event|4|||
42024283|NCT01026831|75831668|FG001|Overall Study|Adverse Event|3|||
42024284|NCT01026831|75831667|FG000|Overall Study|Lost to Follow-up|2|||
42024285|NCT01026831|75831668|FG001|Overall Study|Lost to Follow-up|0|||
42024286|NCT01026831|75831667|FG000|Overall Study|Physician Decision|1|||
42024287|NCT01026831|75831668|FG001|Overall Study|Physician Decision|1|||
42024288|NCT01026831|75831667|FG000|Overall Study|Protocol Violation|0|||
42024289|NCT01026831|75831668|FG001|Overall Study|Protocol Violation|2|||
42024290|NCT01026831|75831667|FG000|Overall Study|Withdrawal by Subject|7|||
42024291|NCT01026831|75831668|FG001|Overall Study|Withdrawal by Subject|5|||
42024292|NCT01016067|75831676|FG000|Overall Study|Lost to Follow-up|1|||
42024293|NCT01016067|75831677|FG001|Overall Study|Lost to Follow-up|2|||
42024294|NCT01016067|75831676|FG000|Overall Study|Physician Decision|1|||
42024295|NCT01016067|75831677|FG001|Overall Study|Physician Decision|1|||
42024296|NCT01016067|75831676|FG000|Overall Study|Withdrew due to Relocation|0|||
42024297|NCT01016067|75831677|FG001|Overall Study|Withdrew due to Relocation|1|||
42024298|NCT01015833|75831685|FG000|Overall Study|Death|1|||
42024299|NCT01015833|75831686|FG001|Overall Study|Death|0|||
42024300|NCT01015833|75831685|FG000|Overall Study|Withdrawal by Subject|3|||
42024301|NCT01015833|75831686|FG001|Overall Study|Withdrawal by Subject|2|||
42024302|NCT01015833|75831685|FG000|Overall Study|Adverse Event|0|||
42024303|NCT01015833|75831686|FG001|Overall Study|Adverse Event|1|||
42024304|NCT01015833|75831685|FG000|Overall Study|Physician Decision|2|||
42024305|NCT01015833|75831686|FG001|Overall Study|Physician Decision|0|||
42024306|NCT01015833|75831685|FG000|Overall Study|Symptomatic deterioration|0|||
42024307|NCT01015833|75831686|FG001|Overall Study|Symptomatic deterioration|1|||
42024308|NCT01015833|75831685|FG000|Overall Study|Other|5|||
42024309|NCT01015833|75831686|FG001|Overall Study|Other|1|||
42024310|NCT01015833|75831685|FG000|Overall Study|Motor Vehicle Accidents|1|||
42024311|NCT01015833|75831686|FG001|Overall Study|Motor Vehicle Accidents|0|||
41957560|NCT01528254|75725467|FG000|Overall Study|Abnormal laboratory value(s)|3|||
41957561|NCT01528254|75725468|FG001|Overall Study|Abnormal laboratory value(s)|7|||
41957562|NCT01528254|75725467|FG000|Overall Study|Abnormal test procedure result(s)|1|||
41957563|NCT01528254|75725468|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42024312|NCT01015833|75831685|FG000|Overall Study|Did not start treatment|1|||
42024313|NCT01015833|75831686|FG001|Overall Study|Did not start treatment|0|||
41957564|NCT01528254|75725467|FG000|Overall Study|No longer requires study drug|1|||
41957565|NCT01528254|75725468|FG001|Overall Study|No longer requires study drug|1|||
41957566|NCT01574352|75725477|FG000|Overall Study|Withdrawal by Subject|6|||
41957567|NCT01574352|75725478|FG001|Overall Study|Withdrawal by Subject|13|||
41957568|NCT01574352|75725477|FG000|Overall Study|Injury in non-camp related sport|1|||
42024314|NCT01015677|75831704|FG000|Overall Study|Adverse Event|0|||
42024315|NCT01015677|75831705|FG001|Overall Study|Adverse Event|1|||
42024316|NCT01015677|75831706|FG002|Overall Study|Adverse Event|0|||
42024317|NCT01015677|75831704|FG000|Overall Study|Lack of Efficacy|0|||
42024318|NCT01015677|75831705|FG001|Overall Study|Lack of Efficacy|1|||
42024319|NCT01015677|75831706|FG002|Overall Study|Lack of Efficacy|0|||
42024320|NCT01015677|75831704|FG000|Overall Study|Protocol Violation|0|||
42024321|NCT01015677|75831705|FG001|Overall Study|Protocol Violation|1|||
41957569|NCT01574352|75725478|FG001|Overall Study|Injury in non-camp related sport|0|||
41957570|NCT01527006|75725486|FG000|Core Study|Adverse Event|0|||
41957571|NCT01527006|75725487|FG001|Core Study|Adverse Event|2|||
41957572|NCT01527006|75725486|FG000|Core Study|Lost to Follow-up|0|||
41957573|NCT01527006|75725487|FG001|Core Study|Lost to Follow-up|1|||
41957574|NCT01527006|75725486|FG000|Core Study|Subject Choice|1|||
41957575|NCT01527006|75725487|FG001|Core Study|Subject Choice|0|||
41957576|NCT01527006|75725486|FG000|Core Study|Inadequate Therapeutic Effect|1|||
41957577|NCT01527006|75725487|FG001|Core Study|Inadequate Therapeutic Effect|0|||
41957578|NCT01527006|75725486|FG000|Core Study|Withdrawal by Subject|0|||
41957579|NCT01527006|75725487|FG001|Core Study|Withdrawal by Subject|1|||
41957580|NCT01527006|75725486|FG000|Core Study|Other|0|||
41957581|NCT01527006|75725487|FG001|Core Study|Other|2|||
41957582|NCT01527006|75725486|FG000|Extension Phase|Adverse Event|4|||
41957583|NCT01527006|75725487|FG001|Extension Phase|Adverse Event|2|||
41957584|NCT01527006|75725486|FG000|Extension Phase|Lost to Follow-up|0|||
41957585|NCT01527006|75725487|FG001|Extension Phase|Lost to Follow-up|1|||
41957586|NCT01527006|75725486|FG000|Extension Phase|Subject Choice|1|||
41957587|NCT01527006|75725487|FG001|Extension Phase|Subject Choice|1|||
41957588|NCT01527006|75725486|FG000|Extension Phase|Inadequate therapeutic effect|1|||
41957589|NCT01527006|75725487|FG001|Extension Phase|Inadequate therapeutic effect|1|||
41957590|NCT01527006|75725486|FG000|Extension Phase|Other|0|||
41957591|NCT01527006|75725487|FG001|Extension Phase|Other|3|||
41957592|NCT01526928|75725505|FG000|Overall Study|Progressive Disease|35|||
41957593|NCT01526928|75725506|FG001|Overall Study|Progressive Disease|17|||
41957594|NCT01526928|75725507|FG002|Overall Study|Progressive Disease|150|||
41957595|NCT01526928|75725508|FG003|Overall Study|Progressive Disease|182|||
41957596|NCT01526928|75725509|FG004|Overall Study|Progressive Disease|76|||
41957597|NCT01526928|75725510|FG005|Overall Study|Progressive Disease|4|||
41957598|NCT01526928|75725505|FG000|Overall Study|Adverse Event|2|||
41957599|NCT01526928|75725506|FG001|Overall Study|Adverse Event|1|||
41957600|NCT01526928|75725507|FG002|Overall Study|Adverse Event|29|||
41957601|NCT01526928|75725508|FG003|Overall Study|Adverse Event|40|||
41957602|NCT01526928|75725509|FG004|Overall Study|Adverse Event|13|||
41957603|NCT01526928|75725510|FG005|Overall Study|Adverse Event|2|||
41957604|NCT01526928|75725505|FG000|Overall Study|Death|0|||
41957605|NCT01526928|75725506|FG001|Overall Study|Death|0|||
41957606|NCT01526928|75725507|FG002|Overall Study|Death|3|||
41957607|NCT01526928|75725508|FG003|Overall Study|Death|0|||
41957608|NCT01526928|75725509|FG004|Overall Study|Death|0|||
41957609|NCT01526928|75725510|FG005|Overall Study|Death|0|||
41957610|NCT01526928|75725505|FG000|Overall Study|Withdrawal by Subject|1|||
41957611|NCT01526928|75725506|FG001|Overall Study|Withdrawal by Subject|0|||
41957612|NCT01526928|75725507|FG002|Overall Study|Withdrawal by Subject|13|||
41957613|NCT01526928|75725508|FG003|Overall Study|Withdrawal by Subject|11|||
41957614|NCT01526928|75725509|FG004|Overall Study|Withdrawal by Subject|3|||
41957615|NCT01526928|75725510|FG005|Overall Study|Withdrawal by Subject|0|||
41957616|NCT01526928|75725505|FG000|Overall Study|Physician Decision|0|||
41957617|NCT01526928|75725506|FG001|Overall Study|Physician Decision|0|||
41957618|NCT01526928|75725507|FG002|Overall Study|Physician Decision|2|||
41957619|NCT01526928|75725508|FG003|Overall Study|Physician Decision|5|||
41957620|NCT01526928|75725509|FG004|Overall Study|Physician Decision|0|||
41957621|NCT01526928|75725510|FG005|Overall Study|Physician Decision|0|||
41957622|NCT01526928|75725505|FG000|Overall Study|Other Reason|0|||
41957623|NCT01526928|75725506|FG001|Overall Study|Other Reason|1|||
41957624|NCT01526928|75725507|FG002|Overall Study|Other Reason|11|||
41957625|NCT01526928|75725508|FG003|Overall Study|Other Reason|4|||
41957626|NCT01526928|75725509|FG004|Overall Study|Other Reason|1|||
41957627|NCT01526928|75725510|FG005|Overall Study|Other Reason|0|||
41957628|NCT01526928|75725505|FG000|Overall Study|Lost to Follow-up|0|||
41957629|NCT01526928|75725506|FG001|Overall Study|Lost to Follow-up|0|||
41957630|NCT01526928|75725507|FG002|Overall Study|Lost to Follow-up|0|||
41957631|NCT01526928|75725508|FG003|Overall Study|Lost to Follow-up|1|||
41957632|NCT01526928|75725509|FG004|Overall Study|Lost to Follow-up|0|||
41957633|NCT01526928|75725510|FG005|Overall Study|Lost to Follow-up|0|||
41957634|NCT01526928|75725505|FG000|Overall Study|Protocol Deviation|0|||
41957635|NCT01526928|75725506|FG001|Overall Study|Protocol Deviation|0|||
41957636|NCT01526928|75725507|FG002|Overall Study|Protocol Deviation|0|||
41957637|NCT01526928|75725508|FG003|Overall Study|Protocol Deviation|2|||
41957638|NCT01526928|75725509|FG004|Overall Study|Protocol Deviation|0|||
41957639|NCT01526928|75725510|FG005|Overall Study|Protocol Deviation|0|||
41957640|NCT01526928|75725505|FG000|Overall Study|Missing|0|||
41957641|NCT01526928|75725506|FG001|Overall Study|Missing|0|||
41957642|NCT01526928|75725507|FG002|Overall Study|Missing|1|||
41957643|NCT01526928|75725508|FG003|Overall Study|Missing|0|||
41957644|NCT01526928|75725509|FG004|Overall Study|Missing|2|||
41957645|NCT01526928|75725510|FG005|Overall Study|Missing|0|||
41957646|NCT01549860|75725568|FG000|Overall Study|Withdrawal by Subject|1|||
41957647|NCT01549860|75725569|FG001|Overall Study|Withdrawal by Subject|0|||
41957648|NCT01549860|75725568|FG000|Overall Study|Physician Decision|1|||
41957649|NCT01549860|75725569|FG001|Overall Study|Physician Decision|1|||
41957650|NCT01549392|75725577|FG000|Overall Study|Withdrawal by Subject|1|||
42024322|NCT01015677|75831706|FG002|Overall Study|Protocol Violation|0|||
42024323|NCT01015677|75831704|FG000|Overall Study|Withdrawal by Subject|1|||
42024324|NCT01015677|75831705|FG001|Overall Study|Withdrawal by Subject|1|||
42024325|NCT01015677|75831706|FG002|Overall Study|Withdrawal by Subject|0|||
42024326|NCT01225211|75831746|FG000|Overall Study|Adverse Event|0|||
41957651|NCT01549392|75725578|FG001|Overall Study|Withdrawal by Subject|0|||
41957652|NCT01526148|75725586|FG000|Overall Study|Adverse Event|6|||
41957653|NCT01526148|75725587|FG001|Overall Study|Adverse Event|5|||
42024327|NCT01225211|75831747|FG001|Overall Study|Adverse Event|0|||
41957654|NCT01526148|75725586|FG000|Overall Study|Lost to Follow-up|3|||
41957655|NCT01526148|75725587|FG001|Overall Study|Lost to Follow-up|6|||
41957656|NCT01526148|75725586|FG000|Overall Study|Withdrawal by Subject|2|||
41957657|NCT01526148|75725587|FG001|Overall Study|Withdrawal by Subject|0|||
41957658|NCT01526148|75725586|FG000|Overall Study|Unstable Medical Condition|1|||
41957659|NCT01526148|75725587|FG001|Overall Study|Unstable Medical Condition|0|||
41957660|NCT01526148|75725586|FG000|Overall Study|Unable to discontinue concomitant med|1|||
41957661|NCT01526148|75725587|FG001|Overall Study|Unable to discontinue concomitant med|0|||
41957662|NCT01526148|75725586|FG000|Overall Study|Moved out of state|1|||
41957663|NCT01526148|75725587|FG001|Overall Study|Moved out of state|0|||
41957664|NCT01526148|75725586|FG000|Overall Study|Incarcerated|0|||
42024328|NCT01225211|75831748|FG002|Overall Study|Adverse Event|1|||
41957665|NCT01526148|75725587|FG001|Overall Study|Incarcerated|2|||
41957666|NCT01572948|75725595|FG000|Overall Study|Lost to Follow-up|1|||
41957667|NCT01572948|75725596|FG001|Overall Study|Lost to Follow-up|0|||
41957668|NCT01572948|75725595|FG000|Overall Study|unable to contact|0|||
41957669|NCT01572948|75725596|FG001|Overall Study|unable to contact|1|||
41957670|NCT01525602|75725614|FG000|Overall Study|Adverse Event|1|||
41957671|NCT01525602|75725615|FG001|Overall Study|Adverse Event|0|||
41957672|NCT01525602|75725616|FG002|Overall Study|Adverse Event|1|||
41957673|NCT01525602|75725617|FG003|Overall Study|Adverse Event|1|||
41957674|NCT01525602|75725618|FG004|Overall Study|Adverse Event|3|||
41957675|NCT01525602|75725619|FG005|Overall Study|Adverse Event|3|||
41957676|NCT01525602|75725620|FG006|Overall Study|Adverse Event|0|||
41957677|NCT01525602|75725621|FG007|Overall Study|Adverse Event|1|||
41957678|NCT01525602|75725614|FG000|Overall Study|Disease progression|6|||
41957679|NCT01525602|75725615|FG001|Overall Study|Disease progression|3|||
41957680|NCT01525602|75725616|FG002|Overall Study|Disease progression|2|||
41957681|NCT01525602|75725617|FG003|Overall Study|Disease progression|5|||
41957682|NCT01525602|75725618|FG004|Overall Study|Disease progression|22|||
41957683|NCT01525602|75725619|FG005|Overall Study|Disease progression|2|||
41957684|NCT01525602|75725620|FG006|Overall Study|Disease progression|3|||
41957685|NCT01525602|75725621|FG007|Overall Study|Disease progression|3|||
41957686|NCT01525602|75725614|FG000|Overall Study|Clinical progression|2|||
41957687|NCT01525602|75725615|FG001|Overall Study|Clinical progression|0|||
41957688|NCT01525602|75725616|FG002|Overall Study|Clinical progression|0|||
41957689|NCT01525602|75725617|FG003|Overall Study|Clinical progression|0|||
41957690|NCT01525602|75725618|FG004|Overall Study|Clinical progression|0|||
41957691|NCT01525602|75725619|FG005|Overall Study|Clinical progression|0|||
41957692|NCT01525602|75725620|FG006|Overall Study|Clinical progression|1|||
41957693|NCT01525602|75725621|FG007|Overall Study|Clinical progression|1|||
41957694|NCT01525602|75725614|FG000|Overall Study|Non-compliance|0|||
41957695|NCT01525602|75725615|FG001|Overall Study|Non-compliance|0|||
41957696|NCT01525602|75725616|FG002|Overall Study|Non-compliance|0|||
41957697|NCT01525602|75725617|FG003|Overall Study|Non-compliance|0|||
41957698|NCT01525602|75725618|FG004|Overall Study|Non-compliance|1|||
41957699|NCT01525602|75725619|FG005|Overall Study|Non-compliance|0|||
41957700|NCT01525602|75725620|FG006|Overall Study|Non-compliance|0|||
41957701|NCT01525602|75725621|FG007|Overall Study|Non-compliance|0|||
41957702|NCT01525602|75725614|FG000|Overall Study|Withdrawal by Subject|0|||
41957703|NCT01525602|75725615|FG001|Overall Study|Withdrawal by Subject|0|||
41957704|NCT01525602|75725616|FG002|Overall Study|Withdrawal by Subject|0|||
41957705|NCT01525602|75725617|FG003|Overall Study|Withdrawal by Subject|0|||
41957706|NCT01525602|75725618|FG004|Overall Study|Withdrawal by Subject|3|||
41957707|NCT01525602|75725619|FG005|Overall Study|Withdrawal by Subject|1|||
41957708|NCT01525602|75725620|FG006|Overall Study|Withdrawal by Subject|0|||
41957709|NCT01525602|75725621|FG007|Overall Study|Withdrawal by Subject|1|||
41957710|NCT01525602|75725614|FG000|Overall Study|Physician Decision|0|||
41957711|NCT01525602|75725615|FG001|Overall Study|Physician Decision|0|||
41957712|NCT01525602|75725616|FG002|Overall Study|Physician Decision|0|||
41957713|NCT01525602|75725617|FG003|Overall Study|Physician Decision|0|||
41957714|NCT01525602|75725618|FG004|Overall Study|Physician Decision|3|||
41957715|NCT01525602|75725619|FG005|Overall Study|Physician Decision|0|||
41957716|NCT01525602|75725620|FG006|Overall Study|Physician Decision|1|||
41957717|NCT01525602|75725621|FG007|Overall Study|Physician Decision|0|||
41957718|NCT01525602|75725614|FG000|Overall Study|Death|0|||
41957719|NCT01525602|75725615|FG001|Overall Study|Death|0|||
41957720|NCT01525602|75725616|FG002|Overall Study|Death|0|||
41957721|NCT01525602|75725617|FG003|Overall Study|Death|0|||
41957722|NCT01525602|75725618|FG004|Overall Study|Death|1|||
41957723|NCT01525602|75725619|FG005|Overall Study|Death|1|||
41957724|NCT01525602|75725620|FG006|Overall Study|Death|0|||
41957725|NCT01525602|75725621|FG007|Overall Study|Death|0|||
41957726|NCT01525602|75725614|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
41957727|NCT01525602|75725615|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
41957728|NCT01525602|75725616|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
41957729|NCT01525602|75725617|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
41957730|NCT01525602|75725618|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
41957731|NCT01525602|75725619|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
41957732|NCT01525602|75725620|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
41957733|NCT01525602|75725621|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
41957734|NCT01549002|75725648|FG000|Overall Study|Excessive pain|0|||
41957735|NCT01549002|75725649|FG001|Overall Study|Excessive pain|2|||
41957736|NCT01549002|75725648|FG000|Overall Study|Moderate sedation required|0|||
41957737|NCT01549002|75725649|FG001|Overall Study|Moderate sedation required|2|||
41957738|NCT01548768|75725659|FG000|Overall Study|Withdrawal by Subject|0|||
41957739|NCT01548768|75725660|FG001|Overall Study|Withdrawal by Subject|2|||
41957740|NCT01548768|75725661|FG002|Overall Study|Withdrawal by Subject|1|||
41957741|NCT01548768|75725662|FG003|Overall Study|Withdrawal by Subject|0|||
41957742|NCT01548768|75725659|FG000|Overall Study|Physician Decision|1|||
41957743|NCT01548768|75725660|FG001|Overall Study|Physician Decision|0|||
41957744|NCT01548768|75725661|FG002|Overall Study|Physician Decision|0|||
41957745|NCT01548768|75725662|FG003|Overall Study|Physician Decision|0|||
41957746|NCT01548768|75725659|FG000|Overall Study|Adverse Event|0|||
41957747|NCT01548768|75725660|FG001|Overall Study|Adverse Event|0|||
41957748|NCT01548768|75725661|FG002|Overall Study|Adverse Event|0|||
41957749|NCT01548768|75725662|FG003|Overall Study|Adverse Event|1|||
41957750|NCT01548768|75725659|FG000|Overall Study|Non-Compliance|0|||
41957751|NCT01548768|75725660|FG001|Overall Study|Non-Compliance|0|||
41957752|NCT01548768|75725661|FG002|Overall Study|Non-Compliance|0|||
41957753|NCT01548768|75725662|FG003|Overall Study|Non-Compliance|3|||
41957754|NCT01572792|75725679|FG000|Lead-in Study|Lost to Follow-up|5|||
41957755|NCT01572792|75725680|FG001|Lead-in Study|Lost to Follow-up|9|||
41957756|NCT01572792|75725681|FG002|Lead-in Study|Lost to Follow-up|4|||
41957757|NCT01572792|75725682|FG003|Lead-in Study|Lost to Follow-up|2|||
41957758|NCT01572792|75725683|FG004|Lead-in Study|Lost to Follow-up|4|||
41957759|NCT01572792|75725679|FG000|Lead-in Study|Withdrawal by Subject|22|||
41957760|NCT01572792|75725680|FG001|Lead-in Study|Withdrawal by Subject|11|||
41957761|NCT01572792|75725681|FG002|Lead-in Study|Withdrawal by Subject|12|||
41957762|NCT01572792|75725682|FG003|Lead-in Study|Withdrawal by Subject|24|||
41957763|NCT01572792|75725683|FG004|Lead-in Study|Withdrawal by Subject|11|||
41957764|NCT01572792|75725679|FG000|Lead-in Study|Protocol Violation|19|||
41957765|NCT01572792|75725680|FG001|Lead-in Study|Protocol Violation|10|||
41957766|NCT01572792|75725681|FG002|Lead-in Study|Protocol Violation|12|||
41957767|NCT01572792|75725682|FG003|Lead-in Study|Protocol Violation|13|||
41957768|NCT01572792|75725683|FG004|Lead-in Study|Protocol Violation|21|||
41957769|NCT01572792|75725679|FG000|Lead-in Study|Lack of Efficacy|20|||
41957770|NCT01572792|75725680|FG001|Lead-in Study|Lack of Efficacy|5|||
41957771|NCT01572792|75725681|FG002|Lead-in Study|Lack of Efficacy|4|||
41957772|NCT01572792|75725682|FG003|Lead-in Study|Lack of Efficacy|8|||
41957773|NCT01572792|75725683|FG004|Lead-in Study|Lack of Efficacy|10|||
41957774|NCT01572792|75725679|FG000|Lead-in Study|Adverse Event|21|||
41957775|NCT01572792|75725680|FG001|Lead-in Study|Adverse Event|21|||
41957776|NCT01572792|75725681|FG002|Lead-in Study|Adverse Event|22|||
41957777|NCT01572792|75725682|FG003|Lead-in Study|Adverse Event|16|||
41957778|NCT01572792|75725683|FG004|Lead-in Study|Adverse Event|14|||
41957779|NCT01572792|75725679|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
41957780|NCT01572792|75725680|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
41957781|NCT01572792|75725681|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
41957782|NCT01572792|75725682|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
41957783|NCT01572792|75725683|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
41957784|NCT01572792|75725679|FG000|Extension Study|Lost to Follow-up|6|||
41957785|NCT01572792|75725680|FG001|Extension Study|Lost to Follow-up|2|||
41957786|NCT01572792|75725681|FG002|Extension Study|Lost to Follow-up|0|||
41957787|NCT01572792|75725682|FG003|Extension Study|Lost to Follow-up|3|||
41957788|NCT01572792|75725683|FG004|Extension Study|Lost to Follow-up|3|||
41957789|NCT01572792|75725679|FG000|Extension Study|Withdrawal by Subject|7|||
41957790|NCT01572792|75725680|FG001|Extension Study|Withdrawal by Subject|6|||
41957791|NCT01572792|75725681|FG002|Extension Study|Withdrawal by Subject|11|||
41957792|NCT01572792|75725682|FG003|Extension Study|Withdrawal by Subject|8|||
41957793|NCT01572792|75725683|FG004|Extension Study|Withdrawal by Subject|14|||
41957794|NCT01572792|75725679|FG000|Extension Study|Protocol Violation|0|||
41957795|NCT01572792|75725680|FG001|Extension Study|Protocol Violation|4|||
41957796|NCT01572792|75725681|FG002|Extension Study|Protocol Violation|3|||
41957797|NCT01572792|75725682|FG003|Extension Study|Protocol Violation|4|||
41957798|NCT01572792|75725683|FG004|Extension Study|Protocol Violation|3|||
41957799|NCT01572792|75725679|FG000|Extension Study|Lack of Efficacy|2|||
41957800|NCT01572792|75725680|FG001|Extension Study|Lack of Efficacy|3|||
41957801|NCT01572792|75725681|FG002|Extension Study|Lack of Efficacy|3|||
41957802|NCT01572792|75725682|FG003|Extension Study|Lack of Efficacy|2|||
41957803|NCT01572792|75725683|FG004|Extension Study|Lack of Efficacy|2|||
41957804|NCT01572792|75725679|FG000|Extension Study|Adverse Event|7|||
41957805|NCT01572792|75725680|FG001|Extension Study|Adverse Event|6|||
41957806|NCT01572792|75725681|FG002|Extension Study|Adverse Event|5|||
41957807|NCT01572792|75725682|FG003|Extension Study|Adverse Event|6|||
41957808|NCT01572792|75725683|FG004|Extension Study|Adverse Event|4|||
41957809|NCT01572792|75725679|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
41957810|NCT01572792|75725680|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
41957811|NCT01572792|75725681|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
41957812|NCT01572792|75725682|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
41957813|NCT01572792|75725683|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
41957814|NCT01547598|75725698|FG000|Overall Study|Withdrew consent|1|||
41957815|NCT01547598|75725699|FG001|Overall Study|Withdrew consent|1|||
41957816|NCT01547598|75725698|FG000|Overall Study|Lost to Follow-up|1|||
41957817|NCT01547598|75725699|FG001|Overall Study|Lost to Follow-up|1|||
41957818|NCT01547598|75725698|FG000|Overall Study|Adverse Event|1|||
41957819|NCT01547598|75725699|FG001|Overall Study|Adverse Event|1|||
41957820|NCT01547598|75725698|FG000|Overall Study|Protocol Violation|1|||
41957821|NCT01547598|75725699|FG001|Overall Study|Protocol Violation|1|||
41957822|NCT01547598|75725698|FG000|Overall Study|Other Miscellaneous Reasons|2|||
41957823|NCT01547598|75725699|FG001|Overall Study|Other Miscellaneous Reasons|1|||
41957824|NCT01547286|75725706|FG000|Overall Study|Did not meet all eligibility criteria|1|||
41957825|NCT01547286|75725706|FG000|Overall Study|Physician Decision|1|||
41957826|NCT01547130|75725713|FG000|Overall Study|Lost to Follow-up|9|||
41957827|NCT01547130|75725714|FG001|Overall Study|Lost to Follow-up|5|||
41957828|NCT01524978|75725739|FG000|Overall Study|Other|16|||
41957829|NCT01524978|75725740|FG001|Overall Study|Other|2|||
41957830|NCT01524978|75725741|FG002|Overall Study|Other|1|||
41957831|NCT01524978|75725742|FG003|Overall Study|Other|2|||
41957832|NCT01524978|75725743|FG004|Overall Study|Other|1|||
41957833|NCT01524978|75725744|FG005|Overall Study|Other|3|||
41957834|NCT01524978|75725745|FG006|Overall Study|Other|17|||
41957835|NCT01524978|75725746|FG007|Overall Study|Other|1|||
41957836|NCT01524978|75725747|FG008|Overall Study|Other|2|||
41957837|NCT01524978|75725748|FG009|Overall Study|Other|2|||
41957838|NCT01524978|75725749|FG010|Overall Study|Other|5|||
41957839|NCT01524978|75725739|FG000|Overall Study|Withdrawal by Subject|12|||
41957840|NCT01524978|75725740|FG001|Overall Study|Withdrawal by Subject|0|||
41957841|NCT01524978|75725741|FG002|Overall Study|Withdrawal by Subject|1|||
41957842|NCT01524978|75725742|FG003|Overall Study|Withdrawal by Subject|1|||
41957843|NCT01524978|75725743|FG004|Overall Study|Withdrawal by Subject|3|||
41957844|NCT01524978|75725744|FG005|Overall Study|Withdrawal by Subject|1|||
41957845|NCT01524978|75725745|FG006|Overall Study|Withdrawal by Subject|6|||
41957846|NCT01524978|75725746|FG007|Overall Study|Withdrawal by Subject|2|||
41957847|NCT01524978|75725747|FG008|Overall Study|Withdrawal by Subject|4|||
41957848|NCT01524978|75725748|FG009|Overall Study|Withdrawal by Subject|0|||
41957849|NCT01524978|75725749|FG010|Overall Study|Withdrawal by Subject|5|||
41957850|NCT01524978|75725739|FG000|Overall Study|Lost to Follow-up|0|||
41957851|NCT01524978|75725740|FG001|Overall Study|Lost to Follow-up|0|||
41957852|NCT01524978|75725741|FG002|Overall Study|Lost to Follow-up|3|||
41957853|NCT01524978|75725742|FG003|Overall Study|Lost to Follow-up|0|||
41957854|NCT01524978|75725743|FG004|Overall Study|Lost to Follow-up|1|||
42300480|NCT02325219|76135657|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
41957855|NCT01524978|75725744|FG005|Overall Study|Lost to Follow-up|1|||
41957856|NCT01524978|75725745|FG006|Overall Study|Lost to Follow-up|2|||
41957857|NCT01524978|75725746|FG007|Overall Study|Lost to Follow-up|0|||
41957858|NCT01524978|75725747|FG008|Overall Study|Lost to Follow-up|1|||
41957859|NCT01524978|75725748|FG009|Overall Study|Lost to Follow-up|1|||
41957860|NCT01524978|75725749|FG010|Overall Study|Lost to Follow-up|1|||
41957861|NCT01524978|75725739|FG000|Overall Study|Death|34|||
41957862|NCT01524978|75725740|FG001|Overall Study|Death|2|||
41957863|NCT01524978|75725741|FG002|Overall Study|Death|5|||
41957864|NCT01524978|75725742|FG003|Overall Study|Death|24|||
41957865|NCT01524978|75725743|FG004|Overall Study|Death|4|||
41957866|NCT01524978|75725744|FG005|Overall Study|Death|4|||
41957867|NCT01524978|75725745|FG006|Overall Study|Death|1|||
41957868|NCT01524978|75725746|FG007|Overall Study|Death|9|||
41957869|NCT01524978|75725747|FG008|Overall Study|Death|5|||
41957870|NCT01524978|75725748|FG009|Overall Study|Death|6|||
41957871|NCT01524978|75725749|FG010|Overall Study|Death|17|||
41957872|NCT01524900|75725769|FG000|Overall Study|Lost to Follow-up|3|||
41957873|NCT01524900|75725770|FG001|Overall Study|Lost to Follow-up|12|||
41957874|NCT01524900|75725771|FG002|Overall Study|Lost to Follow-up|1|||
41957875|NCT01524900|75725772|FG003|Overall Study|Lost to Follow-up|0|||
41957876|NCT01524900|75725773|FG004|Overall Study|Lost to Follow-up|0|||
41957877|NCT01524900|75725769|FG000|Overall Study|Other reason than stated above|1|||
41957878|NCT01524900|75725770|FG001|Overall Study|Other reason than stated above|1|||
41957879|NCT01524900|75725771|FG002|Overall Study|Other reason than stated above|0|||
41957880|NCT01524900|75725772|FG003|Overall Study|Other reason than stated above|0|||
41957881|NCT01524900|75725773|FG004|Overall Study|Other reason than stated above|0|||
41957882|NCT01524900|75725769|FG000|Overall Study|No reason documented|2|||
41957883|NCT01524900|75725770|FG001|Overall Study|No reason documented|1|||
41957884|NCT01524900|75725771|FG002|Overall Study|No reason documented|0|||
41957885|NCT01524900|75725772|FG003|Overall Study|No reason documented|1|||
41957886|NCT01524900|75725773|FG004|Overall Study|No reason documented|0|||
41957887|NCT01524198|75725788|FG000|Overall Study|Protocol Violation|8|||
41957888|NCT01524198|75725789|FG001|Overall Study|Protocol Violation|6|||
41957889|NCT01524198|75725788|FG000|Overall Study|Withdrawal by Subject|15|||
41957890|NCT01524198|75725789|FG001|Overall Study|Withdrawal by Subject|10|||
41957891|NCT01523886|75725797|FG000|Overall Study|surgery cancelled|0|||
41957892|NCT01523886|75725798|FG001|Overall Study|surgery cancelled|1|||
41957893|NCT01546038|75725810|FG000|Overall Study|Death|15|||
41957894|NCT01546038|75725811|FG001|Overall Study|Death|6|||
41957895|NCT01546038|75725812|FG002|Overall Study|Death|4|||
41957896|NCT01546038|75725813|FG003|Overall Study|Death|2|||
41957897|NCT01546038|75725814|FG004|Overall Study|Death|9|||
41957898|NCT01546038|75725815|FG005|Overall Study|Death|3|||
41957899|NCT01546038|75725816|FG006|Overall Study|Death|46|||
41957900|NCT01546038|75725817|FG007|Overall Study|Death|76|||
41957901|NCT01546038|75725818|FG008|Overall Study|Death|39|||
41957902|NCT01546038|75725810|FG000|Overall Study|Lost to Follow-up|0|||
41957903|NCT01546038|75725811|FG001|Overall Study|Lost to Follow-up|0|||
41957904|NCT01546038|75725812|FG002|Overall Study|Lost to Follow-up|0|||
41957905|NCT01546038|75725813|FG003|Overall Study|Lost to Follow-up|0|||
41957906|NCT01546038|75725814|FG004|Overall Study|Lost to Follow-up|1|||
41957907|NCT01546038|75725815|FG005|Overall Study|Lost to Follow-up|0|||
41957908|NCT01546038|75725816|FG006|Overall Study|Lost to Follow-up|2|||
41957909|NCT01546038|75725817|FG007|Overall Study|Lost to Follow-up|1|||
41957910|NCT01546038|75725818|FG008|Overall Study|Lost to Follow-up|0|||
41957911|NCT01546038|75725810|FG000|Overall Study|Withdrawal by Subject|1|||
41957912|NCT01546038|75725811|FG001|Overall Study|Withdrawal by Subject|0|||
41957913|NCT01546038|75725812|FG002|Overall Study|Withdrawal by Subject|0|||
41957914|NCT01546038|75725813|FG003|Overall Study|Withdrawal by Subject|1|||
41957915|NCT01546038|75725814|FG004|Overall Study|Withdrawal by Subject|0|||
41957916|NCT01546038|75725815|FG005|Overall Study|Withdrawal by Subject|1|||
41957917|NCT01546038|75725816|FG006|Overall Study|Withdrawal by Subject|3|||
41957918|NCT01546038|75725817|FG007|Overall Study|Withdrawal by Subject|3|||
41957919|NCT01546038|75725818|FG008|Overall Study|Withdrawal by Subject|1|||
41957920|NCT01546038|75725810|FG000|Overall Study|: Randomized, not treated|0|||
41957921|NCT01546038|75725811|FG001|Overall Study|: Randomized, not treated|0|||
41957922|NCT01546038|75725812|FG002|Overall Study|: Randomized, not treated|0|||
41957923|NCT01546038|75725813|FG003|Overall Study|: Randomized, not treated|0|||
41957924|NCT01546038|75725814|FG004|Overall Study|: Randomized, not treated|0|||
41957925|NCT01546038|75725815|FG005|Overall Study|: Randomized, not treated|0|||
41957926|NCT01546038|75725816|FG006|Overall Study|: Randomized, not treated|2|||
41957927|NCT01546038|75725817|FG007|Overall Study|: Randomized, not treated|4|||
41957928|NCT01546038|75725818|FG008|Overall Study|: Randomized, not treated|3|||
41957929|NCT01571232|75725870|FG000|Overall Study|Lost to Follow-up|0|||
41957930|NCT01571232|75725871|FG001|Overall Study|Lost to Follow-up|1|||
41957931|NCT01571232|75725870|FG000|Overall Study|Withdrawal by Subject|1|||
41957932|NCT01571232|75725871|FG001|Overall Study|Withdrawal by Subject|0|||
41957933|NCT01544478|75725878|FG000|Overall Study|Adverse Event|1|||
41957934|NCT01544478|75725878|FG000|Overall Study|Death|1|||
41957935|NCT01544478|75725878|FG000|Overall Study|Lost to Follow-up|48|||
41957936|NCT01544478|75725878|FG000|Overall Study|Physician Decision|15|||
41957937|NCT01544478|75725878|FG000|Overall Study|Pregnancy|1|||
41957938|NCT01544478|75725878|FG000|Overall Study|Withdrawal by Subject|52|||
41957939|NCT01522950|75725885|FG000|Overall Study|Withdrawal by Subject|3|||
41957940|NCT01522950|75725886|FG001|Overall Study|Withdrawal by Subject|2|||
41957941|NCT01522950|75725887|FG002|Overall Study|Withdrawal by Subject|1|||
41957942|NCT01522950|75725885|FG000|Overall Study|Adverse Event|3|||
41957943|NCT01522950|75725886|FG001|Overall Study|Adverse Event|1|||
41957944|NCT01522950|75725887|FG002|Overall Study|Adverse Event|1|||
41957945|NCT01522950|75725885|FG000|Overall Study|Protocol Violation|0|||
41957946|NCT01522950|75725886|FG001|Overall Study|Protocol Violation|0|||
41957947|NCT01522950|75725887|FG002|Overall Study|Protocol Violation|2|||
41957948|NCT01522950|75725885|FG000|Overall Study|Death|0|||
41957949|NCT01522950|75725886|FG001|Overall Study|Death|1|||
41957950|NCT01522950|75725887|FG002|Overall Study|Death|1|||
41957951|NCT01522950|75725885|FG000|Overall Study|Study Medication Sensitivity|0|||
41957952|NCT01522950|75725886|FG001|Overall Study|Study Medication Sensitivity|1|||
41957953|NCT01522950|75725887|FG002|Overall Study|Study Medication Sensitivity|0|||
41957954|NCT01522404|75725897|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
41957955|NCT01522404|75725898|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
41957956|NCT01522404|75725897|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
41957957|NCT01522404|75725898|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
41957958|NCT01522404|75725897|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
41957959|NCT01522404|75725898|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
41957960|NCT01570686|75725914|FG000|Overall Study|Abnormal test procedure result(s)|1|||
41957961|NCT01570686|75725915|FG001|Overall Study|Abnormal test procedure result(s)|1|||
41957962|NCT01570686|75725914|FG000|Overall Study|Administrative problems|0|||
41957963|NCT01570686|75725915|FG001|Overall Study|Administrative problems|1|||
41957964|NCT01570686|75725914|FG000|Overall Study|Adverse Event|8|||
41957965|NCT01570686|75725915|FG001|Overall Study|Adverse Event|6|||
41957966|NCT01570686|75725914|FG000|Overall Study|Lost to Follow-up|4|||
41957967|NCT01570686|75725915|FG001|Overall Study|Lost to Follow-up|3|||
41957968|NCT01570686|75725914|FG000|Overall Study|Protocol Deviation|3|||
41957969|NCT01570686|75725915|FG001|Overall Study|Protocol Deviation|0|||
41957970|NCT01570686|75725914|FG000|Overall Study|Withdrawal by Subject|4|||
41957971|NCT01570686|75725915|FG001|Overall Study|Withdrawal by Subject|4|||
41957972|NCT01570686|75725914|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
41957973|NCT01570686|75725915|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
41957974|NCT01522248|75725923|FG000|Overall Study|Lost to Follow-up|1|||
41957975|NCT01522248|75725924|FG001|Overall Study|Lost to Follow-up|0|||
41957976|NCT01543776|75725937|FG000|Overall Study|Withdrawal by Subject|2|||
41957977|NCT01543776|75725938|FG001|Overall Study|Withdrawal by Subject|2|||
41957978|NCT01518192|75725947|FG000|Overall Study|Lost to Follow-up|29|||
41957979|NCT01518192|75725948|FG001|Overall Study|Lost to Follow-up|26|||
41957980|NCT01518192|75725949|FG002|Overall Study|Lost to Follow-up|35|||
41957981|NCT01517802|75725963|FG000|Overall Study|Death|1|||
41957982|NCT01520922|75725969|FG000|Treatment Phase|Physician Decision|2|||
41957983|NCT01520922|75725970|FG001|Treatment Phase|Physician Decision|1|||
41957984|NCT01520922|75725969|FG000|Treatment Phase|Progression|0|||
41957985|NCT01520922|75725970|FG001|Treatment Phase|Progression|2|||
41957986|NCT01520922|75725969|FG000|Treatment Phase|Adverse Event|3|||
41957987|NCT01520922|75725970|FG001|Treatment Phase|Adverse Event|5|||
41957988|NCT01520922|75725969|FG000|Follow up|Lost to Follow-up|0|||
41957989|NCT01520922|75725970|FG001|Follow up|Lost to Follow-up|1|||
41957990|NCT01520922|75725969|FG000|Survival Follow-up|Withdrawal by Subject|1|||
41957991|NCT01520922|75725970|FG001|Survival Follow-up|Withdrawal by Subject|0|||
41957992|NCT01569438|75725978|FG000|Overall Study|Lack of Efficacy|1|||
41957993|NCT01569438|75725979|FG001|Overall Study|Lack of Efficacy|2|||
41957994|NCT01569438|75725978|FG000|Overall Study|Withdrawal by Subject|0|||
41957995|NCT01569438|75725979|FG001|Overall Study|Withdrawal by Subject|3|||
41957996|NCT01569438|75725978|FG000|Overall Study|Adverse Event|2|||
41957997|NCT01569438|75725979|FG001|Overall Study|Adverse Event|15|||
41957998|NCT01569438|75725978|FG000|Overall Study|Protocol Violation|2|||
41957999|NCT01569438|75725979|FG001|Overall Study|Protocol Violation|0|||
41958000|NCT01569438|75725978|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
41958001|NCT01569438|75725979|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
41958002|NCT01569438|75725978|FG000|Overall Study|Sponsor/Physician decision|1|||
41958003|NCT01569438|75725979|FG001|Overall Study|Sponsor/Physician decision|1|||
41958004|NCT01569438|75725978|FG000|Overall Study|Unable to adhere to study schedule|0|||
41958005|NCT01569438|75725979|FG001|Overall Study|Unable to adhere to study schedule|1|||
41958006|NCT01517412|75725987|FG000|Overall Study|Adverse Event|10|||
42300481|NCT02325219|76135658|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
41958007|NCT01517412|75725988|FG001|Overall Study|Adverse Event|11|||
41958008|NCT01517412|75725987|FG000|Overall Study|Lack of Efficacy|10|||
42300482|NCT02325219|76135659|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
42300483|NCT02325219|76135655|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
41958009|NCT01517412|75725988|FG001|Overall Study|Lack of Efficacy|5|||
41958010|NCT01517412|75725987|FG000|Overall Study|Poor compliance to protocol|8|||
41958011|NCT01517412|75725988|FG001|Overall Study|Poor compliance to protocol|3|||
41958012|NCT01517412|75725987|FG000|Overall Study|Other than specified above|8|||
41958013|NCT01517412|75725988|FG001|Overall Study|Other than specified above|5|||
41958014|NCT01517178|75725994|FG000|Period 1|Adverse Event|1|||
41958015|NCT01517178|75725995|FG001|Period 1|Adverse Event|2|||
41958016|NCT01517178|75725994|FG000|Period 1|Lack of Efficacy|0|||
41958017|NCT01517178|75725995|FG001|Period 1|Lack of Efficacy|1|||
41958018|NCT01517178|75725994|FG000|Period 1|E.g. study termination|3|||
41958019|NCT01517178|75725995|FG001|Period 1|E.g. study termination|1|||
41958020|NCT01517178|75725994|FG000|Period 1|Withdrawal by Subject|0|||
41958021|NCT01517178|75725995|FG001|Period 1|Withdrawal by Subject|1|||
41958022|NCT01517178|75725994|FG000|Period 2|Adverse Event|1|||
41958023|NCT01517178|75725995|FG001|Period 2|Adverse Event|0|||
41958024|NCT01517178|75725994|FG000|Period 2|Withdrawal by Subject|3|||
41958025|NCT01517178|75725995|FG001|Period 2|Withdrawal by Subject|0|||
41958026|NCT01517178|75725994|FG000|Period 2|E.g. study termination|2|||
41958027|NCT01517178|75725995|FG001|Period 2|E.g. study termination|2|||
41958028|NCT01489956|75726003|FG000|Overall Study|Lost to Follow-up|1|||
41958029|NCT01489956|75726004|FG001|Overall Study|Lost to Follow-up|0|||
41958030|NCT01489956|75726005|FG002|Overall Study|Lost to Follow-up|0|||
41958031|NCT01489956|75726003|FG000|Overall Study|Withdrawal by Subject|0|||
41958032|NCT01489956|75726004|FG001|Overall Study|Withdrawal by Subject|0|||
41958033|NCT01489956|75726005|FG002|Overall Study|Withdrawal by Subject|1|||
41958034|NCT01516008|75726016|FG000|Overall Study|Adverse Event|0|||
41958035|NCT01516008|75726017|FG001|Overall Study|Adverse Event|2|||
41958036|NCT01516008|75726018|FG002|Overall Study|Adverse Event|7|||
41958037|NCT01516008|75726016|FG000|Overall Study|Lack of Efficacy|44|||
41958038|NCT01516008|75726017|FG001|Overall Study|Lack of Efficacy|14|||
41958039|NCT01516008|75726018|FG002|Overall Study|Lack of Efficacy|10|||
41958040|NCT01516008|75726016|FG000|Overall Study|Protocol Violation|1|||
41958041|NCT01516008|75726017|FG001|Overall Study|Protocol Violation|0|||
41958042|NCT01516008|75726018|FG002|Overall Study|Protocol Violation|0|||
41958043|NCT01516008|75726016|FG000|Overall Study|Reason not specified|0|||
41958044|NCT01516008|75726017|FG001|Overall Study|Reason not specified|0|||
41958045|NCT01516008|75726018|FG002|Overall Study|Reason not specified|1|||
41958046|NCT01489254|75726029|FG000|Double-blind Part|Adverse Event|7|||
41958047|NCT01489254|75726030|FG001|Double-blind Part|Adverse Event|2|||
41958048|NCT01489254|75726031|FG002|Double-blind Part|Adverse Event|2|||
41958049|NCT01489254|75726032|FG003|Double-blind Part|Adverse Event|0|||
41958050|NCT01489254|75726029|FG000|Double-blind Part|Pregnancy|1|||
41958051|NCT01489254|75726030|FG001|Double-blind Part|Pregnancy|3|||
41958052|NCT01489254|75726031|FG002|Double-blind Part|Pregnancy|0|||
41958053|NCT01489254|75726032|FG003|Double-blind Part|Pregnancy|0|||
41958054|NCT01489254|75726029|FG000|Double-blind Part|Withdrawal by Subject|12|||
41958055|NCT01489254|75726030|FG001|Double-blind Part|Withdrawal by Subject|20|||
41958056|NCT01489254|75726031|FG002|Double-blind Part|Withdrawal by Subject|1|||
41958057|NCT01489254|75726032|FG003|Double-blind Part|Withdrawal by Subject|0|||
41958058|NCT01489254|75726029|FG000|Double-blind Part|Lost to Follow-up|1|||
41958059|NCT01489254|75726030|FG001|Double-blind Part|Lost to Follow-up|2|||
41958060|NCT01489254|75726031|FG002|Double-blind Part|Lost to Follow-up|0|||
41958061|NCT01489254|75726032|FG003|Double-blind Part|Lost to Follow-up|0|||
41958062|NCT01489254|75726029|FG000|Double-blind Part|Other reasons for not completing study|4|||
41958063|NCT01489254|75726030|FG001|Double-blind Part|Other reasons for not completing study|6|||
41958064|NCT01489254|75726031|FG002|Double-blind Part|Other reasons for not completing study|0|||
41958065|NCT01489254|75726032|FG003|Double-blind Part|Other reasons for not completing study|0|||
41958066|NCT01489254|75726029|FG000|Open-label Extension Part|Adverse Event|0|||
41958067|NCT01489254|75726030|FG001|Open-label Extension Part|Adverse Event|0|||
41958068|NCT01489254|75726031|FG002|Open-label Extension Part|Adverse Event|0|||
41958069|NCT01489254|75726032|FG003|Open-label Extension Part|Adverse Event|10|||
41958070|NCT01489254|75726029|FG000|Open-label Extension Part|Pregnancy|0|||
41958071|NCT01489254|75726030|FG001|Open-label Extension Part|Pregnancy|0|||
41958072|NCT01489254|75726031|FG002|Open-label Extension Part|Pregnancy|0|||
41958073|NCT01489254|75726032|FG003|Open-label Extension Part|Pregnancy|3|||
41958074|NCT01489254|75726029|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
41958075|NCT01489254|75726030|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
41958076|NCT01489254|75726031|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
41958077|NCT01489254|75726032|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
41958078|NCT01489254|75726029|FG000|Open-label Extension Part|Protocol Violation|0|||
41958079|NCT01489254|75726030|FG001|Open-label Extension Part|Protocol Violation|0|||
41958080|NCT01489254|75726031|FG002|Open-label Extension Part|Protocol Violation|0|||
41958081|NCT01489254|75726032|FG003|Open-label Extension Part|Protocol Violation|1|||
41958082|NCT01489254|75726029|FG000|Open-label Extension Part|Lost to Follow-up|0|||
42300484|NCT02325219|76135656|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
42300485|NCT02325219|76135657|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
42300486|NCT02325219|76135658|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
41958083|NCT01489254|75726030|FG001|Open-label Extension Part|Lost to Follow-up|0|||
41958084|NCT01489254|75726031|FG002|Open-label Extension Part|Lost to Follow-up|0|||
41958085|NCT01489254|75726032|FG003|Open-label Extension Part|Lost to Follow-up|9|||
41958086|NCT01489254|75726029|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
42024329|NCT01225211|75831749|FG003|Overall Study|Adverse Event|0|||
41958087|NCT01489254|75726030|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
41958088|NCT01489254|75726031|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
41958089|NCT01489254|75726032|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
41958090|NCT01489020|75726047|FG000|Overall Study|Withdrawal by Subject|1|||
41958091|NCT01489020|75726048|FG001|Overall Study|Withdrawal by Subject|0|||
41958092|NCT01489020|75726049|FG002|Overall Study|Withdrawal by Subject|0|||
41958093|NCT01489020|75726050|FG003|Overall Study|Withdrawal by Subject|0|||
41958094|NCT01489020|75726051|FG004|Overall Study|Withdrawal by Subject|0|||
41958095|NCT01489020|75726052|FG005|Overall Study|Withdrawal by Subject|0|||
41958096|NCT01489020|75726047|FG000|Overall Study|Adverse Event|0|||
41958097|NCT01489020|75726048|FG001|Overall Study|Adverse Event|0|||
41958098|NCT01489020|75726049|FG002|Overall Study|Adverse Event|3|||
41958099|NCT01489020|75726050|FG003|Overall Study|Adverse Event|0|||
41958100|NCT01489020|75726051|FG004|Overall Study|Adverse Event|3|||
41958101|NCT01489020|75726052|FG005|Overall Study|Adverse Event|0|||
41958102|NCT01489020|75726047|FG000|Overall Study|Concomitant disease|0|||
41958103|NCT01489020|75726048|FG001|Overall Study|Concomitant disease|0|||
41958104|NCT01489020|75726049|FG002|Overall Study|Concomitant disease|0|||
41958105|NCT01489020|75726050|FG003|Overall Study|Concomitant disease|0|||
41958106|NCT01489020|75726051|FG004|Overall Study|Concomitant disease|3|||
41958107|NCT01489020|75726052|FG005|Overall Study|Concomitant disease|0|||
41958108|NCT01514760|75726072|FG000|Overall Study|Lost to Follow-up|2|||
41958109|NCT01514682|75726078|FG000|Overall Study|Withdrawal by Subject|2|||
41958110|NCT01514682|75726079|FG001|Overall Study|Withdrawal by Subject|3|||
41958111|NCT01514682|75726078|FG000|Overall Study|Physician Decision|4|||
41958112|NCT01514682|75726079|FG001|Overall Study|Physician Decision|3|||
41958113|NCT01514448|75726087|FG000|Overall Study|Death|7|||
41958114|NCT01514448|75726088|FG001|Overall Study|Death|8|||
41958115|NCT01514448|75726087|FG000|Overall Study|Withdrawal by Subject|2|||
41958116|NCT01514448|75726088|FG001|Overall Study|Withdrawal by Subject|0|||
41958117|NCT01514448|75726087|FG000|Overall Study|Lost to Follow-up|2|||
41958118|NCT01514448|75726088|FG001|Overall Study|Lost to Follow-up|0|||
41958119|NCT01514448|75726087|FG000|Overall Study|New Cancer Therapy|1|||
41958120|NCT01514448|75726088|FG001|Overall Study|New Cancer Therapy|0|||
41958121|NCT01514370|75726097|FG000|Overall Study|Protocol Violation|2|||
41958122|NCT01514370|75726098|FG001|Overall Study|Protocol Violation|3|||
41958123|NCT01514370|75726097|FG000|Overall Study|Lost to Follow-up|0|||
41958124|NCT01514370|75726098|FG001|Overall Study|Lost to Follow-up|2|||
41958125|NCT01514370|75726097|FG000|Overall Study|Withdrawal by Subject|2|||
41958126|NCT01514370|75726098|FG001|Overall Study|Withdrawal by Subject|1|||
41958127|NCT01514370|75726097|FG000|Overall Study|Adverse Event|1|||
41958128|NCT01514370|75726098|FG001|Overall Study|Adverse Event|3|||
41958129|NCT01514370|75726097|FG000|Overall Study|Other|6|||
41958130|NCT01514370|75726098|FG001|Overall Study|Other|7|||
41958131|NCT01519674|75726108|FG000|Overall Study|Adverse Event|3|||
41958132|NCT01519674|75726109|FG001|Overall Study|Adverse Event|3|||
41958133|NCT01519674|75726110|FG002|Overall Study|Adverse Event|0|||
41958134|NCT01519674|75726108|FG000|Overall Study|Lack of Efficacy|1|||
41958135|NCT01519674|75726109|FG001|Overall Study|Lack of Efficacy|1|||
41958136|NCT01519674|75726110|FG002|Overall Study|Lack of Efficacy|1|||
41958137|NCT01519674|75726108|FG000|Overall Study|Protocol Violation|0|||
41958138|NCT01519674|75726109|FG001|Overall Study|Protocol Violation|3|||
41958139|NCT01519674|75726110|FG002|Overall Study|Protocol Violation|1|||
41958140|NCT01519674|75726108|FG000|Overall Study|Withdrawal Criteria|7|||
41958141|NCT01519674|75726109|FG001|Overall Study|Withdrawal Criteria|2|||
41958142|NCT01519674|75726110|FG002|Overall Study|Withdrawal Criteria|7|||
41958143|NCT01519674|75726108|FG000|Overall Study|Unsclassified|10|||
41958144|NCT01519674|75726109|FG001|Overall Study|Unsclassified|4|||
41958145|NCT01519674|75726110|FG002|Overall Study|Unsclassified|3|||
41958146|NCT01519518|75726120|FG000|Overall Study|Consent not available|7|||
41958147|NCT01519518|75726121|FG001|Overall Study|Consent not available|10|||
41958148|NCT01519206|75726127|FG000|Overall Study|Lost to Follow-up|3|||
41958149|NCT01519206|75726127|FG000|Overall Study|Missed Visit|2|||
41958150|NCT01518972|75726140|FG000|Overall Study|Lost to Follow-up|2|||
41958151|NCT01518972|75726141|FG001|Overall Study|Lost to Follow-up|1|||
41958152|NCT01518972|75726140|FG000|Overall Study|Withdrawal by Subject|1|||
41958153|NCT01518972|75726141|FG001|Overall Study|Withdrawal by Subject|0|||
41958154|NCT01518972|75726140|FG000|Overall Study|Moved from area|1|||
41958155|NCT01518972|75726141|FG001|Overall Study|Moved from area|0|||
41958156|NCT01518972|75726140|FG000|Overall Study|Transportation problems|1|||
41958157|NCT01518972|75726141|FG001|Overall Study|Transportation problems|0|||
41958158|NCT01518972|75726140|FG000|Overall Study|Exclusionary medical condition|1|||
41958159|NCT01518972|75726141|FG001|Overall Study|Exclusionary medical condition|0|||
41958160|NCT01518972|75726140|FG000|Overall Study|Missed safety visits|0|||
41958161|NCT01518972|75726141|FG001|Overall Study|Missed safety visits|1|||
41958162|NCT01518972|75726140|FG000|Overall Study|Exclusionary medication|0|||
41958163|NCT01518972|75726141|FG001|Overall Study|Exclusionary medication|1|||
41958164|NCT01518972|75726140|FG000|Overall Study|Declined medication starting on day 12|0|||
41958165|NCT01518972|75726141|FG001|Overall Study|Declined medication starting on day 12|1|||
41958166|NCT01514136|75726149|FG000|Test Period 1; Test A|Protocol Violation|1|||
41958167|NCT01514136|75726150|FG001|Test Period 1; Test A|Protocol Violation|0|||
41958168|NCT01514136|75726151|FG002|Test Period 1; Test A|Protocol Violation|0|||
41958169|NCT01514136|75726152|FG003|Test Period 1; Test A|Protocol Violation|0|||
41958170|NCT01514136|75726153|FG004|Test Period 1; Test A|Protocol Violation|0|||
41958171|NCT01514136|75726154|FG005|Test Period 1; Test A|Protocol Violation|0|||
41958172|NCT01514136|75726155|FG006|Test Period 1; Test A|Protocol Violation|0|||
41958173|NCT01514136|75726156|FG007|Test Period 1; Test A|Protocol Violation|0|||
41958174|NCT01514136|75726149|FG000|Test Period 1; Test A|Break from study holiday|2|||
41958175|NCT01514136|75726150|FG001|Test Period 1; Test A|Break from study holiday|0|||
41958176|NCT01514136|75726151|FG002|Test Period 1; Test A|Break from study holiday|0|||
41958177|NCT01514136|75726152|FG003|Test Period 1; Test A|Break from study holiday|0|||
41958178|NCT01514136|75726153|FG004|Test Period 1; Test A|Break from study holiday|0|||
41958179|NCT01514136|75726154|FG005|Test Period 1; Test A|Break from study holiday|0|||
41958180|NCT01514136|75726155|FG006|Test Period 1; Test A|Break from study holiday|0|||
41958181|NCT01514136|75726156|FG007|Test Period 1; Test A|Break from study holiday|0|||
41958182|NCT01514136|75726149|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
41958183|NCT01514136|75726150|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
41958184|NCT01514136|75726151|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
41958185|NCT01514136|75726152|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
41958186|NCT01514136|75726153|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
41958187|NCT01514136|75726154|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
41958188|NCT01514136|75726155|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
41958189|NCT01514136|75726156|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
41958190|NCT01514136|75726149|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
41958191|NCT01514136|75726150|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
41958192|NCT01514136|75726151|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
41958193|NCT01514136|75726152|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
41958194|NCT01514136|75726153|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
41958195|NCT01514136|75726154|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
41958196|NCT01514136|75726155|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
41958197|NCT01514136|75726156|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
41958198|NCT01514136|75726149|FG000|Test Period 2; Test A*|Adverse Event|0|||
41958199|NCT01514136|75726150|FG001|Test Period 2; Test A*|Adverse Event|0|||
41958200|NCT01514136|75726151|FG002|Test Period 2; Test A*|Adverse Event|0|||
41958201|NCT01514136|75726152|FG003|Test Period 2; Test A*|Adverse Event|0|||
41958202|NCT01514136|75726153|FG004|Test Period 2; Test A*|Adverse Event|1|||
41958203|NCT01514136|75726154|FG005|Test Period 2; Test A*|Adverse Event|0|||
41958204|NCT01514136|75726155|FG006|Test Period 2; Test A*|Adverse Event|0|||
41958205|NCT01514136|75726156|FG007|Test Period 2; Test A*|Adverse Event|0|||
41958206|NCT01514136|75726149|FG000|Test Period 2; Test A*|Holiday|0|||
41958207|NCT01514136|75726150|FG001|Test Period 2; Test A*|Holiday|0|||
41958208|NCT01514136|75726151|FG002|Test Period 2; Test A*|Holiday|0|||
41958209|NCT01514136|75726152|FG003|Test Period 2; Test A*|Holiday|0|||
41958210|NCT01514136|75726153|FG004|Test Period 2; Test A*|Holiday|1|||
41958211|NCT01514136|75726154|FG005|Test Period 2; Test A*|Holiday|0|||
41958212|NCT01514136|75726155|FG006|Test Period 2; Test A*|Holiday|0|||
41958213|NCT01514136|75726156|FG007|Test Period 2; Test A*|Holiday|0|||
41958214|NCT01514136|75726149|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
41958215|NCT01514136|75726150|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
41958216|NCT01514136|75726151|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
41958217|NCT01514136|75726152|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
41958218|NCT01514136|75726153|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
41958219|NCT01514136|75726154|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
41958220|NCT01514136|75726155|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
41958221|NCT01514136|75726156|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
41958222|NCT01514136|75726149|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
41958223|NCT01514136|75726150|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
41958224|NCT01514136|75726151|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
41958225|NCT01514136|75726152|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
41958226|NCT01514136|75726153|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
42024330|NCT01225211|75831750|FG004|Overall Study|Adverse Event|0|||
42024331|NCT01225211|75831751|FG005|Overall Study|Adverse Event|0|||
42024332|NCT01225211|75831752|FG006|Overall Study|Adverse Event|0|||
42024333|NCT01225211|75831753|FG007|Overall Study|Adverse Event|0|||
42300487|NCT02325219|76135659|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
41958227|NCT01514136|75726154|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
41958228|NCT01514136|75726155|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
41958229|NCT01514136|75726156|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
41958230|NCT01514136|75726149|FG000|Test Period 2; Test C*|holiday|0|||
42024334|NCT01225211|75831754|FG008|Overall Study|Adverse Event|0|||
41958231|NCT01514136|75726150|FG001|Test Period 2; Test C*|holiday|0|||
41958232|NCT01514136|75726151|FG002|Test Period 2; Test C*|holiday|0|||
41958233|NCT01514136|75726152|FG003|Test Period 2; Test C*|holiday|0|||
41958234|NCT01514136|75726153|FG004|Test Period 2; Test C*|holiday|0|||
41958235|NCT01514136|75726154|FG005|Test Period 2; Test C*|holiday|0|||
41958236|NCT01514136|75726155|FG006|Test Period 2; Test C*|holiday|1|||
41958237|NCT01514136|75726156|FG007|Test Period 2; Test C*|holiday|0|||
41958238|NCT01514136|75726149|FG000|Test Period 2; Test C*|Protocol Violation|0|||
41958239|NCT01514136|75726150|FG001|Test Period 2; Test C*|Protocol Violation|0|||
41958240|NCT01514136|75726151|FG002|Test Period 2; Test C*|Protocol Violation|0|||
41958241|NCT01514136|75726152|FG003|Test Period 2; Test C*|Protocol Violation|0|||
41958242|NCT01514136|75726153|FG004|Test Period 2; Test C*|Protocol Violation|0|||
41958243|NCT01514136|75726154|FG005|Test Period 2; Test C*|Protocol Violation|0|||
41958244|NCT01514136|75726155|FG006|Test Period 2; Test C*|Protocol Violation|1|||
41958245|NCT01514136|75726156|FG007|Test Period 2; Test C*|Protocol Violation|0|||
41958246|NCT01513590|75726184|FG000|Overall Study|Adverse Event|2|||
41958247|NCT01513590|75726185|FG001|Overall Study|Adverse Event|3|||
41958248|NCT01513590|75726184|FG000|Overall Study|Withdrawal Criteria|3|||
41958249|NCT01513590|75726185|FG001|Overall Study|Withdrawal Criteria|0|||
41958250|NCT01513590|75726184|FG000|Overall Study|Unclassified|5|||
41958251|NCT01513590|75726185|FG001|Overall Study|Unclassified|10|||
41958252|NCT01512264|75726195|FG000|Overall Study|Lost to Follow-up|0|||
41958253|NCT01512264|75726196|FG001|Overall Study|Lost to Follow-up|0|||
41958254|NCT01512264|75726197|FG002|Overall Study|Lost to Follow-up|0|||
41958255|NCT01512264|75726198|FG003|Overall Study|Lost to Follow-up|1|||
41958256|NCT01512108|75726210|FG000|Overall Study|Adverse Event|9|||
41958257|NCT01512108|75726211|FG001|Overall Study|Adverse Event|4|||
41958258|NCT01512108|75726210|FG000|Overall Study|Protocol Violation|1|||
41958259|NCT01512108|75726211|FG001|Overall Study|Protocol Violation|2|||
41958260|NCT01512108|75726210|FG000|Overall Study|Withdrawal Criteria|1|||
41958261|NCT01512108|75726211|FG001|Overall Study|Withdrawal Criteria|0|||
41958262|NCT01512108|75726210|FG000|Overall Study|Unclassified|11|||
41958263|NCT01512108|75726211|FG001|Overall Study|Unclassified|3|||
41958264|NCT01486758|75726219|FG000|Overall Study|Lost to Follow-up|0|||
41958265|NCT01486758|75726220|FG001|Overall Study|Lost to Follow-up|1|||
41958266|NCT01463982|75726231|FG000|Overall Study|Withdrawal by Subject|0|||
41958267|NCT01463982|75726232|FG001|Overall Study|Withdrawal by Subject|1|||
41958268|NCT01463982|75726233|FG002|Overall Study|Withdrawal by Subject|1|||
41958269|NCT01463982|75726234|FG003|Overall Study|Withdrawal by Subject|0|||
41958270|NCT01463982|75726231|FG000|Overall Study|Treatment delay over 5 week|0|||
41958271|NCT01463982|75726232|FG001|Overall Study|Treatment delay over 5 week|0|||
41958272|NCT01463982|75726233|FG002|Overall Study|Treatment delay over 5 week|1|||
41958273|NCT01463982|75726234|FG003|Overall Study|Treatment delay over 5 week|0|||
41958274|NCT01486446|75726246|FG000|Overall Study|Adverse Event|1|||
41958275|NCT01486446|75726247|FG001|Overall Study|Adverse Event|0|||
41958276|NCT01485354|75726253|FG000|Overall Study|Withdrawal by Subject|5|||
41958277|NCT01510158|75726260|FG000|Overall Study|Adverse Event|7|||
41958278|NCT01510158|75726261|FG001|Overall Study|Adverse Event|8|||
41958279|NCT01510158|75726262|FG002|Overall Study|Adverse Event|5|||
41958280|NCT01510158|75726260|FG000|Overall Study|Gout flare|1|||
41958281|NCT01510158|75726261|FG001|Overall Study|Gout flare|0|||
41958282|NCT01510158|75726262|FG002|Overall Study|Gout flare|0|||
41958283|NCT01510158|75726260|FG000|Overall Study|Protocol Violation|17|||
41958284|NCT01510158|75726261|FG001|Overall Study|Protocol Violation|16|||
41958285|NCT01510158|75726262|FG002|Overall Study|Protocol Violation|24|||
41958286|NCT01510158|75726260|FG000|Overall Study|Sponsor terminated study.|2|||
41958287|NCT01510158|75726261|FG001|Overall Study|Sponsor terminated study.|0|||
41958288|NCT01510158|75726262|FG002|Overall Study|Sponsor terminated study.|2|||
41958289|NCT01510158|75726260|FG000|Overall Study|Lost to Follow-up|13|||
41958290|NCT01510158|75726261|FG001|Overall Study|Lost to Follow-up|16|||
41958291|NCT01510158|75726262|FG002|Overall Study|Lost to Follow-up|9|||
41958292|NCT01510158|75726260|FG000|Overall Study|Withdrawal by Subject|10|||
41958293|NCT01510158|75726261|FG001|Overall Study|Withdrawal by Subject|13|||
41958294|NCT01510158|75726262|FG002|Overall Study|Withdrawal by Subject|10|||
41958295|NCT01510158|75726260|FG000|Overall Study|Death|1|||
41958296|NCT01510158|75726261|FG001|Overall Study|Death|0|||
41958297|NCT01510158|75726262|FG002|Overall Study|Death|0|||
41958298|NCT01485120|75726279|FG000|Overall Study|Withdrawal by Subject|2|||
41958299|NCT01484496|75726286|FG000|Period 1|Protocol Violation|3|||
41958300|NCT01484496|75726287|FG001|Period 1|Protocol Violation|4|||
41958301|NCT01484496|75726288|FG002|Period 1|Protocol Violation|0|||
41958302|NCT01484496|75726289|FG003|Period 1|Protocol Violation|0|||
41958303|NCT01484496|75726286|FG000|Period 1|Physician Decision|5|||
41958304|NCT01484496|75726287|FG001|Period 1|Physician Decision|1|||
41958305|NCT01484496|75726288|FG002|Period 1|Physician Decision|0|||
41958306|NCT01484496|75726289|FG003|Period 1|Physician Decision|0|||
41958307|NCT01484496|75726286|FG000|Period 1|Lack of Efficacy|10|||
41958308|NCT01484496|75726287|FG001|Period 1|Lack of Efficacy|15|||
41958309|NCT01484496|75726288|FG002|Period 1|Lack of Efficacy|0|||
41958310|NCT01484496|75726289|FG003|Period 1|Lack of Efficacy|0|||
41958311|NCT01484496|75726286|FG000|Period 1|Adverse Event|25|||
41958312|NCT01484496|75726287|FG001|Period 1|Adverse Event|40|||
41958313|NCT01484496|75726288|FG002|Period 1|Adverse Event|0|||
41958314|NCT01484496|75726289|FG003|Period 1|Adverse Event|0|||
41958315|NCT01484496|75726286|FG000|Period 1|Withdrawal by Subject|15|||
41958316|NCT01484496|75726287|FG001|Period 1|Withdrawal by Subject|12|||
41958317|NCT01484496|75726288|FG002|Period 1|Withdrawal by Subject|0|||
41958318|NCT01484496|75726289|FG003|Period 1|Withdrawal by Subject|0|||
41958319|NCT01484496|75726286|FG000|Period 1|Lost to Follow-up|2|||
41958320|NCT01484496|75726287|FG001|Period 1|Lost to Follow-up|6|||
41958321|NCT01484496|75726288|FG002|Period 1|Lost to Follow-up|0|||
41958322|NCT01484496|75726289|FG003|Period 1|Lost to Follow-up|0|||
41958323|NCT01484496|75726286|FG000|Period 1|Positive Pregnancy|1|||
41958324|NCT01484496|75726287|FG001|Period 1|Positive Pregnancy|6|||
41958325|NCT01484496|75726288|FG002|Period 1|Positive Pregnancy|0|||
41958326|NCT01484496|75726289|FG003|Period 1|Positive Pregnancy|0|||
41958327|NCT01484496|75726286|FG000|Period 1|Treatment Failure|3|||
41958328|NCT01484496|75726287|FG001|Period 1|Treatment Failure|6|||
41958329|NCT01484496|75726288|FG002|Period 1|Treatment Failure|0|||
41958330|NCT01484496|75726289|FG003|Period 1|Treatment Failure|0|||
41958331|NCT01484496|75726286|FG000|Period 1|Lack of Compliance|2|||
41958332|NCT01484496|75726287|FG001|Period 1|Lack of Compliance|1|||
41958333|NCT01484496|75726288|FG002|Period 1|Lack of Compliance|0|||
41958334|NCT01484496|75726289|FG003|Period 1|Lack of Compliance|0|||
41958335|NCT01484496|75726286|FG000|Period 1|Unable to Visit Site|0|||
41958336|NCT01484496|75726287|FG001|Period 1|Unable to Visit Site|2|||
41958337|NCT01484496|75726288|FG002|Period 1|Unable to Visit Site|0|||
41958338|NCT01484496|75726289|FG003|Period 1|Unable to Visit Site|0|||
41958339|NCT01484496|75726286|FG000|Period 2|Lack of Efficacy|0|||
41958340|NCT01484496|75726287|FG001|Period 2|Lack of Efficacy|0|||
41958341|NCT01484496|75726288|FG002|Period 2|Lack of Efficacy|1|||
41958342|NCT01484496|75726289|FG003|Period 2|Lack of Efficacy|3|||
41958343|NCT01484496|75726286|FG000|Period 2|Adverse Event|0|||
41958344|NCT01484496|75726287|FG001|Period 2|Adverse Event|0|||
41958345|NCT01484496|75726288|FG002|Period 2|Adverse Event|5|||
41958346|NCT01484496|75726289|FG003|Period 2|Adverse Event|13|||
41958347|NCT01484496|75726286|FG000|Period 2|Other|0|||
41958348|NCT01484496|75726287|FG001|Period 2|Other|0|||
41958349|NCT01484496|75726288|FG002|Period 2|Other|9|||
41958350|NCT01484496|75726289|FG003|Period 2|Other|6|||
41958351|NCT01509846|75726302|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
41958352|NCT01509846|75726303|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
41958353|NCT01509846|75726304|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
41958354|NCT01509846|75726305|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
41958355|NCT01509846|75726306|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
41958356|NCT01509846|75726302|FG000|Received Vaccination 2|Illness|0|||
41958357|NCT01509846|75726303|FG001|Received Vaccination 2|Illness|0|||
41958358|NCT01509846|75726304|FG002|Received Vaccination 2|Illness|0|||
41958359|NCT01509846|75726305|FG003|Received Vaccination 2|Illness|0|||
41958360|NCT01509846|75726306|FG004|Received Vaccination 2|Illness|1|||
41958361|NCT01509846|75726302|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
41958362|NCT01509846|75726303|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
41958363|NCT01509846|75726304|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
41958364|NCT01509846|75726305|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
41958365|NCT01509846|75726306|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
41958366|NCT01509846|75726302|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
41958367|NCT01509846|75726303|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
41958368|NCT01509846|75726304|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
41958369|NCT01509846|75726305|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
41958370|NCT01509846|75726306|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
41958371|NCT01509846|75726302|FG000|Received Vaccination 3|Pregnancy|0|||
41958372|NCT01509846|75726303|FG001|Received Vaccination 3|Pregnancy|0|||
41958373|NCT01509846|75726304|FG002|Received Vaccination 3|Pregnancy|0|||
41958374|NCT01509846|75726305|FG003|Received Vaccination 3|Pregnancy|1|||
41958375|NCT01509846|75726306|FG004|Received Vaccination 3|Pregnancy|0|||
41958376|NCT01509846|75726302|FG000|Received Vaccination 3|Lost to Follow-up|0|||
41958377|NCT01509846|75726303|FG001|Received Vaccination 3|Lost to Follow-up|0|||
41958378|NCT01509846|75726304|FG002|Received Vaccination 3|Lost to Follow-up|1|||
41958379|NCT01509846|75726305|FG003|Received Vaccination 3|Lost to Follow-up|0|||
41958380|NCT01509846|75726306|FG004|Received Vaccination 3|Lost to Follow-up|0|||
41958381|NCT01462344|75726327|FG000|Overall Study|Withdrawal by Subject|245|||
41958382|NCT01462344|75726328|FG001|Overall Study|Withdrawal by Subject|226|||
41958383|NCT01462344|75726327|FG000|Overall Study|Adverse Event|24|||
41958384|NCT01462344|75726328|FG001|Overall Study|Adverse Event|23|||
41958385|NCT01462344|75726327|FG000|Overall Study|Asthma Exacerbation|34|||
41958386|NCT01462344|75726328|FG001|Overall Study|Asthma Exacerbation|35|||
41958387|NCT01462344|75726327|FG000|Overall Study|Lack of Efficacy|5|||
41958388|NCT01462344|75726328|FG001|Overall Study|Lack of Efficacy|6|||
41958389|NCT01462344|75726327|FG000|Overall Study|Protocol Violation|68|||
41958390|NCT01462344|75726328|FG001|Overall Study|Protocol Violation|53|||
41958391|NCT01462344|75726327|FG000|Overall Study|Lost to Follow-up|7|||
41958392|NCT01462344|75726328|FG001|Overall Study|Lost to Follow-up|7|||
41958393|NCT01484028|75726334|FG000|Period 1|Lost to Follow-up|0|||
41958394|NCT01484028|75726335|FG001|Period 1|Lost to Follow-up|1|||
41958395|NCT01484028|75726336|FG002|Period 1|Lost to Follow-up|0|||
41958396|NCT01484028|75726337|FG003|Period 1|Lost to Follow-up|0|||
41958397|NCT01484028|75726334|FG000|Period 1|Non-Compliance to Protocol|0|||
41958398|NCT01484028|75726335|FG001|Period 1|Non-Compliance to Protocol|1|||
41958399|NCT01484028|75726336|FG002|Period 1|Non-Compliance to Protocol|0|||
41958400|NCT01484028|75726337|FG003|Period 1|Non-Compliance to Protocol|1|||
41958401|NCT01484028|75726334|FG000|Period 1|Lens Discomfort|0|||
41958402|NCT01484028|75726335|FG001|Period 1|Lens Discomfort|1|||
41958403|NCT01484028|75726336|FG002|Period 1|Lens Discomfort|0|||
41958404|NCT01484028|75726337|FG003|Period 1|Lens Discomfort|0|||
41958405|NCT01462266|75726347|FG000|Overall Study|Adverse Event|7|||
41958406|NCT01462266|75726348|FG001|Overall Study|Adverse Event|6|||
41958407|NCT01462266|75726347|FG000|Overall Study|Death|2|||
41958408|NCT01462266|75726348|FG001|Overall Study|Death|1|||
41958409|NCT01462266|75726347|FG000|Overall Study|Lack of Efficacy|0|||
41958410|NCT01462266|75726348|FG001|Overall Study|Lack of Efficacy|2|||
41958411|NCT01462266|75726347|FG000|Overall Study|Lost to Follow-up|4|||
41958412|NCT01462266|75726348|FG001|Overall Study|Lost to Follow-up|3|||
41958413|NCT01462266|75726347|FG000|Overall Study|Non-compliance with study drug|3|||
41958414|NCT01462266|75726348|FG001|Overall Study|Non-compliance with study drug|0|||
41958415|NCT01462266|75726347|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
41958416|NCT01462266|75726348|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
41958417|NCT01462266|75726347|FG000|Overall Study|Physician Decision|2|||
41958418|NCT01462266|75726348|FG001|Overall Study|Physician Decision|5|||
41958419|NCT01462266|75726347|FG000|Overall Study|Protocol Violation|1|||
41958420|NCT01462266|75726348|FG001|Overall Study|Protocol Violation|3|||
41958421|NCT01462266|75726347|FG000|Overall Study|Withdrawal by Subject|7|||
41958422|NCT01462266|75726348|FG001|Overall Study|Withdrawal by Subject|2|||
41958423|NCT01462266|75726347|FG000|Overall Study|Screen failure|1|||
41958424|NCT01462266|75726348|FG001|Overall Study|Screen failure|1|||
41958425|NCT01508910|75726357|FG000|Treatment|Death|2|||
41958426|NCT01508910|75726358|FG001|Treatment|Death|3|||
41958427|NCT01508910|75726359|FG002|Treatment|Death|2|||
41958428|NCT01508910|75726360|FG003|Treatment|Death|0|||
41958429|NCT01508910|75726357|FG000|Treatment|Lost to Follow-up|0|||
41958430|NCT01508910|75726358|FG001|Treatment|Lost to Follow-up|0|||
41958431|NCT01508910|75726359|FG002|Treatment|Lost to Follow-up|2|||
41958432|NCT01508910|75726360|FG003|Treatment|Lost to Follow-up|1|||
41958433|NCT01508910|75726357|FG000|Treatment|Withdrawal by Subject|0|||
41958434|NCT01508910|75726358|FG001|Treatment|Withdrawal by Subject|1|||
41958435|NCT01508910|75726359|FG002|Treatment|Withdrawal by Subject|6|||
41958436|NCT01508910|75726360|FG003|Treatment|Withdrawal by Subject|1|||
41958437|NCT01508910|75726357|FG000|Treatment|Sponsor Decision|0|||
41958438|NCT01508910|75726358|FG001|Treatment|Sponsor Decision|0|||
41958439|NCT01508910|75726359|FG002|Treatment|Sponsor Decision|0|||
41958440|NCT01508910|75726360|FG003|Treatment|Sponsor Decision|1|||
41958441|NCT01462110|75726374|FG000|Overall Study|Adverse Event|1|||
41958442|NCT01462110|75726375|FG001|Overall Study|Adverse Event|0|||
41958443|NCT01508676|75726383|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
41958444|NCT01508676|75726384|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
41958445|NCT01508676|75726383|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
41958446|NCT01508676|75726384|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
41958447|NCT01508676|75726383|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
41958448|NCT01508676|75726384|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
41958449|NCT01508676|75726383|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
41958450|NCT01508676|75726384|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
41958451|NCT01508676|75726383|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
41958452|NCT01508676|75726384|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
41958453|NCT01508130|75726393|FG000|Overall Study|Adverse Event|81|||
41958454|NCT01508130|75726394|FG001|Overall Study|Adverse Event|28|||
41958455|NCT01508130|75726393|FG000|Overall Study|Death|3|||
41958456|NCT01508130|75726394|FG001|Overall Study|Death|1|||
41958457|NCT01508130|75726393|FG000|Overall Study|Protocol Violation|2|||
41958458|NCT01508130|75726394|FG001|Overall Study|Protocol Violation|0|||
41958459|NCT01508130|75726393|FG000|Overall Study|Lost to Follow-up|25|||
41958460|NCT01508130|75726394|FG001|Overall Study|Lost to Follow-up|2|||
41958461|NCT01508130|75726393|FG000|Overall Study|Withdrawal by Subject|3|||
41958462|NCT01508130|75726394|FG001|Overall Study|Withdrawal by Subject|3|||
41958463|NCT01508130|75726393|FG000|Overall Study|Subject's substantial non-compliance|25|||
41958464|NCT01508130|75726394|FG001|Overall Study|Subject's substantial non-compliance|9|||
41958465|NCT01508130|75726393|FG000|Overall Study|Insufficient therapeutic response|74|||
41958466|NCT01508130|75726394|FG001|Overall Study|Insufficient therapeutic response|23|||
41958467|NCT01508130|75726393|FG000|Overall Study|Administrative|14|||
41958468|NCT01508130|75726394|FG001|Overall Study|Administrative|3|||
41958469|NCT01482312|75726402|FG000|Period 1, 90 Minutes of Wear|Other|1|||
41958470|NCT01482312|75726403|FG001|Period 1, 90 Minutes of Wear|Other|0|||
41958471|NCT01482312|75726404|FG002|Period 1, 90 Minutes of Wear|Other|0|||
41958472|NCT01482312|75726402|FG000|Period 2, 90 Minutes of Wear|Other|1|||
41958473|NCT01482312|75726403|FG001|Period 2, 90 Minutes of Wear|Other|0|||
41958474|NCT01482312|75726404|FG002|Period 2, 90 Minutes of Wear|Other|0|||
41958475|NCT01461096|75726414|FG000|Overall Study|Death|3|||
41958476|NCT01461096|75726415|FG001|Overall Study|Death|6|||
41958477|NCT01461096|75726414|FG000|Overall Study|Severe debilitation, unable to continue|1|||
41958478|NCT01461096|75726415|FG001|Overall Study|Severe debilitation, unable to continue|1|||
41958479|NCT01461096|75726414|FG000|Overall Study|Subj not able to get to clinic|15|||
41958480|NCT01461096|75726415|FG001|Overall Study|Subj not able to get to clinic|13|||
41958481|NCT01461096|75726414|FG000|Overall Study|Site is closing|27|||
41958482|NCT01461096|75726415|FG001|Overall Study|Site is closing|30|||
41958483|NCT01461096|75726414|FG000|Overall Study|Withdrawal by Subject|5|||
41958484|NCT01461096|75726415|FG001|Overall Study|Withdrawal by Subject|3|||
41958485|NCT01461096|75726414|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
41958486|NCT01461096|75726415|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
41958487|NCT01461096|75726414|FG000|Overall Study|Lost to Follow-up|8|||
41958488|NCT01461096|75726415|FG001|Overall Study|Lost to Follow-up|4|||
41958489|NCT01507896|75726422|FG000|Overall Study|Withdrawal by Subject|1|||
41958490|NCT01507896|75726422|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
41958491|NCT01507662|75726437|FG000|Overall Study|Death|26|||
41958492|NCT01507662|75726438|FG001|Overall Study|Death|18|||
41958493|NCT01507662|75726437|FG000|Overall Study|Withdrawal by Subject|290|||
41958494|NCT01507662|75726438|FG001|Overall Study|Withdrawal by Subject|287|||
41958495|NCT01507662|75726437|FG000|Overall Study|Lost to Follow-up|498|||
41958496|NCT01507662|75726438|FG001|Overall Study|Lost to Follow-up|523|||
41958497|NCT01507662|75726437|FG000|Overall Study|Proxy interview done|2|||
41958498|NCT01507662|75726438|FG001|Overall Study|Proxy interview done|3|||
41958499|NCT01506960|75726444|FG000|Overall Study|Did not meet angiographic criteria|47|||
41958500|NCT01480674|75726450|FG000|Overall Study|Death|23|||
41958501|NCT01480674|75726450|FG000|Overall Study|Lost to Follow-up|2|||
41958502|NCT01480674|75726450|FG000|Overall Study|visit not done|10|||
41958503|NCT01506882|75726456|FG000|Overall Study|Lack of Efficacy|4|||
41958504|NCT01506882|75726457|FG001|Overall Study|Lack of Efficacy|3|||
41958505|NCT01506882|75726456|FG000|Overall Study|Lost to Follow-up|1|||
41958506|NCT01506882|75726457|FG001|Overall Study|Lost to Follow-up|0|||
41958507|NCT01506882|75726456|FG000|Overall Study|Withdrawal by Subject|9|||
41958508|NCT01506882|75726457|FG001|Overall Study|Withdrawal by Subject|3|||
41958509|NCT01506882|75726456|FG000|Overall Study|SAE, non-fatal|2|||
41958510|NCT01506882|75726457|FG001|Overall Study|SAE, non-fatal|0|||
41958511|NCT01506882|75726456|FG000|Overall Study|AE, non-serious non-fatal|3|||
41958512|NCT01506882|75726457|FG001|Overall Study|AE, non-serious non-fatal|1|||
41958513|NCT01506882|75726456|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
41958514|NCT01506882|75726457|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
41958515|NCT01506882|75726456|FG000|Overall Study|Other Reason|2|||
41958516|NCT01506882|75726457|FG001|Overall Study|Other Reason|0|||
41958517|NCT01506726|75726467|FG000|Overall Study|Adverse Event|1|||
41958518|NCT01506726|75726468|FG001|Overall Study|Adverse Event|2|||
41958519|NCT01505868|75726479|FG000|Overall Study|Withdrawal by Subject|1|||
41958520|NCT01505868|75726480|FG001|Overall Study|Withdrawal by Subject|0|||
41958521|NCT01505868|75726481|FG002|Overall Study|Withdrawal by Subject|0|||
41958522|NCT01505868|75726482|FG003|Overall Study|Withdrawal by Subject|0|||
41958523|NCT01505868|75726483|FG004|Overall Study|Withdrawal by Subject|0|||
41958524|NCT01505634|75726498|FG000|Overall Study|Withdrawal by Subject|2|||
41958525|NCT01505634|75726499|FG001|Overall Study|Withdrawal by Subject|5|||
41958526|NCT01505634|75726500|FG002|Overall Study|Withdrawal by Subject|1|||
41958527|NCT01505634|75726498|FG000|Overall Study|Physician Decision|1|||
41958528|NCT01505634|75726499|FG001|Overall Study|Physician Decision|1|||
41958529|NCT01505634|75726500|FG002|Overall Study|Physician Decision|0|||
41958530|NCT01505634|75726498|FG000|Overall Study|Adverse Event|1|||
41958531|NCT01505634|75726499|FG001|Overall Study|Adverse Event|0|||
41958532|NCT01505634|75726500|FG002|Overall Study|Adverse Event|0|||
41958533|NCT01505634|75726498|FG000|Overall Study|Insufficient supply of drug at site|1|||
41958534|NCT01505634|75726499|FG001|Overall Study|Insufficient supply of drug at site|0|||
41958535|NCT01505634|75726500|FG002|Overall Study|Insufficient supply of drug at site|0|||
41958536|NCT01505634|75726498|FG000|Overall Study|Protocol Violation|2|||
41958537|NCT01505634|75726499|FG001|Overall Study|Protocol Violation|0|||
41958538|NCT01505634|75726500|FG002|Overall Study|Protocol Violation|0|||
41958539|NCT01505634|75726498|FG000|Overall Study|Lost to Follow-up|1|||
41958540|NCT01505634|75726499|FG001|Overall Study|Lost to Follow-up|4|||
41958541|NCT01505634|75726500|FG002|Overall Study|Lost to Follow-up|4|||
41958542|NCT01505634|75726498|FG000|Overall Study|Death|1|||
41958543|NCT01505634|75726499|FG001|Overall Study|Death|0|||
41958544|NCT01505634|75726500|FG002|Overall Study|Death|0|||
41958545|NCT01505634|75726498|FG000|Overall Study|In a conflict zone|0|||
41958546|NCT01505634|75726499|FG001|Overall Study|In a conflict zone|0|||
41958547|NCT01505634|75726500|FG002|Overall Study|In a conflict zone|1|||
41958548|NCT01460628|75726508|FG000|Overall Study|Adverse Event|3|||
41958549|NCT01460628|75726508|FG000|Overall Study|Withdrawal by Subject|2|||
41958550|NCT01480596|75726514|FG000|Overall Study|Adverse Event|3|||
41958551|NCT01480596|75726515|FG001|Overall Study|Adverse Event|0|||
41958552|NCT01480596|75726514|FG000|Overall Study|MG exacerbation or change in medication|2|||
41958553|NCT01480596|75726515|FG001|Overall Study|MG exacerbation or change in medication|2|||
41958554|NCT01480284|75726523|FG000|Overall Study|Withdrawal by Subject|2|||
41958555|NCT01480284|75726524|FG001|Overall Study|Withdrawal by Subject|0|||
41958556|NCT01480284|75726523|FG000|Overall Study|Adverse Event|1|||
41958557|NCT01480284|75726524|FG001|Overall Study|Adverse Event|0|||
42024335|NCT01225211|75831755|FG009|Overall Study|Adverse Event|1|||
42024336|NCT01225211|75831746|FG000|Overall Study|Withdrawal by Subject|0|||
42024337|NCT01225211|75831747|FG001|Overall Study|Withdrawal by Subject|0|||
42024338|NCT01225211|75831748|FG002|Overall Study|Withdrawal by Subject|0|||
42024339|NCT01225211|75831749|FG003|Overall Study|Withdrawal by Subject|0|||
42024340|NCT01225211|75831750|FG004|Overall Study|Withdrawal by Subject|0|||
42024341|NCT01225211|75831751|FG005|Overall Study|Withdrawal by Subject|0|||
42024342|NCT01225211|75831752|FG006|Overall Study|Withdrawal by Subject|1|||
42024343|NCT01225211|75831753|FG007|Overall Study|Withdrawal by Subject|0|||
42024344|NCT01225211|75831754|FG008|Overall Study|Withdrawal by Subject|1|||
42024345|NCT01225211|75831755|FG009|Overall Study|Withdrawal by Subject|3|||
42024346|NCT01225211|75831746|FG000|Overall Study|Other|0|||
42024347|NCT01225211|75831747|FG001|Overall Study|Other|0|||
42024348|NCT01225211|75831748|FG002|Overall Study|Other|0|||
42024349|NCT01225211|75831749|FG003|Overall Study|Other|0|||
42024350|NCT01225211|75831750|FG004|Overall Study|Other|0|||
42024351|NCT01225211|75831751|FG005|Overall Study|Other|0|||
42024352|NCT01225211|75831752|FG006|Overall Study|Other|0|||
42024353|NCT01225211|75831753|FG007|Overall Study|Other|0|||
42024354|NCT01225211|75831754|FG008|Overall Study|Other|0|||
42024355|NCT01225211|75831755|FG009|Overall Study|Other|1|||
42024356|NCT01224821|75831838|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
42024357|NCT01224821|75831838|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
41958558|NCT01480284|75726523|FG000|Overall Study|Study closed/terminated|3|||
41958559|NCT01480284|75726524|FG001|Overall Study|Study closed/terminated|0|||
42024358|NCT01224821|75831838|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
42024359|NCT01224821|75831838|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
42024360|NCT01224821|75831838|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
42024361|NCT01224821|75831838|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
42024362|NCT01224821|75831838|FG000|Long-Term Follow-Up|Death|2|||
42024363|NCT01224821|75831838|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
42024364|NCT01224431|75831855|FG000|Overall Study|not randomized|0|||
42024365|NCT01224431|75831856|FG001|Overall Study|not randomized|4|||
42024366|NCT01224431|75831855|FG000|Overall Study|no video record|0|||
42024367|NCT01224431|75831856|FG001|Overall Study|no video record|1|||
42024368|NCT01223183|75831866|FG000|Imaging Day 1|Physician Decision|0|||
42024369|NCT01223183|75831867|FG001|Imaging Day 1|Physician Decision|1|||
42024370|NCT01223183|75831866|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
42024371|NCT01223183|75831867|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
42024372|NCT01223183|75831866|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
42024373|NCT01223183|75831867|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
42024374|NCT01223027|75831876|FG000|Overall Study|Adverse Event|20|||
42024375|NCT01223027|75831877|FG001|Overall Study|Adverse Event|10|||
42024376|NCT01223027|75831876|FG000|Overall Study|Death|42|||
42024377|NCT01223027|75831877|FG001|Overall Study|Death|42|||
42024378|NCT01223027|75831876|FG000|Overall Study|Lost to Follow-up|2|||
41958560|NCT01480284|75726523|FG000|Overall Study|Lost to Follow-up|1|||
42024379|NCT01223027|75831877|FG001|Overall Study|Lost to Follow-up|1|||
42024380|NCT01223027|75831876|FG000|Overall Study|Physician Decision|4|||
42024381|NCT01223027|75831877|FG001|Overall Study|Physician Decision|8|||
42024382|NCT01223027|75831876|FG000|Overall Study|Progressive Disease|167|||
42024383|NCT01223027|75831877|FG001|Overall Study|Progressive Disease|183|||
42024384|NCT01223027|75831876|FG000|Overall Study|Protocol Violation|2|||
42024385|NCT01223027|75831877|FG001|Overall Study|Protocol Violation|1|||
42024386|NCT01223027|75831876|FG000|Overall Study|Subject/guardian decicion|18|||
42024387|NCT01223027|75831877|FG001|Overall Study|Subject/guardian decicion|16|||
42024388|NCT01223027|75831876|FG000|Overall Study|New therapy for study indication|17|||
42024389|NCT01223027|75831877|FG001|Overall Study|New therapy for study indication|8|||
42024390|NCT01223027|75831876|FG000|Overall Study|Study terminated by sponsor|2|||
42024391|NCT01223027|75831877|FG001|Overall Study|Study terminated by sponsor|8|||
42024392|NCT01015287|75831885|FG000|Overall Study|Death|21|||
42024393|NCT01015287|75831886|FG001|Overall Study|Death|16|||
42024394|NCT01015287|75831885|FG000|Overall Study|Adverse Event|1|||
41958561|NCT01480284|75726524|FG001|Overall Study|Lost to Follow-up|0|||
41958562|NCT01480284|75726523|FG000|Overall Study|Physician Decision|1|||
41958563|NCT01480284|75726524|FG001|Overall Study|Physician Decision|0|||
41958564|NCT01459614|75726532|FG000|Overall Study|Adverse Event|1|||
41958565|NCT01459614|75726533|FG001|Overall Study|Adverse Event|0|||
41958566|NCT01458522|75726541|FG000|Overall Study|Withdrawal by Subject|2|||
41958567|NCT01458522|75726542|FG001|Overall Study|Withdrawal by Subject|2|||
41958568|NCT01458522|75726541|FG000|Overall Study|Physician Decision|1|||
41958569|NCT01458522|75726542|FG001|Overall Study|Physician Decision|9|||
41958570|NCT01505010|75726556|FG000|Overall Study|Protocol Violation|0|||
41958571|NCT01505010|75726557|FG001|Overall Study|Protocol Violation|1|||
41958572|NCT01505010|75726556|FG000|Overall Study|Lost to Follow-up|0|||
42024395|NCT01015287|75831886|FG001|Overall Study|Adverse Event|0|||
42024396|NCT01015287|75831885|FG000|Overall Study|Sponsor Decision|3|||
42024397|NCT01015287|75831886|FG001|Overall Study|Sponsor Decision|7|||
42024398|NCT01015287|75831885|FG000|Overall Study|Physician Decision|19|||
42024399|NCT01015287|75831886|FG001|Overall Study|Physician Decision|21|||
42024400|NCT01015287|75831885|FG000|Overall Study|Withdrawal by Subject|14|||
42024401|NCT01015287|75831886|FG001|Overall Study|Withdrawal by Subject|19|||
42024402|NCT01015287|75831885|FG000|Overall Study|Entry Criteria not Met|11|||
42024403|NCT01015287|75831886|FG001|Overall Study|Entry Criteria not Met|14|||
42024404|NCT01015287|75831885|FG000|Overall Study|Lost to Follow-up|2|||
42024405|NCT01015287|75831886|FG001|Overall Study|Lost to Follow-up|1|||
42024406|NCT01015287|75831885|FG000|Overall Study|Protocol Violation|1|||
42024407|NCT01015287|75831886|FG001|Overall Study|Protocol Violation|1|||
42024408|NCT01015131|75831894|FG000|Overall Study|Physician Decision|1|||
42024409|NCT01015131|75831894|FG000|Overall Study|Protocol Violation|1|||
42024410|NCT01015131|75831894|FG000|Overall Study|Withdrawal by Subject|2|||
42024411|NCT01015131|75831894|FG000|Overall Study|Other Protocol Specified Criteria|4|||
42024412|NCT01222715|75831900|FG000|Overall Study|Adverse Event|0|||
42024413|NCT01222715|75831901|FG001|Overall Study|Adverse Event|4|||
42024414|NCT01222715|75831900|FG000|Overall Study|Death|0|||
41958573|NCT01505010|75726557|FG001|Overall Study|Lost to Follow-up|1|||
41958574|NCT01458210|75726563|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
42024415|NCT01222715|75831901|FG001|Overall Study|Death|1|||
42024416|NCT01222715|75831900|FG000|Overall Study|Lack of Efficacy|22|||
42024417|NCT01222715|75831901|FG001|Overall Study|Lack of Efficacy|14|||
42024418|NCT01222715|75831900|FG000|Overall Study|Physician Decision|12|||
42024419|NCT01222715|75831901|FG001|Overall Study|Physician Decision|2|||
42024420|NCT01222715|75831900|FG000|Overall Study|Refusal of further protocol therapy|0|||
42024421|NCT01222715|75831901|FG001|Overall Study|Refusal of further protocol therapy|4|||
42024422|NCT01222715|75831900|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
42118046|NCT00689117|75928843|FG003|Overall Study|Dispensing Error|0|||
41958575|NCT01458210|75726563|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
41958576|NCT01458210|75726563|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
41958577|NCT01458210|75726563|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
41958578|NCT01478958|75726573|FG000|Overall Study|Withdrawal by Subject|1|||
41958579|NCT01478958|75726574|FG001|Overall Study|Withdrawal by Subject|1|||
41958580|NCT01478958|75726575|FG002|Overall Study|Withdrawal by Subject|1|||
41958581|NCT01478958|75726573|FG000|Overall Study|Weight loss|1|||
41958582|NCT01478958|75726574|FG001|Overall Study|Weight loss|0|||
41958583|NCT01478958|75726575|FG002|Overall Study|Weight loss|0|||
41958584|NCT01478958|75726573|FG000|Overall Study|Re-located|0|||
41958585|NCT01478958|75726574|FG001|Overall Study|Re-located|1|||
41958586|NCT01478958|75726575|FG002|Overall Study|Re-located|0|||
41958587|NCT01478958|75726573|FG000|Overall Study|Unable to comply|0|||
41958588|NCT01478958|75726574|FG001|Overall Study|Unable to comply|0|||
41958589|NCT01478958|75726575|FG002|Overall Study|Unable to comply|2|||
41958590|NCT01458132|75726585|FG000|Overall Study|Other|15|||
41958591|NCT01458132|75726586|FG001|Overall Study|Other|3|||
41958592|NCT05220254|75726596|FG000|Overall Study|Withdrawal by Subject|4|||
41958593|NCT05220254|75726596|FG000|Overall Study|Removed due to ineligibility|1|||
41958594|NCT05220254|75726596|FG000|Overall Study|Lost to Follow-up|7|||
41958595|NCT05178121|75726600|FG000|Overall Study|Other|4|||
41958596|NCT05178121|75726600|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
41958597|NCT05110690|75726605|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
41958598|NCT05110690|75726605|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
41958599|NCT05110690|75726605|FG000|Completion of Intervention|Lost to Follow-up|1|||
41958600|NCT05110690|75726605|FG000|Completion of Intervention|Death|1|||
41958601|NCT05110690|75726605|FG000|Completion of Intervention|Withdrawal by Subject|2|||
41958602|NCT04842604|75726620|FG000|Overall Study|Death|1|||
41958603|NCT04842604|75726621|FG001|Overall Study|Death|0|||
41958604|NCT04842604|75726620|FG000|Overall Study|Other|4|||
41958605|NCT04842604|75726621|FG001|Overall Study|Other|4|||
41958606|NCT04842604|75726620|FG000|Overall Study|Randomized but not treated|1|||
41958607|NCT04842604|75726621|FG001|Overall Study|Randomized but not treated|0|||
41958608|NCT04508621|75726638|FG000|Overall Study|Adverse Event|39|||
41958609|NCT04508621|75726639|FG001|Overall Study|Adverse Event|16|||
41958610|NCT04508621|75726638|FG000|Overall Study|Lack of Efficacy|2|||
41958611|NCT04508621|75726639|FG001|Overall Study|Lack of Efficacy|8|||
41958612|NCT04508621|75726638|FG000|Overall Study|Physician Decision|0|||
41958613|NCT04508621|75726639|FG001|Overall Study|Physician Decision|1|||
41958614|NCT04508621|75726638|FG000|Overall Study|Withdrawal by Subject|10|||
41958615|NCT04508621|75726639|FG001|Overall Study|Withdrawal by Subject|14|||
41958616|NCT04508621|75726638|FG000|Overall Study|Lost to Follow-up|12|||
41958617|NCT04508621|75726639|FG001|Overall Study|Lost to Follow-up|9|||
41958618|NCT04508621|75726638|FG000|Overall Study|COVID-19 related crisis|3|||
41958619|NCT04508621|75726639|FG001|Overall Study|COVID-19 related crisis|0|||
41958620|NCT04508621|75726638|FG000|Overall Study|Subject non-compliance|1|||
41958621|NCT04508621|75726639|FG001|Overall Study|Subject non-compliance|0|||
41958622|NCT04416204|75726647|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
41958623|NCT04416204|75726648|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
41958624|NCT04416204|75726649|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
41958625|NCT04416204|75726650|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
41958626|NCT04158648|75726660|FG000|Overall Study|Ongoing in the Study|69|||
41958627|NCT04158648|75726660|FG000|Overall Study|Withdrawal by Subject|4|||
41958628|NCT04107935|75726669|FG000|Overall Study|Death|1|||
41958629|NCT04107935|75726670|FG001|Overall Study|Death|0|||
41958630|NCT03923491|75726697|FG000|Overall Study|Lost to Follow-up|5|||
41958631|NCT03923491|75726698|FG001|Overall Study|Lost to Follow-up|8|||
41958632|NCT03923491|75726697|FG000|Overall Study|Withdrawal by Subject|4|||
41958633|NCT03923491|75726698|FG001|Overall Study|Withdrawal by Subject|6|||
41958634|NCT03923426|75726704|FG000|Overall Study|Other|19|||
41958635|NCT03923426|75726704|FG000|Overall Study|Lost to Follow-up|16|||
41958636|NCT03923426|75726704|FG000|Overall Study|Death|107|||
41958637|NCT03923426|75726704|FG000|Overall Study|Incomplete response to question|13|||
41958638|NCT03896152|75726710|FG000|Overall Study|Patient/guardian decision|1|||
41958639|NCT03896152|75726711|FG001|Overall Study|Patient/guardian decision|1|||
41958640|NCT03896152|75726710|FG000|Overall Study|Adverse Event|0|||
41958641|NCT03896152|75726711|FG001|Overall Study|Adverse Event|1|||
41958642|NCT03896152|75726710|FG000|Overall Study|Physician Decision|1|||
41958643|NCT03896152|75726711|FG001|Overall Study|Physician Decision|0|||
41958644|NCT03896152|75726710|FG000|Overall Study|Technical problems|1|||
41958645|NCT03896152|75726711|FG001|Overall Study|Technical problems|0|||
41958646|NCT03794583|75726756|FG000|Overall Study|Death|8|||
41958647|NCT03794583|75726756|FG000|Overall Study|Study Terminated by Sponsor|24|||
41958648|NCT03794583|75726756|FG000|Overall Study|Withdrawal by Subject|9|||
41958649|NCT03759379|75726763|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
41958650|NCT03759379|75726764|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
41958651|NCT03759379|75726763|FG000|Treatment Period|Death|2|||
41958652|NCT03759379|75726764|FG001|Treatment Period|Death|3|||
41958653|NCT03759379|75726763|FG000|Treatment Period|Lost to Follow-up|1|||
41958654|NCT03759379|75726764|FG001|Treatment Period|Lost to Follow-up|0|||
41958655|NCT03759379|75726763|FG000|Treatment Period|Physician Decision|0|||
41958656|NCT03759379|75726764|FG001|Treatment Period|Physician Decision|1|||
41958657|NCT03759366|75726770|FG000|Primary Evaluation Period (26 Weeks)|Ongoing during the Primary Evaluation Period|1|||
41958658|NCT03759366|75726770|FG000|Extension Period (Up to 208 Weeks)|Ongoing during the Extension Period|10|||
41958659|NCT03695237|75726785|FG000|Overall Study|Discontinued to Restart Puberty|1|||
41958660|NCT03695237|75726786|FG001|Overall Study|Discontinued to Restart Puberty|0|||
41958661|NCT03584373|75726795|FG000|Overall Study|Lost to Follow-up|7|||
41958662|NCT03584373|75726796|FG001|Overall Study|Lost to Follow-up|8|||
41958663|NCT03386929|75726809|FG000|Overall Study|Death|0|||
41958664|NCT03386929|75726810|FG001|Overall Study|Death|0|||
41958665|NCT03386929|75726811|FG002|Overall Study|Death|1|||
41958666|NCT03386929|75726809|FG000|Overall Study|Withdrawal by Subject|0|||
41958667|NCT03386929|75726810|FG001|Overall Study|Withdrawal by Subject|1|||
41958668|NCT03386929|75726811|FG002|Overall Study|Withdrawal by Subject|0|||
41958669|NCT03386929|75726809|FG000|Overall Study|Physician Decision|0|||
41958670|NCT03386929|75726810|FG001|Overall Study|Physician Decision|0|||
41958671|NCT03386929|75726811|FG002|Overall Study|Physician Decision|1|||
41958672|NCT03386929|75726809|FG000|Overall Study|Progression|4|||
41958673|NCT03386929|75726810|FG001|Overall Study|Progression|4|||
41958674|NCT03386929|75726811|FG002|Overall Study|Progression|0|||
41958675|NCT03386929|75726809|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
41958676|NCT03386929|75726810|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
41958677|NCT03386929|75726811|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
41958678|NCT03386929|75726809|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
41958679|NCT03386929|75726810|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
41958680|NCT03386929|75726811|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
41958681|NCT02914561|75726853|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
41958682|NCT02914561|75726854|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
41958683|NCT02914561|75726855|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
41958684|NCT02914561|75726856|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
41958685|NCT02914561|75726857|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
41958686|NCT02914561|75726858|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
41958687|NCT02914561|75726859|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
41958688|NCT02914561|75726860|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
41958689|NCT02914561|75726861|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
41958690|NCT02914561|75726862|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
41958691|NCT02914561|75726863|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
41958692|NCT02914561|75726853|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
41958693|NCT02914561|75726854|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
41958694|NCT02914561|75726855|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
41958695|NCT02914561|75726856|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
41958696|NCT02914561|75726857|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
41958697|NCT02914561|75726858|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
41958698|NCT02914561|75726859|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
41958699|NCT02914561|75726860|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
41958700|NCT02914561|75726861|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
41958701|NCT02914561|75726862|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
41958702|NCT02914561|75726863|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
41958703|NCT02914561|75726853|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
41958704|NCT02914561|75726854|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
41958705|NCT02914561|75726855|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
41958706|NCT02914561|75726856|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
41958707|NCT02914561|75726857|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
41958708|NCT02914561|75726858|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
41958709|NCT02914561|75726859|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
41958710|NCT02914561|75726860|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
41958711|NCT02914561|75726861|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
41958712|NCT02914561|75726862|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
41958713|NCT02914561|75726863|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
41958714|NCT02914561|75726853|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
41958715|NCT02914561|75726854|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
41958716|NCT02914561|75726855|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
42300488|NCT02297841|76135675|FG000|Overall Study|Withdrawal by Subject|1|||
41958717|NCT02914561|75726856|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
41958718|NCT02914561|75726857|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
41958719|NCT02914561|75726858|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
41958720|NCT02914561|75726859|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
41958721|NCT02914561|75726860|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
41958722|NCT02914561|75726861|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
41958723|NCT02914561|75726862|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
41958724|NCT02914561|75726863|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
41958725|NCT02914561|75726853|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
41958726|NCT02914561|75726854|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
41958727|NCT02914561|75726855|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
41958728|NCT02914561|75726856|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
41958729|NCT02914561|75726857|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
41958730|NCT02914561|75726858|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
41958731|NCT02914561|75726859|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
41958732|NCT02914561|75726860|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
41958733|NCT02914561|75726861|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
41958734|NCT02914561|75726862|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
41958735|NCT02914561|75726863|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
41958736|NCT02914561|75726853|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
41958737|NCT02914561|75726854|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
41958738|NCT02914561|75726855|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
41958739|NCT02914561|75726856|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
41958740|NCT02914561|75726857|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
41958741|NCT02914561|75726858|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
41958742|NCT02914561|75726859|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
41958743|NCT02914561|75726860|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
41958744|NCT02914561|75726861|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
41958745|NCT02914561|75726862|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
41958746|NCT02914561|75726863|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
41958747|NCT02914561|75726853|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
41958748|NCT02914561|75726854|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
41958749|NCT02914561|75726855|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
41958750|NCT02914561|75726856|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
41958751|NCT02914561|75726857|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
41958752|NCT02914561|75726858|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
41958753|NCT02914561|75726859|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
41958754|NCT02914561|75726860|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
41958755|NCT02914561|75726861|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
41958756|NCT02914561|75726862|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
41958757|NCT02914561|75726863|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
41958758|NCT02914561|75726853|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
41958759|NCT02914561|75726854|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
41958760|NCT02914561|75726855|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
41958761|NCT02914561|75726856|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
41958762|NCT02914561|75726857|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
41958763|NCT02914561|75726858|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
41958764|NCT02914561|75726859|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
41958765|NCT02914561|75726860|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
41958766|NCT02914561|75726861|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
41958767|NCT02914561|75726862|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
41958768|NCT02914561|75726863|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
41958769|NCT02914561|75726853|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
41958770|NCT02914561|75726854|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
41958771|NCT02914561|75726855|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
41958772|NCT02914561|75726856|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
41958773|NCT02914561|75726857|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
41958774|NCT02914561|75726858|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
41958775|NCT02914561|75726859|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
41958776|NCT02914561|75726860|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
41958777|NCT02914561|75726861|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
41958778|NCT02914561|75726862|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
41958779|NCT02914561|75726863|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
41958780|NCT02914561|75726853|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
41958781|NCT02914561|75726854|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
41958782|NCT02914561|75726855|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
41958783|NCT02914561|75726856|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
41958784|NCT02914561|75726857|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
41958785|NCT02914561|75726858|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
41958786|NCT02914561|75726859|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
41958787|NCT02914561|75726860|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
41958788|NCT02914561|75726861|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
41958789|NCT02914561|75726862|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
41958790|NCT02914561|75726863|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
41958791|NCT02914561|75726853|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
41958792|NCT02914561|75726854|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
41958793|NCT02914561|75726855|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
41958794|NCT02914561|75726856|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
41958795|NCT02914561|75726857|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
41958796|NCT02914561|75726858|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
41958797|NCT02914561|75726859|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
41958798|NCT02914561|75726860|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
41958799|NCT02914561|75726861|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
41958800|NCT02914561|75726862|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
41958801|NCT02914561|75726863|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
41958802|NCT02914561|75726853|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
41958803|NCT02914561|75726854|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
41958804|NCT02914561|75726855|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
41958805|NCT02914561|75726856|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
41958806|NCT02914561|75726857|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
41958807|NCT02914561|75726858|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
41958808|NCT02914561|75726859|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
41958809|NCT02914561|75726860|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
41958810|NCT02914561|75726861|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
41958811|NCT02914561|75726862|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
41958812|NCT02914561|75726863|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
41958813|NCT02914561|75726853|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
41958814|NCT02914561|75726854|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
41958815|NCT02914561|75726855|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
42024423|NCT01222715|75831901|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
42024424|NCT01222715|75831900|FG000|Overall Study|Ineligible|0|||
42024425|NCT01222715|75831901|FG001|Overall Study|Ineligible|1|||
42024426|NCT01222715|75831900|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
42024427|NCT01222715|75831901|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
42024428|NCT01222403|75831909|FG000|Overall Study|Inappropriate enrollment|0|||
42024429|NCT01222403|75831910|FG001|Overall Study|Inappropriate enrollment|2|||
42300489|NCT02297841|76135675|FG000|Overall Study|Protocol Violation|7|||
41958816|NCT02914561|75726856|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
41958817|NCT02914561|75726857|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
41958818|NCT02914561|75726858|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
41958819|NCT02914561|75726859|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
41958820|NCT02914561|75726860|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
41958821|NCT02914561|75726861|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
41958822|NCT02914561|75726862|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
41958823|NCT02914561|75726863|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
41958824|NCT02914561|75726853|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
41958825|NCT02914561|75726854|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
41958826|NCT02914561|75726855|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
41958827|NCT02914561|75726856|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
41958828|NCT02914561|75726857|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
41958829|NCT02914561|75726858|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
41958830|NCT02914561|75726859|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
41958831|NCT02914561|75726860|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
41958832|NCT02914561|75726861|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
41958833|NCT02914561|75726862|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
41958834|NCT02914561|75726863|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
41958835|NCT02914561|75726853|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
41958836|NCT02914561|75726854|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
41958837|NCT02914561|75726855|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
41958838|NCT02914561|75726856|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
42300490|NCT02324361|76135681|FG000|Overall Study|Lost to Follow-up|5|||
41958839|NCT02914561|75726857|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
41958840|NCT02914561|75726858|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
41958841|NCT02914561|75726859|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
41958842|NCT02914561|75726860|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
41958843|NCT02914561|75726861|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
41958844|NCT02914561|75726862|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
41958845|NCT02914561|75726863|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
41958846|NCT02914561|75726853|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
41958847|NCT02914561|75726854|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
41958848|NCT02914561|75726855|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
41958849|NCT02914561|75726856|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
41958850|NCT02914561|75726857|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
41958851|NCT02914561|75726858|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
41958852|NCT02914561|75726859|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
41958853|NCT02914561|75726860|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
41958854|NCT02914561|75726861|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
41958855|NCT02914561|75726862|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
41958856|NCT02914561|75726863|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
41958857|NCT02914561|75726853|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
41958858|NCT02914561|75726854|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
41958859|NCT02914561|75726855|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
41958860|NCT02914561|75726856|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
41958861|NCT02914561|75726857|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
41958862|NCT02914561|75726858|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
41958863|NCT02914561|75726859|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
41958864|NCT02914561|75726860|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
41958865|NCT02914561|75726861|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
41958866|NCT02914561|75726862|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
41958867|NCT02914561|75726863|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
41958868|NCT02840799|75726893|FG000|Phase 1|Physician Decision|1|||
41958869|NCT02840799|75726894|FG001|Phase 1|Physician Decision|3|||
41958870|NCT02840799|75726893|FG000|Phase 1|Withdrawal by Subject|4|||
41958871|NCT02840799|75726894|FG001|Phase 1|Withdrawal by Subject|0|||
41958872|NCT02840799|75726893|FG000|Phase 2 (Crossover)|Adverse Event|0|||
41958873|NCT02840799|75726894|FG001|Phase 2 (Crossover)|Adverse Event|1|||
41958874|NCT02840799|75726893|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
41958875|NCT02840799|75726894|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
41958876|NCT02400255|75726920|FG000|Overall Study|Relapse|4|||
41958877|NCT02400255|75726921|FG001|Overall Study|Relapse|1|||
41958878|NCT02400255|75726922|FG002|Overall Study|Relapse|1|||
41958879|NCT02400255|75726923|FG003|Overall Study|Relapse|2|||
41958880|NCT02400255|75726920|FG000|Overall Study|Adverse Event|6|||
41958881|NCT02400255|75726921|FG001|Overall Study|Adverse Event|3|||
41958882|NCT02400255|75726922|FG002|Overall Study|Adverse Event|0|||
41958883|NCT02400255|75726923|FG003|Overall Study|Adverse Event|0|||
41958884|NCT02400255|75726920|FG000|Overall Study|Physician Decision|6|||
41958885|NCT02400255|75726921|FG001|Overall Study|Physician Decision|0|||
41958886|NCT02400255|75726922|FG002|Overall Study|Physician Decision|0|||
41958887|NCT02400255|75726923|FG003|Overall Study|Physician Decision|0|||
41958888|NCT02400255|75726920|FG000|Overall Study|Loss of insurance|1|||
41958889|NCT02400255|75726921|FG001|Overall Study|Loss of insurance|0|||
41958890|NCT02400255|75726922|FG002|Overall Study|Loss of insurance|0|||
41958891|NCT02400255|75726923|FG003|Overall Study|Loss of insurance|0|||
41958892|NCT01868438|75726931|FG000|First Intervention|Withdrawal by Subject|5|||
41958893|NCT01868438|75726932|FG001|First Intervention|Withdrawal by Subject|1|||
41958894|NCT01868438|75726931|FG000|First Intervention|Lost to Follow-up|2|||
41958895|NCT01868438|75726932|FG001|First Intervention|Lost to Follow-up|3|||
41958896|NCT01868438|75726931|FG000|First Intervention|Meeting the non-redosing criteria|0|||
41958897|NCT01868438|75726932|FG001|First Intervention|Meeting the non-redosing criteria|1|||
41958898|NCT01868438|75726931|FG000|Second Intervention|Adverse Event|3|||
41958899|NCT01868438|75726932|FG001|Second Intervention|Adverse Event|3|||
41958900|NCT01208662|75726941|FG000|Induction and Consolidation|Disease Progression|23|||
41958901|NCT01208662|75726942|FG001|Induction and Consolidation|Disease Progression|13|||
41958902|NCT01208662|75726943|FG002|Induction and Consolidation|Disease Progression|0|||
41958903|NCT01208662|75726941|FG000|Induction and Consolidation|Adverse Event|16|||
41958904|NCT01208662|75726942|FG001|Induction and Consolidation|Adverse Event|18|||
41958905|NCT01208662|75726943|FG002|Induction and Consolidation|Adverse Event|2|||
41958906|NCT01208662|75726941|FG000|Induction and Consolidation|MD or Participant Decision|16|||
41958907|NCT01208662|75726942|FG001|Induction and Consolidation|MD or Participant Decision|34|||
41958908|NCT01208662|75726943|FG002|Induction and Consolidation|MD or Participant Decision|4|||
41958909|NCT01208662|75726941|FG000|Induction and Consolidation|Death|1|||
41958910|NCT01208662|75726942|FG001|Induction and Consolidation|Death|3|||
41958911|NCT01208662|75726943|FG002|Induction and Consolidation|Death|1|||
41958912|NCT01208662|75726941|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
41958913|NCT01208662|75726942|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
41958914|NCT01208662|75726943|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
41958915|NCT01208662|75726941|FG000|Maintenance|Disease Progression|156|||
41958916|NCT01208662|75726942|FG001|Maintenance|Disease Progression|102|||
41958917|NCT01208662|75726943|FG002|Maintenance|Disease Progression|0|||
41958918|NCT01208662|75726941|FG000|Maintenance|Adverse Event|12|||
41958919|NCT01208662|75726942|FG001|Maintenance|Adverse Event|28|||
41958920|NCT01208662|75726943|FG002|Maintenance|Adverse Event|0|||
41958921|NCT01208662|75726941|FG000|Maintenance|MD or Participant Decision|24|||
41958922|NCT01208662|75726942|FG001|Maintenance|MD or Participant Decision|36|||
41958923|NCT01208662|75726943|FG002|Maintenance|MD or Participant Decision|0|||
41958924|NCT01208662|75726941|FG000|Maintenance|Death|0|||
41958925|NCT01208662|75726942|FG001|Maintenance|Death|3|||
41958926|NCT01208662|75726943|FG002|Maintenance|Death|0|||
41958927|NCT01208662|75726941|FG000|Maintenance|Discontinued for other reasons|21|||
41958928|NCT01208662|75726942|FG001|Maintenance|Discontinued for other reasons|31|||
41958929|NCT01208662|75726943|FG002|Maintenance|Discontinued for other reasons|0|||
41958930|NCT01208662|75726941|FG000|Maintenance|Still on Treatment|78|||
41958931|NCT01208662|75726942|FG001|Maintenance|Still on Treatment|89|||
41958932|NCT01208662|75726943|FG002|Maintenance|Still on Treatment|0|||
41958933|NCT01457352|75726952|FG000|Period 1|Adverse Event|2|||
41958934|NCT01457352|75726953|FG001|Period 1|Adverse Event|0|||
41958935|NCT01457352|75726952|FG000|Period 1|Withdrawal by Subject|2|||
41958936|NCT01457352|75726953|FG001|Period 1|Withdrawal by Subject|0|||
41958937|NCT01457352|75726952|FG000|Period 1|Physician Decision|2|||
41958938|NCT01457352|75726953|FG001|Period 1|Physician Decision|0|||
41958939|NCT01457352|75726952|FG000|Period 1|MS related disease progression|1|||
41958940|NCT01457352|75726953|FG001|Period 1|MS related disease progression|0|||
41958941|NCT01457352|75726952|FG000|Period 1|Withdrawn|1|||
41958942|NCT01457352|75726953|FG001|Period 1|Withdrawn|0|||
41958943|NCT01457352|75726952|FG000|Period 1|withdrew per sponsor|1|||
41958944|NCT01457352|75726953|FG001|Period 1|withdrew per sponsor|0|||
41958945|NCT01457352|75726952|FG000|Period 1|Protocol Violation|4|||
41958946|NCT01457352|75726953|FG001|Period 1|Protocol Violation|0|||
41958947|NCT01457352|75726952|FG000|Period 1|Did not meet eligibility criteria|3|||
41958948|NCT01457352|75726953|FG001|Period 1|Did not meet eligibility criteria|0|||
41958949|NCT01457352|75726952|FG000|Period 2|Withdrawal by Subject|23|||
41958950|NCT01457352|75726953|FG001|Period 2|Withdrawal by Subject|0|||
41958951|NCT01457352|75726952|FG000|Period 2|Adverse Event|22|||
41958952|NCT01457352|75726953|FG001|Period 2|Adverse Event|0|||
41958953|NCT01457352|75726952|FG000|Period 2|no analysis|10|||
41958954|NCT01457352|75726953|FG001|Period 2|no analysis|0|||
41958955|NCT01457352|75726952|FG000|Period 2|Lack of Efficacy|8|||
41958956|NCT01457352|75726953|FG001|Period 2|Lack of Efficacy|0|||
41958957|NCT01457352|75726952|FG000|Period 2|Protocol Violation|4|||
41958958|NCT01457352|75726953|FG001|Period 2|Protocol Violation|0|||
41958959|NCT01457352|75726952|FG000|Period 2|Sponsor's withdrawal|7|||
41958960|NCT01457352|75726953|FG001|Period 2|Sponsor's withdrawal|0|||
41958961|NCT01457352|75726952|FG000|Period 2|Lost to Follow-up|1|||
41958962|NCT01457352|75726953|FG001|Period 2|Lost to Follow-up|0|||
41958963|NCT01457352|75726952|FG000|Period 2|dose change|1|||
41958964|NCT01457352|75726953|FG001|Period 2|dose change|0|||
41958965|NCT01457352|75726952|FG000|Period 2|Physician Decision|1|||
41958966|NCT01457352|75726953|FG001|Period 2|Physician Decision|0|||
41958967|NCT01457352|75726952|FG000|Period 2|Did not meet eligibility criteria|3|||
41958968|NCT01457352|75726953|FG001|Period 2|Did not meet eligibility criteria|0|||
41958969|NCT01457352|75726952|FG000|Period 3|Adverse Event|1|||
41958970|NCT01457352|75726953|FG001|Period 3|Adverse Event|1|||
41958971|NCT01457352|75726952|FG000|Period 3|Withdrawal by Subject|0|||
41958972|NCT01457352|75726953|FG001|Period 3|Withdrawal by Subject|2|||
41958973|NCT01457352|75726952|FG000|Period 3|incorrect treatment|0|||
41958974|NCT01457352|75726953|FG001|Period 3|incorrect treatment|1|||
41958975|NCT01457352|75726952|FG000|Period 3|Sponsor's withdrawal|0|||
41958976|NCT01457352|75726953|FG001|Period 3|Sponsor's withdrawal|1|||
41958977|NCT01457118|75726967|FG000|Overall Study|Adverse Event|1|||
41958978|NCT01457118|75726968|FG001|Overall Study|Adverse Event|0|||
41958979|NCT01457118|75726969|FG002|Overall Study|Adverse Event|0|||
41958980|NCT01457118|75726970|FG003|Overall Study|Adverse Event|1|||
41958981|NCT01457118|75726967|FG000|Overall Study|Clinical Progression|0|||
41958982|NCT01457118|75726968|FG001|Overall Study|Clinical Progression|1|||
41958983|NCT01457118|75726969|FG002|Overall Study|Clinical Progression|0|||
41958984|NCT01457118|75726970|FG003|Overall Study|Clinical Progression|1|||
41958985|NCT01457118|75726967|FG000|Overall Study|Physician Decision|2|||
41958986|NCT01457118|75726968|FG001|Overall Study|Physician Decision|0|||
41958987|NCT01457118|75726969|FG002|Overall Study|Physician Decision|0|||
41958988|NCT01457118|75726970|FG003|Overall Study|Physician Decision|0|||
41958989|NCT01457118|75726967|FG000|Overall Study|Progressive Disease by RECIST|12|||
41958990|NCT01457118|75726968|FG001|Overall Study|Progressive Disease by RECIST|3|||
41958991|NCT01457118|75726969|FG002|Overall Study|Progressive Disease by RECIST|1|||
41958992|NCT01457118|75726970|FG003|Overall Study|Progressive Disease by RECIST|0|||
41958993|NCT01457118|75726967|FG000|Overall Study|Withdrawal by Subject|5|||
41958994|NCT01457118|75726968|FG001|Overall Study|Withdrawal by Subject|0|||
41958995|NCT01457118|75726969|FG002|Overall Study|Withdrawal by Subject|0|||
41958996|NCT01457118|75726970|FG003|Overall Study|Withdrawal by Subject|0|||
41958997|NCT01456962|75726982|FG000|Overall Study|Lost to Follow-up|2|||
41958998|NCT01456962|75726983|FG001|Overall Study|Lost to Follow-up|1|||
41958999|NCT01501110|75726991|FG000|Overall Study|Death|0|||
41959000|NCT01501110|75726992|FG001|Overall Study|Death|1|||
41959001|NCT01500720|75727000|FG000|Overall Study|Randomized But Not Treated|1|||
41959002|NCT01500720|75727001|FG001|Overall Study|Randomized But Not Treated|1|||
41959003|NCT01500720|75727000|FG000|Overall Study|Other|4|||
41959004|NCT01500720|75727001|FG001|Overall Study|Other|8|||
41959005|NCT01500252|75727009|FG000|Overall Study|Death|4|||
41959006|NCT01500252|75727010|FG001|Overall Study|Death|2|||
41959007|NCT01500252|75727009|FG000|Overall Study|Lost to Follow-up|5|||
41959008|NCT01500252|75727010|FG001|Overall Study|Lost to Follow-up|4|||
41959009|NCT01476696|75727017|FG000|Overall Study|Sponsor decision|2|||
41959010|NCT01476696|75727018|FG001|Overall Study|Sponsor decision|1|||
41959011|NCT01476696|75727019|FG002|Overall Study|Sponsor decision|0|||
41959012|NCT01476696|75727017|FG000|Overall Study|Withdrawal by Subject|1|||
41959013|NCT01476696|75727018|FG001|Overall Study|Withdrawal by Subject|0|||
41959014|NCT01476696|75727019|FG002|Overall Study|Withdrawal by Subject|0|||
41959015|NCT01500096|75727036|FG000|Overall Study|Lost to Follow-up|1|||
41959016|NCT01500096|75727037|FG001|Overall Study|Lost to Follow-up|0|||
41959017|NCT01500096|75727038|FG002|Overall Study|Lost to Follow-up|0|||
41959018|NCT01500096|75727039|FG003|Overall Study|Lost to Follow-up|2|||
41959019|NCT01455012|75727051|FG000|Overall Study|Adverse Event|0|||
41959020|NCT01455012|75727052|FG001|Overall Study|Adverse Event|2|||
41959021|NCT01455012|75727051|FG000|Overall Study|Lack of Efficacy|6|||
41959022|NCT01455012|75727052|FG001|Overall Study|Lack of Efficacy|1|||
41959023|NCT01455012|75727051|FG000|Overall Study|Withdrawal by Subject|3|||
41959024|NCT01455012|75727052|FG001|Overall Study|Withdrawal by Subject|1|||
41959025|NCT01455012|75727051|FG000|Overall Study|Unknown reason|2|||
41959026|NCT01455012|75727052|FG001|Overall Study|Unknown reason|0|||
41959027|NCT01454778|75727058|FG000|Overall Study|Lost to Follow-up|2|||
41959028|NCT01454778|75727058|FG000|Overall Study|Death|1|||
41959029|NCT01454076|75727067|FG000|Overall Study|Other|2|||
41959030|NCT01454076|75727068|FG001|Overall Study|Other|0|||
41959031|NCT01454076|75727069|FG002|Overall Study|Other|0|||
41959032|NCT01454076|75727070|FG003|Overall Study|Other|1|||
41959033|NCT01454076|75727071|FG004|Overall Study|Other|2|||
41959034|NCT01454076|75727067|FG000|Overall Study|Withdrawal by Subject|3|||
41959035|NCT01454076|75727068|FG001|Overall Study|Withdrawal by Subject|4|||
41959036|NCT01454076|75727069|FG002|Overall Study|Withdrawal by Subject|2|||
41959037|NCT01454076|75727070|FG003|Overall Study|Withdrawal by Subject|1|||
41959038|NCT01454076|75727071|FG004|Overall Study|Withdrawal by Subject|2|||
41959039|NCT01454076|75727067|FG000|Overall Study|Adverse Event|8|||
41959040|NCT01454076|75727068|FG001|Overall Study|Adverse Event|2|||
41959041|NCT01454076|75727069|FG002|Overall Study|Adverse Event|7|||
41959042|NCT01454076|75727070|FG003|Overall Study|Adverse Event|0|||
41959043|NCT01454076|75727071|FG004|Overall Study|Adverse Event|2|||
41959044|NCT01453998|75727095|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
41959045|NCT01453998|75727096|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
41959046|NCT01453998|75727097|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
41959047|NCT01453374|75727108|FG000|Overall Study|Adverse Event|7|||
41959048|NCT01453374|75727108|FG000|Overall Study|Lack of Efficacy|1|||
41959049|NCT01453374|75727108|FG000|Overall Study|Lost to Follow-up|3|||
41959050|NCT01453374|75727108|FG000|Overall Study|Withdrawal by Subject|5|||
41959051|NCT01453374|75727108|FG000|Overall Study|Incarcerated|2|||
41959052|NCT01453296|75727114|FG000|Treatment Period 1|Adverse Event|0|||
41959053|NCT01453296|75727115|FG001|Treatment Period 1|Adverse Event|1|||
41959054|NCT01453296|75727114|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
41959055|NCT01453296|75727115|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
41959056|NCT01453296|75727114|FG000|Treatment Period 2|Adverse Event|1|||
41959057|NCT01453296|75727115|FG001|Treatment Period 2|Adverse Event|0|||
41959058|NCT01453296|75727114|FG000|Treatment Period 2|Withdrawal by Subject|1|||
41959059|NCT01453296|75727115|FG001|Treatment Period 2|Withdrawal by Subject|0|||
41959060|NCT01453140|75727121|FG000|Overall Study|Adverse Event|3|||
41959061|NCT01499940|75727129|FG000|Overall Study|Study was withdrawn before completion.|9|||
41959062|NCT01499160|75727133|FG000|Overall Study|Adverse Event|1|||
41959063|NCT01499160|75727133|FG000|Overall Study|Withdrawal by Subject|1|||
41959064|NCT01498692|75727138|FG000|Overall Study|Death|4|||
41959065|NCT01498692|75727138|FG000|Overall Study|Withdrawal by Subject|1|||
41959066|NCT01498692|75727138|FG000|Overall Study|Missed 12-month visit|3|||
41959067|NCT01498068|75727144|FG000|Overall Study|Withdrawal by Subject|1|||
41959068|NCT01498068|75727145|FG001|Overall Study|Withdrawal by Subject|1|||
41959069|NCT01497366|75727153|FG000|Overall Study|Virologic failure|2|||
41959070|NCT01497366|75727154|FG001|Overall Study|Virologic failure|50|||
41959071|NCT01497366|75727153|FG000|Overall Study|Lost to Follow-up|11|||
41959072|NCT01497366|75727154|FG001|Overall Study|Lost to Follow-up|10|||
41959073|NCT01497366|75727153|FG000|Overall Study|Withdrawal by Subject|6|||
41959074|NCT01497366|75727154|FG001|Overall Study|Withdrawal by Subject|6|||
41959075|NCT01497366|75727153|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
41959076|NCT01497366|75727154|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
41959077|NCT01497366|75727153|FG000|Overall Study|Other|5|||
41959078|NCT01497366|75727154|FG001|Overall Study|Other|0|||
41959079|NCT01497366|75727153|FG000|Overall Study|Death|1|||
41959080|NCT01497366|75727154|FG001|Overall Study|Death|1|||
41959081|NCT01497366|75727153|FG000|Overall Study|Randomized but not treated|7|||
41959082|NCT01497366|75727154|FG001|Overall Study|Randomized but not treated|21|||
41959083|NCT01475838|75727163|FG000|Randomized Phase|Randomized but Not Treated|0|||
41959084|NCT01475838|75727164|FG001|Randomized Phase|Randomized but Not Treated|5|||
41959085|NCT01475838|75727163|FG000|Randomized Phase|Adverse Event|6|||
41959086|NCT01475838|75727164|FG001|Randomized Phase|Adverse Event|1|||
41959087|NCT01475838|75727163|FG000|Randomized Phase|Pregnancy|0|||
41959088|NCT01475838|75727164|FG001|Randomized Phase|Pregnancy|1|||
41959089|NCT01475838|75727163|FG000|Randomized Phase|Investigators Discretion|1|||
41959090|NCT01475838|75727164|FG001|Randomized Phase|Investigators Discretion|2|||
41959091|NCT01475838|75727163|FG000|Randomized Phase|Withdrew Consent|10|||
41959092|NCT01475838|75727164|FG001|Randomized Phase|Withdrew Consent|14|||
41959093|NCT01475838|75727163|FG000|Randomized Phase|Lost to Follow-up|3|||
41959094|NCT01475838|75727164|FG001|Randomized Phase|Lost to Follow-up|4|||
41959095|NCT01475838|75727163|FG000|Randomized Phase|Participant Noncompliance|1|||
41959096|NCT01475838|75727164|FG001|Randomized Phase|Participant Noncompliance|5|||
41959097|NCT01475838|75727163|FG000|Randomized Phase|Protocol Violation|9|||
41959098|NCT01475838|75727164|FG001|Randomized Phase|Protocol Violation|4|||
41959099|NCT01475838|75727163|FG000|Extension Phase|Participant Noncompliance|1|||
41959100|NCT01475838|75727164|FG001|Extension Phase|Participant Noncompliance|0|||
41959101|NCT01451814|75727173|FG000|Overall Study|Withdrawal by Subject|1|||
41959102|NCT01451814|75727174|FG001|Overall Study|Withdrawal by Subject|1|||
41959103|NCT01451814|75727173|FG000|Overall Study|Lost to Follow-up|5|||
41959104|NCT01451814|75727174|FG001|Overall Study|Lost to Follow-up|4|||
41959105|NCT01475370|75727183|FG000|Overall Study|Exacerbation of primary disease|2|||
41959106|NCT01475370|75727184|FG001|Overall Study|Exacerbation of primary disease|2|||
41959107|NCT01475370|75727185|FG002|Overall Study|Exacerbation of primary disease|2|||
41959108|NCT01475370|75727183|FG000|Overall Study|Study drug administration difficult|0|||
41959109|NCT01475370|75727184|FG001|Overall Study|Study drug administration difficult|1|||
41959110|NCT01475370|75727185|FG002|Overall Study|Study drug administration difficult|1|||
41959111|NCT01475370|75727183|FG000|Overall Study|Other than specified|1|||
41959112|NCT01475370|75727184|FG001|Overall Study|Other than specified|0|||
41959113|NCT01475370|75727185|FG002|Overall Study|Other than specified|0|||
41959114|NCT01496430|75727196|FG000|Overall Study|Adverse Event|0|||
41959115|NCT01496430|75727197|FG001|Overall Study|Adverse Event|0|||
41959116|NCT01496430|75727198|FG002|Overall Study|Adverse Event|1|||
41959117|NCT01496430|75727196|FG000|Overall Study|Major Protocol Deviation|0|||
41959118|NCT01496430|75727197|FG001|Overall Study|Major Protocol Deviation|0|||
41959119|NCT01496430|75727198|FG002|Overall Study|Major Protocol Deviation|1|||
41959120|NCT01496430|75727196|FG000|Overall Study|Lost to Follow-up|2|||
41959121|NCT01496430|75727197|FG001|Overall Study|Lost to Follow-up|3|||
41959122|NCT01496430|75727198|FG002|Overall Study|Lost to Follow-up|1|||
41959123|NCT01496430|75727196|FG000|Overall Study|Voluntary Withdrawal|2|||
41959124|NCT01496430|75727197|FG001|Overall Study|Voluntary Withdrawal|1|||
41959125|NCT01496430|75727198|FG002|Overall Study|Voluntary Withdrawal|6|||
41959126|NCT01496430|75727196|FG000|Overall Study|Principal Investigator Discretion|0|||
41959127|NCT01496430|75727197|FG001|Overall Study|Principal Investigator Discretion|1|||
41959128|NCT01496430|75727198|FG002|Overall Study|Principal Investigator Discretion|1|||
41959129|NCT01496430|75727196|FG000|Overall Study|Other|2|||
41959130|NCT01496430|75727197|FG001|Overall Study|Other|0|||
41959131|NCT01496430|75727198|FG002|Overall Study|Other|0|||
41959132|NCT01451424|75727210|FG000|Overall Study|Withdrawal by Subject|1|||
41959133|NCT01451424|75727211|FG001|Overall Study|Withdrawal by Subject|1|||
41959134|NCT01451424|75727212|FG002|Overall Study|Withdrawal by Subject|0|||
41959135|NCT01451424|75727213|FG003|Overall Study|Withdrawal by Subject|2|||
41959136|NCT01451424|75727210|FG000|Overall Study|Lost to Follow-up|0|||
41959137|NCT01451424|75727211|FG001|Overall Study|Lost to Follow-up|1|||
41959138|NCT01451424|75727212|FG002|Overall Study|Lost to Follow-up|0|||
41959139|NCT01451424|75727213|FG003|Overall Study|Lost to Follow-up|1|||
41959140|NCT01451424|75727210|FG000|Overall Study|Physician Decision|0|||
41959141|NCT01451424|75727211|FG001|Overall Study|Physician Decision|0|||
41959142|NCT01451424|75727212|FG002|Overall Study|Physician Decision|1|||
41959143|NCT01451424|75727213|FG003|Overall Study|Physician Decision|1|||
41959144|NCT01451424|75727210|FG000|Overall Study|Adverse Event|0|||
41959145|NCT01451424|75727211|FG001|Overall Study|Adverse Event|0|||
41959146|NCT01451424|75727212|FG002|Overall Study|Adverse Event|0|||
41959147|NCT01451424|75727213|FG003|Overall Study|Adverse Event|1|||
41959148|NCT01475214|75727231|FG000|Overall Study|Lost to Follow-up|1|||
41959149|NCT01475214|75727232|FG001|Overall Study|Lost to Follow-up|0|||
41959150|NCT01475214|75727233|FG002|Overall Study|Lost to Follow-up|1|||
41959151|NCT01475214|75727231|FG000|Overall Study|Physician Decision|2|||
41959152|NCT01475214|75727232|FG001|Overall Study|Physician Decision|0|||
41959153|NCT01475214|75727233|FG002|Overall Study|Physician Decision|0|||
41959154|NCT01475214|75727231|FG000|Overall Study|Withdrawal by Subject|2|||
41959155|NCT01475214|75727232|FG001|Overall Study|Withdrawal by Subject|4|||
41959156|NCT01475214|75727233|FG002|Overall Study|Withdrawal by Subject|1|||
41959157|NCT01496274|75727244|FG000|Overall Study|Protocol Violation|0|||
41959158|NCT01496274|75727245|FG001|Overall Study|Protocol Violation|1|||
41959159|NCT01496274|75727244|FG000|Overall Study|Adverse Event|1|||
41959160|NCT01496274|75727245|FG001|Overall Study|Adverse Event|1|||
41959161|NCT01496274|75727244|FG000|Overall Study|Withdrawal by Subject|2|||
41959162|NCT01496274|75727245|FG001|Overall Study|Withdrawal by Subject|0|||
41959163|NCT01496274|75727244|FG000|Overall Study|Lost to Follow-up|0|||
41959164|NCT01496274|75727245|FG001|Overall Study|Lost to Follow-up|3|||
41959165|NCT01475136|75727270|FG000|Overall Study|Sponsor Decision|0|||
41959166|NCT01475136|75727271|FG001|Overall Study|Sponsor Decision|1|||
41959167|NCT01475136|75727272|FG002|Overall Study|Sponsor Decision|0|||
41959168|NCT01475136|75727273|FG003|Overall Study|Sponsor Decision|0|||
41959169|NCT01475136|75727270|FG000|Overall Study|Entry Criteria Not Met|0|||
41959170|NCT01475136|75727271|FG001|Overall Study|Entry Criteria Not Met|2|||
41959171|NCT01475136|75727272|FG002|Overall Study|Entry Criteria Not Met|3|||
41959172|NCT01475136|75727273|FG003|Overall Study|Entry Criteria Not Met|1|||
41959173|NCT01475136|75727270|FG000|Overall Study|Withdrawal by Subject|0|||
41959174|NCT01475136|75727271|FG001|Overall Study|Withdrawal by Subject|0|||
41959175|NCT01475136|75727272|FG002|Overall Study|Withdrawal by Subject|0|||
41959176|NCT01475136|75727273|FG003|Overall Study|Withdrawal by Subject|2|||
41959177|NCT01475136|75727270|FG000|Overall Study|Adverse Event|1|||
41959178|NCT01475136|75727271|FG001|Overall Study|Adverse Event|0|||
41959179|NCT01475136|75727272|FG002|Overall Study|Adverse Event|0|||
41959180|NCT01475136|75727273|FG003|Overall Study|Adverse Event|1|||
41959181|NCT01475136|75727270|FG000|Overall Study|Death|0|||
41959182|NCT01475136|75727271|FG001|Overall Study|Death|0|||
41959183|NCT01475136|75727272|FG002|Overall Study|Death|0|||
41959184|NCT01475136|75727273|FG003|Overall Study|Death|1|||
41959185|NCT01474746|75727285|FG000|Overall Study|Lost to Follow-up|1|||
41959186|NCT01474746|75727286|FG001|Overall Study|Lost to Follow-up|1|||
41959187|NCT01474746|75727285|FG000|Overall Study|Withdrawal by Subject|2|||
41959188|NCT01474746|75727286|FG001|Overall Study|Withdrawal by Subject|1|||
41959189|NCT01450800|75727294|FG000|Overall Study|Protocol Violation|1|||
41959190|NCT01450800|75727295|FG001|Overall Study|Protocol Violation|3|||
41959191|NCT01474512|75727306|FG000|Induction Period|Adverse Event|6|||
41959192|NCT01474512|75727307|FG001|Induction Period|Adverse Event|10|||
41959193|NCT01474512|75727308|FG002|Induction Period|Adverse Event|10|||
41959194|NCT01474512|75727309|FG003|Induction Period|Adverse Event|0|||
41959195|NCT01474512|75727310|FG004|Induction Period|Adverse Event|0|||
41959196|NCT01474512|75727311|FG005|Induction Period|Adverse Event|0|||
41959197|NCT01474512|75727312|FG006|Induction Period|Adverse Event|0|||
41959198|NCT01474512|75727313|FG007|Induction Period|Adverse Event|0|||
41959199|NCT01474512|75727314|FG008|Induction Period|Adverse Event|0|||
41959200|NCT01474512|75727315|FG009|Induction Period|Adverse Event|0|||
41959201|NCT01474512|75727316|FG010|Induction Period|Adverse Event|0|||
41959202|NCT01474512|75727317|FG011|Induction Period|Adverse Event|0|||
41959203|NCT01474512|75727318|FG012|Induction Period|Adverse Event|0|||
41959204|NCT01474512|75727319|FG013|Induction Period|Adverse Event|0|||
41959205|NCT01474512|75727320|FG014|Induction Period|Adverse Event|0|||
41959206|NCT01474512|75727321|FG015|Induction Period|Adverse Event|0|||
41959207|NCT01474512|75727322|FG016|Induction Period|Adverse Event|0|||
41959208|NCT01474512|75727323|FG017|Induction Period|Adverse Event|0|||
41959209|NCT01474512|75727306|FG000|Induction Period|Lack of Efficacy|7|||
41959210|NCT01474512|75727307|FG001|Induction Period|Lack of Efficacy|1|||
41959211|NCT01474512|75727308|FG002|Induction Period|Lack of Efficacy|0|||
41959212|NCT01474512|75727309|FG003|Induction Period|Lack of Efficacy|0|||
41959213|NCT01474512|75727310|FG004|Induction Period|Lack of Efficacy|0|||
41959214|NCT01474512|75727311|FG005|Induction Period|Lack of Efficacy|0|||
41959215|NCT01474512|75727312|FG006|Induction Period|Lack of Efficacy|0|||
41959216|NCT01474512|75727313|FG007|Induction Period|Lack of Efficacy|0|||
41959217|NCT01474512|75727314|FG008|Induction Period|Lack of Efficacy|0|||
41959218|NCT01474512|75727315|FG009|Induction Period|Lack of Efficacy|0|||
41959219|NCT01474512|75727316|FG010|Induction Period|Lack of Efficacy|0|||
41959220|NCT01474512|75727317|FG011|Induction Period|Lack of Efficacy|0|||
41959221|NCT01474512|75727318|FG012|Induction Period|Lack of Efficacy|0|||
41959222|NCT01474512|75727319|FG013|Induction Period|Lack of Efficacy|0|||
41959223|NCT01474512|75727320|FG014|Induction Period|Lack of Efficacy|0|||
41959224|NCT01474512|75727321|FG015|Induction Period|Lack of Efficacy|0|||
41959225|NCT01474512|75727322|FG016|Induction Period|Lack of Efficacy|0|||
41959226|NCT01474512|75727323|FG017|Induction Period|Lack of Efficacy|0|||
41959227|NCT01474512|75727306|FG000|Induction Period|Withdrawal by Subject|6|||
41959228|NCT01474512|75727307|FG001|Induction Period|Withdrawal by Subject|6|||
41959229|NCT01474512|75727308|FG002|Induction Period|Withdrawal by Subject|5|||
41959230|NCT01474512|75727309|FG003|Induction Period|Withdrawal by Subject|0|||
41959231|NCT01474512|75727310|FG004|Induction Period|Withdrawal by Subject|0|||
41959232|NCT01474512|75727311|FG005|Induction Period|Withdrawal by Subject|0|||
41959233|NCT01474512|75727312|FG006|Induction Period|Withdrawal by Subject|0|||
41959234|NCT01474512|75727313|FG007|Induction Period|Withdrawal by Subject|0|||
41959235|NCT01474512|75727314|FG008|Induction Period|Withdrawal by Subject|0|||
41959236|NCT01474512|75727315|FG009|Induction Period|Withdrawal by Subject|0|||
41959237|NCT01474512|75727316|FG010|Induction Period|Withdrawal by Subject|0|||
41959238|NCT01474512|75727317|FG011|Induction Period|Withdrawal by Subject|0|||
41959239|NCT01474512|75727318|FG012|Induction Period|Withdrawal by Subject|0|||
41959240|NCT01474512|75727319|FG013|Induction Period|Withdrawal by Subject|0|||
41959241|NCT01474512|75727320|FG014|Induction Period|Withdrawal by Subject|0|||
41959242|NCT01474512|75727321|FG015|Induction Period|Withdrawal by Subject|0|||
41959243|NCT01474512|75727322|FG016|Induction Period|Withdrawal by Subject|0|||
41959244|NCT01474512|75727323|FG017|Induction Period|Withdrawal by Subject|0|||
41959245|NCT01474512|75727306|FG000|Induction Period|Protocol Violation|3|||
41959246|NCT01474512|75727307|FG001|Induction Period|Protocol Violation|6|||
41959247|NCT01474512|75727308|FG002|Induction Period|Protocol Violation|0|||
41959248|NCT01474512|75727309|FG003|Induction Period|Protocol Violation|0|||
41959249|NCT01474512|75727310|FG004|Induction Period|Protocol Violation|0|||
41959250|NCT01474512|75727311|FG005|Induction Period|Protocol Violation|0|||
41959251|NCT01474512|75727312|FG006|Induction Period|Protocol Violation|0|||
41959252|NCT01474512|75727313|FG007|Induction Period|Protocol Violation|0|||
41959253|NCT01474512|75727314|FG008|Induction Period|Protocol Violation|0|||
41959254|NCT01474512|75727315|FG009|Induction Period|Protocol Violation|0|||
41959255|NCT01474512|75727316|FG010|Induction Period|Protocol Violation|0|||
41959256|NCT01474512|75727317|FG011|Induction Period|Protocol Violation|0|||
41959257|NCT01474512|75727318|FG012|Induction Period|Protocol Violation|0|||
41959258|NCT01474512|75727319|FG013|Induction Period|Protocol Violation|0|||
41959259|NCT01474512|75727320|FG014|Induction Period|Protocol Violation|0|||
41959260|NCT01474512|75727321|FG015|Induction Period|Protocol Violation|0|||
41959261|NCT01474512|75727322|FG016|Induction Period|Protocol Violation|0|||
41959262|NCT01474512|75727323|FG017|Induction Period|Protocol Violation|0|||
41959263|NCT01474512|75727306|FG000|Induction Period|Sponsor Decision|1|||
41959264|NCT01474512|75727307|FG001|Induction Period|Sponsor Decision|1|||
41959265|NCT01474512|75727308|FG002|Induction Period|Sponsor Decision|1|||
41959266|NCT01474512|75727309|FG003|Induction Period|Sponsor Decision|0|||
41959267|NCT01474512|75727310|FG004|Induction Period|Sponsor Decision|0|||
41959268|NCT01474512|75727311|FG005|Induction Period|Sponsor Decision|0|||
41959269|NCT01474512|75727312|FG006|Induction Period|Sponsor Decision|0|||
41959270|NCT01474512|75727313|FG007|Induction Period|Sponsor Decision|0|||
41959271|NCT01474512|75727314|FG008|Induction Period|Sponsor Decision|0|||
41959272|NCT01474512|75727315|FG009|Induction Period|Sponsor Decision|0|||
41959273|NCT01474512|75727316|FG010|Induction Period|Sponsor Decision|0|||
41959274|NCT01474512|75727317|FG011|Induction Period|Sponsor Decision|0|||
41959275|NCT01474512|75727318|FG012|Induction Period|Sponsor Decision|0|||
41959276|NCT01474512|75727319|FG013|Induction Period|Sponsor Decision|0|||
41959277|NCT01474512|75727320|FG014|Induction Period|Sponsor Decision|0|||
41959278|NCT01474512|75727321|FG015|Induction Period|Sponsor Decision|0|||
41959279|NCT01474512|75727322|FG016|Induction Period|Sponsor Decision|0|||
41959280|NCT01474512|75727323|FG017|Induction Period|Sponsor Decision|0|||
41959281|NCT01474512|75727306|FG000|Induction Period|Lost to Follow-up|1|||
41959282|NCT01474512|75727307|FG001|Induction Period|Lost to Follow-up|0|||
41959283|NCT01474512|75727308|FG002|Induction Period|Lost to Follow-up|2|||
41959284|NCT01474512|75727309|FG003|Induction Period|Lost to Follow-up|0|||
42024430|NCT01222247|75831918|FG000|Overall Study|Lost to Follow-up|2|||
42024431|NCT01222247|75831919|FG001|Overall Study|Lost to Follow-up|2|||
41959285|NCT01474512|75727310|FG004|Induction Period|Lost to Follow-up|0|||
42024432|NCT01014975|75831925|FG000|Overall Study|Withdrawal by Subject|1|||
42024433|NCT01014975|75831926|FG001|Overall Study|Withdrawal by Subject|0|||
42300491|NCT02324361|76135682|FG001|Overall Study|Lost to Follow-up|2|||
42300492|NCT02365233|76135691|FG000|Overall Study|IRB withheld the data|1|||
41959286|NCT01474512|75727311|FG005|Induction Period|Lost to Follow-up|0|||
41959287|NCT01474512|75727312|FG006|Induction Period|Lost to Follow-up|0|||
41959288|NCT01474512|75727313|FG007|Induction Period|Lost to Follow-up|0|||
41959289|NCT01474512|75727314|FG008|Induction Period|Lost to Follow-up|0|||
41959290|NCT01474512|75727315|FG009|Induction Period|Lost to Follow-up|0|||
41959291|NCT01474512|75727316|FG010|Induction Period|Lost to Follow-up|0|||
41959292|NCT01474512|75727317|FG011|Induction Period|Lost to Follow-up|0|||
41959293|NCT01474512|75727318|FG012|Induction Period|Lost to Follow-up|0|||
41959294|NCT01474512|75727319|FG013|Induction Period|Lost to Follow-up|0|||
41959295|NCT01474512|75727320|FG014|Induction Period|Lost to Follow-up|0|||
41959296|NCT01474512|75727321|FG015|Induction Period|Lost to Follow-up|0|||
41959297|NCT01474512|75727322|FG016|Induction Period|Lost to Follow-up|0|||
41959298|NCT01474512|75727323|FG017|Induction Period|Lost to Follow-up|0|||
41959299|NCT01474512|75727306|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959300|NCT01474512|75727307|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959301|NCT01474512|75727308|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959302|NCT01474512|75727309|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
41959303|NCT01474512|75727310|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
41959304|NCT01474512|75727311|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
41959305|NCT01474512|75727312|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
41959306|NCT01474512|75727313|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959307|NCT01474512|75727314|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959308|NCT01474512|75727315|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959309|NCT01474512|75727316|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959310|NCT01474512|75727317|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959311|NCT01474512|75727318|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959312|NCT01474512|75727319|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959313|NCT01474512|75727320|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959314|NCT01474512|75727321|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959315|NCT01474512|75727322|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959316|NCT01474512|75727323|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
41959317|NCT01474512|75727306|FG000|Maintenance Period|Adverse Event|0|||
41959318|NCT01474512|75727307|FG001|Maintenance Period|Adverse Event|0|||
41959319|NCT01474512|75727308|FG002|Maintenance Period|Adverse Event|0|||
41959320|NCT01474512|75727309|FG003|Maintenance Period|Adverse Event|4|||
41959321|NCT01474512|75727310|FG004|Maintenance Period|Adverse Event|2|||
41959322|NCT01474512|75727311|FG005|Maintenance Period|Adverse Event|7|||
41959323|NCT01474512|75727312|FG006|Maintenance Period|Adverse Event|0|||
41959324|NCT01474512|75727313|FG007|Maintenance Period|Adverse Event|19|||
41959325|NCT01474512|75727314|FG008|Maintenance Period|Adverse Event|1|||
41959326|NCT01474512|75727315|FG009|Maintenance Period|Adverse Event|3|||
41959327|NCT01474512|75727316|FG010|Maintenance Period|Adverse Event|0|||
41959328|NCT01474512|75727317|FG011|Maintenance Period|Adverse Event|0|||
41959329|NCT01474512|75727318|FG012|Maintenance Period|Adverse Event|0|||
41959330|NCT01474512|75727319|FG013|Maintenance Period|Adverse Event|0|||
41959331|NCT01474512|75727320|FG014|Maintenance Period|Adverse Event|0|||
41959332|NCT01474512|75727321|FG015|Maintenance Period|Adverse Event|0|||
41959333|NCT01474512|75727322|FG016|Maintenance Period|Adverse Event|0|||
41959334|NCT01474512|75727323|FG017|Maintenance Period|Adverse Event|0|||
41959335|NCT01474512|75727306|FG000|Maintenance Period|Withdrawal by Subject|0|||
41959336|NCT01474512|75727307|FG001|Maintenance Period|Withdrawal by Subject|0|||
41959337|NCT01474512|75727308|FG002|Maintenance Period|Withdrawal by Subject|0|||
41959338|NCT01474512|75727309|FG003|Maintenance Period|Withdrawal by Subject|6|||
41959339|NCT01474512|75727310|FG004|Maintenance Period|Withdrawal by Subject|2|||
41959340|NCT01474512|75727311|FG005|Maintenance Period|Withdrawal by Subject|3|||
41959341|NCT01474512|75727312|FG006|Maintenance Period|Withdrawal by Subject|1|||
41959342|NCT01474512|75727313|FG007|Maintenance Period|Withdrawal by Subject|6|||
41959343|NCT01474512|75727314|FG008|Maintenance Period|Withdrawal by Subject|3|||
41959344|NCT01474512|75727315|FG009|Maintenance Period|Withdrawal by Subject|1|||
41959345|NCT01474512|75727316|FG010|Maintenance Period|Withdrawal by Subject|0|||
41959346|NCT01474512|75727317|FG011|Maintenance Period|Withdrawal by Subject|0|||
41959347|NCT01474512|75727318|FG012|Maintenance Period|Withdrawal by Subject|0|||
41959348|NCT01474512|75727319|FG013|Maintenance Period|Withdrawal by Subject|0|||
41959349|NCT01474512|75727320|FG014|Maintenance Period|Withdrawal by Subject|0|||
41959350|NCT01474512|75727321|FG015|Maintenance Period|Withdrawal by Subject|0|||
41959351|NCT01474512|75727322|FG016|Maintenance Period|Withdrawal by Subject|0|||
41959352|NCT01474512|75727323|FG017|Maintenance Period|Withdrawal by Subject|0|||
41959353|NCT01474512|75727306|FG000|Maintenance Period|Lost to Follow-up|0|||
41959354|NCT01474512|75727307|FG001|Maintenance Period|Lost to Follow-up|0|||
41959355|NCT01474512|75727308|FG002|Maintenance Period|Lost to Follow-up|0|||
41959356|NCT01474512|75727309|FG003|Maintenance Period|Lost to Follow-up|3|||
41959357|NCT01474512|75727310|FG004|Maintenance Period|Lost to Follow-up|3|||
42024434|NCT01014975|75831927|FG002|Overall Study|Withdrawal by Subject|1|||
42118047|NCT00547248|75928857|FG000|Overall Study|Protocol Violation|0|||
41959358|NCT01474512|75727311|FG005|Maintenance Period|Lost to Follow-up|0|||
41959359|NCT01474512|75727312|FG006|Maintenance Period|Lost to Follow-up|0|||
41959360|NCT01474512|75727313|FG007|Maintenance Period|Lost to Follow-up|2|||
42024435|NCT01014975|75831925|FG000|Overall Study|Death|3|||
41959361|NCT01474512|75727314|FG008|Maintenance Period|Lost to Follow-up|1|||
41959362|NCT01474512|75727315|FG009|Maintenance Period|Lost to Follow-up|1|||
41959363|NCT01474512|75727316|FG010|Maintenance Period|Lost to Follow-up|0|||
41959364|NCT01474512|75727317|FG011|Maintenance Period|Lost to Follow-up|0|||
41959365|NCT01474512|75727318|FG012|Maintenance Period|Lost to Follow-up|0|||
41959366|NCT01474512|75727319|FG013|Maintenance Period|Lost to Follow-up|0|||
41959367|NCT01474512|75727320|FG014|Maintenance Period|Lost to Follow-up|0|||
41959368|NCT01474512|75727321|FG015|Maintenance Period|Lost to Follow-up|0|||
41959369|NCT01474512|75727322|FG016|Maintenance Period|Lost to Follow-up|0|||
41959370|NCT01474512|75727323|FG017|Maintenance Period|Lost to Follow-up|0|||
41959371|NCT01474512|75727306|FG000|Maintenance Period|Death|0|||
41959372|NCT01474512|75727307|FG001|Maintenance Period|Death|0|||
41959373|NCT01474512|75727308|FG002|Maintenance Period|Death|0|||
41959374|NCT01474512|75727309|FG003|Maintenance Period|Death|0|||
41959375|NCT01474512|75727310|FG004|Maintenance Period|Death|0|||
41959376|NCT01474512|75727311|FG005|Maintenance Period|Death|2|||
41959377|NCT01474512|75727312|FG006|Maintenance Period|Death|0|||
41959378|NCT01474512|75727313|FG007|Maintenance Period|Death|0|||
41959379|NCT01474512|75727314|FG008|Maintenance Period|Death|0|||
41959380|NCT01474512|75727315|FG009|Maintenance Period|Death|0|||
41959381|NCT01474512|75727316|FG010|Maintenance Period|Death|0|||
41959382|NCT01474512|75727317|FG011|Maintenance Period|Death|0|||
41959383|NCT01474512|75727318|FG012|Maintenance Period|Death|0|||
41959384|NCT01474512|75727319|FG013|Maintenance Period|Death|0|||
41959385|NCT01474512|75727320|FG014|Maintenance Period|Death|0|||
41959386|NCT01474512|75727321|FG015|Maintenance Period|Death|0|||
41959387|NCT01474512|75727322|FG016|Maintenance Period|Death|0|||
41959388|NCT01474512|75727323|FG017|Maintenance Period|Death|0|||
41959389|NCT01474512|75727306|FG000|Maintenance Period|Physician Decision|0|||
41959390|NCT01474512|75727307|FG001|Maintenance Period|Physician Decision|0|||
41959391|NCT01474512|75727308|FG002|Maintenance Period|Physician Decision|0|||
41959392|NCT01474512|75727309|FG003|Maintenance Period|Physician Decision|0|||
41959393|NCT01474512|75727310|FG004|Maintenance Period|Physician Decision|0|||
41959394|NCT01474512|75727311|FG005|Maintenance Period|Physician Decision|1|||
41959395|NCT01474512|75727312|FG006|Maintenance Period|Physician Decision|0|||
41959396|NCT01474512|75727313|FG007|Maintenance Period|Physician Decision|2|||
41959397|NCT01474512|75727314|FG008|Maintenance Period|Physician Decision|0|||
41959398|NCT01474512|75727315|FG009|Maintenance Period|Physician Decision|0|||
41959399|NCT01474512|75727316|FG010|Maintenance Period|Physician Decision|0|||
41959400|NCT01474512|75727317|FG011|Maintenance Period|Physician Decision|0|||
41959401|NCT01474512|75727318|FG012|Maintenance Period|Physician Decision|0|||
41959402|NCT01474512|75727319|FG013|Maintenance Period|Physician Decision|0|||
41959403|NCT01474512|75727320|FG014|Maintenance Period|Physician Decision|0|||
41959404|NCT01474512|75727321|FG015|Maintenance Period|Physician Decision|0|||
41959405|NCT01474512|75727322|FG016|Maintenance Period|Physician Decision|0|||
41959406|NCT01474512|75727323|FG017|Maintenance Period|Physician Decision|0|||
41959407|NCT01474512|75727306|FG000|Maintenance Period|Clinical Relapse|0|||
41959408|NCT01474512|75727307|FG001|Maintenance Period|Clinical Relapse|0|||
41959409|NCT01474512|75727308|FG002|Maintenance Period|Clinical Relapse|0|||
41959410|NCT01474512|75727309|FG003|Maintenance Period|Clinical Relapse|1|||
41959411|NCT01474512|75727310|FG004|Maintenance Period|Clinical Relapse|0|||
41959412|NCT01474512|75727311|FG005|Maintenance Period|Clinical Relapse|0|||
41959413|NCT01474512|75727312|FG006|Maintenance Period|Clinical Relapse|0|||
41959414|NCT01474512|75727313|FG007|Maintenance Period|Clinical Relapse|0|||
41959415|NCT01474512|75727314|FG008|Maintenance Period|Clinical Relapse|0|||
41959416|NCT01474512|75727315|FG009|Maintenance Period|Clinical Relapse|0|||
41959417|NCT01474512|75727316|FG010|Maintenance Period|Clinical Relapse|0|||
41959418|NCT01474512|75727317|FG011|Maintenance Period|Clinical Relapse|0|||
41959419|NCT01474512|75727318|FG012|Maintenance Period|Clinical Relapse|0|||
41959420|NCT01474512|75727319|FG013|Maintenance Period|Clinical Relapse|0|||
41959421|NCT01474512|75727320|FG014|Maintenance Period|Clinical Relapse|0|||
41959422|NCT01474512|75727321|FG015|Maintenance Period|Clinical Relapse|0|||
42024436|NCT01014975|75831926|FG001|Overall Study|Death|3|||
42024437|NCT01014975|75831927|FG002|Overall Study|Death|4|||
42024438|NCT01014975|75831925|FG000|Overall Study|Lost to Follow-up|0|||
41959423|NCT01474512|75727322|FG016|Maintenance Period|Clinical Relapse|0|||
41959424|NCT01474512|75727323|FG017|Maintenance Period|Clinical Relapse|0|||
41959425|NCT01474512|75727306|FG000|Maintenance Period|Lack of Efficacy|0|||
41959426|NCT01474512|75727307|FG001|Maintenance Period|Lack of Efficacy|0|||
41959427|NCT01474512|75727308|FG002|Maintenance Period|Lack of Efficacy|0|||
41959428|NCT01474512|75727309|FG003|Maintenance Period|Lack of Efficacy|1|||
42024439|NCT01014975|75831926|FG001|Overall Study|Lost to Follow-up|0|||
42024440|NCT01014975|75831927|FG002|Overall Study|Lost to Follow-up|1|||
41959429|NCT01474512|75727310|FG004|Maintenance Period|Lack of Efficacy|0|||
41959430|NCT01474512|75727311|FG005|Maintenance Period|Lack of Efficacy|0|||
41959431|NCT01474512|75727312|FG006|Maintenance Period|Lack of Efficacy|0|||
41959432|NCT01474512|75727313|FG007|Maintenance Period|Lack of Efficacy|11|||
41959433|NCT01474512|75727314|FG008|Maintenance Period|Lack of Efficacy|11|||
41959434|NCT01474512|75727315|FG009|Maintenance Period|Lack of Efficacy|12|||
42024441|NCT01221623|75831937|FG000|Overall Study|Withdrawal by Subject|19|||
42024442|NCT01221623|75831938|FG001|Overall Study|Withdrawal by Subject|8|||
41959435|NCT01474512|75727316|FG010|Maintenance Period|Lack of Efficacy|0|||
42024443|NCT01221623|75831937|FG000|Overall Study|Lost to Follow-up|7|||
41959436|NCT01474512|75727317|FG011|Maintenance Period|Lack of Efficacy|0|||
41959437|NCT01474512|75727318|FG012|Maintenance Period|Lack of Efficacy|0|||
41959438|NCT01474512|75727319|FG013|Maintenance Period|Lack of Efficacy|0|||
41959439|NCT01474512|75727320|FG014|Maintenance Period|Lack of Efficacy|0|||
41959440|NCT01474512|75727321|FG015|Maintenance Period|Lack of Efficacy|0|||
41959441|NCT01474512|75727322|FG016|Maintenance Period|Lack of Efficacy|0|||
41959442|NCT01474512|75727323|FG017|Maintenance Period|Lack of Efficacy|0|||
41959443|NCT01474512|75727306|FG000|Maintenance Period|Protocol Violation|0|||
41959444|NCT01474512|75727307|FG001|Maintenance Period|Protocol Violation|0|||
41959445|NCT01474512|75727308|FG002|Maintenance Period|Protocol Violation|0|||
41959446|NCT01474512|75727309|FG003|Maintenance Period|Protocol Violation|1|||
41959447|NCT01474512|75727310|FG004|Maintenance Period|Protocol Violation|0|||
41959448|NCT01474512|75727311|FG005|Maintenance Period|Protocol Violation|0|||
41959449|NCT01474512|75727312|FG006|Maintenance Period|Protocol Violation|0|||
41959450|NCT01474512|75727313|FG007|Maintenance Period|Protocol Violation|1|||
41959451|NCT01474512|75727314|FG008|Maintenance Period|Protocol Violation|0|||
41959452|NCT01474512|75727315|FG009|Maintenance Period|Protocol Violation|1|||
41959453|NCT01474512|75727316|FG010|Maintenance Period|Protocol Violation|0|||
41959454|NCT01474512|75727317|FG011|Maintenance Period|Protocol Violation|0|||
41959455|NCT01474512|75727318|FG012|Maintenance Period|Protocol Violation|0|||
41959456|NCT01474512|75727319|FG013|Maintenance Period|Protocol Violation|0|||
41959457|NCT01474512|75727320|FG014|Maintenance Period|Protocol Violation|0|||
41959458|NCT01474512|75727321|FG015|Maintenance Period|Protocol Violation|0|||
41959459|NCT01474512|75727322|FG016|Maintenance Period|Protocol Violation|0|||
41959460|NCT01474512|75727323|FG017|Maintenance Period|Protocol Violation|0|||
41959461|NCT01474512|75727306|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
41959462|NCT01474512|75727307|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
41959463|NCT01474512|75727308|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
41959464|NCT01474512|75727309|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
41959465|NCT01474512|75727310|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
41959466|NCT01474512|75727311|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
41959467|NCT01474512|75727312|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
41959468|NCT01474512|75727313|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
41959469|NCT01474512|75727314|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
41959470|NCT01474512|75727315|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
41959471|NCT01474512|75727316|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
41959472|NCT01474512|75727317|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
41959473|NCT01474512|75727318|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
41959474|NCT01474512|75727319|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
41959475|NCT01474512|75727320|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
41959476|NCT01474512|75727321|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
41959477|NCT01474512|75727322|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
41959478|NCT01474512|75727323|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
41959479|NCT01474512|75727306|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
41959480|NCT01474512|75727307|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
41959481|NCT01474512|75727308|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
41959482|NCT01474512|75727309|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
41959483|NCT01474512|75727310|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
41959484|NCT01474512|75727311|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
41959485|NCT01474512|75727312|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
41959486|NCT01474512|75727313|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
41959487|NCT01474512|75727314|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
41959488|NCT01474512|75727315|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
41959489|NCT01474512|75727316|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
41959490|NCT01474512|75727317|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
41959491|NCT01474512|75727318|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
41959492|NCT01474512|75727319|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
41959493|NCT01474512|75727320|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
41959494|NCT01474512|75727321|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
41959495|NCT01474512|75727322|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
41959496|NCT01474512|75727323|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
41959497|NCT01474512|75727306|FG000|Long-Term Extension Period|Adverse Event|0|||
41959498|NCT01474512|75727307|FG001|Long-Term Extension Period|Adverse Event|0|||
41959499|NCT01474512|75727308|FG002|Long-Term Extension Period|Adverse Event|0|||
41959500|NCT01474512|75727309|FG003|Long-Term Extension Period|Adverse Event|0|||
41959501|NCT01474512|75727310|FG004|Long-Term Extension Period|Adverse Event|0|||
42024444|NCT01221623|75831938|FG001|Overall Study|Lost to Follow-up|1|||
42024445|NCT01221623|75831937|FG000|Overall Study|Adverse Event|6|||
41959502|NCT01474512|75727311|FG005|Long-Term Extension Period|Adverse Event|0|||
42024446|NCT01221623|75831938|FG001|Overall Study|Adverse Event|3|||
42024447|NCT01221623|75831937|FG000|Overall Study|Death|1|||
42024448|NCT01221623|75831938|FG001|Overall Study|Death|0|||
42024449|NCT01221623|75831937|FG000|Overall Study|Other|5|||
41959503|NCT01474512|75727312|FG006|Long-Term Extension Period|Adverse Event|0|||
41959504|NCT01474512|75727313|FG007|Long-Term Extension Period|Adverse Event|0|||
41959505|NCT01474512|75727314|FG008|Long-Term Extension Period|Adverse Event|0|||
41959506|NCT01474512|75727315|FG009|Long-Term Extension Period|Adverse Event|0|||
41959507|NCT01474512|75727316|FG010|Long-Term Extension Period|Adverse Event|0|||
41959508|NCT01474512|75727317|FG011|Long-Term Extension Period|Adverse Event|1|||
41959509|NCT01474512|75727318|FG012|Long-Term Extension Period|Adverse Event|57|||
41959510|NCT01474512|75727319|FG013|Long-Term Extension Period|Adverse Event|58|||
41959511|NCT01474512|75727320|FG014|Long-Term Extension Period|Adverse Event|0|||
41959512|NCT01474512|75727321|FG015|Long-Term Extension Period|Adverse Event|0|||
41959513|NCT01474512|75727322|FG016|Long-Term Extension Period|Adverse Event|0|||
41959514|NCT01474512|75727323|FG017|Long-Term Extension Period|Adverse Event|0|||
41959515|NCT01474512|75727306|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
41959516|NCT01474512|75727307|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
41959517|NCT01474512|75727308|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
41959518|NCT01474512|75727309|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
41959519|NCT01474512|75727310|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
41959520|NCT01474512|75727311|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
41959521|NCT01474512|75727312|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
41959522|NCT01474512|75727313|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
41959523|NCT01474512|75727314|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
41959524|NCT01474512|75727315|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
41959525|NCT01474512|75727316|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
41959526|NCT01474512|75727317|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
41959527|NCT01474512|75727318|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
41959528|NCT01474512|75727319|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
41959529|NCT01474512|75727320|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
41959530|NCT01474512|75727321|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
41959531|NCT01474512|75727322|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
41959532|NCT01474512|75727323|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
41959533|NCT01474512|75727306|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
41959534|NCT01474512|75727307|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
41959535|NCT01474512|75727308|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
41959536|NCT01474512|75727309|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
41959537|NCT01474512|75727310|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
41959538|NCT01474512|75727311|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
41959539|NCT01474512|75727312|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
41959540|NCT01474512|75727313|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
41959541|NCT01474512|75727314|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
41959542|NCT01474512|75727315|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
41959543|NCT01474512|75727316|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
41959544|NCT01474512|75727317|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
41959545|NCT01474512|75727318|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
41959546|NCT01474512|75727319|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
41959547|NCT01474512|75727320|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
41959548|NCT01474512|75727321|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
41959549|NCT01474512|75727322|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
41959550|NCT01474512|75727323|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
41959551|NCT01474512|75727306|FG000|Long-Term Extension Period|Physician Decision|0|||
41959552|NCT01474512|75727307|FG001|Long-Term Extension Period|Physician Decision|0|||
41959553|NCT01474512|75727308|FG002|Long-Term Extension Period|Physician Decision|0|||
41959554|NCT01474512|75727309|FG003|Long-Term Extension Period|Physician Decision|0|||
41959555|NCT01474512|75727310|FG004|Long-Term Extension Period|Physician Decision|0|||
41959556|NCT01474512|75727311|FG005|Long-Term Extension Period|Physician Decision|0|||
41959557|NCT01474512|75727312|FG006|Long-Term Extension Period|Physician Decision|0|||
41959558|NCT01474512|75727313|FG007|Long-Term Extension Period|Physician Decision|0|||
41959559|NCT01474512|75727314|FG008|Long-Term Extension Period|Physician Decision|0|||
41959560|NCT01474512|75727315|FG009|Long-Term Extension Period|Physician Decision|0|||
41959561|NCT01474512|75727316|FG010|Long-Term Extension Period|Physician Decision|0|||
41959562|NCT01474512|75727317|FG011|Long-Term Extension Period|Physician Decision|0|||
41959563|NCT01474512|75727318|FG012|Long-Term Extension Period|Physician Decision|21|||
41959564|NCT01474512|75727319|FG013|Long-Term Extension Period|Physician Decision|21|||
41959565|NCT01474512|75727320|FG014|Long-Term Extension Period|Physician Decision|0|||
41959566|NCT01474512|75727321|FG015|Long-Term Extension Period|Physician Decision|0|||
41959567|NCT01474512|75727322|FG016|Long-Term Extension Period|Physician Decision|0|||
41959568|NCT01474512|75727323|FG017|Long-Term Extension Period|Physician Decision|0|||
41959569|NCT01474512|75727306|FG000|Long-Term Extension Period|Clinical Relapse|0|||
41959570|NCT01474512|75727307|FG001|Long-Term Extension Period|Clinical Relapse|0|||
41959571|NCT01474512|75727308|FG002|Long-Term Extension Period|Clinical Relapse|0|||
41959572|NCT01474512|75727309|FG003|Long-Term Extension Period|Clinical Relapse|0|||
41959573|NCT01474512|75727310|FG004|Long-Term Extension Period|Clinical Relapse|0|||
41959574|NCT01474512|75727311|FG005|Long-Term Extension Period|Clinical Relapse|0|||
41959575|NCT01474512|75727312|FG006|Long-Term Extension Period|Clinical Relapse|0|||
41959576|NCT01474512|75727313|FG007|Long-Term Extension Period|Clinical Relapse|0|||
41959577|NCT01474512|75727314|FG008|Long-Term Extension Period|Clinical Relapse|0|||
41959578|NCT01474512|75727315|FG009|Long-Term Extension Period|Clinical Relapse|0|||
41959579|NCT01474512|75727316|FG010|Long-Term Extension Period|Clinical Relapse|0|||
41959580|NCT01474512|75727317|FG011|Long-Term Extension Period|Clinical Relapse|0|||
41959581|NCT01474512|75727318|FG012|Long-Term Extension Period|Clinical Relapse|9|||
41959582|NCT01474512|75727319|FG013|Long-Term Extension Period|Clinical Relapse|9|||
41959583|NCT01474512|75727320|FG014|Long-Term Extension Period|Clinical Relapse|0|||
41959584|NCT01474512|75727321|FG015|Long-Term Extension Period|Clinical Relapse|0|||
41959585|NCT01474512|75727322|FG016|Long-Term Extension Period|Clinical Relapse|0|||
41959586|NCT01474512|75727323|FG017|Long-Term Extension Period|Clinical Relapse|0|||
41959587|NCT01474512|75727306|FG000|Long-Term Extension Period|Death|0|||
41959588|NCT01474512|75727307|FG001|Long-Term Extension Period|Death|0|||
41959589|NCT01474512|75727308|FG002|Long-Term Extension Period|Death|0|||
41959590|NCT01474512|75727309|FG003|Long-Term Extension Period|Death|0|||
41959591|NCT01474512|75727310|FG004|Long-Term Extension Period|Death|0|||
41959592|NCT01474512|75727311|FG005|Long-Term Extension Period|Death|0|||
41959593|NCT01474512|75727312|FG006|Long-Term Extension Period|Death|0|||
41959594|NCT01474512|75727313|FG007|Long-Term Extension Period|Death|0|||
41959595|NCT01474512|75727314|FG008|Long-Term Extension Period|Death|0|||
41959596|NCT01474512|75727315|FG009|Long-Term Extension Period|Death|0|||
41959597|NCT01474512|75727316|FG010|Long-Term Extension Period|Death|0|||
41959598|NCT01474512|75727317|FG011|Long-Term Extension Period|Death|0|||
41959599|NCT01474512|75727318|FG012|Long-Term Extension Period|Death|9|||
41959600|NCT01474512|75727319|FG013|Long-Term Extension Period|Death|9|||
41959601|NCT01474512|75727320|FG014|Long-Term Extension Period|Death|0|||
41959602|NCT01474512|75727321|FG015|Long-Term Extension Period|Death|0|||
41959603|NCT01474512|75727322|FG016|Long-Term Extension Period|Death|0|||
41959604|NCT01474512|75727323|FG017|Long-Term Extension Period|Death|0|||
41959605|NCT01474512|75727306|FG000|Long-Term Extension Period|Sponsor Decision|0|||
41959606|NCT01474512|75727307|FG001|Long-Term Extension Period|Sponsor Decision|0|||
41959607|NCT01474512|75727308|FG002|Long-Term Extension Period|Sponsor Decision|0|||
41959608|NCT01474512|75727309|FG003|Long-Term Extension Period|Sponsor Decision|0|||
41959609|NCT01474512|75727310|FG004|Long-Term Extension Period|Sponsor Decision|0|||
41959610|NCT01474512|75727311|FG005|Long-Term Extension Period|Sponsor Decision|0|||
41959611|NCT01474512|75727312|FG006|Long-Term Extension Period|Sponsor Decision|0|||
41959612|NCT01474512|75727313|FG007|Long-Term Extension Period|Sponsor Decision|0|||
41959613|NCT01474512|75727314|FG008|Long-Term Extension Period|Sponsor Decision|0|||
41959614|NCT01474512|75727315|FG009|Long-Term Extension Period|Sponsor Decision|0|||
41959615|NCT01474512|75727316|FG010|Long-Term Extension Period|Sponsor Decision|0|||
41959616|NCT01474512|75727317|FG011|Long-Term Extension Period|Sponsor Decision|0|||
41959617|NCT01474512|75727318|FG012|Long-Term Extension Period|Sponsor Decision|6|||
41959618|NCT01474512|75727319|FG013|Long-Term Extension Period|Sponsor Decision|6|||
41959619|NCT01474512|75727320|FG014|Long-Term Extension Period|Sponsor Decision|0|||
41959620|NCT01474512|75727321|FG015|Long-Term Extension Period|Sponsor Decision|0|||
41959621|NCT01474512|75727322|FG016|Long-Term Extension Period|Sponsor Decision|0|||
41959622|NCT01474512|75727323|FG017|Long-Term Extension Period|Sponsor Decision|0|||
41959623|NCT01474512|75727306|FG000|Long-Term Extension Period|Protocol Violation|0|||
41959624|NCT01474512|75727307|FG001|Long-Term Extension Period|Protocol Violation|0|||
41959625|NCT01474512|75727308|FG002|Long-Term Extension Period|Protocol Violation|0|||
41959626|NCT01474512|75727309|FG003|Long-Term Extension Period|Protocol Violation|0|||
41959627|NCT01474512|75727310|FG004|Long-Term Extension Period|Protocol Violation|0|||
41959628|NCT01474512|75727311|FG005|Long-Term Extension Period|Protocol Violation|0|||
41959629|NCT01474512|75727312|FG006|Long-Term Extension Period|Protocol Violation|0|||
41959630|NCT01474512|75727313|FG007|Long-Term Extension Period|Protocol Violation|0|||
41959631|NCT01474512|75727314|FG008|Long-Term Extension Period|Protocol Violation|0|||
41959632|NCT01474512|75727315|FG009|Long-Term Extension Period|Protocol Violation|0|||
41959633|NCT01474512|75727316|FG010|Long-Term Extension Period|Protocol Violation|0|||
41959634|NCT01474512|75727317|FG011|Long-Term Extension Period|Protocol Violation|0|||
41959635|NCT01474512|75727318|FG012|Long-Term Extension Period|Protocol Violation|5|||
41959636|NCT01474512|75727319|FG013|Long-Term Extension Period|Protocol Violation|5|||
41959637|NCT01474512|75727320|FG014|Long-Term Extension Period|Protocol Violation|0|||
41959638|NCT01474512|75727321|FG015|Long-Term Extension Period|Protocol Violation|0|||
41959639|NCT01474512|75727322|FG016|Long-Term Extension Period|Protocol Violation|0|||
41959640|NCT01474512|75727323|FG017|Long-Term Extension Period|Protocol Violation|0|||
41959641|NCT01474512|75727306|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959642|NCT01474512|75727307|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959643|NCT01474512|75727308|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959644|NCT01474512|75727309|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959645|NCT01474512|75727310|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959646|NCT01474512|75727311|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959647|NCT01474512|75727312|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959648|NCT01474512|75727313|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959649|NCT01474512|75727314|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959650|NCT01474512|75727315|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959651|NCT01474512|75727316|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959652|NCT01474512|75727317|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959653|NCT01474512|75727318|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
41959654|NCT01474512|75727319|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
41959655|NCT01474512|75727320|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959656|NCT01474512|75727321|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959657|NCT01474512|75727322|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959658|NCT01474512|75727323|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
41959659|NCT01474512|75727306|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959660|NCT01474512|75727307|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959661|NCT01474512|75727308|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959662|NCT01474512|75727309|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959663|NCT01474512|75727310|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959664|NCT01474512|75727311|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959665|NCT01474512|75727312|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959666|NCT01474512|75727313|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959667|NCT01474512|75727314|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959668|NCT01474512|75727315|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959669|NCT01474512|75727316|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959670|NCT01474512|75727317|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
41959671|NCT01474512|75727318|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959672|NCT01474512|75727319|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959673|NCT01474512|75727320|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959674|NCT01474512|75727321|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959675|NCT01474512|75727322|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959676|NCT01474512|75727323|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
41959677|NCT01474512|75727306|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
41959678|NCT01474512|75727307|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
41959679|NCT01474512|75727308|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
41959680|NCT01474512|75727309|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
41959681|NCT01474512|75727310|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
41959682|NCT01474512|75727311|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
41959683|NCT01474512|75727312|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
41959684|NCT01474512|75727313|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
41959685|NCT01474512|75727314|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
41959686|NCT01474512|75727315|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
41959687|NCT01474512|75727316|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
41959688|NCT01474512|75727317|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
41959689|NCT01474512|75727318|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
41959690|NCT01474512|75727319|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
41959691|NCT01474512|75727320|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
41959692|NCT01474512|75727321|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
41959693|NCT01474512|75727322|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
41959694|NCT01474512|75727323|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
41959695|NCT01474512|75727306|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959696|NCT01474512|75727307|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959697|NCT01474512|75727308|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959698|NCT01474512|75727309|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959699|NCT01474512|75727310|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959700|NCT01474512|75727311|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959701|NCT01474512|75727312|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959702|NCT01474512|75727313|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959703|NCT01474512|75727314|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959704|NCT01474512|75727315|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959705|NCT01474512|75727316|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959706|NCT01474512|75727317|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959707|NCT01474512|75727318|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959708|NCT01474512|75727319|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
41959709|NCT01474512|75727320|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
41959710|NCT01474512|75727321|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
41959711|NCT01474512|75727322|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
41959712|NCT01474512|75727323|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
41959713|NCT01474512|75727306|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959714|NCT01474512|75727307|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959715|NCT01474512|75727308|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959716|NCT01474512|75727309|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959717|NCT01474512|75727310|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959718|NCT01474512|75727311|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959719|NCT01474512|75727312|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959720|NCT01474512|75727313|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959721|NCT01474512|75727314|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959722|NCT01474512|75727315|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959723|NCT01474512|75727316|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959724|NCT01474512|75727317|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959725|NCT01474512|75727318|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959726|NCT01474512|75727319|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
41959727|NCT01474512|75727320|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
41959728|NCT01474512|75727321|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
41959729|NCT01474512|75727322|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
41959730|NCT01474512|75727323|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
41959731|NCT01474512|75727306|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959732|NCT01474512|75727307|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959733|NCT01474512|75727308|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959734|NCT01474512|75727309|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959735|NCT01474512|75727310|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959736|NCT01474512|75727311|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959737|NCT01474512|75727312|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959738|NCT01474512|75727313|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959739|NCT01474512|75727314|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959740|NCT01474512|75727315|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959741|NCT01474512|75727316|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959742|NCT01474512|75727317|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959743|NCT01474512|75727318|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959744|NCT01474512|75727319|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959745|NCT01474512|75727320|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959746|NCT01474512|75727321|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
41959747|NCT01474512|75727322|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
41959748|NCT01474512|75727323|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
41959749|NCT01474512|75727306|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
41959750|NCT01474512|75727307|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
41959751|NCT01474512|75727308|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
41959752|NCT01474512|75727309|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
41959753|NCT01474512|75727310|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
41959754|NCT01474512|75727311|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
41959755|NCT01474512|75727312|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
41959756|NCT01474512|75727313|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
41959757|NCT01474512|75727314|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
41959758|NCT01474512|75727315|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
41959759|NCT01474512|75727316|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
41959760|NCT01474512|75727317|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
41959761|NCT01474512|75727318|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
41959762|NCT01474512|75727319|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
41959763|NCT01474512|75727320|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
41959764|NCT01474512|75727321|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
41959765|NCT01474512|75727322|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
41959766|NCT01474512|75727323|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
41959767|NCT01474512|75727306|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959768|NCT01474512|75727307|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959769|NCT01474512|75727308|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959770|NCT01474512|75727309|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959771|NCT01474512|75727310|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959772|NCT01474512|75727311|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959773|NCT01474512|75727312|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959774|NCT01474512|75727313|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959775|NCT01474512|75727314|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959776|NCT01474512|75727315|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959777|NCT01474512|75727316|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959778|NCT01474512|75727317|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959779|NCT01474512|75727318|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959780|NCT01474512|75727319|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959781|NCT01474512|75727320|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959782|NCT01474512|75727321|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
41959783|NCT01474512|75727322|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
41959784|NCT01474512|75727323|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
41959785|NCT01474512|75727306|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
41959786|NCT01474512|75727307|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
41959787|NCT01474512|75727308|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
41959788|NCT01474512|75727309|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
41959789|NCT01474512|75727310|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
41959790|NCT01474512|75727311|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
41959791|NCT01474512|75727312|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
41959792|NCT01474512|75727313|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
41959793|NCT01474512|75727314|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
41959794|NCT01474512|75727315|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
41959795|NCT01474512|75727316|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
41959796|NCT01474512|75727317|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
41959797|NCT01474512|75727318|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
41959798|NCT01474512|75727319|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
41959799|NCT01474512|75727320|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
41959800|NCT01474512|75727321|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
41959801|NCT01474512|75727322|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
41959802|NCT01474512|75727323|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
41959803|NCT01474512|75727306|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959804|NCT01474512|75727307|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959805|NCT01474512|75727308|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959806|NCT01474512|75727309|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959807|NCT01474512|75727310|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959808|NCT01474512|75727311|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959809|NCT01474512|75727312|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959810|NCT01474512|75727313|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959811|NCT01474512|75727314|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959812|NCT01474512|75727315|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959813|NCT01474512|75727316|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959814|NCT01474512|75727317|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959815|NCT01474512|75727318|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959816|NCT01474512|75727319|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959817|NCT01474512|75727320|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
41959818|NCT01474512|75727321|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959819|NCT01474512|75727322|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
41959820|NCT01474512|75727323|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
41959821|NCT01474512|75727306|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959822|NCT01474512|75727307|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959823|NCT01474512|75727308|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959824|NCT01474512|75727309|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959825|NCT01474512|75727310|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959826|NCT01474512|75727311|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959827|NCT01474512|75727312|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959828|NCT01474512|75727313|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959829|NCT01474512|75727314|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959830|NCT01474512|75727315|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959831|NCT01474512|75727316|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959832|NCT01474512|75727317|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959833|NCT01474512|75727318|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959834|NCT01474512|75727319|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959835|NCT01474512|75727320|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
42024450|NCT01221623|75831938|FG001|Overall Study|Other|2|||
42024451|NCT01014585|75831948|FG000|Overall Study|Adverse Event|0|||
42024452|NCT01014585|75831949|FG001|Overall Study|Adverse Event|2|||
42024453|NCT01014585|75831950|FG002|Overall Study|Adverse Event|0|||
42024454|NCT01014585|75831951|FG003|Overall Study|Adverse Event|3|||
42024455|NCT01014585|75831948|FG000|Overall Study|Withdrawal by Subject|2|||
42024456|NCT01014585|75831949|FG001|Overall Study|Withdrawal by Subject|0|||
42024457|NCT01014585|75831950|FG002|Overall Study|Withdrawal by Subject|1|||
42024458|NCT01014585|75831951|FG003|Overall Study|Withdrawal by Subject|3|||
42024459|NCT01014585|75831948|FG000|Overall Study|Lost to Follow-up|0|||
42024460|NCT01014585|75831949|FG001|Overall Study|Lost to Follow-up|0|||
42024461|NCT01014585|75831950|FG002|Overall Study|Lost to Follow-up|0|||
42024462|NCT01014585|75831951|FG003|Overall Study|Lost to Follow-up|2|||
41959836|NCT01474512|75727321|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959837|NCT01474512|75727322|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
41959838|NCT01474512|75727323|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
41959839|NCT01474512|75727306|FG000|Post-Treatment Follow-Up|Death|0|||
41959840|NCT01474512|75727307|FG001|Post-Treatment Follow-Up|Death|0|||
41959841|NCT01474512|75727308|FG002|Post-Treatment Follow-Up|Death|0|||
41959842|NCT01474512|75727309|FG003|Post-Treatment Follow-Up|Death|0|||
41959843|NCT01474512|75727310|FG004|Post-Treatment Follow-Up|Death|0|||
41959844|NCT01474512|75727311|FG005|Post-Treatment Follow-Up|Death|0|||
41959845|NCT01474512|75727312|FG006|Post-Treatment Follow-Up|Death|0|||
41959846|NCT01474512|75727313|FG007|Post-Treatment Follow-Up|Death|0|||
41959847|NCT01474512|75727314|FG008|Post-Treatment Follow-Up|Death|0|||
41959848|NCT01474512|75727315|FG009|Post-Treatment Follow-Up|Death|0|||
41959849|NCT01474512|75727316|FG010|Post-Treatment Follow-Up|Death|0|||
41959850|NCT01474512|75727317|FG011|Post-Treatment Follow-Up|Death|0|||
41959851|NCT01474512|75727318|FG012|Post-Treatment Follow-Up|Death|0|||
41959852|NCT01474512|75727319|FG013|Post-Treatment Follow-Up|Death|0|||
41959853|NCT01474512|75727320|FG014|Post-Treatment Follow-Up|Death|0|||
41959854|NCT01474512|75727321|FG015|Post-Treatment Follow-Up|Death|0|||
41959855|NCT01474512|75727322|FG016|Post-Treatment Follow-Up|Death|1|||
41959856|NCT01474512|75727323|FG017|Post-Treatment Follow-Up|Death|0|||
41959857|NCT01474434|75727357|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
41959858|NCT01474434|75727358|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
41959859|NCT01474434|75727359|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
41959860|NCT01474434|75727360|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
41959861|NCT01474434|75727357|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
41959862|NCT01474434|75727358|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
41959863|NCT01474434|75727359|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
41959864|NCT01474434|75727360|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
41959865|NCT01474434|75727357|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
41959866|NCT01474434|75727358|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
41959867|NCT01474434|75727359|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
41959868|NCT01474434|75727360|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
41959869|NCT01473732|75727376|FG000|Overall Study|Adverse Event|1|||
41959870|NCT01473732|75727377|FG001|Overall Study|Adverse Event|0|||
41959871|NCT01473732|75727376|FG000|Overall Study|Death|1|||
41959872|NCT01473732|75727377|FG001|Overall Study|Death|0|||
41959873|NCT01450098|75727385|FG000|Period 3|Protocol Violation|0|||
41959874|NCT01450098|75727386|FG001|Period 3|Protocol Violation|1|||
41959875|NCT01450098|75727385|FG000|Period 3|Withdrawal by Subject|0|||
41959876|NCT01450098|75727386|FG001|Period 3|Withdrawal by Subject|2|||
41959877|NCT01449708|75727401|FG000|Overall Study|Protocol Violation|0|||
41959878|NCT01449708|75727402|FG001|Overall Study|Protocol Violation|1|||
41959879|NCT01449708|75727401|FG000|Overall Study|surgical complication|1|||
41959880|NCT01449708|75727402|FG001|Overall Study|surgical complication|2|||
41959881|NCT01449708|75727401|FG000|Overall Study|respiratory failure|1|||
41959882|NCT01449708|75727402|FG001|Overall Study|respiratory failure|0|||
41959883|NCT01449630|75727420|FG000|Period 1|Physician Decision|1|||
41959884|NCT01449630|75727421|FG001|Period 1|Physician Decision|0|||
41959885|NCT01449630|75727422|FG002|Period 1|Physician Decision|0|||
41959886|NCT01449630|75727423|FG003|Period 1|Physician Decision|1|||
41959887|NCT01449630|75727424|FG004|Period 1|Physician Decision|0|||
41959888|NCT01449630|75727425|FG005|Period 1|Physician Decision|0|||
41959889|NCT01449630|75727426|FG006|Period 1|Physician Decision|0|||
41959890|NCT01449630|75727427|FG007|Period 1|Physician Decision|0|||
41959891|NCT01449630|75727428|FG008|Period 1|Physician Decision|0|||
41959892|NCT01449630|75727420|FG000|Period 1|Sponsor Decision|0|||
41959893|NCT01449630|75727421|FG001|Period 1|Sponsor Decision|0|||
41959894|NCT01449630|75727422|FG002|Period 1|Sponsor Decision|0|||
41959895|NCT01449630|75727423|FG003|Period 1|Sponsor Decision|0|||
41959896|NCT01449630|75727424|FG004|Period 1|Sponsor Decision|0|||
41959897|NCT01449630|75727425|FG005|Period 1|Sponsor Decision|1|||
41959898|NCT01449630|75727426|FG006|Period 1|Sponsor Decision|0|||
41959899|NCT01449630|75727427|FG007|Period 1|Sponsor Decision|0|||
41959900|NCT01449630|75727428|FG008|Period 1|Sponsor Decision|0|||
41959901|NCT01449630|75727420|FG000|Period 2|Sponsor Decision|0|||
41959902|NCT01449630|75727421|FG001|Period 2|Sponsor Decision|0|||
41959903|NCT01449630|75727422|FG002|Period 2|Sponsor Decision|0|||
41959904|NCT01449630|75727423|FG003|Period 2|Sponsor Decision|0|||
41959905|NCT01449630|75727424|FG004|Period 2|Sponsor Decision|0|||
41959906|NCT01449630|75727425|FG005|Period 2|Sponsor Decision|0|||
41959907|NCT01449630|75727426|FG006|Period 2|Sponsor Decision|1|||
41959908|NCT01449630|75727427|FG007|Period 2|Sponsor Decision|0|||
41959909|NCT01449630|75727428|FG008|Period 2|Sponsor Decision|0|||
41959910|NCT01493778|75727450|FG000|Overall Study|Withdrawal by Subject|8|||
41959911|NCT01473420|75727465|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
42024463|NCT01014585|75831948|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
41959912|NCT01473420|75727466|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
41959913|NCT01473420|75727465|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
41959914|NCT01473420|75727466|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
41959915|NCT01473420|75727465|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
41959916|NCT01473420|75727466|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
41959917|NCT01473420|75727465|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
41959918|NCT01473420|75727466|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
41959919|NCT01473420|75727465|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
41959920|NCT01473420|75727466|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
41959921|NCT01473420|75727465|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
41959922|NCT01473420|75727466|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
41959923|NCT01473420|75727465|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
41959924|NCT01473420|75727466|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
42118048|NCT00547248|75928858|FG001|Overall Study|Protocol Violation|0|||
41959925|NCT01473420|75727465|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
41959926|NCT01473420|75727466|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
41959927|NCT01473420|75727465|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
41959928|NCT01473420|75727466|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
41959929|NCT01473420|75727465|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
41959930|NCT01473420|75727466|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
41959931|NCT01473420|75727465|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
41959932|NCT01473420|75727466|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
41959933|NCT01473420|75727465|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
41959934|NCT01473420|75727466|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
41959935|NCT01473420|75727465|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
41959936|NCT01473420|75727466|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
41959937|NCT01492686|75727480|FG000|Double-blind Phase|Adverse Event|0|||
41959938|NCT01492686|75727481|FG001|Double-blind Phase|Adverse Event|2|||
41959939|NCT01492686|75727480|FG000|Double-blind Phase|Physician Decision|0|||
41959940|NCT01492686|75727481|FG001|Double-blind Phase|Physician Decision|1|||
41959941|NCT01492686|75727480|FG000|Double-blind Phase|Withdrawal by Subject|0|||
41959942|NCT01492686|75727481|FG001|Double-blind Phase|Withdrawal by Subject|2|||
41959943|NCT01492686|75727480|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
41959944|NCT01492686|75727481|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
41959945|NCT01492686|75727480|FG000|Open-label Phase|Adverse Event|1|||
41959946|NCT01492686|75727481|FG001|Open-label Phase|Adverse Event|2|||
41959947|NCT01492686|75727480|FG000|Open-label Phase|Physician Decision|1|||
41959948|NCT01492686|75727481|FG001|Open-label Phase|Physician Decision|0|||
41959949|NCT01492686|75727480|FG000|Open-label Phase|Withdrawal by Subject|6|||
41959950|NCT01492686|75727481|FG001|Open-label Phase|Withdrawal by Subject|7|||
41959951|NCT01492686|75727480|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
41959952|NCT01492686|75727481|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
41959953|NCT01449006|75727491|FG000|Overall Study|Lost to Follow-up|1|||
41959954|NCT01449006|75727492|FG001|Overall Study|Lost to Follow-up|0|||
41959955|NCT01449006|75727491|FG000|Overall Study|Withdrawal by Subject|1|||
41959956|NCT01449006|75727492|FG001|Overall Study|Withdrawal by Subject|0|||
41959957|NCT01449006|75727491|FG000|Overall Study|Protocol Violation|1|||
41959958|NCT01449006|75727492|FG001|Overall Study|Protocol Violation|0|||
41959959|NCT01448850|75727500|FG000|Overall Study|Death|3|||
41959960|NCT01448850|75727501|FG001|Overall Study|Death|6|||
41959961|NCT01448850|75727500|FG000|Overall Study|Withdrawal by Subject|13|||
41959962|NCT01448850|75727501|FG001|Overall Study|Withdrawal by Subject|21|||
41959963|NCT01448850|75727500|FG000|Overall Study|Lost to Follow-up|3|||
41959964|NCT01448850|75727501|FG001|Overall Study|Lost to Follow-up|1|||
41959965|NCT01448850|75727500|FG000|Overall Study|Other|15|||
41959966|NCT01448850|75727501|FG001|Overall Study|Other|12|||
41959967|NCT01491672|75727511|FG000|Overall Study|Lost to Follow-up|0|||
41959968|NCT01491672|75727512|FG001|Overall Study|Lost to Follow-up|4|||
41959969|NCT01491672|75727513|FG002|Overall Study|Lost to Follow-up|1|||
41959970|NCT01491672|75727511|FG000|Overall Study|Withdrawal by Subject|6|||
41959971|NCT01491672|75727512|FG001|Overall Study|Withdrawal by Subject|7|||
41959972|NCT01491672|75727513|FG002|Overall Study|Withdrawal by Subject|0|||
41959973|NCT01491672|75727511|FG000|Overall Study|Adverse Event|8|||
41959974|NCT01491672|75727512|FG001|Overall Study|Adverse Event|10|||
41959975|NCT01491672|75727513|FG002|Overall Study|Adverse Event|4|||
41959976|NCT01491672|75727511|FG000|Overall Study|Disease progression|42|||
41959977|NCT01491672|75727512|FG001|Overall Study|Disease progression|34|||
41959978|NCT01491672|75727513|FG002|Overall Study|Disease progression|6|||
41959979|NCT01491672|75727511|FG000|Overall Study|Protocol deviation|0|||
41959980|NCT01491672|75727512|FG001|Overall Study|Protocol deviation|1|||
41959981|NCT01491672|75727513|FG002|Overall Study|Protocol deviation|0|||
41959982|NCT01491672|75727511|FG000|Overall Study|Death|0|||
41959983|NCT01491672|75727512|FG001|Overall Study|Death|4|||
41959984|NCT01491672|75727513|FG002|Overall Study|Death|0|||
41959985|NCT01447446|75727529|FG000|Overall Study|Death|6|||
41959986|NCT01447446|75727530|FG001|Overall Study|Death|3|||
41959987|NCT01447446|75727531|FG002|Overall Study|Death|2|||
41959988|NCT01447446|75727532|FG003|Overall Study|Death|1|||
41959989|NCT01447446|75727533|FG004|Overall Study|Death|7|||
41959990|NCT01447446|75727534|FG005|Overall Study|Death|0|||
41959991|NCT01447446|75727529|FG000|Overall Study|Adverse Event|3|||
41959992|NCT01447446|75727530|FG001|Overall Study|Adverse Event|0|||
41959993|NCT01447446|75727531|FG002|Overall Study|Adverse Event|1|||
41959994|NCT01447446|75727532|FG003|Overall Study|Adverse Event|0|||
41959995|NCT01447446|75727533|FG004|Overall Study|Adverse Event|2|||
41959996|NCT01447446|75727534|FG005|Overall Study|Adverse Event|0|||
41959997|NCT01447446|75727529|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
41959998|NCT01447446|75727530|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
41959999|NCT01447446|75727531|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
41960000|NCT01447446|75727532|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
41960001|NCT01447446|75727533|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
41960002|NCT01447446|75727534|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
41960003|NCT01447446|75727529|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
41960004|NCT01447446|75727530|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
41960005|NCT01447446|75727531|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
41960006|NCT01447446|75727532|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
41960007|NCT01447446|75727533|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
41960008|NCT01447446|75727534|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
41960009|NCT01447446|75727529|FG000|Overall Study|Administrative/Other|34|||
41960010|NCT01447446|75727530|FG001|Overall Study|Administrative/Other|9|||
41960011|NCT01447446|75727531|FG002|Overall Study|Administrative/Other|10|||
41960012|NCT01447446|75727532|FG003|Overall Study|Administrative/Other|2|||
41960013|NCT01447446|75727533|FG004|Overall Study|Administrative/Other|33|||
41960014|NCT01447446|75727534|FG005|Overall Study|Administrative/Other|4|||
41960015|NCT01447446|75727529|FG000|Overall Study|SVR12 Assessment|13|||
41960016|NCT01447446|75727530|FG001|Overall Study|SVR12 Assessment|1|||
41960017|NCT01447446|75727531|FG002|Overall Study|SVR12 Assessment|2|||
41960018|NCT01447446|75727532|FG003|Overall Study|SVR12 Assessment|1|||
41960019|NCT01447446|75727533|FG004|Overall Study|SVR12 Assessment|5|||
41960020|NCT01447446|75727534|FG005|Overall Study|SVR12 Assessment|5|||
41960021|NCT01447446|75727529|FG000|Overall Study|New Treatment Started|8|||
41960022|NCT01447446|75727530|FG001|Overall Study|New Treatment Started|2|||
41960023|NCT01447446|75727531|FG002|Overall Study|New Treatment Started|1|||
41960024|NCT01447446|75727532|FG003|Overall Study|New Treatment Started|0|||
41960025|NCT01447446|75727533|FG004|Overall Study|New Treatment Started|2|||
41960026|NCT01447446|75727534|FG005|Overall Study|New Treatment Started|0|||
41960027|NCT01447446|75727529|FG000|Overall Study|Reason not Specified|1|||
41960028|NCT01447446|75727530|FG001|Overall Study|Reason not Specified|1|||
41960029|NCT01447446|75727531|FG002|Overall Study|Reason not Specified|1|||
41960030|NCT01447446|75727532|FG003|Overall Study|Reason not Specified|1|||
41960031|NCT01447446|75727533|FG004|Overall Study|Reason not Specified|1|||
41960032|NCT01447446|75727534|FG005|Overall Study|Reason not Specified|0|||
41960033|NCT01490814|75727556|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
41960034|NCT01490814|75727557|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
41960035|NCT01490814|75727556|FG000|Overall Study|Physician Decision|1|||
41960036|NCT01490814|75727557|FG001|Overall Study|Physician Decision|0|||
41960037|NCT01490814|75727556|FG000|Overall Study|Withdrawal by Subject|0|||
41960038|NCT01490814|75727557|FG001|Overall Study|Withdrawal by Subject|5|||
41960039|NCT01471782|75727569|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
41960040|NCT01471782|75727570|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
41960041|NCT01471782|75727571|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
41960042|NCT01471782|75727572|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
41960043|NCT01471782|75727573|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
41960044|NCT01471782|75727574|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
41960045|NCT01471782|75727569|FG000|Overall Study|Lack of Efficacy|1|||
42118049|NCT00547248|75928859|FG002|Overall Study|Protocol Violation|1|||
42300493|NCT02365233|76135692|FG001|Overall Study|IRB withheld the data|2|||
42300494|NCT02365233|76135693|FG002|Overall Study|IRB withheld the data|2|||
41960046|NCT01471782|75727570|FG001|Overall Study|Lack of Efficacy|2|||
41960047|NCT01471782|75727571|FG002|Overall Study|Lack of Efficacy|1|||
41960048|NCT01471782|75727572|FG003|Overall Study|Lack of Efficacy|1|||
41960049|NCT01471782|75727573|FG004|Overall Study|Lack of Efficacy|5|||
41960050|NCT01471782|75727574|FG005|Overall Study|Lack of Efficacy|18|||
41960051|NCT01471782|75727569|FG000|Overall Study|Adverse Event|1|||
41960052|NCT01471782|75727570|FG001|Overall Study|Adverse Event|1|||
41960053|NCT01471782|75727571|FG002|Overall Study|Adverse Event|2|||
41960054|NCT01471782|75727572|FG003|Overall Study|Adverse Event|2|||
41960055|NCT01471782|75727573|FG004|Overall Study|Adverse Event|3|||
41960056|NCT01471782|75727574|FG005|Overall Study|Adverse Event|1|||
41960057|NCT01471782|75727569|FG000|Overall Study|Other|0|||
41960058|NCT01471782|75727570|FG001|Overall Study|Other|0|||
41960059|NCT01471782|75727571|FG002|Overall Study|Other|1|||
41960060|NCT01471782|75727572|FG003|Overall Study|Other|1|||
41960061|NCT01471782|75727573|FG004|Overall Study|Other|6|||
41960062|NCT01471782|75727574|FG005|Overall Study|Other|5|||
41960063|NCT01471782|75727569|FG000|Overall Study|Change of Chemotherapy|1|||
41960064|NCT01471782|75727570|FG001|Overall Study|Change of Chemotherapy|1|||
41960065|NCT01471782|75727571|FG002|Overall Study|Change of Chemotherapy|0|||
41960066|NCT01471782|75727572|FG003|Overall Study|Change of Chemotherapy|0|||
41960067|NCT01471782|75727573|FG004|Overall Study|Change of Chemotherapy|1|||
42300495|NCT02324205|76135701|FG000|Overall Study|Withdrawal by Subject|37|||
42300496|NCT02324049|76135705|FG000|Part C|Study terminated|11|||
42300497|NCT02364999|76135711|FG000|Overall Study|Death|136|||
42300498|NCT02364999|76135712|FG001|Overall Study|Death|138|||
42300499|NCT02364999|76135711|FG000|Overall Study|Lost to Follow-up|10|||
42300500|NCT02364999|76135712|FG001|Overall Study|Lost to Follow-up|15|||
42300501|NCT02364999|76135711|FG000|Overall Study|Protocol Violation|3|||
42300502|NCT02364999|76135712|FG001|Overall Study|Protocol Violation|2|||
42300503|NCT02364999|76135711|FG000|Overall Study|Withdrawal by Subject|14|||
42300504|NCT02364999|76135712|FG001|Overall Study|Withdrawal by Subject|14|||
42300505|NCT02364999|76135711|FG000|Overall Study|Other|0|||
42300506|NCT02364999|76135712|FG001|Overall Study|Other|1|||
42300507|NCT02364999|76135711|FG000|Overall Study|Randomized but did not receive treatment|2|||
42300508|NCT02364999|76135712|FG001|Overall Study|Randomized but did not receive treatment|3|||
41960068|NCT01471782|75727574|FG005|Overall Study|Change of Chemotherapy|4|||
41960069|NCT01471782|75727569|FG000|Overall Study|Disease Relapse|0|||
41960070|NCT01471782|75727570|FG001|Overall Study|Disease Relapse|0|||
41960071|NCT01471782|75727571|FG002|Overall Study|Disease Relapse|0|||
41960072|NCT01471782|75727572|FG003|Overall Study|Disease Relapse|1|||
41960073|NCT01471782|75727573|FG004|Overall Study|Disease Relapse|2|||
41960074|NCT01471782|75727574|FG005|Overall Study|Disease Relapse|1|||
41960075|NCT01471782|75727569|FG000|Overall Study|Physician Decision|0|||
41960076|NCT01471782|75727570|FG001|Overall Study|Physician Decision|0|||
41960077|NCT01471782|75727571|FG002|Overall Study|Physician Decision|0|||
41960078|NCT01471782|75727572|FG003|Overall Study|Physician Decision|0|||
41960079|NCT01471782|75727573|FG004|Overall Study|Physician Decision|3|||
41960080|NCT01471782|75727574|FG005|Overall Study|Physician Decision|8|||
41960081|NCT01471782|75727569|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
41960082|NCT01471782|75727570|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
41960083|NCT01471782|75727571|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
41960084|NCT01471782|75727572|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
41960085|NCT01471782|75727573|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
41960086|NCT01471782|75727574|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
41960087|NCT01471782|75727569|FG000|Overall Study|Death|0|||
41960088|NCT01471782|75727570|FG001|Overall Study|Death|0|||
41960089|NCT01471782|75727571|FG002|Overall Study|Death|0|||
41960090|NCT01471782|75727572|FG003|Overall Study|Death|0|||
41960091|NCT01471782|75727573|FG004|Overall Study|Death|0|||
41960092|NCT01471782|75727574|FG005|Overall Study|Death|1|||
41960093|NCT01490580|75727601|FG000|Overall Study|Parents withdrew consent|0|||
41960094|NCT01490580|75727602|FG001|Overall Study|Parents withdrew consent|2|||
41960095|NCT01490190|75727612|FG000|Overall Study|Withdrawal by Subject|9|||
41960096|NCT01490190|75727612|FG000|Overall Study|Adverse Event|17|||
41960097|NCT01490190|75727612|FG000|Overall Study|Protocol Violation|5|||
41960098|NCT01490190|75727612|FG000|Overall Study|Lost to Follow-up|13|||
41960099|NCT01490190|75727612|FG000|Overall Study|Relocation|1|||
41960100|NCT01490190|75727612|FG000|Overall Study|Inconvenience|1|||
41960101|NCT01490190|75727612|FG000|Overall Study|Ring expulsion|2|||
41960102|NCT01446042|75727619|FG000|Overall Study|Withdrawal by Subject|12|||
41960103|NCT01446042|75727620|FG001|Overall Study|Withdrawal by Subject|2|||
41960104|NCT01446042|75727621|FG002|Overall Study|Withdrawal by Subject|4|||
41960105|NCT01446042|75727619|FG000|Overall Study|Adverse Event|1|||
41960106|NCT01446042|75727620|FG001|Overall Study|Adverse Event|0|||
41960107|NCT01446042|75727621|FG002|Overall Study|Adverse Event|4|||
41960108|NCT01446042|75727619|FG000|Overall Study|Lost to Follow-up|5|||
41960109|NCT01446042|75727620|FG001|Overall Study|Lost to Follow-up|0|||
41960110|NCT01446042|75727621|FG002|Overall Study|Lost to Follow-up|0|||
42300509|NCT02322879|76135721|FG000|First Intervention|Physician Decision|1|||
42300510|NCT02322879|76135722|FG001|First Intervention|Physician Decision|0|||
42300511|NCT02322411|76135730|FG000|Overall Study|Lost to Follow-up|4|||
41960111|NCT01446042|75727619|FG000|Overall Study|Other reasons|2|||
41960112|NCT01446042|75727620|FG001|Overall Study|Other reasons|1|||
41960113|NCT01446042|75727621|FG002|Overall Study|Other reasons|1|||
41960114|NCT01445886|75727629|FG000|Overall Study|Lost to Follow-up|2|||
41960115|NCT01445886|75727629|FG000|Overall Study|Protocol Violation|3|||
41960116|NCT01470612|75727637|FG000|Overall Study|Adverse Event|20|||
41960117|NCT01470612|75727638|FG001|Overall Study|Adverse Event|80|||
41960118|NCT01470612|75727637|FG000|Overall Study|Death|0|||
42300512|NCT02322411|76135731|FG001|Overall Study|Lost to Follow-up|7|||
41960119|NCT01470612|75727638|FG001|Overall Study|Death|1|||
41960120|NCT01470612|75727637|FG000|Overall Study|Lack of Efficacy|20|||
41960121|NCT01470612|75727638|FG001|Overall Study|Lack of Efficacy|326|||
41960122|NCT01470612|75727637|FG000|Overall Study|Lost to Follow-up|2|||
41960123|NCT01470612|75727638|FG001|Overall Study|Lost to Follow-up|5|||
41960124|NCT01470612|75727637|FG000|Overall Study|Did not meet entrance criteria|0|||
41960125|NCT01470612|75727638|FG001|Overall Study|Did not meet entrance criteria|1|||
41960126|NCT01470612|75727637|FG000|Overall Study|Pregnancy|2|||
41960127|NCT01470612|75727638|FG001|Overall Study|Pregnancy|10|||
42300513|NCT02322411|76135730|FG000|Overall Study|Withdrawal by Subject|1|||
42300514|NCT02322411|76135731|FG001|Overall Study|Withdrawal by Subject|0|||
42300515|NCT02322021|76135741|FG000|Core Phase|Adverse Event|1|||
42300516|NCT02322021|76135742|FG001|Core Phase|Adverse Event|3|||
42300517|NCT02322021|76135743|FG002|Core Phase|Adverse Event|4|||
42300518|NCT02322021|76135744|FG003|Core Phase|Adverse Event|2|||
42300519|NCT02322021|76135745|FG004|Core Phase|Adverse Event|0|||
42300520|NCT02322021|76135741|FG000|Core Phase|Participant Choice|4|||
42300521|NCT02322021|76135742|FG001|Core Phase|Participant Choice|5|||
42300522|NCT02322021|76135743|FG002|Core Phase|Participant Choice|4|||
42300523|NCT02322021|76135744|FG003|Core Phase|Participant Choice|2|||
42300524|NCT02322021|76135745|FG004|Core Phase|Participant Choice|0|||
42300525|NCT02322021|76135741|FG000|Core Phase|Lost to Follow-up|0|||
42300526|NCT02322021|76135742|FG001|Core Phase|Lost to Follow-up|0|||
42300527|NCT02322021|76135743|FG002|Core Phase|Lost to Follow-up|0|||
42300528|NCT02322021|76135744|FG003|Core Phase|Lost to Follow-up|1|||
42300529|NCT02322021|76135745|FG004|Core Phase|Lost to Follow-up|0|||
42300530|NCT02322021|76135741|FG000|Core Phase|Other|0|||
42300531|NCT02322021|76135742|FG001|Core Phase|Other|0|||
42300532|NCT02322021|76135743|FG002|Core Phase|Other|1|||
42300533|NCT02322021|76135744|FG003|Core Phase|Other|0|||
42300534|NCT02322021|76135745|FG004|Core Phase|Other|0|||
42300535|NCT02322021|76135741|FG000|Extension Phase|Adverse Event|0|||
42300536|NCT02322021|76135742|FG001|Extension Phase|Adverse Event|0|||
42300537|NCT02322021|76135743|FG002|Extension Phase|Adverse Event|0|||
42300538|NCT02322021|76135744|FG003|Extension Phase|Adverse Event|0|||
42300539|NCT02322021|76135745|FG004|Extension Phase|Adverse Event|3|||
42300540|NCT02322021|76135741|FG000|Extension Phase|Participant Choice|0|||
42300541|NCT02322021|76135742|FG001|Extension Phase|Participant Choice|0|||
42300542|NCT02322021|76135743|FG002|Extension Phase|Participant Choice|0|||
42300543|NCT02322021|76135744|FG003|Extension Phase|Participant Choice|0|||
42300544|NCT02322021|76135745|FG004|Extension Phase|Participant Choice|6|||
42300545|NCT02322021|76135741|FG000|Extension Phase|Other|0|||
42300546|NCT02322021|76135742|FG001|Extension Phase|Other|0|||
42300547|NCT02322021|76135743|FG002|Extension Phase|Other|0|||
42300548|NCT02322021|76135744|FG003|Extension Phase|Other|0|||
42300549|NCT02322021|76135745|FG004|Extension Phase|Other|3|||
42300550|NCT02322021|76135741|FG000|Extension Phase|Lost to Follow-up|0|||
42300551|NCT02322021|76135742|FG001|Extension Phase|Lost to Follow-up|0|||
42300552|NCT02322021|76135743|FG002|Extension Phase|Lost to Follow-up|0|||
42300553|NCT02322021|76135744|FG003|Extension Phase|Lost to Follow-up|0|||
42300554|NCT02322021|76135745|FG004|Extension Phase|Lost to Follow-up|1|||
42300555|NCT02322021|76135741|FG000|Extension Phase|Study terminated by sponsor|0|||
42300556|NCT02322021|76135742|FG001|Extension Phase|Study terminated by sponsor|0|||
42300557|NCT02322021|76135743|FG002|Extension Phase|Study terminated by sponsor|0|||
42300558|NCT02322021|76135744|FG003|Extension Phase|Study terminated by sponsor|0|||
42300559|NCT02322021|76135745|FG004|Extension Phase|Study terminated by sponsor|28|||
42300560|NCT02363439|76135760|FG000|Overall Study|Lack of Efficacy|4|||
42300561|NCT02363283|76135764|FG000|Overall Study|Withdrawal by Subject|1|||
42300562|NCT02363283|76135764|FG000|Overall Study|Not eligible due to transaminitis|1|||
42300563|NCT02321319|76135768|FG000|Overall Study|Product discontinued|5|||
42300564|NCT02294175|76135774|FG000|Overall Study|Withdrawal by Subject|1|||
42300565|NCT02294175|76135775|FG001|Overall Study|Withdrawal by Subject|2|||
42300566|NCT02294175|76135774|FG000|Overall Study|pt taking excluded medication|3|||
42300567|NCT02294175|76135775|FG001|Overall Study|pt taking excluded medication|1|||
42300568|NCT02294175|76135774|FG000|Overall Study|Protocol Violation|1|||
42300569|NCT02294175|76135775|FG001|Overall Study|Protocol Violation|0|||
42300570|NCT02294175|76135774|FG000|Overall Study|Lost to Follow-up|0|||
42300571|NCT02294175|76135775|FG001|Overall Study|Lost to Follow-up|1|||
42300572|NCT02294175|76135774|FG000|Overall Study|wound healed|0|||
42300573|NCT02294175|76135775|FG001|Overall Study|wound healed|2|||
42300574|NCT02088541|76135786|FG000|Overall Study|Adverse Event|3|||
42300575|NCT02088541|76135787|FG001|Overall Study|Adverse Event|0|||
42300576|NCT02088541|76135788|FG002|Overall Study|Adverse Event|3|||
41960128|NCT01470612|75727637|FG000|Overall Study|Protocol Violation|2|||
41960129|NCT01470612|75727638|FG001|Overall Study|Protocol Violation|7|||
42300577|NCT02088541|76135789|FG003|Overall Study|Adverse Event|3|||
42300578|NCT02088541|76135790|FG004|Overall Study|Adverse Event|0|||
42300579|NCT02088541|76135786|FG000|Overall Study|Death|51|||
42300580|NCT02088541|76135787|FG001|Overall Study|Death|21|||
42300581|NCT02088541|76135788|FG002|Overall Study|Death|85|||
42300582|NCT02088541|76135789|FG003|Overall Study|Death|28|||
42300583|NCT02088541|76135790|FG004|Overall Study|Death|38|||
42300584|NCT02088541|76135786|FG000|Overall Study|Lost to Follow-up|2|||
42300585|NCT02088541|76135787|FG001|Overall Study|Lost to Follow-up|0|||
42300586|NCT02088541|76135788|FG002|Overall Study|Lost to Follow-up|1|||
42300587|NCT02088541|76135789|FG003|Overall Study|Lost to Follow-up|0|||
42300588|NCT02088541|76135790|FG004|Overall Study|Lost to Follow-up|0|||
42300589|NCT02088541|76135786|FG000|Overall Study|Physician Decision|2|||
42300590|NCT02088541|76135787|FG001|Overall Study|Physician Decision|1|||
42300591|NCT02088541|76135788|FG002|Overall Study|Physician Decision|2|||
42300592|NCT02088541|76135789|FG003|Overall Study|Physician Decision|0|||
42300593|NCT02088541|76135790|FG004|Overall Study|Physician Decision|2|||
41960130|NCT01470612|75727637|FG000|Overall Study|Withdrawal by Subject|24|||
41960131|NCT01470612|75727638|FG001|Overall Study|Withdrawal by Subject|79|||
41960132|NCT01470612|75727637|FG000|Overall Study|Other|14|||
41960133|NCT01470612|75727638|FG001|Overall Study|Other|156|||
41960134|NCT01445730|75727644|FG000|Overall Study|Adverse Event|1|||
41960135|NCT01445730|75727644|FG000|Overall Study|For the advice of a dentist|1|||
41960136|NCT01445730|75727644|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
41960137|NCT01445652|75727650|FG000|Overall Study|Not comfortable in lenses|5|||
41960138|NCT01445652|75727651|FG001|Overall Study|Not comfortable in lenses|0|||
41960139|NCT01445652|75727650|FG000|Overall Study|Failed to attend scheduled visit|2|||
41960140|NCT01445652|75727651|FG001|Overall Study|Failed to attend scheduled visit|3|||
41960141|NCT01445652|75727650|FG000|Overall Study|Failed teach session|2|||
41960142|NCT01445652|75727651|FG001|Overall Study|Failed teach session|0|||
41960143|NCT01445652|75727650|FG000|Overall Study|Adverse Event|1|||
41960144|NCT01445652|75727651|FG001|Overall Study|Adverse Event|0|||
41960145|NCT01470144|75727657|FG000|Overall Study|Adverse Event|2|||
41960146|NCT01470144|75727657|FG000|Overall Study|Death|1|||
41960147|NCT01470144|75727657|FG000|Overall Study|Lung transplant|6|||
41960148|NCT01470144|75727657|FG000|Overall Study|Patient's and investigator's decision|1|||
41960149|NCT01443858|75727664|FG000|Overall Study|Withdrawal by Subject|9|||
41960150|NCT01443858|75727665|FG001|Overall Study|Withdrawal by Subject|8|||
41960151|NCT01443858|75727666|FG002|Overall Study|Withdrawal by Subject|5|||
41960152|NCT01443858|75727664|FG000|Overall Study|Lack of Efficacy|1|||
41960153|NCT01443858|75727665|FG001|Overall Study|Lack of Efficacy|0|||
41960154|NCT01443858|75727666|FG002|Overall Study|Lack of Efficacy|0|||
41960155|NCT01443858|75727664|FG000|Overall Study|Lost to Follow-up|5|||
41960156|NCT01443858|75727665|FG001|Overall Study|Lost to Follow-up|5|||
41960157|NCT01443858|75727666|FG002|Overall Study|Lost to Follow-up|2|||
41960158|NCT01443078|75727674|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
41960159|NCT01443078|75727674|FG000|Overall Study|Withdrawal by Subject|1|||
41960160|NCT01443078|75727674|FG000|Overall Study|Patient had brain mets|1|||
41960161|NCT01439880|75727680|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
41960162|NCT01439880|75727681|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
41960163|NCT01439880|75727680|FG000|SOC-controlled Period (Year 1)|Death|2|||
41960164|NCT01439880|75727681|FG001|SOC-controlled Period (Year 1)|Death|1|||
41960165|NCT01439880|75727680|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
41960166|NCT01439880|75727681|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
41960167|NCT01439880|75727680|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
41960168|NCT01439880|75727681|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
41960169|NCT01439880|75727680|FG000|SOC-controlled Period (Year 1)|Other|8|||
41960170|NCT01439880|75727681|FG001|SOC-controlled Period (Year 1)|Other|13|||
41960171|NCT01439880|75727680|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
41960172|NCT01439880|75727681|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
41960173|NCT01439880|75727680|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
41960174|NCT01439880|75727681|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
41960175|NCT01439880|75727680|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
41960176|NCT01439880|75727681|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
41960177|NCT01439880|75727680|FG000|All-IP Period (Years 2 to 5)|Death|3|||
41960178|NCT01439880|75727681|FG001|All-IP Period (Years 2 to 5)|Death|13|||
41960179|NCT01439880|75727680|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
41960180|NCT01439880|75727681|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
41960181|NCT01439880|75727680|FG000|All-IP Period (Years 2 to 5)|Other|14|||
41960182|NCT01439880|75727681|FG001|All-IP Period (Years 2 to 5)|Other|31|||
41960183|NCT01439880|75727680|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
42300594|NCT02088541|76135786|FG000|Overall Study|Disease progression|7|||
42300595|NCT02088541|76135787|FG001|Overall Study|Disease progression|1|||
42300596|NCT02088541|76135788|FG002|Overall Study|Disease progression|2|||
41960184|NCT01439880|75727681|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
41960185|NCT01469364|75727698|FG000|Overall Study|Adverse Event|1|||
41960186|NCT01469364|75727698|FG000|Overall Study|Withdrawal by Subject|1|||
41960187|NCT01439724|75727704|FG000|Overall Study|missing consultation|9|||
41960188|NCT01439724|75727705|FG001|Overall Study|missing consultation|8|||
41960189|NCT01439568|75727713|FG000|Overall Study|Lost to Follow-up|1|||
41960190|NCT01439568|75727714|FG001|Overall Study|Lost to Follow-up|0|||
41960191|NCT01439568|75727713|FG000|Overall Study|Withdrawal by Subject|2|||
42300597|NCT02088541|76135789|FG003|Overall Study|Disease progression|3|||
41960192|NCT01439568|75727714|FG001|Overall Study|Withdrawal by Subject|2|||
41960193|NCT01469052|75727726|FG000|Overall Study|Adverse Event|2|||
41960194|NCT01469052|75727727|FG001|Overall Study|Adverse Event|3|||
41960195|NCT01469052|75727728|FG002|Overall Study|Adverse Event|0|||
41960196|NCT01469052|75727729|FG003|Overall Study|Adverse Event|2|||
41960197|NCT01469052|75727730|FG004|Overall Study|Adverse Event|0|||
41960198|NCT01469052|75727731|FG005|Overall Study|Adverse Event|1|||
41960199|NCT01469052|75727726|FG000|Overall Study|Progressive disease|3|||
41960200|NCT01469052|75727727|FG001|Overall Study|Progressive disease|0|||
41960201|NCT01469052|75727728|FG002|Overall Study|Progressive disease|5|||
41960202|NCT01469052|75727729|FG003|Overall Study|Progressive disease|3|||
41960203|NCT01469052|75727730|FG004|Overall Study|Progressive disease|7|||
41960204|NCT01469052|75727731|FG005|Overall Study|Progressive disease|2|||
41960205|NCT01469052|75727726|FG000|Overall Study|Lack of Efficacy|0|||
41960206|NCT01469052|75727727|FG001|Overall Study|Lack of Efficacy|0|||
41960207|NCT01469052|75727728|FG002|Overall Study|Lack of Efficacy|0|||
41960208|NCT01469052|75727729|FG003|Overall Study|Lack of Efficacy|0|||
41960209|NCT01469052|75727730|FG004|Overall Study|Lack of Efficacy|0|||
41960210|NCT01469052|75727731|FG005|Overall Study|Lack of Efficacy|2|||
41960211|NCT01469052|75727726|FG000|Overall Study|Moved to rollover protocol|1|||
41960212|NCT01469052|75727727|FG001|Overall Study|Moved to rollover protocol|0|||
41960213|NCT01469052|75727728|FG002|Overall Study|Moved to rollover protocol|1|||
41960214|NCT01469052|75727729|FG003|Overall Study|Moved to rollover protocol|0|||
41960215|NCT01469052|75727730|FG004|Overall Study|Moved to rollover protocol|0|||
41960216|NCT01469052|75727731|FG005|Overall Study|Moved to rollover protocol|1|||
41960217|NCT01469052|75727726|FG000|Overall Study|Other|0|||
41960218|NCT01469052|75727727|FG001|Overall Study|Other|1|||
41960219|NCT01469052|75727728|FG002|Overall Study|Other|0|||
41960220|NCT01469052|75727729|FG003|Overall Study|Other|0|||
41960221|NCT01469052|75727730|FG004|Overall Study|Other|1|||
41960222|NCT01469052|75727731|FG005|Overall Study|Other|0|||
41960223|NCT01468818|75727743|FG000|Overall Study|Death during treatment|2|||
41960224|NCT01442376|75727750|FG000|Overall Study|Adverse Event|0|||
41960225|NCT01442376|75727751|FG001|Overall Study|Adverse Event|3|||
41960226|NCT01442376|75727752|FG002|Overall Study|Adverse Event|2|||
41960227|NCT01442376|75727750|FG000|Overall Study|Death|0|||
41960228|NCT01442376|75727751|FG001|Overall Study|Death|1|||
41960229|NCT01442376|75727752|FG002|Overall Study|Death|1|||
41960230|NCT01442376|75727750|FG000|Overall Study|Withdrawal of consent|0|||
41960231|NCT01442376|75727751|FG001|Overall Study|Withdrawal of consent|0|||
41960232|NCT01442376|75727752|FG002|Overall Study|Withdrawal of consent|1|||
41960233|NCT01442376|75727750|FG000|Overall Study|Patients not treated|2|||
41960234|NCT01442376|75727751|FG001|Overall Study|Patients not treated|3|||
41960235|NCT01442376|75727752|FG002|Overall Study|Patients not treated|1|||
41960236|NCT01442376|75727750|FG000|Overall Study|Not eligible for subsequent cycles|1|||
41960237|NCT01442376|75727751|FG001|Overall Study|Not eligible for subsequent cycles|2|||
41960238|NCT01442376|75727752|FG002|Overall Study|Not eligible for subsequent cycles|0|||
41960239|NCT01442064|75727766|FG000|Overall Study|Adverse Event|2|||
41960240|NCT01442064|75727767|FG001|Overall Study|Adverse Event|2|||
41960241|NCT01442064|75727768|FG002|Overall Study|Adverse Event|2|||
41960242|NCT01442064|75727769|FG003|Overall Study|Adverse Event|1|||
41960243|NCT01442064|75727770|FG004|Overall Study|Adverse Event|2|||
41960244|NCT01442064|75727771|FG005|Overall Study|Adverse Event|0|||
41960245|NCT01442064|75727766|FG000|Overall Study|Death|0|||
41960246|NCT01442064|75727767|FG001|Overall Study|Death|1|||
41960247|NCT01442064|75727768|FG002|Overall Study|Death|3|||
41960248|NCT01442064|75727769|FG003|Overall Study|Death|3|||
41960249|NCT01442064|75727770|FG004|Overall Study|Death|1|||
41960250|NCT01442064|75727771|FG005|Overall Study|Death|3|||
41960251|NCT01442064|75727766|FG000|Overall Study|Lost to Follow-up|5|||
41960252|NCT01442064|75727767|FG001|Overall Study|Lost to Follow-up|5|||
41960253|NCT01442064|75727768|FG002|Overall Study|Lost to Follow-up|1|||
41960254|NCT01442064|75727769|FG003|Overall Study|Lost to Follow-up|1|||
41960255|NCT01442064|75727770|FG004|Overall Study|Lost to Follow-up|3|||
41960256|NCT01442064|75727771|FG005|Overall Study|Lost to Follow-up|3|||
41960257|NCT01442064|75727766|FG000|Overall Study|Physician Decision|1|||
41960258|NCT01442064|75727767|FG001|Overall Study|Physician Decision|1|||
41960259|NCT01442064|75727768|FG002|Overall Study|Physician Decision|2|||
41960260|NCT01442064|75727769|FG003|Overall Study|Physician Decision|3|||
41960261|NCT01442064|75727770|FG004|Overall Study|Physician Decision|3|||
41960262|NCT01442064|75727771|FG005|Overall Study|Physician Decision|1|||
41960263|NCT01442064|75727766|FG000|Overall Study|Withdrawal by Subject|6|||
41960264|NCT01442064|75727767|FG001|Overall Study|Withdrawal by Subject|3|||
41960265|NCT01442064|75727768|FG002|Overall Study|Withdrawal by Subject|2|||
41960266|NCT01442064|75727769|FG003|Overall Study|Withdrawal by Subject|2|||
41960267|NCT01442064|75727770|FG004|Overall Study|Withdrawal by Subject|2|||
41960268|NCT01442064|75727771|FG005|Overall Study|Withdrawal by Subject|1|||
41960269|NCT01442064|75727766|FG000|Overall Study|Sponsor decision|82|||
41960270|NCT01442064|75727767|FG001|Overall Study|Sponsor decision|88|||
41960271|NCT01442064|75727768|FG002|Overall Study|Sponsor decision|92|||
41960272|NCT01442064|75727769|FG003|Overall Study|Sponsor decision|88|||
41960273|NCT01442064|75727770|FG004|Overall Study|Sponsor decision|95|||
41960274|NCT01442064|75727771|FG005|Overall Study|Sponsor decision|87|||
41960275|NCT01442064|75727766|FG000|Overall Study|Subject non-compliance|0|||
41960276|NCT01442064|75727767|FG001|Overall Study|Subject non-compliance|0|||
41960277|NCT01442064|75727768|FG002|Overall Study|Subject non-compliance|0|||
41960278|NCT01442064|75727769|FG003|Overall Study|Subject non-compliance|0|||
41960279|NCT01442064|75727770|FG004|Overall Study|Subject non-compliance|0|||
41960280|NCT01442064|75727771|FG005|Overall Study|Subject non-compliance|2|||
41960281|NCT01442064|75727766|FG000|Overall Study|Condition mandated other intervention|1|||
41960282|NCT01442064|75727767|FG001|Overall Study|Condition mandated other intervention|1|||
41960283|NCT01442064|75727768|FG002|Overall Study|Condition mandated other intervention|2|||
41960284|NCT01442064|75727769|FG003|Overall Study|Condition mandated other intervention|0|||
41960285|NCT01442064|75727770|FG004|Overall Study|Condition mandated other intervention|0|||
41960286|NCT01442064|75727771|FG005|Overall Study|Condition mandated other intervention|2|||
41960287|NCT01467960|75727794|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
41960288|NCT01467960|75727795|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
41960289|NCT01467960|75727796|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
41960290|NCT01467960|75727797|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
41960291|NCT01467960|75727798|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
41960292|NCT01467960|75727799|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
41960293|NCT01441596|75727816|FG000|Overall Study|Other reason not defined below|0|||
41960294|NCT01441596|75727817|FG001|Overall Study|Other reason not defined below|2|||
41960295|NCT01441596|75727818|FG002|Overall Study|Other reason not defined below|1|||
41960296|NCT01441596|75727816|FG000|Overall Study|Withdrawal by Subject|4|||
41960297|NCT01441596|75727817|FG001|Overall Study|Withdrawal by Subject|0|||
41960298|NCT01441596|75727818|FG002|Overall Study|Withdrawal by Subject|2|||
41960299|NCT01441596|75727816|FG000|Overall Study|Not treated|0|||
41960300|NCT01441596|75727817|FG001|Overall Study|Not treated|1|||
41960301|NCT01441596|75727818|FG002|Overall Study|Not treated|1|||
41960302|NCT01441440|75727829|FG000|Overall Study|Death|1|||
41960303|NCT01441440|75727830|FG001|Overall Study|Death|0|||
41960304|NCT01441440|75727831|FG002|Overall Study|Death|1|||
41960305|NCT01441440|75727829|FG000|Overall Study|Adverse Event|2|||
41960306|NCT01441440|75727830|FG001|Overall Study|Adverse Event|9|||
41960307|NCT01441440|75727831|FG002|Overall Study|Adverse Event|9|||
41960308|NCT01441440|75727829|FG000|Overall Study|Lost to Follow-up|0|||
41960309|NCT01441440|75727830|FG001|Overall Study|Lost to Follow-up|2|||
41960310|NCT01441440|75727831|FG002|Overall Study|Lost to Follow-up|1|||
41960311|NCT01441440|75727829|FG000|Overall Study|Withdrawal by Subject|11|||
41960312|NCT01441440|75727830|FG001|Overall Study|Withdrawal by Subject|9|||
41960313|NCT01441440|75727831|FG002|Overall Study|Withdrawal by Subject|9|||
41960314|NCT01441440|75727829|FG000|Overall Study|Pregnancy|1|||
41960315|NCT01441440|75727830|FG001|Overall Study|Pregnancy|0|||
41960316|NCT01441440|75727831|FG002|Overall Study|Pregnancy|0|||
41960317|NCT01441440|75727829|FG000|Overall Study|Lack of Efficacy|1|||
41960318|NCT01441440|75727830|FG001|Overall Study|Lack of Efficacy|0|||
41960319|NCT01441440|75727831|FG002|Overall Study|Lack of Efficacy|1|||
41960320|NCT01441440|75727829|FG000|Overall Study|Moving|0|||
41960321|NCT01441440|75727830|FG001|Overall Study|Moving|1|||
41960322|NCT01441440|75727831|FG002|Overall Study|Moving|1|||
41960323|NCT01441440|75727829|FG000|Overall Study|Work-related matter|0|||
41960324|NCT01441440|75727830|FG001|Overall Study|Work-related matter|1|||
41960325|NCT01441440|75727831|FG002|Overall Study|Work-related matter|0|||
42024464|NCT01014585|75831949|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
42024465|NCT01014585|75831950|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
42024466|NCT01014585|75831951|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
41960326|NCT01441440|75727829|FG000|Overall Study|Difficllty in keeping the schedule|1|||
41960327|NCT01441440|75727830|FG001|Overall Study|Difficllty in keeping the schedule|1|||
41960328|NCT01441440|75727831|FG002|Overall Study|Difficllty in keeping the schedule|0|||
41960329|NCT01438476|75727841|FG000|Overall Study|Protocol Violation|1|||
41960330|NCT01438476|75727842|FG001|Overall Study|Protocol Violation|0|||
41960331|NCT01438476|75727841|FG000|Overall Study|Withdrawal by Subject|1|||
41960332|NCT01438476|75727842|FG001|Overall Study|Withdrawal by Subject|0|||
41960333|NCT01438476|75727841|FG000|Overall Study|No Surgery- Disease|8|||
41960334|NCT01438476|75727842|FG001|Overall Study|No Surgery- Disease|10|||
41960335|NCT01438476|75727841|FG000|Overall Study|Communication barrier|0|||
41960336|NCT01438476|75727842|FG001|Overall Study|Communication barrier|1|||
41960337|NCT01467570|75727850|FG000|Overall Study|Lost to Follow-up|8|||
41960338|NCT01467570|75727851|FG001|Overall Study|Lost to Follow-up|9|||
41960339|NCT01437540|75727861|FG000|Overall Study|Not listed below|7|||
41960340|NCT01437540|75727862|FG001|Overall Study|Not listed below|6|||
41960341|NCT01437540|75727861|FG000|Overall Study|COPD exacerbation|13|||
41960342|NCT01437540|75727862|FG001|Overall Study|COPD exacerbation|3|||
41960343|NCT01437540|75727861|FG000|Overall Study|Lost to Follow-up|3|||
41960344|NCT01437540|75727862|FG001|Overall Study|Lost to Follow-up|5|||
41960345|NCT01437540|75727861|FG000|Overall Study|Lack of Efficacy|23|||
41960346|NCT01437540|75727862|FG001|Overall Study|Lack of Efficacy|11|||
41960347|NCT01437540|75727861|FG000|Overall Study|Protocol Violation|24|||
41960348|NCT01437540|75727862|FG001|Overall Study|Protocol Violation|12|||
41960349|NCT01437540|75727861|FG000|Overall Study|Adverse Event|26|||
41960350|NCT01437540|75727862|FG001|Overall Study|Adverse Event|13|||
41960351|NCT01437540|75727861|FG000|Overall Study|Withdrawal by Subject|31|||
41960352|NCT01437540|75727862|FG001|Overall Study|Withdrawal by Subject|15|||
41960353|NCT01440972|75727870|FG000|Overall Study|Withdrawal by Subject|3|||
41960354|NCT01440972|75727871|FG001|Overall Study|Withdrawal by Subject|2|||
41960355|NCT01420536|75727879|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
41960356|NCT01420536|75727880|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
41960357|NCT01420068|75727890|FG000|Overall Study|Administrative problems|1|||
41960358|NCT01420068|75727891|FG001|Overall Study|Administrative problems|3|||
41960359|NCT01420068|75727890|FG000|Overall Study|Withdrawal by Subject|1|||
41960360|NCT01420068|75727891|FG001|Overall Study|Withdrawal by Subject|2|||
41960361|NCT01467492|75727899|FG000|Overall Study|Withdrawal by Subject|6|||
41960362|NCT01467492|75727900|FG001|Overall Study|Withdrawal by Subject|4|||
41960363|NCT01467492|75727899|FG000|Overall Study|Study Terminated by Sponsor|6|||
41960364|NCT01467492|75727900|FG001|Overall Study|Study Terminated by Sponsor|4|||
41960365|NCT01467492|75727899|FG000|Overall Study|Adverse Event|4|||
41960366|NCT01467492|75727900|FG001|Overall Study|Adverse Event|3|||
41960367|NCT01467492|75727899|FG000|Overall Study|Lost to Follow-up|3|||
41960368|NCT01467492|75727900|FG001|Overall Study|Lost to Follow-up|2|||
41960369|NCT01467492|75727899|FG000|Overall Study|Undefined|2|||
41960370|NCT01467492|75727900|FG001|Overall Study|Undefined|0|||
41960371|NCT01467492|75727899|FG000|Overall Study|Enrolled But Not Treated|1|||
41960372|NCT01467492|75727900|FG001|Overall Study|Enrolled But Not Treated|0|||
41960373|NCT01466790|75727915|FG000|Overall Study|Adverse Event|1|||
41960374|NCT01466790|75727916|FG001|Overall Study|Adverse Event|0|||
41960375|NCT01466790|75727917|FG002|Overall Study|Adverse Event|0|||
41960376|NCT01466790|75727918|FG003|Overall Study|Adverse Event|0|||
41960377|NCT01466790|75727919|FG004|Overall Study|Adverse Event|2|||
41960378|NCT01466790|75727920|FG005|Overall Study|Adverse Event|0|||
41960379|NCT01466790|75727921|FG006|Overall Study|Adverse Event|0|||
41960380|NCT01466790|75727922|FG007|Overall Study|Adverse Event|0|||
41960381|NCT01466790|75727915|FG000|Overall Study|Lost to Follow-up|2|||
41960382|NCT01466790|75727916|FG001|Overall Study|Lost to Follow-up|0|||
41960383|NCT01466790|75727917|FG002|Overall Study|Lost to Follow-up|0|||
41960384|NCT01466790|75727918|FG003|Overall Study|Lost to Follow-up|0|||
41960385|NCT01466790|75727919|FG004|Overall Study|Lost to Follow-up|0|||
41960386|NCT01466790|75727920|FG005|Overall Study|Lost to Follow-up|0|||
41960387|NCT01466790|75727921|FG006|Overall Study|Lost to Follow-up|0|||
41960388|NCT01466790|75727922|FG007|Overall Study|Lost to Follow-up|0|||
41960389|NCT01466790|75727915|FG000|Overall Study|Withdrawal by Subject|1|||
41960390|NCT01466790|75727916|FG001|Overall Study|Withdrawal by Subject|1|||
41960391|NCT01466790|75727917|FG002|Overall Study|Withdrawal by Subject|0|||
42300598|NCT02088541|76135790|FG004|Overall Study|Disease progression|1|||
41960392|NCT01466790|75727918|FG003|Overall Study|Withdrawal by Subject|0|||
41960393|NCT01466790|75727919|FG004|Overall Study|Withdrawal by Subject|1|||
41960394|NCT01466790|75727920|FG005|Overall Study|Withdrawal by Subject|0|||
41960395|NCT01466790|75727921|FG006|Overall Study|Withdrawal by Subject|1|||
41960396|NCT01466790|75727922|FG007|Overall Study|Withdrawal by Subject|1|||
41960397|NCT01418352|75727940|FG000|Overall Study|Lost to Follow-up|2|||
41960398|NCT01418352|75727941|FG001|Overall Study|Lost to Follow-up|0|||
41960399|NCT01418352|75727942|FG002|Overall Study|Lost to Follow-up|0|||
41960400|NCT01418352|75727943|FG003|Overall Study|Lost to Follow-up|0|||
41960401|NCT01418352|75727940|FG000|Overall Study|Adverse Event|0|||
41960402|NCT01418352|75727941|FG001|Overall Study|Adverse Event|1|||
41960403|NCT01418352|75727942|FG002|Overall Study|Adverse Event|0|||
41960404|NCT01418352|75727943|FG003|Overall Study|Adverse Event|0|||
41960405|NCT01418352|75727940|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
41960406|NCT01418352|75727941|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
41960407|NCT01418352|75727942|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
41960408|NCT01418352|75727943|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
41960409|NCT01418352|75727940|FG000|Overall Study|Subject Withdrew Consent|0|||
41960410|NCT01418352|75727941|FG001|Overall Study|Subject Withdrew Consent|1|||
41960411|NCT01418352|75727942|FG002|Overall Study|Subject Withdrew Consent|2|||
41960412|NCT01418352|75727943|FG003|Overall Study|Subject Withdrew Consent|1|||
42024467|NCT01221233|75831963|FG000|Overall Study|Withdrawal by Subject|3|||
41960413|NCT01418352|75727940|FG000|Overall Study|Protocol Deviation|0|||
42024468|NCT01221233|75831964|FG001|Overall Study|Withdrawal by Subject|1|||
42024469|NCT01220609|75831970|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
42024470|NCT01220609|75831970|FG000|Overall Study|Ineligible- Wrong cell type|1|||
42024471|NCT01220609|75831970|FG000|Overall Study|Ineligible-Never treated|1|||
42024472|NCT01220297|75831982|FG000|Overall Study|Death|2|||
42024473|NCT01220297|75831982|FG000|Overall Study|Lost to Follow-up|1|||
41960414|NCT01418352|75727941|FG001|Overall Study|Protocol Deviation|0|||
41960415|NCT01418352|75727942|FG002|Overall Study|Protocol Deviation|1|||
41960416|NCT01418352|75727943|FG003|Overall Study|Protocol Deviation|0|||
41960417|NCT01418352|75727940|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
41960418|NCT01418352|75727941|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
41960419|NCT01418352|75727942|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
41960420|NCT01418352|75727943|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
41960421|NCT01436370|75727961|FG000|Overall Study|Lost to Follow-up|0|||
41960422|NCT01436370|75727962|FG001|Overall Study|Lost to Follow-up|0|||
41960423|NCT01436370|75727963|FG002|Overall Study|Lost to Follow-up|0|||
41960424|NCT01436370|75727964|FG003|Overall Study|Lost to Follow-up|0|||
41960425|NCT01436370|75727965|FG004|Overall Study|Lost to Follow-up|1|||
41960426|NCT01436370|75727966|FG005|Overall Study|Lost to Follow-up|0|||
41960427|NCT01436370|75727967|FG006|Overall Study|Lost to Follow-up|0|||
41960428|NCT01436370|75727968|FG007|Overall Study|Lost to Follow-up|0|||
41960429|NCT01465464|75727996|FG000|Overall Study|Adverse Event|96|||
41960430|NCT01465464|75727997|FG001|Overall Study|Adverse Event|49|||
41960431|NCT01465464|75727996|FG000|Overall Study|Lack of Efficacy|139|||
41960432|NCT01465464|75727997|FG001|Overall Study|Lack of Efficacy|190|||
41960433|NCT01465464|75727996|FG000|Overall Study|Physician Decision|13|||
41960434|NCT01465464|75727997|FG001|Overall Study|Physician Decision|5|||
41960435|NCT01465464|75727996|FG000|Overall Study|Protocol Violation|1|||
41960436|NCT01465464|75727997|FG001|Overall Study|Protocol Violation|1|||
41960437|NCT01465464|75727996|FG000|Overall Study|Withdrawal by Subject|46|||
41960438|NCT01465464|75727997|FG001|Overall Study|Withdrawal by Subject|30|||
41960439|NCT01465464|75727996|FG000|Overall Study|Other|9|||
41960440|NCT01465464|75727997|FG001|Overall Study|Other|3|||
41960441|NCT01465464|75727996|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
41960442|NCT01465464|75727997|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
41960443|NCT01417104|75728005|FG000|Overall Study|Withdrawal by Subject|5|||
41960444|NCT01417104|75728006|FG001|Overall Study|Withdrawal by Subject|1|||
41960445|NCT01417104|75728005|FG000|Overall Study|Failure to make contact|0|||
42024474|NCT01219985|75831988|FG000|Overall Study|Physician Decision|20|||
42024475|NCT01218659|75831996|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
42024476|NCT01218659|75831997|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
42024477|NCT01218659|75831998|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
42024478|NCT01218659|75831996|FG000|18-Month Randomized Period|Did not receive study drug|0|||
42024479|NCT01218659|75831997|FG001|18-Month Randomized Period|Did not receive study drug|3|||
41960446|NCT01417104|75728006|FG001|Overall Study|Failure to make contact|1|||
41960447|NCT01417104|75728005|FG000|Overall Study|Adverse Event|1|||
41960448|NCT01417104|75728006|FG001|Overall Study|Adverse Event|0|||
41960449|NCT01465386|75728012|FG000|Overall Study|Lack of Efficacy|3|||
41960450|NCT01465386|75728012|FG000|Overall Study|Adverse Event|1|||
41960451|NCT01465230|75728016|FG000|Overall Study|Withdrawal by Subject|2|||
41960452|NCT01435356|75728022|FG000|Overall Study|Adverse Event|2|||
41960453|NCT01435356|75728023|FG001|Overall Study|Adverse Event|0|||
41960454|NCT01435356|75728022|FG000|Overall Study|Disease progression/recurrence|17|||
41960455|NCT01435356|75728023|FG001|Overall Study|Disease progression/recurrence|10|||
41960456|NCT01435356|75728022|FG000|Overall Study|Protocol Violation|0|||
41960457|NCT01435356|75728023|FG001|Overall Study|Protocol Violation|1|||
41960458|NCT01435356|75728022|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
41960459|NCT01435356|75728023|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
41960460|NCT01435356|75728022|FG000|Overall Study|Withdrawal by Subject|1|||
41960461|NCT01435356|75728023|FG001|Overall Study|Withdrawal by Subject|1|||
41960462|NCT01435356|75728022|FG000|Overall Study|Facial palsy|1|||
41960463|NCT01435356|75728023|FG001|Overall Study|Facial palsy|0|||
41960464|NCT01435356|75728022|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
41960465|NCT01435356|75728023|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
41960466|NCT01435356|75728022|FG000|Overall Study|Physician Decision|1|||
41960467|NCT01435356|75728023|FG001|Overall Study|Physician Decision|0|||
41960468|NCT01435356|75728022|FG000|Overall Study|Patient decision|3|||
41960469|NCT01435356|75728023|FG001|Overall Study|Patient decision|0|||
41960470|NCT01435356|75728022|FG000|Overall Study|Patient moved to another city|1|||
41960471|NCT01435356|75728023|FG001|Overall Study|Patient moved to another city|1|||
41960472|NCT01435122|75728029|FG000|Overall Study|Early withdrawal due to toxicity|8|||
41960473|NCT01434810|75728044|FG000|Overall Study|Did not receive treatment|11|||
41960474|NCT01434810|75728045|FG001|Overall Study|Did not receive treatment|3|||
41960475|NCT01434810|75728044|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
41960476|NCT01434810|75728045|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
41960477|NCT01393626|75728055|FG000|Overall Study|Adverse Event|2|||
41960478|NCT01393626|75728056|FG001|Overall Study|Adverse Event|1|||
41960479|NCT01393626|75728057|FG002|Overall Study|Adverse Event|5|||
41960480|NCT01393626|75728058|FG003|Overall Study|Adverse Event|0|||
41960481|NCT01393626|75728055|FG000|Overall Study|Did not meet entrance criteria|1|||
41960482|NCT01393626|75728056|FG001|Overall Study|Did not meet entrance criteria|0|||
41960483|NCT01393626|75728057|FG002|Overall Study|Did not meet entrance criteria|0|||
41960484|NCT01393626|75728058|FG003|Overall Study|Did not meet entrance criteria|0|||
41960485|NCT01393626|75728055|FG000|Overall Study|Lack of Efficacy|6|||
41960486|NCT01393626|75728056|FG001|Overall Study|Lack of Efficacy|6|||
41960487|NCT01393626|75728057|FG002|Overall Study|Lack of Efficacy|4|||
41960488|NCT01393626|75728058|FG003|Overall Study|Lack of Efficacy|1|||
41960489|NCT01393626|75728055|FG000|Overall Study|Lost to Follow-up|1|||
41960490|NCT01393626|75728056|FG001|Overall Study|Lost to Follow-up|1|||
41960491|NCT01393626|75728057|FG002|Overall Study|Lost to Follow-up|1|||
42024480|NCT01218659|75831998|FG002|18-Month Randomized Period|Did not receive study drug|0|||
42024481|NCT01218659|75831996|FG000|12-Month OLE|Withdrawal by Subject|0|||
42024482|NCT01218659|75831997|FG001|12-Month OLE|Withdrawal by Subject|0|||
42024483|NCT01218659|75831998|FG002|12-Month OLE|Withdrawal by Subject|2|||
42024484|NCT01218659|75831996|FG000|12-Month OLE|Physician Decision|0|||
42024485|NCT01218659|75831997|FG001|12-Month OLE|Physician Decision|0|||
42024486|NCT01218659|75831998|FG002|12-Month OLE|Physician Decision|1|||
41960492|NCT01393626|75728058|FG003|Overall Study|Lost to Follow-up|0|||
42024487|NCT01218659|75831996|FG000|12-Month OLE|Lost to Follow-up|0|||
42024488|NCT01218659|75831997|FG001|12-Month OLE|Lost to Follow-up|0|||
41960493|NCT01393626|75728055|FG000|Overall Study|Withdrawal by Subject|6|||
42024489|NCT01218659|75831998|FG002|12-Month OLE|Lost to Follow-up|1|||
41960494|NCT01393626|75728056|FG001|Overall Study|Withdrawal by Subject|4|||
41960495|NCT01393626|75728057|FG002|Overall Study|Withdrawal by Subject|0|||
41960496|NCT01393626|75728058|FG003|Overall Study|Withdrawal by Subject|0|||
41960497|NCT01393626|75728055|FG000|Overall Study|Other|1|||
41960498|NCT01393626|75728056|FG001|Overall Study|Other|0|||
41960499|NCT01393626|75728057|FG002|Overall Study|Other|0|||
41960500|NCT01393626|75728058|FG003|Overall Study|Other|0|||
41960501|NCT01393626|75728055|FG000|Overall Study|Protocol Violation|1|||
41960502|NCT01393626|75728056|FG001|Overall Study|Protocol Violation|0|||
41960503|NCT01393626|75728057|FG002|Overall Study|Protocol Violation|2|||
41960504|NCT01393626|75728058|FG003|Overall Study|Protocol Violation|0|||
42024490|NCT01218659|75831996|FG000|12-Month OLE|Pregnancy|0|||
42024491|NCT01218659|75831997|FG001|12-Month OLE|Pregnancy|0|||
42024492|NCT01218659|75831998|FG002|12-Month OLE|Pregnancy|1|||
41960505|NCT01434654|75728077|FG000|Overall Study|Withdrawal by Subject|1|||
41960506|NCT01434654|75728078|FG001|Overall Study|Withdrawal by Subject|0|||
42024493|NCT01218659|75831996|FG000|12-Month OLE|Lack of Efficacy|0|||
42024494|NCT01218659|75831997|FG001|12-Month OLE|Lack of Efficacy|0|||
42024495|NCT01218659|75831998|FG002|12-Month OLE|Lack of Efficacy|1|||
42024496|NCT01218659|75831996|FG000|12-Month OLE|Declined to participate in the OLE|0|||
42024497|NCT01218659|75831997|FG001|12-Month OLE|Declined to participate in the OLE|0|||
41960507|NCT01434654|75728077|FG000|Overall Study|Lost to Follow-up|1|||
41960508|NCT01434654|75728078|FG001|Overall Study|Lost to Follow-up|0|||
41960509|NCT01393158|75728088|FG000|Overall Study|Adverse Event|1|||
42024498|NCT01218659|75831998|FG002|12-Month OLE|Declined to participate in the OLE|4|||
41960510|NCT01393158|75728089|FG001|Overall Study|Adverse Event|0|||
41960511|NCT01413360|75728101|FG000|Overall Study|Lost to Follow-up|2|||
42024499|NCT00940498|75832013|FG000|Overall Study|Death|2|||
42024500|NCT00940498|75832014|FG001|Overall Study|Death|0|||
42024501|NCT00940498|75832015|FG002|Overall Study|Death|0|||
41960512|NCT01413360|75728101|FG000|Overall Study|Adverse Event|1|||
41960513|NCT01413204|75728108|FG000|Overall Study|Adverse Event|1|||
41960514|NCT01413204|75728109|FG001|Overall Study|Adverse Event|2|||
41960515|NCT01413204|75728110|FG002|Overall Study|Adverse Event|2|||
41960516|NCT01413204|75728108|FG000|Overall Study|Physician Decision|3|||
41960517|NCT01413204|75728109|FG001|Overall Study|Physician Decision|0|||
41960518|NCT01413204|75728110|FG002|Overall Study|Physician Decision|2|||
41960519|NCT01413204|75728108|FG000|Overall Study|Withdrawal by Subject|1|||
41960520|NCT01413204|75728109|FG001|Overall Study|Withdrawal by Subject|4|||
41960521|NCT01413204|75728110|FG002|Overall Study|Withdrawal by Subject|4|||
41960522|NCT01413204|75728108|FG000|Overall Study|Clearly not eligible for the study|0|||
41960523|NCT01413204|75728109|FG001|Overall Study|Clearly not eligible for the study|0|||
41960524|NCT01413204|75728110|FG002|Overall Study|Clearly not eligible for the study|1|||
41960525|NCT01413204|75728108|FG000|Overall Study|Fasting plasma glucose level increased|1|||
41960526|NCT01413204|75728109|FG001|Overall Study|Fasting plasma glucose level increased|0|||
41960527|NCT01413204|75728110|FG002|Overall Study|Fasting plasma glucose level increased|10|||
41960528|NCT01392378|75728123|FG000|Infant Series|Adverse Event|0|||
41960529|NCT01392378|75728124|FG001|Infant Series|Adverse Event|0|||
41960530|NCT01392378|75728125|FG002|Infant Series|Adverse Event|0|||
41960531|NCT01392378|75728126|FG003|Infant Series|Adverse Event|1|||
41960532|NCT01392378|75728127|FG004|Infant Series|Adverse Event|0|||
41960533|NCT01392378|75728123|FG000|Infant Series|Lost to Follow-up|0|||
41960534|NCT01392378|75728124|FG001|Infant Series|Lost to Follow-up|0|||
41960535|NCT01392378|75728125|FG002|Infant Series|Lost to Follow-up|0|||
41960536|NCT01392378|75728126|FG003|Infant Series|Lost to Follow-up|1|||
41960537|NCT01392378|75728127|FG004|Infant Series|Lost to Follow-up|0|||
41960538|NCT01392378|75728123|FG000|Infant Series|Protocol Violation|0|||
41960539|NCT01392378|75728124|FG001|Infant Series|Protocol Violation|1|||
41960540|NCT01392378|75728125|FG002|Infant Series|Protocol Violation|0|||
41960541|NCT01392378|75728126|FG003|Infant Series|Protocol Violation|0|||
41960542|NCT01392378|75728127|FG004|Infant Series|Protocol Violation|0|||
41960543|NCT01392378|75728123|FG000|Infant Series|Withdrawal by Parent|4|||
41960544|NCT01392378|75728124|FG001|Infant Series|Withdrawal by Parent|1|||
41960545|NCT01392378|75728125|FG002|Infant Series|Withdrawal by Parent|0|||
41960546|NCT01392378|75728126|FG003|Infant Series|Withdrawal by Parent|0|||
41960547|NCT01392378|75728127|FG004|Infant Series|Withdrawal by Parent|0|||
41960548|NCT01392378|75728123|FG000|After Infant Series|Lost to Follow-up|0|||
41960549|NCT01392378|75728124|FG001|After Infant Series|Lost to Follow-up|0|||
41960550|NCT01392378|75728125|FG002|After Infant Series|Lost to Follow-up|1|||
41960551|NCT01392378|75728126|FG003|After Infant Series|Lost to Follow-up|0|||
41960552|NCT01392378|75728127|FG004|After Infant Series|Lost to Follow-up|0|||
41960553|NCT01392378|75728123|FG000|After Infant Series|Withdrawal by Parent|0|||
41960554|NCT01392378|75728124|FG001|After Infant Series|Withdrawal by Parent|1|||
41960555|NCT01392378|75728125|FG002|After Infant Series|Withdrawal by Parent|1|||
41960556|NCT01392378|75728126|FG003|After Infant Series|Withdrawal by Parent|0|||
41960557|NCT01392378|75728127|FG004|After Infant Series|Withdrawal by Parent|1|||
41960558|NCT01392378|75728123|FG000|Toddler Dose|Lost to Follow-up|0|||
41960559|NCT01392378|75728124|FG001|Toddler Dose|Lost to Follow-up|0|||
41960560|NCT01392378|75728125|FG002|Toddler Dose|Lost to Follow-up|0|||
41960561|NCT01392378|75728126|FG003|Toddler Dose|Lost to Follow-up|1|||
41960562|NCT01392378|75728127|FG004|Toddler Dose|Lost to Follow-up|0|||
41960563|NCT01392378|75728123|FG000|Toddler Dose|Withdrawal by Parent|0|||
41960564|NCT01392378|75728124|FG001|Toddler Dose|Withdrawal by Parent|1|||
41960565|NCT01392378|75728125|FG002|Toddler Dose|Withdrawal by Parent|0|||
41960566|NCT01392378|75728126|FG003|Toddler Dose|Withdrawal by Parent|1|||
41960567|NCT01392378|75728127|FG004|Toddler Dose|Withdrawal by Parent|1|||
41960568|NCT01412424|75728149|FG000|Core Treatment Period|Treatment Failure|24|||
41960569|NCT01412424|75728149|FG000|Core Treatment Period|Adverse Event|21|||
41960570|NCT01412424|75728149|FG000|Core Treatment Period|Patient Request|5|||
41960571|NCT01412424|75728149|FG000|Core Treatment Period|Lost to Follow-up|2|||
41960572|NCT01412424|75728149|FG000|Core Treatment Period|Sponsor Request|1|||
41960573|NCT01412424|75728149|FG000|Extension Treatment Period|Adverse Event|2|||
41960574|NCT01412424|75728149|FG000|Extension Treatment Period|Treatment Failure|2|||
42300599|NCT02088541|76135786|FG000|Overall Study|Study terminated by sponsor|1|||
41960575|NCT01412424|75728149|FG000|Extension Treatment Period|Patient Request|2|||
41960576|NCT01433250|75728161|FG000|Overall Study|Protocol Violation|0|||
41960577|NCT01433250|75728162|FG001|Overall Study|Protocol Violation|1|||
41960578|NCT01433250|75728161|FG000|Overall Study|Withdrawal by Subject|3|||
41960579|NCT01433250|75728162|FG001|Overall Study|Withdrawal by Subject|2|||
41960580|NCT01433172|75728171|FG000|Overall Study|Withdrawal by Subject|0|||
41960581|NCT01433172|75728172|FG001|Overall Study|Withdrawal by Subject|1|||
41960582|NCT01433172|75728173|FG002|Overall Study|Withdrawal by Subject|0|||
41960583|NCT01433172|75728171|FG000|Overall Study|Disease Progression|0|||
41960584|NCT01433172|75728172|FG001|Overall Study|Disease Progression|0|||
41960585|NCT01433172|75728173|FG002|Overall Study|Disease Progression|1|||
41960586|NCT01433172|75728171|FG000|Overall Study|Death|0|||
41960587|NCT01433172|75728172|FG001|Overall Study|Death|2|||
41960588|NCT01433172|75728173|FG002|Overall Study|Death|0|||
41960589|NCT01432938|75728181|FG000|First Intervention|Protocol Violation|1|||
41960590|NCT01432938|75728182|FG001|First Intervention|Protocol Violation|0|||
41960591|NCT01432938|75728181|FG000|First Intervention|Physician Decision|1|||
41960592|NCT01432938|75728182|FG001|First Intervention|Physician Decision|0|||
41960593|NCT01432938|75728181|FG000|Second Intervention|Adverse Event|1|||
41960594|NCT01432938|75728182|FG001|Second Intervention|Adverse Event|0|||
41960595|NCT01392300|75728191|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
41960596|NCT01392300|75728192|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
41960597|NCT01392300|75728193|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
41960598|NCT01392300|75728191|FG000|Main Period (MP)|Withdrawal by Subject|5|||
41960599|NCT01392300|75728192|FG001|Main Period (MP)|Withdrawal by Subject|1|||
41960600|NCT01392300|75728193|FG002|Main Period (MP)|Withdrawal by Subject|0|||
41960601|NCT01392300|75728191|FG000|Main Period (MP)|Lost to Follow-up|3|||
41960602|NCT01392300|75728192|FG001|Main Period (MP)|Lost to Follow-up|3|||
41960603|NCT01392300|75728193|FG002|Main Period (MP)|Lost to Follow-up|0|||
41960604|NCT01392300|75728191|FG000|Main Period (MP)|Non-compliance|1|||
41960605|NCT01392300|75728192|FG001|Main Period (MP)|Non-compliance|0|||
41960606|NCT01392300|75728193|FG002|Main Period (MP)|Non-compliance|0|||
41960607|NCT01392300|75728191|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
41960608|NCT01392300|75728192|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
41960609|NCT01392300|75728193|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
41960610|NCT01392300|75728191|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
41960611|NCT01392300|75728192|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
41960612|NCT01392300|75728193|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
41960613|NCT01392300|75728191|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
41960614|NCT01392300|75728192|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
41960615|NCT01392300|75728193|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
41960616|NCT01392300|75728191|FG000|Open Label Extension (OLEX) Period|Death|0|||
41960617|NCT01392300|75728192|FG001|Open Label Extension (OLEX) Period|Death|0|||
41960618|NCT01392300|75728193|FG002|Open Label Extension (OLEX) Period|Death|4|||
41960619|NCT01392300|75728191|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
41960620|NCT01392300|75728192|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
41960621|NCT01392300|75728193|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
41960622|NCT01392300|75728191|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
41960623|NCT01392300|75728192|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
41960624|NCT01392300|75728193|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
41960625|NCT01392300|75728191|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
41960626|NCT01392300|75728192|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
41960627|NCT01392300|75728193|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
41960628|NCT01432626|75728200|FG000|Overall Study|LV function recovered|2|||
41960629|NCT01432626|75728200|FG000|Overall Study|Withdrawal by Subject|2|||
41960630|NCT01432626|75728200|FG000|Overall Study|Only 1 image competed|2|||
41960631|NCT01432626|75728200|FG000|Overall Study|Imaging agent not available|1|||
41960632|NCT01410474|75728206|FG000|Overall Study|Withdrawal by Subject|0|||
41960633|NCT01410474|75728207|FG001|Overall Study|Withdrawal by Subject|1|||
41960634|NCT01391130|75728222|FG000|Overall Study|Withdrawal by Subject|3|||
41960635|NCT01391130|75728223|FG001|Overall Study|Withdrawal by Subject|2|||
41960636|NCT01391130|75728222|FG000|Overall Study|Physician Decision|2|||
41960637|NCT01391130|75728223|FG001|Overall Study|Physician Decision|3|||
41960638|NCT01391130|75728222|FG000|Overall Study|Did not Receive Drug|1|||
41960639|NCT01391130|75728223|FG001|Overall Study|Did not Receive Drug|1|||
41960640|NCT01410240|75728232|FG000|Overall Study|Physician Decision|0|||
41960641|NCT01410240|75728233|FG001|Overall Study|Physician Decision|0|||
41960642|NCT01410240|75728234|FG002|Overall Study|Physician Decision|1|||
41960643|NCT01410240|75728232|FG000|Overall Study|Missed week 6 assessments|1|||
41960644|NCT01410240|75728233|FG001|Overall Study|Missed week 6 assessments|1|||
41960645|NCT01410240|75728234|FG002|Overall Study|Missed week 6 assessments|1|||
41960646|NCT01409928|75728243|FG000|Overall Study|Physician Decision|12|||
41960647|NCT01431534|75728250|FG000|Treatment Phase|Adverse Event|0|||
41960648|NCT01431534|75728251|FG001|Treatment Phase|Adverse Event|0|||
41960649|NCT01431534|75728252|FG002|Treatment Phase|Adverse Event|1|||
41960650|NCT01431534|75728250|FG000|Treatment Phase|Progressive Disease|4|||
41960651|NCT01431534|75728251|FG001|Treatment Phase|Progressive Disease|3|||
41960652|NCT01431534|75728252|FG002|Treatment Phase|Progressive Disease|10|||
41960653|NCT01409382|75728262|FG000|Overall Study|Lost to Follow-up|1|||
41960654|NCT01409382|75728263|FG001|Overall Study|Lost to Follow-up|1|||
41960655|NCT01409382|75728262|FG000|Overall Study|Protocol Violation|0|||
41960656|NCT01409382|75728263|FG001|Overall Study|Protocol Violation|3|||
41960657|NCT01409382|75728262|FG000|Overall Study|Multiple pregnancy|2|||
41960658|NCT01409382|75728263|FG001|Overall Study|Multiple pregnancy|4|||
41960659|NCT01409382|75728262|FG000|Overall Study|Still pregnant when study ended|13|||
41960660|NCT01409382|75728263|FG001|Overall Study|Still pregnant when study ended|2|||
41960661|NCT01409382|75728262|FG000|Overall Study|Did not manage to get pregnant|64|||
41960662|NCT01409382|75728263|FG001|Overall Study|Did not manage to get pregnant|70|||
41960663|NCT01409382|75728262|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
41960664|NCT01409382|75728263|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
41960665|NCT01408914|75728276|FG000|Overall Study|Could not complete tx in protocol period|5|||
41960666|NCT01408914|75728277|FG001|Overall Study|Could not complete tx in protocol period|5|||
41960667|NCT01408914|75728278|FG002|Overall Study|Could not complete tx in protocol period|6|||
42024502|NCT00940498|75832016|FG003|Overall Study|Death|1|||
41960668|NCT01408914|75728276|FG000|Overall Study|Lost to Follow-up|4|||
41960669|NCT01408914|75728277|FG001|Overall Study|Lost to Follow-up|1|||
41960670|NCT01408914|75728278|FG002|Overall Study|Lost to Follow-up|2|||
41960671|NCT01408914|75728276|FG000|Overall Study|Physician Decision|1|||
41960672|NCT01408914|75728277|FG001|Overall Study|Physician Decision|1|||
41960673|NCT01408914|75728278|FG002|Overall Study|Physician Decision|0|||
41960674|NCT01408914|75728276|FG000|Overall Study|Withdrawal by Subject|1|||
41960675|NCT01408914|75728277|FG001|Overall Study|Withdrawal by Subject|0|||
41960676|NCT01408914|75728278|FG002|Overall Study|Withdrawal by Subject|1|||
41960677|NCT01408914|75728276|FG000|Overall Study|Moved out of study jurisdiction|1|||
41960678|NCT01408914|75728277|FG001|Overall Study|Moved out of study jurisdiction|1|||
41960679|NCT01408914|75728278|FG002|Overall Study|Moved out of study jurisdiction|0|||
41960680|NCT01408914|75728276|FG000|Overall Study|Late exclusion|0|||
41960681|NCT01408914|75728277|FG001|Overall Study|Late exclusion|3|||
41960682|NCT01408914|75728278|FG002|Overall Study|Late exclusion|3|||
41960683|NCT01408914|75728276|FG000|Overall Study|Change in local TB/HIV norms|0|||
41960684|NCT01408914|75728277|FG001|Overall Study|Change in local TB/HIV norms|1|||
41960685|NCT01408914|75728278|FG002|Overall Study|Change in local TB/HIV norms|1|||
41960686|NCT01431144|75728288|FG000|Overall Study|Implant mobility and removal|2|||
41960687|NCT01431144|75728289|FG001|Overall Study|Implant mobility and removal|0|||
41960688|NCT01430754|75728298|FG000|Run-In Phase|Circadian Period Ineligible|24|||
41960689|NCT01430754|75728299|FG001|Run-In Phase|Circadian Period Ineligible|0|||
41960690|NCT01430754|75728298|FG000|Run-In Phase|Protocol Violation|6|||
41960691|NCT01430754|75728299|FG001|Run-In Phase|Protocol Violation|0|||
41960692|NCT01430754|75728298|FG000|Run-In Phase|Adverse Event|2|||
41960693|NCT01430754|75728299|FG001|Run-In Phase|Adverse Event|0|||
41960694|NCT01430754|75728298|FG000|Run-In Phase|Other|2|||
41960695|NCT01430754|75728299|FG001|Run-In Phase|Other|0|||
41960696|NCT01430754|75728298|FG000|Run-In Phase|Withdrawal by Subject|2|||
41960697|NCT01430754|75728299|FG001|Run-In Phase|Withdrawal by Subject|0|||
41960698|NCT01430754|75728298|FG000|Run-In Phase|Lost to Follow-up|1|||
41960699|NCT01430754|75728299|FG001|Run-In Phase|Lost to Follow-up|0|||
41960700|NCT01390428|75728313|FG000|Overall Study|Elective Surgery|0|||
41960701|NCT01390428|75728314|FG001|Overall Study|Elective Surgery|0|||
41960702|NCT01390428|75728315|FG002|Overall Study|Elective Surgery|0|||
41960703|NCT01390428|75728316|FG003|Overall Study|Elective Surgery|0|||
41960704|NCT01390428|75728317|FG004|Overall Study|Elective Surgery|1|||
41960705|NCT01390428|75728318|FG005|Overall Study|Elective Surgery|0|||
41960706|NCT01390428|75728313|FG000|Overall Study|Withdrawal by Subject|0|||
41960707|NCT01390428|75728314|FG001|Overall Study|Withdrawal by Subject|0|||
41960708|NCT01390428|75728315|FG002|Overall Study|Withdrawal by Subject|1|||
41960709|NCT01390428|75728316|FG003|Overall Study|Withdrawal by Subject|0|||
41960710|NCT01390428|75728317|FG004|Overall Study|Withdrawal by Subject|0|||
41960711|NCT01390428|75728318|FG005|Overall Study|Withdrawal by Subject|0|||
41960712|NCT01430130|75728332|FG000|Overall Study|Lost to Follow-up|1|||
41960713|NCT01430130|75728332|FG000|Overall Study|Infection on Control Side of Incision|1|||
41960714|NCT01407354|75728338|FG000|First Intervention|Withdrawal by Subject|0|||
41960715|NCT01407354|75728339|FG001|First Intervention|Withdrawal by Subject|2|||
41960716|NCT01407354|75728338|FG000|First Intervention|Adverse Event|1|||
41960717|NCT01407354|75728339|FG001|First Intervention|Adverse Event|0|||
41960718|NCT01407354|75728338|FG000|First Intervention|Physician Decision|1|||
41960719|NCT01407354|75728339|FG001|First Intervention|Physician Decision|0|||
41960720|NCT01407276|75728354|FG000|Overall Study|Withdrawal by Subject|0|||
41960721|NCT01407276|75728355|FG001|Overall Study|Withdrawal by Subject|0|||
41960722|NCT01407276|75728356|FG002|Overall Study|Withdrawal by Subject|0|||
41960723|NCT01407276|75728357|FG003|Overall Study|Withdrawal by Subject|0|||
42024503|NCT00940498|75832017|FG004|Overall Study|Death|5|||
42300600|NCT02088541|76135787|FG001|Overall Study|Study terminated by sponsor|1|||
41960724|NCT01407276|75728358|FG004|Overall Study|Withdrawal by Subject|0|||
41960725|NCT01407276|75728359|FG005|Overall Study|Withdrawal by Subject|0|||
41960726|NCT01407276|75728360|FG006|Overall Study|Withdrawal by Subject|0|||
41960727|NCT01407276|75728361|FG007|Overall Study|Withdrawal by Subject|1|||
41960728|NCT01390272|75728388|FG000|Overall Study|Death|3|||
41960729|NCT01390272|75728389|FG001|Overall Study|Death|2|||
41960730|NCT01390272|75728388|FG000|Overall Study|Withdrawal by Subject|9|||
41960731|NCT01390272|75728389|FG001|Overall Study|Withdrawal by Subject|5|||
41960732|NCT01390272|75728388|FG000|Overall Study|Patient moved, no longer eligible|5|||
41960733|NCT01390272|75728389|FG001|Overall Study|Patient moved, no longer eligible|8|||
41960734|NCT01429584|75728397|FG000|Overall Study|Withdrawal by Subject|1|||
41960735|NCT01429584|75728398|FG001|Overall Study|Withdrawal by Subject|0|||
41960736|NCT01429584|75728397|FG000|Overall Study|Protocol Violation|0|||
41960737|NCT01429584|75728398|FG001|Overall Study|Protocol Violation|1|||
41960738|NCT01406652|75728406|FG000|Overall Study|Lost-to-follow-up|3|||
41960739|NCT01406652|75728407|FG001|Overall Study|Lost-to-follow-up|4|||
41960740|NCT01406652|75728406|FG000|Overall Study|Withdrawal by Subject|2|||
41960741|NCT01406652|75728407|FG001|Overall Study|Withdrawal by Subject|2|||
41960742|NCT01406652|75728406|FG000|Overall Study|Insufficient follow-up|5|||
41960743|NCT01406652|75728407|FG001|Overall Study|Insufficient follow-up|4|||
41960744|NCT01406652|75728406|FG000|Overall Study|Infection not sure|10|||
41960745|NCT01406652|75728407|FG001|Overall Study|Infection not sure|10|||
41960746|NCT01406574|75728415|FG000|Overall Study|Adverse Event|0|||
41960747|NCT01406574|75728416|FG001|Overall Study|Adverse Event|0|||
41960748|NCT01406574|75728417|FG002|Overall Study|Adverse Event|1|||
41960749|NCT01406574|75728418|FG003|Overall Study|Adverse Event|3|||
41960750|NCT01406574|75728415|FG000|Overall Study|Physician Decision|0|||
41960751|NCT01406574|75728416|FG001|Overall Study|Physician Decision|0|||
41960752|NCT01406574|75728417|FG002|Overall Study|Physician Decision|0|||
41960753|NCT01406574|75728418|FG003|Overall Study|Physician Decision|1|||
41960754|NCT01406574|75728415|FG000|Overall Study|Withdrawal by Subject|0|||
41960755|NCT01406574|75728416|FG001|Overall Study|Withdrawal by Subject|1|||
41960756|NCT01406574|75728417|FG002|Overall Study|Withdrawal by Subject|0|||
41960757|NCT01406574|75728418|FG003|Overall Study|Withdrawal by Subject|0|||
41960758|NCT01406574|75728415|FG000|Overall Study|Definite progression of primary disease|1|||
41960759|NCT01406574|75728416|FG001|Overall Study|Definite progression of primary disease|0|||
41960760|NCT01406574|75728417|FG002|Overall Study|Definite progression of primary disease|0|||
41960761|NCT01406574|75728418|FG003|Overall Study|Definite progression of primary disease|0|||
41960762|NCT01405950|75728431|FG000|Overall Study|Withdrawal by Subject|1|||
41960763|NCT01405950|75728432|FG001|Overall Study|Withdrawal by Subject|0|||
41960764|NCT01405950|75728433|FG002|Overall Study|Withdrawal by Subject|0|||
41960765|NCT01405950|75728434|FG003|Overall Study|Withdrawal by Subject|0|||
41960766|NCT01405560|75728442|FG000|Overall Study|Physician Decision|1|||
41960767|NCT01428882|75728448|FG000|Overall Study|Lack of Efficacy|2|||
41960768|NCT01428882|75728449|FG001|Overall Study|Lack of Efficacy|7|||
41960769|NCT01428882|75728448|FG000|Overall Study|Protocol Violation|4|||
41960770|NCT01428882|75728449|FG001|Overall Study|Protocol Violation|3|||
41960771|NCT01428258|75728457|FG000|Intervention 1|Withdrawal by Subject|2|||
41960772|NCT01428258|75728458|FG001|Intervention 1|Withdrawal by Subject|0|||
41960773|NCT01389882|75728474|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
41960774|NCT01389882|75728475|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
41960775|NCT01389882|75728474|FG000|Overall Study|Withdrawal by Subject|0|||
41960776|NCT01389882|75728475|FG001|Overall Study|Withdrawal by Subject|1|||
41960777|NCT01442688|75728483|FG000|First Intervention|Withdrawal by Subject|1|||
41960778|NCT01442688|75728484|FG001|First Intervention|Withdrawal by Subject|0|||
41960779|NCT01442688|75728483|FG000|First Intervention|subject incarcerated|1|||
41960780|NCT01442688|75728484|FG001|First Intervention|subject incarcerated|0|||
41960781|NCT01442688|75728483|FG000|Second Intervention|Adverse Event|1|||
41960782|NCT01442688|75728484|FG001|Second Intervention|Adverse Event|0|||
41960783|NCT01466166|75728490|FG000|Overall Study|Death|1|||
41960784|NCT01466166|75728490|FG000|Overall Study|Lost to Follow-up|7|||
41960785|NCT01466166|75728490|FG000|Overall Study|Infusion Reaction (IR)|27|||
42024504|NCT00940498|75832018|FG005|Overall Study|Death|0|||
42024505|NCT00940498|75832019|FG006|Overall Study|Death|1|||
41960786|NCT01466166|75728490|FG000|Overall Study|Adverse Event (Other than IR)|11|||
41960787|NCT01466166|75728490|FG000|Overall Study|Elevated Serum Uric Acid|78|||
41960788|NCT01466166|75728490|FG000|Overall Study|Withdrawal by Subject|13|||
41960789|NCT01466166|75728490|FG000|Overall Study|Sponsor Decision|4|||
41960790|NCT01466166|75728490|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
41960791|NCT01466166|75728490|FG000|Overall Study|Other|20|||
41960792|NCT01426854|75728496|FG000|Overall Study|Adverse Event|1|||
41960793|NCT01426854|75728497|FG001|Overall Study|Adverse Event|5|||
41960794|NCT01426854|75728496|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
41960795|NCT01426854|75728497|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
41960796|NCT01426854|75728496|FG000|Overall Study|Lost to Follow-up|3|||
41960797|NCT01426854|75728497|FG001|Overall Study|Lost to Follow-up|0|||
41960798|NCT01426854|75728496|FG000|Overall Study|Noncompliance|0|||
42024506|NCT00940498|75832020|FG007|Overall Study|Death|0|||
41960799|NCT01426854|75728497|FG001|Overall Study|Noncompliance|1|||
41960800|NCT01426854|75728496|FG000|Overall Study|Treatment Failure|0|||
41960801|NCT01426854|75728497|FG001|Overall Study|Treatment Failure|16|||
41960802|NCT01426854|75728496|FG000|Overall Study|Protocol Deviation|0|||
41960803|NCT01426854|75728497|FG001|Overall Study|Protocol Deviation|1|||
41960804|NCT01426854|75728496|FG000|Overall Study|Other|3|||
41960805|NCT01426854|75728497|FG001|Overall Study|Other|2|||
41960806|NCT01426386|75728509|FG000|Overall Study|Adverse Event|0|||
41960807|NCT01426386|75728510|FG001|Overall Study|Adverse Event|1|||
41960808|NCT01426386|75728511|FG002|Overall Study|Adverse Event|0|||
41960809|NCT01426386|75728512|FG003|Overall Study|Adverse Event|0|||
41960810|NCT01426386|75728513|FG004|Overall Study|Adverse Event|0|||
41960811|NCT01426386|75728514|FG005|Overall Study|Adverse Event|0|||
41960812|NCT01426386|75728509|FG000|Overall Study|Did not attend scheduled visit|1|||
41960813|NCT01426386|75728510|FG001|Overall Study|Did not attend scheduled visit|4|||
41960814|NCT01426386|75728511|FG002|Overall Study|Did not attend scheduled visit|0|||
41960815|NCT01426386|75728512|FG003|Overall Study|Did not attend scheduled visit|0|||
41960816|NCT01426386|75728513|FG004|Overall Study|Did not attend scheduled visit|2|||
41960817|NCT01426386|75728514|FG005|Overall Study|Did not attend scheduled visit|1|||
41960818|NCT01426386|75728509|FG000|Overall Study|Poor response|2|||
41960819|NCT01426386|75728510|FG001|Overall Study|Poor response|1|||
41960820|NCT01426386|75728511|FG002|Overall Study|Poor response|2|||
41960821|NCT01426386|75728512|FG003|Overall Study|Poor response|0|||
41960822|NCT01426386|75728513|FG004|Overall Study|Poor response|1|||
41960823|NCT01426386|75728514|FG005|Overall Study|Poor response|0|||
41960824|NCT01426386|75728509|FG000|Overall Study|Personal reasons|0|||
41960825|NCT01426386|75728510|FG001|Overall Study|Personal reasons|0|||
41960826|NCT01426386|75728511|FG002|Overall Study|Personal reasons|0|||
41960827|NCT01426386|75728512|FG003|Overall Study|Personal reasons|0|||
41960828|NCT01426386|75728513|FG004|Overall Study|Personal reasons|1|||
41960829|NCT01426386|75728514|FG005|Overall Study|Personal reasons|0|||
41960830|NCT01404234|75728528|FG000|Overall Study|Withdrawal by Subject|2|||
41960831|NCT01403610|75728536|FG000|Overall Study|Withdrawal by Subject|2|||
41960832|NCT01403610|75728537|FG001|Overall Study|Withdrawal by Subject|0|||
41960833|NCT01403610|75728538|FG002|Overall Study|Withdrawal by Subject|0|||
41960834|NCT01403610|75728539|FG003|Overall Study|Withdrawal by Subject|0|||
41960835|NCT01403610|75728536|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
41960836|NCT01403610|75728537|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
41960837|NCT01403610|75728538|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
41960838|NCT01403610|75728539|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
41960839|NCT01403064|75728553|FG000|Overall Study|Death|0|||
41960840|NCT01403064|75728554|FG001|Overall Study|Death|0|||
41960841|NCT01403064|75728555|FG002|Overall Study|Death|1|||
41960842|NCT01403064|75728556|FG003|Overall Study|Death|1|||
41960843|NCT01403064|75728553|FG000|Overall Study|Withdrawal by Subject|0|||
41960844|NCT01403064|75728554|FG001|Overall Study|Withdrawal by Subject|0|||
41960845|NCT01403064|75728555|FG002|Overall Study|Withdrawal by Subject|1|||
41960846|NCT01403064|75728556|FG003|Overall Study|Withdrawal by Subject|1|||
41960847|NCT01403064|75728553|FG000|Overall Study|Other|1|||
41960848|NCT01403064|75728554|FG001|Overall Study|Other|0|||
41960849|NCT01403064|75728555|FG002|Overall Study|Other|2|||
41960850|NCT01403064|75728556|FG003|Overall Study|Other|1|||
41960851|NCT01402986|75728575|FG000|Overall Study|Withdrawal by Subject|7|||
41960852|NCT01402986|75728576|FG001|Overall Study|Withdrawal by Subject|10|||
41960853|NCT01402986|75728577|FG002|Overall Study|Withdrawal by Subject|7|||
41960854|NCT01402986|75728578|FG003|Overall Study|Withdrawal by Subject|13|||
41960855|NCT01402986|75728575|FG000|Overall Study|Death|0|||
41960856|NCT01402986|75728576|FG001|Overall Study|Death|0|||
41960857|NCT01402986|75728577|FG002|Overall Study|Death|0|||
41960858|NCT01402986|75728578|FG003|Overall Study|Death|2|||
41960859|NCT01402986|75728575|FG000|Overall Study|Lost to Follow-up|0|||
41960860|NCT01402986|75728576|FG001|Overall Study|Lost to Follow-up|0|||
41960861|NCT01402986|75728577|FG002|Overall Study|Lost to Follow-up|0|||
41960862|NCT01402986|75728578|FG003|Overall Study|Lost to Follow-up|1|||
41960863|NCT01402986|75728575|FG000|Overall Study|Other|2|||
41960864|NCT01402986|75728576|FG001|Overall Study|Other|5|||
41960865|NCT01402986|75728577|FG002|Overall Study|Other|1|||
41960866|NCT01402986|75728578|FG003|Overall Study|Other|6|||
41960867|NCT01402908|75728590|FG000|Overall Study|Withdrawal by Subject|30|||
41960868|NCT01402908|75728591|FG001|Overall Study|Withdrawal by Subject|17|||
41960869|NCT01402908|75728590|FG000|Overall Study|Lost to Follow-up|3|||
41960870|NCT01402908|75728591|FG001|Overall Study|Lost to Follow-up|1|||
41960871|NCT01402908|75728590|FG000|Overall Study|Physician Decision|1|||
41960872|NCT01402908|75728591|FG001|Overall Study|Physician Decision|0|||
41960873|NCT01389258|75728597|FG000|Overall Study|Lost to Follow-up|5|||
41960874|NCT01389102|75728607|FG000|Overall Study|Adverse Event|1|||
41960875|NCT01389102|75728608|FG001|Overall Study|Adverse Event|3|||
41960876|NCT01389102|75728609|FG002|Overall Study|Adverse Event|2|||
41960877|NCT01389102|75728610|FG003|Overall Study|Adverse Event|2|||
41960878|NCT01389102|75728611|FG004|Overall Study|Adverse Event|2|||
41960879|NCT01389102|75728612|FG005|Overall Study|Adverse Event|2|||
41960880|NCT01389102|75728607|FG000|Overall Study|Hurricane Katrina|4|||
41960881|NCT01389102|75728608|FG001|Overall Study|Hurricane Katrina|2|||
41960882|NCT01389102|75728609|FG002|Overall Study|Hurricane Katrina|3|||
41960883|NCT01389102|75728610|FG003|Overall Study|Hurricane Katrina|0|||
41960884|NCT01389102|75728611|FG004|Overall Study|Hurricane Katrina|3|||
41960885|NCT01389102|75728612|FG005|Overall Study|Hurricane Katrina|1|||
41960886|NCT01389102|75728607|FG000|Overall Study|Lost to Follow-up|4|||
41960887|NCT01389102|75728608|FG001|Overall Study|Lost to Follow-up|1|||
41960888|NCT01389102|75728609|FG002|Overall Study|Lost to Follow-up|1|||
41960889|NCT01389102|75728610|FG003|Overall Study|Lost to Follow-up|2|||
41960890|NCT01389102|75728611|FG004|Overall Study|Lost to Follow-up|4|||
41960891|NCT01389102|75728612|FG005|Overall Study|Lost to Follow-up|1|||
42024507|NCT00940498|75832013|FG000|Overall Study|Lost to Follow-up|1|||
42024508|NCT00940498|75832014|FG001|Overall Study|Lost to Follow-up|1|||
42024509|NCT00940498|75832015|FG002|Overall Study|Lost to Follow-up|2|||
42024510|NCT00940498|75832016|FG003|Overall Study|Lost to Follow-up|0|||
42024511|NCT00940498|75832017|FG004|Overall Study|Lost to Follow-up|1|||
42024512|NCT00940498|75832018|FG005|Overall Study|Lost to Follow-up|0|||
42024513|NCT00940498|75832019|FG006|Overall Study|Lost to Follow-up|0|||
42024514|NCT00940498|75832020|FG007|Overall Study|Lost to Follow-up|1|||
42024515|NCT00940498|75832013|FG000|Overall Study|Disease Progression|0|||
42118050|NCT00547248|75928860|FG003|Overall Study|Protocol Violation|1|||
41960892|NCT01389102|75728607|FG000|Overall Study|Protocol Violation|0|||
41960893|NCT01389102|75728608|FG001|Overall Study|Protocol Violation|0|||
41960894|NCT01389102|75728609|FG002|Overall Study|Protocol Violation|3|||
41960895|NCT01389102|75728610|FG003|Overall Study|Protocol Violation|0|||
41960896|NCT01389102|75728611|FG004|Overall Study|Protocol Violation|1|||
42118051|NCT00547248|75928857|FG000|Overall Study|Migrated/moved from study area|0|||
41960897|NCT01389102|75728612|FG005|Overall Study|Protocol Violation|1|||
41960898|NCT01389102|75728607|FG000|Overall Study|Withdrawal by Subject|7|||
41960899|NCT01389102|75728608|FG001|Overall Study|Withdrawal by Subject|4|||
41960900|NCT01389102|75728609|FG002|Overall Study|Withdrawal by Subject|9|||
41960901|NCT01389102|75728610|FG003|Overall Study|Withdrawal by Subject|2|||
41960902|NCT01389102|75728611|FG004|Overall Study|Withdrawal by Subject|3|||
42024516|NCT00940498|75832014|FG001|Overall Study|Disease Progression|0|||
42024517|NCT00940498|75832015|FG002|Overall Study|Disease Progression|1|||
42024518|NCT00940498|75832016|FG003|Overall Study|Disease Progression|1|||
41960903|NCT01389102|75728612|FG005|Overall Study|Withdrawal by Subject|3|||
41960904|NCT01389102|75728607|FG000|Overall Study|Subject Traveling Out of Country|0|||
42024519|NCT00940498|75832017|FG004|Overall Study|Disease Progression|0|||
42024520|NCT00940498|75832018|FG005|Overall Study|Disease Progression|1|||
42024521|NCT00940498|75832019|FG006|Overall Study|Disease Progression|0|||
42024522|NCT00940498|75832020|FG007|Overall Study|Disease Progression|0|||
42024523|NCT00940498|75832013|FG000|Overall Study|Physician Decision|0|||
42024524|NCT00940498|75832014|FG001|Overall Study|Physician Decision|0|||
42024525|NCT00940498|75832015|FG002|Overall Study|Physician Decision|0|||
42024526|NCT00940498|75832016|FG003|Overall Study|Physician Decision|0|||
42024527|NCT00940498|75832017|FG004|Overall Study|Physician Decision|2|||
42024528|NCT00940498|75832018|FG005|Overall Study|Physician Decision|0|||
42024529|NCT00940498|75832019|FG006|Overall Study|Physician Decision|0|||
42024530|NCT00940498|75832020|FG007|Overall Study|Physician Decision|0|||
42024531|NCT00940498|75832013|FG000|Overall Study|Not treated due to disease related pain|0|||
42024532|NCT00940498|75832014|FG001|Overall Study|Not treated due to disease related pain|0|||
42024533|NCT00940498|75832015|FG002|Overall Study|Not treated due to disease related pain|0|||
42024534|NCT00940498|75832016|FG003|Overall Study|Not treated due to disease related pain|0|||
42024535|NCT00940498|75832017|FG004|Overall Study|Not treated due to disease related pain|1|||
42024536|NCT00940498|75832018|FG005|Overall Study|Not treated due to disease related pain|0|||
42024537|NCT00940498|75832019|FG006|Overall Study|Not treated due to disease related pain|0|||
42024538|NCT00940498|75832020|FG007|Overall Study|Not treated due to disease related pain|0|||
42024539|NCT00940342|75832047|FG000|Overall Study|Adverse Event|0|||
42024540|NCT00940342|75832048|FG001|Overall Study|Adverse Event|2|||
42024541|NCT00940342|75832049|FG002|Overall Study|Adverse Event|1|||
42024542|NCT00936910|75832057|FG000|Overall Study|Lack of Efficacy|3|||
42024543|NCT00940108|75832066|FG000|Overall Study|Adverse Event|2|||
42024544|NCT00940108|75832067|FG001|Overall Study|Adverse Event|4|||
42024545|NCT00940108|75832068|FG002|Overall Study|Adverse Event|0|||
42024546|NCT00940108|75832069|FG003|Overall Study|Adverse Event|2|||
42024547|NCT00940108|75832066|FG000|Overall Study|Withdrew Consent|2|||
42024548|NCT00940108|75832067|FG001|Overall Study|Withdrew Consent|1|||
42024549|NCT00940108|75832068|FG002|Overall Study|Withdrew Consent|0|||
42024550|NCT00940108|75832069|FG003|Overall Study|Withdrew Consent|1|||
42024551|NCT00940108|75832066|FG000|Overall Study|Dose 2 contraindicated|1|||
42024552|NCT00940108|75832067|FG001|Overall Study|Dose 2 contraindicated|1|||
42024553|NCT00940108|75832068|FG002|Overall Study|Dose 2 contraindicated|0|||
42024554|NCT00940108|75832069|FG003|Overall Study|Dose 2 contraindicated|1|||
42024555|NCT00940108|75832066|FG000|Overall Study|Declined further vaccination|0|||
42024556|NCT00940108|75832067|FG001|Overall Study|Declined further vaccination|1|||
42024557|NCT00940108|75832068|FG002|Overall Study|Declined further vaccination|3|||
42024558|NCT00940108|75832069|FG003|Overall Study|Declined further vaccination|0|||
42024559|NCT00940108|75832066|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
42024560|NCT00940108|75832067|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
42024561|NCT00940108|75832068|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
42024562|NCT00940108|75832069|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
42024563|NCT00940108|75832066|FG000|Overall Study|Viral illness after Dose 1|0|||
42024564|NCT00940108|75832067|FG001|Overall Study|Viral illness after Dose 1|1|||
42024565|NCT00940108|75832068|FG002|Overall Study|Viral illness after Dose 1|0|||
42024566|NCT00940108|75832069|FG003|Overall Study|Viral illness after Dose 1|0|||
42024567|NCT00940108|75832066|FG000|Overall Study|Diagnosed with H1N1|0|||
42024568|NCT00940108|75832067|FG001|Overall Study|Diagnosed with H1N1|0|||
42024569|NCT00940108|75832068|FG002|Overall Study|Diagnosed with H1N1|0|||
42024570|NCT00940108|75832069|FG003|Overall Study|Diagnosed with H1N1|1|||
42024571|NCT00936598|75832081|FG000|Overall Study|Withdrawal by Subject|1|||
42024572|NCT00936598|75832082|FG001|Overall Study|Withdrawal by Subject|0|||
42024573|NCT00936598|75832081|FG000|Overall Study|Ineligible after consent|1|||
42024574|NCT00936598|75832082|FG001|Overall Study|Ineligible after consent|0|||
42024575|NCT01025817|75832090|FG000|Completed Study Medication|Adverse Event|66|||
42024576|NCT01025817|75832091|FG001|Completed Study Medication|Adverse Event|39|||
42024577|NCT01025817|75832090|FG000|Completed Study Medication|Protocol Deviation|9|||
42024578|NCT01025817|75832091|FG001|Completed Study Medication|Protocol Deviation|8|||
42024579|NCT01025817|75832090|FG000|Completed Study Medication|Withdrawal by Subject|8|||
42024580|NCT01025817|75832091|FG001|Completed Study Medication|Withdrawal by Subject|9|||
42024581|NCT01025817|75832090|FG000|Completed Study Medication|Administrative problems|7|||
42024582|NCT01025817|75832091|FG001|Completed Study Medication|Administrative problems|5|||
42024583|NCT01025817|75832090|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
42024584|NCT01025817|75832091|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
42024585|NCT01025817|75832090|FG000|Completed Study Medication|Abnormal test procedure|4|||
42118052|NCT00547248|75928858|FG001|Overall Study|Migrated/moved from study area|0|||
42024586|NCT01025817|75832091|FG001|Completed Study Medication|Abnormal test procedure|0|||
42024587|NCT01025817|75832090|FG000|Completed Study Medication|Graft loss|2|||
42024588|NCT01025817|75832091|FG001|Completed Study Medication|Graft loss|5|||
42024589|NCT01025817|75832090|FG000|Completed Study Medication|Death|2|||
42024590|NCT01025817|75832091|FG001|Completed Study Medication|Death|2|||
42024591|NCT01025817|75832090|FG000|Completed Study Medication|Abnormal lab values|0|||
42024592|NCT01025817|75832091|FG001|Completed Study Medication|Abnormal lab values|2|||
42024593|NCT01025817|75832090|FG000|Completed Study Medication|Subject no longer required study drug|0|||
42024594|NCT01025817|75832091|FG001|Completed Study Medication|Subject no longer required study drug|1|||
42024595|NCT01025817|75832090|FG000|Completed Study Medication|Lost to Follow-up|0|||
42024596|NCT01025817|75832091|FG001|Completed Study Medication|Lost to Follow-up|1|||
42024597|NCT01025817|75832090|FG000|Completed Study|Withdrawal by Subject|8|||
42024598|NCT01025817|75832091|FG001|Completed Study|Withdrawal by Subject|16|||
42024599|NCT01025817|75832090|FG000|Completed Study|Death|6|||
42024600|NCT01025817|75832091|FG001|Completed Study|Death|5|||
42024601|NCT01025817|75832090|FG000|Completed Study|Missing|2|||
42024602|NCT01025817|75832091|FG001|Completed Study|Missing|0|||
42024603|NCT01025817|75832090|FG000|Completed Study|Lost to Follow-up|0|||
42024604|NCT01025817|75832091|FG001|Completed Study|Lost to Follow-up|1|||
42024605|NCT00939640|75832097|FG000|Overall Study|Physician Decision|1|||
42118053|NCT00547248|75928859|FG002|Overall Study|Migrated/moved from study area|2|||
42118054|NCT00547248|75928860|FG003|Overall Study|Migrated/moved from study area|0|||
42118055|NCT00547248|75928857|FG000|Overall Study|Withdrawal by Subject|0|||
42118056|NCT00547248|75928858|FG001|Overall Study|Withdrawal by Subject|0|||
42118057|NCT00547248|75928859|FG002|Overall Study|Withdrawal by Subject|7|||
42118058|NCT00547248|75928860|FG003|Overall Study|Withdrawal by Subject|1|||
42118059|NCT00688103|75928875|FG000|Overall Study|Adverse Event|4|||
42118060|NCT00688103|75928876|FG001|Overall Study|Adverse Event|1|||
42118061|NCT00688103|75928875|FG000|Overall Study|Lack of Efficacy|11|||
42118062|NCT00688103|75928876|FG001|Overall Study|Lack of Efficacy|1|||
42118063|NCT00688103|75928875|FG000|Overall Study|Withdrawal by Subject|4|||
42118064|NCT00688103|75928876|FG001|Overall Study|Withdrawal by Subject|2|||
42118065|NCT00688103|75928875|FG000|Overall Study|complex reasons|11|||
42118066|NCT00688103|75928876|FG001|Overall Study|complex reasons|9|||
42118067|NCT00686855|75928886|FG000|Overall Study|Lost to Follow-up|1|||
42118068|NCT00686855|75928887|FG001|Overall Study|Lost to Follow-up|0|||
42118069|NCT00686855|75928886|FG000|Overall Study|Progressive GVHD|0|||
42118070|NCT00686855|75928887|FG001|Overall Study|Progressive GVHD|1|||
42118071|NCT00686777|75928893|FG000|Overall Study|Adverse Event|2|||
42118072|NCT00686777|75928893|FG000|Overall Study|Pregnancy|1|||
42118073|NCT00686777|75928893|FG000|Overall Study|Withdrawal by Subject|2|||
42118074|NCT00686777|75928893|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
42118075|NCT00686777|75928893|FG000|Overall Study|No Visit|1|||
42118076|NCT00686699|75928899|FG000|Treatment Period 1|Adverse Event|0|||
42118077|NCT00686699|75928900|FG001|Treatment Period 1|Adverse Event|2|||
42118078|NCT00106639|75928909|FG000|Overall Study|Adverse Event|3|||
42118079|NCT00106639|75928910|FG001|Overall Study|Adverse Event|4|||
42118080|NCT00106639|75928911|FG002|Overall Study|Adverse Event|1|||
42118081|NCT00106639|75928909|FG000|Overall Study|Protocol Violation|0|||
42118082|NCT00106639|75928910|FG001|Overall Study|Protocol Violation|1|||
42118083|NCT00106639|75928911|FG002|Overall Study|Protocol Violation|0|||
42118084|NCT00106639|75928909|FG000|Overall Study|Withdrawal by Subject|0|||
42118085|NCT00106639|75928910|FG001|Overall Study|Withdrawal by Subject|1|||
42118086|NCT00106639|75928911|FG002|Overall Study|Withdrawal by Subject|0|||
42118087|NCT00106639|75928909|FG000|Overall Study|Participant defaulted|0|||
42118088|NCT00106639|75928910|FG001|Overall Study|Participant defaulted|1|||
42118089|NCT00106639|75928911|FG002|Overall Study|Participant defaulted|1|||
42118090|NCT00106249|75928922|FG000|Overall Study|Lost to Follow-up|3|||
42118091|NCT00106249|75928923|FG001|Overall Study|Lost to Follow-up|2|||
42118092|NCT00105469|75928931|FG000|Overall Study|Adverse Event|9|||
42118093|NCT00105469|75928932|FG001|Overall Study|Adverse Event|8|||
42118094|NCT00105469|75928931|FG000|Overall Study|Protocol Violation|4|||
42118095|NCT00105469|75928932|FG001|Overall Study|Protocol Violation|0|||
42118096|NCT00105469|75928931|FG000|Overall Study|Withdrawal by Subject|2|||
42024606|NCT01218113|75832109|FG000|Overall Study|Withdrawal by Subject|1|||
42024607|NCT01218113|75832110|FG001|Overall Study|Withdrawal by Subject|0|||
42118097|NCT00105469|75928932|FG001|Overall Study|Withdrawal by Subject|3|||
42118098|NCT00105469|75928931|FG000|Overall Study|Lost to Follow-up|1|||
42118099|NCT00105469|75928932|FG001|Overall Study|Lost to Follow-up|0|||
42118100|NCT00105469|75928931|FG000|Overall Study|Lack of Efficacy|2|||
42118101|NCT00105469|75928932|FG001|Overall Study|Lack of Efficacy|0|||
42118102|NCT00105469|75928931|FG000|Overall Study|Other Reason|4|||
42024608|NCT01218113|75832111|FG002|Overall Study|Withdrawal by Subject|1|||
42024609|NCT01218113|75832109|FG000|Overall Study|Lost to Follow-up|4|||
42024610|NCT01218113|75832110|FG001|Overall Study|Lost to Follow-up|1|||
42118103|NCT00105469|75928932|FG001|Overall Study|Other Reason|0|||
42118104|NCT00105235|75928938|FG000|Overall Study|Death|4|||
42024611|NCT01218113|75832111|FG002|Overall Study|Lost to Follow-up|4|||
42024612|NCT01218113|75832109|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
42024613|NCT01218113|75832110|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
42024614|NCT01218113|75832111|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
42118105|NCT00105235|75928938|FG000|Overall Study|Physician Decision|1|||
42118106|NCT00105235|75928938|FG000|Overall Study|Withdrawal by Subject|2|||
42118107|NCT00547118|75928948|FG000|Overall Study|Did not qualify prior to starting drug|1|||
42118108|NCT00547118|75928949|FG001|Overall Study|Did not qualify prior to starting drug|1|||
42118109|NCT00547118|75928948|FG000|Overall Study|Study suspended|7|||
42024615|NCT03873493|75832126|FG000|Overall Study|Withdrawal by Subject|1|||
42024616|NCT03873493|75832126|FG000|Overall Study|Death|9|||
42024617|NCT03873493|75832126|FG000|Overall Study|Lost to Follow-up|1|||
42024618|NCT03873493|75832126|FG000|Overall Study|Study Terminated by Sponsor|1|||
42024619|NCT03873493|75832126|FG000|Overall Study|Other|2|||
42024620|NCT00939484|75832146|FG000|Overall Study|Progression/Relapse|8|||
42024621|NCT00939484|75832147|FG001|Overall Study|Progression/Relapse|20|||
42024622|NCT00939484|75832148|FG002|Overall Study|Progression/Relapse|3|||
42024623|NCT01010217|75832163|FG000|Overall Study|Lost to Follow-up|4|||
42024624|NCT01010217|75832164|FG001|Overall Study|Lost to Follow-up|5|||
42024625|NCT01010217|75832165|FG002|Overall Study|Lost to Follow-up|1|||
42024626|NCT01010217|75832166|FG003|Overall Study|Lost to Follow-up|0|||
42024627|NCT01010217|75832167|FG004|Overall Study|Lost to Follow-up|0|||
42024628|NCT01010217|75832163|FG000|Overall Study|Withdrawal by Subject|1|||
42024629|NCT01010217|75832164|FG001|Overall Study|Withdrawal by Subject|0|||
42024630|NCT01010217|75832165|FG002|Overall Study|Withdrawal by Subject|0|||
42024631|NCT01010217|75832166|FG003|Overall Study|Withdrawal by Subject|0|||
42024632|NCT01010217|75832167|FG004|Overall Study|Withdrawal by Subject|0|||
42024633|NCT01010217|75832163|FG000|Overall Study|Physician Decision|0|||
42024634|NCT01010217|75832164|FG001|Overall Study|Physician Decision|0|||
42024635|NCT01010217|75832165|FG002|Overall Study|Physician Decision|0|||
42024636|NCT01010217|75832166|FG003|Overall Study|Physician Decision|6|||
42024637|NCT01010217|75832167|FG004|Overall Study|Physician Decision|3|||
42024638|NCT01217957|75832184|FG000|Phase 1|Withdrawal by Patient|1|||
42024639|NCT01217957|75832185|FG001|Phase 1|Withdrawal by Patient|0|||
42024640|NCT01217957|75832186|FG002|Phase 1|Withdrawal by Patient|1|||
42024641|NCT01217957|75832187|FG003|Phase 1|Withdrawal by Patient|1|||
42024642|NCT01217957|75832188|FG004|Phase 1|Withdrawal by Patient|0|||
42024643|NCT01217957|75832184|FG000|Phase 2|Withdrawal by Patient|0|||
42024644|NCT01217957|75832185|FG001|Phase 2|Withdrawal by Patient|0|||
42118110|NCT00547118|75928949|FG001|Overall Study|Study suspended|8|||
41960905|NCT01389102|75728608|FG001|Overall Study|Subject Traveling Out of Country|0|||
41960906|NCT01389102|75728609|FG002|Overall Study|Subject Traveling Out of Country|0|||
41960907|NCT01389102|75728610|FG003|Overall Study|Subject Traveling Out of Country|1|||
41960908|NCT01389102|75728611|FG004|Overall Study|Subject Traveling Out of Country|0|||
41960909|NCT01389102|75728612|FG005|Overall Study|Subject Traveling Out of Country|0|||
41960910|NCT01389102|75728607|FG000|Overall Study|Subject Moved|2|||
42024645|NCT01217957|75832186|FG002|Phase 2|Withdrawal by Patient|0|||
42024646|NCT01217957|75832187|FG003|Phase 2|Withdrawal by Patient|0|||
42024647|NCT01217957|75832188|FG004|Phase 2|Withdrawal by Patient|1|||
42024648|NCT00939094|75832211|FG000|Overall Study|Adverse Event|9|||
42024649|NCT00939094|75832212|FG001|Overall Study|Adverse Event|0|||
42024650|NCT00939094|75832211|FG000|Overall Study|Withdrawal by Subject|1|||
42024651|NCT00939094|75832212|FG001|Overall Study|Withdrawal by Subject|6|||
42024652|NCT00939094|75832211|FG000|Overall Study|Lost to Follow-up|1|||
41960911|NCT01389102|75728608|FG001|Overall Study|Subject Moved|0|||
41960912|NCT01389102|75728609|FG002|Overall Study|Subject Moved|1|||
41960913|NCT01389102|75728610|FG003|Overall Study|Subject Moved|0|||
42024653|NCT00939094|75832212|FG001|Overall Study|Lost to Follow-up|1|||
42118111|NCT00502593|75928969|FG000|Overall Study|Withdrawn unspecified reason|1|||
42024654|NCT00939094|75832211|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
42024655|NCT00939094|75832212|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
42024656|NCT00939094|75832211|FG000|Overall Study|Severe non-compliance to protocol|0|||
42024657|NCT00939094|75832212|FG001|Overall Study|Severe non-compliance to protocol|1|||
41960914|NCT01389102|75728611|FG004|Overall Study|Subject Moved|0|||
41960915|NCT01389102|75728612|FG005|Overall Study|Subject Moved|0|||
41960916|NCT01389102|75728607|FG000|Overall Study|Unavailable due to husband's illness|0|||
41960917|NCT01389102|75728608|FG001|Overall Study|Unavailable due to husband's illness|1|||
41960918|NCT01389102|75728609|FG002|Overall Study|Unavailable due to husband's illness|0|||
41960919|NCT01389102|75728610|FG003|Overall Study|Unavailable due to husband's illness|0|||
41960920|NCT01389102|75728611|FG004|Overall Study|Unavailable due to husband's illness|0|||
41960921|NCT01389102|75728612|FG005|Overall Study|Unavailable due to husband's illness|0|||
41960922|NCT01389102|75728607|FG000|Overall Study|Investigator Judgement|0|||
41960923|NCT01389102|75728608|FG001|Overall Study|Investigator Judgement|1|||
41960924|NCT01389102|75728609|FG002|Overall Study|Investigator Judgement|0|||
41960925|NCT01389102|75728610|FG003|Overall Study|Investigator Judgement|0|||
41960926|NCT01389102|75728611|FG004|Overall Study|Investigator Judgement|0|||
42024658|NCT00939094|75832211|FG000|Overall Study|Study stopped by sponsor|0|||
42024659|NCT00939094|75832212|FG001|Overall Study|Study stopped by sponsor|2|||
42024660|NCT00939094|75832211|FG000|Overall Study|Abnormal ECG findings|1|||
42024661|NCT00939094|75832212|FG001|Overall Study|Abnormal ECG findings|0|||
42024662|NCT01217801|75832220|FG000|Period 1|Protocol Violation|1|||
42024663|NCT01217801|75832221|FG001|Period 1|Protocol Violation|1|||
42024664|NCT01217801|75832220|FG000|Period 1|Withdrawal by Subject|0|||
42024665|NCT01217801|75832221|FG001|Period 1|Withdrawal by Subject|1|||
42024666|NCT00935818|75832229|FG000|Overall Study|Withdrawal by Subject|45|||
42024667|NCT00935818|75832230|FG001|Overall Study|Withdrawal by Subject|50|||
42024668|NCT00935818|75832229|FG000|Overall Study|Lost to Follow-up|40|||
41960927|NCT01389102|75728612|FG005|Overall Study|Investigator Judgement|0|||
41960928|NCT01402284|75728632|FG000|Overall Study|Withdrawal consent|2|||
41960929|NCT01402284|75728632|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
41960930|NCT01402284|75728632|FG000|Overall Study|Physician Decision|1|||
41960931|NCT01402284|75728632|FG000|Overall Study|Disease progression on study|10|||
41960932|NCT01388790|75728636|FG000|Overall Study|Ongoing at data cut-off date|8|||
41960933|NCT01388478|75728640|FG000|Overall Study|Adverse Event|4|||
41960934|NCT01388478|75728640|FG000|Overall Study|Withdrawal by Subject|1|||
41960935|NCT01424670|75728646|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
41960936|NCT01424670|75728647|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
41960937|NCT01424670|75728646|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
41960938|NCT01424670|75728647|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
41960939|NCT01424670|75728646|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
41960940|NCT01424670|75728647|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
41960941|NCT01424670|75728646|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
41960942|NCT01424670|75728647|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
41960943|NCT01424670|75728646|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
41960944|NCT01424670|75728647|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
41960945|NCT01424670|75728646|FG000|Continuation Period|Adverse Event|13|||
41960946|NCT01424670|75728647|FG001|Continuation Period|Adverse Event|5|||
41960947|NCT01424670|75728646|FG000|Continuation Period|Lost to Follow-up|2|||
41960948|NCT01424670|75728647|FG001|Continuation Period|Lost to Follow-up|0|||
41960949|NCT01424670|75728646|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
41960950|NCT01424670|75728647|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
41960951|NCT01424670|75728646|FG000|Continuation Period|Physician Decision|5|||
41960952|NCT01424670|75728647|FG001|Continuation Period|Physician Decision|4|||
41960953|NCT01424670|75728646|FG000|Continuation Period|Withdrawal by Subject|13|||
41960954|NCT01424670|75728647|FG001|Continuation Period|Withdrawal by Subject|4|||
41960955|NCT01424514|75728655|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
41960956|NCT01424514|75728656|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
41960957|NCT01424514|75728655|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
41960958|NCT01424514|75728656|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
41960959|NCT01400958|75728669|FG000|Overall Study|Physician Decision|0|||
41960960|NCT01400958|75728670|FG001|Overall Study|Physician Decision|1|||
41960961|NCT01400958|75728669|FG000|Overall Study|Withdrawal by Subject|0|||
41960962|NCT01400958|75728670|FG001|Overall Study|Withdrawal by Subject|1|||
41960963|NCT01400958|75728669|FG000|Overall Study|Adverse Event|1|||
41960964|NCT01400958|75728670|FG001|Overall Study|Adverse Event|0|||
42024669|NCT00935818|75832230|FG001|Overall Study|Lost to Follow-up|42|||
42024670|NCT00935818|75832229|FG000|Overall Study|Adverse Event|6|||
41960965|NCT01388166|75728676|FG000|Overall Study|Adverse Event|16|||
41960966|NCT01388166|75728676|FG000|Overall Study|Lost to Follow-up|30|||
41960967|NCT01388166|75728676|FG000|Overall Study|Others than specified above|13|||
41960968|NCT01400412|75728682|FG000|Overall Study|Lost to Follow-up|4|||
42300601|NCT02088541|76135788|FG002|Overall Study|Study terminated by sponsor|12|||
42300602|NCT02088541|76135789|FG003|Overall Study|Study terminated by sponsor|2|||
42024671|NCT00935818|75832230|FG001|Overall Study|Adverse Event|7|||
42024672|NCT00935818|75832229|FG000|Overall Study|Physician Decision|0|||
41960969|NCT01400412|75728683|FG001|Overall Study|Lost to Follow-up|7|||
41960970|NCT01400412|75728682|FG000|Overall Study|Withdrawal by Subject|3|||
41960971|NCT01400412|75728683|FG001|Overall Study|Withdrawal by Subject|4|||
41960972|NCT01400412|75728682|FG000|Overall Study|Unable to complete|3|||
41960973|NCT01400412|75728683|FG001|Overall Study|Unable to complete|3|||
41960974|NCT01400412|75728682|FG000|Overall Study|Never started study treatment|0|||
41960975|NCT01400412|75728683|FG001|Overall Study|Never started study treatment|3|||
41960976|NCT01422876|75728701|FG000|Week 24|Lost to Follow-up|1|||
41960977|NCT01422876|75728702|FG001|Week 24|Lost to Follow-up|1|||
41960978|NCT01422876|75728703|FG002|Week 24|Lost to Follow-up|2|||
41960979|NCT01422876|75728704|FG003|Week 24|Lost to Follow-up|4|||
41960980|NCT01422876|75728705|FG004|Week 24|Lost to Follow-up|2|||
41960981|NCT01422876|75728706|FG005|Week 24|Lost to Follow-up|0|||
41960982|NCT01422876|75728707|FG006|Week 24|Lost to Follow-up|1|||
41960983|NCT01422876|75728708|FG007|Week 24|Lost to Follow-up|3|||
41960984|NCT01422876|75728709|FG008|Week 24|Lost to Follow-up|3|||
41960985|NCT01422876|75728710|FG009|Week 24|Lost to Follow-up|4|||
41960986|NCT01422876|75728701|FG000|Week 24|Consent withdrawn|5|||
41960987|NCT01422876|75728702|FG001|Week 24|Consent withdrawn|1|||
41960988|NCT01422876|75728703|FG002|Week 24|Consent withdrawn|3|||
41960989|NCT01422876|75728704|FG003|Week 24|Consent withdrawn|4|||
41960990|NCT01422876|75728705|FG004|Week 24|Consent withdrawn|5|||
41960991|NCT01422876|75728706|FG005|Week 24|Consent withdrawn|6|||
41960992|NCT01422876|75728707|FG006|Week 24|Consent withdrawn|5|||
41960993|NCT01422876|75728708|FG007|Week 24|Consent withdrawn|4|||
41960994|NCT01422876|75728709|FG008|Week 24|Consent withdrawn|3|||
41960995|NCT01422876|75728710|FG009|Week 24|Consent withdrawn|6|||
41960996|NCT01422876|75728701|FG000|Week 24|Death|0|||
41960997|NCT01422876|75728702|FG001|Week 24|Death|1|||
41960998|NCT01422876|75728703|FG002|Week 24|Death|0|||
41960999|NCT01422876|75728704|FG003|Week 24|Death|0|||
41961000|NCT01422876|75728705|FG004|Week 24|Death|0|||
41961001|NCT01422876|75728706|FG005|Week 24|Death|0|||
41961002|NCT01422876|75728707|FG006|Week 24|Death|0|||
41961003|NCT01422876|75728708|FG007|Week 24|Death|0|||
41961004|NCT01422876|75728709|FG008|Week 24|Death|0|||
41961005|NCT01422876|75728710|FG009|Week 24|Death|0|||
41961006|NCT01422876|75728701|FG000|Week 52|Lost to Follow-up|3|||
41961007|NCT01422876|75728702|FG001|Week 52|Lost to Follow-up|5|||
41961008|NCT01422876|75728703|FG002|Week 52|Lost to Follow-up|7|||
41961009|NCT01422876|75728704|FG003|Week 52|Lost to Follow-up|5|||
41961010|NCT01422876|75728705|FG004|Week 52|Lost to Follow-up|8|||
41961011|NCT01422876|75728706|FG005|Week 52|Lost to Follow-up|5|||
41961012|NCT01422876|75728707|FG006|Week 52|Lost to Follow-up|5|||
41961013|NCT01422876|75728708|FG007|Week 52|Lost to Follow-up|8|||
41961014|NCT01422876|75728709|FG008|Week 52|Lost to Follow-up|7|||
41961015|NCT01422876|75728710|FG009|Week 52|Lost to Follow-up|8|||
41961016|NCT01422876|75728701|FG000|Week 52|Consent withdrawn|9|||
41961017|NCT01422876|75728702|FG001|Week 52|Consent withdrawn|4|||
41961018|NCT01422876|75728703|FG002|Week 52|Consent withdrawn|6|||
41961019|NCT01422876|75728704|FG003|Week 52|Consent withdrawn|12|||
41961020|NCT01422876|75728705|FG004|Week 52|Consent withdrawn|7|||
41961021|NCT01422876|75728706|FG005|Week 52|Consent withdrawn|12|||
41961022|NCT01422876|75728707|FG006|Week 52|Consent withdrawn|10|||
41961023|NCT01422876|75728708|FG007|Week 52|Consent withdrawn|12|||
41961024|NCT01422876|75728709|FG008|Week 52|Consent withdrawn|13|||
41961025|NCT01422876|75728710|FG009|Week 52|Consent withdrawn|9|||
41961026|NCT01422876|75728701|FG000|Week 52|Death|0|||
41961027|NCT01422876|75728702|FG001|Week 52|Death|1|||
41961028|NCT01422876|75728703|FG002|Week 52|Death|0|||
41961029|NCT01422876|75728704|FG003|Week 52|Death|1|||
41961030|NCT01422876|75728705|FG004|Week 52|Death|0|||
41961031|NCT01422876|75728706|FG005|Week 52|Death|0|||
42300603|NCT02088541|76135790|FG004|Overall Study|Study terminated by sponsor|6|||
42300604|NCT02088541|76135786|FG000|Overall Study|Withdrawal by Subject|3|||
42300605|NCT02088541|76135787|FG001|Overall Study|Withdrawal by Subject|2|||
41961032|NCT01422876|75728707|FG006|Week 52|Death|1|||
41961033|NCT01422876|75728708|FG007|Week 52|Death|3|||
41961034|NCT01422876|75728709|FG008|Week 52|Death|1|||
41961035|NCT01422876|75728710|FG009|Week 52|Death|0|||
41961036|NCT01422720|75728728|FG000|Overall Study|Adverse Event|16|||
41961037|NCT01422720|75728728|FG000|Overall Study|Lack of Efficacy|1|||
41961038|NCT01422720|75728728|FG000|Overall Study|Withdrawal by Subject|4|||
41961039|NCT01422720|75728728|FG000|Overall Study|Ineligibility|1|||
41961040|NCT01387932|75728738|FG000|Randomized and Treated|Physician Decision|3|||
41961041|NCT01387932|75728739|FG001|Randomized and Treated|Physician Decision|2|||
41961042|NCT01387932|75728738|FG000|Randomized and Treated|Withdrawal by Subject|4|||
41961043|NCT01387932|75728739|FG001|Randomized and Treated|Withdrawal by Subject|2|||
41961044|NCT01387932|75728738|FG000|Survival Follow-up|Liver Transplant|24|||
41961045|NCT01387932|75728739|FG001|Survival Follow-up|Liver Transplant|28|||
41961046|NCT01387932|75728738|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
41961047|NCT01387932|75728739|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
41961048|NCT01387932|75728738|FG000|Survival Follow-up|Withdrawal by Subject|2|||
41961049|NCT01387932|75728739|FG001|Survival Follow-up|Withdrawal by Subject|4|||
41961050|NCT01387932|75728738|FG000|Survival Follow-up|Lost to Follow-up|6|||
41961051|NCT01387932|75728739|FG001|Survival Follow-up|Lost to Follow-up|5|||
41961052|NCT01422408|75728747|FG000|Overall Study|Adverse Event|1|||
41961053|NCT01422408|75728747|FG000|Overall Study|Withdrawal by Subject|3|||
41961054|NCT01399788|75728751|FG000|First Intervention Period|Adverse Event|1|||
41961055|NCT01399788|75728752|FG001|First Intervention Period|Adverse Event|0|||
41961056|NCT01387542|75728758|FG000|Overall Study|Adverse Event|3|||
41961057|NCT01387542|75728758|FG000|Overall Study|Withdrawal by Subject|1|||
41961058|NCT01387542|75728758|FG000|Overall Study|Changed diagnosis|1|||
41961059|NCT01387542|75728758|FG000|Overall Study|Insufficient response|1|||
41961060|NCT01387542|75728758|FG000|Overall Study|Non-compliant|1|||
41961061|NCT01387542|75728758|FG000|Overall Study|Lost to Follow-up|1|||
41961062|NCT01387230|75728765|FG000|Overall Study|Adverse Event|0|||
41961063|NCT01387230|75728766|FG001|Overall Study|Adverse Event|1|||
41961064|NCT01387230|75728767|FG002|Overall Study|Adverse Event|3|||
41961065|NCT01387230|75728765|FG000|Overall Study|Lack of Efficacy|8|||
41961066|NCT01387230|75728766|FG001|Overall Study|Lack of Efficacy|5|||
41961067|NCT01387230|75728767|FG002|Overall Study|Lack of Efficacy|4|||
41961068|NCT01387230|75728765|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
41961069|NCT01387230|75728766|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
41961070|NCT01387230|75728767|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
41961071|NCT01387230|75728765|FG000|Overall Study|Lost to Follow-up|0|||
41961072|NCT01387230|75728766|FG001|Overall Study|Lost to Follow-up|0|||
41961073|NCT01387230|75728767|FG002|Overall Study|Lost to Follow-up|1|||
41961074|NCT01387230|75728765|FG000|Overall Study|Withdrawal by Subject|4|||
41961075|NCT01387230|75728766|FG001|Overall Study|Withdrawal by Subject|1|||
41961076|NCT01387230|75728767|FG002|Overall Study|Withdrawal by Subject|0|||
41961077|NCT01387074|75728775|FG000|Overall Study|Lost to Follow-up|7|||
41961078|NCT01387074|75728775|FG000|Overall Study|Lack of Efficacy|1|||
41961079|NCT01386606|75728783|FG000|Overall Study|Adverse Event|0|||
41961080|NCT01386606|75728784|FG001|Overall Study|Adverse Event|1|||
41961081|NCT01386606|75728785|FG002|Overall Study|Adverse Event|0|||
41961082|NCT01386606|75728786|FG003|Overall Study|Adverse Event|0|||
41961083|NCT01386606|75728783|FG000|Overall Study|Withdrawal by Subject|0|||
41961084|NCT01386606|75728784|FG001|Overall Study|Withdrawal by Subject|1|||
41961085|NCT01386606|75728785|FG002|Overall Study|Withdrawal by Subject|1|||
41961086|NCT01386606|75728786|FG003|Overall Study|Withdrawal by Subject|0|||
41961087|NCT01386606|75728783|FG000|Overall Study|Protocol Violation|1|||
41961088|NCT01386606|75728784|FG001|Overall Study|Protocol Violation|0|||
41961089|NCT01386606|75728785|FG002|Overall Study|Protocol Violation|1|||
41961090|NCT01386606|75728786|FG003|Overall Study|Protocol Violation|1|||
41961091|NCT01386606|75728783|FG000|Overall Study|Lost to Follow-up|2|||
41961092|NCT01386606|75728784|FG001|Overall Study|Lost to Follow-up|0|||
41961093|NCT01386606|75728785|FG002|Overall Study|Lost to Follow-up|0|||
41961094|NCT01386606|75728786|FG003|Overall Study|Lost to Follow-up|0|||
41961095|NCT01386606|75728783|FG000|Overall Study|Subject incarcerated|0|||
41961096|NCT01386606|75728784|FG001|Overall Study|Subject incarcerated|1|||
41961097|NCT01386606|75728785|FG002|Overall Study|Subject incarcerated|0|||
41961098|NCT01386606|75728786|FG003|Overall Study|Subject incarcerated|0|||
41961099|NCT01386606|75728783|FG000|Overall Study|Unable to draw PK|1|||
41961100|NCT01386606|75728784|FG001|Overall Study|Unable to draw PK|0|||
41961101|NCT01386606|75728785|FG002|Overall Study|Unable to draw PK|0|||
41961102|NCT01386606|75728786|FG003|Overall Study|Unable to draw PK|0|||
41961103|NCT01386606|75728783|FG000|Overall Study|T levels too high|0|||
41961104|NCT01386606|75728784|FG001|Overall Study|T levels too high|1|||
41961105|NCT01386606|75728785|FG002|Overall Study|T levels too high|1|||
41961106|NCT01386606|75728786|FG003|Overall Study|T levels too high|0|||
41961107|NCT01385748|75728803|FG000|Overall Study|Withdrawal by Subject|7|||
41961108|NCT01385748|75728804|FG001|Overall Study|Withdrawal by Subject|4|||
41961109|NCT01385748|75728805|FG002|Overall Study|Withdrawal by Subject|5|||
41961110|NCT01385748|75728803|FG000|Overall Study|Noncompliance|3|||
41961111|NCT01385748|75728804|FG001|Overall Study|Noncompliance|1|||
41961112|NCT01385748|75728805|FG002|Overall Study|Noncompliance|6|||
41961113|NCT01385748|75728803|FG000|Overall Study|Other|1|||
41961114|NCT01385748|75728804|FG001|Overall Study|Other|7|||
41961115|NCT01385748|75728805|FG002|Overall Study|Other|1|||
41961116|NCT01385748|75728803|FG000|Overall Study|Adverse Event|4|||
41961117|NCT01385748|75728804|FG001|Overall Study|Adverse Event|2|||
41961118|NCT01385748|75728805|FG002|Overall Study|Adverse Event|1|||
41961119|NCT01397448|75728820|FG000|Overall Study|Adverse Event|4|||
41961120|NCT01397448|75728821|FG001|Overall Study|Adverse Event|4|||
41961121|NCT01397448|75728822|FG002|Overall Study|Adverse Event|6|||
41961122|NCT01397448|75728820|FG000|Overall Study|Withdrawal by Subject|4|||
41961123|NCT01397448|75728821|FG001|Overall Study|Withdrawal by Subject|4|||
41961124|NCT01397448|75728822|FG002|Overall Study|Withdrawal by Subject|3|||
41961125|NCT01397448|75728820|FG000|Overall Study|Lack of Efficacy|2|||
41961126|NCT01397448|75728821|FG001|Overall Study|Lack of Efficacy|0|||
41961127|NCT01397448|75728822|FG002|Overall Study|Lack of Efficacy|5|||
41961128|NCT01397448|75728820|FG000|Overall Study|Other|8|||
41961129|NCT01397448|75728821|FG001|Overall Study|Other|7|||
41961130|NCT01397448|75728822|FG002|Overall Study|Other|4|||
41961131|NCT01385202|75728830|FG000|Overall Study|Lost to Follow-up|6|||
41961132|NCT01385202|75728830|FG000|Overall Study|Not Eligible|11|||
41961133|NCT01385202|75728830|FG000|Overall Study|Withdrawn|1|||
41961134|NCT01384734|75728841|FG000|Overall Study|Adverse Event|0|||
41961135|NCT01384734|75728842|FG001|Overall Study|Adverse Event|3|||
41961136|NCT01384734|75728843|FG002|Overall Study|Adverse Event|0|||
41961137|NCT01384734|75728844|FG003|Overall Study|Adverse Event|2|||
41961138|NCT01384734|75728845|FG004|Overall Study|Adverse Event|7|||
41961139|NCT01384734|75728841|FG000|Overall Study|Death|1|||
41961140|NCT01384734|75728842|FG001|Overall Study|Death|0|||
41961141|NCT01384734|75728843|FG002|Overall Study|Death|1|||
41961142|NCT01384734|75728844|FG003|Overall Study|Death|0|||
41961143|NCT01384734|75728845|FG004|Overall Study|Death|0|||
41961144|NCT01384734|75728841|FG000|Overall Study|Continuation criteria not met|0|||
41961145|NCT01384734|75728842|FG001|Overall Study|Continuation criteria not met|0|||
41961146|NCT01384734|75728843|FG002|Overall Study|Continuation criteria not met|1|||
41961147|NCT01384734|75728844|FG003|Overall Study|Continuation criteria not met|1|||
41961148|NCT01384734|75728845|FG004|Overall Study|Continuation criteria not met|0|||
41961149|NCT01384734|75728841|FG000|Overall Study|Lack of Efficacy|3|||
41961150|NCT01384734|75728842|FG001|Overall Study|Lack of Efficacy|7|||
41961151|NCT01384734|75728843|FG002|Overall Study|Lack of Efficacy|4|||
41961152|NCT01384734|75728844|FG003|Overall Study|Lack of Efficacy|4|||
41961153|NCT01384734|75728845|FG004|Overall Study|Lack of Efficacy|2|||
41961154|NCT01384734|75728841|FG000|Overall Study|Lost to Follow-up|5|||
41961155|NCT01384734|75728842|FG001|Overall Study|Lost to Follow-up|3|||
41961156|NCT01384734|75728843|FG002|Overall Study|Lost to Follow-up|3|||
41961157|NCT01384734|75728844|FG003|Overall Study|Lost to Follow-up|8|||
41961158|NCT01384734|75728845|FG004|Overall Study|Lost to Follow-up|5|||
41961159|NCT01384734|75728841|FG000|Overall Study|Non-compliance with study drug|1|||
41961160|NCT01384734|75728842|FG001|Overall Study|Non-compliance with study drug|2|||
41961161|NCT01384734|75728843|FG002|Overall Study|Non-compliance with study drug|6|||
41961162|NCT01384734|75728844|FG003|Overall Study|Non-compliance with study drug|0|||
41961163|NCT01384734|75728845|FG004|Overall Study|Non-compliance with study drug|2|||
41961164|NCT01384734|75728841|FG000|Overall Study|Pregnancy|0|||
41961165|NCT01384734|75728842|FG001|Overall Study|Pregnancy|1|||
41961166|NCT01384734|75728843|FG002|Overall Study|Pregnancy|0|||
41961167|NCT01384734|75728844|FG003|Overall Study|Pregnancy|0|||
41961168|NCT01384734|75728845|FG004|Overall Study|Pregnancy|1|||
41961169|NCT01384734|75728841|FG000|Overall Study|Sponsor terminated|0|||
41961170|NCT01384734|75728842|FG001|Overall Study|Sponsor terminated|0|||
41961171|NCT01384734|75728843|FG002|Overall Study|Sponsor terminated|0|||
41961172|NCT01384734|75728844|FG003|Overall Study|Sponsor terminated|0|||
41961173|NCT01384734|75728845|FG004|Overall Study|Sponsor terminated|1|||
41961174|NCT01384734|75728841|FG000|Overall Study|Withdrawal by Subject|5|||
41961175|NCT01384734|75728842|FG001|Overall Study|Withdrawal by Subject|5|||
41961176|NCT01384734|75728843|FG002|Overall Study|Withdrawal by Subject|6|||
41961177|NCT01384734|75728844|FG003|Overall Study|Withdrawal by Subject|7|||
41961178|NCT01384734|75728845|FG004|Overall Study|Withdrawal by Subject|9|||
41961179|NCT01384734|75728841|FG000|Overall Study|Investigator relocating|0|||
41961180|NCT01384734|75728842|FG001|Overall Study|Investigator relocating|2|||
41961181|NCT01384734|75728843|FG002|Overall Study|Investigator relocating|0|||
41961182|NCT01384734|75728844|FG003|Overall Study|Investigator relocating|3|||
41961183|NCT01384734|75728845|FG004|Overall Study|Investigator relocating|1|||
41961184|NCT01384734|75728841|FG000|Overall Study|Unable to come back for visit|1|||
41961185|NCT01384734|75728842|FG001|Overall Study|Unable to come back for visit|0|||
41961186|NCT01384734|75728843|FG002|Overall Study|Unable to come back for visit|1|||
41961187|NCT01384734|75728844|FG003|Overall Study|Unable to come back for visit|1|||
41961188|NCT01384734|75728845|FG004|Overall Study|Unable to come back for visit|0|||
41961189|NCT01384734|75728841|FG000|Overall Study|Prison|0|||
42024673|NCT00935818|75832230|FG001|Overall Study|Physician Decision|1|||
42024674|NCT01216319|75832236|FG000|Overall Study|Lost to Follow-up|2|||
42024675|NCT01216319|75832236|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
42024676|NCT00936208|75832242|FG000|Overall Study|Protocol Violation|37|||
42024677|NCT00936208|75832243|FG001|Overall Study|Protocol Violation|22|||
42024678|NCT01216163|75832252|FG000|Overall Study|Withdrawal by Subject|1|||
42024679|NCT01216163|75832253|FG001|Overall Study|Withdrawal by Subject|1|||
42024680|NCT01216163|75832254|FG002|Overall Study|Withdrawal by Subject|0|||
41961190|NCT01384734|75728842|FG001|Overall Study|Prison|0|||
41961191|NCT01384734|75728843|FG002|Overall Study|Prison|1|||
42024681|NCT00933244|75832265|FG000|Overall Study|Withdrawal by Subject|5|||
41961192|NCT01384734|75728844|FG003|Overall Study|Prison|0|||
41961193|NCT01384734|75728845|FG004|Overall Study|Prison|0|||
41961194|NCT01384734|75728841|FG000|Overall Study|As per Exclusion criteria|0|||
41961195|NCT01384734|75728842|FG001|Overall Study|As per Exclusion criteria|1|||
41961196|NCT01384734|75728843|FG002|Overall Study|As per Exclusion criteria|0|||
41961197|NCT01384734|75728844|FG003|Overall Study|As per Exclusion criteria|0|||
41961198|NCT01384734|75728845|FG004|Overall Study|As per Exclusion criteria|0|||
42024682|NCT00933244|75832266|FG001|Overall Study|Withdrawal by Subject|1|||
41961199|NCT01384734|75728841|FG000|Overall Study|Missed End of treatment visit|0|||
41961200|NCT01384734|75728842|FG001|Overall Study|Missed End of treatment visit|0|||
41961201|NCT01384734|75728843|FG002|Overall Study|Missed End of treatment visit|0|||
41961202|NCT01384734|75728844|FG003|Overall Study|Missed End of treatment visit|1|||
41961203|NCT01384734|75728845|FG004|Overall Study|Missed End of treatment visit|0|||
41961204|NCT01384734|75728841|FG000|Overall Study|Adhesion problem|0|||
41961205|NCT01384734|75728842|FG001|Overall Study|Adhesion problem|0|||
41961206|NCT01384734|75728843|FG002|Overall Study|Adhesion problem|0|||
41961207|NCT01384734|75728844|FG003|Overall Study|Adhesion problem|1|||
41961208|NCT01384734|75728845|FG004|Overall Study|Adhesion problem|0|||
41961209|NCT01384734|75728841|FG000|Overall Study|Early termination|0|||
41961210|NCT01384734|75728842|FG001|Overall Study|Early termination|0|||
41961211|NCT01384734|75728843|FG002|Overall Study|Early termination|0|||
41961212|NCT01384734|75728844|FG003|Overall Study|Early termination|0|||
41961213|NCT01384734|75728845|FG004|Overall Study|Early termination|1|||
41961214|NCT01384734|75728841|FG000|Overall Study|Physician Decision|1|||
41961215|NCT01384734|75728842|FG001|Overall Study|Physician Decision|0|||
41961216|NCT01384734|75728843|FG002|Overall Study|Physician Decision|0|||
41961217|NCT01384734|75728844|FG003|Overall Study|Physician Decision|0|||
41961218|NCT01384734|75728845|FG004|Overall Study|Physician Decision|0|||
41961219|NCT01396512|75728856|FG000|Overall Study|Withdrawal by Subject|0|||
41961220|NCT01396512|75728857|FG001|Overall Study|Withdrawal by Subject|1|||
41961221|NCT01396434|75728866|FG000|Overall Study|Lost to Follow-up|1|||
41961222|NCT01396434|75728867|FG001|Overall Study|Lost to Follow-up|0|||
41961223|NCT01396434|75728868|FG002|Overall Study|Lost to Follow-up|0|||
41961224|NCT01396434|75728866|FG000|Overall Study|Other|10|||
41961225|NCT01396434|75728867|FG001|Overall Study|Other|0|||
41961226|NCT01396434|75728868|FG002|Overall Study|Other|0|||
41961227|NCT01383954|75728876|FG000|Overall Study|Lack of Efficacy|2|||
41961228|NCT01383954|75728876|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
41961229|NCT01383954|75728876|FG000|Overall Study|Adverse Event|1|||
41961230|NCT01383954|75728876|FG000|Overall Study|Reason Not Specified|9|||
41961231|NCT01383486|75728880|FG000|Overall Study|Lost to Follow-up|10|||
41961232|NCT01383486|75728880|FG000|Overall Study|Incomplete information for analysis|2|||
41961233|NCT01383486|75728880|FG000|Overall Study|Did not take any product|6|||
41961234|NCT01383174|75728887|FG000|3 Month Assessment|Death|0|||
41961235|NCT01383174|75728888|FG001|3 Month Assessment|Death|1|||
41961236|NCT01383174|75728887|FG000|3 Month Assessment|Lost to Follow-up|2|||
41961237|NCT01383174|75728888|FG001|3 Month Assessment|Lost to Follow-up|0|||
41961238|NCT01383174|75728887|FG000|3 Month Assessment|Refused to complete|4|||
41961239|NCT01383174|75728888|FG001|3 Month Assessment|Refused to complete|0|||
41961240|NCT01383174|75728887|FG000|6 Month Assessment|Lost to Follow-up|1|||
41961241|NCT01383174|75728888|FG001|6 Month Assessment|Lost to Follow-up|1|||
41961242|NCT01383174|75728887|FG000|6 Month Assessment|Refused to complete|4|||
41961243|NCT01383174|75728888|FG001|6 Month Assessment|Refused to complete|0|||
41961244|NCT01396278|75728899|FG000|Overall Study|Adverse Event|0|||
41961245|NCT01396278|75728900|FG001|Overall Study|Adverse Event|0|||
41961246|NCT01396278|75728901|FG002|Overall Study|Adverse Event|0|||
41961247|NCT01396278|75728902|FG003|Overall Study|Adverse Event|2|||
41961248|NCT01396278|75728903|FG004|Overall Study|Adverse Event|0|||
41961249|NCT01396278|75728899|FG000|Overall Study|Withdraw due to trial termination|2|||
41961250|NCT01396278|75728900|FG001|Overall Study|Withdraw due to trial termination|1|||
41961251|NCT01396278|75728901|FG002|Overall Study|Withdraw due to trial termination|1|||
41961252|NCT01396278|75728902|FG003|Overall Study|Withdraw due to trial termination|0|||
41961253|NCT01396278|75728903|FG004|Overall Study|Withdraw due to trial termination|2|||
41961254|NCT01383096|75728918|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
41961255|NCT01383096|75728919|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
41961256|NCT01383096|75728920|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
41961257|NCT01383096|75728918|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
41961258|NCT01383096|75728919|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
41961259|NCT01383096|75728920|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
41961260|NCT01383096|75728918|FG000|Third Intervention (8 Days)|Elevated AST|0|||
41961261|NCT01383096|75728919|FG001|Third Intervention (8 Days)|Elevated AST|1|||
41961262|NCT01383096|75728920|FG002|Third Intervention (8 Days)|Elevated AST|0|||
41961263|NCT01383096|75728918|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
41961264|NCT01383096|75728919|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
41961265|NCT01383096|75728920|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
41961266|NCT01383096|75728918|FG000|Third Intervention (8 Days)|Adverse Event|1|||
41961267|NCT01383096|75728919|FG001|Third Intervention (8 Days)|Adverse Event|0|||
41961268|NCT01383096|75728920|FG002|Third Intervention (8 Days)|Adverse Event|0|||
41961269|NCT01383096|75728918|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
41961270|NCT01383096|75728919|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
41961271|NCT01383096|75728920|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
41961272|NCT01383096|75728918|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
41961273|NCT01383096|75728919|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
41961274|NCT01383096|75728920|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
41961275|NCT01383096|75728918|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
41961276|NCT01383096|75728919|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
41961277|NCT01383096|75728920|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
41961278|NCT01383096|75728918|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
41961279|NCT01383096|75728919|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
41961280|NCT01383096|75728920|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
41961281|NCT01383096|75728918|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
41961282|NCT01383096|75728919|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
41961283|NCT01383096|75728920|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
41961284|NCT01383096|75728918|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
41961285|NCT01383096|75728919|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
41961286|NCT01383096|75728920|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
41961287|NCT01383018|75728961|FG000|Overall Study|Adverse Event|14|||
41961288|NCT01383018|75728961|FG000|Overall Study|Death|10|||
41961289|NCT01383018|75728961|FG000|Overall Study|Lost to Follow-up|5|||
41961290|NCT01383018|75728961|FG000|Overall Study|Physician Decision|5|||
41961291|NCT01383018|75728961|FG000|Overall Study|Withdrawal by Subject|9|||
41961292|NCT01383018|75728961|FG000|Overall Study|Subject not implanted|76|||
41961293|NCT01383018|75728961|FG000|Overall Study|Missed Visit|247|||
41961294|NCT01383018|75728961|FG000|Overall Study|Site closed early-not compliance related|7|||
41961295|NCT01383018|75728961|FG000|Overall Study|Patient moved away from site|1|||
41961296|NCT01383018|75728961|FG000|Overall Study|Subject Incarcerated|1|||
41961297|NCT01382940|75728975|FG000|Overall Study|Adverse Event|19|||
41961298|NCT01382940|75728975|FG000|Overall Study|Lost to Follow-up|4|||
41961299|NCT01382940|75728975|FG000|Overall Study|Physician Decision|7|||
41961300|NCT01382940|75728975|FG000|Overall Study|Withdrawal by Subject|23|||
41961301|NCT01382940|75728975|FG000|Overall Study|Protocol Violation|20|||
41961302|NCT01381926|75728981|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
41961303|NCT01381926|75728982|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
41961304|NCT01381926|75728981|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
41961305|NCT01381926|75728982|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
41961306|NCT01395888|75728992|FG000|2-week Run-in Period|Adverse Event|2|||
41961307|NCT01395888|75728993|FG001|2-week Run-in Period|Adverse Event|0|||
41961308|NCT01395888|75728994|FG002|2-week Run-in Period|Adverse Event|0|||
41961309|NCT01395888|75728992|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
41961310|NCT01395888|75728993|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
41961311|NCT01395888|75728994|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
41961312|NCT01395888|75728992|FG000|2-week Run-in Period|Lost to Follow-up|1|||
41961313|NCT01395888|75728993|FG001|2-week Run-in Period|Lost to Follow-up|0|||
41961314|NCT01395888|75728994|FG002|2-week Run-in Period|Lost to Follow-up|0|||
41961315|NCT01395888|75728992|FG000|2-week Run-in Period|Protocol Violation|2|||
41961316|NCT01395888|75728993|FG001|2-week Run-in Period|Protocol Violation|0|||
41961317|NCT01395888|75728994|FG002|2-week Run-in Period|Protocol Violation|0|||
41961318|NCT01395888|75728992|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
41961319|NCT01395888|75728993|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
41961320|NCT01395888|75728994|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
41961321|NCT01395888|75728992|FG000|Treatment Period (TP)|Adverse Event|0|||
41961322|NCT01395888|75728993|FG001|Treatment Period (TP)|Adverse Event|7|||
41961323|NCT01395888|75728994|FG002|Treatment Period (TP)|Adverse Event|6|||
41961324|NCT01395888|75728992|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
41961325|NCT01395888|75728993|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
41961326|NCT01395888|75728994|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
41961327|NCT01395888|75728992|FG000|Treatment Period (TP)|Protocol Violation|0|||
41961328|NCT01395888|75728993|FG001|Treatment Period (TP)|Protocol Violation|1|||
41961329|NCT01395888|75728994|FG002|Treatment Period (TP)|Protocol Violation|5|||
41961330|NCT01395888|75728992|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
41961331|NCT01395888|75728993|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
41961332|NCT01395888|75728994|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
41961333|NCT01395888|75728992|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
41961334|NCT01395888|75728993|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
41961335|NCT01395888|75728994|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
41961336|NCT01395810|75729004|FG000|Overall Study|Adverse Event|0|||
41961337|NCT01395810|75729005|FG001|Overall Study|Adverse Event|1|||
41961338|NCT01395810|75729006|FG002|Overall Study|Adverse Event|0|||
41961339|NCT01395810|75729007|FG003|Overall Study|Adverse Event|0|||
41961340|NCT01395810|75729004|FG000|Overall Study|Lack of Efficacy|0|||
41961341|NCT01395810|75729005|FG001|Overall Study|Lack of Efficacy|1|||
41961342|NCT01395810|75729006|FG002|Overall Study|Lack of Efficacy|0|||
41961343|NCT01395810|75729007|FG003|Overall Study|Lack of Efficacy|0|||
41961344|NCT01395810|75729004|FG000|Overall Study|Withdrawal criteria|0|||
41961345|NCT01395810|75729005|FG001|Overall Study|Withdrawal criteria|2|||
41961346|NCT01395810|75729006|FG002|Overall Study|Withdrawal criteria|0|||
41961347|NCT01395810|75729007|FG003|Overall Study|Withdrawal criteria|0|||
41961348|NCT01395810|75729004|FG000|Overall Study|Unclassified|2|||
41961349|NCT01395810|75729005|FG001|Overall Study|Unclassified|0|||
41961350|NCT01395810|75729006|FG002|Overall Study|Unclassified|0|||
41961351|NCT01395810|75729007|FG003|Overall Study|Unclassified|0|||
41961352|NCT01381692|75729020|FG000|Overall Study|Adverse Event|1|||
41961353|NCT01381692|75729021|FG001|Overall Study|Adverse Event|0|||
41961354|NCT01381692|75729022|FG002|Overall Study|Adverse Event|0|||
41961355|NCT01381692|75729023|FG003|Overall Study|Adverse Event|0|||
41961356|NCT01381692|75729024|FG004|Overall Study|Adverse Event|0|||
41961357|NCT01381692|75729025|FG005|Overall Study|Adverse Event|0|||
41961358|NCT01395030|75729033|FG000|Overall Study|Did not complete FCH PET/CT|7|||
41961359|NCT01381068|75729041|FG000|Overall Study|Death|1|||
41961360|NCT01381068|75729042|FG001|Overall Study|Death|0|||
41961361|NCT01394952|75729050|FG000|Overall Study|Lost to Follow-up|0|||
41961362|NCT01394952|75729051|FG001|Overall Study|Lost to Follow-up|5|||
41961363|NCT01394952|75729050|FG000|Overall Study|Withdrawal by Subject|10|||
41961364|NCT01394952|75729051|FG001|Overall Study|Withdrawal by Subject|5|||
41961365|NCT01394952|75729050|FG000|Overall Study|Physician Decision|2|||
41961366|NCT01394952|75729051|FG001|Overall Study|Physician Decision|0|||
41961367|NCT01394952|75729050|FG000|Overall Study|Sponsor Decision|5|||
41961368|NCT01394952|75729051|FG001|Overall Study|Sponsor Decision|7|||
41961369|NCT01394718|75729059|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
41961370|NCT01394718|75729060|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
41961371|NCT01394250|75729068|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
41961372|NCT01394250|75729069|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
41961373|NCT01394250|75729068|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
41961374|NCT01394250|75729069|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
41961375|NCT01380990|75729077|FG000|Overall Study|Treatment Failure|1|||
41961376|NCT01380990|75729078|FG001|Overall Study|Treatment Failure|0|||
41961377|NCT01380990|75729077|FG000|Overall Study|Death|0|||
41961378|NCT01380990|75729078|FG001|Overall Study|Death|1|||
41961379|NCT01380834|75729090|FG000|Overall Study|Physician Decision|1|||
41961380|NCT01380834|75729091|FG001|Overall Study|Physician Decision|0|||
41961381|NCT00214422|75729100|FG000|Overall Study|Physician Decision|2|||
41961382|NCT00214422|75729101|FG001|Overall Study|Physician Decision|0|||
41961383|NCT00214422|75729102|FG002|Overall Study|Physician Decision|0|||
41961384|NCT00214422|75729100|FG000|Overall Study|Developed esophageal ca|1|||
41961385|NCT00214422|75729101|FG001|Overall Study|Developed esophageal ca|0|||
41961386|NCT00214422|75729102|FG002|Overall Study|Developed esophageal ca|0|||
41961387|NCT00214422|75729100|FG000|Overall Study|Pt taken off study|1|||
41961388|NCT00214422|75729101|FG001|Overall Study|Pt taken off study|1|||
41961389|NCT00214422|75729102|FG002|Overall Study|Pt taken off study|0|||
41961390|NCT00214422|75729100|FG000|Overall Study|Disease progression on study|1|||
41961391|NCT00214422|75729101|FG001|Overall Study|Disease progression on study|0|||
41961392|NCT00214422|75729102|FG002|Overall Study|Disease progression on study|0|||
41961393|NCT00214422|75729100|FG000|Overall Study|Unable to make a radiation treatment|0|||
41961394|NCT00214422|75729101|FG001|Overall Study|Unable to make a radiation treatment|0|||
41961395|NCT00214422|75729102|FG002|Overall Study|Unable to make a radiation treatment|1|||
41961396|NCT00218634|75729116|FG000|Overall Study|Lost to Follow-up|8|||
41961397|NCT00218634|75729117|FG001|Overall Study|Lost to Follow-up|15|||
41961398|NCT00217620|75729126|FG000|Overall Study|Adverse Event|2|||
41961399|NCT00217620|75729126|FG000|Overall Study|Progression|31|||
41961400|NCT00217620|75729126|FG000|Overall Study|Not Protocol Specified|4|||
41961401|NCT00217620|75729126|FG000|Overall Study|Ineligible|13|||
41961402|NCT00217620|75729126|FG000|Overall Study|Never received treatment|1|||
41961403|NCT00217464|75729134|FG000|Overall Study|Progression|15|||
41961404|NCT00217464|75729134|FG000|Overall Study|Other|2|||
41961405|NCT00214500|75729138|FG000|Treatment Period|Adverse Event|1|||
41961406|NCT00214500|75729138|FG000|Extension Period|Withdrawal by Subject|2|||
41961407|NCT00211536|75729147|FG000|Overall Study|Withdrawal by Subject|2|||
41961408|NCT00211536|75729148|FG001|Overall Study|Withdrawal by Subject|2|||
41961409|NCT00211536|75729147|FG000|Overall Study|Physician Decision|0|||
41961410|NCT00211536|75729148|FG001|Overall Study|Physician Decision|5|||
41961411|NCT00211536|75729147|FG000|Overall Study|Adverse Event|2|||
41961412|NCT00211536|75729148|FG001|Overall Study|Adverse Event|0|||
41961413|NCT03192462|75729211|FG000|Overall Study|Death|13|||
41961414|NCT03192462|75729212|FG001|Overall Study|Death|11|||
41961415|NCT03192462|75729213|FG002|Overall Study|Death|9|||
41961416|NCT03192462|75729211|FG000|Overall Study|Lost to Follow-up|0|||
41961417|NCT03192462|75729212|FG001|Overall Study|Lost to Follow-up|1|||
41961418|NCT03192462|75729213|FG002|Overall Study|Lost to Follow-up|0|||
41961419|NCT03192462|75729211|FG000|Overall Study|On follow up|0|||
41961420|NCT03192462|75729212|FG001|Overall Study|On follow up|0|||
41961421|NCT03192462|75729213|FG002|Overall Study|On follow up|3|||
41961422|NCT03589326|75729223|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
41961423|NCT03589326|75729224|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
41961424|NCT03589326|75729223|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
41961425|NCT03589326|75729224|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
41961426|NCT03589326|75729223|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
41961427|NCT03589326|75729224|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
41961428|NCT03589326|75729223|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
41961429|NCT03589326|75729224|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
41961430|NCT03589326|75729223|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
41961431|NCT03589326|75729224|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
41961432|NCT03028740|75729245|FG000|Overall Study|Did not Receive Study Drug|4|||
41961433|NCT03028740|75729246|FG001|Overall Study|Did not Receive Study Drug|5|||
41961434|NCT03028740|75729245|FG000|Overall Study|Adverse Event|8|||
41961435|NCT03028740|75729246|FG001|Overall Study|Adverse Event|26|||
41961436|NCT03028740|75729245|FG000|Overall Study|Lack of Efficacy|0|||
41961437|NCT03028740|75729246|FG001|Overall Study|Lack of Efficacy|1|||
41961438|NCT03028740|75729245|FG000|Overall Study|Withdrawal by Subject|48|||
41961439|NCT03028740|75729246|FG001|Overall Study|Withdrawal by Subject|101|||
41961440|NCT03028740|75729245|FG000|Overall Study|Lost to Follow-up|30|||
41961441|NCT03028740|75729246|FG001|Overall Study|Lost to Follow-up|54|||
41961442|NCT03028740|75729245|FG000|Overall Study|Physician Decision|4|||
41961443|NCT03028740|75729246|FG001|Overall Study|Physician Decision|11|||
41961444|NCT03028740|75729245|FG000|Overall Study|Protocol Violation|4|||
41961445|NCT03028740|75729246|FG001|Overall Study|Protocol Violation|8|||
42210289|NCT03259308|76025067|FG002|Overall Study|Withdrawal by Subject|3|||
42210290|NCT03259308|76025065|FG000|Overall Study|Lost to Follow-up|0|||
42210291|NCT03259308|76025066|FG001|Overall Study|Lost to Follow-up|0|||
42210292|NCT03259308|76025067|FG002|Overall Study|Lost to Follow-up|1|||
41961446|NCT03028740|75729245|FG000|Overall Study|Non-compliance with Study Drug|0|||
41961447|NCT03028740|75729246|FG001|Overall Study|Non-compliance with Study Drug|2|||
41961448|NCT03028740|75729245|FG000|Overall Study|Study Terminated by Sponsor|467|||
41961449|NCT03028740|75729246|FG001|Overall Study|Study Terminated by Sponsor|917|||
41961450|NCT03028740|75729245|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
41961451|NCT03028740|75729246|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
41961452|NCT03028740|75729245|FG000|Overall Study|Reason not Specified|1|||
41961453|NCT03028740|75729246|FG001|Overall Study|Reason not Specified|5|||
41961454|NCT02980692|75729269|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
41961455|NCT02980692|75729270|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
41961456|NCT02980692|75729271|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
41961457|NCT02980692|75729272|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
41961458|NCT02980692|75729273|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
41961459|NCT02980692|75729269|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
41961460|NCT02980692|75729270|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
41961461|NCT02980692|75729271|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
41961462|NCT02980692|75729272|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
41961463|NCT02980692|75729273|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
41961464|NCT02980692|75729269|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
41961465|NCT02980692|75729270|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
41961466|NCT02980692|75729271|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
41961467|NCT02980692|75729272|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
41961468|NCT02980692|75729273|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
41961469|NCT02980692|75729269|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
41961470|NCT02980692|75729270|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
41961471|NCT02980692|75729271|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
41961472|NCT02980692|75729272|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
41961473|NCT02980692|75729273|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
41961474|NCT02980692|75729269|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
41961475|NCT02980692|75729270|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
41961476|NCT02980692|75729271|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
41961477|NCT02980692|75729272|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
41961478|NCT02980692|75729273|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
41961479|NCT02980692|75729269|FG000|Double Blind Placebo Controlled Period|Other|1|||
41961480|NCT02980692|75729270|FG001|Double Blind Placebo Controlled Period|Other|0|||
41961481|NCT02980692|75729271|FG002|Double Blind Placebo Controlled Period|Other|0|||
41961482|NCT02980692|75729272|FG003|Double Blind Placebo Controlled Period|Other|0|||
41961483|NCT02980692|75729273|FG004|Double Blind Placebo Controlled Period|Other|1|||
42118112|NCT00502593|75928970|FG001|Overall Study|Withdrawn unspecified reason|1|||
41961484|NCT02980692|75729269|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
42118113|NCT00502593|75928971|FG002|Overall Study|Withdrawn unspecified reason|3|||
42210293|NCT03259308|76025065|FG000|Overall Study|Pregnancy|0|||
41961485|NCT02980692|75729270|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
41961486|NCT02980692|75729271|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
41961487|NCT02980692|75729272|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
41961488|NCT02980692|75729273|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
41961489|NCT02980692|75729269|FG000|Double-blind Follow-up Period|Adverse Event|0|||
41961490|NCT02980692|75729270|FG001|Double-blind Follow-up Period|Adverse Event|0|||
41961491|NCT02980692|75729271|FG002|Double-blind Follow-up Period|Adverse Event|0|||
41961492|NCT02980692|75729272|FG003|Double-blind Follow-up Period|Adverse Event|1|||
41961493|NCT02980692|75729273|FG004|Double-blind Follow-up Period|Adverse Event|1|||
41961494|NCT02980692|75729269|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
41961495|NCT02980692|75729270|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
41961496|NCT02980692|75729271|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
41961497|NCT02980692|75729272|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
41961498|NCT02980692|75729273|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
41961499|NCT02980692|75729269|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
41961500|NCT02980692|75729270|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
41961501|NCT02980692|75729271|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
41961502|NCT02980692|75729272|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
41961503|NCT02980692|75729273|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
41961504|NCT02980692|75729269|FG000|Double-blind Follow-up Period|Pregnancy|0|||
41961505|NCT02980692|75729270|FG001|Double-blind Follow-up Period|Pregnancy|0|||
41961506|NCT02980692|75729271|FG002|Double-blind Follow-up Period|Pregnancy|1|||
41961507|NCT02980692|75729272|FG003|Double-blind Follow-up Period|Pregnancy|1|||
41961508|NCT02980692|75729273|FG004|Double-blind Follow-up Period|Pregnancy|0|||
41961509|NCT02980692|75729269|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
41961510|NCT02980692|75729270|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
41961511|NCT02980692|75729271|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
41961512|NCT02980692|75729272|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
41961513|NCT02980692|75729273|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
41961514|NCT02980692|75729269|FG000|Double-blind Follow-up Period|Other|0|||
41961515|NCT02980692|75729270|FG001|Double-blind Follow-up Period|Other|0|||
41961516|NCT02980692|75729271|FG002|Double-blind Follow-up Period|Other|1|||
41961517|NCT02980692|75729272|FG003|Double-blind Follow-up Period|Other|1|||
41961518|NCT02980692|75729273|FG004|Double-blind Follow-up Period|Other|3|||
41961519|NCT04439279|75729543|FG000|Overall Study|Adverse Event|7|||
41961520|NCT04439279|75729543|FG000|Overall Study|Death|4|||
41961521|NCT04439279|75729543|FG000|Overall Study|Disease progression|17|||
41961522|NCT04439279|75729543|FG000|Overall Study|Complicating disease|3|||
41961523|NCT04439279|75729543|FG000|Overall Study|Withdrawal by Subject|2|||
41961524|NCT04439279|75729543|FG000|Overall Study|Ineligible|1|||
41961525|NCT04439279|75729543|FG000|Overall Study|Treatment still ongoing|1|||
41961526|NCT04123548|75729573|FG000|Overall Study|Withdrawal by Subject|1|||
41961527|NCT04123548|75729573|FG000|Overall Study|Lost to Follow-up|8|||
41961528|NCT04123548|75729573|FG000|Overall Study|Death|4|||
41961529|NCT04123548|75729573|FG000|Overall Study|Reason Not Specified|1|||
41961530|NCT04022733|75729579|FG000|Overall Study|conversion to open surgery|3|||
41961531|NCT04022733|75729580|FG001|Overall Study|conversion to open surgery|2|||
41961532|NCT04022733|75729579|FG000|Overall Study|bradycardia|0|||
41961533|NCT04022733|75729580|FG001|Overall Study|bradycardia|1|||
41961534|NCT03593915|75729609|FG000|Overall Study|Adverse Event|0|||
41961535|NCT03593915|75729610|FG001|Overall Study|Adverse Event|0|||
41961536|NCT03593915|75729611|FG002|Overall Study|Adverse Event|0|||
41961537|NCT03593915|75729612|FG003|Overall Study|Adverse Event|1|||
41961538|NCT03593915|75729613|FG004|Overall Study|Adverse Event|0|||
41961539|NCT03593915|75729614|FG005|Overall Study|Adverse Event|0|||
41961540|NCT03593915|75729609|FG000|Overall Study|Physician Decision|0|||
41961541|NCT03593915|75729610|FG001|Overall Study|Physician Decision|0|||
41961542|NCT03593915|75729611|FG002|Overall Study|Physician Decision|0|||
41961543|NCT03593915|75729612|FG003|Overall Study|Physician Decision|0|||
41961544|NCT03593915|75729613|FG004|Overall Study|Physician Decision|0|||
41961545|NCT03593915|75729614|FG005|Overall Study|Physician Decision|1|||
41961546|NCT03563716|75729640|FG000|Overall Study|Death|20|||
41961547|NCT03563716|75729641|FG001|Overall Study|Death|14|||
41961548|NCT03563716|75729640|FG000|Overall Study|Withdrawal by Subject|3|||
41961549|NCT03563716|75729641|FG001|Overall Study|Withdrawal by Subject|3|||
41961550|NCT03563716|75729640|FG000|Overall Study|Still on Study|45|||
41961551|NCT03563716|75729641|FG001|Overall Study|Still on Study|50|||
41961552|NCT03462030|75729649|FG000|Overall Study|Withdrawal by Subject|1|||
41961553|NCT03462030|75729650|FG001|Overall Study|Withdrawal by Subject|1|||
41961554|NCT03336333|75729659|FG000|Overall Study|Remained on study at time of data cut-off|202|||
41961555|NCT03336333|75729660|FG001|Overall Study|Remained on study at time of data cut-off|219|||
41961556|NCT03336333|75729661|FG002|Overall Study|Remained on study at time of data cut-off|102|||
41961557|NCT03336333|75729659|FG000|Overall Study|Death|14|||
41961558|NCT03336333|75729660|FG001|Overall Study|Death|16|||
41961559|NCT03336333|75729661|FG002|Overall Study|Death|8|||
41961560|NCT03336333|75729659|FG000|Overall Study|Withdrawal by Subject|16|||
41961561|NCT03336333|75729660|FG001|Overall Study|Withdrawal by Subject|5|||
41961562|NCT03336333|75729661|FG002|Overall Study|Withdrawal by Subject|1|||
41961563|NCT03336333|75729659|FG000|Overall Study|Physician Decision|5|||
41961564|NCT03336333|75729660|FG001|Overall Study|Physician Decision|1|||
41961565|NCT03336333|75729661|FG002|Overall Study|Physician Decision|0|||
41961566|NCT03336333|75729659|FG000|Overall Study|Lost to Follow-up|1|||
41961567|NCT03336333|75729660|FG001|Overall Study|Lost to Follow-up|0|||
41961568|NCT03336333|75729661|FG002|Overall Study|Lost to Follow-up|0|||
41961569|NCT03275285|75729670|FG000|Overall Study|Ongoing|61|||
41961570|NCT03275285|75729671|FG001|Overall Study|Ongoing|105|||
41961571|NCT03240874|75729685|FG000|Overall Study|Lost to Follow-up|0|||
41961572|NCT03240874|75729686|FG001|Overall Study|Lost to Follow-up|2|||
41961573|NCT03240874|75729687|FG002|Overall Study|Lost to Follow-up|4|||
41961574|NCT03240874|75729688|FG003|Overall Study|Lost to Follow-up|1|||
41961575|NCT03083665|75729699|FG000|Double-Blind Period|Adverse Event|5|||
41961576|NCT03083665|75729700|FG001|Double-Blind Period|Adverse Event|4|||
41961577|NCT03083665|75729701|FG002|Double-Blind Period|Adverse Event|5|||
41961578|NCT03083665|75729702|FG003|Double-Blind Period|Adverse Event|0|||
41961579|NCT03083665|75729703|FG004|Double-Blind Period|Adverse Event|0|||
41961580|NCT03083665|75729704|FG005|Double-Blind Period|Adverse Event|0|||
41961581|NCT03083665|75729699|FG000|Double-Blind Period|Lack of Efficacy|0|||
41961582|NCT03083665|75729700|FG001|Double-Blind Period|Lack of Efficacy|0|||
41961583|NCT03083665|75729701|FG002|Double-Blind Period|Lack of Efficacy|1|||
41961584|NCT03083665|75729702|FG003|Double-Blind Period|Lack of Efficacy|0|||
41961585|NCT03083665|75729703|FG004|Double-Blind Period|Lack of Efficacy|0|||
41961586|NCT03083665|75729704|FG005|Double-Blind Period|Lack of Efficacy|0|||
41961587|NCT03083665|75729699|FG000|Double-Blind Period|Protocol Violation|1|||
41961588|NCT03083665|75729700|FG001|Double-Blind Period|Protocol Violation|0|||
41961589|NCT03083665|75729701|FG002|Double-Blind Period|Protocol Violation|1|||
41961590|NCT03083665|75729702|FG003|Double-Blind Period|Protocol Violation|0|||
41961591|NCT03083665|75729703|FG004|Double-Blind Period|Protocol Violation|0|||
41961592|NCT03083665|75729704|FG005|Double-Blind Period|Protocol Violation|0|||
41961593|NCT03083665|75729699|FG000|Double-Blind Period|Lost to Follow-up|1|||
41961594|NCT03083665|75729700|FG001|Double-Blind Period|Lost to Follow-up|0|||
41961595|NCT03083665|75729701|FG002|Double-Blind Period|Lost to Follow-up|1|||
41961596|NCT03083665|75729702|FG003|Double-Blind Period|Lost to Follow-up|0|||
41961597|NCT03083665|75729703|FG004|Double-Blind Period|Lost to Follow-up|0|||
41961598|NCT03083665|75729704|FG005|Double-Blind Period|Lost to Follow-up|0|||
41961599|NCT03083665|75729699|FG000|Double-Blind Period|Withdrawal by Subject|3|||
41961600|NCT03083665|75729700|FG001|Double-Blind Period|Withdrawal by Subject|0|||
41961601|NCT03083665|75729701|FG002|Double-Blind Period|Withdrawal by Subject|0|||
41961602|NCT03083665|75729702|FG003|Double-Blind Period|Withdrawal by Subject|0|||
41961603|NCT03083665|75729703|FG004|Double-Blind Period|Withdrawal by Subject|0|||
41961604|NCT03083665|75729704|FG005|Double-Blind Period|Withdrawal by Subject|0|||
41961605|NCT03083665|75729699|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
41961606|NCT03083665|75729700|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
41961607|NCT03083665|75729701|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
41961608|NCT03083665|75729702|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
41961609|NCT03083665|75729703|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
41961610|NCT03083665|75729704|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
41961611|NCT03083665|75729699|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
41961612|NCT03083665|75729700|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
41961613|NCT03083665|75729701|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
41961614|NCT03083665|75729702|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
41961615|NCT03083665|75729703|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
41961616|NCT03083665|75729704|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
41961617|NCT03083665|75729699|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
41961618|NCT03083665|75729700|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
41961619|NCT03083665|75729701|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
41961620|NCT03083665|75729702|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
41961621|NCT03083665|75729703|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
41961622|NCT03083665|75729704|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
41961623|NCT03083665|75729699|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
41961624|NCT03083665|75729700|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
41961625|NCT03083665|75729701|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
41961626|NCT03083665|75729702|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
41961627|NCT03083665|75729703|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
42210294|NCT03259308|76025066|FG001|Overall Study|Pregnancy|0|||
41961628|NCT03083665|75729704|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
41961629|NCT03083665|75729699|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
41961630|NCT03083665|75729700|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
41961631|NCT03083665|75729701|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
41961632|NCT03083665|75729702|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
41961633|NCT03083665|75729703|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
41961634|NCT03083665|75729704|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
41961635|NCT03083665|75729699|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
41961636|NCT03083665|75729700|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
41961637|NCT03083665|75729701|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
41961638|NCT03083665|75729702|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
41961639|NCT03083665|75729703|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
41961640|NCT03083665|75729704|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
41961641|NCT03083665|75729699|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
41961642|NCT03083665|75729700|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
41961643|NCT03083665|75729701|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
41961644|NCT03083665|75729702|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
41961645|NCT03083665|75729703|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
41961646|NCT03083665|75729704|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
41961647|NCT03083665|75729699|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
41961648|NCT03083665|75729700|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
41961649|NCT03083665|75729701|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
42010440|NCT00993499|75817613|FG002|Run-in Period (8 Days)|Adverse Event|0|||
42010441|NCT00993499|75817614|FG003|Run-in Period (8 Days)|Adverse Event|0|||
42010442|NCT00993499|75817615|FG004|Run-in Period (8 Days)|Adverse Event|0|||
42210295|NCT03259308|76025067|FG002|Overall Study|Pregnancy|1|||
42010443|NCT00993499|75817616|FG005|Run-in Period (8 Days)|Adverse Event|0|||
41961650|NCT03083665|75729702|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
41961651|NCT03083665|75729703|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
41961652|NCT03083665|75729704|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
41961653|NCT03083665|75729699|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
41961654|NCT03083665|75729700|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
41961655|NCT03083665|75729701|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
41961656|NCT03083665|75729702|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
41961657|NCT03083665|75729703|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
41961658|NCT03083665|75729704|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
41961659|NCT03045276|75729725|FG000|Intervention Phase|Withdrawal by Subject|7|||
41961660|NCT03045276|75729726|FG001|Intervention Phase|Withdrawal by Subject|2|||
41961661|NCT03045276|75729727|FG002|Intervention Phase|Withdrawal by Subject|3|||
41961662|NCT03045276|75729728|FG003|Intervention Phase|Withdrawal by Subject|7|||
41961663|NCT03045276|75729725|FG000|Intervention Phase|Developed exclusionary criteria|3|||
41961664|NCT03045276|75729726|FG001|Intervention Phase|Developed exclusionary criteria|3|||
41961665|NCT03045276|75729727|FG002|Intervention Phase|Developed exclusionary criteria|0|||
41961666|NCT03045276|75729728|FG003|Intervention Phase|Developed exclusionary criteria|0|||
41961667|NCT03045276|75729725|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
41961668|NCT03045276|75729726|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
41961669|NCT03045276|75729727|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
41961670|NCT03045276|75729728|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
41961671|NCT03045276|75729725|FG000|Follow-Up Phase|Lost to Follow-up|0|||
41961672|NCT03045276|75729726|FG001|Follow-Up Phase|Lost to Follow-up|1|||
41961673|NCT03045276|75729727|FG002|Follow-Up Phase|Lost to Follow-up|0|||
41961674|NCT03045276|75729728|FG003|Follow-Up Phase|Lost to Follow-up|1|||
41961675|NCT03045276|75729725|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
41961676|NCT03045276|75729726|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
41961677|NCT03045276|75729727|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
41961678|NCT03045276|75729728|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
41961679|NCT02819518|75729760|FG000|Overall Study|Death|9|||
41961680|NCT02819518|75729761|FG001|Overall Study|Death|11|||
41961681|NCT02819518|75729762|FG002|Overall Study|Death|9|||
41961682|NCT02819518|75729763|FG003|Overall Study|Death|447|||
41961683|NCT02819518|75729764|FG004|Overall Study|Death|233|||
41961684|NCT02819518|75729760|FG000|Overall Study|Withdrawal by Subject|0|||
41961685|NCT02819518|75729761|FG001|Overall Study|Withdrawal by Subject|0|||
41961686|NCT02819518|75729762|FG002|Overall Study|Withdrawal by Subject|0|||
41961687|NCT02819518|75729763|FG003|Overall Study|Withdrawal by Subject|21|||
41961688|NCT02819518|75729764|FG004|Overall Study|Withdrawal by Subject|6|||
41961689|NCT02819518|75729760|FG000|Overall Study|Ongoing in Study|2|||
41961690|NCT02819518|75729761|FG001|Overall Study|Ongoing in Study|3|||
41961691|NCT02819518|75729762|FG002|Overall Study|Ongoing in Study|1|||
41961692|NCT02819518|75729763|FG003|Overall Study|Ongoing in Study|98|||
41961693|NCT02819518|75729764|FG004|Overall Study|Ongoing in Study|42|||
41961694|NCT02661022|75729780|FG000|Overall Study|Withdrawal by Subject|3|||
41961695|NCT02661022|75729781|FG001|Overall Study|Withdrawal by Subject|0|||
41961696|NCT02661022|75729780|FG000|Overall Study|Adverse Event|1|||
41961697|NCT02661022|75729781|FG001|Overall Study|Adverse Event|1|||
41961698|NCT02661022|75729780|FG000|Overall Study|Physician Decision|1|||
41961699|NCT02661022|75729781|FG001|Overall Study|Physician Decision|0|||
41961700|NCT02661022|75729780|FG000|Overall Study|Progressive Disease|2|||
41961701|NCT02661022|75729781|FG001|Overall Study|Progressive Disease|1|||
41961702|NCT02475681|75729792|FG000|Overall Study|Death|16|||
41961703|NCT02475681|75729793|FG001|Overall Study|Death|6|||
41961704|NCT02475681|75729794|FG002|Overall Study|Death|9|||
41961705|NCT02475681|75729792|FG000|Overall Study|Physician Decision|0|||
41961706|NCT02475681|75729793|FG001|Overall Study|Physician Decision|3|||
41961707|NCT02475681|75729794|FG002|Overall Study|Physician Decision|1|||
41961708|NCT02475681|75729792|FG000|Overall Study|Withdrawal by Subject|12|||
42118114|NCT00502593|75928972|FG003|Overall Study|Withdrawn unspecified reason|1|||
42118115|NCT00502593|75928973|FG004|Overall Study|Withdrawn unspecified reason|2|||
42118116|NCT00502593|75928974|FG005|Overall Study|Withdrawn unspecified reason|0|||
41961709|NCT02475681|75729793|FG001|Overall Study|Withdrawal by Subject|6|||
41961710|NCT02475681|75729794|FG002|Overall Study|Withdrawal by Subject|9|||
41961711|NCT02475681|75729792|FG000|Overall Study|Lost to Follow-up|2|||
41961712|NCT02475681|75729793|FG001|Overall Study|Lost to Follow-up|1|||
41961713|NCT02475681|75729794|FG002|Overall Study|Lost to Follow-up|3|||
41961714|NCT02475681|75729792|FG000|Overall Study|Ongoing in Study|0|||
41961715|NCT02475681|75729793|FG001|Overall Study|Ongoing in Study|163|||
41961716|NCT02475681|75729794|FG002|Overall Study|Ongoing in Study|157|||
41961717|NCT02475681|75729792|FG000|Overall Study|Reasons other than above listed|2|||
41961718|NCT02475681|75729793|FG001|Overall Study|Reasons other than above listed|0|||
41961719|NCT02475681|75729794|FG002|Overall Study|Reasons other than above listed|0|||
41961720|NCT01901562|75729819|FG000|Overall Study|Protocol Violation|5|||
41961721|NCT01901562|75729819|FG000|Overall Study|Excluded intraoperatively|4|||
41961722|NCT00819247|75729826|FG000|Overall Study|Adverse Event|0|||
41961723|NCT00819247|75729827|FG001|Overall Study|Adverse Event|5|||
41961724|NCT00819247|75729828|FG002|Overall Study|Adverse Event|3|||
41961725|NCT00819247|75729826|FG000|Overall Study|Insufficient testosterone response|5|||
41961726|NCT00819247|75729827|FG001|Overall Study|Insufficient testosterone response|8|||
41961727|NCT00819247|75729828|FG002|Overall Study|Insufficient testosterone response|10|||
41961728|NCT00819247|75729826|FG000|Overall Study|Withdrawal by Subject|1|||
41961729|NCT00819247|75729827|FG001|Overall Study|Withdrawal by Subject|0|||
41961730|NCT00819247|75729828|FG002|Overall Study|Withdrawal by Subject|0|||
41961731|NCT00819247|75729826|FG000|Overall Study|Protocol Violation|1|||
41961732|NCT00819247|75729827|FG001|Overall Study|Protocol Violation|0|||
41961733|NCT00819247|75729828|FG002|Overall Study|Protocol Violation|1|||
41961734|NCT00819247|75729826|FG000|Overall Study|Mistakenly withdrawn|0|||
41961735|NCT00819247|75729827|FG001|Overall Study|Mistakenly withdrawn|1|||
41961736|NCT00819247|75729828|FG002|Overall Study|Mistakenly withdrawn|0|||
41961737|NCT00819247|75729826|FG000|Overall Study|Bad prostate-specific antigen response|3|||
41961738|NCT00819247|75729827|FG001|Overall Study|Bad prostate-specific antigen response|2|||
41961739|NCT00819247|75729828|FG002|Overall Study|Bad prostate-specific antigen response|0|||
41961740|NCT00819247|75729826|FG000|Overall Study|Other|1|||
41961741|NCT00819247|75729827|FG001|Overall Study|Other|0|||
41961742|NCT00819247|75729828|FG002|Overall Study|Other|0|||
41961743|NCT00716976|75729838|FG000|Overall Study|Adverse Event|2|||
41961744|NCT00716976|75729839|FG001|Overall Study|Adverse Event|0|||
41961745|NCT00716976|75729838|FG000|Overall Study|Death|1|||
41961746|NCT00716976|75729839|FG001|Overall Study|Death|0|||
41961747|NCT00716976|75729838|FG000|Overall Study|Physician Decision|2|||
41961748|NCT00716976|75729839|FG001|Overall Study|Physician Decision|2|||
41961749|NCT00716976|75729838|FG000|Overall Study|Withdrawal by Subject|5|||
41961750|NCT00716976|75729839|FG001|Overall Study|Withdrawal by Subject|1|||
41961751|NCT00716976|75729838|FG000|Overall Study|Premature discontinuation cisplatin|5|||
41961752|NCT00716976|75729839|FG001|Overall Study|Premature discontinuation cisplatin|4|||
41961753|NCT00716976|75729838|FG000|Overall Study|Radiation during protocol|1|||
41961754|NCT00716976|75729839|FG001|Overall Study|Radiation during protocol|0|||
41961755|NCT00716976|75729838|FG000|Overall Study|Ineligibles|4|||
41961756|NCT00716976|75729839|FG001|Overall Study|Ineligibles|2|||
41961757|NCT00089778|75729961|FG000|Overall Study|Protocol Violation|0|||
41961758|NCT00089778|75729962|FG001|Overall Study|Protocol Violation|0|||
41961759|NCT00089778|75729963|FG002|Overall Study|Protocol Violation|1|||
41961760|NCT00089544|75729975|FG000|Overall Study|Ineligible|1|||
41961761|NCT00089544|75729976|FG001|Overall Study|Ineligible|0|||
41961762|NCT00089076|75729982|FG000|Overall Study|Alternate Therapy|1|||
41961763|NCT00089076|75729982|FG000|Overall Study|Withdrawal by Subject|2|||
41961764|NCT00089076|75729982|FG000|Overall Study|Progression|7|||
41961765|NCT00088374|75729986|FG000|Overall Study|patient did not receive any 17AAG|1|||
41961766|NCT00088374|75729986|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
41961767|NCT00087594|75729992|FG000|Overall Study|Adverse Event|2|||
41961768|NCT00087594|75729993|FG001|Overall Study|Adverse Event|3|||
41961769|NCT00087594|75729992|FG000|Overall Study|Lost to Follow-up|0|||
41961770|NCT00087594|75729993|FG001|Overall Study|Lost to Follow-up|2|||
41961771|NCT00087594|75729992|FG000|Overall Study|Withdrawal by Subject|4|||
41961772|NCT00087594|75729993|FG001|Overall Study|Withdrawal by Subject|2|||
41961773|NCT00087594|75729992|FG000|Overall Study|Lack of Efficacy|2|||
41961774|NCT00087594|75729993|FG001|Overall Study|Lack of Efficacy|5|||
41961775|NCT00087516|75730002|FG000|Overall Study|Adverse Event|10|||
41961776|NCT00087516|75730003|FG001|Overall Study|Adverse Event|10|||
41961777|NCT00087516|75730004|FG002|Overall Study|Adverse Event|3|||
41961778|NCT00087516|75730005|FG003|Overall Study|Adverse Event|6|||
41961779|NCT00087516|75730002|FG000|Overall Study|Lack of Efficacy|82|||
41961780|NCT00087516|75730003|FG001|Overall Study|Lack of Efficacy|80|||
41961781|NCT00087516|75730004|FG002|Overall Study|Lack of Efficacy|39|||
41961782|NCT00087516|75730005|FG003|Overall Study|Lack of Efficacy|29|||
41961783|NCT00087516|75730002|FG000|Overall Study|Lost to Follow-up|8|||
41961784|NCT00087516|75730003|FG001|Overall Study|Lost to Follow-up|6|||
41961785|NCT00087516|75730004|FG002|Overall Study|Lost to Follow-up|5|||
41961786|NCT00087516|75730005|FG003|Overall Study|Lost to Follow-up|5|||
41961787|NCT00087516|75730002|FG000|Overall Study|Protocol Violation|4|||
41961788|NCT00087516|75730003|FG001|Overall Study|Protocol Violation|8|||
41961789|NCT00087516|75730004|FG002|Overall Study|Protocol Violation|3|||
41961790|NCT00087516|75730005|FG003|Overall Study|Protocol Violation|6|||
41961791|NCT00087516|75730002|FG000|Overall Study|Withdrawal by Subject|16|||
41961792|NCT00087516|75730003|FG001|Overall Study|Withdrawal by Subject|27|||
41961793|NCT00087516|75730004|FG002|Overall Study|Withdrawal by Subject|11|||
41961794|NCT00087516|75730005|FG003|Overall Study|Withdrawal by Subject|12|||
41961795|NCT00087516|75730002|FG000|Overall Study|Site terminated|0|||
41961796|NCT00087516|75730003|FG001|Overall Study|Site terminated|2|||
41961797|NCT00087516|75730004|FG002|Overall Study|Site terminated|1|||
41961798|NCT00087516|75730005|FG003|Overall Study|Site terminated|0|||
41961799|NCT00087516|75730002|FG000|Overall Study|Protocol specified discontinuation|35|||
41961800|NCT00087516|75730003|FG001|Overall Study|Protocol specified discontinuation|33|||
41961801|NCT00087516|75730004|FG002|Overall Study|Protocol specified discontinuation|33|||
41961802|NCT00087516|75730005|FG003|Overall Study|Protocol specified discontinuation|26|||
41961803|NCT00087516|75730002|FG000|Overall Study|Patient moved|3|||
41961804|NCT00087516|75730003|FG001|Overall Study|Patient moved|2|||
41961805|NCT00087516|75730004|FG002|Overall Study|Patient moved|1|||
41961806|NCT00087516|75730005|FG003|Overall Study|Patient moved|0|||
41961807|NCT00087516|75730002|FG000|Overall Study|Patient was non-compliant|3|||
41961808|NCT00087516|75730003|FG001|Overall Study|Patient was non-compliant|1|||
41961809|NCT00087516|75730004|FG002|Overall Study|Patient was non-compliant|0|||
41961810|NCT00087516|75730005|FG003|Overall Study|Patient was non-compliant|0|||
41961811|NCT00087516|75730002|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
41961812|NCT00087516|75730003|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
41961813|NCT00087516|75730004|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
41961814|NCT00087516|75730005|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
41961815|NCT00087516|75730002|FG000|Overall Study|Other|0|||
41961816|NCT00087516|75730003|FG001|Overall Study|Other|0|||
41961817|NCT00087516|75730004|FG002|Overall Study|Other|1|||
41961818|NCT00087516|75730005|FG003|Overall Study|Other|0|||
41961819|NCT00087126|75730019|FG000|Overall Study|Ineligible - second primary|1|||
41961820|NCT00087126|75730019|FG000|Overall Study|Never treated|1|||
41961821|NCT03490734|75730032|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
41961822|NCT03490734|75730033|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
41961823|NCT03490734|75730034|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
41961824|NCT03490734|75730035|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
41961825|NCT03490734|75730032|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
41961826|NCT03490734|75730033|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
41961827|NCT03490734|75730034|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
41961828|NCT03490734|75730035|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
41961829|NCT03490734|75730032|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
41961830|NCT03490734|75730033|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
41961831|NCT03490734|75730034|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
41961832|NCT03490734|75730035|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
41961833|NCT03490734|75730032|FG000|Post-intervention Scan Visit|Adverse Event|2|||
41961834|NCT03490734|75730033|FG001|Post-intervention Scan Visit|Adverse Event|0|||
41961835|NCT03490734|75730034|FG002|Post-intervention Scan Visit|Adverse Event|0|||
41961836|NCT03490734|75730035|FG003|Post-intervention Scan Visit|Adverse Event|0|||
41961837|NCT03490734|75730032|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
41961838|NCT03490734|75730033|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
41961839|NCT03490734|75730034|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
41961840|NCT03490734|75730035|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
41961841|NCT03490734|75730032|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
41961842|NCT03490734|75730033|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
41961843|NCT03490734|75730034|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
41961844|NCT03490734|75730035|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
41961845|NCT00086346|75730046|FG000|Randomization|Did not receive test article|4|||
41961846|NCT00086346|75730047|FG001|Randomization|Did not receive test article|4|||
41961847|NCT00086346|75730046|FG000|Patients Dosed With Test Article|Adverse Event|94|||
41961848|NCT00086346|75730047|FG001|Patients Dosed With Test Article|Adverse Event|11|||
41961849|NCT00086346|75730046|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
41961850|NCT00086346|75730047|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
41961851|NCT00086346|75730046|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
41961852|NCT00086346|75730047|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
41961853|NCT00086346|75730046|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
41961854|NCT00086346|75730047|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
41961855|NCT00086346|75730046|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
41961856|NCT00086346|75730047|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
41961857|NCT00086346|75730046|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
41961858|NCT00086346|75730047|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
41961859|NCT00085566|75730056|FG000|Overall Study|Adverse Event|0|||
41961860|NCT00085566|75730057|FG001|Overall Study|Adverse Event|0|||
41961861|NCT00085566|75730058|FG002|Overall Study|Adverse Event|10|||
41961862|NCT00085566|75730056|FG000|Overall Study|Patient Not treated|0|||
41961863|NCT00085566|75730057|FG001|Overall Study|Patient Not treated|0|||
42024683|NCT00933244|75832267|FG002|Overall Study|Withdrawal by Subject|3|||
41961864|NCT00085566|75730058|FG002|Overall Study|Patient Not treated|3|||
41961865|NCT00085566|75730056|FG000|Overall Study|Clinical progression|0|||
41961866|NCT00085566|75730057|FG001|Overall Study|Clinical progression|0|||
42024684|NCT00930046|75832277|FG000|Overall Study|Wound catheter malfunctioned|1|||
41961867|NCT00085566|75730058|FG002|Overall Study|Clinical progression|1|||
41961868|NCT00085098|75730068|FG000|Overall Study|Withdrawal by Subject|0|||
41961869|NCT00085098|75730069|FG001|Overall Study|Withdrawal by Subject|1|||
41961870|NCT00085098|75730068|FG000|Overall Study|Ineligible|1|||
41961871|NCT00085098|75730069|FG001|Overall Study|Ineligible|1|||
41961872|NCT00084864|75730082|FG000|Overall Study|Adverse Event|1|||
41961873|NCT00084864|75730083|FG001|Overall Study|Adverse Event|0|||
41961874|NCT00084864|75730084|FG002|Overall Study|Adverse Event|0|||
41961875|NCT00084864|75730085|FG003|Overall Study|Adverse Event|0|||
41961876|NCT00084318|75730097|FG000|Overall Study|Withdrawal by Subject|5|||
41961877|NCT00084318|75730098|FG001|Overall Study|Withdrawal by Subject|2|||
41961878|NCT00084318|75730097|FG000|Overall Study|Protocol Violation|15|||
41961879|NCT00084318|75730098|FG001|Overall Study|Protocol Violation|11|||
41961880|NCT00084318|75730097|FG000|Overall Study|No protocol treatment|2|||
41961881|NCT00084318|75730098|FG001|Overall Study|No protocol treatment|0|||
41961882|NCT00084084|75730106|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
41961883|NCT00084084|75730106|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
41961884|NCT00083616|75730111|FG000|Overall Study|Disease Progression|16|||
41961885|NCT00083616|75730111|FG000|Overall Study|Lost to Follow-up|1|||
41961886|NCT00083616|75730111|FG000|Overall Study|Physician Decision|2|||
41961887|NCT00083616|75730111|FG000|Overall Study|Withdrawal by Subject|3|||
41961888|NCT00083616|75730111|FG000|Overall Study|Ineligibility determined|2|||
41961889|NCT00083616|75730111|FG000|Overall Study|Non-compliance|1|||
41961890|NCT00083616|75730111|FG000|Overall Study|Other|6|||
41961891|NCT00083226|75730115|FG000|Overall Study|Lack of Efficacy|19|||
41961892|NCT00083226|75730115|FG000|Overall Study|Adverse Event|9|||
41961893|NCT00083226|75730115|FG000|Overall Study|Death|4|||
41961894|NCT00083226|75730115|FG000|Overall Study|Withdrawal by Subject|4|||
41961895|NCT00083226|75730115|FG000|Overall Study|Other|2|||
41961896|NCT00083226|75730115|FG000|Overall Study|ineligible or not receiving treatment|4|||
41961897|NCT00082758|75730122|FG000|Overall Study|Adverse Event|0|||
41961898|NCT00082758|75730123|FG001|Overall Study|Adverse Event|2|||
41961899|NCT00082758|75730124|FG002|Overall Study|Adverse Event|0|||
41961900|NCT00082758|75730122|FG000|Overall Study|Lack of Efficacy|12|||
41961901|NCT00082758|75730123|FG001|Overall Study|Lack of Efficacy|13|||
41961902|NCT00082758|75730124|FG002|Overall Study|Lack of Efficacy|0|||
41961903|NCT00082758|75730122|FG000|Overall Study|Physician Decision|0|||
41961904|NCT00082758|75730123|FG001|Overall Study|Physician Decision|1|||
41961905|NCT00082758|75730124|FG002|Overall Study|Physician Decision|0|||
41961906|NCT00082758|75730122|FG000|Overall Study|Withdrawal by Subject|3|||
41961907|NCT00082758|75730123|FG001|Overall Study|Withdrawal by Subject|0|||
41961908|NCT00082758|75730124|FG002|Overall Study|Withdrawal by Subject|0|||
41961909|NCT00082758|75730122|FG000|Overall Study|Protocol Violation|0|||
41961910|NCT00082758|75730123|FG001|Overall Study|Protocol Violation|1|||
41961911|NCT00082758|75730124|FG002|Overall Study|Protocol Violation|0|||
41961912|NCT00088452|75730135|FG000|Overall Study|Did not receive intervention|1|||
41961913|NCT00088452|75730136|FG001|Overall Study|Did not receive intervention|0|||
41961914|NCT00088452|75730137|FG002|Overall Study|Did not receive intervention|1|||
41961915|NCT03406104|75730165|FG000|Overall Study|Lost to Follow-up|2|||
41961916|NCT03406104|75730165|FG000|Overall Study|Withdrawal by Subject|2|||
41961917|NCT03406104|75730165|FG000|Overall Study|due to Covid patient did not want to travel|1|||
41961918|NCT03406104|75730165|FG000|Overall Study|Death|2|||
41961919|NCT04686084|75730234|FG000|Overall Study|Lost to Follow-up|1|||
41961920|NCT04685538|75730241|FG000|Overall Study|Adverse Event|0|||
41961921|NCT04685538|75730242|FG001|Overall Study|Adverse Event|1|||
41961922|NCT04685538|75730241|FG000|Overall Study|Lost to Follow-up|0|||
41961923|NCT04685538|75730242|FG001|Overall Study|Lost to Follow-up|2|||
41961924|NCT04213326|75730254|FG000|Overall Study|Consent withdrawn|51|||
41961925|NCT04213326|75730255|FG001|Overall Study|Consent withdrawn|241|||
41961926|NCT04213326|75730254|FG000|Overall Study|Lost to Follow-up|50|||
41961927|NCT04213326|75730255|FG001|Overall Study|Lost to Follow-up|902|||
41961928|NCT04213326|75730254|FG000|Overall Study|Protocol Violation|3|||
41961929|NCT04213326|75730255|FG001|Overall Study|Protocol Violation|25|||
41961930|NCT04213326|75730254|FG000|Overall Study|Participant eligibility changed|106|||
41961931|NCT04213326|75730255|FG001|Overall Study|Participant eligibility changed|19|||
41961932|NCT04213326|75730254|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
41961933|NCT04213326|75730255|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
42024685|NCT00930046|75832278|FG001|Overall Study|Wound catheter malfunctioned|2|||
41961934|NCT04213326|75730254|FG000|Overall Study|Incomplete study visit|0|||
41961935|NCT04213326|75730255|FG001|Overall Study|Incomplete study visit|367|||
41961936|NCT01625286|75730268|FG000|Overall Study|Adverse Event|0|||
41961937|NCT01625286|75730269|FG001|Overall Study|Adverse Event|0|||
41961938|NCT01625286|75730270|FG002|Overall Study|Adverse Event|0|||
41961939|NCT01625286|75730271|FG003|Overall Study|Adverse Event|0|||
41961940|NCT01625286|75730272|FG004|Overall Study|Adverse Event|1|||
41961941|NCT01625286|75730273|FG005|Overall Study|Adverse Event|2|||
41961942|NCT01625286|75730274|FG006|Overall Study|Adverse Event|1|||
41961943|NCT01625286|75730268|FG000|Overall Study|Death|0|||
41961944|NCT01625286|75730269|FG001|Overall Study|Death|0|||
41961945|NCT01625286|75730270|FG002|Overall Study|Death|1|||
41961946|NCT01625286|75730271|FG003|Overall Study|Death|1|||
41961947|NCT01625286|75730272|FG004|Overall Study|Death|0|||
41961948|NCT01625286|75730273|FG005|Overall Study|Death|11|||
41961949|NCT01625286|75730274|FG006|Overall Study|Death|16|||
41961950|NCT01625286|75730268|FG000|Overall Study|Withdrawal by Subject|0|||
41961951|NCT01625286|75730269|FG001|Overall Study|Withdrawal by Subject|1|||
41961952|NCT01625286|75730270|FG002|Overall Study|Withdrawal by Subject|0|||
41961953|NCT01625286|75730271|FG003|Overall Study|Withdrawal by Subject|1|||
41961954|NCT01625286|75730272|FG004|Overall Study|Withdrawal by Subject|0|||
41961955|NCT01625286|75730273|FG005|Overall Study|Withdrawal by Subject|0|||
41961956|NCT01625286|75730274|FG006|Overall Study|Withdrawal by Subject|1|||
41961957|NCT01625286|75730268|FG000|Overall Study|Any reason not specifically recorded|0|||
41961958|NCT01625286|75730269|FG001|Overall Study|Any reason not specifically recorded|0|||
41961959|NCT01625286|75730270|FG002|Overall Study|Any reason not specifically recorded|0|||
41961960|NCT01625286|75730271|FG003|Overall Study|Any reason not specifically recorded|0|||
41961961|NCT01625286|75730272|FG004|Overall Study|Any reason not specifically recorded|0|||
41961962|NCT01625286|75730273|FG005|Overall Study|Any reason not specifically recorded|1|||
41961963|NCT01625286|75730274|FG006|Overall Study|Any reason not specifically recorded|0|||
42024686|NCT00935584|75832286|FG000|Overall Study|Withdrawal by Subject|9|||
42024687|NCT00935584|75832287|FG001|Overall Study|Withdrawal by Subject|0|||
42024688|NCT00935584|75832286|FG000|Overall Study|Death|3|||
42024689|NCT00935584|75832287|FG001|Overall Study|Death|0|||
42024690|NCT00935584|75832286|FG000|Overall Study|Lost to Follow-up|8|||
42024691|NCT00935584|75832287|FG001|Overall Study|Lost to Follow-up|0|||
42024692|NCT00935584|75832286|FG000|Overall Study|No show|9|||
42024693|NCT00935584|75832287|FG001|Overall Study|No show|0|||
42024694|NCT00935584|75832286|FG000|Overall Study|Relocated|3|||
42024695|NCT00935584|75832287|FG001|Overall Study|Relocated|0|||
42024696|NCT00935584|75832286|FG000|Overall Study|Patient changed provider|3|||
42024697|NCT00935584|75832287|FG001|Overall Study|Patient changed provider|0|||
42024698|NCT00935584|75832286|FG000|Overall Study|Provider dropped out of study|14|||
42024699|NCT00935584|75832287|FG001|Overall Study|Provider dropped out of study|4|||
42024700|NCT01215851|75832297|FG000|Treatment Period|Adverse Event|1|||
42024701|NCT01215851|75832298|FG001|Treatment Period|Adverse Event|1|||
42024702|NCT01215851|75832299|FG002|Treatment Period|Adverse Event|1|||
42024703|NCT01215851|75832300|FG003|Treatment Period|Adverse Event|3|||
42024704|NCT01215851|75832301|FG004|Treatment Period|Adverse Event|0|||
42024705|NCT01215851|75832302|FG005|Treatment Period|Adverse Event|1|||
42024706|NCT01215851|75832297|FG000|Follow up Period|Lost to Follow-up|0|||
42024707|NCT01215851|75832298|FG001|Follow up Period|Lost to Follow-up|0|||
42024708|NCT01215851|75832299|FG002|Follow up Period|Lost to Follow-up|0|||
42024709|NCT01215851|75832300|FG003|Follow up Period|Lost to Follow-up|0|||
42024710|NCT01215851|75832301|FG004|Follow up Period|Lost to Follow-up|0|||
42024711|NCT01215851|75832302|FG005|Follow up Period|Lost to Follow-up|1|||
42024712|NCT00933166|75832317|FG000|Overall Study|Lost to Follow-up|4|||
42024713|NCT00933166|75832317|FG000|Overall Study|Lack of Efficacy|9|||
42024714|NCT00933166|75832317|FG000|Overall Study|Unavailable|4|||
42024715|NCT00933166|75832317|FG000|Overall Study|Withdrawal by Subject|1|||
42024716|NCT00935272|75832323|FG000|Overall Study|Lost to Follow-up|10|||
42024717|NCT00935272|75832324|FG001|Overall Study|Lost to Follow-up|3|||
42024718|NCT00935272|75832323|FG000|Overall Study|Withdrawal by Subject|8|||
42024719|NCT00935272|75832324|FG001|Overall Study|Withdrawal by Subject|2|||
42024720|NCT00935272|75832323|FG000|Overall Study|Physician Decision|1|||
42024721|NCT00935272|75832324|FG001|Overall Study|Physician Decision|0|||
42024722|NCT00935272|75832323|FG000|Overall Study|Protocol Violation|0|||
42024723|NCT00935272|75832324|FG001|Overall Study|Protocol Violation|1|||
42024724|NCT01010061|75832333|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
42024725|NCT01010061|75832334|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
42024726|NCT01010061|75832333|FG000|Overall Study|Disease Progression|2|||
42024727|NCT01010061|75832334|FG001|Overall Study|Disease Progression|8|||
42024728|NCT01010061|75832333|FG000|Overall Study|Withdrew Consent|5|||
42024729|NCT01010061|75832334|FG001|Overall Study|Withdrew Consent|1|||
41961964|NCT01625286|75730268|FG000|Overall Study|Progressive disease|6|||
41961965|NCT01625286|75730269|FG001|Overall Study|Progressive disease|3|||
42024730|NCT01010061|75832333|FG000|Overall Study|Death|3|||
42024731|NCT01010061|75832334|FG001|Overall Study|Death|6|||
41961966|NCT01625286|75730270|FG002|Overall Study|Progressive disease|4|||
42024732|NCT01010061|75832333|FG000|Overall Study|Administrative/Other|0|||
41961967|NCT01625286|75730271|FG003|Overall Study|Progressive disease|5|||
41961968|NCT01625286|75730272|FG004|Overall Study|Progressive disease|5|||
42024733|NCT01010061|75832334|FG001|Overall Study|Administrative/Other|1|||
41961969|NCT01625286|75730273|FG005|Overall Study|Progressive disease|0|||
41961970|NCT01625286|75730274|FG006|Overall Study|Progressive disease|0|||
42024734|NCT01010061|75832333|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
42024735|NCT01010061|75832334|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
42024736|NCT01010061|75832333|FG000|Overall Study|Insufficient Therapeutic Response|1|||
42024737|NCT01010061|75832334|FG001|Overall Study|Insufficient Therapeutic Response|5|||
41961971|NCT01625286|75730268|FG000|Overall Study|Lost to Follow-up|0|||
42300606|NCT02088541|76135788|FG002|Overall Study|Withdrawal by Subject|9|||
42300607|NCT02088541|76135789|FG003|Overall Study|Withdrawal by Subject|7|||
42300608|NCT02088541|76135790|FG004|Overall Study|Withdrawal by Subject|10|||
42300609|NCT02088541|76135786|FG000|Overall Study|Other|2|||
41961972|NCT01625286|75730269|FG001|Overall Study|Lost to Follow-up|0|||
41961973|NCT01625286|75730270|FG002|Overall Study|Lost to Follow-up|0|||
41961974|NCT01625286|75730271|FG003|Overall Study|Lost to Follow-up|0|||
41961975|NCT01625286|75730272|FG004|Overall Study|Lost to Follow-up|0|||
41961976|NCT01625286|75730273|FG005|Overall Study|Lost to Follow-up|0|||
41961977|NCT01625286|75730274|FG006|Overall Study|Lost to Follow-up|1|||
41961978|NCT04083222|75730319|FG000|Overall Study|Voluntary Withdrawal|0|||
41961979|NCT04083222|75730320|FG001|Overall Study|Voluntary Withdrawal|1|||
41961980|NCT04083222|75730319|FG000|Overall Study|Reason not Specified|0|||
41961981|NCT04083222|75730320|FG001|Overall Study|Reason not Specified|1|||
41961982|NCT03286842|75730326|FG000|Overall Study|Patients rolled over to another study|80|||
41961983|NCT03037476|75730334|FG000|Overall Study|Lost to Follow-up|63|||
41961984|NCT03037476|75730335|FG001|Overall Study|Lost to Follow-up|46|||
41961985|NCT00639678|75730350|FG000|Overall Study|Withdrawal by Subject|3|||
41961986|NCT00639678|75730351|FG001|Overall Study|Withdrawal by Subject|0|||
41961987|NCT00639678|75730352|FG002|Overall Study|Withdrawal by Subject|4|||
41961988|NCT00639678|75730353|FG003|Overall Study|Withdrawal by Subject|0|||
41961989|NCT00639678|75730350|FG000|Overall Study|Lost to Follow-up|1|||
41961990|NCT00639678|75730351|FG001|Overall Study|Lost to Follow-up|0|||
41961991|NCT00639678|75730352|FG002|Overall Study|Lost to Follow-up|6|||
41961992|NCT00639678|75730353|FG003|Overall Study|Lost to Follow-up|0|||
41961993|NCT00639678|75730350|FG000|Overall Study|Adverse Event|0|||
41961994|NCT00639678|75730351|FG001|Overall Study|Adverse Event|1|||
41961995|NCT00639678|75730352|FG002|Overall Study|Adverse Event|0|||
41961996|NCT00639678|75730353|FG003|Overall Study|Adverse Event|0|||
41961997|NCT00639678|75730350|FG000|Overall Study|Lack of Compliance|0|||
42024738|NCT01010061|75832333|FG000|Overall Study|Violation of Selection Criteria|0|||
42024739|NCT01010061|75832334|FG001|Overall Study|Violation of Selection Criteria|1|||
42024740|NCT01010061|75832333|FG000|Overall Study|Did Not Receive Treatment|2|||
42024741|NCT01010061|75832334|FG001|Overall Study|Did Not Receive Treatment|2|||
42024742|NCT00929734|75832354|FG000|Overall Study|Lost to Follow-up|2|||
42024743|NCT00929734|75832355|FG001|Overall Study|Lost to Follow-up|1|||
42024744|NCT00929734|75832354|FG000|Overall Study|Withdrawal by Subject|0|||
42024745|NCT00929734|75832355|FG001|Overall Study|Withdrawal by Subject|2|||
42024746|NCT01013883|75832363|FG000|Overall Study|Lost to Follow-up|2|||
42024747|NCT01013883|75832364|FG001|Overall Study|Lost to Follow-up|2|||
42024748|NCT01009983|75832370|FG000|Overall Study|necessary scans not completed|1|||
42024749|NCT01215227|75832384|FG000|Overall Study|Adverse Event|11|||
42024750|NCT01215227|75832385|FG001|Overall Study|Adverse Event|11|||
42024751|NCT01215227|75832386|FG002|Overall Study|Adverse Event|4|||
42024752|NCT01215227|75832387|FG003|Overall Study|Adverse Event|8|||
42024753|NCT01215227|75832388|FG004|Overall Study|Adverse Event|7|||
42024754|NCT01215227|75832389|FG005|Overall Study|Adverse Event|6|||
42024755|NCT01215227|75832384|FG000|Overall Study|Treatment Failure|8|||
42024756|NCT01215227|75832385|FG001|Overall Study|Treatment Failure|4|||
42024757|NCT01215227|75832386|FG002|Overall Study|Treatment Failure|1|||
42024758|NCT01215227|75832387|FG003|Overall Study|Treatment Failure|5|||
42024759|NCT01215227|75832388|FG004|Overall Study|Treatment Failure|1|||
42024760|NCT01215227|75832389|FG005|Overall Study|Treatment Failure|1|||
42024761|NCT01215227|75832384|FG000|Overall Study|Lost to Follow-up|1|||
42024762|NCT01215227|75832385|FG001|Overall Study|Lost to Follow-up|4|||
42024763|NCT01215227|75832386|FG002|Overall Study|Lost to Follow-up|1|||
42024764|NCT01215227|75832387|FG003|Overall Study|Lost to Follow-up|1|||
42024765|NCT01215227|75832388|FG004|Overall Study|Lost to Follow-up|1|||
42024766|NCT01215227|75832389|FG005|Overall Study|Lost to Follow-up|2|||
42024767|NCT01215227|75832384|FG000|Overall Study|Subject Withdrew Consent|16|||
42024768|NCT01215227|75832385|FG001|Overall Study|Subject Withdrew Consent|20|||
42024769|NCT01215227|75832386|FG002|Overall Study|Subject Withdrew Consent|7|||
42024770|NCT01215227|75832387|FG003|Overall Study|Subject Withdrew Consent|10|||
41961998|NCT00639678|75730351|FG001|Overall Study|Lack of Compliance|0|||
42024771|NCT01215227|75832388|FG004|Overall Study|Subject Withdrew Consent|11|||
42024772|NCT01215227|75832389|FG005|Overall Study|Subject Withdrew Consent|8|||
42024773|NCT01215227|75832384|FG000|Overall Study|Non-Compliance With Protocol|2|||
41961999|NCT00639678|75730352|FG002|Overall Study|Lack of Compliance|1|||
41962000|NCT00639678|75730353|FG003|Overall Study|Lack of Compliance|0|||
41962001|NCT00638508|75730378|FG000|Overall Study|Physician Decision|5|||
41962002|NCT00638508|75730379|FG001|Overall Study|Physician Decision|2|||
41962003|NCT00637806|75730392|FG000|Double-blind Phase|Study Discontinued|2|||
42024774|NCT01215227|75832385|FG001|Overall Study|Non-Compliance With Protocol|6|||
42024775|NCT01215227|75832386|FG002|Overall Study|Non-Compliance With Protocol|1|||
42210296|NCT03259308|76025065|FG000|Overall Study|Protocol Deviation|0|||
42210297|NCT03259308|76025066|FG001|Overall Study|Protocol Deviation|3|||
42210298|NCT03259308|76025067|FG002|Overall Study|Protocol Deviation|0|||
41962004|NCT00637806|75730393|FG001|Double-blind Phase|Study Discontinued|0|||
41962005|NCT00637806|75730394|FG002|Double-blind Phase|Study Discontinued|1|||
41962006|NCT00637806|75730395|FG003|Double-blind Phase|Study Discontinued|0|||
41962007|NCT00637806|75730392|FG000|Extension Phase|Study Discontinued|0|||
41962008|NCT00637806|75730393|FG001|Extension Phase|Study Discontinued|0|||
41962009|NCT00637806|75730394|FG002|Extension Phase|Study Discontinued|0|||
41962010|NCT00637806|75730395|FG003|Extension Phase|Study Discontinued|1|||
41962011|NCT00637728|75730406|FG000|Double-blind Phase|Adverse Event|1|||
41962012|NCT00637728|75730407|FG001|Double-blind Phase|Adverse Event|0|||
41962013|NCT00637728|75730408|FG002|Double-blind Phase|Adverse Event|0|||
41962014|NCT00637728|75730406|FG000|Double-blind Phase|Non-compliance|2|||
41962015|NCT00637728|75730407|FG001|Double-blind Phase|Non-compliance|0|||
41962016|NCT00637728|75730408|FG002|Double-blind Phase|Non-compliance|0|||
41962017|NCT00637728|75730406|FG000|Double-blind Phase|Study Discontinued|1|||
41962018|NCT00637728|75730407|FG001|Double-blind Phase|Study Discontinued|1|||
41962019|NCT00637728|75730408|FG002|Double-blind Phase|Study Discontinued|0|||
41962020|NCT00637572|75730417|FG000|Overall Study|Adverse Event|1|||
41962021|NCT00637572|75730418|FG001|Overall Study|Adverse Event|2|||
41962022|NCT00637572|75730417|FG000|Overall Study|Death|0|||
41962023|NCT00637572|75730418|FG001|Overall Study|Death|1|||
41962024|NCT00637572|75730417|FG000|Overall Study|Lost to Follow-up|0|||
41962025|NCT00637572|75730418|FG001|Overall Study|Lost to Follow-up|1|||
41962026|NCT00637572|75730417|FG000|Overall Study|Physician Decision|1|||
41962027|NCT00637572|75730418|FG001|Overall Study|Physician Decision|1|||
41962028|NCT00637572|75730417|FG000|Overall Study|Withdrawal by Subject|0|||
41962029|NCT00637572|75730418|FG001|Overall Study|Withdrawal by Subject|2|||
41962030|NCT00637572|75730417|FG000|Overall Study|Illicit Drug Use|1|||
41962031|NCT00637572|75730418|FG001|Overall Study|Illicit Drug Use|0|||
41962032|NCT00637416|75730426|FG000|Overall Study|Lost to Follow-up|1|||
41962033|NCT00637416|75730427|FG001|Overall Study|Lost to Follow-up|1|||
41962034|NCT00637416|75730426|FG000|Overall Study|Unable to take study drug|0|||
41962035|NCT00637416|75730427|FG001|Overall Study|Unable to take study drug|1|||
41962036|NCT00636792|75730433|FG000|Overall Study|Adverse Event|16|||
41962037|NCT00636792|75730433|FG000|Overall Study|Physician Decision|7|||
41962038|NCT00636792|75730433|FG000|Overall Study|Progressive Disease|4|||
41962039|NCT00636792|75730433|FG000|Overall Study|Withdrawal by Subject|3|||
41962040|NCT00636792|75730433|FG000|Overall Study|Other|3|||
41962041|NCT00636636|75730465|FG000|Overall Study|Other reason|4|||
41962042|NCT00636636|75730466|FG001|Overall Study|Other reason|6|||
41962043|NCT00636636|75730465|FG000|Overall Study|Adverse Event|19|||
41962044|NCT00636636|75730466|FG001|Overall Study|Adverse Event|8|||
41962045|NCT00636636|75730465|FG000|Overall Study|Lack of Efficacy|7|||
41962046|NCT00636636|75730466|FG001|Overall Study|Lack of Efficacy|12|||
41962047|NCT00636636|75730465|FG000|Overall Study|Protocol Violation|2|||
41962048|NCT00636636|75730466|FG001|Overall Study|Protocol Violation|2|||
41962049|NCT00636636|75730465|FG000|Overall Study|Lost to Follow-up|0|||
41962050|NCT00636636|75730466|FG001|Overall Study|Lost to Follow-up|1|||
41962051|NCT00636636|75730465|FG000|Overall Study|Death|0|||
41962052|NCT00636636|75730466|FG001|Overall Study|Death|1|||
41962053|NCT00636636|75730465|FG000|Overall Study|Withdrawal by Subject|4|||
42024776|NCT01215227|75832387|FG003|Overall Study|Non-Compliance With Protocol|0|||
42024777|NCT01215227|75832388|FG004|Overall Study|Non-Compliance With Protocol|0|||
41962054|NCT00636636|75730466|FG001|Overall Study|Withdrawal by Subject|9|||
41962055|NCT00635778|75730479|FG000|Overall Study|Adverse Event|1|||
41962056|NCT00635778|75730480|FG001|Overall Study|Adverse Event|0|||
41962057|NCT00635778|75730481|FG002|Overall Study|Adverse Event|0|||
41962058|NCT00635778|75730482|FG003|Overall Study|Adverse Event|3|||
41962059|NCT00635778|75730483|FG004|Overall Study|Adverse Event|3|||
41962060|NCT00635778|75730484|FG005|Overall Study|Adverse Event|6|||
41962061|NCT00635778|75730485|FG006|Overall Study|Adverse Event|1|||
41962062|NCT00635778|75730479|FG000|Overall Study|Withdrawal by Subject|0|||
42210299|NCT03259308|76025065|FG000|Overall Study|Lack of Efficacy|0|||
41962063|NCT00635778|75730480|FG001|Overall Study|Withdrawal by Subject|0|||
41962064|NCT00635778|75730481|FG002|Overall Study|Withdrawal by Subject|0|||
41962065|NCT00635778|75730482|FG003|Overall Study|Withdrawal by Subject|1|||
41962066|NCT00635778|75730483|FG004|Overall Study|Withdrawal by Subject|0|||
41962067|NCT00635778|75730484|FG005|Overall Study|Withdrawal by Subject|1|||
41962068|NCT00635778|75730485|FG006|Overall Study|Withdrawal by Subject|1|||
41962069|NCT00635778|75730479|FG000|Overall Study|Progressive disease|0|||
41962070|NCT00635778|75730480|FG001|Overall Study|Progressive disease|3|||
41962071|NCT00635778|75730481|FG002|Overall Study|Progressive disease|3|||
41962072|NCT00635778|75730482|FG003|Overall Study|Progressive disease|4|||
41962073|NCT00635778|75730483|FG004|Overall Study|Progressive disease|5|||
41962074|NCT00635778|75730484|FG005|Overall Study|Progressive disease|14|||
41962075|NCT00635778|75730485|FG006|Overall Study|Progressive disease|4|||
41962076|NCT00634920|75730505|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
41962077|NCT00634920|75730506|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
41962078|NCT00634920|75730507|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
41962079|NCT00634920|75730505|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
41962080|NCT00634920|75730506|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
41962081|NCT00634920|75730507|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
41962082|NCT00634920|75730505|FG000|Period 1 - Pre-Randomization|Rejections|0|||
41962083|NCT00634920|75730506|FG001|Period 1 - Pre-Randomization|Rejections|0|||
41962084|NCT00634920|75730507|FG002|Period 1 - Pre-Randomization|Rejections|55|||
41962085|NCT00634920|75730505|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
41962086|NCT00634920|75730506|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
41962087|NCT00634920|75730507|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
41962088|NCT00634920|75730505|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
41962089|NCT00634920|75730506|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
41962090|NCT00634920|75730507|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
41962091|NCT00634920|75730505|FG000|Period 1 - Pre-Randomization|Other issues|0|||
41962092|NCT00634920|75730506|FG001|Period 1 - Pre-Randomization|Other issues|0|||
41962093|NCT00634920|75730507|FG002|Period 1 - Pre-Randomization|Other issues|6|||
41962094|NCT00634920|75730505|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
41962095|NCT00634920|75730506|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
41962096|NCT00634920|75730507|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
41962097|NCT00634920|75730505|FG000|Period 2 - Post-Randomization|Rejection|11|||
41962098|NCT00634920|75730506|FG001|Period 2 - Post-Randomization|Rejection|5|||
41962099|NCT00634920|75730507|FG002|Period 2 - Post-Randomization|Rejection|0|||
41962100|NCT00634920|75730505|FG000|Period 2 - Post-Randomization|Death|2|||
41962101|NCT00634920|75730506|FG001|Period 2 - Post-Randomization|Death|5|||
41962102|NCT00634920|75730507|FG002|Period 2 - Post-Randomization|Death|0|||
41962103|NCT00634920|75730505|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
41962104|NCT00634920|75730506|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
41962105|NCT00634920|75730507|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
41962106|NCT00634920|75730505|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
41962107|NCT00634920|75730506|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
41962108|NCT00634920|75730507|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
41962109|NCT00634842|75730515|FG000|Overall Study|Adverse Event|2|||
41962110|NCT00634842|75730516|FG001|Overall Study|Adverse Event|3|||
41962111|NCT00634842|75730515|FG000|Overall Study|Protocol Violation|8|||
41962112|NCT00634842|75730516|FG001|Overall Study|Protocol Violation|4|||
41962113|NCT00634842|75730515|FG000|Overall Study|Move to another state|1|||
41962114|NCT00634842|75730516|FG001|Overall Study|Move to another state|0|||
41962115|NCT00634842|75730515|FG000|Overall Study|Inclusion criteria were not met|1|||
41962116|NCT00634842|75730516|FG001|Overall Study|Inclusion criteria were not met|0|||
41962117|NCT00634842|75730515|FG000|Overall Study|Lost to Follow-up|1|||
41962118|NCT00634842|75730516|FG001|Overall Study|Lost to Follow-up|2|||
41962119|NCT00634842|75730515|FG000|Overall Study|Physician Decision|1|||
42024778|NCT01215227|75832389|FG005|Overall Study|Non-Compliance With Protocol|0|||
42024779|NCT01215227|75832384|FG000|Overall Study|Administrative|83|||
41962120|NCT00634842|75730516|FG001|Overall Study|Physician Decision|0|||
42024780|NCT01215227|75832385|FG001|Overall Study|Administrative|73|||
41962121|NCT00634842|75730515|FG000|Overall Study|Withdrawal by Subject|1|||
41962122|NCT00634842|75730516|FG001|Overall Study|Withdrawal by Subject|3|||
41962123|NCT00634842|75730515|FG000|Overall Study|Lack of time and intolerance to drug|0|||
41962124|NCT00634842|75730516|FG001|Overall Study|Lack of time and intolerance to drug|1|||
41962125|NCT00634842|75730515|FG000|Overall Study|Discontinued due to injection|0|||
42024781|NCT01215227|75832386|FG002|Overall Study|Administrative|42|||
41962126|NCT00634842|75730516|FG001|Overall Study|Discontinued due to injection|2|||
41962127|NCT00634842|75730515|FG000|Overall Study|No need of study drug to treat diabetes|0|||
41962128|NCT00634842|75730516|FG001|Overall Study|No need of study drug to treat diabetes|1|||
41962129|NCT00634842|75730515|FG000|Overall Study|No wish to keep taking Avandia|0|||
41962130|NCT00634842|75730516|FG001|Overall Study|No wish to keep taking Avandia|1|||
41962131|NCT00634842|75730515|FG000|Overall Study|Subject off study drug for too long|0|||
41962132|NCT00634842|75730516|FG001|Overall Study|Subject off study drug for too long|1|||
41962133|NCT00633984|75730524|FG000|Overall Study|Lost to Follow-up|0|||
41962134|NCT00633984|75730525|FG001|Overall Study|Lost to Follow-up|6|||
41962135|NCT00633984|75730524|FG000|Overall Study|Withdrawal by Subject|8|||
41962136|NCT00633984|75730525|FG001|Overall Study|Withdrawal by Subject|7|||
41962137|NCT00633984|75730524|FG000|Overall Study|Hospitalized|1|||
41962138|NCT00633984|75730525|FG001|Overall Study|Hospitalized|0|||
41962139|NCT01921218|75730553|FG000|Overall Study|Death|2|||
41962140|NCT01921218|75730554|FG001|Overall Study|Death|1|||
41962141|NCT01921218|75730553|FG000|Overall Study|Withdrawal by Subject|0|||
41962142|NCT01921218|75730554|FG001|Overall Study|Withdrawal by Subject|2|||
41962143|NCT01921218|75730553|FG000|Overall Study|Kidney transplant|1|||
41962144|NCT01921218|75730554|FG001|Overall Study|Kidney transplant|1|||
41962145|NCT00633750|75730560|FG000|Overall Study|Adverse Event|2|||
41962146|NCT00633750|75730560|FG000|Overall Study|Withdrawal by Subject|3|||
41962147|NCT00633360|75730568|FG000|Overall Study|Lost to Follow-up|1|||
41962148|NCT00633360|75730569|FG001|Overall Study|Lost to Follow-up|1|||
41962149|NCT00633360|75730568|FG000|Overall Study|Adverse Event|3|||
41962150|NCT00633360|75730569|FG001|Overall Study|Adverse Event|1|||
41962151|NCT00633360|75730568|FG000|Overall Study|Protocol Violation|0|||
41962152|NCT00633360|75730569|FG001|Overall Study|Protocol Violation|1|||
42010444|NCT00993499|75817611|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
42010445|NCT00993499|75817612|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
42010446|NCT00993499|75817613|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
42010447|NCT00993499|75817614|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
42010448|NCT00993499|75817615|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
42010449|NCT00993499|75817616|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
42010450|NCT00993499|75817611|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
42010451|NCT00993499|75817612|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
42010452|NCT00993499|75817613|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
42010453|NCT00993499|75817614|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
42010454|NCT00993499|75817615|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
42010455|NCT00993499|75817616|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
42010456|NCT00993499|75817611|FG000|Run-in Period (8 Days)|Progressive disease|0|||
42010457|NCT00993499|75817612|FG001|Run-in Period (8 Days)|Progressive disease|1|||
42010458|NCT00993499|75817613|FG002|Run-in Period (8 Days)|Progressive disease|1|||
42010459|NCT00993499|75817614|FG003|Run-in Period (8 Days)|Progressive disease|0|||
42010460|NCT00993499|75817615|FG004|Run-in Period (8 Days)|Progressive disease|0|||
42010461|NCT00993499|75817616|FG005|Run-in Period (8 Days)|Progressive disease|0|||
42010462|NCT00993499|75817611|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
42010463|NCT00993499|75817612|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
42010464|NCT00993499|75817613|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
42010465|NCT00993499|75817614|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
42010466|NCT00993499|75817615|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
42010467|NCT00993499|75817616|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
42010468|NCT00993499|75817611|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
42010469|NCT00993499|75817612|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
42024782|NCT01215227|75832387|FG003|Overall Study|Administrative|24|||
42024783|NCT01215227|75832388|FG004|Overall Study|Administrative|28|||
42024784|NCT01215227|75832389|FG005|Overall Study|Administrative|40|||
42024785|NCT01215227|75832384|FG000|Overall Study|Missing Status|0|||
42024786|NCT01215227|75832385|FG001|Overall Study|Missing Status|1|||
42024787|NCT01215227|75832386|FG002|Overall Study|Missing Status|0|||
42024788|NCT01215227|75832387|FG003|Overall Study|Missing Status|0|||
42024789|NCT01215227|75832388|FG004|Overall Study|Missing Status|0|||
42024790|NCT01215227|75832389|FG005|Overall Study|Missing Status|0|||
42024791|NCT01215227|75832384|FG000|Overall Study|Randomized but not treated|0|||
42024792|NCT01215227|75832385|FG001|Overall Study|Randomized but not treated|0|||
42024793|NCT01215227|75832386|FG002|Overall Study|Randomized but not treated|1|||
42024794|NCT01215227|75832387|FG003|Overall Study|Randomized but not treated|1|||
42024795|NCT01215227|75832388|FG004|Overall Study|Randomized but not treated|0|||
42024796|NCT01215227|75832389|FG005|Overall Study|Randomized but not treated|1|||
42010470|NCT00993499|75817613|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
42024797|NCT01009515|75832403|FG000|Overall Study|Withdrawal by Subject|3|||
42024798|NCT01214915|75832407|FG000|Overall Study|Adverse Event|8|||
42024799|NCT01214915|75832407|FG000|Overall Study|Lack of Efficacy|3|||
42210300|NCT03259308|76025066|FG001|Overall Study|Lack of Efficacy|0|||
42024800|NCT01009281|75832411|FG000|Overall Study|Administrative problems|7|||
41962153|NCT00633126|75730577|FG000|Overall Study|Did not receive full dose|1|||
41962154|NCT00989664|75730581|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
41962155|NCT00989664|75730581|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
41962156|NCT00989664|75730581|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
41962157|NCT00989664|75730581|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
41962158|NCT00989664|75730581|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
41962159|NCT00989664|75730581|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
41962160|NCT00989664|75730581|FG000|Long-Term Follow-Up|Death|3|||
41962161|NCT00632736|75730587|FG000|Overall Study|Adverse Event|104|||
41962162|NCT00632736|75730587|FG000|Overall Study|Lost to Follow-up|15|||
41962163|NCT00632736|75730587|FG000|Overall Study|Protocol Violation|14|||
41962164|NCT00632736|75730587|FG000|Overall Study|Withdrawal by Subject|99|||
41962165|NCT00632736|75730587|FG000|Overall Study|Lack of Efficacy|5|||
41962166|NCT00632736|75730587|FG000|Overall Study|Sponsor terminated study|5|||
41962167|NCT00632736|75730587|FG000|Overall Study|Non-compliance|10|||
41962168|NCT00632736|75730587|FG000|Overall Study|Other|16|||
41962169|NCT00989196|75730591|FG000|Treatment Period|Lost to Follow-up|1|||
41962170|NCT00989196|75730592|FG001|Treatment Period|Lost to Follow-up|0|||
41962171|NCT00632502|75730600|FG000|Overall Study|Adverse Event|0|||
41962172|NCT00632502|75730601|FG001|Overall Study|Adverse Event|1|||
41962173|NCT00632502|75730600|FG000|Overall Study|Randomized not treated|3|||
41962174|NCT00632502|75730601|FG001|Overall Study|Randomized not treated|0|||
41962175|NCT00632424|75730611|FG000|Overall Study|Disease Progression|17|||
41962176|NCT00632424|75730611|FG000|Overall Study|Study Drug Toxicity|1|||
41962177|NCT00631488|75730628|FG000|Overall Study|Adverse Event|1|||
41962178|NCT00631488|75730629|FG001|Overall Study|Adverse Event|0|||
41962179|NCT00631488|75730630|FG002|Overall Study|Adverse Event|0|||
41962180|NCT00631488|75730628|FG000|Overall Study|Lost to Follow-up|2|||
41962181|NCT00631488|75730629|FG001|Overall Study|Lost to Follow-up|2|||
41962182|NCT00631488|75730630|FG002|Overall Study|Lost to Follow-up|0|||
41962183|NCT00631488|75730628|FG000|Overall Study|Physician Decision|1|||
41962184|NCT00631488|75730629|FG001|Overall Study|Physician Decision|0|||
41962185|NCT00631488|75730630|FG002|Overall Study|Physician Decision|1|||
41962186|NCT00631488|75730628|FG000|Overall Study|Protocol Violation|0|||
41962187|NCT00631488|75730629|FG001|Overall Study|Protocol Violation|0|||
41962188|NCT00631488|75730630|FG002|Overall Study|Protocol Violation|1|||
41962189|NCT00988884|75730640|FG000|Overall Study|Adverse Event|0|||
41962190|NCT00988884|75730641|FG001|Overall Study|Adverse Event|1|||
41962191|NCT00988884|75730640|FG000|Overall Study|Lost to Follow-up|20|||
41962192|NCT00988884|75730641|FG001|Overall Study|Lost to Follow-up|16|||
41962193|NCT00988884|75730640|FG000|Overall Study|Protocol Violation|0|||
41962194|NCT00988884|75730641|FG001|Overall Study|Protocol Violation|1|||
41962195|NCT00988884|75730640|FG000|Overall Study|Withdrawal by Subject|15|||
41962196|NCT00988884|75730641|FG001|Overall Study|Withdrawal by Subject|18|||
41962197|NCT00631020|75730647|FG000|Overall Study|Lost to Follow-up|7|||
41962198|NCT00631020|75730647|FG000|Overall Study|Incarcerated|1|||
41962199|NCT00987402|75730653|FG000|Overall Study|Insufficient data entry|86|||
41962200|NCT00987402|75730654|FG001|Overall Study|Insufficient data entry|98|||
41962201|NCT00630864|75730660|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
41962202|NCT00630864|75730660|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
41962203|NCT00630786|75730667|FG000|Overall Study|Physician Decision|0|||
41962204|NCT00630786|75730668|FG001|Overall Study|Physician Decision|0|||
41962205|NCT00630786|75730669|FG002|Overall Study|Physician Decision|1|||
41962206|NCT00630786|75730667|FG000|Overall Study|Withdrawal by Subject|0|||
42024801|NCT01009203|75832415|FG000|Overall Study|Withdrawal by Subject|1|||
42024802|NCT01009203|75832415|FG000|Overall Study|Adverse Event|5|||
42024803|NCT01009203|75832415|FG000|Overall Study|Treatment-unrelated death|1|||
42024804|NCT01009047|75832421|FG000|Overall Study|Adverse Event|5|||
42024805|NCT01009047|75832422|FG001|Overall Study|Adverse Event|0|||
42024806|NCT01009047|75832421|FG000|Overall Study|Lost to Follow-up|0|||
42300610|NCT02088541|76135787|FG001|Overall Study|Other|1|||
42300611|NCT02088541|76135788|FG002|Overall Study|Other|3|||
42024807|NCT01009047|75832422|FG001|Overall Study|Lost to Follow-up|2|||
42024808|NCT01009047|75832421|FG000|Overall Study|Lack of Efficacy|4|||
42300612|NCT02088541|76135789|FG003|Overall Study|Other|1|||
41962207|NCT00630786|75730668|FG001|Overall Study|Withdrawal by Subject|1|||
41962208|NCT00630786|75730669|FG002|Overall Study|Withdrawal by Subject|1|||
41962209|NCT00630786|75730667|FG000|Overall Study|Lost to Follow-up|0|||
41962210|NCT00630786|75730668|FG001|Overall Study|Lost to Follow-up|1|||
41962211|NCT00630786|75730669|FG002|Overall Study|Lost to Follow-up|0|||
41962212|NCT00630786|75730667|FG000|Overall Study|Other|1|||
41962213|NCT00630786|75730668|FG001|Overall Study|Other|0|||
41962214|NCT00630786|75730669|FG002|Overall Study|Other|0|||
41962215|NCT00630396|75730675|FG000|Overall Study|Death|4|||
41962216|NCT00630396|75730675|FG000|Overall Study|Lost to Follow-up|3|||
41962217|NCT00985686|75730683|FG000|Overall Study|Lost to Follow-up|1|||
42024809|NCT01009047|75832422|FG001|Overall Study|Lack of Efficacy|11|||
42024810|NCT01009047|75832421|FG000|Overall Study|Withdrawal by consent|16|||
42118117|NCT00502593|75928975|FG006|Overall Study|Withdrawn unspecified reason|2|||
42118118|NCT00502593|75928976|FG007|Overall Study|Withdrawn unspecified reason|0|||
41962218|NCT00985686|75730684|FG001|Overall Study|Lost to Follow-up|1|||
41962219|NCT00985686|75730685|FG002|Overall Study|Lost to Follow-up|0|||
41962220|NCT00985686|75730686|FG003|Overall Study|Lost to Follow-up|2|||
41962221|NCT03098394|75730696|FG000|Overall Study|Pregnancy|0|||
41962222|NCT03098394|75730697|FG001|Overall Study|Pregnancy|1|||
41962223|NCT00984594|75730708|FG000|Overall Study|Lost to Follow-up|1|||
41962224|NCT00984594|75730709|FG001|Overall Study|Lost to Follow-up|0|||
41962225|NCT00984594|75730708|FG000|Overall Study|Withdrawal by Subject|0|||
41962226|NCT00984594|75730709|FG001|Overall Study|Withdrawal by Subject|1|||
41962227|NCT00984204|75730717|FG000|Overall Study|Death|1|||
41962228|NCT00984204|75730717|FG000|Overall Study|Lost to Follow-up|4|||
41962229|NCT00984204|75730717|FG000|Overall Study|Lack of Efficacy|10|||
41962230|NCT00983892|75730723|FG000|Overall Study|Withdrawal by Subject|10|||
41962231|NCT00983892|75730724|FG001|Overall Study|Withdrawal by Subject|12|||
41962232|NCT00983580|75730732|FG000|Overall Study|Cancel Prior to treatment|1|||
41962233|NCT00983580|75730733|FG001|Overall Study|Cancel Prior to treatment|3|||
41962234|NCT00983580|75730732|FG000|Overall Study|Protocol Violation|1|||
41962235|NCT00983580|75730733|FG001|Overall Study|Protocol Violation|1|||
41962236|NCT00983580|75730732|FG000|Overall Study|Ineligible|3|||
41962237|NCT00983580|75730733|FG001|Overall Study|Ineligible|0|||
41962238|NCT00982878|75730740|FG000|Overall Study|Physician Decision|1|||
41962239|NCT00982488|75730749|FG000|Overall Study|Administrative reason by sponsor|81|||
41962240|NCT00982488|75730750|FG001|Overall Study|Administrative reason by sponsor|3|||
41962241|NCT00982488|75730751|FG002|Overall Study|Administrative reason by sponsor|11|||
41962242|NCT00982488|75730752|FG003|Overall Study|Administrative reason by sponsor|0|||
41962243|NCT00982488|75730753|FG004|Overall Study|Administrative reason by sponsor|0|||
41962244|NCT00982488|75730749|FG000|Overall Study|Adverse event unrelated to study drug|5|||
41962245|NCT00982488|75730750|FG001|Overall Study|Adverse event unrelated to study drug|1|||
41962246|NCT00982488|75730751|FG002|Overall Study|Adverse event unrelated to study drug|0|||
41962247|NCT00982488|75730752|FG003|Overall Study|Adverse event unrelated to study drug|0|||
41962248|NCT00982488|75730753|FG004|Overall Study|Adverse event unrelated to study drug|0|||
41962249|NCT00982488|75730749|FG000|Overall Study|Death|11|||
41962250|NCT00982488|75730750|FG001|Overall Study|Death|0|||
41962251|NCT00982488|75730751|FG002|Overall Study|Death|2|||
41962252|NCT00982488|75730752|FG003|Overall Study|Death|0|||
41962253|NCT00982488|75730753|FG004|Overall Study|Death|0|||
41962254|NCT00982488|75730749|FG000|Overall Study|Disease progression|30|||
41962255|NCT00982488|75730750|FG001|Overall Study|Disease progression|5|||
41962256|NCT00982488|75730751|FG002|Overall Study|Disease progression|10|||
41962257|NCT00982488|75730752|FG003|Overall Study|Disease progression|1|||
41962258|NCT00982488|75730753|FG004|Overall Study|Disease progression|1|||
41962259|NCT00982488|75730749|FG000|Overall Study|Lost to Follow-up|1|||
41962260|NCT00982488|75730750|FG001|Overall Study|Lost to Follow-up|0|||
41962261|NCT00982488|75730751|FG002|Overall Study|Lost to Follow-up|0|||
41962262|NCT00982488|75730752|FG003|Overall Study|Lost to Follow-up|0|||
41962263|NCT00982488|75730753|FG004|Overall Study|Lost to Follow-up|0|||
41962264|NCT00982488|75730749|FG000|Overall Study|Maximum clinical benefit|1|||
41962265|NCT00982488|75730750|FG001|Overall Study|Maximum clinical benefit|1|||
41962266|NCT00982488|75730751|FG002|Overall Study|Maximum clinical benefit|1|||
41962267|NCT00982488|75730752|FG003|Overall Study|Maximum clinical benefit|0|||
41962268|NCT00982488|75730753|FG004|Overall Study|Maximum clinical benefit|0|||
41962269|NCT00982488|75730749|FG000|Overall Study|Other|15|||
41962270|NCT00982488|75730750|FG001|Overall Study|Other|1|||
41962271|NCT00982488|75730751|FG002|Overall Study|Other|3|||
41962272|NCT00982488|75730752|FG003|Overall Study|Other|1|||
41962273|NCT00982488|75730753|FG004|Overall Study|Other|0|||
41962274|NCT00982488|75730749|FG000|Overall Study|Poor compliance/noncompliance|0|||
41962275|NCT00982488|75730750|FG001|Overall Study|Poor compliance/noncompliance|1|||
41962276|NCT00982488|75730751|FG002|Overall Study|Poor compliance/noncompliance|0|||
41962277|NCT00982488|75730752|FG003|Overall Study|Poor compliance/noncompliance|0|||
41962278|NCT00982488|75730753|FG004|Overall Study|Poor compliance/noncompliance|0|||
41962279|NCT00982488|75730749|FG000|Overall Study|Stem cell transplant|2|||
41962280|NCT00982488|75730750|FG001|Overall Study|Stem cell transplant|0|||
41962281|NCT00982488|75730751|FG002|Overall Study|Stem cell transplant|0|||
41962282|NCT00982488|75730752|FG003|Overall Study|Stem cell transplant|1|||
41962283|NCT00982488|75730753|FG004|Overall Study|Stem cell transplant|0|||
41962284|NCT00982488|75730749|FG000|Overall Study|Study drug toxicity|34|||
41962285|NCT00982488|75730750|FG001|Overall Study|Study drug toxicity|1|||
41962286|NCT00982488|75730751|FG002|Overall Study|Study drug toxicity|6|||
41962287|NCT00982488|75730752|FG003|Overall Study|Study drug toxicity|0|||
42210301|NCT03259308|76025067|FG002|Overall Study|Lack of Efficacy|1|||
41962288|NCT00982488|75730753|FG004|Overall Study|Study drug toxicity|0|||
41962289|NCT00982488|75730749|FG000|Overall Study|Withdrawal by Subject|5|||
41962290|NCT00982488|75730750|FG001|Overall Study|Withdrawal by Subject|1|||
41962291|NCT00982488|75730751|FG002|Overall Study|Withdrawal by Subject|1|||
41962292|NCT00982488|75730752|FG003|Overall Study|Withdrawal by Subject|0|||
41962293|NCT00982488|75730753|FG004|Overall Study|Withdrawal by Subject|0|||
41962294|NCT00982410|75730767|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
41962295|NCT00982410|75730768|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
41962296|NCT00982410|75730767|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
41962297|NCT00982410|75730768|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
41962298|NCT00982410|75730767|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
41962299|NCT00982410|75730768|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
41962300|NCT00982410|75730767|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
41962301|NCT00982410|75730768|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
41962302|NCT00982410|75730767|FG000|6-month Follow-up Assessment|participant no transportation|1|||
41962303|NCT00982410|75730768|FG001|6-month Follow-up Assessment|participant no transportation|0|||
41962304|NCT00982410|75730767|FG000|6-month Follow-up Assessment|incarceration|0|||
41962305|NCT00982410|75730768|FG001|6-month Follow-up Assessment|incarceration|2|||
41962306|NCT00982410|75730767|FG000|6-month Follow-up Assessment|patent surgery|0|||
41962307|NCT00982410|75730768|FG001|6-month Follow-up Assessment|patent surgery|1|||
41962308|NCT00982410|75730767|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
41962309|NCT00982410|75730768|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
41962310|NCT00982410|75730767|FG000|12-month Follow-up Assessment|Death|0|||
41962311|NCT00982410|75730768|FG001|12-month Follow-up Assessment|Death|2|||
41962312|NCT00982410|75730767|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
41962313|NCT00982410|75730768|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
41962314|NCT00982410|75730767|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
41962315|NCT00982410|75730768|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
41962316|NCT00982410|75730767|FG000|12-month Follow-up Assessment|incarceration|2|||
41962317|NCT00982410|75730768|FG001|12-month Follow-up Assessment|incarceration|1|||
41962318|NCT00982410|75730767|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
41962319|NCT00982410|75730768|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
41962320|NCT00982020|75730777|FG000|Overall Study|Adverse Event|19|||
42024811|NCT01009047|75832422|FG001|Overall Study|Withdrawal by consent|11|||
41962321|NCT00982020|75730778|FG001|Overall Study|Adverse Event|15|||
41962322|NCT00982020|75730777|FG000|Overall Study|Withdrawal by Subject|11|||
41962323|NCT00982020|75730778|FG001|Overall Study|Withdrawal by Subject|14|||
41962324|NCT00982020|75730777|FG000|Overall Study|Lost to Follow-up|5|||
41962325|NCT00982020|75730778|FG001|Overall Study|Lost to Follow-up|11|||
41962326|NCT00982020|75730777|FG000|Overall Study|Lack of Efficacy|10|||
41962327|NCT00982020|75730778|FG001|Overall Study|Lack of Efficacy|4|||
41962328|NCT00982020|75730777|FG000|Overall Study|Parent/Caregiver Decision|5|||
41962329|NCT00982020|75730778|FG001|Overall Study|Parent/Caregiver Decision|5|||
41962330|NCT00982020|75730777|FG000|Overall Study|Treatment Non-compliance|3|||
41962331|NCT00982020|75730778|FG001|Overall Study|Treatment Non-compliance|6|||
41962332|NCT00982020|75730777|FG000|Overall Study|Physician Decision|2|||
41962333|NCT00982020|75730778|FG001|Overall Study|Physician Decision|5|||
41962334|NCT00982020|75730777|FG000|Overall Study|Entry Criteria Not Met|2|||
41962335|NCT00982020|75730778|FG001|Overall Study|Entry Criteria Not Met|1|||
41962336|NCT00982020|75730777|FG000|Overall Study|Protocol Violation|0|||
41962337|NCT00982020|75730778|FG001|Overall Study|Protocol Violation|2|||
41962338|NCT00982020|75730777|FG000|Overall Study|Clinical Relapse|0|||
41962339|NCT00982020|75730778|FG001|Overall Study|Clinical Relapse|1|||
41962340|NCT00981084|75730791|FG000|Post Intervention (Data Analysis)|poor effort|1|||
41962341|NCT00981084|75730792|FG001|Post Intervention (Data Analysis)|poor effort|1|||
41962342|NCT00981084|75730791|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
41962343|NCT00981084|75730792|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
41962344|NCT00980148|75730802|FG000|Overall Study|Discharged from facility|89|||
41962345|NCT00980148|75730803|FG001|Overall Study|Discharged from facility|96|||
41962346|NCT00980148|75730802|FG000|Overall Study|Received other antichlamydia treatment|20|||
41962347|NCT00980148|75730803|FG001|Overall Study|Received other antichlamydia treatment|14|||
41962348|NCT00980148|75730802|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
41962349|NCT00980148|75730803|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
41962350|NCT00980148|75730802|FG000|Overall Study|Various other reasons|8|||
41962351|NCT00980148|75730803|FG001|Overall Study|Various other reasons|9|||
41962352|NCT04553406|75730840|FG000|Overall Study|Study Discontinuation|0|||
41962353|NCT04553406|75730841|FG001|Overall Study|Study Discontinuation|1|||
41962354|NCT03033576|75730849|FG000|Overall Study|Ineligible|1|||
41962355|NCT03033576|75730850|FG001|Overall Study|Ineligible|1|||
41962356|NCT03033576|75730849|FG000|Overall Study|Adverse Event|4|||
41962357|NCT03033576|75730850|FG001|Overall Study|Adverse Event|20|||
41962358|NCT03033576|75730849|FG000|Overall Study|Progression/relapse|9|||
41962359|NCT03033576|75730850|FG001|Overall Study|Progression/relapse|36|||
41962360|NCT03033576|75730849|FG000|Overall Study|Death|1|||
41962361|NCT03033576|75730850|FG001|Overall Study|Death|1|||
41962362|NCT03033576|75730849|FG000|Overall Study|Patient refusal|1|||
41962363|NCT03033576|75730850|FG001|Overall Study|Patient refusal|6|||
41962364|NCT03033576|75730849|FG000|Overall Study|Other, unspecified reasons|0|||
41962365|NCT03033576|75730850|FG001|Overall Study|Other, unspecified reasons|4|||
41962366|NCT03033576|75730849|FG000|Overall Study|Currently on protocol therapy|0|||
41962367|NCT03033576|75730850|FG001|Overall Study|Currently on protocol therapy|2|||
41962368|NCT04129944|75730860|FG000|Overall Study|Death|0|||
41962369|NCT04129944|75730861|FG001|Overall Study|Death|0|||
41962370|NCT04129944|75730862|FG002|Overall Study|Death|0|||
41962371|NCT04129944|75730863|FG003|Overall Study|Death|1|||
41962372|NCT04129944|75730860|FG000|Overall Study|Lost to Follow-up|1|||
41962373|NCT04129944|75730861|FG001|Overall Study|Lost to Follow-up|0|||
41962374|NCT04129944|75730862|FG002|Overall Study|Lost to Follow-up|0|||
41962375|NCT04129944|75730863|FG003|Overall Study|Lost to Follow-up|0|||
41962376|NCT04129944|75730860|FG000|Overall Study|Withdrawal by Subject|1|||
41962377|NCT04129944|75730861|FG001|Overall Study|Withdrawal by Subject|0|||
41962378|NCT04129944|75730862|FG002|Overall Study|Withdrawal by Subject|1|||
41962379|NCT04129944|75730863|FG003|Overall Study|Withdrawal by Subject|2|||
41962380|NCT03829332|75730927|FG000|Overall Study|Death|145|||
41962381|NCT03829332|75730928|FG001|Overall Study|Death|135|||
41962382|NCT03829332|75730927|FG000|Overall Study|Withdrawal by Subject|10|||
41962383|NCT03829332|75730928|FG001|Overall Study|Withdrawal by Subject|4|||
41962384|NCT03829332|75730927|FG000|Overall Study|Ongoing in Study|154|||
41962385|NCT03829332|75730928|FG001|Overall Study|Ongoing in Study|175|||
41962386|NCT02914314|75730948|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
41962387|NCT02914314|75730949|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
41962388|NCT02914314|75730950|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
41962389|NCT02914314|75730951|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
41962390|NCT02914314|75730948|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
41962391|NCT02914314|75730949|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
41962392|NCT02914314|75730950|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
41962393|NCT02914314|75730951|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
41962394|NCT02914314|75730948|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
41962395|NCT02914314|75730949|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
42024812|NCT01009047|75832421|FG000|Overall Study|Other|3|||
42024813|NCT01009047|75832422|FG001|Overall Study|Other|2|||
42024814|NCT01025193|75832428|FG000|Overall Study|Protocol Violation|1|||
42024815|NCT01025193|75832428|FG000|Overall Study|Adverse Event|3|||
42024816|NCT01025037|75832436|FG000|Overall Study|Adverse Event|3|||
42024817|NCT01025037|75832436|FG000|Overall Study|Lost to Follow-up|7|||
42024818|NCT01025037|75832436|FG000|Overall Study|Withdrawal by Subject|1|||
42024819|NCT01214837|75832443|FG000|Overall Study|Death|0|||
42024820|NCT01214837|75832444|FG001|Overall Study|Death|0|||
42024821|NCT01214837|75832445|FG002|Overall Study|Death|1|||
42024822|NCT01214837|75832443|FG000|Overall Study|Adverse Event|1|||
42024823|NCT01214837|75832444|FG001|Overall Study|Adverse Event|2|||
42024824|NCT01214837|75832445|FG002|Overall Study|Adverse Event|1|||
42024825|NCT01214837|75832443|FG000|Overall Study|Withdrawal by Subject|27|||
42024826|NCT01214837|75832444|FG001|Overall Study|Withdrawal by Subject|36|||
42024827|NCT01214837|75832445|FG002|Overall Study|Withdrawal by Subject|28|||
42024828|NCT01214837|75832443|FG000|Overall Study|Lost to Follow-up|20|||
42024829|NCT01214837|75832444|FG001|Overall Study|Lost to Follow-up|15|||
42024830|NCT01214837|75832445|FG002|Overall Study|Lost to Follow-up|21|||
42024831|NCT01214837|75832443|FG000|Overall Study|Inappropriate Enrolment|0|||
42024832|NCT01214837|75832444|FG001|Overall Study|Inappropriate Enrolment|1|||
42024833|NCT01214837|75832445|FG002|Overall Study|Inappropriate Enrolment|2|||
42024834|NCT01214837|75832443|FG000|Overall Study|Administrative Reason|2|||
42024835|NCT01214837|75832444|FG001|Overall Study|Administrative Reason|6|||
42024836|NCT01214837|75832445|FG002|Overall Study|Administrative Reason|4|||
42024837|NCT01214837|75832443|FG000|Overall Study|Protocol Violation|3|||
42024838|NCT01214837|75832444|FG001|Overall Study|Protocol Violation|1|||
42024839|NCT01214837|75832445|FG002|Overall Study|Protocol Violation|5|||
42024840|NCT01214837|75832443|FG000|Overall Study|Unable to Classify|1|||
42024841|NCT01214837|75832444|FG001|Overall Study|Unable to Classify|3|||
42024842|NCT01214837|75832445|FG002|Overall Study|Unable to Classify|0|||
42024843|NCT01024959|75832454|FG000|Overall Study|ineligible|12|||
42024844|NCT01024959|75832454|FG000|Overall Study|results not evaluable|12|||
42024845|NCT01024959|75832454|FG000|Overall Study|missing results required for analysis|17|||
42024846|NCT01008423|75832465|FG000|Overall Study|Adverse Event|13|||
42024847|NCT01008423|75832466|FG001|Overall Study|Adverse Event|6|||
42024848|NCT01008423|75832465|FG000|Overall Study|Withdrawal by Subject|4|||
42024849|NCT01008423|75832466|FG001|Overall Study|Withdrawal by Subject|7|||
42024850|NCT01008423|75832465|FG000|Overall Study|Lost to Follow-up|0|||
42024851|NCT01008423|75832466|FG001|Overall Study|Lost to Follow-up|2|||
42024852|NCT01008423|75832465|FG000|Overall Study|Low Cortisol|0|||
42024853|NCT01008423|75832466|FG001|Overall Study|Low Cortisol|1|||
42024854|NCT01008423|75832465|FG000|Overall Study|Lack of Efficacy|0|||
42024855|NCT01008423|75832466|FG001|Overall Study|Lack of Efficacy|5|||
42024856|NCT01008423|75832465|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
42024857|NCT01008423|75832466|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
42024858|NCT01008423|75832465|FG000|Overall Study|Personal Conflict|1|||
42024859|NCT01008423|75832466|FG001|Overall Study|Personal Conflict|0|||
42024860|NCT01008423|75832465|FG000|Overall Study|Other|0|||
42024861|NCT01008423|75832466|FG001|Overall Study|Other|1|||
42024862|NCT01012947|75832477|FG000|Overall Study|Lost to Follow-up|131|||
42024863|NCT01012947|75832478|FG001|Overall Study|Lost to Follow-up|135|||
42024864|NCT01012947|75832479|FG002|Overall Study|Lost to Follow-up|130|||
42024865|NCT01012947|75832480|FG003|Overall Study|Lost to Follow-up|118|||
42024866|NCT01012947|75832481|FG004|Overall Study|Lost to Follow-up|142|||
42024867|NCT01214603|75832513|FG000|Overall Study|Adverse Event|0|||
42024868|NCT01214603|75832514|FG001|Overall Study|Adverse Event|0|||
42024869|NCT01214603|75832515|FG002|Overall Study|Adverse Event|1|||
42024870|NCT01214603|75832513|FG000|Overall Study|Death|1|||
42024871|NCT01214603|75832514|FG001|Overall Study|Death|0|||
42024872|NCT01214603|75832515|FG002|Overall Study|Death|0|||
42024873|NCT01214603|75832513|FG000|Overall Study|Progressive Disease|4|||
42024874|NCT01214603|75832514|FG001|Overall Study|Progressive Disease|1|||
42024875|NCT01214603|75832515|FG002|Overall Study|Progressive Disease|3|||
42024876|NCT01212185|75832526|FG000|Overall Study|Protocol Violation|2|||
42024877|NCT01212185|75832527|FG001|Overall Study|Protocol Violation|1|||
42024878|NCT01995175|75832533|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
42024879|NCT01995175|75832533|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
42024880|NCT01995175|75832533|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
42210302|NCT03258762|76025077|FG000|Overall Study|Lost to Follow-up|0|||
42024881|NCT01995175|75832533|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
42024882|NCT01995175|75832533|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
42024883|NCT01995175|75832533|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
42024884|NCT01995175|75832533|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
42024885|NCT01995175|75832533|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
42024886|NCT01995175|75832533|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
42024887|NCT01752907|75832622|FG000|Overall Study|Withdrawal by Subject|4|||
42024888|NCT01752907|75832623|FG001|Overall Study|Withdrawal by Subject|10|||
42024889|NCT01752907|75832622|FG000|Overall Study|Lost to Follow-up|2|||
42024890|NCT01752907|75832623|FG001|Overall Study|Lost to Follow-up|1|||
42024891|NCT01752907|75832622|FG000|Overall Study|Decision by Sponsor|6|||
42024892|NCT01752907|75832623|FG001|Overall Study|Decision by Sponsor|9|||
42024893|NCT03439189|75832629|FG000|Overall Study|Protocol Violation|19|||
42024894|NCT03439189|75832629|FG000|Overall Study|Lack of Efficacy|63|||
42024895|NCT01211483|75832638|FG000|Phase 1b|Death|6|||
42024896|NCT01211483|75832639|FG001|Phase 1b|Death|0|||
42024897|NCT01211483|75832640|FG002|Phase 1b|Death|0|||
42024898|NCT01211483|75832641|FG003|Phase 1b|Death|0|||
42024899|NCT01211483|75832638|FG000|Phase 1b|Withdrawal by Subject|1|||
42024900|NCT01211483|75832639|FG001|Phase 1b|Withdrawal by Subject|0|||
42024901|NCT01211483|75832640|FG002|Phase 1b|Withdrawal by Subject|0|||
42024902|NCT01211483|75832641|FG003|Phase 1b|Withdrawal by Subject|0|||
42024903|NCT01211483|75832638|FG000|Phase 2|Lost to Follow-up|0|||
42024904|NCT01211483|75832639|FG001|Phase 2|Lost to Follow-up|1|||
42024905|NCT01211483|75832640|FG002|Phase 2|Lost to Follow-up|1|||
42024906|NCT01211483|75832641|FG003|Phase 2|Lost to Follow-up|2|||
42024907|NCT01211483|75832638|FG000|Phase 2|Death|0|||
42024908|NCT01211483|75832639|FG001|Phase 2|Death|64|||
42024909|NCT01211483|75832640|FG002|Phase 2|Death|53|||
42024910|NCT01211483|75832641|FG003|Phase 2|Death|53|||
42024911|NCT01211483|75832638|FG000|Phase 2|Withdrawal by Subject|0|||
42024912|NCT01211483|75832639|FG001|Phase 2|Withdrawal by Subject|1|||
42024913|NCT01211483|75832640|FG002|Phase 2|Withdrawal by Subject|10|||
42024914|NCT01211483|75832641|FG003|Phase 2|Withdrawal by Subject|5|||
42024915|NCT01211483|75832638|FG000|Phase 2|Study terminated by Sponsor|0|||
42024916|NCT01211483|75832639|FG001|Phase 2|Study terminated by Sponsor|6|||
42024917|NCT01211483|75832640|FG002|Phase 2|Study terminated by Sponsor|8|||
42024918|NCT01211483|75832641|FG003|Phase 2|Study terminated by Sponsor|11|||
42024919|NCT01210001|75832658|FG000|Overall Study|Not treated|1|||
42024920|NCT01210001|75832659|FG001|Overall Study|Not treated|0|||
42024921|NCT01210001|75832660|FG002|Overall Study|Not treated|0|||
42024922|NCT01210001|75832658|FG000|Overall Study|Adverse Event|4|||
42024923|NCT01210001|75832659|FG001|Overall Study|Adverse Event|2|||
42024924|NCT01210001|75832660|FG002|Overall Study|Adverse Event|5|||
42024925|NCT01210001|75832658|FG000|Overall Study|Non compliant with protocol|2|||
42024926|NCT01210001|75832659|FG001|Overall Study|Non compliant with protocol|2|||
42024927|NCT01210001|75832660|FG002|Overall Study|Non compliant with protocol|3|||
42024928|NCT01210001|75832658|FG000|Overall Study|Lost to Follow-up|4|||
42024929|NCT01210001|75832659|FG001|Overall Study|Lost to Follow-up|3|||
42024930|NCT01210001|75832660|FG002|Overall Study|Lost to Follow-up|2|||
42024931|NCT01210001|75832658|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
42024932|NCT01210001|75832659|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
42024933|NCT01210001|75832660|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
42024934|NCT01210001|75832658|FG000|Overall Study|Other reason not defined above|2|||
42024935|NCT01210001|75832659|FG001|Overall Study|Other reason not defined above|2|||
42024936|NCT01210001|75832660|FG002|Overall Study|Other reason not defined above|1|||
42024937|NCT01209689|75832701|FG000|Overall Study|Insufficient Therapeutic Response|7|||
42024938|NCT01209689|75832702|FG001|Overall Study|Insufficient Therapeutic Response|2|||
42024939|NCT01209689|75832701|FG000|Overall Study|Refused Treatment|8|||
42024940|NCT01209689|75832702|FG001|Overall Study|Refused Treatment|3|||
42024941|NCT01209689|75832701|FG000|Overall Study|Adverse Event|4|||
42024942|NCT01209689|75832702|FG001|Overall Study|Adverse Event|0|||
42024943|NCT01209689|75832701|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
42024944|NCT01209689|75832702|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
42024945|NCT01209689|75832701|FG000|Overall Study|Failure to Return|3|||
42024946|NCT01209689|75832702|FG001|Overall Study|Failure to Return|0|||
42024947|NCT01209689|75832701|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
42024948|NCT01209689|75832702|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
42024949|NCT01209143|75832710|FG000|Overall Study|Adverse Event|2|||
42024950|NCT01209143|75832711|FG001|Overall Study|Adverse Event|1|||
42024951|NCT01209143|75832710|FG000|Overall Study|Death|0|||
42024952|NCT01209143|75832711|FG001|Overall Study|Death|1|||
42024953|NCT01209143|75832710|FG000|Overall Study|Physician Decision|3|||
42024954|NCT01209143|75832711|FG001|Overall Study|Physician Decision|1|||
42024955|NCT01209143|75832710|FG000|Overall Study|Lost to Follow-up|1|||
42024956|NCT01209143|75832711|FG001|Overall Study|Lost to Follow-up|0|||
42024957|NCT01209143|75832710|FG000|Overall Study|Withdrawal by Subject|2|||
42024958|NCT01209143|75832711|FG001|Overall Study|Withdrawal by Subject|1|||
42024959|NCT01209143|75832710|FG000|Overall Study|Disease progression|11|||
42024960|NCT01209143|75832711|FG001|Overall Study|Disease progression|16|||
42024961|NCT01023789|75832717|FG000|3 - Year Visit|Death|29|||
42024962|NCT01023789|75832717|FG000|3 - Year Visit|Withdrawal of consent|1|||
42024963|NCT01023789|75832717|FG000|3 - Year Visit|Lost to Follow-up|13|||
42024964|NCT01208207|75832724|FG000|Part I|Adverse Event|19|||
42024965|NCT01208207|75832725|FG001|Part I|Adverse Event|2|||
42024966|NCT01208207|75832726|FG002|Part I|Adverse Event|6|||
42024967|NCT01208207|75832727|FG003|Part I|Adverse Event|0|||
42024968|NCT01208207|75832728|FG004|Part I|Adverse Event|0|||
42024969|NCT01208207|75832729|FG005|Part I|Adverse Event|0|||
42024970|NCT01208207|75832730|FG006|Part I|Adverse Event|0|||
42024971|NCT01208207|75832724|FG000|Part I|Lack of Efficacy|21|||
42024972|NCT01208207|75832725|FG001|Part I|Lack of Efficacy|3|||
42024973|NCT01208207|75832726|FG002|Part I|Lack of Efficacy|2|||
42024974|NCT01208207|75832727|FG003|Part I|Lack of Efficacy|0|||
42024975|NCT01208207|75832728|FG004|Part I|Lack of Efficacy|0|||
42024976|NCT01208207|75832729|FG005|Part I|Lack of Efficacy|0|||
42024977|NCT01208207|75832730|FG006|Part I|Lack of Efficacy|0|||
42024978|NCT01208207|75832724|FG000|Part I|Lost to Follow-up|6|||
42024979|NCT01208207|75832725|FG001|Part I|Lost to Follow-up|1|||
42024980|NCT01208207|75832726|FG002|Part I|Lost to Follow-up|0|||
42024981|NCT01208207|75832727|FG003|Part I|Lost to Follow-up|0|||
42024982|NCT01208207|75832728|FG004|Part I|Lost to Follow-up|0|||
42024983|NCT01208207|75832729|FG005|Part I|Lost to Follow-up|0|||
42024984|NCT01208207|75832730|FG006|Part I|Lost to Follow-up|0|||
42024985|NCT01208207|75832724|FG000|Part I|Non-Compliance With Study Drug|1|||
42024986|NCT01208207|75832725|FG001|Part I|Non-Compliance With Study Drug|0|||
42024987|NCT01208207|75832726|FG002|Part I|Non-Compliance With Study Drug|1|||
42024988|NCT01208207|75832727|FG003|Part I|Non-Compliance With Study Drug|0|||
42024989|NCT01208207|75832728|FG004|Part I|Non-Compliance With Study Drug|0|||
42024990|NCT01208207|75832729|FG005|Part I|Non-Compliance With Study Drug|0|||
42024991|NCT01208207|75832730|FG006|Part I|Non-Compliance With Study Drug|0|||
42024992|NCT01208207|75832724|FG000|Part I|Physician Decision|0|||
42024993|NCT01208207|75832725|FG001|Part I|Physician Decision|1|||
42024994|NCT01208207|75832726|FG002|Part I|Physician Decision|0|||
42024995|NCT01208207|75832727|FG003|Part I|Physician Decision|0|||
42024996|NCT01208207|75832728|FG004|Part I|Physician Decision|0|||
42024997|NCT01208207|75832729|FG005|Part I|Physician Decision|0|||
42024998|NCT01208207|75832730|FG006|Part I|Physician Decision|0|||
42024999|NCT01208207|75832724|FG000|Part I|Progressive Disease|1|||
42025000|NCT01208207|75832725|FG001|Part I|Progressive Disease|0|||
42025001|NCT01208207|75832726|FG002|Part I|Progressive Disease|0|||
42025002|NCT01208207|75832727|FG003|Part I|Progressive Disease|0|||
42025003|NCT01208207|75832728|FG004|Part I|Progressive Disease|0|||
42025004|NCT01208207|75832729|FG005|Part I|Progressive Disease|0|||
42025005|NCT01208207|75832730|FG006|Part I|Progressive Disease|0|||
42025006|NCT01208207|75832724|FG000|Part I|Protocol Violation|8|||
42025007|NCT01208207|75832725|FG001|Part I|Protocol Violation|0|||
42025008|NCT01208207|75832726|FG002|Part I|Protocol Violation|2|||
42025009|NCT01208207|75832727|FG003|Part I|Protocol Violation|0|||
42025010|NCT01208207|75832728|FG004|Part I|Protocol Violation|0|||
42025011|NCT01208207|75832729|FG005|Part I|Protocol Violation|0|||
42025012|NCT01208207|75832730|FG006|Part I|Protocol Violation|0|||
42025013|NCT01208207|75832724|FG000|Part I|Withdrawal by Subject|14|||
42025014|NCT01208207|75832725|FG001|Part I|Withdrawal by Subject|4|||
42025015|NCT01208207|75832726|FG002|Part I|Withdrawal by Subject|4|||
42025016|NCT01208207|75832727|FG003|Part I|Withdrawal by Subject|0|||
42025017|NCT01208207|75832728|FG004|Part I|Withdrawal by Subject|0|||
42025018|NCT01208207|75832729|FG005|Part I|Withdrawal by Subject|0|||
42025019|NCT01208207|75832730|FG006|Part I|Withdrawal by Subject|0|||
42025020|NCT01208207|75832724|FG000|Part II|Withdrawal by Subject|0|||
42025021|NCT01208207|75832725|FG001|Part II|Withdrawal by Subject|0|||
42025022|NCT01208207|75832726|FG002|Part II|Withdrawal by Subject|0|||
42025023|NCT01208207|75832727|FG003|Part II|Withdrawal by Subject|10|||
42025024|NCT01208207|75832728|FG004|Part II|Withdrawal by Subject|9|||
42025025|NCT01208207|75832729|FG005|Part II|Withdrawal by Subject|3|||
42025026|NCT01208207|75832730|FG006|Part II|Withdrawal by Subject|5|||
42025027|NCT01208207|75832724|FG000|Part II|Adverse Event|0|||
42025028|NCT01208207|75832725|FG001|Part II|Adverse Event|0|||
42025029|NCT01208207|75832726|FG002|Part II|Adverse Event|0|||
42025030|NCT01208207|75832727|FG003|Part II|Adverse Event|5|||
42025031|NCT01208207|75832728|FG004|Part II|Adverse Event|9|||
42025032|NCT01208207|75832729|FG005|Part II|Adverse Event|4|||
42025033|NCT01208207|75832730|FG006|Part II|Adverse Event|2|||
42025034|NCT01208207|75832724|FG000|Part II|Lack of Efficacy|0|||
42025035|NCT01208207|75832725|FG001|Part II|Lack of Efficacy|0|||
42025036|NCT01208207|75832726|FG002|Part II|Lack of Efficacy|0|||
42025037|NCT01208207|75832727|FG003|Part II|Lack of Efficacy|6|||
42025038|NCT01208207|75832728|FG004|Part II|Lack of Efficacy|4|||
42025039|NCT01208207|75832729|FG005|Part II|Lack of Efficacy|3|||
42025040|NCT01208207|75832730|FG006|Part II|Lack of Efficacy|3|||
42025041|NCT01208207|75832724|FG000|Part II|Lost to Follow-up|0|||
42025042|NCT01208207|75832725|FG001|Part II|Lost to Follow-up|0|||
42025043|NCT01208207|75832726|FG002|Part II|Lost to Follow-up|0|||
42025044|NCT01208207|75832727|FG003|Part II|Lost to Follow-up|4|||
42025045|NCT01208207|75832728|FG004|Part II|Lost to Follow-up|0|||
42025046|NCT01208207|75832729|FG005|Part II|Lost to Follow-up|2|||
42025047|NCT01208207|75832730|FG006|Part II|Lost to Follow-up|1|||
42025048|NCT01208207|75832724|FG000|Part II|Non-Compliance With Study Drug|0|||
42025049|NCT01208207|75832725|FG001|Part II|Non-Compliance With Study Drug|0|||
42025050|NCT01208207|75832726|FG002|Part II|Non-Compliance With Study Drug|0|||
42025051|NCT01208207|75832727|FG003|Part II|Non-Compliance With Study Drug|4|||
42025052|NCT01208207|75832728|FG004|Part II|Non-Compliance With Study Drug|1|||
42025053|NCT01208207|75832729|FG005|Part II|Non-Compliance With Study Drug|1|||
42025054|NCT01208207|75832730|FG006|Part II|Non-Compliance With Study Drug|0|||
42025055|NCT01208207|75832724|FG000|Part II|Physician Decision|0|||
42025056|NCT01208207|75832725|FG001|Part II|Physician Decision|0|||
42025057|NCT01208207|75832726|FG002|Part II|Physician Decision|0|||
42025058|NCT01208207|75832727|FG003|Part II|Physician Decision|1|||
42025059|NCT01208207|75832728|FG004|Part II|Physician Decision|0|||
42025060|NCT01208207|75832729|FG005|Part II|Physician Decision|2|||
42025061|NCT01208207|75832730|FG006|Part II|Physician Decision|0|||
42025062|NCT01208207|75832724|FG000|Part II|Protocol Violation|0|||
42025063|NCT01208207|75832725|FG001|Part II|Protocol Violation|0|||
42025064|NCT01208207|75832726|FG002|Part II|Protocol Violation|0|||
42025065|NCT01208207|75832727|FG003|Part II|Protocol Violation|1|||
42025066|NCT01208207|75832728|FG004|Part II|Protocol Violation|0|||
42025067|NCT01208207|75832729|FG005|Part II|Protocol Violation|0|||
42025068|NCT01208207|75832730|FG006|Part II|Protocol Violation|0|||
42025069|NCT01208207|75832724|FG000|Part II|Technical Problems|0|||
42025070|NCT01208207|75832725|FG001|Part II|Technical Problems|0|||
42025071|NCT01208207|75832726|FG002|Part II|Technical Problems|0|||
42025072|NCT01208207|75832727|FG003|Part II|Technical Problems|1|||
42025073|NCT01208207|75832728|FG004|Part II|Technical Problems|0|||
42025074|NCT01208207|75832729|FG005|Part II|Technical Problems|1|||
42025075|NCT01208207|75832730|FG006|Part II|Technical Problems|0|||
42025076|NCT01012713|75832761|FG000|Overall Study|Lack of Efficacy|3|||
42025077|NCT01007253|75832766|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
42025078|NCT01007253|75832767|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
42025079|NCT01007253|75832768|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
41962396|NCT02914314|75730950|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
41962397|NCT02914314|75730951|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
41962398|NCT02914314|75730948|FG000|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
42025080|NCT01007253|75832769|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
42025081|NCT01006707|75832779|FG000|Study Session 1|Lost to Follow-up|2|||
42025082|NCT01006707|75832780|FG001|Study Session 1|Lost to Follow-up|0|||
42025083|NCT01006707|75832781|FG002|Study Session 1|Lost to Follow-up|0|||
42025084|NCT01006707|75832779|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
42025085|NCT01006707|75832780|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
42025086|NCT01006707|75832781|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
42025087|NCT01006629|75832789|FG000|Overall Study|Adverse Event|1|||
42025088|NCT01006629|75832789|FG000|Overall Study|Parent refused to continue participation|1|||
42025089|NCT01006629|75832789|FG000|Overall Study|Parent unable to perform site visit|4|||
42025090|NCT01012323|75832793|FG000|Overall Study|Investigator Judgment|1|||
42025091|NCT01011933|75832797|FG000|Overall Study|Wrong cell type|1|||
42025092|NCT01011933|75832797|FG000|Overall Study|Improper pre-protocol Rx|1|||
42025093|NCT01011933|75832797|FG000|Overall Study|Inadequate pathology|1|||
42025094|NCT01011933|75832797|FG000|Overall Study|Never treated|1|||
42025095|NCT01011465|75832819|FG000|Overall Study|Withdrawal by Subject|2|||
42025096|NCT01011465|75832820|FG001|Overall Study|Withdrawal by Subject|1|||
42025097|NCT01011465|75832821|FG002|Overall Study|Withdrawal by Subject|0|||
41962399|NCT02914314|75730949|FG001|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
41962400|NCT02914314|75730950|FG002|Extension Phase (Up to 32 Weeks)|Participant choice|1|||
41962401|NCT02914314|75730951|FG003|Extension Phase (Up to 32 Weeks)|Participant choice|0|||
41962402|NCT02914314|75730948|FG000|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
41962403|NCT02914314|75730949|FG001|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
41962404|NCT02914314|75730950|FG002|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|1|||
41962405|NCT02914314|75730951|FG003|Extension Phase (Up to 32 Weeks)|Withdrawal by Subject|0|||
41962406|NCT01899144|75732536|FG000|Treatment Period 2|Other|1|||
41962407|NCT01899144|75732536|FG000|Treatment Period 3|Other|2|||
41962408|NCT01899144|75732536|FG000|Treatment Period 5|Other|1|||
41962409|NCT03821844|75733126|FG000|Overall Study|Death|37|||
41962410|NCT03821844|75733127|FG001|Overall Study|Death|31|||
41962411|NCT03821844|75733126|FG000|Overall Study|Discharged|10|||
42025098|NCT01011465|75832822|FG003|Overall Study|Withdrawal by Subject|0|||
42025099|NCT01011465|75832823|FG004|Overall Study|Withdrawal by Subject|1|||
41962412|NCT03821844|75733127|FG001|Overall Study|Discharged|14|||
41962413|NCT03821844|75733126|FG000|Overall Study|Not present in facility at followup|2|||
41962414|NCT03821844|75733127|FG001|Overall Study|Not present in facility at followup|3|||
42025100|NCT01011465|75832824|FG005|Overall Study|Withdrawal by Subject|0|||
42025101|NCT01011465|75832825|FG006|Overall Study|Withdrawal by Subject|1|||
42025102|NCT01011465|75832826|FG007|Overall Study|Withdrawal by Subject|0|||
42025103|NCT01011387|75832851|FG000|Overall Study|Withdrawal by Subject|3|||
42025104|NCT01011387|75832851|FG000|Overall Study|Adverse Event|2|||
42025105|NCT01011387|75832851|FG000|Overall Study|Protocol Violation|1|||
42025106|NCT01011309|75832858|FG000|Overall Study|Adverse Event|2|||
42025107|NCT01011309|75832859|FG001|Overall Study|Adverse Event|1|||
42025108|NCT01011309|75832860|FG002|Overall Study|Adverse Event|2|||
42025109|NCT01011309|75832858|FG000|Overall Study|Lack of Efficacy|0|||
42025110|NCT01011309|75832859|FG001|Overall Study|Lack of Efficacy|1|||
42025111|NCT01011309|75832860|FG002|Overall Study|Lack of Efficacy|0|||
42025112|NCT01011309|75832858|FG000|Overall Study|Protocol Violation|0|||
42025113|NCT01011309|75832859|FG001|Overall Study|Protocol Violation|1|||
42025114|NCT01011309|75832860|FG002|Overall Study|Protocol Violation|3|||
42025115|NCT01011153|75832871|FG000|Overall Study|Less than 78 cases completed|8|||
42025116|NCT01011153|75832872|FG001|Overall Study|Less than 78 cases completed|11|||
42025117|NCT01011153|75832873|FG002|Overall Study|Less than 78 cases completed|9|||
42025118|NCT00997893|75832905|FG000|Overall Study|Adverse Event|1|||
42025119|NCT00997893|75832906|FG001|Overall Study|Adverse Event|0|||
42025120|NCT00997893|75832907|FG002|Overall Study|Adverse Event|0|||
42025121|NCT00997893|75832905|FG000|Overall Study|Unable to meet study timelines|1|||
42025122|NCT00997893|75832906|FG001|Overall Study|Unable to meet study timelines|0|||
42025123|NCT00997893|75832907|FG002|Overall Study|Unable to meet study timelines|0|||
42025124|NCT00997893|75832905|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
42025125|NCT00997893|75832906|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
42025126|NCT00997893|75832907|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
42025127|NCT02905825|75832924|FG000|Overall Study|Protocol Violation|11|||
42025128|NCT02905825|75832924|FG000|Overall Study|Device Malfunction|1|||
42025129|NCT01208051|75832933|FG000|Total Enrollment|Withdrawal by Subject|0|||
42025130|NCT01208051|75832934|FG001|Total Enrollment|Withdrawal by Subject|1|||
42025131|NCT01208051|75832935|FG002|Total Enrollment|Withdrawal by Subject|0|||
42025132|NCT01208051|75832936|FG003|Total Enrollment|Withdrawal by Subject|0|||
42025133|NCT01208051|75832937|FG004|Total Enrollment|Withdrawal by Subject|2|||
42025134|NCT01208051|75832933|FG000|Total Enrollment|Brain metastases|0|||
42025135|NCT01208051|75832934|FG001|Total Enrollment|Brain metastases|0|||
42025136|NCT01208051|75832935|FG002|Total Enrollment|Brain metastases|1|||
42025137|NCT01208051|75832936|FG003|Total Enrollment|Brain metastases|0|||
42025138|NCT01208051|75832937|FG004|Total Enrollment|Brain metastases|0|||
42025139|NCT01207583|75832956|FG000|Overall Study|Withdrawal by Subject|0|||
42025140|NCT01207583|75832957|FG001|Overall Study|Withdrawal by Subject|3|||
42025141|NCT01207583|75832958|FG002|Overall Study|Withdrawal by Subject|1|||
42025142|NCT01207583|75832956|FG000|Overall Study|Participant failed to return|1|||
42025143|NCT01207583|75832957|FG001|Overall Study|Participant failed to return|0|||
42025144|NCT01207583|75832958|FG002|Overall Study|Participant failed to return|0|||
42025145|NCT01207583|75832956|FG000|Overall Study|Lost to Follow-up|0|||
42025146|NCT01207583|75832957|FG001|Overall Study|Lost to Follow-up|2|||
42025147|NCT01207583|75832958|FG002|Overall Study|Lost to Follow-up|0|||
42025148|NCT01207427|75832982|FG000|Double-blind Treatment Period|Adverse Event|0|||
42025149|NCT01207427|75832983|FG001|Double-blind Treatment Period|Adverse Event|1|||
42025150|NCT01207427|75832984|FG002|Double-blind Treatment Period|Adverse Event|0|||
42025151|NCT01207427|75832982|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
42025152|NCT01207427|75832983|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
42025153|NCT01207427|75832984|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
42025154|NCT01207427|75832982|FG000|Double-blind Treatment Period|Protocol Violation|2|||
42025155|NCT01207427|75832983|FG001|Double-blind Treatment Period|Protocol Violation|1|||
42025156|NCT01207427|75832984|FG002|Double-blind Treatment Period|Protocol Violation|1|||
42025157|NCT01207427|75832982|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
42025158|NCT01207427|75832983|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
42025159|NCT01207427|75832984|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
42025160|NCT04713553|75832997|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
42025161|NCT04713553|75832998|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
42025162|NCT04713553|75832999|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
42025163|NCT04713553|75833000|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
42025164|NCT04713553|75833001|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
42025165|NCT04713553|75833002|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
42025166|NCT04713553|75833003|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
42025167|NCT04713553|75832997|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
42025168|NCT04713553|75832998|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
42025169|NCT04713553|75832999|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
42025170|NCT04713553|75833000|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
42025171|NCT04713553|75833001|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
42025172|NCT04713553|75833002|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
42025173|NCT04713553|75833003|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
42025174|NCT04713553|75832997|FG000|Primary Study (2 Months)|Other|1|||
42118119|NCT00502593|75928977|FG008|Overall Study|Withdrawn unspecified reason|0|||
42025175|NCT04713553|75832998|FG001|Primary Study (2 Months)|Other|2|||
42118120|NCT00502593|75928978|FG009|Overall Study|Withdrawn unspecified reason|0|||
42025176|NCT04713553|75832999|FG002|Primary Study (2 Months)|Other|0|||
42118121|NCT00502593|75928979|FG010|Overall Study|Withdrawn unspecified reason|0|||
42300613|NCT02088541|76135790|FG004|Overall Study|Other|1|||
42300614|NCT02294019|76135800|FG000|Overall Study|Adverse Event|2|||
42025177|NCT04713553|75833000|FG003|Primary Study (2 Months)|Other|0|||
42025178|NCT04713553|75833001|FG004|Primary Study (2 Months)|Other|1|||
42025179|NCT04713553|75833002|FG005|Primary Study (2 Months)|Other|0|||
42025180|NCT04713553|75833003|FG006|Primary Study (2 Months)|Other|0|||
42025181|NCT04713553|75832997|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
42025182|NCT04713553|75832998|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
42025183|NCT04713553|75832999|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
42025184|NCT04713553|75833000|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
42025185|NCT04713553|75833001|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
42025186|NCT04713553|75833002|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
42025187|NCT04713553|75833003|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
42025188|NCT04713553|75832997|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
42025189|NCT04713553|75832998|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
42025190|NCT04713553|75832999|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
42025191|NCT04713553|75833000|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
42025192|NCT04713553|75833001|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
42025193|NCT04713553|75833002|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
42025194|NCT04713553|75833003|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
42025195|NCT01206101|75833026|FG000|Overall Study|Adverse Event|1|||
42025196|NCT01206101|75833027|FG001|Overall Study|Adverse Event|0|||
42025197|NCT01206101|75833026|FG000|Overall Study|Physician Decision|0|||
42025198|NCT01206101|75833027|FG001|Overall Study|Physician Decision|1|||
42025199|NCT01206101|75833026|FG000|Overall Study|Unclassified|1|||
42025200|NCT01206101|75833027|FG001|Overall Study|Unclassified|0|||
42025201|NCT01205165|75833033|FG000|Overall Study|Lost to Follow-up|2|||
42025202|NCT00997503|75833038|FG000|Overall Study|Death|53|||
42025203|NCT00997503|75833038|FG000|Overall Study|Withdrawal by Subject|76|||
42025204|NCT00997503|75833038|FG000|Overall Study|Lost to Follow-up|33|||
42025205|NCT00997503|75833038|FG000|Overall Study|Adverse Event|3|||
42025206|NCT00997503|75833038|FG000|Overall Study|Physician Decision|10|||
42025207|NCT00997503|75833038|FG000|Overall Study|Missed 12-month follow-up|85|||
42025208|NCT00997503|75833038|FG000|Overall Study|Other reason|13|||
42025209|NCT01204775|75833047|FG000|Overall Study|Poor/non-compliance|0|||
42025210|NCT01204775|75833048|FG001|Overall Study|Poor/non-compliance|1|||
42025211|NCT01204775|75833047|FG000|Overall Study|Withdrawal by Subject|1|||
42025212|NCT01204775|75833048|FG001|Overall Study|Withdrawal by Subject|0|||
42025213|NCT00997035|75833056|FG000|3-week Followup Visit|Lost to Follow-up|9|||
42025214|NCT00997035|75833057|FG001|3-week Followup Visit|Lost to Follow-up|6|||
42025215|NCT00997035|75833056|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
42025216|NCT00997035|75833057|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
42025217|NCT01204697|75833075|FG000|Overall Study|Death|26|||
42025218|NCT01204697|75833076|FG001|Overall Study|Death|27|||
42025219|NCT01204697|75833075|FG000|Overall Study|Lost to Follow-up|3|||
42025220|NCT01204697|75833076|FG001|Overall Study|Lost to Follow-up|4|||
42025221|NCT01204697|75833075|FG000|Overall Study|Withdrawal by Subject|2|||
42025222|NCT01204697|75833076|FG001|Overall Study|Withdrawal by Subject|4|||
42025223|NCT01204697|75833075|FG000|Overall Study|Randomized, but not treated|0|||
42025224|NCT01204697|75833076|FG001|Overall Study|Randomized, but not treated|1|||
42025225|NCT01001325|75833084|FG000|Overall Study|Lost to Follow-up|16|||
42025226|NCT01001325|75833085|FG001|Overall Study|Lost to Follow-up|10|||
42025227|NCT01001325|75833084|FG000|Overall Study|Protocol Violation|2|||
42025228|NCT01001325|75833085|FG001|Overall Study|Protocol Violation|0|||
42025229|NCT01203917|75833091|FG000|Overall Study|Death|29|||
42025230|NCT01203917|75833091|FG000|Overall Study|Lost to Follow-up|2|||
42025231|NCT01203917|75833091|FG000|Overall Study|Withdrawal by Subject|3|||
42025232|NCT01203917|75833091|FG000|Overall Study|Due to objective disease progression|1|||
41962415|NCT01796106|75734578|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
41962416|NCT01796106|75734579|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
41962417|NCT01168219|75735767|FG000|Overall Study|off study before starting treatment|2|||
41962418|NCT01168219|75735767|FG000|Overall Study|withdrew before transplant|1|||
41962419|NCT01168219|75735767|FG000|Overall Study|ineligible due to CML|2|||
41962420|NCT01115803|75735778|FG000|Overall Study|Withdrawal by Subject|0|||
41962421|NCT01115803|75735779|FG001|Overall Study|Withdrawal by Subject|0|||
41962422|NCT01115803|75735780|FG002|Overall Study|Withdrawal by Subject|0|||
41962423|NCT01115803|75735781|FG003|Overall Study|Withdrawal by Subject|0|||
41962424|NCT01115803|75735782|FG004|Overall Study|Withdrawal by Subject|0|||
41962425|NCT01115803|75735783|FG005|Overall Study|Withdrawal by Subject|0|||
41962426|NCT01115803|75735784|FG006|Overall Study|Withdrawal by Subject|1|||
42025233|NCT01203917|75833091|FG000|Overall Study|Due to EGFR M+I patient|1|||
42025234|NCT01202903|75833097|FG000|Overall Study|Administrative Probelms|1|||
42025235|NCT01202903|75833098|FG001|Overall Study|Administrative Probelms|4|||
42025236|NCT01202903|75833097|FG000|Overall Study|Protocol Violation|0|||
42118122|NCT00502593|75928980|FG011|Overall Study|Withdrawn unspecified reason|0|||
42025237|NCT01202903|75833098|FG001|Overall Study|Protocol Violation|1|||
42118123|NCT00502593|75928969|FG000|Overall Study|Withdrawal by Subject|0|||
42025238|NCT01202903|75833097|FG000|Overall Study|Death|1|||
42025239|NCT01202903|75833098|FG001|Overall Study|Death|0|||
42025240|NCT01202903|75833097|FG000|Overall Study|Lost to Follow-up|1|||
42025241|NCT01202903|75833098|FG001|Overall Study|Lost to Follow-up|1|||
42025242|NCT01202903|75833097|FG000|Overall Study|Lack of Efficacy|1|||
42025243|NCT01202903|75833098|FG001|Overall Study|Lack of Efficacy|3|||
42025244|NCT01202903|75833097|FG000|Overall Study|Adverse Event|3|||
42025245|NCT01202903|75833098|FG001|Overall Study|Adverse Event|3|||
42025246|NCT01202903|75833097|FG000|Overall Study|Withdrawal by Subject|4|||
42025247|NCT01202903|75833098|FG001|Overall Study|Withdrawal by Subject|4|||
42025248|NCT01001169|75833106|FG000|Overall Study|Withdrawal by Subject|2|||
41962427|NCT01115803|75735778|FG000|Overall Study|Lost to Follow-up|0|||
41962428|NCT01115803|75735779|FG001|Overall Study|Lost to Follow-up|0|||
41962429|NCT01115803|75735780|FG002|Overall Study|Lost to Follow-up|1|||
41962430|NCT01115803|75735781|FG003|Overall Study|Lost to Follow-up|0|||
42025249|NCT01001169|75833107|FG001|Overall Study|Withdrawal by Subject|1|||
42025250|NCT01202747|75833121|FG000|Overall Study|Withdrawal by Subject|1|||
42025251|NCT00996801|75833131|FG000|Overall Study|Adverse Event|6|||
42025252|NCT00996801|75833132|FG001|Overall Study|Adverse Event|4|||
42025253|NCT00996801|75833133|FG002|Overall Study|Adverse Event|12|||
42025254|NCT00996801|75833134|FG003|Overall Study|Adverse Event|17|||
42025255|NCT00996801|75833135|FG004|Overall Study|Adverse Event|31|||
42025256|NCT00996801|75833136|FG005|Overall Study|Adverse Event|3|||
42025257|NCT00996801|75833131|FG000|Overall Study|Lack of Efficacy|3|||
42025258|NCT00996801|75833132|FG001|Overall Study|Lack of Efficacy|0|||
42025259|NCT00996801|75833133|FG002|Overall Study|Lack of Efficacy|1|||
42025260|NCT00996801|75833134|FG003|Overall Study|Lack of Efficacy|3|||
42025261|NCT00996801|75833135|FG004|Overall Study|Lack of Efficacy|0|||
42025262|NCT00996801|75833136|FG005|Overall Study|Lack of Efficacy|1|||
42025263|NCT00996801|75833131|FG000|Overall Study|Lost to Follow-up|0|||
42025264|NCT00996801|75833132|FG001|Overall Study|Lost to Follow-up|0|||
42025265|NCT00996801|75833133|FG002|Overall Study|Lost to Follow-up|0|||
42025266|NCT00996801|75833134|FG003|Overall Study|Lost to Follow-up|3|||
42025267|NCT00996801|75833135|FG004|Overall Study|Lost to Follow-up|3|||
41962431|NCT01115803|75735782|FG004|Overall Study|Lost to Follow-up|0|||
42025268|NCT00996801|75833136|FG005|Overall Study|Lost to Follow-up|2|||
41962432|NCT01115803|75735783|FG005|Overall Study|Lost to Follow-up|0|||
41962433|NCT01115803|75735784|FG006|Overall Study|Lost to Follow-up|0|||
41962434|NCT01115803|75735778|FG000|Overall Study|Progressive Disease during Cycle1|0|||
41962435|NCT01115803|75735779|FG001|Overall Study|Progressive Disease during Cycle1|0|||
41962436|NCT01115803|75735780|FG002|Overall Study|Progressive Disease during Cycle1|0|||
42025269|NCT00996801|75833131|FG000|Overall Study|Physician Decision|0|||
42025270|NCT00996801|75833132|FG001|Overall Study|Physician Decision|0|||
42025271|NCT00996801|75833133|FG002|Overall Study|Physician Decision|0|||
42025272|NCT00996801|75833134|FG003|Overall Study|Physician Decision|1|||
42025273|NCT00996801|75833135|FG004|Overall Study|Physician Decision|0|||
42025274|NCT00996801|75833136|FG005|Overall Study|Physician Decision|0|||
42025275|NCT00996801|75833131|FG000|Overall Study|Progressive Disease|0|||
42025276|NCT00996801|75833132|FG001|Overall Study|Progressive Disease|1|||
42025277|NCT00996801|75833133|FG002|Overall Study|Progressive Disease|0|||
42025278|NCT00996801|75833134|FG003|Overall Study|Progressive Disease|0|||
42025279|NCT00996801|75833135|FG004|Overall Study|Progressive Disease|0|||
42025280|NCT00996801|75833136|FG005|Overall Study|Progressive Disease|0|||
42025281|NCT00996801|75833131|FG000|Overall Study|Protocol Violation|3|||
42025282|NCT00996801|75833132|FG001|Overall Study|Protocol Violation|4|||
42025283|NCT00996801|75833133|FG002|Overall Study|Protocol Violation|1|||
42025284|NCT00996801|75833134|FG003|Overall Study|Protocol Violation|2|||
42025285|NCT00996801|75833135|FG004|Overall Study|Protocol Violation|3|||
42025286|NCT00996801|75833136|FG005|Overall Study|Protocol Violation|4|||
42025287|NCT00996801|75833131|FG000|Overall Study|Study Terminated by Sponsor|0|||
42025288|NCT00996801|75833132|FG001|Overall Study|Study Terminated by Sponsor|1|||
42025289|NCT00996801|75833133|FG002|Overall Study|Study Terminated by Sponsor|0|||
42025290|NCT00996801|75833134|FG003|Overall Study|Study Terminated by Sponsor|0|||
42025291|NCT00996801|75833135|FG004|Overall Study|Study Terminated by Sponsor|46|||
42025292|NCT00996801|75833136|FG005|Overall Study|Study Terminated by Sponsor|0|||
42025293|NCT00996801|75833131|FG000|Overall Study|Withdrawal by Subject|8|||
42025294|NCT00996801|75833132|FG001|Overall Study|Withdrawal by Subject|6|||
42025295|NCT00996801|75833133|FG002|Overall Study|Withdrawal by Subject|9|||
42025296|NCT00996801|75833134|FG003|Overall Study|Withdrawal by Subject|5|||
42025297|NCT00996801|75833135|FG004|Overall Study|Withdrawal by Subject|5|||
42025298|NCT00996801|75833136|FG005|Overall Study|Withdrawal by Subject|9|||
42025299|NCT00996489|75833152|FG000|Overall Study|Device failure|45|||
42118124|NCT00502593|75928970|FG001|Overall Study|Withdrawal by Subject|0|||
42025300|NCT00996489|75833152|FG000|Overall Study|Discontinued|116|||
42025301|NCT01000311|75833158|FG000|Overall Study|Adverse Event|2|||
42025302|NCT01000311|75833159|FG001|Overall Study|Adverse Event|5|||
42025303|NCT01000311|75833158|FG000|Overall Study|Withdrawal by Subject|16|||
42025304|NCT01000311|75833159|FG001|Overall Study|Withdrawal by Subject|24|||
42025305|NCT01000311|75833158|FG000|Overall Study|Lost to Follow-up|15|||
41962437|NCT01115803|75735781|FG003|Overall Study|Progressive Disease during Cycle1|0|||
41962438|NCT01115803|75735782|FG004|Overall Study|Progressive Disease during Cycle1|0|||
41962439|NCT01115803|75735783|FG005|Overall Study|Progressive Disease during Cycle1|0|||
41962440|NCT01115803|75735784|FG006|Overall Study|Progressive Disease during Cycle1|1|||
41962441|NCT01115569|75735805|FG000|Conversion/Titration Phase|Adverse Event|59|||
41962442|NCT01115569|75735806|FG001|Conversion/Titration Phase|Adverse Event|0|||
41962443|NCT01115569|75735805|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
41962444|NCT01115569|75735806|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
41962445|NCT01115569|75735805|FG000|Conversion/Titration Phase|Physician Decision|5|||
41962446|NCT01115569|75735806|FG001|Conversion/Titration Phase|Physician Decision|0|||
41962447|NCT01115569|75735805|FG000|Conversion/Titration Phase|Protocol Violation|68|||
41962448|NCT01115569|75735806|FG001|Conversion/Titration Phase|Protocol Violation|0|||
41962449|NCT01115569|75735805|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
41962450|NCT01115569|75735806|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
41962451|NCT01115569|75735805|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
41962452|NCT01115569|75735806|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
41962453|NCT01115569|75735805|FG000|Maintenance Phase|Adverse Event|0|||
41962454|NCT01115569|75735806|FG001|Maintenance Phase|Adverse Event|43|||
41962455|NCT01115569|75735805|FG000|Maintenance Phase|Lost to Follow-up|0|||
41962456|NCT01115569|75735806|FG001|Maintenance Phase|Lost to Follow-up|8|||
41962457|NCT01115569|75735805|FG000|Maintenance Phase|Physician Decision|0|||
41962458|NCT01115569|75735806|FG001|Maintenance Phase|Physician Decision|3|||
41962459|NCT01115569|75735805|FG000|Maintenance Phase|Protocol Violation|0|||
41962460|NCT01115569|75735806|FG001|Maintenance Phase|Protocol Violation|9|||
41962461|NCT01115569|75735805|FG000|Maintenance Phase|Withdrawal by Subject|0|||
41962462|NCT01115569|75735806|FG001|Maintenance Phase|Withdrawal by Subject|27|||
41962463|NCT01115569|75735805|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
41962464|NCT01115569|75735806|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
41962465|NCT01115569|75735805|FG000|Maintenance Phase|Administrative|0|||
41962466|NCT01115569|75735806|FG001|Maintenance Phase|Administrative|1|||
41962467|NCT01107886|75735813|FG000|Overall Study|Lost to Follow-up|15|||
41962468|NCT01107886|75735814|FG001|Overall Study|Lost to Follow-up|13|||
41962469|NCT01107886|75735813|FG000|Overall Study|Withdrawal by Subject|180|||
41962470|NCT01107886|75735814|FG001|Overall Study|Withdrawal by Subject|196|||
41962471|NCT01107886|75735813|FG000|Overall Study|Administrative withdrawal of consent|7|||
41962472|NCT01107886|75735814|FG001|Overall Study|Administrative withdrawal of consent|5|||
41962473|NCT01107457|75735825|FG000|Part A|Adverse Event|1|||
41962474|NCT01107457|75735826|FG001|Part A|Adverse Event|2|||
41962475|NCT01107457|75735827|FG002|Part A|Adverse Event|1|||
41962476|NCT01107457|75735828|FG003|Part A|Adverse Event|0|||
41962477|NCT01107457|75735829|FG004|Part A|Adverse Event|0|||
41962478|NCT01107457|75735830|FG005|Part A|Adverse Event|0|||
41962479|NCT01107457|75735825|FG000|Part A|Withdrawal by Subject|3|||
41962480|NCT01107457|75735826|FG001|Part A|Withdrawal by Subject|3|||
41962481|NCT01107457|75735827|FG002|Part A|Withdrawal by Subject|0|||
41962482|NCT01107457|75735828|FG003|Part A|Withdrawal by Subject|3|||
41962483|NCT01107457|75735829|FG004|Part A|Withdrawal by Subject|1|||
41962484|NCT01107457|75735830|FG005|Part A|Withdrawal by Subject|0|||
41962485|NCT01107457|75735825|FG000|Part A|Lost to Follow-up|0|||
41962486|NCT01107457|75735826|FG001|Part A|Lost to Follow-up|1|||
41962487|NCT01107457|75735827|FG002|Part A|Lost to Follow-up|0|||
41962488|NCT01107457|75735828|FG003|Part A|Lost to Follow-up|0|||
41962489|NCT01107457|75735829|FG004|Part A|Lost to Follow-up|0|||
41962490|NCT01107457|75735830|FG005|Part A|Lost to Follow-up|0|||
41962491|NCT01107457|75735825|FG000|Part A|Lack of Efficacy|1|||
41962492|NCT01107457|75735826|FG001|Part A|Lack of Efficacy|0|||
41962493|NCT01107457|75735827|FG002|Part A|Lack of Efficacy|0|||
41962494|NCT01107457|75735828|FG003|Part A|Lack of Efficacy|0|||
41962495|NCT01107457|75735829|FG004|Part A|Lack of Efficacy|0|||
41962496|NCT01107457|75735830|FG005|Part A|Lack of Efficacy|0|||
41962497|NCT01107457|75735825|FG000|Part A|Protocol Violation|0|||
41962498|NCT01107457|75735826|FG001|Part A|Protocol Violation|1|||
41962499|NCT01107457|75735827|FG002|Part A|Protocol Violation|0|||
41962500|NCT01107457|75735828|FG003|Part A|Protocol Violation|0|||
41962501|NCT01107457|75735829|FG004|Part A|Protocol Violation|0|||
41962502|NCT01107457|75735830|FG005|Part A|Protocol Violation|0|||
41962503|NCT01107457|75735825|FG000|Part B and C|Adverse Event|0|||
41962504|NCT01107457|75735826|FG001|Part B and C|Adverse Event|0|||
41962505|NCT01107457|75735827|FG002|Part B and C|Adverse Event|0|||
41962506|NCT01107457|75735828|FG003|Part B and C|Adverse Event|0|||
41962507|NCT01107457|75735829|FG004|Part B and C|Adverse Event|0|||
41962508|NCT01107457|75735830|FG005|Part B and C|Adverse Event|12|||
41962509|NCT01107457|75735825|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
41962510|NCT01107457|75735826|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
41962511|NCT01107457|75735827|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
41962512|NCT01107457|75735828|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
41962513|NCT01107457|75735829|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
41962514|NCT01107457|75735830|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
42025306|NCT01000311|75833159|FG001|Overall Study|Lost to Follow-up|24|||
42025307|NCT01000311|75833158|FG000|Overall Study|Protocol Violation|1|||
42025308|NCT01000311|75833159|FG001|Overall Study|Protocol Violation|2|||
42025309|NCT01000311|75833158|FG000|Overall Study|Inappropriate enrollment|2|||
42025310|NCT01000311|75833159|FG001|Overall Study|Inappropriate enrollment|0|||
42025311|NCT01000311|75833158|FG000|Overall Study|Administrative reason|9|||
42025312|NCT01000311|75833159|FG001|Overall Study|Administrative reason|15|||
42025313|NCT01003899|75833165|FG000|Overall Study|Other Adverse Event|8|||
42025314|NCT01003899|75833165|FG000|Overall Study|Not entered|4|||
42025315|NCT01003899|75833165|FG000|Overall Study|Not treated|1|||
42025316|NCT01003899|75833165|FG000|Overall Study|Progressive disease|34|||
42025317|NCT01000155|75833169|FG000|Overall Study|Withdrawal by Subject|1|||
42118125|NCT00502593|75928971|FG002|Overall Study|Withdrawal by Subject|6|||
42118126|NCT00502593|75928972|FG003|Overall Study|Withdrawal by Subject|2|||
42118127|NCT00502593|75928973|FG004|Overall Study|Withdrawal by Subject|2|||
42118128|NCT00502593|75928974|FG005|Overall Study|Withdrawal by Subject|0|||
42118129|NCT00502593|75928975|FG006|Overall Study|Withdrawal by Subject|3|||
42118130|NCT00502593|75928976|FG007|Overall Study|Withdrawal by Subject|0|||
42118131|NCT00502593|75928977|FG008|Overall Study|Withdrawal by Subject|3|||
42118132|NCT00502593|75928978|FG009|Overall Study|Withdrawal by Subject|0|||
42118133|NCT00502593|75928979|FG010|Overall Study|Withdrawal by Subject|1|||
42118134|NCT00502593|75928980|FG011|Overall Study|Withdrawal by Subject|0|||
42118135|NCT00502593|75928969|FG000|Overall Study|Lost to Follow-up|2|||
42118136|NCT00502593|75928970|FG001|Overall Study|Lost to Follow-up|1|||
42118137|NCT00502593|75928971|FG002|Overall Study|Lost to Follow-up|1|||
42118138|NCT00502593|75928972|FG003|Overall Study|Lost to Follow-up|1|||
42118139|NCT00502593|75928973|FG004|Overall Study|Lost to Follow-up|0|||
42118140|NCT00502593|75928974|FG005|Overall Study|Lost to Follow-up|0|||
42118141|NCT00502593|75928975|FG006|Overall Study|Lost to Follow-up|0|||
42118142|NCT00502593|75928976|FG007|Overall Study|Lost to Follow-up|0|||
42118143|NCT00502593|75928977|FG008|Overall Study|Lost to Follow-up|3|||
42118144|NCT00502593|75928978|FG009|Overall Study|Lost to Follow-up|0|||
42118145|NCT00502593|75928979|FG010|Overall Study|Lost to Follow-up|1|||
42118146|NCT00502593|75928980|FG011|Overall Study|Lost to Follow-up|0|||
42118147|NCT00686543|75929033|FG000|Overall Study|Adverse Event|9|||
42118148|NCT00686543|75929034|FG001|Overall Study|Adverse Event|1|||
42118149|NCT00686543|75929035|FG002|Overall Study|Adverse Event|3|||
42118150|NCT00686543|75929036|FG003|Overall Study|Adverse Event|2|||
42118151|NCT00686543|75929033|FG000|Overall Study|Withdrawal by Subject|2|||
42118152|NCT00686543|75929034|FG001|Overall Study|Withdrawal by Subject|0|||
42118153|NCT00686543|75929035|FG002|Overall Study|Withdrawal by Subject|0|||
42118154|NCT00686543|75929036|FG003|Overall Study|Withdrawal by Subject|0|||
42118155|NCT00686543|75929033|FG000|Overall Study|Protocol Violation|3|||
42118156|NCT00686543|75929034|FG001|Overall Study|Protocol Violation|0|||
42118157|NCT00686543|75929035|FG002|Overall Study|Protocol Violation|2|||
42118158|NCT00686543|75929036|FG003|Overall Study|Protocol Violation|1|||
42118159|NCT00545688|75929050|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
42118160|NCT00545688|75929051|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
42118161|NCT00545688|75929052|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
42118162|NCT00545688|75929053|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
42118163|NCT00545688|75929050|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
42118164|NCT00545688|75929051|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
42210303|NCT03258762|76025078|FG001|Overall Study|Lost to Follow-up|1|||
42300615|NCT02294019|76135800|FG000|Overall Study|Protocol Violation|68|||
41962515|NCT01107457|75735825|FG000|Part B and C|Physician Decision|0|||
41962516|NCT01107457|75735826|FG001|Part B and C|Physician Decision|0|||
41962517|NCT01107457|75735827|FG002|Part B and C|Physician Decision|0|||
41962518|NCT01107457|75735828|FG003|Part B and C|Physician Decision|0|||
41962519|NCT01107457|75735829|FG004|Part B and C|Physician Decision|0|||
41962520|NCT01107457|75735830|FG005|Part B and C|Physician Decision|3|||
41962521|NCT01107457|75735825|FG000|Part B and C|Lack of Efficacy|0|||
41962522|NCT01107457|75735826|FG001|Part B and C|Lack of Efficacy|0|||
41962523|NCT01107457|75735827|FG002|Part B and C|Lack of Efficacy|0|||
41962524|NCT01107457|75735828|FG003|Part B and C|Lack of Efficacy|0|||
41962525|NCT01107457|75735829|FG004|Part B and C|Lack of Efficacy|0|||
41962526|NCT01107457|75735830|FG005|Part B and C|Lack of Efficacy|7|||
41962527|NCT01107457|75735825|FG000|Part B and C|Lost to Follow-up|0|||
41962528|NCT01107457|75735826|FG001|Part B and C|Lost to Follow-up|0|||
41962529|NCT01107457|75735827|FG002|Part B and C|Lost to Follow-up|0|||
41962530|NCT01107457|75735828|FG003|Part B and C|Lost to Follow-up|0|||
41962531|NCT01107457|75735829|FG004|Part B and C|Lost to Follow-up|0|||
41962532|NCT01107457|75735830|FG005|Part B and C|Lost to Follow-up|10|||
41962533|NCT01107457|75735825|FG000|Part B and C|Protocol Violation|0|||
41962534|NCT01107457|75735826|FG001|Part B and C|Protocol Violation|0|||
41962535|NCT01107457|75735827|FG002|Part B and C|Protocol Violation|0|||
41962536|NCT01107457|75735828|FG003|Part B and C|Protocol Violation|0|||
41962537|NCT01107457|75735829|FG004|Part B and C|Protocol Violation|0|||
41962538|NCT01107457|75735830|FG005|Part B and C|Protocol Violation|1|||
41962539|NCT01107457|75735825|FG000|Part B and C|Sponsor Decision|0|||
42025318|NCT01000155|75833169|FG000|Overall Study|Adverse Event|1|||
42025319|NCT00999921|75833175|FG000|Overall Study|Lost to Follow-up|10|||
42025320|NCT00999921|75833176|FG001|Overall Study|Lost to Follow-up|19|||
42025321|NCT01002573|75833187|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
42025322|NCT01002573|75833188|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
42025323|NCT00999687|75833194|FG000|First Intervention|Withdrawal by Subject|1|||
42025324|NCT00999687|75833194|FG000|Second Intervention|Withdrawal by Subject|2|||
42025325|NCT00999687|75833194|FG000|Second Intervention|Lack of Efficacy|1|||
42025326|NCT00996333|75833200|FG000|Overall Study|Screen failure|1|||
42025327|NCT00996333|75833200|FG000|Overall Study|Withdrawal by Subject|1|||
42025328|NCT00996333|75833200|FG000|Overall Study|Death|4|||
42025329|NCT00996333|75833200|FG000|Overall Study|Adverse Event|1|||
42025330|NCT00996333|75833200|FG000|Overall Study|Physician Decision|1|||
42025331|NCT00996333|75833200|FG000|Overall Study|Other|5|||
42025332|NCT00995865|75833207|FG000|Overall Study|Protocol Violation|2|||
42025333|NCT00995865|75833208|FG001|Overall Study|Protocol Violation|0|||
42025334|NCT00995865|75833209|FG002|Overall Study|Protocol Violation|0|||
42025335|NCT00995865|75833207|FG000|Overall Study|Lost to Follow-up|0|||
42025336|NCT00995865|75833208|FG001|Overall Study|Lost to Follow-up|0|||
42025337|NCT00995865|75833209|FG002|Overall Study|Lost to Follow-up|1|||
42025338|NCT00995709|75833225|FG000|Overall Study|Adverse Event|4|||
42025339|NCT00995709|75833226|FG001|Overall Study|Adverse Event|2|||
42025340|NCT00995709|75833227|FG002|Overall Study|Adverse Event|0|||
42025341|NCT00995709|75833225|FG000|Overall Study|Lack of Efficacy|0|||
42025342|NCT00995709|75833226|FG001|Overall Study|Lack of Efficacy|1|||
42025343|NCT00995709|75833227|FG002|Overall Study|Lack of Efficacy|4|||
42025344|NCT00995709|75833225|FG000|Overall Study|Withdrawal by Subject|0|||
42025345|NCT00995709|75833226|FG001|Overall Study|Withdrawal by Subject|4|||
42025346|NCT00995709|75833227|FG002|Overall Study|Withdrawal by Subject|1|||
42025347|NCT00995709|75833225|FG000|Overall Study|Lost to Follow-up|1|||
42025348|NCT00995709|75833226|FG001|Overall Study|Lost to Follow-up|0|||
42025349|NCT00995709|75833227|FG002|Overall Study|Lost to Follow-up|0|||
42025350|NCT00995709|75833225|FG000|Overall Study|Death|0|||
42025351|NCT00995709|75833226|FG001|Overall Study|Death|1|||
42025352|NCT00995709|75833227|FG002|Overall Study|Death|0|||
42025353|NCT00995709|75833225|FG000|Overall Study|Protocol Violation|2|||
42025354|NCT00995709|75833226|FG001|Overall Study|Protocol Violation|1|||
42025355|NCT00995709|75833227|FG002|Overall Study|Protocol Violation|0|||
42025356|NCT00998985|75833249|FG000|Overall Study|Withdrawal by Subject|0|||
42025357|NCT00998985|75833250|FG001|Overall Study|Withdrawal by Subject|0|||
42025358|NCT00998985|75833251|FG002|Overall Study|Withdrawal by Subject|0|||
42025359|NCT00998985|75833252|FG003|Overall Study|Withdrawal by Subject|0|||
42025360|NCT00998985|75833253|FG004|Overall Study|Withdrawal by Subject|0|||
42025361|NCT00998985|75833254|FG005|Overall Study|Withdrawal by Subject|0|||
42025362|NCT00998985|75833255|FG006|Overall Study|Withdrawal by Subject|0|||
42025363|NCT00998985|75833256|FG007|Overall Study|Withdrawal by Subject|0|||
42025364|NCT00998985|75833257|FG008|Overall Study|Withdrawal by Subject|1|||
42025365|NCT00998985|75833258|FG009|Overall Study|Withdrawal by Subject|0|||
42025366|NCT00998985|75833259|FG010|Overall Study|Withdrawal by Subject|0|||
42025367|NCT00998985|75833260|FG011|Overall Study|Withdrawal by Subject|0|||
42025368|NCT00998985|75833261|FG012|Overall Study|Withdrawal by Subject|0|||
42025369|NCT00998985|75833262|FG013|Overall Study|Withdrawal by Subject|0|||
42025370|NCT00998985|75833249|FG000|Overall Study|Protocol Violation|0|||
42025371|NCT00998985|75833250|FG001|Overall Study|Protocol Violation|0|||
42025372|NCT00998985|75833251|FG002|Overall Study|Protocol Violation|0|||
42025373|NCT00998985|75833252|FG003|Overall Study|Protocol Violation|0|||
42025374|NCT00998985|75833253|FG004|Overall Study|Protocol Violation|0|||
42025375|NCT00998985|75833254|FG005|Overall Study|Protocol Violation|1|||
42025376|NCT00998985|75833255|FG006|Overall Study|Protocol Violation|0|||
42025377|NCT00998985|75833256|FG007|Overall Study|Protocol Violation|0|||
42025378|NCT00998985|75833257|FG008|Overall Study|Protocol Violation|0|||
42025379|NCT00998985|75833258|FG009|Overall Study|Protocol Violation|0|||
42210304|NCT04502589|76025087|FG000|Overall Study|Physician Decision|1|||
42210305|NCT04502589|76025088|FG001|Overall Study|Physician Decision|0|||
42025380|NCT00998985|75833259|FG010|Overall Study|Protocol Violation|0|||
42025381|NCT00998985|75833260|FG011|Overall Study|Protocol Violation|0|||
42025382|NCT00998985|75833261|FG012|Overall Study|Protocol Violation|0|||
42025383|NCT00998985|75833262|FG013|Overall Study|Protocol Violation|0|||
42025384|NCT00995553|75833309|FG000|Overall Study|Withdrawal by Subject|2|||
42025385|NCT00995553|75833310|FG001|Overall Study|Withdrawal by Subject|6|||
42025386|NCT00991887|75833318|FG000|Overall Study|Lost to Follow-up|2|||
42025387|NCT00991887|75833319|FG001|Overall Study|Lost to Follow-up|1|||
42025388|NCT01002339|75833328|FG000|Overall Study|Withdrawal by Subject|0|||
42025389|NCT01002339|75833329|FG001|Overall Study|Withdrawal by Subject|1|||
42025390|NCT01002339|75833330|FG002|Overall Study|Withdrawal by Subject|0|||
42025391|NCT01002339|75833328|FG000|Overall Study|Incorrect treatment assignment|0|||
42025392|NCT01002339|75833329|FG001|Overall Study|Incorrect treatment assignment|0|||
42025393|NCT01002339|75833330|FG002|Overall Study|Incorrect treatment assignment|1|||
42025394|NCT01002339|75833328|FG000|Overall Study|Protocol Violation|0|||
42025395|NCT01002339|75833329|FG001|Overall Study|Protocol Violation|0|||
42025396|NCT01002339|75833330|FG002|Overall Study|Protocol Violation|2|||
42025397|NCT01002339|75833328|FG000|Overall Study|Lung cancer detected before transplant|0|||
42025398|NCT01002339|75833329|FG001|Overall Study|Lung cancer detected before transplant|0|||
42025399|NCT01002339|75833330|FG002|Overall Study|Lung cancer detected before transplant|1|||
42025400|NCT01002339|75833328|FG000|Overall Study|Randomized. Not transplanted|0|||
42025401|NCT01002339|75833329|FG001|Overall Study|Randomized. Not transplanted|0|||
42025402|NCT01002339|75833330|FG002|Overall Study|Randomized. Not transplanted|1|||
42025403|NCT01002105|75833340|FG000|Overall Study|Lost to Follow-up|10|||
42025404|NCT01002105|75833341|FG001|Overall Study|Lost to Follow-up|16|||
42025405|NCT01002105|75833340|FG000|Overall Study|non compliance|5|||
42025406|NCT01002105|75833341|FG001|Overall Study|non compliance|3|||
42025407|NCT01002105|75833340|FG000|Overall Study|condition worsened|4|||
42025408|NCT01002105|75833341|FG001|Overall Study|condition worsened|2|||
42025409|NCT02605993|75833354|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
42300616|NCT02294019|76135800|FG000|Overall Study|Lost to Follow-up|31|||
42300617|NCT02294019|76135800|FG000|Overall Study|Other|1|||
42300618|NCT02294019|76135800|FG000|Overall Study|Withdrawal by Subject|1|||
42300619|NCT02320149|76135806|FG000|Overall Study|Adverse Event|3|||
42300620|NCT02320149|76135807|FG001|Overall Study|Adverse Event|7|||
42300621|NCT02320149|76135806|FG000|Overall Study|Withdrawal of Consent|28|||
42300622|NCT02320149|76135807|FG001|Overall Study|Withdrawal of Consent|32|||
42300623|NCT02320149|76135806|FG000|Overall Study|Lost to Follow-up|21|||
41962540|NCT01107457|75735826|FG001|Part B and C|Sponsor Decision|0|||
41962541|NCT01107457|75735827|FG002|Part B and C|Sponsor Decision|0|||
41962542|NCT01107457|75735828|FG003|Part B and C|Sponsor Decision|0|||
41962543|NCT01107457|75735829|FG004|Part B and C|Sponsor Decision|0|||
41962544|NCT01107457|75735830|FG005|Part B and C|Sponsor Decision|66|||
41962545|NCT01107457|75735825|FG000|Part B and C|Withdrawal by Subject|0|||
41962546|NCT01107457|75735826|FG001|Part B and C|Withdrawal by Subject|0|||
41962547|NCT01107457|75735827|FG002|Part B and C|Withdrawal by Subject|0|||
41962548|NCT01107457|75735828|FG003|Part B and C|Withdrawal by Subject|0|||
41962549|NCT01107457|75735829|FG004|Part B and C|Withdrawal by Subject|0|||
42025410|NCT02605993|75833355|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
42025411|NCT02605993|75833356|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
42025412|NCT02605993|75833357|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
42025413|NCT00995085|75833367|FG000|Overall Study|Withdrawal by Subject|5|||
42025414|NCT00603733|75833373|FG000|Active Phase ITT|Adverse Event|8|||
42025415|NCT00603733|75833374|FG001|Active Phase ITT|Adverse Event|7|||
42025416|NCT00603733|75833373|FG000|Active Phase ITT|Withdrawal by Subject|0|||
42025417|NCT00603733|75833374|FG001|Active Phase ITT|Withdrawal by Subject|3|||
42025418|NCT00603733|75833373|FG000|Active Phase ITT|Lost to Follow-up|0|||
42025419|NCT00603733|75833374|FG001|Active Phase ITT|Lost to Follow-up|1|||
42025420|NCT00603733|75833373|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
42025421|NCT00603733|75833374|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
42025422|NCT00603733|75833373|FG000|Active Phase ITT|Lack of Efficacy|1|||
42025423|NCT00603733|75833374|FG001|Active Phase ITT|Lack of Efficacy|2|||
42025424|NCT00603733|75833373|FG000|Active Phase ITT|Subject moved, site closed|1|||
42025425|NCT00603733|75833374|FG001|Active Phase ITT|Subject moved, site closed|1|||
42210306|NCT03291288|76025094|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
42210307|NCT03291288|76025095|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
42210308|NCT03291288|76025094|FG000|Drug-drug Interaction Phase|Disease progression|1|||
42210309|NCT03291288|76025095|FG001|Drug-drug Interaction Phase|Disease progression|0|||
42210310|NCT03291288|76025094|FG000|Drug-drug Interaction Phase|Other|3|||
42210311|NCT03291288|76025095|FG001|Drug-drug Interaction Phase|Other|0|||
41962550|NCT01107457|75735830|FG005|Part B and C|Withdrawal by Subject|16|||
41962551|NCT01107457|75735825|FG000|Part B and C|Clinical Relapse|0|||
41962552|NCT01107457|75735826|FG001|Part B and C|Clinical Relapse|0|||
41962553|NCT01107457|75735827|FG002|Part B and C|Clinical Relapse|0|||
42025426|NCT00603733|75833373|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
42025427|NCT00603733|75833374|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
42025428|NCT00603733|75833373|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
42025429|NCT00603733|75833374|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
42025430|NCT00603733|75833373|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
42118165|NCT00545688|75929052|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
42118166|NCT00545688|75929053|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
42118167|NCT00545688|75929050|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
42118168|NCT00545688|75929051|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
42118169|NCT00545688|75929052|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
42118170|NCT00545688|75929053|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
42118171|NCT00545688|75929050|FG000|Neo-Adjuvant Treatment Period|Death|0|||
42118172|NCT00545688|75929051|FG001|Neo-Adjuvant Treatment Period|Death|1|||
42118173|NCT00545688|75929052|FG002|Neo-Adjuvant Treatment Period|Death|0|||
42025431|NCT00603733|75833374|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
42025432|NCT00603733|75833373|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
42025433|NCT00603733|75833374|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
42025434|NCT00603733|75833373|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
42025435|NCT00603733|75833374|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
42025436|NCT00603733|75833373|FG000|Maintenance Phase ITT|Adverse Event|3|||
42025437|NCT00603733|75833374|FG001|Maintenance Phase ITT|Adverse Event|6|||
42025438|NCT00603733|75833373|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
42025439|NCT00603733|75833374|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
42025440|NCT00603733|75833373|FG000|Maintenance Phase ITT|Protocol Violation|1|||
42025441|NCT00603733|75833374|FG001|Maintenance Phase ITT|Protocol Violation|1|||
42025442|NCT00603733|75833373|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
42025443|NCT00603733|75833374|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
42025444|NCT00603733|75833373|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
42025445|NCT00603733|75833374|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
42025446|NCT00603733|75833373|FG000|Maintenance Phase ITT|Physician Decision|0|||
42025447|NCT00603733|75833374|FG001|Maintenance Phase ITT|Physician Decision|1|||
42025448|NCT00603733|75833373|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
42025449|NCT00603733|75833374|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
42025450|NCT04631107|75833380|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
42025451|NCT04631107|75833380|FG000|Second Intervention (1 Night)|Adverse Event|1|||
42025452|NCT04631107|75833380|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
42300624|NCT02320149|76135807|FG001|Overall Study|Lost to Follow-up|34|||
42300625|NCT02320149|76135806|FG000|Overall Study|Protocol Violation|2|||
42300626|NCT02320149|76135807|FG001|Overall Study|Protocol Violation|1|||
42300627|NCT02320149|76135806|FG000|Overall Study|Noncompliance with Study Treatment|7|||
42300628|NCT02320149|76135807|FG001|Overall Study|Noncompliance with Study Treatment|2|||
42300629|NCT02320149|76135806|FG000|Overall Study|Lack of Efficacy|0|||
42300630|NCT02320149|76135807|FG001|Overall Study|Lack of Efficacy|1|||
42300631|NCT02320149|76135806|FG000|Overall Study|Other Miscellaneous Reasons|2|||
41962554|NCT01107457|75735828|FG003|Part B and C|Clinical Relapse|0|||
41962555|NCT01107457|75735829|FG004|Part B and C|Clinical Relapse|0|||
42025453|NCT04631107|75833380|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
42025454|NCT00995007|75833390|FG000|Overall Study|Withdrew consent|1|||
42025455|NCT00995007|75833391|FG001|Overall Study|Withdrew consent|0|||
42025456|NCT00995007|75833390|FG000|Overall Study|Refused further treatment|8|||
42025457|NCT00995007|75833391|FG001|Overall Study|Refused further treatment|2|||
42025458|NCT00995007|75833390|FG000|Overall Study|Toxicity|8|||
42025459|NCT00995007|75833391|FG001|Overall Study|Toxicity|0|||
42025460|NCT00994461|75833409|FG000|Overall Study|Adverse Event|2|||
42025461|NCT00994461|75833410|FG001|Overall Study|Adverse Event|1|||
42025462|NCT00994461|75833411|FG002|Overall Study|Adverse Event|0|||
42025463|NCT00993915|75833419|FG000|Overall Study|Insufficient clinical response|3|||
42025464|NCT00993915|75833419|FG000|Overall Study|Withdrawal by Subject|2|||
42025465|NCT00993915|75833419|FG000|Overall Study|Other|1|||
42025466|NCT00993915|75833419|FG000|Overall Study|Ongoing|3|||
42025467|NCT01202591|75833429|FG000|Overall Study|Adverse Event|2|||
42025468|NCT01202591|75833430|FG001|Overall Study|Adverse Event|1|||
42025469|NCT01202591|75833431|FG002|Overall Study|Adverse Event|4|||
42025470|NCT01202591|75833432|FG003|Overall Study|Adverse Event|4|||
42025471|NCT01202591|75833433|FG004|Overall Study|Adverse Event|0|||
42025472|NCT01202591|75833434|FG005|Overall Study|Adverse Event|0|||
42025473|NCT01202591|75833429|FG000|Overall Study|Other reason as per investigator|3|||
42025474|NCT01202591|75833430|FG001|Overall Study|Other reason as per investigator|4|||
42025475|NCT01202591|75833431|FG002|Overall Study|Other reason as per investigator|7|||
42025476|NCT01202591|75833432|FG003|Overall Study|Other reason as per investigator|3|||
41962556|NCT01107457|75735830|FG005|Part B and C|Clinical Relapse|4|||
41962557|NCT04545385|75735860|FG000|Overall Study|Withdrawal by Subject|2|||
41962558|NCT04545385|75735861|FG001|Overall Study|Withdrawal by Subject|0|||
41962559|NCT04545385|75735860|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
41962560|NCT04545385|75735861|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
41962561|NCT04545385|75735860|FG000|Overall Study|Study termination|10|||
41962562|NCT04545385|75735861|FG001|Overall Study|Study termination|10|||
41962563|NCT04545385|75735860|FG000|Overall Study|Sponsor decision|2|||
41962564|NCT04545385|75735861|FG001|Overall Study|Sponsor decision|2|||
41962565|NCT04545385|75735860|FG000|Overall Study|Other than specified|1|||
42025477|NCT01202591|75833433|FG004|Overall Study|Other reason as per investigator|1|||
42025478|NCT01202591|75833434|FG005|Overall Study|Other reason as per investigator|3|||
42025479|NCT01202591|75833429|FG000|Overall Study|Withdrawal by Subject|0|||
42025480|NCT01202591|75833430|FG001|Overall Study|Withdrawal by Subject|0|||
42025481|NCT01202591|75833431|FG002|Overall Study|Withdrawal by Subject|0|||
42025482|NCT01202591|75833432|FG003|Overall Study|Withdrawal by Subject|0|||
42025483|NCT01202591|75833433|FG004|Overall Study|Withdrawal by Subject|2|||
42025484|NCT01202591|75833434|FG005|Overall Study|Withdrawal by Subject|1|||
42025485|NCT01202591|75833429|FG000|Overall Study|Objective Disease Progression|0|||
42025486|NCT01202591|75833430|FG001|Overall Study|Objective Disease Progression|0|||
42025487|NCT01202591|75833431|FG002|Overall Study|Objective Disease Progression|0|||
42025488|NCT01202591|75833432|FG003|Overall Study|Objective Disease Progression|0|||
42025489|NCT01202591|75833433|FG004|Overall Study|Objective Disease Progression|2|||
42025490|NCT01202591|75833434|FG005|Overall Study|Objective Disease Progression|0|||
42025491|NCT01202279|75833450|FG000|Overall Study|Adverse Event|8|||
42025492|NCT01202279|75833451|FG001|Overall Study|Adverse Event|6|||
42025493|NCT01202279|75833450|FG000|Overall Study|Withdrawal by Subject|13|||
42025494|NCT01202279|75833451|FG001|Overall Study|Withdrawal by Subject|10|||
42025495|NCT01202279|75833450|FG000|Overall Study|Physician Decision|0|||
42025496|NCT01202279|75833451|FG001|Overall Study|Physician Decision|1|||
42025497|NCT01202279|75833450|FG000|Overall Study|Lost to Follow-up|10|||
42025498|NCT01202279|75833451|FG001|Overall Study|Lost to Follow-up|7|||
42025499|NCT01202279|75833450|FG000|Overall Study|Protocol Violation|1|||
42025500|NCT01202279|75833451|FG001|Overall Study|Protocol Violation|1|||
42025501|NCT01202279|75833450|FG000|Overall Study|study compliance|5|||
42025502|NCT01202279|75833451|FG001|Overall Study|study compliance|2|||
42025503|NCT01201967|75833459|FG000|Overall Study|Lost to Follow-up|6|||
42025504|NCT01201967|75833460|FG001|Overall Study|Lost to Follow-up|5|||
42025505|NCT01201811|75833476|FG000|Overall Study|Adverse Event|6|||
42025506|NCT01201811|75833476|FG000|Overall Study|Disease progression|3|||
42025507|NCT01201811|75833476|FG000|Overall Study|Withdrawal by Subject|3|||
42025508|NCT01201811|75833476|FG000|Overall Study|Death|4|||
42025509|NCT01201811|75833476|FG000|Overall Study|Treatment Failure|2|||
42025510|NCT01201811|75833476|FG000|Overall Study|Physician Decision|1|||
42025511|NCT01201343|75833480|FG000|Overall Study|Adverse Event|6|||
42025512|NCT01201343|75833480|FG000|Overall Study|Withdrawal by Subject|5|||
42025513|NCT01201343|75833480|FG000|Overall Study|Lost to Follow-up|2|||
42025514|NCT01201343|75833480|FG000|Overall Study|Lack of Efficacy|2|||
42025515|NCT01201343|75833480|FG000|Overall Study|Participant wrongly included in trial|1|||
42025516|NCT01201343|75833480|FG000|Overall Study|Randomized, not treated|3|||
42025517|NCT01201265|75833484|FG000|Overall Study|Death|14|||
42025518|NCT01201265|75833484|FG000|Overall Study|Insufficient Therapeutic Response|3|||
42025519|NCT01201265|75833484|FG000|Overall Study|Lost to Follow-up|10|||
42025520|NCT01201265|75833484|FG000|Overall Study|Withdrawal by Subject|7|||
42025521|NCT01201265|75833484|FG000|Overall Study|Disease Progression|4|||
42025522|NCT04246801|75833490|FG000|Overall Study|Adverse Event|1|||
42025523|NCT04246801|75833491|FG001|Overall Study|Adverse Event|1|||
42025524|NCT04246801|75833490|FG000|Overall Study|Protocol Violation|1|||
42025525|NCT04246801|75833491|FG001|Overall Study|Protocol Violation|1|||
42025526|NCT04246801|75833490|FG000|Overall Study|Lack of Efficacy|0|||
42025527|NCT04246801|75833491|FG001|Overall Study|Lack of Efficacy|2|||
42025528|NCT04246801|75833490|FG000|Overall Study|Lost to Follow-up|1|||
42025529|NCT04246801|75833491|FG001|Overall Study|Lost to Follow-up|1|||
42025530|NCT04246801|75833490|FG000|Overall Study|Withdrawal by Subject|2|||
42025531|NCT04246801|75833491|FG001|Overall Study|Withdrawal by Subject|1|||
42025532|NCT01200797|75833497|FG000|Overall Study|symptomatic deterioration|2|||
42025533|NCT01200797|75833497|FG000|Overall Study|Adverse Event|4|||
42025534|NCT01200797|75833497|FG000|Overall Study|Disease Progression|13|||
42025535|NCT01200485|75833502|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
42025536|NCT01200485|75833503|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
42025537|NCT01200485|75833504|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
42025538|NCT01200485|75833502|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
42025539|NCT01200485|75833503|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
42025540|NCT01200485|75833504|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
42025541|NCT01200407|75833511|FG000|Overall Study|Lost to Follow-up|56|||
42025542|NCT01200407|75833511|FG000|Overall Study|Adverse Event|3|||
42025543|NCT01200407|75833511|FG000|Overall Study|Withdrawal by Subject|4|||
42025544|NCT01200407|75833511|FG000|Overall Study|Other|19|||
42025545|NCT01200329|75833515|FG000|Overall Study|Lack of financial coverage|2|||
42025546|NCT01200329|75833515|FG000|Overall Study|Progressive disease|1|||
42025547|NCT01199939|75833519|FG000|Overall Study|Adverse Event|4|||
42025548|NCT01199939|75833519|FG000|Overall Study|Protocol Violation|3|||
42025549|NCT01199939|75833519|FG000|Overall Study|Lost to Follow-up|2|||
42025550|NCT01199939|75833519|FG000|Overall Study|Reached a virologic endpoint|4|||
42025551|NCT01199861|75833525|FG000|Overall Study|Administrative problems|1|||
42025552|NCT01199861|75833526|FG001|Overall Study|Administrative problems|0|||
42025553|NCT01199861|75833525|FG000|Overall Study|Adverse Event|1|||
42025554|NCT01199861|75833526|FG001|Overall Study|Adverse Event|0|||
42025555|NCT01199705|75833546|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
42025556|NCT01199471|75833561|FG000|Overall Study|Protocol Violation|4|||
42025557|NCT01199471|75833561|FG000|Overall Study|Withdrawal by Subject|1|||
42210312|NCT03291288|76025094|FG000|Pexidartinib Only|Ongoing|0|||
42025558|NCT01199471|75833561|FG000|Overall Study|Physician Decision|1|||
42025559|NCT01198145|75833568|FG000|Overall Study|Withdrawal by Subject|1|||
42025560|NCT01198145|75833569|FG001|Overall Study|Withdrawal by Subject|1|||
42025561|NCT01197911|75833579|FG000|Overall Study|Adverse Event|0|||
42025562|NCT01197911|75833580|FG001|Overall Study|Adverse Event|0|||
42025563|NCT01197911|75833581|FG002|Overall Study|Adverse Event|1|||
42025564|NCT01197755|75833593|FG000|Overall Study|Adverse Event|8|||
42025565|NCT01197755|75833594|FG001|Overall Study|Adverse Event|10|||
42025566|NCT01197755|75833595|FG002|Overall Study|Adverse Event|10|||
42025567|NCT01197755|75833593|FG000|Overall Study|Study-specific discontinuation criteria|2|||
42025568|NCT01197755|75833594|FG001|Overall Study|Study-specific discontinuation criteria|1|||
42025569|NCT01197755|75833595|FG002|Overall Study|Study-specific discontinuation criteria|0|||
42025570|NCT01197755|75833593|FG000|Overall Study|Entered the long-term extension study|18|||
42025571|NCT01197755|75833594|FG001|Overall Study|Entered the long-term extension study|21|||
42025572|NCT01197755|75833595|FG002|Overall Study|Entered the long-term extension study|35|||
42025573|NCT01197755|75833593|FG000|Overall Study|Lack of therapeutic response|0|||
42025574|NCT01197755|75833594|FG001|Overall Study|Lack of therapeutic response|7|||
42025575|NCT01197755|75833595|FG002|Overall Study|Lack of therapeutic response|4|||
42025576|NCT01197755|75833593|FG000|Overall Study|Severe non-compliance to the protocol|2|||
42025577|NCT01197755|75833594|FG001|Overall Study|Severe non-compliance to the protocol|1|||
42025578|NCT01197755|75833595|FG002|Overall Study|Severe non-compliance to the protocol|2|||
42025579|NCT01197755|75833593|FG000|Overall Study|Withdrawal by Subject|1|||
42025580|NCT01197755|75833594|FG001|Overall Study|Withdrawal by Subject|0|||
42025581|NCT01197755|75833595|FG002|Overall Study|Withdrawal by Subject|0|||
42025582|NCT01197755|75833593|FG000|Overall Study|Lost to Follow-up|0|||
42025583|NCT01197755|75833594|FG001|Overall Study|Lost to Follow-up|0|||
42025584|NCT01197755|75833595|FG002|Overall Study|Lost to Follow-up|1|||
42025585|NCT01197755|75833593|FG000|Overall Study|eg, change in circumstances|7|||
42025586|NCT01197755|75833594|FG001|Overall Study|eg, change in circumstances|3|||
42025587|NCT01197755|75833595|FG002|Overall Study|eg, change in circumstances|2|||
42025588|NCT01179048|75833607|FG000|Overall Study|Withdrawn - does not allow contact|4|||
42025589|NCT01179048|75833608|FG001|Overall Study|Withdrawn - does not allow contact|8|||
42025590|NCT01179048|75833607|FG000|Overall Study|Lost to Follow-up|8|||
41962566|NCT04545385|75735861|FG001|Overall Study|Other than specified|0|||
41962567|NCT03783026|75735876|FG000|Treatment Phase|Adverse Event|15|||
41962568|NCT03783026|75735876|FG000|Treatment Phase|Lack of Efficacy|11|||
41962569|NCT03783026|75735876|FG000|Treatment Phase|Withdrawal by Subject|6|||
41962570|NCT03783026|75735876|FG000|Treatment Phase|Lost to Follow-up|2|||
41962571|NCT03783026|75735876|FG000|Treatment Phase|Protocol Deviation|8|||
41962572|NCT03783026|75735876|FG000|Treatment Phase|Did Not Receive Treatment|1|||
41962573|NCT03783026|75735876|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
41962574|NCT03635112|75735883|FG000|Overall Study|Adverse Event|5|||
41962575|NCT03635112|75735884|FG001|Overall Study|Adverse Event|9|||
41962576|NCT03635112|75735885|FG002|Overall Study|Adverse Event|14|||
41962577|NCT03635112|75735883|FG000|Overall Study|Lost to Follow-up|1|||
41962578|NCT03635112|75735884|FG001|Overall Study|Lost to Follow-up|0|||
41962579|NCT03635112|75735885|FG002|Overall Study|Lost to Follow-up|1|||
41962580|NCT03635112|75735883|FG000|Overall Study|Physician Decision|5|||
41962581|NCT03635112|75735884|FG001|Overall Study|Physician Decision|7|||
41962582|NCT03635112|75735885|FG002|Overall Study|Physician Decision|5|||
41962583|NCT03635112|75735883|FG000|Overall Study|Protocol Violation|0|||
41962584|NCT03635112|75735884|FG001|Overall Study|Protocol Violation|0|||
41962585|NCT03635112|75735885|FG002|Overall Study|Protocol Violation|1|||
41962586|NCT03635112|75735883|FG000|Overall Study|Study Terminated by Sponsor|11|||
42025591|NCT01179048|75833608|FG001|Overall Study|Lost to Follow-up|9|||
42025592|NCT01179048|75833607|FG000|Overall Study|Alive|127|||
42025593|NCT01179048|75833608|FG001|Overall Study|Alive|142|||
42025594|NCT00603265|75833617|FG000|Overall Study|Adverse Event|2|||
42025595|NCT00603265|75833618|FG001|Overall Study|Adverse Event|11|||
42025596|NCT00603265|75833619|FG002|Overall Study|Adverse Event|1|||
42025597|NCT00603265|75833617|FG000|Overall Study|Withdrawal by Subject|1|||
41962587|NCT03635112|75735884|FG001|Overall Study|Study Terminated by Sponsor|17|||
41962588|NCT03635112|75735885|FG002|Overall Study|Study Terminated by Sponsor|21|||
41962589|NCT03635112|75735883|FG000|Overall Study|Withdrawal by Subject|4|||
41962590|NCT03635112|75735884|FG001|Overall Study|Withdrawal by Subject|9|||
42025598|NCT00603265|75833618|FG001|Overall Study|Withdrawal by Subject|2|||
42025599|NCT00603265|75833619|FG002|Overall Study|Withdrawal by Subject|1|||
42025600|NCT00603265|75833617|FG000|Overall Study|Lack of Efficacy|3|||
42025601|NCT00603265|75833618|FG001|Overall Study|Lack of Efficacy|0|||
42025602|NCT00603265|75833619|FG002|Overall Study|Lack of Efficacy|3|||
42025603|NCT00603265|75833617|FG000|Overall Study|Lost to Follow-up|0|||
42025604|NCT00603265|75833618|FG001|Overall Study|Lost to Follow-up|1|||
42025605|NCT00603265|75833619|FG002|Overall Study|Lost to Follow-up|0|||
42025606|NCT00603265|75833617|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
42025607|NCT00603265|75833618|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
42025608|NCT00603265|75833619|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
42025609|NCT00603265|75833617|FG000|Overall Study|Participant Left Country, No Responses|0|||
42025610|NCT00603265|75833618|FG001|Overall Study|Participant Left Country, No Responses|1|||
42025611|NCT00603265|75833619|FG002|Overall Study|Participant Left Country, No Responses|0|||
42025612|NCT00603265|75833617|FG000|Overall Study|Protocol Violation|1|||
42025613|NCT00603265|75833618|FG001|Overall Study|Protocol Violation|0|||
42025614|NCT00603265|75833619|FG002|Overall Study|Protocol Violation|0|||
42025615|NCT04010227|75833629|FG000|Overall Study|Death|1|||
42025616|NCT04010227|75833630|FG001|Overall Study|Death|2|||
42025617|NCT04010227|75833629|FG000|Overall Study|Medical Reasons|4|||
42025618|NCT04010227|75833630|FG001|Overall Study|Medical Reasons|3|||
42025619|NCT04010227|75833629|FG000|Overall Study|Withdrawal by Subject|2|||
42025620|NCT04010227|75833630|FG001|Overall Study|Withdrawal by Subject|0|||
42025621|NCT04010227|75833629|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
42025622|NCT04010227|75833630|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
42025623|NCT01158534|75833637|FG000|Overall Study|Withdrawal by Subject|1|||
42025624|NCT01158534|75833637|FG000|Overall Study|Death|1|||
42025625|NCT01158534|75833637|FG000|Overall Study|Other|1|||
42025626|NCT01158378|75833643|FG000|Overall Study|Death|4|||
42025627|NCT01158378|75833644|FG001|Overall Study|Death|5|||
42025628|NCT01158378|75833643|FG000|Overall Study|Lost to Follow-up|2|||
42025629|NCT01158378|75833644|FG001|Overall Study|Lost to Follow-up|4|||
42025630|NCT01158378|75833643|FG000|Overall Study|Withdrawal by Subject|4|||
42025631|NCT01158378|75833644|FG001|Overall Study|Withdrawal by Subject|0|||
42025632|NCT01158222|75833651|FG000|Overall Study|Not eligible for intermediate phase|17|||
42025633|NCT01197521|75833658|FG000|Overall Study|Not reported|24|||
42025634|NCT01197521|75833659|FG001|Overall Study|Not reported|25|||
42025635|NCT01197521|75833660|FG002|Overall Study|Not reported|21|||
42025636|NCT01197521|75833658|FG000|Overall Study|Enrolment in long term extension|42|||
42025637|NCT01197521|75833659|FG001|Overall Study|Enrolment in long term extension|36|||
42025638|NCT01197521|75833660|FG002|Overall Study|Enrolment in long term extension|87|||
42025639|NCT01197521|75833658|FG000|Overall Study|Severe non-compliance to protocol|1|||
42025640|NCT01197521|75833659|FG001|Overall Study|Severe non-compliance to protocol|3|||
42025641|NCT01197521|75833660|FG002|Overall Study|Severe non-compliance to protocol|3|||
42210313|NCT03291288|76025095|FG001|Pexidartinib Only|Ongoing|2|||
42300632|NCT02320149|76135807|FG001|Overall Study|Other Miscellaneous Reasons|3|||
41962591|NCT03635112|75735885|FG002|Overall Study|Withdrawal by Subject|7|||
41962592|NCT03635112|75735883|FG000|Overall Study|Miscellaneous|0|||
41962593|NCT03635112|75735884|FG001|Overall Study|Miscellaneous|0|||
41962594|NCT03635112|75735885|FG002|Overall Study|Miscellaneous|1|||
41962595|NCT03588728|75735898|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
41962596|NCT03588728|75735899|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
41962597|NCT03588728|75735900|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
41962598|NCT03588728|75735901|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
41962599|NCT03588728|75735898|FG000|Overall Study|Lab shut down due to COVID-19|0|||
41962600|NCT03588728|75735899|FG001|Overall Study|Lab shut down due to COVID-19|0|||
41962601|NCT03588728|75735900|FG002|Overall Study|Lab shut down due to COVID-19|0|||
41962602|NCT03588728|75735901|FG003|Overall Study|Lab shut down due to COVID-19|1|||
41962603|NCT03588728|75735898|FG000|Overall Study|multiple technical issues|1|||
41962604|NCT03588728|75735899|FG001|Overall Study|multiple technical issues|0|||
41962605|NCT03588728|75735900|FG002|Overall Study|multiple technical issues|0|||
41962606|NCT03588728|75735901|FG003|Overall Study|multiple technical issues|0|||
41962607|NCT03588728|75735898|FG000|Overall Study|Hospitalized for COVID|1|||
41962608|NCT03588728|75735899|FG001|Overall Study|Hospitalized for COVID|0|||
41962609|NCT03588728|75735900|FG002|Overall Study|Hospitalized for COVID|0|||
41962610|NCT03588728|75735901|FG003|Overall Study|Hospitalized for COVID|0|||
41962611|NCT03588728|75735898|FG000|Overall Study|Schedule change unable to attend sessions|1|||
41962612|NCT03588728|75735899|FG001|Overall Study|Schedule change unable to attend sessions|0|||
41962613|NCT03588728|75735900|FG002|Overall Study|Schedule change unable to attend sessions|0|||
41962614|NCT03588728|75735901|FG003|Overall Study|Schedule change unable to attend sessions|0|||
41962615|NCT02987543|75735923|FG000|Overall Study|Ongoing study at data cut off|49|||
41962616|NCT02987543|75735924|FG001|Overall Study|Ongoing study at data cut off|21|||
41962617|NCT02987543|75735925|FG002|Overall Study|Ongoing study at data cut off|19|||
41962618|NCT02987543|75735926|FG003|Overall Study|Ongoing study at data cut off|12|||
41962619|NCT02987543|75735923|FG000|Overall Study|Death|88|||
41962620|NCT02987543|75735924|FG001|Overall Study|Death|54|||
41962621|NCT02987543|75735925|FG002|Overall Study|Death|67|||
41962622|NCT02987543|75735926|FG003|Overall Study|Death|28|||
41962623|NCT02987543|75735923|FG000|Overall Study|Lost to Follow-up|3|||
41962624|NCT02987543|75735924|FG001|Overall Study|Lost to Follow-up|0|||
42025642|NCT01197521|75833658|FG000|Overall Study|Lack of therapeutic response|2|||
42025643|NCT01197521|75833659|FG001|Overall Study|Lack of therapeutic response|3|||
42025644|NCT01197521|75833660|FG002|Overall Study|Lack of therapeutic response|4|||
42025645|NCT01197521|75833658|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
42025646|NCT01197521|75833659|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
42025647|NCT01197521|75833660|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
42025648|NCT01197521|75833658|FG000|Overall Study|Lost to Follow-up|3|||
42025649|NCT01197521|75833659|FG001|Overall Study|Lost to Follow-up|2|||
42025650|NCT01197521|75833660|FG002|Overall Study|Lost to Follow-up|2|||
42025651|NCT01197521|75833658|FG000|Overall Study|Adverse Event|25|||
42025652|NCT01197521|75833659|FG001|Overall Study|Adverse Event|28|||
42025653|NCT01197521|75833660|FG002|Overall Study|Adverse Event|24|||
42025654|NCT01157676|75833673|FG000|Randomization|Death|1|||
42025655|NCT01157676|75833674|FG001|Randomization|Death|1|||
42025656|NCT01157676|75833673|FG000|Randomization|unresectable|2|||
42025657|NCT01157676|75833674|FG001|Randomization|unresectable|3|||
42025658|NCT01157676|75833673|FG000|Randomization|Withdrawal by Subject|17|||
42025659|NCT01157676|75833674|FG001|Randomization|Withdrawal by Subject|13|||
42025660|NCT01157676|75833673|FG000|Randomization|Physician Decision|1|||
42025661|NCT01157676|75833674|FG001|Randomization|Physician Decision|0|||
42025662|NCT01157676|75833673|FG000|Surgery|underwent open cystectomy|0|||
42025663|NCT01157676|75833674|FG001|Surgery|underwent open cystectomy|4|||
42025664|NCT01157676|75833673|FG000|Surgery|converted to open procedure|0|||
42025665|NCT01157676|75833674|FG001|Surgery|converted to open procedure|5|||
42025666|NCT01157676|75833673|FG000|Surgery|underwent robotic cystectomy|1|||
42118174|NCT00545688|75929053|FG003|Neo-Adjuvant Treatment Period|Death|0|||
42118175|NCT00545688|75929050|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
42118176|NCT00545688|75929051|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
42025667|NCT01157676|75833674|FG001|Surgery|underwent robotic cystectomy|0|||
42025668|NCT00991341|75833688|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
42025669|NCT00991341|75833689|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
42025670|NCT00991341|75833688|FG000|Overall Study|Death|3|||
42025671|NCT00991341|75833689|FG001|Overall Study|Death|0|||
42118177|NCT00545688|75929052|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
42118178|NCT00545688|75929053|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
42118179|NCT00545688|75929050|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
42118180|NCT00545688|75929051|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
42118181|NCT00545688|75929052|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
42118182|NCT00545688|75929053|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
42118183|NCT00545688|75929050|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
42118184|NCT00545688|75929051|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
42118185|NCT00545688|75929052|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
42118186|NCT00545688|75929053|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
42118187|NCT00545688|75929050|FG000|Adjuvant Treatment Period|Disease Progression|3|||
42025672|NCT00991341|75833688|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
42025673|NCT00991341|75833689|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
42025674|NCT00991341|75833688|FG000|Overall Study|Physician Decision|1|||
42118188|NCT00545688|75929051|FG001|Adjuvant Treatment Period|Disease Progression|3|||
42118189|NCT00545688|75929052|FG002|Adjuvant Treatment Period|Disease Progression|0|||
42118190|NCT00545688|75929053|FG003|Adjuvant Treatment Period|Disease Progression|7|||
42118191|NCT00545688|75929050|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
42025675|NCT00991341|75833689|FG001|Overall Study|Physician Decision|2|||
42025676|NCT00991341|75833688|FG000|Overall Study|Withdrawal by Subject|3|||
42025677|NCT00991341|75833689|FG001|Overall Study|Withdrawal by Subject|4|||
42025678|NCT00990249|75833695|FG000|Overall Study|Disease Progression|8|||
42025679|NCT00990249|75833695|FG000|Overall Study|Non-Compliance|1|||
42025680|NCT00990249|75833695|FG000|Overall Study|Death|2|||
42025681|NCT00990249|75833695|FG000|Overall Study|Not treated|2|||
42025682|NCT02846545|75833701|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
42025683|NCT02846545|75833702|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
42025684|NCT02846545|75833701|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
42025685|NCT02846545|75833702|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
42118192|NCT00545688|75929051|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
42118193|NCT00545688|75929052|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
42118194|NCT00545688|75929053|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
42118195|NCT00545688|75929050|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
42118196|NCT00545688|75929051|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
42118197|NCT00545688|75929052|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
42118198|NCT00545688|75929053|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
42118199|NCT00545688|75929050|FG000|Adjuvant Treatment Period|Adverse Event|0|||
42118200|NCT00545688|75929051|FG001|Adjuvant Treatment Period|Adverse Event|3|||
42118201|NCT00545688|75929052|FG002|Adjuvant Treatment Period|Adverse Event|2|||
42118202|NCT00545688|75929053|FG003|Adjuvant Treatment Period|Adverse Event|2|||
42118203|NCT00545688|75929050|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
42118204|NCT00545688|75929051|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
42118205|NCT00545688|75929052|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
42118206|NCT00545688|75929053|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
42118207|NCT00545688|75929050|FG000|Follow-Up Period|Death|4|||
42025686|NCT02846545|75833701|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
42025687|NCT02846545|75833702|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
42025688|NCT02846545|75833701|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
42025689|NCT02846545|75833702|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
42025690|NCT02846545|75833701|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
42025691|NCT02846545|75833702|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
42025692|NCT00990093|75833712|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
42025693|NCT00990093|75833713|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
42025694|NCT00990093|75833712|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
42025695|NCT00990093|75833713|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
42025696|NCT00990093|75833712|FG000|Test Period 1 (1-14 Days)|Other|1|||
42025697|NCT00990093|75833713|FG001|Test Period 1 (1-14 Days)|Other|0|||
42025698|NCT00990093|75833712|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
42025699|NCT00990093|75833713|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
42025700|NCT00990093|75833712|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
42025701|NCT00990093|75833713|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
42025702|NCT00990093|75833712|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
42025703|NCT00990093|75833713|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
42025704|NCT00990093|75833712|FG000|Test Period 2 (15-28 Days)|Other|0|||
42025705|NCT00990093|75833713|FG001|Test Period 2 (15-28 Days)|Other|1|||
42025706|NCT00984165|75833723|FG000|Overall Study|Death on study|2|||
42025707|NCT00984165|75833724|FG001|Overall Study|Death on study|0|||
42025708|NCT00984165|75833725|FG002|Overall Study|Death on study|0|||
42025709|NCT00984165|75833726|FG003|Overall Study|Death on study|0|||
42025710|NCT00984165|75833723|FG000|Overall Study|Disease progression on study|5|||
42025711|NCT00984165|75833724|FG001|Overall Study|Disease progression on study|1|||
42025712|NCT00984165|75833725|FG002|Overall Study|Disease progression on study|0|||
42025713|NCT00984165|75833726|FG003|Overall Study|Disease progression on study|0|||
42025714|NCT00984165|75833723|FG000|Overall Study|Death of recipient|0|||
42025715|NCT00984165|75833724|FG001|Overall Study|Death of recipient|0|||
42025716|NCT00984165|75833725|FG002|Overall Study|Death of recipient|0|||
42025717|NCT00984165|75833726|FG003|Overall Study|Death of recipient|1|||
42025718|NCT00984165|75833723|FG000|Overall Study|New protocol|0|||
42025719|NCT00984165|75833724|FG001|Overall Study|New protocol|0|||
42025720|NCT00984165|75833725|FG002|Overall Study|New protocol|0|||
42025721|NCT00984165|75833726|FG003|Overall Study|New protocol|1|||
42025722|NCT00984165|75833723|FG000|Overall Study|P+/donor pair removed from protocol|0|||
42025723|NCT00984165|75833724|FG001|Overall Study|P+/donor pair removed from protocol|0|||
42025724|NCT00984165|75833725|FG002|Overall Study|P+/donor pair removed from protocol|0|||
42025725|NCT00984165|75833726|FG003|Overall Study|P+/donor pair removed from protocol|1|||
42025726|NCT00984165|75833723|FG000|Overall Study|removed with a pair recipient|0|||
42025727|NCT00984165|75833724|FG001|Overall Study|removed with a pair recipient|0|||
42118208|NCT00545688|75929051|FG001|Follow-Up Period|Death|2|||
42118209|NCT00545688|75929052|FG002|Follow-Up Period|Death|2|||
42025728|NCT00984165|75833725|FG002|Overall Study|removed with a pair recipient|0|||
42025729|NCT00984165|75833726|FG003|Overall Study|removed with a pair recipient|1|||
42025730|NCT00993291|75833737|FG000|Overall Study|Withdrawal by Subject|1|||
42025731|NCT01196975|75833746|FG000|Overall Study|Adverse Event|2|||
42025732|NCT01196975|75833747|FG001|Overall Study|Adverse Event|2|||
42025733|NCT01196975|75833748|FG002|Overall Study|Adverse Event|0|||
42025734|NCT01196975|75833749|FG003|Overall Study|Adverse Event|0|||
42025735|NCT01196975|75833750|FG004|Overall Study|Adverse Event|2|||
42025736|NCT01196975|75833746|FG000|Overall Study|Withdrawal by Subject|2|||
42025737|NCT01196975|75833747|FG001|Overall Study|Withdrawal by Subject|1|||
42025738|NCT01196975|75833748|FG002|Overall Study|Withdrawal by Subject|0|||
42118210|NCT00545688|75929053|FG003|Follow-Up Period|Death|6|||
42025739|NCT01196975|75833749|FG003|Overall Study|Withdrawal by Subject|1|||
42025740|NCT01196975|75833750|FG004|Overall Study|Withdrawal by Subject|0|||
42025741|NCT01196975|75833746|FG000|Overall Study|Lost to Follow-up|11|||
42025742|NCT01196975|75833747|FG001|Overall Study|Lost to Follow-up|6|||
42025743|NCT01196975|75833748|FG002|Overall Study|Lost to Follow-up|5|||
42025744|NCT01196975|75833749|FG003|Overall Study|Lost to Follow-up|5|||
42025745|NCT01196975|75833750|FG004|Overall Study|Lost to Follow-up|11|||
42025746|NCT00992589|75833785|FG000|Open-Label Phase|Adverse Event|4|||
42025747|NCT00992589|75833786|FG001|Open-Label Phase|Adverse Event|0|||
42025748|NCT00992589|75833787|FG002|Open-Label Phase|Adverse Event|0|||
42025749|NCT00992589|75833788|FG003|Open-Label Phase|Adverse Event|0|||
42025750|NCT00992589|75833785|FG000|Open-Label Phase|Withdrawal by Subject|20|||
42025751|NCT00992589|75833786|FG001|Open-Label Phase|Withdrawal by Subject|0|||
42025752|NCT00992589|75833787|FG002|Open-Label Phase|Withdrawal by Subject|0|||
41962625|NCT02987543|75735925|FG002|Overall Study|Lost to Follow-up|1|||
41962626|NCT02987543|75735926|FG003|Overall Study|Lost to Follow-up|0|||
41962627|NCT02987543|75735923|FG000|Overall Study|Screen failure|0|||
42025753|NCT00992589|75833788|FG003|Open-Label Phase|Withdrawal by Subject|0|||
42025754|NCT00992589|75833785|FG000|Open-Label Phase|Lost to Follow-up|1|||
42025755|NCT00992589|75833786|FG001|Open-Label Phase|Lost to Follow-up|0|||
42025756|NCT00992589|75833787|FG002|Open-Label Phase|Lost to Follow-up|0|||
42025757|NCT00992589|75833788|FG003|Open-Label Phase|Lost to Follow-up|0|||
42025758|NCT00992589|75833785|FG000|Open-Label Phase|Protocol Violation|3|||
42025759|NCT00992589|75833786|FG001|Open-Label Phase|Protocol Violation|0|||
42025760|NCT00992589|75833787|FG002|Open-Label Phase|Protocol Violation|0|||
42025761|NCT00992589|75833788|FG003|Open-Label Phase|Protocol Violation|0|||
42025762|NCT00992589|75833785|FG000|Open-Label Phase|Physician Decision|4|||
42025763|NCT00992589|75833786|FG001|Open-Label Phase|Physician Decision|0|||
41962628|NCT02987543|75735924|FG001|Overall Study|Screen failure|0|||
41962629|NCT02987543|75735925|FG002|Overall Study|Screen failure|0|||
41962630|NCT02987543|75735926|FG003|Overall Study|Screen failure|1|||
41962631|NCT02987543|75735923|FG000|Overall Study|Withdrawal by Subject|21|||
41962632|NCT02987543|75735924|FG001|Overall Study|Withdrawal by Subject|7|||
41962633|NCT02987543|75735925|FG002|Overall Study|Withdrawal by Subject|7|||
41962634|NCT02987543|75735926|FG003|Overall Study|Withdrawal by Subject|6|||
41962635|NCT02987543|75735923|FG000|Overall Study|Study terminated by sponsor|1|||
41962636|NCT02987543|75735924|FG001|Overall Study|Study terminated by sponsor|0|||
41962637|NCT02987543|75735925|FG002|Overall Study|Study terminated by sponsor|0|||
41962638|NCT02987543|75735926|FG003|Overall Study|Study terminated by sponsor|0|||
41962639|NCT02987543|75735923|FG000|Overall Study|Investigator decision|0|||
41962640|NCT02987543|75735924|FG001|Overall Study|Investigator decision|1|||
41962641|NCT02987543|75735925|FG002|Overall Study|Investigator decision|0|||
41962642|NCT02987543|75735926|FG003|Overall Study|Investigator decision|0|||
41962643|NCT02987543|75735923|FG000|Overall Study|Disease progression|0|||
41962644|NCT02987543|75735924|FG001|Overall Study|Disease progression|0|||
41962645|NCT02987543|75735925|FG002|Overall Study|Disease progression|0|||
41962646|NCT02987543|75735926|FG003|Overall Study|Disease progression|1|||
41962647|NCT02983045|75735942|FG000|Overall Study|Withdrawal by Subject|0|||
41962648|NCT02983045|75735943|FG001|Overall Study|Withdrawal by Subject|1|||
41962649|NCT02983045|75735944|FG002|Overall Study|Withdrawal by Subject|0|||
41962650|NCT02983045|75735945|FG003|Overall Study|Withdrawal by Subject|5|||
41962651|NCT02983045|75735946|FG004|Overall Study|Withdrawal by Subject|0|||
41962652|NCT02983045|75735947|FG005|Overall Study|Withdrawal by Subject|72|||
41962653|NCT02983045|75735948|FG006|Overall Study|Withdrawal by Subject|0|||
41962654|NCT02983045|75735949|FG007|Overall Study|Withdrawal by Subject|0|||
41962655|NCT02983045|75735950|FG008|Overall Study|Withdrawal by Subject|0|||
41962656|NCT02983045|75735951|FG009|Overall Study|Withdrawal by Subject|2|||
41962657|NCT02983045|75735942|FG000|Overall Study|Lost to Follow-up|0|||
41962658|NCT02983045|75735943|FG001|Overall Study|Lost to Follow-up|0|||
41962659|NCT02983045|75735944|FG002|Overall Study|Lost to Follow-up|0|||
41962660|NCT02983045|75735945|FG003|Overall Study|Lost to Follow-up|0|||
41962661|NCT02983045|75735946|FG004|Overall Study|Lost to Follow-up|0|||
41962662|NCT02983045|75735947|FG005|Overall Study|Lost to Follow-up|10|||
41962663|NCT02983045|75735948|FG006|Overall Study|Lost to Follow-up|0|||
41962664|NCT02983045|75735949|FG007|Overall Study|Lost to Follow-up|0|||
42025764|NCT00992589|75833787|FG002|Open-Label Phase|Physician Decision|0|||
42025765|NCT00992589|75833788|FG003|Open-Label Phase|Physician Decision|0|||
41962665|NCT02983045|75735950|FG008|Overall Study|Lost to Follow-up|0|||
41962666|NCT02983045|75735951|FG009|Overall Study|Lost to Follow-up|0|||
42025766|NCT00992589|75833785|FG000|Open-Label Phase|Other|45|||
42025767|NCT00992589|75833786|FG001|Open-Label Phase|Other|0|||
42025768|NCT00992589|75833787|FG002|Open-Label Phase|Other|0|||
42025769|NCT00992589|75833788|FG003|Open-Label Phase|Other|0|||
42025770|NCT00992589|75833785|FG000|Double-Blind Phase|Adverse Event|0|||
41962667|NCT02564263|75735975|FG000|Overall Study|Adverse Event|31|||
41962668|NCT02564263|75735976|FG001|Overall Study|Adverse Event|29|||
41962669|NCT02564263|75735975|FG000|Overall Study|Death|270|||
41962670|NCT02564263|75735976|FG001|Overall Study|Death|262|||
41962671|NCT02564263|75735975|FG000|Overall Study|Withdrawal by Subject|4|||
42025771|NCT00992589|75833786|FG001|Double-Blind Phase|Adverse Event|6|||
42025772|NCT00992589|75833787|FG002|Double-Blind Phase|Adverse Event|2|||
42025773|NCT00992589|75833788|FG003|Double-Blind Phase|Adverse Event|3|||
42025774|NCT00992589|75833785|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
42025775|NCT00992589|75833786|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
42025776|NCT00992589|75833787|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
42025777|NCT00992589|75833788|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
42025778|NCT00992589|75833785|FG000|Double-Blind Phase|Lost to Follow-up|0|||
42025779|NCT00992589|75833786|FG001|Double-Blind Phase|Lost to Follow-up|0|||
42025780|NCT00992589|75833787|FG002|Double-Blind Phase|Lost to Follow-up|0|||
42025781|NCT00992589|75833788|FG003|Double-Blind Phase|Lost to Follow-up|2|||
42025782|NCT00992589|75833785|FG000|Double-Blind Phase|Other|0|||
42025783|NCT00992589|75833786|FG001|Double-Blind Phase|Other|1|||
42025784|NCT00992589|75833787|FG002|Double-Blind Phase|Other|6|||
42025785|NCT00992589|75833788|FG003|Double-Blind Phase|Other|3|||
42025786|NCT01196741|75833808|FG000|Overall Study|Disease progression|34|||
42025787|NCT01196741|75833809|FG001|Overall Study|Disease progression|14|||
42025788|NCT01196741|75833808|FG000|Overall Study|Adverse Event|10|||
42025789|NCT01196741|75833809|FG001|Overall Study|Adverse Event|6|||
42025790|NCT01196741|75833808|FG000|Overall Study|Serious Adverse Event|3|||
42025791|NCT01196741|75833809|FG001|Overall Study|Serious Adverse Event|1|||
42025792|NCT01196741|75833808|FG000|Overall Study|Dose limiting Adverse Event|2|||
42025793|NCT01196741|75833809|FG001|Overall Study|Dose limiting Adverse Event|1|||
42025794|NCT01196741|75833808|FG000|Overall Study|Withdrawal by Subject|3|||
42025795|NCT01196741|75833809|FG001|Overall Study|Withdrawal by Subject|0|||
42025796|NCT01196741|75833808|FG000|Overall Study|Other reason|3|||
42025797|NCT01196741|75833809|FG001|Overall Study|Other reason|3|||
42025798|NCT01196741|75833808|FG000|Overall Study|Other|3|||
42025799|NCT01196741|75833809|FG001|Overall Study|Other|2|||
42025800|NCT01196741|75833808|FG000|Overall Study|Protocol Violation|2|||
42025801|NCT01196741|75833809|FG001|Overall Study|Protocol Violation|1|||
42025802|NCT00983385|75833815|FG000|Observation Period|Not eligible to be dosed|20|||
42025803|NCT00983385|75833815|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
42025804|NCT00992511|75833838|FG000|Overall Study|Migrated/moved from study area|1|||
42025805|NCT00992511|75833839|FG001|Overall Study|Migrated/moved from study area|0|||
42025806|NCT00992511|75833840|FG002|Overall Study|Migrated/moved from study area|1|||
42025807|NCT00992511|75833841|FG003|Overall Study|Migrated/moved from study area|2|||
42025808|NCT00992511|75833838|FG000|Overall Study|Lost to Follow-up|1|||
42025809|NCT00992511|75833839|FG001|Overall Study|Lost to Follow-up|0|||
42025810|NCT00992511|75833840|FG002|Overall Study|Lost to Follow-up|0|||
42025811|NCT00992511|75833841|FG003|Overall Study|Lost to Follow-up|2|||
42025812|NCT00992511|75833838|FG000|Overall Study|Withdrawal by Subject|0|||
42025813|NCT00992511|75833839|FG001|Overall Study|Withdrawal by Subject|0|||
42118211|NCT00545688|75929050|FG000|Follow-Up Period|Disease Progression|6|||
42118212|NCT00545688|75929051|FG001|Follow-Up Period|Disease Progression|5|||
41962672|NCT02564263|75735976|FG001|Overall Study|Withdrawal by Subject|19|||
41962673|NCT02564263|75735975|FG000|Overall Study|Sponsor's decision|9|||
41962674|NCT02564263|75735976|FG001|Overall Study|Sponsor's decision|4|||
41962675|NCT02379819|75735983|FG000|Overall Study|Withdrawal by Subject|10|||
41962676|NCT02379819|75735983|FG000|Overall Study|Death|2|||
41962677|NCT02379819|75735983|FG000|Overall Study|Lack of Efficacy|1|||
41962678|NCT02379819|75735983|FG000|Overall Study|Lost to Follow-up|1|||
41962679|NCT02368886|75735991|FG000|Overall Study|Cancel|1|||
41962680|NCT02368886|75735992|FG001|Overall Study|Cancel|1|||
41962681|NCT02368886|75735993|FG002|Overall Study|Cancel|1|||
41962682|NCT02368886|75735994|FG003|Overall Study|Cancel|3|||
41962683|NCT02368886|75735991|FG000|Overall Study|Ineligible|0|||
41962684|NCT02368886|75735992|FG001|Overall Study|Ineligible|0|||
41962685|NCT02368886|75735993|FG002|Overall Study|Ineligible|0|||
41962686|NCT02368886|75735994|FG003|Overall Study|Ineligible|1|||
41962687|NCT02227238|75736008|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
41962688|NCT02227238|75736009|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
41962689|NCT02227238|75736010|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
41962690|NCT02227238|75736008|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
41962691|NCT02227238|75736009|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
41962692|NCT02227238|75736010|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
42025814|NCT00992511|75833840|FG002|Overall Study|Withdrawal by Subject|1|||
42025815|NCT00992511|75833841|FG003|Overall Study|Withdrawal by Subject|1|||
42025816|NCT01196429|75833853|FG000|Overall Study|Ineligible - inadequate pathology|1|||
42025817|NCT01196429|75833854|FG001|Overall Study|Ineligible - inadequate pathology|0|||
42025818|NCT01196429|75833853|FG000|Overall Study|Ineligible - wrong cell type|1|||
42025819|NCT01196429|75833854|FG001|Overall Study|Ineligible - wrong cell type|0|||
42025820|NCT01196429|75833853|FG000|Overall Study|Refused - Never Treated|1|||
42025821|NCT01196429|75833854|FG001|Overall Study|Refused - Never Treated|0|||
42025822|NCT01157364|75833868|FG000|Overall Study|Other Reasons|1|||
41962693|NCT02227238|75736008|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
42025823|NCT01157364|75833869|FG001|Overall Study|Other Reasons|1|||
41962694|NCT02227238|75736009|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
41962695|NCT02227238|75736010|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
41962696|NCT02227238|75736008|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
41962697|NCT02227238|75736009|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
41962698|NCT02227238|75736010|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
41962699|NCT02227238|75736008|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
41962700|NCT02227238|75736009|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
41962701|NCT02227238|75736010|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
41962702|NCT02227238|75736008|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
41962703|NCT02227238|75736009|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
41962704|NCT02227238|75736010|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
41962705|NCT02227238|75736008|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
41962706|NCT02227238|75736009|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
41962707|NCT02227238|75736010|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
41962708|NCT02227238|75736008|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
41962709|NCT02227238|75736009|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
41962710|NCT02227238|75736010|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
41962711|NCT02227238|75736008|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
41962712|NCT02227238|75736009|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
41962713|NCT02227238|75736010|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
41962714|NCT02227238|75736008|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
41962715|NCT02227238|75736009|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
41962716|NCT02227238|75736010|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
41962717|NCT02227238|75736008|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
41962718|NCT02227238|75736009|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
41962719|NCT02227238|75736010|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
41962720|NCT02227238|75736008|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
41962721|NCT02227238|75736009|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
41962722|NCT02227238|75736010|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
41962723|NCT02227238|75736008|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
41962724|NCT02227238|75736009|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
41962725|NCT02227238|75736010|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
41962726|NCT02227238|75736008|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
41962727|NCT02227238|75736009|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
41962728|NCT02227238|75736010|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
41962729|NCT02126969|75736031|FG000|Overall Study|Withdrawal by Subject|1|||
41962730|NCT02126969|75736032|FG001|Overall Study|Withdrawal by Subject|2|||
41962731|NCT01715285|75736040|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
41962732|NCT01715285|75736041|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
41962733|NCT01715285|75736042|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
41962734|NCT01715285|75736040|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
41962735|NCT01715285|75736041|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
41962736|NCT01715285|75736042|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
41962737|NCT01715285|75736040|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
41962738|NCT01715285|75736041|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
41962739|NCT01715285|75736042|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
41962740|NCT01715285|75736040|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
41962741|NCT01715285|75736041|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
41962742|NCT01715285|75736042|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
41962743|NCT01715285|75736040|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
41962744|NCT01715285|75736041|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
41962745|NCT01715285|75736042|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
41962746|NCT01715285|75736040|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
41962747|NCT01715285|75736041|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
41962748|NCT01715285|75736042|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
41962749|NCT01715285|75736040|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
41962750|NCT01715285|75736041|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
41962751|NCT01715285|75736042|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
41962752|NCT01715285|75736040|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
41962753|NCT01715285|75736041|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
41962754|NCT01715285|75736042|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
41962755|NCT01715285|75736040|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
41962756|NCT01715285|75736041|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
41962757|NCT01715285|75736042|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
42025824|NCT01157364|75833870|FG002|Overall Study|Other Reasons|2|||
42025825|NCT01157364|75833871|FG003|Overall Study|Other Reasons|1|||
42025826|NCT01157364|75833872|FG004|Overall Study|Other Reasons|0|||
42025827|NCT01157364|75833873|FG005|Overall Study|Other Reasons|0|||
42025828|NCT01157364|75833868|FG000|Overall Study|Personal Reasons|0|||
42025829|NCT01157364|75833869|FG001|Overall Study|Personal Reasons|2|||
42025830|NCT01157364|75833870|FG002|Overall Study|Personal Reasons|0|||
42025831|NCT01157364|75833871|FG003|Overall Study|Personal Reasons|0|||
42025832|NCT01157364|75833872|FG004|Overall Study|Personal Reasons|1|||
42025833|NCT01157364|75833873|FG005|Overall Study|Personal Reasons|1|||
42025834|NCT01157364|75833868|FG000|Overall Study|Lost to Follow-up|1|||
42025835|NCT01157364|75833869|FG001|Overall Study|Lost to Follow-up|0|||
42025836|NCT01157364|75833870|FG002|Overall Study|Lost to Follow-up|1|||
42025837|NCT01157364|75833871|FG003|Overall Study|Lost to Follow-up|0|||
42025838|NCT01157364|75833872|FG004|Overall Study|Lost to Follow-up|0|||
42025839|NCT01157364|75833873|FG005|Overall Study|Lost to Follow-up|0|||
42025840|NCT01157364|75833868|FG000|Overall Study|Lack of Efficacy|0|||
42025841|NCT01157364|75833869|FG001|Overall Study|Lack of Efficacy|0|||
42300633|NCT02540083|76135813|FG000|Overall Study|Withdrawal by Subject|16|||
41962758|NCT01715285|75736040|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
41962759|NCT01715285|75736041|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
41962760|NCT01715285|75736042|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
41962761|NCT01715285|75736040|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
41962762|NCT01715285|75736041|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
41962763|NCT01715285|75736042|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
41962764|NCT01715285|75736040|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
41962765|NCT01715285|75736041|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
41962766|NCT01715285|75736042|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
41962767|NCT01715285|75736040|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
41962768|NCT01715285|75736041|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
42025842|NCT01157364|75833870|FG002|Overall Study|Lack of Efficacy|0|||
42025843|NCT01157364|75833871|FG003|Overall Study|Lack of Efficacy|1|||
42025844|NCT01157364|75833872|FG004|Overall Study|Lack of Efficacy|0|||
42025845|NCT01157364|75833873|FG005|Overall Study|Lack of Efficacy|0|||
42025846|NCT01157364|75833868|FG000|Overall Study|Adverse Event|0|||
42025847|NCT01157364|75833869|FG001|Overall Study|Adverse Event|1|||
42025848|NCT01157364|75833870|FG002|Overall Study|Adverse Event|1|||
42025849|NCT01157364|75833871|FG003|Overall Study|Adverse Event|0|||
42025850|NCT01157364|75833872|FG004|Overall Study|Adverse Event|1|||
42025851|NCT01157364|75833873|FG005|Overall Study|Adverse Event|0|||
42025852|NCT01195415|75833887|FG000|Overall Study|No repeat biopsy due to progression|2|||
42118213|NCT00545688|75929052|FG002|Follow-Up Period|Disease Progression|9|||
42118214|NCT00545688|75929053|FG003|Follow-Up Period|Disease Progression|9|||
42118215|NCT00545688|75929050|FG000|Follow-Up Period|Refused Treatment|6|||
42118216|NCT00545688|75929051|FG001|Follow-Up Period|Refused Treatment|2|||
42118217|NCT00545688|75929052|FG002|Follow-Up Period|Refused Treatment|0|||
42118218|NCT00545688|75929053|FG003|Follow-Up Period|Refused Treatment|2|||
42118219|NCT00545688|75929050|FG000|Follow-Up Period|Lost to Follow-up|3|||
42118220|NCT00545688|75929051|FG001|Follow-Up Period|Lost to Follow-up|3|||
41962769|NCT01715285|75736042|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
41962770|NCT01715285|75736040|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
41962771|NCT01715285|75736041|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
41962772|NCT01715285|75736042|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
41962773|NCT01250496|75736051|FG000|Overall Study|Study terminated|124|||
41962774|NCT01250496|75736052|FG001|Overall Study|Study terminated|124|||
41962775|NCT01105975|75736068|FG000|Overall Study|Adverse Event|2|||
41962776|NCT01105975|75736069|FG001|Overall Study|Adverse Event|1|||
41962777|NCT01105975|75736070|FG002|Overall Study|Adverse Event|5|||
41962778|NCT01105975|75736071|FG003|Overall Study|Adverse Event|1|||
41962779|NCT01105975|75736072|FG004|Overall Study|Adverse Event|0|||
41962780|NCT01105975|75736073|FG005|Overall Study|Adverse Event|1|||
41962781|NCT01105975|75736074|FG006|Overall Study|Adverse Event|2|||
41962782|NCT01105975|75736075|FG007|Overall Study|Adverse Event|4|||
41962783|NCT01105975|75736076|FG008|Overall Study|Adverse Event|1|||
41962784|NCT01105975|75736077|FG009|Overall Study|Adverse Event|4|||
41962785|NCT01105975|75736068|FG000|Overall Study|Withdrawal by Subject|2|||
41962786|NCT01105975|75736069|FG001|Overall Study|Withdrawal by Subject|2|||
41962787|NCT01105975|75736070|FG002|Overall Study|Withdrawal by Subject|2|||
41962788|NCT01105975|75736071|FG003|Overall Study|Withdrawal by Subject|0|||
41962789|NCT01105975|75736072|FG004|Overall Study|Withdrawal by Subject|4|||
41962790|NCT01105975|75736073|FG005|Overall Study|Withdrawal by Subject|1|||
41962791|NCT01105975|75736074|FG006|Overall Study|Withdrawal by Subject|2|||
41962792|NCT01105975|75736075|FG007|Overall Study|Withdrawal by Subject|1|||
41962793|NCT01105975|75736076|FG008|Overall Study|Withdrawal by Subject|0|||
41962794|NCT01105975|75736077|FG009|Overall Study|Withdrawal by Subject|3|||
41962795|NCT01105975|75736068|FG000|Overall Study|Lost to Follow-up|1|||
41962796|NCT01105975|75736069|FG001|Overall Study|Lost to Follow-up|0|||
41962797|NCT01105975|75736070|FG002|Overall Study|Lost to Follow-up|0|||
41962798|NCT01105975|75736071|FG003|Overall Study|Lost to Follow-up|1|||
41962799|NCT01105975|75736072|FG004|Overall Study|Lost to Follow-up|1|||
41962800|NCT01105975|75736073|FG005|Overall Study|Lost to Follow-up|0|||
41962801|NCT01105975|75736074|FG006|Overall Study|Lost to Follow-up|0|||
41962802|NCT01105975|75736075|FG007|Overall Study|Lost to Follow-up|0|||
41962803|NCT01105975|75736076|FG008|Overall Study|Lost to Follow-up|1|||
41962804|NCT01105975|75736077|FG009|Overall Study|Lost to Follow-up|0|||
41962805|NCT01105975|75736068|FG000|Overall Study|Physician Decision|0|||
41962806|NCT01105975|75736069|FG001|Overall Study|Physician Decision|0|||
41962807|NCT01105975|75736070|FG002|Overall Study|Physician Decision|0|||
41962808|NCT01105975|75736071|FG003|Overall Study|Physician Decision|0|||
41962809|NCT01105975|75736072|FG004|Overall Study|Physician Decision|0|||
41962810|NCT01105975|75736073|FG005|Overall Study|Physician Decision|0|||
41962811|NCT01105975|75736074|FG006|Overall Study|Physician Decision|2|||
41962812|NCT01105975|75736075|FG007|Overall Study|Physician Decision|0|||
41962813|NCT01105975|75736076|FG008|Overall Study|Physician Decision|0|||
41962814|NCT01105975|75736077|FG009|Overall Study|Physician Decision|0|||
41962815|NCT01105975|75736068|FG000|Overall Study|Protocol Violation|0|||
41962816|NCT01105975|75736069|FG001|Overall Study|Protocol Violation|2|||
41962817|NCT01105975|75736070|FG002|Overall Study|Protocol Violation|2|||
41962818|NCT01105975|75736071|FG003|Overall Study|Protocol Violation|0|||
41962819|NCT01105975|75736072|FG004|Overall Study|Protocol Violation|1|||
41962820|NCT01105975|75736073|FG005|Overall Study|Protocol Violation|1|||
41962821|NCT01105975|75736074|FG006|Overall Study|Protocol Violation|1|||
42025853|NCT01195103|75833894|FG000|Overall Study|Withdrawal by Subject|1|||
41962822|NCT01105975|75736075|FG007|Overall Study|Protocol Violation|1|||
41962823|NCT01105975|75736076|FG008|Overall Study|Protocol Violation|2|||
41962824|NCT01105975|75736077|FG009|Overall Study|Protocol Violation|2|||
41962825|NCT01105975|75736068|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
41962826|NCT01105975|75736069|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
41962827|NCT01105975|75736070|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
41962828|NCT01105975|75736071|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
41962829|NCT01105975|75736072|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
41962830|NCT01105975|75736073|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
41962831|NCT01105975|75736074|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
41962832|NCT01105975|75736075|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
41962833|NCT01105975|75736076|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
42025854|NCT01195103|75833895|FG001|Overall Study|Withdrawal by Subject|0|||
41962834|NCT01105975|75736077|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
42118221|NCT00545688|75929052|FG002|Follow-Up Period|Lost to Follow-up|3|||
42118222|NCT00545688|75929053|FG003|Follow-Up Period|Lost to Follow-up|1|||
42118223|NCT00545688|75929050|FG000|Follow-Up Period|Unspecified Reason|2|||
42118224|NCT00545688|75929051|FG001|Follow-Up Period|Unspecified Reason|5|||
42118225|NCT00545688|75929052|FG002|Follow-Up Period|Unspecified Reason|6|||
42118226|NCT00545688|75929053|FG003|Follow-Up Period|Unspecified Reason|8|||
42118227|NCT00545688|75929050|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
42118228|NCT00545688|75929051|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
42118229|NCT00545688|75929052|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
42118230|NCT00545688|75929053|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
42118231|NCT00502203|75929066|FG000|Overall Study|Inevaluable|1|||
42118232|NCT00546078|75929072|FG000|Overall Study|Lost to Follow-up|1|||
42118233|NCT00546078|75929073|FG001|Overall Study|Lost to Follow-up|3|||
42118234|NCT00546078|75929072|FG000|Overall Study|Withdrawal by Subject|2|||
42118235|NCT00546078|75929073|FG001|Overall Study|Withdrawal by Subject|3|||
42118236|NCT00546078|75929072|FG000|Overall Study|Other reason|1|||
42118237|NCT00546078|75929073|FG001|Overall Study|Other reason|1|||
42118238|NCT00546000|75929079|FG000|Overall Study|Adverse Event|1|||
42118239|NCT00546000|75929079|FG000|Overall Study|Lost to Follow-up|1|||
42118240|NCT00546000|75929079|FG000|Overall Study|Baseline HPA Axis Supression|2|||
42118241|NCT00501969|75929083|FG000|Overall Study|Major Protocol Violation|4|||
42118242|NCT00501969|75929083|FG000|Overall Study|Lack of Efficacy|29|||
41962835|NCT00831623|75736118|FG000|Overall Study|Withdrawal by Subject|9|||
41962836|NCT00831623|75736118|FG000|Overall Study|Lost to Follow-up|1|||
41962837|NCT00831623|75736118|FG000|Overall Study|Not 2 years post-treatment|12|||
41962838|NCT00079417|75736122|FG000|Overall Study|Physician Decision|2|||
41962839|NCT00079417|75736122|FG000|Overall Study|Ineligible|7|||
41962840|NCT04627038|75740841|FG000|Overall Study|Adverse Event|36|||
42118243|NCT00501969|75929083|FG000|Overall Study|Adverse Event|76|||
42118244|NCT00501969|75929083|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
41962841|NCT04627038|75740842|FG001|Overall Study|Adverse Event|8|||
41962842|NCT04627038|75740841|FG000|Overall Study|Lost to Follow-up|1|||
41962843|NCT04627038|75740842|FG001|Overall Study|Lost to Follow-up|0|||
41962844|NCT04627038|75740841|FG000|Overall Study|Physician Decision|0|||
41962845|NCT04627038|75740842|FG001|Overall Study|Physician Decision|1|||
41962846|NCT04627038|75740841|FG000|Overall Study|Protocol Violation|3|||
41962847|NCT04627038|75740842|FG001|Overall Study|Protocol Violation|1|||
41962848|NCT04627038|75740841|FG000|Overall Study|Withdrawal by Subject|13|||
41962849|NCT04627038|75740842|FG001|Overall Study|Withdrawal by Subject|3|||
41962850|NCT04627038|75740841|FG000|Overall Study|Non-compliance with study drug|0|||
41962851|NCT04627038|75740842|FG001|Overall Study|Non-compliance with study drug|1|||
41962852|NCT04627038|75740841|FG000|Overall Study|Prohibited Concomitant Medication|1|||
41962853|NCT04627038|75740842|FG001|Overall Study|Prohibited Concomitant Medication|0|||
41962854|NCT05483686|75741056|FG000|Overall Study|Lost to Follow-up|5|||
41962855|NCT05483686|75741057|FG001|Overall Study|Lost to Follow-up|7|||
41962856|NCT05292755|75741065|FG000|Overall Study|Lost to Follow-up|5|||
41962857|NCT05292755|75741066|FG001|Overall Study|Lost to Follow-up|9|||
41962858|NCT04590781|75741080|FG000|Overall Study|Death|0|||
41962859|NCT04590781|75741081|FG001|Overall Study|Death|2|||
41962860|NCT04590781|75741080|FG000|Overall Study|Withdrawal by Subject|2|||
41962861|NCT04590781|75741081|FG001|Overall Study|Withdrawal by Subject|0|||
41962862|NCT04248868|75741088|FG000|Overall Study|Death|1|||
41962863|NCT04248868|75741088|FG000|Overall Study|Lost to Follow-up|3|||
41962864|NCT04248868|75741088|FG000|Overall Study|Protocol Violation|2|||
42025855|NCT01195103|75833896|FG002|Overall Study|Withdrawal by Subject|0|||
42025856|NCT01194869|75833904|FG000|Overall Study|Disease Progression|2|||
42025857|NCT01194869|75833904|FG000|Overall Study|Toxicity|2|||
42025858|NCT01177800|75833910|FG000|Overall Study|Adverse Event|9|||
42025859|NCT01177800|75833911|FG001|Overall Study|Adverse Event|3|||
42025860|NCT01177800|75833910|FG000|Overall Study|Protocol Violation|0|||
42025861|NCT01177800|75833911|FG001|Overall Study|Protocol Violation|1|||
42025862|NCT01177800|75833910|FG000|Overall Study|Physician Decision|1|||
42118245|NCT00501969|75929083|FG000|Overall Study|Subject withdrew consent|51|||
42118246|NCT00501969|75929083|FG000|Overall Study|Lost to Follow-up|4|||
41962865|NCT04211831|75741095|FG000|Overall Study|Withdrawal by Subject|4|||
41962866|NCT04211831|75741096|FG001|Overall Study|Withdrawal by Subject|1|||
41962867|NCT04211831|75741097|FG002|Overall Study|Withdrawal by Subject|1|||
42118247|NCT00501969|75929083|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
42118248|NCT00501969|75929083|FG000|Overall Study|Other: Sponsors Request|10|||
41962868|NCT04211831|75741095|FG000|Overall Study|Protocol Violation|0|||
41962869|NCT04211831|75741096|FG001|Overall Study|Protocol Violation|0|||
41962870|NCT04211831|75741097|FG002|Overall Study|Protocol Violation|1|||
41962871|NCT04211831|75741095|FG000|Overall Study|Adverse Event|0|||
42025863|NCT01177800|75833911|FG001|Overall Study|Physician Decision|0|||
42025864|NCT01177800|75833910|FG000|Overall Study|Withdrawal of informed consent|0|||
42025865|NCT01177800|75833911|FG001|Overall Study|Withdrawal of informed consent|1|||
42118249|NCT00501969|75929083|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
41962872|NCT04211831|75741096|FG001|Overall Study|Adverse Event|1|||
41962873|NCT04211831|75741097|FG002|Overall Study|Adverse Event|0|||
41962874|NCT04211831|75741095|FG000|Overall Study|Lack of Efficacy|0|||
41962875|NCT04211831|75741096|FG001|Overall Study|Lack of Efficacy|0|||
41962876|NCT04211831|75741097|FG002|Overall Study|Lack of Efficacy|1|||
41962877|NCT04211831|75741095|FG000|Overall Study|Lost to Follow-up|0|||
41962878|NCT04211831|75741096|FG001|Overall Study|Lost to Follow-up|0|||
41962879|NCT04211831|75741097|FG002|Overall Study|Lost to Follow-up|2|||
41962880|NCT04211831|75741095|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
41962881|NCT04211831|75741096|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
41962882|NCT04211831|75741097|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
41962883|NCT04211831|75741095|FG000|Overall Study|Other|0|||
41962884|NCT04211831|75741096|FG001|Overall Study|Other|1|||
41962885|NCT04211831|75741097|FG002|Overall Study|Other|0|||
41962886|NCT04067518|75741155|FG000|Overall Study|Adverse Event|1|||
41962887|NCT04067518|75741156|FG001|Overall Study|Adverse Event|3|||
41962888|NCT04067518|75741155|FG000|Overall Study|Screen failures|0|||
41962889|NCT04067518|75741156|FG001|Overall Study|Screen failures|1|||
41962890|NCT04067518|75741155|FG000|Overall Study|Enrolled but not treated|0|||
41962891|NCT04067518|75741156|FG001|Overall Study|Enrolled but not treated|1|||
42118250|NCT00501969|75929083|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
42118251|NCT00501969|75929083|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
42118252|NCT00501969|75929083|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
42118253|NCT00501969|75929083|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
41962892|NCT03912233|75741197|FG000|Overall Study|Adverse Event|1|||
41962893|NCT03912233|75741198|FG001|Overall Study|Adverse Event|0|||
41962894|NCT03912233|75741199|FG002|Overall Study|Adverse Event|0|||
41962895|NCT03912233|75741200|FG003|Overall Study|Adverse Event|0|||
41962896|NCT03912233|75741201|FG004|Overall Study|Adverse Event|0|||
41962897|NCT03912233|75741202|FG005|Overall Study|Adverse Event|0|||
41962898|NCT03912233|75741197|FG000|Overall Study|Physician Decision|1|||
42118254|NCT00501969|75929083|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
42118255|NCT00501969|75929083|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
42118256|NCT00501969|75929083|FG000|Overall Study|Other: As Required by Local EC|2|||
42118257|NCT00501969|75929083|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
42118258|NCT00501969|75929083|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
42118259|NCT03942042|75929089|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
42118260|NCT03942042|75929090|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
42118261|NCT03942042|75929089|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
42118262|NCT03942042|75929090|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
42118263|NCT00104299|75929102|FG000|Overall Study|Adverse Event|3|||
42118264|NCT00104299|75929103|FG001|Overall Study|Adverse Event|1|||
42118265|NCT00104299|75929102|FG000|Overall Study|Death|2|||
42118266|NCT00104299|75929103|FG001|Overall Study|Death|2|||
42118267|NCT00104299|75929102|FG000|Overall Study|Withdrawal by Subject|2|||
42118268|NCT00104299|75929103|FG001|Overall Study|Withdrawal by Subject|6|||
42118269|NCT00104299|75929102|FG000|Overall Study|Physician Decision|1|||
42118270|NCT00104299|75929103|FG001|Overall Study|Physician Decision|1|||
42118271|NCT00104299|75929102|FG000|Overall Study|To have renal transplant|1|||
42118272|NCT00104299|75929103|FG001|Overall Study|To have renal transplant|0|||
42118273|NCT03939312|75929109|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
42118274|NCT03939312|75929109|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
42118275|NCT03939312|75929109|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
42118276|NCT03939312|75929109|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
42118277|NCT03939312|75929109|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
42118278|NCT03939312|75929109|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
42118279|NCT03939312|75929109|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
42118280|NCT03939312|75929109|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
42118281|NCT03939312|75929109|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
42118282|NCT03939312|75929109|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
42118283|NCT03939312|75929109|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
42118284|NCT03939312|75929109|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
42118285|NCT00082381|75929117|FG000|Overall Study|Adverse Event|27|||
42118286|NCT00082381|75929118|FG001|Overall Study|Adverse Event|2|||
42118287|NCT00082381|75929117|FG000|Overall Study|Lost to Follow-up|5|||
42118288|NCT00082381|75929118|FG001|Overall Study|Lost to Follow-up|7|||
42118289|NCT00082381|75929117|FG000|Overall Study|Patient Decision|8|||
42118290|NCT00082381|75929118|FG001|Overall Study|Patient Decision|4|||
42118291|NCT00082381|75929117|FG000|Overall Study|Physician Decision|1|||
42118292|NCT00082381|75929118|FG001|Overall Study|Physician Decision|2|||
42118293|NCT00082381|75929117|FG000|Overall Study|Protocol Violation|10|||
42118294|NCT00082381|75929118|FG001|Overall Study|Protocol Violation|11|||
42118295|NCT00082381|75929117|FG000|Overall Study|Loss of Glucose Control|4|||
42118296|NCT00082381|75929118|FG001|Overall Study|Loss of Glucose Control|0|||
42118297|NCT00545844|75929124|FG000|Overall Study|Lost to Follow-up|9|||
42118298|NCT00545844|75929124|FG000|Overall Study|Protocol Violation|1|||
42118299|NCT00545844|75929124|FG000|Overall Study|Withdrawal by Subject|2|||
42118300|NCT00492063|75929134|FG000|Overall Study|Death|0|||
42118301|NCT00492063|75929135|FG001|Overall Study|Death|0|||
42118302|NCT00492063|75929136|FG002|Overall Study|Death|1|||
42118303|NCT00492063|75929137|FG003|Overall Study|Death|2|||
42118304|NCT00492063|75929134|FG000|Overall Study|Withdrawal by Subject|4|||
42118305|NCT00492063|75929135|FG001|Overall Study|Withdrawal by Subject|3|||
42118306|NCT00492063|75929136|FG002|Overall Study|Withdrawal by Subject|5|||
42118307|NCT00492063|75929137|FG003|Overall Study|Withdrawal by Subject|4|||
42118308|NCT00492063|75929134|FG000|Overall Study|Lost to Follow-up|6|||
42118309|NCT00492063|75929135|FG001|Overall Study|Lost to Follow-up|11|||
42118310|NCT00492063|75929136|FG002|Overall Study|Lost to Follow-up|5|||
42118311|NCT00492063|75929137|FG003|Overall Study|Lost to Follow-up|3|||
42118312|NCT00492063|75929134|FG000|Overall Study|Protocol Violation|0|||
42118313|NCT00492063|75929135|FG001|Overall Study|Protocol Violation|0|||
42118314|NCT00492063|75929136|FG002|Overall Study|Protocol Violation|0|||
42118315|NCT00492063|75929137|FG003|Overall Study|Protocol Violation|1|||
42118316|NCT00093145|75929147|FG000|Overall Study|Unacceptable Toxicity Only|2|||
42118317|NCT00093145|75929147|FG000|Overall Study|Physician Decision|5|||
42118318|NCT00093145|75929147|FG000|Overall Study|Withdrawal by Subject|9|||
42118319|NCT00093145|75929147|FG000|Overall Study|Other|1|||
42118320|NCT00513357|75929153|FG000|Overall Study|did not receive allocated placebo|2|||
42118321|NCT00513357|75929154|FG001|Overall Study|did not receive allocated placebo|3|||
42118322|NCT00513357|75929153|FG000|Overall Study|Adverse Event|4|||
42118323|NCT00513357|75929154|FG001|Overall Study|Adverse Event|2|||
42118324|NCT00513357|75929153|FG000|Overall Study|Death|2|||
42118325|NCT00513357|75929154|FG001|Overall Study|Death|0|||
42118326|NCT00513357|75929153|FG000|Overall Study|Withdrawal by Subject|5|||
42118327|NCT00513357|75929154|FG001|Overall Study|Withdrawal by Subject|4|||
42118328|NCT00513357|75929153|FG000|Overall Study|Disease Progression|2|||
42118329|NCT00513357|75929154|FG001|Overall Study|Disease Progression|1|||
42118330|NCT03933462|75929160|FG000|Overall Study|Adverse Event|2|||
42118331|NCT03933462|75929161|FG001|Overall Study|Adverse Event|0|||
42118332|NCT03929562|75929169|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
42118333|NCT03929562|75929170|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
42118334|NCT03929562|75929169|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
42025866|NCT01177722|75833921|FG000|Overall Study|Serious Adverse Event|0|||
42025867|NCT01177722|75833922|FG001|Overall Study|Serious Adverse Event|0|||
42025868|NCT01177722|75833923|FG002|Overall Study|Serious Adverse Event|1|||
42025869|NCT01177722|75833924|FG003|Overall Study|Serious Adverse Event|0|||
42025870|NCT01177722|75833921|FG000|Overall Study|Protocol Violation|0|||
42025871|NCT01177722|75833922|FG001|Overall Study|Protocol Violation|0|||
42025872|NCT01177722|75833923|FG002|Overall Study|Protocol Violation|1|||
42025873|NCT01177722|75833924|FG003|Overall Study|Protocol Violation|0|||
42025874|NCT01177722|75833921|FG000|Overall Study|Lost to Follow-up|3|||
42025875|NCT01177722|75833922|FG001|Overall Study|Lost to Follow-up|4|||
42025876|NCT01177722|75833923|FG002|Overall Study|Lost to Follow-up|3|||
42025877|NCT01177722|75833924|FG003|Overall Study|Lost to Follow-up|1|||
42025878|NCT01177722|75833921|FG000|Overall Study|Withdrawal by Subject|10|||
42025879|NCT01177722|75833922|FG001|Overall Study|Withdrawal by Subject|6|||
42025880|NCT01177722|75833923|FG002|Overall Study|Withdrawal by Subject|4|||
42025881|NCT01177722|75833924|FG003|Overall Study|Withdrawal by Subject|6|||
42025882|NCT01177410|75833938|FG000|Overall Study|Adverse Event|0|||
42025883|NCT01177410|75833939|FG001|Overall Study|Adverse Event|2|||
42025884|NCT01177410|75833940|FG002|Overall Study|Adverse Event|2|||
42025885|NCT01177410|75833938|FG000|Overall Study|Withdrawal by Subject|1|||
42025886|NCT01177410|75833939|FG001|Overall Study|Withdrawal by Subject|4|||
42025887|NCT01177410|75833940|FG002|Overall Study|Withdrawal by Subject|3|||
42025888|NCT01177410|75833938|FG000|Overall Study|Lost to Follow-up|0|||
42025889|NCT01177410|75833939|FG001|Overall Study|Lost to Follow-up|1|||
42025890|NCT01177410|75833940|FG002|Overall Study|Lost to Follow-up|0|||
42025891|NCT01156116|75833950|FG000|Overall Study|Withdrawal by Subject|3|||
42025892|NCT01156116|75833951|FG001|Overall Study|Withdrawal by Subject|1|||
42025893|NCT01156116|75833950|FG000|Overall Study|CPAP intolerance|2|||
42025894|NCT01156116|75833951|FG001|Overall Study|CPAP intolerance|0|||
42025895|NCT01155726|75833957|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
42025896|NCT01155726|75833958|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
42025897|NCT01155726|75833959|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
42025898|NCT01155726|75833960|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
42025899|NCT01155570|75833982|FG000|Overall Study|Adverse Event|39|||
42025900|NCT01155570|75833982|FG000|Overall Study|Lack of Efficacy|46|||
42025901|NCT01155570|75833982|FG000|Overall Study|Participant's Economic Reasons|17|||
42025902|NCT01155570|75833982|FG000|Overall Study|No Hospital Visits|7|||
42025903|NCT01155570|75833982|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
42025904|NCT01155570|75833982|FG000|Overall Study|Adverse Event + Other Reasons|7|||
42025905|NCT01155570|75833982|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
42025906|NCT01155570|75833982|FG000|Overall Study|Other Reasons|23|||
42118335|NCT03929562|75929170|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
42118336|NCT03929562|75929169|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
42210314|NCT03257358|76025120|FG000|Overall Study|Adverse Event|25|||
42300634|NCT02293863|76135820|FG000|Overall Study|Death|4|||
42300635|NCT02293863|76135821|FG001|Overall Study|Death|6|||
42300636|NCT02293863|76135822|FG002|Overall Study|Death|4|||
42025907|NCT01155024|75833988|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
42025908|NCT01155024|75833989|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
42025909|NCT01155024|75833988|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
42025910|NCT01155024|75833989|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
42025911|NCT01155024|75833988|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
42025912|NCT01155024|75833989|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
42025913|NCT01176240|75834000|FG000|Study 306A|Lack of Efficacy|2|||
42025914|NCT01176240|75834001|FG001|Study 306A|Lack of Efficacy|1|||
42210315|NCT03257358|76025121|FG001|Overall Study|Adverse Event|12|||
42210316|NCT03257358|76025120|FG000|Overall Study|Lack of Efficacy|1|||
42210317|NCT03257358|76025121|FG001|Overall Study|Lack of Efficacy|1|||
42210318|NCT03257358|76025120|FG000|Overall Study|Lost to Follow-up|12|||
42210319|NCT03257358|76025121|FG001|Overall Study|Lost to Follow-up|4|||
42210320|NCT03257358|76025120|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
42210321|NCT03257358|76025121|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
42210322|NCT03257358|76025120|FG000|Overall Study|Physician Decision|2|||
42210323|NCT03257358|76025121|FG001|Overall Study|Physician Decision|2|||
41962899|NCT03912233|75741198|FG001|Overall Study|Physician Decision|0|||
41962900|NCT03912233|75741199|FG002|Overall Study|Physician Decision|0|||
41962901|NCT03912233|75741200|FG003|Overall Study|Physician Decision|0|||
41962902|NCT03912233|75741201|FG004|Overall Study|Physician Decision|0|||
41962903|NCT03912233|75741202|FG005|Overall Study|Physician Decision|0|||
41962904|NCT03912233|75741197|FG000|Overall Study|Other|0|||
41962905|NCT03912233|75741198|FG001|Overall Study|Other|0|||
41962906|NCT03912233|75741199|FG002|Overall Study|Other|0|||
41962907|NCT03912233|75741200|FG003|Overall Study|Other|0|||
41962908|NCT03912233|75741201|FG004|Overall Study|Other|7|||
41962909|NCT03912233|75741202|FG005|Overall Study|Other|12|||
41962910|NCT03546062|75741245|FG000|Overall Study|Adverse Event|6|||
41962911|NCT03546062|75741246|FG001|Overall Study|Adverse Event|5|||
41962912|NCT03546062|75741247|FG002|Overall Study|Adverse Event|8|||
41962913|NCT03539952|75741257|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
41962914|NCT03539952|75741258|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
41962915|NCT03539952|75741257|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
42025915|NCT01176240|75834000|FG000|Study 306A|Protocol Violation|0|||
42025916|NCT01176240|75834001|FG001|Study 306A|Protocol Violation|1|||
42025917|NCT01176240|75834000|FG000|Study 306A|Withdrawal by Subject|0|||
42025918|NCT01176240|75834001|FG001|Study 306A|Withdrawal by Subject|1|||
42025919|NCT01176240|75834000|FG000|Study 306A|Stop due to diverse problems|1|||
42025920|NCT01176240|75834001|FG001|Study 306A|Stop due to diverse problems|0|||
42025921|NCT01176240|75834000|FG000|Study 306B|Lack of Efficacy|5|||
42025922|NCT01176240|75834001|FG001|Study 306B|Lack of Efficacy|3|||
42025923|NCT01176240|75834000|FG000|Study 306B|Adverse Event|10|||
42025924|NCT01176240|75834001|FG001|Study 306B|Adverse Event|5|||
42025925|NCT01176240|75834000|FG000|Study 306B|Protocol Violation|2|||
42025926|NCT01176240|75834001|FG001|Study 306B|Protocol Violation|3|||
42025927|NCT01176240|75834000|FG000|Study 306B|Withdrawal by Subject|4|||
42025928|NCT01176240|75834001|FG001|Study 306B|Withdrawal by Subject|1|||
42025929|NCT01176240|75834000|FG000|Study 306B|Physician Decision|2|||
42025930|NCT01176240|75834001|FG001|Study 306B|Physician Decision|1|||
42025931|NCT01176240|75834000|FG000|Study 306B|Supine Hypertension|1|||
42025932|NCT01176240|75834001|FG001|Study 306B|Supine Hypertension|2|||
42025933|NCT01176240|75834000|FG000|Study 306B|Lost to Follow-up|0|||
42025934|NCT01176240|75834001|FG001|Study 306B|Lost to Follow-up|1|||
42025935|NCT01176240|75834000|FG000|Study 306B|withdrew prior to dosing|2|||
42025936|NCT01176240|75834001|FG001|Study 306B|withdrew prior to dosing|1|||
42025937|NCT00988221|75834010|FG000|Part I|Adverse Event|0|||
42025938|NCT00988221|75834011|FG001|Part I|Adverse Event|1|||
42025939|NCT00988221|75834012|FG002|Part I|Adverse Event|2|||
42025940|NCT00988221|75834013|FG003|Part I|Adverse Event|0|||
42025941|NCT00988221|75834010|FG000|Part I|Insufficient Therapeutic Response|4|||
42025942|NCT00988221|75834011|FG001|Part I|Insufficient Therapeutic Response|6|||
42025943|NCT00988221|75834012|FG002|Part I|Insufficient Therapeutic Response|5|||
42025944|NCT00988221|75834013|FG003|Part I|Insufficient Therapeutic Response|0|||
42025945|NCT00988221|75834010|FG000|Part I|Refused Treatment|0|||
42025946|NCT00988221|75834011|FG001|Part I|Refused Treatment|2|||
42025947|NCT00988221|75834012|FG002|Part I|Refused Treatment|1|||
42025948|NCT00988221|75834013|FG003|Part I|Refused Treatment|0|||
42025949|NCT00988221|75834010|FG000|Part I|Lost to Follow-up|0|||
42025950|NCT00988221|75834011|FG001|Part I|Lost to Follow-up|1|||
42025951|NCT00988221|75834012|FG002|Part I|Lost to Follow-up|0|||
42025952|NCT00988221|75834013|FG003|Part I|Lost to Follow-up|0|||
42025953|NCT00988221|75834010|FG000|Part II|Adverse Event|1|||
42025954|NCT00988221|75834011|FG001|Part II|Adverse Event|0|||
42025955|NCT00988221|75834012|FG002|Part II|Adverse Event|0|||
42025956|NCT00988221|75834013|FG003|Part II|Adverse Event|1|||
41962916|NCT03539952|75741258|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
41962917|NCT03539952|75741257|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
42025957|NCT00988221|75834010|FG000|Part II|Withdrawal by Subject|0|||
42025958|NCT00988221|75834011|FG001|Part II|Withdrawal by Subject|0|||
42025959|NCT00988221|75834012|FG002|Part II|Withdrawal by Subject|2|||
42025960|NCT00988221|75834013|FG003|Part II|Withdrawal by Subject|2|||
42025961|NCT00988221|75834010|FG000|Part II|Reason not Specified|0|||
42025962|NCT00988221|75834011|FG001|Part II|Reason not Specified|0|||
42025963|NCT00988221|75834012|FG002|Part II|Reason not Specified|1|||
42025964|NCT00988221|75834013|FG003|Part II|Reason not Specified|0|||
42025965|NCT00988221|75834010|FG000|Part III|Adverse Event|1|||
42025966|NCT00988221|75834011|FG001|Part III|Adverse Event|0|||
42025967|NCT00988221|75834012|FG002|Part III|Adverse Event|1|||
42025968|NCT00988221|75834013|FG003|Part III|Adverse Event|0|||
42025969|NCT00988221|75834010|FG000|Part III|Insufficient Therapeutic Response|0|||
42025970|NCT00988221|75834011|FG001|Part III|Insufficient Therapeutic Response|1|||
42025971|NCT00988221|75834012|FG002|Part III|Insufficient Therapeutic Response|1|||
42025972|NCT00988221|75834013|FG003|Part III|Insufficient Therapeutic Response|0|||
42025973|NCT00988221|75834010|FG000|Part III|Refused Treatment|0|||
42025974|NCT00988221|75834011|FG001|Part III|Refused Treatment|0|||
42025975|NCT00988221|75834012|FG002|Part III|Refused Treatment|1|||
42025976|NCT00988221|75834013|FG003|Part III|Refused Treatment|0|||
42118337|NCT03929562|75929170|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
42118338|NCT00415636|75929184|FG000|Overall Study|Symptomatic deterioration|1|||
42118339|NCT00415636|75929185|FG001|Overall Study|Symptomatic deterioration|0|||
42118340|NCT00415636|75929186|FG002|Overall Study|Symptomatic deterioration|1|||
42118341|NCT00415636|75929187|FG003|Overall Study|Symptomatic deterioration|2|||
42118342|NCT00415636|75929188|FG004|Overall Study|Symptomatic deterioration|0|||
42118343|NCT00415636|75929189|FG005|Overall Study|Symptomatic deterioration|1|||
42118344|NCT00415636|75929184|FG000|Overall Study|Adverse Event|0|||
42118345|NCT00415636|75929185|FG001|Overall Study|Adverse Event|0|||
42118346|NCT00415636|75929186|FG002|Overall Study|Adverse Event|0|||
42118347|NCT00415636|75929187|FG003|Overall Study|Adverse Event|1|||
42118348|NCT00415636|75929188|FG004|Overall Study|Adverse Event|1|||
42118349|NCT00415636|75929189|FG005|Overall Study|Adverse Event|0|||
42118350|NCT00415636|75929184|FG000|Overall Study|Withdrawal by Subject|0|||
42118351|NCT00415636|75929185|FG001|Overall Study|Withdrawal by Subject|0|||
42118352|NCT00415636|75929186|FG002|Overall Study|Withdrawal by Subject|0|||
42118353|NCT00415636|75929187|FG003|Overall Study|Withdrawal by Subject|0|||
42118354|NCT00415636|75929188|FG004|Overall Study|Withdrawal by Subject|1|||
42118355|NCT00415636|75929189|FG005|Overall Study|Withdrawal by Subject|0|||
42118356|NCT00415636|75929184|FG000|Overall Study|Disease progression|0|||
42118357|NCT00415636|75929185|FG001|Overall Study|Disease progression|0|||
42118358|NCT00415636|75929186|FG002|Overall Study|Disease progression|0|||
42118359|NCT00415636|75929187|FG003|Overall Study|Disease progression|3|||
42118360|NCT00415636|75929188|FG004|Overall Study|Disease progression|0|||
42118361|NCT00415636|75929189|FG005|Overall Study|Disease progression|1|||
42118362|NCT00425854|75929213|FG000|Overall Study|Progressive Disease|19|||
42118363|NCT00425854|75929214|FG001|Overall Study|Progressive Disease|12|||
42118364|NCT00425854|75929213|FG000|Overall Study|Dose reduction toxicity AE|8|||
42118365|NCT00425854|75929214|FG001|Overall Study|Dose reduction toxicity AE|7|||
42118366|NCT00425854|75929213|FG000|Overall Study|Other Adverse Event|2|||
42118367|NCT00425854|75929214|FG001|Overall Study|Other Adverse Event|2|||
42118368|NCT00425698|75929223|FG000|Overall Study|Adverse Event|3|||
42118369|NCT00425698|75929224|FG001|Overall Study|Adverse Event|1|||
42118370|NCT00425698|75929223|FG000|Overall Study|Withdrawal by Subject|0|||
42118371|NCT00425698|75929224|FG001|Overall Study|Withdrawal by Subject|1|||
42118372|NCT00425308|75929232|FG000|Overall Study|Adverse Event|2|||
42118373|NCT00425308|75929233|FG001|Overall Study|Adverse Event|1|||
42118374|NCT00425308|75929232|FG000|Overall Study|Withdrawal by Subject|1|||
42118375|NCT00425308|75929233|FG001|Overall Study|Withdrawal by Subject|0|||
42118376|NCT00425308|75929232|FG000|Overall Study|Death|1|||
42118377|NCT00425308|75929233|FG001|Overall Study|Death|0|||
42118378|NCT00545064|75929239|FG000|Overall Study|Lost to Follow-up|3|||
42118379|NCT00545064|75929239|FG000|Overall Study|Withdrawal by Subject|2|||
42118380|NCT00545064|75929239|FG000|Overall Study|did not complete course of treatment|1|||
42025977|NCT01149096|75834034|FG000|Overall Study|Lost to Follow-up|0|||
42025978|NCT01149096|75834035|FG001|Overall Study|Lost to Follow-up|1|||
42025979|NCT01175382|75834045|FG000|Overall Study|Lost to Follow-up|4|||
42025980|NCT01175382|75834046|FG001|Overall Study|Lost to Follow-up|3|||
42025981|NCT01175382|75834047|FG002|Overall Study|Lost to Follow-up|1|||
42025982|NCT01175382|75834045|FG000|Overall Study|Physician Decision|0|||
42025983|NCT01175382|75834046|FG001|Overall Study|Physician Decision|1|||
42025984|NCT01175382|75834047|FG002|Overall Study|Physician Decision|0|||
42025985|NCT01175382|75834045|FG000|Overall Study|Withdrawal by Subject|0|||
42025986|NCT01175382|75834046|FG001|Overall Study|Withdrawal by Subject|0|||
42025987|NCT01175382|75834047|FG002|Overall Study|Withdrawal by Subject|1|||
42025988|NCT01175382|75834045|FG000|Overall Study|No longer having problem|1|||
42025989|NCT01175382|75834046|FG001|Overall Study|No longer having problem|0|||
42025990|NCT01175382|75834047|FG002|Overall Study|No longer having problem|1|||
42025991|NCT01175382|75834045|FG000|Overall Study|Unable/unwilling to attend visits|3|||
42118381|NCT00545064|75929239|FG000|Overall Study|cancel all appointments, no rebooking|1|||
42118382|NCT00545064|75929239|FG000|Overall Study|inclement weather|1|||
42118383|NCT00432562|75929247|FG000|Overall Study|Death|3|||
42118384|NCT00432562|75929248|FG001|Overall Study|Death|0|||
42118385|NCT00432172|75929258|FG000|Overall Study|Physician Decision|0|||
42118386|NCT00432172|75929259|FG001|Overall Study|Physician Decision|0|||
42118387|NCT00432172|75929260|FG002|Overall Study|Physician Decision|2|||
42118388|NCT00432172|75929261|FG003|Overall Study|Physician Decision|0|||
42118389|NCT00432172|75929258|FG000|Overall Study|Adverse Event|4|||
42118390|NCT00432172|75929259|FG001|Overall Study|Adverse Event|2|||
42118391|NCT00432172|75929260|FG002|Overall Study|Adverse Event|4|||
42025992|NCT01175382|75834046|FG001|Overall Study|Unable/unwilling to attend visits|1|||
42025993|NCT01175382|75834047|FG002|Overall Study|Unable/unwilling to attend visits|2|||
42025994|NCT01175382|75834045|FG000|Overall Study|Unwilling to follow protocol|0|||
42025995|NCT01175382|75834046|FG001|Overall Study|Unwilling to follow protocol|1|||
42025996|NCT01175382|75834047|FG002|Overall Study|Unwilling to follow protocol|0|||
42025997|NCT01175382|75834045|FG000|Overall Study|Unable to tolerate study meds|0|||
42118392|NCT00432172|75929261|FG003|Overall Study|Adverse Event|3|||
42118393|NCT00432172|75929258|FG000|Overall Study|Disease progression|0|||
42118394|NCT00432172|75929259|FG001|Overall Study|Disease progression|2|||
42118395|NCT00432172|75929260|FG002|Overall Study|Disease progression|5|||
42118396|NCT00432172|75929261|FG003|Overall Study|Disease progression|1|||
42118397|NCT00432172|75929258|FG000|Overall Study|Withdrawal by Subject|0|||
42118398|NCT00432172|75929259|FG001|Overall Study|Withdrawal by Subject|1|||
42118399|NCT00432172|75929260|FG002|Overall Study|Withdrawal by Subject|0|||
42118400|NCT00432172|75929261|FG003|Overall Study|Withdrawal by Subject|2|||
42118401|NCT00432172|75929258|FG000|Overall Study|No treatment received|2|||
42118402|NCT00432172|75929259|FG001|Overall Study|No treatment received|2|||
42118403|NCT00432172|75929260|FG002|Overall Study|No treatment received|0|||
42118404|NCT00432172|75929261|FG003|Overall Study|No treatment received|1|||
42118405|NCT00415168|75929273|FG000|Overall Study|Death|26|||
42118406|NCT00415168|75929273|FG000|Overall Study|Lost to Follow-up|3|||
42118407|NCT00415168|75929273|FG000|Overall Study|Physician Decision|13|||
42118408|NCT00415168|75929273|FG000|Overall Study|Sponsor Decision|4|||
42118409|NCT00415168|75929273|FG000|Overall Study|Withdrawal by Subject|6|||
42118410|NCT00424762|75929279|FG000|Overall Study|Withdrawal by Subject|18|||
42118411|NCT00424762|75929280|FG001|Overall Study|Withdrawal by Subject|19|||
42118412|NCT00424762|75929279|FG000|Overall Study|Lost to Follow-up|2|||
42118413|NCT00424762|75929280|FG001|Overall Study|Lost to Follow-up|3|||
42118414|NCT00414544|75929286|FG000|Overall Study|Lost to Follow-up|14|||
42118415|NCT00414466|75929296|FG000|Overall Study|Adverse Event|0|||
42118416|NCT00414466|75929297|FG001|Overall Study|Adverse Event|0|||
42118417|NCT00414466|75929298|FG002|Overall Study|Adverse Event|1|||
42118418|NCT00414466|75929299|FG003|Overall Study|Adverse Event|1|||
42118419|NCT00414466|75929296|FG000|Overall Study|Lack of Efficacy|1|||
42118420|NCT00414466|75929297|FG001|Overall Study|Lack of Efficacy|0|||
42118421|NCT00414466|75929298|FG002|Overall Study|Lack of Efficacy|0|||
42118422|NCT00414466|75929299|FG003|Overall Study|Lack of Efficacy|0|||
42118423|NCT00414466|75929296|FG000|Overall Study|Withdrawn by Sponsor|1|||
42118424|NCT00414466|75929297|FG001|Overall Study|Withdrawn by Sponsor|0|||
42118425|NCT00414466|75929298|FG002|Overall Study|Withdrawn by Sponsor|0|||
42118426|NCT00414466|75929299|FG003|Overall Study|Withdrawn by Sponsor|0|||
42118427|NCT00424528|75929315|FG000|Overall Study|Adverse Event|2|||
42118428|NCT00424528|75929316|FG001|Overall Study|Adverse Event|1|||
42118429|NCT00424528|75929317|FG002|Overall Study|Adverse Event|2|||
42118430|NCT00424528|75929315|FG000|Overall Study|Protocol Violation|1|||
42118431|NCT00424528|75929316|FG001|Overall Study|Protocol Violation|1|||
42118432|NCT00424528|75929317|FG002|Overall Study|Protocol Violation|0|||
42118433|NCT00424528|75929315|FG000|Overall Study|Lost to Follow-up|0|||
42118434|NCT00424528|75929316|FG001|Overall Study|Lost to Follow-up|1|||
42118435|NCT00424528|75929317|FG002|Overall Study|Lost to Follow-up|0|||
42118436|NCT00424528|75929315|FG000|Overall Study|noncompliance with study requirements|2|||
42118437|NCT00424528|75929316|FG001|Overall Study|noncompliance with study requirements|1|||
42118438|NCT00424528|75929317|FG002|Overall Study|noncompliance with study requirements|2|||
42118439|NCT00545532|75929327|FG000|Overall Study|Withdrawal by Subject|1|||
42118440|NCT00545532|75929328|FG001|Overall Study|Withdrawal by Subject|3|||
42118441|NCT00545532|75929327|FG000|Overall Study|Lost to Follow-up|5|||
42118442|NCT00545532|75929328|FG001|Overall Study|Lost to Follow-up|6|||
42118443|NCT00545532|75929327|FG000|Overall Study|Death|0|||
42118444|NCT00545532|75929328|FG001|Overall Study|Death|1|||
42118445|NCT00544440|75929336|FG000|Overall Study|Other|1|||
42118446|NCT00544440|75929336|FG000|Overall Study|Adverse Event|1|||
42118447|NCT00544440|75929336|FG000|Overall Study|Withdrawal by Subject|2|||
42118448|NCT00544440|75929336|FG000|Overall Study|Subject Non-compliance|1|||
42118449|NCT00544440|75929336|FG000|Overall Study|Progressive Disease|47|||
42118450|NCT00544440|75929336|FG000|Overall Study|Other|5|||
42118451|NCT03920670|75929342|FG000|Overall Study|Protocol Violation|2|||
42118452|NCT03920670|75929343|FG001|Overall Study|Protocol Violation|2|||
42118453|NCT03920670|75929342|FG000|Overall Study|Adverse Event|1|||
42118454|NCT03920670|75929343|FG001|Overall Study|Adverse Event|0|||
42118455|NCT00430300|75929353|FG000|Overall Study|Adverse Event|0|||
42118456|NCT00430300|75929354|FG001|Overall Study|Adverse Event|2|||
42118457|NCT00430300|75929355|FG002|Overall Study|Adverse Event|1|||
42118458|NCT00430300|75929356|FG003|Overall Study|Adverse Event|1|||
42118459|NCT00430300|75929353|FG000|Overall Study|Withdrawal by Subject|1|||
42118460|NCT00430300|75929354|FG001|Overall Study|Withdrawal by Subject|0|||
42118461|NCT00430300|75929355|FG002|Overall Study|Withdrawal by Subject|5|||
42118462|NCT00430300|75929356|FG003|Overall Study|Withdrawal by Subject|0|||
42118463|NCT00430300|75929353|FG000|Overall Study|Laboratory abnormality|1|||
42118464|NCT00430300|75929354|FG001|Overall Study|Laboratory abnormality|0|||
42118465|NCT00430300|75929355|FG002|Overall Study|Laboratory abnormality|0|||
42118466|NCT00430300|75929356|FG003|Overall Study|Laboratory abnormality|0|||
42118467|NCT00430300|75929353|FG000|Overall Study|Other|0|||
42118468|NCT00430300|75929354|FG001|Overall Study|Other|0|||
42118469|NCT00430300|75929355|FG002|Overall Study|Other|0|||
42118470|NCT00430300|75929356|FG003|Overall Study|Other|1|||
42118471|NCT03927846|75929368|FG000|Overall Study|Lost to Follow-up|10|||
42118472|NCT03927846|75929369|FG001|Overall Study|Lost to Follow-up|11|||
42118473|NCT00545298|75929378|FG000|Overall Study|Issues with Standard of Care|2|||
42118474|NCT00545298|75929379|FG001|Overall Study|Issues with Standard of Care|0|||
42118475|NCT00545298|75929380|FG002|Overall Study|Issues with Standard of Care|1|||
42118476|NCT00429364|75929393|FG000|Overall Study|Withdrawal by Subject|11|||
42118477|NCT00429364|75929394|FG001|Overall Study|Withdrawal by Subject|5|||
42118478|NCT00429364|75929393|FG000|Overall Study|Physician Decision|4|||
42118479|NCT00429364|75929394|FG001|Overall Study|Physician Decision|2|||
42118480|NCT00429364|75929393|FG000|Overall Study|Lost to Follow-up|7|||
42118481|NCT00429364|75929394|FG001|Overall Study|Lost to Follow-up|6|||
42118482|NCT00429364|75929393|FG000|Overall Study|Death|0|||
42118483|NCT00429364|75929394|FG001|Overall Study|Death|1|||
42118484|NCT00429364|75929393|FG000|Overall Study|Underwent aortic root surgery|10|||
42118485|NCT00429364|75929394|FG001|Overall Study|Underwent aortic root surgery|18|||
42118486|NCT00429364|75929393|FG000|Overall Study|Pregnancy|0|||
42118487|NCT00429364|75929394|FG001|Overall Study|Pregnancy|1|||
42118488|NCT00414388|75929400|FG000|Overall Study|Adverse Event|1|||
42118489|NCT03920280|75929407|FG000|Overall Study|Adverse Event|2|||
41962918|NCT03539952|75741258|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
41962919|NCT03539952|75741257|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
41962920|NCT03539952|75741258|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
41962921|NCT03539952|75741257|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
41962922|NCT03539952|75741258|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
41962923|NCT03539952|75741257|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
41962924|NCT03539952|75741258|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
42118490|NCT03920280|75929408|FG001|Overall Study|Adverse Event|3|||
42118491|NCT03920280|75929407|FG000|Overall Study|Lost to Follow-up|0|||
42118492|NCT03920280|75929408|FG001|Overall Study|Lost to Follow-up|1|||
42118493|NCT03920280|75929407|FG000|Overall Study|Withdrawal by Subject|1|||
42118494|NCT03920280|75929408|FG001|Overall Study|Withdrawal by Subject|1|||
42118495|NCT03920280|75929407|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
42118496|NCT03920280|75929408|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
42118497|NCT00424372|75929417|FG000|Overall Study|Death|1|||
42118498|NCT00424372|75929417|FG000|Overall Study|Adverse Event|18|||
42118499|NCT00424372|75929417|FG000|Overall Study|Lack of Efficacy|6|||
42118500|NCT00424372|75929417|FG000|Overall Study|Withdrawal by Subject|4|||
42118501|NCT00424372|75929417|FG000|Overall Study|Protocol Violation|1|||
42118502|NCT00424372|75929417|FG000|Overall Study|Health deterioration|1|||
42118503|NCT00414310|75929423|FG000|Overall Study|Not treated|1|||
42118504|NCT00414310|75929424|FG001|Overall Study|Not treated|0|||
42118505|NCT00542880|75929434|FG000|Period 1|Eligibility criteria not fulfilled|2|||
42118506|NCT00542880|75929435|FG001|Period 1|Eligibility criteria not fulfilled|6|||
42118507|NCT00542880|75929434|FG000|Period 1|Adverse Event|2|||
42118508|NCT00542880|75929435|FG001|Period 1|Adverse Event|2|||
42118509|NCT00542880|75929434|FG000|Period 1|Development of study-specific criteria|1|||
41962925|NCT03539952|75741257|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
41962926|NCT03539952|75741258|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
41962927|NCT02929108|75741290|FG000|Overall Study|Hospice patient death|100|||
41962928|NCT02929108|75741291|FG001|Overall Study|Hospice patient death|64|||
42118510|NCT00542880|75929435|FG001|Period 1|Development of study-specific criteria|2|||
42118511|NCT00542880|75929434|FG000|Period 1|Withdrawal by Subject|1|||
42118512|NCT00542880|75929435|FG001|Period 1|Withdrawal by Subject|1|||
42118513|NCT00542880|75929434|FG000|Period 1|Protocol Violation|0|||
42118514|NCT00542880|75929435|FG001|Period 1|Protocol Violation|1|||
42118515|NCT00542880|75929434|FG000|Period 2|Adverse Event|5|||
42118516|NCT00542880|75929435|FG001|Period 2|Adverse Event|7|||
42118517|NCT00542880|75929434|FG000|Period 2|Eligibility not fulfilled|0|||
42118518|NCT00542880|75929435|FG001|Period 2|Eligibility not fulfilled|1|||
42118519|NCT00542880|75929434|FG000|Period 2|Discontinuation criteria|2|||
42118520|NCT00542880|75929435|FG001|Period 2|Discontinuation criteria|0|||
42118521|NCT00542880|75929434|FG000|Period 2|Severe non-compliance|0|||
42118522|NCT00542880|75929435|FG001|Period 2|Severe non-compliance|1|||
42118523|NCT00542880|75929434|FG000|Period 2|Other|0|||
42118524|NCT00542880|75929435|FG001|Period 2|Other|1|||
42118525|NCT00542880|75929434|FG000|Period 3|Adverse Event|0|||
42118526|NCT00542880|75929435|FG001|Period 3|Adverse Event|2|||
42118527|NCT00414076|75929444|FG000|Overall Study|Progression|1|||
42118528|NCT00414076|75929445|FG001|Overall Study|Progression|2|||
42118529|NCT00414076|75929444|FG000|Overall Study|Withdrawal by Subject|1|||
42118530|NCT00414076|75929445|FG001|Overall Study|Withdrawal by Subject|3|||
42118531|NCT00414076|75929444|FG000|Overall Study|Adverse Event|1|||
42118532|NCT00414076|75929445|FG001|Overall Study|Adverse Event|0|||
42118533|NCT00092677|75929453|FG000|Overall Study|Lost to Follow-up|0|||
42118534|NCT00092677|75929454|FG001|Overall Study|Lost to Follow-up|2|||
42118535|NCT00092677|75929453|FG000|Overall Study|Adminstrative|5|||
42118536|NCT00092677|75929454|FG001|Overall Study|Adminstrative|9|||
42118537|NCT00542178|75929466|FG000|Overall Study|did not complete year 4 follow-up|75|||
42118538|NCT00542178|75929467|FG001|Overall Study|did not complete year 4 follow-up|80|||
42118539|NCT00542178|75929468|FG002|Overall Study|did not complete year 4 follow-up|74|||
42118540|NCT00542178|75929469|FG003|Overall Study|did not complete year 4 follow-up|62|||
42118541|NCT00542178|75929470|FG004|Overall Study|did not complete year 4 follow-up|64|||
42118542|NCT00542178|75929471|FG005|Overall Study|did not complete year 4 follow-up|89|||
42118543|NCT00542178|75929472|FG006|Overall Study|did not complete year 4 follow-up|87|||
42118544|NCT00542178|75929473|FG007|Overall Study|did not complete year 4 follow-up|85|||
42118545|NCT00424294|75929489|FG000|Overall Study|Adverse Event|4|||
42118546|NCT00424294|75929490|FG001|Overall Study|Adverse Event|10|||
42118547|NCT00424294|75929489|FG000|Overall Study|Lack of Efficacy|2|||
42118548|NCT00424294|75929490|FG001|Overall Study|Lack of Efficacy|1|||
42118549|NCT00424294|75929489|FG000|Overall Study|Withdrawal by Subject|1|||
41962929|NCT02929108|75741292|FG002|Overall Study|Hospice patient death|28|||
41962930|NCT02929108|75741293|FG003|Overall Study|Hospice patient death|46|||
41962931|NCT02929108|75741294|FG004|Overall Study|Hospice patient death|55|||
41962932|NCT02929108|75741295|FG005|Overall Study|Hospice patient death|28|||
41962933|NCT02929108|75741296|FG006|Overall Study|Hospice patient death|78|||
41962934|NCT02661295|75741304|FG000|Overall Study|Death|1|||
41962935|NCT02661295|75741304|FG000|Overall Study|Transferred Out|1|||
41962936|NCT02661295|75741304|FG000|Overall Study|Kidney Transplant|1|||
41962937|NCT02661295|75741304|FG000|Overall Study|Withdrawn due to side effects|8|||
41962938|NCT02661295|75741304|FG000|Overall Study|Withdrawn due to access type|1|||
41962939|NCT02661295|75741304|FG000|Overall Study|Withdrawn due to allergies|1|||
41962940|NCT02661295|75741304|FG000|Overall Study|Withdrawn due to non-compliance|1|||
41962941|NCT02661295|75741304|FG000|Overall Study|Withdrawal by Subject|3|||
41962942|NCT02661295|75741304|FG000|Overall Study|Failed screening|2|||
41962943|NCT02412748|75741310|FG000|Overall Study|Lost to Follow-up|38|||
41962944|NCT02412748|75741311|FG001|Overall Study|Lost to Follow-up|39|||
41962945|NCT01844726|75741336|FG000|Overall Study|Withdrawal by Subject|0|||
41962946|NCT01844726|75741337|FG001|Overall Study|Withdrawal by Subject|1|||
41962947|NCT01844726|75741336|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
42025998|NCT01175382|75834046|FG001|Overall Study|Unable to tolerate study meds|1|||
42025999|NCT01175382|75834047|FG002|Overall Study|Unable to tolerate study meds|1|||
42026000|NCT01194245|75834060|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
42026001|NCT01194245|75834061|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
42026002|NCT01194245|75834062|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
42026003|NCT01194245|75834063|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
42026004|NCT01194245|75834064|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
42026005|NCT01194245|75834060|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
42026006|NCT01194245|75834061|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
42026007|NCT01194245|75834062|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
42026008|NCT01194245|75834063|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
42026009|NCT01194245|75834064|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
42026010|NCT01194245|75834060|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
42026011|NCT01194245|75834061|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
42026012|NCT01194245|75834062|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
42026013|NCT01194245|75834063|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
42026014|NCT01194245|75834064|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
42026015|NCT01194245|75834060|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
42026016|NCT01194245|75834061|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
42026017|NCT01194245|75834062|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
42026018|NCT01194245|75834063|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
42026019|NCT01194245|75834064|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
42026020|NCT01194245|75834060|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42026021|NCT01194245|75834061|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42026022|NCT01194245|75834062|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42026023|NCT01194245|75834063|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
42026024|NCT01194245|75834064|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
42026025|NCT01194245|75834060|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42026026|NCT01194245|75834061|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
42026027|NCT01194245|75834062|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
42026028|NCT01194245|75834063|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
42026029|NCT01194245|75834064|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
41962948|NCT01844726|75741337|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
42118550|NCT00424294|75929490|FG001|Overall Study|Withdrawal by Subject|2|||
42118551|NCT00424294|75929489|FG000|Overall Study|Other|0|||
42118552|NCT00424294|75929490|FG001|Overall Study|Other|2|||
42118553|NCT00424294|75929489|FG000|Overall Study|Randomized but not Treated|1|||
42118554|NCT00424294|75929490|FG001|Overall Study|Randomized but not Treated|0|||
42118555|NCT00092521|75929499|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
42118556|NCT00092521|75929500|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
42118557|NCT00092521|75929501|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
42118558|NCT00092521|75929502|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
42300637|NCT02293863|76135820|FG000|Overall Study|Lost to Follow-up|2|||
41962949|NCT05131451|75746291|FG000|Overall Study|Protocol Violation|1|||
41962950|NCT05131451|75746292|FG001|Overall Study|Protocol Violation|0|||
41962951|NCT05108922|75746300|FG000|Overall Study|Adverse Event|0|||
41962952|NCT05108922|75746301|FG001|Overall Study|Adverse Event|1|||
41962953|NCT05108922|75746300|FG000|Overall Study|Physician Decision|1|||
41962954|NCT05108922|75746301|FG001|Overall Study|Physician Decision|1|||
41962955|NCT05108922|75746300|FG000|Overall Study|Screen Failure|1|||
41962956|NCT05108922|75746301|FG001|Overall Study|Screen Failure|1|||
41962957|NCT05108922|75746300|FG000|Overall Study|Withdrawal by Subject|7|||
41962958|NCT05108922|75746301|FG001|Overall Study|Withdrawal by Subject|4|||
41962959|NCT04874636|75746317|FG000|Overall Study|Adverse Event|17|||
41962960|NCT04874636|75746318|FG001|Overall Study|Adverse Event|7|||
41962961|NCT04874636|75746317|FG000|Overall Study|Lost to Follow-up|1|||
41962962|NCT04874636|75746318|FG001|Overall Study|Lost to Follow-up|0|||
41962963|NCT04874636|75746317|FG000|Overall Study|Non-Compliance with Study Drug|2|||
41962964|NCT04874636|75746318|FG001|Overall Study|Non-Compliance with Study Drug|0|||
41962965|NCT04874636|75746317|FG000|Overall Study|Physician Decision|1|||
42026030|NCT00979407|75834075|FG000|Overall Study|Withdrawal by Subject|3|||
42026031|NCT00979407|75834076|FG001|Overall Study|Withdrawal by Subject|4|||
42026032|NCT00979407|75834075|FG000|Overall Study|Lost to Follow-up|3|||
42026033|NCT00979407|75834076|FG001|Overall Study|Lost to Follow-up|3|||
42026034|NCT01148862|75834084|FG000|Second Intervention|Withdrawal by Subject|0|||
42026035|NCT01148862|75834085|FG001|Second Intervention|Withdrawal by Subject|2|||
42026036|NCT00975975|75834091|FG000|Overall Study|Death|6|||
42026037|NCT01193153|75834095|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
42026038|NCT01193153|75834096|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
42026039|NCT01193153|75834095|FG000|Open-label Lead in Period|Pregnancy|1|||
42026040|NCT01193153|75834096|FG001|Open-label Lead in Period|Pregnancy|0|||
42026041|NCT01193153|75834095|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
42026042|NCT01193153|75834096|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
42026043|NCT01193153|75834095|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
42026044|NCT01193153|75834096|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
42026045|NCT01193153|75834095|FG000|Open-label Lead in Period|Other|14|||
42026046|NCT01193153|75834096|FG001|Open-label Lead in Period|Other|0|||
42026047|NCT01193153|75834095|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
42026048|NCT01193153|75834096|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
42026049|NCT01193153|75834095|FG000|Open-label Lead in Period|Adverse Event|41|||
42026050|NCT01193153|75834096|FG001|Open-label Lead in Period|Adverse Event|0|||
42026051|NCT01193153|75834095|FG000|Open-label Lead in Period|Death|1|||
42026052|NCT01193153|75834096|FG001|Open-label Lead in Period|Death|0|||
42026053|NCT01193153|75834095|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
42026054|NCT01193153|75834096|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
42026055|NCT01193153|75834095|FG000|Open-label Stabilization Period|Adverse Event|9|||
42026056|NCT01193153|75834096|FG001|Open-label Stabilization Period|Adverse Event|0|||
42026057|NCT01193153|75834095|FG000|Open-label Stabilization Period|Death|2|||
42026058|NCT01193153|75834096|FG001|Open-label Stabilization Period|Death|0|||
42026059|NCT01193153|75834095|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
42026060|NCT01193153|75834096|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
42026061|NCT01193153|75834095|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
42026062|NCT01193153|75834096|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
42026063|NCT01193153|75834095|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
42026064|NCT01193153|75834096|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
42026065|NCT01193153|75834095|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
42026066|NCT01193153|75834096|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
42026067|NCT01193153|75834095|FG000|Open-label Stabilization Period|Other|8|||
42026068|NCT01193153|75834096|FG001|Open-label Stabilization Period|Other|0|||
42026069|NCT01193153|75834095|FG000|Double Blind Relapse Prevention Period|Other|2|||
42026070|NCT01193153|75834096|FG001|Double Blind Relapse Prevention Period|Other|3|||
42026071|NCT01193153|75834095|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
42026072|NCT01193153|75834096|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
42026073|NCT01193153|75834095|FG000|Double Blind Relapse Prevention Period|Death|2|||
42026074|NCT01193153|75834096|FG001|Double Blind Relapse Prevention Period|Death|0|||
41962966|NCT04874636|75746318|FG001|Overall Study|Physician Decision|0|||
41962967|NCT04874636|75746317|FG000|Overall Study|Withdrawal by Subject|6|||
41962968|NCT04874636|75746318|FG001|Overall Study|Withdrawal by Subject|5|||
42118559|NCT00092521|75929499|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
42118560|NCT00092521|75929500|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
42118561|NCT00092521|75929501|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
42118562|NCT00092521|75929502|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
42118563|NCT00092521|75929499|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
42118564|NCT00092521|75929500|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
42118565|NCT00092521|75929501|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
42118566|NCT00092521|75929502|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
42118567|NCT00092521|75929499|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
42300638|NCT02293863|76135821|FG001|Overall Study|Lost to Follow-up|2|||
42026075|NCT01193153|75834095|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
42026076|NCT01193153|75834096|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
42026077|NCT01193153|75834095|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
42026078|NCT01193153|75834096|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
42026079|NCT01193153|75834095|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
42026080|NCT01193153|75834096|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
42026081|NCT01193153|75834095|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
42026082|NCT01193153|75834096|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
42026083|NCT01193153|75834095|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
42026084|NCT01193153|75834096|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
42026085|NCT01192295|75834107|FG000|Overall Study|Adverse Event|3|||
42026086|NCT01192295|75834108|FG001|Overall Study|Adverse Event|7|||
42026087|NCT01192295|75834107|FG000|Overall Study|Withdrawal by Subject|3|||
42026088|NCT01192295|75834108|FG001|Overall Study|Withdrawal by Subject|4|||
42026089|NCT01192295|75834107|FG000|Overall Study|Lost to Follow-up|0|||
42026090|NCT01192295|75834108|FG001|Overall Study|Lost to Follow-up|1|||
42026091|NCT01192295|75834107|FG000|Overall Study|Lack of Efficacy|0|||
42026092|NCT01192295|75834108|FG001|Overall Study|Lack of Efficacy|5|||
42026093|NCT01192295|75834107|FG000|Overall Study|Administrative|4|||
42026094|NCT01192295|75834108|FG001|Overall Study|Administrative|6|||
42026095|NCT01154166|75834118|FG000|Overall Study|Adverse Event|14|||
42026096|NCT01154166|75834119|FG001|Overall Study|Adverse Event|9|||
42026097|NCT01154166|75834118|FG000|Overall Study|Lost to Follow-up|1|||
42026098|NCT01154166|75834119|FG001|Overall Study|Lost to Follow-up|1|||
42026099|NCT01154166|75834118|FG000|Overall Study|Protocol Violation|4|||
42026100|NCT01154166|75834119|FG001|Overall Study|Protocol Violation|1|||
42026101|NCT01154166|75834118|FG000|Overall Study|Withdrawal by Subject|10|||
42026102|NCT01154166|75834119|FG001|Overall Study|Withdrawal by Subject|1|||
42026103|NCT01154166|75834118|FG000|Overall Study|Lack of Efficacy|3|||
42026104|NCT01154166|75834119|FG001|Overall Study|Lack of Efficacy|0|||
42026105|NCT01154166|75834118|FG000|Overall Study|Disease Progression|1|||
42026106|NCT01154166|75834119|FG001|Overall Study|Disease Progression|0|||
42026107|NCT01154166|75834118|FG000|Overall Study|Poor Compliance|1|||
42026108|NCT01154166|75834119|FG001|Overall Study|Poor Compliance|0|||
42026109|NCT00975585|75834127|FG000|Overall Study|Adverse Event|0|||
42026110|NCT00975585|75834128|FG001|Overall Study|Adverse Event|4|||
42026111|NCT00975585|75834127|FG000|Overall Study|Lost to Follow-up|3|||
42026112|NCT00975585|75834128|FG001|Overall Study|Lost to Follow-up|5|||
42026113|NCT00975585|75834127|FG000|Overall Study|Withdrawal by Subject|2|||
42026114|NCT00975585|75834128|FG001|Overall Study|Withdrawal by Subject|1|||
42026115|NCT00975585|75834127|FG000|Overall Study|Lens issue|2|||
42026116|NCT00975585|75834128|FG001|Overall Study|Lens issue|2|||
42026117|NCT01181921|75834136|FG000|Overall Study|Lost to Follow-up|1|||
42026118|NCT01174446|75834140|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
42026119|NCT01174446|75834141|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
42026120|NCT01174446|75834142|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
42026121|NCT01174446|75834143|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
42026122|NCT01174446|75834140|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
42026123|NCT01174446|75834141|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
42118568|NCT00092521|75929500|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
42026124|NCT01174446|75834142|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
42026125|NCT01174446|75834143|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
42026126|NCT01174446|75834140|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
42026127|NCT01174446|75834141|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
42026128|NCT01174446|75834142|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
42026129|NCT01174446|75834143|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
42026130|NCT01174446|75834140|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
42026131|NCT01174446|75834141|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
42026132|NCT01174446|75834142|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
42026133|NCT01174446|75834143|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
42026134|NCT00932698|75834201|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
42026135|NCT00932698|75834202|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
42026136|NCT00932698|75834203|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
42026137|NCT00932698|75834204|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
42026138|NCT00932698|75834205|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
42026139|NCT00932698|75834206|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
42026140|NCT00932698|75834207|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
42026141|NCT00932698|75834208|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
42026142|NCT00932698|75834209|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
42026143|NCT00932698|75834210|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
42118569|NCT00092521|75929501|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
42118570|NCT00092521|75929502|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
42118571|NCT00092521|75929499|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
42118572|NCT00092521|75929500|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
42118573|NCT00092521|75929501|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
42118574|NCT00092521|75929502|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
42118575|NCT00092521|75929499|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
42118576|NCT00092521|75929500|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
42118577|NCT00092521|75929501|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
42118578|NCT00092521|75929502|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
42118579|NCT00092521|75929499|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
42118580|NCT00092521|75929500|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
41962969|NCT04707157|75746334|FG000|Overall Study|Adverse Event|12|||
41962970|NCT04707157|75746335|FG001|Overall Study|Adverse Event|3|||
41962971|NCT04707157|75746334|FG000|Overall Study|Lost to Follow-up|2|||
41962972|NCT04707157|75746335|FG001|Overall Study|Lost to Follow-up|0|||
41962973|NCT04707157|75746334|FG000|Overall Study|Sponsor's decision|1|||
41962974|NCT04707157|75746335|FG001|Overall Study|Sponsor's decision|0|||
41962975|NCT04707157|75746334|FG000|Overall Study|Physician Decision|8|||
41962976|NCT04707157|75746335|FG001|Overall Study|Physician Decision|5|||
41962977|NCT04707157|75746334|FG000|Overall Study|Protocol Deviation|1|||
41962978|NCT04707157|75746335|FG001|Overall Study|Protocol Deviation|0|||
41962979|NCT04707157|75746334|FG000|Overall Study|Withdrawal by Subject|1|||
41962980|NCT04707157|75746335|FG001|Overall Study|Withdrawal by Subject|1|||
41962981|NCT04700449|75746344|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
41962982|NCT04700449|75746345|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
41962983|NCT04700449|75746346|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
41962984|NCT04700449|75746347|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
41962985|NCT04700449|75746344|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
41962986|NCT04700449|75746345|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
41962987|NCT04700449|75746346|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
41962988|NCT04700449|75746347|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
41962989|NCT04700449|75746344|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
41962990|NCT04700449|75746345|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
41962991|NCT04700449|75746346|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
41962992|NCT04700449|75746347|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
41962993|NCT04700449|75746344|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
41962994|NCT04700449|75746345|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
41962995|NCT04700449|75746346|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
41962996|NCT04700449|75746347|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
41962997|NCT04700449|75746344|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
41962998|NCT04700449|75746345|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
41962999|NCT04700449|75746346|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
41963000|NCT04700449|75746347|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
41963001|NCT04700449|75746344|FG000|Stage 1: Double-Blind Period|Other|0|||
41963002|NCT04700449|75746345|FG001|Stage 1: Double-Blind Period|Other|0|||
42118581|NCT00092521|75929501|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
42118582|NCT00092521|75929502|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
41963003|NCT04700449|75746346|FG002|Stage 1: Double-Blind Period|Other|1|||
41963004|NCT04700449|75746347|FG003|Stage 1: Double-Blind Period|Other|0|||
42118583|NCT00092521|75929499|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
42118584|NCT00092521|75929500|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
42118585|NCT00092521|75929501|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
42118586|NCT00092521|75929502|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
42118587|NCT00092521|75929499|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
42118588|NCT00092521|75929500|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
42118589|NCT00092521|75929501|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
42118590|NCT00092521|75929502|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
42118591|NCT00092521|75929499|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
42118592|NCT00092521|75929500|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
42118593|NCT00092521|75929501|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
42118594|NCT00092521|75929502|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
42118595|NCT00092521|75929499|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
42118596|NCT00092521|75929500|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
42118597|NCT00092521|75929501|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
42118598|NCT00092521|75929502|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
42118599|NCT00092521|75929499|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
42118600|NCT00092521|75929500|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
42118601|NCT00092521|75929501|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
42118602|NCT00092521|75929502|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
42118603|NCT00092521|75929499|FG000|Follow-Up (After Month 7)|Death|2|||
42118604|NCT00092521|75929500|FG001|Follow-Up (After Month 7)|Death|0|||
42118605|NCT00092521|75929501|FG002|Follow-Up (After Month 7)|Death|1|||
42118606|NCT00092521|75929502|FG003|Follow-Up (After Month 7)|Death|0|||
42118607|NCT00092521|75929499|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
42118608|NCT00092521|75929500|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
42118609|NCT00092521|75929501|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
42118610|NCT00092521|75929502|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
42118611|NCT00092521|75929499|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
42118612|NCT00092521|75929500|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
42118613|NCT00092521|75929501|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
42118614|NCT00092521|75929502|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
42118615|NCT00092521|75929499|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
42118616|NCT00092521|75929500|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
42118617|NCT00092521|75929501|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
42118618|NCT00092521|75929502|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
42118619|NCT00092521|75929499|FG000|Follow-Up (After Month 7)|Moved|32|||
42118620|NCT00092521|75929500|FG001|Follow-Up (After Month 7)|Moved|2|||
42118621|NCT00092521|75929501|FG002|Follow-Up (After Month 7)|Moved|28|||
42118622|NCT00092521|75929502|FG003|Follow-Up (After Month 7)|Moved|0|||
42118623|NCT00092521|75929499|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
42118624|NCT00092521|75929500|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
42118625|NCT00092521|75929501|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
42118626|NCT00092521|75929502|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
42118627|NCT00092521|75929499|FG000|Follow-Up (After Month 7)|Travel|2|||
42118628|NCT00092521|75929500|FG001|Follow-Up (After Month 7)|Travel|0|||
42118629|NCT00092521|75929501|FG002|Follow-Up (After Month 7)|Travel|0|||
42118630|NCT00092521|75929502|FG003|Follow-Up (After Month 7)|Travel|0|||
42118631|NCT00092521|75929499|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
42118632|NCT00092521|75929500|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
42118633|NCT00092521|75929501|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
42118634|NCT00092521|75929502|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
42118635|NCT00092521|75929499|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
42118636|NCT00092521|75929500|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
42118637|NCT00092521|75929501|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
42118638|NCT00092521|75929502|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
42118639|NCT00092521|75929499|FG000|Extension Study (Group 4)|Adverse Event|0|||
42026144|NCT00932698|75834211|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
42026145|NCT00932698|75834201|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
42026146|NCT00932698|75834202|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
42026147|NCT00932698|75834203|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
42026148|NCT00932698|75834204|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
42026149|NCT00932698|75834205|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
42026150|NCT00932698|75834206|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
42026151|NCT00932698|75834207|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
42026152|NCT00932698|75834208|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
42118640|NCT00092521|75929500|FG001|Extension Study (Group 4)|Adverse Event|0|||
42118641|NCT00092521|75929501|FG002|Extension Study (Group 4)|Adverse Event|0|||
42118642|NCT00092521|75929502|FG003|Extension Study (Group 4)|Adverse Event|2|||
42118643|NCT00092521|75929499|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
42118644|NCT00092521|75929500|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
42118645|NCT00092521|75929501|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
42118646|NCT00092521|75929502|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
42118647|NCT00092521|75929499|FG000|Extension Study (Group 4)|Pregnancy|0|||
42118648|NCT00092521|75929500|FG001|Extension Study (Group 4)|Pregnancy|0|||
42118649|NCT00092521|75929501|FG002|Extension Study (Group 4)|Pregnancy|0|||
41963005|NCT04700449|75746344|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
41963006|NCT04700449|75746345|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
41963007|NCT04700449|75746346|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
41963008|NCT04700449|75746347|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
41963009|NCT04700449|75746344|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
41963010|NCT04700449|75746345|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
41963011|NCT04700449|75746346|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
41963012|NCT04700449|75746347|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
41963013|NCT04700449|75746344|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
41963014|NCT04700449|75746345|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
41963015|NCT04700449|75746346|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
41963016|NCT04700449|75746347|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
41963017|NCT04700449|75746344|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
42026153|NCT00932698|75834209|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
42026154|NCT00932698|75834210|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
42026155|NCT00932698|75834211|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
42026156|NCT00932698|75834201|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
42026157|NCT00932698|75834202|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
42026158|NCT00932698|75834203|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
42026159|NCT00932698|75834204|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
42026160|NCT00932698|75834205|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
42026161|NCT00932698|75834206|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
42026162|NCT00932698|75834207|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
42026163|NCT00932698|75834208|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
42026164|NCT00932698|75834209|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
42026165|NCT00932698|75834210|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
42026166|NCT00932698|75834211|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
42026167|NCT00932698|75834201|FG000|Part 1 (Dose Escalation)|Other|0|||
42026168|NCT00932698|75834202|FG001|Part 1 (Dose Escalation)|Other|0|||
42026169|NCT00932698|75834203|FG002|Part 1 (Dose Escalation)|Other|1|||
42026170|NCT00932698|75834204|FG003|Part 1 (Dose Escalation)|Other|0|||
42026171|NCT00932698|75834205|FG004|Part 1 (Dose Escalation)|Other|0|||
42026172|NCT00932698|75834206|FG005|Part 1 (Dose Escalation)|Other|0|||
42026173|NCT00932698|75834207|FG006|Part 1 (Dose Escalation)|Other|1|||
42026174|NCT00932698|75834208|FG007|Part 1 (Dose Escalation)|Other|0|||
42026175|NCT00932698|75834209|FG008|Part 1 (Dose Escalation)|Other|0|||
42026176|NCT00932698|75834210|FG009|Part 1 (Dose Escalation)|Other|0|||
42026177|NCT00932698|75834211|FG010|Part 1 (Dose Escalation)|Other|0|||
42026178|NCT00932698|75834201|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
42026179|NCT00932698|75834202|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
42026180|NCT00932698|75834203|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
42026181|NCT00932698|75834204|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
42026182|NCT00932698|75834205|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
42026183|NCT00932698|75834206|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
42026184|NCT00932698|75834207|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
42026185|NCT00932698|75834208|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
42026186|NCT00932698|75834209|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
42026187|NCT00932698|75834210|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
42026188|NCT00932698|75834211|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
42026189|NCT00932698|75834201|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
42026190|NCT00932698|75834202|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
42026191|NCT00932698|75834203|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
42026192|NCT00932698|75834204|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
42026193|NCT00932698|75834205|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
42026194|NCT00932698|75834206|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
42026195|NCT00932698|75834207|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
42026196|NCT00932698|75834208|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
42118650|NCT00092521|75929502|FG003|Extension Study (Group 4)|Pregnancy|4|||
42118651|NCT00092521|75929499|FG000|Extension Study (Group 4)|Protocol Violation|0|||
41963018|NCT04700449|75746345|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
41963019|NCT04700449|75746346|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
41963020|NCT04700449|75746347|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
41963021|NCT04700449|75746344|FG000|Stage 2 Sub-study 1|Other|1|||
42026197|NCT00932698|75834209|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
42026198|NCT00932698|75834210|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
42026199|NCT00932698|75834211|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
42026200|NCT00932698|75834201|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
42026201|NCT00932698|75834202|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
42026202|NCT00932698|75834203|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
42118652|NCT00092521|75929500|FG001|Extension Study (Group 4)|Protocol Violation|0|||
42118653|NCT00092521|75929501|FG002|Extension Study (Group 4)|Protocol Violation|0|||
42118654|NCT00092521|75929502|FG003|Extension Study (Group 4)|Protocol Violation|2|||
42118655|NCT00092521|75929499|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
42118656|NCT00092521|75929500|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
42118657|NCT00092521|75929501|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
42118658|NCT00092521|75929502|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
42118659|NCT00092521|75929499|FG000|Extension Study (Group 4)|Moved|0|||
42118660|NCT00092521|75929500|FG001|Extension Study (Group 4)|Moved|0|||
42118661|NCT00092521|75929501|FG002|Extension Study (Group 4)|Moved|0|||
42118662|NCT00092521|75929502|FG003|Extension Study (Group 4)|Moved|16|||
42118663|NCT00092521|75929499|FG000|Extension Study (Group 4)|Site Terminated|0|||
42118664|NCT00092521|75929500|FG001|Extension Study (Group 4)|Site Terminated|0|||
42118665|NCT00092521|75929501|FG002|Extension Study (Group 4)|Site Terminated|0|||
42118666|NCT00092521|75929502|FG003|Extension Study (Group 4)|Site Terminated|4|||
42118667|NCT00092521|75929499|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
42118668|NCT00092521|75929500|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
42118669|NCT00092521|75929501|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
42118670|NCT00092521|75929502|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
42118671|NCT03908970|75929512|FG000|Overall Study|Adverse Event|7|||
42118672|NCT03908970|75929513|FG001|Overall Study|Adverse Event|21|||
42118673|NCT03908970|75929512|FG000|Overall Study|Physician Decision|1|||
42118674|NCT03908970|75929513|FG001|Overall Study|Physician Decision|4|||
41963022|NCT04700449|75746345|FG001|Stage 2 Sub-study 1|Other|2|||
41963023|NCT04700449|75746346|FG002|Stage 2 Sub-study 1|Other|0|||
41963024|NCT04700449|75746347|FG003|Stage 2 Sub-study 1|Other|0|||
41963025|NCT04700449|75746344|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
41963026|NCT04700449|75746345|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
41963027|NCT04700449|75746346|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
41963028|NCT04700449|75746347|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
41963029|NCT04700449|75746344|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
41963030|NCT04700449|75746345|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
41963031|NCT04700449|75746346|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
41963032|NCT04700449|75746347|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
41963033|NCT04700449|75746344|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
41963034|NCT04700449|75746345|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
41963035|NCT04700449|75746346|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
41963036|NCT04700449|75746347|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
41963037|NCT04700449|75746344|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
41963038|NCT04700449|75746345|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
41963039|NCT04700449|75746346|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
41963040|NCT04700449|75746347|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
41963041|NCT04700449|75746344|FG000|Stage 2 Sub-study 2|Other|0|||
41963042|NCT04700449|75746345|FG001|Stage 2 Sub-study 2|Other|0|||
41963043|NCT04700449|75746346|FG002|Stage 2 Sub-study 2|Other|0|||
41963044|NCT04700449|75746347|FG003|Stage 2 Sub-study 2|Other|5|||
42026203|NCT00932698|75834204|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
42026204|NCT00932698|75834205|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
42026205|NCT00932698|75834206|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
42026206|NCT00932698|75834207|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
42026207|NCT00932698|75834208|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
42026208|NCT00932698|75834209|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
42026209|NCT00932698|75834210|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
42026210|NCT00932698|75834211|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
42026211|NCT00978627|75834239|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
42026212|NCT00978627|75834240|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
42026213|NCT00978627|75834239|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
42026214|NCT00978627|75834240|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
42026215|NCT00978627|75834239|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
42026216|NCT00978627|75834240|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
42026217|NCT00978627|75834239|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
42026218|NCT00978627|75834240|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
42026219|NCT00978627|75834239|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
42026220|NCT00978627|75834240|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
42118675|NCT03908970|75929512|FG000|Overall Study|Withdrawal by Subject|9|||
42118676|NCT03908970|75929513|FG001|Overall Study|Withdrawal by Subject|22|||
42118677|NCT00092443|75929521|FG000|Overall Study|Adverse Event|9|||
42118678|NCT00092443|75929522|FG001|Overall Study|Adverse Event|13|||
41963045|NCT04667377|75746371|FG000|Dose Escalation Period|Other not specified below|3|||
42118679|NCT00092443|75929521|FG000|Overall Study|Lost to Follow-up|7|||
42118680|NCT00092443|75929522|FG001|Overall Study|Lost to Follow-up|3|||
41963046|NCT04667377|75746372|FG001|Dose Escalation Period|Other not specified below|3|||
41963047|NCT04667377|75746373|FG002|Dose Escalation Period|Other not specified below|2|||
42026221|NCT00978627|75834239|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
42026222|NCT00978627|75834240|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
42118681|NCT00092443|75929521|FG000|Overall Study|Protocol Violation|11|||
42118682|NCT00092443|75929522|FG001|Overall Study|Protocol Violation|9|||
42118683|NCT00092443|75929521|FG000|Overall Study|Withdrawal by Subject|9|||
42118684|NCT00092443|75929522|FG001|Overall Study|Withdrawal by Subject|11|||
42118685|NCT00092443|75929521|FG000|Overall Study|Moved|5|||
42118686|NCT00092443|75929522|FG001|Overall Study|Moved|5|||
42118687|NCT00092443|75929521|FG000|Overall Study|Other|17|||
42118688|NCT00092443|75929522|FG001|Overall Study|Other|13|||
42118689|NCT00413920|75929540|FG000|Overall Study|Adverse Event|9|||
42118690|NCT00413920|75929541|FG001|Overall Study|Adverse Event|11|||
42118691|NCT00413920|75929540|FG000|Overall Study|Lack of Efficacy|11|||
42118692|NCT00413920|75929541|FG001|Overall Study|Lack of Efficacy|9|||
42118693|NCT00413920|75929540|FG000|Overall Study|Death|3|||
42118694|NCT00413920|75929541|FG001|Overall Study|Death|5|||
42118695|NCT00413920|75929540|FG000|Overall Study|Graft Loss|5|||
42118696|NCT00413920|75929541|FG001|Overall Study|Graft Loss|3|||
42118697|NCT00091819|75929549|FG000|Overall Study|Adverse Event|1|||
42118698|NCT00091819|75929550|FG001|Overall Study|Adverse Event|1|||
42118699|NCT00091819|75929549|FG000|Overall Study|Death|4|||
42118700|NCT00091819|75929550|FG001|Overall Study|Death|5|||
42118701|NCT00091819|75929549|FG000|Overall Study|Lost to Follow-up|26|||
42118702|NCT00091819|75929550|FG001|Overall Study|Lost to Follow-up|23|||
42118703|NCT00091819|75929549|FG000|Overall Study|Withdrawal by Subject|5|||
42118704|NCT00091819|75929550|FG001|Overall Study|Withdrawal by Subject|8|||
42118705|NCT00091819|75929549|FG000|Overall Study|Protocol Violation|1|||
42118706|NCT00091819|75929550|FG001|Overall Study|Protocol Violation|2|||
42118707|NCT00091819|75929549|FG000|Overall Study|Other|2|||
42118708|NCT00091819|75929550|FG001|Overall Study|Other|3|||
42118709|NCT00091819|75929549|FG000|Overall Study|Never received study treatment|3|||
42118710|NCT00091819|75929550|FG001|Overall Study|Never received study treatment|4|||
42118711|NCT00540228|75929561|FG000|Overall Study|Adverse Event|2|||
42118712|NCT00540228|75929562|FG001|Overall Study|Adverse Event|0|||
42118713|NCT00540228|75929563|FG002|Overall Study|Adverse Event|0|||
42118714|NCT00540228|75929564|FG003|Overall Study|Adverse Event|0|||
42118715|NCT00540228|75929565|FG004|Overall Study|Adverse Event|0|||
42118716|NCT00540228|75929561|FG000|Overall Study|Lost to Follow-up|1|||
42118717|NCT00540228|75929562|FG001|Overall Study|Lost to Follow-up|1|||
42118718|NCT00540228|75929563|FG002|Overall Study|Lost to Follow-up|0|||
42118719|NCT00540228|75929564|FG003|Overall Study|Lost to Follow-up|0|||
42118720|NCT00540228|75929565|FG004|Overall Study|Lost to Follow-up|0|||
42118721|NCT05013385|75929590|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
42118722|NCT04250636|75929613|FG000|Overall Study|Lost to Follow-up|2|||
42118723|NCT03989115|75929625|FG000|Overall Study|Withdrawal by Subject|2|||
42118724|NCT03989115|75929626|FG001|Overall Study|Withdrawal by Subject|1|||
42118725|NCT03989115|75929627|FG002|Overall Study|Withdrawal by Subject|3|||
42118726|NCT03989115|75929628|FG003|Overall Study|Withdrawal by Subject|0|||
42300639|NCT02293863|76135822|FG002|Overall Study|Lost to Follow-up|2|||
41963048|NCT04667377|75746374|FG003|Dose Escalation Period|Other not specified below|1|||
41963049|NCT04667377|75746375|FG004|Dose Escalation Period|Other not specified below|3|||
41963050|NCT04667377|75746371|FG000|Dose Escalation Period|Protocol Violation|2|||
41963051|NCT04667377|75746372|FG001|Dose Escalation Period|Protocol Violation|2|||
41963052|NCT04667377|75746373|FG002|Dose Escalation Period|Protocol Violation|0|||
41963053|NCT04667377|75746374|FG003|Dose Escalation Period|Protocol Violation|2|||
41963054|NCT04667377|75746375|FG004|Dose Escalation Period|Protocol Violation|1|||
41963055|NCT04667377|75746371|FG000|Dose Escalation Period|Burden of study procedures|2|||
42026223|NCT00978627|75834239|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
42026224|NCT00978627|75834240|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
42026225|NCT00978627|75834239|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
42026226|NCT00978627|75834240|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
42026227|NCT00978627|75834239|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
42026228|NCT00978627|75834240|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
42026229|NCT01181609|75834246|FG000|Overall Study|Adverse Event|1|||
42026230|NCT01181609|75834246|FG000|Overall Study|Withdrawal by Subject|1|||
42026231|NCT01181609|75834246|FG000|Overall Study|Lost to Follow-up|1|||
42026232|NCT01181609|75834246|FG000|Overall Study|Death|50|||
42118727|NCT03989115|75929629|FG004|Overall Study|Withdrawal by Subject|17|||
42118728|NCT03989115|75929630|FG005|Overall Study|Withdrawal by Subject|1|||
42118729|NCT03989115|75929631|FG006|Overall Study|Withdrawal by Subject|0|||
42118730|NCT03989115|75929632|FG007|Overall Study|Withdrawal by Subject|0|||
42118731|NCT03989115|75929625|FG000|Overall Study|Sponsor decision to terminate the study|1|||
42118732|NCT03989115|75929626|FG001|Overall Study|Sponsor decision to terminate the study|1|||
42118733|NCT03989115|75929627|FG002|Overall Study|Sponsor decision to terminate the study|0|||
42026233|NCT01154010|75834252|FG000|Overall Study|Lost to Follow-up|0|||
42118734|NCT03989115|75929628|FG003|Overall Study|Sponsor decision to terminate the study|1|||
42118735|NCT03989115|75929629|FG004|Overall Study|Sponsor decision to terminate the study|11|||
42118736|NCT03989115|75929630|FG005|Overall Study|Sponsor decision to terminate the study|0|||
42210324|NCT03257358|76025120|FG000|Overall Study|Protocol Violation|5|||
42118737|NCT03989115|75929631|FG006|Overall Study|Sponsor decision to terminate the study|2|||
42118738|NCT03989115|75929632|FG007|Overall Study|Sponsor decision to terminate the study|1|||
42118739|NCT03989115|75929625|FG000|Overall Study|Lost to Follow-up|2|||
42118740|NCT03989115|75929626|FG001|Overall Study|Lost to Follow-up|0|||
42118741|NCT03989115|75929627|FG002|Overall Study|Lost to Follow-up|0|||
42118742|NCT03989115|75929628|FG003|Overall Study|Lost to Follow-up|0|||
42118743|NCT03989115|75929629|FG004|Overall Study|Lost to Follow-up|1|||
42118744|NCT03989115|75929630|FG005|Overall Study|Lost to Follow-up|0|||
42118745|NCT03989115|75929631|FG006|Overall Study|Lost to Follow-up|0|||
42118746|NCT03989115|75929632|FG007|Overall Study|Lost to Follow-up|0|||
42118747|NCT03989115|75929625|FG000|Overall Study|Death|2|||
42118748|NCT03989115|75929626|FG001|Overall Study|Death|2|||
42118749|NCT03989115|75929627|FG002|Overall Study|Death|9|||
42118750|NCT03989115|75929628|FG003|Overall Study|Death|6|||
42118751|NCT03989115|75929629|FG004|Overall Study|Death|31|||
42118752|NCT03989115|75929630|FG005|Overall Study|Death|6|||
42118753|NCT03989115|75929631|FG006|Overall Study|Death|2|||
42118754|NCT03989115|75929632|FG007|Overall Study|Death|3|||
42118755|NCT03989115|75929625|FG000|Overall Study|Other|1|||
42118756|NCT03989115|75929626|FG001|Overall Study|Other|2|||
42118757|NCT03989115|75929627|FG002|Overall Study|Other|0|||
42118758|NCT03989115|75929628|FG003|Overall Study|Other|0|||
42118759|NCT03989115|75929629|FG004|Overall Study|Other|5|||
42118760|NCT03989115|75929630|FG005|Overall Study|Other|0|||
42118761|NCT03989115|75929631|FG006|Overall Study|Other|0|||
42118762|NCT03989115|75929632|FG007|Overall Study|Other|0|||
42118763|NCT03971071|75929658|FG000|Overall Study|Sponsor decision|0|||
42118764|NCT03971071|75929659|FG001|Overall Study|Sponsor decision|1|||
42210325|NCT03257358|76025121|FG001|Overall Study|Protocol Violation|3|||
42210326|NCT03257358|76025120|FG000|Overall Study|Technical problems|4|||
42210327|NCT03257358|76025121|FG001|Overall Study|Technical problems|1|||
42210328|NCT03257358|76025120|FG000|Overall Study|Withdrawal by Subject|8|||
42210329|NCT03257358|76025121|FG001|Overall Study|Withdrawal by Subject|3|||
42210330|NCT03257358|76025120|FG000|Overall Study|Withdrawal of informed consent|9|||
42210331|NCT03257358|76025121|FG001|Overall Study|Withdrawal of informed consent|5|||
42210332|NCT03257358|76025120|FG000|Overall Study|New therapy for study indication|1|||
41963056|NCT04667377|75746372|FG001|Dose Escalation Period|Burden of study procedures|1|||
41963057|NCT04667377|75746373|FG002|Dose Escalation Period|Burden of study procedures|1|||
41963058|NCT04667377|75746374|FG003|Dose Escalation Period|Burden of study procedures|1|||
41963059|NCT04667377|75746375|FG004|Dose Escalation Period|Burden of study procedures|5|||
41963060|NCT04667377|75746371|FG000|Dose Escalation Period|Change of residence|0|||
41963061|NCT04667377|75746372|FG001|Dose Escalation Period|Change of residence|0|||
41963062|NCT04667377|75746373|FG002|Dose Escalation Period|Change of residence|1|||
42026234|NCT01154010|75834253|FG001|Overall Study|Lost to Follow-up|1|||
42026235|NCT01174368|75834259|FG000|Overall Study|Withdrawal by Subject|1|||
42026236|NCT01147926|75834265|FG000|Overall Study|Subject Withdrew Consent|9|||
42026237|NCT01147926|75834266|FG001|Overall Study|Subject Withdrew Consent|10|||
42026238|NCT01147926|75834265|FG000|Overall Study|Adverse Event|7|||
42026239|NCT01147926|75834266|FG001|Overall Study|Adverse Event|6|||
42026240|NCT01147926|75834265|FG000|Overall Study|Subject Non-Compliant|5|||
42026241|NCT01147926|75834266|FG001|Overall Study|Subject Non-Compliant|4|||
42026242|NCT01147926|75834265|FG000|Overall Study|Principal investigator left hospital|1|||
42026243|NCT01147926|75834266|FG001|Overall Study|Principal investigator left hospital|3|||
42026244|NCT01147926|75834265|FG000|Overall Study|Selection criteria not met|3|||
42026245|NCT01147926|75834266|FG001|Overall Study|Selection criteria not met|1|||
42026246|NCT01147926|75834265|FG000|Overall Study|Lost to Follow-up|0|||
42026247|NCT01147926|75834266|FG001|Overall Study|Lost to Follow-up|2|||
42026248|NCT01147926|75834265|FG000|Overall Study|Sponsor's Decision|0|||
42026249|NCT01147926|75834266|FG001|Overall Study|Sponsor's Decision|1|||
42026250|NCT01147926|75834265|FG000|Overall Study|Lack of Efficacy|1|||
42026251|NCT01147926|75834266|FG001|Overall Study|Lack of Efficacy|0|||
42026252|NCT01147926|75834265|FG000|Overall Study|Too busy, no time for study|1|||
42026253|NCT01147926|75834266|FG001|Overall Study|Too busy, no time for study|0|||
42026254|NCT01147926|75834265|FG000|Overall Study|Went on holiday|0|||
42026255|NCT01147926|75834266|FG001|Overall Study|Went on holiday|1|||
42026256|NCT01147926|75834265|FG000|Overall Study|Colonoscopy result|0|||
42118765|NCT03971071|75929660|FG002|Overall Study|Sponsor decision|0|||
42118766|NCT03971071|75929658|FG000|Overall Study|Withdrawal by Subject|7|||
42118767|NCT03971071|75929659|FG001|Overall Study|Withdrawal by Subject|11|||
42118768|NCT03971071|75929660|FG002|Overall Study|Withdrawal by Subject|6|||
42118769|NCT03971071|75929658|FG000|Overall Study|Other|2|||
42118770|NCT03971071|75929659|FG001|Overall Study|Other|2|||
42118771|NCT03971071|75929660|FG002|Overall Study|Other|0|||
42118772|NCT03797898|75929674|FG000|Overall Study|Lost to Follow-up|60|||
42026257|NCT01147926|75834266|FG001|Overall Study|Colonoscopy result|1|||
42026258|NCT00975507|75834274|FG000|Overall Study|Adverse Event|1|||
42118773|NCT03797898|75929675|FG001|Overall Study|Lost to Follow-up|69|||
42118774|NCT03797898|75929674|FG000|Overall Study|Withdrawal by Subject|9|||
42118775|NCT03797898|75929675|FG001|Overall Study|Withdrawal by Subject|7|||
42118776|NCT03797898|75929674|FG000|Overall Study|Became ineligible|5|||
42118777|NCT03797898|75929675|FG001|Overall Study|Became ineligible|2|||
42118778|NCT03559192|75929697|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
42118779|NCT03559192|75929698|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
42118780|NCT03559192|75929699|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
42118781|NCT03559192|75929697|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
42118782|NCT03559192|75929698|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
42118783|NCT03559192|75929699|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
42118784|NCT03559192|75929697|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
42118785|NCT03559192|75929698|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
42118786|NCT03559192|75929699|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
42118787|NCT03559192|75929697|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
42118788|NCT03559192|75929698|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
42118789|NCT03559192|75929699|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
42118790|NCT03559192|75929697|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
42118791|NCT03559192|75929698|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
42118792|NCT03559192|75929699|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
42118793|NCT03559192|75929697|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
42118794|NCT03559192|75929698|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
42118795|NCT03559192|75929699|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
42118796|NCT03559192|75929697|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
42118797|NCT03559192|75929698|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
42118798|NCT03559192|75929699|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
42118799|NCT03559192|75929697|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
42118800|NCT03559192|75929698|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
42118801|NCT03559192|75929699|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
42118802|NCT03559192|75929697|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
42118803|NCT03559192|75929698|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
42118804|NCT03559192|75929699|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
42118805|NCT03523585|75929710|FG000|Overall Study|Progressive Disease|174|||
42118806|NCT03523585|75929711|FG001|Overall Study|Progressive Disease|64|||
42118807|NCT03523585|75929712|FG002|Overall Study|Progressive Disease|77|||
42118808|NCT03523585|75929710|FG000|Overall Study|Adverse Event|74|||
42118809|NCT03523585|75929711|FG001|Overall Study|Adverse Event|5|||
42118810|NCT03523585|75929712|FG002|Overall Study|Adverse Event|9|||
42118811|NCT03523585|75929710|FG000|Overall Study|Withdrawal by Subject|30|||
41963063|NCT04667377|75746374|FG003|Dose Escalation Period|Change of residence|0|||
41963064|NCT04667377|75746375|FG004|Dose Escalation Period|Change of residence|0|||
41963065|NCT04667377|75746371|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
41963066|NCT04667377|75746372|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
41963067|NCT04667377|75746373|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
41963068|NCT04667377|75746374|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
41963069|NCT04667377|75746375|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
41963070|NCT04667377|75746371|FG000|Dose Escalation Period|Adverse Event|9|||
41963071|NCT04667377|75746372|FG001|Dose Escalation Period|Adverse Event|10|||
41963072|NCT04667377|75746373|FG002|Dose Escalation Period|Adverse Event|12|||
41963073|NCT04667377|75746374|FG003|Dose Escalation Period|Adverse Event|17|||
41963074|NCT04667377|75746375|FG004|Dose Escalation Period|Adverse Event|3|||
41963075|NCT04667377|75746371|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
41963076|NCT04667377|75746372|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
41963077|NCT04667377|75746373|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
42026259|NCT00975507|75834275|FG001|Overall Study|Adverse Event|0|||
42026260|NCT00975507|75834274|FG000|Overall Study|Lost to Follow-up|7|||
42026261|NCT00975507|75834275|FG001|Overall Study|Lost to Follow-up|1|||
42026262|NCT00975507|75834274|FG000|Overall Study|Protocol Violation|2|||
42026263|NCT00975507|75834275|FG001|Overall Study|Protocol Violation|0|||
42026264|NCT00975507|75834274|FG000|Overall Study|Withdrawal by Subject|10|||
42026265|NCT00975507|75834275|FG001|Overall Study|Withdrawal by Subject|3|||
42026266|NCT01147848|75834285|FG000|Run-in Period|Screen Failure|623|||
42026267|NCT01147848|75834286|FG001|Run-in Period|Screen Failure|0|||
42026268|NCT01147848|75834287|FG002|Run-in Period|Screen Failure|0|||
42118812|NCT03523585|75929711|FG001|Overall Study|Withdrawal by Subject|11|||
42118813|NCT03523585|75929712|FG002|Overall Study|Withdrawal by Subject|6|||
42118814|NCT03523585|75929710|FG000|Overall Study|Clinical Progression|23|||
42118815|NCT03523585|75929711|FG001|Overall Study|Clinical Progression|5|||
42210333|NCT03257358|76025121|FG001|Overall Study|New therapy for study indication|0|||
42210334|NCT03257358|76025120|FG000|Overall Study|No longer requires treatment|0|||
41963078|NCT04667377|75746374|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
42026269|NCT01147848|75834285|FG000|Run-in Period|Run-in Failure|135|||
41963079|NCT04667377|75746375|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
41963080|NCT04667377|75746371|FG000|Dose Escalation Period|Not treated|1|||
41963081|NCT04667377|75746372|FG001|Dose Escalation Period|Not treated|0|||
41963082|NCT04667377|75746373|FG002|Dose Escalation Period|Not treated|0|||
41963083|NCT04667377|75746374|FG003|Dose Escalation Period|Not treated|0|||
41963084|NCT04667377|75746375|FG004|Dose Escalation Period|Not treated|0|||
41963085|NCT04667377|75746371|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
41963086|NCT04667377|75746372|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
41963087|NCT04667377|75746373|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
41963088|NCT04667377|75746374|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
41963089|NCT04667377|75746375|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
41963090|NCT04667377|75746371|FG000|Dose Escalation Period|Lost to Follow-up|0|||
41963091|NCT04667377|75746372|FG001|Dose Escalation Period|Lost to Follow-up|1|||
41963092|NCT04667377|75746373|FG002|Dose Escalation Period|Lost to Follow-up|0|||
41963093|NCT04667377|75746374|FG003|Dose Escalation Period|Lost to Follow-up|0|||
41963094|NCT04667377|75746375|FG004|Dose Escalation Period|Lost to Follow-up|0|||
41963095|NCT04667377|75746371|FG000|Maintenance Period|Perceived lack of efficacy|0|||
41963096|NCT04667377|75746372|FG001|Maintenance Period|Perceived lack of efficacy|2|||
41963097|NCT04667377|75746373|FG002|Maintenance Period|Perceived lack of efficacy|1|||
41963098|NCT04667377|75746374|FG003|Maintenance Period|Perceived lack of efficacy|0|||
41963099|NCT04667377|75746375|FG004|Maintenance Period|Perceived lack of efficacy|1|||
41963100|NCT04667377|75746371|FG000|Maintenance Period|Adverse Event|2|||
41963101|NCT04667377|75746372|FG001|Maintenance Period|Adverse Event|8|||
42118816|NCT03523585|75929712|FG002|Overall Study|Clinical Progression|10|||
42118817|NCT03523585|75929710|FG000|Overall Study|Death|4|||
42118818|NCT03523585|75929711|FG001|Overall Study|Death|0|||
42026270|NCT01147848|75834286|FG001|Run-in Period|Run-in Failure|0|||
42026271|NCT01147848|75834287|FG002|Run-in Period|Run-in Failure|0|||
42026272|NCT01147848|75834285|FG000|Randomized Phase|Adverse Event|0|||
42026273|NCT01147848|75834286|FG001|Randomized Phase|Adverse Event|6|||
42026274|NCT01147848|75834287|FG002|Randomized Phase|Adverse Event|8|||
42026275|NCT01147848|75834285|FG000|Randomized Phase|Lack of Efficacy|0|||
42026276|NCT01147848|75834286|FG001|Randomized Phase|Lack of Efficacy|20|||
42026277|NCT01147848|75834287|FG002|Randomized Phase|Lack of Efficacy|11|||
42026278|NCT01147848|75834285|FG000|Randomized Phase|Protocol Violation|0|||
42026279|NCT01147848|75834286|FG001|Randomized Phase|Protocol Violation|7|||
42026280|NCT01147848|75834287|FG002|Randomized Phase|Protocol Violation|10|||
42026281|NCT01147848|75834285|FG000|Randomized Phase|Lost to Follow-up|0|||
42026282|NCT01147848|75834286|FG001|Randomized Phase|Lost to Follow-up|5|||
42026283|NCT01147848|75834287|FG002|Randomized Phase|Lost to Follow-up|7|||
42026284|NCT01147848|75834285|FG000|Randomized Phase|Physician Decision|0|||
42026285|NCT01147848|75834286|FG001|Randomized Phase|Physician Decision|0|||
42026286|NCT01147848|75834287|FG002|Randomized Phase|Physician Decision|1|||
42026287|NCT01147848|75834285|FG000|Randomized Phase|Withdrawal by Subject|0|||
42118819|NCT03523585|75929712|FG002|Overall Study|Death|1|||
42118820|NCT03523585|75929710|FG000|Overall Study|Physician Decision|2|||
42118821|NCT03523585|75929711|FG001|Overall Study|Physician Decision|1|||
42300640|NCT02293863|76135820|FG000|Overall Study|Withdrawal by Subject|3|||
41963102|NCT04667377|75746373|FG002|Maintenance Period|Adverse Event|5|||
41963103|NCT04667377|75746374|FG003|Maintenance Period|Adverse Event|4|||
42026288|NCT01147848|75834286|FG001|Randomized Phase|Withdrawal by Subject|7|||
42026289|NCT01147848|75834287|FG002|Randomized Phase|Withdrawal by Subject|9|||
42118822|NCT03523585|75929712|FG002|Overall Study|Physician Decision|0|||
42300641|NCT02293863|76135821|FG001|Overall Study|Withdrawal by Subject|3|||
42118823|NCT03523585|75929710|FG000|Overall Study|Lost to Follow-up|1|||
42118824|NCT03523585|75929711|FG001|Overall Study|Lost to Follow-up|0|||
42118825|NCT03523585|75929712|FG002|Overall Study|Lost to Follow-up|0|||
42118826|NCT03523585|75929710|FG000|Overall Study|Miscellaneous|1|||
42118827|NCT03523585|75929711|FG001|Overall Study|Miscellaneous|0|||
42118828|NCT03523585|75929712|FG002|Overall Study|Miscellaneous|0|||
42118829|NCT03523585|75929710|FG000|Overall Study|Protocol Deviation|1|||
42118830|NCT03523585|75929711|FG001|Overall Study|Protocol Deviation|0|||
42118831|NCT03523585|75929712|FG002|Overall Study|Protocol Deviation|1|||
42118832|NCT03523585|75929710|FG000|Overall Study|Randomized But Not Treated|2|||
42118833|NCT03523585|75929711|FG001|Overall Study|Randomized But Not Treated|4|||
42118834|NCT03523585|75929712|FG002|Overall Study|Randomized But Not Treated|3|||
42026290|NCT00929656|75834296|FG000|Overall Study|Lost to Follow-up|0|||
42026291|NCT00929656|75834297|FG001|Overall Study|Lost to Follow-up|1|||
41963104|NCT04667377|75746375|FG004|Maintenance Period|Adverse Event|1|||
42026292|NCT00977613|75834303|FG000|Overall Study|Lost to Follow-up|16|||
42026293|NCT01152996|75834307|FG000|Overall Study|Withdrawal by Subject|142|||
42026294|NCT01152996|75834307|FG000|Overall Study|Adverse Event|115|||
42026295|NCT01152996|75834307|FG000|Overall Study|Lost to Follow-up|112|||
42026296|NCT01152996|75834307|FG000|Overall Study|Lack of Efficacy|68|||
42026297|NCT01152996|75834307|FG000|Overall Study|Noncompliance|41|||
42026298|NCT01152996|75834307|FG000|Overall Study|Other|36|||
42026299|NCT01152996|75834307|FG000|Overall Study|Protocol Violation|22|||
42026300|NCT01152996|75834307|FG000|Overall Study|Elevated liver enzymes|1|||
42026301|NCT00979953|75834315|FG000|Overall Study|Adverse Event|5|||
42026302|NCT00979953|75834316|FG001|Overall Study|Adverse Event|2|||
42026303|NCT00979953|75834317|FG002|Overall Study|Adverse Event|17|||
42026304|NCT00979953|75834318|FG003|Overall Study|Adverse Event|4|||
42026305|NCT00979953|75834315|FG000|Overall Study|Lack of Efficacy|1|||
42026306|NCT00979953|75834316|FG001|Overall Study|Lack of Efficacy|2|||
42210335|NCT03257358|76025121|FG001|Overall Study|No longer requires treatment|1|||
42210336|NCT02936037|76025129|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
41963105|NCT04667377|75746371|FG000|Maintenance Period|Adverse event: COVID infection|0|||
41963106|NCT04667377|75746372|FG001|Maintenance Period|Adverse event: COVID infection|1|||
41963107|NCT04667377|75746373|FG002|Maintenance Period|Adverse event: COVID infection|0|||
41963108|NCT04667377|75746374|FG003|Maintenance Period|Adverse event: COVID infection|0|||
41963109|NCT04667377|75746375|FG004|Maintenance Period|Adverse event: COVID infection|0|||
41963110|NCT04667377|75746371|FG000|Maintenance Period|COVID-related|0|||
41963111|NCT04667377|75746372|FG001|Maintenance Period|COVID-related|0|||
41963112|NCT04667377|75746373|FG002|Maintenance Period|COVID-related|1|||
41963113|NCT04667377|75746374|FG003|Maintenance Period|COVID-related|1|||
41963114|NCT04667377|75746375|FG004|Maintenance Period|COVID-related|0|||
41963115|NCT04667377|75746371|FG000|Maintenance Period|Protocol Violation|1|||
42118835|NCT03485911|75929722|FG000|Part 1|Perceived lack of efficacy|1|||
42118836|NCT03485911|75929723|FG001|Part 1|Perceived lack of efficacy|1|||
42118837|NCT03485911|75929724|FG002|Part 1|Perceived lack of efficacy|2|||
42118838|NCT03485911|75929725|FG003|Part 1|Perceived lack of efficacy|0|||
42118839|NCT03485911|75929722|FG000|Part 1|Subject withdrew consent|0|||
42118840|NCT03485911|75929723|FG001|Part 1|Subject withdrew consent|1|||
42118841|NCT03485911|75929724|FG002|Part 1|Subject withdrew consent|0|||
42118842|NCT03485911|75929725|FG003|Part 1|Subject withdrew consent|1|||
42118843|NCT03485911|75929722|FG000|Part 1|Lab abnormalities/AEs|3|||
42118844|NCT03485911|75929723|FG001|Part 1|Lab abnormalities/AEs|1|||
42118845|NCT03485911|75929724|FG002|Part 1|Lab abnormalities/AEs|1|||
42118846|NCT03485911|75929725|FG003|Part 1|Lab abnormalities/AEs|0|||
42118847|NCT03485911|75929722|FG000|Part 1|Withdrew Consent prior to dosing|0|||
42118848|NCT03485911|75929723|FG001|Part 1|Withdrew Consent prior to dosing|0|||
42118849|NCT03485911|75929724|FG002|Part 1|Withdrew Consent prior to dosing|0|||
42118850|NCT03485911|75929725|FG003|Part 1|Withdrew Consent prior to dosing|1|||
42118851|NCT03485911|75929722|FG000|Part 1|Other NOS|0|||
42118852|NCT03485911|75929723|FG001|Part 1|Other NOS|0|||
42118853|NCT03485911|75929724|FG002|Part 1|Other NOS|0|||
42118854|NCT03485911|75929725|FG003|Part 1|Other NOS|1|||
42118855|NCT03485911|75929722|FG000|Part 2|Perceived lack of efficacy|5|||
42118856|NCT03485911|75929723|FG001|Part 2|Perceived lack of efficacy|3|||
42118857|NCT03485911|75929724|FG002|Part 2|Perceived lack of efficacy|0|||
42118858|NCT03485911|75929725|FG003|Part 2|Perceived lack of efficacy|2|||
42118859|NCT03485911|75929722|FG000|Part 2|Subject withdrew consent|1|||
42118860|NCT03485911|75929723|FG001|Part 2|Subject withdrew consent|0|||
42118861|NCT03485911|75929724|FG002|Part 2|Subject withdrew consent|2|||
42118862|NCT03485911|75929725|FG003|Part 2|Subject withdrew consent|1|||
42118863|NCT03485911|75929722|FG000|Part 2|Lab abnormalities/AEs|1|||
42210337|NCT02936037|76025130|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
41963116|NCT04667377|75746372|FG001|Maintenance Period|Protocol Violation|0|||
41963117|NCT04667377|75746373|FG002|Maintenance Period|Protocol Violation|0|||
41963118|NCT04667377|75746374|FG003|Maintenance Period|Protocol Violation|0|||
41963119|NCT04667377|75746375|FG004|Maintenance Period|Protocol Violation|1|||
41963120|NCT04667377|75746371|FG000|Maintenance Period|Burden of study procedures|1|||
41963121|NCT04667377|75746372|FG001|Maintenance Period|Burden of study procedures|2|||
41963122|NCT04667377|75746373|FG002|Maintenance Period|Burden of study procedures|0|||
41963123|NCT04667377|75746374|FG003|Maintenance Period|Burden of study procedures|1|||
41963124|NCT04667377|75746375|FG004|Maintenance Period|Burden of study procedures|0|||
41963125|NCT04667377|75746371|FG000|Maintenance Period|Change of residence|0|||
41963126|NCT04667377|75746372|FG001|Maintenance Period|Change of residence|1|||
41963127|NCT04667377|75746373|FG002|Maintenance Period|Change of residence|0|||
41963128|NCT04667377|75746374|FG003|Maintenance Period|Change of residence|0|||
41963129|NCT04667377|75746375|FG004|Maintenance Period|Change of residence|1|||
41963130|NCT04667377|75746371|FG000|Maintenance Period|Missing|1|||
41963131|NCT04667377|75746372|FG001|Maintenance Period|Missing|0|||
42026307|NCT00979953|75834317|FG002|Overall Study|Lack of Efficacy|0|||
42026308|NCT00979953|75834318|FG003|Overall Study|Lack of Efficacy|0|||
42026309|NCT00979953|75834315|FG000|Overall Study|Lost to Follow-up|1|||
42026310|NCT00979953|75834316|FG001|Overall Study|Lost to Follow-up|1|||
42026311|NCT00979953|75834317|FG002|Overall Study|Lost to Follow-up|1|||
42026312|NCT00979953|75834318|FG003|Overall Study|Lost to Follow-up|0|||
42026313|NCT00979953|75834315|FG000|Overall Study|Withdrawal by Subject|0|||
42026314|NCT00979953|75834316|FG001|Overall Study|Withdrawal by Subject|0|||
42026315|NCT00979953|75834317|FG002|Overall Study|Withdrawal by Subject|2|||
42026316|NCT00979953|75834318|FG003|Overall Study|Withdrawal by Subject|1|||
42026317|NCT00979953|75834315|FG000|Overall Study|Protocol Violation|1|||
42026318|NCT00979953|75834316|FG001|Overall Study|Protocol Violation|0|||
42026319|NCT00979953|75834317|FG002|Overall Study|Protocol Violation|2|||
42118864|NCT03485911|75929723|FG001|Part 2|Lab abnormalities/AEs|2|||
42118865|NCT03485911|75929724|FG002|Part 2|Lab abnormalities/AEs|0|||
42118866|NCT03485911|75929725|FG003|Part 2|Lab abnormalities/AEs|0|||
42118867|NCT03485911|75929722|FG000|Part 2|Other NOS|0|||
42118868|NCT03485911|75929723|FG001|Part 2|Other NOS|1|||
42118869|NCT03485911|75929724|FG002|Part 2|Other NOS|0|||
42118870|NCT03485911|75929725|FG003|Part 2|Other NOS|0|||
42118871|NCT03485911|75929722|FG000|Part 2|Intercurrent illness/new medical condition|1|||
42118872|NCT03485911|75929723|FG001|Part 2|Intercurrent illness/new medical condition|0|||
41963132|NCT04667377|75746373|FG002|Maintenance Period|Missing|0|||
41963133|NCT04667377|75746374|FG003|Maintenance Period|Missing|0|||
41963134|NCT04667377|75746375|FG004|Maintenance Period|Missing|0|||
41963135|NCT04667377|75746371|FG000|Maintenance Period|Other than listed above|2|||
41963136|NCT04667377|75746372|FG001|Maintenance Period|Other than listed above|0|||
41963137|NCT04667377|75746373|FG002|Maintenance Period|Other than listed above|3|||
41963138|NCT04667377|75746374|FG003|Maintenance Period|Other than listed above|2|||
41963139|NCT04667377|75746375|FG004|Maintenance Period|Other than listed above|6|||
41963140|NCT04667377|75746371|FG000|Maintenance Period|Withdrawal by Subject|0|||
41963141|NCT04667377|75746372|FG001|Maintenance Period|Withdrawal by Subject|1|||
41963142|NCT04667377|75746373|FG002|Maintenance Period|Withdrawal by Subject|0|||
41963143|NCT04667377|75746374|FG003|Maintenance Period|Withdrawal by Subject|0|||
41963144|NCT04667377|75746375|FG004|Maintenance Period|Withdrawal by Subject|0|||
41963145|NCT04667377|75746371|FG000|Maintenance Period|Lost to Follow-up|1|||
41963146|NCT04667377|75746372|FG001|Maintenance Period|Lost to Follow-up|0|||
41963147|NCT04667377|75746373|FG002|Maintenance Period|Lost to Follow-up|1|||
41963148|NCT04667377|75746374|FG003|Maintenance Period|Lost to Follow-up|0|||
41963149|NCT04667377|75746375|FG004|Maintenance Period|Lost to Follow-up|1|||
41963150|NCT04537923|75746395|FG000|Overall Study|Adverse Event|2|||
41963151|NCT04537923|75746396|FG001|Overall Study|Adverse Event|1|||
41963152|NCT04537923|75746397|FG002|Overall Study|Adverse Event|2|||
41963153|NCT04537923|75746398|FG003|Overall Study|Adverse Event|4|||
41963154|NCT04537923|75746395|FG000|Overall Study|Death|3|||
41963155|NCT04537923|75746396|FG001|Overall Study|Death|3|||
41963156|NCT04537923|75746397|FG002|Overall Study|Death|1|||
41963157|NCT04537923|75746398|FG003|Overall Study|Death|11|||
41963158|NCT04537923|75746395|FG000|Overall Study|Lost to Follow-up|1|||
41963159|NCT04537923|75746396|FG001|Overall Study|Lost to Follow-up|2|||
41963160|NCT04537923|75746397|FG002|Overall Study|Lost to Follow-up|1|||
41963161|NCT04537923|75746398|FG003|Overall Study|Lost to Follow-up|6|||
41963162|NCT04537923|75746395|FG000|Overall Study|Physician Decision|1|||
41963163|NCT04537923|75746396|FG001|Overall Study|Physician Decision|0|||
41963164|NCT04537923|75746397|FG002|Overall Study|Physician Decision|2|||
41963165|NCT04537923|75746398|FG003|Overall Study|Physician Decision|5|||
41963166|NCT04537923|75746395|FG000|Overall Study|Pregnancy|1|||
41963167|NCT04537923|75746396|FG001|Overall Study|Pregnancy|0|||
41963168|NCT04537923|75746397|FG002|Overall Study|Pregnancy|0|||
41963169|NCT04537923|75746398|FG003|Overall Study|Pregnancy|0|||
41963170|NCT04537923|75746395|FG000|Overall Study|Withdrawal by Subject|4|||
41963171|NCT04537923|75746396|FG001|Overall Study|Withdrawal by Subject|4|||
41963172|NCT04537923|75746397|FG002|Overall Study|Withdrawal by Subject|4|||
41963173|NCT04537923|75746398|FG003|Overall Study|Withdrawal by Subject|58|||
41963174|NCT04537923|75746395|FG000|Overall Study|Missed study visits|2|||
41963175|NCT04537923|75746396|FG001|Overall Study|Missed study visits|0|||
41963176|NCT04537923|75746397|FG002|Overall Study|Missed study visits|0|||
41963177|NCT04537923|75746398|FG003|Overall Study|Missed study visits|3|||
41963178|NCT04537923|75746395|FG000|Overall Study|Sponsor's decision|0|||
41963179|NCT04537923|75746396|FG001|Overall Study|Sponsor's decision|0|||
41963180|NCT04537923|75746397|FG002|Overall Study|Sponsor's decision|1|||
42026320|NCT00979953|75834318|FG003|Overall Study|Protocol Violation|2|||
42118873|NCT03485911|75929724|FG002|Part 2|Intercurrent illness/new medical condition|0|||
42118874|NCT03485911|75929725|FG003|Part 2|Intercurrent illness/new medical condition|0|||
42026321|NCT01181531|75834330|FG000|Overall Study|Other|17|||
42026322|NCT01181531|75834331|FG001|Overall Study|Other|12|||
42026323|NCT01181531|75834330|FG000|Overall Study|Partial consent by subject withdrawn|0|||
42026324|NCT01181531|75834331|FG001|Overall Study|Partial consent by subject withdrawn|1|||
42026325|NCT01181531|75834330|FG000|Overall Study|Physician Decision|3|||
42026326|NCT01181531|75834331|FG001|Overall Study|Physician Decision|1|||
42026327|NCT01181531|75834330|FG000|Overall Study|Noncompliance|2|||
42026328|NCT01181531|75834331|FG001|Overall Study|Noncompliance|2|||
42026329|NCT01181531|75834330|FG000|Overall Study|Ineligibility determined|1|||
42026330|NCT01181531|75834331|FG001|Overall Study|Ineligibility determined|2|||
42026331|NCT01181531|75834330|FG000|Overall Study|Protocol Specified Criteria|15|||
42026332|NCT01181531|75834331|FG001|Overall Study|Protocol Specified Criteria|8|||
42026333|NCT01181531|75834330|FG000|Overall Study|Pregnancy|0|||
42118875|NCT03485911|75929722|FG000|Part 2|Investigator judgement|1|||
42118876|NCT03485911|75929723|FG001|Part 2|Investigator judgement|0|||
41963181|NCT04537923|75746398|FG003|Overall Study|Sponsor's decision|1|||
41963182|NCT04537923|75746395|FG000|Overall Study|Safety reasons|1|||
41963183|NCT04537923|75746396|FG001|Overall Study|Safety reasons|0|||
42026334|NCT01181531|75834331|FG001|Overall Study|Pregnancy|1|||
42026335|NCT01181531|75834330|FG000|Overall Study|Withdrawal by Subject|8|||
42118877|NCT03485911|75929724|FG002|Part 2|Investigator judgement|0|||
42118878|NCT03485911|75929725|FG003|Part 2|Investigator judgement|0|||
41963184|NCT04537923|75746397|FG002|Overall Study|Safety reasons|0|||
41963185|NCT04537923|75746398|FG003|Overall Study|Safety reasons|0|||
42118879|NCT03485911|75929722|FG000|Part 3|Perceived lack of efficacy|2|||
41963186|NCT04428333|75746421|FG000|Overall Study|Physician Decision|2|||
41963187|NCT04428333|75746422|FG001|Overall Study|Physician Decision|0|||
42118880|NCT03485911|75929723|FG001|Part 3|Perceived lack of efficacy|2|||
42118881|NCT03485911|75929724|FG002|Part 3|Perceived lack of efficacy|2|||
42118882|NCT03485911|75929725|FG003|Part 3|Perceived lack of efficacy|0|||
42118883|NCT03485911|75929722|FG000|Part 3|Subject withdrew consent|1|||
42118884|NCT03485911|75929723|FG001|Part 3|Subject withdrew consent|4|||
42118885|NCT03485911|75929724|FG002|Part 3|Subject withdrew consent|0|||
42118886|NCT03485911|75929725|FG003|Part 3|Subject withdrew consent|1|||
42118887|NCT03485911|75929722|FG000|Part 3|Lab abnormalities/AEs|1|||
42118888|NCT03485911|75929723|FG001|Part 3|Lab abnormalities/AEs|1|||
42118889|NCT03485911|75929724|FG002|Part 3|Lab abnormalities/AEs|0|||
42118890|NCT03485911|75929725|FG003|Part 3|Lab abnormalities/AEs|2|||
42118891|NCT03485911|75929722|FG000|Part 3|Other NOS|1|||
42118892|NCT03485911|75929723|FG001|Part 3|Other NOS|1|||
42118893|NCT03485911|75929724|FG002|Part 3|Other NOS|0|||
42118894|NCT03485911|75929725|FG003|Part 3|Other NOS|0|||
42118895|NCT03485911|75929722|FG000|Part 3|Intercurrent illness/new medical condition|0|||
42118896|NCT03485911|75929723|FG001|Part 3|Intercurrent illness/new medical condition|1|||
42118897|NCT03485911|75929724|FG002|Part 3|Intercurrent illness/new medical condition|1|||
42118898|NCT03485911|75929725|FG003|Part 3|Intercurrent illness/new medical condition|0|||
42118899|NCT03485911|75929722|FG000|Part 3|Sponsor discontinuation|1|||
42118900|NCT03485911|75929723|FG001|Part 3|Sponsor discontinuation|0|||
42118901|NCT03485911|75929724|FG002|Part 3|Sponsor discontinuation|0|||
42118902|NCT03485911|75929725|FG003|Part 3|Sponsor discontinuation|0|||
42118903|NCT03485911|75929722|FG000|Part 3|Berotralstat provided by alternative means|13|||
42118904|NCT03485911|75929723|FG001|Part 3|Berotralstat provided by alternative means|13|||
42118905|NCT03485911|75929724|FG002|Part 3|Berotralstat provided by alternative means|7|||
42118906|NCT03485911|75929725|FG003|Part 3|Berotralstat provided by alternative means|7|||
42118907|NCT02886936|75929800|FG000|Overall Study|Lost to Follow-up|4|||
42118908|NCT02886936|75929801|FG001|Overall Study|Lost to Follow-up|3|||
42118909|NCT02886936|75929802|FG002|Overall Study|Lost to Follow-up|0|||
42118910|NCT02162511|75929837|FG000|Overall Study|Lack of Efficacy|0|||
42118911|NCT02162511|75929838|FG001|Overall Study|Lack of Efficacy|0|||
41963188|NCT04428333|75746421|FG000|Overall Study|Withdrawal by Subject|0|||
41963189|NCT04428333|75746422|FG001|Overall Study|Withdrawal by Subject|1|||
41963190|NCT04428333|75746421|FG000|Overall Study|In Follow-Up|5|||
41963191|NCT04428333|75746422|FG001|Overall Study|In Follow-Up|10|||
41963192|NCT04428333|75746421|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
41963193|NCT04428333|75746422|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|47|||
41963194|NCT04160468|75746430|FG000|Overall Study|Lost to Follow-up|19|||
41963195|NCT04160468|75746431|FG001|Overall Study|Lost to Follow-up|4|||
41963196|NCT04160468|75746430|FG000|Overall Study|Randomized but not dosed|6|||
41963197|NCT04160468|75746431|FG001|Overall Study|Randomized but not dosed|0|||
41963198|NCT04160468|75746430|FG000|Overall Study|Withdrawal by Subject|4|||
41963199|NCT04160468|75746431|FG001|Overall Study|Withdrawal by Subject|1|||
41963200|NCT04160468|75746430|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
41963201|NCT04160468|75746431|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
42026336|NCT01181531|75834331|FG001|Overall Study|Withdrawal by Subject|7|||
42026337|NCT01181531|75834330|FG000|Overall Study|Protocol Violation|6|||
42026338|NCT01181531|75834331|FG001|Overall Study|Protocol Violation|6|||
42026339|NCT01181531|75834330|FG000|Overall Study|Death|9|||
42026340|NCT01181531|75834331|FG001|Overall Study|Death|12|||
42026341|NCT01181531|75834330|FG000|Overall Study|Adverse Event|0|||
42026342|NCT01181531|75834331|FG001|Overall Study|Adverse Event|1|||
42026343|NCT01152450|75834337|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
42026344|NCT01152450|75834338|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
42026345|NCT01152450|75834339|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
42026346|NCT01152450|75834340|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
42026347|NCT01152450|75834341|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
42026348|NCT01152450|75834342|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
42026349|NCT01152450|75834337|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
42026350|NCT01152450|75834338|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
42026351|NCT01152450|75834339|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
42026352|NCT01152450|75834340|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
42026353|NCT01152450|75834341|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
42118912|NCT02162511|75929839|FG002|Overall Study|Lack of Efficacy|2|||
42118913|NCT00539994|75929884|FG000|Overall Study|Lost to Follow-up|2|||
41963202|NCT04160468|75746430|FG000|Overall Study|Participant incarcerated|1|||
41963203|NCT04160468|75746431|FG001|Overall Study|Participant incarcerated|0|||
41963204|NCT03761056|75746450|FG000|Overall Study|Still on Study|34|||
42026354|NCT01152450|75834342|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
42118914|NCT00539994|75929885|FG001|Overall Study|Lost to Follow-up|1|||
42118915|NCT00539994|75929886|FG002|Overall Study|Lost to Follow-up|0|||
42118916|NCT00539994|75929884|FG000|Overall Study|Withdrawal by Subject|1|||
42118917|NCT00539994|75929885|FG001|Overall Study|Withdrawal by Subject|0|||
42026355|NCT01152450|75834337|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
42026356|NCT01152450|75834338|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
42118918|NCT00539994|75929886|FG002|Overall Study|Withdrawal by Subject|1|||
42118919|NCT00539994|75929884|FG000|Overall Study|Physician Decision|0|||
42118920|NCT00539994|75929885|FG001|Overall Study|Physician Decision|0|||
42118921|NCT00539994|75929886|FG002|Overall Study|Physician Decision|1|||
42118922|NCT00098839|75929903|FG000|Overall Study|Adverse Event|5|||
42118923|NCT00098839|75929904|FG001|Overall Study|Adverse Event|2|||
42118924|NCT00098839|75929903|FG000|Overall Study|Death|1|||
42118925|NCT00098839|75929904|FG001|Overall Study|Death|2|||
42118926|NCT00098839|75929903|FG000|Overall Study|Physician Decision|4|||
42118927|NCT00098839|75929904|FG001|Overall Study|Physician Decision|14|||
42118928|NCT00098839|75929903|FG000|Overall Study|Withdrawal by Subject|1|||
42118929|NCT00098839|75929904|FG001|Overall Study|Withdrawal by Subject|0|||
42118930|NCT00098839|75929903|FG000|Overall Study|Refusal of further protocol therapy|3|||
42118931|NCT00098839|75929904|FG001|Overall Study|Refusal of further protocol therapy|1|||
42118932|NCT00098839|75929903|FG000|Overall Study|Relapse|6|||
42118933|NCT00098839|75929904|FG001|Overall Study|Relapse|3|||
42118934|NCT00098839|75929903|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
42118935|NCT00098839|75929904|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
42118936|NCT00098839|75929903|FG000|Overall Study|Ineligible|2|||
42118937|NCT00098839|75929904|FG001|Overall Study|Ineligible|0|||
42118938|NCT03811093|75929913|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
42026357|NCT01152450|75834339|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
42026358|NCT01152450|75834340|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
42026359|NCT01152450|75834341|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
42026360|NCT01152450|75834342|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
42026361|NCT01181141|75834352|FG000|Overall Study|Adverse Event|2|||
42026362|NCT01181141|75834353|FG001|Overall Study|Adverse Event|1|||
42026363|NCT01181141|75834352|FG000|Overall Study|Lack of Efficacy|1|||
42026364|NCT01181141|75834353|FG001|Overall Study|Lack of Efficacy|0|||
42026365|NCT01181141|75834352|FG000|Overall Study|Lost to Follow-up|1|||
42026366|NCT01181141|75834353|FG001|Overall Study|Lost to Follow-up|1|||
42026367|NCT01181141|75834352|FG000|Overall Study|Physician Decision|2|||
42026368|NCT01181141|75834353|FG001|Overall Study|Physician Decision|0|||
42026369|NCT01181141|75834352|FG000|Overall Study|Protocol Violation|3|||
42026370|NCT01181141|75834353|FG001|Overall Study|Protocol Violation|1|||
42026371|NCT01181141|75834352|FG000|Overall Study|Withdrawal by Subject|3|||
42026372|NCT01181141|75834353|FG001|Overall Study|Withdrawal by Subject|1|||
42026373|NCT01173120|75834359|FG000|Overall Study|Lack of Efficacy|2|||
42026374|NCT01173120|75834359|FG000|Overall Study|Lost to Follow-up|1|||
42026375|NCT01173120|75834359|FG000|Overall Study|Participant Decision|2|||
42026376|NCT01173120|75834359|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
42026377|NCT01173120|75834359|FG000|Overall Study|Switch-Participant Decision|12|||
42026378|NCT01173120|75834359|FG000|Overall Study|Switch-Difficulty With Device|12|||
42026379|NCT00977379|75834367|FG000|Overall Study|Withdrawal by Subject|1|||
42026380|NCT00977379|75834368|FG001|Overall Study|Withdrawal by Subject|1|||
42026381|NCT00977379|75834367|FG000|Overall Study|Death|7|||
42026382|NCT00977379|75834368|FG001|Overall Study|Death|9|||
42026383|NCT00977379|75834367|FG000|Overall Study|Premature Study Termination|4|||
42026384|NCT00977379|75834368|FG001|Overall Study|Premature Study Termination|0|||
42026385|NCT00977379|75834367|FG000|Overall Study|Participant Moving House|0|||
42026386|NCT00977379|75834368|FG001|Overall Study|Participant Moving House|1|||
42026387|NCT00977379|75834367|FG000|Overall Study|Randomization Error|0|||
42026388|NCT00977379|75834368|FG001|Overall Study|Randomization Error|1|||
42026389|NCT01180985|75834374|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
42026390|NCT01180985|75834375|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
42026391|NCT01147536|75834382|FG000|Overall Study|Administrative study close|2|||
42026392|NCT01147536|75834382|FG000|Overall Study|Death|1|||
42026393|NCT01154088|75834389|FG000|Overall Study|Lost to Follow-up|4|||
42026394|NCT01154088|75834390|FG001|Overall Study|Lost to Follow-up|6|||
42026395|NCT01154088|75834391|FG002|Overall Study|Lost to Follow-up|7|||
42026396|NCT01180049|75834402|FG000|Overall Study|Other|9|||
42026397|NCT01180049|75834403|FG001|Overall Study|Other|7|||
42026398|NCT01180049|75834402|FG000|Overall Study|Lost to Follow-up|8|||
42026399|NCT01180049|75834403|FG001|Overall Study|Lost to Follow-up|6|||
42026400|NCT01180049|75834402|FG000|Overall Study|Death|36|||
42118939|NCT03811093|75929914|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
42118940|NCT03811093|75929913|FG000|Overall Study|Unable to measure body fat percentage|2|||
42118941|NCT03811093|75929914|FG001|Overall Study|Unable to measure body fat percentage|0|||
42118942|NCT00485589|75929926|FG000|Overall Study|Death|2|||
42118943|NCT00485589|75929927|FG001|Overall Study|Death|2|||
42118944|NCT00485589|75929928|FG002|Overall Study|Death|0|||
42118945|NCT00485589|75929926|FG000|Overall Study|Failure to return|6|||
42026401|NCT01180049|75834403|FG001|Overall Study|Death|35|||
42026402|NCT01147458|75834409|FG000|First Intervention|Study terminated by sponsor|8|||
42026403|NCT01147458|75834410|FG001|First Intervention|Study terminated by sponsor|8|||
42026404|NCT01147458|75834411|FG002|First Intervention|Study terminated by sponsor|7|||
42118946|NCT00485589|75929927|FG001|Overall Study|Failure to return|5|||
42118947|NCT00485589|75929928|FG002|Overall Study|Failure to return|1|||
42118948|NCT00485589|75929926|FG000|Overall Study|Protocol Violation|1|||
42118949|NCT00485589|75929927|FG001|Overall Study|Protocol Violation|0|||
42118950|NCT00485589|75929928|FG002|Overall Study|Protocol Violation|0|||
42118951|NCT00485589|75929926|FG000|Overall Study|Violation of selection criteria at entry|0|||
42118952|NCT00485589|75929927|FG001|Overall Study|Violation of selection criteria at entry|3|||
42118953|NCT00485589|75929928|FG002|Overall Study|Violation of selection criteria at entry|1|||
42118954|NCT00485589|75929926|FG000|Overall Study|Administrative/Other|1|||
42118955|NCT00485589|75929927|FG001|Overall Study|Administrative/Other|2|||
42118956|NCT00485589|75929928|FG002|Overall Study|Administrative/Other|1|||
42118957|NCT00485589|75929926|FG000|Overall Study|Insufficient therapeutic response|10|||
42118958|NCT00485589|75929927|FG001|Overall Study|Insufficient therapeutic response|3|||
42118959|NCT00485589|75929928|FG002|Overall Study|Insufficient therapeutic response|1|||
42118960|NCT00485589|75929926|FG000|Overall Study|Refused treatment/did not cooperate|1|||
42118961|NCT00485589|75929927|FG001|Overall Study|Refused treatment/did not cooperate|0|||
42118962|NCT00485589|75929928|FG002|Overall Study|Refused treatment/did not cooperate|2|||
42118963|NCT00485589|75929926|FG000|Overall Study|Withdrawal by Subject|3|||
42118964|NCT00485589|75929927|FG001|Overall Study|Withdrawal by Subject|2|||
42118965|NCT00485589|75929928|FG002|Overall Study|Withdrawal by Subject|2|||
42118966|NCT00485589|75929926|FG000|Overall Study|Adverse Event|3|||
42118967|NCT00485589|75929927|FG001|Overall Study|Adverse Event|3|||
42118968|NCT00485589|75929928|FG002|Overall Study|Adverse Event|10|||
42118969|NCT00490971|75929947|FG000|Acute/Continuation|Adverse Event|62|||
42118970|NCT00490971|75929948|FG001|Acute/Continuation|Adverse Event|13|||
42118971|NCT00490971|75929949|FG002|Acute/Continuation|Adverse Event|0|||
42118972|NCT00490971|75929950|FG003|Acute/Continuation|Adverse Event|0|||
42118973|NCT00490971|75929951|FG004|Acute/Continuation|Adverse Event|0|||
42118974|NCT00490971|75929947|FG000|Acute/Continuation|Death|2|||
42118975|NCT00490971|75929948|FG001|Acute/Continuation|Death|0|||
42118976|NCT00490971|75929949|FG002|Acute/Continuation|Death|0|||
42118977|NCT00490971|75929950|FG003|Acute/Continuation|Death|0|||
42118978|NCT00490971|75929951|FG004|Acute/Continuation|Death|0|||
42118979|NCT00490971|75929947|FG000|Acute/Continuation|Lack of Efficacy|106|||
42118980|NCT00490971|75929948|FG001|Acute/Continuation|Lack of Efficacy|12|||
42118981|NCT00490971|75929949|FG002|Acute/Continuation|Lack of Efficacy|0|||
42118982|NCT00490971|75929950|FG003|Acute/Continuation|Lack of Efficacy|0|||
42118983|NCT00490971|75929951|FG004|Acute/Continuation|Lack of Efficacy|0|||
42118984|NCT00490971|75929947|FG000|Acute/Continuation|Lost to Follow-up|23|||
42118985|NCT00490971|75929948|FG001|Acute/Continuation|Lost to Follow-up|7|||
42118986|NCT00490971|75929949|FG002|Acute/Continuation|Lost to Follow-up|0|||
42118987|NCT00490971|75929950|FG003|Acute/Continuation|Lost to Follow-up|0|||
42118988|NCT00490971|75929951|FG004|Acute/Continuation|Lost to Follow-up|0|||
42118989|NCT00490971|75929947|FG000|Acute/Continuation|Protocol Violation|10|||
42118990|NCT00490971|75929948|FG001|Acute/Continuation|Protocol Violation|2|||
42118991|NCT00490971|75929949|FG002|Acute/Continuation|Protocol Violation|0|||
42118992|NCT00490971|75929950|FG003|Acute/Continuation|Protocol Violation|0|||
42118993|NCT00490971|75929951|FG004|Acute/Continuation|Protocol Violation|0|||
42118994|NCT00490971|75929947|FG000|Acute/Continuation|Withdrawal by Subject|92|||
42118995|NCT00490971|75929948|FG001|Acute/Continuation|Withdrawal by Subject|24|||
42118996|NCT00490971|75929949|FG002|Acute/Continuation|Withdrawal by Subject|0|||
42118997|NCT00490971|75929950|FG003|Acute/Continuation|Withdrawal by Subject|0|||
42118998|NCT00490971|75929951|FG004|Acute/Continuation|Withdrawal by Subject|0|||
41963205|NCT03761056|75746450|FG000|Overall Study|Death|6|||
41963206|NCT03761056|75746450|FG000|Overall Study|Investigator Decision|1|||
41963207|NCT03761056|75746450|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|1|||
41963208|NCT03276572|75746472|FG000|Overall Study|In follow-up|0|||
41963209|NCT03276572|75746473|FG001|Overall Study|In follow-up|0|||
41963210|NCT03276572|75746474|FG002|Overall Study|In follow-up|0|||
41963211|NCT03276572|75746475|FG003|Overall Study|In follow-up|0|||
41963212|NCT03276572|75746476|FG004|Overall Study|In follow-up|0|||
41963213|NCT03276572|75746477|FG005|Overall Study|In follow-up|1|||
41963214|NCT03276572|75746478|FG006|Overall Study|In follow-up|1|||
41963215|NCT03276572|75746472|FG000|Overall Study|Lost to Follow-up|0|||
41963216|NCT03276572|75746473|FG001|Overall Study|Lost to Follow-up|0|||
41963217|NCT03276572|75746474|FG002|Overall Study|Lost to Follow-up|0|||
42118999|NCT00490971|75929947|FG000|Acute/Continuation|Other|11|||
42119000|NCT00490971|75929948|FG001|Acute/Continuation|Other|4|||
42119001|NCT00490971|75929949|FG002|Acute/Continuation|Other|0|||
42119002|NCT00490971|75929950|FG003|Acute/Continuation|Other|0|||
42119003|NCT00490971|75929951|FG004|Acute/Continuation|Other|0|||
41963218|NCT03276572|75746475|FG003|Overall Study|Lost to Follow-up|0|||
41963219|NCT03276572|75746476|FG004|Overall Study|Lost to Follow-up|0|||
41963220|NCT03276572|75746477|FG005|Overall Study|Lost to Follow-up|0|||
41963221|NCT03276572|75746478|FG006|Overall Study|Lost to Follow-up|1|||
41963222|NCT02840877|75746504|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
42119004|NCT00490971|75929947|FG000|Maintenance|Adverse Event|0|||
42119005|NCT00490971|75929948|FG001|Maintenance|Adverse Event|0|||
42119006|NCT00490971|75929949|FG002|Maintenance|Adverse Event|4|||
42119007|NCT00490971|75929950|FG003|Maintenance|Adverse Event|5|||
42119008|NCT00490971|75929951|FG004|Maintenance|Adverse Event|7|||
42119009|NCT00490971|75929947|FG000|Maintenance|Death|0|||
42119010|NCT00490971|75929948|FG001|Maintenance|Death|0|||
42119011|NCT00490971|75929949|FG002|Maintenance|Death|0|||
42119012|NCT00490971|75929950|FG003|Maintenance|Death|2|||
42119013|NCT00490971|75929951|FG004|Maintenance|Death|0|||
42119014|NCT00490971|75929947|FG000|Maintenance|Lost to Follow-up|0|||
42119015|NCT00490971|75929948|FG001|Maintenance|Lost to Follow-up|0|||
42119016|NCT00490971|75929949|FG002|Maintenance|Lost to Follow-up|5|||
42119017|NCT00490971|75929950|FG003|Maintenance|Lost to Follow-up|8|||
42119018|NCT00490971|75929951|FG004|Maintenance|Lost to Follow-up|10|||
42119019|NCT00490971|75929947|FG000|Maintenance|Pregnancy|0|||
42119020|NCT00490971|75929948|FG001|Maintenance|Pregnancy|0|||
42119021|NCT00490971|75929949|FG002|Maintenance|Pregnancy|1|||
42119022|NCT00490971|75929950|FG003|Maintenance|Pregnancy|0|||
42119023|NCT00490971|75929951|FG004|Maintenance|Pregnancy|0|||
42119024|NCT00490971|75929947|FG000|Maintenance|Protocol Violation|0|||
42119025|NCT00490971|75929948|FG001|Maintenance|Protocol Violation|0|||
42119026|NCT00490971|75929949|FG002|Maintenance|Protocol Violation|4|||
42119027|NCT00490971|75929950|FG003|Maintenance|Protocol Violation|1|||
42119028|NCT00490971|75929951|FG004|Maintenance|Protocol Violation|1|||
42119029|NCT00490971|75929947|FG000|Maintenance|Withdrawal by Subject|0|||
42119030|NCT00490971|75929948|FG001|Maintenance|Withdrawal by Subject|0|||
42119031|NCT00490971|75929949|FG002|Maintenance|Withdrawal by Subject|26|||
42119032|NCT00490971|75929950|FG003|Maintenance|Withdrawal by Subject|28|||
42119033|NCT00490971|75929951|FG004|Maintenance|Withdrawal by Subject|18|||
42119034|NCT00490971|75929947|FG000|Maintenance|Other|0|||
42119035|NCT00490971|75929948|FG001|Maintenance|Other|0|||
42119036|NCT00490971|75929949|FG002|Maintenance|Other|11|||
42119037|NCT00490971|75929950|FG003|Maintenance|Other|9|||
42119038|NCT00490971|75929951|FG004|Maintenance|Other|3|||
42119039|NCT00686075|75929973|FG000|Overall Study|Withdrawal by Subject|4|||
42119040|NCT00686075|75929974|FG001|Overall Study|Withdrawal by Subject|3|||
42119041|NCT00686075|75929975|FG002|Overall Study|Withdrawal by Subject|3|||
42119042|NCT00686075|75929976|FG003|Overall Study|Withdrawal by Subject|7|||
42119043|NCT00686075|75929977|FG004|Overall Study|Withdrawal by Subject|1|||
42119044|NCT00686075|75929978|FG005|Overall Study|Withdrawal by Subject|0|||
42119045|NCT00686075|75929979|FG006|Overall Study|Withdrawal by Subject|0|||
42119046|NCT00686075|75929980|FG007|Overall Study|Withdrawal by Subject|2|||
42119047|NCT00686075|75929981|FG008|Overall Study|Withdrawal by Subject|4|||
42119048|NCT00686075|75929982|FG009|Overall Study|Withdrawal by Subject|6|||
42300642|NCT02293863|76135822|FG002|Overall Study|Withdrawal by Subject|1|||
42300643|NCT02293863|76135820|FG000|Overall Study|Reason Not Specified|0|||
42300644|NCT02293863|76135821|FG001|Overall Study|Reason Not Specified|2|||
42300645|NCT02293863|76135822|FG002|Overall Study|Reason Not Specified|2|||
42300646|NCT02293395|76135834|FG000|Overall Study|Lost to Follow-up|1|||
42300647|NCT02293395|76135835|FG001|Overall Study|Lost to Follow-up|0|||
42026405|NCT01147458|75834412|FG003|First Intervention|Study terminated by sponsor|8|||
42026406|NCT01147458|75834409|FG000|First Intervention|Protocol Violation|2|||
42026407|NCT01147458|75834410|FG001|First Intervention|Protocol Violation|3|||
42300648|NCT02293395|76135834|FG000|Overall Study|Withdrawal by Subject|8|||
42026408|NCT01147458|75834411|FG002|First Intervention|Protocol Violation|2|||
42026409|NCT01147458|75834412|FG003|First Intervention|Protocol Violation|3|||
42026410|NCT01147458|75834409|FG000|First Intervention|Withdrawal by Subject|3|||
42026411|NCT01147458|75834410|FG001|First Intervention|Withdrawal by Subject|0|||
42026412|NCT01147458|75834411|FG002|First Intervention|Withdrawal by Subject|1|||
42026413|NCT01147458|75834412|FG003|First Intervention|Withdrawal by Subject|0|||
42026414|NCT01147458|75834409|FG000|First Intervention|Adverse Event|0|||
42026415|NCT01147458|75834410|FG001|First Intervention|Adverse Event|3|||
42026416|NCT01147458|75834411|FG002|First Intervention|Adverse Event|2|||
42026417|NCT01147458|75834412|FG003|First Intervention|Adverse Event|3|||
42026418|NCT01147458|75834409|FG000|First Intervention|Other|1|||
42026419|NCT01147458|75834410|FG001|First Intervention|Other|2|||
42119049|NCT00686075|75929973|FG000|Overall Study|Lost to Follow-up|3|||
42119050|NCT00686075|75929974|FG001|Overall Study|Lost to Follow-up|6|||
42119051|NCT00686075|75929975|FG002|Overall Study|Lost to Follow-up|3|||
42300649|NCT02293395|76135835|FG001|Overall Study|Withdrawal by Subject|7|||
42119052|NCT00686075|75929976|FG003|Overall Study|Lost to Follow-up|2|||
42119053|NCT00686075|75929977|FG004|Overall Study|Lost to Follow-up|3|||
42119054|NCT00686075|75929978|FG005|Overall Study|Lost to Follow-up|3|||
42119055|NCT00686075|75929979|FG006|Overall Study|Lost to Follow-up|0|||
42119056|NCT00686075|75929980|FG007|Overall Study|Lost to Follow-up|0|||
42026420|NCT01147458|75834411|FG002|First Intervention|Other|0|||
42026421|NCT01147458|75834412|FG003|First Intervention|Other|0|||
42119057|NCT00686075|75929981|FG008|Overall Study|Lost to Follow-up|2|||
42119058|NCT00686075|75929982|FG009|Overall Study|Lost to Follow-up|3|||
42119059|NCT00686075|75929973|FG000|Overall Study|Other|1|||
42119060|NCT00686075|75929974|FG001|Overall Study|Other|1|||
42119061|NCT00686075|75929975|FG002|Overall Study|Other|0|||
42119062|NCT00686075|75929976|FG003|Overall Study|Other|0|||
42119063|NCT00686075|75929977|FG004|Overall Study|Other|0|||
42119064|NCT00686075|75929978|FG005|Overall Study|Other|0|||
42119065|NCT00686075|75929979|FG006|Overall Study|Other|0|||
42119066|NCT00686075|75929980|FG007|Overall Study|Other|0|||
42119067|NCT00686075|75929981|FG008|Overall Study|Other|0|||
42119068|NCT00686075|75929982|FG009|Overall Study|Other|1|||
42119069|NCT00685763|75930004|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
42119070|NCT00685763|75930004|FG000|Overall Study|Protocol Violation|1|||
42119071|NCT00098293|75930011|FG000|Double-blind (DB) Phase|Adverse Event|14|||
42119072|NCT00098293|75930012|FG001|Double-blind (DB) Phase|Adverse Event|27|||
42119073|NCT00098293|75930013|FG002|Double-blind (DB) Phase|Adverse Event|60|||
42119074|NCT00098293|75930014|FG003|Double-blind (DB) Phase|Adverse Event|0|||
42119075|NCT00098293|75930015|FG004|Double-blind (DB) Phase|Adverse Event|0|||
42119076|NCT00098293|75930011|FG000|Double-blind (DB) Phase|Pregnancy|0|||
42119077|NCT00098293|75930012|FG001|Double-blind (DB) Phase|Pregnancy|7|||
42119078|NCT00098293|75930013|FG002|Double-blind (DB) Phase|Pregnancy|9|||
42119079|NCT00098293|75930014|FG003|Double-blind (DB) Phase|Pregnancy|0|||
42119080|NCT00098293|75930015|FG004|Double-blind (DB) Phase|Pregnancy|0|||
42119081|NCT00098293|75930011|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
42119082|NCT00098293|75930012|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
42119083|NCT00098293|75930013|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
42119084|NCT00098293|75930014|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
42119085|NCT00098293|75930015|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
42119086|NCT00098293|75930011|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
42119087|NCT00098293|75930012|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
42119088|NCT00098293|75930013|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
42119089|NCT00098293|75930014|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
42119090|NCT00098293|75930015|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
42119091|NCT00098293|75930011|FG000|Double-blind (DB) Phase|Death|1|||
42119092|NCT00098293|75930012|FG001|Double-blind (DB) Phase|Death|2|||
42119093|NCT00098293|75930013|FG002|Double-blind (DB) Phase|Death|2|||
42119094|NCT00098293|75930014|FG003|Double-blind (DB) Phase|Death|0|||
42119095|NCT00098293|75930015|FG004|Double-blind (DB) Phase|Death|0|||
42119096|NCT00098293|75930011|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
42119097|NCT00098293|75930012|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
42119098|NCT00098293|75930013|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
42119099|NCT00098293|75930014|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
42119100|NCT00098293|75930015|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
42119101|NCT00098293|75930011|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
42119102|NCT00098293|75930012|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
42119103|NCT00098293|75930013|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
42119104|NCT00098293|75930014|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
42119105|NCT00098293|75930015|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
42119106|NCT00098293|75930011|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
42119107|NCT00098293|75930012|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
42026422|NCT01147458|75834409|FG000|Second Intervention|Study terminated by sponsor|7|||
42026423|NCT01147458|75834410|FG001|Second Intervention|Study terminated by sponsor|5|||
42026424|NCT01147458|75834411|FG002|Second Intervention|Study terminated by sponsor|5|||
42026425|NCT01147458|75834412|FG003|Second Intervention|Study terminated by sponsor|3|||
42026426|NCT01147458|75834409|FG000|Second Intervention|Protocol Violation|0|||
42026427|NCT01147458|75834410|FG001|Second Intervention|Protocol Violation|1|||
42026428|NCT01147458|75834411|FG002|Second Intervention|Protocol Violation|1|||
42026429|NCT01147458|75834412|FG003|Second Intervention|Protocol Violation|0|||
42026430|NCT01147458|75834409|FG000|Second Intervention|Withdrawal by Subject|0|||
42026431|NCT01147458|75834410|FG001|Second Intervention|Withdrawal by Subject|1|||
42026432|NCT01147458|75834411|FG002|Second Intervention|Withdrawal by Subject|0|||
42026433|NCT01147458|75834412|FG003|Second Intervention|Withdrawal by Subject|0|||
42026434|NCT01147458|75834409|FG000|Second Intervention|Adverse Event|2|||
42026435|NCT01147458|75834410|FG001|Second Intervention|Adverse Event|0|||
42026436|NCT01147458|75834411|FG002|Second Intervention|Adverse Event|1|||
42026437|NCT01147458|75834412|FG003|Second Intervention|Adverse Event|1|||
42026438|NCT01147458|75834409|FG000|Second Intervention|Other|0|||
42026439|NCT01147458|75834410|FG001|Second Intervention|Other|0|||
42026440|NCT01147458|75834411|FG002|Second Intervention|Other|1|||
42026441|NCT01147458|75834412|FG003|Second Intervention|Other|0|||
42119108|NCT00098293|75930013|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
42119109|NCT00098293|75930014|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
42119110|NCT00098293|75930015|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
42119111|NCT00098293|75930011|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
42119112|NCT00098293|75930012|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
42119113|NCT00098293|75930013|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
42119114|NCT00098293|75930014|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
42026442|NCT01172808|75834428|FG000|Overall Study|Adverse Event|8|||
42026443|NCT01172808|75834429|FG001|Overall Study|Adverse Event|4|||
42026444|NCT01172808|75834430|FG002|Overall Study|Adverse Event|8|||
42119115|NCT00098293|75930015|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
42119116|NCT00098293|75930011|FG000|Open-label (OL) Phase|Adverse Event|0|||
42119117|NCT00098293|75930012|FG001|Open-label (OL) Phase|Adverse Event|3|||
42119118|NCT00098293|75930013|FG002|Open-label (OL) Phase|Adverse Event|7|||
42119119|NCT00098293|75930014|FG003|Open-label (OL) Phase|Adverse Event|6|||
42119120|NCT00098293|75930015|FG004|Open-label (OL) Phase|Adverse Event|0|||
42119121|NCT00098293|75930011|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
42119122|NCT00098293|75930012|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
42119123|NCT00098293|75930013|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
41963223|NCT02840877|75746504|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
42119124|NCT00098293|75930014|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
41963224|NCT02840877|75746504|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
41963225|NCT02840877|75746504|FG000|Baseline to 12 Weeks|Death|1|||
41963226|NCT02840877|75746504|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
41963227|NCT02840877|75746504|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
41963228|NCT02840877|75746504|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
41963229|NCT02840877|75746504|FG000|12 Weeks to 6 Months|Treatment failure|1|||
41963230|NCT02840877|75746504|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
41963231|NCT02840877|75746504|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
41963232|NCT02840877|75746504|FG000|12 Weeks to 6 Months|Death|1|||
41963233|NCT02840877|75746504|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
41963234|NCT02840877|75746504|FG000|6 Months to 18 Months|Treatment failure|7|||
41963235|NCT02840877|75746504|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
42026445|NCT01172808|75834431|FG003|Overall Study|Adverse Event|3|||
42026446|NCT01172808|75834428|FG000|Overall Study|Lack of Efficacy|1|||
42026447|NCT01172808|75834429|FG001|Overall Study|Lack of Efficacy|0|||
42026448|NCT01172808|75834430|FG002|Overall Study|Lack of Efficacy|0|||
42026449|NCT01172808|75834431|FG003|Overall Study|Lack of Efficacy|0|||
42026450|NCT01172808|75834428|FG000|Overall Study|Protocol Violation|2|||
42026451|NCT01172808|75834429|FG001|Overall Study|Protocol Violation|2|||
42026452|NCT01172808|75834430|FG002|Overall Study|Protocol Violation|2|||
42026453|NCT01172808|75834431|FG003|Overall Study|Protocol Violation|0|||
42026454|NCT01172808|75834428|FG000|Overall Study|Lost to Follow-up|0|||
42026455|NCT01172808|75834429|FG001|Overall Study|Lost to Follow-up|1|||
42026456|NCT01172808|75834430|FG002|Overall Study|Lost to Follow-up|1|||
42026457|NCT01172808|75834431|FG003|Overall Study|Lost to Follow-up|3|||
42026458|NCT01172808|75834428|FG000|Overall Study|Withdrawal by Subject|4|||
42026459|NCT01172808|75834429|FG001|Overall Study|Withdrawal by Subject|1|||
42026460|NCT01172808|75834430|FG002|Overall Study|Withdrawal by Subject|3|||
42026461|NCT01172808|75834431|FG003|Overall Study|Withdrawal by Subject|2|||
42026462|NCT01172808|75834428|FG000|Overall Study|Other|6|||
42026463|NCT01172808|75834429|FG001|Overall Study|Other|5|||
42026464|NCT01172808|75834430|FG002|Overall Study|Other|9|||
42026465|NCT01172808|75834431|FG003|Overall Study|Other|7|||
42026466|NCT01151280|75834441|FG000|Overall Study|Adverse Event|1|||
42026467|NCT01151280|75834441|FG000|Overall Study|Lack of Efficacy|3|||
42026468|NCT01149486|75834447|FG000|First Intervention|Adverse Event|0|||
42026469|NCT01149486|75834448|FG001|First Intervention|Adverse Event|1|||
42026470|NCT00601705|75834454|FG000|Overall Study|Withdrawal by Subject|1|||
42026471|NCT01179737|75834463|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
42026472|NCT01179737|75834464|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
42026473|NCT01179737|75834465|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
42026474|NCT01179737|75834466|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
42026475|NCT01179737|75834463|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
42026476|NCT01179737|75834464|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
42026477|NCT01179737|75834465|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
42026478|NCT01179737|75834466|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
42026479|NCT01179737|75834463|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
42026480|NCT01179737|75834464|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
42026481|NCT01179737|75834465|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
42026482|NCT01179737|75834466|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
42026483|NCT01179737|75834463|FG000|Cohort 1 & Cohort 2|Death|0|||
42026484|NCT01179737|75834464|FG001|Cohort 1 & Cohort 2|Death|0|||
42026485|NCT01179737|75834465|FG002|Cohort 1 & Cohort 2|Death|1|||
42026486|NCT01179737|75834466|FG003|Cohort 1 & Cohort 2|Death|0|||
42026487|NCT01179737|75834463|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
42026488|NCT01179737|75834464|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
42026489|NCT01179737|75834465|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
42026490|NCT01179737|75834466|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
42026491|NCT01179737|75834463|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
42026492|NCT01179737|75834464|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
42026493|NCT01179737|75834465|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
42026494|NCT01179737|75834466|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
42119125|NCT00098293|75930015|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
42119126|NCT00098293|75930011|FG000|Open-label (OL) Phase|Pregnancy|0|||
41963236|NCT02840877|75746504|FG000|6 Months to 18 Months|Moved/transferred out|6|||
42119127|NCT00098293|75930012|FG001|Open-label (OL) Phase|Pregnancy|1|||
42119128|NCT00098293|75930013|FG002|Open-label (OL) Phase|Pregnancy|0|||
42119129|NCT00098293|75930014|FG003|Open-label (OL) Phase|Pregnancy|3|||
42119130|NCT00098293|75930015|FG004|Open-label (OL) Phase|Pregnancy|0|||
42300650|NCT02025985|76135846|FG000|Overall Study|Consent withdrawn|0|||
42300651|NCT02025985|76135847|FG001|Overall Study|Consent withdrawn|0|||
42300652|NCT02025985|76135848|FG002|Overall Study|Consent withdrawn|1|||
42300653|NCT02025985|76135849|FG003|Overall Study|Consent withdrawn|0|||
42119131|NCT00098293|75930011|FG000|Open-label (OL) Phase|Protocol Violation|0|||
42119132|NCT00098293|75930012|FG001|Open-label (OL) Phase|Protocol Violation|6|||
42119133|NCT00098293|75930013|FG002|Open-label (OL) Phase|Protocol Violation|13|||
42300654|NCT02025985|76135850|FG004|Overall Study|Consent withdrawn|0|||
42026495|NCT01179737|75834463|FG000|Extension|The study was terminated|3|||
42026496|NCT01179737|75834464|FG001|Extension|The study was terminated|0|||
42026497|NCT01179737|75834465|FG002|Extension|The study was terminated|0|||
42026498|NCT01179737|75834466|FG003|Extension|The study was terminated|0|||
42026499|NCT00929110|75834478|FG000|Overall Study|Adverse Event|40|||
42026500|NCT00929110|75834479|FG001|Overall Study|Adverse Event|29|||
42026501|NCT00929110|75834480|FG002|Overall Study|Adverse Event|18|||
42026502|NCT00929110|75834478|FG000|Overall Study|Subject withdrew consent|40|||
42026503|NCT00929110|75834479|FG001|Overall Study|Subject withdrew consent|23|||
42026504|NCT00929110|75834480|FG002|Overall Study|Subject withdrew consent|26|||
42119134|NCT00098293|75930014|FG003|Open-label (OL) Phase|Protocol Violation|16|||
42119135|NCT00098293|75930015|FG004|Open-label (OL) Phase|Protocol Violation|0|||
42119136|NCT00098293|75930011|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
42119137|NCT00098293|75930012|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
42300655|NCT02025985|76135846|FG000|Overall Study|Termination of study by Sponsor|4|||
42300656|NCT02025985|76135847|FG001|Overall Study|Termination of study by Sponsor|3|||
42300657|NCT02025985|76135848|FG002|Overall Study|Termination of study by Sponsor|1|||
42300658|NCT02025985|76135849|FG003|Overall Study|Termination of study by Sponsor|1|||
42300659|NCT02025985|76135850|FG004|Overall Study|Termination of study by Sponsor|3|||
42300660|NCT02025985|76135846|FG000|Overall Study|Death|21|||
42300661|NCT02025985|76135847|FG001|Overall Study|Death|20|||
42300662|NCT02025985|76135848|FG002|Overall Study|Death|23|||
42300663|NCT02025985|76135849|FG003|Overall Study|Death|20|||
42300664|NCT02025985|76135850|FG004|Overall Study|Death|17|||
42300665|NCT02528305|76135864|FG000|Overall Study|Withdrawal by Subject|1|||
42300666|NCT02528305|76135864|FG000|Overall Study|Adverse Event|1|||
42300667|NCT02528305|76135864|FG000|Overall Study|Physician Decision|1|||
42300668|NCT02532517|76135870|FG000|Overall Study|Did not complete 24-Month visit|4|||
42300669|NCT02532517|76135870|FG000|Overall Study|Failed Angiographic eligibility|1|||
42300670|NCT02532517|76135870|FG000|Overall Study|Lost to Follow-up|4|||
42300671|NCT02532517|76135870|FG000|Overall Study|Withdrawal by Subject|4|||
42300672|NCT02532517|76135870|FG000|Overall Study|Death|4|||
42026505|NCT00929110|75834478|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
42119138|NCT00098293|75930013|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
42119139|NCT00098293|75930014|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
42119140|NCT00098293|75930015|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
42119141|NCT00098293|75930011|FG000|Open-label (OL) Phase|Death|0|||
42119142|NCT00098293|75930012|FG001|Open-label (OL) Phase|Death|2|||
42119143|NCT00098293|75930013|FG002|Open-label (OL) Phase|Death|3|||
42119144|NCT00098293|75930014|FG003|Open-label (OL) Phase|Death|0|||
42119145|NCT00098293|75930015|FG004|Open-label (OL) Phase|Death|0|||
42119146|NCT00098293|75930011|FG000|Supplemental Phase (SP)|Death|0|||
41963237|NCT02840877|75746504|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
42119147|NCT00098293|75930012|FG001|Supplemental Phase (SP)|Death|0|||
42119148|NCT00098293|75930013|FG002|Supplemental Phase (SP)|Death|0|||
42119149|NCT00098293|75930014|FG003|Supplemental Phase (SP)|Death|0|||
42300673|NCT02545049|76135876|FG000|Overall Study|Withdrawal by Subject|1|||
42300674|NCT02545049|76135877|FG001|Overall Study|Withdrawal by Subject|7|||
42300675|NCT02545049|76135876|FG000|Overall Study|Lost to Follow-up|4|||
42300676|NCT02545049|76135877|FG001|Overall Study|Lost to Follow-up|6|||
41963238|NCT02840877|75746504|FG000|6 Months to 18 Months|Death|4|||
41963239|NCT02840877|75746504|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
41963240|NCT02840877|75746504|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
41963241|NCT02840877|75746504|FG000|6 Months to 18 Months|Still in study.|14|||
41963242|NCT02694185|75746510|FG000|Overall Study|Withdrawal by Subject|45|||
41963243|NCT02694185|75746511|FG001|Overall Study|Withdrawal by Subject|0|||
42300677|NCT02545049|76135876|FG000|Overall Study|GCP violations|37|||
42300678|NCT02545049|76135877|FG001|Overall Study|GCP violations|48|||
41963244|NCT02684903|75746519|FG000|Overall Study|COVID-19 shutdown of lab|4|||
41963245|NCT02684903|75746520|FG001|Overall Study|COVID-19 shutdown of lab|6|||
41963246|NCT02684903|75746519|FG000|Overall Study|Lost to Follow-up|31|||
41963247|NCT02684903|75746520|FG001|Overall Study|Lost to Follow-up|41|||
41963248|NCT02621424|75746535|FG000|Overall Study|Withdrawal by Subject|1|||
41963249|NCT02621424|75746536|FG001|Overall Study|Withdrawal by Subject|2|||
41963250|NCT02616185|75746551|FG000|Overall Study|Death|0|||
41963251|NCT02616185|75746552|FG001|Overall Study|Death|0|||
41963252|NCT02616185|75746553|FG002|Overall Study|Death|0|||
41963253|NCT02616185|75746554|FG003|Overall Study|Death|1|||
41963254|NCT02616185|75746555|FG004|Overall Study|Death|2|||
41963255|NCT02616185|75746556|FG005|Overall Study|Death|0|||
41963256|NCT02616185|75746557|FG006|Overall Study|Death|0|||
42300679|NCT02532283|76135885|FG000|Overall Study|Adverse Event|0|||
42300680|NCT02532283|76135886|FG001|Overall Study|Adverse Event|1|||
42300681|NCT02532283|76135885|FG000|Overall Study|Death|1|||
42300682|NCT02532283|76135886|FG001|Overall Study|Death|0|||
42119150|NCT00098293|75930015|FG004|Supplemental Phase (SP)|Death|1|||
42119151|NCT00098293|75930011|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
42119152|NCT00098293|75930012|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
42119153|NCT00098293|75930013|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
42119154|NCT00098293|75930014|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
42119155|NCT00098293|75930015|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
42300683|NCT02532283|76135885|FG000|Overall Study|Lost to Follow-up|0|||
42300684|NCT02532283|76135886|FG001|Overall Study|Lost to Follow-up|1|||
42300685|NCT02532283|76135885|FG000|Overall Study|Withdrawal by Subject|8|||
42300686|NCT02532283|76135886|FG001|Overall Study|Withdrawal by Subject|3|||
42300687|NCT01295125|76135907|FG000|Overall Study|Study stopped prematurely|9|||
42300688|NCT02540291|76135915|FG000|Overall Study|Death|7|||
42300689|NCT02540291|76135916|FG001|Overall Study|Death|7|||
42300690|NCT02540291|76135917|FG002|Overall Study|Death|5|||
42300691|NCT02540291|76135918|FG003|Overall Study|Death|7|||
41963257|NCT02616185|75746558|FG007|Overall Study|Death|2|||
42119156|NCT00098293|75930011|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
42119157|NCT00098293|75930012|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
42119158|NCT00098293|75930013|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
42119159|NCT00098293|75930014|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
42119160|NCT00098293|75930015|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
42119161|NCT00098293|75930011|FG000|Supplemental Phase (SP)|Other|0|||
42119162|NCT00098293|75930012|FG001|Supplemental Phase (SP)|Other|0|||
42119163|NCT00098293|75930013|FG002|Supplemental Phase (SP)|Other|0|||
42119164|NCT00098293|75930014|FG003|Supplemental Phase (SP)|Other|0|||
42300692|NCT02540291|76135915|FG000|Overall Study|Lost to Follow-up|0|||
42300693|NCT02540291|76135916|FG001|Overall Study|Lost to Follow-up|0|||
42300694|NCT02540291|76135917|FG002|Overall Study|Lost to Follow-up|1|||
42300695|NCT02540291|76135918|FG003|Overall Study|Lost to Follow-up|0|||
42300696|NCT02540291|76135915|FG000|Overall Study|Withdrawal Of Consent|0|||
41963258|NCT02616185|75746559|FG008|Overall Study|Death|1|||
42119165|NCT00098293|75930015|FG004|Supplemental Phase (SP)|Other|22|||
42119166|NCT00685685|75930026|FG000|Washout Period of 7 Days|Adverse Event|2|||
42119167|NCT00685685|75930027|FG001|Washout Period of 7 Days|Adverse Event|0|||
42119168|NCT00685685|75930026|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
42119169|NCT00685685|75930027|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
42119170|NCT00684671|75930036|FG000|Overall Study|Adverse Event|1|||
42119171|NCT00684671|75930037|FG001|Overall Study|Adverse Event|0|||
42300697|NCT02540291|76135916|FG001|Overall Study|Withdrawal Of Consent|1|||
42300698|NCT02540291|76135917|FG002|Overall Study|Withdrawal Of Consent|0|||
42300699|NCT02540291|76135918|FG003|Overall Study|Withdrawal Of Consent|0|||
42300700|NCT02540291|76135915|FG000|Overall Study|Study Terminated By Sponsor|1|||
42300701|NCT02540291|76135916|FG001|Overall Study|Study Terminated By Sponsor|0|||
42300702|NCT02540291|76135917|FG002|Overall Study|Study Terminated By Sponsor|0|||
42300703|NCT02540291|76135918|FG003|Overall Study|Study Terminated By Sponsor|0|||
42300704|NCT02540291|76135915|FG000|Overall Study|Other|0|||
42300705|NCT02540291|76135916|FG001|Overall Study|Other|0|||
42300706|NCT02540291|76135917|FG002|Overall Study|Other|1|||
42300707|NCT02540291|76135918|FG003|Overall Study|Other|0|||
42300708|NCT02540213|76135930|FG000|Overall Study|Death/adverse event|18|||
42300709|NCT02540213|76135930|FG000|Overall Study|Administrative reasons|3|||
42300710|NCT02540213|76135930|FG000|Overall Study|Kidney transplant|3|||
42300711|NCT02540213|76135930|FG000|Overall Study|Lack of Efficacy|6|||
42300712|NCT02540213|76135930|FG000|Overall Study|Consent withdrawn|7|||
42300713|NCT02540213|76135930|FG000|Overall Study|Enrolled but not treated|2|||
42300714|NCT02552303|76135938|FG000|Allocation|Withdrawal by Subject|2|||
42300715|NCT02552303|76135939|FG001|Allocation|Withdrawal by Subject|1|||
42300716|NCT02552303|76135940|FG002|Allocation|Withdrawal by Subject|1|||
42300717|NCT02552303|76135941|FG003|Allocation|Withdrawal by Subject|1|||
42300718|NCT02552303|76135938|FG000|Allocation|ineligible|1|||
42300719|NCT02552303|76135939|FG001|Allocation|ineligible|1|||
42300720|NCT02552303|76135940|FG002|Allocation|ineligible|0|||
42300721|NCT02552303|76135941|FG003|Allocation|ineligible|0|||
41963259|NCT02616185|75746551|FG000|Overall Study|Study terminated by sponsor|0|||
41963260|NCT02616185|75746552|FG001|Overall Study|Study terminated by sponsor|0|||
41963261|NCT02616185|75746553|FG002|Overall Study|Study terminated by sponsor|1|||
41963262|NCT02616185|75746554|FG003|Overall Study|Study terminated by sponsor|0|||
41963263|NCT02616185|75746555|FG004|Overall Study|Study terminated by sponsor|0|||
41963264|NCT02616185|75746556|FG005|Overall Study|Study terminated by sponsor|0|||
41963265|NCT02616185|75746557|FG006|Overall Study|Study terminated by sponsor|5|||
41963266|NCT02616185|75746558|FG007|Overall Study|Study terminated by sponsor|2|||
41963267|NCT02616185|75746559|FG008|Overall Study|Study terminated by sponsor|0|||
41963268|NCT02616185|75746551|FG000|Overall Study|Participant refused further follow-up|1|||
41963269|NCT02616185|75746552|FG001|Overall Study|Participant refused further follow-up|1|||
41963270|NCT02616185|75746553|FG002|Overall Study|Participant refused further follow-up|2|||
41963271|NCT02616185|75746554|FG003|Overall Study|Participant refused further follow-up|3|||
41963272|NCT02616185|75746555|FG004|Overall Study|Participant refused further follow-up|4|||
41963273|NCT02616185|75746556|FG005|Overall Study|Participant refused further follow-up|0|||
41963274|NCT02616185|75746557|FG006|Overall Study|Participant refused further follow-up|3|||
41963275|NCT02616185|75746558|FG007|Overall Study|Participant refused further follow-up|4|||
41963276|NCT02616185|75746559|FG008|Overall Study|Participant refused further follow-up|3|||
41963277|NCT02616185|75746551|FG000|Overall Study|Not reported|0|||
41963278|NCT02616185|75746552|FG001|Overall Study|Not reported|0|||
41963279|NCT02616185|75746553|FG002|Overall Study|Not reported|0|||
41963280|NCT02616185|75746554|FG003|Overall Study|Not reported|1|||
41963281|NCT02616185|75746555|FG004|Overall Study|Not reported|3|||
41963282|NCT02616185|75746556|FG005|Overall Study|Not reported|1|||
41963283|NCT02616185|75746557|FG006|Overall Study|Not reported|0|||
41963284|NCT02616185|75746558|FG007|Overall Study|Not reported|5|||
41963285|NCT02616185|75746559|FG008|Overall Study|Not reported|2|||
41963286|NCT01967888|75746625|FG000|Overall Study|Lost to Follow-up|6|||
42300722|NCT02552303|76135938|FG000|Follow-Up|Lost to Follow-up|0|||
42300723|NCT02552303|76135939|FG001|Follow-Up|Lost to Follow-up|0|||
42300724|NCT02552303|76135940|FG002|Follow-Up|Lost to Follow-up|1|||
42300725|NCT02552303|76135941|FG003|Follow-Up|Lost to Follow-up|0|||
42300726|NCT02552303|76135938|FG000|Follow-Up|ineligible|0|||
42300727|NCT02552303|76135939|FG001|Follow-Up|ineligible|2|||
42300728|NCT02552303|76135940|FG002|Follow-Up|ineligible|0|||
41963287|NCT01967888|75746626|FG001|Overall Study|Lost to Follow-up|4|||
41963288|NCT01967888|75746625|FG000|Overall Study|Withdrawal by Subject|1|||
41963289|NCT01967888|75746626|FG001|Overall Study|Withdrawal by Subject|1|||
41963290|NCT01967888|75746625|FG000|Overall Study|Did Not Have Transplant|1|||
41963291|NCT01967888|75746626|FG001|Overall Study|Did Not Have Transplant|0|||
42300729|NCT02552303|76135941|FG003|Follow-Up|ineligible|0|||
42300730|NCT01660711|76135951|FG000|Overall Study|Adverse Event|7|||
42300731|NCT01660711|76135951|FG000|Overall Study|Withdrawal by Subject|1|||
42300732|NCT02544113|76135957|FG000|Overall Study|Death|3|||
42300733|NCT02544113|76135958|FG001|Overall Study|Death|4|||
42300734|NCT02538965|76135964|FG000|Treatment Period|Other = Death due to disease progression|1|||
42300735|NCT02538965|76135964|FG000|Treatment Period|Adverse Event|2|||
42300736|NCT02538965|76135964|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
42119172|NCT00684671|75930038|FG002|Overall Study|Adverse Event|0|||
42119173|NCT00684671|75930036|FG000|Overall Study|Lost to Follow-up|1|||
42119174|NCT00684671|75930037|FG001|Overall Study|Lost to Follow-up|0|||
42119175|NCT00684671|75930038|FG002|Overall Study|Lost to Follow-up|0|||
42119176|NCT00684671|75930036|FG000|Overall Study|Alcoholic dependance|1|||
42119177|NCT00684671|75930037|FG001|Overall Study|Alcoholic dependance|0|||
42119178|NCT00684671|75930038|FG002|Overall Study|Alcoholic dependance|0|||
42119179|NCT03859323|75930059|FG000|Overall Study|Lost to Follow-up|0|||
42119180|NCT03859323|75930060|FG001|Overall Study|Lost to Follow-up|0|||
42119181|NCT03859323|75930061|FG002|Overall Study|Lost to Follow-up|0|||
42119182|NCT03859323|75930062|FG003|Overall Study|Lost to Follow-up|0|||
42119183|NCT03859323|75930063|FG004|Overall Study|Lost to Follow-up|0|||
42119184|NCT03859323|75930064|FG005|Overall Study|Lost to Follow-up|0|||
42119185|NCT03859323|75930065|FG006|Overall Study|Lost to Follow-up|1|||
42119186|NCT03859323|75930066|FG007|Overall Study|Lost to Follow-up|0|||
42119187|NCT03859323|75930067|FG008|Overall Study|Lost to Follow-up|0|||
42119188|NCT03859323|75930068|FG009|Overall Study|Lost to Follow-up|0|||
42119189|NCT03859323|75930069|FG010|Overall Study|Lost to Follow-up|0|||
42119190|NCT03859323|75930070|FG011|Overall Study|Lost to Follow-up|0|||
42119191|NCT03859323|75930071|FG012|Overall Study|Lost to Follow-up|0|||
42300737|NCT02538965|76135964|FG000|Treatment Period|Treatment Failure|9|||
42300738|NCT02538965|76135964|FG000|Treatment Period|Disease Progression|1|||
42300739|NCT02538965|76135964|FG000|Treatment Period|Physician Decision|2|||
42300740|NCT02538965|76135964|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
42300741|NCT02538965|76135964|FG000|Follow-Up Period|Withdrawal by Parent|4|||
42300742|NCT02543801|76135972|FG000|Overall Study|Protocol Violation|1|||
42300743|NCT02543801|76135973|FG001|Overall Study|Protocol Violation|2|||
42300744|NCT02543801|76135974|FG002|Overall Study|Protocol Violation|0|||
42300745|NCT02543801|76135975|FG003|Overall Study|Protocol Violation|0|||
42300746|NCT02535065|76135985|FG000|Overall Study|Death|13|||
42300747|NCT02535065|76135985|FG000|Overall Study|Lost to Follow-up|1|||
42300748|NCT02535065|76135985|FG000|Overall Study|Withdrawal by Subject|6|||
42119192|NCT03859323|75930059|FG000|Overall Study|Withdrawal by Subject|0|||
42119193|NCT03859323|75930060|FG001|Overall Study|Withdrawal by Subject|0|||
42119194|NCT03859323|75930061|FG002|Overall Study|Withdrawal by Subject|1|||
42119195|NCT03859323|75930062|FG003|Overall Study|Withdrawal by Subject|0|||
42119196|NCT03859323|75930063|FG004|Overall Study|Withdrawal by Subject|0|||
42119197|NCT03859323|75930064|FG005|Overall Study|Withdrawal by Subject|1|||
42300749|NCT02530619|76135989|FG000|Registered for Study|Withdrawal by Subject|2|||
42300750|NCT02530619|76135989|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
42300751|NCT02530619|76135989|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
42300752|NCT02530619|76135989|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
42300753|NCT02530619|76135989|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
42300754|NCT02530619|76135989|FG000|Follow-up Period (6 Months)|Death|4|||
42300755|NCT02530619|76135989|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
41963292|NCT01967888|75746625|FG000|Overall Study|Research visit not done, data recorded|1|||
42300756|NCT02530619|76135989|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
42300757|NCT02530385|76135995|FG000|Overall Study|Withdrawal by Subject|0|||
41963293|NCT01967888|75746626|FG001|Overall Study|Research visit not done, data recorded|0|||
41963294|NCT01967888|75746625|FG000|Overall Study|Subject excluded after randomization|1|||
41963295|NCT01967888|75746626|FG001|Overall Study|Subject excluded after randomization|0|||
41963296|NCT01967888|75746625|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
41963297|NCT01967888|75746626|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
41963298|NCT01967888|75746625|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
41963299|NCT01967888|75746626|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
41963300|NCT00653068|75746649|FG000|Overall Study|Death|9|||
41963301|NCT00653068|75746649|FG000|Overall Study|Lack of Efficacy|34|||
41963302|NCT00653068|75746649|FG000|Overall Study|Physician Decision|4|||
41963303|NCT00653068|75746649|FG000|Overall Study|Withdrawal by Subject|1|||
41963304|NCT00653068|75746649|FG000|Overall Study|Ineligible|2|||
41963305|NCT00414648|75746658|FG000|Overall Study|Adverse Event|5|||
41963306|NCT00414648|75746659|FG001|Overall Study|Adverse Event|5|||
41963307|NCT00414648|75746658|FG000|Overall Study|Death|0|||
41963308|NCT00414648|75746659|FG001|Overall Study|Death|1|||
41963309|NCT00414648|75746658|FG000|Overall Study|Lack of Efficacy|0|||
41963310|NCT00414648|75746659|FG001|Overall Study|Lack of Efficacy|2|||
41963311|NCT00414648|75746658|FG000|Overall Study|Withdrawal by Subject|0|||
41963312|NCT00414648|75746659|FG001|Overall Study|Withdrawal by Subject|1|||
42119198|NCT03859323|75930065|FG006|Overall Study|Withdrawal by Subject|0|||
42119199|NCT03859323|75930066|FG007|Overall Study|Withdrawal by Subject|0|||
42119200|NCT03859323|75930067|FG008|Overall Study|Withdrawal by Subject|0|||
42119201|NCT03859323|75930068|FG009|Overall Study|Withdrawal by Subject|1|||
42119202|NCT03859323|75930069|FG010|Overall Study|Withdrawal by Subject|1|||
42300758|NCT02530385|76135996|FG001|Overall Study|Withdrawal by Subject|1|||
42300759|NCT02362425|76136006|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
42300760|NCT02362425|76136007|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
42300761|NCT02362425|76136008|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
42300762|NCT02362425|76136009|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
42300763|NCT02362425|76136006|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
42300764|NCT02362425|76136007|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
42300765|NCT02362425|76136008|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
42300766|NCT02362425|76136009|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
42300767|NCT02362425|76136006|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
42300768|NCT02362425|76136007|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
42300769|NCT02362425|76136008|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
42300770|NCT02362425|76136009|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
42300771|NCT02362425|76136006|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
42300772|NCT02362425|76136007|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
42300773|NCT02362425|76136008|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
42300774|NCT02362425|76136009|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
42300775|NCT02362425|76136006|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
42300776|NCT02362425|76136007|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
42300777|NCT02362425|76136008|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
42300778|NCT02362425|76136009|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
42300779|NCT02362425|76136006|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
42300780|NCT02362425|76136007|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
42300781|NCT02362425|76136008|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
42300782|NCT02362425|76136009|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
42300783|NCT02362425|76136006|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
42300784|NCT02362425|76136007|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
41963313|NCT02538666|75747264|FG000|Pre-Treatment|Disease progression|1|||
42119203|NCT03859323|75930070|FG011|Overall Study|Withdrawal by Subject|2|||
42119204|NCT03859323|75930071|FG012|Overall Study|Withdrawal by Subject|1|||
42119205|NCT03859323|75930059|FG000|Overall Study|Pregnancy|0|||
42119206|NCT03859323|75930060|FG001|Overall Study|Pregnancy|0|||
42119207|NCT03859323|75930061|FG002|Overall Study|Pregnancy|0|||
42119208|NCT03859323|75930062|FG003|Overall Study|Pregnancy|0|||
42119209|NCT03859323|75930063|FG004|Overall Study|Pregnancy|0|||
41963314|NCT02538666|75747265|FG001|Pre-Treatment|Disease progression|0|||
41963315|NCT02538666|75747266|FG002|Pre-Treatment|Disease progression|0|||
41963316|NCT02538666|75747264|FG000|Pre-Treatment|no longer meets study criteria|1|||
41963317|NCT02538666|75747265|FG001|Pre-Treatment|no longer meets study criteria|0|||
41963318|NCT02538666|75747266|FG002|Pre-Treatment|no longer meets study criteria|0|||
41963319|NCT02538666|75747264|FG000|Pre-Treatment|Withdrew Consent|0|||
41963320|NCT02538666|75747265|FG001|Pre-Treatment|Withdrew Consent|1|||
41963321|NCT02538666|75747266|FG002|Pre-Treatment|Withdrew Consent|1|||
41963322|NCT02538666|75747264|FG000|Treatment|Disease progression|270|||
41963323|NCT02538666|75747265|FG001|Treatment|Disease progression|227|||
41963324|NCT02538666|75747266|FG002|Treatment|Disease progression|165|||
41963325|NCT02538666|75747264|FG000|Treatment|Study drug toxicity|1|||
41963326|NCT02538666|75747265|FG001|Treatment|Study drug toxicity|29|||
41963327|NCT02538666|75747266|FG002|Treatment|Study drug toxicity|92|||
42026506|NCT00929110|75834479|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
42026507|NCT00929110|75834480|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
42026508|NCT00929110|75834478|FG000|Overall Study|Lost to Follow-up|7|||
42026509|NCT00929110|75834479|FG001|Overall Study|Lost to Follow-up|7|||
42026510|NCT00929110|75834480|FG002|Overall Study|Lost to Follow-up|3|||
42026511|NCT00929110|75834478|FG000|Overall Study|Protocol deviation|5|||
42026512|NCT00929110|75834479|FG001|Overall Study|Protocol deviation|2|||
42026513|NCT00929110|75834480|FG002|Overall Study|Protocol deviation|4|||
42026514|NCT00929110|75834478|FG000|Overall Study|Administrative problems|4|||
42026515|NCT00929110|75834479|FG001|Overall Study|Administrative problems|1|||
42026516|NCT00929110|75834480|FG002|Overall Study|Administrative problems|2|||
42026517|NCT00929110|75834478|FG000|Overall Study|Death|2|||
42119210|NCT03859323|75930064|FG005|Overall Study|Pregnancy|0|||
42119211|NCT03859323|75930065|FG006|Overall Study|Pregnancy|0|||
42119212|NCT03859323|75930066|FG007|Overall Study|Pregnancy|0|||
42300785|NCT02362425|76136008|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
41963328|NCT02538666|75747264|FG000|Treatment|Death|0|||
41963329|NCT02538666|75747265|FG001|Treatment|Death|2|||
42026518|NCT00929110|75834479|FG001|Overall Study|Death|2|||
41963330|NCT02538666|75747266|FG002|Treatment|Death|3|||
41963331|NCT02538666|75747264|FG000|Treatment|Adverse event unrelated to study drug|8|||
41963332|NCT02538666|75747265|FG001|Treatment|Adverse event unrelated to study drug|10|||
42026519|NCT00929110|75834480|FG002|Overall Study|Death|2|||
42026520|NCT00929110|75834478|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42119213|NCT03859323|75930067|FG008|Overall Study|Pregnancy|0|||
42119214|NCT03859323|75930068|FG009|Overall Study|Pregnancy|1|||
41963333|NCT02538666|75747266|FG002|Treatment|Adverse event unrelated to study drug|15|||
41963334|NCT02538666|75747264|FG000|Treatment|Participant request to discontinue study treatment|3|||
41963335|NCT02538666|75747265|FG001|Treatment|Participant request to discontinue study treatment|6|||
41963336|NCT02538666|75747266|FG002|Treatment|Participant request to discontinue study treatment|11|||
41963337|NCT02538666|75747264|FG000|Treatment|Participant withdrew consent|2|||
41963338|NCT02538666|75747265|FG001|Treatment|Participant withdrew consent|5|||
41963339|NCT02538666|75747266|FG002|Treatment|Participant withdrew consent|3|||
41963340|NCT02538666|75747264|FG000|Treatment|Lost to Follow-up|0|||
41963341|NCT02538666|75747265|FG001|Treatment|Lost to Follow-up|1|||
41963342|NCT02538666|75747266|FG002|Treatment|Lost to Follow-up|1|||
41963343|NCT02538666|75747264|FG000|Treatment|Maximum clinical benefit|4|||
41963344|NCT02538666|75747265|FG001|Treatment|Maximum clinical benefit|3|||
41963345|NCT02538666|75747266|FG002|Treatment|Maximum clinical benefit|4|||
41963346|NCT02538666|75747264|FG000|Treatment|Poor/non-compliance|0|||
41963347|NCT02538666|75747265|FG001|Treatment|Poor/non-compliance|1|||
41963348|NCT02538666|75747266|FG002|Treatment|Poor/non-compliance|0|||
41963349|NCT02538666|75747264|FG000|Treatment|Participant no longer meets study criteria|0|||
41963350|NCT02538666|75747265|FG001|Treatment|Participant no longer meets study criteria|2|||
41963351|NCT02538666|75747266|FG002|Treatment|Participant no longer meets study criteria|0|||
41963352|NCT02538666|75747264|FG000|Treatment|Administrative reason by sponsor|0|||
41963353|NCT02538666|75747265|FG001|Treatment|Administrative reason by sponsor|0|||
41963354|NCT02538666|75747266|FG002|Treatment|Administrative reason by sponsor|1|||
41963355|NCT02538666|75747264|FG000|Treatment|Other reasons|8|||
41963356|NCT02538666|75747265|FG001|Treatment|Other reasons|15|||
41963357|NCT02538666|75747266|FG002|Treatment|Other reasons|5|||
41963358|NCT02538666|75747264|FG000|Treatment|Not reported|2|||
41963359|NCT02538666|75747265|FG001|Treatment|Not reported|2|||
41963360|NCT02538666|75747266|FG002|Treatment|Not reported|2|||
41963361|NCT02407236|75747320|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
41963362|NCT02407236|75747321|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
41963363|NCT02407236|75747322|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
41963364|NCT02407236|75747323|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
41963365|NCT02407236|75747324|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
41963366|NCT02407236|75747325|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
41963367|NCT02407236|75747326|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
41963368|NCT02407236|75747327|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
41963369|NCT02407236|75747328|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
41963370|NCT02407236|75747329|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
41963371|NCT02407236|75747330|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
41963372|NCT02407236|75747331|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
41963373|NCT02407236|75747332|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
42300786|NCT02362425|76136009|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
42300787|NCT02362425|76136006|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
42300788|NCT02362425|76136007|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
42300789|NCT02362425|76136008|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
42300790|NCT02362425|76136009|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
42300791|NCT02362269|76136022|FG000|Overall Study|Moved|1|||
42300792|NCT02362269|76136023|FG001|Overall Study|Moved|0|||
42300793|NCT02362269|76136022|FG000|Overall Study|Lost to Follow-up|0|||
42300794|NCT02362269|76136023|FG001|Overall Study|Lost to Follow-up|6|||
42300795|NCT02529995|76136031|FG000|Part A|Ongoing Study at Data Cut-off|14|||
42300796|NCT02529995|76136032|FG001|Part A|Ongoing Study at Data Cut-off|16|||
42300797|NCT02529995|76136031|FG000|Part A|Discontinued Study|1|||
42300798|NCT02529995|76136032|FG001|Part A|Discontinued Study|0|||
42300799|NCT02529995|76136031|FG000|Part B|Ongoing Study at Data Cut-off|0|||
42300800|NCT02529995|76136032|FG001|Part B|Ongoing Study at Data Cut-off|7|||
42300801|NCT02529995|76136031|FG000|Part B|Discontinued Study|6|||
42300802|NCT02529995|76136032|FG001|Part B|Discontinued Study|5|||
42300803|NCT02529137|76136038|FG000|Overall Study|Discontinuation for different reasons|8|||
42300804|NCT02319759|76136045|FG000|Week 0 - 16|Lack of Efficacy|1|||
42300805|NCT02319759|76136046|FG001|Week 0 - 16|Lack of Efficacy|0|||
42300806|NCT02319759|76136047|FG002|Week 0 - 16|Lack of Efficacy|0|||
42300807|NCT02319759|76136048|FG003|Week 0 - 16|Lack of Efficacy|0|||
41963374|NCT02407236|75747320|FG000|Induction Study (8 Weeks)|Death|0|||
42026521|NCT00929110|75834479|FG001|Overall Study|Abnormal laboratory value(s)|1|||
42026522|NCT00929110|75834480|FG002|Overall Study|Abnormal laboratory value(s)|0|||
42300808|NCT02319759|76136049|FG004|Week 0 - 16|Lack of Efficacy|0|||
42026523|NCT00929110|75834478|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42300809|NCT02319759|76136045|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
41963375|NCT02407236|75747321|FG001|Induction Study (8 Weeks)|Death|0|||
41963376|NCT02407236|75747322|FG002|Induction Study (8 Weeks)|Death|1|||
41963377|NCT02407236|75747323|FG003|Induction Study (8 Weeks)|Death|0|||
41963378|NCT02407236|75747324|FG004|Induction Study (8 Weeks)|Death|0|||
41963379|NCT02407236|75747325|FG005|Induction Study (8 Weeks)|Death|0|||
41963380|NCT02407236|75747326|FG006|Induction Study (8 Weeks)|Death|0|||
42300810|NCT02319759|76136046|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
42300811|NCT02319759|76136047|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
42300812|NCT02319759|76136048|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
42300813|NCT02319759|76136049|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
42300814|NCT02319759|76136045|FG000|Week 16 - 24|Lack of Efficacy|1|||
42300815|NCT02319759|76136046|FG001|Week 16 - 24|Lack of Efficacy|0|||
42300816|NCT02319759|76136047|FG002|Week 16 - 24|Lack of Efficacy|1|||
42300817|NCT02319759|76136048|FG003|Week 16 - 24|Lack of Efficacy|0|||
42300818|NCT02319759|76136049|FG004|Week 16 - 24|Lack of Efficacy|0|||
42300819|NCT02319759|76136045|FG000|Week 16 - 24|Lost to Follow-up|1|||
42300820|NCT02319759|76136046|FG001|Week 16 - 24|Lost to Follow-up|0|||
42300821|NCT02319759|76136047|FG002|Week 16 - 24|Lost to Follow-up|0|||
42300822|NCT02319759|76136048|FG003|Week 16 - 24|Lost to Follow-up|0|||
42300823|NCT02319759|76136049|FG004|Week 16 - 24|Lost to Follow-up|0|||
42300824|NCT02319759|76136045|FG000|Week 16 - 24|Withdrawal by Subject|0|||
42300825|NCT02319759|76136046|FG001|Week 16 - 24|Withdrawal by Subject|0|||
42300826|NCT02319759|76136047|FG002|Week 16 - 24|Withdrawal by Subject|2|||
42300827|NCT02319759|76136048|FG003|Week 16 - 24|Withdrawal by Subject|0|||
42300828|NCT02319759|76136049|FG004|Week 16 - 24|Withdrawal by Subject|0|||
42300829|NCT02319759|76136045|FG000|Week 24 - 56|Adverse Event|0|||
42300830|NCT02319759|76136046|FG001|Week 24 - 56|Adverse Event|0|||
42300831|NCT02319759|76136047|FG002|Week 24 - 56|Adverse Event|2|||
42300832|NCT02319759|76136048|FG003|Week 24 - 56|Adverse Event|0|||
42300833|NCT02319759|76136049|FG004|Week 24 - 56|Adverse Event|0|||
42300834|NCT02319759|76136045|FG000|Week 24 - 56|Lack of Efficacy|0|||
42300835|NCT02319759|76136046|FG001|Week 24 - 56|Lack of Efficacy|0|||
42300836|NCT02319759|76136047|FG002|Week 24 - 56|Lack of Efficacy|0|||
42300837|NCT02319759|76136048|FG003|Week 24 - 56|Lack of Efficacy|2|||
42300838|NCT02319759|76136049|FG004|Week 24 - 56|Lack of Efficacy|1|||
42300839|NCT02319759|76136045|FG000|Week 24 - 56|Withdrawal by Subject|0|||
42300840|NCT02319759|76136046|FG001|Week 24 - 56|Withdrawal by Subject|1|||
42300841|NCT02319759|76136047|FG002|Week 24 - 56|Withdrawal by Subject|0|||
42300842|NCT02319759|76136048|FG003|Week 24 - 56|Withdrawal by Subject|0|||
42300843|NCT02319759|76136049|FG004|Week 24 - 56|Withdrawal by Subject|0|||
42300844|NCT02319759|76136045|FG000|Week 24 - 56|Lost to Follow-up|0|||
42300845|NCT02319759|76136046|FG001|Week 24 - 56|Lost to Follow-up|0|||
42300846|NCT02319759|76136047|FG002|Week 24 - 56|Lost to Follow-up|0|||
42300847|NCT02319759|76136048|FG003|Week 24 - 56|Lost to Follow-up|0|||
42300848|NCT02319759|76136049|FG004|Week 24 - 56|Lost to Follow-up|1|||
42300849|NCT02293005|76136062|FG000|Overall Study|Adverse Event|2|||
42300850|NCT02293005|76136062|FG000|Overall Study|Death|4|||
42300851|NCT02293005|76136062|FG000|Overall Study|Lost to Follow-up|1|||
42300852|NCT02293005|76136062|FG000|Overall Study|Withdrawal by Subject|2|||
42300853|NCT02293005|76136062|FG000|Overall Study|Progression|17|||
42300854|NCT02319525|76136068|FG000|Overall Study|Withdrawal by Subject|2|||
42300855|NCT02319525|76136069|FG001|Overall Study|Withdrawal by Subject|1|||
42300856|NCT02292927|76136077|FG000|Overall Study|Protocol Violation|13|||
42300857|NCT02292927|76136078|FG001|Overall Study|Protocol Violation|7|||
42300858|NCT02292849|76136090|FG000|Overall Study|Lost to Follow-up|0|||
42300859|NCT02292849|76136091|FG001|Overall Study|Lost to Follow-up|2|||
42300860|NCT02292849|76136092|FG002|Overall Study|Lost to Follow-up|2|||
42300861|NCT02292849|76136090|FG000|Overall Study|Physician Decision|4|||
42300862|NCT02292849|76136091|FG001|Overall Study|Physician Decision|0|||
42300863|NCT02292849|76136092|FG002|Overall Study|Physician Decision|0|||
42300864|NCT02318667|76136100|FG000|Overall Study|Adverse Event|1|||
42300865|NCT02318667|76136100|FG000|Overall Study|Lack of Efficacy|6|||
42300866|NCT02318667|76136100|FG000|Overall Study|Protocol Violation|2|||
42300867|NCT02292771|76136110|FG000|Overall Study|Withdrawal by Subject|2|||
42300868|NCT02292771|76136111|FG001|Overall Study|Withdrawal by Subject|1|||
42300869|NCT02292771|76136110|FG000|Overall Study|Lost to Follow-up|2|||
42300870|NCT02292771|76136111|FG001|Overall Study|Lost to Follow-up|1|||
42300871|NCT02291913|76136121|FG000|Overall Study|Progressive Disease|32|||
42300872|NCT02291913|76136121|FG000|Overall Study|Adverse Event|11|||
42300873|NCT02291913|76136121|FG000|Overall Study|Death|2|||
42300874|NCT02291913|76136121|FG000|Overall Study|Physician Decision|1|||
42300875|NCT02291913|76136121|FG000|Overall Study|Withdrawal by Subject|1|||
42300876|NCT02291913|76136121|FG000|Overall Study|Protocol Violation|1|||
42300877|NCT02291679|76136128|FG000|Overall Study|Adverse Event|2|||
42300878|NCT02291679|76136129|FG001|Overall Study|Adverse Event|12|||
42300879|NCT02291679|76136130|FG002|Overall Study|Adverse Event|19|||
42300880|NCT02291679|76136128|FG000|Overall Study|Protocol Violation|5|||
42300881|NCT02291679|76136129|FG001|Overall Study|Protocol Violation|1|||
42300882|NCT02291679|76136130|FG002|Overall Study|Protocol Violation|7|||
42300883|NCT02291679|76136128|FG000|Overall Study|Withdrew Consent|18|||
42300884|NCT02291679|76136129|FG001|Overall Study|Withdrew Consent|10|||
42300885|NCT02291679|76136130|FG002|Overall Study|Withdrew Consent|15|||
42300886|NCT02291679|76136128|FG000|Overall Study|Lost to Follow-up|12|||
42300887|NCT02291679|76136129|FG001|Overall Study|Lost to Follow-up|10|||
42300888|NCT02291679|76136130|FG002|Overall Study|Lost to Follow-up|9|||
42300889|NCT02291679|76136128|FG000|Overall Study|Insufficient Therapeutic Response|5|||
42300890|NCT02291679|76136129|FG001|Overall Study|Insufficient Therapeutic Response|5|||
42300891|NCT02291679|76136130|FG002|Overall Study|Insufficient Therapeutic Response|7|||
42300892|NCT02291679|76136128|FG000|Overall Study|Other|2|||
42300893|NCT02291679|76136129|FG001|Overall Study|Other|4|||
42300894|NCT02291679|76136130|FG002|Overall Study|Other|2|||
42300895|NCT02291601|76136137|FG000|Abdomen|Did not qualify|333|||
42300896|NCT02291601|76136138|FG001|Abdomen|Did not qualify|54|||
42300897|NCT02291601|76136139|FG002|Abdomen|Did not qualify|339|||
42300898|NCT02291601|76136137|FG000|Groin|Did not qualify|183|||
42300899|NCT02291601|76136138|FG001|Groin|Did not qualify|30|||
42300900|NCT02291601|76136139|FG002|Groin|Did not qualify|177|||
42300901|NCT02360475|76136154|FG000|Overall Study|Lost to Follow-up|4|||
42300902|NCT02360475|76136155|FG001|Overall Study|Lost to Follow-up|12|||
42300903|NCT02360475|76136156|FG002|Overall Study|Lost to Follow-up|6|||
42300904|NCT02360475|76136157|FG003|Overall Study|Lost to Follow-up|4|||
42300905|NCT02360475|76136154|FG000|Overall Study|Withdrawal by Subject|0|||
42300906|NCT02360475|76136155|FG001|Overall Study|Withdrawal by Subject|1|||
41963381|NCT02407236|75747327|FG007|Induction Study (8 Weeks)|Death|0|||
41963382|NCT02407236|75747328|FG008|Induction Study (8 Weeks)|Death|0|||
41963383|NCT02407236|75747329|FG009|Induction Study (8 Weeks)|Death|0|||
41963384|NCT02407236|75747330|FG010|Induction Study (8 Weeks)|Death|0|||
41963385|NCT02407236|75747331|FG011|Induction Study (8 Weeks)|Death|0|||
41963386|NCT02407236|75747332|FG012|Induction Study (8 Weeks)|Death|0|||
41963387|NCT02407236|75747320|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
41963388|NCT02407236|75747321|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
41963389|NCT02407236|75747322|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
41963390|NCT02407236|75747323|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
41963391|NCT02407236|75747324|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
41963392|NCT02407236|75747325|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
41963393|NCT02407236|75747326|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
41963394|NCT02407236|75747327|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
41963395|NCT02407236|75747328|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
41963396|NCT02407236|75747329|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
41963397|NCT02407236|75747330|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
41963398|NCT02407236|75747331|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
42026524|NCT00929110|75834479|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42026525|NCT00929110|75834480|FG002|Overall Study|Abnormal test procedure result(s)|1|||
42026526|NCT00929110|75834478|FG000|Overall Study|Patient inability to use the device|0|||
42026527|NCT00929110|75834479|FG001|Overall Study|Patient inability to use the device|1|||
42026528|NCT00929110|75834480|FG002|Overall Study|Patient inability to use the device|0|||
42026529|NCT01147068|75834495|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
42026530|NCT01147068|75834496|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
42026531|NCT01147068|75834497|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
42026532|NCT01147068|75834498|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
42026533|NCT01147068|75834499|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
42026534|NCT01147068|75834500|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
42026535|NCT01147068|75834501|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
42026536|NCT01147068|75834495|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
42026537|NCT01147068|75834496|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
42026538|NCT01147068|75834497|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
42026539|NCT01147068|75834498|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
42300907|NCT02360475|76136156|FG002|Overall Study|Withdrawal by Subject|2|||
42300908|NCT02360475|76136157|FG003|Overall Study|Withdrawal by Subject|0|||
41963399|NCT02407236|75747332|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
41963400|NCT02407236|75747320|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
42026540|NCT01147068|75834499|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
42300909|NCT02360475|76136154|FG000|Overall Study|Migrated/moved from study area|0|||
42300910|NCT02360475|76136155|FG001|Overall Study|Migrated/moved from study area|0|||
42300911|NCT02360475|76136156|FG002|Overall Study|Migrated/moved from study area|0|||
41963401|NCT02407236|75747321|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
42300912|NCT02360475|76136157|FG003|Overall Study|Migrated/moved from study area|1|||
41963402|NCT02407236|75747322|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
41963403|NCT02407236|75747323|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
41963404|NCT02407236|75747324|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
41963405|NCT02407236|75747325|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
41963406|NCT02407236|75747326|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
41963407|NCT02407236|75747327|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
41963408|NCT02407236|75747328|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
41963409|NCT02407236|75747329|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
41963410|NCT02407236|75747330|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
41963411|NCT02407236|75747331|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
41963412|NCT02407236|75747332|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
41963413|NCT02407236|75747320|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
41963414|NCT02407236|75747321|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
41963415|NCT02407236|75747322|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
41963416|NCT02407236|75747323|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
41963417|NCT02407236|75747324|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
41963418|NCT02407236|75747325|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
41963419|NCT02407236|75747326|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
41963420|NCT02407236|75747327|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
41963421|NCT02407236|75747328|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
41963422|NCT02407236|75747329|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
41963423|NCT02407236|75747330|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
41963424|NCT02407236|75747331|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
41963425|NCT02407236|75747332|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
41963426|NCT02407236|75747320|FG000|Induction Study (8 Weeks)|Other|2|||
41963427|NCT02407236|75747321|FG001|Induction Study (8 Weeks)|Other|1|||
41963428|NCT02407236|75747322|FG002|Induction Study (8 Weeks)|Other|5|||
41963429|NCT02407236|75747323|FG003|Induction Study (8 Weeks)|Other|0|||
41963430|NCT02407236|75747324|FG004|Induction Study (8 Weeks)|Other|0|||
41963431|NCT02407236|75747325|FG005|Induction Study (8 Weeks)|Other|0|||
41963432|NCT02407236|75747326|FG006|Induction Study (8 Weeks)|Other|0|||
41963433|NCT02407236|75747327|FG007|Induction Study (8 Weeks)|Other|0|||
41963434|NCT02407236|75747328|FG008|Induction Study (8 Weeks)|Other|0|||
41963435|NCT02407236|75747329|FG009|Induction Study (8 Weeks)|Other|0|||
41963436|NCT02407236|75747330|FG010|Induction Study (8 Weeks)|Other|0|||
41963437|NCT02407236|75747331|FG011|Induction Study (8 Weeks)|Other|0|||
41963438|NCT02407236|75747332|FG012|Induction Study (8 Weeks)|Other|0|||
42300913|NCT02360397|76136167|FG000|Overall Study|Incomplete screening|3|||
42300914|NCT02360397|76136167|FG000|Overall Study|Adverse Event|1|||
42300915|NCT02317809|76136172|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
42300916|NCT02317809|76136173|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
42300917|NCT02317809|76136172|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
42300918|NCT02317809|76136173|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
42300919|NCT02359851|76136182|FG000|Overall Study|Death|1|||
42300920|NCT02359851|76136182|FG000|Overall Study|Disease progression|1|||
42300921|NCT01607905|76136193|FG000|Overall Study|Withdrawal by participant|7|||
42300922|NCT01607905|76136194|FG001|Overall Study|Withdrawal by participant|2|||
42300923|NCT01607905|76136195|FG002|Overall Study|Withdrawal by participant|4|||
42300924|NCT01607905|76136196|FG003|Overall Study|Withdrawal by participant|6|||
42300925|NCT01607905|76136197|FG004|Overall Study|Withdrawal by participant|0|||
42300926|NCT01607905|76136198|FG005|Overall Study|Withdrawal by participant|4|||
42300927|NCT01607905|76136199|FG006|Overall Study|Withdrawal by participant|12|||
42300928|NCT01607905|76136193|FG000|Overall Study|Incidence or severity of AEs|5|||
42300929|NCT01607905|76136194|FG001|Overall Study|Incidence or severity of AEs|1|||
42300930|NCT01607905|76136195|FG002|Overall Study|Incidence or severity of AEs|1|||
42026541|NCT01147068|75834500|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
42026542|NCT01147068|75834501|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
42026543|NCT01147068|75834495|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
42026544|NCT01147068|75834496|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
42026545|NCT01147068|75834497|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
42026546|NCT01147068|75834498|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
42300931|NCT01607905|76136196|FG003|Overall Study|Incidence or severity of AEs|3|||
41963439|NCT02407236|75747320|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
41963440|NCT02407236|75747321|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
41963441|NCT02407236|75747322|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
41963442|NCT02407236|75747323|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
41963443|NCT02407236|75747324|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
42026547|NCT01147068|75834499|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
41963444|NCT02407236|75747325|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
41963445|NCT02407236|75747326|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
41963446|NCT02407236|75747327|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
42300932|NCT01607905|76136197|FG004|Overall Study|Incidence or severity of AEs|0|||
42300933|NCT01607905|76136198|FG005|Overall Study|Incidence or severity of AEs|2|||
42300934|NCT01607905|76136199|FG006|Overall Study|Incidence or severity of AEs|8|||
42300935|NCT01607905|76136193|FG000|Overall Study|Disease progression|44|||
42300936|NCT01607905|76136194|FG001|Overall Study|Disease progression|16|||
41963447|NCT02407236|75747328|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
41963448|NCT02407236|75747329|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
41963449|NCT02407236|75747330|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
41963450|NCT02407236|75747331|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
41963451|NCT02407236|75747332|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
41963452|NCT02407236|75747320|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
41963453|NCT02407236|75747321|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
41963454|NCT02407236|75747322|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
41963455|NCT02407236|75747323|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
41963456|NCT02407236|75747324|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
41963457|NCT02407236|75747325|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
41963458|NCT02407236|75747326|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
41963459|NCT02407236|75747327|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
41963460|NCT02407236|75747328|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
41963461|NCT02407236|75747329|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
41963462|NCT02407236|75747330|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
42300937|NCT01607905|76136195|FG002|Overall Study|Disease progression|15|||
42300938|NCT01607905|76136196|FG003|Overall Study|Disease progression|11|||
42300939|NCT01607905|76136197|FG004|Overall Study|Disease progression|6|||
42300940|NCT01607905|76136198|FG005|Overall Study|Disease progression|7|||
42300941|NCT01607905|76136199|FG006|Overall Study|Disease progression|21|||
42300942|NCT01607905|76136193|FG000|Overall Study|Non-compliance with study procedures|0|||
42300943|NCT01607905|76136194|FG001|Overall Study|Non-compliance with study procedures|0|||
42300944|NCT01607905|76136195|FG002|Overall Study|Non-compliance with study procedures|0|||
42300945|NCT01607905|76136196|FG003|Overall Study|Non-compliance with study procedures|0|||
42300946|NCT01607905|76136197|FG004|Overall Study|Non-compliance with study procedures|0|||
42300947|NCT01607905|76136198|FG005|Overall Study|Non-compliance with study procedures|0|||
42300948|NCT01607905|76136199|FG006|Overall Study|Non-compliance with study procedures|1|||
41963463|NCT02407236|75747331|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
41963464|NCT02407236|75747332|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
41963465|NCT02407236|75747320|FG000|Maintenance Study (44 Weeks)|Other|0|||
42210338|NCT02936037|76025129|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
42210339|NCT02936037|76025130|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
42210340|NCT02936037|76025129|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
42210341|NCT02936037|76025130|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
42210342|NCT02936037|76025129|FG000|Double-Blind Treatment Period|Death|0|||
42210343|NCT02936037|76025130|FG001|Double-Blind Treatment Period|Death|1|||
42210344|NCT02936037|76025129|FG000|Double-Blind Treatment Period|Adverse Event|11|||
42300949|NCT01607905|76136193|FG000|Overall Study|Death|1|||
41963466|NCT02407236|75747321|FG001|Maintenance Study (44 Weeks)|Other|0|||
41963467|NCT02407236|75747322|FG002|Maintenance Study (44 Weeks)|Other|0|||
41963468|NCT02407236|75747323|FG003|Maintenance Study (44 Weeks)|Other|5|||
41963469|NCT02407236|75747324|FG004|Maintenance Study (44 Weeks)|Other|7|||
41963470|NCT02407236|75747325|FG005|Maintenance Study (44 Weeks)|Other|8|||
41963471|NCT02407236|75747326|FG006|Maintenance Study (44 Weeks)|Other|4|||
41963472|NCT02407236|75747327|FG007|Maintenance Study (44 Weeks)|Other|6|||
41963473|NCT02407236|75747328|FG008|Maintenance Study (44 Weeks)|Other|0|||
41963474|NCT02407236|75747329|FG009|Maintenance Study (44 Weeks)|Other|0|||
41963475|NCT02407236|75747330|FG010|Maintenance Study (44 Weeks)|Other|0|||
41963476|NCT02407236|75747331|FG011|Maintenance Study (44 Weeks)|Other|0|||
41963477|NCT02407236|75747332|FG012|Maintenance Study (44 Weeks)|Other|0|||
42026548|NCT01147068|75834500|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
42300950|NCT01607905|76136194|FG001|Overall Study|Death|1|||
42300951|NCT01607905|76136195|FG002|Overall Study|Death|1|||
42300952|NCT01607905|76136196|FG003|Overall Study|Death|1|||
42300953|NCT01607905|76136197|FG004|Overall Study|Death|0|||
42026549|NCT01147068|75834501|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
42300954|NCT01607905|76136198|FG005|Overall Study|Death|0|||
42300955|NCT01607905|76136199|FG006|Overall Study|Death|3|||
42026550|NCT01147068|75834495|FG000|Subjects That Received 2nd Dose|Other|0|||
42026551|NCT01147068|75834496|FG001|Subjects That Received 2nd Dose|Other|3|||
41963478|NCT02407236|75747320|FG000|Maintenance Study (44 Weeks)|Death|0|||
41963479|NCT02407236|75747321|FG001|Maintenance Study (44 Weeks)|Death|0|||
41963480|NCT02407236|75747322|FG002|Maintenance Study (44 Weeks)|Death|0|||
42300956|NCT01607905|76136193|FG000|Overall Study|Other treatments become available|1|||
42300957|NCT01607905|76136194|FG001|Overall Study|Other treatments become available|0|||
42300958|NCT01607905|76136195|FG002|Overall Study|Other treatments become available|0|||
42300959|NCT01607905|76136196|FG003|Overall Study|Other treatments become available|0|||
42300960|NCT01607905|76136197|FG004|Overall Study|Other treatments become available|0|||
42300961|NCT01607905|76136198|FG005|Overall Study|Other treatments become available|0|||
42300962|NCT01607905|76136199|FG006|Overall Study|Other treatments become available|1|||
42300963|NCT01607905|76136193|FG000|Overall Study|Investigator discretion|0|||
42300964|NCT01607905|76136194|FG001|Overall Study|Investigator discretion|0|||
42300965|NCT01607905|76136195|FG002|Overall Study|Investigator discretion|0|||
42300966|NCT01607905|76136196|FG003|Overall Study|Investigator discretion|0|||
42300967|NCT01607905|76136197|FG004|Overall Study|Investigator discretion|0|||
42300968|NCT01607905|76136198|FG005|Overall Study|Investigator discretion|1|||
42300969|NCT01607905|76136199|FG006|Overall Study|Investigator discretion|0|||
42300970|NCT01607905|76136193|FG000|Overall Study|Other|1|||
42300971|NCT01607905|76136194|FG001|Overall Study|Other|0|||
42300972|NCT01607905|76136195|FG002|Overall Study|Other|0|||
42300973|NCT01607905|76136196|FG003|Overall Study|Other|0|||
42300974|NCT01607905|76136197|FG004|Overall Study|Other|0|||
42300975|NCT01607905|76136198|FG005|Overall Study|Other|0|||
42300976|NCT01607905|76136199|FG006|Overall Study|Other|1|||
42300977|NCT01607905|76136193|FG000|Overall Study|Randomized but not treated|1|||
41963481|NCT02407236|75747323|FG003|Maintenance Study (44 Weeks)|Death|0|||
41963482|NCT02407236|75747324|FG004|Maintenance Study (44 Weeks)|Death|0|||
41963483|NCT02407236|75747325|FG005|Maintenance Study (44 Weeks)|Death|0|||
41963484|NCT02407236|75747326|FG006|Maintenance Study (44 Weeks)|Death|0|||
41963485|NCT02407236|75747327|FG007|Maintenance Study (44 Weeks)|Death|1|||
41963486|NCT02407236|75747328|FG008|Maintenance Study (44 Weeks)|Death|0|||
41963487|NCT02407236|75747329|FG009|Maintenance Study (44 Weeks)|Death|0|||
41963488|NCT02407236|75747330|FG010|Maintenance Study (44 Weeks)|Death|0|||
41963489|NCT02407236|75747331|FG011|Maintenance Study (44 Weeks)|Death|0|||
41963490|NCT02407236|75747332|FG012|Maintenance Study (44 Weeks)|Death|0|||
41963491|NCT02407236|75747320|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
41963492|NCT02407236|75747321|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
41963493|NCT02407236|75747322|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
41963494|NCT02407236|75747323|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
41963495|NCT02407236|75747324|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
41963496|NCT02407236|75747325|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
41963497|NCT02407236|75747326|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
41963498|NCT02407236|75747327|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
41963499|NCT02407236|75747328|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
41963500|NCT02407236|75747329|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
41963501|NCT02407236|75747330|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
41963502|NCT02407236|75747331|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
42119215|NCT03859323|75930069|FG010|Overall Study|Pregnancy|0|||
42300978|NCT01607905|76136194|FG001|Overall Study|Randomized but not treated|0|||
42300979|NCT01607905|76136195|FG002|Overall Study|Randomized but not treated|0|||
42300980|NCT01607905|76136196|FG003|Overall Study|Randomized but not treated|0|||
42300981|NCT01607905|76136197|FG004|Overall Study|Randomized but not treated|1|||
41963503|NCT02407236|75747332|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
41963504|NCT02407236|75747320|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
42026552|NCT01147068|75834497|FG002|Subjects That Received 2nd Dose|Other|3|||
42119216|NCT03859323|75930070|FG011|Overall Study|Pregnancy|0|||
42300982|NCT01607905|76136198|FG005|Overall Study|Randomized but not treated|1|||
42300983|NCT01607905|76136199|FG006|Overall Study|Randomized but not treated|0|||
42300984|NCT02536963|76136257|FG000|Overall Study|Withdrawal by Subject|18|||
42300985|NCT02531035|76136263|FG000|Overall Study|Death|0|||
42300986|NCT02531035|76136264|FG001|Overall Study|Death|1|||
42300987|NCT02531035|76136263|FG000|Overall Study|Protocol Violation|1|||
42300988|NCT02531035|76136264|FG001|Overall Study|Protocol Violation|1|||
42026553|NCT01147068|75834498|FG003|Subjects That Received 2nd Dose|Other|0|||
42026554|NCT01147068|75834499|FG004|Subjects That Received 2nd Dose|Other|1|||
42026555|NCT01147068|75834500|FG005|Subjects That Received 2nd Dose|Other|0|||
42026556|NCT01147068|75834501|FG006|Subjects That Received 2nd Dose|Other|0|||
42026557|NCT01147068|75834495|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
42119217|NCT03859323|75930071|FG012|Overall Study|Pregnancy|0|||
42119218|NCT03857841|75930114|FG000|Overall Study|Death|1|||
42119219|NCT03857841|75930115|FG001|Overall Study|Death|0|||
42119220|NCT03857841|75930116|FG002|Overall Study|Death|0|||
42119221|NCT03857841|75930117|FG003|Overall Study|Death|0|||
42119222|NCT03857841|75930114|FG000|Overall Study|Study Terminated by Sponsor|1|||
42119223|NCT03857841|75930115|FG001|Overall Study|Study Terminated by Sponsor|0|||
42119224|NCT03857841|75930116|FG002|Overall Study|Study Terminated by Sponsor|0|||
42119225|NCT03857841|75930117|FG003|Overall Study|Study Terminated by Sponsor|0|||
42119226|NCT00500331|75930134|FG000|Overall Study|Adverse Event|0|||
42119227|NCT00500331|75930135|FG001|Overall Study|Adverse Event|2|||
42119228|NCT00500331|75930136|FG002|Overall Study|Adverse Event|0|||
42119229|NCT00500331|75930137|FG003|Overall Study|Adverse Event|1|||
42119230|NCT00500331|75930138|FG004|Overall Study|Adverse Event|2|||
42119231|NCT00500331|75930139|FG005|Overall Study|Adverse Event|2|||
42119232|NCT00500331|75930140|FG006|Overall Study|Adverse Event|0|||
42300989|NCT02531035|76136263|FG000|Overall Study|Noncompliance with study drug|8|||
42300990|NCT02531035|76136264|FG001|Overall Study|Noncompliance with study drug|3|||
42300991|NCT02531035|76136263|FG000|Overall Study|Physician Decision|1|||
42300992|NCT02531035|76136264|FG001|Overall Study|Physician Decision|0|||
42300993|NCT02531035|76136263|FG000|Overall Study|Adverse Event|16|||
42300994|NCT02531035|76136264|FG001|Overall Study|Adverse Event|45|||
42300995|NCT02531035|76136263|FG000|Overall Study|Other|3|||
42300996|NCT02531035|76136264|FG001|Overall Study|Other|2|||
42300997|NCT02531035|76136263|FG000|Overall Study|Withdrawal by Subject|42|||
42119233|NCT00500331|75930134|FG000|Overall Study|Lost to Follow-up|1|||
42119234|NCT00500331|75930135|FG001|Overall Study|Lost to Follow-up|1|||
42119235|NCT00500331|75930136|FG002|Overall Study|Lost to Follow-up|1|||
42119236|NCT00500331|75930137|FG003|Overall Study|Lost to Follow-up|2|||
42119237|NCT00500331|75930138|FG004|Overall Study|Lost to Follow-up|1|||
42119238|NCT00500331|75930139|FG005|Overall Study|Lost to Follow-up|0|||
42119239|NCT00500331|75930140|FG006|Overall Study|Lost to Follow-up|0|||
42119240|NCT00500331|75930134|FG000|Overall Study|Protocol Violation|3|||
42300998|NCT02531035|76136264|FG001|Overall Study|Withdrawal by Subject|32|||
42300999|NCT02531035|76136263|FG000|Overall Study|Lost to Follow-up|8|||
42301000|NCT02531035|76136264|FG001|Overall Study|Lost to Follow-up|10|||
42301001|NCT02531035|76136263|FG000|Overall Study|Randomized, not treated|2|||
42301002|NCT02531035|76136264|FG001|Overall Study|Randomized, not treated|1|||
42301003|NCT01659853|76136280|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
42301004|NCT01659853|76136281|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
42301005|NCT01659853|76136280|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
42301006|NCT01659853|76136281|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
42301007|NCT01660243|76136293|FG000|Overall Study|Adverse Event|1|||
42301008|NCT01660243|76136294|FG001|Overall Study|Adverse Event|0|||
42119241|NCT00500331|75930135|FG001|Overall Study|Protocol Violation|1|||
42119242|NCT00500331|75930136|FG002|Overall Study|Protocol Violation|1|||
42119243|NCT00500331|75930137|FG003|Overall Study|Protocol Violation|0|||
42119244|NCT00500331|75930138|FG004|Overall Study|Protocol Violation|1|||
42119245|NCT00500331|75930139|FG005|Overall Study|Protocol Violation|1|||
42119246|NCT00500331|75930140|FG006|Overall Study|Protocol Violation|1|||
42119247|NCT00500331|75930134|FG000|Overall Study|Withdrawal by Subject|4|||
42119248|NCT00500331|75930135|FG001|Overall Study|Withdrawal by Subject|0|||
42119249|NCT00500331|75930136|FG002|Overall Study|Withdrawal by Subject|1|||
42119250|NCT00500331|75930137|FG003|Overall Study|Withdrawal by Subject|5|||
42119251|NCT00500331|75930138|FG004|Overall Study|Withdrawal by Subject|0|||
42119252|NCT00500331|75930139|FG005|Overall Study|Withdrawal by Subject|1|||
42119253|NCT00500331|75930140|FG006|Overall Study|Withdrawal by Subject|1|||
42119254|NCT00500331|75930134|FG000|Overall Study|Lack of Efficacy|3|||
42119255|NCT00500331|75930135|FG001|Overall Study|Lack of Efficacy|1|||
42119256|NCT00500331|75930136|FG002|Overall Study|Lack of Efficacy|0|||
42119257|NCT00500331|75930137|FG003|Overall Study|Lack of Efficacy|0|||
42119258|NCT00500331|75930138|FG004|Overall Study|Lack of Efficacy|0|||
42119259|NCT00500331|75930139|FG005|Overall Study|Lack of Efficacy|0|||
42119260|NCT00500331|75930140|FG006|Overall Study|Lack of Efficacy|0|||
42119261|NCT00500331|75930134|FG000|Overall Study|Liver function test abnormality|0|||
42119262|NCT00500331|75930135|FG001|Overall Study|Liver function test abnormality|0|||
42119263|NCT00500331|75930136|FG002|Overall Study|Liver function test abnormality|1|||
42301009|NCT01660243|76136295|FG002|Overall Study|Adverse Event|1|||
42301010|NCT01660243|76136296|FG003|Overall Study|Adverse Event|0|||
42301011|NCT01660243|76136293|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
42301012|NCT01660243|76136294|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
42301013|NCT01660243|76136295|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
42346916|NCT01707693|76185934|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
42119264|NCT00500331|75930137|FG003|Overall Study|Liver function test abnormality|0|||
42119265|NCT00500331|75930138|FG004|Overall Study|Liver function test abnormality|0|||
42119266|NCT00500331|75930139|FG005|Overall Study|Liver function test abnormality|0|||
42119267|NCT00500331|75930140|FG006|Overall Study|Liver function test abnormality|0|||
42119268|NCT00500331|75930134|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
42119269|NCT00500331|75930135|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
42119270|NCT00500331|75930136|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
42119271|NCT00500331|75930137|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
42119272|NCT00500331|75930138|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
42119273|NCT00500331|75930139|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
42119274|NCT00500331|75930140|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
42119275|NCT00500331|75930134|FG000|Overall Study|Didn't return for continuation of study|1|||
42119276|NCT00500331|75930135|FG001|Overall Study|Didn't return for continuation of study|0|||
42119277|NCT00500331|75930136|FG002|Overall Study|Didn't return for continuation of study|0|||
42301014|NCT01660243|76136296|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
42301015|NCT01660243|76136293|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
42301016|NCT01660243|76136294|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
42301017|NCT01660243|76136295|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
42346917|NCT01707693|76185933|FG000|Overall Study Allocation|Protocol Violation|4|||
42119278|NCT00500331|75930137|FG003|Overall Study|Didn't return for continuation of study|0|||
42119279|NCT00500331|75930138|FG004|Overall Study|Didn't return for continuation of study|0|||
42119280|NCT00500331|75930139|FG005|Overall Study|Didn't return for continuation of study|0|||
42119281|NCT00500331|75930140|FG006|Overall Study|Didn't return for continuation of study|0|||
42119282|NCT00500331|75930134|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
42119283|NCT00500331|75930135|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
42119284|NCT00500331|75930136|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
42119285|NCT00500331|75930137|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
42119286|NCT00500331|75930138|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
42119287|NCT00500331|75930139|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
42119288|NCT00500331|75930140|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
42119289|NCT00500331|75930134|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
42119290|NCT00500331|75930135|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
42119291|NCT00500331|75930136|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
42119292|NCT00500331|75930137|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
42119293|NCT00500331|75930138|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
42119294|NCT00500331|75930139|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
42119295|NCT00500331|75930140|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
42119296|NCT00500331|75930134|FG000|Overall Study|Participant was randomized by mistake|1|||
42119297|NCT00500331|75930135|FG001|Overall Study|Participant was randomized by mistake|0|||
42119298|NCT00500331|75930136|FG002|Overall Study|Participant was randomized by mistake|0|||
42119299|NCT00500331|75930137|FG003|Overall Study|Participant was randomized by mistake|0|||
42119300|NCT00500331|75930138|FG004|Overall Study|Participant was randomized by mistake|0|||
42119301|NCT00500331|75930139|FG005|Overall Study|Participant was randomized by mistake|0|||
42119302|NCT00500331|75930140|FG006|Overall Study|Participant was randomized by mistake|0|||
42119303|NCT00500331|75930134|FG000|Overall Study|Diabetologist nurse in the study|0|||
42119304|NCT00500331|75930135|FG001|Overall Study|Diabetologist nurse in the study|0|||
42119305|NCT00500331|75930136|FG002|Overall Study|Diabetologist nurse in the study|1|||
42119306|NCT00500331|75930137|FG003|Overall Study|Diabetologist nurse in the study|0|||
42119307|NCT00500331|75930138|FG004|Overall Study|Diabetologist nurse in the study|0|||
42119308|NCT00500331|75930139|FG005|Overall Study|Diabetologist nurse in the study|0|||
42119309|NCT00500331|75930140|FG006|Overall Study|Diabetologist nurse in the study|0|||
42119310|NCT00500331|75930134|FG000|Overall Study|State ban of biological samples export|0|||
42119311|NCT00500331|75930135|FG001|Overall Study|State ban of biological samples export|0|||
42119312|NCT00500331|75930136|FG002|Overall Study|State ban of biological samples export|0|||
42119313|NCT00500331|75930137|FG003|Overall Study|State ban of biological samples export|1|||
42119314|NCT00500331|75930138|FG004|Overall Study|State ban of biological samples export|0|||
42119315|NCT00500331|75930139|FG005|Overall Study|State ban of biological samples export|0|||
42119316|NCT00500331|75930140|FG006|Overall Study|State ban of biological samples export|0|||
42119317|NCT00500331|75930134|FG000|Overall Study|Protocol violated|0|||
42119318|NCT00500331|75930135|FG001|Overall Study|Protocol violated|0|||
42119319|NCT00500331|75930136|FG002|Overall Study|Protocol violated|0|||
42119320|NCT00500331|75930137|FG003|Overall Study|Protocol violated|1|||
42119321|NCT00500331|75930138|FG004|Overall Study|Protocol violated|0|||
42119322|NCT00500331|75930139|FG005|Overall Study|Protocol violated|0|||
42119323|NCT00500331|75930140|FG006|Overall Study|Protocol violated|0|||
42119324|NCT00499863|75930159|FG000|Overall Study|Lack of Efficacy|21|||
42119325|NCT00499863|75930160|FG001|Overall Study|Lack of Efficacy|27|||
42119326|NCT00499863|75930159|FG000|Overall Study|Protocol Violation|12|||
42119327|NCT00499863|75930160|FG001|Overall Study|Protocol Violation|7|||
42119328|NCT00499863|75930159|FG000|Overall Study|Withdrawal by Subject|6|||
42119329|NCT00499863|75930160|FG001|Overall Study|Withdrawal by Subject|4|||
42119330|NCT00499863|75930159|FG000|Overall Study|Adverse Event|8|||
42119331|NCT00499863|75930160|FG001|Overall Study|Adverse Event|2|||
42119332|NCT00499863|75930159|FG000|Overall Study|Sponsor decision|2|||
42119333|NCT00499863|75930160|FG001|Overall Study|Sponsor decision|2|||
42119334|NCT00499863|75930159|FG000|Overall Study|Lost to Follow-up|1|||
42119335|NCT00499863|75930160|FG001|Overall Study|Lost to Follow-up|1|||
42119336|NCT00484185|75930166|FG000|Overall Study|Lost to Follow-up|44|||
42119337|NCT00484185|75930166|FG000|Overall Study|Other|20|||
42119338|NCT00484185|75930166|FG000|Overall Study|Randomized but not treated|5|||
42119339|NCT00484185|75930166|FG000|Overall Study|Death|2|||
42119340|NCT00097981|75930172|FG000|Overall Study|Adverse Event|31|||
42119341|NCT00097981|75930173|FG001|Overall Study|Adverse Event|44|||
42119342|NCT00097981|75930172|FG000|Overall Study|Withdrawal by Subject|10|||
42119343|NCT00097981|75930173|FG001|Overall Study|Withdrawal by Subject|8|||
42119344|NCT00097981|75930172|FG000|Overall Study|Protocol Violation|1|||
42119345|NCT00097981|75930173|FG001|Overall Study|Protocol Violation|1|||
42119346|NCT00097981|75930172|FG000|Overall Study|Death|2|||
42119347|NCT00097981|75930173|FG001|Overall Study|Death|4|||
42119348|NCT00097981|75930172|FG000|Overall Study|Physician Decision|7|||
42119349|NCT00097981|75930173|FG001|Overall Study|Physician Decision|1|||
42119350|NCT00097981|75930172|FG000|Overall Study|Disease Progression|8|||
42119351|NCT00097981|75930173|FG001|Overall Study|Disease Progression|2|||
42119352|NCT00097981|75930172|FG000|Overall Study|Transplant planned|28|||
42119353|NCT00097981|75930173|FG001|Overall Study|Transplant planned|27|||
42119354|NCT00097981|75930172|FG000|Overall Study|Other|19|||
42119355|NCT00097981|75930173|FG001|Overall Study|Other|13|||
42119356|NCT00572195|75930179|FG000|Overall Study|Withdrawal by Subject|50|||
42119357|NCT00572195|75930179|FG000|Overall Study|Death|9|||
42119358|NCT00572195|75930179|FG000|Overall Study|Adverse Event|4|||
42119359|NCT00572195|75930179|FG000|Overall Study|Lost to Follow-up|5|||
42119360|NCT00572039|75930185|FG000|Overall Study|Withdrawal by Subject|9|||
42119361|NCT00572039|75930186|FG001|Overall Study|Withdrawal by Subject|6|||
42119362|NCT00572039|75930185|FG000|Overall Study|Death|2|||
42119363|NCT00572039|75930186|FG001|Overall Study|Death|3|||
42119364|NCT00572039|75930185|FG000|Overall Study|Ill|5|||
42119365|NCT00572039|75930186|FG001|Overall Study|Ill|1|||
42119366|NCT00684593|75930196|FG000|Overall Study|Adverse Event|0|||
42119367|NCT00684593|75930197|FG001|Overall Study|Adverse Event|2|||
42119368|NCT00685373|75930203|FG000|Overall Study|Adverse Event|3|||
42119369|NCT00685373|75930203|FG000|Overall Study|Withdrawal by Subject|5|||
42119370|NCT00685373|75930203|FG000|Overall Study|Lack of Efficacy|3|||
42119371|NCT00685373|75930203|FG000|Overall Study|Condition no longer requires study drug|1|||
42119372|NCT00685373|75930203|FG000|Overall Study|Lost to Follow-up|2|||
42119373|NCT00685373|75930203|FG000|Overall Study|Protocol Violation|1|||
42119374|NCT00684515|75930210|FG000|Overall Study|Adverse Event|3|||
42119375|NCT00684515|75930211|FG001|Overall Study|Adverse Event|3|||
42119376|NCT00684515|75930212|FG002|Overall Study|Adverse Event|1|||
42119377|NCT00684515|75930210|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
42119378|NCT00684515|75930211|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
42119379|NCT00684515|75930212|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
42119380|NCT00490815|75930222|FG000|Overall Study|Adverse Event|2|||
42119381|NCT00490815|75930223|FG001|Overall Study|Adverse Event|3|||
42119382|NCT00490815|75930222|FG000|Overall Study|Withdrawal by Subject|4|||
42119383|NCT00490815|75930223|FG001|Overall Study|Withdrawal by Subject|0|||
42119384|NCT00490815|75930222|FG000|Overall Study|Lost to Follow-up|1|||
42119385|NCT00490815|75930223|FG001|Overall Study|Lost to Follow-up|3|||
42119386|NCT00490815|75930222|FG000|Overall Study|Death|1|||
42119387|NCT00490815|75930223|FG001|Overall Study|Death|3|||
42119388|NCT03855189|75930232|FG000|Overall Study|Adverse Event|5|||
42119389|NCT03855189|75930233|FG001|Overall Study|Adverse Event|2|||
42346918|NCT01707693|76185934|FG001|Overall Study Allocation|Protocol Violation|3|||
42026558|NCT01147068|75834496|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
42026559|NCT01147068|75834497|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
42026560|NCT01147068|75834498|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
42026561|NCT01147068|75834499|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
42026562|NCT01147068|75834500|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
42026563|NCT01147068|75834501|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
42026564|NCT01147068|75834495|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
42026565|NCT01147068|75834496|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
42026566|NCT01147068|75834497|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
42026567|NCT01147068|75834498|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
42026568|NCT01147068|75834499|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
42119390|NCT03855189|75930234|FG002|Overall Study|Adverse Event|4|||
42119391|NCT03855189|75930232|FG000|Overall Study|Treatment Failure|1|||
42119392|NCT03855189|75930233|FG001|Overall Study|Treatment Failure|1|||
42119393|NCT03855189|75930234|FG002|Overall Study|Treatment Failure|2|||
42119394|NCT03855189|75930232|FG000|Overall Study|Noncompliance with Protocol|0|||
42119395|NCT03855189|75930233|FG001|Overall Study|Noncompliance with Protocol|1|||
42119396|NCT03855189|75930234|FG002|Overall Study|Noncompliance with Protocol|0|||
42119397|NCT03855189|75930232|FG000|Overall Study|Did Not Return|4|||
42119398|NCT03855189|75930233|FG001|Overall Study|Did Not Return|3|||
42119399|NCT03855189|75930234|FG002|Overall Study|Did Not Return|0|||
42119400|NCT03853551|75930242|FG000|Overall Study|Death|2|||
42119401|NCT03853551|75930242|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
42119402|NCT00423670|75930253|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
42119403|NCT00423670|75930254|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
42119404|NCT00423670|75930255|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
42119405|NCT00423670|75930256|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
42119406|NCT00423670|75930257|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
42119407|NCT00423670|75930258|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
42119408|NCT00423670|75930259|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
42119409|NCT00423670|75930260|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
42119410|NCT00423670|75930253|FG000|Treatment Period|Adverse Event|8|||
41963505|NCT02407236|75747321|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
41963506|NCT02407236|75747322|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
41963507|NCT02407236|75747323|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
41963508|NCT02407236|75747324|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
41963509|NCT02407236|75747325|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
41963510|NCT02407236|75747326|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
41963511|NCT02407236|75747327|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
41963512|NCT02407236|75747328|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
41963513|NCT02407236|75747329|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
41963514|NCT02407236|75747330|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
41963515|NCT02407236|75747331|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
41963516|NCT02407236|75747332|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
41963517|NCT02407236|75747320|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
41963518|NCT02407236|75747321|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
41963519|NCT02407236|75747322|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
41963520|NCT02407236|75747323|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
41963521|NCT02407236|75747324|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
41963522|NCT02407236|75747325|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
42119411|NCT00423670|75930254|FG001|Treatment Period|Adverse Event|12|||
42119412|NCT00423670|75930255|FG002|Treatment Period|Adverse Event|15|||
42119413|NCT00423670|75930256|FG003|Treatment Period|Adverse Event|20|||
42119414|NCT00423670|75930257|FG004|Treatment Period|Adverse Event|9|||
42119415|NCT00423670|75930258|FG005|Treatment Period|Adverse Event|4|||
42119416|NCT00423670|75930259|FG006|Treatment Period|Adverse Event|7|||
42119417|NCT00423670|75930260|FG007|Treatment Period|Adverse Event|2|||
42119418|NCT00423670|75930253|FG000|Treatment Period|Protocol-defined clinical event|0|||
42119419|NCT00423670|75930254|FG001|Treatment Period|Protocol-defined clinical event|7|||
42119420|NCT00423670|75930255|FG002|Treatment Period|Protocol-defined clinical event|4|||
42119421|NCT00423670|75930256|FG003|Treatment Period|Protocol-defined clinical event|12|||
42119422|NCT00423670|75930257|FG004|Treatment Period|Protocol-defined clinical event|5|||
42119423|NCT00423670|75930258|FG005|Treatment Period|Protocol-defined clinical event|4|||
42119424|NCT00423670|75930259|FG006|Treatment Period|Protocol-defined clinical event|16|||
42119425|NCT00423670|75930260|FG007|Treatment Period|Protocol-defined clinical event|15|||
42119426|NCT00423670|75930253|FG000|Treatment Period|Lost to Follow-up|2|||
42119427|NCT00423670|75930254|FG001|Treatment Period|Lost to Follow-up|1|||
42119428|NCT00423670|75930255|FG002|Treatment Period|Lost to Follow-up|3|||
42119429|NCT00423670|75930256|FG003|Treatment Period|Lost to Follow-up|1|||
42119430|NCT00423670|75930257|FG004|Treatment Period|Lost to Follow-up|6|||
42119431|NCT00423670|75930258|FG005|Treatment Period|Lost to Follow-up|0|||
42119432|NCT00423670|75930259|FG006|Treatment Period|Lost to Follow-up|3|||
42119433|NCT00423670|75930260|FG007|Treatment Period|Lost to Follow-up|1|||
41963523|NCT02407236|75747326|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
42119434|NCT00423670|75930253|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
42119435|NCT00423670|75930254|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
42119436|NCT00423670|75930255|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
42119437|NCT00423670|75930256|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
42119438|NCT00423670|75930257|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
42119439|NCT00423670|75930258|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
42119440|NCT00423670|75930259|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
42119441|NCT00423670|75930260|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
42119442|NCT00423670|75930253|FG000|Treatment Period|Investigator decision|0|||
42119443|NCT00423670|75930254|FG001|Treatment Period|Investigator decision|0|||
42119444|NCT00423670|75930255|FG002|Treatment Period|Investigator decision|0|||
42119445|NCT00423670|75930256|FG003|Treatment Period|Investigator decision|0|||
42119446|NCT00423670|75930257|FG004|Treatment Period|Investigator decision|0|||
42119447|NCT00423670|75930258|FG005|Treatment Period|Investigator decision|0|||
42119448|NCT00423670|75930259|FG006|Treatment Period|Investigator decision|0|||
42119449|NCT00423670|75930260|FG007|Treatment Period|Investigator decision|1|||
42119450|NCT00423670|75930253|FG000|Treatment Period|Non-compliance with protocol|3|||
42119451|NCT00423670|75930254|FG001|Treatment Period|Non-compliance with protocol|1|||
42119452|NCT00423670|75930255|FG002|Treatment Period|Non-compliance with protocol|1|||
42119453|NCT00423670|75930256|FG003|Treatment Period|Non-compliance with protocol|3|||
42119454|NCT00423670|75930257|FG004|Treatment Period|Non-compliance with protocol|2|||
42119455|NCT00423670|75930258|FG005|Treatment Period|Non-compliance with protocol|0|||
42119456|NCT00423670|75930259|FG006|Treatment Period|Non-compliance with protocol|2|||
42119457|NCT00423670|75930260|FG007|Treatment Period|Non-compliance with protocol|2|||
42119458|NCT00423670|75930253|FG000|Follow-up Period|Lost to Follow-up|0|||
42119459|NCT00423670|75930254|FG001|Follow-up Period|Lost to Follow-up|12|||
42119460|NCT00423670|75930255|FG002|Follow-up Period|Lost to Follow-up|8|||
42119461|NCT00423670|75930256|FG003|Follow-up Period|Lost to Follow-up|3|||
42119462|NCT00423670|75930257|FG004|Follow-up Period|Lost to Follow-up|1|||
42119463|NCT00423670|75930258|FG005|Follow-up Period|Lost to Follow-up|0|||
42119464|NCT00423670|75930259|FG006|Follow-up Period|Lost to Follow-up|5|||
42119465|NCT00423670|75930260|FG007|Follow-up Period|Lost to Follow-up|0|||
42119466|NCT00423670|75930253|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
42119467|NCT00423670|75930254|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
42119468|NCT00423670|75930255|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
42119469|NCT00423670|75930256|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
42119470|NCT00423670|75930257|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
42119471|NCT00423670|75930258|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
42119472|NCT00423670|75930259|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
42119473|NCT00423670|75930260|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
42119474|NCT00423670|75930253|FG000|Follow-up Period|Non-compliance with protocol|2|||
42119475|NCT00423670|75930254|FG001|Follow-up Period|Non-compliance with protocol|0|||
42119476|NCT00423670|75930255|FG002|Follow-up Period|Non-compliance with protocol|1|||
42119477|NCT00423670|75930256|FG003|Follow-up Period|Non-compliance with protocol|1|||
42119478|NCT00423670|75930257|FG004|Follow-up Period|Non-compliance with protocol|0|||
42119479|NCT00423670|75930258|FG005|Follow-up Period|Non-compliance with protocol|0|||
42119480|NCT00423670|75930259|FG006|Follow-up Period|Non-compliance with protocol|3|||
42119481|NCT00423670|75930260|FG007|Follow-up Period|Non-compliance with protocol|2|||
42119482|NCT00483717|75930283|FG000|Overall Study|Protocol Violation|5|||
42119483|NCT00483717|75930284|FG001|Overall Study|Protocol Violation|7|||
42119484|NCT00483717|75930283|FG000|Overall Study|Time of dosing missing|1|||
42119485|NCT00483717|75930284|FG001|Overall Study|Time of dosing missing|1|||
42119486|NCT00483717|75930283|FG000|Overall Study|No treatment for migraine|16|||
42119487|NCT00483717|75930284|FG001|Overall Study|No treatment for migraine|13|||
42119488|NCT00483717|75930283|FG000|Overall Study|Lost to Follow-up|1|||
42119489|NCT00483717|75930284|FG001|Overall Study|Lost to Follow-up|0|||
42119490|NCT00483717|75930283|FG000|Overall Study|Withdrawal by Subject|1|||
42119491|NCT00483717|75930284|FG001|Overall Study|Withdrawal by Subject|0|||
42119492|NCT00406354|75930293|FG000|All Randomized Patients|Protocol Violation|0|||
42119493|NCT00406354|75930294|FG001|All Randomized Patients|Protocol Violation|0|||
42119494|NCT00406354|75930295|FG002|All Randomized Patients|Protocol Violation|1|||
42119495|NCT00406354|75930293|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
42119496|NCT00406354|75930294|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
42119497|NCT00406354|75930295|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
42119498|NCT00406354|75930293|FG000|All Randomized and Treated Patients|Adverse Event|6|||
42119499|NCT00406354|75930294|FG001|All Randomized and Treated Patients|Adverse Event|2|||
42119500|NCT00406354|75930295|FG002|All Randomized and Treated Patients|Adverse Event|1|||
42119501|NCT00406354|75930293|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
42301018|NCT01660243|76136296|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
42119502|NCT00406354|75930294|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
42119503|NCT00406354|75930295|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
42119504|NCT00406354|75930293|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
42119505|NCT00406354|75930294|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
42119506|NCT00406354|75930295|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
42119507|NCT00406354|75930293|FG000|All Randomized and Treated Patients|Physician Decision|0|||
42119508|NCT00406354|75930294|FG001|All Randomized and Treated Patients|Physician Decision|0|||
42119509|NCT00406354|75930295|FG002|All Randomized and Treated Patients|Physician Decision|1|||
42119510|NCT00483405|75930303|FG000|Overall Study|Adverse Event|8|||
42119511|NCT00483405|75930303|FG000|Overall Study|Lack of Efficacy|14|||
42119512|NCT00483405|75930303|FG000|Overall Study|Death|3|||
42119513|NCT00483405|75930303|FG000|Overall Study|Withdrawal by Subject|2|||
42119514|NCT00483405|75930303|FG000|Overall Study|Other complicating disease|1|||
42119515|NCT00483327|75930311|FG000|Overall Study|Adverse Event|1|||
42119516|NCT00483327|75930311|FG000|Overall Study|Withdrawal by Subject|3|||
42119517|NCT00483327|75930311|FG000|Overall Study|Lost to Follow-up|4|||
42119518|NCT00483327|75930311|FG000|Overall Study|Patient Non Compliance|2|||
42119519|NCT00684203|75930323|FG000|Overall Study|Adverse Event|6|||
42119520|NCT00684203|75930324|FG001|Overall Study|Adverse Event|4|||
42119521|NCT00684203|75930325|FG002|Overall Study|Adverse Event|8|||
42119522|NCT00684203|75930326|FG003|Overall Study|Adverse Event|0|||
42119523|NCT00684203|75930327|FG004|Overall Study|Adverse Event|0|||
42119524|NCT00684203|75930328|FG005|Overall Study|Adverse Event|0|||
42119525|NCT00684203|75930323|FG000|Overall Study|Protocol-defined clinical event|3|||
42119526|NCT00684203|75930324|FG001|Overall Study|Protocol-defined clinical event|1|||
42119527|NCT00684203|75930325|FG002|Overall Study|Protocol-defined clinical event|0|||
42119528|NCT00684203|75930326|FG003|Overall Study|Protocol-defined clinical event|0|||
42119529|NCT00684203|75930327|FG004|Overall Study|Protocol-defined clinical event|0|||
42119530|NCT00684203|75930328|FG005|Overall Study|Protocol-defined clinical event|0|||
42119531|NCT00684203|75930323|FG000|Overall Study|Withdrawal by Subject|0|||
42119532|NCT00684203|75930324|FG001|Overall Study|Withdrawal by Subject|2|||
42301019|NCT01660243|76136293|FG000|Overall Study|Randomization error|0|||
42301020|NCT01660243|76136294|FG001|Overall Study|Randomization error|0|||
41963524|NCT02407236|75747327|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
41963525|NCT02407236|75747328|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
41963526|NCT02407236|75747329|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
42026569|NCT01147068|75834500|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
42026570|NCT01147068|75834501|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
42026571|NCT01147068|75834495|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
42026572|NCT01147068|75834496|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
42026573|NCT01147068|75834497|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
42026574|NCT01147068|75834498|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
42026575|NCT01147068|75834499|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
42026576|NCT01147068|75834500|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
42026577|NCT01147068|75834501|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
42026578|NCT01146912|75834524|FG000|Overall Study|Already received influenza vaccination|817|||
42026579|NCT01146912|75834525|FG001|Overall Study|Already received influenza vaccination|822|||
42026580|NCT01146912|75834526|FG002|Overall Study|Already received influenza vaccination|13|||
42026581|NCT01146912|75834527|FG003|Overall Study|Already received influenza vaccination|15|||
42026582|NCT01146912|75834528|FG004|Overall Study|Already received influenza vaccination|41|||
42026583|NCT01146912|75834529|FG005|Overall Study|Already received influenza vaccination|61|||
42026584|NCT01146912|75834530|FG006|Overall Study|Already received influenza vaccination|56|||
42026585|NCT01146912|75834531|FG007|Overall Study|Already received influenza vaccination|0|||
42026586|NCT01146912|75834524|FG000|Overall Study|< 14 weeks gestational age|0|||
42026587|NCT01146912|75834525|FG001|Overall Study|< 14 weeks gestational age|0|||
42119533|NCT00684203|75930325|FG002|Overall Study|Withdrawal by Subject|1|||
42119534|NCT00684203|75930326|FG003|Overall Study|Withdrawal by Subject|0|||
41963527|NCT02407236|75747330|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
41963528|NCT02407236|75747331|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
41963529|NCT02407236|75747332|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
41963530|NCT02407236|75747320|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
41963531|NCT02407236|75747321|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
41963532|NCT02407236|75747322|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
41963533|NCT02407236|75747323|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
41963534|NCT02407236|75747324|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
41963535|NCT02407236|75747325|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
42119535|NCT00684203|75930327|FG004|Overall Study|Withdrawal by Subject|0|||
42119536|NCT00684203|75930328|FG005|Overall Study|Withdrawal by Subject|0|||
42301021|NCT01660243|76136295|FG002|Overall Study|Randomization error|0|||
42119537|NCT00684203|75930323|FG000|Overall Study|Did not meet protocol eligibility|0|||
42119538|NCT00684203|75930324|FG001|Overall Study|Did not meet protocol eligibility|1|||
42301022|NCT01660243|76136296|FG003|Overall Study|Randomization error|1|||
42119539|NCT00684203|75930325|FG002|Overall Study|Did not meet protocol eligibility|0|||
42119540|NCT00684203|75930326|FG003|Overall Study|Did not meet protocol eligibility|0|||
42119541|NCT00684203|75930327|FG004|Overall Study|Did not meet protocol eligibility|0|||
42119542|NCT00684203|75930328|FG005|Overall Study|Did not meet protocol eligibility|0|||
42119543|NCT00423592|75930349|FG000|Overall Study|Adverse Event (through Week 12)|2|||
42119544|NCT00423592|75930349|FG000|Overall Study|Adverse Event (post Week 12)|5|||
42119545|NCT00683657|75930355|FG000|Overall Study|Adverse Event|0|||
42119546|NCT00683657|75930356|FG001|Overall Study|Adverse Event|1|||
42119547|NCT00683657|75930355|FG000|Overall Study|Subject Withdrew Consent|1|||
42119548|NCT00683657|75930356|FG001|Overall Study|Subject Withdrew Consent|0|||
42119549|NCT00680771|75930364|FG000|Overall Study|Withdrawal by Subject|1|||
42119550|NCT00680771|75930365|FG001|Overall Study|Withdrawal by Subject|0|||
42119551|NCT00680771|75930364|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
42119552|NCT00680771|75930365|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
41963536|NCT02407236|75747326|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
42119553|NCT00680771|75930364|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
42119554|NCT00680771|75930365|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
42119555|NCT00482703|75930373|FG000|Overall Study|Poor compliance|1|||
42119556|NCT00482703|75930374|FG001|Overall Study|Poor compliance|0|||
42119557|NCT00482391|75930387|FG000|Overall Study|Withdrawal by Subject|1|||
42119558|NCT00482391|75930387|FG000|Overall Study|Adverse Event|1|||
42119559|NCT00482391|75930387|FG000|Overall Study|Death|1|||
42119560|NCT00423046|75930394|FG000|Overall Study|Other|340|||
42119561|NCT00423046|75930395|FG001|Overall Study|Other|345|||
42119562|NCT00496587|75930403|FG000|Overall Study|Adverse Event|2|||
42119563|NCT00496587|75930403|FG000|Overall Study|Progressive Disease|24|||
42119564|NCT00496587|75930403|FG000|Overall Study|Withdrawal by Subject|2|||
42119565|NCT00496587|75930403|FG000|Overall Study|Death|1|||
42119566|NCT00496587|75930403|FG000|Overall Study|Complications unrelated|2|||
42119567|NCT00405652|75930407|FG000|Overall Study|Adverse Event|4|||
42119568|NCT00422734|75930413|FG000|Overall Study|Physician Decision|1|||
42119569|NCT00422734|75930414|FG001|Overall Study|Physician Decision|1|||
42119570|NCT00422734|75930413|FG000|Overall Study|Protocol Violation|1|||
42119571|NCT00422734|75930414|FG001|Overall Study|Protocol Violation|6|||
42119572|NCT00422734|75930413|FG000|Overall Study|Withdrawal by Subject|12|||
42119573|NCT00422734|75930414|FG001|Overall Study|Withdrawal by Subject|8|||
41963537|NCT02407236|75747327|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
41963538|NCT02407236|75747328|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
41963539|NCT02407236|75747329|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
41963540|NCT02407236|75747330|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
41963541|NCT02407236|75747331|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
42119574|NCT00422734|75930413|FG000|Overall Study|Adverse Event|0|||
42119575|NCT00422734|75930414|FG001|Overall Study|Adverse Event|3|||
41963542|NCT02407236|75747332|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
41963543|NCT01893138|75747360|FG000|Double-Blind Period|Withdrawal by Subject|1|||
41963544|NCT01893138|75747361|FG001|Double-Blind Period|Withdrawal by Subject|1|||
41963545|NCT01893138|75747360|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
42119576|NCT00422734|75930413|FG000|Overall Study|Partner Decision|0|||
42119577|NCT00422734|75930414|FG001|Overall Study|Partner Decision|3|||
42119578|NCT00422422|75930420|FG000|Overall Study|Lack of Efficacy|1|||
42119579|NCT00422422|75930420|FG000|Overall Study|Protocol Violation|1|||
42119580|NCT00422422|75930420|FG000|Overall Study|Withdrawal by Subject|2|||
42119581|NCT00422422|75930420|FG000|Overall Study|SAE, non-fatal|1|||
42119582|NCT00422422|75930420|FG000|Overall Study|AE, non-serious non-fatal|5|||
42119583|NCT00413374|75930428|FG000|Overall Study|Ineligible due to screening criteria.|3|||
41963546|NCT01893138|75747361|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
41963547|NCT01893138|75747360|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
41963548|NCT01893138|75747361|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
41963549|NCT01893138|75747360|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
42119584|NCT00413374|75930429|FG001|Overall Study|Ineligible due to screening criteria.|0|||
42119585|NCT00413374|75930428|FG000|Overall Study|Adverse Event|1|||
42119586|NCT00413374|75930429|FG001|Overall Study|Adverse Event|0|||
42119587|NCT00413374|75930428|FG000|Overall Study|Lost to Follow-up|1|||
42119588|NCT00413374|75930429|FG001|Overall Study|Lost to Follow-up|0|||
42119589|NCT00413374|75930428|FG000|Overall Study|Surgery|1|||
42119590|NCT00413374|75930429|FG001|Overall Study|Surgery|0|||
42119591|NCT00682643|75930440|FG000|Overall Study|Adverse Event|12|||
42119592|NCT00682643|75930441|FG001|Overall Study|Adverse Event|23|||
42119593|NCT00682643|75930440|FG000|Overall Study|Lack of Efficacy|2|||
42119594|NCT00682643|75930441|FG001|Overall Study|Lack of Efficacy|0|||
42119595|NCT00682643|75930440|FG000|Overall Study|Protocol Violation|38|||
42119596|NCT00682643|75930441|FG001|Overall Study|Protocol Violation|76|||
42119597|NCT00682643|75930440|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
42119598|NCT00682643|75930441|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
41963550|NCT01893138|75747361|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
42119599|NCT00682643|75930440|FG000|Overall Study|Lost to Follow-up|1|||
41963551|NCT01893138|75747360|FG000|Open Label - Unblinded Period|Adverse Event|1|||
41963552|NCT01893138|75747361|FG001|Open Label - Unblinded Period|Adverse Event|0|||
41963553|NCT04309500|75747373|FG000|Overall Study|Lost to Follow-up|1|||
41963554|NCT04309500|75747374|FG001|Overall Study|Lost to Follow-up|0|||
41963555|NCT04309500|75747375|FG002|Overall Study|Lost to Follow-up|0|||
41963556|NCT04309500|75747376|FG003|Overall Study|Lost to Follow-up|0|||
41963557|NCT03671304|75748711|FG000|Overall Study|study terminated|7|||
41963558|NCT03447990|75748722|FG000|Overall Study|Withdrawal by Subject|0|||
42119600|NCT00682643|75930441|FG001|Overall Study|Lost to Follow-up|6|||
42119601|NCT00682643|75930440|FG000|Overall Study|Physician Decision|2|||
42119602|NCT00682643|75930441|FG001|Overall Study|Physician Decision|6|||
42119603|NCT00682643|75930440|FG000|Overall Study|Withdrawal by Subject|19|||
42119604|NCT00682643|75930441|FG001|Overall Study|Withdrawal by Subject|53|||
42119605|NCT00682643|75930440|FG000|Overall Study|Did Not Receive Study Drug|1|||
42119606|NCT00682643|75930441|FG001|Overall Study|Did Not Receive Study Drug|1|||
42119607|NCT00421408|75930450|FG000|Overall Study|Lost to Follow-up|30|||
42119608|NCT00421408|75930451|FG001|Overall Study|Lost to Follow-up|20|||
42119609|NCT00421408|75930450|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
42119610|NCT00421408|75930451|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
42119611|NCT00679913|75930459|FG000|Overall Study|Protocol Violation|18|||
42119612|NCT00679913|75930460|FG001|Overall Study|Protocol Violation|13|||
42119613|NCT00482001|75930469|FG000|Overall Study|Protocol Violation|1|||
42119614|NCT00482001|75930470|FG001|Overall Study|Protocol Violation|1|||
42119615|NCT00490035|75930482|FG000|Overall Study|AE, non-serious non-fatal|3|||
42119616|NCT00490035|75930483|FG001|Overall Study|AE, non-serious non-fatal|4|||
42119617|NCT00490035|75930484|FG002|Overall Study|AE, non-serious non-fatal|4|||
42119618|NCT00490035|75930485|FG003|Overall Study|AE, non-serious non-fatal|5|||
42119619|NCT00490035|75930482|FG000|Overall Study|Lost to Follow-up|2|||
42119620|NCT00490035|75930483|FG001|Overall Study|Lost to Follow-up|0|||
42119621|NCT00490035|75930484|FG002|Overall Study|Lost to Follow-up|1|||
42119622|NCT00490035|75930485|FG003|Overall Study|Lost to Follow-up|0|||
42119623|NCT00490035|75930482|FG000|Overall Study|Withdrawal by Subject|2|||
42119624|NCT00490035|75930483|FG001|Overall Study|Withdrawal by Subject|1|||
42119625|NCT00490035|75930484|FG002|Overall Study|Withdrawal by Subject|1|||
42119626|NCT00490035|75930485|FG003|Overall Study|Withdrawal by Subject|0|||
42119627|NCT00490035|75930482|FG000|Overall Study|Other reason|0|||
41963559|NCT03447990|75748723|FG001|Overall Study|Withdrawal by Subject|0|||
41963560|NCT03447990|75748724|FG002|Overall Study|Withdrawal by Subject|0|||
41963561|NCT03447990|75748725|FG003|Overall Study|Withdrawal by Subject|0|||
41963562|NCT03447990|75748726|FG004|Overall Study|Withdrawal by Subject|0|||
41963563|NCT03447990|75748727|FG005|Overall Study|Withdrawal by Subject|0|||
41963564|NCT03447990|75748728|FG006|Overall Study|Withdrawal by Subject|1|||
41963565|NCT01376778|75748780|FG000|Overall Study|Lost to Follow-up|3|||
41963566|NCT01376778|75748781|FG001|Overall Study|Lost to Follow-up|2|||
41963567|NCT01074294|75748790|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
41963568|NCT01074294|75748791|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
41963569|NCT01074294|75748792|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
41963570|NCT01074294|75748793|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
41963571|NCT01074294|75748790|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
41963572|NCT01074294|75748791|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
41963573|NCT01074294|75748792|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
42119628|NCT00490035|75930483|FG001|Overall Study|Other reason|1|||
42119629|NCT00490035|75930484|FG002|Overall Study|Other reason|3|||
42119630|NCT00490035|75930485|FG003|Overall Study|Other reason|1|||
42119631|NCT00490035|75930482|FG000|Overall Study|AE, serious fatal|1|||
42119632|NCT00490035|75930483|FG001|Overall Study|AE, serious fatal|0|||
42119633|NCT00490035|75930484|FG002|Overall Study|AE, serious fatal|0|||
42119634|NCT00490035|75930485|FG003|Overall Study|AE, serious fatal|0|||
42119635|NCT00490035|75930482|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
42301023|NCT02531113|76136306|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
42301024|NCT02531113|76136306|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
42301025|NCT02531113|76136306|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
42301026|NCT02531113|76136306|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
42301027|NCT02531113|76136306|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
42301028|NCT02531113|76136306|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
42301029|NCT02531113|76136306|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
42301030|NCT02531113|76136306|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
42301031|NCT02522767|76136316|FG000|Double-blind|Withdrawal by Subject|8|||
41963574|NCT01074294|75748793|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
42119636|NCT00490035|75930483|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
41963575|NCT01074294|75748790|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
42119637|NCT00490035|75930484|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
42119638|NCT00490035|75930485|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
42301032|NCT02522767|76136317|FG001|Double-blind|Withdrawal by Subject|11|||
42301033|NCT02522767|76136316|FG000|Double-blind|Lost to Follow-up|1|||
42119639|NCT00490035|75930482|FG000|Overall Study|AE of unknown type|0|||
42119640|NCT00490035|75930483|FG001|Overall Study|AE of unknown type|0|||
42119641|NCT00490035|75930484|FG002|Overall Study|AE of unknown type|2|||
42119642|NCT00490035|75930485|FG003|Overall Study|AE of unknown type|0|||
42301034|NCT02522767|76136317|FG001|Double-blind|Lost to Follow-up|0|||
42119643|NCT00404248|75930498|FG000|Overall Study|pts declining status|0|||
42119644|NCT00404248|75930499|FG001|Overall Study|pts declining status|1|||
42119645|NCT00404248|75930500|FG002|Overall Study|pts declining status|0|||
42119646|NCT00404248|75930501|FG003|Overall Study|pts declining status|0|||
42119647|NCT00404248|75930502|FG004|Overall Study|pts declining status|0|||
42119648|NCT00404248|75930503|FG005|Overall Study|pts declining status|0|||
42119649|NCT00404248|75930504|FG006|Overall Study|pts declining status|0|||
42119650|NCT00404248|75930505|FG007|Overall Study|pts declining status|0|||
42119651|NCT00404248|75930506|FG008|Overall Study|pts declining status|0|||
42119652|NCT00421174|75930534|FG000|Overall Study|Withdrawal by Subject|0|||
42119653|NCT00421174|75930535|FG001|Overall Study|Withdrawal by Subject|1|||
42119654|NCT00421174|75930534|FG000|Overall Study|Ineligible due to infection|2|||
42119655|NCT00421174|75930535|FG001|Overall Study|Ineligible due to infection|0|||
42119656|NCT00496197|75930541|FG000|Overall Study|Discontinued study due to death|43|||
42119657|NCT00496197|75930541|FG000|Overall Study|Adverse Event|13|||
42119658|NCT00496197|75930541|FG000|Overall Study|Does not meet entrance criteria|5|||
42119659|NCT00496197|75930541|FG000|Overall Study|Insufficient clinical response|3|||
42119660|NCT00496197|75930541|FG000|Overall Study|Insufficient bacteriological response|10|||
42119661|NCT00496197|75930541|FG000|Overall Study|Lost to Follow-up|11|||
42119662|NCT00496197|75930541|FG000|Overall Study|Withdrawal by Subject|11|||
42119663|NCT00496197|75930541|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
42119664|NCT00496197|75930541|FG000|Overall Study|Other|14|||
42119665|NCT00496197|75930541|FG000|Overall Study|Protocol Violation|8|||
42119666|NCT00495495|75930545|FG000|Overall Study|Protocol Violation|99|||
42301035|NCT02522767|76136316|FG000|Double-blind|Adverse Event|1|||
42301036|NCT02522767|76136317|FG001|Double-blind|Adverse Event|10|||
42119667|NCT00404092|75930554|FG000|Overall Study|Death|1|||
42119668|NCT00404092|75930555|FG001|Overall Study|Death|0|||
42119669|NCT00404092|75930556|FG002|Overall Study|Death|0|||
41963576|NCT01074294|75748791|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
41963577|NCT01074294|75748792|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
41963578|NCT01074294|75748793|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
41963579|NCT01074294|75748790|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
41963580|NCT01074294|75748791|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
41963581|NCT01074294|75748792|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
41963582|NCT01074294|75748793|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
41963583|NCT01074294|75748790|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
41963584|NCT01074294|75748791|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
41963585|NCT01074294|75748792|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
41963586|NCT01074294|75748793|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
41963587|NCT01074294|75748790|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
41963588|NCT01074294|75748791|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
41963589|NCT01074294|75748792|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
41963590|NCT01074294|75748793|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
41963591|NCT01074294|75748790|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
41963592|NCT01074294|75748791|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
41963593|NCT01074294|75748792|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
41963594|NCT01074294|75748793|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
41963595|NCT01074294|75748790|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
41963596|NCT01074294|75748791|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
41963597|NCT01074294|75748792|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
41963598|NCT01074294|75748793|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
41963599|NCT01074294|75748790|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
41963600|NCT01074294|75748791|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
41963601|NCT01074294|75748792|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
41963602|NCT01074294|75748793|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
41963603|NCT01074294|75748790|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
41963604|NCT01074294|75748791|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
41963605|NCT01074294|75748792|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
41963606|NCT01074294|75748793|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
41963607|NCT01074294|75748790|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
41963608|NCT01074294|75748791|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
41963609|NCT01074294|75748792|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
41963610|NCT01074294|75748793|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
41963611|NCT01074294|75748790|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
41963612|NCT01074294|75748791|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
41963613|NCT01074294|75748792|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
41963614|NCT01074294|75748793|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
41963615|NCT01074294|75748790|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
41963616|NCT01074294|75748791|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
41963617|NCT01074294|75748792|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
41963618|NCT01074294|75748793|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
41963619|NCT04753437|75749733|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
41963620|NCT04753437|75749734|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
41963621|NCT04753437|75749733|FG000|Overall Study|Liver Function Test Abnormalities|2|||
41963622|NCT04753437|75749734|FG001|Overall Study|Liver Function Test Abnormalities|4|||
41963623|NCT04605094|75749742|FG000|Overall Study|Adverse Event|2|||
41963624|NCT04605094|75749743|FG001|Overall Study|Adverse Event|2|||
41963625|NCT04605094|75749742|FG000|Overall Study|Lost to Follow-up|1|||
41963626|NCT04605094|75749743|FG001|Overall Study|Lost to Follow-up|4|||
41963627|NCT04605094|75749742|FG000|Overall Study|Physician Decision|2|||
41963628|NCT04605094|75749743|FG001|Overall Study|Physician Decision|2|||
41963629|NCT04605094|75749742|FG000|Overall Study|Study terminated by Sponsor|31|||
41963630|NCT04605094|75749743|FG001|Overall Study|Study terminated by Sponsor|33|||
41963631|NCT04605094|75749742|FG000|Overall Study|Withdrawal by Subject|22|||
41963632|NCT04605094|75749743|FG001|Overall Study|Withdrawal by Subject|19|||
41963633|NCT04605094|75749742|FG000|Overall Study|Other|1|||
41963634|NCT04605094|75749743|FG001|Overall Study|Other|1|||
41963635|NCT04526210|75749752|FG000|Overall Study|Sponsor decision|7|||
41963636|NCT04526210|75749753|FG001|Overall Study|Sponsor decision|5|||
41963637|NCT04526210|75749752|FG000|Overall Study|Withdrawal by Subject|3|||
41963638|NCT04526210|75749753|FG001|Overall Study|Withdrawal by Subject|2|||
41963639|NCT04149964|75749771|FG000|Overall Study|Lost to Follow-up|19|||
41963640|NCT04149964|75749772|FG001|Overall Study|Lost to Follow-up|18|||
41963641|NCT03842969|75749798|FG000|Overall Study|Participant declined follow-up visit|0|||
41963642|NCT03842969|75749799|FG001|Overall Study|Participant declined follow-up visit|1|||
42119670|NCT00404092|75930557|FG003|Overall Study|Death|0|||
42119671|NCT00404092|75930554|FG000|Overall Study|Adverse Event|0|||
42119672|NCT00404092|75930555|FG001|Overall Study|Adverse Event|0|||
42119673|NCT00404092|75930556|FG002|Overall Study|Adverse Event|1|||
42119674|NCT00404092|75930557|FG003|Overall Study|Adverse Event|0|||
42119675|NCT00481767|75930569|FG000|Overall Study|Withdrawal by Subject|16|||
42119676|NCT00481767|75930570|FG001|Overall Study|Withdrawal by Subject|11|||
42119677|NCT00481767|75930569|FG000|Overall Study|Lost to Follow-up|16|||
42119678|NCT00481767|75930570|FG001|Overall Study|Lost to Follow-up|10|||
42119679|NCT00489489|75930579|FG000|Overall Study|Not treated due to protocol violation|0|||
42119680|NCT00489489|75930580|FG001|Overall Study|Not treated due to protocol violation|1|||
42119681|NCT00489489|75930581|FG002|Overall Study|Not treated due to protocol violation|1|||
42119682|NCT00489489|75930579|FG000|Overall Study|Adverse Event|1|||
42119683|NCT00489489|75930580|FG001|Overall Study|Adverse Event|1|||
42119684|NCT00489489|75930581|FG002|Overall Study|Adverse Event|1|||
42119685|NCT00489489|75930579|FG000|Overall Study|Protocol Violation|1|||
42119686|NCT00489489|75930580|FG001|Overall Study|Protocol Violation|0|||
42119687|NCT00489489|75930581|FG002|Overall Study|Protocol Violation|1|||
42119688|NCT00489489|75930579|FG000|Overall Study|Progressive disease|0|||
42119689|NCT00489489|75930580|FG001|Overall Study|Progressive disease|1|||
42119690|NCT00489489|75930581|FG002|Overall Study|Progressive disease|0|||
42119691|NCT00489489|75930579|FG000|Overall Study|Participant did not wish to continue|1|||
42119692|NCT00489489|75930580|FG001|Overall Study|Participant did not wish to continue|1|||
42119693|NCT00489489|75930581|FG002|Overall Study|Participant did not wish to continue|0|||
42119694|NCT00489489|75930579|FG000|Overall Study|Other than above|0|||
42119695|NCT00489489|75930580|FG001|Overall Study|Other than above|1|||
42301037|NCT02522767|76136316|FG000|Double-blind|Protocol Violation|0|||
41963643|NCT03842969|75749800|FG002|Overall Study|Participant declined follow-up visit|0|||
42119696|NCT00489489|75930581|FG002|Overall Study|Other than above|0|||
42119697|NCT00489411|75930593|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
42301038|NCT02522767|76136317|FG001|Double-blind|Protocol Violation|1|||
42301039|NCT02522767|76136316|FG000|Double-blind|Lack of Efficacy|0|||
42301040|NCT02522767|76136317|FG001|Double-blind|Lack of Efficacy|2|||
42301041|NCT02522767|76136316|FG000|Double-blind|Protocol Deviation|1|||
42301042|NCT02522767|76136317|FG001|Double-blind|Protocol Deviation|0|||
42301043|NCT02522767|76136316|FG000|Open-label|Withdrawal by Subject|2|||
42301044|NCT02522767|76136317|FG001|Open-label|Withdrawal by Subject|3|||
42301045|NCT02522767|76136316|FG000|Open-label|Lost to Follow-up|0|||
42301046|NCT02522767|76136317|FG001|Open-label|Lost to Follow-up|1|||
42301047|NCT02522767|76136316|FG000|Open-label|Adverse Event|2|||
42301048|NCT02522767|76136317|FG001|Open-label|Adverse Event|1|||
42301049|NCT02522767|76136316|FG000|Open-label|Lack of Efficacy|1|||
42301050|NCT02522767|76136317|FG001|Open-label|Lack of Efficacy|1|||
42301051|NCT02522767|76136316|FG000|Open-label|Protocol Violation|0|||
42301052|NCT02522767|76136317|FG001|Open-label|Protocol Violation|1|||
42301053|NCT02522377|76136327|FG000|Overall Study|Withdrawal by Subject|1|||
42301054|NCT02522377|76136328|FG001|Overall Study|Withdrawal by Subject|0|||
42301055|NCT02522377|76136327|FG000|Overall Study|Remission Achieved|3|||
42301056|NCT02522377|76136328|FG001|Overall Study|Remission Achieved|0|||
42301057|NCT01657903|76136334|FG000|Overall Study|Lost to Follow-up|1|||
42301058|NCT01657903|76136334|FG000|Overall Study|Withdrawal by Subject|1|||
42301059|NCT01656733|76136347|FG000|Overall Study|No permission to collect birth outcomes|0|||
42301060|NCT01656733|76136348|FG001|Overall Study|No permission to collect birth outcomes|1|||
42301061|NCT01656733|76136347|FG000|Overall Study|Delivery at another hospital|0|||
42301062|NCT01656733|76136348|FG001|Overall Study|Delivery at another hospital|2|||
42301063|NCT01656733|76136347|FG000|Overall Study|Spontaneous abortion|0|||
41963644|NCT03842969|75749798|FG000|Overall Study|Sponsor's decision|12|||
41963645|NCT03842969|75749799|FG001|Overall Study|Sponsor's decision|99|||
42119698|NCT00489411|75930594|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
42119699|NCT00489411|75930593|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
42301064|NCT01656733|76136348|FG001|Overall Study|Spontaneous abortion|1|||
42301065|NCT01656967|76136356|FG000|Overall Study|faulty monitor|1|||
41963646|NCT03842969|75749800|FG002|Overall Study|Sponsor's decision|61|||
42301066|NCT01656967|76136357|FG001|Overall Study|faulty monitor|0|||
42301067|NCT01656967|76136356|FG000|Overall Study|unsuccessful ETT insertion|3|||
42301068|NCT01656967|76136357|FG001|Overall Study|unsuccessful ETT insertion|2|||
42119700|NCT00489411|75930594|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
42119701|NCT00489411|75930593|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
42119702|NCT00489411|75930594|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
42119703|NCT00489411|75930593|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
42119704|NCT00489411|75930594|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
42119705|NCT00489411|75930593|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
42119706|NCT00489411|75930594|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
42119707|NCT00420784|75930604|FG000|Overall Study|Adverse Event|11|||
42119708|NCT00420784|75930605|FG001|Overall Study|Adverse Event|29|||
42119709|NCT00420784|75930606|FG002|Overall Study|Adverse Event|10|||
42119710|NCT00420784|75930607|FG003|Overall Study|Adverse Event|5|||
42119711|NCT00420784|75930604|FG000|Overall Study|Withdrawal by Subject|0|||
42119712|NCT00420784|75930605|FG001|Overall Study|Withdrawal by Subject|1|||
42119713|NCT00420784|75930606|FG002|Overall Study|Withdrawal by Subject|0|||
42119714|NCT00420784|75930607|FG003|Overall Study|Withdrawal by Subject|0|||
42119715|NCT00420784|75930604|FG000|Overall Study|Lost to Follow-up|0|||
42119716|NCT00420784|75930605|FG001|Overall Study|Lost to Follow-up|0|||
42119717|NCT00420784|75930606|FG002|Overall Study|Lost to Follow-up|2|||
42119718|NCT00420784|75930607|FG003|Overall Study|Lost to Follow-up|1|||
42119719|NCT00420784|75930604|FG000|Overall Study|Virologic Stopping Rule|17|||
42119720|NCT00420784|75930605|FG001|Overall Study|Virologic Stopping Rule|26|||
42119721|NCT00420784|75930606|FG002|Overall Study|Virologic Stopping Rule|41|||
42119722|NCT00420784|75930607|FG003|Overall Study|Virologic Stopping Rule|67|||
42119723|NCT00420784|75930604|FG000|Overall Study|Other|1|||
42119724|NCT00420784|75930605|FG001|Overall Study|Other|2|||
42119725|NCT00420784|75930606|FG002|Overall Study|Other|0|||
42119726|NCT00420784|75930607|FG003|Overall Study|Other|5|||
42119727|NCT00420628|75930620|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
42119728|NCT00420628|75930621|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
42119729|NCT00420628|75930620|FG000|Overall Study|Lost to Follow-up|3|||
42119730|NCT00420628|75930621|FG001|Overall Study|Lost to Follow-up|2|||
42119731|NCT00420628|75930620|FG000|Overall Study|Adverse Event|1|||
42119732|NCT00420628|75930621|FG001|Overall Study|Adverse Event|0|||
42119733|NCT00489255|75930629|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
42119734|NCT00489255|75930630|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
42119735|NCT00489255|75930629|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
42119736|NCT00489255|75930630|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
42119737|NCT00489255|75930629|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
42119738|NCT00489255|75930630|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
42119739|NCT00489255|75930629|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
42119740|NCT00489255|75930630|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
42119741|NCT00489255|75930629|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
42119742|NCT00489255|75930630|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
42119743|NCT00489255|75930629|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
42119744|NCT00489255|75930630|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
42119745|NCT00489255|75930629|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
42119746|NCT00489255|75930630|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
42119747|NCT00489255|75930629|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
42119748|NCT00489255|75930630|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
42119749|NCT00489255|75930629|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
42119750|NCT00489255|75930630|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
42119751|NCT00489255|75930629|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
42119752|NCT00489255|75930630|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
42119753|NCT00413218|75930638|FG000|Overall Study|Randomized but didn't receive study drug|2|||
42119754|NCT00413218|75930639|FG001|Overall Study|Randomized but didn't receive study drug|8|||
42119755|NCT00413218|75930638|FG000|Overall Study|Death|57|||
42119756|NCT00413218|75930639|FG001|Overall Study|Death|56|||
42119757|NCT00413218|75930638|FG000|Overall Study|Lost to Follow-up|14|||
42119758|NCT00413218|75930639|FG001|Overall Study|Lost to Follow-up|17|||
42119759|NCT00413218|75930638|FG000|Overall Study|Admin|20|||
41963647|NCT03842969|75749798|FG000|Overall Study|Pregnancy|0|||
41963648|NCT03842969|75749799|FG001|Overall Study|Pregnancy|0|||
41963649|NCT03842969|75749800|FG002|Overall Study|Pregnancy|1|||
41963650|NCT03842969|75749798|FG000|Overall Study|Death|1|||
41963651|NCT03842969|75749799|FG001|Overall Study|Death|0|||
41963652|NCT03842969|75749800|FG002|Overall Study|Death|1|||
41963653|NCT03842969|75749798|FG000|Overall Study|Withdrawal by Subject|3|||
41963654|NCT03842969|75749799|FG001|Overall Study|Withdrawal by Subject|30|||
42119760|NCT00413218|75930639|FG001|Overall Study|Admin|14|||
42119761|NCT00413218|75930638|FG000|Overall Study|Missing|1|||
42119762|NCT00413218|75930639|FG001|Overall Study|Missing|0|||
42119763|NCT00413218|75930638|FG000|Overall Study|Withdrawal by Subject|9|||
42119764|NCT00413218|75930639|FG001|Overall Study|Withdrawal by Subject|1|||
42119765|NCT00420316|75930648|FG000|Overall Study|Withdrawal by Subject|0|||
42119766|NCT00420316|75930649|FG001|Overall Study|Withdrawal by Subject|1|||
42119767|NCT00420316|75930648|FG000|Overall Study|Lost to Follow-up|12|||
42119768|NCT00420316|75930649|FG001|Overall Study|Lost to Follow-up|8|||
42119769|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
42119770|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
42119771|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
42119772|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
42119773|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Death|8|||
42119774|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Death|3|||
42119775|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
42119776|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
42119777|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
42119778|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
42119779|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
42119780|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
42119781|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
42119782|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
42119783|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
42119784|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
42119785|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
42119786|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
42119787|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
42119788|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
42119789|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
42119790|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
42119791|NCT00494871|75930657|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
41963655|NCT03842969|75749800|FG002|Overall Study|Withdrawal by Subject|18|||
41963656|NCT03842969|75749798|FG000|Overall Study|Protocol Violation|1|||
41963657|NCT03842969|75749799|FG001|Overall Study|Protocol Violation|1|||
41963658|NCT03842969|75749800|FG002|Overall Study|Protocol Violation|0|||
41963659|NCT03842969|75749798|FG000|Overall Study|Physician Decision|0|||
41963660|NCT03842969|75749799|FG001|Overall Study|Physician Decision|3|||
41963661|NCT03842969|75749800|FG002|Overall Study|Physician Decision|0|||
41963662|NCT03842969|75749798|FG000|Overall Study|Lost to Follow-up|0|||
41963663|NCT03842969|75749799|FG001|Overall Study|Lost to Follow-up|2|||
41963664|NCT03842969|75749800|FG002|Overall Study|Lost to Follow-up|0|||
41963665|NCT03842969|75749798|FG000|Overall Study|Adverse Event|0|||
42026588|NCT01146912|75834526|FG002|Overall Study|< 14 weeks gestational age|3|||
41963666|NCT03842969|75749799|FG001|Overall Study|Adverse Event|2|||
41963667|NCT03842969|75749800|FG002|Overall Study|Adverse Event|0|||
41963668|NCT02938520|75749823|FG000|Overall Study|On-going at the time of analysis|258|||
41963669|NCT02938520|75749824|FG001|Overall Study|On-going at the time of analysis|261|||
41963670|NCT02938520|75749823|FG000|Overall Study|Physician Decision|2|||
41963671|NCT02938520|75749824|FG001|Overall Study|Physician Decision|5|||
41963672|NCT02938520|75749823|FG000|Overall Study|Lost to Follow-up|2|||
41963673|NCT02938520|75749824|FG001|Overall Study|Lost to Follow-up|2|||
41963674|NCT02938520|75749823|FG000|Overall Study|Withdrawal by Subject|7|||
41963675|NCT02938520|75749824|FG001|Overall Study|Withdrawal by Subject|7|||
41963676|NCT02938520|75749823|FG000|Overall Study|Protocol Violation|0|||
41963677|NCT02938520|75749824|FG001|Overall Study|Protocol Violation|1|||
41963678|NCT02938520|75749823|FG000|Overall Study|Lack of Efficacy|5|||
41963679|NCT02938520|75749824|FG001|Overall Study|Lack of Efficacy|3|||
41963680|NCT02938520|75749823|FG000|Overall Study|Adverse Event|9|||
42026589|NCT01146912|75834527|FG003|Overall Study|< 14 weeks gestational age|2|||
42026590|NCT01146912|75834528|FG004|Overall Study|< 14 weeks gestational age|0|||
42026591|NCT01146912|75834529|FG005|Overall Study|< 14 weeks gestational age|0|||
42026592|NCT01146912|75834530|FG006|Overall Study|< 14 weeks gestational age|0|||
42026593|NCT01146912|75834531|FG007|Overall Study|< 14 weeks gestational age|0|||
42026594|NCT01146912|75834524|FG000|Overall Study|Duplicate patient|0|||
42026595|NCT01146912|75834525|FG001|Overall Study|Duplicate patient|0|||
42026596|NCT01146912|75834526|FG002|Overall Study|Duplicate patient|1|||
42119792|NCT00494871|75930658|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
42119793|NCT00494871|75930657|FG000|Follow-up (FU) Period|Adverse Event|1|||
42119794|NCT00494871|75930658|FG001|Follow-up (FU) Period|Adverse Event|1|||
41963681|NCT02938520|75749824|FG001|Overall Study|Adverse Event|4|||
41963682|NCT02764541|75749841|FG000|Overall Study|Withdrawal by Subject|0|||
41963683|NCT02764541|75749842|FG001|Overall Study|Withdrawal by Subject|0|||
41963684|NCT02764541|75749843|FG002|Overall Study|Withdrawal by Subject|0|||
42119795|NCT00494871|75930657|FG000|Follow-up (FU) Period|Death|13|||
41963685|NCT02764541|75749844|FG003|Overall Study|Withdrawal by Subject|0|||
41963686|NCT02764541|75749845|FG004|Overall Study|Withdrawal by Subject|1|||
41963687|NCT02764541|75749846|FG005|Overall Study|Withdrawal by Subject|1|||
41963688|NCT02764541|75749847|FG006|Overall Study|Withdrawal by Subject|0|||
42026597|NCT01146912|75834527|FG003|Overall Study|Duplicate patient|0|||
42026598|NCT01146912|75834528|FG004|Overall Study|Duplicate patient|0|||
42119796|NCT00494871|75930658|FG001|Follow-up (FU) Period|Death|12|||
42119797|NCT00494871|75930657|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
42119798|NCT00494871|75930658|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
42119799|NCT00494871|75930657|FG000|Follow-up (FU) Period|Physician Decision|0|||
42119800|NCT00494871|75930658|FG001|Follow-up (FU) Period|Physician Decision|1|||
42119801|NCT00494871|75930657|FG000|Follow-up (FU) Period|Protocol Violation|1|||
42119802|NCT00494871|75930658|FG001|Follow-up (FU) Period|Protocol Violation|0|||
42119803|NCT00494871|75930657|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
42119804|NCT00494871|75930658|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
42119805|NCT00494871|75930657|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
42119806|NCT00494871|75930658|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
42119807|NCT00420238|75930668|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
42119808|NCT00420238|75930669|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
42119809|NCT00420238|75930668|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
42119810|NCT00420238|75930669|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
42119811|NCT00420238|75930668|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
42119812|NCT00420238|75930669|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
42119813|NCT00420238|75930668|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
42119814|NCT00420238|75930669|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
42119815|NCT00420238|75930668|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
42119816|NCT00420238|75930669|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
42119817|NCT00420238|75930668|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
42119818|NCT00420238|75930669|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
42119819|NCT00420004|75930684|FG000|Overall Study|Adverse Event|4|||
42119820|NCT00420004|75930685|FG001|Overall Study|Adverse Event|1|||
42119821|NCT00420004|75930686|FG002|Overall Study|Adverse Event|1|||
42119822|NCT00420004|75930684|FG000|Overall Study|Lack of Efficacy|5|||
42119823|NCT00420004|75930685|FG001|Overall Study|Lack of Efficacy|4|||
42301069|NCT01656889|76136369|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
42301070|NCT01656889|76136370|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
42301071|NCT01656889|76136369|FG000|Treatment Period, 12 Weeks|Death|0|||
41963689|NCT02764541|75749848|FG007|Overall Study|Withdrawal by Subject|1|||
41963690|NCT02764541|75749841|FG000|Overall Study|Adverse Event|1|||
41963691|NCT02764541|75749842|FG001|Overall Study|Adverse Event|0|||
41963692|NCT02764541|75749843|FG002|Overall Study|Adverse Event|0|||
41963693|NCT02764541|75749844|FG003|Overall Study|Adverse Event|0|||
41963694|NCT02764541|75749845|FG004|Overall Study|Adverse Event|0|||
41963695|NCT02764541|75749846|FG005|Overall Study|Adverse Event|0|||
41963696|NCT02764541|75749847|FG006|Overall Study|Adverse Event|1|||
41963697|NCT02764541|75749848|FG007|Overall Study|Adverse Event|0|||
41963698|NCT02764541|75749841|FG000|Overall Study|Metastasis|1|||
41963699|NCT02764541|75749842|FG001|Overall Study|Metastasis|0|||
41963700|NCT02764541|75749843|FG002|Overall Study|Metastasis|0|||
41963701|NCT02764541|75749844|FG003|Overall Study|Metastasis|0|||
41963702|NCT02764541|75749845|FG004|Overall Study|Metastasis|0|||
41963703|NCT02764541|75749846|FG005|Overall Study|Metastasis|0|||
41963704|NCT02764541|75749847|FG006|Overall Study|Metastasis|0|||
41963705|NCT02764541|75749848|FG007|Overall Study|Metastasis|0|||
41963706|NCT02764541|75749841|FG000|Overall Study|Disease progression|1|||
41963707|NCT02764541|75749842|FG001|Overall Study|Disease progression|1|||
41963708|NCT02764541|75749843|FG002|Overall Study|Disease progression|0|||
41963709|NCT02764541|75749844|FG003|Overall Study|Disease progression|0|||
41963710|NCT02764541|75749845|FG004|Overall Study|Disease progression|0|||
41963711|NCT02764541|75749846|FG005|Overall Study|Disease progression|0|||
41963712|NCT02764541|75749847|FG006|Overall Study|Disease progression|0|||
41963713|NCT02764541|75749848|FG007|Overall Study|Disease progression|1|||
41963714|NCT02764541|75749841|FG000|Overall Study|Protocol Violation|0|||
41963715|NCT02764541|75749842|FG001|Overall Study|Protocol Violation|0|||
41963716|NCT02764541|75749843|FG002|Overall Study|Protocol Violation|0|||
41963717|NCT02764541|75749844|FG003|Overall Study|Protocol Violation|1|||
41963718|NCT02764541|75749845|FG004|Overall Study|Protocol Violation|0|||
41963719|NCT02764541|75749846|FG005|Overall Study|Protocol Violation|1|||
41963720|NCT02764541|75749847|FG006|Overall Study|Protocol Violation|0|||
41963721|NCT02764541|75749848|FG007|Overall Study|Protocol Violation|0|||
41963722|NCT02764541|75749841|FG000|Overall Study|Physician Decision|0|||
41963723|NCT02764541|75749842|FG001|Overall Study|Physician Decision|0|||
41963724|NCT02764541|75749843|FG002|Overall Study|Physician Decision|0|||
42301072|NCT01656889|76136370|FG001|Treatment Period, 12 Weeks|Death|1|||
42301073|NCT01656889|76136369|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
42301074|NCT01656889|76136370|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
42301075|NCT01656889|76136369|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
42301076|NCT01656889|76136370|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
42301077|NCT01656889|76136369|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
42301078|NCT01656889|76136370|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
42301079|NCT01656889|76136369|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
42301080|NCT01656889|76136370|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
42301081|NCT01656889|76136369|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
42119824|NCT00420004|75930686|FG002|Overall Study|Lack of Efficacy|1|||
42119825|NCT00420004|75930684|FG000|Overall Study|Lost to Follow-up|31|||
42119826|NCT00420004|75930685|FG001|Overall Study|Lost to Follow-up|12|||
42119827|NCT00420004|75930686|FG002|Overall Study|Lost to Follow-up|10|||
42119828|NCT00420004|75930684|FG000|Overall Study|Entry Criteria Not Met|0|||
42119829|NCT00420004|75930685|FG001|Overall Study|Entry Criteria Not Met|1|||
41963725|NCT02764541|75749844|FG003|Overall Study|Physician Decision|1|||
41963726|NCT02764541|75749845|FG004|Overall Study|Physician Decision|0|||
41963727|NCT02764541|75749846|FG005|Overall Study|Physician Decision|0|||
41963728|NCT02764541|75749847|FG006|Overall Study|Physician Decision|0|||
41963729|NCT02764541|75749848|FG007|Overall Study|Physician Decision|1|||
41963730|NCT02764541|75749841|FG000|Overall Study|Three Cycles completed before surgery|0|||
41963731|NCT02764541|75749842|FG001|Overall Study|Three Cycles completed before surgery|0|||
41963732|NCT02764541|75749843|FG002|Overall Study|Three Cycles completed before surgery|0|||
41963733|NCT02764541|75749844|FG003|Overall Study|Three Cycles completed before surgery|1|||
41963734|NCT02764541|75749845|FG004|Overall Study|Three Cycles completed before surgery|0|||
41963735|NCT02764541|75749846|FG005|Overall Study|Three Cycles completed before surgery|0|||
41963736|NCT02764541|75749847|FG006|Overall Study|Three Cycles completed before surgery|0|||
41963737|NCT02764541|75749848|FG007|Overall Study|Three Cycles completed before surgery|0|||
41963738|NCT02764541|75749841|FG000|Overall Study|Patient Compliance|0|||
41963739|NCT02764541|75749842|FG001|Overall Study|Patient Compliance|0|||
41963740|NCT02764541|75749843|FG002|Overall Study|Patient Compliance|1|||
41963741|NCT02764541|75749844|FG003|Overall Study|Patient Compliance|0|||
42119830|NCT00420004|75930686|FG002|Overall Study|Entry Criteria Not Met|0|||
41963742|NCT02764541|75749845|FG004|Overall Study|Patient Compliance|0|||
42119831|NCT00420004|75930684|FG000|Overall Study|Physician Decision|14|||
42119832|NCT00420004|75930685|FG001|Overall Study|Physician Decision|4|||
42119833|NCT00420004|75930686|FG002|Overall Study|Physician Decision|2|||
42119834|NCT00420004|75930684|FG000|Overall Study|Protocol Violation|5|||
42119835|NCT00420004|75930685|FG001|Overall Study|Protocol Violation|4|||
41963743|NCT02764541|75749846|FG005|Overall Study|Patient Compliance|0|||
41963744|NCT02764541|75749847|FG006|Overall Study|Patient Compliance|0|||
41963745|NCT02764541|75749848|FG007|Overall Study|Patient Compliance|0|||
42119836|NCT00420004|75930686|FG002|Overall Study|Protocol Violation|3|||
42119837|NCT00420004|75930684|FG000|Overall Study|Withdrawal by Subject|67|||
42119838|NCT00420004|75930685|FG001|Overall Study|Withdrawal by Subject|42|||
42119839|NCT00420004|75930686|FG002|Overall Study|Withdrawal by Subject|14|||
42119840|NCT00420004|75930684|FG000|Overall Study|Sponsor Decision|3|||
42119841|NCT00420004|75930685|FG001|Overall Study|Sponsor Decision|3|||
42119842|NCT00420004|75930686|FG002|Overall Study|Sponsor Decision|1|||
42119843|NCT00494481|75930700|FG000|Overall Study|Condition under investigation worsened|11|||
42119844|NCT00494481|75930701|FG001|Overall Study|Condition under investigation worsened|13|||
42119845|NCT00494481|75930700|FG000|Overall Study|Adverse Event|15|||
42119846|NCT00494481|75930701|FG001|Overall Study|Adverse Event|11|||
42119847|NCT00494481|75930700|FG000|Overall Study|Other|1|||
42119848|NCT00494481|75930701|FG001|Overall Study|Other|0|||
42119849|NCT00494481|75930700|FG000|Overall Study|Never received IP|2|||
42119850|NCT00494481|75930701|FG001|Overall Study|Never received IP|0|||
42119851|NCT00097591|75930709|FG000|Overall Study|Withdrawal of consent|342|||
41963746|NCT02764541|75749841|FG000|Overall Study|Death|0|||
42119852|NCT00097591|75930710|FG001|Overall Study|Withdrawal of consent|323|||
42119853|NCT00097591|75930709|FG000|Overall Study|Less than 6 months on study drug|9|||
42210345|NCT02936037|76025130|FG001|Double-Blind Treatment Period|Adverse Event|11|||
42119854|NCT00097591|75930710|FG001|Overall Study|Less than 6 months on study drug|7|||
42210346|NCT02936037|76025129|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
42210347|NCT02936037|76025130|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
42210348|NCT02936037|76025129|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
42210349|NCT02936037|76025130|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
42210350|NCT02936037|76025129|FG000|Open Label Extension|Adverse Event|0|||
42210351|NCT02936037|76025130|FG001|Open Label Extension|Adverse Event|3|||
42119855|NCT00097591|75930709|FG000|Overall Study|Unable to attend termination visit|53|||
42119856|NCT00097591|75930710|FG001|Overall Study|Unable to attend termination visit|51|||
42119857|NCT00097591|75930709|FG000|Overall Study|Lost to follow up|6|||
42119858|NCT00097591|75930710|FG001|Overall Study|Lost to follow up|10|||
42119859|NCT00097591|75930709|FG000|Overall Study|Other|0|||
42119860|NCT00097591|75930710|FG001|Overall Study|Other|3|||
42119861|NCT00419926|75930718|FG000|Overall Study|Withdrawal by Subject|7|||
42119862|NCT00419926|75930719|FG001|Overall Study|Withdrawal by Subject|3|||
42119863|NCT00419926|75930718|FG000|Overall Study|Administrative Problem|4|||
42119864|NCT00419926|75930719|FG001|Overall Study|Administrative Problem|4|||
42119865|NCT00419926|75930718|FG000|Overall Study|Lost to Follow-up|1|||
42119866|NCT00419926|75930719|FG001|Overall Study|Lost to Follow-up|2|||
42119867|NCT00419926|75930718|FG000|Overall Study|Death|2|||
42119868|NCT00419926|75930719|FG001|Overall Study|Death|1|||
42119869|NCT00080119|75930729|FG000|Overall Study|Discontinued because of study closure|0|||
42119870|NCT00080119|75930730|FG001|Overall Study|Discontinued because of study closure|0|||
42119871|NCT00080119|75930731|FG002|Overall Study|Discontinued because of study closure|130|||
42119872|NCT00080119|75930732|FG003|Overall Study|Discontinued because of study closure|141|||
42119873|NCT00080119|75930729|FG000|Overall Study|Unable to get to clinic|24|||
42119874|NCT00080119|75930730|FG001|Overall Study|Unable to get to clinic|24|||
42119875|NCT00080119|75930731|FG002|Overall Study|Unable to get to clinic|7|||
42119876|NCT00080119|75930732|FG003|Overall Study|Unable to get to clinic|1|||
42119877|NCT00080119|75930729|FG000|Overall Study|Consent withdrawn|13|||
42119878|NCT00080119|75930730|FG001|Overall Study|Consent withdrawn|17|||
42119879|NCT00080119|75930731|FG002|Overall Study|Consent withdrawn|4|||
42119880|NCT00080119|75930732|FG003|Overall Study|Consent withdrawn|6|||
42119881|NCT00080119|75930729|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
42119882|NCT00080119|75930730|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
42119883|NCT00080119|75930731|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
42119884|NCT00080119|75930732|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
42119885|NCT00080119|75930729|FG000|Overall Study|Lost to Follow-up|16|||
42119886|NCT00080119|75930730|FG001|Overall Study|Lost to Follow-up|19|||
42119887|NCT00080119|75930731|FG002|Overall Study|Lost to Follow-up|19|||
42119888|NCT00080119|75930732|FG003|Overall Study|Lost to Follow-up|14|||
42119889|NCT00419380|75930746|FG000|Overall Study|Lack of Efficacy|1|||
42119890|NCT00419380|75930747|FG001|Overall Study|Lack of Efficacy|7|||
42119891|NCT00419380|75930746|FG000|Overall Study|Physician Decision|0|||
42119892|NCT00419380|75930747|FG001|Overall Study|Physician Decision|1|||
42119893|NCT00419380|75930746|FG000|Overall Study|Lost to Follow-up|0|||
42119894|NCT00419380|75930747|FG001|Overall Study|Lost to Follow-up|1|||
42119895|NCT00419380|75930746|FG000|Overall Study|Withdrawal by Subject|0|||
42119896|NCT00419380|75930747|FG001|Overall Study|Withdrawal by Subject|1|||
42119897|NCT00413062|75930755|FG000|Overall Study|Adverse event/serious adverse event|289|||
42119898|NCT00413062|75930756|FG001|Overall Study|Adverse event/serious adverse event|56|||
42119899|NCT00413062|75930755|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
42119900|NCT00413062|75930756|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
42119901|NCT00413062|75930755|FG000|Overall Study|Withdrawal of informed consent|111|||
42119902|NCT00413062|75930756|FG001|Overall Study|Withdrawal of informed consent|36|||
42119903|NCT00413062|75930755|FG000|Overall Study|Pregnancy|15|||
42119904|NCT00413062|75930756|FG001|Overall Study|Pregnancy|5|||
42119905|NCT00413062|75930755|FG000|Overall Study|Pregnancy wish|17|||
42119906|NCT00413062|75930756|FG001|Overall Study|Pregnancy wish|6|||
42119907|NCT00413062|75930755|FG000|Overall Study|Lost to Follow-up|175|||
42119908|NCT00413062|75930756|FG001|Overall Study|Lost to Follow-up|73|||
42119909|NCT00413062|75930755|FG000|Overall Study|Other reason|70|||
42119910|NCT00413062|75930756|FG001|Overall Study|Other reason|34|||
42119911|NCT00494091|75930766|FG000|Overall Study|Death|5|||
42119912|NCT00494091|75930767|FG001|Overall Study|Death|54|||
42119913|NCT00494091|75930766|FG000|Overall Study|Lost to Follow-up|0|||
42119914|NCT00494091|75930767|FG001|Overall Study|Lost to Follow-up|4|||
42119915|NCT00494091|75930766|FG000|Overall Study|Other|1|||
42119916|NCT00494091|75930767|FG001|Overall Study|Other|11|||
42119917|NCT00494091|75930766|FG000|Overall Study|Withdrawal by Subject|0|||
42119918|NCT00494091|75930767|FG001|Overall Study|Withdrawal by Subject|7|||
42119919|NCT00494013|75930776|FG000|Overall Study|Adverse Event|0|||
42119920|NCT00494013|75930777|FG001|Overall Study|Adverse Event|1|||
42119921|NCT00494013|75930776|FG000|Overall Study|Entry Criteria Not Met|1|||
42119922|NCT00494013|75930777|FG001|Overall Study|Entry Criteria Not Met|4|||
42119923|NCT00494013|75930776|FG000|Overall Study|Lost to Follow-up|5|||
42119924|NCT00494013|75930777|FG001|Overall Study|Lost to Follow-up|6|||
42119925|NCT00494013|75930776|FG000|Overall Study|Physician Decision|3|||
42119926|NCT00494013|75930777|FG001|Overall Study|Physician Decision|5|||
42119927|NCT00494013|75930776|FG000|Overall Study|Protocol Violation|8|||
42119928|NCT00494013|75930777|FG001|Overall Study|Protocol Violation|5|||
42119929|NCT00494013|75930776|FG000|Overall Study|Withdrawal by Subject|13|||
42119930|NCT00494013|75930777|FG001|Overall Study|Withdrawal by Subject|14|||
42119931|NCT00494013|75930776|FG000|Overall Study|Sponsor Decision|0|||
42119932|NCT00494013|75930777|FG001|Overall Study|Sponsor Decision|1|||
42119933|NCT00079339|75930786|FG000|Overall Study|Adverse Event|1|||
42119934|NCT00079339|75930787|FG001|Overall Study|Adverse Event|7|||
42119935|NCT00079339|75930788|FG002|Overall Study|Adverse Event|2|||
42119936|NCT00079339|75930786|FG000|Overall Study|Death|1|||
42119937|NCT00079339|75930787|FG001|Overall Study|Death|0|||
42119938|NCT00079339|75930788|FG002|Overall Study|Death|0|||
42119939|NCT00079339|75930786|FG000|Overall Study|Non-compliance|0|||
42119940|NCT00079339|75930787|FG001|Overall Study|Non-compliance|0|||
42119941|NCT00079339|75930788|FG002|Overall Study|Non-compliance|1|||
42119942|NCT00079339|75930786|FG000|Overall Study|Withdrawal by Subject|0|||
42119943|NCT00079339|75930787|FG001|Overall Study|Withdrawal by Subject|4|||
42119944|NCT00079339|75930788|FG002|Overall Study|Withdrawal by Subject|1|||
42119945|NCT00079339|75930786|FG000|Overall Study|Disease progression|3|||
42119946|NCT00079339|75930787|FG001|Overall Study|Disease progression|28|||
42119947|NCT00079339|75930788|FG002|Overall Study|Disease progression|2|||
42119948|NCT00493779|75930801|FG000|Overall Study|Logistical issue at site|1|||
42119949|NCT00541866|75930811|FG000|Overall Study|Adverse Event|3|||
42119950|NCT00541866|75930812|FG001|Overall Study|Adverse Event|0|||
42119951|NCT00541866|75930813|FG002|Overall Study|Adverse Event|0|||
42119952|NCT00541866|75930814|FG003|Overall Study|Adverse Event|0|||
42119953|NCT00541866|75930815|FG004|Overall Study|Adverse Event|0|||
42119954|NCT00541866|75930811|FG000|Overall Study|Death|1|||
42119955|NCT00541866|75930812|FG001|Overall Study|Death|0|||
42119956|NCT00541866|75930813|FG002|Overall Study|Death|0|||
42119957|NCT00541866|75930814|FG003|Overall Study|Death|0|||
42119958|NCT00541866|75930815|FG004|Overall Study|Death|0|||
42119959|NCT00541866|75930811|FG000|Overall Study|Lack of Efficacy|19|||
42119960|NCT00541866|75930812|FG001|Overall Study|Lack of Efficacy|15|||
42119961|NCT00541866|75930813|FG002|Overall Study|Lack of Efficacy|10|||
42119962|NCT00541866|75930814|FG003|Overall Study|Lack of Efficacy|12|||
42119963|NCT00541866|75930815|FG004|Overall Study|Lack of Efficacy|14|||
42119964|NCT00541866|75930811|FG000|Overall Study|Not Reported or Other|11|||
42119965|NCT00541866|75930812|FG001|Overall Study|Not Reported or Other|3|||
42119966|NCT00541866|75930813|FG002|Overall Study|Not Reported or Other|3|||
42119967|NCT00541866|75930814|FG003|Overall Study|Not Reported or Other|3|||
42119968|NCT00541866|75930815|FG004|Overall Study|Not Reported or Other|1|||
42119969|NCT00541866|75930811|FG000|Overall Study|Physician Decision|0|||
42119970|NCT00541866|75930812|FG001|Overall Study|Physician Decision|0|||
42119971|NCT00541866|75930813|FG002|Overall Study|Physician Decision|2|||
42119972|NCT00541866|75930814|FG003|Overall Study|Physician Decision|1|||
42119973|NCT00541866|75930815|FG004|Overall Study|Physician Decision|0|||
42119974|NCT00493467|75930843|FG000|Overall Study|Death|1|||
42119975|NCT00090493|75930847|FG000|Overall Study|Physician Decision|2|||
42119976|NCT04329702|75930854|FG000|Overall Study|illness|3|||
42119977|NCT04329702|75930855|FG001|Overall Study|illness|4|||
42119978|NCT04329702|75930856|FG002|Overall Study|illness|0|||
42119979|NCT04329702|75930854|FG000|Overall Study|Lost to Follow-up|0|||
42119980|NCT04329702|75930855|FG001|Overall Study|Lost to Follow-up|0|||
42119981|NCT04329702|75930856|FG002|Overall Study|Lost to Follow-up|2|||
42119982|NCT04329702|75930854|FG000|Overall Study|Death|0|||
42119983|NCT04329702|75930855|FG001|Overall Study|Death|2|||
42119984|NCT04329702|75930856|FG002|Overall Study|Death|0|||
42119985|NCT00481065|75930877|FG000|Overall Study|Adverse event or death|1|||
42119986|NCT00481065|75930878|FG001|Overall Study|Adverse event or death|1|||
42119987|NCT00481065|75930879|FG002|Overall Study|Adverse event or death|3|||
42119988|NCT00481065|75930880|FG003|Overall Study|Adverse event or death|0|||
42119989|NCT00481065|75930881|FG004|Overall Study|Adverse event or death|2|||
42119990|NCT00481065|75930882|FG005|Overall Study|Adverse event or death|0|||
42119991|NCT00481065|75930883|FG006|Overall Study|Adverse event or death|1|||
42119992|NCT00481065|75930884|FG007|Overall Study|Adverse event or death|1|||
42119993|NCT00481065|75930877|FG000|Overall Study|Withdrawal by Subject|11|||
42119994|NCT00481065|75930878|FG001|Overall Study|Withdrawal by Subject|12|||
42119995|NCT00481065|75930879|FG002|Overall Study|Withdrawal by Subject|7|||
42119996|NCT00481065|75930880|FG003|Overall Study|Withdrawal by Subject|11|||
42210352|NCT02936037|76025129|FG000|Open Label Extension|Other|0|||
42119997|NCT00481065|75930881|FG004|Overall Study|Withdrawal by Subject|13|||
42119998|NCT00481065|75930882|FG005|Overall Study|Withdrawal by Subject|12|||
42119999|NCT00481065|75930883|FG006|Overall Study|Withdrawal by Subject|9|||
42120000|NCT00481065|75930884|FG007|Overall Study|Withdrawal by Subject|10|||
42120001|NCT00481065|75930877|FG000|Overall Study|Lost to Follow-up|4|||
42120002|NCT00481065|75930878|FG001|Overall Study|Lost to Follow-up|2|||
42120003|NCT00481065|75930879|FG002|Overall Study|Lost to Follow-up|4|||
42120004|NCT00481065|75930880|FG003|Overall Study|Lost to Follow-up|3|||
42120005|NCT00481065|75930881|FG004|Overall Study|Lost to Follow-up|3|||
42120006|NCT00481065|75930882|FG005|Overall Study|Lost to Follow-up|3|||
42120007|NCT00481065|75930883|FG006|Overall Study|Lost to Follow-up|2|||
42120008|NCT00481065|75930884|FG007|Overall Study|Lost to Follow-up|5|||
42120009|NCT00481065|75930877|FG000|Overall Study|Inappropriate enrollment|4|||
42120010|NCT00481065|75930878|FG001|Overall Study|Inappropriate enrollment|0|||
42120011|NCT00481065|75930879|FG002|Overall Study|Inappropriate enrollment|2|||
42120012|NCT00481065|75930880|FG003|Overall Study|Inappropriate enrollment|0|||
42120013|NCT00481065|75930881|FG004|Overall Study|Inappropriate enrollment|2|||
42120014|NCT00481065|75930882|FG005|Overall Study|Inappropriate enrollment|1|||
42120015|NCT00481065|75930883|FG006|Overall Study|Inappropriate enrollment|0|||
42120016|NCT00481065|75930884|FG007|Overall Study|Inappropriate enrollment|1|||
42120017|NCT00481065|75930877|FG000|Overall Study|Administrative reason|0|||
42120018|NCT00481065|75930878|FG001|Overall Study|Administrative reason|0|||
42120019|NCT00481065|75930879|FG002|Overall Study|Administrative reason|0|||
42120020|NCT00481065|75930880|FG003|Overall Study|Administrative reason|0|||
42120021|NCT00481065|75930881|FG004|Overall Study|Administrative reason|0|||
42120022|NCT00481065|75930882|FG005|Overall Study|Administrative reason|2|||
42120023|NCT00481065|75930883|FG006|Overall Study|Administrative reason|1|||
42120024|NCT00481065|75930884|FG007|Overall Study|Administrative reason|0|||
41963747|NCT02764541|75749842|FG001|Overall Study|Death|0|||
41963748|NCT02764541|75749843|FG002|Overall Study|Death|0|||
41963749|NCT02764541|75749844|FG003|Overall Study|Death|0|||
41963750|NCT02764541|75749845|FG004|Overall Study|Death|0|||
41963751|NCT02764541|75749846|FG005|Overall Study|Death|0|||
41963752|NCT02764541|75749847|FG006|Overall Study|Death|1|||
41963753|NCT02764541|75749848|FG007|Overall Study|Death|0|||
41963754|NCT02764541|75749841|FG000|Overall Study|Insurance reasons|0|||
41963755|NCT02764541|75749842|FG001|Overall Study|Insurance reasons|0|||
41963756|NCT02764541|75749843|FG002|Overall Study|Insurance reasons|0|||
41963757|NCT02764541|75749844|FG003|Overall Study|Insurance reasons|0|||
41963758|NCT02764541|75749845|FG004|Overall Study|Insurance reasons|0|||
41963759|NCT02764541|75749846|FG005|Overall Study|Insurance reasons|0|||
41963760|NCT02764541|75749847|FG006|Overall Study|Insurance reasons|1|||
41963761|NCT02764541|75749848|FG007|Overall Study|Insurance reasons|0|||
41963762|NCT02587065|75749868|FG000|Overall Study|Adverse Event|14|||
41963763|NCT02587065|75749868|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
41963764|NCT02587065|75749868|FG000|Overall Study|Non-adherence to the Protocol|3|||
41963765|NCT02587065|75749868|FG000|Overall Study|Discontinuation of Study Medication|2|||
41963766|NCT02587065|75749868|FG000|Overall Study|Reason not Specified|3|||
41963767|NCT02544503|75749878|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
41963768|NCT02544503|75749879|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
41963769|NCT02544503|75749878|FG000|Overall Study|Lost to Follow-up|9|||
41963770|NCT02544503|75749879|FG001|Overall Study|Lost to Follow-up|0|||
41963771|NCT02544503|75749878|FG000|Overall Study|Withdrawal by Subject|1|||
41963772|NCT02544503|75749879|FG001|Overall Study|Withdrawal by Subject|0|||
41963773|NCT01705977|75749887|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
41963774|NCT01705977|75749888|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
41963775|NCT01705977|75749887|FG000|Treatment Period (Year 1)|Adverse Event|57|||
41963776|NCT01705977|75749888|FG001|Treatment Period (Year 1)|Adverse Event|49|||
41963777|NCT01705977|75749887|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
41963778|NCT01705977|75749888|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
41963779|NCT01705977|75749887|FG000|Treatment Period (Year 1)|Site closure|3|||
41963780|NCT01705977|75749888|FG001|Treatment Period (Year 1)|Site closure|2|||
41963781|NCT01705977|75749887|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
41963782|NCT01705977|75749888|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
41963783|NCT01705977|75749887|FG000|Treatment Period (Year 1)|Physician Decision|48|||
41963784|NCT01705977|75749888|FG001|Treatment Period (Year 1)|Physician Decision|38|||
41963785|NCT01705977|75749887|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
41963786|NCT01705977|75749888|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
41963787|NCT01705977|75749887|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
42026599|NCT01146912|75834529|FG005|Overall Study|Duplicate patient|0|||
42026600|NCT01146912|75834530|FG006|Overall Study|Duplicate patient|0|||
42026601|NCT01146912|75834531|FG007|Overall Study|Duplicate patient|0|||
42026602|NCT01134042|75834553|FG000|Overall Study|Adverse Event|3|||
42026603|NCT01134042|75834554|FG001|Overall Study|Adverse Event|7|||
42026604|NCT01134042|75834555|FG002|Overall Study|Adverse Event|2|||
42026605|NCT01134042|75834553|FG000|Overall Study|Lack of Efficacy|21|||
42026606|NCT01134042|75834554|FG001|Overall Study|Lack of Efficacy|6|||
42026607|NCT01134042|75834555|FG002|Overall Study|Lack of Efficacy|18|||
42026608|NCT01134042|75834553|FG000|Overall Study|Protocol Violation|5|||
42026609|NCT01134042|75834554|FG001|Overall Study|Protocol Violation|3|||
42026610|NCT01134042|75834555|FG002|Overall Study|Protocol Violation|5|||
42026611|NCT01134042|75834553|FG000|Overall Study|Lost to Follow-up|2|||
42026612|NCT01134042|75834554|FG001|Overall Study|Lost to Follow-up|0|||
42026613|NCT01134042|75834555|FG002|Overall Study|Lost to Follow-up|1|||
42026614|NCT01134042|75834553|FG000|Overall Study|Physician Decision|4|||
42120025|NCT00481065|75930877|FG000|Overall Study|Protocol Violation|2|||
42120026|NCT00481065|75930878|FG001|Overall Study|Protocol Violation|1|||
42120027|NCT00481065|75930879|FG002|Overall Study|Protocol Violation|1|||
42120028|NCT00481065|75930880|FG003|Overall Study|Protocol Violation|1|||
42120029|NCT00481065|75930881|FG004|Overall Study|Protocol Violation|2|||
42120030|NCT00481065|75930882|FG005|Overall Study|Protocol Violation|6|||
42120031|NCT00481065|75930883|FG006|Overall Study|Protocol Violation|3|||
42120032|NCT00481065|75930884|FG007|Overall Study|Protocol Violation|2|||
42120033|NCT00481065|75930877|FG000|Overall Study|Unable to classify|0|||
42120034|NCT00481065|75930878|FG001|Overall Study|Unable to classify|1|||
42120035|NCT00481065|75930879|FG002|Overall Study|Unable to classify|2|||
42120036|NCT00481065|75930880|FG003|Overall Study|Unable to classify|0|||
42120037|NCT00481065|75930881|FG004|Overall Study|Unable to classify|1|||
42120038|NCT00481065|75930882|FG005|Overall Study|Unable to classify|0|||
42120039|NCT00481065|75930883|FG006|Overall Study|Unable to classify|0|||
42120040|NCT00481065|75930884|FG007|Overall Study|Unable to classify|0|||
42120041|NCT00493311|75930906|FG000|Overall Study|Need for rescue medication|2|||
42120042|NCT00493311|75930907|FG001|Overall Study|Need for rescue medication|2|||
42120043|NCT00571649|75930915|FG000|Treatment Period|Adverse Event|438|||
42120044|NCT00571649|75930916|FG001|Treatment Period|Adverse Event|385|||
42120045|NCT00571649|75930915|FG000|Treatment Period|Clinical endpoint reached|50|||
42120046|NCT00571649|75930916|FG001|Treatment Period|Clinical endpoint reached|56|||
42120047|NCT00571649|75930915|FG000|Treatment Period|Withdrawal by Subject|285|||
42120048|NCT00571649|75930916|FG001|Treatment Period|Withdrawal by Subject|255|||
42120049|NCT00571649|75930915|FG000|Treatment Period|Death|76|||
42120050|NCT00571649|75930916|FG001|Treatment Period|Death|59|||
42120051|NCT00571649|75930915|FG000|Treatment Period|Physician Decision|8|||
42120052|NCT00571649|75930916|FG001|Treatment Period|Physician Decision|9|||
42120053|NCT00571649|75930915|FG000|Treatment Period|Lost to Follow-up|43|||
42120054|NCT00571649|75930916|FG001|Treatment Period|Lost to Follow-up|41|||
42120055|NCT00571649|75930915|FG000|Treatment Period|Non-compliant with study medication|88|||
42120056|NCT00571649|75930916|FG001|Treatment Period|Non-compliant with study medication|89|||
42120057|NCT00571649|75930915|FG000|Treatment Period|Patient convenience|11|||
42120058|NCT00571649|75930916|FG001|Treatment Period|Patient convenience|13|||
42120059|NCT00571649|75930915|FG000|Treatment Period|Protocol Violation|90|||
42120060|NCT00571649|75930916|FG001|Treatment Period|Protocol Violation|92|||
42120061|NCT00571649|75930915|FG000|Treatment Period|Technical problems|3|||
42120062|NCT00571649|75930916|FG001|Treatment Period|Technical problems|5|||
42120063|NCT00571649|75930915|FG000|Follow-up Period|Adverse Event|46|||
42120064|NCT00571649|75930916|FG001|Follow-up Period|Adverse Event|40|||
42120065|NCT00571649|75930915|FG000|Follow-up Period|Clinical endpoint reached|5|||
42120066|NCT00571649|75930916|FG001|Follow-up Period|Clinical endpoint reached|2|||
42120067|NCT00571649|75930915|FG000|Follow-up Period|Withdrawal by Subject|119|||
42120068|NCT00571649|75930916|FG001|Follow-up Period|Withdrawal by Subject|115|||
42120069|NCT00571649|75930915|FG000|Follow-up Period|Death|132|||
42120070|NCT00571649|75930916|FG001|Follow-up Period|Death|133|||
42120071|NCT00571649|75930915|FG000|Follow-up Period|Physician Decision|7|||
42120072|NCT00571649|75930916|FG001|Follow-up Period|Physician Decision|13|||
42120073|NCT00571649|75930915|FG000|Follow-up Period|Lost to Follow-up|95|||
42120074|NCT00571649|75930916|FG001|Follow-up Period|Lost to Follow-up|92|||
42120075|NCT00571649|75930915|FG000|Follow-up Period|Patient convenience|136|||
42120076|NCT00571649|75930916|FG001|Follow-up Period|Patient convenience|121|||
42120077|NCT00571649|75930915|FG000|Follow-up Period|Protocol Violation|5|||
42120078|NCT00571649|75930916|FG001|Follow-up Period|Protocol Violation|12|||
42120079|NCT00546572|75930924|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
42120080|NCT00546572|75930925|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
42026615|NCT01134042|75834554|FG001|Overall Study|Physician Decision|8|||
42026616|NCT01134042|75834555|FG002|Overall Study|Physician Decision|1|||
42026617|NCT01134042|75834553|FG000|Overall Study|Withdrawal by Subject|13|||
42026618|NCT01134042|75834554|FG001|Overall Study|Withdrawal by Subject|4|||
42026619|NCT01134042|75834555|FG002|Overall Study|Withdrawal by Subject|7|||
42026620|NCT01179347|75834566|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
42026621|NCT01179347|75834567|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
42026622|NCT01179347|75834566|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
42026623|NCT01179347|75834567|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
42026624|NCT01179347|75834566|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
42120081|NCT00546572|75930924|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
42026625|NCT01179347|75834567|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
42026626|NCT01179347|75834566|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
42026627|NCT01179347|75834567|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
42120082|NCT00546572|75930925|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
42120083|NCT00546572|75930924|FG000|Vax 1 / Year 0|Protocol Violation|3|||
42120084|NCT00546572|75930925|FG001|Vax 1 / Year 0|Protocol Violation|4|||
42120085|NCT00546572|75930924|FG000|Vax 1 / Year 0|Death|2|||
42120086|NCT00546572|75930925|FG001|Vax 1 / Year 0|Death|2|||
42120087|NCT00546572|75930924|FG000|Vax 1 / Year 0|Adverse Event|0|||
42120088|NCT00546572|75930925|FG001|Vax 1 / Year 0|Adverse Event|1|||
42120089|NCT00546572|75930924|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
42120090|NCT00546572|75930925|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
42120091|NCT00546572|75930924|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
42120092|NCT00546572|75930925|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
42120093|NCT00546572|75930924|FG000|Vax 2 / Year 1|Other|1|||
42120094|NCT00546572|75930925|FG001|Vax 2 / Year 1|Other|1|||
42120095|NCT00546572|75930924|FG000|Vax 2 / Year 1|Adverse Event|1|||
42120096|NCT00546572|75930925|FG001|Vax 2 / Year 1|Adverse Event|0|||
42120097|NCT00546572|75930924|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
42120098|NCT00546572|75930925|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
42120099|NCT03917472|75930944|FG000|Overall Study|Physician Decision|4|||
42120100|NCT03917472|75930945|FG001|Overall Study|Physician Decision|0|||
42120101|NCT03917472|75930944|FG000|Overall Study|Adverse Event|3|||
42120102|NCT03917472|75930945|FG001|Overall Study|Adverse Event|1|||
42120103|NCT03917472|75930944|FG000|Overall Study|Death|7|||
42120104|NCT03917472|75930945|FG001|Overall Study|Death|5|||
42120105|NCT03917472|75930944|FG000|Overall Study|Withdrawal by Subject|11|||
42120106|NCT03917472|75930945|FG001|Overall Study|Withdrawal by Subject|4|||
42120107|NCT03917472|75930944|FG000|Overall Study|Lost to Follow-up|10|||
42120108|NCT03917472|75930945|FG001|Overall Study|Lost to Follow-up|5|||
42120109|NCT00681863|75930952|FG000|Overall Study|Adverse Event|1|||
42120110|NCT00681863|75930952|FG000|Overall Study|Lost to Follow-up|2|||
41963788|NCT01705977|75749888|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
41963789|NCT01705977|75749887|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
41963790|NCT01705977|75749888|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
41963791|NCT01705977|75749887|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
41963792|NCT01705977|75749888|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
41963793|NCT01705977|75749887|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
41963794|NCT01705977|75749888|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
41963795|NCT01705977|75749887|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
42120111|NCT00681863|75930952|FG000|Overall Study|Lack of Efficacy|2|||
42120112|NCT00681863|75930952|FG000|Overall Study|Other|18|||
42120113|NCT00681629|75930958|FG000|Overall Study|Study termination|4|||
42120114|NCT00681629|75930959|FG001|Overall Study|Study termination|2|||
42120115|NCT00681629|75930958|FG000|Overall Study|Adverse Event|1|||
42120116|NCT00681629|75930959|FG001|Overall Study|Adverse Event|0|||
42120117|NCT00679367|75930965|FG000|Overall Study|Adverse Event|7|||
42120118|NCT00679367|75930965|FG000|Overall Study|inability to swallow oral drugs|1|||
42120119|NCT00679367|75930965|FG000|Overall Study|Lack of Efficacy|3|||
42120120|NCT00679367|75930965|FG000|Overall Study|Withdrawal by Subject|1|||
42120121|NCT03937778|75930970|FG000|Overall Study|Withdrawal by Subject|1|||
42120122|NCT03937778|75930970|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
42120123|NCT03935126|75930974|FG000|Overall Study|Study termination by sponsor|3|||
42120124|NCT00545714|75930978|FG000|Induction Phase (6 Months)|Physician Decision|3|||
42120125|NCT00545714|75930978|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
42120126|NCT00545714|75930978|FG000|Induction Phase (6 Months)|Disease Progression|1|||
42120127|NCT00545714|75930978|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
42120128|NCT00545714|75930978|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
42120129|NCT00545714|75930978|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
42120130|NCT00545714|75930978|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
42120131|NCT00545714|75930978|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
42120132|NCT00545714|75930978|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
42120133|NCT00545714|75930978|FG000|Maintenance Phase (36 Months)|Death|2|||
42120134|NCT00539838|75930985|FG000|Overall Study|Fail to return|2|||
42120135|NCT00539838|75930986|FG001|Overall Study|Fail to return|0|||
42120136|NCT00539838|75930987|FG002|Overall Study|Fail to return|0|||
42120137|NCT00539838|75930985|FG000|Overall Study|Withdrawal by Subject|0|||
42120138|NCT00539838|75930986|FG001|Overall Study|Withdrawal by Subject|4|||
42120139|NCT00539838|75930987|FG002|Overall Study|Withdrawal by Subject|0|||
42120140|NCT00539838|75930985|FG000|Overall Study|Death|0|||
41963796|NCT01705977|75749888|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
42120141|NCT00539838|75930986|FG001|Overall Study|Death|2|||
42120142|NCT00539838|75930987|FG002|Overall Study|Death|0|||
42120143|NCT00539838|75930985|FG000|Overall Study|Did not cooperate|1|||
42120144|NCT00539838|75930986|FG001|Overall Study|Did not cooperate|0|||
42120145|NCT00539838|75930987|FG002|Overall Study|Did not cooperate|1|||
42120146|NCT00539838|75930985|FG000|Overall Study|Administrative|4|||
42120147|NCT00539838|75930986|FG001|Overall Study|Administrative|0|||
42120148|NCT00539838|75930987|FG002|Overall Study|Administrative|8|||
42120149|NCT00679289|75931000|FG000|Overall Study|Progressive disease|4|||
42120150|NCT00679289|75931001|FG001|Overall Study|Progressive disease|5|||
42120151|NCT00679289|75931002|FG002|Overall Study|Progressive disease|18|||
42120152|NCT00679289|75931000|FG000|Overall Study|Withdrawal by Subject|0|||
42120153|NCT00679289|75931001|FG001|Overall Study|Withdrawal by Subject|1|||
41963797|NCT01474889|75749897|FG000|Overall Study|Physician Decision|1|||
42120154|NCT00679289|75931002|FG002|Overall Study|Withdrawal by Subject|1|||
42120155|NCT00679289|75931000|FG000|Overall Study|Adverse Event|0|||
42120156|NCT00679289|75931001|FG001|Overall Study|Adverse Event|0|||
41963798|NCT01474889|75749898|FG001|Overall Study|Physician Decision|0|||
41963799|NCT01474889|75749899|FG002|Overall Study|Physician Decision|0|||
41963800|NCT01474889|75749897|FG000|Overall Study|Did not meet inclusion|1|||
41963801|NCT01474889|75749898|FG001|Overall Study|Did not meet inclusion|0|||
41963802|NCT01474889|75749899|FG002|Overall Study|Did not meet inclusion|0|||
41963803|NCT01474889|75749897|FG000|Overall Study|Withdrawal by Subject|0|||
41963804|NCT01474889|75749898|FG001|Overall Study|Withdrawal by Subject|1|||
41963805|NCT01474889|75749899|FG002|Overall Study|Withdrawal by Subject|0|||
41963806|NCT01231906|75749907|FG000|Overall Study|Lack of Efficacy|75|||
41963807|NCT01231906|75749908|FG001|Overall Study|Lack of Efficacy|68|||
42026628|NCT01179347|75834566|FG000|Double-blind Period (12 Weeks)|Other|2|||
42026629|NCT01179347|75834567|FG001|Double-blind Period (12 Weeks)|Other|4|||
42026630|NCT01179347|75834566|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
42026631|NCT01179347|75834567|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
42026632|NCT01179347|75834566|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
42026633|NCT01179347|75834567|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
42026634|NCT01179347|75834566|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
42026635|NCT01179347|75834567|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
42026636|NCT01179347|75834566|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
42026637|NCT01179347|75834567|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
42026638|NCT01179347|75834566|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
42026639|NCT01179347|75834567|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
42026640|NCT01179347|75834566|FG000|Open-label Period (12 Weeks)|Other|7|||
42026641|NCT01179347|75834567|FG001|Open-label Period (12 Weeks)|Other|4|||
42120157|NCT00679289|75931002|FG002|Overall Study|Adverse Event|3|||
42120158|NCT00679289|75931000|FG000|Overall Study|Physician Decision|1|||
42120159|NCT00679289|75931001|FG001|Overall Study|Physician Decision|0|||
42120160|NCT00679289|75931002|FG002|Overall Study|Physician Decision|1|||
42120161|NCT00679211|75931012|FG000|Overall Study|Progressive disease|82|||
42120162|NCT00679211|75931012|FG000|Overall Study|Adverse Event|7|||
42120163|NCT00679211|75931012|FG000|Overall Study|Withdrawal by Subject|2|||
42026642|NCT01146288|75834577|FG000|First Intervention(1 Day)|Adverse Event|0|||
42026643|NCT01146288|75834578|FG001|First Intervention(1 Day)|Adverse Event|1|||
42026644|NCT01146054|75834585|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
42026645|NCT01146054|75834585|FG000|Overall Study|Rapid tumor progression|2|||
42026646|NCT01146054|75834585|FG000|Overall Study|Other illness precluded treatment|2|||
42026647|NCT01146054|75834585|FG000|Overall Study|Lost to Follow-up|1|||
42026648|NCT01145898|75834591|FG000|3-year Treatment|medication change by treating physician|3|||
42120164|NCT00679211|75931012|FG000|Overall Study|Physician Decision|5|||
42120165|NCT00679211|75931012|FG000|Overall Study|Refused to undergo protocol procedures|1|||
42120166|NCT00679211|75931012|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
42120167|NCT00679211|75931012|FG000|Overall Study|Other|1|||
42120168|NCT00545948|75931021|FG000|Overall Study|Not Treated|1|||
42120169|NCT00545948|75931022|FG001|Overall Study|Not Treated|1|||
42120170|NCT00545948|75931023|FG002|Overall Study|Not Treated|7|||
42120171|NCT00679055|75931034|FG000|Overall Study|Adverse Event|0|||
42120172|NCT00679055|75931035|FG001|Overall Study|Adverse Event|1|||
42120173|NCT00679055|75931034|FG000|Overall Study|Other|0|||
42120174|NCT00679055|75931035|FG001|Overall Study|Other|3|||
41963808|NCT01231906|75749907|FG000|Overall Study|Lost to Follow-up|1|||
41963809|NCT01231906|75749908|FG001|Overall Study|Lost to Follow-up|0|||
41963810|NCT01231906|75749907|FG000|Overall Study|Physician Decision|34|||
42026649|NCT01145898|75834592|FG001|3-year Treatment|medication change by treating physician|16|||
42026650|NCT01133418|75834599|FG000|Overall Study|Lost to Follow-up|5|||
42026651|NCT01133418|75834600|FG001|Overall Study|Lost to Follow-up|6|||
42026652|NCT00931918|75834608|FG000|Overall Study|Adverse Event|4|||
42026653|NCT00931918|75834609|FG001|Overall Study|Adverse Event|6|||
42026654|NCT00931918|75834608|FG000|Overall Study|Progressive Disease|2|||
42120175|NCT00679055|75931034|FG000|Overall Study|Study Terminated|2|||
42120176|NCT00679055|75931035|FG001|Overall Study|Study Terminated|1|||
42120177|NCT03927950|75931041|FG000|Overall Study|Adverse Event|9|||
42120178|NCT00678899|75931046|FG000|Overall Study|Adverse Event|1|||
42120179|NCT00678587|75931053|FG000|Overall Study|Adverse Event|3|||
42120180|NCT00678587|75931054|FG001|Overall Study|Adverse Event|3|||
42120181|NCT00678587|75931053|FG000|Overall Study|Lack of Efficacy|1|||
42120182|NCT00678587|75931054|FG001|Overall Study|Lack of Efficacy|0|||
42120183|NCT00678587|75931053|FG000|Overall Study|Protocol Violation|2|||
42120184|NCT00678587|75931054|FG001|Overall Study|Protocol Violation|1|||
42120185|NCT00678587|75931053|FG000|Overall Study|Study Closed/Terminated|1|||
42120186|NCT00678587|75931054|FG001|Overall Study|Study Closed/Terminated|0|||
42120187|NCT00678587|75931053|FG000|Overall Study|Lost to Follow-up|3|||
41963811|NCT01231906|75749908|FG001|Overall Study|Physician Decision|24|||
41963812|NCT01231906|75749907|FG000|Overall Study|Withdrawal by Subject|0|||
41963813|NCT01231906|75749908|FG001|Overall Study|Withdrawal by Subject|4|||
41963814|NCT01231906|75749907|FG000|Overall Study|Ineligible|10|||
41963815|NCT01231906|75749908|FG001|Overall Study|Ineligible|3|||
41963816|NCT01231906|75749907|FG000|Overall Study|No treatment|1|||
41963817|NCT01231906|75749908|FG001|Overall Study|No treatment|2|||
41963818|NCT00724048|75749918|FG000|Overall Study|Adverse Event|1|||
41963819|NCT00724048|75749919|FG001|Overall Study|Adverse Event|1|||
41963820|NCT00724048|75749920|FG002|Overall Study|Adverse Event|1|||
41963821|NCT00724048|75749921|FG003|Overall Study|Adverse Event|0|||
41963822|NCT00724048|75749918|FG000|Overall Study|Lost to Follow-up|0|||
41963823|NCT00724048|75749919|FG001|Overall Study|Lost to Follow-up|1|||
41963824|NCT00724048|75749920|FG002|Overall Study|Lost to Follow-up|0|||
41963825|NCT00724048|75749921|FG003|Overall Study|Lost to Follow-up|0|||
41963826|NCT00724048|75749918|FG000|Overall Study|Withdrawal by Subject|1|||
41963827|NCT00724048|75749919|FG001|Overall Study|Withdrawal by Subject|2|||
41963828|NCT00724048|75749920|FG002|Overall Study|Withdrawal by Subject|1|||
41963829|NCT00724048|75749921|FG003|Overall Study|Withdrawal by Subject|2|||
41963830|NCT00724048|75749918|FG000|Overall Study|Investigator decision|0|||
41963831|NCT00724048|75749919|FG001|Overall Study|Investigator decision|0|||
41963832|NCT00724048|75749920|FG002|Overall Study|Investigator decision|1|||
41963833|NCT00724048|75749921|FG003|Overall Study|Investigator decision|0|||
41963834|NCT00724048|75749918|FG000|Overall Study|Did not tolerate study drug|0|||
41963835|NCT00724048|75749919|FG001|Overall Study|Did not tolerate study drug|0|||
41963836|NCT00724048|75749920|FG002|Overall Study|Did not tolerate study drug|0|||
41963837|NCT00724048|75749921|FG003|Overall Study|Did not tolerate study drug|1|||
41963838|NCT00724048|75749918|FG000|Overall Study|Other than specified|1|||
41963839|NCT00724048|75749919|FG001|Overall Study|Other than specified|1|||
41963840|NCT00724048|75749920|FG002|Overall Study|Other than specified|0|||
41963841|NCT00724048|75749921|FG003|Overall Study|Other than specified|0|||
41963842|NCT00304070|75749934|FG000|Overall Study|Death|0|||
41963843|NCT00304070|75749935|FG001|Overall Study|Death|0|||
41963844|NCT00304070|75749936|FG002|Overall Study|Death|3|||
41963845|NCT00304070|75749934|FG000|Overall Study|Lost to Follow-up|0|||
42120188|NCT00678587|75931054|FG001|Overall Study|Lost to Follow-up|5|||
42120189|NCT00678587|75931053|FG000|Overall Study|Investigator Discretion|2|||
42120190|NCT00678587|75931054|FG001|Overall Study|Investigator Discretion|6|||
42120191|NCT00678587|75931053|FG000|Overall Study|Withdrew Consent|8|||
42120192|NCT00678587|75931054|FG001|Overall Study|Withdrew Consent|3|||
42120193|NCT03523728|75931066|FG000|Stage 1 (24 Months)|Adverse Event|2|||
42120194|NCT03523728|75931067|FG001|Stage 1 (24 Months)|Adverse Event|2|||
42120195|NCT03523728|75931068|FG002|Stage 1 (24 Months)|Adverse Event|4|||
42120196|NCT03523728|75931069|FG003|Stage 1 (24 Months)|Adverse Event|0|||
42120197|NCT03523728|75931070|FG004|Stage 1 (24 Months)|Adverse Event|0|||
42120198|NCT03523728|75931066|FG000|Stage 1 (24 Months)|Progressive disease|0|||
42120199|NCT03523728|75931067|FG001|Stage 1 (24 Months)|Progressive disease|0|||
42120200|NCT03523728|75931068|FG002|Stage 1 (24 Months)|Progressive disease|1|||
42120201|NCT03523728|75931069|FG003|Stage 1 (24 Months)|Progressive disease|0|||
42120202|NCT03523728|75931070|FG004|Stage 1 (24 Months)|Progressive disease|0|||
42120203|NCT03523728|75931066|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
42120204|NCT03523728|75931067|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
42120205|NCT03523728|75931068|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
42120206|NCT03523728|75931069|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
42120207|NCT03523728|75931070|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
42120208|NCT03523728|75931066|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
42120209|NCT03523728|75931067|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
42120210|NCT03523728|75931068|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
42120211|NCT03523728|75931069|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
42210353|NCT02936037|76025130|FG001|Open Label Extension|Other|3|||
41963846|NCT00304070|75749935|FG001|Overall Study|Lost to Follow-up|0|||
41963847|NCT00304070|75749936|FG002|Overall Study|Lost to Follow-up|1|||
41963848|NCT00304070|75749934|FG000|Overall Study|Physician Decision|0|||
41963849|NCT00304070|75749935|FG001|Overall Study|Physician Decision|0|||
41963850|NCT00304070|75749936|FG002|Overall Study|Physician Decision|3|||
41963851|NCT00304070|75749934|FG000|Overall Study|Withdrawal by Subject|0|||
41963852|NCT00304070|75749935|FG001|Overall Study|Withdrawal by Subject|0|||
41963853|NCT00304070|75749936|FG002|Overall Study|Withdrawal by Subject|1|||
41963854|NCT00304070|75749934|FG000|Overall Study|Progressive Disease|3|||
42120212|NCT03523728|75931070|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
42120213|NCT03523728|75931066|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
42120214|NCT03523728|75931067|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
42120215|NCT03523728|75931068|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
41963855|NCT00304070|75749935|FG001|Overall Study|Progressive Disease|7|||
41963856|NCT00304070|75749936|FG002|Overall Study|Progressive Disease|4|||
42120216|NCT03523728|75931069|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
41963857|NCT00160680|75749950|FG000|Overall Study|Adverse Event|0|||
41963858|NCT00160680|75749951|FG001|Overall Study|Adverse Event|1|||
42120217|NCT03523728|75931070|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
42120218|NCT03523728|75931066|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
42120219|NCT03523728|75931067|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
42120220|NCT03523728|75931068|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
42120221|NCT03523728|75931069|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
42120222|NCT03523728|75931070|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
42120223|NCT03523728|75931066|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
42120224|NCT03523728|75931067|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
42120225|NCT03523728|75931068|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
42120226|NCT03523728|75931069|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
42120227|NCT03523728|75931070|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
42120228|NCT03523728|75931066|FG000|Stage 2 (24 Months)|Adverse Event|0|||
42120229|NCT03523728|75931067|FG001|Stage 2 (24 Months)|Adverse Event|0|||
42120230|NCT03523728|75931068|FG002|Stage 2 (24 Months)|Adverse Event|0|||
42120231|NCT03523728|75931069|FG003|Stage 2 (24 Months)|Adverse Event|1|||
42120232|NCT03523728|75931070|FG004|Stage 2 (24 Months)|Adverse Event|2|||
42120233|NCT03523728|75931066|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
42120234|NCT03523728|75931067|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
42120235|NCT03523728|75931068|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
42120236|NCT03523728|75931069|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
42120237|NCT03523728|75931070|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
42120238|NCT03523728|75931066|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
42120239|NCT03523728|75931067|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
42120240|NCT03523728|75931068|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
42120241|NCT03523728|75931069|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
42120242|NCT03523728|75931070|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
42120243|NCT03523728|75931066|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
42120244|NCT03523728|75931067|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
42120245|NCT03523728|75931068|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
42120246|NCT03523728|75931069|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
42120247|NCT03523728|75931070|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
42120248|NCT03523728|75931066|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
42120249|NCT03523728|75931067|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
42120250|NCT03523728|75931068|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
42120251|NCT03523728|75931069|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
42120252|NCT03523728|75931070|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
42120253|NCT00538590|75931089|FG000|Overall Study|Death|1|||
42120254|NCT00538590|75931090|FG001|Overall Study|Death|0|||
42120255|NCT00466947|75931098|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
42120256|NCT00466947|75931099|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
42120257|NCT00466947|75931098|FG000|Study End Analysis Period|Adverse Event|35|||
42120258|NCT00466947|75931099|FG001|Study End Analysis Period|Adverse Event|43|||
42120259|NCT00466947|75931098|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
42120260|NCT00466947|75931099|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
42120261|NCT00466947|75931098|FG000|Study End Analysis Period|Physician Decision|29|||
42120262|NCT00466947|75931099|FG001|Study End Analysis Period|Physician Decision|29|||
42120263|NCT00466947|75931098|FG000|Study End Analysis Period|Protocol Violation|9|||
42120264|NCT00466947|75931099|FG001|Study End Analysis Period|Protocol Violation|17|||
42120265|NCT00466947|75931098|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
42120266|NCT00466947|75931099|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
42120267|NCT00466947|75931098|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
42120268|NCT00466947|75931099|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
42120269|NCT00466947|75931098|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
42120270|NCT00466947|75931099|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
42120271|NCT00466947|75931098|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
42120272|NCT00466947|75931099|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
42120273|NCT00537810|75931110|FG000|Overall Study|Withdrawal by Subject|4|||
42120274|NCT00537810|75931111|FG001|Overall Study|Withdrawal by Subject|11|||
42120275|NCT00537810|75931112|FG002|Overall Study|Withdrawal by Subject|4|||
41963859|NCT00160680|75749950|FG000|Overall Study|Lack of Efficacy|2|||
41963860|NCT00160680|75749951|FG001|Overall Study|Lack of Efficacy|1|||
41963861|NCT00160680|75749950|FG000|Overall Study|Lost to Follow-up|3|||
41963862|NCT00160680|75749951|FG001|Overall Study|Lost to Follow-up|2|||
41963863|NCT00160680|75749950|FG000|Overall Study|Withdrawal by Subject|4|||
41963864|NCT00160680|75749951|FG001|Overall Study|Withdrawal by Subject|9|||
41963865|NCT03671148|75750806|FG000|Overall Study|Adverse Event|3|||
41963866|NCT03671148|75750807|FG001|Overall Study|Adverse Event|2|||
41963867|NCT03671148|75750806|FG000|Overall Study|Withdrawal by Subject|8|||
41963868|NCT03671148|75750807|FG001|Overall Study|Withdrawal by Subject|2|||
41963869|NCT03671148|75750806|FG000|Overall Study|Lost to Follow-up|1|||
41963870|NCT03671148|75750807|FG001|Overall Study|Lost to Follow-up|2|||
41963871|NCT03671148|75750806|FG000|Overall Study|Lack of Efficacy|7|||
41963872|NCT03671148|75750807|FG001|Overall Study|Lack of Efficacy|2|||
41963873|NCT03671148|75750806|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
41963874|NCT03671148|75750807|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
41963875|NCT03671148|75750806|FG000|Overall Study|Other|1|||
41963876|NCT03671148|75750807|FG001|Overall Study|Other|0|||
42026655|NCT00931918|75834609|FG001|Overall Study|Progressive Disease|1|||
42026656|NCT00931918|75834608|FG000|Overall Study|Symptomatic Deterioration|1|||
42026657|NCT00931918|75834609|FG001|Overall Study|Symptomatic Deterioration|0|||
42026658|NCT00931918|75834608|FG000|Overall Study|Withdrawal by Patient|3|||
42026659|NCT00931918|75834609|FG001|Overall Study|Withdrawal by Patient|4|||
42026660|NCT00931918|75834608|FG000|Overall Study|Other Reason not Specified|4|||
42026661|NCT00931918|75834609|FG001|Overall Study|Other Reason not Specified|4|||
42026662|NCT00931918|75834608|FG000|Overall Study|Did not receive study drug|3|||
42026663|NCT00931918|75834609|FG001|Overall Study|Did not receive study drug|2|||
42026664|NCT01179191|75834615|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
42026665|NCT01179191|75834615|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
42026666|NCT01179191|75834615|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
42026667|NCT01179191|75834615|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
42026668|NCT01179191|75834615|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
42026669|NCT01179191|75834615|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
42026670|NCT01179191|75834615|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
42026671|NCT01179191|75834615|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
42026672|NCT01179191|75834615|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
42026673|NCT01179191|75834615|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
42026674|NCT01179191|75834615|FG000|Maintenance Phase (8 Weeks)|Other|66|||
42026675|NCT01169844|75834621|FG000|Overall Study|Adverse Event|0|||
42026676|NCT01169844|75834622|FG001|Overall Study|Adverse Event|1|||
42026677|NCT01169844|75834621|FG000|Overall Study|Patient withdrew consent|4|||
42026678|NCT01169844|75834622|FG001|Overall Study|Patient withdrew consent|0|||
42026679|NCT01169844|75834621|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42120276|NCT00537810|75931113|FG003|Overall Study|Withdrawal by Subject|3|||
41963877|NCT03671148|75750806|FG000|Overall Study|Incomplete Randomization Visit|1|||
41963878|NCT03671148|75750807|FG001|Overall Study|Incomplete Randomization Visit|0|||
41963879|NCT01430442|75750821|FG000|Overall Study|Subject Withdrew Consent|3|||
42026680|NCT01169844|75834622|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42026681|NCT01132482|75834630|FG000|Overall Study|Adverse Event|1|||
41963880|NCT01430442|75750822|FG001|Overall Study|Subject Withdrew Consent|0|||
41963881|NCT01430442|75750823|FG002|Overall Study|Subject Withdrew Consent|1|||
41963882|NCT01430442|75750824|FG003|Overall Study|Subject Withdrew Consent|0|||
41963883|NCT01430442|75750825|FG004|Overall Study|Subject Withdrew Consent|2|||
41963884|NCT01430442|75750826|FG005|Overall Study|Subject Withdrew Consent|1|||
41963885|NCT01430442|75750827|FG006|Overall Study|Subject Withdrew Consent|5|||
42120277|NCT00537810|75931110|FG000|Overall Study|Medically withdrawn|2|||
42120278|NCT00537810|75931111|FG001|Overall Study|Medically withdrawn|2|||
42120279|NCT00537810|75931112|FG002|Overall Study|Medically withdrawn|0|||
42120280|NCT00537810|75931113|FG003|Overall Study|Medically withdrawn|1|||
42120281|NCT01287936|75931126|FG000|Overall Study|Lost to Follow-up|0|||
42120282|NCT01287936|75931127|FG001|Overall Study|Lost to Follow-up|1|||
42120283|NCT01287936|75931128|FG002|Overall Study|Lost to Follow-up|1|||
42120284|NCT00090259|75931138|FG000|Overall Study|Lost to Follow-up|30|||
42120285|NCT00090259|75931139|FG001|Overall Study|Lost to Follow-up|26|||
42120286|NCT00090259|75931138|FG000|Overall Study|Withdrawal by Subject|21|||
42120287|NCT00090259|75931139|FG001|Overall Study|Withdrawal by Subject|15|||
42120288|NCT00090259|75931138|FG000|Overall Study|Investigator site closed|11|||
42120289|NCT00090259|75931139|FG001|Overall Study|Investigator site closed|7|||
42120290|NCT00079183|75931145|FG000|Overall Study|Withdrawal by Subject|4|||
42120291|NCT00079183|75931145|FG000|Overall Study|Study medication non-compliance|2|||
42120292|NCT00079183|75931145|FG000|Overall Study|Specimen collection non-compliance|1|||
42120293|NCT00676403|75931156|FG000|Overall Study|Adverse Event|1|||
42120294|NCT00676403|75931157|FG001|Overall Study|Adverse Event|2|||
42120295|NCT00676403|75931158|FG002|Overall Study|Adverse Event|0|||
42120296|NCT00676403|75931159|FG003|Overall Study|Adverse Event|5|||
42120297|NCT00676403|75931160|FG004|Overall Study|Adverse Event|1|||
42120298|NCT00676403|75931161|FG005|Overall Study|Adverse Event|2|||
42120299|NCT00676403|75931156|FG000|Overall Study|Lost to Follow-up|0|||
42120300|NCT00676403|75931157|FG001|Overall Study|Lost to Follow-up|0|||
42120301|NCT00676403|75931158|FG002|Overall Study|Lost to Follow-up|0|||
42120302|NCT00676403|75931159|FG003|Overall Study|Lost to Follow-up|0|||
42120303|NCT00676403|75931160|FG004|Overall Study|Lost to Follow-up|0|||
42120304|NCT00676403|75931161|FG005|Overall Study|Lost to Follow-up|1|||
42120305|NCT00676403|75931156|FG000|Overall Study|Reason Unspecified|1|||
42120306|NCT00676403|75931157|FG001|Overall Study|Reason Unspecified|0|||
42120307|NCT00676403|75931158|FG002|Overall Study|Reason Unspecified|1|||
42120308|NCT00676403|75931159|FG003|Overall Study|Reason Unspecified|0|||
42120309|NCT00676403|75931160|FG004|Overall Study|Reason Unspecified|0|||
41963886|NCT01430442|75750828|FG007|Overall Study|Subject Withdrew Consent|2|||
41963887|NCT01430442|75750821|FG000|Overall Study|Lost to Follow-up|2|||
41963888|NCT01430442|75750822|FG001|Overall Study|Lost to Follow-up|0|||
41963889|NCT01430442|75750823|FG002|Overall Study|Lost to Follow-up|1|||
42026682|NCT01132482|75834631|FG001|Overall Study|Adverse Event|0|||
42026683|NCT00931762|75834637|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
42026684|NCT00931762|75834637|FG000|Overall Study|Administrative Problems|5|||
42026685|NCT00931762|75834637|FG000|Overall Study|Death|1|||
42026686|NCT00931762|75834637|FG000|Overall Study|Disease Progression|3|||
42026687|NCT00931762|75834637|FG000|Overall Study|Adverse Event (s)|11|||
42026688|NCT00931762|75834637|FG000|Overall Study|Subject withdrew consent|13|||
42026689|NCT01132326|75834641|FG000|Overall Study|Lack of Efficacy|25|||
42026690|NCT01132326|75834641|FG000|Overall Study|Adverse Event|37|||
42026691|NCT01132326|75834641|FG000|Overall Study|Protocol Violation|1|||
42026692|NCT01132326|75834641|FG000|Overall Study|Lost to Follow-up|16|||
42026693|NCT01132326|75834641|FG000|Overall Study|Withdrawal by Subject|40|||
42026694|NCT01132326|75834641|FG000|Overall Study|Physician Decision|10|||
42026695|NCT01132326|75834641|FG000|Overall Study|Study Termination|80|||
42120310|NCT00676403|75931161|FG005|Overall Study|Reason Unspecified|1|||
42120311|NCT00676403|75931156|FG000|Overall Study|Withdrawal by Subject|0|||
42120312|NCT00676403|75931157|FG001|Overall Study|Withdrawal by Subject|0|||
42120313|NCT00676403|75931158|FG002|Overall Study|Withdrawal by Subject|0|||
42120314|NCT00676403|75931159|FG003|Overall Study|Withdrawal by Subject|0|||
42120315|NCT00676403|75931160|FG004|Overall Study|Withdrawal by Subject|0|||
42120316|NCT00676403|75931161|FG005|Overall Study|Withdrawal by Subject|1|||
42120317|NCT00078325|75931184|FG000|Overall Study|Adverse Event|15|||
42120318|NCT00078325|75931185|FG001|Overall Study|Adverse Event|10|||
42120319|NCT00078325|75931186|FG002|Overall Study|Adverse Event|5|||
42120320|NCT00078325|75931184|FG000|Overall Study|Protocol Violation|2|||
42120321|NCT00078325|75931185|FG001|Overall Study|Protocol Violation|2|||
42120322|NCT00078325|75931186|FG002|Overall Study|Protocol Violation|0|||
41963890|NCT01430442|75750824|FG003|Overall Study|Lost to Follow-up|2|||
42026696|NCT01132326|75834641|FG000|Overall Study|Declining Health|1|||
42026697|NCT01132326|75834641|FG000|Overall Study|Pregnancy|1|||
42120323|NCT00078325|75931184|FG000|Overall Study|Withdrawal by Subject|1|||
42120324|NCT00078325|75931185|FG001|Overall Study|Withdrawal by Subject|5|||
42120325|NCT00078325|75931186|FG002|Overall Study|Withdrawal by Subject|3|||
42120326|NCT00078325|75931184|FG000|Overall Study|Lost to Follow-up|0|||
42120327|NCT00078325|75931185|FG001|Overall Study|Lost to Follow-up|1|||
42120328|NCT00078325|75931186|FG002|Overall Study|Lost to Follow-up|1|||
42120329|NCT00078325|75931184|FG000|Overall Study|Physician Decision|2|||
42120330|NCT00078325|75931185|FG001|Overall Study|Physician Decision|0|||
42120331|NCT00078325|75931186|FG002|Overall Study|Physician Decision|1|||
42120332|NCT00078325|75931184|FG000|Overall Study|Miscellaneous|1|||
42120333|NCT00078325|75931185|FG001|Overall Study|Miscellaneous|1|||
42120334|NCT00078325|75931186|FG002|Overall Study|Miscellaneous|1|||
42120335|NCT00077857|75931196|FG000|Overall Study|Adverse Event|30|||
42120336|NCT00077857|75931197|FG001|Overall Study|Adverse Event|32|||
42120337|NCT00077857|75931196|FG000|Overall Study|Death|7|||
42120338|NCT00077857|75931197|FG001|Overall Study|Death|3|||
42120339|NCT00077857|75931196|FG000|Overall Study|Insufficient therapeutic response|112|||
42120340|NCT00077857|75931197|FG001|Overall Study|Insufficient therapeutic response|128|||
42120341|NCT00077857|75931196|FG000|Overall Study|Violation of selection criteria at entry|3|||
42120342|NCT00077857|75931197|FG001|Overall Study|Violation of selection criteria at entry|1|||
42120343|NCT00077857|75931196|FG000|Overall Study|Other protocol violation|0|||
41963891|NCT01430442|75750825|FG004|Overall Study|Lost to Follow-up|2|||
41963892|NCT01430442|75750826|FG005|Overall Study|Lost to Follow-up|1|||
41963893|NCT01430442|75750827|FG006|Overall Study|Lost to Follow-up|5|||
41963894|NCT01430442|75750828|FG007|Overall Study|Lost to Follow-up|1|||
41963895|NCT01430442|75750821|FG000|Overall Study|Pregnancy|1|||
41963896|NCT01430442|75750822|FG001|Overall Study|Pregnancy|0|||
41963897|NCT01430442|75750823|FG002|Overall Study|Pregnancy|0|||
41963898|NCT01430442|75750824|FG003|Overall Study|Pregnancy|0|||
41963899|NCT01430442|75750825|FG004|Overall Study|Pregnancy|0|||
41963900|NCT01430442|75750826|FG005|Overall Study|Pregnancy|1|||
41963901|NCT01430442|75750827|FG006|Overall Study|Pregnancy|0|||
41963902|NCT01430442|75750828|FG007|Overall Study|Pregnancy|0|||
41963903|NCT01430442|75750821|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
41963904|NCT01430442|75750822|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
41963905|NCT01430442|75750823|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
41963906|NCT01430442|75750824|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
41963907|NCT01430442|75750825|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
41963908|NCT01430442|75750826|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
41963909|NCT01430442|75750827|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
41963910|NCT01430442|75750828|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
41963911|NCT01420926|75750848|FG000|Overall Study|Adverse Event|6|||
41963912|NCT01420926|75750849|FG001|Overall Study|Adverse Event|4|||
42120344|NCT00077857|75931197|FG001|Overall Study|Other protocol violation|1|||
42120345|NCT00077857|75931196|FG000|Overall Study|Refused treatment|29|||
42120346|NCT00077857|75931197|FG001|Overall Study|Refused treatment|21|||
42120347|NCT00077857|75931196|FG000|Overall Study|Failure to return|5|||
42120348|NCT00077857|75931197|FG001|Overall Study|Failure to return|5|||
42120349|NCT00077857|75931196|FG000|Overall Study|Other|15|||
41963913|NCT01420926|75750848|FG000|Overall Study|Death|18|||
41963914|NCT01420926|75750849|FG001|Overall Study|Death|17|||
41963915|NCT01420926|75750848|FG000|Overall Study|Withdrawal by Subject|11|||
42026698|NCT01132326|75834641|FG000|Overall Study|Caregiver Withdrew Consent|1|||
42026699|NCT01132326|75834641|FG000|Overall Study|Death|5|||
42026700|NCT01132326|75834641|FG000|Overall Study|Subject Unable to Come To Visits|1|||
42026701|NCT01178411|75834645|FG000|Overall Study|Adverse Event|5|||
42026702|NCT01178411|75834645|FG000|Overall Study|Withdrawal by Subject|4|||
42026703|NCT01178411|75834645|FG000|Overall Study|Protocol Violation|1|||
42026704|NCT01178411|75834645|FG000|Overall Study|Progressive disease per RECIST|32|||
42026705|NCT01178411|75834645|FG000|Overall Study|Progressive disease per clinician|9|||
42026706|NCT01178411|75834645|FG000|Overall Study|Physician Decision|6|||
42026707|NCT01178411|75834645|FG000|Overall Study|Death|1|||
42026708|NCT01178411|75834645|FG000|Overall Study|No reason provided|1|||
42026709|NCT01178411|75834645|FG000|Overall Study|Drug manufacturing ended|1|||
42026710|NCT01145508|75834651|FG000|Overall Study|Adverse Event|1|||
42026711|NCT01145508|75834652|FG001|Overall Study|Adverse Event|0|||
42120350|NCT00077857|75931197|FG001|Overall Study|Other|13|||
42120351|NCT00545402|75931205|FG000|Overall Study|Discontinuation of treatment|17|||
42120352|NCT00545402|75931206|FG001|Overall Study|Discontinuation of treatment|9|||
41963916|NCT01420926|75750849|FG001|Overall Study|Withdrawal by Subject|17|||
41963917|NCT01420926|75750848|FG000|Overall Study|Non-protocol treatment|17|||
41963918|NCT01420926|75750849|FG001|Overall Study|Non-protocol treatment|20|||
41963919|NCT01420926|75750848|FG000|Overall Study|Physician Decision|8|||
42026712|NCT01145508|75834651|FG000|Overall Study|Death|1|||
42026713|NCT01145508|75834652|FG001|Overall Study|Death|0|||
42026714|NCT01145508|75834651|FG000|Overall Study|Physician Decision|2|||
42026715|NCT01145508|75834652|FG001|Overall Study|Physician Decision|1|||
42120353|NCT00545402|75931205|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
42120354|NCT00545402|75931206|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
42120355|NCT00545402|75931205|FG000|Overall Study|Death|5|||
42120356|NCT00545402|75931206|FG001|Overall Study|Death|7|||
42120357|NCT00545402|75931205|FG000|Overall Study|Graft loss|2|||
42120358|NCT00545402|75931206|FG001|Overall Study|Graft loss|4|||
42120359|NCT00545402|75931205|FG000|Overall Study|Withdrawal by Subject|0|||
42120360|NCT00545402|75931206|FG001|Overall Study|Withdrawal by Subject|1|||
42120361|NCT00545402|75931205|FG000|Overall Study|Protocol Violation|1|||
42120362|NCT00545402|75931206|FG001|Overall Study|Protocol Violation|0|||
42120363|NCT00545402|75931205|FG000|Overall Study|Reason not specified|1|||
42120364|NCT00545402|75931206|FG001|Overall Study|Reason not specified|1|||
42120365|NCT00545792|75931212|FG000|Overall Study|Withdrawal by Subject|1|||
42120366|NCT00545168|75931219|FG000|Overall Study|Lost to Follow-up|5|||
42120367|NCT00545168|75931220|FG001|Overall Study|Lost to Follow-up|5|||
42120368|NCT00545168|75931221|FG002|Overall Study|Lost to Follow-up|5|||
42120369|NCT00545168|75931219|FG000|Overall Study|Withdrawal by Subject|9|||
42120370|NCT00545168|75931220|FG001|Overall Study|Withdrawal by Subject|0|||
42120371|NCT00545168|75931221|FG002|Overall Study|Withdrawal by Subject|13|||
42120372|NCT00545168|75931219|FG000|Overall Study|Protocol Violation|1|||
42120373|NCT00545168|75931220|FG001|Overall Study|Protocol Violation|0|||
42120374|NCT00545168|75931221|FG002|Overall Study|Protocol Violation|1|||
42120375|NCT00545168|75931219|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
42120376|NCT00545168|75931220|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
42120377|NCT00545168|75931221|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
42120378|NCT00544544|75931230|FG000|Overall Study|Withdrawal by Subject|1|||
42120379|NCT00544544|75931230|FG000|Overall Study|Adverse Event|1|||
42120380|NCT00544544|75931230|FG000|Overall Study|Lost to Follow-up|1|||
42120381|NCT00541346|75931234|FG000|Follow-up|Adverse Event|1|||
42120382|NCT00077623|75931241|FG000|Overall Study|Adverse Event|1|||
42120383|NCT00077623|75931242|FG001|Overall Study|Adverse Event|0|||
42120384|NCT00077623|75931243|FG002|Overall Study|Adverse Event|1|||
42120385|NCT00077623|75931241|FG000|Overall Study|Withdrawal by Subject|2|||
42120386|NCT00077623|75931242|FG001|Overall Study|Withdrawal by Subject|10|||
42120387|NCT00077623|75931243|FG002|Overall Study|Withdrawal by Subject|1|||
42120388|NCT00077623|75931241|FG000|Overall Study|Other-Non safety reason|18|||
42120389|NCT00077623|75931242|FG001|Overall Study|Other-Non safety reason|15|||
42120390|NCT00077623|75931243|FG002|Overall Study|Other-Non safety reason|19|||
42120391|NCT00077623|75931241|FG000|Overall Study|Insufficient therapeutic response|2|||
42120392|NCT00077623|75931242|FG001|Overall Study|Insufficient therapeutic response|0|||
42120393|NCT00077623|75931243|FG002|Overall Study|Insufficient therapeutic response|0|||
42120394|NCT00077623|75931241|FG000|Overall Study|Death|12|||
42120395|NCT00077623|75931242|FG001|Overall Study|Death|18|||
42120396|NCT00077623|75931243|FG002|Overall Study|Death|11|||
42120397|NCT00077623|75931241|FG000|Overall Study|Failure to return|1|||
42120398|NCT00077623|75931242|FG001|Overall Study|Failure to return|0|||
42026716|NCT01145508|75834651|FG000|Overall Study|Never started treatment|1|||
42026717|NCT01145508|75834652|FG001|Overall Study|Never started treatment|1|||
42026718|NCT00931528|75834660|FG000|Overall Study|Protocol Violation|9|||
42026719|NCT00931528|75834661|FG001|Overall Study|Protocol Violation|12|||
42026720|NCT00931528|75834660|FG000|Overall Study|Withdrawal by Subject|4|||
42026721|NCT00931528|75834661|FG001|Overall Study|Withdrawal by Subject|12|||
42026722|NCT00931528|75834660|FG000|Overall Study|Lost to Follow-up|6|||
42026723|NCT00931528|75834661|FG001|Overall Study|Lost to Follow-up|13|||
42026724|NCT00931528|75834660|FG000|Overall Study|Assessment outside of Time Frame|22|||
42026725|NCT00931528|75834661|FG001|Overall Study|Assessment outside of Time Frame|23|||
42026726|NCT00975195|75834670|FG000|Overall Study|Adverse Event|108|||
42026727|NCT00975195|75834671|FG001|Overall Study|Adverse Event|101|||
42026728|NCT00975195|75834670|FG000|Overall Study|Lack of Efficacy|6|||
42026729|NCT00975195|75834671|FG001|Overall Study|Lack of Efficacy|6|||
42026730|NCT00975195|75834670|FG000|Overall Study|Protocol Violation|27|||
42026731|NCT00975195|75834671|FG001|Overall Study|Protocol Violation|23|||
42026732|NCT00975195|75834670|FG000|Overall Study|Lost to Follow-up|9|||
42026733|NCT00975195|75834671|FG001|Overall Study|Lost to Follow-up|7|||
42026734|NCT00975195|75834670|FG000|Overall Study|Withdrawal by Subject|48|||
42026735|NCT00975195|75834671|FG001|Overall Study|Withdrawal by Subject|61|||
42026736|NCT00975195|75834670|FG000|Overall Study|Other reason not defined above|29|||
42120399|NCT00077623|75931243|FG002|Overall Study|Failure to return|0|||
42120400|NCT00541034|75931251|FG000|Overall Study|Non-Compliance|3|||
42120401|NCT00540644|75931257|FG000|Overall Study|Adverse Event|3|||
42120402|NCT00540644|75931258|FG001|Overall Study|Adverse Event|1|||
42120403|NCT00540644|75931257|FG000|Overall Study|Disease Progression|3|||
42120404|NCT00540644|75931258|FG001|Overall Study|Disease Progression|1|||
42120405|NCT00540644|75931257|FG000|Overall Study|Physician Decision|0|||
42120406|NCT00540644|75931258|FG001|Overall Study|Physician Decision|5|||
42026737|NCT00975195|75834671|FG001|Overall Study|Other reason not defined above|33|||
42026738|NCT00975195|75834670|FG000|Overall Study|Not treated|1|||
42026739|NCT00975195|75834671|FG001|Overall Study|Not treated|2|||
42026740|NCT01145352|75834677|FG000|Overall Study|Found to have been registered twice|6|||
42120407|NCT00540644|75931257|FG000|Overall Study|Withdrawal by Subject|2|||
42120408|NCT00540644|75931258|FG001|Overall Study|Withdrawal by Subject|2|||
42120409|NCT00540644|75931257|FG000|Overall Study|Noncomplilance|1|||
42120410|NCT00540644|75931258|FG001|Overall Study|Noncomplilance|0|||
42120411|NCT00543296|75931264|FG000|Overall Study|Physician Decision|7|||
42120412|NCT00543140|75931268|FG000|Overall Study|Lost to Follow-up|33|||
42120413|NCT00543140|75931268|FG000|Overall Study|Withdrawal by Subject|13|||
42120414|NCT00543140|75931268|FG000|Overall Study|Protocol Violation|10|||
42120415|NCT00543140|75931268|FG000|Overall Study|Insufficient weight loss|10|||
42120416|NCT00543140|75931268|FG000|Overall Study|SAE leading to explant of SAGB|3|||
42120417|NCT00543140|75931268|FG000|Overall Study|Death|1|||
42120418|NCT00543140|75931268|FG000|Overall Study|Subject moved|1|||
42120419|NCT00543140|75931268|FG000|Overall Study|Conversion to different procedure|1|||
42120420|NCT00543062|75931272|FG000|Overall Study|Withdrawal by Subject|1|||
42120421|NCT00543062|75931273|FG001|Overall Study|Withdrawal by Subject|0|||
42120422|NCT00543062|75931274|FG002|Overall Study|Withdrawal by Subject|2|||
42120423|NCT00543062|75931275|FG003|Overall Study|Withdrawal by Subject|0|||
42120424|NCT00543062|75931272|FG000|Overall Study|Adverse Event|0|||
42120425|NCT00543062|75931273|FG001|Overall Study|Adverse Event|1|||
42120426|NCT00543062|75931274|FG002|Overall Study|Adverse Event|1|||
42120427|NCT00543062|75931275|FG003|Overall Study|Adverse Event|1|||
41963920|NCT01420926|75750849|FG001|Overall Study|Physician Decision|5|||
41963921|NCT04303572|75751405|FG000|Overall Study|Study closed due to poor enrollment|1|||
41963922|NCT03551730|75751437|FG000|Overall Study|Adverse Event|1|||
41963923|NCT03551730|75751438|FG001|Overall Study|Adverse Event|0|||
41963924|NCT03551730|75751439|FG002|Overall Study|Adverse Event|0|||
41963925|NCT03551730|75751440|FG003|Overall Study|Adverse Event|0|||
41963926|NCT02534844|75751452|FG000|Part B|Withdrawal by Subject|0|||
41963927|NCT02534844|75751453|FG001|Part B|Withdrawal by Subject|0|||
41963928|NCT02534844|75751454|FG002|Part B|Withdrawal by Subject|0|||
41963929|NCT02534844|75751455|FG003|Part B|Withdrawal by Subject|0|||
41963930|NCT02534844|75751456|FG004|Part B|Withdrawal by Subject|2|||
41963931|NCT02534844|75751457|FG005|Part B|Withdrawal by Subject|1|||
41963932|NCT01818492|75751474|FG000|Overall Study|Adverse Event|2|||
42026741|NCT01145352|75834677|FG000|Overall Study|Treated before marketing approval|4|||
42026742|NCT01145352|75834677|FG000|Overall Study|Syringe formulation was used|1|||
42026743|NCT01178099|75834685|FG000|Overall Study|Physician Decision|0|||
42026744|NCT01178099|75834686|FG001|Overall Study|Physician Decision|1|||
42026745|NCT01169532|75834696|FG000|Overall Study|Withdrawal by Subject|1|||
42026746|NCT00928564|75834702|FG000|Overall Study|Lost to Follow-up|6|||
42026747|NCT00928564|75834703|FG001|Overall Study|Lost to Follow-up|0|||
42026748|NCT01177943|75834711|FG000|First Intervention|Withdrawal by Subject|2|||
42026749|NCT01177943|75834712|FG001|First Intervention|Withdrawal by Subject|0|||
42026750|NCT01131312|75834721|FG000|Overall Study|Lost to Follow-up|425|||
42026751|NCT01131312|75834722|FG001|Overall Study|Lost to Follow-up|229|||
42026752|NCT01131312|75834723|FG002|Overall Study|Lost to Follow-up|351|||
42026753|NCT01177787|75834731|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
42026754|NCT01177787|75834731|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
42026755|NCT01177787|75834731|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
42026756|NCT00928486|75834743|FG000|Overall Study|Adverse Event|2|||
42026757|NCT00928486|75834743|FG000|Overall Study|Disease Progression|7|||
42026758|NCT00928486|75834743|FG000|Overall Study|Withdrawal by Subject|1|||
42026759|NCT01168596|75834749|FG000|Overall Study|Withdrawal by Subject|3|||
42026760|NCT01168596|75834750|FG001|Overall Study|Withdrawal by Subject|1|||
42026761|NCT01177553|75834758|FG000|Overall Study|babies not yet 6 months of age|1|||
42026762|NCT01177553|75834759|FG001|Overall Study|babies not yet 6 months of age|0|||
42026763|NCT00928408|75834765|FG000|Overall Study|Other|2|||
42026764|NCT00928408|75834765|FG000|Overall Study|Withdrawal by Subject|4|||
42026765|NCT00928408|75834765|FG000|Overall Study|Death|5|||
42026766|NCT00928408|75834765|FG000|Overall Study|Lost to Follow-up|12|||
42026767|NCT00928252|75834769|FG000|Overall Study|Physician Decision|3|||
42026768|NCT01177007|75834775|FG000|Overall Study|Lost to Follow-up|2|||
42026769|NCT01177007|75834775|FG000|Overall Study|Death|4|||
42026770|NCT01177007|75834775|FG000|Overall Study|Entered hospice care|5|||
42026771|NCT01177007|75834775|FG000|Overall Study|Required additional Y90 treatment|6|||
42026772|NCT01177007|75834775|FG000|Overall Study|Change in treatment modality|21|||
42026773|NCT00930982|75834783|FG000|Overall Study|Adverse Event|19|||
42026774|NCT00930982|75834784|FG001|Overall Study|Adverse Event|23|||
42120428|NCT00543062|75931272|FG000|Overall Study|Protocol Violation|1|||
41963933|NCT01818492|75751474|FG000|Overall Study|Death|3|||
41963934|NCT01818492|75751474|FG000|Overall Study|Withdrawal by Subject|1|||
42026775|NCT00930982|75834783|FG000|Overall Study|Protocol Violation|1|||
42026776|NCT00930982|75834784|FG001|Overall Study|Protocol Violation|5|||
42026777|NCT00930982|75834783|FG000|Overall Study|Withdrawal by Subject|1|||
42026778|NCT00930982|75834784|FG001|Overall Study|Withdrawal by Subject|1|||
42026779|NCT01176773|75834790|FG000|Overall Study|Screen Failure|2|||
42026780|NCT01176773|75834790|FG000|Overall Study|Withdrew consent|1|||
42120429|NCT00543062|75931273|FG001|Overall Study|Protocol Violation|0|||
42120430|NCT00543062|75931274|FG002|Overall Study|Protocol Violation|0|||
42120431|NCT00543062|75931275|FG003|Overall Study|Protocol Violation|0|||
42120432|NCT03911960|75931295|FG000|Overall Study|Lost to Follow-up|5|||
42120433|NCT03911960|75931296|FG001|Overall Study|Lost to Follow-up|3|||
42120434|NCT00676091|75931305|FG000|Infant Series|Parent or legal guardian request|10|||
42120435|NCT00676091|75931306|FG001|Infant Series|Parent or legal guardian request|8|||
42120436|NCT00676091|75931305|FG000|Infant Series|Protocol Violation|6|||
42120437|NCT00676091|75931306|FG001|Infant Series|Protocol Violation|3|||
42120438|NCT00676091|75931305|FG000|Infant Series|Adverse Event|2|||
42120439|NCT00676091|75931306|FG001|Infant Series|Adverse Event|3|||
42120440|NCT00676091|75931305|FG000|Infant Series|Failed to return|1|||
42120441|NCT00676091|75931306|FG001|Infant Series|Failed to return|3|||
42120442|NCT00676091|75931305|FG000|Infant Series|Lost to Follow-up|1|||
42120443|NCT00676091|75931306|FG001|Infant Series|Lost to Follow-up|0|||
42120444|NCT00676091|75931305|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
42120445|NCT00676091|75931306|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
42120446|NCT00676091|75931305|FG000|After Infant Series|Adverse Event|0|||
42120447|NCT00676091|75931306|FG001|After Infant Series|Adverse Event|1|||
42120448|NCT00676091|75931305|FG000|After Infant Series|Protocol Violation|0|||
42120449|NCT00676091|75931306|FG001|After Infant Series|Protocol Violation|1|||
42120450|NCT00676091|75931305|FG000|After Infant Series|Failed to return|1|||
42120451|NCT00676091|75931306|FG001|After Infant Series|Failed to return|1|||
42120452|NCT00676091|75931305|FG000|Toddler Dose|Failed to return|2|||
42120453|NCT00676091|75931306|FG001|Toddler Dose|Failed to return|0|||
42120454|NCT00676091|75931305|FG000|Toddler Dose|Parent or legal guardian request|1|||
42120455|NCT00676091|75931306|FG001|Toddler Dose|Parent or legal guardian request|0|||
42120456|NCT00678041|75931318|FG000|Overall Study|Physician Decision|5|||
42120457|NCT00678041|75931319|FG001|Overall Study|Physician Decision|5|||
42120458|NCT03903822|75931334|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
42120459|NCT03903822|75931335|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
42120460|NCT03903822|75931336|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
42120461|NCT03903822|75931337|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
42120462|NCT03903822|75931338|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
42120463|NCT03903822|75931339|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
42120464|NCT03903822|75931340|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
42120465|NCT03903822|75931341|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
42120466|NCT03903822|75931334|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
42120467|NCT03903822|75931335|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
42120468|NCT03903822|75931336|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
42120469|NCT03903822|75931337|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
42120470|NCT03903822|75931338|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
42120471|NCT03903822|75931339|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
42120472|NCT03903822|75931340|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
42120473|NCT03903822|75931341|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
42120474|NCT03903822|75931334|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
42120475|NCT03903822|75931335|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
42120476|NCT03903822|75931336|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
42120477|NCT03903822|75931337|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
42120478|NCT03903822|75931338|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
42120479|NCT03903822|75931339|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
42120480|NCT03903822|75931340|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
42120481|NCT03903822|75931341|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
42120482|NCT03903822|75931334|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
42120483|NCT03903822|75931335|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
42120484|NCT03903822|75931336|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
42120485|NCT03903822|75931337|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
42301082|NCT01656889|76136370|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
42120486|NCT03903822|75931338|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
42120487|NCT03903822|75931339|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
42120488|NCT03903822|75931340|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
42120489|NCT03903822|75931341|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
42120490|NCT03903822|75931334|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
42120491|NCT03903822|75931335|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
42120492|NCT03903822|75931336|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
42120493|NCT03903822|75931337|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
42120494|NCT03903822|75931338|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
42120495|NCT03903822|75931339|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
42120496|NCT03903822|75931340|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
42120497|NCT03903822|75931341|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
42120498|NCT03903822|75931334|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
42120499|NCT03903822|75931335|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
42120500|NCT03903822|75931336|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
42120501|NCT03903822|75931337|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
42120502|NCT03903822|75931338|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
42120503|NCT03903822|75931339|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
42120504|NCT03903822|75931340|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
42120505|NCT03903822|75931341|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
42120506|NCT03903822|75931334|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
42120507|NCT03903822|75931335|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
42120508|NCT03903822|75931336|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
42120509|NCT03903822|75931337|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
42120510|NCT03903822|75931338|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
42120511|NCT03903822|75931339|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
42120512|NCT03903822|75931340|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
42120513|NCT03903822|75931341|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
42120514|NCT03903822|75931334|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
42120515|NCT03903822|75931335|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
42120516|NCT03903822|75931336|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
42120517|NCT03903822|75931337|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
42120518|NCT03903822|75931338|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
42120519|NCT03903822|75931339|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
42120520|NCT03903822|75931340|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
42120521|NCT03903822|75931341|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
42120522|NCT03903822|75931334|FG000|Treatment Phase (6 Weeks)|Other|2|||
42120523|NCT03903822|75931335|FG001|Treatment Phase (6 Weeks)|Other|1|||
42120524|NCT03903822|75931336|FG002|Treatment Phase (6 Weeks)|Other|0|||
42120525|NCT03903822|75931337|FG003|Treatment Phase (6 Weeks)|Other|0|||
42120526|NCT03903822|75931338|FG004|Treatment Phase (6 Weeks)|Other|1|||
42120527|NCT03903822|75931339|FG005|Treatment Phase (6 Weeks)|Other|1|||
42120528|NCT03903822|75931340|FG006|Treatment Phase (6 Weeks)|Other|0|||
42120529|NCT03903822|75931341|FG007|Treatment Phase (6 Weeks)|Other|0|||
42120530|NCT03903822|75931334|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
42120531|NCT03903822|75931335|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
42120532|NCT03903822|75931336|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
42120533|NCT03903822|75931337|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
42120534|NCT03903822|75931338|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
42120535|NCT03903822|75931339|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
42120536|NCT03903822|75931340|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
42120537|NCT03903822|75931341|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
42120538|NCT03903822|75931334|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
42120539|NCT03903822|75931335|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
42120540|NCT03903822|75931336|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
42120541|NCT03903822|75931337|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
42120542|NCT03903822|75931338|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
42120543|NCT03903822|75931339|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
42120544|NCT03903822|75931340|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
42120545|NCT03903822|75931341|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
42120546|NCT03903822|75931334|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
42120547|NCT03903822|75931335|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
42120548|NCT03903822|75931336|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
42120549|NCT03903822|75931337|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
42120550|NCT03903822|75931338|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
42120551|NCT03903822|75931339|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
42120552|NCT03903822|75931340|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
42120553|NCT03903822|75931341|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
41963935|NCT01818492|75751474|FG000|Overall Study|Additional therapy when not allowed PP|4|||
41963936|NCT01239030|75751484|FG000|Double Blind|Adverse Event|0|||
41963937|NCT01239030|75751485|FG001|Double Blind|Adverse Event|1|||
42120554|NCT03903822|75931334|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
42120555|NCT03903822|75931335|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
42120556|NCT03903822|75931336|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
42120557|NCT03903822|75931337|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
42120558|NCT03903822|75931338|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
42120559|NCT03903822|75931339|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
42120560|NCT03903822|75931340|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
41963938|NCT01239030|75751486|FG002|Double Blind|Adverse Event|0|||
41963939|NCT01239030|75751487|FG003|Double Blind|Adverse Event|2|||
41963940|NCT01239030|75751488|FG004|Double Blind|Adverse Event|0|||
41963941|NCT01239030|75751484|FG000|Double Blind|Withdrawal by Subject|0|||
41963942|NCT01239030|75751485|FG001|Double Blind|Withdrawal by Subject|1|||
41963943|NCT01239030|75751486|FG002|Double Blind|Withdrawal by Subject|1|||
41963944|NCT01239030|75751487|FG003|Double Blind|Withdrawal by Subject|0|||
41963945|NCT01239030|75751488|FG004|Double Blind|Withdrawal by Subject|1|||
41963946|NCT01239030|75751484|FG000|Double Blind|Lost to Follow-up|1|||
41963947|NCT01239030|75751485|FG001|Double Blind|Lost to Follow-up|1|||
41963948|NCT01239030|75751486|FG002|Double Blind|Lost to Follow-up|0|||
41963949|NCT01239030|75751487|FG003|Double Blind|Lost to Follow-up|0|||
41963950|NCT01239030|75751488|FG004|Double Blind|Lost to Follow-up|0|||
41963951|NCT01239030|75751484|FG000|Double Blind|Physician Decision|0|||
41963952|NCT01239030|75751485|FG001|Double Blind|Physician Decision|1|||
41963953|NCT01239030|75751486|FG002|Double Blind|Physician Decision|0|||
41963954|NCT01239030|75751487|FG003|Double Blind|Physician Decision|0|||
41963955|NCT01239030|75751488|FG004|Double Blind|Physician Decision|0|||
41963956|NCT01239030|75751484|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
41963957|NCT01239030|75751485|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
41963958|NCT01239030|75751486|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
41963959|NCT01239030|75751487|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
41963960|NCT01239030|75751488|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
41963961|NCT01239030|75751484|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
41963962|NCT01239030|75751485|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
41963963|NCT01239030|75751486|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
41963964|NCT01239030|75751487|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
41963965|NCT01239030|75751488|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
41963966|NCT01239030|75751484|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
41963967|NCT01239030|75751485|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
41963968|NCT01239030|75751486|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
41963969|NCT01239030|75751487|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
41963970|NCT01239030|75751488|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
41963971|NCT01239030|75751484|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
41963972|NCT01239030|75751485|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
41963973|NCT01239030|75751486|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
41963974|NCT01239030|75751487|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
41963975|NCT01239030|75751488|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
41963976|NCT01086540|75751503|FG000|Overall Study|Death|3|||
41963977|NCT01086540|75751504|FG001|Overall Study|Death|1|||
41963978|NCT01086540|75751503|FG000|Overall Study|Physician Decision|2|||
41963979|NCT01086540|75751504|FG001|Overall Study|Physician Decision|1|||
41963980|NCT01086540|75751503|FG000|Overall Study|Addition of new therapy for PAH|1|||
41963981|NCT01086540|75751504|FG001|Overall Study|Addition of new therapy for PAH|0|||
41963982|NCT04567524|75754779|FG000|Overall Study|Adverse Event|1|||
41963983|NCT04567524|75754780|FG001|Overall Study|Adverse Event|1|||
41963984|NCT04567524|75754781|FG002|Overall Study|Adverse Event|0|||
41963985|NCT04567524|75754782|FG003|Overall Study|Adverse Event|0|||
41963986|NCT04567524|75754779|FG000|Overall Study|Withdrawal by Subject|2|||
41963987|NCT04567524|75754780|FG001|Overall Study|Withdrawal by Subject|0|||
41963988|NCT04567524|75754781|FG002|Overall Study|Withdrawal by Subject|0|||
41963989|NCT04567524|75754782|FG003|Overall Study|Withdrawal by Subject|1|||
41963990|NCT03370302|75754818|FG000|Dose Escalation Phase|Other|0|||
41963991|NCT03370302|75754819|FG001|Dose Escalation Phase|Other|1|||
41963992|NCT03370302|75754820|FG002|Dose Escalation Phase|Other|1|||
41963993|NCT03370302|75754821|FG003|Dose Escalation Phase|Other|0|||
41963994|NCT03370302|75754822|FG004|Dose Escalation Phase|Other|0|||
41963995|NCT03370302|75754823|FG005|Dose Escalation Phase|Other|0|||
41963996|NCT03370302|75754818|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
41963997|NCT03370302|75754819|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
41963998|NCT03370302|75754820|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
41963999|NCT03370302|75754821|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
41964000|NCT03370302|75754822|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
41964001|NCT03370302|75754823|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
41964002|NCT03370302|75754818|FG000|Dose Escalation Phase|Adverse Event|1|||
41964003|NCT03370302|75754819|FG001|Dose Escalation Phase|Adverse Event|0|||
41964004|NCT03370302|75754820|FG002|Dose Escalation Phase|Adverse Event|2|||
41964005|NCT03370302|75754821|FG003|Dose Escalation Phase|Adverse Event|0|||
41964006|NCT03370302|75754822|FG004|Dose Escalation Phase|Adverse Event|0|||
42210354|NCT02936037|76025129|FG000|Open Label Extension|Withdrawal by Subject|0|||
42210355|NCT02936037|76025130|FG001|Open Label Extension|Withdrawal by Subject|4|||
41964007|NCT03370302|75754823|FG005|Dose Escalation Phase|Adverse Event|0|||
41964008|NCT03370302|75754818|FG000|Dose Escalation Phase|Progressive Disease|2|||
41964009|NCT03370302|75754819|FG001|Dose Escalation Phase|Progressive Disease|4|||
41964010|NCT03370302|75754820|FG002|Dose Escalation Phase|Progressive Disease|2|||
41964011|NCT03370302|75754821|FG003|Dose Escalation Phase|Progressive Disease|0|||
41964012|NCT03370302|75754822|FG004|Dose Escalation Phase|Progressive Disease|3|||
41964013|NCT03370302|75754823|FG005|Dose Escalation Phase|Progressive Disease|1|||
41964014|NCT03370302|75754818|FG000|Dose Expansion Phase|Progressive Disease|0|||
41964015|NCT03370302|75754819|FG001|Dose Expansion Phase|Progressive Disease|0|||
41964016|NCT03370302|75754820|FG002|Dose Expansion Phase|Progressive Disease|0|||
41964017|NCT03370302|75754821|FG003|Dose Expansion Phase|Progressive Disease|6|||
41964018|NCT03370302|75754822|FG004|Dose Expansion Phase|Progressive Disease|0|||
41964019|NCT03370302|75754823|FG005|Dose Expansion Phase|Progressive Disease|0|||
41964020|NCT03327324|75754847|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964021|NCT03327324|75754848|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
41964022|NCT03327324|75754849|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964023|NCT03327324|75754850|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
41964024|NCT03327324|75754851|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964025|NCT03327324|75754852|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
41964026|NCT03327324|75754847|FG000|Baseline (Month 0-Month 3)|Refused|0|||
41964027|NCT03327324|75754848|FG001|Baseline (Month 0-Month 3)|Refused|0|||
41964028|NCT03327324|75754849|FG002|Baseline (Month 0-Month 3)|Refused|0|||
41964029|NCT03327324|75754850|FG003|Baseline (Month 0-Month 3)|Refused|0|||
41964030|NCT03327324|75754851|FG004|Baseline (Month 0-Month 3)|Refused|1|||
41964031|NCT03327324|75754852|FG005|Baseline (Month 0-Month 3)|Refused|0|||
41964032|NCT03327324|75754847|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
41964033|NCT03327324|75754848|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
41964034|NCT03327324|75754849|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
41964035|NCT03327324|75754850|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
41964036|NCT03327324|75754851|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
41964037|NCT03327324|75754852|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
41964038|NCT03327324|75754847|FG000|Baseline (Month 0-Month 3)|Death|0|||
41964039|NCT03327324|75754848|FG001|Baseline (Month 0-Month 3)|Death|0|||
41964040|NCT03327324|75754849|FG002|Baseline (Month 0-Month 3)|Death|0|||
41964041|NCT03327324|75754850|FG003|Baseline (Month 0-Month 3)|Death|0|||
41964042|NCT03327324|75754851|FG004|Baseline (Month 0-Month 3)|Death|1|||
41964043|NCT03327324|75754852|FG005|Baseline (Month 0-Month 3)|Death|0|||
41964044|NCT03327324|75754847|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964045|NCT03327324|75754848|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964046|NCT03327324|75754849|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964047|NCT03327324|75754850|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964048|NCT03327324|75754851|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964049|NCT03327324|75754852|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
41964050|NCT03327324|75754847|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964051|NCT03327324|75754848|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964052|NCT03327324|75754849|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
41964053|NCT03327324|75754850|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964054|NCT03327324|75754851|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964055|NCT03327324|75754852|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964056|NCT03327324|75754847|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
41964057|NCT03327324|75754848|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
41964058|NCT03327324|75754849|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
41964059|NCT03327324|75754850|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
41964060|NCT03327324|75754851|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
41964061|NCT03327324|75754852|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
42026781|NCT00928018|75834797|FG000|Overall Study|Withdrawal by Subject|1|||
42026782|NCT00928018|75834798|FG001|Overall Study|Withdrawal by Subject|0|||
42026783|NCT00927940|75834808|FG000|Overall Study|Death|1|||
42026784|NCT00927862|75834815|FG000|Overall Study|Missing data needed for endpt analyses|27|||
42026785|NCT00927862|75834816|FG001|Overall Study|Missing data needed for endpt analyses|45|||
42210356|NCT03288714|76025138|FG000|Overall Study|Lost to Follow-up|2|||
42301083|NCT01656889|76136369|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
42301084|NCT01656889|76136370|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
42301085|NCT01656889|76136369|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
42301086|NCT01656889|76136370|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
42301087|NCT01656889|76136369|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
41964062|NCT03327324|75754847|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
41964063|NCT03327324|75754848|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
41964064|NCT03327324|75754849|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
41964065|NCT03327324|75754850|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
41964066|NCT03327324|75754851|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
41964067|NCT03327324|75754852|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
41964068|NCT03327324|75754847|FG000|Intervention (Month 3-Month 6)|Death|1|||
41964069|NCT03327324|75754848|FG001|Intervention (Month 3-Month 6)|Death|0|||
41964070|NCT03327324|75754849|FG002|Intervention (Month 3-Month 6)|Death|1|||
41964071|NCT03327324|75754850|FG003|Intervention (Month 3-Month 6)|Death|1|||
41964072|NCT03327324|75754851|FG004|Intervention (Month 3-Month 6)|Death|1|||
41964073|NCT03327324|75754852|FG005|Intervention (Month 3-Month 6)|Death|0|||
41964074|NCT03327324|75754847|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964075|NCT03327324|75754848|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964076|NCT03327324|75754849|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964077|NCT03327324|75754850|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964078|NCT03327324|75754851|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964079|NCT03327324|75754852|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
41964080|NCT03327324|75754847|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
41964081|NCT03327324|75754848|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964082|NCT03327324|75754849|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964083|NCT03327324|75754850|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964084|NCT03327324|75754851|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964085|NCT03327324|75754852|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
41964086|NCT03327324|75754847|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
41964087|NCT03327324|75754848|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
41964088|NCT03327324|75754849|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
41964089|NCT03327324|75754850|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
42120561|NCT03903822|75931341|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
42120562|NCT03903822|75931334|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
42120563|NCT03903822|75931335|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
42120564|NCT03903822|75931336|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
42120565|NCT03903822|75931337|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
42120566|NCT03903822|75931338|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
42120567|NCT03903822|75931339|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
42120568|NCT03903822|75931340|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
42120569|NCT03903822|75931341|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
42120570|NCT03903822|75931334|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
42120571|NCT03903822|75931335|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
42120572|NCT03903822|75931336|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
42120573|NCT03903822|75931337|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
42120574|NCT03903822|75931338|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
42120575|NCT03903822|75931339|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
42120576|NCT03903822|75931340|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
42120577|NCT03903822|75931341|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
42120578|NCT03903822|75931334|FG000|Follow up Phase (4 Weeks)|Other|1|||
42120579|NCT03903822|75931335|FG001|Follow up Phase (4 Weeks)|Other|1|||
42120580|NCT03903822|75931336|FG002|Follow up Phase (4 Weeks)|Other|0|||
42120581|NCT03903822|75931337|FG003|Follow up Phase (4 Weeks)|Other|0|||
42120582|NCT03903822|75931338|FG004|Follow up Phase (4 Weeks)|Other|0|||
42120583|NCT03903822|75931339|FG005|Follow up Phase (4 Weeks)|Other|0|||
42120584|NCT03903822|75931340|FG006|Follow up Phase (4 Weeks)|Other|0|||
42120585|NCT03903822|75931341|FG007|Follow up Phase (4 Weeks)|Other|0|||
42120586|NCT00677807|75931362|FG000|Overall Study|Adverse Event|4|||
42120587|NCT00677807|75931363|FG001|Overall Study|Adverse Event|1|||
42120588|NCT00677807|75931364|FG002|Overall Study|Adverse Event|6|||
42120589|NCT00677807|75931362|FG000|Overall Study|Lack of Efficacy|0|||
42120590|NCT00677807|75931363|FG001|Overall Study|Lack of Efficacy|0|||
42120591|NCT00677807|75931364|FG002|Overall Study|Lack of Efficacy|2|||
42120592|NCT00677807|75931362|FG000|Overall Study|Participant no longer needs study drug|0|||
42120593|NCT00677807|75931363|FG001|Overall Study|Participant no longer needs study drug|0|||
41964090|NCT03327324|75754851|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
41964091|NCT03327324|75754852|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
41964092|NCT03327324|75754847|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
41964093|NCT03327324|75754848|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
41964094|NCT03327324|75754849|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
41964095|NCT03327324|75754850|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
41964096|NCT03327324|75754851|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
41964097|NCT03327324|75754852|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
41964098|NCT03327324|75754847|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964099|NCT03327324|75754848|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964100|NCT03327324|75754849|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964101|NCT03327324|75754850|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
41964102|NCT03327324|75754851|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
41964103|NCT03327324|75754852|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
41964104|NCT03327324|75754847|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
41964105|NCT03327324|75754848|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
41964106|NCT03327324|75754849|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
41964107|NCT03327324|75754850|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
41964108|NCT03327324|75754851|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
41964109|NCT03327324|75754852|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
41964110|NCT03327324|75754847|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
41964111|NCT03327324|75754848|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
41964112|NCT03327324|75754849|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
41964113|NCT03327324|75754850|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
41964114|NCT03327324|75754851|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
41964115|NCT03327324|75754852|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
41964116|NCT03252522|75754858|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
41964117|NCT03252522|75754859|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
41964118|NCT03252522|75754860|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
41964119|NCT03252522|75754858|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
41964120|NCT03252522|75754859|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
41964121|NCT03252522|75754860|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
41964122|NCT03252522|75754858|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
41964123|NCT03252522|75754859|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
42026786|NCT00976989|75834827|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
42026787|NCT00976989|75834828|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
42026788|NCT00976989|75834829|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
42120594|NCT00677807|75931364|FG002|Overall Study|Participant no longer needs study drug|1|||
42120595|NCT00677807|75931362|FG000|Overall Study|Withdrawal by Subject|10|||
42120596|NCT00677807|75931363|FG001|Overall Study|Withdrawal by Subject|3|||
42120597|NCT00677807|75931364|FG002|Overall Study|Withdrawal by Subject|6|||
42120598|NCT00677807|75931362|FG000|Overall Study|Lost to Follow-up|2|||
42120599|NCT00677807|75931363|FG001|Overall Study|Lost to Follow-up|2|||
42120600|NCT00677807|75931364|FG002|Overall Study|Lost to Follow-up|2|||
42120601|NCT00677807|75931362|FG000|Overall Study|Administrative problems|1|||
42120602|NCT00677807|75931363|FG001|Overall Study|Administrative problems|1|||
42120603|NCT00677807|75931364|FG002|Overall Study|Administrative problems|2|||
42120604|NCT00677807|75931362|FG000|Overall Study|Death|0|||
42026789|NCT00976989|75834827|FG000|Overall Study|Death|5|||
42026790|NCT00976989|75834828|FG001|Overall Study|Death|7|||
42026791|NCT00976989|75834829|FG002|Overall Study|Death|10|||
42026792|NCT00976989|75834827|FG000|Overall Study|Refused Treatment|4|||
42026793|NCT00976989|75834828|FG001|Overall Study|Refused Treatment|3|||
42026794|NCT00976989|75834829|FG002|Overall Study|Refused Treatment|5|||
42026795|NCT00976989|75834827|FG000|Overall Study|Failure to Return|2|||
42026796|NCT00976989|75834828|FG001|Overall Study|Failure to Return|1|||
42026797|NCT00976989|75834829|FG002|Overall Study|Failure to Return|0|||
42026798|NCT00976989|75834827|FG000|Overall Study|Recurrence of Disease|0|||
42026799|NCT00976989|75834828|FG001|Overall Study|Recurrence of Disease|1|||
42026800|NCT00976989|75834829|FG002|Overall Study|Recurrence of Disease|0|||
42026801|NCT00976989|75834827|FG000|Overall Study|Other|1|||
42026802|NCT00976989|75834828|FG001|Overall Study|Other|0|||
42026803|NCT00976989|75834829|FG002|Overall Study|Other|1|||
42026804|NCT00927784|75834839|FG000|Overall Study|Death|1|||
42026805|NCT00927784|75834840|FG001|Overall Study|Death|0|||
42026806|NCT00927784|75834839|FG000|Overall Study|Withdrawal by Subject|1|||
42026807|NCT00927784|75834840|FG001|Overall Study|Withdrawal by Subject|0|||
42120605|NCT00677807|75931363|FG001|Overall Study|Death|1|||
42120606|NCT00677807|75931364|FG002|Overall Study|Death|1|||
42120607|NCT00677807|75931362|FG000|Overall Study|Protocol Deviation|1|||
42120608|NCT00677807|75931363|FG001|Overall Study|Protocol Deviation|3|||
42120609|NCT00677807|75931364|FG002|Overall Study|Protocol Deviation|0|||
42120610|NCT00687401|75931372|FG000|Overall Study|Protocol Violation|7|||
42120611|NCT00687401|75931372|FG000|Overall Study|Adverse Event|6|||
42120612|NCT00687401|75931372|FG000|Overall Study|Lack of Efficacy|6|||
42120613|NCT00687401|75931372|FG000|Overall Study|Withdrawal by Subject|4|||
42120614|NCT00687401|75931372|FG000|Overall Study|Did not return for visit|3|||
42120615|NCT00687401|75931372|FG000|Overall Study|For reasons different from those above|4|||
41964124|NCT03252522|75754860|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
41964125|NCT03252522|75754858|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
41964126|NCT03252522|75754859|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
41964127|NCT03252522|75754860|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
41964128|NCT03252522|75754858|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
41964129|NCT03252522|75754859|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
41964130|NCT03252522|75754860|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
41964131|NCT03252522|75754858|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
41964132|NCT03252522|75754859|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
41964133|NCT03252522|75754860|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
41964134|NCT03252522|75754858|FG000|Phase 2: Open Label|Adverse Event|0|||
41964135|NCT03252522|75754859|FG001|Phase 2: Open Label|Adverse Event|0|||
41964136|NCT03252522|75754860|FG002|Phase 2: Open Label|Adverse Event|2|||
41964137|NCT03252522|75754858|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
41964138|NCT03252522|75754859|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
41964139|NCT03252522|75754860|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
41964140|NCT02756364|75754875|FG000|Overall Study|Site Terminated by Sponsor|24|||
41964141|NCT02756364|75754876|FG001|Overall Study|Site Terminated by Sponsor|30|||
41964142|NCT02756364|75754877|FG002|Overall Study|Site Terminated by Sponsor|21|||
41964143|NCT02756364|75754875|FG000|Overall Study|Death|20|||
41964144|NCT02756364|75754876|FG001|Overall Study|Death|15|||
41964145|NCT02756364|75754877|FG002|Overall Study|Death|18|||
41964146|NCT02756364|75754875|FG000|Overall Study|Withdrawal by Patient|2|||
41964147|NCT02756364|75754876|FG001|Overall Study|Withdrawal by Patient|1|||
41964148|NCT02756364|75754877|FG002|Overall Study|Withdrawal by Patient|8|||
41964149|NCT02756364|75754875|FG000|Overall Study|Lost to Follow-up|0|||
41964150|NCT02756364|75754876|FG001|Overall Study|Lost to Follow-up|1|||
41964151|NCT02756364|75754877|FG002|Overall Study|Lost to Follow-up|1|||
41964152|NCT01906476|75754887|FG000|Overall Study|Lost to Follow-up|17|||
41964153|NCT01906476|75754888|FG001|Overall Study|Lost to Follow-up|16|||
41964154|NCT05343624|75754894|FG000|Overall Study|Chart review not completed|1|||
41964155|NCT04208412|75754927|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
41964156|NCT04208412|75754928|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
41964157|NCT04208412|75754927|FG000|Overall Study|Withdrawal by Subject|1|||
41964158|NCT04208412|75754928|FG001|Overall Study|Withdrawal by Subject|0|||
41964159|NCT04208412|75754927|FG000|Overall Study|Lost to Follow-up|0|||
41964160|NCT04208412|75754928|FG001|Overall Study|Lost to Follow-up|1|||
41964161|NCT04095858|75754938|FG000|Overall Study|Death|1|||
41964162|NCT04095858|75754939|FG001|Overall Study|Death|0|||
41964163|NCT04095858|75754938|FG000|Overall Study|Study terminated by Sponsor|2|||
41964164|NCT04095858|75754939|FG001|Overall Study|Study terminated by Sponsor|4|||
42120616|NCT00538902|75931392|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
42120617|NCT00538902|75931393|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
42120618|NCT00538902|75931394|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
42120619|NCT00538902|75931392|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
42120620|NCT00538902|75931393|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
42120621|NCT00538902|75931394|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
42120622|NCT00538902|75931392|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
42120623|NCT00538902|75931393|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
42120624|NCT00538902|75931394|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
42120625|NCT00538902|75931392|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
42120626|NCT00538902|75931393|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
41964165|NCT03937986|75754945|FG000|Overall Study|COVID-19 Pandemic|1|||
41964166|NCT03738150|75754960|FG000|Base Study|Withdrawal by Subject|1|||
41964167|NCT03738150|75754960|FG000|Extension Study|Withdrawal by Subject|1|||
41964168|NCT03567174|75754976|FG000|Overall Study|Death|24|||
41964169|NCT03567174|75754977|FG001|Overall Study|Death|31|||
41964170|NCT03567174|75754976|FG000|Overall Study|Lost to Follow-up|165|||
41964171|NCT03567174|75754977|FG001|Overall Study|Lost to Follow-up|174|||
41964172|NCT02545998|75755022|FG000|Overall Study|Lost to Follow-up|12|||
41964173|NCT02545998|75755023|FG001|Overall Study|Lost to Follow-up|3|||
41964174|NCT02545998|75755022|FG000|Overall Study|Withdrawal by Subject|3|||
41964175|NCT02545998|75755023|FG001|Overall Study|Withdrawal by Subject|2|||
41964176|NCT02257242|75755047|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
41964177|NCT02257242|75755048|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
41964178|NCT02257242|75755049|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
41964179|NCT02257242|75755050|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
41964180|NCT02257242|75755051|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
41964181|NCT02257242|75755052|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
41964182|NCT02257242|75755053|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
41964183|NCT02257242|75755054|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
41964184|NCT02257242|75755055|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
41964185|NCT01943916|75755085|FG000|Overall Study|Technically invalid images|10|||
41964186|NCT01943916|75755085|FG000|Overall Study|Enrollment Failure|23|||
41964187|NCT01943916|75755085|FG000|Overall Study|Pilot Phase exclusion|100|||
41964188|NCT01943916|75755085|FG000|Overall Study|Quality Assurance Reader Fail|130|||
41964189|NCT01943916|75755085|FG000|Overall Study|Technical Failure|39|||
41964190|NCT01943916|75755085|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
41964191|NCT01943916|75755085|FG000|Overall Study|No Truth Panel Review|38|||
41964192|NCT01943916|75755085|FG000|Overall Study|Protocol Deviation|1|||
41964193|NCT01564368|75755094|FG000|Overall Study|Ineligible|18|||
41964194|NCT01564368|75755094|FG000|Overall Study|Not Randomized in Parent study|116|||
41964195|NCT01564368|75755094|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
41964196|NCT01564368|75755094|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
41964197|NCT00281658|75755102|FG000|Randomized Phase|Adverse Event|0|||
41964198|NCT00281658|75755103|FG001|Randomized Phase|Adverse Event|2|||
41964199|NCT00281658|75755104|FG002|Randomized Phase|Adverse Event|0|||
41964200|NCT00281658|75755105|FG003|Randomized Phase|Adverse Event|0|||
41964201|NCT00281658|75755102|FG000|Randomized Phase|Lost to Follow-up|34|||
41964202|NCT00281658|75755103|FG001|Randomized Phase|Lost to Follow-up|27|||
41964203|NCT00281658|75755104|FG002|Randomized Phase|Lost to Follow-up|0|||
41964204|NCT00281658|75755105|FG003|Randomized Phase|Lost to Follow-up|0|||
41964205|NCT00281658|75755102|FG000|Randomized Phase|Withdrawal by Subject|8|||
41964206|NCT00281658|75755103|FG001|Randomized Phase|Withdrawal by Subject|7|||
41964207|NCT00281658|75755104|FG002|Randomized Phase|Withdrawal by Subject|0|||
41964208|NCT00281658|75755105|FG003|Randomized Phase|Withdrawal by Subject|0|||
41964209|NCT00281658|75755102|FG000|Randomized Phase|Study closed/terminated|1|||
41964210|NCT00281658|75755103|FG001|Randomized Phase|Study closed/terminated|1|||
41964211|NCT00281658|75755104|FG002|Randomized Phase|Study closed/terminated|0|||
41964212|NCT00281658|75755105|FG003|Randomized Phase|Study closed/terminated|0|||
41964213|NCT00281658|75755102|FG000|Randomized Phase|Disease progression|36|||
41964214|NCT00281658|75755103|FG001|Randomized Phase|Disease progression|27|||
41964215|NCT00281658|75755104|FG002|Randomized Phase|Disease progression|0|||
41964216|NCT00281658|75755105|FG003|Randomized Phase|Disease progression|0|||
41964217|NCT00281658|75755102|FG000|Randomized Phase|Physician Decision|1|||
41964218|NCT00281658|75755103|FG001|Randomized Phase|Physician Decision|1|||
41964219|NCT00281658|75755104|FG002|Randomized Phase|Physician Decision|0|||
41964220|NCT00281658|75755105|FG003|Randomized Phase|Physician Decision|0|||
42120627|NCT00538902|75931394|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
42120628|NCT00538902|75931392|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
42120629|NCT00538902|75931393|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
42120630|NCT00538902|75931394|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
42120631|NCT00538902|75931392|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
42120632|NCT00538902|75931393|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
42120633|NCT00538902|75931394|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
42120634|NCT00538902|75931392|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
42120635|NCT00538902|75931393|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
42120636|NCT00538902|75931394|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
42120637|NCT00538902|75931392|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
42120638|NCT00538902|75931393|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
42120639|NCT00538902|75931394|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
41964221|NCT00281658|75755102|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
41964222|NCT00281658|75755103|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
41964223|NCT00281658|75755104|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
41964224|NCT00281658|75755105|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
41964225|NCT00281658|75755102|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
41964226|NCT00281658|75755103|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
41964227|NCT00281658|75755104|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
41964228|NCT00281658|75755105|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
41964229|NCT00281658|75755102|FG000|Randomized Phase|Treatment ongoing|1|||
42120640|NCT00541970|75931408|FG000|Month 7|Protocol Violation|9|||
41964230|NCT00281658|75755103|FG001|Randomized Phase|Treatment ongoing|0|||
41964231|NCT00281658|75755104|FG002|Randomized Phase|Treatment ongoing|0|||
41964232|NCT00281658|75755105|FG003|Randomized Phase|Treatment ongoing|0|||
41964233|NCT00281658|75755102|FG000|Open Label Phase|Adverse Event|0|||
41964234|NCT00281658|75755103|FG001|Open Label Phase|Adverse Event|0|||
41964235|NCT00281658|75755104|FG002|Open Label Phase|Adverse Event|1|||
41964236|NCT00281658|75755105|FG003|Open Label Phase|Adverse Event|0|||
41964237|NCT00281658|75755102|FG000|Open Label Phase|Lost to Follow-up|0|||
41964238|NCT00281658|75755103|FG001|Open Label Phase|Lost to Follow-up|0|||
41964239|NCT00281658|75755104|FG002|Open Label Phase|Lost to Follow-up|16|||
41964240|NCT00281658|75755105|FG003|Open Label Phase|Lost to Follow-up|2|||
41964241|NCT00281658|75755102|FG000|Open Label Phase|Withdrawal by Subject|0|||
41964242|NCT00281658|75755103|FG001|Open Label Phase|Withdrawal by Subject|0|||
41964243|NCT00281658|75755104|FG002|Open Label Phase|Withdrawal by Subject|3|||
41964244|NCT00281658|75755105|FG003|Open Label Phase|Withdrawal by Subject|2|||
41964245|NCT00281658|75755102|FG000|Open Label Phase|Disease progression|0|||
41964246|NCT00281658|75755103|FG001|Open Label Phase|Disease progression|0|||
41964247|NCT00281658|75755104|FG002|Open Label Phase|Disease progression|18|||
41964248|NCT00281658|75755105|FG003|Open Label Phase|Disease progression|0|||
41964249|NCT00281658|75755102|FG000|Open Label Phase|Physician Decision|0|||
41964250|NCT00281658|75755103|FG001|Open Label Phase|Physician Decision|0|||
41964251|NCT00281658|75755104|FG002|Open Label Phase|Physician Decision|1|||
41964252|NCT00281658|75755105|FG003|Open Label Phase|Physician Decision|0|||
41964253|NCT00281658|75755102|FG000|Open Label Phase|Relocation of patient|0|||
41964254|NCT00281658|75755103|FG001|Open Label Phase|Relocation of patient|0|||
41964255|NCT00281658|75755104|FG002|Open Label Phase|Relocation of patient|1|||
41964256|NCT00281658|75755105|FG003|Open Label Phase|Relocation of patient|0|||
41964257|NCT00281658|75755102|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
41964258|NCT00281658|75755103|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
41964259|NCT00281658|75755104|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
41964260|NCT00281658|75755105|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
41964261|NCT02758626|75756498|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
41964262|NCT02758626|75756499|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
41964263|NCT02758626|75756498|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
41964264|NCT02758626|75756499|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
41964265|NCT02758626|75756498|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
41964266|NCT02758626|75756499|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
41964267|NCT02758626|75756498|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
41964268|NCT02758626|75756499|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
41964269|NCT02357784|75756505|FG000|Overall Study|Withdrawal by Subject|1|||
41964270|NCT01448616|75756512|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
41964271|NCT01448616|75756513|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
41964272|NCT01448616|75756514|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
41964273|NCT01448616|75756515|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
41964274|NCT01448616|75756512|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
41964275|NCT01448616|75756513|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
41964276|NCT01448616|75756514|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
41964277|NCT01448616|75756515|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
41964278|NCT01448616|75756512|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
41964279|NCT01448616|75756513|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
41964280|NCT01448616|75756514|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
41964281|NCT01448616|75756515|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
41964282|NCT01448616|75756512|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
41964283|NCT01448616|75756513|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
41964284|NCT01448616|75756514|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
41964285|NCT01448616|75756515|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
41964286|NCT01448616|75756512|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
41964287|NCT01448616|75756513|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
41964288|NCT01448616|75756514|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
41964289|NCT01448616|75756515|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
41964290|NCT00074412|75756552|FG000|Overall Study|Death|30|||
41964291|NCT00074412|75756553|FG001|Overall Study|Death|26|||
41964292|NCT00074412|75756552|FG000|Overall Study|Lost to Follow-up|52|||
41964293|NCT00074412|75756553|FG001|Overall Study|Lost to Follow-up|58|||
41964294|NCT04505592|75757559|FG000|Overall Study|Death|2|||
41964295|NCT04505592|75757560|FG001|Overall Study|Death|1|||
41964296|NCT04706793|75757863|FG000|Treatment|Disease worsening|10|||
41964297|NCT04706793|75757864|FG001|Treatment|Disease worsening|10|||
41964298|NCT04706793|75757863|FG000|Follow-up|Lack of Efficacy|1|||
41964299|NCT04706793|75757864|FG001|Follow-up|Lack of Efficacy|0|||
41964300|NCT04706793|75757863|FG000|Follow-up|Disease worsening|8|||
41964301|NCT04706793|75757864|FG001|Follow-up|Disease worsening|10|||
41964302|NCT04706793|75757863|FG000|Follow-up|Adverse Event|1|||
41964303|NCT04706793|75757864|FG001|Follow-up|Adverse Event|0|||
41964304|NCT04607148|75757874|FG000|Overall Study|Withdrawal by Subject|0|||
41964305|NCT04607148|75757875|FG001|Overall Study|Withdrawal by Subject|4|||
41964306|NCT04607148|75757876|FG002|Overall Study|Withdrawal by Subject|2|||
41964307|NCT04607148|75757877|FG003|Overall Study|Withdrawal by Subject|8|||
41964308|NCT04607148|75757874|FG000|Overall Study|Study Terminated by Sponsor|14|||
41964309|NCT04607148|75757875|FG001|Overall Study|Study Terminated by Sponsor|59|||
41964310|NCT04607148|75757876|FG002|Overall Study|Study Terminated by Sponsor|9|||
41964311|NCT04607148|75757877|FG003|Overall Study|Study Terminated by Sponsor|39|||
41964312|NCT04607148|75757874|FG000|Overall Study|Sponsor Decision|0|||
41964313|NCT04607148|75757875|FG001|Overall Study|Sponsor Decision|0|||
41964314|NCT04607148|75757876|FG002|Overall Study|Sponsor Decision|1|||
41964315|NCT04607148|75757877|FG003|Overall Study|Sponsor Decision|0|||
41964316|NCT04607148|75757874|FG000|Overall Study|Non-Compliance With Study Drug|0|||
41964317|NCT04607148|75757875|FG001|Overall Study|Non-Compliance With Study Drug|1|||
41964318|NCT04607148|75757876|FG002|Overall Study|Non-Compliance With Study Drug|0|||
41964319|NCT04607148|75757877|FG003|Overall Study|Non-Compliance With Study Drug|0|||
41964320|NCT04607148|75757874|FG000|Overall Study|Lost to Follow-up|0|||
41964321|NCT04607148|75757875|FG001|Overall Study|Lost to Follow-up|2|||
41964322|NCT04607148|75757876|FG002|Overall Study|Lost to Follow-up|0|||
41964323|NCT04607148|75757877|FG003|Overall Study|Lost to Follow-up|0|||
41964324|NCT04607148|75757874|FG000|Overall Study|Death|0|||
41964325|NCT04607148|75757875|FG001|Overall Study|Death|3|||
41964326|NCT04607148|75757876|FG002|Overall Study|Death|0|||
41964327|NCT04607148|75757877|FG003|Overall Study|Death|1|||
41964328|NCT04607148|75757874|FG000|Overall Study|Adverse Event|0|||
41964329|NCT04607148|75757875|FG001|Overall Study|Adverse Event|1|||
41964330|NCT04607148|75757876|FG002|Overall Study|Adverse Event|0|||
41964331|NCT04607148|75757877|FG003|Overall Study|Adverse Event|0|||
41964332|NCT04542057|75757889|FG000|Overall Study|Death|3|||
41964333|NCT04542057|75757890|FG001|Overall Study|Death|1|||
41964334|NCT04542057|75757889|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
41964335|NCT04542057|75757890|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
41964336|NCT04542057|75757889|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
41964337|NCT04542057|75757890|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
41964338|NCT04542057|75757889|FG000|Overall Study|Adverse Event|15|||
41964339|NCT04542057|75757890|FG001|Overall Study|Adverse Event|6|||
41964340|NCT04542057|75757889|FG000|Overall Study|COVID-19 adverse event|6|||
41964341|NCT04542057|75757890|FG001|Overall Study|COVID-19 adverse event|4|||
41964342|NCT04542057|75757889|FG000|Overall Study|Lack of Efficacy|2|||
41964343|NCT04542057|75757890|FG001|Overall Study|Lack of Efficacy|5|||
41964344|NCT04542057|75757889|FG000|Overall Study|Study terminated by sponsor|1|||
41964345|NCT04542057|75757890|FG001|Overall Study|Study terminated by sponsor|0|||
41964346|NCT04542057|75757889|FG000|Overall Study|Investigator discretion|2|||
41964347|NCT04542057|75757890|FG001|Overall Study|Investigator discretion|1|||
41964348|NCT04542057|75757889|FG000|Overall Study|Withdrawal by Subject|52|||
41964349|NCT04542057|75757890|FG001|Overall Study|Withdrawal by Subject|30|||
41964350|NCT04542057|75757889|FG000|Overall Study|Lost to Follow-up|8|||
41964351|NCT04542057|75757890|FG001|Overall Study|Lost to Follow-up|11|||
41964352|NCT04542057|75757889|FG000|Overall Study|Other|2|||
41964353|NCT04542057|75757890|FG001|Overall Study|Other|2|||
41964354|NCT04193527|75757904|FG000|Overall Study|Other|1|||
41964355|NCT04193527|75757905|FG001|Overall Study|Other|1|||
41964356|NCT04193527|75757906|FG002|Overall Study|Other|0|||
41964357|NCT03915470|75757919|FG000|Overall Study|Death|3|||
41964358|NCT03915470|75757920|FG001|Overall Study|Death|1|||
41964359|NCT03915470|75757919|FG000|Overall Study|Adverse Event|1|||
41964360|NCT03915470|75757920|FG001|Overall Study|Adverse Event|0|||
41964361|NCT03915470|75757919|FG000|Overall Study|Physician Decision|1|||
42026808|NCT05056987|75834857|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
42026809|NCT05056987|75834858|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
42026810|NCT05056987|75834857|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
42026811|NCT05056987|75834858|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
42026812|NCT03439852|75834891|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
42026813|NCT03439852|75834892|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
42026814|NCT03439852|75834891|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
42026815|NCT03439852|75834892|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
42026816|NCT03439852|75834891|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
42026817|NCT03439852|75834892|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
42026818|NCT03355300|75834903|FG000|Overall Study|Physician Decision|0|||
41964362|NCT03915470|75757920|FG001|Overall Study|Physician Decision|0|||
41964363|NCT03915470|75757919|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
41964364|NCT03915470|75757920|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
41964365|NCT03575468|75757928|FG000|Overall Study|Withdrawal by Subject|3|||
41964366|NCT03575468|75757929|FG001|Overall Study|Withdrawal by Subject|0|||
41964367|NCT03575468|75757928|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
41964368|NCT03575468|75757929|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
41964369|NCT03575468|75757928|FG000|Overall Study|Lost to Follow-up|13|||
41964370|NCT03575468|75757929|FG001|Overall Study|Lost to Follow-up|17|||
41964371|NCT03555981|75757937|FG000|Overall Study|Lost to Follow-up|0|||
41964372|NCT03555981|75757938|FG001|Overall Study|Lost to Follow-up|2|||
41964373|NCT03488225|75757944|FG000|Overall Study|Off Protocol Therapy|2|||
41964374|NCT03488225|75757944|FG000|Overall Study|Stem Cell Transplant|2|||
41964375|NCT03382834|75757950|FG000|Overall Study|Lost to Follow-up|1|||
41964376|NCT03382834|75757951|FG001|Overall Study|Lost to Follow-up|0|||
41964377|NCT03382834|75757950|FG000|Overall Study|Withdrawal by Subject|0|||
41964378|NCT03382834|75757951|FG001|Overall Study|Withdrawal by Subject|1|||
41964379|NCT03308942|75757962|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
41964380|NCT03308942|75757963|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
41964381|NCT03308942|75757964|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
41964382|NCT03308942|75757965|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
41964383|NCT03308942|75757966|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
41964384|NCT03308942|75757962|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
41964385|NCT03308942|75757963|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
41964386|NCT03308942|75757964|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
41964387|NCT03308942|75757965|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
41964388|NCT03308942|75757966|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
41964389|NCT03308942|75757962|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
41964390|NCT03308942|75757963|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
41964391|NCT03308942|75757964|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
41964392|NCT03308942|75757965|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
41964393|NCT03308942|75757966|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
41964394|NCT03308942|75757962|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
41964395|NCT03308942|75757963|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
41964396|NCT03308942|75757964|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
41964397|NCT03308942|75757965|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
41964398|NCT03308942|75757966|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
41964399|NCT03308942|75757962|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
41964400|NCT03308942|75757963|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
41964401|NCT03308942|75757964|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
41964402|NCT03308942|75757965|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
41964403|NCT03308942|75757966|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
41964404|NCT03308942|75757962|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
41964405|NCT03308942|75757963|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
41964406|NCT03308942|75757964|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
41964407|NCT03308942|75757965|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
41964408|NCT03308942|75757966|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
41964409|NCT03308942|75757962|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
41964410|NCT03308942|75757963|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
41964411|NCT03308942|75757964|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
41964412|NCT03308942|75757965|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
41964413|NCT03308942|75757966|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
41964414|NCT03291431|75757981|FG000|Overall Study|Protocol Violation|2|||
41964415|NCT03291431|75757982|FG001|Overall Study|Protocol Violation|1|||
41964416|NCT03291431|75757981|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
41964417|NCT03291431|75757982|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
41964418|NCT03291431|75757981|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
41964419|NCT03291431|75757982|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
41964420|NCT03261401|75758001|FG000|Overall Study|Withdrawal by Subject|0|||
41964421|NCT03261401|75758002|FG001|Overall Study|Withdrawal by Subject|0|||
41964422|NCT03261401|75758003|FG002|Overall Study|Withdrawal by Subject|0|||
41964423|NCT03261401|75758004|FG003|Overall Study|Withdrawal by Subject|0|||
41964424|NCT03261401|75758005|FG004|Overall Study|Withdrawal by Subject|0|||
41964425|NCT03261401|75758006|FG005|Overall Study|Withdrawal by Subject|1|||
41964426|NCT03261401|75758007|FG006|Overall Study|Withdrawal by Subject|0|||
41964427|NCT03261401|75758008|FG007|Overall Study|Withdrawal by Subject|0|||
41964428|NCT03261401|75758009|FG008|Overall Study|Withdrawal by Subject|0|||
41964429|NCT03261401|75758010|FG009|Overall Study|Withdrawal by Subject|0|||
41964430|NCT03261401|75758011|FG010|Overall Study|Withdrawal by Subject|0|||
41964431|NCT03261401|75758012|FG011|Overall Study|Withdrawal by Subject|0|||
41964432|NCT03261401|75758013|FG012|Overall Study|Withdrawal by Subject|0|||
41964433|NCT03261401|75758001|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
41964434|NCT03261401|75758002|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
41964435|NCT03261401|75758003|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
41964436|NCT03261401|75758004|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
41964437|NCT03261401|75758005|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
41964438|NCT03261401|75758006|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
41964439|NCT03261401|75758007|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
41964440|NCT03261401|75758008|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
41964441|NCT03261401|75758009|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
41964442|NCT03261401|75758010|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
41964443|NCT03261401|75758011|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
41964444|NCT03261401|75758012|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
41964445|NCT03261401|75758013|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
41964446|NCT02998528|75758053|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
41964447|NCT02998528|75758054|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
41964448|NCT02998528|75758055|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
41964449|NCT02998528|75758053|FG000|Randomization Period|Participant withdrew consent|0|||
41964450|NCT02998528|75758054|FG001|Randomization Period|Participant withdrew consent|3|||
41964451|NCT02998528|75758055|FG002|Randomization Period|Participant withdrew consent|0|||
41964452|NCT02998528|75758053|FG000|Randomization Period|Participant no longer meets study criteria|1|||
41964453|NCT02998528|75758054|FG001|Randomization Period|Participant no longer meets study criteria|3|||
41964454|NCT02998528|75758055|FG002|Randomization Period|Participant no longer meets study criteria|2|||
41964455|NCT02998528|75758053|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
41964456|NCT02998528|75758054|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
41964457|NCT02998528|75758055|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
41964458|NCT02998528|75758053|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
41964459|NCT02998528|75758054|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
42026819|NCT03355300|75834904|FG001|Overall Study|Physician Decision|1|||
42026820|NCT03355300|75834903|FG000|Overall Study|Lack of Efficacy|2|||
42026821|NCT03355300|75834904|FG001|Overall Study|Lack of Efficacy|1|||
42026822|NCT03355300|75834903|FG000|Overall Study|Other reason|1|||
42026823|NCT03355300|75834904|FG001|Overall Study|Other reason|0|||
42026824|NCT03332056|75834912|FG000|Overall Study|Incomplete questionnaires|8|||
42026825|NCT03332056|75834913|FG001|Overall Study|Incomplete questionnaires|9|||
42120641|NCT00541970|75931409|FG001|Month 7|Protocol Violation|13|||
42120642|NCT00541970|75931410|FG002|Month 7|Protocol Violation|11|||
42120643|NCT00541970|75931411|FG003|Month 7|Protocol Violation|5|||
42120644|NCT00541970|75931408|FG000|Month 12|Adverse Event|0|||
42120645|NCT00541970|75931409|FG001|Month 12|Adverse Event|1|||
42120646|NCT00541970|75931410|FG002|Month 12|Adverse Event|1|||
42120647|NCT00541970|75931411|FG003|Month 12|Adverse Event|1|||
42120648|NCT00541970|75931408|FG000|Month 12|Protocol Violation|12|||
42120649|NCT00541970|75931409|FG001|Month 12|Protocol Violation|21|||
42120650|NCT00541970|75931410|FG002|Month 12|Protocol Violation|20|||
42120651|NCT00541970|75931411|FG003|Month 12|Protocol Violation|15|||
42120652|NCT00541970|75931408|FG000|Month 18|Adverse Event|0|||
42120653|NCT00541970|75931409|FG001|Month 18|Adverse Event|1|||
42120654|NCT00541970|75931410|FG002|Month 18|Adverse Event|1|||
42120655|NCT00541970|75931411|FG003|Month 18|Adverse Event|1|||
42120656|NCT00541970|75931408|FG000|Month 18|Protocol Violation|14|||
42120657|NCT00541970|75931409|FG001|Month 18|Protocol Violation|23|||
42120658|NCT00541970|75931410|FG002|Month 18|Protocol Violation|24|||
42120659|NCT00541970|75931411|FG003|Month 18|Protocol Violation|16|||
42120660|NCT00541970|75931408|FG000|Month 24|Adverse Event|0|||
42120661|NCT00541970|75931409|FG001|Month 24|Adverse Event|1|||
42120662|NCT00541970|75931410|FG002|Month 24|Adverse Event|1|||
41964460|NCT02998528|75758055|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
41964461|NCT02998528|75758053|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
41964462|NCT02998528|75758054|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
41964463|NCT02998528|75758055|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
41964464|NCT02998528|75758053|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
41964465|NCT02998528|75758054|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
42026826|NCT03332056|75834912|FG000|Overall Study|Passed stone prior to surgery date|1|||
42026827|NCT03332056|75834913|FG001|Overall Study|Passed stone prior to surgery date|0|||
42026828|NCT03332056|75834912|FG000|Overall Study|Did not require a ureteral stent|0|||
42026829|NCT03332056|75834913|FG001|Overall Study|Did not require a ureteral stent|1|||
42026830|NCT03093350|75834919|FG000|Overall Study|Death|1|||
42026831|NCT03093350|75834919|FG000|Overall Study|Signed consent, never began treartment|1|||
42026832|NCT02901041|75834925|FG000|Overall Study|Withdrawal by PI|4|||
42120663|NCT00541970|75931411|FG003|Month 24|Adverse Event|1|||
42120664|NCT00541970|75931408|FG000|Month 24|Protocol Violation|29|||
42120665|NCT00541970|75931409|FG001|Month 24|Protocol Violation|31|||
42026833|NCT02901041|75834926|FG001|Overall Study|Withdrawal by PI|8|||
42026834|NCT02901041|75834925|FG000|Overall Study|Withdrawal by Subject|7|||
42026835|NCT02901041|75834926|FG001|Overall Study|Withdrawal by Subject|3|||
42026836|NCT02547987|75834960|FG000|Overall Study|Withdrawal by Subject|1|||
42026837|NCT02547987|75834960|FG000|Overall Study|Adverse Event|2|||
42026838|NCT02513199|75834964|FG000|Treatment|Death|1|||
42026839|NCT02513199|75834964|FG000|Treatment|Lost to Follow-up|1|||
42026840|NCT02513199|75834964|FG000|Follow-Up|Death|11|||
41964466|NCT02998528|75758055|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
41964467|NCT02998528|75758053|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
41964468|NCT02998528|75758054|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
41964469|NCT02998528|75758055|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
41964470|NCT02998528|75758053|FG000|Neoadjuvant Treatment Period|Death|1|||
41964471|NCT02998528|75758054|FG001|Neoadjuvant Treatment Period|Death|0|||
41964472|NCT02998528|75758055|FG002|Neoadjuvant Treatment Period|Death|0|||
41964473|NCT02998528|75758053|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
41964474|NCT02998528|75758054|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
41964475|NCT02998528|75758055|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
41964476|NCT02998528|75758053|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
41964477|NCT02998528|75758054|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
41964478|NCT02998528|75758055|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
41964479|NCT02998528|75758053|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
42026841|NCT00999804|75834986|FG000|Overall Study|Lack of Efficacy|9|||
42026842|NCT00999804|75834987|FG001|Overall Study|Lack of Efficacy|2|||
42026843|NCT00999804|75834986|FG000|Overall Study|Adverse Event|4|||
42026844|NCT00999804|75834987|FG001|Overall Study|Adverse Event|3|||
42026845|NCT00999804|75834986|FG000|Overall Study|Withdrawal by Subject|4|||
42026846|NCT00999804|75834987|FG001|Overall Study|Withdrawal by Subject|0|||
42026847|NCT00999804|75834986|FG000|Overall Study|Death|1|||
42026848|NCT00999804|75834987|FG001|Overall Study|Death|0|||
42026849|NCT00999804|75834986|FG000|Overall Study|Ineligible|3|||
42026850|NCT00999804|75834987|FG001|Overall Study|Ineligible|0|||
42026851|NCT00927472|75834999|FG000|Overall Study|Withdrawal by Subject|10|||
42026852|NCT00927472|75835000|FG001|Overall Study|Withdrawal by Subject|11|||
42026853|NCT00927472|75834999|FG000|Overall Study|Lost to Follow-up|1|||
42026854|NCT00927472|75835000|FG001|Overall Study|Lost to Follow-up|6|||
42026855|NCT00927472|75834999|FG000|Overall Study|Protocol Violation|0|||
42120666|NCT00541970|75931410|FG002|Month 24|Protocol Violation|31|||
42120667|NCT00541970|75931411|FG003|Month 24|Protocol Violation|21|||
42120668|NCT00541970|75931408|FG000|Month 36|Protocol Violation|61|||
42120669|NCT00541970|75931409|FG001|Month 36|Protocol Violation|66|||
42120670|NCT00541970|75931410|FG002|Month 36|Protocol Violation|66|||
42120671|NCT00541970|75931411|FG003|Month 36|Protocol Violation|60|||
42120672|NCT00541970|75931408|FG000|Month 48|Withdrawal by Subject|2|||
42120673|NCT00541970|75931409|FG001|Month 48|Withdrawal by Subject|4|||
42120674|NCT00541970|75931410|FG002|Month 48|Withdrawal by Subject|4|||
42120675|NCT00541970|75931411|FG003|Month 48|Withdrawal by Subject|2|||
42120676|NCT00541970|75931408|FG000|Month 48|Other|3|||
42120677|NCT00541970|75931409|FG001|Month 48|Other|1|||
42120678|NCT00541970|75931410|FG002|Month 48|Other|1|||
42120679|NCT00541970|75931411|FG003|Month 48|Other|0|||
42120680|NCT00541970|75931408|FG000|Month 48|Lost to Follow-up|66|||
41964480|NCT02998528|75758054|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
42026856|NCT00927472|75835000|FG001|Overall Study|Protocol Violation|1|||
42026857|NCT00927472|75834999|FG000|Overall Study|Post treatment Assessment out of window|0|||
42026858|NCT00927472|75835000|FG001|Overall Study|Post treatment Assessment out of window|4|||
42120681|NCT00541970|75931409|FG001|Month 48|Lost to Follow-up|68|||
42120682|NCT00541970|75931410|FG002|Month 48|Lost to Follow-up|68|||
42120683|NCT00541970|75931411|FG003|Month 48|Lost to Follow-up|73|||
42120684|NCT00541970|75931408|FG000|Month 60|Protocol Violation|78|||
42120685|NCT00541970|75931409|FG001|Month 60|Protocol Violation|77|||
42026859|NCT00927394|75835008|FG000|Overall Study|Adverse Event|14|||
42026860|NCT00927394|75835009|FG001|Overall Study|Adverse Event|9|||
42026861|NCT00927394|75835008|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
42026862|NCT00927394|75835009|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
42026863|NCT00927394|75835008|FG000|Overall Study|Withdrawal by Subject|20|||
42120686|NCT00541970|75931410|FG002|Month 60|Protocol Violation|82|||
42120687|NCT00541970|75931411|FG003|Month 60|Protocol Violation|72|||
42120688|NCT00687323|75931421|FG000|Overall Study|Death|25|||
42120689|NCT00687323|75931421|FG000|Overall Study|Withdrawal by Subject|1|||
42120690|NCT00687323|75931421|FG000|Overall Study|Excluded from efficacy evaluations|6|||
42120691|NCT00687323|75931421|FG000|Overall Study|Screen failure|148|||
41964481|NCT02998528|75758055|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
41964482|NCT02998528|75758053|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
41964483|NCT02998528|75758054|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
41964484|NCT02998528|75758055|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
41964485|NCT02998528|75758053|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
41964486|NCT02998528|75758054|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
41964487|NCT02998528|75758055|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
41964488|NCT02998528|75758053|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
41964489|NCT02998528|75758054|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
41964490|NCT02998528|75758055|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
41964491|NCT02718911|75758076|FG000|Overall Study|Adverse Event|0|||
41964492|NCT02718911|75758077|FG001|Overall Study|Adverse Event|0|||
41964493|NCT02718911|75758078|FG002|Overall Study|Adverse Event|0|||
41964494|NCT02718911|75758079|FG003|Overall Study|Adverse Event|0|||
41964495|NCT02718911|75758080|FG004|Overall Study|Adverse Event|0|||
41964496|NCT02718911|75758081|FG005|Overall Study|Adverse Event|0|||
41964497|NCT02718911|75758082|FG006|Overall Study|Adverse Event|0|||
41964498|NCT02718911|75758083|FG007|Overall Study|Adverse Event|0|||
41964499|NCT02718911|75758084|FG008|Overall Study|Adverse Event|0|||
41964500|NCT02718911|75758085|FG009|Overall Study|Adverse Event|2|||
41964501|NCT02718911|75758076|FG000|Overall Study|Death|2|||
41964502|NCT02718911|75758077|FG001|Overall Study|Death|3|||
41964503|NCT02718911|75758078|FG002|Overall Study|Death|1|||
41964504|NCT02718911|75758079|FG003|Overall Study|Death|0|||
41964505|NCT02718911|75758080|FG004|Overall Study|Death|1|||
41964506|NCT02718911|75758081|FG005|Overall Study|Death|3|||
41964507|NCT02718911|75758082|FG006|Overall Study|Death|1|||
41964508|NCT02718911|75758083|FG007|Overall Study|Death|1|||
41964509|NCT02718911|75758084|FG008|Overall Study|Death|4|||
41964510|NCT02718911|75758085|FG009|Overall Study|Death|3|||
41964511|NCT02718911|75758076|FG000|Overall Study|Lost to Follow-up|0|||
41964512|NCT02718911|75758077|FG001|Overall Study|Lost to Follow-up|0|||
41964513|NCT02718911|75758078|FG002|Overall Study|Lost to Follow-up|0|||
41964514|NCT02718911|75758079|FG003|Overall Study|Lost to Follow-up|0|||
41964515|NCT02718911|75758080|FG004|Overall Study|Lost to Follow-up|0|||
41964516|NCT02718911|75758081|FG005|Overall Study|Lost to Follow-up|0|||
41964517|NCT02718911|75758082|FG006|Overall Study|Lost to Follow-up|0|||
41964518|NCT02718911|75758083|FG007|Overall Study|Lost to Follow-up|0|||
41964519|NCT02718911|75758084|FG008|Overall Study|Lost to Follow-up|1|||
41964520|NCT02718911|75758085|FG009|Overall Study|Lost to Follow-up|0|||
41964521|NCT02718911|75758076|FG000|Overall Study|Physician Decision|2|||
41964522|NCT02718911|75758077|FG001|Overall Study|Physician Decision|0|||
41964523|NCT02718911|75758078|FG002|Overall Study|Physician Decision|1|||
41964524|NCT02718911|75758079|FG003|Overall Study|Physician Decision|1|||
41964525|NCT02718911|75758080|FG004|Overall Study|Physician Decision|0|||
41964526|NCT02718911|75758081|FG005|Overall Study|Physician Decision|0|||
41964527|NCT02718911|75758082|FG006|Overall Study|Physician Decision|0|||
41964528|NCT02718911|75758083|FG007|Overall Study|Physician Decision|1|||
41964529|NCT02718911|75758084|FG008|Overall Study|Physician Decision|2|||
41964530|NCT02718911|75758085|FG009|Overall Study|Physician Decision|1|||
41964531|NCT02718911|75758076|FG000|Overall Study|Withdrawal by Subject|0|||
41964532|NCT02718911|75758077|FG001|Overall Study|Withdrawal by Subject|0|||
41964533|NCT02718911|75758078|FG002|Overall Study|Withdrawal by Subject|0|||
41964534|NCT02718911|75758079|FG003|Overall Study|Withdrawal by Subject|0|||
41964535|NCT02718911|75758080|FG004|Overall Study|Withdrawal by Subject|1|||
41964536|NCT02718911|75758081|FG005|Overall Study|Withdrawal by Subject|0|||
41964537|NCT02718911|75758082|FG006|Overall Study|Withdrawal by Subject|0|||
41964538|NCT02718911|75758083|FG007|Overall Study|Withdrawal by Subject|0|||
41964539|NCT02718911|75758084|FG008|Overall Study|Withdrawal by Subject|1|||
41964540|NCT02718911|75758085|FG009|Overall Study|Withdrawal by Subject|4|||
41964541|NCT02718911|75758076|FG000|Overall Study|Reason Not Collected|0|||
41964542|NCT02718911|75758077|FG001|Overall Study|Reason Not Collected|0|||
41964543|NCT02718911|75758078|FG002|Overall Study|Reason Not Collected|1|||
41964544|NCT02718911|75758079|FG003|Overall Study|Reason Not Collected|0|||
41964545|NCT02718911|75758080|FG004|Overall Study|Reason Not Collected|0|||
41964546|NCT02718911|75758081|FG005|Overall Study|Reason Not Collected|0|||
41964547|NCT02718911|75758082|FG006|Overall Study|Reason Not Collected|2|||
41964548|NCT02718911|75758083|FG007|Overall Study|Reason Not Collected|1|||
41964549|NCT02718911|75758084|FG008|Overall Study|Reason Not Collected|4|||
41964550|NCT02718911|75758085|FG009|Overall Study|Reason Not Collected|9|||
41964551|NCT02542267|75758109|FG000|Overall Study|Withdrawal by Subject|10|||
41964552|NCT02542267|75758109|FG000|Overall Study|Physician Decision|6|||
41964553|NCT02542267|75758109|FG000|Overall Study|Lost to Follow-up|4|||
41964554|NCT02542267|75758109|FG000|Overall Study|Death|13|||
41964555|NCT02542267|75758109|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
42120692|NCT03899064|75931438|FG000|Overall Study|Lost to Follow-up|1|||
41964556|NCT02542267|75758109|FG000|Overall Study|Other|9|||
41964557|NCT02017717|75758161|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
41964558|NCT02017717|75758162|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
41964559|NCT02017717|75758163|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
41964560|NCT02017717|75758164|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
41964561|NCT02017717|75758165|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
41964562|NCT02017717|75758166|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
41964563|NCT02017717|75758167|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
41964564|NCT02017717|75758168|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
41964565|NCT02017717|75758169|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
41964566|NCT02017717|75758161|FG000|Before Treatment Period|Participant request to stop therapy|0|||
41964567|NCT02017717|75758162|FG001|Before Treatment Period|Participant request to stop therapy|0|||
41964568|NCT02017717|75758163|FG002|Before Treatment Period|Participant request to stop therapy|0|||
41964569|NCT02017717|75758164|FG003|Before Treatment Period|Participant request to stop therapy|0|||
41964570|NCT02017717|75758165|FG004|Before Treatment Period|Participant request to stop therapy|5|||
41964571|NCT02017717|75758166|FG005|Before Treatment Period|Participant request to stop therapy|0|||
41964572|NCT02017717|75758167|FG006|Before Treatment Period|Participant request to stop therapy|0|||
41964573|NCT02017717|75758168|FG007|Before Treatment Period|Participant request to stop therapy|0|||
41964574|NCT02017717|75758169|FG008|Before Treatment Period|Participant request to stop therapy|0|||
41964575|NCT02017717|75758161|FG000|Before Treatment Period|Participant withdrew consent|0|||
41964576|NCT02017717|75758162|FG001|Before Treatment Period|Participant withdrew consent|0|||
41964577|NCT02017717|75758163|FG002|Before Treatment Period|Participant withdrew consent|0|||
41964578|NCT02017717|75758164|FG003|Before Treatment Period|Participant withdrew consent|0|||
41964579|NCT02017717|75758165|FG004|Before Treatment Period|Participant withdrew consent|11|||
41964580|NCT02017717|75758166|FG005|Before Treatment Period|Participant withdrew consent|0|||
41964581|NCT02017717|75758167|FG006|Before Treatment Period|Participant withdrew consent|0|||
41964582|NCT02017717|75758168|FG007|Before Treatment Period|Participant withdrew consent|0|||
41964583|NCT02017717|75758169|FG008|Before Treatment Period|Participant withdrew consent|2|||
41964584|NCT02017717|75758161|FG000|Before Treatment Period|Lost to Follow-up|0|||
41964585|NCT02017717|75758162|FG001|Before Treatment Period|Lost to Follow-up|0|||
41964586|NCT02017717|75758163|FG002|Before Treatment Period|Lost to Follow-up|0|||
41964587|NCT02017717|75758164|FG003|Before Treatment Period|Lost to Follow-up|0|||
41964588|NCT02017717|75758165|FG004|Before Treatment Period|Lost to Follow-up|1|||
41964589|NCT02017717|75758166|FG005|Before Treatment Period|Lost to Follow-up|0|||
41964590|NCT02017717|75758167|FG006|Before Treatment Period|Lost to Follow-up|0|||
41964591|NCT02017717|75758168|FG007|Before Treatment Period|Lost to Follow-up|0|||
41964592|NCT02017717|75758169|FG008|Before Treatment Period|Lost to Follow-up|0|||
41964593|NCT02017717|75758161|FG000|Before Treatment Period|Participant no longer met criteria|0|||
41964594|NCT02017717|75758162|FG001|Before Treatment Period|Participant no longer met criteria|0|||
41964595|NCT02017717|75758163|FG002|Before Treatment Period|Participant no longer met criteria|0|||
41964596|NCT02017717|75758164|FG003|Before Treatment Period|Participant no longer met criteria|1|||
41964597|NCT02017717|75758165|FG004|Before Treatment Period|Participant no longer met criteria|2|||
41964598|NCT02017717|75758166|FG005|Before Treatment Period|Participant no longer met criteria|0|||
41964599|NCT02017717|75758167|FG006|Before Treatment Period|Participant no longer met criteria|0|||
41964600|NCT02017717|75758168|FG007|Before Treatment Period|Participant no longer met criteria|1|||
41964601|NCT02017717|75758169|FG008|Before Treatment Period|Participant no longer met criteria|0|||
41964602|NCT02017717|75758161|FG000|Before Treatment Period|other reason|0|||
41964603|NCT02017717|75758162|FG001|Before Treatment Period|other reason|0|||
41964604|NCT02017717|75758163|FG002|Before Treatment Period|other reason|0|||
41964605|NCT02017717|75758164|FG003|Before Treatment Period|other reason|0|||
41964606|NCT02017717|75758165|FG004|Before Treatment Period|other reason|1|||
41964607|NCT02017717|75758166|FG005|Before Treatment Period|other reason|0|||
41964608|NCT02017717|75758167|FG006|Before Treatment Period|other reason|0|||
41964609|NCT02017717|75758168|FG007|Before Treatment Period|other reason|0|||
41964610|NCT02017717|75758169|FG008|Before Treatment Period|other reason|0|||
41964611|NCT02017717|75758161|FG000|Treatment Period|Disease progression|7|||
41964612|NCT02017717|75758162|FG001|Treatment Period|Disease progression|9|||
41964613|NCT02017717|75758163|FG002|Treatment Period|Disease progression|12|||
41964614|NCT02017717|75758164|FG003|Treatment Period|Disease progression|165|||
41964615|NCT02017717|75758165|FG004|Treatment Period|Disease progression|134|||
41964616|NCT02017717|75758166|FG005|Treatment Period|Disease progression|20|||
41964617|NCT02017717|75758167|FG006|Treatment Period|Disease progression|26|||
41964618|NCT02017717|75758168|FG007|Treatment Period|Disease progression|17|||
41964619|NCT02017717|75758169|FG008|Treatment Period|Disease progression|22|||
41964620|NCT02017717|75758161|FG000|Treatment Period|Study drug toxicity|3|||
41964621|NCT02017717|75758162|FG001|Treatment Period|Study drug toxicity|0|||
41964622|NCT02017717|75758163|FG002|Treatment Period|Study drug toxicity|1|||
41964623|NCT02017717|75758164|FG003|Treatment Period|Study drug toxicity|7|||
41964624|NCT02017717|75758165|FG004|Treatment Period|Study drug toxicity|11|||
41964625|NCT02017717|75758166|FG005|Treatment Period|Study drug toxicity|4|||
41964626|NCT02017717|75758167|FG006|Treatment Period|Study drug toxicity|4|||
41964627|NCT02017717|75758168|FG007|Treatment Period|Study drug toxicity|5|||
41964628|NCT02017717|75758169|FG008|Treatment Period|Study drug toxicity|3|||
41964629|NCT02017717|75758161|FG000|Treatment Period|Death|0|||
41964630|NCT02017717|75758162|FG001|Treatment Period|Death|0|||
41964631|NCT02017717|75758163|FG002|Treatment Period|Death|1|||
41964632|NCT02017717|75758164|FG003|Treatment Period|Death|0|||
41964633|NCT02017717|75758165|FG004|Treatment Period|Death|0|||
41964634|NCT02017717|75758166|FG005|Treatment Period|Death|0|||
41964635|NCT02017717|75758167|FG006|Treatment Period|Death|0|||
41964636|NCT02017717|75758168|FG007|Treatment Period|Death|1|||
41964637|NCT02017717|75758169|FG008|Treatment Period|Death|0|||
41964638|NCT02017717|75758161|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
41964639|NCT02017717|75758162|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
41964640|NCT02017717|75758163|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
41964641|NCT02017717|75758164|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
41964642|NCT02017717|75758165|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
41964643|NCT02017717|75758166|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
41964644|NCT02017717|75758167|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
41964645|NCT02017717|75758168|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
41964646|NCT02017717|75758169|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
41964647|NCT02017717|75758161|FG000|Treatment Period|Participant request to stop therapy|0|||
41964648|NCT02017717|75758162|FG001|Treatment Period|Participant request to stop therapy|0|||
41964649|NCT02017717|75758163|FG002|Treatment Period|Participant request to stop therapy|3|||
41964650|NCT02017717|75758164|FG003|Treatment Period|Participant request to stop therapy|4|||
41964651|NCT02017717|75758165|FG004|Treatment Period|Participant request to stop therapy|7|||
41964652|NCT02017717|75758166|FG005|Treatment Period|Participant request to stop therapy|5|||
41964653|NCT02017717|75758167|FG006|Treatment Period|Participant request to stop therapy|0|||
41964654|NCT02017717|75758168|FG007|Treatment Period|Participant request to stop therapy|2|||
41964655|NCT02017717|75758169|FG008|Treatment Period|Participant request to stop therapy|1|||
41964656|NCT02017717|75758161|FG000|Treatment Period|Participant withdrew consent|0|||
41964657|NCT02017717|75758162|FG001|Treatment Period|Participant withdrew consent|0|||
41964658|NCT02017717|75758163|FG002|Treatment Period|Participant withdrew consent|1|||
41964659|NCT02017717|75758164|FG003|Treatment Period|Participant withdrew consent|1|||
41964660|NCT02017717|75758165|FG004|Treatment Period|Participant withdrew consent|4|||
41964661|NCT02017717|75758166|FG005|Treatment Period|Participant withdrew consent|0|||
41964662|NCT02017717|75758167|FG006|Treatment Period|Participant withdrew consent|0|||
41964663|NCT02017717|75758168|FG007|Treatment Period|Participant withdrew consent|2|||
41964664|NCT02017717|75758169|FG008|Treatment Period|Participant withdrew consent|0|||
41964665|NCT02017717|75758161|FG000|Treatment Period|Participant no longer met criteria|0|||
41964666|NCT02017717|75758162|FG001|Treatment Period|Participant no longer met criteria|0|||
41964667|NCT02017717|75758163|FG002|Treatment Period|Participant no longer met criteria|0|||
41964668|NCT02017717|75758164|FG003|Treatment Period|Participant no longer met criteria|0|||
41964669|NCT02017717|75758165|FG004|Treatment Period|Participant no longer met criteria|1|||
41964670|NCT02017717|75758166|FG005|Treatment Period|Participant no longer met criteria|0|||
41964671|NCT02017717|75758167|FG006|Treatment Period|Participant no longer met criteria|0|||
41964672|NCT02017717|75758168|FG007|Treatment Period|Participant no longer met criteria|0|||
41964673|NCT02017717|75758169|FG008|Treatment Period|Participant no longer met criteria|0|||
41964674|NCT02017717|75758161|FG000|Treatment Period|other reasons|0|||
41964675|NCT02017717|75758162|FG001|Treatment Period|other reasons|0|||
41964676|NCT02017717|75758163|FG002|Treatment Period|other reasons|0|||
41964677|NCT02017717|75758164|FG003|Treatment Period|other reasons|0|||
41964678|NCT02017717|75758165|FG004|Treatment Period|other reasons|1|||
41964679|NCT02017717|75758166|FG005|Treatment Period|other reasons|0|||
41964680|NCT02017717|75758167|FG006|Treatment Period|other reasons|0|||
41964681|NCT02017717|75758168|FG007|Treatment Period|other reasons|1|||
41964682|NCT02017717|75758169|FG008|Treatment Period|other reasons|1|||
41964683|NCT02017717|75758161|FG000|Treatment Period|Maximum clinical benefit|0|||
41964684|NCT02017717|75758162|FG001|Treatment Period|Maximum clinical benefit|0|||
41964685|NCT02017717|75758163|FG002|Treatment Period|Maximum clinical benefit|0|||
41964686|NCT02017717|75758164|FG003|Treatment Period|Maximum clinical benefit|0|||
41964687|NCT02017717|75758165|FG004|Treatment Period|Maximum clinical benefit|1|||
41964688|NCT02017717|75758166|FG005|Treatment Period|Maximum clinical benefit|0|||
41964689|NCT02017717|75758167|FG006|Treatment Period|Maximum clinical benefit|0|||
41964690|NCT02017717|75758168|FG007|Treatment Period|Maximum clinical benefit|0|||
41964691|NCT02017717|75758169|FG008|Treatment Period|Maximum clinical benefit|0|||
41964692|NCT01539863|75758195|FG000|Overall Study|Lost to Follow-up|5|||
41964693|NCT01539863|75758196|FG001|Overall Study|Lost to Follow-up|4|||
41964694|NCT00942331|75758204|FG000|Overall Study|Did not start treatment|15|||
41964695|NCT00942331|75758205|FG001|Overall Study|Did not start treatment|22|||
41964696|NCT00827372|75758211|FG000|Overall Study|Adverse Event|5|||
41964697|NCT00827372|75758211|FG000|Overall Study|Lack of Efficacy|3|||
41964698|NCT00590902|75758220|FG000|Overall Study|Death|1|||
42120693|NCT03899064|75931438|FG000|Overall Study|Protocol Violation|2|||
42120694|NCT03899064|75931438|FG000|Overall Study|Withdrawal by Subject|2|||
41964699|NCT00577122|75758226|FG000|Overall Study|Adverse Event|0|||
41964700|NCT00577122|75758227|FG001|Overall Study|Adverse Event|2|||
41964701|NCT00577122|75758226|FG000|Overall Study|Progression, relapse during active trt|6|||
41964702|NCT00577122|75758227|FG001|Overall Study|Progression, relapse during active trt|8|||
41964703|NCT00577122|75758226|FG000|Overall Study|Prog, refract disease during active trt|8|||
41964704|NCT00577122|75758227|FG001|Overall Study|Prog, refract disease during active trt|5|||
41964705|NCT00577122|75758226|FG000|Overall Study|Alternative Therapy|0|||
41964706|NCT00577122|75758227|FG001|Overall Study|Alternative Therapy|1|||
41964707|NCT00419770|75758236|FG000|Overall Study|Withdrawal by Subject|5|||
41964708|NCT00419770|75758237|FG001|Overall Study|Withdrawal by Subject|1|||
41964709|NCT00129701|75758243|FG000|Overall Study|Withdrawal by Subject|33|||
41964710|NCT04521114|75764249|FG000|Overall Study|Lost to Follow-up|1|||
41964711|NCT04521114|75764250|FG001|Overall Study|Lost to Follow-up|2|||
41964712|NCT04521114|75764251|FG002|Overall Study|Lost to Follow-up|0|||
41964713|NCT04521114|75764249|FG000|Overall Study|Withdrawal by Subject|1|||
41964714|NCT04521114|75764250|FG001|Overall Study|Withdrawal by Subject|2|||
41964715|NCT04521114|75764251|FG002|Overall Study|Withdrawal by Subject|2|||
41964716|NCT04521114|75764249|FG000|Overall Study|Adverse Event|1|||
41964717|NCT04521114|75764250|FG001|Overall Study|Adverse Event|0|||
41964718|NCT04521114|75764251|FG002|Overall Study|Adverse Event|0|||
41964719|NCT04521114|75764249|FG000|Overall Study|Sponsor Wish|1|||
41964720|NCT04521114|75764250|FG001|Overall Study|Sponsor Wish|0|||
41964721|NCT04521114|75764251|FG002|Overall Study|Sponsor Wish|0|||
41964722|NCT04521114|75764249|FG000|Overall Study|Withdrawal of Consent|2|||
41964723|NCT04521114|75764250|FG001|Overall Study|Withdrawal of Consent|2|||
41964724|NCT04521114|75764251|FG002|Overall Study|Withdrawal of Consent|0|||
41964725|NCT04360824|75764273|FG000|Overall Study|Withdrawal by Subject|2|||
41964726|NCT04360824|75764274|FG001|Overall Study|Withdrawal by Subject|1|||
41964727|NCT04360824|75764273|FG000|Overall Study|Did not receive assigned treatment|1|||
41964728|NCT04360824|75764274|FG001|Overall Study|Did not receive assigned treatment|3|||
41964729|NCT03711786|75764283|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
41964730|NCT03711786|75764284|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
41964731|NCT03711786|75764283|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
41964732|NCT03711786|75764284|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
41964733|NCT03711786|75764283|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
41964734|NCT03711786|75764284|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
41964735|NCT03711786|75764283|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
41964736|NCT03711786|75764284|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
41964737|NCT03711786|75764283|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
41964738|NCT03711786|75764284|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
41964739|NCT03711786|75764283|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
41964740|NCT03711786|75764284|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
41964741|NCT03691974|75764294|FG000|Overall Study|Physician Decision|1|||
41964742|NCT03691974|75764295|FG001|Overall Study|Physician Decision|0|||
41964743|NCT03691974|75764294|FG000|Overall Study|Adverse Event|1|||
41964744|NCT03691974|75764295|FG001|Overall Study|Adverse Event|0|||
41964745|NCT03691974|75764294|FG000|Overall Study|Withdrawal by Subject|11|||
41964746|NCT03691974|75764295|FG001|Overall Study|Withdrawal by Subject|9|||
41964747|NCT03691974|75764294|FG000|Overall Study|Protocol Violation|1|||
41964748|NCT03691974|75764295|FG001|Overall Study|Protocol Violation|0|||
41964749|NCT03691974|75764294|FG000|Overall Study|Lost to Follow-up|8|||
41964750|NCT03691974|75764295|FG001|Overall Study|Lost to Follow-up|7|||
41964751|NCT02454972|75764322|FG000|Overall Study|Progressive disease|17|||
41964752|NCT02454972|75764323|FG001|Overall Study|Progressive disease|16|||
41964753|NCT02454972|75764324|FG002|Overall Study|Progressive disease|59|||
41964754|NCT02454972|75764325|FG003|Overall Study|Progressive disease|23|||
41964755|NCT02454972|75764326|FG004|Overall Study|Progressive disease|16|||
41964756|NCT02454972|75764327|FG005|Overall Study|Progressive disease|12|||
41964757|NCT02454972|75764328|FG006|Overall Study|Progressive disease|19|||
41964758|NCT02454972|75764329|FG007|Overall Study|Progressive disease|27|||
41964759|NCT02454972|75764330|FG008|Overall Study|Progressive disease|0|||
41964760|NCT02454972|75764322|FG000|Overall Study|Death|0|||
41964761|NCT02454972|75764323|FG001|Overall Study|Death|0|||
41964762|NCT02454972|75764324|FG002|Overall Study|Death|5|||
41964763|NCT02454972|75764325|FG003|Overall Study|Death|1|||
41964764|NCT02454972|75764326|FG004|Overall Study|Death|0|||
42120695|NCT03899064|75931438|FG000|Overall Study|Other|2|||
41964765|NCT02454972|75764327|FG005|Overall Study|Death|0|||
41964766|NCT02454972|75764328|FG006|Overall Study|Death|0|||
41964767|NCT02454972|75764329|FG007|Overall Study|Death|0|||
41964768|NCT02454972|75764330|FG008|Overall Study|Death|95|||
41964769|NCT02454972|75764322|FG000|Overall Study|Physician Decision|0|||
42301088|NCT01656889|76136370|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
41964770|NCT02454972|75764323|FG001|Overall Study|Physician Decision|1|||
41964771|NCT02454972|75764324|FG002|Overall Study|Physician Decision|2|||
41964772|NCT02454972|75764325|FG003|Overall Study|Physician Decision|1|||
41964773|NCT02454972|75764326|FG004|Overall Study|Physician Decision|2|||
41964774|NCT02454972|75764327|FG005|Overall Study|Physician Decision|0|||
41964775|NCT02454972|75764328|FG006|Overall Study|Physician Decision|0|||
41964776|NCT02454972|75764329|FG007|Overall Study|Physician Decision|1|||
41964777|NCT02454972|75764330|FG008|Overall Study|Physician Decision|0|||
41964778|NCT02454972|75764322|FG000|Overall Study|Non treatment-related adverse event|2|||
41964779|NCT02454972|75764323|FG001|Overall Study|Non treatment-related adverse event|0|||
41964780|NCT02454972|75764324|FG002|Overall Study|Non treatment-related adverse event|1|||
41964781|NCT02454972|75764325|FG003|Overall Study|Non treatment-related adverse event|0|||
41964782|NCT02454972|75764326|FG004|Overall Study|Non treatment-related adverse event|0|||
41964783|NCT02454972|75764327|FG005|Overall Study|Non treatment-related adverse event|1|||
41964784|NCT02454972|75764328|FG006|Overall Study|Non treatment-related adverse event|0|||
41964785|NCT02454972|75764329|FG007|Overall Study|Non treatment-related adverse event|1|||
41964786|NCT02454972|75764330|FG008|Overall Study|Non treatment-related adverse event|0|||
41964787|NCT02454972|75764322|FG000|Overall Study|Treatment-related adverse events|0|||
41964788|NCT02454972|75764323|FG001|Overall Study|Treatment-related adverse events|1|||
41964789|NCT02454972|75764324|FG002|Overall Study|Treatment-related adverse events|1|||
41964790|NCT02454972|75764325|FG003|Overall Study|Treatment-related adverse events|0|||
41964791|NCT02454972|75764326|FG004|Overall Study|Treatment-related adverse events|2|||
41964792|NCT02454972|75764327|FG005|Overall Study|Treatment-related adverse events|0|||
41964793|NCT02454972|75764328|FG006|Overall Study|Treatment-related adverse events|0|||
41964794|NCT02454972|75764329|FG007|Overall Study|Treatment-related adverse events|2|||
41964795|NCT02454972|75764330|FG008|Overall Study|Treatment-related adverse events|0|||
41964796|NCT02454972|75764322|FG000|Overall Study|Patient moves to compassionate use|0|||
41964797|NCT02454972|75764323|FG001|Overall Study|Patient moves to compassionate use|0|||
41964798|NCT02454972|75764324|FG002|Overall Study|Patient moves to compassionate use|0|||
41964799|NCT02454972|75764325|FG003|Overall Study|Patient moves to compassionate use|0|||
41964800|NCT02454972|75764326|FG004|Overall Study|Patient moves to compassionate use|0|||
41964801|NCT02454972|75764327|FG005|Overall Study|Patient moves to compassionate use|0|||
41964802|NCT02454972|75764328|FG006|Overall Study|Patient moves to compassionate use|2|||
41964803|NCT02454972|75764329|FG007|Overall Study|Patient moves to compassionate use|0|||
41964804|NCT02454972|75764330|FG008|Overall Study|Patient moves to compassionate use|0|||
41964805|NCT02454972|75764322|FG000|Overall Study|Withdrawal by Subject|0|||
41964806|NCT02454972|75764323|FG001|Overall Study|Withdrawal by Subject|1|||
41964807|NCT02454972|75764324|FG002|Overall Study|Withdrawal by Subject|5|||
41964808|NCT02454972|75764325|FG003|Overall Study|Withdrawal by Subject|2|||
41964809|NCT02454972|75764326|FG004|Overall Study|Withdrawal by Subject|3|||
41964810|NCT02454972|75764327|FG005|Overall Study|Withdrawal by Subject|2|||
41964811|NCT02454972|75764328|FG006|Overall Study|Withdrawal by Subject|0|||
41964812|NCT02454972|75764329|FG007|Overall Study|Withdrawal by Subject|1|||
41964813|NCT02454972|75764330|FG008|Overall Study|Withdrawal by Subject|2|||
41964814|NCT02454972|75764322|FG000|Overall Study|Multiple delay/holds on treatment|0|||
41964815|NCT02454972|75764323|FG001|Overall Study|Multiple delay/holds on treatment|0|||
41964816|NCT02454972|75764324|FG002|Overall Study|Multiple delay/holds on treatment|0|||
41964817|NCT02454972|75764325|FG003|Overall Study|Multiple delay/holds on treatment|1|||
41964818|NCT02454972|75764326|FG004|Overall Study|Multiple delay/holds on treatment|0|||
41964819|NCT02454972|75764327|FG005|Overall Study|Multiple delay/holds on treatment|0|||
41964820|NCT02454972|75764328|FG006|Overall Study|Multiple delay/holds on treatment|0|||
41964821|NCT02454972|75764329|FG007|Overall Study|Multiple delay/holds on treatment|0|||
41964822|NCT02454972|75764330|FG008|Overall Study|Multiple delay/holds on treatment|0|||
41964823|NCT02454972|75764322|FG000|Overall Study|Never treated|0|||
41964824|NCT02454972|75764323|FG001|Overall Study|Never treated|0|||
41964825|NCT02454972|75764324|FG002|Overall Study|Never treated|3|||
41964826|NCT02454972|75764325|FG003|Overall Study|Never treated|1|||
41964827|NCT02454972|75764326|FG004|Overall Study|Never treated|1|||
41964828|NCT02454972|75764327|FG005|Overall Study|Never treated|0|||
41964829|NCT02454972|75764328|FG006|Overall Study|Never treated|0|||
41964830|NCT02454972|75764329|FG007|Overall Study|Never treated|0|||
41964831|NCT02454972|75764330|FG008|Overall Study|Never treated|5|||
41964832|NCT02454972|75764322|FG000|Overall Study|Lost to Follow-up|0|||
41964833|NCT02454972|75764323|FG001|Overall Study|Lost to Follow-up|0|||
41964834|NCT02454972|75764324|FG002|Overall Study|Lost to Follow-up|0|||
41964835|NCT02454972|75764325|FG003|Overall Study|Lost to Follow-up|0|||
42301089|NCT02522299|76136378|FG000|Overall Study|Adverse Event|2|||
41964836|NCT02454972|75764326|FG004|Overall Study|Lost to Follow-up|0|||
41964837|NCT02454972|75764327|FG005|Overall Study|Lost to Follow-up|0|||
41964838|NCT02454972|75764328|FG006|Overall Study|Lost to Follow-up|0|||
41964839|NCT02454972|75764329|FG007|Overall Study|Lost to Follow-up|0|||
41964840|NCT02454972|75764330|FG008|Overall Study|Lost to Follow-up|2|||
42120696|NCT03902574|75931445|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
41964841|NCT02454972|75764322|FG000|Overall Study|Study termination|0|||
41964842|NCT02454972|75764323|FG001|Overall Study|Study termination|0|||
41964843|NCT02454972|75764324|FG002|Overall Study|Study termination|0|||
41964844|NCT02454972|75764325|FG003|Overall Study|Study termination|0|||
41964845|NCT02454972|75764326|FG004|Overall Study|Study termination|0|||
42026864|NCT00927394|75835009|FG001|Overall Study|Withdrawal by Subject|24|||
42026865|NCT00927394|75835008|FG000|Overall Study|Lost to Follow-up|8|||
42120697|NCT03902574|75931446|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
42120698|NCT03902574|75931447|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
42120699|NCT00542828|75931459|FG000|Overall Study|Physician Decision|1|||
42120700|NCT00542828|75931459|FG000|Overall Study|Need for Prohibited Treatment|3|||
42120701|NCT00542828|75931459|FG000|Overall Study|Study Prematurely Discontinued|7|||
42120702|NCT00542828|75931459|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
42120703|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
42120704|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
42120705|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
41964846|NCT02454972|75764327|FG005|Overall Study|Study termination|0|||
41964847|NCT02454972|75764328|FG006|Overall Study|Study termination|0|||
41964848|NCT02454972|75764329|FG007|Overall Study|Study termination|0|||
41964849|NCT02454972|75764330|FG008|Overall Study|Study termination|6|||
41964850|NCT00063882|75764348|FG000|Overall Study|Protocol Violation|3|||
41964851|NCT00063882|75764349|FG001|Overall Study|Protocol Violation|3|||
41964852|NCT00063882|75764348|FG000|Overall Study|Withdrawal by Subject|2|||
41964853|NCT00063882|75764349|FG001|Overall Study|Withdrawal by Subject|1|||
41964854|NCT01279044|75764358|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
41964855|NCT01279044|75764359|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
41964856|NCT01279044|75764360|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
41964857|NCT01279044|75764358|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
42026866|NCT00927394|75835009|FG001|Overall Study|Lost to Follow-up|14|||
42026867|NCT00927394|75835008|FG000|Overall Study|Administrative Problem|1|||
42026868|NCT00927394|75835009|FG001|Overall Study|Administrative Problem|0|||
42026869|NCT00927394|75835008|FG000|Overall Study|Death|1|||
42026870|NCT00927394|75835009|FG001|Overall Study|Death|1|||
42026871|NCT00927394|75835008|FG000|Overall Study|Protocol deviation|16|||
42026872|NCT00927394|75835009|FG001|Overall Study|Protocol deviation|13|||
42026873|NCT00927394|75835008|FG000|Overall Study|Randomized in error|0|||
42026874|NCT00927394|75835009|FG001|Overall Study|Randomized in error|1|||
42026875|NCT00976911|75835018|FG000|Overall Study|Withdrawal by Subject|4|||
42026876|NCT00976911|75835019|FG001|Overall Study|Withdrawal by Subject|6|||
42026877|NCT00976911|75835018|FG000|Overall Study|Death|138|||
42026878|NCT00976911|75835019|FG001|Overall Study|Death|126|||
42026879|NCT00976911|75835018|FG000|Overall Study|Adverse Event|0|||
42026880|NCT00976911|75835019|FG001|Overall Study|Adverse Event|1|||
42026881|NCT00976911|75835018|FG000|Overall Study|Protocol Violation|2|||
42026882|NCT00976911|75835019|FG001|Overall Study|Protocol Violation|0|||
42026883|NCT00976911|75835018|FG000|Overall Study|Other|8|||
42026884|NCT00976911|75835019|FG001|Overall Study|Other|9|||
42026885|NCT00976911|75835018|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
42026886|NCT00976911|75835019|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
42026887|NCT00934648|75835025|FG000|Overall Study|Failure to return|8|||
42026888|NCT00934648|75835025|FG000|Overall Study|Withdrawal by Subject|1|||
42026889|NCT01175213|75835033|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
42026890|NCT01175213|75835034|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
42026891|NCT01175213|75835033|FG000|IGSC, 10%/rHuPH20|Death|1|||
42026892|NCT01175213|75835034|FG001|IGSC, 10%/rHuPH20|Death|0|||
42026893|NCT01175213|75835033|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
42026894|NCT01175213|75835034|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
42026895|NCT01175213|75835033|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
42026896|NCT01175213|75835034|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
42026897|NCT01175213|75835033|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
42026898|NCT01175213|75835034|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
42026899|NCT01175213|75835033|FG000|Safety Follow-up|Adverse Event|1|||
42026900|NCT01175213|75835034|FG001|Safety Follow-up|Adverse Event|0|||
42026901|NCT00974259|75835045|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
42026902|NCT00974259|75835046|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
42026903|NCT00927082|75835056|FG000|Overall Study|Lost to Follow-up|9|||
42026904|NCT00927082|75835057|FG001|Overall Study|Lost to Follow-up|8|||
42026905|NCT00927082|75835058|FG002|Overall Study|Lost to Follow-up|12|||
42026906|NCT00927082|75835059|FG003|Overall Study|Lost to Follow-up|16|||
42026907|NCT00927082|75835056|FG000|Overall Study|Withdrawal by Subject|3|||
42026908|NCT00927082|75835057|FG001|Overall Study|Withdrawal by Subject|2|||
42026909|NCT00927082|75835058|FG002|Overall Study|Withdrawal by Subject|7|||
42026910|NCT00927082|75835059|FG003|Overall Study|Withdrawal by Subject|2|||
42026911|NCT00927082|75835056|FG000|Overall Study|Death|0|||
42026912|NCT00927082|75835057|FG001|Overall Study|Death|0|||
42026913|NCT00927082|75835058|FG002|Overall Study|Death|1|||
42026914|NCT00927082|75835059|FG003|Overall Study|Death|0|||
42120706|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
42120707|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
42120708|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
42120709|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
42120710|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
42120711|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
42120712|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
42120713|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
42120714|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
42120715|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
42120716|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
42120717|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
42120718|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
42120719|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
42120720|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
42120721|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
42120722|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
42120723|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
42120724|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
42120725|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
42026915|NCT00927082|75835056|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
42026916|NCT00927082|75835057|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
42026917|NCT00927082|75835058|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
42026918|NCT00927082|75835059|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
42026919|NCT00976677|75835075|FG000|Overall Study|Adverse Event|1|||
42026920|NCT00976677|75835076|FG001|Overall Study|Adverse Event|0|||
42026921|NCT00976677|75835075|FG000|Overall Study|Withdrawal by Subject|0|||
42026922|NCT00976677|75835076|FG001|Overall Study|Withdrawal by Subject|2|||
42026923|NCT00976677|75835075|FG000|Overall Study|Disease progression|1|||
42026924|NCT00976677|75835076|FG001|Overall Study|Disease progression|1|||
42026925|NCT00976677|75835075|FG000|Overall Study|Trial unblinded|2|||
42026926|NCT00976677|75835076|FG001|Overall Study|Trial unblinded|2|||
42026927|NCT00976677|75835075|FG000|Overall Study|Unknown/Missing|1|||
42026928|NCT00976677|75835076|FG001|Overall Study|Unknown/Missing|0|||
42026929|NCT00926536|75835084|FG000|Overall Study|Physician Decision|1|||
42026930|NCT00926536|75835085|FG001|Overall Study|Physician Decision|2|||
42026931|NCT00923260|75835093|FG000|Overall Study|Lost to Follow-up|1|||
42026932|NCT00923260|75835094|FG001|Overall Study|Lost to Follow-up|1|||
42026933|NCT00934102|75835100|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
42026934|NCT00934102|75835101|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
42026935|NCT00934102|75835102|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
42026936|NCT00970281|75835121|FG000|Overall Study|Lack of Efficacy|1|||
42026937|NCT00970281|75835122|FG001|Overall Study|Lack of Efficacy|14|||
42026938|NCT00970281|75835121|FG000|Overall Study|Withdrawal by Subject|0|||
42026939|NCT00970281|75835122|FG001|Overall Study|Withdrawal by Subject|1|||
42026940|NCT00970281|75835121|FG000|Overall Study|Physician Decision|1|||
42026941|NCT00970281|75835122|FG001|Overall Study|Physician Decision|1|||
42026942|NCT00976209|75835130|FG000|Treatment Period 1|Protocol Violation|1|||
42026943|NCT00976209|75835131|FG001|Treatment Period 1|Protocol Violation|0|||
42026944|NCT00976209|75835130|FG000|Treatment Period 1|Lost to Follow-up|2|||
42026945|NCT00976209|75835131|FG001|Treatment Period 1|Lost to Follow-up|0|||
42026946|NCT00976209|75835130|FG000|Treatment Period 1|Other|0|||
42026947|NCT00976209|75835131|FG001|Treatment Period 1|Other|1|||
42026948|NCT00976209|75835130|FG000|Wash-out Period|Adverse Event|1|||
42120726|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
42120727|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
42026949|NCT00976209|75835131|FG001|Wash-out Period|Adverse Event|2|||
42026950|NCT00976209|75835130|FG000|Wash-out Period|Lost to Follow-up|1|||
42026951|NCT00976209|75835131|FG001|Wash-out Period|Lost to Follow-up|0|||
42026952|NCT00976209|75835130|FG000|Wash-out Period|Protocol Violation|1|||
42026953|NCT00976209|75835131|FG001|Wash-out Period|Protocol Violation|0|||
42026954|NCT00976209|75835130|FG000|Wash-out Period|Other|1|||
42026955|NCT00976209|75835131|FG001|Wash-out Period|Other|0|||
42026956|NCT00976209|75835130|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42026957|NCT00976209|75835131|FG001|Treatment Period 2|Withdrawal by Subject|1|||
42026958|NCT00976209|75835130|FG000|Treatment Period 2|Lost to Follow-up|0|||
42026959|NCT00976209|75835131|FG001|Treatment Period 2|Lost to Follow-up|1|||
42026960|NCT00925990|75835138|FG000|Overall Study|Adverse Event|1|||
42026961|NCT00925990|75835139|FG001|Overall Study|Adverse Event|3|||
42026962|NCT00925990|75835138|FG000|Overall Study|Withdrawal by Subject|2|||
42120728|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
42301090|NCT02522299|76136379|FG001|Overall Study|Adverse Event|0|||
42301091|NCT02522299|76136378|FG000|Overall Study|Physician Decision|0|||
42301092|NCT02522299|76136379|FG001|Overall Study|Physician Decision|1|||
42301093|NCT02522299|76136378|FG000|Overall Study|Withdrawal by Subject|2|||
42301094|NCT02522299|76136379|FG001|Overall Study|Withdrawal by Subject|0|||
42301095|NCT01365091|76136403|FG000|Period 1|Adverse Event|1|||
42301096|NCT01365091|76136404|FG001|Period 1|Adverse Event|0|||
42301097|NCT01365091|76136405|FG002|Period 1|Adverse Event|2|||
42301098|NCT01365091|76136406|FG003|Period 1|Adverse Event|3|||
42301099|NCT01365091|76136403|FG000|Period 1|Positive test result for drugs of abuse|1|||
42301100|NCT01365091|76136404|FG001|Period 1|Positive test result for drugs of abuse|0|||
42301101|NCT01365091|76136405|FG002|Period 1|Positive test result for drugs of abuse|0|||
42301102|NCT01365091|76136406|FG003|Period 1|Positive test result for drugs of abuse|0|||
42301103|NCT01365091|76136403|FG000|Period 1|No longer met study criteria|0|||
41964858|NCT01279044|75764359|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
41964859|NCT01279044|75764360|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
42120729|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
42120730|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
42120731|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
42120732|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
42120733|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
42120734|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
42120735|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
42120736|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
42120737|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
42120738|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
42120739|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
42120740|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
42120741|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
42120742|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
42120743|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
42120744|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
42120745|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
42120746|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
42120747|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
42120748|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
42120749|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
42120750|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
42120751|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
42120752|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
42120753|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
42120754|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
42120755|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
42120756|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
42301104|NCT01365091|76136404|FG001|Period 1|No longer met study criteria|1|||
42301105|NCT01365091|76136405|FG002|Period 1|No longer met study criteria|0|||
41964860|NCT01279044|75764358|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
41964861|NCT01279044|75764359|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
41964862|NCT01279044|75764360|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
41964863|NCT01278342|75764369|FG000|Overall Study|Physician Decision|0|||
41964864|NCT01278342|75764370|FG001|Overall Study|Physician Decision|1|||
41964865|NCT01278342|75764371|FG002|Overall Study|Physician Decision|0|||
41964866|NCT01278342|75764369|FG000|Overall Study|Lost to Follow-up|1|||
42026963|NCT00925990|75835139|FG001|Overall Study|Withdrawal by Subject|2|||
42026964|NCT00925990|75835138|FG000|Overall Study|Lost to Follow-up|1|||
42026965|NCT00925990|75835139|FG001|Overall Study|Lost to Follow-up|3|||
42026966|NCT00925990|75835138|FG000|Overall Study|Physician Decision|1|||
42026967|NCT00925990|75835139|FG001|Overall Study|Physician Decision|1|||
42026968|NCT00925990|75835138|FG000|Overall Study|moved out of state, missed medication|0|||
42026969|NCT00925990|75835139|FG001|Overall Study|moved out of state, missed medication|2|||
42026970|NCT01131078|75835148|FG000|Overall Study|Adverse Event|22|||
42026971|NCT01131078|75835149|FG001|Overall Study|Adverse Event|12|||
42026972|NCT01131078|75835150|FG002|Overall Study|Adverse Event|17|||
42301106|NCT01365091|76136406|FG003|Period 1|No longer met study criteria|0|||
42026973|NCT01131078|75835148|FG000|Overall Study|Progressive Disease|58|||
42026974|NCT01131078|75835149|FG001|Overall Study|Progressive Disease|77|||
41964867|NCT01278342|75764370|FG001|Overall Study|Lost to Follow-up|0|||
42120757|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
42120758|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
42120759|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
42120760|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
42120761|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
42120762|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
42120763|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
42120764|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
42120765|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
42120766|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
42120767|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
42120768|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
42120769|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
42120770|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
42120771|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
42120772|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
42120773|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
42120774|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
42120775|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
42120776|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
42120777|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
42120778|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
42120779|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
42120780|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
42120781|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
42120782|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
42120783|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
42120784|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
42120785|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
42120786|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
42120787|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
42120788|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
42120789|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
42120790|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
42120791|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
42120792|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
42120793|NCT00090103|75931466|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
42120794|NCT00090103|75931467|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
42120795|NCT00090103|75931468|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
42120796|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
42120797|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
42120798|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
42120799|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
42120800|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
42120801|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
42120802|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
42120803|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
42120804|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
42120805|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
42120806|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
42120807|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
42120808|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
42120809|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
42120810|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
42120811|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
42120812|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
42120813|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
42120814|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
42120815|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
42120816|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
42120817|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
42301107|NCT01365091|76136403|FG000|Period 1|Withdrawal by Subject|0|||
42301108|NCT01365091|76136404|FG001|Period 1|Withdrawal by Subject|1|||
42120818|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
42120819|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
42120820|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
42120821|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
42120822|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
42120823|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
42120824|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
42120825|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
42120826|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
42120827|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
42120828|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
42120829|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
42120830|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
42120831|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
42120832|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
42120833|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
41964868|NCT01278342|75764371|FG002|Overall Study|Lost to Follow-up|0|||
41964869|NCT01278342|75764369|FG000|Overall Study|Administrative problems|2|||
41964870|NCT01278342|75764370|FG001|Overall Study|Administrative problems|0|||
41964871|NCT01278342|75764371|FG002|Overall Study|Administrative problems|0|||
41964872|NCT01278342|75764369|FG000|Overall Study|Other|1|||
41964873|NCT01278342|75764370|FG001|Overall Study|Other|0|||
41964874|NCT01278342|75764371|FG002|Overall Study|Other|0|||
42120834|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
41964875|NCT01278030|75764381|FG000|Overall Study|Withdrawal by Subject|8|||
41964876|NCT01278030|75764382|FG001|Overall Study|Withdrawal by Subject|4|||
41964877|NCT01277718|75764388|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
42026975|NCT01131078|75835150|FG002|Overall Study|Progressive Disease|71|||
42026976|NCT01131078|75835148|FG000|Overall Study|Protocol Violation|1|||
42026977|NCT01131078|75835149|FG001|Overall Study|Protocol Violation|0|||
42026978|NCT01131078|75835150|FG002|Overall Study|Protocol Violation|0|||
42026979|NCT01131078|75835148|FG000|Overall Study|Lost to Follow-up|1|||
42026980|NCT01131078|75835149|FG001|Overall Study|Lost to Follow-up|1|||
42026981|NCT01131078|75835150|FG002|Overall Study|Lost to Follow-up|1|||
42026982|NCT01131078|75835148|FG000|Overall Study|Withdrawal by Subject|2|||
42026983|NCT01131078|75835149|FG001|Overall Study|Withdrawal by Subject|4|||
42026984|NCT01131078|75835150|FG002|Overall Study|Withdrawal by Subject|3|||
42026985|NCT01131078|75835148|FG000|Overall Study|Non-compliance|3|||
42026986|NCT01131078|75835149|FG001|Overall Study|Non-compliance|0|||
42026987|NCT01131078|75835150|FG002|Overall Study|Non-compliance|0|||
42026988|NCT01131078|75835148|FG000|Overall Study|Physician Decision|10|||
42026989|NCT01131078|75835149|FG001|Overall Study|Physician Decision|6|||
42026990|NCT01131078|75835150|FG002|Overall Study|Physician Decision|8|||
42026991|NCT01131078|75835148|FG000|Overall Study|Death|4|||
42026992|NCT01131078|75835149|FG001|Overall Study|Death|0|||
42026993|NCT01131078|75835150|FG002|Overall Study|Death|2|||
42026994|NCT01131078|75835148|FG000|Overall Study|Other|0|||
42026995|NCT01131078|75835149|FG001|Overall Study|Other|1|||
42026996|NCT01131078|75835150|FG002|Overall Study|Other|0|||
42026997|NCT01167582|75835162|FG000|Overall Study|Lost to Follow-up|0|||
42026998|NCT01167582|75835163|FG001|Overall Study|Lost to Follow-up|1|||
42026999|NCT01167426|75835169|FG000|Overall Study|Lost to Follow-up|6|||
42027000|NCT01167426|75835169|FG000|Overall Study|Protocol Violation|1|||
42027001|NCT01167426|75835169|FG000|Overall Study|Withdrawal by Subject|2|||
42027002|NCT01167426|75835169|FG000|Overall Study|Sponsor Decision|1|||
42027003|NCT00922636|75835179|FG000|Overall Study|Adverse Event|3|||
42027004|NCT00922636|75835180|FG001|Overall Study|Adverse Event|3|||
42027005|NCT00922636|75835181|FG002|Overall Study|Adverse Event|2|||
42027006|NCT00922636|75835182|FG003|Overall Study|Adverse Event|3|||
42027007|NCT00922636|75835183|FG004|Overall Study|Adverse Event|2|||
42027008|NCT00922636|75835179|FG000|Overall Study|Lack of Efficacy|1|||
42027009|NCT00922636|75835180|FG001|Overall Study|Lack of Efficacy|7|||
42027010|NCT00922636|75835181|FG002|Overall Study|Lack of Efficacy|3|||
42027011|NCT00922636|75835182|FG003|Overall Study|Lack of Efficacy|2|||
42120835|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
42120836|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
42120837|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
42210357|NCT03288714|76025139|FG001|Overall Study|Lost to Follow-up|1|||
42027012|NCT00922636|75835183|FG004|Overall Study|Lack of Efficacy|4|||
42027013|NCT00922636|75835179|FG000|Overall Study|Sponsor Decision|0|||
42027014|NCT00922636|75835180|FG001|Overall Study|Sponsor Decision|0|||
42027015|NCT00922636|75835181|FG002|Overall Study|Sponsor Decision|2|||
41964878|NCT01277718|75764389|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
42027016|NCT00922636|75835182|FG003|Overall Study|Sponsor Decision|0|||
42027017|NCT00922636|75835183|FG004|Overall Study|Sponsor Decision|0|||
42027018|NCT00922636|75835179|FG000|Overall Study|Withdrawal by Subject|0|||
42027019|NCT00922636|75835180|FG001|Overall Study|Withdrawal by Subject|0|||
42120838|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
42120839|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
42120840|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
42120841|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
42120842|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
42120843|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
42120844|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Death|1|||
42301109|NCT01365091|76136405|FG002|Period 1|Withdrawal by Subject|0|||
41964879|NCT01277718|75764388|FG000|Period 2 - Second Intervention|Physician Decision|0|||
41964880|NCT01277718|75764389|FG001|Period 2 - Second Intervention|Physician Decision|2|||
41964881|NCT01276236|75764397|FG000|Overall Study|Lack of Efficacy|2|||
41964882|NCT01276236|75764397|FG000|Overall Study|Withdrawal by Subject|4|||
41964883|NCT01275222|75764407|FG000|Phase l by Treatment|Adverse Event|1|||
41964884|NCT01275222|75764408|FG001|Phase l by Treatment|Adverse Event|4|||
41964885|NCT01275222|75764409|FG002|Phase l by Treatment|Adverse Event|2|||
41964886|NCT01275222|75764410|FG003|Phase l by Treatment|Adverse Event|3|||
41964887|NCT01275222|75764411|FG004|Phase l by Treatment|Adverse Event|0|||
41964888|NCT01275222|75764412|FG005|Phase l by Treatment|Adverse Event|0|||
41964889|NCT01275222|75764407|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
41964890|NCT01275222|75764408|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
41964891|NCT01275222|75764409|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
41964892|NCT01275222|75764410|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
41964893|NCT01275222|75764411|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
41964894|NCT01275222|75764412|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
41964895|NCT01275222|75764407|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
41964896|NCT01275222|75764408|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
41964897|NCT01275222|75764409|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
41964898|NCT01275222|75764410|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
41964899|NCT01275222|75764411|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
41964900|NCT01275222|75764412|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
41964901|NCT01275222|75764407|FG000|Phase l by Treatment|Disease progression|12|||
41964902|NCT01275222|75764408|FG001|Phase l by Treatment|Disease progression|8|||
41964903|NCT01275222|75764409|FG002|Phase l by Treatment|Disease progression|2|||
41964904|NCT01275222|75764410|FG003|Phase l by Treatment|Disease progression|5|||
41964905|NCT01275222|75764411|FG004|Phase l by Treatment|Disease progression|0|||
41964906|NCT01275222|75764412|FG005|Phase l by Treatment|Disease progression|0|||
41964907|NCT01275222|75764407|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
41964908|NCT01275222|75764408|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
41964909|NCT01275222|75764409|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
41964910|NCT01275222|75764410|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
41964911|NCT01275222|75764411|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
41964912|NCT01275222|75764412|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
41964913|NCT01275222|75764407|FG000|Phase l by Treatment|Death|0|||
41964914|NCT01275222|75764408|FG001|Phase l by Treatment|Death|1|||
41964915|NCT01275222|75764409|FG002|Phase l by Treatment|Death|0|||
41964916|NCT01275222|75764410|FG003|Phase l by Treatment|Death|1|||
41964917|NCT01275222|75764411|FG004|Phase l by Treatment|Death|0|||
41964918|NCT01275222|75764412|FG005|Phase l by Treatment|Death|0|||
41964919|NCT01275222|75764407|FG000|Phase ll by Stratum|Adverse Event|0|||
41964920|NCT01275222|75764408|FG001|Phase ll by Stratum|Adverse Event|0|||
41964921|NCT01275222|75764409|FG002|Phase ll by Stratum|Adverse Event|0|||
41964922|NCT01275222|75764410|FG003|Phase ll by Stratum|Adverse Event|0|||
41964923|NCT01275222|75764411|FG004|Phase ll by Stratum|Adverse Event|2|||
41964924|NCT01275222|75764412|FG005|Phase ll by Stratum|Adverse Event|10|||
41964925|NCT01275222|75764407|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
42027020|NCT00922636|75835181|FG002|Overall Study|Withdrawal by Subject|5|||
42027021|NCT00922636|75835182|FG003|Overall Study|Withdrawal by Subject|2|||
42027022|NCT00922636|75835183|FG004|Overall Study|Withdrawal by Subject|4|||
42027023|NCT00922636|75835179|FG000|Overall Study|Protocol Violation|0|||
42027024|NCT00922636|75835180|FG001|Overall Study|Protocol Violation|0|||
42027025|NCT00922636|75835181|FG002|Overall Study|Protocol Violation|2|||
42301110|NCT01365091|76136406|FG003|Period 1|Withdrawal by Subject|0|||
42301111|NCT01365091|76136403|FG000|Period 1|Personal reasons|0|||
41964926|NCT01275222|75764408|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
42027026|NCT00922636|75835182|FG003|Overall Study|Protocol Violation|2|||
42027027|NCT00922636|75835183|FG004|Overall Study|Protocol Violation|0|||
42120845|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Death|0|||
41964927|NCT01275222|75764409|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
41964928|NCT01275222|75764410|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
41964929|NCT01275222|75764411|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
42027028|NCT00922636|75835179|FG000|Overall Study|Entry Criteria Not Met|0|||
42301112|NCT01365091|76136404|FG001|Period 1|Personal reasons|0|||
41964930|NCT01275222|75764412|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
41964931|NCT01275222|75764407|FG000|Phase ll by Stratum|Disease progression|0|||
41964932|NCT01275222|75764408|FG001|Phase ll by Stratum|Disease progression|0|||
41964933|NCT01275222|75764409|FG002|Phase ll by Stratum|Disease progression|0|||
41964934|NCT01275222|75764410|FG003|Phase ll by Stratum|Disease progression|0|||
41964935|NCT01275222|75764411|FG004|Phase ll by Stratum|Disease progression|23|||
41964936|NCT01275222|75764412|FG005|Phase ll by Stratum|Disease progression|31|||
41964937|NCT01275222|75764407|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
42301113|NCT01365091|76136405|FG002|Period 1|Personal reasons|1|||
42301114|NCT01365091|76136406|FG003|Period 1|Personal reasons|0|||
41964938|NCT01275222|75764408|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
42120846|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Death|1|||
42120847|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
42120848|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
42120849|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
42120850|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
42120851|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
41964939|NCT01275222|75764409|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
41964940|NCT01275222|75764410|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
41964941|NCT01275222|75764411|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
41964942|NCT01275222|75764412|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
41964943|NCT01275222|75764407|FG000|Phase ll by Stratum|Death|0|||
41964944|NCT01275222|75764408|FG001|Phase ll by Stratum|Death|0|||
41964945|NCT01275222|75764409|FG002|Phase ll by Stratum|Death|0|||
41964946|NCT01275222|75764410|FG003|Phase ll by Stratum|Death|0|||
41964947|NCT01275222|75764411|FG004|Phase ll by Stratum|Death|1|||
41964948|NCT01275222|75764412|FG005|Phase ll by Stratum|Death|1|||
41964949|NCT01275144|75764430|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
41964950|NCT01275144|75764431|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
41964951|NCT01275066|75764442|FG000|Overall Study|Withdrawal by Subject|0|||
41964952|NCT01275066|75764443|FG001|Overall Study|Withdrawal by Subject|0|||
41964953|NCT01275066|75764444|FG002|Overall Study|Withdrawal by Subject|1|||
41964954|NCT01275066|75764442|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
41964955|NCT01275066|75764443|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
42301115|NCT01365091|76136403|FG000|Period 2|Withdrawal by Subject|1|||
42301116|NCT01365091|76136404|FG001|Period 2|Withdrawal by Subject|0|||
41964956|NCT01275066|75764444|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
41964957|NCT01273038|75764454|FG000|Second Intervention (14 Days)|Adverse Event|0|||
42120852|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
42120853|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
42120854|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
42120855|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
42120856|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
42120857|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
42120858|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
42120859|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
42120860|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
42120861|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
42120862|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
42120863|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
42120864|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
42120865|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
42120866|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
42120867|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
42120868|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Depression|0|||
42120869|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Depression|1|||
42120870|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Depression|0|||
42120871|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
42120872|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
42120873|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
42120874|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Jailed|0|||
42120875|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Jailed|1|||
42120876|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Jailed|0|||
42120877|NCT00090103|75931466|FG000|16-Week Safety Follow-up Period|Other|0|||
42120878|NCT00090103|75931467|FG001|16-Week Safety Follow-up Period|Other|1|||
42120879|NCT00090103|75931468|FG002|16-Week Safety Follow-up Period|Other|0|||
41964958|NCT01273038|75764455|FG001|Second Intervention (14 Days)|Adverse Event|1|||
41964959|NCT01273038|75764454|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
41964960|NCT01273038|75764455|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
41964961|NCT01272180|75764465|FG000|Overall Study|Adverse Event|0|||
42120880|NCT00087607|75931478|FG000|Overall Study|Adverse Event|14|||
41964962|NCT01272180|75764466|FG001|Overall Study|Adverse Event|0|||
41964963|NCT01272180|75764467|FG002|Overall Study|Adverse Event|1|||
41964964|NCT01272180|75764468|FG003|Overall Study|Adverse Event|0|||
41964965|NCT01272180|75764465|FG000|Overall Study|Withdrawal by Subject|2|||
41964966|NCT01272180|75764466|FG001|Overall Study|Withdrawal by Subject|6|||
41964967|NCT01272180|75764467|FG002|Overall Study|Withdrawal by Subject|3|||
41964968|NCT01272180|75764468|FG003|Overall Study|Withdrawal by Subject|2|||
41964969|NCT01272180|75764465|FG000|Overall Study|Lost to Follow-up|15|||
41964970|NCT01272180|75764466|FG001|Overall Study|Lost to Follow-up|14|||
41964971|NCT01272180|75764467|FG002|Overall Study|Lost to Follow-up|8|||
41964972|NCT01272180|75764468|FG003|Overall Study|Lost to Follow-up|10|||
41964973|NCT01272180|75764465|FG000|Overall Study|Inappropriate enrollment|0|||
41964974|NCT01272180|75764466|FG001|Overall Study|Inappropriate enrollment|0|||
41964975|NCT01272180|75764467|FG002|Overall Study|Inappropriate enrollment|1|||
41964976|NCT01272180|75764468|FG003|Overall Study|Inappropriate enrollment|1|||
41964977|NCT01272180|75764465|FG000|Overall Study|Protocol Violation|0|||
41964978|NCT01272180|75764466|FG001|Overall Study|Protocol Violation|1|||
42120881|NCT00087607|75931479|FG001|Overall Study|Adverse Event|24|||
42120882|NCT00087607|75931478|FG000|Overall Study|Death|0|||
42120883|NCT00087607|75931479|FG001|Overall Study|Death|1|||
42120884|NCT00087607|75931478|FG000|Overall Study|Insufficient Therapeutic Response|53|||
42120885|NCT00087607|75931479|FG001|Overall Study|Insufficient Therapeutic Response|42|||
42120886|NCT00087607|75931478|FG000|Overall Study|Failure to return|21|||
42120887|NCT00087607|75931479|FG001|Overall Study|Failure to return|17|||
42120888|NCT00087607|75931478|FG000|Overall Study|Withdrew Consent|12|||
42120889|NCT00087607|75931479|FG001|Overall Study|Withdrew Consent|16|||
42120890|NCT00087607|75931478|FG000|Overall Study|Administrative|12|||
42120891|NCT00087607|75931479|FG001|Overall Study|Administrative|12|||
42120892|NCT00087607|75931478|FG000|Overall Study|Refused Treatment|5|||
42120893|NCT00087607|75931479|FG001|Overall Study|Refused Treatment|7|||
42120894|NCT00087607|75931478|FG000|Overall Study|Other Protocol Violation|5|||
42120895|NCT00087607|75931479|FG001|Overall Study|Other Protocol Violation|2|||
42120896|NCT00087607|75931478|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
42120897|NCT00087607|75931479|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
42120898|NCT00069823|75931491|FG000|Overall Study|Did not have follow-up diary cards|6|||
42120899|NCT00069823|75931492|FG001|Overall Study|Did not have follow-up diary cards|3|||
42120900|NCT00086515|75931504|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
42120901|NCT00086515|75931505|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
42027029|NCT00922636|75835180|FG001|Overall Study|Entry Criteria Not Met|0|||
42027030|NCT00922636|75835181|FG002|Overall Study|Entry Criteria Not Met|1|||
42027031|NCT00922636|75835182|FG003|Overall Study|Entry Criteria Not Met|1|||
42027032|NCT00922636|75835183|FG004|Overall Study|Entry Criteria Not Met|0|||
42027033|NCT00922636|75835179|FG000|Overall Study|Parent/Caregiver Decision|2|||
42027034|NCT00922636|75835180|FG001|Overall Study|Parent/Caregiver Decision|4|||
42027035|NCT00922636|75835181|FG002|Overall Study|Parent/Caregiver Decision|3|||
42027036|NCT00922636|75835182|FG003|Overall Study|Parent/Caregiver Decision|5|||
42027037|NCT00922636|75835183|FG004|Overall Study|Parent/Caregiver Decision|2|||
42027038|NCT00922636|75835179|FG000|Overall Study|Lost to Follow-up|1|||
42120902|NCT00086515|75931504|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
42120903|NCT00086515|75931505|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
42120904|NCT00086515|75931504|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
42120905|NCT00086515|75931505|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
42120906|NCT00086515|75931504|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
42120907|NCT00086515|75931505|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
42120908|NCT00086515|75931504|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
42120909|NCT00086515|75931505|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
42120910|NCT00086515|75931504|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
42120911|NCT00086515|75931505|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
42120912|NCT00086515|75931504|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
42120913|NCT00086515|75931505|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
42120914|NCT00086515|75931504|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
42120915|NCT00086515|75931505|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
42120916|NCT00086515|75931504|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
42027039|NCT00922636|75835180|FG001|Overall Study|Lost to Follow-up|2|||
42120917|NCT00086515|75931505|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
42120918|NCT00086515|75931504|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
42120919|NCT00086515|75931505|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
42120920|NCT00086515|75931504|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
42120921|NCT00086515|75931505|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
41964979|NCT01272180|75764467|FG002|Overall Study|Protocol Violation|0|||
41964980|NCT01272180|75764468|FG003|Overall Study|Protocol Violation|1|||
41964981|NCT01271712|75764484|FG000|Double Blind Treatment|Death|2|||
41964982|NCT01271712|75764485|FG001|Double Blind Treatment|Death|0|||
42120922|NCT00086515|75931504|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
42120923|NCT00086515|75931505|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
42120924|NCT00086515|75931504|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
42120925|NCT00086515|75931505|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
42120926|NCT00086515|75931504|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
41964983|NCT01271712|75764484|FG000|Double Blind Treatment|Lack of Efficacy|1|||
41964984|NCT01271712|75764485|FG001|Double Blind Treatment|Lack of Efficacy|0|||
41964985|NCT01271712|75764484|FG000|Double Blind Treatment|Adverse Event|9|||
41964986|NCT01271712|75764485|FG001|Double Blind Treatment|Adverse Event|4|||
41964987|NCT01271712|75764484|FG000|Double Blind Treatment|Progressive disease|23|||
41964988|NCT01271712|75764485|FG001|Double Blind Treatment|Progressive disease|3|||
41964989|NCT01271712|75764484|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
42027040|NCT00922636|75835181|FG002|Overall Study|Lost to Follow-up|2|||
42027041|NCT00922636|75835182|FG003|Overall Study|Lost to Follow-up|2|||
42027042|NCT00922636|75835183|FG004|Overall Study|Lost to Follow-up|4|||
42027043|NCT01175135|75835204|FG000|Overall Study|Adverse Event|2|||
42027044|NCT01175135|75835205|FG001|Overall Study|Adverse Event|5|||
42027045|NCT01175135|75835206|FG002|Overall Study|Adverse Event|3|||
42027046|NCT01175135|75835207|FG003|Overall Study|Adverse Event|4|||
42027047|NCT01175135|75835204|FG000|Overall Study|Death|1|||
42027048|NCT01175135|75835205|FG001|Overall Study|Death|0|||
42027049|NCT01175135|75835206|FG002|Overall Study|Death|0|||
42027050|NCT01175135|75835207|FG003|Overall Study|Death|0|||
42027051|NCT01175135|75835204|FG000|Overall Study|Lack of Efficacy|4|||
42027052|NCT01175135|75835205|FG001|Overall Study|Lack of Efficacy|5|||
42027053|NCT01175135|75835206|FG002|Overall Study|Lack of Efficacy|0|||
42027054|NCT01175135|75835207|FG003|Overall Study|Lack of Efficacy|5|||
42027055|NCT01175135|75835204|FG000|Overall Study|Lost to Follow-up|1|||
42027056|NCT01175135|75835205|FG001|Overall Study|Lost to Follow-up|2|||
42027057|NCT01175135|75835206|FG002|Overall Study|Lost to Follow-up|0|||
42027058|NCT01175135|75835207|FG003|Overall Study|Lost to Follow-up|0|||
42027059|NCT01175135|75835204|FG000|Overall Study|Protocol Violation|1|||
42027060|NCT01175135|75835205|FG001|Overall Study|Protocol Violation|1|||
42027061|NCT01175135|75835206|FG002|Overall Study|Protocol Violation|0|||
42027062|NCT01175135|75835207|FG003|Overall Study|Protocol Violation|0|||
42027063|NCT01175135|75835204|FG000|Overall Study|Withdrawal by Subject|4|||
42027064|NCT01175135|75835205|FG001|Overall Study|Withdrawal by Subject|8|||
42027065|NCT01175135|75835206|FG002|Overall Study|Withdrawal by Subject|5|||
42027066|NCT01175135|75835207|FG003|Overall Study|Withdrawal by Subject|5|||
42027067|NCT01175135|75835204|FG000|Overall Study|Other|3|||
42027068|NCT01175135|75835205|FG001|Overall Study|Other|1|||
42027069|NCT01175135|75835206|FG002|Overall Study|Other|3|||
42027070|NCT01175135|75835207|FG003|Overall Study|Other|0|||
42027071|NCT01175135|75835204|FG000|Overall Study|Randomized But Not Treated|0|||
42027072|NCT01175135|75835205|FG001|Overall Study|Randomized But Not Treated|0|||
42027073|NCT01175135|75835206|FG002|Overall Study|Randomized But Not Treated|1|||
42027074|NCT01175135|75835207|FG003|Overall Study|Randomized But Not Treated|0|||
42027075|NCT00922480|75835219|FG000|Main Study|Protocol Violation|3|||
42027076|NCT00922480|75835220|FG001|Main Study|Protocol Violation|6|||
42027077|NCT00922480|75835219|FG000|Main Study|Adverse Event|6|||
42027078|NCT00922480|75835220|FG001|Main Study|Adverse Event|7|||
42027079|NCT00922480|75835219|FG000|Main Study|Lack of Efficacy|3|||
42027080|NCT00922480|75835220|FG001|Main Study|Lack of Efficacy|0|||
42027081|NCT00922480|75835219|FG000|Main Study|Withdrawal by Subject|20|||
42027082|NCT00922480|75835220|FG001|Main Study|Withdrawal by Subject|15|||
42027083|NCT00922480|75835219|FG000|Main Study|Lost to Follow-up|5|||
42027084|NCT00922480|75835220|FG001|Main Study|Lost to Follow-up|0|||
42027085|NCT00922480|75835219|FG000|Main Study|Physician Decision|0|||
42027086|NCT00922480|75835220|FG001|Main Study|Physician Decision|1|||
42027087|NCT00922480|75835219|FG000|Extension Study|Protocol Violation|3|||
42027088|NCT00922480|75835220|FG001|Extension Study|Protocol Violation|0|||
42027089|NCT00922480|75835219|FG000|Extension Study|Adverse Event|1|||
42120927|NCT00086515|75931505|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
42120928|NCT00086515|75931504|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
41964990|NCT01271712|75764485|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
41964991|NCT01271712|75764484|FG000|Double Blind Treatment|Non compliance with study drug|2|||
42027090|NCT00922480|75835220|FG001|Extension Study|Adverse Event|1|||
42027091|NCT00922480|75835219|FG000|Extension Study|Withdrawal by Subject|1|||
42027092|NCT00922480|75835220|FG001|Extension Study|Withdrawal by Subject|1|||
42137780|NCT00334737|75948120|FG002|Hospital Phase|Did not receive study drug|0|||
41964992|NCT01271712|75764485|FG001|Double Blind Treatment|Non compliance with study drug|0|||
41964993|NCT01271712|75764484|FG000|Double Blind Treatment|receive no study drug|1|||
42027093|NCT00922480|75835219|FG000|Extension Study|Others|0|||
42027094|NCT00922480|75835220|FG001|Extension Study|Others|1|||
42027095|NCT00973479|75835230|FG000|Overall Study|Lost to Follow-up|0|||
42027096|NCT00973479|75835231|FG001|Overall Study|Lost to Follow-up|3|||
42027097|NCT00973479|75835230|FG000|Overall Study|Death|2|||
42027098|NCT00973479|75835231|FG001|Overall Study|Death|2|||
42027099|NCT00973479|75835230|FG000|Overall Study|Withdrawal by Subject|15|||
42027100|NCT00973479|75835231|FG001|Overall Study|Withdrawal by Subject|16|||
42137781|NCT00334737|75948118|FG000|Follow up Phase|Lost to Follow-up|5|||
42301117|NCT01365091|76136405|FG002|Period 2|Withdrawal by Subject|0|||
42027101|NCT00973479|75835230|FG000|Overall Study|Lack of Efficacy|5|||
42027102|NCT00973479|75835231|FG001|Overall Study|Lack of Efficacy|7|||
42027103|NCT00973479|75835230|FG000|Overall Study|Adverse Event|12|||
42027104|NCT00973479|75835231|FG001|Overall Study|Adverse Event|32|||
42027105|NCT00973479|75835230|FG000|Overall Study|Protocol Violation|2|||
42027106|NCT00973479|75835231|FG001|Overall Study|Protocol Violation|2|||
42027107|NCT00973479|75835230|FG000|Overall Study|Other|1|||
42027108|NCT00973479|75835231|FG001|Overall Study|Other|7|||
42027109|NCT01173653|75835241|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
42027110|NCT01173653|75835242|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
42027111|NCT01172873|75835250|FG000|Overall Study|Withdrawal by Subject|3|||
42027112|NCT01172873|75835251|FG001|Overall Study|Withdrawal by Subject|2|||
42027113|NCT00925600|75835263|FG000|Overall Study|Withdrawal by Subject|16|||
42027114|NCT00925600|75835264|FG001|Overall Study|Withdrawal by Subject|14|||
42027115|NCT00925600|75835263|FG000|Overall Study|Death|4|||
42027116|NCT00925600|75835264|FG001|Overall Study|Death|3|||
42027117|NCT00925600|75835263|FG000|Overall Study|Lost to Follow-up|2|||
42027118|NCT00925600|75835264|FG001|Overall Study|Lost to Follow-up|2|||
42027119|NCT00925600|75835263|FG000|Overall Study|Disease Progression|1|||
42027120|NCT00925600|75835264|FG001|Overall Study|Disease Progression|3|||
42027121|NCT00925600|75835263|FG000|Overall Study|Administrative Decision|1|||
42027122|NCT00925600|75835264|FG001|Overall Study|Administrative Decision|1|||
42027123|NCT00925600|75835263|FG000|Overall Study|Noncompliance|2|||
41964994|NCT01271712|75764485|FG001|Double Blind Treatment|receive no study drug|0|||
41964995|NCT01271712|75764484|FG000|Open Label Treatment|Death|6|||
41964996|NCT01271712|75764485|FG001|Open Label Treatment|Death|5|||
41964997|NCT01271712|75764484|FG000|Open Label Treatment|Withdrawal by Subject|6|||
41964998|NCT01271712|75764485|FG001|Open Label Treatment|Withdrawal by Subject|11|||
41964999|NCT01271712|75764484|FG000|Open Label Treatment|Physician Decision|2|||
41965000|NCT01271712|75764485|FG001|Open Label Treatment|Physician Decision|0|||
41965001|NCT01271712|75764484|FG000|Open Label Treatment|Adverse Event|14|||
41965002|NCT01271712|75764485|FG001|Open Label Treatment|Adverse Event|8|||
41965003|NCT01271712|75764484|FG000|Open Label Treatment|Progressive disease|59|||
41965004|NCT01271712|75764485|FG001|Open Label Treatment|Progressive disease|32|||
41965005|NCT01271712|75764484|FG000|Open Label Treatment|transferred to rollover study|1|||
41965006|NCT01271712|75764485|FG001|Open Label Treatment|transferred to rollover study|0|||
41965007|NCT01271712|75764484|FG000|Open Label Treatment|Non-compliance with study drug|1|||
41965008|NCT01271712|75764485|FG001|Open Label Treatment|Non-compliance with study drug|0|||
41965009|NCT01271712|75764484|FG000|Open Label Treatment|Protocol Violation|0|||
41965010|NCT01271712|75764485|FG001|Open Label Treatment|Protocol Violation|1|||
41965011|NCT01271712|75764484|FG000|Open Label Treatment|Switching to other therapy|2|||
41965012|NCT01271712|75764485|FG001|Open Label Treatment|Switching to other therapy|1|||
41965013|NCT01271712|75764484|FG000|Safety Follow-up|Death|11|||
41965014|NCT01271712|75764485|FG001|Safety Follow-up|Death|7|||
41965015|NCT01271712|75764484|FG000|Safety Follow-up|Withdrawal by Subject|4|||
41965016|NCT01271712|75764485|FG001|Safety Follow-up|Withdrawal by Subject|2|||
41965017|NCT01271712|75764484|FG000|Safety Follow-up|Protocol Violation|1|||
41965018|NCT01271712|75764485|FG001|Safety Follow-up|Protocol Violation|1|||
41965019|NCT01271712|75764484|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
41965020|NCT01271712|75764485|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
41965021|NCT01271712|75764484|FG000|Safety Follow-up|No follow-up|1|||
41965022|NCT01271712|75764485|FG001|Safety Follow-up|No follow-up|1|||
41965023|NCT01271712|75764484|FG000|Safety Follow-up|Progressive disease|1|||
41965024|NCT01271712|75764485|FG001|Safety Follow-up|Progressive disease|0|||
41965025|NCT01271712|75764484|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
41965026|NCT01271712|75764485|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
41965027|NCT01271010|75764494|FG000|Overall Study|Reason not specified|11|||
41965028|NCT01271010|75764494|FG000|Overall Study|Start of new CLL therapy|1|||
41965029|NCT01271010|75764494|FG000|Overall Study|Protocol Violation|1|||
41965030|NCT01271010|75764494|FG000|Overall Study|Death|2|||
41965031|NCT01271010|75764494|FG000|Overall Study|Progression and relapse of disease|1|||
42301118|NCT01365091|76136406|FG003|Period 2|Withdrawal by Subject|0|||
41965032|NCT01271010|75764494|FG000|Overall Study|Withdrawal by Subject|18|||
41965033|NCT01271010|75764494|FG000|Overall Study|Disease progression|27|||
41965034|NCT01270620|75764500|FG000|Overall Study|Withdrawal by Subject|1|||
41965035|NCT01270620|75764501|FG001|Overall Study|Withdrawal by Subject|3|||
41965036|NCT01270464|75764516|FG000|Overall Study|Protocol Violation|4|||
42027124|NCT00925600|75835264|FG001|Overall Study|Noncompliance|0|||
42027125|NCT00925600|75835263|FG000|Overall Study|Ineligibility Determined|2|||
42027126|NCT00925600|75835264|FG001|Overall Study|Ineligibility Determined|0|||
42027127|NCT00925600|75835263|FG000|Overall Study|Protocol Deviation|0|||
42120929|NCT00086515|75931505|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
42120930|NCT00086515|75931504|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
42120931|NCT00086515|75931505|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
42120932|NCT00086515|75931504|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
42120933|NCT00086515|75931505|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
42120934|NCT00086515|75931504|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
42120935|NCT00086515|75931505|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
41965037|NCT01270464|75764517|FG001|Overall Study|Protocol Violation|3|||
41965038|NCT01270464|75764518|FG002|Overall Study|Protocol Violation|2|||
41965039|NCT01270464|75764516|FG000|Overall Study|Lack of Efficacy|2|||
41965040|NCT01270464|75764517|FG001|Overall Study|Lack of Efficacy|3|||
41965041|NCT01270464|75764518|FG002|Overall Study|Lack of Efficacy|1|||
41965042|NCT01270464|75764516|FG000|Overall Study|Adverse Event|9|||
41965043|NCT01270464|75764517|FG001|Overall Study|Adverse Event|1|||
41965044|NCT01270464|75764518|FG002|Overall Study|Adverse Event|7|||
41965045|NCT01270464|75764516|FG000|Overall Study|Withdrawal by Subject|2|||
41965046|NCT01270464|75764517|FG001|Overall Study|Withdrawal by Subject|1|||
41965047|NCT01270464|75764518|FG002|Overall Study|Withdrawal by Subject|4|||
41965048|NCT01270464|75764516|FG000|Overall Study|Lost to Follow-up|2|||
41965049|NCT01270464|75764517|FG001|Overall Study|Lost to Follow-up|3|||
41965050|NCT01270464|75764518|FG002|Overall Study|Lost to Follow-up|1|||
41965051|NCT01270464|75764516|FG000|Overall Study|Other|1|||
41965052|NCT01270464|75764517|FG001|Overall Study|Other|1|||
41965053|NCT01270464|75764518|FG002|Overall Study|Other|3|||
41965054|NCT00249834|75764534|FG000|Overall Study|Ovarian stimulation failed|1|||
41965055|NCT00249834|75764535|FG001|Overall Study|Ovarian stimulation failed|0|||
41965056|NCT00249834|75764536|FG002|Overall Study|Ovarian stimulation failed|0|||
41965057|NCT00249834|75764537|FG003|Overall Study|Ovarian stimulation failed|0|||
41965058|NCT00249834|75764538|FG004|Overall Study|Ovarian stimulation failed|0|||
41965059|NCT00249834|75764539|FG005|Overall Study|Ovarian stimulation failed|0|||
41965060|NCT00249834|75764540|FG006|Overall Study|Ovarian stimulation failed|0|||
41965061|NCT00249834|75764541|FG007|Overall Study|Ovarian stimulation failed|0|||
41965062|NCT00249834|75764534|FG000|Overall Study|Failure of down-regulation|0|||
41965063|NCT00249834|75764535|FG001|Overall Study|Failure of down-regulation|0|||
41965064|NCT00249834|75764536|FG002|Overall Study|Failure of down-regulation|0|||
41965065|NCT00249834|75764537|FG003|Overall Study|Failure of down-regulation|0|||
41965066|NCT00249834|75764538|FG004|Overall Study|Failure of down-regulation|0|||
41965067|NCT00249834|75764539|FG005|Overall Study|Failure of down-regulation|0|||
41965068|NCT00249834|75764540|FG006|Overall Study|Failure of down-regulation|1|||
41965069|NCT00249834|75764541|FG007|Overall Study|Failure of down-regulation|0|||
41965070|NCT00249834|75764534|FG000|Overall Study|Protocol Violation|0|||
41965071|NCT00249834|75764535|FG001|Overall Study|Protocol Violation|19|||
41965072|NCT00249834|75764536|FG002|Overall Study|Protocol Violation|14|||
41965073|NCT00249834|75764537|FG003|Overall Study|Protocol Violation|8|||
42027128|NCT00925600|75835264|FG001|Overall Study|Protocol Deviation|1|||
42027129|NCT00925600|75835263|FG000|Overall Study|Requirement for Alternative Therapy|0|||
42027130|NCT00925600|75835264|FG001|Overall Study|Requirement for Alternative Therapy|1|||
42027131|NCT00925600|75835263|FG000|Overall Study|Other|3|||
42027132|NCT00925600|75835264|FG001|Overall Study|Other|1|||
42027133|NCT00925600|75835263|FG000|Overall Study|Adverse Event|1|||
42027134|NCT00925600|75835264|FG001|Overall Study|Adverse Event|2|||
42027135|NCT00968253|75835277|FG000|Overall Study|Death|0|||
42027136|NCT00968253|75835278|FG001|Overall Study|Death|0|||
42027137|NCT00968253|75835279|FG002|Overall Study|Death|2|||
42027138|NCT00968253|75835277|FG000|Overall Study|Withdrawal by Subject|0|||
42027139|NCT00968253|75835278|FG001|Overall Study|Withdrawal by Subject|0|||
42027140|NCT00968253|75835279|FG002|Overall Study|Withdrawal by Subject|1|||
42027141|NCT00968253|75835277|FG000|Overall Study|Disease Progression|0|||
42027142|NCT00968253|75835278|FG001|Overall Study|Disease Progression|3|||
42027143|NCT00968253|75835279|FG002|Overall Study|Disease Progression|3|||
42027144|NCT00968253|75835277|FG000|Overall Study|Adverse Event|0|||
41965074|NCT00249834|75764538|FG004|Overall Study|Protocol Violation|5|||
41965075|NCT00249834|75764539|FG005|Overall Study|Protocol Violation|2|||
41965076|NCT00249834|75764540|FG006|Overall Study|Protocol Violation|0|||
41965077|NCT00249834|75764541|FG007|Overall Study|Protocol Violation|0|||
41965078|NCT00249444|75764555|FG000|Overall Study|Lost to Follow-up|2|||
41965079|NCT00249444|75764556|FG001|Overall Study|Lost to Follow-up|2|||
41965080|NCT00249444|75764555|FG000|Overall Study|non-compliant|9|||
41965081|NCT00249444|75764556|FG001|Overall Study|non-compliant|11|||
41965082|NCT00249444|75764555|FG000|Overall Study|Adverse Event|1|||
41965083|NCT00249444|75764556|FG001|Overall Study|Adverse Event|1|||
42027145|NCT00968253|75835278|FG001|Overall Study|Adverse Event|0|||
42027146|NCT00968253|75835279|FG002|Overall Study|Adverse Event|1|||
42027147|NCT00964743|75835288|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
41965084|NCT00249444|75764555|FG000|Overall Study|life event|0|||
42027148|NCT00925522|75835292|FG000|Overall Study|study closed -- business decision|20|||
41965085|NCT00249444|75764556|FG001|Overall Study|life event|1|||
41965086|NCT00249288|75764564|FG000|Overall Study|Lost to Follow-up|3|||
41965087|NCT00249288|75764565|FG001|Overall Study|Lost to Follow-up|3|||
41965088|NCT00249288|75764564|FG000|Overall Study|Withdrawal by Subject|2|||
41965089|NCT00249288|75764565|FG001|Overall Study|Withdrawal by Subject|2|||
41965090|NCT00247962|75764581|FG000|Overall Study|Adverse Event|15|||
41965091|NCT00247962|75764582|FG001|Overall Study|Adverse Event|12|||
41965092|NCT00247962|75764581|FG000|Overall Study|Lost to Follow-up|3|||
41965093|NCT00247962|75764582|FG001|Overall Study|Lost to Follow-up|1|||
41965094|NCT00247962|75764581|FG000|Overall Study|Physician Decision|0|||
41965095|NCT00247962|75764582|FG001|Overall Study|Physician Decision|1|||
42120936|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
42120937|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
42120938|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
42120939|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
42120940|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
42120941|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
42120942|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
42120943|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
42120944|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
42120945|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
42120946|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
42120947|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
42120948|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
42120949|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
42120950|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
42120951|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
42120952|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
42120953|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
42120954|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
42120955|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
42120956|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
42120957|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
42120958|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
42120959|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
42120960|NCT00086515|75931504|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
42120961|NCT00086515|75931505|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
42120962|NCT00541658|75931514|FG000|Overall Study|Adverse Event|28|||
42120963|NCT00541658|75931515|FG001|Overall Study|Adverse Event|37|||
42120964|NCT00541658|75931516|FG002|Overall Study|Adverse Event|25|||
42120965|NCT00541658|75931514|FG000|Overall Study|Physician Decision|0|||
42120966|NCT00541658|75931515|FG001|Overall Study|Physician Decision|0|||
42120967|NCT00541658|75931516|FG002|Overall Study|Physician Decision|4|||
42120968|NCT00541658|75931514|FG000|Overall Study|Lost to Follow-up|3|||
42120969|NCT00541658|75931515|FG001|Overall Study|Lost to Follow-up|3|||
42120970|NCT00541658|75931516|FG002|Overall Study|Lost to Follow-up|6|||
42120971|NCT00541658|75931514|FG000|Overall Study|Protocol Violation|0|||
42120972|NCT00541658|75931515|FG001|Overall Study|Protocol Violation|1|||
42120973|NCT00541658|75931516|FG002|Overall Study|Protocol Violation|1|||
42120974|NCT00541658|75931514|FG000|Overall Study|Withdrawal by Subject|28|||
42120975|NCT00541658|75931515|FG001|Overall Study|Withdrawal by Subject|32|||
42120976|NCT00541658|75931516|FG002|Overall Study|Withdrawal by Subject|32|||
42120977|NCT00541658|75931514|FG000|Overall Study|Took No Study Drug|1|||
42120978|NCT00541658|75931515|FG001|Overall Study|Took No Study Drug|0|||
42120979|NCT00541658|75931516|FG002|Overall Study|Took No Study Drug|0|||
42120980|NCT03907280|75931540|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
42120981|NCT03907280|75931541|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
42120982|NCT03907280|75931542|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
42120983|NCT04120376|75931554|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
42120984|NCT04120376|75931555|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
42120985|NCT03905642|75931562|FG000|Overall Study|Withdrawal by Subject|3|||
42120986|NCT03905642|75931562|FG000|Overall Study|Pregnancy|1|||
42120987|NCT03905642|75931562|FG000|Overall Study|Adverse Event|1|||
42120988|NCT03905642|75931562|FG000|Overall Study|Lack of Efficacy|1|||
42120989|NCT03905642|75931562|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
42210358|NCT03288714|76025138|FG000|Overall Study|Non-compliance with study schedule|2|||
42301119|NCT01365091|76136403|FG000|Period 2|Adverse Event|0|||
41965096|NCT00247962|75764581|FG000|Overall Study|Protocol Violation|1|||
41965097|NCT00247962|75764582|FG001|Overall Study|Protocol Violation|1|||
42210359|NCT03288714|76025139|FG001|Overall Study|Non-compliance with study schedule|0|||
41965098|NCT00247962|75764581|FG000|Overall Study|Withdrawal by Subject|3|||
42120990|NCT00412984|75931602|FG000|Overall Study|Death|331|||
42120991|NCT00412984|75931603|FG001|Overall Study|Death|349|||
42120992|NCT00412984|75931602|FG000|Overall Study|Adverse Event|679|||
42120993|NCT00412984|75931603|FG001|Overall Study|Adverse Event|738|||
42120994|NCT00412984|75931602|FG000|Overall Study|Withdrawal by Subject|921|||
42120995|NCT00412984|75931603|FG001|Overall Study|Withdrawal by Subject|989|||
42120996|NCT00412984|75931602|FG000|Overall Study|Lost to Follow-up|51|||
42120997|NCT00412984|75931603|FG001|Overall Study|Lost to Follow-up|39|||
42120998|NCT00412984|75931602|FG000|Overall Study|Poor/Noncompliance|57|||
42120999|NCT00412984|75931603|FG001|Overall Study|Poor/Noncompliance|77|||
42121000|NCT00412984|75931602|FG000|Overall Study|Pregnancy|1|||
42121001|NCT00412984|75931603|FG001|Overall Study|Pregnancy|0|||
42121002|NCT00412984|75931602|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
42121003|NCT00412984|75931603|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
42121004|NCT00412984|75931602|FG000|Overall Study|Administrative Reason by Sponsor|11|||
42121005|NCT00412984|75931603|FG001|Overall Study|Administrative Reason by Sponsor|8|||
42121006|NCT00412984|75931602|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
42121007|NCT00412984|75931603|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
42121008|NCT00412984|75931602|FG000|Overall Study|Other Reason|80|||
42121009|NCT00412984|75931603|FG001|Overall Study|Other Reason|92|||
42121010|NCT00412984|75931602|FG000|Overall Study|Not Reported|11|||
42027149|NCT01130532|75835299|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
42027150|NCT01130532|75835300|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
42027151|NCT01130532|75835301|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
42027152|NCT01130532|75835302|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
42027153|NCT01130532|75835299|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
42027154|NCT01130532|75835300|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
42027155|NCT01130532|75835301|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
42027156|NCT01130532|75835302|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
42027157|NCT01130532|75835299|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
42027158|NCT01130532|75835300|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
42027159|NCT01130532|75835301|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
42121011|NCT00412984|75931603|FG001|Overall Study|Not Reported|12|||
42121012|NCT00539864|75931611|FG000|Overall Study|Lost to Follow-up|0|||
42121013|NCT00539864|75931612|FG001|Overall Study|Lost to Follow-up|1|||
42121014|NCT00539864|75931611|FG000|Overall Study|Withdrawal by Subject|1|||
42121015|NCT00539864|75931612|FG001|Overall Study|Withdrawal by Subject|1|||
42121016|NCT00673049|75931620|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
42027160|NCT01130532|75835302|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
42027161|NCT01130532|75835299|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
42027162|NCT01130532|75835300|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
42027163|NCT01130532|75835301|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
42027164|NCT01130532|75835302|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
42027165|NCT01130532|75835299|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
42027166|NCT01130532|75835300|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
42027167|NCT01130532|75835301|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
42027168|NCT01130532|75835302|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
42027169|NCT01130532|75835299|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
42027170|NCT01130532|75835300|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
42027171|NCT01130532|75835301|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
42027172|NCT01130532|75835302|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
42027173|NCT01130532|75835299|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
42027174|NCT01130532|75835300|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
42027175|NCT01130532|75835301|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
42027176|NCT01130532|75835302|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
42027177|NCT01130532|75835299|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
42027178|NCT01130532|75835300|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
42027179|NCT01130532|75835301|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
42027180|NCT01130532|75835302|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
42027181|NCT01130532|75835299|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
42027182|NCT01130532|75835300|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
42027183|NCT01130532|75835301|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
42027184|NCT01130532|75835302|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
42027185|NCT01130532|75835299|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
42121017|NCT00673049|75931621|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
42121018|NCT00673049|75931622|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
42027186|NCT01130532|75835300|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
42027187|NCT01130532|75835301|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
42027188|NCT01130532|75835302|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
42027189|NCT01130532|75835299|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
42121019|NCT00673049|75931623|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
42121020|NCT00673049|75931620|FG000|Before Progression on Erlotinib|Death|235|||
42210360|NCT03288714|76025138|FG000|Overall Study|Withdrawal by Subject|3|||
42027190|NCT01130532|75835300|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
42121021|NCT00673049|75931621|FG001|Before Progression on Erlotinib|Death|167|||
42121022|NCT00673049|75931622|FG002|Before Progression on Erlotinib|Death|1|||
42121023|NCT00673049|75931623|FG003|Before Progression on Erlotinib|Death|0|||
42121024|NCT00673049|75931620|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
42121025|NCT00673049|75931621|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
42121026|NCT00673049|75931622|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
42121027|NCT00673049|75931623|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
42121028|NCT00673049|75931620|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
42121029|NCT00673049|75931621|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
42121030|NCT00673049|75931622|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
42121031|NCT00673049|75931623|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
42121032|NCT00673049|75931620|FG000|Before Progression on Erlotinib|Other|1|||
42121033|NCT00673049|75931621|FG001|Before Progression on Erlotinib|Other|2|||
42121034|NCT00673049|75931622|FG002|Before Progression on Erlotinib|Other|0|||
42121035|NCT00673049|75931623|FG003|Before Progression on Erlotinib|Other|0|||
42121036|NCT00673049|75931620|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
42121037|NCT00673049|75931621|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
42121038|NCT00673049|75931622|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
41965099|NCT00247962|75764582|FG001|Overall Study|Withdrawal by Subject|2|||
42121039|NCT00673049|75931623|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
42121040|NCT00673049|75931620|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
42121041|NCT00673049|75931621|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
42121042|NCT00673049|75931622|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
41965100|NCT00247962|75764581|FG000|Overall Study|Lack of Efficacy|4|||
41965101|NCT00247962|75764582|FG001|Overall Study|Lack of Efficacy|2|||
41965102|NCT00247416|75764590|FG000|Overall Study|3 patients were found to be ineligible|1|||
41965103|NCT00247416|75764591|FG001|Overall Study|3 patients were found to be ineligible|2|||
41965104|NCT00246090|75764599|FG000|Overall Study|Adverse Event|25|||
41965105|NCT00246090|75764599|FG000|Overall Study|Withdrawal by Subject|7|||
41965106|NCT00246090|75764599|FG000|Overall Study|Progressive Disease|212|||
41965107|NCT00246090|75764599|FG000|Overall Study|Clinical Progression|30|||
41965108|NCT00246090|75764599|FG000|Overall Study|Physician Decision|11|||
41965109|NCT00246090|75764599|FG000|Overall Study|Not Otherwise Specified|10|||
41965110|NCT00246012|75764612|FG000|Overall Study|Adverse Event|0|||
41965111|NCT00246012|75764613|FG001|Overall Study|Adverse Event|0|||
41965112|NCT00246012|75764614|FG002|Overall Study|Adverse Event|0|||
41965113|NCT00246012|75764615|FG003|Overall Study|Adverse Event|0|||
41965114|NCT00246012|75764616|FG004|Overall Study|Adverse Event|0|||
41965115|NCT00246012|75764617|FG005|Overall Study|Adverse Event|1|||
41965116|NCT00246012|75764618|FG006|Overall Study|Adverse Event|0|||
42027191|NCT01130532|75835301|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
42027192|NCT01130532|75835302|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
42027193|NCT00972777|75835316|FG000|Overall Study|Adverse Event|3|||
42027194|NCT00972777|75835317|FG001|Overall Study|Adverse Event|2|||
42027195|NCT00972777|75835316|FG000|Overall Study|Lost to Follow-up|0|||
42027196|NCT00972777|75835317|FG001|Overall Study|Lost to Follow-up|4|||
42027197|NCT00972777|75835316|FG000|Overall Study|Withdrawal by Subject|4|||
42027198|NCT00972777|75835317|FG001|Overall Study|Withdrawal by Subject|5|||
42027199|NCT00972777|75835316|FG000|Overall Study|Physician Decision|4|||
42027200|NCT00972777|75835317|FG001|Overall Study|Physician Decision|0|||
42027201|NCT00972777|75835316|FG000|Overall Study|Protocol Violation|0|||
42027202|NCT00972777|75835317|FG001|Overall Study|Protocol Violation|2|||
42027203|NCT00972777|75835316|FG000|Overall Study|Screening Failure|2|||
42027204|NCT00972777|75835317|FG001|Overall Study|Screening Failure|1|||
42027205|NCT00972777|75835316|FG000|Overall Study|Missed visit|1|||
42027206|NCT00972777|75835317|FG001|Overall Study|Missed visit|0|||
42027207|NCT00918736|75835323|FG000|Overall Study|Withdrawal by Subject|4|||
42027208|NCT01172639|75835332|FG000|Overall Study|Death|1|||
42027209|NCT01172639|75835333|FG001|Overall Study|Death|1|||
42027210|NCT01172639|75835334|FG002|Overall Study|Death|0|||
42027211|NCT01172639|75835335|FG003|Overall Study|Death|0|||
42121043|NCT00673049|75931623|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
42121044|NCT00673049|75931620|FG000|After Progression on Erlotinib|Death|0|||
42121045|NCT00673049|75931621|FG001|After Progression on Erlotinib|Death|0|||
42121046|NCT00673049|75931622|FG002|After Progression on Erlotinib|Death|0|||
41965117|NCT00246012|75764619|FG007|Overall Study|Adverse Event|0|||
41965118|NCT00246012|75764620|FG008|Overall Study|Adverse Event|2|||
41965119|NCT00246012|75764612|FG000|Overall Study|Withdrawal by Subject|0|||
41965120|NCT00246012|75764613|FG001|Overall Study|Withdrawal by Subject|0|||
42027212|NCT01172639|75835336|FG004|Overall Study|Death|0|||
42027213|NCT01172639|75835332|FG000|Overall Study|Lost to Follow-up|9|||
42027214|NCT01172639|75835333|FG001|Overall Study|Lost to Follow-up|7|||
42027215|NCT01172639|75835334|FG002|Overall Study|Lost to Follow-up|11|||
42027216|NCT01172639|75835335|FG003|Overall Study|Lost to Follow-up|6|||
42027217|NCT01172639|75835336|FG004|Overall Study|Lost to Follow-up|6|||
42027218|NCT01172639|75835332|FG000|Overall Study|Withdrawal by Subject|3|||
41965121|NCT00246012|75764614|FG002|Overall Study|Withdrawal by Subject|0|||
41965122|NCT00246012|75764615|FG003|Overall Study|Withdrawal by Subject|0|||
41965123|NCT00246012|75764616|FG004|Overall Study|Withdrawal by Subject|0|||
41965124|NCT00246012|75764617|FG005|Overall Study|Withdrawal by Subject|1|||
41965125|NCT00246012|75764618|FG006|Overall Study|Withdrawal by Subject|0|||
41965126|NCT00246012|75764619|FG007|Overall Study|Withdrawal by Subject|0|||
41965127|NCT00246012|75764620|FG008|Overall Study|Withdrawal by Subject|0|||
41965128|NCT00246012|75764612|FG000|Overall Study|Disease progression|3|||
41965129|NCT00246012|75764613|FG001|Overall Study|Disease progression|1|||
42027219|NCT01172639|75835333|FG001|Overall Study|Withdrawal by Subject|3|||
42027220|NCT01172639|75835334|FG002|Overall Study|Withdrawal by Subject|5|||
42027221|NCT01172639|75835335|FG003|Overall Study|Withdrawal by Subject|5|||
42027222|NCT01172639|75835336|FG004|Overall Study|Withdrawal by Subject|0|||
41965130|NCT00246012|75764614|FG002|Overall Study|Disease progression|2|||
41965131|NCT00246012|75764615|FG003|Overall Study|Disease progression|3|||
42027223|NCT01144182|75835350|FG000|Overall Study|Death|5|||
42027224|NCT01144182|75835351|FG001|Overall Study|Death|6|||
42027225|NCT01144182|75835350|FG000|Overall Study|Withdrawal by Subject|3|||
42027226|NCT01144182|75835351|FG001|Overall Study|Withdrawal by Subject|6|||
42027227|NCT01144182|75835350|FG000|Overall Study|Lost to Follow-up|9|||
42027228|NCT01144182|75835351|FG001|Overall Study|Lost to Follow-up|9|||
42027229|NCT01225562|75835361|FG000|Overall Study|Withdrawal by Subject|52|||
42027230|NCT01225562|75835362|FG001|Overall Study|Withdrawal by Subject|50|||
42027231|NCT01225562|75835363|FG002|Overall Study|Withdrawal by Subject|52|||
42027232|NCT01225562|75835361|FG000|Overall Study|Lost to Follow-up|3|||
42027233|NCT01225562|75835362|FG001|Overall Study|Lost to Follow-up|6|||
42027234|NCT01225562|75835363|FG002|Overall Study|Lost to Follow-up|1|||
42027235|NCT00925288|75835373|FG000|Overall Study|Lost to Follow-up|9|||
42027236|NCT00925288|75835374|FG001|Overall Study|Lost to Follow-up|7|||
42027237|NCT01143714|75835384|FG000|Overall Study|Adverse Event|4|||
42027238|NCT01143714|75835385|FG001|Overall Study|Adverse Event|2|||
42027239|NCT01143714|75835384|FG000|Overall Study|Withdrawal by Subject|1|||
42027240|NCT01143714|75835385|FG001|Overall Study|Withdrawal by Subject|0|||
42027241|NCT01143714|75835384|FG000|Overall Study|Subject non-compliance|0|||
42027242|NCT01143714|75835385|FG001|Overall Study|Subject non-compliance|1|||
42027243|NCT01143714|75835384|FG000|Overall Study|wound closed = deemed healed|1|||
42027244|NCT01143714|75835385|FG001|Overall Study|wound closed = deemed healed|0|||
42027245|NCT01143714|75835384|FG000|Overall Study|wound size increased|1|||
42027246|NCT01143714|75835385|FG001|Overall Study|wound size increased|0|||
42027247|NCT00972543|75835406|FG000|Overall Study|Adverse Event|1|||
42027248|NCT00972543|75835407|FG001|Overall Study|Adverse Event|0|||
42027249|NCT00972543|75835406|FG000|Overall Study|Early study termination by sponsor|4|||
42027250|NCT00972543|75835407|FG001|Overall Study|Early study termination by sponsor|1|||
42027251|NCT00925132|75835413|FG000|Overall Study|Withdrawal by Subject|2|||
42027252|NCT00925132|75835414|FG001|Overall Study|Withdrawal by Subject|0|||
42027253|NCT00925132|75835415|FG002|Overall Study|Withdrawal by Subject|0|||
42027254|NCT00925132|75835416|FG003|Overall Study|Withdrawal by Subject|0|||
42027255|NCT00925132|75835417|FG004|Overall Study|Withdrawal by Subject|1|||
42027256|NCT00925132|75835413|FG000|Overall Study|Removed due to disease progression|0|||
42027257|NCT00925132|75835414|FG001|Overall Study|Removed due to disease progression|0|||
42027258|NCT00925132|75835415|FG002|Overall Study|Removed due to disease progression|0|||
42027259|NCT00925132|75835416|FG003|Overall Study|Removed due to disease progression|0|||
42027260|NCT00925132|75835417|FG004|Overall Study|Removed due to disease progression|4|||
42027261|NCT01143402|75835426|FG000|Overall Study|Rapid clinical decline|1|||
42027262|NCT01143402|75835427|FG001|Overall Study|Rapid clinical decline|1|||
42027263|NCT01143402|75835428|FG002|Overall Study|Rapid clinical decline|0|||
42027264|NCT01143402|75835426|FG000|Overall Study|Not Treated|0|||
42027265|NCT01143402|75835427|FG001|Overall Study|Not Treated|0|||
42027266|NCT01143402|75835428|FG002|Overall Study|Not Treated|1|||
42027267|NCT01171625|75835435|FG000|Overall Study|On-Protocol|67|||
42027268|NCT01171625|75835435|FG000|Overall Study|Death|38|||
42027269|NCT01171625|75835435|FG000|Overall Study|Withdrawal by Subject|31|||
42027270|NCT01171625|75835435|FG000|Overall Study|Explanted|10|||
42027271|NCT01171625|75835435|FG000|Overall Study|Lost to Follow-up|5|||
42027272|NCT01171625|75835435|FG000|Overall Study|Patient received valve-in-valve|3|||
42027273|NCT01171625|75835435|FG000|Overall Study|Other|1|||
41965132|NCT00246012|75764616|FG004|Overall Study|Disease progression|3|||
42027274|NCT01171625|75835435|FG000|Overall Study|Consented but did not receive device|25|||
42027275|NCT00924898|75835447|FG000|Overall Study|Withdrawal by Subject|2|||
42027276|NCT01167192|75835456|FG000|Overall Study|Adverse Event|1|||
42027277|NCT01167192|75835456|FG000|Overall Study|Death|1|||
42027278|NCT01167192|75835456|FG000|Overall Study|Withdrawal by Subject|1|||
42027279|NCT01167192|75835456|FG000|Overall Study|Insurance denial|1|||
42027280|NCT01166958|75835462|FG000|Overall Study|Withdrawal by Subject|1|||
42027281|NCT01166958|75835463|FG001|Overall Study|Withdrawal by Subject|0|||
42027282|NCT01170221|75835471|FG000|Overall Study|Lost to Follow-up|22|||
42027283|NCT01170221|75835472|FG001|Overall Study|Lost to Follow-up|21|||
42027284|NCT01170221|75835471|FG000|Overall Study|Withdrawal by Subject|9|||
42027285|NCT01170221|75835472|FG001|Overall Study|Withdrawal by Subject|7|||
42027286|NCT01170221|75835471|FG000|Overall Study|Subject completed only screening and LFU|1|||
42027287|NCT01170221|75835472|FG001|Overall Study|Subject completed only screening and LFU|0|||
42027288|NCT01170221|75835471|FG000|Overall Study|Randomized but not treated|1|||
42027289|NCT01170221|75835472|FG001|Overall Study|Randomized but not treated|0|||
42027290|NCT01166646|75835480|FG000|Overall Study|Protocol Violation|0|||
42027291|NCT01166646|75835481|FG001|Overall Study|Protocol Violation|1|||
42027292|NCT01166646|75835480|FG000|Overall Study|Adverse Event|1|||
42027293|NCT01166646|75835481|FG001|Overall Study|Adverse Event|0|||
42027294|NCT01129284|75835490|FG000|Overall Study|Adverse Event|2|||
42027295|NCT01129284|75835491|FG001|Overall Study|Adverse Event|0|||
42027296|NCT01129284|75835492|FG002|Overall Study|Adverse Event|1|||
42027297|NCT01166568|75835503|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
42027298|NCT01166568|75835504|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
42027299|NCT01166568|75835505|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
42027300|NCT01166568|75835503|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
42027301|NCT01166568|75835504|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
42027302|NCT01166568|75835505|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
42121047|NCT00673049|75931623|FG003|After Progression on Erlotinib|Death|71|||
42121048|NCT00673049|75931620|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
42121049|NCT00673049|75931621|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
42121050|NCT00673049|75931622|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
42121051|NCT00673049|75931623|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
42121052|NCT00673049|75931620|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
42121053|NCT00673049|75931621|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
42121054|NCT00673049|75931622|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
42121055|NCT00673049|75931623|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
42121056|NCT00673049|75931620|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
42121057|NCT00673049|75931621|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
42121058|NCT00673049|75931622|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
42121059|NCT00673049|75931623|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
42121060|NCT00412750|75931634|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42121061|NCT00412750|75931635|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42121062|NCT00412750|75931636|FG002|Overall Study|Abnormal laboratory value(s)|0|||
42121063|NCT00412750|75931634|FG000|Overall Study|Administrative problems|21|||
42121064|NCT00412750|75931635|FG001|Overall Study|Administrative problems|17|||
42121065|NCT00412750|75931636|FG002|Overall Study|Administrative problems|14|||
42121066|NCT00412750|75931634|FG000|Overall Study|Adverse Event|8|||
42121067|NCT00412750|75931635|FG001|Overall Study|Adverse Event|3|||
42121068|NCT00412750|75931636|FG002|Overall Study|Adverse Event|3|||
42121069|NCT00412750|75931634|FG000|Overall Study|Lost to Follow-up|1|||
42121070|NCT00412750|75931635|FG001|Overall Study|Lost to Follow-up|0|||
42121071|NCT00412750|75931636|FG002|Overall Study|Lost to Follow-up|1|||
42121072|NCT00412750|75931634|FG000|Overall Study|Withdrawal by Subject|0|||
42121073|NCT00412750|75931635|FG001|Overall Study|Withdrawal by Subject|1|||
42121074|NCT00412750|75931636|FG002|Overall Study|Withdrawal by Subject|2|||
42121075|NCT00412750|75931634|FG000|Overall Study|Lack of Efficacy|0|||
42121076|NCT00412750|75931635|FG001|Overall Study|Lack of Efficacy|0|||
42121077|NCT00412750|75931636|FG002|Overall Study|Lack of Efficacy|3|||
42121078|NCT00076999|75931650|FG000|Overall Study|Adverse Event|2|||
42121079|NCT00076999|75931651|FG001|Overall Study|Adverse Event|8|||
42121080|NCT00076999|75931652|FG002|Overall Study|Adverse Event|6|||
42121081|NCT00076999|75931653|FG003|Overall Study|Adverse Event|0|||
42121082|NCT00076999|75931654|FG004|Overall Study|Adverse Event|2|||
42121083|NCT00076999|75931650|FG000|Overall Study|Protocol Violation|0|||
42121084|NCT00076999|75931651|FG001|Overall Study|Protocol Violation|3|||
42121085|NCT00076999|75931652|FG002|Overall Study|Protocol Violation|4|||
42121086|NCT00076999|75931653|FG003|Overall Study|Protocol Violation|0|||
42121087|NCT00076999|75931654|FG004|Overall Study|Protocol Violation|9|||
42121088|NCT00076999|75931650|FG000|Overall Study|Lost to Follow-up|2|||
42121089|NCT00076999|75931651|FG001|Overall Study|Lost to Follow-up|1|||
42121090|NCT00076999|75931652|FG002|Overall Study|Lost to Follow-up|0|||
42121091|NCT00076999|75931653|FG003|Overall Study|Lost to Follow-up|0|||
42121092|NCT00076999|75931654|FG004|Overall Study|Lost to Follow-up|0|||
42121093|NCT00076999|75931650|FG000|Overall Study|Withdrawal by Subject|0|||
42121094|NCT00076999|75931651|FG001|Overall Study|Withdrawal by Subject|4|||
42121095|NCT00076999|75931652|FG002|Overall Study|Withdrawal by Subject|3|||
42121096|NCT00076999|75931653|FG003|Overall Study|Withdrawal by Subject|0|||
42027303|NCT01166568|75835503|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
42027304|NCT01166568|75835504|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
42027305|NCT01166568|75835505|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
42027306|NCT01166178|75835513|FG000|Overall Study|Withdrawal by Subject|1|||
42121097|NCT00076999|75931654|FG004|Overall Study|Withdrawal by Subject|1|||
42121098|NCT00076999|75931650|FG000|Overall Study|Other reason (not specified)|8|||
42121099|NCT00076999|75931651|FG001|Overall Study|Other reason (not specified)|8|||
42121100|NCT00076999|75931652|FG002|Overall Study|Other reason (not specified)|4|||
42121101|NCT00076999|75931653|FG003|Overall Study|Other reason (not specified)|1|||
42121102|NCT00076999|75931654|FG004|Overall Study|Other reason (not specified)|13|||
42121103|NCT03905096|75931669|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
42121104|NCT03905096|75931670|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
42121105|NCT00412360|75931685|FG000|Overall Study|Lost to Follow-up|0|||
42121106|NCT00412360|75931686|FG001|Overall Study|Lost to Follow-up|1|||
42121107|NCT00412360|75931685|FG000|Overall Study|Not Transplanted|1|||
42121108|NCT00412360|75931686|FG001|Overall Study|Not Transplanted|2|||
42121109|NCT00571103|75931692|FG000|Overall Study|Withdrawal by Subject|1|||
42121110|NCT00571103|75931692|FG000|Overall Study|Lost to Follow-up|1|||
42121111|NCT00069277|75931696|FG000|Overall Study|Adverse Event|3|||
42121112|NCT00069277|75931696|FG000|Overall Study|Withdrawal by Subject|1|||
42121113|NCT00069277|75931696|FG000|Overall Study|Progressive Disease|15|||
42121114|NCT00069277|75931696|FG000|Overall Study|Physician Decision|2|||
42121115|NCT00418522|75931702|FG000|Overall Study|Adverse Event|7|||
42121116|NCT00418522|75931703|FG001|Overall Study|Adverse Event|1|||
42121117|NCT00418522|75931702|FG000|Overall Study|Lack of Efficacy|1|||
42121118|NCT00418522|75931703|FG001|Overall Study|Lack of Efficacy|3|||
42121119|NCT00418522|75931702|FG000|Overall Study|Lost to Follow-up|10|||
42121120|NCT00418522|75931703|FG001|Overall Study|Lost to Follow-up|4|||
42121121|NCT00418522|75931702|FG000|Overall Study|Withdrawal by Subject|31|||
42121122|NCT00418522|75931703|FG001|Overall Study|Withdrawal by Subject|7|||
42121123|NCT00418522|75931702|FG000|Overall Study|Other|27|||
42121124|NCT00418522|75931703|FG001|Overall Study|Other|23|||
42121125|NCT00418522|75931702|FG000|Overall Study|Randomized but did not receive treatment|7|||
42121126|NCT00418522|75931703|FG001|Overall Study|Randomized but did not receive treatment|4|||
42121127|NCT00403546|75931711|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
42121128|NCT00403546|75931712|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
42121129|NCT00403546|75931713|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
42121130|NCT00403546|75931711|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
42121131|NCT00403546|75931712|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
42121132|NCT00403546|75931713|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
42121133|NCT00403546|75931711|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
42121134|NCT00403546|75931712|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
42121135|NCT00403546|75931713|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
42121136|NCT00403546|75931711|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
42121137|NCT00403546|75931712|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
42121138|NCT00403546|75931713|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
42121139|NCT00403546|75931711|FG000|Screening Phase|Screening Failure|22|||
42121140|NCT00403546|75931712|FG001|Screening Phase|Screening Failure|0|||
42121141|NCT00403546|75931713|FG002|Screening Phase|Screening Failure|0|||
42121142|NCT00403546|75931711|FG000|Screening Phase|Adverse Event|1|||
42121143|NCT00403546|75931712|FG001|Screening Phase|Adverse Event|0|||
42121144|NCT00403546|75931713|FG002|Screening Phase|Adverse Event|0|||
42121145|NCT00403546|75931711|FG000|Screening Phase|Terminated Prior to Randomization|5|||
42121146|NCT00403546|75931712|FG001|Screening Phase|Terminated Prior to Randomization|0|||
42121147|NCT00403546|75931713|FG002|Screening Phase|Terminated Prior to Randomization|0|||
42121148|NCT00403546|75931711|FG000|Randomized Trial|Early Terminations|0|||
42121149|NCT00403546|75931712|FG001|Randomized Trial|Early Terminations|17|||
42121150|NCT00403546|75931713|FG002|Randomized Trial|Early Terminations|16|||
42121151|NCT00403390|75931724|FG000|Overall Study|Withdrawal by Subject|1|||
42121152|NCT00403390|75931725|FG001|Overall Study|Withdrawal by Subject|0|||
42121153|NCT00403390|75931724|FG000|Overall Study|samples lost|1|||
42121154|NCT00403390|75931725|FG001|Overall Study|samples lost|0|||
42121155|NCT00403390|75931724|FG000|Overall Study|non-compliant|1|||
42027307|NCT01166178|75835514|FG001|Overall Study|Withdrawal by Subject|0|||
42027308|NCT01166178|75835513|FG000|Overall Study|Study was terminated|20|||
42027309|NCT01166178|75835514|FG001|Overall Study|Study was terminated|8|||
42027310|NCT00924820|75835520|FG000|Overall Study|Death|2|||
42027311|NCT00924820|75835520|FG000|Overall Study|Ineligible, Screen Failure|5|||
42027312|NCT01225172|75835526|FG000|Overall Study|Subject decision to stop|1|||
42027313|NCT01225172|75835527|FG001|Overall Study|Subject decision to stop|0|||
42121156|NCT00403390|75931725|FG001|Overall Study|non-compliant|0|||
42121157|NCT00403234|75931735|FG000|Overall Study|Withdrawal by Subject|0|||
42121158|NCT00403234|75931736|FG001|Overall Study|Withdrawal by Subject|1|||
42121159|NCT00403234|75931737|FG002|Overall Study|Withdrawal by Subject|0|||
42121160|NCT00403234|75931738|FG003|Overall Study|Withdrawal by Subject|0|||
42121161|NCT00403234|75931735|FG000|Overall Study|Adverse Event|1|||
42210361|NCT03288714|76025139|FG001|Overall Study|Withdrawal by Subject|1|||
42027314|NCT01225172|75835526|FG000|Overall Study|Subject request to discontinue treatment|3|||
42121162|NCT00403234|75931736|FG001|Overall Study|Adverse Event|0|||
42121163|NCT00403234|75931737|FG002|Overall Study|Adverse Event|1|||
42121164|NCT00403234|75931738|FG003|Overall Study|Adverse Event|0|||
42121165|NCT00402688|75931751|FG000|Overall Study|Adverse Event|12|||
42121166|NCT00402688|75931752|FG001|Overall Study|Adverse Event|9|||
42121167|NCT00402688|75931753|FG002|Overall Study|Adverse Event|3|||
42121168|NCT00402688|75931751|FG000|Overall Study|Withdrawal by Subject|3|||
42121169|NCT00402688|75931752|FG001|Overall Study|Withdrawal by Subject|1|||
42121170|NCT00402688|75931753|FG002|Overall Study|Withdrawal by Subject|1|||
42121171|NCT00402688|75931751|FG000|Overall Study|Physician Decision|0|||
42121172|NCT00402688|75931752|FG001|Overall Study|Physician Decision|0|||
42121173|NCT00402688|75931753|FG002|Overall Study|Physician Decision|1|||
42121174|NCT00402688|75931751|FG000|Overall Study|Lack of Efficacy|4|||
42121175|NCT00402688|75931752|FG001|Overall Study|Lack of Efficacy|4|||
42121176|NCT00402688|75931753|FG002|Overall Study|Lack of Efficacy|5|||
42121177|NCT00402688|75931751|FG000|Overall Study|Protocol Violation|1|||
42121178|NCT00402688|75931752|FG001|Overall Study|Protocol Violation|1|||
42121179|NCT00402688|75931753|FG002|Overall Study|Protocol Violation|1|||
42121180|NCT00402688|75931751|FG000|Overall Study|Lost to Follow-up|1|||
42121181|NCT00402688|75931752|FG001|Overall Study|Lost to Follow-up|0|||
42121182|NCT00402688|75931753|FG002|Overall Study|Lost to Follow-up|2|||
42121183|NCT00402688|75931751|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
42121184|NCT00402688|75931752|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
42027315|NCT01225172|75835527|FG001|Overall Study|Subject request to discontinue treatment|1|||
42027316|NCT01225172|75835526|FG000|Overall Study|Subject no longer meets study criteria|1|||
42027317|NCT01225172|75835527|FG001|Overall Study|Subject no longer meets study criteria|0|||
42027318|NCT01225172|75835526|FG000|Overall Study|Withdrawal by Subject|1|||
42027319|NCT01225172|75835527|FG001|Overall Study|Withdrawal by Subject|0|||
42027320|NCT01143324|75835533|FG000|Overall Study|Lost to Follow-up|11|||
42027321|NCT01143324|75835533|FG000|Overall Study|Withdrawal by Subject|4|||
42027322|NCT01143324|75835533|FG000|Overall Study|Explant of the device|4|||
42027323|NCT01224782|75835537|FG000|Overall Study|Lost to Follow-up|177|||
42027324|NCT01224782|75835537|FG000|Overall Study|Withdrawal by Subject|16|||
42027325|NCT01224782|75835537|FG000|Overall Study|Death|14|||
42027326|NCT01224782|75835537|FG000|Overall Study|Improvement|13|||
42027327|NCT01224782|75835537|FG000|Overall Study|Adverse Event|12|||
42027328|NCT01224782|75835537|FG000|Overall Study|Adverse Reaction|11|||
42027329|NCT01224782|75835537|FG000|Overall Study|Noncompliance|10|||
42027330|NCT01224782|75835537|FG000|Overall Study|Other|4|||
42027331|NCT01224782|75835537|FG000|Overall Study|Start of Dialysis|3|||
42027332|NCT01224782|75835537|FG000|Overall Study|Change of Treatment|1|||
42027333|NCT01224782|75835537|FG000|Overall Study|Financial Reasons|1|||
42027334|NCT01224782|75835537|FG000|Overall Study|Deterioration|1|||
42027335|NCT01224782|75835537|FG000|Overall Study|Transplantation|1|||
42027336|NCT01224158|75835543|FG000|Overall Study|Withdrawal by Subject|1|||
42027337|NCT01224158|75835544|FG001|Overall Study|Withdrawal by Subject|0|||
42027338|NCT01129128|75835553|FG000|Overall Study|Lost to Follow-up|2|||
42027339|NCT01129128|75835554|FG001|Overall Study|Lost to Follow-up|2|||
42121185|NCT00402688|75931753|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
42121186|NCT00402688|75931751|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
42121187|NCT00402688|75931752|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
42121188|NCT00402688|75931753|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
42121189|NCT00402688|75931751|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
42121190|NCT00402688|75931752|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
42121191|NCT00402688|75931753|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
42121192|NCT00671879|75931764|FG000|Overall Study|Withdrawal by Subject|0|||
42121193|NCT00671879|75931765|FG001|Overall Study|Withdrawal by Subject|4|||
42121194|NCT00671879|75931766|FG002|Overall Study|Withdrawal by Subject|6|||
42121195|NCT00401830|75931777|FG000|Overall Study|Adverse Event|10|||
42121196|NCT00401830|75931778|FG001|Overall Study|Adverse Event|18|||
42121197|NCT00401830|75931777|FG000|Overall Study|Lack of Efficacy|11|||
42121198|NCT00401830|75931778|FG001|Overall Study|Lack of Efficacy|5|||
42121199|NCT00401830|75931777|FG000|Overall Study|Withdrawal by Subject|4|||
42121200|NCT00401830|75931778|FG001|Overall Study|Withdrawal by Subject|3|||
42121201|NCT00401830|75931777|FG000|Overall Study|Protocol Violation|3|||
42121202|NCT00401830|75931778|FG001|Overall Study|Protocol Violation|3|||
42121203|NCT00401830|75931777|FG000|Overall Study|Non-compliance with drug study|1|||
42121204|NCT00401830|75931778|FG001|Overall Study|Non-compliance with drug study|0|||
42121205|NCT00401830|75931777|FG000|Overall Study|Lost to Follow-up|1|||
42121206|NCT00401830|75931778|FG001|Overall Study|Lost to Follow-up|3|||
42121207|NCT00401830|75931777|FG000|Overall Study|Other: Personal / Family problems|1|||
42121208|NCT00401830|75931778|FG001|Overall Study|Other: Personal / Family problems|0|||
42027340|NCT01129128|75835555|FG002|Overall Study|Lost to Follow-up|1|||
42027341|NCT01129128|75835553|FG000|Overall Study|Protocol Violation|0|||
42027342|NCT01129128|75835554|FG001|Overall Study|Protocol Violation|1|||
42027343|NCT01129128|75835555|FG002|Overall Study|Protocol Violation|0|||
42027344|NCT01129128|75835553|FG000|Overall Study|Withdrawal by Subject|0|||
42121209|NCT00401752|75931786|FG000|Overall Study|Adverse Event|2|||
42121210|NCT00401752|75931787|FG001|Overall Study|Adverse Event|5|||
42121211|NCT00401752|75931786|FG000|Overall Study|Withdrawal by Subject|2|||
42121212|NCT00401752|75931787|FG001|Overall Study|Withdrawal by Subject|6|||
42121213|NCT00401752|75931786|FG000|Overall Study|Lost to Follow-up|1|||
42121214|NCT00401752|75931787|FG001|Overall Study|Lost to Follow-up|4|||
42121215|NCT00401752|75931786|FG000|Overall Study|Development of any exclusion criteria|4|||
42121216|NCT00401752|75931787|FG001|Overall Study|Development of any exclusion criteria|2|||
42121217|NCT00401752|75931786|FG000|Overall Study|Physician Decision|1|||
42121218|NCT00401752|75931787|FG001|Overall Study|Physician Decision|1|||
42121219|NCT00539240|75931796|FG000|Overall Study|Withdrawal by Subject|0|||
42121220|NCT00539240|75931797|FG001|Overall Study|Withdrawal by Subject|2|||
42121221|NCT00539240|75931798|FG002|Overall Study|Withdrawal by Subject|0|||
42121222|NCT00539240|75931796|FG000|Overall Study|Protocol Violation|1|||
42121223|NCT00539240|75931797|FG001|Overall Study|Protocol Violation|1|||
42121224|NCT00539240|75931798|FG002|Overall Study|Protocol Violation|4|||
42121225|NCT00539240|75931796|FG000|Overall Study|Lost to Follow-up|2|||
42121226|NCT00539240|75931797|FG001|Overall Study|Lost to Follow-up|3|||
42121227|NCT00539240|75931798|FG002|Overall Study|Lost to Follow-up|1|||
42121228|NCT00539240|75931796|FG000|Overall Study|Adverse Event|3|||
42121229|NCT00539240|75931797|FG001|Overall Study|Adverse Event|1|||
42121230|NCT00539240|75931798|FG002|Overall Study|Adverse Event|10|||
41965133|NCT00246012|75764617|FG005|Overall Study|Disease progression|25|||
41965134|NCT00246012|75764618|FG006|Overall Study|Disease progression|30|||
41965135|NCT00246012|75764619|FG007|Overall Study|Disease progression|27|||
41965136|NCT00246012|75764620|FG008|Overall Study|Disease progression|26|||
41965137|NCT00246012|75764612|FG000|Overall Study|Other|0|||
41965138|NCT00246012|75764613|FG001|Overall Study|Other|0|||
41965139|NCT00246012|75764614|FG002|Overall Study|Other|0|||
41965140|NCT00246012|75764615|FG003|Overall Study|Other|0|||
41965141|NCT00246012|75764616|FG004|Overall Study|Other|0|||
41965142|NCT00246012|75764617|FG005|Overall Study|Other|0|||
41965143|NCT00246012|75764618|FG006|Overall Study|Other|0|||
41965144|NCT00246012|75764619|FG007|Overall Study|Other|1|||
41965145|NCT00246012|75764620|FG008|Overall Study|Other|0|||
41965146|NCT00246012|75764612|FG000|Overall Study|Randomly assigned but not treated|0|||
41965147|NCT00246012|75764613|FG001|Overall Study|Randomly assigned but not treated|0|||
41965148|NCT00246012|75764614|FG002|Overall Study|Randomly assigned but not treated|0|||
41965149|NCT00246012|75764615|FG003|Overall Study|Randomly assigned but not treated|0|||
41965150|NCT00246012|75764616|FG004|Overall Study|Randomly assigned but not treated|0|||
41965151|NCT00246012|75764617|FG005|Overall Study|Randomly assigned but not treated|1|||
41965152|NCT00246012|75764618|FG006|Overall Study|Randomly assigned but not treated|1|||
41965153|NCT00246012|75764619|FG007|Overall Study|Randomly assigned but not treated|0|||
41965154|NCT00246012|75764620|FG008|Overall Study|Randomly assigned but not treated|0|||
41965155|NCT00245856|75764642|FG000|Period Two|Withdrawal by Subject|0|||
41965156|NCT00245856|75764643|FG001|Period Two|Withdrawal by Subject|1|||
41965157|NCT00245466|75764653|FG000|Overall Study|Adverse Event|2|||
41965158|NCT00245466|75764654|FG001|Overall Study|Adverse Event|8|||
41965159|NCT00245466|75764655|FG002|Overall Study|Adverse Event|4|||
41965160|NCT00245466|75764653|FG000|Overall Study|Low prostate specific antigen suppr|16|||
41965161|NCT00245466|75764654|FG001|Overall Study|Low prostate specific antigen suppr|14|||
41965162|NCT00245466|75764655|FG002|Overall Study|Low prostate specific antigen suppr|5|||
41965163|NCT00245466|75764653|FG000|Overall Study|Insufficient testosterone suppr|12|||
41965164|NCT00245466|75764654|FG001|Overall Study|Insufficient testosterone suppr|12|||
41965165|NCT00245466|75764655|FG002|Overall Study|Insufficient testosterone suppr|21|||
41965166|NCT00245466|75764653|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
41965167|NCT00245466|75764654|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
42027345|NCT01129128|75835554|FG001|Overall Study|Withdrawal by Subject|1|||
42027346|NCT01129128|75835555|FG002|Overall Study|Withdrawal by Subject|3|||
42027347|NCT01129128|75835553|FG000|Overall Study|Physician Decision|1|||
42027348|NCT01129128|75835554|FG001|Overall Study|Physician Decision|0|||
42027349|NCT01129128|75835555|FG002|Overall Study|Physician Decision|0|||
42027350|NCT01222520|75835565|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
42027351|NCT01222520|75835566|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
42027352|NCT01222520|75835565|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
42121231|NCT00417976|75931806|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
42121232|NCT00417976|75931806|FG000|Overall Study|Treatment -related toxicity|2|||
42121233|NCT00673673|75931811|FG000|Overall Study|Progressive disease|27|||
42121234|NCT00673673|75931811|FG000|Overall Study|Adverse Event|4|||
42121235|NCT00673673|75931811|FG000|Overall Study|Withdrawal by Subject|3|||
42121236|NCT00673673|75931811|FG000|Overall Study|Investigators' discretion|2|||
41965168|NCT00245466|75764655|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
41965169|NCT00245466|75764653|FG000|Overall Study|Withdrawal by Subject|2|||
41965170|NCT00245466|75764654|FG001|Overall Study|Withdrawal by Subject|2|||
42027353|NCT01222520|75835566|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
42121237|NCT00069121|75931817|FG000|Overall Study|Death|286|||
41965171|NCT00245466|75764655|FG002|Overall Study|Withdrawal by Subject|1|||
41965172|NCT00245466|75764653|FG000|Overall Study|Lost to Follow-up|3|||
41965173|NCT00245466|75764654|FG001|Overall Study|Lost to Follow-up|0|||
41965174|NCT00245466|75764655|FG002|Overall Study|Lost to Follow-up|0|||
41965175|NCT00245466|75764653|FG000|Overall Study|Disease progression|0|||
41965176|NCT00245466|75764654|FG001|Overall Study|Disease progression|3|||
41965177|NCT00245466|75764655|FG002|Overall Study|Disease progression|1|||
41965178|NCT00245466|75764653|FG000|Overall Study|Protocol Violation|1|||
42027354|NCT01222520|75835565|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
42027355|NCT01222520|75835566|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
42121238|NCT00069121|75931818|FG001|Overall Study|Death|242|||
42121239|NCT00069121|75931817|FG000|Overall Study|Withdrawal by Subject|18|||
42121240|NCT00069121|75931818|FG001|Overall Study|Withdrawal by Subject|20|||
42121241|NCT00069121|75931817|FG000|Overall Study|Lost to Follow-up|63|||
42121242|NCT00069121|75931818|FG001|Overall Study|Lost to Follow-up|63|||
42121243|NCT00399802|75931830|FG000|Overall Study|Adverse Event|0|||
42121244|NCT00399802|75931831|FG001|Overall Study|Adverse Event|2|||
42121245|NCT00399802|75931830|FG000|Overall Study|Participant discontinued by mistake|0|||
42121246|NCT00399802|75931831|FG001|Overall Study|Participant discontinued by mistake|1|||
42121247|NCT00399568|75931839|FG000|Overall Study|Adverse Event|1|||
42121248|NCT00399568|75931840|FG001|Overall Study|Adverse Event|2|||
42121249|NCT00399568|75931839|FG000|Overall Study|Withdrawal by Subject|7|||
42121250|NCT00399568|75931840|FG001|Overall Study|Withdrawal by Subject|3|||
42121251|NCT00399568|75931839|FG000|Overall Study|Protocol non-compliance|2|||
42121252|NCT00399568|75931840|FG001|Overall Study|Protocol non-compliance|2|||
42121253|NCT00399568|75931839|FG000|Overall Study|Lost to Follow-up|2|||
42121254|NCT00399568|75931840|FG001|Overall Study|Lost to Follow-up|2|||
42121255|NCT03900728|75931851|FG000|Overall Study|No text responses|0|||
42121256|NCT03900728|75931852|FG001|Overall Study|No text responses|0|||
42121257|NCT03900728|75931853|FG002|Overall Study|No text responses|4|||
42121258|NCT00068419|75931861|FG000|Overall Study|Adverse Event|3|||
42121259|NCT00068419|75931861|FG000|Overall Study|Lack of Efficacy|24|||
42121260|NCT00068419|75931861|FG000|Overall Study|Lost to Follow-up|1|||
42121261|NCT00068419|75931861|FG000|Overall Study|Physician Decision|7|||
42121262|NCT00068419|75931861|FG000|Overall Study|Withdrawal by Subject|14|||
42121263|NCT00068419|75931861|FG000|Overall Study|Ineligible|11|||
42121264|NCT00068107|75931865|FG000|Overall Study|end-stage renal disease|6|||
42121265|NCT00068107|75931865|FG000|Overall Study|Death|2|||
42121266|NCT00068107|75931865|FG000|Overall Study|Withdrawal by Subject|1|||
42121267|NCT00394654|75931874|FG000|Overall Study|Lost to Follow-up|1|||
42121268|NCT00394654|75931875|FG001|Overall Study|Lost to Follow-up|0|||
42121269|NCT00394654|75931874|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
42121270|NCT00394654|75931875|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
42121271|NCT03900416|75931883|FG000|Six Week Follow-up|Lost to Follow-up|1|||
42121272|NCT03900416|75931884|FG001|Six Week Follow-up|Lost to Follow-up|0|||
42121273|NCT03900416|75931883|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
42121274|NCT03900416|75931884|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
42121275|NCT03900416|75931883|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
42121276|NCT03900416|75931884|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
42121277|NCT03900416|75931883|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
42121278|NCT03900416|75931884|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
42121279|NCT03900416|75931883|FG000|Twelve Week Follow-up|Adverse Event|1|||
42121280|NCT03900416|75931884|FG001|Twelve Week Follow-up|Adverse Event|1|||
42121281|NCT03900416|75931883|FG000|Six Month Follow-up|Lost to Follow-up|4|||
42121282|NCT03900416|75931884|FG001|Six Month Follow-up|Lost to Follow-up|3|||
42027356|NCT01222520|75835565|FG000|Double-blind Period|Adverse Event|0|||
42027357|NCT01222520|75835566|FG001|Double-blind Period|Adverse Event|1|||
42027358|NCT01222520|75835565|FG000|Double-blind Period|Lack of Efficacy|0|||
42027359|NCT01222520|75835566|FG001|Double-blind Period|Lack of Efficacy|1|||
42027360|NCT01222520|75835565|FG000|Double-blind Period|Study medication stolen|1|||
42027361|NCT01222520|75835566|FG001|Double-blind Period|Study medication stolen|0|||
42027362|NCT01221350|75835574|FG000|Overall Study|Discontinued intervention (GERD)|1|||
42121283|NCT03900416|75931883|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
42121284|NCT03900416|75931884|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
42121285|NCT00399490|75931890|FG000|Overall Study|Adverse Event|19|||
42121286|NCT00399490|75931890|FG000|Overall Study|Lack of Efficacy|31|||
42121287|NCT00399490|75931890|FG000|Overall Study|Lost to Follow-up|5|||
41965179|NCT00245466|75764654|FG001|Overall Study|Protocol Violation|2|||
42121288|NCT00399490|75931890|FG000|Overall Study|Withdrawal by Subject|18|||
42121289|NCT00399490|75931890|FG000|Overall Study|Other|25|||
42121290|NCT00398866|75931899|FG000|Overall Study|Adverse Event|1|||
42121291|NCT00398866|75931900|FG001|Overall Study|Adverse Event|0|||
42121292|NCT00398866|75931901|FG002|Overall Study|Adverse Event|0|||
41965180|NCT00245466|75764655|FG002|Overall Study|Protocol Violation|2|||
42027363|NCT01221350|75835575|FG001|Overall Study|Discontinued intervention (GERD)|0|||
42027364|NCT01221350|75835574|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
42121293|NCT00398866|75931899|FG000|Overall Study|Lack of Efficacy|0|||
42121294|NCT00398866|75931900|FG001|Overall Study|Lack of Efficacy|0|||
42121295|NCT00398866|75931901|FG002|Overall Study|Lack of Efficacy|1|||
42121296|NCT00398866|75931899|FG000|Overall Study|Lost to Follow-up|7|||
42121297|NCT00398866|75931900|FG001|Overall Study|Lost to Follow-up|6|||
42027365|NCT01221350|75835575|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
42027366|NCT01221350|75835574|FG000|Overall Study|Withdrawal by Subject|4|||
42027367|NCT01221350|75835575|FG001|Overall Study|Withdrawal by Subject|2|||
42121298|NCT00398866|75931901|FG002|Overall Study|Lost to Follow-up|4|||
42121299|NCT00398866|75931899|FG000|Overall Study|Withdrawal by Subject|5|||
42121300|NCT00398866|75931900|FG001|Overall Study|Withdrawal by Subject|1|||
42121301|NCT00398866|75931901|FG002|Overall Study|Withdrawal by Subject|2|||
42121302|NCT00398866|75931899|FG000|Overall Study|Unable to complete requirements of study|1|||
42121303|NCT00398866|75931900|FG001|Overall Study|Unable to complete requirements of study|1|||
42027368|NCT01221272|75835583|FG000|Period 1|Adverse Event|2|||
42027369|NCT01221272|75835584|FG001|Period 1|Adverse Event|0|||
42027370|NCT01221272|75835583|FG000|Period 1|Consent Withdrawal|0|||
42027371|NCT01221272|75835584|FG001|Period 1|Consent Withdrawal|1|||
42027372|NCT01221272|75835583|FG000|Period 1|Significant Dosing Noncompliance|0|||
42027373|NCT01221272|75835584|FG001|Period 1|Significant Dosing Noncompliance|1|||
42027374|NCT01221272|75835583|FG000|Period 2|Adverse Event|0|||
42027375|NCT01221272|75835584|FG001|Period 2|Adverse Event|2|||
42027376|NCT01220414|75835595|FG000|Overall Study|Withdrawal by Subject|1|||
42027377|NCT01220414|75835596|FG001|Overall Study|Withdrawal by Subject|0|||
42027378|NCT01220414|75835597|FG002|Overall Study|Withdrawal by Subject|0|||
42027379|NCT01220414|75835598|FG003|Overall Study|Withdrawal by Subject|1|||
42027380|NCT01128894|75835607|FG000|Overall Study|Adverse Event|31|||
42027381|NCT01128894|75835608|FG001|Overall Study|Adverse Event|41|||
42027382|NCT01128894|75835607|FG000|Overall Study|Protocol Violation|2|||
42027383|NCT01128894|75835608|FG001|Overall Study|Protocol Violation|1|||
42027384|NCT01128894|75835607|FG000|Overall Study|Noncompliance|4|||
42027385|NCT01128894|75835608|FG001|Overall Study|Noncompliance|5|||
42027386|NCT01128894|75835607|FG000|Overall Study|Lost to Follow-up|8|||
42027387|NCT01128894|75835608|FG001|Overall Study|Lost to Follow-up|8|||
42027388|NCT01128894|75835607|FG000|Overall Study|Withdrawal by Subject|10|||
42027389|NCT01128894|75835608|FG001|Overall Study|Withdrawal by Subject|12|||
42027390|NCT01128894|75835607|FG000|Overall Study|Physician Decision|2|||
42027391|NCT01128894|75835608|FG001|Overall Study|Physician Decision|1|||
42121304|NCT00398866|75931901|FG002|Overall Study|Unable to complete requirements of study|1|||
42121305|NCT00398632|75931910|FG000|Overall Study|Withdrawal by Subject|1|||
42121306|NCT00398632|75931910|FG000|Overall Study|Lack of Efficacy|1|||
42121307|NCT00673361|75931915|FG000|Overall Study|Screen Failure|2|||
42121308|NCT00393718|75931921|FG000|Overall Study|Adverse Event|20|||
42121309|NCT00393718|75931922|FG001|Overall Study|Adverse Event|8|||
42121310|NCT00393718|75931921|FG000|Overall Study|Protocol Violation|1|||
42121311|NCT00393718|75931922|FG001|Overall Study|Protocol Violation|2|||
42121312|NCT00393718|75931921|FG000|Overall Study|Lack of Efficacy|10|||
42121313|NCT00393718|75931922|FG001|Overall Study|Lack of Efficacy|9|||
42121314|NCT00393718|75931921|FG000|Overall Study|Hypoglycaemia|3|||
42121315|NCT00393718|75931922|FG001|Overall Study|Hypoglycaemia|2|||
42121316|NCT00393718|75931921|FG000|Overall Study|Subject decision|5|||
42121317|NCT00393718|75931922|FG001|Overall Study|Subject decision|0|||
42121318|NCT00393718|75931921|FG000|Overall Study|Withdrawal of consent|2|||
42121319|NCT00393718|75931922|FG001|Overall Study|Withdrawal of consent|1|||
42121320|NCT00393718|75931921|FG000|Overall Study|Missed measurement|1|||
42121321|NCT00393718|75931922|FG001|Overall Study|Missed measurement|0|||
42121322|NCT00393718|75931921|FG000|Overall Study|Move|1|||
42121323|NCT00393718|75931922|FG001|Overall Study|Move|0|||
42121324|NCT00669071|75931928|FG000|Overall Study|Lost to Follow-up|3|||
42121325|NCT00669071|75931928|FG000|Overall Study|Final visit 40 days out of window|1|||
42121326|NCT00398320|75931934|FG000|Overall Study|Death|1|||
42121327|NCT00398320|75931934|FG000|Overall Study|Adverse Event|4|||
42210362|NCT03288714|76025138|FG000|Overall Study|Clinical Worsening|2|||
42027392|NCT01128894|75835607|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
42027393|NCT01128894|75835608|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
42027394|NCT01220180|75835617|FG000|Overall Study|Lost to Follow-up|76|||
42027395|NCT01220180|75835617|FG000|Overall Study|Other|72|||
42027396|NCT01220180|75835617|FG000|Overall Study|Adverse Event|35|||
42027397|NCT01220180|75835617|FG000|Overall Study|Lack of Efficacy|22|||
42027398|NCT01220180|75835617|FG000|Overall Study|Death|1|||
42027399|NCT01220180|75835617|FG000|Overall Study|Randomized but not treated|1|||
41965181|NCT00245466|75764653|FG000|Overall Study|Death|0|||
41965182|NCT00245466|75764654|FG001|Overall Study|Death|2|||
41965183|NCT00245466|75764655|FG002|Overall Study|Death|0|||
41965184|NCT00245466|75764653|FG000|Overall Study|Administrative reasons|0|||
41965185|NCT00245466|75764654|FG001|Overall Study|Administrative reasons|1|||
41965186|NCT00245466|75764655|FG002|Overall Study|Administrative reasons|0|||
41965187|NCT00244764|75764663|FG000|Overall Study|Adverse Event|37|||
41965188|NCT00244764|75764663|FG000|Overall Study|Lost to Follow-up|23|||
41965189|NCT00244764|75764663|FG000|Overall Study|Withdrawal by Subject|12|||
41965190|NCT00244764|75764663|FG000|Overall Study|Disease Progression|13|||
41965191|NCT00244764|75764663|FG000|Overall Study|Protocol Violation|2|||
41965192|NCT00244764|75764663|FG000|Overall Study|Death|1|||
41965193|NCT00244764|75764663|FG000|Overall Study|Off Study Medication for >21 Days|1|||
41965194|NCT00244764|75764663|FG000|Overall Study|Declining Performance Status|1|||
41965195|NCT00244764|75764663|FG000|Overall Study|Participant was Hospitalized until Death|1|||
41965196|NCT00244764|75764663|FG000|Overall Study|Primary Investigator Discretion|2|||
41965197|NCT00244764|75764663|FG000|Overall Study|Sponsor Terminated Study|2|||
41965198|NCT00244764|75764663|FG000|Overall Study|Developed Secondary Malignancy|1|||
41965199|NCT00244374|75764668|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
41965200|NCT00244374|75764669|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
41965201|NCT00244374|75764670|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
41965202|NCT00244374|75764671|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
41965203|NCT00244374|75764672|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
41965204|NCT00244374|75764668|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
41965205|NCT00244374|75764669|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
41965206|NCT00244374|75764670|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
41965207|NCT00244374|75764671|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
41965208|NCT00244374|75764672|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
41965209|NCT00244374|75764668|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
41965210|NCT00244374|75764669|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
41965211|NCT00244374|75764670|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
41965212|NCT00244374|75764671|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
41965213|NCT00244374|75764672|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
41965214|NCT00244374|75764668|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
41965215|NCT00244374|75764669|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
41965216|NCT00244374|75764670|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
41965217|NCT00244374|75764671|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
41965218|NCT00244374|75764672|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
41965219|NCT00244374|75764668|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
41965220|NCT00244374|75764669|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
41965221|NCT00244374|75764670|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
41965222|NCT00244374|75764671|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
41965223|NCT00244374|75764672|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
41965224|NCT00244374|75764668|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
41965225|NCT00244374|75764669|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
41965226|NCT00244374|75764670|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
41965227|NCT00244374|75764671|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
41965228|NCT00244374|75764672|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
41965229|NCT00244374|75764668|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
42027400|NCT01220024|75835623|FG000|Overall Study|Lost to Follow-up|1|||
42027401|NCT01220024|75835624|FG001|Overall Study|Lost to Follow-up|1|||
42027402|NCT01128738|75835632|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
42210363|NCT03288714|76025139|FG001|Overall Study|Clinical Worsening|1|||
42121328|NCT00398320|75931934|FG000|Overall Study|Physician Decision|1|||
42121329|NCT00670007|75931938|FG000|Overall Study|Drug abuse|1|||
42121330|NCT00670007|75931938|FG000|Overall Study|Lung transplant|1|||
42121331|NCT00670007|75931938|FG000|Overall Study|Travel/Vacation|1|||
42121332|NCT00670007|75931938|FG000|Overall Study|Adverse event, serious fatal|1|||
42121333|NCT00670007|75931938|FG000|Overall Study|Adverse Event|1|||
42121334|NCT00670007|75931938|FG000|Overall Study|Withdrawal by Subject|4|||
42121335|NCT00535496|75931945|FG000|Overall Study|Lost to Follow-up|0|||
42121336|NCT00535496|75931946|FG001|Overall Study|Lost to Follow-up|1|||
42121337|NCT00535496|75931947|FG002|Overall Study|Lost to Follow-up|0|||
42121338|NCT00535496|75931948|FG003|Overall Study|Lost to Follow-up|0|||
42121339|NCT00535496|75931945|FG000|Overall Study|Not treated with sugammadex|0|||
42121340|NCT00535496|75931946|FG001|Overall Study|Not treated with sugammadex|1|||
42121341|NCT00535496|75931947|FG002|Overall Study|Not treated with sugammadex|0|||
42121342|NCT00535496|75931948|FG003|Overall Study|Not treated with sugammadex|0|||
42121343|NCT00539006|75931959|FG000|Pre-treatment|Other|0|||
42121344|NCT00539006|75931960|FG001|Pre-treatment|Other|1|||
42121345|NCT00539006|75931961|FG002|Pre-treatment|Other|0|||
42121346|NCT00539006|75931962|FG003|Pre-treatment|Other|0|||
42121347|NCT00539006|75931959|FG000|Treatment Period 1|Lost to Follow-up|0|||
42121348|NCT00539006|75931960|FG001|Treatment Period 1|Lost to Follow-up|0|||
42121349|NCT00539006|75931961|FG002|Treatment Period 1|Lost to Follow-up|1|||
42121350|NCT00539006|75931962|FG003|Treatment Period 1|Lost to Follow-up|0|||
42121351|NCT00539006|75931959|FG000|Treatment Period 1|Protocol Violation|0|||
42121352|NCT00539006|75931960|FG001|Treatment Period 1|Protocol Violation|0|||
42121353|NCT00539006|75931961|FG002|Treatment Period 1|Protocol Violation|1|||
42121354|NCT00539006|75931962|FG003|Treatment Period 1|Protocol Violation|0|||
42121355|NCT00539006|75931959|FG000|Treatment Period 1|Lack of Efficacy|0|||
42121356|NCT00539006|75931960|FG001|Treatment Period 1|Lack of Efficacy|0|||
42121357|NCT00539006|75931961|FG002|Treatment Period 1|Lack of Efficacy|0|||
42121358|NCT00539006|75931962|FG003|Treatment Period 1|Lack of Efficacy|1|||
42121359|NCT00539006|75931959|FG000|Washout|Adverse Event|2|||
42121360|NCT00539006|75931960|FG001|Washout|Adverse Event|1|||
42121361|NCT00539006|75931961|FG002|Washout|Adverse Event|0|||
42121362|NCT00539006|75931962|FG003|Washout|Adverse Event|0|||
42121363|NCT00539006|75931959|FG000|Washout|Protocol Violation|1|||
42121364|NCT00539006|75931960|FG001|Washout|Protocol Violation|1|||
42121365|NCT00539006|75931961|FG002|Washout|Protocol Violation|0|||
42121366|NCT00539006|75931962|FG003|Washout|Protocol Violation|0|||
42121367|NCT00539006|75931959|FG000|Washout|Withdrawal by Subject|0|||
42027403|NCT01128738|75835633|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
42027404|NCT01128738|75835632|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
42027405|NCT01128738|75835633|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
42027406|NCT01128738|75835632|FG000|Second TP|Lost to Follow-up|0|||
42027407|NCT01128738|75835633|FG001|Second TP|Lost to Follow-up|1|||
42027408|NCT01128738|75835632|FG000|Second TP|Withdrawal by Subject|0|||
42027409|NCT01128738|75835633|FG001|Second TP|Withdrawal by Subject|2|||
42027410|NCT01143090|75835640|FG000|Overall Study|Lack of Efficacy|2|||
42027411|NCT01143090|75835640|FG000|Overall Study|Adverse Event|17|||
42027412|NCT01143090|75835640|FG000|Overall Study|Lost to Follow-up|9|||
42027413|NCT01143090|75835640|FG000|Overall Study|Protocol Violation|2|||
42027414|NCT01143090|75835640|FG000|Overall Study|Withdrawal by Subject|18|||
42027415|NCT01143090|75835640|FG000|Overall Study|Non-compliance with study drug|1|||
42027416|NCT01143090|75835640|FG000|Overall Study|Failure to meet eligibility criteria|1|||
42027417|NCT01143090|75835640|FG000|Overall Study|Administrative|1|||
42027418|NCT01165554|75835644|FG000|Overall Study|Withdrawal by Subject|23|||
42027419|NCT01218308|75835653|FG000|Overall Study|Adverse Event|1|||
42027420|NCT01218308|75835654|FG001|Overall Study|Adverse Event|2|||
42027421|NCT01218308|75835653|FG000|Overall Study|Protocol Violation|0|||
42027422|NCT01218308|75835654|FG001|Overall Study|Protocol Violation|2|||
42121368|NCT00539006|75931960|FG001|Washout|Withdrawal by Subject|2|||
42121369|NCT00539006|75931961|FG002|Washout|Withdrawal by Subject|0|||
42121370|NCT00539006|75931962|FG003|Washout|Withdrawal by Subject|0|||
42121371|NCT00539006|75931959|FG000|Washout|Failed to meet continuation criteria|16|||
42121372|NCT00539006|75931960|FG001|Washout|Failed to meet continuation criteria|5|||
42121373|NCT00539006|75931961|FG002|Washout|Failed to meet continuation criteria|14|||
42121374|NCT00539006|75931962|FG003|Washout|Failed to meet continuation criteria|6|||
42121375|NCT00539006|75931959|FG000|Washout|Other|1|||
42121376|NCT00539006|75931960|FG001|Washout|Other|1|||
42121377|NCT00539006|75931961|FG002|Washout|Other|2|||
42121378|NCT00539006|75931962|FG003|Washout|Other|3|||
42027423|NCT01218308|75835653|FG000|Overall Study|Withdrawal by Subject|61|||
42027424|NCT01218308|75835654|FG001|Overall Study|Withdrawal by Subject|64|||
42121379|NCT00539006|75931959|FG000|Treatment Period 2|Protocol Violation|1|||
42121380|NCT00539006|75931960|FG001|Treatment Period 2|Protocol Violation|0|||
42121381|NCT00539006|75931961|FG002|Treatment Period 2|Protocol Violation|0|||
42121382|NCT00539006|75931962|FG003|Treatment Period 2|Protocol Violation|0|||
42121383|NCT00539006|75931959|FG000|Treatment Period 2|Other|0|||
42121384|NCT00539006|75931960|FG001|Treatment Period 2|Other|1|||
42121385|NCT00539006|75931961|FG002|Treatment Period 2|Other|0|||
42121386|NCT00539006|75931962|FG003|Treatment Period 2|Other|0|||
42121387|NCT00537056|75931978|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
42121388|NCT00535262|75931984|FG000|Overall Study|No funding|3|||
42121389|NCT00074581|75931990|FG000|Overall Study|Death|15|||
42121390|NCT00074581|75931991|FG001|Overall Study|Death|16|||
42121391|NCT00074581|75931990|FG000|Overall Study|Withdrawal by Subject|50|||
42121392|NCT00074581|75931991|FG001|Overall Study|Withdrawal by Subject|49|||
42121393|NCT00074581|75931990|FG000|Overall Study|Unable to adhere to visit schedule|13|||
42121394|NCT00074581|75931991|FG001|Overall Study|Unable to adhere to visit schedule|14|||
42121395|NCT00074581|75931990|FG000|Overall Study|Relocated|14|||
42121396|NCT00074581|75931991|FG001|Overall Study|Relocated|9|||
42121397|NCT00074581|75931990|FG000|Overall Study|Were withdrawn by investigator|5|||
42121398|NCT00074581|75931991|FG001|Overall Study|Were withdrawn by investigator|2|||
42121399|NCT00074581|75931990|FG000|Overall Study|Lost to Follow-up|16|||
42121400|NCT00074581|75931991|FG001|Overall Study|Lost to Follow-up|11|||
42121401|NCT00074581|75931990|FG000|Overall Study|Ended relationship w. index participant|117|||
42121402|NCT00074581|75931991|FG001|Overall Study|Ended relationship w. index participant|106|||
42121403|NCT00074581|75931990|FG000|Overall Study|Other|14|||
42121404|NCT00074581|75931991|FG001|Overall Study|Other|19|||
42121405|NCT03895034|75931997|FG000|Overall Study|Lost to Follow-up|2|||
42121406|NCT00536978|75932001|FG000|Overall Study|Not eligible for Adback Infusion|22|||
42121407|NCT03809611|75932007|FG000|Overall Study|Withdrawal by Subject|1|||
42121408|NCT03809611|75932008|FG001|Overall Study|Withdrawal by Subject|1|||
42121409|NCT03807739|75932019|FG000|Overall Study|Adverse Event|1|||
42121410|NCT03807739|75932020|FG001|Overall Study|Adverse Event|0|||
42121411|NCT03807739|75932021|FG002|Overall Study|Adverse Event|0|||
42121412|NCT03807739|75932022|FG003|Overall Study|Adverse Event|0|||
42121413|NCT03807739|75932019|FG000|Overall Study|Withdrawal by Subject|1|||
42121414|NCT03807739|75932020|FG001|Overall Study|Withdrawal by Subject|0|||
42121415|NCT03807739|75932021|FG002|Overall Study|Withdrawal by Subject|0|||
42121416|NCT03807739|75932022|FG003|Overall Study|Withdrawal by Subject|0|||
42121417|NCT00536744|75932034|FG000|Overall Study|Adverse Event|13|||
42121418|NCT00536744|75932035|FG001|Overall Study|Adverse Event|10|||
42121419|NCT00536744|75932034|FG000|Overall Study|Death|2|||
42121420|NCT00536744|75932035|FG001|Overall Study|Death|1|||
42121421|NCT00536744|75932034|FG000|Overall Study|Physician Decision|3|||
42121422|NCT00536744|75932035|FG001|Overall Study|Physician Decision|1|||
42121423|NCT00536744|75932034|FG000|Overall Study|Lost to Follow-up|3|||
42121424|NCT00536744|75932035|FG001|Overall Study|Lost to Follow-up|5|||
42121425|NCT00536744|75932034|FG000|Overall Study|Withdrawal by Subject|7|||
42121426|NCT00536744|75932035|FG001|Overall Study|Withdrawal by Subject|8|||
42121427|NCT00536744|75932034|FG000|Overall Study|PI tried alternative treatment|1|||
42121428|NCT00536744|75932035|FG001|Overall Study|PI tried alternative treatment|3|||
42121429|NCT00536510|75932052|FG000|Overall Study|Adverse Event|27|||
42121430|NCT00536510|75932053|FG001|Overall Study|Adverse Event|4|||
42121431|NCT00536510|75932052|FG000|Overall Study|Lost to Follow-up|11|||
42121432|NCT00536510|75932053|FG001|Overall Study|Lost to Follow-up|8|||
42121433|NCT00536510|75932052|FG000|Overall Study|Protocol Violation|4|||
42121434|NCT00536510|75932053|FG001|Overall Study|Protocol Violation|5|||
42121435|NCT00536510|75932052|FG000|Overall Study|Withdrawal by Subject|16|||
42121436|NCT00536510|75932053|FG001|Overall Study|Withdrawal by Subject|9|||
42121437|NCT00536510|75932052|FG000|Overall Study|Flushing with Product|20|||
42121438|NCT00536510|75932053|FG001|Overall Study|Flushing with Product|0|||
42121439|NCT00536510|75932052|FG000|Overall Study|Laboratory Adverse Event|2|||
42121440|NCT00536510|75932053|FG001|Overall Study|Laboratory Adverse Event|1|||
42121441|NCT00536510|75932052|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
42121442|NCT00536510|75932053|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
42121443|NCT00398086|75932062|FG000|Overall Study|Unacceptable Toxicity|2|||
42121444|NCT00398086|75932063|FG001|Overall Study|Unacceptable Toxicity|8|||
42121445|NCT00398086|75932064|FG002|Overall Study|Unacceptable Toxicity|2|||
42121446|NCT00398086|75932062|FG000|Overall Study|Adverse Event|1|||
42121447|NCT00398086|75932063|FG001|Overall Study|Adverse Event|4|||
42121448|NCT00398086|75932064|FG002|Overall Study|Adverse Event|0|||
42121449|NCT00398086|75932062|FG000|Overall Study|Physician Decision|1|||
42121450|NCT00398086|75932063|FG001|Overall Study|Physician Decision|4|||
42121451|NCT00398086|75932064|FG002|Overall Study|Physician Decision|0|||
42121452|NCT00398086|75932062|FG000|Overall Study|Withdrawal by Subject|5|||
42121453|NCT00398086|75932063|FG001|Overall Study|Withdrawal by Subject|7|||
42121454|NCT00398086|75932064|FG002|Overall Study|Withdrawal by Subject|0|||
42121455|NCT00536198|75932074|FG000|Overall Study|Lost to Follow-up|15|||
42121456|NCT00536198|75932075|FG001|Overall Study|Lost to Follow-up|14|||
42121457|NCT00536198|75932074|FG000|Overall Study|Withdrawal by Subject|16|||
42121458|NCT00536198|75932075|FG001|Overall Study|Withdrawal by Subject|12|||
42121459|NCT00536198|75932074|FG000|Overall Study|Adverse Event|2|||
42121460|NCT00536198|75932075|FG001|Overall Study|Adverse Event|2|||
42121461|NCT00536198|75932074|FG000|Overall Study|Rescue|3|||
42121462|NCT00536198|75932075|FG001|Overall Study|Rescue|9|||
42121463|NCT00536198|75932074|FG000|Overall Study|Pregnancy|1|||
42121464|NCT00536198|75932075|FG001|Overall Study|Pregnancy|1|||
42121465|NCT00536198|75932074|FG000|Overall Study|Protocol Violation|0|||
42121466|NCT00536198|75932075|FG001|Overall Study|Protocol Violation|1|||
42121467|NCT00393484|75932085|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
42121468|NCT00393484|75932086|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
42121469|NCT00393484|75932085|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
42121470|NCT00393484|75932086|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
42121471|NCT00393484|75932085|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
42121472|NCT00393484|75932086|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
42121473|NCT00393484|75932085|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
42121474|NCT00393484|75932086|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
42121475|NCT00393484|75932085|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
42121476|NCT00393484|75932086|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
42121477|NCT00393484|75932085|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
42121478|NCT00393484|75932086|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
42121479|NCT00393484|75932085|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
42121480|NCT00393484|75932086|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
42121481|NCT00393484|75932085|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
42121482|NCT00393484|75932086|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
42121483|NCT00393484|75932085|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
41965230|NCT00244374|75764669|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
41965231|NCT00244374|75764670|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
41965232|NCT00244374|75764671|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
41965233|NCT00244374|75764672|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
41965234|NCT00244374|75764668|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
41965235|NCT00244374|75764669|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
41965236|NCT00244374|75764670|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
41965237|NCT00244374|75764671|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
41965238|NCT00244374|75764672|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
41965239|NCT00244374|75764668|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
41965240|NCT00244374|75764669|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
41965241|NCT00244374|75764670|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
41965242|NCT00244374|75764671|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
41965243|NCT00244374|75764672|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
41965244|NCT00242658|75764690|FG000|Overall Study|Lost to Follow-up|22|||
41965245|NCT00242658|75764691|FG001|Overall Study|Lost to Follow-up|19|||
41965246|NCT00242580|75764700|FG000|Overall Study|Adverse Event|3|||
41965247|NCT00242580|75764701|FG001|Overall Study|Adverse Event|0|||
41965248|NCT00242580|75764702|FG002|Overall Study|Adverse Event|2|||
41965249|NCT00242580|75764700|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
41965250|NCT00242580|75764701|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
41965251|NCT00242580|75764702|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
41965252|NCT00242580|75764700|FG000|Overall Study|Protocol Violation|0|||
41965253|NCT00242580|75764701|FG001|Overall Study|Protocol Violation|0|||
41965254|NCT00242580|75764702|FG002|Overall Study|Protocol Violation|1|||
41965255|NCT00242580|75764700|FG000|Overall Study|Subject withdrew consent|2|||
41965256|NCT00242580|75764701|FG001|Overall Study|Subject withdrew consent|2|||
42027425|NCT01218308|75835653|FG000|Overall Study|Lost to Follow-up|27|||
42027426|NCT01218308|75835654|FG001|Overall Study|Lost to Follow-up|31|||
42027427|NCT01218308|75835653|FG000|Overall Study|Other|14|||
42027428|NCT01218308|75835654|FG001|Overall Study|Other|21|||
42027429|NCT01165320|75835662|FG000|Overall Study|Clinical adverse experience|2|||
42027430|NCT01165320|75835663|FG001|Overall Study|Clinical adverse experience|1|||
42027431|NCT01165320|75835664|FG002|Overall Study|Clinical adverse experience|0|||
42027432|NCT01165320|75835662|FG000|Overall Study|Laboratory adverse experience|1|||
42027433|NCT01165320|75835663|FG001|Overall Study|Laboratory adverse experience|0|||
42121484|NCT00393484|75932086|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
42121485|NCT00393484|75932085|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
42121486|NCT00393484|75932086|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
42121487|NCT00667823|75932094|FG000|Overall Study|Lost to Follow-up|5|||
42121488|NCT00667823|75932094|FG000|Overall Study|Adverse Event|7|||
42121489|NCT00667823|75932094|FG000|Overall Study|Death|182|||
42121490|NCT00667823|75932094|FG000|Overall Study|Withdrawal by Subject|12|||
42027434|NCT01165320|75835664|FG002|Overall Study|Laboratory adverse experience|0|||
42121491|NCT00667823|75932094|FG000|Overall Study|Other|8|||
42121492|NCT00667823|75932094|FG000|Overall Study|Missing (completion page missing)|2|||
42121493|NCT00397930|75932100|FG000|Overall Study|Personal reasons|14|||
42121494|NCT00397930|75932101|FG001|Overall Study|Personal reasons|8|||
42121495|NCT00397930|75932100|FG000|Overall Study|Other medical|9|||
41965257|NCT00242580|75764702|FG002|Overall Study|Subject withdrew consent|5|||
41965258|NCT00242580|75764700|FG000|Overall Study|Lost to Follow-up|0|||
42121496|NCT00397930|75932101|FG001|Overall Study|Other medical|4|||
42121497|NCT00397930|75932100|FG000|Overall Study|Unknown reasons|9|||
42121498|NCT00397930|75932101|FG001|Overall Study|Unknown reasons|14|||
42121499|NCT00397930|75932100|FG000|Overall Study|Noncompliant|3|||
42121500|NCT00397930|75932101|FG001|Overall Study|Noncompliant|2|||
42121501|NCT00397930|75932100|FG000|Overall Study|Too time-consuming|2|||
42121502|NCT00397930|75932101|FG001|Overall Study|Too time-consuming|9|||
42121503|NCT00397930|75932100|FG000|Overall Study|Started own yoga program|1|||
42121504|NCT00397930|75932101|FG001|Overall Study|Started own yoga program|1|||
42121505|NCT00397930|75932100|FG000|Overall Study|Did not want to be in control group|0|||
42121506|NCT00397930|75932101|FG001|Overall Study|Did not want to be in control group|1|||
42121507|NCT00397930|75932100|FG000|Overall Study|Withdrawal by Subject|0|||
42121508|NCT00397930|75932101|FG001|Overall Study|Withdrawal by Subject|8|||
42121509|NCT00397930|75932100|FG000|Overall Study|Missing data|0|||
42121510|NCT00397930|75932101|FG001|Overall Study|Missing data|4|||
42121511|NCT00397540|75932109|FG000|Overall Study|short follow-up duration < 12 months|1|||
42121512|NCT00397540|75932110|FG001|Overall Study|short follow-up duration < 12 months|0|||
42121513|NCT00536120|75932119|FG000|Overall Study|Lost to Follow-up|1|||
42121514|NCT00536120|75932120|FG001|Overall Study|Lost to Follow-up|0|||
42121515|NCT00536120|75932119|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
42121516|NCT00536120|75932120|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
42121517|NCT00536120|75932119|FG000|Overall Study|Non-compliance|1|||
42121518|NCT00536120|75932120|FG001|Overall Study|Non-compliance|0|||
42121519|NCT00536120|75932119|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
42121520|NCT00536120|75932120|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
42121521|NCT00536120|75932119|FG000|Overall Study|Steroid Use|0|||
42121522|NCT00536120|75932120|FG001|Overall Study|Steroid Use|2|||
42121523|NCT00536120|75932119|FG000|Overall Study|Missed Study Visit|0|||
42121524|NCT00536120|75932120|FG001|Overall Study|Missed Study Visit|1|||
42121525|NCT00057811|75932128|FG000|Overall Study|Lack of Efficacy|1|||
42121526|NCT00057811|75932129|FG001|Overall Study|Lack of Efficacy|4|||
42121527|NCT00057811|75932128|FG000|Overall Study|Physician Decision|1|||
42121528|NCT00057811|75932129|FG001|Overall Study|Physician Decision|0|||
42121529|NCT00057811|75932128|FG000|Overall Study|Withdrawal by Subject|3|||
42121530|NCT00057811|75932129|FG001|Overall Study|Withdrawal by Subject|4|||
42121531|NCT00057811|75932128|FG000|Overall Study|Ineligible|4|||
42121532|NCT00057811|75932129|FG001|Overall Study|Ineligible|2|||
42121533|NCT00057811|75932128|FG000|Overall Study|Inevaluable|1|||
42121534|NCT00057811|75932129|FG001|Overall Study|Inevaluable|2|||
42121535|NCT02866682|75932142|FG000|Overall Study|Death|0|||
42121536|NCT02866682|75932143|FG001|Overall Study|Death|1|||
42121537|NCT02866682|75932142|FG000|Overall Study|Lost to Follow-up|0|||
42121538|NCT02866682|75932143|FG001|Overall Study|Lost to Follow-up|4|||
42121539|NCT02866682|75932142|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
42121540|NCT02866682|75932143|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
41965259|NCT00242580|75764701|FG001|Overall Study|Lost to Follow-up|3|||
41965260|NCT00242580|75764702|FG002|Overall Study|Lost to Follow-up|0|||
41965261|NCT00242580|75764700|FG000|Overall Study|Death|1|||
41965262|NCT00242580|75764701|FG001|Overall Study|Death|2|||
42121541|NCT02866682|75932142|FG000|Overall Study|Other|0|||
42121542|NCT02866682|75932143|FG001|Overall Study|Other|1|||
42121543|NCT00570713|75932160|FG000|Overall Study|Adverse Event|16|||
41965263|NCT00242580|75764702|FG002|Overall Study|Death|1|||
41965264|NCT00241644|75764714|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
41965265|NCT00241644|75764715|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
41965266|NCT00241644|75764716|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
42121544|NCT00570713|75932161|FG001|Overall Study|Adverse Event|9|||
41965267|NCT00241644|75764717|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
41965268|NCT00241644|75764714|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
42121545|NCT00570713|75932160|FG000|Overall Study|Death|7|||
42121546|NCT00570713|75932161|FG001|Overall Study|Death|7|||
42121547|NCT00570713|75932160|FG000|Overall Study|Lack of Efficacy|40|||
42121548|NCT00570713|75932161|FG001|Overall Study|Lack of Efficacy|49|||
42121549|NCT00570713|75932160|FG000|Overall Study|Physician Decision|2|||
42121550|NCT00570713|75932161|FG001|Overall Study|Physician Decision|2|||
42121551|NCT00570713|75932160|FG000|Overall Study|Withdrawal by Subject|3|||
41965269|NCT00241644|75764715|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
42121552|NCT00570713|75932161|FG001|Overall Study|Withdrawal by Subject|3|||
42121553|NCT00570713|75932160|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
42121554|NCT00570713|75932161|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
42121555|NCT00669617|75932171|FG000|Period 1|Withdrawal by Subject|0|||
41965270|NCT00241644|75764716|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
41965271|NCT00241644|75764717|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
41965272|NCT00241644|75764714|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
41965273|NCT00241644|75764715|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
41965274|NCT00241644|75764716|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
41965275|NCT00241644|75764717|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
41965276|NCT00241644|75764714|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
41965277|NCT00241644|75764715|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
41965278|NCT00241644|75764716|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
41965279|NCT00241644|75764717|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
41965280|NCT00241644|75764714|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
41965281|NCT00241644|75764715|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
41965282|NCT00241644|75764716|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
41965283|NCT00241644|75764717|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
41965284|NCT00241644|75764714|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
41965285|NCT00241644|75764715|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
41965286|NCT00241644|75764716|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
41965287|NCT00241644|75764717|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
41965288|NCT00241644|75764714|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
41965289|NCT00241644|75764715|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
41965290|NCT00241644|75764716|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
41965291|NCT00241644|75764717|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
41965292|NCT00241644|75764714|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
41965293|NCT00241644|75764715|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
41965294|NCT00241644|75764716|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
41965295|NCT00241644|75764717|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
41965296|NCT00241644|75764714|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
41965297|NCT00241644|75764715|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
41965298|NCT00241644|75764716|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
41965299|NCT00241644|75764717|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
41965300|NCT00241644|75764714|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
41965301|NCT00241644|75764715|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
41965302|NCT00241644|75764716|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
41965303|NCT00241644|75764717|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
41965304|NCT00241644|75764714|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
41965305|NCT00241644|75764715|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
41965306|NCT00241644|75764716|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
41965307|NCT00241644|75764717|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
41965308|NCT00241644|75764714|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
41965309|NCT00241644|75764715|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
41965310|NCT00241644|75764716|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
41965311|NCT00241644|75764717|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
41965312|NCT00241644|75764714|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
41965313|NCT00241644|75764715|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
41965314|NCT00241644|75764716|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
41965315|NCT00241644|75764717|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
41965316|NCT03804684|75764738|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
41965317|NCT03804684|75764739|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
41965318|NCT04295772|75764754|FG000|Overall Study|Protocol Violation|1|||
41965319|NCT04295772|75764755|FG001|Overall Study|Protocol Violation|0|||
41965320|NCT04295772|75764754|FG000|Overall Study|Ongoing for safety monitoring|14|||
41965321|NCT04295772|75764755|FG001|Overall Study|Ongoing for safety monitoring|1|||
41965322|NCT04295772|75764754|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
41965323|NCT04295772|75764755|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
41965324|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #1|24|||
41965325|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #1|0|||
41965326|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
41965327|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
41965328|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
41965329|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
41965330|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
41965331|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
41965332|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
41965333|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
41965334|NCT03888066|75764764|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
42121556|NCT00669617|75932172|FG001|Period 1|Withdrawal by Subject|0|||
42121557|NCT00669617|75932173|FG002|Period 1|Withdrawal by Subject|1|||
42121558|NCT00669617|75932174|FG003|Period 1|Withdrawal by Subject|0|||
42121559|NCT00669617|75932175|FG004|Period 1|Withdrawal by Subject|0|||
42121560|NCT00669617|75932171|FG000|Period 1|Protocol Deviation|0|||
42121561|NCT00669617|75932172|FG001|Period 1|Protocol Deviation|0|||
42121562|NCT00669617|75932173|FG002|Period 1|Protocol Deviation|0|||
42121563|NCT00669617|75932174|FG003|Period 1|Protocol Deviation|0|||
42121564|NCT00669617|75932175|FG004|Period 1|Protocol Deviation|1|||
42121565|NCT00669617|75932171|FG000|Period 3|Lost to Follow-up|1|||
41965335|NCT03888066|75764765|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
41965336|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
41965337|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
41965338|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
41965339|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
41965340|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
41965341|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
41965342|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
41965343|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
41965344|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #2|5|||
41965345|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #2|0|||
41965346|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
41965347|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
41965348|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
41965349|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
41965350|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
41965351|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
41965352|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #3|11|||
41965353|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #3|0|||
41965354|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
41965355|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
41965356|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
41965357|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
41965358|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
41965359|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
41965360|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #4|3|||
41965361|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #4|0|||
41965362|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
41965363|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
41965364|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
41965365|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
41965366|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
41965367|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
41965368|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
41965369|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
41965370|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
41965371|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
41965372|NCT03888066|75764764|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
41965373|NCT03888066|75764765|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
41965374|NCT03888066|75764764|FG000|Run-in Phase|AE (Adverse Event)|17|||
41965375|NCT03888066|75764765|FG001|Run-in Phase|AE (Adverse Event)|0|||
41965376|NCT03888066|75764764|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
41965377|NCT03888066|75764765|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
41965378|NCT03888066|75764764|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
41965379|NCT03888066|75764765|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
41965380|NCT03888066|75764764|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
41965381|NCT03888066|75764765|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
41965382|NCT03888066|75764764|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
41965383|NCT03888066|75764765|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
42121566|NCT00669617|75932172|FG001|Period 3|Lost to Follow-up|0|||
42121567|NCT00669617|75932173|FG002|Period 3|Lost to Follow-up|0|||
42121568|NCT00669617|75932174|FG003|Period 3|Lost to Follow-up|0|||
42121569|NCT00669617|75932175|FG004|Period 3|Lost to Follow-up|0|||
41965384|NCT03888066|75764764|FG000|Run-in Phase|Withdrawal by Subject|43|||
41965385|NCT03888066|75764765|FG001|Run-in Phase|Withdrawal by Subject|0|||
41965386|NCT03888066|75764764|FG000|Run-in Phase|AE; Physician Decision|1|||
41965387|NCT03888066|75764765|FG001|Run-in Phase|AE; Physician Decision|0|||
41965388|NCT03888066|75764764|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
41965389|NCT03888066|75764765|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
41965390|NCT03888066|75764764|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
42121570|NCT00535730|75932189|FG000|Overall Study|Adverse Event|1|||
42121571|NCT00535730|75932190|FG001|Overall Study|Adverse Event|1|||
42121572|NCT00535730|75932189|FG000|Overall Study|Lost to Follow-up|0|||
42121573|NCT00535730|75932190|FG001|Overall Study|Lost to Follow-up|1|||
42121574|NCT00535730|75932189|FG000|Overall Study|Physician Decision|0|||
42121575|NCT00535730|75932190|FG001|Overall Study|Physician Decision|1|||
42121576|NCT00535730|75932189|FG000|Overall Study|Protocol Violation|1|||
42121577|NCT00535730|75932190|FG001|Overall Study|Protocol Violation|0|||
42121578|NCT00535730|75932189|FG000|Overall Study|Withdrawal by Subject|0|||
42121579|NCT00535730|75932190|FG001|Overall Study|Withdrawal by Subject|4|||
42121580|NCT00666965|75932201|FG000|Overall Study|Adverse Event|0|||
42121581|NCT00666965|75932202|FG001|Overall Study|Adverse Event|2|||
42121582|NCT00666965|75932203|FG002|Overall Study|Adverse Event|1|||
42121583|NCT00666965|75932204|FG003|Overall Study|Adverse Event|9|||
42121584|NCT00666965|75932201|FG000|Overall Study|Lack of Efficacy|1|||
42121585|NCT00666965|75932202|FG001|Overall Study|Lack of Efficacy|1|||
42121586|NCT00666965|75932203|FG002|Overall Study|Lack of Efficacy|0|||
42121587|NCT00666965|75932204|FG003|Overall Study|Lack of Efficacy|0|||
42121588|NCT00666965|75932201|FG000|Overall Study|Protocol Violation|0|||
42121589|NCT00666965|75932202|FG001|Overall Study|Protocol Violation|0|||
42121590|NCT00666965|75932203|FG002|Overall Study|Protocol Violation|0|||
42121591|NCT00666965|75932204|FG003|Overall Study|Protocol Violation|2|||
42121592|NCT00666965|75932201|FG000|Overall Study|Discontinuation criteria|2|||
42121593|NCT00666965|75932202|FG001|Overall Study|Discontinuation criteria|1|||
42121594|NCT00666965|75932203|FG002|Overall Study|Discontinuation criteria|1|||
42121595|NCT00666965|75932204|FG003|Overall Study|Discontinuation criteria|2|||
42121596|NCT00666965|75932201|FG000|Overall Study|Withdrawal by Subject|0|||
42121597|NCT00666965|75932202|FG001|Overall Study|Withdrawal by Subject|0|||
42121598|NCT00666965|75932203|FG002|Overall Study|Withdrawal by Subject|0|||
42121599|NCT00666965|75932204|FG003|Overall Study|Withdrawal by Subject|2|||
42121600|NCT03889886|75932218|FG000|Overall Study|Other|0|||
42121601|NCT03889886|75932219|FG001|Overall Study|Other|1|||
42121602|NCT03889886|75932220|FG002|Overall Study|Other|0|||
42121603|NCT03889886|75932221|FG003|Overall Study|Other|1|||
42121604|NCT03889886|75932218|FG000|Overall Study|Withdrawal by Subject|0|||
41965391|NCT03888066|75764765|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
41965392|NCT03888066|75764764|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
41965393|NCT03888066|75764765|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
41965394|NCT03888066|75764764|FG000|Run-in Phase|Death|1|||
41965395|NCT03888066|75764765|FG001|Run-in Phase|Death|0|||
41965396|NCT03888066|75764764|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
41965397|NCT03888066|75764765|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
41965398|NCT03888066|75764764|FG000|Run-in Phase|Physician Decision|1|||
41965399|NCT03888066|75764765|FG001|Run-in Phase|Physician Decision|0|||
41965400|NCT03888066|75764764|FG000|Run-in Phase|Protocol Violation|13|||
41965401|NCT03888066|75764765|FG001|Run-in Phase|Protocol Violation|0|||
41965402|NCT03888066|75764764|FG000|Run-in Phase|Sponsor Request|34|||
41965403|NCT03888066|75764765|FG001|Run-in Phase|Sponsor Request|0|||
41965404|NCT03888066|75764764|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
41965405|NCT03888066|75764765|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
41965406|NCT03888066|75764764|FG000|Run-in Phase|Withdrawal Of Consent|1|||
42121605|NCT03889886|75932219|FG001|Overall Study|Withdrawal by Subject|0|||
42121606|NCT03889886|75932220|FG002|Overall Study|Withdrawal by Subject|1|||
41965407|NCT03888066|75764765|FG001|Run-in Phase|Withdrawal Of Consent|0|||
41965408|NCT03888066|75764764|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
41965409|NCT03888066|75764765|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
41965410|NCT03888066|75764764|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
42121607|NCT03889886|75932221|FG003|Overall Study|Withdrawal by Subject|0|||
42121608|NCT03889886|75932218|FG000|Overall Study|Adverse Event|0|||
42121609|NCT03889886|75932219|FG001|Overall Study|Adverse Event|0|||
42121610|NCT03889886|75932220|FG002|Overall Study|Adverse Event|0|||
42210364|NCT03288714|76025138|FG000|Overall Study|Adverse Event|1|||
41965411|NCT03888066|75764765|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
41965412|NCT03888066|75764764|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
41965413|NCT03888066|75764765|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
41965414|NCT03888066|75764764|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
41965415|NCT03888066|75764765|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
42121611|NCT03889886|75932221|FG003|Overall Study|Adverse Event|6|||
42121612|NCT03888482|75932233|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
41965416|NCT03888066|75764764|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
41965417|NCT03888066|75764765|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
41965418|NCT03888066|75764764|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
41965419|NCT03888066|75764765|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
41965420|NCT03888066|75764764|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
41965421|NCT03888066|75764765|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
41965422|NCT03888066|75764764|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
41965423|NCT03888066|75764765|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
41965424|NCT03888066|75764764|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
41965425|NCT03888066|75764765|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
41965426|NCT03888066|75764764|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
41965427|NCT03888066|75764765|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
41965428|NCT03888066|75764764|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
42027435|NCT01165320|75835662|FG000|Overall Study|Lack of Efficacy|0|||
42027436|NCT01165320|75835663|FG001|Overall Study|Lack of Efficacy|2|||
42027437|NCT01165320|75835664|FG002|Overall Study|Lack of Efficacy|0|||
42027438|NCT01165320|75835662|FG000|Overall Study|Reason unknown|0|||
42027439|NCT01165320|75835663|FG001|Overall Study|Reason unknown|1|||
42027440|NCT01165320|75835664|FG002|Overall Study|Reason unknown|0|||
42027441|NCT01217606|75835672|FG000|Initial Treatment Phase|Other Reasons|0|||
42027442|NCT01217606|75835673|FG001|Initial Treatment Phase|Other Reasons|2|||
42027443|NCT01217606|75835672|FG000|Initial Treatment Phase|Protocol Violation|3|||
42027444|NCT01217606|75835673|FG001|Initial Treatment Phase|Protocol Violation|2|||
42027445|NCT01217606|75835672|FG000|Initial Treatment Phase|Personal Reasons|0|||
42027446|NCT01217606|75835673|FG001|Initial Treatment Phase|Personal Reasons|2|||
42027447|NCT01217606|75835672|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
42027448|NCT01217606|75835673|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
42027449|NCT01217606|75835672|FG000|Initial Treatment Phase|Adverse Event|10|||
42027450|NCT01217606|75835673|FG001|Initial Treatment Phase|Adverse Event|6|||
42027451|NCT01217606|75835672|FG000|9-Month Masked Extension|Adverse Event|3|||
42027452|NCT01217606|75835673|FG001|9-Month Masked Extension|Adverse Event|6|||
42027453|NCT01217606|75835672|FG000|9-Month Masked Extension|Other Reasons|4|||
42027454|NCT01217606|75835673|FG001|9-Month Masked Extension|Other Reasons|4|||
42027455|NCT01217606|75835672|FG000|9-Month Masked Extension|Personal Reasons|2|||
42027456|NCT01217606|75835673|FG001|9-Month Masked Extension|Personal Reasons|1|||
42027457|NCT01217606|75835672|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
42027458|NCT01217606|75835673|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
42027459|NCT01217606|75835672|FG000|9-Month Masked Extension|Pregnancy|1|||
42027460|NCT01217606|75835673|FG001|9-Month Masked Extension|Pregnancy|0|||
42027461|NCT01217606|75835672|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
42027462|NCT01217606|75835673|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
42027463|NCT01128114|75835679|FG000|Overall Study|Treatment Withdrawn|6|||
42027464|NCT01128114|75835679|FG000|Overall Study|Screening Failed|2|||
42027465|NCT01217060|75835683|FG000|Overall Study|Withdrawal by Subject|1|||
42027466|NCT04816669|75835691|FG000|Part 1|Adverse Event|1|||
42027467|NCT04816669|75835692|FG001|Part 1|Adverse Event|1|||
42027468|NCT04816669|75835693|FG002|Part 1|Adverse Event|0|||
42027469|NCT04816669|75835694|FG003|Part 1|Adverse Event|0|||
42027470|NCT04816669|75835691|FG000|Part 1|Lost to Follow-up|2|||
42027471|NCT04816669|75835692|FG001|Part 1|Lost to Follow-up|2|||
42027472|NCT04816669|75835693|FG002|Part 1|Lost to Follow-up|0|||
42027473|NCT04816669|75835694|FG003|Part 1|Lost to Follow-up|0|||
42027474|NCT04816669|75835691|FG000|Part 1|Protocol Violation|0|||
42027475|NCT04816669|75835692|FG001|Part 1|Protocol Violation|1|||
42027476|NCT04816669|75835693|FG002|Part 1|Protocol Violation|0|||
42027477|NCT04816669|75835694|FG003|Part 1|Protocol Violation|0|||
42027478|NCT04816669|75835691|FG000|Part 1|Withdrawal by Subject|1|||
42027479|NCT04816669|75835692|FG001|Part 1|Withdrawal by Subject|2|||
42121613|NCT03888482|75932234|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
42027480|NCT04816669|75835693|FG002|Part 1|Withdrawal by Subject|0|||
42027481|NCT04816669|75835694|FG003|Part 1|Withdrawal by Subject|0|||
42027482|NCT04816669|75835691|FG000|Part 2|Other|0|||
42121614|NCT03888482|75932233|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
42121615|NCT03888482|75932234|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
41965429|NCT03888066|75764765|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
41965430|NCT03888066|75764764|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
41965431|NCT03888066|75764765|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
41965432|NCT01049334|75764774|FG000|Overall Study|Withdrawal by Subject|5|||
42027483|NCT04816669|75835692|FG001|Part 2|Other|0|||
41965433|NCT01049334|75764775|FG001|Overall Study|Withdrawal by Subject|3|||
42027484|NCT04816669|75835693|FG002|Part 2|Other|1|||
42027485|NCT04816669|75835694|FG003|Part 2|Other|0|||
42027486|NCT04816669|75835691|FG000|Part 2|Withdrawal by Subject|0|||
42027487|NCT04816669|75835692|FG001|Part 2|Withdrawal by Subject|0|||
42027488|NCT04816669|75835693|FG002|Part 2|Withdrawal by Subject|0|||
42027489|NCT04816669|75835694|FG003|Part 2|Withdrawal by Subject|1|||
42121616|NCT00667355|75932242|FG000|Overall Study|Adverse Event|5|||
42121617|NCT00667355|75932242|FG000|Overall Study|Lost to Follow-up|1|||
42121618|NCT00667355|75932242|FG000|Overall Study|Other reason was not specified|5|||
42121619|NCT00532844|75932248|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
42121620|NCT00532844|75932249|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
42121621|NCT00532844|75932248|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
42121622|NCT00532844|75932249|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
42121623|NCT00532844|75932248|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
42121624|NCT00532844|75932249|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
42121625|NCT00532844|75932248|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
42121626|NCT00532844|75932249|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
42121627|NCT00532844|75932248|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
42121628|NCT00532844|75932249|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
42121629|NCT00666263|75932277|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
42121630|NCT00666263|75932278|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
42121631|NCT00666263|75932277|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
42121632|NCT00666263|75932278|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
42121633|NCT00666263|75932277|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
42121634|NCT00666263|75932278|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
42121635|NCT00667277|75932323|FG000|Overall Study|Withdrawal by Subject|2|||
42121636|NCT00534638|75932329|FG000|Overall Study|Withdrawal by Subject|3|||
42121637|NCT00534638|75932330|FG001|Overall Study|Withdrawal by Subject|4|||
42121638|NCT00534638|75932329|FG000|Overall Study|Migrated/moved from study area|13|||
42121639|NCT00534638|75932330|FG001|Overall Study|Migrated/moved from study area|11|||
42121640|NCT00534638|75932329|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
42121641|NCT00534638|75932330|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
42121642|NCT00534638|75932329|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
42121643|NCT00534638|75932330|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
42121644|NCT00534638|75932329|FG000|Overall Study|Other|1685|||
41965434|NCT01049334|75764774|FG000|Overall Study|Adverse Event|2|||
41965435|NCT01049334|75764775|FG001|Overall Study|Adverse Event|3|||
41965436|NCT01049334|75764774|FG000|Overall Study|Physician Decision|2|||
41965437|NCT01049334|75764775|FG001|Overall Study|Physician Decision|0|||
41965438|NCT01049334|75764774|FG000|Overall Study|Protocol Violation|0|||
41965439|NCT01049334|75764775|FG001|Overall Study|Protocol Violation|1|||
41965440|NCT01048944|75764785|FG000|Overall Study|Protocol Violation|8|||
41965441|NCT01048944|75764786|FG001|Overall Study|Protocol Violation|10|||
41965442|NCT01048944|75764787|FG002|Overall Study|Protocol Violation|10|||
41965443|NCT01048944|75764788|FG003|Overall Study|Protocol Violation|2|||
41965444|NCT01048866|75764800|FG000|Overall Study|Adverse Event|1|||
41965445|NCT01048866|75764801|FG001|Overall Study|Adverse Event|0|||
41965446|NCT01048866|75764800|FG000|Overall Study|Protocol Violation|1|||
41965447|NCT01048866|75764801|FG001|Overall Study|Protocol Violation|0|||
41965448|NCT01048866|75764800|FG000|Overall Study|Physician Decision|1|||
41965449|NCT01048866|75764801|FG001|Overall Study|Physician Decision|0|||
41965450|NCT01048866|75764800|FG000|Overall Study|Withdrawal by Subject|0|||
41965451|NCT01048866|75764801|FG001|Overall Study|Withdrawal by Subject|2|||
41965452|NCT01048866|75764800|FG000|Overall Study|Lost to Follow-up|0|||
41965453|NCT01048866|75764801|FG001|Overall Study|Lost to Follow-up|2|||
41965454|NCT01048866|75764800|FG000|Overall Study|Other|1|||
41965455|NCT01048866|75764801|FG001|Overall Study|Other|1|||
41965456|NCT01048788|75764810|FG000|Overall Study|Adverse Event|5|||
41965457|NCT01048788|75764811|FG001|Overall Study|Adverse Event|1|||
41965458|NCT01048788|75764812|FG002|Overall Study|Adverse Event|1|||
42121645|NCT00534638|75932330|FG001|Overall Study|Other|902|||
42121646|NCT00662129|75932341|FG000|Overall Study|Protocol Violation|1|||
42121647|NCT00662129|75932341|FG000|Overall Study|Cancel prior to beginning treatment|1|||
42121648|NCT00662129|75932341|FG000|Overall Study|Ineligible|1|||
42121649|NCT00664859|75932348|FG000|Overall Study|Adverse Event|2|||
42121650|NCT00664859|75932349|FG001|Overall Study|Adverse Event|1|||
42121651|NCT00664859|75932350|FG002|Overall Study|Adverse Event|3|||
42121652|NCT00664859|75932348|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
42301120|NCT01365091|76136404|FG001|Period 2|Adverse Event|0|||
41965459|NCT01048788|75764810|FG000|Overall Study|Lack of Efficacy|0|||
41965460|NCT01048788|75764811|FG001|Overall Study|Lack of Efficacy|0|||
41965461|NCT01048788|75764812|FG002|Overall Study|Lack of Efficacy|1|||
41965462|NCT01048788|75764810|FG000|Overall Study|Withdrawal by Subject|0|||
41965463|NCT01048788|75764811|FG001|Overall Study|Withdrawal by Subject|1|||
41965464|NCT01048788|75764812|FG002|Overall Study|Withdrawal by Subject|0|||
41965465|NCT01048242|75764822|FG000|Overall Study|See study flow chart|4|||
41965466|NCT01048242|75764823|FG001|Overall Study|See study flow chart|2|||
41965467|NCT01047306|75764831|FG000|Overall Study|Withdrawal by Subject|2|||
41965468|NCT01047306|75764832|FG001|Overall Study|Withdrawal by Subject|0|||
41965469|NCT01047306|75764831|FG000|Overall Study|Lost to Follow-up|1|||
41965470|NCT01047306|75764832|FG001|Overall Study|Lost to Follow-up|0|||
42301121|NCT01365091|76136405|FG002|Period 2|Adverse Event|1|||
42121653|NCT00664859|75932349|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
42121654|NCT00664859|75932350|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
42121655|NCT00664859|75932348|FG000|Overall Study|Noncompliance with protocol|1|||
42121656|NCT00664859|75932349|FG001|Overall Study|Noncompliance with protocol|0|||
42121657|NCT00664859|75932350|FG002|Overall Study|Noncompliance with protocol|4|||
42121658|NCT00664859|75932348|FG000|Overall Study|Laboratory abnormality|2|||
42121659|NCT00664859|75932349|FG001|Overall Study|Laboratory abnormality|1|||
42121660|NCT00664859|75932350|FG002|Overall Study|Laboratory abnormality|4|||
42121661|NCT00664859|75932348|FG000|Overall Study|Withdrawal by Subject|4|||
42121662|NCT00664859|75932349|FG001|Overall Study|Withdrawal by Subject|1|||
42121663|NCT00664859|75932350|FG002|Overall Study|Withdrawal by Subject|3|||
42121664|NCT00664859|75932348|FG000|Overall Study|Lost to Follow-up|2|||
42121665|NCT00664859|75932349|FG001|Overall Study|Lost to Follow-up|2|||
42121666|NCT00664859|75932350|FG002|Overall Study|Lost to Follow-up|1|||
42121667|NCT00664859|75932348|FG000|Overall Study|Other|0|||
42121668|NCT00664859|75932349|FG001|Overall Study|Other|1|||
42121669|NCT00664859|75932350|FG002|Overall Study|Other|2|||
42121670|NCT00570401|75932358|FG000|Overall Study|Adverse Event|2|||
42121671|NCT00532298|75932368|FG000|Overall Study|Adverse Event|1|||
42121672|NCT00532298|75932369|FG001|Overall Study|Adverse Event|0|||
42121673|NCT00532298|75932370|FG002|Overall Study|Adverse Event|0|||
42121674|NCT00532298|75932371|FG003|Overall Study|Adverse Event|0|||
42121675|NCT00532298|75932372|FG004|Overall Study|Adverse Event|1|||
42121676|NCT00532298|75932373|FG005|Overall Study|Adverse Event|1|||
42121677|NCT00532298|75932368|FG000|Overall Study|Lost to Follow-up|1|||
42121678|NCT00532298|75932369|FG001|Overall Study|Lost to Follow-up|1|||
42121679|NCT00532298|75932370|FG002|Overall Study|Lost to Follow-up|1|||
42121680|NCT00532298|75932371|FG003|Overall Study|Lost to Follow-up|0|||
42121681|NCT00532298|75932372|FG004|Overall Study|Lost to Follow-up|0|||
42121682|NCT00532298|75932373|FG005|Overall Study|Lost to Follow-up|1|||
42121683|NCT00410410|75932393|FG000|Induction Period (IP)|Death|1|||
42121684|NCT00410410|75932394|FG001|Induction Period (IP)|Death|0|||
42121685|NCT00410410|75932395|FG002|Induction Period (IP)|Death|0|||
42121686|NCT00410410|75932396|FG003|Induction Period (IP)|Death|0|||
42121687|NCT00410410|75932397|FG004|Induction Period (IP)|Death|0|||
42121688|NCT00410410|75932398|FG005|Induction Period (IP)|Death|0|||
42121689|NCT00410410|75932399|FG006|Induction Period (IP)|Death|0|||
42121690|NCT00410410|75932400|FG007|Induction Period (IP)|Death|0|||
42121691|NCT00410410|75932401|FG008|Induction Period (IP)|Death|0|||
42121692|NCT00410410|75932393|FG000|Induction Period (IP)|Adverse Event|3|||
42121693|NCT00410410|75932394|FG001|Induction Period (IP)|Adverse Event|4|||
42121694|NCT00410410|75932395|FG002|Induction Period (IP)|Adverse Event|2|||
42121695|NCT00410410|75932396|FG003|Induction Period (IP)|Adverse Event|4|||
42121696|NCT00410410|75932397|FG004|Induction Period (IP)|Adverse Event|1|||
41965471|NCT01046682|75764842|FG000|Overall Study|Adverse Event|2|||
42121697|NCT00410410|75932398|FG005|Induction Period (IP)|Adverse Event|0|||
42121698|NCT00410410|75932399|FG006|Induction Period (IP)|Adverse Event|0|||
42121699|NCT00410410|75932400|FG007|Induction Period (IP)|Adverse Event|0|||
42121700|NCT00410410|75932401|FG008|Induction Period (IP)|Adverse Event|0|||
42121701|NCT00410410|75932393|FG000|Induction Period (IP)|Lack of Efficacy|26|||
42121702|NCT00410410|75932394|FG001|Induction Period (IP)|Lack of Efficacy|24|||
42121703|NCT00410410|75932395|FG002|Induction Period (IP)|Lack of Efficacy|8|||
42121704|NCT00410410|75932396|FG003|Induction Period (IP)|Lack of Efficacy|8|||
42121705|NCT00410410|75932397|FG004|Induction Period (IP)|Lack of Efficacy|7|||
41965472|NCT01046682|75764843|FG001|Overall Study|Adverse Event|0|||
41965473|NCT01044732|75764851|FG000|Overall Study|Lost to Follow-up|2|||
41965474|NCT01044732|75764852|FG001|Overall Study|Lost to Follow-up|1|||
41965475|NCT01044732|75764851|FG000|Overall Study|Physician Decision|5|||
41965476|NCT01044732|75764852|FG001|Overall Study|Physician Decision|3|||
41965477|NCT01044732|75764851|FG000|Overall Study|Protocol Violation|11|||
41965478|NCT01044732|75764852|FG001|Overall Study|Protocol Violation|12|||
41965479|NCT01044732|75764851|FG000|Overall Study|Withdrawal by Subject|0|||
41965480|NCT01044732|75764852|FG001|Overall Study|Withdrawal by Subject|1|||
41965481|NCT01044732|75764851|FG000|Overall Study|Inadequate bowel preparation|11|||
41965482|NCT01044732|75764852|FG001|Overall Study|Inadequate bowel preparation|17|||
42121706|NCT00410410|75932398|FG005|Induction Period (IP)|Lack of Efficacy|7|||
42121707|NCT00410410|75932399|FG006|Induction Period (IP)|Lack of Efficacy|0|||
42121708|NCT00410410|75932400|FG007|Induction Period (IP)|Lack of Efficacy|0|||
42301122|NCT01365091|76136406|FG003|Period 2|Adverse Event|0|||
41965483|NCT01044732|75764851|FG000|Overall Study|Inability to reach cecum|5|||
41965484|NCT01044732|75764852|FG001|Overall Study|Inability to reach cecum|2|||
41965485|NCT01044732|75764851|FG000|Overall Study|Technical error or malfunction|15|||
42121709|NCT00410410|75932401|FG008|Induction Period (IP)|Lack of Efficacy|0|||
42301123|NCT01364467|76136432|FG000|Overall Study|Lost to Follow-up|1|||
42121710|NCT00410410|75932393|FG000|Induction Period (IP)|Lost to Follow-up|2|||
42121711|NCT00410410|75932394|FG001|Induction Period (IP)|Lost to Follow-up|2|||
42121712|NCT00410410|75932395|FG002|Induction Period (IP)|Lost to Follow-up|2|||
42121713|NCT00410410|75932396|FG003|Induction Period (IP)|Lost to Follow-up|3|||
42121714|NCT00410410|75932397|FG004|Induction Period (IP)|Lost to Follow-up|0|||
42121715|NCT00410410|75932398|FG005|Induction Period (IP)|Lost to Follow-up|1|||
42121716|NCT00410410|75932399|FG006|Induction Period (IP)|Lost to Follow-up|0|||
42121717|NCT00410410|75932400|FG007|Induction Period (IP)|Lost to Follow-up|0|||
42121718|NCT00410410|75932401|FG008|Induction Period (IP)|Lost to Follow-up|0|||
42121719|NCT00410410|75932393|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
42121720|NCT00410410|75932394|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
42121721|NCT00410410|75932395|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
42121722|NCT00410410|75932396|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
42121723|NCT00410410|75932397|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
42121724|NCT00410410|75932398|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
42121725|NCT00410410|75932399|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
42121726|NCT00410410|75932400|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
42121727|NCT00410410|75932401|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
42121728|NCT00410410|75932393|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
42121729|NCT00410410|75932394|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
42121730|NCT00410410|75932395|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
42121731|NCT00410410|75932396|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
42121732|NCT00410410|75932397|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
42121733|NCT00410410|75932398|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
42121734|NCT00410410|75932399|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
42121735|NCT00410410|75932400|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
42121736|NCT00410410|75932401|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
42121737|NCT00410410|75932393|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
42121738|NCT00410410|75932394|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
42121739|NCT00410410|75932395|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
42121740|NCT00410410|75932396|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
42121741|NCT00410410|75932397|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
42121742|NCT00410410|75932398|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
42121743|NCT00410410|75932399|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
42121744|NCT00410410|75932400|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
42121745|NCT00410410|75932401|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
42121746|NCT00410410|75932393|FG000|Induction Period (IP)|Other|0|||
42121747|NCT00410410|75932394|FG001|Induction Period (IP)|Other|0|||
42121748|NCT00410410|75932395|FG002|Induction Period (IP)|Other|1|||
42121749|NCT00410410|75932396|FG003|Induction Period (IP)|Other|0|||
42121750|NCT00410410|75932397|FG004|Induction Period (IP)|Other|0|||
42121751|NCT00410410|75932398|FG005|Induction Period (IP)|Other|0|||
42121752|NCT00410410|75932399|FG006|Induction Period (IP)|Other|0|||
42121753|NCT00410410|75932400|FG007|Induction Period (IP)|Other|0|||
42121754|NCT00410410|75932401|FG008|Induction Period (IP)|Other|0|||
42121755|NCT00410410|75932393|FG000|Maintenance Period (MP)|Death|0|||
42121756|NCT00410410|75932394|FG001|Maintenance Period (MP)|Death|0|||
42121757|NCT00410410|75932395|FG002|Maintenance Period (MP)|Death|0|||
42121758|NCT00410410|75932396|FG003|Maintenance Period (MP)|Death|0|||
42121759|NCT00410410|75932397|FG004|Maintenance Period (MP)|Death|0|||
42121760|NCT00410410|75932398|FG005|Maintenance Period (MP)|Death|0|||
42121761|NCT00410410|75932399|FG006|Maintenance Period (MP)|Death|1|||
42121762|NCT00410410|75932400|FG007|Maintenance Period (MP)|Death|0|||
42121763|NCT00410410|75932401|FG008|Maintenance Period (MP)|Death|0|||
42121764|NCT00410410|75932393|FG000|Maintenance Period (MP)|Adverse Event|0|||
42121765|NCT00410410|75932394|FG001|Maintenance Period (MP)|Adverse Event|0|||
42121766|NCT00410410|75932395|FG002|Maintenance Period (MP)|Adverse Event|0|||
42121767|NCT00410410|75932396|FG003|Maintenance Period (MP)|Adverse Event|0|||
42121768|NCT00410410|75932397|FG004|Maintenance Period (MP)|Adverse Event|0|||
42121769|NCT00410410|75932398|FG005|Maintenance Period (MP)|Adverse Event|0|||
42121770|NCT00410410|75932399|FG006|Maintenance Period (MP)|Adverse Event|1|||
42121771|NCT00410410|75932400|FG007|Maintenance Period (MP)|Adverse Event|3|||
42121772|NCT00410410|75932401|FG008|Maintenance Period (MP)|Adverse Event|0|||
42121773|NCT00410410|75932393|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
42121774|NCT00410410|75932394|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
42121775|NCT00410410|75932395|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
42121776|NCT00410410|75932396|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
42121777|NCT00410410|75932397|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
42121778|NCT00410410|75932398|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
42121779|NCT00410410|75932399|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
42121780|NCT00410410|75932400|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
42121781|NCT00410410|75932401|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
42137782|NCT00334737|75948119|FG001|Follow up Phase|Lost to Follow-up|3|||
42121782|NCT00410410|75932393|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
42121783|NCT00410410|75932394|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
41965486|NCT01044732|75764852|FG001|Overall Study|Technical error or malfunction|14|||
41965487|NCT01044498|75764862|FG000|Overall Study|Withdrew consent|1|||
41965488|NCT01044498|75764863|FG001|Overall Study|Withdrew consent|1|||
41965489|NCT01044498|75764862|FG000|Overall Study|Adverse Event|1|||
41965490|NCT01044498|75764863|FG001|Overall Study|Adverse Event|1|||
41965491|NCT01044498|75764862|FG000|Overall Study|Other|1|||
41965492|NCT01044498|75764863|FG001|Overall Study|Other|0|||
41965493|NCT01043874|75764869|FG000|Overall Study|Adverse Event|3|||
41965494|NCT01043874|75764869|FG000|Overall Study|Withdrawal by Subject|1|||
41965495|NCT01043874|75764869|FG000|Overall Study|Lack of Efficacy|1|||
41965496|NCT01043874|75764869|FG000|Overall Study|Administrative Problems|1|||
41965497|NCT01042938|75764875|FG000|Overall Study|Withdrawal by Subject|1|||
41965498|NCT01042938|75764876|FG001|Overall Study|Withdrawal by Subject|1|||
41965499|NCT01042938|75764875|FG000|Overall Study|Protocol Violation|1|||
41965500|NCT01042938|75764876|FG001|Overall Study|Protocol Violation|1|||
41965501|NCT01042938|75764875|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
41965502|NCT01042938|75764876|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
41965503|NCT01042158|75764884|FG000|Overall Study|Physician Decision|1|||
41965504|NCT03408444|75764892|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
41965505|NCT03408444|75764893|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
41965506|NCT03408444|75764894|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
41965507|NCT03408444|75764895|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
41965508|NCT03408444|75764892|FG000|Overall Study|Lens Discomfort|0|||
41965509|NCT03408444|75764893|FG001|Overall Study|Lens Discomfort|1|||
41965510|NCT03408444|75764894|FG002|Overall Study|Lens Discomfort|0|||
41965511|NCT03408444|75764895|FG003|Overall Study|Lens Discomfort|0|||
41965512|NCT03408444|75764892|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
41965513|NCT03408444|75764893|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
41965514|NCT03408444|75764894|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
41965515|NCT03408444|75764895|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
41965516|NCT03408444|75764892|FG000|Overall Study|Withdrawal by Subject|0|||
41965517|NCT03408444|75764893|FG001|Overall Study|Withdrawal by Subject|2|||
41965518|NCT03408444|75764894|FG002|Overall Study|Withdrawal by Subject|3|||
41965519|NCT03408444|75764895|FG003|Overall Study|Withdrawal by Subject|0|||
41965520|NCT03408444|75764892|FG000|Overall Study|Lost to Follow-up|0|||
41965521|NCT03408444|75764893|FG001|Overall Study|Lost to Follow-up|0|||
41965522|NCT03408444|75764894|FG002|Overall Study|Lost to Follow-up|1|||
41965523|NCT03408444|75764895|FG003|Overall Study|Lost to Follow-up|0|||
41965524|NCT03408444|75764892|FG000|Overall Study|Adverse Event|0|||
41965525|NCT03408444|75764893|FG001|Overall Study|Adverse Event|0|||
41965526|NCT03408444|75764894|FG002|Overall Study|Adverse Event|0|||
41965527|NCT03408444|75764895|FG003|Overall Study|Adverse Event|1|||
41965528|NCT03408444|75764892|FG000|Overall Study|Lens Handling Difficulties|0|||
41965529|NCT03408444|75764893|FG001|Overall Study|Lens Handling Difficulties|0|||
41965530|NCT03408444|75764894|FG002|Overall Study|Lens Handling Difficulties|1|||
41965531|NCT03408444|75764895|FG003|Overall Study|Lens Handling Difficulties|0|||
41965532|NCT03408444|75764892|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
41965533|NCT03408444|75764893|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
41965534|NCT03408444|75764894|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
41965535|NCT03408444|75764895|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
41965536|NCT03400956|75764925|FG000|Treatment Period 1|Adverse Event|0|||
41965537|NCT03400956|75764926|FG001|Treatment Period 1|Adverse Event|1|||
41965538|NCT03400956|75764927|FG002|Treatment Period 1|Adverse Event|0|||
42121784|NCT00410410|75932395|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
42121785|NCT00410410|75932396|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
42121786|NCT00410410|75932397|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
42121787|NCT00410410|75932398|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
42121788|NCT00410410|75932399|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
42121789|NCT00410410|75932400|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
42121790|NCT00410410|75932401|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
42121791|NCT00410410|75932393|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
42121792|NCT00410410|75932394|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
42121793|NCT00410410|75932395|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
41965539|NCT03400956|75764925|FG000|Treatment Period 1|Lost to Follow-up|0|||
41965540|NCT03400956|75764926|FG001|Treatment Period 1|Lost to Follow-up|0|||
41965541|NCT03400956|75764927|FG002|Treatment Period 1|Lost to Follow-up|1|||
41965542|NCT03400956|75764925|FG000|Treatment Period 1|Protocol Violation|0|||
41965543|NCT03400956|75764926|FG001|Treatment Period 1|Protocol Violation|2|||
41965544|NCT03400956|75764927|FG002|Treatment Period 1|Protocol Violation|0|||
41965545|NCT03400956|75764925|FG000|Treatment Period 1|Study terminated by sponsor|3|||
41965546|NCT03400956|75764926|FG001|Treatment Period 1|Study terminated by sponsor|1|||
41965547|NCT03400956|75764927|FG002|Treatment Period 1|Study terminated by sponsor|1|||
42121794|NCT00410410|75932396|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
42121795|NCT00410410|75932397|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
42121796|NCT00410410|75932398|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
42121797|NCT00410410|75932399|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
42121798|NCT00410410|75932400|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
42121799|NCT00410410|75932401|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
42121800|NCT00410410|75932393|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
42121801|NCT00410410|75932394|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
42121802|NCT00410410|75932395|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
42121803|NCT00410410|75932396|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
42121804|NCT00410410|75932397|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
42121805|NCT00410410|75932398|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
42121806|NCT00410410|75932399|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
42121807|NCT00410410|75932400|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
42121808|NCT00410410|75932401|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
42121809|NCT00410410|75932393|FG000|Open-Label Period (OL)|Death|0|||
42121810|NCT00410410|75932394|FG001|Open-Label Period (OL)|Death|0|||
42121811|NCT00410410|75932395|FG002|Open-Label Period (OL)|Death|0|||
42121812|NCT00410410|75932396|FG003|Open-Label Period (OL)|Death|0|||
42121813|NCT00410410|75932397|FG004|Open-Label Period (OL)|Death|0|||
42121814|NCT00410410|75932398|FG005|Open-Label Period (OL)|Death|0|||
42121815|NCT00410410|75932399|FG006|Open-Label Period (OL)|Death|0|||
42121816|NCT00410410|75932400|FG007|Open-Label Period (OL)|Death|0|||
42121817|NCT00410410|75932401|FG008|Open-Label Period (OL)|Death|1|||
42121818|NCT00410410|75932393|FG000|Open-Label Period (OL)|Adverse Event|0|||
42121819|NCT00410410|75932394|FG001|Open-Label Period (OL)|Adverse Event|0|||
42121820|NCT00410410|75932395|FG002|Open-Label Period (OL)|Adverse Event|0|||
42121821|NCT00410410|75932396|FG003|Open-Label Period (OL)|Adverse Event|0|||
42121822|NCT00410410|75932397|FG004|Open-Label Period (OL)|Adverse Event|0|||
42121823|NCT00410410|75932398|FG005|Open-Label Period (OL)|Adverse Event|0|||
42121824|NCT00410410|75932399|FG006|Open-Label Period (OL)|Adverse Event|0|||
42121825|NCT00410410|75932400|FG007|Open-Label Period (OL)|Adverse Event|0|||
42121826|NCT00410410|75932401|FG008|Open-Label Period (OL)|Adverse Event|10|||
42121827|NCT00410410|75932393|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
42121828|NCT00410410|75932394|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
42121829|NCT00410410|75932395|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
42121830|NCT00410410|75932396|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
42121831|NCT00410410|75932397|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
42121832|NCT00410410|75932398|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
42121833|NCT00410410|75932399|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
42121834|NCT00410410|75932400|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
42121835|NCT00410410|75932401|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
42121836|NCT00410410|75932393|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
42121837|NCT00410410|75932394|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
42121838|NCT00410410|75932395|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
42121839|NCT00410410|75932396|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
42121840|NCT00410410|75932397|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
42121841|NCT00410410|75932398|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
42121842|NCT00410410|75932399|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
42121843|NCT00410410|75932400|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
42121844|NCT00410410|75932401|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
42027490|NCT04816669|75835691|FG000|Part 2|Lost to Follow-up|0|||
42121845|NCT00410410|75932393|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
42121846|NCT00410410|75932394|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
42121847|NCT00410410|75932395|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
42121848|NCT00410410|75932396|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
42121849|NCT00410410|75932397|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
42121850|NCT00410410|75932398|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
42121851|NCT00410410|75932399|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
42121852|NCT00410410|75932400|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
42121853|NCT00410410|75932401|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
42121854|NCT00410410|75932393|FG000|Open-Label Period (OL)|Pregnancy|0|||
42301124|NCT01364467|76136433|FG001|Overall Study|Lost to Follow-up|2|||
41965548|NCT03400956|75764925|FG000|Treatment Period 1|Withdrawal by Subject|0|||
41965549|NCT03400956|75764926|FG001|Treatment Period 1|Withdrawal by Subject|2|||
41965550|NCT03400956|75764927|FG002|Treatment Period 1|Withdrawal by Subject|4|||
41965551|NCT03400956|75764925|FG000|Treatment Period 1|Other|1|||
41965552|NCT03400956|75764926|FG001|Treatment Period 1|Other|2|||
41965553|NCT03400956|75764927|FG002|Treatment Period 1|Other|3|||
41965554|NCT03400956|75764925|FG000|Post-treatment Period 1|Adverse Event|0|||
41965555|NCT03400956|75764926|FG001|Post-treatment Period 1|Adverse Event|0|||
41965556|NCT03400956|75764927|FG002|Post-treatment Period 1|Adverse Event|1|||
41965557|NCT03400956|75764925|FG000|Post-treatment Period 1|Physician Decision|2|||
41965558|NCT03400956|75764926|FG001|Post-treatment Period 1|Physician Decision|3|||
42121855|NCT00410410|75932394|FG001|Open-Label Period (OL)|Pregnancy|0|||
42121856|NCT00410410|75932395|FG002|Open-Label Period (OL)|Pregnancy|0|||
42121857|NCT00410410|75932396|FG003|Open-Label Period (OL)|Pregnancy|0|||
42121858|NCT00410410|75932397|FG004|Open-Label Period (OL)|Pregnancy|0|||
42121859|NCT00410410|75932398|FG005|Open-Label Period (OL)|Pregnancy|0|||
42121860|NCT00410410|75932399|FG006|Open-Label Period (OL)|Pregnancy|0|||
42121861|NCT00410410|75932400|FG007|Open-Label Period (OL)|Pregnancy|0|||
42121862|NCT00410410|75932401|FG008|Open-Label Period (OL)|Pregnancy|1|||
42121863|NCT00410410|75932393|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
42121864|NCT00410410|75932394|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
42121865|NCT00410410|75932395|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
42121866|NCT00410410|75932396|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
42121867|NCT00410410|75932397|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
42121868|NCT00410410|75932398|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
42121869|NCT00410410|75932399|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
42121870|NCT00410410|75932400|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
42121871|NCT00410410|75932401|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
42121872|NCT00410410|75932393|FG000|Open-Label Period (OL)|Other|0|||
42121873|NCT00410410|75932394|FG001|Open-Label Period (OL)|Other|0|||
42121874|NCT00410410|75932395|FG002|Open-Label Period (OL)|Other|0|||
42121875|NCT00410410|75932396|FG003|Open-Label Period (OL)|Other|0|||
42121876|NCT00410410|75932397|FG004|Open-Label Period (OL)|Other|0|||
42121877|NCT00410410|75932398|FG005|Open-Label Period (OL)|Other|0|||
42121878|NCT00410410|75932399|FG006|Open-Label Period (OL)|Other|0|||
42121879|NCT00410410|75932400|FG007|Open-Label Period (OL)|Other|0|||
42121880|NCT00410410|75932401|FG008|Open-Label Period (OL)|Other|7|||
42121881|NCT00534404|75932439|FG000|Overall Study|Death|0|||
42121882|NCT00534404|75932440|FG001|Overall Study|Death|0|||
42121883|NCT00534404|75932441|FG002|Overall Study|Death|2|||
42121884|NCT00534404|75932439|FG000|Overall Study|Withdrawal by Subject|8|||
42121885|NCT00534404|75932440|FG001|Overall Study|Withdrawal by Subject|2|||
42121886|NCT00534404|75932441|FG002|Overall Study|Withdrawal by Subject|38|||
42121887|NCT00534404|75932439|FG000|Overall Study|Removed by study staff|2|||
42121888|NCT00534404|75932440|FG001|Overall Study|Removed by study staff|3|||
42121889|NCT00534404|75932441|FG002|Overall Study|Removed by study staff|1|||
42121890|NCT00534404|75932439|FG000|Overall Study|Lost to Follow-up|170|||
42121891|NCT00534404|75932440|FG001|Overall Study|Lost to Follow-up|138|||
42121892|NCT00534404|75932441|FG002|Overall Study|Lost to Follow-up|201|||
42121893|NCT00393094|75932449|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
42121894|NCT00393094|75932449|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
42121895|NCT00409786|75932455|FG000|Overall Study|Withdrawal by Subject|3|||
42121896|NCT00409708|75932461|FG000|Treatment|Abnormal test procedure result(s)|1|||
42121897|NCT00409708|75932462|FG001|Treatment|Abnormal test procedure result(s)|0|||
42121898|NCT00409708|75932461|FG000|Treatment|Lack of Efficacy|0|||
42121899|NCT00409708|75932462|FG001|Treatment|Lack of Efficacy|1|||
42121900|NCT00409708|75932461|FG000|Treatment|Protocol Violation|6|||
42121901|NCT00409708|75932462|FG001|Treatment|Protocol Violation|2|||
42121902|NCT00409708|75932461|FG000|Treatment|Withdrawal by Subject|3|||
42121903|NCT00409708|75932462|FG001|Treatment|Withdrawal by Subject|8|||
42121904|NCT00409708|75932461|FG000|Treatment|Lost to Follow-up|0|||
42121905|NCT00409708|75932462|FG001|Treatment|Lost to Follow-up|6|||
42121906|NCT00409708|75932461|FG000|Treatment|Administrative problems|5|||
42121907|NCT00409708|75932462|FG001|Treatment|Administrative problems|0|||
42121908|NCT00409708|75932461|FG000|Washout|Lack of Efficacy|9|||
42121909|NCT00409708|75932462|FG001|Washout|Lack of Efficacy|1|||
42121910|NCT00409708|75932461|FG000|Washout|Protocol Violation|0|||
42121911|NCT00409708|75932462|FG001|Washout|Protocol Violation|1|||
42121912|NCT00409708|75932461|FG000|Washout|Withdrawal by Subject|11|||
42121913|NCT00409708|75932462|FG001|Washout|Withdrawal by Subject|5|||
42121914|NCT00409708|75932461|FG000|Washout|Lost to Follow-up|1|||
42121915|NCT00409708|75932462|FG001|Washout|Lost to Follow-up|3|||
42121916|NCT00391846|75932479|FG000|Overall Study|Adverse Event|4|||
42121917|NCT00391846|75932480|FG001|Overall Study|Adverse Event|1|||
42121918|NCT00391846|75932479|FG000|Overall Study|Did not meet the required elig. crit|2|||
42121919|NCT00391846|75932480|FG001|Overall Study|Did not meet the required elig. crit|2|||
42121920|NCT00391846|75932479|FG000|Overall Study|Withdrawal by Subject|2|||
41965559|NCT03400956|75764927|FG002|Post-treatment Period 1|Physician Decision|0|||
42121921|NCT00391846|75932480|FG001|Overall Study|Withdrawal by Subject|3|||
42121922|NCT00391846|75932479|FG000|Overall Study|Developed study specific DC criteria|0|||
42121923|NCT00391846|75932480|FG001|Overall Study|Developed study specific DC criteria|1|||
42121924|NCT00534248|75932505|FG000|Overall Study|Adverse Event|19|||
42121925|NCT00534248|75932506|FG001|Overall Study|Adverse Event|29|||
42121926|NCT00534248|75932505|FG000|Overall Study|Lost to Follow-up|353|||
42121927|NCT00534248|75932506|FG001|Overall Study|Lost to Follow-up|375|||
42121928|NCT00534248|75932505|FG000|Overall Study|Other protocol specified criteria|13|||
42121929|NCT00534248|75932506|FG001|Overall Study|Other protocol specified criteria|3|||
42121930|NCT00534248|75932505|FG000|Overall Study|Physician Decision|10|||
42121931|NCT00534248|75932506|FG001|Overall Study|Physician Decision|7|||
42121932|NCT00534248|75932505|FG000|Overall Study|Protocol Violation|3|||
42121933|NCT00534248|75932506|FG001|Overall Study|Protocol Violation|4|||
42121934|NCT00534248|75932505|FG000|Overall Study|Withdrawal by Subject|263|||
42121935|NCT00534248|75932506|FG001|Overall Study|Withdrawal by Subject|255|||
42121936|NCT00391768|75932519|FG000|Overall Study|Withdrawal by Subject|0|||
42121937|NCT00391768|75932520|FG001|Overall Study|Withdrawal by Subject|0|||
42121938|NCT00391768|75932521|FG002|Overall Study|Withdrawal by Subject|1|||
42121939|NCT00391768|75932522|FG003|Overall Study|Withdrawal by Subject|0|||
42121940|NCT00391768|75932523|FG004|Overall Study|Withdrawal by Subject|0|||
42121941|NCT00391768|75932524|FG005|Overall Study|Withdrawal by Subject|1|||
42121942|NCT00391768|75932525|FG006|Overall Study|Withdrawal by Subject|1|||
42121943|NCT00391768|75932519|FG000|Overall Study|Lost to Follow-up|0|||
42121944|NCT00391768|75932520|FG001|Overall Study|Lost to Follow-up|0|||
42121945|NCT00391768|75932521|FG002|Overall Study|Lost to Follow-up|0|||
42121946|NCT00391768|75932522|FG003|Overall Study|Lost to Follow-up|1|||
42121947|NCT00391768|75932523|FG004|Overall Study|Lost to Follow-up|2|||
42121948|NCT00391768|75932524|FG005|Overall Study|Lost to Follow-up|2|||
42121949|NCT00391768|75932525|FG006|Overall Study|Lost to Follow-up|3|||
42121950|NCT00391222|75932562|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
42121951|NCT00391222|75932563|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
42121952|NCT00391222|75932564|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
42121953|NCT00391222|75932565|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
42121954|NCT00391222|75932562|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
42121955|NCT00391222|75932563|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
42121956|NCT00391222|75932564|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
42121957|NCT00391222|75932565|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
42121958|NCT00391222|75932562|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
42121959|NCT00391222|75932563|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
42121960|NCT00391222|75932564|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
42121961|NCT00391222|75932565|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
42121962|NCT00391222|75932562|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
42121963|NCT00391222|75932563|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
42121964|NCT00391222|75932564|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
42121965|NCT00391222|75932565|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
42121966|NCT00391222|75932562|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
42121967|NCT00391222|75932563|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
42121968|NCT00391222|75932564|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
42121969|NCT00391222|75932565|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
42121970|NCT00391222|75932562|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
42121971|NCT00391222|75932563|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
42121972|NCT00391222|75932564|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
42121973|NCT00391222|75932565|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
42121974|NCT00391222|75932562|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
42121975|NCT00391222|75932563|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
42121976|NCT00391222|75932564|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
42121977|NCT00391222|75932565|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
42121978|NCT00391222|75932562|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
42121979|NCT00391222|75932563|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
42121980|NCT00391222|75932564|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
42121981|NCT00391222|75932565|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
42121982|NCT00391222|75932562|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
42121983|NCT00391222|75932563|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
42121984|NCT00391222|75932564|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
42121985|NCT00391222|75932565|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
42121986|NCT00391222|75932562|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
42121987|NCT00391222|75932563|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
42121988|NCT00391222|75932564|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
42121989|NCT00391222|75932565|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
42121990|NCT00391222|75932562|FG000|Period III (Double-Blind Treatment)|Other|6|||
42121991|NCT00391222|75932563|FG001|Period III (Double-Blind Treatment)|Other|1|||
42121992|NCT00391222|75932564|FG002|Period III (Double-Blind Treatment)|Other|6|||
42121993|NCT00391222|75932565|FG003|Period III (Double-Blind Treatment)|Other|0|||
42121994|NCT00409006|75932577|FG000|Overall Study|Death|15|||
42121995|NCT00409006|75932578|FG001|Overall Study|Death|6|||
42210365|NCT03288714|76025139|FG001|Overall Study|Adverse Event|0|||
42121996|NCT00409006|75932577|FG000|Overall Study|Lost to Follow-up|1|||
42121997|NCT00409006|75932578|FG001|Overall Study|Lost to Follow-up|2|||
42121998|NCT00409006|75932577|FG000|Overall Study|Withdrawal by Subject|3|||
42121999|NCT00409006|75932578|FG001|Overall Study|Withdrawal by Subject|2|||
42122000|NCT00409006|75932577|FG000|Overall Study|Physician Decision|1|||
42122001|NCT00409006|75932578|FG001|Overall Study|Physician Decision|2|||
42122002|NCT00534092|75932586|FG000|Overall Study|Lost to Follow-up|1|||
42122003|NCT00534092|75932587|FG001|Overall Study|Lost to Follow-up|0|||
42122004|NCT00534092|75932586|FG000|Overall Study|personal reasons/family concerns|1|||
42122005|NCT00534092|75932587|FG001|Overall Study|personal reasons/family concerns|0|||
42122006|NCT00408928|75932595|FG000|Overall Study|Withdrawal by Subject|1|||
42122007|NCT00408928|75932595|FG000|Overall Study|Death|1|||
42122008|NCT00408928|75932595|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
42122009|NCT00390910|75932602|FG000|Overall Study|Adverse Event|1|||
41965560|NCT03400956|75764925|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
41965561|NCT03400956|75764926|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
41965562|NCT03400956|75764927|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
41965563|NCT03400956|75764925|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
41965564|NCT03400956|75764926|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
41965565|NCT03400956|75764927|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
41965566|NCT03400956|75764925|FG000|Post-treatment Period 1|Other|4|||
41965567|NCT03400956|75764926|FG001|Post-treatment Period 1|Other|3|||
41965568|NCT03400956|75764927|FG002|Post-treatment Period 1|Other|4|||
41965569|NCT03400956|75764925|FG000|Treatment Period 2|Adverse Event|2|||
41965570|NCT03400956|75764926|FG001|Treatment Period 2|Adverse Event|1|||
41965571|NCT03400956|75764927|FG002|Treatment Period 2|Adverse Event|1|||
41965572|NCT03400956|75764925|FG000|Treatment Period 2|Lost to Follow-up|1|||
41965573|NCT03400956|75764926|FG001|Treatment Period 2|Lost to Follow-up|1|||
41965574|NCT03400956|75764927|FG002|Treatment Period 2|Lost to Follow-up|0|||
41965575|NCT03400956|75764925|FG000|Treatment Period 2|Withdrawal by Subject|0|||
41965576|NCT03400956|75764926|FG001|Treatment Period 2|Withdrawal by Subject|0|||
41965577|NCT03400956|75764927|FG002|Treatment Period 2|Withdrawal by Subject|3|||
41965578|NCT03400956|75764925|FG000|Treatment Period 2|Other|1|||
41965579|NCT03400956|75764926|FG001|Treatment Period 2|Other|1|||
41965580|NCT03400956|75764927|FG002|Treatment Period 2|Other|0|||
41965581|NCT03400956|75764925|FG000|Follow-up Period|Withdrawal by Subject|0|||
41965582|NCT03400956|75764926|FG001|Follow-up Period|Withdrawal by Subject|0|||
41965583|NCT03400956|75764927|FG002|Follow-up Period|Withdrawal by Subject|1|||
41965584|NCT03400956|75764925|FG000|Follow-up Period|Other|0|||
41965585|NCT03400956|75764926|FG001|Follow-up Period|Other|0|||
41965586|NCT03400956|75764927|FG002|Follow-up Period|Other|1|||
41965587|NCT00012012|75764940|FG000|Overall Study|Protocol Violation|1|||
41965588|NCT00012012|75764941|FG001|Overall Study|Protocol Violation|1|||
41965589|NCT00012012|75764940|FG000|Overall Study|Withdrawal by Subject|0|||
41965590|NCT00012012|75764941|FG001|Overall Study|Withdrawal by Subject|2|||
41965591|NCT00010374|75764947|FG000|Overall Study|False positive phrenic nerve test|1|||
41965592|NCT00559962|75764973|FG000|Overall Study|Adverse Event|1|||
41965593|NCT00559962|75764974|FG001|Overall Study|Adverse Event|7|||
41965594|NCT00559962|75764975|FG002|Overall Study|Adverse Event|8|||
41965595|NCT00559962|75764976|FG003|Overall Study|Adverse Event|5|||
41965596|NCT00559962|75764977|FG004|Overall Study|Adverse Event|11|||
41965597|NCT00559962|75764978|FG005|Overall Study|Adverse Event|4|||
41965598|NCT00559962|75764979|FG006|Overall Study|Adverse Event|4|||
41965599|NCT00559962|75764980|FG007|Overall Study|Adverse Event|2|||
41965600|NCT00559962|75764973|FG000|Overall Study|Lost to Follow-up|0|||
41965601|NCT00559962|75764974|FG001|Overall Study|Lost to Follow-up|1|||
41965602|NCT00559962|75764975|FG002|Overall Study|Lost to Follow-up|0|||
41965603|NCT00559962|75764976|FG003|Overall Study|Lost to Follow-up|0|||
41965604|NCT00559962|75764977|FG004|Overall Study|Lost to Follow-up|0|||
41965605|NCT00559962|75764978|FG005|Overall Study|Lost to Follow-up|0|||
41965606|NCT00559962|75764979|FG006|Overall Study|Lost to Follow-up|0|||
41965607|NCT00559962|75764980|FG007|Overall Study|Lost to Follow-up|0|||
41965608|NCT00559962|75764973|FG000|Overall Study|Withdrawal by Subject|1|||
41965609|NCT00559962|75764974|FG001|Overall Study|Withdrawal by Subject|1|||
41965610|NCT00559962|75764975|FG002|Overall Study|Withdrawal by Subject|2|||
41965611|NCT00559962|75764976|FG003|Overall Study|Withdrawal by Subject|0|||
41965612|NCT00559962|75764977|FG004|Overall Study|Withdrawal by Subject|3|||
41965613|NCT00559962|75764978|FG005|Overall Study|Withdrawal by Subject|1|||
41965614|NCT00559962|75764979|FG006|Overall Study|Withdrawal by Subject|0|||
41965615|NCT00559962|75764980|FG007|Overall Study|Withdrawal by Subject|2|||
41965616|NCT00559962|75764973|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
41965617|NCT00559962|75764974|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
41965618|NCT00559962|75764975|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
41965619|NCT00559962|75764976|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
41965620|NCT00559962|75764977|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
41965621|NCT00559962|75764978|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
42122010|NCT00390910|75932603|FG001|Overall Study|Adverse Event|0|||
41965622|NCT00559962|75764979|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
42122011|NCT00390910|75932604|FG002|Overall Study|Adverse Event|0|||
42122012|NCT00390910|75932602|FG000|Overall Study|Lost to Follow-up|0|||
42122013|NCT00390910|75932603|FG001|Overall Study|Lost to Follow-up|1|||
42122014|NCT00390910|75932604|FG002|Overall Study|Lost to Follow-up|5|||
42122015|NCT00390910|75932602|FG000|Overall Study|Withdrawal by Subject|1|||
42122016|NCT00390910|75932603|FG001|Overall Study|Withdrawal by Subject|3|||
42122017|NCT00390910|75932604|FG002|Overall Study|Withdrawal by Subject|2|||
42122018|NCT00390910|75932602|FG000|Overall Study|Migrated/moved from study area|0|||
42122019|NCT00390910|75932603|FG001|Overall Study|Migrated/moved from study area|0|||
42122020|NCT00390910|75932604|FG002|Overall Study|Migrated/moved from study area|3|||
42122021|NCT00533702|75932616|FG000|Overall Study|Withdrawal by Subject|3|||
42122022|NCT00533702|75932617|FG001|Overall Study|Withdrawal by Subject|1|||
42122023|NCT00533702|75932616|FG000|Overall Study|Found ineligible after randomization|2|||
42122024|NCT00533702|75932617|FG001|Overall Study|Found ineligible after randomization|1|||
42122025|NCT00408694|75932623|FG000|Overall Study|Ineligible|1|||
42122026|NCT00408694|75932623|FG000|Overall Study|No protocol treatment|1|||
42122027|NCT00396136|75932627|FG000|Overall Study|Death|43|||
42122028|NCT00396136|75932627|FG000|Overall Study|Withdrawal by Subject|59|||
42122029|NCT00396136|75932627|FG000|Overall Study|Lost to Follow-up|15|||
41965623|NCT00559962|75764980|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
41965624|NCT00559104|75765001|FG000|Overall Study|Lack of Efficacy|9|||
41965625|NCT00559104|75765002|FG001|Overall Study|Lack of Efficacy|0|||
41965626|NCT00558636|75765010|FG000|Treatment|Adverse Event|9|||
41965627|NCT00558636|75765011|FG001|Treatment|Adverse Event|2|||
41965628|NCT00558636|75765010|FG000|Treatment|Withdrawal by Subject|2|||
41965629|NCT00558636|75765011|FG001|Treatment|Withdrawal by Subject|0|||
41965630|NCT00558636|75765010|FG000|Treatment|Premature termination of the study|35|||
41965631|NCT00558636|75765011|FG001|Treatment|Premature termination of the study|37|||
41965632|NCT00558636|75765010|FG000|Treatment|Disease progression|1|||
41965633|NCT00558636|75765011|FG001|Treatment|Disease progression|5|||
41965634|NCT00558636|75765010|FG000|Follow-up|Premature termination of the study|12|||
41965635|NCT00558636|75765011|FG001|Follow-up|Premature termination of the study|7|||
41965636|NCT00558558|75765017|FG000|Overall Study|Unable to swallow|1|||
41965637|NCT00558558|75765017|FG000|Overall Study|Withdrawal by Subject|1|||
41965638|NCT00558558|75765017|FG000|Overall Study|Lack of Efficacy|4|||
41965639|NCT00557622|75765023|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
41965640|NCT00557622|75765024|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
41965641|NCT00557622|75765023|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
41965642|NCT00557622|75765024|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
41965643|NCT00557622|75765023|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
41965644|NCT00557622|75765024|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
41965645|NCT00557466|75765036|FG000|Overall Study|Adverse Event|3|||
41965646|NCT00557466|75765037|FG001|Overall Study|Adverse Event|1|||
41965647|NCT00557466|75765038|FG002|Overall Study|Adverse Event|4|||
41965648|NCT00557466|75765039|FG003|Overall Study|Adverse Event|1|||
41965649|NCT00557466|75765040|FG004|Overall Study|Adverse Event|2|||
41965650|NCT00557466|75765041|FG005|Overall Study|Adverse Event|4|||
41965651|NCT00557466|75765036|FG000|Overall Study|Abnormal laboratory value(s)|1|||
41965652|NCT00557466|75765037|FG001|Overall Study|Abnormal laboratory value(s)|2|||
41965653|NCT00557466|75765038|FG002|Overall Study|Abnormal laboratory value(s)|0|||
41965654|NCT00557466|75765039|FG003|Overall Study|Abnormal laboratory value(s)|0|||
41965655|NCT00557466|75765040|FG004|Overall Study|Abnormal laboratory value(s)|0|||
41965656|NCT00557466|75765041|FG005|Overall Study|Abnormal laboratory value(s)|0|||
41965657|NCT00557466|75765036|FG000|Overall Study|Protocol deviation|0|||
41965658|NCT00557466|75765037|FG001|Overall Study|Protocol deviation|1|||
41965659|NCT00557466|75765038|FG002|Overall Study|Protocol deviation|0|||
41965660|NCT00557466|75765039|FG003|Overall Study|Protocol deviation|2|||
41965661|NCT00557466|75765040|FG004|Overall Study|Protocol deviation|0|||
41965662|NCT00557466|75765041|FG005|Overall Study|Protocol deviation|0|||
41965663|NCT00557466|75765036|FG000|Overall Study|Subject withdrew consent|0|||
41965664|NCT00557466|75765037|FG001|Overall Study|Subject withdrew consent|0|||
41965665|NCT00557466|75765038|FG002|Overall Study|Subject withdrew consent|0|||
42027491|NCT04816669|75835692|FG001|Part 2|Lost to Follow-up|0|||
42027492|NCT04816669|75835693|FG002|Part 2|Lost to Follow-up|1|||
42122030|NCT00396136|75932627|FG000|Overall Study|Study device explanted|8|||
42027493|NCT04816669|75835694|FG003|Part 2|Lost to Follow-up|0|||
42027494|NCT01165242|75835711|FG000|Overall Study|Unreachable Subjects|1|||
42027495|NCT01165242|75835712|FG001|Overall Study|Unreachable Subjects|0|||
41965666|NCT00557466|75765039|FG003|Overall Study|Subject withdrew consent|0|||
41965667|NCT00557466|75765040|FG004|Overall Study|Subject withdrew consent|1|||
41965668|NCT00557466|75765041|FG005|Overall Study|Subject withdrew consent|2|||
41965669|NCT00557466|75765036|FG000|Overall Study|Administrative problems|0|||
41965670|NCT00557466|75765037|FG001|Overall Study|Administrative problems|1|||
41965671|NCT00557466|75765038|FG002|Overall Study|Administrative problems|1|||
41965672|NCT00557466|75765039|FG003|Overall Study|Administrative problems|0|||
42122031|NCT00530894|75932635|FG000|Overall Study|Death|84|||
42122032|NCT00530894|75932636|FG001|Overall Study|Death|89|||
42122033|NCT00530894|75932637|FG002|Overall Study|Death|55|||
42122034|NCT00530894|75932638|FG003|Overall Study|Death|89|||
42122035|NCT00530894|75932635|FG000|Overall Study|Lost to Follow-up|1|||
42122036|NCT00530894|75932636|FG001|Overall Study|Lost to Follow-up|3|||
42122037|NCT00530894|75932637|FG002|Overall Study|Lost to Follow-up|0|||
42122038|NCT00530894|75932638|FG003|Overall Study|Lost to Follow-up|0|||
42122039|NCT00530894|75932635|FG000|Overall Study|Withdrawal by Subject|1|||
42122040|NCT00530894|75932636|FG001|Overall Study|Withdrawal by Subject|23|||
42122041|NCT00530894|75932637|FG002|Overall Study|Withdrawal by Subject|0|||
42122042|NCT00530894|75932638|FG003|Overall Study|Withdrawal by Subject|5|||
42122043|NCT00530894|75932635|FG000|Overall Study|Alive and censored prior to 1 year|2|||
42122044|NCT00530894|75932636|FG001|Overall Study|Alive and censored prior to 1 year|0|||
42122045|NCT00530894|75932637|FG002|Overall Study|Alive and censored prior to 1 year|0|||
42122046|NCT00530894|75932638|FG003|Overall Study|Alive and censored prior to 1 year|0|||
42122047|NCT00056407|75932652|FG000|Overall Study|Adverse Event|282|||
42122048|NCT00056407|75932653|FG001|Overall Study|Adverse Event|364|||
42122049|NCT00056407|75932652|FG000|Overall Study|Withdrawal by Subject|377|||
42122050|NCT00056407|75932653|FG001|Overall Study|Withdrawal by Subject|361|||
42122051|NCT00056407|75932652|FG000|Overall Study|Lost to Follow-up|123|||
42122052|NCT00056407|75932653|FG001|Overall Study|Lost to Follow-up|113|||
42122053|NCT00056407|75932652|FG000|Overall Study|Protocol Violation|104|||
42122054|NCT00056407|75932653|FG001|Overall Study|Protocol Violation|95|||
42122055|NCT00056407|75932652|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
42122056|NCT00056407|75932653|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
42122057|NCT00056407|75932652|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
42122058|NCT00056407|75932653|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
42122059|NCT00056407|75932652|FG000|Overall Study|Missing|25|||
42122060|NCT00056407|75932653|FG001|Overall Study|Missing|34|||
42122061|NCT00388726|75932661|FG000|Overall Study|Adverse Event|50|||
42122062|NCT00388726|75932662|FG001|Overall Study|Adverse Event|24|||
42122063|NCT00388726|75932661|FG000|Overall Study|Progressive Disease|336|||
42122064|NCT00388726|75932662|FG001|Overall Study|Progressive Disease|153|||
42122065|NCT00388726|75932661|FG000|Overall Study|Clinical Progression|61|||
42122066|NCT00388726|75932662|FG001|Overall Study|Clinical Progression|36|||
42122067|NCT00388726|75932661|FG000|Overall Study|Withdrawal by Subject|10|||
42122068|NCT00388726|75932662|FG001|Overall Study|Withdrawal by Subject|7|||
42122069|NCT00388726|75932661|FG000|Overall Study|Administrative|6|||
42122070|NCT00388726|75932662|FG001|Overall Study|Administrative|9|||
42122071|NCT00388726|75932661|FG000|Overall Study|Physician Decision|18|||
42122072|NCT00388726|75932662|FG001|Overall Study|Physician Decision|13|||
42122073|NCT00388726|75932661|FG000|Overall Study|Death|3|||
42122074|NCT00388726|75932662|FG001|Overall Study|Death|2|||
42122075|NCT00387790|75932668|FG000|Overall Study|Adverse Event|5|||
42122076|NCT00387790|75932668|FG000|Overall Study|Lack of Efficacy|2|||
42122077|NCT00387790|75932668|FG000|Overall Study|Physician Decision|2|||
42122078|NCT00387790|75932668|FG000|Overall Study|Withdrawal by Subject|3|||
42122079|NCT00387790|75932668|FG000|Overall Study|Ineligible for study|2|||
42122080|NCT00073021|75932674|FG000|Overall Study|Protocol Violation|2|||
42122081|NCT00073021|75932675|FG001|Overall Study|Protocol Violation|1|||
42122082|NCT00073021|75932674|FG000|Overall Study|Adverse Event|4|||
42122083|NCT00073021|75932675|FG001|Overall Study|Adverse Event|4|||
42122084|NCT00073021|75932674|FG000|Overall Study|Withdrawal by Subject|6|||
42122085|NCT00073021|75932675|FG001|Overall Study|Withdrawal by Subject|5|||
42122086|NCT00073021|75932674|FG000|Overall Study|Physician Decision|3|||
42122087|NCT00073021|75932675|FG001|Overall Study|Physician Decision|1|||
42122088|NCT00073021|75932674|FG000|Overall Study|Lack of Efficacy|11|||
42122089|NCT00073021|75932675|FG001|Overall Study|Lack of Efficacy|5|||
42122090|NCT00407758|75932681|FG000|Overall Study|ineligible -improper prior treatment|1|||
42122091|NCT00531752|75932689|FG000|First Double-blind Intervention Period|Adverse Event|2|||
42122092|NCT00531752|75932690|FG001|First Double-blind Intervention Period|Adverse Event|0|||
42122093|NCT00531752|75932691|FG002|First Double-blind Intervention Period|Adverse Event|1|||
42122094|NCT00531752|75932692|FG003|First Double-blind Intervention Period|Adverse Event|1|||
42122095|NCT00531752|75932689|FG000|First Double-blind Intervention Period|Other|1|||
42122096|NCT00531752|75932690|FG001|First Double-blind Intervention Period|Other|4|||
42122097|NCT00531752|75932691|FG002|First Double-blind Intervention Period|Other|4|||
42122098|NCT00531752|75932692|FG003|First Double-blind Intervention Period|Other|0|||
42122099|NCT00531752|75932689|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
42122100|NCT00531752|75932690|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
42122101|NCT00531752|75932691|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
42122102|NCT00531752|75932692|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
42122103|NCT00531752|75932689|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
42122104|NCT00531752|75932690|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
42137783|NCT00334737|75948120|FG002|Follow up Phase|Lost to Follow-up|6|||
42122105|NCT00531752|75932691|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
42122106|NCT00531752|75932692|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
42122107|NCT00531752|75932689|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
42122108|NCT00531752|75932690|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
42122109|NCT00531752|75932691|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
42122110|NCT00531752|75932692|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
42122111|NCT00531752|75932689|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
42122112|NCT00531752|75932690|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
42122113|NCT00531752|75932691|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
42122114|NCT00531752|75932692|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
42122115|NCT00531752|75932689|FG000|Second Double-blind Intervention Period|Other|1|||
42122116|NCT00531752|75932690|FG001|Second Double-blind Intervention Period|Other|1|||
42122117|NCT00531752|75932691|FG002|Second Double-blind Intervention Period|Other|0|||
42122118|NCT00531752|75932692|FG003|Second Double-blind Intervention Period|Other|0|||
42122119|NCT00531752|75932689|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
42122120|NCT00531752|75932690|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
42122121|NCT00531752|75932691|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
42122122|NCT00531752|75932692|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
42122123|NCT00531752|75932689|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
42122124|NCT00531752|75932690|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
41965673|NCT00557466|75765040|FG004|Overall Study|Administrative problems|0|||
41965674|NCT00557466|75765041|FG005|Overall Study|Administrative problems|0|||
41965675|NCT00557466|75765036|FG000|Overall Study|Abnormal test procedure results|0|||
41965676|NCT00557466|75765037|FG001|Overall Study|Abnormal test procedure results|0|||
41965677|NCT00557466|75765038|FG002|Overall Study|Abnormal test procedure results|1|||
41965678|NCT00557466|75765039|FG003|Overall Study|Abnormal test procedure results|0|||
41965679|NCT00557466|75765040|FG004|Overall Study|Abnormal test procedure results|0|||
41965680|NCT00557466|75765041|FG005|Overall Study|Abnormal test procedure results|0|||
41965681|NCT00557466|75765036|FG000|Overall Study|Lost to Follow-up|0|||
41965682|NCT00557466|75765037|FG001|Overall Study|Lost to Follow-up|0|||
41965683|NCT00557466|75765038|FG002|Overall Study|Lost to Follow-up|0|||
41965684|NCT00557466|75765039|FG003|Overall Study|Lost to Follow-up|1|||
42122125|NCT00531752|75932691|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
42122126|NCT00531752|75932692|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
42122127|NCT00395746|75932703|FG000|Overall Study|Adverse Event|5|||
42122128|NCT00395746|75932704|FG001|Overall Study|Adverse Event|2|||
42122129|NCT00395746|75932705|FG002|Overall Study|Adverse Event|2|||
42122130|NCT00395746|75932703|FG000|Overall Study|Protocol Violation|0|||
42122131|NCT00395746|75932704|FG001|Overall Study|Protocol Violation|1|||
42122132|NCT00395746|75932705|FG002|Overall Study|Protocol Violation|0|||
42122133|NCT00395746|75932703|FG000|Overall Study|Lack of Efficacy|2|||
42122134|NCT00395746|75932704|FG001|Overall Study|Lack of Efficacy|0|||
42122135|NCT00395746|75932705|FG002|Overall Study|Lack of Efficacy|17|||
42122136|NCT00395746|75932703|FG000|Overall Study|Hypoglycaemia|2|||
42122137|NCT00395746|75932704|FG001|Overall Study|Hypoglycaemia|1|||
42122138|NCT00395746|75932705|FG002|Overall Study|Hypoglycaemia|0|||
42122139|NCT00395746|75932703|FG000|Overall Study|Subject decision|0|||
42122140|NCT00395746|75932704|FG001|Overall Study|Subject decision|0|||
42122141|NCT00395746|75932705|FG002|Overall Study|Subject decision|1|||
42122142|NCT00395746|75932703|FG000|Overall Study|Withdrawal of consent|0|||
42122143|NCT00395746|75932704|FG001|Overall Study|Withdrawal of consent|0|||
42122144|NCT00395746|75932705|FG002|Overall Study|Withdrawal of consent|1|||
42122145|NCT00395746|75932703|FG000|Overall Study|Difficultulty in use of device|0|||
42122146|NCT00395746|75932704|FG001|Overall Study|Difficultulty in use of device|0|||
42122147|NCT00395746|75932705|FG002|Overall Study|Difficultulty in use of device|1|||
42122148|NCT00395746|75932703|FG000|Overall Study|Unable to visit site on schedule|1|||
42122149|NCT00395746|75932704|FG001|Overall Study|Unable to visit site on schedule|0|||
42122150|NCT00395746|75932705|FG002|Overall Study|Unable to visit site on schedule|0|||
42122151|NCT00055471|75932716|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
42122152|NCT00055471|75932717|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
42122153|NCT00055471|75932718|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
42122154|NCT00055471|75932716|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
42122155|NCT00055471|75932717|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
42122156|NCT00055471|75932718|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
42301125|NCT02520661|76136441|FG000|Overall Study|Lost to Follow-up|7|||
42301126|NCT02520661|76136442|FG001|Overall Study|Lost to Follow-up|3|||
41965685|NCT00557466|75765040|FG004|Overall Study|Lost to Follow-up|0|||
42122157|NCT00055471|75932716|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
42122158|NCT00055471|75932717|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
42210366|NCT03256578|76025149|FG000|Overall Study|Excluded Post Randomization|66|||
42210367|NCT03256578|76025150|FG001|Overall Study|Excluded Post Randomization|56|||
42122159|NCT00055471|75932718|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
42122160|NCT00395512|75932730|FG000|Overall Study|Adverse Event|3|||
42122161|NCT00395512|75932731|FG001|Overall Study|Adverse Event|8|||
42122162|NCT00395512|75932732|FG002|Overall Study|Adverse Event|6|||
42122163|NCT00395512|75932733|FG003|Overall Study|Adverse Event|6|||
42122164|NCT00395512|75932730|FG000|Overall Study|Protocol Violation|2|||
42122165|NCT00395512|75932731|FG001|Overall Study|Protocol Violation|3|||
42122166|NCT00395512|75932732|FG002|Overall Study|Protocol Violation|6|||
42122167|NCT00395512|75932733|FG003|Overall Study|Protocol Violation|7|||
42122168|NCT00395512|75932730|FG000|Overall Study|Lost to Follow-up|2|||
42122169|NCT00395512|75932731|FG001|Overall Study|Lost to Follow-up|6|||
42122170|NCT00395512|75932732|FG002|Overall Study|Lost to Follow-up|5|||
42122171|NCT00395512|75932733|FG003|Overall Study|Lost to Follow-up|5|||
42122172|NCT00395512|75932730|FG000|Overall Study|Withdrawal by Subject|6|||
42122173|NCT00395512|75932731|FG001|Overall Study|Withdrawal by Subject|5|||
42122174|NCT00395512|75932732|FG002|Overall Study|Withdrawal by Subject|5|||
42122175|NCT00395512|75932733|FG003|Overall Study|Withdrawal by Subject|12|||
42122176|NCT00395512|75932730|FG000|Overall Study|Physician Decision|6|||
42122177|NCT00395512|75932731|FG001|Overall Study|Physician Decision|4|||
42122178|NCT00395512|75932732|FG002|Overall Study|Physician Decision|2|||
42122179|NCT00395512|75932733|FG003|Overall Study|Physician Decision|2|||
42122180|NCT00395512|75932730|FG000|Overall Study|Other|1|||
42122181|NCT00395512|75932731|FG001|Overall Study|Other|1|||
42122182|NCT00395512|75932732|FG002|Overall Study|Other|0|||
42122183|NCT00395512|75932733|FG003|Overall Study|Other|0|||
42122184|NCT00395512|75932730|FG000|Overall Study|Hyperglycemic Rescue|18|||
42122185|NCT00395512|75932731|FG001|Overall Study|Hyperglycemic Rescue|10|||
42122186|NCT00395512|75932732|FG002|Overall Study|Hyperglycemic Rescue|4|||
42122187|NCT00395512|75932733|FG003|Overall Study|Hyperglycemic Rescue|6|||
42122188|NCT00054691|75932743|FG000|Overall Study|Unmeasurable Disease|2|||
42122189|NCT00054691|75932743|FG000|Overall Study|Noncompliant|1|||
42122190|NCT00387712|75932749|FG000|Overall Study|Physician Decision|6|||
42122191|NCT00387712|75932750|FG001|Overall Study|Physician Decision|4|||
42122192|NCT00387712|75932749|FG000|Overall Study|Lost to Follow-up|17|||
42122193|NCT00387712|75932750|FG001|Overall Study|Lost to Follow-up|20|||
42122194|NCT00387712|75932749|FG000|Overall Study|Withdrawal by Subject|6|||
42122195|NCT00387712|75932750|FG001|Overall Study|Withdrawal by Subject|12|||
42122196|NCT00072475|75932756|FG000|Overall Study|Adverse Event|44|||
42122197|NCT00072475|75932756|FG000|Overall Study|Death|3|||
42122198|NCT00072475|75932756|FG000|Overall Study|Withdrawal by Subject|46|||
42122199|NCT00072475|75932756|FG000|Overall Study|Patient/Investigator Decision|4|||
42122200|NCT00066469|75932760|FG000|Overall Study|Death|3|||
42122201|NCT00066469|75932760|FG000|Overall Study|Lack of Efficacy|9|||
42122202|NCT00066469|75932760|FG000|Overall Study|Lost to Follow-up|1|||
42122203|NCT00066469|75932760|FG000|Overall Study|Physician Decision|1|||
42122204|NCT00066469|75932760|FG000|Overall Study|Withdrawal by Subject|1|||
42122205|NCT00066469|75932760|FG000|Overall Study|ineligible|1|||
42122206|NCT00387088|75932766|FG000|Overall Study|Adverse Event|143|||
42122207|NCT00387088|75932767|FG001|Overall Study|Adverse Event|156|||
42122208|NCT00387088|75932766|FG000|Overall Study|Protocol Violation|47|||
42122209|NCT00387088|75932767|FG001|Overall Study|Protocol Violation|35|||
42122210|NCT00387088|75932766|FG000|Overall Study|Withdrawal by Subject|20|||
42122211|NCT00387088|75932767|FG001|Overall Study|Withdrawal by Subject|35|||
42122212|NCT00387088|75932766|FG000|Overall Study|Lack of Efficacy|28|||
42122213|NCT00387088|75932767|FG001|Overall Study|Lack of Efficacy|67|||
42122214|NCT00387088|75932766|FG000|Overall Study|Lost to Follow-up|22|||
42122215|NCT00387088|75932767|FG001|Overall Study|Lost to Follow-up|28|||
42122216|NCT00387088|75932766|FG000|Overall Study|Other|58|||
42027496|NCT01165242|75835713|FG002|Overall Study|Unreachable Subjects|0|||
42027497|NCT01165242|75835711|FG000|Overall Study|Incarcerated Subjects|0|||
42027498|NCT01165242|75835712|FG001|Overall Study|Incarcerated Subjects|1|||
42027499|NCT01165242|75835713|FG002|Overall Study|Incarcerated Subjects|0|||
42027500|NCT01165242|75835711|FG000|Overall Study|Visit 2 Declined by Subject|0|||
42027501|NCT01165242|75835712|FG001|Overall Study|Visit 2 Declined by Subject|0|||
42027502|NCT01165242|75835713|FG002|Overall Study|Visit 2 Declined by Subject|1|||
42027503|NCT01165242|75835711|FG000|Overall Study|Withdrawal by Subject|0|||
42027504|NCT01165242|75835712|FG001|Overall Study|Withdrawal by Subject|2|||
42122217|NCT00387088|75932767|FG001|Overall Study|Other|52|||
42122218|NCT00053365|75932773|FG000|Overall Study|Incorrect cell type|1|||
42122219|NCT00053365|75932773|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
42122220|NCT00053365|75932773|FG000|Overall Study|Never treated|4|||
42122221|NCT00387010|75932779|FG000|Dose Titration Period|Adverse Event|12|||
42122222|NCT00387010|75932779|FG000|Dose Titration Period|Lack of Efficacy|5|||
42122223|NCT00387010|75932779|FG000|Dose Titration Period|Withdrawal by Subject|3|||
42027505|NCT01165242|75835713|FG002|Overall Study|Withdrawal by Subject|2|||
42027506|NCT01165242|75835711|FG000|Overall Study|Extended Holiday|0|||
42027507|NCT01165242|75835712|FG001|Overall Study|Extended Holiday|0|||
42122224|NCT00387010|75932779|FG000|Dose Titration Period|Protocol Violation|1|||
42122225|NCT00387010|75932779|FG000|Dose Titration Period|Lost to Follow-up|2|||
41965686|NCT00557466|75765041|FG005|Overall Study|Lost to Follow-up|0|||
41965687|NCT00557310|75765055|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
41965688|NCT00557310|75765055|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
41965689|NCT00557310|75765055|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
41965690|NCT00557310|75765055|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
41965691|NCT00557310|75765055|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
41965692|NCT00557310|75765055|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
41965693|NCT00555438|75765059|FG000|10 Days Post-operative|Death|4|||
41965694|NCT00555438|75765059|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
41965695|NCT00553644|75765063|FG000|Overall Study|Adverse Event|17|||
41965696|NCT00553644|75765063|FG000|Overall Study|Withdrawal by Subject|4|||
41965697|NCT00553644|75765063|FG000|Overall Study|Physician Decision|1|||
41965698|NCT00553644|75765063|FG000|Overall Study|Alternative therapy|6|||
41965699|NCT00553332|75765067|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
42301127|NCT02520661|76136441|FG000|Overall Study|Admitted from ED|49|||
42301128|NCT02520661|76136442|FG001|Overall Study|Admitted from ED|48|||
42301129|NCT02520661|76136441|FG000|Overall Study|ED greater than 24 hours|29|||
41965700|NCT00552396|75765078|FG000|Overall Study|protocol withdrawal criteria|3|||
41965701|NCT00552396|75765079|FG001|Overall Study|protocol withdrawal criteria|3|||
41965702|NCT00552396|75765080|FG002|Overall Study|protocol withdrawal criteria|3|||
41965703|NCT00552396|75765081|FG003|Overall Study|protocol withdrawal criteria|6|||
41965704|NCT00552396|75765082|FG004|Overall Study|protocol withdrawal criteria|3|||
41965705|NCT00552396|75765083|FG005|Overall Study|protocol withdrawal criteria|3|||
41965706|NCT00552396|75765084|FG006|Overall Study|protocol withdrawal criteria|9|||
41965707|NCT00552240|75765120|FG000|Overall Study|Adverse Event|9|||
41965708|NCT00552240|75765121|FG001|Overall Study|Adverse Event|9|||
41965709|NCT00552240|75765120|FG000|Overall Study|Protocol Violation|1|||
41965710|NCT00552240|75765121|FG001|Overall Study|Protocol Violation|1|||
41965711|NCT00552240|75765120|FG000|Overall Study|Lost to Follow-up|5|||
41965712|NCT00552240|75765121|FG001|Overall Study|Lost to Follow-up|6|||
41965713|NCT00552240|75765120|FG000|Overall Study|Withdrawal by Subject|2|||
41965714|NCT00552240|75765121|FG001|Overall Study|Withdrawal by Subject|2|||
41965715|NCT00552240|75765120|FG000|Overall Study|Lack of Efficacy|6|||
41965716|NCT00552240|75765121|FG001|Overall Study|Lack of Efficacy|0|||
41965717|NCT00552240|75765120|FG000|Overall Study|Other|1|||
41965718|NCT00552240|75765121|FG001|Overall Study|Other|0|||
41965719|NCT00552084|75765129|FG000|Overall Study|Adverse Event|2|||
41965720|NCT00552084|75765130|FG001|Overall Study|Adverse Event|3|||
41965721|NCT00552084|75765129|FG000|Overall Study|Withdrawal by Subject|4|||
41965722|NCT00552084|75765130|FG001|Overall Study|Withdrawal by Subject|5|||
41965723|NCT00552084|75765129|FG000|Overall Study|Protocol Violation|1|||
41965724|NCT00552084|75765130|FG001|Overall Study|Protocol Violation|0|||
41965725|NCT00552084|75765129|FG000|Overall Study|change in anti-arrythmic drug|1|||
41965726|NCT00552084|75765130|FG001|Overall Study|change in anti-arrythmic drug|1|||
41965727|NCT00550836|75765138|FG000|Overall Study|Withdrawal by Subject|3|||
41965728|NCT00550836|75765139|FG001|Overall Study|Withdrawal by Subject|9|||
41965729|NCT00550680|75765145|FG000|Overall Study|Administrative Reasons|1|||
41965730|NCT00550680|75765145|FG000|Overall Study|Adverse Event|5|||
41965731|NCT00550680|75765145|FG000|Overall Study|Death|3|||
41965732|NCT00550680|75765145|FG000|Overall Study|Early Improvement|1|||
41965733|NCT00550680|75765145|FG000|Overall Study|Lost to Follow-up|3|||
41965734|NCT00550680|75765145|FG000|Overall Study|Lack of Efficacy|1|||
41965735|NCT00550680|75765145|FG000|Overall Study|Other|10|||
41965736|NCT00550680|75765145|FG000|Overall Study|Protocol Violation|7|||
41965737|NCT00550680|75765145|FG000|Overall Study|Refused Treatment|19|||
41965738|NCT00550680|75765145|FG000|Overall Study|Screen Failure|6|||
41965739|NCT00554190|75765149|FG000|Overall Study|Termination forms not completed|10|||
41965740|NCT00556374|75765155|FG000|Overall Study|Withdrawal by Subject|235|||
41965741|NCT00556374|75765156|FG001|Overall Study|Withdrawal by Subject|205|||
41965742|NCT00556374|75765155|FG000|Overall Study|Death|158|||
41965743|NCT00556374|75765156|FG001|Overall Study|Death|127|||
41965744|NCT00556374|75765155|FG000|Overall Study|Lost to Follow-up|24|||
41965745|NCT00556374|75765156|FG001|Overall Study|Lost to Follow-up|17|||
41965746|NCT00556374|75765155|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
41965747|NCT00556374|75765156|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
41965748|NCT04677959|75765187|FG000|Overall Study|Adverse Event|1|||
41965749|NCT04677959|75765188|FG001|Overall Study|Adverse Event|9|||
42122226|NCT00387010|75932779|FG000|Dose Titration Period|Noncompliance with study medication|8|||
41965750|NCT04677959|75765187|FG000|Overall Study|Withdrawal by Subject|2|||
42137784|NCT00427908|75948132|FG000|Primary Phase|Lost to Follow-up|4|||
41965751|NCT04677959|75765188|FG001|Overall Study|Withdrawal by Subject|15|||
41965752|NCT04677959|75765187|FG000|Overall Study|Withdrawal by parent/guardian|0|||
41965753|NCT04677959|75765188|FG001|Overall Study|Withdrawal by parent/guardian|1|||
41965754|NCT04677959|75765187|FG000|Overall Study|Non-compliance with study drug|0|||
41965755|NCT04677959|75765188|FG001|Overall Study|Non-compliance with study drug|2|||
42210368|NCT03227445|76025156|FG000|Period 1 (28 Days)|Adverse Event|1|||
41965756|NCT04677959|75765187|FG000|Overall Study|Protocol deviation|0|||
41965757|NCT04677959|75765188|FG001|Overall Study|Protocol deviation|11|||
41965758|NCT04677959|75765187|FG000|Overall Study|Lost to Follow-up|9|||
42122227|NCT00387010|75932779|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
42122228|NCT00387010|75932779|FG000|Treatment Period|Adverse Event|4|||
42122229|NCT00387010|75932779|FG000|Treatment Period|Withdrawal by Subject|1|||
42122230|NCT00387010|75932779|FG000|Treatment Period|Noncompliance with study medication|2|||
42122231|NCT00387010|75932779|FG000|Treatment Period|Noncompliance with study procedures|3|||
42122232|NCT00387010|75932779|FG000|Treatment Period|Participant reported study drug stolen|1|||
42122233|NCT00386776|75932783|FG000|Overall Study|Withdrawal by Subject|8|||
42122234|NCT00065065|75932791|FG000|Overall Study|Adverse Event|3|||
41965759|NCT04677959|75765188|FG001|Overall Study|Lost to Follow-up|13|||
41965760|NCT04677959|75765187|FG000|Overall Study|Other than specified|0|||
41965761|NCT04677959|75765188|FG001|Overall Study|Other than specified|8|||
41965762|NCT04330638|75765215|FG000|Overall Study|Adverse Event|9|||
41965763|NCT04330638|75765216|FG001|Overall Study|Adverse Event|10|||
41965764|NCT04330638|75765217|FG002|Overall Study|Adverse Event|15|||
41965765|NCT04330638|75765218|FG003|Overall Study|Adverse Event|6|||
41965766|NCT04330638|75765219|FG004|Overall Study|Adverse Event|10|||
41965767|NCT04330638|75765220|FG005|Overall Study|Adverse Event|5|||
41965768|NCT04330638|75765215|FG000|Overall Study|Other|2|||
41965769|NCT04330638|75765216|FG001|Overall Study|Other|2|||
41965770|NCT04330638|75765217|FG002|Overall Study|Other|5|||
41965771|NCT04330638|75765218|FG003|Overall Study|Other|1|||
41965772|NCT04330638|75765219|FG004|Overall Study|Other|3|||
41965773|NCT04330638|75765220|FG005|Overall Study|Other|2|||
41965774|NCT04330638|75765215|FG000|Overall Study|Withdrawal by Subject|4|||
41965775|NCT04330638|75765216|FG001|Overall Study|Withdrawal by Subject|0|||
41965776|NCT04330638|75765217|FG002|Overall Study|Withdrawal by Subject|0|||
41965777|NCT04330638|75765218|FG003|Overall Study|Withdrawal by Subject|0|||
41965778|NCT04330638|75765219|FG004|Overall Study|Withdrawal by Subject|0|||
41965779|NCT04330638|75765220|FG005|Overall Study|Withdrawal by Subject|0|||
41965780|NCT04330638|75765215|FG000|Overall Study|Lost to Follow-up|3|||
41965781|NCT04330638|75765216|FG001|Overall Study|Lost to Follow-up|2|||
41965782|NCT04330638|75765217|FG002|Overall Study|Lost to Follow-up|3|||
41965783|NCT04330638|75765218|FG003|Overall Study|Lost to Follow-up|2|||
41965784|NCT04330638|75765219|FG004|Overall Study|Lost to Follow-up|3|||
41965785|NCT04330638|75765220|FG005|Overall Study|Lost to Follow-up|0|||
41965786|NCT04194541|75765241|FG000|Day 1 Through 13|Lost to Follow-up|3|||
41965787|NCT04194541|75765241|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
41965788|NCT04194541|75765241|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
41965789|NCT04006392|75765259|FG000|Overall Study|Lost to Follow-up|0|||
41965790|NCT04006392|75765260|FG001|Overall Study|Lost to Follow-up|1|||
41965791|NCT03959423|75765268|FG000|Overall Study|Withdrawal by Subject|2|||
41965792|NCT03959423|75765269|FG001|Overall Study|Withdrawal by Subject|3|||
41965793|NCT03959423|75765268|FG000|Overall Study|Physician Decision|0|||
42122235|NCT00065065|75932792|FG001|Overall Study|Adverse Event|2|||
42122236|NCT00065065|75932791|FG000|Overall Study|Withdrawal by Subject|1|||
42122237|NCT00065065|75932792|FG001|Overall Study|Withdrawal by Subject|5|||
42122238|NCT00065065|75932791|FG000|Overall Study|Lack of Efficacy|4|||
42122239|NCT00065065|75932792|FG001|Overall Study|Lack of Efficacy|11|||
42122240|NCT00065065|75932791|FG000|Overall Study|Other|2|||
42122241|NCT00065065|75932792|FG001|Overall Study|Other|2|||
42122242|NCT00386308|75932802|FG000|Overall Study|Adverse Event|3|||
42122243|NCT00386308|75932803|FG001|Overall Study|Adverse Event|3|||
42122244|NCT00386308|75932802|FG000|Overall Study|Protocol Violation|2|||
42122245|NCT00386308|75932803|FG001|Overall Study|Protocol Violation|5|||
42122246|NCT00386308|75932802|FG000|Overall Study|Lack of Efficacy|0|||
42122247|NCT00386308|75932803|FG001|Overall Study|Lack of Efficacy|2|||
42122248|NCT00386308|75932802|FG000|Overall Study|Lost to Follow-up|10|||
42122249|NCT00386308|75932803|FG001|Overall Study|Lost to Follow-up|6|||
42122250|NCT00386308|75932802|FG000|Overall Study|Withdrawal by Subject|6|||
42122251|NCT00386308|75932803|FG001|Overall Study|Withdrawal by Subject|2|||
42122252|NCT00386308|75932802|FG000|Overall Study|Other Event|8|||
42122253|NCT00386308|75932803|FG001|Overall Study|Other Event|1|||
41965794|NCT03959423|75765269|FG001|Overall Study|Physician Decision|1|||
41965795|NCT03959423|75765268|FG000|Overall Study|Lost to Follow-up|1|||
41965796|NCT03959423|75765269|FG001|Overall Study|Lost to Follow-up|0|||
41965797|NCT03959423|75765268|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
42122254|NCT00064987|75932811|FG000|Overall Study|Physician Decision|3|||
42122255|NCT00064987|75932812|FG001|Overall Study|Physician Decision|0|||
42122256|NCT00374452|75932820|FG000|Overall Study|Left clinic before intervention started|4|||
42122257|NCT00374452|75932821|FG001|Overall Study|Left clinic before intervention started|1|||
42122258|NCT00374452|75932820|FG000|Overall Study|Change in job role before intervention|0|||
42210369|NCT03227445|76025157|FG001|Period 1 (28 Days)|Adverse Event|2|||
41965798|NCT03959423|75765269|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
41965799|NCT03786783|75765275|FG000|Overall Study|Death|1|||
41965800|NCT03786783|75765275|FG000|Overall Study|Physician Decision|6|||
42122259|NCT00374452|75932821|FG001|Overall Study|Change in job role before intervention|1|||
42122260|NCT00374452|75932820|FG000|Overall Study|Left clinic after intervention started|1|||
42122261|NCT00374452|75932821|FG001|Overall Study|Left clinic after intervention started|1|||
42122262|NCT00374452|75932820|FG000|Overall Study|Withdrawal by Subject|0|||
42122263|NCT00374452|75932821|FG001|Overall Study|Withdrawal by Subject|2|||
41965801|NCT03786783|75765275|FG000|Overall Study|Withdrawal by Subject|2|||
41965802|NCT03786783|75765275|FG000|Overall Study|Disease Progression|7|||
41965803|NCT03786783|75765275|FG000|Overall Study|Patient/Parent Refusal|4|||
41965804|NCT03432494|75765289|FG000|Overall Study|Death|1|||
41965805|NCT03432494|75765289|FG000|Overall Study|Noncompliance|1|||
41965806|NCT03287830|75765295|FG000|Overall Study|Withdrawal by Subject|1|||
41965807|NCT03287830|75765296|FG001|Overall Study|Withdrawal by Subject|1|||
41965808|NCT03287830|75765295|FG000|Overall Study|not meeting inclusion criteria|5|||
41965809|NCT03287830|75765296|FG001|Overall Study|not meeting inclusion criteria|12|||
41965810|NCT03181633|75765306|FG000|Overall Study|Withdrawal by Subject|1|||
41965811|NCT03181633|75765306|FG000|Overall Study|Missing follow-up visit|1|||
41965812|NCT03122223|75765323|FG000|Overall Study|Withdrawal by Subject|2|||
41965813|NCT03122223|75765324|FG001|Overall Study|Withdrawal by Subject|2|||
41965814|NCT03122223|75765325|FG002|Overall Study|Withdrawal by Subject|1|||
41965815|NCT03122223|75765326|FG003|Overall Study|Withdrawal by Subject|0|||
41965816|NCT03122223|75765323|FG000|Overall Study|Lost to Follow-up|0|||
41965817|NCT03122223|75765324|FG001|Overall Study|Lost to Follow-up|2|||
41965818|NCT03122223|75765325|FG002|Overall Study|Lost to Follow-up|2|||
41965819|NCT03122223|75765326|FG003|Overall Study|Lost to Follow-up|0|||
41965820|NCT03122223|75765323|FG000|Overall Study|Participant unable to adhere|1|||
41965821|NCT03122223|75765324|FG001|Overall Study|Participant unable to adhere|1|||
41965822|NCT03122223|75765325|FG002|Overall Study|Participant unable to adhere|1|||
41965823|NCT03122223|75765326|FG003|Overall Study|Participant unable to adhere|0|||
41965824|NCT03077087|75765336|FG000|Overall Study|Physician Decision|2|||
41965825|NCT02853604|75765342|FG000|Overall Study|Withdrawal by Subject|12|||
41965826|NCT02853604|75765343|FG001|Overall Study|Withdrawal by Subject|35|||
41965827|NCT02853604|75765342|FG000|Overall Study|Lost to Follow-up|4|||
41965828|NCT02853604|75765343|FG001|Overall Study|Lost to Follow-up|8|||
41965829|NCT02853604|75765342|FG000|Overall Study|Death|1|||
41965830|NCT02853604|75765343|FG001|Overall Study|Death|5|||
41965831|NCT02853604|75765342|FG000|Overall Study|Miscellaneous|11|||
41965832|NCT02853604|75765343|FG001|Overall Study|Miscellaneous|2|||
41965833|NCT02853604|75765342|FG000|Overall Study|Progressive Disease|0|||
41965834|NCT02853604|75765343|FG001|Overall Study|Progressive Disease|2|||
41965835|NCT02632552|75765369|FG000|Overall Study|Lost to Follow-up|14|||
41965836|NCT02632552|75765370|FG001|Overall Study|Lost to Follow-up|8|||
41965837|NCT02632552|75765369|FG000|Overall Study|Withdrawal by Subject|2|||
41965838|NCT02632552|75765370|FG001|Overall Study|Withdrawal by Subject|0|||
41965839|NCT02632552|75765369|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
41965840|NCT02632552|75765370|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
41965841|NCT02525562|75765395|FG000|Overall Study|Death|9|||
41965842|NCT02525562|75765396|FG001|Overall Study|Death|0|||
41965843|NCT02525562|75765397|FG002|Overall Study|Death|0|||
41965844|NCT02525562|75765395|FG000|Overall Study|Lost to Follow-up|19|||
41965845|NCT02525562|75765396|FG001|Overall Study|Lost to Follow-up|0|||
41965846|NCT02525562|75765397|FG002|Overall Study|Lost to Follow-up|0|||
41965847|NCT02525562|75765395|FG000|Overall Study|Withdrawal by Subject|37|||
41965848|NCT02525562|75765396|FG001|Overall Study|Withdrawal by Subject|0|||
41965849|NCT02525562|75765397|FG002|Overall Study|Withdrawal by Subject|0|||
41965850|NCT02525562|75765395|FG000|Overall Study|Revision/Removal of Study Device|4|||
41965851|NCT02525562|75765396|FG001|Overall Study|Revision/Removal of Study Device|0|||
41965852|NCT02525562|75765397|FG002|Overall Study|Revision/Removal of Study Device|0|||
41965853|NCT02525562|75765395|FG000|Overall Study|Study Closed by Sponsor|154|||
41965854|NCT02525562|75765396|FG001|Overall Study|Study Closed by Sponsor|0|||
41965855|NCT02525562|75765397|FG002|Overall Study|Study Closed by Sponsor|0|||
41965856|NCT01992653|75765410|FG000|Overall Study|Death|0|||
41965857|NCT01992653|75765411|FG001|Overall Study|Death|0|||
41965858|NCT01992653|75765412|FG002|Overall Study|Death|1|||
42122264|NCT00064753|75932829|FG000|Overall Study|Death|251|||
42122265|NCT00064753|75932830|FG001|Overall Study|Death|242|||
41965859|NCT01992653|75765413|FG003|Overall Study|Death|0|||
41965860|NCT01992653|75765414|FG004|Overall Study|Death|1|||
41965861|NCT01992653|75765415|FG005|Overall Study|Death|0|||
41965862|NCT01992653|75765416|FG006|Overall Study|Death|4|||
41965863|NCT01992653|75765417|FG007|Overall Study|Death|2|||
41965864|NCT01992653|75765410|FG000|Overall Study|Lost to Follow-up|0|||
41965865|NCT01992653|75765411|FG001|Overall Study|Lost to Follow-up|0|||
41965866|NCT01992653|75765412|FG002|Overall Study|Lost to Follow-up|0|||
41965867|NCT01992653|75765413|FG003|Overall Study|Lost to Follow-up|0|||
41965868|NCT01992653|75765414|FG004|Overall Study|Lost to Follow-up|0|||
42122266|NCT00064753|75932829|FG000|Overall Study|Withdrawal by Subject|198|||
41965869|NCT01992653|75765415|FG005|Overall Study|Lost to Follow-up|0|||
41965870|NCT01992653|75765416|FG006|Overall Study|Lost to Follow-up|0|||
42122267|NCT00064753|75932830|FG001|Overall Study|Withdrawal by Subject|171|||
42122268|NCT00064753|75932829|FG000|Overall Study|Lost to Follow-up|225|||
42122269|NCT00064753|75932830|FG001|Overall Study|Lost to Follow-up|235|||
42122270|NCT00374140|75932836|FG000|Overall Study|Lost to Follow-up|1|||
42122271|NCT00374140|75932836|FG000|Overall Study|Protocol Violation|1|||
42122272|NCT00665561|75932842|FG000|Overall Study|Death recorded on subject summary pages|75|||
41965871|NCT01992653|75765417|FG007|Overall Study|Lost to Follow-up|1|||
41965872|NCT01992653|75765410|FG000|Overall Study|Study Completed|0|||
41965873|NCT01992653|75765411|FG001|Overall Study|Study Completed|0|||
41965874|NCT01992653|75765412|FG002|Overall Study|Study Completed|0|||
41965875|NCT01992653|75765413|FG003|Overall Study|Study Completed|0|||
41965876|NCT01992653|75765414|FG004|Overall Study|Study Completed|0|||
41965877|NCT01992653|75765415|FG005|Overall Study|Study Completed|0|||
41965878|NCT01992653|75765416|FG006|Overall Study|Study Completed|0|||
41965879|NCT01992653|75765417|FG007|Overall Study|Study Completed|1|||
41965880|NCT01992653|75765410|FG000|Overall Study|Disease Progression|0|||
41965881|NCT01992653|75765411|FG001|Overall Study|Disease Progression|0|||
41965882|NCT01992653|75765412|FG002|Overall Study|Disease Progression|0|||
41965883|NCT01992653|75765413|FG003|Overall Study|Disease Progression|0|||
41965884|NCT01992653|75765414|FG004|Overall Study|Disease Progression|0|||
41965885|NCT01992653|75765415|FG005|Overall Study|Disease Progression|0|||
41965886|NCT01992653|75765416|FG006|Overall Study|Disease Progression|4|||
41965887|NCT01992653|75765417|FG007|Overall Study|Disease Progression|0|||
41965888|NCT01654276|75765452|FG000|Overall Study|Lack of Efficacy|1|||
41965889|NCT01654276|75765452|FG000|Overall Study|Lost to Follow-up|4|||
41965890|NCT01654276|75765452|FG000|Overall Study|Withdrawal by Subject|1|||
41965891|NCT01399658|75765456|FG000|Overall Study|Ineligible|1|||
41965892|NCT01399658|75765456|FG000|Overall Study|Machine Technical Issue|3|||
41965893|NCT01399658|75765456|FG000|Overall Study|Alternative therapy|1|||
41965894|NCT01399658|75765456|FG000|Overall Study|No reason given|1|||
41965895|NCT00590122|75765462|FG000|Overall Study|swallowed oral dissolving dose|1|||
41965896|NCT00590122|75765463|FG001|Overall Study|swallowed oral dissolving dose|0|||
41965897|NCT01386658|75765492|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
41965898|NCT01386658|75765493|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
41965899|NCT01386658|75765492|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
41965900|NCT01386658|75765493|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
41965901|NCT01386684|75765503|FG000|Overall Study|Lost to Follow-up|51|||
41965902|NCT01386684|75765503|FG000|Overall Study|Other|51|||
41965903|NCT01386684|75765503|FG000|Overall Study|Death|47|||
41965904|NCT01386684|75765503|FG000|Overall Study|Withdrawal of Consent|44|||
41965905|NCT01386684|75765503|FG000|Overall Study|Alternative Therapy Required|37|||
41965906|NCT01386684|75765503|FG000|Overall Study|Disease Progression|28|||
41965907|NCT01386684|75765503|FG000|Overall Study|Adverse Event|20|||
41965908|NCT01386684|75765503|FG000|Overall Study|Noncompliance|8|||
41965909|NCT01386684|75765503|FG000|Overall Study|Protocol Violation|4|||
41965910|NCT01386684|75765503|FG000|Overall Study|Missing|3|||
41965911|NCT04980014|75765520|FG000|Overall Study|Participants who are Duplicated|1|||
41965912|NCT04980014|75765520|FG000|Overall Study|Follow-up Failure|13|||
41965913|NCT04980014|75765520|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
41965914|NCT04980014|75765520|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
41965915|NCT04980014|75765520|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
41965916|NCT05301322|75765543|FG000|Overall Study|Adverse Event|7|||
41965917|NCT05301322|75765544|FG001|Overall Study|Adverse Event|3|||
41965918|NCT05301322|75765543|FG000|Overall Study|Death|0|||
41965919|NCT05301322|75765544|FG001|Overall Study|Death|1|||
41965920|NCT05301322|75765543|FG000|Overall Study|Lost to Follow-up|2|||
41965921|NCT05301322|75765544|FG001|Overall Study|Lost to Follow-up|1|||
41965922|NCT05301322|75765543|FG000|Overall Study|Protocol Violation|3|||
41965923|NCT05301322|75765544|FG001|Overall Study|Protocol Violation|1|||
41965924|NCT05301322|75765543|FG000|Overall Study|Withdrawal by Subject|3|||
41965925|NCT05301322|75765544|FG001|Overall Study|Withdrawal by Subject|0|||
42301130|NCT02520661|76136442|FG001|Overall Study|ED greater than 24 hours|38|||
42301131|NCT02520661|76136441|FG000|Overall Study|other ineligibility|14|||
42301132|NCT02520661|76136442|FG001|Overall Study|other ineligibility|22|||
41965926|NCT05301322|75765543|FG000|Overall Study|Other|4|||
41965927|NCT05301322|75765544|FG001|Overall Study|Other|0|||
41965928|NCT04956575|75765582|FG000|Overall Study|Death|1|||
41965929|NCT04956575|75765583|FG001|Overall Study|Death|0|||
41965930|NCT04956575|75765584|FG002|Overall Study|Death|0|||
41965931|NCT04956575|75765585|FG003|Overall Study|Death|0|||
41965932|NCT04956575|75765586|FG004|Overall Study|Death|0|||
41965933|NCT04956575|75765587|FG005|Overall Study|Death|0|||
41965934|NCT04956575|75765588|FG006|Overall Study|Death|0|||
41965935|NCT04956575|75765589|FG007|Overall Study|Death|1|||
41965936|NCT04956575|75765590|FG008|Overall Study|Death|0|||
41965937|NCT04956575|75765591|FG009|Overall Study|Death|1|||
41965938|NCT04956575|75765592|FG010|Overall Study|Death|0|||
41965939|NCT04956575|75765593|FG011|Overall Study|Death|0|||
41965940|NCT04956575|75765582|FG000|Overall Study|Lost to Follow-up|3|||
42122273|NCT00665561|75932843|FG001|Overall Study|Death recorded on subject summary pages|75|||
42122274|NCT00665561|75932842|FG000|Overall Study|Does not meet entrance criteria|19|||
42122275|NCT00665561|75932843|FG001|Overall Study|Does not meet entrance criteria|21|||
42122276|NCT00665561|75932842|FG000|Overall Study|Lost to Follow-up|203|||
42122277|NCT00665561|75932843|FG001|Overall Study|Lost to Follow-up|264|||
42122278|NCT00665561|75932842|FG000|Overall Study|Withdrawal by Subject|74|||
42122279|NCT00665561|75932843|FG001|Overall Study|Withdrawal by Subject|65|||
42122280|NCT00665561|75932842|FG000|Overall Study|Other|123|||
42122281|NCT00665561|75932843|FG001|Overall Study|Other|108|||
42122282|NCT00665561|75932842|FG000|Overall Study|Site closed|8|||
42122283|NCT00665561|75932843|FG001|Overall Study|Site closed|0|||
42122284|NCT00665561|75932842|FG000|Overall Study|Withdrawn due to pregnancy|0|||
42122285|NCT00665561|75932843|FG001|Overall Study|Withdrawn due to pregnancy|1|||
42122286|NCT00663923|75932849|FG000|Overall Study|Lost to Follow-up|2|||
42122287|NCT00386152|75932858|FG000|Overall Study|Adverse Event|6|||
42122288|NCT00386152|75932859|FG001|Overall Study|Adverse Event|5|||
42122289|NCT00386152|75932860|FG002|Overall Study|Adverse Event|4|||
42122290|NCT00386152|75932858|FG000|Overall Study|Chang from original chemo stratification|4|||
42122291|NCT00386152|75932859|FG001|Overall Study|Chang from original chemo stratification|5|||
42122292|NCT00386152|75932860|FG002|Overall Study|Chang from original chemo stratification|6|||
42122293|NCT00386152|75932858|FG000|Overall Study|Death|3|||
41965941|NCT04956575|75765583|FG001|Overall Study|Lost to Follow-up|4|||
41965942|NCT04956575|75765584|FG002|Overall Study|Lost to Follow-up|2|||
41965943|NCT04956575|75765585|FG003|Overall Study|Lost to Follow-up|3|||
41965944|NCT04956575|75765586|FG004|Overall Study|Lost to Follow-up|1|||
41965945|NCT04956575|75765587|FG005|Overall Study|Lost to Follow-up|10|||
41965946|NCT04956575|75765588|FG006|Overall Study|Lost to Follow-up|11|||
41965947|NCT04956575|75765589|FG007|Overall Study|Lost to Follow-up|7|||
41965948|NCT04956575|75765590|FG008|Overall Study|Lost to Follow-up|4|||
41965949|NCT04956575|75765591|FG009|Overall Study|Lost to Follow-up|2|||
41965950|NCT04956575|75765592|FG010|Overall Study|Lost to Follow-up|3|||
41965951|NCT04956575|75765593|FG011|Overall Study|Lost to Follow-up|8|||
41965952|NCT04956575|75765582|FG000|Overall Study|Withdrawal by Subject|1|||
41965953|NCT04956575|75765583|FG001|Overall Study|Withdrawal by Subject|2|||
41965954|NCT04956575|75765584|FG002|Overall Study|Withdrawal by Subject|1|||
41965955|NCT04956575|75765585|FG003|Overall Study|Withdrawal by Subject|4|||
41965956|NCT04956575|75765586|FG004|Overall Study|Withdrawal by Subject|2|||
41965957|NCT04956575|75765587|FG005|Overall Study|Withdrawal by Subject|8|||
41965958|NCT04956575|75765588|FG006|Overall Study|Withdrawal by Subject|5|||
41965959|NCT04956575|75765589|FG007|Overall Study|Withdrawal by Subject|1|||
41965960|NCT04956575|75765590|FG008|Overall Study|Withdrawal by Subject|1|||
41965961|NCT04956575|75765591|FG009|Overall Study|Withdrawal by Subject|0|||
41965962|NCT04956575|75765592|FG010|Overall Study|Withdrawal by Subject|3|||
41965963|NCT04956575|75765593|FG011|Overall Study|Withdrawal by Subject|1|||
41965964|NCT04720105|75765644|FG000|Overall Study|Lack of Efficacy|1|||
41965965|NCT04720105|75765644|FG000|Overall Study|Lost to Follow-up|1|||
41965966|NCT04720105|75765644|FG000|Overall Study|Withdrawal by Subject|3|||
41965967|NCT04573309|75765654|FG000|Overall Study|Protocol Violation|1|||
41965968|NCT04573309|75765655|FG001|Overall Study|Protocol Violation|0|||
41965969|NCT04220866|75765672|FG000|Overall Study|Death|4|||
41965970|NCT04220866|75765673|FG001|Overall Study|Death|5|||
41965971|NCT04220866|75765672|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
41965972|NCT04220866|75765673|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
41965973|NCT04220866|75765672|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
41965974|NCT04220866|75765673|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
41965975|NCT04220866|75765672|FG000|Overall Study|Withdrawal by Subject|0|||
41965976|NCT04220866|75765673|FG001|Overall Study|Withdrawal by Subject|1|||
41965977|NCT04004611|75765686|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
41965978|NCT04004611|75765687|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
41965979|NCT04004611|75765688|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
41965980|NCT04004611|75765689|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
41965981|NCT04004611|75765690|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
41965982|NCT04004611|75765691|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
41965983|NCT04004611|75765692|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
41965984|NCT04004611|75765693|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
42122294|NCT00386152|75932859|FG001|Overall Study|Death|0|||
41965985|NCT04004611|75765694|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
41965986|NCT04004611|75765686|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
41965987|NCT04004611|75765687|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
42122295|NCT00386152|75932860|FG002|Overall Study|Death|1|||
41965988|NCT04004611|75765688|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
41965989|NCT04004611|75765689|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
42122296|NCT00386152|75932858|FG000|Overall Study|Disease progression|7|||
42122297|NCT00386152|75932859|FG001|Overall Study|Disease progression|4|||
42122298|NCT00386152|75932860|FG002|Overall Study|Disease progression|5|||
42122299|NCT00386152|75932858|FG000|Overall Study|Physician Decision|13|||
42122300|NCT00386152|75932859|FG001|Overall Study|Physician Decision|10|||
42122301|NCT00386152|75932860|FG002|Overall Study|Physician Decision|4|||
42122302|NCT00386152|75932858|FG000|Overall Study|Lost to Follow-up|1|||
42122303|NCT00386152|75932859|FG001|Overall Study|Lost to Follow-up|0|||
42122304|NCT00386152|75932860|FG002|Overall Study|Lost to Follow-up|0|||
42122305|NCT00386152|75932858|FG000|Overall Study|Completed chemotherapy|4|||
42122306|NCT00386152|75932859|FG001|Overall Study|Completed chemotherapy|5|||
42122307|NCT00386152|75932860|FG002|Overall Study|Completed chemotherapy|1|||
42122308|NCT00386152|75932858|FG000|Overall Study|Protocol Violation|3|||
42122309|NCT00386152|75932859|FG001|Overall Study|Protocol Violation|5|||
42122310|NCT00386152|75932860|FG002|Overall Study|Protocol Violation|2|||
42122311|NCT00386152|75932858|FG000|Overall Study|Withdrawal by Subject|3|||
42122312|NCT00386152|75932859|FG001|Overall Study|Withdrawal by Subject|6|||
42122313|NCT00386152|75932860|FG002|Overall Study|Withdrawal by Subject|10|||
42122314|NCT00385918|75932870|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
42122315|NCT00385918|75932871|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
42122316|NCT00385918|75932872|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
42122317|NCT00385918|75932870|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
42122318|NCT00385918|75932871|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
42122319|NCT00385918|75932872|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
42122320|NCT00385918|75932870|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
42122321|NCT00385918|75932871|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
42122322|NCT00385918|75932872|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
42122323|NCT00385918|75932870|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
42122324|NCT00385918|75932871|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
42122325|NCT00385918|75932872|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
42122326|NCT00385918|75932870|FG000|Intervention Phase After Randomization|Physician Decision|1|||
42122327|NCT00385918|75932871|FG001|Intervention Phase After Randomization|Physician Decision|0|||
42122328|NCT00385918|75932872|FG002|Intervention Phase After Randomization|Physician Decision|0|||
42122329|NCT00385918|75932870|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
42122330|NCT00385918|75932871|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
42122331|NCT00385918|75932872|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
42122332|NCT00385840|75932881|FG000|Overall Study|Adverse Event|1|||
42122333|NCT00385840|75932882|FG001|Overall Study|Adverse Event|1|||
42122334|NCT00385840|75932881|FG000|Overall Study|Lost to Follow-up|3|||
42122335|NCT00385840|75932882|FG001|Overall Study|Lost to Follow-up|13|||
42122336|NCT00385762|75932888|FG000|Overall Study|Adverse Event|1|||
42122337|NCT00385762|75932888|FG000|Overall Study|Lost to Follow-up|1|||
42122338|NCT00385684|75932892|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
42122339|NCT00385684|75932893|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
42122340|NCT00385684|75932892|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
42122341|NCT00385684|75932893|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
42122342|NCT00385684|75932892|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
42122343|NCT00385684|75932893|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
42122344|NCT00661661|75932901|FG000|Overall Study|Adverse Event|99|||
42122345|NCT00661661|75932902|FG001|Overall Study|Adverse Event|24|||
42122346|NCT00661661|75932901|FG000|Overall Study|Lack of Efficacy|3|||
42122347|NCT00661661|75932902|FG001|Overall Study|Lack of Efficacy|2|||
42122348|NCT00661661|75932901|FG000|Overall Study|Lost to Follow-up|0|||
42122349|NCT00661661|75932902|FG001|Overall Study|Lost to Follow-up|1|||
42122350|NCT00661661|75932901|FG000|Overall Study|Withdrawal by Subject|15|||
42122351|NCT00661661|75932902|FG001|Overall Study|Withdrawal by Subject|5|||
42122352|NCT00661661|75932901|FG000|Overall Study|Other|22|||
42122353|NCT00661661|75932902|FG001|Overall Study|Other|7|||
42122354|NCT00661661|75932901|FG000|Overall Study|Not assigned treatment|1|||
42122355|NCT00661661|75932902|FG001|Overall Study|Not assigned treatment|0|||
42122356|NCT00038467|75932912|FG000|Overall Study|Adverse Event|170|||
42122357|NCT00038467|75932913|FG001|Overall Study|Adverse Event|145|||
42122358|NCT00038467|75932912|FG000|Overall Study|Withdrawal by Subject|150|||
42122359|NCT00038467|75932913|FG001|Overall Study|Withdrawal by Subject|107|||
42122360|NCT00038467|75932912|FG000|Overall Study|Protocol Violation|19|||
42301133|NCT02520661|76136441|FG000|Overall Study|Withdrawal by Subject|7|||
42122361|NCT00038467|75932913|FG001|Overall Study|Protocol Violation|22|||
42122362|NCT00038467|75932912|FG000|Overall Study|Death|22|||
42122363|NCT00038467|75932913|FG001|Overall Study|Death|16|||
42122364|NCT00038467|75932912|FG000|Overall Study|Lost to Follow-up|15|||
42122365|NCT00038467|75932913|FG001|Overall Study|Lost to Follow-up|10|||
42122366|NCT00038467|75932912|FG000|Overall Study|Recurrence|109|||
42122367|NCT00038467|75932913|FG001|Overall Study|Recurrence|179|||
42122368|NCT00038467|75932912|FG000|Overall Study|Randomized, but not treated|31|||
42122369|NCT00038467|75932913|FG001|Overall Study|Randomized, but not treated|35|||
42122370|NCT00038467|75932912|FG000|Overall Study|Other|26|||
42122371|NCT00038467|75932913|FG001|Overall Study|Other|28|||
42122372|NCT00051025|75932921|FG000|Overall Study|Progressive Disease|1|||
42122373|NCT00051025|75932922|FG001|Overall Study|Progressive Disease|1|||
42122374|NCT00051025|75932921|FG000|Overall Study|Adverse Event|1|||
42122375|NCT00051025|75932922|FG001|Overall Study|Adverse Event|1|||
42122376|NCT00051025|75932921|FG000|Overall Study|Withdrawal by Subject|0|||
42122377|NCT00051025|75932922|FG001|Overall Study|Withdrawal by Subject|1|||
42122378|NCT00051025|75932921|FG000|Overall Study|Death|0|||
42122379|NCT00051025|75932922|FG001|Overall Study|Death|1|||
42122380|NCT00660179|75932931|FG000|Overall Study|Death|44|||
42122381|NCT00660179|75932932|FG001|Overall Study|Death|47|||
42122382|NCT00660179|75932933|FG002|Overall Study|Death|34|||
42122383|NCT00660179|75932931|FG000|Overall Study|Withdrawal of consent|4|||
42122384|NCT00660179|75932932|FG001|Overall Study|Withdrawal of consent|6|||
42122385|NCT00660179|75932933|FG002|Overall Study|Withdrawal of consent|4|||
42122386|NCT00660179|75932931|FG000|Overall Study|Lost to Follow-up|7|||
42122387|NCT00660179|75932932|FG001|Overall Study|Lost to Follow-up|5|||
42122388|NCT00660179|75932933|FG002|Overall Study|Lost to Follow-up|2|||
42122389|NCT00660179|75932931|FG000|Overall Study|Administrative reason|0|||
42122390|NCT00660179|75932932|FG001|Overall Study|Administrative reason|0|||
41965990|NCT04004611|75765690|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
41965991|NCT04004611|75765691|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
41965992|NCT04004611|75765692|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
41965993|NCT04004611|75765693|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
41965994|NCT04004611|75765694|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
41965995|NCT04004611|75765686|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
41965996|NCT04004611|75765687|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
41965997|NCT04004611|75765688|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
41965998|NCT04004611|75765689|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
41965999|NCT04004611|75765690|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
41966000|NCT04004611|75765691|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
41966001|NCT04004611|75765692|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
41966002|NCT04004611|75765693|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
41966003|NCT04004611|75765694|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
41966004|NCT04004611|75765686|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
41966005|NCT04004611|75765687|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
41966006|NCT04004611|75765688|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
41966007|NCT04004611|75765689|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
41966008|NCT04004611|75765690|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
41966009|NCT04004611|75765691|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
41966010|NCT04004611|75765692|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
41966011|NCT04004611|75765693|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
41966012|NCT04004611|75765694|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
41966013|NCT04004611|75765686|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
41966014|NCT04004611|75765687|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
41966015|NCT04004611|75765688|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
41966016|NCT04004611|75765689|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
41966017|NCT04004611|75765690|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
41966018|NCT04004611|75765691|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
41966019|NCT04004611|75765692|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
41966020|NCT04004611|75765693|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
41966021|NCT04004611|75765694|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
41966022|NCT04004611|75765686|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
41966023|NCT04004611|75765687|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
41966024|NCT04004611|75765688|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
41966025|NCT04004611|75765689|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
41966026|NCT04004611|75765690|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
41966027|NCT04004611|75765691|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
41966028|NCT04004611|75765692|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
41966029|NCT04004611|75765693|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
42122391|NCT00660179|75932933|FG002|Overall Study|Administrative reason|1|||
42122392|NCT00660179|75932931|FG000|Overall Study|Incorrect randomization|1|||
42122393|NCT00660179|75932932|FG001|Overall Study|Incorrect randomization|0|||
41966030|NCT04004611|75765694|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
42122394|NCT00660179|75932933|FG002|Overall Study|Incorrect randomization|0|||
42122395|NCT00050167|75932943|FG000|Overall Study|not eligible not invasive|1|||
42122396|NCT00050167|75932944|FG001|Overall Study|not eligible not invasive|1|||
42122397|NCT00660023|75932950|FG000|Overall Study|Adverse Event|2|||
42122398|NCT00660023|75932950|FG000|Overall Study|Death|8|||
42122399|NCT00660023|75932950|FG000|Overall Study|Blood Transfusion|5|||
42122400|NCT00660023|75932950|FG000|Overall Study|Renal Transplantation|3|||
42122401|NCT00660023|75932950|FG000|Overall Study|Withdrawal by Subject|1|||
42122402|NCT00660023|75932950|FG000|Overall Study|Missed Pregnancy Test|1|||
42122403|NCT00660023|75932950|FG000|Overall Study|Other Screening Failure|9|||
42122404|NCT00062647|75932956|FG000|Overall Study|Death|2|||
42122405|NCT00062647|75932957|FG001|Overall Study|Death|2|||
41966031|NCT03824938|75765724|FG000|Overall Study|Withdrawal by Subject|2|||
41966032|NCT03824938|75765725|FG001|Overall Study|Withdrawal by Subject|1|||
41966033|NCT03824938|75765726|FG002|Overall Study|Withdrawal by Subject|0|||
41966034|NCT03824938|75765727|FG003|Overall Study|Withdrawal by Subject|2|||
41966035|NCT03824938|75765728|FG004|Overall Study|Withdrawal by Subject|0|||
41966036|NCT03824938|75765729|FG005|Overall Study|Withdrawal by Subject|1|||
41966037|NCT03824938|75765724|FG000|Overall Study|Lost to Follow-up|0|||
41966038|NCT03824938|75765725|FG001|Overall Study|Lost to Follow-up|1|||
41966039|NCT03824938|75765726|FG002|Overall Study|Lost to Follow-up|0|||
41966040|NCT03824938|75765727|FG003|Overall Study|Lost to Follow-up|0|||
41966041|NCT03824938|75765728|FG004|Overall Study|Lost to Follow-up|1|||
41966042|NCT03824938|75765729|FG005|Overall Study|Lost to Follow-up|0|||
41966043|NCT03636373|75765739|FG000|Overall Study|Study closure due to Covid-19|1|||
41966044|NCT03636373|75765740|FG001|Overall Study|Study closure due to Covid-19|0|||
41966045|NCT03631706|75765754|FG000|Overall Study|Randomized, not treated|1|||
41966046|NCT03631706|75765755|FG001|Overall Study|Randomized, not treated|0|||
41966047|NCT03631706|75765754|FG000|Overall Study|Treatment ongoing|26|||
41966048|NCT03631706|75765755|FG001|Overall Study|Treatment ongoing|57|||
42122406|NCT00062647|75932956|FG000|Overall Study|Adverse Event|1|||
41966049|NCT03631706|75765754|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
41966050|NCT03631706|75765755|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
41966051|NCT03004443|75765763|FG000|Overall Study|Pregnancy|0|||
41966052|NCT03004443|75765764|FG001|Overall Study|Pregnancy|1|||
41966053|NCT02277028|75765772|FG000|Overall Study|Lost to Follow-up|1|||
41966054|NCT02277028|75765773|FG001|Overall Study|Lost to Follow-up|0|||
41966055|NCT02277028|75765772|FG000|Overall Study|Withdrawal by Subject|0|||
41966056|NCT02277028|75765773|FG001|Overall Study|Withdrawal by Subject|1|||
41966057|NCT03735849|75765825|FG000|Overall Study|Lost to Follow-up|1|||
41966058|NCT03735849|75765826|FG001|Overall Study|Lost to Follow-up|0|||
41966059|NCT03735849|75765827|FG002|Overall Study|Lost to Follow-up|0|||
41966060|NCT03735849|75765825|FG000|Overall Study|Participant unable to adhere to visit|1|||
41966061|NCT03735849|75765826|FG001|Overall Study|Participant unable to adhere to visit|0|||
41966062|NCT03735849|75765827|FG002|Overall Study|Participant unable to adhere to visit|0|||
41966063|NCT03735849|75765825|FG000|Overall Study|Not Randomized|0|||
41966064|NCT03735849|75765826|FG001|Overall Study|Not Randomized|0|||
41966065|NCT03735849|75765827|FG002|Overall Study|Not Randomized|4|||
41966066|NCT03552393|75765834|FG000|Core Period|Kidney Transplant|1|||
41966067|NCT03552393|75765834|FG000|Core Period|Prohibited Medication|1|||
41966068|NCT03552393|75765834|FG000|Safety Extension Period|Kidney Transplant|4|||
41966069|NCT03333382|75765840|FG000|Overall Study|Lost to Follow-up|1|||
41966070|NCT03333382|75765841|FG001|Overall Study|Lost to Follow-up|0|||
41966071|NCT03107611|75765880|FG000|Overall Study|Adverse Event|1|||
41966072|NCT03107611|75765881|FG001|Overall Study|Adverse Event|0|||
41966073|NCT03107611|75765882|FG002|Overall Study|Adverse Event|2|||
41966074|NCT03107611|75765880|FG000|Overall Study|Lost to Follow-up|3|||
41966075|NCT03107611|75765881|FG001|Overall Study|Lost to Follow-up|3|||
41966076|NCT03107611|75765882|FG002|Overall Study|Lost to Follow-up|3|||
42122407|NCT00062647|75932957|FG001|Overall Study|Adverse Event|1|||
42122408|NCT00062647|75932956|FG000|Overall Study|Withdrawal by Subject|2|||
42122409|NCT00062647|75932957|FG001|Overall Study|Withdrawal by Subject|1|||
42122410|NCT00062647|75932956|FG000|Overall Study|Protocol Violation|1|||
42122411|NCT00062647|75932957|FG001|Overall Study|Protocol Violation|0|||
42122412|NCT00062647|75932956|FG000|Overall Study|Lost to Follow-up|1|||
42122413|NCT00062647|75932957|FG001|Overall Study|Lost to Follow-up|2|||
42122414|NCT00062647|75932956|FG000|Overall Study|Failed continuation criteria|4|||
42122415|NCT00062647|75932957|FG001|Overall Study|Failed continuation criteria|2|||
42122416|NCT00062647|75932956|FG000|Overall Study|Other|4|||
42122417|NCT00062647|75932957|FG001|Overall Study|Other|4|||
42122418|NCT00062647|75932956|FG000|Overall Study|Never received study treatment|1|||
42122419|NCT00062647|75932957|FG001|Overall Study|Never received study treatment|1|||
42122420|NCT00570323|75932965|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
42122421|NCT00570323|75932966|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
42122422|NCT00570323|75932965|FG000|Started Treatment After Randomization|Protocol Violation|1|||
42122423|NCT00570323|75932966|FG001|Started Treatment After Randomization|Protocol Violation|0|||
42122424|NCT00570323|75932965|FG000|Started Treatment After Randomization|Physician Decision|1|||
42122425|NCT00570323|75932966|FG001|Started Treatment After Randomization|Physician Decision|0|||
42122426|NCT00570323|75932965|FG000|Complete Study After Start|Lost to Follow-up|0|||
42122427|NCT00570323|75932966|FG001|Complete Study After Start|Lost to Follow-up|1|||
42122428|NCT00570323|75932965|FG000|Complete Study After Start|Withdrawal by Subject|2|||
42122429|NCT00570323|75932966|FG001|Complete Study After Start|Withdrawal by Subject|0|||
42122430|NCT00570323|75932965|FG000|Complete Study After Start|Physician Decision|1|||
42122431|NCT00570323|75932966|FG001|Complete Study After Start|Physician Decision|0|||
42122432|NCT00661505|75932974|FG000|Overall Study|Adverse Event|3|||
42122433|NCT00661505|75932974|FG000|Overall Study|Protocol Violation|14|||
42122434|NCT00661505|75932974|FG000|Overall Study|Withdrawal by Subject|8|||
42122435|NCT00661505|75932974|FG000|Overall Study|Lost to Follow-up|3|||
42122436|NCT00661505|75932974|FG000|Overall Study|Other|2|||
42122437|NCT00662909|75932982|FG000|Overall Study|Adverse Event|17|||
42122438|NCT00662909|75932983|FG001|Overall Study|Adverse Event|18|||
42122439|NCT00662909|75932984|FG002|Overall Study|Adverse Event|19|||
42122440|NCT00662909|75932982|FG000|Overall Study|Lack of Efficacy|9|||
42122441|NCT00662909|75932983|FG001|Overall Study|Lack of Efficacy|1|||
42122442|NCT00662909|75932984|FG002|Overall Study|Lack of Efficacy|5|||
42122443|NCT00662909|75932982|FG000|Overall Study|Withdrawal by Subject|29|||
42122444|NCT00662909|75932983|FG001|Overall Study|Withdrawal by Subject|22|||
42122445|NCT00662909|75932984|FG002|Overall Study|Withdrawal by Subject|16|||
42122446|NCT00662909|75932982|FG000|Overall Study|Lost to Follow-up|2|||
42122447|NCT00662909|75932983|FG001|Overall Study|Lost to Follow-up|9|||
42122448|NCT00662909|75932984|FG002|Overall Study|Lost to Follow-up|3|||
42122449|NCT00662909|75932982|FG000|Overall Study|Protocol Violation|7|||
42122450|NCT00662909|75932983|FG001|Overall Study|Protocol Violation|4|||
42122451|NCT00662909|75932984|FG002|Overall Study|Protocol Violation|5|||
42122452|NCT00662909|75932982|FG000|Overall Study|Randomized- never received study drug|1|||
42122453|NCT00662909|75932983|FG001|Overall Study|Randomized- never received study drug|0|||
42122454|NCT00662909|75932984|FG002|Overall Study|Randomized- never received study drug|0|||
42122455|NCT00662909|75932982|FG000|Overall Study|Non-compliance with study procedures|3|||
42122456|NCT00662909|75932983|FG001|Overall Study|Non-compliance with study procedures|3|||
42122457|NCT00662909|75932984|FG002|Overall Study|Non-compliance with study procedures|2|||
42122458|NCT00662909|75932982|FG000|Overall Study|Physician Decision|1|||
42122459|NCT00662909|75932983|FG001|Overall Study|Physician Decision|1|||
42122460|NCT00662909|75932984|FG002|Overall Study|Physician Decision|2|||
42122461|NCT00662909|75932982|FG000|Overall Study|Eligibility criterion not met|0|||
42122462|NCT00662909|75932983|FG001|Overall Study|Eligibility criterion not met|1|||
42122463|NCT00662909|75932984|FG002|Overall Study|Eligibility criterion not met|1|||
42122464|NCT00050011|75932994|FG000|Overall Study|Adverse Event|41|||
42122465|NCT00050011|75932995|FG001|Overall Study|Adverse Event|46|||
42122466|NCT00050011|75932994|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42122467|NCT00050011|75932995|FG001|Overall Study|Abnormal laboratory value(s)|1|||
42122468|NCT00050011|75932994|FG000|Overall Study|Abnormal test procedure results|0|||
42122469|NCT00050011|75932995|FG001|Overall Study|Abnormal test procedure results|1|||
42122470|NCT00050011|75932994|FG000|Overall Study|Lack of Efficacy|16|||
42122471|NCT00050011|75932995|FG001|Overall Study|Lack of Efficacy|21|||
42122472|NCT00050011|75932994|FG000|Overall Study|Participant condition no longer required|1|||
42122473|NCT00050011|75932995|FG001|Overall Study|Participant condition no longer required|0|||
41966077|NCT03107611|75765880|FG000|Overall Study|Protocol Violation|0|||
42122474|NCT00050011|75932994|FG000|Overall Study|Protocol Violation|4|||
42122475|NCT00050011|75932995|FG001|Overall Study|Protocol Violation|10|||
42122476|NCT00050011|75932994|FG000|Overall Study|Withdrawal by Subject|34|||
42122477|NCT00050011|75932995|FG001|Overall Study|Withdrawal by Subject|26|||
42122478|NCT00050011|75932994|FG000|Overall Study|Lost to Follow-up|7|||
42122479|NCT00050011|75932995|FG001|Overall Study|Lost to Follow-up|9|||
42122480|NCT00050011|75932994|FG000|Overall Study|Administrative problems|10|||
42122481|NCT00050011|75932995|FG001|Overall Study|Administrative problems|6|||
42122482|NCT00050011|75932994|FG000|Overall Study|Death|7|||
41966078|NCT03107611|75765881|FG001|Overall Study|Protocol Violation|0|||
41966079|NCT03107611|75765882|FG002|Overall Study|Protocol Violation|1|||
41966080|NCT03107611|75765880|FG000|Overall Study|Withdrawal by Subject|1|||
41966081|NCT03107611|75765881|FG001|Overall Study|Withdrawal by Subject|0|||
41966082|NCT03107611|75765882|FG002|Overall Study|Withdrawal by Subject|1|||
41966083|NCT03107611|75765880|FG000|Overall Study|Worsening signs/symptoms|2|||
41966084|NCT03107611|75765881|FG001|Overall Study|Worsening signs/symptoms|1|||
41966085|NCT03107611|75765882|FG002|Overall Study|Worsening signs/symptoms|2|||
41966086|NCT02720016|75765893|FG000|Overall Study|Separation of couple|6|||
41966087|NCT02720016|75765894|FG001|Overall Study|Separation of couple|8|||
41966088|NCT02720016|75765895|FG002|Overall Study|Separation of couple|2|||
41966089|NCT02720016|75765893|FG000|Overall Study|Withdrawal by Subject|6|||
41966090|NCT02720016|75765894|FG001|Overall Study|Withdrawal by Subject|6|||
41966091|NCT02720016|75765895|FG002|Overall Study|Withdrawal by Subject|4|||
41966092|NCT02720016|75765893|FG000|Overall Study|Scheduling issues|2|||
41966093|NCT02720016|75765894|FG001|Overall Study|Scheduling issues|4|||
41966094|NCT02720016|75765895|FG002|Overall Study|Scheduling issues|7|||
41966095|NCT02720016|75765893|FG000|Overall Study|Childcare|2|||
41966096|NCT02720016|75765894|FG001|Overall Study|Childcare|0|||
41966097|NCT02720016|75765895|FG002|Overall Study|Childcare|2|||
41966098|NCT02720016|75765893|FG000|Overall Study|Withdrawal by PI|2|||
41966099|NCT02720016|75765894|FG001|Overall Study|Withdrawal by PI|2|||
41966100|NCT02720016|75765895|FG002|Overall Study|Withdrawal by PI|0|||
41966101|NCT02720016|75765893|FG000|Overall Study|Moved away|2|||
41966102|NCT02720016|75765894|FG001|Overall Study|Moved away|0|||
41966103|NCT02720016|75765895|FG002|Overall Study|Moved away|0|||
41966104|NCT02720016|75765893|FG000|Overall Study|Not Primary Health Concern|0|||
41966105|NCT02720016|75765894|FG001|Overall Study|Not Primary Health Concern|0|||
41966106|NCT02720016|75765895|FG002|Overall Study|Not Primary Health Concern|2|||
41966107|NCT02720016|75765893|FG000|Overall Study|Transportation issues|0|||
41966108|NCT02720016|75765894|FG001|Overall Study|Transportation issues|0|||
41966109|NCT02720016|75765895|FG002|Overall Study|Transportation issues|1|||
41966110|NCT02720016|75765893|FG000|Overall Study|Other|0|||
41966111|NCT02720016|75765894|FG001|Overall Study|Other|0|||
41966112|NCT02720016|75765895|FG002|Overall Study|Other|2|||
41966113|NCT02607956|75765906|FG000|Double-Blinded Phase|Withdrew Consent|17|||
41966114|NCT02607956|75765907|FG001|Double-Blinded Phase|Withdrew Consent|19|||
41966115|NCT02607956|75765908|FG002|Double-Blinded Phase|Withdrew Consent|0|||
41966116|NCT02607956|75765909|FG003|Double-Blinded Phase|Withdrew Consent|0|||
41966117|NCT02607956|75765906|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
41966118|NCT02607956|75765907|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
41966119|NCT02607956|75765908|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
41966120|NCT02607956|75765909|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
41966121|NCT02607956|75765906|FG000|Double-Blinded Phase|Randomized but never treated|7|||
41966122|NCT02607956|75765907|FG001|Double-Blinded Phase|Randomized but never treated|5|||
41966123|NCT02607956|75765908|FG002|Double-Blinded Phase|Randomized but never treated|0|||
41966124|NCT02607956|75765909|FG003|Double-Blinded Phase|Randomized but never treated|0|||
41966125|NCT02607956|75765906|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
41966126|NCT02607956|75765907|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
41966127|NCT02607956|75765908|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
42027508|NCT01165242|75835713|FG002|Overall Study|Extended Holiday|1|||
42027509|NCT01165242|75835711|FG000|Overall Study|Lost to Follow-up|9|||
42027510|NCT01165242|75835712|FG001|Overall Study|Lost to Follow-up|7|||
42027511|NCT01165242|75835713|FG002|Overall Study|Lost to Follow-up|10|||
42027512|NCT01170065|75835726|FG000|Overall Study|Adverse Event|17|||
42027513|NCT01170065|75835727|FG001|Overall Study|Adverse Event|50|||
42027514|NCT01170065|75835728|FG002|Overall Study|Adverse Event|10|||
42027515|NCT01170065|75835726|FG000|Overall Study|Lost to Follow-up|1|||
42027516|NCT01170065|75835727|FG001|Overall Study|Lost to Follow-up|4|||
42027517|NCT01170065|75835728|FG002|Overall Study|Lost to Follow-up|1|||
42027518|NCT01170065|75835726|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
42027519|NCT01170065|75835727|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
42027520|NCT01170065|75835728|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
42027521|NCT01170065|75835726|FG000|Overall Study|Reason other than specified|3|||
42027522|NCT01170065|75835727|FG001|Overall Study|Reason other than specified|8|||
42122483|NCT00050011|75932995|FG001|Overall Study|Death|4|||
41966128|NCT02607956|75765909|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
41966129|NCT02607956|75765906|FG000|Double-Blinded Phase|Death|4|||
41966130|NCT02607956|75765907|FG001|Double-Blinded Phase|Death|4|||
41966131|NCT02607956|75765908|FG002|Double-Blinded Phase|Death|0|||
41966132|NCT02607956|75765909|FG003|Double-Blinded Phase|Death|0|||
41966133|NCT02607956|75765906|FG000|Double-Blinded Phase|Adverse Event|4|||
42027523|NCT01170065|75835728|FG002|Overall Study|Reason other than specified|3|||
42027524|NCT01170065|75835726|FG000|Overall Study|Ongoing after planned observation time|5|||
42027525|NCT01170065|75835727|FG001|Overall Study|Ongoing after planned observation time|26|||
42027526|NCT01170065|75835728|FG002|Overall Study|Ongoing after planned observation time|10|||
42122484|NCT00050011|75932994|FG000|Overall Study|Unknown - Reason is missing|0|||
42122485|NCT00050011|75932995|FG001|Overall Study|Unknown - Reason is missing|2|||
42122486|NCT00661427|75933004|FG000|Overall Study|Adverse Event|5|||
42122487|NCT00661427|75933005|FG001|Overall Study|Adverse Event|5|||
42122488|NCT00661427|75933004|FG000|Overall Study|Patient not treated|0|||
42122489|NCT00661427|75933005|FG001|Overall Study|Patient not treated|2|||
42122490|NCT00049543|75933013|FG000|Overall Study|still on treatment|2|||
42122491|NCT00049543|75933014|FG001|Overall Study|still on treatment|9|||
42122492|NCT00048997|75933022|FG000|Overall Study|Protocol Violation|7|||
42122493|NCT00048997|75933023|FG001|Overall Study|Protocol Violation|2|||
42122494|NCT00048997|75933022|FG000|Overall Study|Withdrawal by Subject|6|||
42122495|NCT00048997|75933023|FG001|Overall Study|Withdrawal by Subject|1|||
42122496|NCT00035815|75933030|FG000|Overall Study|Withdrawal by Subject|17|||
42122497|NCT00035815|75933031|FG001|Overall Study|Withdrawal by Subject|11|||
42122498|NCT00662831|75933039|FG000|Overall Study|Death|4|||
42122499|NCT00662831|75933040|FG001|Overall Study|Death|1|||
42122500|NCT00662831|75933039|FG000|Overall Study|Lack of Efficacy|6|||
42122501|NCT00662831|75933040|FG001|Overall Study|Lack of Efficacy|6|||
42122502|NCT00662831|75933039|FG000|Overall Study|Lost to Follow-up|1|||
42122503|NCT00662831|75933040|FG001|Overall Study|Lost to Follow-up|0|||
42122504|NCT00662831|75933039|FG000|Overall Study|Withdrawal by Subject|2|||
42122505|NCT00662831|75933040|FG001|Overall Study|Withdrawal by Subject|1|||
42122506|NCT00662831|75933039|FG000|Overall Study|Other|62|||
42122507|NCT00662831|75933040|FG001|Overall Study|Other|31|||
42122508|NCT00662831|75933039|FG000|Overall Study|Protocol Violation|8|||
42122509|NCT00662831|75933040|FG001|Overall Study|Protocol Violation|4|||
42122510|NCT00662831|75933039|FG000|Overall Study|Adverse Event|23|||
42122511|NCT00662831|75933040|FG001|Overall Study|Adverse Event|16|||
42122512|NCT00662363|75933048|FG000|Overall Study|Withdrawal by Subject|6|||
42122513|NCT00662363|75933049|FG001|Overall Study|Withdrawal by Subject|5|||
42122514|NCT00662363|75933048|FG000|Overall Study|Adverse Event|0|||
42122515|NCT00662363|75933049|FG001|Overall Study|Adverse Event|3|||
42122516|NCT00662363|75933048|FG000|Overall Study|Discharged early from rehab|4|||
42122517|NCT00662363|75933049|FG001|Overall Study|Discharged early from rehab|1|||
42122518|NCT00662363|75933048|FG000|Overall Study|Protocol Violation|1|||
42122519|NCT00662363|75933049|FG001|Overall Study|Protocol Violation|1|||
42122520|NCT00661271|75933059|FG000|Overall Study|Lost to Follow-up|28|||
42122521|NCT00661271|75933060|FG001|Overall Study|Lost to Follow-up|25|||
42122522|NCT00661193|75933068|FG000|Overall Study|Adverse Event|2|||
42122523|NCT00661193|75933069|FG001|Overall Study|Adverse Event|1|||
42122524|NCT00661193|75933068|FG000|Overall Study|Withdrawal by Subject|3|||
42122525|NCT00661193|75933069|FG001|Overall Study|Withdrawal by Subject|1|||
42122526|NCT00661193|75933068|FG000|Overall Study|Progression|27|||
42122527|NCT00661193|75933069|FG001|Overall Study|Progression|24|||
42122528|NCT00661193|75933068|FG000|Overall Study|Not protocol specified|1|||
42122529|NCT00661193|75933069|FG001|Overall Study|Not protocol specified|0|||
42122530|NCT00658541|75933075|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
42122531|NCT00658541|75933076|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
42122532|NCT00658541|75933075|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
42122533|NCT00658541|75933076|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
42122534|NCT00048061|75933086|FG000|Overall Study|Adverse Event|41|||
42122535|NCT00048061|75933087|FG001|Overall Study|Adverse Event|32|||
42122536|NCT00048061|75933088|FG002|Overall Study|Adverse Event|44|||
42122537|NCT00048061|75933089|FG003|Overall Study|Adverse Event|37|||
42122538|NCT00048061|75933086|FG000|Overall Study|Lost to Follow-up|3|||
42122539|NCT00048061|75933087|FG001|Overall Study|Lost to Follow-up|2|||
42122540|NCT00048061|75933088|FG002|Overall Study|Lost to Follow-up|4|||
42122541|NCT00048061|75933089|FG003|Overall Study|Lost to Follow-up|5|||
42122542|NCT00048061|75933086|FG000|Overall Study|Withdrawal by Subject|20|||
42122543|NCT00048061|75933087|FG001|Overall Study|Withdrawal by Subject|29|||
42301134|NCT02520661|76136442|FG001|Overall Study|Withdrawal by Subject|16|||
41966134|NCT02607956|75765907|FG001|Double-Blinded Phase|Adverse Event|3|||
42122544|NCT00048061|75933088|FG002|Overall Study|Withdrawal by Subject|29|||
42122545|NCT00048061|75933089|FG003|Overall Study|Withdrawal by Subject|32|||
42122546|NCT00048061|75933086|FG000|Overall Study|Did not follow-up|5|||
42122547|NCT00048061|75933087|FG001|Overall Study|Did not follow-up|5|||
42122548|NCT00048061|75933088|FG002|Overall Study|Did not follow-up|4|||
42122549|NCT00048061|75933089|FG003|Overall Study|Did not follow-up|5|||
42122550|NCT00048061|75933086|FG000|Overall Study|Early improvement|6|||
42122551|NCT00048061|75933087|FG001|Overall Study|Early improvement|5|||
42122552|NCT00048061|75933088|FG002|Overall Study|Early improvement|3|||
42122553|NCT00048061|75933089|FG003|Overall Study|Early improvement|0|||
42122554|NCT00656513|75933102|FG000|Overall Study|Protocol Violation|1|||
42122555|NCT00656513|75933103|FG001|Overall Study|Protocol Violation|0|||
42122556|NCT00656513|75933104|FG002|Overall Study|Protocol Violation|2|||
42122557|NCT00656513|75933102|FG000|Overall Study|Withdrawal by Subject|0|||
42122558|NCT00656513|75933103|FG001|Overall Study|Withdrawal by Subject|11|||
42122559|NCT00656513|75933104|FG002|Overall Study|Withdrawal by Subject|4|||
42122560|NCT00656513|75933102|FG000|Overall Study|Death|0|||
42122561|NCT00656513|75933103|FG001|Overall Study|Death|0|||
42122562|NCT00656513|75933104|FG002|Overall Study|Death|1|||
42122563|NCT00656513|75933102|FG000|Overall Study|Missing data|0|||
42122564|NCT00656513|75933103|FG001|Overall Study|Missing data|11|||
42122565|NCT00656513|75933104|FG002|Overall Study|Missing data|9|||
42122566|NCT00656513|75933102|FG000|Overall Study|Incomplete treatment|3|||
42122567|NCT00656513|75933103|FG001|Overall Study|Incomplete treatment|0|||
42122568|NCT00656513|75933104|FG002|Overall Study|Incomplete treatment|0|||
42122569|NCT00656513|75933102|FG000|Overall Study|Treatment completed outside of timeframe|0|||
42122570|NCT00656513|75933103|FG001|Overall Study|Treatment completed outside of timeframe|3|||
42122571|NCT00656513|75933104|FG002|Overall Study|Treatment completed outside of timeframe|1|||
42122572|NCT00656513|75933102|FG000|Overall Study|Missing baseline form|0|||
42122573|NCT00656513|75933103|FG001|Overall Study|Missing baseline form|5|||
42122574|NCT00656513|75933104|FG002|Overall Study|Missing baseline form|5|||
42122575|NCT00655889|75933112|FG000|Overall Study|Inadequate cell growth|1|||
42122576|NCT00655889|75933112|FG000|Overall Study|Protocol Violation|1|||
42122577|NCT00655733|75933118|FG000|Overall Study|Lost to Follow-up|2|||
42122578|NCT00655733|75933119|FG001|Overall Study|Lost to Follow-up|2|||
42122579|NCT00655733|75933118|FG000|Overall Study|Adverse Event|2|||
42122580|NCT00655733|75933119|FG001|Overall Study|Adverse Event|2|||
42122581|NCT00655733|75933118|FG000|Overall Study|Withdrawal by Subject|3|||
42122582|NCT00655733|75933119|FG001|Overall Study|Withdrawal by Subject|3|||
42122583|NCT00655733|75933118|FG000|Overall Study|Physician Decision|0|||
42122584|NCT00655733|75933119|FG001|Overall Study|Physician Decision|1|||
42122585|NCT00657371|75933127|FG000|Overall Study|Poor bowel preparation|15|||
42122586|NCT00657371|75933127|FG000|Overall Study|Unable to intubate the cecum|5|||
42122587|NCT00657371|75933127|FG000|Overall Study|Protocol Violation|2|||
42122588|NCT00657371|75933127|FG000|Overall Study|Device- related reasons|13|||
42122589|NCT00657371|75933127|FG000|Overall Study|Pre-existing medical condition|4|||
42122590|NCT00658775|75933133|FG000|Overall Study|Adverse Event|4|||
42122591|NCT00658775|75933134|FG001|Overall Study|Adverse Event|6|||
42122592|NCT00658775|75933133|FG000|Overall Study|Lost to Follow-up|17|||
42122593|NCT00658775|75933134|FG001|Overall Study|Lost to Follow-up|18|||
42122594|NCT00658775|75933133|FG000|Overall Study|Withdrawal by Subject|6|||
42122595|NCT00658775|75933134|FG001|Overall Study|Withdrawal by Subject|4|||
42122596|NCT00658775|75933133|FG000|Overall Study|Withdrawal of consent|8|||
42122597|NCT00658775|75933134|FG001|Overall Study|Withdrawal of consent|7|||
42122598|NCT00658775|75933133|FG000|Overall Study|Other|7|||
42122599|NCT00658775|75933134|FG001|Overall Study|Other|8|||
42122600|NCT00488631|75933146|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
42122601|NCT00488631|75933147|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
42122602|NCT00488631|75933148|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
42122603|NCT00488631|75933149|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
42122604|NCT00488631|75933150|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
42122605|NCT00488631|75933151|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
42122606|NCT00488631|75933152|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
42122607|NCT00488631|75933153|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
42122608|NCT00488631|75933154|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
42122609|NCT00488631|75933155|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
42122610|NCT00488631|75933146|FG000|Double Blind Period (Week 0-54)|Death|0|||
42122611|NCT00488631|75933147|FG001|Double Blind Period (Week 0-54)|Death|0|||
42122612|NCT00488631|75933148|FG002|Double Blind Period (Week 0-54)|Death|0|||
41966135|NCT02607956|75765908|FG002|Double-Blinded Phase|Adverse Event|0|||
42027527|NCT00966693|75835740|FG000|Overall Study|Adverse Event|0|||
42027528|NCT00966693|75835741|FG001|Overall Study|Adverse Event|0|||
41966136|NCT02607956|75765909|FG003|Double-Blinded Phase|Adverse Event|0|||
41966137|NCT02607956|75765906|FG000|Double-Blinded Phase|Protocol Violation|3|||
41966138|NCT02607956|75765907|FG001|Double-Blinded Phase|Protocol Violation|1|||
41966139|NCT02607956|75765908|FG002|Double-Blinded Phase|Protocol Violation|0|||
41966140|NCT02607956|75765909|FG003|Double-Blinded Phase|Protocol Violation|0|||
41966141|NCT02607956|75765906|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
41966142|NCT02607956|75765907|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
41966143|NCT02607956|75765908|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
41966144|NCT02607956|75765909|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
41966145|NCT02607956|75765906|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
41966146|NCT02607956|75765907|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
41966147|NCT02607956|75765908|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
41966148|NCT02607956|75765909|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
42027529|NCT00966693|75835742|FG002|Overall Study|Adverse Event|1|||
42122613|NCT00488631|75933149|FG003|Double Blind Period (Week 0-54)|Death|0|||
42122614|NCT00488631|75933150|FG004|Double Blind Period (Week 0-54)|Death|0|||
42122615|NCT00488631|75933151|FG005|Double Blind Period (Week 0-54)|Death|1|||
42122616|NCT00488631|75933152|FG006|Double Blind Period (Week 0-54)|Death|0|||
42122617|NCT00488631|75933153|FG007|Double Blind Period (Week 0-54)|Death|0|||
42122618|NCT00488631|75933154|FG008|Double Blind Period (Week 0-54)|Death|0|||
42027530|NCT00966693|75835743|FG003|Overall Study|Adverse Event|2|||
42027531|NCT00966693|75835740|FG000|Overall Study|Death|0|||
42027532|NCT00966693|75835741|FG001|Overall Study|Death|0|||
42027533|NCT00966693|75835742|FG002|Overall Study|Death|1|||
42027534|NCT00966693|75835743|FG003|Overall Study|Death|0|||
42027535|NCT00966693|75835740|FG000|Overall Study|Withdrawal by Subject|1|||
42027536|NCT00966693|75835741|FG001|Overall Study|Withdrawal by Subject|0|||
42027537|NCT00966693|75835742|FG002|Overall Study|Withdrawal by Subject|0|||
42027538|NCT00966693|75835743|FG003|Overall Study|Withdrawal by Subject|5|||
42027539|NCT00966693|75835740|FG000|Overall Study|Disease Progression|0|||
42027540|NCT00966693|75835741|FG001|Overall Study|Disease Progression|0|||
42027541|NCT00966693|75835742|FG002|Overall Study|Disease Progression|1|||
42027542|NCT00966693|75835743|FG003|Overall Study|Disease Progression|16|||
42027543|NCT01215968|75835755|FG000|Overall Study|Adverse Event|0|||
42027544|NCT01215968|75835756|FG001|Overall Study|Adverse Event|2|||
42027545|NCT01215968|75835755|FG000|Overall Study|Protocol Violation|2|||
42027546|NCT01215968|75835756|FG001|Overall Study|Protocol Violation|4|||
42027547|NCT01215968|75835755|FG000|Overall Study|Not received study drug|0|||
42027548|NCT01215968|75835756|FG001|Overall Study|Not received study drug|1|||
42027549|NCT00963807|75835765|FG000|Overall Study|Physician Decision|2|||
42027550|NCT00963807|75835765|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
42122619|NCT00488631|75933155|FG009|Double Blind Period (Week 0-54)|Death|0|||
42122620|NCT00488631|75933146|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
42122621|NCT00488631|75933147|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
42122622|NCT00488631|75933148|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
42122623|NCT00488631|75933149|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
42122624|NCT00488631|75933150|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
42122625|NCT00488631|75933151|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
42122626|NCT00488631|75933152|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
42122627|NCT00488631|75933153|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
42122628|NCT00488631|75933154|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
42122629|NCT00488631|75933155|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
42122630|NCT00488631|75933146|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
42122631|NCT00488631|75933147|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
42122632|NCT00488631|75933148|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
42122633|NCT00488631|75933149|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
42027551|NCT00963807|75835765|FG000|Overall Study|Disease progression|15|||
42122634|NCT00488631|75933150|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
42122635|NCT00488631|75933151|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
42122636|NCT00488631|75933152|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
42122637|NCT00488631|75933153|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
42122638|NCT00488631|75933154|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
42122639|NCT00488631|75933155|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
42122640|NCT00488631|75933146|FG000|Double Blind Period (Week 0-54)|Other|6|||
42122641|NCT00488631|75933147|FG001|Double Blind Period (Week 0-54)|Other|12|||
42122642|NCT00488631|75933148|FG002|Double Blind Period (Week 0-54)|Other|10|||
42122643|NCT00488631|75933149|FG003|Double Blind Period (Week 0-54)|Other|11|||
42122644|NCT00488631|75933150|FG004|Double Blind Period (Week 0-54)|Other|14|||
42122645|NCT00488631|75933151|FG005|Double Blind Period (Week 0-54)|Other|34|||
42122646|NCT00488631|75933152|FG006|Double Blind Period (Week 0-54)|Other|0|||
42122647|NCT00488631|75933153|FG007|Double Blind Period (Week 0-54)|Other|0|||
42122648|NCT00488631|75933154|FG008|Double Blind Period (Week 0-54)|Other|0|||
42122649|NCT00488631|75933155|FG009|Double Blind Period (Week 0-54)|Other|0|||
42122650|NCT00488631|75933146|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
42122651|NCT00488631|75933147|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
42210370|NCT03227445|76025158|FG002|Period 1 (28 Days)|Adverse Event|0|||
42027552|NCT01142466|75835773|FG000|Overall Study|Adverse Event|2|||
42027553|NCT01142466|75835774|FG001|Overall Study|Adverse Event|1|||
42027554|NCT01142466|75835773|FG000|Overall Study|Withdrawal by Subject|1|||
42027555|NCT01142466|75835774|FG001|Overall Study|Withdrawal by Subject|1|||
42027556|NCT01215734|75835782|FG000|Overall Study|Death|0|||
42027557|NCT01215734|75835783|FG001|Overall Study|Death|1|||
42027558|NCT01169987|75835789|FG000|Overall Study|Withdrawal by Subject|3|||
42122652|NCT00488631|75933148|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
42137785|NCT00427908|75948133|FG001|Primary Phase|Lost to Follow-up|0|||
42027559|NCT01169987|75835789|FG000|Overall Study|Lost to Follow-up|24|||
42027560|NCT01169987|75835789|FG000|Overall Study|Other|4|||
42027561|NCT01215422|75835803|FG000|Overall Study|Relocation|1|||
42027562|NCT01215422|75835804|FG001|Overall Study|Relocation|0|||
42027563|NCT01215422|75835805|FG002|Overall Study|Relocation|0|||
42027564|NCT01215422|75835806|FG003|Overall Study|Relocation|0|||
42027565|NCT01215422|75835803|FG000|Overall Study|Failed intubations|0|||
42122653|NCT00488631|75933149|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
42122654|NCT00488631|75933150|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
42122655|NCT00488631|75933151|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
42122656|NCT00488631|75933152|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
42122657|NCT00488631|75933153|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
42122658|NCT00488631|75933154|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
42122659|NCT00488631|75933155|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
42122660|NCT00488631|75933146|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
42122661|NCT00488631|75933147|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
42122662|NCT00488631|75933148|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
42122663|NCT00488631|75933149|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
42122664|NCT00488631|75933150|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
42122665|NCT00488631|75933151|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
42122666|NCT00488631|75933152|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
42122667|NCT00488631|75933153|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
42027566|NCT01215422|75835804|FG001|Overall Study|Failed intubations|0|||
42027567|NCT01215422|75835805|FG002|Overall Study|Failed intubations|3|||
42027568|NCT01215422|75835806|FG003|Overall Study|Failed intubations|8|||
42027569|NCT01215422|75835803|FG000|Overall Study|Did not complete all intubations|7|||
42027570|NCT01215422|75835804|FG001|Overall Study|Did not complete all intubations|0|||
42027571|NCT01215422|75835805|FG002|Overall Study|Did not complete all intubations|0|||
42027572|NCT01215422|75835806|FG003|Overall Study|Did not complete all intubations|0|||
42027573|NCT00972153|75835831|FG000|Overall Study|Equipment malfunction during case|0|||
42027574|NCT00972153|75835832|FG001|Overall Study|Equipment malfunction during case|1|||
42027575|NCT00972153|75835833|FG002|Overall Study|Equipment malfunction during case|0|||
42027576|NCT00971997|75835841|FG000|Overall Study|Adverse Event|2|||
42027577|NCT00971997|75835841|FG000|Overall Study|Death|1|||
42027578|NCT00971997|75835841|FG000|Overall Study|Protocol Violation|4|||
42027579|NCT00971997|75835841|FG000|Overall Study|Withdrawal by Subject|5|||
42027580|NCT00971997|75835841|FG000|Overall Study|Physician Decision|7|||
42027581|NCT01127646|75835850|FG000|Overall Study|Entry Criteria Not Met|1|||
42027582|NCT01127646|75835851|FG001|Overall Study|Entry Criteria Not Met|0|||
42027583|NCT01127646|75835850|FG000|Overall Study|Protocol Violation|0|||
42122668|NCT00488631|75933154|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
42122669|NCT00488631|75933155|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
42122670|NCT00488631|75933146|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
42122671|NCT00488631|75933147|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
42122672|NCT00488631|75933148|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
42122673|NCT00488631|75933149|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
42122674|NCT00488631|75933150|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
42122675|NCT00488631|75933151|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
42122676|NCT00488631|75933152|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
42122677|NCT00488631|75933153|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
42122678|NCT00488631|75933154|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
42122679|NCT00488631|75933155|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
42122680|NCT00488631|75933146|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
42122681|NCT00488631|75933147|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
42122682|NCT00488631|75933148|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
42122683|NCT00488631|75933149|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
42122684|NCT00488631|75933150|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
42122685|NCT00488631|75933151|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
42122686|NCT00488631|75933152|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
42122687|NCT00488631|75933153|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
42122688|NCT00488631|75933154|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
42122689|NCT00488631|75933155|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
42122690|NCT00488631|75933146|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
42122691|NCT00488631|75933147|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
42122692|NCT00488631|75933148|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
42122693|NCT00488631|75933149|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
42122694|NCT00488631|75933150|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
42122695|NCT00488631|75933151|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
42210371|NCT03227445|76025159|FG003|Period 1 (28 Days)|Adverse Event|1|||
42210372|NCT03227445|76025156|FG000|Period 1 (28 Days)|Protocol Violation|1|||
42027584|NCT01127646|75835851|FG001|Overall Study|Protocol Violation|1|||
42027585|NCT01215188|75835862|FG000|Overall Study|Lost to Follow-up|22|||
42027586|NCT01215188|75835863|FG001|Overall Study|Lost to Follow-up|22|||
42122696|NCT00488631|75933152|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
42122697|NCT00488631|75933153|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
42122698|NCT00488631|75933154|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
42122699|NCT00488631|75933155|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
42122700|NCT00655499|75933178|FG000|Overall Study|not eligible|4|||
42122701|NCT00654875|75933185|FG000|Overall Study|Adverse Event|5|||
42122702|NCT00654875|75933186|FG001|Overall Study|Adverse Event|5|||
42122703|NCT00654875|75933185|FG000|Overall Study|Withdrawal by Subject|4|||
42122704|NCT00654875|75933186|FG001|Overall Study|Withdrawal by Subject|4|||
42122705|NCT00654875|75933185|FG000|Overall Study|Protocol Violation|3|||
42122706|NCT00654875|75933186|FG001|Overall Study|Protocol Violation|3|||
42122707|NCT00654875|75933185|FG000|Overall Study|Lack of Efficacy|2|||
42122708|NCT00654875|75933186|FG001|Overall Study|Lack of Efficacy|2|||
42122709|NCT00654875|75933185|FG000|Overall Study|Lost to Follow-up|1|||
42122710|NCT00654875|75933186|FG001|Overall Study|Lost to Follow-up|3|||
42122711|NCT00654875|75933185|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
42122712|NCT00654875|75933186|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
42122713|NCT00654875|75933185|FG000|Overall Study|Administrative Problems|1|||
42122714|NCT00654875|75933186|FG001|Overall Study|Administrative Problems|0|||
42122715|NCT00651755|75933192|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
42122716|NCT00651755|75933193|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
42122717|NCT00651755|75933192|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
42122718|NCT00651755|75933193|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
42122719|NCT00654641|75933202|FG000|Overall Study|Lost to Follow-up|2|||
42122720|NCT00654641|75933203|FG001|Overall Study|Lost to Follow-up|3|||
42122721|NCT00569777|75933211|FG000|Overall Study|Withdrawal by Subject|4|||
42122722|NCT00569777|75933212|FG001|Overall Study|Withdrawal by Subject|0|||
42122723|NCT00569777|75933211|FG000|Overall Study|Adverse Event|3|||
42122724|NCT00569777|75933212|FG001|Overall Study|Adverse Event|0|||
42122725|NCT00569777|75933211|FG000|Overall Study|Lost to Follow-up|1|||
42122726|NCT00569777|75933212|FG001|Overall Study|Lost to Follow-up|0|||
42122727|NCT00569777|75933211|FG000|Overall Study|scheduled eye surgery|0|||
42122728|NCT00569777|75933212|FG001|Overall Study|scheduled eye surgery|1|||
42122729|NCT00569777|75933211|FG000|Overall Study|did not meet exclusion criteria|1|||
42122730|NCT00569777|75933212|FG001|Overall Study|did not meet exclusion criteria|2|||
42122731|NCT00569777|75933211|FG000|Overall Study|pregnant|1|||
42122732|NCT00569777|75933212|FG001|Overall Study|pregnant|0|||
42122733|NCT00569231|75933218|FG000|Overall Study|Study unrelated surgery|1|||
42122734|NCT00569231|75933218|FG000|Overall Study|Airfare expense|2|||
42122735|NCT00569231|75933218|FG000|Overall Study|Withdrawal by Subject|1|||
42122736|NCT00569231|75933218|FG000|Overall Study|Car accident injury|1|||
42122737|NCT00569231|75933218|FG000|Overall Study|Non-compliance|2|||
42122738|NCT00654095|75933222|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
42122739|NCT00654095|75933222|FG000|Overall Study|Elevated triglyceride level (2)|1|||
42122740|NCT00654095|75933222|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
42122741|NCT00654095|75933222|FG000|Overall Study|Adverse Event|11|||
42122742|NCT00654095|75933222|FG000|Overall Study|Withdrawal by Subject|5|||
42122743|NCT00654095|75933222|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
42122744|NCT00654095|75933222|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
42122745|NCT00654095|75933222|FG000|Overall Study|Did not meet inclusion criteria|1|||
42122746|NCT00650585|75933228|FG000|Overall Study|Lost to Follow-up|505|||
42122747|NCT00650585|75933229|FG001|Overall Study|Lost to Follow-up|482|||
42122748|NCT00650585|75933228|FG000|Overall Study|No parental consent|935|||
42122749|NCT00650585|75933229|FG001|Overall Study|No parental consent|866|||
42122750|NCT00650585|75933228|FG000|Overall Study|Excluded/ruled ineligible|357|||
42122751|NCT00650585|75933229|FG001|Overall Study|Excluded/ruled ineligible|129|||
42122752|NCT00653939|75933237|FG000|Overall Study|Adverse Event|1|||
42122753|NCT00653939|75933238|FG001|Overall Study|Adverse Event|3|||
42122754|NCT00653939|75933237|FG000|Overall Study|Withdrawal by Subject|3|||
42122755|NCT00653939|75933238|FG001|Overall Study|Withdrawal by Subject|3|||
42122756|NCT00653939|75933237|FG000|Overall Study|Physician Decision|4|||
42122757|NCT00653939|75933238|FG001|Overall Study|Physician Decision|0|||
42122758|NCT00653939|75933237|FG000|Overall Study|Disease Progression|2|||
42122759|NCT00653939|75933238|FG001|Overall Study|Disease Progression|3|||
42122760|NCT00653939|75933237|FG000|Overall Study|Other|2|||
42122761|NCT00653939|75933238|FG001|Overall Study|Other|6|||
42122762|NCT00646451|75933246|FG000|Overall Study|Adverse Event|3|||
42122763|NCT00646451|75933247|FG001|Overall Study|Adverse Event|0|||
42122764|NCT00646451|75933246|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
42122765|NCT00646451|75933247|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
42122766|NCT00642707|75933259|FG000|Overall Study|Adverse Event|0|||
42122767|NCT00642707|75933260|FG001|Overall Study|Adverse Event|0|||
41966149|NCT02607956|75765906|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
42122768|NCT00642707|75933261|FG002|Overall Study|Adverse Event|0|||
42122769|NCT00642707|75933262|FG003|Overall Study|Adverse Event|2|||
42122770|NCT00642707|75933259|FG000|Overall Study|Withdrawal by Subject|1|||
42122771|NCT00642707|75933260|FG001|Overall Study|Withdrawal by Subject|0|||
42122772|NCT00642707|75933261|FG002|Overall Study|Withdrawal by Subject|0|||
42122773|NCT00642707|75933262|FG003|Overall Study|Withdrawal by Subject|0|||
42122774|NCT00568685|75933275|FG000|Overall Study|Adverse Event|2|||
42122775|NCT00568685|75933276|FG001|Overall Study|Adverse Event|3|||
42122776|NCT00568685|75933277|FG002|Overall Study|Adverse Event|3|||
42122777|NCT00568685|75933275|FG000|Overall Study|Withdrawal by Subject|7|||
42122778|NCT00568685|75933276|FG001|Overall Study|Withdrawal by Subject|2|||
42122779|NCT00568685|75933277|FG002|Overall Study|Withdrawal by Subject|2|||
42122780|NCT00568685|75933275|FG000|Overall Study|Protocol Violation|1|||
42122781|NCT00568685|75933276|FG001|Overall Study|Protocol Violation|0|||
42122782|NCT00568685|75933277|FG002|Overall Study|Protocol Violation|0|||
42122783|NCT00061945|75933291|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
42122784|NCT00061945|75933292|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
42122785|NCT00061945|75933291|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
42122786|NCT00061945|75933292|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
42122787|NCT00061945|75933291|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
42122788|NCT00061945|75933292|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
42122789|NCT00061945|75933291|FG000|Course IV: Alemtuzumab|Early exits|6|||
42122790|NCT00061945|75933292|FG001|Course IV: Alemtuzumab|Early exits|15|||
42122791|NCT00642473|75933303|FG000|Overall Study|Withdrawal by Subject|0|||
42122792|NCT00642473|75933304|FG001|Overall Study|Withdrawal by Subject|5|||
42122793|NCT00642473|75933303|FG000|Overall Study|Progression or death|2|||
42122794|NCT00642473|75933304|FG001|Overall Study|Progression or death|4|||
42122795|NCT00642473|75933303|FG000|Overall Study|Other|2|||
42122796|NCT00642473|75933304|FG001|Overall Study|Other|2|||
42122797|NCT00645671|75933315|FG000|Overall Study|Protocol Violation|1|||
42122798|NCT00645671|75933316|FG001|Overall Study|Protocol Violation|0|||
42122799|NCT00645671|75933315|FG000|Overall Study|Withdrawal by Subject|0|||
42122800|NCT00645671|75933316|FG001|Overall Study|Withdrawal by Subject|4|||
42122801|NCT00645671|75933315|FG000|Overall Study|Adverse Event|0|||
42122802|NCT00645671|75933316|FG001|Overall Study|Adverse Event|1|||
42122803|NCT00645671|75933315|FG000|Overall Study|Physician Decision|0|||
42122804|NCT00645671|75933316|FG001|Overall Study|Physician Decision|1|||
42122805|NCT00366340|75933324|FG000|Infant Series|Protocol Violation|3|||
42122806|NCT00366340|75933325|FG001|Infant Series|Protocol Violation|4|||
42122807|NCT00366340|75933324|FG000|Infant Series|Withdrawal by Subject|3|||
42122808|NCT00366340|75933325|FG001|Infant Series|Withdrawal by Subject|3|||
42122809|NCT00366340|75933324|FG000|Infant Series|Adverse Event|0|||
42122810|NCT00366340|75933325|FG001|Infant Series|Adverse Event|2|||
41966150|NCT02607956|75765907|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
41966151|NCT02607956|75765908|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
41966152|NCT02607956|75765909|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
41966153|NCT02607956|75765906|FG000|Open-Label Extension Phase|Death|0|||
41966154|NCT02607956|75765907|FG001|Open-Label Extension Phase|Death|0|||
41966155|NCT02607956|75765908|FG002|Open-Label Extension Phase|Death|1|||
42122811|NCT00366340|75933324|FG000|Infant Series|Lost to Follow-up|1|||
42122812|NCT00366340|75933325|FG001|Infant Series|Lost to Follow-up|1|||
42122813|NCT00366340|75933324|FG000|Infant Series|Failure to return|1|||
42122814|NCT00366340|75933325|FG001|Infant Series|Failure to return|0|||
42122815|NCT00366340|75933324|FG000|After the Infant Series|Parent/legal guardian request|1|||
42122816|NCT00366340|75933325|FG001|After the Infant Series|Parent/legal guardian request|1|||
42122817|NCT00366340|75933324|FG000|After the Infant Series|Failed to return|0|||
42122818|NCT00366340|75933325|FG001|After the Infant Series|Failed to return|1|||
42122819|NCT00366340|75933324|FG000|After the Infant Series|Protocol Violation|2|||
42122820|NCT00366340|75933325|FG001|After the Infant Series|Protocol Violation|2|||
42122821|NCT00366340|75933324|FG000|After the Infant Series|Adverse Event|0|||
42122822|NCT00366340|75933325|FG001|After the Infant Series|Adverse Event|1|||
42122823|NCT00366340|75933324|FG000|After the Infant Series|Lost to Follow-up|0|||
42122824|NCT00366340|75933325|FG001|After the Infant Series|Lost to Follow-up|1|||
41966156|NCT02607956|75765909|FG003|Open-Label Extension Phase|Death|3|||
41966157|NCT02607956|75765906|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
41966158|NCT02607956|75765907|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
41966159|NCT02607956|75765908|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
42122825|NCT00366340|75933324|FG000|Toddler Dose|Failed to return|1|||
42122826|NCT00366340|75933325|FG001|Toddler Dose|Failed to return|0|||
42122827|NCT00366340|75933324|FG000|Toddler Dose|Parent/legal guardian request|0|||
42122828|NCT00366340|75933325|FG001|Toddler Dose|Parent/legal guardian request|1|||
42122829|NCT00061633|75933357|FG000|Overall Study|Adverse Event|1|||
42122830|NCT00061633|75933358|FG001|Overall Study|Adverse Event|2|||
42122831|NCT00061633|75933357|FG000|Overall Study|Withdrawal by Subject|2|||
42122832|NCT00061633|75933358|FG001|Overall Study|Withdrawal by Subject|2|||
42122833|NCT00061633|75933357|FG000|Overall Study|Lost to Follow-up|1|||
41966160|NCT02607956|75765909|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
42122834|NCT00061633|75933358|FG001|Overall Study|Lost to Follow-up|4|||
42122835|NCT00061633|75933357|FG000|Overall Study|Other|1|||
42122836|NCT00061633|75933358|FG001|Overall Study|Other|1|||
42122837|NCT00061633|75933357|FG000|Overall Study|Never received study treatment|0|||
42122838|NCT00061633|75933358|FG001|Overall Study|Never received study treatment|2|||
42122839|NCT00645593|75933366|FG000|Overall Study|Later found to be ineligible|1|||
42122840|NCT00645593|75933367|FG001|Overall Study|Later found to be ineligible|0|||
42122841|NCT03832738|75933376|FG000|Overall Study|Withdrawal by Subject|6|||
42122842|NCT03832738|75933377|FG001|Overall Study|Withdrawal by Subject|7|||
41966161|NCT02607956|75765906|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
41966162|NCT02607956|75765907|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
41966163|NCT02607956|75765908|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
41966164|NCT02607956|75765909|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
41966165|NCT02607956|75765906|FG000|Open-Label Extension Phase|Protocol Violation|0|||
41966166|NCT02607956|75765907|FG001|Open-Label Extension Phase|Protocol Violation|0|||
41966167|NCT02607956|75765908|FG002|Open-Label Extension Phase|Protocol Violation|0|||
41966168|NCT02607956|75765909|FG003|Open-Label Extension Phase|Protocol Violation|2|||
41966169|NCT02607956|75765906|FG000|Open-Label Extension Phase|Pregnancy|0|||
41966170|NCT02607956|75765907|FG001|Open-Label Extension Phase|Pregnancy|0|||
41966171|NCT02607956|75765908|FG002|Open-Label Extension Phase|Pregnancy|0|||
41966172|NCT02607956|75765909|FG003|Open-Label Extension Phase|Pregnancy|1|||
41966173|NCT02564523|75765939|FG000|Overall Study|Withdrawal by Subject|3|||
41966174|NCT02564523|75765940|FG001|Overall Study|Withdrawal by Subject|0|||
41966175|NCT02564523|75765941|FG002|Overall Study|Withdrawal by Subject|1|||
41966176|NCT02564523|75765942|FG003|Overall Study|Withdrawal by Subject|0|||
41966177|NCT02564523|75765943|FG004|Overall Study|Withdrawal by Subject|1|||
41966178|NCT02564523|75765944|FG005|Overall Study|Withdrawal by Subject|0|||
41966179|NCT02564523|75765945|FG006|Overall Study|Withdrawal by Subject|1|||
41966180|NCT02564523|75765946|FG007|Overall Study|Withdrawal by Subject|0|||
41966181|NCT02564523|75765947|FG008|Overall Study|Withdrawal by Subject|0|||
41966182|NCT02564523|75765948|FG009|Overall Study|Withdrawal by Subject|0|||
41966183|NCT02564523|75765949|FG010|Overall Study|Withdrawal by Subject|1|||
41966184|NCT02564523|75765950|FG011|Overall Study|Withdrawal by Subject|0|||
41966185|NCT02564523|75765951|FG012|Overall Study|Withdrawal by Subject|1|||
41966186|NCT02564523|75765952|FG013|Overall Study|Withdrawal by Subject|0|||
41966187|NCT02564523|75765953|FG014|Overall Study|Withdrawal by Subject|0|||
41966188|NCT02564523|75765954|FG015|Overall Study|Withdrawal by Subject|0|||
41966189|NCT02564523|75765955|FG016|Overall Study|Withdrawal by Subject|0|||
41966190|NCT02564523|75765956|FG017|Overall Study|Withdrawal by Subject|0|||
41966191|NCT02564523|75765939|FG000|Overall Study|Adverse Event|0|||
41966192|NCT02564523|75765940|FG001|Overall Study|Adverse Event|0|||
41966193|NCT02564523|75765941|FG002|Overall Study|Adverse Event|0|||
41966194|NCT02564523|75765942|FG003|Overall Study|Adverse Event|0|||
41966195|NCT02564523|75765943|FG004|Overall Study|Adverse Event|0|||
41966196|NCT02564523|75765944|FG005|Overall Study|Adverse Event|0|||
41966197|NCT02564523|75765945|FG006|Overall Study|Adverse Event|0|||
41966198|NCT02564523|75765946|FG007|Overall Study|Adverse Event|0|||
41966199|NCT02564523|75765947|FG008|Overall Study|Adverse Event|0|||
41966200|NCT02564523|75765948|FG009|Overall Study|Adverse Event|0|||
41966201|NCT02564523|75765949|FG010|Overall Study|Adverse Event|0|||
41966202|NCT02564523|75765950|FG011|Overall Study|Adverse Event|0|||
41966203|NCT02564523|75765951|FG012|Overall Study|Adverse Event|0|||
41966204|NCT02564523|75765952|FG013|Overall Study|Adverse Event|0|||
41966205|NCT02564523|75765953|FG014|Overall Study|Adverse Event|0|||
41966206|NCT02564523|75765954|FG015|Overall Study|Adverse Event|0|||
41966207|NCT02564523|75765955|FG016|Overall Study|Adverse Event|0|||
41966208|NCT02564523|75765956|FG017|Overall Study|Adverse Event|1|||
42027587|NCT01215188|75835864|FG002|Overall Study|Lost to Follow-up|16|||
42027588|NCT01215188|75835862|FG000|Overall Study|Adverse Event|1|||
42027589|NCT01215188|75835863|FG001|Overall Study|Adverse Event|1|||
42027590|NCT01215188|75835864|FG002|Overall Study|Adverse Event|3|||
42027591|NCT01215188|75835862|FG000|Overall Study|Physician Decision|2|||
42027592|NCT01215188|75835863|FG001|Overall Study|Physician Decision|1|||
42027593|NCT01215188|75835864|FG002|Overall Study|Physician Decision|0|||
42027594|NCT01215188|75835862|FG000|Overall Study|Lack of Efficacy|0|||
42122843|NCT03832738|75933378|FG002|Overall Study|Withdrawal by Subject|16|||
42122844|NCT03832738|75933376|FG000|Overall Study|Physician Decision|0|||
42210373|NCT03227445|76025157|FG001|Period 1 (28 Days)|Protocol Violation|0|||
41966209|NCT02564523|75765939|FG000|Overall Study|Death|0|||
41966210|NCT02564523|75765940|FG001|Overall Study|Death|0|||
41966211|NCT02564523|75765941|FG002|Overall Study|Death|0|||
41966212|NCT02564523|75765942|FG003|Overall Study|Death|0|||
41966213|NCT02564523|75765943|FG004|Overall Study|Death|0|||
41966214|NCT02564523|75765944|FG005|Overall Study|Death|0|||
41966215|NCT02564523|75765945|FG006|Overall Study|Death|1|||
42027595|NCT01215188|75835863|FG001|Overall Study|Lack of Efficacy|0|||
42027596|NCT01215188|75835864|FG002|Overall Study|Lack of Efficacy|1|||
42122845|NCT03832738|75933377|FG001|Overall Study|Physician Decision|1|||
42122846|NCT03832738|75933378|FG002|Overall Study|Physician Decision|2|||
42122847|NCT03832738|75933376|FG000|Overall Study|Adverse Event|2|||
42122848|NCT03832738|75933377|FG001|Overall Study|Adverse Event|3|||
42122849|NCT03832738|75933378|FG002|Overall Study|Adverse Event|1|||
42122850|NCT03832738|75933376|FG000|Overall Study|Pregnancy|0|||
42122851|NCT03832738|75933377|FG001|Overall Study|Pregnancy|1|||
42122852|NCT03832738|75933378|FG002|Overall Study|Pregnancy|0|||
42122853|NCT00046891|75933388|FG000|Overall Study|Cancels|5|||
42122854|NCT00046891|75933389|FG001|Overall Study|Cancels|9|||
42122855|NCT00046891|75933388|FG000|Overall Study|Ineligible|1|||
42122856|NCT00046891|75933389|FG001|Overall Study|Ineligible|1|||
42122857|NCT00046891|75933388|FG000|Overall Study|Withdrawal by Subject|18|||
42122858|NCT00046891|75933389|FG001|Overall Study|Withdrawal by Subject|15|||
42122859|NCT00046891|75933388|FG000|Overall Study|Adverse Event|5|||
42122860|NCT00046891|75933389|FG001|Overall Study|Adverse Event|5|||
42122861|NCT00365794|75933403|FG000|Overall Study|Withdrawal by Subject|2|||
42122862|NCT00383500|75933411|FG000|Overall Study|Withdrawal by Subject|8|||
42122863|NCT00383500|75933412|FG001|Overall Study|Withdrawal by Subject|3|||
42122864|NCT00383500|75933413|FG002|Overall Study|Withdrawal by Subject|0|||
42122865|NCT00383500|75933411|FG000|Overall Study|Lost to Follow-up|0|||
42122866|NCT00383500|75933412|FG001|Overall Study|Lost to Follow-up|0|||
42122867|NCT00383500|75933413|FG002|Overall Study|Lost to Follow-up|2|||
42122868|NCT00365716|75933427|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
42122869|NCT00365716|75933428|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
42122870|NCT00365716|75933429|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
42122871|NCT00365716|75933430|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
42122872|NCT00365716|75933431|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
42122873|NCT00365716|75933432|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
42122874|NCT00365716|75933433|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
42122875|NCT00365716|75933427|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
42122876|NCT00365716|75933428|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
42122877|NCT00365716|75933429|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
42122878|NCT00365716|75933430|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
42122879|NCT00365716|75933431|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
42122880|NCT00365716|75933432|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
42122881|NCT00365716|75933433|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
42122882|NCT00365716|75933427|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
42122883|NCT00365716|75933428|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
42122884|NCT00365716|75933429|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
42122885|NCT00365716|75933430|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
42122886|NCT00365716|75933431|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
42122887|NCT00365716|75933432|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
42122888|NCT00365716|75933433|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
42122889|NCT00365716|75933427|FG000|Base Study (Day 1 to Month 7)|Other|0|||
42122890|NCT00365716|75933428|FG001|Base Study (Day 1 to Month 7)|Other|1|||
42122891|NCT00365716|75933429|FG002|Base Study (Day 1 to Month 7)|Other|0|||
42122892|NCT00365716|75933430|FG003|Base Study (Day 1 to Month 7)|Other|0|||
42122893|NCT00365716|75933431|FG004|Base Study (Day 1 to Month 7)|Other|0|||
42122894|NCT00365716|75933432|FG005|Base Study (Day 1 to Month 7)|Other|0|||
42122895|NCT00365716|75933433|FG006|Base Study (Day 1 to Month 7)|Other|0|||
42122896|NCT00365716|75933427|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
42122897|NCT00365716|75933428|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
42122898|NCT00365716|75933429|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
42122899|NCT00365716|75933430|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
42122900|NCT00365716|75933431|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
42122901|NCT00365716|75933432|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
42122902|NCT00365716|75933433|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
42122903|NCT00365716|75933427|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
42122904|NCT00365716|75933428|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
42122905|NCT00365716|75933429|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
42122906|NCT00365716|75933430|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
42122907|NCT00365716|75933431|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
42122908|NCT00365716|75933432|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
42122909|NCT00365716|75933433|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
42122910|NCT00365716|75933427|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
42122911|NCT00365716|75933428|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
42122912|NCT00365716|75933429|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
42122913|NCT00365716|75933430|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
42122914|NCT00365716|75933431|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
42122915|NCT00365716|75933432|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
42122916|NCT00365716|75933433|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
42122917|NCT00365716|75933427|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
41966216|NCT02564523|75765946|FG007|Overall Study|Death|0|||
42122918|NCT00365716|75933428|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
42122919|NCT00365716|75933429|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
42122920|NCT00365716|75933430|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
42122921|NCT00365716|75933431|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
42122922|NCT00365716|75933432|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
42122923|NCT00365716|75933433|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
42122924|NCT00365716|75933427|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
42122925|NCT00365716|75933428|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
42122926|NCT00365716|75933429|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
42122927|NCT00365716|75933430|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
42122928|NCT00365716|75933431|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
42122929|NCT00365716|75933432|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
42122930|NCT00365716|75933433|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
42122931|NCT00365716|75933427|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
42122932|NCT00365716|75933428|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
42122933|NCT00365716|75933429|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
42122934|NCT00365716|75933430|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
42122935|NCT00365716|75933431|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
42122936|NCT00365716|75933432|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
42122937|NCT00365716|75933433|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
42122938|NCT00365716|75933427|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
42122939|NCT00365716|75933428|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
42122940|NCT00365716|75933429|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
42122941|NCT00365716|75933430|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
42122942|NCT00365716|75933431|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
41966217|NCT02564523|75765947|FG008|Overall Study|Death|0|||
41966218|NCT02564523|75765948|FG009|Overall Study|Death|0|||
41966219|NCT02564523|75765949|FG010|Overall Study|Death|1|||
41966220|NCT02564523|75765950|FG011|Overall Study|Death|0|||
41966221|NCT02564523|75765951|FG012|Overall Study|Death|0|||
41966222|NCT02564523|75765952|FG013|Overall Study|Death|0|||
41966223|NCT02564523|75765953|FG014|Overall Study|Death|0|||
41966224|NCT02564523|75765954|FG015|Overall Study|Death|0|||
41966225|NCT02564523|75765955|FG016|Overall Study|Death|0|||
41966226|NCT02564523|75765956|FG017|Overall Study|Death|0|||
41966227|NCT02564523|75765939|FG000|Overall Study|Lost to Follow-up|2|||
41966228|NCT02564523|75765940|FG001|Overall Study|Lost to Follow-up|1|||
41966229|NCT02564523|75765941|FG002|Overall Study|Lost to Follow-up|4|||
41966230|NCT02564523|75765942|FG003|Overall Study|Lost to Follow-up|0|||
41966231|NCT02564523|75765943|FG004|Overall Study|Lost to Follow-up|1|||
41966232|NCT02564523|75765944|FG005|Overall Study|Lost to Follow-up|0|||
41966233|NCT02564523|75765945|FG006|Overall Study|Lost to Follow-up|1|||
41966234|NCT02564523|75765946|FG007|Overall Study|Lost to Follow-up|0|||
41966235|NCT02564523|75765947|FG008|Overall Study|Lost to Follow-up|0|||
41966236|NCT02564523|75765948|FG009|Overall Study|Lost to Follow-up|0|||
41966237|NCT02564523|75765949|FG010|Overall Study|Lost to Follow-up|0|||
41966238|NCT02564523|75765950|FG011|Overall Study|Lost to Follow-up|1|||
41966239|NCT02564523|75765951|FG012|Overall Study|Lost to Follow-up|1|||
41966240|NCT02564523|75765952|FG013|Overall Study|Lost to Follow-up|0|||
41966241|NCT02564523|75765953|FG014|Overall Study|Lost to Follow-up|0|||
41966242|NCT02564523|75765954|FG015|Overall Study|Lost to Follow-up|0|||
41966243|NCT02564523|75765955|FG016|Overall Study|Lost to Follow-up|0|||
41966244|NCT02564523|75765956|FG017|Overall Study|Lost to Follow-up|0|||
41966245|NCT02564523|75765939|FG000|Overall Study|Physician Decision|0|||
41966246|NCT02564523|75765940|FG001|Overall Study|Physician Decision|0|||
41966247|NCT02564523|75765941|FG002|Overall Study|Physician Decision|0|||
41966248|NCT02564523|75765942|FG003|Overall Study|Physician Decision|0|||
41966249|NCT02564523|75765943|FG004|Overall Study|Physician Decision|1|||
41966250|NCT02564523|75765944|FG005|Overall Study|Physician Decision|0|||
41966251|NCT02564523|75765945|FG006|Overall Study|Physician Decision|0|||
41966252|NCT02564523|75765946|FG007|Overall Study|Physician Decision|0|||
41966253|NCT02564523|75765947|FG008|Overall Study|Physician Decision|0|||
41966254|NCT02564523|75765948|FG009|Overall Study|Physician Decision|0|||
41966255|NCT02564523|75765949|FG010|Overall Study|Physician Decision|1|||
41966256|NCT02564523|75765950|FG011|Overall Study|Physician Decision|0|||
41966257|NCT02564523|75765951|FG012|Overall Study|Physician Decision|0|||
41966258|NCT02564523|75765952|FG013|Overall Study|Physician Decision|0|||
41966259|NCT02564523|75765953|FG014|Overall Study|Physician Decision|0|||
41966260|NCT02564523|75765954|FG015|Overall Study|Physician Decision|0|||
41966261|NCT02564523|75765955|FG016|Overall Study|Physician Decision|0|||
41966262|NCT02564523|75765956|FG017|Overall Study|Physician Decision|0|||
41966263|NCT02564523|75765939|FG000|Overall Study|Protocol Violation|2|||
41966264|NCT02564523|75765940|FG001|Overall Study|Protocol Violation|2|||
41966265|NCT02564523|75765941|FG002|Overall Study|Protocol Violation|5|||
41966266|NCT02564523|75765942|FG003|Overall Study|Protocol Violation|0|||
41966267|NCT02564523|75765943|FG004|Overall Study|Protocol Violation|1|||
41966268|NCT02564523|75765944|FG005|Overall Study|Protocol Violation|0|||
42122943|NCT00365716|75933432|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
42122944|NCT00365716|75933433|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
42122945|NCT00365716|75933427|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
42122946|NCT00365716|75933428|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
42122947|NCT00365716|75933429|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
42122948|NCT00365716|75933430|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
41966269|NCT02564523|75765945|FG006|Overall Study|Protocol Violation|0|||
41966270|NCT02564523|75765946|FG007|Overall Study|Protocol Violation|0|||
41966271|NCT02564523|75765947|FG008|Overall Study|Protocol Violation|0|||
41966272|NCT02564523|75765948|FG009|Overall Study|Protocol Violation|0|||
41966273|NCT02564523|75765949|FG010|Overall Study|Protocol Violation|0|||
41966274|NCT02564523|75765950|FG011|Overall Study|Protocol Violation|0|||
41966275|NCT02564523|75765951|FG012|Overall Study|Protocol Violation|0|||
41966276|NCT02564523|75765952|FG013|Overall Study|Protocol Violation|0|||
41966277|NCT02564523|75765953|FG014|Overall Study|Protocol Violation|0|||
41966278|NCT02564523|75765954|FG015|Overall Study|Protocol Violation|0|||
41966279|NCT02564523|75765955|FG016|Overall Study|Protocol Violation|0|||
41966280|NCT02564523|75765956|FG017|Overall Study|Protocol Violation|0|||
42027597|NCT01215188|75835862|FG000|Overall Study|Protocol Violation|1|||
42122949|NCT00365716|75933431|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
41966281|NCT02564523|75765939|FG000|Overall Study|Other|3|||
41966282|NCT02564523|75765940|FG001|Overall Study|Other|0|||
41966283|NCT02564523|75765941|FG002|Overall Study|Other|0|||
41966284|NCT02564523|75765942|FG003|Overall Study|Other|1|||
41966285|NCT02564523|75765943|FG004|Overall Study|Other|0|||
41966286|NCT02564523|75765944|FG005|Overall Study|Other|0|||
41966287|NCT02564523|75765945|FG006|Overall Study|Other|0|||
41966288|NCT02564523|75765946|FG007|Overall Study|Other|0|||
41966289|NCT02564523|75765947|FG008|Overall Study|Other|0|||
41966290|NCT02564523|75765948|FG009|Overall Study|Other|0|||
41966291|NCT02564523|75765949|FG010|Overall Study|Other|0|||
42122950|NCT00365716|75933432|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
41966292|NCT02564523|75765950|FG011|Overall Study|Other|0|||
41966293|NCT02564523|75765951|FG012|Overall Study|Other|0|||
41966294|NCT02564523|75765952|FG013|Overall Study|Other|0|||
41966295|NCT02564523|75765953|FG014|Overall Study|Other|0|||
41966296|NCT02564523|75765954|FG015|Overall Study|Other|0|||
41966297|NCT02564523|75765955|FG016|Overall Study|Other|0|||
41966298|NCT02564523|75765956|FG017|Overall Study|Other|0|||
41966299|NCT01447628|75766063|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
41966300|NCT01447628|75766064|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
42027598|NCT01215188|75835863|FG001|Overall Study|Protocol Violation|1|||
41966301|NCT01447628|75766065|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
41966302|NCT01447628|75766066|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
41966303|NCT00515853|75766088|FG000|Overall Study|Lost to Follow-up|9|||
41966304|NCT00515853|75766089|FG001|Overall Study|Lost to Follow-up|13|||
41966305|NCT00515853|75766088|FG000|Overall Study|Withdrawal by Subject|6|||
41966306|NCT00515853|75766089|FG001|Overall Study|Withdrawal by Subject|4|||
41966307|NCT00003458|75766095|FG000|Overall Study|Not evaluable|4|||
41966308|NCT05032872|75766102|FG000|Overall Study|Adverse Event|1|||
41966309|NCT05032872|75766103|FG001|Overall Study|Adverse Event|0|||
41966310|NCT05032872|75766102|FG000|Overall Study|Lost to Follow-up|2|||
41966311|NCT05032872|75766103|FG001|Overall Study|Lost to Follow-up|4|||
41966312|NCT05032872|75766102|FG000|Overall Study|Withdrawal by Subject|4|||
41966313|NCT05032872|75766103|FG001|Overall Study|Withdrawal by Subject|3|||
41966314|NCT04613739|75766129|FG000|Overall Study|Lost to Follow-up|6|||
41966315|NCT04613739|75766130|FG001|Overall Study|Lost to Follow-up|9|||
41966316|NCT04613739|75766129|FG000|Overall Study|potentially duplicative/fraudulent|1|||
41966317|NCT04613739|75766130|FG001|Overall Study|potentially duplicative/fraudulent|3|||
41966318|NCT04407806|75766157|FG000|Overall Study|Withdrawal by Subject|1|||
41966319|NCT04407806|75766158|FG001|Overall Study|Withdrawal by Subject|2|||
41966320|NCT04324021|75766167|FG000|Overall Study|Adverse Event|1|||
41966321|NCT04324021|75766168|FG001|Overall Study|Adverse Event|0|||
41966322|NCT04324021|75766169|FG002|Overall Study|Adverse Event|0|||
41966323|NCT04324021|75766167|FG000|Overall Study|Lack of Efficacy|0|||
41966324|NCT04324021|75766168|FG001|Overall Study|Lack of Efficacy|0|||
41966325|NCT04324021|75766169|FG002|Overall Study|Lack of Efficacy|1|||
41966326|NCT04324021|75766167|FG000|Overall Study|Death|1|||
41966327|NCT04324021|75766168|FG001|Overall Study|Death|1|||
41966328|NCT04324021|75766169|FG002|Overall Study|Death|0|||
41966329|NCT04209621|75766180|FG000|Overall Study|Death|1|||
41966330|NCT04209621|75766180|FG000|Overall Study|Study Terminated Early|2|||
41966331|NCT04186663|75766185|FG000|Overall Study|Lost to Follow-up|1|||
41966332|NCT04186663|75766185|FG000|Overall Study|Unable to complete blood draw|3|||
41966333|NCT04158219|75766189|FG000|Overall Study|Lost to Follow-up|1|||
41966334|NCT03954743|75766222|FG000|Overall Study|Adverse Event|1|||
41966335|NCT03954743|75766223|FG001|Overall Study|Adverse Event|0|||
41966336|NCT03954743|75766222|FG000|Overall Study|Lost to Follow-up|6|||
41966337|NCT03954743|75766223|FG001|Overall Study|Lost to Follow-up|4|||
41966338|NCT03954743|75766222|FG000|Overall Study|Protocol Violation|1|||
41966339|NCT03954743|75766223|FG001|Overall Study|Protocol Violation|0|||
41966340|NCT03954743|75766222|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
41966341|NCT03954743|75766223|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
41966342|NCT03954743|75766222|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
41966343|NCT03954743|75766223|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
41966344|NCT03880565|75766244|FG000|Overall Study|Withdrawal by Subject|1|||
41966345|NCT03880565|75766245|FG001|Overall Study|Withdrawal by Subject|0|||
41966346|NCT03782792|75766253|FG000|Overall Study|Patient left the country|0|||
41966347|NCT03782792|75766254|FG001|Overall Study|Patient left the country|1|||
41966348|NCT03782792|75766253|FG000|Overall Study|Withdrawal by Subject|1|||
41966349|NCT03782792|75766254|FG001|Overall Study|Withdrawal by Subject|2|||
41966350|NCT03733119|75766264|FG000|Overall Study|Physician Decision|2|||
41966351|NCT03733119|75766265|FG001|Overall Study|Physician Decision|1|||
41966352|NCT03733119|75766264|FG000|Overall Study|ineligible to treat per protocol|0|||
41966353|NCT03733119|75766265|FG001|Overall Study|ineligible to treat per protocol|1|||
41966354|NCT03661996|75766276|FG000|Overall Study|Adverse Event|0|||
41966355|NCT03661996|75766277|FG001|Overall Study|Adverse Event|0|||
41966356|NCT03661996|75766278|FG002|Overall Study|Adverse Event|1|||
41966357|NCT03661996|75766279|FG003|Overall Study|Adverse Event|1|||
41966358|NCT03661996|75766280|FG004|Overall Study|Adverse Event|0|||
41966359|NCT03661996|75766276|FG000|Overall Study|Lost to Follow-up|5|||
41966360|NCT03661996|75766277|FG001|Overall Study|Lost to Follow-up|1|||
41966361|NCT03661996|75766278|FG002|Overall Study|Lost to Follow-up|2|||
42122951|NCT00365716|75933433|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
41966362|NCT03661996|75766279|FG003|Overall Study|Lost to Follow-up|2|||
41966363|NCT03661996|75766280|FG004|Overall Study|Lost to Follow-up|6|||
41966364|NCT03661996|75766276|FG000|Overall Study|Physician Decision|1|||
41966365|NCT03661996|75766277|FG001|Overall Study|Physician Decision|1|||
41966366|NCT03661996|75766278|FG002|Overall Study|Physician Decision|1|||
41966367|NCT03661996|75766279|FG003|Overall Study|Physician Decision|2|||
41966368|NCT03661996|75766280|FG004|Overall Study|Physician Decision|0|||
41966369|NCT03661996|75766276|FG000|Overall Study|Protocol Violation|0|||
41966370|NCT03661996|75766277|FG001|Overall Study|Protocol Violation|0|||
41966371|NCT03661996|75766278|FG002|Overall Study|Protocol Violation|0|||
42122952|NCT00365716|75933427|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
41966372|NCT03661996|75766279|FG003|Overall Study|Protocol Violation|0|||
42122953|NCT00365716|75933428|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
41966373|NCT03661996|75766280|FG004|Overall Study|Protocol Violation|1|||
41966374|NCT03661996|75766276|FG000|Overall Study|Withdrawal by Subject|3|||
41966375|NCT03661996|75766277|FG001|Overall Study|Withdrawal by Subject|5|||
41966376|NCT03661996|75766278|FG002|Overall Study|Withdrawal by Subject|1|||
41966377|NCT03661996|75766279|FG003|Overall Study|Withdrawal by Subject|7|||
41966378|NCT03661996|75766280|FG004|Overall Study|Withdrawal by Subject|7|||
41966379|NCT03661996|75766276|FG000|Overall Study|Sponsors Decision|2|||
41966380|NCT03661996|75766277|FG001|Overall Study|Sponsors Decision|0|||
41966381|NCT03661996|75766278|FG002|Overall Study|Sponsors Decision|0|||
41966382|NCT03661996|75766279|FG003|Overall Study|Sponsors Decision|0|||
41966383|NCT03661996|75766280|FG004|Overall Study|Sponsors Decision|0|||
41966384|NCT03661996|75766276|FG000|Overall Study|Other|1|||
41966385|NCT03661996|75766277|FG001|Overall Study|Other|1|||
41966386|NCT03661996|75766278|FG002|Overall Study|Other|1|||
41966387|NCT03661996|75766279|FG003|Overall Study|Other|1|||
41966388|NCT03661996|75766280|FG004|Overall Study|Other|0|||
41966389|NCT03633461|75766297|FG000|Overall Study|Lost to Follow-up|0|||
41966390|NCT03633461|75766298|FG001|Overall Study|Lost to Follow-up|1|||
41966391|NCT03499314|75766326|FG000|Overall Study|Time Commitment|1|||
41966392|NCT03499314|75766327|FG001|Overall Study|Time Commitment|2|||
41966393|NCT03499314|75766326|FG000|Overall Study|Medical issue unrelated to research study|1|||
41966394|NCT03499314|75766327|FG001|Overall Study|Medical issue unrelated to research study|1|||
41966395|NCT03369431|75766335|FG000|Overall Study|Lost to Follow-up|1|||
41966396|NCT03369431|75766336|FG001|Overall Study|Lost to Follow-up|3|||
41966397|NCT03369431|75766335|FG000|Overall Study|Withdrawal by Subject|2|||
41966398|NCT03369431|75766336|FG001|Overall Study|Withdrawal by Subject|3|||
41966399|NCT03369431|75766335|FG000|Overall Study|Protocol Violation|1|||
41966400|NCT03369431|75766336|FG001|Overall Study|Protocol Violation|1|||
41966401|NCT03336866|75766345|FG000|Overall Study|Lost to Follow-up|2|||
41966402|NCT03336866|75766346|FG001|Overall Study|Lost to Follow-up|0|||
41966403|NCT03336866|75766347|FG002|Overall Study|Lost to Follow-up|3|||
41966404|NCT03336866|75766345|FG000|Overall Study|Withdrawal by Subject|1|||
41966405|NCT03336866|75766346|FG001|Overall Study|Withdrawal by Subject|1|||
41966406|NCT03336866|75766347|FG002|Overall Study|Withdrawal by Subject|0|||
41966407|NCT03336866|75766345|FG000|Overall Study|Noncompliance with clinic house rules|0|||
41966408|NCT03336866|75766346|FG001|Overall Study|Noncompliance with clinic house rules|0|||
41966409|NCT03336866|75766347|FG002|Overall Study|Noncompliance with clinic house rules|1|||
41966410|NCT03332173|75766360|FG000|Overall Study|Death|7|||
41966411|NCT03332173|75766360|FG000|Overall Study|Withdrawal by Subject|6|||
41966412|NCT03332173|75766360|FG000|Overall Study|Lost to Follow-up|2|||
41966413|NCT03332173|75766360|FG000|Overall Study|Transferred to long-term extension study|29|||
41966414|NCT03322293|75766367|FG000|Overall Study|Lost to Follow-up|0|||
41966415|NCT03322293|75766368|FG001|Overall Study|Lost to Follow-up|0|||
41966416|NCT03322293|75766369|FG002|Overall Study|Lost to Follow-up|1|||
41966417|NCT03254394|75766391|FG000|Overall Study|Withdrawal by Subject|0|||
41966418|NCT03254394|75766392|FG001|Overall Study|Withdrawal by Subject|2|||
41966419|NCT03253809|75766398|FG000|Overall Study|Unable to obtain study related data|14|||
41966420|NCT02998476|75766477|FG000|Overall Study|Lost to Follow-up|1|||
41966421|NCT02998476|75766478|FG001|Overall Study|Lost to Follow-up|0|||
41966422|NCT02998476|75766477|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
41966423|NCT02998476|75766478|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
41966424|NCT02998476|75766477|FG000|Overall Study|Withdrawal by Subject|1|||
41966425|NCT02998476|75766478|FG001|Overall Study|Withdrawal by Subject|2|||
41966426|NCT02998476|75766477|FG000|Overall Study|Death|45|||
41966427|NCT02998476|75766478|FG001|Overall Study|Death|2|||
41966428|NCT02998476|75766477|FG000|Overall Study|Other|6|||
41966429|NCT02998476|75766478|FG001|Overall Study|Other|1|||
41966430|NCT02924064|75766496|FG000|Overall Study|Adverse Event|2|||
41966431|NCT02924064|75766497|FG001|Overall Study|Adverse Event|2|||
41966432|NCT02924064|75766496|FG000|Overall Study|Lost to Follow-up|0|||
41966433|NCT02924064|75766497|FG001|Overall Study|Lost to Follow-up|2|||
42027599|NCT01215188|75835864|FG002|Overall Study|Protocol Violation|1|||
42122954|NCT00365716|75933429|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
42122955|NCT00365716|75933430|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
42122956|NCT00365716|75933431|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
42122957|NCT00365716|75933432|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
42122958|NCT00365716|75933433|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
42122959|NCT00365716|75933427|FG000|Extension 1|Lost to Follow-up|0|||
42122960|NCT00365716|75933428|FG001|Extension 1|Lost to Follow-up|0|||
42122961|NCT00365716|75933429|FG002|Extension 1|Lost to Follow-up|0|||
42122962|NCT00365716|75933430|FG003|Extension 1|Lost to Follow-up|0|||
41966434|NCT02924064|75766496|FG000|Overall Study|Physician Decision|0|||
41966435|NCT02924064|75766497|FG001|Overall Study|Physician Decision|2|||
41966436|NCT02924064|75766496|FG000|Overall Study|Protocol Violation|1|||
41966437|NCT02924064|75766497|FG001|Overall Study|Protocol Violation|3|||
41966438|NCT02924064|75766496|FG000|Overall Study|Withdrawal by Subject|4|||
41966439|NCT02924064|75766497|FG001|Overall Study|Withdrawal by Subject|5|||
41966440|NCT02924064|75766496|FG000|Overall Study|Other|17|||
42122963|NCT00365716|75933431|FG004|Extension 1|Lost to Follow-up|0|||
42122964|NCT00365716|75933432|FG005|Extension 1|Lost to Follow-up|1|||
42122965|NCT00365716|75933433|FG006|Extension 1|Lost to Follow-up|0|||
42122966|NCT00365716|75933427|FG000|Extension 1|Other|0|||
42122967|NCT00365716|75933428|FG001|Extension 1|Other|0|||
42122968|NCT00365716|75933429|FG002|Extension 1|Other|0|||
42122969|NCT00365716|75933430|FG003|Extension 1|Other|0|||
42122970|NCT00365716|75933431|FG004|Extension 1|Other|0|||
42122971|NCT00365716|75933432|FG005|Extension 1|Other|9|||
42122972|NCT00365716|75933433|FG006|Extension 1|Other|0|||
42122973|NCT00365716|75933427|FG000|Extension 1|Moved|0|||
42122974|NCT00365716|75933428|FG001|Extension 1|Moved|0|||
42122975|NCT00365716|75933429|FG002|Extension 1|Moved|0|||
42122976|NCT00365716|75933430|FG003|Extension 1|Moved|0|||
42122977|NCT00365716|75933431|FG004|Extension 1|Moved|0|||
42122978|NCT00365716|75933432|FG005|Extension 1|Moved|4|||
42122979|NCT00365716|75933433|FG006|Extension 1|Moved|0|||
42122980|NCT00365716|75933427|FG000|Extension 1|Withdrawal by Subject|0|||
42122981|NCT00365716|75933428|FG001|Extension 1|Withdrawal by Subject|0|||
42122982|NCT00365716|75933429|FG002|Extension 1|Withdrawal by Subject|0|||
42122983|NCT00365716|75933430|FG003|Extension 1|Withdrawal by Subject|0|||
42122984|NCT00365716|75933431|FG004|Extension 1|Withdrawal by Subject|0|||
42122985|NCT00365716|75933432|FG005|Extension 1|Withdrawal by Subject|3|||
42122986|NCT00365716|75933433|FG006|Extension 1|Withdrawal by Subject|0|||
42122987|NCT00365716|75933427|FG000|Extension 1|Pregnancy|0|||
42122988|NCT00365716|75933428|FG001|Extension 1|Pregnancy|0|||
42122989|NCT00365716|75933429|FG002|Extension 1|Pregnancy|0|||
42122990|NCT00365716|75933430|FG003|Extension 1|Pregnancy|0|||
42122991|NCT00365716|75933431|FG004|Extension 1|Pregnancy|0|||
42122992|NCT00365716|75933432|FG005|Extension 1|Pregnancy|4|||
42122993|NCT00365716|75933433|FG006|Extension 1|Pregnancy|0|||
42122994|NCT00365716|75933427|FG000|Extension 1|Protocol Violation|0|||
42122995|NCT00365716|75933428|FG001|Extension 1|Protocol Violation|0|||
42122996|NCT00365716|75933429|FG002|Extension 1|Protocol Violation|0|||
42122997|NCT00365716|75933430|FG003|Extension 1|Protocol Violation|0|||
42122998|NCT00365716|75933431|FG004|Extension 1|Protocol Violation|0|||
42122999|NCT00365716|75933432|FG005|Extension 1|Protocol Violation|1|||
42123000|NCT00365716|75933433|FG006|Extension 1|Protocol Violation|0|||
42123001|NCT00365716|75933427|FG000|Extension 2|Lost to Follow-up|0|||
42123002|NCT00365716|75933428|FG001|Extension 2|Lost to Follow-up|0|||
42123003|NCT00365716|75933429|FG002|Extension 2|Lost to Follow-up|0|||
42123004|NCT00365716|75933430|FG003|Extension 2|Lost to Follow-up|0|||
42123005|NCT00365716|75933431|FG004|Extension 2|Lost to Follow-up|0|||
42123006|NCT00365716|75933432|FG005|Extension 2|Lost to Follow-up|0|||
42123007|NCT00365716|75933433|FG006|Extension 2|Lost to Follow-up|2|||
42123008|NCT00365716|75933427|FG000|Extension 2|Other|0|||
42123009|NCT00365716|75933428|FG001|Extension 2|Other|0|||
42123010|NCT00365716|75933429|FG002|Extension 2|Other|0|||
42123011|NCT00365716|75933430|FG003|Extension 2|Other|0|||
42123012|NCT00365716|75933431|FG004|Extension 2|Other|0|||
42123013|NCT00365716|75933432|FG005|Extension 2|Other|0|||
42123014|NCT00365716|75933433|FG006|Extension 2|Other|3|||
42123015|NCT00365716|75933427|FG000|Extension 2|Withdrawal by Subject|0|||
42123016|NCT00365716|75933428|FG001|Extension 2|Withdrawal by Subject|0|||
42123017|NCT00365716|75933429|FG002|Extension 2|Withdrawal by Subject|0|||
42123018|NCT00365716|75933430|FG003|Extension 2|Withdrawal by Subject|0|||
42123019|NCT00365716|75933431|FG004|Extension 2|Withdrawal by Subject|0|||
42123020|NCT00365716|75933432|FG005|Extension 2|Withdrawal by Subject|0|||
42123021|NCT00365716|75933433|FG006|Extension 2|Withdrawal by Subject|5|||
42123022|NCT00059839|75933449|FG000|Overall Study|Death|1|||
42123023|NCT00059839|75933450|FG001|Overall Study|Death|1|||
42123024|NCT00059839|75933449|FG000|Overall Study|Lack of Efficacy|6|||
42123025|NCT00059839|75933450|FG001|Overall Study|Lack of Efficacy|5|||
42123026|NCT00059839|75933449|FG000|Overall Study|Lost to Follow-up|2|||
42123027|NCT00059839|75933450|FG001|Overall Study|Lost to Follow-up|0|||
42123028|NCT00059839|75933449|FG000|Overall Study|Physician Decision|1|||
42123029|NCT00059839|75933450|FG001|Overall Study|Physician Decision|2|||
42123030|NCT00059839|75933449|FG000|Overall Study|Withdrawal by Subject|1|||
42123031|NCT00059839|75933450|FG001|Overall Study|Withdrawal by Subject|6|||
41966441|NCT02924064|75766497|FG001|Overall Study|Other|29|||
42123032|NCT00059839|75933449|FG000|Overall Study|Ineligible|1|||
42123033|NCT00059839|75933450|FG001|Overall Study|Ineligible|3|||
42123034|NCT00059215|75933460|FG000|Overall Study|Adverse Event|5|||
42123035|NCT00059215|75933461|FG001|Overall Study|Adverse Event|5|||
42123036|NCT00059215|75933462|FG002|Overall Study|Adverse Event|9|||
42123037|NCT00059215|75933463|FG003|Overall Study|Adverse Event|9|||
42123038|NCT00059215|75933460|FG000|Overall Study|Death|0|||
42123039|NCT00059215|75933461|FG001|Overall Study|Death|0|||
42123040|NCT00059215|75933462|FG002|Overall Study|Death|3|||
42123041|NCT00059215|75933463|FG003|Overall Study|Death|0|||
42123042|NCT00059215|75933460|FG000|Overall Study|Lost to Follow-up|1|||
42123043|NCT00059215|75933461|FG001|Overall Study|Lost to Follow-up|2|||
42123044|NCT00059215|75933462|FG002|Overall Study|Lost to Follow-up|0|||
42123045|NCT00059215|75933463|FG003|Overall Study|Lost to Follow-up|0|||
42123046|NCT00059215|75933460|FG000|Overall Study|Withdrawal by Subject|4|||
42123047|NCT00059215|75933461|FG001|Overall Study|Withdrawal by Subject|4|||
41966442|NCT02916706|75766505|FG000|Overall Study|Adverse Event|0|||
41966443|NCT02916706|75766506|FG001|Overall Study|Adverse Event|1|||
41966444|NCT02916706|75766505|FG000|Overall Study|Lost to Follow-up|0|||
41966445|NCT02916706|75766506|FG001|Overall Study|Lost to Follow-up|1|||
41966446|NCT02916706|75766505|FG000|Overall Study|Physician Decision|1|||
41966447|NCT02916706|75766506|FG001|Overall Study|Physician Decision|0|||
41966448|NCT02916706|75766505|FG000|Overall Study|Protocol Violation|3|||
41966449|NCT02916706|75766506|FG001|Overall Study|Protocol Violation|1|||
41966450|NCT02916706|75766505|FG000|Overall Study|Withdrawal by Subject|6|||
41966451|NCT02916706|75766506|FG001|Overall Study|Withdrawal by Subject|9|||
41966452|NCT02916706|75766505|FG000|Overall Study|Other|5|||
41966453|NCT02916706|75766506|FG001|Overall Study|Other|19|||
41966454|NCT02889900|75766512|FG000|Overall Study|Adverse Event|11|||
41966455|NCT02889900|75766512|FG000|Overall Study|Condition under investigation worsened|32|||
41966456|NCT02889900|75766512|FG000|Overall Study|Other|5|||
41966457|NCT02889900|75766512|FG000|Overall Study|Withdrawal by Subject|7|||
41966458|NCT02889900|75766512|FG000|Overall Study|Not treated|2|||
41966459|NCT02866695|75766516|FG000|Overall Study|Adverse Event|1|||
41966460|NCT02866695|75766516|FG000|Overall Study|Lost to Follow-up|1|||
41966461|NCT02834793|75766522|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
41966462|NCT02834793|75766523|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
42027600|NCT01215188|75835862|FG000|Overall Study|Withdrawal by Subject|32|||
42027601|NCT01215188|75835863|FG001|Overall Study|Withdrawal by Subject|34|||
42027602|NCT01215188|75835864|FG002|Overall Study|Withdrawal by Subject|31|||
42027603|NCT01215032|75835872|FG000|Overall Study|Adverse Event|3|||
42027604|NCT01215032|75835872|FG000|Overall Study|Lack of Efficacy|17|||
42027605|NCT00962247|75835878|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
42027606|NCT00962247|75835878|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
41966463|NCT02834793|75766524|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
42027607|NCT00918580|75835884|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
42027608|NCT00918580|75835884|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
42027609|NCT00918580|75835884|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
42027610|NCT00918580|75835884|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
42027611|NCT00918580|75835884|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
42027612|NCT00918580|75835884|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
42123048|NCT00059215|75933462|FG002|Overall Study|Withdrawal by Subject|1|||
41966464|NCT02834793|75766525|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
41966465|NCT02834793|75766522|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
41966466|NCT02834793|75766523|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
41966467|NCT02834793|75766524|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
41966468|NCT02834793|75766525|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
41966469|NCT02834793|75766522|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
42027613|NCT00918580|75835884|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
41966470|NCT02834793|75766523|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
41966471|NCT02834793|75766524|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
41966472|NCT02834793|75766525|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
41966473|NCT02834793|75766522|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
41966474|NCT02834793|75766523|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
41966475|NCT02834793|75766524|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
41966476|NCT02834793|75766525|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
41966477|NCT02834793|75766522|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
41966478|NCT02834793|75766523|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
41966479|NCT02834793|75766524|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
41966480|NCT02834793|75766525|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
41966481|NCT02834793|75766522|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
41966482|NCT02834793|75766523|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
42123049|NCT00059215|75933463|FG003|Overall Study|Withdrawal by Subject|3|||
42123050|NCT00059215|75933460|FG000|Overall Study|Protocol Violation|1|||
42123051|NCT00059215|75933461|FG001|Overall Study|Protocol Violation|0|||
41966483|NCT02834793|75766524|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
41966484|NCT02834793|75766525|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
41966485|NCT02834793|75766522|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
41966486|NCT02834793|75766523|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
41966487|NCT02834793|75766524|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
41966488|NCT02834793|75766525|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
41966489|NCT02834793|75766522|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
41966490|NCT02834793|75766523|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
41966491|NCT02834793|75766524|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
41966492|NCT02834793|75766525|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
41966493|NCT02834793|75766522|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
41966494|NCT02834793|75766523|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
41966495|NCT02834793|75766524|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
41966496|NCT02834793|75766525|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
42123052|NCT00059215|75933462|FG002|Overall Study|Protocol Violation|1|||
42123053|NCT00059215|75933463|FG003|Overall Study|Protocol Violation|0|||
42123054|NCT00059215|75933460|FG000|Overall Study|Protocol entry criteria not met|1|||
42123055|NCT00059215|75933461|FG001|Overall Study|Protocol entry criteria not met|1|||
42123056|NCT00059215|75933462|FG002|Overall Study|Protocol entry criteria not met|0|||
42123057|NCT00059215|75933463|FG003|Overall Study|Protocol entry criteria not met|2|||
42123058|NCT00059215|75933460|FG000|Overall Study|Physician Decision|1|||
42123059|NCT00059215|75933461|FG001|Overall Study|Physician Decision|2|||
42123060|NCT00059215|75933462|FG002|Overall Study|Physician Decision|1|||
42123061|NCT00059215|75933463|FG003|Overall Study|Physician Decision|1|||
42123062|NCT00058825|75933474|FG000|Overall Study|Relapse|9|||
42123063|NCT00058825|75933474|FG000|Overall Study|Progressive Disease|5|||
42123064|NCT00058825|75933474|FG000|Overall Study|Graft Failure|5|||
42123065|NCT00058825|75933474|FG000|Overall Study|Death|3|||
42123066|NCT00364858|75933482|FG000|Overall Study|Adverse Event|1|||
42123067|NCT00364858|75933483|FG001|Overall Study|Adverse Event|5|||
42123068|NCT00364858|75933482|FG000|Overall Study|Withdrawal by Subject|1|||
42123069|NCT00364858|75933483|FG001|Overall Study|Withdrawal by Subject|1|||
42123070|NCT00364858|75933482|FG000|Overall Study|Pregnancy|1|||
42123071|NCT00364858|75933483|FG001|Overall Study|Pregnancy|1|||
42123072|NCT00364858|75933482|FG000|Overall Study|Clinical failure|2|||
42123073|NCT00364858|75933483|FG001|Overall Study|Clinical failure|13|||
42123074|NCT00364858|75933482|FG000|Overall Study|Discontinuation at baseline|1|||
42123075|NCT00364858|75933483|FG001|Overall Study|Discontinuation at baseline|0|||
41966497|NCT02834793|75766522|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
41966498|NCT02834793|75766523|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
41966499|NCT02834793|75766524|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
41966500|NCT02834793|75766525|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
42123076|NCT00364858|75933482|FG000|Overall Study|Non-compliant|1|||
42123077|NCT00364858|75933483|FG001|Overall Study|Non-compliant|0|||
42123078|NCT00364858|75933482|FG000|Overall Study|Return to Q2 regimen|0|||
42123079|NCT00364858|75933483|FG001|Overall Study|Return to Q2 regimen|1|||
42123080|NCT00364858|75933482|FG000|Overall Study|Clinical baseline issue|0|||
42123081|NCT00364858|75933483|FG001|Overall Study|Clinical baseline issue|1|||
42123082|NCT03803059|75933490|FG000|Overall Study|Protocol Violation|2|||
42123083|NCT03803059|75933490|FG000|Overall Study|Lost to Follow-up|1|||
42123084|NCT00372424|75933495|FG000|Overall Study|Adverse Event|2|||
42123085|NCT00372424|75933495|FG000|Overall Study|Withdrawal by Subject|1|||
42123086|NCT00372424|75933495|FG000|Overall Study|Death|1|||
42123087|NCT00372424|75933495|FG000|Overall Study|Objective Progression or Relapse|14|||
42123088|NCT00372424|75933495|FG000|Overall Study|Other|7|||
42123089|NCT00372424|75933495|FG000|Overall Study|Enrolled, Not Treated|1|||
42123090|NCT00372190|75933501|FG000|Overall Study|Lost to Follow-up|3|||
42123091|NCT00372190|75933502|FG001|Overall Study|Lost to Follow-up|1|||
42123092|NCT00044083|75933512|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
42123093|NCT00044083|75933513|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
42123094|NCT00044083|75933512|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
42123095|NCT00044083|75933513|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
42123096|NCT00044083|75933512|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
42123097|NCT00044083|75933513|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
42123098|NCT00044083|75933512|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
42123099|NCT00044083|75933513|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
42123100|NCT00044083|75933512|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
42123101|NCT00044083|75933513|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
42123102|NCT00044083|75933512|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
42123103|NCT00044083|75933513|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
42123104|NCT00044083|75933512|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
42123105|NCT00044083|75933513|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
42123106|NCT00044083|75933512|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
42123107|NCT00044083|75933513|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
42123108|NCT00044083|75933512|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
42123109|NCT00044083|75933513|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
42123110|NCT00044083|75933512|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
42123111|NCT00044083|75933513|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
42123112|NCT00058123|75933546|FG000|Overall Study|Wrong histology|9|||
42123113|NCT00058123|75933546|FG000|Overall Study|Received >3 prior treatments|1|||
42123114|NCT00022633|75933553|FG000|Overall Study|Adverse Event|11|||
42123115|NCT00022633|75933554|FG001|Overall Study|Adverse Event|1|||
42123116|NCT00022633|75933553|FG000|Overall Study|Refusal unrelated to adverse event|1|||
42123117|NCT00022633|75933554|FG001|Overall Study|Refusal unrelated to adverse event|0|||
42123118|NCT00022633|75933553|FG000|Overall Study|Progression/relapse|9|||
42123119|NCT00022633|75933554|FG001|Overall Study|Progression/relapse|2|||
42123120|NCT00022633|75933553|FG000|Overall Study|Death|4|||
42123121|NCT00022633|75933554|FG001|Overall Study|Death|0|||
42123122|NCT00022633|75933553|FG000|Overall Study|Other - not protocol specified|3|||
42123123|NCT00022633|75933554|FG001|Overall Study|Other - not protocol specified|2|||
42123124|NCT00022633|75933553|FG000|Overall Study|Ineligible|4|||
42123125|NCT00022633|75933554|FG001|Overall Study|Ineligible|0|||
42123126|NCT00021541|75933561|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
42123127|NCT00021541|75933562|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
42123128|NCT00021541|75933561|FG000|Period 1-First Treatment|Adverse Event|2|||
42123129|NCT00021541|75933562|FG001|Period 1-First Treatment|Adverse Event|1|||
42123130|NCT00021541|75933561|FG000|Period 1-First Treatment|non-adherence|3|||
42123131|NCT00021541|75933562|FG001|Period 1-First Treatment|non-adherence|0|||
42123132|NCT00021541|75933561|FG000|Period 1-First Treatment|Death|1|||
42123133|NCT00021541|75933562|FG001|Period 1-First Treatment|Death|0|||
42123134|NCT00021541|75933561|FG000|Period 1-First Treatment|Pts that did not progress|2|||
42123135|NCT00021541|75933562|FG001|Period 1-First Treatment|Pts that did not progress|2|||
42027614|NCT00920686|75835894|FG000|Overall Study|Lost to Follow-up|2|||
42123136|NCT00021541|75933561|FG000|Period 1-First Treatment|Ineligible|0|||
42123137|NCT00021541|75933562|FG001|Period 1-First Treatment|Ineligible|2|||
42123138|NCT00021541|75933561|FG000|Period 2-crossover|refused phase B|2|||
41966501|NCT02834793|75766522|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
41966502|NCT02834793|75766523|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
41966503|NCT02834793|75766524|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
41966504|NCT02834793|75766525|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
41966505|NCT02834793|75766522|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
41966506|NCT02834793|75766523|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
41966507|NCT02834793|75766524|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
41966508|NCT02834793|75766525|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
41966509|NCT02834793|75766522|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
42027615|NCT00920686|75835895|FG001|Overall Study|Lost to Follow-up|3|||
42123139|NCT00021541|75933562|FG001|Period 2-crossover|refused phase B|2|||
42123140|NCT00021541|75933561|FG000|Period 2-crossover|Withdrawal by Subject|3|||
42123141|NCT00021541|75933562|FG001|Period 2-crossover|Withdrawal by Subject|4|||
42123142|NCT00021541|75933561|FG000|Period 2-crossover|Adverse Event|2|||
42123143|NCT00021541|75933562|FG001|Period 2-crossover|Adverse Event|2|||
42123144|NCT00021541|75933561|FG000|Period 2-crossover|non-adherence|1|||
42123145|NCT00021541|75933562|FG001|Period 2-crossover|non-adherence|0|||
42123146|NCT00021541|75933561|FG000|Period 2-crossover|Pts that did not progress|2|||
42123147|NCT00021541|75933562|FG001|Period 2-crossover|Pts that did not progress|3|||
42123148|NCT00021229|75933573|FG000|Overall Study|Adverse Event|10|||
42123149|NCT00021229|75933574|FG001|Overall Study|Adverse Event|5|||
42123150|NCT00021229|75933575|FG002|Overall Study|Adverse Event|2|||
42123151|NCT00021229|75933573|FG000|Overall Study|Death|0|||
42123152|NCT00021229|75933574|FG001|Overall Study|Death|1|||
42123153|NCT00021229|75933575|FG002|Overall Study|Death|0|||
42123154|NCT00021229|75933573|FG000|Overall Study|Withdrawal by Subject|7|||
42123155|NCT00021229|75933574|FG001|Overall Study|Withdrawal by Subject|7|||
42123156|NCT00021229|75933575|FG002|Overall Study|Withdrawal by Subject|1|||
42123157|NCT00021229|75933573|FG000|Overall Study|Progressive Disease|15|||
42123158|NCT00021229|75933574|FG001|Overall Study|Progressive Disease|19|||
42123159|NCT00021229|75933575|FG002|Overall Study|Progressive Disease|12|||
42123160|NCT00021229|75933573|FG000|Overall Study|Protocol Violation|1|||
42123161|NCT00021229|75933574|FG001|Overall Study|Protocol Violation|1|||
42123162|NCT00021229|75933575|FG002|Overall Study|Protocol Violation|0|||
42123163|NCT00021229|75933573|FG000|Overall Study|Physician Decision|0|||
42123164|NCT00021229|75933574|FG001|Overall Study|Physician Decision|0|||
42123165|NCT00021229|75933575|FG002|Overall Study|Physician Decision|1|||
42123166|NCT00021229|75933573|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
42123167|NCT00021229|75933574|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
42123168|NCT00021229|75933575|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
42123169|NCT00372112|75933589|FG000|Overall Study|Adverse Event|0|||
42123170|NCT00372112|75933590|FG001|Overall Study|Adverse Event|1|||
42123171|NCT00372112|75933591|FG002|Overall Study|Adverse Event|1|||
42123172|NCT00372112|75933592|FG003|Overall Study|Adverse Event|1|||
42123173|NCT00372112|75933589|FG000|Overall Study|Withdrawal by Subject|0|||
42123174|NCT00372112|75933590|FG001|Overall Study|Withdrawal by Subject|0|||
42123175|NCT00372112|75933591|FG002|Overall Study|Withdrawal by Subject|2|||
42123176|NCT00372112|75933592|FG003|Overall Study|Withdrawal by Subject|1|||
42123177|NCT00372112|75933589|FG000|Overall Study|Exacerbation|0|||
42123178|NCT00372112|75933590|FG001|Overall Study|Exacerbation|0|||
42123179|NCT00372112|75933591|FG002|Overall Study|Exacerbation|0|||
42123180|NCT00372112|75933592|FG003|Overall Study|Exacerbation|1|||
42123181|NCT00372112|75933589|FG000|Overall Study|PR >240 at Visit 3|0|||
42123182|NCT00372112|75933590|FG001|Overall Study|PR >240 at Visit 3|0|||
42123183|NCT00372112|75933591|FG002|Overall Study|PR >240 at Visit 3|0|||
42123184|NCT00372112|75933592|FG003|Overall Study|PR >240 at Visit 3|1|||
42123185|NCT00372112|75933589|FG000|Overall Study|Hepatitis B|1|||
42123186|NCT00372112|75933590|FG001|Overall Study|Hepatitis B|0|||
42123187|NCT00372112|75933591|FG002|Overall Study|Hepatitis B|0|||
42123188|NCT00372112|75933592|FG003|Overall Study|Hepatitis B|0|||
42123189|NCT00372112|75933589|FG000|Overall Study|Other-protocol violation|0|||
42123190|NCT00372112|75933590|FG001|Overall Study|Other-protocol violation|0|||
42123191|NCT00372112|75933591|FG002|Overall Study|Other-protocol violation|1|||
42123192|NCT00372112|75933592|FG003|Overall Study|Other-protocol violation|0|||
42123193|NCT00488475|75933605|FG000|Overall Study|Other|1754|||
42123194|NCT00042991|75933616|FG000|Overall Study|Adverse Event|1|||
42123195|NCT00042991|75933617|FG001|Overall Study|Adverse Event|4|||
42123196|NCT00042991|75933618|FG002|Overall Study|Adverse Event|2|||
42123197|NCT00042991|75933619|FG003|Overall Study|Adverse Event|0|||
42123198|NCT00042991|75933620|FG004|Overall Study|Adverse Event|0|||
42123199|NCT00042991|75933621|FG005|Overall Study|Adverse Event|1|||
42123200|NCT00042991|75933622|FG006|Overall Study|Adverse Event|0|||
42123201|NCT00042991|75933616|FG000|Overall Study|Withdrawal by Subject|0|||
42123202|NCT00042991|75933617|FG001|Overall Study|Withdrawal by Subject|7|||
42123203|NCT00042991|75933618|FG002|Overall Study|Withdrawal by Subject|2|||
42123204|NCT00042991|75933619|FG003|Overall Study|Withdrawal by Subject|0|||
42123205|NCT00042991|75933620|FG004|Overall Study|Withdrawal by Subject|1|||
42123206|NCT00042991|75933621|FG005|Overall Study|Withdrawal by Subject|0|||
42123207|NCT00042991|75933622|FG006|Overall Study|Withdrawal by Subject|0|||
42123208|NCT00042991|75933616|FG000|Overall Study|Disease Progression|5|||
42123209|NCT00042991|75933617|FG001|Overall Study|Disease Progression|29|||
42123210|NCT00042991|75933618|FG002|Overall Study|Disease Progression|2|||
42123211|NCT00042991|75933619|FG003|Overall Study|Disease Progression|2|||
42123212|NCT00042991|75933620|FG004|Overall Study|Disease Progression|1|||
42123213|NCT00042991|75933621|FG005|Overall Study|Disease Progression|4|||
42123214|NCT00042991|75933622|FG006|Overall Study|Disease Progression|2|||
42123215|NCT00042991|75933616|FG000|Overall Study|Alternative Therapy|0|||
42123216|NCT00042991|75933617|FG001|Overall Study|Alternative Therapy|0|||
42123217|NCT00042991|75933618|FG002|Overall Study|Alternative Therapy|0|||
42123218|NCT00042991|75933619|FG003|Overall Study|Alternative Therapy|0|||
42123219|NCT00042991|75933620|FG004|Overall Study|Alternative Therapy|1|||
42123220|NCT00042991|75933621|FG005|Overall Study|Alternative Therapy|0|||
42123221|NCT00042991|75933622|FG006|Overall Study|Alternative Therapy|0|||
42123222|NCT00466167|75933643|FG000|Overall Study|Adverse Event|8|||
42123223|NCT00466167|75933644|FG001|Overall Study|Adverse Event|8|||
42123224|NCT00466167|75933645|FG002|Overall Study|Adverse Event|7|||
42123225|NCT00466167|75933643|FG000|Overall Study|Lack of Efficacy|2|||
42123226|NCT00466167|75933644|FG001|Overall Study|Lack of Efficacy|0|||
42123227|NCT00466167|75933645|FG002|Overall Study|Lack of Efficacy|3|||
42123228|NCT00466167|75933643|FG000|Overall Study|Protocol Violation|1|||
42123229|NCT00466167|75933644|FG001|Overall Study|Protocol Violation|1|||
42123230|NCT00466167|75933645|FG002|Overall Study|Protocol Violation|2|||
42123231|NCT00466167|75933643|FG000|Overall Study|Lost to Follow-up|3|||
42123232|NCT00466167|75933644|FG001|Overall Study|Lost to Follow-up|2|||
42123233|NCT00466167|75933645|FG002|Overall Study|Lost to Follow-up|2|||
42123234|NCT00466167|75933643|FG000|Overall Study|Withdrawal by Subject|4|||
42123235|NCT00466167|75933644|FG001|Overall Study|Withdrawal by Subject|1|||
42123236|NCT00466167|75933645|FG002|Overall Study|Withdrawal by Subject|6|||
42123237|NCT00466167|75933643|FG000|Overall Study|patient did not meet inclusion criteria|1|||
42123238|NCT00466167|75933644|FG001|Overall Study|patient did not meet inclusion criteria|0|||
42123239|NCT00466167|75933645|FG002|Overall Study|patient did not meet inclusion criteria|1|||
42123240|NCT00466167|75933643|FG000|Overall Study|Not treated|1|||
42123241|NCT00466167|75933644|FG001|Overall Study|Not treated|0|||
42123242|NCT00466167|75933645|FG002|Overall Study|Not treated|0|||
42123243|NCT00480441|75933655|FG000|Screening|Not Eligible|37|||
42123244|NCT00480441|75933656|FG001|Screening|Not Eligible|0|||
42123245|NCT00480441|75933657|FG002|Screening|Not Eligible|0|||
42123246|NCT00480441|75933655|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
42123247|NCT00480441|75933656|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
42123248|NCT00480441|75933657|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
42123249|NCT00480441|75933655|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
42123250|NCT00480441|75933656|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
42123251|NCT00480441|75933657|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
42123252|NCT00480441|75933655|FG000|Baseline Functional MRI|physical contraindication|4|||
42123253|NCT00480441|75933656|FG001|Baseline Functional MRI|physical contraindication|0|||
42123254|NCT00480441|75933657|FG002|Baseline Functional MRI|physical contraindication|0|||
41966510|NCT02834793|75766523|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
41966511|NCT02834793|75766524|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
41966512|NCT02834793|75766525|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
41966513|NCT02834793|75766522|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
41966514|NCT02834793|75766523|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
41966515|NCT02834793|75766524|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
41966516|NCT02834793|75766525|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
41966517|NCT02834793|75766522|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
41966518|NCT02834793|75766523|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
41966519|NCT02834793|75766524|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
41966520|NCT02834793|75766525|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
41966521|NCT02810457|75766535|FG000|Overall Study|Randomised but no treatment received|2|||
41966522|NCT02810457|75766536|FG001|Overall Study|Randomised but no treatment received|1|||
41966523|NCT02810457|75766535|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
41966524|NCT02810457|75766536|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
41966525|NCT02810457|75766535|FG000|Overall Study|Adverse Event|37|||
41966526|NCT02810457|75766536|FG001|Overall Study|Adverse Event|43|||
41966527|NCT02810457|75766535|FG000|Overall Study|Patient decision|31|||
41966528|NCT02810457|75766536|FG001|Overall Study|Patient decision|35|||
41966529|NCT02810457|75766535|FG000|Overall Study|Patient lost to follow-up|2|||
42027616|NCT00920686|75835896|FG002|Overall Study|Lost to Follow-up|1|||
42027617|NCT00920686|75835894|FG000|Overall Study|Study drug dosing criteria not met|17|||
42027618|NCT00920686|75835895|FG001|Overall Study|Study drug dosing criteria not met|19|||
42027619|NCT00920686|75835896|FG002|Overall Study|Study drug dosing criteria not met|12|||
42027620|NCT01214720|75835910|FG000|Overall Study|Alive and still on treatment|34|||
42027621|NCT01214720|75835911|FG001|Overall Study|Alive and still on treatment|18|||
42027622|NCT01214720|75835910|FG000|Overall Study|Alive and in follow-up|45|||
42027623|NCT01214720|75835911|FG001|Overall Study|Alive and in follow-up|48|||
42123255|NCT00480441|75933655|FG000|Randomization|Lost to Follow-up|0|||
42123256|NCT00480441|75933656|FG001|Randomization|Lost to Follow-up|7|||
42123257|NCT00480441|75933657|FG002|Randomization|Lost to Follow-up|2|||
42123258|NCT00488319|75933667|FG000|Overall Study|Adverse Event|1|||
42123259|NCT00488319|75933668|FG001|Overall Study|Adverse Event|2|||
42123260|NCT00488319|75933669|FG002|Overall Study|Adverse Event|23|||
42123261|NCT00488319|75933667|FG000|Overall Study|Lack of Efficacy|6|||
42123262|NCT00488319|75933668|FG001|Overall Study|Lack of Efficacy|12|||
42123263|NCT00488319|75933669|FG002|Overall Study|Lack of Efficacy|27|||
42123264|NCT00488319|75933667|FG000|Overall Study|Lost to Follow-up|3|||
42123265|NCT00488319|75933668|FG001|Overall Study|Lost to Follow-up|5|||
42123266|NCT00488319|75933669|FG002|Overall Study|Lost to Follow-up|16|||
42123267|NCT00488319|75933667|FG000|Overall Study|Withdrawal by Subject|5|||
42123268|NCT00488319|75933668|FG001|Overall Study|Withdrawal by Subject|20|||
42123269|NCT00488319|75933669|FG002|Overall Study|Withdrawal by Subject|44|||
42123270|NCT00488319|75933667|FG000|Overall Study|Other reasons for withdrawal|0|||
42123271|NCT00488319|75933668|FG001|Overall Study|Other reasons for withdrawal|4|||
42123272|NCT00488319|75933669|FG002|Overall Study|Other reasons for withdrawal|12|||
42123273|NCT00463047|75933678|FG000|Titration Period 1|Adverse Event|10|||
42123274|NCT00463047|75933679|FG001|Titration Period 1|Adverse Event|8|||
42123275|NCT00463047|75933678|FG000|Titration Period 1|Lack of Efficacy|10|||
42123276|NCT00463047|75933679|FG001|Titration Period 1|Lack of Efficacy|4|||
42123277|NCT00463047|75933678|FG000|Titration Period 1|Lost to Follow-up|2|||
42123278|NCT00463047|75933679|FG001|Titration Period 1|Lost to Follow-up|0|||
42123279|NCT00463047|75933678|FG000|Titration Period 1|Non-compliance with study medication|3|||
42123280|NCT00463047|75933679|FG001|Titration Period 1|Non-compliance with study medication|5|||
42123281|NCT00463047|75933678|FG000|Titration Period 1|Protocol Violation|5|||
42123282|NCT00463047|75933679|FG001|Titration Period 1|Protocol Violation|5|||
42123283|NCT00463047|75933678|FG000|Titration Period 1|Withdrawal by Subject|3|||
42123284|NCT00463047|75933679|FG001|Titration Period 1|Withdrawal by Subject|5|||
42123285|NCT00463047|75933678|FG000|Titration Period 1|Non-compliance procedures|4|||
42123286|NCT00463047|75933679|FG001|Titration Period 1|Non-compliance procedures|10|||
42123287|NCT00463047|75933678|FG000|Titration Period 1|Other|0|||
42123288|NCT00463047|75933679|FG001|Titration Period 1|Other|2|||
42123289|NCT00463047|75933678|FG000|Titration Period 2|Adverse Event|9|||
42123290|NCT00463047|75933679|FG001|Titration Period 2|Adverse Event|9|||
42123291|NCT00463047|75933678|FG000|Titration Period 2|Lack of Efficacy|6|||
42123292|NCT00463047|75933679|FG001|Titration Period 2|Lack of Efficacy|4|||
42123293|NCT00463047|75933678|FG000|Titration Period 2|Withdrawal by Subject|1|||
42123294|NCT00463047|75933679|FG001|Titration Period 2|Withdrawal by Subject|0|||
42123295|NCT00463047|75933678|FG000|Titration Period 2|Protocol Violation|2|||
42123296|NCT00463047|75933679|FG001|Titration Period 2|Protocol Violation|3|||
42123297|NCT00463047|75933678|FG000|Titration Period 2|Lost to Follow-up|1|||
42123298|NCT00463047|75933679|FG001|Titration Period 2|Lost to Follow-up|2|||
42123299|NCT00463047|75933678|FG000|Titration Period 2|Non-compliance study medication|4|||
42123300|NCT00463047|75933679|FG001|Titration Period 2|Non-compliance study medication|2|||
42123301|NCT00463047|75933678|FG000|Titration Period 2|Non-compliance procedures|4|||
42123302|NCT00463047|75933679|FG001|Titration Period 2|Non-compliance procedures|1|||
42123303|NCT00463047|75933678|FG000|Titration Period 2|Other|3|||
42123304|NCT00463047|75933679|FG001|Titration Period 2|Other|2|||
42123305|NCT00463047|75933678|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
42123306|NCT00463047|75933679|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
42123307|NCT00463047|75933678|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
42123308|NCT00463047|75933679|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
42123309|NCT00463047|75933678|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
42123310|NCT00463047|75933679|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
42123311|NCT00463047|75933678|FG000|Double-Blind Treatment Period 1|Other|1|||
42123312|NCT00463047|75933679|FG001|Double-Blind Treatment Period 1|Other|0|||
41966530|NCT02810457|75766536|FG001|Overall Study|Patient lost to follow-up|2|||
41966531|NCT02810457|75766535|FG000|Overall Study|Death|39|||
42123313|NCT00463047|75933678|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
42123314|NCT00463047|75933679|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
42123315|NCT00463047|75933678|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
42123316|NCT00463047|75933679|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
42123317|NCT00463047|75933678|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
42123318|NCT00463047|75933679|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
42123319|NCT00487695|75933686|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
42123320|NCT00487695|75933687|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
42123321|NCT00487695|75933686|FG000|First Procedure|active wheezing (did not have procedure)|1|||
42123322|NCT00487695|75933687|FG001|First Procedure|active wheezing (did not have procedure)|0|||
42123323|NCT00487695|75933686|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
42123324|NCT00487695|75933687|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
42123325|NCT00487695|75933686|FG000|Second Procedure|active wheezing|0|||
42123326|NCT00487695|75933687|FG001|Second Procedure|active wheezing|1|||
42123327|NCT00487695|75933686|FG000|Second Procedure|Withdrawal by Subject|1|||
42123328|NCT00487695|75933687|FG001|Second Procedure|Withdrawal by Subject|2|||
41966532|NCT02810457|75766536|FG001|Overall Study|Death|28|||
42123329|NCT00487539|75933697|FG000|Overall Study|Adverse Event|3|||
42123330|NCT00487539|75933698|FG001|Overall Study|Adverse Event|2|||
42123331|NCT00487539|75933699|FG002|Overall Study|Adverse Event|1|||
42123332|NCT00487539|75933700|FG003|Overall Study|Adverse Event|1|||
42123333|NCT00487539|75933697|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42123334|NCT00487539|75933698|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42123335|NCT00487539|75933699|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
42123336|NCT00487539|75933700|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
42123337|NCT00487539|75933697|FG000|Overall Study|Other|3|||
42123338|NCT00487539|75933698|FG001|Overall Study|Other|1|||
42123339|NCT00487539|75933699|FG002|Overall Study|Other|2|||
42123340|NCT00487539|75933700|FG003|Overall Study|Other|2|||
42123341|NCT00486837|75933711|FG000|Overall Study|Withdrawal by Subject|1|||
42123342|NCT00486837|75933712|FG001|Overall Study|Withdrawal by Subject|0|||
42123343|NCT00486837|75933711|FG000|Overall Study|Adverse Event|1|||
42123344|NCT00486837|75933712|FG001|Overall Study|Adverse Event|1|||
42123345|NCT00486837|75933711|FG000|Overall Study|Protocol Violation|4|||
42123346|NCT00486837|75933712|FG001|Overall Study|Protocol Violation|2|||
42123347|NCT00486837|75933711|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
42123348|NCT00486837|75933712|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
42123349|NCT00486759|75933722|FG000|Treatment|Adverse event/intercurrent illness|86|||
42123350|NCT00486759|75933723|FG001|Treatment|Adverse event/intercurrent illness|39|||
42123351|NCT00486759|75933722|FG000|Treatment|Insufficient therapeutic response|37|||
42123352|NCT00486759|75933723|FG001|Treatment|Insufficient therapeutic response|39|||
42123353|NCT00486759|75933722|FG000|Treatment|Death|17|||
42123354|NCT00486759|75933723|FG001|Treatment|Death|10|||
42123355|NCT00486759|75933722|FG000|Treatment|Withdrew consent|15|||
42123356|NCT00486759|75933723|FG001|Treatment|Withdrew consent|12|||
42123357|NCT00486759|75933722|FG000|Treatment|Administrative/reason not specified|17|||
42123358|NCT00486759|75933723|FG001|Treatment|Administrative/reason not specified|21|||
42123359|NCT00486759|75933722|FG000|Treatment|Refused treatment|10|||
42123360|NCT00486759|75933723|FG001|Treatment|Refused treatment|7|||
42123361|NCT00486759|75933722|FG000|Treatment|Violation of selection criteria at entry|3|||
42123362|NCT00486759|75933723|FG001|Treatment|Violation of selection criteria at entry|3|||
42123363|NCT00486759|75933722|FG000|Treatment|Other protocol violation|1|||
42123364|NCT00486759|75933723|FG001|Treatment|Other protocol violation|5|||
42123365|NCT00486759|75933722|FG000|Treatment|Failure to return|1|||
42123366|NCT00486759|75933723|FG001|Treatment|Failure to return|1|||
42123367|NCT00486759|75933722|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
42123368|NCT00486759|75933723|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
42123369|NCT00486759|75933722|FG000|Safety Follow-up|Death|40|||
42123370|NCT00486759|75933723|FG001|Safety Follow-up|Death|29|||
42123371|NCT00486759|75933722|FG000|Safety Follow-up|Withdrew consent|32|||
42123372|NCT00486759|75933723|FG001|Safety Follow-up|Withdrew consent|23|||
42123373|NCT00486759|75933722|FG000|Safety Follow-up|Failure to return|9|||
41966533|NCT02810457|75766535|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
41966534|NCT02810457|75766536|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
41966535|NCT02810457|75766535|FG000|Overall Study|Clinical progression|15|||
41966536|NCT02810457|75766536|FG001|Overall Study|Clinical progression|16|||
41966537|NCT02810457|75766535|FG000|Overall Study|Investigator decision|3|||
41966538|NCT02810457|75766536|FG001|Overall Study|Investigator decision|2|||
41966539|NCT02810457|75766535|FG000|Overall Study|Patient ineligibility|3|||
41966540|NCT02810457|75766536|FG001|Overall Study|Patient ineligibility|0|||
41966541|NCT02810457|75766535|FG000|Overall Study|Miscalculated PD|1|||
41966542|NCT02810457|75766536|FG001|Overall Study|Miscalculated PD|0|||
41966543|NCT02810457|75766535|FG000|Overall Study|Physician Decision|0|||
42027624|NCT01214720|75835910|FG000|Overall Study|Lost to Follow-up|6|||
42027625|NCT01214720|75835911|FG001|Overall Study|Lost to Follow-up|2|||
42027626|NCT01142232|75835922|FG000|Overall Study|Adverse Event|1|||
42027627|NCT01142232|75835923|FG001|Overall Study|Adverse Event|2|||
42027628|NCT01142232|75835924|FG002|Overall Study|Adverse Event|1|||
42027629|NCT01142232|75835925|FG003|Overall Study|Adverse Event|0|||
42123374|NCT00486759|75933723|FG001|Safety Follow-up|Failure to return|6|||
42123375|NCT00486759|75933722|FG000|Safety Follow-up|Administrative/not specified|8|||
42123376|NCT00486759|75933723|FG001|Safety Follow-up|Administrative/not specified|6|||
42123377|NCT00486759|75933722|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
42123378|NCT00486759|75933723|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
42123379|NCT00486759|75933722|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
41966544|NCT02810457|75766536|FG001|Overall Study|Physician Decision|1|||
41966545|NCT02745535|75766542|FG000|Overall Study|Death|1|||
41966546|NCT02745535|75766542|FG000|Overall Study|Adverse Event|3|||
41966547|NCT02745535|75766542|FG000|Overall Study|Lost to Follow-up|2|||
41966548|NCT02625090|75766576|FG000|Overall Study|Participant wants to be pregnant|2|||
41966549|NCT02625090|75766576|FG000|Overall Study|For the Promoter|1|||
42123380|NCT00486759|75933723|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
42027630|NCT01142232|75835926|FG004|Overall Study|Adverse Event|4|||
42123381|NCT00486603|75933731|FG000|Overall Study|Withdrawal by Subject|1|||
42123382|NCT00486603|75933732|FG001|Overall Study|Withdrawal by Subject|0|||
42123383|NCT00486603|75933733|FG002|Overall Study|Withdrawal by Subject|0|||
42123384|NCT00486603|75933734|FG003|Overall Study|Withdrawal by Subject|0|||
42123385|NCT00486603|75933735|FG004|Overall Study|Withdrawal by Subject|0|||
42123386|NCT00486603|75933731|FG000|Overall Study|Physician Decision|0|||
42123387|NCT00486603|75933732|FG001|Overall Study|Physician Decision|1|||
42123388|NCT00486603|75933733|FG002|Overall Study|Physician Decision|0|||
42123389|NCT00486603|75933734|FG003|Overall Study|Physician Decision|0|||
42123390|NCT00486603|75933735|FG004|Overall Study|Physician Decision|0|||
42123391|NCT00486291|75933752|FG000|Overall Study|Adverse Event|3|||
42123392|NCT00486291|75933753|FG001|Overall Study|Adverse Event|4|||
42123393|NCT00486291|75933752|FG000|Overall Study|Lost to Follow-up|3|||
42123394|NCT00486291|75933753|FG001|Overall Study|Lost to Follow-up|7|||
42123395|NCT00486291|75933752|FG000|Overall Study|protocol non-compliance|10|||
42123396|NCT00486291|75933753|FG001|Overall Study|protocol non-compliance|15|||
42123397|NCT00486291|75933752|FG000|Overall Study|requirement for restricted medication|0|||
42123398|NCT00486291|75933753|FG001|Overall Study|requirement for restricted medication|3|||
42123399|NCT00474045|75933761|FG000|Overall Study|Adverse Event|18|||
42123400|NCT00474045|75933762|FG001|Overall Study|Adverse Event|8|||
42123401|NCT00474045|75933761|FG000|Overall Study|Unclassified|1|||
42123402|NCT00474045|75933762|FG001|Overall Study|Unclassified|3|||
42123403|NCT00474045|75933761|FG000|Overall Study|Lack of Efficacy|0|||
42123404|NCT00474045|75933762|FG001|Overall Study|Lack of Efficacy|9|||
42123405|NCT00474045|75933761|FG000|Overall Study|Lost to Follow-up|1|||
42123406|NCT00474045|75933762|FG001|Overall Study|Lost to Follow-up|1|||
42123407|NCT00474045|75933761|FG000|Overall Study|Protocol Violation|10|||
42123408|NCT00474045|75933762|FG001|Overall Study|Protocol Violation|12|||
42123409|NCT00474045|75933761|FG000|Overall Study|Withdrawal by Subject|16|||
42123410|NCT00474045|75933762|FG001|Overall Study|Withdrawal by Subject|18|||
42123411|NCT00474045|75933761|FG000|Overall Study|Withdrawal criteria|60|||
42123412|NCT00474045|75933762|FG001|Overall Study|Withdrawal criteria|50|||
42123413|NCT00462501|75933768|FG000|Overall Study|Not treated|3|||
42123414|NCT00462501|75933768|FG000|Overall Study|Adverse Event|2|||
42123415|NCT00383188|75933777|FG000|Overall Study|Adverse Event|4|||
42123416|NCT00383188|75933778|FG001|Overall Study|Adverse Event|7|||
42123417|NCT00383188|75933779|FG002|Overall Study|Adverse Event|9|||
42123418|NCT00383188|75933780|FG003|Overall Study|Adverse Event|8|||
42123419|NCT00383188|75933781|FG004|Overall Study|Adverse Event|8|||
42123420|NCT00383188|75933777|FG000|Overall Study|Lack of Efficacy|9|||
42123421|NCT00383188|75933778|FG001|Overall Study|Lack of Efficacy|3|||
42123422|NCT00383188|75933779|FG002|Overall Study|Lack of Efficacy|3|||
42123423|NCT00383188|75933780|FG003|Overall Study|Lack of Efficacy|2|||
42123424|NCT00383188|75933781|FG004|Overall Study|Lack of Efficacy|6|||
42123425|NCT00383188|75933777|FG000|Overall Study|Other|3|||
42123426|NCT00383188|75933778|FG001|Overall Study|Other|1|||
42123427|NCT00383188|75933779|FG002|Overall Study|Other|0|||
42123428|NCT00383188|75933780|FG003|Overall Study|Other|2|||
42123429|NCT00383188|75933781|FG004|Overall Study|Other|6|||
42123430|NCT00383188|75933777|FG000|Overall Study|No longer willing to participate|1|||
42123431|NCT00383188|75933778|FG001|Overall Study|No longer willing to participate|0|||
42123432|NCT00383188|75933779|FG002|Overall Study|No longer willing to participate|1|||
42123433|NCT00383188|75933780|FG003|Overall Study|No longer willing to participate|0|||
42123434|NCT00383188|75933781|FG004|Overall Study|No longer willing to participate|2|||
42123435|NCT00383188|75933777|FG000|Overall Study|Lost to Follow-up|0|||
42123436|NCT00383188|75933778|FG001|Overall Study|Lost to Follow-up|0|||
42123437|NCT00383188|75933779|FG002|Overall Study|Lost to Follow-up|0|||
42123438|NCT00383188|75933780|FG003|Overall Study|Lost to Follow-up|0|||
42123439|NCT00383188|75933781|FG004|Overall Study|Lost to Follow-up|1|||
42123440|NCT00462345|75933795|FG000|Overall Study|Withdrawal by Subject|2|||
42123441|NCT00462345|75933795|FG000|Overall Study|Did not complete second course|1|||
42123442|NCT00453999|75933802|FG000|Overall Study|Adverse Event|1|||
42123443|NCT00453999|75933803|FG001|Overall Study|Adverse Event|2|||
42123444|NCT00453999|75933804|FG002|Overall Study|Adverse Event|1|||
42123445|NCT00453999|75933802|FG000|Overall Study|Lost to Follow-up|0|||
41966550|NCT02625090|75766576|FG000|Overall Study|Sponsor's Decision|9|||
41966551|NCT02625090|75766576|FG000|Overall Study|Somnolence|1|||
42123446|NCT00453999|75933803|FG001|Overall Study|Lost to Follow-up|1|||
42123447|NCT00453999|75933804|FG002|Overall Study|Lost to Follow-up|1|||
42123448|NCT00453999|75933802|FG000|Overall Study|Withdrawal by Subject|2|||
42123449|NCT00453999|75933803|FG001|Overall Study|Withdrawal by Subject|1|||
42123450|NCT00453999|75933804|FG002|Overall Study|Withdrawal by Subject|1|||
42123451|NCT00453999|75933802|FG000|Overall Study|Subject Request|2|||
42123452|NCT00453999|75933803|FG001|Overall Study|Subject Request|1|||
42123453|NCT00453999|75933804|FG002|Overall Study|Subject Request|0|||
42123454|NCT00453921|75933817|FG000|Overall Study|Withdrawal by Subject|1|||
42123455|NCT00453921|75933818|FG001|Overall Study|Withdrawal by Subject|1|||
42123456|NCT00453921|75933819|FG002|Overall Study|Withdrawal by Subject|1|||
42123457|NCT00453921|75933820|FG003|Overall Study|Withdrawal by Subject|1|||
42123458|NCT00453921|75933817|FG000|Overall Study|Lost to Follow-up|0|||
42123459|NCT00453921|75933818|FG001|Overall Study|Lost to Follow-up|0|||
42123460|NCT00453921|75933819|FG002|Overall Study|Lost to Follow-up|1|||
42123461|NCT00453921|75933820|FG003|Overall Study|Lost to Follow-up|0|||
42123462|NCT00382720|75933837|FG000|Overall Study|Adverse Event|21|||
42123463|NCT00382720|75933838|FG001|Overall Study|Adverse Event|23|||
42123464|NCT00382720|75933839|FG002|Overall Study|Adverse Event|15|||
42123465|NCT00382720|75933837|FG000|Overall Study|Protocol Violation|2|||
42123466|NCT00382720|75933838|FG001|Overall Study|Protocol Violation|5|||
42123467|NCT00382720|75933839|FG002|Overall Study|Protocol Violation|1|||
42123468|NCT00382720|75933837|FG000|Overall Study|Death|0|||
42123469|NCT00382720|75933838|FG001|Overall Study|Death|1|||
42123470|NCT00382720|75933839|FG002|Overall Study|Death|2|||
42123471|NCT00382720|75933837|FG000|Overall Study|Progressive disease|37|||
42123472|NCT00382720|75933838|FG001|Overall Study|Progressive disease|28|||
42123473|NCT00382720|75933839|FG002|Overall Study|Progressive disease|38|||
41966552|NCT02625090|75766576|FG000|Overall Study|Study terminated by Sponsor|7|||
42123474|NCT00382720|75933837|FG000|Overall Study|Withdrew consent|1|||
42123475|NCT00382720|75933838|FG001|Overall Study|Withdrew consent|1|||
42123476|NCT00382720|75933839|FG002|Overall Study|Withdrew consent|2|||
42123477|NCT00382720|75933837|FG000|Overall Study|Withdrawal by Subject|11|||
42123478|NCT00382720|75933838|FG001|Overall Study|Withdrawal by Subject|20|||
42123479|NCT00382720|75933839|FG002|Overall Study|Withdrawal by Subject|12|||
42123480|NCT00382720|75933837|FG000|Overall Study|Surgery|1|||
42123481|NCT00382720|75933838|FG001|Overall Study|Surgery|1|||
42123482|NCT00382720|75933839|FG002|Overall Study|Surgery|4|||
42123483|NCT00382720|75933837|FG000|Overall Study|Patient did not receive study medication|1|||
42123484|NCT00382720|75933838|FG001|Overall Study|Patient did not receive study medication|1|||
42123485|NCT00382720|75933839|FG002|Overall Study|Patient did not receive study medication|4|||
41966553|NCT02625090|75766576|FG000|Overall Study|Negative Benefit/Risk|1|||
41966554|NCT02625090|75766576|FG000|Overall Study|Protocol Deviation|2|||
41966555|NCT02625090|75766576|FG000|Overall Study|Lack of Efficacy|16|||
41966556|NCT02625090|75766576|FG000|Overall Study|Adverse Event|3|||
41966557|NCT02539225|75766583|FG000|Part A|Adverse Event|13|||
41966558|NCT02539225|75766584|FG001|Part A|Adverse Event|4|||
41966559|NCT02539225|75766583|FG000|Part A|Withdrawal by Subject|2|||
41966560|NCT02539225|75766584|FG001|Part A|Withdrawal by Subject|4|||
41966561|NCT02539225|75766583|FG000|Part A|Physician Decision|4|||
41966562|NCT02539225|75766584|FG001|Part A|Physician Decision|7|||
41966563|NCT02539225|75766583|FG000|Part A|Did Not Receive study Drug|1|||
41966564|NCT02539225|75766584|FG001|Part A|Did Not Receive study Drug|1|||
42123486|NCT00382720|75933837|FG000|Overall Study|Clinically progressive disease|0|||
42123487|NCT00382720|75933838|FG001|Overall Study|Clinically progressive disease|1|||
42123488|NCT00382720|75933839|FG002|Overall Study|Clinically progressive disease|0|||
42123489|NCT00382720|75933837|FG000|Overall Study|Good prognosis|0|||
42123490|NCT00382720|75933838|FG001|Overall Study|Good prognosis|1|||
42123491|NCT00382720|75933839|FG002|Overall Study|Good prognosis|0|||
42301135|NCT01364389|76136455|FG000|Overall Study|Withdrawal by Subject|0|||
42301136|NCT01364389|76136456|FG001|Overall Study|Withdrawal by Subject|1|||
41966565|NCT02539225|75766583|FG000|Pre Treatment for Part B|Progressive disease|1|||
41966566|NCT02539225|75766584|FG001|Pre Treatment for Part B|Progressive disease|1|||
42123492|NCT00382720|75933837|FG000|Overall Study|Investigator/Clinical decision|5|||
42123493|NCT00382720|75933838|FG001|Overall Study|Investigator/Clinical decision|6|||
42123494|NCT00382720|75933839|FG002|Overall Study|Investigator/Clinical decision|6|||
42123495|NCT00382720|75933837|FG000|Overall Study|Discontinued at end of study|0|||
42123496|NCT00382720|75933838|FG001|Overall Study|Discontinued at end of study|1|||
42123497|NCT00382720|75933839|FG002|Overall Study|Discontinued at end of study|2|||
42123498|NCT00453063|75933849|FG000|Overall Study|Adverse Event|1|||
42123499|NCT00453063|75933850|FG001|Overall Study|Adverse Event|2|||
42123500|NCT00453063|75933849|FG000|Overall Study|Withdrawal by Subject|1|||
42123501|NCT00453063|75933850|FG001|Overall Study|Withdrawal by Subject|1|||
42123502|NCT00453063|75933849|FG000|Overall Study|Protocol Violation|1|||
42123503|NCT00453063|75933850|FG001|Overall Study|Protocol Violation|0|||
42123504|NCT00371566|75933858|FG000|Treatment Phase|Withdrawal by Subject|0|||
42123505|NCT00371566|75933859|FG001|Treatment Phase|Withdrawal by Subject|1|||
42123506|NCT00371566|75933858|FG000|Treatment Phase|Adverse Event|0|||
42123507|NCT00371566|75933859|FG001|Treatment Phase|Adverse Event|1|||
42123508|NCT00371566|75933858|FG000|Treatment Phase|Protocol Violation|0|||
42123509|NCT00371566|75933859|FG001|Treatment Phase|Protocol Violation|1|||
42123510|NCT00371566|75933858|FG000|Chemoradiation Phase|Physician Decision|2|||
42123511|NCT00371566|75933859|FG001|Chemoradiation Phase|Physician Decision|0|||
42123512|NCT00371566|75933858|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
42123513|NCT00371566|75933859|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
42123514|NCT00371566|75933858|FG000|Chemoradiation Phase|Non compliant|0|||
42123515|NCT00371566|75933859|FG001|Chemoradiation Phase|Non compliant|1|||
42123516|NCT00371566|75933858|FG000|Chemoradiation Phase|Progressive Disease|1|||
42123517|NCT00371566|75933859|FG001|Chemoradiation Phase|Progressive Disease|1|||
42123518|NCT00371566|75933858|FG000|Chemoradiation Phase|Death|2|||
42123519|NCT00371566|75933859|FG001|Chemoradiation Phase|Death|0|||
42123520|NCT00371566|75933858|FG000|Follow Up Phase|Death|0|||
42123521|NCT00371566|75933859|FG001|Follow Up Phase|Death|5|||
42123522|NCT00371566|75933858|FG000|Follow Up Phase|Disease progression|1|||
42123523|NCT00371566|75933859|FG001|Follow Up Phase|Disease progression|0|||
42123524|NCT00371566|75933858|FG000|Follow Up Phase|Withdrawal by Subject|0|||
42123525|NCT00371566|75933859|FG001|Follow Up Phase|Withdrawal by Subject|1|||
42123526|NCT00371566|75933858|FG000|Follow Up Phase|Physician Decision|1|||
42123527|NCT00371566|75933859|FG001|Follow Up Phase|Physician Decision|1|||
42123528|NCT00371566|75933858|FG000|Follow Up Phase|Lost to Follow-up|1|||
42123529|NCT00371566|75933859|FG001|Follow Up Phase|Lost to Follow-up|0|||
42123530|NCT00382408|75933867|FG000|Overall Study|Did not meet protocol requirement|3|||
42123531|NCT00382408|75933868|FG001|Overall Study|Did not meet protocol requirement|3|||
42123532|NCT00382408|75933867|FG000|Overall Study|Protocol Violation|2|||
42123533|NCT00382408|75933868|FG001|Overall Study|Protocol Violation|2|||
42123534|NCT00382408|75933867|FG000|Overall Study|Physician Decision|1|||
42123535|NCT00382408|75933868|FG001|Overall Study|Physician Decision|0|||
42123536|NCT00382408|75933867|FG000|Overall Study|Withdrawal by Subject|17|||
42123537|NCT00382408|75933868|FG001|Overall Study|Withdrawal by Subject|6|||
42123538|NCT00382408|75933867|FG000|Overall Study|Pregnancy|2|||
42123539|NCT00382408|75933868|FG001|Overall Study|Pregnancy|0|||
42123540|NCT00382408|75933867|FG000|Overall Study|Lost to Follow-up|19|||
42123541|NCT00382408|75933868|FG001|Overall Study|Lost to Follow-up|8|||
42123542|NCT00382408|75933867|FG000|Overall Study|Other|100|||
42123543|NCT00382408|75933868|FG001|Overall Study|Other|35|||
42123544|NCT00371254|75933876|FG000|Overall Study|Disease progression|13|||
42123545|NCT00371254|75933877|FG001|Overall Study|Disease progression|13|||
42123546|NCT00371254|75933876|FG000|Overall Study|Study drug toxicity|3|||
42123547|NCT00371254|75933877|FG001|Overall Study|Study drug toxicity|5|||
42123548|NCT00371254|75933876|FG000|Overall Study|Subject request|5|||
42123549|NCT00371254|75933877|FG001|Overall Study|Subject request|0|||
42123550|NCT00371254|75933876|FG000|Overall Study|Investigator Decision|2|||
42123551|NCT00371254|75933877|FG001|Overall Study|Investigator Decision|0|||
42123552|NCT00371254|75933876|FG000|Overall Study|Adverse event unrelated to study drug|0|||
42123553|NCT00371254|75933877|FG001|Overall Study|Adverse event unrelated to study drug|1|||
42123554|NCT00371254|75933876|FG000|Overall Study|Lost to Follow-up|0|||
42123555|NCT00371254|75933877|FG001|Overall Study|Lost to Follow-up|1|||
42123556|NCT00371254|75933876|FG000|Overall Study|Withdrawal by Subject|0|||
42123557|NCT00371254|75933877|FG001|Overall Study|Withdrawal by Subject|1|||
42123558|NCT00452673|75933887|FG000|Dose Escalation Period|Disease Progression|6|||
42123559|NCT00452673|75933888|FG001|Dose Escalation Period|Disease Progression|6|||
42123560|NCT00452673|75933889|FG002|Dose Escalation Period|Disease Progression|2|||
42123561|NCT00452673|75933890|FG003|Dose Escalation Period|Disease Progression|6|||
42123562|NCT00452673|75933891|FG004|Dose Escalation Period|Disease Progression|0|||
42123563|NCT00452673|75933887|FG000|Dose Escalation Period|study drug toxicity|1|||
42123564|NCT00452673|75933888|FG001|Dose Escalation Period|study drug toxicity|3|||
42123565|NCT00452673|75933889|FG002|Dose Escalation Period|study drug toxicity|3|||
42123566|NCT00452673|75933890|FG003|Dose Escalation Period|study drug toxicity|1|||
42123567|NCT00452673|75933891|FG004|Dose Escalation Period|study drug toxicity|0|||
42123568|NCT00452673|75933887|FG000|Dose Escalation Period|Other|0|||
42123569|NCT00452673|75933888|FG001|Dose Escalation Period|Other|0|||
42123570|NCT00452673|75933889|FG002|Dose Escalation Period|Other|1|||
42123571|NCT00452673|75933890|FG003|Dose Escalation Period|Other|0|||
42123572|NCT00452673|75933891|FG004|Dose Escalation Period|Other|0|||
42123573|NCT00452673|75933887|FG000|Dose Escalation Period|Adverse Event|0|||
42123574|NCT00452673|75933888|FG001|Dose Escalation Period|Adverse Event|0|||
42123575|NCT00452673|75933889|FG002|Dose Escalation Period|Adverse Event|0|||
42123576|NCT00452673|75933890|FG003|Dose Escalation Period|Adverse Event|1|||
42123577|NCT00452673|75933891|FG004|Dose Escalation Period|Adverse Event|0|||
42123578|NCT00452673|75933887|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
42123579|NCT00452673|75933888|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
42123580|NCT00452673|75933889|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
42123581|NCT00452673|75933890|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
42123582|NCT00452673|75933891|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
42123583|NCT00452673|75933887|FG000|Dose Expansion Period|Disease Progression|0|||
42123584|NCT00452673|75933888|FG001|Dose Expansion Period|Disease Progression|0|||
42027631|NCT01142232|75835922|FG000|Overall Study|Death|0|||
42123585|NCT00452673|75933889|FG002|Dose Expansion Period|Disease Progression|0|||
42123586|NCT00452673|75933890|FG003|Dose Expansion Period|Disease Progression|0|||
42123587|NCT00452673|75933891|FG004|Dose Expansion Period|Disease Progression|19|||
42123588|NCT00452673|75933887|FG000|Dose Expansion Period|Other|0|||
42123589|NCT00452673|75933888|FG001|Dose Expansion Period|Other|0|||
42123590|NCT00452673|75933889|FG002|Dose Expansion Period|Other|0|||
42123591|NCT00452673|75933890|FG003|Dose Expansion Period|Other|0|||
42123592|NCT00452673|75933891|FG004|Dose Expansion Period|Other|2|||
42123593|NCT00461253|75933904|FG000|Overall Study|Death|985|||
42123594|NCT00461253|75933905|FG001|Overall Study|Death|0|||
42123595|NCT00461253|75933904|FG000|Overall Study|Protocol Violation|613|||
42123596|NCT00461253|75933905|FG001|Overall Study|Protocol Violation|236|||
42123597|NCT00461253|75933904|FG000|Overall Study|no response|2609|||
42301137|NCT01364389|76136457|FG002|Overall Study|Withdrawal by Subject|0|||
42027632|NCT01142232|75835923|FG001|Overall Study|Death|0|||
42027633|NCT01142232|75835924|FG002|Overall Study|Death|0|||
42027634|NCT01142232|75835925|FG003|Overall Study|Death|0|||
42027635|NCT01142232|75835926|FG004|Overall Study|Death|1|||
42027636|NCT01142232|75835922|FG000|Overall Study|Disease Progression|2|||
42027637|NCT01142232|75835923|FG001|Overall Study|Disease Progression|0|||
42027638|NCT01142232|75835924|FG002|Overall Study|Disease Progression|1|||
42027639|NCT01142232|75835925|FG003|Overall Study|Disease Progression|2|||
42027640|NCT01142232|75835926|FG004|Overall Study|Disease Progression|12|||
42027641|NCT01142232|75835922|FG000|Overall Study|Withdrawal by Subject|0|||
42027642|NCT01142232|75835923|FG001|Overall Study|Withdrawal by Subject|0|||
42027643|NCT01142232|75835924|FG002|Overall Study|Withdrawal by Subject|0|||
42123598|NCT00461253|75933905|FG001|Overall Study|no response|11789|||
42123599|NCT00461253|75933904|FG000|Overall Study|administrative|773|||
42123600|NCT00461253|75933905|FG001|Overall Study|administrative|7773|||
42123601|NCT00469833|75933911|FG000|Overall Study|No IV access|2|||
42123602|NCT00382174|75933923|FG000|Overall Study|Lost to Follow-up|1|||
42123603|NCT00382174|75933924|FG001|Overall Study|Lost to Follow-up|4|||
42123604|NCT00382174|75933925|FG002|Overall Study|Lost to Follow-up|5|||
42123605|NCT00382174|75933923|FG000|Overall Study|Adverse Event|1|||
42123606|NCT00382174|75933924|FG001|Overall Study|Adverse Event|4|||
42027644|NCT01142232|75835925|FG003|Overall Study|Withdrawal by Subject|1|||
42027645|NCT01142232|75835926|FG004|Overall Study|Withdrawal by Subject|3|||
42027646|NCT01142232|75835922|FG000|Overall Study|Physician Decision|0|||
42123607|NCT00382174|75933925|FG002|Overall Study|Adverse Event|5|||
42123608|NCT00382174|75933923|FG000|Overall Study|Withdrawal by Subject|1|||
42123609|NCT00382174|75933924|FG001|Overall Study|Withdrawal by Subject|4|||
42123610|NCT00382174|75933925|FG002|Overall Study|Withdrawal by Subject|5|||
42123611|NCT00382174|75933923|FG000|Overall Study|Non compliance|1|||
42123612|NCT00382174|75933924|FG001|Overall Study|Non compliance|0|||
42123613|NCT00382174|75933925|FG002|Overall Study|Non compliance|1|||
42123614|NCT00382174|75933923|FG000|Overall Study|Physician Decision|0|||
42123615|NCT00382174|75933924|FG001|Overall Study|Physician Decision|2|||
42123616|NCT00382174|75933925|FG002|Overall Study|Physician Decision|2|||
42123617|NCT00382174|75933923|FG000|Overall Study|Failed to meet criteria|0|||
42123618|NCT00382174|75933924|FG001|Overall Study|Failed to meet criteria|1|||
42123619|NCT00382174|75933925|FG002|Overall Study|Failed to meet criteria|1|||
42123620|NCT00382174|75933923|FG000|Overall Study|Wounds merged|0|||
42123621|NCT00382174|75933924|FG001|Overall Study|Wounds merged|2|||
42123622|NCT00382174|75933925|FG002|Overall Study|Wounds merged|2|||
42123623|NCT00641537|75933938|FG000|96-week Period|Adverse Event|0|||
42123624|NCT00641537|75933939|FG001|96-week Period|Adverse Event|1|||
42123625|NCT00641537|75933940|FG002|96-week Period|Adverse Event|3|||
42123626|NCT00641537|75933941|FG003|96-week Period|Adverse Event|0|||
42123627|NCT00641537|75933942|FG004|96-week Period|Adverse Event|2|||
42123628|NCT00641537|75933943|FG005|96-week Period|Adverse Event|0|||
42123629|NCT00641537|75933944|FG006|96-week Period|Adverse Event|0|||
42123630|NCT00641537|75933945|FG007|96-week Period|Adverse Event|0|||
42123631|NCT00641537|75933938|FG000|96-week Period|Lost to Follow-up|3|||
42123632|NCT00641537|75933939|FG001|96-week Period|Lost to Follow-up|1|||
42123633|NCT00641537|75933940|FG002|96-week Period|Lost to Follow-up|2|||
42123634|NCT00641537|75933941|FG003|96-week Period|Lost to Follow-up|2|||
42123635|NCT00641537|75933942|FG004|96-week Period|Lost to Follow-up|4|||
42123636|NCT00641537|75933943|FG005|96-week Period|Lost to Follow-up|0|||
42123637|NCT00641537|75933944|FG006|96-week Period|Lost to Follow-up|1|||
42123638|NCT00641537|75933945|FG007|96-week Period|Lost to Follow-up|0|||
42123639|NCT00641537|75933938|FG000|96-week Period|Protocol Violation|0|||
42123640|NCT00641537|75933939|FG001|96-week Period|Protocol Violation|1|||
42123641|NCT00641537|75933940|FG002|96-week Period|Protocol Violation|0|||
42123642|NCT00641537|75933941|FG003|96-week Period|Protocol Violation|1|||
42123643|NCT00641537|75933942|FG004|96-week Period|Protocol Violation|0|||
42123644|NCT00641537|75933943|FG005|96-week Period|Protocol Violation|1|||
42027647|NCT01142232|75835923|FG001|Overall Study|Physician Decision|1|||
42027648|NCT01142232|75835924|FG002|Overall Study|Physician Decision|0|||
42027649|NCT01142232|75835925|FG003|Overall Study|Physician Decision|2|||
42027650|NCT01142232|75835926|FG004|Overall Study|Physician Decision|10|||
42027651|NCT01142232|75835922|FG000|Overall Study|Alternative Therapy|0|||
42027652|NCT01142232|75835923|FG001|Overall Study|Alternative Therapy|1|||
42027653|NCT01142232|75835924|FG002|Overall Study|Alternative Therapy|1|||
42027654|NCT01142232|75835925|FG003|Overall Study|Alternative Therapy|0|||
42027655|NCT01142232|75835926|FG004|Overall Study|Alternative Therapy|1|||
42027656|NCT01142232|75835922|FG000|Overall Study|Off Trt for other complicating disease|0|||
42027657|NCT01142232|75835923|FG001|Overall Study|Off Trt for other complicating disease|0|||
42027658|NCT01142232|75835924|FG002|Overall Study|Off Trt for other complicating disease|0|||
42123645|NCT00641537|75933944|FG006|96-week Period|Protocol Violation|0|||
42123646|NCT00641537|75933945|FG007|96-week Period|Protocol Violation|0|||
42123647|NCT00641537|75933938|FG000|96-week Period|Death|2|||
42123648|NCT00641537|75933939|FG001|96-week Period|Death|0|||
42027659|NCT01142232|75835925|FG003|Overall Study|Off Trt for other complicating disease|0|||
42123649|NCT00641537|75933940|FG002|96-week Period|Death|1|||
42123650|NCT00641537|75933941|FG003|96-week Period|Death|0|||
42123651|NCT00641537|75933942|FG004|96-week Period|Death|0|||
42123652|NCT00641537|75933943|FG005|96-week Period|Death|0|||
42123653|NCT00641537|75933944|FG006|96-week Period|Death|0|||
42123654|NCT00641537|75933945|FG007|96-week Period|Death|0|||
42123655|NCT00641537|75933938|FG000|96-week Period|Other|4|||
42123656|NCT00641537|75933939|FG001|96-week Period|Other|7|||
42027660|NCT01142232|75835926|FG004|Overall Study|Off Trt for other complicating disease|1|||
42123657|NCT00641537|75933940|FG002|96-week Period|Other|14|||
42123658|NCT00641537|75933941|FG003|96-week Period|Other|9|||
42123659|NCT00641537|75933942|FG004|96-week Period|Other|11|||
41966567|NCT02539225|75766583|FG000|Pre Treatment for Part B|Adverse Event|1|||
41966568|NCT02539225|75766584|FG001|Pre Treatment for Part B|Adverse Event|1|||
41966569|NCT02539225|75766583|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
41966570|NCT02539225|75766584|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
41966571|NCT02539225|75766583|FG000|Pre Treatment for Part B|Physician Decision|2|||
41966572|NCT02539225|75766584|FG001|Pre Treatment for Part B|Physician Decision|0|||
41966573|NCT02539225|75766583|FG000|Part B|Adverse Event|4|||
41966574|NCT02539225|75766584|FG001|Part B|Adverse Event|4|||
41966575|NCT02539225|75766583|FG000|Part B|Withdrawal by Subject|0|||
41966576|NCT02539225|75766584|FG001|Part B|Withdrawal by Subject|3|||
41966577|NCT02539225|75766583|FG000|Part B|Physician Decision|0|||
41966578|NCT02539225|75766584|FG001|Part B|Physician Decision|9|||
41966579|NCT02526017|75766604|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
41966580|NCT02526017|75766605|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
41966581|NCT02526017|75766606|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
41966582|NCT02526017|75766607|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
41966583|NCT02526017|75766608|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
41966584|NCT02526017|75766609|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
41966585|NCT02526017|75766610|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
41966586|NCT02526017|75766611|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
41966587|NCT02526017|75766612|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
41966588|NCT02369653|75766681|FG000|Overall Study|Lost to Follow-up|0|||
41966589|NCT02369653|75766682|FG001|Overall Study|Lost to Follow-up|1|||
41966590|NCT02369653|75766681|FG000|Overall Study|Administrative reason by sponsor|0|||
41966591|NCT02369653|75766682|FG001|Overall Study|Administrative reason by sponsor|1|||
41966592|NCT02369653|75766681|FG000|Overall Study|Death|1|||
41966593|NCT02369653|75766682|FG001|Overall Study|Death|2|||
41966594|NCT02369653|75766681|FG000|Overall Study|Participant withdrew consent|13|||
41966595|NCT02369653|75766682|FG001|Overall Study|Participant withdrew consent|3|||
41966596|NCT02284568|75766695|FG000|Overall Study|Adverse Event|2|||
41966597|NCT02284568|75766696|FG001|Overall Study|Adverse Event|9|||
41966598|NCT02284568|75766697|FG002|Overall Study|Adverse Event|4|||
41966599|NCT02284568|75766695|FG000|Overall Study|Withdrawal by Subject|22|||
41966600|NCT02284568|75766696|FG001|Overall Study|Withdrawal by Subject|21|||
41966601|NCT02284568|75766697|FG002|Overall Study|Withdrawal by Subject|1|||
41966602|NCT02284568|75766695|FG000|Overall Study|Noncompliance with study drug admin|1|||
41966603|NCT02284568|75766696|FG001|Overall Study|Noncompliance with study drug admin|2|||
41966604|NCT02284568|75766697|FG002|Overall Study|Noncompliance with study drug admin|0|||
41966605|NCT02284568|75766695|FG000|Overall Study|Noncompliance|1|||
41966606|NCT02284568|75766696|FG001|Overall Study|Noncompliance|0|||
41966607|NCT02284568|75766697|FG002|Overall Study|Noncompliance|0|||
41966608|NCT02284568|75766695|FG000|Overall Study|Protocol Violation|0|||
41966609|NCT02284568|75766696|FG001|Overall Study|Protocol Violation|1|||
41966610|NCT02284568|75766697|FG002|Overall Study|Protocol Violation|0|||
41966611|NCT02284568|75766695|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
41966612|NCT02284568|75766696|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
41966613|NCT02284568|75766697|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
41966614|NCT02284568|75766695|FG000|Overall Study|Lost to Follow-up|0|||
41966615|NCT02284568|75766696|FG001|Overall Study|Lost to Follow-up|3|||
41966616|NCT02284568|75766697|FG002|Overall Study|Lost to Follow-up|0|||
41966617|NCT02284568|75766695|FG000|Overall Study|Lack of Efficacy|4|||
42123660|NCT00641537|75933943|FG005|96-week Period|Other|6|||
42123661|NCT00641537|75933944|FG006|96-week Period|Other|4|||
42123662|NCT00641537|75933945|FG007|96-week Period|Other|6|||
42123663|NCT00641537|75933938|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
42123664|NCT00641537|75933939|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
42123665|NCT00641537|75933940|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
41966618|NCT02284568|75766696|FG001|Overall Study|Lack of Efficacy|7|||
41966619|NCT02284568|75766697|FG002|Overall Study|Lack of Efficacy|0|||
41966620|NCT02284568|75766695|FG000|Overall Study|Other|1|||
41966621|NCT02284568|75766696|FG001|Overall Study|Other|2|||
41966622|NCT02284568|75766697|FG002|Overall Study|Other|0|||
41966623|NCT02284568|75766695|FG000|Overall Study|Withdrew before taking study drug|0|||
42123666|NCT00641537|75933941|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
42137786|NCT00427908|75948134|FG002|Primary Phase|Lost to Follow-up|2|||
42301138|NCT01364389|76136455|FG000|Overall Study|Protocol deviation|0|||
41966624|NCT02284568|75766696|FG001|Overall Study|Withdrew before taking study drug|1|||
41966625|NCT02284568|75766697|FG002|Overall Study|Withdrew before taking study drug|0|||
41966626|NCT02195986|75766712|FG000|Overall Study|Adverse Event|3|||
42123667|NCT00641537|75933942|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
42123668|NCT00641537|75933943|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
42123669|NCT00641537|75933944|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
42123670|NCT00641537|75933945|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
42123671|NCT00641537|75933938|FG000|24-Week Supplemental Follow-up Period|Other|0|||
42123672|NCT00641537|75933939|FG001|24-Week Supplemental Follow-up Period|Other|2|||
42123673|NCT00641537|75933940|FG002|24-Week Supplemental Follow-up Period|Other|2|||
42123674|NCT00641537|75933941|FG003|24-Week Supplemental Follow-up Period|Other|1|||
42123675|NCT00641537|75933942|FG004|24-Week Supplemental Follow-up Period|Other|3|||
41966627|NCT02195986|75766713|FG001|Overall Study|Adverse Event|0|||
41966628|NCT02195986|75766714|FG002|Overall Study|Adverse Event|0|||
41966629|NCT02195986|75766712|FG000|Overall Study|Withdrawal by Subject|0|||
41966630|NCT02195986|75766713|FG001|Overall Study|Withdrawal by Subject|3|||
41966631|NCT02195986|75766714|FG002|Overall Study|Withdrawal by Subject|0|||
41966632|NCT02195986|75766712|FG000|Overall Study|Family Emergency|0|||
41966633|NCT02195986|75766713|FG001|Overall Study|Family Emergency|0|||
41966634|NCT02195986|75766714|FG002|Overall Study|Family Emergency|1|||
41966635|NCT02195986|75766712|FG000|Overall Study|Protocol Violation|0|||
41966636|NCT02195986|75766713|FG001|Overall Study|Protocol Violation|1|||
41966637|NCT02195986|75766714|FG002|Overall Study|Protocol Violation|1|||
41966638|NCT02195986|75766712|FG000|Overall Study|Non-compliance|0|||
41966639|NCT02195986|75766713|FG001|Overall Study|Non-compliance|1|||
41966640|NCT02195986|75766714|FG002|Overall Study|Non-compliance|0|||
41966641|NCT01982630|75766730|FG000|Overall Study|Adverse Event|2|||
41966642|NCT01982630|75766731|FG001|Overall Study|Adverse Event|0|||
41966643|NCT01982630|75766732|FG002|Overall Study|Adverse Event|1|||
41966644|NCT01982630|75766733|FG003|Overall Study|Adverse Event|0|||
41966645|NCT01982630|75766734|FG004|Overall Study|Adverse Event|1|||
41966646|NCT01982630|75766735|FG005|Overall Study|Adverse Event|2|||
41966647|NCT01982630|75766736|FG006|Overall Study|Adverse Event|1|||
41966648|NCT01982630|75766737|FG007|Overall Study|Adverse Event|0|||
41966649|NCT01982630|75766730|FG000|Overall Study|Physician Decision|1|||
41966650|NCT01982630|75766731|FG001|Overall Study|Physician Decision|0|||
41966651|NCT01982630|75766732|FG002|Overall Study|Physician Decision|2|||
41966652|NCT01982630|75766733|FG003|Overall Study|Physician Decision|1|||
41966653|NCT01982630|75766734|FG004|Overall Study|Physician Decision|2|||
41966654|NCT01982630|75766735|FG005|Overall Study|Physician Decision|0|||
41966655|NCT01982630|75766736|FG006|Overall Study|Physician Decision|0|||
41966656|NCT01982630|75766737|FG007|Overall Study|Physician Decision|0|||
41966657|NCT01982630|75766730|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
41966658|NCT01982630|75766731|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
41966659|NCT01982630|75766732|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
41966660|NCT01982630|75766733|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
41966661|NCT01982630|75766734|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
41966662|NCT01982630|75766735|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
41966663|NCT01982630|75766736|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
41966664|NCT01982630|75766737|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
41966665|NCT01982630|75766730|FG000|Overall Study|Withdrawal by Subject|0|||
42027661|NCT01142232|75835922|FG000|Overall Study|Noncompliance|0|||
42027662|NCT01142232|75835923|FG001|Overall Study|Noncompliance|0|||
42027663|NCT01142232|75835924|FG002|Overall Study|Noncompliance|0|||
42027664|NCT01142232|75835925|FG003|Overall Study|Noncompliance|0|||
42027665|NCT01142232|75835926|FG004|Overall Study|Noncompliance|2|||
42027666|NCT01140906|75835942|FG000|Overall Study|Adverse Event|7|||
42027667|NCT01140906|75835943|FG001|Overall Study|Adverse Event|10|||
42027668|NCT01140906|75835944|FG002|Overall Study|Adverse Event|17|||
42027669|NCT01140906|75835945|FG003|Overall Study|Adverse Event|7|||
42027670|NCT01140906|75835942|FG000|Overall Study|Lack of Efficacy|6|||
42027671|NCT01140906|75835943|FG001|Overall Study|Lack of Efficacy|8|||
42027672|NCT01140906|75835944|FG002|Overall Study|Lack of Efficacy|2|||
42027673|NCT01140906|75835945|FG003|Overall Study|Lack of Efficacy|1|||
42027674|NCT01140906|75835942|FG000|Overall Study|Non-compliance|0|||
42027675|NCT01140906|75835943|FG001|Overall Study|Non-compliance|1|||
42123676|NCT00641537|75933943|FG005|24-Week Supplemental Follow-up Period|Other|0|||
42123677|NCT00641537|75933944|FG006|24-Week Supplemental Follow-up Period|Other|1|||
42123678|NCT00641537|75933945|FG007|24-Week Supplemental Follow-up Period|Other|1|||
42123679|NCT03840135|75933965|FG000|Overall Study|Protocol Violation|6|||
42123680|NCT03840135|75933966|FG001|Overall Study|Protocol Violation|1|||
41966666|NCT01982630|75766731|FG001|Overall Study|Withdrawal by Subject|0|||
41966667|NCT01982630|75766732|FG002|Overall Study|Withdrawal by Subject|0|||
41966668|NCT01982630|75766733|FG003|Overall Study|Withdrawal by Subject|0|||
41966669|NCT01982630|75766734|FG004|Overall Study|Withdrawal by Subject|0|||
41966670|NCT01982630|75766735|FG005|Overall Study|Withdrawal by Subject|1|||
42027676|NCT01140906|75835944|FG002|Overall Study|Non-compliance|0|||
42027677|NCT01140906|75835945|FG003|Overall Study|Non-compliance|1|||
42027678|NCT01140906|75835942|FG000|Overall Study|Protocol Violation|5|||
42123681|NCT03840135|75933965|FG000|Overall Study|Withdrawal by Subject|1|||
42123682|NCT03840135|75933966|FG001|Overall Study|Withdrawal by Subject|0|||
42123683|NCT00461175|75933978|FG000|Overall Study|Protocol Violation|522|||
42123684|NCT00461175|75933979|FG001|Overall Study|Protocol Violation|365|||
42123685|NCT00641147|75933987|FG000|Completed 4 Months.|Physician Decision|1|||
42123686|NCT00641147|75933988|FG001|Completed 4 Months.|Physician Decision|0|||
42123687|NCT00641147|75933987|FG000|Completed 4 Months.|Adverse Event|1|||
42123688|NCT00641147|75933988|FG001|Completed 4 Months.|Adverse Event|0|||
42123689|NCT00641147|75933987|FG000|Completed 8 Months.|Physician Decision|2|||
42123690|NCT00641147|75933988|FG001|Completed 8 Months.|Physician Decision|1|||
42123691|NCT00641147|75933987|FG000|Completed 8 Months.|non compliance|1|||
42123692|NCT00641147|75933988|FG001|Completed 8 Months.|non compliance|0|||
42123693|NCT00641147|75933987|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
42123694|NCT00641147|75933988|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
42123695|NCT00641147|75933987|FG000|Completed 12 Months.|Physician Decision|1|||
42123696|NCT00641147|75933988|FG001|Completed 12 Months.|Physician Decision|1|||
42123697|NCT00641147|75933987|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
42123698|NCT00641147|75933988|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
42123699|NCT00641147|75933987|FG000|Completed 16 Months.|Physician Decision|1|||
42123700|NCT00641147|75933988|FG001|Completed 16 Months.|Physician Decision|0|||
42123701|NCT00641147|75933987|FG000|Completed 16 Months.|Lost to Follow-up|1|||
42123702|NCT00641147|75933988|FG001|Completed 16 Months.|Lost to Follow-up|0|||
42123703|NCT00460239|75933998|FG000|Overall Study|Physician Decision|0|||
42123704|NCT00460239|75933999|FG001|Overall Study|Physician Decision|1|||
42123705|NCT00460239|75934000|FG002|Overall Study|Physician Decision|0|||
42123706|NCT00460239|75934001|FG003|Overall Study|Physician Decision|0|||
42123707|NCT00460239|75934002|FG004|Overall Study|Physician Decision|0|||
42123708|NCT00460239|75934003|FG005|Overall Study|Physician Decision|2|||
42123709|NCT00460239|75934004|FG006|Overall Study|Physician Decision|0|||
42123710|NCT00460239|75934005|FG007|Overall Study|Physician Decision|0|||
42123711|NCT00460239|75934006|FG008|Overall Study|Physician Decision|0|||
42123712|NCT00460239|75933998|FG000|Overall Study|Withdrawal by Subject|0|||
42123713|NCT00460239|75933999|FG001|Overall Study|Withdrawal by Subject|0|||
42123714|NCT00460239|75934000|FG002|Overall Study|Withdrawal by Subject|0|||
42123715|NCT00460239|75934001|FG003|Overall Study|Withdrawal by Subject|0|||
42123716|NCT00460239|75934002|FG004|Overall Study|Withdrawal by Subject|0|||
42123717|NCT00460239|75934003|FG005|Overall Study|Withdrawal by Subject|1|||
42123718|NCT00460239|75934004|FG006|Overall Study|Withdrawal by Subject|0|||
42123719|NCT00460239|75934005|FG007|Overall Study|Withdrawal by Subject|0|||
42123720|NCT00460239|75934006|FG008|Overall Study|Withdrawal by Subject|0|||
42123721|NCT00640835|75934021|FG000|Overall Study|Adverse Event|5|||
42123722|NCT00640835|75934022|FG001|Overall Study|Adverse Event|3|||
42123723|NCT00640835|75934021|FG000|Overall Study|Withdrawal by Subject|12|||
42123724|NCT00640835|75934022|FG001|Overall Study|Withdrawal by Subject|14|||
42123725|NCT00640835|75934021|FG000|Overall Study|Physician Decision|10|||
42123726|NCT00640835|75934022|FG001|Overall Study|Physician Decision|14|||
42123727|NCT00640835|75934021|FG000|Overall Study|Sponsor's Decision|11|||
42123728|NCT00640835|75934022|FG001|Overall Study|Sponsor's Decision|7|||
42123729|NCT00640835|75934021|FG000|Overall Study|Protocol Violation|2|||
42123730|NCT00640835|75934022|FG001|Overall Study|Protocol Violation|2|||
42123731|NCT00640835|75934021|FG000|Overall Study|Lost to Follow-up|17|||
42123732|NCT00640835|75934022|FG001|Overall Study|Lost to Follow-up|13|||
42123733|NCT00640835|75934021|FG000|Overall Study|Other Reason|19|||
42123734|NCT00640835|75934022|FG001|Overall Study|Other Reason|4|||
42123735|NCT03839355|75934030|FG000|Overall Study|Withdrawal by Subject|1|||
42123736|NCT03839355|75934031|FG001|Overall Study|Withdrawal by Subject|0|||
42123737|NCT00382018|75934041|FG000|Overall Study|Progression|0|||
42123738|NCT00382018|75934042|FG001|Overall Study|Progression|136|||
42123739|NCT00382018|75934043|FG002|Overall Study|Progression|51|||
42123740|NCT00382018|75934044|FG003|Overall Study|Progression|43|||
42123741|NCT00382018|75934041|FG000|Overall Study|Death|0|||
42123742|NCT00382018|75934042|FG001|Overall Study|Death|9|||
42123743|NCT00382018|75934043|FG002|Overall Study|Death|7|||
42123744|NCT00382018|75934044|FG003|Overall Study|Death|11|||
42123745|NCT00382018|75934041|FG000|Overall Study|Withdrawal by Subject|0|||
42123746|NCT00382018|75934042|FG001|Overall Study|Withdrawal by Subject|4|||
42123747|NCT00382018|75934043|FG002|Overall Study|Withdrawal by Subject|3|||
42123748|NCT00382018|75934044|FG003|Overall Study|Withdrawal by Subject|4|||
42123749|NCT00382018|75934041|FG000|Overall Study|Other, not protocol specified|0|||
42123750|NCT00382018|75934042|FG001|Overall Study|Other, not protocol specified|16|||
42123751|NCT00382018|75934043|FG002|Overall Study|Other, not protocol specified|3|||
42123752|NCT00382018|75934044|FG003|Overall Study|Other, not protocol specified|1|||
42123753|NCT00640601|75934057|FG000|Overall Study|Adverse Event|43|||
42123754|NCT00640601|75934057|FG000|Overall Study|Withdrawal by Subject|20|||
42123755|NCT00640601|75934057|FG000|Overall Study|Protocol Violation|6|||
42123756|NCT00640601|75934057|FG000|Overall Study|Lack of Efficacy|16|||
42123757|NCT00640601|75934057|FG000|Overall Study|Lost to Follow-up|9|||
42123758|NCT00640601|75934057|FG000|Overall Study|Physician Decision|8|||
42123759|NCT00640601|75934057|FG000|Overall Study|treatment naive, combination therapy|10|||
42123760|NCT03838731|75934063|FG000|Overall Study|Pregnancy|0|||
42123761|NCT03838731|75934064|FG001|Overall Study|Pregnancy|1|||
42123762|NCT03838731|75934063|FG000|Overall Study|Withdrawal of consent|1|||
42123763|NCT03838731|75934064|FG001|Overall Study|Withdrawal of consent|0|||
42123764|NCT00452439|75934072|FG000|Overall Study|Lost to Follow-up|1|||
42123765|NCT00452439|75934073|FG001|Overall Study|Lost to Follow-up|1|||
42123766|NCT00452439|75934072|FG000|Overall Study|Refused Treatment|4|||
42123767|NCT00452439|75934073|FG001|Overall Study|Refused Treatment|3|||
42123768|NCT00452439|75934072|FG000|Overall Study|Death|3|||
41966671|NCT01982630|75766736|FG006|Overall Study|Withdrawal by Subject|0|||
41966672|NCT01982630|75766737|FG007|Overall Study|Withdrawal by Subject|0|||
41966673|NCT01740297|75766802|FG000|Overall Study|Withdrawal by Subject|4|||
41966674|NCT01740297|75766803|FG001|Overall Study|Withdrawal by Subject|16|||
41966675|NCT01740297|75766804|FG002|Overall Study|Withdrawal by Subject|17|||
41966676|NCT01740297|75766802|FG000|Overall Study|Death|8|||
41966677|NCT01740297|75766803|FG001|Overall Study|Death|46|||
41966678|NCT01740297|75766804|FG002|Overall Study|Death|40|||
41966679|NCT01740297|75766802|FG000|Overall Study|Lost to Follow-up|1|||
41966680|NCT01740297|75766803|FG001|Overall Study|Lost to Follow-up|2|||
41966681|NCT01740297|75766804|FG002|Overall Study|Lost to Follow-up|4|||
41966682|NCT01729754|75766818|FG000|Part 1|Adverse Event|2|||
41966683|NCT01729754|75766819|FG001|Part 1|Adverse Event|0|||
41966684|NCT01729754|75766820|FG002|Part 1|Adverse Event|0|||
41966685|NCT01729754|75766821|FG003|Part 1|Adverse Event|1|||
41966686|NCT01729754|75766822|FG004|Part 1|Adverse Event|0|||
42123769|NCT00452439|75934073|FG001|Overall Study|Death|1|||
42123770|NCT00452439|75934072|FG000|Overall Study|Bone Marrow Transplant|0|||
42123771|NCT00452439|75934073|FG001|Overall Study|Bone Marrow Transplant|1|||
42123772|NCT00452439|75934072|FG000|Overall Study|Too Ill to Continue|0|||
42123773|NCT00452439|75934073|FG001|Overall Study|Too Ill to Continue|1|||
42123774|NCT00452439|75934072|FG000|Overall Study|Failed to achieve complete response|2|||
42123775|NCT00452439|75934073|FG001|Overall Study|Failed to achieve complete response|0|||
42123776|NCT00452439|75934072|FG000|Overall Study|Relapse|3|||
42123777|NCT00452439|75934073|FG001|Overall Study|Relapse|0|||
42123778|NCT00452439|75934072|FG000|Overall Study|Fracture|1|||
42123779|NCT00452439|75934073|FG001|Overall Study|Fracture|0|||
42123780|NCT00381940|75934079|FG000|Overall Study|Lack of Efficacy|3|||
42123781|NCT00381940|75934079|FG000|Overall Study|Protocol Violation|1|||
42123782|NCT00381940|75934079|FG000|Overall Study|Ineligible|1|||
42123783|NCT00364156|75934085|FG000|Overall Study|Withdrawal by Subject|73|||
42123784|NCT00364156|75934086|FG001|Overall Study|Withdrawal by Subject|80|||
42123785|NCT00364156|75934085|FG000|Overall Study|Protocol Violation|6|||
42123786|NCT00364156|75934086|FG001|Overall Study|Protocol Violation|1|||
42123787|NCT00452361|75934094|FG000|Overall Study|Adverse Event|8|||
42123788|NCT00452361|75934095|FG001|Overall Study|Adverse Event|0|||
42123789|NCT00452361|75934094|FG000|Overall Study|Withdrawal by Subject|0|||
42123790|NCT00452361|75934095|FG001|Overall Study|Withdrawal by Subject|1|||
42123791|NCT00452361|75934094|FG000|Overall Study|Premature termination|13|||
42123792|NCT00452361|75934095|FG001|Overall Study|Premature termination|9|||
42123793|NCT00640289|75934101|FG000|Overall Study|Death|3|||
42123794|NCT00640289|75934101|FG000|Overall Study|Withdrawal by Subject|1|||
42123795|NCT00640289|75934101|FG000|Overall Study|Lost to Follow-up|1|||
42123796|NCT00640289|75934101|FG000|Overall Study|Data collected under different amendment|2|||
41966687|NCT01729754|75766823|FG005|Part 1|Adverse Event|0|||
41966688|NCT01729754|75766824|FG006|Part 1|Adverse Event|2|||
41966689|NCT01729754|75766825|FG007|Part 1|Adverse Event|0|||
41966690|NCT01729754|75766826|FG008|Part 1|Adverse Event|0|||
41966691|NCT01729754|75766827|FG009|Part 1|Adverse Event|5|||
42123797|NCT00640289|75934101|FG000|Overall Study|Transferred to another center|1|||
42123798|NCT00640289|75934101|FG000|Overall Study|Missing status|5|||
42123799|NCT00568451|75934109|FG000|Overall Study|Disease Progression|0|||
42123800|NCT00568451|75934110|FG001|Overall Study|Disease Progression|0|||
42123801|NCT00568451|75934111|FG002|Overall Study|Disease Progression|2|||
42123802|NCT00568451|75934112|FG003|Overall Study|Disease Progression|7|||
42123803|NCT00459537|75934125|FG000|Overall Study|Adverse Event|1|||
42123804|NCT00459537|75934126|FG001|Overall Study|Adverse Event|6|||
42123805|NCT00459537|75934125|FG000|Overall Study|Lack of Efficacy|10|||
42123806|NCT00459537|75934126|FG001|Overall Study|Lack of Efficacy|11|||
42123807|NCT00459537|75934125|FG000|Overall Study|Withdrawal by Subject|20|||
42123808|NCT00459537|75934126|FG001|Overall Study|Withdrawal by Subject|26|||
42123809|NCT00459537|75934125|FG000|Overall Study|Lost to Follow-up|27|||
42123810|NCT00459537|75934126|FG001|Overall Study|Lost to Follow-up|30|||
42123811|NCT00459537|75934125|FG000|Overall Study|Administrative problems|3|||
42123812|NCT00459537|75934126|FG001|Overall Study|Administrative problems|0|||
42123813|NCT00459537|75934125|FG000|Overall Study|Protocol Violation|4|||
41966692|NCT01729754|75766818|FG000|Part 1|Lack of Efficacy|1|||
41966693|NCT01729754|75766819|FG001|Part 1|Lack of Efficacy|0|||
41966694|NCT01729754|75766820|FG002|Part 1|Lack of Efficacy|0|||
41966695|NCT01729754|75766821|FG003|Part 1|Lack of Efficacy|0|||
41966696|NCT01729754|75766822|FG004|Part 1|Lack of Efficacy|0|||
42123814|NCT00459537|75934126|FG001|Overall Study|Protocol Violation|3|||
42123815|NCT00459537|75934125|FG000|Overall Study|Missing|1|||
42123816|NCT00459537|75934126|FG001|Overall Study|Missing|0|||
42123817|NCT03850509|75934134|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
42123818|NCT03850509|75934135|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
42123819|NCT00635999|75934144|FG000|Overall Study|Withdrawal by Subject|4|||
42123820|NCT00635999|75934145|FG001|Overall Study|Withdrawal by Subject|2|||
42123821|NCT00635999|75934146|FG002|Overall Study|Withdrawal by Subject|1|||
42123822|NCT00469209|75934157|FG000|Overall Study|Adverse Event|1|||
42123823|NCT00469209|75934158|FG001|Overall Study|Adverse Event|0|||
42123824|NCT00469209|75934159|FG002|Overall Study|Adverse Event|1|||
42123825|NCT00635219|75934172|FG000|Overall Study|Adverse Event|12|||
42123826|NCT00635219|75934173|FG001|Overall Study|Adverse Event|10|||
42123827|NCT00635219|75934174|FG002|Overall Study|Adverse Event|18|||
42123828|NCT00635219|75934175|FG003|Overall Study|Adverse Event|15|||
42123829|NCT00635219|75934176|FG004|Overall Study|Adverse Event|19|||
42123830|NCT00635219|75934172|FG000|Overall Study|Lack of Efficacy|5|||
42123831|NCT00635219|75934173|FG001|Overall Study|Lack of Efficacy|6|||
42123832|NCT00635219|75934174|FG002|Overall Study|Lack of Efficacy|3|||
42123833|NCT00635219|75934175|FG003|Overall Study|Lack of Efficacy|4|||
42123834|NCT00635219|75934176|FG004|Overall Study|Lack of Efficacy|6|||
42123835|NCT00635219|75934172|FG000|Overall Study|Non-compliance With Study Product|0|||
42123836|NCT00635219|75934173|FG001|Overall Study|Non-compliance With Study Product|0|||
42123837|NCT00635219|75934174|FG002|Overall Study|Non-compliance With Study Product|0|||
42123838|NCT00635219|75934175|FG003|Overall Study|Non-compliance With Study Product|2|||
42123839|NCT00635219|75934176|FG004|Overall Study|Non-compliance With Study Product|1|||
42123840|NCT00635219|75934172|FG000|Overall Study|Protocol Violation|0|||
42123841|NCT00635219|75934173|FG001|Overall Study|Protocol Violation|2|||
42123842|NCT00635219|75934174|FG002|Overall Study|Protocol Violation|3|||
42123843|NCT00635219|75934175|FG003|Overall Study|Protocol Violation|2|||
42123844|NCT00635219|75934176|FG004|Overall Study|Protocol Violation|4|||
42123845|NCT00635219|75934172|FG000|Overall Study|Withdrawal of Consent|8|||
42123846|NCT00635219|75934173|FG001|Overall Study|Withdrawal of Consent|6|||
42123847|NCT00635219|75934174|FG002|Overall Study|Withdrawal of Consent|8|||
42123848|NCT00635219|75934175|FG003|Overall Study|Withdrawal of Consent|11|||
42123849|NCT00635219|75934176|FG004|Overall Study|Withdrawal of Consent|8|||
42123850|NCT00635219|75934172|FG000|Overall Study|Lost to Follow-up|0|||
42123851|NCT00635219|75934173|FG001|Overall Study|Lost to Follow-up|0|||
42123852|NCT00635219|75934174|FG002|Overall Study|Lost to Follow-up|2|||
42123853|NCT00635219|75934175|FG003|Overall Study|Lost to Follow-up|0|||
42123854|NCT00635219|75934176|FG004|Overall Study|Lost to Follow-up|3|||
42123855|NCT00635219|75934172|FG000|Overall Study|Administrative or Other Reasons|0|||
42123856|NCT00635219|75934173|FG001|Overall Study|Administrative or Other Reasons|1|||
42123857|NCT00635219|75934174|FG002|Overall Study|Administrative or Other Reasons|1|||
41966697|NCT01729754|75766823|FG005|Part 1|Lack of Efficacy|0|||
41966698|NCT01729754|75766824|FG006|Part 1|Lack of Efficacy|2|||
41966699|NCT01729754|75766825|FG007|Part 1|Lack of Efficacy|0|||
41966700|NCT01729754|75766826|FG008|Part 1|Lack of Efficacy|0|||
41966701|NCT01729754|75766827|FG009|Part 1|Lack of Efficacy|0|||
41966702|NCT01729754|75766818|FG000|Part 1|Lost to Follow-up|1|||
41966703|NCT01729754|75766819|FG001|Part 1|Lost to Follow-up|0|||
41966704|NCT01729754|75766820|FG002|Part 1|Lost to Follow-up|0|||
41966705|NCT01729754|75766821|FG003|Part 1|Lost to Follow-up|2|||
41966706|NCT01729754|75766822|FG004|Part 1|Lost to Follow-up|0|||
41966707|NCT01729754|75766823|FG005|Part 1|Lost to Follow-up|0|||
42123858|NCT00635219|75934175|FG003|Overall Study|Administrative or Other Reasons|0|||
42123859|NCT00635219|75934176|FG004|Overall Study|Administrative or Other Reasons|1|||
42123860|NCT00363766|75934190|FG000|Overall Study|Progressive Disease|15|||
42123861|NCT00363766|75934191|FG001|Overall Study|Progressive Disease|9|||
42123862|NCT00363766|75934190|FG000|Overall Study|Adverse Event|10|||
42123863|NCT00363766|75934191|FG001|Overall Study|Adverse Event|2|||
42123864|NCT00363766|75934190|FG000|Overall Study|Disease Related Death|1|||
42123865|NCT00363766|75934191|FG001|Overall Study|Disease Related Death|3|||
42123866|NCT00363766|75934190|FG000|Overall Study|Not Disease Related Death|3|||
42123867|NCT00363766|75934191|FG001|Overall Study|Not Disease Related Death|4|||
41966708|NCT01729754|75766824|FG006|Part 1|Lost to Follow-up|3|||
41966709|NCT01729754|75766825|FG007|Part 1|Lost to Follow-up|0|||
42123868|NCT00363766|75934190|FG000|Overall Study|Withdrawal by Subject|2|||
41966710|NCT01729754|75766826|FG008|Part 1|Lost to Follow-up|0|||
41966711|NCT01729754|75766827|FG009|Part 1|Lost to Follow-up|3|||
41966712|NCT01729754|75766818|FG000|Part 1|Non-compliance with Study Drug|1|||
42123869|NCT00363766|75934191|FG001|Overall Study|Withdrawal by Subject|0|||
42123870|NCT00363766|75934190|FG000|Overall Study|Physician Decision|1|||
42123871|NCT00363766|75934191|FG001|Overall Study|Physician Decision|2|||
42123872|NCT00468819|75934201|FG000|Overall Study|Withdrawal by Subject|4|||
42123873|NCT00468819|75934202|FG001|Overall Study|Withdrawal by Subject|0|||
42137787|NCT00427908|75948135|FG003|Primary Phase|Lost to Follow-up|0|||
41966713|NCT01729754|75766819|FG001|Part 1|Non-compliance with Study Drug|0|||
41966714|NCT01729754|75766820|FG002|Part 1|Non-compliance with Study Drug|0|||
42123874|NCT00468819|75934203|FG002|Overall Study|Withdrawal by Subject|1|||
42123875|NCT00468819|75934201|FG000|Overall Study|Lost to Follow-up|0|||
42123876|NCT00468819|75934202|FG001|Overall Study|Lost to Follow-up|0|||
42123877|NCT00468819|75934203|FG002|Overall Study|Lost to Follow-up|1|||
42123878|NCT00468819|75934201|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
42123879|NCT00468819|75934202|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
42123880|NCT00468819|75934203|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
42123881|NCT00451191|75934215|FG000|Overall Study|withdrawal or received alternate tx|15|||
42123882|NCT00451191|75934216|FG001|Overall Study|withdrawal or received alternate tx|11|||
42123883|NCT00451035|75934222|FG000|Overall Study|Disease progression|11|||
42123884|NCT00451035|75934222|FG000|Overall Study|Death|3|||
42123885|NCT00451035|75934222|FG000|Overall Study|New anti-neoplastic therapy|3|||
42123886|NCT00468585|75934231|FG000|Overall Study|Patient not treated|1|||
42123887|NCT00468585|75934232|FG001|Overall Study|Patient not treated|0|||
42123888|NCT00468585|75934233|FG002|Overall Study|Patient not treated|1|||
42123889|NCT00468585|75934234|FG003|Overall Study|Patient not treated|0|||
42123890|NCT00468585|75934231|FG000|Overall Study|Patient found to be ineligible|0|||
42123891|NCT00468585|75934232|FG001|Overall Study|Patient found to be ineligible|0|||
42123892|NCT00468585|75934233|FG002|Overall Study|Patient found to be ineligible|1|||
42123893|NCT00468585|75934234|FG003|Overall Study|Patient found to be ineligible|0|||
42123894|NCT00468585|75934231|FG000|Overall Study|Adverse Event|0|||
42123895|NCT00468585|75934232|FG001|Overall Study|Adverse Event|0|||
42123896|NCT00468585|75934233|FG002|Overall Study|Adverse Event|1|||
42123897|NCT00468585|75934234|FG003|Overall Study|Adverse Event|0|||
42123898|NCT00468585|75934231|FG000|Overall Study|Withdrawal by Subject|0|||
42123899|NCT00468585|75934232|FG001|Overall Study|Withdrawal by Subject|0|||
42123900|NCT00468585|75934233|FG002|Overall Study|Withdrawal by Subject|2|||
42123901|NCT00468585|75934234|FG003|Overall Study|Withdrawal by Subject|1|||
42123902|NCT00450801|75934244|FG000|Overall Study|Death|1|||
42123903|NCT00458211|75934253|FG000|Overall Study|Lack of Efficacy|12|||
42123904|NCT00458211|75934253|FG000|Overall Study|Withdrawal by Subject|2|||
42123905|NCT00458211|75934253|FG000|Overall Study|Protocol Violation|2|||
42123906|NCT00450723|75934261|FG000|Overall Study|Physician Decision|5|||
42123907|NCT00467961|75934266|FG000|Overall Study|Technical Failures|5|||
42123908|NCT00467961|75934266|FG000|Overall Study|Disease Progression|2|||
42123909|NCT00457821|75934278|FG000|Part 2|Withdrawal by Subject|0|||
42123910|NCT00457821|75934279|FG001|Part 2|Withdrawal by Subject|0|||
42123911|NCT00457821|75934280|FG002|Part 2|Withdrawal by Subject|0|||
42123912|NCT00457821|75934281|FG003|Part 2|Withdrawal by Subject|0|||
42123913|NCT00457821|75934282|FG004|Part 2|Withdrawal by Subject|0|||
41966715|NCT01729754|75766821|FG003|Part 1|Non-compliance with Study Drug|0|||
41966716|NCT01729754|75766822|FG004|Part 1|Non-compliance with Study Drug|0|||
41966717|NCT01729754|75766823|FG005|Part 1|Non-compliance with Study Drug|0|||
41966718|NCT01729754|75766824|FG006|Part 1|Non-compliance with Study Drug|0|||
41966719|NCT01729754|75766825|FG007|Part 1|Non-compliance with Study Drug|0|||
41966720|NCT01729754|75766826|FG008|Part 1|Non-compliance with Study Drug|0|||
41966721|NCT01729754|75766827|FG009|Part 1|Non-compliance with Study Drug|0|||
41966722|NCT01729754|75766818|FG000|Part 1|Physician Decision|0|||
41966723|NCT01729754|75766819|FG001|Part 1|Physician Decision|0|||
41966724|NCT01729754|75766820|FG002|Part 1|Physician Decision|0|||
41966725|NCT01729754|75766821|FG003|Part 1|Physician Decision|0|||
41966726|NCT01729754|75766822|FG004|Part 1|Physician Decision|0|||
42123914|NCT00457821|75934283|FG005|Part 2|Withdrawal by Subject|0|||
42123915|NCT00457821|75934284|FG006|Part 2|Withdrawal by Subject|0|||
42123916|NCT00457821|75934285|FG007|Part 2|Withdrawal by Subject|1|||
41966727|NCT01729754|75766823|FG005|Part 1|Physician Decision|0|||
41966728|NCT01729754|75766824|FG006|Part 1|Physician Decision|0|||
41966729|NCT01729754|75766825|FG007|Part 1|Physician Decision|0|||
42123917|NCT00633893|75934305|FG000|Overall Study|Death|1|||
42123918|NCT00633893|75934306|FG001|Overall Study|Death|3|||
42123919|NCT00633893|75934307|FG002|Overall Study|Death|9|||
42123920|NCT00633893|75934305|FG000|Overall Study|Adverse Event|65|||
42123921|NCT00633893|75934306|FG001|Overall Study|Adverse Event|58|||
42123922|NCT00633893|75934307|FG002|Overall Study|Adverse Event|126|||
42123923|NCT00633893|75934305|FG000|Overall Study|Withdrawal by Subject|7|||
42123924|NCT00633893|75934306|FG001|Overall Study|Withdrawal by Subject|12|||
42123925|NCT00633893|75934307|FG002|Overall Study|Withdrawal by Subject|6|||
42123926|NCT00633893|75934305|FG000|Overall Study|Lost to Follow-up|2|||
42123927|NCT00633893|75934306|FG001|Overall Study|Lost to Follow-up|4|||
41966730|NCT01729754|75766826|FG008|Part 1|Physician Decision|0|||
41966731|NCT01729754|75766827|FG009|Part 1|Physician Decision|4|||
41966732|NCT01729754|75766818|FG000|Part 1|Pregnancy|0|||
42123928|NCT00633893|75934307|FG002|Overall Study|Lost to Follow-up|8|||
42123929|NCT00633893|75934305|FG000|Overall Study|Poor/non-compliance|5|||
42123930|NCT00633893|75934306|FG001|Overall Study|Poor/non-compliance|12|||
42123931|NCT00633893|75934307|FG002|Overall Study|Poor/non-compliance|3|||
42123932|NCT00633893|75934305|FG000|Overall Study|Pregnancy|2|||
42123933|NCT00633893|75934306|FG001|Overall Study|Pregnancy|1|||
42123934|NCT00633893|75934307|FG002|Overall Study|Pregnancy|1|||
42123935|NCT00633893|75934305|FG000|Overall Study|Not meet/no longer meets criteria|4|||
42123936|NCT00633893|75934306|FG001|Overall Study|Not meet/no longer meets criteria|6|||
42123937|NCT00633893|75934307|FG002|Overall Study|Not meet/no longer meets criteria|4|||
42123938|NCT00633893|75934305|FG000|Overall Study|Other|28|||
42123939|NCT00633893|75934306|FG001|Overall Study|Other|33|||
42123940|NCT00633893|75934307|FG002|Overall Study|Other|31|||
42123941|NCT00457743|75934318|FG000|Overall Study|Adverse Event|0|||
42123942|NCT00457743|75934319|FG001|Overall Study|Adverse Event|4|||
42123943|NCT00457743|75934320|FG002|Overall Study|Adverse Event|0|||
42123944|NCT00457743|75934318|FG000|Overall Study|Lack of Efficacy|3|||
42123945|NCT00457743|75934319|FG001|Overall Study|Lack of Efficacy|23|||
42123946|NCT00457743|75934320|FG002|Overall Study|Lack of Efficacy|3|||
42123947|NCT00450411|75934329|FG000|Overall Study|Protocol Violation|6|||
42123948|NCT00450411|75934329|FG000|Overall Study|No protocol treatment|2|||
42123949|NCT00644969|75934335|FG000|Treatment Phase|Randomized, not treated|1|||
42123950|NCT00644969|75934336|FG001|Treatment Phase|Randomized, not treated|0|||
42123951|NCT00644969|75934335|FG000|Treatment Phase|Adverse Event|3|||
42123952|NCT00644969|75934336|FG001|Treatment Phase|Adverse Event|0|||
42123953|NCT00644969|75934335|FG000|Treatment Phase|Withdrawal by Subject|4|||
42123954|NCT00644969|75934336|FG001|Treatment Phase|Withdrawal by Subject|0|||
42123955|NCT00644969|75934335|FG000|Treatment Phase|Lost to Follow-up|2|||
42123956|NCT00644969|75934336|FG001|Treatment Phase|Lost to Follow-up|2|||
42123957|NCT00644969|75934335|FG000|Treatment Phase|Other|4|||
42123958|NCT00644969|75934336|FG001|Treatment Phase|Other|1|||
42123959|NCT00644969|75934335|FG000|Post Treatment Phase|Death|1|||
42123960|NCT00644969|75934336|FG001|Post Treatment Phase|Death|0|||
42123961|NCT00644969|75934335|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
42123962|NCT00644969|75934336|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
42123963|NCT00644969|75934335|FG000|Post Treatment Phase|Lost to Follow-up|4|||
42123964|NCT00644969|75934336|FG001|Post Treatment Phase|Lost to Follow-up|1|||
42123965|NCT00644969|75934335|FG000|Post Treatment Phase|Other|1|||
42123966|NCT00644969|75934336|FG001|Post Treatment Phase|Other|0|||
42123967|NCT00644423|75934344|FG000|Overall Study|Lost to Follow-up|1|||
42123968|NCT00644423|75934345|FG001|Overall Study|Lost to Follow-up|1|||
42123969|NCT00628355|75934353|FG000|Overall Study|Withdrawal by Subject|1|||
42123970|NCT00628355|75934354|FG001|Overall Study|Withdrawal by Subject|1|||
42123971|NCT00627497|75934365|FG000|Overall Study|Lost to Follow-up|1|||
42123972|NCT00627497|75934366|FG001|Overall Study|Lost to Follow-up|1|||
42123973|NCT00627497|75934367|FG002|Overall Study|Lost to Follow-up|0|||
42123974|NCT00627497|75934368|FG003|Overall Study|Lost to Follow-up|0|||
42123975|NCT00648167|75934378|FG000|Overall Study|Adverse Event|6|||
42123976|NCT00648167|75934378|FG000|Overall Study|unable to swallow tablets|1|||
42123977|NCT00647699|75934412|FG000|Overall Study|Lost to Follow-up|5|||
42123978|NCT00647699|75934413|FG001|Overall Study|Lost to Follow-up|4|||
42123979|NCT00647699|75934412|FG000|Overall Study|Withdrawal by Subject|3|||
42123980|NCT00647699|75934413|FG001|Overall Study|Withdrawal by Subject|8|||
42123981|NCT00467649|75934421|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
42123982|NCT00467649|75934422|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
42123983|NCT00467649|75934423|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
42123984|NCT00467649|75934424|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
42123985|NCT00467649|75934425|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
42123986|NCT00467649|75934426|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
42123987|NCT00467649|75934421|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
42123988|NCT00467649|75934422|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
42123989|NCT00467649|75934423|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
42123990|NCT00467649|75934424|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
42123991|NCT00467649|75934425|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
42123992|NCT00467649|75934426|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
42123993|NCT00467649|75934421|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
42123994|NCT00467649|75934422|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
42123995|NCT00467649|75934423|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
42123996|NCT00467649|75934424|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
42123997|NCT00467649|75934425|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
42123998|NCT00467649|75934426|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
42123999|NCT00467649|75934421|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
42124000|NCT00467649|75934422|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
42124001|NCT00467649|75934423|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
42124002|NCT00467649|75934424|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
42124003|NCT00467649|75934425|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
42124004|NCT00467649|75934426|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
42124005|NCT00467649|75934421|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
42124006|NCT00467649|75934422|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
42124007|NCT00467649|75934423|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
42124008|NCT00467649|75934424|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
42124009|NCT00467649|75934425|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
42124010|NCT00467649|75934426|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
42124011|NCT00467649|75934421|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
42124012|NCT00467649|75934422|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
42124013|NCT00467649|75934423|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
42124014|NCT00467649|75934424|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
42124015|NCT00467649|75934425|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
42124016|NCT00467649|75934426|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
42124017|NCT00467649|75934421|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
42124018|NCT00467649|75934422|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
42124019|NCT00467649|75934423|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
42124020|NCT00467649|75934424|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
42124021|NCT00467649|75934425|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
42124022|NCT00467649|75934426|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
42124023|NCT00450333|75934448|FG000|Overall Study|Study terminated|47|||
42124024|NCT00450333|75934449|FG001|Overall Study|Study terminated|54|||
42124025|NCT00450333|75934450|FG002|Overall Study|Study terminated|16|||
42124026|NCT00450333|75934451|FG003|Overall Study|Study terminated|21|||
42124027|NCT00450333|75934448|FG000|Overall Study|Adverse Event|1|||
42124028|NCT00450333|75934449|FG001|Overall Study|Adverse Event|7|||
42124029|NCT00450333|75934450|FG002|Overall Study|Adverse Event|2|||
42124030|NCT00450333|75934451|FG003|Overall Study|Adverse Event|2|||
42124031|NCT00450333|75934448|FG000|Overall Study|Protocol Violation|1|||
42124032|NCT00450333|75934449|FG001|Overall Study|Protocol Violation|0|||
42124033|NCT00450333|75934450|FG002|Overall Study|Protocol Violation|1|||
42124034|NCT00450333|75934451|FG003|Overall Study|Protocol Violation|0|||
42124035|NCT00450333|75934448|FG000|Overall Study|Withdrawal by Subject|1|||
42124036|NCT00450333|75934449|FG001|Overall Study|Withdrawal by Subject|0|||
41966733|NCT01729754|75766819|FG001|Part 1|Pregnancy|0|||
41966734|NCT01729754|75766820|FG002|Part 1|Pregnancy|0|||
41966735|NCT01729754|75766821|FG003|Part 1|Pregnancy|1|||
41966736|NCT01729754|75766822|FG004|Part 1|Pregnancy|0|||
42124037|NCT00450333|75934450|FG002|Overall Study|Withdrawal by Subject|3|||
42124038|NCT00450333|75934451|FG003|Overall Study|Withdrawal by Subject|0|||
42124039|NCT00450333|75934448|FG000|Overall Study|Kidney transplant|1|||
42124040|NCT00450333|75934449|FG001|Overall Study|Kidney transplant|0|||
42124041|NCT00450333|75934450|FG002|Overall Study|Kidney transplant|1|||
42124042|NCT00450333|75934451|FG003|Overall Study|Kidney transplant|3|||
42124043|NCT00450333|75934448|FG000|Overall Study|Death|3|||
42124044|NCT00450333|75934449|FG001|Overall Study|Death|2|||
42124045|NCT00450333|75934450|FG002|Overall Study|Death|2|||
42124046|NCT00450333|75934451|FG003|Overall Study|Death|2|||
41966737|NCT01729754|75766823|FG005|Part 1|Pregnancy|0|||
41966738|NCT01729754|75766824|FG006|Part 1|Pregnancy|0|||
41966739|NCT01729754|75766825|FG007|Part 1|Pregnancy|0|||
41966740|NCT01729754|75766826|FG008|Part 1|Pregnancy|0|||
42124047|NCT00643565|75934463|FG000|Overall Study|Death|12|||
42124048|NCT00643565|75934464|FG001|Overall Study|Death|11|||
42124049|NCT00643565|75934463|FG000|Overall Study|Withdrawal by Subject|4|||
42124050|NCT00643565|75934464|FG001|Overall Study|Withdrawal by Subject|1|||
42301139|NCT01364389|76136456|FG001|Overall Study|Protocol deviation|0|||
42301140|NCT01364389|76136457|FG002|Overall Study|Protocol deviation|1|||
41966741|NCT01729754|75766827|FG009|Part 1|Pregnancy|1|||
41966742|NCT01729754|75766818|FG000|Part 1|Progressive Disease|0|||
41966743|NCT01729754|75766819|FG001|Part 1|Progressive Disease|0|||
41966744|NCT01729754|75766820|FG002|Part 1|Progressive Disease|0|||
42124051|NCT00643565|75934463|FG000|Overall Study|Lost to Follow-up|0|||
42124052|NCT00643565|75934464|FG001|Overall Study|Lost to Follow-up|6|||
42124053|NCT00643565|75934463|FG000|Overall Study|Other|7|||
42124054|NCT00643565|75934464|FG001|Overall Study|Other|8|||
42124055|NCT00643565|75934463|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
42124056|NCT00643565|75934464|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
42124057|NCT00643565|75934463|FG000|Overall Study|Recurrence of Disease|2|||
42124058|NCT00643565|75934464|FG001|Overall Study|Recurrence of Disease|1|||
42124059|NCT00643565|75934463|FG000|Overall Study|Progression of Disease|18|||
42124060|NCT00643565|75934464|FG001|Overall Study|Progression of Disease|14|||
42124061|NCT00643565|75934463|FG000|Overall Study|Protocol Violation|3|||
42124062|NCT00643565|75934464|FG001|Overall Study|Protocol Violation|0|||
42124063|NCT00643565|75934463|FG000|Overall Study|Did Not Cooperate|0|||
42124064|NCT00643565|75934464|FG001|Overall Study|Did Not Cooperate|1|||
42124065|NCT00643565|75934463|FG000|Overall Study|Administrative|22|||
42124066|NCT00643565|75934464|FG001|Overall Study|Administrative|16|||
42124067|NCT00643565|75934463|FG000|Overall Study|Adverse Event|5|||
42124068|NCT00643565|75934464|FG001|Overall Study|Adverse Event|8|||
42124069|NCT00643487|75934471|FG000|Overall Study|Technical difficulty|3|||
42124070|NCT00450255|75934475|FG000|Overall Study|Prior RFA ablation of liver|1|||
42124071|NCT00450177|75934482|FG000|Overall Study|Adverse Event|7|||
42124072|NCT00450177|75934483|FG001|Overall Study|Adverse Event|4|||
42124073|NCT00450177|75934482|FG000|Overall Study|Withdrawal by Subject|1|||
42124074|NCT00450177|75934483|FG001|Overall Study|Withdrawal by Subject|6|||
42124075|NCT00450177|75934482|FG000|Overall Study|Withdrawal by Primary Team|1|||
42124076|NCT00450177|75934483|FG001|Overall Study|Withdrawal by Primary Team|1|||
42124077|NCT03848949|75934491|FG000|Overall Study|Lost to Follow-up|5|||
42124078|NCT03848949|75934492|FG001|Overall Study|Lost to Follow-up|7|||
42124079|NCT00467259|75934500|FG000|Overall Study|Adverse Event|24|||
42124080|NCT00467259|75934501|FG001|Overall Study|Adverse Event|90|||
42124081|NCT00467259|75934500|FG000|Overall Study|Protocol Violation|1|||
42124082|NCT00467259|75934501|FG001|Overall Study|Protocol Violation|7|||
42124083|NCT00467259|75934500|FG000|Overall Study|Withdrawal by Subject|34|||
41966745|NCT01729754|75766821|FG003|Part 1|Progressive Disease|0|||
41966746|NCT01729754|75766822|FG004|Part 1|Progressive Disease|0|||
41966747|NCT01729754|75766823|FG005|Part 1|Progressive Disease|0|||
41966748|NCT01729754|75766824|FG006|Part 1|Progressive Disease|0|||
41966749|NCT01729754|75766825|FG007|Part 1|Progressive Disease|0|||
41966750|NCT01729754|75766826|FG008|Part 1|Progressive Disease|0|||
41966751|NCT01729754|75766827|FG009|Part 1|Progressive Disease|1|||
41966752|NCT01729754|75766818|FG000|Part 1|Protocol Violation|2|||
41966753|NCT01729754|75766819|FG001|Part 1|Protocol Violation|0|||
41966754|NCT01729754|75766820|FG002|Part 1|Protocol Violation|0|||
41966755|NCT01729754|75766821|FG003|Part 1|Protocol Violation|1|||
41966756|NCT01729754|75766822|FG004|Part 1|Protocol Violation|0|||
41966757|NCT01729754|75766823|FG005|Part 1|Protocol Violation|0|||
41966758|NCT01729754|75766824|FG006|Part 1|Protocol Violation|1|||
41966759|NCT01729754|75766825|FG007|Part 1|Protocol Violation|0|||
41966760|NCT01729754|75766826|FG008|Part 1|Protocol Violation|0|||
41966761|NCT01729754|75766827|FG009|Part 1|Protocol Violation|0|||
41966762|NCT01729754|75766818|FG000|Part 1|Withdrawal by Subject|5|||
41966763|NCT01729754|75766819|FG001|Part 1|Withdrawal by Subject|0|||
41966764|NCT01729754|75766820|FG002|Part 1|Withdrawal by Subject|0|||
41966765|NCT01729754|75766821|FG003|Part 1|Withdrawal by Subject|7|||
41966766|NCT01729754|75766822|FG004|Part 1|Withdrawal by Subject|0|||
41966767|NCT01729754|75766823|FG005|Part 1|Withdrawal by Subject|0|||
41966768|NCT01729754|75766824|FG006|Part 1|Withdrawal by Subject|5|||
41966769|NCT01729754|75766825|FG007|Part 1|Withdrawal by Subject|0|||
41966770|NCT01729754|75766826|FG008|Part 1|Withdrawal by Subject|0|||
41966771|NCT01729754|75766827|FG009|Part 1|Withdrawal by Subject|6|||
41966772|NCT01729754|75766818|FG000|Part 1|Other Protocol Specified Criteria|2|||
41966773|NCT01729754|75766819|FG001|Part 1|Other Protocol Specified Criteria|0|||
41966774|NCT01729754|75766820|FG002|Part 1|Other Protocol Specified Criteria|0|||
42124084|NCT00467259|75934501|FG001|Overall Study|Withdrawal by Subject|108|||
42124085|NCT00467259|75934500|FG000|Overall Study|Physician Decision|0|||
42124086|NCT00467259|75934501|FG001|Overall Study|Physician Decision|2|||
42124087|NCT00467259|75934500|FG000|Overall Study|Lost to Follow-up|14|||
42124088|NCT00467259|75934501|FG001|Overall Study|Lost to Follow-up|34|||
42124089|NCT00467259|75934500|FG000|Overall Study|Site Closed|2|||
42124090|NCT00467259|75934501|FG001|Overall Study|Site Closed|1|||
42124091|NCT00449865|75934509|FG000|Overall Study|Withdrawal by Subject|110|||
42210374|NCT03227445|76025158|FG002|Period 1 (28 Days)|Protocol Violation|0|||
41966775|NCT01729754|75766821|FG003|Part 1|Other Protocol Specified Criteria|0|||
41966776|NCT01729754|75766822|FG004|Part 1|Other Protocol Specified Criteria|0|||
41966777|NCT01729754|75766823|FG005|Part 1|Other Protocol Specified Criteria|0|||
41966778|NCT01729754|75766824|FG006|Part 1|Other Protocol Specified Criteria|1|||
42124092|NCT00449865|75934510|FG001|Overall Study|Withdrawal by Subject|110|||
42124093|NCT00449865|75934509|FG000|Overall Study|Lost to Follow-up|36|||
42124094|NCT00449865|75934510|FG001|Overall Study|Lost to Follow-up|37|||
42124095|NCT00449865|75934509|FG000|Overall Study|Physician Decision|13|||
41966779|NCT01729754|75766825|FG007|Part 1|Other Protocol Specified Criteria|0|||
41966780|NCT01729754|75766826|FG008|Part 1|Other Protocol Specified Criteria|0|||
41966781|NCT01729754|75766827|FG009|Part 1|Other Protocol Specified Criteria|4|||
41966782|NCT01729754|75766818|FG000|Part 2|Adverse Event|2|||
41966783|NCT01729754|75766819|FG001|Part 2|Adverse Event|0|||
41966784|NCT01729754|75766820|FG002|Part 2|Adverse Event|0|||
41966785|NCT01729754|75766821|FG003|Part 2|Adverse Event|0|||
41966786|NCT01729754|75766822|FG004|Part 2|Adverse Event|0|||
41966787|NCT01729754|75766823|FG005|Part 2|Adverse Event|0|||
41966788|NCT01729754|75766824|FG006|Part 2|Adverse Event|0|||
41966789|NCT01729754|75766825|FG007|Part 2|Adverse Event|0|||
41966790|NCT01729754|75766826|FG008|Part 2|Adverse Event|1|||
41966791|NCT01729754|75766827|FG009|Part 2|Adverse Event|2|||
41966792|NCT01729754|75766818|FG000|Part 2|Lack of Efficacy|0|||
41966793|NCT01729754|75766819|FG001|Part 2|Lack of Efficacy|0|||
41966794|NCT01729754|75766820|FG002|Part 2|Lack of Efficacy|0|||
41966795|NCT01729754|75766821|FG003|Part 2|Lack of Efficacy|0|||
41966796|NCT01729754|75766822|FG004|Part 2|Lack of Efficacy|0|||
41966797|NCT01729754|75766823|FG005|Part 2|Lack of Efficacy|0|||
41966798|NCT01729754|75766824|FG006|Part 2|Lack of Efficacy|0|||
41966799|NCT01729754|75766825|FG007|Part 2|Lack of Efficacy|0|||
41966800|NCT01729754|75766826|FG008|Part 2|Lack of Efficacy|2|||
41966801|NCT01729754|75766827|FG009|Part 2|Lack of Efficacy|2|||
41966802|NCT01729754|75766818|FG000|Part 2|Lost to Follow-up|0|||
41966803|NCT01729754|75766819|FG001|Part 2|Lost to Follow-up|0|||
41966804|NCT01729754|75766820|FG002|Part 2|Lost to Follow-up|0|||
41966805|NCT01729754|75766821|FG003|Part 2|Lost to Follow-up|2|||
41966806|NCT01729754|75766822|FG004|Part 2|Lost to Follow-up|0|||
41966807|NCT01729754|75766823|FG005|Part 2|Lost to Follow-up|0|||
41966808|NCT01729754|75766824|FG006|Part 2|Lost to Follow-up|0|||
41966809|NCT01729754|75766825|FG007|Part 2|Lost to Follow-up|1|||
41966810|NCT01729754|75766826|FG008|Part 2|Lost to Follow-up|0|||
41966811|NCT01729754|75766827|FG009|Part 2|Lost to Follow-up|2|||
41966812|NCT01729754|75766818|FG000|Part 2|Non-Compliance with Study Drug|0|||
41966813|NCT01729754|75766819|FG001|Part 2|Non-Compliance with Study Drug|0|||
41966814|NCT01729754|75766820|FG002|Part 2|Non-Compliance with Study Drug|0|||
41966815|NCT01729754|75766821|FG003|Part 2|Non-Compliance with Study Drug|0|||
41966816|NCT01729754|75766822|FG004|Part 2|Non-Compliance with Study Drug|0|||
41966817|NCT01729754|75766823|FG005|Part 2|Non-Compliance with Study Drug|0|||
41966818|NCT01729754|75766824|FG006|Part 2|Non-Compliance with Study Drug|0|||
41966819|NCT01729754|75766825|FG007|Part 2|Non-Compliance with Study Drug|0|||
42301141|NCT01364389|76136455|FG000|Overall Study|Administrative problems|1|||
42301142|NCT01364389|76136456|FG001|Overall Study|Administrative problems|0|||
42301143|NCT01364389|76136457|FG002|Overall Study|Administrative problems|0|||
41966820|NCT01729754|75766826|FG008|Part 2|Non-Compliance with Study Drug|0|||
41966821|NCT01729754|75766827|FG009|Part 2|Non-Compliance with Study Drug|1|||
41966822|NCT01729754|75766818|FG000|Part 2|Pregnancy|0|||
41966823|NCT01729754|75766819|FG001|Part 2|Pregnancy|0|||
41966824|NCT01729754|75766820|FG002|Part 2|Pregnancy|0|||
41966825|NCT01729754|75766821|FG003|Part 2|Pregnancy|1|||
41966826|NCT01729754|75766822|FG004|Part 2|Pregnancy|0|||
41966827|NCT01729754|75766823|FG005|Part 2|Pregnancy|0|||
41966828|NCT01729754|75766824|FG006|Part 2|Pregnancy|0|||
41966829|NCT01729754|75766825|FG007|Part 2|Pregnancy|0|||
41966830|NCT01729754|75766826|FG008|Part 2|Pregnancy|0|||
41966831|NCT01729754|75766827|FG009|Part 2|Pregnancy|1|||
41966832|NCT01729754|75766818|FG000|Part 2|Withdrawal by Subject|3|||
41966833|NCT01729754|75766819|FG001|Part 2|Withdrawal by Subject|0|||
41966834|NCT01729754|75766820|FG002|Part 2|Withdrawal by Subject|0|||
41966835|NCT01729754|75766821|FG003|Part 2|Withdrawal by Subject|2|||
42027679|NCT01140906|75835943|FG001|Overall Study|Protocol Violation|3|||
42027680|NCT01140906|75835944|FG002|Overall Study|Protocol Violation|2|||
42027681|NCT01140906|75835945|FG003|Overall Study|Protocol Violation|1|||
42027682|NCT01140906|75835942|FG000|Overall Study|Withdrawal of consent|6|||
42027683|NCT01140906|75835943|FG001|Overall Study|Withdrawal of consent|6|||
42027684|NCT01140906|75835944|FG002|Overall Study|Withdrawal of consent|2|||
42027685|NCT01140906|75835945|FG003|Overall Study|Withdrawal of consent|2|||
42027686|NCT01140906|75835942|FG000|Overall Study|Lost to Follow-up|1|||
42027687|NCT01140906|75835943|FG001|Overall Study|Lost to Follow-up|1|||
42027688|NCT01140906|75835944|FG002|Overall Study|Lost to Follow-up|0|||
42027689|NCT01140906|75835945|FG003|Overall Study|Lost to Follow-up|2|||
42027690|NCT01140906|75835942|FG000|Overall Study|Administrative or other reason|0|||
42027691|NCT01140906|75835943|FG001|Overall Study|Administrative or other reason|5|||
42027692|NCT01140906|75835944|FG002|Overall Study|Administrative or other reason|3|||
42027693|NCT01140906|75835945|FG003|Overall Study|Administrative or other reason|2|||
42027694|NCT00962091|75835962|FG000|Overall Study|Withdrawal by Subject|1|||
42027695|NCT00962091|75835963|FG001|Overall Study|Withdrawal by Subject|2|||
42124096|NCT00449865|75934510|FG001|Overall Study|Physician Decision|12|||
41966836|NCT01729754|75766822|FG004|Part 2|Withdrawal by Subject|0|||
41966837|NCT01729754|75766823|FG005|Part 2|Withdrawal by Subject|0|||
41966838|NCT01729754|75766824|FG006|Part 2|Withdrawal by Subject|0|||
41966839|NCT01729754|75766825|FG007|Part 2|Withdrawal by Subject|1|||
42124097|NCT00449865|75934509|FG000|Overall Study|Death|31|||
42124098|NCT00449865|75934510|FG001|Overall Study|Death|40|||
42124099|NCT00449865|75934509|FG000|Overall Study|Protocol Violation|8|||
42124100|NCT00449865|75934510|FG001|Overall Study|Protocol Violation|7|||
41966840|NCT01729754|75766826|FG008|Part 2|Withdrawal by Subject|1|||
41966841|NCT01729754|75766827|FG009|Part 2|Withdrawal by Subject|4|||
41966842|NCT01729754|75766818|FG000|Part 2|Other Protocol Specified Criteria|1|||
41966843|NCT01729754|75766819|FG001|Part 2|Other Protocol Specified Criteria|0|||
41966844|NCT01729754|75766820|FG002|Part 2|Other Protocol Specified Criteria|0|||
41966845|NCT01729754|75766821|FG003|Part 2|Other Protocol Specified Criteria|0|||
41966846|NCT01729754|75766822|FG004|Part 2|Other Protocol Specified Criteria|0|||
41966847|NCT01729754|75766823|FG005|Part 2|Other Protocol Specified Criteria|0|||
41966848|NCT01729754|75766824|FG006|Part 2|Other Protocol Specified Criteria|0|||
41966849|NCT01729754|75766825|FG007|Part 2|Other Protocol Specified Criteria|1|||
41966850|NCT01729754|75766826|FG008|Part 2|Other Protocol Specified Criteria|0|||
41966851|NCT01729754|75766827|FG009|Part 2|Other Protocol Specified Criteria|0|||
41966852|NCT01729754|75766818|FG000|Part 3|Adverse Event|0|||
41966853|NCT01729754|75766819|FG001|Part 3|Adverse Event|0|||
41966854|NCT01729754|75766820|FG002|Part 3|Adverse Event|1|||
41966855|NCT01729754|75766821|FG003|Part 3|Adverse Event|0|||
41966856|NCT01729754|75766822|FG004|Part 3|Adverse Event|0|||
41966857|NCT01729754|75766823|FG005|Part 3|Adverse Event|5|||
41966858|NCT01729754|75766824|FG006|Part 3|Adverse Event|0|||
41966859|NCT01729754|75766825|FG007|Part 3|Adverse Event|0|||
41966860|NCT01729754|75766826|FG008|Part 3|Adverse Event|0|||
41966861|NCT01729754|75766827|FG009|Part 3|Adverse Event|3|||
41966862|NCT01729754|75766818|FG000|Part 3|Death|0|||
41966863|NCT01729754|75766819|FG001|Part 3|Death|0|||
41966864|NCT01729754|75766820|FG002|Part 3|Death|0|||
41966865|NCT01729754|75766821|FG003|Part 3|Death|0|||
41966866|NCT01729754|75766822|FG004|Part 3|Death|0|||
41966867|NCT01729754|75766823|FG005|Part 3|Death|2|||
41966868|NCT01729754|75766824|FG006|Part 3|Death|0|||
41966869|NCT01729754|75766825|FG007|Part 3|Death|0|||
41966870|NCT01729754|75766826|FG008|Part 3|Death|0|||
41966871|NCT01729754|75766827|FG009|Part 3|Death|0|||
41966872|NCT01729754|75766818|FG000|Part 3|Lack of Efficacy|0|||
41966873|NCT01729754|75766819|FG001|Part 3|Lack of Efficacy|0|||
41966874|NCT01729754|75766820|FG002|Part 3|Lack of Efficacy|0|||
41966875|NCT01729754|75766821|FG003|Part 3|Lack of Efficacy|0|||
41966876|NCT01729754|75766822|FG004|Part 3|Lack of Efficacy|2|||
41966877|NCT01729754|75766823|FG005|Part 3|Lack of Efficacy|0|||
41966878|NCT01729754|75766824|FG006|Part 3|Lack of Efficacy|0|||
41966879|NCT01729754|75766825|FG007|Part 3|Lack of Efficacy|0|||
41966880|NCT01729754|75766826|FG008|Part 3|Lack of Efficacy|0|||
41966881|NCT01729754|75766827|FG009|Part 3|Lack of Efficacy|4|||
42027696|NCT00962091|75835964|FG002|Overall Study|Withdrawal by Subject|1|||
42027697|NCT00962091|75835965|FG003|Overall Study|Withdrawal by Subject|1|||
42027698|NCT00962091|75835966|FG004|Overall Study|Withdrawal by Subject|0|||
42027699|NCT00962091|75835967|FG005|Overall Study|Withdrawal by Subject|1|||
42027700|NCT00962091|75835968|FG006|Overall Study|Withdrawal by Subject|0|||
42027701|NCT00962091|75835962|FG000|Overall Study|Adverse Event|0|||
42027702|NCT00962091|75835963|FG001|Overall Study|Adverse Event|0|||
42027703|NCT00962091|75835964|FG002|Overall Study|Adverse Event|0|||
42027704|NCT00962091|75835965|FG003|Overall Study|Adverse Event|0|||
42027705|NCT00962091|75835966|FG004|Overall Study|Adverse Event|0|||
42027706|NCT00962091|75835967|FG005|Overall Study|Adverse Event|0|||
42027707|NCT00962091|75835968|FG006|Overall Study|Adverse Event|1|||
42027708|NCT01163916|75835995|FG000|Overall Study|Withdrawal by Subject|2|||
42027709|NCT01163916|75835996|FG001|Overall Study|Withdrawal by Subject|0|||
42027710|NCT01163916|75835997|FG002|Overall Study|Withdrawal by Subject|2|||
42027711|NCT01163916|75835995|FG000|Overall Study|Adverse Event|2|||
42027712|NCT01163916|75835996|FG001|Overall Study|Adverse Event|0|||
42027713|NCT01163916|75835997|FG002|Overall Study|Adverse Event|1|||
42027714|NCT01163916|75835995|FG000|Overall Study|Lack of Efficacy|2|||
42027715|NCT01163916|75835996|FG001|Overall Study|Lack of Efficacy|0|||
42027716|NCT01163916|75835997|FG002|Overall Study|Lack of Efficacy|1|||
42027717|NCT01163916|75835995|FG000|Overall Study|Other|24|||
42027718|NCT01163916|75835996|FG001|Overall Study|Other|4|||
42027719|NCT01163916|75835997|FG002|Overall Study|Other|16|||
42027720|NCT01122576|75836013|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
42027721|NCT01122576|75836014|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
42027722|NCT01122576|75836015|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
42027723|NCT01122576|75836013|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
42027724|NCT01122576|75836014|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
41966882|NCT01729754|75766818|FG000|Part 3|Lost to Follow-up|0|||
41966883|NCT01729754|75766819|FG001|Part 3|Lost to Follow-up|1|||
42124101|NCT00449865|75934509|FG000|Overall Study|Study was stopped|324|||
41966884|NCT01729754|75766820|FG002|Part 3|Lost to Follow-up|2|||
41966885|NCT01729754|75766821|FG003|Part 3|Lost to Follow-up|0|||
41966886|NCT01729754|75766822|FG004|Part 3|Lost to Follow-up|0|||
41966887|NCT01729754|75766823|FG005|Part 3|Lost to Follow-up|3|||
41966888|NCT01729754|75766824|FG006|Part 3|Lost to Follow-up|0|||
42124102|NCT00449865|75934510|FG001|Overall Study|Study was stopped|328|||
42124103|NCT00449787|75934518|FG000|Overall Study|Lost to Follow-up|10|||
42124104|NCT00449787|75934519|FG001|Overall Study|Lost to Follow-up|8|||
42124105|NCT00449787|75934518|FG000|Overall Study|Did not require medication|95|||
42124106|NCT00449787|75934519|FG001|Overall Study|Did not require medication|92|||
42124107|NCT00449163|75934527|FG000|Overall Study|Physician Decision|3|||
42124108|NCT00448539|75934533|FG000|Overall Study|Medication non-compliance|4|||
42124109|NCT00448539|75934534|FG001|Overall Study|Medication non-compliance|1|||
42124110|NCT00448539|75934533|FG000|Overall Study|Protocol Violation|1|||
42124111|NCT00448539|75934534|FG001|Overall Study|Protocol Violation|0|||
42124112|NCT00448539|75934533|FG000|Overall Study|Request of the investigator or sponsor|67|||
41966889|NCT01729754|75766825|FG007|Part 3|Lost to Follow-up|0|||
41966890|NCT01729754|75766826|FG008|Part 3|Lost to Follow-up|1|||
41966891|NCT01729754|75766827|FG009|Part 3|Lost to Follow-up|0|||
42124113|NCT00448539|75934534|FG001|Overall Study|Request of the investigator or sponsor|54|||
42124114|NCT00448539|75934533|FG000|Overall Study|Withdrawal by Subject|20|||
42124115|NCT00448539|75934534|FG001|Overall Study|Withdrawal by Subject|24|||
42124116|NCT00448539|75934533|FG000|Overall Study|Diary non-compliance|1|||
42124117|NCT00448539|75934534|FG001|Overall Study|Diary non-compliance|0|||
42124118|NCT00448539|75934533|FG000|Overall Study|Adverse Event|9|||
41966892|NCT01729754|75766818|FG000|Part 3|Physician Decision|0|||
41966893|NCT01729754|75766819|FG001|Part 3|Physician Decision|0|||
41966894|NCT01729754|75766820|FG002|Part 3|Physician Decision|1|||
41966895|NCT01729754|75766821|FG003|Part 3|Physician Decision|0|||
41966896|NCT01729754|75766822|FG004|Part 3|Physician Decision|0|||
41966897|NCT01729754|75766823|FG005|Part 3|Physician Decision|0|||
41966898|NCT01729754|75766824|FG006|Part 3|Physician Decision|0|||
41966899|NCT01729754|75766825|FG007|Part 3|Physician Decision|0|||
41966900|NCT01729754|75766826|FG008|Part 3|Physician Decision|0|||
41966901|NCT01729754|75766827|FG009|Part 3|Physician Decision|0|||
41966902|NCT01729754|75766818|FG000|Part 3|Withdrawal by Subject|0|||
41966903|NCT01729754|75766819|FG001|Part 3|Withdrawal by Subject|4|||
41966904|NCT01729754|75766820|FG002|Part 3|Withdrawal by Subject|1|||
41966905|NCT01729754|75766821|FG003|Part 3|Withdrawal by Subject|0|||
41966906|NCT01729754|75766822|FG004|Part 3|Withdrawal by Subject|2|||
41966907|NCT01729754|75766823|FG005|Part 3|Withdrawal by Subject|1|||
41966908|NCT01729754|75766824|FG006|Part 3|Withdrawal by Subject|0|||
41966909|NCT01729754|75766825|FG007|Part 3|Withdrawal by Subject|2|||
41966910|NCT01729754|75766826|FG008|Part 3|Withdrawal by Subject|0|||
41966911|NCT01729754|75766827|FG009|Part 3|Withdrawal by Subject|0|||
41966912|NCT01729754|75766818|FG000|Part 3|Other Protocol Specified Criteria|0|||
41966913|NCT01729754|75766819|FG001|Part 3|Other Protocol Specified Criteria|0|||
41966914|NCT01729754|75766820|FG002|Part 3|Other Protocol Specified Criteria|0|||
41966915|NCT01729754|75766821|FG003|Part 3|Other Protocol Specified Criteria|0|||
41966916|NCT01729754|75766822|FG004|Part 3|Other Protocol Specified Criteria|0|||
41966917|NCT01729754|75766823|FG005|Part 3|Other Protocol Specified Criteria|2|||
41966918|NCT01729754|75766824|FG006|Part 3|Other Protocol Specified Criteria|0|||
41966919|NCT01729754|75766825|FG007|Part 3|Other Protocol Specified Criteria|1|||
41966920|NCT01729754|75766826|FG008|Part 3|Other Protocol Specified Criteria|0|||
42124119|NCT00448539|75934534|FG001|Overall Study|Adverse Event|26|||
42124120|NCT00448539|75934533|FG000|Overall Study|Lack of Efficacy|27|||
42124121|NCT00448539|75934534|FG001|Overall Study|Lack of Efficacy|40|||
42124122|NCT00448539|75934533|FG000|Overall Study|Miscellaneous|2|||
42124123|NCT00448539|75934534|FG001|Overall Study|Miscellaneous|1|||
42124124|NCT00448539|75934533|FG000|Overall Study|Change of meds|2|||
42124125|NCT00448539|75934534|FG001|Overall Study|Change of meds|3|||
42124126|NCT00448539|75934533|FG000|Overall Study|Lost to Follow-up|1|||
42124127|NCT00448539|75934534|FG001|Overall Study|Lost to Follow-up|3|||
42124128|NCT00457665|75934542|FG000|12 Months|Drug allergy|1|||
42124129|NCT00457665|75934543|FG001|12 Months|Drug allergy|1|||
42124130|NCT00457665|75934542|FG000|12 Months|High HIV viral load|5|||
42124131|NCT00457665|75934543|FG001|12 Months|High HIV viral load|1|||
42124132|NCT00457665|75934542|FG000|12 Months|Lipodystrophy|2|||
42124133|NCT00457665|75934543|FG001|12 Months|Lipodystrophy|0|||
42301144|NCT01364389|76136455|FG000|Overall Study|Adverse Event|1|||
41966921|NCT01729754|75766827|FG009|Part 3|Other Protocol Specified Criteria|0|||
41966922|NCT01515306|75766872|FG000|Overall Study|Adverse Event|3|||
41966923|NCT01515306|75766873|FG001|Overall Study|Adverse Event|2|||
41966924|NCT01515306|75766872|FG000|Overall Study|Progressive Disease|19|||
41966925|NCT01515306|75766873|FG001|Overall Study|Progressive Disease|9|||
41966926|NCT01515306|75766872|FG000|Overall Study|Withdrawal by Subject|1|||
41966927|NCT01515306|75766873|FG001|Overall Study|Withdrawal by Subject|2|||
41966928|NCT01515306|75766872|FG000|Overall Study|Physician Decision|1|||
41966929|NCT01515306|75766873|FG001|Overall Study|Physician Decision|1|||
41966930|NCT01423851|75766894|FG000|Whole Study|Disease progression|2|||
42124134|NCT00457665|75934542|FG000|12 Months|Withdrawal by Subject|0|||
42124135|NCT00457665|75934543|FG001|12 Months|Withdrawal by Subject|2|||
42124136|NCT00457665|75934542|FG000|12 Months|Abnormal Liver function tests|0|||
42124137|NCT00457665|75934543|FG001|12 Months|Abnormal Liver function tests|5|||
41966931|NCT01423851|75766895|FG001|Whole Study|Disease progression|1|||
41966932|NCT01423851|75766896|FG002|Whole Study|Disease progression|1|||
41966933|NCT01423851|75766897|FG003|Whole Study|Disease progression|4|||
41966934|NCT01423851|75766898|FG004|Whole Study|Disease progression|1|||
41966935|NCT01423851|75766899|FG005|Whole Study|Disease progression|3|||
41966936|NCT01423851|75766900|FG006|Whole Study|Disease progression|1|||
41966937|NCT01423851|75766901|FG007|Whole Study|Disease progression|4|||
41966938|NCT01423851|75766902|FG008|Whole Study|Disease progression|0|||
41966939|NCT01423851|75766903|FG009|Whole Study|Disease progression|2|||
41966940|NCT01423851|75766904|FG010|Whole Study|Disease progression|10|||
41966941|NCT01423851|75766894|FG000|Whole Study|Physician Decision|0|||
41966942|NCT01423851|75766895|FG001|Whole Study|Physician Decision|1|||
41966943|NCT01423851|75766896|FG002|Whole Study|Physician Decision|2|||
41966944|NCT01423851|75766897|FG003|Whole Study|Physician Decision|0|||
41966945|NCT01423851|75766898|FG004|Whole Study|Physician Decision|2|||
41966946|NCT01423851|75766899|FG005|Whole Study|Physician Decision|0|||
41966947|NCT01423851|75766900|FG006|Whole Study|Physician Decision|2|||
41966948|NCT01423851|75766901|FG007|Whole Study|Physician Decision|1|||
41966949|NCT01423851|75766902|FG008|Whole Study|Physician Decision|3|||
41966950|NCT01423851|75766903|FG009|Whole Study|Physician Decision|4|||
41966951|NCT01423851|75766904|FG010|Whole Study|Physician Decision|12|||
41966952|NCT01423851|75766894|FG000|Whole Study|Withdrawal by Subject|1|||
41966953|NCT01423851|75766895|FG001|Whole Study|Withdrawal by Subject|1|||
41966954|NCT01423851|75766896|FG002|Whole Study|Withdrawal by Subject|0|||
41966955|NCT01423851|75766897|FG003|Whole Study|Withdrawal by Subject|0|||
41966956|NCT01423851|75766898|FG004|Whole Study|Withdrawal by Subject|0|||
41966957|NCT01423851|75766899|FG005|Whole Study|Withdrawal by Subject|0|||
41966958|NCT01423851|75766900|FG006|Whole Study|Withdrawal by Subject|0|||
41966959|NCT01423851|75766901|FG007|Whole Study|Withdrawal by Subject|0|||
41966960|NCT01423851|75766902|FG008|Whole Study|Withdrawal by Subject|2|||
41966961|NCT01423851|75766903|FG009|Whole Study|Withdrawal by Subject|0|||
41966962|NCT01423851|75766904|FG010|Whole Study|Withdrawal by Subject|4|||
41966963|NCT01423851|75766894|FG000|Whole Study|Adverse Event|0|||
41966964|NCT01423851|75766895|FG001|Whole Study|Adverse Event|0|||
41966965|NCT01423851|75766896|FG002|Whole Study|Adverse Event|0|||
41966966|NCT01423851|75766897|FG003|Whole Study|Adverse Event|2|||
41966967|NCT01423851|75766898|FG004|Whole Study|Adverse Event|0|||
41966968|NCT01423851|75766899|FG005|Whole Study|Adverse Event|0|||
41966969|NCT01423851|75766900|FG006|Whole Study|Adverse Event|0|||
41966970|NCT01423851|75766901|FG007|Whole Study|Adverse Event|3|||
41966971|NCT01423851|75766902|FG008|Whole Study|Adverse Event|3|||
41966972|NCT01423851|75766903|FG009|Whole Study|Adverse Event|2|||
41966973|NCT01423851|75766904|FG010|Whole Study|Adverse Event|3|||
41966974|NCT01334606|75766946|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
41966975|NCT01317875|75766962|FG000|Overall Study|Other|0|||
41966976|NCT01317875|75766963|FG001|Overall Study|Other|0|||
41966977|NCT01317875|75766964|FG002|Overall Study|Other|1|||
41966978|NCT01317875|75766965|FG003|Overall Study|Other|0|||
41966979|NCT01317875|75766966|FG004|Overall Study|Other|0|||
41966980|NCT01317875|75766967|FG005|Overall Study|Other|0|||
42124138|NCT00457665|75934542|FG000|24 Months|Withdrawal by Subject|3|||
42124139|NCT00457665|75934543|FG001|24 Months|Withdrawal by Subject|2|||
42124140|NCT00457665|75934542|FG000|24 Months|Lipodystrophy|1|||
42124141|NCT00457665|75934543|FG001|24 Months|Lipodystrophy|1|||
42124142|NCT00457665|75934542|FG000|24 Months|Abnormal liver function tests|1|||
42124143|NCT00457665|75934543|FG001|24 Months|Abnormal liver function tests|5|||
42124144|NCT00447603|75934549|FG000|Screening|Withdrawal by Subject|1|||
42124145|NCT00447603|75934550|FG001|Screening|Withdrawal by Subject|0|||
42124146|NCT00447603|75934551|FG002|Screening|Withdrawal by Subject|0|||
41966981|NCT01317875|75766968|FG006|Overall Study|Other|0|||
41966982|NCT01317875|75766969|FG007|Overall Study|Other|0|||
41966983|NCT01317875|75766970|FG008|Overall Study|Other|0|||
41966984|NCT01317875|75766971|FG009|Overall Study|Other|0|||
41966985|NCT01317875|75766962|FG000|Overall Study|Noncompliance with study drug|0|||
41966986|NCT01317875|75766963|FG001|Overall Study|Noncompliance with study drug|0|||
41966987|NCT01317875|75766964|FG002|Overall Study|Noncompliance with study drug|1|||
41966988|NCT01317875|75766965|FG003|Overall Study|Noncompliance with study drug|0|||
41966989|NCT01317875|75766966|FG004|Overall Study|Noncompliance with study drug|0|||
41966990|NCT01317875|75766967|FG005|Overall Study|Noncompliance with study drug|0|||
41966991|NCT01317875|75766968|FG006|Overall Study|Noncompliance with study drug|0|||
41966992|NCT01317875|75766969|FG007|Overall Study|Noncompliance with study drug|0|||
41966993|NCT01317875|75766970|FG008|Overall Study|Noncompliance with study drug|0|||
41966994|NCT01317875|75766971|FG009|Overall Study|Noncompliance with study drug|0|||
41966995|NCT01317875|75766962|FG000|Overall Study|Progressive Disease|1|||
41966996|NCT01317875|75766963|FG001|Overall Study|Progressive Disease|0|||
41966997|NCT01317875|75766964|FG002|Overall Study|Progressive Disease|2|||
42124147|NCT00447603|75934549|FG000|Screening|Protocol Violation|1|||
41966998|NCT01317875|75766965|FG003|Overall Study|Progressive Disease|0|||
41966999|NCT01317875|75766966|FG004|Overall Study|Progressive Disease|1|||
41967000|NCT01317875|75766967|FG005|Overall Study|Progressive Disease|0|||
41967001|NCT01317875|75766968|FG006|Overall Study|Progressive Disease|0|||
41967002|NCT01317875|75766969|FG007|Overall Study|Progressive Disease|1|||
41967003|NCT01317875|75766970|FG008|Overall Study|Progressive Disease|0|||
41967004|NCT01317875|75766971|FG009|Overall Study|Progressive Disease|0|||
41967005|NCT01317875|75766962|FG000|Overall Study|Withdrawal by Subject|0|||
41967006|NCT01317875|75766963|FG001|Overall Study|Withdrawal by Subject|0|||
41967007|NCT01317875|75766964|FG002|Overall Study|Withdrawal by Subject|0|||
41967008|NCT01317875|75766965|FG003|Overall Study|Withdrawal by Subject|0|||
41967009|NCT01317875|75766966|FG004|Overall Study|Withdrawal by Subject|1|||
41967010|NCT01317875|75766967|FG005|Overall Study|Withdrawal by Subject|0|||
41967011|NCT01317875|75766968|FG006|Overall Study|Withdrawal by Subject|0|||
41967012|NCT01317875|75766969|FG007|Overall Study|Withdrawal by Subject|3|||
41967013|NCT01317875|75766970|FG008|Overall Study|Withdrawal by Subject|0|||
41967014|NCT01317875|75766971|FG009|Overall Study|Withdrawal by Subject|0|||
41967015|NCT01317875|75766962|FG000|Overall Study|Physician Decision|0|||
41967016|NCT01317875|75766963|FG001|Overall Study|Physician Decision|1|||
41967017|NCT01317875|75766964|FG002|Overall Study|Physician Decision|1|||
41967018|NCT01317875|75766965|FG003|Overall Study|Physician Decision|0|||
41967019|NCT01317875|75766966|FG004|Overall Study|Physician Decision|2|||
41967020|NCT01317875|75766967|FG005|Overall Study|Physician Decision|0|||
41967021|NCT01317875|75766968|FG006|Overall Study|Physician Decision|0|||
41967022|NCT01317875|75766969|FG007|Overall Study|Physician Decision|2|||
41967023|NCT01317875|75766970|FG008|Overall Study|Physician Decision|0|||
41967024|NCT01317875|75766971|FG009|Overall Study|Physician Decision|0|||
41967025|NCT01317875|75766962|FG000|Overall Study|Death|0|||
41967026|NCT01317875|75766963|FG001|Overall Study|Death|0|||
41967027|NCT01317875|75766964|FG002|Overall Study|Death|2|||
41967028|NCT01317875|75766965|FG003|Overall Study|Death|1|||
41967029|NCT01317875|75766966|FG004|Overall Study|Death|0|||
41967030|NCT01317875|75766967|FG005|Overall Study|Death|1|||
41967031|NCT01317875|75766968|FG006|Overall Study|Death|0|||
41967032|NCT01317875|75766969|FG007|Overall Study|Death|4|||
41967033|NCT01317875|75766970|FG008|Overall Study|Death|0|||
41967034|NCT01317875|75766971|FG009|Overall Study|Death|0|||
41967035|NCT01317875|75766962|FG000|Overall Study|Adverse Event|2|||
41967036|NCT01317875|75766963|FG001|Overall Study|Adverse Event|1|||
41967037|NCT01317875|75766964|FG002|Overall Study|Adverse Event|2|||
41967038|NCT01317875|75766965|FG003|Overall Study|Adverse Event|1|||
41967039|NCT01317875|75766966|FG004|Overall Study|Adverse Event|5|||
41967040|NCT01317875|75766967|FG005|Overall Study|Adverse Event|1|||
42124148|NCT00447603|75934550|FG001|Screening|Protocol Violation|0|||
42124149|NCT00447603|75934551|FG002|Screening|Protocol Violation|0|||
42124150|NCT00447603|75934549|FG000|Screening|Screen Failure|4|||
42124151|NCT00447603|75934550|FG001|Screening|Screen Failure|0|||
42124152|NCT00447603|75934551|FG002|Screening|Screen Failure|0|||
42124153|NCT00447603|75934549|FG000|Screening|Study Terminated by Sponsor|15|||
42124154|NCT00447603|75934550|FG001|Screening|Study Terminated by Sponsor|0|||
42124155|NCT00447603|75934551|FG002|Screening|Study Terminated by Sponsor|0|||
42124156|NCT00447603|75934549|FG000|Filter Period|Adverse Event|0|||
42124157|NCT00447603|75934550|FG001|Filter Period|Adverse Event|0|||
42124158|NCT00447603|75934551|FG002|Filter Period|Adverse Event|1|||
42124159|NCT00447603|75934549|FG000|Filter Period|Screen Failure|0|||
42124160|NCT00447603|75934550|FG001|Filter Period|Screen Failure|3|||
42124161|NCT00447603|75934551|FG002|Filter Period|Screen Failure|4|||
42124162|NCT00447603|75934549|FG000|Filter Period|Study terminated by Sponsor|0|||
42124163|NCT00447603|75934550|FG001|Filter Period|Study terminated by Sponsor|1|||
42124164|NCT00447603|75934551|FG002|Filter Period|Study terminated by Sponsor|10|||
41967041|NCT01317875|75766968|FG006|Overall Study|Adverse Event|2|||
41967042|NCT01317875|75766969|FG007|Overall Study|Adverse Event|5|||
41967043|NCT01317875|75766970|FG008|Overall Study|Adverse Event|0|||
41967044|NCT01317875|75766971|FG009|Overall Study|Adverse Event|0|||
41967045|NCT00500071|75767047|FG000|Screening and Washout Phase|Protocol Violation|1|||
41967046|NCT00500071|75767047|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
41967047|NCT00500071|75767047|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
41967048|NCT00500071|75767047|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
41967049|NCT00500071|75767047|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
41967050|NCT00500071|75767047|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
41967051|NCT00500071|75767047|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
41967052|NCT00447122|75767055|FG000|Overall Study|worsening medical condition -came off|0|||
41967053|NCT00447122|75767056|FG001|Overall Study|worsening medical condition -came off|1|||
41967054|NCT00447122|75767057|FG002|Overall Study|worsening medical condition -came off|0|||
41967055|NCT00447122|75767058|FG003|Overall Study|worsening medical condition -came off|0|||
41967056|NCT00382252|75767068|FG000|Overall Study|Death|4|||
42124165|NCT00447057|75934563|FG000|Overall Study|Adverse Event|4|||
42124166|NCT00447057|75934564|FG001|Overall Study|Adverse Event|10|||
42124167|NCT00447057|75934565|FG002|Overall Study|Adverse Event|0|||
41967057|NCT00382252|75767068|FG000|Overall Study|Protocol Violation|8|||
41967058|NCT00382252|75767068|FG000|Overall Study|Not treated by RFA|1|||
41967059|NCT00290251|75767075|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
41967060|NCT00290251|75767076|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
41967061|NCT00290251|75767077|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
41967062|NCT00290251|75767078|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
41967063|NCT00290251|75767079|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
41967064|NCT00290251|75767080|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
41967065|NCT00290251|75767075|FG000|Treatment 1 (Months 2-4)|headache|0|||
41967066|NCT00290251|75767076|FG001|Treatment 1 (Months 2-4)|headache|0|||
41967067|NCT00290251|75767077|FG002|Treatment 1 (Months 2-4)|headache|0|||
41967068|NCT00290251|75767078|FG003|Treatment 1 (Months 2-4)|headache|0|||
41967069|NCT00290251|75767079|FG004|Treatment 1 (Months 2-4)|headache|1|||
41967070|NCT00290251|75767080|FG005|Treatment 1 (Months 2-4)|headache|0|||
41967071|NCT00290251|75767075|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
41967072|NCT00290251|75767076|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
41967073|NCT00290251|75767077|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
41967074|NCT00290251|75767078|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
41967075|NCT00290251|75767079|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
41967076|NCT00290251|75767080|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
41967077|NCT01403948|75767116|FG000|Overall Study|Progressive disease|0|||
41967078|NCT01403948|75767117|FG001|Overall Study|Progressive disease|2|||
41967079|NCT01403948|75767118|FG002|Overall Study|Progressive disease|2|||
41967080|NCT01403948|75767119|FG003|Overall Study|Progressive disease|4|||
41967081|NCT01403948|75767120|FG004|Overall Study|Progressive disease|2|||
41967082|NCT01403948|75767121|FG005|Overall Study|Progressive disease|6|||
41967083|NCT01403948|75767122|FG006|Overall Study|Progressive disease|2|||
41967084|NCT01403948|75767123|FG007|Overall Study|Progressive disease|4|||
41967085|NCT01403948|75767124|FG008|Overall Study|Progressive disease|5|||
41967086|NCT01403948|75767125|FG009|Overall Study|Progressive disease|5|||
41967087|NCT01403948|75767116|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
41967088|NCT01403948|75767117|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
41967089|NCT01403948|75767118|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
42027725|NCT01122576|75836015|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
42027726|NCT01122576|75836013|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
42027727|NCT01122576|75836014|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
42027728|NCT01122576|75836015|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
42027729|NCT00965523|75836026|FG000|Study 221|Progressive Disease|4|||
42027730|NCT00965523|75836026|FG000|Study 221|Physician Decision|3|||
42027731|NCT00965523|75836026|FG000|Study 224|Progressive Disease|5|||
42027732|NCT00965523|75836026|FG000|Study 224|Physician Decision|1|||
42027733|NCT01122264|75836033|FG000|Overall Study|Adverse Event|6|||
42027734|NCT01122264|75836034|FG001|Overall Study|Adverse Event|5|||
42027735|NCT01122264|75836035|FG002|Overall Study|Adverse Event|7|||
42027736|NCT01122264|75836033|FG000|Overall Study|Death|1|||
42027737|NCT01122264|75836034|FG001|Overall Study|Death|0|||
42027738|NCT01122264|75836035|FG002|Overall Study|Death|0|||
42027739|NCT01122264|75836033|FG000|Overall Study|Lost to Follow-up|5|||
42027740|NCT01122264|75836034|FG001|Overall Study|Lost to Follow-up|9|||
42027741|NCT01122264|75836035|FG002|Overall Study|Lost to Follow-up|13|||
42027742|NCT01122264|75836033|FG000|Overall Study|Entry Criteria Not Met|1|||
42027743|NCT01122264|75836034|FG001|Overall Study|Entry Criteria Not Met|0|||
42027744|NCT01122264|75836035|FG002|Overall Study|Entry Criteria Not Met|0|||
42027745|NCT01122264|75836033|FG000|Overall Study|Protocol Violation|7|||
42027746|NCT01122264|75836034|FG001|Overall Study|Protocol Violation|7|||
42027747|NCT01122264|75836035|FG002|Overall Study|Protocol Violation|9|||
42027748|NCT01122264|75836033|FG000|Overall Study|Withdrawal by Subject|6|||
42027749|NCT01122264|75836034|FG001|Overall Study|Withdrawal by Subject|6|||
42027750|NCT01122264|75836035|FG002|Overall Study|Withdrawal by Subject|16|||
42124168|NCT00447057|75934566|FG003|Overall Study|Adverse Event|3|||
41967090|NCT01403948|75767119|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
41967091|NCT01403948|75767120|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
41967092|NCT01403948|75767121|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
41967093|NCT01403948|75767122|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
42027751|NCT01122264|75836033|FG000|Overall Study|Physician Decision|3|||
42027752|NCT01122264|75836034|FG001|Overall Study|Physician Decision|1|||
42124169|NCT00447057|75934563|FG000|Overall Study|Death due to study disease|6|||
42124170|NCT00447057|75934564|FG001|Overall Study|Death due to study disease|4|||
42124171|NCT00447057|75934565|FG002|Overall Study|Death due to study disease|1|||
42124172|NCT00447057|75934566|FG003|Overall Study|Death due to study disease|1|||
42124173|NCT00447057|75934563|FG000|Overall Study|Lost to Follow-up|0|||
42124174|NCT00447057|75934564|FG001|Overall Study|Lost to Follow-up|1|||
42124175|NCT00447057|75934565|FG002|Overall Study|Lost to Follow-up|0|||
41967094|NCT01403948|75767123|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
41967095|NCT01403948|75767124|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
41967096|NCT01403948|75767125|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
41967097|NCT01403948|75767116|FG000|Overall Study|Lost to Follow-up|0|||
41967098|NCT01403948|75767117|FG001|Overall Study|Lost to Follow-up|0|||
41967099|NCT01403948|75767118|FG002|Overall Study|Lost to Follow-up|0|||
41967100|NCT01403948|75767119|FG003|Overall Study|Lost to Follow-up|0|||
41967101|NCT01403948|75767120|FG004|Overall Study|Lost to Follow-up|0|||
41967102|NCT01403948|75767121|FG005|Overall Study|Lost to Follow-up|0|||
41967103|NCT01403948|75767122|FG006|Overall Study|Lost to Follow-up|0|||
41967104|NCT01403948|75767123|FG007|Overall Study|Lost to Follow-up|0|||
41967105|NCT01403948|75767124|FG008|Overall Study|Lost to Follow-up|0|||
41967106|NCT01403948|75767125|FG009|Overall Study|Lost to Follow-up|1|||
41967107|NCT01403948|75767116|FG000|Overall Study|Refused cont. medication|0|||
41967108|NCT01403948|75767117|FG001|Overall Study|Refused cont. medication|0|||
41967109|NCT01403948|75767118|FG002|Overall Study|Refused cont. medication|0|||
41967110|NCT01403948|75767119|FG003|Overall Study|Refused cont. medication|0|||
41967111|NCT01403948|75767120|FG004|Overall Study|Refused cont. medication|1|||
41967112|NCT01403948|75767121|FG005|Overall Study|Refused cont. medication|0|||
41967113|NCT01403948|75767122|FG006|Overall Study|Refused cont. medication|0|||
41967114|NCT01403948|75767123|FG007|Overall Study|Refused cont. medication|0|||
41967115|NCT01403948|75767124|FG008|Overall Study|Refused cont. medication|0|||
41967116|NCT01403948|75767125|FG009|Overall Study|Refused cont. medication|1|||
41967117|NCT01403948|75767116|FG000|Overall Study|other than above|1|||
41967118|NCT01403948|75767117|FG001|Overall Study|other than above|2|||
41967119|NCT01403948|75767118|FG002|Overall Study|other than above|1|||
42124176|NCT00447057|75934566|FG003|Overall Study|Lost to Follow-up|0|||
41967120|NCT01403948|75767119|FG003|Overall Study|other than above|0|||
41967121|NCT01403948|75767120|FG004|Overall Study|other than above|1|||
42124177|NCT00447057|75934563|FG000|Overall Study|Entry criteria not met|1|||
42301145|NCT01364389|76136456|FG001|Overall Study|Adverse Event|0|||
42301146|NCT01364389|76136457|FG002|Overall Study|Adverse Event|0|||
42301147|NCT01364233|76136465|FG000|Overall Study|Lost to Follow-up|1|||
42301148|NCT02291289|76136473|FG000|Induction Treatment|Not Dosed|2|||
42301149|NCT02291289|76136474|FG001|Induction Treatment|Not Dosed|0|||
42301150|NCT02291289|76136475|FG002|Induction Treatment|Not Dosed|0|||
42301151|NCT02291289|76136476|FG003|Induction Treatment|Not Dosed|9|||
42301152|NCT02291289|76136477|FG004|Induction Treatment|Not Dosed|0|||
42301153|NCT02291289|76136478|FG005|Induction Treatment|Not Dosed|0|||
42301154|NCT02291289|76136479|FG006|Induction Treatment|Not Dosed|0|||
42301155|NCT02291289|76136480|FG007|Induction Treatment|Not Dosed|0|||
42301156|NCT02291289|76136481|FG008|Induction Treatment|Not Dosed|0|||
42301157|NCT02291289|76136482|FG009|Induction Treatment|Not Dosed|1|||
42301158|NCT02291289|76136483|FG010|Induction Treatment|Not Dosed|0|||
42301159|NCT02291289|76136484|FG011|Induction Treatment|Not Dosed|0|||
42301160|NCT02291289|76136473|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
42301161|NCT02291289|76136474|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
42301162|NCT02291289|76136475|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
42301163|NCT02291289|76136476|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
42301164|NCT02291289|76136477|FG004|Maintenance Treatment Phase|Withdrawal by Subject|13|||
42301165|NCT02291289|76136478|FG005|Maintenance Treatment Phase|Withdrawal by Subject|11|||
42301166|NCT02291289|76136479|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
42301167|NCT02291289|76136480|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
42301168|NCT02291289|76136481|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
42301169|NCT02291289|76136482|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
42301170|NCT02291289|76136483|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
42301171|NCT02291289|76136484|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
42301172|NCT02291289|76136473|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
42301173|NCT02291289|76136474|FG001|Maintenance Treatment Phase|Protocol Violation|1|||
42301174|NCT02291289|76136475|FG002|Maintenance Treatment Phase|Protocol Violation|0|||
42301175|NCT02291289|76136476|FG003|Maintenance Treatment Phase|Protocol Violation|0|||
42301176|NCT02291289|76136477|FG004|Maintenance Treatment Phase|Protocol Violation|2|||
42301177|NCT02291289|76136478|FG005|Maintenance Treatment Phase|Protocol Violation|1|||
42301178|NCT02291289|76136479|FG006|Maintenance Treatment Phase|Protocol Violation|0|||
42301179|NCT02291289|76136480|FG007|Maintenance Treatment Phase|Protocol Violation|0|||
42301180|NCT02291289|76136481|FG008|Maintenance Treatment Phase|Protocol Violation|0|||
42301181|NCT02291289|76136482|FG009|Maintenance Treatment Phase|Protocol Violation|0|||
42301182|NCT02291289|76136483|FG010|Maintenance Treatment Phase|Protocol Violation|0|||
42301183|NCT02291289|76136484|FG011|Maintenance Treatment Phase|Protocol Violation|0|||
42301184|NCT02291289|76136473|FG000|Maintenance Treatment Phase|Death|0|||
42301185|NCT02291289|76136474|FG001|Maintenance Treatment Phase|Death|23|||
42301186|NCT02291289|76136475|FG002|Maintenance Treatment Phase|Death|13|||
42301187|NCT02291289|76136476|FG003|Maintenance Treatment Phase|Death|0|||
42301188|NCT02291289|76136477|FG004|Maintenance Treatment Phase|Death|185|||
42301189|NCT02291289|76136478|FG005|Maintenance Treatment Phase|Death|100|||
42301190|NCT02291289|76136479|FG006|Maintenance Treatment Phase|Death|0|||
42301191|NCT02291289|76136480|FG007|Maintenance Treatment Phase|Death|1|||
42301192|NCT02291289|76136481|FG008|Maintenance Treatment Phase|Death|1|||
42301193|NCT02291289|76136482|FG009|Maintenance Treatment Phase|Death|0|||
42301194|NCT02291289|76136483|FG010|Maintenance Treatment Phase|Death|26|||
42301195|NCT02291289|76136484|FG011|Maintenance Treatment Phase|Death|11|||
42210375|NCT03227445|76025159|FG003|Period 1 (28 Days)|Protocol Violation|0|||
42210376|NCT03227445|76025156|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
42210377|NCT03227445|76025157|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
42210378|NCT03227445|76025158|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
42210379|NCT03227445|76025159|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
42210380|NCT03227445|76025156|FG000|Period 2 (28 Days)|Adverse Event|1|||
42210381|NCT03227445|76025157|FG001|Period 2 (28 Days)|Adverse Event|0|||
42210382|NCT03227445|76025158|FG002|Period 2 (28 Days)|Adverse Event|2|||
42210383|NCT03227445|76025159|FG003|Period 2 (28 Days)|Adverse Event|1|||
42210384|NCT03227445|76025156|FG000|Period 2 (28 Days)|Protocol Violation|0|||
42210385|NCT03227445|76025157|FG001|Period 2 (28 Days)|Protocol Violation|0|||
42210386|NCT03227445|76025158|FG002|Period 2 (28 Days)|Protocol Violation|0|||
42210387|NCT03227445|76025159|FG003|Period 2 (28 Days)|Protocol Violation|1|||
42210388|NCT03227445|76025156|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
42301196|NCT02291289|76136473|FG000|Maintenance Treatment Phase|Adverse Event|0|||
42301197|NCT02291289|76136474|FG001|Maintenance Treatment Phase|Adverse Event|0|||
42301198|NCT02291289|76136475|FG002|Maintenance Treatment Phase|Adverse Event|0|||
42301199|NCT02291289|76136476|FG003|Maintenance Treatment Phase|Adverse Event|0|||
42301200|NCT02291289|76136477|FG004|Maintenance Treatment Phase|Adverse Event|1|||
42301201|NCT02291289|76136478|FG005|Maintenance Treatment Phase|Adverse Event|0|||
42301202|NCT02291289|76136479|FG006|Maintenance Treatment Phase|Adverse Event|0|||
42301203|NCT02291289|76136480|FG007|Maintenance Treatment Phase|Adverse Event|0|||
42301204|NCT02291289|76136481|FG008|Maintenance Treatment Phase|Adverse Event|0|||
42301205|NCT02291289|76136482|FG009|Maintenance Treatment Phase|Adverse Event|0|||
42301206|NCT02291289|76136483|FG010|Maintenance Treatment Phase|Adverse Event|0|||
42301207|NCT02291289|76136484|FG011|Maintenance Treatment Phase|Adverse Event|0|||
42301208|NCT02291289|76136473|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
42301209|NCT02291289|76136474|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
42301210|NCT02291289|76136475|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
42301211|NCT02291289|76136476|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
42301212|NCT02291289|76136477|FG004|Maintenance Treatment Phase|Lost to Follow-up|12|||
42301213|NCT02291289|76136478|FG005|Maintenance Treatment Phase|Lost to Follow-up|3|||
42301214|NCT02291289|76136479|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
42301215|NCT02291289|76136480|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
42301216|NCT02291289|76136481|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
42301217|NCT02291289|76136482|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
42301218|NCT02291289|76136483|FG010|Maintenance Treatment Phase|Lost to Follow-up|2|||
42301219|NCT02291289|76136484|FG011|Maintenance Treatment Phase|Lost to Follow-up|1|||
42301220|NCT02291289|76136473|FG000|Maintenance Treatment Phase|Other|0|||
42301221|NCT02291289|76136474|FG001|Maintenance Treatment Phase|Other|0|||
42301222|NCT02291289|76136475|FG002|Maintenance Treatment Phase|Other|1|||
42301223|NCT02291289|76136476|FG003|Maintenance Treatment Phase|Other|0|||
42301224|NCT02291289|76136477|FG004|Maintenance Treatment Phase|Other|29|||
42301225|NCT02291289|76136478|FG005|Maintenance Treatment Phase|Other|8|||
42301226|NCT02291289|76136479|FG006|Maintenance Treatment Phase|Other|0|||
42301227|NCT02291289|76136480|FG007|Maintenance Treatment Phase|Other|0|||
42301228|NCT02291289|76136481|FG008|Maintenance Treatment Phase|Other|1|||
41967122|NCT01403948|75767121|FG005|Overall Study|other than above|1|||
41967123|NCT01403948|75767122|FG006|Overall Study|other than above|2|||
41967124|NCT01403948|75767123|FG007|Overall Study|other than above|0|||
41967125|NCT01403948|75767124|FG008|Overall Study|other than above|0|||
41967126|NCT01403948|75767125|FG009|Overall Study|other than above|0|||
41967127|NCT01404312|75767153|FG000|Overall Study|Death|21|||
41967128|NCT01404312|75767154|FG001|Overall Study|Death|27|||
41967129|NCT01404312|75767153|FG000|Overall Study|Withdrawal by Subject|15|||
41967130|NCT01404312|75767154|FG001|Overall Study|Withdrawal by Subject|18|||
41967131|NCT01404312|75767153|FG000|Overall Study|Participant Unable to get to clinic|93|||
41967132|NCT01404312|75767154|FG001|Overall Study|Participant Unable to get to clinic|103|||
41967133|NCT01404312|75767153|FG000|Overall Study|Lost to Follow-up|115|||
41967134|NCT01404312|75767154|FG001|Overall Study|Lost to Follow-up|111|||
41967135|NCT01404312|75767153|FG000|Overall Study|Site closed|22|||
41967136|NCT01404312|75767154|FG001|Overall Study|Site closed|21|||
41967137|NCT01404312|75767153|FG000|Overall Study|Participant not willing to adhere to req|31|||
41967138|NCT01404312|75767154|FG001|Overall Study|Participant not willing to adhere to req|29|||
41967139|NCT01404312|75767153|FG000|Overall Study|Severe debilitation, unable to continue|1|||
41967140|NCT01404312|75767154|FG001|Overall Study|Severe debilitation, unable to continue|2|||
41967141|NCT01414608|75767163|FG000|Overall Study|Ineligible|5|||
41967142|NCT01414608|75767164|FG001|Overall Study|Ineligible|2|||
42301229|NCT02291289|76136482|FG009|Maintenance Treatment Phase|Other|0|||
42301230|NCT02291289|76136483|FG010|Maintenance Treatment Phase|Other|0|||
42301231|NCT02291289|76136484|FG011|Maintenance Treatment Phase|Other|0|||
42301232|NCT02291289|76136473|FG000|Maintenance Treatment Phase|Physician Decision|0|||
42301233|NCT02291289|76136474|FG001|Maintenance Treatment Phase|Physician Decision|0|||
42301234|NCT02291289|76136475|FG002|Maintenance Treatment Phase|Physician Decision|0|||
42301235|NCT02291289|76136476|FG003|Maintenance Treatment Phase|Physician Decision|0|||
41967143|NCT01420861|75767174|FG000|Overall Study|Adverse Event|2|||
41967144|NCT01420861|75767174|FG000|Overall Study|Study terminated by Sponsor|7|||
41967145|NCT01420861|75767174|FG000|Overall Study|Screen failure|7|||
41967146|NCT01420861|75767174|FG000|Overall Study|Randomized not Treated|2|||
41967147|NCT01425008|75767197|FG000|Dose Escalation Phase|Progressive Disease|2|||
41967148|NCT01425008|75767198|FG001|Dose Escalation Phase|Progressive Disease|3|||
41967149|NCT01425008|75767199|FG002|Dose Escalation Phase|Progressive Disease|2|||
41967150|NCT01425008|75767200|FG003|Dose Escalation Phase|Progressive Disease|3|||
41967151|NCT01425008|75767201|FG004|Dose Escalation Phase|Progressive Disease|5|||
41967152|NCT01425008|75767202|FG005|Dose Escalation Phase|Progressive Disease|4|||
41967153|NCT01425008|75767203|FG006|Dose Escalation Phase|Progressive Disease|0|||
41967154|NCT01425008|75767204|FG007|Dose Escalation Phase|Progressive Disease|2|||
41967155|NCT01425008|75767205|FG008|Dose Escalation Phase|Progressive Disease|6|||
41967156|NCT01425008|75767206|FG009|Dose Escalation Phase|Progressive Disease|2|||
41967157|NCT01425008|75767207|FG010|Dose Escalation Phase|Progressive Disease|0|||
41967158|NCT01425008|75767208|FG011|Dose Escalation Phase|Progressive Disease|0|||
41967159|NCT01425008|75767209|FG012|Dose Escalation Phase|Progressive Disease|0|||
41967160|NCT01425008|75767210|FG013|Dose Escalation Phase|Progressive Disease|0|||
41967161|NCT01425008|75767211|FG014|Dose Escalation Phase|Progressive Disease|0|||
41967162|NCT01425008|75767212|FG015|Dose Escalation Phase|Progressive Disease|0|||
42301236|NCT02291289|76136477|FG004|Maintenance Treatment Phase|Physician Decision|2|||
42301237|NCT02291289|76136478|FG005|Maintenance Treatment Phase|Physician Decision|0|||
42301238|NCT02291289|76136479|FG006|Maintenance Treatment Phase|Physician Decision|0|||
42301239|NCT02291289|76136480|FG007|Maintenance Treatment Phase|Physician Decision|0|||
42301240|NCT02291289|76136481|FG008|Maintenance Treatment Phase|Physician Decision|0|||
41967163|NCT01425008|75767213|FG016|Dose Escalation Phase|Progressive Disease|0|||
41967164|NCT01425008|75767214|FG017|Dose Escalation Phase|Progressive Disease|0|||
41967165|NCT01425008|75767215|FG018|Dose Escalation Phase|Progressive Disease|0|||
41967166|NCT01425008|75767197|FG000|Dose Escalation Phase|Adverse Event|2|||
41967167|NCT01425008|75767198|FG001|Dose Escalation Phase|Adverse Event|0|||
41967168|NCT01425008|75767199|FG002|Dose Escalation Phase|Adverse Event|0|||
41967169|NCT01425008|75767200|FG003|Dose Escalation Phase|Adverse Event|0|||
41967170|NCT01425008|75767201|FG004|Dose Escalation Phase|Adverse Event|0|||
41967171|NCT01425008|75767202|FG005|Dose Escalation Phase|Adverse Event|2|||
41967172|NCT01425008|75767203|FG006|Dose Escalation Phase|Adverse Event|0|||
41967173|NCT01425008|75767204|FG007|Dose Escalation Phase|Adverse Event|0|||
41967174|NCT01425008|75767205|FG008|Dose Escalation Phase|Adverse Event|2|||
41967175|NCT01425008|75767206|FG009|Dose Escalation Phase|Adverse Event|0|||
41967176|NCT01425008|75767207|FG010|Dose Escalation Phase|Adverse Event|0|||
41967177|NCT01425008|75767208|FG011|Dose Escalation Phase|Adverse Event|0|||
41967178|NCT01425008|75767209|FG012|Dose Escalation Phase|Adverse Event|0|||
41967179|NCT01425008|75767210|FG013|Dose Escalation Phase|Adverse Event|0|||
41967180|NCT01425008|75767211|FG014|Dose Escalation Phase|Adverse Event|0|||
41967181|NCT01425008|75767212|FG015|Dose Escalation Phase|Adverse Event|0|||
41967182|NCT01425008|75767213|FG016|Dose Escalation Phase|Adverse Event|0|||
41967183|NCT01425008|75767214|FG017|Dose Escalation Phase|Adverse Event|0|||
41967184|NCT01425008|75767215|FG018|Dose Escalation Phase|Adverse Event|0|||
41967185|NCT01425008|75767197|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967186|NCT01425008|75767198|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967187|NCT01425008|75767199|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967188|NCT01425008|75767200|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967189|NCT01425008|75767201|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
41967190|NCT01425008|75767202|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967191|NCT01425008|75767203|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
41967192|NCT01425008|75767204|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
41967193|NCT01425008|75767205|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
41967194|NCT01425008|75767206|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967195|NCT01425008|75767207|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967196|NCT01425008|75767208|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967197|NCT01425008|75767209|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967198|NCT01425008|75767210|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967199|NCT01425008|75767211|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967200|NCT01425008|75767212|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967201|NCT01425008|75767213|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
42301241|NCT02291289|76136482|FG009|Maintenance Treatment Phase|Physician Decision|0|||
42301242|NCT02291289|76136483|FG010|Maintenance Treatment Phase|Physician Decision|0|||
42301243|NCT02291289|76136484|FG011|Maintenance Treatment Phase|Physician Decision|1|||
42301244|NCT02291289|76136473|FG000|Maintenance Treatment Phase|Multiple Reasons|0|||
42301245|NCT02291289|76136474|FG001|Maintenance Treatment Phase|Multiple Reasons|0|||
42301246|NCT02291289|76136475|FG002|Maintenance Treatment Phase|Multiple Reasons|0|||
42301247|NCT02291289|76136476|FG003|Maintenance Treatment Phase|Multiple Reasons|0|||
42301248|NCT02291289|76136477|FG004|Maintenance Treatment Phase|Multiple Reasons|4|||
42301249|NCT02291289|76136478|FG005|Maintenance Treatment Phase|Multiple Reasons|1|||
42301250|NCT02291289|76136479|FG006|Maintenance Treatment Phase|Multiple Reasons|0|||
42301251|NCT02291289|76136480|FG007|Maintenance Treatment Phase|Multiple Reasons|0|||
42301252|NCT02291289|76136481|FG008|Maintenance Treatment Phase|Multiple Reasons|0|||
42301253|NCT02291289|76136482|FG009|Maintenance Treatment Phase|Multiple Reasons|0|||
42301254|NCT02291289|76136483|FG010|Maintenance Treatment Phase|Multiple Reasons|0|||
42301255|NCT02291289|76136484|FG011|Maintenance Treatment Phase|Multiple Reasons|0|||
42301256|NCT02291289|76136473|FG000|Maintenance Treatment Phase|No Treatment Received|0|||
42301257|NCT02291289|76136474|FG001|Maintenance Treatment Phase|No Treatment Received|0|||
42301258|NCT02291289|76136475|FG002|Maintenance Treatment Phase|No Treatment Received|2|||
42301259|NCT02291289|76136476|FG003|Maintenance Treatment Phase|No Treatment Received|0|||
42301260|NCT02291289|76136477|FG004|Maintenance Treatment Phase|No Treatment Received|4|||
42301261|NCT02291289|76136478|FG005|Maintenance Treatment Phase|No Treatment Received|5|||
41967202|NCT01425008|75767214|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967203|NCT01425008|75767215|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
41967204|NCT01425008|75767197|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
41967205|NCT01425008|75767198|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
41967206|NCT01425008|75767199|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
42301262|NCT02291289|76136479|FG006|Maintenance Treatment Phase|No Treatment Received|0|||
42301263|NCT02291289|76136480|FG007|Maintenance Treatment Phase|No Treatment Received|0|||
42301264|NCT02291289|76136481|FG008|Maintenance Treatment Phase|No Treatment Received|0|||
42301265|NCT02291289|76136482|FG009|Maintenance Treatment Phase|No Treatment Received|0|||
42301266|NCT02291289|76136483|FG010|Maintenance Treatment Phase|No Treatment Received|1|||
42301267|NCT02291289|76136484|FG011|Maintenance Treatment Phase|No Treatment Received|0|||
42301268|NCT02317575|76136509|FG000|Period 1|Difficulty with venous cannulation|0|||
42301269|NCT02317575|76136510|FG001|Period 1|Difficulty with venous cannulation|1|||
42301270|NCT02317575|76136511|FG002|Period 1|Difficulty with venous cannulation|0|||
42301271|NCT02317575|76136512|FG003|Period 1|Difficulty with venous cannulation|0|||
42301272|NCT02317575|76136513|FG004|Period 1|Difficulty with venous cannulation|0|||
42301273|NCT02317575|76136509|FG000|Period 1|Withdrawal by Subject|1|||
42301274|NCT02317575|76136510|FG001|Period 1|Withdrawal by Subject|0|||
42301275|NCT02317575|76136511|FG002|Period 1|Withdrawal by Subject|0|||
42301276|NCT02317575|76136512|FG003|Period 1|Withdrawal by Subject|0|||
42301277|NCT02317575|76136513|FG004|Period 1|Withdrawal by Subject|0|||
42301278|NCT02316717|76136534|FG000|Overall Study|Adverse Event|2|||
42301279|NCT02316717|76136535|FG001|Overall Study|Adverse Event|2|||
42301280|NCT02316717|76136536|FG002|Overall Study|Adverse Event|0|||
42301281|NCT02316717|76136534|FG000|Overall Study|Lost to Follow-up|1|||
42301282|NCT02316717|76136535|FG001|Overall Study|Lost to Follow-up|2|||
42301283|NCT02316717|76136536|FG002|Overall Study|Lost to Follow-up|1|||
42301284|NCT02316717|76136534|FG000|Overall Study|Non compliance|3|||
42301285|NCT02316717|76136535|FG001|Overall Study|Non compliance|1|||
42301286|NCT02316717|76136536|FG002|Overall Study|Non compliance|0|||
42301287|NCT02316717|76136534|FG000|Overall Study|Protocol Violation|2|||
42301288|NCT02316717|76136535|FG001|Overall Study|Protocol Violation|0|||
42301289|NCT02316717|76136536|FG002|Overall Study|Protocol Violation|0|||
42301290|NCT02316717|76136534|FG000|Overall Study|Withdrawal by Subject|2|||
42301291|NCT02316717|76136535|FG001|Overall Study|Withdrawal by Subject|1|||
42301292|NCT02316717|76136536|FG002|Overall Study|Withdrawal by Subject|1|||
42301293|NCT02316717|76136534|FG000|Overall Study|Death|0|||
42301294|NCT02316717|76136535|FG001|Overall Study|Death|0|||
42301295|NCT02316717|76136536|FG002|Overall Study|Death|1|||
42301296|NCT02316717|76136534|FG000|Overall Study|Physician Decision|0|||
42301297|NCT02316717|76136535|FG001|Overall Study|Physician Decision|1|||
42301298|NCT02316717|76136536|FG002|Overall Study|Physician Decision|0|||
42301299|NCT02316717|76136534|FG000|Overall Study|TBC|1|||
42301300|NCT02316717|76136535|FG001|Overall Study|TBC|0|||
42301301|NCT02316717|76136536|FG002|Overall Study|TBC|0|||
42301302|NCT02290821|76136549|FG000|Overall Study|Withdrawal by Subject|1|||
42301303|NCT02290821|76136550|FG001|Overall Study|Withdrawal by Subject|1|||
42301304|NCT02290821|76136549|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
42301305|NCT02290821|76136550|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
42301306|NCT02290821|76136549|FG000|Overall Study|Lost to Follow-up|3|||
42301307|NCT02290821|76136550|FG001|Overall Study|Lost to Follow-up|2|||
42301308|NCT02289963|76136558|FG000|Overall Study|Adverse Event|1|||
42301309|NCT02289963|76136559|FG001|Overall Study|Adverse Event|2|||
42301310|NCT02289963|76136558|FG000|Overall Study|Poor compliance to protocol|1|||
42301311|NCT02289963|76136559|FG001|Overall Study|Poor compliance to protocol|0|||
42301312|NCT02289963|76136558|FG000|Overall Study|Withdrawal by Subject|1|||
42301313|NCT02289963|76136559|FG001|Overall Study|Withdrawal by Subject|0|||
42301314|NCT02289963|76136558|FG000|Overall Study|Last injection missed|2|||
42301315|NCT02289963|76136559|FG001|Overall Study|Last injection missed|2|||
42301316|NCT02289963|76136558|FG000|Overall Study|End treatment visit outside visit window|0|||
42301317|NCT02289963|76136559|FG001|Overall Study|End treatment visit outside visit window|4|||
42301318|NCT02289963|76136558|FG000|Overall Study|Other than specified above|0|||
41967207|NCT01425008|75767200|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
41967208|NCT01425008|75767201|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
42301319|NCT02289963|76136559|FG001|Overall Study|Other than specified above|2|||
42301320|NCT02358369|76136568|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
42301321|NCT02358369|76136569|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
42301322|NCT02358369|76136570|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
42301323|NCT02358369|76136571|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
42301324|NCT02358369|76136572|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
42301325|NCT02358369|76136568|FG000|Treatment Period A/B|Adverse Event|0|||
42301326|NCT02358369|76136569|FG001|Treatment Period A/B|Adverse Event|0|||
42301327|NCT02358369|76136570|FG002|Treatment Period A/B|Adverse Event|1|||
42301328|NCT02358369|76136571|FG003|Treatment Period A/B|Adverse Event|2|||
42301329|NCT02358369|76136572|FG004|Treatment Period A/B|Adverse Event|0|||
42301330|NCT02358369|76136568|FG000|Treatment Period A/B|Death|0|||
42301331|NCT02358369|76136569|FG001|Treatment Period A/B|Death|0|||
42301332|NCT02358369|76136570|FG002|Treatment Period A/B|Death|1|||
42301333|NCT02358369|76136571|FG003|Treatment Period A/B|Death|0|||
42301334|NCT02358369|76136572|FG004|Treatment Period A/B|Death|0|||
42301335|NCT02358369|76136568|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
42301336|NCT02358369|76136569|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
42301337|NCT02358369|76136570|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
42301338|NCT02358369|76136571|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
42301339|NCT02358369|76136572|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
42301340|NCT02358369|76136568|FG000|Treatment Period C|Adverse Event|0|||
42301341|NCT02358369|76136569|FG001|Treatment Period C|Adverse Event|0|||
42301342|NCT02358369|76136570|FG002|Treatment Period C|Adverse Event|0|||
41967209|NCT01425008|75767202|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
41967210|NCT01425008|75767203|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
41967211|NCT01425008|75767204|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
41967212|NCT01425008|75767205|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
41967213|NCT01425008|75767206|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
41967214|NCT01425008|75767207|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
41967215|NCT01425008|75767208|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
41967216|NCT01425008|75767209|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
41967217|NCT01425008|75767210|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
41967218|NCT01425008|75767211|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
41967219|NCT01425008|75767212|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
41967220|NCT01425008|75767213|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
41967221|NCT01425008|75767214|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
41967222|NCT01425008|75767215|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
41967223|NCT01425008|75767197|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967224|NCT01425008|75767198|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967225|NCT01425008|75767199|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
41967226|NCT01425008|75767200|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967227|NCT01425008|75767201|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967228|NCT01425008|75767202|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967229|NCT01425008|75767203|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967230|NCT01425008|75767204|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967231|NCT01425008|75767205|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
41967232|NCT01425008|75767206|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
41967233|NCT01425008|75767207|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967234|NCT01425008|75767208|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967235|NCT01425008|75767209|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
42301343|NCT02358369|76136571|FG003|Treatment Period C|Adverse Event|0|||
42301344|NCT02358369|76136572|FG004|Treatment Period C|Adverse Event|7|||
42301345|NCT02316171|76136584|FG000|Overall Study|difficulties with urinary catheter|1|||
42301346|NCT02316171|76136585|FG001|Overall Study|difficulties with urinary catheter|0|||
42301347|NCT02316171|76136586|FG002|Overall Study|difficulties with urinary catheter|0|||
42301348|NCT02316171|76136587|FG003|Overall Study|difficulties with urinary catheter|0|||
42301349|NCT02289729|76136593|FG000|Overall Study|Lack of Efficacy|3|||
42301350|NCT02289729|76136593|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
42301351|NCT02289729|76136593|FG000|Overall Study|Withdrawal by Subject|1|||
42301352|NCT02289729|76136593|FG000|Overall Study|Death|1|||
42301353|NCT02315625|76136599|FG000|First Intervention|Disease Progression|1|||
42301354|NCT02315625|76136600|FG001|First Intervention|Disease Progression|0|||
42301355|NCT02315625|76136599|FG000|Second Intervention|Physician Decision|2|||
42301356|NCT02315625|76136600|FG001|Second Intervention|Physician Decision|1|||
42301357|NCT02315625|76136599|FG000|Second Intervention|Study closure|1|||
42301358|NCT02315625|76136600|FG001|Second Intervention|Study closure|0|||
41967236|NCT01425008|75767210|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967237|NCT01425008|75767211|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967238|NCT01425008|75767212|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967239|NCT01425008|75767213|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967240|NCT01425008|75767214|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
42027753|NCT01122264|75836035|FG002|Overall Study|Physician Decision|1|||
42301359|NCT02315625|76136599|FG000|Second Intervention|Disease Progression|1|||
42301360|NCT02315625|76136600|FG001|Second Intervention|Disease Progression|0|||
42301361|NCT02357979|76136610|FG000|Overall Study|Lost to Follow-up|5|||
42301362|NCT02357979|76136611|FG001|Overall Study|Lost to Follow-up|5|||
42301363|NCT02357901|76136620|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
42301364|NCT02357901|76136621|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
42301365|NCT02357901|76136622|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
42301366|NCT02357901|76136623|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
42301367|NCT02357901|76136620|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
42301368|NCT02357901|76136621|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
42301369|NCT02357901|76136622|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
42301370|NCT02357901|76136623|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
42301371|NCT02357901|76136620|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
42301372|NCT02357901|76136621|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
42301373|NCT02357901|76136622|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
42301374|NCT02357901|76136623|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
42301375|NCT02357901|76136620|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
42301376|NCT02357901|76136621|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
42301377|NCT02357901|76136622|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
42301378|NCT02357901|76136623|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
42301379|NCT02357901|76136620|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
42301380|NCT02357901|76136621|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
42301381|NCT02357901|76136622|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
42301382|NCT02357901|76136623|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
42301383|NCT02357901|76136620|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
42301384|NCT02357901|76136621|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
42301385|NCT02357901|76136622|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
42301386|NCT02357901|76136623|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
42301387|NCT02357901|76136620|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
42301388|NCT02357901|76136621|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
42301389|NCT02357901|76136622|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
42301390|NCT02357901|76136623|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
42301391|NCT02357901|76136620|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
42301392|NCT02357901|76136621|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
42301393|NCT02357901|76136622|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
42301394|NCT02357901|76136623|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
42301395|NCT02357901|76136620|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
42301396|NCT02357901|76136621|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
42301397|NCT02357901|76136622|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
42301398|NCT02357901|76136623|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
42301399|NCT02357901|76136620|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
42301400|NCT02357901|76136621|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
42301401|NCT02357901|76136622|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
42301402|NCT02357901|76136623|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
42301403|NCT02357901|76136620|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
42301404|NCT02357901|76136621|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
42301405|NCT02357901|76136622|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
42301406|NCT02357901|76136623|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
42301407|NCT01601847|76136633|FG000|Overall Study|Death|1|||
42301408|NCT01601847|76136634|FG001|Overall Study|Death|0|||
42301409|NCT01601847|76136633|FG000|Overall Study|Withdrawal by Subject|11|||
42301410|NCT01601847|76136634|FG001|Overall Study|Withdrawal by Subject|7|||
42301411|NCT01601847|76136633|FG000|Overall Study|Lost to Follow-up|1|||
42301412|NCT01601847|76136634|FG001|Overall Study|Lost to Follow-up|3|||
42301413|NCT02515669|76136644|FG000|228 Week Open-Label Phase|Other|0|||
42301414|NCT02515669|76136645|FG001|228 Week Open-Label Phase|Other|0|||
42301415|NCT02515669|76136646|FG002|228 Week Open-Label Phase|Other|1|||
42301416|NCT02515669|76136647|FG003|228 Week Open-Label Phase|Other|4|||
42301417|NCT02515669|76136644|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
42301418|NCT02515669|76136645|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
42301419|NCT02515669|76136646|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
42301420|NCT02515669|76136647|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
42301421|NCT02515669|76136644|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
42301422|NCT02515669|76136645|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
42301423|NCT02515669|76136646|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
42301424|NCT02515669|76136647|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
41967241|NCT01425008|75767215|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
41967242|NCT01425008|75767197|FG000|Dose Escalation Phase|Other|0|||
41967243|NCT01425008|75767198|FG001|Dose Escalation Phase|Other|0|||
42301425|NCT02515669|76136644|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
42301426|NCT02515669|76136645|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
42301427|NCT02515669|76136646|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
41967244|NCT01425008|75767199|FG002|Dose Escalation Phase|Other|0|||
41967245|NCT01425008|75767200|FG003|Dose Escalation Phase|Other|0|||
41967246|NCT01425008|75767201|FG004|Dose Escalation Phase|Other|0|||
41967247|NCT01425008|75767202|FG005|Dose Escalation Phase|Other|0|||
41967248|NCT01425008|75767203|FG006|Dose Escalation Phase|Other|0|||
41967249|NCT01425008|75767204|FG007|Dose Escalation Phase|Other|0|||
41967250|NCT01425008|75767205|FG008|Dose Escalation Phase|Other|1|||
41967251|NCT01425008|75767206|FG009|Dose Escalation Phase|Other|0|||
41967252|NCT01425008|75767207|FG010|Dose Escalation Phase|Other|0|||
41967253|NCT01425008|75767208|FG011|Dose Escalation Phase|Other|0|||
41967254|NCT01425008|75767209|FG012|Dose Escalation Phase|Other|0|||
41967255|NCT01425008|75767210|FG013|Dose Escalation Phase|Other|0|||
41967256|NCT01425008|75767211|FG014|Dose Escalation Phase|Other|0|||
41967257|NCT01425008|75767212|FG015|Dose Escalation Phase|Other|0|||
41967258|NCT01425008|75767213|FG016|Dose Escalation Phase|Other|0|||
41967259|NCT01425008|75767214|FG017|Dose Escalation Phase|Other|0|||
41967260|NCT01425008|75767215|FG018|Dose Escalation Phase|Other|0|||
41967261|NCT01425008|75767197|FG000|Dose Expansion Phase|Progressive Disease|0|||
41967262|NCT01425008|75767198|FG001|Dose Expansion Phase|Progressive Disease|0|||
41967263|NCT01425008|75767199|FG002|Dose Expansion Phase|Progressive Disease|0|||
41967264|NCT01425008|75767200|FG003|Dose Expansion Phase|Progressive Disease|0|||
41967265|NCT01425008|75767201|FG004|Dose Expansion Phase|Progressive Disease|0|||
41967266|NCT01425008|75767202|FG005|Dose Expansion Phase|Progressive Disease|0|||
41967267|NCT01425008|75767203|FG006|Dose Expansion Phase|Progressive Disease|0|||
41967268|NCT01425008|75767204|FG007|Dose Expansion Phase|Progressive Disease|0|||
41967269|NCT01425008|75767205|FG008|Dose Expansion Phase|Progressive Disease|0|||
41967270|NCT01425008|75767206|FG009|Dose Expansion Phase|Progressive Disease|0|||
41967271|NCT01425008|75767207|FG010|Dose Expansion Phase|Progressive Disease|10|||
41967272|NCT01425008|75767208|FG011|Dose Expansion Phase|Progressive Disease|4|||
41967273|NCT01425008|75767209|FG012|Dose Expansion Phase|Progressive Disease|12|||
41967274|NCT01425008|75767210|FG013|Dose Expansion Phase|Progressive Disease|1|||
41967275|NCT01425008|75767211|FG014|Dose Expansion Phase|Progressive Disease|5|||
41967276|NCT01425008|75767212|FG015|Dose Expansion Phase|Progressive Disease|8|||
41967277|NCT01425008|75767213|FG016|Dose Expansion Phase|Progressive Disease|9|||
41967278|NCT01425008|75767214|FG017|Dose Expansion Phase|Progressive Disease|2|||
41967279|NCT01425008|75767215|FG018|Dose Expansion Phase|Progressive Disease|10|||
42210389|NCT03227445|76025157|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
42210390|NCT03227445|76025158|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
41967280|NCT01425008|75767197|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
41967281|NCT01425008|75767198|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
41967282|NCT01425008|75767199|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
41967283|NCT01425008|75767200|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
41967284|NCT01425008|75767201|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
41967285|NCT01425008|75767202|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
41967286|NCT01425008|75767203|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
41967287|NCT01425008|75767204|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
41967288|NCT01425008|75767205|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
41967289|NCT01425008|75767206|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
41967290|NCT01425008|75767207|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
41967291|NCT01425008|75767208|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
41967292|NCT01425008|75767209|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
41967293|NCT01425008|75767210|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
41967294|NCT01425008|75767211|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
41967295|NCT01425008|75767212|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
41967296|NCT01425008|75767213|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
41967297|NCT01425008|75767214|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
41967298|NCT01425008|75767215|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
41967299|NCT01425008|75767197|FG000|Dose Expansion Phase|Other|0|||
41967300|NCT01425008|75767198|FG001|Dose Expansion Phase|Other|0|||
41967301|NCT01425008|75767199|FG002|Dose Expansion Phase|Other|0|||
41967302|NCT01425008|75767200|FG003|Dose Expansion Phase|Other|0|||
41967303|NCT01425008|75767201|FG004|Dose Expansion Phase|Other|0|||
41967304|NCT01425008|75767202|FG005|Dose Expansion Phase|Other|0|||
41967305|NCT01425008|75767203|FG006|Dose Expansion Phase|Other|0|||
41967306|NCT01425008|75767204|FG007|Dose Expansion Phase|Other|0|||
41967307|NCT01425008|75767205|FG008|Dose Expansion Phase|Other|0|||
41967308|NCT01425008|75767206|FG009|Dose Expansion Phase|Other|0|||
41967309|NCT01425008|75767207|FG010|Dose Expansion Phase|Other|0|||
41967310|NCT01425008|75767208|FG011|Dose Expansion Phase|Other|0|||
41967311|NCT01425008|75767209|FG012|Dose Expansion Phase|Other|1|||
41967312|NCT01425008|75767210|FG013|Dose Expansion Phase|Other|0|||
41967313|NCT01425008|75767211|FG014|Dose Expansion Phase|Other|0|||
41967314|NCT01425008|75767212|FG015|Dose Expansion Phase|Other|0|||
41967315|NCT01425008|75767213|FG016|Dose Expansion Phase|Other|2|||
41967316|NCT01425008|75767214|FG017|Dose Expansion Phase|Other|0|||
41967317|NCT01425008|75767215|FG018|Dose Expansion Phase|Other|4|||
41967318|NCT01425008|75767197|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967319|NCT01425008|75767198|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967320|NCT01425008|75767199|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967321|NCT01425008|75767200|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967322|NCT01425008|75767201|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967323|NCT01425008|75767202|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967324|NCT01425008|75767203|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967325|NCT01425008|75767204|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967326|NCT01425008|75767205|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967327|NCT01425008|75767206|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967328|NCT01425008|75767207|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
41967329|NCT01425008|75767208|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
41967330|NCT01425008|75767209|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967331|NCT01425008|75767210|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967332|NCT01425008|75767211|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967333|NCT01425008|75767212|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
41967334|NCT01425008|75767213|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
41967335|NCT01425008|75767214|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
41967336|NCT01425008|75767215|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
41967337|NCT01425008|75767197|FG000|Dose Expansion Phase|Adverse Event|0|||
41967338|NCT01425008|75767198|FG001|Dose Expansion Phase|Adverse Event|0|||
41967339|NCT01425008|75767199|FG002|Dose Expansion Phase|Adverse Event|0|||
41967340|NCT01425008|75767200|FG003|Dose Expansion Phase|Adverse Event|0|||
42124178|NCT00447057|75934564|FG001|Overall Study|Entry criteria not met|1|||
42124179|NCT00447057|75934565|FG002|Overall Study|Entry criteria not met|0|||
42124180|NCT00447057|75934566|FG003|Overall Study|Entry criteria not met|0|||
42124181|NCT00447057|75934563|FG000|Overall Study|Protocol Violation|0|||
42124182|NCT00447057|75934564|FG001|Overall Study|Protocol Violation|1|||
42124183|NCT00447057|75934565|FG002|Overall Study|Protocol Violation|0|||
42124184|NCT00447057|75934566|FG003|Overall Study|Protocol Violation|0|||
42301428|NCT02515669|76136647|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
42301429|NCT02515669|76136644|FG000|228 Week Open-Label Phase|Missing|0|||
42301430|NCT02515669|76136645|FG001|228 Week Open-Label Phase|Missing|2|||
42301431|NCT02515669|76136646|FG002|228 Week Open-Label Phase|Missing|2|||
42301432|NCT02515669|76136647|FG003|228 Week Open-Label Phase|Missing|2|||
42301433|NCT02515279|76136677|FG000|Overall Study|Adverse Event|7|||
42301434|NCT02515279|76136677|FG000|Overall Study|Lack of Efficacy|31|||
42301435|NCT02515279|76136677|FG000|Overall Study|Lost to Follow-up|9|||
42301436|NCT02515279|76136677|FG000|Overall Study|Withdrawal by Subject|18|||
42301437|NCT02515279|76136677|FG000|Overall Study|End-of-treatment visit not attended|17|||
42301438|NCT02515279|76136677|FG000|Overall Study|Other|22|||
42124185|NCT00447057|75934563|FG000|Overall Study|Withdrawal by Subject|4|||
42124186|NCT00447057|75934564|FG001|Overall Study|Withdrawal by Subject|5|||
42301439|NCT02515045|76136683|FG000|Overall Study|Adverse Event|0|||
41967341|NCT01425008|75767201|FG004|Dose Expansion Phase|Adverse Event|0|||
42027754|NCT01122264|75836033|FG000|Overall Study|Lack of Efficacy|3|||
42027755|NCT01122264|75836034|FG001|Overall Study|Lack of Efficacy|1|||
42124187|NCT00447057|75934565|FG002|Overall Study|Withdrawal by Subject|1|||
42124188|NCT00447057|75934566|FG003|Overall Study|Withdrawal by Subject|1|||
42124189|NCT00447057|75934563|FG000|Overall Study|Physician Decision|9|||
42124190|NCT00447057|75934564|FG001|Overall Study|Physician Decision|6|||
42124191|NCT00447057|75934565|FG002|Overall Study|Physician Decision|3|||
41967342|NCT01425008|75767202|FG005|Dose Expansion Phase|Adverse Event|0|||
41967343|NCT01425008|75767203|FG006|Dose Expansion Phase|Adverse Event|0|||
41967344|NCT01425008|75767204|FG007|Dose Expansion Phase|Adverse Event|0|||
42124192|NCT00447057|75934566|FG003|Overall Study|Physician Decision|1|||
42124193|NCT00447057|75934563|FG000|Overall Study|Sponsor decision|1|||
42124194|NCT00447057|75934564|FG001|Overall Study|Sponsor decision|1|||
41967345|NCT01425008|75767205|FG008|Dose Expansion Phase|Adverse Event|0|||
41967346|NCT01425008|75767206|FG009|Dose Expansion Phase|Adverse Event|0|||
41967347|NCT01425008|75767207|FG010|Dose Expansion Phase|Adverse Event|2|||
41967348|NCT01425008|75767208|FG011|Dose Expansion Phase|Adverse Event|3|||
41967349|NCT01425008|75767209|FG012|Dose Expansion Phase|Adverse Event|3|||
41967350|NCT01425008|75767210|FG013|Dose Expansion Phase|Adverse Event|0|||
41967351|NCT01425008|75767211|FG014|Dose Expansion Phase|Adverse Event|1|||
41967352|NCT01425008|75767212|FG015|Dose Expansion Phase|Adverse Event|1|||
41967353|NCT01425008|75767213|FG016|Dose Expansion Phase|Adverse Event|5|||
41967354|NCT01425008|75767214|FG017|Dose Expansion Phase|Adverse Event|0|||
41967355|NCT01425008|75767215|FG018|Dose Expansion Phase|Adverse Event|3|||
41967356|NCT01425008|75767197|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
41967357|NCT01425008|75767198|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
41967358|NCT01425008|75767199|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
41967359|NCT01425008|75767200|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
41967360|NCT01425008|75767201|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
41967361|NCT01425008|75767202|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
41967362|NCT01425008|75767203|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
41967363|NCT01425008|75767204|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
41967364|NCT01425008|75767205|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
41967365|NCT01425008|75767206|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
41967366|NCT01425008|75767207|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
41967367|NCT01425008|75767208|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
41967368|NCT01425008|75767209|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
41967369|NCT01425008|75767210|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
41967370|NCT01425008|75767211|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
41967371|NCT01425008|75767212|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
41967372|NCT01425008|75767213|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
41967373|NCT01425008|75767214|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
41967374|NCT01425008|75767215|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
41967375|NCT01425008|75767197|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967376|NCT01425008|75767198|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967377|NCT01425008|75767199|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967378|NCT01425008|75767200|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
42027756|NCT01122264|75836035|FG002|Overall Study|Lack of Efficacy|1|||
42027757|NCT00920218|75836051|FG000|Overall Study|Serious Adverse Event|2|||
42027758|NCT00920218|75836052|FG001|Overall Study|Serious Adverse Event|0|||
42027759|NCT00920218|75836053|FG002|Overall Study|Serious Adverse Event|2|||
42027760|NCT00920218|75836054|FG003|Overall Study|Serious Adverse Event|1|||
42027761|NCT00920218|75836051|FG000|Overall Study|Withdrawal by Subject|0|||
42027762|NCT00920218|75836052|FG001|Overall Study|Withdrawal by Subject|3|||
42027763|NCT00920218|75836053|FG002|Overall Study|Withdrawal by Subject|2|||
42027764|NCT00920218|75836054|FG003|Overall Study|Withdrawal by Subject|0|||
42027765|NCT00920218|75836051|FG000|Overall Study|Migrated/moved from study area|0|||
42027766|NCT00920218|75836052|FG001|Overall Study|Migrated/moved from study area|0|||
42027767|NCT00920218|75836053|FG002|Overall Study|Migrated/moved from study area|1|||
42027768|NCT00920218|75836054|FG003|Overall Study|Migrated/moved from study area|0|||
41967379|NCT01425008|75767201|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967380|NCT01425008|75767202|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967381|NCT01425008|75767203|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967382|NCT01425008|75767204|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967383|NCT01425008|75767205|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967384|NCT01425008|75767206|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
42027769|NCT00920218|75836051|FG000|Overall Study|Lost to Follow-up|0|||
42027770|NCT00920218|75836052|FG001|Overall Study|Lost to Follow-up|1|||
42027771|NCT00920218|75836053|FG002|Overall Study|Lost to Follow-up|0|||
42027772|NCT00920218|75836054|FG003|Overall Study|Lost to Follow-up|3|||
42027773|NCT00920218|75836051|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
42027774|NCT00920218|75836052|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
41967385|NCT01425008|75767207|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967386|NCT01425008|75767208|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967387|NCT01425008|75767209|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967388|NCT01425008|75767210|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967389|NCT01425008|75767211|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967390|NCT01425008|75767212|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967391|NCT01425008|75767213|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967392|NCT01425008|75767214|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
41967393|NCT01425008|75767215|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
41967394|NCT04072146|75767270|FG000|Overall Study|Adverse Event|0|||
41967395|NCT04072146|75767271|FG001|Overall Study|Adverse Event|1|||
41967396|NCT03861481|75767285|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
41967397|NCT03861481|75767286|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
41967398|NCT03861481|75767285|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
41967399|NCT03861481|75767286|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
41967400|NCT03861481|75767285|FG000|Overall Study|Relapse|1|||
41967401|NCT03861481|75767286|FG001|Overall Study|Relapse|0|||
41967402|NCT03861481|75767285|FG000|Overall Study|Withdrawal by Subject|0|||
41967403|NCT03861481|75767286|FG001|Overall Study|Withdrawal by Subject|1|||
41967404|NCT03861481|75767285|FG000|Overall Study|Lack of Efficacy|4|||
41967405|NCT03861481|75767286|FG001|Overall Study|Lack of Efficacy|5|||
41967406|NCT03648476|75767298|FG000|Overall Study|Withdrawal by Subject|2|||
41967407|NCT03648476|75767299|FG001|Overall Study|Withdrawal by Subject|1|||
41967408|NCT04545060|75767330|FG000|Overall Study|Adverse Event|0|||
41967409|NCT04545060|75767331|FG001|Overall Study|Adverse Event|1|||
41967410|NCT04545060|75767330|FG000|Overall Study|Death|0|||
41967411|NCT04545060|75767331|FG001|Overall Study|Death|5|||
41967412|NCT04545060|75767330|FG000|Overall Study|Lost to Follow-up|10|||
41967413|NCT04545060|75767331|FG001|Overall Study|Lost to Follow-up|13|||
41967414|NCT04545060|75767330|FG000|Overall Study|Physician Decision|3|||
41967415|NCT04545060|75767331|FG001|Overall Study|Physician Decision|0|||
41967416|NCT04545060|75767330|FG000|Overall Study|Withdrawal by Subject|17|||
42027775|NCT00920218|75836053|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
42027776|NCT00920218|75836054|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
42027777|NCT00920218|75836051|FG000|Overall Study|Other|0|||
42027778|NCT00920218|75836052|FG001|Overall Study|Other|0|||
42027779|NCT00920218|75836053|FG002|Overall Study|Other|1|||
42027780|NCT00920218|75836054|FG003|Overall Study|Other|0|||
42027781|NCT01121562|75836068|FG000|Overall Study|Objective progression or relapse|8|||
42027782|NCT01121562|75836068|FG000|Overall Study|Withdrawal by Subject|1|||
42027783|NCT01121562|75836068|FG000|Overall Study|Adverse Event|1|||
42027784|NCT01121562|75836068|FG000|Overall Study|Sponsor Decision|1|||
41967417|NCT04545060|75767331|FG001|Overall Study|Withdrawal by Subject|22|||
41967418|NCT03533660|75767408|FG000|Overall Study|Withdrawal by Subject|2|||
41967419|NCT03533660|75767409|FG001|Overall Study|Withdrawal by Subject|2|||
41967420|NCT03533660|75767408|FG000|Overall Study|Death|2|||
41967421|NCT03533660|75767409|FG001|Overall Study|Death|4|||
42124195|NCT00447057|75934565|FG002|Overall Study|Sponsor decision|0|||
42124196|NCT00447057|75934566|FG003|Overall Study|Sponsor decision|0|||
42124197|NCT00447057|75934563|FG000|Overall Study|Progressive disease|58|||
42124198|NCT00447057|75934564|FG001|Overall Study|Progressive disease|43|||
42124199|NCT00447057|75934565|FG002|Overall Study|Progressive disease|13|||
42124200|NCT00447057|75934566|FG003|Overall Study|Progressive disease|18|||
42124201|NCT00447057|75934563|FG000|Overall Study|Death due to adverse event|0|||
42124202|NCT00447057|75934564|FG001|Overall Study|Death due to adverse event|0|||
42124203|NCT00447057|75934565|FG002|Overall Study|Death due to adverse event|1|||
42124204|NCT00447057|75934566|FG003|Overall Study|Death due to adverse event|2|||
42124205|NCT00447057|75934563|FG000|Overall Study|Death, study drug related|0|||
42124206|NCT00447057|75934564|FG001|Overall Study|Death, study drug related|1|||
42124207|NCT00447057|75934565|FG002|Overall Study|Death, study drug related|0|||
42124208|NCT00447057|75934566|FG003|Overall Study|Death, study drug related|0|||
42124209|NCT00446511|75934578|FG000|Overall Study|Adverse Event|7|||
42124210|NCT00446511|75934579|FG001|Overall Study|Adverse Event|2|||
42124211|NCT00446511|75934580|FG002|Overall Study|Adverse Event|3|||
42124212|NCT00446511|75934581|FG003|Overall Study|Adverse Event|1|||
42124213|NCT00446511|75934578|FG000|Overall Study|Protocol Violation|0|||
42301440|NCT02515045|76136684|FG001|Overall Study|Adverse Event|3|||
42301441|NCT02515045|76136685|FG002|Overall Study|Adverse Event|3|||
41967422|NCT03533660|75767408|FG000|Overall Study|Adverse Event|0|||
41967423|NCT03533660|75767409|FG001|Overall Study|Adverse Event|2|||
41967424|NCT03416127|75767423|FG000|Overall Study|Withdrawal by Subject|0|||
41967425|NCT03416127|75767424|FG001|Overall Study|Withdrawal by Subject|1|||
41967426|NCT03416127|75767425|FG002|Overall Study|Withdrawal by Subject|1|||
41967427|NCT02986334|75767459|FG000|Overall Study|Withdrawal by Subject|0|||
41967428|NCT02986334|75767460|FG001|Overall Study|Withdrawal by Subject|1|||
42027785|NCT01121562|75836068|FG000|Overall Study|Met study discontinuation criteria|1|||
42027786|NCT01121484|75836074|FG000|Overall Study|Adverse Event|12|||
42027787|NCT01121484|75836075|FG001|Overall Study|Adverse Event|5|||
42124214|NCT00446511|75934579|FG001|Overall Study|Protocol Violation|0|||
41967429|NCT02986334|75767461|FG002|Overall Study|Withdrawal by Subject|2|||
41967430|NCT02986334|75767459|FG000|Overall Study|Lost to Follow-up|1|||
42124215|NCT00446511|75934580|FG002|Overall Study|Protocol Violation|0|||
42124216|NCT00446511|75934581|FG003|Overall Study|Protocol Violation|1|||
42301442|NCT02515045|76136683|FG000|Overall Study|Lost to Follow-up|0|||
42124217|NCT00446511|75934578|FG000|Overall Study|Withdrawal by Subject|0|||
42124218|NCT00446511|75934579|FG001|Overall Study|Withdrawal by Subject|0|||
42124219|NCT00446511|75934580|FG002|Overall Study|Withdrawal by Subject|0|||
42124220|NCT00446511|75934581|FG003|Overall Study|Withdrawal by Subject|3|||
42124221|NCT00446511|75934578|FG000|Overall Study|Administrative Problems|3|||
42124222|NCT00446511|75934579|FG001|Overall Study|Administrative Problems|0|||
42124223|NCT00446511|75934580|FG002|Overall Study|Administrative Problems|4|||
42124224|NCT00446511|75934581|FG003|Overall Study|Administrative Problems|1|||
41967431|NCT02986334|75767460|FG001|Overall Study|Lost to Follow-up|2|||
41967432|NCT02986334|75767461|FG002|Overall Study|Lost to Follow-up|1|||
41967433|NCT02986334|75767459|FG000|Overall Study|Adverse Event|0|||
41967434|NCT02986334|75767460|FG001|Overall Study|Adverse Event|2|||
41967435|NCT02986334|75767461|FG002|Overall Study|Adverse Event|1|||
41967436|NCT02986334|75767459|FG000|Overall Study|non compliance in phone ratings|2|||
41967437|NCT02986334|75767460|FG001|Overall Study|non compliance in phone ratings|1|||
41967438|NCT02986334|75767461|FG002|Overall Study|non compliance in phone ratings|2|||
41967439|NCT02986334|75767459|FG000|Overall Study|undisclosed comorbidities|0|||
41967440|NCT02986334|75767460|FG001|Overall Study|undisclosed comorbidities|1|||
41967441|NCT02986334|75767461|FG002|Overall Study|undisclosed comorbidities|1|||
41967442|NCT02210221|75767483|FG000|Overall Study|Lack of Efficacy|7|||
41967443|NCT02210221|75767483|FG000|Overall Study|Withdrawal by Subject|43|||
41967444|NCT02124902|75767496|FG000|Overall Study|Adverse Event|7|||
41967445|NCT02124902|75767497|FG001|Overall Study|Adverse Event|2|||
41967446|NCT02124902|75767496|FG000|Overall Study|Went to alternative treatment|4|||
41967447|NCT02124902|75767497|FG001|Overall Study|Went to alternative treatment|0|||
41967448|NCT02124902|75767496|FG000|Overall Study|Withdrawal by Subject|2|||
41967449|NCT02124902|75767497|FG001|Overall Study|Withdrawal by Subject|1|||
41967450|NCT02124902|75767496|FG000|Overall Study|Physician Decision|2|||
41967451|NCT02124902|75767497|FG001|Overall Study|Physician Decision|0|||
41967452|NCT02124902|75767496|FG000|Overall Study|Not eligible|1|||
41967453|NCT02124902|75767497|FG001|Overall Study|Not eligible|0|||
41967454|NCT02124902|75767496|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
41967455|NCT02124902|75767497|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
42124225|NCT00446199|75934597|FG000|Overall Study|Adverse Event|7|||
42124226|NCT00446199|75934598|FG001|Overall Study|Adverse Event|4|||
42124227|NCT00446199|75934599|FG002|Overall Study|Adverse Event|6|||
42124228|NCT00446199|75934600|FG003|Overall Study|Adverse Event|4|||
42124229|NCT00446199|75934597|FG000|Overall Study|Lost to Follow-up|4|||
42124230|NCT00446199|75934598|FG001|Overall Study|Lost to Follow-up|5|||
42124231|NCT00446199|75934599|FG002|Overall Study|Lost to Follow-up|2|||
42124232|NCT00446199|75934600|FG003|Overall Study|Lost to Follow-up|6|||
42124233|NCT00446199|75934597|FG000|Overall Study|Protocol Violation|1|||
42124234|NCT00446199|75934598|FG001|Overall Study|Protocol Violation|2|||
42124235|NCT00446199|75934599|FG002|Overall Study|Protocol Violation|1|||
42124236|NCT00446199|75934600|FG003|Overall Study|Protocol Violation|3|||
42124237|NCT00446199|75934597|FG000|Overall Study|Withdrawal by Subject|2|||
42124238|NCT00446199|75934598|FG001|Overall Study|Withdrawal by Subject|5|||
42124239|NCT00446199|75934599|FG002|Overall Study|Withdrawal by Subject|9|||
42124240|NCT00446199|75934600|FG003|Overall Study|Withdrawal by Subject|10|||
42124241|NCT00446199|75934597|FG000|Overall Study|Site termination|2|||
42124242|NCT00446199|75934598|FG001|Overall Study|Site termination|0|||
42124243|NCT00446199|75934599|FG002|Overall Study|Site termination|0|||
42124244|NCT00446199|75934600|FG003|Overall Study|Site termination|1|||
42124245|NCT00446199|75934597|FG000|Overall Study|Randomization in Error|2|||
42124246|NCT00446199|75934598|FG001|Overall Study|Randomization in Error|0|||
42124247|NCT00446199|75934599|FG002|Overall Study|Randomization in Error|1|||
42124248|NCT00446199|75934600|FG003|Overall Study|Randomization in Error|1|||
42124249|NCT00446199|75934597|FG000|Overall Study|Lack of Efficacy|1|||
42124250|NCT00446199|75934598|FG001|Overall Study|Lack of Efficacy|0|||
42124251|NCT00446199|75934599|FG002|Overall Study|Lack of Efficacy|0|||
42124252|NCT00446199|75934600|FG003|Overall Study|Lack of Efficacy|1|||
42124253|NCT00446199|75934597|FG000|Overall Study|Non-compliant with study drug|1|||
42124254|NCT00446199|75934598|FG001|Overall Study|Non-compliant with study drug|0|||
42124255|NCT00446199|75934599|FG002|Overall Study|Non-compliant with study drug|5|||
41967456|NCT01940341|75767505|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
41967457|NCT01940341|75767506|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
41967458|NCT01940341|75767507|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
41967459|NCT01940341|75767508|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
41967460|NCT01940341|75767505|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
42124256|NCT00446199|75934600|FG003|Overall Study|Non-compliant with study drug|0|||
42124257|NCT00446199|75934597|FG000|Overall Study|Non-compliant with visit schedule|1|||
41967461|NCT01940341|75767506|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
42124258|NCT00446199|75934598|FG001|Overall Study|Non-compliant with visit schedule|1|||
42124259|NCT00446199|75934599|FG002|Overall Study|Non-compliant with visit schedule|1|||
42124260|NCT00446199|75934600|FG003|Overall Study|Non-compliant with visit schedule|2|||
42124261|NCT00446199|75934597|FG000|Overall Study|Hormone fear|0|||
42124262|NCT00446199|75934598|FG001|Overall Study|Hormone fear|0|||
42124263|NCT00446199|75934599|FG002|Overall Study|Hormone fear|0|||
42124264|NCT00446199|75934600|FG003|Overall Study|Hormone fear|1|||
42124265|NCT00446199|75934597|FG000|Overall Study|Lost interest in study participation|0|||
42124266|NCT00446199|75934598|FG001|Overall Study|Lost interest in study participation|1|||
42124267|NCT00446199|75934599|FG002|Overall Study|Lost interest in study participation|0|||
42124268|NCT00446199|75934600|FG003|Overall Study|Lost interest in study participation|0|||
42301443|NCT02515045|76136684|FG001|Overall Study|Lost to Follow-up|1|||
42301444|NCT02515045|76136685|FG002|Overall Study|Lost to Follow-up|1|||
42301445|NCT02514577|76136695|FG000|Overall Study|Lost to Follow-up|6|||
42301446|NCT02514577|76136696|FG001|Overall Study|Lost to Follow-up|6|||
42301447|NCT02514577|76136695|FG000|Overall Study|Protocol Violation|1|||
42301448|NCT02514577|76136696|FG001|Overall Study|Protocol Violation|0|||
42301449|NCT02514577|76136695|FG000|Overall Study|Withdrawal by Subject|6|||
42301450|NCT02514577|76136696|FG001|Overall Study|Withdrawal by Subject|6|||
41967462|NCT01940341|75767507|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
41967463|NCT01940341|75767508|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
41967464|NCT01940341|75767505|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
41967465|NCT01940341|75767506|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
41967466|NCT01940341|75767507|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
41967467|NCT01940341|75767508|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
41967468|NCT01940341|75767505|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
41967469|NCT01940341|75767506|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
41967470|NCT01940341|75767507|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
41967471|NCT01940341|75767508|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
42124269|NCT00446199|75934597|FG000|Overall Study|In-/Exclusion criterion violated|2|||
42124270|NCT00446199|75934598|FG001|Overall Study|In-/Exclusion criterion violated|1|||
42124271|NCT00446199|75934599|FG002|Overall Study|In-/Exclusion criterion violated|2|||
42124272|NCT00446199|75934600|FG003|Overall Study|In-/Exclusion criterion violated|1|||
42124273|NCT00446199|75934597|FG000|Overall Study|Move|0|||
42124274|NCT00446199|75934598|FG001|Overall Study|Move|1|||
42124275|NCT00446199|75934599|FG002|Overall Study|Move|0|||
42124276|NCT00446199|75934600|FG003|Overall Study|Move|0|||
42124277|NCT00456495|75934610|FG000|Overall Study|Physician Decision|2|||
42124278|NCT00445341|75934615|FG000|Overall Study|refused further treatment|1|||
42124279|NCT00445341|75934615|FG000|Overall Study|taken off treatment too early|1|||
42124280|NCT03846453|75934621|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
42124281|NCT03846453|75934622|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
42124282|NCT03846453|75934623|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
42124283|NCT03846453|75934621|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
42124284|NCT03846453|75934622|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
42124285|NCT03846453|75934623|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
42124286|NCT03846453|75934621|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
42124287|NCT03846453|75934622|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
42124288|NCT03846453|75934623|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
42124289|NCT03846453|75934621|FG000|Placebo Run-in (14 Days)|Other|2|||
42124290|NCT03846453|75934622|FG001|Placebo Run-in (14 Days)|Other|0|||
42124291|NCT03846453|75934623|FG002|Placebo Run-in (14 Days)|Other|0|||
42124292|NCT03846453|75934621|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
42124293|NCT03846453|75934622|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
42124294|NCT03846453|75934623|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
42124295|NCT03846453|75934621|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
42124296|NCT03846453|75934622|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
42124297|NCT03846453|75934623|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
42124298|NCT03846453|75934621|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
42124299|NCT03846453|75934622|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
42124300|NCT03846453|75934623|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
42124301|NCT03846453|75934621|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
42124302|NCT03846453|75934622|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
42124303|NCT03846453|75934623|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
42124304|NCT03846453|75934621|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
42124305|NCT03846453|75934622|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
42124306|NCT03846453|75934623|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
42124307|NCT00444951|75934634|FG000|Overall Study|Lost to Follow-up|1|||
42124308|NCT00444951|75934635|FG001|Overall Study|Lost to Follow-up|1|||
42124309|NCT00444951|75934636|FG002|Overall Study|Lost to Follow-up|0|||
42124310|NCT00444951|75934634|FG000|Overall Study|Withdrawal by Subject|4|||
41967472|NCT01940341|75767505|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
41967473|NCT01940341|75767506|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
42124311|NCT00444951|75934635|FG001|Overall Study|Withdrawal by Subject|5|||
42301451|NCT02514577|76136695|FG000|Overall Study|Adverse Event|1|||
42124312|NCT00444951|75934636|FG002|Overall Study|Withdrawal by Subject|3|||
42124313|NCT00444795|75934644|FG000|Overall Study|Not Treated|1|||
42124314|NCT00444795|75934644|FG000|Overall Study|Treated Prior to the Contract Date|2|||
42124315|NCT03846219|75934651|FG000|Overall Study|Withdrawal by Subject|3|||
41967474|NCT01940341|75767507|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
41967475|NCT01940341|75767508|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
41967476|NCT01940341|75767505|FG000|Period 1: Double-blind Phase|Death|0|||
41967477|NCT01940341|75767506|FG001|Period 1: Double-blind Phase|Death|1|||
41967478|NCT01940341|75767507|FG002|Period 1: Double-blind Phase|Death|0|||
41967479|NCT01940341|75767508|FG003|Period 1: Double-blind Phase|Death|0|||
41967480|NCT01940341|75767505|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
41967481|NCT01940341|75767506|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
41967482|NCT01940341|75767507|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
41967483|NCT01940341|75767508|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
41967484|NCT01940341|75767505|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
41967485|NCT01940341|75767506|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
41967486|NCT01940341|75767507|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
41967487|NCT01940341|75767508|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
41967488|NCT01940341|75767505|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
41967489|NCT01940341|75767506|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
41967490|NCT01940341|75767507|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
41967491|NCT01940341|75767508|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
41967492|NCT01940341|75767505|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
41967493|NCT01940341|75767506|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
41967494|NCT01940341|75767507|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
41967495|NCT01940341|75767508|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
41967496|NCT01940341|75767505|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
41967497|NCT01940341|75767506|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
41967498|NCT01940341|75767507|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
41967499|NCT01940341|75767508|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
41967500|NCT01940341|75767505|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
41967501|NCT01940341|75767506|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
42124316|NCT03846219|75934652|FG001|Overall Study|Withdrawal by Subject|2|||
42124317|NCT03846219|75934653|FG002|Overall Study|Withdrawal by Subject|2|||
42124318|NCT03846219|75934651|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
42124319|NCT03846219|75934652|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
42124320|NCT03846219|75934653|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
42124321|NCT03846219|75934651|FG000|Overall Study|Physician Decision|0|||
42124322|NCT03846219|75934652|FG001|Overall Study|Physician Decision|0|||
42124323|NCT03846219|75934653|FG002|Overall Study|Physician Decision|2|||
42124324|NCT00455325|75934669|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
42124325|NCT00455325|75934670|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
42124326|NCT00455325|75934671|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
42124327|NCT00455325|75934672|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
42124328|NCT00455325|75934669|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
42124329|NCT00455325|75934670|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
42124330|NCT00455325|75934671|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
42124331|NCT00455325|75934672|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
42124332|NCT00455325|75934669|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
42124333|NCT00455325|75934670|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
42124334|NCT00455325|75934671|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
42124335|NCT00455325|75934672|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
42124336|NCT00455325|75934669|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
42124337|NCT00455325|75934670|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
42124338|NCT00455325|75934671|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
42124339|NCT00455325|75934672|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
42124340|NCT00455325|75934669|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
42124341|NCT00455325|75934670|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
42124342|NCT00455325|75934671|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
41967502|NCT01940341|75767507|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
41967503|NCT01940341|75767508|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
41967504|NCT01940341|75767505|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
42124343|NCT00455325|75934672|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
42124344|NCT00455325|75934669|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
42124345|NCT00455325|75934670|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
42124346|NCT00455325|75934671|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
42124347|NCT00455325|75934672|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
42124348|NCT00455325|75934669|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
42124349|NCT00455325|75934670|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
42124350|NCT00455325|75934671|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
42124351|NCT00455325|75934672|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
42124352|NCT00443781|75934683|FG000|Overall Study|Lost to Follow-up|10|||
42124353|NCT00443781|75934683|FG000|Overall Study|Physician Decision|2|||
42124354|NCT00443781|75934683|FG000|Overall Study|Protocol Violation|1|||
42124355|NCT00443781|75934683|FG000|Overall Study|Withdrawal by Subject|6|||
42124356|NCT00443781|75934683|FG000|Overall Study|Unable to comply with study follow up|2|||
42124357|NCT00443781|75934683|FG000|Overall Study|Investigator terminated participation|1|||
42124358|NCT00443781|75934683|FG000|Overall Study|Insurance not covered|2|||
42124359|NCT00443781|75934683|FG000|Overall Study|PD/FAD not done|1|||
42124360|NCT00443703|75934689|FG000|Overall Study|Never Treated|3|||
42124361|NCT00443703|75934690|FG001|Overall Study|Never Treated|1|||
42124362|NCT00443703|75934689|FG000|Overall Study|Adverse Event|7|||
42124363|NCT00443703|75934690|FG001|Overall Study|Adverse Event|3|||
42124364|NCT00443703|75934689|FG000|Overall Study|Lack of Efficacy|3|||
42124365|NCT00443703|75934690|FG001|Overall Study|Lack of Efficacy|1|||
42124366|NCT00443703|75934689|FG000|Overall Study|Lost to Follow-up|0|||
42124367|NCT00443703|75934690|FG001|Overall Study|Lost to Follow-up|4|||
42124368|NCT00443703|75934689|FG000|Overall Study|Physician Decision|4|||
42124369|NCT00443703|75934690|FG001|Overall Study|Physician Decision|2|||
42124370|NCT00443703|75934689|FG000|Overall Study|Protocol Violation|1|||
42124371|NCT00443703|75934690|FG001|Overall Study|Protocol Violation|1|||
42124372|NCT00443703|75934689|FG000|Overall Study|Withdrawal by Subject|9|||
42124373|NCT00443703|75934690|FG001|Overall Study|Withdrawal by Subject|6|||
42124374|NCT00443703|75934689|FG000|Overall Study|Progressive Disease|1|||
42124375|NCT00443703|75934690|FG001|Overall Study|Progressive Disease|0|||
42124376|NCT00381706|75934702|FG000|Overall Study|Never treated|7|||
42124377|NCT00381706|75934703|FG001|Overall Study|Never treated|2|||
42124378|NCT00381706|75934704|FG002|Overall Study|Never treated|1|||
42124379|NCT00535236|75934728|FG000|Overall Study|Adverse Event|1|||
42124380|NCT00535236|75934729|FG001|Overall Study|Adverse Event|0|||
42124381|NCT00535236|75934730|FG002|Overall Study|Adverse Event|9|||
42124382|NCT00535236|75934731|FG003|Overall Study|Adverse Event|3|||
42124383|NCT00535236|75934732|FG004|Overall Study|Adverse Event|3|||
42124384|NCT00535236|75934733|FG005|Overall Study|Adverse Event|0|||
42124385|NCT00535236|75934734|FG006|Overall Study|Adverse Event|5|||
42124386|NCT00535236|75934735|FG007|Overall Study|Adverse Event|1|||
42124387|NCT00535236|75934736|FG008|Overall Study|Adverse Event|2|||
42124388|NCT00535236|75934737|FG009|Overall Study|Adverse Event|1|||
42124389|NCT00535236|75934728|FG000|Overall Study|Lost to Follow-up|1|||
42124390|NCT00535236|75934729|FG001|Overall Study|Lost to Follow-up|2|||
42124391|NCT00535236|75934730|FG002|Overall Study|Lost to Follow-up|0|||
42124392|NCT00535236|75934731|FG003|Overall Study|Lost to Follow-up|0|||
42124393|NCT00535236|75934732|FG004|Overall Study|Lost to Follow-up|2|||
42124394|NCT00535236|75934733|FG005|Overall Study|Lost to Follow-up|0|||
42124395|NCT00535236|75934734|FG006|Overall Study|Lost to Follow-up|0|||
42124396|NCT00535236|75934735|FG007|Overall Study|Lost to Follow-up|0|||
42124397|NCT00535236|75934736|FG008|Overall Study|Lost to Follow-up|6|||
42124398|NCT00535236|75934737|FG009|Overall Study|Lost to Follow-up|1|||
41967505|NCT01940341|75767506|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
41967506|NCT01940341|75767507|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
41967507|NCT01940341|75767508|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
41967508|NCT01940341|75767505|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
41967509|NCT01940341|75767506|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
41967510|NCT01940341|75767507|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
41967511|NCT01940341|75767508|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
41967512|NCT01940341|75767505|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
41967513|NCT01940341|75767506|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
41967514|NCT01940341|75767507|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
42124399|NCT00535236|75934728|FG000|Overall Study|Physician Decision|0|||
42124400|NCT00535236|75934729|FG001|Overall Study|Physician Decision|0|||
42124401|NCT00535236|75934730|FG002|Overall Study|Physician Decision|0|||
42124402|NCT00535236|75934731|FG003|Overall Study|Physician Decision|0|||
42124403|NCT00535236|75934732|FG004|Overall Study|Physician Decision|1|||
42124404|NCT00535236|75934733|FG005|Overall Study|Physician Decision|0|||
42124405|NCT00535236|75934734|FG006|Overall Study|Physician Decision|1|||
42124406|NCT00535236|75934735|FG007|Overall Study|Physician Decision|0|||
42124407|NCT00535236|75934736|FG008|Overall Study|Physician Decision|0|||
42124408|NCT00535236|75934737|FG009|Overall Study|Physician Decision|0|||
42124409|NCT00535236|75934728|FG000|Overall Study|Protocol Violation|2|||
42124410|NCT00535236|75934729|FG001|Overall Study|Protocol Violation|0|||
42124411|NCT00535236|75934730|FG002|Overall Study|Protocol Violation|1|||
42124412|NCT00535236|75934731|FG003|Overall Study|Protocol Violation|0|||
42027788|NCT01121484|75836074|FG000|Overall Study|Lack of Efficacy|3|||
42124413|NCT00535236|75934732|FG004|Overall Study|Protocol Violation|0|||
41967515|NCT01940341|75767508|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
41967516|NCT01940341|75767505|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
41967517|NCT01940341|75767506|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
41967518|NCT01940341|75767507|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
41967519|NCT01940341|75767508|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
41967520|NCT01940341|75767505|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
41967521|NCT01940341|75767506|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
41967522|NCT01940341|75767507|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
41967523|NCT01940341|75767508|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
41967524|NCT01940341|75767505|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
41967525|NCT01940341|75767506|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
41967526|NCT01940341|75767507|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
41967527|NCT01940341|75767508|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
41967528|NCT01940341|75767505|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
41967529|NCT01940341|75767506|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
41967530|NCT01940341|75767507|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
41967531|NCT01940341|75767508|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
41967532|NCT01877837|75767516|FG000|Overall Study|Lost to Follow-up|1|||
41967533|NCT01877837|75767516|FG000|Overall Study|Ineligible|4|||
41967534|NCT01624142|75767522|FG000|Overall Study|Withdrawal by Subject|14|||
41967535|NCT01624142|75767523|FG001|Overall Study|Withdrawal by Subject|4|||
41967536|NCT01624142|75767522|FG000|Overall Study|Death|3|||
41967537|NCT01624142|75767523|FG001|Overall Study|Death|6|||
41967538|NCT01624142|75767522|FG000|Overall Study|Study Closure|12|||
41967539|NCT01624142|75767523|FG001|Overall Study|Study Closure|6|||
41967540|NCT01624142|75767522|FG000|Overall Study|Lost to Follow-up|2|||
41967541|NCT01624142|75767523|FG001|Overall Study|Lost to Follow-up|0|||
41967542|NCT01624142|75767522|FG000|Overall Study|Other|1|||
41967543|NCT01624142|75767523|FG001|Overall Study|Other|0|||
41967544|NCT01535807|75767532|FG000|Overall Study|Withdrawal by Subject|1|||
41967545|NCT01535807|75767533|FG001|Overall Study|Withdrawal by Subject|1|||
41967546|NCT01535807|75767532|FG000|Overall Study|Data collection error|1|||
41967547|NCT01535807|75767533|FG001|Overall Study|Data collection error|1|||
41967548|NCT01375764|75767545|FG000|Overall Study|Lost to Follow-up|0|||
41967549|NCT01375764|75767546|FG001|Overall Study|Lost to Follow-up|1|||
41967550|NCT01375764|75767547|FG002|Overall Study|Lost to Follow-up|0|||
41967551|NCT01375764|75767548|FG003|Overall Study|Lost to Follow-up|0|||
41967552|NCT01375764|75767549|FG004|Overall Study|Lost to Follow-up|0|||
41967553|NCT01375764|75767545|FG000|Overall Study|Withdrawal by Subject|2|||
41967554|NCT01375764|75767546|FG001|Overall Study|Withdrawal by Subject|0|||
41967555|NCT01375764|75767547|FG002|Overall Study|Withdrawal by Subject|0|||
41967556|NCT01375764|75767548|FG003|Overall Study|Withdrawal by Subject|0|||
41967557|NCT01375764|75767549|FG004|Overall Study|Withdrawal by Subject|1|||
41967558|NCT01375764|75767545|FG000|Overall Study|Other|0|||
41967559|NCT01375764|75767546|FG001|Overall Study|Other|0|||
41967560|NCT01375764|75767547|FG002|Overall Study|Other|0|||
41967561|NCT01375764|75767548|FG003|Overall Study|Other|1|||
41967562|NCT01375764|75767549|FG004|Overall Study|Other|0|||
41967563|NCT00722046|75767568|FG000|Overall Study|Adverse Event|0|||
41967564|NCT00722046|75767569|FG001|Overall Study|Adverse Event|1|||
41967565|NCT00722046|75767570|FG002|Overall Study|Adverse Event|2|||
41967566|NCT00722046|75767571|FG003|Overall Study|Adverse Event|1|||
41967567|NCT00722046|75767572|FG004|Overall Study|Adverse Event|2|||
41967568|NCT00722046|75767573|FG005|Overall Study|Adverse Event|1|||
41967569|NCT00722046|75767574|FG006|Overall Study|Adverse Event|0|||
41967570|NCT00722046|75767568|FG000|Overall Study|Death|0|||
41967571|NCT00722046|75767569|FG001|Overall Study|Death|1|||
41967572|NCT00722046|75767570|FG002|Overall Study|Death|0|||
41967573|NCT00722046|75767571|FG003|Overall Study|Death|0|||
41967574|NCT00722046|75767572|FG004|Overall Study|Death|0|||
41967575|NCT00722046|75767573|FG005|Overall Study|Death|0|||
41967576|NCT00722046|75767574|FG006|Overall Study|Death|2|||
41967577|NCT00722046|75767568|FG000|Overall Study|Protocol Violation|1|||
41967578|NCT00722046|75767569|FG001|Overall Study|Protocol Violation|0|||
41967579|NCT00722046|75767570|FG002|Overall Study|Protocol Violation|0|||
41967580|NCT00722046|75767571|FG003|Overall Study|Protocol Violation|0|||
41967581|NCT00722046|75767572|FG004|Overall Study|Protocol Violation|0|||
41967582|NCT00722046|75767573|FG005|Overall Study|Protocol Violation|1|||
41967583|NCT00722046|75767574|FG006|Overall Study|Protocol Violation|0|||
41967584|NCT00722046|75767568|FG000|Overall Study|Withdrawal by Subject|3|||
41967585|NCT00722046|75767569|FG001|Overall Study|Withdrawal by Subject|3|||
41967586|NCT00722046|75767570|FG002|Overall Study|Withdrawal by Subject|4|||
41967587|NCT00722046|75767571|FG003|Overall Study|Withdrawal by Subject|4|||
41967588|NCT00722046|75767572|FG004|Overall Study|Withdrawal by Subject|4|||
41967589|NCT00722046|75767573|FG005|Overall Study|Withdrawal by Subject|7|||
42027789|NCT01121484|75836075|FG001|Overall Study|Lack of Efficacy|11|||
41967590|NCT00722046|75767574|FG006|Overall Study|Withdrawal by Subject|3|||
41967591|NCT00722046|75767568|FG000|Overall Study|Randomized, but not treated|1|||
41967592|NCT00722046|75767569|FG001|Overall Study|Randomized, but not treated|1|||
41967593|NCT00722046|75767570|FG002|Overall Study|Randomized, but not treated|0|||
41967594|NCT00722046|75767571|FG003|Overall Study|Randomized, but not treated|2|||
41967595|NCT00722046|75767572|FG004|Overall Study|Randomized, but not treated|0|||
41967596|NCT00722046|75767573|FG005|Overall Study|Randomized, but not treated|0|||
41967597|NCT00722046|75767574|FG006|Overall Study|Randomized, but not treated|0|||
41967598|NCT00722046|75767568|FG000|Overall Study|Other|0|||
41967599|NCT00722046|75767569|FG001|Overall Study|Other|0|||
41967600|NCT00722046|75767570|FG002|Overall Study|Other|1|||
41967601|NCT00722046|75767571|FG003|Overall Study|Other|1|||
41967602|NCT00722046|75767572|FG004|Overall Study|Other|3|||
41967603|NCT00722046|75767573|FG005|Overall Study|Other|2|||
41967604|NCT00722046|75767574|FG006|Overall Study|Other|1|||
41967605|NCT00614523|75767594|FG000|Overall Study|Adverse Event|4|||
41967606|NCT00614523|75767595|FG001|Overall Study|Adverse Event|20|||
41967607|NCT00614523|75767594|FG000|Overall Study|Death|5|||
41967608|NCT00614523|75767595|FG001|Overall Study|Death|8|||
41967609|NCT00614523|75767594|FG000|Overall Study|Lack of Efficacy|9|||
41967610|NCT00614523|75767595|FG001|Overall Study|Lack of Efficacy|11|||
41967611|NCT00614523|75767594|FG000|Overall Study|Lost to Follow-up|0|||
41967612|NCT00614523|75767595|FG001|Overall Study|Lost to Follow-up|1|||
41967613|NCT00614523|75767594|FG000|Overall Study|Protocol Violation|3|||
41967614|NCT00614523|75767595|FG001|Overall Study|Protocol Violation|2|||
41967615|NCT00614523|75767594|FG000|Overall Study|Withdrawal by Subject|12|||
41967616|NCT00614523|75767595|FG001|Overall Study|Withdrawal by Subject|22|||
41967617|NCT00614523|75767594|FG000|Overall Study|Other|6|||
41967618|NCT00614523|75767595|FG001|Overall Study|Other|11|||
41967619|NCT00614523|75767594|FG000|Overall Study|Ineligibility Determined|1|||
41967620|NCT00614523|75767595|FG001|Overall Study|Ineligibility Determined|2|||
41967621|NCT00614523|75767594|FG000|Overall Study|Disease Progression|0|||
41967622|NCT00614523|75767595|FG001|Overall Study|Disease Progression|8|||
41967623|NCT00614523|75767594|FG000|Overall Study|Administrative Decision|23|||
41967624|NCT00614523|75767595|FG001|Overall Study|Administrative Decision|46|||
41967625|NCT00523341|75767603|FG000|Overall Study|Withdrawal by Subject|399|||
41967626|NCT00523341|75767604|FG001|Overall Study|Withdrawal by Subject|427|||
41967627|NCT00523341|75767603|FG000|Overall Study|Other|181|||
42124414|NCT00535236|75934733|FG005|Overall Study|Protocol Violation|0|||
42124415|NCT00535236|75934734|FG006|Overall Study|Protocol Violation|0|||
42124416|NCT00535236|75934735|FG007|Overall Study|Protocol Violation|0|||
42124417|NCT00535236|75934736|FG008|Overall Study|Protocol Violation|1|||
42124418|NCT00535236|75934737|FG009|Overall Study|Protocol Violation|0|||
42124419|NCT00535236|75934728|FG000|Overall Study|Withdrawal by Subject|3|||
42124420|NCT00535236|75934729|FG001|Overall Study|Withdrawal by Subject|0|||
42124421|NCT00535236|75934730|FG002|Overall Study|Withdrawal by Subject|2|||
42124422|NCT00535236|75934731|FG003|Overall Study|Withdrawal by Subject|1|||
42124423|NCT00535236|75934732|FG004|Overall Study|Withdrawal by Subject|6|||
42124424|NCT00535236|75934733|FG005|Overall Study|Withdrawal by Subject|1|||
42124425|NCT00535236|75934734|FG006|Overall Study|Withdrawal by Subject|5|||
42124426|NCT00535236|75934735|FG007|Overall Study|Withdrawal by Subject|0|||
42124427|NCT00535236|75934736|FG008|Overall Study|Withdrawal by Subject|4|||
42124428|NCT00535236|75934737|FG009|Overall Study|Withdrawal by Subject|2|||
42124429|NCT00370552|75934765|FG000|Overall Study|Adverse Event|2|||
42124430|NCT00370552|75934766|FG001|Overall Study|Adverse Event|2|||
42124431|NCT00370552|75934767|FG002|Overall Study|Adverse Event|2|||
42124432|NCT00370552|75934765|FG000|Overall Study|Disease progression|23|||
42124433|NCT00370552|75934766|FG001|Overall Study|Disease progression|23|||
42124434|NCT00370552|75934767|FG002|Overall Study|Disease progression|15|||
42124435|NCT00370552|75934765|FG000|Overall Study|Maximum clinical benefit|3|||
41967628|NCT00523341|75767604|FG001|Overall Study|Other|198|||
41967629|NCT00523341|75767603|FG000|Overall Study|Adverse Event|122|||
41967630|NCT00523341|75767604|FG001|Overall Study|Adverse Event|155|||
42124436|NCT00370552|75934766|FG001|Overall Study|Maximum clinical benefit|5|||
42124437|NCT00370552|75934767|FG002|Overall Study|Maximum clinical benefit|5|||
42124438|NCT00370552|75934765|FG000|Overall Study|Poor or noncompliance|0|||
41967631|NCT00523341|75767603|FG000|Overall Study|Death|101|||
41967632|NCT00523341|75767604|FG001|Overall Study|Death|110|||
41967633|NCT00523341|75767603|FG000|Overall Study|Lost to Follow-up|73|||
42124439|NCT00370552|75934766|FG001|Overall Study|Poor or noncompliance|0|||
42124440|NCT00370552|75934767|FG002|Overall Study|Poor or noncompliance|1|||
42124441|NCT00370552|75934765|FG000|Overall Study|Study drug toxicity|11|||
42124442|NCT00370552|75934766|FG001|Overall Study|Study drug toxicity|8|||
42124443|NCT00370552|75934767|FG002|Overall Study|Study drug toxicity|6|||
41967634|NCT00523341|75767604|FG001|Overall Study|Lost to Follow-up|61|||
41967635|NCT00523341|75767603|FG000|Overall Study|Non-compliance|20|||
41967636|NCT00523341|75767604|FG001|Overall Study|Non-compliance|13|||
41967637|NCT00523341|75767603|FG000|Overall Study|Physician Decision|14|||
41967638|NCT00523341|75767604|FG001|Overall Study|Physician Decision|13|||
41967639|NCT00523341|75767603|FG000|Overall Study|Requirement for Alternative Therapy|4|||
41967640|NCT00523341|75767604|FG001|Overall Study|Requirement for Alternative Therapy|14|||
41967641|NCT00523341|75767603|FG000|Overall Study|Protocol Deviation|6|||
41967642|NCT00523341|75767604|FG001|Overall Study|Protocol Deviation|5|||
41967643|NCT00523341|75767603|FG000|Overall Study|Ineligibility Determined|3|||
41967644|NCT00523341|75767604|FG001|Overall Study|Ineligibility Determined|4|||
41967645|NCT00523341|75767603|FG000|Overall Study|Disease Progression|1|||
41967646|NCT00523341|75767604|FG001|Overall Study|Disease Progression|0|||
41967647|NCT00364013|75767612|FG000|Overall Study|Ineligibility determined|4|||
41967648|NCT00364013|75767613|FG001|Overall Study|Ineligibility determined|2|||
41967649|NCT00364013|75767612|FG000|Overall Study|Adverse Event|4|||
41967650|NCT00364013|75767613|FG001|Overall Study|Adverse Event|3|||
41967651|NCT00364013|75767612|FG000|Overall Study|Withdrawal by Subject|13|||
41967652|NCT00364013|75767613|FG001|Overall Study|Withdrawal by Subject|18|||
41967653|NCT00364013|75767612|FG000|Overall Study|Physician Decision|3|||
41967654|NCT00364013|75767613|FG001|Overall Study|Physician Decision|3|||
41967655|NCT00364013|75767612|FG000|Overall Study|Lost to Follow-up|10|||
41967656|NCT00364013|75767613|FG001|Overall Study|Lost to Follow-up|3|||
41967657|NCT00364013|75767612|FG000|Overall Study|Protocol-specified criteria|6|||
41967658|NCT00364013|75767613|FG001|Overall Study|Protocol-specified criteria|6|||
41967659|NCT00364013|75767612|FG000|Overall Study|Other|41|||
41967660|NCT00364013|75767613|FG001|Overall Study|Other|47|||
41967661|NCT00364013|75767612|FG000|Overall Study|Ongoing|20|||
41967662|NCT00364013|75767613|FG001|Overall Study|Ongoing|13|||
41967663|NCT00345839|75767625|FG000|Overall Study|Withdrawal by Subject|91|||
41967664|NCT00345839|75767626|FG001|Overall Study|Withdrawal by Subject|98|||
41967665|NCT00345839|75767625|FG000|Overall Study|Lost to Follow-up|58|||
41967666|NCT00345839|75767626|FG001|Overall Study|Lost to Follow-up|61|||
41967667|NCT00330759|75767634|FG000|Overall Study|Death|316|||
42027790|NCT01121484|75836074|FG000|Overall Study|Lost to Follow-up|5|||
42124444|NCT00370552|75934765|FG000|Overall Study|Withdrawal by Subject|2|||
42124445|NCT00370552|75934766|FG001|Overall Study|Withdrawal by Subject|0|||
42124446|NCT00370552|75934767|FG002|Overall Study|Withdrawal by Subject|1|||
42124447|NCT00370552|75934765|FG000|Overall Study|Still on treatment|1|||
42124448|NCT00370552|75934766|FG001|Overall Study|Still on treatment|3|||
42124449|NCT00370552|75934767|FG002|Overall Study|Still on treatment|2|||
42124450|NCT00370552|75934765|FG000|Overall Study|Never treated|1|||
42124451|NCT00370552|75934766|FG001|Overall Study|Never treated|0|||
42124452|NCT00370552|75934767|FG002|Overall Study|Never treated|0|||
42124453|NCT00370552|75934765|FG000|Overall Study|Physician Decision|1|||
42124454|NCT00370552|75934766|FG001|Overall Study|Physician Decision|1|||
42124455|NCT00370552|75934767|FG002|Overall Study|Physician Decision|0|||
42124456|NCT00370552|75934765|FG000|Overall Study|Investigator decision|2|||
42124457|NCT00370552|75934766|FG001|Overall Study|Investigator decision|1|||
42124458|NCT00370552|75934767|FG002|Overall Study|Investigator decision|0|||
42124459|NCT00370552|75934765|FG000|Overall Study|High risk of allergic reaction|0|||
42124460|NCT00370552|75934766|FG001|Overall Study|High risk of allergic reaction|1|||
42124461|NCT00370552|75934767|FG002|Overall Study|High risk of allergic reaction|0|||
42124462|NCT00370552|75934765|FG000|Overall Study|Planned radiation for palliation|0|||
42124463|NCT00370552|75934766|FG001|Overall Study|Planned radiation for palliation|1|||
42124464|NCT00370552|75934767|FG002|Overall Study|Planned radiation for palliation|0|||
42124465|NCT00537030|75934775|FG000|Overall Study|Physician Decision|2|||
42124466|NCT00537030|75934775|FG000|Overall Study|Withdrawal by Subject|2|||
42124467|NCT00537030|75934775|FG000|Overall Study|≥ Grade 2 allergy|7|||
42124468|NCT00537030|75934775|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
42124469|NCT00537030|75934775|FG000|Overall Study|Ineligible|2|||
42124470|NCT00537030|75934775|FG000|Overall Study|Inevaluable|2|||
42124471|NCT00381238|75934779|FG000|Overall Study|Adverse Event|3|||
42124472|NCT00381238|75934779|FG000|Overall Study|Protocol Violation|1|||
42124473|NCT00381238|75934779|FG000|Overall Study|Withdrawal by Subject|4|||
42124474|NCT00381238|75934779|FG000|Overall Study|Lack of Efficacy|2|||
42124475|NCT00381238|75934779|FG000|Overall Study|Withdrew by physician|1|||
42124476|NCT00381238|75934779|FG000|Overall Study|Disease progression|1|||
42124477|NCT03896022|75934786|FG000|Overall Study|Withdrawal by Subject|1|||
42124478|NCT03896022|75934787|FG001|Overall Study|Withdrawal by Subject|0|||
42124479|NCT03896022|75934788|FG002|Overall Study|Withdrawal by Subject|0|||
42027791|NCT01121484|75836075|FG001|Overall Study|Lost to Follow-up|9|||
42210391|NCT03227445|76025159|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
42124480|NCT03896022|75934786|FG000|Overall Study|Did not have procedure|3|||
41967668|NCT00330759|75767635|FG001|Overall Study|Death|310|||
41967669|NCT00330759|75767634|FG000|Overall Study|Disease progression|104|||
41967670|NCT00330759|75767635|FG001|Overall Study|Disease progression|126|||
41967671|NCT00330759|75767634|FG000|Overall Study|Withdrawal by Subject|143|||
41967672|NCT00330759|75767635|FG001|Overall Study|Withdrawal by Subject|124|||
41967673|NCT00330759|75767634|FG000|Overall Study|Adverse Event|48|||
41967674|NCT00330759|75767635|FG001|Overall Study|Adverse Event|36|||
42124481|NCT03896022|75934787|FG001|Overall Study|Did not have procedure|0|||
42124482|NCT03896022|75934788|FG002|Overall Study|Did not have procedure|0|||
41967675|NCT00330759|75767634|FG000|Overall Study|Participant request|31|||
41967676|NCT00330759|75767635|FG001|Overall Study|Participant request|22|||
41967677|NCT00330759|75767634|FG000|Overall Study|Lost to Follow-up|16|||
41967678|NCT00330759|75767635|FG001|Overall Study|Lost to Follow-up|22|||
41967679|NCT00330759|75767634|FG000|Overall Study|Noncompliance|15|||
41967680|NCT00330759|75767635|FG001|Overall Study|Noncompliance|17|||
41967681|NCT00330759|75767634|FG000|Overall Study|Physician Decision|1|||
41967682|NCT00330759|75767635|FG001|Overall Study|Physician Decision|2|||
41967683|NCT00330759|75767634|FG000|Overall Study|Protocol deviation|0|||
41967684|NCT00330759|75767635|FG001|Overall Study|Protocol deviation|2|||
41967685|NCT00330759|75767634|FG000|Overall Study|Ineligibility determined|2|||
41967686|NCT00330759|75767635|FG001|Overall Study|Ineligibility determined|1|||
41967687|NCT00330759|75767634|FG000|Overall Study|Other|36|||
41967688|NCT00330759|75767635|FG001|Overall Study|Other|44|||
41967689|NCT00113763|75767643|FG000|Overall Study|Adverse Event|5|||
41967690|NCT00113763|75767644|FG001|Overall Study|Adverse Event|2|||
41967691|NCT00113763|75767643|FG000|Overall Study|Disease Progression|28|||
41967692|NCT00113763|75767644|FG001|Overall Study|Disease Progression|14|||
41967693|NCT00113763|75767643|FG000|Overall Study|Lost to Follow-up|10|||
41967694|NCT00113763|75767644|FG001|Overall Study|Lost to Follow-up|0|||
41967695|NCT00113763|75767643|FG000|Overall Study|Withdrawal by Subject|1|||
41967696|NCT00113763|75767644|FG001|Overall Study|Withdrawal by Subject|4|||
41967697|NCT00113763|75767643|FG000|Overall Study|Other|27|||
41967698|NCT00113763|75767644|FG001|Overall Study|Other|6|||
41967699|NCT00113763|75767643|FG000|Overall Study|Non-compliance|1|||
41967700|NCT00113763|75767644|FG001|Overall Study|Non-compliance|0|||
41967701|NCT00113763|75767643|FG000|Overall Study|Ongoing|1|||
42027792|NCT01121484|75836074|FG000|Overall Study|Physician Decision|0|||
42210392|NCT04067401|76025170|FG000|Overall Study|Withdrawal by Subject|7|||
42210393|NCT04067401|76025171|FG001|Overall Study|Withdrawal by Subject|0|||
42210394|NCT04067401|76025170|FG000|Overall Study|no data provided|1|||
42210395|NCT04067401|76025171|FG001|Overall Study|no data provided|0|||
42210396|NCT04194151|76025183|FG000|Overall Study|Physician Decision|1|||
42210397|NCT04194151|76025184|FG001|Overall Study|Physician Decision|1|||
42210398|NCT04194151|76025185|FG002|Overall Study|Physician Decision|1|||
42210399|NCT04194151|76025186|FG003|Overall Study|Physician Decision|1|||
42210400|NCT04194151|76025187|FG004|Overall Study|Physician Decision|0|||
42210401|NCT04194151|76025188|FG005|Overall Study|Physician Decision|1|||
42210402|NCT04194151|76025183|FG000|Overall Study|Monitorization problem|0|||
42210403|NCT04194151|76025184|FG001|Overall Study|Monitorization problem|1|||
42210404|NCT04194151|76025185|FG002|Overall Study|Monitorization problem|0|||
42210405|NCT04194151|76025186|FG003|Overall Study|Monitorization problem|0|||
42210406|NCT04194151|76025187|FG004|Overall Study|Monitorization problem|0|||
42301452|NCT02514577|76136696|FG001|Overall Study|Adverse Event|1|||
42027793|NCT01121484|75836075|FG001|Overall Study|Physician Decision|3|||
42027794|NCT01121484|75836074|FG000|Overall Study|Protocol Violation|1|||
42027795|NCT01121484|75836075|FG001|Overall Study|Protocol Violation|0|||
42027796|NCT01121484|75836074|FG000|Overall Study|Withdrawal by Subject|8|||
42027797|NCT01121484|75836075|FG001|Overall Study|Withdrawal by Subject|7|||
42027798|NCT01121484|75836074|FG000|Overall Study|Discontinuation of study by sponsor|0|||
42027799|NCT01121484|75836075|FG001|Overall Study|Discontinuation of study by sponsor|1|||
42027800|NCT01121484|75836074|FG000|Overall Study|Other|3|||
42027801|NCT01121484|75836075|FG001|Overall Study|Other|3|||
42027802|NCT01121484|75836074|FG000|Overall Study|Randomized, not treated|1|||
42027803|NCT01121484|75836075|FG001|Overall Study|Randomized, not treated|4|||
42027804|NCT01169675|75836086|FG000|Overall Study|Progressive disease|13|||
42027805|NCT01169675|75836087|FG001|Overall Study|Progressive disease|2|||
42027806|NCT01169675|75836088|FG002|Overall Study|Progressive disease|5|||
42027807|NCT01169675|75836089|FG003|Overall Study|Progressive disease|15|||
42027808|NCT01169675|75836090|FG004|Overall Study|Progressive disease|1|||
42027809|NCT01169675|75836086|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
42027810|NCT01169675|75836087|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42027811|NCT01169675|75836088|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42027812|NCT01169675|75836089|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42027813|NCT01169675|75836090|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
42027814|NCT01169675|75836086|FG000|Overall Study|Adverse Event|5|||
42027815|NCT01169675|75836087|FG001|Overall Study|Adverse Event|1|||
42027816|NCT01169675|75836088|FG002|Overall Study|Adverse Event|2|||
42027817|NCT01169675|75836089|FG003|Overall Study|Adverse Event|0|||
42027818|NCT01169675|75836090|FG004|Overall Study|Adverse Event|0|||
42027819|NCT01169675|75836086|FG000|Overall Study|Withdrawal by Subject|1|||
42210407|NCT04194151|76025188|FG005|Overall Study|Monitorization problem|0|||
42210408|NCT03820323|76025204|FG000|Overall Study|Lost to Follow-up|2|||
42027820|NCT01169675|75836087|FG001|Overall Study|Withdrawal by Subject|0|||
41967702|NCT00113763|75767644|FG001|Overall Study|Ongoing|0|||
41967703|NCT05166902|75767658|FG000|First Intervention|Lost to Follow-up|0|||
41967704|NCT05166902|75767659|FG001|First Intervention|Lost to Follow-up|1|||
41967705|NCT05142566|75767665|FG000|Overall Study|Protocol Violation|1|||
41967706|NCT05083949|75767671|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
42210409|NCT03820323|76025205|FG001|Overall Study|Lost to Follow-up|1|||
42301453|NCT02513485|76136704|FG000|Overall Study|Adverse Event|1|||
41967707|NCT05083949|75767672|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
41967708|NCT05083949|75767671|FG000|Period 1|Adverse Event|1|||
41967709|NCT05083949|75767672|FG001|Period 1|Adverse Event|1|||
41967710|NCT05083949|75767671|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
41967711|NCT05083949|75767672|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
41967712|NCT05083949|75767671|FG000|Period 2|Adverse Event|0|||
41967713|NCT05083949|75767672|FG001|Period 2|Adverse Event|2|||
41967714|NCT04982575|75767684|FG000|Overall Study|Withdrawal by Subject|2|||
41967715|NCT04982575|75767685|FG001|Overall Study|Withdrawal by Subject|0|||
41967716|NCT04982575|75767686|FG002|Overall Study|Withdrawal by Subject|2|||
42301454|NCT02513485|76136705|FG001|Overall Study|Adverse Event|0|||
42301455|NCT02289417|76136714|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
42301456|NCT02289417|76136715|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
42301457|NCT02289417|76136716|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
42301458|NCT02289417|76136717|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
42301459|NCT02289417|76136718|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
42301460|NCT02289417|76136719|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
42301461|NCT02289417|76136720|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
42301462|NCT02289417|76136721|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
41967717|NCT05776901|75767717|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
41967718|NCT05344560|75767721|FG000|Period 1|Subject out of visit window|1|||
41967719|NCT05344560|75767722|FG001|Period 1|Subject out of visit window|1|||
41967720|NCT05344560|75767721|FG000|Period 2|Covid-19 Related|1|||
41967721|NCT05344560|75767722|FG001|Period 2|Covid-19 Related|0|||
41967722|NCT05344560|75767721|FG000|Period 2|Adverse Event|1|||
41967723|NCT05344560|75767722|FG001|Period 2|Adverse Event|0|||
41967724|NCT05344560|75767721|FG000|Period 2|Subject out of visit window|1|||
42124483|NCT03831880|75934800|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
42124484|NCT03831880|75934801|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
41967725|NCT05344560|75767722|FG001|Period 2|Subject out of visit window|1|||
41967726|NCT05344560|75767721|FG000|Period 3|Subject out of visit window|1|||
41967727|NCT05344560|75767722|FG001|Period 3|Subject out of visit window|0|||
41967728|NCT05024058|75767742|FG000|Treatment|Study terminated by sponsor|5|||
42124485|NCT03831880|75934800|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
42124486|NCT03831880|75934801|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
42124487|NCT00380692|75934824|FG000|Study Period II - Double Blind|Adverse Event|1|||
42124488|NCT00380692|75934825|FG001|Study Period II - Double Blind|Adverse Event|0|||
42124489|NCT00380692|75934824|FG000|Study Period II - Double Blind|Protocol Violation|2|||
42124490|NCT00380692|75934825|FG001|Study Period II - Double Blind|Protocol Violation|2|||
42124491|NCT00380692|75934824|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
42124492|NCT00380692|75934825|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
42124493|NCT00380692|75934824|FG000|Study Period II - Double Blind|Physician Decision|0|||
42124494|NCT00380692|75934825|FG001|Study Period II - Double Blind|Physician Decision|1|||
42124495|NCT00380692|75934824|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
42124496|NCT00380692|75934825|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
42124497|NCT00380692|75934824|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
42124498|NCT00380692|75934825|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
42124499|NCT00380692|75934824|FG000|Study Period III - Open Label|Adverse Event|5|||
42124500|NCT00380692|75934825|FG001|Study Period III - Open Label|Adverse Event|3|||
42124501|NCT00380692|75934824|FG000|Study Period III - Open Label|Protocol Violation|0|||
42124502|NCT00380692|75934825|FG001|Study Period III - Open Label|Protocol Violation|0|||
42124503|NCT00380692|75934824|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
42124504|NCT00380692|75934825|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
42124505|NCT00380692|75934824|FG000|Study Period III - Open Label|Physician Decision|0|||
42124506|NCT00380692|75934825|FG001|Study Period III - Open Label|Physician Decision|3|||
42124507|NCT00380692|75934824|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
42124508|NCT00380692|75934825|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
42124509|NCT00380692|75934824|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
41967729|NCT05024058|75767743|FG001|Treatment|Study terminated by sponsor|6|||
41967730|NCT05024058|75767744|FG002|Treatment|Study terminated by sponsor|4|||
41967731|NCT05024058|75767745|FG003|Treatment|Study terminated by sponsor|2|||
41967732|NCT05024058|75767746|FG004|Treatment|Study terminated by sponsor|3|||
41967733|NCT05024058|75767747|FG005|Treatment|Study terminated by sponsor|3|||
41967734|NCT05024058|75767748|FG006|Treatment|Study terminated by sponsor|1|||
41967735|NCT05024058|75767749|FG007|Treatment|Study terminated by sponsor|3|||
41967736|NCT05024058|75767750|FG008|Treatment|Study terminated by sponsor|6|||
41967737|NCT05024058|75767751|FG009|Treatment|Study terminated by sponsor|6|||
41967738|NCT05024058|75767742|FG000|Follow-up|Withdrawal by Subject|1|||
42124510|NCT00380692|75934825|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
42124511|NCT00536874|75934831|FG000|Overall Study|Adverse Event|1|||
42301463|NCT02289417|76136722|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
42124512|NCT00536874|75934831|FG000|Overall Study|Death|2|||
42124513|NCT00536874|75934831|FG000|Overall Study|Withdrawal by Subject|1|||
42124514|NCT00380068|75934835|FG000|Overall Study|Adverse Event|40|||
42124515|NCT00380068|75934835|FG000|Overall Study|Withdrawal by Subject|10|||
42124516|NCT00380068|75934835|FG000|Overall Study|Not compliant|6|||
42124517|NCT00380068|75934835|FG000|Overall Study|Lost to Follow-up|1|||
42124518|NCT00380068|75934835|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
42124519|NCT00380068|75934835|FG000|Overall Study|Lung transplant|3|||
42124520|NCT00380068|75934835|FG000|Overall Study|Physician Decision|2|||
42124521|NCT00380068|75934835|FG000|Overall Study|Partipant moved away|1|||
42124522|NCT00380068|75934835|FG000|Overall Study|Lack of Efficacy|5|||
42124523|NCT00536484|75934841|FG000|Overall Study|Adverse Event|21|||
42124524|NCT00536484|75934842|FG001|Overall Study|Adverse Event|34|||
42124525|NCT00536484|75934841|FG000|Overall Study|Withdrawal by Subject|11|||
42124526|NCT00536484|75934842|FG001|Overall Study|Withdrawal by Subject|11|||
42124527|NCT00536484|75934841|FG000|Overall Study|Lost to Follow-up|8|||
42124528|NCT00536484|75934842|FG001|Overall Study|Lost to Follow-up|6|||
42124529|NCT00536484|75934841|FG000|Overall Study|Lack of Efficacy|16|||
42124530|NCT00536484|75934842|FG001|Overall Study|Lack of Efficacy|5|||
42124531|NCT00536484|75934841|FG000|Overall Study|Other|4|||
42124532|NCT00536484|75934842|FG001|Overall Study|Other|0|||
42124533|NCT00370396|75934851|FG000|Overall Study|Withdrawal by Subject|0|||
42124534|NCT00370396|75934852|FG001|Overall Study|Withdrawal by Subject|0|||
42124535|NCT00370396|75934853|FG002|Overall Study|Withdrawal by Subject|1|||
42124536|NCT00370396|75934851|FG000|Overall Study|Lost to Follow-up|11|||
42124537|NCT00370396|75934852|FG001|Overall Study|Lost to Follow-up|1|||
42124538|NCT00370396|75934853|FG002|Overall Study|Lost to Follow-up|0|||
42124539|NCT00455013|75934864|FG000|Short Term Period|Adverse Event|2|||
42124540|NCT00455013|75934865|FG001|Short Term Period|Adverse Event|5|||
42124541|NCT00455013|75934866|FG002|Short Term Period|Adverse Event|0|||
42124542|NCT00455013|75934864|FG000|Short Term Period|Withdrawal by Subject|0|||
42124543|NCT00455013|75934865|FG001|Short Term Period|Withdrawal by Subject|0|||
42124544|NCT00455013|75934866|FG002|Short Term Period|Withdrawal by Subject|1|||
42124545|NCT00455013|75934864|FG000|Short Term Period|Lack of Efficacy|4|||
42124546|NCT00455013|75934865|FG001|Short Term Period|Lack of Efficacy|0|||
42124547|NCT00455013|75934866|FG002|Short Term Period|Lack of Efficacy|0|||
42124548|NCT00455013|75934864|FG000|Short Term Period|Other|0|||
42124549|NCT00455013|75934865|FG001|Short Term Period|Other|0|||
42124550|NCT00455013|75934866|FG002|Short Term Period|Other|1|||
42124551|NCT00455013|75934864|FG000|Long Term Extension (LTE)|Adverse Event|0|||
41967739|NCT05024058|75767743|FG001|Follow-up|Withdrawal by Subject|0|||
41967740|NCT05024058|75767744|FG002|Follow-up|Withdrawal by Subject|1|||
41967741|NCT05024058|75767745|FG003|Follow-up|Withdrawal by Subject|0|||
41967742|NCT05024058|75767746|FG004|Follow-up|Withdrawal by Subject|0|||
41967743|NCT05024058|75767747|FG005|Follow-up|Withdrawal by Subject|0|||
41967744|NCT05024058|75767748|FG006|Follow-up|Withdrawal by Subject|0|||
41967745|NCT05024058|75767749|FG007|Follow-up|Withdrawal by Subject|1|||
42124552|NCT00455013|75934865|FG001|Long Term Extension (LTE)|Adverse Event|1|||
42124553|NCT00455013|75934866|FG002|Long Term Extension (LTE)|Adverse Event|1|||
42124554|NCT00455013|75934864|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
42124555|NCT00455013|75934865|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
42124556|NCT00455013|75934866|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
42124557|NCT00455013|75934864|FG000|Long Term Extension (LTE)|Death|1|||
42124558|NCT00455013|75934865|FG001|Long Term Extension (LTE)|Death|1|||
42124559|NCT00455013|75934866|FG002|Long Term Extension (LTE)|Death|0|||
42124560|NCT00455013|75934864|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
42124561|NCT00455013|75934865|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
42124562|NCT00455013|75934866|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
42124563|NCT00455013|75934864|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
42124564|NCT00455013|75934865|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
42124565|NCT00455013|75934866|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
42124566|NCT00455013|75934864|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
42124567|NCT00455013|75934865|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
41967746|NCT05024058|75767750|FG008|Follow-up|Withdrawal by Subject|0|||
41967747|NCT05024058|75767751|FG009|Follow-up|Withdrawal by Subject|1|||
41967748|NCT05013008|75767774|FG000|Overall Study|Exclusion from mBFAS|5|||
42027821|NCT01169675|75836088|FG002|Overall Study|Withdrawal by Subject|0|||
42124568|NCT00455013|75934866|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
42124569|NCT00455013|75934864|FG000|Long Term Extension (LTE)|non-specified|0|||
42124570|NCT00455013|75934865|FG001|Long Term Extension (LTE)|non-specified|0|||
42124571|NCT00455013|75934866|FG002|Long Term Extension (LTE)|non-specified|1|||
42124572|NCT00363298|75934876|FG000|First Study Week|Lack of Efficacy|6|||
42124573|NCT00363298|75934877|FG001|First Study Week|Lack of Efficacy|5|||
42124574|NCT00363298|75934876|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
42124575|NCT00363298|75934877|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
42124576|NCT00363142|75934886|FG000|Overall Study|Adverse Event|2|||
42124577|NCT00363142|75934887|FG001|Overall Study|Adverse Event|0|||
42124578|NCT00363142|75934886|FG000|Overall Study|Lack of Efficacy|0|||
42124579|NCT00363142|75934887|FG001|Overall Study|Lack of Efficacy|1|||
42124580|NCT00363142|75934886|FG000|Overall Study|Lost to Follow-up|1|||
42124581|NCT00363142|75934887|FG001|Overall Study|Lost to Follow-up|0|||
42124582|NCT00363142|75934886|FG000|Overall Study|Non-compliance|1|||
42124583|NCT00363142|75934887|FG001|Overall Study|Non-compliance|1|||
42124584|NCT00363142|75934886|FG000|Overall Study|Withdrawal by Subject|3|||
42124585|NCT00363142|75934887|FG001|Overall Study|Withdrawal by Subject|1|||
42124586|NCT00454857|75934896|FG000|Overall Study|Withdrawal by Subject|15|||
42124587|NCT00454857|75934896|FG000|Overall Study|Lost to Follow-up|16|||
42124588|NCT00454857|75934896|FG000|Overall Study|Noncompliance|6|||
42124589|NCT00454857|75934896|FG000|Overall Study|Death|5|||
42124590|NCT00454857|75934896|FG000|Overall Study|Other|11|||
42124591|NCT00454857|75934896|FG000|Overall Study|Reason unknown|1|||
42124592|NCT00379912|75934902|FG000|Overall Study|Lack of Efficacy|1|||
42124593|NCT00379912|75934903|FG001|Overall Study|Lack of Efficacy|0|||
42124594|NCT00379834|75934915|FG000|Overall Study|Time constraints|2|||
42124595|NCT00379210|75934921|FG000|Overall Study|Withdrawal by Subject|10|||
42124596|NCT00379210|75934922|FG001|Overall Study|Withdrawal by Subject|7|||
42124597|NCT00378898|75934930|FG000|Overall Study|Withdrawal by Subject|10|||
42124598|NCT00378898|75934931|FG001|Overall Study|Withdrawal by Subject|5|||
42124599|NCT00378898|75934930|FG000|Overall Study|Protocol Violation|1|||
42124600|NCT00378898|75934931|FG001|Overall Study|Protocol Violation|1|||
42124601|NCT00378508|75934941|FG000|Overall Study|Withdrawal by Subject|1|||
42124602|NCT00378508|75934942|FG001|Overall Study|Withdrawal by Subject|3|||
42124603|NCT00378508|75934941|FG000|Overall Study|Lost to Follow-up|1|||
42124604|NCT00378508|75934942|FG001|Overall Study|Lost to Follow-up|0|||
42124605|NCT00454779|75934951|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
42124606|NCT00454779|75934952|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
42124607|NCT00454779|75934951|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
42124608|NCT00454779|75934952|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
42124609|NCT00454779|75934951|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
42124610|NCT00454779|75934952|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
42124611|NCT00454779|75934951|FG000|First-line Treatment Phase|Protocol Violation|0|||
42124612|NCT00454779|75934952|FG001|First-line Treatment Phase|Protocol Violation|1|||
42124613|NCT00454779|75934951|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
42124614|NCT00454779|75934952|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
42124615|NCT00454779|75934951|FG000|First-line Treatment Phase|Ongoing|1|||
42124616|NCT00454779|75934952|FG001|First-line Treatment Phase|Ongoing|0|||
42124617|NCT00454779|75934951|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
42124618|NCT00454779|75934952|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
42124619|NCT00454779|75934951|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
42124620|NCT00454779|75934952|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
42124621|NCT00454779|75934951|FG000|Second-line Treatment Phase|Ongoing|0|||
42124622|NCT00454779|75934952|FG001|Second-line Treatment Phase|Ongoing|1|||
42124623|NCT00439569|75934962|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
42124624|NCT00439569|75934962|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
42124625|NCT00439569|75934962|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
42124626|NCT00443079|75934968|FG000|Overall Study|Lost to Follow-up|0|||
42124627|NCT00443079|75934969|FG001|Overall Study|Lost to Follow-up|1|||
42124628|NCT00427635|75935005|FG000|Treatment Phase|Withdrawal by Subject|1|||
42124629|NCT00427635|75935006|FG001|Treatment Phase|Withdrawal by Subject|0|||
41967749|NCT05013008|75767775|FG001|Overall Study|Exclusion from mBFAS|25|||
41967750|NCT04826900|75767783|FG000|Overall Study|Family factor|1|||
41967751|NCT04826900|75767784|FG001|Overall Study|Family factor|1|||
41967752|NCT04721158|75767790|FG000|Overall Study|Lost to Follow-up|4|||
41967753|NCT04721158|75767790|FG000|Overall Study|Device did not connect|1|||
41967754|NCT04263766|75767797|FG000|Overall Study|Withdrawal by Subject|6|||
41967755|NCT04263766|75767798|FG001|Overall Study|Withdrawal by Subject|4|||
42124630|NCT00427635|75935005|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
42124631|NCT00427635|75935006|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
42210410|NCT03820323|76025204|FG000|Overall Study|Missed 12-month visit|22|||
41967756|NCT04263766|75767797|FG000|Overall Study|Lack of Efficacy|1|||
41967757|NCT04263766|75767798|FG001|Overall Study|Lack of Efficacy|3|||
42124632|NCT00427011|75935012|FG000|Overall Study|Adverse Event|10|||
41967758|NCT04203199|75767820|FG000|First Intervention Period|Lost to Follow-up|0|||
42124633|NCT00427011|75935012|FG000|Overall Study|Withdrawal by Subject|1|||
42124634|NCT00427011|75935012|FG000|Overall Study|Lack of Efficacy|2|||
42124635|NCT00427011|75935012|FG000|Overall Study|Other|12|||
42124636|NCT03891264|75935017|FG000|Overall Study|Adverse Event|1|||
42124637|NCT03891264|75935017|FG000|Overall Study|Withdrawal by Subject|2|||
42124638|NCT03891264|75935017|FG000|Overall Study|Physician Decision|2|||
42124639|NCT00439179|75935025|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
42124640|NCT00439179|75935026|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
42124641|NCT00439179|75935027|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
41967759|NCT04203199|75767821|FG001|First Intervention Period|Lost to Follow-up|1|||
41967760|NCT04203199|75767820|FG000|Second Intervention Period|Medication change|1|||
41967761|NCT04203199|75767821|FG001|Second Intervention Period|Medication change|0|||
41967762|NCT04191733|75767829|FG000|Overall Study|Withdrawn due to study closure|13|||
41967763|NCT04191733|75767830|FG001|Overall Study|Withdrawn due to study closure|14|||
41967764|NCT04191733|75767829|FG000|Overall Study|Withdrawal by Subject|2|||
41967765|NCT04191733|75767830|FG001|Overall Study|Withdrawal by Subject|4|||
41967766|NCT04191733|75767829|FG000|Overall Study|Physician Decision|1|||
41967767|NCT04191733|75767830|FG001|Overall Study|Physician Decision|1|||
41967768|NCT04191733|75767829|FG000|Overall Study|Lost to Follow-up|5|||
41967769|NCT04191733|75767830|FG001|Overall Study|Lost to Follow-up|6|||
41967770|NCT04191733|75767829|FG000|Overall Study|Death|0|||
42124642|NCT00439179|75935028|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
42124643|NCT00438633|75935043|FG000|Overall Study|Withdrawal by Subject|1|||
42124644|NCT00438633|75935044|FG001|Overall Study|Withdrawal by Subject|0|||
42124645|NCT00438633|75935043|FG000|Overall Study|Lost to Follow-up|15|||
42124646|NCT00438633|75935044|FG001|Overall Study|Lost to Follow-up|17|||
42124647|NCT00438399|75935053|FG000|Overall Study|Lost to Follow-up|2|||
42124648|NCT00438399|75935054|FG001|Overall Study|Lost to Follow-up|2|||
42124649|NCT00438399|75935055|FG002|Overall Study|Lost to Follow-up|1|||
42124650|NCT00438399|75935056|FG003|Overall Study|Lost to Follow-up|1|||
42124651|NCT00438399|75935057|FG004|Overall Study|Lost to Follow-up|1|||
42124652|NCT00438399|75935058|FG005|Overall Study|Lost to Follow-up|1|||
42124653|NCT00438399|75935053|FG000|Overall Study|Adverse Event|0|||
42124654|NCT00438399|75935054|FG001|Overall Study|Adverse Event|0|||
41967771|NCT04191733|75767830|FG001|Overall Study|Death|1|||
41967772|NCT04049097|75767836|FG000|Overall Study|Adverse Event|18|||
41967773|NCT04049097|75767836|FG000|Overall Study|Death|2|||
41967774|NCT04049097|75767836|FG000|Overall Study|Lost to Follow-up|1|||
41967775|NCT04049097|75767836|FG000|Overall Study|Physician Decision|2|||
41967776|NCT04049097|75767836|FG000|Overall Study|Withdrawal by Subject|9|||
41967777|NCT04049097|75767836|FG000|Overall Study|Protocol Violation|2|||
41967778|NCT04049097|75767836|FG000|Overall Study|Other|1|||
41967779|NCT04049097|75767836|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
41967780|NCT04002310|75767845|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
41967781|NCT04002310|75767846|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
41967782|NCT04002310|75767847|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
41967783|NCT04002310|75767848|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
41967784|NCT04002310|75767849|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
41967785|NCT03887650|75767872|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
41967786|NCT03887650|75767873|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
41967787|NCT03887650|75767872|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
41967788|NCT03887650|75767873|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
41967789|NCT03887650|75767872|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
41967790|NCT03887650|75767873|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
41967791|NCT03345342|75767911|FG000|Open-Label Phase|Adverse Event|30|||
41967792|NCT03345342|75767912|FG001|Open-Label Phase|Adverse Event|0|||
41967793|NCT03345342|75767913|FG002|Open-Label Phase|Adverse Event|0|||
41967794|NCT03345342|75767914|FG003|Open-Label Phase|Adverse Event|0|||
41967795|NCT03345342|75767915|FG004|Open-Label Phase|Adverse Event|0|||
41967796|NCT03345342|75767911|FG000|Open-Label Phase|Death|1|||
41967797|NCT03345342|75767912|FG001|Open-Label Phase|Death|0|||
41967798|NCT03345342|75767913|FG002|Open-Label Phase|Death|0|||
41967799|NCT03345342|75767914|FG003|Open-Label Phase|Death|0|||
41967800|NCT03345342|75767915|FG004|Open-Label Phase|Death|0|||
41967801|NCT03345342|75767911|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
41967802|NCT03345342|75767912|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
41967803|NCT03345342|75767913|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
41967804|NCT03345342|75767914|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
42124655|NCT00438399|75935055|FG002|Overall Study|Adverse Event|1|||
42124656|NCT00438399|75935056|FG003|Overall Study|Adverse Event|1|||
42124657|NCT00438399|75935057|FG004|Overall Study|Adverse Event|0|||
42124658|NCT00438399|75935058|FG005|Overall Study|Adverse Event|1|||
41967805|NCT03345342|75767915|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
42124659|NCT00438399|75935053|FG000|Overall Study|Withdrawal by Subject|5|||
42124660|NCT00438399|75935054|FG001|Overall Study|Withdrawal by Subject|6|||
42124661|NCT00438399|75935055|FG002|Overall Study|Withdrawal by Subject|3|||
42124662|NCT00438399|75935056|FG003|Overall Study|Withdrawal by Subject|2|||
42124663|NCT00438399|75935057|FG004|Overall Study|Withdrawal by Subject|2|||
42124664|NCT00438399|75935058|FG005|Overall Study|Withdrawal by Subject|2|||
42124665|NCT00438399|75935053|FG000|Overall Study|Protocol Violation|0|||
41967806|NCT03345342|75767911|FG000|Open-Label Phase|Lack of Efficacy|6|||
41967807|NCT03345342|75767912|FG001|Open-Label Phase|Lack of Efficacy|0|||
41967808|NCT03345342|75767913|FG002|Open-Label Phase|Lack of Efficacy|0|||
41967809|NCT03345342|75767914|FG003|Open-Label Phase|Lack of Efficacy|0|||
42124666|NCT00438399|75935054|FG001|Overall Study|Protocol Violation|0|||
42124667|NCT00438399|75935055|FG002|Overall Study|Protocol Violation|1|||
41967810|NCT03345342|75767915|FG004|Open-Label Phase|Lack of Efficacy|0|||
41967811|NCT03345342|75767911|FG000|Open-Label Phase|Lost to Follow-up|9|||
41967812|NCT03345342|75767912|FG001|Open-Label Phase|Lost to Follow-up|0|||
41967813|NCT03345342|75767913|FG002|Open-Label Phase|Lost to Follow-up|0|||
41967814|NCT03345342|75767914|FG003|Open-Label Phase|Lost to Follow-up|0|||
41967815|NCT03345342|75767915|FG004|Open-Label Phase|Lost to Follow-up|0|||
41967816|NCT03345342|75767911|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
41967817|NCT03345342|75767912|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
41967818|NCT03345342|75767913|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
41967819|NCT03345342|75767914|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
41967820|NCT03345342|75767915|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
41967821|NCT03345342|75767911|FG000|Open-Label Phase|Physician Decision|4|||
41967822|NCT03345342|75767912|FG001|Open-Label Phase|Physician Decision|0|||
41967823|NCT03345342|75767913|FG002|Open-Label Phase|Physician Decision|0|||
41967824|NCT03345342|75767914|FG003|Open-Label Phase|Physician Decision|0|||
41967825|NCT03345342|75767915|FG004|Open-Label Phase|Physician Decision|0|||
41967826|NCT03345342|75767911|FG000|Open-Label Phase|Protocol Violation|8|||
41967827|NCT03345342|75767912|FG001|Open-Label Phase|Protocol Violation|0|||
41967828|NCT03345342|75767913|FG002|Open-Label Phase|Protocol Violation|0|||
41967829|NCT03345342|75767914|FG003|Open-Label Phase|Protocol Violation|0|||
41967830|NCT03345342|75767915|FG004|Open-Label Phase|Protocol Violation|0|||
41967831|NCT03345342|75767911|FG000|Open-Label Phase|Withdrawal by Subject|57|||
41967832|NCT03345342|75767912|FG001|Open-Label Phase|Withdrawal by Subject|0|||
42124668|NCT00438399|75935056|FG003|Overall Study|Protocol Violation|0|||
42124669|NCT00438399|75935057|FG004|Overall Study|Protocol Violation|0|||
42124670|NCT00438399|75935058|FG005|Overall Study|Protocol Violation|1|||
42124671|NCT00438399|75935053|FG000|Overall Study|Subje stopped study|0|||
42124672|NCT00438399|75935054|FG001|Overall Study|Subje stopped study|0|||
42124673|NCT00438399|75935055|FG002|Overall Study|Subje stopped study|1|||
42124674|NCT00438399|75935056|FG003|Overall Study|Subje stopped study|0|||
42124675|NCT00438399|75935057|FG004|Overall Study|Subje stopped study|0|||
42124676|NCT00438399|75935058|FG005|Overall Study|Subje stopped study|0|||
42124677|NCT00438399|75935053|FG000|Overall Study|Pregnancy|0|||
42124678|NCT00438399|75935054|FG001|Overall Study|Pregnancy|0|||
42124679|NCT00438399|75935055|FG002|Overall Study|Pregnancy|0|||
42124680|NCT00438399|75935056|FG003|Overall Study|Pregnancy|0|||
42124681|NCT00438399|75935057|FG004|Overall Study|Pregnancy|0|||
42124682|NCT00438399|75935058|FG005|Overall Study|Pregnancy|1|||
42124683|NCT00438399|75935053|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
42124684|NCT00438399|75935054|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
42124685|NCT00438399|75935055|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
42124686|NCT00438399|75935056|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
42124687|NCT00438399|75935057|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
42124688|NCT00438399|75935058|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
42124689|NCT00426231|75935069|FG000|Overall Study|Withdrawal by Subject|9|||
42124690|NCT00426231|75935070|FG001|Overall Study|Withdrawal by Subject|12|||
42124691|NCT00425607|75935076|FG000|Overall Study|Death|1|||
42124692|NCT00425607|75935076|FG000|Overall Study|Withdrawal by Subject|1|||
42124693|NCT00437073|75935082|FG000|Overall Study|Sponsor Terminated Study|1|||
42124694|NCT00437073|75935083|FG001|Overall Study|Sponsor Terminated Study|0|||
42124695|NCT00437073|75935082|FG000|Overall Study|Physician Decision|0|||
42124696|NCT00437073|75935083|FG001|Overall Study|Physician Decision|1|||
42124697|NCT00425373|75935098|FG000|Overall Study|Adverse Event|2|||
42124698|NCT00425373|75935099|FG001|Overall Study|Adverse Event|2|||
42124699|NCT00425373|75935100|FG002|Overall Study|Adverse Event|0|||
42124700|NCT00425373|75935101|FG003|Overall Study|Adverse Event|1|||
42124701|NCT00425373|75935102|FG004|Overall Study|Adverse Event|4|||
42124702|NCT00425373|75935103|FG005|Overall Study|Adverse Event|6|||
42124703|NCT00425373|75935104|FG006|Overall Study|Adverse Event|2|||
42124704|NCT00425373|75935105|FG007|Overall Study|Adverse Event|3|||
42124705|NCT00425373|75935106|FG008|Overall Study|Adverse Event|8|||
42124706|NCT00425373|75935098|FG000|Overall Study|Lost to Follow-up|0|||
42124707|NCT00425373|75935099|FG001|Overall Study|Lost to Follow-up|1|||
42124708|NCT00425373|75935100|FG002|Overall Study|Lost to Follow-up|0|||
42124709|NCT00425373|75935101|FG003|Overall Study|Lost to Follow-up|0|||
41967833|NCT03345342|75767913|FG002|Open-Label Phase|Withdrawal by Subject|0|||
42124710|NCT00425373|75935102|FG004|Overall Study|Lost to Follow-up|1|||
42124711|NCT00425373|75935103|FG005|Overall Study|Lost to Follow-up|0|||
42124712|NCT00425373|75935104|FG006|Overall Study|Lost to Follow-up|0|||
42124713|NCT00425373|75935105|FG007|Overall Study|Lost to Follow-up|0|||
42124714|NCT00425373|75935106|FG008|Overall Study|Lost to Follow-up|0|||
42124715|NCT00425373|75935098|FG000|Overall Study|Protocol Violation|1|||
42124716|NCT00425373|75935099|FG001|Overall Study|Protocol Violation|0|||
42124717|NCT00425373|75935100|FG002|Overall Study|Protocol Violation|1|||
42124718|NCT00425373|75935101|FG003|Overall Study|Protocol Violation|0|||
41967834|NCT03345342|75767914|FG003|Open-Label Phase|Withdrawal by Subject|0|||
41967835|NCT03345342|75767915|FG004|Open-Label Phase|Withdrawal by Subject|0|||
41967836|NCT03345342|75767911|FG000|Open-Label Phase|Other|15|||
42124719|NCT00425373|75935102|FG004|Overall Study|Protocol Violation|0|||
42124720|NCT00425373|75935103|FG005|Overall Study|Protocol Violation|0|||
42124721|NCT00425373|75935104|FG006|Overall Study|Protocol Violation|0|||
42124722|NCT00425373|75935105|FG007|Overall Study|Protocol Violation|5|||
42124723|NCT00425373|75935106|FG008|Overall Study|Protocol Violation|3|||
42124724|NCT00425373|75935098|FG000|Overall Study|Withdrawal by Subject|2|||
42124725|NCT00425373|75935099|FG001|Overall Study|Withdrawal by Subject|0|||
42124726|NCT00425373|75935100|FG002|Overall Study|Withdrawal by Subject|2|||
42124727|NCT00425373|75935101|FG003|Overall Study|Withdrawal by Subject|1|||
42124728|NCT00425373|75935102|FG004|Overall Study|Withdrawal by Subject|4|||
42124729|NCT00425373|75935103|FG005|Overall Study|Withdrawal by Subject|0|||
42124730|NCT00425373|75935104|FG006|Overall Study|Withdrawal by Subject|2|||
42124731|NCT00425373|75935105|FG007|Overall Study|Withdrawal by Subject|2|||
42124732|NCT00425373|75935106|FG008|Overall Study|Withdrawal by Subject|2|||
42124733|NCT00425373|75935098|FG000|Overall Study|Lack of Efficacy|0|||
42124734|NCT00425373|75935099|FG001|Overall Study|Lack of Efficacy|0|||
42124735|NCT00425373|75935100|FG002|Overall Study|Lack of Efficacy|0|||
42124736|NCT00425373|75935101|FG003|Overall Study|Lack of Efficacy|0|||
42124737|NCT00425373|75935102|FG004|Overall Study|Lack of Efficacy|1|||
42124738|NCT00425373|75935103|FG005|Overall Study|Lack of Efficacy|3|||
42124739|NCT00425373|75935104|FG006|Overall Study|Lack of Efficacy|3|||
42124740|NCT00425373|75935105|FG007|Overall Study|Lack of Efficacy|0|||
42124741|NCT00425373|75935106|FG008|Overall Study|Lack of Efficacy|5|||
42124742|NCT03894540|75935132|FG000|Overall Study|Adverse Event|0|||
42124743|NCT03894540|75935133|FG001|Overall Study|Adverse Event|0|||
42124744|NCT03894540|75935134|FG002|Overall Study|Adverse Event|0|||
42124745|NCT03894540|75935135|FG003|Overall Study|Adverse Event|0|||
42124746|NCT03894540|75935136|FG004|Overall Study|Adverse Event|1|||
42124747|NCT03894540|75935137|FG005|Overall Study|Adverse Event|0|||
42124748|NCT03894540|75935132|FG000|Overall Study|Withdrawal by Subject|0|||
42124749|NCT03894540|75935133|FG001|Overall Study|Withdrawal by Subject|0|||
42124750|NCT03894540|75935134|FG002|Overall Study|Withdrawal by Subject|0|||
42124751|NCT03894540|75935135|FG003|Overall Study|Withdrawal by Subject|0|||
42124752|NCT03894540|75935136|FG004|Overall Study|Withdrawal by Subject|1|||
42124753|NCT03894540|75935137|FG005|Overall Study|Withdrawal by Subject|0|||
42124754|NCT03894540|75935132|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
42124755|NCT03894540|75935133|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
42124756|NCT03894540|75935134|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
41967837|NCT03345342|75767912|FG001|Open-Label Phase|Other|0|||
41967838|NCT03345342|75767913|FG002|Open-Label Phase|Other|0|||
41967839|NCT03345342|75767914|FG003|Open-Label Phase|Other|0|||
41967840|NCT03345342|75767915|FG004|Open-Label Phase|Other|0|||
41967841|NCT03345342|75767911|FG000|Double-Blind Phase|Adverse Event|0|||
41967842|NCT03345342|75767912|FG001|Double-Blind Phase|Adverse Event|1|||
41967843|NCT03345342|75767913|FG002|Double-Blind Phase|Adverse Event|6|||
41967844|NCT03345342|75767914|FG003|Double-Blind Phase|Adverse Event|0|||
41967845|NCT03345342|75767915|FG004|Double-Blind Phase|Adverse Event|0|||
41967846|NCT03345342|75767911|FG000|Double-Blind Phase|Death|0|||
41967847|NCT03345342|75767912|FG001|Double-Blind Phase|Death|2|||
41967848|NCT03345342|75767913|FG002|Double-Blind Phase|Death|1|||
41967849|NCT03345342|75767914|FG003|Double-Blind Phase|Death|0|||
41967850|NCT03345342|75767915|FG004|Double-Blind Phase|Death|0|||
41967851|NCT03345342|75767911|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
41967852|NCT03345342|75767912|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
41967853|NCT03345342|75767913|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
41967854|NCT03345342|75767914|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
41967855|NCT03345342|75767915|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
41967856|NCT03345342|75767911|FG000|Double-Blind Phase|Lost to Follow-up|0|||
41967857|NCT03345342|75767912|FG001|Double-Blind Phase|Lost to Follow-up|1|||
41967858|NCT03345342|75767913|FG002|Double-Blind Phase|Lost to Follow-up|7|||
41967859|NCT03345342|75767914|FG003|Double-Blind Phase|Lost to Follow-up|0|||
42124757|NCT03894540|75935135|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
42124758|NCT03894540|75935136|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
42124759|NCT03894540|75935137|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
42124760|NCT03894540|75935132|FG000|Overall Study|Progressive Disease Clinical|1|||
42124761|NCT03894540|75935133|FG001|Overall Study|Progressive Disease Clinical|1|||
42124762|NCT03894540|75935134|FG002|Overall Study|Progressive Disease Clinical|0|||
42124763|NCT03894540|75935135|FG003|Overall Study|Progressive Disease Clinical|1|||
41967860|NCT03345342|75767915|FG004|Double-Blind Phase|Lost to Follow-up|0|||
41967861|NCT03345342|75767911|FG000|Double-Blind Phase|Physician Decision|0|||
41967862|NCT03345342|75767912|FG001|Double-Blind Phase|Physician Decision|1|||
41967863|NCT03345342|75767913|FG002|Double-Blind Phase|Physician Decision|4|||
41967864|NCT03345342|75767914|FG003|Double-Blind Phase|Physician Decision|0|||
42124764|NCT03894540|75935136|FG004|Overall Study|Progressive Disease Clinical|5|||
41967865|NCT03345342|75767915|FG004|Double-Blind Phase|Physician Decision|0|||
41967866|NCT03345342|75767911|FG000|Double-Blind Phase|Protocol Violation|0|||
41967867|NCT03345342|75767912|FG001|Double-Blind Phase|Protocol Violation|0|||
41967868|NCT03345342|75767913|FG002|Double-Blind Phase|Protocol Violation|1|||
41967869|NCT03345342|75767914|FG003|Double-Blind Phase|Protocol Violation|0|||
41967870|NCT03345342|75767915|FG004|Double-Blind Phase|Protocol Violation|0|||
41967871|NCT03345342|75767911|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
41967872|NCT03345342|75767912|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
41967873|NCT03345342|75767913|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
41967874|NCT03345342|75767914|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
42124765|NCT03894540|75935137|FG005|Overall Study|Progressive Disease Clinical|1|||
42124766|NCT03894540|75935132|FG000|Overall Study|Study termination by sponsor|0|||
42124767|NCT03894540|75935133|FG001|Overall Study|Study termination by sponsor|0|||
42124768|NCT03894540|75935134|FG002|Overall Study|Study termination by sponsor|0|||
42124769|NCT03894540|75935135|FG003|Overall Study|Study termination by sponsor|0|||
42124770|NCT03894540|75935136|FG004|Overall Study|Study termination by sponsor|2|||
42124771|NCT03894540|75935137|FG005|Overall Study|Study termination by sponsor|0|||
42124772|NCT00535626|75935155|FG000|Overall Study|Death|15|||
42124773|NCT00535626|75935155|FG000|Overall Study|Lost to Follow-up|29|||
42124774|NCT00535626|75935155|FG000|Overall Study|Withdrawal by Subject|20|||
42124775|NCT00535626|75935155|FG000|Overall Study|Removal/revision of study component|8|||
42124776|NCT00535626|75935155|FG000|Overall Study|Subject terminated|31|||
42124777|NCT00535626|75935155|FG000|Overall Study|Unable to return|2|||
42124778|NCT03889704|75935178|FG000|Overall Study|Study terminated due to pandemic|1|||
42124779|NCT03887442|75935184|FG000|Overall Study|Adverse Event|1|||
42124780|NCT03887442|75935185|FG001|Overall Study|Adverse Event|0|||
42301464|NCT02289417|76136714|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
42124781|NCT00425061|75935200|FG000|Overall Study|Adverse Event|1|||
42124782|NCT00425061|75935201|FG001|Overall Study|Adverse Event|0|||
42124783|NCT00425061|75935202|FG002|Overall Study|Adverse Event|0|||
42124784|NCT00425061|75935203|FG003|Overall Study|Adverse Event|2|||
42124785|NCT00425061|75935204|FG004|Overall Study|Adverse Event|2|||
42124786|NCT00425061|75935205|FG005|Overall Study|Adverse Event|0|||
42124787|NCT00425061|75935206|FG006|Overall Study|Adverse Event|0|||
42124788|NCT00425061|75935200|FG000|Overall Study|Lost to Follow-up|0|||
42124789|NCT00425061|75935201|FG001|Overall Study|Lost to Follow-up|1|||
42124790|NCT00425061|75935202|FG002|Overall Study|Lost to Follow-up|0|||
42124791|NCT00425061|75935203|FG003|Overall Study|Lost to Follow-up|0|||
42124792|NCT00425061|75935204|FG004|Overall Study|Lost to Follow-up|0|||
42124793|NCT00425061|75935205|FG005|Overall Study|Lost to Follow-up|0|||
42124794|NCT00425061|75935206|FG006|Overall Study|Lost to Follow-up|0|||
42124795|NCT00425061|75935200|FG000|Overall Study|Protocol Violation|1|||
42124796|NCT00425061|75935201|FG001|Overall Study|Protocol Violation|0|||
42124797|NCT00425061|75935202|FG002|Overall Study|Protocol Violation|0|||
42124798|NCT00425061|75935203|FG003|Overall Study|Protocol Violation|0|||
42124799|NCT00425061|75935204|FG004|Overall Study|Protocol Violation|0|||
42124800|NCT00425061|75935205|FG005|Overall Study|Protocol Violation|0|||
42124801|NCT00425061|75935206|FG006|Overall Study|Protocol Violation|0|||
42124802|NCT00425061|75935200|FG000|Overall Study|Withdrawal by Subject|0|||
42124803|NCT00425061|75935201|FG001|Overall Study|Withdrawal by Subject|1|||
42124804|NCT00425061|75935202|FG002|Overall Study|Withdrawal by Subject|0|||
42124805|NCT00425061|75935203|FG003|Overall Study|Withdrawal by Subject|0|||
42124806|NCT00425061|75935204|FG004|Overall Study|Withdrawal by Subject|1|||
42124807|NCT00425061|75935205|FG005|Overall Study|Withdrawal by Subject|0|||
42124808|NCT00425061|75935206|FG006|Overall Study|Withdrawal by Subject|3|||
42301465|NCT02289417|76136715|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
42124809|NCT00425061|75935200|FG000|Overall Study|Sponsor's request|0|||
42124810|NCT00425061|75935201|FG001|Overall Study|Sponsor's request|0|||
42124811|NCT00425061|75935202|FG002|Overall Study|Sponsor's request|0|||
42124812|NCT00425061|75935203|FG003|Overall Study|Sponsor's request|0|||
42124813|NCT00425061|75935204|FG004|Overall Study|Sponsor's request|19|||
42124814|NCT00425061|75935205|FG005|Overall Study|Sponsor's request|4|||
42124815|NCT00425061|75935206|FG006|Overall Study|Sponsor's request|15|||
42124816|NCT00425061|75935200|FG000|Overall Study|Physician Decision|0|||
41967875|NCT03345342|75767915|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
41967876|NCT03345342|75767911|FG000|Double-Blind Phase|Other|0|||
41967877|NCT03345342|75767912|FG001|Double-Blind Phase|Other|1|||
42124817|NCT00425061|75935201|FG001|Overall Study|Physician Decision|0|||
42124818|NCT00425061|75935202|FG002|Overall Study|Physician Decision|0|||
42124819|NCT00425061|75935203|FG003|Overall Study|Physician Decision|0|||
41967878|NCT03345342|75767913|FG002|Double-Blind Phase|Other|3|||
41967879|NCT03345342|75767914|FG003|Double-Blind Phase|Other|0|||
41967880|NCT03345342|75767915|FG004|Double-Blind Phase|Other|0|||
41967881|NCT03345342|75767911|FG000|Follow-Up Phase|Adverse Event|0|||
41967882|NCT03345342|75767912|FG001|Follow-Up Phase|Adverse Event|0|||
41967883|NCT03345342|75767913|FG002|Follow-Up Phase|Adverse Event|0|||
41967884|NCT03345342|75767914|FG003|Follow-Up Phase|Adverse Event|0|||
41967885|NCT03345342|75767915|FG004|Follow-Up Phase|Adverse Event|4|||
41967886|NCT03345342|75767911|FG000|Follow-Up Phase|Lost to Follow-up|0|||
41967887|NCT03345342|75767912|FG001|Follow-Up Phase|Lost to Follow-up|0|||
41967888|NCT03345342|75767913|FG002|Follow-Up Phase|Lost to Follow-up|0|||
41967889|NCT03345342|75767914|FG003|Follow-Up Phase|Lost to Follow-up|0|||
41967890|NCT03345342|75767915|FG004|Follow-Up Phase|Lost to Follow-up|6|||
41967891|NCT03345342|75767911|FG000|Follow-Up Phase|Physician Decision|0|||
41967892|NCT03345342|75767912|FG001|Follow-Up Phase|Physician Decision|0|||
41967893|NCT03345342|75767913|FG002|Follow-Up Phase|Physician Decision|0|||
41967894|NCT03345342|75767914|FG003|Follow-Up Phase|Physician Decision|0|||
41967895|NCT03345342|75767915|FG004|Follow-Up Phase|Physician Decision|5|||
41967896|NCT03345342|75767911|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
41967897|NCT03345342|75767912|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
42124820|NCT00425061|75935204|FG004|Overall Study|Physician Decision|1|||
41967898|NCT03345342|75767913|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
41967899|NCT03345342|75767914|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
41967900|NCT03345342|75767915|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
41967901|NCT03345342|75767911|FG000|Follow-Up Phase|Other|0|||
41967902|NCT03345342|75767912|FG001|Follow-Up Phase|Other|0|||
41967903|NCT03345342|75767913|FG002|Follow-Up Phase|Other|0|||
41967904|NCT03345342|75767914|FG003|Follow-Up Phase|Other|3|||
41967905|NCT03345342|75767915|FG004|Follow-Up Phase|Other|1|||
41967906|NCT03192176|75767939|FG000|Overall Study|Adverse Event|1|||
41967907|NCT03192176|75767940|FG001|Overall Study|Adverse Event|0|||
41967908|NCT03192176|75767941|FG002|Overall Study|Adverse Event|4|||
41967909|NCT03192176|75767942|FG003|Overall Study|Adverse Event|5|||
41967910|NCT03192176|75767943|FG004|Overall Study|Adverse Event|3|||
41967911|NCT03192176|75767944|FG005|Overall Study|Adverse Event|2|||
41967912|NCT03192176|75767945|FG006|Overall Study|Adverse Event|3|||
41967913|NCT03192176|75767946|FG007|Overall Study|Adverse Event|3|||
41967914|NCT03192176|75767939|FG000|Overall Study|Lost to Follow-up|0|||
41967915|NCT03192176|75767940|FG001|Overall Study|Lost to Follow-up|0|||
41967916|NCT03192176|75767941|FG002|Overall Study|Lost to Follow-up|1|||
41967917|NCT03192176|75767942|FG003|Overall Study|Lost to Follow-up|2|||
41967918|NCT03192176|75767943|FG004|Overall Study|Lost to Follow-up|3|||
41967919|NCT03192176|75767944|FG005|Overall Study|Lost to Follow-up|1|||
41967920|NCT03192176|75767945|FG006|Overall Study|Lost to Follow-up|1|||
41967921|NCT03192176|75767946|FG007|Overall Study|Lost to Follow-up|1|||
41967922|NCT03192176|75767939|FG000|Overall Study|Physician Decision|1|||
41967923|NCT03192176|75767940|FG001|Overall Study|Physician Decision|0|||
41967924|NCT03192176|75767941|FG002|Overall Study|Physician Decision|0|||
41967925|NCT03192176|75767942|FG003|Overall Study|Physician Decision|0|||
41967926|NCT03192176|75767943|FG004|Overall Study|Physician Decision|0|||
41967927|NCT03192176|75767944|FG005|Overall Study|Physician Decision|2|||
41967928|NCT03192176|75767945|FG006|Overall Study|Physician Decision|1|||
41967929|NCT03192176|75767946|FG007|Overall Study|Physician Decision|0|||
41967930|NCT03192176|75767939|FG000|Overall Study|Protocol Deviation|1|||
41967931|NCT03192176|75767940|FG001|Overall Study|Protocol Deviation|1|||
42124821|NCT00425061|75935205|FG005|Overall Study|Physician Decision|0|||
42124822|NCT00425061|75935206|FG006|Overall Study|Physician Decision|0|||
42124823|NCT00425061|75935200|FG000|Overall Study|Other|0|||
42124824|NCT00425061|75935201|FG001|Overall Study|Other|0|||
42124825|NCT00425061|75935202|FG002|Overall Study|Other|0|||
42124826|NCT00425061|75935203|FG003|Overall Study|Other|0|||
42124827|NCT00425061|75935204|FG004|Overall Study|Other|3|||
42124828|NCT00425061|75935205|FG005|Overall Study|Other|0|||
42124829|NCT00425061|75935206|FG006|Overall Study|Other|1|||
42124830|NCT00424827|75935224|FG000|Overall Study|Adverse Event|1|||
42124831|NCT03885726|75935229|FG000|Overall Study|Staffing issues/lost interest|1|||
42124832|NCT03885726|75935229|FG000|Overall Study|Early discharge from hospital|3|||
41967932|NCT03192176|75767941|FG002|Overall Study|Protocol Deviation|0|||
41967933|NCT03192176|75767942|FG003|Overall Study|Protocol Deviation|0|||
41967934|NCT03192176|75767943|FG004|Overall Study|Protocol Deviation|2|||
41967935|NCT03192176|75767944|FG005|Overall Study|Protocol Deviation|0|||
42124833|NCT00377962|75935239|FG000|Core Study: 0-12 Months|Adverse Event|18|||
42124834|NCT00377962|75935240|FG001|Core Study: 0-12 Months|Adverse Event|2|||
42124835|NCT00377962|75935239|FG000|Core Study: 0-12 Months|Death|3|||
42124836|NCT00377962|75935240|FG001|Core Study: 0-12 Months|Death|0|||
42124837|NCT00377962|75935239|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
41967936|NCT03192176|75767945|FG006|Overall Study|Protocol Deviation|0|||
41967937|NCT03192176|75767946|FG007|Overall Study|Protocol Deviation|0|||
41967938|NCT03192176|75767939|FG000|Overall Study|Withdrawal by Subject|3|||
41967939|NCT03192176|75767940|FG001|Overall Study|Withdrawal by Subject|4|||
41967940|NCT03192176|75767941|FG002|Overall Study|Withdrawal by Subject|0|||
41967941|NCT03192176|75767942|FG003|Overall Study|Withdrawal by Subject|4|||
42027822|NCT01169675|75836089|FG003|Overall Study|Withdrawal by Subject|1|||
42027823|NCT01169675|75836090|FG004|Overall Study|Withdrawal by Subject|2|||
42027824|NCT01169675|75836086|FG000|Overall Study|Other Reason Not Defined Above|0|||
42124838|NCT00377962|75935240|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
41967942|NCT03192176|75767943|FG004|Overall Study|Withdrawal by Subject|3|||
41967943|NCT03192176|75767944|FG005|Overall Study|Withdrawal by Subject|4|||
41967944|NCT03192176|75767945|FG006|Overall Study|Withdrawal by Subject|4|||
41967945|NCT03192176|75767946|FG007|Overall Study|Withdrawal by Subject|2|||
42124839|NCT00377962|75935239|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
42124840|NCT00377962|75935240|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
42124841|NCT00377962|75935239|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
42124842|NCT00377962|75935240|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
41967946|NCT03192176|75767939|FG000|Overall Study|Miscellaneous|1|||
41967947|NCT03192176|75767940|FG001|Overall Study|Miscellaneous|0|||
41967948|NCT03192176|75767941|FG002|Overall Study|Miscellaneous|1|||
41967949|NCT03192176|75767942|FG003|Overall Study|Miscellaneous|1|||
41967950|NCT03192176|75767943|FG004|Overall Study|Miscellaneous|1|||
41967951|NCT03192176|75767944|FG005|Overall Study|Miscellaneous|2|||
41967952|NCT03192176|75767945|FG006|Overall Study|Miscellaneous|0|||
41967953|NCT03192176|75767946|FG007|Overall Study|Miscellaneous|1|||
42124843|NCT00377962|75935239|FG000|Extension Study: 12-24 Months|Death|1|||
42124844|NCT00377962|75935240|FG001|Extension Study: 12-24 Months|Death|1|||
41967954|NCT02531594|75767975|FG000|Overall Study|Withdrawal by Subject|7|||
41967955|NCT02531594|75767976|FG001|Overall Study|Withdrawal by Subject|8|||
41967956|NCT02365467|75767991|FG000|Overall Study|Death|3|||
41967957|NCT01256593|75768004|FG000|Overall Study|Protocol Violation|26|||
41967958|NCT01256593|75768004|FG000|Overall Study|No Drug Administration Information|2|||
41967959|NCT01256593|75768004|FG000|Overall Study|No Visit After Treatment|186|||
41967960|NCT00562640|75768022|FG000|Overall Study|Death|0|||
41967961|NCT00562640|75768023|FG001|Overall Study|Death|1|||
41967962|NCT00562640|75768024|FG002|Overall Study|Death|1|||
41967963|NCT00562640|75768025|FG003|Overall Study|Death|0|||
41967964|NCT04554394|75768050|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
41967965|NCT04554394|75768051|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
41967966|NCT04554394|75768050|FG000|Overall Study|Withdrawal by Subject|2|||
41967967|NCT04554394|75768051|FG001|Overall Study|Withdrawal by Subject|2|||
41967968|NCT04554394|75768050|FG000|Overall Study|Lost to Follow-up|2|||
41967969|NCT04554394|75768051|FG001|Overall Study|Lost to Follow-up|2|||
41967970|NCT04554394|75768050|FG000|Overall Study|Physician Decision|1|||
41967971|NCT04554394|75768051|FG001|Overall Study|Physician Decision|1|||
41967972|NCT04518410|75768081|FG000|Overall Study|Lost to Follow-up|1|||
41967973|NCT04518410|75768082|FG001|Overall Study|Lost to Follow-up|1|||
41967974|NCT04518410|75768083|FG002|Overall Study|Lost to Follow-up|8|||
41967975|NCT04518410|75768084|FG003|Overall Study|Lost to Follow-up|5|||
42301466|NCT02289417|76136716|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
42301467|NCT02289417|76136717|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
41967976|NCT04518410|75768085|FG004|Overall Study|Lost to Follow-up|92|||
41967977|NCT04518410|75768086|FG005|Overall Study|Lost to Follow-up|27|||
42124845|NCT00377962|75935239|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
42124846|NCT00377962|75935240|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
42124847|NCT00377962|75935239|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
42124848|NCT00377962|75935240|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
42124849|NCT00377962|75935239|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
42124850|NCT00377962|75935240|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
42124851|NCT00424749|75935252|FG000|Overall Study|Withdrawal by Subject|1|||
42124852|NCT00424593|75935258|FG000|Acute Double-Blind Period|Adverse Event|16|||
42124853|NCT00424593|75935259|FG001|Acute Double-Blind Period|Adverse Event|7|||
42124854|NCT00424593|75935258|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
41967978|NCT04518410|75768087|FG006|Overall Study|Lost to Follow-up|26|||
41967979|NCT04518410|75768088|FG007|Overall Study|Lost to Follow-up|3|||
41967980|NCT04518410|75768089|FG008|Overall Study|Lost to Follow-up|2|||
41967981|NCT04518410|75768090|FG009|Overall Study|Lost to Follow-up|15|||
41967982|NCT04518410|75768091|FG010|Overall Study|Lost to Follow-up|9|||
41967983|NCT04518410|75768092|FG011|Overall Study|Lost to Follow-up|13|||
41967984|NCT04518410|75768093|FG012|Overall Study|Lost to Follow-up|9|||
41967985|NCT04518410|75768094|FG013|Overall Study|Lost to Follow-up|14|||
41967986|NCT04518410|75768095|FG014|Overall Study|Lost to Follow-up|8|||
41967987|NCT04518410|75768096|FG015|Overall Study|Lost to Follow-up|10|||
41967988|NCT04518410|75768097|FG016|Overall Study|Lost to Follow-up|6|||
41967989|NCT04518410|75768098|FG017|Overall Study|Lost to Follow-up|8|||
41967990|NCT04518410|75768099|FG018|Overall Study|Lost to Follow-up|20|||
42301468|NCT02289417|76136718|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
41967991|NCT04518410|75768100|FG019|Overall Study|Lost to Follow-up|6|||
41967992|NCT04518410|75768101|FG020|Overall Study|Lost to Follow-up|4|||
41967993|NCT04518410|75768102|FG021|Overall Study|Lost to Follow-up|22|||
41967994|NCT04518410|75768103|FG022|Overall Study|Lost to Follow-up|1|||
41967995|NCT04518410|75768104|FG023|Overall Study|Lost to Follow-up|7|||
41967996|NCT04518410|75768105|FG024|Overall Study|Lost to Follow-up|6|||
42124855|NCT00424593|75935259|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
42124856|NCT00424593|75935258|FG000|Acute Double-Blind Period|Protocol Violation|2|||
41967997|NCT04518410|75768081|FG000|Overall Study|Withdrawal by Subject|1|||
41967998|NCT04518410|75768082|FG001|Overall Study|Withdrawal by Subject|2|||
41967999|NCT04518410|75768083|FG002|Overall Study|Withdrawal by Subject|2|||
41968000|NCT04518410|75768084|FG003|Overall Study|Withdrawal by Subject|3|||
41968001|NCT04518410|75768085|FG004|Overall Study|Withdrawal by Subject|20|||
41968002|NCT04518410|75768086|FG005|Overall Study|Withdrawal by Subject|21|||
41968003|NCT04518410|75768087|FG006|Overall Study|Withdrawal by Subject|27|||
41968004|NCT04518410|75768088|FG007|Overall Study|Withdrawal by Subject|6|||
41968005|NCT04518410|75768089|FG008|Overall Study|Withdrawal by Subject|2|||
41968006|NCT04518410|75768090|FG009|Overall Study|Withdrawal by Subject|12|||
41968007|NCT04518410|75768091|FG010|Overall Study|Withdrawal by Subject|6|||
41968008|NCT04518410|75768092|FG011|Overall Study|Withdrawal by Subject|7|||
41968009|NCT04518410|75768093|FG012|Overall Study|Withdrawal by Subject|2|||
42124857|NCT00424593|75935259|FG001|Acute Double-Blind Period|Protocol Violation|2|||
42124858|NCT00424593|75935258|FG000|Acute Double-Blind Period|Physician Decision|1|||
42124859|NCT00424593|75935259|FG001|Acute Double-Blind Period|Physician Decision|2|||
42124860|NCT00424593|75935258|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
42124861|NCT00424593|75935259|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
42124862|NCT00424593|75935258|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
42124863|NCT00424593|75935259|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
42124864|NCT00424593|75935258|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
42124865|NCT00424593|75935259|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
42124866|NCT00424593|75935258|FG000|Dose-Blind Extension Period|Adverse Event|18|||
42124867|NCT00424593|75935259|FG001|Dose-Blind Extension Period|Adverse Event|0|||
42124868|NCT00424593|75935258|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
42124869|NCT00424593|75935259|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
42124870|NCT00424593|75935258|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
42124871|NCT00424593|75935259|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
42124872|NCT00424593|75935258|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
41968010|NCT04518410|75768094|FG013|Overall Study|Withdrawal by Subject|13|||
41968011|NCT04518410|75768095|FG014|Overall Study|Withdrawal by Subject|4|||
41968012|NCT04518410|75768096|FG015|Overall Study|Withdrawal by Subject|9|||
41968013|NCT04518410|75768097|FG016|Overall Study|Withdrawal by Subject|0|||
41968014|NCT04518410|75768098|FG017|Overall Study|Withdrawal by Subject|14|||
41968015|NCT04518410|75768099|FG018|Overall Study|Withdrawal by Subject|13|||
41968016|NCT04518410|75768100|FG019|Overall Study|Withdrawal by Subject|9|||
41968017|NCT04518410|75768101|FG020|Overall Study|Withdrawal by Subject|13|||
41968018|NCT04518410|75768102|FG021|Overall Study|Withdrawal by Subject|3|||
41968019|NCT04518410|75768103|FG022|Overall Study|Withdrawal by Subject|2|||
41968020|NCT04518410|75768104|FG023|Overall Study|Withdrawal by Subject|9|||
41968021|NCT04518410|75768105|FG024|Overall Study|Withdrawal by Subject|8|||
41968022|NCT04518410|75768081|FG000|Overall Study|Other|1|||
41968023|NCT04518410|75768082|FG001|Overall Study|Other|0|||
41968024|NCT04518410|75768083|FG002|Overall Study|Other|0|||
41968025|NCT04518410|75768084|FG003|Overall Study|Other|1|||
41968026|NCT04518410|75768085|FG004|Overall Study|Other|6|||
42124873|NCT00424593|75935259|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
42124874|NCT00424593|75935258|FG000|Dose-Blind Extension Period|Physician Decision|3|||
42124875|NCT00424593|75935259|FG001|Dose-Blind Extension Period|Physician Decision|0|||
42124876|NCT00369382|75935267|FG000|Overall Study|Death|0|||
42124877|NCT00369382|75935268|FG001|Overall Study|Death|2|||
42124878|NCT00369382|75935267|FG000|Overall Study|Physician Decision|2|||
42124879|NCT00369382|75935268|FG001|Overall Study|Physician Decision|1|||
42124880|NCT00369382|75935267|FG000|Overall Study|Withdrawal by Subject|5|||
42124881|NCT00369382|75935268|FG001|Overall Study|Withdrawal by Subject|0|||
42124882|NCT00369382|75935267|FG000|Overall Study|Randomized, not treated|2|||
41968027|NCT04518410|75768086|FG005|Overall Study|Other|6|||
41968028|NCT04518410|75768087|FG006|Overall Study|Other|5|||
41968029|NCT04518410|75768088|FG007|Overall Study|Other|2|||
41968030|NCT04518410|75768089|FG008|Overall Study|Other|0|||
42027825|NCT01169675|75836087|FG001|Overall Study|Other Reason Not Defined Above|0|||
41968031|NCT04518410|75768090|FG009|Overall Study|Other|1|||
41968032|NCT04518410|75768091|FG010|Overall Study|Other|0|||
41968033|NCT04518410|75768092|FG011|Overall Study|Other|2|||
41968034|NCT04518410|75768093|FG012|Overall Study|Other|0|||
42027826|NCT01169675|75836088|FG002|Overall Study|Other Reason Not Defined Above|0|||
41968035|NCT04518410|75768094|FG013|Overall Study|Other|0|||
42124883|NCT00369382|75935268|FG001|Overall Study|Randomized, not treated|0|||
42124884|NCT00369382|75935267|FG000|Overall Study|Other|1|||
42124885|NCT00369382|75935268|FG001|Overall Study|Other|0|||
42124886|NCT00424515|75935277|FG000|Overall Study|Progressive Disease|10|||
42124887|NCT00424515|75935278|FG001|Overall Study|Progressive Disease|11|||
42124888|NCT00424515|75935277|FG000|Overall Study|Adverse Event|0|||
42124889|NCT00424515|75935278|FG001|Overall Study|Adverse Event|1|||
42124890|NCT00424515|75935277|FG000|Overall Study|Intercurrent Illness|0|||
42124891|NCT00424515|75935278|FG001|Overall Study|Intercurrent Illness|1|||
41968036|NCT04518410|75768095|FG014|Overall Study|Other|0|||
41968037|NCT04518410|75768096|FG015|Overall Study|Other|3|||
41968038|NCT04518410|75768097|FG016|Overall Study|Other|1|||
41968039|NCT04518410|75768098|FG017|Overall Study|Other|1|||
41968040|NCT04518410|75768099|FG018|Overall Study|Other|1|||
41968041|NCT04518410|75768100|FG019|Overall Study|Other|0|||
42301469|NCT02289417|76136719|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
42301470|NCT02289417|76136720|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
42301471|NCT02289417|76136721|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
42301472|NCT02289417|76136722|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
42301473|NCT02289417|76136714|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
42301474|NCT02289417|76136715|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
42301475|NCT02289417|76136716|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
42301476|NCT02289417|76136717|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
42301477|NCT02289417|76136718|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
42301478|NCT02289417|76136719|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
42301479|NCT02289417|76136720|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
42301480|NCT02289417|76136721|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
42301481|NCT02289417|76136722|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
42301482|NCT02289417|76136714|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
42301483|NCT02289417|76136715|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
41968042|NCT04518410|75768101|FG020|Overall Study|Other|0|||
41968043|NCT04518410|75768102|FG021|Overall Study|Other|0|||
41968044|NCT04518410|75768103|FG022|Overall Study|Other|1|||
42301484|NCT02289417|76136716|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
42301485|NCT02289417|76136717|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
42301486|NCT02289417|76136718|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
42301487|NCT02289417|76136719|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
42301488|NCT02289417|76136720|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
42301489|NCT02289417|76136721|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
42301490|NCT02289417|76136722|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
42301491|NCT02289417|76136714|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
42301492|NCT02289417|76136715|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
42301493|NCT02289417|76136716|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
42301494|NCT02289417|76136717|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
42301495|NCT02289417|76136718|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
42301496|NCT02289417|76136719|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
42301497|NCT02289417|76136720|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
42301498|NCT02289417|76136721|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
42301499|NCT02289417|76136722|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
42301500|NCT02289417|76136714|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
42301501|NCT02289417|76136715|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
42301502|NCT02289417|76136716|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
42301503|NCT02289417|76136717|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
42301504|NCT02289417|76136718|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
42301505|NCT02289417|76136719|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
41968045|NCT04518410|75768104|FG023|Overall Study|Other|2|||
41968046|NCT04518410|75768105|FG024|Overall Study|Other|2|||
41968047|NCT04518410|75768081|FG000|Overall Study|Protocol Violation|0|||
41968048|NCT04518410|75768082|FG001|Overall Study|Protocol Violation|0|||
41968049|NCT04518410|75768083|FG002|Overall Study|Protocol Violation|0|||
41968050|NCT04518410|75768084|FG003|Overall Study|Protocol Violation|2|||
41968051|NCT04518410|75768085|FG004|Overall Study|Protocol Violation|17|||
41968052|NCT04518410|75768086|FG005|Overall Study|Protocol Violation|1|||
41968053|NCT04518410|75768087|FG006|Overall Study|Protocol Violation|2|||
41968054|NCT04518410|75768088|FG007|Overall Study|Protocol Violation|1|||
42027827|NCT01169675|75836089|FG003|Overall Study|Other Reason Not Defined Above|1|||
42027828|NCT01169675|75836090|FG004|Overall Study|Other Reason Not Defined Above|1|||
42027829|NCT00924664|75836104|FG000|Overall Study|Adverse Event|23|||
42027830|NCT00924664|75836105|FG001|Overall Study|Adverse Event|39|||
42027831|NCT00924664|75836104|FG000|Overall Study|Lack of Efficacy|10|||
42027832|NCT00924664|75836105|FG001|Overall Study|Lack of Efficacy|15|||
42027833|NCT00924664|75836104|FG000|Overall Study|Lost to Follow-up|10|||
42027834|NCT00924664|75836105|FG001|Overall Study|Lost to Follow-up|12|||
42027835|NCT00924664|75836104|FG000|Overall Study|Withdrawal by Subject|47|||
42027836|NCT00924664|75836105|FG001|Overall Study|Withdrawal by Subject|71|||
42027837|NCT00924664|75836104|FG000|Overall Study|Protocol Violation|2|||
42301506|NCT02289417|76136720|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
41968055|NCT04518410|75768089|FG008|Overall Study|Protocol Violation|0|||
41968056|NCT04518410|75768090|FG009|Overall Study|Protocol Violation|0|||
41968057|NCT04518410|75768091|FG010|Overall Study|Protocol Violation|0|||
41968058|NCT04518410|75768092|FG011|Overall Study|Protocol Violation|0|||
41968059|NCT04518410|75768093|FG012|Overall Study|Protocol Violation|0|||
42027838|NCT00924664|75836105|FG001|Overall Study|Protocol Violation|5|||
41968060|NCT04518410|75768094|FG013|Overall Study|Protocol Violation|0|||
41968061|NCT04518410|75768095|FG014|Overall Study|Protocol Violation|0|||
41968062|NCT04518410|75768096|FG015|Overall Study|Protocol Violation|0|||
41968063|NCT04518410|75768097|FG016|Overall Study|Protocol Violation|1|||
41968064|NCT04518410|75768098|FG017|Overall Study|Protocol Violation|1|||
41968065|NCT04518410|75768099|FG018|Overall Study|Protocol Violation|0|||
41968066|NCT04518410|75768100|FG019|Overall Study|Protocol Violation|0|||
41968067|NCT04518410|75768101|FG020|Overall Study|Protocol Violation|1|||
41968068|NCT04518410|75768102|FG021|Overall Study|Protocol Violation|2|||
41968069|NCT04518410|75768103|FG022|Overall Study|Protocol Violation|0|||
41968070|NCT04518410|75768104|FG023|Overall Study|Protocol Violation|3|||
41968071|NCT04518410|75768105|FG024|Overall Study|Protocol Violation|0|||
41968072|NCT04518410|75768081|FG000|Overall Study|Death|0|||
41968073|NCT04518410|75768082|FG001|Overall Study|Death|0|||
41968074|NCT04518410|75768083|FG002|Overall Study|Death|0|||
41968075|NCT04518410|75768084|FG003|Overall Study|Death|0|||
41968076|NCT04518410|75768085|FG004|Overall Study|Death|12|||
41968077|NCT04518410|75768086|FG005|Overall Study|Death|2|||
41968078|NCT04518410|75768087|FG006|Overall Study|Death|11|||
41968079|NCT04518410|75768088|FG007|Overall Study|Death|0|||
41968080|NCT04518410|75768089|FG008|Overall Study|Death|1|||
41968081|NCT04518410|75768090|FG009|Overall Study|Death|0|||
42027839|NCT00924664|75836104|FG000|Overall Study|Pregnancy|1|||
42301507|NCT02289417|76136721|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
41968082|NCT04518410|75768091|FG010|Overall Study|Death|0|||
41968083|NCT04518410|75768092|FG011|Overall Study|Death|0|||
41968084|NCT04518410|75768093|FG012|Overall Study|Death|0|||
41968085|NCT04518410|75768094|FG013|Overall Study|Death|1|||
41968086|NCT04518410|75768095|FG014|Overall Study|Death|1|||
42027840|NCT00924664|75836105|FG001|Overall Study|Pregnancy|1|||
42027841|NCT00924664|75836104|FG000|Overall Study|Death|0|||
42027842|NCT00924664|75836105|FG001|Overall Study|Death|2|||
42027843|NCT00924664|75836104|FG000|Overall Study|Study terminated by sponsor|199|||
42027844|NCT00924664|75836105|FG001|Overall Study|Study terminated by sponsor|330|||
42027845|NCT00924664|75836104|FG000|Overall Study|Other|29|||
42027846|NCT00924664|75836105|FG001|Overall Study|Other|52|||
42027847|NCT00924664|75836104|FG000|Overall Study|Randomized but not Treated|1|||
42027848|NCT00924664|75836105|FG001|Overall Study|Randomized but not Treated|0|||
42027849|NCT00600067|75836113|FG000|Overall Study|Adverse Event|0|||
42027850|NCT00600067|75836114|FG001|Overall Study|Adverse Event|1|||
42027851|NCT00600067|75836113|FG000|Overall Study|Lost to Follow-up|2|||
42027852|NCT00600067|75836114|FG001|Overall Study|Lost to Follow-up|3|||
42027853|NCT00600067|75836113|FG000|Overall Study|protocol non-compliance|0|||
42027854|NCT00600067|75836114|FG001|Overall Study|protocol non-compliance|3|||
42027855|NCT00600067|75836113|FG000|Overall Study|Lack of Efficacy|1|||
42027856|NCT00600067|75836114|FG001|Overall Study|Lack of Efficacy|0|||
42027857|NCT00970593|75836128|FG000|Overall Study|Adverse Event|1|||
42027858|NCT00970593|75836129|FG001|Overall Study|Adverse Event|1|||
42027859|NCT00970593|75836130|FG002|Overall Study|Adverse Event|0|||
42027860|NCT00970593|75836131|FG003|Overall Study|Adverse Event|0|||
42027861|NCT00970593|75836132|FG004|Overall Study|Adverse Event|0|||
42027862|NCT00970593|75836133|FG005|Overall Study|Adverse Event|0|||
42027863|NCT00970593|75836134|FG006|Overall Study|Adverse Event|0|||
42027864|NCT00970593|75836128|FG000|Overall Study|Discontinuation of study by sponsor|0|||
42027865|NCT00970593|75836129|FG001|Overall Study|Discontinuation of study by sponsor|0|||
42027866|NCT00970593|75836130|FG002|Overall Study|Discontinuation of study by sponsor|5|||
42027867|NCT00970593|75836131|FG003|Overall Study|Discontinuation of study by sponsor|0|||
42027868|NCT00970593|75836132|FG004|Overall Study|Discontinuation of study by sponsor|0|||
42027869|NCT00970593|75836133|FG005|Overall Study|Discontinuation of study by sponsor|0|||
42027870|NCT00970593|75836134|FG006|Overall Study|Discontinuation of study by sponsor|2|||
41968087|NCT04518410|75768096|FG015|Overall Study|Death|0|||
41968088|NCT04518410|75768097|FG016|Overall Study|Death|0|||
41968089|NCT04518410|75768098|FG017|Overall Study|Death|1|||
41968090|NCT04518410|75768099|FG018|Overall Study|Death|3|||
41968091|NCT04518410|75768100|FG019|Overall Study|Death|4|||
41968092|NCT04518410|75768101|FG020|Overall Study|Death|1|||
42124892|NCT00424515|75935277|FG000|Overall Study|Withdrawal by Subject|1|||
42124893|NCT00424515|75935278|FG001|Overall Study|Withdrawal by Subject|0|||
42124894|NCT00377260|75935286|FG000|Overall Study|Lost to Follow-up|0|||
42124895|NCT00377260|75935287|FG001|Overall Study|Lost to Follow-up|1|||
42124896|NCT00377260|75935286|FG000|Overall Study|Withdrawal by Subject|2|||
42124897|NCT00377260|75935287|FG001|Overall Study|Withdrawal by Subject|4|||
42124898|NCT00441441|75935295|FG000|Overall Study|Adverse Event|2|||
42124899|NCT00441441|75935296|FG001|Overall Study|Adverse Event|1|||
42124900|NCT00441441|75935295|FG000|Overall Study|Protocol Violation|4|||
42124901|NCT00441441|75935296|FG001|Overall Study|Protocol Violation|6|||
42124902|NCT00441441|75935295|FG000|Overall Study|Exacerbation of asthma|1|||
42124903|NCT00441441|75935296|FG001|Overall Study|Exacerbation of asthma|2|||
42124904|NCT00441441|75935295|FG000|Overall Study|Withdrawal by Subject|1|||
42124905|NCT00441441|75935296|FG001|Overall Study|Withdrawal by Subject|2|||
42124906|NCT00441441|75935295|FG000|Overall Study|Other|3|||
42124907|NCT00441441|75935296|FG001|Overall Study|Other|3|||
42124908|NCT00436917|75935316|FG000|Overall Study|Withdrawal by Subject|13|||
42124909|NCT00436917|75935316|FG000|Overall Study|Adverse Event|2|||
42124910|NCT00436917|75935316|FG000|Overall Study|Physician Decision|1|||
42124911|NCT00436917|75935316|FG000|Overall Study|Death|1|||
42124912|NCT00436917|75935316|FG000|Overall Study|Lost to Follow-up|1|||
42124913|NCT00436917|75935316|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
42124914|NCT00436917|75935316|FG000|Overall Study|Increased creatinine|1|||
42124915|NCT00436917|75935316|FG000|Overall Study|Personal conflicts of patient|1|||
42124916|NCT00436605|75935320|FG000|Overall Study|Protocol Violation|3|||
42124917|NCT00368992|75935324|FG000|Overall Study|Ineligible|5|||
42124918|NCT00368992|75935324|FG000|Overall Study|Refused treatment|3|||
42124919|NCT00368992|75935324|FG000|Overall Study|Lack of Efficacy|63|||
42124920|NCT00368992|75935324|FG000|Overall Study|Adverse Event|26|||
42124921|NCT00368992|75935324|FG000|Overall Study|Death|4|||
42124922|NCT00368992|75935324|FG000|Overall Study|Other|9|||
42124923|NCT00376246|75935329|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
42124924|NCT00376246|75935330|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
42124925|NCT00376246|75935329|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
42124926|NCT00376246|75935330|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
42124927|NCT00376246|75935329|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
42124928|NCT00376246|75935330|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
42124929|NCT00368836|75935340|FG000|Phase II|Screen Failure|1|||
42124930|NCT00368836|75935340|FG000|Phase II|Withdrawal by Subject|1|||
42124931|NCT00368836|75935340|FG000|Phase II|unable to collect blood and/or breath|17|||
42124932|NCT00368836|75935340|FG000|Phase II|Protocol Violation|2|||
42124933|NCT00376168|75935349|FG000|Overall Study|Adverse Event|1|||
42124934|NCT00376168|75935350|FG001|Overall Study|Adverse Event|1|||
42124935|NCT00376168|75935349|FG000|Overall Study|Pregnancy|1|||
42124936|NCT00376168|75935350|FG001|Overall Study|Pregnancy|0|||
42124937|NCT00375934|75935358|FG000|Overall Study|Adverse Event|1|||
42124938|NCT00375934|75935359|FG001|Overall Study|Adverse Event|1|||
42124939|NCT00375934|75935358|FG000|Overall Study|Withdrawal by Subject|2|||
42124940|NCT00375934|75935359|FG001|Overall Study|Withdrawal by Subject|2|||
42124941|NCT00375934|75935358|FG000|Overall Study|Lack of Efficacy|0|||
41968093|NCT04518410|75768102|FG021|Overall Study|Death|0|||
41968094|NCT04518410|75768103|FG022|Overall Study|Death|0|||
41968095|NCT04518410|75768104|FG023|Overall Study|Death|0|||
42124942|NCT00375934|75935359|FG001|Overall Study|Lack of Efficacy|2|||
42124943|NCT00375934|75935358|FG000|Overall Study|Physician Decision|0|||
42124944|NCT00375934|75935359|FG001|Overall Study|Physician Decision|1|||
42124945|NCT00642941|75935377|FG000|Overall Study|Physician Decision|3|||
41968096|NCT04518410|75768105|FG024|Overall Study|Death|0|||
41968097|NCT04518410|75768081|FG000|Overall Study|Requirement to start alternative therapy|0|||
41968098|NCT04518410|75768082|FG001|Overall Study|Requirement to start alternative therapy|0|||
42124946|NCT00642941|75935378|FG001|Overall Study|Physician Decision|1|||
42124947|NCT00642941|75935379|FG002|Overall Study|Physician Decision|0|||
42124948|NCT00642941|75935380|FG003|Overall Study|Physician Decision|0|||
42124949|NCT00642941|75935381|FG004|Overall Study|Physician Decision|0|||
42124950|NCT00642941|75935382|FG005|Overall Study|Physician Decision|0|||
42124951|NCT00642941|75935383|FG006|Overall Study|Physician Decision|1|||
42124952|NCT00642941|75935384|FG007|Overall Study|Physician Decision|0|||
42124953|NCT00642941|75935385|FG008|Overall Study|Physician Decision|0|||
42124954|NCT00642941|75935386|FG009|Overall Study|Physician Decision|1|||
42124955|NCT00642941|75935387|FG010|Overall Study|Physician Decision|0|||
42124956|NCT00642941|75935388|FG011|Overall Study|Physician Decision|1|||
42124957|NCT00642941|75935377|FG000|Overall Study|Death|4|||
42124958|NCT00642941|75935378|FG001|Overall Study|Death|0|||
42124959|NCT00642941|75935379|FG002|Overall Study|Death|1|||
42124960|NCT00642941|75935380|FG003|Overall Study|Death|1|||
42124961|NCT00642941|75935381|FG004|Overall Study|Death|2|||
42124962|NCT00642941|75935382|FG005|Overall Study|Death|1|||
42124963|NCT00642941|75935383|FG006|Overall Study|Death|0|||
42124964|NCT00642941|75935384|FG007|Overall Study|Death|0|||
42124965|NCT00642941|75935385|FG008|Overall Study|Death|0|||
42124966|NCT00642941|75935386|FG009|Overall Study|Death|0|||
42124967|NCT00642941|75935387|FG010|Overall Study|Death|0|||
42124968|NCT00642941|75935388|FG011|Overall Study|Death|1|||
42124969|NCT00642941|75935377|FG000|Overall Study|Study closed by Sponsor|0|||
42124970|NCT00642941|75935378|FG001|Overall Study|Study closed by Sponsor|1|||
42124971|NCT00642941|75935379|FG002|Overall Study|Study closed by Sponsor|0|||
42124972|NCT00642941|75935380|FG003|Overall Study|Study closed by Sponsor|0|||
42124973|NCT00642941|75935381|FG004|Overall Study|Study closed by Sponsor|0|||
42124974|NCT00642941|75935382|FG005|Overall Study|Study closed by Sponsor|0|||
42124975|NCT00642941|75935383|FG006|Overall Study|Study closed by Sponsor|0|||
42124976|NCT00642941|75935384|FG007|Overall Study|Study closed by Sponsor|0|||
42124977|NCT00642941|75935385|FG008|Overall Study|Study closed by Sponsor|0|||
42124978|NCT00642941|75935386|FG009|Overall Study|Study closed by Sponsor|0|||
42124979|NCT00642941|75935387|FG010|Overall Study|Study closed by Sponsor|0|||
42124980|NCT00642941|75935388|FG011|Overall Study|Study closed by Sponsor|0|||
42124981|NCT00642941|75935377|FG000|Overall Study|Withdrawal by Subject|1|||
42124982|NCT00642941|75935378|FG001|Overall Study|Withdrawal by Subject|0|||
42124983|NCT00642941|75935379|FG002|Overall Study|Withdrawal by Subject|0|||
42124984|NCT00642941|75935380|FG003|Overall Study|Withdrawal by Subject|2|||
42124985|NCT00642941|75935381|FG004|Overall Study|Withdrawal by Subject|0|||
42124986|NCT00642941|75935382|FG005|Overall Study|Withdrawal by Subject|0|||
42124987|NCT00642941|75935383|FG006|Overall Study|Withdrawal by Subject|2|||
42124988|NCT00642941|75935384|FG007|Overall Study|Withdrawal by Subject|0|||
42124989|NCT00642941|75935385|FG008|Overall Study|Withdrawal by Subject|1|||
42124990|NCT00642941|75935386|FG009|Overall Study|Withdrawal by Subject|0|||
42124991|NCT00642941|75935387|FG010|Overall Study|Withdrawal by Subject|0|||
42124992|NCT00642941|75935388|FG011|Overall Study|Withdrawal by Subject|1|||
42124993|NCT00642941|75935377|FG000|Overall Study|Protocol Violation|0|||
42124994|NCT00642941|75935378|FG001|Overall Study|Protocol Violation|0|||
42124995|NCT00642941|75935379|FG002|Overall Study|Protocol Violation|0|||
42124996|NCT00642941|75935380|FG003|Overall Study|Protocol Violation|0|||
42124997|NCT00642941|75935381|FG004|Overall Study|Protocol Violation|0|||
42124998|NCT00642941|75935382|FG005|Overall Study|Protocol Violation|0|||
42124999|NCT00642941|75935383|FG006|Overall Study|Protocol Violation|1|||
42125000|NCT00642941|75935384|FG007|Overall Study|Protocol Violation|0|||
42125001|NCT00642941|75935385|FG008|Overall Study|Protocol Violation|0|||
42125002|NCT00642941|75935386|FG009|Overall Study|Protocol Violation|0|||
42125003|NCT00642941|75935387|FG010|Overall Study|Protocol Violation|0|||
42125004|NCT00642941|75935388|FG011|Overall Study|Protocol Violation|0|||
42125005|NCT00642941|75935377|FG000|Overall Study|Adverse Event|1|||
42125006|NCT00642941|75935378|FG001|Overall Study|Adverse Event|1|||
42125007|NCT00642941|75935379|FG002|Overall Study|Adverse Event|0|||
42125008|NCT00642941|75935380|FG003|Overall Study|Adverse Event|0|||
42125009|NCT00642941|75935381|FG004|Overall Study|Adverse Event|0|||
42125010|NCT00642941|75935382|FG005|Overall Study|Adverse Event|0|||
42125011|NCT00642941|75935383|FG006|Overall Study|Adverse Event|1|||
42125012|NCT00642941|75935384|FG007|Overall Study|Adverse Event|1|||
42125013|NCT00642941|75935385|FG008|Overall Study|Adverse Event|0|||
42125014|NCT00642941|75935386|FG009|Overall Study|Adverse Event|1|||
42125015|NCT00642941|75935387|FG010|Overall Study|Adverse Event|0|||
42125016|NCT00642941|75935388|FG011|Overall Study|Adverse Event|0|||
42125017|NCT00642941|75935377|FG000|Overall Study|Other|1|||
42125018|NCT00642941|75935378|FG001|Overall Study|Other|1|||
42125019|NCT00642941|75935379|FG002|Overall Study|Other|1|||
42125020|NCT00642941|75935380|FG003|Overall Study|Other|1|||
42125021|NCT00642941|75935381|FG004|Overall Study|Other|0|||
42125022|NCT00642941|75935382|FG005|Overall Study|Other|1|||
42125023|NCT00642941|75935383|FG006|Overall Study|Other|0|||
42125024|NCT00642941|75935384|FG007|Overall Study|Other|1|||
42125025|NCT00642941|75935385|FG008|Overall Study|Other|0|||
42125026|NCT00642941|75935386|FG009|Overall Study|Other|0|||
42125027|NCT00642941|75935387|FG010|Overall Study|Other|0|||
42125028|NCT00642941|75935388|FG011|Overall Study|Other|1|||
42125029|NCT00642941|75935377|FG000|Overall Study|Disease progression|60|||
42125030|NCT00642941|75935378|FG001|Overall Study|Disease progression|50|||
42125031|NCT00642941|75935379|FG002|Overall Study|Disease progression|5|||
42125032|NCT00642941|75935380|FG003|Overall Study|Disease progression|36|||
42125033|NCT00642941|75935381|FG004|Overall Study|Disease progression|23|||
42125034|NCT00642941|75935382|FG005|Overall Study|Disease progression|39|||
42125035|NCT00642941|75935383|FG006|Overall Study|Disease progression|18|||
42125036|NCT00642941|75935384|FG007|Overall Study|Disease progression|12|||
42125037|NCT00642941|75935385|FG008|Overall Study|Disease progression|10|||
42125038|NCT00642941|75935386|FG009|Overall Study|Disease progression|7|||
42125039|NCT00642941|75935387|FG010|Overall Study|Disease progression|12|||
42125040|NCT00642941|75935388|FG011|Overall Study|Disease progression|7|||
42125041|NCT00531960|75935437|FG000|Overall Study|Adverse Event|5|||
42125042|NCT00531960|75935438|FG001|Overall Study|Adverse Event|4|||
42125043|NCT00531960|75935437|FG000|Overall Study|Death|3|||
42125044|NCT00531960|75935438|FG001|Overall Study|Death|2|||
42125045|NCT00531960|75935437|FG000|Overall Study|Lack of Efficacy|42|||
42125046|NCT00531960|75935438|FG001|Overall Study|Lack of Efficacy|41|||
42125047|NCT00531960|75935437|FG000|Overall Study|Violation of Selection Criteria|2|||
42125048|NCT00531960|75935438|FG001|Overall Study|Violation of Selection Criteria|0|||
42125049|NCT00531960|75935437|FG000|Overall Study|Refused Treatment|5|||
42125050|NCT00531960|75935438|FG001|Overall Study|Refused Treatment|6|||
42125051|NCT00531960|75935437|FG000|Overall Study|Other|4|||
42125052|NCT00531960|75935438|FG001|Overall Study|Other|10|||
42125053|NCT00361504|75935446|FG000|Overall Study|Withdrawal by Subject|94|||
42125054|NCT00361504|75935447|FG001|Overall Study|Withdrawal by Subject|31|||
42125055|NCT00361504|75935446|FG000|Overall Study|Lost to Follow-up|40|||
42125056|NCT00361504|75935447|FG001|Overall Study|Lost to Follow-up|7|||
42125057|NCT00361504|75935446|FG000|Overall Study|Adverse Event|203|||
42125058|NCT00361504|75935447|FG001|Overall Study|Adverse Event|82|||
42125059|NCT00361504|75935446|FG000|Overall Study|Lack of Efficacy|72|||
42125060|NCT00361504|75935447|FG001|Overall Study|Lack of Efficacy|7|||
42125061|NCT00361504|75935446|FG000|Overall Study|Resolution of Pain|2|||
42125062|NCT00361504|75935447|FG001|Overall Study|Resolution of Pain|0|||
42125063|NCT00361504|75935446|FG000|Overall Study|Study medication non compliant|42|||
42125064|NCT00361504|75935447|FG001|Overall Study|Study medication non compliant|15|||
42125065|NCT00361504|75935446|FG000|Overall Study|All other|28|||
42125066|NCT00361504|75935447|FG001|Overall Study|All other|3|||
42125067|NCT00361270|75935457|FG000|Overall Study|Death|0|||
42125068|NCT00361270|75935458|FG001|Overall Study|Death|0|||
42125069|NCT00361270|75935459|FG002|Overall Study|Death|0|||
42125070|NCT00361270|75935460|FG003|Overall Study|Death|2|||
42301508|NCT02289417|76136722|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
42301509|NCT02289417|76136714|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
41968099|NCT04518410|75768083|FG002|Overall Study|Requirement to start alternative therapy|1|||
41968100|NCT04518410|75768084|FG003|Overall Study|Requirement to start alternative therapy|0|||
41968101|NCT04518410|75768085|FG004|Overall Study|Requirement to start alternative therapy|0|||
41968102|NCT04518410|75768086|FG005|Overall Study|Requirement to start alternative therapy|0|||
41968103|NCT04518410|75768087|FG006|Overall Study|Requirement to start alternative therapy|0|||
41968104|NCT04518410|75768088|FG007|Overall Study|Requirement to start alternative therapy|0|||
41968105|NCT04518410|75768089|FG008|Overall Study|Requirement to start alternative therapy|0|||
41968106|NCT04518410|75768090|FG009|Overall Study|Requirement to start alternative therapy|0|||
41968107|NCT04518410|75768091|FG010|Overall Study|Requirement to start alternative therapy|0|||
41968108|NCT04518410|75768092|FG011|Overall Study|Requirement to start alternative therapy|0|||
41968109|NCT04518410|75768093|FG012|Overall Study|Requirement to start alternative therapy|0|||
41968110|NCT04518410|75768094|FG013|Overall Study|Requirement to start alternative therapy|0|||
41968111|NCT04518410|75768095|FG014|Overall Study|Requirement to start alternative therapy|0|||
41968112|NCT04518410|75768096|FG015|Overall Study|Requirement to start alternative therapy|0|||
41968113|NCT04518410|75768097|FG016|Overall Study|Requirement to start alternative therapy|0|||
41968114|NCT04518410|75768098|FG017|Overall Study|Requirement to start alternative therapy|0|||
41968115|NCT04518410|75768099|FG018|Overall Study|Requirement to start alternative therapy|0|||
41968116|NCT04518410|75768100|FG019|Overall Study|Requirement to start alternative therapy|0|||
41968117|NCT04518410|75768101|FG020|Overall Study|Requirement to start alternative therapy|0|||
41968118|NCT04518410|75768102|FG021|Overall Study|Requirement to start alternative therapy|0|||
41968119|NCT04518410|75768103|FG022|Overall Study|Requirement to start alternative therapy|1|||
41968120|NCT04518410|75768104|FG023|Overall Study|Requirement to start alternative therapy|0|||
41968121|NCT04518410|75768105|FG024|Overall Study|Requirement to start alternative therapy|0|||
41968122|NCT04518410|75768081|FG000|Overall Study|Ongoing in study|0|||
41968123|NCT04518410|75768082|FG001|Overall Study|Ongoing in study|0|||
41968124|NCT04518410|75768083|FG002|Overall Study|Ongoing in study|0|||
41968125|NCT04518410|75768084|FG003|Overall Study|Ongoing in study|0|||
41968126|NCT04518410|75768085|FG004|Overall Study|Ongoing in study|0|||
41968127|NCT04518410|75768086|FG005|Overall Study|Ongoing in study|0|||
41968128|NCT04518410|75768087|FG006|Overall Study|Ongoing in study|0|||
41968129|NCT04518410|75768088|FG007|Overall Study|Ongoing in study|0|||
41968130|NCT04518410|75768089|FG008|Overall Study|Ongoing in study|0|||
41968131|NCT04518410|75768090|FG009|Overall Study|Ongoing in study|0|||
42125071|NCT00361270|75935457|FG000|Overall Study|Lost to Follow-up|4|||
42301510|NCT02289417|76136715|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
42301511|NCT02289417|76136716|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
42301512|NCT02289417|76136717|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
42301513|NCT02289417|76136718|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
42301514|NCT02289417|76136719|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
42301515|NCT02289417|76136720|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
42301516|NCT02289417|76136721|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
42301517|NCT02289417|76136722|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
42125072|NCT00361270|75935458|FG001|Overall Study|Lost to Follow-up|1|||
42125073|NCT00361270|75935459|FG002|Overall Study|Lost to Follow-up|0|||
42125074|NCT00361270|75935460|FG003|Overall Study|Lost to Follow-up|0|||
42125075|NCT00361270|75935457|FG000|Overall Study|Physician Decision|0|||
42125076|NCT00361270|75935458|FG001|Overall Study|Physician Decision|0|||
42301518|NCT02289417|76136714|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
42301519|NCT02289417|76136715|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
42301520|NCT02289417|76136716|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
42301521|NCT02289417|76136717|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
42301522|NCT02289417|76136718|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
42301523|NCT02289417|76136719|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
42301524|NCT02289417|76136720|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
42301525|NCT02289417|76136721|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
42301526|NCT02289417|76136722|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
42301527|NCT02289417|76136714|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
42301528|NCT02289417|76136715|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
42301529|NCT02289417|76136716|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
42301530|NCT02289417|76136717|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
42301531|NCT02289417|76136718|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
42301532|NCT02289417|76136719|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
42301533|NCT02289417|76136720|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
42301534|NCT02289417|76136721|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
42301535|NCT02289417|76136722|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
42301536|NCT02289417|76136714|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
42301537|NCT02289417|76136715|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
42301538|NCT02289417|76136716|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
42301539|NCT02289417|76136717|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
42301540|NCT02289417|76136718|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
42301541|NCT02289417|76136719|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
42301542|NCT02289417|76136720|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
42125077|NCT00361270|75935459|FG002|Overall Study|Physician Decision|1|||
42301543|NCT02289417|76136721|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
42301544|NCT02289417|76136722|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
42301545|NCT02289417|76136714|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
42301546|NCT02289417|76136715|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
42301547|NCT02289417|76136716|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
42301548|NCT02289417|76136717|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
42301549|NCT02289417|76136718|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
42301550|NCT02289417|76136719|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
42301551|NCT02289417|76136720|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
42301552|NCT02289417|76136721|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
42301553|NCT02289417|76136722|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
42301554|NCT02289417|76136714|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
42301555|NCT02289417|76136715|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
42301556|NCT02289417|76136716|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
42301557|NCT02289417|76136717|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
42301558|NCT02289417|76136718|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
42301559|NCT02289417|76136719|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
42301560|NCT02289417|76136720|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
42301561|NCT02289417|76136721|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
42301562|NCT02289417|76136722|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
42301563|NCT02289417|76136714|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
42301564|NCT02289417|76136715|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
42301565|NCT02289417|76136716|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
42301566|NCT02289417|76136717|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
42301567|NCT02289417|76136718|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
42125078|NCT00361270|75935460|FG003|Overall Study|Physician Decision|0|||
42125079|NCT00361270|75935457|FG000|Overall Study|Protocol Violation|9|||
42125080|NCT00361270|75935458|FG001|Overall Study|Protocol Violation|4|||
42125081|NCT00361270|75935459|FG002|Overall Study|Protocol Violation|5|||
42301568|NCT02289417|76136719|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
42301569|NCT02289417|76136720|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
42301570|NCT02289417|76136721|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
42301571|NCT02289417|76136722|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
42301572|NCT02289417|76136714|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
42301573|NCT02289417|76136715|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
42301574|NCT02289417|76136716|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
42301575|NCT02289417|76136717|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
42301576|NCT02289417|76136718|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
42301577|NCT02289417|76136719|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
42301578|NCT02289417|76136720|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
42125082|NCT00361270|75935460|FG003|Overall Study|Protocol Violation|4|||
42125083|NCT00361270|75935457|FG000|Overall Study|Withdrawal by Subject|6|||
42125084|NCT00361270|75935458|FG001|Overall Study|Withdrawal by Subject|6|||
42125085|NCT00361270|75935459|FG002|Overall Study|Withdrawal by Subject|3|||
42125086|NCT00361270|75935460|FG003|Overall Study|Withdrawal by Subject|7|||
42125087|NCT00361270|75935457|FG000|Overall Study|Afraid of Hypnosis|1|||
42125088|NCT00361270|75935458|FG001|Overall Study|Afraid of Hypnosis|2|||
42125089|NCT00361270|75935459|FG002|Overall Study|Afraid of Hypnosis|0|||
42125090|NCT00361270|75935460|FG003|Overall Study|Afraid of Hypnosis|0|||
42125091|NCT00361270|75935457|FG000|Overall Study|Problems with Transportation|4|||
42125092|NCT00361270|75935458|FG001|Overall Study|Problems with Transportation|0|||
42125093|NCT00361270|75935459|FG002|Overall Study|Problems with Transportation|0|||
42125094|NCT00361270|75935460|FG003|Overall Study|Problems with Transportation|0|||
42125095|NCT00361270|75935457|FG000|Overall Study|Adverse Event|0|||
42125096|NCT00361270|75935458|FG001|Overall Study|Adverse Event|1|||
42125097|NCT00361270|75935459|FG002|Overall Study|Adverse Event|1|||
42125098|NCT00361270|75935460|FG003|Overall Study|Adverse Event|0|||
42301579|NCT02289417|76136721|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
42301580|NCT02289417|76136722|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
42301581|NCT02512861|76136740|FG000|Overall Study|Protocol Violation|3|||
42301582|NCT02512861|76136741|FG001|Overall Study|Protocol Violation|7|||
42301583|NCT02512861|76136740|FG000|Overall Study|Physician Decision|3|||
42301584|NCT02512861|76136741|FG001|Overall Study|Physician Decision|1|||
42301585|NCT02512861|76136740|FG000|Overall Study|Withdrawal by Subject|0|||
42301586|NCT02512861|76136741|FG001|Overall Study|Withdrawal by Subject|1|||
42301587|NCT02288559|76136751|FG000|Overall Study|Adverse Event|1|||
42301588|NCT02288559|76136752|FG001|Overall Study|Adverse Event|1|||
42301589|NCT02288559|76136753|FG002|Overall Study|Adverse Event|5|||
42301590|NCT02288559|76136754|FG003|Overall Study|Adverse Event|0|||
42301591|NCT02288559|76136751|FG000|Overall Study|Death|0|||
42301592|NCT02288559|76136752|FG001|Overall Study|Death|0|||
42301593|NCT02288559|76136753|FG002|Overall Study|Death|1|||
41968132|NCT04518410|75768091|FG010|Overall Study|Ongoing in study|0|||
41968133|NCT04518410|75768092|FG011|Overall Study|Ongoing in study|0|||
41968134|NCT04518410|75768093|FG012|Overall Study|Ongoing in study|0|||
41968135|NCT04518410|75768094|FG013|Overall Study|Ongoing in study|0|||
41968136|NCT04518410|75768095|FG014|Overall Study|Ongoing in study|0|||
41968137|NCT04518410|75768096|FG015|Overall Study|Ongoing in study|0|||
41968138|NCT04518410|75768097|FG016|Overall Study|Ongoing in study|0|||
41968139|NCT04518410|75768098|FG017|Overall Study|Ongoing in study|193|||
41968140|NCT04518410|75768099|FG018|Overall Study|Ongoing in study|173|||
41968141|NCT04518410|75768100|FG019|Overall Study|Ongoing in study|50|||
41968142|NCT04518410|75768101|FG020|Overall Study|Ongoing in study|65|||
41968143|NCT04518410|75768102|FG021|Overall Study|Ongoing in study|0|||
41968144|NCT04518410|75768103|FG022|Overall Study|Ongoing in study|0|||
41968145|NCT04518410|75768104|FG023|Overall Study|Ongoing in study|0|||
41968146|NCT04518410|75768105|FG024|Overall Study|Ongoing in study|0|||
41968147|NCT04518410|75768081|FG000|Overall Study|Randomized but not treated|0|||
41968148|NCT04518410|75768082|FG001|Overall Study|Randomized but not treated|0|||
41968149|NCT04518410|75768083|FG002|Overall Study|Randomized but not treated|0|||
41968150|NCT04518410|75768084|FG003|Overall Study|Randomized but not treated|2|||
41968151|NCT04518410|75768085|FG004|Overall Study|Randomized but not treated|6|||
41968152|NCT04518410|75768086|FG005|Overall Study|Randomized but not treated|6|||
41968153|NCT04518410|75768087|FG006|Overall Study|Randomized but not treated|3|||
41968154|NCT04518410|75768088|FG007|Overall Study|Randomized but not treated|3|||
41968155|NCT04518410|75768089|FG008|Overall Study|Randomized but not treated|0|||
41968156|NCT04518410|75768090|FG009|Overall Study|Randomized but not treated|4|||
41968157|NCT04518410|75768091|FG010|Overall Study|Randomized but not treated|0|||
41968158|NCT04518410|75768092|FG011|Overall Study|Randomized but not treated|0|||
41968159|NCT04518410|75768093|FG012|Overall Study|Randomized but not treated|1|||
41968160|NCT04518410|75768094|FG013|Overall Study|Randomized but not treated|4|||
41968161|NCT04518410|75768095|FG014|Overall Study|Randomized but not treated|3|||
41968162|NCT04518410|75768096|FG015|Overall Study|Randomized but not treated|3|||
42027871|NCT00970593|75836128|FG000|Overall Study|Withdrawal by Subject|0|||
42137788|NCT00427908|75948132|FG000|Primary Phase|Withdrawal by Subject|1|||
42137789|NCT00427908|75948133|FG001|Primary Phase|Withdrawal by Subject|2|||
42137790|NCT00427908|75948134|FG002|Primary Phase|Withdrawal by Subject|1|||
42301594|NCT02288559|76136754|FG003|Overall Study|Death|0|||
42301595|NCT02288559|76136751|FG000|Overall Study|Lost to Follow-up|0|||
42301596|NCT02288559|76136752|FG001|Overall Study|Lost to Follow-up|0|||
42301597|NCT02288559|76136753|FG002|Overall Study|Lost to Follow-up|0|||
42301598|NCT02288559|76136754|FG003|Overall Study|Lost to Follow-up|1|||
42301599|NCT02288559|76136751|FG000|Overall Study|Withdrawal by Subject|0|||
41968163|NCT04518410|75768097|FG016|Overall Study|Randomized but not treated|4|||
41968164|NCT04518410|75768098|FG017|Overall Study|Randomized but not treated|6|||
42137791|NCT00427908|75948135|FG003|Primary Phase|Withdrawal by Subject|0|||
42137792|NCT00427908|75948132|FG000|Primary Phase|Adverse Event|0|||
42137793|NCT00427908|75948133|FG001|Primary Phase|Adverse Event|1|||
42137794|NCT00427908|75948134|FG002|Primary Phase|Adverse Event|0|||
42301600|NCT02288559|76136752|FG001|Overall Study|Withdrawal by Subject|0|||
41968165|NCT04518410|75768099|FG018|Overall Study|Randomized but not treated|4|||
41968166|NCT04518410|75768100|FG019|Overall Study|Randomized but not treated|0|||
41968167|NCT04518410|75768101|FG020|Overall Study|Randomized but not treated|0|||
41968168|NCT04518410|75768102|FG021|Overall Study|Randomized but not treated|5|||
41968169|NCT04518410|75768103|FG022|Overall Study|Randomized but not treated|0|||
41968170|NCT04518410|75768104|FG023|Overall Study|Randomized but not treated|3|||
41968171|NCT04518410|75768105|FG024|Overall Study|Randomized but not treated|1|||
41968172|NCT04518410|75768081|FG000|Overall Study|Screen Fail but Randomized|0|||
41968173|NCT04518410|75768082|FG001|Overall Study|Screen Fail but Randomized|0|||
41968174|NCT04518410|75768083|FG002|Overall Study|Screen Fail but Randomized|0|||
41968175|NCT04518410|75768084|FG003|Overall Study|Screen Fail but Randomized|0|||
41968176|NCT04518410|75768085|FG004|Overall Study|Screen Fail but Randomized|2|||
41968177|NCT04518410|75768086|FG005|Overall Study|Screen Fail but Randomized|0|||
41968178|NCT04518410|75768087|FG006|Overall Study|Screen Fail but Randomized|0|||
41968179|NCT04518410|75768088|FG007|Overall Study|Screen Fail but Randomized|0|||
41968180|NCT04518410|75768089|FG008|Overall Study|Screen Fail but Randomized|0|||
41968181|NCT04518410|75768090|FG009|Overall Study|Screen Fail but Randomized|0|||
41968182|NCT04518410|75768091|FG010|Overall Study|Screen Fail but Randomized|0|||
41968183|NCT04518410|75768092|FG011|Overall Study|Screen Fail but Randomized|0|||
41968184|NCT04518410|75768093|FG012|Overall Study|Screen Fail but Randomized|0|||
41968185|NCT04518410|75768094|FG013|Overall Study|Screen Fail but Randomized|0|||
41968186|NCT04518410|75768095|FG014|Overall Study|Screen Fail but Randomized|0|||
41968187|NCT04518410|75768096|FG015|Overall Study|Screen Fail but Randomized|0|||
41968188|NCT04518410|75768097|FG016|Overall Study|Screen Fail but Randomized|0|||
41968189|NCT04518410|75768098|FG017|Overall Study|Screen Fail but Randomized|0|||
41968190|NCT04518410|75768099|FG018|Overall Study|Screen Fail but Randomized|0|||
41968191|NCT04518410|75768100|FG019|Overall Study|Screen Fail but Randomized|0|||
41968192|NCT04518410|75768101|FG020|Overall Study|Screen Fail but Randomized|0|||
41968193|NCT04518410|75768102|FG021|Overall Study|Screen Fail but Randomized|0|||
41968194|NCT04518410|75768103|FG022|Overall Study|Screen Fail but Randomized|0|||
41968195|NCT04518410|75768104|FG023|Overall Study|Screen Fail but Randomized|0|||
41968196|NCT04518410|75768105|FG024|Overall Study|Screen Fail but Randomized|0|||
41968197|NCT04518410|75768081|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968198|NCT04518410|75768082|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968199|NCT04518410|75768083|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968200|NCT04518410|75768084|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968201|NCT04518410|75768085|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
41968202|NCT04518410|75768086|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
41968203|NCT04518410|75768087|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|9|||
41968204|NCT04518410|75768088|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968205|NCT04518410|75768089|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
41968206|NCT04518410|75768090|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968207|NCT04518410|75768091|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968208|NCT04518410|75768092|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968209|NCT04518410|75768093|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968210|NCT04518410|75768094|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968211|NCT04518410|75768095|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968212|NCT04518410|75768096|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968213|NCT04518410|75768097|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968214|NCT04518410|75768098|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968215|NCT04518410|75768099|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968216|NCT04518410|75768100|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968217|NCT04518410|75768101|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968218|NCT04518410|75768102|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968219|NCT04518410|75768103|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
41968220|NCT04518410|75768104|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
42010471|NCT00993499|75817614|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
42010472|NCT00993499|75817615|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
42125099|NCT00367744|75935479|FG000|Overall Study|Lost to Follow-up|4|||
41968221|NCT04518410|75768105|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
41968222|NCT04518410|75768081|FG000|Overall Study|Dual Enrolled Subject|0|||
41968223|NCT04518410|75768082|FG001|Overall Study|Dual Enrolled Subject|0|||
41968224|NCT04518410|75768083|FG002|Overall Study|Dual Enrolled Subject|0|||
41968225|NCT04518410|75768084|FG003|Overall Study|Dual Enrolled Subject|0|||
41968226|NCT04518410|75768085|FG004|Overall Study|Dual Enrolled Subject|0|||
41968227|NCT04518410|75768086|FG005|Overall Study|Dual Enrolled Subject|0|||
41968228|NCT04518410|75768087|FG006|Overall Study|Dual Enrolled Subject|0|||
41968229|NCT04518410|75768088|FG007|Overall Study|Dual Enrolled Subject|0|||
41968230|NCT04518410|75768089|FG008|Overall Study|Dual Enrolled Subject|0|||
41968231|NCT04518410|75768090|FG009|Overall Study|Dual Enrolled Subject|0|||
41968232|NCT04518410|75768091|FG010|Overall Study|Dual Enrolled Subject|0|||
41968233|NCT04518410|75768092|FG011|Overall Study|Dual Enrolled Subject|0|||
41968234|NCT04518410|75768093|FG012|Overall Study|Dual Enrolled Subject|0|||
41968235|NCT04518410|75768094|FG013|Overall Study|Dual Enrolled Subject|0|||
41968236|NCT04518410|75768095|FG014|Overall Study|Dual Enrolled Subject|0|||
41968237|NCT04518410|75768096|FG015|Overall Study|Dual Enrolled Subject|0|||
41968238|NCT04518410|75768097|FG016|Overall Study|Dual Enrolled Subject|0|||
41968239|NCT04518410|75768098|FG017|Overall Study|Dual Enrolled Subject|1|||
42125100|NCT00367744|75935480|FG001|Overall Study|Lost to Follow-up|5|||
42125101|NCT03883386|75935489|FG000|First Assignment|Lost to Follow-up|1|||
42125102|NCT03883386|75935490|FG001|First Assignment|Lost to Follow-up|0|||
42125103|NCT03883386|75935489|FG000|First Assignment|Withdrawal by Subject|1|||
42125104|NCT03883386|75935490|FG001|First Assignment|Withdrawal by Subject|1|||
42125105|NCT00530946|75935500|FG000|Overall Study|Adverse Event|1|||
42125106|NCT00530946|75935501|FG001|Overall Study|Adverse Event|2|||
42125107|NCT00530946|75935502|FG002|Overall Study|Adverse Event|1|||
42125108|NCT00530946|75935503|FG003|Overall Study|Adverse Event|1|||
42125109|NCT00530946|75935500|FG000|Overall Study|Protocol Violation|0|||
42125110|NCT00530946|75935501|FG001|Overall Study|Protocol Violation|0|||
42125111|NCT00530946|75935502|FG002|Overall Study|Protocol Violation|0|||
42125112|NCT00530946|75935503|FG003|Overall Study|Protocol Violation|1|||
42125113|NCT00530946|75935500|FG000|Overall Study|Noncompliance|1|||
41968240|NCT04518410|75768099|FG018|Overall Study|Dual Enrolled Subject|0|||
41968241|NCT04518410|75768100|FG019|Overall Study|Dual Enrolled Subject|0|||
41968242|NCT04518410|75768101|FG020|Overall Study|Dual Enrolled Subject|0|||
41968243|NCT04518410|75768102|FG021|Overall Study|Dual Enrolled Subject|0|||
41968244|NCT04518410|75768103|FG022|Overall Study|Dual Enrolled Subject|0|||
41968245|NCT04518410|75768104|FG023|Overall Study|Dual Enrolled Subject|0|||
41968246|NCT04518410|75768105|FG024|Overall Study|Dual Enrolled Subject|0|||
41968247|NCT04517864|75768165|FG000|Placebo-Controlled Phase|Adverse Event|1|||
41968248|NCT04517864|75768166|FG001|Placebo-Controlled Phase|Adverse Event|0|||
41968249|NCT04517864|75768165|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
41968250|NCT04517864|75768166|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
41968251|NCT04517864|75768165|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
41968252|NCT04517864|75768166|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
41968253|NCT04517864|75768165|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
41968254|NCT04517864|75768166|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
41968255|NCT04517864|75768165|FG000|Active Therapy Extension Phase|Adverse Event|1|||
41968256|NCT04517864|75768166|FG001|Active Therapy Extension Phase|Adverse Event|0|||
41968257|NCT04507204|75768187|FG000|Overall Study|Adverse Event|8|||
41968258|NCT04507204|75768188|FG001|Overall Study|Adverse Event|13|||
41968259|NCT04507204|75768187|FG000|Overall Study|Death|0|||
41968260|NCT04507204|75768188|FG001|Overall Study|Death|1|||
41968261|NCT04507204|75768187|FG000|Overall Study|Lost to Follow-up|15|||
41968262|NCT04507204|75768188|FG001|Overall Study|Lost to Follow-up|14|||
41968263|NCT04507204|75768187|FG000|Overall Study|Poor Compliance with Protocol|2|||
41968264|NCT04507204|75768188|FG001|Overall Study|Poor Compliance with Protocol|4|||
41968265|NCT04507204|75768187|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
41968266|NCT04507204|75768188|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
42125114|NCT00530946|75935501|FG001|Overall Study|Noncompliance|0|||
42125115|NCT00530946|75935502|FG002|Overall Study|Noncompliance|0|||
41968267|NCT04507204|75768187|FG000|Overall Study|Withdrawal of Patient Consent|21|||
41968268|NCT04507204|75768188|FG001|Overall Study|Withdrawal of Patient Consent|13|||
41968269|NCT04135937|75768212|FG000|Overall Study|Lost to Follow-up|2|||
41968270|NCT04135937|75768212|FG000|Overall Study|Withdrawal by Subject|1|||
41968271|NCT04060147|75768216|FG000|Overall Study|Withdrew consent|1|||
42125116|NCT00530946|75935503|FG003|Overall Study|Noncompliance|0|||
42125117|NCT00424047|75935515|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
42125118|NCT00424047|75935516|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
42125119|NCT00424047|75935515|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
42137795|NCT00427908|75948135|FG003|Primary Phase|Adverse Event|0|||
42125120|NCT00424047|75935516|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
42125121|NCT00424047|75935515|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
42125122|NCT00424047|75935516|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
42125123|NCT00424047|75935515|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
42125124|NCT00424047|75935516|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
42125125|NCT00424047|75935515|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
42125126|NCT00424047|75935516|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
42125127|NCT00424047|75935515|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
42125128|NCT00424047|75935516|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
42125129|NCT00424047|75935515|FG000|On Study at Time of Unblinding|Adverse Event|22|||
42125130|NCT00424047|75935516|FG001|On Study at Time of Unblinding|Adverse Event|12|||
42125131|NCT00424047|75935515|FG000|On Study at Time of Unblinding|Progression of disease|92|||
42125132|NCT00424047|75935516|FG001|On Study at Time of Unblinding|Progression of disease|128|||
42125133|NCT00424047|75935515|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
42125134|NCT00424047|75935516|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
42125135|NCT00424047|75935515|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
42125136|NCT00424047|75935516|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
42125137|NCT00424047|75935515|FG000|On Study at Time of Unblinding|Death|11|||
42125138|NCT00424047|75935516|FG001|On Study at Time of Unblinding|Death|11|||
42125139|NCT00424047|75935515|FG000|On Study at Time of Unblinding|Other|5|||
42125140|NCT00424047|75935516|FG001|On Study at Time of Unblinding|Other|4|||
42125141|NCT00424047|75935515|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
42125142|NCT00424047|75935516|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
42125143|NCT00424047|75935515|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
42125144|NCT00424047|75935516|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
42125145|NCT00424047|75935515|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
42125146|NCT00424047|75935516|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
42125147|NCT00424047|75935515|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
42125148|NCT00424047|75935516|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
42125149|NCT00424047|75935515|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
42125150|NCT00424047|75935516|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
42125151|NCT00530790|75935527|FG000|Overall Study|Adverse Event|2|||
41968272|NCT04019041|75768250|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
41968273|NCT04019041|75768251|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
41968274|NCT04019041|75768252|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
41968275|NCT04019041|75768253|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
41968276|NCT04019041|75768254|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
41968277|NCT04019041|75768255|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
41968278|NCT04019041|75768250|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
41968279|NCT04019041|75768251|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
41968280|NCT04019041|75768252|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
41968281|NCT04019041|75768253|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
41968282|NCT04019041|75768254|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
41968283|NCT04019041|75768255|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
41968284|NCT04019041|75768250|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
41968285|NCT04019041|75768251|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
41968286|NCT04019041|75768252|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
41968287|NCT04019041|75768253|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
41968288|NCT04019041|75768254|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
41968289|NCT04019041|75768255|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
41968290|NCT04019041|75768250|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
42125152|NCT00530790|75935527|FG000|Overall Study|Withdrawal by Subject|2|||
42125153|NCT00530790|75935527|FG000|Overall Study|Physician Decision|1|||
42125154|NCT00530088|75935531|FG000|Overall Study|Disease Progression|4|||
42125155|NCT00530088|75935531|FG000|Overall Study|Physician Decision|4|||
42301601|NCT02288559|76136753|FG002|Overall Study|Withdrawal by Subject|2|||
41968291|NCT04019041|75768251|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
42027872|NCT00970593|75836129|FG001|Overall Study|Withdrawal by Subject|0|||
42027873|NCT00970593|75836130|FG002|Overall Study|Withdrawal by Subject|1|||
42027874|NCT00970593|75836131|FG003|Overall Study|Withdrawal by Subject|0|||
42027875|NCT00970593|75836132|FG004|Overall Study|Withdrawal by Subject|0|||
42027876|NCT00970593|75836133|FG005|Overall Study|Withdrawal by Subject|0|||
42027877|NCT00970593|75836134|FG006|Overall Study|Withdrawal by Subject|0|||
42027878|NCT00962013|75836154|FG000|Overall Study|Did not have surgery|1|||
42027879|NCT00962013|75836154|FG000|Overall Study|Death|8|||
42125156|NCT00530088|75935531|FG000|Overall Study|Other Not Specified|2|||
42125157|NCT00360568|75935537|FG000|Overall Study|Adverse Event|1|||
42125158|NCT00360568|75935538|FG001|Overall Study|Adverse Event|2|||
42125159|NCT00360568|75935537|FG000|Overall Study|Lack of Efficacy|1|||
41968292|NCT04019041|75768252|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
41968293|NCT04019041|75768253|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
41968294|NCT04019041|75768254|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
41968295|NCT04019041|75768255|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
41968296|NCT04019041|75768250|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
41968297|NCT04019041|75768251|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
41968298|NCT04019041|75768252|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
41968299|NCT04019041|75768253|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
41968300|NCT04019041|75768254|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
41968301|NCT04019041|75768255|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
41968302|NCT04019041|75768250|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
41968303|NCT04019041|75768251|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
41968304|NCT04019041|75768252|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
41968305|NCT04019041|75768253|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
41968306|NCT04019041|75768254|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
41968307|NCT04019041|75768255|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
42125160|NCT00360568|75935538|FG001|Overall Study|Lack of Efficacy|0|||
42125161|NCT00360568|75935537|FG000|Overall Study|Withdrawal by Subject|0|||
42125162|NCT00360568|75935538|FG001|Overall Study|Withdrawal by Subject|3|||
42125163|NCT00436215|75935546|FG000|Overall Study|Refused further treatment|3|||
42125164|NCT00436215|75935546|FG000|Overall Study|Small bowel obstruction|1|||
42125165|NCT00441363|75935552|FG000|Overall Study|Adverse Event|4|||
42125166|NCT00441363|75935553|FG001|Overall Study|Adverse Event|2|||
42125167|NCT00441363|75935552|FG000|Overall Study|Withdrawal by Subject|3|||
42125168|NCT00441363|75935553|FG001|Overall Study|Withdrawal by Subject|4|||
42125169|NCT00441363|75935552|FG000|Overall Study|Physician Decision|6|||
42125170|NCT00441363|75935553|FG001|Overall Study|Physician Decision|7|||
42125171|NCT00441363|75935552|FG000|Overall Study|Lost to Follow-up|2|||
42125172|NCT00441363|75935553|FG001|Overall Study|Lost to Follow-up|2|||
42125173|NCT00441363|75935552|FG000|Overall Study|Other|2|||
42125174|NCT00441363|75935553|FG001|Overall Study|Other|0|||
41968308|NCT04019041|75768250|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
41968309|NCT04019041|75768251|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
41968310|NCT04019041|75768252|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
41968311|NCT04019041|75768253|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
41968312|NCT04019041|75768254|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
41968313|NCT04019041|75768255|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
41968314|NCT04019041|75768250|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
41968315|NCT04019041|75768251|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
41968316|NCT04019041|75768252|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
41968317|NCT04019041|75768253|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
41968318|NCT04019041|75768254|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
41968319|NCT04019041|75768255|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
41968320|NCT04019041|75768250|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
41968321|NCT04019041|75768251|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
41968322|NCT04019041|75768252|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
41968323|NCT04019041|75768253|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
41968324|NCT04019041|75768254|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
41968325|NCT04019041|75768255|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
41968326|NCT03919448|75768284|FG000|Overall Study|Withdrawal by Subject|1|||
41968327|NCT03919448|75768285|FG001|Overall Study|Withdrawal by Subject|0|||
41968328|NCT03919448|75768286|FG002|Overall Study|Withdrawal by Subject|0|||
41968329|NCT03795922|75768313|FG000|Overall Study|Adverse Event|2|||
41968330|NCT03795922|75768314|FG001|Overall Study|Adverse Event|1|||
41968331|NCT03795922|75768313|FG000|Overall Study|Withdrawal by Subject|5|||
42301602|NCT02288559|76136754|FG003|Overall Study|Withdrawal by Subject|1|||
41968332|NCT03795922|75768314|FG001|Overall Study|Withdrawal by Subject|13|||
41968333|NCT03795922|75768313|FG000|Overall Study|Lost to Follow-up|2|||
41968334|NCT03795922|75768314|FG001|Overall Study|Lost to Follow-up|3|||
41968335|NCT03795922|75768313|FG000|Overall Study|Pregnancy|0|||
41968336|NCT03795922|75768314|FG001|Overall Study|Pregnancy|1|||
41968337|NCT03795922|75768313|FG000|Overall Study|Physician Decision|1|||
41968338|NCT03795922|75768314|FG001|Overall Study|Physician Decision|2|||
41968339|NCT03795922|75768313|FG000|Overall Study|Protocol Violation|0|||
42125175|NCT00530712|75935559|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
42125176|NCT00530712|75935559|FG000|30 Day Follow-up Visit|Missed Visit|5|||
42125177|NCT00530712|75935559|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
42125178|NCT00530712|75935559|FG000|6 Month Follow-up Visit|Missed Visit|3|||
41968340|NCT03795922|75768314|FG001|Overall Study|Protocol Violation|1|||
41968341|NCT03795922|75768313|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
41968342|NCT03795922|75768314|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
41968343|NCT03794089|75768324|FG000|Overall Study|Lost to Follow-up|4|||
41968344|NCT03794089|75768325|FG001|Overall Study|Lost to Follow-up|1|||
41968345|NCT03794089|75768324|FG000|Overall Study|Withdrawal by Subject|2|||
41968346|NCT03794089|75768325|FG001|Overall Study|Withdrawal by Subject|0|||
41968347|NCT03769025|75768333|FG000|Overall Study|Withdrawal by Subject|1|||
41968348|NCT03769025|75768334|FG001|Overall Study|Withdrawal by Subject|1|||
41968349|NCT03769025|75768333|FG000|Overall Study|Lost to Follow-up|4|||
41968350|NCT03769025|75768334|FG001|Overall Study|Lost to Follow-up|3|||
41968351|NCT03762473|75768342|FG000|Overall Study|Death|1|||
42125179|NCT00530712|75935559|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
42125180|NCT00530712|75935559|FG000|6 Month Follow-up Visit|Death|2|||
42125181|NCT00530712|75935559|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
42125182|NCT00530712|75935559|FG000|12 Month Follow-up Visit|Missed Visit|3|||
42125183|NCT00530712|75935559|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
42125184|NCT00530712|75935559|FG000|12 Month Follow-up Visit|Death|9|||
42125185|NCT00626795|75935567|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
42125186|NCT00626795|75935568|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
42125187|NCT00626795|75935569|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
42125188|NCT00626795|75935567|FG000|Blinded Treatment|Lack of Efficacy|2|||
42125189|NCT00626795|75935568|FG001|Blinded Treatment|Lack of Efficacy|0|||
42125190|NCT00626795|75935569|FG002|Blinded Treatment|Lack of Efficacy|0|||
42125191|NCT00626795|75935567|FG000|Blinded Treatment|Unacceptable adverse event|0|||
42125192|NCT00626795|75935568|FG001|Blinded Treatment|Unacceptable adverse event|0|||
42125193|NCT00626795|75935569|FG002|Blinded Treatment|Unacceptable adverse event|1|||
42125194|NCT00626795|75935567|FG000|Blinded Treatment|Protocol Violation|0|||
42125195|NCT00626795|75935568|FG001|Blinded Treatment|Protocol Violation|1|||
42125196|NCT00626795|75935569|FG002|Blinded Treatment|Protocol Violation|1|||
42125197|NCT00626795|75935567|FG000|Blinded Treatment|Withdrawal by Subject|1|||
42125198|NCT00626795|75935568|FG001|Blinded Treatment|Withdrawal by Subject|1|||
42125199|NCT00626795|75935569|FG002|Blinded Treatment|Withdrawal by Subject|0|||
42125200|NCT00626795|75935567|FG000|Blinded Treatment|Other reasons|2|||
42125201|NCT00626795|75935568|FG001|Blinded Treatment|Other reasons|0|||
42125202|NCT00626795|75935569|FG002|Blinded Treatment|Other reasons|2|||
42125203|NCT00626795|75935567|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
42125204|NCT00626795|75935568|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
42125205|NCT00626795|75935569|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
42125206|NCT00626639|75935583|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
42125207|NCT00626639|75935584|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
42125208|NCT00626561|75935592|FG000|Overall Study|Withdrawal by Subject|2|||
42125209|NCT00626561|75935592|FG000|Overall Study|Disease Progression|2|||
42125210|NCT03880266|75935604|FG000|Overall Study|Withdrawal by Subject|0|||
42125211|NCT03880266|75935605|FG001|Overall Study|Withdrawal by Subject|1|||
42125212|NCT03880266|75935606|FG002|Overall Study|Withdrawal by Subject|1|||
42125213|NCT03880266|75935607|FG003|Overall Study|Withdrawal by Subject|0|||
42125214|NCT03880266|75935608|FG004|Overall Study|Withdrawal by Subject|0|||
42125215|NCT03880266|75935609|FG005|Overall Study|Withdrawal by Subject|0|||
42125216|NCT03880266|75935610|FG006|Overall Study|Withdrawal by Subject|0|||
42125217|NCT03880266|75935611|FG007|Overall Study|Withdrawal by Subject|0|||
42125218|NCT00423891|75935632|FG000|Enrolled|Withdrawal by Subject|0|||
42125219|NCT00423891|75935633|FG001|Enrolled|Withdrawal by Subject|0|||
42125220|NCT00423891|75935634|FG002|Enrolled|Withdrawal by Subject|1|||
42125221|NCT00423891|75935632|FG000|Enrolled|Lost to Follow-up|0|||
42125222|NCT00423891|75935633|FG001|Enrolled|Lost to Follow-up|0|||
41968352|NCT03762473|75768343|FG001|Overall Study|Death|0|||
41968353|NCT03745989|75768352|FG000|Overall Study|Death|3|||
41968354|NCT03745989|75768353|FG001|Overall Study|Death|7|||
41968355|NCT03745989|75768354|FG002|Overall Study|Death|4|||
41968356|NCT03745989|75768352|FG000|Overall Study|Lost to Follow-up|0|||
41968357|NCT03745989|75768353|FG001|Overall Study|Lost to Follow-up|2|||
41968358|NCT03745989|75768354|FG002|Overall Study|Lost to Follow-up|0|||
41968359|NCT03745989|75768352|FG000|Overall Study|Sponsor Decision|0|||
41968360|NCT03745989|75768353|FG001|Overall Study|Sponsor Decision|2|||
42125223|NCT00423891|75935634|FG002|Enrolled|Lost to Follow-up|1|||
42125224|NCT00423891|75935632|FG000|Enrolled|No longer met criteria|11|||
42125225|NCT00423891|75935633|FG001|Enrolled|No longer met criteria|2|||
42125226|NCT00423891|75935634|FG002|Enrolled|No longer met criteria|1|||
42125227|NCT00423891|75935632|FG000|Treatment|Withdrawal by Subject|1|||
42125228|NCT00423891|75935633|FG001|Treatment|Withdrawal by Subject|0|||
42125229|NCT00423891|75935634|FG002|Treatment|Withdrawal by Subject|0|||
42125230|NCT00423891|75935632|FG000|Treatment|Lost to Follow-up|1|||
42125231|NCT00423891|75935633|FG001|Treatment|Lost to Follow-up|0|||
42125232|NCT00423891|75935634|FG002|Treatment|Lost to Follow-up|0|||
42137796|NCT00334113|75948172|FG000|Overall Study|Lost to Follow-up|2|||
42125233|NCT00423891|75935632|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
42125234|NCT00423891|75935633|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
42125235|NCT00423891|75935634|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
42125236|NCT00423891|75935632|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
42125237|NCT00423891|75935633|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
42125238|NCT00423891|75935634|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
42125239|NCT00423813|75935647|FG000|Overall Study|Adverse Event|11|||
42125240|NCT00423813|75935648|FG001|Overall Study|Adverse Event|30|||
42125241|NCT00423813|75935649|FG002|Overall Study|Adverse Event|40|||
42125242|NCT00423813|75935647|FG000|Overall Study|Withdrawal by Subject|6|||
42125243|NCT00423813|75935648|FG001|Overall Study|Withdrawal by Subject|8|||
42125244|NCT00423813|75935649|FG002|Overall Study|Withdrawal by Subject|5|||
42125245|NCT00423813|75935647|FG000|Overall Study|Lost to Follow-up|5|||
42125246|NCT00423813|75935648|FG001|Overall Study|Lost to Follow-up|4|||
42125247|NCT00423813|75935649|FG002|Overall Study|Lost to Follow-up|4|||
42125248|NCT00423813|75935647|FG000|Overall Study|Lack of Efficacy|23|||
42125249|NCT00423813|75935648|FG001|Overall Study|Lack of Efficacy|18|||
42125250|NCT00423813|75935649|FG002|Overall Study|Lack of Efficacy|19|||
42125251|NCT00423813|75935647|FG000|Overall Study|Physician Decision|2|||
42125252|NCT00423813|75935648|FG001|Overall Study|Physician Decision|0|||
42125253|NCT00423813|75935649|FG002|Overall Study|Physician Decision|0|||
42125254|NCT00423813|75935647|FG000|Overall Study|Sponsor Decision|0|||
42125255|NCT00423813|75935648|FG001|Overall Study|Sponsor Decision|1|||
42125256|NCT00423813|75935649|FG002|Overall Study|Sponsor Decision|0|||
42125257|NCT00423813|75935647|FG000|Overall Study|Protocol Violation|9|||
42125258|NCT00423813|75935648|FG001|Overall Study|Protocol Violation|4|||
42125259|NCT00423813|75935649|FG002|Overall Study|Protocol Violation|4|||
42125260|NCT00423813|75935647|FG000|Overall Study|Pregnancy|0|||
42125261|NCT00423813|75935648|FG001|Overall Study|Pregnancy|0|||
42125262|NCT00423813|75935649|FG002|Overall Study|Pregnancy|1|||
42125263|NCT00423813|75935647|FG000|Overall Study|Subject started night shift work|1|||
41968361|NCT03745989|75768354|FG002|Overall Study|Sponsor Decision|8|||
41968362|NCT03745989|75768352|FG000|Overall Study|Withdrawal by Subject|0|||
41968363|NCT03745989|75768353|FG001|Overall Study|Withdrawal by Subject|1|||
41968364|NCT03745989|75768354|FG002|Overall Study|Withdrawal by Subject|3|||
41968365|NCT03646656|75768384|FG000|Overall Study|Lost to Follow-up|1|||
41968366|NCT03646656|75768385|FG001|Overall Study|Lost to Follow-up|0|||
42125264|NCT00423813|75935648|FG001|Overall Study|Subject started night shift work|0|||
42125265|NCT00423813|75935649|FG002|Overall Study|Subject started night shift work|0|||
42125266|NCT00423813|75935647|FG000|Overall Study|Will start exclusionary medications|0|||
42125267|NCT00423813|75935648|FG001|Overall Study|Will start exclusionary medications|1|||
42125268|NCT00423813|75935649|FG002|Overall Study|Will start exclusionary medications|0|||
42125269|NCT00423813|75935647|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
42125270|NCT00423813|75935648|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
42125271|NCT00423813|75935649|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
42125272|NCT03687372|75935659|FG000|Overall Study|Lost to Follow-up|12|||
42125273|NCT03687372|75935660|FG001|Overall Study|Lost to Follow-up|21|||
42125274|NCT03687372|75935659|FG000|Overall Study|Withdrawal by Subject|4|||
42125275|NCT03687372|75935660|FG001|Overall Study|Withdrawal by Subject|17|||
42125276|NCT03687372|75935659|FG000|Overall Study|Investigator Decision|1|||
42125277|NCT03687372|75935660|FG001|Overall Study|Investigator Decision|1|||
42125278|NCT00626405|75935670|FG000|Overall Study|Deemed Ineligible|1|||
42125279|NCT00626405|75935671|FG001|Overall Study|Deemed Ineligible|0|||
42125280|NCT00626405|75935670|FG000|Overall Study|Withdrawal by Subject|0|||
42125281|NCT00626405|75935671|FG001|Overall Study|Withdrawal by Subject|1|||
42125282|NCT00358150|75935677|FG000|Overall Study|Adverse Event|3|||
42125283|NCT00358150|75935677|FG000|Overall Study|Withdrawal by Subject|1|||
42125284|NCT00358150|75935677|FG000|Overall Study|Undefined|3|||
42125285|NCT05061966|75935704|FG000|Overall Study|Lost to Follow-up|13|||
42125286|NCT05061966|75935705|FG001|Overall Study|Lost to Follow-up|13|||
42125287|NCT05027815|75935713|FG000|Overall Study|Death|2|||
42125288|NCT05027815|75935714|FG001|Overall Study|Death|1|||
42125289|NCT04827134|75935724|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
42125290|NCT04827134|75935725|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
42125291|NCT04827134|75935726|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
42125292|NCT04827134|75935727|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
42125293|NCT04818593|75935741|FG000|Overall Study|Low Oocyte Yield|8|||
42125294|NCT04818593|75935742|FG001|Overall Study|Low Oocyte Yield|8|||
42125295|NCT04818593|75935741|FG000|Overall Study|Not ICSI Insemination|7|||
41968367|NCT03646656|75768384|FG000|Overall Study|Withdrawal by Subject|2|||
41968368|NCT03646656|75768385|FG001|Overall Study|Withdrawal by Subject|0|||
42125296|NCT04818593|75935742|FG001|Overall Study|Not ICSI Insemination|7|||
42125297|NCT04818593|75935741|FG000|Overall Study|Poor Sperm Quality|2|||
42125298|NCT04818593|75935742|FG001|Overall Study|Poor Sperm Quality|2|||
42125299|NCT04818593|75935741|FG000|Overall Study|Withdrawal by Subject|2|||
42125300|NCT04818593|75935742|FG001|Overall Study|Withdrawal by Subject|2|||
42125301|NCT04818593|75935741|FG000|Overall Study|Conversion to IUI due to low response|1|||
42125302|NCT04818593|75935742|FG001|Overall Study|Conversion to IUI due to low response|1|||
42125303|NCT04680975|75935748|FG000|Overall Study|Adverse Event|3|||
42125304|NCT04680975|75935748|FG000|Overall Study|Death|1|||
42125305|NCT04680975|75935748|FG000|Overall Study|Progressive Disease|1|||
42125306|NCT04680975|75935748|FG000|Overall Study|Withdrawal by Subject|1|||
42125307|NCT04673786|75935754|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
42125308|NCT04673786|75935755|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
42125309|NCT04673786|75935756|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
42125310|NCT04673786|75935754|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
42125311|NCT04673786|75935755|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
42125312|NCT04673786|75935756|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
42125313|NCT04673786|75935754|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
42125314|NCT04673786|75935755|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
42125315|NCT04673786|75935756|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
42125316|NCT04673786|75935754|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
42125317|NCT04673786|75935755|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
42125318|NCT04673786|75935756|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
42125319|NCT04673786|75935754|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
42125320|NCT04673786|75935755|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
42125321|NCT04673786|75935756|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
42125322|NCT04673786|75935754|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
42125323|NCT04673786|75935755|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
42125324|NCT04673786|75935756|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
42125325|NCT04583969|75935780|FG000|Overall Study|Death|31|||
42125326|NCT04583969|75935781|FG001|Overall Study|Death|38|||
42125327|NCT04583969|75935780|FG000|Overall Study|Lost to Follow-up|16|||
42125328|NCT04583969|75935781|FG001|Overall Study|Lost to Follow-up|13|||
42125329|NCT04583969|75935780|FG000|Overall Study|Protocol Violation|1|||
42125330|NCT04583969|75935781|FG001|Overall Study|Protocol Violation|0|||
42125331|NCT04583969|75935780|FG000|Overall Study|Withdrawal by Subject|3|||
42125332|NCT04583969|75935781|FG001|Overall Study|Withdrawal by Subject|3|||
42125333|NCT04583969|75935780|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
42125334|NCT04583969|75935781|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
42125335|NCT04583969|75935780|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
42125336|NCT04583969|75935781|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
42125337|NCT04583969|75935780|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
42125338|NCT04583969|75935781|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
42125339|NCT04583969|75935780|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
42125340|NCT04583969|75935781|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
42125341|NCT04583969|75935780|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
42125342|NCT04583969|75935781|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
42125343|NCT04561115|75935787|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
42125344|NCT04561115|75935788|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
42125345|NCT04561115|75935787|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
42125346|NCT04561115|75935788|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
42125347|NCT04561115|75935787|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
42125348|NCT04561115|75935788|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
42125349|NCT04366258|75935794|FG000|Baseline Assessments|Screen Failure|21|||
42125350|NCT04366258|75935794|FG000|Baseline Assessments|Early Termination|3|||
42125351|NCT04101331|75935842|FG000|Overall Study|Adverse Event|7|||
42125352|NCT04101331|75935842|FG000|Overall Study|Disease progression|79|||
42125353|NCT04101331|75935842|FG000|Overall Study|Withdrawal by Subject|1|||
42125354|NCT04101331|75935842|FG000|Overall Study|Investigator decision|6|||
42125355|NCT04101331|75935842|FG000|Overall Study|Death|6|||
42125356|NCT04101331|75935842|FG000|Overall Study|Allogenic transplant|1|||
42125357|NCT04082884|75935846|FG000|Overall Study|Withdrawal by Subject|1|||
42125358|NCT03891667|75935852|FG000|Overall Study|Physician Decision|1|||
42125359|NCT03891667|75935853|FG001|Overall Study|Physician Decision|0|||
42125360|NCT03891667|75935852|FG000|Overall Study|COVID related pause|1|||
42125361|NCT03891667|75935853|FG001|Overall Study|COVID related pause|1|||
42125362|NCT03891667|75935852|FG000|Overall Study|Withdrawal by Subject|0|||
42125363|NCT03891667|75935853|FG001|Overall Study|Withdrawal by Subject|1|||
42125364|NCT03891667|75935852|FG000|Overall Study|Adverse Event|0|||
42125365|NCT03891667|75935853|FG001|Overall Study|Adverse Event|1|||
42125366|NCT03715153|75935877|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
42125367|NCT03715153|75935878|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
42125368|NCT03715153|75935877|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
42125369|NCT03715153|75935878|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
42125370|NCT03715153|75935877|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
42125371|NCT03715153|75935878|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
42125372|NCT03715153|75935877|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
42125373|NCT03715153|75935878|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
42125374|NCT03715153|75935877|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
42125375|NCT03715153|75935878|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
42125376|NCT03715153|75935877|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
42125377|NCT03715153|75935878|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
42125378|NCT03569293|75935907|FG000|Overall Study|Adverse Event|4|||
42125379|NCT03569293|75935908|FG001|Overall Study|Adverse Event|1|||
42125380|NCT03569293|75935909|FG002|Overall Study|Adverse Event|5|||
42125381|NCT03569293|75935910|FG003|Overall Study|Adverse Event|1|||
42125382|NCT03569293|75935911|FG004|Overall Study|Adverse Event|0|||
42125383|NCT03569293|75935912|FG005|Overall Study|Adverse Event|0|||
42125384|NCT03569293|75935907|FG000|Overall Study|Withdrawal by Subject|16|||
42125385|NCT03569293|75935908|FG001|Overall Study|Withdrawal by Subject|2|||
42125386|NCT03569293|75935909|FG002|Overall Study|Withdrawal by Subject|4|||
42125387|NCT03569293|75935910|FG003|Overall Study|Withdrawal by Subject|1|||
42125388|NCT03569293|75935911|FG004|Overall Study|Withdrawal by Subject|0|||
42125389|NCT03569293|75935912|FG005|Overall Study|Withdrawal by Subject|0|||
42125390|NCT03569293|75935907|FG000|Overall Study|Lost to Follow-up|1|||
42125391|NCT03569293|75935908|FG001|Overall Study|Lost to Follow-up|3|||
42125392|NCT03569293|75935909|FG002|Overall Study|Lost to Follow-up|1|||
42125393|NCT03569293|75935910|FG003|Overall Study|Lost to Follow-up|1|||
42125394|NCT03569293|75935911|FG004|Overall Study|Lost to Follow-up|0|||
42125395|NCT03569293|75935912|FG005|Overall Study|Lost to Follow-up|0|||
42125396|NCT03569293|75935907|FG000|Overall Study|Other|8|||
42125397|NCT03569293|75935908|FG001|Overall Study|Other|2|||
42125398|NCT03569293|75935909|FG002|Overall Study|Other|1|||
42125399|NCT03569293|75935910|FG003|Overall Study|Other|1|||
42125400|NCT03569293|75935911|FG004|Overall Study|Other|0|||
42125401|NCT03569293|75935912|FG005|Overall Study|Other|0|||
42125402|NCT03569293|75935907|FG000|Overall Study|Ongoing at Time of Analysis|8|||
42125403|NCT03569293|75935908|FG001|Overall Study|Ongoing at Time of Analysis|1|||
42125404|NCT03569293|75935909|FG002|Overall Study|Ongoing at Time of Analysis|3|||
42125405|NCT03569293|75935910|FG003|Overall Study|Ongoing at Time of Analysis|0|||
42125406|NCT03569293|75935911|FG004|Overall Study|Ongoing at Time of Analysis|0|||
42125407|NCT03569293|75935912|FG005|Overall Study|Ongoing at Time of Analysis|0|||
42125408|NCT03464136|75935928|FG000|Overall Study|Lost to Follow-up|5|||
42125409|NCT03464136|75935929|FG001|Overall Study|Lost to Follow-up|8|||
42125410|NCT03464136|75935928|FG000|Overall Study|Withdrawal by Subject|16|||
42125411|NCT03464136|75935929|FG001|Overall Study|Withdrawal by Subject|13|||
42125412|NCT03464136|75935928|FG000|Overall Study|Death|1|||
42125413|NCT03464136|75935929|FG001|Overall Study|Death|0|||
42125414|NCT03464136|75935928|FG000|Overall Study|Other|8|||
42125415|NCT03464136|75935929|FG001|Overall Study|Other|4|||
42125416|NCT03020823|75935953|FG000|Overall Study|Physician Decision|4|||
42125417|NCT03020823|75935953|FG000|Overall Study|Lack of Efficacy|4|||
42125418|NCT03020823|75935953|FG000|Overall Study|Adverse Event|2|||
41968369|NCT03555435|75768398|FG000|Overall Study|Lost to Follow-up|17|||
41968370|NCT03555435|75768399|FG001|Overall Study|Lost to Follow-up|19|||
41968371|NCT03555435|75768400|FG002|Overall Study|Lost to Follow-up|8|||
41968372|NCT03521115|75768410|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
41968373|NCT03521115|75768411|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
41968374|NCT03521115|75768410|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
41968375|NCT03521115|75768411|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
41968376|NCT03520413|75768425|FG000|Overall Study|Lost to Follow-up|1|||
41968377|NCT03520413|75768426|FG001|Overall Study|Lost to Follow-up|1|||
41968378|NCT03520413|75768425|FG000|Overall Study|Withdrawal by Subject|1|||
41968379|NCT03520413|75768426|FG001|Overall Study|Withdrawal by Subject|2|||
41968380|NCT03520413|75768425|FG000|Overall Study|Death|0|||
41968381|NCT03520413|75768426|FG001|Overall Study|Death|1|||
41968382|NCT03520413|75768425|FG000|Overall Study|Physician Decision|3|||
41968383|NCT03520413|75768426|FG001|Overall Study|Physician Decision|3|||
42125419|NCT02969369|75935961|FG000|Study|Adverse Event|1|||
42125420|NCT02969369|75935962|FG001|Study|Adverse Event|6|||
42125421|NCT02969369|75935961|FG000|Study|Lack of Efficacy|0|||
41968384|NCT03520413|75768425|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
42125422|NCT02969369|75935962|FG001|Study|Lack of Efficacy|1|||
42125423|NCT02969369|75935961|FG000|Study|Lost to Follow-up|0|||
42125424|NCT02969369|75935962|FG001|Study|Lost to Follow-up|1|||
42125425|NCT02969369|75935961|FG000|Study|Withdrawal by Subject|3|||
42125426|NCT02969369|75935962|FG001|Study|Withdrawal by Subject|5|||
41968385|NCT03520413|75768426|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
41968386|NCT03419897|75768433|FG000|Overall Study|Death|180|||
42125427|NCT02969369|75935961|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
42125428|NCT02969369|75935962|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
41968387|NCT03419897|75768433|FG000|Overall Study|Lost to Follow-up|1|||
41968388|NCT03419897|75768433|FG000|Overall Study|Withdrawal by Subject|6|||
41968389|NCT03419897|75768433|FG000|Overall Study|Sponsor Decision|61|||
41968390|NCT03419897|75768433|FG000|Overall Study|Physician Decision|1|||
41968391|NCT03418129|75768440|FG000|Overall Study|Lost to Follow-up|11|||
41968392|NCT03418129|75768441|FG001|Overall Study|Lost to Follow-up|20|||
41968393|NCT03418129|75768442|FG002|Overall Study|Lost to Follow-up|15|||
41968394|NCT03418129|75768440|FG000|Overall Study|Withdrawal by Subject|3|||
41968395|NCT03418129|75768441|FG001|Overall Study|Withdrawal by Subject|6|||
41968396|NCT03418129|75768442|FG002|Overall Study|Withdrawal by Subject|4|||
41968397|NCT03344796|75768460|FG000|Overall Study|Lost to Follow-up|0|||
41968398|NCT03344796|75768461|FG001|Overall Study|Lost to Follow-up|0|||
41968399|NCT03344796|75768462|FG002|Overall Study|Lost to Follow-up|0|||
41968400|NCT03344796|75768463|FG003|Overall Study|Lost to Follow-up|0|||
41968401|NCT03344796|75768464|FG004|Overall Study|Lost to Follow-up|0|||
42125429|NCT02969369|75935961|FG000|Double-blind Period|Adverse Event|1|||
42125430|NCT02969369|75935962|FG001|Double-blind Period|Adverse Event|5|||
41968402|NCT03344796|75768465|FG005|Overall Study|Lost to Follow-up|2|||
41968403|NCT03335488|75768488|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
41968404|NCT03335488|75768489|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
41968405|NCT03335488|75768488|FG000|Safety Extension Period|Adverse Event|1|||
41968406|NCT03335488|75768489|FG001|Safety Extension Period|Adverse Event|0|||
41968407|NCT03335488|75768488|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
41968408|NCT03335488|75768489|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
41968409|NCT03261700|75768508|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
41968410|NCT03261700|75768509|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
41968411|NCT03238417|75768520|FG000|Overall|non-response|955|||
41968412|NCT03238417|75768521|FG001|Overall|non-response|1920|||
41968413|NCT03238417|75768520|FG000|Overall|partial completion|48|||
41968414|NCT03238417|75768521|FG001|Overall|partial completion|68|||
41968415|NCT03238417|75768520|FG000|Baseline|Partial completion|17|||
41968416|NCT03238417|75768521|FG001|Baseline|Partial completion|48|||
41968417|NCT03238417|75768520|FG000|Baseline|non-response|372|||
41968418|NCT03238417|75768521|FG001|Baseline|non-response|669|||
41968419|NCT03238417|75768520|FG000|12-month|non-response|296|||
41968420|NCT03238417|75768521|FG001|12-month|non-response|669|||
41968421|NCT03238417|75768520|FG000|12-month|partial completion|23|||
41968422|NCT03238417|75768521|FG001|12-month|partial completion|37|||
41968423|NCT03238417|75768520|FG000|24-month|non-response|287|||
41968424|NCT03238417|75768521|FG001|24-month|non-response|594|||
41968425|NCT03238417|75768520|FG000|24-month|partial completion|8|||
41968426|NCT03238417|75768521|FG001|24-month|partial completion|31|||
41968427|NCT03215277|75768529|FG000|Overall Study|Adverse Event|2|||
41968428|NCT03215277|75768530|FG001|Overall Study|Adverse Event|3|||
41968429|NCT03215277|75768529|FG000|Overall Study|Death|1|||
41968430|NCT03215277|75768530|FG001|Overall Study|Death|0|||
41968431|NCT03215277|75768529|FG000|Overall Study|Lost to Follow-up|0|||
41968432|NCT03215277|75768530|FG001|Overall Study|Lost to Follow-up|1|||
41968433|NCT03215277|75768529|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
41968434|NCT03215277|75768530|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
41968435|NCT03185013|75768540|FG000|Overall Study|Withdrawal by Subject|5|||
41968436|NCT03185013|75768541|FG001|Overall Study|Withdrawal by Subject|3|||
41968437|NCT03185013|75768540|FG000|Overall Study|Adverse Event|1|||
41968438|NCT03185013|75768541|FG001|Overall Study|Adverse Event|0|||
41968439|NCT03185013|75768540|FG000|Overall Study|Progressive Disease|1|||
41968440|NCT03185013|75768541|FG001|Overall Study|Progressive Disease|0|||
41968441|NCT03185013|75768540|FG000|Overall Study|Lost to Follow-up|8|||
41968442|NCT03185013|75768541|FG001|Overall Study|Lost to Follow-up|2|||
41968443|NCT03185013|75768540|FG000|Overall Study|Physician Decision|1|||
41968444|NCT03185013|75768541|FG001|Overall Study|Physician Decision|0|||
42125431|NCT02969369|75935961|FG000|Double-blind Period|Lost to Follow-up|0|||
41968445|NCT03185013|75768540|FG000|Overall Study|Protocol Deviation|2|||
41968446|NCT03185013|75768541|FG001|Overall Study|Protocol Deviation|0|||
41968447|NCT03185013|75768540|FG000|Overall Study|Reason not Specified|3|||
42125432|NCT02969369|75935962|FG001|Double-blind Period|Lost to Follow-up|1|||
42125433|NCT02969369|75935961|FG000|Double-blind Period|Withdrawal by Subject|2|||
42301603|NCT02288559|76136751|FG000|Overall Study|Reason Not Specified|0|||
41968448|NCT03185013|75768541|FG001|Overall Study|Reason not Specified|2|||
42027880|NCT00962013|75836154|FG000|Overall Study|Lost to Follow-up|12|||
41968449|NCT03185013|75768540|FG000|Overall Study|Death|1|||
41968450|NCT03185013|75768541|FG001|Overall Study|Death|0|||
41968451|NCT03182907|75768549|FG000|Overall Study|Death|3|||
41968452|NCT03182907|75768550|FG001|Overall Study|Death|0|||
41968453|NCT03182907|75768549|FG000|Overall Study|Protocol Violation|4|||
41968454|NCT03182907|75768550|FG001|Overall Study|Protocol Violation|0|||
41968455|NCT03182907|75768549|FG000|Overall Study|Lost to Follow-up|1|||
41968456|NCT03182907|75768550|FG001|Overall Study|Lost to Follow-up|0|||
41968457|NCT03182907|75768549|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
41968458|NCT03182907|75768550|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
41968459|NCT03036813|75768562|FG000|Overall Study|Adverse Event|6|||
41968460|NCT03036813|75768563|FG001|Overall Study|Adverse Event|11|||
42125434|NCT02969369|75935962|FG001|Double-blind Period|Withdrawal by Subject|3|||
42125435|NCT02969369|75935961|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
42125436|NCT02969369|75935962|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
42125437|NCT02969369|75935961|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
42125438|NCT02969369|75935962|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
42125439|NCT02969369|75935961|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
42125440|NCT02969369|75935962|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
42125441|NCT02969369|75935961|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
42125442|NCT02969369|75935962|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
42125443|NCT02583269|75935982|FG000|Overall Study|Patient hospitalized prior to start|1|||
42125444|NCT02583269|75935983|FG001|Overall Study|Patient hospitalized prior to start|0|||
41968461|NCT03036813|75768564|FG002|Overall Study|Adverse Event|6|||
41968462|NCT03036813|75768562|FG000|Overall Study|Withdrawal by Subject|12|||
41968463|NCT03036813|75768563|FG001|Overall Study|Withdrawal by Subject|6|||
41968464|NCT03036813|75768564|FG002|Overall Study|Withdrawal by Subject|10|||
41968465|NCT03036813|75768562|FG000|Overall Study|Lost to Follow-up|1|||
41968466|NCT03036813|75768563|FG001|Overall Study|Lost to Follow-up|1|||
41968467|NCT03036813|75768564|FG002|Overall Study|Lost to Follow-up|0|||
41968468|NCT03036813|75768562|FG000|Overall Study|Physician Decision|2|||
41968469|NCT03036813|75768563|FG001|Overall Study|Physician Decision|1|||
41968470|NCT03036813|75768564|FG002|Overall Study|Physician Decision|1|||
41968471|NCT03036813|75768562|FG000|Overall Study|Non-Compliance|1|||
41968472|NCT03036813|75768563|FG001|Overall Study|Non-Compliance|5|||
41968473|NCT03036813|75768564|FG002|Overall Study|Non-Compliance|3|||
41968474|NCT03036813|75768562|FG000|Overall Study|Pregnancy|0|||
41968475|NCT03036813|75768563|FG001|Overall Study|Pregnancy|0|||
41968476|NCT03036813|75768564|FG002|Overall Study|Pregnancy|1|||
41968477|NCT03036813|75768562|FG000|Overall Study|Other|0|||
41968478|NCT03036813|75768563|FG001|Overall Study|Other|3|||
42125445|NCT02583269|75935984|FG002|Overall Study|Patient hospitalized prior to start|0|||
42125446|NCT02583269|75935985|FG003|Overall Study|Patient hospitalized prior to start|0|||
42125447|NCT02583269|75935986|FG004|Overall Study|Patient hospitalized prior to start|0|||
42125448|NCT02546921|75936006|FG000|Overall Study|Adverse Event|0|||
42125449|NCT02546921|75936007|FG001|Overall Study|Adverse Event|5|||
42125450|NCT02546921|75936008|FG002|Overall Study|Adverse Event|2|||
42125451|NCT02546921|75936009|FG003|Overall Study|Adverse Event|0|||
42125452|NCT02546921|75936010|FG004|Overall Study|Adverse Event|0|||
42125453|NCT02546921|75936011|FG005|Overall Study|Adverse Event|0|||
42125454|NCT02546921|75936012|FG006|Overall Study|Adverse Event|0|||
42125455|NCT02546921|75936006|FG000|Overall Study|Evidence of Disease Progression|1|||
42125456|NCT02546921|75936007|FG001|Overall Study|Evidence of Disease Progression|0|||
42125457|NCT02546921|75936008|FG002|Overall Study|Evidence of Disease Progression|0|||
42125458|NCT02546921|75936009|FG003|Overall Study|Evidence of Disease Progression|0|||
42125459|NCT02546921|75936010|FG004|Overall Study|Evidence of Disease Progression|1|||
42125460|NCT02546921|75936011|FG005|Overall Study|Evidence of Disease Progression|0|||
42125461|NCT02546921|75936012|FG006|Overall Study|Evidence of Disease Progression|0|||
42125462|NCT02546921|75936006|FG000|Overall Study|Patient Choice|0|||
42125463|NCT02546921|75936007|FG001|Overall Study|Patient Choice|1|||
42125464|NCT02546921|75936008|FG002|Overall Study|Patient Choice|0|||
42125465|NCT02546921|75936009|FG003|Overall Study|Patient Choice|0|||
42125466|NCT02546921|75936010|FG004|Overall Study|Patient Choice|0|||
42125467|NCT02546921|75936011|FG005|Overall Study|Patient Choice|1|||
42125468|NCT02546921|75936012|FG006|Overall Study|Patient Choice|0|||
42125469|NCT02513329|75936046|FG000|Overall Study|Lost to Follow-up|5|||
42125470|NCT02513329|75936047|FG001|Overall Study|Lost to Follow-up|2|||
42125471|NCT02425826|75936057|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
42125472|NCT02425826|75936058|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
42125473|NCT02425826|75936059|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
41968479|NCT03036813|75768564|FG002|Overall Study|Other|5|||
42125474|NCT02425826|75936057|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
42125475|NCT02425826|75936058|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
41968480|NCT03007953|75768577|FG000|Overall Study|Withdrawal by Subject|5|||
41968481|NCT03007953|75768578|FG001|Overall Study|Withdrawal by Subject|2|||
41968482|NCT03007953|75768577|FG000|Overall Study|Death|5|||
41968483|NCT03007953|75768578|FG001|Overall Study|Death|7|||
42125476|NCT02425826|75936059|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
42137797|NCT00334113|75948173|FG001|Overall Study|Lost to Follow-up|2|||
41968484|NCT03007953|75768577|FG000|Overall Study|Lost to Follow-up|3|||
41968485|NCT03007953|75768578|FG001|Overall Study|Lost to Follow-up|2|||
41968486|NCT03007953|75768577|FG000|Overall Study|Enrolled in Hospice|3|||
42125477|NCT02425826|75936057|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
42125478|NCT02425826|75936058|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
42125479|NCT02425826|75936059|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
42125480|NCT02425826|75936057|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
42125481|NCT02425826|75936058|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
42125482|NCT02425826|75936059|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
42125483|NCT02425826|75936057|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
42125484|NCT02425826|75936058|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
42125485|NCT02425826|75936059|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
42125486|NCT02425826|75936057|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
42125487|NCT02425826|75936058|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
42125488|NCT02425826|75936059|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
42125489|NCT02425826|75936057|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
42125490|NCT02425826|75936058|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
42125491|NCT02425826|75936059|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
42125492|NCT02425826|75936057|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
41968487|NCT03007953|75768578|FG001|Overall Study|Enrolled in Hospice|2|||
41968488|NCT02919618|75768593|FG000|Overall Study|Death|1|||
41968489|NCT02911701|75768610|FG000|Overall Study|Withdrawal by Subject|2|||
41968490|NCT02911701|75768611|FG001|Overall Study|Withdrawal by Subject|4|||
41968491|NCT02911701|75768610|FG000|Overall Study|Adverse Event|1|||
41968492|NCT02911701|75768611|FG001|Overall Study|Adverse Event|0|||
41968493|NCT02896257|75768621|FG000|Providers|Without eligible patients|21|||
41968494|NCT02896257|75768622|FG001|Providers|Without eligible patients|28|||
41968495|NCT02896257|75768621|FG000|Patients|PFT entry criteria not met|43|||
41968496|NCT02896257|75768622|FG001|Patients|PFT entry criteria not met|50|||
41968497|NCT02896257|75768621|FG000|Patients|No capacity to review|8|||
41968498|NCT02896257|75768622|FG001|Patients|No capacity to review|11|||
41968499|NCT02896257|75768621|FG000|Patients|Appointment rescheduled/cancelled|5|||
41968500|NCT02896257|75768622|FG001|Patients|Appointment rescheduled/cancelled|7|||
42125493|NCT02425826|75936058|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
42125494|NCT02425826|75936059|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
42125495|NCT02425826|75936057|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
42125496|NCT02425826|75936058|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
42125497|NCT02425826|75936059|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
42125498|NCT02425826|75936057|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
42125499|NCT02425826|75936058|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
42125500|NCT02425826|75936059|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
42125501|NCT02406027|75936072|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
42125502|NCT02406027|75936073|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
42125503|NCT02406027|75936074|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
42125504|NCT02406027|75936075|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
42125505|NCT02406027|75936076|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
42125506|NCT02406027|75936077|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
42125507|NCT02406027|75936078|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
42125508|NCT02406027|75936072|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
42125509|NCT02406027|75936073|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
42125510|NCT02406027|75936074|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
42125511|NCT02406027|75936075|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
42125512|NCT02406027|75936076|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
42125513|NCT02406027|75936077|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
42125514|NCT02406027|75936078|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
42125515|NCT02406027|75936072|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
42125516|NCT02406027|75936073|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
42125517|NCT02406027|75936074|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
42125518|NCT02406027|75936075|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
42125519|NCT02406027|75936076|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
42125520|NCT02406027|75936077|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
42125521|NCT02406027|75936078|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
42125522|NCT02406027|75936072|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
42125523|NCT02406027|75936073|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
41968501|NCT02896257|75768621|FG000|Patients|PCP not assigned a clinic|4|||
41968502|NCT02896257|75768622|FG001|Patients|PCP not assigned a clinic|0|||
42027881|NCT00962013|75836154|FG000|Overall Study|Unable/Unwilling to return|6|||
41968503|NCT02896257|75768621|FG000|Patients|No history of COPD|0|||
41968504|NCT02896257|75768622|FG001|Patients|No history of COPD|1|||
42125524|NCT02406027|75936074|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
42125525|NCT02406027|75936075|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
41968505|NCT02896257|75768621|FG000|Patients|Deceased between review and index date|0|||
41968506|NCT02896257|75768622|FG001|Patients|Deceased between review and index date|1|||
41968507|NCT02896257|75768621|FG000|Patients|No ICS Rx upon review|1|||
41968508|NCT02896257|75768622|FG001|Patients|No ICS Rx upon review|1|||
41968509|NCT02896257|75768621|FG000|Patients|Protocol Violation|2|||
41968510|NCT02896257|75768622|FG001|Patients|Protocol Violation|1|||
41968511|NCT02896257|75768621|FG000|Patients|Hospice care|0|||
41968512|NCT02896257|75768622|FG001|Patients|Hospice care|1|||
41968513|NCT02874742|75768632|FG000|Overall Study|Death|0|||
41968514|NCT02874742|75768633|FG001|Overall Study|Death|1|||
41968515|NCT02874742|75768634|FG002|Overall Study|Death|0|||
41968516|NCT02874742|75768632|FG000|Overall Study|Lost to Follow-up|5|||
41968517|NCT02874742|75768633|FG001|Overall Study|Lost to Follow-up|4|||
41968518|NCT02874742|75768634|FG002|Overall Study|Lost to Follow-up|1|||
41968519|NCT02874742|75768632|FG000|Overall Study|Withdrawal by Subject|17|||
41968520|NCT02874742|75768633|FG001|Overall Study|Withdrawal by Subject|8|||
41968521|NCT02874742|75768634|FG002|Overall Study|Withdrawal by Subject|0|||
41968522|NCT02874742|75768632|FG000|Overall Study|Other|4|||
41968523|NCT02874742|75768633|FG001|Overall Study|Other|1|||
41968524|NCT02874742|75768634|FG002|Overall Study|Other|0|||
41968525|NCT02874742|75768632|FG000|Overall Study|Progressive Disease|1|||
41968526|NCT02874742|75768633|FG001|Overall Study|Progressive Disease|0|||
41968527|NCT02874742|75768634|FG002|Overall Study|Progressive Disease|0|||
41968528|NCT02874742|75768632|FG000|Overall Study|Screen Failure|0|||
41968529|NCT02874742|75768633|FG001|Overall Study|Screen Failure|2|||
41968530|NCT02874742|75768634|FG002|Overall Study|Screen Failure|0|||
41968531|NCT02749292|75768644|FG000|Overall Study|Physician Decision|1|||
41968532|NCT02749292|75768645|FG001|Overall Study|Physician Decision|0|||
41968533|NCT02749292|75768644|FG000|Overall Study|Withdrawal by Subject|5|||
41968534|NCT02749292|75768645|FG001|Overall Study|Withdrawal by Subject|7|||
41968535|NCT02749292|75768644|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
41968536|NCT02749292|75768645|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
41968537|NCT02749292|75768644|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
41968538|NCT02749292|75768645|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
41968539|NCT02749292|75768644|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
41968540|NCT02749292|75768645|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
41968541|NCT02749292|75768644|FG000|Overall Study|Adverse Event|4|||
41968542|NCT02749292|75768645|FG001|Overall Study|Adverse Event|1|||
41968543|NCT02749292|75768644|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
41968544|NCT02749292|75768645|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
41968545|NCT02749292|75768644|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
41968546|NCT02749292|75768645|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
41968547|NCT02749292|75768644|FG000|Overall Study|Requiring glucocorticoids|0|||
41968548|NCT02749292|75768645|FG001|Overall Study|Requiring glucocorticoids|3|||
41968549|NCT02749292|75768644|FG000|Overall Study|Cancer|1|||
41968550|NCT02749292|75768645|FG001|Overall Study|Cancer|0|||
42010473|NCT00993499|75817616|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
41968551|NCT02689076|75768664|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
41968552|NCT02689076|75768665|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
41968553|NCT02689076|75768666|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
41968554|NCT02689076|75768664|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
41968555|NCT02689076|75768665|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
41968556|NCT02689076|75768666|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
41968557|NCT02689076|75768664|FG000|Overall Study|Did not have an HIE match|2|||
41968558|NCT02689076|75768665|FG001|Overall Study|Did not have an HIE match|0|||
41968559|NCT02689076|75768666|FG002|Overall Study|Did not have an HIE match|0|||
41968560|NCT02689076|75768664|FG000|Overall Study|Death during non-VA encounter|2|||
41968561|NCT02689076|75768665|FG001|Overall Study|Death during non-VA encounter|5|||
41968562|NCT02689076|75768666|FG002|Overall Study|Death during non-VA encounter|0|||
41968563|NCT02689076|75768664|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
41968564|NCT02689076|75768665|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
41968565|NCT02689076|75768666|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
41968566|NCT02689076|75768664|FG000|Overall Study|Participant no longer active in VA system|1|||
41968567|NCT02689076|75768665|FG001|Overall Study|Participant no longer active in VA system|0|||
42027882|NCT00962013|75836154|FG000|Overall Study|Withdrawal by Subject|8|||
42027883|NCT00962013|75836154|FG000|Overall Study|Removal of study device|3|||
42027884|NCT00962013|75836154|FG000|Overall Study|Site Termination|24|||
42027885|NCT00962013|75836154|FG000|Overall Study|No 5 year evaluation|6|||
42027886|NCT00970359|75836158|FG000|Overall Study|Not Treated|4|||
42027887|NCT01121406|75836164|FG000|Overall Study|Progressive disease RECIST|44|||
42125526|NCT02406027|75936076|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
41968568|NCT02689076|75768666|FG002|Overall Study|Participant no longer active in VA system|0|||
41968569|NCT02689076|75768664|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
41968570|NCT02689076|75768665|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
41968571|NCT02689076|75768666|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
41968572|NCT02576990|75768676|FG000|Overall Study|Death|29|||
41968573|NCT02576990|75768677|FG001|Overall Study|Death|18|||
41968574|NCT02576990|75768676|FG000|Overall Study|Physician Decision|1|||
41968575|NCT02576990|75768677|FG001|Overall Study|Physician Decision|0|||
41968576|NCT02576990|75768676|FG000|Overall Study|Screen failure|2|||
41968577|NCT02576990|75768677|FG001|Overall Study|Screen failure|0|||
41968578|NCT02576990|75768676|FG000|Overall Study|Sponsor's decision|24|||
41968579|NCT02576990|75768677|FG001|Overall Study|Sponsor's decision|4|||
41968580|NCT02576990|75768676|FG000|Overall Study|Withdrawal by Subject|0|||
41968581|NCT02576990|75768677|FG001|Overall Study|Withdrawal by Subject|2|||
41968582|NCT02550561|75768683|FG000|Overall Study|Lost to Follow-up|5|||
41968583|NCT02550561|75768683|FG000|Overall Study|Withdrawal by Subject|1|||
41968584|NCT02524171|75768693|FG000|6-month Follow-up|Lost to Follow-up|53|||
41968585|NCT02524171|75768694|FG001|6-month Follow-up|Lost to Follow-up|45|||
41968586|NCT02524171|75768693|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
41968587|NCT02524171|75768694|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
41968588|NCT02511106|75768702|FG000|Overall Study|Lost to Follow-up|1|||
41968589|NCT02511106|75768703|FG001|Overall Study|Lost to Follow-up|2|||
41968590|NCT02511106|75768702|FG000|Overall Study|Withdrawal by Subject|19|||
41968591|NCT02511106|75768703|FG001|Overall Study|Withdrawal by Subject|14|||
41968592|NCT02511106|75768702|FG000|Overall Study|Ongoing study at data cut-off|309|||
41968593|NCT02511106|75768703|FG001|Overall Study|Ongoing study at data cut-off|307|||
41968594|NCT02511106|75768702|FG000|Overall Study|Without specified reason|1|||
41968595|NCT02511106|75768703|FG001|Overall Study|Without specified reason|0|||
41968596|NCT02511106|75768702|FG000|Overall Study|Missing|1|||
41968597|NCT02511106|75768703|FG001|Overall Study|Missing|0|||
41968598|NCT02500589|75768713|FG000|Overall Study|Withdrawal by Subject|11|||
41968599|NCT02500589|75768714|FG001|Overall Study|Withdrawal by Subject|14|||
41968600|NCT02500589|75768713|FG000|Overall Study|Lost to Follow-up|10|||
42125527|NCT02406027|75936077|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
42125528|NCT02406027|75936078|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
42125529|NCT02406027|75936072|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
41968601|NCT02500589|75768714|FG001|Overall Study|Lost to Follow-up|12|||
41968602|NCT02500589|75768713|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
42027888|NCT01121406|75836165|FG001|Overall Study|Progressive disease RECIST|28|||
41968603|NCT02500589|75768714|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
41968604|NCT02500589|75768713|FG000|Overall Study|Death|7|||
42125530|NCT02406027|75936073|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
42125531|NCT02406027|75936074|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
42125532|NCT02406027|75936075|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
42125533|NCT02406027|75936076|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
42125534|NCT02406027|75936077|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
42125535|NCT02406027|75936078|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
41968605|NCT02500589|75768714|FG001|Overall Study|Death|5|||
41968606|NCT02481830|75768726|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
41968607|NCT02481830|75768727|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
41968608|NCT02481830|75768726|FG000|Pre-treatment|Withdrawal by Subject|0|||
41968609|NCT02481830|75768727|FG001|Pre-treatment|Withdrawal by Subject|10|||
41968610|NCT02481830|75768726|FG000|Pre-treatment|Disease Progression|1|||
41968611|NCT02481830|75768727|FG001|Pre-treatment|Disease Progression|1|||
41968612|NCT02481830|75768726|FG000|Pre-treatment|Other reasons|0|||
41968613|NCT02481830|75768727|FG001|Pre-treatment|Other reasons|1|||
41968614|NCT02481830|75768726|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
41968615|NCT02481830|75768727|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
41968616|NCT02481830|75768726|FG000|Treatment|Disease Progression|233|||
41968617|NCT02481830|75768727|FG001|Treatment|Disease Progression|171|||
41968618|NCT02481830|75768726|FG000|Treatment|Study drug toxicity|18|||
41968619|NCT02481830|75768727|FG001|Treatment|Study drug toxicity|38|||
41968620|NCT02481830|75768726|FG000|Treatment|Death|1|||
41968621|NCT02481830|75768727|FG001|Treatment|Death|1|||
41968622|NCT02481830|75768726|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
41968623|NCT02481830|75768727|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
41968624|NCT02481830|75768726|FG000|Treatment|Participants request to discontinue Study treatment|6|||
41968625|NCT02481830|75768727|FG001|Treatment|Participants request to discontinue Study treatment|34|||
41968626|NCT02481830|75768726|FG000|Treatment|Withdrawal by Subject|2|||
41968627|NCT02481830|75768727|FG001|Treatment|Withdrawal by Subject|3|||
41968628|NCT02481830|75768726|FG000|Treatment|Lost to Follow-up|1|||
41968629|NCT02481830|75768727|FG001|Treatment|Lost to Follow-up|0|||
41968630|NCT02481830|75768726|FG000|Treatment|Maximum Clinical Benefit|0|||
41968631|NCT02481830|75768727|FG001|Treatment|Maximum Clinical Benefit|5|||
41968632|NCT02481830|75768726|FG000|Treatment|Administrative reason by sponsor|1|||
41968633|NCT02481830|75768727|FG001|Treatment|Administrative reason by sponsor|1|||
41968634|NCT02481830|75768726|FG000|Treatment|Other reasons|6|||
41968635|NCT02481830|75768727|FG001|Treatment|Other reasons|1|||
41968636|NCT02477111|75768733|FG000|Overall Study|Death|5|||
41968637|NCT02477111|75768733|FG000|Overall Study|Withdrawal by Subject|2|||
41968638|NCT02477111|75768733|FG000|Overall Study|missed visit|4|||
41968639|NCT02425943|75768741|FG000|Overall Study|Adverse Event|3|||
41968640|NCT02425943|75768742|FG001|Overall Study|Adverse Event|1|||
41968641|NCT02425943|75768741|FG000|Overall Study|Lost to Follow-up|59|||
41968642|NCT02425943|75768742|FG001|Overall Study|Lost to Follow-up|37|||
41968643|NCT02425943|75768741|FG000|Overall Study|Protocol Violation|4|||
41968644|NCT02425943|75768742|FG001|Overall Study|Protocol Violation|1|||
41968645|NCT02425943|75768741|FG000|Overall Study|Withdrawal by Subject|64|||
41968646|NCT02425943|75768742|FG001|Overall Study|Withdrawal by Subject|31|||
41968647|NCT02425943|75768741|FG000|Overall Study|Other|6|||
41968648|NCT02425943|75768742|FG001|Overall Study|Other|0|||
41968649|NCT02383173|75768752|FG000|Overall Study|Palliative Care Team withdrew|0|||
41968650|NCT02383173|75768753|FG001|Overall Study|Palliative Care Team withdrew|2|||
41968651|NCT02380690|75768761|FG000|Overall Study|Lost to Follow-up|14|||
41968652|NCT02380690|75768762|FG001|Overall Study|Lost to Follow-up|4|||
41968653|NCT02380690|75768761|FG000|Overall Study|Withdrawal by Subject|20|||
41968654|NCT02380690|75768762|FG001|Overall Study|Withdrawal by Subject|8|||
41968655|NCT02311673|75768804|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
41968656|NCT02311673|75768805|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
41968657|NCT02311673|75768806|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
41968658|NCT02311673|75768807|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
41968659|NCT02233738|75768841|FG000|Overall Study|Lost to Follow-up|5|||
41968660|NCT02233738|75768842|FG001|Overall Study|Lost to Follow-up|12|||
41968661|NCT02233738|75768841|FG000|Overall Study|Death|0|||
41968662|NCT02233738|75768842|FG001|Overall Study|Death|1|||
41968663|NCT02233738|75768841|FG000|Overall Study|Withdrawal by Subject|0|||
41968664|NCT02233738|75768842|FG001|Overall Study|Withdrawal by Subject|1|||
41968665|NCT02233738|75768841|FG000|Overall Study|Did not return after Baseline|3|||
41968666|NCT02233738|75768842|FG001|Overall Study|Did not return after Baseline|2|||
41968667|NCT01959698|75769030|FG000|Overall Study|Adverse Event|0|||
41968668|NCT01959698|75769031|FG001|Overall Study|Adverse Event|0|||
41968669|NCT01959698|75769032|FG002|Overall Study|Adverse Event|0|||
41968670|NCT01959698|75769033|FG003|Overall Study|Adverse Event|0|||
41968671|NCT01959698|75769034|FG004|Overall Study|Adverse Event|0|||
41968672|NCT01959698|75769035|FG005|Overall Study|Adverse Event|0|||
41968673|NCT01959698|75769036|FG006|Overall Study|Adverse Event|1|||
41968674|NCT01959698|75769030|FG000|Overall Study|Physician Decision|1|||
41968675|NCT01959698|75769031|FG001|Overall Study|Physician Decision|0|||
41968676|NCT01959698|75769032|FG002|Overall Study|Physician Decision|1|||
41968677|NCT01959698|75769033|FG003|Overall Study|Physician Decision|2|||
41968678|NCT01959698|75769034|FG004|Overall Study|Physician Decision|0|||
41968679|NCT01959698|75769035|FG005|Overall Study|Physician Decision|3|||
41968680|NCT01959698|75769036|FG006|Overall Study|Physician Decision|3|||
41968681|NCT01910402|75769055|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
41968682|NCT01910402|75769056|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
41968683|NCT01910402|75769057|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
41968684|NCT01910402|75769055|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
41968685|NCT01910402|75769056|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
41968686|NCT01910402|75769057|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
41968687|NCT01910402|75769055|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
41968688|NCT01910402|75769056|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
41968689|NCT01910402|75769057|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
41968690|NCT01910402|75769055|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
41968691|NCT01910402|75769056|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
41968692|NCT01910402|75769057|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
41968693|NCT01910402|75769055|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
41968694|NCT01910402|75769056|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
41968695|NCT01910402|75769057|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
41968696|NCT01910402|75769055|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
41968697|NCT01910402|75769056|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
41968698|NCT01910402|75769057|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
41968699|NCT01910402|75769055|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
41968700|NCT01910402|75769056|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
41968701|NCT01910402|75769057|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
41968702|NCT01910402|75769055|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
41968703|NCT01910402|75769056|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
41968704|NCT01910402|75769057|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
41968705|NCT01910402|75769055|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
41968706|NCT01910402|75769056|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
41968707|NCT01910402|75769057|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
41968708|NCT01910402|75769055|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
41968709|NCT01910402|75769056|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
41968710|NCT01910402|75769057|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
41968711|NCT01910402|75769055|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
41968712|NCT01910402|75769056|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
41968713|NCT01910402|75769057|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
41968714|NCT01910402|75769055|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
41968715|NCT01910402|75769056|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
41968716|NCT01910402|75769057|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
41968717|NCT01910402|75769055|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
41968718|NCT01910402|75769056|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
41968719|NCT01910402|75769057|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
41968720|NCT01614197|75769086|FG000|Overall Study|Withdrawal by Subject|0|||
41968721|NCT01614197|75769087|FG001|Overall Study|Withdrawal by Subject|1|||
41968722|NCT01614197|75769088|FG002|Overall Study|Withdrawal by Subject|0|||
41968723|NCT01614197|75769089|FG003|Overall Study|Withdrawal by Subject|0|||
41968724|NCT01236521|75769123|FG000|Overall Study|Withdrawal by Subject|12|||
41968725|NCT01236521|75769124|FG001|Overall Study|Withdrawal by Subject|17|||
41968726|NCT01236521|75769123|FG000|Overall Study|Death|2|||
41968727|NCT01236521|75769124|FG001|Overall Study|Death|1|||
41968728|NCT01236521|75769123|FG000|Overall Study|Lost to Follow-up|9|||
42027889|NCT01121406|75836164|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
42027890|NCT01121406|75836165|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
42027891|NCT01121406|75836164|FG000|Overall Study|Other AE|3|||
41968729|NCT01236521|75769124|FG001|Overall Study|Lost to Follow-up|7|||
41968730|NCT01226797|75769132|FG000|Overall Study|Adverse Event|1|||
41968731|NCT01226797|75769133|FG001|Overall Study|Adverse Event|0|||
42125536|NCT02406027|75936072|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
42125537|NCT02406027|75936073|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
42125538|NCT02406027|75936074|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
42125539|NCT02406027|75936075|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
42125540|NCT02406027|75936076|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
41968732|NCT01226797|75769132|FG000|Overall Study|No longer willing to participate|1|||
41968733|NCT01226797|75769133|FG001|Overall Study|No longer willing to participate|0|||
41968734|NCT01226797|75769132|FG000|Overall Study|Protocol Violation|0|||
41968735|NCT01226797|75769133|FG001|Overall Study|Protocol Violation|1|||
41968736|NCT01142908|75769141|FG000|Overall Study|Lost to Follow-up|19|||
41968737|NCT01142908|75769142|FG001|Overall Study|Lost to Follow-up|13|||
41968738|NCT01142908|75769141|FG000|Overall Study|Death|1|||
41968739|NCT01142908|75769142|FG001|Overall Study|Death|4|||
41968740|NCT01142908|75769141|FG000|Overall Study|Excluded - did not meet criteria|9|||
41968741|NCT01142908|75769142|FG001|Overall Study|Excluded - did not meet criteria|5|||
41968742|NCT01142908|75769141|FG000|Overall Study|Withdrawal by Subject|3|||
41968743|NCT01142908|75769142|FG001|Overall Study|Withdrawal by Subject|0|||
41968744|NCT04962230|75769191|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
41968745|NCT04962230|75769191|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
41968746|NCT04919317|75769272|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
41968747|NCT04919317|75769273|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
41968748|NCT04919317|75769272|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
41968749|NCT04919317|75769273|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
41968750|NCT04789577|75769343|FG000|Overall Study|Withdrawal by Subject|1|||
41968751|NCT04789577|75769344|FG001|Overall Study|Withdrawal by Subject|1|||
41968752|NCT04789577|75769345|FG002|Overall Study|Withdrawal by Subject|1|||
41968753|NCT04789577|75769346|FG003|Overall Study|Withdrawal by Subject|3|||
41968754|NCT04789577|75769347|FG004|Overall Study|Withdrawal by Subject|1|||
41968755|NCT04789577|75769348|FG005|Overall Study|Withdrawal by Subject|7|||
41968756|NCT04789577|75769349|FG006|Overall Study|Withdrawal by Subject|1|||
41968757|NCT04789577|75769343|FG000|Overall Study|Lost to Follow-up|7|||
41968758|NCT04789577|75769344|FG001|Overall Study|Lost to Follow-up|12|||
41968759|NCT04789577|75769345|FG002|Overall Study|Lost to Follow-up|7|||
41968760|NCT04789577|75769346|FG003|Overall Study|Lost to Follow-up|10|||
41968761|NCT04789577|75769347|FG004|Overall Study|Lost to Follow-up|8|||
41968762|NCT04789577|75769348|FG005|Overall Study|Lost to Follow-up|6|||
41968763|NCT04789577|75769349|FG006|Overall Study|Lost to Follow-up|10|||
41968764|NCT04789577|75769343|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
41968765|NCT04789577|75769344|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
41968766|NCT04789577|75769345|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
41968767|NCT04789577|75769346|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
41968768|NCT04789577|75769347|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
41968769|NCT04789577|75769348|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
41968770|NCT04789577|75769349|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
41968771|NCT04789577|75769343|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
41968772|NCT04789577|75769344|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
41968773|NCT04789577|75769345|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
41968774|NCT04789577|75769346|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
41968775|NCT04789577|75769347|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
41968776|NCT04789577|75769348|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
41968777|NCT04789577|75769349|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
41968778|NCT04480463|75769410|FG000|Overall Study|Death|0|||
41968779|NCT04480463|75769411|FG001|Overall Study|Death|1|||
41968780|NCT04480463|75769410|FG000|Overall Study|Adverse Event|6|||
41968781|NCT04480463|75769411|FG001|Overall Study|Adverse Event|8|||
41968782|NCT04480463|75769410|FG000|Overall Study|Lost to Follow-up|3|||
41968783|NCT04480463|75769411|FG001|Overall Study|Lost to Follow-up|2|||
41968784|NCT04480463|75769410|FG000|Overall Study|Physician Decision|2|||
41968785|NCT04480463|75769411|FG001|Overall Study|Physician Decision|5|||
41968786|NCT04480463|75769410|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
41968787|NCT04480463|75769411|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
41968788|NCT04480463|75769410|FG000|Overall Study|Protocol Violation|2|||
41968789|NCT04480463|75769411|FG001|Overall Study|Protocol Violation|1|||
42125541|NCT02406027|75936077|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
42125542|NCT02406027|75936078|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
42125543|NCT02406027|75936072|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
42125544|NCT02406027|75936073|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
42125545|NCT02406027|75936074|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
41968790|NCT04480463|75769410|FG000|Overall Study|Withdrawal by Subject|6|||
41968791|NCT04480463|75769411|FG001|Overall Study|Withdrawal by Subject|7|||
41968792|NCT04480463|75769410|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
41968793|NCT04480463|75769411|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
41968794|NCT04480463|75769410|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
42125546|NCT02406027|75936075|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
42125547|NCT02406027|75936076|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
41968795|NCT04480463|75769411|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
41968796|NCT04480463|75769410|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
41968797|NCT04480463|75769411|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
41968798|NCT04480463|75769410|FG000|Overall Study|Other|6|||
41968799|NCT04480463|75769411|FG001|Overall Study|Other|4|||
41968800|NCT04285853|75769419|FG000|Overall Study|Withdrawal by Subject|1|||
41968801|NCT04285853|75769420|FG001|Overall Study|Withdrawal by Subject|0|||
41968802|NCT04285853|75769419|FG000|Overall Study|Lost to Follow-up|9|||
41968803|NCT04285853|75769420|FG001|Overall Study|Lost to Follow-up|5|||
41968804|NCT04128696|75769428|FG000|Overall Study|Lost to Follow-up|0|||
41968805|NCT04128696|75769429|FG001|Overall Study|Lost to Follow-up|1|||
41968806|NCT04128696|75769428|FG000|Overall Study|Withdrawal by Subject|8|||
41968807|NCT04128696|75769429|FG001|Overall Study|Withdrawal by Subject|5|||
41968808|NCT04128696|75769428|FG000|Overall Study|In Follow-up|47|||
41968809|NCT04128696|75769429|FG001|Overall Study|In Follow-up|51|||
41968810|NCT04128696|75769428|FG000|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|52|||
41968811|NCT04128696|75769429|FG001|Overall Study|On Study Treatment (pembrolizumab) All participants discontinued feladilimab/placebo|62|||
41968812|NCT04102579|75769437|FG000|Overall Study|Withdrawal by Subject|3|||
41968813|NCT04102579|75769438|FG001|Overall Study|Withdrawal by Subject|4|||
41968814|NCT04102579|75769437|FG000|Overall Study|Lost to Follow-up|0|||
41968815|NCT04102579|75769438|FG001|Overall Study|Lost to Follow-up|1|||
41968816|NCT04102579|75769437|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
41968817|NCT04102579|75769438|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
41968818|NCT04102579|75769437|FG000|Overall Study|Other than Specified|1|||
41968819|NCT04102579|75769438|FG001|Overall Study|Other than Specified|0|||
41968820|NCT04102579|75769437|FG000|Overall Study|Not Dosed with Study Drug|0|||
41968821|NCT04102579|75769438|FG001|Overall Study|Not Dosed with Study Drug|1|||
41968822|NCT04034004|75769548|FG000|Overall Study|Withdrawal by Subject|1|||
41968823|NCT04034004|75769549|FG001|Overall Study|Withdrawal by Subject|2|||
41968824|NCT04034004|75769550|FG002|Overall Study|Withdrawal by Subject|2|||
41968825|NCT04034004|75769551|FG003|Overall Study|Withdrawal by Subject|3|||
41968826|NCT04034004|75769548|FG000|Overall Study|could not find vein to administer IV|2|||
41968827|NCT04034004|75769549|FG001|Overall Study|could not find vein to administer IV|1|||
41968828|NCT04034004|75769550|FG002|Overall Study|could not find vein to administer IV|0|||
41968829|NCT04034004|75769551|FG003|Overall Study|could not find vein to administer IV|0|||
41968830|NCT04034004|75769548|FG000|Overall Study|nurse accidentally unblinded subject|0|||
41968831|NCT04034004|75769549|FG001|Overall Study|nurse accidentally unblinded subject|0|||
41968832|NCT04034004|75769550|FG002|Overall Study|nurse accidentally unblinded subject|0|||
41968833|NCT04034004|75769551|FG003|Overall Study|nurse accidentally unblinded subject|1|||
41968834|NCT03848065|75769566|FG000|Overall Study|Death|0|||
41968835|NCT03848065|75769567|FG001|Overall Study|Death|1|||
42125548|NCT02406027|75936077|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
42125549|NCT02406027|75936078|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
42125550|NCT02406027|75936072|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
42125551|NCT02406027|75936073|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
41968836|NCT03848065|75769568|FG002|Overall Study|Death|0|||
41968837|NCT03848065|75769566|FG000|Overall Study|Lost to Follow-up|0|||
41968838|NCT03848065|75769567|FG001|Overall Study|Lost to Follow-up|0|||
41968839|NCT03848065|75769568|FG002|Overall Study|Lost to Follow-up|1|||
42125552|NCT02406027|75936074|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
42125553|NCT02406027|75936075|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
42125554|NCT02406027|75936076|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
42125555|NCT02406027|75936077|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
42125556|NCT02406027|75936078|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
42125557|NCT02406027|75936072|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
42027892|NCT01121406|75836165|FG001|Overall Study|Other AE|10|||
42027893|NCT01121406|75836164|FG000|Overall Study|Non-compliant with protocol|0|||
42027894|NCT01121406|75836165|FG001|Overall Study|Non-compliant with protocol|2|||
42027895|NCT01121406|75836164|FG000|Overall Study|Lost to Follow-up|0|||
42027896|NCT01121406|75836165|FG001|Overall Study|Lost to Follow-up|1|||
42027897|NCT01121406|75836164|FG000|Overall Study|Refused continuation of study med.|1|||
42027898|NCT01121406|75836165|FG001|Overall Study|Refused continuation of study med.|2|||
42027899|NCT01121406|75836164|FG000|Overall Study|Reason other than specified above|2|||
42125558|NCT02406027|75936073|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
41968840|NCT03848065|75769566|FG000|Overall Study|Physician Decision|0|||
41968841|NCT03848065|75769567|FG001|Overall Study|Physician Decision|0|||
41968842|NCT03848065|75769568|FG002|Overall Study|Physician Decision|1|||
41968843|NCT03629223|75769579|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
41968844|NCT03629223|75769580|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
41968845|NCT03629223|75769581|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
42027900|NCT01121406|75836165|FG001|Overall Study|Reason other than specified above|6|||
42027901|NCT01121406|75836164|FG000|Overall Study|Not treated|1|||
42125559|NCT02406027|75936074|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
42125560|NCT02406027|75936075|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
42125561|NCT02406027|75936076|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
42125562|NCT02406027|75936077|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
42125563|NCT02406027|75936078|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
42125564|NCT02406027|75936072|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
42125565|NCT02406027|75936073|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
42125566|NCT02406027|75936074|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
42125567|NCT02406027|75936075|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
41968846|NCT03629223|75769582|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
41968847|NCT03629223|75769583|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
41968848|NCT03629223|75769584|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
41968849|NCT03629223|75769579|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
41968850|NCT03629223|75769580|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
41968851|NCT03629223|75769581|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
41968852|NCT03629223|75769582|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
41968853|NCT03629223|75769583|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
41968854|NCT03629223|75769584|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
41968855|NCT03629223|75769579|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
41968856|NCT03629223|75769580|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
41968857|NCT03629223|75769581|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
41968858|NCT03629223|75769582|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
41968859|NCT03629223|75769583|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
41968860|NCT03629223|75769584|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
41968861|NCT03629223|75769579|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
41968862|NCT03629223|75769580|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
41968863|NCT03629223|75769581|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
41968864|NCT03629223|75769582|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
41968865|NCT03629223|75769583|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
41968866|NCT03629223|75769584|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
41968867|NCT03629223|75769579|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
41968868|NCT03629223|75769580|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
41968869|NCT03629223|75769581|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
41968870|NCT03629223|75769582|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
41968871|NCT03629223|75769583|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
41968872|NCT03629223|75769584|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
41968873|NCT03547908|75769600|FG000|Overall Study|Still On Study|115|||
41968874|NCT03547908|75769601|FG001|Overall Study|Still On Study|118|||
41968875|NCT03547908|75769600|FG000|Overall Study|Lost to Follow-up|2|||
41968876|NCT03547908|75769601|FG001|Overall Study|Lost to Follow-up|2|||
41968877|NCT03547908|75769600|FG000|Overall Study|Withdrew Consent|2|||
41968878|NCT03547908|75769601|FG001|Overall Study|Withdrew Consent|1|||
42125568|NCT02406027|75936076|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
42125569|NCT02406027|75936077|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
42125570|NCT02406027|75936078|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
42125571|NCT02278120|75936096|FG000|Overall Study|Progressive disease|122|||
42125572|NCT02278120|75936097|FG001|Overall Study|Progressive disease|174|||
42125573|NCT02278120|75936096|FG000|Overall Study|Patient/guardian decision|14|||
42125574|NCT02278120|75936097|FG001|Overall Study|Patient/guardian decision|8|||
42125575|NCT02278120|75936096|FG000|Overall Study|Adverse Event|12|||
42125576|NCT02278120|75936097|FG001|Overall Study|Adverse Event|10|||
42125577|NCT02278120|75936096|FG000|Overall Study|Physician Decision|8|||
42125578|NCT02278120|75936097|FG001|Overall Study|Physician Decision|19|||
42125579|NCT02278120|75936096|FG000|Overall Study|Death|3|||
42125580|NCT02278120|75936097|FG001|Overall Study|Death|3|||
42125581|NCT02278120|75936096|FG000|Overall Study|Lost to Follow-up|2|||
42125582|NCT02278120|75936097|FG001|Overall Study|Lost to Follow-up|0|||
42125583|NCT02278120|75936096|FG000|Overall Study|Protocol Violation|0|||
42125584|NCT02278120|75936097|FG001|Overall Study|Protocol Violation|2|||
42125585|NCT02255357|75936105|FG000|Overall Study|Physician Decision|10|||
42125586|NCT02255357|75936106|FG001|Overall Study|Physician Decision|24|||
42125587|NCT02211131|75936114|FG000|Overall Study|Death|26|||
42125588|NCT02211131|75936115|FG001|Overall Study|Death|16|||
42125589|NCT02211131|75936114|FG000|Overall Study|Lost to Follow-up|4|||
41968879|NCT03547908|75769600|FG000|Overall Study|Adverse Event|1|||
42125590|NCT02211131|75936115|FG001|Overall Study|Lost to Follow-up|3|||
42125591|NCT02211131|75936114|FG000|Overall Study|Decision by Sponsor|1|||
41968880|NCT03547908|75769601|FG001|Overall Study|Adverse Event|0|||
41968881|NCT03547908|75769600|FG000|Overall Study|Death|1|||
41968882|NCT03547908|75769601|FG001|Overall Study|Death|0|||
41968883|NCT03547908|75769600|FG000|Overall Study|Investigator's Discretion|0|||
42125592|NCT02211131|75936115|FG001|Overall Study|Decision by Sponsor|1|||
42125593|NCT02211131|75936114|FG000|Overall Study|Withdrawal by Subject|3|||
42125594|NCT02211131|75936115|FG001|Overall Study|Withdrawal by Subject|8|||
42125595|NCT02155647|75936130|FG000|Overall Study|Still on Treatment|26|||
42125596|NCT02155647|75936131|FG001|Overall Study|Still on Treatment|26|||
42125597|NCT02155647|75936130|FG000|Overall Study|Off-Treatment, but follow up ongoing|15|||
42125598|NCT02155647|75936131|FG001|Overall Study|Off-Treatment, but follow up ongoing|26|||
42125599|NCT02134587|75936141|FG000|Overall Study|Did not completed all meetings|30|||
42125600|NCT01752920|75936154|FG000|Overall Study|Adverse Event|1|||
42125601|NCT01752920|75936155|FG001|Overall Study|Adverse Event|0|||
42125602|NCT01752920|75936156|FG002|Overall Study|Adverse Event|5|||
42125603|NCT01752920|75936157|FG003|Overall Study|Adverse Event|10|||
42125604|NCT01752920|75936154|FG000|Overall Study|Clinical Disease Progression|6|||
42125605|NCT01752920|75936155|FG001|Overall Study|Clinical Disease Progression|4|||
42125606|NCT01752920|75936156|FG002|Overall Study|Clinical Disease Progression|1|||
41968884|NCT03547908|75769601|FG001|Overall Study|Investigator's Discretion|1|||
41968885|NCT03547908|75769600|FG000|Overall Study|Randomized But Never Treated|1|||
41968886|NCT03547908|75769601|FG001|Overall Study|Randomized But Never Treated|0|||
41968887|NCT03395405|75769609|FG000|Overall Study|Death|0|||
41968888|NCT03395405|75769610|FG001|Overall Study|Death|2|||
41968889|NCT03395405|75769609|FG000|Overall Study|Lost to Follow-up|0|||
41968890|NCT03395405|75769610|FG001|Overall Study|Lost to Follow-up|1|||
41968891|NCT03395405|75769609|FG000|Overall Study|Protocol Violation|0|||
41968892|NCT03395405|75769610|FG001|Overall Study|Protocol Violation|1|||
41968893|NCT03395405|75769609|FG000|Overall Study|Withdrawal by Subject|3|||
41968894|NCT03395405|75769610|FG001|Overall Study|Withdrawal by Subject|1|||
41968895|NCT03395405|75769609|FG000|Overall Study|COVID-19 Pandemic|1|||
41968896|NCT03395405|75769610|FG001|Overall Study|COVID-19 Pandemic|0|||
41968897|NCT03381248|75769618|FG000|0-6 Months|Withdrawal by Subject|4|||
41968898|NCT03381248|75769619|FG001|0-6 Months|Withdrawal by Subject|1|||
41968899|NCT03381248|75769618|FG000|0-6 Months|Lost to Follow-up|3|||
41968900|NCT03381248|75769619|FG001|0-6 Months|Lost to Follow-up|2|||
41968901|NCT03381248|75769618|FG000|0-6 Months|Lack of Efficacy|1|||
41968902|NCT03381248|75769619|FG001|0-6 Months|Lack of Efficacy|0|||
41968903|NCT03381248|75769618|FG000|0-6 Months|Adverse Event|1|||
41968904|NCT03381248|75769619|FG001|0-6 Months|Adverse Event|0|||
41968905|NCT03381248|75769618|FG000|0-6 Months|Protocol Violation|2|||
41968906|NCT03381248|75769619|FG001|0-6 Months|Protocol Violation|1|||
41968907|NCT03381248|75769618|FG000|0-6 Months|Physician Decision|1|||
41968908|NCT03381248|75769619|FG001|0-6 Months|Physician Decision|0|||
41968909|NCT03381248|75769618|FG000|0-6 Months|Planning another procedure|1|||
41968910|NCT03381248|75769619|FG001|0-6 Months|Planning another procedure|2|||
41968911|NCT03381248|75769618|FG000|6-12 Months|Withdrawal by Subject|1|||
41968912|NCT03381248|75769619|FG001|6-12 Months|Withdrawal by Subject|3|||
41968913|NCT03381248|75769618|FG000|6-12 Months|Lost to Follow-up|0|||
41968914|NCT03381248|75769619|FG001|6-12 Months|Lost to Follow-up|2|||
41968915|NCT03381248|75769618|FG000|6-12 Months|Protocol Violation|3|||
42125607|NCT01752920|75936157|FG003|Overall Study|Clinical Disease Progression|13|||
42125608|NCT01752920|75936154|FG000|Overall Study|Physician Decision|1|||
42125609|NCT01752920|75936155|FG001|Overall Study|Physician Decision|0|||
42125610|NCT01752920|75936156|FG002|Overall Study|Physician Decision|0|||
42125611|NCT01752920|75936157|FG003|Overall Study|Physician Decision|3|||
42125612|NCT01752920|75936154|FG000|Overall Study|Radiographic Disease Progression|20|||
42125613|NCT01752920|75936155|FG001|Overall Study|Radiographic Disease Progression|7|||
42125614|NCT01752920|75936156|FG002|Overall Study|Radiographic Disease Progression|12|||
42125615|NCT01752920|75936157|FG003|Overall Study|Radiographic Disease Progression|29|||
42125616|NCT01752920|75936154|FG000|Overall Study|Study Terminated by Sponsor|0|||
42125617|NCT01752920|75936155|FG001|Overall Study|Study Terminated by Sponsor|0|||
42125618|NCT01752920|75936156|FG002|Overall Study|Study Terminated by Sponsor|0|||
42125619|NCT01752920|75936157|FG003|Overall Study|Study Terminated by Sponsor|1|||
42125620|NCT01752920|75936154|FG000|Overall Study|Withdrawal by Subject|0|||
42125621|NCT01752920|75936155|FG001|Overall Study|Withdrawal by Subject|1|||
42125622|NCT01752920|75936156|FG002|Overall Study|Withdrawal by Subject|0|||
42125623|NCT01752920|75936157|FG003|Overall Study|Withdrawal by Subject|1|||
42125624|NCT01752920|75936154|FG000|Overall Study|Lack of clinical benefit|1|||
42125625|NCT01752920|75936155|FG001|Overall Study|Lack of clinical benefit|1|||
42125626|NCT01752920|75936156|FG002|Overall Study|Lack of clinical benefit|1|||
42125627|NCT01752920|75936157|FG003|Overall Study|Lack of clinical benefit|1|||
42125628|NCT00976963|75936171|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
42125629|NCT00976963|75936172|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
42125630|NCT00976963|75936171|FG000|Overall Study|administrative error|1|||
42125631|NCT00976963|75936172|FG001|Overall Study|administrative error|0|||
42125632|NCT00976963|75936171|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
42125633|NCT00976963|75936172|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
42125634|NCT00423735|75936189|FG000|Overall Study|Ineligible / No protocol treatment|8|||
41968916|NCT03381248|75769619|FG001|6-12 Months|Protocol Violation|2|||
41968917|NCT03381248|75769618|FG000|6-12 Months|Planning another procedure|6|||
41968918|NCT03381248|75769619|FG001|6-12 Months|Planning another procedure|2|||
42125635|NCT00423735|75936190|FG001|Overall Study|Ineligible / No protocol treatment|6|||
42125636|NCT00423735|75936191|FG002|Overall Study|Ineligible / No protocol treatment|0|||
42125637|NCT00626327|75936204|FG000|Overall Study|Withdrawal by Subject|21|||
42125638|NCT00626327|75936205|FG001|Overall Study|Withdrawal by Subject|29|||
42125639|NCT00626327|75936206|FG002|Overall Study|Withdrawal by Subject|30|||
42125640|NCT00626327|75936204|FG000|Overall Study|Adverse Event|1|||
42125641|NCT00626327|75936205|FG001|Overall Study|Adverse Event|0|||
41968919|NCT03381248|75769618|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
41968920|NCT03381248|75769619|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
41968921|NCT03381248|75769618|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
41968922|NCT03381248|75769619|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
41968923|NCT03381248|75769618|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
41968924|NCT03381248|75769619|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
41968925|NCT03354663|75769630|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
41968926|NCT03354663|75769630|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
41968927|NCT03354663|75769630|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
41968928|NCT03354663|75769630|FG000|Completed 30-day Visit|Missed Visit|1|||
41968929|NCT03305419|75769646|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
41968930|NCT03305419|75769647|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
41968931|NCT03305419|75769648|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
41968932|NCT03305419|75769649|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
41968933|NCT03305419|75769650|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
41968934|NCT03305419|75769651|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
41968935|NCT03305419|75769652|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
41968936|NCT03305419|75769653|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
41968937|NCT03305419|75769646|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
41968938|NCT03305419|75769647|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
41968939|NCT03305419|75769648|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
41968940|NCT03305419|75769649|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
41968941|NCT03305419|75769650|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
41968942|NCT03305419|75769651|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
41968943|NCT03305419|75769652|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
41968944|NCT03305419|75769653|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
41968945|NCT03305419|75769646|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
41968946|NCT03305419|75769647|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
41968947|NCT03305419|75769648|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
41968948|NCT03305419|75769649|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
41968949|NCT03305419|75769650|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
41968950|NCT03305419|75769651|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
41968951|NCT03305419|75769652|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
41968952|NCT03305419|75769653|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
41968953|NCT03305419|75769646|FG000|Part B (14 Days)|Adverse Event|0|||
41968954|NCT03305419|75769647|FG001|Part B (14 Days)|Adverse Event|0|||
41968955|NCT03305419|75769648|FG002|Part B (14 Days)|Adverse Event|0|||
41968956|NCT03305419|75769649|FG003|Part B (14 Days)|Adverse Event|0|||
41968957|NCT03305419|75769650|FG004|Part B (14 Days)|Adverse Event|1|||
41968958|NCT03305419|75769651|FG005|Part B (14 Days)|Adverse Event|2|||
41968959|NCT03305419|75769652|FG006|Part B (14 Days)|Adverse Event|4|||
41968960|NCT03305419|75769653|FG007|Part B (14 Days)|Adverse Event|0|||
41968961|NCT03305419|75769646|FG000|Part B (14 Days)|Physician Decision|0|||
41968962|NCT03305419|75769647|FG001|Part B (14 Days)|Physician Decision|0|||
41968963|NCT03305419|75769648|FG002|Part B (14 Days)|Physician Decision|0|||
41968964|NCT03305419|75769649|FG003|Part B (14 Days)|Physician Decision|0|||
41968965|NCT03305419|75769650|FG004|Part B (14 Days)|Physician Decision|2|||
41968966|NCT03305419|75769651|FG005|Part B (14 Days)|Physician Decision|8|||
41968967|NCT03305419|75769652|FG006|Part B (14 Days)|Physician Decision|1|||
41968968|NCT03305419|75769653|FG007|Part B (14 Days)|Physician Decision|0|||
41968969|NCT03096782|75769696|FG000|Overall Study|Death|1|||
41968970|NCT03096782|75769696|FG000|Overall Study|Participant Relapsed|1|||
41968971|NCT03052049|75769707|FG000|Overall Study|Withdrawal by Subject|2|||
41968972|NCT03019536|75769727|FG000|Overall Study|Withdrawal by Subject|1|||
41968973|NCT03019536|75769728|FG001|Overall Study|Withdrawal by Subject|1|||
41968974|NCT03019536|75769729|FG002|Overall Study|Withdrawal by Subject|0|||
42027902|NCT01121406|75836165|FG001|Overall Study|Not treated|0|||
42027903|NCT00960687|75836174|FG000|Washout Period of 7 Days|Adverse Event|3|||
42027904|NCT00960687|75836175|FG001|Washout Period of 7 Days|Adverse Event|2|||
42301604|NCT02288559|76136752|FG001|Overall Study|Reason Not Specified|0|||
42027905|NCT00960687|75836174|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
42027906|NCT00960687|75836175|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
42301605|NCT02288559|76136753|FG002|Overall Study|Reason Not Specified|3|||
41968975|NCT03019536|75769727|FG000|Overall Study|Adverse Event|0|||
41968976|NCT03019536|75769728|FG001|Overall Study|Adverse Event|0|||
41968977|NCT03019536|75769729|FG002|Overall Study|Adverse Event|2|||
41968978|NCT02673775|75769739|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
41968979|NCT02673775|75769740|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
41968980|NCT02673775|75769739|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
41968981|NCT02673775|75769740|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
41968982|NCT02673775|75769739|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
41968983|NCT02673775|75769740|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
41968984|NCT02673775|75769739|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
41968985|NCT02673775|75769740|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
41968986|NCT02666768|75769746|FG000|Overall Study|Withdrawal by Subject|4|||
41968987|NCT02471144|75769754|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
41968988|NCT02471144|75769755|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
41968989|NCT02471144|75769756|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
41968990|NCT02471144|75769757|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
41968991|NCT02471144|75769758|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
41968992|NCT02471144|75769759|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
42125642|NCT00626327|75936206|FG002|Overall Study|Adverse Event|0|||
42125643|NCT00626327|75936204|FG000|Overall Study|Lost to Follow-up|24|||
42125644|NCT00626327|75936205|FG001|Overall Study|Lost to Follow-up|21|||
42125645|NCT00626327|75936206|FG002|Overall Study|Lost to Follow-up|23|||
42125646|NCT00626327|75936204|FG000|Overall Study|Inappropriate enrollment|4|||
42125647|NCT00626327|75936205|FG001|Overall Study|Inappropriate enrollment|5|||
42125648|NCT00626327|75936206|FG002|Overall Study|Inappropriate enrollment|3|||
42125649|NCT00626327|75936204|FG000|Overall Study|Administrative Reason|2|||
42125650|NCT00626327|75936205|FG001|Overall Study|Administrative Reason|0|||
42125651|NCT00626327|75936206|FG002|Overall Study|Administrative Reason|6|||
42125652|NCT00626327|75936204|FG000|Overall Study|Protocol Violation|26|||
42125653|NCT00626327|75936205|FG001|Overall Study|Protocol Violation|4|||
42125654|NCT00626327|75936206|FG002|Overall Study|Protocol Violation|26|||
42125655|NCT00357994|75936224|FG000|Overall Study|Adverse Event|1|||
42125656|NCT00357994|75936225|FG001|Overall Study|Adverse Event|2|||
42125657|NCT00357994|75936224|FG000|Overall Study|Lack of Efficacy|0|||
42125658|NCT00357994|75936225|FG001|Overall Study|Lack of Efficacy|1|||
42125659|NCT00357994|75936224|FG000|Overall Study|Protocol Violation|1|||
42125660|NCT00357994|75936225|FG001|Overall Study|Protocol Violation|0|||
42125661|NCT00423657|75936233|FG000|Overall Study|Withdrew consent|10|||
42125662|NCT00423657|75936234|FG001|Overall Study|Withdrew consent|8|||
42125663|NCT00423657|75936233|FG000|Overall Study|Non-compliance|0|||
42125664|NCT00423657|75936234|FG001|Overall Study|Non-compliance|1|||
42125665|NCT00423657|75936233|FG000|Overall Study|Other|15|||
42125666|NCT00423657|75936234|FG001|Overall Study|Other|16|||
42125667|NCT00423657|75936233|FG000|Overall Study|Request of sponsor/investigator|1|||
42125668|NCT00423657|75936234|FG001|Overall Study|Request of sponsor/investigator|0|||
42125669|NCT00367432|75936240|FG000|First Period (16 Weeks)|Adverse Event|6|||
42125670|NCT00367432|75936241|FG001|First Period (16 Weeks)|Adverse Event|0|||
42125671|NCT00367432|75936240|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
42125672|NCT00367432|75936241|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
42125673|NCT00367432|75936240|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
42125674|NCT00367432|75936241|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
42125675|NCT00367432|75936240|FG000|First Period (16 Weeks)|Other Reason|2|||
42125676|NCT00367432|75936241|FG001|First Period (16 Weeks)|Other Reason|0|||
42125677|NCT00367432|75936240|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
42125678|NCT00367432|75936241|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
42125679|NCT00367432|75936240|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
42125680|NCT00367432|75936241|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
42125681|NCT00367432|75936240|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
42125682|NCT00367432|75936241|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
42125683|NCT00367432|75936240|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
42125684|NCT00367432|75936241|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
42125685|NCT00367432|75936240|FG000|Second Period (up to 54 Months)|Other Reason|6|||
42125686|NCT00367432|75936241|FG001|Second Period (up to 54 Months)|Other Reason|2|||
42125687|NCT00623363|75936247|FG000|Overall Study|Adverse Event|2|||
42301606|NCT02288559|76136754|FG003|Overall Study|Reason Not Specified|0|||
41968993|NCT02471144|75769760|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
42125688|NCT00623363|75936248|FG001|Overall Study|Adverse Event|2|||
42125689|NCT00423267|75936257|FG000|Period A|Withdrawal by Subject|0|||
42125690|NCT00423267|75936258|FG001|Period A|Withdrawal by Subject|1|||
42125691|NCT00423267|75936257|FG000|Period A|Non-compliance with protocol|1|||
42125692|NCT00423267|75936258|FG001|Period A|Non-compliance with protocol|0|||
42125693|NCT00423267|75936257|FG000|Period A|Administrative|1|||
41968994|NCT02471144|75769761|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
41968995|NCT02471144|75769762|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
42125694|NCT00423267|75936258|FG001|Period A|Administrative|0|||
42125695|NCT00626093|75936266|FG000|Overall Study|Lost to Follow-up|5|||
42125696|NCT00626093|75936266|FG000|Overall Study|Death|1|||
42125697|NCT00626093|75936266|FG000|Overall Study|Physician Decision|4|||
42125698|NCT00626093|75936266|FG000|Overall Study|Withdrawal by Subject|6|||
42125699|NCT00626093|75936266|FG000|Overall Study|Protocol Violation|1|||
42125700|NCT00626093|75936266|FG000|Overall Study|One of the required devices not implante|6|||
42125701|NCT00357760|75936272|FG000|Overall Study|Disease progression|44|||
42125702|NCT00357760|75936273|FG001|Overall Study|Disease progression|17|||
42125703|NCT00357760|75936272|FG000|Overall Study|Adverse Event|10|||
41968996|NCT02471144|75769763|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
41968997|NCT02471144|75769764|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
41968998|NCT02471144|75769754|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
41968999|NCT02471144|75769755|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
41969000|NCT02471144|75769756|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
41969001|NCT02471144|75769757|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
41969002|NCT02471144|75769758|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
41969003|NCT02471144|75769759|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
41969004|NCT02471144|75769760|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
41969005|NCT02471144|75769761|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
41969006|NCT02471144|75769762|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
41969007|NCT02471144|75769763|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
41969008|NCT02471144|75769764|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
41969009|NCT02471144|75769754|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
41969010|NCT02471144|75769755|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
41969011|NCT02471144|75769756|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
41969012|NCT02471144|75769757|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
41969013|NCT02471144|75769758|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
41969014|NCT02471144|75769759|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
41969015|NCT02471144|75769760|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
41969016|NCT02471144|75769761|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
41969017|NCT02471144|75769762|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
41969018|NCT02471144|75769763|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
41969019|NCT02471144|75769764|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
41969020|NCT02471144|75769754|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
41969021|NCT02471144|75769755|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
41969022|NCT02471144|75769756|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
41969023|NCT02471144|75769757|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
42125704|NCT00357760|75936273|FG001|Overall Study|Adverse Event|7|||
42125705|NCT00357760|75936272|FG000|Overall Study|Death|0|||
42125706|NCT00357760|75936273|FG001|Overall Study|Death|3|||
42125707|NCT00357760|75936272|FG000|Overall Study|Alternative therapy|1|||
42125708|NCT00357760|75936273|FG001|Overall Study|Alternative therapy|0|||
42125709|NCT00357760|75936272|FG000|Overall Study|Withdrawal by Subject|0|||
42125710|NCT00357760|75936273|FG001|Overall Study|Withdrawal by Subject|2|||
42125711|NCT00357760|75936272|FG000|Overall Study|Never started treatment|2|||
42125712|NCT00357760|75936273|FG001|Overall Study|Never started treatment|1|||
42125713|NCT00357760|75936272|FG000|Overall Study|Ineligible|0|||
42125714|NCT00357760|75936273|FG001|Overall Study|Ineligible|2|||
42125715|NCT00357760|75936272|FG000|Overall Study|Physician Decision|2|||
42125716|NCT00357760|75936273|FG001|Overall Study|Physician Decision|1|||
42125717|NCT00357760|75936272|FG000|Overall Study|Protocol Violation|0|||
42125718|NCT00357760|75936273|FG001|Overall Study|Protocol Violation|1|||
42125719|NCT00357760|75936272|FG000|Overall Study|To receive hospice care|0|||
42125720|NCT00357760|75936273|FG001|Overall Study|To receive hospice care|1|||
42125721|NCT00622739|75936281|FG000|Overall Study|Physician Decision|1|||
42125722|NCT00622739|75936282|FG001|Overall Study|Physician Decision|0|||
42125723|NCT00622739|75936281|FG000|Overall Study|Adverse Event|1|||
42125724|NCT00622739|75936282|FG001|Overall Study|Adverse Event|2|||
42125725|NCT00622739|75936281|FG000|Overall Study|Lack of Efficacy|0|||
41969024|NCT02471144|75769758|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
41969025|NCT02471144|75769759|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
41969026|NCT02471144|75769760|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
41969027|NCT02471144|75769761|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
41969028|NCT02471144|75769762|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
42125726|NCT00622739|75936282|FG001|Overall Study|Lack of Efficacy|2|||
42125727|NCT00622739|75936281|FG000|Overall Study|Withdrawal by Subject|0|||
42125728|NCT00622739|75936282|FG001|Overall Study|Withdrawal by Subject|1|||
42125729|NCT00622739|75936281|FG000|Overall Study|Lost to Follow-up|0|||
42125730|NCT00622739|75936282|FG001|Overall Study|Lost to Follow-up|1|||
42125731|NCT00435825|75936294|FG000|Overall Study|Abnormality of Laboratory Test|0|||
42125732|NCT00435825|75936295|FG001|Overall Study|Abnormality of Laboratory Test|1|||
42125733|NCT00435825|75936296|FG002|Overall Study|Abnormality of Laboratory Test|0|||
42125734|NCT00435825|75936297|FG003|Overall Study|Abnormality of Laboratory Test|0|||
42125735|NCT00435825|75936294|FG000|Overall Study|Insufficient Therapeutic Response|3|||
42125736|NCT00435825|75936295|FG001|Overall Study|Insufficient Therapeutic Response|1|||
42125737|NCT00435825|75936296|FG002|Overall Study|Insufficient Therapeutic Response|0|||
42125738|NCT00435825|75936297|FG003|Overall Study|Insufficient Therapeutic Response|3|||
42125739|NCT00435825|75936294|FG000|Overall Study|Other Protocol Violation|1|||
42125740|NCT00435825|75936295|FG001|Overall Study|Other Protocol Violation|0|||
42125741|NCT00435825|75936296|FG002|Overall Study|Other Protocol Violation|0|||
41969029|NCT02471144|75769763|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
41969030|NCT02471144|75769764|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
41969031|NCT02471144|75769754|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
41969032|NCT02471144|75769755|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
41969033|NCT02471144|75769756|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
41969034|NCT02471144|75769757|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
41969035|NCT02471144|75769758|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
41969036|NCT02471144|75769759|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
41969037|NCT02471144|75769760|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
41969038|NCT02471144|75769761|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
41969039|NCT02471144|75769762|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
41969040|NCT02471144|75769763|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
41969041|NCT02471144|75769764|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
41969042|NCT02471144|75769754|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
41969043|NCT02471144|75769755|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
41969044|NCT02471144|75769756|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
41969045|NCT02471144|75769757|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
41969046|NCT02471144|75769758|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
41969047|NCT02471144|75769759|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
42125742|NCT00435825|75936297|FG003|Overall Study|Other Protocol Violation|0|||
42125743|NCT00435825|75936294|FG000|Overall Study|Refused treatment|2|||
42125744|NCT00435825|75936295|FG001|Overall Study|Refused treatment|0|||
42125745|NCT00435825|75936296|FG002|Overall Study|Refused treatment|0|||
42125746|NCT00435825|75936297|FG003|Overall Study|Refused treatment|5|||
42125747|NCT00435825|75936294|FG000|Overall Study|Failure to return|5|||
42125748|NCT00435825|75936295|FG001|Overall Study|Failure to return|0|||
42125749|NCT00435825|75936296|FG002|Overall Study|Failure to return|4|||
42125750|NCT00435825|75936297|FG003|Overall Study|Failure to return|0|||
42125751|NCT00435825|75936294|FG000|Overall Study|Did not receive study drug|1|||
42125752|NCT00435825|75936295|FG001|Overall Study|Did not receive study drug|0|||
41969048|NCT02471144|75769760|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
41969049|NCT02471144|75769761|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
41969050|NCT02471144|75769762|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
41969051|NCT02471144|75769763|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
41969052|NCT02471144|75769764|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
41969053|NCT02471144|75769754|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
41969054|NCT02471144|75769755|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
41969055|NCT02471144|75769756|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
41969056|NCT02471144|75769757|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
41969057|NCT02471144|75769758|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
41969058|NCT02471144|75769759|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
41969059|NCT02471144|75769760|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
42125753|NCT00435825|75936296|FG002|Overall Study|Did not receive study drug|2|||
42125754|NCT00435825|75936297|FG003|Overall Study|Did not receive study drug|0|||
42125755|NCT00435825|75936294|FG000|Overall Study|Did not enter follow-up|0|||
42125756|NCT00435825|75936295|FG001|Overall Study|Did not enter follow-up|4|||
42125757|NCT00435825|75936296|FG002|Overall Study|Did not enter follow-up|1|||
42125758|NCT00435825|75936297|FG003|Overall Study|Did not enter follow-up|3|||
42125759|NCT00435825|75936294|FG000|Overall Study|Did not complete full follow-up period|6|||
42125760|NCT00435825|75936295|FG001|Overall Study|Did not complete full follow-up period|6|||
42125761|NCT00435825|75936296|FG002|Overall Study|Did not complete full follow-up period|4|||
42125762|NCT00435825|75936297|FG003|Overall Study|Did not complete full follow-up period|5|||
42125763|NCT00574145|75936309|FG000|Overall Study|Withdrawal by Subject|2|||
42125764|NCT00574145|75936310|FG001|Overall Study|Withdrawal by Subject|1|||
42125765|NCT00423189|75936319|FG000|Overall Study|Death|0|||
42125766|NCT00423189|75936320|FG001|Overall Study|Death|1|||
42125767|NCT00423189|75936321|FG002|Overall Study|Death|0|||
42125768|NCT00422799|75936334|FG000|Overall Study|Withdrawal by Subject|6|||
42125769|NCT00422799|75936334|FG000|Overall Study|Adverse Event|7|||
42125770|NCT00435045|75936340|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
41969060|NCT02471144|75769761|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
41969061|NCT02471144|75769762|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
42125771|NCT00435045|75936341|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
42125772|NCT00435045|75936340|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
42125773|NCT00435045|75936341|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
42125774|NCT00435045|75936340|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
42125775|NCT00435045|75936341|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
42125776|NCT00435045|75936340|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
41969062|NCT02471144|75769763|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
41969063|NCT02471144|75769764|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
41969064|NCT02471144|75769754|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
41969065|NCT02471144|75769755|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
41969066|NCT02471144|75769756|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
41969067|NCT02471144|75769757|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
41969068|NCT02471144|75769758|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
41969069|NCT02471144|75769759|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
41969070|NCT02471144|75769760|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
41969071|NCT02471144|75769761|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
41969072|NCT02471144|75769762|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
41969073|NCT02471144|75769763|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
41969074|NCT02471144|75769764|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
41969075|NCT02471144|75769754|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
41969076|NCT02471144|75769755|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
41969077|NCT02471144|75769756|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
41969078|NCT02471144|75769757|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
41969079|NCT02471144|75769758|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
41969080|NCT02471144|75769759|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
41969081|NCT02471144|75769760|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
41969082|NCT02471144|75769761|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
41969083|NCT02471144|75769762|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
41969084|NCT02471144|75769763|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
41969085|NCT02471144|75769764|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
41969086|NCT02471144|75769754|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
41969087|NCT02471144|75769755|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
41969088|NCT02471144|75769756|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
41969089|NCT02471144|75769757|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
41969090|NCT02471144|75769758|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
41969091|NCT02471144|75769759|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
41969092|NCT02471144|75769760|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
41969093|NCT02471144|75769761|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
41969094|NCT02471144|75769762|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
41969095|NCT02471144|75769763|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
41969096|NCT02471144|75769764|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
41969097|NCT02471144|75769754|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
41969098|NCT02471144|75769755|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
41969099|NCT02471144|75769756|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
41969100|NCT02471144|75769757|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
41969101|NCT02471144|75769758|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
41969102|NCT02471144|75769759|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
41969103|NCT02471144|75769760|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
41969104|NCT02471144|75769761|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
41969105|NCT02471144|75769762|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
41969106|NCT02471144|75769763|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
41969107|NCT02471144|75769764|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
41969108|NCT02471144|75769754|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
41969109|NCT02471144|75769755|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
41969110|NCT02471144|75769756|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
41969111|NCT02471144|75769757|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
41969112|NCT02471144|75769758|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
41969113|NCT02471144|75769759|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
41969114|NCT02471144|75769760|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
42125777|NCT00435045|75936341|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
42125778|NCT00435045|75936340|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
42125779|NCT00435045|75936341|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
42125780|NCT00435045|75936340|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
42125781|NCT00435045|75936341|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
42125782|NCT00435045|75936340|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
42125783|NCT00435045|75936341|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
41969115|NCT02471144|75769761|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
41969116|NCT02471144|75769762|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
41969117|NCT02471144|75769763|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
41969118|NCT02471144|75769764|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
41969119|NCT02471144|75769754|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
41969120|NCT02471144|75769755|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
41969121|NCT02471144|75769756|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
41969122|NCT02471144|75769757|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
41969123|NCT02471144|75769758|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
41969124|NCT02471144|75769759|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
41969125|NCT02471144|75769760|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
41969126|NCT02471144|75769761|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
41969127|NCT02471144|75769762|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
41969128|NCT02471144|75769763|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
41969129|NCT02471144|75769764|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
41969130|NCT02471144|75769754|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
41969131|NCT02471144|75769755|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
41969132|NCT02471144|75769756|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
41969133|NCT02471144|75769757|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
41969134|NCT02471144|75769758|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
41969135|NCT02471144|75769759|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
41969136|NCT02471144|75769760|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
41969137|NCT02471144|75769761|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
41969138|NCT02471144|75769762|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
41969139|NCT02471144|75769763|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
41969140|NCT02471144|75769764|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
41969141|NCT02403674|75769786|FG000|Overall Study|Adverse Event|10|||
41969142|NCT02403674|75769787|FG001|Overall Study|Adverse Event|23|||
41969143|NCT02403674|75769786|FG000|Overall Study|Death|1|||
41969144|NCT02403674|75769787|FG001|Overall Study|Death|3|||
41969145|NCT02403674|75769786|FG000|Overall Study|Lack of Efficacy|18|||
41969146|NCT02403674|75769787|FG001|Overall Study|Lack of Efficacy|10|||
41969147|NCT02403674|75769786|FG000|Overall Study|Lost to Follow-up|6|||
41969148|NCT02403674|75769787|FG001|Overall Study|Lost to Follow-up|7|||
41969149|NCT02403674|75769786|FG000|Overall Study|Noncompliance with study drug|1|||
41969150|NCT02403674|75769787|FG001|Overall Study|Noncompliance with study drug|2|||
41969151|NCT02403674|75769786|FG000|Overall Study|Withdrawal by Subject|8|||
41969152|NCT02403674|75769787|FG001|Overall Study|Withdrawal by Subject|11|||
41969153|NCT02403674|75769786|FG000|Overall Study|Physician Decision|2|||
41969154|NCT02403674|75769787|FG001|Overall Study|Physician Decision|2|||
41969155|NCT02403674|75769786|FG000|Overall Study|Not treated with study drug|4|||
41969156|NCT02403674|75769787|FG001|Overall Study|Not treated with study drug|2|||
41969157|NCT02403674|75769786|FG000|Overall Study|Pregnancy|1|||
41969158|NCT02403674|75769787|FG001|Overall Study|Pregnancy|1|||
41969159|NCT02403674|75769786|FG000|Overall Study|Protocol Violation|4|||
41969160|NCT02403674|75769787|FG001|Overall Study|Protocol Violation|2|||
41969161|NCT02352948|75769804|FG000|Overall Study|Death|47|||
41969162|NCT02352948|75769805|FG001|Overall Study|Death|48|||
41969163|NCT02352948|75769806|FG002|Overall Study|Death|114|||
41969164|NCT02352948|75769807|FG003|Overall Study|Death|74|||
41969165|NCT02352948|75769808|FG004|Overall Study|Death|77|||
41969166|NCT02352948|75769809|FG005|Overall Study|Death|44|||
41969167|NCT02352948|75769804|FG000|Overall Study|Lost to Follow-up|1|||
41969168|NCT02352948|75769805|FG001|Overall Study|Lost to Follow-up|0|||
41969169|NCT02352948|75769806|FG002|Overall Study|Lost to Follow-up|2|||
41969170|NCT02352948|75769807|FG003|Overall Study|Lost to Follow-up|1|||
41969171|NCT02352948|75769808|FG004|Overall Study|Lost to Follow-up|2|||
41969172|NCT02352948|75769809|FG005|Overall Study|Lost to Follow-up|1|||
41969173|NCT02352948|75769804|FG000|Overall Study|Withdrawal by Subject|1|||
41969174|NCT02352948|75769805|FG001|Overall Study|Withdrawal by Subject|10|||
41969175|NCT02352948|75769806|FG002|Overall Study|Withdrawal by Subject|11|||
42301607|NCT02288325|76136766|FG000|Run-in Period|Adverse Event|48|||
41969176|NCT02352948|75769807|FG003|Overall Study|Withdrawal by Subject|23|||
41969177|NCT02352948|75769808|FG004|Overall Study|Withdrawal by Subject|9|||
41969178|NCT02352948|75769809|FG005|Overall Study|Withdrawal by Subject|4|||
41969179|NCT02352948|75769804|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
41969180|NCT02352948|75769805|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
42027907|NCT00920140|75836186|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
42027908|NCT00920140|75836187|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
42027909|NCT00920140|75836188|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
42027910|NCT00920140|75836189|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
42027911|NCT00920140|75836190|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
42027912|NCT00920140|75836186|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
41969181|NCT02352948|75769806|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
41969182|NCT02352948|75769807|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
41969183|NCT02352948|75769808|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
41969184|NCT02352948|75769809|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
41969185|NCT02352948|75769804|FG000|Overall Study|Other|0|||
41969186|NCT02352948|75769805|FG001|Overall Study|Other|0|||
41969187|NCT02352948|75769806|FG002|Overall Study|Other|2|||
41969188|NCT02352948|75769807|FG003|Overall Study|Other|0|||
41969189|NCT02352948|75769808|FG004|Overall Study|Other|0|||
41969190|NCT02352948|75769809|FG005|Overall Study|Other|0|||
41969191|NCT02246621|75769885|FG000|Overall Study|Withdrawal by Subject|28|||
41969192|NCT02246621|75769886|FG001|Overall Study|Withdrawal by Subject|16|||
41969193|NCT02246621|75769885|FG000|Overall Study|Lost to Follow-up|1|||
41969194|NCT02246621|75769886|FG001|Overall Study|Lost to Follow-up|0|||
41969195|NCT02246621|75769885|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
41969196|NCT02246621|75769886|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
41969197|NCT02197234|75769892|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
41969198|NCT02197234|75769892|FG000|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1|||
41969199|NCT02197234|75769892|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
41969200|NCT02197234|75769892|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
41969201|NCT02197234|75769892|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
41969202|NCT02197234|75769892|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
41969203|NCT02197234|75769892|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
41969204|NCT02125461|75769901|FG000|Overall Study|Withdrawal by Subject|30|||
41969205|NCT02125461|75769902|FG001|Overall Study|Withdrawal by Subject|16|||
41969206|NCT02125461|75769901|FG000|Overall Study|Lost to Follow-up|8|||
41969207|NCT02125461|75769902|FG001|Overall Study|Lost to Follow-up|3|||
41969208|NCT02125461|75769901|FG000|Overall Study|Death|260|||
41969209|NCT02125461|75769902|FG001|Overall Study|Death|149|||
41969210|NCT02125461|75769901|FG000|Overall Study|Missing Termination Reason|0|||
41969211|NCT02125461|75769902|FG001|Overall Study|Missing Termination Reason|1|||
41969212|NCT02096042|75769908|FG000|Overall Study|Disease Progression|1|||
41969213|NCT02096042|75769909|FG001|Overall Study|Disease Progression|0|||
41969214|NCT02096042|75769910|FG002|Overall Study|Disease Progression|0|||
41969215|NCT02003924|75769919|FG000|Double-blind Phase|Lost to Follow-up|2|||
41969216|NCT02003924|75769920|FG001|Double-blind Phase|Lost to Follow-up|1|||
41969217|NCT02003924|75769921|FG002|Double-blind Phase|Lost to Follow-up|0|||
41969218|NCT02003924|75769919|FG000|Double-blind Phase|Protocol Violation|1|||
41969219|NCT02003924|75769920|FG001|Double-blind Phase|Protocol Violation|2|||
41969220|NCT02003924|75769921|FG002|Double-blind Phase|Protocol Violation|0|||
41969221|NCT02003924|75769919|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
41969222|NCT02003924|75769920|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
41969223|NCT02003924|75769921|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
41969224|NCT02003924|75769919|FG000|Double-blind Phase|Disease Progression|229|||
41969225|NCT02003924|75769920|FG001|Double-blind Phase|Disease Progression|247|||
41969226|NCT02003924|75769921|FG002|Double-blind Phase|Disease Progression|0|||
41969227|NCT02003924|75769919|FG000|Double-blind Phase|Adverse Event|120|||
41969228|NCT02003924|75769920|FG001|Double-blind Phase|Adverse Event|31|||
41969229|NCT02003924|75769921|FG002|Double-blind Phase|Adverse Event|0|||
41969230|NCT02003924|75769919|FG000|Double-blind Phase|Randomized But not Treated|3|||
41969231|NCT02003924|75769920|FG001|Double-blind Phase|Randomized But not Treated|3|||
41969232|NCT02003924|75769921|FG002|Double-blind Phase|Randomized But not Treated|0|||
42125784|NCT00435045|75936340|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
42125785|NCT00435045|75936341|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
42125786|NCT00435045|75936340|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
42125787|NCT00435045|75936341|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
42125788|NCT00435045|75936340|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
42125789|NCT00435045|75936341|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
42125790|NCT00435045|75936340|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
41969233|NCT02003924|75769919|FG000|Double-blind Phase|Other|29|||
41969234|NCT02003924|75769920|FG001|Double-blind Phase|Other|50|||
41969235|NCT02003924|75769921|FG002|Double-blind Phase|Other|0|||
41969236|NCT02003924|75769919|FG000|Open-label Phase|Lost to Follow-up|0|||
42125791|NCT00435045|75936341|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
42125792|NCT00441129|75936349|FG000|Overall Study|Withdrawal by Subject|6|||
41969237|NCT02003924|75769920|FG001|Open-label Phase|Lost to Follow-up|0|||
41969238|NCT02003924|75769921|FG002|Open-label Phase|Lost to Follow-up|1|||
41969239|NCT02003924|75769919|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
41969240|NCT02003924|75769920|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
41969241|NCT02003924|75769921|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
41969242|NCT02003924|75769919|FG000|Open-label Phase|Disease Progression|59|||
41969243|NCT02003924|75769920|FG001|Open-label Phase|Disease Progression|0|||
41969244|NCT02003924|75769921|FG002|Open-label Phase|Disease Progression|5|||
42125793|NCT00441129|75936350|FG001|Overall Study|Withdrawal by Subject|14|||
42125794|NCT00622505|75936358|FG000|Overall Study|Adverse Event|9|||
42125795|NCT00622505|75936359|FG001|Overall Study|Adverse Event|7|||
42125796|NCT00622505|75936358|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
42125797|NCT00622505|75936359|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
42125798|NCT00622505|75936358|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
42125799|NCT00622505|75936359|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
42125800|NCT00622505|75936358|FG000|Overall Study|Withdrawal by Subject|12|||
42125801|NCT00622505|75936359|FG001|Overall Study|Withdrawal by Subject|5|||
41969245|NCT02003924|75769919|FG000|Open-label Phase|Adverse Event|25|||
41969246|NCT02003924|75769920|FG001|Open-label Phase|Adverse Event|0|||
41969247|NCT02003924|75769921|FG002|Open-label Phase|Adverse Event|10|||
41969248|NCT02003924|75769919|FG000|Open-label Phase|Other|7|||
41969249|NCT02003924|75769920|FG001|Open-label Phase|Other|0|||
41969250|NCT02003924|75769921|FG002|Open-label Phase|Other|0|||
41969251|NCT02003924|75769919|FG000|Long-term Follow-up Phase|Death|288|||
42125802|NCT00622505|75936358|FG000|Overall Study|Administrative Problems|2|||
42125803|NCT00622505|75936359|FG001|Overall Study|Administrative Problems|4|||
42125804|NCT00622505|75936358|FG000|Overall Study|Death|2|||
42125805|NCT00622505|75936359|FG001|Overall Study|Death|2|||
42125806|NCT00357370|75936368|FG000|Cohort 2|Lack of Efficacy|0|||
42125807|NCT00357370|75936369|FG001|Cohort 2|Lack of Efficacy|2|||
42125808|NCT00357370|75936370|FG002|Cohort 2|Lack of Efficacy|1|||
42125809|NCT00357370|75936368|FG000|Cohort 2|Adverse Event|1|||
42125810|NCT00357370|75936369|FG001|Cohort 2|Adverse Event|1|||
42125811|NCT00357370|75936370|FG002|Cohort 2|Adverse Event|1|||
42125812|NCT00357370|75936368|FG000|Cohort 2|Lost to Follow-up|0|||
42125813|NCT00357370|75936369|FG001|Cohort 2|Lost to Follow-up|1|||
42125814|NCT00357370|75936370|FG002|Cohort 2|Lost to Follow-up|0|||
42125815|NCT00357370|75936368|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
42125816|NCT00357370|75936369|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
42125817|NCT00357370|75936370|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
42125818|NCT00357370|75936368|FG000|Cohort 2|Withdrawal by Subject|0|||
42125819|NCT00357370|75936369|FG001|Cohort 2|Withdrawal by Subject|2|||
42125820|NCT00357370|75936370|FG002|Cohort 2|Withdrawal by Subject|0|||
42125821|NCT00574847|75936380|FG000|Overall Study|Adverse Event|2|||
42125822|NCT00574847|75936381|FG001|Overall Study|Adverse Event|0|||
42125823|NCT00574847|75936380|FG000|Overall Study|Death|1|||
42125824|NCT00574847|75936381|FG001|Overall Study|Death|0|||
42125825|NCT00574847|75936380|FG000|Overall Study|Withdrawal by Subject|2|||
42125826|NCT00574847|75936381|FG001|Overall Study|Withdrawal by Subject|2|||
42125827|NCT00574847|75936380|FG000|Overall Study|Physician Decision|1|||
42125828|NCT00574847|75936381|FG001|Overall Study|Physician Decision|0|||
42125829|NCT00574847|75936380|FG000|Overall Study|Did not receive medication (declined)|2|||
42125830|NCT00574847|75936381|FG001|Overall Study|Did not receive medication (declined)|5|||
42125831|NCT00348790|75936387|FG000|Completed Treatment|Withdrawal by Subject|4|||
42125832|NCT00348790|75936387|FG000|Completed Treatment|Disease progression|14|||
42125833|NCT00348790|75936387|FG000|Completed Treatment|Adverse Event|4|||
42125834|NCT00348790|75936387|FG000|Completed Treatment|Required surgery|2|||
42125835|NCT00348790|75936387|FG000|Completed Treatment|Unable to travel to study site|1|||
42125836|NCT00360490|75936394|FG000|Overall Study|Adverse Event|4|||
42125837|NCT00360490|75936395|FG001|Overall Study|Adverse Event|2|||
42125838|NCT00360490|75936394|FG000|Overall Study|Lost to Follow-up|2|||
42125839|NCT00360490|75936395|FG001|Overall Study|Lost to Follow-up|1|||
42125840|NCT00360490|75936394|FG000|Overall Study|Physician Decision|2|||
42125841|NCT00360490|75936395|FG001|Overall Study|Physician Decision|1|||
42125842|NCT00360490|75936394|FG000|Overall Study|Protocol Violation|0|||
42125843|NCT00360490|75936395|FG001|Overall Study|Protocol Violation|4|||
42125844|NCT00360490|75936394|FG000|Overall Study|Withdrawal by Subject|1|||
42125845|NCT00360490|75936395|FG001|Overall Study|Withdrawal by Subject|3|||
42125846|NCT00624377|75936401|FG000|Overall Study|Lost to Follow-up|355|||
42125847|NCT00624377|75936401|FG000|Overall Study|Withdrawal by Subject|100|||
41969252|NCT02003924|75769920|FG001|Long-term Follow-up Phase|Death|174|||
42125848|NCT00624377|75936401|FG000|Overall Study|Adverse Event|14|||
42125849|NCT00624377|75936401|FG000|Overall Study|Other|91|||
42125850|NCT00624377|75936401|FG000|Overall Study|Non-evaluable population|84|||
42125851|NCT00624065|75936407|FG000|Overall Study|Adverse Event|5|||
42125852|NCT00624065|75936408|FG001|Overall Study|Adverse Event|6|||
42125853|NCT00624065|75936407|FG000|Overall Study|Lost to Follow-up|4|||
42125854|NCT00624065|75936408|FG001|Overall Study|Lost to Follow-up|1|||
42125855|NCT00624065|75936407|FG000|Overall Study|Consent withdrawn|6|||
42125856|NCT00624065|75936408|FG001|Overall Study|Consent withdrawn|5|||
42125857|NCT00624065|75936407|FG000|Overall Study|Lack of Efficacy|0|||
42125858|NCT00624065|75936408|FG001|Overall Study|Lack of Efficacy|3|||
42125859|NCT00624065|75936407|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
41969253|NCT02003924|75769921|FG002|Long-term Follow-up Phase|Death|4|||
41969254|NCT02003924|75769919|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
41969255|NCT02003924|75769920|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
42125860|NCT00624065|75936408|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
42125861|NCT00360412|75936416|FG000|Overall Study|Adverse Event|37|||
42125862|NCT00360412|75936417|FG001|Overall Study|Adverse Event|65|||
42125863|NCT00360412|75936416|FG000|Overall Study|Protocol Violation|2|||
42125864|NCT00360412|75936417|FG001|Overall Study|Protocol Violation|5|||
42125865|NCT00360412|75936416|FG000|Overall Study|Patient withdrew consent|27|||
42125866|NCT00360412|75936417|FG001|Overall Study|Patient withdrew consent|52|||
41969256|NCT02003924|75769921|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
41969257|NCT02003924|75769919|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
41969258|NCT02003924|75769920|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
41969259|NCT02003924|75769921|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
41969260|NCT02003924|75769919|FG000|Long-term Follow-up Phase|Other|5|||
41969261|NCT02003924|75769920|FG001|Long-term Follow-up Phase|Other|2|||
41969262|NCT02003924|75769921|FG002|Long-term Follow-up Phase|Other|1|||
41969263|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
41969264|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
41969265|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
41969266|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
41969267|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
41969268|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
41969269|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
41969270|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
41969271|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
41969272|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
41969273|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
41969274|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
41969275|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
41969276|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
41969277|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
41969278|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
41969279|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
41969280|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
41969281|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
41969282|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
41969283|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
41969284|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
41969285|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
41969286|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
41969287|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|Death|2|||
41969288|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|Death|1|||
41969289|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|Death|0|||
41969290|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|Death|0|||
41969291|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
41969292|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
41969293|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
41969294|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
41969295|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
41969296|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
41969297|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
41969298|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
41969299|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
41969300|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
42125867|NCT00360412|75936416|FG000|Overall Study|Lack of therapeutic efficacy|46|||
41969301|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
41969302|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
41969303|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
41969304|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
41969305|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
41969306|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
41969307|NCT01940471|75769930|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
41969308|NCT01940471|75769931|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
41969309|NCT01940471|75769932|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
41969310|NCT01940471|75769933|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
41969311|NCT01940471|75769930|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
41969312|NCT01940471|75769931|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
41969313|NCT01940471|75769932|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
41969314|NCT01940471|75769933|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
42125868|NCT00360412|75936417|FG001|Overall Study|Lack of therapeutic efficacy|61|||
42125869|NCT00360412|75936416|FG000|Overall Study|Physician Decision|2|||
42125870|NCT00360412|75936417|FG001|Overall Study|Physician Decision|4|||
42125871|NCT00360412|75936416|FG000|Overall Study|Other|5|||
41969315|NCT01940471|75769930|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
41969316|NCT01940471|75769931|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
41969317|NCT01940471|75769932|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
41969318|NCT01940471|75769933|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
41969319|NCT01940471|75769930|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
41969320|NCT01940471|75769931|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
41969321|NCT01940471|75769932|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
41969322|NCT01940471|75769933|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
41969323|NCT01940471|75769930|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
41969324|NCT01940471|75769931|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
41969325|NCT01940471|75769932|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
41969326|NCT01940471|75769933|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
41969327|NCT01940471|75769930|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
42125872|NCT00360412|75936417|FG001|Overall Study|Other|6|||
42125873|NCT00360412|75936416|FG000|Overall Study|Study termination by Sponsor|214|||
42125874|NCT00360412|75936417|FG001|Overall Study|Study termination by Sponsor|469|||
42125875|NCT00623831|75936425|FG000|Overall Study|Withdrawal by Subject|1|||
42125876|NCT00623831|75936426|FG001|Overall Study|Withdrawal by Subject|0|||
42125877|NCT00623831|75936425|FG000|Overall Study|Progressive Disease|0|||
42125878|NCT00623831|75936426|FG001|Overall Study|Progressive Disease|1|||
42125879|NCT00360334|75936437|FG000|Overall Study|Adverse Event|7|||
42125880|NCT00360334|75936438|FG001|Overall Study|Adverse Event|4|||
42125881|NCT00360334|75936437|FG000|Overall Study|Protocol Violation|1|||
42125882|NCT00360334|75936438|FG001|Overall Study|Protocol Violation|1|||
42125883|NCT00360334|75936437|FG000|Overall Study|Physician Decision|2|||
42125884|NCT00360334|75936438|FG001|Overall Study|Physician Decision|3|||
42125885|NCT00360334|75936437|FG000|Overall Study|Lack of Efficacy|0|||
42125886|NCT00360334|75936438|FG001|Overall Study|Lack of Efficacy|1|||
42125887|NCT00360334|75936437|FG000|Overall Study|Entry criterion not met|1|||
42125888|NCT00360334|75936438|FG001|Overall Study|Entry criterion not met|2|||
42125889|NCT00360334|75936437|FG000|Overall Study|Subject decision|8|||
42125890|NCT00360334|75936438|FG001|Overall Study|Subject decision|2|||
42125891|NCT00422097|75936450|FG000|Dose Level 2|Still on treatment|0|||
42125892|NCT00422097|75936451|FG001|Dose Level 2|Still on treatment|1|||
42125893|NCT00422097|75936452|FG002|Dose Level 2|Still on treatment|0|||
42125894|NCT00422097|75936453|FG003|Dose Level 2|Still on treatment|0|||
42125895|NCT00422097|75936454|FG004|Dose Level 2|Still on treatment|0|||
42125896|NCT00422097|75936455|FG005|Dose Level 2|Still on treatment|0|||
42125897|NCT00422097|75936456|FG006|Dose Level 2|Still on treatment|0|||
42125898|NCT00422097|75936457|FG007|Dose Level 2|Still on treatment|0|||
42125899|NCT00348556|75936481|FG000|Overall Study|Adverse Event|1|||
42125900|NCT00434967|75936489|FG000|Overall Study|Adverse Event|2|||
42125901|NCT00434967|75936490|FG001|Overall Study|Adverse Event|4|||
42125902|NCT00434967|75936491|FG002|Overall Study|Adverse Event|3|||
42125903|NCT00434967|75936492|FG003|Overall Study|Adverse Event|3|||
42125904|NCT00434967|75936489|FG000|Overall Study|Lost to Follow-up|0|||
42125905|NCT00434967|75936490|FG001|Overall Study|Lost to Follow-up|0|||
42125906|NCT00434967|75936491|FG002|Overall Study|Lost to Follow-up|1|||
42125907|NCT00434967|75936492|FG003|Overall Study|Lost to Follow-up|0|||
42125908|NCT00434967|75936489|FG000|Overall Study|Withdrawal by Subject|2|||
41969328|NCT01940471|75769931|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
41969329|NCT01940471|75769932|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
41969330|NCT01940471|75769933|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
41969331|NCT01940471|75769930|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
41969332|NCT01940471|75769931|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
42125909|NCT00434967|75936490|FG001|Overall Study|Withdrawal by Subject|2|||
42125910|NCT00434967|75936491|FG002|Overall Study|Withdrawal by Subject|4|||
42125911|NCT00434967|75936492|FG003|Overall Study|Withdrawal by Subject|6|||
42125912|NCT00434967|75936489|FG000|Overall Study|Randomized in error|0|||
42125913|NCT00434967|75936490|FG001|Overall Study|Randomized in error|0|||
41969333|NCT01940471|75769932|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
41969334|NCT01940471|75769933|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
41969335|NCT01940471|75769930|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
42125914|NCT00434967|75936491|FG002|Overall Study|Randomized in error|0|||
42125915|NCT00434967|75936492|FG003|Overall Study|Randomized in error|1|||
42125916|NCT00434967|75936489|FG000|Overall Study|Protocol Violation|0|||
42125917|NCT00434967|75936490|FG001|Overall Study|Protocol Violation|1|||
42125918|NCT00434967|75936491|FG002|Overall Study|Protocol Violation|0|||
42125919|NCT00434967|75936492|FG003|Overall Study|Protocol Violation|1|||
42125920|NCT00434967|75936489|FG000|Overall Study|Physician Decision|1|||
42125921|NCT00434967|75936490|FG001|Overall Study|Physician Decision|1|||
42125922|NCT00434967|75936491|FG002|Overall Study|Physician Decision|1|||
41969336|NCT01940471|75769931|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
41969337|NCT01940471|75769932|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
41969338|NCT01940471|75769933|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
41969339|NCT01940471|75769930|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
41969340|NCT01940471|75769931|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
41969341|NCT01940471|75769932|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
41969342|NCT01940471|75769933|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
41969343|NCT01940471|75769930|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
41969344|NCT01940471|75769931|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
41969345|NCT01940471|75769932|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
41969346|NCT01940471|75769933|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
41969347|NCT01751906|75769953|FG000|Overall Study|Lost to Follow-up|151|||
41969348|NCT01751906|75769954|FG001|Overall Study|Lost to Follow-up|68|||
41969349|NCT01751906|75769953|FG000|Overall Study|Withdrawal by Subject|22|||
41969350|NCT01751906|75769954|FG001|Overall Study|Withdrawal by Subject|18|||
41969351|NCT01751906|75769953|FG000|Overall Study|Physician Decision|5|||
41969352|NCT01751906|75769954|FG001|Overall Study|Physician Decision|2|||
41969353|NCT01751906|75769953|FG000|Overall Study|Death|84|||
41969354|NCT01751906|75769954|FG001|Overall Study|Death|43|||
41969355|NCT01751906|75769953|FG000|Overall Study|Denied on premises for follow-up by law|1|||
41969356|NCT01751906|75769954|FG001|Overall Study|Denied on premises for follow-up by law|0|||
41969357|NCT01730937|75769962|FG000|Overall Study|Protocol Violation|5|||
41969358|NCT01730937|75769963|FG001|Overall Study|Protocol Violation|11|||
41969359|NCT01560416|75769971|FG000|Randomized Phase|Crossover Participants|7|||
41969360|NCT01560416|75769972|FG001|Randomized Phase|Crossover Participants|0|||
41969361|NCT01279850|75769984|FG000|Overall Study|Protocol Violation|50|||
41969362|NCT01279850|75769984|FG000|Overall Study|No Drug Administration Information|7|||
42125923|NCT00434967|75936492|FG003|Overall Study|Physician Decision|0|||
42125924|NCT00434967|75936489|FG000|Overall Study|Patient Disposition Challenges|2|||
42125925|NCT00434967|75936490|FG001|Overall Study|Patient Disposition Challenges|0|||
42125926|NCT00434967|75936491|FG002|Overall Study|Patient Disposition Challenges|0|||
42125927|NCT00434967|75936492|FG003|Overall Study|Patient Disposition Challenges|3|||
42125928|NCT00356590|75936502|FG000|Overall Study|Adverse Event|54|||
42125929|NCT00356590|75936502|FG000|Overall Study|Death|10|||
42125930|NCT00356590|75936502|FG000|Overall Study|Lost to Follow-up|35|||
42125931|NCT00356590|75936502|FG000|Overall Study|Physician Decision|46|||
42125932|NCT00356590|75936502|FG000|Overall Study|Withdrawal by Subject|41|||
42125933|NCT00356590|75936502|FG000|Overall Study|Completed month 12 only|2|||
42125934|NCT00356590|75936502|FG000|Overall Study|Protocol issues|6|||
42125935|NCT00356590|75936502|FG000|Overall Study|Response status|28|||
42125936|NCT00356590|75936502|FG000|Overall Study|Other|52|||
42125937|NCT00356278|75936509|FG000|Overall Study|Withdrawal by Subject|25|||
42125938|NCT00356278|75936510|FG001|Overall Study|Withdrawal by Subject|15|||
42125939|NCT00356278|75936511|FG002|Overall Study|Withdrawal by Subject|19|||
42125940|NCT00356200|75936521|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
42125941|NCT00356200|75936522|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
42125942|NCT00356200|75936521|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
42125943|NCT00356200|75936522|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
42125944|NCT00356122|75936534|FG000|TREATMENT|Lack of Efficacy|26|||
42125945|NCT00356122|75936534|FG000|TREATMENT|Adverse Event|10|||
42125946|NCT00356122|75936534|FG000|TREATMENT|Subject's request|4|||
42125947|NCT00356122|75936534|FG000|TREATMENT|Other|4|||
42125948|NCT00356122|75936534|FG000|TREATMENT|Did not receive study medication|1|||
42125949|NCT00356122|75936534|FG000|FOLLOW-UP|Death|37|||
41969363|NCT01279850|75769984|FG000|Overall Study|No Visit After Treatment|34|||
42125950|NCT00356122|75936534|FG000|FOLLOW-UP|Lost to Follow-up|2|||
42125951|NCT00356122|75936534|FG000|FOLLOW-UP|Other|2|||
42125952|NCT00347932|75936540|FG000|Overall Study|Adverse Event|4|||
42125953|NCT00347932|75936541|FG001|Overall Study|Adverse Event|5|||
41969364|NCT01035463|75769990|FG000|Overall Study|Adverse Event|0|||
41969365|NCT01035463|75769991|FG001|Overall Study|Adverse Event|0|||
41969366|NCT01035463|75769992|FG002|Overall Study|Adverse Event|4|||
41969367|NCT01035463|75769993|FG003|Overall Study|Adverse Event|1|||
41969368|NCT01035463|75769994|FG004|Overall Study|Adverse Event|5|||
41969369|NCT01035463|75769995|FG005|Overall Study|Adverse Event|7|||
41969370|NCT01035463|75769990|FG000|Overall Study|Withdrawal by Subject|0|||
41969371|NCT01035463|75769991|FG001|Overall Study|Withdrawal by Subject|2|||
41969372|NCT01035463|75769992|FG002|Overall Study|Withdrawal by Subject|1|||
41969373|NCT01035463|75769993|FG003|Overall Study|Withdrawal by Subject|0|||
41969374|NCT01035463|75769994|FG004|Overall Study|Withdrawal by Subject|1|||
41969375|NCT01035463|75769995|FG005|Overall Study|Withdrawal by Subject|4|||
41969376|NCT01035463|75769990|FG000|Overall Study|Disease progression|0|||
41969377|NCT01035463|75769991|FG001|Overall Study|Disease progression|0|||
41969378|NCT01035463|75769992|FG002|Overall Study|Disease progression|0|||
41969379|NCT01035463|75769993|FG003|Overall Study|Disease progression|0|||
41969380|NCT01035463|75769994|FG004|Overall Study|Disease progression|0|||
41969381|NCT01035463|75769995|FG005|Overall Study|Disease progression|3|||
41969382|NCT01035463|75769990|FG000|Overall Study|Other Malignancy|0|||
41969383|NCT01035463|75769991|FG001|Overall Study|Other Malignancy|0|||
41969384|NCT01035463|75769992|FG002|Overall Study|Other Malignancy|0|||
41969385|NCT01035463|75769993|FG003|Overall Study|Other Malignancy|0|||
41969386|NCT01035463|75769994|FG004|Overall Study|Other Malignancy|0|||
41969387|NCT01035463|75769995|FG005|Overall Study|Other Malignancy|2|||
41969388|NCT01035463|75769990|FG000|Overall Study|Other|0|||
41969389|NCT01035463|75769991|FG001|Overall Study|Other|0|||
41969390|NCT01035463|75769992|FG002|Overall Study|Other|0|||
41969391|NCT01035463|75769993|FG003|Overall Study|Other|1|||
41969392|NCT01035463|75769994|FG004|Overall Study|Other|0|||
41969393|NCT01035463|75769995|FG005|Overall Study|Other|2|||
41969394|NCT00936390|75770004|FG000|Overall Study|Protocol Violation|21|||
41969395|NCT00936390|75770005|FG001|Overall Study|Protocol Violation|25|||
41969396|NCT00085202|75770032|FG000|Overall Study|Still on therapy|2|||
41969397|NCT00085202|75770033|FG001|Overall Study|Still on therapy|0|||
41969398|NCT00085202|75770032|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
41969399|NCT00085202|75770033|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
41969400|NCT00085202|75770032|FG000|Overall Study|Excessive toxicity|6|||
41969401|NCT00085202|75770033|FG001|Overall Study|Excessive toxicity|5|||
41969402|NCT00085202|75770032|FG000|Overall Study|Non-specified|3|||
41969403|NCT00085202|75770033|FG001|Overall Study|Non-specified|5|||
41969404|NCT00085202|75770032|FG000|Overall Study|Withdrawal by Subject|2|||
41969405|NCT00085202|75770033|FG001|Overall Study|Withdrawal by Subject|1|||
41969406|NCT00085202|75770032|FG000|Overall Study|Physician Decision|4|||
41969407|NCT00085202|75770033|FG001|Overall Study|Physician Decision|1|||
41969408|NCT00085202|75770032|FG000|Overall Study|Progressive disease|1|||
41969409|NCT00085202|75770033|FG001|Overall Study|Progressive disease|11|||
41969410|NCT01470326|75770057|FG000|Overall Study|Protocol Violation|32|||
41969411|NCT01470326|75770057|FG000|Overall Study|No Drug Administration Information|2|||
41969412|NCT01470326|75770057|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
41969413|NCT01480180|75770072|FG000|Main Phase|Withdrawal criteria|12|||
41969414|NCT01480180|75770073|FG001|Main Phase|Withdrawal criteria|1|||
41969415|NCT01480180|75770074|FG002|Main Phase|Withdrawal criteria|0|||
41969416|NCT01480180|75770075|FG003|Main Phase|Withdrawal criteria|0|||
41969417|NCT01480180|75770076|FG004|Main Phase|Withdrawal criteria|0|||
41969418|NCT01480180|75770077|FG005|Main Phase|Withdrawal criteria|0|||
41969419|NCT01480180|75770072|FG000|Main Phase|Lack of Efficacy|1|||
41969420|NCT01480180|75770073|FG001|Main Phase|Lack of Efficacy|0|||
41969421|NCT01480180|75770074|FG002|Main Phase|Lack of Efficacy|0|||
42125954|NCT00347932|75936540|FG000|Overall Study|Lack of Efficacy|3|||
42125955|NCT00347932|75936541|FG001|Overall Study|Lack of Efficacy|14|||
42125956|NCT00347932|75936540|FG000|Overall Study|Lost to Follow-up|10|||
41969422|NCT01480180|75770075|FG003|Main Phase|Lack of Efficacy|0|||
41969423|NCT01480180|75770076|FG004|Main Phase|Lack of Efficacy|0|||
41969424|NCT01480180|75770077|FG005|Main Phase|Lack of Efficacy|0|||
41969425|NCT01480180|75770072|FG000|Main Phase|Non-compliance|3|||
41969426|NCT01480180|75770073|FG001|Main Phase|Non-compliance|0|||
41969427|NCT01480180|75770074|FG002|Main Phase|Non-compliance|0|||
41969428|NCT01480180|75770075|FG003|Main Phase|Non-compliance|0|||
41969429|NCT01480180|75770076|FG004|Main Phase|Non-compliance|0|||
41969430|NCT01480180|75770077|FG005|Main Phase|Non-compliance|0|||
41969431|NCT01480180|75770072|FG000|Main Phase|Unclassified|3|||
42125957|NCT00347932|75936541|FG001|Overall Study|Lost to Follow-up|9|||
41969432|NCT01480180|75770073|FG001|Main Phase|Unclassified|0|||
41969433|NCT01480180|75770074|FG002|Main Phase|Unclassified|0|||
41969434|NCT01480180|75770075|FG003|Main Phase|Unclassified|0|||
41969435|NCT01480180|75770076|FG004|Main Phase|Unclassified|0|||
41969436|NCT01480180|75770077|FG005|Main Phase|Unclassified|0|||
42027913|NCT00920140|75836187|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
42027914|NCT00920140|75836188|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
42027915|NCT00920140|75836189|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
42027916|NCT00920140|75836190|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
42027917|NCT00920140|75836186|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
42027918|NCT00920140|75836187|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
42027919|NCT00920140|75836188|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
42027920|NCT00920140|75836189|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
42027921|NCT00920140|75836190|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
42027922|NCT00920140|75836186|FG000|Phase 2|Adverse Event|0|||
42027923|NCT00920140|75836187|FG001|Phase 2|Adverse Event|0|||
41969437|NCT01480180|75770072|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
41969438|NCT01480180|75770073|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
41969439|NCT01480180|75770074|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
41969440|NCT01480180|75770075|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
41969441|NCT01480180|75770076|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
41969442|NCT01480180|75770077|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
41969443|NCT01480180|75770072|FG000|Extension Phase, Part 1|Unclassified|0|||
41969444|NCT01480180|75770073|FG001|Extension Phase, Part 1|Unclassified|0|||
41969445|NCT01480180|75770074|FG002|Extension Phase, Part 1|Unclassified|1|||
41969446|NCT01480180|75770075|FG003|Extension Phase, Part 1|Unclassified|0|||
41969447|NCT01480180|75770076|FG004|Extension Phase, Part 1|Unclassified|0|||
41969448|NCT01480180|75770077|FG005|Extension Phase, Part 1|Unclassified|0|||
41969449|NCT01480180|75770072|FG000|Extension Phase, Part 1|Adverse Event|0|||
41969450|NCT01480180|75770073|FG001|Extension Phase, Part 1|Adverse Event|0|||
41969451|NCT01480180|75770074|FG002|Extension Phase, Part 1|Adverse Event|4|||
41969452|NCT01480180|75770075|FG003|Extension Phase, Part 1|Adverse Event|1|||
41969453|NCT01480180|75770076|FG004|Extension Phase, Part 1|Adverse Event|0|||
41969454|NCT01480180|75770077|FG005|Extension Phase, Part 1|Adverse Event|0|||
41969455|NCT01480180|75770072|FG000|Extension Phase, Part 1|Change of treatment|0|||
41969456|NCT01480180|75770073|FG001|Extension Phase, Part 1|Change of treatment|0|||
41969457|NCT01480180|75770074|FG002|Extension Phase, Part 1|Change of treatment|0|||
41969458|NCT01480180|75770075|FG003|Extension Phase, Part 1|Change of treatment|9|||
41969459|NCT01480180|75770076|FG004|Extension Phase, Part 1|Change of treatment|0|||
41969460|NCT01480180|75770077|FG005|Extension Phase, Part 1|Change of treatment|0|||
41969461|NCT01480180|75770072|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
41969462|NCT01480180|75770073|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
41969463|NCT01480180|75770074|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
41969464|NCT01480180|75770075|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
41969465|NCT01480180|75770076|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
41969466|NCT01480180|75770077|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
41969467|NCT01480180|75770072|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
41969468|NCT01480180|75770073|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
41969469|NCT01480180|75770074|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
41969470|NCT01480180|75770075|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
41969471|NCT01480180|75770076|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
41969472|NCT01480180|75770077|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
41969473|NCT01480180|75770072|FG000|Extension Phase, Part 2|Unclassified|0|||
41969474|NCT01480180|75770073|FG001|Extension Phase, Part 2|Unclassified|0|||
41969475|NCT01480180|75770074|FG002|Extension Phase, Part 2|Unclassified|3|||
41969476|NCT01480180|75770075|FG003|Extension Phase, Part 2|Unclassified|1|||
41969477|NCT01480180|75770076|FG004|Extension Phase, Part 2|Unclassified|1|||
41969478|NCT01480180|75770077|FG005|Extension Phase, Part 2|Unclassified|0|||
41969479|NCT05300087|75770108|FG000|Overall Study|Withdrawal by Subject|0|||
41969480|NCT05300087|75770109|FG001|Overall Study|Withdrawal by Subject|1|||
41969481|NCT04803734|75770122|FG000|Overall Study|Withdrawal by Subject|0|||
41969482|NCT04803734|75770123|FG001|Overall Study|Withdrawal by Subject|1|||
41969483|NCT04803734|75770122|FG000|Overall Study|Protocol Violation|0|||
42027924|NCT00920140|75836188|FG002|Phase 2|Adverse Event|14|||
42027925|NCT00920140|75836189|FG003|Phase 2|Adverse Event|2|||
42027926|NCT00920140|75836190|FG004|Phase 2|Adverse Event|3|||
42027927|NCT00920140|75836186|FG000|Phase 2|Lack of Efficacy|0|||
41969484|NCT04803734|75770123|FG001|Overall Study|Protocol Violation|1|||
42027928|NCT00920140|75836187|FG001|Phase 2|Lack of Efficacy|0|||
42301608|NCT02288325|76136767|FG001|Run-in Period|Adverse Event|0|||
42027929|NCT00920140|75836188|FG002|Phase 2|Lack of Efficacy|29|||
42027930|NCT00920140|75836189|FG003|Phase 2|Lack of Efficacy|14|||
41969485|NCT04112173|75770159|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
41969486|NCT03872453|75770167|FG000|Overall Study|Adverse Event|1|||
41969487|NCT03872453|75770168|FG001|Overall Study|Adverse Event|1|||
41969488|NCT03872453|75770169|FG002|Overall Study|Adverse Event|0|||
41969489|NCT03872453|75770170|FG003|Overall Study|Adverse Event|0|||
41969490|NCT03872453|75770167|FG000|Overall Study|Lost to Follow-up|8|||
41969491|NCT03872453|75770168|FG001|Overall Study|Lost to Follow-up|7|||
41969492|NCT03872453|75770169|FG002|Overall Study|Lost to Follow-up|4|||
41969493|NCT03872453|75770170|FG003|Overall Study|Lost to Follow-up|4|||
41969494|NCT03872453|75770167|FG000|Overall Study|Never Treated Migraine|19|||
41969495|NCT03872453|75770168|FG001|Overall Study|Never Treated Migraine|17|||
41969496|NCT03872453|75770169|FG002|Overall Study|Never Treated Migraine|13|||
41969497|NCT03872453|75770170|FG003|Overall Study|Never Treated Migraine|12|||
41969498|NCT03872453|75770167|FG000|Overall Study|Pregnancy|1|||
41969499|NCT03872453|75770168|FG001|Overall Study|Pregnancy|0|||
41969500|NCT03872453|75770169|FG002|Overall Study|Pregnancy|0|||
41969501|NCT03872453|75770170|FG003|Overall Study|Pregnancy|0|||
41969502|NCT03872453|75770167|FG000|Overall Study|Protocol Deviation|2|||
41969503|NCT03872453|75770168|FG001|Overall Study|Protocol Deviation|0|||
41969504|NCT03872453|75770169|FG002|Overall Study|Protocol Deviation|0|||
41969505|NCT03872453|75770170|FG003|Overall Study|Protocol Deviation|2|||
42125958|NCT00347932|75936540|FG000|Overall Study|Withdrawal by Subject|10|||
42125959|NCT00347932|75936541|FG001|Overall Study|Withdrawal by Subject|16|||
42125960|NCT00347932|75936540|FG000|Overall Study|Did not meet inclusion criteria|4|||
42125961|NCT00347932|75936541|FG001|Overall Study|Did not meet inclusion criteria|8|||
42125962|NCT00528996|75936552|FG000|Overall Study|Other reasons than listing|6|||
41969506|NCT03872453|75770167|FG000|Overall Study|Withdrawal by Subject|0|||
41969507|NCT03872453|75770168|FG001|Overall Study|Withdrawal by Subject|1|||
41969508|NCT03872453|75770169|FG002|Overall Study|Withdrawal by Subject|2|||
41969509|NCT03872453|75770170|FG003|Overall Study|Withdrawal by Subject|0|||
41969510|NCT03872453|75770167|FG000|Overall Study|Other Than Specified|1|||
42125963|NCT00528996|75936553|FG001|Overall Study|Other reasons than listing|7|||
42125964|NCT00528996|75936554|FG002|Overall Study|Other reasons than listing|14|||
42125965|NCT00528996|75936555|FG003|Overall Study|Other reasons than listing|11|||
42125966|NCT00528996|75936556|FG004|Overall Study|Other reasons than listing|5|||
42125967|NCT00528996|75936552|FG000|Overall Study|Refused continue medication|16|||
42125968|NCT00528996|75936553|FG001|Overall Study|Refused continue medication|0|||
42125969|NCT00528996|75936554|FG002|Overall Study|Refused continue medication|3|||
42125970|NCT00528996|75936555|FG003|Overall Study|Refused continue medication|3|||
42125971|NCT00528996|75936556|FG004|Overall Study|Refused continue medication|6|||
41969511|NCT03872453|75770168|FG001|Overall Study|Other Than Specified|0|||
41969512|NCT03872453|75770169|FG002|Overall Study|Other Than Specified|0|||
41969513|NCT03872453|75770170|FG003|Overall Study|Other Than Specified|0|||
41969514|NCT03726879|75770182|FG000|Overall Study|Death|6|||
41969515|NCT03726879|75770183|FG001|Overall Study|Death|4|||
41969516|NCT03726879|75770182|FG000|Overall Study|Physician Decision|0|||
41969517|NCT03726879|75770183|FG001|Overall Study|Physician Decision|2|||
41969518|NCT03726879|75770182|FG000|Overall Study|Protocol Violation|0|||
41969519|NCT03726879|75770183|FG001|Overall Study|Protocol Violation|1|||
41969520|NCT03726879|75770182|FG000|Overall Study|Withdrawal by Subject|5|||
41969521|NCT03726879|75770183|FG001|Overall Study|Withdrawal by Subject|5|||
41969522|NCT03726879|75770182|FG000|Overall Study|TSH result is unstable|0|||
41969523|NCT03726879|75770183|FG001|Overall Study|TSH result is unstable|1|||
41969524|NCT03726879|75770182|FG000|Overall Study|Continuing on Study|215|||
41969525|NCT03726879|75770183|FG001|Overall Study|Continuing on Study|215|||
41969526|NCT03721835|75770189|FG000|Overall Study|Participant not able to return|1|||
41969527|NCT03721835|75770189|FG000|Overall Study|Lost to Follow-up|1|||
41969528|NCT03721835|75770189|FG000|Overall Study|Revision of the components of the study device|2|||
41969529|NCT03721835|75770189|FG000|Overall Study|Sponsor terminated study|6|||
41969530|NCT03721835|75770189|FG000|Overall Study|Death|1|||
41969531|NCT03721835|75770189|FG000|Overall Study|Sponsor decision|1|||
41969532|NCT03565991|75770195|FG000|Overall Study|Other|11|||
41969533|NCT03565991|75770196|FG001|Overall Study|Other|0|||
42125972|NCT00528996|75936552|FG000|Overall Study|Lost to Follow-up|2|||
42125973|NCT00528996|75936553|FG001|Overall Study|Lost to Follow-up|0|||
42125974|NCT00528996|75936554|FG002|Overall Study|Lost to Follow-up|4|||
42125975|NCT00528996|75936555|FG003|Overall Study|Lost to Follow-up|1|||
42125976|NCT00528996|75936556|FG004|Overall Study|Lost to Follow-up|3|||
42125977|NCT00528996|75936552|FG000|Overall Study|Protocol Violation|1|||
41969534|NCT03565991|75770195|FG000|Overall Study|Global deterioration of health status|14|||
41969535|NCT03565991|75770196|FG001|Overall Study|Global deterioration of health status|4|||
41969536|NCT03565991|75770195|FG000|Overall Study|Withdrawal by Subject|2|||
41969537|NCT03565991|75770196|FG001|Overall Study|Withdrawal by Subject|6|||
41969538|NCT03565991|75770195|FG000|Overall Study|Progressive disease|121|||
41969539|NCT03565991|75770196|FG001|Overall Study|Progressive disease|29|||
41969540|NCT03565991|75770195|FG000|Overall Study|Death|3|||
41969541|NCT03565991|75770196|FG001|Overall Study|Death|0|||
41969542|NCT03565991|75770195|FG000|Overall Study|Adverse Event|7|||
41969543|NCT03565991|75770196|FG001|Overall Study|Adverse Event|2|||
41969544|NCT03186638|75770206|FG000|Overall Study|Withdrawal by Subject|4|||
41969545|NCT03186638|75770207|FG001|Overall Study|Withdrawal by Subject|4|||
42125978|NCT00528996|75936553|FG001|Overall Study|Protocol Violation|2|||
42125979|NCT00528996|75936554|FG002|Overall Study|Protocol Violation|3|||
42125980|NCT00528996|75936555|FG003|Overall Study|Protocol Violation|3|||
41969546|NCT03186638|75770206|FG000|Overall Study|Withdrawn due to medical problem|3|||
42125981|NCT00528996|75936556|FG004|Overall Study|Protocol Violation|2|||
42125982|NCT00528996|75936552|FG000|Overall Study|Lack of Efficacy|7|||
41969547|NCT03186638|75770207|FG001|Overall Study|Withdrawn due to medical problem|2|||
41969548|NCT03186638|75770206|FG000|Overall Study|Lost to Follow-up|1|||
41969549|NCT03186638|75770207|FG001|Overall Study|Lost to Follow-up|0|||
42027931|NCT00920140|75836190|FG004|Phase 2|Lack of Efficacy|5|||
42027932|NCT00920140|75836186|FG000|Phase 2|Lost to Follow-up|0|||
42027933|NCT00920140|75836187|FG001|Phase 2|Lost to Follow-up|0|||
41969553|NCT02691663|75770228|FG000|Overall Study|Screen failure after baseline|2|||
41969554|NCT02691663|75770229|FG001|Overall Study|Screen failure after baseline|2|||
41969555|NCT02691663|75770228|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
41969556|NCT02691663|75770229|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
41969557|NCT02691663|75770228|FG000|Overall Study|Withdrawn after Follow up 2|1|||
41969558|NCT02691663|75770229|FG001|Overall Study|Withdrawn after Follow up 2|1|||
41969559|NCT02691663|75770228|FG000|Overall Study|Lost to Follow-up|3|||
41969560|NCT02691663|75770229|FG001|Overall Study|Lost to Follow-up|2|||
41969561|NCT02639065|75770236|FG000|Study Treatment|Disease Progression|13|||
41969562|NCT02639065|75770236|FG000|Study Treatment|Adverse Event|9|||
41969563|NCT02639065|75770236|FG000|Study Treatment|Withdrawal by Subject|1|||
41969564|NCT02639065|75770236|FG000|Follow up|Subject refused to follow up|1|||
41969565|NCT02639065|75770236|FG000|Follow up|Symptomatic Deterioration|2|||
41969566|NCT02639065|75770236|FG000|Follow up|Death|2|||
41969567|NCT02639065|75770236|FG000|Follow up|Study Terminated|1|||
41969568|NCT02639065|75770236|FG000|Follow up|Disease Progression|3|||
41969569|NCT02566785|75770242|FG000|Overall Study|Lost to Follow-up|0|||
41969570|NCT02566785|75770243|FG001|Overall Study|Lost to Follow-up|2|||
41969571|NCT02566785|75770242|FG000|Overall Study|Worsening condition|1|||
41969572|NCT02566785|75770243|FG001|Overall Study|Worsening condition|1|||
41969573|NCT02344537|75770251|FG000|Overall Study|Protocol Violation|1|||
41969574|NCT02344537|75770252|FG001|Overall Study|Protocol Violation|1|||
41969575|NCT02344537|75770251|FG000|Overall Study|Subject started another treatment after wk 6|1|||
41969576|NCT02344537|75770252|FG001|Overall Study|Subject started another treatment after wk 6|0|||
41969577|NCT02344537|75770251|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
41969578|NCT02344537|75770252|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
41969579|NCT01092702|75770269|FG000|Overall Study|Withdrawal by Subject|7|||
41969580|NCT01092702|75770269|FG000|Overall Study|Lost to Follow-up|2|||
41969581|NCT00658879|75770298|FG000|Overall Study|Protocol Violation|1|||
41969582|NCT00591851|75770302|FG000|Overall Study|Withdrawal by Subject|3|||
41969583|NCT00591851|75770302|FG000|Overall Study|Adverse Event|2|||
41969584|NCT00591851|75770302|FG000|Overall Study|Progressive Disease|1|||
41969585|NCT00336024|75770308|FG000|Overall Study|Death|2|||
41969586|NCT00336024|75770309|FG001|Overall Study|Death|1|||
41969587|NCT00336024|75770308|FG000|Overall Study|Physician Decision|4|||
41969588|NCT00336024|75770309|FG001|Overall Study|Physician Decision|1|||
41969589|NCT00336024|75770308|FG000|Overall Study|Protocol Violation|1|||
41969590|NCT00336024|75770309|FG001|Overall Study|Protocol Violation|0|||
41969591|NCT00336024|75770308|FG000|Overall Study|Withdrawal by Subject|1|||
41969592|NCT00336024|75770309|FG001|Overall Study|Withdrawal by Subject|2|||
41969593|NCT00336024|75770308|FG000|Overall Study|Failure to fulfill consolidation|1|||
41969594|NCT00336024|75770309|FG001|Overall Study|Failure to fulfill consolidation|1|||
41969595|NCT00336024|75770308|FG000|Overall Study|Progressive Disease|4|||
41969596|NCT00336024|75770309|FG001|Overall Study|Progressive Disease|7|||
41969597|NCT00336024|75770308|FG000|Overall Study|Ineligible|7|||
41969598|NCT00336024|75770309|FG001|Overall Study|Ineligible|7|||
41969599|NCT00133705|75770317|FG000|Overall Study|Withdrawal by Subject|2|||
41969600|NCT00133705|75770318|FG001|Overall Study|Withdrawal by Subject|3|||
41969601|NCT01545050|75770329|FG000|Overall Study|Lack of Efficacy|0|||
41969602|NCT01545050|75770330|FG001|Overall Study|Lack of Efficacy|0|||
41969603|NCT01545050|75770331|FG002|Overall Study|Lack of Efficacy|0|||
41969604|NCT01545050|75770332|FG003|Overall Study|Lack of Efficacy|3|||
41969605|NCT01545050|75770333|FG004|Overall Study|Lack of Efficacy|2|||
41969606|NCT01545050|75770329|FG000|Overall Study|Adverse Event|1|||
42125983|NCT00528996|75936553|FG001|Overall Study|Lack of Efficacy|2|||
42125984|NCT00528996|75936554|FG002|Overall Study|Lack of Efficacy|1|||
42125985|NCT00528996|75936555|FG003|Overall Study|Lack of Efficacy|3|||
42125986|NCT00528996|75936556|FG004|Overall Study|Lack of Efficacy|3|||
41969607|NCT01545050|75770330|FG001|Overall Study|Adverse Event|1|||
41969608|NCT01545050|75770331|FG002|Overall Study|Adverse Event|2|||
41969609|NCT01545050|75770332|FG003|Overall Study|Adverse Event|2|||
41969610|NCT01545050|75770333|FG004|Overall Study|Adverse Event|0|||
41969611|NCT01545050|75770329|FG000|Overall Study|Discontinued study treatment|1|||
41969612|NCT01545050|75770330|FG001|Overall Study|Discontinued study treatment|0|||
41969613|NCT01545050|75770331|FG002|Overall Study|Discontinued study treatment|0|||
41969614|NCT01545050|75770332|FG003|Overall Study|Discontinued study treatment|0|||
41969615|NCT01545050|75770333|FG004|Overall Study|Discontinued study treatment|0|||
41969616|NCT01545050|75770329|FG000|Overall Study|Withdrawal by Subject|1|||
42027934|NCT00920140|75836188|FG002|Phase 2|Lost to Follow-up|0|||
42301609|NCT02288325|76136768|FG002|Run-in Period|Adverse Event|0|||
41969617|NCT01545050|75770330|FG001|Overall Study|Withdrawal by Subject|0|||
41969618|NCT01545050|75770331|FG002|Overall Study|Withdrawal by Subject|0|||
41969619|NCT01545050|75770332|FG003|Overall Study|Withdrawal by Subject|2|||
41969620|NCT01545050|75770333|FG004|Overall Study|Withdrawal by Subject|1|||
41969621|NCT01545050|75770329|FG000|Overall Study|Participant no longer meets study criteria|0|||
41969622|NCT01545050|75770330|FG001|Overall Study|Participant no longer meets study criteria|2|||
41969623|NCT01545050|75770331|FG002|Overall Study|Participant no longer meets study criteria|0|||
41969624|NCT01545050|75770332|FG003|Overall Study|Participant no longer meets study criteria|0|||
41969625|NCT01545050|75770333|FG004|Overall Study|Participant no longer meets study criteria|1|||
41969626|NCT01545050|75770329|FG000|Overall Study|Administrative reason by sponsor|4|||
41969627|NCT01545050|75770330|FG001|Overall Study|Administrative reason by sponsor|2|||
41969628|NCT01545050|75770331|FG002|Overall Study|Administrative reason by sponsor|3|||
41969629|NCT01545050|75770332|FG003|Overall Study|Administrative reason by sponsor|5|||
41969630|NCT01545050|75770333|FG004|Overall Study|Administrative reason by sponsor|5|||
41969631|NCT01555021|75770360|FG000|Overall Study|Lost to Follow-up|1|||
41969632|NCT01555021|75770361|FG001|Overall Study|Lost to Follow-up|2|||
41969633|NCT04721925|75770375|FG000|2-Month Assessment|Lost to Follow-up|5|||
41969634|NCT04721925|75770376|FG001|2-Month Assessment|Lost to Follow-up|3|||
41969635|NCT04721925|75770375|FG000|4-Month Assessment|Lost to Follow-up|3|||
41969636|NCT04721925|75770376|FG001|4-Month Assessment|Lost to Follow-up|6|||
41969637|NCT04677660|75770383|FG000|Overall Study|Lost to Follow-up|0|||
41969638|NCT04677660|75770384|FG001|Overall Study|Lost to Follow-up|2|||
41969639|NCT04677660|75770383|FG000|Overall Study|Withdrawal by Subject|0|||
41969640|NCT04677660|75770384|FG001|Overall Study|Withdrawal by Subject|1|||
41969641|NCT04677660|75770383|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
41969642|NCT04677660|75770384|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
41969643|NCT04518995|75770393|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
41969644|NCT04518995|75770394|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
41969645|NCT04518995|75770395|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
41969646|NCT04518995|75770393|FG000|Overall Study|Lack of Efficacy|2|||
41969647|NCT04518995|75770394|FG001|Overall Study|Lack of Efficacy|1|||
41969648|NCT04518995|75770395|FG002|Overall Study|Lack of Efficacy|0|||
41969649|NCT04518995|75770393|FG000|Overall Study|Non-compliance With Study Drug|0|||
41969650|NCT04518995|75770394|FG001|Overall Study|Non-compliance With Study Drug|3|||
41969651|NCT04518995|75770395|FG002|Overall Study|Non-compliance With Study Drug|2|||
41969652|NCT04518995|75770393|FG000|Overall Study|Pregnancy|0|||
41969653|NCT04518995|75770394|FG001|Overall Study|Pregnancy|0|||
41969654|NCT04518995|75770395|FG002|Overall Study|Pregnancy|1|||
41969655|NCT04518995|75770393|FG000|Overall Study|Protocol Violation|2|||
41969656|NCT04518995|75770394|FG001|Overall Study|Protocol Violation|0|||
41969657|NCT04518995|75770395|FG002|Overall Study|Protocol Violation|1|||
41969658|NCT04518995|75770393|FG000|Overall Study|Reason not Specified|4|||
41969659|NCT04518995|75770394|FG001|Overall Study|Reason not Specified|11|||
41969660|NCT04518995|75770395|FG002|Overall Study|Reason not Specified|2|||
41969661|NCT04518995|75770393|FG000|Overall Study|Lost to Follow-up|1|||
41969662|NCT04518995|75770394|FG001|Overall Study|Lost to Follow-up|10|||
41969663|NCT04518995|75770395|FG002|Overall Study|Lost to Follow-up|6|||
41969664|NCT04474691|75770403|FG000|Overall Study|Withdrawal by Subject|9|||
41969665|NCT04014075|75770435|FG000|Overall Study|Progressive Disease|48|||
41969666|NCT04014075|75770435|FG000|Overall Study|Adverse Event|11|||
41969667|NCT04014075|75770435|FG000|Overall Study|Clinical Progression|4|||
41969668|NCT04014075|75770435|FG000|Overall Study|Death|2|||
41969669|NCT04014075|75770435|FG000|Overall Study|Withdrawal by Subject|2|||
41969670|NCT04014075|75770435|FG000|Overall Study|Miscellaneous|1|||
41969671|NCT04014075|75770435|FG000|Overall Study|Physician Decision|1|||
41969672|NCT03840174|75770443|FG000|Overall Study|Withdrawal by Subject|1|||
41969673|NCT03840174|75770444|FG001|Overall Study|Withdrawal by Subject|0|||
41969674|NCT03840174|75770445|FG002|Overall Study|Withdrawal by Subject|0|||
41969675|NCT03840174|75770446|FG003|Overall Study|Withdrawal by Subject|0|||
41969676|NCT03786718|75770457|FG000|Overall Study|Lost to Follow-up|3|||
41969677|NCT03786718|75770457|FG000|Overall Study|Withdrawal by Subject|1|||
41969678|NCT03786718|75770457|FG000|Overall Study|Did not use the intervention|2|||
41969679|NCT03786718|75770457|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
41969680|NCT03400943|75770490|FG000|Treatment Period 1|Adverse Event|0|||
41969681|NCT03400943|75770491|FG001|Treatment Period 1|Adverse Event|0|||
41969682|NCT03400943|75770492|FG002|Treatment Period 1|Adverse Event|0|||
41969683|NCT03400943|75770493|FG003|Treatment Period 1|Adverse Event|1|||
41969684|NCT03400943|75770490|FG000|Treatment Period 1|Lost to Follow-up|1|||
41969685|NCT03400943|75770491|FG001|Treatment Period 1|Lost to Follow-up|0|||
41969686|NCT03400943|75770492|FG002|Treatment Period 1|Lost to Follow-up|0|||
41969687|NCT03400943|75770493|FG003|Treatment Period 1|Lost to Follow-up|0|||
41969688|NCT03400943|75770490|FG000|Treatment Period 1|Protocol Violation|0|||
41969689|NCT03400943|75770491|FG001|Treatment Period 1|Protocol Violation|1|||
41969690|NCT03400943|75770492|FG002|Treatment Period 1|Protocol Violation|1|||
41969691|NCT03400943|75770493|FG003|Treatment Period 1|Protocol Violation|0|||
41969692|NCT03400943|75770490|FG000|Treatment Period 1|Study terminated by sponsor|2|||
41969693|NCT03400943|75770491|FG001|Treatment Period 1|Study terminated by sponsor|0|||
41969694|NCT03400943|75770492|FG002|Treatment Period 1|Study terminated by sponsor|0|||
41969695|NCT03400943|75770493|FG003|Treatment Period 1|Study terminated by sponsor|1|||
41969696|NCT03400943|75770490|FG000|Treatment Period 1|Withdrawal by Subject|0|||
41969697|NCT03400943|75770491|FG001|Treatment Period 1|Withdrawal by Subject|0|||
41969698|NCT03400943|75770492|FG002|Treatment Period 1|Withdrawal by Subject|3|||
41969699|NCT03400943|75770493|FG003|Treatment Period 1|Withdrawal by Subject|1|||
41969700|NCT03400943|75770490|FG000|Treatment Period 1|Other|2|||
41969701|NCT03400943|75770491|FG001|Treatment Period 1|Other|1|||
41969702|NCT03400943|75770492|FG002|Treatment Period 1|Other|2|||
41969703|NCT03400943|75770493|FG003|Treatment Period 1|Other|2|||
41969704|NCT03400943|75770490|FG000|Post-treatment Period 1|Adverse Event|2|||
41969705|NCT03400943|75770491|FG001|Post-treatment Period 1|Adverse Event|0|||
41969706|NCT03400943|75770492|FG002|Post-treatment Period 1|Adverse Event|0|||
41969707|NCT03400943|75770493|FG003|Post-treatment Period 1|Adverse Event|0|||
41969708|NCT03400943|75770490|FG000|Post-treatment Period 1|Protocol Violation|1|||
41969709|NCT03400943|75770491|FG001|Post-treatment Period 1|Protocol Violation|0|||
42125987|NCT00528996|75936552|FG000|Overall Study|Adverse Event|32|||
42125988|NCT00528996|75936553|FG001|Overall Study|Adverse Event|13|||
42125989|NCT00528996|75936554|FG002|Overall Study|Adverse Event|18|||
42125990|NCT00528996|75936555|FG003|Overall Study|Adverse Event|29|||
42125991|NCT00528996|75936556|FG004|Overall Study|Adverse Event|18|||
42125992|NCT00359788|75936573|FG000|Overall Study|Adverse Event|11|||
42125993|NCT00359788|75936574|FG001|Overall Study|Adverse Event|10|||
42125994|NCT00359788|75936573|FG000|Overall Study|Lack of Efficacy|1|||
42125995|NCT00359788|75936574|FG001|Overall Study|Lack of Efficacy|2|||
42125996|NCT00359788|75936573|FG000|Overall Study|Lost to Follow-up|3|||
42125997|NCT00359788|75936574|FG001|Overall Study|Lost to Follow-up|2|||
42125998|NCT00359788|75936573|FG000|Overall Study|Withdrawal by Subject|4|||
42125999|NCT00359788|75936574|FG001|Overall Study|Withdrawal by Subject|1|||
42126000|NCT00359788|75936573|FG000|Overall Study|Protocol Violation|4|||
42126001|NCT00359788|75936574|FG001|Overall Study|Protocol Violation|2|||
42126002|NCT03878160|75936583|FG000|Overall Study|Lost to Follow-up|1|||
42126003|NCT03878160|75936584|FG001|Overall Study|Lost to Follow-up|1|||
42126004|NCT03878160|75936585|FG002|Overall Study|Lost to Follow-up|1|||
42126005|NCT03878160|75936583|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
42126006|NCT03878160|75936584|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
42126007|NCT03878160|75936585|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
42126008|NCT00623597|75936595|FG000|Overall Study|Failed to return|1|||
42126009|NCT00623597|75936596|FG001|Overall Study|Failed to return|0|||
42126010|NCT00347776|75936607|FG000|1.5 Month Follow-up|Death|2|||
42126011|NCT00347776|75936608|FG001|1.5 Month Follow-up|Death|0|||
42126012|NCT00347776|75936609|FG002|1.5 Month Follow-up|Death|0|||
42126013|NCT00347776|75936607|FG000|1.5 Month Follow-up|reached the endpoint|12|||
42126014|NCT00347776|75936608|FG001|1.5 Month Follow-up|reached the endpoint|8|||
42126015|NCT00347776|75936609|FG002|1.5 Month Follow-up|reached the endpoint|12|||
42126016|NCT00347776|75936607|FG000|6 Month Follow-up|Death|2|||
42126017|NCT00347776|75936608|FG001|6 Month Follow-up|Death|1|||
42126018|NCT00347776|75936609|FG002|6 Month Follow-up|Death|3|||
42126019|NCT00347776|75936607|FG000|6 Month Follow-up|reached endpont|20|||
42126020|NCT00347776|75936608|FG001|6 Month Follow-up|reached endpont|12|||
42126021|NCT00347776|75936609|FG002|6 Month Follow-up|reached endpont|15|||
42126022|NCT00347776|75936607|FG000|12 Month Follow-up|Lost to Follow-up|7|||
42126023|NCT00347776|75936608|FG001|12 Month Follow-up|Lost to Follow-up|6|||
42126024|NCT00347776|75936609|FG002|12 Month Follow-up|Lost to Follow-up|6|||
42126025|NCT00347776|75936607|FG000|12 Month Follow-up|Death|3|||
41969710|NCT03400943|75770492|FG002|Post-treatment Period 1|Protocol Violation|0|||
41969711|NCT03400943|75770493|FG003|Post-treatment Period 1|Protocol Violation|0|||
41969712|NCT03400943|75770490|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
41969713|NCT03400943|75770491|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
41969714|NCT03400943|75770492|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
41969715|NCT03400943|75770493|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
41969716|NCT03400943|75770490|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
42126026|NCT00347776|75936608|FG001|12 Month Follow-up|Death|4|||
42126027|NCT00347776|75936609|FG002|12 Month Follow-up|Death|4|||
42126028|NCT00347776|75936607|FG000|12 Month Follow-up|Reached endpoint|13|||
42126029|NCT00347776|75936608|FG001|12 Month Follow-up|Reached endpoint|6|||
42126030|NCT00347776|75936609|FG002|12 Month Follow-up|Reached endpoint|9|||
42301610|NCT02288325|76136766|FG000|Run-in Period|Lack of Efficacy|16|||
41969717|NCT03400943|75770491|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
41969718|NCT03400943|75770492|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
41969719|NCT03400943|75770493|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
42126031|NCT03829228|75936617|FG000|Overall Study|Protocol Violation|1|||
42126032|NCT00529542|75936623|FG000|Overall Study|Withdrawal by Subject|1|||
42126033|NCT00529542|75936624|FG001|Overall Study|Withdrawal by Subject|0|||
42126034|NCT00529542|75936623|FG000|Overall Study|Lost to Follow-up|0|||
41969720|NCT03400943|75770490|FG000|Post-treatment Period 1|Other|2|||
41969721|NCT03400943|75770491|FG001|Post-treatment Period 1|Other|0|||
41969722|NCT03400943|75770492|FG002|Post-treatment Period 1|Other|4|||
41969723|NCT03400943|75770493|FG003|Post-treatment Period 1|Other|5|||
41969724|NCT03400943|75770490|FG000|Treatment Period 2|Study terminated by sponsor|0|||
41969725|NCT03400943|75770491|FG001|Treatment Period 2|Study terminated by sponsor|1|||
41969726|NCT03400943|75770492|FG002|Treatment Period 2|Study terminated by sponsor|0|||
41969727|NCT03400943|75770493|FG003|Treatment Period 2|Study terminated by sponsor|0|||
41969728|NCT03400943|75770490|FG000|Treatment Period 2|Withdrawal by Subject|0|||
41969729|NCT03400943|75770491|FG001|Treatment Period 2|Withdrawal by Subject|1|||
41969730|NCT03400943|75770492|FG002|Treatment Period 2|Withdrawal by Subject|0|||
41969731|NCT03400943|75770493|FG003|Treatment Period 2|Withdrawal by Subject|0|||
41969732|NCT03400943|75770490|FG000|Treatment Period 2|Other|1|||
41969733|NCT03400943|75770491|FG001|Treatment Period 2|Other|6|||
41969734|NCT03400943|75770492|FG002|Treatment Period 2|Other|0|||
41969735|NCT03400943|75770493|FG003|Treatment Period 2|Other|0|||
41969736|NCT03400943|75770490|FG000|Follow-up Period|Withdrawal by Subject|1|||
41969737|NCT03400943|75770491|FG001|Follow-up Period|Withdrawal by Subject|0|||
41969738|NCT03400943|75770492|FG002|Follow-up Period|Withdrawal by Subject|0|||
41969739|NCT03400943|75770493|FG003|Follow-up Period|Withdrawal by Subject|0|||
41969740|NCT03321526|75770507|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
41969741|NCT03321526|75770508|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
41969742|NCT03321526|75770507|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
41969743|NCT03321526|75770508|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
41969744|NCT03321526|75770507|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
41969745|NCT03321526|75770508|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
41969746|NCT03321526|75770507|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
41969747|NCT03321526|75770508|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
41969748|NCT03321526|75770507|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
41969749|NCT03321526|75770508|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
41969750|NCT03321526|75770507|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
41969751|NCT03321526|75770508|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
41969752|NCT03321526|75770507|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
41969753|NCT03321526|75770508|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
41969754|NCT03321526|75770507|FG000|Follow-up Phase (2 Weeks)|Other|24|||
41969755|NCT03321526|75770508|FG001|Follow-up Phase (2 Weeks)|Other|24|||
41969756|NCT03153111|75770522|FG000|Overall Study|Death|2|||
41969757|NCT03153111|75770523|FG001|Overall Study|Death|5|||
41969758|NCT03153111|75770522|FG000|Overall Study|Lost to Follow-up|1|||
41969759|NCT03153111|75770523|FG001|Overall Study|Lost to Follow-up|0|||
41969760|NCT03153111|75770522|FG000|Overall Study|Physician Decision|5|||
41969761|NCT03153111|75770523|FG001|Overall Study|Physician Decision|1|||
41969762|NCT03153111|75770522|FG000|Overall Study|Withdrawal by Subject|3|||
41969763|NCT03153111|75770523|FG001|Overall Study|Withdrawal by Subject|3|||
41969764|NCT03126435|75770531|FG000|Overall Study|Death|90|||
41969765|NCT03126435|75770532|FG001|Overall Study|Death|84|||
41969766|NCT03126435|75770531|FG000|Overall Study|Lost to Follow-up|4|||
41969767|NCT03126435|75770532|FG001|Overall Study|Lost to Follow-up|3|||
42126035|NCT00529542|75936624|FG001|Overall Study|Lost to Follow-up|1|||
42126036|NCT00621959|75936632|FG000|Overall Study|Adverse Event|4|||
42126037|NCT00621959|75936633|FG001|Overall Study|Adverse Event|2|||
42126038|NCT00621959|75936632|FG000|Overall Study|Lack of Efficacy|1|||
42126039|NCT00621959|75936633|FG001|Overall Study|Lack of Efficacy|1|||
42126040|NCT00621959|75936632|FG000|Overall Study|Lost to Follow-up|0|||
42126041|NCT00621959|75936633|FG001|Overall Study|Lost to Follow-up|2|||
42126042|NCT00621959|75936632|FG000|Overall Study|Withdrawal by Subject|1|||
42126043|NCT00621959|75936633|FG001|Overall Study|Withdrawal by Subject|1|||
42126044|NCT00621959|75936632|FG000|Overall Study|Other|1|||
42126045|NCT00621959|75936633|FG001|Overall Study|Other|3|||
41969768|NCT03126435|75770531|FG000|Overall Study|Physician Decision|0|||
41969769|NCT03126435|75770532|FG001|Overall Study|Physician Decision|1|||
42126046|NCT03877224|75936641|FG000|Overall Study|Death|3|||
42126047|NCT03877224|75936642|FG001|Overall Study|Death|2|||
42126048|NCT03877224|75936641|FG000|Overall Study|Withdrawal by Subject|1|||
42126049|NCT03877224|75936642|FG001|Overall Study|Withdrawal by Subject|6|||
41969770|NCT03126435|75770531|FG000|Overall Study|Withdrawal by Subject|6|||
41969771|NCT03126435|75770532|FG001|Overall Study|Withdrawal by Subject|12|||
41969772|NCT03126435|75770531|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
41969773|NCT03126435|75770532|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
41969774|NCT02823574|75770553|FG000|Randomization|Disease Progression|0|||
41969775|NCT02823574|75770554|FG001|Randomization|Disease Progression|0|||
41969776|NCT02823574|75770555|FG002|Randomization|Disease Progression|1|||
41969777|NCT02823574|75770556|FG003|Randomization|Disease Progression|0|||
41969778|NCT02823574|75770553|FG000|Randomization|AE unrelated to Study Drug|1|||
42126050|NCT03877224|75936641|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
41969779|NCT02823574|75770554|FG001|Randomization|AE unrelated to Study Drug|0|||
41969780|NCT02823574|75770555|FG002|Randomization|AE unrelated to Study Drug|0|||
41969781|NCT02823574|75770556|FG003|Randomization|AE unrelated to Study Drug|0|||
41969782|NCT02823574|75770553|FG000|Treatment Period|Poor/Non Compliance|1|||
41969783|NCT02823574|75770554|FG001|Treatment Period|Poor/Non Compliance|0|||
41969784|NCT02823574|75770555|FG002|Treatment Period|Poor/Non Compliance|0|||
41969785|NCT02823574|75770556|FG003|Treatment Period|Poor/Non Compliance|1|||
41969786|NCT02823574|75770553|FG000|Treatment Period|Maximum Clinical Benefit|8|||
41969787|NCT02823574|75770554|FG001|Treatment Period|Maximum Clinical Benefit|4|||
41969788|NCT02823574|75770555|FG002|Treatment Period|Maximum Clinical Benefit|7|||
41969789|NCT02823574|75770556|FG003|Treatment Period|Maximum Clinical Benefit|1|||
41969790|NCT02823574|75770553|FG000|Treatment Period|Lost to Follow-up|1|||
42126051|NCT03877224|75936642|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
41969791|NCT02823574|75770554|FG001|Treatment Period|Lost to Follow-up|1|||
41969792|NCT02823574|75770555|FG002|Treatment Period|Lost to Follow-up|0|||
41969793|NCT02823574|75770556|FG003|Treatment Period|Lost to Follow-up|0|||
42126052|NCT00528606|75936650|FG000|Overall Study|Withdrew consent|4|||
42126053|NCT00528606|75936651|FG001|Overall Study|Withdrew consent|3|||
42126054|NCT00528606|75936650|FG000|Overall Study|Lost to Follow-up|4|||
42126055|NCT00528606|75936651|FG001|Overall Study|Lost to Follow-up|1|||
42126056|NCT00528606|75936650|FG000|Overall Study|Adverse Event|3|||
42126057|NCT00528606|75936651|FG001|Overall Study|Adverse Event|0|||
42126058|NCT00528606|75936650|FG000|Overall Study|Other|2|||
42126059|NCT00528606|75936651|FG001|Overall Study|Other|0|||
42126060|NCT00621257|75936662|FG000|Overall Study|Lost to Follow-up|4|||
42126061|NCT00621257|75936663|FG001|Overall Study|Lost to Follow-up|0|||
42126062|NCT00621257|75936664|FG002|Overall Study|Lost to Follow-up|2|||
42126063|NCT00621257|75936665|FG003|Overall Study|Lost to Follow-up|4|||
42126064|NCT00621257|75936666|FG004|Overall Study|Lost to Follow-up|7|||
41969794|NCT02823574|75770553|FG000|Treatment Period|Participant withdrew consent|4|||
42126065|NCT00621257|75936662|FG000|Overall Study|Adverse Event|0|||
42126066|NCT00621257|75936663|FG001|Overall Study|Adverse Event|1|||
42126067|NCT00621257|75936664|FG002|Overall Study|Adverse Event|1|||
41969795|NCT02823574|75770554|FG001|Treatment Period|Participant withdrew consent|0|||
41969796|NCT02823574|75770555|FG002|Treatment Period|Participant withdrew consent|0|||
42126068|NCT00621257|75936665|FG003|Overall Study|Adverse Event|0|||
41969797|NCT02823574|75770556|FG003|Treatment Period|Participant withdrew consent|1|||
41969798|NCT02823574|75770553|FG000|Treatment Period|Participant request to discontinue|5|||
41969799|NCT02823574|75770554|FG001|Treatment Period|Participant request to discontinue|0|||
41969800|NCT02823574|75770555|FG002|Treatment Period|Participant request to discontinue|3|||
41969801|NCT02823574|75770556|FG003|Treatment Period|Participant request to discontinue|2|||
41969802|NCT02823574|75770553|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
41969803|NCT02823574|75770554|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
41969804|NCT02823574|75770555|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
41969805|NCT02823574|75770556|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
41969806|NCT02823574|75770553|FG000|Treatment Period|Study Drug Toxicity|11|||
41969807|NCT02823574|75770554|FG001|Treatment Period|Study Drug Toxicity|2|||
41969808|NCT02823574|75770555|FG002|Treatment Period|Study Drug Toxicity|14|||
41969809|NCT02823574|75770556|FG003|Treatment Period|Study Drug Toxicity|4|||
41969810|NCT02823574|75770553|FG000|Treatment Period|Disease Progression|113|||
41969811|NCT02823574|75770554|FG001|Treatment Period|Disease Progression|64|||
41969812|NCT02823574|75770555|FG002|Treatment Period|Disease Progression|82|||
41969813|NCT02823574|75770556|FG003|Treatment Period|Disease Progression|43|||
41969814|NCT02823574|75770553|FG000|Treatment Period|Other reasons|5|||
41969815|NCT02823574|75770554|FG001|Treatment Period|Other reasons|9|||
41969816|NCT02823574|75770555|FG002|Treatment Period|Other reasons|3|||
41969817|NCT02823574|75770556|FG003|Treatment Period|Other reasons|6|||
41969818|NCT02823574|75770553|FG000|Treatment Period|Participant no longer meets study criteria|0|||
41969819|NCT02823574|75770554|FG001|Treatment Period|Participant no longer meets study criteria|0|||
41969820|NCT02823574|75770555|FG002|Treatment Period|Participant no longer meets study criteria|1|||
41969821|NCT02823574|75770556|FG003|Treatment Period|Participant no longer meets study criteria|0|||
41969822|NCT02823574|75770553|FG000|Treatment Period|Death|0|||
41969823|NCT02823574|75770554|FG001|Treatment Period|Death|0|||
41969824|NCT02823574|75770555|FG002|Treatment Period|Death|3|||
41969825|NCT02823574|75770556|FG003|Treatment Period|Death|1|||
41969826|NCT02746809|75770569|FG000|Enrollment|Inclusion Exclusion not met|9|||
41969827|NCT02746809|75770569|FG000|Enrollment|Withdrawal by Subject|1|||
41969828|NCT02746809|75770569|FG000|Enrollment|Expected Enrollment Met|2|||
41969829|NCT02746809|75770569|FG000|Procedure|Death|1|||
41969830|NCT02746809|75770569|FG000|1-Month|Death|5|||
41969831|NCT02746809|75770569|FG000|6-Month|Death|2|||
41969832|NCT02746809|75770569|FG000|6-Month|Withdrawal by Subject|1|||
41969833|NCT02746809|75770569|FG000|12-Month|Death|3|||
41969834|NCT02746809|75770569|FG000|12-Month|Withdrawal by Subject|2|||
41969835|NCT02746809|75770569|FG000|24-Month|Death|1|||
41969836|NCT02746809|75770569|FG000|24-Month|Withdrawal by Subject|1|||
41969837|NCT02746809|75770569|FG000|36-Month|Death|8|||
41969838|NCT02746809|75770569|FG000|36-Month|Withdrawal by Subject|1|||
41969839|NCT02746809|75770569|FG000|48-Month|Death|7|||
41969840|NCT02746809|75770569|FG000|48-Month|Withdrawal by Subject|1|||
41969841|NCT02746809|75770569|FG000|60-Month|Death|1|||
41969842|NCT02746809|75770569|FG000|60-Month|Lost to Follow-up|2|||
41969843|NCT02525796|75770578|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
41969844|NCT02525796|75770579|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
41969845|NCT02525796|75770580|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
41969846|NCT02525796|75770578|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
41969847|NCT02525796|75770579|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
41969848|NCT02525796|75770580|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
41969849|NCT02525796|75770578|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
41969850|NCT02525796|75770579|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
41969851|NCT02525796|75770580|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
41969852|NCT02525796|75770578|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
41969853|NCT02525796|75770579|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
41969854|NCT02525796|75770580|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
41969855|NCT02525796|75770578|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
41969856|NCT02525796|75770579|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
41969857|NCT02525796|75770580|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
41969858|NCT02360280|75770596|FG000|Overall Study|Withdrawal by Subject|2|||
41969859|NCT02360280|75770597|FG001|Overall Study|Withdrawal by Subject|0|||
41969860|NCT02360280|75770596|FG000|Overall Study|Adverse Event|0|||
41969861|NCT02360280|75770597|FG001|Overall Study|Adverse Event|1|||
41969862|NCT02360280|75770596|FG000|Overall Study|Lost to Follow-up|1|||
41969863|NCT02360280|75770597|FG001|Overall Study|Lost to Follow-up|0|||
41969864|NCT02201251|75770605|FG000|Overall Study|Adverse Event|1|||
41969865|NCT02201251|75770606|FG001|Overall Study|Adverse Event|1|||
41969866|NCT02201251|75770605|FG000|Overall Study|Protocol Violation|1|||
41969867|NCT02201251|75770606|FG001|Overall Study|Protocol Violation|0|||
41969868|NCT02201251|75770605|FG000|Overall Study|Noncompliance with Study Drug|0|||
41969869|NCT02201251|75770606|FG001|Overall Study|Noncompliance with Study Drug|1|||
41969870|NCT02201251|75770605|FG000|Overall Study|Withdrawal by Subject|2|||
41969871|NCT02201251|75770606|FG001|Overall Study|Withdrawal by Subject|1|||
41969872|NCT02027545|75770614|FG000|Overall Study|Failed to sign HIPAA|0|||
41969873|NCT02027545|75770615|FG001|Overall Study|Failed to sign HIPAA|2|||
41969874|NCT02027545|75770614|FG000|Overall Study|Failed to attend study visit|2|||
41969875|NCT02027545|75770615|FG001|Overall Study|Failed to attend study visit|0|||
41969876|NCT02027545|75770614|FG000|Overall Study|Protocol Violation|1|||
41969877|NCT02027545|75770615|FG001|Overall Study|Protocol Violation|0|||
41969878|NCT01867242|75770633|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
41969879|NCT01867242|75770634|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
41969880|NCT01867242|75770635|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
41969881|NCT01858688|75770643|FG000|Overall Study|Withdrawal by Subject|8|||
42301611|NCT02288325|76136767|FG001|Run-in Period|Lack of Efficacy|0|||
41969882|NCT01858688|75770643|FG000|Overall Study|Participant began another therapy|3|||
41969883|NCT01858688|75770643|FG000|Overall Study|Physician Decision|2|||
41969884|NCT01858688|75770643|FG000|Overall Study|Progressive Disease|2|||
41969885|NCT01858688|75770643|FG000|Overall Study|Reason not reproted|5|||
41969886|NCT01599234|75770662|FG000|Overall Study|Adverse Event|9|||
41969887|NCT01599234|75770663|FG001|Overall Study|Adverse Event|5|||
41969888|NCT01599234|75770662|FG000|Overall Study|Withdrawal by Subject|2|||
41969889|NCT01599234|75770663|FG001|Overall Study|Withdrawal by Subject|1|||
41969890|NCT01599234|75770662|FG000|Overall Study|Lost to Follow-up|1|||
41969891|NCT01599234|75770663|FG001|Overall Study|Lost to Follow-up|2|||
41969892|NCT01599234|75770662|FG000|Overall Study|Lack of Efficacy|2|||
41969893|NCT01599234|75770663|FG001|Overall Study|Lack of Efficacy|4|||
41969894|NCT01599234|75770662|FG000|Overall Study|Unable to operate spray|1|||
41969895|NCT01599234|75770663|FG001|Overall Study|Unable to operate spray|0|||
41969896|NCT01599234|75770662|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
41969897|NCT01599234|75770663|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
41969898|NCT01599234|75770662|FG000|Overall Study|Death|1|||
41969899|NCT01599234|75770663|FG001|Overall Study|Death|0|||
41969900|NCT01599234|75770662|FG000|Overall Study|Patient would not stop driving|1|||
41969901|NCT01599234|75770663|FG001|Overall Study|Patient would not stop driving|0|||
41969902|NCT01599234|75770662|FG000|Overall Study|Contra-indication discovered|0|||
41969903|NCT01599234|75770663|FG001|Overall Study|Contra-indication discovered|1|||
41969904|NCT01599234|75770662|FG000|Overall Study|Pregnancy|0|||
41969905|NCT01599234|75770663|FG001|Overall Study|Pregnancy|1|||
41969906|NCT01393301|75770671|FG000|Overall Study|Lost to Follow-up|5|||
41969907|NCT01393301|75770672|FG001|Overall Study|Lost to Follow-up|3|||
41969908|NCT01393301|75770671|FG000|Overall Study|Withdrawal by Subject|2|||
41969909|NCT01393301|75770672|FG001|Overall Study|Withdrawal by Subject|0|||
41969910|NCT01393301|75770671|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
41969911|NCT01393301|75770672|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
41969912|NCT00716625|75770678|FG000|Overall Study|Safety was not Assessable|1|||
41969913|NCT00713323|75770705|FG000|Overall Study|Adverse Event|75|||
41969914|NCT00713323|75770705|FG000|Overall Study|Withdrawal by Subject|15|||
41969915|NCT00713323|75770705|FG000|Overall Study|Lost to Follow-up|11|||
41969916|NCT00713323|75770705|FG000|Overall Study|Lack of Efficacy|36|||
41969917|NCT00713323|75770705|FG000|Overall Study|Low creatine clearance at screening|1|||
41969918|NCT00713323|75770705|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
41969919|NCT00713323|75770705|FG000|Overall Study|Surgery cured allodynic pain|1|||
42126069|NCT00621257|75936666|FG004|Overall Study|Adverse Event|0|||
42126070|NCT00621257|75936662|FG000|Overall Study|Physician Decision|0|||
42126071|NCT00621257|75936663|FG001|Overall Study|Physician Decision|2|||
42126072|NCT00621257|75936664|FG002|Overall Study|Physician Decision|0|||
42126073|NCT00621257|75936665|FG003|Overall Study|Physician Decision|1|||
42126074|NCT00621257|75936666|FG004|Overall Study|Physician Decision|1|||
42126075|NCT00621257|75936662|FG000|Overall Study|Withdrawal by Subject|0|||
41969920|NCT00713323|75770705|FG000|Overall Study|Pain free|1|||
41969921|NCT00713323|75770705|FG000|Overall Study|Non-compliance|1|||
41969922|NCT00713323|75770705|FG000|Overall Study|Pain resolved|1|||
41969923|NCT00713323|75770705|FG000|Overall Study|Subject travelling to USA|1|||
41969924|NCT00713323|75770705|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
41969925|NCT00713323|75770705|FG000|Overall Study|Treatment that may interact with Sativex|1|||
42126076|NCT00621257|75936663|FG001|Overall Study|Withdrawal by Subject|0|||
42126077|NCT00621257|75936664|FG002|Overall Study|Withdrawal by Subject|0|||
42126078|NCT00621257|75936665|FG003|Overall Study|Withdrawal by Subject|1|||
41969926|NCT00710554|75770722|FG000|Overall Study|Adverse Event|24|||
41969927|NCT00710554|75770723|FG001|Overall Study|Adverse Event|7|||
41969928|NCT00710554|75770722|FG000|Overall Study|Withdrawal by Subject|7|||
41969929|NCT00710554|75770723|FG001|Overall Study|Withdrawal by Subject|3|||
41969930|NCT00710554|75770722|FG000|Overall Study|Lost to Follow-up|7|||
41969931|NCT00710554|75770723|FG001|Overall Study|Lost to Follow-up|1|||
41969932|NCT00710554|75770722|FG000|Overall Study|Lack of Efficacy|11|||
41969933|NCT00710554|75770723|FG001|Overall Study|Lack of Efficacy|12|||
42027935|NCT00920140|75836189|FG003|Phase 2|Lost to Follow-up|1|||
41969934|NCT00710554|75770722|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
41969935|NCT00710554|75770723|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
41969936|NCT00710424|75770731|FG000|Overall Study|Adverse Event|30|||
41969937|NCT00710424|75770732|FG001|Overall Study|Adverse Event|12|||
41969938|NCT00710424|75770731|FG000|Overall Study|Lack of Efficacy|4|||
41969939|NCT00710424|75770732|FG001|Overall Study|Lack of Efficacy|5|||
41969940|NCT00710424|75770731|FG000|Overall Study|Withdrawal by Subject|5|||
41969941|NCT00710424|75770732|FG001|Overall Study|Withdrawal by Subject|3|||
41969942|NCT00710424|75770731|FG000|Overall Study|Lost to Follow-up|0|||
41969943|NCT00710424|75770732|FG001|Overall Study|Lost to Follow-up|1|||
41969944|NCT00710424|75770731|FG000|Overall Study|Refused medication, no side effects|1|||
41969945|NCT00710424|75770732|FG001|Overall Study|Refused medication, no side effects|0|||
41969946|NCT00710424|75770731|FG000|Overall Study|Non-compliance with stable analgesia|1|||
41969947|NCT00710424|75770732|FG001|Overall Study|Non-compliance with stable analgesia|0|||
41969948|NCT00710424|75770731|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
41969949|NCT00710424|75770732|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
41969950|NCT00710424|75770731|FG000|Overall Study|Subject thought medication changed|1|||
41969951|NCT00710424|75770732|FG001|Overall Study|Subject thought medication changed|0|||
41969952|NCT00710424|75770731|FG000|Overall Study|Ceased treatment due to travel|1|||
41969953|NCT00710424|75770732|FG001|Overall Study|Ceased treatment due to travel|0|||
41969954|NCT00710424|75770731|FG000|Overall Study|Subject preferred paracetamol|0|||
41969955|NCT00710424|75770732|FG001|Overall Study|Subject preferred paracetamol|1|||
41969956|NCT00710424|75770731|FG000|Overall Study|Felt good so stopped treatment|0|||
41969957|NCT00710424|75770732|FG001|Overall Study|Felt good so stopped treatment|1|||
41969958|NCT00118846|75770762|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
41969959|NCT00118846|75770763|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
41969960|NCT00118846|75770762|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
41969961|NCT00118846|75770763|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
41969962|NCT00118846|75770762|FG000|Overall Study|Physician Decision|1|||
42027936|NCT00920140|75836190|FG004|Phase 2|Lost to Follow-up|0|||
42126079|NCT00621257|75936666|FG004|Overall Study|Withdrawal by Subject|1|||
42126080|NCT00528840|75936678|FG000|Overall Study|Lost to Follow-up|10|||
42126081|NCT00528840|75936678|FG000|Overall Study|Adverse Event|1|||
42126082|NCT00528840|75936678|FG000|Overall Study|Withdrawal by Subject|17|||
42126083|NCT00528840|75936678|FG000|Overall Study|Death|2|||
42126084|NCT00528840|75936678|FG000|Overall Study|Administrative Reasons|1|||
42126085|NCT00528840|75936678|FG000|Overall Study|Other|2|||
42126086|NCT00528528|75936686|FG000|Overall Study|Lost to Follow-up|0|||
42126087|NCT00528528|75936687|FG001|Overall Study|Lost to Follow-up|0|||
42126088|NCT00528528|75936688|FG002|Overall Study|Lost to Follow-up|1|||
42126089|NCT00528528|75936689|FG003|Overall Study|Lost to Follow-up|1|||
42126090|NCT00528528|75936686|FG000|Overall Study|Ineligible to continue the trial|0|||
42126091|NCT00528528|75936687|FG001|Overall Study|Ineligible to continue the trial|0|||
42126092|NCT00528528|75936688|FG002|Overall Study|Ineligible to continue the trial|0|||
42126093|NCT00528528|75936689|FG003|Overall Study|Ineligible to continue the trial|1|||
42126094|NCT00528528|75936686|FG000|Overall Study|Other|0|||
42126095|NCT00528528|75936687|FG001|Overall Study|Other|1|||
42126096|NCT00528528|75936688|FG002|Overall Study|Other|0|||
42126097|NCT00528528|75936689|FG003|Overall Study|Other|0|||
42126098|NCT00528528|75936686|FG000|Overall Study|Withdrawal by Subject|3|||
42126099|NCT00528528|75936687|FG001|Overall Study|Withdrawal by Subject|2|||
42126100|NCT00528528|75936688|FG002|Overall Study|Withdrawal by Subject|1|||
42126101|NCT00528528|75936689|FG003|Overall Study|Withdrawal by Subject|1|||
42126102|NCT00528528|75936686|FG000|Overall Study|Ongoing participant|0|||
42126103|NCT00528528|75936687|FG001|Overall Study|Ongoing participant|0|||
42126104|NCT00528528|75936688|FG002|Overall Study|Ongoing participant|1|||
42126105|NCT00528528|75936689|FG003|Overall Study|Ongoing participant|0|||
42126106|NCT00620555|75936701|FG000|Overall Study|Adverse Event|4|||
42126107|NCT00620555|75936701|FG000|Overall Study|Protocol Violation|2|||
42126108|NCT00620555|75936701|FG000|Overall Study|Lack of Efficacy|12|||
42027937|NCT00920140|75836186|FG000|Phase 2|Physician Decision|0|||
42126109|NCT00620555|75936701|FG000|Overall Study|Withdrawal by Subject|1|||
42126110|NCT00620555|75936701|FG000|Overall Study|Choice of other treatment|1|||
42126111|NCT00620555|75936701|FG000|Overall Study|Visit failure against planned|1|||
42126112|NCT00529386|75936705|FG000|Overall Study|Lost to Follow-up|1|||
42027938|NCT00920140|75836187|FG001|Phase 2|Physician Decision|0|||
42126113|NCT03875118|75936711|FG000|Overall Study|Withdrawal by Subject|4|||
41969963|NCT00118846|75770763|FG001|Overall Study|Physician Decision|0|||
41969964|NCT00118846|75770762|FG000|Overall Study|Medical condition|2|||
41969965|NCT00118846|75770763|FG001|Overall Study|Medical condition|2|||
41969966|NCT00118846|75770762|FG000|Overall Study|Lost to Follow-up|0|||
41969967|NCT00118846|75770763|FG001|Overall Study|Lost to Follow-up|2|||
41969968|NCT00118846|75770762|FG000|Overall Study|Personal reason|4|||
42126114|NCT03875118|75936712|FG001|Overall Study|Withdrawal by Subject|4|||
42126115|NCT00529308|75936720|FG000|Overall Study|Withdrawal by Subject|1|||
41969969|NCT00118846|75770763|FG001|Overall Study|Personal reason|5|||
41969970|NCT04705051|75770769|FG000|Overall Study|Enrolled but not treated|1|||
41969971|NCT04705051|75770769|FG000|Overall Study|Study terminated by sponsor|23|||
41969972|NCT04464421|75770776|FG000|Overall Study|Lost to Follow-up|2|||
41969973|NCT04464421|75770777|FG001|Overall Study|Lost to Follow-up|2|||
41969974|NCT04112784|75770795|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
42126116|NCT00529308|75936721|FG001|Overall Study|Withdrawal by Subject|1|||
42126117|NCT03875508|75936727|FG000|Overall Study|Adverse Event|1|||
42126118|NCT03875508|75936727|FG000|Overall Study|Lost to Follow-up|8|||
42126119|NCT03875508|75936727|FG000|Overall Study|Lack of Efficacy|1|||
42126120|NCT03875508|75936727|FG000|Overall Study|Other, not specified|2|||
42126121|NCT00620321|75936733|FG000|Overall Study|Adverse Event|1|||
42126122|NCT00620321|75936734|FG001|Overall Study|Adverse Event|1|||
42126123|NCT00620321|75936733|FG000|Overall Study|Death|1|||
42126124|NCT00620321|75936734|FG001|Overall Study|Death|1|||
42126125|NCT00620321|75936733|FG000|Overall Study|Physician Decision|0|||
42126126|NCT00620321|75936734|FG001|Overall Study|Physician Decision|7|||
42126127|NCT00620321|75936733|FG000|Overall Study|Progressive Disease|5|||
42126128|NCT00620321|75936734|FG001|Overall Study|Progressive Disease|5|||
42126129|NCT00620321|75936733|FG000|Overall Study|Sponsor Decision|0|||
42126130|NCT00620321|75936734|FG001|Overall Study|Sponsor Decision|1|||
42126131|NCT00620321|75936733|FG000|Overall Study|Withdrawal by Subject|1|||
42126132|NCT00620321|75936734|FG001|Overall Study|Withdrawal by Subject|1|||
42126133|NCT00621023|75936740|FG000|Overall Study|Death|5|||
42126134|NCT00621023|75936740|FG000|Overall Study|Follow up discontinued|1|||
42126135|NCT00528372|75936753|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
42126136|NCT00528372|75936754|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
42126137|NCT00528372|75936755|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
42126138|NCT00528372|75936756|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
42126139|NCT00528372|75936757|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
42126140|NCT00528372|75936758|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
42126141|NCT00528372|75936759|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
42126142|NCT00528372|75936760|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
42126143|NCT00528372|75936761|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
42126144|NCT00528372|75936753|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
42126145|NCT00528372|75936754|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
42126146|NCT00528372|75936755|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
42126147|NCT00528372|75936756|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
42126148|NCT00528372|75936757|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
42126149|NCT00528372|75936758|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
42126150|NCT00528372|75936759|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
42126151|NCT00528372|75936760|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
42126152|NCT00528372|75936761|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
42126153|NCT00528372|75936753|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
42126154|NCT00528372|75936754|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
42126155|NCT00528372|75936755|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
42126156|NCT00528372|75936756|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
42126157|NCT00528372|75936757|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
42126158|NCT00528372|75936758|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
42126159|NCT00528372|75936759|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
42126160|NCT00528372|75936760|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
42126161|NCT00528372|75936761|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
42126162|NCT00528372|75936753|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
42126163|NCT00528372|75936754|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
42126164|NCT00528372|75936755|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
42126165|NCT00528372|75936756|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
42126166|NCT00528372|75936757|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
41969975|NCT04112784|75770795|FG000|Overall Study|Screen Failures|4|||
41969976|NCT04049617|75770805|FG000|Overall Study|Adverse Event|0|||
41969977|NCT04049617|75770806|FG001|Overall Study|Adverse Event|0|||
41969978|NCT04049617|75770807|FG002|Overall Study|Adverse Event|0|||
41969979|NCT04049617|75770808|FG003|Overall Study|Adverse Event|1|||
42126167|NCT00528372|75936758|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
41969980|NCT04049617|75770809|FG004|Overall Study|Adverse Event|0|||
41969981|NCT04049617|75770810|FG005|Overall Study|Adverse Event|0|||
41969982|NCT04049617|75770805|FG000|Overall Study|Death|0|||
41969983|NCT04049617|75770806|FG001|Overall Study|Death|0|||
41969984|NCT04049617|75770807|FG002|Overall Study|Death|0|||
41969985|NCT04049617|75770808|FG003|Overall Study|Death|0|||
41969986|NCT04049617|75770809|FG004|Overall Study|Death|0|||
41969987|NCT04049617|75770810|FG005|Overall Study|Death|1|||
41969988|NCT04049617|75770805|FG000|Overall Study|Lost to Follow-up|0|||
41969989|NCT04049617|75770806|FG001|Overall Study|Lost to Follow-up|0|||
41969990|NCT04049617|75770807|FG002|Overall Study|Lost to Follow-up|0|||
41969991|NCT04049617|75770808|FG003|Overall Study|Lost to Follow-up|1|||
41969992|NCT04049617|75770809|FG004|Overall Study|Lost to Follow-up|0|||
41969993|NCT04049617|75770810|FG005|Overall Study|Lost to Follow-up|0|||
41969994|NCT04049617|75770805|FG000|Overall Study|Withdrew consent|0|||
41969995|NCT04049617|75770806|FG001|Overall Study|Withdrew consent|0|||
41969996|NCT04049617|75770807|FG002|Overall Study|Withdrew consent|1|||
41969997|NCT04049617|75770808|FG003|Overall Study|Withdrew consent|0|||
41969998|NCT04049617|75770809|FG004|Overall Study|Withdrew consent|0|||
41969999|NCT04049617|75770810|FG005|Overall Study|Withdrew consent|0|||
41970000|NCT03911154|75770826|FG000|Overall Study|Withdrawal by Subject|1|||
41970001|NCT03781778|75770844|FG000|Overall Study|Withdrawal by Subject|2|||
41970002|NCT03781778|75770845|FG001|Overall Study|Withdrawal by Subject|2|||
41970003|NCT03710590|75770853|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
41970004|NCT03710590|75770854|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
41970005|NCT03465722|75770906|FG000|Overall Study|Withdrawal by Subject|21|||
41970006|NCT03465722|75770907|FG001|Overall Study|Withdrawal by Subject|14|||
41970007|NCT03465722|75770906|FG000|Overall Study|Death|89|||
41970008|NCT03465722|75770907|FG001|Overall Study|Death|87|||
41970009|NCT03465722|75770906|FG000|Overall Study|Lost to Follow-up|5|||
41970010|NCT03465722|75770907|FG001|Overall Study|Lost to Follow-up|3|||
41970011|NCT03465722|75770906|FG000|Overall Study|Administrative/Other|33|||
41970012|NCT03465722|75770907|FG001|Overall Study|Administrative/Other|32|||
41970013|NCT03465722|75770906|FG000|Overall Study|Not treated|1|||
41970014|NCT03465722|75770907|FG001|Overall Study|Not treated|2|||
41970015|NCT03465722|75770906|FG000|Overall Study|Sponsor decision|91|||
41970016|NCT03465722|75770907|FG001|Overall Study|Sponsor decision|98|||
41970017|NCT03205423|75770913|FG000|Overall Study|Personal|1|||
41970018|NCT03205423|75770914|FG001|Overall Study|Personal|1|||
41970019|NCT03205423|75770913|FG000|Overall Study|Physician Decision|0|||
41970020|NCT03205423|75770914|FG001|Overall Study|Physician Decision|2|||
41970021|NCT03073603|75770923|FG000|Overall Study|Noncompliance|3|||
41970022|NCT03073603|75770924|FG001|Overall Study|Noncompliance|1|||
41970023|NCT03073603|75770923|FG000|Overall Study|Adverse Event|5|||
41970024|NCT03073603|75770924|FG001|Overall Study|Adverse Event|3|||
41970025|NCT03073603|75770923|FG000|Overall Study|Physician Decision|1|||
41970026|NCT03073603|75770924|FG001|Overall Study|Physician Decision|2|||
41970027|NCT03073603|75770923|FG000|Overall Study|Required treatment not allowed by protocol|1|||
41970028|NCT03073603|75770924|FG001|Overall Study|Required treatment not allowed by protocol|0|||
41970029|NCT03073603|75770923|FG000|Overall Study|Financial or insurance-related|8|||
41970030|NCT03073603|75770924|FG001|Overall Study|Financial or insurance-related|0|||
41970031|NCT03073603|75770923|FG000|Overall Study|Withdrawal by Subject|0|||
41970032|NCT03073603|75770924|FG001|Overall Study|Withdrawal by Subject|1|||
41970033|NCT03073603|75770923|FG000|Overall Study|Discontinued DMT|4|||
41970034|NCT03073603|75770924|FG001|Overall Study|Discontinued DMT|0|||
41970035|NCT03073603|75770923|FG000|Overall Study|Restarted DMT|0|||
41970036|NCT03073603|75770924|FG001|Overall Study|Restarted DMT|1|||
41970037|NCT03002155|75770936|FG000|Overall Study|Lost to Follow-up|1|||
41970038|NCT03002155|75770937|FG001|Overall Study|Lost to Follow-up|2|||
41970039|NCT03002155|75770936|FG000|Overall Study|Withdrawal by Subject|1|||
41970040|NCT03002155|75770937|FG001|Overall Study|Withdrawal by Subject|0|||
41970041|NCT03002155|75770936|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
41970042|NCT03002155|75770937|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
41970043|NCT02918006|75770947|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
41970044|NCT02918006|75770948|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
41970045|NCT02918006|75770949|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
41970046|NCT02918006|75770947|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
41970047|NCT02918006|75770948|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
41970048|NCT02918006|75770949|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
41970049|NCT02918006|75770947|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
41970050|NCT02918006|75770948|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
42126168|NCT00528372|75936759|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
42301612|NCT02288325|76136768|FG002|Run-in Period|Lack of Efficacy|0|||
41970051|NCT02918006|75770949|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
41970052|NCT02918006|75770947|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
41970053|NCT02918006|75770948|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
42027939|NCT00920140|75836188|FG002|Phase 2|Physician Decision|3|||
42301613|NCT02288325|76136766|FG000|Run-in Period|Withdrawal of Consent|28|||
41970054|NCT02918006|75770949|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
41970055|NCT02918006|75770947|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
41970056|NCT02918006|75770948|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
41970057|NCT02918006|75770949|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
41970058|NCT02918006|75770947|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
42027940|NCT00920140|75836189|FG003|Phase 2|Physician Decision|3|||
41970059|NCT02918006|75770948|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
41970060|NCT02918006|75770949|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
41970061|NCT02918006|75770947|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
41970062|NCT02918006|75770948|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
41970063|NCT02918006|75770949|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
41970064|NCT02918006|75770947|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
41970065|NCT02918006|75770948|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
41970066|NCT02918006|75770949|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
41970067|NCT02918006|75770947|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
42126169|NCT00528372|75936760|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
42126170|NCT00528372|75936761|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
42126171|NCT00528372|75936753|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
42126172|NCT00528372|75936754|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
42126173|NCT00528372|75936755|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
42126174|NCT00528372|75936756|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
42126175|NCT00528372|75936757|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
42126176|NCT00528372|75936758|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
42126177|NCT00528372|75936759|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
42126178|NCT00528372|75936760|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
42126179|NCT00528372|75936761|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
42126180|NCT00528372|75936753|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
42126181|NCT00528372|75936754|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
42126182|NCT00528372|75936755|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
42126183|NCT00528372|75936756|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
42126184|NCT00528372|75936757|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
42126185|NCT00528372|75936758|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
42126186|NCT00528372|75936759|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
42126187|NCT00528372|75936760|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
42126188|NCT00528372|75936761|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
42126189|NCT00528372|75936753|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
42126190|NCT00528372|75936754|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
42126191|NCT00528372|75936755|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
42126192|NCT00528372|75936756|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
42126193|NCT00528372|75936757|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
42126194|NCT00528372|75936758|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
42126195|NCT00528372|75936759|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
42126196|NCT00528372|75936760|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
42126197|NCT00528372|75936761|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
42126198|NCT00528372|75936753|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
42126199|NCT00528372|75936754|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
42126200|NCT00528372|75936755|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
42126201|NCT00528372|75936756|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
42126202|NCT00528372|75936757|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
42126203|NCT00528372|75936758|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
42126204|NCT00528372|75936759|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
42126205|NCT00528372|75936760|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
42126206|NCT00528372|75936761|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
42126207|NCT00528372|75936753|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
42126208|NCT00528372|75936754|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
42126209|NCT00528372|75936755|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
42126210|NCT00528372|75936756|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
42126211|NCT00528372|75936757|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
42126212|NCT00528372|75936758|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
42126213|NCT00528372|75936759|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
42126214|NCT00528372|75936760|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
42126215|NCT00528372|75936761|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
42126216|NCT00528372|75936753|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
42126217|NCT00528372|75936754|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
42301614|NCT02288325|76136767|FG001|Run-in Period|Withdrawal of Consent|0|||
42301615|NCT02288325|76136768|FG002|Run-in Period|Withdrawal of Consent|0|||
42301616|NCT02288325|76136766|FG000|Run-in Period|Lost to Follow-up|25|||
41970068|NCT02918006|75770948|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
41970069|NCT02918006|75770949|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
41970070|NCT02179749|75770994|FG000|Overall Study|Adverse Event|0|||
41970071|NCT02179749|75770995|FG001|Overall Study|Adverse Event|0|||
42126218|NCT00528372|75936755|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
42126219|NCT00528372|75936756|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
42126220|NCT00528372|75936757|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
42126221|NCT00528372|75936758|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
42126222|NCT00528372|75936759|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
42126223|NCT00528372|75936760|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
42126224|NCT00528372|75936761|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
42126225|NCT00528372|75936753|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
42126226|NCT00528372|75936754|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
42126227|NCT00528372|75936755|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
42126228|NCT00528372|75936756|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
42126229|NCT00528372|75936757|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
42126230|NCT00528372|75936758|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
42126231|NCT00528372|75936759|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
42126232|NCT00528372|75936760|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
42126233|NCT00528372|75936761|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
42126234|NCT00528372|75936753|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
42126235|NCT00528372|75936754|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
42126236|NCT00528372|75936755|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
42126237|NCT00528372|75936756|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
42126238|NCT00528372|75936757|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
42126239|NCT00528372|75936758|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
42126240|NCT00528372|75936759|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
42126241|NCT00528372|75936760|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
42126242|NCT00528372|75936761|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
42126243|NCT00528372|75936753|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
42126244|NCT00528372|75936754|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
42126245|NCT00528372|75936755|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
42126246|NCT00528372|75936756|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
42126247|NCT00528372|75936757|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
42126248|NCT00528372|75936758|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
42126249|NCT00528372|75936759|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
42126250|NCT00528372|75936760|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
42126251|NCT00528372|75936761|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
42126252|NCT00528372|75936753|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
42126253|NCT00528372|75936754|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
42126254|NCT00528372|75936755|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
42126255|NCT00528372|75936756|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
42126256|NCT00528372|75936757|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
42126257|NCT00528372|75936758|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
42126258|NCT00528372|75936759|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
42126259|NCT00528372|75936760|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
42126260|NCT00528372|75936761|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
42126261|NCT00528372|75936753|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
42126262|NCT00528372|75936754|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
42126263|NCT00528372|75936755|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
42126264|NCT00528372|75936756|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
42126265|NCT00528372|75936757|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
42126266|NCT00528372|75936758|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
42126267|NCT00528372|75936759|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
42126268|NCT00528372|75936760|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
42126269|NCT00528372|75936761|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
42126270|NCT00527982|75936809|FG000|Overall Study|Physician Decision|1|||
42126271|NCT00527982|75936810|FG001|Overall Study|Physician Decision|0|||
42126272|NCT00527904|75936816|FG000|Overall Study|Adverse Event|45|||
42126273|NCT00527904|75936816|FG000|Overall Study|Withdrawal by Subject|21|||
42126274|NCT00527904|75936816|FG000|Overall Study|Lost to Follow-up|8|||
42126275|NCT00527904|75936816|FG000|Overall Study|misc|22|||
42126276|NCT00619619|75936828|FG000|Overall Study|Physician Decision|0|||
42126277|NCT00619619|75936829|FG001|Overall Study|Physician Decision|0|||
42126278|NCT00619619|75936830|FG002|Overall Study|Physician Decision|1|||
42126279|NCT00619619|75936831|FG003|Overall Study|Physician Decision|0|||
42126280|NCT00619619|75936832|FG004|Overall Study|Physician Decision|0|||
42126281|NCT00619619|75936833|FG005|Overall Study|Physician Decision|0|||
42126282|NCT00619619|75936834|FG006|Overall Study|Physician Decision|0|||
42126283|NCT00619619|75936835|FG007|Overall Study|Physician Decision|0|||
42126284|NCT00619619|75936828|FG000|Overall Study|Protocol Violation|0|||
42126285|NCT00619619|75936829|FG001|Overall Study|Protocol Violation|0|||
42126286|NCT00619619|75936830|FG002|Overall Study|Protocol Violation|0|||
42126287|NCT00619619|75936831|FG003|Overall Study|Protocol Violation|1|||
42126288|NCT00619619|75936832|FG004|Overall Study|Protocol Violation|0|||
42126289|NCT00619619|75936833|FG005|Overall Study|Protocol Violation|0|||
42126290|NCT00619619|75936834|FG006|Overall Study|Protocol Violation|1|||
42126291|NCT00619619|75936835|FG007|Overall Study|Protocol Violation|1|||
42126292|NCT00619619|75936828|FG000|Overall Study|Adverse Event|0|||
42126293|NCT00619619|75936829|FG001|Overall Study|Adverse Event|0|||
42126294|NCT00619619|75936830|FG002|Overall Study|Adverse Event|0|||
42126295|NCT00619619|75936831|FG003|Overall Study|Adverse Event|0|||
42126296|NCT00619619|75936832|FG004|Overall Study|Adverse Event|2|||
42126297|NCT00619619|75936833|FG005|Overall Study|Adverse Event|0|||
42126298|NCT00619619|75936834|FG006|Overall Study|Adverse Event|0|||
42126299|NCT00619619|75936835|FG007|Overall Study|Adverse Event|2|||
42126300|NCT00527826|75936858|FG000|Overall Study|Adverse Event|10|||
42126301|NCT00527826|75936859|FG001|Overall Study|Adverse Event|10|||
42126302|NCT00527826|75936858|FG000|Overall Study|Lost to Follow-up|3|||
42126303|NCT00527826|75936859|FG001|Overall Study|Lost to Follow-up|2|||
42126304|NCT00527826|75936858|FG000|Overall Study|Withdrawal by Subject|5|||
41970072|NCT02179749|75770996|FG002|Overall Study|Adverse Event|1|||
41970073|NCT02179749|75770994|FG000|Overall Study|Withdrawal by Subject|0|||
41970074|NCT02179749|75770995|FG001|Overall Study|Withdrawal by Subject|0|||
41970075|NCT02179749|75770996|FG002|Overall Study|Withdrawal by Subject|1|||
41970076|NCT02075593|75771007|FG000|Overall Study|Withdrawal by Subject|1|||
41970077|NCT00641186|75771040|FG000|Overall Study|Adverse Event|3|||
41970078|NCT01595009|75771046|FG000|Core|Patients completed per protocol|85|||
41970079|NCT01595009|75771047|FG001|Core|Patients completed per protocol|44|||
41970080|NCT01595009|75771048|FG002|Core|Patients completed per protocol|0|||
41970081|NCT01595009|75771049|FG003|Core|Patients completed per protocol|0|||
41970082|NCT01595009|75771046|FG000|Core|Adverse Event|19|||
41970083|NCT01595009|75771047|FG001|Core|Adverse Event|23|||
41970084|NCT01595009|75771048|FG002|Core|Adverse Event|0|||
41970085|NCT01595009|75771049|FG003|Core|Adverse Event|0|||
41970086|NCT01595009|75771046|FG000|Core|Disease progression|14|||
41970087|NCT01595009|75771047|FG001|Core|Disease progression|26|||
41970088|NCT01595009|75771048|FG002|Core|Disease progression|0|||
41970089|NCT01595009|75771049|FG003|Core|Disease progression|0|||
41970090|NCT01595009|75771046|FG000|Core|Withdrawal by Subject|4|||
41970091|NCT01595009|75771047|FG001|Core|Withdrawal by Subject|17|||
42126305|NCT00527826|75936859|FG001|Overall Study|Withdrawal by Subject|8|||
42126306|NCT00527826|75936858|FG000|Overall Study|Inclusion Criteria Not Met|3|||
42126307|NCT00527826|75936859|FG001|Overall Study|Inclusion Criteria Not Met|3|||
42126308|NCT00527826|75936858|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
42126309|NCT00527826|75936859|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
42126310|NCT00527826|75936858|FG000|Overall Study|Additional Intake of Viani forte|0|||
41970092|NCT01595009|75771048|FG002|Core|Withdrawal by Subject|0|||
42027941|NCT00920140|75836190|FG004|Phase 2|Physician Decision|2|||
42027942|NCT00920140|75836186|FG000|Phase 2|Withdrawal by Subject|0|||
42027943|NCT00920140|75836187|FG001|Phase 2|Withdrawal by Subject|0|||
42027944|NCT00920140|75836188|FG002|Phase 2|Withdrawal by Subject|4|||
42027945|NCT00920140|75836189|FG003|Phase 2|Withdrawal by Subject|2|||
42027946|NCT00920140|75836190|FG004|Phase 2|Withdrawal by Subject|1|||
42027947|NCT01120782|75836203|FG000|Overall Study|Test article shipping error|11|||
42027948|NCT01120626|75836209|FG000|Overall Study|Withdrawal by Subject|1|||
41970093|NCT01595009|75771049|FG003|Core|Withdrawal by Subject|0|||
41970094|NCT01595009|75771046|FG000|Core|Death|3|||
41970095|NCT01595009|75771047|FG001|Core|Death|6|||
42027949|NCT01120626|75836210|FG001|Overall Study|Withdrawal by Subject|0|||
42027950|NCT00924508|75836216|FG000|Overall Study|Withdrawal by Subject|3|||
42027951|NCT01139658|75836225|FG000|Overall Study|Adverse Event|10|||
42126311|NCT00527826|75936859|FG001|Overall Study|Additional Intake of Viani forte|1|||
42126312|NCT00527826|75936858|FG000|Overall Study|Participant moved away|0|||
42126313|NCT00527826|75936859|FG001|Overall Study|Participant moved away|1|||
42126314|NCT00527748|75936868|FG000|Overall Study|Other|3|||
42126315|NCT00619385|75936875|FG000|Overall Study|Adverse Event|0|||
42126316|NCT00619385|75936876|FG001|Overall Study|Adverse Event|0|||
42126317|NCT00619385|75936877|FG002|Overall Study|Adverse Event|3|||
42126318|NCT00619385|75936875|FG000|Overall Study|Other|1|||
41970096|NCT01595009|75771048|FG002|Core|Death|0|||
41970097|NCT01595009|75771049|FG003|Core|Death|0|||
41970098|NCT01595009|75771046|FG000|Core|Lost to Follow-up|1|||
41970099|NCT01595009|75771047|FG001|Core|Lost to Follow-up|2|||
41970100|NCT01595009|75771048|FG002|Core|Lost to Follow-up|0|||
41970101|NCT01595009|75771049|FG003|Core|Lost to Follow-up|0|||
41970102|NCT01595009|75771046|FG000|Core|Protocol deviation|0|||
41970103|NCT01595009|75771047|FG001|Core|Protocol deviation|1|||
41970104|NCT01595009|75771048|FG002|Core|Protocol deviation|0|||
41970105|NCT01595009|75771049|FG003|Core|Protocol deviation|0|||
41970106|NCT01595009|75771046|FG000|Core|Administrative problems|0|||
41970107|NCT01595009|75771047|FG001|Core|Administrative problems|1|||
41970108|NCT01595009|75771048|FG002|Core|Administrative problems|0|||
41970109|NCT01595009|75771049|FG003|Core|Administrative problems|0|||
41970110|NCT01595009|75771046|FG000|Extension|Administrative problems|0|||
41970111|NCT01595009|75771047|FG001|Extension|Administrative problems|0|||
41970112|NCT01595009|75771048|FG002|Extension|Administrative problems|0|||
41970113|NCT01595009|75771049|FG003|Extension|Administrative problems|1|||
41970114|NCT01595009|75771046|FG000|Extension|Patients completed per protocol|0|||
41970115|NCT01595009|75771047|FG001|Extension|Patients completed per protocol|0|||
41970116|NCT01595009|75771048|FG002|Extension|Patients completed per protocol|0|||
41970117|NCT01595009|75771049|FG003|Extension|Patients completed per protocol|2|||
41970118|NCT01595009|75771046|FG000|Extension|Disease progression|0|||
41970119|NCT01595009|75771047|FG001|Extension|Disease progression|0|||
41970120|NCT01595009|75771048|FG002|Extension|Disease progression|4|||
41970121|NCT01595009|75771049|FG003|Extension|Disease progression|7|||
41970122|NCT01595009|75771046|FG000|Extension|Adverse Event|0|||
41970123|NCT01595009|75771047|FG001|Extension|Adverse Event|0|||
41970124|NCT01595009|75771048|FG002|Extension|Adverse Event|0|||
41970125|NCT01595009|75771049|FG003|Extension|Adverse Event|1|||
41970126|NCT05553808|75771066|FG000|Overall Study|Death|25|||
41970127|NCT05553808|75771067|FG001|Overall Study|Death|62|||
41970128|NCT05553808|75771066|FG000|Overall Study|Site Closed|6|||
41970129|NCT05553808|75771067|FG001|Overall Study|Site Closed|6|||
41970130|NCT05553808|75771066|FG000|Overall Study|Lost to Follow-up|1|||
41970131|NCT05553808|75771067|FG001|Overall Study|Lost to Follow-up|0|||
41970132|NCT05553808|75771066|FG000|Overall Study|Withdrawal by Subject|3|||
41970133|NCT05553808|75771067|FG001|Overall Study|Withdrawal by Subject|2|||
41970134|NCT04997161|75771083|FG000|Overall Study|Study terminated by sponsor|3|||
41970135|NCT04753216|75771087|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
41970136|NCT04753216|75771087|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
41970137|NCT04753216|75771087|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
41970138|NCT04530747|75771120|FG000|Overall Study|Withdrawal by Subject|1|||
41970139|NCT04530747|75771121|FG001|Overall Study|Withdrawal by Subject|0|||
41970140|NCT04493242|75771132|FG000|Overall Study|Death|10|||
41970141|NCT04493242|75771133|FG001|Overall Study|Death|14|||
41970142|NCT04493242|75771134|FG002|Overall Study|Death|16|||
41970143|NCT04493242|75771132|FG000|Overall Study|Lost to Follow-up|1|||
41970144|NCT04493242|75771133|FG001|Overall Study|Lost to Follow-up|1|||
41970145|NCT04493242|75771134|FG002|Overall Study|Lost to Follow-up|0|||
41970146|NCT04493242|75771132|FG000|Overall Study|Withdrawal by Subject|1|||
41970147|NCT04493242|75771133|FG001|Overall Study|Withdrawal by Subject|0|||
41970148|NCT04493242|75771134|FG002|Overall Study|Withdrawal by Subject|0|||
41970149|NCT04493242|75771132|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
41970150|NCT04493242|75771133|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
41970151|NCT04493242|75771134|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
41970152|NCT04493242|75771132|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
41970153|NCT04493242|75771133|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
41970154|NCT04493242|75771134|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
41970155|NCT04040751|75771155|FG000|Overall Study|Withdrawal by Subject|2|||
41970156|NCT04040751|75771156|FG001|Overall Study|Withdrawal by Subject|0|||
41970157|NCT04040751|75771157|FG002|Overall Study|Withdrawal by Subject|2|||
41970158|NCT04040751|75771158|FG003|Overall Study|Withdrawal by Subject|0|||
41970159|NCT03997916|75771168|FG000|Overall Study|Protocol Violation|35|||
41970160|NCT03596177|75771187|FG000|Single Blind Period|Withdrawal by Subject|1|||
41970161|NCT03596177|75771188|FG001|Single Blind Period|Withdrawal by Subject|1|||
41970162|NCT03596177|75771187|FG000|Single Blind Period|Other|1|||
41970163|NCT03596177|75771188|FG001|Single Blind Period|Other|0|||
41970164|NCT03596177|75771187|FG000|Double Blind Period|Withdrawal by Subject|0|||
41970165|NCT03596177|75771188|FG001|Double Blind Period|Withdrawal by Subject|1|||
41970166|NCT03596177|75771187|FG000|Double Blind Period|Other|0|||
41970167|NCT03596177|75771188|FG001|Double Blind Period|Other|4|||
41970168|NCT03596177|75771187|FG000|Double Blind Period|Death during safety follow-up|0|||
41970169|NCT03596177|75771188|FG001|Double Blind Period|Death during safety follow-up|1|||
41970170|NCT03579459|75771198|FG000|Overall Study|Adverse Event|7|||
41970171|NCT03579459|75771199|FG001|Overall Study|Adverse Event|6|||
41970172|NCT03579459|75771200|FG002|Overall Study|Adverse Event|2|||
41970173|NCT03579459|75771201|FG003|Overall Study|Adverse Event|6|||
41970174|NCT03579459|75771198|FG000|Overall Study|Death|1|||
41970175|NCT03579459|75771199|FG001|Overall Study|Death|0|||
41970176|NCT03579459|75771200|FG002|Overall Study|Death|1|||
41970177|NCT03579459|75771201|FG003|Overall Study|Death|2|||
41970178|NCT03579459|75771198|FG000|Overall Study|Lost to Follow-up|6|||
41970179|NCT03579459|75771199|FG001|Overall Study|Lost to Follow-up|2|||
41970180|NCT03579459|75771200|FG002|Overall Study|Lost to Follow-up|4|||
41970181|NCT03579459|75771201|FG003|Overall Study|Lost to Follow-up|1|||
41970182|NCT03579459|75771198|FG000|Overall Study|Physician Decision|0|||
41970183|NCT03579459|75771199|FG001|Overall Study|Physician Decision|1|||
41970184|NCT03579459|75771200|FG002|Overall Study|Physician Decision|0|||
41970185|NCT03579459|75771201|FG003|Overall Study|Physician Decision|1|||
41970186|NCT03579459|75771198|FG000|Overall Study|Protocol Violation|1|||
41970187|NCT03579459|75771199|FG001|Overall Study|Protocol Violation|2|||
41970188|NCT03579459|75771200|FG002|Overall Study|Protocol Violation|3|||
41970189|NCT03579459|75771201|FG003|Overall Study|Protocol Violation|5|||
41970190|NCT03579459|75771198|FG000|Overall Study|Withdrawal by Subject|12|||
41970191|NCT03579459|75771199|FG001|Overall Study|Withdrawal by Subject|8|||
41970192|NCT03579459|75771200|FG002|Overall Study|Withdrawal by Subject|11|||
41970193|NCT03579459|75771201|FG003|Overall Study|Withdrawal by Subject|8|||
42027952|NCT01139658|75836226|FG001|Overall Study|Adverse Event|27|||
42027953|NCT01139658|75836225|FG000|Overall Study|Lack of Efficacy|15|||
42027954|NCT01139658|75836226|FG001|Overall Study|Lack of Efficacy|7|||
42027955|NCT01139658|75836225|FG000|Overall Study|Withdrawal by Subject|2|||
42027956|NCT01139658|75836226|FG001|Overall Study|Withdrawal by Subject|4|||
42027957|NCT01139658|75836225|FG000|Overall Study|No documentation of treatment|1|||
41970194|NCT03579459|75771198|FG000|Overall Study|Medication error without associated adverse event|2|||
41970195|NCT03579459|75771199|FG001|Overall Study|Medication error without associated adverse event|1|||
41970196|NCT03579459|75771200|FG002|Overall Study|Medication error without associated adverse event|1|||
41970197|NCT03579459|75771201|FG003|Overall Study|Medication error without associated adverse event|0|||
41970198|NCT03579459|75771198|FG000|Overall Study|Other|0|||
41970199|NCT03579459|75771199|FG001|Overall Study|Other|1|||
41970200|NCT03579459|75771200|FG002|Overall Study|Other|1|||
41970201|NCT03579459|75771201|FG003|Overall Study|Other|0|||
41970202|NCT03579459|75771198|FG000|Overall Study|Randomized not vaccinated|0|||
41970203|NCT03579459|75771199|FG001|Overall Study|Randomized not vaccinated|2|||
41970204|NCT03579459|75771200|FG002|Overall Study|Randomized not vaccinated|0|||
41970205|NCT03579459|75771201|FG003|Overall Study|Randomized not vaccinated|1|||
41970206|NCT04449276|75771228|FG000|Overall Study|Adverse Event|1|||
41970207|NCT04449276|75771229|FG001|Overall Study|Adverse Event|2|||
41970208|NCT04449276|75771230|FG002|Overall Study|Adverse Event|0|||
41970209|NCT04449276|75771231|FG003|Overall Study|Adverse Event|0|||
41970210|NCT04449276|75771232|FG004|Overall Study|Adverse Event|2|||
41970211|NCT04449276|75771233|FG005|Overall Study|Adverse Event|0|||
41970212|NCT04449276|75771234|FG006|Overall Study|Adverse Event|0|||
41970213|NCT04449276|75771235|FG007|Overall Study|Adverse Event|1|||
41970214|NCT04449276|75771228|FG000|Overall Study|Withdrawal by Subject|2|||
41970215|NCT04449276|75771229|FG001|Overall Study|Withdrawal by Subject|0|||
41970216|NCT04449276|75771230|FG002|Overall Study|Withdrawal by Subject|0|||
41970217|NCT04449276|75771231|FG003|Overall Study|Withdrawal by Subject|1|||
41970218|NCT04449276|75771232|FG004|Overall Study|Withdrawal by Subject|0|||
41970219|NCT04449276|75771233|FG005|Overall Study|Withdrawal by Subject|0|||
41970220|NCT04449276|75771234|FG006|Overall Study|Withdrawal by Subject|0|||
41970221|NCT04449276|75771235|FG007|Overall Study|Withdrawal by Subject|0|||
41970222|NCT04449276|75771228|FG000|Overall Study|Other|0|||
41970223|NCT04449276|75771229|FG001|Overall Study|Other|2|||
41970224|NCT04449276|75771230|FG002|Overall Study|Other|3|||
41970225|NCT04449276|75771231|FG003|Overall Study|Other|2|||
41970226|NCT04449276|75771232|FG004|Overall Study|Other|0|||
41970227|NCT04449276|75771233|FG005|Overall Study|Other|0|||
41970228|NCT04449276|75771234|FG006|Overall Study|Other|0|||
41970229|NCT04449276|75771235|FG007|Overall Study|Other|1|||
41970230|NCT04391894|75771275|FG000|Overall Study|Adverse Event|1|||
41970231|NCT04391894|75771276|FG001|Overall Study|Adverse Event|1|||
41970232|NCT04391894|75771277|FG002|Overall Study|Adverse Event|1|||
41970233|NCT04391894|75771278|FG003|Overall Study|Adverse Event|1|||
41970234|NCT04391894|75771279|FG004|Overall Study|Adverse Event|1|||
41970235|NCT04391894|75771275|FG000|Overall Study|Lost to Follow-up|1|||
41970236|NCT04391894|75771276|FG001|Overall Study|Lost to Follow-up|0|||
41970237|NCT04391894|75771277|FG002|Overall Study|Lost to Follow-up|0|||
41970238|NCT04391894|75771278|FG003|Overall Study|Lost to Follow-up|0|||
41970239|NCT04391894|75771279|FG004|Overall Study|Lost to Follow-up|0|||
41970240|NCT04391894|75771275|FG000|Overall Study|Protocol Violation|0|||
41970241|NCT04391894|75771276|FG001|Overall Study|Protocol Violation|0|||
41970242|NCT04391894|75771277|FG002|Overall Study|Protocol Violation|0|||
41970243|NCT04391894|75771278|FG003|Overall Study|Protocol Violation|1|||
41970244|NCT04391894|75771279|FG004|Overall Study|Protocol Violation|0|||
41970245|NCT04391894|75771275|FG000|Overall Study|Withdrawal by Subject|2|||
42027958|NCT01139658|75836226|FG001|Overall Study|No documentation of treatment|0|||
41970246|NCT04391894|75771276|FG001|Overall Study|Withdrawal by Subject|0|||
41970247|NCT04391894|75771277|FG002|Overall Study|Withdrawal by Subject|3|||
41970248|NCT04391894|75771278|FG003|Overall Study|Withdrawal by Subject|0|||
42027959|NCT01139658|75836225|FG000|Overall Study|Other|28|||
42126319|NCT00619385|75936876|FG001|Overall Study|Other|2|||
41970249|NCT04391894|75771279|FG004|Overall Study|Withdrawal by Subject|1|||
41970250|NCT04391894|75771275|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
41970251|NCT04391894|75771276|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
42027960|NCT01139658|75836226|FG001|Overall Study|Other|75|||
42126320|NCT00619385|75936877|FG002|Overall Study|Other|1|||
41970252|NCT04391894|75771277|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
41970253|NCT04391894|75771278|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
41970254|NCT04391894|75771279|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
41970255|NCT03851705|75771297|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
41970256|NCT03851705|75771298|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
41970257|NCT03851705|75771299|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
41970258|NCT03851705|75771300|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
41970259|NCT03851705|75771297|FG000|Part 1: Double-Blind Period|Other reason|1|||
41970260|NCT03851705|75771298|FG001|Part 1: Double-Blind Period|Other reason|0|||
41970261|NCT03851705|75771299|FG002|Part 1: Double-Blind Period|Other reason|0|||
41970262|NCT03851705|75771300|FG003|Part 1: Double-Blind Period|Other reason|0|||
41970263|NCT03851705|75771297|FG000|Part 2: Open-Label Period|Other reason|0|||
41970264|NCT03851705|75771298|FG001|Part 2: Open-Label Period|Other reason|0|||
41970265|NCT03851705|75771299|FG002|Part 2: Open-Label Period|Other reason|0|||
41970266|NCT03851705|75771300|FG003|Part 2: Open-Label Period|Other reason|1|||
41970267|NCT03851705|75771297|FG000|Part 2: Open-Label Period|Death|0|||
41970268|NCT03851705|75771298|FG001|Part 2: Open-Label Period|Death|0|||
41970269|NCT03851705|75771299|FG002|Part 2: Open-Label Period|Death|3|||
41970270|NCT03851705|75771300|FG003|Part 2: Open-Label Period|Death|0|||
41970271|NCT03851705|75771297|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
41970272|NCT03851705|75771298|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
41970273|NCT03851705|75771299|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
41970274|NCT03851705|75771300|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
41970275|NCT03824366|75771313|FG000|Overall Study|Death|1|||
41970276|NCT03824366|75771313|FG000|Overall Study|Previously unidentified metal artifact|1|||
41970277|NCT03824366|75771313|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
41970278|NCT03824366|75771313|FG000|Overall Study|Withdrawal by Subject|1|||
41970279|NCT03810313|75771319|FG000|Overall Study|Study terminated by sponsor|164|||
41970280|NCT03810313|75771320|FG001|Overall Study|Study terminated by sponsor|159|||
41970281|NCT03810313|75771319|FG000|Overall Study|Subject decision|10|||
41970282|NCT03810313|75771320|FG001|Overall Study|Subject decision|11|||
41970283|NCT03810313|75771319|FG000|Overall Study|Lost to Follow-up|3|||
41970284|NCT03810313|75771320|FG001|Overall Study|Lost to Follow-up|3|||
41970285|NCT03810313|75771319|FG000|Overall Study|Adverse Event|2|||
41970286|NCT03810313|75771320|FG001|Overall Study|Adverse Event|1|||
41970287|NCT03810313|75771319|FG000|Overall Study|Death|2|||
41970288|NCT03810313|75771320|FG001|Overall Study|Death|1|||
41970289|NCT03810313|75771319|FG000|Overall Study|Physician Decision|0|||
41970290|NCT03810313|75771320|FG001|Overall Study|Physician Decision|1|||
41970291|NCT03802630|75771329|FG000|Overall Study|Study terminated by sponsor|130|||
41970292|NCT03802630|75771330|FG001|Overall Study|Study terminated by sponsor|134|||
41970293|NCT03802630|75771329|FG000|Overall Study|Subject decision|16|||
41970294|NCT03802630|75771330|FG001|Overall Study|Subject decision|9|||
41970295|NCT03802630|75771329|FG000|Overall Study|Adverse Event|3|||
41970296|NCT03802630|75771330|FG001|Overall Study|Adverse Event|1|||
41970297|NCT03802630|75771329|FG000|Overall Study|Lost to Follow-up|2|||
41970298|NCT03802630|75771330|FG001|Overall Study|Lost to Follow-up|2|||
41970299|NCT03802630|75771329|FG000|Overall Study|Physician Decision|2|||
41970300|NCT03802630|75771330|FG001|Overall Study|Physician Decision|0|||
41970301|NCT03802630|75771329|FG000|Overall Study|Death|0|||
41970302|NCT03802630|75771330|FG001|Overall Study|Death|2|||
41970303|NCT03775213|75771339|FG000|Overall Study|Withdrawal by Subject|51|||
41970304|NCT03775213|75771340|FG001|Overall Study|Withdrawal by Subject|53|||
41970305|NCT03775213|75771339|FG000|Overall Study|Incomplete Survey|7|||
41970306|NCT03775213|75771340|FG001|Overall Study|Incomplete Survey|7|||
41970307|NCT03710564|75771348|FG000|Overall Study|Study Terminated by Sponsor|104|||
41970308|NCT03710564|75771349|FG001|Overall Study|Study Terminated by Sponsor|55|||
41970309|NCT03710564|75771348|FG000|Overall Study|Withdrawal by Subject|57|||
41970310|NCT03710564|75771349|FG001|Overall Study|Withdrawal by Subject|25|||
41970311|NCT03710564|75771348|FG000|Overall Study|Death|10|||
41970312|NCT03710564|75771349|FG001|Overall Study|Death|4|||
41970313|NCT03710564|75771348|FG000|Overall Study|Lost to Follow-up|5|||
41970314|NCT03710564|75771349|FG001|Overall Study|Lost to Follow-up|4|||
41970315|NCT03710564|75771348|FG000|Overall Study|Protocol Violation|3|||
41970316|NCT03710564|75771349|FG001|Overall Study|Protocol Violation|2|||
41970317|NCT03710564|75771348|FG000|Overall Study|Adverse Event|3|||
41970318|NCT03710564|75771349|FG001|Overall Study|Adverse Event|0|||
41970319|NCT03710564|75771348|FG000|Overall Study|Physician Decision|2|||
41970320|NCT03710564|75771349|FG001|Overall Study|Physician Decision|3|||
41970321|NCT03624127|75771359|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
41970322|NCT03624127|75771360|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
42010617|NCT00991939|75817728|FG001|Overall Study|Withdrawal by Subject|0|||
42010618|NCT00991939|75817727|FG000|Overall Study|Entire study terminated|4|||
42010619|NCT00991939|75817728|FG001|Overall Study|Entire study terminated|1|||
42010620|NCT00993265|75817738|FG000|Overall Study|Adverse Event|1|||
42010621|NCT00993265|75817739|FG001|Overall Study|Adverse Event|0|||
41970323|NCT03624127|75771361|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
41970324|NCT03624127|75771359|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
41970325|NCT03624127|75771360|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
41970326|NCT03624127|75771361|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
41970327|NCT03624127|75771359|FG000|Treatment Week 0 - Week 16|Death|0|||
41970328|NCT03624127|75771360|FG001|Treatment Week 0 - Week 16|Death|1|||
41970329|NCT03624127|75771361|FG002|Treatment Week 0 - Week 16|Death|0|||
41970330|NCT03624127|75771359|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
41970331|NCT03624127|75771360|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
41970332|NCT03624127|75771361|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
41970333|NCT03624127|75771359|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
41970334|NCT03624127|75771360|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
41970335|NCT03624127|75771361|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
41970336|NCT03624127|75771359|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
41970337|NCT03624127|75771360|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
41970338|NCT03624127|75771361|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
41970339|NCT03624127|75771359|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
41970340|NCT03624127|75771360|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
41970341|NCT03624127|75771361|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
41970342|NCT03624127|75771359|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
41970343|NCT03624127|75771360|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
41970344|NCT03624127|75771361|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
41970345|NCT03624127|75771359|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
41970346|NCT03624127|75771360|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
41970347|NCT03624127|75771361|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
41970348|NCT03624127|75771359|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
41970349|NCT03624127|75771360|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
41970350|NCT03624127|75771361|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
41970351|NCT03624127|75771359|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
41970352|NCT03624127|75771360|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
41970353|NCT03624127|75771361|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
41970354|NCT03624127|75771359|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
41970355|NCT03624127|75771360|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
41970356|NCT03624127|75771361|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
41970357|NCT03624127|75771359|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
41970358|NCT03624127|75771360|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
41970359|NCT03624127|75771361|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
41970360|NCT03624127|75771359|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
41970361|NCT03624127|75771360|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
41970362|NCT03624127|75771361|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
42027961|NCT01139580|75836234|FG000|Overall Study|Adverse Event|5|||
42126321|NCT00619307|75936890|FG000|Overall Study|Adverse Event|0|||
42126322|NCT00619307|75936891|FG001|Overall Study|Adverse Event|1|||
42126323|NCT00619307|75936890|FG000|Overall Study|Lost to Follow-up|0|||
42126324|NCT00619307|75936891|FG001|Overall Study|Lost to Follow-up|1|||
42126325|NCT00619307|75936890|FG000|Overall Study|Protocol Violation|3|||
42126326|NCT00619307|75936891|FG001|Overall Study|Protocol Violation|0|||
42126327|NCT00619307|75936890|FG000|Overall Study|Withdrew consent|1|||
42126328|NCT00619307|75936891|FG001|Overall Study|Withdrew consent|0|||
42126329|NCT00619307|75936890|FG000|Overall Study|Severe migraine|0|||
42126330|NCT00619307|75936891|FG001|Overall Study|Severe migraine|1|||
42126331|NCT00619307|75936890|FG000|Overall Study|MS attack plus steroids|0|||
42126332|NCT00619307|75936891|FG001|Overall Study|MS attack plus steroids|1|||
42126333|NCT00619229|75936899|FG000|Overall Study|Withdrawal by Subject|1|||
42126334|NCT00619229|75936900|FG001|Overall Study|Withdrawal by Subject|1|||
42126335|NCT00619229|75936899|FG000|Overall Study|Lost to Follow-up|1|||
42126336|NCT00619229|75936900|FG001|Overall Study|Lost to Follow-up|0|||
42126337|NCT00619229|75936899|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
42126338|NCT00619229|75936900|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
42027962|NCT01139580|75836235|FG001|Overall Study|Adverse Event|4|||
42027963|NCT01139580|75836234|FG000|Overall Study|Lost to Follow-up|9|||
42027964|NCT01139580|75836235|FG001|Overall Study|Lost to Follow-up|1|||
42126339|NCT00619229|75936899|FG000|Overall Study|Investigator planned Cataract Operation|1|||
42126340|NCT00619229|75936900|FG001|Overall Study|Investigator planned Cataract Operation|0|||
42126341|NCT00619151|75936908|FG000|Overall Study|Study terminated prior to followup|1|||
42126342|NCT00619151|75936909|FG001|Overall Study|Study terminated prior to followup|0|||
42126343|NCT00618995|75936915|FG000|Period 1|Adverse Event|0|||
42126344|NCT00618995|75936916|FG001|Period 1|Adverse Event|0|||
42126345|NCT00618995|75936917|FG002|Period 1|Adverse Event|1|||
42126346|NCT00618995|75936918|FG003|Period 1|Adverse Event|0|||
42126347|NCT00618995|75936915|FG000|Period 1|Protocol Violation|0|||
42126348|NCT00618995|75936916|FG001|Period 1|Protocol Violation|1|||
42027965|NCT01139580|75836234|FG000|Overall Study|Lack of Efficacy|0|||
42126349|NCT00618995|75936917|FG002|Period 1|Protocol Violation|1|||
42126350|NCT00618995|75936918|FG003|Period 1|Protocol Violation|0|||
42126351|NCT00618995|75936915|FG000|Period 2|Protocol Violation|0|||
42126352|NCT00618995|75936916|FG001|Period 2|Protocol Violation|0|||
42126353|NCT00618995|75936917|FG002|Period 2|Protocol Violation|1|||
42126354|NCT00618995|75936918|FG003|Period 2|Protocol Violation|0|||
42126355|NCT00618995|75936915|FG000|Period 4|Adverse Event|1|||
42126356|NCT00618995|75936916|FG001|Period 4|Adverse Event|0|||
42126357|NCT00618995|75936917|FG002|Period 4|Adverse Event|0|||
42126358|NCT00618995|75936918|FG003|Period 4|Adverse Event|0|||
42126359|NCT03685344|75936932|FG000|Overall Study|Withdrawal by Subject|1|||
42126360|NCT03685344|75936933|FG001|Overall Study|Withdrawal by Subject|1|||
42126361|NCT03685344|75936934|FG002|Overall Study|Withdrawal by Subject|2|||
42126362|NCT03685344|75936935|FG003|Overall Study|Withdrawal by Subject|0|||
42126363|NCT03685344|75936932|FG000|Overall Study|Physician Decision|1|||
42126364|NCT03685344|75936933|FG001|Overall Study|Physician Decision|1|||
42126365|NCT03685344|75936934|FG002|Overall Study|Physician Decision|5|||
42126366|NCT03685344|75936935|FG003|Overall Study|Physician Decision|0|||
42126367|NCT03685344|75936932|FG000|Overall Study|Death|1|||
42126368|NCT03685344|75936933|FG001|Overall Study|Death|1|||
42126369|NCT03685344|75936934|FG002|Overall Study|Death|0|||
42126370|NCT03685344|75936935|FG003|Overall Study|Death|0|||
42126371|NCT00520572|75936951|FG000|Overall Study|Adverse Event|9|||
42126372|NCT00520572|75936952|FG001|Overall Study|Adverse Event|3|||
42126373|NCT00520572|75936953|FG002|Overall Study|Adverse Event|6|||
42126374|NCT00520572|75936954|FG003|Overall Study|Adverse Event|9|||
42126375|NCT00520572|75936955|FG004|Overall Study|Adverse Event|7|||
42126376|NCT00520572|75936956|FG005|Overall Study|Adverse Event|2|||
42126377|NCT00520572|75936951|FG000|Overall Study|Withdrawal by Subject|0|||
42126378|NCT00520572|75936952|FG001|Overall Study|Withdrawal by Subject|9|||
42126379|NCT00520572|75936953|FG002|Overall Study|Withdrawal by Subject|5|||
42126380|NCT00520572|75936954|FG003|Overall Study|Withdrawal by Subject|2|||
42126381|NCT00520572|75936955|FG004|Overall Study|Withdrawal by Subject|2|||
42126382|NCT00520572|75936956|FG005|Overall Study|Withdrawal by Subject|0|||
42126383|NCT00520572|75936951|FG000|Overall Study|Protocol Violation|0|||
42126384|NCT00520572|75936952|FG001|Overall Study|Protocol Violation|0|||
42126385|NCT00520572|75936953|FG002|Overall Study|Protocol Violation|1|||
42126386|NCT00520572|75936954|FG003|Overall Study|Protocol Violation|0|||
42126387|NCT00520572|75936955|FG004|Overall Study|Protocol Violation|0|||
42126388|NCT00520572|75936956|FG005|Overall Study|Protocol Violation|0|||
42126389|NCT00520572|75936951|FG000|Overall Study|Lack of Efficacy|1|||
42126390|NCT00520572|75936952|FG001|Overall Study|Lack of Efficacy|1|||
42126391|NCT00520572|75936953|FG002|Overall Study|Lack of Efficacy|1|||
42126392|NCT00520572|75936954|FG003|Overall Study|Lack of Efficacy|2|||
42126393|NCT00520572|75936955|FG004|Overall Study|Lack of Efficacy|1|||
42126394|NCT00520572|75936956|FG005|Overall Study|Lack of Efficacy|0|||
42126395|NCT00520572|75936951|FG000|Overall Study|Lost to Follow-up|0|||
42126396|NCT00520572|75936952|FG001|Overall Study|Lost to Follow-up|0|||
42126397|NCT00520572|75936953|FG002|Overall Study|Lost to Follow-up|0|||
42126398|NCT00520572|75936954|FG003|Overall Study|Lost to Follow-up|0|||
42126399|NCT00520572|75936955|FG004|Overall Study|Lost to Follow-up|1|||
41970363|NCT03624127|75771359|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
41970364|NCT03624127|75771360|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
41970365|NCT03624127|75771361|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
41970366|NCT03624127|75771359|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
41970367|NCT03624127|75771360|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
41970368|NCT03624127|75771361|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
41970369|NCT03624127|75771359|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
41970370|NCT03624127|75771360|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
41970371|NCT03624127|75771361|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
41970372|NCT03624127|75771359|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
41970373|NCT03624127|75771360|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
41970374|NCT03624127|75771361|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
41970375|NCT03624127|75771359|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
41970376|NCT03624127|75771360|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
41970377|NCT03624127|75771361|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
41970378|NCT03624127|75771359|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
42027966|NCT01139580|75836235|FG001|Overall Study|Lack of Efficacy|2|||
42027967|NCT01139580|75836234|FG000|Overall Study|Withdrawal by Subject|6|||
42027968|NCT01139580|75836235|FG001|Overall Study|Withdrawal by Subject|9|||
42126400|NCT00520572|75936956|FG005|Overall Study|Lost to Follow-up|0|||
42126401|NCT00520572|75936951|FG000|Overall Study|Incorrect enrollment|1|||
42126402|NCT00520572|75936952|FG001|Overall Study|Incorrect enrollment|0|||
42126403|NCT00520572|75936953|FG002|Overall Study|Incorrect enrollment|1|||
42126404|NCT00520572|75936954|FG003|Overall Study|Incorrect enrollment|0|||
42126405|NCT00520572|75936955|FG004|Overall Study|Incorrect enrollment|1|||
41970379|NCT03624127|75771360|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
42126406|NCT00520572|75936956|FG005|Overall Study|Incorrect enrollment|0|||
42301617|NCT02288325|76136767|FG001|Run-in Period|Lost to Follow-up|0|||
41970380|NCT03624127|75771361|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
41970381|NCT03624127|75771359|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
41970382|NCT03624127|75771360|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
41970383|NCT03624127|75771361|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
41970384|NCT03616912|75771379|FG000|Overall Study|Adverse Event|17|||
41970385|NCT03616912|75771380|FG001|Overall Study|Adverse Event|21|||
41970386|NCT03616912|75771381|FG002|Overall Study|Adverse Event|9|||
41970387|NCT03616912|75771382|FG003|Overall Study|Adverse Event|0|||
41970388|NCT03616912|75771383|FG004|Overall Study|Adverse Event|0|||
41970389|NCT03616912|75771384|FG005|Overall Study|Adverse Event|0|||
41970390|NCT03616912|75771379|FG000|Overall Study|Death|1|||
41970391|NCT03616912|75771380|FG001|Overall Study|Death|1|||
41970392|NCT03616912|75771381|FG002|Overall Study|Death|0|||
41970393|NCT03616912|75771382|FG003|Overall Study|Death|0|||
41970394|NCT03616912|75771383|FG004|Overall Study|Death|0|||
41970395|NCT03616912|75771384|FG005|Overall Study|Death|0|||
41970396|NCT03616912|75771379|FG000|Overall Study|Lack of Efficacy|13|||
41970397|NCT03616912|75771380|FG001|Overall Study|Lack of Efficacy|6|||
41970398|NCT03616912|75771381|FG002|Overall Study|Lack of Efficacy|8|||
41970399|NCT03616912|75771382|FG003|Overall Study|Lack of Efficacy|4|||
41970400|NCT03616912|75771383|FG004|Overall Study|Lack of Efficacy|5|||
41970401|NCT03616912|75771384|FG005|Overall Study|Lack of Efficacy|1|||
41970402|NCT03616912|75771379|FG000|Overall Study|Lost to Follow-up|1|||
41970403|NCT03616912|75771380|FG001|Overall Study|Lost to Follow-up|2|||
41970404|NCT03616912|75771381|FG002|Overall Study|Lost to Follow-up|3|||
41970405|NCT03616912|75771382|FG003|Overall Study|Lost to Follow-up|0|||
41970406|NCT03616912|75771383|FG004|Overall Study|Lost to Follow-up|0|||
41970407|NCT03616912|75771384|FG005|Overall Study|Lost to Follow-up|0|||
41970408|NCT03616912|75771379|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
41970409|NCT03616912|75771380|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
41970410|NCT03616912|75771381|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
41970411|NCT03616912|75771382|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
41970412|NCT03616912|75771383|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
41970413|NCT03616912|75771384|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
41970414|NCT03616912|75771379|FG000|Overall Study|Withdrawal by Subject|12|||
41970415|NCT03616912|75771380|FG001|Overall Study|Withdrawal by Subject|12|||
41970416|NCT03616912|75771381|FG002|Overall Study|Withdrawal by Subject|15|||
41970417|NCT03616912|75771382|FG003|Overall Study|Withdrawal by Subject|2|||
41970418|NCT03616912|75771383|FG004|Overall Study|Withdrawal by Subject|0|||
41970419|NCT03616912|75771384|FG005|Overall Study|Withdrawal by Subject|2|||
41970420|NCT03616912|75771379|FG000|Overall Study|Study Terminated by Sponsor|0|||
41970421|NCT03616912|75771380|FG001|Overall Study|Study Terminated by Sponsor|0|||
41970422|NCT03616912|75771381|FG002|Overall Study|Study Terminated by Sponsor|0|||
41970423|NCT03616912|75771382|FG003|Overall Study|Study Terminated by Sponsor|10|||
41970424|NCT03616912|75771383|FG004|Overall Study|Study Terminated by Sponsor|9|||
41970425|NCT03616912|75771384|FG005|Overall Study|Study Terminated by Sponsor|11|||
41970426|NCT03616912|75771379|FG000|Overall Study|Protocol Deviation|1|||
41970427|NCT03616912|75771380|FG001|Overall Study|Protocol Deviation|1|||
41970428|NCT03616912|75771381|FG002|Overall Study|Protocol Deviation|0|||
41970429|NCT03616912|75771382|FG003|Overall Study|Protocol Deviation|0|||
41970430|NCT03616912|75771383|FG004|Overall Study|Protocol Deviation|0|||
41970431|NCT03616912|75771384|FG005|Overall Study|Protocol Deviation|0|||
41970432|NCT03616912|75771379|FG000|Overall Study|Pregnancy|1|||
41970433|NCT03616912|75771380|FG001|Overall Study|Pregnancy|0|||
41970434|NCT03616912|75771381|FG002|Overall Study|Pregnancy|4|||
41970435|NCT03616912|75771382|FG003|Overall Study|Pregnancy|0|||
41970436|NCT03616912|75771383|FG004|Overall Study|Pregnancy|0|||
41970437|NCT03616912|75771384|FG005|Overall Study|Pregnancy|0|||
41970438|NCT03616912|75771379|FG000|Overall Study|Protocol Violation|1|||
41970439|NCT03616912|75771380|FG001|Overall Study|Protocol Violation|0|||
41970440|NCT03616912|75771381|FG002|Overall Study|Protocol Violation|2|||
41970441|NCT03616912|75771382|FG003|Overall Study|Protocol Violation|0|||
41970442|NCT03616912|75771383|FG004|Overall Study|Protocol Violation|0|||
41970443|NCT03616912|75771384|FG005|Overall Study|Protocol Violation|0|||
41970444|NCT03616912|75771379|FG000|Overall Study|Physician Decision|2|||
41970445|NCT03616912|75771380|FG001|Overall Study|Physician Decision|0|||
41970446|NCT03616912|75771381|FG002|Overall Study|Physician Decision|0|||
41970447|NCT03616912|75771382|FG003|Overall Study|Physician Decision|0|||
41970448|NCT03616912|75771383|FG004|Overall Study|Physician Decision|1|||
41970449|NCT03616912|75771384|FG005|Overall Study|Physician Decision|0|||
41970450|NCT03616912|75771379|FG000|Overall Study|Randomized But Never Treated|0|||
41970451|NCT03616912|75771380|FG001|Overall Study|Randomized But Never Treated|2|||
41970452|NCT03616912|75771381|FG002|Overall Study|Randomized But Never Treated|0|||
41970453|NCT03616912|75771382|FG003|Overall Study|Randomized But Never Treated|0|||
41970454|NCT03616912|75771383|FG004|Overall Study|Randomized But Never Treated|0|||
41970455|NCT03616912|75771384|FG005|Overall Study|Randomized But Never Treated|0|||
41970456|NCT03499899|75771401|FG000|Overall Study|Adverse Event|2|||
41970457|NCT03499899|75771402|FG001|Overall Study|Adverse Event|3|||
41970458|NCT03499899|75771403|FG002|Overall Study|Adverse Event|3|||
41970459|NCT03499899|75771401|FG000|Overall Study|Death|0|||
41970460|NCT03499899|75771402|FG001|Overall Study|Death|0|||
41970461|NCT03499899|75771403|FG002|Overall Study|Death|1|||
42301618|NCT02288325|76136768|FG002|Run-in Period|Lost to Follow-up|0|||
42301619|NCT02288325|76136766|FG000|Run-in Period|Protocol Violation|17|||
41970462|NCT03499899|75771401|FG000|Overall Study|Physician Decision|3|||
41970463|NCT03499899|75771402|FG001|Overall Study|Physician Decision|6|||
41970464|NCT03499899|75771403|FG002|Overall Study|Physician Decision|6|||
41970465|NCT03499899|75771401|FG000|Overall Study|Progressive disease|15|||
41970466|NCT03499899|75771402|FG001|Overall Study|Progressive disease|23|||
41970467|NCT03499899|75771403|FG002|Overall Study|Progressive disease|23|||
41970468|NCT03499899|75771401|FG000|Overall Study|Patient decision|0|||
41970469|NCT03499899|75771402|FG001|Overall Study|Patient decision|1|||
41970470|NCT03499899|75771403|FG002|Overall Study|Patient decision|1|||
41970471|NCT03499899|75771401|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
41970472|NCT03499899|75771402|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
41970473|NCT03499899|75771403|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
41970474|NCT03481634|75771419|FG000|Overall Study|Withdrawal by Subject|16|||
41970475|NCT03481634|75771420|FG001|Overall Study|Withdrawal by Subject|19|||
41970476|NCT03481634|75771421|FG002|Overall Study|Withdrawal by Subject|14|||
41970477|NCT03481634|75771419|FG000|Overall Study|Protocol Violation|1|||
41970478|NCT03481634|75771420|FG001|Overall Study|Protocol Violation|0|||
41970479|NCT03481634|75771421|FG002|Overall Study|Protocol Violation|1|||
41970480|NCT03481634|75771419|FG000|Overall Study|Progressive disease|0|||
41970481|NCT03481634|75771420|FG001|Overall Study|Progressive disease|1|||
41970482|NCT03481634|75771421|FG002|Overall Study|Progressive disease|0|||
41970483|NCT03481634|75771419|FG000|Overall Study|Physician Decision|3|||
41970484|NCT03481634|75771420|FG001|Overall Study|Physician Decision|0|||
41970485|NCT03481634|75771421|FG002|Overall Study|Physician Decision|1|||
41970486|NCT03481634|75771419|FG000|Overall Study|Lost to Follow-up|3|||
41970487|NCT03481634|75771420|FG001|Overall Study|Lost to Follow-up|4|||
41970488|NCT03481634|75771421|FG002|Overall Study|Lost to Follow-up|4|||
41970489|NCT03481634|75771419|FG000|Overall Study|Death|4|||
41970490|NCT03481634|75771420|FG001|Overall Study|Death|8|||
41970491|NCT03481634|75771421|FG002|Overall Study|Death|7|||
41970492|NCT03481634|75771419|FG000|Overall Study|Adverse Event|6|||
41970493|NCT03481634|75771420|FG001|Overall Study|Adverse Event|3|||
41970494|NCT03481634|75771421|FG002|Overall Study|Adverse Event|7|||
41970495|NCT03373461|75771435|FG000|Part 2|Adverse Event|0|||
41970496|NCT03373461|75771436|FG001|Part 2|Adverse Event|1|||
41970497|NCT03373461|75771437|FG002|Part 2|Adverse Event|0|||
41970498|NCT03373461|75771438|FG003|Part 2|Adverse Event|0|||
41970499|NCT03373461|75771439|FG004|Part 2|Adverse Event|1|||
41970500|NCT03364751|75771490|FG000|Overall Study|Withdrawal by Subject|1|||
41970501|NCT03364751|75771491|FG001|Overall Study|Withdrawal by Subject|0|||
41970502|NCT03364751|75771492|FG002|Overall Study|Withdrawal by Subject|0|||
41970503|NCT03364751|75771493|FG003|Overall Study|Withdrawal by Subject|0|||
41970504|NCT03364751|75771490|FG000|Overall Study|Lost to Follow-up|0|||
41970505|NCT03364751|75771491|FG001|Overall Study|Lost to Follow-up|1|||
41970506|NCT03364751|75771492|FG002|Overall Study|Lost to Follow-up|0|||
41970507|NCT03364751|75771493|FG003|Overall Study|Lost to Follow-up|0|||
41970508|NCT02990806|75771513|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
41970509|NCT02990806|75771514|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
41970510|NCT02990806|75771515|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
41970511|NCT02990806|75771516|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
41970512|NCT02990806|75771513|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
41970513|NCT02990806|75771514|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
41970514|NCT02990806|75771515|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
41970515|NCT02990806|75771516|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
42301620|NCT02288325|76136767|FG001|Run-in Period|Protocol Violation|0|||
42301621|NCT02288325|76136768|FG002|Run-in Period|Protocol Violation|0|||
42301622|NCT02288325|76136766|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
42301623|NCT02288325|76136767|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
42301624|NCT02288325|76136768|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
42301625|NCT02288325|76136766|FG000|Run-in Period|Reason not Specified|8|||
42301626|NCT02288325|76136767|FG001|Run-in Period|Reason not Specified|0|||
42301627|NCT02288325|76136768|FG002|Run-in Period|Reason not Specified|0|||
42301628|NCT02288325|76136766|FG000|Stabilization Period|Adverse Event|13|||
42301629|NCT02288325|76136767|FG001|Stabilization Period|Adverse Event|0|||
42301630|NCT02288325|76136768|FG002|Stabilization Period|Adverse Event|0|||
41970516|NCT02990806|75771513|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
41970517|NCT02990806|75771514|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
41970518|NCT02990806|75771515|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
41970519|NCT02990806|75771516|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
41970520|NCT02990806|75771513|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
41970521|NCT02990806|75771514|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
41970522|NCT02990806|75771515|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
41970523|NCT02990806|75771516|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
41970524|NCT02990806|75771513|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
41970525|NCT02990806|75771514|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
41970526|NCT02990806|75771515|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
41970527|NCT02990806|75771516|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
41970528|NCT02990806|75771513|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
41970529|NCT02990806|75771514|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
41970530|NCT02990806|75771515|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
41970531|NCT02990806|75771516|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
41970532|NCT02990806|75771513|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
41970533|NCT02990806|75771514|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
41970534|NCT02990806|75771515|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
41970535|NCT02990806|75771516|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
41970536|NCT02990806|75771513|FG000|Stage 1 (22 Weeks)|Death|0|||
41970537|NCT02990806|75771514|FG001|Stage 1 (22 Weeks)|Death|1|||
41970538|NCT02990806|75771515|FG002|Stage 1 (22 Weeks)|Death|0|||
41970539|NCT02990806|75771516|FG003|Stage 1 (22 Weeks)|Death|0|||
41970540|NCT02990806|75771513|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
41970541|NCT02990806|75771514|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
41970542|NCT02990806|75771515|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
41970543|NCT02990806|75771516|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
41970544|NCT02990806|75771513|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
41970545|NCT02990806|75771514|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
41970546|NCT02990806|75771515|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
41970547|NCT02990806|75771516|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
41970548|NCT02990806|75771513|FG000|Stage 1 (22 Weeks)|Other|1|||
41970549|NCT02990806|75771514|FG001|Stage 1 (22 Weeks)|Other|3|||
41970550|NCT02990806|75771515|FG002|Stage 1 (22 Weeks)|Other|0|||
41970551|NCT02990806|75771516|FG003|Stage 1 (22 Weeks)|Other|0|||
41970552|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
41970553|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
41970554|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
41970555|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
41970556|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Death|1|||
41970557|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Death|0|||
41970558|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Death|0|||
41970559|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Death|0|||
41970560|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
41970561|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
41970562|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
41970563|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
41970564|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
41970565|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
41970566|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
41970567|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
41970568|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
41970569|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
41970570|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
41970571|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
41970572|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
41970573|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
41970574|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
41970575|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
41970576|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
41970577|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
41970578|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
41970579|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
41970580|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
41970581|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
41970582|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
41970583|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
41970584|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
41970585|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
41970586|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
41970587|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
42126407|NCT00520572|75936951|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
42126408|NCT00520572|75936952|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
41970588|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
41970589|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
41970590|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
41970591|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
41970592|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
41970593|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
41970594|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
41970595|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
41970596|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Other|3|||
41970597|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Other|0|||
41970598|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Other|4|||
41970599|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Other|1|||
42027969|NCT01139580|75836234|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
42027970|NCT01139580|75836235|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
42027971|NCT01139580|75836234|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
42027972|NCT01139580|75836235|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
42027973|NCT01139580|75836234|FG000|Overall Study|Misrandomized|1|||
42027974|NCT01139580|75836235|FG001|Overall Study|Misrandomized|0|||
42027975|NCT01139580|75836234|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
42027976|NCT01139580|75836235|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
42027977|NCT01139580|75836234|FG000|Overall Study|Participant Randomization in Error|0|||
42027978|NCT01139580|75836235|FG001|Overall Study|Participant Randomization in Error|1|||
41970600|NCT02990806|75771513|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
41970601|NCT02990806|75771514|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
41970602|NCT02990806|75771515|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
41970603|NCT02990806|75771516|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
41970604|NCT02990806|75771513|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
41970605|NCT02990806|75771514|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
41970606|NCT02990806|75771515|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
41970607|NCT02990806|75771516|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
41970608|NCT02990806|75771513|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
41970609|NCT02990806|75771514|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
41970610|NCT02990806|75771515|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
41970611|NCT02990806|75771516|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
41970612|NCT02990806|75771513|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
41970613|NCT02990806|75771514|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
41970614|NCT02990806|75771515|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
41970615|NCT02990806|75771516|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
41970616|NCT02990806|75771513|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
41970617|NCT02990806|75771514|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
41970618|NCT02990806|75771515|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
41970619|NCT02990806|75771516|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
41970620|NCT02990806|75771513|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
41970621|NCT02990806|75771514|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
41970622|NCT02990806|75771515|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
41970623|NCT02990806|75771516|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
41970624|NCT02990806|75771513|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
41970625|NCT02990806|75771514|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
41970626|NCT02990806|75771515|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
41970627|NCT02990806|75771516|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
41970628|NCT02990806|75771513|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
41970629|NCT02990806|75771514|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
41970630|NCT02990806|75771515|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
41970631|NCT02990806|75771516|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
42126409|NCT00520572|75936953|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
42301631|NCT02288325|76136766|FG000|Stabilization Period|Lack of Efficacy|22|||
41970632|NCT02990806|75771513|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
41970633|NCT02990806|75771514|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
41970634|NCT02990806|75771515|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
41970635|NCT02990806|75771516|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
41970636|NCT02420821|75771587|FG000|Overall Study|Lost to Follow-up|6|||
41970637|NCT02420821|75771588|FG001|Overall Study|Lost to Follow-up|6|||
41970638|NCT02420821|75771587|FG000|Overall Study|Non-compliance|0|||
41970639|NCT02420821|75771588|FG001|Overall Study|Non-compliance|2|||
41970640|NCT02420821|75771587|FG000|Overall Study|Physician Decision|6|||
41970641|NCT02420821|75771588|FG001|Overall Study|Physician Decision|2|||
41970642|NCT02420821|75771587|FG000|Overall Study|Withdrawal by Subject|32|||
41970643|NCT02420821|75771588|FG001|Overall Study|Withdrawal by Subject|25|||
41970644|NCT02420821|75771587|FG000|Overall Study|Death|270|||
41970645|NCT02420821|75771588|FG001|Overall Study|Death|263|||
41970646|NCT02420821|75771587|FG000|Overall Study|Study Terminated By Sponsor|145|||
41970647|NCT02420821|75771588|FG001|Overall Study|Study Terminated By Sponsor|149|||
41970648|NCT02420821|75771587|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
41970649|NCT02420821|75771588|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
41970650|NCT02420821|75771587|FG000|Overall Study|Adverse Event|0|||
41970651|NCT02420821|75771588|FG001|Overall Study|Adverse Event|1|||
41970652|NCT02420821|75771587|FG000|Overall Study|Protinuria|0|||
41970653|NCT02420821|75771588|FG001|Overall Study|Protinuria|1|||
41970654|NCT02420821|75771587|FG000|Overall Study|Progressive Disease|1|||
41970655|NCT02420821|75771588|FG001|Overall Study|Progressive Disease|1|||
41970656|NCT02420821|75771587|FG000|Overall Study|Disease Progression|0|||
41970657|NCT02420821|75771588|FG001|Overall Study|Disease Progression|1|||
41970658|NCT02420821|75771587|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
41970659|NCT02420821|75771588|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
41970660|NCT02039063|75771619|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
41970661|NCT02039063|75771620|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
41970662|NCT02039063|75771621|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
41970663|NCT02039063|75771622|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
41970664|NCT02039063|75771619|FG000|Treatment Phase|Progression of disease|0|||
41970665|NCT02039063|75771620|FG001|Treatment Phase|Progression of disease|0|||
41970666|NCT02039063|75771621|FG002|Treatment Phase|Progression of disease|1|||
41970667|NCT02039063|75771622|FG003|Treatment Phase|Progression of disease|1|||
41970668|NCT02039063|75771619|FG000|Extension Phase|Inadequate therapeutic effect|0|||
41970669|NCT02039063|75771620|FG001|Extension Phase|Inadequate therapeutic effect|1|||
41970670|NCT02039063|75771621|FG002|Extension Phase|Inadequate therapeutic effect|2|||
41970671|NCT02039063|75771622|FG003|Extension Phase|Inadequate therapeutic effect|0|||
41970672|NCT02039063|75771619|FG000|Extension Phase|Progression of disease|0|||
41970673|NCT02039063|75771620|FG001|Extension Phase|Progression of disease|0|||
41970674|NCT02039063|75771621|FG002|Extension Phase|Progression of disease|0|||
41970675|NCT02039063|75771622|FG003|Extension Phase|Progression of disease|1|||
41970676|NCT02039063|75771619|FG000|Extension Phase|Adverse Event|0|||
41970677|NCT02039063|75771620|FG001|Extension Phase|Adverse Event|0|||
41970678|NCT02039063|75771621|FG002|Extension Phase|Adverse Event|1|||
41970679|NCT02039063|75771622|FG003|Extension Phase|Adverse Event|0|||
41970680|NCT01746173|75771639|FG000|Overall Study|Disease Progression|2|||
41970681|NCT02995733|75771679|FG000|Overall Study|Study site closed|9|||
41970682|NCT02995733|75771680|FG001|Overall Study|Study site closed|10|||
41970683|NCT02995733|75771679|FG000|Overall Study|Death|3|||
41970684|NCT02995733|75771680|FG001|Overall Study|Death|4|||
41970685|NCT02995733|75771679|FG000|Overall Study|Withdrawal by Subject|6|||
41970686|NCT02995733|75771680|FG001|Overall Study|Withdrawal by Subject|2|||
41970687|NCT02995733|75771679|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
41970688|NCT02995733|75771680|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
41970689|NCT02995733|75771679|FG000|Overall Study|Lost to Follow-up|48|||
41970690|NCT02995733|75771680|FG001|Overall Study|Lost to Follow-up|37|||
41970691|NCT02995733|75771679|FG000|Overall Study|Other|0|||
41970692|NCT02995733|75771680|FG001|Overall Study|Other|1|||
41970693|NCT02815566|75771697|FG000|Overall Study|Adverse Event|1|||
41970694|NCT02815566|75771698|FG001|Overall Study|Adverse Event|1|||
41970695|NCT02815566|75771697|FG000|Overall Study|Withdrawal by Subject|1|||
41970696|NCT02815566|75771698|FG001|Overall Study|Withdrawal by Subject|0|||
41970697|NCT02815566|75771697|FG000|Overall Study|Lost to Follow-up|0|||
41970698|NCT02815566|75771698|FG001|Overall Study|Lost to Follow-up|1|||
41970699|NCT02525783|75771705|FG000|Overall Study|Lost to Follow-up|10|||
41970700|NCT02466243|75771721|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
41970701|NCT02466243|75771722|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
41970702|NCT02466243|75771721|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
41970703|NCT02466243|75771722|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
41970704|NCT02466243|75771721|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
41970705|NCT02466243|75771722|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
41970706|NCT02466243|75771721|FG000|Part B Open-label Treatment Period|Missing|2|||
41970707|NCT02466243|75771722|FG001|Part B Open-label Treatment Period|Missing|2|||
41970708|NCT02321098|75771735|FG000|12 Weeks Treament|Lost to Follow-up|1|||
41970709|NCT02321098|75771736|FG001|12 Weeks Treament|Lost to Follow-up|1|||
41970710|NCT02321098|75771737|FG002|12 Weeks Treament|Lost to Follow-up|0|||
41970711|NCT02321098|75771735|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
41970712|NCT02321098|75771736|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
41970713|NCT02321098|75771737|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
41970714|NCT02321098|75771735|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
41970715|NCT02321098|75771736|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
41970716|NCT02321098|75771737|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
41970717|NCT02321098|75771735|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
41970718|NCT02321098|75771736|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
41970719|NCT02321098|75771737|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
41970720|NCT01627561|75771759|FG000|Overall Study|Lost to Follow-up|1|||
41970721|NCT01627561|75771760|FG001|Overall Study|Lost to Follow-up|0|||
41970722|NCT01627561|75771759|FG000|Overall Study|Withdrawal by Subject|0|||
41970723|NCT01627561|75771760|FG001|Overall Study|Withdrawal by Subject|1|||
41970724|NCT01627561|75771759|FG000|Overall Study|Migrated/moved from study area|0|||
41970725|NCT01627561|75771760|FG001|Overall Study|Migrated/moved from study area|2|||
41970726|NCT01652534|75771794|FG000|Overall Study|Lack of Efficacy|1|||
41970727|NCT01652534|75771795|FG001|Overall Study|Lack of Efficacy|0|||
41970728|NCT04709575|75771803|FG000|Overall Study|Withdrawal by Subject|6|||
41970729|NCT04709575|75771804|FG001|Overall Study|Withdrawal by Subject|2|||
41970730|NCT04709575|75771803|FG000|Overall Study|Lost to Follow-up|2|||
41970731|NCT04709575|75771804|FG001|Overall Study|Lost to Follow-up|2|||
41970732|NCT04709575|75771803|FG000|Overall Study|Adverse Event|1|||
41970733|NCT04709575|75771804|FG001|Overall Study|Adverse Event|0|||
41970734|NCT04709575|75771803|FG000|Overall Study|Protocol Violation|1|||
42301632|NCT02288325|76136767|FG001|Stabilization Period|Lack of Efficacy|0|||
42301633|NCT02288325|76136768|FG002|Stabilization Period|Lack of Efficacy|0|||
42301634|NCT02288325|76136766|FG000|Stabilization Period|Withdrawal of Consent|23|||
42301635|NCT02288325|76136767|FG001|Stabilization Period|Withdrawal of Consent|0|||
42301636|NCT02288325|76136768|FG002|Stabilization Period|Withdrawal of Consent|0|||
42301637|NCT02288325|76136766|FG000|Stabilization Period|Lost to Follow-up|12|||
42301638|NCT02288325|76136767|FG001|Stabilization Period|Lost to Follow-up|0|||
42301639|NCT02288325|76136768|FG002|Stabilization Period|Lost to Follow-up|0|||
42301640|NCT02288325|76136766|FG000|Stabilization Period|Protocol Violation|8|||
41970735|NCT04709575|75771804|FG001|Overall Study|Protocol Violation|1|||
41970736|NCT04450407|75771813|FG000|Overall Study|Withdrawal by Subject|10|||
41970737|NCT04450407|75771814|FG001|Overall Study|Withdrawal by Subject|1|||
41970738|NCT04450407|75771815|FG002|Overall Study|Withdrawal by Subject|4|||
41970739|NCT04450407|75771813|FG000|Overall Study|Adverse Event|0|||
41970740|NCT04450407|75771814|FG001|Overall Study|Adverse Event|0|||
41970741|NCT04450407|75771815|FG002|Overall Study|Adverse Event|1|||
41970742|NCT04450407|75771813|FG000|Overall Study|Lost to Follow-up|1|||
41970743|NCT04450407|75771814|FG001|Overall Study|Lost to Follow-up|0|||
41970744|NCT04450407|75771815|FG002|Overall Study|Lost to Follow-up|0|||
41970745|NCT04450407|75771813|FG000|Overall Study|Physician Decision|0|||
41970746|NCT04450407|75771814|FG001|Overall Study|Physician Decision|0|||
41970747|NCT04450407|75771815|FG002|Overall Study|Physician Decision|1|||
41970748|NCT04450407|75771813|FG000|Overall Study|Pregnancy|1|||
41970749|NCT04450407|75771814|FG001|Overall Study|Pregnancy|0|||
41970750|NCT04450407|75771815|FG002|Overall Study|Pregnancy|0|||
41970751|NCT04450407|75771813|FG000|Overall Study|Protocol Violation|2|||
41970752|NCT04450407|75771814|FG001|Overall Study|Protocol Violation|0|||
41970753|NCT04450407|75771815|FG002|Overall Study|Protocol Violation|0|||
41970754|NCT04450407|75771813|FG000|Overall Study|Investigational site terminated by sponsor|3|||
41970755|NCT04450407|75771814|FG001|Overall Study|Investigational site terminated by sponsor|0|||
41970756|NCT04450407|75771815|FG002|Overall Study|Investigational site terminated by sponsor|2|||
41970757|NCT04388826|75771824|FG000|Overall Study|Lost to Follow-up|3|||
42301641|NCT02288325|76136767|FG001|Stabilization Period|Protocol Violation|0|||
41970758|NCT04388826|75771825|FG001|Overall Study|Lost to Follow-up|2|||
41970759|NCT04388826|75771824|FG000|Overall Study|Adverse Event|1|||
41970760|NCT04388826|75771825|FG001|Overall Study|Adverse Event|0|||
41970761|NCT04218266|75771847|FG000|Overall Study|Death|1|||
41970762|NCT04218266|75771848|FG001|Overall Study|Death|2|||
41970763|NCT04218266|75771849|FG002|Overall Study|Death|3|||
41970764|NCT04218266|75771847|FG000|Overall Study|Adverse Event|13|||
41970765|NCT04218266|75771848|FG001|Overall Study|Adverse Event|14|||
41970766|NCT04218266|75771849|FG002|Overall Study|Adverse Event|11|||
41970767|NCT04218266|75771847|FG000|Overall Study|Other|7|||
41970768|NCT04218266|75771848|FG001|Overall Study|Other|5|||
41970769|NCT04218266|75771849|FG002|Overall Study|Other|14|||
41970770|NCT04218266|75771847|FG000|Overall Study|Physician Decision|1|||
41970771|NCT04218266|75771848|FG001|Overall Study|Physician Decision|3|||
41970772|NCT04218266|75771849|FG002|Overall Study|Physician Decision|2|||
41970773|NCT04218266|75771847|FG000|Overall Study|Non-compliance with study drug|0|||
41970774|NCT04218266|75771848|FG001|Overall Study|Non-compliance with study drug|0|||
41970775|NCT04218266|75771849|FG002|Overall Study|Non-compliance with study drug|1|||
41970776|NCT04218266|75771847|FG000|Overall Study|Withdrawal by Subject|1|||
41970777|NCT04218266|75771848|FG001|Overall Study|Withdrawal by Subject|3|||
41970778|NCT04218266|75771849|FG002|Overall Study|Withdrawal by Subject|1|||
41970779|NCT04218266|75771847|FG000|Overall Study|Study drug never administered|2|||
41970780|NCT04218266|75771848|FG001|Overall Study|Study drug never administered|0|||
41970781|NCT04218266|75771849|FG002|Overall Study|Study drug never administered|0|||
41970782|NCT03894904|75771871|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
42126410|NCT00520572|75936954|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
42126411|NCT00520572|75936955|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
42301642|NCT02288325|76136768|FG002|Stabilization Period|Protocol Violation|0|||
41970783|NCT03894904|75771872|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
41970784|NCT03894904|75771871|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
41970785|NCT03894904|75771872|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
41970786|NCT03099265|75771892|FG000|Overall Study|Adverse Event|1|||
41970787|NCT02658656|75771910|FG000|Screening|Failed eligibility criteria|0|||
41970788|NCT02658656|75771911|FG001|Screening|Failed eligibility criteria|0|||
41970789|NCT02658656|75771912|FG002|Screening|Failed eligibility criteria|263|||
41970790|NCT02658656|75771910|FG000|Randomization|Withdrawal by Subject|8|||
41970791|NCT02658656|75771911|FG001|Randomization|Withdrawal by Subject|7|||
41970792|NCT02658656|75771912|FG002|Randomization|Withdrawal by Subject|0|||
41970793|NCT02658656|75771910|FG000|Randomization|Lost to Follow-up|1|||
41970794|NCT02658656|75771911|FG001|Randomization|Lost to Follow-up|3|||
41970795|NCT02658656|75771912|FG002|Randomization|Lost to Follow-up|0|||
41970796|NCT02658656|75771910|FG000|Randomization|Adverse Event|4|||
41970797|NCT02658656|75771911|FG001|Randomization|Adverse Event|0|||
41970798|NCT02658656|75771912|FG002|Randomization|Adverse Event|0|||
41970799|NCT02658656|75771910|FG000|Randomization|Administrative Termination|3|||
41970800|NCT02658656|75771911|FG001|Randomization|Administrative Termination|1|||
41970801|NCT02658656|75771912|FG002|Randomization|Administrative Termination|0|||
41970802|NCT02658656|75771910|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
41970803|NCT02658656|75771911|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
41970804|NCT02658656|75771912|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
41970805|NCT02658656|75771910|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
41970806|NCT02658656|75771911|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
41970807|NCT02658656|75771912|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
41970808|NCT02658656|75771910|FG000|Randomization|Not eligible for Randomization|1|||
41970809|NCT02658656|75771911|FG001|Randomization|Not eligible for Randomization|0|||
41970810|NCT02658656|75771912|FG002|Randomization|Not eligible for Randomization|0|||
41970811|NCT02658656|75771910|FG000|Randomization|Protocol Violation|1|||
41970812|NCT02658656|75771911|FG001|Randomization|Protocol Violation|0|||
41970813|NCT02658656|75771912|FG002|Randomization|Protocol Violation|0|||
41970814|NCT05141175|75771970|FG000|Overall Study|Withdrawal by Subject|1|||
42126412|NCT00520572|75936956|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
42126413|NCT00520572|75936951|FG000|Overall Study|Long break in taking Medication|0|||
42126414|NCT00520572|75936952|FG001|Overall Study|Long break in taking Medication|0|||
42126415|NCT00520572|75936953|FG002|Overall Study|Long break in taking Medication|0|||
42126416|NCT00520572|75936954|FG003|Overall Study|Long break in taking Medication|1|||
42126417|NCT00520572|75936955|FG004|Overall Study|Long break in taking Medication|0|||
42126418|NCT00520572|75936956|FG005|Overall Study|Long break in taking Medication|0|||
42126419|NCT00520572|75936951|FG000|Overall Study|Did not receive Treatment|1|||
42126420|NCT00520572|75936952|FG001|Overall Study|Did not receive Treatment|0|||
42126421|NCT00520572|75936953|FG002|Overall Study|Did not receive Treatment|1|||
42126422|NCT00520572|75936954|FG003|Overall Study|Did not receive Treatment|0|||
42301643|NCT02288325|76136766|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
41970815|NCT04869345|75771976|FG000|Overall Study|Lost to Follow-up|8|||
41970816|NCT04869345|75771977|FG001|Overall Study|Lost to Follow-up|3|||
42126423|NCT00520572|75936955|FG004|Overall Study|Did not receive Treatment|0|||
42126424|NCT00520572|75936956|FG005|Overall Study|Did not receive Treatment|0|||
41970817|NCT03610737|75772049|FG000|Overall Study|Withdrawal by Subject|1|||
41970818|NCT03610737|75772050|FG001|Overall Study|Withdrawal by Subject|5|||
41970819|NCT03610737|75772049|FG000|Overall Study|Death|1|||
41970820|NCT03610737|75772050|FG001|Overall Study|Death|0|||
41970821|NCT03610737|75772049|FG000|Overall Study|Not treated|5|||
41970822|NCT03610737|75772050|FG001|Overall Study|Not treated|2|||
41970823|NCT03610737|75772049|FG000|Overall Study|Missed Visit|1|||
41970824|NCT03610737|75772050|FG001|Overall Study|Missed Visit|2|||
41970825|NCT03321929|75772056|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
41970826|NCT03250624|75772063|FG000|Overall Study|Lack of Efficacy|1|||
41970827|NCT03250624|75772064|FG001|Overall Study|Lack of Efficacy|4|||
41970828|NCT03250624|75772063|FG000|Overall Study|Adverse Event|0|||
41970829|NCT03250624|75772064|FG001|Overall Study|Adverse Event|1|||
41970830|NCT03250624|75772063|FG000|Overall Study|Other|1|||
41970831|NCT03250624|75772064|FG001|Overall Study|Other|2|||
41970832|NCT02507297|75772072|FG000|Overall Study|Withdrawal by Subject|1|||
41970833|NCT02507297|75772073|FG001|Overall Study|Withdrawal by Subject|0|||
41970834|NCT02507297|75772072|FG000|Overall Study|Lost to Follow-up|0|||
41970835|NCT02507297|75772073|FG001|Overall Study|Lost to Follow-up|1|||
41970836|NCT01333514|75772081|FG000|Overall Study|Withdrawal by Subject|1|||
41970837|NCT01333514|75772082|FG001|Overall Study|Withdrawal by Subject|0|||
41970838|NCT02066636|75772091|FG000|Overall Study|Disease progression|51|||
41970839|NCT02066636|75772092|FG001|Overall Study|Disease progression|60|||
41970840|NCT02066636|75772093|FG002|Overall Study|Disease progression|700|||
41970841|NCT02066636|75772091|FG000|Overall Study|Study drug toxicity|13|||
41970842|NCT02066636|75772092|FG001|Overall Study|Study drug toxicity|2|||
41970843|NCT02066636|75772093|FG002|Overall Study|Study drug toxicity|58|||
41970844|NCT02066636|75772091|FG000|Overall Study|Death|4|||
41970845|NCT02066636|75772092|FG001|Overall Study|Death|2|||
41970846|NCT02066636|75772093|FG002|Overall Study|Death|158|||
41970847|NCT02066636|75772091|FG000|Overall Study|Adverse event unrelated to study drug|6|||
41970848|NCT02066636|75772092|FG001|Overall Study|Adverse event unrelated to study drug|4|||
41970849|NCT02066636|75772093|FG002|Overall Study|Adverse event unrelated to study drug|45|||
41970850|NCT02066636|75772091|FG000|Overall Study|Participant request to discontinue treatment|12|||
41970851|NCT02066636|75772092|FG001|Overall Study|Participant request to discontinue treatment|12|||
41970852|NCT02066636|75772093|FG002|Overall Study|Participant request to discontinue treatment|70|||
41970853|NCT02066636|75772091|FG000|Overall Study|Participant withdrew consent|10|||
41970854|NCT02066636|75772092|FG001|Overall Study|Participant withdrew consent|18|||
41970855|NCT02066636|75772093|FG002|Overall Study|Participant withdrew consent|61|||
41970856|NCT02066636|75772091|FG000|Overall Study|Lost to Follow-up|0|||
41970857|NCT02066636|75772092|FG001|Overall Study|Lost to Follow-up|2|||
41970858|NCT02066636|75772093|FG002|Overall Study|Lost to Follow-up|2|||
41970859|NCT02066636|75772091|FG000|Overall Study|Maximum clinical benefit|2|||
41970860|NCT02066636|75772092|FG001|Overall Study|Maximum clinical benefit|2|||
41970861|NCT02066636|75772093|FG002|Overall Study|Maximum clinical benefit|3|||
42301644|NCT02288325|76136767|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
42301645|NCT02288325|76136768|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
42301646|NCT02288325|76136766|FG000|Stabilization Period|Reason not Specified|15|||
42301647|NCT02288325|76136767|FG001|Stabilization Period|Reason not Specified|0|||
42301648|NCT02288325|76136768|FG002|Stabilization Period|Reason not Specified|0|||
42301649|NCT02288325|76136766|FG000|Double-blind Treatment Period|Adverse Event|0|||
41970862|NCT02066636|75772091|FG000|Overall Study|Poor/non-compliance|2|||
41970863|NCT02066636|75772092|FG001|Overall Study|Poor/non-compliance|1|||
41970864|NCT02066636|75772093|FG002|Overall Study|Poor/non-compliance|1|||
42126425|NCT00573833|75936970|FG000|Overall Study|Not Treated|2|||
42126426|NCT00520494|75936974|FG000|Overall Study|Withdrawal by Subject|1|||
42126427|NCT00527514|75936978|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
42126428|NCT00527514|75936978|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
42126429|NCT00527514|75936978|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
42126430|NCT00527514|75936978|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
42126431|NCT00527514|75936978|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
42126432|NCT00527514|75936978|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
42126433|NCT00527514|75936978|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
42126434|NCT00618449|75936991|FG000|Overall Study|Lost to Follow-up|98|||
42301650|NCT02288325|76136767|FG001|Double-blind Treatment Period|Adverse Event|2|||
41970865|NCT02066636|75772091|FG000|Overall Study|Participant no loner meets study criteria|3|||
41970866|NCT02066636|75772092|FG001|Overall Study|Participant no loner meets study criteria|2|||
41970867|NCT02066636|75772093|FG002|Overall Study|Participant no loner meets study criteria|28|||
41970868|NCT02066636|75772091|FG000|Overall Study|Administrative reasons by sponsor|8|||
42126435|NCT00618449|75936992|FG001|Overall Study|Lost to Follow-up|110|||
41970869|NCT02066636|75772092|FG001|Overall Study|Administrative reasons by sponsor|5|||
41970870|NCT02066636|75772093|FG002|Overall Study|Administrative reasons by sponsor|0|||
41970871|NCT02066636|75772091|FG000|Overall Study|Other reasons|16|||
41970872|NCT02066636|75772092|FG001|Overall Study|Other reasons|15|||
41970873|NCT02066636|75772093|FG002|Overall Study|Other reasons|50|||
41970874|NCT01486264|75772105|FG000|Overall Study|Death|1|||
41970875|NCT01486264|75772106|FG001|Overall Study|Death|1|||
41970876|NCT01486264|75772105|FG000|Overall Study|Adverse Event|3|||
41970877|NCT01486264|75772106|FG001|Overall Study|Adverse Event|3|||
41970878|NCT01486264|75772105|FG000|Overall Study|Lack of Efficacy|6|||
41970879|NCT01486264|75772106|FG001|Overall Study|Lack of Efficacy|10|||
41970880|NCT01486264|75772105|FG000|Overall Study|Withdrawal by Subject|7|||
41970881|NCT01486264|75772106|FG001|Overall Study|Withdrawal by Subject|18|||
41970882|NCT01486264|75772105|FG000|Overall Study|Physician Decision|1|||
41970883|NCT01486264|75772106|FG001|Overall Study|Physician Decision|1|||
41970884|NCT01486264|75772105|FG000|Overall Study|Protocol Violation|3|||
41970885|NCT01486264|75772106|FG001|Overall Study|Protocol Violation|0|||
41970886|NCT01486264|75772105|FG000|Overall Study|Lost to Follow-up|3|||
41970887|NCT01486264|75772106|FG001|Overall Study|Lost to Follow-up|2|||
41970888|NCT01486264|75772105|FG000|Overall Study|Other|5|||
41970889|NCT01486264|75772106|FG001|Overall Study|Other|11|||
41970890|NCT01486264|75772105|FG000|Overall Study|Not treated|0|||
41970891|NCT01486264|75772106|FG001|Overall Study|Not treated|1|||
41970892|NCT01323270|75772114|FG000|Overall Study|Withdrawal by Subject|19|||
41970893|NCT01323270|75772115|FG001|Overall Study|Withdrawal by Subject|10|||
41970894|NCT01323270|75772114|FG000|Overall Study|Protocol Violation|9|||
41970895|NCT01323270|75772115|FG001|Overall Study|Protocol Violation|7|||
41970896|NCT01323270|75772114|FG000|Overall Study|Lost to Follow-up|4|||
41970897|NCT01323270|75772115|FG001|Overall Study|Lost to Follow-up|6|||
41970898|NCT01323270|75772114|FG000|Overall Study|Adverse Event|8|||
41970899|NCT01323270|75772115|FG001|Overall Study|Adverse Event|0|||
41970900|NCT01323270|75772114|FG000|Overall Study|Other|0|||
41970901|NCT01323270|75772115|FG001|Overall Study|Other|3|||
41970902|NCT01323270|75772114|FG000|Overall Study|Physician Decision|0|||
41970903|NCT01323270|75772115|FG001|Overall Study|Physician Decision|2|||
42126436|NCT03684642|75937001|FG000|Overall Study|Adverse Event|6|||
42126437|NCT03684642|75937002|FG001|Overall Study|Adverse Event|15|||
42126438|NCT03684642|75937003|FG002|Overall Study|Adverse Event|11|||
42126439|NCT03684642|75937001|FG000|Overall Study|Withdrawal by Subject|35|||
42126440|NCT03684642|75937002|FG001|Overall Study|Withdrawal by Subject|53|||
42126441|NCT03684642|75937003|FG002|Overall Study|Withdrawal by Subject|23|||
42126442|NCT03684642|75937001|FG000|Overall Study|Lack of Efficacy|0|||
42126443|NCT03684642|75937002|FG001|Overall Study|Lack of Efficacy|0|||
42126444|NCT03684642|75937003|FG002|Overall Study|Lack of Efficacy|1|||
42126445|NCT03684642|75937001|FG000|Overall Study|Poor compliance to protocol|0|||
42126446|NCT03684642|75937002|FG001|Overall Study|Poor compliance to protocol|4|||
42126447|NCT03684642|75937003|FG002|Overall Study|Poor compliance to protocol|1|||
42126448|NCT03684642|75937001|FG000|Overall Study|Other than specified|62|||
42126449|NCT03684642|75937002|FG001|Overall Study|Other than specified|60|||
42126450|NCT03684642|75937003|FG002|Overall Study|Other than specified|67|||
42126451|NCT03684642|75937001|FG000|Overall Study|Randomized and not treated|0|||
41970904|NCT01323270|75772114|FG000|Overall Study|Not eligible|1|||
41970905|NCT01323270|75772115|FG001|Overall Study|Not eligible|1|||
41970906|NCT01323270|75772114|FG000|Overall Study|Death|1|||
41970907|NCT01323270|75772115|FG001|Overall Study|Death|0|||
42027979|NCT00917644|75836241|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
42027980|NCT00917644|75836242|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
42027981|NCT00917644|75836241|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
42027982|NCT00917644|75836242|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
42027983|NCT00917644|75836241|FG000|Period 2: Second Intervention|family emergency|1|||
42027984|NCT00917644|75836242|FG001|Period 2: Second Intervention|family emergency|0|||
42027985|NCT01137786|75836250|FG000|Overall Study|Lost to Follow-up|0|||
42027986|NCT01137786|75836251|FG001|Overall Study|Lost to Follow-up|2|||
42126452|NCT03684642|75937002|FG001|Overall Study|Randomized and not treated|0|||
42027987|NCT01137786|75836250|FG000|Overall Study|Withdrawal by Subject|1|||
42126453|NCT03684642|75937003|FG002|Overall Study|Randomized and not treated|1|||
42027988|NCT01137786|75836251|FG001|Overall Study|Withdrawal by Subject|1|||
42027989|NCT00599755|75836259|FG000|Overall Study|Adverse Event|11|||
42027990|NCT00599755|75836259|FG000|Overall Study|Withdrawal by Subject|2|||
42126454|NCT03684642|75937001|FG000|Overall Study|Missing completion status but alive at last contact|0|||
41970908|NCT01323270|75772114|FG000|Overall Study|Randomized, but not vaccinated|1|||
41970909|NCT01323270|75772115|FG001|Overall Study|Randomized, but not vaccinated|0|||
41970910|NCT01300728|75772124|FG000|Overall Study|Withdrawal by Subject|1|||
41970911|NCT01300728|75772125|FG001|Overall Study|Withdrawal by Subject|1|||
41970912|NCT01300728|75772124|FG000|Overall Study|Physician Decision|1|||
42027991|NCT00599755|75836259|FG000|Overall Study|Progression of Disease|3|||
42126455|NCT03684642|75937002|FG001|Overall Study|Missing completion status but alive at last contact|1|||
41970913|NCT01300728|75772125|FG001|Overall Study|Physician Decision|0|||
41970914|NCT01299480|75772136|FG000|Overall Study|No longer willing to participate|19|||
41970915|NCT01299480|75772137|FG001|Overall Study|No longer willing to participate|17|||
41970916|NCT01299480|75772138|FG002|Overall Study|No longer willing to participate|14|||
41970917|NCT01299480|75772139|FG003|Overall Study|No longer willing to participate|13|||
41970918|NCT01299480|75772140|FG004|Overall Study|No longer willing to participate|10|||
41970919|NCT01299480|75772136|FG000|Overall Study|Protocol Violation|7|||
41970920|NCT01299480|75772137|FG001|Overall Study|Protocol Violation|5|||
42027992|NCT00599755|75836259|FG000|Overall Study|Other Reason|2|||
41970921|NCT01299480|75772138|FG002|Overall Study|Protocol Violation|8|||
41970922|NCT01299480|75772139|FG003|Overall Study|Protocol Violation|1|||
41970923|NCT01299480|75772140|FG004|Overall Study|Protocol Violation|1|||
41970924|NCT01299480|75772136|FG000|Overall Study|Withdrawal by Subject|3|||
41970925|NCT01299480|75772137|FG001|Overall Study|Withdrawal by Subject|4|||
41970926|NCT01299480|75772138|FG002|Overall Study|Withdrawal by Subject|7|||
41970927|NCT01299480|75772139|FG003|Overall Study|Withdrawal by Subject|3|||
41970928|NCT01299480|75772140|FG004|Overall Study|Withdrawal by Subject|4|||
41970929|NCT01299480|75772136|FG000|Overall Study|Adverse Event|6|||
41970930|NCT01299480|75772137|FG001|Overall Study|Adverse Event|4|||
41970931|NCT01299480|75772138|FG002|Overall Study|Adverse Event|5|||
41970932|NCT01299480|75772139|FG003|Overall Study|Adverse Event|4|||
41970933|NCT01299480|75772140|FG004|Overall Study|Adverse Event|0|||
41970934|NCT01299480|75772136|FG000|Overall Study|Withdrawal due to pregnancy|0|||
41970935|NCT01299480|75772137|FG001|Overall Study|Withdrawal due to pregnancy|1|||
41970936|NCT01299480|75772138|FG002|Overall Study|Withdrawal due to pregnancy|1|||
41970937|NCT01299480|75772139|FG003|Overall Study|Withdrawal due to pregnancy|0|||
41970938|NCT01299480|75772140|FG004|Overall Study|Withdrawal due to pregnancy|0|||
41970939|NCT01299480|75772136|FG000|Overall Study|Physician Decision|1|||
41970940|NCT01299480|75772137|FG001|Overall Study|Physician Decision|1|||
41970941|NCT01299480|75772138|FG002|Overall Study|Physician Decision|0|||
41970942|NCT01299480|75772139|FG003|Overall Study|Physician Decision|2|||
41970943|NCT01299480|75772140|FG004|Overall Study|Physician Decision|0|||
41970944|NCT01299480|75772136|FG000|Overall Study|Lost to Follow-up|3|||
41970945|NCT01299480|75772137|FG001|Overall Study|Lost to Follow-up|1|||
41970946|NCT01299480|75772138|FG002|Overall Study|Lost to Follow-up|2|||
41970947|NCT01299480|75772139|FG003|Overall Study|Lost to Follow-up|1|||
41970948|NCT01299480|75772140|FG004|Overall Study|Lost to Follow-up|2|||
41970949|NCT01299480|75772136|FG000|Overall Study|Other|3|||
41970950|NCT01299480|75772137|FG001|Overall Study|Other|2|||
41970951|NCT01299480|75772138|FG002|Overall Study|Other|3|||
41970952|NCT01299480|75772139|FG003|Overall Study|Other|0|||
41970953|NCT01299480|75772140|FG004|Overall Study|Other|3|||
41970954|NCT01299480|75772136|FG000|Overall Study|Started, but not vaccinated|0|||
41970955|NCT01299480|75772137|FG001|Overall Study|Started, but not vaccinated|0|||
41970956|NCT01299480|75772138|FG002|Overall Study|Started, but not vaccinated|1|||
41970957|NCT01299480|75772139|FG003|Overall Study|Started, but not vaccinated|1|||
41970958|NCT01299480|75772140|FG004|Overall Study|Started, but not vaccinated|0|||
41970959|NCT04700137|75772199|FG000|Overall Study|Lost to Follow-up|1|||
41970960|NCT04700137|75772200|FG001|Overall Study|Lost to Follow-up|6|||
41970961|NCT04700137|75772201|FG002|Overall Study|Lost to Follow-up|1|||
41970962|NCT04700137|75772202|FG003|Overall Study|Lost to Follow-up|1|||
41970963|NCT04700137|75772199|FG000|Overall Study|Withdrawal by Subject|0|||
41970964|NCT04700137|75772200|FG001|Overall Study|Withdrawal by Subject|0|||
41970965|NCT04700137|75772201|FG002|Overall Study|Withdrawal by Subject|1|||
41970966|NCT04700137|75772202|FG003|Overall Study|Withdrawal by Subject|0|||
41970967|NCT04700137|75772199|FG000|Overall Study|Death|0|||
41970968|NCT04700137|75772200|FG001|Overall Study|Death|0|||
41970969|NCT04700137|75772201|FG002|Overall Study|Death|1|||
41970970|NCT04700137|75772202|FG003|Overall Study|Death|0|||
41970971|NCT04260191|75772232|FG000|Overall Study|Decision by Sponsor|0|||
41970972|NCT04260191|75772233|FG001|Overall Study|Decision by Sponsor|1|||
41970973|NCT04260191|75772234|FG002|Overall Study|Decision by Sponsor|0|||
41970974|NCT04260191|75772232|FG000|Overall Study|Withdrawal by Subject|1|||
41970975|NCT04260191|75772233|FG001|Overall Study|Withdrawal by Subject|0|||
41970976|NCT04260191|75772234|FG002|Overall Study|Withdrawal by Subject|3|||
41970977|NCT04260191|75772232|FG000|Overall Study|Death|4|||
41970978|NCT04260191|75772233|FG001|Overall Study|Death|3|||
41970979|NCT04260191|75772234|FG002|Overall Study|Death|2|||
41970980|NCT03188510|75772295|FG000|Overall Study|Inappropriate behavior with site staff|0|||
41970981|NCT03188510|75772296|FG001|Overall Study|Inappropriate behavior with site staff|1|||
41970982|NCT03188510|75772297|FG002|Overall Study|Inappropriate behavior with site staff|0|||
41970983|NCT03100149|75772308|FG000|Overall Study|Adverse Event|0|||
41970984|NCT03100149|75772309|FG001|Overall Study|Adverse Event|1|||
41970985|NCT03100149|75772310|FG002|Overall Study|Adverse Event|0|||
41970986|NCT03100149|75772308|FG000|Overall Study|Participant Moved out of Country|0|||
42126456|NCT03684642|75937003|FG002|Overall Study|Missing completion status but alive at last contact|2|||
41970987|NCT03100149|75772309|FG001|Overall Study|Participant Moved out of Country|0|||
41970988|NCT03100149|75772310|FG002|Overall Study|Participant Moved out of Country|1|||
41970989|NCT03100149|75772308|FG000|Overall Study|Withdrawal by Subject|0|||
41970990|NCT03100149|75772309|FG001|Overall Study|Withdrawal by Subject|3|||
41970991|NCT03100149|75772310|FG002|Overall Study|Withdrawal by Subject|1|||
41970992|NCT03075527|75772318|FG000|Overall Study|Ongoing treatment|2|||
41970993|NCT02734004|75772338|FG000|Overall Study|Death|36|||
41970994|NCT02734004|75772339|FG001|Overall Study|Death|24|||
41970995|NCT02734004|75772340|FG002|Overall Study|Death|26|||
41970996|NCT02734004|75772341|FG003|Overall Study|Death|35|||
41970997|NCT02734004|75772342|FG004|Overall Study|Death|13|||
41970998|NCT02734004|75772343|FG005|Overall Study|Death|17|||
41970999|NCT02734004|75772344|FG006|Overall Study|Death|20|||
41971000|NCT02734004|75772338|FG000|Overall Study|Lost to Follow-up|1|||
41971001|NCT02734004|75772339|FG001|Overall Study|Lost to Follow-up|1|||
41971002|NCT02734004|75772340|FG002|Overall Study|Lost to Follow-up|0|||
41971003|NCT02734004|75772341|FG003|Overall Study|Lost to Follow-up|0|||
41971004|NCT02734004|75772342|FG004|Overall Study|Lost to Follow-up|1|||
41971005|NCT02734004|75772343|FG005|Overall Study|Lost to Follow-up|0|||
41971006|NCT02734004|75772344|FG006|Overall Study|Lost to Follow-up|0|||
41971007|NCT02734004|75772338|FG000|Overall Study|Withdrawal by Subject|3|||
41971008|NCT02734004|75772339|FG001|Overall Study|Withdrawal by Subject|1|||
41971009|NCT02734004|75772340|FG002|Overall Study|Withdrawal by Subject|1|||
41971010|NCT02734004|75772341|FG003|Overall Study|Withdrawal by Subject|1|||
41971011|NCT02734004|75772342|FG004|Overall Study|Withdrawal by Subject|3|||
41971012|NCT02734004|75772343|FG005|Overall Study|Withdrawal by Subject|0|||
41971013|NCT02734004|75772344|FG006|Overall Study|Withdrawal by Subject|2|||
41971014|NCT02734004|75772338|FG000|Overall Study|Other|0|||
41971015|NCT02734004|75772339|FG001|Overall Study|Other|8|||
41971016|NCT02734004|75772340|FG002|Overall Study|Other|7|||
41971017|NCT02734004|75772341|FG003|Overall Study|Other|4|||
41971018|NCT02734004|75772342|FG004|Overall Study|Other|34|||
41971019|NCT02734004|75772343|FG005|Overall Study|Other|14|||
41971020|NCT02734004|75772344|FG006|Overall Study|Other|10|||
41971021|NCT02677922|75772373|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
41971022|NCT02677922|75772374|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
41971023|NCT02677922|75772375|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
41971024|NCT02677922|75772376|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
41971025|NCT02677922|75772377|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
41971026|NCT02677922|75772378|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
41971027|NCT02677922|75772373|FG000|Treatment Period|Adverse Event|0|||
41971028|NCT02677922|75772374|FG001|Treatment Period|Adverse Event|0|||
41971029|NCT02677922|75772375|FG002|Treatment Period|Adverse Event|1|||
41971030|NCT02677922|75772376|FG003|Treatment Period|Adverse Event|3|||
41971031|NCT02677922|75772377|FG004|Treatment Period|Adverse Event|5|||
41971032|NCT02677922|75772378|FG005|Treatment Period|Adverse Event|2|||
41971033|NCT02677922|75772373|FG000|Treatment Period|Progressive Disease|1|||
41971034|NCT02677922|75772374|FG001|Treatment Period|Progressive Disease|1|||
41971035|NCT02677922|75772375|FG002|Treatment Period|Progressive Disease|0|||
41971036|NCT02677922|75772376|FG003|Treatment Period|Progressive Disease|0|||
41971037|NCT02677922|75772377|FG004|Treatment Period|Progressive Disease|8|||
41971038|NCT02677922|75772378|FG005|Treatment Period|Progressive Disease|7|||
41971039|NCT02677922|75772373|FG000|Treatment Period|Lack of Efficacy|0|||
41971040|NCT02677922|75772374|FG001|Treatment Period|Lack of Efficacy|0|||
41971041|NCT02677922|75772375|FG002|Treatment Period|Lack of Efficacy|0|||
41971042|NCT02677922|75772376|FG003|Treatment Period|Lack of Efficacy|1|||
41971043|NCT02677922|75772377|FG004|Treatment Period|Lack of Efficacy|1|||
42126457|NCT00519636|75937015|FG000|Treatment Period 1|Adverse Event|1|||
41971044|NCT02677922|75772378|FG005|Treatment Period|Lack of Efficacy|6|||
41971045|NCT02677922|75772373|FG000|Treatment Period|Withdrawal by Subject|0|||
41971046|NCT02677922|75772374|FG001|Treatment Period|Withdrawal by Subject|0|||
41971047|NCT02677922|75772375|FG002|Treatment Period|Withdrawal by Subject|1|||
41971048|NCT02677922|75772376|FG003|Treatment Period|Withdrawal by Subject|3|||
41971049|NCT02677922|75772377|FG004|Treatment Period|Withdrawal by Subject|5|||
41971050|NCT02677922|75772378|FG005|Treatment Period|Withdrawal by Subject|5|||
41971051|NCT02677922|75772373|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
41971052|NCT02677922|75772374|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
41971053|NCT02677922|75772375|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
41971054|NCT02677922|75772376|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
41971055|NCT02677922|75772377|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
41971056|NCT02677922|75772378|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
41971057|NCT02677922|75772373|FG000|Treatment Period|Disease Relapse|0|||
41971058|NCT02677922|75772374|FG001|Treatment Period|Disease Relapse|0|||
41971059|NCT02677922|75772375|FG002|Treatment Period|Disease Relapse|0|||
41971060|NCT02677922|75772376|FG003|Treatment Period|Disease Relapse|3|||
41971061|NCT02677922|75772377|FG004|Treatment Period|Disease Relapse|6|||
41971062|NCT02677922|75772378|FG005|Treatment Period|Disease Relapse|1|||
41971063|NCT02677922|75772373|FG000|Treatment Period|Allogeneic HSCT|1|||
41971064|NCT02677922|75772374|FG001|Treatment Period|Allogeneic HSCT|0|||
41971065|NCT02677922|75772375|FG002|Treatment Period|Allogeneic HSCT|0|||
41971066|NCT02677922|75772376|FG003|Treatment Period|Allogeneic HSCT|1|||
41971067|NCT02677922|75772377|FG004|Treatment Period|Allogeneic HSCT|4|||
41971068|NCT02677922|75772378|FG005|Treatment Period|Allogeneic HSCT|1|||
41971069|NCT02677922|75772373|FG000|Treatment Period|Other Reasons|0|||
41971070|NCT02677922|75772374|FG001|Treatment Period|Other Reasons|0|||
41971071|NCT02677922|75772375|FG002|Treatment Period|Other Reasons|0|||
41971072|NCT02677922|75772376|FG003|Treatment Period|Other Reasons|1|||
41971073|NCT02677922|75772377|FG004|Treatment Period|Other Reasons|3|||
41971074|NCT02677922|75772378|FG005|Treatment Period|Other Reasons|5|||
41971075|NCT02677922|75772373|FG000|Treatment Period|Death|0|||
41971076|NCT02677922|75772374|FG001|Treatment Period|Death|0|||
41971077|NCT02677922|75772375|FG002|Treatment Period|Death|0|||
41971078|NCT02677922|75772376|FG003|Treatment Period|Death|0|||
41971079|NCT02677922|75772377|FG004|Treatment Period|Death|12|||
41971080|NCT02677922|75772378|FG005|Treatment Period|Death|1|||
41971081|NCT02677922|75772373|FG000|Treatment Period|Non-compliance with Study Drug|0|||
41971082|NCT02677922|75772374|FG001|Treatment Period|Non-compliance with Study Drug|0|||
41971083|NCT02677922|75772375|FG002|Treatment Period|Non-compliance with Study Drug|0|||
41971084|NCT02677922|75772376|FG003|Treatment Period|Non-compliance with Study Drug|0|||
41971085|NCT02677922|75772377|FG004|Treatment Period|Non-compliance with Study Drug|1|||
41971086|NCT02677922|75772378|FG005|Treatment Period|Non-compliance with Study Drug|0|||
41971087|NCT02677922|75772373|FG000|Treatment Period|Physician Decision|0|||
41971088|NCT02677922|75772374|FG001|Treatment Period|Physician Decision|0|||
41971089|NCT02677922|75772375|FG002|Treatment Period|Physician Decision|0|||
41971090|NCT02677922|75772376|FG003|Treatment Period|Physician Decision|0|||
41971091|NCT02677922|75772377|FG004|Treatment Period|Physician Decision|0|||
41971092|NCT02677922|75772378|FG005|Treatment Period|Physician Decision|1|||
41971093|NCT02677922|75772373|FG000|Treatment Period|Symptomatic Deterioration|0|||
41971094|NCT02677922|75772374|FG001|Treatment Period|Symptomatic Deterioration|0|||
41971095|NCT02677922|75772375|FG002|Treatment Period|Symptomatic Deterioration|0|||
41971096|NCT02677922|75772376|FG003|Treatment Period|Symptomatic Deterioration|0|||
41971097|NCT02677922|75772377|FG004|Treatment Period|Symptomatic Deterioration|1|||
41971098|NCT02677922|75772378|FG005|Treatment Period|Symptomatic Deterioration|0|||
41971099|NCT02567799|75772396|FG000|Concurrent Chemoradiotherapy|Death|1|||
41971100|NCT02567799|75772397|FG001|Concurrent Chemoradiotherapy|Death|0|||
41971101|NCT02567799|75772398|FG002|Concurrent Chemoradiotherapy|Death|0|||
41971102|NCT02567799|75772396|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
41971103|NCT02567799|75772397|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
41971104|NCT02567799|75772398|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
41971105|NCT02567799|75772396|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
41971106|NCT02567799|75772397|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
41971107|NCT02567799|75772398|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
41971108|NCT02567799|75772396|FG000|Follow-up|Death|1|||
41971109|NCT02567799|75772397|FG001|Follow-up|Death|0|||
41971110|NCT02567799|75772398|FG002|Follow-up|Death|1|||
41971111|NCT02567799|75772396|FG000|Follow-up|Progressive Disease|1|||
42126458|NCT00519636|75937016|FG001|Treatment Period 1|Adverse Event|0|||
42126459|NCT00519636|75937017|FG002|Treatment Period 1|Adverse Event|1|||
42126460|NCT00519636|75937018|FG003|Treatment Period 1|Adverse Event|0|||
42126461|NCT00519636|75937015|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
42126462|NCT00519636|75937016|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
41971112|NCT02567799|75772397|FG001|Follow-up|Progressive Disease|1|||
41971113|NCT02567799|75772398|FG002|Follow-up|Progressive Disease|3|||
41971114|NCT01696994|75772427|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
41971115|NCT01696994|75772428|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
41971116|NCT01696994|75772427|FG000|Overall Study|Died Before Randomization|1|||
41971117|NCT01696994|75772428|FG001|Overall Study|Died Before Randomization|2|||
41971118|NCT01696994|75772427|FG000|Overall Study|Died Before ASU (Control)|73|||
41971119|NCT01696994|75772428|FG001|Overall Study|Died Before ASU (Control)|0|||
41971120|NCT01696994|75772427|FG000|Overall Study|No Ovaries at Baseline|4807|||
41971121|NCT01696994|75772428|FG001|Overall Study|No Ovaries at Baseline|4851|||
42126463|NCT00519636|75937017|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
41971122|NCT01696994|75772427|FG000|Overall Study|Refused ASU (Control)|311|||
41971123|NCT01696994|75772428|FG001|Overall Study|Refused ASU (Control)|0|||
41971124|NCT01696994|75772427|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
41971125|NCT01696994|75772428|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
41971126|NCT01696981|75772438|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
41971127|NCT01696981|75772439|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
41971128|NCT01696981|75772438|FG000|Overall Study|Died Before Randomization|3|||
41971129|NCT01696981|75772439|FG001|Overall Study|Died Before Randomization|8|||
41971130|NCT01696981|75772438|FG000|Overall Study|Died Before ASU (Control)|278|||
41971131|NCT01696981|75772439|FG001|Overall Study|Died Before ASU (Control)|0|||
41971132|NCT01696981|75772438|FG000|Overall Study|Refused ASU (Control)|920|||
41971133|NCT01696981|75772439|FG001|Overall Study|Refused ASU (Control)|0|||
41971134|NCT01696981|75772438|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
41971135|NCT01696981|75772439|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
41971136|NCT01696968|75772447|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
41971137|NCT01696968|75772448|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
41971138|NCT01696968|75772447|FG000|Overall Study|Died Before Randomization|3|||
41971139|NCT01696968|75772448|FG001|Overall Study|Died Before Randomization|8|||
41971140|NCT01696968|75772447|FG000|Overall Study|Died Before ASU (Control)|278|||
42126464|NCT00519636|75937018|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
42126465|NCT00519636|75937015|FG000|Washout Period|Adverse Event|2|||
42126466|NCT00519636|75937016|FG001|Washout Period|Adverse Event|1|||
42126467|NCT00519636|75937017|FG002|Washout Period|Adverse Event|1|||
42126468|NCT00519636|75937018|FG003|Washout Period|Adverse Event|0|||
42126469|NCT00519636|75937015|FG000|Washout Period|Lost to Follow-up|1|||
42126470|NCT00519636|75937016|FG001|Washout Period|Lost to Follow-up|0|||
42126471|NCT00519636|75937017|FG002|Washout Period|Lost to Follow-up|0|||
42126472|NCT00519636|75937018|FG003|Washout Period|Lost to Follow-up|0|||
42126473|NCT00519636|75937015|FG000|Washout Period|Protocol Violation|0|||
42126474|NCT00519636|75937016|FG001|Washout Period|Protocol Violation|0|||
42126475|NCT00519636|75937017|FG002|Washout Period|Protocol Violation|1|||
42126476|NCT00519636|75937018|FG003|Washout Period|Protocol Violation|2|||
42126477|NCT00519636|75937015|FG000|Washout Period|Withdrawal by Subject|1|||
42126478|NCT00519636|75937016|FG001|Washout Period|Withdrawal by Subject|0|||
42126479|NCT00519636|75937017|FG002|Washout Period|Withdrawal by Subject|1|||
42126480|NCT00519636|75937018|FG003|Washout Period|Withdrawal by Subject|0|||
42126481|NCT00519636|75937015|FG000|Washout Period|Failed to meet continuation criteria|14|||
42126482|NCT00519636|75937016|FG001|Washout Period|Failed to meet continuation criteria|11|||
42126483|NCT00519636|75937017|FG002|Washout Period|Failed to meet continuation criteria|9|||
42126484|NCT00519636|75937018|FG003|Washout Period|Failed to meet continuation criteria|3|||
42126485|NCT00519636|75937015|FG000|Washout Period|Out of pollen area > 48 hours|1|||
42126486|NCT00519636|75937016|FG001|Washout Period|Out of pollen area > 48 hours|0|||
42126487|NCT00519636|75937017|FG002|Washout Period|Out of pollen area > 48 hours|0|||
42126488|NCT00519636|75937018|FG003|Washout Period|Out of pollen area > 48 hours|0|||
42126489|NCT00519636|75937015|FG000|Washout Period|Participating in study at another site|1|||
41971141|NCT01696968|75772448|FG001|Overall Study|Died Before ASU (Control)|0|||
41971142|NCT01696968|75772447|FG000|Overall Study|Refused ASU (Control)|920|||
42126490|NCT00519636|75937016|FG001|Washout Period|Participating in study at another site|0|||
41971143|NCT01696968|75772448|FG001|Overall Study|Refused ASU (Control)|0|||
41971144|NCT01696968|75772447|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
41971145|NCT01696968|75772448|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
41971146|NCT01155050|75772459|FG000|Overall Study|Lost to Follow-up|15|||
41971147|NCT01155050|75772460|FG001|Overall Study|Lost to Follow-up|20|||
41971148|NCT01155050|75772461|FG002|Overall Study|Lost to Follow-up|19|||
41971149|NCT01155050|75772462|FG003|Overall Study|Lost to Follow-up|22|||
41971150|NCT00002540|75772484|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
41971151|NCT00002540|75772485|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
41971152|NCT00002540|75772484|FG000|Overall Study|Died Before Randomization|2|||
41971153|NCT00002540|75772485|FG001|Overall Study|Died Before Randomization|6|||
41971154|NCT00002540|75772484|FG000|Overall Study|Died Before ASU (Control)|202|||
41971155|NCT00002540|75772485|FG001|Overall Study|Died Before ASU (Control)|0|||
41971156|NCT00002540|75772484|FG000|Overall Study|Refused ASU (Control)|597|||
41971157|NCT00002540|75772485|FG001|Overall Study|Refused ASU (Control)|0|||
41971158|NCT00002540|75772484|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
41971159|NCT00002540|75772485|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
42126491|NCT00519636|75937017|FG002|Washout Period|Participating in study at another site|0|||
42126492|NCT00519636|75937018|FG003|Washout Period|Participating in study at another site|0|||
42301651|NCT02288325|76136768|FG002|Double-blind Treatment Period|Adverse Event|5|||
42010474|NCT00993499|75817611|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
42010475|NCT00993499|75817612|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
42010476|NCT00993499|75817613|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
42010477|NCT00993499|75817614|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
41971160|NCT04799405|75772500|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
41971161|NCT04529499|75772510|FG000|Overall Study|Withdrawal by Subject|9|||
41971162|NCT04529499|75772511|FG001|Overall Study|Withdrawal by Subject|11|||
41971163|NCT04529499|75772510|FG000|Overall Study|Physician Decision|1|||
41971164|NCT04529499|75772511|FG001|Overall Study|Physician Decision|2|||
41971165|NCT04529499|75772510|FG000|Overall Study|Adverse Event|4|||
41971166|NCT04529499|75772511|FG001|Overall Study|Adverse Event|4|||
41971167|NCT04529499|75772510|FG000|Overall Study|Death|14|||
41971168|NCT04529499|75772511|FG001|Overall Study|Death|11|||
41971169|NCT04529499|75772510|FG000|Overall Study|Lost to Follow-up|1|||
41971170|NCT04529499|75772511|FG001|Overall Study|Lost to Follow-up|1|||
41971171|NCT04529499|75772510|FG000|Overall Study|Others|7|||
41971172|NCT04529499|75772511|FG001|Overall Study|Others|11|||
41971173|NCT04501094|75772519|FG000|Overall Study|Death (unrelated to research)|1|||
41971174|NCT04501094|75772520|FG001|Overall Study|Death (unrelated to research)|0|||
41971175|NCT04414618|75772528|FG000|Overall Study|Death|3|||
41971176|NCT04414618|75772529|FG001|Overall Study|Death|3|||
41971177|NCT04414618|75772528|FG000|Overall Study|Withdrawal by Subject|2|||
41971178|NCT04414618|75772529|FG001|Overall Study|Withdrawal by Subject|1|||
41971179|NCT04414618|75772528|FG000|Overall Study|Lost to Follow-up|2|||
41971180|NCT04414618|75772529|FG001|Overall Study|Lost to Follow-up|3|||
41971181|NCT04414618|75772528|FG000|Overall Study|Physician Decision|1|||
41971182|NCT04414618|75772529|FG001|Overall Study|Physician Decision|0|||
41971183|NCT04412057|75772538|FG000|Overall Study|Death|3|||
41971184|NCT04412057|75772539|FG001|Overall Study|Death|7|||
41971185|NCT04412057|75772538|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
41971186|NCT04412057|75772539|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
41971187|NCT04402060|75772548|FG000|Overall Study|Death|1|||
41971188|NCT04402060|75772549|FG001|Overall Study|Death|12|||
41971189|NCT04402060|75772550|FG002|Overall Study|Death|7|||
41971190|NCT04402060|75772548|FG000|Overall Study|Adverse Event|0|||
41971191|NCT04402060|75772549|FG001|Overall Study|Adverse Event|0|||
41971192|NCT04402060|75772550|FG002|Overall Study|Adverse Event|1|||
41971193|NCT04402060|75772548|FG000|Overall Study|Withdrawal by Subject|0|||
41971194|NCT04402060|75772549|FG001|Overall Study|Withdrawal by Subject|1|||
41971195|NCT04402060|75772550|FG002|Overall Study|Withdrawal by Subject|2|||
41971196|NCT04402060|75772548|FG000|Overall Study|Sponsor Request|0|||
41971197|NCT04402060|75772549|FG001|Overall Study|Sponsor Request|2|||
41971198|NCT04402060|75772550|FG002|Overall Study|Sponsor Request|0|||
41971199|NCT04402060|75772548|FG000|Overall Study|Physician Decision|0|||
41971200|NCT04402060|75772549|FG001|Overall Study|Physician Decision|0|||
41971201|NCT04402060|75772550|FG002|Overall Study|Physician Decision|1|||
41971202|NCT04402060|75772548|FG000|Overall Study|Other|0|||
41971203|NCT04402060|75772549|FG001|Overall Study|Other|1|||
41971204|NCT04402060|75772550|FG002|Overall Study|Other|0|||
41971205|NCT04376684|75772585|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
41971206|NCT04376684|75772586|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
41971207|NCT04376684|75772587|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
41971208|NCT04376684|75772588|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
41971209|NCT04376684|75772585|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
41971210|NCT04376684|75772586|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
41971211|NCT04376684|75772587|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
41971212|NCT04376684|75772588|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
41971213|NCT04376684|75772585|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
41971214|NCT04376684|75772586|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
41971215|NCT04376684|75772587|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
41971216|NCT04376684|75772588|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
41971217|NCT04376684|75772585|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
41971218|NCT04376684|75772586|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
41971219|NCT04376684|75772587|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
41971220|NCT04376684|75772588|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
41971221|NCT04376684|75772585|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
41971222|NCT04376684|75772586|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
41971223|NCT04376684|75772587|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
41971224|NCT04376684|75772588|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
41971225|NCT04376684|75772585|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
41971226|NCT04376684|75772586|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
42027993|NCT00599755|75836259|FG000|Overall Study|No data available|1|||
42027994|NCT00600613|75836263|FG000|Overall Study|Protocol Deviation|1|||
42027995|NCT01125930|75836269|FG000|Overall Study|Adverse Event|0|||
42301652|NCT02288325|76136766|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
42301653|NCT02288325|76136767|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
42301654|NCT02288325|76136768|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
42301655|NCT02288325|76136766|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
41971227|NCT04376684|75772587|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
42027996|NCT01125930|75836270|FG001|Overall Study|Adverse Event|1|||
41971228|NCT04376684|75772588|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
41971229|NCT04376684|75772585|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
41971230|NCT04376684|75772586|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
42301656|NCT02288325|76136767|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
42301657|NCT02288325|76136768|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
41971231|NCT04376684|75772587|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
41971232|NCT04376684|75772588|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
41971233|NCT04353284|75772600|FG000|Overall Study|Adverse Event|1|||
41971234|NCT04353284|75772601|FG001|Overall Study|Adverse Event|1|||
41971235|NCT04353284|75772600|FG000|Overall Study|Lost to Follow-up|1|||
41971236|NCT04353284|75772601|FG001|Overall Study|Lost to Follow-up|0|||
41971237|NCT04294147|75772609|FG000|Overall Study|Protocol Violation|2|||
41971238|NCT04294147|75772610|FG001|Overall Study|Protocol Violation|0|||
41971239|NCT04231825|75772622|FG000|Overall Study|Protocol Violation|3|||
41971240|NCT04231825|75772623|FG001|Overall Study|Protocol Violation|3|||
41971241|NCT04231825|75772622|FG000|Overall Study|Lost to Follow-up|0|||
41971242|NCT04231825|75772623|FG001|Overall Study|Lost to Follow-up|1|||
41971243|NCT04178772|75772629|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
41971244|NCT04178772|75772629|FG000|Overall Study|study terminated early due to COVID-19|7|||
41971245|NCT04148651|75772633|FG000|Overall Study|Lost to Follow-up|2|||
41971246|NCT03924427|75772646|FG000|Overall Study|Adverse Event|4|||
41971247|NCT03924427|75772646|FG000|Overall Study|Lack of Efficacy|1|||
41971248|NCT03924427|75772646|FG000|Overall Study|Withdrawal by Subject|1|||
41971249|NCT03642132|75772690|FG000|Chemotherapy Period|Adverse Event|1|||
41971250|NCT03642132|75772691|FG001|Chemotherapy Period|Adverse Event|1|||
41971251|NCT03642132|75772692|FG002|Chemotherapy Period|Adverse Event|0|||
41971252|NCT03642132|75772690|FG000|Chemotherapy Period|Physician's decision|4|||
41971253|NCT03642132|75772691|FG001|Chemotherapy Period|Physician's decision|1|||
41971254|NCT03642132|75772692|FG002|Chemotherapy Period|Physician's decision|0|||
41971255|NCT03642132|75772690|FG000|Chemotherapy Period|Progressive disease|0|||
41971256|NCT03642132|75772691|FG001|Chemotherapy Period|Progressive disease|0|||
41971257|NCT03642132|75772692|FG002|Chemotherapy Period|Progressive disease|1|||
41971258|NCT03642132|75772690|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
41971259|NCT03642132|75772691|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
41971260|NCT03642132|75772692|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
41971261|NCT03642132|75772690|FG000|Chemotherapy Period|Other|1|||
41971262|NCT03642132|75772691|FG001|Chemotherapy Period|Other|0|||
41971263|NCT03642132|75772692|FG002|Chemotherapy Period|Other|2|||
41971264|NCT03642132|75772690|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
41971265|NCT03642132|75772691|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
41971266|NCT03642132|75772692|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
41971267|NCT03642132|75772690|FG000|Maintenance Period|Adverse Event|1|||
41971268|NCT03642132|75772691|FG001|Maintenance Period|Adverse Event|2|||
41971269|NCT03642132|75772692|FG002|Maintenance Period|Adverse Event|0|||
41971270|NCT03642132|75772690|FG000|Maintenance Period|Non-compliance with study drug|0|||
41971271|NCT03642132|75772691|FG001|Maintenance Period|Non-compliance with study drug|0|||
41971272|NCT03642132|75772692|FG002|Maintenance Period|Non-compliance with study drug|1|||
41971273|NCT03642132|75772690|FG000|Maintenance Period|Physician's decision|2|||
41971274|NCT03642132|75772691|FG001|Maintenance Period|Physician's decision|2|||
41971275|NCT03642132|75772692|FG002|Maintenance Period|Physician's decision|2|||
41971276|NCT03642132|75772690|FG000|Maintenance Period|Progressive disease|9|||
41971277|NCT03642132|75772691|FG001|Maintenance Period|Progressive disease|3|||
41971278|NCT03642132|75772692|FG002|Maintenance Period|Progressive disease|6|||
41971279|NCT03642132|75772690|FG000|Maintenance Period|Other|0|||
41971280|NCT03642132|75772691|FG001|Maintenance Period|Other|0|||
41971281|NCT03642132|75772692|FG002|Maintenance Period|Other|3|||
41971282|NCT03642132|75772690|FG000|Maintenance Period|Withdrawal by Subject|1|||
41971283|NCT03642132|75772691|FG001|Maintenance Period|Withdrawal by Subject|1|||
41971284|NCT03642132|75772692|FG002|Maintenance Period|Withdrawal by Subject|2|||
41971285|NCT03642132|75772690|FG000|Follow-up Period|Other|0|||
42126493|NCT00519636|75937015|FG000|Washout Period|Non-compliant|0|||
42126494|NCT00519636|75937016|FG001|Washout Period|Non-compliant|1|||
42126495|NCT00519636|75937017|FG002|Washout Period|Non-compliant|0|||
42126496|NCT00519636|75937018|FG003|Washout Period|Non-compliant|0|||
41971286|NCT03642132|75772691|FG001|Follow-up Period|Other|0|||
41971287|NCT03642132|75772692|FG002|Follow-up Period|Other|1|||
41971288|NCT03642132|75772690|FG000|Follow-up Period|Withdrawal by Subject|1|||
41971289|NCT03642132|75772691|FG001|Follow-up Period|Withdrawal by Subject|2|||
42126497|NCT00519636|75937015|FG000|Washout Period|Per doctors request|0|||
42126498|NCT00519636|75937016|FG001|Washout Period|Per doctors request|1|||
41971290|NCT03642132|75772692|FG002|Follow-up Period|Withdrawal by Subject|0|||
41971291|NCT03642132|75772690|FG000|Follow-up Period|Study terminated by sponsor|1|||
41971292|NCT03642132|75772691|FG001|Follow-up Period|Study terminated by sponsor|0|||
42126499|NCT00519636|75937017|FG002|Washout Period|Per doctors request|0|||
42126500|NCT00519636|75937018|FG003|Washout Period|Per doctors request|0|||
41971293|NCT03642132|75772692|FG002|Follow-up Period|Study terminated by sponsor|1|||
41971294|NCT03642132|75772690|FG000|Follow-up Period|Lack of Efficacy|1|||
41971295|NCT03642132|75772691|FG001|Follow-up Period|Lack of Efficacy|0|||
41971296|NCT03642132|75772692|FG002|Follow-up Period|Lack of Efficacy|0|||
42126501|NCT00519636|75937015|FG000|Washout Period|Subject randomized in error|0|||
42126502|NCT00519636|75937016|FG001|Washout Period|Subject randomized in error|0|||
42126503|NCT00519636|75937017|FG002|Washout Period|Subject randomized in error|1|||
42126504|NCT00519636|75937018|FG003|Washout Period|Subject randomized in error|0|||
42126505|NCT00519636|75937015|FG000|Washout Period|Prohibited medications|0|||
42126506|NCT00519636|75937016|FG001|Washout Period|Prohibited medications|0|||
42126507|NCT00519636|75937017|FG002|Washout Period|Prohibited medications|1|||
42126508|NCT00519636|75937018|FG003|Washout Period|Prohibited medications|0|||
42126509|NCT00519636|75937015|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
42126510|NCT00519636|75937016|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
42126511|NCT00519636|75937017|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
42126512|NCT00519636|75937018|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
42126513|NCT00519636|75937015|FG000|Treatment Period 2|Subject randomized in error|0|||
42126514|NCT00519636|75937016|FG001|Treatment Period 2|Subject randomized in error|1|||
42126515|NCT00519636|75937017|FG002|Treatment Period 2|Subject randomized in error|0|||
42126516|NCT00519636|75937018|FG003|Treatment Period 2|Subject randomized in error|0|||
42126517|NCT00519636|75937015|FG000|Treatment Period 2|Per doctors request|0|||
42126518|NCT00519636|75937016|FG001|Treatment Period 2|Per doctors request|0|||
42126519|NCT00519636|75937017|FG002|Treatment Period 2|Per doctors request|1|||
42126520|NCT00519636|75937018|FG003|Treatment Period 2|Per doctors request|0|||
42126521|NCT00519636|75937015|FG000|Treatment Period 2|Subject misrandomized|0|||
42126522|NCT00519636|75937016|FG001|Treatment Period 2|Subject misrandomized|0|||
42126523|NCT00519636|75937017|FG002|Treatment Period 2|Subject misrandomized|0|||
42126524|NCT00519636|75937018|FG003|Treatment Period 2|Subject misrandomized|1|||
42126525|NCT00519636|75937015|FG000|Post Study Period|Subject randomized in error|0|||
42126526|NCT00519636|75937016|FG001|Post Study Period|Subject randomized in error|0|||
42126527|NCT00519636|75937017|FG002|Post Study Period|Subject randomized in error|0|||
42126528|NCT00519636|75937018|FG003|Post Study Period|Subject randomized in error|1|||
42126529|NCT00618371|75937032|FG000|Overall Study|Withdrawal by Subject|2|||
42126530|NCT00526890|75937037|FG000|Overall Study|Adverse Event|2|||
42126531|NCT03864900|75937043|FG000|Overall Study|Withdrawal by Subject|1|||
42126532|NCT03864900|75937044|FG001|Overall Study|Withdrawal by Subject|1|||
42126533|NCT03864900|75937043|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
42126534|NCT03864900|75937044|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
42126535|NCT00526656|75937050|FG000|Overall Study|Death|1|||
42126536|NCT00526656|75937050|FG000|Overall Study|Refused surgery|1|||
42126537|NCT00617903|75937057|FG000|Overall Study|Withdrawal by Subject|2|||
42126538|NCT00617903|75937058|FG001|Overall Study|Withdrawal by Subject|3|||
42126539|NCT00617903|75937057|FG000|Overall Study|Lost to Follow-up|1|||
42126540|NCT00617903|75937058|FG001|Overall Study|Lost to Follow-up|1|||
42126541|NCT00617903|75937057|FG000|Overall Study|Lack of Efficacy|0|||
42126542|NCT00617903|75937058|FG001|Overall Study|Lack of Efficacy|1|||
42126543|NCT00617903|75937057|FG000|Overall Study|Adverse Event|0|||
42126544|NCT00617903|75937058|FG001|Overall Study|Adverse Event|1|||
42126545|NCT00617903|75937057|FG000|Overall Study|noncompliance|0|||
42126546|NCT00617903|75937058|FG001|Overall Study|noncompliance|1|||
42126547|NCT00526110|75937066|FG000|Overall Study|Adverse Event|2|||
42126548|NCT00526110|75937067|FG001|Overall Study|Adverse Event|9|||
41971297|NCT03642132|75772690|FG000|Follow-up Period|Death|1|||
41971298|NCT03642132|75772691|FG001|Follow-up Period|Death|0|||
41971299|NCT03642132|75772692|FG002|Follow-up Period|Death|2|||
41971300|NCT03642132|75772690|FG000|Follow-up Period|Adverse Event|1|||
41971301|NCT03642132|75772691|FG001|Follow-up Period|Adverse Event|0|||
41971302|NCT03642132|75772692|FG002|Follow-up Period|Adverse Event|0|||
41971303|NCT03008122|75772703|FG000|Overall Study|Physician Decision|3|||
41971304|NCT03008122|75772704|FG001|Overall Study|Physician Decision|2|||
42126549|NCT00526110|75937066|FG000|Overall Study|Disease Progression|0|||
42126550|NCT00526110|75937067|FG001|Overall Study|Disease Progression|19|||
42126551|NCT00526110|75937066|FG000|Overall Study|Maximal Response|0|||
42126552|NCT00526110|75937067|FG001|Overall Study|Maximal Response|6|||
41971305|NCT03008122|75772705|FG002|Overall Study|Physician Decision|0|||
41971306|NCT03008122|75772703|FG000|Overall Study|Withdrawal by Subject|1|||
41971307|NCT03008122|75772704|FG001|Overall Study|Withdrawal by Subject|3|||
42126553|NCT00526110|75937066|FG000|Overall Study|Withdrawal by Subject|0|||
42126554|NCT00526110|75937067|FG001|Overall Study|Withdrawal by Subject|2|||
42126555|NCT00526110|75937066|FG000|Overall Study|Poor Tolerance|0|||
42126556|NCT00526110|75937067|FG001|Overall Study|Poor Tolerance|5|||
42126557|NCT00512148|75937073|FG000|Primay Study Period|Withdrawal by Subject|1|||
42126558|NCT00511836|75937081|FG000|Double-blind Period|Lost to Follow-up|1|||
42126559|NCT00511836|75937082|FG001|Double-blind Period|Lost to Follow-up|0|||
42126560|NCT00573755|75937104|FG000|Overall Study|Still receiving treatment|1|||
42126561|NCT00573755|75937105|FG001|Overall Study|Still receiving treatment|0|||
42126562|NCT00524316|75937111|FG000|Overall Study|Withdrawal by Subject|2|||
42126563|NCT00524316|75937111|FG000|Overall Study|Adverse Event|7|||
41971308|NCT03008122|75772705|FG002|Overall Study|Withdrawal by Subject|0|||
41971309|NCT03008122|75772703|FG000|Overall Study|Lost to Follow-up|4|||
42126564|NCT00524316|75937111|FG000|Overall Study|Disease Progression|7|||
42126565|NCT03861936|75937128|FG000|Overall Study|Withdrawal by Subject|4|||
42126566|NCT03861936|75937129|FG001|Overall Study|Withdrawal by Subject|1|||
42126567|NCT03861936|75937130|FG002|Overall Study|Withdrawal by Subject|3|||
42126568|NCT03861936|75937128|FG000|Overall Study|Lost to Follow-up|5|||
42126569|NCT03861936|75937129|FG001|Overall Study|Lost to Follow-up|3|||
42126570|NCT03861936|75937130|FG002|Overall Study|Lost to Follow-up|3|||
42126571|NCT03861936|75937128|FG000|Overall Study|Physician Decision|0|||
42126572|NCT03861936|75937129|FG001|Overall Study|Physician Decision|1|||
42126573|NCT03861936|75937130|FG002|Overall Study|Physician Decision|0|||
42126574|NCT03861936|75937128|FG000|Overall Study|Protocol Deviation|0|||
42126575|NCT03861936|75937129|FG001|Overall Study|Protocol Deviation|0|||
42126576|NCT03861936|75937130|FG002|Overall Study|Protocol Deviation|1|||
42126577|NCT03861936|75937128|FG000|Overall Study|Reason not Specified|5|||
42126578|NCT03861936|75937129|FG001|Overall Study|Reason not Specified|5|||
42126579|NCT03861936|75937130|FG002|Overall Study|Reason not Specified|3|||
42126580|NCT00434577|75937143|FG000|Months 0-3|Serious Adverse Event|0|||
42126581|NCT00434577|75937144|FG001|Months 0-3|Serious Adverse Event|0|||
42126582|NCT00434577|75937145|FG002|Months 0-3|Serious Adverse Event|1|||
42126583|NCT00434577|75937146|FG003|Months 0-3|Serious Adverse Event|0|||
42126584|NCT00434577|75937147|FG004|Months 0-3|Serious Adverse Event|0|||
42126585|NCT00434577|75937143|FG000|Months 0-3|Adverse Event|0|||
42126586|NCT00434577|75937144|FG001|Months 0-3|Adverse Event|1|||
42126587|NCT00434577|75937145|FG002|Months 0-3|Adverse Event|1|||
42126588|NCT00434577|75937146|FG003|Months 0-3|Adverse Event|0|||
42126589|NCT00434577|75937147|FG004|Months 0-3|Adverse Event|0|||
42126590|NCT00434577|75937143|FG000|Months 0-3|Lost to Follow-up|0|||
42126591|NCT00434577|75937144|FG001|Months 0-3|Lost to Follow-up|0|||
42126592|NCT00434577|75937145|FG002|Months 0-3|Lost to Follow-up|0|||
42126593|NCT00434577|75937146|FG003|Months 0-3|Lost to Follow-up|0|||
42126594|NCT00434577|75937147|FG004|Months 0-3|Lost to Follow-up|2|||
42126595|NCT00434577|75937143|FG000|Months 0-3|Protocol Violation|1|||
42126596|NCT00434577|75937144|FG001|Months 0-3|Protocol Violation|0|||
42126597|NCT00434577|75937145|FG002|Months 0-3|Protocol Violation|1|||
42126598|NCT00434577|75937146|FG003|Months 0-3|Protocol Violation|0|||
42126599|NCT00434577|75937147|FG004|Months 0-3|Protocol Violation|0|||
42126600|NCT00434577|75937143|FG000|Months 0-3|Withdrawal by Subject|2|||
42126601|NCT00434577|75937144|FG001|Months 0-3|Withdrawal by Subject|1|||
42126602|NCT00434577|75937145|FG002|Months 0-3|Withdrawal by Subject|1|||
42126603|NCT00434577|75937146|FG003|Months 0-3|Withdrawal by Subject|1|||
42126604|NCT00434577|75937147|FG004|Months 0-3|Withdrawal by Subject|1|||
42126605|NCT00434421|75937159|FG000|Overall Study|Withdrawal by Subject|1|||
42126606|NCT00434421|75937159|FG000|Overall Study|Non-compliance with study treatment|1|||
42126607|NCT00421707|75937165|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
41971310|NCT03008122|75772704|FG001|Overall Study|Lost to Follow-up|8|||
41971311|NCT03008122|75772705|FG002|Overall Study|Lost to Follow-up|3|||
41971312|NCT03008122|75772703|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
41971313|NCT03008122|75772704|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
41971314|NCT03008122|75772705|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
41971315|NCT03008122|75772703|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
41971316|NCT03008122|75772704|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
41971317|NCT03008122|75772705|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
41971318|NCT03008122|75772703|FG000|Overall Study|Death|0|||
41971319|NCT03008122|75772704|FG001|Overall Study|Death|0|||
41971320|NCT03008122|75772705|FG002|Overall Study|Death|1|||
41971321|NCT01817751|75772747|FG000|Overall Study|Physician Decision|1|||
41971322|NCT01349322|75772763|FG000|Overall Study|Protocol Violation|45|||
41971323|NCT01349322|75772764|FG001|Overall Study|Protocol Violation|47|||
41971324|NCT01182415|75772776|FG000|Overall Study|Lost to Follow-up|1|||
41971325|NCT01030523|75772782|FG000|Initial Study (5 Years)|Death|1|||
41971326|NCT01030523|75772783|FG001|Initial Study (5 Years)|Death|0|||
41971327|NCT01030523|75772782|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
41971328|NCT01030523|75772783|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
42126608|NCT00421707|75937166|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
42126609|NCT00421707|75937165|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
42126610|NCT00421707|75937166|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
42126611|NCT00421707|75937165|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
42126612|NCT00421707|75937166|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
42126613|NCT00421707|75937165|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
42126614|NCT00421707|75937166|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
41971329|NCT01030523|75772782|FG000|Initial Study (5 Years)|Implant failure|1|||
41971330|NCT01030523|75772783|FG001|Initial Study (5 Years)|Implant failure|0|||
41971331|NCT01030523|75772782|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
41971332|NCT01030523|75772783|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
41971333|NCT01030523|75772782|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
41971334|NCT01030523|75772783|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
41971335|NCT01030523|75772782|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
41971336|NCT01030523|75772783|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
41971337|NCT03811574|75772822|FG000|Overall Study|Withdrawal by Subject|2|||
41971338|NCT03811574|75772823|FG001|Overall Study|Withdrawal by Subject|4|||
42126615|NCT00421707|75937165|FG000|Period 2: Washout|Adverse Event|1|||
42126616|NCT00421707|75937166|FG001|Period 2: Washout|Adverse Event|1|||
42126617|NCT00421707|75937165|FG000|Period 2: Washout|Withdrawal by Subject|0|||
42126618|NCT00421707|75937166|FG001|Period 2: Washout|Withdrawal by Subject|1|||
42126619|NCT00421707|75937165|FG000|Period 2: Washout|Lost to Follow-up|0|||
42126620|NCT00421707|75937166|FG001|Period 2: Washout|Lost to Follow-up|1|||
42126621|NCT00421707|75937165|FG000|Period 2: Washout|Other: Pregnancy|0|||
42126622|NCT00421707|75937166|FG001|Period 2: Washout|Other: Pregnancy|1|||
42126623|NCT00421707|75937165|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
42126624|NCT00421707|75937166|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
42126625|NCT00421707|75937165|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
42126626|NCT00421707|75937166|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
42126627|NCT00421707|75937165|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
42126628|NCT00421707|75937166|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
41971339|NCT03811574|75772824|FG002|Overall Study|Withdrawal by Subject|0|||
41971340|NCT03727750|75772847|FG000|Overall Study|Death|45|||
41971341|NCT03727750|75772847|FG000|Overall Study|Withdrawal by Subject|2|||
41971342|NCT03727750|75772847|FG000|Overall Study|Lost to Follow-up|1|||
42126629|NCT00518622|75937192|FG000|Overall Study|Lost to Follow-up|0|||
42126630|NCT00518622|75937193|FG001|Overall Study|Lost to Follow-up|0|||
42126631|NCT00518622|75937194|FG002|Overall Study|Lost to Follow-up|1|||
42126632|NCT00518622|75937195|FG003|Overall Study|Lost to Follow-up|0|||
42126633|NCT00518622|75937196|FG004|Overall Study|Lost to Follow-up|0|||
42126634|NCT00518622|75937197|FG005|Overall Study|Lost to Follow-up|0|||
42126635|NCT00518622|75937198|FG006|Overall Study|Lost to Follow-up|0|||
42126636|NCT00518622|75937199|FG007|Overall Study|Lost to Follow-up|0|||
42126637|NCT00518622|75937192|FG000|Overall Study|Study medication taken incorrectly|0|||
42126638|NCT00518622|75937193|FG001|Overall Study|Study medication taken incorrectly|1|||
42126639|NCT00518622|75937194|FG002|Overall Study|Study medication taken incorrectly|0|||
42126640|NCT00518622|75937195|FG003|Overall Study|Study medication taken incorrectly|0|||
42126641|NCT00518622|75937196|FG004|Overall Study|Study medication taken incorrectly|0|||
42126642|NCT00518622|75937197|FG005|Overall Study|Study medication taken incorrectly|0|||
42126643|NCT00518622|75937198|FG006|Overall Study|Study medication taken incorrectly|0|||
42126644|NCT00518622|75937199|FG007|Overall Study|Study medication taken incorrectly|0|||
41971343|NCT03727750|75772847|FG000|Overall Study|Other|1|||
41971344|NCT03715829|75772857|FG000|Dose Ranging Period|Adverse Event|2|||
41971345|NCT03715829|75772858|FG001|Dose Ranging Period|Adverse Event|4|||
41971346|NCT03715829|75772859|FG002|Dose Ranging Period|Adverse Event|5|||
41971347|NCT03715829|75772860|FG003|Dose Ranging Period|Adverse Event|2|||
41971348|NCT03715829|75772861|FG004|Dose Ranging Period|Adverse Event|3|||
41971349|NCT03715829|75772862|FG005|Dose Ranging Period|Adverse Event|3|||
41971350|NCT03715829|75772863|FG006|Dose Ranging Period|Adverse Event|0|||
41971351|NCT03715829|75772864|FG007|Dose Ranging Period|Adverse Event|0|||
41971352|NCT03715829|75772865|FG008|Dose Ranging Period|Adverse Event|0|||
41971353|NCT03715829|75772866|FG009|Dose Ranging Period|Adverse Event|0|||
41971354|NCT03715829|75772867|FG010|Dose Ranging Period|Adverse Event|0|||
41971355|NCT03715829|75772857|FG000|Dose Ranging Period|Lack of Efficacy|0|||
41971356|NCT03715829|75772858|FG001|Dose Ranging Period|Lack of Efficacy|1|||
41971357|NCT03715829|75772859|FG002|Dose Ranging Period|Lack of Efficacy|0|||
41971358|NCT03715829|75772860|FG003|Dose Ranging Period|Lack of Efficacy|1|||
41971359|NCT03715829|75772861|FG004|Dose Ranging Period|Lack of Efficacy|0|||
41971360|NCT03715829|75772862|FG005|Dose Ranging Period|Lack of Efficacy|0|||
42126645|NCT00517296|75937219|FG000|Overall Study|Withdrawal by Subject|1|||
42126646|NCT00517296|75937220|FG001|Overall Study|Withdrawal by Subject|0|||
42126647|NCT00516906|75937228|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
41971361|NCT03715829|75772863|FG006|Dose Ranging Period|Lack of Efficacy|0|||
41971362|NCT03715829|75772864|FG007|Dose Ranging Period|Lack of Efficacy|0|||
41971363|NCT03715829|75772865|FG008|Dose Ranging Period|Lack of Efficacy|0|||
41971364|NCT03715829|75772866|FG009|Dose Ranging Period|Lack of Efficacy|0|||
41971365|NCT03715829|75772867|FG010|Dose Ranging Period|Lack of Efficacy|0|||
42126648|NCT00516906|75937229|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
41971366|NCT03715829|75772857|FG000|Dose Ranging Period|Lost to Follow-up|2|||
41971367|NCT03715829|75772858|FG001|Dose Ranging Period|Lost to Follow-up|0|||
42126649|NCT00523848|75937235|FG000|Overall Study|Adverse Event|11|||
41971368|NCT03715829|75772859|FG002|Dose Ranging Period|Lost to Follow-up|1|||
42126650|NCT00523848|75937235|FG000|Overall Study|Withdrawal by Subject|2|||
42126651|NCT00523848|75937235|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
42126652|NCT00523848|75937235|FG000|Overall Study|Disease Progression|5|||
42126653|NCT00523848|75937235|FG000|Overall Study|Other, unspecified|4|||
42126654|NCT00617669|75937241|FG000|Overall Study|Withdrawal by Subject|71|||
42126655|NCT00617669|75937242|FG001|Overall Study|Withdrawal by Subject|77|||
42126656|NCT00617669|75937241|FG000|Overall Study|Lost to Follow-up|3|||
42126657|NCT00617669|75937242|FG001|Overall Study|Lost to Follow-up|2|||
42126658|NCT00617669|75937241|FG000|Overall Study|Adverse Event|87|||
42126659|NCT00617669|75937242|FG001|Overall Study|Adverse Event|76|||
42126660|NCT00617669|75937241|FG000|Overall Study|Protocol Violation|2|||
42126661|NCT00617669|75937242|FG001|Overall Study|Protocol Violation|3|||
42126662|NCT00617669|75937241|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
42126663|NCT00617669|75937242|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
42126664|NCT00617669|75937241|FG000|Overall Study|Patients randomized but not treated|2|||
42126665|NCT00617669|75937242|FG001|Overall Study|Patients randomized but not treated|3|||
42126666|NCT03682848|75937248|FG000|Overall Study|Withdrawal by Subject|2|||
42126667|NCT03682848|75937248|FG000|Overall Study|Site closed|5|||
42126668|NCT03682848|75937248|FG000|Overall Study|Protocol Deviation|1|||
42126669|NCT03682848|75937248|FG000|Overall Study|Adverse Event|1|||
42126670|NCT00510510|75937255|FG000|Overall Study|Adverse Event|4|||
42126671|NCT00510510|75937256|FG001|Overall Study|Adverse Event|3|||
42126672|NCT00510510|75937257|FG002|Overall Study|Adverse Event|6|||
42126673|NCT00510510|75937255|FG000|Overall Study|Lack of Efficacy|0|||
42126674|NCT00510510|75937256|FG001|Overall Study|Lack of Efficacy|1|||
42126675|NCT00510510|75937257|FG002|Overall Study|Lack of Efficacy|1|||
42126676|NCT00510510|75937255|FG000|Overall Study|Subjects no longer requires study drug|0|||
42126677|NCT00510510|75937256|FG001|Overall Study|Subjects no longer requires study drug|0|||
42126678|NCT00510510|75937257|FG002|Overall Study|Subjects no longer requires study drug|2|||
42126679|NCT00510510|75937255|FG000|Overall Study|Withdrawal by Subject|1|||
42126680|NCT00510510|75937256|FG001|Overall Study|Withdrawal by Subject|2|||
42126681|NCT00510510|75937257|FG002|Overall Study|Withdrawal by Subject|3|||
42126682|NCT00510510|75937255|FG000|Overall Study|Lost to Follow-up|0|||
42126683|NCT00510510|75937256|FG001|Overall Study|Lost to Follow-up|0|||
42126684|NCT00510510|75937257|FG002|Overall Study|Lost to Follow-up|1|||
42126685|NCT00510510|75937255|FG000|Overall Study|Protocol Violation|0|||
42126686|NCT00510510|75937256|FG001|Overall Study|Protocol Violation|3|||
42126687|NCT00510510|75937257|FG002|Overall Study|Protocol Violation|4|||
42126688|NCT00617591|75937265|FG000|Overall Study|Withdrew consent during Induction|4|||
42301658|NCT02288325|76136766|FG000|Double-blind Treatment Period|Protocol Violation|0|||
41971369|NCT03715829|75772860|FG003|Dose Ranging Period|Lost to Follow-up|1|||
41971370|NCT03715829|75772861|FG004|Dose Ranging Period|Lost to Follow-up|1|||
41971371|NCT03715829|75772862|FG005|Dose Ranging Period|Lost to Follow-up|2|||
41971372|NCT03715829|75772863|FG006|Dose Ranging Period|Lost to Follow-up|0|||
41971373|NCT03715829|75772864|FG007|Dose Ranging Period|Lost to Follow-up|0|||
41971374|NCT03715829|75772865|FG008|Dose Ranging Period|Lost to Follow-up|0|||
41971375|NCT03715829|75772866|FG009|Dose Ranging Period|Lost to Follow-up|0|||
41971376|NCT03715829|75772867|FG010|Dose Ranging Period|Lost to Follow-up|0|||
41971377|NCT03715829|75772857|FG000|Dose Ranging Period|Protocol Violation|0|||
41971378|NCT03715829|75772858|FG001|Dose Ranging Period|Protocol Violation|0|||
41971379|NCT03715829|75772859|FG002|Dose Ranging Period|Protocol Violation|0|||
41971380|NCT03715829|75772860|FG003|Dose Ranging Period|Protocol Violation|1|||
41971381|NCT03715829|75772861|FG004|Dose Ranging Period|Protocol Violation|0|||
41971382|NCT03715829|75772862|FG005|Dose Ranging Period|Protocol Violation|0|||
41971383|NCT03715829|75772863|FG006|Dose Ranging Period|Protocol Violation|0|||
41971384|NCT03715829|75772864|FG007|Dose Ranging Period|Protocol Violation|0|||
41971385|NCT03715829|75772865|FG008|Dose Ranging Period|Protocol Violation|0|||
41971386|NCT03715829|75772866|FG009|Dose Ranging Period|Protocol Violation|0|||
41971387|NCT03715829|75772867|FG010|Dose Ranging Period|Protocol Violation|0|||
41971388|NCT03715829|75772857|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
41971389|NCT03715829|75772858|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
41971390|NCT03715829|75772859|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
41971391|NCT03715829|75772860|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
41971392|NCT03715829|75772861|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
41971393|NCT03715829|75772862|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
41971394|NCT03715829|75772863|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
41971395|NCT03715829|75772864|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
41971396|NCT03715829|75772865|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
42126689|NCT00617591|75937265|FG000|Overall Study|Withdrew consent during Maintenance|6|||
42126690|NCT00510276|75937272|FG000|Acute Double-Blind Phase|Adverse Event|21|||
42126691|NCT00510276|75937273|FG001|Acute Double-Blind Phase|Adverse Event|6|||
42126692|NCT00510276|75937272|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
42126693|NCT00510276|75937273|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
42126694|NCT00510276|75937272|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
42126695|NCT00510276|75937273|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
41971397|NCT03715829|75772866|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
41971398|NCT03715829|75772867|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
41971399|NCT03715829|75772857|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
41971400|NCT03715829|75772858|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
41971401|NCT03715829|75772859|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
41971402|NCT03715829|75772860|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
41971403|NCT03715829|75772861|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
42126696|NCT00510276|75937272|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
42126697|NCT00510276|75937273|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
42126698|NCT00510276|75937272|FG000|Acute Double-Blind Phase|Physician Decision|0|||
42126699|NCT00510276|75937273|FG001|Acute Double-Blind Phase|Physician Decision|3|||
42126700|NCT00510276|75937272|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
42126701|NCT00510276|75937273|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
42126702|NCT00510276|75937272|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
41971404|NCT03715829|75772862|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
41971405|NCT03715829|75772863|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
41971406|NCT03715829|75772864|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
41971407|NCT03715829|75772865|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
41971408|NCT03715829|75772866|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
41971409|NCT03715829|75772867|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
41971410|NCT03715829|75772857|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
41971411|NCT03715829|75772858|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
41971412|NCT03715829|75772859|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
41971413|NCT03715829|75772860|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
41971414|NCT03715829|75772861|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
41971415|NCT03715829|75772862|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
41971416|NCT03715829|75772863|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
41971417|NCT03715829|75772864|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
41971418|NCT03715829|75772865|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
41971419|NCT03715829|75772866|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
41971420|NCT03715829|75772867|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
41971421|NCT03715829|75772857|FG000|Dose Ranging Period|Other|0|||
41971422|NCT03715829|75772858|FG001|Dose Ranging Period|Other|0|||
41971423|NCT03715829|75772859|FG002|Dose Ranging Period|Other|2|||
42126703|NCT00510276|75937273|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
42126704|NCT00510276|75937272|FG000|Acute Double-Blind Phase|Subject Decision|26|||
42126705|NCT00510276|75937273|FG001|Acute Double-Blind Phase|Subject Decision|28|||
42126706|NCT00510276|75937272|FG000|Extension Open-Label Phase|Adverse Event|9|||
42126707|NCT00510276|75937273|FG001|Extension Open-Label Phase|Adverse Event|18|||
42126708|NCT00510276|75937272|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
42126709|NCT00510276|75937273|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
42126710|NCT00510276|75937272|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
42126711|NCT00510276|75937273|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
42126712|NCT00510276|75937272|FG000|Extension Open-Label Phase|Physician Decision|2|||
42126713|NCT00510276|75937273|FG001|Extension Open-Label Phase|Physician Decision|3|||
42126714|NCT00510276|75937272|FG000|Extension Open-Label Phase|Protocol Violation|0|||
42126715|NCT00510276|75937273|FG001|Extension Open-Label Phase|Protocol Violation|1|||
41971424|NCT03715829|75772860|FG003|Dose Ranging Period|Other|0|||
41971425|NCT03715829|75772861|FG004|Dose Ranging Period|Other|0|||
41971426|NCT03715829|75772862|FG005|Dose Ranging Period|Other|3|||
41971427|NCT03715829|75772863|FG006|Dose Ranging Period|Other|0|||
41971428|NCT03715829|75772864|FG007|Dose Ranging Period|Other|0|||
41971429|NCT03715829|75772865|FG008|Dose Ranging Period|Other|0|||
41971430|NCT03715829|75772866|FG009|Dose Ranging Period|Other|0|||
41971431|NCT03715829|75772867|FG010|Dose Ranging Period|Other|0|||
41971432|NCT03715829|75772857|FG000|Extension Period|Adverse Event|0|||
41971433|NCT03715829|75772858|FG001|Extension Period|Adverse Event|0|||
41971434|NCT03715829|75772859|FG002|Extension Period|Adverse Event|0|||
41971435|NCT03715829|75772860|FG003|Extension Period|Adverse Event|0|||
42126716|NCT00510276|75937272|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
42126717|NCT00510276|75937273|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
42126718|NCT00510276|75937272|FG000|Extension Open-Label Phase|Subject Decision|7|||
42126719|NCT00510276|75937273|FG001|Extension Open-Label Phase|Subject Decision|9|||
42126720|NCT00616655|75937289|FG000|Overall Study|Adverse Event|10|||
42126721|NCT00616655|75937290|FG001|Overall Study|Adverse Event|7|||
41971436|NCT03715829|75772861|FG004|Extension Period|Adverse Event|0|||
41971437|NCT03715829|75772862|FG005|Extension Period|Adverse Event|0|||
41971438|NCT03715829|75772863|FG006|Extension Period|Adverse Event|3|||
41971439|NCT03715829|75772864|FG007|Extension Period|Adverse Event|1|||
42126722|NCT00616655|75937291|FG002|Overall Study|Adverse Event|12|||
42301659|NCT02288325|76136767|FG001|Double-blind Treatment Period|Protocol Violation|1|||
41971440|NCT03715829|75772865|FG008|Extension Period|Adverse Event|6|||
41971441|NCT03715829|75772866|FG009|Extension Period|Adverse Event|0|||
41971442|NCT03715829|75772867|FG010|Extension Period|Adverse Event|0|||
41971443|NCT03715829|75772857|FG000|Extension Period|Lack of Efficacy|0|||
41971444|NCT03715829|75772858|FG001|Extension Period|Lack of Efficacy|0|||
41971445|NCT03715829|75772859|FG002|Extension Period|Lack of Efficacy|0|||
41971446|NCT03715829|75772860|FG003|Extension Period|Lack of Efficacy|0|||
41971447|NCT03715829|75772861|FG004|Extension Period|Lack of Efficacy|0|||
41971448|NCT03715829|75772862|FG005|Extension Period|Lack of Efficacy|0|||
41971449|NCT03715829|75772863|FG006|Extension Period|Lack of Efficacy|1|||
41971450|NCT03715829|75772864|FG007|Extension Period|Lack of Efficacy|9|||
41971451|NCT03715829|75772865|FG008|Extension Period|Lack of Efficacy|2|||
41971452|NCT03715829|75772866|FG009|Extension Period|Lack of Efficacy|0|||
41971453|NCT03715829|75772867|FG010|Extension Period|Lack of Efficacy|0|||
41971454|NCT03715829|75772857|FG000|Extension Period|Lost to Follow-up|0|||
41971455|NCT03715829|75772858|FG001|Extension Period|Lost to Follow-up|0|||
41971456|NCT03715829|75772859|FG002|Extension Period|Lost to Follow-up|0|||
41971457|NCT03715829|75772860|FG003|Extension Period|Lost to Follow-up|0|||
41971458|NCT03715829|75772861|FG004|Extension Period|Lost to Follow-up|0|||
41971459|NCT03715829|75772862|FG005|Extension Period|Lost to Follow-up|0|||
41971460|NCT03715829|75772863|FG006|Extension Period|Lost to Follow-up|0|||
41971461|NCT03715829|75772864|FG007|Extension Period|Lost to Follow-up|0|||
41971462|NCT03715829|75772865|FG008|Extension Period|Lost to Follow-up|2|||
42126723|NCT00616655|75937289|FG000|Overall Study|Lack of Efficacy|5|||
42126724|NCT00616655|75937290|FG001|Overall Study|Lack of Efficacy|5|||
41971463|NCT03715829|75772866|FG009|Extension Period|Lost to Follow-up|0|||
41971464|NCT03715829|75772867|FG010|Extension Period|Lost to Follow-up|0|||
41971465|NCT03715829|75772857|FG000|Extension Period|Protocol Violation|0|||
41971466|NCT03715829|75772858|FG001|Extension Period|Protocol Violation|0|||
41971467|NCT03715829|75772859|FG002|Extension Period|Protocol Violation|0|||
41971468|NCT03715829|75772860|FG003|Extension Period|Protocol Violation|0|||
41971469|NCT03715829|75772861|FG004|Extension Period|Protocol Violation|0|||
41971470|NCT03715829|75772862|FG005|Extension Period|Protocol Violation|0|||
41971471|NCT03715829|75772863|FG006|Extension Period|Protocol Violation|0|||
41971472|NCT03715829|75772864|FG007|Extension Period|Protocol Violation|0|||
41971473|NCT03715829|75772865|FG008|Extension Period|Protocol Violation|1|||
41971474|NCT03715829|75772866|FG009|Extension Period|Protocol Violation|0|||
41971475|NCT03715829|75772867|FG010|Extension Period|Protocol Violation|0|||
41971476|NCT03715829|75772857|FG000|Extension Period|Withdrawal by Subject|0|||
41971477|NCT03715829|75772858|FG001|Extension Period|Withdrawal by Subject|0|||
41971478|NCT03715829|75772859|FG002|Extension Period|Withdrawal by Subject|0|||
41971479|NCT03715829|75772860|FG003|Extension Period|Withdrawal by Subject|0|||
41971480|NCT03715829|75772861|FG004|Extension Period|Withdrawal by Subject|0|||
41971481|NCT03715829|75772862|FG005|Extension Period|Withdrawal by Subject|0|||
41971482|NCT03715829|75772863|FG006|Extension Period|Withdrawal by Subject|3|||
41971483|NCT03715829|75772864|FG007|Extension Period|Withdrawal by Subject|3|||
41971484|NCT03715829|75772865|FG008|Extension Period|Withdrawal by Subject|12|||
41971485|NCT03715829|75772866|FG009|Extension Period|Withdrawal by Subject|3|||
41971486|NCT03715829|75772867|FG010|Extension Period|Withdrawal by Subject|0|||
42126725|NCT00616655|75937291|FG002|Overall Study|Lack of Efficacy|5|||
42126726|NCT00616655|75937289|FG000|Overall Study|Lost to Follow-up|3|||
42126727|NCT00616655|75937290|FG001|Overall Study|Lost to Follow-up|12|||
41971487|NCT03715829|75772857|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
41971488|NCT03715829|75772858|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
41971489|NCT03715829|75772859|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
41971490|NCT03715829|75772860|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
41971491|NCT03715829|75772861|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
41971492|NCT03715829|75772862|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
41971493|NCT03715829|75772863|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
41971494|NCT03715829|75772864|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
41971495|NCT03715829|75772865|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
41971496|NCT03715829|75772866|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
41971497|NCT03715829|75772867|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
41971498|NCT03715829|75772857|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
41971499|NCT03715829|75772858|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
41971500|NCT03715829|75772859|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
41971501|NCT03715829|75772860|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
41971502|NCT03715829|75772861|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
41971503|NCT03715829|75772862|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
42126728|NCT00616655|75937291|FG002|Overall Study|Lost to Follow-up|10|||
42126729|NCT00616655|75937289|FG000|Overall Study|Protocol Violation|2|||
42126730|NCT00616655|75937290|FG001|Overall Study|Protocol Violation|4|||
42126731|NCT00616655|75937291|FG002|Overall Study|Protocol Violation|3|||
41971504|NCT03715829|75772863|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
41971505|NCT03715829|75772864|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
41971506|NCT03715829|75772865|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
41971507|NCT03715829|75772866|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
41971508|NCT03715829|75772867|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
41971509|NCT03715829|75772857|FG000|Extension Period|Other|0|||
41971510|NCT03715829|75772858|FG001|Extension Period|Other|0|||
41971511|NCT03715829|75772859|FG002|Extension Period|Other|0|||
41971512|NCT03715829|75772860|FG003|Extension Period|Other|0|||
41971513|NCT03715829|75772861|FG004|Extension Period|Other|0|||
41971514|NCT03715829|75772862|FG005|Extension Period|Other|0|||
41971515|NCT03715829|75772863|FG006|Extension Period|Other|1|||
42126732|NCT00616655|75937289|FG000|Overall Study|Withdrawal by Subject|9|||
42126733|NCT00616655|75937290|FG001|Overall Study|Withdrawal by Subject|7|||
42126734|NCT00616655|75937291|FG002|Overall Study|Withdrawal by Subject|11|||
42126735|NCT00616655|75937289|FG000|Overall Study|Does not meet in/ex criteria|0|||
42126736|NCT00616655|75937290|FG001|Overall Study|Does not meet in/ex criteria|0|||
42126737|NCT00616655|75937291|FG002|Overall Study|Does not meet in/ex criteria|2|||
42126738|NCT00616655|75937289|FG000|Overall Study|Other|6|||
42126739|NCT00616655|75937290|FG001|Overall Study|Other|6|||
42126740|NCT00616655|75937291|FG002|Overall Study|Other|5|||
42126741|NCT00510198|75937301|FG000|Overall Study|Withdrawal by Subject|5|||
42126742|NCT00510198|75937302|FG001|Overall Study|Withdrawal by Subject|4|||
42126743|NCT00516048|75937312|FG000|Overall Study|Death|0|||
42126744|NCT00516048|75937313|FG001|Overall Study|Death|0|||
42126745|NCT00516048|75937314|FG002|Overall Study|Death|1|||
42126746|NCT00516048|75937312|FG000|Overall Study|Subject Decision|0|||
42126747|NCT00516048|75937313|FG001|Overall Study|Subject Decision|2|||
42126748|NCT00516048|75937314|FG002|Overall Study|Subject Decision|0|||
42126749|NCT00617357|75937322|FG000|Overall Study|Lost to Follow-up|7|||
42126750|NCT00617357|75937322|FG000|Overall Study|Death|5|||
42126751|NCT00617357|75937322|FG000|Overall Study|insurance concerns|2|||
42126752|NCT00617357|75937322|FG000|Overall Study|Withdrawal by Subject|1|||
42126753|NCT00617357|75937322|FG000|Overall Study|Physician Decision|1|||
42126754|NCT00420927|75937334|FG000|Period 1|Adverse Event|19|||
42126755|NCT00420927|75937335|FG001|Period 1|Adverse Event|15|||
42126756|NCT00420927|75937336|FG002|Period 1|Adverse Event|0|||
42126757|NCT00420927|75937337|FG003|Period 1|Adverse Event|0|||
42126758|NCT00420927|75937338|FG004|Period 1|Adverse Event|0|||
42126759|NCT00420927|75937339|FG005|Period 1|Adverse Event|0|||
42126760|NCT00420927|75937340|FG006|Period 1|Adverse Event|0|||
42126761|NCT00420927|75937334|FG000|Period 1|Withdrawal by Subject|7|||
42126762|NCT00420927|75937335|FG001|Period 1|Withdrawal by Subject|12|||
42126763|NCT00420927|75937336|FG002|Period 1|Withdrawal by Subject|0|||
41971516|NCT03715829|75772864|FG007|Extension Period|Other|2|||
41971517|NCT03715829|75772865|FG008|Extension Period|Other|4|||
41971518|NCT03715829|75772866|FG009|Extension Period|Other|0|||
41971519|NCT03715829|75772867|FG010|Extension Period|Other|0|||
41971520|NCT03575104|75772929|FG000|Overall Study|Adverse Event|4|||
41971521|NCT03575104|75772930|FG001|Overall Study|Adverse Event|3|||
41971522|NCT03575104|75772931|FG002|Overall Study|Adverse Event|4|||
41971523|NCT03575104|75772929|FG000|Overall Study|Withdrawal by Subject|13|||
41971524|NCT03575104|75772930|FG001|Overall Study|Withdrawal by Subject|16|||
41971525|NCT03575104|75772931|FG002|Overall Study|Withdrawal by Subject|11|||
41971526|NCT03575104|75772929|FG000|Overall Study|Other reasons|6|||
41971527|NCT03575104|75772930|FG001|Overall Study|Other reasons|8|||
41971528|NCT03575104|75772931|FG002|Overall Study|Other reasons|6|||
41971529|NCT03575104|75772929|FG000|Overall Study|Lost to Follow-up|1|||
42126764|NCT00420927|75937337|FG003|Period 1|Withdrawal by Subject|0|||
42126765|NCT00420927|75937338|FG004|Period 1|Withdrawal by Subject|0|||
42126766|NCT00420927|75937339|FG005|Period 1|Withdrawal by Subject|0|||
42126767|NCT00420927|75937340|FG006|Period 1|Withdrawal by Subject|0|||
42126768|NCT00420927|75937334|FG000|Period 1|Lost to Follow-up|8|||
42126769|NCT00420927|75937335|FG001|Period 1|Lost to Follow-up|6|||
42126770|NCT00420927|75937336|FG002|Period 1|Lost to Follow-up|0|||
42126771|NCT00420927|75937337|FG003|Period 1|Lost to Follow-up|0|||
42126772|NCT00420927|75937338|FG004|Period 1|Lost to Follow-up|0|||
41971530|NCT03575104|75772930|FG001|Overall Study|Lost to Follow-up|2|||
41971531|NCT03575104|75772931|FG002|Overall Study|Lost to Follow-up|1|||
41971532|NCT03569475|75772942|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
41971533|NCT03569475|75772943|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
41971534|NCT03569475|75772944|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
41971535|NCT03569475|75772942|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
41971536|NCT03569475|75772943|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
41971537|NCT03569475|75772944|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
42126773|NCT00420927|75937339|FG005|Period 1|Lost to Follow-up|0|||
42126774|NCT00420927|75937340|FG006|Period 1|Lost to Follow-up|0|||
42126775|NCT00420927|75937334|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
42126776|NCT00420927|75937335|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
41971538|NCT03569475|75772942|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
41971539|NCT03569475|75772943|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
41971540|NCT03569475|75772944|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
41971541|NCT03569475|75772942|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
41971542|NCT03569475|75772943|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
41971543|NCT03569475|75772944|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
41971544|NCT03569475|75772942|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
41971545|NCT03569475|75772943|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
41971546|NCT03569475|75772944|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
41971547|NCT03569475|75772942|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
41971548|NCT03569475|75772943|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
41971549|NCT03569475|75772944|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
41971550|NCT03569475|75772942|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
41971551|NCT03569475|75772943|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
41971552|NCT03569475|75772944|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
41971553|NCT03569475|75772942|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
41971554|NCT03569475|75772943|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
41971555|NCT03569475|75772944|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
41971556|NCT03569475|75772942|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
41971557|NCT03569475|75772943|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
41971558|NCT03569475|75772944|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
41971559|NCT03545191|75772958|FG000|Overall Study|Death|1|||
41971560|NCT03545191|75772959|FG001|Overall Study|Death|0|||
41971561|NCT03545191|75772960|FG002|Overall Study|Death|0|||
41971562|NCT03545191|75772958|FG000|Overall Study|Adverse Event|4|||
41971563|NCT03545191|75772959|FG001|Overall Study|Adverse Event|2|||
41971564|NCT03545191|75772960|FG002|Overall Study|Adverse Event|7|||
41971565|NCT03545191|75772958|FG000|Overall Study|Other reasons|3|||
41971566|NCT03545191|75772959|FG001|Overall Study|Other reasons|11|||
41971567|NCT03545191|75772960|FG002|Overall Study|Other reasons|8|||
41971568|NCT03545191|75772958|FG000|Overall Study|Withdrawal by Subject|13|||
41971569|NCT03545191|75772959|FG001|Overall Study|Withdrawal by Subject|10|||
41971570|NCT03545191|75772960|FG002|Overall Study|Withdrawal by Subject|12|||
41971571|NCT03545191|75772958|FG000|Overall Study|Lost to Follow-up|1|||
41971572|NCT03545191|75772959|FG001|Overall Study|Lost to Follow-up|2|||
41971573|NCT03545191|75772960|FG002|Overall Study|Lost to Follow-up|3|||
41971574|NCT03500549|75772970|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
41971575|NCT03500549|75772971|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
41971576|NCT03500549|75772970|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
42126777|NCT00420927|75937336|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
42126778|NCT00420927|75937337|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
41971577|NCT03500549|75772971|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
41971578|NCT03366792|75772991|FG000|Overall Study|Withdrawal by Subject|7|||
41971579|NCT03366792|75772991|FG000|Overall Study|Lost to Follow-up|2|||
41971580|NCT03366792|75772991|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
41971581|NCT03366792|75772991|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
41971582|NCT03342053|75772997|FG000|Overall Study|Adverse Event|2|||
41971583|NCT03342053|75772998|FG001|Overall Study|Adverse Event|0|||
41971584|NCT03342053|75772997|FG000|Overall Study|Withdrawal by Subject|0|||
41971585|NCT03342053|75772998|FG001|Overall Study|Withdrawal by Subject|1|||
41971586|NCT03325777|75773006|FG000|Overall Study|Lost to Follow-up|9|||
41971587|NCT03325777|75773007|FG001|Overall Study|Lost to Follow-up|12|||
41971588|NCT03283241|75773015|FG000|Overall Study|Adverse Event|4|||
41971589|NCT03283241|75773016|FG001|Overall Study|Adverse Event|1|||
41971590|NCT03283241|75773015|FG000|Overall Study|Withdrawal by Subject|0|||
41971591|NCT03283241|75773016|FG001|Overall Study|Withdrawal by Subject|1|||
41971592|NCT03283241|75773015|FG000|Overall Study|Subject relocated to Finland|0|||
41971593|NCT03283241|75773016|FG001|Overall Study|Subject relocated to Finland|1|||
41971594|NCT03242772|75773024|FG000|Overall Study|Lost to Follow-up|2|||
41971595|NCT03242772|75773025|FG001|Overall Study|Lost to Follow-up|0|||
41971596|NCT03242772|75773024|FG000|Overall Study|Physician Decision|0|||
41971597|NCT03242772|75773025|FG001|Overall Study|Physician Decision|1|||
42126779|NCT00420927|75937338|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
42126780|NCT00420927|75937339|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
42126781|NCT00420927|75937340|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
41971598|NCT03242772|75773024|FG000|Overall Study|Withdrawal by Subject|1|||
41971599|NCT03242772|75773025|FG001|Overall Study|Withdrawal by Subject|0|||
41971600|NCT03236311|75773033|FG000|Overall Study|Study terminated by sponsor|0|||
41971601|NCT03236311|75773034|FG001|Overall Study|Study terminated by sponsor|2|||
41971602|NCT03236311|75773033|FG000|Overall Study|Adverse Event|0|||
41971603|NCT03236311|75773034|FG001|Overall Study|Adverse Event|1|||
41971604|NCT03192046|75773042|FG000|Overall Study|Withdrawal by Subject|1|||
41971605|NCT03192046|75773043|FG001|Overall Study|Withdrawal by Subject|1|||
41971606|NCT03190369|75773051|FG000|Overall Study|Poor compliance to protocol|0|||
41971607|NCT03190369|75773052|FG001|Overall Study|Poor compliance to protocol|1|||
41971608|NCT03190369|75773051|FG000|Overall Study|Withdraw before treatment|1|||
41971609|NCT03190369|75773052|FG001|Overall Study|Withdraw before treatment|5|||
41971610|NCT03190369|75773051|FG000|Overall Study|Randomized but not treated|0|||
41971611|NCT03190369|75773052|FG001|Overall Study|Randomized but not treated|2|||
41971612|NCT04657198|75773061|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
41971613|NCT04657198|75773062|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
41971614|NCT04657198|75773063|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
41971615|NCT04590586|75773077|FG000|Overall Study|Death|7|||
41971616|NCT04590586|75773078|FG001|Overall Study|Death|1|||
41971617|NCT04590586|75773079|FG002|Overall Study|Death|37|||
41971618|NCT04590586|75773080|FG003|Overall Study|Death|34|||
41971619|NCT04590586|75773081|FG004|Overall Study|Death|19|||
41971620|NCT04590586|75773082|FG005|Overall Study|Death|3|||
41971621|NCT04590586|75773077|FG000|Overall Study|Lost to Follow-up|3|||
41971622|NCT04590586|75773078|FG001|Overall Study|Lost to Follow-up|0|||
41971623|NCT04590586|75773079|FG002|Overall Study|Lost to Follow-up|11|||
41971624|NCT04590586|75773080|FG003|Overall Study|Lost to Follow-up|11|||
41971625|NCT04590586|75773081|FG004|Overall Study|Lost to Follow-up|6|||
41971626|NCT04590586|75773082|FG005|Overall Study|Lost to Follow-up|0|||
41971627|NCT04590586|75773077|FG000|Overall Study|Withdrawal by Subject|0|||
41971628|NCT04590586|75773078|FG001|Overall Study|Withdrawal by Subject|0|||
41971629|NCT04590586|75773079|FG002|Overall Study|Withdrawal by Subject|6|||
41971630|NCT04590586|75773080|FG003|Overall Study|Withdrawal by Subject|0|||
41971631|NCT04590586|75773081|FG004|Overall Study|Withdrawal by Subject|3|||
41971632|NCT04590586|75773082|FG005|Overall Study|Withdrawal by Subject|0|||
41971633|NCT04590586|75773077|FG000|Overall Study|Other|3|||
41971634|NCT04590586|75773078|FG001|Overall Study|Other|0|||
41971635|NCT04590586|75773079|FG002|Overall Study|Other|1|||
41971636|NCT04590586|75773080|FG003|Overall Study|Other|1|||
41971637|NCT04590586|75773081|FG004|Overall Study|Other|2|||
41971638|NCT04590586|75773082|FG005|Overall Study|Other|1|||
41971639|NCT04312009|75773108|FG000|Overall Study|Withdrawal by Subject|2|||
41971640|NCT04312009|75773109|FG001|Overall Study|Withdrawal by Subject|1|||
41971641|NCT03937466|75773124|FG000|Overall Study|not eligbile after the 2-week diary|9|||
41971642|NCT03937466|75773124|FG000|Overall Study|never returned their diary|6|||
41971643|NCT03937466|75773124|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
41971644|NCT03937466|75773124|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
41971645|NCT03850483|75773137|FG000|Treatment for Stage 1|Adverse Event|1|||
41971646|NCT03850483|75773138|FG001|Treatment for Stage 1|Adverse Event|1|||
41971647|NCT03850483|75773139|FG002|Treatment for Stage 1|Adverse Event|3|||
42126782|NCT00420927|75937334|FG000|Period 1|Death|2|||
42126783|NCT00420927|75937335|FG001|Period 1|Death|0|||
42126784|NCT00420927|75937336|FG002|Period 1|Death|0|||
42126785|NCT00420927|75937337|FG003|Period 1|Death|0|||
42126786|NCT00420927|75937338|FG004|Period 1|Death|0|||
42126787|NCT00420927|75937339|FG005|Period 1|Death|0|||
42126788|NCT00420927|75937340|FG006|Period 1|Death|0|||
41971648|NCT03850483|75773140|FG003|Treatment for Stage 1|Adverse Event|0|||
41971649|NCT03850483|75773141|FG004|Treatment for Stage 1|Adverse Event|2|||
41971650|NCT03850483|75773142|FG005|Treatment for Stage 1|Adverse Event|0|||
41971651|NCT03850483|75773143|FG006|Treatment for Stage 1|Adverse Event|2|||
41971652|NCT03850483|75773144|FG007|Treatment for Stage 1|Adverse Event|2|||
41971653|NCT03850483|75773145|FG008|Treatment for Stage 1|Adverse Event|0|||
41971654|NCT03850483|75773146|FG009|Treatment for Stage 1|Adverse Event|0|||
41971655|NCT03850483|75773137|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
41971656|NCT03850483|75773138|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
41971657|NCT03850483|75773139|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
42126789|NCT00420927|75937334|FG000|Period 1|Subject moved/relocated|0|||
42301660|NCT02288325|76136768|FG002|Double-blind Treatment Period|Protocol Violation|2|||
42126790|NCT00420927|75937335|FG001|Period 1|Subject moved/relocated|2|||
41971658|NCT03850483|75773140|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
41971659|NCT03850483|75773141|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
41971660|NCT03850483|75773142|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
41971661|NCT03850483|75773143|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
41971662|NCT03850483|75773144|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
41971663|NCT03850483|75773145|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
42126791|NCT00420927|75937336|FG002|Period 1|Subject moved/relocated|0|||
42126792|NCT00420927|75937337|FG003|Period 1|Subject moved/relocated|0|||
41971664|NCT03850483|75773146|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
41971665|NCT03850483|75773137|FG000|Treatment for Stage 1|Protocol Violation|1|||
41971666|NCT03850483|75773138|FG001|Treatment for Stage 1|Protocol Violation|0|||
41971667|NCT03850483|75773139|FG002|Treatment for Stage 1|Protocol Violation|0|||
41971668|NCT03850483|75773140|FG003|Treatment for Stage 1|Protocol Violation|0|||
41971669|NCT03850483|75773141|FG004|Treatment for Stage 1|Protocol Violation|0|||
41971670|NCT03850483|75773142|FG005|Treatment for Stage 1|Protocol Violation|0|||
41971671|NCT03850483|75773143|FG006|Treatment for Stage 1|Protocol Violation|1|||
41971672|NCT03850483|75773144|FG007|Treatment for Stage 1|Protocol Violation|0|||
41971673|NCT03850483|75773145|FG008|Treatment for Stage 1|Protocol Violation|0|||
41971674|NCT03850483|75773146|FG009|Treatment for Stage 1|Protocol Violation|0|||
41971675|NCT03850483|75773137|FG000|Treatment for Stage 1|Physician Decision|0|||
41971676|NCT03850483|75773138|FG001|Treatment for Stage 1|Physician Decision|0|||
41971677|NCT03850483|75773139|FG002|Treatment for Stage 1|Physician Decision|0|||
41971678|NCT03850483|75773140|FG003|Treatment for Stage 1|Physician Decision|0|||
41971679|NCT03850483|75773141|FG004|Treatment for Stage 1|Physician Decision|0|||
41971680|NCT03850483|75773142|FG005|Treatment for Stage 1|Physician Decision|1|||
41971681|NCT03850483|75773143|FG006|Treatment for Stage 1|Physician Decision|0|||
41971682|NCT03850483|75773144|FG007|Treatment for Stage 1|Physician Decision|0|||
41971683|NCT03850483|75773145|FG008|Treatment for Stage 1|Physician Decision|0|||
41971684|NCT03850483|75773146|FG009|Treatment for Stage 1|Physician Decision|0|||
41971685|NCT03850483|75773137|FG000|Treatment for Stage 1|Other|0|||
41971686|NCT03850483|75773138|FG001|Treatment for Stage 1|Other|0|||
41971687|NCT03850483|75773139|FG002|Treatment for Stage 1|Other|0|||
41971688|NCT03850483|75773140|FG003|Treatment for Stage 1|Other|0|||
41971689|NCT03850483|75773141|FG004|Treatment for Stage 1|Other|2|||
41971690|NCT03850483|75773142|FG005|Treatment for Stage 1|Other|1|||
41971691|NCT03850483|75773143|FG006|Treatment for Stage 1|Other|0|||
41971692|NCT03850483|75773144|FG007|Treatment for Stage 1|Other|0|||
41971693|NCT03850483|75773145|FG008|Treatment for Stage 1|Other|0|||
41971694|NCT03850483|75773146|FG009|Treatment for Stage 1|Other|0|||
41971695|NCT03850483|75773137|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
41971696|NCT03850483|75773138|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
41971697|NCT03850483|75773139|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
41971698|NCT03850483|75773140|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
41971699|NCT03850483|75773141|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
41971700|NCT03850483|75773142|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
41971701|NCT03850483|75773143|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
41971702|NCT03850483|75773144|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
41971703|NCT03850483|75773145|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
41971704|NCT03850483|75773146|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
41971705|NCT03850483|75773137|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
41971706|NCT03850483|75773138|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
41971707|NCT03850483|75773139|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
41971708|NCT03850483|75773140|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
41971709|NCT03850483|75773141|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
41971710|NCT03850483|75773142|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
41971711|NCT03850483|75773143|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
41971712|NCT03850483|75773144|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
41971713|NCT03850483|75773145|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
41971714|NCT03850483|75773146|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
41971715|NCT03850483|75773137|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
41971716|NCT03850483|75773138|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
41971717|NCT03850483|75773139|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
41971718|NCT03850483|75773140|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
41971719|NCT03850483|75773141|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
41971720|NCT03850483|75773142|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
41971721|NCT03850483|75773143|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
41971722|NCT03850483|75773144|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
41971723|NCT03850483|75773145|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
41971724|NCT03850483|75773146|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
42126793|NCT00420927|75937338|FG004|Period 1|Subject moved/relocated|0|||
41971725|NCT03850483|75773137|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
41971726|NCT03850483|75773138|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
41971727|NCT03850483|75773139|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
41971728|NCT03850483|75773140|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
41971729|NCT03850483|75773141|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
41971730|NCT03850483|75773142|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
42126794|NCT00420927|75937339|FG005|Period 1|Subject moved/relocated|0|||
42126795|NCT00420927|75937340|FG006|Period 1|Subject moved/relocated|0|||
42027997|NCT01125930|75836269|FG000|Overall Study|Withdrawal by Subject|1|||
42027998|NCT01125930|75836270|FG001|Overall Study|Withdrawal by Subject|6|||
42126796|NCT00420927|75937334|FG000|Period 1|Noncompliant with study drug|1|||
41971731|NCT03850483|75773143|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
41971732|NCT03850483|75773144|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
41971733|NCT03850483|75773145|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
41971734|NCT03850483|75773146|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
41971735|NCT03850483|75773137|FG000|Treatment for Stage 1|Death|0|||
41971736|NCT03850483|75773138|FG001|Treatment for Stage 1|Death|0|||
41971737|NCT03850483|75773139|FG002|Treatment for Stage 1|Death|0|||
41971738|NCT03850483|75773140|FG003|Treatment for Stage 1|Death|0|||
41971739|NCT03850483|75773141|FG004|Treatment for Stage 1|Death|0|||
41971740|NCT03850483|75773142|FG005|Treatment for Stage 1|Death|1|||
41971741|NCT03850483|75773143|FG006|Treatment for Stage 1|Death|0|||
41971742|NCT03850483|75773144|FG007|Treatment for Stage 1|Death|0|||
41971743|NCT03850483|75773145|FG008|Treatment for Stage 1|Death|0|||
41971744|NCT03850483|75773146|FG009|Treatment for Stage 1|Death|0|||
41971745|NCT03850483|75773137|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
41971746|NCT03850483|75773138|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
41971747|NCT03850483|75773139|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
41971748|NCT03850483|75773140|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
41971749|NCT03850483|75773141|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
41971750|NCT03850483|75773142|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
42027999|NCT01125930|75836269|FG000|Overall Study|Protocol Violation|0|||
42028000|NCT01125930|75836270|FG001|Overall Study|Protocol Violation|1|||
42126797|NCT00420927|75937335|FG001|Period 1|Noncompliant with study drug|1|||
42028001|NCT01125930|75836269|FG000|Overall Study|Lost to Follow-up|0|||
42028002|NCT01125930|75836270|FG001|Overall Study|Lost to Follow-up|2|||
42028003|NCT00918346|75836301|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
42126798|NCT00420927|75937336|FG002|Period 1|Noncompliant with study drug|0|||
42126799|NCT00420927|75937337|FG003|Period 1|Noncompliant with study drug|0|||
42126800|NCT00420927|75937338|FG004|Period 1|Noncompliant with study drug|0|||
41971751|NCT03850483|75773143|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
42028004|NCT00918346|75836302|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
42028005|NCT00913978|75836313|FG000|Overall Study|Surgeon choice|1|||
42028006|NCT00913978|75836314|FG001|Overall Study|Surgeon choice|3|||
42126801|NCT00420927|75937339|FG005|Period 1|Noncompliant with study drug|0|||
42126802|NCT00420927|75937340|FG006|Period 1|Noncompliant with study drug|0|||
41971752|NCT03850483|75773144|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
42126803|NCT00420927|75937334|FG000|Period 1|Randomization error|1|||
41971753|NCT03850483|75773145|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
41971754|NCT03850483|75773146|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
41971755|NCT03850483|75773137|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
41971756|NCT03850483|75773138|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
41971757|NCT03850483|75773139|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
41971758|NCT03850483|75773140|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
41971759|NCT03850483|75773141|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
41971760|NCT03850483|75773142|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
41971761|NCT03850483|75773143|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
41971762|NCT03850483|75773144|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
41971763|NCT03850483|75773145|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
41971764|NCT03850483|75773146|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
41971765|NCT03850483|75773137|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
41971766|NCT03850483|75773138|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
41971767|NCT03850483|75773139|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
41971768|NCT03850483|75773140|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
41971769|NCT03850483|75773141|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
41971770|NCT03850483|75773142|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
41971771|NCT03850483|75773143|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
41971772|NCT03850483|75773144|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
41971773|NCT03850483|75773145|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
41971774|NCT03850483|75773146|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
41971775|NCT03850483|75773137|FG000|Follow-up for Stage 1|Physician Decision|0|||
41971776|NCT03850483|75773138|FG001|Follow-up for Stage 1|Physician Decision|0|||
41971777|NCT03850483|75773139|FG002|Follow-up for Stage 1|Physician Decision|0|||
41971778|NCT03850483|75773140|FG003|Follow-up for Stage 1|Physician Decision|0|||
41971779|NCT03850483|75773141|FG004|Follow-up for Stage 1|Physician Decision|1|||
42126804|NCT00420927|75937335|FG001|Period 1|Randomization error|0|||
42126805|NCT00420927|75937336|FG002|Period 1|Randomization error|0|||
42126806|NCT00420927|75937337|FG003|Period 1|Randomization error|0|||
42126807|NCT00420927|75937338|FG004|Period 1|Randomization error|0|||
42126808|NCT00420927|75937339|FG005|Period 1|Randomization error|0|||
42126809|NCT00420927|75937340|FG006|Period 1|Randomization error|0|||
42126810|NCT00420927|75937334|FG000|Period 1|Suspected tuberculosis/positive test|1|||
42126811|NCT00420927|75937335|FG001|Period 1|Suspected tuberculosis/positive test|1|||
42126812|NCT00420927|75937336|FG002|Period 1|Suspected tuberculosis/positive test|0|||
42126813|NCT00420927|75937337|FG003|Period 1|Suspected tuberculosis/positive test|0|||
42126814|NCT00420927|75937338|FG004|Period 1|Suspected tuberculosis/positive test|0|||
42126815|NCT00420927|75937339|FG005|Period 1|Suspected tuberculosis/positive test|0|||
42126816|NCT00420927|75937340|FG006|Period 1|Suspected tuberculosis/positive test|0|||
42126817|NCT00420927|75937334|FG000|Period 1|Study site closure|0|||
42126818|NCT00420927|75937335|FG001|Period 1|Study site closure|1|||
42126819|NCT00420927|75937336|FG002|Period 1|Study site closure|0|||
42126820|NCT00420927|75937337|FG003|Period 1|Study site closure|0|||
42126821|NCT00420927|75937338|FG004|Period 1|Study site closure|0|||
42126822|NCT00420927|75937339|FG005|Period 1|Study site closure|0|||
42126823|NCT00420927|75937340|FG006|Period 1|Study site closure|0|||
42126824|NCT00420927|75937334|FG000|Period 1|Subject received new diagnosis|0|||
42126825|NCT00420927|75937335|FG001|Period 1|Subject received new diagnosis|2|||
42126826|NCT00420927|75937336|FG002|Period 1|Subject received new diagnosis|0|||
42126827|NCT00420927|75937337|FG003|Period 1|Subject received new diagnosis|0|||
42126828|NCT00420927|75937338|FG004|Period 1|Subject received new diagnosis|0|||
41971780|NCT03850483|75773142|FG005|Follow-up for Stage 1|Physician Decision|0|||
41971781|NCT03850483|75773143|FG006|Follow-up for Stage 1|Physician Decision|1|||
41971782|NCT03850483|75773144|FG007|Follow-up for Stage 1|Physician Decision|0|||
41971783|NCT03850483|75773145|FG008|Follow-up for Stage 1|Physician Decision|0|||
41971784|NCT03850483|75773146|FG009|Follow-up for Stage 1|Physician Decision|0|||
41971785|NCT03850483|75773137|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
41971786|NCT03850483|75773138|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
42126829|NCT00420927|75937339|FG005|Period 1|Subject received new diagnosis|0|||
42301661|NCT02288325|76136766|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
42301662|NCT02288325|76136767|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
41971787|NCT03850483|75773139|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
41971788|NCT03850483|75773140|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
41971789|NCT03850483|75773141|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
41971790|NCT03850483|75773142|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
41971791|NCT03850483|75773143|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
42126830|NCT00420927|75937340|FG006|Period 1|Subject received new diagnosis|0|||
42126831|NCT00420927|75937334|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
42126832|NCT00420927|75937335|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
42126833|NCT00420927|75937336|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
42126834|NCT00420927|75937337|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
42301663|NCT02288325|76136768|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
41971792|NCT03850483|75773144|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
41971793|NCT03850483|75773145|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
41971794|NCT03850483|75773146|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
41971795|NCT03850483|75773137|FG000|Follow-up for Stage 1|Adverse Event|0|||
41971796|NCT03850483|75773138|FG001|Follow-up for Stage 1|Adverse Event|0|||
41971797|NCT03850483|75773139|FG002|Follow-up for Stage 1|Adverse Event|1|||
41971798|NCT03850483|75773140|FG003|Follow-up for Stage 1|Adverse Event|0|||
41971799|NCT03850483|75773141|FG004|Follow-up for Stage 1|Adverse Event|0|||
41971800|NCT03850483|75773142|FG005|Follow-up for Stage 1|Adverse Event|1|||
41971801|NCT03850483|75773143|FG006|Follow-up for Stage 1|Adverse Event|0|||
41971802|NCT03850483|75773144|FG007|Follow-up for Stage 1|Adverse Event|0|||
41971803|NCT03850483|75773145|FG008|Follow-up for Stage 1|Adverse Event|0|||
41971804|NCT03850483|75773146|FG009|Follow-up for Stage 1|Adverse Event|0|||
41971805|NCT03850483|75773137|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
41971806|NCT03850483|75773138|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
41971807|NCT03850483|75773139|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
41971808|NCT03850483|75773140|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
41971809|NCT03850483|75773141|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
41971810|NCT03850483|75773142|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
41971811|NCT03850483|75773143|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
41971812|NCT03850483|75773144|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
41971813|NCT03850483|75773145|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
41971814|NCT03850483|75773146|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
41971815|NCT03850483|75773137|FG000|Follow-up for Stage 1|Other|0|||
41971816|NCT03850483|75773138|FG001|Follow-up for Stage 1|Other|2|||
41971817|NCT03850483|75773139|FG002|Follow-up for Stage 1|Other|0|||
41971818|NCT03850483|75773140|FG003|Follow-up for Stage 1|Other|2|||
41971819|NCT03850483|75773141|FG004|Follow-up for Stage 1|Other|0|||
41971820|NCT03850483|75773142|FG005|Follow-up for Stage 1|Other|1|||
41971821|NCT03850483|75773143|FG006|Follow-up for Stage 1|Other|0|||
41971822|NCT03850483|75773144|FG007|Follow-up for Stage 1|Other|0|||
41971823|NCT03850483|75773145|FG008|Follow-up for Stage 1|Other|0|||
41971824|NCT03850483|75773146|FG009|Follow-up for Stage 1|Other|0|||
41971825|NCT03850483|75773137|FG000|Treatment for Stage 2|Adverse Event|0|||
41971826|NCT03850483|75773138|FG001|Treatment for Stage 2|Adverse Event|0|||
41971827|NCT03850483|75773139|FG002|Treatment for Stage 2|Adverse Event|0|||
41971828|NCT03850483|75773140|FG003|Treatment for Stage 2|Adverse Event|0|||
41971829|NCT03850483|75773141|FG004|Treatment for Stage 2|Adverse Event|0|||
41971830|NCT03850483|75773142|FG005|Treatment for Stage 2|Adverse Event|0|||
41971831|NCT03850483|75773143|FG006|Treatment for Stage 2|Adverse Event|0|||
41971832|NCT03850483|75773144|FG007|Treatment for Stage 2|Adverse Event|0|||
41971833|NCT03850483|75773145|FG008|Treatment for Stage 2|Adverse Event|0|||
41971834|NCT03850483|75773146|FG009|Treatment for Stage 2|Adverse Event|1|||
41971835|NCT03850483|75773137|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
41971836|NCT03850483|75773138|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
41971837|NCT03850483|75773139|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
41971838|NCT03850483|75773140|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
41971839|NCT03850483|75773141|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
41971840|NCT03850483|75773142|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
41971841|NCT03850483|75773143|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
41971842|NCT03850483|75773144|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
41971843|NCT03850483|75773145|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
41971844|NCT03850483|75773146|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
41971845|NCT03850483|75773137|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
41971846|NCT03850483|75773138|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
41971847|NCT03850483|75773139|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
41971848|NCT03850483|75773140|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
41971849|NCT03850483|75773141|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
41971850|NCT03850483|75773142|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
42028007|NCT01137474|75836324|FG000|Overall Study|Adverse Event|3|||
41971851|NCT03850483|75773143|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
41971852|NCT03850483|75773144|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
41971853|NCT03850483|75773145|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
41971854|NCT03850483|75773146|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
41971855|NCT03850483|75773137|FG000|Treatment for Stage 2|Physician Decision|0|||
41971856|NCT03850483|75773138|FG001|Treatment for Stage 2|Physician Decision|0|||
41971857|NCT03850483|75773139|FG002|Treatment for Stage 2|Physician Decision|0|||
41971858|NCT03850483|75773140|FG003|Treatment for Stage 2|Physician Decision|0|||
41971859|NCT03850483|75773141|FG004|Treatment for Stage 2|Physician Decision|0|||
41971860|NCT03850483|75773142|FG005|Treatment for Stage 2|Physician Decision|0|||
42126835|NCT00420927|75937338|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
42126836|NCT00420927|75937339|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
42126837|NCT00420927|75937340|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
42028008|NCT01137474|75836325|FG001|Overall Study|Adverse Event|5|||
42028009|NCT01137474|75836326|FG002|Overall Study|Adverse Event|1|||
42028010|NCT01137474|75836327|FG003|Overall Study|Adverse Event|3|||
42028011|NCT01137474|75836324|FG000|Overall Study|Withdrawal by Subject|7|||
42028012|NCT01137474|75836325|FG001|Overall Study|Withdrawal by Subject|2|||
42028013|NCT01137474|75836326|FG002|Overall Study|Withdrawal by Subject|6|||
42126838|NCT00420927|75937334|FG000|Period 1|Failed to meet entry criteria|8|||
42126839|NCT00420927|75937335|FG001|Period 1|Failed to meet entry criteria|7|||
42126840|NCT00420927|75937336|FG002|Period 1|Failed to meet entry criteria|0|||
42126841|NCT00420927|75937337|FG003|Period 1|Failed to meet entry criteria|0|||
42126842|NCT00420927|75937338|FG004|Period 1|Failed to meet entry criteria|0|||
42126843|NCT00420927|75937339|FG005|Period 1|Failed to meet entry criteria|0|||
42126844|NCT00420927|75937340|FG006|Period 1|Failed to meet entry criteria|0|||
42126845|NCT00420927|75937334|FG000|Period 1|Took prohibited medication|1|||
42126846|NCT00420927|75937335|FG001|Period 1|Took prohibited medication|3|||
42301664|NCT02288325|76136766|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
42301665|NCT02288325|76136767|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
42301666|NCT02288325|76136768|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
42301667|NCT02509117|76136785|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
42301668|NCT02509117|76136786|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
42301669|NCT02509117|76136787|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
42301670|NCT02509117|76136788|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
42301671|NCT02509117|76136789|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
41971861|NCT03850483|75773143|FG006|Treatment for Stage 2|Physician Decision|0|||
41971862|NCT03850483|75773144|FG007|Treatment for Stage 2|Physician Decision|0|||
42126847|NCT00420927|75937336|FG002|Period 1|Took prohibited medication|0|||
42126848|NCT00420927|75937337|FG003|Period 1|Took prohibited medication|0|||
41971863|NCT03850483|75773145|FG008|Treatment for Stage 2|Physician Decision|0|||
41971864|NCT03850483|75773146|FG009|Treatment for Stage 2|Physician Decision|1|||
41971865|NCT03850483|75773137|FG000|Treatment for Stage 2|Protocol Violation|0|||
41971866|NCT03850483|75773138|FG001|Treatment for Stage 2|Protocol Violation|0|||
41971867|NCT03850483|75773139|FG002|Treatment for Stage 2|Protocol Violation|0|||
41971868|NCT03850483|75773140|FG003|Treatment for Stage 2|Protocol Violation|0|||
41971869|NCT03850483|75773141|FG004|Treatment for Stage 2|Protocol Violation|0|||
41971870|NCT03850483|75773142|FG005|Treatment for Stage 2|Protocol Violation|0|||
41971871|NCT03850483|75773143|FG006|Treatment for Stage 2|Protocol Violation|0|||
41971872|NCT03850483|75773144|FG007|Treatment for Stage 2|Protocol Violation|0|||
41971873|NCT03850483|75773145|FG008|Treatment for Stage 2|Protocol Violation|1|||
41971874|NCT03850483|75773146|FG009|Treatment for Stage 2|Protocol Violation|0|||
41971875|NCT03850483|75773137|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
41971876|NCT03850483|75773138|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
41971877|NCT03850483|75773139|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
41971878|NCT03850483|75773140|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
41971879|NCT03850483|75773141|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
41971880|NCT03850483|75773142|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
41971881|NCT03850483|75773143|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
41971882|NCT03850483|75773144|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
41971883|NCT03850483|75773145|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
41971884|NCT03850483|75773146|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
41971885|NCT03850483|75773137|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
41971886|NCT03850483|75773138|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
41971887|NCT03850483|75773139|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
41971888|NCT03850483|75773140|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
42028014|NCT01137474|75836327|FG003|Overall Study|Withdrawal by Subject|9|||
42028015|NCT01137474|75836324|FG000|Overall Study|No longer met study criteria|6|||
42028016|NCT01137474|75836325|FG001|Overall Study|No longer met study criteria|1|||
42028017|NCT01137474|75836326|FG002|Overall Study|No longer met study criteria|0|||
42126849|NCT00420927|75937338|FG004|Period 1|Took prohibited medication|0|||
42126850|NCT00420927|75937339|FG005|Period 1|Took prohibited medication|0|||
41971889|NCT03850483|75773141|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
41971890|NCT03850483|75773142|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
41971891|NCT03850483|75773143|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
41971892|NCT03850483|75773144|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
41971893|NCT03850483|75773145|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
41971894|NCT03850483|75773146|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
41971895|NCT03850483|75773137|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
41971896|NCT03850483|75773138|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
41971897|NCT03850483|75773139|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
41971898|NCT03850483|75773140|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
41971899|NCT03850483|75773141|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
41971900|NCT03850483|75773142|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
41971901|NCT03850483|75773143|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
41971902|NCT03850483|75773144|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
41971903|NCT03850483|75773145|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
41971904|NCT03850483|75773146|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
41971905|NCT03850483|75773137|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
41971906|NCT03850483|75773138|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
41971907|NCT03850483|75773139|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
41971908|NCT03850483|75773140|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
41971909|NCT03850483|75773141|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
41971910|NCT03850483|75773142|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
41971911|NCT03850483|75773143|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
41971912|NCT03850483|75773144|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
41971913|NCT03850483|75773145|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
42126851|NCT00420927|75937340|FG006|Period 1|Took prohibited medication|0|||
42126852|NCT00420927|75937334|FG000|Period 2|Adverse Event|0|||
42126853|NCT00420927|75937335|FG001|Period 2|Adverse Event|0|||
42126854|NCT00420927|75937336|FG002|Period 2|Adverse Event|7|||
42126855|NCT00420927|75937337|FG003|Period 2|Adverse Event|3|||
42126856|NCT00420927|75937338|FG004|Period 2|Adverse Event|17|||
42126857|NCT00420927|75937339|FG005|Period 2|Adverse Event|6|||
42126858|NCT00420927|75937340|FG006|Period 2|Adverse Event|20|||
42126859|NCT00420927|75937334|FG000|Period 2|Withdrawal by Subject|0|||
42126860|NCT00420927|75937335|FG001|Period 2|Withdrawal by Subject|0|||
42126861|NCT00420927|75937336|FG002|Period 2|Withdrawal by Subject|1|||
42126862|NCT00420927|75937337|FG003|Period 2|Withdrawal by Subject|3|||
42126863|NCT00420927|75937338|FG004|Period 2|Withdrawal by Subject|11|||
42126864|NCT00420927|75937339|FG005|Period 2|Withdrawal by Subject|2|||
42126865|NCT00420927|75937340|FG006|Period 2|Withdrawal by Subject|12|||
42126866|NCT00420927|75937334|FG000|Period 2|Lost to Follow-up|0|||
42126867|NCT00420927|75937335|FG001|Period 2|Lost to Follow-up|0|||
42126868|NCT00420927|75937336|FG002|Period 2|Lost to Follow-up|2|||
42126869|NCT00420927|75937337|FG003|Period 2|Lost to Follow-up|2|||
42126870|NCT00420927|75937338|FG004|Period 2|Lost to Follow-up|6|||
41971914|NCT03850483|75773146|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
41971915|NCT03850483|75773137|FG000|Follow-up For Stage 2|Other|0|||
41971916|NCT03850483|75773138|FG001|Follow-up For Stage 2|Other|0|||
41971917|NCT03850483|75773139|FG002|Follow-up For Stage 2|Other|0|||
41971918|NCT03850483|75773140|FG003|Follow-up For Stage 2|Other|0|||
41971919|NCT03850483|75773141|FG004|Follow-up For Stage 2|Other|0|||
42126871|NCT00420927|75937339|FG005|Period 2|Lost to Follow-up|3|||
42126872|NCT00420927|75937340|FG006|Period 2|Lost to Follow-up|9|||
42126873|NCT00420927|75937334|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
42126874|NCT00420927|75937335|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
42126875|NCT00420927|75937336|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
42126876|NCT00420927|75937337|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
42126877|NCT00420927|75937338|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
42126878|NCT00420927|75937339|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
42126879|NCT00420927|75937340|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
42126880|NCT00420927|75937334|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
42126881|NCT00420927|75937335|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
42126882|NCT00420927|75937336|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
42126883|NCT00420927|75937337|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
42126884|NCT00420927|75937338|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
41971920|NCT03850483|75773142|FG005|Follow-up For Stage 2|Other|0|||
41971921|NCT03850483|75773143|FG006|Follow-up For Stage 2|Other|0|||
41971922|NCT03850483|75773144|FG007|Follow-up For Stage 2|Other|0|||
41971923|NCT03850483|75773145|FG008|Follow-up For Stage 2|Other|0|||
42126885|NCT00420927|75937339|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
42126886|NCT00420927|75937340|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
42126887|NCT00420927|75937334|FG000|Period 2|Subject unable to find transportation|0|||
42126888|NCT00420927|75937335|FG001|Period 2|Subject unable to find transportation|0|||
42126889|NCT00420927|75937336|FG002|Period 2|Subject unable to find transportation|0|||
41971924|NCT03850483|75773146|FG009|Follow-up For Stage 2|Other|1|||
41971925|NCT03473925|75773177|FG000|Overall Study|Death|48|||
41971926|NCT03473925|75773178|FG001|Overall Study|Death|44|||
42126890|NCT00420927|75937337|FG003|Period 2|Subject unable to find transportation|0|||
42126891|NCT00420927|75937338|FG004|Period 2|Subject unable to find transportation|0|||
42126892|NCT00420927|75937339|FG005|Period 2|Subject unable to find transportation|0|||
42126893|NCT00420927|75937340|FG006|Period 2|Subject unable to find transportation|1|||
42126894|NCT00420927|75937334|FG000|Period 2|Physician Decision|0|||
42126895|NCT00420927|75937335|FG001|Period 2|Physician Decision|0|||
42126896|NCT00420927|75937336|FG002|Period 2|Physician Decision|0|||
42126897|NCT00420927|75937337|FG003|Period 2|Physician Decision|0|||
42126898|NCT00420927|75937338|FG004|Period 2|Physician Decision|1|||
42126899|NCT00420927|75937339|FG005|Period 2|Physician Decision|1|||
42126900|NCT00420927|75937340|FG006|Period 2|Physician Decision|0|||
42126901|NCT00420927|75937334|FG000|Period 2|Sponsor decision|0|||
42126902|NCT00420927|75937335|FG001|Period 2|Sponsor decision|0|||
42126903|NCT00420927|75937336|FG002|Period 2|Sponsor decision|1|||
42126904|NCT00420927|75937337|FG003|Period 2|Sponsor decision|0|||
42126905|NCT00420927|75937338|FG004|Period 2|Sponsor decision|0|||
41971927|NCT03473925|75773177|FG000|Overall Study|Sponsor Decision|2|||
41971928|NCT03473925|75773178|FG001|Overall Study|Sponsor Decision|7|||
42126906|NCT00420927|75937339|FG005|Period 2|Sponsor decision|0|||
42126907|NCT00420927|75937340|FG006|Period 2|Sponsor decision|1|||
42126908|NCT00420927|75937334|FG000|Period 2|Randomization error|0|||
42126909|NCT00420927|75937335|FG001|Period 2|Randomization error|0|||
42126910|NCT00420927|75937336|FG002|Period 2|Randomization error|0|||
42126911|NCT00420927|75937337|FG003|Period 2|Randomization error|0|||
42126912|NCT00420927|75937338|FG004|Period 2|Randomization error|1|||
42126913|NCT00420927|75937339|FG005|Period 2|Randomization error|1|||
42126914|NCT00420927|75937340|FG006|Period 2|Randomization error|0|||
42126915|NCT00420927|75937334|FG000|Period 2|Noncompliant with study drug|0|||
42126916|NCT00420927|75937335|FG001|Period 2|Noncompliant with study drug|0|||
42126917|NCT00420927|75937336|FG002|Period 2|Noncompliant with study drug|0|||
42126918|NCT00420927|75937337|FG003|Period 2|Noncompliant with study drug|1|||
42126919|NCT00420927|75937338|FG004|Period 2|Noncompliant with study drug|0|||
42126920|NCT00420927|75937339|FG005|Period 2|Noncompliant with study drug|0|||
42126921|NCT00420927|75937340|FG006|Period 2|Noncompliant with study drug|2|||
42126922|NCT00420927|75937334|FG000|Period 2|Methotrexate intolerance|0|||
42126923|NCT00420927|75937335|FG001|Period 2|Methotrexate intolerance|0|||
42126924|NCT00420927|75937336|FG002|Period 2|Methotrexate intolerance|0|||
42126925|NCT00420927|75937337|FG003|Period 2|Methotrexate intolerance|0|||
41971929|NCT03473925|75773177|FG000|Overall Study|Withdrawal by Subject|1|||
41971930|NCT03473925|75773178|FG001|Overall Study|Withdrawal by Subject|3|||
41971931|NCT03473925|75773177|FG000|Overall Study|Not Treated|1|||
41971932|NCT03473925|75773178|FG001|Overall Study|Not Treated|1|||
41971933|NCT03230097|75773186|FG000|Overall Study|Adverse Event|2|||
41971934|NCT03230097|75773187|FG001|Overall Study|Adverse Event|1|||
41971935|NCT03230097|75773186|FG000|Overall Study|non-compliance|0|||
41971936|NCT03230097|75773187|FG001|Overall Study|non-compliance|1|||
41971937|NCT03230097|75773186|FG000|Overall Study|Lost to Follow-up|2|||
41971938|NCT03230097|75773187|FG001|Overall Study|Lost to Follow-up|4|||
41971939|NCT03230097|75773186|FG000|Overall Study|Withdrawal by Subject|7|||
41971940|NCT03230097|75773187|FG001|Overall Study|Withdrawal by Subject|3|||
42126926|NCT00420927|75937338|FG004|Period 2|Methotrexate intolerance|0|||
42126927|NCT00420927|75937339|FG005|Period 2|Methotrexate intolerance|0|||
42126928|NCT00420927|75937340|FG006|Period 2|Methotrexate intolerance|1|||
42126929|NCT00420927|75937334|FG000|Period 2|Took prohibited medication|0|||
42126930|NCT00420927|75937335|FG001|Period 2|Took prohibited medication|0|||
41971941|NCT03230097|75773186|FG000|Overall Study|Trial termination|4|||
41971942|NCT03230097|75773187|FG001|Overall Study|Trial termination|5|||
41971943|NCT03230097|75773186|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
41971944|NCT03230097|75773187|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
41971945|NCT03230097|75773186|FG000|Overall Study|outcome event|0|||
42126931|NCT00420927|75937336|FG002|Period 2|Took prohibited medication|0|||
42126932|NCT00420927|75937337|FG003|Period 2|Took prohibited medication|0|||
42126933|NCT00420927|75937338|FG004|Period 2|Took prohibited medication|1|||
42126934|NCT00420927|75937339|FG005|Period 2|Took prohibited medication|0|||
42126935|NCT00420927|75937340|FG006|Period 2|Took prohibited medication|0|||
42126936|NCT00573443|75937357|FG000|Double-Blind Phase|Lost to Follow-up|1|||
42301672|NCT02509117|76136790|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
41971946|NCT03230097|75773187|FG001|Overall Study|outcome event|1|||
42126937|NCT00573443|75937358|FG001|Double-Blind Phase|Lost to Follow-up|3|||
42126938|NCT00573443|75937359|FG002|Double-Blind Phase|Lost to Follow-up|2|||
42126939|NCT00573443|75937357|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
42126940|NCT00573443|75937358|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
42126941|NCT00573443|75937359|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
42126942|NCT00573443|75937357|FG000|Double-Blind Phase|Adverse Event|1|||
41971947|NCT02803593|75773212|FG000|Overall Study|Lost to Follow-up|17|||
41971948|NCT02803593|75773213|FG001|Overall Study|Lost to Follow-up|35|||
42126943|NCT00573443|75937358|FG001|Double-Blind Phase|Adverse Event|5|||
42126944|NCT00573443|75937359|FG002|Double-Blind Phase|Adverse Event|0|||
41971949|NCT02663908|75773221|FG000|Overall Study|Withdrawal by Subject|8|||
41971950|NCT02663908|75773222|FG001|Overall Study|Withdrawal by Subject|5|||
41971951|NCT02663908|75773221|FG000|Overall Study|Lost to Follow-up|1|||
41971952|NCT02663908|75773222|FG001|Overall Study|Lost to Follow-up|5|||
41971953|NCT02663908|75773221|FG000|Overall Study|Adverse Event|13|||
41971954|NCT02663908|75773222|FG001|Overall Study|Adverse Event|11|||
41971955|NCT02663908|75773221|FG000|Overall Study|Protocol Violation|1|||
41971956|NCT02663908|75773222|FG001|Overall Study|Protocol Violation|2|||
41971957|NCT02663908|75773221|FG000|Overall Study|Lack of therapeutic response|2|||
41971958|NCT02663908|75773222|FG001|Overall Study|Lack of therapeutic response|0|||
41971959|NCT02663908|75773221|FG000|Overall Study|COVID-19|1|||
41971960|NCT02663908|75773222|FG001|Overall Study|COVID-19|0|||
41971961|NCT02663908|75773221|FG000|Overall Study|Site closed|1|||
41971962|NCT02663908|75773222|FG001|Overall Study|Site closed|0|||
41971963|NCT02663908|75773221|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
41971964|NCT02663908|75773222|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
41971965|NCT02663908|75773221|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
41971966|NCT02663908|75773222|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
41971967|NCT02663908|75773221|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
42126945|NCT00573443|75937357|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
42126946|NCT00573443|75937358|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
42126947|NCT00573443|75937359|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
42126948|NCT00573443|75937357|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
42126949|NCT00573443|75937358|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
42126950|NCT00573443|75937359|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
42126951|NCT00573443|75937357|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
42126952|NCT00573443|75937358|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
42126953|NCT00573443|75937359|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
42126954|NCT00573443|75937357|FG000|Double-Blind Phase|Protocol Violation|0|||
42126955|NCT00573443|75937358|FG001|Double-Blind Phase|Protocol Violation|2|||
42126956|NCT00573443|75937359|FG002|Double-Blind Phase|Protocol Violation|1|||
42126957|NCT00573443|75937357|FG000|Double-Blind Phase|Other|0|||
42126958|NCT00573443|75937358|FG001|Double-Blind Phase|Other|2|||
42126959|NCT00573443|75937359|FG002|Double-Blind Phase|Other|3|||
42126960|NCT00573443|75937357|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
42126961|NCT00573443|75937358|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
42126962|NCT00573443|75937359|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
41971968|NCT02663908|75773222|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
41971969|NCT02663908|75773221|FG000|Overall Study|Death|1|||
41971970|NCT02663908|75773222|FG001|Overall Study|Death|0|||
41971971|NCT02663908|75773221|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
41971972|NCT02663908|75773222|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
41971973|NCT02663908|75773221|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
41971974|NCT02663908|75773222|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
41971975|NCT02650284|75773230|FG000|Overall Study|Lost to Follow-up|3|||
41971976|NCT02650284|75773231|FG001|Overall Study|Lost to Follow-up|3|||
41971977|NCT02650284|75773230|FG000|Overall Study|Consent incorrectly taken|0|||
41971978|NCT02650284|75773231|FG001|Overall Study|Consent incorrectly taken|1|||
41971979|NCT02175030|75773239|FG000|Overall Study|Failed screen after consent|7|||
41971980|NCT02175030|75773240|FG001|Overall Study|Failed screen after consent|6|||
41971981|NCT02175030|75773239|FG000|Overall Study|Failed IUD Insertion|20|||
41971982|NCT02175030|75773240|FG001|Overall Study|Failed IUD Insertion|21|||
41971983|NCT02175030|75773239|FG000|Overall Study|Physician Decision|1|||
41971984|NCT02175030|75773240|FG001|Overall Study|Physician Decision|1|||
41971985|NCT02175030|75773239|FG000|Overall Study|Lost to Follow-up|6|||
41971986|NCT02175030|75773240|FG001|Overall Study|Lost to Follow-up|6|||
41971987|NCT02175030|75773239|FG000|Overall Study|Withdrawal by Subject|1|||
41971988|NCT02175030|75773240|FG001|Overall Study|Withdrawal by Subject|4|||
42126963|NCT00573443|75937357|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
42126964|NCT00573443|75937358|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
41971989|NCT03096834|75773265|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
41971990|NCT03096834|75773266|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
41971991|NCT03096834|75773267|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
41971992|NCT03096834|75773268|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
41971993|NCT03096834|75773265|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
41971994|NCT03096834|75773266|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
41971995|NCT03096834|75773267|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
41971996|NCT03096834|75773268|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
41971997|NCT03096834|75773265|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
42126965|NCT00573443|75937359|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
42126966|NCT00573443|75937357|FG000|Open-Label Extension Phase|Adverse Event|3|||
42126967|NCT00573443|75937358|FG001|Open-Label Extension Phase|Adverse Event|0|||
41971998|NCT03096834|75773266|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
41971999|NCT03096834|75773267|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
41972000|NCT03096834|75773268|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
41972001|NCT03096834|75773265|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
41972002|NCT03096834|75773266|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
41972003|NCT03096834|75773267|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
41972004|NCT03096834|75773268|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
41972005|NCT03096834|75773265|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
41972006|NCT03096834|75773266|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
41972007|NCT03096834|75773267|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
41972008|NCT03096834|75773268|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
41972009|NCT03096834|75773265|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
41972010|NCT03096834|75773266|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
41972011|NCT03096834|75773267|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
41972012|NCT03096834|75773268|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
41972013|NCT03096834|75773265|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
41972014|NCT03096834|75773266|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
41972015|NCT03096834|75773267|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
41972016|NCT03096834|75773268|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
41972017|NCT03096834|75773265|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
41972018|NCT03096834|75773266|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
41972019|NCT03096834|75773267|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
41972020|NCT03096834|75773268|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
41972021|NCT03096834|75773265|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
41972022|NCT03096834|75773266|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
41972023|NCT03096834|75773267|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
41972024|NCT03096834|75773268|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
41972025|NCT03096834|75773265|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
41972026|NCT03096834|75773266|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
42028018|NCT01137474|75836327|FG003|Overall Study|No longer met study criteria|5|||
42028019|NCT01137474|75836324|FG000|Overall Study|Lost to Follow-up|5|||
42028020|NCT01137474|75836325|FG001|Overall Study|Lost to Follow-up|1|||
42028021|NCT01137474|75836326|FG002|Overall Study|Lost to Follow-up|0|||
42028022|NCT01137474|75836327|FG003|Overall Study|Lost to Follow-up|2|||
42028023|NCT01137474|75836324|FG000|Overall Study|Lack of Efficacy|0|||
42028024|NCT01137474|75836325|FG001|Overall Study|Lack of Efficacy|0|||
42028025|NCT01137474|75836326|FG002|Overall Study|Lack of Efficacy|0|||
41972027|NCT03096834|75773267|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
41972028|NCT03096834|75773268|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
41972029|NCT03096834|75773265|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
41972030|NCT03096834|75773266|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
41972031|NCT03096834|75773267|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
41972032|NCT03096834|75773268|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
41972033|NCT03096834|75773265|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
41972034|NCT03096834|75773266|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
41972035|NCT03096834|75773267|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
41972036|NCT03096834|75773268|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
41972037|NCT03012815|75773279|FG000|Overall Study|Lost to Follow-up|1|||
41972038|NCT03012815|75773280|FG001|Overall Study|Lost to Follow-up|0|||
42028026|NCT01137474|75836327|FG003|Overall Study|Lack of Efficacy|2|||
42028027|NCT01137474|75836324|FG000|Overall Study|Other|3|||
42028028|NCT01137474|75836325|FG001|Overall Study|Other|1|||
42126968|NCT00573443|75937359|FG002|Open-Label Extension Phase|Adverse Event|0|||
42126969|NCT00573443|75937357|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
42028029|NCT01137474|75836326|FG002|Overall Study|Other|0|||
42028030|NCT01137474|75836327|FG003|Overall Study|Other|0|||
42028031|NCT01137474|75836324|FG000|Overall Study|Pregnancy|0|||
42028032|NCT01137474|75836325|FG001|Overall Study|Pregnancy|1|||
42028033|NCT01137474|75836326|FG002|Overall Study|Pregnancy|0|||
41972039|NCT03012815|75773279|FG000|Overall Study|Physician Decision|3|||
41972040|NCT03012815|75773280|FG001|Overall Study|Physician Decision|2|||
41972041|NCT03012815|75773279|FG000|Overall Study|Adverse Event|1|||
41972042|NCT03012815|75773280|FG001|Overall Study|Adverse Event|0|||
41972043|NCT03001011|75773289|FG000|Overall Study|Adverse Event|9|||
41972044|NCT03001011|75773290|FG001|Overall Study|Adverse Event|3|||
41972045|NCT03001011|75773289|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
41972046|NCT03001011|75773290|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
41972047|NCT03001011|75773289|FG000|Overall Study|Other than specified above|3|||
41972048|NCT03001011|75773290|FG001|Overall Study|Other than specified above|8|||
41972049|NCT02993757|75773299|FG000|Overall Study|Non compliance with the protocol|155|||
41972050|NCT02993757|75773300|FG001|Overall Study|Non compliance with the protocol|170|||
41972051|NCT02993757|75773299|FG000|Overall Study|Lost to Follow-up|1|||
41972052|NCT02993757|75773300|FG001|Overall Study|Lost to Follow-up|0|||
41972053|NCT02993757|75773299|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
41972054|NCT02993757|75773300|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
42028034|NCT01137474|75836327|FG003|Overall Study|Pregnancy|0|||
42028035|NCT01137474|75836324|FG000|Overall Study|Administrative reason by sponsor|0|||
42028036|NCT01137474|75836325|FG001|Overall Study|Administrative reason by sponsor|1|||
42028037|NCT01137474|75836326|FG002|Overall Study|Administrative reason by sponsor|0|||
42028038|NCT01137474|75836327|FG003|Overall Study|Administrative reason by sponsor|0|||
42028039|NCT01168973|75836339|FG000|Overall Study|Progressive Disease|341|||
42028040|NCT01168973|75836340|FG001|Overall Study|Progressive Disease|429|||
42028041|NCT01168973|75836339|FG000|Overall Study|Adverse Event|94|||
42028042|NCT01168973|75836340|FG001|Overall Study|Adverse Event|55|||
42028043|NCT01168973|75836339|FG000|Overall Study|Withdrawal by Subject|90|||
42028044|NCT01168973|75836340|FG001|Overall Study|Withdrawal by Subject|53|||
42028045|NCT01168973|75836339|FG000|Overall Study|Death|42|||
42028046|NCT01168973|75836340|FG001|Overall Study|Death|45|||
42028047|NCT01168973|75836339|FG000|Overall Study|Physician Decision|37|||
42028048|NCT01168973|75836340|FG001|Overall Study|Physician Decision|19|||
42028049|NCT01168973|75836339|FG000|Overall Study|Sponsor Decision|2|||
42028050|NCT01168973|75836340|FG001|Overall Study|Sponsor Decision|1|||
42028051|NCT01168973|75836339|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
42028052|NCT01168973|75836340|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
42028053|NCT03918109|75836350|FG000|Overall Study|Withdrawal by Subject|0|||
41972055|NCT02979535|75773308|FG000|Overall Study|Non compliance with the protocol|78|||
41972056|NCT02979535|75773309|FG001|Overall Study|Non compliance with the protocol|82|||
41972057|NCT02979535|75773308|FG000|Overall Study|Consent withdrawn by participant|11|||
41972058|NCT02979535|75773309|FG001|Overall Study|Consent withdrawn by participant|18|||
41972059|NCT02979535|75773308|FG000|Overall Study|Lost to Follow-up|6|||
41972060|NCT02979535|75773309|FG001|Overall Study|Lost to Follow-up|1|||
41972061|NCT02978716|75773318|FG000|Overall Study|Death|25|||
41972062|NCT02978716|75773319|FG001|Overall Study|Death|13|||
41972063|NCT02978716|75773320|FG002|Overall Study|Death|20|||
41972064|NCT02978716|75773318|FG000|Overall Study|Lost to Follow-up|0|||
41972065|NCT02978716|75773319|FG001|Overall Study|Lost to Follow-up|0|||
41972066|NCT02978716|75773320|FG002|Overall Study|Lost to Follow-up|1|||
41972067|NCT02978716|75773318|FG000|Overall Study|Withdrawal by Subject|6|||
41972068|NCT02978716|75773319|FG001|Overall Study|Withdrawal by Subject|4|||
41972069|NCT02978716|75773320|FG002|Overall Study|Withdrawal by Subject|5|||
41972070|NCT02978716|75773318|FG000|Overall Study|Sponsor terminated|2|||
41972071|NCT02978716|75773319|FG001|Overall Study|Sponsor terminated|13|||
41972072|NCT02978716|75773320|FG002|Overall Study|Sponsor terminated|9|||
41972073|NCT02978716|75773318|FG000|Overall Study|Other|1|||
41972074|NCT02978716|75773319|FG001|Overall Study|Other|3|||
41972075|NCT02978716|75773320|FG002|Overall Study|Other|0|||
41972076|NCT02973321|75773335|FG000|Overall Study|Other than specified|0|||
41972077|NCT02973321|75773336|FG001|Overall Study|Other than specified|5|||
41972078|NCT02973321|75773337|FG002|Overall Study|Other than specified|3|||
42028054|NCT03918109|75836351|FG001|Overall Study|Withdrawal by Subject|0|||
42028055|NCT03918109|75836352|FG002|Overall Study|Withdrawal by Subject|2|||
41972079|NCT02973321|75773338|FG003|Overall Study|Other than specified|3|||
41972080|NCT02973321|75773339|FG004|Overall Study|Other than specified|1|||
41972081|NCT02973321|75773335|FG000|Overall Study|Lack of Efficacy|0|||
41972082|NCT02973321|75773336|FG001|Overall Study|Lack of Efficacy|0|||
41972083|NCT02973321|75773337|FG002|Overall Study|Lack of Efficacy|0|||
41972084|NCT02973321|75773338|FG003|Overall Study|Lack of Efficacy|0|||
41972085|NCT02973321|75773339|FG004|Overall Study|Lack of Efficacy|1|||
41972086|NCT02973321|75773335|FG000|Overall Study|Adverse Event|1|||
41972087|NCT02973321|75773336|FG001|Overall Study|Adverse Event|10|||
41972088|NCT02973321|75773337|FG002|Overall Study|Adverse Event|11|||
42028056|NCT03918109|75836353|FG003|Overall Study|Withdrawal by Subject|1|||
42028057|NCT03918109|75836350|FG000|Overall Study|Lost to Follow-up|0|||
42028058|NCT03918109|75836351|FG001|Overall Study|Lost to Follow-up|0|||
42028059|NCT03918109|75836352|FG002|Overall Study|Lost to Follow-up|0|||
42028060|NCT03918109|75836353|FG003|Overall Study|Lost to Follow-up|1|||
41972089|NCT02973321|75773338|FG003|Overall Study|Adverse Event|13|||
41972090|NCT02973321|75773339|FG004|Overall Study|Adverse Event|3|||
41972091|NCT02943785|75773354|FG000|Overall Study|Adverse Event|112|||
41972092|NCT02943785|75773355|FG001|Overall Study|Adverse Event|97|||
41972093|NCT02943785|75773354|FG000|Overall Study|Withdrawal by Subject|63|||
41972094|NCT02943785|75773355|FG001|Overall Study|Withdrawal by Subject|126|||
41972095|NCT02943785|75773354|FG000|Overall Study|Physician Decision|23|||
41972096|NCT02943785|75773355|FG001|Overall Study|Physician Decision|47|||
41972097|NCT02943785|75773354|FG000|Overall Study|Death|46|||
41972098|NCT02943785|75773355|FG001|Overall Study|Death|46|||
41972099|NCT02943785|75773354|FG000|Overall Study|Lost to Follow-up|1|||
41972100|NCT02943785|75773355|FG001|Overall Study|Lost to Follow-up|0|||
41972101|NCT02943785|75773354|FG000|Overall Study|Other|16|||
41972102|NCT02943785|75773355|FG001|Overall Study|Other|19|||
41972103|NCT02943785|75773354|FG000|Overall Study|Did not receive any study medication|21|||
41972104|NCT02943785|75773355|FG001|Overall Study|Did not receive any study medication|28|||
41972105|NCT02923674|75773364|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
41972106|NCT02923674|75773365|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
41972107|NCT02923674|75773366|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
41972108|NCT02923674|75773364|FG000|Overall Study|Lost to Follow-up|7|||
41972109|NCT02923674|75773365|FG001|Overall Study|Lost to Follow-up|12|||
41972110|NCT02923674|75773366|FG002|Overall Study|Lost to Follow-up|7|||
41972111|NCT02923674|75773364|FG000|Overall Study|Problem with intervention|2|||
41972112|NCT02923674|75773365|FG001|Overall Study|Problem with intervention|2|||
41972113|NCT02923674|75773366|FG002|Overall Study|Problem with intervention|1|||
41972114|NCT02923674|75773364|FG000|Overall Study|Adverse Event|3|||
41972115|NCT02923674|75773365|FG001|Overall Study|Adverse Event|1|||
41972116|NCT02923674|75773366|FG002|Overall Study|Adverse Event|1|||
41972117|NCT02923674|75773364|FG000|Overall Study|Withdrawal by Subject|2|||
41972118|NCT02923674|75773365|FG001|Overall Study|Withdrawal by Subject|2|||
41972119|NCT02923674|75773366|FG002|Overall Study|Withdrawal by Subject|2|||
41972120|NCT02921971|75773376|FG000|Overall Study|Adverse Event|1|||
41972121|NCT02921971|75773377|FG001|Overall Study|Adverse Event|2|||
41972122|NCT02921971|75773376|FG000|Overall Study|Lack of Efficacy|3|||
41972123|NCT02921971|75773377|FG001|Overall Study|Lack of Efficacy|1|||
41972124|NCT02921971|75773376|FG000|Overall Study|Other than specified above|2|||
41972125|NCT02921971|75773377|FG001|Overall Study|Other than specified above|1|||
41972126|NCT02886286|75773385|FG000|Overall Study|pump motor stall|0|||
41972127|NCT02886286|75773386|FG001|Overall Study|pump motor stall|1|||
41972128|NCT02865187|75773394|FG000|Overall Study|Lost to Follow-up|12|||
41972129|NCT02865187|75773395|FG001|Overall Study|Lost to Follow-up|7|||
41972130|NCT02865187|75773394|FG000|Overall Study|Adverse Event|1|||
42028061|NCT01168427|75836363|FG000|Overall Study|Patient exited prior to implant|1|||
42028062|NCT01124916|75836369|FG000|Overall Study|Lost to Follow-up|3|||
41972131|NCT02865187|75773395|FG001|Overall Study|Adverse Event|0|||
41972132|NCT02824198|75773403|FG000|Overall Study|Non-compliance with the protocol|5|||
41972133|NCT02824198|75773404|FG001|Overall Study|Non-compliance with the protocol|1|||
41972134|NCT02824198|75773403|FG000|Overall Study|Lost to Follow-up|5|||
41972135|NCT02824198|75773404|FG001|Overall Study|Lost to Follow-up|2|||
41972136|NCT02824198|75773403|FG000|Overall Study|Withdrawal by Subject|5|||
41972137|NCT02824198|75773404|FG001|Overall Study|Withdrawal by Subject|0|||
41972138|NCT02787551|75773414|FG000|Core Period: 26 Weeks|Adverse Event|10|||
41972139|NCT02787551|75773415|FG001|Core Period: 26 Weeks|Adverse Event|0|||
41972140|NCT02787551|75773414|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
41972141|NCT02787551|75773415|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
41972142|NCT02787551|75773414|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
41972143|NCT02787551|75773415|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
41972144|NCT02787551|75773414|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
41972145|NCT02787551|75773415|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
41972146|NCT02787551|75773414|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
41972147|NCT02787551|75773415|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
41972148|NCT02787551|75773414|FG000|Core Period: 26 Weeks|Other than specified|3|||
42028063|NCT01124916|75836370|FG001|Overall Study|Lost to Follow-up|2|||
41972149|NCT02787551|75773415|FG001|Core Period: 26 Weeks|Other than specified|1|||
41972150|NCT02787551|75773414|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
41972151|NCT02787551|75773415|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
41972152|NCT02787551|75773414|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
41972153|NCT02787551|75773415|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
41972154|NCT02787551|75773414|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
41972155|NCT02787551|75773415|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
41972156|NCT02735044|75773435|FG000|Overall Study|Adverse Event|3|||
41972157|NCT02735044|75773436|FG001|Overall Study|Adverse Event|3|||
41972158|NCT02735044|75773435|FG000|Overall Study|Lack of Efficacy|1|||
41972159|NCT02735044|75773436|FG001|Overall Study|Lack of Efficacy|0|||
41972160|NCT02735044|75773435|FG000|Overall Study|Poor compliance to protocol|7|||
42028064|NCT00916006|75836378|FG000|Overall Study|Adverse Event|1|||
42028065|NCT00916006|75836379|FG001|Overall Study|Adverse Event|1|||
42028066|NCT00916006|75836378|FG000|Overall Study|Withdrawal by Subject|2|||
42028067|NCT00916006|75836379|FG001|Overall Study|Withdrawal by Subject|5|||
42028068|NCT00916006|75836378|FG000|Overall Study|Protocol Violation|0|||
42028069|NCT00916006|75836379|FG001|Overall Study|Protocol Violation|1|||
42028070|NCT01168349|75836396|FG000|Overall Study|Death|157|||
42028071|NCT01168349|75836396|FG000|Overall Study|Lost to Follow-up|34|||
42028072|NCT01168349|75836396|FG000|Overall Study|Withdrawal by Subject|9|||
42028073|NCT01168349|75836396|FG000|Overall Study|Kidney transplantation|3|||
42028074|NCT01168349|75836396|FG000|Overall Study|Other|22|||
42126970|NCT00573443|75937358|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
42126971|NCT00573443|75937359|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
42126972|NCT00573443|75937357|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
42028075|NCT01168349|75836396|FG000|Overall Study|Protocol Violation|76|||
42028076|NCT00915772|75836419|FG000|Overall Study|Adverse Event|12|||
42028077|NCT00915772|75836420|FG001|Overall Study|Adverse Event|13|||
42028078|NCT00915772|75836421|FG002|Overall Study|Adverse Event|11|||
42126973|NCT00573443|75937358|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
42126974|NCT00573443|75937359|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
42126975|NCT00573443|75937357|FG000|Open-Label Extension Phase|Protocol Violation|2|||
42126976|NCT00573443|75937358|FG001|Open-Label Extension Phase|Protocol Violation|0|||
41972161|NCT02735044|75773436|FG001|Overall Study|Poor compliance to protocol|7|||
41972162|NCT02735044|75773435|FG000|Overall Study|Randomized and not treated|0|||
41972163|NCT02735044|75773436|FG001|Overall Study|Randomized and not treated|2|||
41972164|NCT02735044|75773435|FG000|Overall Study|Other, not specified above|5|||
41972165|NCT02735044|75773436|FG001|Overall Study|Other, not specified above|11|||
41972166|NCT02720744|75773444|FG000|Overall Study|Protocol Violation|0|||
41972167|NCT02720744|75773445|FG001|Overall Study|Protocol Violation|2|||
41972168|NCT02720744|75773444|FG000|Overall Study|Pregnancy|2|||
41972169|NCT02720744|75773445|FG001|Overall Study|Pregnancy|0|||
41972170|NCT02720744|75773444|FG000|Overall Study|Lack of Efficacy|2|||
41972171|NCT02720744|75773445|FG001|Overall Study|Lack of Efficacy|8|||
41972172|NCT02720744|75773444|FG000|Overall Study|Adverse Event|21|||
41972173|NCT02720744|75773445|FG001|Overall Study|Adverse Event|3|||
41972174|NCT02720744|75773444|FG000|Overall Study|Withdrawal by Subject|11|||
41972175|NCT02720744|75773445|FG001|Overall Study|Withdrawal by Subject|11|||
41972176|NCT02720744|75773444|FG000|Overall Study|Lost to follow up|2|||
41972177|NCT02720744|75773445|FG001|Overall Study|Lost to follow up|0|||
41972178|NCT02720744|75773444|FG000|Overall Study|Non Compliance with Investigational Product|0|||
41972179|NCT02720744|75773445|FG001|Overall Study|Non Compliance with Investigational Product|1|||
41972180|NCT02720744|75773444|FG000|Overall Study|Excluded Concomitant Medication|0|||
41972181|NCT02720744|75773445|FG001|Overall Study|Excluded Concomitant Medication|1|||
41972182|NCT02692651|75773453|FG000|Study Treatment|Death|7|||
41972183|NCT02692651|75773454|FG001|Study Treatment|Death|3|||
41972184|NCT02692651|75773453|FG000|Study Treatment|comfort care|1|||
41972185|NCT02692651|75773454|FG001|Study Treatment|comfort care|1|||
41972186|NCT02692651|75773453|FG000|Study Treatment|Protocol violation per treating team preference|8|||
41972187|NCT02692651|75773454|FG001|Study Treatment|Protocol violation per treating team preference|6|||
41972188|NCT02692651|75773453|FG000|Post Study Treatment Follow-up|Death|4|||
41972189|NCT02692651|75773454|FG001|Post Study Treatment Follow-up|Death|4|||
42126977|NCT00573443|75937359|FG002|Open-Label Extension Phase|Protocol Violation|0|||
42126978|NCT00573443|75937357|FG000|Open-Label Extension Phase|Other|2|||
42126979|NCT00573443|75937358|FG001|Open-Label Extension Phase|Other|0|||
42126980|NCT00573443|75937359|FG002|Open-Label Extension Phase|Other|0|||
42126981|NCT00420849|75937368|FG000|Overall Study|Lack of Efficacy|154|||
42126982|NCT00420849|75937368|FG000|Overall Study|Adverse Event|107|||
42126983|NCT00420849|75937368|FG000|Overall Study|Withdrawal by Subject|28|||
42126984|NCT00420849|75937368|FG000|Overall Study|Death|18|||
42126985|NCT00420849|75937368|FG000|Overall Study|Other|14|||
42126986|NCT00420849|75937368|FG000|Overall Study|Transplant|8|||
42126987|NCT00420849|75937368|FG000|Overall Study|Protocol Violation|1|||
42126988|NCT00420849|75937368|FG000|Overall Study|Lost to Follow-up|1|||
41972190|NCT02686658|75773466|FG000|Overall Study|Adverse Event|0|||
41972191|NCT02686658|75773467|FG001|Overall Study|Adverse Event|0|||
41972192|NCT02686658|75773468|FG002|Overall Study|Adverse Event|1|||
41972193|NCT02686658|75773469|FG003|Overall Study|Adverse Event|1|||
42028079|NCT00915772|75836419|FG000|Overall Study|Protocol Violation|4|||
42028080|NCT00915772|75836420|FG001|Overall Study|Protocol Violation|1|||
42126989|NCT00617279|75937377|FG000|Overall Study|Study terminated by Sponsor|10|||
42126990|NCT00617279|75937378|FG001|Overall Study|Study terminated by Sponsor|15|||
42126991|NCT00617279|75937377|FG000|Overall Study|Graft abandonment|2|||
41972194|NCT02686658|75773470|FG004|Overall Study|Adverse Event|2|||
42028081|NCT00915772|75836421|FG002|Overall Study|Protocol Violation|2|||
42028082|NCT00915772|75836419|FG000|Overall Study|Lost to Follow-up|1|||
41972195|NCT02686658|75773471|FG005|Overall Study|Adverse Event|1|||
41972196|NCT02686658|75773466|FG000|Overall Study|Investigator decision|0|||
41972197|NCT02686658|75773467|FG001|Overall Study|Investigator decision|0|||
41972198|NCT02686658|75773468|FG002|Overall Study|Investigator decision|0|||
41972199|NCT02686658|75773469|FG003|Overall Study|Investigator decision|1|||
41972200|NCT02686658|75773470|FG004|Overall Study|Investigator decision|2|||
41972201|NCT02686658|75773471|FG005|Overall Study|Investigator decision|1|||
41972202|NCT02686658|75773466|FG000|Overall Study|Sponsor decision|1|||
41972203|NCT02686658|75773467|FG001|Overall Study|Sponsor decision|2|||
41972204|NCT02686658|75773468|FG002|Overall Study|Sponsor decision|1|||
41972205|NCT02686658|75773469|FG003|Overall Study|Sponsor decision|5|||
41972206|NCT02686658|75773470|FG004|Overall Study|Sponsor decision|13|||
41972207|NCT02686658|75773471|FG005|Overall Study|Sponsor decision|2|||
41972208|NCT02686658|75773466|FG000|Overall Study|Lost to Follow-up|0|||
41972209|NCT02686658|75773467|FG001|Overall Study|Lost to Follow-up|0|||
41972210|NCT02686658|75773468|FG002|Overall Study|Lost to Follow-up|2|||
41972211|NCT02686658|75773469|FG003|Overall Study|Lost to Follow-up|0|||
41972212|NCT02686658|75773470|FG004|Overall Study|Lost to Follow-up|0|||
41972213|NCT02686658|75773471|FG005|Overall Study|Lost to Follow-up|1|||
41972214|NCT02686658|75773466|FG000|Overall Study|Death|1|||
41972215|NCT02686658|75773467|FG001|Overall Study|Death|0|||
41972216|NCT02686658|75773468|FG002|Overall Study|Death|0|||
41972217|NCT02686658|75773469|FG003|Overall Study|Death|1|||
41972218|NCT02686658|75773470|FG004|Overall Study|Death|1|||
41972219|NCT02686658|75773471|FG005|Overall Study|Death|1|||
41972220|NCT02686658|75773466|FG000|Overall Study|Withdrawal by Subject|2|||
41972221|NCT02686658|75773467|FG001|Overall Study|Withdrawal by Subject|5|||
41972222|NCT02686658|75773468|FG002|Overall Study|Withdrawal by Subject|4|||
41972223|NCT02686658|75773469|FG003|Overall Study|Withdrawal by Subject|4|||
41972224|NCT02686658|75773470|FG004|Overall Study|Withdrawal by Subject|17|||
41972225|NCT02686658|75773471|FG005|Overall Study|Withdrawal by Subject|8|||
41972226|NCT02686658|75773466|FG000|Overall Study|Placed in hospice care|0|||
41972227|NCT02686658|75773467|FG001|Overall Study|Placed in hospice care|0|||
41972228|NCT02686658|75773468|FG002|Overall Study|Placed in hospice care|1|||
41972229|NCT02686658|75773469|FG003|Overall Study|Placed in hospice care|0|||
41972230|NCT02686658|75773470|FG004|Overall Study|Placed in hospice care|0|||
41972231|NCT02686658|75773471|FG005|Overall Study|Placed in hospice care|0|||
41972232|NCT02686658|75773466|FG000|Overall Study|Participant non-compliance|0|||
41972233|NCT02686658|75773467|FG001|Overall Study|Participant non-compliance|0|||
41972234|NCT02686658|75773468|FG002|Overall Study|Participant non-compliance|0|||
41972235|NCT02686658|75773469|FG003|Overall Study|Participant non-compliance|0|||
41972236|NCT02686658|75773470|FG004|Overall Study|Participant non-compliance|0|||
41972237|NCT02686658|75773471|FG005|Overall Study|Participant non-compliance|1|||
41972238|NCT02686658|75773466|FG000|Overall Study|Concern over coronavirus disease care|0|||
41972239|NCT02686658|75773467|FG001|Overall Study|Concern over coronavirus disease care|0|||
41972240|NCT02686658|75773468|FG002|Overall Study|Concern over coronavirus disease care|0|||
41972241|NCT02686658|75773469|FG003|Overall Study|Concern over coronavirus disease care|0|||
41972242|NCT02686658|75773470|FG004|Overall Study|Concern over coronavirus disease care|2|||
41972243|NCT02686658|75773471|FG005|Overall Study|Concern over coronavirus disease care|1|||
41972244|NCT02674061|75773487|FG000|Overall Study|Death|229|||
41972245|NCT02674061|75773488|FG001|Overall Study|Death|77|||
41972246|NCT02674061|75773487|FG000|Overall Study|Lost to Follow-up|3|||
41972247|NCT02674061|75773488|FG001|Overall Study|Lost to Follow-up|3|||
41972248|NCT02674061|75773487|FG000|Overall Study|Withdrawal by Subject|9|||
41972249|NCT02674061|75773488|FG001|Overall Study|Withdrawal by Subject|1|||
41972250|NCT02674061|75773487|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
41972251|NCT02674061|75773488|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
41972252|NCT02628444|75773508|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
41972253|NCT02628444|75773509|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
41972254|NCT02628444|75773510|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
41972255|NCT02628444|75773511|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
41972256|NCT02628444|75773512|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
41972257|NCT02628444|75773513|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
41972258|NCT02628444|75773514|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
41972259|NCT02628444|75773515|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
41972260|NCT02628444|75773516|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
41972261|NCT02628444|75773508|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
41972262|NCT02628444|75773509|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
41972263|NCT02628444|75773510|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
41972264|NCT02628444|75773511|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
41972265|NCT02628444|75773512|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
41972266|NCT02628444|75773513|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
41972267|NCT02628444|75773514|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
41972268|NCT02628444|75773515|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
41972269|NCT02628444|75773516|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
41972270|NCT02628444|75773508|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
41972271|NCT02628444|75773509|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
41972272|NCT02628444|75773510|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
41972273|NCT02628444|75773511|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
41972274|NCT02628444|75773512|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
41972275|NCT02628444|75773513|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
41972276|NCT02628444|75773514|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
41972277|NCT02628444|75773515|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
41972278|NCT02628444|75773516|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
42028083|NCT00915772|75836420|FG001|Overall Study|Lost to Follow-up|2|||
42126992|NCT00617279|75937378|FG001|Overall Study|Graft abandonment|0|||
42126993|NCT00617279|75937377|FG000|Overall Study|Lost to Follow-up|1|||
42126994|NCT00617279|75937378|FG001|Overall Study|Lost to Follow-up|0|||
42126995|NCT00617279|75937377|FG000|Overall Study|Death|1|||
42126996|NCT00617279|75937378|FG001|Overall Study|Death|2|||
42126997|NCT00420381|75937384|FG000|Overall Study|Protocol Violation|1|||
42126998|NCT00617201|75937390|FG000|Overall Study|Lost to Follow-up|9|||
42126999|NCT00617201|75937391|FG001|Overall Study|Lost to Follow-up|13|||
42127000|NCT00420303|75937401|FG000|Overall Study|Serious Adverse Event|1|||
42127001|NCT00420303|75937402|FG001|Overall Study|Serious Adverse Event|0|||
42127002|NCT00420303|75937401|FG000|Overall Study|Lack of Efficacy|0|||
42127003|NCT00420303|75937402|FG001|Overall Study|Lack of Efficacy|3|||
42127004|NCT00420303|75937401|FG000|Overall Study|Physician Decision|0|||
42127005|NCT00420303|75937402|FG001|Overall Study|Physician Decision|1|||
42127006|NCT00617123|75937410|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
42127007|NCT00617123|75937411|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
42127008|NCT00617123|75937410|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
42127009|NCT00617123|75937411|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
42127010|NCT00617123|75937410|FG000|Referral Screening Period|Adverse Event|0|||
42127011|NCT00617123|75937411|FG001|Referral Screening Period|Adverse Event|1|||
42127012|NCT00617123|75937410|FG000|Study Treatment Period|Withdrawal by Subject|8|||
42127013|NCT00617123|75937411|FG001|Study Treatment Period|Withdrawal by Subject|12|||
42127014|NCT00617123|75937410|FG000|Study Treatment Period|Adverse Event|7|||
42127015|NCT00617123|75937411|FG001|Study Treatment Period|Adverse Event|3|||
42127016|NCT00617123|75937410|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
42127017|NCT00617123|75937411|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
42127018|NCT00617123|75937410|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
42127019|NCT00617123|75937411|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
42127020|NCT00419757|75937419|FG000|Overall Study|Adverse Event|1|||
42028084|NCT00915772|75836421|FG002|Overall Study|Lost to Follow-up|2|||
42127021|NCT00419757|75937420|FG001|Overall Study|Adverse Event|4|||
42127022|NCT00419757|75937419|FG000|Overall Study|Lost to Follow-up|1|||
42127023|NCT00419757|75937420|FG001|Overall Study|Lost to Follow-up|4|||
42127024|NCT00419757|75937419|FG000|Overall Study|Withdrawal by Subject|7|||
42127025|NCT00419757|75937420|FG001|Overall Study|Withdrawal by Subject|1|||
42127026|NCT00419757|75937419|FG000|Overall Study|Protocol Violation|2|||
42127027|NCT00419757|75937420|FG001|Overall Study|Protocol Violation|3|||
42127028|NCT00419757|75937419|FG000|Overall Study|Study specific discontinuation criteria|4|||
42127029|NCT00419757|75937420|FG001|Overall Study|Study specific discontinuation criteria|8|||
42127030|NCT00419757|75937419|FG000|Overall Study|Multiple reasons|3|||
42127031|NCT00419757|75937420|FG001|Overall Study|Multiple reasons|1|||
42127032|NCT00434109|75937428|FG000|Overall Study|Physician Decision|9|||
42127033|NCT00434109|75937428|FG000|Overall Study|Adverse Event|5|||
42127034|NCT00434109|75937428|FG000|Overall Study|Protocol Violation|1|||
42127035|NCT00434109|75937428|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
42127036|NCT00433329|75937432|FG000|Overall Study|Adverse Event|9|||
42127037|NCT00433329|75937432|FG000|Overall Study|Death|4|||
42127038|NCT00433329|75937432|FG000|Overall Study|Withdrew consent|3|||
42127039|NCT00433329|75937432|FG000|Overall Study|Discontinued sildenafil|2|||
42127040|NCT00433329|75937432|FG000|Overall Study|Moved out of state|1|||
42127041|NCT00433329|75937432|FG000|Overall Study|Lost to Follow-up|1|||
42127042|NCT00433329|75937432|FG000|Overall Study|Physician Decision|1|||
42127043|NCT00616421|75937439|FG000|Overall Study|Withdrawal by Subject|9|||
42127044|NCT00616421|75937440|FG001|Overall Study|Withdrawal by Subject|11|||
42127045|NCT00616421|75937441|FG002|Overall Study|Withdrawal by Subject|8|||
42127046|NCT00616421|75937439|FG000|Overall Study|Lost to Follow-up|12|||
42127047|NCT00616421|75937440|FG001|Overall Study|Lost to Follow-up|26|||
42127048|NCT00616421|75937441|FG002|Overall Study|Lost to Follow-up|30|||
42127049|NCT00616421|75937439|FG000|Overall Study|Inappropriate enrollment|3|||
42210411|NCT03820323|76025205|FG001|Overall Study|Missed 12-month visit|14|||
42210412|NCT03820323|76025204|FG000|Overall Study|Death|2|||
42210413|NCT03820323|76025205|FG001|Overall Study|Death|1|||
42210414|NCT03820323|76025204|FG000|Overall Study|Transferred out|13|||
42210415|NCT03820323|76025205|FG001|Overall Study|Transferred out|11|||
42210416|NCT03820323|76025204|FG000|Overall Study|Terminated|0|||
42210417|NCT03820323|76025205|FG001|Overall Study|Terminated|3|||
42210418|NCT03820323|76025204|FG000|Overall Study|Withdrawal by Subject|1|||
42210419|NCT03820323|76025205|FG001|Overall Study|Withdrawal by Subject|6|||
42210420|NCT03287622|76025220|FG000|Overall Study|Withdrawal by Subject|1|||
42210421|NCT03287622|76025221|FG001|Overall Study|Withdrawal by Subject|0|||
42210422|NCT03287622|76025220|FG000|Overall Study|Lost to Follow-up|27|||
41972279|NCT02628444|75773508|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
41972280|NCT02628444|75773509|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
41972281|NCT02628444|75773510|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
41972282|NCT02628444|75773511|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
41972283|NCT02628444|75773512|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
41972284|NCT02628444|75773513|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
42127050|NCT00616421|75937440|FG001|Overall Study|Inappropriate enrollment|0|||
42127051|NCT00616421|75937441|FG002|Overall Study|Inappropriate enrollment|1|||
42127052|NCT00616421|75937439|FG000|Overall Study|Administrative reason|1|||
42127053|NCT00616421|75937440|FG001|Overall Study|Administrative reason|0|||
42127054|NCT00616421|75937441|FG002|Overall Study|Administrative reason|0|||
42127055|NCT00616421|75937439|FG000|Overall Study|Protocol Violation|0|||
42127056|NCT00616421|75937440|FG001|Overall Study|Protocol Violation|1|||
42127057|NCT00616421|75937441|FG002|Overall Study|Protocol Violation|2|||
42127058|NCT00616421|75937439|FG000|Overall Study|Unable to classify|1|||
42127059|NCT00616421|75937440|FG001|Overall Study|Unable to classify|0|||
42127060|NCT00616421|75937441|FG002|Overall Study|Unable to classify|0|||
42127061|NCT00433017|75937465|FG000|Overall Study|Adverse Event|5|||
42127062|NCT00433017|75937466|FG001|Overall Study|Adverse Event|3|||
42127063|NCT00433017|75937465|FG000|Overall Study|Withdrawal by Subject|4|||
42127064|NCT00433017|75937466|FG001|Overall Study|Withdrawal by Subject|5|||
42127065|NCT00433017|75937465|FG000|Overall Study|Lost to Follow-up|3|||
42127066|NCT00433017|75937466|FG001|Overall Study|Lost to Follow-up|4|||
42127067|NCT00433017|75937465|FG000|Overall Study|Administrative problems|80|||
42210423|NCT03287622|76025221|FG001|Overall Study|Lost to Follow-up|15|||
42210424|NCT03287622|76025220|FG000|Overall Study|No prescripion after surgery|28|||
42210425|NCT03287622|76025221|FG001|Overall Study|No prescripion after surgery|31|||
42210426|NCT03287622|76025220|FG000|Overall Study|prolonged Length of stay|2|||
42210427|NCT03287622|76025221|FG001|Overall Study|prolonged Length of stay|0|||
42210428|NCT03287622|76025220|FG000|Overall Study|surgery related|0|||
42127068|NCT00433017|75937466|FG001|Overall Study|Administrative problems|86|||
42127069|NCT00433017|75937465|FG000|Overall Study|Protocol Violation|1|||
42127070|NCT00433017|75937466|FG001|Overall Study|Protocol Violation|0|||
42127071|NCT00433017|75937465|FG000|Overall Study|Death|2|||
42127072|NCT00433017|75937466|FG001|Overall Study|Death|2|||
42127073|NCT00433017|75937465|FG000|Overall Study|Subject no longer requires study drug|1|||
42127074|NCT00433017|75937466|FG001|Overall Study|Subject no longer requires study drug|1|||
42127075|NCT00615719|75937498|FG000|Overall Study|Physician Decision|5|||
42210429|NCT03287622|76025221|FG001|Overall Study|surgery related|2|||
42210430|NCT04063657|76025236|FG000|Overall Study|Lost to Follow-up|1|||
42210431|NCT04063657|76025237|FG001|Overall Study|Lost to Follow-up|0|||
42210432|NCT04058353|76025254|FG000|Overall Study|Adverse Event|2|||
42210433|NCT04058353|76025255|FG001|Overall Study|Adverse Event|1|||
42210434|NCT04058353|76025254|FG000|Overall Study|Physician Decision|1|||
42210435|NCT04058353|76025255|FG001|Overall Study|Physician Decision|0|||
42210436|NCT04058353|76025254|FG000|Overall Study|Other|1|||
42210437|NCT04058353|76025255|FG001|Overall Study|Other|0|||
42210438|NCT03226353|76025262|FG000|Overall Study|Withdrawal by Subject|1|||
42210439|NCT03226353|76025262|FG000|Overall Study|Screen Failure|5|||
42210440|NCT02730598|76025271|FG000|Overall Study|Withdrawal by Subject|3|||
42210441|NCT02730598|76025272|FG001|Overall Study|Withdrawal by Subject|3|||
42210442|NCT02730598|76025271|FG000|Overall Study|Protocol Violation|0|||
42210443|NCT02730598|76025272|FG001|Overall Study|Protocol Violation|1|||
42210444|NCT02730598|76025271|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
42210445|NCT02730598|76025272|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
42210446|NCT03226275|76025282|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
42210447|NCT03226275|76025283|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
42210448|NCT03226275|76025284|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
42210449|NCT03226275|76025285|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
42210450|NCT03226275|76025282|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
42210451|NCT03226275|76025283|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
42210452|NCT03226275|76025284|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
42210453|NCT03226275|76025285|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
42210454|NCT04189081|76025298|FG000|Overall Study|Lost to Follow-up|1|||
42210455|NCT04189081|76025299|FG001|Overall Study|Lost to Follow-up|0|||
42210456|NCT04189081|76025300|FG002|Overall Study|Lost to Follow-up|0|||
42210457|NCT04189081|76025298|FG000|Overall Study|Withdrawal by Subject|0|||
42210458|NCT04189081|76025299|FG001|Overall Study|Withdrawal by Subject|0|||
42210459|NCT04189081|76025300|FG002|Overall Study|Withdrawal by Subject|1|||
42210460|NCT04187989|76025310|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
42210461|NCT04187989|76025311|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
42210462|NCT04187989|76025310|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
42210463|NCT04187989|76025311|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
42210464|NCT01150890|76025321|FG000|Overall Study|Other|0|||
42210465|NCT01150890|76025322|FG001|Overall Study|Other|1|||
42210466|NCT01150890|76025323|FG002|Overall Study|Other|0|||
41972285|NCT02628444|75773514|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
41972286|NCT02628444|75773515|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
41972287|NCT02628444|75773516|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
41972288|NCT02628444|75773508|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
41972289|NCT02628444|75773509|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
41972290|NCT02628444|75773510|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
41972291|NCT02628444|75773511|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
41972292|NCT02628444|75773512|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
41972293|NCT02628444|75773513|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
41972294|NCT02628444|75773514|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
41972295|NCT02628444|75773515|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
41972296|NCT02628444|75773516|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
41972297|NCT02628444|75773508|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
41972298|NCT02628444|75773509|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
41972299|NCT02628444|75773510|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
42028085|NCT00915772|75836419|FG000|Overall Study|Lack of Efficacy|9|||
42127076|NCT00418665|75937505|FG000|Treatment Period|Ineligibility determined|1|||
42127077|NCT00418665|75937506|FG001|Treatment Period|Ineligibility determined|1|||
42127078|NCT00418665|75937507|FG002|Treatment Period|Ineligibility determined|0|||
42127079|NCT00418665|75937505|FG000|Treatment Period|Adverse Event|2|||
42127080|NCT00418665|75937506|FG001|Treatment Period|Adverse Event|2|||
42127081|NCT00418665|75937507|FG002|Treatment Period|Adverse Event|0|||
42127082|NCT00418665|75937505|FG000|Treatment Period|Withdrawal by Subject|0|||
42127083|NCT00418665|75937506|FG001|Treatment Period|Withdrawal by Subject|3|||
42127084|NCT00418665|75937507|FG002|Treatment Period|Withdrawal by Subject|1|||
42127085|NCT00418665|75937505|FG000|Treatment Period|Requirement for alternative therapy|1|||
42127086|NCT00418665|75937506|FG001|Treatment Period|Requirement for alternative therapy|0|||
42210467|NCT01150890|76025324|FG003|Overall Study|Other|2|||
42127087|NCT00418665|75937507|FG002|Treatment Period|Requirement for alternative therapy|0|||
42127088|NCT00418665|75937505|FG000|Treatment Period|Physician Decision|1|||
42210468|NCT01150890|76025321|FG000|Overall Study|Pregnancy|0|||
42210469|NCT01150890|76025322|FG001|Overall Study|Pregnancy|0|||
42127089|NCT00418665|75937506|FG001|Treatment Period|Physician Decision|0|||
42127090|NCT00418665|75937507|FG002|Treatment Period|Physician Decision|3|||
42210470|NCT01150890|76025323|FG002|Overall Study|Pregnancy|0|||
42210471|NCT01150890|76025324|FG003|Overall Study|Pregnancy|1|||
42210472|NCT01150890|76025321|FG000|Overall Study|Administrative Decision|4|||
42210473|NCT01150890|76025322|FG001|Overall Study|Administrative Decision|4|||
42210474|NCT01150890|76025323|FG002|Overall Study|Administrative Decision|5|||
42210475|NCT01150890|76025324|FG003|Overall Study|Administrative Decision|6|||
42210476|NCT01150890|76025321|FG000|Overall Study|Ineligibility determined|0|||
42210477|NCT01150890|76025322|FG001|Overall Study|Ineligibility determined|1|||
42210478|NCT01150890|76025323|FG002|Overall Study|Ineligibility determined|0|||
42210479|NCT01150890|76025324|FG003|Overall Study|Ineligibility determined|0|||
42210480|NCT01150890|76025321|FG000|Overall Study|Adverse Event|0|||
42210481|NCT01150890|76025322|FG001|Overall Study|Adverse Event|0|||
42210482|NCT01150890|76025323|FG002|Overall Study|Adverse Event|2|||
42210483|NCT01150890|76025324|FG003|Overall Study|Adverse Event|0|||
42210484|NCT01150890|76025321|FG000|Overall Study|Withdrawal by Subject|0|||
42210485|NCT01150890|76025322|FG001|Overall Study|Withdrawal by Subject|0|||
42210486|NCT01150890|76025323|FG002|Overall Study|Withdrawal by Subject|2|||
42210487|NCT01150890|76025324|FG003|Overall Study|Withdrawal by Subject|1|||
42210488|NCT01150890|76025321|FG000|Overall Study|Disease progression|0|||
42210489|NCT01150890|76025322|FG001|Overall Study|Disease progression|7|||
42210490|NCT01150890|76025323|FG002|Overall Study|Disease progression|3|||
42210491|NCT01150890|76025324|FG003|Overall Study|Disease progression|7|||
42210492|NCT04057573|76025339|FG000|24-Week Double-Blind Period|Adverse Event|2|||
42210493|NCT04057573|76025340|FG001|24-Week Double-Blind Period|Adverse Event|0|||
42210494|NCT04057573|76025341|FG002|24-Week Double-Blind Period|Adverse Event|0|||
42210495|NCT04057573|76025342|FG003|24-Week Double-Blind Period|Adverse Event|0|||
42210496|NCT04057573|76025339|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
42210497|NCT04057573|76025340|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
42210498|NCT04057573|76025341|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
42210499|NCT04057573|76025342|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
42210500|NCT04057573|76025339|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
42210501|NCT04057573|76025340|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
42210502|NCT04057573|76025341|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
42210503|NCT04057573|76025342|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
42210504|NCT04057573|76025339|FG000|24-Week Double-Blind Period|Physician Decision|1|||
42210505|NCT04057573|76025340|FG001|24-Week Double-Blind Period|Physician Decision|0|||
42210506|NCT04057573|76025341|FG002|24-Week Double-Blind Period|Physician Decision|0|||
42210507|NCT04057573|76025342|FG003|24-Week Double-Blind Period|Physician Decision|0|||
42210508|NCT04057573|76025339|FG000|24-Week Double-Blind Period|Pregnancy|1|||
42210509|NCT04057573|76025340|FG001|24-Week Double-Blind Period|Pregnancy|0|||
42210510|NCT04057573|76025341|FG002|24-Week Double-Blind Period|Pregnancy|0|||
42210511|NCT04057573|76025342|FG003|24-Week Double-Blind Period|Pregnancy|0|||
42210512|NCT04057573|76025339|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
42210513|NCT04057573|76025340|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
42210514|NCT04057573|76025341|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
42210515|NCT04057573|76025342|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
42210516|NCT04057573|76025339|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
42210517|NCT04057573|76025340|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
42210518|NCT04057573|76025341|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
42210519|NCT04057573|76025342|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
41972300|NCT02628444|75773511|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
41972301|NCT02628444|75773512|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
41972302|NCT02628444|75773513|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
41972303|NCT02628444|75773514|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
41972304|NCT02628444|75773515|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
41972305|NCT02628444|75773516|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
41972306|NCT02628444|75773508|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
41972307|NCT02628444|75773509|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
41972308|NCT02628444|75773510|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
41972309|NCT02628444|75773511|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
42127091|NCT00418665|75937505|FG000|Treatment Extension|Adverse Event|1|||
42127092|NCT00418665|75937506|FG001|Treatment Extension|Adverse Event|0|||
42127093|NCT00418665|75937507|FG002|Treatment Extension|Adverse Event|0|||
42127094|NCT00418665|75937505|FG000|Treatment Extension|Withdrawal by Subject|1|||
42127095|NCT00418665|75937506|FG001|Treatment Extension|Withdrawal by Subject|0|||
42127096|NCT00418665|75937507|FG002|Treatment Extension|Withdrawal by Subject|0|||
42127097|NCT00418665|75937505|FG000|Treatment Extension|Requirement for alternative therapy|2|||
42127098|NCT00418665|75937506|FG001|Treatment Extension|Requirement for alternative therapy|2|||
42127099|NCT00418665|75937507|FG002|Treatment Extension|Requirement for alternative therapy|0|||
42127100|NCT00418665|75937505|FG000|Treatment Extension|Physician Decision|2|||
42127101|NCT00418665|75937506|FG001|Treatment Extension|Physician Decision|2|||
42272600|NCT01657292|76102840|FG000|Overall Study|Withdrawal by Subject|2|||
41972310|NCT02628444|75773512|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
42210520|NCT04057573|76025339|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
42210521|NCT04057573|76025340|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
42210522|NCT04057573|76025341|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
42210523|NCT04057573|76025342|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
42210524|NCT04057573|76025339|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
42210525|NCT04057573|76025340|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
42210526|NCT04057573|76025341|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
42210527|NCT04057573|76025342|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
42210528|NCT04057573|76025339|FG000|24-Week Double-Blind Period|Not Treated|1|||
42210529|NCT04057573|76025340|FG001|24-Week Double-Blind Period|Not Treated|0|||
42210530|NCT04057573|76025341|FG002|24-Week Double-Blind Period|Not Treated|0|||
42210531|NCT04057573|76025342|FG003|24-Week Double-Blind Period|Not Treated|0|||
42210532|NCT04057573|76025339|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
42210533|NCT04057573|76025340|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
42210534|NCT04057573|76025341|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
42210535|NCT04057573|76025342|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
42210536|NCT04057573|76025339|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
42210537|NCT04057573|76025340|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
42210538|NCT04057573|76025341|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
42210539|NCT04057573|76025342|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
42210540|NCT04057573|76025339|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
42210541|NCT04057573|76025340|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
42210542|NCT04057573|76025341|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
42210543|NCT04057573|76025342|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
42210544|NCT04057573|76025339|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
42210545|NCT04057573|76025340|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
42210546|NCT04057573|76025341|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
42210547|NCT04057573|76025342|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
42210548|NCT04057573|76025339|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
42210549|NCT04057573|76025340|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
42210550|NCT04057573|76025341|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
42210551|NCT04057573|76025342|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
42210552|NCT04054765|76025355|FG000|Baseline|Withdrawal by Subject|5|||
42210553|NCT04054765|76025356|FG001|Baseline|Withdrawal by Subject|3|||
42210554|NCT04054765|76025355|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
41972311|NCT02628444|75773513|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
41972312|NCT02628444|75773514|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
41972313|NCT02628444|75773515|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
41972314|NCT02628444|75773516|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
41972315|NCT02628444|75773508|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
41972316|NCT02628444|75773509|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
41972317|NCT02628444|75773510|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
41972318|NCT02628444|75773511|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
41972319|NCT02628444|75773512|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
41972320|NCT02628444|75773513|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
42010622|NCT00993265|75817738|FG000|Overall Study|Changed dose of concomitant drug|2|||
42127102|NCT00418665|75937507|FG002|Treatment Extension|Physician Decision|1|||
42127103|NCT00418665|75937505|FG000|Treatment Extension|Death|0|||
42127104|NCT00418665|75937506|FG001|Treatment Extension|Death|0|||
42127105|NCT00418665|75937507|FG002|Treatment Extension|Death|1|||
42127106|NCT00432237|75937519|FG000|Overall Study|Adverse Event|0|||
42127107|NCT00432237|75937520|FG001|Overall Study|Adverse Event|0|||
42127108|NCT00432237|75937521|FG002|Overall Study|Adverse Event|0|||
42127109|NCT00432237|75937522|FG003|Overall Study|Adverse Event|1|||
42127110|NCT00432237|75937519|FG000|Overall Study|Lack of Efficacy|0|||
42127111|NCT00432237|75937520|FG001|Overall Study|Lack of Efficacy|0|||
42127112|NCT00432237|75937521|FG002|Overall Study|Lack of Efficacy|0|||
42127113|NCT00432237|75937522|FG003|Overall Study|Lack of Efficacy|1|||
42127114|NCT00432237|75937519|FG000|Overall Study|Lost to Follow-up|10|||
42127115|NCT00432237|75937520|FG001|Overall Study|Lost to Follow-up|10|||
42127116|NCT00432237|75937521|FG002|Overall Study|Lost to Follow-up|18|||
42127117|NCT00432237|75937522|FG003|Overall Study|Lost to Follow-up|18|||
42127118|NCT00432237|75937519|FG000|Overall Study|Physician Decision|1|||
42127119|NCT00432237|75937520|FG001|Overall Study|Physician Decision|3|||
42127120|NCT00432237|75937521|FG002|Overall Study|Physician Decision|2|||
42127121|NCT00432237|75937522|FG003|Overall Study|Physician Decision|1|||
42127122|NCT00432237|75937519|FG000|Overall Study|Pregnancy|0|||
42127123|NCT00432237|75937520|FG001|Overall Study|Pregnancy|1|||
42210555|NCT04054765|76025356|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
42210556|NCT04054765|76025355|FG000|3-month Follow up|Withdrawal by Subject|0|||
42210557|NCT04054765|76025356|FG001|3-month Follow up|Withdrawal by Subject|3|||
42210558|NCT04054765|76025355|FG000|6-month Follow up|Lost to Follow-up|32|||
42210559|NCT04054765|76025356|FG001|6-month Follow up|Lost to Follow-up|32|||
42210560|NCT04179721|76025364|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
42210561|NCT04179721|76025365|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
42210562|NCT04179721|76025364|FG000|Overall Study|Lost to Follow-up|0|||
42210563|NCT04179721|76025365|FG001|Overall Study|Lost to Follow-up|1|||
42210564|NCT03286218|76025371|FG000|Qualification Phase Period 1|Adverse Event|1|||
42210565|NCT03286218|76025372|FG001|Qualification Phase Period 1|Adverse Event|0|||
41972321|NCT02628444|75773514|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
41972322|NCT02628444|75773515|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
41972323|NCT02628444|75773516|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
41972324|NCT02628444|75773508|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
41972325|NCT02628444|75773509|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
41972326|NCT02628444|75773510|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
41972327|NCT02628444|75773511|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
41972328|NCT02628444|75773512|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
41972329|NCT02628444|75773513|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
41972330|NCT02628444|75773514|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
41972331|NCT02628444|75773515|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
41972332|NCT02628444|75773516|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
41972333|NCT02628444|75773508|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
41972334|NCT02628444|75773509|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
41972335|NCT02628444|75773510|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
41972336|NCT02628444|75773511|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
41972337|NCT02628444|75773512|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
41972338|NCT02628444|75773513|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
41972339|NCT02628444|75773514|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
41972340|NCT02628444|75773515|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
41972341|NCT02628444|75773516|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
41972342|NCT02623725|75773552|FG000|Overall Study|Non compliance with protocol|9|||
41972343|NCT02623725|75773553|FG001|Overall Study|Non compliance with protocol|3|||
41972344|NCT02623725|75773552|FG000|Overall Study|Serious adverse event|0|||
41972345|NCT02623725|75773553|FG001|Overall Study|Serious adverse event|2|||
41972346|NCT02623725|75773552|FG000|Overall Study|Withdrawal by Subject|7|||
41972347|NCT02623725|75773553|FG001|Overall Study|Withdrawal by Subject|1|||
41972348|NCT02608684|75773561|FG000|Overall Study|Physician Decision|2|||
41972349|NCT02608684|75773561|FG000|Overall Study|Withdrawal by Subject|1|||
41972350|NCT02587520|75773583|FG000|Overall Study|Protocol Violation|2|||
41972351|NCT02587520|75773584|FG001|Overall Study|Protocol Violation|0|||
41972352|NCT02587520|75773585|FG002|Overall Study|Protocol Violation|0|||
41972353|NCT02587520|75773586|FG003|Overall Study|Protocol Violation|2|||
41972354|NCT02587520|75773587|FG004|Overall Study|Protocol Violation|0|||
41972355|NCT02587520|75773588|FG005|Overall Study|Protocol Violation|1|||
41972356|NCT02587520|75773589|FG006|Overall Study|Protocol Violation|1|||
41972357|NCT02587520|75773590|FG007|Overall Study|Protocol Violation|1|||
41972358|NCT02587520|75773591|FG008|Overall Study|Protocol Violation|3|||
41972359|NCT02587520|75773592|FG009|Overall Study|Protocol Violation|3|||
41972360|NCT02587520|75773593|FG010|Overall Study|Protocol Violation|1|||
41972361|NCT02587520|75773594|FG011|Overall Study|Protocol Violation|2|||
41972362|NCT02587520|75773595|FG012|Overall Study|Protocol Violation|0|||
41972363|NCT02587520|75773596|FG013|Overall Study|Protocol Violation|0|||
41972364|NCT02587520|75773597|FG014|Overall Study|Protocol Violation|0|||
41972365|NCT02587520|75773598|FG015|Overall Study|Protocol Violation|0|||
41972366|NCT02587520|75773599|FG016|Overall Study|Protocol Violation|0|||
41972367|NCT02587520|75773600|FG017|Overall Study|Protocol Violation|0|||
41972368|NCT02587520|75773583|FG000|Overall Study|Adverse Event|0|||
41972369|NCT02587520|75773584|FG001|Overall Study|Adverse Event|0|||
41972370|NCT02587520|75773585|FG002|Overall Study|Adverse Event|0|||
41972371|NCT02587520|75773586|FG003|Overall Study|Adverse Event|0|||
42210566|NCT03286218|76025373|FG002|Qualification Phase Period 1|Adverse Event|0|||
42210567|NCT03286218|76025374|FG003|Qualification Phase Period 1|Adverse Event|0|||
41972372|NCT02587520|75773587|FG004|Overall Study|Adverse Event|0|||
42210568|NCT03286218|76025375|FG004|Qualification Phase Period 1|Adverse Event|0|||
41972373|NCT02587520|75773588|FG005|Overall Study|Adverse Event|0|||
41972374|NCT02587520|75773589|FG006|Overall Study|Adverse Event|0|||
42210569|NCT03286218|76025376|FG005|Qualification Phase Period 1|Adverse Event|0|||
42210570|NCT03286218|76025377|FG006|Qualification Phase Period 1|Adverse Event|0|||
42210571|NCT03286218|76025378|FG007|Qualification Phase Period 1|Adverse Event|0|||
41972375|NCT02587520|75773590|FG007|Overall Study|Adverse Event|0|||
41972376|NCT02587520|75773591|FG008|Overall Study|Adverse Event|0|||
41972377|NCT02587520|75773592|FG009|Overall Study|Adverse Event|0|||
41972378|NCT02587520|75773593|FG010|Overall Study|Adverse Event|0|||
41972379|NCT02587520|75773594|FG011|Overall Study|Adverse Event|1|||
41972380|NCT02587520|75773595|FG012|Overall Study|Adverse Event|0|||
41972381|NCT02587520|75773596|FG013|Overall Study|Adverse Event|0|||
41972382|NCT02587520|75773597|FG014|Overall Study|Adverse Event|0|||
41972383|NCT02587520|75773598|FG015|Overall Study|Adverse Event|0|||
41972384|NCT02587520|75773599|FG016|Overall Study|Adverse Event|0|||
41972385|NCT02587520|75773600|FG017|Overall Study|Adverse Event|0|||
41972386|NCT02587520|75773583|FG000|Overall Study|Withdrawal by Subject|0|||
41972387|NCT02587520|75773584|FG001|Overall Study|Withdrawal by Subject|0|||
41972388|NCT02587520|75773585|FG002|Overall Study|Withdrawal by Subject|1|||
41972389|NCT02587520|75773586|FG003|Overall Study|Withdrawal by Subject|1|||
41972390|NCT02587520|75773587|FG004|Overall Study|Withdrawal by Subject|0|||
41972391|NCT02587520|75773588|FG005|Overall Study|Withdrawal by Subject|1|||
41972392|NCT02587520|75773589|FG006|Overall Study|Withdrawal by Subject|1|||
41972393|NCT02587520|75773590|FG007|Overall Study|Withdrawal by Subject|0|||
41972394|NCT02587520|75773591|FG008|Overall Study|Withdrawal by Subject|0|||
41972395|NCT02587520|75773592|FG009|Overall Study|Withdrawal by Subject|0|||
41972396|NCT02587520|75773593|FG010|Overall Study|Withdrawal by Subject|0|||
41972397|NCT02587520|75773594|FG011|Overall Study|Withdrawal by Subject|0|||
41972398|NCT02587520|75773595|FG012|Overall Study|Withdrawal by Subject|0|||
41972399|NCT02587520|75773596|FG013|Overall Study|Withdrawal by Subject|1|||
41972400|NCT02587520|75773597|FG014|Overall Study|Withdrawal by Subject|0|||
41972401|NCT02587520|75773598|FG015|Overall Study|Withdrawal by Subject|0|||
41972402|NCT02587520|75773599|FG016|Overall Study|Withdrawal by Subject|0|||
41972403|NCT02587520|75773600|FG017|Overall Study|Withdrawal by Subject|0|||
41972404|NCT02587520|75773583|FG000|Overall Study|Lost to Follow-up|0|||
41972405|NCT02587520|75773584|FG001|Overall Study|Lost to Follow-up|2|||
41972406|NCT02587520|75773585|FG002|Overall Study|Lost to Follow-up|0|||
41972407|NCT02587520|75773586|FG003|Overall Study|Lost to Follow-up|2|||
41972408|NCT02587520|75773587|FG004|Overall Study|Lost to Follow-up|0|||
41972409|NCT02587520|75773588|FG005|Overall Study|Lost to Follow-up|1|||
41972410|NCT02587520|75773589|FG006|Overall Study|Lost to Follow-up|1|||
41972411|NCT02587520|75773590|FG007|Overall Study|Lost to Follow-up|1|||
41972412|NCT02587520|75773591|FG008|Overall Study|Lost to Follow-up|0|||
41972413|NCT02587520|75773592|FG009|Overall Study|Lost to Follow-up|2|||
41972414|NCT02587520|75773593|FG010|Overall Study|Lost to Follow-up|2|||
41972415|NCT02587520|75773594|FG011|Overall Study|Lost to Follow-up|1|||
41972416|NCT02587520|75773595|FG012|Overall Study|Lost to Follow-up|0|||
41972417|NCT02587520|75773596|FG013|Overall Study|Lost to Follow-up|0|||
41972418|NCT02587520|75773597|FG014|Overall Study|Lost to Follow-up|0|||
41972419|NCT02587520|75773598|FG015|Overall Study|Lost to Follow-up|0|||
41972420|NCT02587520|75773599|FG016|Overall Study|Lost to Follow-up|0|||
41972421|NCT02587520|75773600|FG017|Overall Study|Lost to Follow-up|0|||
41972422|NCT02584829|75773640|FG000|Overall Study|Physician Decision|1|||
41972423|NCT02584829|75773641|FG001|Overall Study|Physician Decision|0|||
41972424|NCT02584829|75773640|FG000|Overall Study|Withdrawal by Subject|0|||
41972425|NCT02584829|75773641|FG001|Overall Study|Withdrawal by Subject|1|||
41972426|NCT02584829|75773640|FG000|Overall Study|Progressive Disease|0|||
41972427|NCT02584829|75773641|FG001|Overall Study|Progressive Disease|3|||
41972428|NCT02570308|75773654|FG000|Overall Study|Death|1|||
41972429|NCT02570308|75773655|FG001|Overall Study|Death|5|||
41972430|NCT02570308|75773656|FG002|Overall Study|Death|4|||
42127124|NCT00432237|75937521|FG002|Overall Study|Pregnancy|0|||
42127125|NCT00432237|75937522|FG003|Overall Study|Pregnancy|0|||
42127126|NCT00432237|75937519|FG000|Overall Study|Protocol Violation|13|||
42127127|NCT00432237|75937520|FG001|Overall Study|Protocol Violation|10|||
42127128|NCT00432237|75937521|FG002|Overall Study|Protocol Violation|11|||
42127129|NCT00432237|75937522|FG003|Overall Study|Protocol Violation|8|||
42127130|NCT00432237|75937519|FG000|Overall Study|Withdrawal by Subject|5|||
42127131|NCT00432237|75937520|FG001|Overall Study|Withdrawal by Subject|6|||
42127132|NCT00432237|75937521|FG002|Overall Study|Withdrawal by Subject|9|||
42127133|NCT00432237|75937522|FG003|Overall Study|Withdrawal by Subject|11|||
42127134|NCT00432237|75937519|FG000|Overall Study|Lack of Qualifying Event|38|||
42210572|NCT03286218|76025379|FG008|Qualification Phase Period 1|Adverse Event|0|||
41972431|NCT02570308|75773657|FG003|Overall Study|Death|4|||
41972432|NCT02570308|75773658|FG004|Overall Study|Death|69|||
42127135|NCT00432237|75937520|FG001|Overall Study|Lack of Qualifying Event|71|||
42127136|NCT00432237|75937521|FG002|Overall Study|Lack of Qualifying Event|69|||
42127137|NCT00432237|75937522|FG003|Overall Study|Lack of Qualifying Event|84|||
42127138|NCT00531284|75937549|FG000|Overall Study|Progressive Disease|1|||
41972433|NCT02570308|75773654|FG000|Overall Study|Lost to Follow-up|0|||
41972434|NCT02570308|75773655|FG001|Overall Study|Lost to Follow-up|0|||
41972435|NCT02570308|75773656|FG002|Overall Study|Lost to Follow-up|0|||
41972436|NCT02570308|75773657|FG003|Overall Study|Lost to Follow-up|0|||
41972437|NCT02570308|75773658|FG004|Overall Study|Lost to Follow-up|2|||
41972438|NCT02570308|75773654|FG000|Overall Study|Withdrawal by Subject|0|||
41972439|NCT02570308|75773655|FG001|Overall Study|Withdrawal by Subject|0|||
41972440|NCT02570308|75773656|FG002|Overall Study|Withdrawal by Subject|0|||
41972441|NCT02570308|75773657|FG003|Overall Study|Withdrawal by Subject|0|||
41972442|NCT02570308|75773658|FG004|Overall Study|Withdrawal by Subject|1|||
41972443|NCT02570308|75773654|FG000|Overall Study|Other|0|||
41972444|NCT02570308|75773655|FG001|Overall Study|Other|0|||
41972445|NCT02570308|75773656|FG002|Overall Study|Other|0|||
41972446|NCT02570308|75773657|FG003|Overall Study|Other|0|||
41972447|NCT02570308|75773658|FG004|Overall Study|Other|2|||
41972448|NCT02497612|75773680|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
41972449|NCT02497612|75773681|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
41972450|NCT02497612|75773682|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
41972451|NCT02497612|75773683|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
41972452|NCT02497612|75773680|FG000|Overall Study|Participant's request|2|||
41972453|NCT02497612|75773681|FG001|Overall Study|Participant's request|3|||
41972454|NCT02497612|75773682|FG002|Overall Study|Participant's request|4|||
41972455|NCT02497612|75773683|FG003|Overall Study|Participant's request|1|||
41972456|NCT02497612|75773680|FG000|Overall Study|Investigator's judgement|1|||
41972457|NCT02497612|75773681|FG001|Overall Study|Investigator's judgement|0|||
41972458|NCT02497612|75773682|FG002|Overall Study|Investigator's judgement|0|||
41972459|NCT02497612|75773683|FG003|Overall Study|Investigator's judgement|2|||
41972460|NCT02497612|75773680|FG000|Overall Study|Adverse Event|3|||
41972461|NCT02497612|75773681|FG001|Overall Study|Adverse Event|1|||
41972462|NCT02497612|75773682|FG002|Overall Study|Adverse Event|4|||
41972463|NCT02497612|75773683|FG003|Overall Study|Adverse Event|1|||
41972464|NCT02497612|75773680|FG000|Overall Study|Lost to Follow-up|1|||
41972465|NCT02497612|75773681|FG001|Overall Study|Lost to Follow-up|1|||
41972466|NCT02497612|75773682|FG002|Overall Study|Lost to Follow-up|0|||
41972467|NCT02497612|75773683|FG003|Overall Study|Lost to Follow-up|1|||
41972468|NCT02497612|75773680|FG000|Overall Study|Other unspecified|1|||
41972469|NCT02497612|75773681|FG001|Overall Study|Other unspecified|1|||
41972470|NCT02497612|75773682|FG002|Overall Study|Other unspecified|2|||
41972471|NCT02497612|75773683|FG003|Overall Study|Other unspecified|0|||
41972472|NCT02497612|75773680|FG000|Overall Study|Not eligible|1|||
41972473|NCT02497612|75773681|FG001|Overall Study|Not eligible|0|||
41972474|NCT02497612|75773682|FG002|Overall Study|Not eligible|0|||
41972475|NCT02497612|75773683|FG003|Overall Study|Not eligible|1|||
41972476|NCT02460458|75773693|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analyses|47|||
41972477|NCT02460458|75773693|FG000|Confirmatory Phase|Patients excluded due to lack of samples for central analyses|27|||
41972478|NCT02460458|75773693|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|14|||
41972479|NCT02460458|75773693|FG000|First Prospective Phase|Lost to Follow-up|16|||
41972480|NCT02460458|75773693|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|9|||
41972481|NCT02457559|75773708|FG000|Overall Study|Progressive Disease|1|||
41972482|NCT02457559|75773709|FG001|Overall Study|Progressive Disease|2|||
41972483|NCT02457559|75773710|FG002|Overall Study|Progressive Disease|3|||
41972484|NCT02457559|75773711|FG003|Overall Study|Progressive Disease|0|||
41972485|NCT02457559|75773712|FG004|Overall Study|Progressive Disease|0|||
41972486|NCT02457559|75773713|FG005|Overall Study|Progressive Disease|2|||
41972487|NCT02457559|75773714|FG006|Overall Study|Progressive Disease|1|||
41972488|NCT02457559|75773715|FG007|Overall Study|Progressive Disease|0|||
41972489|NCT02457559|75773716|FG008|Overall Study|Progressive Disease|1|||
41972490|NCT02457559|75773717|FG009|Overall Study|Progressive Disease|1|||
41972491|NCT02457559|75773718|FG010|Overall Study|Progressive Disease|1|||
41972492|NCT02457559|75773708|FG000|Overall Study|Investigator's Discretion|0|||
41972493|NCT02457559|75773709|FG001|Overall Study|Investigator's Discretion|0|||
41972494|NCT02457559|75773710|FG002|Overall Study|Investigator's Discretion|2|||
41972495|NCT02457559|75773711|FG003|Overall Study|Investigator's Discretion|0|||
41972496|NCT02457559|75773712|FG004|Overall Study|Investigator's Discretion|1|||
41972497|NCT02457559|75773713|FG005|Overall Study|Investigator's Discretion|0|||
41972498|NCT02457559|75773714|FG006|Overall Study|Investigator's Discretion|1|||
41972499|NCT02457559|75773715|FG007|Overall Study|Investigator's Discretion|0|||
41972500|NCT02457559|75773716|FG008|Overall Study|Investigator's Discretion|1|||
41972501|NCT02457559|75773717|FG009|Overall Study|Investigator's Discretion|0|||
41972502|NCT02457559|75773718|FG010|Overall Study|Investigator's Discretion|1|||
41972503|NCT02457559|75773708|FG000|Overall Study|Adverse Event|0|||
42028086|NCT00915772|75836420|FG001|Overall Study|Lack of Efficacy|15|||
41972504|NCT02457559|75773709|FG001|Overall Study|Adverse Event|1|||
41972505|NCT02457559|75773710|FG002|Overall Study|Adverse Event|2|||
41972506|NCT02457559|75773711|FG003|Overall Study|Adverse Event|0|||
41972507|NCT02457559|75773712|FG004|Overall Study|Adverse Event|0|||
41972508|NCT02457559|75773713|FG005|Overall Study|Adverse Event|0|||
41972509|NCT02457559|75773714|FG006|Overall Study|Adverse Event|0|||
41972510|NCT02457559|75773715|FG007|Overall Study|Adverse Event|0|||
41972511|NCT02457559|75773716|FG008|Overall Study|Adverse Event|0|||
41972512|NCT02457559|75773717|FG009|Overall Study|Adverse Event|0|||
41972513|NCT02457559|75773718|FG010|Overall Study|Adverse Event|0|||
41972514|NCT02457559|75773708|FG000|Overall Study|Reason not Specified|1|||
41972515|NCT02457559|75773709|FG001|Overall Study|Reason not Specified|0|||
41972516|NCT02457559|75773710|FG002|Overall Study|Reason not Specified|0|||
41972517|NCT02457559|75773711|FG003|Overall Study|Reason not Specified|0|||
41972518|NCT02457559|75773712|FG004|Overall Study|Reason not Specified|0|||
41972519|NCT02457559|75773713|FG005|Overall Study|Reason not Specified|0|||
41972520|NCT02457559|75773714|FG006|Overall Study|Reason not Specified|0|||
41972521|NCT02457559|75773715|FG007|Overall Study|Reason not Specified|0|||
41972522|NCT02457559|75773716|FG008|Overall Study|Reason not Specified|0|||
41972523|NCT02457559|75773717|FG009|Overall Study|Reason not Specified|2|||
41972524|NCT02457559|75773718|FG010|Overall Study|Reason not Specified|0|||
41972525|NCT02457559|75773708|FG000|Overall Study|Death|0|||
41972526|NCT02457559|75773709|FG001|Overall Study|Death|0|||
41972527|NCT02457559|75773710|FG002|Overall Study|Death|0|||
41972528|NCT02457559|75773711|FG003|Overall Study|Death|0|||
41972529|NCT02457559|75773712|FG004|Overall Study|Death|0|||
41972530|NCT02457559|75773713|FG005|Overall Study|Death|0|||
41972531|NCT02457559|75773714|FG006|Overall Study|Death|0|||
41972532|NCT02457559|75773715|FG007|Overall Study|Death|0|||
41972533|NCT02457559|75773716|FG008|Overall Study|Death|1|||
41972534|NCT02457559|75773717|FG009|Overall Study|Death|1|||
41972535|NCT02457559|75773718|FG010|Overall Study|Death|0|||
41972536|NCT02381652|75773768|FG000|Overall Study|Withdrawal by Subject|0|||
41972537|NCT02381652|75773769|FG001|Overall Study|Withdrawal by Subject|0|||
41972538|NCT02381652|75773770|FG002|Overall Study|Withdrawal by Subject|1|||
41972539|NCT02367794|75773779|FG000|Overall Study|Death|252|||
41972540|NCT02367794|75773780|FG001|Overall Study|Death|245|||
41972541|NCT02367794|75773781|FG002|Overall Study|Death|243|||
41972542|NCT02367794|75773779|FG000|Overall Study|Lost to Follow-up|1|||
41972543|NCT02367794|75773780|FG001|Overall Study|Lost to Follow-up|2|||
41972544|NCT02367794|75773781|FG002|Overall Study|Lost to Follow-up|2|||
41972545|NCT02367794|75773779|FG000|Overall Study|Physician Decision|0|||
41972546|NCT02367794|75773780|FG001|Overall Study|Physician Decision|5|||
41972547|NCT02367794|75773781|FG002|Overall Study|Physician Decision|3|||
41972548|NCT02367794|75773779|FG000|Overall Study|Protocol Violation|1|||
41972549|NCT02367794|75773780|FG001|Overall Study|Protocol Violation|0|||
41972550|NCT02367794|75773781|FG002|Overall Study|Protocol Violation|1|||
41972551|NCT02367794|75773779|FG000|Overall Study|Withdrawal by Subject|25|||
41972552|NCT02367794|75773780|FG001|Overall Study|Withdrawal by Subject|12|||
41972553|NCT02367794|75773781|FG002|Overall Study|Withdrawal by Subject|20|||
41972554|NCT02367794|75773779|FG000|Overall Study|Brain metastasis|1|||
41972555|NCT02367794|75773780|FG001|Overall Study|Brain metastasis|0|||
41972556|NCT02367794|75773781|FG002|Overall Study|Brain metastasis|0|||
41972557|NCT02367794|75773779|FG000|Overall Study|Randomized in error|0|||
41972558|NCT02367794|75773780|FG001|Overall Study|Randomized in error|0|||
41972559|NCT02367794|75773781|FG002|Overall Study|Randomized in error|1|||
41972560|NCT02367794|75773779|FG000|Overall Study|Patient unable to receive carboplatin|0|||
41972561|NCT02367794|75773780|FG001|Overall Study|Patient unable to receive carboplatin|0|||
41972562|NCT02367794|75773781|FG002|Overall Study|Patient unable to receive carboplatin|1|||
41972563|NCT02367794|75773779|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
41972564|NCT02367794|75773780|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
42028087|NCT00915772|75836421|FG002|Overall Study|Lack of Efficacy|3|||
42127139|NCT00531284|75937550|FG001|Overall Study|Progressive Disease|3|||
42127140|NCT00531284|75937551|FG002|Overall Study|Progressive Disease|5|||
41972565|NCT02367794|75773781|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
41972566|NCT02367794|75773779|FG000|Overall Study|Adverse Event|0|||
41972567|NCT02367794|75773780|FG001|Overall Study|Adverse Event|0|||
41972568|NCT02367794|75773781|FG002|Overall Study|Adverse Event|2|||
41972569|NCT02367794|75773779|FG000|Overall Study|Study Terminated By Sponsor|0|||
41972570|NCT02367794|75773780|FG001|Overall Study|Study Terminated By Sponsor|1|||
41972571|NCT02367794|75773781|FG002|Overall Study|Study Terminated By Sponsor|1|||
41972572|NCT02367794|75773779|FG000|Overall Study|Moved to Roll-Over Study|0|||
41972573|NCT02367794|75773780|FG001|Overall Study|Moved to Roll-Over Study|15|||
42210573|NCT03286218|76025380|FG009|Qualification Phase Period 1|Adverse Event|0|||
41972574|NCT02367794|75773781|FG002|Overall Study|Moved to Roll-Over Study|13|||
41972575|NCT02367794|75773779|FG000|Overall Study|Sponsor Request|60|||
41972576|NCT02367794|75773780|FG001|Overall Study|Sponsor Request|57|||
41972577|NCT02367794|75773781|FG002|Overall Study|Sponsor Request|45|||
41972578|NCT02367794|75773779|FG000|Overall Study|Moved into PTAP Study|0|||
41972579|NCT02367794|75773780|FG001|Overall Study|Moved into PTAP Study|2|||
41972580|NCT02367794|75773781|FG002|Overall Study|Moved into PTAP Study|3|||
41972581|NCT02367794|75773779|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
42210574|NCT03286218|76025381|FG010|Qualification Phase Period 1|Adverse Event|0|||
42210575|NCT03286218|76025382|FG011|Qualification Phase Period 1|Adverse Event|0|||
42210576|NCT03286218|76025371|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
42210577|NCT03286218|76025372|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
42210578|NCT03286218|76025373|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
42210579|NCT03286218|76025374|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
42210580|NCT03286218|76025375|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
42210581|NCT03286218|76025376|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
42210582|NCT03286218|76025377|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
42210583|NCT03286218|76025378|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
41972582|NCT02367794|75773780|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
41972583|NCT02367794|75773781|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
41972584|NCT02367794|75773779|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
41972585|NCT02367794|75773780|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
41972586|NCT02367794|75773781|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
41972587|NCT02367794|75773779|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
41972588|NCT02367794|75773780|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
41972589|NCT02367794|75773781|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
41972590|NCT02367794|75773779|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
41972591|NCT02367794|75773780|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
41972592|NCT02367794|75773781|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
41972593|NCT02353832|75773814|FG000|Overall Study|Ineligible after enrollment|1|||
41972594|NCT02353832|75773814|FG000|Overall Study|Lost to Follow-up|1|||
41972595|NCT02353728|75773818|FG000|Overall Study|Subject non-compliance|1|||
41972596|NCT02345070|75773825|FG000|Overall Study|Adverse Event|12|||
41972597|NCT02345070|75773826|FG001|Overall Study|Adverse Event|8|||
41972598|NCT02345070|75773827|FG002|Overall Study|Adverse Event|16|||
41972599|NCT02345070|75773825|FG000|Overall Study|Poor compliance to protocol|2|||
41972600|NCT02345070|75773826|FG001|Overall Study|Poor compliance to protocol|0|||
41972601|NCT02345070|75773827|FG002|Overall Study|Poor compliance to protocol|0|||
41972602|NCT02345070|75773825|FG000|Overall Study|Other than specified above|6|||
41972603|NCT02345070|75773826|FG001|Overall Study|Other than specified above|3|||
41972604|NCT02345070|75773827|FG002|Overall Study|Other than specified above|7|||
41972605|NCT02325466|75773835|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
41972606|NCT02325466|75773836|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
41972607|NCT02325466|75773837|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
41972608|NCT02325466|75773835|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
41972609|NCT02325466|75773836|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
41972610|NCT02325466|75773837|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
42210584|NCT03286218|76025379|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
42210585|NCT03286218|76025380|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
42210586|NCT03286218|76025381|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
42210587|NCT03286218|76025382|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
42210588|NCT03286218|76025371|FG000|Qualification Phase Period 2|Adverse Event|0|||
42210589|NCT03286218|76025372|FG001|Qualification Phase Period 2|Adverse Event|1|||
42210590|NCT03286218|76025373|FG002|Qualification Phase Period 2|Adverse Event|0|||
42210591|NCT03286218|76025374|FG003|Qualification Phase Period 2|Adverse Event|0|||
42210592|NCT03286218|76025375|FG004|Qualification Phase Period 2|Adverse Event|0|||
42210593|NCT03286218|76025376|FG005|Qualification Phase Period 2|Adverse Event|0|||
42210594|NCT03286218|76025377|FG006|Qualification Phase Period 2|Adverse Event|0|||
42210595|NCT03286218|76025378|FG007|Qualification Phase Period 2|Adverse Event|0|||
42127141|NCT00531284|75937552|FG003|Overall Study|Progressive Disease|42|||
42127142|NCT00531284|75937553|FG004|Overall Study|Progressive Disease|4|||
42127143|NCT00531284|75937554|FG005|Overall Study|Progressive Disease|4|||
42127144|NCT00531284|75937555|FG006|Overall Study|Progressive Disease|3|||
42127145|NCT00531284|75937556|FG007|Overall Study|Progressive Disease|8|||
42127146|NCT00531284|75937557|FG008|Overall Study|Progressive Disease|6|||
42127147|NCT00531284|75937558|FG009|Overall Study|Progressive Disease|3|||
42127148|NCT00531284|75937559|FG010|Overall Study|Progressive Disease|3|||
42127149|NCT00531284|75937560|FG011|Overall Study|Progressive Disease|14|||
42127150|NCT00531284|75937561|FG012|Overall Study|Progressive Disease|2|||
42127151|NCT00531284|75937562|FG013|Overall Study|Progressive Disease|1|||
42127152|NCT00531284|75937563|FG014|Overall Study|Progressive Disease|2|||
42127153|NCT00531284|75937564|FG015|Overall Study|Progressive Disease|11|||
42127154|NCT00531284|75937565|FG016|Overall Study|Progressive Disease|5|||
42210596|NCT03286218|76025379|FG008|Qualification Phase Period 2|Adverse Event|0|||
42127155|NCT00531284|75937549|FG000|Overall Study|Adverse Event|0|||
42127156|NCT00531284|75937550|FG001|Overall Study|Adverse Event|1|||
42127157|NCT00531284|75937551|FG002|Overall Study|Adverse Event|1|||
42127158|NCT00531284|75937552|FG003|Overall Study|Adverse Event|7|||
42210597|NCT03286218|76025380|FG009|Qualification Phase Period 2|Adverse Event|0|||
42210598|NCT03286218|76025381|FG010|Qualification Phase Period 2|Adverse Event|0|||
42210599|NCT03286218|76025382|FG011|Qualification Phase Period 2|Adverse Event|0|||
42210600|NCT03286218|76025371|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
42210601|NCT03286218|76025372|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
42210602|NCT03286218|76025373|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
42210603|NCT03286218|76025374|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
42210604|NCT03286218|76025375|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
42210605|NCT03286218|76025376|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
42210606|NCT03286218|76025377|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
42210607|NCT03286218|76025378|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
42210608|NCT03286218|76025379|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
42210609|NCT03286218|76025380|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
42210610|NCT03286218|76025381|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
42210611|NCT03286218|76025382|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
42210612|NCT03286218|76025371|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
42210613|NCT03286218|76025372|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
42210614|NCT03286218|76025373|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
42210615|NCT03286218|76025374|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
42210616|NCT03286218|76025375|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
42210617|NCT03286218|76025376|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
42210618|NCT03286218|76025377|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
42210619|NCT03286218|76025378|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
42210620|NCT03286218|76025379|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
42210621|NCT03286218|76025380|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
42210622|NCT03286218|76025381|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
42127159|NCT00531284|75937553|FG004|Overall Study|Adverse Event|0|||
42127160|NCT00531284|75937554|FG005|Overall Study|Adverse Event|2|||
42127161|NCT00531284|75937555|FG006|Overall Study|Adverse Event|3|||
42127162|NCT00531284|75937556|FG007|Overall Study|Adverse Event|2|||
42127163|NCT00531284|75937557|FG008|Overall Study|Adverse Event|3|||
42127164|NCT00531284|75937558|FG009|Overall Study|Adverse Event|0|||
42127165|NCT00531284|75937559|FG010|Overall Study|Adverse Event|0|||
42127166|NCT00531284|75937560|FG011|Overall Study|Adverse Event|5|||
42127167|NCT00531284|75937561|FG012|Overall Study|Adverse Event|0|||
42127168|NCT00531284|75937562|FG013|Overall Study|Adverse Event|1|||
42127169|NCT00531284|75937563|FG014|Overall Study|Adverse Event|1|||
42127170|NCT00531284|75937564|FG015|Overall Study|Adverse Event|0|||
42127171|NCT00531284|75937565|FG016|Overall Study|Adverse Event|2|||
42127172|NCT00531284|75937549|FG000|Overall Study|Withdrawal by Subject|1|||
42127173|NCT00531284|75937550|FG001|Overall Study|Withdrawal by Subject|0|||
42127174|NCT00531284|75937551|FG002|Overall Study|Withdrawal by Subject|0|||
42127175|NCT00531284|75937552|FG003|Overall Study|Withdrawal by Subject|4|||
42127176|NCT00531284|75937553|FG004|Overall Study|Withdrawal by Subject|0|||
42127177|NCT00531284|75937554|FG005|Overall Study|Withdrawal by Subject|0|||
42127178|NCT00531284|75937555|FG006|Overall Study|Withdrawal by Subject|0|||
42127179|NCT00531284|75937556|FG007|Overall Study|Withdrawal by Subject|0|||
42127180|NCT00531284|75937557|FG008|Overall Study|Withdrawal by Subject|0|||
42210623|NCT03286218|76025382|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
41972611|NCT02325466|75773835|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
42127181|NCT00531284|75937558|FG009|Overall Study|Withdrawal by Subject|0|||
42127182|NCT00531284|75937559|FG010|Overall Study|Withdrawal by Subject|0|||
42127183|NCT00531284|75937560|FG011|Overall Study|Withdrawal by Subject|3|||
42127184|NCT00531284|75937561|FG012|Overall Study|Withdrawal by Subject|0|||
42127185|NCT00531284|75937562|FG013|Overall Study|Withdrawal by Subject|1|||
42127186|NCT00531284|75937563|FG014|Overall Study|Withdrawal by Subject|0|||
41972612|NCT02325466|75773836|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
41972613|NCT02325466|75773837|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
41972614|NCT02325466|75773835|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
41972615|NCT02325466|75773836|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
41972616|NCT02325466|75773837|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
41972617|NCT02325466|75773835|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
41972618|NCT02325466|75773836|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
42127187|NCT00531284|75937564|FG015|Overall Study|Withdrawal by Subject|1|||
42127188|NCT00531284|75937565|FG016|Overall Study|Withdrawal by Subject|1|||
42127189|NCT00531284|75937549|FG000|Overall Study|Other|1|||
42127190|NCT00531284|75937550|FG001|Overall Study|Other|0|||
42127191|NCT00531284|75937551|FG002|Overall Study|Other|0|||
42127192|NCT00531284|75937552|FG003|Overall Study|Other|10|||
42127193|NCT00531284|75937553|FG004|Overall Study|Other|2|||
42127194|NCT00531284|75937554|FG005|Overall Study|Other|1|||
42127195|NCT00531284|75937555|FG006|Overall Study|Other|0|||
42127196|NCT00531284|75937556|FG007|Overall Study|Other|0|||
42127197|NCT00531284|75937557|FG008|Overall Study|Other|2|||
42127198|NCT00531284|75937558|FG009|Overall Study|Other|1|||
42127199|NCT00531284|75937559|FG010|Overall Study|Other|0|||
42127200|NCT00531284|75937560|FG011|Overall Study|Other|2|||
42127201|NCT00531284|75937561|FG012|Overall Study|Other|0|||
42127202|NCT00531284|75937562|FG013|Overall Study|Other|0|||
42127203|NCT00531284|75937563|FG014|Overall Study|Other|1|||
42127204|NCT00531284|75937564|FG015|Overall Study|Other|0|||
42127205|NCT00531284|75937565|FG016|Overall Study|Other|0|||
42127206|NCT00531206|75937621|FG000|Overall Study|Adverse Event related|5|||
42127207|NCT00531206|75937621|FG000|Overall Study|Lack of Efficacy|2|||
42127208|NCT00531206|75937621|FG000|Overall Study|Lost to Follow-up|5|||
42127209|NCT00531206|75937621|FG000|Overall Study|including non-related adverse events|8|||
42127210|NCT00530816|75937628|FG000|Overall Study|Progressive Disease|16|||
42127211|NCT00530816|75937629|FG001|Overall Study|Progressive Disease|24|||
42127212|NCT00530816|75937630|FG002|Overall Study|Progressive Disease|24|||
42127213|NCT00530816|75937628|FG000|Overall Study|Adverse Event|6|||
42127214|NCT00530816|75937629|FG001|Overall Study|Adverse Event|13|||
42127215|NCT00530816|75937630|FG002|Overall Study|Adverse Event|7|||
42127216|NCT00530816|75937628|FG000|Overall Study|Other|3|||
42127217|NCT00530816|75937629|FG001|Overall Study|Other|3|||
42127218|NCT00530816|75937630|FG002|Overall Study|Other|4|||
42127219|NCT00530816|75937628|FG000|Overall Study|Withdrawal by Subject|1|||
42127220|NCT00530816|75937629|FG001|Overall Study|Withdrawal by Subject|2|||
42127221|NCT00530816|75937630|FG002|Overall Study|Withdrawal by Subject|6|||
42127222|NCT00615017|75937644|FG000|Overall Study|Adverse Event|0|||
42127223|NCT00615017|75937645|FG001|Overall Study|Adverse Event|1|||
42127224|NCT00615017|75937646|FG002|Overall Study|Adverse Event|2|||
42127225|NCT00615017|75937647|FG003|Overall Study|Adverse Event|0|||
42127226|NCT00615017|75937648|FG004|Overall Study|Adverse Event|0|||
42127227|NCT00615017|75937649|FG005|Overall Study|Adverse Event|1|||
42127228|NCT00615017|75937644|FG000|Overall Study|Death|0|||
42127229|NCT00615017|75937645|FG001|Overall Study|Death|0|||
42127230|NCT00615017|75937646|FG002|Overall Study|Death|2|||
42127231|NCT00615017|75937647|FG003|Overall Study|Death|0|||
42127232|NCT00615017|75937648|FG004|Overall Study|Death|1|||
42127233|NCT00615017|75937649|FG005|Overall Study|Death|1|||
42127234|NCT00615017|75937644|FG000|Overall Study|Sepsis resolved|0|||
42127235|NCT00615017|75937645|FG001|Overall Study|Sepsis resolved|0|||
42127236|NCT00615017|75937646|FG002|Overall Study|Sepsis resolved|1|||
42127237|NCT00615017|75937647|FG003|Overall Study|Sepsis resolved|0|||
42127238|NCT00615017|75937648|FG004|Overall Study|Sepsis resolved|0|||
42127239|NCT00615017|75937649|FG005|Overall Study|Sepsis resolved|0|||
42127240|NCT00615017|75937644|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
42127241|NCT00615017|75937645|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
42127242|NCT00615017|75937646|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
42127243|NCT00615017|75937647|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
42127244|NCT00615017|75937648|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
42127245|NCT00615017|75937649|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
42127246|NCT00615017|75937644|FG000|Overall Study|Physician discontinued drug|0|||
42127247|NCT00615017|75937645|FG001|Overall Study|Physician discontinued drug|0|||
42127248|NCT00615017|75937646|FG002|Overall Study|Physician discontinued drug|0|||
42127249|NCT00615017|75937647|FG003|Overall Study|Physician discontinued drug|0|||
42127250|NCT00615017|75937648|FG004|Overall Study|Physician discontinued drug|0|||
42127251|NCT00615017|75937649|FG005|Overall Study|Physician discontinued drug|1|||
42127252|NCT00614939|75937665|FG000|Overall Study|Withdrawal by Subject|10|||
42127253|NCT00614939|75937666|FG001|Overall Study|Withdrawal by Subject|17|||
42127254|NCT00614939|75937665|FG000|Overall Study|Study specific discontinuation criteris|13|||
42127255|NCT00614939|75937666|FG001|Overall Study|Study specific discontinuation criteris|16|||
42127256|NCT00614939|75937665|FG000|Overall Study|Adverse Event|2|||
42127257|NCT00614939|75937666|FG001|Overall Study|Adverse Event|5|||
42210624|NCT03286218|76025371|FG000|Qualification Phase Period 2|Protocol Violation|2|||
42210625|NCT03286218|76025372|FG001|Qualification Phase Period 2|Protocol Violation|0|||
42210626|NCT03286218|76025373|FG002|Qualification Phase Period 2|Protocol Violation|0|||
42210627|NCT03286218|76025374|FG003|Qualification Phase Period 2|Protocol Violation|0|||
42210628|NCT03286218|76025375|FG004|Qualification Phase Period 2|Protocol Violation|0|||
42210629|NCT03286218|76025376|FG005|Qualification Phase Period 2|Protocol Violation|0|||
42210630|NCT03286218|76025377|FG006|Qualification Phase Period 2|Protocol Violation|0|||
42210631|NCT03286218|76025378|FG007|Qualification Phase Period 2|Protocol Violation|0|||
42210632|NCT03286218|76025379|FG008|Qualification Phase Period 2|Protocol Violation|0|||
41972619|NCT02325466|75773837|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
41972620|NCT02325466|75773835|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
41972621|NCT02325466|75773836|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
41972622|NCT02325466|75773837|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
41972623|NCT02325466|75773835|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
41972624|NCT02325466|75773836|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
41972625|NCT02325466|75773837|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
41972626|NCT02325466|75773835|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
41972627|NCT02325466|75773836|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
41972628|NCT02325466|75773837|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
41972629|NCT02325466|75773835|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
41972630|NCT02325466|75773836|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
41972631|NCT02325466|75773837|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
41972632|NCT02322710|75773848|FG000|Overall Study|No efficacy assessment post-baseline|0|||
41972633|NCT02322710|75773849|FG001|Overall Study|No efficacy assessment post-baseline|1|||
41972634|NCT02322710|75773848|FG000|Overall Study|Protocol Violation|20|||
41972635|NCT02322710|75773849|FG001|Overall Study|Protocol Violation|25|||
41972636|NCT02234310|75773892|FG000|Overall Study|Physician Decision|1|||
41972637|NCT02234310|75773892|FG000|Overall Study|Adverse Event|1|||
42127258|NCT00614939|75937665|FG000|Overall Study|Incorrect enrollment|1|||
42127259|NCT00614939|75937666|FG001|Overall Study|Incorrect enrollment|2|||
42127260|NCT00614939|75937665|FG000|Overall Study|Death|4|||
42127261|NCT00614939|75937666|FG001|Overall Study|Death|3|||
42127262|NCT00614939|75937665|FG000|Overall Study|Poor/non-compliance|4|||
42127263|NCT00614939|75937666|FG001|Overall Study|Poor/non-compliance|0|||
42127264|NCT00614939|75937665|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
42210633|NCT03286218|76025380|FG009|Qualification Phase Period 2|Protocol Violation|0|||
42210634|NCT03286218|76025381|FG010|Qualification Phase Period 2|Protocol Violation|0|||
42210635|NCT03286218|76025382|FG011|Qualification Phase Period 2|Protocol Violation|0|||
42210636|NCT03286218|76025371|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
42301673|NCT02509117|76136791|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
42301674|NCT02509117|76136792|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
41972638|NCT02234310|75773892|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
41972639|NCT02234310|75773892|FG000|Overall Study|Withdrawal by Subject|2|||
42127265|NCT00614939|75937666|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
42127266|NCT00530504|75937672|FG000|Overall Study|Death|54|||
42127267|NCT00530504|75937672|FG000|Overall Study|Lost to Follow-up|26|||
42127268|NCT00530504|75937672|FG000|Overall Study|Withdrawal by Subject|39|||
42127269|NCT00530504|75937672|FG000|Overall Study|Exited study due to other reasons|33|||
42127270|NCT04720664|75937702|FG000|Overall Study|Adverse Event|2|||
42127271|NCT04720664|75937702|FG000|Overall Study|Lack of Efficacy|9|||
42127272|NCT04371198|75937715|FG000|Overall Study|inadequate sample|4|||
42127273|NCT04288154|75937721|FG000|Overall Study|Withdrawal by Subject|9|||
42127274|NCT04288154|75937722|FG001|Overall Study|Withdrawal by Subject|9|||
42127275|NCT04258579|75937728|FG000|Overall Study|Withdrawal by Subject|7|||
42127276|NCT04258579|75937728|FG000|Overall Study|Lost to Follow-up|3|||
42127277|NCT04258579|75937728|FG000|Overall Study|Protocol Violation|2|||
42127278|NCT04258579|75937728|FG000|Overall Study|Adverse Event|1|||
42210637|NCT03286218|76025372|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
42210638|NCT03286218|76025373|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
42210639|NCT03286218|76025374|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
42127279|NCT03945214|75937736|FG000|Overall Study|Lost to Follow-up|3|||
41972640|NCT02106195|75773925|FG000|Overall Study|Adverse Event|2|||
41972641|NCT02106195|75773925|FG000|Overall Study|Protocol Violation|1|||
41972642|NCT02104180|75773937|FG000|Overall Study|Protocol Violation|1|||
41972643|NCT02104180|75773938|FG001|Overall Study|Protocol Violation|0|||
41972644|NCT01943825|75773961|FG000|Overall Study|Lost to Follow-up|9|||
41972645|NCT01943825|75773962|FG001|Overall Study|Lost to Follow-up|3|||
41972646|NCT01943825|75773963|FG002|Overall Study|Lost to Follow-up|12|||
41972647|NCT01943825|75773964|FG003|Overall Study|Lost to Follow-up|8|||
41972648|NCT01943825|75773961|FG000|Overall Study|Withdrawal by Subject|1|||
41972649|NCT01943825|75773962|FG001|Overall Study|Withdrawal by Subject|0|||
42127280|NCT03945214|75937737|FG001|Overall Study|Lost to Follow-up|4|||
42127281|NCT03945214|75937738|FG002|Overall Study|Lost to Follow-up|7|||
42127282|NCT03945214|75937739|FG003|Overall Study|Lost to Follow-up|4|||
42127283|NCT03829683|75937751|FG000|Overall Study|Lost to Follow-up|1|||
41972650|NCT01943825|75773963|FG002|Overall Study|Withdrawal by Subject|3|||
41972651|NCT01943825|75773964|FG003|Overall Study|Withdrawal by Subject|2|||
41972652|NCT01943825|75773961|FG000|Overall Study|Other than specified above|0|||
41972653|NCT01943825|75773962|FG001|Overall Study|Other than specified above|1|||
41972654|NCT01943825|75773963|FG002|Overall Study|Other than specified above|0|||
41972655|NCT01943825|75773964|FG003|Overall Study|Other than specified above|1|||
41972656|NCT01722331|75773996|FG000|Part 1|Adverse Event|5|||
41972657|NCT01722331|75773997|FG001|Part 1|Adverse Event|0|||
41972658|NCT01722331|75773998|FG002|Part 1|Adverse Event|0|||
41972659|NCT01722331|75773999|FG003|Part 1|Adverse Event|0|||
41972660|NCT01722331|75774000|FG004|Part 1|Adverse Event|0|||
41972661|NCT01722331|75774001|FG005|Part 1|Adverse Event|0|||
41972662|NCT01722331|75774002|FG006|Part 1|Adverse Event|0|||
41972663|NCT01722331|75773996|FG000|Part 1|Lack of Efficacy|0|||
41972664|NCT01722331|75773997|FG001|Part 1|Lack of Efficacy|0|||
41972665|NCT01722331|75773998|FG002|Part 1|Lack of Efficacy|1|||
41972666|NCT01722331|75773999|FG003|Part 1|Lack of Efficacy|0|||
41972667|NCT01722331|75774000|FG004|Part 1|Lack of Efficacy|2|||
41972668|NCT01722331|75774001|FG005|Part 1|Lack of Efficacy|0|||
41972669|NCT01722331|75774002|FG006|Part 1|Lack of Efficacy|0|||
41972670|NCT01722331|75773996|FG000|Part 1|Lost to Follow-up|1|||
41972671|NCT01722331|75773997|FG001|Part 1|Lost to Follow-up|0|||
41972672|NCT01722331|75773998|FG002|Part 1|Lost to Follow-up|2|||
41972673|NCT01722331|75773999|FG003|Part 1|Lost to Follow-up|0|||
41972674|NCT01722331|75774000|FG004|Part 1|Lost to Follow-up|1|||
41972675|NCT01722331|75774001|FG005|Part 1|Lost to Follow-up|0|||
41972676|NCT01722331|75774002|FG006|Part 1|Lost to Follow-up|0|||
41972677|NCT01722331|75773996|FG000|Part 1|Physician Decision|0|||
41972678|NCT01722331|75773997|FG001|Part 1|Physician Decision|0|||
41972679|NCT01722331|75773998|FG002|Part 1|Physician Decision|3|||
41972680|NCT01722331|75773999|FG003|Part 1|Physician Decision|0|||
41972681|NCT01722331|75774000|FG004|Part 1|Physician Decision|1|||
41972682|NCT01722331|75774001|FG005|Part 1|Physician Decision|0|||
41972683|NCT01722331|75774002|FG006|Part 1|Physician Decision|0|||
41972684|NCT01722331|75773996|FG000|Part 1|Pregnancy|1|||
41972685|NCT01722331|75773997|FG001|Part 1|Pregnancy|0|||
41972686|NCT01722331|75773998|FG002|Part 1|Pregnancy|0|||
41972687|NCT01722331|75773999|FG003|Part 1|Pregnancy|0|||
41972688|NCT01722331|75774000|FG004|Part 1|Pregnancy|0|||
41972689|NCT01722331|75774001|FG005|Part 1|Pregnancy|0|||
41972690|NCT01722331|75774002|FG006|Part 1|Pregnancy|0|||
41972691|NCT01722331|75773996|FG000|Part 1|Progressive Disease|0|||
41972692|NCT01722331|75773997|FG001|Part 1|Progressive Disease|0|||
41972693|NCT01722331|75773998|FG002|Part 1|Progressive Disease|0|||
41972694|NCT01722331|75773999|FG003|Part 1|Progressive Disease|0|||
41972695|NCT01722331|75774000|FG004|Part 1|Progressive Disease|1|||
41972696|NCT01722331|75774001|FG005|Part 1|Progressive Disease|0|||
41972697|NCT01722331|75774002|FG006|Part 1|Progressive Disease|0|||
41972698|NCT01722331|75773996|FG000|Part 1|Protocol Violation|1|||
41972699|NCT01722331|75773997|FG001|Part 1|Protocol Violation|0|||
41972700|NCT01722331|75773998|FG002|Part 1|Protocol Violation|0|||
41972701|NCT01722331|75773999|FG003|Part 1|Protocol Violation|0|||
41972702|NCT01722331|75774000|FG004|Part 1|Protocol Violation|1|||
41972703|NCT01722331|75774001|FG005|Part 1|Protocol Violation|0|||
41972704|NCT01722331|75774002|FG006|Part 1|Protocol Violation|0|||
42127284|NCT03829683|75937752|FG001|Overall Study|Lost to Follow-up|0|||
41972705|NCT01722331|75773996|FG000|Part 1|Withdrawal by Subject|2|||
41972706|NCT01722331|75773997|FG001|Part 1|Withdrawal by Subject|0|||
41972707|NCT01722331|75773998|FG002|Part 1|Withdrawal by Subject|3|||
41972708|NCT01722331|75773999|FG003|Part 1|Withdrawal by Subject|0|||
41972709|NCT01722331|75774000|FG004|Part 1|Withdrawal by Subject|3|||
41972710|NCT01722331|75774001|FG005|Part 1|Withdrawal by Subject|0|||
42127285|NCT03829683|75937751|FG000|Overall Study|Physician Decision|3|||
41972711|NCT01722331|75774002|FG006|Part 1|Withdrawal by Subject|0|||
41972712|NCT01722331|75773996|FG000|Part 2|Adverse Event|3|||
41972713|NCT01722331|75773997|FG001|Part 2|Adverse Event|0|||
41972714|NCT01722331|75773998|FG002|Part 2|Adverse Event|0|||
41972715|NCT01722331|75773999|FG003|Part 2|Adverse Event|0|||
41972716|NCT01722331|75774000|FG004|Part 2|Adverse Event|0|||
41972717|NCT01722331|75774001|FG005|Part 2|Adverse Event|1|||
41972718|NCT01722331|75774002|FG006|Part 2|Adverse Event|0|||
42210640|NCT03286218|76025375|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
42210641|NCT03286218|76025376|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
42210642|NCT03286218|76025377|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
42210643|NCT03286218|76025378|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
42210644|NCT03286218|76025379|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
42210645|NCT03286218|76025380|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
42210646|NCT03286218|76025381|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
42210647|NCT03286218|76025382|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
42210648|NCT03286218|76025371|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
42210649|NCT03286218|76025372|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
42301675|NCT02509117|76136793|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
42301676|NCT02509117|76136794|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
42301677|NCT02509117|76136785|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
42301678|NCT02509117|76136786|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
42301679|NCT02509117|76136787|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
42301680|NCT02509117|76136788|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
42301681|NCT02509117|76136789|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
41972719|NCT01722331|75773996|FG000|Part 2|Lack of Efficacy|3|||
41972720|NCT01722331|75773997|FG001|Part 2|Lack of Efficacy|0|||
41972721|NCT01722331|75773998|FG002|Part 2|Lack of Efficacy|11|||
41972722|NCT01722331|75773999|FG003|Part 2|Lack of Efficacy|0|||
41972723|NCT01722331|75774000|FG004|Part 2|Lack of Efficacy|0|||
41972724|NCT01722331|75774001|FG005|Part 2|Lack of Efficacy|3|||
41972725|NCT01722331|75774002|FG006|Part 2|Lack of Efficacy|3|||
41972726|NCT01722331|75773996|FG000|Part 2|Lost to Follow-up|0|||
41972727|NCT01722331|75773997|FG001|Part 2|Lost to Follow-up|0|||
41972728|NCT01722331|75773998|FG002|Part 2|Lost to Follow-up|3|||
41972729|NCT01722331|75773999|FG003|Part 2|Lost to Follow-up|0|||
41972730|NCT01722331|75774000|FG004|Part 2|Lost to Follow-up|0|||
41972731|NCT01722331|75774001|FG005|Part 2|Lost to Follow-up|1|||
41972732|NCT01722331|75774002|FG006|Part 2|Lost to Follow-up|1|||
41972733|NCT01722331|75773996|FG000|Part 2|Non-Compliance with Study Drug|1|||
41972734|NCT01722331|75773997|FG001|Part 2|Non-Compliance with Study Drug|0|||
41972735|NCT01722331|75773998|FG002|Part 2|Non-Compliance with Study Drug|1|||
41972736|NCT01722331|75773999|FG003|Part 2|Non-Compliance with Study Drug|0|||
41972737|NCT01722331|75774000|FG004|Part 2|Non-Compliance with Study Drug|0|||
41972738|NCT01722331|75774001|FG005|Part 2|Non-Compliance with Study Drug|0|||
41972739|NCT01722331|75774002|FG006|Part 2|Non-Compliance with Study Drug|0|||
41972740|NCT01722331|75773996|FG000|Part 2|Physician Decision|0|||
41972741|NCT01722331|75773997|FG001|Part 2|Physician Decision|0|||
41972742|NCT01722331|75773998|FG002|Part 2|Physician Decision|2|||
41972743|NCT01722331|75773999|FG003|Part 2|Physician Decision|0|||
41972744|NCT01722331|75774000|FG004|Part 2|Physician Decision|0|||
41972745|NCT01722331|75774001|FG005|Part 2|Physician Decision|0|||
41972746|NCT01722331|75774002|FG006|Part 2|Physician Decision|0|||
41972747|NCT01722331|75773996|FG000|Part 2|Pregnancy|0|||
41972748|NCT01722331|75773997|FG001|Part 2|Pregnancy|0|||
41972749|NCT01722331|75773998|FG002|Part 2|Pregnancy|0|||
41972750|NCT01722331|75773999|FG003|Part 2|Pregnancy|0|||
41972751|NCT01722331|75774000|FG004|Part 2|Pregnancy|0|||
41972752|NCT01722331|75774001|FG005|Part 2|Pregnancy|1|||
41972753|NCT01722331|75774002|FG006|Part 2|Pregnancy|0|||
41972754|NCT01722331|75773996|FG000|Part 2|Progressive Disease|0|||
42127286|NCT03829683|75937752|FG001|Overall Study|Physician Decision|1|||
41972755|NCT01722331|75773997|FG001|Part 2|Progressive Disease|0|||
41972756|NCT01722331|75773998|FG002|Part 2|Progressive Disease|1|||
41972757|NCT01722331|75773999|FG003|Part 2|Progressive Disease|0|||
41972758|NCT01722331|75774000|FG004|Part 2|Progressive Disease|0|||
41972759|NCT01722331|75774001|FG005|Part 2|Progressive Disease|0|||
42127287|NCT03829683|75937751|FG000|Overall Study|Withdrawal by Subject|0|||
42127288|NCT03829683|75937752|FG001|Overall Study|Withdrawal by Subject|1|||
42127289|NCT03829683|75937751|FG000|Overall Study|Discharge from hospital|1|||
42127290|NCT03829683|75937752|FG001|Overall Study|Discharge from hospital|0|||
42127291|NCT03810456|75937761|FG000|Treatment|Urgent Family Matters|3|||
42127292|NCT03810456|75937762|FG001|Treatment|Urgent Family Matters|0|||
42127293|NCT03810456|75937763|FG002|Treatment|Urgent Family Matters|0|||
42127294|NCT03810456|75937761|FG000|Treatment|Scheduling Conflicts|0|||
42127295|NCT03810456|75937762|FG001|Treatment|Scheduling Conflicts|11|||
42127296|NCT03810456|75937763|FG002|Treatment|Scheduling Conflicts|0|||
42127297|NCT03810456|75937761|FG000|Treatment|No Longer Interested|0|||
42127298|NCT03810456|75937762|FG001|Treatment|No Longer Interested|12|||
42127299|NCT03810456|75937763|FG002|Treatment|No Longer Interested|0|||
42127300|NCT03810456|75937761|FG000|Treatment|Transportation Issues|0|||
41972760|NCT01722331|75774002|FG006|Part 2|Progressive Disease|0|||
41972761|NCT01722331|75773996|FG000|Part 2|Protocol Violation|1|||
41972762|NCT01722331|75773997|FG001|Part 2|Protocol Violation|0|||
41972763|NCT01722331|75773998|FG002|Part 2|Protocol Violation|0|||
41972764|NCT01722331|75773999|FG003|Part 2|Protocol Violation|0|||
41972765|NCT01722331|75774000|FG004|Part 2|Protocol Violation|0|||
41972766|NCT01722331|75774001|FG005|Part 2|Protocol Violation|0|||
41972767|NCT01722331|75774002|FG006|Part 2|Protocol Violation|0|||
41972768|NCT01722331|75773996|FG000|Part 2|Withdrawal by Subject|5|||
41972769|NCT01722331|75773997|FG001|Part 2|Withdrawal by Subject|0|||
41972770|NCT01722331|75773998|FG002|Part 2|Withdrawal by Subject|3|||
41972771|NCT01722331|75773999|FG003|Part 2|Withdrawal by Subject|0|||
41972772|NCT01722331|75774000|FG004|Part 2|Withdrawal by Subject|0|||
41972773|NCT01722331|75774001|FG005|Part 2|Withdrawal by Subject|2|||
41972774|NCT01722331|75774002|FG006|Part 2|Withdrawal by Subject|2|||
41972775|NCT01722331|75773996|FG000|Part 2|Other Protocol Specified Criteria|6|||
41972776|NCT01722331|75773997|FG001|Part 2|Other Protocol Specified Criteria|0|||
41972777|NCT01722331|75773998|FG002|Part 2|Other Protocol Specified Criteria|10|||
41972778|NCT01722331|75773999|FG003|Part 2|Other Protocol Specified Criteria|0|||
41972779|NCT01722331|75774000|FG004|Part 2|Other Protocol Specified Criteria|0|||
41972780|NCT01722331|75774001|FG005|Part 2|Other Protocol Specified Criteria|2|||
41972781|NCT01722331|75774002|FG006|Part 2|Other Protocol Specified Criteria|1|||
41972782|NCT01722331|75773996|FG000|Part 3|Adverse Event|2|||
41972783|NCT01722331|75773997|FG001|Part 3|Adverse Event|2|||
41972784|NCT01722331|75773998|FG002|Part 3|Adverse Event|0|||
41972785|NCT01722331|75773999|FG003|Part 3|Adverse Event|1|||
41972786|NCT01722331|75774000|FG004|Part 3|Adverse Event|0|||
41972787|NCT01722331|75774001|FG005|Part 3|Adverse Event|0|||
41972788|NCT01722331|75774002|FG006|Part 3|Adverse Event|0|||
41972789|NCT01722331|75773996|FG000|Part 3|Death|1|||
41972790|NCT01722331|75773997|FG001|Part 3|Death|0|||
41972791|NCT01722331|75773998|FG002|Part 3|Death|0|||
41972792|NCT01722331|75773999|FG003|Part 3|Death|0|||
41972793|NCT01722331|75774000|FG004|Part 3|Death|0|||
41972794|NCT01722331|75774001|FG005|Part 3|Death|0|||
41972795|NCT01722331|75774002|FG006|Part 3|Death|0|||
41972796|NCT01722331|75773996|FG000|Part 3|Lack of Efficacy|1|||
41972797|NCT01722331|75773997|FG001|Part 3|Lack of Efficacy|0|||
41972798|NCT01722331|75773998|FG002|Part 3|Lack of Efficacy|0|||
41972799|NCT01722331|75773999|FG003|Part 3|Lack of Efficacy|0|||
41972800|NCT01722331|75774000|FG004|Part 3|Lack of Efficacy|0|||
41972801|NCT01722331|75774001|FG005|Part 3|Lack of Efficacy|0|||
41972802|NCT01722331|75774002|FG006|Part 3|Lack of Efficacy|0|||
41972803|NCT01722331|75773996|FG000|Part 3|Lost to Follow-up|3|||
41972804|NCT01722331|75773997|FG001|Part 3|Lost to Follow-up|4|||
41972805|NCT01722331|75773998|FG002|Part 3|Lost to Follow-up|0|||
41972806|NCT01722331|75773999|FG003|Part 3|Lost to Follow-up|0|||
41972807|NCT01722331|75774000|FG004|Part 3|Lost to Follow-up|0|||
41972808|NCT01722331|75774001|FG005|Part 3|Lost to Follow-up|1|||
41972809|NCT01722331|75774002|FG006|Part 3|Lost to Follow-up|0|||
41972810|NCT01722331|75773996|FG000|Part 3|Non-Compliance with Study Drug|0|||
41972811|NCT01722331|75773997|FG001|Part 3|Non-Compliance with Study Drug|1|||
41972812|NCT01722331|75773998|FG002|Part 3|Non-Compliance with Study Drug|0|||
41972813|NCT01722331|75773999|FG003|Part 3|Non-Compliance with Study Drug|0|||
41972814|NCT01722331|75774000|FG004|Part 3|Non-Compliance with Study Drug|0|||
41972815|NCT01722331|75774001|FG005|Part 3|Non-Compliance with Study Drug|0|||
41972816|NCT01722331|75774002|FG006|Part 3|Non-Compliance with Study Drug|0|||
41972817|NCT01722331|75773996|FG000|Part 3|Physician Decision|1|||
41972818|NCT01722331|75773997|FG001|Part 3|Physician Decision|1|||
41972819|NCT01722331|75773998|FG002|Part 3|Physician Decision|0|||
41972820|NCT01722331|75773999|FG003|Part 3|Physician Decision|0|||
41972821|NCT01722331|75774000|FG004|Part 3|Physician Decision|0|||
41972822|NCT01722331|75774001|FG005|Part 3|Physician Decision|0|||
41972823|NCT01722331|75774002|FG006|Part 3|Physician Decision|1|||
41972824|NCT01722331|75773996|FG000|Part 3|Protocol Violation|2|||
41972825|NCT01722331|75773997|FG001|Part 3|Protocol Violation|1|||
41972826|NCT01722331|75773998|FG002|Part 3|Protocol Violation|0|||
41972827|NCT01722331|75773999|FG003|Part 3|Protocol Violation|0|||
41972828|NCT01722331|75774000|FG004|Part 3|Protocol Violation|0|||
42028088|NCT00915772|75836419|FG000|Overall Study|Refused to continue trial medication|6|||
41972829|NCT01722331|75774001|FG005|Part 3|Protocol Violation|0|||
41972830|NCT01722331|75774002|FG006|Part 3|Protocol Violation|0|||
41972831|NCT01722331|75773996|FG000|Part 3|Withdrawal by Subject|4|||
41972832|NCT01722331|75773997|FG001|Part 3|Withdrawal by Subject|7|||
41972833|NCT01722331|75773998|FG002|Part 3|Withdrawal by Subject|0|||
41972834|NCT01722331|75773999|FG003|Part 3|Withdrawal by Subject|0|||
41972835|NCT01722331|75774000|FG004|Part 3|Withdrawal by Subject|0|||
41972836|NCT01722331|75774001|FG005|Part 3|Withdrawal by Subject|2|||
41972837|NCT01722331|75774002|FG006|Part 3|Withdrawal by Subject|1|||
41972838|NCT01722331|75773996|FG000|Part 3|Other Protocol Specified Criteria|1|||
41972839|NCT01722331|75773997|FG001|Part 3|Other Protocol Specified Criteria|1|||
41972840|NCT01722331|75773998|FG002|Part 3|Other Protocol Specified Criteria|0|||
41972841|NCT01722331|75773999|FG003|Part 3|Other Protocol Specified Criteria|0|||
41972842|NCT01722331|75774000|FG004|Part 3|Other Protocol Specified Criteria|0|||
42210650|NCT03286218|76025373|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
42210651|NCT03286218|76025374|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
42210652|NCT03286218|76025375|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
42210653|NCT03286218|76025376|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
42210654|NCT03286218|76025377|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
42210655|NCT03286218|76025378|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
42210656|NCT03286218|76025379|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
42210657|NCT03286218|76025380|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
42210658|NCT03286218|76025381|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
42210659|NCT03286218|76025382|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
42210660|NCT03286218|76025371|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
42210661|NCT03286218|76025372|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
42210662|NCT03286218|76025373|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
42210663|NCT03286218|76025374|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
42210664|NCT03286218|76025375|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
42210665|NCT03286218|76025376|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
42210666|NCT03286218|76025377|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
41972843|NCT01722331|75774001|FG005|Part 3|Other Protocol Specified Criteria|0|||
41972844|NCT01722331|75774002|FG006|Part 3|Other Protocol Specified Criteria|0|||
41972845|NCT01630590|75774014|FG000|Overall Study|Adverse Event|9|||
41972846|NCT01630590|75774014|FG000|Overall Study|Lack of Efficacy|37|||
41972847|NCT01630590|75774014|FG000|Overall Study|Withdrawal by Subject|4|||
41972848|NCT01630590|75774014|FG000|Overall Study|2nd primary tumor|2|||
41972849|NCT01630590|75774014|FG000|Overall Study|Automobile accident|1|||
41972850|NCT01630590|75774014|FG000|Overall Study|Maximum benefit|4|||
41972851|NCT01619085|75774018|FG000|Overall Study|Adverse Event|231|||
41972852|NCT01619085|75774018|FG000|Overall Study|Protocol Violation|4|||
41972853|NCT01619085|75774018|FG000|Overall Study|Lost to Follow-up|3|||
41972854|NCT01619085|75774018|FG000|Overall Study|Withdrawal by Subject|45|||
41972855|NCT01619085|75774018|FG000|Overall Study|Other than specified|96|||
41972856|NCT01619085|75774018|FG000|Overall Study|Not treated|1|||
41972857|NCT01619085|75774018|FG000|Overall Study|Death|145|||
41972858|NCT01499095|75774031|FG000|Overall Study|Randomized But Not Treated|1|||
41972859|NCT01499095|75774032|FG001|Overall Study|Randomized But Not Treated|1|||
41972860|NCT01499095|75774031|FG000|Overall Study|Adverse Event|12|||
41972861|NCT01499095|75774032|FG001|Overall Study|Adverse Event|7|||
41972862|NCT01499095|75774031|FG000|Overall Study|Lack of Efficacy|2|||
41972863|NCT01499095|75774032|FG001|Overall Study|Lack of Efficacy|1|||
41972864|NCT01499095|75774031|FG000|Overall Study|Protocol Violation|6|||
41972865|NCT01499095|75774032|FG001|Overall Study|Protocol Violation|7|||
41972866|NCT01499095|75774031|FG000|Overall Study|Received Rescue Therapy|32|||
41972867|NCT01499095|75774032|FG001|Overall Study|Received Rescue Therapy|40|||
41972868|NCT01499095|75774031|FG000|Overall Study|Diverse Reasons|22|||
41972869|NCT01499095|75774032|FG001|Overall Study|Diverse Reasons|25|||
41972870|NCT01499095|75774031|FG000|Overall Study|Lost to Follow-up|6|||
41972871|NCT01499095|75774032|FG001|Overall Study|Lost to Follow-up|4|||
41972872|NCT01499095|75774031|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
41972873|NCT01499095|75774032|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
41972874|NCT01499095|75774031|FG000|Overall Study|Hypoglycemia|3|||
41972875|NCT01499095|75774032|FG001|Overall Study|Hypoglycemia|1|||
41972876|NCT01499095|75774031|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
41972877|NCT01499095|75774032|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
41972878|NCT01499095|75774031|FG000|Overall Study|Change in Injection Schedule|2|||
41972879|NCT01499095|75774032|FG001|Overall Study|Change in Injection Schedule|0|||
41972880|NCT01499095|75774031|FG000|Overall Study|Perceived Lack of Efficacy|1|||
41972881|NCT01499095|75774032|FG001|Overall Study|Perceived Lack of Efficacy|1|||
41972882|NCT01499082|75774043|FG000|Overall Study|Randomized but not Treated|0|||
41972883|NCT01499082|75774044|FG001|Overall Study|Randomized but not Treated|1|||
41972884|NCT01499082|75774043|FG000|Overall Study|Adverse Event|12|||
41972885|NCT01499082|75774044|FG001|Overall Study|Adverse Event|16|||
41972886|NCT01499082|75774043|FG000|Overall Study|Lack of Efficacy|1|||
41972887|NCT01499082|75774044|FG001|Overall Study|Lack of Efficacy|1|||
41972888|NCT01499082|75774043|FG000|Overall Study|Protocol Violation|6|||
41972889|NCT01499082|75774044|FG001|Overall Study|Protocol Violation|8|||
42028089|NCT00915772|75836420|FG001|Overall Study|Refused to continue trial medication|8|||
42028090|NCT00915772|75836421|FG002|Overall Study|Refused to continue trial medication|4|||
42028091|NCT00915772|75836419|FG000|Overall Study|Any other reason|4|||
42301682|NCT02509117|76136790|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
42301683|NCT02509117|76136791|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
42301684|NCT02509117|76136792|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
42301685|NCT02509117|76136793|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
41972890|NCT01499082|75774043|FG000|Overall Study|Diverse Reasons|18|||
42301686|NCT02509117|76136794|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
42301687|NCT02509117|76136785|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
42301688|NCT02509117|76136786|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
42301689|NCT02509117|76136787|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
42301690|NCT02509117|76136788|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
42301691|NCT02509117|76136789|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
42301692|NCT02509117|76136790|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
42301693|NCT02509117|76136791|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
42301694|NCT02509117|76136792|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
42301695|NCT02509117|76136793|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
42301696|NCT02509117|76136794|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
42301697|NCT01654549|76136834|FG000|Overall Study|H.pylori eradication not successful|0|||
42301698|NCT01654549|76136835|FG001|Overall Study|H.pylori eradication not successful|1|||
42301699|NCT02508649|76136849|FG000|Overall Study|Withdrawal by Subject|4|||
42301700|NCT02508649|76136850|FG001|Overall Study|Withdrawal by Subject|6|||
42301701|NCT02508649|76136851|FG002|Overall Study|Withdrawal by Subject|5|||
42301702|NCT02508649|76136852|FG003|Overall Study|Withdrawal by Subject|6|||
42301703|NCT02508649|76136849|FG000|Overall Study|Investigator withdrew the subject|1|||
42301704|NCT02508649|76136850|FG001|Overall Study|Investigator withdrew the subject|2|||
42301705|NCT02508649|76136851|FG002|Overall Study|Investigator withdrew the subject|1|||
42301706|NCT02508649|76136852|FG003|Overall Study|Investigator withdrew the subject|0|||
42301707|NCT02508649|76136849|FG000|Overall Study|Post randomization screening failure|12|||
41972891|NCT01499082|75774044|FG001|Overall Study|Diverse Reasons|14|||
41972892|NCT01499082|75774043|FG000|Overall Study|Site Closure for Noncompliance|5|||
41972893|NCT01499082|75774044|FG001|Overall Study|Site Closure for Noncompliance|2|||
41972894|NCT01499082|75774043|FG000|Overall Study|Hypoglycemia|2|||
41972895|NCT01499082|75774044|FG001|Overall Study|Hypoglycemia|3|||
41972896|NCT01499082|75774043|FG000|Overall Study|Lost to Follow-up|1|||
41972897|NCT01499082|75774044|FG001|Overall Study|Lost to Follow-up|3|||
41972898|NCT01488890|75774056|FG000|Overall Study|Serious adverse event|2|||
41972899|NCT01488890|75774057|FG001|Overall Study|Serious adverse event|0|||
41972900|NCT01488890|75774058|FG002|Overall Study|Serious adverse event|0|||
41972901|NCT01488890|75774059|FG003|Overall Study|Serious adverse event|0|||
41972902|NCT01488890|75774056|FG000|Overall Study|Protocol Violation|3|||
41972903|NCT01488890|75774057|FG001|Overall Study|Protocol Violation|0|||
41972904|NCT01488890|75774058|FG002|Overall Study|Protocol Violation|4|||
41972905|NCT01488890|75774059|FG003|Overall Study|Protocol Violation|0|||
41972906|NCT01488890|75774056|FG000|Overall Study|Lost to Follow-up|13|||
41972907|NCT01488890|75774057|FG001|Overall Study|Lost to Follow-up|10|||
41972908|NCT01488890|75774058|FG002|Overall Study|Lost to Follow-up|20|||
41972909|NCT01488890|75774059|FG003|Overall Study|Lost to Follow-up|3|||
41972910|NCT01488890|75774056|FG000|Overall Study|Withdrawal by Subject|14|||
41972911|NCT01488890|75774057|FG001|Overall Study|Withdrawal by Subject|10|||
41972912|NCT01488890|75774058|FG002|Overall Study|Withdrawal by Subject|11|||
41972913|NCT01488890|75774059|FG003|Overall Study|Withdrawal by Subject|2|||
41972914|NCT01436396|75774075|FG000|Overall Study|Protocol Violation|7|||
41972915|NCT01436396|75774076|FG001|Overall Study|Protocol Violation|5|||
41972916|NCT01436396|75774075|FG000|Overall Study|Adverse Event|1|||
41972917|NCT01436396|75774076|FG001|Overall Study|Adverse Event|2|||
41972918|NCT01436396|75774075|FG000|Overall Study|Withdrawal by Subject|19|||
41972919|NCT01436396|75774076|FG001|Overall Study|Withdrawal by Subject|29|||
41972920|NCT01436396|75774075|FG000|Overall Study|Serious adverse event|2|||
41972921|NCT01436396|75774076|FG001|Overall Study|Serious adverse event|3|||
41972922|NCT01436396|75774075|FG000|Overall Study|Lost to Follow-up|3|||
41972923|NCT01436396|75774076|FG001|Overall Study|Lost to Follow-up|3|||
41972924|NCT01411241|75774084|FG000|Overall Study|Protocol Violation|0|||
41972925|NCT01411241|75774085|FG001|Overall Study|Protocol Violation|5|||
41972926|NCT01411241|75774084|FG000|Overall Study|Withdrawal by Subject|9|||
41972927|NCT01411241|75774085|FG001|Overall Study|Withdrawal by Subject|10|||
41972928|NCT01411241|75774084|FG000|Overall Study|Serious Adverse Event|0|||
41972929|NCT01411241|75774085|FG001|Overall Study|Serious Adverse Event|3|||
41972930|NCT01411241|75774084|FG000|Overall Study|Lost to Follow-up|2|||
42028092|NCT00915772|75836420|FG001|Overall Study|Any other reason|7|||
41972931|NCT01411241|75774085|FG001|Overall Study|Lost to Follow-up|4|||
41972932|NCT01374516|75774093|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
41972933|NCT01374516|75774094|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
41972934|NCT01374516|75774093|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
41972935|NCT01374516|75774094|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
41972936|NCT01374516|75774093|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
41972937|NCT01374516|75774094|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
41972938|NCT01374516|75774093|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
41972939|NCT01374516|75774094|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
41972940|NCT01374516|75774093|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
41972941|NCT01374516|75774094|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
41972942|NCT01374516|75774093|FG000|Surveillance Expansion Period|Protocol Violation|386|||
41972943|NCT01374516|75774094|FG001|Surveillance Expansion Period|Protocol Violation|217|||
41972944|NCT01374516|75774093|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
41972945|NCT01374516|75774094|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
41972946|NCT01374516|75774093|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
41972947|NCT01374516|75774094|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
41972948|NCT01374516|75774093|FG000|Surveillance Expansion Period|Serious adverse event|20|||
41972949|NCT01374516|75774094|FG001|Surveillance Expansion Period|Serious adverse event|5|||
41972950|NCT01373281|75774109|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
41972951|NCT01373281|75774110|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
41972952|NCT01373281|75774109|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
41972953|NCT01373281|75774110|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
41972954|NCT01373281|75774109|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
41972955|NCT01373281|75774110|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
41972956|NCT01373281|75774109|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
41972957|NCT01373281|75774110|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
41972958|NCT01373281|75774109|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
41972959|NCT01373281|75774110|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
41972960|NCT01373281|75774109|FG000|Surveillance Expansion Period|Protocol Violation|9|||
41972961|NCT01373281|75774110|FG001|Surveillance Expansion Period|Protocol Violation|1|||
41972962|NCT01373281|75774109|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
41972963|NCT01373281|75774110|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
41972964|NCT01373281|75774109|FG000|Surveillance Expansion Period|Serious adverse event|3|||
41972965|NCT01373281|75774110|FG001|Surveillance Expansion Period|Serious adverse event|4|||
41972966|NCT01254422|75774125|FG000|Overall Study|Protocol Violation|1|||
41972967|NCT01254422|75774126|FG001|Overall Study|Protocol Violation|0|||
41972968|NCT01254422|75774125|FG000|Overall Study|Adverse Event|1|||
41972969|NCT01254422|75774126|FG001|Overall Study|Adverse Event|0|||
41972970|NCT01254422|75774125|FG000|Overall Study|Serious adverse event|0|||
41972971|NCT01254422|75774126|FG001|Overall Study|Serious adverse event|1|||
41972972|NCT01254422|75774125|FG000|Overall Study|Lost to Follow-up|1|||
41972973|NCT01254422|75774126|FG001|Overall Study|Lost to Follow-up|0|||
41972974|NCT01187433|75774134|FG000|Overall Study|Protocol Violation|6|||
41972975|NCT01187433|75774135|FG001|Overall Study|Protocol Violation|2|||
41972976|NCT01187433|75774134|FG000|Overall Study|Withdrawal by Subject|5|||
41972977|NCT01187433|75774135|FG001|Overall Study|Withdrawal by Subject|2|||
41972978|NCT01150045|75774145|FG000|Overall Study|Protocol Violation|0|||
41972979|NCT01150045|75774146|FG001|Overall Study|Protocol Violation|1|||
41972980|NCT01150045|75774147|FG002|Overall Study|Protocol Violation|0|||
41972981|NCT01150045|75774148|FG003|Overall Study|Protocol Violation|1|||
41972982|NCT01098032|75774158|FG000|Overall Study|Withdrawal by Subject|1|||
42210667|NCT03286218|76025378|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
42210668|NCT03286218|76025379|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
42210669|NCT03286218|76025380|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
41972983|NCT01098032|75774159|FG001|Overall Study|Withdrawal by Subject|1|||
41972984|NCT01034306|75774167|FG000|Overall Study|Adverse Event|1|||
41972985|NCT01034306|75774168|FG001|Overall Study|Adverse Event|0|||
41972986|NCT01034306|75774167|FG000|Overall Study|Lost to Follow-up|0|||
41972987|NCT01034306|75774168|FG001|Overall Study|Lost to Follow-up|1|||
41972988|NCT01034306|75774167|FG000|Overall Study|Withdrawal by Subject|2|||
41972989|NCT01034306|75774168|FG001|Overall Study|Withdrawal by Subject|2|||
42127301|NCT03810456|75937762|FG001|Treatment|Transportation Issues|1|||
42127302|NCT03810456|75937763|FG002|Treatment|Transportation Issues|0|||
42127303|NCT03810456|75937761|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
42127304|NCT03810456|75937762|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
42127305|NCT03810456|75937763|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
42127306|NCT03810456|75937761|FG000|1 Month Follow-Up|Relocated to Different State|1|||
42127307|NCT03810456|75937762|FG001|1 Month Follow-Up|Relocated to Different State|0|||
42127308|NCT03810456|75937763|FG002|1 Month Follow-Up|Relocated to Different State|1|||
42127309|NCT03810456|75937761|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
41972990|NCT01034306|75774167|FG000|Overall Study|hospitalized and decided to stop|1|||
42127310|NCT03810456|75937762|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
41972991|NCT01034306|75774168|FG001|Overall Study|hospitalized and decided to stop|0|||
41972992|NCT01034306|75774167|FG000|Overall Study|Noncomplience|1|||
41972993|NCT01034306|75774168|FG001|Overall Study|Noncomplience|0|||
41972994|NCT00993447|75774176|FG000|Overall Study|Withdrawal by Subject|23|||
41972995|NCT00993447|75774177|FG001|Overall Study|Withdrawal by Subject|8|||
41972996|NCT00993447|75774176|FG000|Overall Study|Protocol Violation|12|||
41972997|NCT00993447|75774177|FG001|Overall Study|Protocol Violation|8|||
41972998|NCT00993447|75774176|FG000|Overall Study|Lost to Follow-up|1|||
41972999|NCT00993447|75774177|FG001|Overall Study|Lost to Follow-up|3|||
41973000|NCT00993447|75774176|FG000|Overall Study|Adverse Event|1|||
41973001|NCT00993447|75774177|FG001|Overall Study|Adverse Event|0|||
41973002|NCT00945009|75774186|FG000|Overall Study|Lack of Efficacy|10|||
41973003|NCT00945009|75774187|FG001|Overall Study|Lack of Efficacy|0|||
41973004|NCT00945009|75774188|FG002|Overall Study|Lack of Efficacy|0|||
41973005|NCT00945009|75774186|FG000|Overall Study|Physician Decision|21|||
41973006|NCT00945009|75774187|FG001|Overall Study|Physician Decision|4|||
41973007|NCT00945009|75774188|FG002|Overall Study|Physician Decision|3|||
41973008|NCT00945009|75774186|FG000|Overall Study|Protocol Violation|6|||
41973009|NCT00945009|75774187|FG001|Overall Study|Protocol Violation|1|||
41973010|NCT00945009|75774188|FG002|Overall Study|Protocol Violation|0|||
41973011|NCT00945009|75774186|FG000|Overall Study|Withdrawal by Subject|1|||
41973012|NCT00945009|75774187|FG001|Overall Study|Withdrawal by Subject|0|||
41973013|NCT00945009|75774188|FG002|Overall Study|Withdrawal by Subject|0|||
41973014|NCT00945009|75774186|FG000|Overall Study|Ineligible|6|||
41973015|NCT00945009|75774187|FG001|Overall Study|Ineligible|1|||
41973016|NCT00945009|75774188|FG002|Overall Study|Ineligible|0|||
41973017|NCT00945009|75774186|FG000|Overall Study|Inevaluable|0|||
41973018|NCT00945009|75774187|FG001|Overall Study|Inevaluable|1|||
41973019|NCT00945009|75774188|FG002|Overall Study|Inevaluable|0|||
41973020|NCT00945009|75774186|FG000|Overall Study|Refusal of further protocol|1|||
41973021|NCT00945009|75774187|FG001|Overall Study|Refusal of further protocol|0|||
41973022|NCT00945009|75774188|FG002|Overall Study|Refusal of further protocol|0|||
41973023|NCT00942877|75774198|FG000|Overall Study|Refused further treatment|1|||
41973024|NCT00942877|75774199|FG001|Overall Study|Refused further treatment|1|||
41973025|NCT00942877|75774198|FG000|Overall Study|Patient was not treated|1|||
41973026|NCT00942877|75774199|FG001|Overall Study|Patient was not treated|0|||
41973027|NCT00942877|75774198|FG000|Overall Study|Adverse Event|1|||
41973028|NCT00942877|75774199|FG001|Overall Study|Adverse Event|0|||
41973029|NCT00942877|75774198|FG000|Overall Study|Progressive disease|42|||
41973030|NCT00942877|75774199|FG001|Overall Study|Progressive disease|3|||
41973031|NCT00880893|75774214|FG000|Overall Study|Protocol Violation|13|||
41973032|NCT00880893|75774215|FG001|Overall Study|Protocol Violation|1|||
41973033|NCT00880893|75774214|FG000|Overall Study|Withdrawal by Subject|15|||
41973034|NCT00880893|75774215|FG001|Overall Study|Withdrawal by Subject|11|||
41973035|NCT00880893|75774214|FG000|Overall Study|Lost to Follow-up|76|||
41973036|NCT00880893|75774215|FG001|Overall Study|Lost to Follow-up|33|||
41973037|NCT00880893|75774214|FG000|Overall Study|Serious adverse event|3|||
41973038|NCT00880893|75774215|FG001|Overall Study|Serious adverse event|0|||
41973039|NCT00587301|75774221|FG000|Overall Study|Screen Failure|9|||
41973040|NCT00587301|75774221|FG000|Overall Study|Lost to Follow-up|22|||
41973041|NCT00587301|75774221|FG000|Overall Study|Withdrawal by Subject|7|||
41973042|NCT00587301|75774221|FG000|Overall Study|Protocol Violation|7|||
41973043|NCT00579527|75774225|FG000|Overall Study|Death|4|||
41973044|NCT00576836|75774230|FG000|Overall Study|Death|0|||
41973045|NCT00576836|75774231|FG001|Overall Study|Death|1|||
41973046|NCT00576836|75774230|FG000|Overall Study|Physician Decision|0|||
41973047|NCT00576836|75774231|FG001|Overall Study|Physician Decision|1|||
41973048|NCT00576407|75774235|FG000|Overall Study|Death|7|||
41973049|NCT00576407|75774235|FG000|Overall Study|Physician Decision|1|||
41973050|NCT00531232|75774243|FG000|Overall Study|Investigator decision|0|||
41973051|NCT00531232|75774244|FG001|Overall Study|Investigator decision|0|||
41973052|NCT00531232|75774245|FG002|Overall Study|Investigator decision|4|||
41973053|NCT00531232|75774243|FG000|Overall Study|Participants refused further treatment|0|||
41973054|NCT00531232|75774244|FG001|Overall Study|Participants refused further treatment|1|||
42210670|NCT03286218|76025381|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
42210671|NCT03286218|76025382|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
41973055|NCT00531232|75774245|FG002|Overall Study|Participants refused further treatment|2|||
41973056|NCT00531232|75774243|FG000|Overall Study|Adverse events (AEs)|1|||
41973057|NCT00531232|75774244|FG001|Overall Study|Adverse events (AEs)|2|||
41973058|NCT00531232|75774245|FG002|Overall Study|Adverse events (AEs)|2|||
41973059|NCT00531232|75774243|FG000|Overall Study|Treatment failure|1|||
42301708|NCT02508649|76136850|FG001|Overall Study|Post randomization screening failure|4|||
41973060|NCT00531232|75774244|FG001|Overall Study|Treatment failure|3|||
42028093|NCT00915772|75836421|FG002|Overall Study|Any other reason|7|||
41973061|NCT00531232|75774245|FG002|Overall Study|Treatment failure|7|||
41973062|NCT00531232|75774243|FG000|Overall Study|Disease recurrence|0|||
41973063|NCT00531232|75774244|FG001|Overall Study|Disease recurrence|0|||
41973064|NCT00531232|75774245|FG002|Overall Study|Disease recurrence|1|||
41973065|NCT00531232|75774243|FG000|Overall Study|Deceased|2|||
41973066|NCT00531232|75774244|FG001|Overall Study|Deceased|2|||
41973067|NCT00531232|75774245|FG002|Overall Study|Deceased|2|||
41973068|NCT00531232|75774243|FG000|Overall Study|Withdrawal by Subject|0|||
41973069|NCT00531232|75774244|FG001|Overall Study|Withdrawal by Subject|1|||
41973070|NCT00531232|75774245|FG002|Overall Study|Withdrawal by Subject|2|||
41973071|NCT00531232|75774243|FG000|Overall Study|Other|0|||
41973072|NCT00531232|75774244|FG001|Overall Study|Other|0|||
41973073|NCT00531232|75774245|FG002|Overall Study|Other|5|||
41973074|NCT01701583|75774258|FG000|Overall Study|Withdrawal by Subject|2|||
41973075|NCT01701583|75774259|FG001|Overall Study|Withdrawal by Subject|0|||
41973076|NCT01714817|75774268|FG000|Year 1 Period|Lack of Efficacy|11|||
41973077|NCT01714817|75774269|FG001|Year 1 Period|Lack of Efficacy|9|||
41973078|NCT01714817|75774268|FG000|Year 1 Period|Adverse Event|20|||
41973079|NCT01714817|75774269|FG001|Year 1 Period|Adverse Event|17|||
41973080|NCT01714817|75774268|FG000|Year 1 Period|Withdrawal by Subject|6|||
41973081|NCT01714817|75774269|FG001|Year 1 Period|Withdrawal by Subject|7|||
41973082|NCT01714817|75774268|FG000|Year 1 Period|Death|1|||
41973083|NCT01714817|75774269|FG001|Year 1 Period|Death|1|||
41973084|NCT01714817|75774268|FG000|Year 1 Period|Lost to Follow-up|0|||
41973085|NCT01714817|75774269|FG001|Year 1 Period|Lost to Follow-up|2|||
41973086|NCT01714817|75774268|FG000|Year 1 Period|Poor / non-compliance|0|||
41973087|NCT01714817|75774269|FG001|Year 1 Period|Poor / non-compliance|1|||
41973088|NCT01714817|75774268|FG000|Year 1 Period|Pregnancy|2|||
41973089|NCT01714817|75774269|FG001|Year 1 Period|Pregnancy|0|||
41973090|NCT01714817|75774268|FG000|Year 1 Period|Participant no longer meets criteria|6|||
41973091|NCT01714817|75774269|FG001|Year 1 Period|Participant no longer meets criteria|2|||
42210672|NCT03224325|76025416|FG000|Overall Study|Adverse Event|1|||
41973092|NCT01714817|75774268|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
42127311|NCT03810456|75937763|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
42127312|NCT03810456|75937761|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
42127313|NCT03810456|75937762|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
42210673|NCT03224325|76025417|FG001|Overall Study|Adverse Event|0|||
42210674|NCT03224325|76025418|FG002|Overall Study|Adverse Event|0|||
42210675|NCT03224325|76025419|FG003|Overall Study|Adverse Event|0|||
42210676|NCT03224325|76025420|FG004|Overall Study|Adverse Event|0|||
42210677|NCT03224325|76025421|FG005|Overall Study|Adverse Event|0|||
42210678|NCT03224325|76025422|FG006|Overall Study|Adverse Event|1|||
42210679|NCT03224325|76025416|FG000|Overall Study|Withdrawal by Subject|0|||
42210680|NCT03224325|76025417|FG001|Overall Study|Withdrawal by Subject|0|||
42210681|NCT03224325|76025418|FG002|Overall Study|Withdrawal by Subject|0|||
42210682|NCT03224325|76025419|FG003|Overall Study|Withdrawal by Subject|1|||
42210683|NCT03224325|76025420|FG004|Overall Study|Withdrawal by Subject|0|||
42210684|NCT03224325|76025421|FG005|Overall Study|Withdrawal by Subject|0|||
42210685|NCT03224325|76025422|FG006|Overall Study|Withdrawal by Subject|0|||
42210686|NCT04016779|76025446|FG000|Overall Study|Adverse Event|9|||
42210687|NCT04016779|76025447|FG001|Overall Study|Adverse Event|17|||
42210688|NCT04016779|76025446|FG000|Overall Study|Lack of Efficacy|4|||
42210689|NCT04016779|76025447|FG001|Overall Study|Lack of Efficacy|1|||
42210690|NCT04016779|76025446|FG000|Overall Study|Lost to Follow-up|5|||
42210691|NCT04016779|76025447|FG001|Overall Study|Lost to Follow-up|14|||
42210692|NCT04016779|76025446|FG000|Overall Study|Physician Decision|1|||
42210693|NCT04016779|76025447|FG001|Overall Study|Physician Decision|3|||
42210694|NCT04016779|76025446|FG000|Overall Study|Withdrawal by Subject|6|||
42210695|NCT04016779|76025447|FG001|Overall Study|Withdrawal by Subject|8|||
42127314|NCT03810456|75937763|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
42127315|NCT03810456|75937761|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
42127316|NCT03810456|75937762|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
42210696|NCT04016779|76025446|FG000|Overall Study|Non-compliance with Study Drug|2|||
42210697|NCT04016779|76025447|FG001|Overall Study|Non-compliance with Study Drug|3|||
41973093|NCT01714817|75774269|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
42127317|NCT03810456|75937763|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
42127318|NCT03810456|75937761|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
42127319|NCT03810456|75937762|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
42127320|NCT03810456|75937763|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
42210698|NCT04016779|76025446|FG000|Overall Study|Other, Multiple categories|17|||
41973094|NCT01714817|75774268|FG000|Year 1 Period|Change in Concomitant Medication|0|||
41973095|NCT01714817|75774269|FG001|Year 1 Period|Change in Concomitant Medication|1|||
41973096|NCT01714817|75774268|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
41973097|NCT01714817|75774269|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
41973098|NCT01714817|75774268|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
42127321|NCT03810456|75937761|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
42127322|NCT03810456|75937762|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
42210699|NCT04016779|76025447|FG001|Overall Study|Other, Multiple categories|17|||
42210700|NCT02857426|76025457|FG000|Overall Study|Disease progression|34|||
42210701|NCT02857426|76025458|FG001|Overall Study|Disease progression|13|||
42210702|NCT02857426|76025457|FG000|Overall Study|Study drug toxicity|4|||
42210703|NCT02857426|76025458|FG001|Overall Study|Study drug toxicity|1|||
42210704|NCT02857426|76025457|FG000|Overall Study|Death|1|||
42210705|NCT02857426|76025458|FG001|Overall Study|Death|0|||
42210706|NCT02857426|76025457|FG000|Overall Study|Adverse event unrelated to study drug|6|||
42210707|NCT02857426|76025458|FG001|Overall Study|Adverse event unrelated to study drug|2|||
42210708|NCT02857426|76025457|FG000|Overall Study|Participant withdrew consent|1|||
42210709|NCT02857426|76025458|FG001|Overall Study|Participant withdrew consent|1|||
42210710|NCT02857426|76025457|FG000|Overall Study|Maximum clinical benefit|1|||
42210711|NCT02857426|76025458|FG001|Overall Study|Maximum clinical benefit|0|||
42210712|NCT02857426|76025457|FG000|Overall Study|Completed treatment|0|||
41973099|NCT01714817|75774269|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
41973100|NCT01714817|75774268|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
41973101|NCT01714817|75774269|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
41973102|NCT01714817|75774268|FG000|Year 2 Period|Lack of Efficacy|4|||
41973103|NCT01714817|75774269|FG001|Year 2 Period|Lack of Efficacy|12|||
41973104|NCT01714817|75774268|FG000|Year 2 Period|Adverse Event|7|||
41973105|NCT01714817|75774269|FG001|Year 2 Period|Adverse Event|6|||
41973106|NCT01714817|75774268|FG000|Year 2 Period|Participant request to stop treatment|4|||
41973107|NCT01714817|75774269|FG001|Year 2 Period|Participant request to stop treatment|4|||
41973108|NCT01714817|75774268|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
41973109|NCT01714817|75774269|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
41973110|NCT01714817|75774268|FG000|Year 2 Period|Participant withdrew consent|1|||
41973111|NCT01714817|75774269|FG001|Year 2 Period|Participant withdrew consent|5|||
41973112|NCT01714817|75774268|FG000|Year 2 Period|Participant no longer meets criteria|1|||
41973113|NCT01714817|75774269|FG001|Year 2 Period|Participant no longer meets criteria|4|||
41973114|NCT01714817|75774268|FG000|Year 2 Period|Lost to Follow-up|2|||
41973115|NCT01714817|75774269|FG001|Year 2 Period|Lost to Follow-up|0|||
41973116|NCT01714817|75774268|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
41973117|NCT01714817|75774269|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
41973118|NCT01714817|75774268|FG000|Year 2 Period|Pregnancy|1|||
41973119|NCT01714817|75774269|FG001|Year 2 Period|Pregnancy|1|||
41973120|NCT01714817|75774268|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
41973121|NCT01714817|75774269|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
41973122|NCT01714817|75774268|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
42210713|NCT02857426|76025458|FG001|Overall Study|Completed treatment|2|||
42210714|NCT01127256|76025466|FG000|Overall Study|Adverse Event|13|||
42210715|NCT01127256|76025467|FG001|Overall Study|Adverse Event|13|||
42210716|NCT01127256|76025466|FG000|Overall Study|Lack of Efficacy|4|||
42210717|NCT01127256|76025467|FG001|Overall Study|Lack of Efficacy|0|||
42210718|NCT01127256|76025466|FG000|Overall Study|Lost to Follow-up|16|||
42210719|NCT01127256|76025467|FG001|Overall Study|Lost to Follow-up|17|||
42210720|NCT01127256|76025466|FG000|Overall Study|Withdrawal by Subject|5|||
42210721|NCT01127256|76025467|FG001|Overall Study|Withdrawal by Subject|9|||
42210722|NCT01127256|76025466|FG000|Overall Study|Protocol Violation|1|||
42210723|NCT01127256|76025467|FG001|Overall Study|Protocol Violation|0|||
42210724|NCT04016311|76025475|FG000|Overall Study|Withdrawal by Subject|1|||
42210725|NCT04016311|76025476|FG001|Overall Study|Withdrawal by Subject|0|||
42210726|NCT04052425|76025486|FG000|24-Week Double-blind Period|Adverse Event|0|||
42210727|NCT04052425|76025487|FG001|24-Week Double-blind Period|Adverse Event|1|||
42210728|NCT04052425|76025488|FG002|24-Week Double-blind Period|Adverse Event|0|||
42028094|NCT00912964|75836433|FG000|Overall Study|Eligibility criterion not met|1|||
42028095|NCT00912964|75836434|FG001|Overall Study|Eligibility criterion not met|1|||
42028096|NCT00912964|75836435|FG002|Overall Study|Eligibility criterion not met|0|||
42127323|NCT03810456|75937763|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
42028097|NCT00912964|75836433|FG000|Overall Study|Adverse Event|15|||
42127324|NCT03450057|75937775|FG000|Overall Study|Death|17|||
42127325|NCT03450057|75937775|FG000|Overall Study|ICF withdrawal|4|||
42127326|NCT03450057|75937775|FG000|Overall Study|Lost to Follow-up|2|||
42127327|NCT03353415|75937788|FG000|Masked CGM Wear|Lost to Follow-up|2|||
42127328|NCT03353415|75937788|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
42127329|NCT02658890|75937830|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127330|NCT02658890|75937831|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127331|NCT02658890|75937832|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
41973123|NCT01714817|75774269|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
42127332|NCT02658890|75937833|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42210729|NCT04052425|76025489|FG003|24-Week Double-blind Period|Adverse Event|0|||
42210730|NCT04052425|76025486|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
42210731|NCT04052425|76025487|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
42210732|NCT04052425|76025488|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
42210733|NCT04052425|76025489|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
42210734|NCT04052425|76025486|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
42301709|NCT02508649|76136851|FG002|Overall Study|Post randomization screening failure|9|||
42127333|NCT02658890|75937834|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127334|NCT02658890|75937835|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127335|NCT02658890|75937836|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127336|NCT02658890|75937837|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127337|NCT02658890|75937838|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
42127338|NCT02658890|75937839|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127339|NCT02658890|75937840|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127340|NCT02658890|75937841|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127341|NCT02658890|75937842|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127342|NCT02658890|75937843|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127343|NCT02658890|75937844|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127344|NCT02658890|75937845|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127345|NCT02658890|75937846|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
41973124|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
41973125|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
41973126|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
41973127|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
41973128|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
41973129|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
41973130|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
41973131|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
41973132|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
41973133|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
41973134|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
41973135|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
41973136|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
41973137|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
41973138|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
41973139|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
41973140|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
41973141|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
41973142|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
41973143|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
41973144|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
42127346|NCT02658890|75937847|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127347|NCT02658890|75937848|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127348|NCT02658890|75937849|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42210735|NCT04052425|76025487|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
42210736|NCT04052425|76025488|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
42210737|NCT04052425|76025489|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
42210738|NCT04052425|76025486|FG000|24-Week Double-blind Period|Physician Decision|1|||
42210739|NCT04052425|76025487|FG001|24-Week Double-blind Period|Physician Decision|0|||
42210740|NCT04052425|76025488|FG002|24-Week Double-blind Period|Physician Decision|0|||
42210741|NCT04052425|76025489|FG003|24-Week Double-blind Period|Physician Decision|0|||
42210742|NCT04052425|76025486|FG000|24-Week Double-blind Period|Protocol Violation|1|||
42210743|NCT04052425|76025487|FG001|24-Week Double-blind Period|Protocol Violation|0|||
42210744|NCT04052425|76025488|FG002|24-Week Double-blind Period|Protocol Violation|0|||
42210745|NCT04052425|76025489|FG003|24-Week Double-blind Period|Protocol Violation|0|||
42210746|NCT04052425|76025486|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
42301710|NCT02508649|76136852|FG003|Overall Study|Post randomization screening failure|3|||
42127349|NCT02658890|75937850|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127350|NCT02658890|75937851|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127351|NCT02658890|75937852|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127352|NCT02658890|75937853|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127353|NCT02658890|75937854|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127354|NCT02658890|75937855|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127355|NCT02658890|75937856|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127356|NCT02658890|75937830|FG000|Treatment Phase|Adverse Event|0|||
42210747|NCT04052425|76025487|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
41973145|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
41973146|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
41973147|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
41973148|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
41973149|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
41973150|NCT01714817|75774268|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
41973151|NCT01714817|75774269|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
41973152|NCT04477187|75774306|FG000|Overall Study|Lost to Follow-up|2|||
41973153|NCT04142242|75774326|FG000|Stage I|Non-compliance with the protocol|1|||
41973154|NCT04142242|75774327|FG001|Stage I|Non-compliance with the protocol|0|||
41973155|NCT04142242|75774328|FG002|Stage I|Non-compliance with the protocol|0|||
41973156|NCT04142242|75774329|FG003|Stage I|Non-compliance with the protocol|0|||
41973157|NCT04142242|75774330|FG004|Stage I|Non-compliance with the protocol|0|||
41973158|NCT04142242|75774331|FG005|Stage I|Non-compliance with the protocol|1|||
41973159|NCT04142242|75774326|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
41973160|NCT04142242|75774327|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
41973161|NCT04142242|75774328|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
41973162|NCT04142242|75774329|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
41973163|NCT04142242|75774330|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
41973164|NCT04142242|75774331|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
41973165|NCT04142242|75774326|FG000|Stage II|Non-compliance with the protocol|0|||
41973166|NCT04142242|75774327|FG001|Stage II|Non-compliance with the protocol|0|||
41973167|NCT04142242|75774328|FG002|Stage II|Non-compliance with the protocol|0|||
41973168|NCT04142242|75774329|FG003|Stage II|Non-compliance with the protocol|2|||
41973169|NCT04142242|75774330|FG004|Stage II|Non-compliance with the protocol|0|||
41973170|NCT04142242|75774331|FG005|Stage II|Non-compliance with the protocol|0|||
41973171|NCT04142242|75774326|FG000|Stage II|Lost to Follow-up|0|||
41973172|NCT04142242|75774327|FG001|Stage II|Lost to Follow-up|0|||
41973173|NCT04142242|75774328|FG002|Stage II|Lost to Follow-up|1|||
41973174|NCT04142242|75774329|FG003|Stage II|Lost to Follow-up|2|||
41973175|NCT04142242|75774330|FG004|Stage II|Lost to Follow-up|0|||
41973176|NCT04142242|75774331|FG005|Stage II|Lost to Follow-up|0|||
41973177|NCT04142242|75774326|FG000|Stage II|Withdrawal by Subject|0|||
41973178|NCT04142242|75774327|FG001|Stage II|Withdrawal by Subject|0|||
41973179|NCT04142242|75774328|FG002|Stage II|Withdrawal by Subject|5|||
41973180|NCT04142242|75774329|FG003|Stage II|Withdrawal by Subject|9|||
41973181|NCT04142242|75774330|FG004|Stage II|Withdrawal by Subject|0|||
41973182|NCT04142242|75774331|FG005|Stage II|Withdrawal by Subject|0|||
41973183|NCT03912259|75774350|FG000|Overall Study|Adverse Event (AE)|2|||
41973184|NCT03912259|75774351|FG001|Overall Study|Adverse Event (AE)|4|||
41973185|NCT03912259|75774350|FG000|Overall Study|Lack of Efficacy|4|||
41973186|NCT03912259|75774351|FG001|Overall Study|Lack of Efficacy|1|||
41973187|NCT03912259|75774350|FG000|Overall Study|Withdrawal by Subject|11|||
41973188|NCT03912259|75774351|FG001|Overall Study|Withdrawal by Subject|1|||
41973189|NCT03871829|75774360|FG000|Overall Study|Lost to Follow-up|0|||
41973190|NCT03871829|75774361|FG001|Overall Study|Lost to Follow-up|1|||
41973191|NCT03871829|75774360|FG000|Overall Study|Withdrawal by Subject|1|||
41973192|NCT03871829|75774361|FG001|Overall Study|Withdrawal by Subject|1|||
41973193|NCT03871829|75774360|FG000|Overall Study|Death|12|||
41973194|NCT03871829|75774361|FG001|Overall Study|Death|8|||
41973195|NCT03871829|75774360|FG000|Overall Study|Study terminated by sponsor|31|||
41973196|NCT03871829|75774361|FG001|Overall Study|Study terminated by sponsor|34|||
41973197|NCT03373383|75774408|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
42127357|NCT02658890|75937831|FG001|Treatment Phase|Adverse Event|1|||
42127358|NCT02658890|75937832|FG002|Treatment Phase|Adverse Event|2|||
42127359|NCT02658890|75937833|FG003|Treatment Phase|Adverse Event|2|||
42127360|NCT02658890|75937834|FG004|Treatment Phase|Adverse Event|1|||
41973198|NCT03373383|75774409|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
42210748|NCT04052425|76025488|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
41973199|NCT03373383|75774410|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
41973200|NCT03373383|75774411|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
41973201|NCT03373383|75774412|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
41973202|NCT03373383|75774408|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
41973203|NCT03373383|75774409|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
41973204|NCT03373383|75774410|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
41973205|NCT03373383|75774411|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
41973206|NCT03373383|75774412|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
41973207|NCT03373383|75774408|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
41973208|NCT03373383|75774409|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
41973209|NCT03373383|75774410|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
41973210|NCT03373383|75774411|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
41973211|NCT03373383|75774412|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
41973212|NCT03373383|75774408|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
41973213|NCT03373383|75774409|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
41973214|NCT03373383|75774410|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
41973215|NCT03373383|75774411|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
42127361|NCT02658890|75937835|FG005|Treatment Phase|Adverse Event|0|||
42127362|NCT02658890|75937836|FG006|Treatment Phase|Adverse Event|0|||
42210749|NCT04052425|76025489|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
42210750|NCT04052425|76025486|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
42210751|NCT04052425|76025487|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
42210752|NCT04052425|76025488|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
42210753|NCT04052425|76025489|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
42210754|NCT04052425|76025486|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
42210755|NCT04052425|76025487|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
42210756|NCT04052425|76025488|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
42210757|NCT04052425|76025489|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
42210758|NCT04052425|76025486|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
42210759|NCT04052425|76025487|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
42210760|NCT04052425|76025488|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
42210761|NCT04052425|76025489|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
42210762|NCT04052425|76025486|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
42210763|NCT04052425|76025487|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
42210764|NCT04052425|76025488|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
42210765|NCT04052425|76025489|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
42210766|NCT04052425|76025486|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
42210767|NCT04052425|76025487|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
42210768|NCT04052425|76025488|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
42127363|NCT02658890|75937837|FG007|Treatment Phase|Adverse Event|2|||
42127364|NCT02658890|75937838|FG008|Treatment Phase|Adverse Event|1|||
42127365|NCT02658890|75937839|FG009|Treatment Phase|Adverse Event|2|||
42127366|NCT02658890|75937840|FG010|Treatment Phase|Adverse Event|3|||
42127367|NCT02658890|75937841|FG011|Treatment Phase|Adverse Event|0|||
42127368|NCT02658890|75937842|FG012|Treatment Phase|Adverse Event|1|||
42127369|NCT02658890|75937843|FG013|Treatment Phase|Adverse Event|4|||
42127370|NCT02658890|75937844|FG014|Treatment Phase|Adverse Event|0|||
42127371|NCT02658890|75937845|FG015|Treatment Phase|Adverse Event|0|||
42127372|NCT02658890|75937846|FG016|Treatment Phase|Adverse Event|0|||
42127373|NCT02658890|75937847|FG017|Treatment Phase|Adverse Event|0|||
42127374|NCT02658890|75937848|FG018|Treatment Phase|Adverse Event|5|||
42210769|NCT04052425|76025489|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
42210770|NCT04052425|76025486|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
42210771|NCT04052425|76025487|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
41973216|NCT03373383|75774412|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
41973217|NCT03373383|75774408|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
42028098|NCT00912964|75836434|FG001|Overall Study|Adverse Event|18|||
42127375|NCT02658890|75937849|FG019|Treatment Phase|Adverse Event|1|||
42127376|NCT02658890|75937850|FG020|Treatment Phase|Adverse Event|3|||
41973218|NCT03373383|75774409|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
41973219|NCT03373383|75774410|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
42127377|NCT02658890|75937851|FG021|Treatment Phase|Adverse Event|0|||
41973220|NCT03373383|75774411|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
41973221|NCT03373383|75774412|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
41973222|NCT03373383|75774408|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
41973223|NCT03373383|75774409|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
41973224|NCT03373383|75774410|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
41973225|NCT03373383|75774411|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
41973226|NCT03373383|75774412|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
41973227|NCT03373383|75774408|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
41973228|NCT03373383|75774409|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
41973229|NCT03373383|75774410|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
41973230|NCT03373383|75774411|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
41973231|NCT03373383|75774412|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
41973232|NCT03373383|75774408|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
41973233|NCT03373383|75774409|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
41973234|NCT03373383|75774410|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
41973235|NCT03373383|75774411|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
41973236|NCT03373383|75774412|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
41973237|NCT03373383|75774408|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
41973238|NCT03373383|75774409|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
41973239|NCT03373383|75774410|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
41973240|NCT03373383|75774411|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
41973241|NCT03373383|75774412|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
41973242|NCT03320018|75774441|FG000|Treatment Period|Withdrawal by Subject|1|||
41973243|NCT03320018|75774442|FG001|Treatment Period|Withdrawal by Subject|0|||
41973244|NCT03320018|75774441|FG000|Day 90 Follow up|Death|0|||
41973245|NCT03320018|75774442|FG001|Day 90 Follow up|Death|1|||
41973246|NCT03230318|75774450|FG000|Overall Study|Radiographic disease progression|72|||
41973247|NCT03230318|75774451|FG001|Overall Study|Radiographic disease progression|19|||
41973248|NCT03230318|75774450|FG000|Overall Study|Clinical progression|17|||
41973249|NCT03230318|75774451|FG001|Overall Study|Clinical progression|7|||
41973250|NCT03230318|75774450|FG000|Overall Study|Adverse Event|5|||
41973251|NCT03230318|75774451|FG001|Overall Study|Adverse Event|3|||
41973252|NCT03230318|75774450|FG000|Overall Study|Physician Decision|2|||
41973253|NCT03230318|75774451|FG001|Overall Study|Physician Decision|3|||
41973254|NCT03230318|75774450|FG000|Overall Study|Death|3|||
41973255|NCT03230318|75774451|FG001|Overall Study|Death|2|||
41973256|NCT03230318|75774450|FG000|Overall Study|Lost to Follow-up|1|||
41973257|NCT03230318|75774451|FG001|Overall Study|Lost to Follow-up|0|||
41973258|NCT03230318|75774450|FG000|Overall Study|Withdrawal by Subject|1|||
41973259|NCT03230318|75774451|FG001|Overall Study|Withdrawal by Subject|3|||
41973260|NCT03230318|75774450|FG000|Overall Study|Other|3|||
41973261|NCT03230318|75774451|FG001|Overall Study|Other|7|||
41973262|NCT03080883|75774462|FG000|Overall Study|Withdrawal by Subject|11|||
41973263|NCT03080883|75774463|FG001|Overall Study|Withdrawal by Subject|15|||
41973264|NCT03080883|75774462|FG000|Overall Study|Adverse Event|22|||
41973265|NCT03080883|75774463|FG001|Overall Study|Adverse Event|22|||
41973266|NCT03080883|75774462|FG000|Overall Study|Alternative Therapy|0|||
41973267|NCT03080883|75774463|FG001|Overall Study|Alternative Therapy|3|||
41973268|NCT03080883|75774462|FG000|Overall Study|Other Complicating Disease|9|||
41973269|NCT03080883|75774463|FG001|Overall Study|Other Complicating Disease|5|||
41973270|NCT03080883|75774462|FG000|Overall Study|Death|21|||
41973271|NCT03080883|75774463|FG001|Overall Study|Death|16|||
41973272|NCT03080883|75774462|FG000|Overall Study|Physician Decision|2|||
41973273|NCT03080883|75774463|FG001|Overall Study|Physician Decision|2|||
41973274|NCT03080883|75774462|FG000|Overall Study|Disease Progression|2|||
41973275|NCT03080883|75774463|FG001|Overall Study|Disease Progression|8|||
41973276|NCT03080883|75774462|FG000|Overall Study|Lost to Follow-up|1|||
41973277|NCT03080883|75774463|FG001|Overall Study|Lost to Follow-up|1|||
41973278|NCT03060291|75774472|FG000|3-month Follow-up|Declined to respond|8|||
41973279|NCT03060291|75774473|FG001|3-month Follow-up|Declined to respond|10|||
41973280|NCT03060291|75774474|FG002|3-month Follow-up|Declined to respond|2|||
41973281|NCT03060291|75774472|FG000|6-month Follow-up|Declined to respond|7|||
41973282|NCT03060291|75774473|FG001|6-month Follow-up|Declined to respond|13|||
42127378|NCT02658890|75937852|FG022|Treatment Phase|Adverse Event|5|||
42127379|NCT02658890|75937853|FG023|Treatment Phase|Adverse Event|0|||
42127380|NCT02658890|75937854|FG024|Treatment Phase|Adverse Event|0|||
41973283|NCT03060291|75774474|FG002|6-month Follow-up|Declined to respond|4|||
42127381|NCT02658890|75937855|FG025|Treatment Phase|Adverse Event|2|||
41973284|NCT03060291|75774472|FG000|12-month Follow-up|Declined to respond|7|||
41973285|NCT03060291|75774473|FG001|12-month Follow-up|Declined to respond|16|||
41973286|NCT03060291|75774474|FG002|12-month Follow-up|Declined to respond|6|||
41973287|NCT02887859|75774482|FG000|Overall Study|Ongoing|6|||
41973288|NCT02887859|75774482|FG000|Overall Study|Adverse Event|7|||
41973289|NCT02887859|75774482|FG000|Overall Study|Death|1|||
42127382|NCT02658890|75937856|FG026|Treatment Phase|Adverse Event|1|||
41973290|NCT02887859|75774482|FG000|Overall Study|Physician Decision|1|||
41973291|NCT01514864|75774524|FG000|Overall Study|Disease progression|7|||
41973292|NCT01514864|75774525|FG001|Overall Study|Disease progression|5|||
41973293|NCT01514864|75774524|FG000|Overall Study|Study drug toxicity|2|||
41973294|NCT01514864|75774525|FG001|Overall Study|Study drug toxicity|0|||
41973295|NCT01458366|75774537|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
41973296|NCT01458366|75774538|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
41973297|NCT01458366|75774539|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
41973298|NCT01458366|75774540|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
41973299|NCT01458366|75774541|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
41973300|NCT01458366|75774537|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
41973301|NCT01458366|75774538|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
41973302|NCT01458366|75774539|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
41973303|NCT01458366|75774540|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
41973304|NCT01458366|75774541|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
41973305|NCT00364286|75774558|FG000|Overall Study|Withdrawal by Subject|1|||
41973306|NCT00364286|75774558|FG000|Overall Study|Adverse Event|2|||
41973307|NCT01755689|75774587|FG000|Overall Study|Withdrawal by Subject|1|||
41973308|NCT01755689|75774588|FG001|Overall Study|Withdrawal by Subject|3|||
41973309|NCT01755689|75774589|FG002|Overall Study|Withdrawal by Subject|2|||
41973310|NCT01755689|75774590|FG003|Overall Study|Withdrawal by Subject|1|||
41973311|NCT01755689|75774591|FG004|Overall Study|Withdrawal by Subject|1|||
41973312|NCT01755689|75774587|FG000|Overall Study|Migrated/moved from study area|0|||
41973313|NCT01755689|75774588|FG001|Overall Study|Migrated/moved from study area|1|||
41973314|NCT01755689|75774589|FG002|Overall Study|Migrated/moved from study area|1|||
41973315|NCT01755689|75774590|FG003|Overall Study|Migrated/moved from study area|1|||
41973316|NCT01755689|75774591|FG004|Overall Study|Migrated/moved from study area|1|||
41973317|NCT01755689|75774587|FG000|Overall Study|Lost to Follow-up|1|||
41973318|NCT01755689|75774588|FG001|Overall Study|Lost to Follow-up|0|||
41973319|NCT01755689|75774589|FG002|Overall Study|Lost to Follow-up|1|||
41973320|NCT01755689|75774590|FG003|Overall Study|Lost to Follow-up|0|||
41973321|NCT01755689|75774591|FG004|Overall Study|Lost to Follow-up|2|||
41973322|NCT01755689|75774587|FG000|Overall Study|Pregnancy|1|||
41973323|NCT01755689|75774588|FG001|Overall Study|Pregnancy|1|||
41973324|NCT01755689|75774589|FG002|Overall Study|Pregnancy|2|||
41973325|NCT01755689|75774590|FG003|Overall Study|Pregnancy|4|||
41973326|NCT01755689|75774591|FG004|Overall Study|Pregnancy|2|||
41973327|NCT01762761|75774613|FG000|Overall Study|Adverse Event|15|||
41973328|NCT01762761|75774614|FG001|Overall Study|Adverse Event|17|||
41973329|NCT01762761|75774613|FG000|Overall Study|Lack of Efficacy|9|||
41973330|NCT01762761|75774614|FG001|Overall Study|Lack of Efficacy|25|||
41973331|NCT01762761|75774613|FG000|Overall Study|Protocol Violation|1|||
41973332|NCT01762761|75774614|FG001|Overall Study|Protocol Violation|1|||
41973333|NCT01762761|75774613|FG000|Overall Study|Study closed/terminated|0|||
41973334|NCT01762761|75774614|FG001|Overall Study|Study closed/terminated|2|||
41973335|NCT01762761|75774613|FG000|Overall Study|Lost to Follow-up|3|||
41973336|NCT01762761|75774614|FG001|Overall Study|Lost to Follow-up|6|||
41973337|NCT01762761|75774613|FG000|Overall Study|Physician Decision|4|||
41973338|NCT01762761|75774614|FG001|Overall Study|Physician Decision|6|||
41973339|NCT01762761|75774613|FG000|Overall Study|Withdrawal by Subject|7|||
41973340|NCT01762761|75774614|FG001|Overall Study|Withdrawal by Subject|8|||
41973341|NCT01763788|75774625|FG000|Overall Study|Lost to Follow-up|0|||
41973342|NCT01763788|75774626|FG001|Overall Study|Lost to Follow-up|0|||
41973343|NCT01763788|75774627|FG002|Overall Study|Lost to Follow-up|1|||
41973344|NCT01763788|75774628|FG003|Overall Study|Lost to Follow-up|0|||
41973345|NCT01774370|75774638|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
41973346|NCT01774370|75774638|FG000|Overall Study|Administered prior to the contract date|4|||
41973347|NCT01774370|75774638|FG000|Overall Study|Subjects of contraindications|34|||
41973348|NCT01774370|75774638|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
41973349|NCT01774370|75774638|FG000|Overall Study|Follow-up failure|34|||
41973350|NCT01777295|75774644|FG000|Overall Study|Withdrawal by Subject|2|||
41973351|NCT01777295|75774645|FG001|Overall Study|Withdrawal by Subject|2|||
41973352|NCT01777295|75774644|FG000|Overall Study|Pregnancy|0|||
41973353|NCT01777295|75774645|FG001|Overall Study|Pregnancy|1|||
41973354|NCT01777295|75774644|FG000|Overall Study|Personal problem|1|||
41973355|NCT01777295|75774645|FG001|Overall Study|Personal problem|0|||
41973356|NCT01777295|75774644|FG000|Overall Study|Investigator call for AEs check|1|||
41973357|NCT01777295|75774645|FG001|Overall Study|Investigator call for AEs check|0|||
41973358|NCT01787552|75774682|FG000|Overall Study|Withdrawal by Subject|2|||
41973359|NCT01787552|75774683|FG001|Overall Study|Withdrawal by Subject|0|||
41973360|NCT01787552|75774684|FG002|Overall Study|Withdrawal by Subject|0|||
41973361|NCT01787552|75774685|FG003|Overall Study|Withdrawal by Subject|4|||
41973362|NCT01787552|75774682|FG000|Overall Study|Physician Decision|2|||
41973363|NCT01787552|75774683|FG001|Overall Study|Physician Decision|2|||
41973364|NCT01787552|75774684|FG002|Overall Study|Physician Decision|1|||
41973365|NCT01787552|75774685|FG003|Overall Study|Physician Decision|2|||
41973366|NCT01787552|75774682|FG000|Overall Study|Death|0|||
41973367|NCT01787552|75774683|FG001|Overall Study|Death|0|||
41973368|NCT01787552|75774684|FG002|Overall Study|Death|0|||
41973369|NCT01787552|75774685|FG003|Overall Study|Death|1|||
41973370|NCT01787552|75774682|FG000|Overall Study|Adverse Event|2|||
41973371|NCT01787552|75774683|FG001|Overall Study|Adverse Event|5|||
41973372|NCT01787552|75774684|FG002|Overall Study|Adverse Event|2|||
41973373|NCT01787552|75774685|FG003|Overall Study|Adverse Event|16|||
41973374|NCT01787552|75774682|FG000|Overall Study|Study terminated by Sponsor|0|||
41973375|NCT01787552|75774683|FG001|Overall Study|Study terminated by Sponsor|0|||
41973376|NCT01787552|75774684|FG002|Overall Study|Study terminated by Sponsor|1|||
41973377|NCT01787552|75774685|FG003|Overall Study|Study terminated by Sponsor|3|||
41973378|NCT01787552|75774682|FG000|Overall Study|Progressive Disease|2|||
41973379|NCT01787552|75774683|FG001|Overall Study|Progressive Disease|2|||
41973380|NCT01787552|75774684|FG002|Overall Study|Progressive Disease|1|||
41973381|NCT01787552|75774685|FG003|Overall Study|Progressive Disease|1|||
41973382|NCT01808261|75774702|FG000|Overall Study|Physician Decision|0|||
41973383|NCT01808261|75774703|FG001|Overall Study|Physician Decision|2|||
41973384|NCT01808261|75774702|FG000|Overall Study|Study Closed/Terminated|25|||
41973385|NCT01808261|75774703|FG001|Overall Study|Study Closed/Terminated|23|||
41973386|NCT01808261|75774702|FG000|Overall Study|Adverse event, non-fatal|2|||
42127383|NCT02658890|75937830|FG000|Treatment Phase|Death|0|||
42127384|NCT02658890|75937831|FG001|Treatment Phase|Death|0|||
42127385|NCT02658890|75937832|FG002|Treatment Phase|Death|0|||
41973387|NCT01808261|75774703|FG001|Overall Study|Adverse event, non-fatal|0|||
41973388|NCT01808261|75774702|FG000|Overall Study|Consent withdrawn by subject|6|||
41973389|NCT01808261|75774703|FG001|Overall Study|Consent withdrawn by subject|7|||
42127386|NCT02658890|75937833|FG003|Treatment Phase|Death|0|||
41973390|NCT01808261|75774702|FG000|Overall Study|Lost to Follow-up|3|||
41973391|NCT01808261|75774703|FG001|Overall Study|Lost to Follow-up|1|||
41973392|NCT01814826|75774722|FG000|Overall Study|Other|3|||
41973393|NCT01814826|75774723|FG001|Overall Study|Other|5|||
41973394|NCT01814826|75774724|FG002|Overall Study|Other|0|||
41973395|NCT01814826|75774722|FG000|Overall Study|Death|29|||
41973396|NCT01814826|75774723|FG001|Overall Study|Death|24|||
41973397|NCT01814826|75774724|FG002|Overall Study|Death|3|||
41973398|NCT01819467|75774735|FG000|Overall Study|Physician Decision|20|||
41973399|NCT01819467|75774736|FG001|Overall Study|Physician Decision|9|||
41973400|NCT01829711|75774742|FG000|Overall Study|Lost to Follow-up|2|||
41973401|NCT01829711|75774742|FG000|Overall Study|Withdrawal by Subject|3|||
41973402|NCT01829711|75774742|FG000|Overall Study|Death|4|||
41973403|NCT01829711|75774742|FG000|Overall Study|Started new therapies|17|||
41973404|NCT01829711|75774742|FG000|Overall Study|Adverse Event|3|||
41973405|NCT01829711|75774742|FG000|Overall Study|Due to progression of disease|13|||
41973406|NCT01829711|75774742|FG000|Overall Study|Due to lack of response|1|||
41973407|NCT01846273|75774749|FG000|Overall Study|Adverse Event|9|||
41973408|NCT01846273|75774750|FG001|Overall Study|Adverse Event|7|||
41973409|NCT01846273|75774751|FG002|Overall Study|Adverse Event|0|||
42028099|NCT00912964|75836435|FG002|Overall Study|Adverse Event|12|||
42028100|NCT00912964|75836433|FG000|Overall Study|Lack of Efficacy|11|||
42028101|NCT00912964|75836434|FG001|Overall Study|Lack of Efficacy|4|||
42028102|NCT00912964|75836435|FG002|Overall Study|Lack of Efficacy|3|||
42028103|NCT00912964|75836433|FG000|Overall Study|Withdrawal by Subject|20|||
42028104|NCT00912964|75836434|FG001|Overall Study|Withdrawal by Subject|12|||
42127387|NCT02658890|75937834|FG004|Treatment Phase|Death|0|||
41973410|NCT01846273|75774749|FG000|Overall Study|Subject withdrew consent|5|||
41973411|NCT01846273|75774750|FG001|Overall Study|Subject withdrew consent|8|||
41973412|NCT01846273|75774751|FG002|Overall Study|Subject withdrew consent|0|||
41973413|NCT01846273|75774749|FG000|Overall Study|Lost to Follow-up|2|||
42028105|NCT00912964|75836435|FG002|Overall Study|Withdrawal by Subject|18|||
42028106|NCT00912964|75836433|FG000|Overall Study|Lost to Follow-up|4|||
42028107|NCT00912964|75836434|FG001|Overall Study|Lost to Follow-up|3|||
42028108|NCT00912964|75836435|FG002|Overall Study|Lost to Follow-up|3|||
42127388|NCT02658890|75937835|FG005|Treatment Phase|Death|0|||
41973414|NCT01846273|75774750|FG001|Overall Study|Lost to Follow-up|1|||
41973415|NCT01846273|75774751|FG002|Overall Study|Lost to Follow-up|0|||
41973416|NCT01846273|75774749|FG000|Overall Study|Administrative problems|1|||
41973417|NCT01846273|75774750|FG001|Overall Study|Administrative problems|0|||
41973418|NCT01846273|75774751|FG002|Overall Study|Administrative problems|0|||
41973419|NCT01846273|75774749|FG000|Overall Study|Death|2|||
41973420|NCT01846273|75774750|FG001|Overall Study|Death|1|||
41973421|NCT01846273|75774751|FG002|Overall Study|Death|0|||
41973422|NCT01846273|75774749|FG000|Overall Study|Disease Progression|0|||
41973423|NCT01846273|75774750|FG001|Overall Study|Disease Progression|4|||
41973424|NCT01846273|75774751|FG002|Overall Study|Disease Progression|0|||
41973425|NCT01846273|75774749|FG000|Overall Study|Protocol Deviation|2|||
41973426|NCT01846273|75774750|FG001|Overall Study|Protocol Deviation|3|||
41973427|NCT01846273|75774751|FG002|Overall Study|Protocol Deviation|0|||
41973428|NCT01846273|75774749|FG000|Overall Study|Physician Decision|1|||
41973429|NCT01846273|75774750|FG001|Overall Study|Physician Decision|2|||
41973430|NCT01846273|75774751|FG002|Overall Study|Physician Decision|0|||
41973431|NCT01871896|75774759|FG000|Overall Study|Lost to Follow-up|1|||
41973432|NCT04752475|75774766|FG000|Overall Study|Withdrawal by Subject|1|||
41973433|NCT04752475|75774767|FG001|Overall Study|Withdrawal by Subject|1|||
41973434|NCT03846947|75774813|FG000|Overall Study|technical issues with imaging sequence|2|||
41973435|NCT03675308|75774826|FG000|Overall Study|Adverse Event|3|||
42127389|NCT02658890|75937836|FG006|Treatment Phase|Death|0|||
42127390|NCT02658890|75937837|FG007|Treatment Phase|Death|0|||
42127391|NCT02658890|75937838|FG008|Treatment Phase|Death|0|||
42127392|NCT02658890|75937839|FG009|Treatment Phase|Death|0|||
42127393|NCT02658890|75937840|FG010|Treatment Phase|Death|0|||
42127394|NCT02658890|75937841|FG011|Treatment Phase|Death|0|||
42127395|NCT02658890|75937842|FG012|Treatment Phase|Death|0|||
42210772|NCT04052425|76025488|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
42210773|NCT04052425|76025489|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
42301711|NCT02508649|76136849|FG000|Overall Study|Lost to Follow-up|1|||
41973436|NCT03675308|75774827|FG001|Overall Study|Adverse Event|2|||
41973437|NCT03675308|75774826|FG000|Overall Study|Withdrawal by Subject|6|||
41973438|NCT03675308|75774827|FG001|Overall Study|Withdrawal by Subject|4|||
41973439|NCT03675308|75774826|FG000|Overall Study|Lost to Follow-up|3|||
41973440|NCT03675308|75774827|FG001|Overall Study|Lost to Follow-up|0|||
42127396|NCT02658890|75937843|FG013|Treatment Phase|Death|0|||
42127397|NCT02658890|75937844|FG014|Treatment Phase|Death|0|||
42127398|NCT02658890|75937845|FG015|Treatment Phase|Death|0|||
41973441|NCT03675308|75774826|FG000|Overall Study|Lack of Efficacy|1|||
41973442|NCT03675308|75774827|FG001|Overall Study|Lack of Efficacy|1|||
41973443|NCT03675308|75774826|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
41973444|NCT03675308|75774827|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
41973445|NCT03675308|75774826|FG000|Overall Study|Other|0|||
41973446|NCT03675308|75774827|FG001|Overall Study|Other|1|||
41973447|NCT03131219|75774835|FG000|Initial Evaluation Period|Adverse Event|1|||
41973448|NCT03131219|75774836|FG001|Initial Evaluation Period|Adverse Event|0|||
41973449|NCT03131219|75774835|FG000|Initial Evaluation Period|Protocol Violation|1|||
41973450|NCT03131219|75774836|FG001|Initial Evaluation Period|Protocol Violation|0|||
41973451|NCT03131219|75774835|FG000|Initial Evaluation Period|Deemed ineligible post treatment|2|||
41973452|NCT03131219|75774836|FG001|Initial Evaluation Period|Deemed ineligible post treatment|0|||
41973453|NCT02914613|75774844|FG000|Overall Study|Withdrawal by Subject|1|||
41973454|NCT02914613|75774845|FG001|Overall Study|Withdrawal by Subject|2|||
41973455|NCT02914613|75774844|FG000|Overall Study|Adverse Event|1|||
41973456|NCT02914613|75774845|FG001|Overall Study|Adverse Event|0|||
41973457|NCT02586207|75774855|FG000|Overall Study|Physician Decision|1|||
41973458|NCT02586207|75774855|FG000|Overall Study|Withdrawal by Subject|1|||
41973459|NCT02573324|75774862|FG000|Overall Study|Withdrawal by Subject|26|||
41973460|NCT02573324|75774863|FG001|Overall Study|Withdrawal by Subject|23|||
41973461|NCT02573324|75774864|FG002|Overall Study|Withdrawal by Subject|3|||
41973462|NCT02573324|75774862|FG000|Overall Study|Lost to Follow-up|4|||
41973463|NCT02573324|75774863|FG001|Overall Study|Lost to Follow-up|5|||
41973464|NCT02573324|75774864|FG002|Overall Study|Lost to Follow-up|0|||
41973465|NCT02573324|75774862|FG000|Overall Study|Study Terminated by Sponsor|107|||
41973466|NCT02573324|75774863|FG001|Overall Study|Study Terminated by Sponsor|89|||
41973467|NCT02573324|75774864|FG002|Overall Study|Study Terminated by Sponsor|2|||
41973468|NCT02573324|75774862|FG000|Overall Study|Death|182|||
41973469|NCT02573324|75774863|FG001|Overall Study|Death|200|||
41973470|NCT02573324|75774864|FG002|Overall Study|Death|1|||
41973471|NCT02573324|75774862|FG000|Overall Study|Other, Not Specified|20|||
41973472|NCT02573324|75774863|FG001|Overall Study|Other, Not Specified|27|||
41973473|NCT02573324|75774864|FG002|Overall Study|Other, Not Specified|0|||
41973474|NCT02573324|75774862|FG000|Overall Study|Unknown Reason|2|||
41973475|NCT02573324|75774863|FG001|Overall Study|Unknown Reason|0|||
41973476|NCT02573324|75774864|FG002|Overall Study|Unknown Reason|0|||
41973477|NCT02296684|75774880|FG000|Overall Study|Withdrawal by Subject|0|||
41973478|NCT02296684|75774881|FG001|Overall Study|Withdrawal by Subject|1|||
41973479|NCT02296684|75774882|FG002|Overall Study|Withdrawal by Subject|1|||
42127399|NCT02658890|75937846|FG016|Treatment Phase|Death|0|||
42127400|NCT02658890|75937847|FG017|Treatment Phase|Death|0|||
42127401|NCT02658890|75937848|FG018|Treatment Phase|Death|1|||
42127402|NCT02658890|75937849|FG019|Treatment Phase|Death|0|||
42127403|NCT02658890|75937850|FG020|Treatment Phase|Death|0|||
42127404|NCT02658890|75937851|FG021|Treatment Phase|Death|0|||
42127405|NCT02658890|75937852|FG022|Treatment Phase|Death|0|||
42127406|NCT02658890|75937853|FG023|Treatment Phase|Death|0|||
42210774|NCT04052425|76025486|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
41973480|NCT02296684|75774880|FG000|Overall Study|Death|2|||
41973481|NCT02296684|75774881|FG001|Overall Study|Death|0|||
41973482|NCT02296684|75774882|FG002|Overall Study|Death|0|||
41973483|NCT02107261|75774891|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
41973484|NCT02107261|75774892|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
41973485|NCT02107261|75774891|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
41973486|NCT02107261|75774892|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
41973487|NCT02014597|75774902|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
41973488|NCT02014597|75774903|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
41973489|NCT01342367|75774915|FG000|Overall Study|Death|1|||
41973490|NCT01342367|75774916|FG001|Overall Study|Death|0|||
41973491|NCT01342367|75774915|FG000|Overall Study|Withdrawal by Subject|1|||
41973492|NCT01342367|75774916|FG001|Overall Study|Withdrawal by Subject|2|||
41973493|NCT01185171|75774922|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
41973494|NCT01185171|75774922|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
41973495|NCT01185171|75774922|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
41973496|NCT01185171|75774922|FG000|Maintenance|Elevated liver transaminases|3|||
41973497|NCT01185171|75774922|FG000|Maintenance|Rush|2|||
42127407|NCT02658890|75937854|FG024|Treatment Phase|Death|0|||
42127408|NCT02658890|75937855|FG025|Treatment Phase|Death|0|||
42127409|NCT02658890|75937856|FG026|Treatment Phase|Death|0|||
42127410|NCT02658890|75937830|FG000|Treatment Phase|Lost to Follow-up|0|||
42127411|NCT02658890|75937831|FG001|Treatment Phase|Lost to Follow-up|0|||
42127412|NCT02658890|75937832|FG002|Treatment Phase|Lost to Follow-up|0|||
42272601|NCT01657292|76102840|FG000|Overall Study|Violation of eligibility criteria|1|||
42127413|NCT02658890|75937833|FG003|Treatment Phase|Lost to Follow-up|0|||
41973498|NCT01185171|75774922|FG000|Maintenance|Diarrhea|1|||
41973499|NCT01185171|75774922|FG000|Maintenance|Xerostomia|1|||
41973500|NCT01185171|75774922|FG000|Maintenance|Nausea|1|||
41973501|NCT01185171|75774922|FG000|Maintenance|Comorbid Illness|2|||
41973502|NCT01185171|75774922|FG000|Maintenance|Withdrawal by Subject|1|||
41973503|NCT01185171|75774922|FG000|Maintenance|Disease Recurrence|1|||
41973504|NCT00896493|75774926|FG000|Overall Study|Early disease relapse|3|||
41973505|NCT01875185|75774941|FG000|Overall Study|study was terminated|52|||
41973506|NCT01875185|75774942|FG001|Overall Study|study was terminated|48|||
41973507|NCT01901432|75774971|FG000|Overall Study|Adverse Event|0|||
41973508|NCT01901432|75774972|FG001|Overall Study|Adverse Event|1|||
41973509|NCT01901432|75774973|FG002|Overall Study|Adverse Event|1|||
41973510|NCT01901432|75774974|FG003|Overall Study|Adverse Event|0|||
41973511|NCT01901432|75774975|FG004|Overall Study|Adverse Event|1|||
41973512|NCT01901432|75774971|FG000|Overall Study|Withdrawal by Subject|0|||
41973513|NCT01901432|75774972|FG001|Overall Study|Withdrawal by Subject|0|||
41973514|NCT01901432|75774973|FG002|Overall Study|Withdrawal by Subject|1|||
41973515|NCT01901432|75774974|FG003|Overall Study|Withdrawal by Subject|0|||
41973516|NCT01901432|75774975|FG004|Overall Study|Withdrawal by Subject|5|||
41973517|NCT01901432|75774971|FG000|Overall Study|Physician Decision|0|||
42127414|NCT02658890|75937834|FG004|Treatment Phase|Lost to Follow-up|0|||
42127415|NCT02658890|75937835|FG005|Treatment Phase|Lost to Follow-up|0|||
42127416|NCT02658890|75937836|FG006|Treatment Phase|Lost to Follow-up|1|||
42210775|NCT04052425|76025487|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
42210776|NCT04052425|76025488|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
42210777|NCT04052425|76025489|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
42210778|NCT04052425|76025486|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
42210779|NCT04052425|76025487|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
42210780|NCT04052425|76025488|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
42210781|NCT04052425|76025489|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
42210782|NCT03235089|76025499|FG000|Overall Study|Lost to Follow-up|1|||
42210783|NCT03235089|76025500|FG001|Overall Study|Lost to Follow-up|1|||
42210784|NCT03235089|76025499|FG000|Overall Study|Physician Decision|2|||
42210785|NCT03235089|76025500|FG001|Overall Study|Physician Decision|2|||
42210786|NCT04013191|76025509|FG000|Overall Study|Adverse Event|1|||
42210787|NCT04013191|76025510|FG001|Overall Study|Adverse Event|0|||
42210788|NCT03285594|76025523|FG000|Overall Study|At the Participant's Own Request|10|||
42127417|NCT02658890|75937837|FG007|Treatment Phase|Lost to Follow-up|0|||
42127418|NCT02658890|75937838|FG008|Treatment Phase|Lost to Follow-up|0|||
42127419|NCT02658890|75937839|FG009|Treatment Phase|Lost to Follow-up|0|||
42127420|NCT02658890|75937840|FG010|Treatment Phase|Lost to Follow-up|0|||
42127421|NCT02658890|75937841|FG011|Treatment Phase|Lost to Follow-up|0|||
42127422|NCT02658890|75937842|FG012|Treatment Phase|Lost to Follow-up|0|||
42127423|NCT02658890|75937843|FG013|Treatment Phase|Lost to Follow-up|0|||
42127424|NCT02658890|75937844|FG014|Treatment Phase|Lost to Follow-up|0|||
42127425|NCT02658890|75937845|FG015|Treatment Phase|Lost to Follow-up|0|||
42127426|NCT02658890|75937846|FG016|Treatment Phase|Lost to Follow-up|0|||
42127427|NCT02658890|75937847|FG017|Treatment Phase|Lost to Follow-up|0|||
42127428|NCT02658890|75937848|FG018|Treatment Phase|Lost to Follow-up|0|||
42127429|NCT02658890|75937849|FG019|Treatment Phase|Lost to Follow-up|0|||
42127430|NCT02658890|75937850|FG020|Treatment Phase|Lost to Follow-up|0|||
42127431|NCT02658890|75937851|FG021|Treatment Phase|Lost to Follow-up|0|||
42127432|NCT02658890|75937852|FG022|Treatment Phase|Lost to Follow-up|0|||
42127433|NCT02658890|75937853|FG023|Treatment Phase|Lost to Follow-up|0|||
42127434|NCT02658890|75937854|FG024|Treatment Phase|Lost to Follow-up|0|||
42127435|NCT02658890|75937855|FG025|Treatment Phase|Lost to Follow-up|0|||
42127436|NCT02658890|75937856|FG026|Treatment Phase|Lost to Follow-up|0|||
42127437|NCT02658890|75937830|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
42127438|NCT02658890|75937831|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
42127439|NCT02658890|75937832|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
42127440|NCT02658890|75937833|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
42127441|NCT02658890|75937834|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
42127442|NCT02658890|75937835|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
42210789|NCT03285594|76025524|FG001|Overall Study|At the Participant's Own Request|5|||
42210790|NCT03285594|76025525|FG002|Overall Study|At the Participant's Own Request|21|||
42210791|NCT03285594|76025523|FG000|Overall Study|Adverse Event|2|||
42127443|NCT02658890|75937836|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
41973518|NCT01901432|75774972|FG001|Overall Study|Physician Decision|0|||
41973519|NCT01901432|75774973|FG002|Overall Study|Physician Decision|0|||
41973520|NCT01901432|75774974|FG003|Overall Study|Physician Decision|0|||
41973521|NCT01901432|75774975|FG004|Overall Study|Physician Decision|2|||
41973522|NCT01901432|75774971|FG000|Overall Study|Patient decision to stop study drug|0|||
42127444|NCT02658890|75937837|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
42127445|NCT02658890|75937838|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
42127446|NCT02658890|75937839|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
41973523|NCT01901432|75774972|FG001|Overall Study|Patient decision to stop study drug|0|||
42127447|NCT02658890|75937840|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
41973524|NCT01901432|75774973|FG002|Overall Study|Patient decision to stop study drug|0|||
41973525|NCT01901432|75774974|FG003|Overall Study|Patient decision to stop study drug|0|||
41973526|NCT01901432|75774975|FG004|Overall Study|Patient decision to stop study drug|1|||
41973527|NCT01904279|75774996|FG000|Overall Study|Lack of Efficacy|2|||
41973528|NCT01904279|75774997|FG001|Overall Study|Lack of Efficacy|3|||
41973529|NCT01904279|75774996|FG000|Overall Study|Withdrawal by Subject|1|||
41973530|NCT01904279|75774997|FG001|Overall Study|Withdrawal by Subject|0|||
41973531|NCT01917318|75775006|FG000|First Treatment|Withdrawal by Subject|0|||
41973532|NCT01917318|75775007|FG001|First Treatment|Withdrawal by Subject|1|||
41973533|NCT01923168|75775016|FG000|Overall Study|Protocol Violation|1|||
41973534|NCT01923168|75775017|FG001|Overall Study|Protocol Violation|1|||
41973535|NCT01923168|75775018|FG002|Overall Study|Protocol Violation|0|||
41973536|NCT01923168|75775016|FG000|Overall Study|Subject/guardian decision|14|||
41973537|NCT01923168|75775017|FG001|Overall Study|Subject/guardian decision|14|||
41973538|NCT01923168|75775018|FG002|Overall Study|Subject/guardian decision|4|||
41973539|NCT01923168|75775016|FG000|Overall Study|Adverse Event|12|||
41973540|NCT01923168|75775017|FG001|Overall Study|Adverse Event|12|||
41973541|NCT01923168|75775018|FG002|Overall Study|Adverse Event|0|||
41973542|NCT01923168|75775016|FG000|Overall Study|Physician Decision|6|||
41973543|NCT01923168|75775017|FG001|Overall Study|Physician Decision|9|||
41973544|NCT01923168|75775018|FG002|Overall Study|Physician Decision|5|||
41973545|NCT01923168|75775016|FG000|Overall Study|Progressive disease|4|||
41973546|NCT01923168|75775017|FG001|Overall Study|Progressive disease|3|||
41973547|NCT01923168|75775018|FG002|Overall Study|Progressive disease|7|||
41973548|NCT01923168|75775016|FG000|Overall Study|Death|0|||
41973549|NCT01923168|75775017|FG001|Overall Study|Death|0|||
41973550|NCT01923168|75775018|FG002|Overall Study|Death|1|||
41973551|NCT01931098|75775028|FG000|Overall Study|Withdrawal by Subject|0|||
41973552|NCT01931098|75775029|FG001|Overall Study|Withdrawal by Subject|1|||
41973553|NCT01931098|75775028|FG000|Overall Study|Enrolled in different protocol|0|||
41973554|NCT01931098|75775029|FG001|Overall Study|Enrolled in different protocol|1|||
41973555|NCT01931098|75775028|FG000|Overall Study|Unable to begin trmt:active infection|0|||
41973556|NCT01931098|75775029|FG001|Overall Study|Unable to begin trmt:active infection|1|||
41973557|NCT01931098|75775028|FG000|Overall Study|Refused further treatment|0|||
41973558|NCT01931098|75775029|FG001|Overall Study|Refused further treatment|1|||
41973559|NCT05097716|75775039|FG000|Period 1|Adverse Event|1|||
41973560|NCT05097716|75775039|FG000|Period 1|Close contact with highly-transmissible infection|1|||
41973561|NCT04781647|75775060|FG000|Overall Study|Study terminated by Sponsor|11|||
41973562|NCT04781647|75775061|FG001|Overall Study|Study terminated by Sponsor|9|||
41973563|NCT04781647|75775062|FG002|Overall Study|Study terminated by Sponsor|9|||
41973564|NCT04781647|75775060|FG000|Overall Study|Withdrawal by Subject|1|||
41973565|NCT04781647|75775061|FG001|Overall Study|Withdrawal by Subject|2|||
41973566|NCT04781647|75775062|FG002|Overall Study|Withdrawal by Subject|0|||
41973567|NCT04781647|75775060|FG000|Overall Study|Adverse Event|0|||
41973568|NCT04781647|75775061|FG001|Overall Study|Adverse Event|1|||
41973569|NCT04781647|75775062|FG002|Overall Study|Adverse Event|1|||
41973570|NCT04781647|75775060|FG000|Overall Study|Protocol Violation|1|||
41973571|NCT04781647|75775061|FG001|Overall Study|Protocol Violation|0|||
41973572|NCT04781647|75775062|FG002|Overall Study|Protocol Violation|0|||
41973573|NCT04781647|75775060|FG000|Overall Study|Pregnancy|0|||
41973574|NCT04781647|75775061|FG001|Overall Study|Pregnancy|0|||
42127448|NCT02658890|75937841|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
42127449|NCT02658890|75937842|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
42127450|NCT02658890|75937843|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
42127451|NCT02658890|75937844|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
42127452|NCT02658890|75937845|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
42127453|NCT02658890|75937846|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
42127454|NCT02658890|75937847|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
42127455|NCT02658890|75937848|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
42127456|NCT02658890|75937849|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
42127457|NCT02658890|75937850|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
42127458|NCT02658890|75937851|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
41973575|NCT04781647|75775062|FG002|Overall Study|Pregnancy|1|||
41973576|NCT04781647|75775060|FG000|Overall Study|Virology rebounded|1|||
41973577|NCT04781647|75775061|FG001|Overall Study|Virology rebounded|0|||
41973578|NCT04781647|75775062|FG002|Overall Study|Virology rebounded|0|||
41973579|NCT04727528|75775074|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
41973580|NCT04727528|75775075|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
41973581|NCT04727528|75775074|FG000|Open-label Period|Randomized who did not receive treatment|1|||
41973582|NCT04727528|75775075|FG001|Open-label Period|Randomized who did not receive treatment|0|||
41973583|NCT04727528|75775074|FG000|Double-blind Treatment Phase|Adverse Event|0|||
41973584|NCT04727528|75775075|FG001|Double-blind Treatment Phase|Adverse Event|1|||
41973585|NCT04727528|75775074|FG000|Double-blind Treatment Phase|Death|0|||
41973586|NCT04727528|75775075|FG001|Double-blind Treatment Phase|Death|1|||
42127459|NCT02658890|75937852|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
41973587|NCT04727528|75775074|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
41973588|NCT04727528|75775075|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
41973589|NCT04727528|75775074|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
41973590|NCT04727528|75775075|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
41973591|NCT04727528|75775074|FG000|Double-blind Treatment Phase|Physician Decision|0|||
41973592|NCT04727528|75775075|FG001|Double-blind Treatment Phase|Physician Decision|1|||
41973593|NCT04727528|75775074|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
41973594|NCT04727528|75775075|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
41973595|NCT04674189|75775103|FG000|Overall Study|Adverse Event|0|||
41973596|NCT04674189|75775104|FG001|Overall Study|Adverse Event|0|||
41973597|NCT04674189|75775105|FG002|Overall Study|Adverse Event|1|||
41973598|NCT04674189|75775103|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
41973599|NCT04674189|75775104|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
41973600|NCT04674189|75775105|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
41973601|NCT04674189|75775103|FG000|Overall Study|Physician Decision|1|||
41973602|NCT04674189|75775104|FG001|Overall Study|Physician Decision|0|||
41973603|NCT04674189|75775105|FG002|Overall Study|Physician Decision|0|||
41973604|NCT04674189|75775103|FG000|Overall Study|Withdrawal by Participant|83|||
41973605|NCT04674189|75775104|FG001|Overall Study|Withdrawal by Participant|71|||
41973606|NCT04674189|75775105|FG002|Overall Study|Withdrawal by Participant|142|||
41973607|NCT04674189|75775103|FG000|Overall Study|Lost to Follow-up|55|||
41973608|NCT04674189|75775104|FG001|Overall Study|Lost to Follow-up|53|||
41973609|NCT04674189|75775105|FG002|Overall Study|Lost to Follow-up|44|||
41973610|NCT04674189|75775103|FG000|Overall Study|Miscellaneous|27|||
41973611|NCT04674189|75775104|FG001|Overall Study|Miscellaneous|23|||
41973612|NCT04674189|75775105|FG002|Overall Study|Miscellaneous|207|||
41973613|NCT04674189|75775103|FG000|Overall Study|Did Not Receive Treatment|3|||
41973614|NCT04674189|75775104|FG001|Overall Study|Did Not Receive Treatment|1|||
41973615|NCT04674189|75775105|FG002|Overall Study|Did Not Receive Treatment|2|||
41973616|NCT04380857|75775137|FG000|Overall Study|Lost to Follow-up|3|||
41973617|NCT04380857|75775138|FG001|Overall Study|Lost to Follow-up|3|||
41973618|NCT04189588|75775147|FG000|Overall Study|Death|0|||
41973619|NCT04189588|75775148|FG001|Overall Study|Death|1|||
41973620|NCT04189588|75775147|FG000|Overall Study|Lost to Follow-up|0|||
41973621|NCT04189588|75775148|FG001|Overall Study|Lost to Follow-up|1|||
41973622|NCT04162210|75775156|FG000|Overall Study|Lost to Follow-up|4|||
41973623|NCT04162210|75775157|FG001|Overall Study|Lost to Follow-up|1|||
41973624|NCT04162210|75775156|FG000|Overall Study|Withdrawal by Subject|17|||
41973625|NCT04162210|75775157|FG001|Overall Study|Withdrawal by Subject|9|||
41973626|NCT04162210|75775156|FG000|Overall Study|Ongoing|113|||
41973627|NCT04162210|75775157|FG001|Overall Study|Ongoing|59|||
42127460|NCT02658890|75937853|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
42127461|NCT02658890|75937854|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
42127462|NCT02658890|75937855|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
42127463|NCT02658890|75937856|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
42127464|NCT02658890|75937830|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
42127465|NCT02658890|75937831|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
42127466|NCT02658890|75937832|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
42127467|NCT02658890|75937833|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
42127468|NCT02658890|75937834|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
42127469|NCT02658890|75937835|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
42127470|NCT02658890|75937836|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
42127471|NCT02658890|75937837|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
42127472|NCT02658890|75937838|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
42127473|NCT02658890|75937839|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
42301712|NCT02508649|76136850|FG001|Overall Study|Lost to Follow-up|1|||
41973628|NCT04010461|75775163|FG000|Overall Study|COVID based withdrawal|5|||
41973629|NCT04010461|75775163|FG000|Overall Study|Withdrawal by Subject|5|||
41973630|NCT04010461|75775163|FG000|Overall Study|Adverse Event|1|||
41973631|NCT04010461|75775163|FG000|Overall Study|No Motor Threshold obtainable|1|||
41973632|NCT04010461|75775163|FG000|Overall Study|Physician Decision|1|||
41973633|NCT03985423|75775172|FG000|Overall Study|Adverse Event|1|||
41973634|NCT03985423|75775172|FG000|Overall Study|Death|2|||
41973635|NCT03985423|75775172|FG000|Overall Study|Physician Decision|1|||
42028109|NCT00912964|75836433|FG000|Overall Study|Protocol Violation|5|||
42301713|NCT02508649|76136851|FG002|Overall Study|Lost to Follow-up|0|||
41973636|NCT03985423|75775172|FG000|Overall Study|Withdrawal by Subject|2|||
41973637|NCT03985423|75775172|FG000|Overall Study|Lack of insurance and citizenship|1|||
41973638|NCT03875092|75775178|FG000|Overall Study|Adverse Event|2|||
41973639|NCT03875092|75775179|FG001|Overall Study|Adverse Event|5|||
42127474|NCT02658890|75937840|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
42127475|NCT02658890|75937841|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
41973640|NCT03875092|75775178|FG000|Overall Study|Death|28|||
41973641|NCT03875092|75775179|FG001|Overall Study|Death|41|||
41973642|NCT03875092|75775178|FG000|Overall Study|Ongoing in Study|35|||
42210792|NCT03285594|76025524|FG001|Overall Study|Adverse Event|2|||
42210793|NCT03285594|76025525|FG002|Overall Study|Adverse Event|6|||
42210794|NCT03285594|76025523|FG000|Overall Study|Poor Compliance to Protocol|0|||
42210795|NCT03285594|76025524|FG001|Overall Study|Poor Compliance to Protocol|0|||
42210796|NCT03285594|76025525|FG002|Overall Study|Poor Compliance to Protocol|1|||
42210797|NCT03285594|76025523|FG000|Overall Study|Lost to Follow-up|0|||
42210798|NCT03285594|76025524|FG001|Overall Study|Lost to Follow-up|0|||
42210799|NCT03285594|76025525|FG002|Overall Study|Lost to Follow-up|1|||
42210800|NCT03285594|76025523|FG000|Overall Study|Reason Not Specified|3|||
42210801|NCT03285594|76025524|FG001|Overall Study|Reason Not Specified|4|||
42210802|NCT03285594|76025525|FG002|Overall Study|Reason Not Specified|8|||
42210803|NCT03234465|76025536|FG000|Overall Study|Adverse Event|4|||
42210804|NCT03234465|76025537|FG001|Overall Study|Adverse Event|2|||
42210805|NCT03234465|76025536|FG000|Overall Study|Death|0|||
41973643|NCT03875092|75775179|FG001|Overall Study|Ongoing in Study|14|||
41973644|NCT03634072|75775187|FG000|Overall Study|Early termination of overall study|1|||
41973645|NCT03634072|75775188|FG001|Overall Study|Early termination of overall study|0|||
41973646|NCT03471182|75775199|FG000|Overall Study|Withdrawal by Subject|1|||
41973647|NCT03471182|75775200|FG001|Overall Study|Withdrawal by Subject|1|||
41973648|NCT03471182|75775201|FG002|Overall Study|Withdrawal by Subject|0|||
41973649|NCT03471182|75775199|FG000|Overall Study|Technical failure|2|||
42210806|NCT03234465|76025537|FG001|Overall Study|Death|1|||
42210807|NCT03234465|76025536|FG000|Overall Study|Lost to Follow-up|1|||
42210808|NCT03234465|76025537|FG001|Overall Study|Lost to Follow-up|1|||
42210809|NCT03234465|76025536|FG000|Overall Study|Withdrawal by Subject|12|||
42210810|NCT03234465|76025537|FG001|Overall Study|Withdrawal by Subject|27|||
42210811|NCT03234465|76025536|FG000|Overall Study|Symptomatic deterioration|0|||
42210812|NCT03234465|76025537|FG001|Overall Study|Symptomatic deterioration|1|||
42210813|NCT03234465|76025536|FG000|Overall Study|Non-compliance|2|||
42210814|NCT03234465|76025537|FG001|Overall Study|Non-compliance|0|||
42210815|NCT03234465|76025536|FG000|Overall Study|Other|14|||
42210816|NCT03234465|76025537|FG001|Overall Study|Other|8|||
42210817|NCT03290131|76025546|FG000|Overall Study|Adverse Event|22|||
42210818|NCT03290131|76025547|FG001|Overall Study|Adverse Event|57|||
42210819|NCT03290131|76025548|FG002|Overall Study|Adverse Event|11|||
42210820|NCT03290131|76025546|FG000|Overall Study|Withdrawal by Subject|18|||
42210821|NCT03290131|76025547|FG001|Overall Study|Withdrawal by Subject|13|||
42210822|NCT03290131|76025548|FG002|Overall Study|Withdrawal by Subject|8|||
42210823|NCT03290131|76025546|FG000|Overall Study|MS Relapse|2|||
42210824|NCT03290131|76025547|FG001|Overall Study|MS Relapse|1|||
42210825|NCT03290131|76025548|FG002|Overall Study|MS Relapse|0|||
42210826|NCT03290131|76025546|FG000|Overall Study|Unknown reason|0|||
42210827|NCT03290131|76025547|FG001|Overall Study|Unknown reason|1|||
42210828|NCT03290131|76025548|FG002|Overall Study|Unknown reason|0|||
42028110|NCT00912964|75836434|FG001|Overall Study|Protocol Violation|3|||
42028111|NCT00912964|75836435|FG002|Overall Study|Protocol Violation|8|||
42127476|NCT02658890|75937842|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
42127477|NCT02658890|75937843|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
42210829|NCT04050865|76025559|FG000|Overall Study|Adverse Event|1|||
42210830|NCT04050865|76025560|FG001|Overall Study|Adverse Event|0|||
42210831|NCT04050865|76025559|FG000|Overall Study|no insert|1|||
42210832|NCT04050865|76025560|FG001|Overall Study|no insert|0|||
42210833|NCT04050865|76025559|FG000|Overall Study|Only 1 insert|2|||
42210834|NCT04050865|76025560|FG001|Overall Study|Only 1 insert|3|||
42210835|NCT04050865|76025559|FG000|Overall Study|Physician Decision|0|||
42210836|NCT04050865|76025560|FG001|Overall Study|Physician Decision|1|||
41973650|NCT03471182|75775200|FG001|Overall Study|Technical failure|0|||
42127478|NCT02658890|75937844|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
42127479|NCT02658890|75937845|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
42127480|NCT02658890|75937846|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
42127481|NCT02658890|75937847|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
42127482|NCT02658890|75937848|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
42210837|NCT04050865|76025559|FG000|Overall Study|Withdrawal by Subject|0|||
42210838|NCT04050865|76025560|FG001|Overall Study|Withdrawal by Subject|1|||
41973651|NCT03471182|75775201|FG002|Overall Study|Technical failure|0|||
41973652|NCT03051659|75775238|FG000|Treatment Period|Withdrawal by Subject|0|||
41973653|NCT03051659|75775239|FG001|Treatment Period|Withdrawal by Subject|2|||
41973654|NCT03051659|75775238|FG000|Survival Follow-up|Lost to Follow-up|23|||
41973655|NCT03051659|75775239|FG001|Survival Follow-up|Lost to Follow-up|22|||
41973656|NCT02975882|75775249|FG000|Overall Study|Adverse Event|1|||
42210839|NCT03283566|76025568|FG000|Overall Study|Lost to Follow-up|1|||
42210840|NCT03283566|76025569|FG001|Overall Study|Lost to Follow-up|2|||
42210841|NCT03210519|76025577|FG000|Overall Study|Adverse Event|2|||
41973657|NCT02975882|75775250|FG001|Overall Study|Adverse Event|2|||
42127483|NCT02658890|75937849|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
42210842|NCT03210519|76025578|FG001|Overall Study|Adverse Event|0|||
42210843|NCT04048681|76025584|FG000|Overall Study|family emergency|0|||
42210844|NCT04048681|76025585|FG001|Overall Study|family emergency|0|||
42210845|NCT04048681|76025586|FG002|Overall Study|family emergency|0|||
41973658|NCT02975882|75775251|FG002|Overall Study|Adverse Event|1|||
41973659|NCT02975882|75775252|FG003|Overall Study|Adverse Event|1|||
41973660|NCT02975882|75775249|FG000|Overall Study|Death|0|||
41973661|NCT02975882|75775250|FG001|Overall Study|Death|1|||
41973662|NCT02975882|75775251|FG002|Overall Study|Death|0|||
41973663|NCT02975882|75775252|FG003|Overall Study|Death|0|||
41973664|NCT02975882|75775249|FG000|Overall Study|Lack of Efficacy|3|||
41973665|NCT02975882|75775250|FG001|Overall Study|Lack of Efficacy|7|||
41973666|NCT02975882|75775251|FG002|Overall Study|Lack of Efficacy|4|||
41973667|NCT02975882|75775252|FG003|Overall Study|Lack of Efficacy|3|||
41973668|NCT02975882|75775249|FG000|Overall Study|Physician Decision|0|||
41973669|NCT02975882|75775250|FG001|Overall Study|Physician Decision|2|||
41973670|NCT02975882|75775251|FG002|Overall Study|Physician Decision|4|||
41973671|NCT02975882|75775252|FG003|Overall Study|Physician Decision|2|||
41973672|NCT02975882|75775249|FG000|Overall Study|Ineligible|0|||
41973673|NCT02975882|75775250|FG001|Overall Study|Ineligible|1|||
41973674|NCT02975882|75775251|FG002|Overall Study|Ineligible|0|||
41973675|NCT02975882|75775252|FG003|Overall Study|Ineligible|0|||
41973676|NCT02908672|75775264|FG000|Overall Study|Death|112|||
41973677|NCT02908672|75775265|FG001|Overall Study|Death|93|||
41973678|NCT02908672|75775264|FG000|Overall Study|Lost to Follow-up|3|||
41973679|NCT02908672|75775265|FG001|Overall Study|Lost to Follow-up|3|||
41973680|NCT02908672|75775264|FG000|Overall Study|Other|2|||
41973681|NCT02908672|75775265|FG001|Overall Study|Other|0|||
41973682|NCT02908672|75775264|FG000|Overall Study|Protocol Violation|1|||
41973683|NCT02908672|75775265|FG001|Overall Study|Protocol Violation|1|||
41973684|NCT02908672|75775264|FG000|Overall Study|Withdrawal by Subject|13|||
41973685|NCT02908672|75775265|FG001|Overall Study|Withdrawal by Subject|18|||
41973686|NCT02908672|75775264|FG000|Overall Study|Study is ongoing|124|||
41973687|NCT02908672|75775265|FG001|Overall Study|Study is ongoing|141|||
41973688|NCT02908672|75775264|FG000|Overall Study|Discontinued the study during run-in|3|||
41973689|NCT02908672|75775265|FG001|Overall Study|Discontinued the study during run-in|0|||
41973690|NCT02775435|75775273|FG000|Overall Study|Adverse Event|48|||
41973691|NCT02775435|75775274|FG001|Overall Study|Adverse Event|25|||
41973692|NCT02775435|75775273|FG000|Overall Study|Lost to Follow-up|0|||
41973693|NCT02775435|75775274|FG001|Overall Study|Lost to Follow-up|2|||
41973694|NCT02775435|75775273|FG000|Overall Study|Physician Decision|5|||
41973695|NCT02775435|75775274|FG001|Overall Study|Physician Decision|6|||
41973696|NCT02775435|75775273|FG000|Overall Study|Withdrawal by Subject|5|||
41973697|NCT02775435|75775274|FG001|Overall Study|Withdrawal by Subject|9|||
41973698|NCT02775435|75775273|FG000|Overall Study|Progressive Disease|86|||
41973699|NCT02775435|75775274|FG001|Overall Study|Progressive Disease|140|||
41973700|NCT02775435|75775273|FG000|Overall Study|Clinical Progression|13|||
42127484|NCT02658890|75937850|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
42127485|NCT02658890|75937851|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
42127486|NCT02658890|75937852|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
42127487|NCT02658890|75937853|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
42127488|NCT02658890|75937854|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
42127489|NCT02658890|75937855|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
42127490|NCT02658890|75937856|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
42127491|NCT02658890|75937830|FG000|Treatment Phase|Other Reasons|0|||
42127492|NCT02658890|75937831|FG001|Treatment Phase|Other Reasons|0|||
42127493|NCT02658890|75937832|FG002|Treatment Phase|Other Reasons|0|||
41973701|NCT02775435|75775274|FG001|Overall Study|Clinical Progression|26|||
41973702|NCT02775435|75775273|FG000|Overall Study|Ongoing in Study|121|||
42301714|NCT02508649|76136852|FG003|Overall Study|Lost to Follow-up|1|||
41973703|NCT02775435|75775274|FG001|Overall Study|Ongoing in Study|72|||
41973704|NCT02775435|75775273|FG000|Overall Study|Not Treated|0|||
41973705|NCT02775435|75775274|FG001|Overall Study|Not Treated|1|||
41973706|NCT02685826|75775283|FG000|Overall Study|Adverse Event|2|||
41973707|NCT02685826|75775284|FG001|Overall Study|Adverse Event|0|||
41973708|NCT02685826|75775285|FG002|Overall Study|Adverse Event|1|||
41973709|NCT02685826|75775283|FG000|Overall Study|Progressive Disease|2|||
41973710|NCT02685826|75775284|FG001|Overall Study|Progressive Disease|1|||
42127494|NCT02658890|75937833|FG003|Treatment Phase|Other Reasons|0|||
42127495|NCT02658890|75937834|FG004|Treatment Phase|Other Reasons|0|||
42127496|NCT02658890|75937835|FG005|Treatment Phase|Other Reasons|0|||
41973711|NCT02685826|75775285|FG002|Overall Study|Progressive Disease|0|||
41973712|NCT02685826|75775283|FG000|Overall Study|Withdrawal by Subject|2|||
41973713|NCT02685826|75775284|FG001|Overall Study|Withdrawal by Subject|0|||
41973714|NCT02685826|75775285|FG002|Overall Study|Withdrawal by Subject|0|||
41973715|NCT02685826|75775283|FG000|Overall Study|Full Clinical Hold by FDA|19|||
41973716|NCT02685826|75775284|FG001|Overall Study|Full Clinical Hold by FDA|9|||
41973717|NCT02685826|75775285|FG002|Overall Study|Full Clinical Hold by FDA|20|||
41973718|NCT01177683|75775296|FG000|Study Treatment|Disease Progressions during treatment|2|||
41973719|NCT01177683|75775297|FG001|Study Treatment|Disease Progressions during treatment|0|||
41973720|NCT01177683|75775298|FG002|Study Treatment|Disease Progressions during treatment|3|||
41973721|NCT01177683|75775296|FG000|Study Treatment|Adverse Event|0|||
41973722|NCT01177683|75775297|FG001|Study Treatment|Adverse Event|1|||
41973723|NCT01177683|75775298|FG002|Study Treatment|Adverse Event|12|||
42127497|NCT02658890|75937836|FG006|Treatment Phase|Other Reasons|1|||
42127498|NCT02658890|75937837|FG007|Treatment Phase|Other Reasons|0|||
42127499|NCT02658890|75937838|FG008|Treatment Phase|Other Reasons|1|||
42210846|NCT04048681|76025587|FG003|Overall Study|family emergency|1|||
42210847|NCT04048681|76025588|FG004|Overall Study|family emergency|0|||
42210848|NCT04007107|76025596|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
42210849|NCT04007107|76025597|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
42210850|NCT04007107|76025598|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
42210851|NCT04007107|76025599|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
42210852|NCT04046341|76025604|FG000|Overall Study|Lost to Follow-up|2|||
42210853|NCT04046341|76025604|FG000|Overall Study|Withdrawal by Subject|1|||
42210854|NCT03233529|76025608|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
42210855|NCT03233529|76025608|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
42210856|NCT04006171|76025618|FG000|Overall Study|Withdrawal by Subject|8|||
42210857|NCT04006171|76025619|FG001|Overall Study|Withdrawal by Subject|7|||
42210858|NCT04006171|76025618|FG000|Overall Study|missing serum samples|2|||
42210859|NCT04006171|76025619|FG001|Overall Study|missing serum samples|2|||
42210860|NCT04006171|76025618|FG000|Overall Study|insufficient sample volume|2|||
42210861|NCT04006171|76025619|FG001|Overall Study|insufficient sample volume|3|||
42210862|NCT04043143|76025632|FG000|Overall Study|Lost to Follow-up|5|||
42210863|NCT04043143|76025633|FG001|Overall Study|Lost to Follow-up|5|||
42210864|NCT04043143|76025632|FG000|Overall Study|screen failure|1|||
42210865|NCT04043143|76025633|FG001|Overall Study|screen failure|0|||
42210866|NCT03283098|76025641|FG000|Overall Study|Withdrawal by Subject|0|||
42210867|NCT03283098|76025642|FG001|Overall Study|Withdrawal by Subject|1|||
42210868|NCT03655951|76025650|FG000|Overall Study|Lost to Follow-up|39|||
42210869|NCT03655951|76025651|FG001|Overall Study|Lost to Follow-up|20|||
42210870|NCT03655951|76025650|FG000|Overall Study|Withdrawal by Subject|0|||
42210871|NCT03655951|76025651|FG001|Overall Study|Withdrawal by Subject|1|||
42127500|NCT02658890|75937839|FG009|Treatment Phase|Other Reasons|0|||
42127501|NCT02658890|75937840|FG010|Treatment Phase|Other Reasons|0|||
42127502|NCT02658890|75937841|FG011|Treatment Phase|Other Reasons|0|||
42127503|NCT02658890|75937842|FG012|Treatment Phase|Other Reasons|0|||
42127504|NCT02658890|75937843|FG013|Treatment Phase|Other Reasons|2|||
42127505|NCT02658890|75937844|FG014|Treatment Phase|Other Reasons|0|||
42127506|NCT02658890|75937845|FG015|Treatment Phase|Other Reasons|0|||
42127507|NCT02658890|75937846|FG016|Treatment Phase|Other Reasons|0|||
42127508|NCT02658890|75937847|FG017|Treatment Phase|Other Reasons|0|||
42127509|NCT02658890|75937848|FG018|Treatment Phase|Other Reasons|1|||
42127510|NCT02658890|75937849|FG019|Treatment Phase|Other Reasons|0|||
42210872|NCT02527798|76025663|FG000|Overall Study|Physician Decision|1|||
42210873|NCT02527798|76025664|FG001|Overall Study|Physician Decision|0|||
42210874|NCT02527798|76025665|FG002|Overall Study|Physician Decision|1|||
42210875|NCT02527798|76025666|FG003|Overall Study|Physician Decision|1|||
42210876|NCT02527798|76025667|FG004|Overall Study|Physician Decision|0|||
42210877|NCT02527798|76025668|FG005|Overall Study|Physician Decision|0|||
42210878|NCT02527798|76025663|FG000|Overall Study|Death|0|||
42210879|NCT02527798|76025664|FG001|Overall Study|Death|0|||
42210880|NCT02527798|76025665|FG002|Overall Study|Death|1|||
42210881|NCT02527798|76025666|FG003|Overall Study|Death|0|||
42210882|NCT02527798|76025667|FG004|Overall Study|Death|0|||
42210883|NCT02527798|76025668|FG005|Overall Study|Death|0|||
42210884|NCT02527798|76025663|FG000|Overall Study|Withdrawal by Subject|0|||
42210885|NCT02527798|76025664|FG001|Overall Study|Withdrawal by Subject|1|||
42210886|NCT02527798|76025665|FG002|Overall Study|Withdrawal by Subject|2|||
42210887|NCT02527798|76025666|FG003|Overall Study|Withdrawal by Subject|0|||
42210888|NCT02527798|76025667|FG004|Overall Study|Withdrawal by Subject|0|||
42210889|NCT02527798|76025668|FG005|Overall Study|Withdrawal by Subject|0|||
42210890|NCT02527798|76025663|FG000|Overall Study|Reason undisclosed|1|||
41973724|NCT01177683|75775296|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
41973725|NCT01177683|75775297|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
42210891|NCT02527798|76025664|FG001|Overall Study|Reason undisclosed|0|||
42210892|NCT02527798|76025665|FG002|Overall Study|Reason undisclosed|1|||
42210893|NCT02527798|76025666|FG003|Overall Study|Reason undisclosed|0|||
42127511|NCT02658890|75937850|FG020|Treatment Phase|Other Reasons|0|||
42127512|NCT02658890|75937851|FG021|Treatment Phase|Other Reasons|0|||
42127513|NCT02658890|75937852|FG022|Treatment Phase|Other Reasons|0|||
42127514|NCT02658890|75937853|FG023|Treatment Phase|Other Reasons|0|||
42210894|NCT02527798|76025667|FG004|Overall Study|Reason undisclosed|0|||
42210895|NCT02527798|76025668|FG005|Overall Study|Reason undisclosed|0|||
42210896|NCT02527798|76025663|FG000|Overall Study|Did not receive intervention|1|||
42210897|NCT02527798|76025664|FG001|Overall Study|Did not receive intervention|1|||
42210898|NCT02527798|76025665|FG002|Overall Study|Did not receive intervention|0|||
42210899|NCT02527798|76025666|FG003|Overall Study|Did not receive intervention|0|||
42210900|NCT02527798|76025667|FG004|Overall Study|Did not receive intervention|0|||
41973726|NCT01177683|75775298|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
41973727|NCT01177683|75775296|FG000|Study Treatment|Alternative therapy|0|||
41973728|NCT01177683|75775297|FG001|Study Treatment|Alternative therapy|0|||
42210901|NCT02527798|76025668|FG005|Overall Study|Did not receive intervention|0|||
42210902|NCT03188991|76025699|FG000|Overall Study|Withdrawal by Subject|0|||
42210903|NCT03188991|76025700|FG001|Overall Study|Withdrawal by Subject|0|||
42210904|NCT03188991|76025701|FG002|Overall Study|Withdrawal by Subject|0|||
42210905|NCT03188991|76025702|FG003|Overall Study|Withdrawal by Subject|1|||
42210906|NCT03857542|76025714|FG000|Overall Study|Adverse Event|1|||
42210907|NCT03857542|76025715|FG001|Overall Study|Adverse Event|3|||
42210908|NCT03857542|76025714|FG000|Overall Study|Withdrawal by Subject|2|||
42210909|NCT03857542|76025715|FG001|Overall Study|Withdrawal by Subject|1|||
42210910|NCT03857542|76025714|FG000|Overall Study|Lost to Follow-up|2|||
42210911|NCT03857542|76025715|FG001|Overall Study|Lost to Follow-up|1|||
42210912|NCT03857542|76025714|FG000|Overall Study|Reason not Specified|1|||
42210913|NCT03857542|76025715|FG001|Overall Study|Reason not Specified|0|||
41973729|NCT01177683|75775298|FG002|Study Treatment|Alternative therapy|4|||
41973730|NCT01177683|75775296|FG000|Study Treatment|Physician Decision|1|||
41973731|NCT01177683|75775297|FG001|Study Treatment|Physician Decision|0|||
41973732|NCT01177683|75775298|FG002|Study Treatment|Physician Decision|1|||
41973733|NCT01177683|75775296|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
41973734|NCT01177683|75775297|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
41973735|NCT01177683|75775298|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
41973736|NCT01177683|75775296|FG000|Study Treatment|Symptomatic Deterioration|0|||
41973737|NCT01177683|75775297|FG001|Study Treatment|Symptomatic Deterioration|0|||
41973738|NCT01177683|75775298|FG002|Study Treatment|Symptomatic Deterioration|1|||
41973739|NCT01177683|75775296|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
41973740|NCT01177683|75775297|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
41973741|NCT01177683|75775298|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
41973742|NCT01177683|75775296|FG000|Follow up|Patient lost to follow up|0|||
41973743|NCT01177683|75775297|FG001|Follow up|Patient lost to follow up|0|||
41973744|NCT01177683|75775298|FG002|Follow up|Patient lost to follow up|2|||
41973745|NCT01177683|75775296|FG000|Follow up|Death|2|||
41973746|NCT01177683|75775297|FG001|Follow up|Death|1|||
41973747|NCT01177683|75775298|FG002|Follow up|Death|7|||
41973748|NCT01177683|75775296|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
41973749|NCT01177683|75775297|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
41973750|NCT01177683|75775298|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
41973751|NCT01084252|75775323|FG000|Phase 1 (120 Weeks)|Adverse Event|0|||
41973752|NCT01084252|75775324|FG001|Phase 1 (120 Weeks)|Adverse Event|0|||
41973753|NCT01084252|75775325|FG002|Phase 1 (120 Weeks)|Adverse Event|1|||
41973754|NCT01084252|75775326|FG003|Phase 1 (120 Weeks)|Adverse Event|1|||
41973755|NCT01084252|75775327|FG004|Phase 1 (120 Weeks)|Adverse Event|1|||
41973756|NCT01084252|75775328|FG005|Phase 1 (120 Weeks)|Adverse Event|0|||
41973757|NCT01084252|75775329|FG006|Phase 1 (120 Weeks)|Adverse Event|1|||
41973758|NCT01084252|75775330|FG007|Phase 1 (120 Weeks)|Adverse Event|0|||
41973759|NCT01084252|75775331|FG008|Phase 1 (120 Weeks)|Adverse Event|0|||
41973760|NCT01084252|75775332|FG009|Phase 1 (120 Weeks)|Adverse Event|0|||
41973761|NCT01084252|75775333|FG010|Phase 1 (120 Weeks)|Adverse Event|0|||
41973762|NCT01084252|75775334|FG011|Phase 1 (120 Weeks)|Adverse Event|0|||
41973763|NCT01084252|75775335|FG012|Phase 1 (120 Weeks)|Adverse Event|0|||
41973764|NCT01084252|75775336|FG013|Phase 1 (120 Weeks)|Adverse Event|0|||
41973765|NCT01084252|75775323|FG000|Phase 1 (120 Weeks)|Progressive disease|15|||
42210914|NCT03209973|76025722|FG000|Overall Study|Withdrawal by Subject|7|||
42210915|NCT03209973|76025722|FG000|Overall Study|Lost to Follow-up|2|||
41973766|NCT01084252|75775324|FG001|Phase 1 (120 Weeks)|Progressive disease|5|||
41973767|NCT01084252|75775325|FG002|Phase 1 (120 Weeks)|Progressive disease|2|||
41973768|NCT01084252|75775326|FG003|Phase 1 (120 Weeks)|Progressive disease|22|||
41973769|NCT01084252|75775327|FG004|Phase 1 (120 Weeks)|Progressive disease|16|||
41973770|NCT01084252|75775328|FG005|Phase 1 (120 Weeks)|Progressive disease|6|||
41973771|NCT01084252|75775329|FG006|Phase 1 (120 Weeks)|Progressive disease|5|||
41973772|NCT01084252|75775330|FG007|Phase 1 (120 Weeks)|Progressive disease|6|||
41973773|NCT01084252|75775331|FG008|Phase 1 (120 Weeks)|Progressive disease|0|||
41973774|NCT01084252|75775332|FG009|Phase 1 (120 Weeks)|Progressive disease|0|||
42210916|NCT03209973|76025722|FG000|Overall Study|Death|8|||
42210917|NCT03209973|76025722|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
42210918|NCT03209973|76025722|FG000|Overall Study|Sponsor Decision|18|||
42210919|NCT03209973|76025722|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
41973775|NCT01084252|75775333|FG010|Phase 1 (120 Weeks)|Progressive disease|0|||
41973776|NCT01084252|75775334|FG011|Phase 1 (120 Weeks)|Progressive disease|0|||
41973777|NCT01084252|75775335|FG012|Phase 1 (120 Weeks)|Progressive disease|0|||
41973778|NCT01084252|75775336|FG013|Phase 1 (120 Weeks)|Progressive disease|0|||
41973779|NCT01084252|75775323|FG000|Phase 1 (120 Weeks)|Other than specified above|1|||
41973780|NCT01084252|75775324|FG001|Phase 1 (120 Weeks)|Other than specified above|1|||
41973781|NCT01084252|75775325|FG002|Phase 1 (120 Weeks)|Other than specified above|0|||
41973782|NCT01084252|75775326|FG003|Phase 1 (120 Weeks)|Other than specified above|3|||
41973783|NCT01084252|75775327|FG004|Phase 1 (120 Weeks)|Other than specified above|1|||
41973784|NCT01084252|75775328|FG005|Phase 1 (120 Weeks)|Other than specified above|0|||
41973785|NCT01084252|75775329|FG006|Phase 1 (120 Weeks)|Other than specified above|1|||
41973786|NCT01084252|75775330|FG007|Phase 1 (120 Weeks)|Other than specified above|1|||
41973787|NCT01084252|75775331|FG008|Phase 1 (120 Weeks)|Other than specified above|0|||
41973788|NCT01084252|75775332|FG009|Phase 1 (120 Weeks)|Other than specified above|0|||
41973789|NCT01084252|75775333|FG010|Phase 1 (120 Weeks)|Other than specified above|0|||
41973790|NCT01084252|75775334|FG011|Phase 1 (120 Weeks)|Other than specified above|0|||
41973791|NCT01084252|75775335|FG012|Phase 1 (120 Weeks)|Other than specified above|0|||
41973792|NCT01084252|75775336|FG013|Phase 1 (120 Weeks)|Other than specified above|0|||
41973793|NCT01084252|75775323|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
41973794|NCT01084252|75775324|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
41973795|NCT01084252|75775325|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
41973796|NCT01084252|75775326|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
41973797|NCT01084252|75775327|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
41973798|NCT01084252|75775328|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
41973799|NCT01084252|75775329|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
41973800|NCT01084252|75775330|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
41973801|NCT01084252|75775331|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
41973802|NCT01084252|75775332|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
41973803|NCT01084252|75775333|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2|||
41973804|NCT01084252|75775334|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1|||
41973805|NCT01084252|75775335|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
41973806|NCT01084252|75775336|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0|||
41973807|NCT01084252|75775323|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
41973808|NCT01084252|75775324|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
41973809|NCT01084252|75775325|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
41973810|NCT01084252|75775326|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
41973811|NCT01084252|75775327|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
41973812|NCT01084252|75775328|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
41973813|NCT01084252|75775329|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
41973814|NCT01084252|75775330|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
41973815|NCT01084252|75775331|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20|||
41973816|NCT01084252|75775332|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18|||
41973817|NCT01084252|75775333|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17|||
41973818|NCT01084252|75775334|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19|||
41973819|NCT01084252|75775335|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
41973820|NCT01084252|75775336|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0|||
41973821|NCT01084252|75775323|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
41973822|NCT01084252|75775324|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
41973823|NCT01084252|75775325|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
41973824|NCT01084252|75775326|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
41973825|NCT01084252|75775327|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
41973826|NCT01084252|75775328|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
41973827|NCT01084252|75775329|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
41973828|NCT01084252|75775330|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
41973829|NCT01084252|75775331|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2|||
41973830|NCT01084252|75775332|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
41973831|NCT01084252|75775333|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4|||
41973832|NCT01084252|75775334|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3|||
41973833|NCT01084252|75775335|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
41973834|NCT01084252|75775336|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0|||
41973835|NCT01084252|75775323|FG000|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
41973836|NCT01084252|75775324|FG001|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
41973837|NCT01084252|75775325|FG002|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
41973838|NCT01084252|75775326|FG003|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
41973839|NCT01084252|75775327|FG004|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
41973840|NCT01084252|75775328|FG005|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
41973841|NCT01084252|75775329|FG006|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
41973842|NCT01084252|75775330|FG007|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
41973843|NCT01084252|75775331|FG008|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1|||
41973844|NCT01084252|75775332|FG009|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4|||
41973845|NCT01084252|75775333|FG010|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
41973846|NCT01084252|75775334|FG011|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2|||
41973847|NCT01084252|75775335|FG012|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
41973848|NCT01084252|75775336|FG013|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0|||
41973849|NCT01084252|75775323|FG000|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973850|NCT01084252|75775324|FG001|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973851|NCT01084252|75775325|FG002|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973852|NCT01084252|75775326|FG003|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973853|NCT01084252|75775327|FG004|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973854|NCT01084252|75775328|FG005|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973855|NCT01084252|75775329|FG006|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973856|NCT01084252|75775330|FG007|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973857|NCT01084252|75775331|FG008|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973858|NCT01084252|75775332|FG009|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973859|NCT01084252|75775333|FG010|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973860|NCT01084252|75775334|FG011|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0|||
41973861|NCT01084252|75775335|FG012|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13|||
41973862|NCT01084252|75775336|FG013|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5|||
41973863|NCT01084252|75775323|FG000|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973864|NCT01084252|75775324|FG001|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973865|NCT01084252|75775325|FG002|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973866|NCT01084252|75775326|FG003|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973867|NCT01084252|75775327|FG004|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973868|NCT01084252|75775328|FG005|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973869|NCT01084252|75775329|FG006|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973870|NCT01084252|75775330|FG007|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973871|NCT01084252|75775331|FG008|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973872|NCT01084252|75775332|FG009|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973873|NCT01084252|75775333|FG010|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973874|NCT01084252|75775334|FG011|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0|||
41973875|NCT01084252|75775335|FG012|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70|||
41973876|NCT01084252|75775336|FG013|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33|||
41973877|NCT01084252|75775323|FG000|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973878|NCT01084252|75775324|FG001|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973879|NCT01084252|75775325|FG002|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973880|NCT01084252|75775326|FG003|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973881|NCT01084252|75775327|FG004|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973882|NCT01084252|75775328|FG005|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973883|NCT01084252|75775329|FG006|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973884|NCT01084252|75775330|FG007|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973885|NCT01084252|75775331|FG008|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973886|NCT01084252|75775332|FG009|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973887|NCT01084252|75775333|FG010|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973888|NCT01084252|75775334|FG011|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973889|NCT01084252|75775335|FG012|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1|||
41973890|NCT01084252|75775336|FG013|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0|||
41973891|NCT01084252|75775323|FG000|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
41973892|NCT01084252|75775324|FG001|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
41973893|NCT01084252|75775325|FG002|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
41973894|NCT01084252|75775326|FG003|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
41973895|NCT01084252|75775327|FG004|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
41973896|NCT01084252|75775328|FG005|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
41973897|NCT01084252|75775329|FG006|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
41973898|NCT01084252|75775330|FG007|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
41973899|NCT01084252|75775331|FG008|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
41973900|NCT01084252|75775332|FG009|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
42210920|NCT03209973|76025722|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
42210921|NCT03751631|76025728|FG000|Overall Study|Withdrawal by Subject|0|||
41973901|NCT01084252|75775333|FG010|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
41973902|NCT01084252|75775334|FG011|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0|||
41973903|NCT01084252|75775335|FG012|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12|||
42127515|NCT02658890|75937854|FG024|Treatment Phase|Other Reasons|1|||
41973904|NCT01084252|75775336|FG013|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2|||
41973905|NCT01084252|75775323|FG000|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
41973906|NCT01084252|75775324|FG001|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
41973907|NCT01084252|75775325|FG002|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
42210922|NCT03751631|76025729|FG001|Overall Study|Withdrawal by Subject|0|||
42210923|NCT03751631|76025730|FG002|Overall Study|Withdrawal by Subject|1|||
42210924|NCT03751631|76025731|FG003|Overall Study|Withdrawal by Subject|1|||
42210925|NCT03751631|76025732|FG004|Overall Study|Withdrawal by Subject|0|||
42210926|NCT03751631|76025733|FG005|Overall Study|Withdrawal by Subject|0|||
42210927|NCT03688711|76025746|FG000|Overall Study|Withdrawal by Subject|0|||
42210928|NCT03688711|76025747|FG001|Overall Study|Withdrawal by Subject|1|||
42210929|NCT03188055|76025755|FG000|Overall Study|Unavailable for training|0|||
42210930|NCT03188055|76025756|FG001|Overall Study|Unavailable for training|0|||
42210931|NCT03188055|76025757|FG002|Overall Study|Unavailable for training|19|||
42210932|NCT03188055|76025758|FG003|Overall Study|Unavailable for training|0|||
42210933|NCT03188055|76025759|FG004|Overall Study|Unavailable for training|0|||
41973908|NCT01084252|75775326|FG003|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
41973909|NCT01084252|75775327|FG004|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
41973910|NCT01084252|75775328|FG005|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
41973911|NCT01084252|75775329|FG006|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
41973912|NCT01084252|75775330|FG007|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
41973913|NCT01084252|75775331|FG008|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
41973914|NCT01084252|75775332|FG009|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
41973915|NCT01084252|75775333|FG010|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
41973916|NCT01084252|75775334|FG011|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0|||
41973917|NCT01084252|75775335|FG012|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13|||
41973918|NCT01084252|75775336|FG013|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15|||
41973919|NCT01084252|75775323|FG000|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973920|NCT01084252|75775324|FG001|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973921|NCT01084252|75775325|FG002|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973922|NCT01084252|75775326|FG003|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973923|NCT01084252|75775327|FG004|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973924|NCT01084252|75775328|FG005|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973925|NCT01084252|75775329|FG006|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973926|NCT01084252|75775330|FG007|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973927|NCT01084252|75775331|FG008|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973928|NCT01084252|75775332|FG009|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973929|NCT01084252|75775333|FG010|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973930|NCT01084252|75775334|FG011|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973931|NCT01084252|75775335|FG012|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1|||
41973932|NCT01084252|75775336|FG013|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0|||
41973933|NCT00993044|75775400|FG000|Irinotecan 50 mg|Physician Decision|1|||
41973934|NCT00116272|75775407|FG000|Overall Study|Lost to Follow-up|11|||
41973935|NCT00116272|75775408|FG001|Overall Study|Lost to Follow-up|6|||
41973936|NCT01945021|75775416|FG000|Overall Study|Adverse Event|1|||
41973937|NCT01945021|75775416|FG000|Overall Study|Withdrawal of consent|12|||
41973938|NCT01945021|75775416|FG000|Overall Study|Lost to Follow-up|5|||
41973939|NCT01945021|75775416|FG000|Overall Study|Death|65|||
41973940|NCT01945060|75775422|FG000|Overall Study|Lost to follow up|1|||
41973941|NCT01945060|75775423|FG001|Overall Study|Lost to follow up|0|||
41973942|NCT01945060|75775422|FG000|Overall Study|Distress related to IV access|0|||
41973943|NCT01945060|75775423|FG001|Overall Study|Distress related to IV access|1|||
41973944|NCT03951077|75775466|FG000|Overall Study|Adverse Event|1|||
41973945|NCT03951077|75775467|FG001|Overall Study|Adverse Event|0|||
41973946|NCT03951077|75775468|FG002|Overall Study|Adverse Event|0|||
41973947|NCT03951077|75775469|FG003|Overall Study|Adverse Event|0|||
41973948|NCT03951077|75775470|FG004|Overall Study|Adverse Event|0|||
41973949|NCT03951077|75775471|FG005|Overall Study|Adverse Event|0|||
41973950|NCT03951077|75775466|FG000|Overall Study|Withdrawal by Subject|3|||
41973951|NCT03951077|75775467|FG001|Overall Study|Withdrawal by Subject|3|||
41973952|NCT03951077|75775468|FG002|Overall Study|Withdrawal by Subject|0|||
41973953|NCT03951077|75775469|FG003|Overall Study|Withdrawal by Subject|3|||
41973954|NCT03951077|75775470|FG004|Overall Study|Withdrawal by Subject|3|||
41973955|NCT03951077|75775471|FG005|Overall Study|Withdrawal by Subject|2|||
41973956|NCT03951077|75775466|FG000|Overall Study|Lost to Follow-up|1|||
42210934|NCT03188055|76025760|FG005|Overall Study|Unavailable for training||||
42210935|NCT03188055|76025755|FG000|Overall Study|Lost to Follow-up|0|||
42210936|NCT03188055|76025756|FG001|Overall Study|Lost to Follow-up|18|||
42210937|NCT03188055|76025757|FG002|Overall Study|Lost to Follow-up|0|||
42210938|NCT03188055|76025758|FG003|Overall Study|Lost to Follow-up|11|||
42210939|NCT03188055|76025759|FG004|Overall Study|Lost to Follow-up|0|||
42210940|NCT03188055|76025760|FG005|Overall Study|Lost to Follow-up||||
42210941|NCT03188055|76025755|FG000|Overall Study|Withdrawal by Subject|0|||
42210942|NCT03188055|76025756|FG001|Overall Study|Withdrawal by Subject|1|||
42210943|NCT03188055|76025757|FG002|Overall Study|Withdrawal by Subject|0|||
41973957|NCT03951077|75775467|FG001|Overall Study|Lost to Follow-up|1|||
42210944|NCT03188055|76025758|FG003|Overall Study|Withdrawal by Subject|1|||
41973958|NCT03951077|75775468|FG002|Overall Study|Lost to Follow-up|2|||
41973959|NCT03951077|75775469|FG003|Overall Study|Lost to Follow-up|3|||
42210945|NCT03188055|76025759|FG004|Overall Study|Withdrawal by Subject|0|||
41973960|NCT03951077|75775470|FG004|Overall Study|Lost to Follow-up|2|||
41973961|NCT03951077|75775471|FG005|Overall Study|Lost to Follow-up|3|||
41973962|NCT03951077|75775466|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
42210946|NCT03188055|76025760|FG005|Overall Study|Withdrawal by Subject||||
42210947|NCT04035577|76025771|FG000|Overall Study|Lost to Follow-up|1|||
42210948|NCT04035577|76025771|FG000|Overall Study|Withdrawal by Subject|1|||
42210949|NCT03655717|76025799|FG000|Overall Study|Withdrawal by Subject|4|||
42210950|NCT03655717|76025800|FG001|Overall Study|Withdrawal by Subject|8|||
42210951|NCT03655717|76025801|FG002|Overall Study|Withdrawal by Subject|1|||
42210952|NCT03655717|76025802|FG003|Overall Study|Withdrawal by Subject|0|||
42210953|NCT03655717|76025803|FG004|Overall Study|Withdrawal by Subject|0|||
41973963|NCT03951077|75775467|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
41973964|NCT03951077|75775468|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
41973965|NCT03951077|75775469|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
41973966|NCT03951077|75775470|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
41973967|NCT03951077|75775471|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
41973968|NCT03951077|75775466|FG000|Overall Study|Other, Not Specified|12|||
41973969|NCT03951077|75775467|FG001|Overall Study|Other, Not Specified|10|||
41973970|NCT03951077|75775468|FG002|Overall Study|Other, Not Specified|10|||
41973971|NCT03951077|75775469|FG003|Overall Study|Other, Not Specified|5|||
41973972|NCT03951077|75775470|FG004|Overall Study|Other, Not Specified|9|||
41973973|NCT03951077|75775471|FG005|Overall Study|Other, Not Specified|6|||
41973974|NCT03951077|75775466|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
42210954|NCT03655717|76025804|FG005|Overall Study|Withdrawal by Subject|1|||
42210955|NCT03655717|76025805|FG006|Overall Study|Withdrawal by Subject|3|||
42210956|NCT03655717|76025806|FG007|Overall Study|Withdrawal by Subject|1|||
42210957|NCT03655717|76025807|FG008|Overall Study|Withdrawal by Subject|2|||
42210958|NCT03655717|76025808|FG009|Overall Study|Withdrawal by Subject|0|||
42210959|NCT03655717|76025809|FG010|Overall Study|Withdrawal by Subject|0|||
42210960|NCT03655717|76025810|FG011|Overall Study|Withdrawal by Subject|1|||
42210961|NCT03655717|76025811|FG012|Overall Study|Withdrawal by Subject|0|||
42210962|NCT03655717|76025812|FG013|Overall Study|Withdrawal by Subject|3|||
42210963|NCT03655717|76025813|FG014|Overall Study|Withdrawal by Subject|0|||
42210964|NCT03655717|76025814|FG015|Overall Study|Withdrawal by Subject|1|||
42210965|NCT03655717|76025815|FG016|Overall Study|Withdrawal by Subject|0|||
42210966|NCT03655717|76025816|FG017|Overall Study|Withdrawal by Subject|0|||
42210967|NCT03655717|76025817|FG018|Overall Study|Withdrawal by Subject|1|||
42210968|NCT03655717|76025818|FG019|Overall Study|Withdrawal by Subject|0|||
42210969|NCT03655717|76025819|FG020|Overall Study|Withdrawal by Subject|0|||
42210970|NCT03655717|76025820|FG021|Overall Study|Withdrawal by Subject|1|||
42210971|NCT03655717|76025821|FG022|Overall Study|Withdrawal by Subject|2|||
42210972|NCT03655717|76025822|FG023|Overall Study|Withdrawal by Subject|1|||
42210973|NCT03655717|76025823|FG024|Overall Study|Withdrawal by Subject|1|||
42210974|NCT03655717|76025824|FG025|Overall Study|Withdrawal by Subject|0|||
42210975|NCT03655717|76025799|FG000|Overall Study|Physician Decision|3|||
42210976|NCT03655717|76025800|FG001|Overall Study|Physician Decision|3|||
42210977|NCT03655717|76025801|FG002|Overall Study|Physician Decision|0|||
42210978|NCT03655717|76025802|FG003|Overall Study|Physician Decision|0|||
42210979|NCT03655717|76025803|FG004|Overall Study|Physician Decision|0|||
42210980|NCT03655717|76025804|FG005|Overall Study|Physician Decision|0|||
42210981|NCT03655717|76025805|FG006|Overall Study|Physician Decision|0|||
42210982|NCT03655717|76025806|FG007|Overall Study|Physician Decision|0|||
42210983|NCT03655717|76025807|FG008|Overall Study|Physician Decision|0|||
42210984|NCT03655717|76025808|FG009|Overall Study|Physician Decision|1|||
42210985|NCT03655717|76025809|FG010|Overall Study|Physician Decision|0|||
42210986|NCT03655717|76025810|FG011|Overall Study|Physician Decision|0|||
42210987|NCT03655717|76025811|FG012|Overall Study|Physician Decision|0|||
42210988|NCT03655717|76025812|FG013|Overall Study|Physician Decision|0|||
42210989|NCT03655717|76025813|FG014|Overall Study|Physician Decision|0|||
42210990|NCT03655717|76025814|FG015|Overall Study|Physician Decision|0|||
42210991|NCT03655717|76025815|FG016|Overall Study|Physician Decision|0|||
42210992|NCT03655717|76025816|FG017|Overall Study|Physician Decision|0|||
42210993|NCT03655717|76025817|FG018|Overall Study|Physician Decision|0|||
42210994|NCT03655717|76025818|FG019|Overall Study|Physician Decision|1|||
42210995|NCT03655717|76025819|FG020|Overall Study|Physician Decision|0|||
42210996|NCT03655717|76025820|FG021|Overall Study|Physician Decision|0|||
42210997|NCT03655717|76025821|FG022|Overall Study|Physician Decision|0|||
41973975|NCT03951077|75775467|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
42210998|NCT03655717|76025822|FG023|Overall Study|Physician Decision|1|||
42210999|NCT03655717|76025823|FG024|Overall Study|Physician Decision|0|||
42211000|NCT03655717|76025824|FG025|Overall Study|Physician Decision|0|||
42211001|NCT03655717|76025799|FG000|Overall Study|Lost to Follow-up|3|||
42211002|NCT03655717|76025800|FG001|Overall Study|Lost to Follow-up|1|||
42211003|NCT03655717|76025801|FG002|Overall Study|Lost to Follow-up|0|||
42211004|NCT03655717|76025802|FG003|Overall Study|Lost to Follow-up|1|||
41973976|NCT03951077|75775468|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
41973977|NCT03951077|75775469|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
42211005|NCT03655717|76025803|FG004|Overall Study|Lost to Follow-up|0|||
42211006|NCT03655717|76025804|FG005|Overall Study|Lost to Follow-up|1|||
42211007|NCT03655717|76025805|FG006|Overall Study|Lost to Follow-up|0|||
42211008|NCT03655717|76025806|FG007|Overall Study|Lost to Follow-up|0|||
42211009|NCT03655717|76025807|FG008|Overall Study|Lost to Follow-up|0|||
42211010|NCT03655717|76025808|FG009|Overall Study|Lost to Follow-up|0|||
42211011|NCT03655717|76025809|FG010|Overall Study|Lost to Follow-up|0|||
42211012|NCT03655717|76025810|FG011|Overall Study|Lost to Follow-up|1|||
42211013|NCT03655717|76025811|FG012|Overall Study|Lost to Follow-up|0|||
42211014|NCT03655717|76025812|FG013|Overall Study|Lost to Follow-up|0|||
42211015|NCT03655717|76025813|FG014|Overall Study|Lost to Follow-up|0|||
42211016|NCT03655717|76025814|FG015|Overall Study|Lost to Follow-up|0|||
41973978|NCT03951077|75775470|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
41973979|NCT03951077|75775471|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
42211017|NCT03655717|76025815|FG016|Overall Study|Lost to Follow-up|0|||
41973980|NCT03873246|75775488|FG000|Overall Study|Adverse Event|1|||
41973981|NCT03873246|75775489|FG001|Overall Study|Adverse Event|3|||
41973982|NCT03873246|75775490|FG002|Overall Study|Adverse Event|3|||
41973983|NCT03873246|75775488|FG000|Overall Study|Lost to Follow-up|4|||
41973984|NCT03873246|75775489|FG001|Overall Study|Lost to Follow-up|4|||
41973985|NCT03873246|75775490|FG002|Overall Study|Lost to Follow-up|5|||
41973986|NCT03873246|75775488|FG000|Overall Study|Protocol Violation|0|||
41973987|NCT03873246|75775489|FG001|Overall Study|Protocol Violation|1|||
41973988|NCT03873246|75775490|FG002|Overall Study|Protocol Violation|0|||
41973989|NCT03873246|75775488|FG000|Overall Study|Withdrawal by Subject|0|||
41973990|NCT03873246|75775489|FG001|Overall Study|Withdrawal by Subject|4|||
41973991|NCT03873246|75775490|FG002|Overall Study|Withdrawal by Subject|1|||
41973992|NCT03769649|75775499|FG000|Overall Study|Lost to Follow-up|4|||
41973993|NCT02862548|75775525|FG000|Randomized Phase (Up to Week 48)|Death|0|||
41973994|NCT02862548|75775526|FG001|Randomized Phase (Up to Week 48)|Death|1|||
41973995|NCT02862548|75775525|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
41973996|NCT02862548|75775526|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
41973997|NCT02862548|75775525|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
41973998|NCT02862548|75775526|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
41973999|NCT02862548|75775525|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
41974000|NCT02862548|75775526|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
41974001|NCT02335099|75775545|FG000|Treatment|Withdrawal by Subject|1|||
41974002|NCT02335099|75775546|FG001|Treatment|Withdrawal by Subject|3|||
41974003|NCT02335099|75775545|FG000|Treatment|Lost to Follow-up|2|||
41974004|NCT02335099|75775546|FG001|Treatment|Lost to Follow-up|0|||
41974005|NCT02335099|75775545|FG000|Treatment|Death|1|||
41974006|NCT02335099|75775546|FG001|Treatment|Death|0|||
41974007|NCT02335099|75775545|FG000|Treatment|Adverse Event|1|||
41974008|NCT02335099|75775546|FG001|Treatment|Adverse Event|2|||
41974009|NCT02335099|75775545|FG000|Follow-up|Death|0|||
41974010|NCT02335099|75775546|FG001|Follow-up|Death|1|||
41974011|NCT02330562|75775563|FG000|Overall Study|Adverse Event|0|||
41974012|NCT02330562|75775564|FG001|Overall Study|Adverse Event|0|||
41974013|NCT02330562|75775565|FG002|Overall Study|Adverse Event|3|||
41974014|NCT02330562|75775566|FG003|Overall Study|Adverse Event|0|||
41974015|NCT02330562|75775567|FG004|Overall Study|Adverse Event|3|||
41974016|NCT02330562|75775568|FG005|Overall Study|Adverse Event|1|||
41974017|NCT02330562|75775569|FG006|Overall Study|Adverse Event|0|||
41974018|NCT02330562|75775570|FG007|Overall Study|Adverse Event|0|||
41974019|NCT02330562|75775571|FG008|Overall Study|Adverse Event|0|||
41974020|NCT02330562|75775572|FG009|Overall Study|Adverse Event|1|||
42127516|NCT02658890|75937855|FG025|Treatment Phase|Other Reasons|0|||
42211018|NCT03655717|76025816|FG017|Overall Study|Lost to Follow-up|0|||
42127517|NCT02658890|75937856|FG026|Treatment Phase|Other Reasons|1|||
42127518|NCT02658890|75937830|FG000|Treatment Phase|Progressive Disease|6|||
42127519|NCT02658890|75937831|FG001|Treatment Phase|Progressive Disease|7|||
42127520|NCT02658890|75937832|FG002|Treatment Phase|Progressive Disease|6|||
42127521|NCT02658890|75937833|FG003|Treatment Phase|Progressive Disease|12|||
42127522|NCT02658890|75937834|FG004|Treatment Phase|Progressive Disease|6|||
42127523|NCT02658890|75937835|FG005|Treatment Phase|Progressive Disease|18|||
42211019|NCT03655717|76025817|FG018|Overall Study|Lost to Follow-up|0|||
42211020|NCT03655717|76025818|FG019|Overall Study|Lost to Follow-up|0|||
42211021|NCT03655717|76025819|FG020|Overall Study|Lost to Follow-up|0|||
42211022|NCT03655717|76025820|FG021|Overall Study|Lost to Follow-up|0|||
42211023|NCT03655717|76025821|FG022|Overall Study|Lost to Follow-up|0|||
42211024|NCT03655717|76025822|FG023|Overall Study|Lost to Follow-up|0|||
41974021|NCT02330562|75775573|FG010|Overall Study|Adverse Event|1|||
41974022|NCT02330562|75775563|FG000|Overall Study|Participant decision|1|||
41974023|NCT02330562|75775564|FG001|Overall Study|Participant decision|0|||
41974024|NCT02330562|75775565|FG002|Overall Study|Participant decision|4|||
42127524|NCT02658890|75937836|FG006|Treatment Phase|Progressive Disease|12|||
41974025|NCT02330562|75775566|FG003|Overall Study|Participant decision|1|||
41974026|NCT02330562|75775567|FG004|Overall Study|Participant decision|5|||
41974027|NCT02330562|75775568|FG005|Overall Study|Participant decision|2|||
41974028|NCT02330562|75775569|FG006|Overall Study|Participant decision|0|||
42127525|NCT02658890|75937837|FG007|Treatment Phase|Progressive Disease|19|||
42127526|NCT02658890|75937838|FG008|Treatment Phase|Progressive Disease|26|||
42211025|NCT03655717|76025823|FG024|Overall Study|Lost to Follow-up|0|||
42211026|NCT03655717|76025824|FG025|Overall Study|Lost to Follow-up|0|||
41974029|NCT02330562|75775570|FG007|Overall Study|Participant decision|0|||
41974030|NCT02330562|75775571|FG008|Overall Study|Participant decision|0|||
41974031|NCT02330562|75775572|FG009|Overall Study|Participant decision|3|||
41974032|NCT02330562|75775573|FG010|Overall Study|Participant decision|0|||
41974033|NCT02330562|75775563|FG000|Overall Study|Disease progression|5|||
41974034|NCT02330562|75775564|FG001|Overall Study|Disease progression|3|||
41974035|NCT02330562|75775565|FG002|Overall Study|Disease progression|20|||
42211027|NCT04032613|76025840|FG000|Overall Study|Did not complete post-program assessment|5|||
42211028|NCT04032613|76025841|FG001|Overall Study|Did not complete post-program assessment|2|||
42211029|NCT04000165|76025847|FG000|Overall Study|Physician Decision|1|||
42211030|NCT04000165|76025847|FG000|Overall Study|Withdrawal by Subject|1|||
42211031|NCT03187197|76025854|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
42211032|NCT03187197|76025855|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
42211033|NCT03187197|76025856|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
42211034|NCT03187197|76025854|FG000|Overall Study|Withdrawal by Subject|8|||
42211035|NCT03187197|76025855|FG001|Overall Study|Withdrawal by Subject|63|||
42211036|NCT03187197|76025856|FG002|Overall Study|Withdrawal by Subject|4|||
42211037|NCT03187197|76025854|FG000|Overall Study|Lost to Follow-up|1|||
42211038|NCT03187197|76025855|FG001|Overall Study|Lost to Follow-up|60|||
42211039|NCT03187197|76025856|FG002|Overall Study|Lost to Follow-up|7|||
42211040|NCT03187197|76025854|FG000|Overall Study|Adverse Event|6|||
42211041|NCT03187197|76025855|FG001|Overall Study|Adverse Event|29|||
42211042|NCT03187197|76025856|FG002|Overall Study|Adverse Event|0|||
42211043|NCT03187197|76025854|FG000|Overall Study|Death|0|||
41974036|NCT02330562|75775566|FG003|Overall Study|Disease progression|28|||
41974037|NCT02330562|75775567|FG004|Overall Study|Disease progression|23|||
41974038|NCT02330562|75775568|FG005|Overall Study|Disease progression|7|||
41974039|NCT02330562|75775569|FG006|Overall Study|Disease progression|1|||
42211044|NCT03187197|76025855|FG001|Overall Study|Death|11|||
42211045|NCT03187197|76025856|FG002|Overall Study|Death|0|||
42211046|NCT03187197|76025854|FG000|Overall Study|Administrative problem|1|||
42211047|NCT03187197|76025855|FG001|Overall Study|Administrative problem|1|||
42211048|NCT03187197|76025856|FG002|Overall Study|Administrative problem|0|||
42211049|NCT03187197|76025854|FG000|Overall Study|Reason not listed|2|||
42211050|NCT03187197|76025855|FG001|Overall Study|Reason not listed|54|||
42211051|NCT03187197|76025856|FG002|Overall Study|Reason not listed|1|||
42211052|NCT03187197|76025854|FG000|Overall Study|Missing|1|||
42211053|NCT03187197|76025855|FG001|Overall Study|Missing|32|||
42211054|NCT03187197|76025856|FG002|Overall Study|Missing|3|||
42211055|NCT03187197|76025854|FG000|Overall Study|Status missing|2|||
42211056|NCT03187197|76025855|FG001|Overall Study|Status missing|33|||
42211057|NCT03187197|76025856|FG002|Overall Study|Status missing|3|||
42211058|NCT03187197|76025854|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
41974040|NCT02330562|75775570|FG007|Overall Study|Disease progression|1|||
41974041|NCT02330562|75775571|FG008|Overall Study|Disease progression|1|||
41974042|NCT02330562|75775572|FG009|Overall Study|Disease progression|0|||
41974043|NCT02330562|75775573|FG010|Overall Study|Disease progression|5|||
41974044|NCT02330562|75775563|FG000|Overall Study|Other reasons|0|||
41974045|NCT02330562|75775564|FG001|Overall Study|Other reasons|0|||
41974046|NCT02330562|75775565|FG002|Overall Study|Other reasons|0|||
41974047|NCT02330562|75775566|FG003|Overall Study|Other reasons|1|||
41974048|NCT02330562|75775567|FG004|Overall Study|Other reasons|0|||
41974049|NCT02330562|75775568|FG005|Overall Study|Other reasons|0|||
41974050|NCT02330562|75775569|FG006|Overall Study|Other reasons|0|||
41974051|NCT02330562|75775570|FG007|Overall Study|Other reasons|0|||
41974052|NCT02330562|75775571|FG008|Overall Study|Other reasons|0|||
41974053|NCT02330562|75775572|FG009|Overall Study|Other reasons|0|||
41974054|NCT02330562|75775573|FG010|Overall Study|Other reasons|0|||
41974055|NCT02330562|75775563|FG000|Overall Study|Withdrawal by Subject|0|||
41974056|NCT02330562|75775564|FG001|Overall Study|Withdrawal by Subject|0|||
41974057|NCT02330562|75775565|FG002|Overall Study|Withdrawal by Subject|0|||
41974058|NCT02330562|75775566|FG003|Overall Study|Withdrawal by Subject|0|||
41974059|NCT02330562|75775567|FG004|Overall Study|Withdrawal by Subject|0|||
41974060|NCT02330562|75775568|FG005|Overall Study|Withdrawal by Subject|0|||
41974061|NCT02330562|75775569|FG006|Overall Study|Withdrawal by Subject|0|||
42127527|NCT02658890|75937839|FG009|Treatment Phase|Progressive Disease|8|||
42127528|NCT02658890|75937840|FG010|Treatment Phase|Progressive Disease|7|||
42127529|NCT02658890|75937841|FG011|Treatment Phase|Progressive Disease|9|||
42127530|NCT02658890|75937842|FG012|Treatment Phase|Progressive Disease|8|||
42127531|NCT02658890|75937843|FG013|Treatment Phase|Progressive Disease|29|||
42127532|NCT02658890|75937844|FG014|Treatment Phase|Progressive Disease|6|||
42127533|NCT02658890|75937845|FG015|Treatment Phase|Progressive Disease|2|||
42211059|NCT03187197|76025855|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
42211060|NCT03187197|76025856|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
42211061|NCT04000009|76025864|FG000|Overall Study|Adverse Event|13|||
42211062|NCT04000009|76025864|FG000|Overall Study|Lack of Efficacy|7|||
42211063|NCT04000009|76025864|FG000|Overall Study|Lost to Follow-up|8|||
42211064|NCT04000009|76025864|FG000|Overall Study|Noncompliance with study drug|4|||
42211065|NCT04000009|76025864|FG000|Overall Study|Physician Decision|1|||
42211066|NCT04000009|76025864|FG000|Overall Study|Use of prohibited medication|3|||
42211067|NCT04000009|76025864|FG000|Overall Study|Pregnancy|1|||
42211068|NCT04000009|76025864|FG000|Overall Study|Withdrawal by Subject|22|||
42211069|NCT04000009|76025864|FG000|Overall Study|Study terminated by sponsor|98|||
42211070|NCT04000009|76025864|FG000|Overall Study|Not further specified|8|||
42211071|NCT03282240|76025871|FG000|Overall Study|Adverse Event|2|||
42211072|NCT03282240|76025872|FG001|Overall Study|Adverse Event|2|||
42211073|NCT03282240|76025873|FG002|Overall Study|Adverse Event|0|||
42211074|NCT03282240|76025871|FG000|Overall Study|Lost to Follow-up|3|||
42211075|NCT03282240|76025872|FG001|Overall Study|Lost to Follow-up|0|||
42211076|NCT03282240|76025873|FG002|Overall Study|Lost to Follow-up|0|||
42211077|NCT03282240|76025871|FG000|Overall Study|Protocol Deviation|4|||
42211078|NCT03282240|76025872|FG001|Overall Study|Protocol Deviation|1|||
42211079|NCT03282240|76025873|FG002|Overall Study|Protocol Deviation|2|||
42211080|NCT03282240|76025871|FG000|Overall Study|Withdrawal by Subject|1|||
42211081|NCT03282240|76025872|FG001|Overall Study|Withdrawal by Subject|0|||
42211082|NCT03282240|76025873|FG002|Overall Study|Withdrawal by Subject|1|||
42211083|NCT03185949|76025886|FG000|ITT Analysis|Withdrawal by Subject|4|||
42127534|NCT02658890|75937846|FG016|Treatment Phase|Progressive Disease|32|||
42127535|NCT02658890|75937847|FG017|Treatment Phase|Progressive Disease|14|||
42127536|NCT02658890|75937848|FG018|Treatment Phase|Progressive Disease|40|||
42127537|NCT02658890|75937849|FG019|Treatment Phase|Progressive Disease|32|||
42127538|NCT02658890|75937850|FG020|Treatment Phase|Progressive Disease|19|||
42211084|NCT03185949|76025887|FG001|ITT Analysis|Withdrawal by Subject|3|||
42211085|NCT03185949|76025886|FG000|PP Analysis|Protocol Violation|2|||
42211086|NCT03185949|76025887|FG001|PP Analysis|Protocol Violation|2|||
42211087|NCT03185949|76025886|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
41974062|NCT02330562|75775570|FG007|Overall Study|Withdrawal by Subject|0|||
41974063|NCT02330562|75775571|FG008|Overall Study|Withdrawal by Subject|0|||
41974064|NCT02330562|75775572|FG009|Overall Study|Withdrawal by Subject|1|||
41974065|NCT02330562|75775573|FG010|Overall Study|Withdrawal by Subject|0|||
42211088|NCT03185949|76025887|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
41974066|NCT03703102|75775687|FG000|Overall Study|Adverse Event|4|||
41974067|NCT03703102|75775688|FG001|Overall Study|Adverse Event|3|||
41974068|NCT03703102|75775689|FG002|Overall Study|Adverse Event|7|||
42127539|NCT02658890|75937851|FG021|Treatment Phase|Progressive Disease|30|||
42127540|NCT02658890|75937852|FG022|Treatment Phase|Progressive Disease|15|||
41974069|NCT03703102|75775690|FG003|Overall Study|Adverse Event|3|||
42127541|NCT02658890|75937853|FG023|Treatment Phase|Progressive Disease|0|||
42127542|NCT02658890|75937854|FG024|Treatment Phase|Progressive Disease|0|||
42127543|NCT02658890|75937855|FG025|Treatment Phase|Progressive Disease|14|||
41974070|NCT03703102|75775691|FG004|Overall Study|Adverse Event|13|||
41974071|NCT03703102|75775687|FG000|Overall Study|Lack of Efficacy|4|||
41974072|NCT03703102|75775688|FG001|Overall Study|Lack of Efficacy|0|||
41974073|NCT03703102|75775689|FG002|Overall Study|Lack of Efficacy|1|||
41974074|NCT03703102|75775690|FG003|Overall Study|Lack of Efficacy|4|||
41974075|NCT03703102|75775691|FG004|Overall Study|Lack of Efficacy|1|||
41974076|NCT03703102|75775687|FG000|Overall Study|Lost to Follow-up|0|||
41974077|NCT03703102|75775688|FG001|Overall Study|Lost to Follow-up|0|||
41974078|NCT03703102|75775689|FG002|Overall Study|Lost to Follow-up|1|||
41974079|NCT03703102|75775690|FG003|Overall Study|Lost to Follow-up|2|||
41974080|NCT03703102|75775691|FG004|Overall Study|Lost to Follow-up|2|||
41974081|NCT03703102|75775687|FG000|Overall Study|Physician Decision|2|||
41974082|NCT03703102|75775688|FG001|Overall Study|Physician Decision|2|||
41974083|NCT03703102|75775689|FG002|Overall Study|Physician Decision|2|||
41974084|NCT03703102|75775690|FG003|Overall Study|Physician Decision|2|||
41974085|NCT03703102|75775691|FG004|Overall Study|Physician Decision|4|||
41974086|NCT03703102|75775687|FG000|Overall Study|Withdrawal by Subject|7|||
41974087|NCT03703102|75775688|FG001|Overall Study|Withdrawal by Subject|5|||
41974088|NCT03703102|75775689|FG002|Overall Study|Withdrawal by Subject|5|||
41974089|NCT03703102|75775690|FG003|Overall Study|Withdrawal by Subject|5|||
41974090|NCT03703102|75775691|FG004|Overall Study|Withdrawal by Subject|9|||
41974091|NCT03703102|75775687|FG000|Overall Study|Ineligibility|0|||
41974092|NCT03703102|75775688|FG001|Overall Study|Ineligibility|0|||
41974093|NCT03703102|75775689|FG002|Overall Study|Ineligibility|1|||
41974094|NCT03703102|75775690|FG003|Overall Study|Ineligibility|0|||
41974095|NCT03703102|75775691|FG004|Overall Study|Ineligibility|0|||
41974096|NCT03703102|75775687|FG000|Overall Study|Protocol Deviation|4|||
41974097|NCT03703102|75775688|FG001|Overall Study|Protocol Deviation|4|||
41974098|NCT03703102|75775689|FG002|Overall Study|Protocol Deviation|3|||
41974099|NCT03703102|75775690|FG003|Overall Study|Protocol Deviation|0|||
41974100|NCT03703102|75775691|FG004|Overall Study|Protocol Deviation|0|||
41974101|NCT03703102|75775687|FG000|Overall Study|Non-Compliance with Study Drug|1|||
41974102|NCT03703102|75775688|FG001|Overall Study|Non-Compliance with Study Drug|1|||
41974103|NCT03703102|75775689|FG002|Overall Study|Non-Compliance with Study Drug|2|||
41974104|NCT03703102|75775690|FG003|Overall Study|Non-Compliance with Study Drug|1|||
41974105|NCT03703102|75775691|FG004|Overall Study|Non-Compliance with Study Drug|4|||
41974106|NCT03395704|75775710|FG000|Overall Study|Adverse Event|2|||
41974107|NCT03395704|75775711|FG001|Overall Study|Adverse Event|1|||
41974108|NCT03395704|75775710|FG000|Overall Study|Withdrawal by Subject|2|||
41974109|NCT03395704|75775711|FG001|Overall Study|Withdrawal by Subject|1|||
41974110|NCT03395704|75775710|FG000|Overall Study|Physician Decision|0|||
41974111|NCT03395704|75775711|FG001|Overall Study|Physician Decision|1|||
41974112|NCT03335813|75775717|FG000|Overall Study|Withdrawal by Subject|1|||
41974113|NCT03246503|75775721|FG000|Overall Study|Lost to Follow-up|23|||
41974114|NCT03246503|75775721|FG000|Overall Study|Withdrawal by Subject|20|||
41974115|NCT03246503|75775721|FG000|Overall Study|Physician Decision|5|||
41974116|NCT03246503|75775721|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
41974117|NCT02514447|75775782|FG000|Overall Study|Withdrawal by Subject|3|||
41974118|NCT02514447|75775783|FG001|Overall Study|Withdrawal by Subject|1|||
41974119|NCT02514447|75775784|FG002|Overall Study|Withdrawal by Subject|1|||
41974120|NCT02514447|75775785|FG003|Overall Study|Withdrawal by Subject|0|||
41974121|NCT02514447|75775786|FG004|Overall Study|Withdrawal by Subject|0|||
41974122|NCT02514447|75775787|FG005|Overall Study|Withdrawal by Subject|0|||
41974123|NCT02514447|75775788|FG006|Overall Study|Withdrawal by Subject|0|||
41974124|NCT02514447|75775789|FG007|Overall Study|Withdrawal by Subject|1|||
42127544|NCT02658890|75937856|FG026|Treatment Phase|Progressive Disease|11|||
42127545|NCT02658890|75937830|FG000|Treatment Phase|Study Drug Toxicity|0|||
42127546|NCT02658890|75937831|FG001|Treatment Phase|Study Drug Toxicity|0|||
42127547|NCT02658890|75937832|FG002|Treatment Phase|Study Drug Toxicity|2|||
42127548|NCT02658890|75937833|FG003|Treatment Phase|Study Drug Toxicity|0|||
42127549|NCT02658890|75937834|FG004|Treatment Phase|Study Drug Toxicity|0|||
42211089|NCT03655405|76025897|FG000|Overall Study|Death after initial data collection|4|||
42211090|NCT03655405|76025898|FG001|Overall Study|Death after initial data collection|2|||
41974125|NCT02514447|75775790|FG008|Overall Study|Withdrawal by Subject|1|||
41974126|NCT02514447|75775782|FG000|Overall Study|Death|24|||
41974127|NCT02514447|75775783|FG001|Overall Study|Death|28|||
41974128|NCT02514447|75775784|FG002|Overall Study|Death|29|||
41974129|NCT02514447|75775785|FG003|Overall Study|Death|0|||
41974130|NCT02514447|75775786|FG004|Overall Study|Death|3|||
41974131|NCT02514447|75775787|FG005|Overall Study|Death|4|||
41974132|NCT02514447|75775788|FG006|Overall Study|Death|8|||
41974133|NCT02514447|75775789|FG007|Overall Study|Death|6|||
41974134|NCT02514447|75775790|FG008|Overall Study|Death|5|||
41974135|NCT02514447|75775782|FG000|Overall Study|Lost to Follow-up|1|||
41974136|NCT02514447|75775783|FG001|Overall Study|Lost to Follow-up|0|||
42127550|NCT02658890|75937835|FG005|Treatment Phase|Study Drug Toxicity|0|||
42127551|NCT02658890|75937836|FG006|Treatment Phase|Study Drug Toxicity|0|||
41974137|NCT02514447|75775784|FG002|Overall Study|Lost to Follow-up|0|||
41974138|NCT02514447|75775785|FG003|Overall Study|Lost to Follow-up|0|||
41974139|NCT02514447|75775786|FG004|Overall Study|Lost to Follow-up|0|||
41974140|NCT02514447|75775787|FG005|Overall Study|Lost to Follow-up|0|||
41974141|NCT02514447|75775788|FG006|Overall Study|Lost to Follow-up|0|||
41974142|NCT02514447|75775789|FG007|Overall Study|Lost to Follow-up|0|||
41974143|NCT02514447|75775790|FG008|Overall Study|Lost to Follow-up|1|||
42127552|NCT02658890|75937837|FG007|Treatment Phase|Study Drug Toxicity|0|||
42127553|NCT02658890|75937838|FG008|Treatment Phase|Study Drug Toxicity|3|||
42211091|NCT03655405|76025897|FG000|Overall Study|Died before initial data collection|1|||
42211092|NCT03655405|76025898|FG001|Overall Study|Died before initial data collection|2|||
42211093|NCT03655405|76025897|FG000|Overall Study|Protocol Violation|0|||
42211094|NCT03655405|76025898|FG001|Overall Study|Protocol Violation|1|||
42211095|NCT03510598|76025904|FG000|Overall Study|Withdrawal by Subject|1|||
42211096|NCT03222141|76025908|FG000|Overall Study|Death|15|||
42211097|NCT03222141|76025908|FG000|Overall Study|Lost to Follow-up|3|||
42211098|NCT04029961|76025915|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
42211099|NCT04029961|76025916|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
42211100|NCT04029961|76025915|FG000|Overall Study|Change in Treatment Course|0|||
42211101|NCT04029961|76025916|FG001|Overall Study|Change in Treatment Course|1|||
42211102|NCT03997825|76025922|FG000|Overall Study|Death|3|||
42211103|NCT03997825|76025922|FG000|Overall Study|Lost to Follow-up|10|||
42211104|NCT03997825|76025922|FG000|Overall Study|Withdrawal by Subject|3|||
42211105|NCT03997825|76025922|FG000|Overall Study|Refused participation|1|||
42211106|NCT04024891|76025928|FG000|Overall Study|Pregnancy|0|||
42211107|NCT04024891|76025929|FG001|Overall Study|Pregnancy|1|||
42211108|NCT03250182|76025935|FG000|Overall Study|Withdrawal by Subject|1|||
42211109|NCT03993379|76025943|FG000|Overall Study|The study was terminated early due to business decision.|0|||
42211110|NCT03993379|76025944|FG001|Overall Study|The study was terminated early due to business decision.|2|||
42211111|NCT03993379|76025945|FG002|Overall Study|The study was terminated early due to business decision.|0|||
42211112|NCT03993379|76025946|FG003|Overall Study|The study was terminated early due to business decision.|0|||
42211113|NCT03993379|76025943|FG000|Overall Study|Withdrawal by Subject|0|||
42211114|NCT03993379|76025944|FG001|Overall Study|Withdrawal by Subject|1|||
42211115|NCT03993379|76025945|FG002|Overall Study|Withdrawal by Subject|0|||
42211116|NCT03993379|76025946|FG003|Overall Study|Withdrawal by Subject|0|||
42211117|NCT03370120|76025956|FG000|Overall Study|Adverse event, non-fatal|24|||
42211118|NCT03370120|76025956|FG000|Overall Study|Withdrawal by Subject|6|||
42211119|NCT03370120|76025956|FG000|Overall Study|Lost to Follow-up|1|||
42211120|NCT03370120|76025956|FG000|Overall Study|Lack of Efficacy|37|||
42211121|NCT03370120|76025956|FG000|Overall Study|Per sponsor's instructions|1|||
42211122|NCT03370120|76025956|FG000|Overall Study|Study was terminated by parent company UCB|2|||
42211123|NCT03370120|76025956|FG000|Overall Study|The study was ended by the promoter|3|||
42211124|NCT03370120|76025956|FG000|Overall Study|Discontinuation of drug development|3|||
42211125|NCT03370120|76025956|FG000|Overall Study|End of project|2|||
42211126|NCT03370120|76025956|FG000|Overall Study|Premature study closure|2|||
42211127|NCT03370120|76025956|FG000|Overall Study|Premature program termination|1|||
42211128|NCT03370120|76025956|FG000|Overall Study|Premature study termination|7|||
42211129|NCT03370120|76025956|FG000|Overall Study|Trial terminated by sponsor|2|||
42211130|NCT03370120|76025956|FG000|Overall Study|Trial discontinued by sponsor|2|||
42211131|NCT03370120|76025956|FG000|Overall Study|Study ended|15|||
42211132|NCT03370120|76025956|FG000|Overall Study|Clinical trial has been cancelled|1|||
42211133|NCT03370120|76025956|FG000|Overall Study|End of study per sponsor decision|2|||
42211134|NCT03370120|76025956|FG000|Overall Study|Promoter's decision|2|||
42127554|NCT02658890|75937839|FG009|Treatment Phase|Study Drug Toxicity|0|||
42127555|NCT02658890|75937840|FG010|Treatment Phase|Study Drug Toxicity|1|||
42127556|NCT02658890|75937841|FG011|Treatment Phase|Study Drug Toxicity|1|||
42127557|NCT02658890|75937842|FG012|Treatment Phase|Study Drug Toxicity|2|||
42127558|NCT02658890|75937843|FG013|Treatment Phase|Study Drug Toxicity|9|||
42127559|NCT02658890|75937844|FG014|Treatment Phase|Study Drug Toxicity|0|||
42127560|NCT02658890|75937845|FG015|Treatment Phase|Study Drug Toxicity|1|||
42127561|NCT02658890|75937846|FG016|Treatment Phase|Study Drug Toxicity|1|||
42127562|NCT02658890|75937847|FG017|Treatment Phase|Study Drug Toxicity|0|||
42211135|NCT03370120|76025956|FG000|Overall Study|The trial has been suspended|3|||
42211136|NCT03370120|76025956|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
42211137|NCT03370120|76025956|FG000|Overall Study|Early termination by order of sponsor|2|||
42211138|NCT03370120|76025956|FG000|Overall Study|Discontinuation of the study|5|||
42211139|NCT03370120|76025956|FG000|Overall Study|End of clinical trial discontinuation|1|||
42211140|NCT03370120|76025956|FG000|Overall Study|Because the clinical trial ended halfway|4|||
42211141|NCT03370120|76025956|FG000|Overall Study|Development discontinued|5|||
41974144|NCT02514447|75775782|FG000|Overall Study|Sponsor Termination of Study|0|||
41974145|NCT02514447|75775783|FG001|Overall Study|Sponsor Termination of Study|1|||
42127563|NCT02658890|75937848|FG018|Treatment Phase|Study Drug Toxicity|8|||
42127564|NCT02658890|75937849|FG019|Treatment Phase|Study Drug Toxicity|3|||
42211142|NCT03370120|76025956|FG000|Overall Study|Padsenovil program closed|3|||
42211143|NCT03370120|76025956|FG000|Overall Study|End of project|2|||
42211144|NCT03370120|76025956|FG000|Overall Study|Termination of project|1|||
42211145|NCT03370120|76025956|FG000|Overall Study|The study was interrupted by sponsor|4|||
42211146|NCT03370120|76025956|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
42211147|NCT03370120|76025956|FG000|Overall Study|End of sponsor decision|1|||
42211148|NCT03370120|76025956|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
42211149|NCT03370120|76025956|FG000|Overall Study|Early termination of studies|5|||
42211150|NCT03370120|76025956|FG000|Overall Study|This study is ended early|1|||
42211151|NCT03370120|76025956|FG000|Overall Study|End of padsevonil program|2|||
42211152|NCT03370120|76025956|FG000|Overall Study|Decision of sponsor|6|||
42211153|NCT03370120|76025956|FG000|Overall Study|Asked by the sponsor|3|||
42211154|NCT03370120|76025956|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
42211155|NCT03370120|76025956|FG000|Overall Study|PI decision poor compliance from participant|1|||
41974146|NCT02514447|75775784|FG002|Overall Study|Sponsor Termination of Study|1|||
41974147|NCT02514447|75775785|FG003|Overall Study|Sponsor Termination of Study|0|||
41974148|NCT02514447|75775786|FG004|Overall Study|Sponsor Termination of Study|0|||
41974149|NCT02514447|75775787|FG005|Overall Study|Sponsor Termination of Study|0|||
41974150|NCT02514447|75775788|FG006|Overall Study|Sponsor Termination of Study|0|||
41974151|NCT02514447|75775789|FG007|Overall Study|Sponsor Termination of Study|0|||
41974152|NCT02514447|75775790|FG008|Overall Study|Sponsor Termination of Study|0|||
41974153|NCT02514447|75775782|FG000|Overall Study|Study completion per Investigator|1|||
41974154|NCT02514447|75775783|FG001|Overall Study|Study completion per Investigator|0|||
41974155|NCT02514447|75775784|FG002|Overall Study|Study completion per Investigator|1|||
41974156|NCT02514447|75775785|FG003|Overall Study|Study completion per Investigator|2|||
41974157|NCT02514447|75775786|FG004|Overall Study|Study completion per Investigator|0|||
41974158|NCT02514447|75775787|FG005|Overall Study|Study completion per Investigator|0|||
41974159|NCT02514447|75775788|FG006|Overall Study|Study completion per Investigator|0|||
41974160|NCT02514447|75775789|FG007|Overall Study|Study completion per Investigator|0|||
41974161|NCT02514447|75775790|FG008|Overall Study|Study completion per Investigator|1|||
41974162|NCT01785563|75775834|FG000|Overall Study|Physician Decision|10|||
41974163|NCT01785563|75775834|FG000|Overall Study|Withdrawal by Subject|1|||
41974164|NCT01785563|75775834|FG000|Overall Study|Protocol Violation|2|||
41974165|NCT01434290|75775840|FG000|Overall Study|Protocol Violation|6|||
41974166|NCT01434290|75775841|FG001|Overall Study|Protocol Violation|3|||
41974167|NCT01434290|75775840|FG000|Overall Study|No protocol treatment|2|||
41974168|NCT01434290|75775841|FG001|Overall Study|No protocol treatment|4|||
41974169|NCT00750269|75775853|FG000|Overall Study|Protocol Violation|0|||
41974170|NCT00750269|75775854|FG001|Overall Study|Protocol Violation|1|||
41974171|NCT00750269|75775855|FG002|Overall Study|Protocol Violation|1|||
41974172|NCT00750269|75775856|FG003|Overall Study|Protocol Violation|2|||
41974173|NCT00750269|75775857|FG004|Overall Study|Protocol Violation|4|||
41974174|NCT00750269|75775853|FG000|Overall Study|Withdrawal by Subject|0|||
41974175|NCT00750269|75775854|FG001|Overall Study|Withdrawal by Subject|0|||
42127565|NCT02658890|75937850|FG020|Treatment Phase|Study Drug Toxicity|2|||
42127566|NCT02658890|75937851|FG021|Treatment Phase|Study Drug Toxicity|0|||
42127567|NCT02658890|75937852|FG022|Treatment Phase|Study Drug Toxicity|8|||
42127568|NCT02658890|75937853|FG023|Treatment Phase|Study Drug Toxicity|0|||
42127569|NCT02658890|75937854|FG024|Treatment Phase|Study Drug Toxicity|0|||
42127570|NCT02658890|75937855|FG025|Treatment Phase|Study Drug Toxicity|2|||
42127571|NCT02658890|75937856|FG026|Treatment Phase|Study Drug Toxicity|0|||
42127572|NCT02658890|75937830|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127573|NCT02658890|75937831|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127574|NCT02658890|75937832|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127575|NCT02658890|75937833|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
42127576|NCT02658890|75937834|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127577|NCT02658890|75937835|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127578|NCT02658890|75937836|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127579|NCT02658890|75937837|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127580|NCT02658890|75937838|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
41974176|NCT00750269|75775855|FG002|Overall Study|Withdrawal by Subject|2|||
41974177|NCT00750269|75775856|FG003|Overall Study|Withdrawal by Subject|2|||
41974178|NCT00750269|75775857|FG004|Overall Study|Withdrawal by Subject|2|||
42127581|NCT02658890|75937839|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
42211156|NCT03370120|76025956|FG000|Overall Study|Promoter ended the study|3|||
42211157|NCT03370120|76025956|FG000|Overall Study|Premature study close by sponsor's decision|4|||
42211158|NCT03370120|76025956|FG000|Overall Study|Study terminated by sponsor|33|||
42211159|NCT03370120|76025956|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
41974179|NCT00750269|75775853|FG000|Overall Study|Physician Decision|0|||
41974180|NCT00750269|75775854|FG001|Overall Study|Physician Decision|0|||
41974181|NCT00750269|75775855|FG002|Overall Study|Physician Decision|0|||
41974182|NCT00750269|75775856|FG003|Overall Study|Physician Decision|0|||
41974183|NCT00750269|75775857|FG004|Overall Study|Physician Decision|2|||
41974184|NCT00750269|75775853|FG000|Overall Study|Patient too large for positioning|0|||
41974185|NCT00750269|75775854|FG001|Overall Study|Patient too large for positioning|0|||
41974186|NCT00750269|75775855|FG002|Overall Study|Patient too large for positioning|1|||
41974187|NCT00750269|75775856|FG003|Overall Study|Patient too large for positioning|0|||
41974188|NCT00750269|75775857|FG004|Overall Study|Patient too large for positioning|0|||
41974189|NCT00750269|75775853|FG000|Overall Study|Site error|0|||
41974190|NCT00750269|75775854|FG001|Overall Study|Site error|0|||
41974191|NCT00750269|75775855|FG002|Overall Study|Site error|0|||
41974192|NCT00750269|75775856|FG003|Overall Study|Site error|1|||
41974193|NCT00750269|75775857|FG004|Overall Study|Site error|0|||
41974194|NCT00750269|75775853|FG000|Overall Study|SBRT plan could not be drawn|0|||
41974195|NCT00750269|75775854|FG001|Overall Study|SBRT plan could not be drawn|0|||
41974196|NCT00750269|75775855|FG002|Overall Study|SBRT plan could not be drawn|0|||
41974197|NCT00750269|75775856|FG003|Overall Study|SBRT plan could not be drawn|0|||
41974198|NCT00750269|75775857|FG004|Overall Study|SBRT plan could not be drawn|1|||
41974199|NCT00750269|75775853|FG000|Overall Study|Fiducials could not be placed|0|||
41974200|NCT00750269|75775854|FG001|Overall Study|Fiducials could not be placed|0|||
41974201|NCT00750269|75775855|FG002|Overall Study|Fiducials could not be placed|0|||
41974202|NCT00750269|75775856|FG003|Overall Study|Fiducials could not be placed|0|||
41974203|NCT00750269|75775857|FG004|Overall Study|Fiducials could not be placed|1|||
41974204|NCT00712322|75775879|FG000|Overall Study|Protocol deviation|0|||
41974205|NCT00712322|75775880|FG001|Overall Study|Protocol deviation|1|||
41974206|NCT00712322|75775881|FG002|Overall Study|Protocol deviation|0|||
41974207|NCT00323856|75775889|FG000|Overall Study|Withdrawal by Subject|1|||
41974208|NCT00323856|75775889|FG000|Overall Study|Was uncooperative and noncompliant|1|||
41974209|NCT00323856|75775889|FG000|Overall Study|Reason not specified|1|||
41974210|NCT00323856|75775889|FG000|Overall Study|Missing|2|||
41974211|NCT04594941|75775904|FG000|Overall Study|Other|0|||
41974212|NCT04594941|75775905|FG001|Overall Study|Other|3|||
41974213|NCT04594941|75775906|FG002|Overall Study|Other|1|||
41974214|NCT04594941|75775907|FG003|Overall Study|Other|0|||
41974215|NCT04524663|75775925|FG000|Overall Study|Withdrawal by Subject|0|||
41974216|NCT04524663|75775926|FG001|Overall Study|Withdrawal by Subject|2|||
41974217|NCT03738423|75775955|FG000|Overall Study|Withdrawal by Subject|9|||
41974218|NCT03738423|75775956|FG001|Overall Study|Withdrawal by Subject|12|||
41974219|NCT03738423|75775957|FG002|Overall Study|Withdrawal by Subject|9|||
41974220|NCT03738423|75775958|FG003|Overall Study|Withdrawal by Subject|12|||
41974221|NCT03738423|75775959|FG004|Overall Study|Withdrawal by Subject|10|||
41974222|NCT03738423|75775955|FG000|Overall Study|Lack of Efficacy|3|||
41974223|NCT03738423|75775956|FG001|Overall Study|Lack of Efficacy|1|||
41974224|NCT03738423|75775957|FG002|Overall Study|Lack of Efficacy|1|||
41974225|NCT03738423|75775958|FG003|Overall Study|Lack of Efficacy|1|||
41974226|NCT03738423|75775959|FG004|Overall Study|Lack of Efficacy|2|||
41974227|NCT03738423|75775955|FG000|Overall Study|Lost to Follow-up|1|||
41974228|NCT03738423|75775956|FG001|Overall Study|Lost to Follow-up|0|||
41974229|NCT03738423|75775957|FG002|Overall Study|Lost to Follow-up|1|||
41974230|NCT03738423|75775958|FG003|Overall Study|Lost to Follow-up|1|||
41974231|NCT03738423|75775959|FG004|Overall Study|Lost to Follow-up|0|||
41974232|NCT03738423|75775955|FG000|Overall Study|Protocol Violation|1|||
41974233|NCT03738423|75775956|FG001|Overall Study|Protocol Violation|0|||
41974234|NCT03738423|75775957|FG002|Overall Study|Protocol Violation|0|||
41974235|NCT03738423|75775958|FG003|Overall Study|Protocol Violation|0|||
41974236|NCT03738423|75775959|FG004|Overall Study|Protocol Violation|1|||
41974237|NCT03738423|75775955|FG000|Overall Study|Physician Decision|0|||
41974238|NCT03738423|75775956|FG001|Overall Study|Physician Decision|0|||
41974239|NCT03738423|75775957|FG002|Overall Study|Physician Decision|1|||
41974240|NCT03738423|75775958|FG003|Overall Study|Physician Decision|0|||
41974241|NCT03738423|75775959|FG004|Overall Study|Physician Decision|1|||
41974242|NCT03738423|75775955|FG000|Overall Study|Death|0|||
41974243|NCT03738423|75775956|FG001|Overall Study|Death|0|||
41974244|NCT03738423|75775957|FG002|Overall Study|Death|0|||
41974245|NCT03738423|75775958|FG003|Overall Study|Death|0|||
41974246|NCT03738423|75775959|FG004|Overall Study|Death|1|||
41974247|NCT03738423|75775955|FG000|Overall Study|Randomized but never treated|0|||
42211160|NCT03370120|76025956|FG000|Overall Study|Sponsor decision to terminate study|63|||
41974248|NCT03738423|75775956|FG001|Overall Study|Randomized but never treated|0|||
42211161|NCT03370120|76025956|FG000|Overall Study|Program closure|3|||
41974249|NCT03738423|75775957|FG002|Overall Study|Randomized but never treated|1|||
41974250|NCT03738423|75775958|FG003|Overall Study|Randomized but never treated|1|||
41974251|NCT03738423|75775959|FG004|Overall Study|Randomized but never treated|0|||
41974252|NCT03712228|75775977|FG000|Treatment Period 1|Lack of Efficacy|0|||
41974253|NCT03712228|75775978|FG001|Treatment Period 1|Lack of Efficacy|0|||
41974254|NCT03712228|75775979|FG002|Treatment Period 1|Lack of Efficacy|0|||
41974255|NCT03712228|75775980|FG003|Treatment Period 1|Lack of Efficacy|0|||
42211162|NCT03370120|76025956|FG000|Overall Study|Study ended prematurely|1|||
41974256|NCT03712228|75775981|FG004|Treatment Period 1|Lack of Efficacy|0|||
42211163|NCT03370120|76025956|FG000|Overall Study|Study stopped by sponsor|2|||
41974257|NCT03712228|75775982|FG005|Treatment Period 1|Lack of Efficacy|1|||
41974258|NCT03712228|75775977|FG000|Treatment Period 2|Pregnancy|0|||
41974259|NCT03712228|75775978|FG001|Treatment Period 2|Pregnancy|0|||
41974260|NCT03712228|75775979|FG002|Treatment Period 2|Pregnancy|0|||
41974261|NCT03712228|75775980|FG003|Treatment Period 2|Pregnancy|1|||
41974262|NCT03712228|75775981|FG004|Treatment Period 2|Pregnancy|0|||
41974263|NCT03712228|75775982|FG005|Treatment Period 2|Pregnancy|0|||
41974264|NCT03712228|75775977|FG000|Treatment Period 2|Withdrawal by Subject|0|||
41974265|NCT03712228|75775978|FG001|Treatment Period 2|Withdrawal by Subject|0|||
41974266|NCT03712228|75775979|FG002|Treatment Period 2|Withdrawal by Subject|0|||
41974267|NCT03712228|75775980|FG003|Treatment Period 2|Withdrawal by Subject|1|||
41974268|NCT03712228|75775981|FG004|Treatment Period 2|Withdrawal by Subject|0|||
41974269|NCT03712228|75775982|FG005|Treatment Period 2|Withdrawal by Subject|0|||
41974270|NCT03600818|75776001|FG000|Overall Study|Adverse Event|4|||
41974271|NCT03600818|75776002|FG001|Overall Study|Adverse Event|7|||
41974272|NCT03600818|75776001|FG000|Overall Study|Lack of Efficacy|9|||
41974273|NCT03600818|75776002|FG001|Overall Study|Lack of Efficacy|4|||
41974274|NCT03600818|75776001|FG000|Overall Study|Withdrawal by Subject|4|||
41974275|NCT03600818|75776002|FG001|Overall Study|Withdrawal by Subject|3|||
41974276|NCT03600818|75776001|FG000|Overall Study|Other-unspecified|5|||
41974277|NCT03600818|75776002|FG001|Overall Study|Other-unspecified|3|||
41974278|NCT03600818|75776001|FG000|Overall Study|Randomized and not treated|0|||
41974279|NCT03600818|75776002|FG001|Overall Study|Randomized and not treated|1|||
41974280|NCT03578276|75776011|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
41974281|NCT03578276|75776012|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
41974282|NCT02034110|75776077|FG000|Overall Study|Physician Decision|0|||
41974283|NCT02034110|75776078|FG001|Overall Study|Physician Decision|0|||
41974284|NCT02034110|75776079|FG002|Overall Study|Physician Decision|0|||
41974285|NCT02034110|75776080|FG003|Overall Study|Physician Decision|0|||
41974286|NCT02034110|75776081|FG004|Overall Study|Physician Decision|2|||
41974287|NCT02034110|75776082|FG005|Overall Study|Physician Decision|0|||
41974288|NCT02034110|75776083|FG006|Overall Study|Physician Decision|1|||
41974289|NCT02034110|75776084|FG007|Overall Study|Physician Decision|0|||
41974290|NCT02034110|75776077|FG000|Overall Study|Lost to Follow-up|1|||
41974291|NCT02034110|75776078|FG001|Overall Study|Lost to Follow-up|0|||
41974292|NCT02034110|75776079|FG002|Overall Study|Lost to Follow-up|0|||
41974293|NCT02034110|75776080|FG003|Overall Study|Lost to Follow-up|0|||
41974294|NCT02034110|75776081|FG004|Overall Study|Lost to Follow-up|1|||
41974295|NCT02034110|75776082|FG005|Overall Study|Lost to Follow-up|0|||
41974296|NCT02034110|75776083|FG006|Overall Study|Lost to Follow-up|1|||
41974297|NCT02034110|75776084|FG007|Overall Study|Lost to Follow-up|0|||
41974298|NCT02034110|75776077|FG000|Overall Study|Withdrawal by Subject|5|||
41974299|NCT02034110|75776078|FG001|Overall Study|Withdrawal by Subject|7|||
41974300|NCT02034110|75776079|FG002|Overall Study|Withdrawal by Subject|0|||
41974301|NCT02034110|75776080|FG003|Overall Study|Withdrawal by Subject|3|||
41974302|NCT02034110|75776081|FG004|Overall Study|Withdrawal by Subject|7|||
41974303|NCT02034110|75776082|FG005|Overall Study|Withdrawal by Subject|0|||
41974304|NCT02034110|75776083|FG006|Overall Study|Withdrawal by Subject|3|||
42211164|NCT03370120|76025956|FG000|Overall Study|Program termination|55|||
42211165|NCT03370120|76025956|FG000|Overall Study|Sponsor decision|62|||
42211166|NCT03370120|76025956|FG000|Overall Study|Sponsor study closure|10|||
42211167|NCT03247686|76025964|FG000|Overall Study|Withdrawal by Subject|1|||
42211168|NCT03247686|76025965|FG001|Overall Study|Withdrawal by Subject|2|||
41974305|NCT02034110|75776084|FG007|Overall Study|Withdrawal by Subject|1|||
41974306|NCT02034110|75776077|FG000|Overall Study|Study closed by sponsor|6|||
42211169|NCT03990649|76025976|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
42211170|NCT03990649|76025977|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
42211171|NCT03990649|76025978|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
41974307|NCT02034110|75776078|FG001|Overall Study|Study closed by sponsor|2|||
41974308|NCT02034110|75776079|FG002|Overall Study|Study closed by sponsor|0|||
41974309|NCT02034110|75776080|FG003|Overall Study|Study closed by sponsor|6|||
41974310|NCT02034110|75776081|FG004|Overall Study|Study closed by sponsor|7|||
41974311|NCT02034110|75776082|FG005|Overall Study|Study closed by sponsor|0|||
41974312|NCT02034110|75776083|FG006|Overall Study|Study closed by sponsor|42|||
41974313|NCT02034110|75776084|FG007|Overall Study|Study closed by sponsor|0|||
41974314|NCT01627574|75776132|FG000|Overall Study|Withdrawal by Subject|8|||
41974315|NCT01627574|75776133|FG001|Overall Study|Withdrawal by Subject|5|||
41974316|NCT01627574|75776132|FG000|Overall Study|Lost to Follow-up|13|||
42211172|NCT03990649|76025976|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
42272602|NCT01657292|76102840|FG000|Overall Study|Change of therapy|1|||
41974317|NCT01627574|75776133|FG001|Overall Study|Lost to Follow-up|13|||
41974318|NCT01498458|75776139|FG000|Overall Study|Adverse Event|4|||
41974319|NCT01498458|75776139|FG000|Overall Study|Physician Decision|3|||
41974320|NCT01427712|75776148|FG000|Overall Study|Transfer to a different hospital|2|||
41974321|NCT01427712|75776148|FG000|Overall Study|Lost to Follow-up|1|||
42272603|NCT00905567|76102856|FG000|Washout|Withdrawal by Subject|0|||
42272604|NCT00905567|76102857|FG001|Washout|Withdrawal by Subject|1|||
42211173|NCT03990649|76025977|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
42211174|NCT03990649|76025978|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
41974322|NCT01427712|75776148|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
41974323|NCT01427712|75776148|FG000|Overall Study|Failure to visit|1|||
41974324|NCT01369147|75776155|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
41974325|NCT01369147|75776156|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
41974326|NCT01369147|75776157|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
41974327|NCT04846231|75776173|FG000|Overall Study|Lost to Follow-up|1|||
41974328|NCT04846231|75776174|FG001|Overall Study|Lost to Follow-up|0|||
41974329|NCT04846231|75776175|FG002|Overall Study|Lost to Follow-up|0|||
41974330|NCT04846231|75776176|FG003|Overall Study|Lost to Follow-up|0|||
41974331|NCT04846231|75776177|FG004|Overall Study|Lost to Follow-up|0|||
41974332|NCT04846231|75776178|FG005|Overall Study|Lost to Follow-up|0|||
41974333|NCT04846231|75776179|FG006|Overall Study|Lost to Follow-up|0|||
41974334|NCT04846231|75776180|FG007|Overall Study|Lost to Follow-up|1|||
41974335|NCT04846231|75776173|FG000|Overall Study|Withdrawal by Subject|0|||
41974336|NCT04846231|75776174|FG001|Overall Study|Withdrawal by Subject|1|||
41974337|NCT04846231|75776175|FG002|Overall Study|Withdrawal by Subject|2|||
41974338|NCT04846231|75776176|FG003|Overall Study|Withdrawal by Subject|1|||
41974339|NCT04846231|75776177|FG004|Overall Study|Withdrawal by Subject|0|||
41974340|NCT04846231|75776178|FG005|Overall Study|Withdrawal by Subject|0|||
41974341|NCT04846231|75776179|FG006|Overall Study|Withdrawal by Subject|0|||
41974342|NCT04846231|75776180|FG007|Overall Study|Withdrawal by Subject|0|||
41974343|NCT04846231|75776173|FG000|Overall Study|Protocol Violation|0|||
41974344|NCT04846231|75776174|FG001|Overall Study|Protocol Violation|1|||
41974345|NCT04846231|75776175|FG002|Overall Study|Protocol Violation|0|||
41974346|NCT04846231|75776176|FG003|Overall Study|Protocol Violation|0|||
41974347|NCT04846231|75776177|FG004|Overall Study|Protocol Violation|0|||
41974348|NCT04846231|75776178|FG005|Overall Study|Protocol Violation|0|||
42127582|NCT02658890|75937840|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127583|NCT02658890|75937841|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42211175|NCT03990649|76025976|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
42211176|NCT03990649|76025977|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
41974349|NCT04846231|75776179|FG006|Overall Study|Protocol Violation|0|||
42127584|NCT02658890|75937842|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127585|NCT02658890|75937843|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127586|NCT02658890|75937844|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127587|NCT02658890|75937845|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127588|NCT02658890|75937846|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127589|NCT02658890|75937847|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127590|NCT02658890|75937848|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
42127591|NCT02658890|75937849|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127592|NCT02658890|75937850|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127593|NCT02658890|75937851|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127594|NCT02658890|75937852|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
42127595|NCT02658890|75937853|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127596|NCT02658890|75937854|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127597|NCT02658890|75937855|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127598|NCT02658890|75937856|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
42127599|NCT02658890|75937830|FG000|Treatment Phase|Withdrawal by Subject|0|||
42127600|NCT02658890|75937831|FG001|Treatment Phase|Withdrawal by Subject|1|||
42127601|NCT02658890|75937832|FG002|Treatment Phase|Withdrawal by Subject|0|||
42127602|NCT02658890|75937833|FG003|Treatment Phase|Withdrawal by Subject|0|||
42127603|NCT02658890|75937834|FG004|Treatment Phase|Withdrawal by Subject|0|||
42127604|NCT02658890|75937835|FG005|Treatment Phase|Withdrawal by Subject|0|||
42127605|NCT02658890|75937836|FG006|Treatment Phase|Withdrawal by Subject|1|||
42127606|NCT02658890|75937837|FG007|Treatment Phase|Withdrawal by Subject|0|||
42127607|NCT02658890|75937838|FG008|Treatment Phase|Withdrawal by Subject|0|||
42127608|NCT02658890|75937839|FG009|Treatment Phase|Withdrawal by Subject|1|||
42127609|NCT02658890|75937840|FG010|Treatment Phase|Withdrawal by Subject|0|||
42127610|NCT02658890|75937841|FG011|Treatment Phase|Withdrawal by Subject|0|||
42127611|NCT02658890|75937842|FG012|Treatment Phase|Withdrawal by Subject|1|||
42127612|NCT02658890|75937843|FG013|Treatment Phase|Withdrawal by Subject|3|||
41974350|NCT04846231|75776180|FG007|Overall Study|Protocol Violation|0|||
41974351|NCT04846231|75776173|FG000|Overall Study|Adverse Event|0|||
41974352|NCT04846231|75776174|FG001|Overall Study|Adverse Event|0|||
41974353|NCT04846231|75776175|FG002|Overall Study|Adverse Event|0|||
42127613|NCT02658890|75937844|FG014|Treatment Phase|Withdrawal by Subject|0|||
41974354|NCT04846231|75776176|FG003|Overall Study|Adverse Event|0|||
41974355|NCT04846231|75776177|FG004|Overall Study|Adverse Event|0|||
41974356|NCT04846231|75776178|FG005|Overall Study|Adverse Event|0|||
42211177|NCT03990649|76025978|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
41974357|NCT04846231|75776179|FG006|Overall Study|Adverse Event|1|||
41974358|NCT04846231|75776180|FG007|Overall Study|Adverse Event|1|||
42211178|NCT03990649|76025976|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
42211179|NCT03990649|76025977|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
42211180|NCT03990649|76025978|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
42211181|NCT03990649|76025976|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
42211182|NCT03990649|76025977|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
42211183|NCT03990649|76025978|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
42211184|NCT03990649|76025976|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
42211185|NCT03990649|76025977|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
42211186|NCT03990649|76025978|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
42211187|NCT03990649|76025976|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
42211188|NCT03990649|76025977|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
42211189|NCT03990649|76025978|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
42211190|NCT03185481|76025985|FG000|Overall Study|Adverse Event|1|||
42211191|NCT03185481|76025985|FG000|Overall Study|Study Terminated by Sponsor|4|||
42211192|NCT03652675|76025991|FG000|Overall Study|Lost to Follow-up|4|||
42211193|NCT03652675|76025992|FG001|Overall Study|Lost to Follow-up|4|||
42211194|NCT03241368|76025998|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
42211195|NCT03241368|76025998|FG000|Overall Study|Lost to Follow-up|1|||
42211196|NCT03241368|76025998|FG000|Overall Study|Physician Decision|6|||
42211197|NCT03241368|76025998|FG000|Overall Study|Withdrawal by Subject|6|||
41974359|NCT04533594|75776206|FG000|Overall Study|Death|26|||
41974360|NCT04447846|75776210|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
41974361|NCT04405245|75776217|FG000|Overall Study|Adverse Event|0|||
41974362|NCT04405245|75776218|FG001|Overall Study|Adverse Event|1|||
41974363|NCT04405245|75776219|FG002|Overall Study|Adverse Event|0|||
41974364|NCT04277507|75776227|FG000|Overall Study|Lost to Follow-up|17|||
41974365|NCT04277507|75776227|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
41974366|NCT04277507|75776227|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
42127614|NCT02658890|75937845|FG015|Treatment Phase|Withdrawal by Subject|0|||
42127615|NCT02658890|75937846|FG016|Treatment Phase|Withdrawal by Subject|1|||
42127616|NCT02658890|75937847|FG017|Treatment Phase|Withdrawal by Subject|0|||
42127617|NCT02658890|75937848|FG018|Treatment Phase|Withdrawal by Subject|4|||
42127618|NCT02658890|75937849|FG019|Treatment Phase|Withdrawal by Subject|3|||
42127619|NCT02658890|75937850|FG020|Treatment Phase|Withdrawal by Subject|0|||
42127620|NCT02658890|75937851|FG021|Treatment Phase|Withdrawal by Subject|4|||
42127621|NCT02658890|75937852|FG022|Treatment Phase|Withdrawal by Subject|1|||
42127622|NCT02658890|75937853|FG023|Treatment Phase|Withdrawal by Subject|1|||
42127623|NCT02658890|75937854|FG024|Treatment Phase|Withdrawal by Subject|0|||
42127624|NCT02658890|75937855|FG025|Treatment Phase|Withdrawal by Subject|0|||
42127625|NCT02658890|75937856|FG026|Treatment Phase|Withdrawal by Subject|0|||
42127626|NCT02597062|75937948|FG000|Overall Study|Ineligible|1|||
42127627|NCT05159362|75937998|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
42127628|NCT05159362|75937999|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
42127629|NCT05159362|75938000|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
42127630|NCT04975191|75938015|FG000|Overall Study|Protocol Violation|1|||
42127631|NCT04975191|75938016|FG001|Overall Study|Protocol Violation|2|||
42127632|NCT04975191|75938017|FG002|Overall Study|Protocol Violation|2|||
42127633|NCT04975191|75938018|FG003|Overall Study|Protocol Violation|2|||
42127634|NCT04975191|75938015|FG000|Overall Study|Lost to Follow-up|13|||
42127635|NCT04975191|75938016|FG001|Overall Study|Lost to Follow-up|3|||
42127636|NCT04975191|75938017|FG002|Overall Study|Lost to Follow-up|8|||
42127637|NCT04975191|75938018|FG003|Overall Study|Lost to Follow-up|8|||
42127638|NCT04492020|75938044|FG000|Overall Study|Adverse Event|1|||
42127639|NCT04492020|75938045|FG001|Overall Study|Adverse Event|3|||
42127640|NCT04492020|75938044|FG000|Overall Study|Withdrawal by Subject|4|||
42127641|NCT04492020|75938045|FG001|Overall Study|Withdrawal by Subject|3|||
42127642|NCT04492020|75938044|FG000|Overall Study|Lost to Follow-up|4|||
42211198|NCT03241368|76025998|FG000|Overall Study|Protocol Violation|1|||
42211199|NCT03220581|76026005|FG000|Overall Study|Withdrawal by Subject|0|||
42211200|NCT03220581|76026006|FG001|Overall Study|Withdrawal by Subject|1|||
41974367|NCT04277507|75776227|FG000|Overall Study|Withdrawal by Subject|3|||
41974368|NCT04277507|75776227|FG000|Overall Study|Death due to COVID-19|1|||
41974369|NCT04277507|75776227|FG000|Overall Study|Data missing for full evaluation|5|||
41974370|NCT04198805|75776248|FG000|Overall Study|Death|0|||
42127643|NCT04492020|75938045|FG001|Overall Study|Lost to Follow-up|3|||
42127644|NCT04492020|75938044|FG000|Overall Study|Protocol Violation|5|||
42127645|NCT04492020|75938045|FG001|Overall Study|Protocol Violation|2|||
42127646|NCT04492020|75938044|FG000|Overall Study|Lack of Qualifying Event|25|||
42127647|NCT04492020|75938045|FG001|Overall Study|Lack of Qualifying Event|27|||
42127648|NCT04492020|75938044|FG000|Overall Study|Non-compliance with Study Drug|2|||
41974371|NCT04198805|75776249|FG001|Overall Study|Death|0|||
41974372|NCT04198805|75776250|FG002|Overall Study|Death|0|||
41974373|NCT04198805|75776251|FG003|Overall Study|Death|1|||
41974374|NCT04198805|75776248|FG000|Overall Study|Early Termination|8|||
41974375|NCT04198805|75776249|FG001|Overall Study|Early Termination|4|||
41974376|NCT04198805|75776250|FG002|Overall Study|Early Termination|6|||
41974377|NCT04198805|75776251|FG003|Overall Study|Early Termination|9|||
41974378|NCT04179890|75776267|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
41974379|NCT04179890|75776268|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
41974380|NCT04179890|75776267|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
41974381|NCT04179890|75776268|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
41974382|NCT04179890|75776267|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
41974383|NCT04179890|75776268|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
41974384|NCT04179890|75776267|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
41974385|NCT04179890|75776268|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
41974386|NCT04179890|75776267|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
41974387|NCT04179890|75776268|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
41974388|NCT04179890|75776267|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
41974389|NCT04179890|75776268|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
41974390|NCT04179890|75776267|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
41974391|NCT04179890|75776268|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
41974392|NCT04179890|75776267|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
41974393|NCT04179890|75776268|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
41974394|NCT04179890|75776267|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
41974395|NCT04179890|75776268|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
41974396|NCT03721016|75776309|FG000|Overall Study|Adverse Event|0|||
41974397|NCT03721016|75776310|FG001|Overall Study|Adverse Event|1|||
41974398|NCT03721016|75776311|FG002|Overall Study|Adverse Event|1|||
41974399|NCT03721016|75776309|FG000|Overall Study|Withdrawal by Subject|8|||
41974400|NCT03721016|75776310|FG001|Overall Study|Withdrawal by Subject|16|||
41974401|NCT03721016|75776311|FG002|Overall Study|Withdrawal by Subject|13|||
41974402|NCT03721016|75776309|FG000|Overall Study|Lost to Follow-up|4|||
41974403|NCT03721016|75776310|FG001|Overall Study|Lost to Follow-up|6|||
41974404|NCT03721016|75776311|FG002|Overall Study|Lost to Follow-up|5|||
41974405|NCT03721016|75776309|FG000|Overall Study|Physician Decision|0|||
41974406|NCT03721016|75776310|FG001|Overall Study|Physician Decision|1|||
41974407|NCT03721016|75776311|FG002|Overall Study|Physician Decision|2|||
41974408|NCT03721016|75776309|FG000|Overall Study|Protocol Violation|0|||
41974409|NCT03721016|75776310|FG001|Overall Study|Protocol Violation|1|||
41974410|NCT03721016|75776311|FG002|Overall Study|Protocol Violation|0|||
41974411|NCT03721016|75776309|FG000|Overall Study|Site terminated by sponsor|3|||
41974412|NCT03721016|75776310|FG001|Overall Study|Site terminated by sponsor|7|||
41974413|NCT03721016|75776311|FG002|Overall Study|Site terminated by sponsor|6|||
41974414|NCT03721016|75776309|FG000|Overall Study|Subject exited early due to COVID-19|1|||
41974415|NCT03721016|75776310|FG001|Overall Study|Subject exited early due to COVID-19|0|||
41974416|NCT03721016|75776311|FG002|Overall Study|Subject exited early due to COVID-19|0|||
41974417|NCT03117998|75776347|FG000|Overall Study|Adverse Event|1|||
41974418|NCT03117998|75776348|FG001|Overall Study|Adverse Event|0|||
41974419|NCT03117998|75776349|FG002|Overall Study|Adverse Event|0|||
41974420|NCT03117998|75776350|FG003|Overall Study|Adverse Event|0|||
41974421|NCT03117998|75776351|FG004|Overall Study|Adverse Event|0|||
41974422|NCT03117998|75776352|FG005|Overall Study|Adverse Event|0|||
41974423|NCT03117998|75776347|FG000|Overall Study|Withdrawal by Subject|0|||
41974424|NCT03117998|75776348|FG001|Overall Study|Withdrawal by Subject|0|||
41974425|NCT03117998|75776349|FG002|Overall Study|Withdrawal by Subject|2|||
41974426|NCT03117998|75776350|FG003|Overall Study|Withdrawal by Subject|3|||
42127649|NCT04492020|75938045|FG001|Overall Study|Non-compliance with Study Drug|1|||
42127650|NCT04382911|75938051|FG000|Overall Study|unable to be imaged prior to surgery|2|||
42127651|NCT04072575|75938059|FG000|Overall Study|Physician Decision|1|||
42127652|NCT04072575|75938059|FG000|Overall Study|Adverse Event|7|||
42127653|NCT04072575|75938059|FG000|Overall Study|Withdrawal by Subject|14|||
42127654|NCT04072575|75938059|FG000|Overall Study|Other|2|||
42127655|NCT03911869|75938065|FG000|Safety Lead-in Phase|Death|7|||
42127656|NCT03911869|75938066|FG001|Safety Lead-in Phase|Death|0|||
42127657|NCT03911869|75938067|FG002|Safety Lead-in Phase|Death|0|||
42127658|NCT03911869|75938065|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
42127659|NCT03911869|75938066|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
42127660|NCT03911869|75938067|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
41974427|NCT03117998|75776351|FG004|Overall Study|Withdrawal by Subject|3|||
42211201|NCT03220581|76026005|FG000|Overall Study|Lost to Follow-up|3|||
42211202|NCT03220581|76026006|FG001|Overall Study|Lost to Follow-up|6|||
42211203|NCT02954575|76026014|FG000|Overall Study|Withdrawal by Subject|2|||
42211204|NCT02954575|76026014|FG000|Overall Study|Adverse Event|1|||
42211205|NCT03184701|76026022|FG000|Overall Study|Death|3|||
42211206|NCT03184701|76026022|FG000|Overall Study|Physician Decision|3|||
42211207|NCT03184701|76026022|FG000|Overall Study|Withdrawal by Subject|6|||
42211208|NCT03184701|76026022|FG000|Overall Study|Lost to Follow-up|5|||
42211209|NCT03247530|76026029|FG000|Overall Study|Withdrawal by caregiver|19|||
42211210|NCT03247530|76026030|FG001|Overall Study|Withdrawal by caregiver|8|||
42211211|NCT03247530|76026031|FG002|Overall Study|Withdrawal by caregiver|10|||
42211212|NCT03247530|76026029|FG000|Overall Study|Lost to Follow-up|3|||
42211213|NCT03247530|76026030|FG001|Overall Study|Lost to Follow-up|9|||
42211214|NCT03247530|76026031|FG002|Overall Study|Lost to Follow-up|6|||
42211215|NCT03247530|76026029|FG000|Overall Study|Adverse Event|2|||
42211216|NCT03247530|76026030|FG001|Overall Study|Adverse Event|5|||
42211217|NCT03247530|76026031|FG002|Overall Study|Adverse Event|2|||
42211218|NCT03247530|76026029|FG000|Overall Study|Failure to follow procedure|1|||
42211219|NCT03247530|76026030|FG001|Overall Study|Failure to follow procedure|1|||
42211220|NCT03247530|76026031|FG002|Overall Study|Failure to follow procedure|1|||
42211221|NCT03247530|76026029|FG000|Overall Study|Withdrawal by Subject|1|||
42211222|NCT03247530|76026030|FG001|Overall Study|Withdrawal by Subject|1|||
42211223|NCT03247530|76026031|FG002|Overall Study|Withdrawal by Subject|0|||
42211224|NCT03247530|76026029|FG000|Overall Study|Study medication misuse|0|||
42211225|NCT03247530|76026030|FG001|Overall Study|Study medication misuse|1|||
42211226|NCT03247530|76026031|FG002|Overall Study|Study medication misuse|0|||
42211227|NCT03247530|76026029|FG000|Overall Study|Other, multiple categories|1|||
42211228|NCT03247530|76026030|FG001|Overall Study|Other, multiple categories|3|||
42211229|NCT03247530|76026031|FG002|Overall Study|Other, multiple categories|1|||
42211230|NCT03246672|76026042|FG000|Overall Study|Lost to Follow-up|2|||
42211231|NCT03983317|76026046|FG000|Overall Study|Physician Decision|5|||
42211232|NCT03207243|76026052|FG000|Overall Study|Adverse Event|2|||
42211233|NCT03207243|76026053|FG001|Overall Study|Adverse Event|2|||
42211234|NCT03207243|76026052|FG000|Overall Study|Loss of Asthma Control|47|||
42211235|NCT03207243|76026053|FG001|Overall Study|Loss of Asthma Control|31|||
42211236|NCT03207243|76026052|FG000|Overall Study|Withdrawal by Subject|2|||
42301715|NCT02505217|76136867|FG000|Overall Study|Withdrawal by Subject|1|||
42301716|NCT02505217|76136868|FG001|Overall Study|Withdrawal by Subject|2|||
42301717|NCT02504827|76136874|FG000|Overall Study|Could not produce sputum|1|||
42301718|NCT02504671|76136884|FG000|Overall Study|Withdrawal by Subject|1|||
42301719|NCT02504671|76136885|FG001|Overall Study|Withdrawal by Subject|5|||
42301720|NCT02504671|76136886|FG002|Overall Study|Withdrawal by Subject|4|||
42301721|NCT02504671|76136887|FG003|Overall Study|Withdrawal by Subject|4|||
42301722|NCT02504671|76136888|FG004|Overall Study|Withdrawal by Subject|5|||
42301723|NCT02504671|76136889|FG005|Overall Study|Withdrawal by Subject|3|||
42301724|NCT02504671|76136884|FG000|Overall Study|Lack of Efficacy|1|||
42301725|NCT02504671|76136885|FG001|Overall Study|Lack of Efficacy|3|||
41974428|NCT03117998|75776352|FG005|Overall Study|Withdrawal by Subject|0|||
41974429|NCT03117998|75776347|FG000|Overall Study|Physician Decision|0|||
41974430|NCT03117998|75776348|FG001|Overall Study|Physician Decision|1|||
41974431|NCT03117998|75776349|FG002|Overall Study|Physician Decision|1|||
41974432|NCT03117998|75776350|FG003|Overall Study|Physician Decision|0|||
42127661|NCT03911869|75938065|FG000|Safety Lead-in Phase|Other|1|||
42127662|NCT03911869|75938066|FG001|Safety Lead-in Phase|Other|0|||
42127663|NCT03911869|75938067|FG002|Safety Lead-in Phase|Other|0|||
42301726|NCT02504671|76136886|FG002|Overall Study|Lack of Efficacy|1|||
42301727|NCT02504671|76136887|FG003|Overall Study|Lack of Efficacy|0|||
42127664|NCT03911869|75938065|FG000|Phase 2|Death|0|||
42127665|NCT03911869|75938066|FG001|Phase 2|Death|3|||
42127666|NCT03911869|75938067|FG002|Phase 2|Death|0|||
42127667|NCT03897088|75938076|FG000|Overall Study|Withdrawal by Subject|12|||
42301728|NCT02504671|76136888|FG004|Overall Study|Lack of Efficacy|4|||
42301729|NCT02504671|76136889|FG005|Overall Study|Lack of Efficacy|4|||
42301730|NCT02504671|76136884|FG000|Overall Study|Adverse Event|1|||
42301731|NCT02504671|76136885|FG001|Overall Study|Adverse Event|1|||
41974433|NCT03117998|75776351|FG004|Overall Study|Physician Decision|0|||
41974434|NCT03117998|75776352|FG005|Overall Study|Physician Decision|0|||
42127668|NCT03897088|75938077|FG001|Overall Study|Withdrawal by Subject|12|||
42127669|NCT03897088|75938076|FG000|Overall Study|Lost to Follow-up|7|||
42211237|NCT03207243|76026053|FG001|Overall Study|Withdrawal by Subject|4|||
42211238|NCT03207243|76026052|FG000|Overall Study|Physician Decision|1|||
41974435|NCT03117998|75776347|FG000|Overall Study|Lost to Follow-up|0|||
41974436|NCT03117998|75776348|FG001|Overall Study|Lost to Follow-up|0|||
42127670|NCT03897088|75938077|FG001|Overall Study|Lost to Follow-up|15|||
42127671|NCT03897088|75938076|FG000|Overall Study|Sponsor Decision|1|||
42127672|NCT03897088|75938077|FG001|Overall Study|Sponsor Decision|2|||
42127673|NCT03897088|75938076|FG000|Overall Study|COVID-19|2|||
42301732|NCT02504671|76136886|FG002|Overall Study|Adverse Event|0|||
41974437|NCT03117998|75776349|FG002|Overall Study|Lost to Follow-up|0|||
41974438|NCT03117998|75776350|FG003|Overall Study|Lost to Follow-up|1|||
41974439|NCT03117998|75776351|FG004|Overall Study|Lost to Follow-up|4|||
41974440|NCT03117998|75776352|FG005|Overall Study|Lost to Follow-up|0|||
41974441|NCT03117998|75776347|FG000|Overall Study|Subject noncompliance|0|||
41974442|NCT03117998|75776348|FG001|Overall Study|Subject noncompliance|0|||
41974443|NCT03117998|75776349|FG002|Overall Study|Subject noncompliance|1|||
41974444|NCT03117998|75776350|FG003|Overall Study|Subject noncompliance|0|||
41974445|NCT03117998|75776351|FG004|Overall Study|Subject noncompliance|0|||
41974446|NCT03117998|75776352|FG005|Overall Study|Subject noncompliance|2|||
41974447|NCT03117998|75776347|FG000|Overall Study|Protocol Violation|0|||
41974448|NCT03117998|75776348|FG001|Overall Study|Protocol Violation|0|||
41974449|NCT03117998|75776349|FG002|Overall Study|Protocol Violation|0|||
41974450|NCT03117998|75776350|FG003|Overall Study|Protocol Violation|0|||
41974451|NCT03117998|75776351|FG004|Overall Study|Protocol Violation|0|||
41974452|NCT03117998|75776352|FG005|Overall Study|Protocol Violation|1|||
41974453|NCT03100370|75776377|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
41974454|NCT03100370|75776378|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
41974455|NCT03100370|75776379|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
41974456|NCT03100370|75776380|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
41974457|NCT03100370|75776381|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
41974458|NCT03100370|75776382|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
42301733|NCT02504671|76136887|FG003|Overall Study|Adverse Event|1|||
42301734|NCT02504671|76136888|FG004|Overall Study|Adverse Event|0|||
42301735|NCT02504671|76136889|FG005|Overall Study|Adverse Event|2|||
42301736|NCT02504671|76136884|FG000|Overall Study|Protocol Violation|2|||
42301737|NCT02504671|76136885|FG001|Overall Study|Protocol Violation|1|||
42301738|NCT02504671|76136886|FG002|Overall Study|Protocol Violation|0|||
42301739|NCT02504671|76136887|FG003|Overall Study|Protocol Violation|0|||
42301740|NCT02504671|76136888|FG004|Overall Study|Protocol Violation|0|||
42301741|NCT02504671|76136889|FG005|Overall Study|Protocol Violation|1|||
42301742|NCT02504671|76136884|FG000|Overall Study|Lost to Follow-up|0|||
42301743|NCT02504671|76136885|FG001|Overall Study|Lost to Follow-up|0|||
42301744|NCT02504671|76136886|FG002|Overall Study|Lost to Follow-up|2|||
42301745|NCT02504671|76136887|FG003|Overall Study|Lost to Follow-up|0|||
42211239|NCT03207243|76026053|FG001|Overall Study|Physician Decision|1|||
42211240|NCT03207243|76026052|FG000|Overall Study|Lost to Follow-up|0|||
42211241|NCT03207243|76026053|FG001|Overall Study|Lost to Follow-up|1|||
42211242|NCT03207243|76026052|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
42211243|NCT03207243|76026053|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
42211244|NCT03207243|76026052|FG000|Overall Study|Protocol Violation|0|||
42211245|NCT03207243|76026053|FG001|Overall Study|Protocol Violation|3|||
42211246|NCT03982069|76026064|FG000|Overall Study|Lost to Follow-up|5|||
42211247|NCT03982069|76026065|FG001|Overall Study|Lost to Follow-up|5|||
42211248|NCT03982069|76026066|FG002|Overall Study|Lost to Follow-up|3|||
42211249|NCT03982069|76026067|FG003|Overall Study|Lost to Follow-up|5|||
42211250|NCT03982069|76026064|FG000|Overall Study|Physician Decision|0|||
42211251|NCT03982069|76026065|FG001|Overall Study|Physician Decision|1|||
42211252|NCT03982069|76026066|FG002|Overall Study|Physician Decision|0|||
42301746|NCT02504671|76136888|FG004|Overall Study|Lost to Follow-up|0|||
42301747|NCT02504671|76136889|FG005|Overall Study|Lost to Follow-up|1|||
42301748|NCT02504671|76136884|FG000|Overall Study|Protocol defined stopping criteria|7|||
42301749|NCT02504671|76136885|FG001|Overall Study|Protocol defined stopping criteria|4|||
42301750|NCT02504671|76136886|FG002|Overall Study|Protocol defined stopping criteria|3|||
41974459|NCT02920008|75776392|FG000|Overall Study|Death|117|||
41974460|NCT02920008|75776393|FG001|Overall Study|Death|127|||
41974461|NCT02920008|75776392|FG000|Overall Study|Withdrawal by Subject|3|||
41974462|NCT02920008|75776393|FG001|Overall Study|Withdrawal by Subject|6|||
41974463|NCT02920008|75776392|FG000|Overall Study|Lost to Follow-up|0|||
41974464|NCT02920008|75776393|FG001|Overall Study|Lost to Follow-up|1|||
41974465|NCT02766335|75776401|FG000|Initial Registration|Adverse Event|6|||
41974466|NCT02766335|75776402|FG001|Initial Registration|Adverse Event|3|||
41974467|NCT02766335|75776403|FG002|Initial Registration|Adverse Event|0|||
41974468|NCT02766335|75776401|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
42127674|NCT03897088|75938077|FG001|Overall Study|COVID-19|0|||
42127675|NCT03897088|75938076|FG000|Overall Study|Other|3|||
42127676|NCT03897088|75938077|FG001|Overall Study|Other|0|||
42127677|NCT03897088|75938076|FG000|Overall Study|Non-compliance with Study Drug|1|||
42127678|NCT03897088|75938077|FG001|Overall Study|Non-compliance with Study Drug|1|||
42127679|NCT03897088|75938076|FG000|Overall Study|Pregnancy|0|||
42127680|NCT03897088|75938077|FG001|Overall Study|Pregnancy|1|||
42127681|NCT03700684|75938105|FG000|Overall Study|COVID-19|0|||
42127682|NCT03700684|75938106|FG001|Overall Study|COVID-19|0|||
42127683|NCT03700684|75938107|FG002|Overall Study|COVID-19|2|||
42127684|NCT03659136|75938117|FG000|Overall Study|Not treated|2|||
42127685|NCT03659136|75938118|FG001|Overall Study|Not treated|0|||
42127686|NCT03659136|75938117|FG000|Overall Study|Covid-19 related|1|||
42127687|NCT03659136|75938118|FG001|Overall Study|Covid-19 related|1|||
41974469|NCT02766335|75776402|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
41974470|NCT02766335|75776403|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
41974471|NCT02766335|75776401|FG000|Initial Registration|Progression/relapse|49|||
41974472|NCT02766335|75776402|FG001|Initial Registration|Progression/relapse|15|||
41974473|NCT02766335|75776403|FG002|Initial Registration|Progression/relapse|0|||
41974474|NCT02766335|75776401|FG000|Initial Registration|Death|1|||
41974475|NCT02766335|75776402|FG001|Initial Registration|Death|3|||
41974476|NCT02766335|75776403|FG002|Initial Registration|Death|0|||
41974477|NCT02766335|75776401|FG000|Initial Registration|not protocol specified|1|||
41974478|NCT02766335|75776402|FG001|Initial Registration|not protocol specified|9|||
41974479|NCT02766335|75776403|FG002|Initial Registration|not protocol specified|0|||
41974480|NCT02766335|75776401|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
41974481|NCT02766335|75776402|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
41974482|NCT02766335|75776403|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
41974483|NCT02766335|75776401|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
41974484|NCT02766335|75776402|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
41974485|NCT02766335|75776403|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
41974486|NCT02577523|75776411|FG000|Overall Study|Adverse Event|1|||
41974487|NCT02577523|75776412|FG001|Overall Study|Adverse Event|1|||
41974488|NCT02577523|75776411|FG000|Overall Study|Lack of Efficacy|1|||
42211253|NCT03982069|76026067|FG003|Overall Study|Physician Decision|0|||
42211254|NCT03982069|76026064|FG000|Overall Study|Withdrawal by Subject|2|||
42211255|NCT03982069|76026065|FG001|Overall Study|Withdrawal by Subject|1|||
42211256|NCT03982069|76026066|FG002|Overall Study|Withdrawal by Subject|5|||
42211257|NCT03982069|76026067|FG003|Overall Study|Withdrawal by Subject|2|||
42211258|NCT03982069|76026064|FG000|Overall Study|Specimen loss|3|||
42211259|NCT03982069|76026065|FG001|Overall Study|Specimen loss|3|||
42211260|NCT03982069|76026066|FG002|Overall Study|Specimen loss|1|||
42211261|NCT03982069|76026067|FG003|Overall Study|Specimen loss|1|||
42211262|NCT02937870|76026075|FG000|Overall Study|Adverse Event|1|||
42211263|NCT02937870|76026075|FG000|Overall Study|Protocol Deviation|2|||
42211264|NCT03629041|76026089|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
42211265|NCT03629041|76026090|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
42211266|NCT03629041|76026091|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
42211267|NCT03629041|76026092|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
42211268|NCT03219723|76026110|FG000|Overall Study|Case Report Forms Uncollected|6|||
42211269|NCT03219723|76026110|FG000|Overall Study|Protocol Deviation|4|||
42211270|NCT03628417|76026114|FG000|Overall Study|Death|1|||
42211271|NCT03628417|76026115|FG001|Overall Study|Death|1|||
42211272|NCT03184077|76026127|FG000|Overall Study|Lost to Follow-up|21|||
42211273|NCT03184077|76026128|FG001|Overall Study|Lost to Follow-up|21|||
42211274|NCT03245736|76026134|FG000|Overall Study|Adverse Event|1|||
42211275|NCT03245736|76026134|FG000|Overall Study|Progressive Disease|4|||
42211276|NCT02954887|76026138|FG000|Overall Study|Withdrawal by Subject|3|||
42211277|NCT02954887|76026138|FG000|Overall Study|Lack of Efficacy|3|||
42211278|NCT02954887|76026138|FG000|Overall Study|Other|1|||
42211279|NCT03183063|76026145|FG000|Overall Study|Withdrawal by Subject|2|||
41974489|NCT02577523|75776412|FG001|Overall Study|Lack of Efficacy|1|||
41974490|NCT02577523|75776411|FG000|Overall Study|Withdrawal by Subject|1|||
41974491|NCT02577523|75776412|FG001|Overall Study|Withdrawal by Subject|0|||
42127688|NCT03659136|75938117|FG000|Overall Study|Withdrawal by Subject|1|||
42127689|NCT03659136|75938118|FG001|Overall Study|Withdrawal by Subject|6|||
42127690|NCT03659136|75938117|FG000|Overall Study|Adverse Event|4|||
42127691|NCT03659136|75938118|FG001|Overall Study|Adverse Event|6|||
42127692|NCT03659136|75938117|FG000|Overall Study|Progressive disease|37|||
42127693|NCT03659136|75938118|FG001|Overall Study|Progressive disease|31|||
42127694|NCT03659136|75938117|FG000|Overall Study|Study closure|2|||
42127695|NCT03659136|75938118|FG001|Overall Study|Study closure|2|||
42127696|NCT03659136|75938117|FG000|Overall Study|Sponsor decision/recommendation|3|||
42127697|NCT03659136|75938118|FG001|Overall Study|Sponsor decision/recommendation|2|||
42127698|NCT03659136|75938117|FG000|Overall Study|Switched to other drug/therapy|2|||
42127699|NCT03659136|75938118|FG001|Overall Study|Switched to other drug/therapy|2|||
42127700|NCT03659136|75938117|FG000|Overall Study|Lack of clinical benefit|0|||
42211280|NCT03183063|76026146|FG001|Overall Study|Withdrawal by Subject|0|||
42211281|NCT03183063|76026147|FG002|Overall Study|Withdrawal by Subject|0|||
42211282|NCT03183063|76026145|FG000|Overall Study|Physician Decision|3|||
42211283|NCT03183063|76026146|FG001|Overall Study|Physician Decision|4|||
42211284|NCT03183063|76026147|FG002|Overall Study|Physician Decision|4|||
41974492|NCT02499328|75776437|FG000|Overall Study|Withdrawal by Subject|1|||
41974493|NCT02499328|75776438|FG001|Overall Study|Withdrawal by Subject|1|||
41974494|NCT02499328|75776439|FG002|Overall Study|Withdrawal by Subject|5|||
42127701|NCT03659136|75938118|FG001|Overall Study|Lack of clinical benefit|1|||
42127702|NCT03390036|75938153|FG000|Overall Study|Lost to Follow-up|1|||
42127703|NCT03390036|75938154|FG001|Overall Study|Lost to Follow-up|0|||
42211285|NCT03182829|76026163|FG000|Overall Study|Protocol Violation|12|||
42211286|NCT03182829|76026164|FG001|Overall Study|Protocol Violation|12|||
41974495|NCT02499328|75776440|FG003|Overall Study|Withdrawal by Subject|3|||
41974496|NCT02499328|75776441|FG004|Overall Study|Withdrawal by Subject|5|||
41974497|NCT02499328|75776442|FG005|Overall Study|Withdrawal by Subject|0|||
41974498|NCT02499328|75776443|FG006|Overall Study|Withdrawal by Subject|0|||
41974499|NCT02499328|75776444|FG007|Overall Study|Withdrawal by Subject|0|||
41974500|NCT02499328|75776445|FG008|Overall Study|Withdrawal by Subject|2|||
41974501|NCT02499328|75776446|FG009|Overall Study|Withdrawal by Subject|2|||
41974502|NCT02499328|75776447|FG010|Overall Study|Withdrawal by Subject|0|||
41974503|NCT02499328|75776448|FG011|Overall Study|Withdrawal by Subject|3|||
41974504|NCT02499328|75776449|FG012|Overall Study|Withdrawal by Subject|7|||
41974505|NCT02499328|75776450|FG013|Overall Study|Withdrawal by Subject|3|||
41974506|NCT02499328|75776451|FG014|Overall Study|Withdrawal by Subject|1|||
41974507|NCT02499328|75776452|FG015|Overall Study|Withdrawal by Subject|0|||
41974508|NCT02499328|75776453|FG016|Overall Study|Withdrawal by Subject|0|||
41974509|NCT02499328|75776454|FG017|Overall Study|Withdrawal by Subject|3|||
41974510|NCT02499328|75776455|FG018|Overall Study|Withdrawal by Subject|0|||
42028112|NCT00912964|75836433|FG000|Overall Study|Taking exclusionary medications|7|||
42028113|NCT00912964|75836434|FG001|Overall Study|Taking exclusionary medications|4|||
41974511|NCT02499328|75776437|FG000|Overall Study|Lost to Follow-up|0|||
41974512|NCT02499328|75776438|FG001|Overall Study|Lost to Follow-up|1|||
41974513|NCT02499328|75776439|FG002|Overall Study|Lost to Follow-up|1|||
41974514|NCT02499328|75776440|FG003|Overall Study|Lost to Follow-up|2|||
41974515|NCT02499328|75776441|FG004|Overall Study|Lost to Follow-up|0|||
41974516|NCT02499328|75776442|FG005|Overall Study|Lost to Follow-up|0|||
41974517|NCT02499328|75776443|FG006|Overall Study|Lost to Follow-up|0|||
41974518|NCT02499328|75776444|FG007|Overall Study|Lost to Follow-up|2|||
42127704|NCT03390036|75938155|FG002|Overall Study|Lost to Follow-up|0|||
42127705|NCT03390036|75938153|FG000|Overall Study|Lack of Efficacy|1|||
42127706|NCT03390036|75938154|FG001|Overall Study|Lack of Efficacy|0|||
42211287|NCT03182829|76026163|FG000|Overall Study|Other|4|||
42211288|NCT03182829|76026164|FG001|Overall Study|Other|3|||
42211289|NCT03278028|76026172|FG000|Overall Study|Lost to Follow-up|1|||
42211290|NCT03278028|76026173|FG001|Overall Study|Lost to Follow-up|0|||
42211291|NCT03278028|76026172|FG000|Overall Study|Withdrawal by Subject|3|||
42211292|NCT03278028|76026173|FG001|Overall Study|Withdrawal by Subject|1|||
42211293|NCT03278028|76026172|FG000|Overall Study|Pregnancy|0|||
42211294|NCT03278028|76026173|FG001|Overall Study|Pregnancy|1|||
42211295|NCT03181503|76026181|FG000|Overall Study|Adverse Event|2|||
42211296|NCT03181503|76026182|FG001|Overall Study|Adverse Event|2|||
42211297|NCT03181503|76026181|FG000|Overall Study|Protocol Violation|1|||
42211298|NCT03181503|76026182|FG001|Overall Study|Protocol Violation|0|||
42211299|NCT03181503|76026181|FG000|Overall Study|Withdrawal by Subject|3|||
42211300|NCT03181503|76026182|FG001|Overall Study|Withdrawal by Subject|0|||
42211301|NCT03181503|76026181|FG000|Overall Study|Lost to Follow-up|1|||
42211302|NCT03181503|76026182|FG001|Overall Study|Lost to Follow-up|1|||
42211303|NCT03277794|76026193|FG000|Overall Study|Lost to Follow-up|2|||
42211304|NCT03277794|76026194|FG001|Overall Study|Lost to Follow-up|4|||
42211305|NCT03277794|76026193|FG000|Overall Study|Withdrew due to high acuity|1|||
42211306|NCT03277794|76026194|FG001|Overall Study|Withdrew due to high acuity|0|||
42211307|NCT03276078|76026201|FG000|Overall Study|Adverse Event|1|||
42211308|NCT03180801|76026208|FG000|Overall Study|Physician Decision|3|||
42211309|NCT03180801|76026209|FG001|Overall Study|Physician Decision|3|||
42211310|NCT03180801|76026210|FG002|Overall Study|Physician Decision|1|||
42211311|NCT03180801|76026208|FG000|Overall Study|Non-compliance|1|||
42127707|NCT03390036|75938155|FG002|Overall Study|Lack of Efficacy|0|||
42127708|NCT03341936|75938180|FG000|Overall Study|Ineligible|1|||
42127709|NCT03341936|75938180|FG000|Overall Study|Disease Progression|2|||
42127710|NCT03341936|75938180|FG000|Overall Study|Withdrew Consent|4|||
42127711|NCT03341936|75938180|FG000|Overall Study|Non-Compliance|1|||
42127712|NCT03341936|75938180|FG000|Overall Study|Physician Decision|1|||
42211312|NCT03180801|76026209|FG001|Overall Study|Non-compliance|4|||
42211313|NCT03180801|76026210|FG002|Overall Study|Non-compliance|0|||
42211314|NCT03180801|76026208|FG000|Overall Study|Inoculation Target Reached|1|||
42211315|NCT03180801|76026209|FG001|Overall Study|Inoculation Target Reached|1|||
42211316|NCT03180801|76026210|FG002|Overall Study|Inoculation Target Reached|3|||
42211317|NCT03180801|76026208|FG000|Overall Study|Adverse Event|1|||
42211318|NCT03180801|76026209|FG001|Overall Study|Adverse Event|0|||
42211319|NCT03180801|76026210|FG002|Overall Study|Adverse Event|2|||
41974519|NCT02499328|75776445|FG008|Overall Study|Lost to Follow-up|3|||
41974520|NCT02499328|75776446|FG009|Overall Study|Lost to Follow-up|0|||
42028114|NCT00912964|75836435|FG002|Overall Study|Taking exclusionary medications|8|||
42127713|NCT03341936|75938180|FG000|Overall Study|Withdrawal by Subject|1|||
42127714|NCT03341936|75938180|FG000|Overall Study|Other|1|||
42127715|NCT03284203|75938184|FG000|Overall Study|Lost to Follow-up|3|||
42211320|NCT03180801|76026208|FG000|Overall Study|Withdrawal by Subject|2|||
42211321|NCT03180801|76026209|FG001|Overall Study|Withdrawal by Subject|2|||
42211322|NCT03180801|76026210|FG002|Overall Study|Withdrawal by Subject|1|||
42211323|NCT03180801|76026208|FG000|Overall Study|Lost to Follow-up|0|||
42211324|NCT03180801|76026209|FG001|Overall Study|Lost to Follow-up|2|||
41974521|NCT02499328|75776447|FG010|Overall Study|Lost to Follow-up|0|||
41974522|NCT02499328|75776448|FG011|Overall Study|Lost to Follow-up|0|||
41974523|NCT02499328|75776449|FG012|Overall Study|Lost to Follow-up|0|||
41974524|NCT02499328|75776450|FG013|Overall Study|Lost to Follow-up|0|||
41974525|NCT02499328|75776451|FG014|Overall Study|Lost to Follow-up|0|||
41974526|NCT02499328|75776452|FG015|Overall Study|Lost to Follow-up|0|||
41974527|NCT02499328|75776453|FG016|Overall Study|Lost to Follow-up|0|||
41974528|NCT02499328|75776454|FG017|Overall Study|Lost to Follow-up|0|||
41974529|NCT02499328|75776455|FG018|Overall Study|Lost to Follow-up|1|||
41974530|NCT02499328|75776437|FG000|Overall Study|Death|0|||
41974531|NCT02499328|75776438|FG001|Overall Study|Death|3|||
41974532|NCT02499328|75776439|FG002|Overall Study|Death|3|||
41974533|NCT02499328|75776440|FG003|Overall Study|Death|2|||
41974534|NCT02499328|75776441|FG004|Overall Study|Death|4|||
41974535|NCT02499328|75776442|FG005|Overall Study|Death|7|||
41974536|NCT02499328|75776443|FG006|Overall Study|Death|3|||
41974537|NCT02499328|75776444|FG007|Overall Study|Death|0|||
42211325|NCT03180801|76026210|FG002|Overall Study|Lost to Follow-up|3|||
42211326|NCT03742271|76026221|FG000|Overall Study|Unsatisfactory Visual Response|1|||
42211327|NCT03742271|76026221|FG000|Overall Study|Withdrawal by Subject|3|||
42211328|NCT03742271|76026221|FG000|Overall Study|Lost to Follow-up|4|||
42211329|NCT03742271|76026221|FG000|Overall Study|Failed Insertion & removal|3|||
42211330|NCT03742271|76026221|FG000|Overall Study|Protocol Violation|1|||
42211331|NCT03214224|76026225|FG000|Overall Study|Protocol Violation|1|||
42211332|NCT03214224|76026225|FG000|Overall Study|Withdrawal by Subject|2|||
42211333|NCT03214224|76026225|FG000|Overall Study|Practice controls or therapists|6|||
42211334|NCT03180645|76026232|FG000|Overall Study|Adverse Event|0|||
42211335|NCT03180645|76026233|FG001|Overall Study|Adverse Event|1|||
42211336|NCT03180645|76026234|FG002|Overall Study|Adverse Event|2|||
42211337|NCT03750695|76026246|FG000|Overall Study|Lost to Follow-up|0|||
42211338|NCT03750695|76026247|FG001|Overall Study|Lost to Follow-up|1|||
42211339|NCT03231228|76026260|FG000|Overall Study|Lost to Follow-up|2|||
42211340|NCT03231228|76026261|FG001|Overall Study|Lost to Follow-up|0|||
42211341|NCT03231228|76026260|FG000|Overall Study|Physician Decision|1|||
42211342|NCT03231228|76026261|FG001|Overall Study|Physician Decision|0|||
42211343|NCT03213366|76026269|FG000|Overall Study|Lost to Follow-up|9|||
42211344|NCT03213366|76026270|FG001|Overall Study|Lost to Follow-up|4|||
42211345|NCT03213210|76026276|FG000|Overall Study|Lost to Follow-up|2|||
42211346|NCT03213210|76026276|FG000|Overall Study|Study termination|3|||
42211347|NCT02932878|76026282|FG000|Overall Study|Due to Lab Results|2|||
42211348|NCT02932878|76026283|FG001|Overall Study|Due to Lab Results|1|||
42211349|NCT03230292|76026289|FG000|Overall Study|Adverse Event|1|||
42211350|NCT03230292|76026289|FG000|Overall Study|Protocol Violation|1|||
42211351|NCT03230292|76026289|FG000|Overall Study|Lost to Follow-up|1|||
42211352|NCT03230292|76026289|FG000|Overall Study|Withdrawal by Subject|3|||
42211353|NCT03228420|76026297|FG000|Overall Study|Lost to Follow-up|5|||
42211354|NCT03228420|76026298|FG001|Overall Study|Lost to Follow-up|3|||
42211355|NCT03228420|76026297|FG000|Overall Study|Withdrawal by Subject|10|||
42211356|NCT03228420|76026298|FG001|Overall Study|Withdrawal by Subject|0|||
42211357|NCT03228420|76026297|FG000|Overall Study|Adverse Event|5|||
42211358|NCT03228420|76026298|FG001|Overall Study|Adverse Event|2|||
42211359|NCT03746483|76026306|FG000|Overall Study|Adverse Event|0|||
42211360|NCT03746483|76026307|FG001|Overall Study|Adverse Event|1|||
42211361|NCT03746483|76026306|FG000|Overall Study|Lack of Efficacy|3|||
42211362|NCT03746483|76026307|FG001|Overall Study|Lack of Efficacy|2|||
42211363|NCT03746483|76026306|FG000|Overall Study|Lost to Follow-up|1|||
42211364|NCT03746483|76026307|FG001|Overall Study|Lost to Follow-up|0|||
42211365|NCT03746483|76026306|FG000|Overall Study|Protocol Violation|2|||
42211366|NCT03746483|76026307|FG001|Overall Study|Protocol Violation|0|||
42211367|NCT03746405|76026317|FG000|Overall Study|Withdrawal by Subject|3|||
42211368|NCT03746405|76026318|FG001|Overall Study|Withdrawal by Subject|0|||
42211369|NCT03746405|76026317|FG000|Overall Study|technical difficulties|0|||
42211370|NCT03746405|76026318|FG001|Overall Study|technical difficulties|2|||
42211371|NCT03226392|76026326|FG000|Overall Study|Protocol Deviation|1|||
42211372|NCT03226392|76026327|FG001|Overall Study|Protocol Deviation|0|||
42211373|NCT03226392|76026326|FG000|Overall Study|Physician Decision|1|||
42211374|NCT03226392|76026327|FG001|Overall Study|Physician Decision|0|||
42301751|NCT02504671|76136887|FG003|Overall Study|Protocol defined stopping criteria|5|||
42301752|NCT02504671|76136888|FG004|Overall Study|Protocol defined stopping criteria|3|||
41974538|NCT02499328|75776445|FG008|Overall Study|Death|2|||
41974539|NCT02499328|75776446|FG009|Overall Study|Death|6|||
41974540|NCT02499328|75776447|FG010|Overall Study|Death|6|||
42211375|NCT03226392|76026326|FG000|Overall Study|Lost to Follow-up|1|||
42211376|NCT03226392|76026327|FG001|Overall Study|Lost to Follow-up|0|||
42211377|NCT03226392|76026326|FG000|Overall Study|Adverse Event|1|||
42211378|NCT03226392|76026327|FG001|Overall Study|Adverse Event|0|||
42211379|NCT03226392|76026326|FG000|Overall Study|Technical Problems|0|||
42211380|NCT03226392|76026327|FG001|Overall Study|Technical Problems|2|||
41974541|NCT02499328|75776448|FG011|Overall Study|Death|20|||
41974542|NCT02499328|75776449|FG012|Overall Study|Death|9|||
42211381|NCT03226392|76026326|FG000|Overall Study|Subject/Guardian Decision|7|||
42211382|NCT03226392|76026327|FG001|Overall Study|Subject/Guardian Decision|6|||
41974543|NCT02499328|75776450|FG013|Overall Study|Death|7|||
41974544|NCT02499328|75776451|FG014|Overall Study|Death|3|||
41974545|NCT02499328|75776452|FG015|Overall Study|Death|1|||
41974546|NCT02499328|75776453|FG016|Overall Study|Death|1|||
41974547|NCT02499328|75776454|FG017|Overall Study|Death|16|||
41974548|NCT02499328|75776455|FG018|Overall Study|Death|5|||
41974549|NCT02499328|75776437|FG000|Overall Study|"Other"|2|||
41974550|NCT02499328|75776438|FG001|Overall Study|"Other"|2|||
41974551|NCT02499328|75776439|FG002|Overall Study|"Other"|1|||
41974552|NCT02499328|75776440|FG003|Overall Study|"Other"|3|||
41974553|NCT02499328|75776441|FG004|Overall Study|"Other"|6|||
41974554|NCT02499328|75776442|FG005|Overall Study|"Other"|2|||
41974555|NCT02499328|75776443|FG006|Overall Study|"Other"|3|||
41974556|NCT02499328|75776444|FG007|Overall Study|"Other"|4|||
41974557|NCT02499328|75776445|FG008|Overall Study|"Other"|6|||
41974558|NCT02499328|75776446|FG009|Overall Study|"Other"|16|||
41974559|NCT02499328|75776447|FG010|Overall Study|"Other"|13|||
41974560|NCT02499328|75776448|FG011|Overall Study|"Other"|31|||
41974561|NCT02499328|75776449|FG012|Overall Study|"Other"|8|||
41974562|NCT02499328|75776450|FG013|Overall Study|"Other"|7|||
41974563|NCT02499328|75776451|FG014|Overall Study|"Other"|6|||
41974564|NCT02499328|75776452|FG015|Overall Study|"Other"|0|||
41974565|NCT02499328|75776453|FG016|Overall Study|"Other"|0|||
41974566|NCT02499328|75776454|FG017|Overall Study|"Other"|34|||
41974567|NCT02499328|75776455|FG018|Overall Study|"Other"|43|||
41974568|NCT02499328|75776437|FG000|Overall Study|Disease Progression|0|||
41974569|NCT02499328|75776438|FG001|Overall Study|Disease Progression|0|||
41974570|NCT02499328|75776439|FG002|Overall Study|Disease Progression|0|||
41974571|NCT02499328|75776440|FG003|Overall Study|Disease Progression|0|||
41974572|NCT02499328|75776441|FG004|Overall Study|Disease Progression|0|||
41974573|NCT02499328|75776442|FG005|Overall Study|Disease Progression|0|||
41974574|NCT02499328|75776443|FG006|Overall Study|Disease Progression|1|||
41974575|NCT02499328|75776444|FG007|Overall Study|Disease Progression|0|||
41974576|NCT02499328|75776445|FG008|Overall Study|Disease Progression|1|||
41974577|NCT02499328|75776446|FG009|Overall Study|Disease Progression|0|||
41974578|NCT02499328|75776447|FG010|Overall Study|Disease Progression|1|||
42211383|NCT03205371|76026345|FG000|Overall Study|Withdrawal by Subject|4|||
42211384|NCT03205371|76026346|FG001|Overall Study|Withdrawal by Subject|1|||
42211385|NCT03205371|76026347|FG002|Overall Study|Withdrawal by Subject|0|||
42211386|NCT03205371|76026348|FG003|Overall Study|Withdrawal by Subject|0|||
42211387|NCT03205371|76026349|FG004|Overall Study|Withdrawal by Subject|0|||
42211388|NCT03205371|76026350|FG005|Overall Study|Withdrawal by Subject|0|||
42211389|NCT03205371|76026351|FG006|Overall Study|Withdrawal by Subject|4|||
42211390|NCT03205371|76026352|FG007|Overall Study|Withdrawal by Subject|0|||
42211391|NCT03205371|76026353|FG008|Overall Study|Withdrawal by Subject|2|||
41974579|NCT02499328|75776448|FG011|Overall Study|Disease Progression|0|||
41974580|NCT02499328|75776449|FG012|Overall Study|Disease Progression|0|||
41974581|NCT02499328|75776450|FG013|Overall Study|Disease Progression|0|||
41974582|NCT02499328|75776451|FG014|Overall Study|Disease Progression|0|||
41974583|NCT02499328|75776452|FG015|Overall Study|Disease Progression|0|||
41974584|NCT02499328|75776453|FG016|Overall Study|Disease Progression|0|||
41974585|NCT02499328|75776454|FG017|Overall Study|Disease Progression|2|||
42127716|NCT03233724|75938193|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
42127717|NCT03233724|75938194|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
42127718|NCT03233724|75938195|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
42127719|NCT03233724|75938196|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
42127720|NCT03233724|75938197|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
42127721|NCT03233724|75938193|FG000|Phase I Dose Escalation|Best interest of participant|1|||
42127722|NCT03233724|75938194|FG001|Phase I Dose Escalation|Best interest of participant|1|||
42127723|NCT03233724|75938195|FG002|Phase I Dose Escalation|Best interest of participant|1|||
41974586|NCT02499328|75776455|FG018|Overall Study|Disease Progression|0|||
41974587|NCT02499328|75776437|FG000|Overall Study|Adverse Event|1|||
41974588|NCT02499328|75776438|FG001|Overall Study|Adverse Event|0|||
41974589|NCT02499328|75776439|FG002|Overall Study|Adverse Event|0|||
42211392|NCT03205371|76026354|FG009|Overall Study|Withdrawal by Subject|0|||
42211393|NCT03205371|76026355|FG010|Overall Study|Withdrawal by Subject|0|||
42211394|NCT03205371|76026356|FG011|Overall Study|Withdrawal by Subject|1|||
42211395|NCT03205371|76026345|FG000|Overall Study|Lost to Follow-up|0|||
41974590|NCT02499328|75776440|FG003|Overall Study|Adverse Event|1|||
41974591|NCT02499328|75776441|FG004|Overall Study|Adverse Event|0|||
41974592|NCT02499328|75776442|FG005|Overall Study|Adverse Event|0|||
41974593|NCT02499328|75776443|FG006|Overall Study|Adverse Event|0|||
41974594|NCT02499328|75776444|FG007|Overall Study|Adverse Event|0|||
41974595|NCT02499328|75776445|FG008|Overall Study|Adverse Event|0|||
41974596|NCT02499328|75776446|FG009|Overall Study|Adverse Event|0|||
41974597|NCT02499328|75776447|FG010|Overall Study|Adverse Event|0|||
41974598|NCT02499328|75776448|FG011|Overall Study|Adverse Event|0|||
41974599|NCT02499328|75776449|FG012|Overall Study|Adverse Event|1|||
41974600|NCT02499328|75776450|FG013|Overall Study|Adverse Event|0|||
41974601|NCT02499328|75776451|FG014|Overall Study|Adverse Event|0|||
41974602|NCT02499328|75776452|FG015|Overall Study|Adverse Event|0|||
41974603|NCT02499328|75776453|FG016|Overall Study|Adverse Event|0|||
41974604|NCT02499328|75776454|FG017|Overall Study|Adverse Event|0|||
41974605|NCT02499328|75776455|FG018|Overall Study|Adverse Event|0|||
41974606|NCT02177695|75776551|FG000|ITT Analysis|Ineligible|5|||
41974607|NCT02177695|75776552|FG001|ITT Analysis|Ineligible|5|||
41974608|NCT02177695|75776551|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
42211396|NCT03205371|76026346|FG001|Overall Study|Lost to Follow-up|0|||
42211397|NCT03205371|76026347|FG002|Overall Study|Lost to Follow-up|0|||
42211398|NCT03205371|76026348|FG003|Overall Study|Lost to Follow-up|0|||
42211399|NCT03205371|76026349|FG004|Overall Study|Lost to Follow-up|0|||
42211400|NCT03205371|76026350|FG005|Overall Study|Lost to Follow-up|0|||
42211401|NCT03205371|76026351|FG006|Overall Study|Lost to Follow-up|5|||
42211402|NCT03205371|76026352|FG007|Overall Study|Lost to Follow-up|2|||
42211403|NCT03205371|76026353|FG008|Overall Study|Lost to Follow-up|3|||
42211404|NCT03205371|76026354|FG009|Overall Study|Lost to Follow-up|0|||
42211405|NCT03205371|76026355|FG010|Overall Study|Lost to Follow-up|0|||
42211406|NCT03205371|76026356|FG011|Overall Study|Lost to Follow-up|0|||
42211407|NCT03205371|76026345|FG000|Overall Study|Protocol Violation|0|||
42211408|NCT03205371|76026346|FG001|Overall Study|Protocol Violation|0|||
42211409|NCT03205371|76026347|FG002|Overall Study|Protocol Violation|0|||
42211410|NCT03205371|76026348|FG003|Overall Study|Protocol Violation|0|||
42211411|NCT03205371|76026349|FG004|Overall Study|Protocol Violation|0|||
42211412|NCT03205371|76026350|FG005|Overall Study|Protocol Violation|0|||
42211413|NCT03205371|76026351|FG006|Overall Study|Protocol Violation|1|||
42211414|NCT03205371|76026352|FG007|Overall Study|Protocol Violation|0|||
42211415|NCT03205371|76026353|FG008|Overall Study|Protocol Violation|0|||
42211416|NCT03205371|76026354|FG009|Overall Study|Protocol Violation|0|||
42211417|NCT03205371|76026355|FG010|Overall Study|Protocol Violation|0|||
42211418|NCT03205371|76026356|FG011|Overall Study|Protocol Violation|0|||
42211419|NCT03205371|76026345|FG000|Overall Study|Adverse Event|0|||
42211420|NCT03205371|76026346|FG001|Overall Study|Adverse Event|0|||
42211421|NCT03205371|76026347|FG002|Overall Study|Adverse Event|0|||
42211422|NCT03205371|76026348|FG003|Overall Study|Adverse Event|0|||
42211423|NCT03205371|76026349|FG004|Overall Study|Adverse Event|0|||
42211424|NCT03205371|76026350|FG005|Overall Study|Adverse Event|0|||
42211425|NCT03205371|76026351|FG006|Overall Study|Adverse Event|0|||
42211426|NCT03205371|76026352|FG007|Overall Study|Adverse Event|1|||
42211427|NCT03205371|76026353|FG008|Overall Study|Adverse Event|0|||
42211428|NCT03205371|76026354|FG009|Overall Study|Adverse Event|0|||
42211429|NCT03205371|76026355|FG010|Overall Study|Adverse Event|0|||
42211430|NCT03205371|76026356|FG011|Overall Study|Adverse Event|0|||
42211431|NCT03367858|76026404|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
42211432|NCT03367858|76026405|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
41974609|NCT02177695|75776552|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
42028115|NCT00912964|75836433|FG000|Overall Study|Medical History|1|||
42028116|NCT00912964|75836434|FG001|Overall Study|Medical History|0|||
42028117|NCT00912964|75836435|FG002|Overall Study|Medical History|0|||
42028118|NCT00912964|75836433|FG000|Overall Study|Non-compliance with study procedures|2|||
42028119|NCT00912964|75836434|FG001|Overall Study|Non-compliance with study procedures|0|||
42028120|NCT00912964|75836435|FG002|Overall Study|Non-compliance with study procedures|0|||
42028121|NCT00912964|75836433|FG000|Overall Study|Violation of exclusion criterion|0|||
42028122|NCT00912964|75836434|FG001|Overall Study|Violation of exclusion criterion|0|||
42028123|NCT00912964|75836435|FG002|Overall Study|Violation of exclusion criterion|2|||
42028124|NCT00912964|75836433|FG000|Overall Study|Randomized but never received study drug|0|||
42028125|NCT00912964|75836434|FG001|Overall Study|Randomized but never received study drug|1|||
42028126|NCT00912964|75836435|FG002|Overall Study|Randomized but never received study drug|0|||
42028127|NCT00913744|75836445|FG000|Overall Study|Adverse Event|2|||
42028128|NCT00913744|75836446|FG001|Overall Study|Adverse Event|0|||
42028129|NCT00913744|75836445|FG000|Overall Study|Withdrawal by Subject|2|||
42028130|NCT00913744|75836446|FG001|Overall Study|Withdrawal by Subject|1|||
42028131|NCT00913744|75836445|FG000|Overall Study|Death|1|||
42028132|NCT00913744|75836446|FG001|Overall Study|Death|0|||
42028133|NCT00912808|75836454|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
42028134|NCT00912808|75836455|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
42028135|NCT00912808|75836454|FG000|Washout|Withdrawal by Subject|0|||
42028136|NCT00912808|75836455|FG001|Washout|Withdrawal by Subject|1|||
42211433|NCT03367858|76026404|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
42211434|NCT03367858|76026405|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
42211435|NCT03367858|76026404|FG000|3 Month Follow Up|Lost to Follow-up|8|||
42301753|NCT02504671|76136889|FG005|Overall Study|Protocol defined stopping criteria|3|||
41974610|NCT02177695|75776551|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
42211436|NCT03367858|76026405|FG001|3 Month Follow Up|Lost to Follow-up|3|||
42211437|NCT03367858|76026404|FG000|3 Month Follow Up|Moved out of study area|2|||
42211438|NCT03367858|76026405|FG001|3 Month Follow Up|Moved out of study area|6|||
42211439|NCT03367858|76026404|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
42211440|NCT03367858|76026405|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
42211441|NCT03367858|76026404|FG000|3 Month Follow Up|MRI contraindication|2|||
42211442|NCT03367858|76026405|FG001|3 Month Follow Up|MRI contraindication|1|||
42211443|NCT03367858|76026404|FG000|3 Month Follow Up|Incarcerated|0|||
42211444|NCT03367858|76026405|FG001|3 Month Follow Up|Incarcerated|1|||
42211445|NCT03367858|76026404|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
42211446|NCT03367858|76026405|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
42211447|NCT03367858|76026404|FG000|6 Month Follow Up|Lost to Follow-up|5|||
42211448|NCT03367858|76026405|FG001|6 Month Follow Up|Lost to Follow-up|2|||
42211449|NCT03367858|76026404|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
42211450|NCT03367858|76026405|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
42211451|NCT03367858|76026404|FG000|12 Month Follow Up|Lost to Follow-up|3|||
42211452|NCT03367858|76026405|FG001|12 Month Follow Up|Lost to Follow-up|3|||
42211453|NCT03367858|76026404|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
41974611|NCT02177695|75776552|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
41974612|NCT02177695|75776551|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
42127724|NCT03233724|75938196|FG003|Phase I Dose Escalation|Best interest of participant|0|||
42127725|NCT03233724|75938197|FG004|Phase I Dose Escalation|Best interest of participant|0|||
42127726|NCT03233724|75938193|FG000|Phase I Dose Escalation|Physician Decision|0|||
42127727|NCT03233724|75938194|FG001|Phase I Dose Escalation|Physician Decision|0|||
42127728|NCT03233724|75938195|FG002|Phase I Dose Escalation|Physician Decision|1|||
42127729|NCT03233724|75938196|FG003|Phase I Dose Escalation|Physician Decision|0|||
42127730|NCT03233724|75938197|FG004|Phase I Dose Escalation|Physician Decision|0|||
42127731|NCT03233724|75938193|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
42127732|NCT03233724|75938194|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
42127733|NCT03233724|75938195|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
42127734|NCT03233724|75938196|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
42211454|NCT03367858|76026405|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
42211455|NCT03682705|76026417|FG000|Overall Study|Adverse Event|1|||
42211456|NCT03682705|76026418|FG001|Overall Study|Adverse Event|1|||
42211457|NCT03682705|76026419|FG002|Overall Study|Adverse Event|1|||
42211458|NCT03682705|76026420|FG003|Overall Study|Adverse Event|0|||
42211459|NCT03682705|76026421|FG004|Overall Study|Adverse Event|1|||
41974613|NCT02177695|75776552|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
41974614|NCT01719237|75776567|FG000|Overall Study|Physician Decision|0|||
41974615|NCT01719237|75776568|FG001|Overall Study|Physician Decision|1|||
41974616|NCT01956669|75776591|FG000|Overall Study|Disease Progression|12|||
41974617|NCT01956669|75776592|FG001|Overall Study|Disease Progression|7|||
41974618|NCT01956669|75776593|FG002|Overall Study|Disease Progression|7|||
41974619|NCT01956669|75776594|FG003|Overall Study|Disease Progression|8|||
41974620|NCT01956669|75776595|FG004|Overall Study|Disease Progression|4|||
41974621|NCT01956669|75776596|FG005|Overall Study|Disease Progression|3|||
41974622|NCT01956669|75776597|FG006|Overall Study|Disease Progression|5|||
41974623|NCT01956669|75776591|FG000|Overall Study|Adverse Event|0|||
41974624|NCT01956669|75776592|FG001|Overall Study|Adverse Event|2|||
41974625|NCT01956669|75776593|FG002|Overall Study|Adverse Event|2|||
41974626|NCT01956669|75776594|FG003|Overall Study|Adverse Event|1|||
41974627|NCT01956669|75776595|FG004|Overall Study|Adverse Event|0|||
41974628|NCT01956669|75776596|FG005|Overall Study|Adverse Event|0|||
41974629|NCT01956669|75776597|FG006|Overall Study|Adverse Event|0|||
41974630|NCT01956669|75776591|FG000|Overall Study|Physician Decision|0|||
41974631|NCT01956669|75776592|FG001|Overall Study|Physician Decision|2|||
41974632|NCT01956669|75776593|FG002|Overall Study|Physician Decision|0|||
41974633|NCT01956669|75776594|FG003|Overall Study|Physician Decision|0|||
41974634|NCT01956669|75776595|FG004|Overall Study|Physician Decision|0|||
41974635|NCT01956669|75776596|FG005|Overall Study|Physician Decision|1|||
41974636|NCT01956669|75776597|FG006|Overall Study|Physician Decision|0|||
41974637|NCT01956669|75776591|FG000|Overall Study|Withdrawal by Subject|0|||
41974638|NCT01956669|75776592|FG001|Overall Study|Withdrawal by Subject|0|||
41974639|NCT01956669|75776593|FG002|Overall Study|Withdrawal by Subject|1|||
42211460|NCT03682705|76026422|FG005|Overall Study|Adverse Event|1|||
42211461|NCT03682705|76026417|FG000|Overall Study|Withdrawal by Subject|1|||
42028137|NCT00912808|75836454|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
42211462|NCT03682705|76026418|FG001|Overall Study|Withdrawal by Subject|3|||
42211463|NCT03682705|76026419|FG002|Overall Study|Withdrawal by Subject|2|||
41974640|NCT01956669|75776594|FG003|Overall Study|Withdrawal by Subject|1|||
41974641|NCT01956669|75776595|FG004|Overall Study|Withdrawal by Subject|0|||
41974642|NCT01956669|75776596|FG005|Overall Study|Withdrawal by Subject|0|||
42127735|NCT03233724|75938197|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
42127736|NCT03026283|75938211|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
42127737|NCT03026283|75938212|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
41974643|NCT01956669|75776597|FG006|Overall Study|Withdrawal by Subject|1|||
41974644|NCT01967823|75776626|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
41974645|NCT01982760|75776636|FG000|Overall Study|Physician Decision|1|||
41974646|NCT01982760|75776637|FG001|Overall Study|Physician Decision|0|||
41974647|NCT01985022|75776645|FG000|Overall Study|Lost to Follow-up|0|||
41974648|NCT01985022|75776646|FG001|Overall Study|Lost to Follow-up|1|||
41974649|NCT01985022|75776645|FG000|Overall Study|Protocol Violation|0|||
41974650|NCT01985022|75776646|FG001|Overall Study|Protocol Violation|1|||
41974651|NCT01985022|75776645|FG000|Overall Study|Withdrawal by Subject|4|||
41974652|NCT01985022|75776646|FG001|Overall Study|Withdrawal by Subject|1|||
41974653|NCT01989676|75776654|FG000|Overall Study|Death|52|||
41974654|NCT01989676|75776655|FG001|Overall Study|Death|60|||
41974655|NCT01989676|75776654|FG000|Overall Study|Protocol Violation|2|||
41974656|NCT01989676|75776655|FG001|Overall Study|Protocol Violation|1|||
41974657|NCT01989676|75776654|FG000|Overall Study|Lost to Follow-up|8|||
41974658|NCT01989676|75776655|FG001|Overall Study|Lost to Follow-up|18|||
41974659|NCT01989676|75776654|FG000|Overall Study|No longer willing to participate in study|26|||
41974660|NCT01989676|75776655|FG001|Overall Study|No longer willing to participate in study|26|||
41974661|NCT01989676|75776654|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
41974662|NCT01989676|75776655|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
41974663|NCT01989676|75776654|FG000|Overall Study|Other|4|||
41974664|NCT01989676|75776655|FG001|Overall Study|Other|3|||
41974665|NCT02001974|75776665|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
41974666|NCT02001974|75776666|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
41974667|NCT02001974|75776667|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
41974668|NCT02001974|75776665|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
41974669|NCT02001974|75776666|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
41974670|NCT02001974|75776667|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
41974671|NCT02001974|75776665|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
41974672|NCT02001974|75776666|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
41974673|NCT02001974|75776667|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
41974674|NCT02001974|75776665|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
41974675|NCT02001974|75776666|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
41974676|NCT02001974|75776667|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
41974677|NCT05229406|75776705|FG000|Overall Study|Withdrawal by Subject|1|||
41974678|NCT05229406|75776706|FG001|Overall Study|Withdrawal by Subject|2|||
41974679|NCT04971187|75776721|FG000|Overall Study|Screen failures|2|||
41974680|NCT04756154|75776746|FG000|Overall Study|Did not meet treatment day baseline|30|||
41974681|NCT04756154|75776747|FG001|Overall Study|Did not meet treatment day baseline|28|||
41974682|NCT04756154|75776748|FG002|Overall Study|Did not meet treatment day baseline|7|||
41974683|NCT04756154|75776746|FG000|Overall Study|Did not return for final sample collection|1|||
41974684|NCT04756154|75776747|FG001|Overall Study|Did not return for final sample collection|1|||
41974685|NCT04756154|75776748|FG002|Overall Study|Did not return for final sample collection|0|||
41974686|NCT04614246|75776766|FG000|Overall Study|Adverse Event|0|||
41974687|NCT04614246|75776767|FG001|Overall Study|Adverse Event|1|||
41974688|NCT04614246|75776768|FG002|Overall Study|Adverse Event|1|||
41974689|NCT04614246|75776769|FG003|Overall Study|Adverse Event|2|||
41974690|NCT04614246|75776770|FG004|Overall Study|Adverse Event|1|||
41974691|NCT04614246|75776766|FG000|Overall Study|Lost to Follow-up|0|||
41974692|NCT04614246|75776767|FG001|Overall Study|Lost to Follow-up|1|||
41974693|NCT04614246|75776768|FG002|Overall Study|Lost to Follow-up|0|||
41974694|NCT04614246|75776769|FG003|Overall Study|Lost to Follow-up|1|||
41974695|NCT04614246|75776770|FG004|Overall Study|Lost to Follow-up|3|||
41974696|NCT04614246|75776766|FG000|Overall Study|Other reason|0|||
41974697|NCT04614246|75776767|FG001|Overall Study|Other reason|1|||
41974698|NCT04614246|75776768|FG002|Overall Study|Other reason|2|||
41974699|NCT04614246|75776769|FG003|Overall Study|Other reason|0|||
41974700|NCT04614246|75776770|FG004|Overall Study|Other reason|0|||
41974701|NCT04614246|75776766|FG000|Overall Study|Withdrawal by Subject|4|||
42028138|NCT00912808|75836455|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
42127738|NCT03026283|75938213|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
42127739|NCT03026283|75938214|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
42127740|NCT03026283|75938215|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
42127741|NCT03026283|75938216|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
41974702|NCT04614246|75776767|FG001|Overall Study|Withdrawal by Subject|2|||
41974703|NCT04614246|75776768|FG002|Overall Study|Withdrawal by Subject|4|||
41974704|NCT04614246|75776769|FG003|Overall Study|Withdrawal by Subject|3|||
41974705|NCT04614246|75776770|FG004|Overall Study|Withdrawal by Subject|4|||
41974706|NCT04614246|75776766|FG000|Overall Study|Physician Decision|0|||
41974707|NCT04614246|75776767|FG001|Overall Study|Physician Decision|2|||
41974708|NCT04614246|75776768|FG002|Overall Study|Physician Decision|1|||
41974709|NCT04614246|75776769|FG003|Overall Study|Physician Decision|0|||
41974710|NCT04614246|75776770|FG004|Overall Study|Physician Decision|0|||
41974711|NCT04614246|75776766|FG000|Overall Study|Study terminated by sponsor|10|||
41974712|NCT04614246|75776767|FG001|Overall Study|Study terminated by sponsor|15|||
41974713|NCT04614246|75776768|FG002|Overall Study|Study terminated by sponsor|12|||
42028139|NCT00912808|75836454|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
42028140|NCT00912808|75836455|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
42028141|NCT00960531|75836472|FG000|Overall Study|Lack of Efficacy|1|||
42211464|NCT03682705|76026420|FG003|Overall Study|Withdrawal by Subject|4|||
42211465|NCT03682705|76026421|FG004|Overall Study|Withdrawal by Subject|0|||
42211466|NCT03682705|76026422|FG005|Overall Study|Withdrawal by Subject|1|||
41974714|NCT04614246|75776769|FG003|Overall Study|Study terminated by sponsor|13|||
41974715|NCT04614246|75776770|FG004|Overall Study|Study terminated by sponsor|9|||
41974716|NCT04614246|75776766|FG000|Overall Study|Pregnancy|2|||
41974717|NCT04614246|75776767|FG001|Overall Study|Pregnancy|0|||
41974718|NCT04614246|75776768|FG002|Overall Study|Pregnancy|1|||
41974719|NCT04614246|75776769|FG003|Overall Study|Pregnancy|0|||
41974720|NCT04614246|75776770|FG004|Overall Study|Pregnancy|0|||
41974721|NCT04593823|75776788|FG000|Overall Study|Withdrawal by Subject|1|||
41974722|NCT04593823|75776789|FG001|Overall Study|Withdrawal by Subject|1|||
41974723|NCT04593823|75776788|FG000|Overall Study|Lost to Follow-up|0|||
41974724|NCT04593823|75776789|FG001|Overall Study|Lost to Follow-up|1|||
41974725|NCT04556383|75776809|FG000|PCP|Lack of Efficacy|28|||
41974726|NCT04556383|75776810|FG001|PCP|Lack of Efficacy|23|||
41974727|NCT04556383|75776811|FG002|PCP|Lack of Efficacy|23|||
41974728|NCT04556383|75776812|FG003|PCP|Lack of Efficacy|0|||
41974729|NCT04556383|75776809|FG000|PCP|Study terminated by sponsor|15|||
41974730|NCT04556383|75776810|FG001|PCP|Study terminated by sponsor|13|||
41974731|NCT04556383|75776811|FG002|PCP|Study terminated by sponsor|16|||
41974732|NCT04556383|75776812|FG003|PCP|Study terminated by sponsor|0|||
41974733|NCT04556383|75776809|FG000|PCP|Withdrawal by Subject|8|||
41974734|NCT04556383|75776810|FG001|PCP|Withdrawal by Subject|6|||
41974735|NCT04556383|75776811|FG002|PCP|Withdrawal by Subject|6|||
41974736|NCT04556383|75776812|FG003|PCP|Withdrawal by Subject|0|||
41974737|NCT04556383|75776809|FG000|PCP|Adverse Event|1|||
41974738|NCT04556383|75776810|FG001|PCP|Adverse Event|7|||
41974739|NCT04556383|75776811|FG002|PCP|Adverse Event|7|||
41974740|NCT04556383|75776812|FG003|PCP|Adverse Event|0|||
41974741|NCT04556383|75776809|FG000|PCP|Other, Not Specified|1|||
41974742|NCT04556383|75776810|FG001|PCP|Other, Not Specified|2|||
41974743|NCT04556383|75776811|FG002|PCP|Other, Not Specified|1|||
41974744|NCT04556383|75776812|FG003|PCP|Other, Not Specified|0|||
41974745|NCT04556383|75776809|FG000|PCP|Protocol Violation|1|||
41974746|NCT04556383|75776810|FG001|PCP|Protocol Violation|0|||
41974747|NCT04556383|75776811|FG002|PCP|Protocol Violation|1|||
41974748|NCT04556383|75776812|FG003|PCP|Protocol Violation|0|||
41974749|NCT04556383|75776809|FG000|PCP|Lost to Follow-up|1|||
41974750|NCT04556383|75776810|FG001|PCP|Lost to Follow-up|0|||
41974751|NCT04556383|75776811|FG002|PCP|Lost to Follow-up|0|||
41974752|NCT04556383|75776812|FG003|PCP|Lost to Follow-up|0|||
41974753|NCT04556383|75776809|FG000|PCP|Physician Decision|0|||
41974754|NCT04556383|75776810|FG001|PCP|Physician Decision|1|||
41974755|NCT04556383|75776811|FG002|PCP|Physician Decision|0|||
41974756|NCT04556383|75776812|FG003|PCP|Physician Decision|0|||
41974757|NCT04556383|75776809|FG000|PCP|Site terminated by sponsor|0|||
41974758|NCT04556383|75776810|FG001|PCP|Site terminated by sponsor|1|||
41974759|NCT04556383|75776811|FG002|PCP|Site terminated by sponsor|0|||
41974760|NCT04556383|75776812|FG003|PCP|Site terminated by sponsor|0|||
41974761|NCT04556383|75776809|FG000|OLE|Study terminated by sponsor|0|||
41974762|NCT04556383|75776810|FG001|OLE|Study terminated by sponsor|0|||
41974763|NCT04556383|75776811|FG002|OLE|Study terminated by sponsor|0|||
42211467|NCT03682705|76026417|FG000|Overall Study|Other, not specified|0|||
42211468|NCT03682705|76026418|FG001|Overall Study|Other, not specified|0|||
42211469|NCT03682705|76026419|FG002|Overall Study|Other, not specified|0|||
42211470|NCT03682705|76026420|FG003|Overall Study|Other, not specified|1|||
42211471|NCT03682705|76026421|FG004|Overall Study|Other, not specified|2|||
42211472|NCT03682705|76026422|FG005|Overall Study|Other, not specified|0|||
42301754|NCT02314143|76136906|FG000|Overall Study|Adverse Event|0|||
42301755|NCT02314143|76136907|FG001|Overall Study|Adverse Event|6|||
41974764|NCT04556383|75776812|FG003|OLE|Study terminated by sponsor|68|||
41974765|NCT04556383|75776809|FG000|OLE|Withdrawal by Subject|0|||
41974766|NCT04556383|75776810|FG001|OLE|Withdrawal by Subject|0|||
42028142|NCT00960531|75836473|FG001|Overall Study|Lack of Efficacy|0|||
42211473|NCT03682705|76026417|FG000|Overall Study|Lost to Follow-up|0|||
42028143|NCT00960531|75836474|FG002|Overall Study|Lack of Efficacy|0|||
42301756|NCT02314143|76136908|FG002|Overall Study|Adverse Event|4|||
41974767|NCT04556383|75776811|FG002|OLE|Withdrawal by Subject|0|||
41974768|NCT04556383|75776812|FG003|OLE|Withdrawal by Subject|10|||
42028144|NCT00960531|75836475|FG003|Overall Study|Lack of Efficacy|0|||
41974769|NCT04556383|75776809|FG000|OLE|Lack of Efficacy|0|||
41974770|NCT04556383|75776810|FG001|OLE|Lack of Efficacy|0|||
41974771|NCT04556383|75776811|FG002|OLE|Lack of Efficacy|0|||
41974772|NCT04556383|75776812|FG003|OLE|Lack of Efficacy|7|||
41974773|NCT04556383|75776809|FG000|OLE|Adverse Event|0|||
41974774|NCT04556383|75776810|FG001|OLE|Adverse Event|0|||
41974775|NCT04556383|75776811|FG002|OLE|Adverse Event|0|||
41974776|NCT04556383|75776812|FG003|OLE|Adverse Event|2|||
42211474|NCT03682705|76026418|FG001|Overall Study|Lost to Follow-up|0|||
42211475|NCT03682705|76026419|FG002|Overall Study|Lost to Follow-up|0|||
42211476|NCT03682705|76026420|FG003|Overall Study|Lost to Follow-up|0|||
42211477|NCT03682705|76026421|FG004|Overall Study|Lost to Follow-up|3|||
42211478|NCT03682705|76026422|FG005|Overall Study|Lost to Follow-up|0|||
42211479|NCT03179787|76026436|FG000|Overall Study|Lost to Follow-up|15|||
42211480|NCT03179787|76026436|FG000|Overall Study|Case report failures|2|||
42211481|NCT03179787|76026436|FG000|Overall Study|Treatment not administered|1|||
42211482|NCT03745937|76026444|FG000|Overall Study|Withdrawal by Subject|0|||
42211483|NCT03745937|76026445|FG001|Overall Study|Withdrawal by Subject|0|||
42211484|NCT03745937|76026446|FG002|Overall Study|Withdrawal by Subject|0|||
42211485|NCT03745937|76026447|FG003|Overall Study|Withdrawal by Subject|1|||
42211486|NCT03745937|76026444|FG000|Overall Study|Not-specifed|0|||
42211487|NCT03745937|76026445|FG001|Overall Study|Not-specifed|1|||
42211488|NCT03745937|76026446|FG002|Overall Study|Not-specifed|0|||
42211489|NCT03745937|76026447|FG003|Overall Study|Not-specifed|1|||
42211490|NCT02956057|76026464|FG000|Overall Study|Discontinued intervention|14|||
42211491|NCT02956057|76026465|FG001|Overall Study|Discontinued intervention|10|||
42211492|NCT02956057|76026466|FG002|Overall Study|Discontinued intervention|7|||
42211493|NCT02956057|76026467|FG003|Overall Study|Discontinued intervention|14|||
42211494|NCT02956057|76026468|FG004|Overall Study|Discontinued intervention|4|||
42211495|NCT02956057|76026469|FG005|Overall Study|Discontinued intervention|17|||
42211496|NCT02956057|76026464|FG000|Overall Study|Lost to Follow-up|0|||
42211497|NCT02956057|76026465|FG001|Overall Study|Lost to Follow-up|2|||
42211498|NCT02956057|76026466|FG002|Overall Study|Lost to Follow-up|1|||
42211499|NCT02956057|76026467|FG003|Overall Study|Lost to Follow-up|1|||
42211500|NCT02956057|76026468|FG004|Overall Study|Lost to Follow-up|1|||
42211501|NCT02956057|76026469|FG005|Overall Study|Lost to Follow-up|0|||
42211502|NCT03179319|76026485|FG000|Overall Study|Lost to Follow-up|6|||
42301757|NCT02314143|76136906|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
42301758|NCT02314143|76136907|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
41974777|NCT04556383|75776809|FG000|OLE|Other, Not Specified|0|||
41974778|NCT04556383|75776810|FG001|OLE|Other, Not Specified|0|||
41974779|NCT04556383|75776811|FG002|OLE|Other, Not Specified|0|||
41974780|NCT04556383|75776812|FG003|OLE|Other, Not Specified|2|||
41974781|NCT04556383|75776809|FG000|OLE|Death|0|||
41974782|NCT04556383|75776810|FG001|OLE|Death|0|||
41974783|NCT04556383|75776811|FG002|OLE|Death|0|||
41974784|NCT04556383|75776812|FG003|OLE|Death|1|||
41974785|NCT04556383|75776809|FG000|OLE|Lost to Follow-up|0|||
41974786|NCT04556383|75776810|FG001|OLE|Lost to Follow-up|0|||
41974787|NCT04556383|75776811|FG002|OLE|Lost to Follow-up|0|||
42127742|NCT03026283|75938217|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
42127743|NCT03026283|75938218|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
42127744|NCT03026283|75938211|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
42127745|NCT03026283|75938212|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
42127746|NCT03026283|75938213|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
42127747|NCT03026283|75938214|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
42127748|NCT03026283|75938215|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
42127749|NCT03026283|75938216|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
42127750|NCT03026283|75938217|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
42127751|NCT03026283|75938218|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
42127752|NCT03026283|75938211|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
42127753|NCT03026283|75938212|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
42127754|NCT03026283|75938213|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
42211503|NCT03179319|76026486|FG001|Overall Study|Lost to Follow-up|0|||
42211504|NCT03627091|76026495|FG000|Overall Study|Adverse Event|0|||
42211505|NCT03627091|76026496|FG001|Overall Study|Adverse Event|0|||
42211506|NCT03627091|76026497|FG002|Overall Study|Adverse Event|2|||
42211507|NCT03627091|76026495|FG000|Overall Study|Withdrawal by Subject|2|||
42211508|NCT03627091|76026496|FG001|Overall Study|Withdrawal by Subject|0|||
42211509|NCT03627091|76026497|FG002|Overall Study|Withdrawal by Subject|2|||
42211510|NCT03627091|76026495|FG000|Overall Study|Physician Decision|2|||
42211511|NCT03627091|76026496|FG001|Overall Study|Physician Decision|0|||
42211512|NCT03627091|76026497|FG002|Overall Study|Physician Decision|0|||
42211513|NCT03627091|76026495|FG000|Overall Study|Site terminated by sponsor|0|||
42211514|NCT03627091|76026496|FG001|Overall Study|Site terminated by sponsor|1|||
42211515|NCT03627091|76026497|FG002|Overall Study|Site terminated by sponsor|0|||
42211516|NCT03627091|76026495|FG000|Overall Study|Disease relapse|7|||
42211517|NCT03627091|76026496|FG001|Overall Study|Disease relapse|5|||
42211518|NCT03627091|76026497|FG002|Overall Study|Disease relapse|1|||
42301759|NCT02314143|76136908|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
41974788|NCT04556383|75776812|FG003|OLE|Lost to Follow-up|1|||
42127755|NCT03026283|75938214|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
41974789|NCT04444752|75776846|FG000|Overall Study|Adverse Event|1|||
42211519|NCT03627091|76026495|FG000|Overall Study|Other|1|||
42211520|NCT03627091|76026496|FG001|Overall Study|Other|0|||
41974790|NCT04444752|75776847|FG001|Overall Study|Adverse Event|0|||
42211521|NCT03627091|76026497|FG002|Overall Study|Other|0|||
42301760|NCT02314143|76136906|FG000|Overall Study|Physician Decision|2|||
42211522|NCT04237584|76026510|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
42211523|NCT04237584|76026511|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
42211524|NCT04237584|76026512|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
42211525|NCT04237584|76026513|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
42211526|NCT04237584|76026510|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
42211527|NCT04237584|76026511|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
42211528|NCT04237584|76026512|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
42211529|NCT04237584|76026513|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
42211530|NCT04237584|76026510|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
42211531|NCT04237584|76026511|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
42211532|NCT04237584|76026512|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
42211533|NCT04237584|76026513|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
42211534|NCT04237584|76026510|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
42211535|NCT04237584|76026511|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
42211536|NCT04237584|76026512|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
42211537|NCT04237584|76026513|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
42211538|NCT04237584|76026510|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
42211539|NCT04237584|76026511|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
42211540|NCT04237584|76026512|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
42211541|NCT04237584|76026513|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
42211542|NCT03224598|76026530|FG000|Overall Study|Lost to Follow-up|0|||
42211543|NCT03224598|76026531|FG001|Overall Study|Lost to Follow-up|2|||
42211544|NCT03224598|76026532|FG002|Overall Study|Lost to Follow-up|0|||
42211545|NCT03224598|76026530|FG000|Overall Study|Other|0|||
42211546|NCT03224598|76026531|FG001|Overall Study|Other|1|||
42211547|NCT03224598|76026532|FG002|Overall Study|Other|0|||
41974791|NCT04444752|75776848|FG002|Overall Study|Adverse Event|0|||
41974792|NCT04444752|75776849|FG003|Overall Study|Adverse Event|2|||
41974793|NCT04444752|75776846|FG000|Overall Study|Lost to Follow-up|2|||
41974794|NCT04444752|75776847|FG001|Overall Study|Lost to Follow-up|6|||
41974795|NCT04444752|75776848|FG002|Overall Study|Lost to Follow-up|2|||
41974796|NCT04444752|75776849|FG003|Overall Study|Lost to Follow-up|5|||
41974797|NCT04444752|75776846|FG000|Overall Study|Physician Decision|0|||
41974798|NCT04444752|75776847|FG001|Overall Study|Physician Decision|0|||
41974799|NCT04444752|75776848|FG002|Overall Study|Physician Decision|0|||
41974800|NCT04444752|75776849|FG003|Overall Study|Physician Decision|2|||
41974801|NCT04444752|75776846|FG000|Overall Study|Pregnancy|0|||
41974802|NCT04444752|75776847|FG001|Overall Study|Pregnancy|0|||
41974803|NCT04444752|75776848|FG002|Overall Study|Pregnancy|0|||
41974804|NCT04444752|75776849|FG003|Overall Study|Pregnancy|1|||
41974805|NCT04444752|75776846|FG000|Overall Study|Withdrawal by Subject|6|||
41974806|NCT04444752|75776847|FG001|Overall Study|Withdrawal by Subject|5|||
41974807|NCT04444752|75776848|FG002|Overall Study|Withdrawal by Subject|3|||
41974808|NCT04444752|75776849|FG003|Overall Study|Withdrawal by Subject|4|||
41974809|NCT04444752|75776846|FG000|Overall Study|Protocol Violation|1|||
41974810|NCT04444752|75776847|FG001|Overall Study|Protocol Violation|1|||
41974811|NCT04444752|75776848|FG002|Overall Study|Protocol Violation|0|||
41974812|NCT04444752|75776849|FG003|Overall Study|Protocol Violation|0|||
41974813|NCT04444752|75776846|FG000|Overall Study|Patient moving out of town|1|||
41974814|NCT04444752|75776847|FG001|Overall Study|Patient moving out of town|0|||
41974815|NCT04444752|75776848|FG002|Overall Study|Patient moving out of town|0|||
41974816|NCT04444752|75776849|FG003|Overall Study|Patient moving out of town|1|||
41974817|NCT04444752|75776846|FG000|Overall Study|Lack of Efficacy|0|||
41974818|NCT04444752|75776847|FG001|Overall Study|Lack of Efficacy|0|||
42127756|NCT03026283|75938215|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
42127757|NCT03026283|75938216|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
42127758|NCT03026283|75938217|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
42127759|NCT03026283|75938218|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
42127760|NCT03026283|75938211|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
42127761|NCT03026283|75938212|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
42127762|NCT03026283|75938213|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
42127763|NCT03026283|75938214|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
42127764|NCT03026283|75938215|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
42211548|NCT03681691|76026542|FG000|Overall Study|COVID|1|||
42301761|NCT02314143|76136907|FG001|Overall Study|Physician Decision|1|||
41974819|NCT04444752|75776848|FG002|Overall Study|Lack of Efficacy|0|||
41974820|NCT04444752|75776849|FG003|Overall Study|Lack of Efficacy|1|||
41974821|NCT04444752|75776846|FG000|Overall Study|Death|0|||
41974822|NCT04444752|75776847|FG001|Overall Study|Death|0|||
41974823|NCT04444752|75776848|FG002|Overall Study|Death|1|||
41974824|NCT04444752|75776849|FG003|Overall Study|Death|0|||
42211549|NCT03681691|76026543|FG001|Overall Study|COVID|0|||
42211550|NCT03681691|76026542|FG000|Overall Study|prolonged bleeding|1|||
42211551|NCT03681691|76026543|FG001|Overall Study|prolonged bleeding|0|||
42211552|NCT03681691|76026542|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
42211553|NCT03681691|76026543|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
42211554|NCT02935842|76026555|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
42211555|NCT02935842|76026556|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
42211556|NCT02935842|76026557|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
42211557|NCT02935842|76026558|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
42211558|NCT02935842|76026555|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
41974825|NCT04429022|75776861|FG000|Overall Study|Protocol Violation|18|||
41974826|NCT04429022|75776862|FG001|Overall Study|Protocol Violation|1|||
41974827|NCT04351373|75776892|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
41974828|NCT04239924|75776905|FG000|Overall Study|Lost to Follow-up|2|||
41974829|NCT04154904|75776917|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
41974830|NCT04154904|75776918|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
41974831|NCT04154904|75776919|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
41974832|NCT04114656|75776931|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
41974833|NCT04114656|75776932|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
41974834|NCT04114656|75776931|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
41974835|NCT04114656|75776932|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
41974836|NCT04114656|75776931|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
41974837|NCT04114656|75776932|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
41974838|NCT04114656|75776931|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
41974839|NCT04114656|75776932|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
41974840|NCT04114656|75776931|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
41974841|NCT04114656|75776932|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
41974842|NCT04034238|75776950|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
41974843|NCT04034238|75776951|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
41974844|NCT04034238|75776952|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
41974845|NCT04034238|75776953|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
41974846|NCT04034238|75776950|FG000|Dose Escalation Phase|Screen failures|0|||
41974847|NCT04034238|75776951|FG001|Dose Escalation Phase|Screen failures|0|||
41974848|NCT04034238|75776952|FG002|Dose Escalation Phase|Screen failures|0|||
41974849|NCT04034238|75776953|FG003|Dose Escalation Phase|Screen failures|2|||
41974850|NCT04034238|75776950|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
41974851|NCT04034238|75776951|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
41974852|NCT04034238|75776952|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
41974853|NCT04034238|75776953|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
41974854|NCT04034238|75776950|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
41974855|NCT04034238|75776951|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
41974856|NCT04034238|75776952|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
41974857|NCT04034238|75776953|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
41974858|NCT03956056|75776964|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
41974859|NCT03956056|75776964|FG000|Overall Study|Lack of Efficacy|1|||
41974860|NCT03954041|75776971|FG000|Overall Study|Lost to Follow-up|3|||
41974861|NCT03954041|75776972|FG001|Overall Study|Lost to Follow-up|3|||
41974862|NCT03954041|75776973|FG002|Overall Study|Lost to Follow-up|6|||
41974863|NCT03954041|75776971|FG000|Overall Study|Death|4|||
41974864|NCT03954041|75776972|FG001|Overall Study|Death|0|||
42127765|NCT03026283|75938216|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
42127766|NCT03026283|75938217|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
42127767|NCT03026283|75938218|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
42127768|NCT03026283|75938211|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
42127769|NCT03026283|75938212|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
42127770|NCT03026283|75938213|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
42127771|NCT03026283|75938214|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
42127772|NCT03026283|75938215|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
42127773|NCT03026283|75938216|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
42127774|NCT03026283|75938217|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
42127775|NCT03026283|75938218|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
42127776|NCT03026283|75938211|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
42127777|NCT03026283|75938212|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
42127778|NCT03026283|75938213|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
42127779|NCT03026283|75938214|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
42211559|NCT02935842|76026556|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
41974865|NCT03954041|75776973|FG002|Overall Study|Death|1|||
41974866|NCT03954041|75776971|FG000|Overall Study|Death by neurologic criteria|0|||
41974867|NCT03954041|75776972|FG001|Overall Study|Death by neurologic criteria|0|||
42211560|NCT02935842|76026557|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
42211561|NCT02935842|76026558|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
42211562|NCT02935842|76026555|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
42211563|NCT02935842|76026556|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
42211564|NCT02935842|76026557|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
42211565|NCT02935842|76026558|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
42211566|NCT02935842|76026555|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
42211567|NCT02935842|76026556|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
42211568|NCT02935842|76026557|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
42211569|NCT02935842|76026558|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
42211570|NCT02935842|76026555|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
42211571|NCT02935842|76026556|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
42211572|NCT02935842|76026557|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
42211573|NCT02935842|76026558|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
42211574|NCT03680911|76026577|FG000|At Home Treatment|Study Termination|3|||
42211575|NCT03680911|76026578|FG001|At Home Treatment|Study Termination|0|||
42211576|NCT03680911|76026577|FG000|At Home Treatment|Lost to Follow-up|0|||
42211577|NCT03680911|76026578|FG001|At Home Treatment|Lost to Follow-up|1|||
42211578|NCT03680911|76026577|FG000|At Home Treatment|Withdrawal by Subject|0|||
42211579|NCT03680911|76026578|FG001|At Home Treatment|Withdrawal by Subject|2|||
42211580|NCT03680911|76026577|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
42301762|NCT02314143|76136908|FG002|Overall Study|Physician Decision|0|||
41974868|NCT03954041|75776973|FG002|Overall Study|Death by neurologic criteria|1|||
41974869|NCT03954041|75776971|FG000|Overall Study|Reason not specified|7|||
41974870|NCT03954041|75776972|FG001|Overall Study|Reason not specified|4|||
41974871|NCT03954041|75776973|FG002|Overall Study|Reason not specified|2|||
41974872|NCT03954041|75776971|FG000|Overall Study|Withdrew prior to dosing|4|||
41974873|NCT03954041|75776972|FG001|Overall Study|Withdrew prior to dosing|2|||
41974874|NCT03954041|75776973|FG002|Overall Study|Withdrew prior to dosing|0|||
41974875|NCT03926195|75776983|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
41974876|NCT03926195|75776984|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
41974877|NCT03926195|75776983|FG000|EXT Phase (Through Week 26)|Ongoing in the study|29|||
41974878|NCT03926195|75776984|FG001|EXT Phase (Through Week 26)|Ongoing in the study|36|||
41974879|NCT03926195|75776983|FG000|EXT Phase (Through Week 26)|Adverse Event|5|||
41974880|NCT03926195|75776984|FG001|EXT Phase (Through Week 26)|Adverse Event|0|||
42301763|NCT02314143|76136906|FG000|Overall Study|Withdrawal by Subject|1|||
42301764|NCT02314143|76136907|FG001|Overall Study|Withdrawal by Subject|0|||
42301765|NCT02314143|76136908|FG002|Overall Study|Withdrawal by Subject|1|||
42301766|NCT02288091|76136917|FG000|Overall Study|Lost to Follow-up|1|||
42301767|NCT02288091|76136917|FG000|Overall Study|Screen fail|7|||
42301768|NCT02503501|76136923|FG000|Overall Study|Physician Decision|1|||
42301769|NCT02503501|76136924|FG001|Overall Study|Physician Decision|0|||
42301770|NCT02503501|76136923|FG000|Overall Study|Protocol Violation|0|||
42301771|NCT02503501|76136924|FG001|Overall Study|Protocol Violation|1|||
42301772|NCT02503501|76136923|FG000|Overall Study|Withdrawal by Subject|0|||
42301773|NCT02503501|76136924|FG001|Overall Study|Withdrawal by Subject|2|||
42301774|NCT02502097|76136934|FG000|Period 1|Adverse Event|0|||
42301775|NCT02502097|76136935|FG001|Period 1|Adverse Event|0|||
42301776|NCT02502097|76136936|FG002|Period 1|Adverse Event|1|||
42301777|NCT02502097|76136937|FG003|Period 1|Adverse Event|0|||
42301778|NCT02502097|76136934|FG000|Wash Out Period|Adverse Event|0|||
42301779|NCT02502097|76136935|FG001|Wash Out Period|Adverse Event|1|||
42301780|NCT02502097|76136936|FG002|Wash Out Period|Adverse Event|1|||
42301781|NCT02502097|76136937|FG003|Wash Out Period|Adverse Event|1|||
42301782|NCT02502097|76136934|FG000|Period 2|Adverse Event|0|||
42301783|NCT02502097|76136935|FG001|Period 2|Adverse Event|0|||
42301784|NCT02502097|76136936|FG002|Period 2|Adverse Event|1|||
41974881|NCT03926195|75776983|FG000|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|12|||
42301785|NCT02502097|76136937|FG003|Period 2|Adverse Event|0|||
42301786|NCT02501629|76136946|FG000|Overall Study|Death|0|||
42301787|NCT02501629|76136947|FG001|Overall Study|Death|1|||
41974882|NCT03926195|75776984|FG001|EXT Phase (Through Week 26)|Pre-Specified Decrease In Sperm Parameters|11|||
41974883|NCT03926195|75776983|FG000|EXT Phase (Through Week 26)|Withdrawal by Subject|0|||
41974884|NCT03926195|75776984|FG001|EXT Phase (Through Week 26)|Withdrawal by Subject|2|||
41974885|NCT03908476|75776999|FG000|Overall Study|Death|3|||
41974886|NCT03908476|75777000|FG001|Overall Study|Death|0|||
41974887|NCT03908476|75776999|FG000|Overall Study|Lost to Follow-up|3|||
41974888|NCT03908476|75777000|FG001|Overall Study|Lost to Follow-up|1|||
41974889|NCT03908476|75776999|FG000|Overall Study|Withdrawal by Subject|7|||
41974890|NCT03908476|75777000|FG001|Overall Study|Withdrawal by Subject|1|||
41974891|NCT03908476|75776999|FG000|Overall Study|Physician Decision|2|||
41974892|NCT03908476|75777000|FG001|Overall Study|Physician Decision|0|||
41974893|NCT03908476|75776999|FG000|Overall Study|System Explanted and not Replaced|4|||
41974894|NCT03908476|75777000|FG001|Overall Study|System Explanted and not Replaced|0|||
41974895|NCT03908476|75776999|FG000|Overall Study|Intrathecal Pump|1|||
41974896|NCT03908476|75777000|FG001|Overall Study|Intrathecal Pump|0|||
41974897|NCT03908476|75776999|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
41974898|NCT03908476|75777000|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
41974899|NCT03830866|75777008|FG000|Overall Study|Ongoing study at DCO|312|||
41974900|NCT03830866|75777009|FG001|Overall Study|Ongoing study at DCO|295|||
41974901|NCT03830866|75777008|FG000|Overall Study|Death|58|||
41974902|NCT03830866|75777009|FG001|Overall Study|Death|74|||
41974903|NCT03830866|75777008|FG000|Overall Study|Lost to Follow-up|0|||
41974904|NCT03830866|75777009|FG001|Overall Study|Lost to Follow-up|1|||
41974905|NCT03830866|75777008|FG000|Overall Study|Withdrawal by Subject|15|||
41974906|NCT03830866|75777009|FG001|Overall Study|Withdrawal by Subject|13|||
41974907|NCT03830866|75777008|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
41974908|NCT03830866|75777009|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
41974909|NCT03830866|75777008|FG000|Overall Study|Other|0|||
41974910|NCT03830866|75777009|FG001|Overall Study|Other|1|||
41974911|NCT03699007|75777026|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
41974912|NCT03699007|75777027|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
41974913|NCT03699007|75777026|FG000|6-month Follow Up|Lost to Follow-up|2|||
41974914|NCT03699007|75777027|FG001|6-month Follow Up|Lost to Follow-up|3|||
41974915|NCT03581188|75777037|FG000|Overall Study|Inclusion criteria not met|3|||
41974916|NCT03581188|75777038|FG001|Overall Study|Inclusion criteria not met|2|||
41974917|NCT03581188|75777037|FG000|Overall Study|Lost to Follow-up|5|||
41974918|NCT03581188|75777038|FG001|Overall Study|Lost to Follow-up|5|||
41974919|NCT03581188|75777037|FG000|Overall Study|Discontinued intervention|11|||
41974920|NCT03581188|75777038|FG001|Overall Study|Discontinued intervention|8|||
41974921|NCT03576131|75777055|FG000|Overall Study|Investigator decision|0|||
41974922|NCT03576131|75777056|FG001|Overall Study|Investigator decision|0|||
41974923|NCT03576131|75777057|FG002|Overall Study|Investigator decision|0|||
42127780|NCT03026283|75938215|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
42127781|NCT03026283|75938216|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
42127782|NCT03026283|75938217|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
42127783|NCT03026283|75938218|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
42127784|NCT03026283|75938211|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
42127785|NCT03026283|75938212|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
42211581|NCT03680911|76026578|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
42211582|NCT03224130|76026586|FG000|Overall Study|consent issue|0|||
42211583|NCT03224130|76026587|FG001|Overall Study|consent issue|1|||
42211584|NCT03679741|76026593|FG000|Period 1|No longer meet eligibility criteria|1|||
42211585|NCT03679741|76026594|FG001|Period 1|No longer meet eligibility criteria|0|||
42211586|NCT03679741|76026593|FG000|Period 1|Lost to Follow-up|0|||
42211587|NCT03679741|76026594|FG001|Period 1|Lost to Follow-up|1|||
42211588|NCT03679741|76026593|FG000|Period 1|Adverse Event|1|||
42127786|NCT03026283|75938213|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
42127787|NCT03026283|75938214|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
42127788|NCT03026283|75938215|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
42211589|NCT03679741|76026594|FG001|Period 1|Adverse Event|1|||
42211590|NCT03679741|76026593|FG000|Period 1|Withdrawal by Subject|0|||
42211591|NCT03679741|76026594|FG001|Period 1|Withdrawal by Subject|1|||
42211592|NCT03679741|76026593|FG000|Period 2|Adverse Event|2|||
42211593|NCT03679741|76026594|FG001|Period 2|Adverse Event|1|||
42211594|NCT03679741|76026593|FG000|Period 2|Withdrawal by Subject|1|||
42211595|NCT03679741|76026594|FG001|Period 2|Withdrawal by Subject|1|||
42211596|NCT03678103|76026600|FG000|Overall Study|Withdrawn prior to completion|4|||
42211597|NCT03649477|76026607|FG000|Overall Study|Adverse Event|2|||
41974924|NCT03576131|75777058|FG003|Overall Study|Investigator decision|1|||
41974925|NCT03576131|75777059|FG004|Overall Study|Investigator decision|0|||
41974926|NCT03576131|75777060|FG005|Overall Study|Investigator decision|1|||
41974927|NCT03576131|75777061|FG006|Overall Study|Investigator decision|0|||
41974928|NCT03576131|75777062|FG007|Overall Study|Investigator decision|0|||
42211598|NCT03649477|76026608|FG001|Overall Study|Adverse Event|0|||
41974929|NCT03576131|75777055|FG000|Overall Study|Withdrawal by Subject|1|||
41974930|NCT03576131|75777056|FG001|Overall Study|Withdrawal by Subject|1|||
41974931|NCT03576131|75777057|FG002|Overall Study|Withdrawal by Subject|0|||
41974932|NCT03576131|75777058|FG003|Overall Study|Withdrawal by Subject|1|||
41974933|NCT03576131|75777059|FG004|Overall Study|Withdrawal by Subject|2|||
41974934|NCT03576131|75777060|FG005|Overall Study|Withdrawal by Subject|3|||
41974935|NCT03576131|75777061|FG006|Overall Study|Withdrawal by Subject|1|||
41974936|NCT03576131|75777062|FG007|Overall Study|Withdrawal by Subject|0|||
41974937|NCT03576131|75777055|FG000|Overall Study|Death|3|||
41974938|NCT03576131|75777056|FG001|Overall Study|Death|3|||
41974939|NCT03576131|75777057|FG002|Overall Study|Death|1|||
41974940|NCT03576131|75777058|FG003|Overall Study|Death|5|||
41974941|NCT03576131|75777059|FG004|Overall Study|Death|4|||
41974942|NCT03576131|75777060|FG005|Overall Study|Death|1|||
41974943|NCT03576131|75777061|FG006|Overall Study|Death|0|||
41974944|NCT03576131|75777062|FG007|Overall Study|Death|1|||
41974945|NCT03576131|75777055|FG000|Overall Study|New anti-cancer treatment|5|||
41974946|NCT03576131|75777056|FG001|Overall Study|New anti-cancer treatment|1|||
41974947|NCT03576131|75777057|FG002|Overall Study|New anti-cancer treatment|2|||
41974948|NCT03576131|75777058|FG003|Overall Study|New anti-cancer treatment|3|||
41974949|NCT03576131|75777059|FG004|Overall Study|New anti-cancer treatment|0|||
41974950|NCT03576131|75777060|FG005|Overall Study|New anti-cancer treatment|0|||
41974951|NCT03576131|75777061|FG006|Overall Study|New anti-cancer treatment|0|||
41974952|NCT03576131|75777062|FG007|Overall Study|New anti-cancer treatment|0|||
41974953|NCT03576131|75777055|FG000|Overall Study|Unspecified reason|0|||
41974954|NCT03576131|75777056|FG001|Overall Study|Unspecified reason|0|||
41974955|NCT03576131|75777057|FG002|Overall Study|Unspecified reason|1|||
41974956|NCT03576131|75777058|FG003|Overall Study|Unspecified reason|1|||
41974957|NCT03576131|75777059|FG004|Overall Study|Unspecified reason|1|||
41974958|NCT03576131|75777060|FG005|Overall Study|Unspecified reason|1|||
41974959|NCT03576131|75777061|FG006|Overall Study|Unspecified reason|0|||
41974960|NCT03576131|75777062|FG007|Overall Study|Unspecified reason|0|||
41974961|NCT03576131|75777055|FG000|Overall Study|Subject non-compliance|0|||
41974962|NCT03576131|75777056|FG001|Overall Study|Subject non-compliance|0|||
41974963|NCT03576131|75777057|FG002|Overall Study|Subject non-compliance|0|||
41974964|NCT03576131|75777058|FG003|Overall Study|Subject non-compliance|0|||
41974965|NCT03576131|75777059|FG004|Overall Study|Subject non-compliance|0|||
41974966|NCT03576131|75777060|FG005|Overall Study|Subject non-compliance|1|||
41974967|NCT03576131|75777061|FG006|Overall Study|Subject non-compliance|0|||
41974968|NCT03576131|75777062|FG007|Overall Study|Subject non-compliance|0|||
41974969|NCT03454529|75777099|FG000|Overall Study|Did not receive treatment|6|||
41974970|NCT03454529|75777099|FG000|Overall Study|Received < 80% doses|1|||
41974971|NCT03409731|75777103|FG000|Overall Study|Withdrawal by Subject|1|||
41974972|NCT03409731|75777103|FG000|Overall Study|Death|4|||
41974973|NCT03246061|75777118|FG000|Overall Study|Still in follow-up|15|||
41974974|NCT03246061|75777119|FG001|Overall Study|Still in follow-up|21|||
41974975|NCT02988817|75777156|FG000|Overall Study|Withdrawal by Subject|1|||
41974976|NCT02988817|75777157|FG001|Overall Study|Withdrawal by Subject|0|||
41974977|NCT02988817|75777158|FG002|Overall Study|Withdrawal by Subject|0|||
41974978|NCT02988817|75777159|FG003|Overall Study|Withdrawal by Subject|1|||
41974979|NCT02988817|75777160|FG004|Overall Study|Withdrawal by Subject|3|||
41974980|NCT02988817|75777161|FG005|Overall Study|Withdrawal by Subject|1|||
42127789|NCT03026283|75938216|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
42127790|NCT03026283|75938217|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
42127791|NCT03026283|75938218|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
42127792|NCT03026283|75938211|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
42127793|NCT03026283|75938212|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
42127794|NCT03026283|75938213|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
41974981|NCT02988817|75777162|FG006|Overall Study|Withdrawal by Subject|2|||
41974982|NCT02988817|75777163|FG007|Overall Study|Withdrawal by Subject|1|||
41974983|NCT02988817|75777164|FG008|Overall Study|Withdrawal by Subject|1|||
41974984|NCT02988817|75777165|FG009|Overall Study|Withdrawal by Subject|1|||
41974985|NCT02988817|75777166|FG010|Overall Study|Withdrawal by Subject|1|||
41974986|NCT02988817|75777167|FG011|Overall Study|Withdrawal by Subject|12|||
41974987|NCT02988817|75777168|FG012|Overall Study|Withdrawal by Subject|6|||
41974988|NCT02988817|75777169|FG013|Overall Study|Withdrawal by Subject|6|||
41974989|NCT02988817|75777170|FG014|Overall Study|Withdrawal by Subject|4|||
41974990|NCT02988817|75777171|FG015|Overall Study|Withdrawal by Subject|5|||
41974991|NCT02988817|75777172|FG016|Overall Study|Withdrawal by Subject|4|||
41974992|NCT02988817|75777173|FG017|Overall Study|Withdrawal by Subject|11|||
41974993|NCT02988817|75777174|FG018|Overall Study|Withdrawal by Subject|4|||
41974994|NCT02988817|75777175|FG019|Overall Study|Withdrawal by Subject|2|||
41974995|NCT02988817|75777156|FG000|Overall Study|Death|0|||
41974996|NCT02988817|75777157|FG001|Overall Study|Death|1|||
41974997|NCT02988817|75777158|FG002|Overall Study|Death|3|||
41974998|NCT02988817|75777159|FG003|Overall Study|Death|1|||
42127795|NCT03026283|75938214|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
42211599|NCT03649477|76026609|FG002|Overall Study|Adverse Event|0|||
42211600|NCT03677869|76026617|FG000|Overall Study|Withdrawal by Subject|1|||
42211601|NCT03677401|76026623|FG000|Overall Study|Adverse Event|4|||
42301788|NCT02501629|76136946|FG000|Overall Study|Withdrawn from study by sponsor|1|||
41974999|NCT02988817|75777160|FG004|Overall Study|Death|6|||
41975000|NCT02988817|75777161|FG005|Overall Study|Death|10|||
41975001|NCT02988817|75777162|FG006|Overall Study|Death|1|||
41975002|NCT02988817|75777163|FG007|Overall Study|Death|2|||
41975003|NCT02988817|75777164|FG008|Overall Study|Death|1|||
41975004|NCT02988817|75777165|FG009|Overall Study|Death|5|||
41975005|NCT02988817|75777166|FG010|Overall Study|Death|1|||
41975006|NCT02988817|75777167|FG011|Overall Study|Death|8|||
41975007|NCT02988817|75777168|FG012|Overall Study|Death|9|||
41975008|NCT02988817|75777169|FG013|Overall Study|Death|17|||
41975009|NCT02988817|75777170|FG014|Overall Study|Death|18|||
41975010|NCT02988817|75777171|FG015|Overall Study|Death|30|||
41975011|NCT02988817|75777172|FG016|Overall Study|Death|17|||
41975012|NCT02988817|75777173|FG017|Overall Study|Death|38|||
41975013|NCT02988817|75777174|FG018|Overall Study|Death|14|||
41975014|NCT02988817|75777175|FG019|Overall Study|Death|16|||
41975015|NCT02988817|75777156|FG000|Overall Study|Other|0|||
41975016|NCT02988817|75777157|FG001|Overall Study|Other|0|||
41975017|NCT02988817|75777158|FG002|Overall Study|Other|0|||
41975018|NCT02988817|75777159|FG003|Overall Study|Other|1|||
41975019|NCT02988817|75777160|FG004|Overall Study|Other|1|||
41975020|NCT02988817|75777161|FG005|Overall Study|Other|0|||
41975021|NCT02988817|75777162|FG006|Overall Study|Other|0|||
41975022|NCT02988817|75777163|FG007|Overall Study|Other|0|||
41975023|NCT02988817|75777164|FG008|Overall Study|Other|0|||
41975024|NCT02988817|75777165|FG009|Overall Study|Other|0|||
41975025|NCT02988817|75777166|FG010|Overall Study|Other|0|||
41975026|NCT02988817|75777167|FG011|Overall Study|Other|0|||
41975027|NCT02988817|75777168|FG012|Overall Study|Other|0|||
41975028|NCT02988817|75777169|FG013|Overall Study|Other|0|||
41975029|NCT02988817|75777170|FG014|Overall Study|Other|0|||
41975030|NCT02988817|75777171|FG015|Overall Study|Other|1|||
41975031|NCT02988817|75777172|FG016|Overall Study|Other|0|||
41975032|NCT02988817|75777173|FG017|Overall Study|Other|0|||
41975033|NCT02988817|75777174|FG018|Overall Study|Other|0|||
41975034|NCT02988817|75777175|FG019|Overall Study|Other|0|||
41975035|NCT02988817|75777156|FG000|Overall Study|Lost to Follow-up|0|||
41975036|NCT02988817|75777157|FG001|Overall Study|Lost to Follow-up|0|||
41975037|NCT02988817|75777158|FG002|Overall Study|Lost to Follow-up|0|||
41975038|NCT02988817|75777159|FG003|Overall Study|Lost to Follow-up|0|||
41975039|NCT02988817|75777160|FG004|Overall Study|Lost to Follow-up|0|||
41975040|NCT02988817|75777161|FG005|Overall Study|Lost to Follow-up|0|||
41975041|NCT02988817|75777162|FG006|Overall Study|Lost to Follow-up|0|||
41975042|NCT02988817|75777163|FG007|Overall Study|Lost to Follow-up|0|||
41975043|NCT02988817|75777164|FG008|Overall Study|Lost to Follow-up|1|||
41975044|NCT02988817|75777165|FG009|Overall Study|Lost to Follow-up|0|||
41975045|NCT02988817|75777166|FG010|Overall Study|Lost to Follow-up|1|||
41975046|NCT02988817|75777167|FG011|Overall Study|Lost to Follow-up|1|||
41975047|NCT02988817|75777168|FG012|Overall Study|Lost to Follow-up|0|||
41975048|NCT02988817|75777169|FG013|Overall Study|Lost to Follow-up|0|||
41975049|NCT02988817|75777170|FG014|Overall Study|Lost to Follow-up|1|||
41975050|NCT02988817|75777171|FG015|Overall Study|Lost to Follow-up|1|||
41975051|NCT02988817|75777172|FG016|Overall Study|Lost to Follow-up|2|||
42127796|NCT03026283|75938215|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
42127797|NCT03026283|75938216|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
42127798|NCT03026283|75938217|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
42127799|NCT03026283|75938218|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
42127800|NCT03026283|75938211|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
42127801|NCT03026283|75938212|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
42127802|NCT03026283|75938213|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
42127803|NCT03026283|75938214|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
42127804|NCT03026283|75938215|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
41975052|NCT02988817|75777173|FG017|Overall Study|Lost to Follow-up|3|||
41975053|NCT02988817|75777174|FG018|Overall Study|Lost to Follow-up|0|||
41975054|NCT02988817|75777175|FG019|Overall Study|Lost to Follow-up|0|||
41975055|NCT02988817|75777156|FG000|Overall Study|Sponsor decision|0|||
42211602|NCT03677401|76026624|FG001|Overall Study|Adverse Event|14|||
42211603|NCT03677401|76026623|FG000|Overall Study|Lack of Efficacy|3|||
41975056|NCT02988817|75777157|FG001|Overall Study|Sponsor decision|0|||
41975057|NCT02988817|75777158|FG002|Overall Study|Sponsor decision|0|||
41975058|NCT02988817|75777159|FG003|Overall Study|Sponsor decision|0|||
41975059|NCT02988817|75777160|FG004|Overall Study|Sponsor decision|0|||
41975060|NCT02988817|75777161|FG005|Overall Study|Sponsor decision|0|||
41975061|NCT02988817|75777162|FG006|Overall Study|Sponsor decision|0|||
41975062|NCT02988817|75777163|FG007|Overall Study|Sponsor decision|0|||
41975063|NCT02988817|75777164|FG008|Overall Study|Sponsor decision|0|||
41975064|NCT02988817|75777165|FG009|Overall Study|Sponsor decision|0|||
42211604|NCT03677401|76026624|FG001|Overall Study|Lack of Efficacy|1|||
42211605|NCT03677401|76026623|FG000|Overall Study|Withdrawal by Subject|2|||
42211606|NCT03677401|76026624|FG001|Overall Study|Withdrawal by Subject|2|||
42211607|NCT03677401|76026623|FG000|Overall Study|Sponsor decision|0|||
42211608|NCT03677401|76026624|FG001|Overall Study|Sponsor decision|1|||
42211609|NCT03677401|76026623|FG000|Overall Study|Reason Unspecified|1|||
42211610|NCT03677401|76026624|FG001|Overall Study|Reason Unspecified|0|||
42211611|NCT03218787|76026630|FG000|Overall Study|Lost to Follow-up|12|||
42211612|NCT03218787|76026630|FG000|Overall Study|Withdrawal by Subject|72|||
42211613|NCT03218787|76026630|FG000|Overall Study|Physician Decision|11|||
42211614|NCT03218787|76026630|FG000|Overall Study|Death|111|||
42211615|NCT01348087|76026634|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
42211616|NCT01348087|76026634|FG000|Overall Study|Administrative problems|79|||
42211617|NCT01348087|76026634|FG000|Overall Study|protocol deviation|1|||
42211618|NCT01348087|76026634|FG000|Overall Study|Lost to Follow-up|1|||
41975065|NCT02988817|75777166|FG010|Overall Study|Sponsor decision|0|||
41975066|NCT02988817|75777167|FG011|Overall Study|Sponsor decision|1|||
41975067|NCT02988817|75777168|FG012|Overall Study|Sponsor decision|1|||
41975068|NCT02988817|75777169|FG013|Overall Study|Sponsor decision|2|||
41975069|NCT02988817|75777170|FG014|Overall Study|Sponsor decision|2|||
41975070|NCT02988817|75777171|FG015|Overall Study|Sponsor decision|6|||
41975071|NCT02988817|75777172|FG016|Overall Study|Sponsor decision|2|||
41975072|NCT02988817|75777173|FG017|Overall Study|Sponsor decision|3|||
41975073|NCT02988817|75777174|FG018|Overall Study|Sponsor decision|2|||
41975074|NCT02988817|75777175|FG019|Overall Study|Sponsor decision|7|||
41975075|NCT02988817|75777156|FG000|Overall Study|Physician Decision|0|||
41975076|NCT02988817|75777157|FG001|Overall Study|Physician Decision|0|||
42028145|NCT00960531|75836476|FG004|Overall Study|Lack of Efficacy|0|||
42028146|NCT00960531|75836477|FG005|Overall Study|Lack of Efficacy|0|||
42028147|NCT00960531|75836478|FG006|Overall Study|Lack of Efficacy|0|||
42028148|NCT00960531|75836479|FG007|Overall Study|Lack of Efficacy|0|||
42127805|NCT03026283|75938216|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
42127806|NCT03026283|75938217|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
41975077|NCT02988817|75777158|FG002|Overall Study|Physician Decision|0|||
41975078|NCT02988817|75777159|FG003|Overall Study|Physician Decision|0|||
41975079|NCT02988817|75777160|FG004|Overall Study|Physician Decision|0|||
42127807|NCT03026283|75938218|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
42127808|NCT01994954|75938285|FG000|Overall Study|Death|1|||
42127809|NCT01994954|75938286|FG001|Overall Study|Death|0|||
42127810|NCT01994954|75938285|FG000|Overall Study|Withdrawal by Subject|9|||
42127811|NCT01994954|75938286|FG001|Overall Study|Withdrawal by Subject|14|||
42127812|NCT01994954|75938285|FG000|Overall Study|Physician Decision|2|||
42127813|NCT01994954|75938286|FG001|Overall Study|Physician Decision|2|||
42127814|NCT01994954|75938285|FG000|Overall Study|Lost to Follow-up|8|||
42127815|NCT01994954|75938286|FG001|Overall Study|Lost to Follow-up|10|||
42127816|NCT01994954|75938285|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
42127817|NCT01994954|75938286|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
42127818|NCT00380367|75938363|FG000|Overall Study|Lost to Follow-up|1|||
42127819|NCT00380367|75938363|FG000|Overall Study|Withdrawal by Subject|1|||
42127820|NCT00531050|75938373|FG000|Part 1: Period 1|Adverse Event|0|||
42127821|NCT00531050|75938374|FG001|Part 1: Period 1|Adverse Event|1|||
42127822|NCT00531050|75938375|FG002|Part 1: Period 1|Adverse Event|0|||
42127823|NCT00531050|75938376|FG003|Part 1: Period 1|Adverse Event|0|||
42127824|NCT00531050|75938377|FG004|Part 1: Period 1|Adverse Event|0|||
42127825|NCT00531050|75938378|FG005|Part 1: Period 1|Adverse Event|0|||
42127826|NCT00531050|75938373|FG000|Part 1: Period 1|Protocol Deviation|0|||
42127827|NCT00531050|75938374|FG001|Part 1: Period 1|Protocol Deviation|0|||
42127828|NCT00531050|75938375|FG002|Part 1: Period 1|Protocol Deviation|0|||
42127829|NCT00531050|75938376|FG003|Part 1: Period 1|Protocol Deviation|1|||
42127830|NCT00531050|75938377|FG004|Part 1: Period 1|Protocol Deviation|0|||
42127831|NCT00531050|75938378|FG005|Part 1: Period 1|Protocol Deviation|0|||
42127832|NCT00531050|75938373|FG000|Part 1: Period 3|Adverse Event|1|||
42127833|NCT00531050|75938374|FG001|Part 1: Period 3|Adverse Event|0|||
42127834|NCT00531050|75938375|FG002|Part 1: Period 3|Adverse Event|0|||
42211619|NCT01348087|76026634|FG000|Overall Study|Subject withdrew consent|7|||
41975080|NCT02988817|75777161|FG005|Overall Study|Physician Decision|0|||
41975081|NCT02988817|75777162|FG006|Overall Study|Physician Decision|0|||
42211620|NCT01348087|76026634|FG000|Overall Study|Adverse Event|25|||
42211621|NCT01347931|76026648|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
42211622|NCT03645421|76026658|FG000|Overall Study|Adverse Event|0|||
42211623|NCT03645421|76026659|FG001|Overall Study|Adverse Event|0|||
41975082|NCT02988817|75777163|FG007|Overall Study|Physician Decision|0|||
42127835|NCT00531050|75938376|FG003|Part 1: Period 3|Adverse Event|0|||
42127836|NCT00531050|75938377|FG004|Part 1: Period 3|Adverse Event|0|||
42127837|NCT00531050|75938378|FG005|Part 1: Period 3|Adverse Event|0|||
42127838|NCT00531050|75938373|FG000|Part 2: Period 1|Adverse Event|0|||
42127839|NCT00531050|75938374|FG001|Part 2: Period 1|Adverse Event|0|||
42127840|NCT00531050|75938375|FG002|Part 2: Period 1|Adverse Event|0|||
41975083|NCT02988817|75777164|FG008|Overall Study|Physician Decision|0|||
41975084|NCT02988817|75777165|FG009|Overall Study|Physician Decision|0|||
41975085|NCT02988817|75777166|FG010|Overall Study|Physician Decision|0|||
41975086|NCT02988817|75777167|FG011|Overall Study|Physician Decision|0|||
41975087|NCT02988817|75777168|FG012|Overall Study|Physician Decision|0|||
41975088|NCT02988817|75777169|FG013|Overall Study|Physician Decision|0|||
41975089|NCT02988817|75777170|FG014|Overall Study|Physician Decision|0|||
41975090|NCT02988817|75777171|FG015|Overall Study|Physician Decision|1|||
41975091|NCT02988817|75777172|FG016|Overall Study|Physician Decision|0|||
41975092|NCT02988817|75777173|FG017|Overall Study|Physician Decision|0|||
41975093|NCT02988817|75777174|FG018|Overall Study|Physician Decision|1|||
41975094|NCT02988817|75777175|FG019|Overall Study|Physician Decision|1|||
41975095|NCT02960659|75777230|FG000|Overall Study|Withdrawal by Subject|1|||
41975096|NCT02960659|75777231|FG001|Overall Study|Withdrawal by Subject|0|||
41975097|NCT02960659|75777230|FG000|Overall Study|Poor compliance|0|||
41975098|NCT02960659|75777231|FG001|Overall Study|Poor compliance|1|||
41975099|NCT02844933|75777239|FG000|Overall Study|Discontinued due to premature termination of study|3|||
41975100|NCT02844933|75777240|FG001|Overall Study|Discontinued due to premature termination of study|2|||
41975101|NCT02499835|75777269|FG000|Overall Study|Withdrawal by Subject|1|||
41975102|NCT02499835|75777270|FG001|Overall Study|Withdrawal by Subject|0|||
41975103|NCT02499835|75777271|FG002|Overall Study|Withdrawal by Subject|0|||
41975104|NCT02499835|75777272|FG003|Overall Study|Withdrawal by Subject|1|||
41975105|NCT02499835|75777269|FG000|Overall Study|Physician Decision|0|||
41975106|NCT02499835|75777270|FG001|Overall Study|Physician Decision|3|||
41975107|NCT02499835|75777271|FG002|Overall Study|Physician Decision|18|||
41975108|NCT02499835|75777272|FG003|Overall Study|Physician Decision|7|||
41975109|NCT02499835|75777269|FG000|Overall Study|Adverse Event|0|||
41975110|NCT02499835|75777270|FG001|Overall Study|Adverse Event|0|||
41975111|NCT02499835|75777271|FG002|Overall Study|Adverse Event|0|||
41975112|NCT02499835|75777272|FG003|Overall Study|Adverse Event|1|||
41975113|NCT02499835|75777269|FG000|Overall Study|Disease progression|2|||
41975114|NCT02499835|75777270|FG001|Overall Study|Disease progression|1|||
41975115|NCT02499835|75777271|FG002|Overall Study|Disease progression|0|||
41975116|NCT02499835|75777272|FG003|Overall Study|Disease progression|7|||
41975117|NCT02460497|75777284|FG000|Overall Study|Participant Requested Withdrawal|4|||
41975118|NCT02460497|75777284|FG000|Overall Study|Non-Compliance|1|||
41975119|NCT02460497|75777284|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
41975120|NCT02460497|75777284|FG000|Overall Study|Lost to Follow-up|2|||
41975121|NCT02460497|75777284|FG000|Overall Study|Investigator Decision|1|||
41975122|NCT02460289|75777288|FG000|Overall Study|Adverse Event|1|||
41975123|NCT02460289|75777288|FG000|Overall Study|Withdrawal by Subject|8|||
41975124|NCT02460289|75777288|FG000|Overall Study|Lost to Follow-up|1|||
41975125|NCT02354651|75777299|FG000|Overall Study|Withdrawal by Subject|2|||
41975126|NCT02354651|75777299|FG000|Overall Study|Physician Decision|1|||
41975127|NCT02253316|75777306|FG000|Consolidation|Progression|4|||
41975128|NCT02253316|75777307|FG001|Consolidation|Progression|0|||
41975129|NCT02253316|75777308|FG002|Consolidation|Progression|0|||
41975130|NCT02253316|75777306|FG000|Consolidation|Non-Compliance|1|||
41975131|NCT02253316|75777307|FG001|Consolidation|Non-Compliance|0|||
41975132|NCT02253316|75777308|FG002|Consolidation|Non-Compliance|0|||
41975133|NCT02253316|75777306|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
41975134|NCT02253316|75777307|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
41975135|NCT02253316|75777308|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
41975136|NCT02253316|75777306|FG000|Consolidation|Secondary Malignancy|2|||
41975137|NCT02253316|75777307|FG001|Consolidation|Secondary Malignancy|0|||
41975138|NCT02253316|75777308|FG002|Consolidation|Secondary Malignancy|0|||
41975139|NCT02253316|75777306|FG000|Consolidation|Adverse Event|7|||
41975140|NCT02253316|75777307|FG001|Consolidation|Adverse Event|0|||
41975141|NCT02253316|75777308|FG002|Consolidation|Adverse Event|0|||
41975142|NCT02253316|75777306|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
41975143|NCT02253316|75777307|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
41975144|NCT02253316|75777308|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
41975145|NCT02253316|75777306|FG000|Maintenance|Physician Decision|0|||
41975146|NCT02253316|75777307|FG001|Maintenance|Physician Decision|5|||
41975147|NCT02253316|75777308|FG002|Maintenance|Physician Decision|16|||
41975148|NCT02253316|75777306|FG000|Maintenance|Non-Compliance|0|||
41975149|NCT02253316|75777307|FG001|Maintenance|Non-Compliance|1|||
41975150|NCT02253316|75777308|FG002|Maintenance|Non-Compliance|1|||
41975151|NCT02253316|75777306|FG000|Maintenance|Secondary Malignancy|0|||
41975152|NCT02253316|75777307|FG001|Maintenance|Secondary Malignancy|2|||
41975153|NCT02253316|75777308|FG002|Maintenance|Secondary Malignancy|5|||
41975154|NCT02253316|75777306|FG000|Maintenance|Adverse Event|0|||
41975155|NCT02253316|75777307|FG001|Maintenance|Adverse Event|8|||
41975156|NCT02253316|75777308|FG002|Maintenance|Adverse Event|12|||
41975157|NCT02253316|75777306|FG000|Maintenance|Still receiving active treatment|0|||
41975158|NCT02253316|75777307|FG001|Maintenance|Still receiving active treatment|8|||
41975159|NCT02253316|75777308|FG002|Maintenance|Still receiving active treatment|1|||
42211624|NCT03645421|76026660|FG002|Overall Study|Adverse Event|4|||
42211625|NCT03645421|76026661|FG003|Overall Study|Adverse Event|1|||
42211626|NCT03645421|76026658|FG000|Overall Study|Withdrawal by patient|0|||
42211627|NCT03645421|76026659|FG001|Overall Study|Withdrawal by patient|0|||
42211628|NCT03645421|76026660|FG002|Overall Study|Withdrawal by patient|0|||
42211629|NCT03645421|76026661|FG003|Overall Study|Withdrawal by patient|3|||
42211630|NCT03645421|76026658|FG000|Overall Study|Study specific withdrawal criteria|0|||
42211631|NCT03645421|76026659|FG001|Overall Study|Study specific withdrawal criteria|0|||
42211632|NCT03645421|76026660|FG002|Overall Study|Study specific withdrawal criteria|1|||
42211633|NCT03645421|76026661|FG003|Overall Study|Study specific withdrawal criteria|0|||
42211634|NCT03207750|76026676|FG000|Overall Study|Adverse Event|3|||
42211635|NCT03207750|76026677|FG001|Overall Study|Adverse Event|2|||
42211636|NCT03207750|76026676|FG000|Overall Study|Lost to Follow-up|21|||
42211637|NCT03207750|76026677|FG001|Overall Study|Lost to Follow-up|29|||
42211638|NCT03207750|76026676|FG000|Overall Study|Protocol Violation|0|||
42211639|NCT03207750|76026677|FG001|Overall Study|Protocol Violation|1|||
42211640|NCT03207750|76026676|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
42211641|NCT03207750|76026677|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
42211642|NCT03207750|76026676|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
42211643|NCT03207750|76026677|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
42211644|NCT03207750|76026676|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
42211645|NCT03207750|76026677|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
41975160|NCT02214160|75777319|FG000|Overall Study|Withdrawal by Subject|1|||
41975161|NCT02214160|75777320|FG001|Overall Study|Withdrawal by Subject|0|||
41975162|NCT02214160|75777321|FG002|Overall Study|Withdrawal by Subject|6|||
41975163|NCT02214160|75777319|FG000|Overall Study|Death|2|||
41975164|NCT02214160|75777320|FG001|Overall Study|Death|2|||
41975165|NCT02214160|75777321|FG002|Overall Study|Death|1|||
41975166|NCT02214160|75777319|FG000|Overall Study|Subject Non-Compliance|0|||
41975167|NCT02214160|75777320|FG001|Overall Study|Subject Non-Compliance|3|||
41975168|NCT02214160|75777321|FG002|Overall Study|Subject Non-Compliance|1|||
41975169|NCT02214160|75777319|FG000|Overall Study|Adverse Event|0|||
41975170|NCT02214160|75777320|FG001|Overall Study|Adverse Event|1|||
41975171|NCT02214160|75777321|FG002|Overall Study|Adverse Event|1|||
41975172|NCT02214160|75777319|FG000|Overall Study|Sponsor Decision|0|||
41975173|NCT02214160|75777320|FG001|Overall Study|Sponsor Decision|2|||
41975174|NCT02214160|75777321|FG002|Overall Study|Sponsor Decision|0|||
41975175|NCT02214160|75777319|FG000|Overall Study|Protocol Violation|1|||
41975176|NCT02214160|75777320|FG001|Overall Study|Protocol Violation|0|||
41975177|NCT02214160|75777321|FG002|Overall Study|Protocol Violation|0|||
41975178|NCT02214160|75777319|FG000|Overall Study|Physician Decision|0|||
41975179|NCT02214160|75777320|FG001|Overall Study|Physician Decision|0|||
41975180|NCT02214160|75777321|FG002|Overall Study|Physician Decision|1|||
41975181|NCT02059265|75777350|FG000|Overall Study|Ineligible|4|||
41975182|NCT04983589|75777377|FG000|Overall Study|Withdrawal by Subject|0|||
41975183|NCT04983589|75777378|FG001|Overall Study|Withdrawal by Subject|3|||
41975184|NCT04983589|75777377|FG000|Overall Study|COVID-19 Infection|1|||
41975185|NCT04983589|75777378|FG001|Overall Study|COVID-19 Infection|0|||
41975186|NCT04983589|75777377|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
41975187|NCT04983589|75777378|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
41975188|NCT04783389|75777399|FG000|Overall Study|Withdrawal by Subject|2|||
41975189|NCT04783389|75777400|FG001|Overall Study|Withdrawal by Subject|0|||
41975190|NCT04783389|75777401|FG002|Overall Study|Withdrawal by Subject|0|||
41975191|NCT04783389|75777399|FG000|Overall Study|Termination of Study by Sponsor|10|||
41975192|NCT04783389|75777400|FG001|Overall Study|Termination of Study by Sponsor|12|||
41975193|NCT04783389|75777401|FG002|Overall Study|Termination of Study by Sponsor|14|||
41975194|NCT04556591|75777422|FG000|Overall Study|Lost to Follow-up|1|||
41975195|NCT04556591|75777423|FG001|Overall Study|Lost to Follow-up|0|||
41975196|NCT04556591|75777422|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
42028149|NCT00960531|75836480|FG008|Overall Study|Lack of Efficacy|0|||
42211646|NCT03207750|76026676|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
42211647|NCT03207750|76026677|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
42211648|NCT03207750|76026676|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
42211649|NCT03207750|76026677|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
42211650|NCT03674281|76026686|FG000|Overall Study|screen failure|2|||
42211651|NCT03674281|76026687|FG001|Overall Study|screen failure|0|||
41975197|NCT04556591|75777423|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
41975198|NCT04428034|75777432|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
41975199|NCT04364984|75777443|FG000|Overall Study|Death|2|||
41975200|NCT04364984|75777444|FG001|Overall Study|Death|2|||
41975201|NCT04364984|75777445|FG002|Overall Study|Death|0|||
41975202|NCT04294095|75777455|FG000|Overall Study|Adverse Event|1|||
41975203|NCT04294095|75777456|FG001|Overall Study|Adverse Event|0|||
41975204|NCT04266028|75777472|FG000|Overall Study|Adverse Event|0|||
41975205|NCT04266028|75777473|FG001|Overall Study|Adverse Event|0|||
41975206|NCT04266028|75777474|FG002|Overall Study|Adverse Event|1|||
41975207|NCT04266028|75777475|FG003|Overall Study|Adverse Event|0|||
41975208|NCT04266028|75777476|FG004|Overall Study|Adverse Event|1|||
41975209|NCT04266028|75777477|FG005|Overall Study|Adverse Event|0|||
41975210|NCT04266028|75777478|FG006|Overall Study|Adverse Event|2|||
41975211|NCT04266028|75777479|FG007|Overall Study|Adverse Event|0|||
41975212|NCT04266028|75777472|FG000|Overall Study|temporary halt of the study|0|||
41975213|NCT04266028|75777473|FG001|Overall Study|temporary halt of the study|0|||
41975214|NCT04266028|75777474|FG002|Overall Study|temporary halt of the study|0|||
41975215|NCT04266028|75777475|FG003|Overall Study|temporary halt of the study|0|||
41975216|NCT04266028|75777476|FG004|Overall Study|temporary halt of the study|0|||
41975217|NCT04266028|75777477|FG005|Overall Study|temporary halt of the study|0|||
41975218|NCT04266028|75777478|FG006|Overall Study|temporary halt of the study|2|||
41975219|NCT04266028|75777479|FG007|Overall Study|temporary halt of the study|1|||
41975220|NCT04266028|75777472|FG000|Overall Study|Onset of birch pollen season|0|||
41975221|NCT04266028|75777473|FG001|Overall Study|Onset of birch pollen season|0|||
41975222|NCT04266028|75777474|FG002|Overall Study|Onset of birch pollen season|0|||
41975223|NCT04266028|75777475|FG003|Overall Study|Onset of birch pollen season|0|||
41975224|NCT04266028|75777476|FG004|Overall Study|Onset of birch pollen season|1|||
41975225|NCT04266028|75777477|FG005|Overall Study|Onset of birch pollen season|0|||
41975226|NCT04266028|75777478|FG006|Overall Study|Onset of birch pollen season|0|||
41975227|NCT04266028|75777479|FG007|Overall Study|Onset of birch pollen season|0|||
41975228|NCT03994731|75777521|FG000|Pegloticase + IMM Period|Death|2|||
42211652|NCT03674281|76026688|FG002|Overall Study|screen failure|0|||
42211653|NCT03674281|76026686|FG000|Overall Study|Withdrawal by Subject|1|||
42211654|NCT03674281|76026687|FG001|Overall Study|Withdrawal by Subject|3|||
42211655|NCT03674281|76026688|FG002|Overall Study|Withdrawal by Subject|3|||
42211656|NCT03673345|76026712|FG000|Overall Study|Lost to Follow-up|1|||
42211657|NCT03673345|76026713|FG001|Overall Study|Lost to Follow-up|0|||
42211658|NCT03673345|76026714|FG002|Overall Study|Lost to Follow-up|3|||
42211659|NCT03673345|76026715|FG003|Overall Study|Lost to Follow-up|3|||
42211660|NCT03673345|76026716|FG004|Overall Study|Lost to Follow-up|2|||
42211661|NCT03673345|76026717|FG005|Overall Study|Lost to Follow-up|1|||
42211662|NCT03673345|76026718|FG006|Overall Study|Lost to Follow-up|0|||
42211663|NCT03673345|76026719|FG007|Overall Study|Lost to Follow-up|0|||
42211664|NCT03673345|76026712|FG000|Overall Study|Withdrawal by Subject|1|||
42211665|NCT03673345|76026713|FG001|Overall Study|Withdrawal by Subject|0|||
42211666|NCT03673345|76026714|FG002|Overall Study|Withdrawal by Subject|4|||
42211667|NCT03673345|76026715|FG003|Overall Study|Withdrawal by Subject|2|||
42211668|NCT03673345|76026716|FG004|Overall Study|Withdrawal by Subject|0|||
42211669|NCT03673345|76026717|FG005|Overall Study|Withdrawal by Subject|0|||
42211670|NCT03673345|76026718|FG006|Overall Study|Withdrawal by Subject|0|||
42211671|NCT03673345|76026719|FG007|Overall Study|Withdrawal by Subject|0|||
42211672|NCT03673345|76026712|FG000|Overall Study|Physician Decision|0|||
42211673|NCT03673345|76026713|FG001|Overall Study|Physician Decision|0|||
42211674|NCT03673345|76026714|FG002|Overall Study|Physician Decision|2|||
42211675|NCT03673345|76026715|FG003|Overall Study|Physician Decision|0|||
42211676|NCT03673345|76026716|FG004|Overall Study|Physician Decision|0|||
42211677|NCT03673345|76026717|FG005|Overall Study|Physician Decision|0|||
42211678|NCT03673345|76026718|FG006|Overall Study|Physician Decision|0|||
42211679|NCT03673345|76026719|FG007|Overall Study|Physician Decision|0|||
42211680|NCT03223662|76026737|FG000|Overall Study|Physician Decision|1|||
42211681|NCT03223662|76026737|FG000|Overall Study|Study closure|1|||
41975229|NCT03994731|75777522|FG001|Pegloticase + IMM Period|Death|0|||
41975230|NCT03994731|75777521|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
41975231|NCT03994731|75777522|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
41975232|NCT03994731|75777521|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
41975233|NCT03994731|75777522|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
41975234|NCT03801915|75777534|FG000|Overall Study|Screen failure|0|||
41975235|NCT03801915|75777535|FG001|Overall Study|Screen failure|0|||
41975236|NCT03801915|75777536|FG002|Overall Study|Screen failure|1|||
42211682|NCT03672097|76026741|FG000|Period 1|Withdrawal by Subject|2|||
42211683|NCT03672097|76026741|FG000|Period 1|Adverse Event|1|||
42211684|NCT03672097|76026741|FG000|Period 1|Did not receive treatment|1|||
42211685|NCT03672097|76026741|FG000|Period 2|Withdrawal by Subject|3|||
42211686|NCT03672097|76026741|FG000|Period 2|Other|1|||
42211687|NCT03847896|76026750|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
42211688|NCT03847896|76026751|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
41975237|NCT03801915|75777534|FG000|Overall Study|Ineligible|1|||
41975238|NCT03801915|75777535|FG001|Overall Study|Ineligible|0|||
41975239|NCT03801915|75777536|FG002|Overall Study|Ineligible|0|||
41975240|NCT03801915|75777534|FG000|Overall Study|Physician Decision|2|||
41975241|NCT03801915|75777535|FG001|Overall Study|Physician Decision|1|||
41975242|NCT03801915|75777536|FG002|Overall Study|Physician Decision|0|||
41975243|NCT03581305|75777550|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
41975244|NCT03581305|75777551|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
41975245|NCT03581305|75777550|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
41975246|NCT03581305|75777551|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
41975247|NCT03581305|75777550|FG000|Serotonergic Study|Withdrawal by Subject|5|||
41975248|NCT03581305|75777551|FG001|Serotonergic Study|Withdrawal by Subject|1|||
41975249|NCT03556202|75777562|FG000|Extension Treatment Period|Adverse Event|18|||
41975250|NCT03556202|75777563|FG001|Extension Treatment Period|Adverse Event|14|||
41975251|NCT03556202|75777564|FG002|Extension Treatment Period|Adverse Event|9|||
41975252|NCT03556202|75777562|FG000|Extension Treatment Period|Death|2|||
41975253|NCT03556202|75777563|FG001|Extension Treatment Period|Death|6|||
41975254|NCT03556202|75777564|FG002|Extension Treatment Period|Death|0|||
41975255|NCT03556202|75777562|FG000|Extension Treatment Period|Lack of Efficacy|5|||
41975256|NCT03556202|75777563|FG001|Extension Treatment Period|Lack of Efficacy|12|||
41975257|NCT03556202|75777564|FG002|Extension Treatment Period|Lack of Efficacy|18|||
41975258|NCT03556202|75777562|FG000|Extension Treatment Period|Lost to Follow-up|9|||
41975259|NCT03556202|75777563|FG001|Extension Treatment Period|Lost to Follow-up|20|||
41975260|NCT03556202|75777564|FG002|Extension Treatment Period|Lost to Follow-up|2|||
41975261|NCT03556202|75777562|FG000|Extension Treatment Period|Pregnancy|2|||
41975262|NCT03556202|75777563|FG001|Extension Treatment Period|Pregnancy|4|||
41975263|NCT03556202|75777564|FG002|Extension Treatment Period|Pregnancy|3|||
41975264|NCT03556202|75777562|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
41975265|NCT03556202|75777563|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
41975266|NCT03556202|75777564|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
41975267|NCT03556202|75777562|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
41975268|NCT03556202|75777563|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
41975269|NCT03556202|75777564|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
41975270|NCT03556202|75777562|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
41975271|NCT03556202|75777563|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
41975272|NCT03556202|75777564|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
41975273|NCT03556202|75777562|FG000|Extension Treatment Period|Physician Decision|0|||
41975274|NCT03556202|75777563|FG001|Extension Treatment Period|Physician Decision|8|||
41975275|NCT03556202|75777564|FG002|Extension Treatment Period|Physician Decision|2|||
41975276|NCT03556202|75777562|FG000|Extension Treatment Period|Protocol Violation|0|||
41975277|NCT03556202|75777563|FG001|Extension Treatment Period|Protocol Violation|1|||
41975278|NCT03556202|75777564|FG002|Extension Treatment Period|Protocol Violation|1|||
41975279|NCT03556202|75777562|FG000|Extension Treatment Period|Sponsor Decision|0|||
41975280|NCT03556202|75777563|FG001|Extension Treatment Period|Sponsor Decision|1|||
41975281|NCT03556202|75777564|FG002|Extension Treatment Period|Sponsor Decision|0|||
41975282|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
41975283|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
42211689|NCT03847896|76026752|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
42211690|NCT03847896|76026753|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
42211691|NCT03847896|76026754|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
42211692|NCT03847896|76026750|FG000|Overall Study|Withdrawal by Subject|2|||
42211693|NCT03847896|76026751|FG001|Overall Study|Withdrawal by Subject|10|||
42211694|NCT03847896|76026752|FG002|Overall Study|Withdrawal by Subject|5|||
42211695|NCT03847896|76026753|FG003|Overall Study|Withdrawal by Subject|9|||
42211696|NCT03847896|76026754|FG004|Overall Study|Withdrawal by Subject|8|||
42211697|NCT03847896|76026750|FG000|Overall Study|Withdrawal by parent/guardian|0|||
42211698|NCT03847896|76026751|FG001|Overall Study|Withdrawal by parent/guardian|0|||
42211699|NCT03847896|76026752|FG002|Overall Study|Withdrawal by parent/guardian|1|||
42211700|NCT03847896|76026753|FG003|Overall Study|Withdrawal by parent/guardian|0|||
42211701|NCT03847896|76026754|FG004|Overall Study|Withdrawal by parent/guardian|0|||
42211702|NCT03847896|76026750|FG000|Overall Study|Adverse Event|2|||
42211703|NCT03847896|76026751|FG001|Overall Study|Adverse Event|1|||
42211704|NCT03847896|76026752|FG002|Overall Study|Adverse Event|3|||
42211705|NCT03847896|76026753|FG003|Overall Study|Adverse Event|2|||
42211706|NCT03847896|76026754|FG004|Overall Study|Adverse Event|4|||
42211707|NCT03847896|76026750|FG000|Overall Study|A severe exacerbation event|0|||
42211708|NCT03847896|76026751|FG001|Overall Study|A severe exacerbation event|0|||
42211709|NCT03847896|76026752|FG002|Overall Study|A severe exacerbation event|0|||
42211710|NCT03847896|76026753|FG003|Overall Study|A severe exacerbation event|0|||
42211711|NCT03847896|76026754|FG004|Overall Study|A severe exacerbation event|3|||
42211712|NCT03847896|76026750|FG000|Overall Study|Protocol Violation|0|||
41975284|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
41975285|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Death|1|||
41975286|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Death|0|||
42211713|NCT03847896|76026751|FG001|Overall Study|Protocol Violation|2|||
42211714|NCT03847896|76026752|FG002|Overall Study|Protocol Violation|1|||
41975287|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Death|0|||
41975288|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
42211715|NCT03847896|76026753|FG003|Overall Study|Protocol Violation|0|||
42211716|NCT03847896|76026754|FG004|Overall Study|Protocol Violation|2|||
42211717|NCT03847896|76026750|FG000|Overall Study|Lost to Follow-up|0|||
42211718|NCT03847896|76026751|FG001|Overall Study|Lost to Follow-up|0|||
42211719|NCT03847896|76026752|FG002|Overall Study|Lost to Follow-up|0|||
42211720|NCT03847896|76026753|FG003|Overall Study|Lost to Follow-up|1|||
42211721|NCT03847896|76026754|FG004|Overall Study|Lost to Follow-up|0|||
42211722|NCT03847896|76026750|FG000|Overall Study|Condition under investigation worsened|0|||
42211723|NCT03847896|76026751|FG001|Overall Study|Condition under investigation worsened|0|||
42211724|NCT03847896|76026752|FG002|Overall Study|Condition under investigation worsened|0|||
42211725|NCT03847896|76026753|FG003|Overall Study|Condition under investigation worsened|1|||
42211726|NCT03847896|76026754|FG004|Overall Study|Condition under investigation worsened|1|||
42211727|NCT03847896|76026750|FG000|Overall Study|Lack of Efficacy|0|||
42211728|NCT03847896|76026751|FG001|Overall Study|Lack of Efficacy|0|||
42211729|NCT03847896|76026752|FG002|Overall Study|Lack of Efficacy|0|||
42211730|NCT03847896|76026753|FG003|Overall Study|Lack of Efficacy|2|||
42211731|NCT03847896|76026754|FG004|Overall Study|Lack of Efficacy|2|||
42211732|NCT03847896|76026750|FG000|Overall Study|Other reasons|3|||
42211733|NCT03847896|76026751|FG001|Overall Study|Other reasons|3|||
42211734|NCT03847896|76026752|FG002|Overall Study|Other reasons|1|||
42211735|NCT03847896|76026753|FG003|Overall Study|Other reasons|2|||
42211736|NCT03847896|76026754|FG004|Overall Study|Other reasons|1|||
42211737|NCT03670537|76026766|FG000|Overall Study|Protocol Violation|1|||
42211738|NCT03619837|76026770|FG000|Screening|received organs from HCV-negative donors|47|||
42211739|NCT03619837|76026770|FG000|Screening|died on the wait-list|2|||
42211740|NCT03619837|76026770|FG000|Screening|remained on the wait list|40|||
42211741|NCT03619837|76026770|FG000|Screening|didn't meet eligibility criteria|3|||
42211742|NCT03619837|76026770|FG000|Screening|withdrew consent|2|||
42211743|NCT03619837|76026770|FG000|Screening|never listed for HCV-viremic donor|1|||
42211744|NCT03619837|76026770|FG000|Screening|developed exclusion criteria|2|||
42211745|NCT03619837|76026770|FG000|Screening|excluded by the investigator due to non-compliance|1|||
42211746|NCT03206970|76026774|FG000|Overall Study|Death|21|||
41975289|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
41975290|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
41975291|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
41975292|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
41975293|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
41975294|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
41975295|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
41975296|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
41975297|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
41975298|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
41975299|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
41975300|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
42211747|NCT03206970|76026774|FG000|Overall Study|Withdrawal by Subject|13|||
42211748|NCT03206970|76026774|FG000|Overall Study|Lost to Follow-up|3|||
42211749|NCT03206970|76026774|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
42211750|NCT03644173|76026778|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
41975301|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
41975302|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
42211751|NCT03644173|76026778|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
42211752|NCT03644173|76026778|FG000|Participants at the 1-month Follow up|Death|2|||
42211753|NCT03644173|76026778|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
42211754|NCT03178851|76026786|FG000|Overall Study|Death|48|||
42211755|NCT03178851|76026787|FG001|Overall Study|Death|2|||
42211756|NCT03178851|76026788|FG002|Overall Study|Death|25|||
42211757|NCT03178851|76026786|FG000|Overall Study|Withdrawal by Subject|8|||
41975303|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
41975304|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
41975305|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
41975306|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
41975307|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
41975308|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
41975309|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
41975310|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
41975311|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
41975312|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
41975313|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
41975314|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
41975315|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
41975316|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
41975317|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
41975318|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
41975319|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
41975320|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
41975321|NCT03556202|75777562|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
41975322|NCT03556202|75777563|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
41975323|NCT03556202|75777564|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
41975324|NCT03541174|75777578|FG000|Part 1 Double-Blind|Adverse Event|6|||
41975325|NCT03541174|75777579|FG001|Part 1 Double-Blind|Adverse Event|5|||
41975326|NCT03541174|75777580|FG002|Part 1 Double-Blind|Adverse Event|2|||
41975327|NCT03541174|75777581|FG003|Part 1 Double-Blind|Adverse Event|0|||
41975328|NCT03541174|75777582|FG004|Part 1 Double-Blind|Adverse Event|0|||
41975329|NCT03541174|75777583|FG005|Part 1 Double-Blind|Adverse Event|0|||
41975330|NCT03541174|75777578|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
41975331|NCT03541174|75777579|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
41975332|NCT03541174|75777580|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
41975333|NCT03541174|75777581|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
41975334|NCT03541174|75777582|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
41975335|NCT03541174|75777583|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
41975336|NCT03541174|75777578|FG000|Part 1 Double-Blind|Other reasons|3|||
41975337|NCT03541174|75777579|FG001|Part 1 Double-Blind|Other reasons|2|||
41975338|NCT03541174|75777580|FG002|Part 1 Double-Blind|Other reasons|3|||
41975339|NCT03541174|75777581|FG003|Part 1 Double-Blind|Other reasons|0|||
41975340|NCT03541174|75777582|FG004|Part 1 Double-Blind|Other reasons|0|||
41975341|NCT03541174|75777583|FG005|Part 1 Double-Blind|Other reasons|0|||
41975342|NCT03541174|75777578|FG000|Part 2 Single-Blind|Adverse Event|0|||
41975343|NCT03541174|75777579|FG001|Part 2 Single-Blind|Adverse Event|0|||
41975344|NCT03541174|75777580|FG002|Part 2 Single-Blind|Adverse Event|0|||
41975345|NCT03541174|75777581|FG003|Part 2 Single-Blind|Adverse Event|25|||
41975346|NCT03541174|75777582|FG004|Part 2 Single-Blind|Adverse Event|0|||
41975347|NCT03541174|75777583|FG005|Part 2 Single-Blind|Adverse Event|0|||
41975348|NCT03541174|75777578|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
41975349|NCT03541174|75777579|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
41975350|NCT03541174|75777580|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
41975351|NCT03541174|75777581|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
41975352|NCT03541174|75777582|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
41975353|NCT03541174|75777583|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
41975354|NCT03541174|75777578|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
41975355|NCT03541174|75777579|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
41975356|NCT03541174|75777580|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
41975357|NCT03541174|75777581|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
41975358|NCT03541174|75777582|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
41975359|NCT03541174|75777583|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
42127841|NCT00531050|75938376|FG003|Part 2: Period 1|Adverse Event|0|||
42127842|NCT00531050|75938377|FG004|Part 2: Period 1|Adverse Event|0|||
42127843|NCT00531050|75938378|FG005|Part 2: Period 1|Adverse Event|1|||
42127844|NCT00531050|75938373|FG000|Part 2: Period 3|Abnormal test procedure|1|||
42127845|NCT00531050|75938374|FG001|Part 2: Period 3|Abnormal test procedure|0|||
42127846|NCT00531050|75938375|FG002|Part 2: Period 3|Abnormal test procedure|0|||
42127847|NCT00531050|75938376|FG003|Part 2: Period 3|Abnormal test procedure|0|||
42127848|NCT00531050|75938377|FG004|Part 2: Period 3|Abnormal test procedure|0|||
42127849|NCT00531050|75938378|FG005|Part 2: Period 3|Abnormal test procedure|1|||
41975360|NCT03541174|75777578|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
41975361|NCT03541174|75777579|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
42028150|NCT00960531|75836481|FG009|Overall Study|Lack of Efficacy|0|||
42127850|NCT00530348|75938397|FG000|Overall Study|Adverse Event|5|||
42127851|NCT00530348|75938398|FG001|Overall Study|Adverse Event|1|||
42127852|NCT00530348|75938397|FG000|Overall Study|Death|0|||
42211758|NCT03178851|76026787|FG001|Overall Study|Withdrawal by Subject|0|||
42211759|NCT03178851|76026788|FG002|Overall Study|Withdrawal by Subject|0|||
42211760|NCT03178851|76026786|FG000|Overall Study|Lost to Follow-up|5|||
42211761|NCT03178851|76026787|FG001|Overall Study|Lost to Follow-up|2|||
42211762|NCT03178851|76026788|FG002|Overall Study|Lost to Follow-up|0|||
42211763|NCT03178851|76026786|FG000|Overall Study|Adverse Event|0|||
42211764|NCT03178851|76026787|FG001|Overall Study|Adverse Event|0|||
42211765|NCT03178851|76026788|FG002|Overall Study|Adverse Event|1|||
42211766|NCT03178851|76026786|FG000|Overall Study|Study Termination by Sponsor|31|||
42211767|NCT03178851|76026787|FG001|Overall Study|Study Termination by Sponsor|7|||
42211768|NCT03178851|76026788|FG002|Overall Study|Study Termination by Sponsor|26|||
42211769|NCT03643159|76026799|FG000|Overall Study|Adverse Event|1|||
42211770|NCT03643159|76026799|FG000|Overall Study|Withdrawal by Subject|1|||
42211771|NCT03205566|76026806|FG000|Phase 1|Protocol Violation|1|||
42211772|NCT03205566|76026807|FG001|Phase 1|Protocol Violation|1|||
42211773|NCT02935452|76026819|FG000|Overall Study|work and life commintment|3|||
42211774|NCT02935452|76026820|FG001|Overall Study|work and life commintment|1|||
42211775|NCT03178773|76026828|FG000|Overall Study|Death|0|||
42211776|NCT03178773|76026829|FG001|Overall Study|Death|1|||
42211777|NCT03178773|76026828|FG000|Overall Study|Lost to Follow-up|29|||
42211778|NCT03178773|76026829|FG001|Overall Study|Lost to Follow-up|25|||
42211779|NCT03178773|76026828|FG000|Overall Study|Withdrawal by Subject|10|||
42211780|NCT03178773|76026829|FG001|Overall Study|Withdrawal by Subject|14|||
42211781|NCT03713034|76026838|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
42211782|NCT03713034|76026839|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
42211783|NCT03218397|76026849|FG000|Overall Study|Prior positive blood culture|8|||
42211784|NCT03218397|76026850|FG001|Overall Study|Prior positive blood culture|13|||
42211785|NCT03218397|76026849|FG000|Overall Study|Comfort care|8|||
42211786|NCT03218397|76026850|FG001|Overall Study|Comfort care|5|||
42211787|NCT03218397|76026849|FG000|Overall Study|Comfort care and positive blood culture|1|||
42211788|NCT03218397|76026850|FG001|Overall Study|Comfort care and positive blood culture|0|||
41975362|NCT03541174|75777580|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
41975363|NCT03541174|75777581|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
41975364|NCT03541174|75777582|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
41975365|NCT03541174|75777583|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
41975366|NCT03541174|75777578|FG000|Part 2 Single-Blind|Death|0|||
41975367|NCT03541174|75777579|FG001|Part 2 Single-Blind|Death|0|||
41975368|NCT03541174|75777580|FG002|Part 2 Single-Blind|Death|0|||
41975369|NCT03541174|75777581|FG003|Part 2 Single-Blind|Death|5|||
41975370|NCT03541174|75777582|FG004|Part 2 Single-Blind|Death|0|||
41975371|NCT03541174|75777583|FG005|Part 2 Single-Blind|Death|0|||
41975372|NCT03541174|75777578|FG000|Part 2 Single-Blind|Pregnancy|0|||
41975373|NCT03541174|75777579|FG001|Part 2 Single-Blind|Pregnancy|0|||
41975374|NCT03541174|75777580|FG002|Part 2 Single-Blind|Pregnancy|0|||
41975375|NCT03541174|75777581|FG003|Part 2 Single-Blind|Pregnancy|1|||
41975376|NCT03541174|75777582|FG004|Part 2 Single-Blind|Pregnancy|0|||
41975377|NCT03541174|75777583|FG005|Part 2 Single-Blind|Pregnancy|0|||
41975378|NCT03541174|75777578|FG000|Part 2 Single-Blind|Other reasons|0|||
41975379|NCT03541174|75777579|FG001|Part 2 Single-Blind|Other reasons|0|||
41975380|NCT03541174|75777580|FG002|Part 2 Single-Blind|Other reasons|0|||
41975381|NCT03541174|75777581|FG003|Part 2 Single-Blind|Other reasons|32|||
41975382|NCT03541174|75777582|FG004|Part 2 Single-Blind|Other reasons|0|||
41975383|NCT03541174|75777583|FG005|Part 2 Single-Blind|Other reasons|0|||
41975384|NCT03541174|75777578|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
41975385|NCT03541174|75777579|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
41975386|NCT03541174|75777580|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
41975387|NCT03541174|75777581|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
42211789|NCT03218397|76026849|FG000|Overall Study|Comfort care and mixed culture|0|||
42211790|NCT03218397|76026850|FG001|Overall Study|Comfort care and mixed culture|1|||
42211791|NCT03218397|76026849|FG000|Overall Study|Mixed culture|2|||
42211792|NCT03218397|76026850|FG001|Overall Study|Mixed culture|2|||
42211793|NCT03218397|76026849|FG000|Overall Study|Inaccessible hospital records|2|||
42211794|NCT03218397|76026850|FG001|Overall Study|Inaccessible hospital records|5|||
42211795|NCT03218397|76026849|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
42211796|NCT03218397|76026850|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
42211797|NCT03218397|76026849|FG000|Overall Study|Randomized during laboratory off hours|2|||
42211798|NCT03218397|76026850|FG001|Overall Study|Randomized during laboratory off hours|1|||
42211799|NCT03618823|76026858|FG000|Overall Study|Lost to Follow-up|63|||
42211800|NCT03618823|76026859|FG001|Overall Study|Lost to Follow-up|61|||
41975388|NCT03541174|75777582|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
41975389|NCT03541174|75777583|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
41975390|NCT03541174|75777578|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
41975391|NCT03541174|75777579|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
41975392|NCT03541174|75777580|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
41975393|NCT03541174|75777581|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
42211801|NCT03640507|76026871|FG000|Overall Study|Withdrawal by Subject|0|||
42211802|NCT03640507|76026872|FG001|Overall Study|Withdrawal by Subject|0|||
42211803|NCT03640507|76026873|FG002|Overall Study|Withdrawal by Subject|1|||
42211804|NCT02937636|76026883|FG000|Overall Study|Other (Not specified)|3|||
42211805|NCT02937636|76026884|FG001|Overall Study|Other (Not specified)|2|||
41975394|NCT03541174|75777582|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
41975395|NCT03541174|75777583|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
41975396|NCT03541174|75777578|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
41975397|NCT03541174|75777579|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
41975398|NCT03541174|75777580|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
41975399|NCT03541174|75777581|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
41975400|NCT03541174|75777582|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
41975401|NCT03541174|75777583|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
41975402|NCT03541174|75777578|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
41975403|NCT03541174|75777579|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
41975404|NCT03541174|75777580|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
41975405|NCT03541174|75777581|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
41975406|NCT03541174|75777582|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
41975407|NCT03541174|75777583|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
41975408|NCT03541174|75777578|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
41975409|NCT03541174|75777579|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
41975410|NCT03541174|75777580|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
41975411|NCT03541174|75777581|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
41975412|NCT03541174|75777582|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
41975413|NCT03541174|75777583|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
42211806|NCT03638635|76026893|FG000|Initial Hospitalization|Study terminated prematurely|0|||
42211807|NCT03638635|76026894|FG001|Initial Hospitalization|Study terminated prematurely|1|||
42211808|NCT03638635|76026893|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
42211809|NCT03638635|76026894|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
42211810|NCT03638635|76026893|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
42211811|NCT03638635|76026894|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
42211812|NCT03204981|76026900|FG000|Overall Study|Physician Decision|2|||
42211813|NCT03204981|76026900|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
42211814|NCT03205488|76026909|FG000|Overall Study|Adverse Event|1|||
42211815|NCT03205488|76026910|FG001|Overall Study|Adverse Event|2|||
42211816|NCT03205488|76026911|FG002|Overall Study|Adverse Event|4|||
42211817|NCT03205488|76026909|FG000|Overall Study|Protocol Violation|0|||
42211818|NCT03205488|76026910|FG001|Overall Study|Protocol Violation|0|||
42211819|NCT03205488|76026911|FG002|Overall Study|Protocol Violation|1|||
42211820|NCT03204279|76026925|FG000|Overall Study|Withdrawal by Subject|0|||
42211821|NCT03204279|76026926|FG001|Overall Study|Withdrawal by Subject|1|||
42211822|NCT03173547|76026935|FG000|Overall Study|Adverse Event|2|||
42211823|NCT03173547|76026936|FG001|Overall Study|Adverse Event|0|||
42211824|NCT03173547|76026935|FG000|Overall Study|Withdrawal by Subject|2|||
42211825|NCT03173547|76026936|FG001|Overall Study|Withdrawal by Subject|2|||
42211826|NCT02954653|76026944|FG000|Overall Study|Death|3|||
42211827|NCT02954653|76026945|FG001|Overall Study|Death|1|||
42211828|NCT02954653|76026946|FG002|Overall Study|Death|0|||
42211829|NCT02954653|76026947|FG003|Overall Study|Death|0|||
42211830|NCT02954653|76026948|FG004|Overall Study|Death|0|||
42211831|NCT02954653|76026949|FG005|Overall Study|Death|0|||
42211832|NCT02954653|76026950|FG006|Overall Study|Death|0|||
42211833|NCT02954653|76026951|FG007|Overall Study|Death|0|||
41975414|NCT03289039|75777615|FG000|Overall Study|Withdrawal by Subject|0|||
42127853|NCT00530348|75938398|FG001|Overall Study|Death|1|||
42127854|NCT00530348|75938397|FG000|Overall Study|Lack of Efficacy|2|||
42127855|NCT00530348|75938398|FG001|Overall Study|Lack of Efficacy|0|||
42127856|NCT00530348|75938397|FG000|Overall Study|Lost to Follow-up|0|||
42127857|NCT00530348|75938398|FG001|Overall Study|Lost to Follow-up|2|||
42127858|NCT00530348|75938397|FG000|Overall Study|Physician Decision|1|||
42127859|NCT00530348|75938398|FG001|Overall Study|Physician Decision|2|||
42127860|NCT00530348|75938397|FG000|Overall Study|Pregnancy|1|||
42127861|NCT00530348|75938398|FG001|Overall Study|Pregnancy|0|||
42127862|NCT00530348|75938397|FG000|Overall Study|Withdrawal by Subject|12|||
42127863|NCT00530348|75938398|FG001|Overall Study|Withdrawal by Subject|12|||
42127864|NCT00530348|75938397|FG000|Overall Study|Randomised in error|1|||
42211834|NCT02954653|76026952|FG008|Overall Study|Death|0|||
42211835|NCT02954653|76026944|FG000|Overall Study|Randomized but did not receive treatment|1|||
42211836|NCT02954653|76026945|FG001|Overall Study|Randomized but did not receive treatment|0|||
42211837|NCT02954653|76026946|FG002|Overall Study|Randomized but did not receive treatment|0|||
42211838|NCT02954653|76026947|FG003|Overall Study|Randomized but did not receive treatment|0|||
41975415|NCT03289039|75777616|FG001|Overall Study|Withdrawal by Subject|1|||
42127865|NCT00530348|75938398|FG001|Overall Study|Randomised in error|0|||
42211839|NCT02954653|76026948|FG004|Overall Study|Randomized but did not receive treatment|0|||
41975416|NCT03289039|75777615|FG000|Overall Study|Became ineligible prior to treatment start|0|||
41975417|NCT03289039|75777616|FG001|Overall Study|Became ineligible prior to treatment start|1|||
41975418|NCT03289039|75777615|FG000|Overall Study|progressed before treatment start|1|||
41975419|NCT03289039|75777616|FG001|Overall Study|progressed before treatment start|0|||
41975420|NCT03281304|75777624|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
41975421|NCT03281304|75777625|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
41975422|NCT03281304|75777624|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
41975423|NCT03281304|75777625|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
41975424|NCT03281304|75777624|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
41975425|NCT03281304|75777625|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
41975426|NCT03281304|75777624|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
41975427|NCT03281304|75777625|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
41975428|NCT03281304|75777624|FG000|Treatment Phase (up to 42 Months)|Death|0|||
41975429|NCT03281304|75777625|FG001|Treatment Phase (up to 42 Months)|Death|1|||
41975430|NCT03281304|75777624|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
41975431|NCT03281304|75777625|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
41975432|NCT03281304|75777624|FG000|Treatment Phase (up to 42 Months)|Other|0|||
41975433|NCT03281304|75777625|FG001|Treatment Phase (up to 42 Months)|Other|2|||
41975434|NCT03281304|75777624|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
41975435|NCT03281304|75777625|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
42211840|NCT02954653|76026949|FG005|Overall Study|Randomized but did not receive treatment|0|||
42211841|NCT02954653|76026950|FG006|Overall Study|Randomized but did not receive treatment|0|||
42211842|NCT02954653|76026951|FG007|Overall Study|Randomized but did not receive treatment|0|||
42211843|NCT02954653|76026952|FG008|Overall Study|Randomized but did not receive treatment|0|||
42211844|NCT02954653|76026944|FG000|Overall Study|Started another anti-cancer therapy|0|||
42211845|NCT02954653|76026945|FG001|Overall Study|Started another anti-cancer therapy|1|||
42211846|NCT02954653|76026946|FG002|Overall Study|Started another anti-cancer therapy|0|||
42211847|NCT02954653|76026947|FG003|Overall Study|Started another anti-cancer therapy|0|||
42211848|NCT02954653|76026948|FG004|Overall Study|Started another anti-cancer therapy|0|||
42211849|NCT02954653|76026949|FG005|Overall Study|Started another anti-cancer therapy|0|||
42211850|NCT02954653|76026950|FG006|Overall Study|Started another anti-cancer therapy|0|||
42211851|NCT02954653|76026951|FG007|Overall Study|Started another anti-cancer therapy|0|||
42211852|NCT02954653|76026952|FG008|Overall Study|Started another anti-cancer therapy|0|||
42211853|NCT02954653|76026944|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
42211854|NCT02954653|76026945|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
42211855|NCT02954653|76026946|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
42211856|NCT02954653|76026947|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
42211857|NCT02954653|76026948|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
42211858|NCT02954653|76026949|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
42211859|NCT02954653|76026950|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
42211860|NCT02954653|76026951|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
42211861|NCT02954653|76026952|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
42211862|NCT03173313|76026966|FG000|Overall Study|Lost to Follow-up|2|||
42211863|NCT03173313|76026967|FG001|Overall Study|Lost to Follow-up|3|||
42211864|NCT03173313|76026966|FG000|Overall Study|Withdrawal by Subject|0|||
42211865|NCT03173313|76026967|FG001|Overall Study|Withdrawal by Subject|1|||
42211866|NCT03173313|76026966|FG000|Overall Study|Death|5|||
41975436|NCT03204305|75777634|FG000|Overall Study|Lost to Follow-up|6|||
41975437|NCT03204305|75777635|FG001|Overall Study|Lost to Follow-up|4|||
41975438|NCT03204305|75777636|FG002|Overall Study|Lost to Follow-up|0|||
41975439|NCT03204305|75777637|FG003|Overall Study|Lost to Follow-up|0|||
41975440|NCT03204305|75777634|FG000|Overall Study|Physician Decision|1|||
41975441|NCT03204305|75777635|FG001|Overall Study|Physician Decision|0|||
41975442|NCT03204305|75777636|FG002|Overall Study|Physician Decision|0|||
41975443|NCT03204305|75777637|FG003|Overall Study|Physician Decision|0|||
41975444|NCT03204305|75777634|FG000|Overall Study|failure to place arterial line|2|||
41975445|NCT03204305|75777635|FG001|Overall Study|failure to place arterial line|1|||
41975446|NCT03204305|75777636|FG002|Overall Study|failure to place arterial line|0|||
41975447|NCT03204305|75777637|FG003|Overall Study|failure to place arterial line|0|||
41975448|NCT03204305|75777634|FG000|Overall Study|Withdrawal by Subject|2|||
41975449|NCT03204305|75777635|FG001|Overall Study|Withdrawal by Subject|0|||
42211867|NCT03173313|76026967|FG001|Overall Study|Death|0|||
42211868|NCT03173313|76026966|FG000|Overall Study|Physician Decision|1|||
41975450|NCT03204305|75777636|FG002|Overall Study|Withdrawal by Subject|0|||
42028151|NCT00960531|75836472|FG000|Overall Study|Withdrawal by Subject|1|||
42028152|NCT00960531|75836473|FG001|Overall Study|Withdrawal by Subject|0|||
41975451|NCT03204305|75777637|FG003|Overall Study|Withdrawal by Subject|0|||
41975452|NCT03200717|75777649|FG000|Overall Study|Progressive disease|24|||
41975453|NCT03200717|75777650|FG001|Overall Study|Progressive disease|5|||
42211869|NCT03173313|76026967|FG001|Overall Study|Physician Decision|0|||
42211870|NCT03173313|76026966|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
42211871|NCT03173313|76026967|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
42211872|NCT03173313|76026966|FG000|Overall Study|Bone Fracture|1|||
42211873|NCT03173313|76026967|FG001|Overall Study|Bone Fracture|0|||
42211874|NCT03215667|76026973|FG000|Overall Study|Physician Decision|4|||
42211875|NCT03634579|76026977|FG000|Overall Study|study termination|9|||
42211876|NCT02730208|76026983|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
42211877|NCT02730208|76026984|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
42211878|NCT01291511|76026992|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
42211879|NCT01291511|76026993|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
42211880|NCT01291511|76026992|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
42211881|NCT01291511|76026993|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
42211882|NCT01291511|76026992|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
42211883|NCT01291511|76026993|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
42211884|NCT01291511|76026992|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
42211885|NCT01291511|76026993|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
42211886|NCT01291511|76026992|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
42211887|NCT01291511|76026993|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
42211888|NCT01291511|76026992|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
42211889|NCT01291511|76026993|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
42211890|NCT01291511|76026992|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
42211891|NCT01291511|76026993|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
42211892|NCT01291511|76026992|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
42211893|NCT01291511|76026993|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
42211894|NCT01291511|76026992|FG000|Cross-Titration and Stabilization Phase|Death|1|||
42211895|NCT01291511|76026993|FG001|Cross-Titration and Stabilization Phase|Death|0|||
41975454|NCT03200717|75777649|FG000|Overall Study|Adverse Event|11|||
41975455|NCT03200717|75777650|FG001|Overall Study|Adverse Event|8|||
41975456|NCT03200717|75777649|FG000|Overall Study|Physician Decision|3|||
41975457|NCT03200717|75777650|FG001|Overall Study|Physician Decision|2|||
41975458|NCT03200717|75777649|FG000|Overall Study|Death|2|||
41975459|NCT03200717|75777650|FG001|Overall Study|Death|0|||
41975460|NCT03200717|75777649|FG000|Overall Study|Subject/Guardian Decision|1|||
41975461|NCT03200717|75777650|FG001|Overall Study|Subject/Guardian Decision|0|||
41975462|NCT03105700|75777659|FG000|Overall Study|screen fail|3|||
41975463|NCT03105700|75777659|FG000|Overall Study|Lost to Follow-up|4|||
41975464|NCT02738853|75777682|FG000|Enrollment|Inclusion/Exclusion not met|21|||
41975465|NCT02738853|75777682|FG000|Enrollment|Withdrawal by Subject|3|||
41975466|NCT02738853|75777682|FG000|Enrollment|Subject treated with commercially available device|6|||
41975467|NCT02738853|75777682|FG000|Enrollment|Study Enrollment Closed|3|||
41975468|NCT02738853|75777682|FG000|Procedure|Death|1|||
42028153|NCT00960531|75836474|FG002|Overall Study|Withdrawal by Subject|5|||
42127866|NCT00530348|75938397|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
42127867|NCT00530348|75938398|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
42127868|NCT03886220|75938406|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
42127869|NCT03886220|75938407|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
42127870|NCT03886220|75938406|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
42127871|NCT03886220|75938407|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42127872|NCT03886220|75938406|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
42127873|NCT03886220|75938407|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
42127874|NCT00530270|75938415|FG000|Overall Study|Protocol Violation|1|||
42127875|NCT00530270|75938416|FG001|Overall Study|Protocol Violation|0|||
42127876|NCT03885596|75938426|FG000|Overall Study|Withdrawal by Subject|2|||
42127877|NCT03885596|75938427|FG001|Overall Study|Withdrawal by Subject|1|||
42127878|NCT03885596|75938428|FG002|Overall Study|Withdrawal by Subject|0|||
42127879|NCT03885596|75938429|FG003|Overall Study|Withdrawal by Subject|0|||
42127880|NCT00529100|75938445|FG000|Overall Study|Adverse Event|0|||
42127881|NCT00529100|75938446|FG001|Overall Study|Adverse Event|5|||
42127882|NCT00529100|75938445|FG000|Overall Study|Protocol Violation|0|||
42127883|NCT00529100|75938446|FG001|Overall Study|Protocol Violation|1|||
42127884|NCT00529100|75938445|FG000|Overall Study|Progressive Disease|0|||
42127885|NCT00529100|75938446|FG001|Overall Study|Progressive Disease|1|||
42127886|NCT00529100|75938445|FG000|Overall Study|Withdrawal by Subject|0|||
42127887|NCT00529100|75938446|FG001|Overall Study|Withdrawal by Subject|1|||
42127888|NCT00529100|75938445|FG000|Overall Study|Participant Ineligibility|0|||
42127889|NCT00529100|75938446|FG001|Overall Study|Participant Ineligibility|1|||
42127890|NCT03878108|75938458|FG000|Overall Study|Adverse Event|1|||
41975469|NCT02738853|75777682|FG000|1 Month|Death|2|||
41975470|NCT02738853|75777682|FG000|6 Month|Death|4|||
41975471|NCT02738853|75777682|FG000|6 Month|Withdrawal by Subject|2|||
42127891|NCT03878108|75938459|FG001|Overall Study|Adverse Event|0|||
42127892|NCT00529958|75938468|FG000|2-Year Follow-up|Lost to Follow-up|1|||
41975472|NCT02738853|75777682|FG000|1 Year|Death|6|||
41975473|NCT02738853|75777682|FG000|1 Year|Withdrawal by Subject|1|||
41975474|NCT02738853|75777682|FG000|2 Year|Death|2|||
41975475|NCT02738853|75777682|FG000|2 Year|Lost to Follow-up|1|||
41975476|NCT02738853|75777682|FG000|3 Year|Death|2|||
41975477|NCT02738853|75777682|FG000|3 Year|Withdrawal by Subject|1|||
41975478|NCT02738853|75777682|FG000|4 Year|Death|9|||
41975479|NCT02738853|75777682|FG000|5 Year|Lost to Follow-up|4|||
42211896|NCT01291511|76026992|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
42211897|NCT01291511|76026993|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
42211898|NCT01291511|76026992|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
42211899|NCT01291511|76026993|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
42211900|NCT01291511|76026992|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
42211901|NCT01291511|76026993|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
42211902|NCT01291511|76026992|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
42211903|NCT01291511|76026993|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
42211904|NCT01291511|76026992|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
42211905|NCT01291511|76026993|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
41975480|NCT02358538|75777690|FG000|Through Week 26|Adverse Event|0|||
41975481|NCT02358538|75777691|FG001|Through Week 26|Adverse Event|1|||
41975482|NCT02358538|75777692|FG002|Through Week 26|Adverse Event|1|||
41975483|NCT02358538|75777693|FG003|Through Week 26|Adverse Event|2|||
41975484|NCT02358538|75777690|FG000|Through Week 26|Lack of Efficacy|1|||
41975485|NCT02358538|75777691|FG001|Through Week 26|Lack of Efficacy|1|||
41975486|NCT02358538|75777692|FG002|Through Week 26|Lack of Efficacy|3|||
41975487|NCT02358538|75777693|FG003|Through Week 26|Lack of Efficacy|3|||
42211906|NCT01291511|76026992|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
42211907|NCT01291511|76026993|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
42211908|NCT01291511|76026992|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
42211909|NCT01291511|76026993|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
41975488|NCT02358538|75777690|FG000|Through Week 26|Withdrawal by Subject|1|||
41975489|NCT02358538|75777691|FG001|Through Week 26|Withdrawal by Subject|0|||
41975490|NCT02358538|75777692|FG002|Through Week 26|Withdrawal by Subject|0|||
41975491|NCT02358538|75777693|FG003|Through Week 26|Withdrawal by Subject|0|||
41975492|NCT02358538|75777690|FG000|Through Week 26|Non-Compliance|0|||
41975493|NCT02358538|75777691|FG001|Through Week 26|Non-Compliance|0|||
41975494|NCT02358538|75777692|FG002|Through Week 26|Non-Compliance|1|||
41975495|NCT02358538|75777693|FG003|Through Week 26|Non-Compliance|0|||
41975496|NCT02358538|75777690|FG000|Through Week 26|Family did not see benefit from IP|1|||
42028154|NCT00960531|75836475|FG003|Overall Study|Withdrawal by Subject|2|||
42127893|NCT00529958|75938469|FG001|2-Year Follow-up|Lost to Follow-up|2|||
42127894|NCT00529958|75938470|FG002|2-Year Follow-up|Lost to Follow-up|2|||
42127895|NCT00529958|75938468|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
42127896|NCT00529958|75938469|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
42127897|NCT00529958|75938470|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
42127898|NCT00529958|75938468|FG000|5-Year Follow-up|Lost to Follow-up|2|||
42127899|NCT00529958|75938469|FG001|5-Year Follow-up|Lost to Follow-up|3|||
42127900|NCT00529958|75938470|FG002|5-Year Follow-up|Lost to Follow-up|1|||
42127901|NCT00529958|75938468|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
42127902|NCT00529958|75938469|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
42127903|NCT00529958|75938470|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
42127904|NCT00529802|75938478|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
42127905|NCT00529802|75938478|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
42127906|NCT00529802|75938478|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
42127907|NCT00529802|75938478|FG000|Evaluable for Primary Endpoint|Death|1|||
42127908|NCT00529802|75938478|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
42127909|NCT00529802|75938478|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
42127910|NCT00529802|75938478|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
42127911|NCT00528866|75938484|FG000|Overall Study|Protocol Violation|6|||
42127912|NCT00614393|75938494|FG000|Overall Study|Adverse Event|20|||
42127913|NCT00614393|75938495|FG001|Overall Study|Adverse Event|2|||
42127914|NCT00614393|75938496|FG002|Overall Study|Adverse Event|3|||
42127915|NCT00614393|75938497|FG003|Overall Study|Adverse Event|13|||
42127916|NCT00614393|75938498|FG004|Overall Study|Adverse Event|21|||
42127917|NCT00614393|75938494|FG000|Overall Study|Lost to Follow-up|0|||
42127918|NCT00614393|75938495|FG001|Overall Study|Lost to Follow-up|0|||
42127919|NCT00614393|75938496|FG002|Overall Study|Lost to Follow-up|0|||
42127920|NCT00614393|75938497|FG003|Overall Study|Lost to Follow-up|1|||
41975497|NCT02358538|75777691|FG001|Through Week 26|Family did not see benefit from IP|0|||
41975498|NCT02358538|75777692|FG002|Through Week 26|Family did not see benefit from IP|0|||
42211910|NCT01291511|76026992|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
42211911|NCT01291511|76026993|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
42211912|NCT01291511|76026992|FG000|Double-blind Relapse Prevention Phase|Death|1|||
42211913|NCT01291511|76026993|FG001|Double-blind Relapse Prevention Phase|Death|0|||
42211914|NCT03201900|76027000|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
42211915|NCT03201900|76027000|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
42211916|NCT03201900|76027000|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
42211917|NCT03201900|76027000|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
42211918|NCT03201900|76027000|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
42211919|NCT03201900|76027000|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
42211920|NCT03201900|76027000|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
42211921|NCT03201900|76027000|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
42211922|NCT03201900|76027000|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
42211923|NCT03201900|76027000|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
42211924|NCT03201900|76027000|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
42211925|NCT03201900|76027000|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
42211926|NCT03201900|76027000|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
42211927|NCT03170271|76027015|FG000|Overall Study|Adverse Event|7|||
42211928|NCT03170271|76027016|FG001|Overall Study|Adverse Event|2|||
42211929|NCT03170271|76027015|FG000|Overall Study|Lost to Follow-up|0|||
42211930|NCT03170271|76027016|FG001|Overall Study|Lost to Follow-up|1|||
42211931|NCT03170271|76027015|FG000|Overall Study|Physician Decision|1|||
42211932|NCT03170271|76027016|FG001|Overall Study|Physician Decision|0|||
41975499|NCT02358538|75777693|FG003|Through Week 26|Family did not see benefit from IP|0|||
41975500|NCT02358538|75777690|FG000|52 Week Extension Period|Lack of Efficacy|0|||
41975501|NCT02358538|75777691|FG001|52 Week Extension Period|Lack of Efficacy|0|||
41975502|NCT02358538|75777692|FG002|52 Week Extension Period|Lack of Efficacy|2|||
41975503|NCT02358538|75777693|FG003|52 Week Extension Period|Lack of Efficacy|4|||
41975504|NCT02056119|75777728|FG000|Overall Study|Death|1|||
41975505|NCT02056119|75777729|FG001|Overall Study|Death|2|||
41975506|NCT02056119|75777728|FG000|Overall Study|Intubated for less than 24 hrs|2|||
41975507|NCT02056119|75777729|FG001|Overall Study|Intubated for less than 24 hrs|7|||
41975508|NCT02056119|75777728|FG000|Overall Study|No aerosol treatments were given.|3|||
41975509|NCT02056119|75777729|FG001|Overall Study|No aerosol treatments were given.|2|||
41975510|NCT02056119|75777728|FG000|Overall Study|Received Metaneb treatment|0|||
41975511|NCT02056119|75777729|FG001|Overall Study|Received Metaneb treatment|2|||
41975512|NCT02056119|75777728|FG000|Overall Study|Protocol Violation|4|||
41975513|NCT02056119|75777729|FG001|Overall Study|Protocol Violation|7|||
41975514|NCT02038452|75777737|FG000|Overall Study|Withdrawal by Subject|7|||
41975515|NCT02038452|75777738|FG001|Overall Study|Withdrawal by Subject|9|||
41975516|NCT02038452|75777737|FG000|Overall Study|Lost to Follow-up|31|||
41975517|NCT02038452|75777738|FG001|Overall Study|Lost to Follow-up|28|||
41975518|NCT01238172|75777777|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
42127921|NCT00614393|75938498|FG004|Overall Study|Lost to Follow-up|2|||
42127922|NCT00614393|75938494|FG000|Overall Study|Physician Decision|17|||
42127923|NCT00614393|75938495|FG001|Overall Study|Physician Decision|0|||
42127924|NCT00614393|75938496|FG002|Overall Study|Physician Decision|1|||
42127925|NCT00614393|75938497|FG003|Overall Study|Physician Decision|8|||
42127926|NCT00614393|75938498|FG004|Overall Study|Physician Decision|9|||
42127927|NCT00614393|75938494|FG000|Overall Study|Progressive Disease|118|||
42127928|NCT00614393|75938495|FG001|Overall Study|Progressive Disease|5|||
42127929|NCT00614393|75938496|FG002|Overall Study|Progressive Disease|5|||
42127930|NCT00614393|75938497|FG003|Overall Study|Progressive Disease|138|||
42127931|NCT00614393|75938498|FG004|Overall Study|Progressive Disease|130|||
42127932|NCT00614393|75938494|FG000|Overall Study|Protocol Violation|1|||
42127933|NCT00614393|75938495|FG001|Overall Study|Protocol Violation|0|||
42127934|NCT00614393|75938496|FG002|Overall Study|Protocol Violation|0|||
42127935|NCT00614393|75938497|FG003|Overall Study|Protocol Violation|0|||
42127936|NCT00614393|75938498|FG004|Overall Study|Protocol Violation|0|||
42127937|NCT00614393|75938494|FG000|Overall Study|Terminated by Sponsor|0|||
42127938|NCT00614393|75938495|FG001|Overall Study|Terminated by Sponsor|0|||
42127939|NCT00614393|75938496|FG002|Overall Study|Terminated by Sponsor|0|||
42127940|NCT00614393|75938497|FG003|Overall Study|Terminated by Sponsor|0|||
42127941|NCT00614393|75938498|FG004|Overall Study|Terminated by Sponsor|1|||
42127942|NCT00614393|75938494|FG000|Overall Study|Withdrawal by Subject|20|||
42127943|NCT00614393|75938495|FG001|Overall Study|Withdrawal by Subject|1|||
42127944|NCT00614393|75938496|FG002|Overall Study|Withdrawal by Subject|1|||
42127945|NCT00614393|75938497|FG003|Overall Study|Withdrawal by Subject|16|||
42211933|NCT03170271|76027015|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
42211934|NCT03170271|76027016|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
42211935|NCT03170271|76027015|FG000|Overall Study|Withdrawal by Subject|17|||
42211936|NCT03170271|76027016|FG001|Overall Study|Withdrawal by Subject|5|||
42211937|NCT03170271|76027015|FG000|Overall Study|Other|2|||
42211938|NCT03170271|76027016|FG001|Overall Study|Other|2|||
42211939|NCT03170271|76027015|FG000|Overall Study|Randomized in error|4|||
42211940|NCT03170271|76027016|FG001|Overall Study|Randomized in error|0|||
42211941|NCT03613129|76027026|FG000|Pre-treatment Assessment|Protocol Violation|2|||
42211942|NCT03613129|76027027|FG001|Pre-treatment Assessment|Protocol Violation|0|||
42211943|NCT03613129|76027028|FG002|Pre-treatment Assessment|Protocol Violation|0|||
42211944|NCT03613129|76027029|FG003|Pre-treatment Assessment|Protocol Violation|0|||
42211945|NCT03613129|76027030|FG004|Pre-treatment Assessment|Protocol Violation|0|||
42211946|NCT03613129|76027026|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
42211947|NCT03613129|76027027|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
42211948|NCT03613129|76027028|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
42211949|NCT03613129|76027029|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
42211950|NCT03613129|76027030|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
42211951|NCT03235284|76027045|FG000|Overall Study|Adverse Event|1|||
42211952|NCT03235284|76027046|FG001|Overall Study|Adverse Event|2|||
42211953|NCT03235284|76027047|FG002|Overall Study|Adverse Event|1|||
42211954|NCT03170193|76027062|FG000|Overall Study|Withdrawal by Subject|0|||
41975519|NCT01238172|75777778|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
41975520|NCT01238172|75777777|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
41975521|NCT01238172|75777778|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
41975522|NCT00967005|75777786|FG000|Overall Study|Lost to Follow-up|7|||
41975523|NCT00967005|75777787|FG001|Overall Study|Lost to Follow-up|10|||
41975524|NCT00203996|75777845|FG000|Overall Study|Lost to Follow-up|0|||
41975525|NCT00203996|75777846|FG001|Overall Study|Lost to Follow-up|0|||
41975526|NCT00203996|75777847|FG002|Overall Study|Lost to Follow-up|0|||
41975527|NCT00203996|75777848|FG003|Overall Study|Lost to Follow-up|1|||
41975528|NCT00203996|75777849|FG004|Overall Study|Lost to Follow-up|0|||
41975529|NCT00203996|75777850|FG005|Overall Study|Lost to Follow-up|0|||
41975530|NCT00203996|75777851|FG006|Overall Study|Lost to Follow-up|0|||
41975531|NCT00203996|75777852|FG007|Overall Study|Lost to Follow-up|0|||
41975532|NCT00203996|75777853|FG008|Overall Study|Lost to Follow-up|0|||
41975533|NCT00203996|75777854|FG009|Overall Study|Lost to Follow-up|0|||
41975534|NCT00203996|75777845|FG000|Overall Study|Protocol Violation|0|||
41975535|NCT00203996|75777846|FG001|Overall Study|Protocol Violation|0|||
41975536|NCT00203996|75777847|FG002|Overall Study|Protocol Violation|0|||
41975537|NCT00203996|75777848|FG003|Overall Study|Protocol Violation|6|||
41975538|NCT00203996|75777849|FG004|Overall Study|Protocol Violation|1|||
42211955|NCT03170193|76027063|FG001|Overall Study|Withdrawal by Subject|0|||
42211956|NCT03170193|76027064|FG002|Overall Study|Withdrawal by Subject|0|||
42211957|NCT03170193|76027065|FG003|Overall Study|Withdrawal by Subject|1|||
42211958|NCT03170193|76027066|FG004|Overall Study|Withdrawal by Subject|0|||
42211959|NCT03170193|76027067|FG005|Overall Study|Withdrawal by Subject|0|||
42211960|NCT03170193|76027068|FG006|Overall Study|Withdrawal by Subject|0|||
42211961|NCT03170193|76027062|FG000|Overall Study|Lost to Follow-up|1|||
42211962|NCT03170193|76027063|FG001|Overall Study|Lost to Follow-up|1|||
42211963|NCT03170193|76027064|FG002|Overall Study|Lost to Follow-up|0|||
42211964|NCT03170193|76027065|FG003|Overall Study|Lost to Follow-up|0|||
42211965|NCT03170193|76027066|FG004|Overall Study|Lost to Follow-up|0|||
42211966|NCT03170193|76027067|FG005|Overall Study|Lost to Follow-up|0|||
42211967|NCT03170193|76027068|FG006|Overall Study|Lost to Follow-up|0|||
42211968|NCT03633331|76027090|FG000|Overall Study|Withdrawal by Subject|1|||
42211969|NCT03201003|76027096|FG000|Overall Study|Adverse Event|14|||
42211970|NCT03201003|76027097|FG001|Overall Study|Adverse Event|1|||
42211971|NCT03201003|76027096|FG000|Overall Study|Other reasons|5|||
42211972|NCT03201003|76027097|FG001|Overall Study|Other reasons|1|||
42211973|NCT03201003|76027096|FG000|Overall Study|Withdrawal by Subject|4|||
42211974|NCT03201003|76027097|FG001|Overall Study|Withdrawal by Subject|1|||
42211975|NCT03201003|76027096|FG000|Overall Study|Lost to Follow-up|2|||
42211976|NCT03201003|76027097|FG001|Overall Study|Lost to Follow-up|0|||
42211977|NCT03201003|76027096|FG000|Overall Study|Protocol Violation|1|||
42211978|NCT03201003|76027097|FG001|Overall Study|Protocol Violation|0|||
41975539|NCT00203996|75777850|FG005|Overall Study|Protocol Violation|0|||
41975540|NCT00203996|75777851|FG006|Overall Study|Protocol Violation|0|||
41975541|NCT00203996|75777852|FG007|Overall Study|Protocol Violation|0|||
41975542|NCT00203996|75777853|FG008|Overall Study|Protocol Violation|0|||
41975543|NCT00203996|75777854|FG009|Overall Study|Protocol Violation|0|||
42211979|NCT03166215|76027105|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
42211980|NCT03166215|76027106|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
42211981|NCT03166215|76027107|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
42211982|NCT03166215|76027105|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
41975544|NCT00203996|75777845|FG000|Overall Study|Physician Decision|0|||
42211983|NCT03166215|76027106|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
42211984|NCT03166215|76027107|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
42211985|NCT03168711|76027129|FG000|Overall Study|Adverse Event|2|||
42211986|NCT03168711|76027130|FG001|Overall Study|Adverse Event|0|||
42211987|NCT03168711|76027129|FG000|Overall Study|Withdrawal by Subject|0|||
42211988|NCT03168711|76027130|FG001|Overall Study|Withdrawal by Subject|1|||
42211989|NCT03168711|76027129|FG000|Overall Study|Death|0|||
42211990|NCT03168711|76027130|FG001|Overall Study|Death|1|||
42211991|NCT03738215|76027139|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
42211992|NCT03738215|76027140|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
42211993|NCT03738215|76027141|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
42211994|NCT03738215|76027139|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
42211995|NCT03738215|76027140|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
42211996|NCT03738215|76027141|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
42211997|NCT03738215|76027139|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
42211998|NCT03738215|76027140|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
41975545|NCT00203996|75777846|FG001|Overall Study|Physician Decision|0|||
42211999|NCT03738215|76027141|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
42212000|NCT03738215|76027139|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
42212001|NCT03738215|76027140|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
42212002|NCT03738215|76027141|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
42212003|NCT03738215|76027139|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
42212004|NCT03738215|76027140|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
42212005|NCT03738215|76027141|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
42212006|NCT03738215|76027139|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
42212007|NCT03738215|76027140|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
42212008|NCT03738215|76027141|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
42212009|NCT03738215|76027139|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
42212010|NCT03738215|76027140|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
42212011|NCT03738215|76027141|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
42212012|NCT03738215|76027139|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
42212013|NCT03738215|76027140|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
42212014|NCT03738215|76027141|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
42212015|NCT03738215|76027139|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
42212016|NCT03738215|76027140|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
42212017|NCT03738215|76027141|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
42212018|NCT03738215|76027139|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
42212019|NCT03738215|76027140|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
42212020|NCT03738215|76027141|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
42212021|NCT03199911|76027151|FG000|Overall Study|Lost to Follow-up|5|||
41975546|NCT00203996|75777847|FG002|Overall Study|Physician Decision|0|||
41975547|NCT00203996|75777848|FG003|Overall Study|Physician Decision|2|||
41975548|NCT00203996|75777849|FG004|Overall Study|Physician Decision|0|||
41975549|NCT00203996|75777850|FG005|Overall Study|Physician Decision|0|||
41975550|NCT00203996|75777851|FG006|Overall Study|Physician Decision|0|||
41975551|NCT00203996|75777852|FG007|Overall Study|Physician Decision|0|||
41975552|NCT00203996|75777853|FG008|Overall Study|Physician Decision|0|||
41975553|NCT00203996|75777854|FG009|Overall Study|Physician Decision|1|||
41975554|NCT00203996|75777845|FG000|Overall Study|CPAP machine malfunction|0|||
41975555|NCT00203996|75777846|FG001|Overall Study|CPAP machine malfunction|0|||
41975556|NCT00203996|75777847|FG002|Overall Study|CPAP machine malfunction|0|||
42028155|NCT00960531|75836476|FG004|Overall Study|Withdrawal by Subject|0|||
41975557|NCT00203996|75777848|FG003|Overall Study|CPAP machine malfunction|1|||
42028156|NCT00960531|75836477|FG005|Overall Study|Withdrawal by Subject|0|||
41975558|NCT00203996|75777849|FG004|Overall Study|CPAP machine malfunction|0|||
41975559|NCT00203996|75777850|FG005|Overall Study|CPAP machine malfunction|0|||
42127946|NCT00614393|75938498|FG004|Overall Study|Withdrawal by Subject|13|||
42127947|NCT00614393|75938494|FG000|Overall Study|Other|4|||
42127948|NCT00614393|75938495|FG001|Overall Study|Other|0|||
42127949|NCT00614393|75938496|FG002|Overall Study|Other|0|||
42127950|NCT00614393|75938497|FG003|Overall Study|Other|4|||
42127951|NCT00614393|75938498|FG004|Overall Study|Other|2|||
42127952|NCT00614393|75938494|FG000|Overall Study|Not Treated|0|||
42127953|NCT00614393|75938495|FG001|Overall Study|Not Treated|0|||
42127954|NCT00614393|75938496|FG002|Overall Study|Not Treated|0|||
42127955|NCT00614393|75938497|FG003|Overall Study|Not Treated|0|||
42127956|NCT00614393|75938498|FG004|Overall Study|Not Treated|2|||
42127957|NCT00612677|75938510|FG000|Overall Study|study closed before treatment started|1|||
42127958|NCT00613925|75938516|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
41975560|NCT00203996|75777851|FG006|Overall Study|CPAP machine malfunction|0|||
42301789|NCT02501629|76136947|FG001|Overall Study|Withdrawn from study by sponsor|0|||
42301790|NCT02501629|76136946|FG000|Overall Study|Early termination by sponsor|1|||
42301791|NCT02501629|76136947|FG001|Overall Study|Early termination by sponsor|0|||
42301792|NCT02501629|76136946|FG000|Overall Study|Withdrawal by Subject|3|||
42301793|NCT02501629|76136947|FG001|Overall Study|Withdrawal by Subject|5|||
42301794|NCT02501629|76136946|FG000|Overall Study|Subject did not return to site|0|||
42301795|NCT02501629|76136947|FG001|Overall Study|Subject did not return to site|1|||
42301796|NCT02501473|76136960|FG000|Overall Study|Study Terminated|2|||
42301797|NCT02501473|76136961|FG001|Overall Study|Study Terminated|3|||
42301798|NCT02501473|76136962|FG002|Overall Study|Study Terminated|7|||
42301799|NCT02501473|76136963|FG003|Overall Study|Study Terminated|9|||
42301800|NCT02501473|76136964|FG004|Overall Study|Study Terminated|2|||
42301801|NCT02501473|76136965|FG005|Overall Study|Study Terminated|10|||
42301802|NCT02501473|76136966|FG006|Overall Study|Study Terminated|1|||
42301803|NCT02501473|76136967|FG007|Overall Study|Study Terminated|0|||
42301804|NCT02501473|76136960|FG000|Overall Study|Withdrawal by Subject|0|||
42301805|NCT02501473|76136961|FG001|Overall Study|Withdrawal by Subject|0|||
42301806|NCT02501473|76136962|FG002|Overall Study|Withdrawal by Subject|3|||
42301807|NCT02501473|76136963|FG003|Overall Study|Withdrawal by Subject|3|||
42301808|NCT02501473|76136964|FG004|Overall Study|Withdrawal by Subject|2|||
41975561|NCT00203996|75777852|FG007|Overall Study|CPAP machine malfunction|0|||
41975562|NCT00203996|75777853|FG008|Overall Study|CPAP machine malfunction|0|||
41975563|NCT00203996|75777854|FG009|Overall Study|CPAP machine malfunction|0|||
41975564|NCT00203996|75777845|FG000|Overall Study|Scheduling issue|0|||
41975565|NCT00203996|75777846|FG001|Overall Study|Scheduling issue|0|||
41975566|NCT00203996|75777847|FG002|Overall Study|Scheduling issue|0|||
41975567|NCT00203996|75777848|FG003|Overall Study|Scheduling issue|0|||
41975568|NCT00203996|75777849|FG004|Overall Study|Scheduling issue|0|||
41975569|NCT00203996|75777850|FG005|Overall Study|Scheduling issue|0|||
41975570|NCT00203996|75777851|FG006|Overall Study|Scheduling issue|0|||
41975571|NCT00203996|75777852|FG007|Overall Study|Scheduling issue|2|||
41975572|NCT00203996|75777853|FG008|Overall Study|Scheduling issue|0|||
41975573|NCT00203996|75777854|FG009|Overall Study|Scheduling issue|0|||
42212022|NCT03199911|76027152|FG001|Overall Study|Lost to Follow-up|5|||
42212023|NCT03199911|76027151|FG000|Overall Study|Did not proceed with surgery|2|||
42212024|NCT03199911|76027152|FG001|Overall Study|Did not proceed with surgery|1|||
42212025|NCT03736967|76027162|FG000|Overall Study|Withdrawal by Subject|26|||
42212026|NCT03736967|76027163|FG001|Overall Study|Withdrawal by Subject|25|||
42212027|NCT03736967|76027164|FG002|Overall Study|Withdrawal by Subject|23|||
42212028|NCT03736967|76027165|FG003|Overall Study|Withdrawal by Subject|26|||
42212029|NCT03736967|76027162|FG000|Overall Study|Lost to Follow-up|3|||
42212030|NCT03736967|76027163|FG001|Overall Study|Lost to Follow-up|2|||
42212031|NCT03736967|76027164|FG002|Overall Study|Lost to Follow-up|1|||
42212032|NCT03736967|76027165|FG003|Overall Study|Lost to Follow-up|1|||
42212033|NCT03736967|76027162|FG000|Overall Study|Physician Decision|1|||
42212034|NCT03736967|76027163|FG001|Overall Study|Physician Decision|0|||
42212035|NCT03736967|76027164|FG002|Overall Study|Physician Decision|0|||
42212036|NCT03736967|76027165|FG003|Overall Study|Physician Decision|1|||
42212037|NCT03736967|76027162|FG000|Overall Study|Adverse Event|0|||
42212038|NCT03736967|76027163|FG001|Overall Study|Adverse Event|1|||
42212039|NCT03736967|76027164|FG002|Overall Study|Adverse Event|0|||
42212040|NCT03736967|76027165|FG003|Overall Study|Adverse Event|1|||
41975574|NCT02014558|75777883|FG000|Overall Study|Never Received Study Drug|0|||
41975575|NCT02014558|75777884|FG001|Overall Study|Never Received Study Drug|0|||
41975576|NCT02014558|75777885|FG002|Overall Study|Never Received Study Drug|0|||
41975577|NCT02014558|75777886|FG003|Overall Study|Never Received Study Drug|0|||
41975578|NCT02014558|75777887|FG004|Overall Study|Never Received Study Drug|1|||
41975579|NCT02014558|75777888|FG005|Overall Study|Never Received Study Drug|0|||
42212041|NCT03736967|76027162|FG000|Overall Study|Death|0|||
42212042|NCT03736967|76027163|FG001|Overall Study|Death|0|||
42212043|NCT03736967|76027164|FG002|Overall Study|Death|0|||
42212044|NCT03736967|76027165|FG003|Overall Study|Death|1|||
42212045|NCT03736967|76027162|FG000|Overall Study|Randomized but never treated|1|||
42212046|NCT03736967|76027163|FG001|Overall Study|Randomized but never treated|0|||
42212047|NCT03736967|76027164|FG002|Overall Study|Randomized but never treated|0|||
42212048|NCT03736967|76027165|FG003|Overall Study|Randomized but never treated|0|||
42212049|NCT03168555|76027178|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
42212050|NCT03168555|76027178|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
42212051|NCT03168555|76027178|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
41975580|NCT02014558|75777889|FG006|Overall Study|Never Received Study Drug|1|||
42212052|NCT03168555|76027178|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
42212053|NCT03235050|76027190|FG000|Overall Study|Adverse Event|0|||
42301809|NCT02501473|76136965|FG005|Overall Study|Withdrawal by Subject|2|||
42301810|NCT02501473|76136966|FG006|Overall Study|Withdrawal by Subject|0|||
41975581|NCT02014558|75777890|FG007|Overall Study|Never Received Study Drug|0|||
41975582|NCT02014558|75777891|FG008|Overall Study|Never Received Study Drug|2|||
41975583|NCT02014558|75777892|FG009|Overall Study|Never Received Study Drug|0|||
41975584|NCT02014558|75777893|FG010|Overall Study|Never Received Study Drug|2|||
41975585|NCT02014558|75777894|FG011|Overall Study|Never Received Study Drug|2|||
41975586|NCT02014558|75777895|FG012|Overall Study|Never Received Study Drug|0|||
41975587|NCT02014558|75777883|FG000|Overall Study|Adverse Event|0|||
41975588|NCT02014558|75777884|FG001|Overall Study|Adverse Event|0|||
41975589|NCT02014558|75777885|FG002|Overall Study|Adverse Event|0|||
41975590|NCT02014558|75777886|FG003|Overall Study|Adverse Event|0|||
41975591|NCT02014558|75777887|FG004|Overall Study|Adverse Event|1|||
41975592|NCT02014558|75777888|FG005|Overall Study|Adverse Event|0|||
42212054|NCT03235050|76027191|FG001|Overall Study|Adverse Event|0|||
42212055|NCT03235050|76027192|FG002|Overall Study|Adverse Event|1|||
42212056|NCT03235050|76027193|FG003|Overall Study|Adverse Event|4|||
42028157|NCT00960531|75836478|FG006|Overall Study|Withdrawal by Subject|2|||
42028158|NCT00960531|75836479|FG007|Overall Study|Withdrawal by Subject|0|||
42028159|NCT00960531|75836480|FG008|Overall Study|Withdrawal by Subject|1|||
42028160|NCT00960531|75836481|FG009|Overall Study|Withdrawal by Subject|0|||
42028161|NCT00960531|75836472|FG000|Overall Study|Caregiver Request|2|||
42028162|NCT00960531|75836473|FG001|Overall Study|Caregiver Request|0|||
42028163|NCT00960531|75836474|FG002|Overall Study|Caregiver Request|6|||
42028164|NCT00960531|75836475|FG003|Overall Study|Caregiver Request|5|||
42212057|NCT03235050|76027194|FG004|Overall Study|Adverse Event|1|||
42212058|NCT03235050|76027190|FG000|Overall Study|Death|0|||
42212059|NCT03235050|76027191|FG001|Overall Study|Death|0|||
42212060|NCT03235050|76027192|FG002|Overall Study|Death|0|||
42212061|NCT03235050|76027193|FG003|Overall Study|Death|2|||
42212062|NCT03235050|76027194|FG004|Overall Study|Death|1|||
42212063|NCT03235050|76027190|FG000|Overall Study|Lost to Follow-up|1|||
42212064|NCT03235050|76027191|FG001|Overall Study|Lost to Follow-up|2|||
41975593|NCT02014558|75777889|FG006|Overall Study|Adverse Event|0|||
41975594|NCT02014558|75777890|FG007|Overall Study|Adverse Event|0|||
41975595|NCT02014558|75777891|FG008|Overall Study|Adverse Event|2|||
41975596|NCT02014558|75777892|FG009|Overall Study|Adverse Event|2|||
41975597|NCT02014558|75777893|FG010|Overall Study|Adverse Event|5|||
41975598|NCT02014558|75777894|FG011|Overall Study|Adverse Event|21|||
41975599|NCT02014558|75777895|FG012|Overall Study|Adverse Event|3|||
41975600|NCT02014558|75777883|FG000|Overall Study|Death|1|||
41975601|NCT02014558|75777884|FG001|Overall Study|Death|0|||
41975602|NCT02014558|75777885|FG002|Overall Study|Death|0|||
41975603|NCT02014558|75777886|FG003|Overall Study|Death|0|||
41975604|NCT02014558|75777887|FG004|Overall Study|Death|0|||
41975605|NCT02014558|75777888|FG005|Overall Study|Death|0|||
41975606|NCT02014558|75777889|FG006|Overall Study|Death|1|||
41975607|NCT02014558|75777890|FG007|Overall Study|Death|1|||
41975608|NCT02014558|75777891|FG008|Overall Study|Death|2|||
41975609|NCT02014558|75777892|FG009|Overall Study|Death|5|||
41975610|NCT02014558|75777893|FG010|Overall Study|Death|5|||
41975611|NCT02014558|75777894|FG011|Overall Study|Death|19|||
41975612|NCT02014558|75777895|FG012|Overall Study|Death|2|||
41975613|NCT02014558|75777883|FG000|Overall Study|Lack of Efficacy|1|||
42127959|NCT00613925|75938517|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
42127960|NCT00613301|75938523|FG000|Overall Study|Adverse Event|49|||
42127961|NCT00613301|75938523|FG000|Overall Study|Lost to Follow-up|88|||
42127962|NCT00613301|75938523|FG000|Overall Study|Withdrawal by Subject|5|||
42127963|NCT00613301|75938523|FG000|Overall Study|Death|6|||
42127964|NCT00613301|75938523|FG000|Overall Study|Lack of Efficacy|13|||
42127965|NCT00613301|75938523|FG000|Overall Study|Physician Decision|2|||
42127966|NCT00613301|75938523|FG000|Overall Study|No data was collected|53|||
42127967|NCT00613301|75938523|FG000|Overall Study|Irregularly enrolled patients|12|||
42127968|NCT00609947|75938528|FG000|Overall Study|Death|1|||
42127969|NCT00609869|75938533|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
42127970|NCT00609869|75938533|FG000|Overall Study|Severe hematologic toxicity|1|||
41975614|NCT02014558|75777884|FG001|Overall Study|Lack of Efficacy|2|||
41975615|NCT02014558|75777885|FG002|Overall Study|Lack of Efficacy|1|||
41975616|NCT02014558|75777886|FG003|Overall Study|Lack of Efficacy|1|||
41975617|NCT02014558|75777887|FG004|Overall Study|Lack of Efficacy|0|||
42028165|NCT00960531|75836476|FG004|Overall Study|Caregiver Request|0|||
42127971|NCT00609869|75938533|FG000|Overall Study|Withdrawal by Subject|1|||
42127972|NCT00609869|75938533|FG000|Overall Study|Seizures|1|||
42127973|NCT00609869|75938533|FG000|Overall Study|Severe tumor flare reaction|1|||
42212065|NCT03235050|76027192|FG002|Overall Study|Lost to Follow-up|1|||
42212066|NCT03235050|76027193|FG003|Overall Study|Lost to Follow-up|2|||
41975618|NCT02014558|75777888|FG005|Overall Study|Lack of Efficacy|0|||
41975619|NCT02014558|75777889|FG006|Overall Study|Lack of Efficacy|1|||
41975620|NCT02014558|75777890|FG007|Overall Study|Lack of Efficacy|3|||
41975621|NCT02014558|75777891|FG008|Overall Study|Lack of Efficacy|3|||
41975622|NCT02014558|75777892|FG009|Overall Study|Lack of Efficacy|3|||
41975623|NCT02014558|75777893|FG010|Overall Study|Lack of Efficacy|16|||
41975624|NCT02014558|75777894|FG011|Overall Study|Lack of Efficacy|8|||
41975625|NCT02014558|75777895|FG012|Overall Study|Lack of Efficacy|5|||
41975626|NCT02014558|75777883|FG000|Overall Study|Lost to Follow-up|0|||
41975627|NCT02014558|75777884|FG001|Overall Study|Lost to Follow-up|0|||
41975628|NCT02014558|75777885|FG002|Overall Study|Lost to Follow-up|0|||
41975629|NCT02014558|75777886|FG003|Overall Study|Lost to Follow-up|0|||
41975630|NCT02014558|75777887|FG004|Overall Study|Lost to Follow-up|0|||
41975631|NCT02014558|75777888|FG005|Overall Study|Lost to Follow-up|0|||
41975632|NCT02014558|75777889|FG006|Overall Study|Lost to Follow-up|0|||
41975633|NCT02014558|75777890|FG007|Overall Study|Lost to Follow-up|0|||
41975634|NCT02014558|75777891|FG008|Overall Study|Lost to Follow-up|0|||
41975635|NCT02014558|75777892|FG009|Overall Study|Lost to Follow-up|0|||
41975636|NCT02014558|75777893|FG010|Overall Study|Lost to Follow-up|1|||
41975637|NCT02014558|75777894|FG011|Overall Study|Lost to Follow-up|0|||
41975638|NCT02014558|75777895|FG012|Overall Study|Lost to Follow-up|0|||
41975639|NCT02014558|75777883|FG000|Overall Study|Progressive Disease|1|||
41975640|NCT02014558|75777884|FG001|Overall Study|Progressive Disease|0|||
41975641|NCT02014558|75777885|FG002|Overall Study|Progressive Disease|1|||
41975642|NCT02014558|75777886|FG003|Overall Study|Progressive Disease|1|||
41975643|NCT02014558|75777887|FG004|Overall Study|Progressive Disease|1|||
41975644|NCT02014558|75777888|FG005|Overall Study|Progressive Disease|2|||
41975645|NCT02014558|75777889|FG006|Overall Study|Progressive Disease|1|||
41975646|NCT02014558|75777890|FG007|Overall Study|Progressive Disease|6|||
41975647|NCT02014558|75777891|FG008|Overall Study|Progressive Disease|5|||
41975648|NCT02014558|75777892|FG009|Overall Study|Progressive Disease|6|||
41975649|NCT02014558|75777893|FG010|Overall Study|Progressive Disease|22|||
41975650|NCT02014558|75777894|FG011|Overall Study|Progressive Disease|31|||
41975651|NCT02014558|75777895|FG012|Overall Study|Progressive Disease|6|||
41975652|NCT02014558|75777883|FG000|Overall Study|Withdrawal by Subject|0|||
41975653|NCT02014558|75777884|FG001|Overall Study|Withdrawal by Subject|0|||
41975654|NCT02014558|75777885|FG002|Overall Study|Withdrawal by Subject|0|||
41975655|NCT02014558|75777886|FG003|Overall Study|Withdrawal by Subject|0|||
41975656|NCT02014558|75777887|FG004|Overall Study|Withdrawal by Subject|1|||
41975657|NCT02014558|75777888|FG005|Overall Study|Withdrawal by Subject|0|||
41975658|NCT02014558|75777889|FG006|Overall Study|Withdrawal by Subject|0|||
41975659|NCT02014558|75777890|FG007|Overall Study|Withdrawal by Subject|0|||
41975660|NCT02014558|75777891|FG008|Overall Study|Withdrawal by Subject|0|||
41975661|NCT02014558|75777892|FG009|Overall Study|Withdrawal by Subject|2|||
41975662|NCT02014558|75777893|FG010|Overall Study|Withdrawal by Subject|6|||
41975663|NCT02014558|75777894|FG011|Overall Study|Withdrawal by Subject|10|||
41975664|NCT02014558|75777895|FG012|Overall Study|Withdrawal by Subject|0|||
41975665|NCT02014558|75777883|FG000|Overall Study|Miscellaneous|2|||
42127974|NCT00609869|75938533|FG000|Overall Study|Hepatitis B infection|1|||
42127975|NCT00609869|75938533|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
42127976|NCT00609869|75938533|FG000|Overall Study|Mantle cell: not evaluable|4|||
42127977|NCT00529568|75938539|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
42127978|NCT00529568|75938540|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
42127979|NCT00529568|75938541|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
42127980|NCT00529568|75938539|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
42127981|NCT00529568|75938540|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
42301811|NCT02501473|76136967|FG007|Overall Study|Withdrawal by Subject|0|||
41975666|NCT02014558|75777884|FG001|Overall Study|Miscellaneous|1|||
41975667|NCT02014558|75777885|FG002|Overall Study|Miscellaneous|1|||
41975668|NCT02014558|75777886|FG003|Overall Study|Miscellaneous|1|||
41975669|NCT02014558|75777887|FG004|Overall Study|Miscellaneous|0|||
41975670|NCT02014558|75777888|FG005|Overall Study|Miscellaneous|1|||
41975671|NCT02014558|75777889|FG006|Overall Study|Miscellaneous|0|||
41975672|NCT02014558|75777890|FG007|Overall Study|Miscellaneous|1|||
41975673|NCT02014558|75777891|FG008|Overall Study|Miscellaneous|1|||
41975674|NCT02014558|75777892|FG009|Overall Study|Miscellaneous|3|||
41975675|NCT02014558|75777893|FG010|Overall Study|Miscellaneous|12|||
42127982|NCT00529568|75938541|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
42127983|NCT00529568|75938539|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
42127984|NCT00529568|75938540|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
41975676|NCT02014558|75777894|FG011|Overall Study|Miscellaneous|11|||
41975677|NCT02014558|75777895|FG012|Overall Study|Miscellaneous|1|||
41975678|NCT02024555|75777950|FG000|Overall Study|Lost to Follow-up|1|||
41975679|NCT02024555|75777951|FG001|Overall Study|Lost to Follow-up|1|||
41975680|NCT02024555|75777950|FG000|Overall Study|Withdrawal by Subject|5|||
41975681|NCT02024555|75777951|FG001|Overall Study|Withdrawal by Subject|1|||
41975682|NCT02040584|75777959|FG000|Overall Study|Adverse Event|13|||
42212067|NCT03235050|76027194|FG004|Overall Study|Lost to Follow-up|0|||
42212068|NCT03235050|76027190|FG000|Overall Study|Withdrawal by Subject|3|||
42212069|NCT03235050|76027191|FG001|Overall Study|Withdrawal by Subject|2|||
42212070|NCT03235050|76027192|FG002|Overall Study|Withdrawal by Subject|2|||
42212071|NCT03235050|76027193|FG003|Overall Study|Withdrawal by Subject|5|||
42212072|NCT03235050|76027194|FG004|Overall Study|Withdrawal by Subject|7|||
42212073|NCT03235050|76027190|FG000|Overall Study|Other reasons|0|||
42212074|NCT03235050|76027191|FG001|Overall Study|Other reasons|1|||
42212075|NCT03235050|76027192|FG002|Overall Study|Other reasons|0|||
42212076|NCT03235050|76027193|FG003|Overall Study|Other reasons|1|||
42212077|NCT03235050|76027194|FG004|Overall Study|Other reasons|2|||
42212078|NCT04502212|76027223|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
42212079|NCT04502212|76027223|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
42212080|NCT03167619|76027230|FG000|Overall Study|Death|11|||
42212081|NCT03167619|76027231|FG001|Overall Study|Death|8|||
42212082|NCT03167619|76027230|FG000|Overall Study|Withdrawal by Subject|1|||
42212083|NCT03167619|76027231|FG001|Overall Study|Withdrawal by Subject|2|||
42212084|NCT03167619|76027230|FG000|Overall Study|Physician Decision|0|||
42212085|NCT03167619|76027231|FG001|Overall Study|Physician Decision|1|||
42212086|NCT03578809|76027241|FG000|Overall Study|Death|0|||
42212087|NCT03578809|76027242|FG001|Overall Study|Death|2|||
42212088|NCT03578809|76027243|FG002|Overall Study|Death|0|||
42212089|NCT03578809|76027244|FG003|Overall Study|Death|1|||
42212090|NCT03578809|76027241|FG000|Overall Study|Lost to Follow-up|0|||
41975683|NCT02040584|75777960|FG001|Overall Study|Adverse Event|6|||
41975684|NCT02040584|75777959|FG000|Overall Study|Protocol Violation|9|||
41975685|NCT02040584|75777960|FG001|Overall Study|Protocol Violation|11|||
41975686|NCT02040584|75777959|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
41975687|NCT02040584|75777960|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
41975688|NCT02040584|75777959|FG000|Overall Study|Death|6|||
41975689|NCT02040584|75777960|FG001|Overall Study|Death|3|||
41975690|NCT02040584|75777959|FG000|Overall Study|Transplant rejection/retransplant|0|||
41975691|NCT02040584|75777960|FG001|Overall Study|Transplant rejection/retransplant|1|||
41975692|NCT02040584|75777959|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
41975693|NCT02040584|75777960|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
41975694|NCT02045797|75777979|FG000|Overall Study|Adverse Event|3|||
41975695|NCT02045797|75777980|FG001|Overall Study|Adverse Event|1|||
41975696|NCT02045797|75777981|FG002|Overall Study|Adverse Event|0|||
41975697|NCT02045797|75777979|FG000|Overall Study|Lack of Efficacy|1|||
41975698|NCT02045797|75777980|FG001|Overall Study|Lack of Efficacy|0|||
41975699|NCT02045797|75777981|FG002|Overall Study|Lack of Efficacy|0|||
41975700|NCT02045797|75777979|FG000|Overall Study|Lost to Follow-up|2|||
41975701|NCT02045797|75777980|FG001|Overall Study|Lost to Follow-up|3|||
41975702|NCT02045797|75777981|FG002|Overall Study|Lost to Follow-up|1|||
41975703|NCT02045797|75777979|FG000|Overall Study|Physician Decision|0|||
41975704|NCT02045797|75777980|FG001|Overall Study|Physician Decision|1|||
41975705|NCT02045797|75777981|FG002|Overall Study|Physician Decision|0|||
41975706|NCT02045797|75777979|FG000|Overall Study|Withdrawal by Subject|1|||
41975707|NCT02045797|75777980|FG001|Overall Study|Withdrawal by Subject|2|||
42127985|NCT00529568|75938541|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
42127986|NCT00529568|75938539|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
42127987|NCT00529568|75938540|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
42127988|NCT00529568|75938541|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
42127989|NCT00529568|75938539|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
42127990|NCT00529568|75938540|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
42127991|NCT00529568|75938541|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
42127992|NCT00529568|75938539|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
42127993|NCT00529568|75938540|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
42127994|NCT00529568|75938541|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
42127995|NCT00529568|75938539|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
42127996|NCT00529568|75938540|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
42127997|NCT00529568|75938541|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
42212091|NCT03578809|76027242|FG001|Overall Study|Lost to Follow-up|1|||
42212092|NCT03578809|76027243|FG002|Overall Study|Lost to Follow-up|0|||
42212093|NCT03578809|76027244|FG003|Overall Study|Lost to Follow-up|0|||
42212094|NCT03578809|76027241|FG000|Overall Study|Withdrawal by Subject|3|||
41975708|NCT02045797|75777981|FG002|Overall Study|Withdrawal by Subject|0|||
41975709|NCT03385239|75778011|FG000|Overall Study|Voluntary Withdrawal|2|||
41975710|NCT03385239|75778012|FG001|Overall Study|Voluntary Withdrawal|3|||
41975711|NCT03385239|75778013|FG002|Overall Study|Voluntary Withdrawal|2|||
41975712|NCT03385239|75778014|FG003|Overall Study|Voluntary Withdrawal|3|||
42212095|NCT03578809|76027242|FG001|Overall Study|Withdrawal by Subject|5|||
42212096|NCT03578809|76027243|FG002|Overall Study|Withdrawal by Subject|2|||
42301812|NCT02501473|76136960|FG000|Overall Study|Death|0|||
42212097|NCT03578809|76027244|FG003|Overall Study|Withdrawal by Subject|0|||
42212098|NCT03578809|76027241|FG000|Overall Study|Other|3|||
42212099|NCT03578809|76027242|FG001|Overall Study|Other|6|||
42212100|NCT03578809|76027243|FG002|Overall Study|Other|2|||
41975713|NCT03385239|75778015|FG004|Overall Study|Voluntary Withdrawal|0|||
41975714|NCT03385239|75778011|FG000|Overall Study|Adverse Event|0|||
41975715|NCT03385239|75778012|FG001|Overall Study|Adverse Event|0|||
41975716|NCT03385239|75778013|FG002|Overall Study|Adverse Event|1|||
41975717|NCT03385239|75778014|FG003|Overall Study|Adverse Event|0|||
41975718|NCT03385239|75778015|FG004|Overall Study|Adverse Event|0|||
41975719|NCT03385239|75778011|FG000|Overall Study|Other|0|||
41975720|NCT03385239|75778012|FG001|Overall Study|Other|0|||
41975721|NCT03385239|75778013|FG002|Overall Study|Other|0|||
41975722|NCT03385239|75778014|FG003|Overall Study|Other|1|||
41975723|NCT03385239|75778015|FG004|Overall Study|Other|0|||
41975724|NCT03020160|75778033|FG000|Overall Study|Withdrawal by Subject|1|||
41975725|NCT03020160|75778034|FG001|Overall Study|Withdrawal by Subject|0|||
41975726|NCT02593110|75778045|FG000|Overall Study|Withdrawal by Subject|0|||
41975727|NCT02593110|75778046|FG001|Overall Study|Withdrawal by Subject|3|||
41975728|NCT02593110|75778047|FG002|Overall Study|Withdrawal by Subject|3|||
41975729|NCT02593110|75778048|FG003|Overall Study|Withdrawal by Subject|2|||
41975730|NCT02593110|75778045|FG000|Overall Study|Death|0|||
41975731|NCT02593110|75778046|FG001|Overall Study|Death|0|||
41975732|NCT02593110|75778047|FG002|Overall Study|Death|1|||
41975733|NCT02593110|75778048|FG003|Overall Study|Death|0|||
41975734|NCT02373813|75778061|FG000|Run-In Period|Other, Not Specified|5|||
41975735|NCT02373813|75778062|FG001|Run-In Period|Other, Not Specified|0|||
41975736|NCT02373813|75778063|FG002|Run-In Period|Other, Not Specified|0|||
41975737|NCT02373813|75778064|FG003|Run-In Period|Other, Not Specified|0|||
42028166|NCT00960531|75836477|FG005|Overall Study|Caregiver Request|2|||
41975738|NCT02373813|75778061|FG000|Run-In Period|Withdrawal by Subject|16|||
41975739|NCT02373813|75778062|FG001|Run-In Period|Withdrawal by Subject|0|||
41975740|NCT02373813|75778063|FG002|Run-In Period|Withdrawal by Subject|0|||
41975741|NCT02373813|75778064|FG003|Run-In Period|Withdrawal by Subject|0|||
41975742|NCT02373813|75778061|FG000|Run-In Period|Decision by Sponsor|11|||
41975743|NCT02373813|75778062|FG001|Run-In Period|Decision by Sponsor|0|||
41975744|NCT02373813|75778063|FG002|Run-In Period|Decision by Sponsor|0|||
42212101|NCT03578809|76027244|FG003|Overall Study|Other|8|||
42212102|NCT03198507|76027259|FG000|Overall Study|Withdrawal by Subject|1|||
41975745|NCT02373813|75778064|FG003|Run-In Period|Decision by Sponsor|0|||
41975746|NCT02373813|75778061|FG000|Run-In Period|Protocol Violation|75|||
41975747|NCT02373813|75778062|FG001|Run-In Period|Protocol Violation|0|||
41975748|NCT02373813|75778063|FG002|Run-In Period|Protocol Violation|0|||
41975749|NCT02373813|75778064|FG003|Run-In Period|Protocol Violation|0|||
41975750|NCT02373813|75778061|FG000|Run-In Period|Lost to Follow-up|2|||
41975751|NCT02373813|75778062|FG001|Run-In Period|Lost to Follow-up|0|||
41975752|NCT02373813|75778063|FG002|Run-In Period|Lost to Follow-up|0|||
41975753|NCT02373813|75778064|FG003|Run-In Period|Lost to Follow-up|0|||
41975754|NCT02373813|75778061|FG000|Run-In Period|Adverse Event|3|||
42212103|NCT03198507|76027260|FG001|Overall Study|Withdrawal by Subject|0|||
42212104|NCT03610165|76027268|FG000|Overall Study|Device didn't work|0|||
42212105|NCT03610165|76027269|FG001|Overall Study|Device didn't work|1|||
42212106|NCT03609619|76027277|FG000|Overall Study|Adverse Event|1|||
42212107|NCT03609619|76027278|FG001|Overall Study|Adverse Event|0|||
41975755|NCT02373813|75778062|FG001|Run-In Period|Adverse Event|0|||
41975756|NCT02373813|75778063|FG002|Run-In Period|Adverse Event|0|||
41975757|NCT02373813|75778064|FG003|Run-In Period|Adverse Event|0|||
41975758|NCT02373813|75778061|FG000|Run-In Period|Noncompliance|1|||
42212108|NCT03609619|76027277|FG000|Overall Study|Lack of Efficacy|1|||
42212109|NCT03609619|76027278|FG001|Overall Study|Lack of Efficacy|2|||
42212110|NCT03609619|76027277|FG000|Overall Study|Protocol Violation|5|||
42212111|NCT03609619|76027278|FG001|Overall Study|Protocol Violation|0|||
42212112|NCT03609619|76027277|FG000|Overall Study|Withdrawal by Subject|2|||
42212113|NCT03609619|76027278|FG001|Overall Study|Withdrawal by Subject|3|||
42212114|NCT03609619|76027277|FG000|Overall Study|Lost to Follow-up|1|||
42212115|NCT03609619|76027278|FG001|Overall Study|Lost to Follow-up|1|||
42212116|NCT03167151|76027287|FG000|Overall Study|Withdrawal by Subject|1|||
42212117|NCT03167151|76027288|FG001|Overall Study|Withdrawal by Subject|0|||
42212118|NCT03167151|76027289|FG002|Overall Study|Withdrawal by Subject|0|||
42212119|NCT03167151|76027287|FG000|Overall Study|No evidence of tumour at surgery|0|||
42028167|NCT00960531|75836478|FG006|Overall Study|Caregiver Request|3|||
42028168|NCT00960531|75836479|FG007|Overall Study|Caregiver Request|1|||
42028169|NCT00960531|75836480|FG008|Overall Study|Caregiver Request|3|||
42028170|NCT00960531|75836481|FG009|Overall Study|Caregiver Request|0|||
42212120|NCT03167151|76027288|FG001|Overall Study|No evidence of tumour at surgery|1|||
42212121|NCT03167151|76027289|FG002|Overall Study|No evidence of tumour at surgery|1|||
42212122|NCT03660943|76027299|FG000|Overall Study|Adverse Event|5|||
42212123|NCT03660943|76027300|FG001|Overall Study|Adverse Event|3|||
42212124|NCT03660943|76027299|FG000|Overall Study|Death|0|||
42212125|NCT03660943|76027300|FG001|Overall Study|Death|2|||
42212126|NCT03660943|76027299|FG000|Overall Study|Lost to Follow-up|7|||
42212127|NCT03660943|76027300|FG001|Overall Study|Lost to Follow-up|3|||
42212128|NCT03660943|76027299|FG000|Overall Study|Protocol Violation|3|||
42212129|NCT03660943|76027300|FG001|Overall Study|Protocol Violation|5|||
42212130|NCT03660943|76027299|FG000|Overall Study|Withdrawal by Subject|8|||
42212131|NCT03660943|76027300|FG001|Overall Study|Withdrawal by Subject|15|||
41975759|NCT02373813|75778062|FG001|Run-In Period|Noncompliance|0|||
41975760|NCT02373813|75778063|FG002|Run-In Period|Noncompliance|0|||
41975761|NCT02373813|75778064|FG003|Run-In Period|Noncompliance|0|||
41975762|NCT02373813|75778061|FG000|Run-In Period|Ineligibility Determined|3|||
41975763|NCT02373813|75778062|FG001|Run-In Period|Ineligibility Determined|0|||
41975764|NCT02373813|75778063|FG002|Run-In Period|Ineligibility Determined|0|||
41975765|NCT02373813|75778064|FG003|Run-In Period|Ineligibility Determined|0|||
41975766|NCT02373813|75778061|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
41975767|NCT02373813|75778062|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
41975768|NCT02373813|75778063|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
41975769|NCT02373813|75778064|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
41975770|NCT02373813|75778061|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
41975771|NCT02373813|75778062|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
41975772|NCT02373813|75778063|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
41975773|NCT02373813|75778064|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
42028171|NCT00960531|75836472|FG000|Overall Study|Investigator Request|0|||
42028172|NCT00960531|75836473|FG001|Overall Study|Investigator Request|0|||
42028173|NCT00960531|75836474|FG002|Overall Study|Investigator Request|1|||
42028174|NCT00960531|75836475|FG003|Overall Study|Investigator Request|0|||
42028175|NCT00960531|75836476|FG004|Overall Study|Investigator Request|0|||
42028176|NCT00960531|75836477|FG005|Overall Study|Investigator Request|0|||
42028177|NCT00960531|75836478|FG006|Overall Study|Investigator Request|0|||
42028178|NCT00960531|75836479|FG007|Overall Study|Investigator Request|0|||
42028179|NCT00960531|75836480|FG008|Overall Study|Investigator Request|0|||
42212132|NCT03660943|76027299|FG000|Overall Study|Lack of Efficacy|9|||
42212133|NCT03660943|76027300|FG001|Overall Study|Lack of Efficacy|12|||
42212134|NCT03660943|76027299|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
42212135|NCT03660943|76027300|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
42212136|NCT03167073|76027308|FG000|Overall Study|Stillbirth|1|||
42028180|NCT00960531|75836481|FG009|Overall Study|Investigator Request|0|||
42212137|NCT03167073|76027309|FG001|Overall Study|Stillbirth|0|||
42212138|NCT03657277|76027315|FG000|Overall Study|Physician Decision|2|||
42028181|NCT00960531|75836472|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
42028182|NCT00960531|75836473|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
42212139|NCT03657277|76027315|FG000|Overall Study|Lost to Follow-up|1|||
42212140|NCT03657277|76027315|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
42212141|NCT03197883|76027321|FG000|Overall Study|Adverse Event|1|||
42212142|NCT03197883|76027322|FG001|Overall Study|Adverse Event|1|||
42212143|NCT03197883|76027321|FG000|Overall Study|Lost to Follow-up|1|||
41975774|NCT02373813|75778061|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
41975775|NCT02373813|75778062|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
41975776|NCT02373813|75778063|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
42212144|NCT03197883|76027322|FG001|Overall Study|Lost to Follow-up|0|||
42212145|NCT03197883|76027321|FG000|Overall Study|Protocol Violation|1|||
42212146|NCT03197883|76027322|FG001|Overall Study|Protocol Violation|0|||
42212147|NCT03197883|76027321|FG000|Overall Study|Other (Not Specified)|0|||
42212148|NCT03197883|76027322|FG001|Overall Study|Other (Not Specified)|5|||
42212149|NCT03234036|76027331|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
41975777|NCT02373813|75778064|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
41975778|NCT02373813|75778061|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42212150|NCT03234036|76027332|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
42212151|NCT03234036|76027333|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
42212152|NCT03234036|76027334|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
42212153|NCT03606109|76027352|FG000|Overall Study|Lost to Follow-up|2|||
42212154|NCT03606109|76027353|FG001|Overall Study|Lost to Follow-up|1|||
42212155|NCT02729896|76027362|FG000|Overall Study|Death|0|||
42212156|NCT02729896|76027363|FG001|Overall Study|Death|2|||
42212157|NCT02729896|76027364|FG002|Overall Study|Death|13|||
42212158|NCT02729896|76027362|FG000|Overall Study|Lost to Follow-up|0|||
42212159|NCT02729896|76027363|FG001|Overall Study|Lost to Follow-up|2|||
42212160|NCT02729896|76027364|FG002|Overall Study|Lost to Follow-up|3|||
41975779|NCT02373813|75778062|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
42212161|NCT02729896|76027362|FG000|Overall Study|Other|0|||
42212162|NCT02729896|76027363|FG001|Overall Study|Other|2|||
42212163|NCT02729896|76027364|FG002|Overall Study|Other|0|||
42212164|NCT02729896|76027362|FG000|Overall Study|Physician Decision|1|||
42212165|NCT02729896|76027363|FG001|Overall Study|Physician Decision|2|||
42212166|NCT02729896|76027364|FG002|Overall Study|Physician Decision|3|||
42212167|NCT02729896|76027362|FG000|Overall Study|Progressive Disease|0|||
42212168|NCT02729896|76027363|FG001|Overall Study|Progressive Disease|1|||
42212169|NCT02729896|76027364|FG002|Overall Study|Progressive Disease|0|||
42212170|NCT02729896|76027362|FG000|Overall Study|Withdrawal by Subject|1|||
42212171|NCT02729896|76027363|FG001|Overall Study|Withdrawal by Subject|0|||
42212172|NCT02729896|76027364|FG002|Overall Study|Withdrawal by Subject|3|||
41975780|NCT02373813|75778063|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
41975781|NCT02373813|75778064|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
41975782|NCT03863509|75778099|FG000|Overall Study|COVID-19 shutdown period|0|||
41975783|NCT03863509|75778100|FG001|Overall Study|COVID-19 shutdown period|4|||
41975784|NCT03863509|75778101|FG002|Overall Study|COVID-19 shutdown period|0|||
41975785|NCT03863509|75778099|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
41975786|NCT03863509|75778100|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
41975787|NCT03863509|75778101|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
41975788|NCT03863509|75778099|FG000|Overall Study|Lost to Follow-up|8|||
41975789|NCT03863509|75778100|FG001|Overall Study|Lost to Follow-up|0|||
41975790|NCT03863509|75778101|FG002|Overall Study|Lost to Follow-up|2|||
42212173|NCT03575065|76027375|FG000|Overall Study|Death|31|||
41975791|NCT03863509|75778099|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
41975792|NCT03863509|75778100|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
41975793|NCT03863509|75778101|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
42028183|NCT00960531|75836474|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
42127998|NCT00529568|75938539|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
42127999|NCT00529568|75938540|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
42128000|NCT00529568|75938541|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
42128001|NCT00529568|75938539|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
42128002|NCT00529568|75938540|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
42128003|NCT00529568|75938541|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
42128004|NCT00529568|75938539|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
42212174|NCT03575065|76027376|FG001|Overall Study|Death|12|||
42212175|NCT03575065|76027375|FG000|Overall Study|Sponsor's Decision|28|||
42128005|NCT00529568|75938540|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
42212176|NCT03575065|76027376|FG001|Overall Study|Sponsor's Decision|13|||
42212177|NCT03575065|76027375|FG000|Overall Study|Withdrawal by Subject|2|||
42212178|NCT03575065|76027376|FG001|Overall Study|Withdrawal by Subject|1|||
42212179|NCT03575065|76027375|FG000|Overall Study|Lost to Follow-up|1|||
42212180|NCT03575065|76027376|FG001|Overall Study|Lost to Follow-up|0|||
42212181|NCT03514134|76027385|FG000|Overall Study|Lost to Follow-up|0|||
42212182|NCT03514134|76027386|FG001|Overall Study|Lost to Follow-up|1|||
42212183|NCT03188718|76027392|FG000|Overall Study|Participant noncompliance|4|||
42212184|NCT03188718|76027392|FG000|Overall Study|Withdrawal by Subject|1|||
42212185|NCT03188718|76027392|FG000|Overall Study|Device failure|3|||
42212186|NCT03574753|76027396|FG000|Overall Study|Adverse Event|3|||
42212187|NCT03574753|76027396|FG000|Overall Study|Progression/relapse|19|||
42212188|NCT03574753|76027396|FG000|Overall Study|Death|1|||
42212189|NCT03573505|76027403|FG000|Overall Study|Adverse Event|1|||
42212190|NCT03573505|76027404|FG001|Overall Study|Adverse Event|1|||
42212191|NCT03573505|76027403|FG000|Overall Study|Consent withdrawn|0|||
42212192|NCT03573505|76027404|FG001|Overall Study|Consent withdrawn|1|||
42212193|NCT03573505|76027403|FG000|Overall Study|Disease progression|0|||
42212194|NCT03573505|76027404|FG001|Overall Study|Disease progression|1|||
42212195|NCT03573505|76027403|FG000|Overall Study|Site Terminated by Sponsor|1|||
42212196|NCT03573505|76027404|FG001|Overall Study|Site Terminated by Sponsor|1|||
42212197|NCT03573505|76027403|FG000|Overall Study|Study terminated by sponsor|50|||
42212198|NCT03573505|76027404|FG001|Overall Study|Study terminated by sponsor|45|||
42212199|NCT03573505|76027403|FG000|Overall Study|Reason not specified|0|||
42212200|NCT03573505|76027404|FG001|Overall Study|Reason not specified|1|||
42212201|NCT03573505|76027403|FG000|Overall Study|Death|0|||
42212202|NCT03573505|76027404|FG001|Overall Study|Death|4|||
42212203|NCT01376908|76027413|FG000|Overall Study|Protocol Violation|1|||
42212204|NCT01376908|76027414|FG001|Overall Study|Protocol Violation|1|||
42212205|NCT01376908|76027413|FG000|Overall Study|Withdrawal by Subject|1|||
42212206|NCT01376908|76027414|FG001|Overall Study|Withdrawal by Subject|2|||
42212207|NCT03736031|76027429|FG000|Overall Study|Death|2|||
42212208|NCT03736031|76027430|FG001|Overall Study|Death|4|||
42212209|NCT03736031|76027429|FG000|Overall Study|Lost to Follow-up|21|||
42212210|NCT03736031|76027430|FG001|Overall Study|Lost to Follow-up|2|||
42212211|NCT03736031|76027429|FG000|Overall Study|Withdrawal by Subject|9|||
42212212|NCT03736031|76027430|FG001|Overall Study|Withdrawal by Subject|0|||
42212213|NCT03602053|76027439|FG000|Overall Study|Withdrawal by Subject|7|||
42212214|NCT03602053|76027440|FG001|Overall Study|Withdrawal by Subject|9|||
42212215|NCT03602053|76027441|FG002|Overall Study|Withdrawal by Subject|7|||
42212216|NCT03602053|76027439|FG000|Overall Study|Lost to Follow-up|5|||
42212217|NCT03602053|76027440|FG001|Overall Study|Lost to Follow-up|6|||
42212218|NCT03602053|76027441|FG002|Overall Study|Lost to Follow-up|0|||
42212219|NCT03602053|76027439|FG000|Overall Study|Protocol Violation|3|||
42212220|NCT03602053|76027440|FG001|Overall Study|Protocol Violation|0|||
42212221|NCT03602053|76027441|FG002|Overall Study|Protocol Violation|4|||
42212222|NCT03602053|76027439|FG000|Overall Study|Physician Decision|1|||
42212223|NCT03602053|76027440|FG001|Overall Study|Physician Decision|0|||
42212224|NCT03602053|76027441|FG002|Overall Study|Physician Decision|0|||
42212225|NCT03602053|76027439|FG000|Overall Study|migration|2|||
42212226|NCT03602053|76027440|FG001|Overall Study|migration|3|||
42212227|NCT03602053|76027441|FG002|Overall Study|migration|0|||
41975794|NCT03863509|75778099|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
41975795|NCT03863509|75778100|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
41975796|NCT03863509|75778101|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
41975797|NCT03116347|75778130|FG000|Overall Study|Withdrawal by Subject|1|||
41975798|NCT03116347|75778131|FG001|Overall Study|Withdrawal by Subject|2|||
41975799|NCT00001213|75778177|FG000|Overall Study|Death|18|||
41975800|NCT00000135|75778183|FG000|Overall Study|Death|27|||
42212228|NCT03602053|76027439|FG000|Overall Study|Other|1|||
41975801|NCT00000135|75778184|FG001|Overall Study|Death|14|||
41975802|NCT00001723|75778192|FG000|Overall Study|Lack of Efficacy|6|||
42128006|NCT00529568|75938541|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
42128007|NCT00529568|75938539|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
42128008|NCT00529568|75938540|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
42128009|NCT00529568|75938541|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
42128010|NCT00611975|75938552|FG000|Overall Study|Withdrawal by Subject|3|||
42128011|NCT00611975|75938553|FG001|Overall Study|Withdrawal by Subject|7|||
42128012|NCT00611975|75938552|FG000|Overall Study|Pregnancy|2|||
42212229|NCT03602053|76027440|FG001|Overall Study|Other|0|||
42212230|NCT03602053|76027441|FG002|Overall Study|Other|0|||
42212231|NCT04831515|76027453|FG000|First Intervention|Adverse Event|0|||
42212232|NCT04831515|76027454|FG001|First Intervention|Adverse Event|1|||
42212233|NCT03554629|76027460|FG000|Overall Study|Inadequate data|6|||
42212234|NCT03196791|76027490|FG000|Overall Study|Protocol Violation|7|||
42212235|NCT03196791|76027491|FG001|Overall Study|Protocol Violation|3|||
42128013|NCT00611975|75938553|FG001|Overall Study|Pregnancy|1|||
42212236|NCT03196791|76027490|FG000|Overall Study|Withdrawal by Subject|3|||
42212237|NCT03196791|76027491|FG001|Overall Study|Withdrawal by Subject|2|||
42212238|NCT03196635|76027497|FG000|Overall Study|Withdrawal by Subject|1|||
42212239|NCT03194217|76027519|FG000|Overall Study|Adverse Event|0|||
42212240|NCT03194217|76027520|FG001|Overall Study|Adverse Event|2|||
41975803|NCT00001723|75778193|FG001|Overall Study|Lack of Efficacy|7|||
41975804|NCT00001723|75778192|FG000|Overall Study|Lack of family interest|4|||
41975805|NCT00001723|75778193|FG001|Overall Study|Lack of family interest|5|||
41975806|NCT00001723|75778192|FG000|Overall Study|Lost to Follow-up|2|||
42212241|NCT03194217|76027521|FG002|Overall Study|Adverse Event|3|||
41975807|NCT00001723|75778193|FG001|Overall Study|Lost to Follow-up|2|||
41975808|NCT00001723|75778192|FG000|Overall Study|medication intolerance|1|||
41975809|NCT00001723|75778193|FG001|Overall Study|medication intolerance|2|||
41975810|NCT00000378|75778205|FG000|Overall Study|Lack of Efficacy|16|||
41975811|NCT00000378|75778206|FG001|Overall Study|Lack of Efficacy|14|||
42028184|NCT00960531|75836475|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
42028185|NCT00960531|75836476|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
42028186|NCT00960531|75836477|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
42212242|NCT03194217|76027522|FG003|Overall Study|Adverse Event|3|||
42212243|NCT03194217|76027519|FG000|Overall Study|Failure to meet randomisation criteria|0|||
42212244|NCT03194217|76027520|FG001|Overall Study|Failure to meet randomisation criteria|0|||
42212245|NCT03194217|76027521|FG002|Overall Study|Failure to meet randomisation criteria|0|||
42212246|NCT03194217|76027522|FG003|Overall Study|Failure to meet randomisation criteria|1|||
42028187|NCT00960531|75836478|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
42028188|NCT00960531|75836479|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
42028189|NCT00960531|75836480|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
42028190|NCT00960531|75836481|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
42028191|NCT00960531|75836472|FG000|Overall Study|Lost to Follow-up|0|||
42028192|NCT00960531|75836473|FG001|Overall Study|Lost to Follow-up|0|||
42028193|NCT00960531|75836474|FG002|Overall Study|Lost to Follow-up|1|||
42028194|NCT00960531|75836475|FG003|Overall Study|Lost to Follow-up|0|||
42028195|NCT00960531|75836476|FG004|Overall Study|Lost to Follow-up|0|||
42028196|NCT00960531|75836477|FG005|Overall Study|Lost to Follow-up|0|||
42028197|NCT00960531|75836478|FG006|Overall Study|Lost to Follow-up|1|||
42028198|NCT00960531|75836479|FG007|Overall Study|Lost to Follow-up|0|||
42028199|NCT00960531|75836480|FG008|Overall Study|Lost to Follow-up|0|||
42028200|NCT00960531|75836481|FG009|Overall Study|Lost to Follow-up|0|||
42028201|NCT00960531|75836472|FG000|Overall Study|Failed to Return|2|||
42028202|NCT00960531|75836473|FG001|Overall Study|Failed to Return|0|||
42128014|NCT00573131|75938561|FG000|Overall Study|Withdrawal by Subject|10|||
42128015|NCT00573131|75938562|FG001|Overall Study|Withdrawal by Subject|8|||
42128016|NCT00521144|75938573|FG000|Overall Study|Not Treated|0|||
42128017|NCT00521144|75938574|FG001|Overall Study|Not Treated|0|||
42128018|NCT00521144|75938575|FG002|Overall Study|Not Treated|0|||
42028203|NCT00960531|75836474|FG002|Overall Study|Failed to Return|0|||
42028204|NCT00960531|75836475|FG003|Overall Study|Failed to Return|0|||
42028205|NCT00960531|75836476|FG004|Overall Study|Failed to Return|0|||
42028206|NCT00960531|75836477|FG005|Overall Study|Failed to Return|0|||
42028207|NCT00960531|75836478|FG006|Overall Study|Failed to Return|0|||
42028208|NCT00960531|75836479|FG007|Overall Study|Failed to Return|2|||
42028209|NCT00960531|75836480|FG008|Overall Study|Failed to Return|0|||
41975812|NCT01350115|75778214|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
41975813|NCT01350115|75778215|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
41975814|NCT01350115|75778214|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
42128019|NCT00521144|75938576|FG003|Overall Study|Not Treated|1|||
42128020|NCT00521144|75938577|FG004|Overall Study|Not Treated|0|||
42128021|NCT00521144|75938573|FG000|Overall Study|Adverse Event|0|||
42128022|NCT00521144|75938574|FG001|Overall Study|Adverse Event|1|||
42128023|NCT00521144|75938575|FG002|Overall Study|Adverse Event|0|||
42128024|NCT00521144|75938576|FG003|Overall Study|Adverse Event|0|||
42128025|NCT00521144|75938577|FG004|Overall Study|Adverse Event|1|||
42128026|NCT00521144|75938573|FG000|Overall Study|Progressive Disease|4|||
42128027|NCT00521144|75938574|FG001|Overall Study|Progressive Disease|2|||
42128028|NCT00521144|75938575|FG002|Overall Study|Progressive Disease|2|||
42128029|NCT00521144|75938576|FG003|Overall Study|Progressive Disease|0|||
42128030|NCT00521144|75938577|FG004|Overall Study|Progressive Disease|6|||
42128031|NCT00520676|75938591|FG000|Overall Study|Death|84|||
42128032|NCT00520676|75938592|FG001|Overall Study|Death|81|||
41975815|NCT01350115|75778215|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
41975816|NCT01350115|75778214|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
42028210|NCT00960531|75836481|FG009|Overall Study|Failed to Return|0|||
42028211|NCT00960531|75836472|FG000|Overall Study|Adverse Event (AE)|2|||
42028212|NCT00960531|75836473|FG001|Overall Study|Adverse Event (AE)|0|||
42028213|NCT00960531|75836474|FG002|Overall Study|Adverse Event (AE)|0|||
42028214|NCT00960531|75836475|FG003|Overall Study|Adverse Event (AE)|0|||
42128033|NCT00520676|75938591|FG000|Overall Study|Lost to Follow-up|6|||
42128034|NCT00520676|75938592|FG001|Overall Study|Lost to Follow-up|10|||
42128035|NCT00520676|75938591|FG000|Overall Study|Physician Decision|4|||
42128036|NCT00520676|75938592|FG001|Overall Study|Physician Decision|1|||
42128037|NCT00520676|75938591|FG000|Overall Study|Withdrawal by Subject|7|||
42128038|NCT00520676|75938592|FG001|Overall Study|Withdrawal by Subject|11|||
42212247|NCT03194217|76027519|FG000|Overall Study|Other|0|||
42212248|NCT03194217|76027520|FG001|Overall Study|Other|1|||
42212249|NCT03194217|76027521|FG002|Overall Study|Other|1|||
42212250|NCT03194217|76027522|FG003|Overall Study|Other|0|||
42212251|NCT00709618|76027532|FG000|Overall Study|Withdrawal by Subject|4|||
42212252|NCT00709618|76027532|FG000|Overall Study|Lost to Follow-up|1|||
42212253|NCT00709618|76027532|FG000|Overall Study|Study Closed/Terminated|25|||
42212254|NCT03193047|76027538|FG000|Overall Study|Physician Decision|1|||
42212255|NCT03193047|76027539|FG001|Overall Study|Physician Decision|0|||
42212256|NCT03193047|76027538|FG000|Overall Study|Participant Left State|1|||
42212257|NCT03193047|76027539|FG001|Overall Study|Participant Left State|0|||
42212258|NCT02918019|76027551|FG000|Overall Study|Death|0|||
42212259|NCT02918019|76027552|FG001|Overall Study|Death|0|||
42212260|NCT02918019|76027553|FG002|Overall Study|Death|1|||
42212261|NCT02918019|76027554|FG003|Overall Study|Death|0|||
42212262|NCT02918019|76027551|FG000|Overall Study|Lost to Follow-up|1|||
42212263|NCT02918019|76027552|FG001|Overall Study|Lost to Follow-up|1|||
42212264|NCT02918019|76027553|FG002|Overall Study|Lost to Follow-up|0|||
42212265|NCT02918019|76027554|FG003|Overall Study|Lost to Follow-up|1|||
42212266|NCT02918019|76027551|FG000|Overall Study|Principal investigator request|0|||
41975817|NCT01350115|75778215|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
41975818|NCT04142983|75778223|FG000|Overall Study|Lost to Follow-up|73|||
41975819|NCT04142983|75778223|FG000|Overall Study|Withdrawal by Subject|10|||
41975820|NCT04142983|75778223|FG000|Overall Study|Physician Decision|1|||
41975821|NCT04142983|75778223|FG000|Overall Study|Adverse Event|1|||
41975822|NCT04142983|75778223|FG000|Overall Study|No longer eligible|4|||
41975823|NCT04142983|75778223|FG000|Overall Study|Screen Failure|10|||
41975824|NCT03801031|75778230|FG000|Overall Study|Lost to Follow-up|1|||
41975825|NCT03801031|75778231|FG001|Overall Study|Lost to Follow-up|0|||
41975826|NCT03801031|75778230|FG000|Overall Study|Unable to comply|1|||
41975827|NCT03801031|75778231|FG001|Overall Study|Unable to comply|0|||
42028215|NCT00960531|75836476|FG004|Overall Study|Adverse Event (AE)|0|||
42028216|NCT00960531|75836477|FG005|Overall Study|Adverse Event (AE)|1|||
42028217|NCT00960531|75836478|FG006|Overall Study|Adverse Event (AE)|2|||
42028218|NCT00960531|75836479|FG007|Overall Study|Adverse Event (AE)|0|||
42028219|NCT00960531|75836480|FG008|Overall Study|Adverse Event (AE)|2|||
42028220|NCT00960531|75836481|FG009|Overall Study|Adverse Event (AE)|0|||
42028221|NCT00960531|75836472|FG000|Overall Study|Reason not Specified|2|||
42028222|NCT00960531|75836473|FG001|Overall Study|Reason not Specified|1|||
42028223|NCT00960531|75836474|FG002|Overall Study|Reason not Specified|13|||
42028224|NCT00960531|75836475|FG003|Overall Study|Reason not Specified|1|||
42028225|NCT00960531|75836476|FG004|Overall Study|Reason not Specified|2|||
42028226|NCT00960531|75836477|FG005|Overall Study|Reason not Specified|0|||
42028227|NCT00960531|75836478|FG006|Overall Study|Reason not Specified|16|||
42028228|NCT00960531|75836479|FG007|Overall Study|Reason not Specified|0|||
42028229|NCT00960531|75836480|FG008|Overall Study|Reason not Specified|8|||
42028230|NCT00960531|75836481|FG009|Overall Study|Reason not Specified|1|||
42028231|NCT00960375|75836509|FG000|Overall Study|Lost to Follow-up|20|||
42028232|NCT00960375|75836510|FG001|Overall Study|Lost to Follow-up|22|||
42128039|NCT00610649|75938609|FG000|Overall Study|Adverse Event|1|||
42128040|NCT00610649|75938610|FG001|Overall Study|Adverse Event|0|||
42128041|NCT00610649|75938611|FG002|Overall Study|Adverse Event|0|||
42128042|NCT00610649|75938612|FG003|Overall Study|Adverse Event|0|||
42128043|NCT00610649|75938613|FG004|Overall Study|Adverse Event|0|||
42128044|NCT00610649|75938614|FG005|Overall Study|Adverse Event|0|||
42128045|NCT00610649|75938615|FG006|Overall Study|Adverse Event|0|||
42128046|NCT00610649|75938616|FG007|Overall Study|Adverse Event|0|||
42128047|NCT00610649|75938617|FG008|Overall Study|Adverse Event|0|||
42128048|NCT00610649|75938618|FG009|Overall Study|Adverse Event|0|||
42128049|NCT00610649|75938619|FG010|Overall Study|Adverse Event|1|||
42128050|NCT00610649|75938609|FG000|Overall Study|Family Emergency|0|||
42128051|NCT00610649|75938610|FG001|Overall Study|Family Emergency|1|||
42128052|NCT00610649|75938611|FG002|Overall Study|Family Emergency|0|||
42128053|NCT00610649|75938612|FG003|Overall Study|Family Emergency|0|||
42128054|NCT00610649|75938613|FG004|Overall Study|Family Emergency|0|||
42128055|NCT00610649|75938614|FG005|Overall Study|Family Emergency|0|||
42128056|NCT00610649|75938615|FG006|Overall Study|Family Emergency|0|||
42128057|NCT00610649|75938616|FG007|Overall Study|Family Emergency|0|||
42128058|NCT00610649|75938617|FG008|Overall Study|Family Emergency|0|||
42128059|NCT00610649|75938618|FG009|Overall Study|Family Emergency|0|||
42128060|NCT00610649|75938619|FG010|Overall Study|Family Emergency|0|||
42128061|NCT00610649|75938609|FG000|Overall Study|Withdrawal by Subject|0|||
42128062|NCT00610649|75938610|FG001|Overall Study|Withdrawal by Subject|0|||
42212267|NCT02918019|76027552|FG001|Overall Study|Principal investigator request|0|||
42212268|NCT02918019|76027553|FG002|Overall Study|Principal investigator request|0|||
42212269|NCT02918019|76027554|FG003|Overall Study|Principal investigator request|1|||
42212270|NCT02918019|76027551|FG000|Overall Study|Physician Decision|1|||
41975828|NCT03801031|75778230|FG000|Overall Study|Withdrawal by Subject|0|||
42212271|NCT02918019|76027552|FG001|Overall Study|Physician Decision|3|||
42212272|NCT02918019|76027553|FG002|Overall Study|Physician Decision|2|||
42212273|NCT02918019|76027554|FG003|Overall Study|Physician Decision|0|||
42212274|NCT02918019|76027551|FG000|Overall Study|Protocol deviation|1|||
42212275|NCT02918019|76027552|FG001|Overall Study|Protocol deviation|1|||
42212276|NCT02918019|76027553|FG002|Overall Study|Protocol deviation|0|||
42212277|NCT02918019|76027554|FG003|Overall Study|Protocol deviation|2|||
42212278|NCT02918019|76027551|FG000|Overall Study|Withdrawal by Subject|3|||
42212279|NCT02918019|76027552|FG001|Overall Study|Withdrawal by Subject|4|||
42212280|NCT02918019|76027553|FG002|Overall Study|Withdrawal by Subject|6|||
42212281|NCT02918019|76027554|FG003|Overall Study|Withdrawal by Subject|4|||
42212282|NCT02918019|76027551|FG000|Overall Study|Adverse Event|0|||
42212283|NCT02918019|76027552|FG001|Overall Study|Adverse Event|1|||
42212284|NCT02918019|76027553|FG002|Overall Study|Adverse Event|0|||
42212285|NCT02918019|76027554|FG003|Overall Study|Adverse Event|1|||
42212286|NCT03055988|76027572|FG000|Period 1|Adverse Event|0|||
42212287|NCT03055988|76027573|FG001|Period 1|Adverse Event|1|||
42212288|NCT03055988|76027572|FG000|Period 1|Lost to Follow-up|1|||
42301813|NCT02501473|76136961|FG001|Overall Study|Death|0|||
41975829|NCT03801031|75778231|FG001|Overall Study|Withdrawal by Subject|1|||
41975830|NCT03357952|75778239|FG000|Overall Study|Withdrawal by Subject|0|||
41975831|NCT03357952|75778240|FG001|Overall Study|Withdrawal by Subject|1|||
41975832|NCT03357952|75778239|FG000|Overall Study|Sponsor Decision|9|||
41975833|NCT03357952|75778240|FG001|Overall Study|Sponsor Decision|0|||
41975834|NCT03055858|75778246|FG000|Overall Study|Death|9|||
41975835|NCT03055858|75778246|FG000|Overall Study|Withdrawal by Subject|11|||
41975836|NCT03055858|75778246|FG000|Overall Study|Lost to Follow-up|6|||
41975837|NCT03055858|75778246|FG000|Overall Study|Missed Follow-Up Visits|18|||
41975838|NCT02393716|75778271|FG000|Overall Study|Death|29|||
41975839|NCT02393716|75778271|FG000|Overall Study|Withdrawal by Subject|8|||
41975840|NCT02393716|75778271|FG000|Overall Study|Device Explanted|8|||
41975841|NCT02393716|75778271|FG000|Overall Study|Missed visit|16|||
41975842|NCT00584233|75778276|FG000|Overall Study|Withdrawal by Subject|5|||
41975843|NCT00584233|75778276|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
41975844|NCT00001566|75778288|FG000|Overall Study|patients' choice to discontinue protocol|3|||
41975845|NCT00001566|75778288|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
41975846|NCT00001566|75778288|FG000|Overall Study|Death|13|||
42028233|NCT00957801|75836529|FG000|Overall Study|Withdrawal by Subject|0|||
42028234|NCT00957801|75836530|FG001|Overall Study|Withdrawal by Subject|0|||
42028235|NCT00957801|75836531|FG002|Overall Study|Withdrawal by Subject|0|||
41975847|NCT00001566|75778288|FG000|Overall Study|Lost to Follow-up|1|||
41975848|NCT00001566|75778288|FG000|Overall Study|unable to complete initial apheresis|1|||
41975849|NCT00001575|75778292|FG000|Overall Study|Screening failures-Ph I portion|22|||
41975850|NCT00001575|75778292|FG000|Overall Study|Withdrawn/deaths|23|||
41975851|NCT00001596|75778298|FG000|Overall Study|Death|1|||
42128063|NCT00610649|75938611|FG002|Overall Study|Withdrawal by Subject|0|||
42128064|NCT00610649|75938612|FG003|Overall Study|Withdrawal by Subject|0|||
42128065|NCT00610649|75938613|FG004|Overall Study|Withdrawal by Subject|0|||
42128066|NCT00610649|75938614|FG005|Overall Study|Withdrawal by Subject|0|||
42128067|NCT00610649|75938615|FG006|Overall Study|Withdrawal by Subject|0|||
42128068|NCT00610649|75938616|FG007|Overall Study|Withdrawal by Subject|0|||
42128069|NCT00610649|75938617|FG008|Overall Study|Withdrawal by Subject|0|||
42128070|NCT00610649|75938618|FG009|Overall Study|Withdrawal by Subject|1|||
42128071|NCT00610649|75938619|FG010|Overall Study|Withdrawal by Subject|0|||
42128072|NCT00608543|75938643|FG000|Overall Study|Adverse Event|4|||
42128073|NCT00520130|75938650|FG000|Overall Study|Disease progression on study|4|||
42128074|NCT00520130|75938651|FG001|Overall Study|Disease progression on study|0|||
42128075|NCT00520130|75938650|FG000|Overall Study|Physician Decision|1|||
42128076|NCT00520130|75938651|FG001|Overall Study|Physician Decision|1|||
41975852|NCT00001596|75778299|FG001|Overall Study|Death|0|||
41975853|NCT00001596|75778298|FG000|Overall Study|Withdrawal by Subject|3|||
41975854|NCT00001596|75778299|FG001|Overall Study|Withdrawal by Subject|1|||
42028236|NCT00957801|75836532|FG003|Overall Study|Withdrawal by Subject|1|||
42128077|NCT00519896|75938661|FG000|Overall Study|Protocol Violation|1|||
42128078|NCT00519896|75938661|FG000|Overall Study|Adverse Event|1|||
42128079|NCT00527618|75938674|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
42128080|NCT00527618|75938675|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
42212289|NCT03055988|76027573|FG001|Period 1|Lost to Follow-up|0|||
42212290|NCT03055988|76027572|FG000|Period 1|Withdrawal by Subject|0|||
42212291|NCT03055988|76027573|FG001|Period 1|Withdrawal by Subject|4|||
42212292|NCT03055988|76027572|FG000|Period 2|Adverse Event|0|||
42028237|NCT00957723|75836542|FG000|Overall Study|Death|3|||
42128081|NCT00527618|75938674|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
42301814|NCT02501473|76136962|FG002|Overall Study|Death|1|||
42212293|NCT03055988|76027573|FG001|Period 2|Adverse Event|1|||
42212294|NCT03055988|76027572|FG000|Period 2|Other than listed|1|||
42301815|NCT02501473|76136963|FG003|Overall Study|Death|1|||
42212295|NCT03055988|76027573|FG001|Period 2|Other than listed|1|||
42212296|NCT01250912|76027579|FG000|Overall Study|Lost to Follow-up|1|||
42212297|NCT03733301|76027589|FG000|Overall Study|Screen Fail|1|||
42212298|NCT03733301|76027590|FG001|Overall Study|Screen Fail|0|||
42212299|NCT03733301|76027591|FG002|Overall Study|Screen Fail|0|||
42212300|NCT03733301|76027589|FG000|Overall Study|Non-compliance|1|||
42212301|NCT03733301|76027590|FG001|Overall Study|Non-compliance|0|||
42212302|NCT03733301|76027591|FG002|Overall Study|Non-compliance|0|||
42212303|NCT03733301|76027589|FG000|Overall Study|Lack of Efficacy|2|||
42212304|NCT03733301|76027590|FG001|Overall Study|Lack of Efficacy|3|||
42212305|NCT03733301|76027591|FG002|Overall Study|Lack of Efficacy|0|||
42212306|NCT03733301|76027589|FG000|Overall Study|Adverse Event|0|||
42212307|NCT03733301|76027590|FG001|Overall Study|Adverse Event|1|||
42212308|NCT03733301|76027591|FG002|Overall Study|Adverse Event|3|||
42212309|NCT03733301|76027589|FG000|Overall Study|Withdrawal by Subject|3|||
42212310|NCT03733301|76027590|FG001|Overall Study|Withdrawal by Subject|5|||
42212311|NCT03733301|76027591|FG002|Overall Study|Withdrawal by Subject|1|||
42212312|NCT02871297|76027600|FG000|Overall Study|Adverse Event|34|||
42301816|NCT02501473|76136964|FG004|Overall Study|Death|0|||
42301817|NCT02501473|76136965|FG005|Overall Study|Death|1|||
41975855|NCT00001596|75778298|FG000|Overall Study|Study Termination|12|||
41975856|NCT00001596|75778299|FG001|Overall Study|Study Termination|9|||
41975857|NCT00001596|75778298|FG000|Overall Study|Adverse Event|1|||
41975858|NCT00001596|75778299|FG001|Overall Study|Adverse Event|0|||
41975859|NCT01349803|75778336|FG000|Overall Study|Adverse Event|0|||
41975860|NCT01349803|75778337|FG001|Overall Study|Adverse Event|0|||
41975861|NCT01349803|75778338|FG002|Overall Study|Adverse Event|0|||
41975862|NCT01349803|75778339|FG003|Overall Study|Adverse Event|2|||
41975863|NCT01349803|75778336|FG000|Overall Study|Withdrawal by Subject|1|||
41975864|NCT01349803|75778337|FG001|Overall Study|Withdrawal by Subject|0|||
41975865|NCT01349803|75778338|FG002|Overall Study|Withdrawal by Subject|0|||
41975866|NCT01349803|75778339|FG003|Overall Study|Withdrawal by Subject|0|||
42028238|NCT00957723|75836542|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
42028239|NCT00957723|75836542|FG000|Overall Study|Lost to Follow-up|8|||
42028240|NCT00957723|75836542|FG000|Overall Study|Withdrawal by Subject|24|||
42028241|NCT00957723|75836542|FG000|Overall Study|Investigative Site Terminated|61|||
42028242|NCT00957723|75836542|FG000|Overall Study|Intercurrent Illness|2|||
42028243|NCT00957723|75836542|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
42028244|NCT03778021|75836550|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
42028245|NCT03778021|75836551|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
42028246|NCT00911170|75836560|FG000|Treatment Period|Randomized in error|1|||
42028247|NCT00911170|75836561|FG001|Treatment Period|Randomized in error|1|||
42028248|NCT00911170|75836560|FG000|Treatment Period|Ineligibility determined|1|||
42028249|NCT00911170|75836561|FG001|Treatment Period|Ineligibility determined|3|||
42028250|NCT00911170|75836560|FG000|Treatment Period|Protocol deviation|1|||
42028251|NCT00911170|75836561|FG001|Treatment Period|Protocol deviation|2|||
42028252|NCT00911170|75836560|FG000|Treatment Period|Adverse Event|9|||
42028253|NCT00911170|75836561|FG001|Treatment Period|Adverse Event|10|||
42028254|NCT00911170|75836560|FG000|Treatment Period|Withdrawal by Subject|4|||
42028255|NCT00911170|75836561|FG001|Treatment Period|Withdrawal by Subject|4|||
42028256|NCT00911170|75836560|FG000|Treatment Period|Disease progression|0|||
41975867|NCT01349803|75778336|FG000|Overall Study|Protocol-specified criteria|0|||
41975868|NCT01349803|75778337|FG001|Overall Study|Protocol-specified criteria|1|||
42028257|NCT00911170|75836561|FG001|Treatment Period|Disease progression|2|||
42028258|NCT00911170|75836560|FG000|Treatment Period|Physician Decision|5|||
42028259|NCT00911170|75836561|FG001|Treatment Period|Physician Decision|5|||
42028260|NCT00911170|75836560|FG000|Treatment Period|Lost to Follow-up|0|||
42028261|NCT00911170|75836561|FG001|Treatment Period|Lost to Follow-up|1|||
42028262|NCT00911170|75836560|FG000|Treatment Period|Death|6|||
42128082|NCT00527618|75938675|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
42128083|NCT00527618|75938674|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
42128084|NCT00527618|75938675|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
42128085|NCT00527618|75938674|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
42128086|NCT00527618|75938675|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
42128087|NCT00527618|75938674|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
42128088|NCT00527618|75938675|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
42128089|NCT00527618|75938674|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
42128090|NCT00527618|75938675|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
42128091|NCT00527072|75938682|FG000|Overall Study|Adverse Event|13|||
42128092|NCT00527072|75938682|FG000|Overall Study|Lack of Efficacy|11|||
42128093|NCT00527072|75938682|FG000|Overall Study|Lost to Follow-up|3|||
42128094|NCT00527072|75938682|FG000|Overall Study|Protocol Violation|2|||
42128095|NCT00527072|75938682|FG000|Overall Study|Withdrawal by Subject|7|||
42212313|NCT02871297|76027600|FG000|Overall Study|Lack of Efficacy|10|||
42212314|NCT02871297|76027600|FG000|Overall Study|Non-compliance with study drug|15|||
42212315|NCT02871297|76027600|FG000|Overall Study|Protocol Violation|3|||
42301818|NCT02501473|76136966|FG006|Overall Study|Death|0|||
42212316|NCT02871297|76027600|FG000|Overall Study|Withdrawal by Subject|20|||
42212317|NCT02871297|76027600|FG000|Overall Study|Lost to Follow-up|13|||
42212318|NCT02871297|76027600|FG000|Overall Study|Rolled over to 13546A|2|||
42212319|NCT02871297|76027600|FG000|Overall Study|Other than specified|39|||
42028263|NCT00911170|75836561|FG001|Treatment Period|Death|9|||
42028264|NCT00911170|75836560|FG000|Long Term Follow-Up|Continuing in study|274|||
42028265|NCT00911170|75836561|FG001|Long Term Follow-Up|Continuing in study|269|||
42028266|NCT00911170|75836560|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
42028267|NCT00911170|75836561|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
42028268|NCT00911170|75836560|FG000|Long Term Follow-Up|Physician Decision|5|||
42028269|NCT00911170|75836561|FG001|Long Term Follow-Up|Physician Decision|4|||
42028270|NCT00911170|75836560|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
42028271|NCT00911170|75836561|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
42028272|NCT00911170|75836560|FG000|Long Term Follow-Up|Death|116|||
42028273|NCT00911170|75836561|FG001|Long Term Follow-Up|Death|121|||
42028274|NCT01167881|75836569|FG000|Overall Study|Adverse Event|47|||
42028275|NCT01167881|75836570|FG001|Overall Study|Adverse Event|51|||
42028276|NCT01167881|75836569|FG000|Overall Study|Lack of Efficacy|4|||
42028277|NCT01167881|75836570|FG001|Overall Study|Lack of Efficacy|7|||
42028278|NCT01167881|75836569|FG000|Overall Study|Non compliant with protocol|9|||
42128096|NCT00526994|75938690|FG000|Overall Study|Lost to Follow-up|98|||
42128097|NCT00526994|75938691|FG001|Overall Study|Lost to Follow-up|108|||
42128098|NCT00526994|75938692|FG002|Overall Study|Lost to Follow-up|96|||
41975869|NCT01349803|75778338|FG002|Overall Study|Protocol-specified criteria|3|||
41975870|NCT01349803|75778339|FG003|Overall Study|Protocol-specified criteria|0|||
41975871|NCT04059146|75778452|FG000|Overall Study|Withdrawal by Subject|0|||
41975872|NCT04059146|75778453|FG001|Overall Study|Withdrawal by Subject|1|||
41975873|NCT03969641|75778474|FG000|Overall Study|Lost to Follow-up|5|||
41975874|NCT03969641|75778475|FG001|Overall Study|Lost to Follow-up|3|||
41975875|NCT03969641|75778474|FG000|Overall Study|Withdrawal by Subject|1|||
41975876|NCT03969641|75778475|FG001|Overall Study|Withdrawal by Subject|2|||
41975877|NCT03969641|75778474|FG000|Overall Study|Found to be ineligible|1|||
41975878|NCT03969641|75778475|FG001|Overall Study|Found to be ineligible|1|||
41975879|NCT03969641|75778474|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
41975880|NCT03969641|75778475|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
41975881|NCT03969641|75778474|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
41975882|NCT03969641|75778475|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
41975883|NCT03969641|75778474|FG000|Overall Study|Elective termination|0|||
41975884|NCT03969641|75778475|FG001|Overall Study|Elective termination|1|||
41975885|NCT03721172|75778525|FG000|Placebo-controlled Phase|Adverse Event|7|||
41975886|NCT03721172|75778526|FG001|Placebo-controlled Phase|Adverse Event|7|||
41975887|NCT03721172|75778527|FG002|Placebo-controlled Phase|Adverse Event|0|||
41975888|NCT03721172|75778525|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
41975889|NCT03721172|75778526|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
41975890|NCT03721172|75778527|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
41975891|NCT03721172|75778525|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
41975892|NCT03721172|75778526|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
42128099|NCT00526994|75938690|FG000|Overall Study|Death|4|||
42212320|NCT03554005|76027610|FG000|Overall Study|Not in participant's best interest|0|||
42212321|NCT03554005|76027611|FG001|Overall Study|Not in participant's best interest|0|||
42212322|NCT03554005|76027612|FG002|Overall Study|Not in participant's best interest|0|||
42212323|NCT03554005|76027613|FG003|Overall Study|Not in participant's best interest|0|||
42212324|NCT03554005|76027614|FG004|Overall Study|Not in participant's best interest|0|||
42212325|NCT03554005|76027615|FG005|Overall Study|Not in participant's best interest|1|||
42212326|NCT03554005|76027610|FG000|Overall Study|Disease Progression|1|||
42212327|NCT03554005|76027611|FG001|Overall Study|Disease Progression|1|||
42212328|NCT03554005|76027612|FG002|Overall Study|Disease Progression|1|||
42212329|NCT03554005|76027613|FG003|Overall Study|Disease Progression|1|||
42212330|NCT03554005|76027614|FG004|Overall Study|Disease Progression|5|||
42212331|NCT03554005|76027615|FG005|Overall Study|Disease Progression|6|||
42212332|NCT03554005|76027610|FG000|Overall Study|Adverse Event|0|||
42212333|NCT03554005|76027611|FG001|Overall Study|Adverse Event|0|||
41975893|NCT03721172|75778527|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
41975894|NCT03721172|75778525|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
41975895|NCT03721172|75778526|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
41975896|NCT03721172|75778527|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
42028279|NCT01167881|75836570|FG001|Overall Study|Non compliant with protocol|18|||
42028280|NCT01167881|75836569|FG000|Overall Study|Lost to Follow-up|19|||
42128100|NCT00526994|75938691|FG001|Overall Study|Death|3|||
42028281|NCT01167881|75836570|FG001|Overall Study|Lost to Follow-up|20|||
42128101|NCT00526994|75938692|FG002|Overall Study|Death|3|||
42128102|NCT00526994|75938690|FG000|Overall Study|Withdrawal by Subject|2|||
42128103|NCT00526994|75938691|FG001|Overall Study|Withdrawal by Subject|7|||
42128104|NCT00526994|75938692|FG002|Overall Study|Withdrawal by Subject|5|||
42128105|NCT00526994|75938690|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
42128106|NCT00526994|75938691|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
42212334|NCT03554005|76027612|FG002|Overall Study|Adverse Event|0|||
42212335|NCT03554005|76027613|FG003|Overall Study|Adverse Event|0|||
42212336|NCT03554005|76027614|FG004|Overall Study|Adverse Event|0|||
42212337|NCT03554005|76027615|FG005|Overall Study|Adverse Event|3|||
42212338|NCT03554005|76027610|FG000|Overall Study|Physician Decision|0|||
42212339|NCT03554005|76027611|FG001|Overall Study|Physician Decision|0|||
42212340|NCT03554005|76027612|FG002|Overall Study|Physician Decision|0|||
42212341|NCT03554005|76027613|FG003|Overall Study|Physician Decision|0|||
42212342|NCT03554005|76027614|FG004|Overall Study|Physician Decision|1|||
42212343|NCT03554005|76027615|FG005|Overall Study|Physician Decision|0|||
42212344|NCT03554005|76027610|FG000|Overall Study|Other|0|||
42212345|NCT03554005|76027611|FG001|Overall Study|Other|0|||
42212346|NCT03554005|76027612|FG002|Overall Study|Other|0|||
42212347|NCT03554005|76027613|FG003|Overall Study|Other|0|||
42212348|NCT03554005|76027614|FG004|Overall Study|Other|0|||
42212349|NCT03554005|76027615|FG005|Overall Study|Other|1|||
42212350|NCT00709228|76027629|FG000|Overall Study|Not treated|14|||
42212351|NCT00709228|76027629|FG000|Overall Study|Eligibility criteria not met|281|||
42212352|NCT00709228|76027629|FG000|Overall Study|Adverse events|2|||
42212353|NCT00709228|76027629|FG000|Overall Study|Discontinued treatment|14|||
42212354|NCT00709228|76027629|FG000|Overall Study|Did not enter follow-up|4|||
42212355|NCT00709228|76027629|FG000|Overall Study|Discontinued follow-up|5|||
42212356|NCT00709228|76027629|FG000|Overall Study|Disease progression|1|||
42212357|NCT00709228|76027629|FG000|Overall Study|Lost to Follow-up|6|||
42212358|NCT00709228|76027629|FG000|Overall Study|Non-compliance|5|||
42212359|NCT03219372|76027635|FG000|Overall Study|Withdrawal by Subject|1|||
42212360|NCT03219372|76027636|FG001|Overall Study|Withdrawal by Subject|0|||
42212361|NCT03056690|76027651|FG000|Overall Study|Adverse Event|3|||
42212362|NCT03056690|76027652|FG001|Overall Study|Adverse Event|2|||
41975897|NCT03721172|75778525|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
41975898|NCT03721172|75778526|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
41975899|NCT03721172|75778527|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
41975900|NCT03721172|75778525|FG000|Placebo-controlled Phase|Other|3|||
41975901|NCT03721172|75778526|FG001|Placebo-controlled Phase|Other|0|||
41975902|NCT03721172|75778527|FG002|Placebo-controlled Phase|Other|0|||
41975903|NCT03721172|75778525|FG000|Apremilast Extension Phase|Adverse Event|0|||
41975904|NCT03721172|75778526|FG001|Apremilast Extension Phase|Adverse Event|0|||
41975905|NCT03721172|75778527|FG002|Apremilast Extension Phase|Adverse Event|10|||
42212363|NCT03056690|76027651|FG000|Overall Study|Lack of Efficacy|1|||
42212364|NCT03056690|76027652|FG001|Overall Study|Lack of Efficacy|2|||
42212365|NCT03056690|76027651|FG000|Overall Study|Lost to Follow-up|3|||
42212366|NCT03056690|76027652|FG001|Overall Study|Lost to Follow-up|2|||
42212367|NCT03056690|76027651|FG000|Overall Study|Protocol Violation|2|||
42212368|NCT03056690|76027652|FG001|Overall Study|Protocol Violation|2|||
42212369|NCT03056690|76027651|FG000|Overall Study|Withdrawal by Subject|3|||
42212370|NCT03056690|76027652|FG001|Overall Study|Withdrawal by Subject|6|||
42212371|NCT03056690|76027651|FG000|Overall Study|Non-compliance with Study Drug|1|||
42212372|NCT03056690|76027652|FG001|Overall Study|Non-compliance with Study Drug|0|||
42212373|NCT03056690|76027651|FG000|Overall Study|Miscellaneous|1|||
42212374|NCT03056690|76027652|FG001|Overall Study|Miscellaneous|2|||
42212375|NCT03191799|76027658|FG000|Overall Study|Withdrawal by Subject|4|||
42212376|NCT03191799|76027658|FG000|Overall Study|Physician Decision|2|||
42212377|NCT03191799|76027658|FG000|Overall Study|Lost to Follow-up|1|||
42212378|NCT03191799|76027658|FG000|Overall Study|Death|2|||
42212379|NCT00708916|76027662|FG000|Overall Study|Subject Noncompliance|2|||
42212380|NCT00708916|76027662|FG000|Overall Study|Adverse Event|2|||
42212381|NCT02352753|76027667|FG000|6-Month Dosing Period|Decision by sponsor|2|||
42028282|NCT01167881|75836569|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
42028283|NCT01167881|75836570|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
42028284|NCT01167881|75836569|FG000|Overall Study|Not treated|4|||
42028285|NCT01167881|75836570|FG001|Overall Study|Not treated|0|||
42028286|NCT01167881|75836569|FG000|Overall Study|Other not defined above|31|||
42028287|NCT01167881|75836570|FG001|Overall Study|Other not defined above|55|||
42028288|NCT00960063|75836579|FG000|Overall Study|Adverse Event|1|||
42028289|NCT00960063|75836580|FG001|Overall Study|Adverse Event|0|||
42028290|NCT00960063|75836581|FG002|Overall Study|Adverse Event|0|||
42212382|NCT02352753|76027667|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
42301819|NCT02501473|76136967|FG007|Overall Study|Death|0|||
41975906|NCT03721172|75778525|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
41975907|NCT03721172|75778526|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
42028291|NCT00960063|75836579|FG000|Overall Study|Progression of Disease|0|||
42212383|NCT02352753|76027667|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
42212384|NCT02352753|76027667|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
42301820|NCT02501473|76136960|FG000|Overall Study|Lost to Follow-up|1|||
42028292|NCT00960063|75836580|FG001|Overall Study|Progression of Disease|0|||
42028293|NCT00960063|75836581|FG002|Overall Study|Progression of Disease|3|||
42212385|NCT02352753|76027667|FG000|3-Month Dosing Period|Decision by sponsor|14|||
42212386|NCT02352753|76027667|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
42028294|NCT00959907|75836591|FG000|Overall Study|Protocol Violation|0|||
42028295|NCT00959907|75836592|FG001|Overall Study|Protocol Violation|1|||
42028296|NCT00959907|75836591|FG000|Overall Study|Adverse Event|1|||
42212387|NCT04532294|76027678|FG000|Overall Study|Withdrawal by Subject|0|||
42212388|NCT04532294|76027679|FG001|Overall Study|Withdrawal by Subject|0|||
42212389|NCT04532294|76027680|FG002|Overall Study|Withdrawal by Subject|1|||
42212390|NCT04532294|76027678|FG000|Overall Study|Participants Not Dosed|0|||
42212391|NCT04532294|76027679|FG001|Overall Study|Participants Not Dosed|0|||
42212392|NCT04532294|76027680|FG002|Overall Study|Participants Not Dosed|2|||
42212393|NCT03197766|76027692|FG000|Overall Study|Withdrawal by Subject|2|||
42212394|NCT03197766|76027693|FG001|Overall Study|Withdrawal by Subject|0|||
42212395|NCT03738332|76027699|FG000|Overall Study|Withdrawal by Subject|1|||
42212396|NCT03173456|76027709|FG000|Baseline|Medication dispensing system malfunction'|0|||
42212397|NCT03173456|76027710|FG001|Baseline|Medication dispensing system malfunction'|1|||
42212398|NCT03173456|76027711|FG002|Baseline|Medication dispensing system malfunction'|0|||
42212399|NCT03173456|76027712|FG003|Baseline|Medication dispensing system malfunction'|0|||
42212400|NCT03173456|76027713|FG004|Baseline|Medication dispensing system malfunction'|2|||
42212401|NCT03173456|76027709|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
42212402|NCT03173456|76027710|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
42212403|NCT03173456|76027711|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
42212404|NCT03173456|76027712|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
42212405|NCT03173456|76027713|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
42212406|NCT03197376|76027736|FG000|Primary and Booster Phase|Adverse Event|0|||
42212407|NCT03197376|76027737|FG001|Primary and Booster Phase|Adverse Event|0|||
42212408|NCT03197376|76027738|FG002|Primary and Booster Phase|Adverse Event|0|||
41975908|NCT03721172|75778527|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
41975909|NCT03721172|75778525|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
41975910|NCT03721172|75778526|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
41975911|NCT03721172|75778527|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
41975912|NCT03721172|75778525|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
41975913|NCT03721172|75778526|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
41975914|NCT03721172|75778527|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
41975915|NCT03721172|75778525|FG000|Apremilast Extension Phase|Protocol Violation|0|||
41975916|NCT03721172|75778526|FG001|Apremilast Extension Phase|Protocol Violation|0|||
41975917|NCT03721172|75778527|FG002|Apremilast Extension Phase|Protocol Violation|1|||
41975918|NCT03721172|75778525|FG000|Apremilast Extension Phase|Physician Decision|0|||
41975919|NCT03721172|75778526|FG001|Apremilast Extension Phase|Physician Decision|0|||
41975920|NCT03721172|75778527|FG002|Apremilast Extension Phase|Physician Decision|1|||
41975921|NCT03721172|75778525|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
41975922|NCT03721172|75778526|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
42212409|NCT03197376|76027739|FG003|Primary and Booster Phase|Adverse Event|1|||
42212410|NCT03197376|76027736|FG000|Primary and Booster Phase|Death|1|||
42212411|NCT03197376|76027737|FG001|Primary and Booster Phase|Death|0|||
42212412|NCT03197376|76027738|FG002|Primary and Booster Phase|Death|0|||
42212413|NCT03197376|76027739|FG003|Primary and Booster Phase|Death|2|||
42212414|NCT03197376|76027736|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
42212415|NCT03197376|76027737|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
42212416|NCT03197376|76027738|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
42212417|NCT03197376|76027739|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
42212418|NCT03197376|76027736|FG000|Primary and Booster Phase|Physician Decision|1|||
42212419|NCT03197376|76027737|FG001|Primary and Booster Phase|Physician Decision|0|||
42212420|NCT03197376|76027738|FG002|Primary and Booster Phase|Physician Decision|1|||
42212421|NCT03197376|76027739|FG003|Primary and Booster Phase|Physician Decision|3|||
42212422|NCT03197376|76027736|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
42212423|NCT03197376|76027737|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
42212424|NCT03197376|76027738|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
42212425|NCT03197376|76027739|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
42212426|NCT03197376|76027736|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
42212427|NCT03197376|76027737|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
42212428|NCT03197376|76027738|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
42212429|NCT03197376|76027739|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
42212430|NCT03197376|76027736|FG000|Primary and Booster Phase|Not vaccine related|1|||
42212431|NCT03197376|76027737|FG001|Primary and Booster Phase|Not vaccine related|2|||
42212432|NCT03197376|76027738|FG002|Primary and Booster Phase|Not vaccine related|0|||
42212433|NCT03197376|76027739|FG003|Primary and Booster Phase|Not vaccine related|6|||
42212434|NCT03197376|76027736|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
42212435|NCT03197376|76027737|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
42212436|NCT03197376|76027738|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
42212437|NCT03197376|76027739|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
42212438|NCT03197376|76027736|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
42212439|NCT03197376|76027737|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
42212440|NCT03197376|76027738|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
42212441|NCT03197376|76027739|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
42212442|NCT03197376|76027736|FG000|Immune Persistence Phase|Not vaccine related|1|||
42212443|NCT03197376|76027737|FG001|Immune Persistence Phase|Not vaccine related|0|||
42212444|NCT03197376|76027738|FG002|Immune Persistence Phase|Not vaccine related|1|||
42212445|NCT03197376|76027739|FG003|Immune Persistence Phase|Not vaccine related|1|||
42212446|NCT03600805|76027776|FG000|Overall Study|Adverse Event|2|||
42212447|NCT03600805|76027777|FG001|Overall Study|Adverse Event|1|||
42212448|NCT03600805|76027778|FG002|Overall Study|Adverse Event|1|||
42212449|NCT03600805|76027779|FG003|Overall Study|Adverse Event|7|||
42212450|NCT03600805|76027776|FG000|Overall Study|Lack of Efficacy|2|||
42212451|NCT03600805|76027777|FG001|Overall Study|Lack of Efficacy|1|||
42212452|NCT03600805|76027778|FG002|Overall Study|Lack of Efficacy|0|||
42212453|NCT03600805|76027779|FG003|Overall Study|Lack of Efficacy|0|||
42212454|NCT03600805|76027776|FG000|Overall Study|Withdrawal by Subject|1|||
42212455|NCT03600805|76027777|FG001|Overall Study|Withdrawal by Subject|0|||
42212456|NCT03600805|76027778|FG002|Overall Study|Withdrawal by Subject|0|||
42212457|NCT03600805|76027779|FG003|Overall Study|Withdrawal by Subject|1|||
42212458|NCT03600805|76027776|FG000|Overall Study|Other unspecified|14|||
42212459|NCT03600805|76027777|FG001|Overall Study|Other unspecified|6|||
42212460|NCT03600805|76027778|FG002|Overall Study|Other unspecified|7|||
42212461|NCT03600805|76027779|FG003|Overall Study|Other unspecified|11|||
42212462|NCT02729740|76027791|FG000|Overall Study|Early Termination|130|||
42212463|NCT02729740|76027791|FG000|Overall Study|Other|1|||
42212464|NCT03196284|76027801|FG000|Main Part|Withdrawal by Subject|0|||
42212465|NCT03196284|76027802|FG001|Main Part|Withdrawal by Subject|1|||
42212466|NCT03196284|76027803|FG002|Main Part|Withdrawal by Subject|0|||
42212467|NCT03196284|76027801|FG000|Extension Part|Lack of Efficacy|0|||
42212468|NCT03196284|76027802|FG001|Extension Part|Lack of Efficacy|0|||
42212469|NCT03196284|76027803|FG002|Extension Part|Lack of Efficacy|1|||
42212470|NCT03196284|76027801|FG000|Extension Part|Withdrawal by Subject|0|||
42212471|NCT03196284|76027802|FG001|Extension Part|Withdrawal by Subject|0|||
42212472|NCT03196284|76027803|FG002|Extension Part|Withdrawal by Subject|1|||
42212473|NCT03196284|76027801|FG000|Extension Part|Physician Decision|0|||
42212474|NCT03196284|76027802|FG001|Extension Part|Physician Decision|0|||
42212475|NCT03196284|76027803|FG002|Extension Part|Physician Decision|1|||
42212476|NCT03730961|76027825|FG000|Overall Study|Adverse Event|0|||
42212477|NCT03730961|76027826|FG001|Overall Study|Adverse Event|1|||
42212478|NCT01078454|76027834|FG000|Overall Study|Adverse Event|1|||
42212479|NCT01078454|76027835|FG001|Overall Study|Adverse Event|1|||
42212480|NCT01078454|76027834|FG000|Overall Study|Death|0|||
42212481|NCT01078454|76027835|FG001|Overall Study|Death|1|||
42212482|NCT03345004|76027852|FG000|Overall Study|Physician Decision|1|||
42212483|NCT03345004|76027853|FG001|Overall Study|Physician Decision|0|||
42212484|NCT03345004|76027852|FG000|Overall Study|Withdrawal by Subject|0|||
42212485|NCT03345004|76027853|FG001|Overall Study|Withdrawal by Subject|1|||
42212486|NCT03552757|76027864|FG000|Overall Study|Withdrawal by Subject|10|||
42212487|NCT03552757|76027865|FG001|Overall Study|Withdrawal by Subject|5|||
42212488|NCT03552757|76027866|FG002|Overall Study|Withdrawal by Subject|12|||
42212489|NCT03552757|76027864|FG000|Overall Study|Lost to Follow-up|2|||
42212490|NCT03552757|76027865|FG001|Overall Study|Lost to Follow-up|7|||
42212491|NCT03552757|76027866|FG002|Overall Study|Lost to Follow-up|7|||
42212492|NCT03552757|76027864|FG000|Overall Study|Death|1|||
42212493|NCT03552757|76027865|FG001|Overall Study|Death|1|||
42212494|NCT03552757|76027866|FG002|Overall Study|Death|1|||
42212495|NCT03730103|76027879|FG000|Overall Study|Did not meet inclusion criteria|0|||
42212496|NCT03730103|76027880|FG001|Overall Study|Did not meet inclusion criteria|5|||
42212497|NCT03727841|76027888|FG000|Overall Study|Physician Decision|3|||
42212498|NCT03727841|76027889|FG001|Overall Study|Physician Decision|1|||
42212499|NCT03552523|76027895|FG000|Overall Study|Withdrawal by Subject|1|||
42212500|NCT03552523|76027896|FG001|Overall Study|Withdrawal by Subject|1|||
41975923|NCT03721172|75778527|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
41975924|NCT03721172|75778525|FG000|Apremilast Extension Phase|Other|0|||
41975925|NCT03721172|75778526|FG001|Apremilast Extension Phase|Other|0|||
42212501|NCT03345550|76027904|FG000|Overall Study|Withdrawal by Subject|1|||
42212502|NCT03345550|76027905|FG001|Overall Study|Withdrawal by Subject|0|||
42212503|NCT03345550|76027904|FG000|Overall Study|Lost to Follow-up|4|||
42212504|NCT03345550|76027905|FG001|Overall Study|Lost to Follow-up|5|||
42212505|NCT03186378|76027913|FG000|Overall Study|Lost to Follow-up|1|||
41975926|NCT03721172|75778527|FG002|Apremilast Extension Phase|Other|3|||
41975927|NCT03721172|75778525|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
41975928|NCT03721172|75778526|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
42212506|NCT03186378|76027914|FG001|Overall Study|Lost to Follow-up|0|||
42212507|NCT00687596|76027922|FG000|Overall Study|Adverse Event (AE)|10|||
42212508|NCT00687596|76027923|FG001|Overall Study|Adverse Event (AE)|3|||
42212509|NCT00687596|76027922|FG000|Overall Study|Radiological Disease Progression|6|||
42212510|NCT00687596|76027923|FG001|Overall Study|Radiological Disease Progression|2|||
42212511|NCT00687596|76027922|FG000|Overall Study|Clinical Disease Progression|1|||
41975929|NCT03721172|75778527|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
41975930|NCT04540887|75778583|FG000|Overall Study|Withdrawal by Subject|2|||
42212512|NCT00687596|76027923|FG001|Overall Study|Clinical Disease Progression|3|||
42212513|NCT00687596|76027922|FG000|Overall Study|Investigator Discretion|3|||
42212514|NCT00687596|76027923|FG001|Overall Study|Investigator Discretion|1|||
42212515|NCT00687596|76027922|FG000|Overall Study|Sponsor Terminated Study|6|||
42212516|NCT00687596|76027923|FG001|Overall Study|Sponsor Terminated Study|17|||
42212517|NCT02892409|76027931|FG000|Overall Study|Adverse Event|1|||
42212518|NCT02892409|76027932|FG001|Overall Study|Adverse Event|0|||
42212519|NCT02892409|76027931|FG000|Overall Study|Withdrawal by Subject|2|||
42212520|NCT02892409|76027932|FG001|Overall Study|Withdrawal by Subject|1|||
42212521|NCT03219216|76027940|FG000|Overall Study|Lost to Follow-up|0|||
42212522|NCT03219216|76027941|FG001|Overall Study|Lost to Follow-up|1|||
42212523|NCT03195660|76027955|FG000|Overall Study|The study was terminated|2|||
42212524|NCT03194490|76027961|FG000|Overall Study|Lost to Follow-up|1|||
42212525|NCT03194490|76027962|FG001|Overall Study|Lost to Follow-up|3|||
42212526|NCT03194490|76027961|FG000|Overall Study|participant developed specific neck pain|1|||
42212527|NCT03194490|76027962|FG001|Overall Study|participant developed specific neck pain|0|||
42212528|NCT03217968|76027969|FG000|Overall Study|Withdrawal by Subject|4|||
42212529|NCT03217968|76027969|FG000|Overall Study|Lost to Follow-up|1|||
42212530|NCT03217968|76027969|FG000|Overall Study|Protocol Violation|6|||
42212531|NCT03192306|76027975|FG000|Overall Study|Did not treat cold sore during study|149|||
42212532|NCT03192306|76027976|FG001|Overall Study|Did not treat cold sore during study|143|||
42212533|NCT03192306|76027975|FG000|Overall Study|Withdrawal by Subject|1|||
42212534|NCT03192306|76027976|FG001|Overall Study|Withdrawal by Subject|1|||
42212535|NCT03192306|76027975|FG000|Overall Study|Lost to Follow-up|1|||
42212536|NCT03192306|76027976|FG001|Overall Study|Lost to Follow-up|0|||
42212537|NCT03192306|76027975|FG000|Overall Study|Protocol Violation|1|||
42212538|NCT03192306|76027976|FG001|Overall Study|Protocol Violation|1|||
42212539|NCT03216954|76027999|FG000|Overall Study|Adverse Event|0|||
42212540|NCT03216954|76028000|FG001|Overall Study|Adverse Event|0|||
42212541|NCT03216954|76028001|FG002|Overall Study|Adverse Event|1|||
42212542|NCT03216954|76028002|FG003|Overall Study|Adverse Event|0|||
42212543|NCT03216954|76028003|FG004|Overall Study|Adverse Event|1|||
42212544|NCT03216954|76027999|FG000|Overall Study|Withdrawal by Subject|2|||
42212545|NCT03216954|76028000|FG001|Overall Study|Withdrawal by Subject|0|||
42212546|NCT03216954|76028001|FG002|Overall Study|Withdrawal by Subject|0|||
42212547|NCT03216954|76028002|FG003|Overall Study|Withdrawal by Subject|0|||
42212548|NCT03216954|76028003|FG004|Overall Study|Withdrawal by Subject|0|||
42212549|NCT03216954|76027999|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
42212550|NCT03216954|76028000|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
42212551|NCT03216954|76028001|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
42212552|NCT03216954|76028002|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
41975931|NCT04294680|75778594|FG000|Overall Study|Withdrawal by Subject|2|||
41975932|NCT04294680|75778595|FG001|Overall Study|Withdrawal by Subject|1|||
41975933|NCT04294680|75778594|FG000|Overall Study|Follow-up visits completed outside of window|1|||
41975934|NCT04294680|75778595|FG001|Overall Study|Follow-up visits completed outside of window|0|||
41975935|NCT01350102|75778605|FG000|Overall Study|Adverse Event|0|||
41975936|NCT01350102|75778606|FG001|Overall Study|Adverse Event|0|||
41975937|NCT01350102|75778607|FG002|Overall Study|Adverse Event|1|||
41975938|NCT01350102|75778608|FG003|Overall Study|Adverse Event|0|||
41975939|NCT04059549|75778622|FG000|Overall Study|Withdrawal by Subject|2|||
41975940|NCT04059549|75778623|FG001|Overall Study|Withdrawal by Subject|0|||
41975941|NCT04041570|75778635|FG000|Overall Study|Moved from Area|0|||
42212553|NCT03216954|76028003|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
42212554|NCT03599089|76028015|FG000|Overall Study|Lost to Follow-up|1|||
42212555|NCT03599089|76028016|FG001|Overall Study|Lost to Follow-up|0|||
42212556|NCT03599089|76028017|FG002|Overall Study|Lost to Follow-up|0|||
42212557|NCT03599089|76028018|FG003|Overall Study|Lost to Follow-up|0|||
42028297|NCT00959907|75836592|FG001|Overall Study|Adverse Event|0|||
42028298|NCT00959907|75836591|FG000|Overall Study|Withdrawal by Subject|2|||
42028299|NCT00959907|75836592|FG001|Overall Study|Withdrawal by Subject|0|||
42028300|NCT00912340|75836601|FG000|Overall Study|Adverse Event|2|||
42212558|NCT03599089|76028015|FG000|Overall Study|Withdrawal by Subject|2|||
42212559|NCT03599089|76028016|FG001|Overall Study|Withdrawal by Subject|1|||
42212560|NCT03599089|76028017|FG002|Overall Study|Withdrawal by Subject|0|||
42212561|NCT03599089|76028018|FG003|Overall Study|Withdrawal by Subject|0|||
42212562|NCT03599089|76028015|FG000|Overall Study|Lack of Efficacy|0|||
42212563|NCT03599089|76028016|FG001|Overall Study|Lack of Efficacy|0|||
42212564|NCT03599089|76028017|FG002|Overall Study|Lack of Efficacy|1|||
42028301|NCT00912340|75836602|FG001|Overall Study|Adverse Event|4|||
42212565|NCT03599089|76028018|FG003|Overall Study|Lack of Efficacy|2|||
41975942|NCT04041570|75778636|FG001|Overall Study|Moved from Area|2|||
42212566|NCT03192150|76028030|FG000|Overall Study|Adverse Event|14|||
42212567|NCT03192150|76028031|FG001|Overall Study|Adverse Event|12|||
42212568|NCT03192150|76028030|FG000|Overall Study|Lack of Efficacy|23|||
42212569|NCT03192150|76028031|FG001|Overall Study|Lack of Efficacy|30|||
42212570|NCT03192150|76028030|FG000|Overall Study|Lost to Follow-up|1|||
42212571|NCT03192150|76028031|FG001|Overall Study|Lost to Follow-up|1|||
42212572|NCT03192150|76028030|FG000|Overall Study|Withdrawal by Subject|4|||
42212573|NCT03192150|76028031|FG001|Overall Study|Withdrawal by Subject|2|||
42212574|NCT03192150|76028030|FG000|Overall Study|Protocol Violation|5|||
42212575|NCT03192150|76028031|FG001|Overall Study|Protocol Violation|2|||
42212576|NCT03192150|76028030|FG000|Overall Study|Surgery Canceled|6|||
42212577|NCT03192150|76028031|FG001|Overall Study|Surgery Canceled|2|||
42212578|NCT03192150|76028030|FG000|Overall Study|Other-Various Administrative Reasons|2|||
42212579|NCT03192150|76028031|FG001|Overall Study|Other-Various Administrative Reasons|5|||
42212580|NCT03597529|76028039|FG000|Overall Study|Lost to Follow-up|10|||
42212581|NCT03597529|76028040|FG001|Overall Study|Lost to Follow-up|12|||
42212582|NCT03597529|76028039|FG000|Overall Study|Physician Decision|3|||
42212583|NCT03597529|76028040|FG001|Overall Study|Physician Decision|1|||
42212584|NCT03597529|76028039|FG000|Overall Study|Withdrawal by Subject|6|||
42212585|NCT03597529|76028040|FG001|Overall Study|Withdrawal by Subject|3|||
42212586|NCT03597529|76028039|FG000|Overall Study|Non-compliant with study activities|1|||
42212587|NCT03597529|76028040|FG001|Overall Study|Non-compliant with study activities|2|||
42212588|NCT03180528|76028046|FG000|Overall Study|Adverse Event|1|||
42212589|NCT03180528|76028046|FG000|Overall Study|Withdrawal by Subject|1|||
42212590|NCT03180528|76028046|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
42212591|NCT03597295|76028050|FG000|Overall Study|Death|70|||
42212592|NCT03597295|76028050|FG000|Overall Study|Lost to Follow-up|7|||
42212593|NCT03180138|76028057|FG000|Overall Study|Mobile-phone could not be verified|2|||
42212594|NCT03180138|76028058|FG001|Overall Study|Mobile-phone could not be verified|13|||
42212595|NCT03180138|76028059|FG002|Overall Study|Mobile-phone could not be verified|15|||
42212596|NCT03180138|76028057|FG000|Overall Study|No prior immunization records|17|||
42212597|NCT03180138|76028058|FG001|Overall Study|No prior immunization records|0|||
42212598|NCT03180138|76028059|FG002|Overall Study|No prior immunization records|6|||
42212599|NCT03180138|76028057|FG000|Overall Study|Found to be >24 mon after randomization|3|||
42212600|NCT03180138|76028058|FG001|Overall Study|Found to be >24 mon after randomization|0|||
42212601|NCT03180138|76028059|FG002|Overall Study|Found to be >24 mon after randomization|3|||
42212602|NCT03597139|76028069|FG000|Overall Study|Adverse Event|3|||
42212603|NCT03597139|76028070|FG001|Overall Study|Adverse Event|0|||
42212604|NCT03597139|76028069|FG000|Overall Study|Protocol Non-compliance|1|||
42212605|NCT03597139|76028070|FG001|Overall Study|Protocol Non-compliance|0|||
42212606|NCT03179202|76028076|FG000|Overall Study|Screen Failure|67|||
42212607|NCT03179202|76028076|FG000|Overall Study|Subject Lost to Follow Up|12|||
42212608|NCT03179202|76028076|FG000|Overall Study|Withdrawal by Subject|7|||
42212609|NCT03179202|76028076|FG000|Overall Study|Adverse Event|3|||
42212610|NCT03179202|76028076|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
42212611|NCT03179202|76028076|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
42212612|NCT00708214|76028085|FG000|Overall Study|Other Adverse Event|3|||
42212613|NCT00708214|76028086|FG001|Overall Study|Other Adverse Event|6|||
42212614|NCT00708214|76028087|FG002|Overall Study|Other Adverse Event|2|||
42212615|NCT00708214|76028085|FG000|Overall Study|Other|0|||
42212616|NCT00708214|76028086|FG001|Overall Study|Other|1|||
42212617|NCT00708214|76028087|FG002|Overall Study|Other|1|||
41975943|NCT03879408|75778648|FG000|Overall Study|Lost to Follow-up|0|||
41975944|NCT03879408|75778649|FG001|Overall Study|Lost to Follow-up|3|||
41975945|NCT03879408|75778650|FG002|Overall Study|Lost to Follow-up|2|||
41975946|NCT03879408|75778651|FG003|Overall Study|Lost to Follow-up|1|||
41975947|NCT03879408|75778652|FG004|Overall Study|Lost to Follow-up|0|||
41975948|NCT03879408|75778648|FG000|Overall Study|Withdrawal by Subject|2|||
41975949|NCT03879408|75778649|FG001|Overall Study|Withdrawal by Subject|1|||
41975950|NCT03879408|75778650|FG002|Overall Study|Withdrawal by Subject|1|||
41975951|NCT03879408|75778651|FG003|Overall Study|Withdrawal by Subject|0|||
41975952|NCT03879408|75778652|FG004|Overall Study|Withdrawal by Subject|1|||
41975953|NCT02993406|75778670|FG000|Overall Study|Withdrawal by Subject|170|||
42212618|NCT00708214|76028085|FG000|Overall Study|Progressive Disease|4|||
41975954|NCT02993406|75778671|FG001|Overall Study|Withdrawal by Subject|196|||
41975955|NCT02993406|75778670|FG000|Overall Study|Physician Decision|3|||
41975956|NCT02993406|75778671|FG001|Overall Study|Physician Decision|5|||
41975957|NCT02993406|75778670|FG000|Overall Study|Lost to Follow-up|12|||
41975958|NCT02993406|75778671|FG001|Overall Study|Lost to Follow-up|13|||
41975959|NCT02993406|75778670|FG000|Overall Study|Unclassifiable Response|105|||
41975960|NCT02993406|75778671|FG001|Overall Study|Unclassifiable Response|139|||
42212619|NCT00708214|76028086|FG001|Overall Study|Progressive Disease|6|||
42212620|NCT00708214|76028087|FG002|Overall Study|Progressive Disease|5|||
42212621|NCT03570697|76028102|FG000|Overall Study|Lost to Follow-up|0|||
42212622|NCT03570697|76028103|FG001|Overall Study|Lost to Follow-up|1|||
42212623|NCT03570697|76028102|FG000|Overall Study|Death|2|||
42212624|NCT03570697|76028103|FG001|Overall Study|Death|0|||
41975961|NCT02993406|75778670|FG000|Overall Study|Administrative decision|1|||
41975962|NCT02993406|75778671|FG001|Overall Study|Administrative decision|0|||
41975963|NCT02993406|75778670|FG000|Overall Study|Sponsor decision|4|||
41975964|NCT02993406|75778671|FG001|Overall Study|Sponsor decision|5|||
41975965|NCT00819780|75778679|FG000|Overall Study|Did not receive study drug|3|||
41975966|NCT00819780|75778680|FG001|Overall Study|Did not receive study drug|4|||
41975967|NCT00819780|75778679|FG000|Overall Study|Still in treatment|25|||
41975968|NCT00819780|75778680|FG001|Overall Study|Still in treatment|17|||
41975969|NCT00000620|75778772|FG000|Overall Study|Death|86|||
41975970|NCT00000620|75778773|FG001|Overall Study|Death|67|||
41975971|NCT00000620|75778774|FG002|Overall Study|Death|112|||
41975972|NCT00000620|75778775|FG003|Overall Study|Death|126|||
41975973|NCT00000620|75778776|FG004|Overall Study|Death|64|||
41975974|NCT00000620|75778777|FG005|Overall Study|Death|77|||
41975975|NCT00000620|75778778|FG006|Overall Study|Death|91|||
41975976|NCT00000620|75778779|FG007|Overall Study|Death|95|||
41975977|NCT00000620|75778772|FG000|Overall Study|Lost to Follow-up|14|||
41975978|NCT00000620|75778773|FG001|Overall Study|Lost to Follow-up|14|||
41975979|NCT00000620|75778774|FG002|Overall Study|Lost to Follow-up|14|||
41975980|NCT00000620|75778775|FG003|Overall Study|Lost to Follow-up|14|||
41975981|NCT00000620|75778776|FG004|Overall Study|Lost to Follow-up|15|||
41975982|NCT00000620|75778777|FG005|Overall Study|Lost to Follow-up|15|||
41975983|NCT00000620|75778778|FG006|Overall Study|Lost to Follow-up|13|||
41975984|NCT00000620|75778779|FG007|Overall Study|Lost to Follow-up|14|||
41975985|NCT00000620|75778772|FG000|Overall Study|Withdrawal by Subject|40|||
41975986|NCT00000620|75778773|FG001|Overall Study|Withdrawal by Subject|27|||
41975987|NCT00000620|75778774|FG002|Overall Study|Withdrawal by Subject|28|||
41975988|NCT00000620|75778775|FG003|Overall Study|Withdrawal by Subject|27|||
41975989|NCT00000620|75778776|FG004|Overall Study|Withdrawal by Subject|30|||
41975990|NCT00000620|75778777|FG005|Overall Study|Withdrawal by Subject|32|||
41975991|NCT00000620|75778778|FG006|Overall Study|Withdrawal by Subject|32|||
41975992|NCT00000620|75778779|FG007|Overall Study|Withdrawal by Subject|21|||
41975993|NCT00000620|75778772|FG000|Overall Study|missed closeout visit|22|||
41975994|NCT00000620|75778773|FG001|Overall Study|missed closeout visit|28|||
41975995|NCT00000620|75778774|FG002|Overall Study|missed closeout visit|16|||
42212625|NCT03570697|76028102|FG000|Overall Study|Withdrawal by Subject|4|||
42212626|NCT03570697|76028103|FG001|Overall Study|Withdrawal by Subject|2|||
42212627|NCT03569371|76028120|FG000|Overall Study|Lack of Efficacy|1|||
42212628|NCT03569371|76028120|FG000|Overall Study|Lost to Follow-up|1|||
42212629|NCT03569371|76028120|FG000|Overall Study|Adverse Event|1|||
42212630|NCT01318070|76028127|FG000|Overall Study|Adverse Event|1|||
42212631|NCT01318070|76028128|FG001|Overall Study|Adverse Event|1|||
42212632|NCT01318070|76028129|FG002|Overall Study|Adverse Event|5|||
42212633|NCT01318070|76028127|FG000|Overall Study|Withdrawal by Subject|0|||
42212634|NCT01318070|76028128|FG001|Overall Study|Withdrawal by Subject|1|||
42212635|NCT01318070|76028129|FG002|Overall Study|Withdrawal by Subject|1|||
42212636|NCT01318070|76028127|FG000|Overall Study|Lack of Efficacy|0|||
42212637|NCT01318070|76028128|FG001|Overall Study|Lack of Efficacy|0|||
42212638|NCT01318070|76028129|FG002|Overall Study|Lack of Efficacy|1|||
42212639|NCT01318070|76028127|FG000|Overall Study|Principal Investigator Discretion|1|||
42212640|NCT01318070|76028128|FG001|Overall Study|Principal Investigator Discretion|0|||
42212641|NCT01318070|76028129|FG002|Overall Study|Principal Investigator Discretion|0|||
42212642|NCT02895295|76028140|FG000|Overall Study|Survey Non-response|71|||
42212643|NCT02895295|76028141|FG001|Overall Study|Survey Non-response|94|||
42212644|NCT02895295|76028142|FG002|Overall Study|Survey Non-response|92|||
42212645|NCT00245960|76028152|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
42212646|NCT00245960|76028153|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
42212647|NCT00245960|76028152|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
42212648|NCT00245960|76028153|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
42212649|NCT00245960|76028152|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
42212650|NCT00245960|76028153|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
41975996|NCT00000620|75778775|FG003|Overall Study|missed closeout visit|11|||
41975997|NCT00000620|75778776|FG004|Overall Study|missed closeout visit|26|||
41975998|NCT00000620|75778777|FG005|Overall Study|missed closeout visit|28|||
41975999|NCT00000620|75778778|FG006|Overall Study|missed closeout visit|13|||
41976000|NCT00000620|75778779|FG007|Overall Study|missed closeout visit|16|||
41976001|NCT00001262|75778842|FG000|Overall Study|Death|10|||
41976002|NCT00001262|75778843|FG001|Overall Study|Death|11|||
41976003|NCT00001262|75778844|FG002|Overall Study|Death|0|||
42212651|NCT00245960|76028152|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
42212652|NCT00245960|76028153|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
41976004|NCT00001262|75778842|FG000|Overall Study|Withdrawal by Subject|0|||
42212653|NCT00245960|76028152|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
42212654|NCT00245960|76028153|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
41976005|NCT00001262|75778843|FG001|Overall Study|Withdrawal by Subject|3|||
42212655|NCT00245960|76028152|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
42212656|NCT00245960|76028153|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
42212657|NCT00245960|76028152|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
42212658|NCT00245960|76028153|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
42212659|NCT00245960|76028152|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
42212660|NCT00245960|76028153|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
42212661|NCT00245960|76028152|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
42212662|NCT00245960|76028153|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
42212663|NCT00245960|76028152|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
42212664|NCT00245960|76028153|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
42212665|NCT00245960|76028152|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
42212666|NCT00245960|76028153|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
42212667|NCT00245960|76028152|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
42212668|NCT00245960|76028153|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
42212669|NCT02729194|76028159|FG000|Overall Study|Withdrawal by Subject|3|||
42212670|NCT03178266|76028165|FG000|Overall Study|Death|0|||
42212671|NCT03178266|76028166|FG001|Overall Study|Death|1|||
42212672|NCT03178266|76028165|FG000|Overall Study|Disont. Early|0|||
42212673|NCT03178266|76028166|FG001|Overall Study|Disont. Early|1|||
42212674|NCT03178266|76028165|FG000|Overall Study|Withdrawal by Subject|0|||
42212675|NCT03178266|76028166|FG001|Overall Study|Withdrawal by Subject|2|||
42212676|NCT03548935|76028174|FG000|Overall Study|Withdrawal by Subject|26|||
42212677|NCT03548935|76028175|FG001|Overall Study|Withdrawal by Subject|17|||
42212678|NCT03548935|76028174|FG000|Overall Study|Lost to Follow-up|39|||
42212679|NCT03548935|76028175|FG001|Overall Study|Lost to Follow-up|28|||
42212680|NCT03548935|76028174|FG000|Overall Study|Death|1|||
42212681|NCT03548935|76028175|FG001|Overall Study|Death|1|||
42212682|NCT03547687|76028181|FG000|Overall Study|Withdrawal by Subject|1|||
41976006|NCT00001262|75778844|FG002|Overall Study|Withdrawal by Subject|0|||
41976007|NCT00001277|75778861|FG000|Overall Study|Adverse Event|0|||
41976008|NCT00001277|75778862|FG001|Overall Study|Adverse Event|0|||
42212683|NCT03547687|76028181|FG000|Overall Study|Death|1|||
42212684|NCT03547531|76028187|FG000|Overall Study|not coming in data collection : sick|2|||
42212685|NCT03547531|76028188|FG001|Overall Study|not coming in data collection : sick|2|||
42212686|NCT03547531|76028187|FG000|Overall Study|having family occasion|0|||
42212687|NCT03547531|76028188|FG001|Overall Study|having family occasion|2|||
42212688|NCT03566485|76028196|FG000|Overall Study|Disease progression|5|||
42212689|NCT03566485|76028197|FG001|Overall Study|Disease progression|4|||
42212690|NCT03566485|76028196|FG000|Overall Study|Clinical progression|0|||
42212691|NCT03566485|76028197|FG001|Overall Study|Clinical progression|1|||
42212692|NCT03566485|76028196|FG000|Overall Study|Toxicity|0|||
42212693|NCT03566485|76028197|FG001|Overall Study|Toxicity|2|||
42212694|NCT03176238|76028205|FG000|Overall Study|Unacceptable AEs|15|||
42212695|NCT03176238|76028206|FG001|Overall Study|Unacceptable AEs|8|||
42212696|NCT03176238|76028205|FG000|Overall Study|Abnormal lab value(s)|2|||
42212697|NCT03176238|76028206|FG001|Overall Study|Abnormal lab value(s)|0|||
42212698|NCT03176238|76028205|FG000|Overall Study|Inter-current illness|0|||
42212699|NCT03176238|76028206|FG001|Overall Study|Inter-current illness|1|||
42212700|NCT03176238|76028205|FG000|Overall Study|Consent withdrawal|14|||
42212701|NCT03176238|76028206|FG001|Overall Study|Consent withdrawal|2|||
42212702|NCT03176238|76028205|FG000|Overall Study|Lost to Follow-up|3|||
42212703|NCT03176238|76028206|FG001|Overall Study|Lost to Follow-up|0|||
42212704|NCT03176238|76028205|FG000|Overall Study|Administrative problems|1|||
42212705|NCT03176238|76028206|FG001|Overall Study|Administrative problems|0|||
42212706|NCT03176238|76028205|FG000|Overall Study|Death|3|||
42212707|NCT03176238|76028206|FG001|Overall Study|Death|0|||
42212708|NCT03176238|76028205|FG000|Overall Study|Disease Progression|133|||
42212709|NCT03176238|76028206|FG001|Overall Study|Disease Progression|22|||
42212710|NCT03176238|76028205|FG000|Overall Study|Tx duration completed per EAP|0|||
42212711|NCT03176238|76028206|FG001|Overall Study|Tx duration completed per EAP|1|||
42212712|NCT03176238|76028205|FG000|Overall Study|Patient is switched to commercial drug|16|||
42301821|NCT02501473|76136961|FG001|Overall Study|Lost to Follow-up|0|||
42301822|NCT02501473|76136962|FG002|Overall Study|Lost to Follow-up|1|||
41976009|NCT00001277|75778863|FG002|Overall Study|Adverse Event|1|||
42028302|NCT00912340|75836603|FG002|Overall Study|Adverse Event|0|||
42212713|NCT03176238|76028206|FG001|Overall Study|Patient is switched to commercial drug|1|||
42212714|NCT03176238|76028205|FG000|Overall Study|Protocol Violation|1|||
42212715|NCT03176238|76028206|FG001|Overall Study|Protocol Violation|0|||
42212716|NCT03176238|76028205|FG000|Overall Study|Changes in the patient's condition|2|||
42301823|NCT02501473|76136963|FG003|Overall Study|Lost to Follow-up|0|||
42301824|NCT02501473|76136964|FG004|Overall Study|Lost to Follow-up|0|||
42301825|NCT02501473|76136965|FG005|Overall Study|Lost to Follow-up|1|||
42212717|NCT03176238|76028206|FG001|Overall Study|Changes in the patient's condition|1|||
42212718|NCT03176238|76028205|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
42212719|NCT03176238|76028206|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
42212720|NCT03565315|76028220|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
41976010|NCT00001277|75778861|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
41976011|NCT00001277|75778862|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
41976012|NCT00001277|75778863|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
41976013|NCT00001703|75778905|FG000|Overall Study|progressed disease|2|||
41976014|NCT00001703|75778905|FG000|Overall Study|No evidence of disease|1|||
41976015|NCT00001703|75778905|FG000|Overall Study|recurrent disease|2|||
41976016|NCT01349907|75778929|FG000|Overall Study|Adverse Event|37|||
41976017|NCT01349907|75778930|FG001|Overall Study|Adverse Event|11|||
41976018|NCT01349907|75778929|FG000|Overall Study|Treatment failure|13|||
42212721|NCT03565315|76028221|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
42212722|NCT03565315|76028222|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
42212723|NCT03565315|76028223|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
42212724|NCT03565237|76028246|FG000|Overall Study|Non-compliance of Investigational Product|1|||
42212725|NCT03565237|76028246|FG000|Overall Study|Physician Decision|1|||
42212726|NCT01345682|76028252|FG000|Overall Study|Progressive disease per RECIST|226|||
42212727|NCT01345682|76028253|FG001|Overall Study|Progressive disease per RECIST|93|||
42028303|NCT00912340|75836601|FG000|Overall Study|Protocol revised to remove arm|0|||
42028304|NCT00912340|75836602|FG001|Overall Study|Protocol revised to remove arm|0|||
42028305|NCT00912340|75836603|FG002|Overall Study|Protocol revised to remove arm|4|||
42028306|NCT01167257|75836613|FG000|Overall Study|Lost to Follow-up|2|||
42028307|NCT01167257|75836614|FG001|Overall Study|Lost to Follow-up|2|||
42028308|NCT01167257|75836613|FG000|Overall Study|Withdrew consent|1|||
42028309|NCT01167257|75836614|FG001|Overall Study|Withdrew consent|1|||
42028310|NCT01119846|75836627|FG000|Overall Study|Adverse Event|1|||
42028311|NCT01119846|75836628|FG001|Overall Study|Adverse Event|0|||
42028312|NCT01119846|75836629|FG002|Overall Study|Adverse Event|6|||
42028313|NCT01119846|75836627|FG000|Overall Study|Physician Decision|1|||
42028314|NCT01119846|75836628|FG001|Overall Study|Physician Decision|0|||
42028315|NCT01119846|75836629|FG002|Overall Study|Physician Decision|0|||
42028316|NCT01119846|75836627|FG000|Overall Study|Protocol Violation|0|||
42028317|NCT01119846|75836628|FG001|Overall Study|Protocol Violation|0|||
42028318|NCT01119846|75836629|FG002|Overall Study|Protocol Violation|1|||
42028319|NCT01119846|75836627|FG000|Overall Study|Withdrawal by Subject|0|||
42028320|NCT01119846|75836628|FG001|Overall Study|Withdrawal by Subject|0|||
42028321|NCT01119846|75836629|FG002|Overall Study|Withdrawal by Subject|4|||
42028322|NCT01167179|75836666|FG000|Overall Study|disease recurrence|4|||
42028323|NCT01167179|75836667|FG001|Overall Study|disease recurrence|4|||
42028324|NCT01167179|75836666|FG000|Overall Study|Death|4|||
42028325|NCT01167179|75836667|FG001|Overall Study|Death|10|||
42028326|NCT01167179|75836666|FG000|Overall Study|Withdrawal by Subject|1|||
42028327|NCT01167179|75836667|FG001|Overall Study|Withdrawal by Subject|2|||
42028328|NCT01167179|75836666|FG000|Overall Study|diverse|6|||
42028329|NCT01167179|75836667|FG001|Overall Study|diverse|5|||
42028330|NCT01167023|75836740|FG000|Overall Study|Lost to Follow-up|0|||
42028331|NCT01167023|75836741|FG001|Overall Study|Lost to Follow-up|1|||
42028332|NCT01167023|75836742|FG002|Overall Study|Lost to Follow-up|1|||
42028333|NCT01167023|75836740|FG000|Overall Study|Screen Failure|0|||
42028334|NCT01167023|75836741|FG001|Overall Study|Screen Failure|1|||
42028335|NCT01167023|75836742|FG002|Overall Study|Screen Failure|0|||
42028336|NCT01167023|75836740|FG000|Overall Study|Sponsor Decision|0|||
42028337|NCT01167023|75836741|FG001|Overall Study|Sponsor Decision|1|||
42028338|NCT01167023|75836742|FG002|Overall Study|Sponsor Decision|0|||
42028339|NCT01167023|75836740|FG000|Overall Study|Withdrawal by Subject|0|||
42028340|NCT01167023|75836741|FG001|Overall Study|Withdrawal by Subject|0|||
42028341|NCT01167023|75836742|FG002|Overall Study|Withdrawal by Subject|1|||
41976019|NCT01349907|75778930|FG001|Overall Study|Treatment failure|4|||
41976020|NCT01349907|75778929|FG000|Overall Study|Lost to Follow-up|25|||
41976021|NCT01349907|75778930|FG001|Overall Study|Lost to Follow-up|6|||
41976022|NCT01349907|75778929|FG000|Overall Study|Withdrawal by Subject|30|||
42301826|NCT02501473|76136966|FG006|Overall Study|Lost to Follow-up|0|||
42301827|NCT02501473|76136967|FG007|Overall Study|Lost to Follow-up|0|||
42301828|NCT02501473|76136960|FG000|Overall Study|Reason not specified|0|||
42301829|NCT02501473|76136961|FG001|Overall Study|Reason not specified|0|||
42028342|NCT03484117|75836750|FG000|Overall Study|Lost to Follow-up|1|||
42028343|NCT03484117|75836751|FG001|Overall Study|Lost to Follow-up|3|||
42301830|NCT02501473|76136962|FG002|Overall Study|Reason not specified|1|||
41976023|NCT01349907|75778930|FG001|Overall Study|Withdrawal by Subject|8|||
41976024|NCT01349907|75778929|FG000|Overall Study|Protocol Violation|33|||
42028344|NCT03484117|75836750|FG000|Overall Study|Declined participation in exit assess|1|||
42301831|NCT02501473|76136963|FG003|Overall Study|Reason not specified|1|||
42028345|NCT03484117|75836751|FG001|Overall Study|Declined participation in exit assess|1|||
42028346|NCT01166945|75836759|FG000|Randomized|diagnosed with Group A strep|4|||
42028347|NCT01166945|75836760|FG001|Randomized|diagnosed with Group A strep|4|||
42028348|NCT01166945|75836759|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
42028349|NCT01166945|75836760|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
42028350|NCT01166945|75836759|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
42028351|NCT01166945|75836760|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
42028352|NCT01166945|75836759|FG000|Day 30|Lost to Follow-up|4|||
42028353|NCT01166945|75836760|FG001|Day 30|Lost to Follow-up|3|||
42028354|NCT00910000|75836774|FG000|Overall Study|Adverse Event|0|||
42028355|NCT00910000|75836775|FG001|Overall Study|Adverse Event|3|||
42028356|NCT00910000|75836776|FG002|Overall Study|Adverse Event|2|||
42028357|NCT00910000|75836777|FG003|Overall Study|Adverse Event|2|||
42028358|NCT00910000|75836778|FG004|Overall Study|Adverse Event|0|||
42028359|NCT00910000|75836779|FG005|Overall Study|Adverse Event|1|||
42028360|NCT00910000|75836774|FG000|Overall Study|Withdrawal by Subject|0|||
42028361|NCT00910000|75836775|FG001|Overall Study|Withdrawal by Subject|0|||
42028362|NCT00910000|75836776|FG002|Overall Study|Withdrawal by Subject|1|||
42028363|NCT00910000|75836777|FG003|Overall Study|Withdrawal by Subject|0|||
42028364|NCT00910000|75836778|FG004|Overall Study|Withdrawal by Subject|1|||
42028365|NCT00910000|75836779|FG005|Overall Study|Withdrawal by Subject|0|||
42028366|NCT01119768|75836800|FG000|Treatment Period|Lack of Efficacy|18|||
42028367|NCT01119768|75836801|FG001|Treatment Period|Lack of Efficacy|25|||
42028368|NCT01165307|75836809|FG000|Overall Study|Lost to Follow-up|11|||
42028369|NCT01165307|75836810|FG001|Overall Study|Lost to Follow-up|3|||
42028370|NCT01165307|75836809|FG000|Overall Study|Withdrawal by Subject|2|||
42028371|NCT01165307|75836810|FG001|Overall Study|Withdrawal by Subject|0|||
42028372|NCT01165307|75836809|FG000|Overall Study|Subject not available for contact|1|||
42028373|NCT01165307|75836810|FG001|Overall Study|Subject not available for contact|0|||
42028374|NCT00960999|75836818|FG000|Overall Study|Withdrawal by Subject|1|||
42028375|NCT00960999|75836819|FG001|Overall Study|Withdrawal by Subject|0|||
42028376|NCT00960999|75836818|FG000|Overall Study|Protocol Violation|5|||
42028377|NCT00960999|75836819|FG001|Overall Study|Protocol Violation|2|||
42028378|NCT00960999|75836818|FG000|Overall Study|RT dose constraints not met|2|||
42028379|NCT00960999|75836819|FG001|Overall Study|RT dose constraints not met|0|||
42028380|NCT01124838|75836827|FG000|Overall Study|Miscellaneous|4|||
42028381|NCT01124838|75836828|FG001|Overall Study|Miscellaneous|2|||
42028382|NCT01124838|75836827|FG000|Overall Study|Adverse Event|7|||
42028383|NCT01124838|75836828|FG001|Overall Study|Adverse Event|11|||
42028384|NCT01124838|75836827|FG000|Overall Study|Lack of Efficacy|2|||
42028385|NCT01124838|75836828|FG001|Overall Study|Lack of Efficacy|0|||
42028386|NCT01124838|75836827|FG000|Overall Study|Withdrawal by Subject|3|||
42028387|NCT01124838|75836828|FG001|Overall Study|Withdrawal by Subject|2|||
42028388|NCT01124838|75836827|FG000|Overall Study|Lost to Follow-up|2|||
42028389|NCT01124838|75836828|FG001|Overall Study|Lost to Follow-up|0|||
42028390|NCT00959751|75836838|FG000|Overall Study|Lost to Follow-up|2|||
42028391|NCT00959751|75836839|FG001|Overall Study|Lost to Follow-up|3|||
42028392|NCT00959751|75836838|FG000|Overall Study|Consent Withdrawn|0|||
42028393|NCT00959751|75836839|FG001|Overall Study|Consent Withdrawn|1|||
42028394|NCT00959751|75836838|FG000|Overall Study|Non-compliance to Study Procedures|0|||
42028395|NCT00959751|75836839|FG001|Overall Study|Non-compliance to Study Procedures|1|||
42028396|NCT00959751|75836838|FG000|Overall Study|No migraine headache without aura|7|||
42028397|NCT00959751|75836839|FG001|Overall Study|No migraine headache without aura|7|||
42028398|NCT00910858|75836848|FG000|Pharmacokinetic Phase|Adverse Event|1|||
42212728|NCT01345682|76028252|FG000|Overall Study|Worsening of underlying cancer disease|23|||
42212729|NCT01345682|76028253|FG001|Overall Study|Worsening of underlying cancer disease|12|||
42212730|NCT01345682|76028252|FG000|Overall Study|Adverse Event|51|||
42212731|NCT01345682|76028253|FG001|Overall Study|Adverse Event|41|||
42212732|NCT01345682|76028252|FG000|Overall Study|Non-compliance with protocol|0|||
42212733|NCT01345682|76028253|FG001|Overall Study|Non-compliance with protocol|1|||
42212734|NCT01345682|76028252|FG000|Overall Study|Lost to Follow-up|0|||
42212735|NCT01345682|76028253|FG001|Overall Study|Lost to Follow-up|1|||
42212736|NCT01345682|76028252|FG000|Overall Study|Refused to continue trial medication|16|||
41976025|NCT01349907|75778930|FG001|Overall Study|Protocol Violation|13|||
41976026|NCT01349907|75778929|FG000|Overall Study|Administrative|1|||
41976027|NCT01349907|75778930|FG001|Overall Study|Administrative|1|||
41976028|NCT05512949|75778939|FG000|Overall Study|Lost to Follow-up|4|||
41976029|NCT05512949|75778940|FG001|Overall Study|Lost to Follow-up|6|||
41976030|NCT05512949|75778941|FG002|Overall Study|Lost to Follow-up|2|||
41976031|NCT05512949|75778939|FG000|Overall Study|Protocol Violation|0|||
41976032|NCT05512949|75778940|FG001|Overall Study|Protocol Violation|0|||
42028399|NCT00910858|75836849|FG001|Pharmacokinetic Phase|Adverse Event|0|||
42028400|NCT00910858|75836850|FG002|Pharmacokinetic Phase|Adverse Event|0|||
42028401|NCT00910858|75836848|FG000|Monotherapy Phase|Adverse Event|3|||
42028402|NCT00910858|75836849|FG001|Monotherapy Phase|Adverse Event|2|||
41976033|NCT05512949|75778941|FG002|Overall Study|Protocol Violation|1|||
41976034|NCT05512949|75778939|FG000|Overall Study|Withdrawal by Subject|1|||
42028403|NCT00910858|75836850|FG002|Monotherapy Phase|Adverse Event|0|||
42028404|NCT00910858|75836848|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
42028405|NCT00910858|75836849|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
42028406|NCT00910858|75836850|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
42212737|NCT01345682|76028253|FG001|Overall Study|Refused to continue trial medication|9|||
42212738|NCT01345682|76028252|FG000|Overall Study|Not treated|2|||
42212739|NCT01345682|76028253|FG001|Overall Study|Not treated|1|||
42212740|NCT01345682|76028252|FG000|Overall Study|Reason other than those specified above|4|||
42212741|NCT01345682|76028253|FG001|Overall Study|Reason other than those specified above|3|||
42212742|NCT03562117|76028262|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
42212743|NCT03562117|76028263|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
42212744|NCT03562117|76028264|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
42212745|NCT03561883|76028274|FG000|Overall Study|Adverse Event|10|||
42212746|NCT03561883|76028275|FG001|Overall Study|Adverse Event|13|||
42212747|NCT03561883|76028274|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42212748|NCT03561883|76028275|FG001|Overall Study|Non-Compliance With Study Drug|2|||
42212749|NCT03561883|76028274|FG000|Overall Study|Protocol Violation|2|||
42212750|NCT03561883|76028275|FG001|Overall Study|Protocol Violation|3|||
42212751|NCT03561883|76028274|FG000|Overall Study|Withdrawal by Subject|14|||
42212752|NCT03561883|76028275|FG001|Overall Study|Withdrawal by Subject|6|||
42212753|NCT03561883|76028274|FG000|Overall Study|Lost to Follow-up|2|||
42212754|NCT03561883|76028275|FG001|Overall Study|Lost to Follow-up|6|||
42212755|NCT03561883|76028274|FG000|Overall Study|Study Terminated by Sponsor|12|||
42212756|NCT03561883|76028275|FG001|Overall Study|Study Terminated by Sponsor|11|||
42212757|NCT03561883|76028274|FG000|Overall Study|Physician Decision|1|||
42212758|NCT03561883|76028275|FG001|Overall Study|Physician Decision|0|||
42212759|NCT03561883|76028274|FG000|Overall Study|Randomized by Mistake|1|||
42212760|NCT03561883|76028275|FG001|Overall Study|Randomized by Mistake|0|||
42212761|NCT03561883|76028274|FG000|Overall Study|Other, Not Specified|3|||
42212762|NCT03561883|76028275|FG001|Overall Study|Other, Not Specified|2|||
42212763|NCT03546907|76028283|FG000|Overall Study|Lack of Efficacy|1|||
42212764|NCT03546907|76028284|FG001|Overall Study|Lack of Efficacy|1|||
42212765|NCT03546907|76028283|FG000|Overall Study|Withdrawal by Subject|8|||
42212766|NCT03546907|76028284|FG001|Overall Study|Withdrawal by Subject|9|||
42212767|NCT03546907|76028283|FG000|Overall Study|Adverse events (AEs)|7|||
42212768|NCT03546907|76028284|FG001|Overall Study|Adverse events (AEs)|10|||
42212769|NCT03546907|76028283|FG000|Overall Study|Other-unspecified|1|||
42212770|NCT03546907|76028284|FG001|Overall Study|Other-unspecified|1|||
42212771|NCT01318382|76028290|FG000|Overall Study|Physician Decision|2|||
42212772|NCT01318382|76028290|FG000|Overall Study|Device Malfunction|10|||
42212773|NCT01318382|76028290|FG000|Overall Study|Protocol Violation|1|||
42212774|NCT03053180|76028308|FG000|Overall Study|Failure to Return|1|||
42212775|NCT03560869|76028312|FG000|Overall Study|Withdrawal by Subject|3|||
42301832|NCT02501473|76136964|FG004|Overall Study|Reason not specified|0|||
41976035|NCT05512949|75778940|FG001|Overall Study|Withdrawal by Subject|1|||
41976036|NCT05512949|75778941|FG002|Overall Study|Withdrawal by Subject|2|||
41976037|NCT05512949|75778939|FG000|Overall Study|Completion status unknown|1|||
41976038|NCT05512949|75778940|FG001|Overall Study|Completion status unknown|3|||
42128107|NCT00526994|75938692|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
42128108|NCT00519428|75938703|FG000|Overall Study|Adverse Event|5|||
42128109|NCT00519428|75938704|FG001|Overall Study|Adverse Event|2|||
42128110|NCT00519428|75938705|FG002|Overall Study|Adverse Event|10|||
42128111|NCT00519428|75938703|FG000|Overall Study|Lost to Follow-up|7|||
42128112|NCT00519428|75938704|FG001|Overall Study|Lost to Follow-up|7|||
42128113|NCT00519428|75938705|FG002|Overall Study|Lost to Follow-up|6|||
42128114|NCT00519428|75938703|FG000|Overall Study|Withdrawal by Subject|8|||
42128115|NCT00519428|75938704|FG001|Overall Study|Withdrawal by Subject|3|||
42128116|NCT00519428|75938705|FG002|Overall Study|Withdrawal by Subject|7|||
42128117|NCT00519428|75938703|FG000|Overall Study|unstated|1|||
42128118|NCT00519428|75938704|FG001|Overall Study|unstated|3|||
42128119|NCT00519428|75938705|FG002|Overall Study|unstated|2|||
42128120|NCT00432159|75938721|FG000|Overall Study|Death|0|||
42128121|NCT00432159|75938722|FG001|Overall Study|Death|1|||
42128122|NCT00432159|75938723|FG002|Overall Study|Death|0|||
42128123|NCT00432159|75938724|FG003|Overall Study|Death|0|||
42128124|NCT00432159|75938725|FG004|Overall Study|Death|0|||
42128125|NCT00432159|75938721|FG000|Overall Study|Failure|9|||
42128126|NCT00432159|75938722|FG001|Overall Study|Failure|5|||
42128127|NCT00432159|75938723|FG002|Overall Study|Failure|3|||
42128128|NCT00432159|75938724|FG003|Overall Study|Failure|2|||
42128129|NCT00432159|75938725|FG004|Overall Study|Failure|3|||
42128130|NCT00432159|75938721|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
42128131|NCT00432159|75938722|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
42128132|NCT00432159|75938723|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
42212776|NCT03560869|76028313|FG001|Overall Study|Withdrawal by Subject|4|||
42212777|NCT03560869|76028312|FG000|Overall Study|Screening failure|4|||
42212778|NCT03560869|76028313|FG001|Overall Study|Screening failure|4|||
41976039|NCT05512949|75778941|FG002|Overall Study|Completion status unknown|0|||
42128133|NCT00432159|75938724|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
42212779|NCT03560869|76028312|FG000|Overall Study|Withdrawal by PI|0|||
42212780|NCT03560869|76028313|FG001|Overall Study|Withdrawal by PI|1|||
42212781|NCT03590743|76028321|FG000|Overall Study|Withdrawal by Subject|0|||
42212782|NCT03590743|76028322|FG001|Overall Study|Withdrawal by Subject|1|||
42212783|NCT03053102|76028328|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
42212784|NCT03053102|76028328|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
42212785|NCT03589885|76028336|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
42212786|NCT03589885|76028337|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
42212787|NCT03589885|76028338|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
42212788|NCT03589885|76028339|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
42212789|NCT03589885|76028340|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
42212790|NCT03589885|76028336|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
42212791|NCT03589885|76028337|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
42212792|NCT03589885|76028338|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
42212793|NCT03589885|76028339|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
42212794|NCT03589885|76028340|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
42212795|NCT03589885|76028336|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
42212796|NCT03589885|76028337|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
42212797|NCT03589885|76028338|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
42212798|NCT03589885|76028339|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
42212799|NCT03589885|76028340|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
42212800|NCT03589885|76028336|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
42212801|NCT03589885|76028337|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
42212802|NCT03589885|76028338|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
42212803|NCT03589885|76028339|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
42212804|NCT03589885|76028340|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
42212805|NCT03589885|76028336|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
42212806|NCT03589885|76028337|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
42212807|NCT03589885|76028338|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
42212808|NCT03589885|76028339|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
42212809|NCT03589885|76028340|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
42212810|NCT03589885|76028336|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
42212811|NCT03589885|76028337|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
42212812|NCT03589885|76028338|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
42212813|NCT03589885|76028339|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
42212814|NCT03589885|76028340|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
42212815|NCT03589885|76028336|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
42212816|NCT03589885|76028337|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
42212817|NCT03589885|76028338|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
42212818|NCT03589885|76028339|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
42212819|NCT03589885|76028340|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
42212820|NCT03589885|76028336|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
42212821|NCT03589885|76028337|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
42212822|NCT03589885|76028338|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
42212823|NCT03589885|76028339|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
42212824|NCT03589885|76028340|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
42212825|NCT03545503|76028360|FG000|Overall Study|Protocol Violation|14|||
42212826|NCT03545503|76028361|FG001|Overall Study|Protocol Violation|16|||
42212827|NCT03545113|76028369|FG000|Overall Study|Surgery Cancelled|1|||
42212828|NCT03545113|76028370|FG001|Overall Study|Surgery Cancelled|0|||
42212829|NCT03545113|76028369|FG000|Overall Study|Death|1|||
42212830|NCT03545113|76028370|FG001|Overall Study|Death|0|||
42212831|NCT03545113|76028369|FG000|Overall Study|Adverse Event|2|||
42212832|NCT03545113|76028370|FG001|Overall Study|Adverse Event|0|||
42212833|NCT03545113|76028369|FG000|Overall Study|Received different surgery|1|||
42212834|NCT03545113|76028370|FG001|Overall Study|Received different surgery|0|||
42212835|NCT03214380|76028382|FG000|Lead-in|Adverse Event|3|||
42212836|NCT03214380|76028383|FG001|Lead-in|Adverse Event|0|||
42212837|NCT03214380|76028384|FG002|Lead-in|Adverse Event|0|||
42212838|NCT03214380|76028385|FG003|Lead-in|Adverse Event|1|||
42212839|NCT03214380|76028386|FG004|Lead-in|Adverse Event|0|||
42212840|NCT03214380|76028387|FG005|Lead-in|Adverse Event|0|||
42212841|NCT03214380|76028382|FG000|Lead-in|Lost to Follow-up|4|||
42212842|NCT03214380|76028383|FG001|Lead-in|Lost to Follow-up|0|||
42212843|NCT03214380|76028384|FG002|Lead-in|Lost to Follow-up|0|||
42212844|NCT03214380|76028385|FG003|Lead-in|Lost to Follow-up|1|||
42212845|NCT03214380|76028386|FG004|Lead-in|Lost to Follow-up|0|||
42212846|NCT03214380|76028387|FG005|Lead-in|Lost to Follow-up|0|||
42212847|NCT03214380|76028382|FG000|Lead-in|Eligibility Criteria|3|||
42212848|NCT03214380|76028383|FG001|Lead-in|Eligibility Criteria|0|||
42212849|NCT03214380|76028384|FG002|Lead-in|Eligibility Criteria|0|||
42212850|NCT03214380|76028385|FG003|Lead-in|Eligibility Criteria|0|||
42212851|NCT03214380|76028386|FG004|Lead-in|Eligibility Criteria|0|||
42212852|NCT03214380|76028387|FG005|Lead-in|Eligibility Criteria|0|||
42212853|NCT03214380|76028382|FG000|Lead-in|Physician Decision|6|||
42212854|NCT03214380|76028383|FG001|Lead-in|Physician Decision|0|||
42212855|NCT03214380|76028384|FG002|Lead-in|Physician Decision|0|||
42212856|NCT03214380|76028385|FG003|Lead-in|Physician Decision|0|||
42212857|NCT03214380|76028386|FG004|Lead-in|Physician Decision|0|||
42212858|NCT03214380|76028387|FG005|Lead-in|Physician Decision|0|||
42212859|NCT03214380|76028382|FG000|Lead-in|Protocol Deviation|7|||
42212860|NCT03214380|76028383|FG001|Lead-in|Protocol Deviation|0|||
42212861|NCT03214380|76028384|FG002|Lead-in|Protocol Deviation|0|||
42212862|NCT03214380|76028385|FG003|Lead-in|Protocol Deviation|3|||
42212863|NCT03214380|76028386|FG004|Lead-in|Protocol Deviation|0|||
42212864|NCT03214380|76028387|FG005|Lead-in|Protocol Deviation|0|||
42212865|NCT03214380|76028382|FG000|Lead-in|Withdrawal by Subject|41|||
42212866|NCT03214380|76028383|FG001|Lead-in|Withdrawal by Subject|0|||
42212867|NCT03214380|76028384|FG002|Lead-in|Withdrawal by Subject|0|||
42212868|NCT03214380|76028385|FG003|Lead-in|Withdrawal by Subject|14|||
42212869|NCT03214380|76028386|FG004|Lead-in|Withdrawal by Subject|0|||
42212870|NCT03214380|76028387|FG005|Lead-in|Withdrawal by Subject|0|||
42212871|NCT03214380|76028382|FG000|Lead-in|Family Emergency|1|||
42212872|NCT03214380|76028383|FG001|Lead-in|Family Emergency|0|||
42212873|NCT03214380|76028384|FG002|Lead-in|Family Emergency|0|||
42212874|NCT03214380|76028385|FG003|Lead-in|Family Emergency|0|||
42212875|NCT03214380|76028386|FG004|Lead-in|Family Emergency|0|||
42212876|NCT03214380|76028387|FG005|Lead-in|Family Emergency|0|||
42212877|NCT03214380|76028382|FG000|Lead-in|Natural Disaster|9|||
42212878|NCT03214380|76028383|FG001|Lead-in|Natural Disaster|0|||
42212879|NCT03214380|76028384|FG002|Lead-in|Natural Disaster|0|||
42212880|NCT03214380|76028385|FG003|Lead-in|Natural Disaster|0|||
42212881|NCT03214380|76028386|FG004|Lead-in|Natural Disaster|0|||
42212882|NCT03214380|76028387|FG005|Lead-in|Natural Disaster|0|||
42212883|NCT03214380|76028382|FG000|Lead-in|Non Compliance|1|||
42212884|NCT03214380|76028383|FG001|Lead-in|Non Compliance|0|||
42212885|NCT03214380|76028384|FG002|Lead-in|Non Compliance|0|||
42212886|NCT03214380|76028385|FG003|Lead-in|Non Compliance|0|||
42212887|NCT03214380|76028386|FG004|Lead-in|Non Compliance|0|||
42212888|NCT03214380|76028387|FG005|Lead-in|Non Compliance|0|||
42212889|NCT03214380|76028382|FG000|Lead-in|Participant Schedule|2|||
42212890|NCT03214380|76028383|FG001|Lead-in|Participant Schedule|0|||
42212891|NCT03214380|76028384|FG002|Lead-in|Participant Schedule|0|||
42212892|NCT03214380|76028385|FG003|Lead-in|Participant Schedule|0|||
42212893|NCT03214380|76028386|FG004|Lead-in|Participant Schedule|0|||
42212894|NCT03214380|76028387|FG005|Lead-in|Participant Schedule|0|||
42212895|NCT03214380|76028382|FG000|Treatment Period|Adverse Event|0|||
42212896|NCT03214380|76028383|FG001|Treatment Period|Adverse Event|1|||
42212897|NCT03214380|76028384|FG002|Treatment Period|Adverse Event|1|||
42212898|NCT03214380|76028385|FG003|Treatment Period|Adverse Event|0|||
42212899|NCT03214380|76028386|FG004|Treatment Period|Adverse Event|1|||
42212900|NCT03214380|76028387|FG005|Treatment Period|Adverse Event|0|||
42212901|NCT03214380|76028382|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
42212902|NCT03214380|76028383|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
42212903|NCT03214380|76028384|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
42212904|NCT03214380|76028385|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
42212905|NCT03214380|76028386|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
42212906|NCT03214380|76028387|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
42212907|NCT03214380|76028382|FG000|Treatment Period|Withdrawal by Subject|0|||
42212908|NCT03214380|76028383|FG001|Treatment Period|Withdrawal by Subject|10|||
42212909|NCT03214380|76028384|FG002|Treatment Period|Withdrawal by Subject|8|||
42212910|NCT03214380|76028385|FG003|Treatment Period|Withdrawal by Subject|0|||
42212911|NCT03214380|76028386|FG004|Treatment Period|Withdrawal by Subject|7|||
41976040|NCT04794491|75778968|FG000|Overall Study|Adverse Event|1|||
41976041|NCT04794491|75778968|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
41976042|NCT04794491|75778968|FG000|Overall Study|Noncompliance With Study Intervention|1|||
41976043|NCT04794491|75778968|FG000|Overall Study|Withdrawal by Subject|2|||
42212912|NCT03214380|76028387|FG005|Treatment Period|Withdrawal by Subject|11|||
41976044|NCT04458922|75778984|FG000|Overall Study|Withdrawal by Subject|1|||
41976045|NCT04458922|75778985|FG001|Overall Study|Withdrawal by Subject|0|||
41976046|NCT04458922|75778986|FG002|Overall Study|Withdrawal by Subject|2|||
41976047|NCT04458922|75778984|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
41976048|NCT04458922|75778985|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
41976049|NCT04458922|75778986|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
41976050|NCT04458922|75778984|FG000|Overall Study|Adverse Event|1|||
41976051|NCT04458922|75778985|FG001|Overall Study|Adverse Event|0|||
41976052|NCT04458922|75778986|FG002|Overall Study|Adverse Event|0|||
42212913|NCT03214380|76028382|FG000|Treatment Period|Death|0|||
42212914|NCT03214380|76028383|FG001|Treatment Period|Death|1|||
42212915|NCT03214380|76028384|FG002|Treatment Period|Death|2|||
42212916|NCT03214380|76028385|FG003|Treatment Period|Death|0|||
42212917|NCT03214380|76028386|FG004|Treatment Period|Death|0|||
42212918|NCT03214380|76028387|FG005|Treatment Period|Death|0|||
42212919|NCT03214380|76028382|FG000|Treatment Period|Lost to Follow-up|0|||
42212920|NCT03214380|76028383|FG001|Treatment Period|Lost to Follow-up|6|||
42212921|NCT03214380|76028384|FG002|Treatment Period|Lost to Follow-up|3|||
42212922|NCT03214380|76028385|FG003|Treatment Period|Lost to Follow-up|0|||
42212923|NCT03214380|76028386|FG004|Treatment Period|Lost to Follow-up|0|||
42212924|NCT03214380|76028387|FG005|Treatment Period|Lost to Follow-up|0|||
42212925|NCT03214380|76028382|FG000|Treatment Period|Participant schedule|0|||
42212926|NCT03214380|76028383|FG001|Treatment Period|Participant schedule|0|||
42212927|NCT03214380|76028384|FG002|Treatment Period|Participant schedule|1|||
42212928|NCT03214380|76028385|FG003|Treatment Period|Participant schedule|0|||
42212929|NCT03214380|76028386|FG004|Treatment Period|Participant schedule|0|||
42212930|NCT03214380|76028387|FG005|Treatment Period|Participant schedule|0|||
42212931|NCT03214380|76028382|FG000|Treatment Period|Treatment Interruption|0|||
42212932|NCT03214380|76028383|FG001|Treatment Period|Treatment Interruption|0|||
42212933|NCT03214380|76028384|FG002|Treatment Period|Treatment Interruption|1|||
42212934|NCT03214380|76028385|FG003|Treatment Period|Treatment Interruption|0|||
42212935|NCT03214380|76028386|FG004|Treatment Period|Treatment Interruption|0|||
42212936|NCT03214380|76028387|FG005|Treatment Period|Treatment Interruption|0|||
42212937|NCT02674464|76028401|FG000|Overall Study|Death|10|||
42212938|NCT02674464|76028402|FG001|Overall Study|Death|21|||
42212939|NCT02674464|76028401|FG000|Overall Study|Withdrawal by Subject|24|||
42212940|NCT02674464|76028402|FG001|Overall Study|Withdrawal by Subject|44|||
42212941|NCT02674464|76028401|FG000|Overall Study|Lost to Follow-up|97|||
42212942|NCT02674464|76028402|FG001|Overall Study|Lost to Follow-up|92|||
42212943|NCT02674464|76028401|FG000|Overall Study|Outside survey window|6|||
42212944|NCT02674464|76028402|FG001|Overall Study|Outside survey window|3|||
42212945|NCT03172026|76028410|FG000|Overall Study|Withdrawal by Subject|1|||
42212946|NCT03172026|76028411|FG001|Overall Study|Withdrawal by Subject|0|||
42212947|NCT03172026|76028410|FG000|Overall Study|COVID restrictions|1|||
42212948|NCT03172026|76028411|FG001|Overall Study|COVID restrictions|0|||
42212949|NCT01343888|76028421|FG000|Overall Study|Adverse Event|12|||
42212950|NCT01343888|76028422|FG001|Overall Study|Adverse Event|22|||
42212951|NCT01343888|76028423|FG002|Overall Study|Adverse Event|5|||
42212952|NCT01343888|76028421|FG000|Overall Study|Lack of Efficacy|9|||
42212953|NCT01343888|76028422|FG001|Overall Study|Lack of Efficacy|9|||
42212954|NCT01343888|76028423|FG002|Overall Study|Lack of Efficacy|13|||
42212955|NCT01343888|76028421|FG000|Overall Study|Lost to Follow-up|0|||
42212956|NCT01343888|76028422|FG001|Overall Study|Lost to Follow-up|2|||
42212957|NCT01343888|76028423|FG002|Overall Study|Lost to Follow-up|1|||
42212958|NCT01343888|76028421|FG000|Overall Study|Protocol Violation|0|||
42212959|NCT01343888|76028422|FG001|Overall Study|Protocol Violation|2|||
42212960|NCT01343888|76028423|FG002|Overall Study|Protocol Violation|0|||
42212961|NCT01343888|76028421|FG000|Overall Study|Withdrawal by Subject|4|||
42212962|NCT01343888|76028422|FG001|Overall Study|Withdrawal by Subject|4|||
42212963|NCT01343888|76028423|FG002|Overall Study|Withdrawal by Subject|2|||
42212964|NCT01343888|76028421|FG000|Overall Study|other than stated above|0|||
42301833|NCT02501473|76136965|FG005|Overall Study|Reason not specified|0|||
42301834|NCT02501473|76136966|FG006|Overall Study|Reason not specified|0|||
41976053|NCT04458922|75778984|FG000|Overall Study|Started new study|0|||
41976054|NCT04458922|75778985|FG001|Overall Study|Started new study|0|||
41976055|NCT04458922|75778986|FG002|Overall Study|Started new study|1|||
41976056|NCT04458922|75778984|FG000|Overall Study|Progressive disease|6|||
41976057|NCT04458922|75778985|FG001|Overall Study|Progressive disease|8|||
41976058|NCT04458922|75778986|FG002|Overall Study|Progressive disease|2|||
41976059|NCT04458922|75778984|FG000|Overall Study|Death|1|||
41976060|NCT04458922|75778985|FG001|Overall Study|Death|0|||
41976061|NCT04458922|75778986|FG002|Overall Study|Death|2|||
41976062|NCT04458922|75778984|FG000|Overall Study|Participant started chemotherapy|0|||
41976063|NCT04458922|75778985|FG001|Overall Study|Participant started chemotherapy|1|||
41976064|NCT04458922|75778986|FG002|Overall Study|Participant started chemotherapy|0|||
41976065|NCT04453202|75779005|FG000|Overall Study|Adverse Event|0|||
41976066|NCT04453202|75779006|FG001|Overall Study|Adverse Event|0|||
41976067|NCT04453202|75779007|FG002|Overall Study|Adverse Event|0|||
41976068|NCT04453202|75779008|FG003|Overall Study|Adverse Event|0|||
41976069|NCT04453202|75779009|FG004|Overall Study|Adverse Event|0|||
41976070|NCT04453202|75779010|FG005|Overall Study|Adverse Event|0|||
41976071|NCT04453202|75779011|FG006|Overall Study|Adverse Event|1|||
41976072|NCT04453202|75779012|FG007|Overall Study|Adverse Event|0|||
41976073|NCT04453202|75779013|FG008|Overall Study|Adverse Event|0|||
41976074|NCT04453202|75779014|FG009|Overall Study|Adverse Event|0|||
41976075|NCT04453202|75779015|FG010|Overall Study|Adverse Event|0|||
41976076|NCT04453202|75779005|FG000|Overall Study|Death|0|||
41976077|NCT04453202|75779006|FG001|Overall Study|Death|0|||
42212965|NCT01343888|76028422|FG001|Overall Study|other than stated above|0|||
42212966|NCT01343888|76028423|FG002|Overall Study|other than stated above|1|||
42212967|NCT03589807|76028437|FG000|Overall Study|Lost to Follow-up|0|||
42212968|NCT03589807|76028438|FG001|Overall Study|Lost to Follow-up|2|||
42212969|NCT03589807|76028439|FG002|Overall Study|Lost to Follow-up|2|||
42212970|NCT03589807|76028440|FG003|Overall Study|Lost to Follow-up|3|||
42212971|NCT03589807|76028441|FG004|Overall Study|Lost to Follow-up|1|||
42212972|NCT03589807|76028442|FG005|Overall Study|Lost to Follow-up|1|||
42212973|NCT03589807|76028437|FG000|Overall Study|Withdrawal by Subject|0|||
42212974|NCT03589807|76028438|FG001|Overall Study|Withdrawal by Subject|5|||
42212975|NCT03589807|76028439|FG002|Overall Study|Withdrawal by Subject|0|||
42212976|NCT03589807|76028440|FG003|Overall Study|Withdrawal by Subject|0|||
42212977|NCT03589807|76028441|FG004|Overall Study|Withdrawal by Subject|0|||
42212978|NCT03589807|76028442|FG005|Overall Study|Withdrawal by Subject|0|||
42212979|NCT03589807|76028437|FG000|Overall Study|Protocol Violation|0|||
42212980|NCT03589807|76028438|FG001|Overall Study|Protocol Violation|0|||
42212981|NCT03589807|76028439|FG002|Overall Study|Protocol Violation|0|||
42212982|NCT03589807|76028440|FG003|Overall Study|Protocol Violation|1|||
42212983|NCT03589807|76028441|FG004|Overall Study|Protocol Violation|0|||
42212984|NCT03589807|76028442|FG005|Overall Study|Protocol Violation|0|||
42212985|NCT03589807|76028437|FG000|Overall Study|Enrolled but treatment not administered|0|||
42212986|NCT03589807|76028438|FG001|Overall Study|Enrolled but treatment not administered|0|||
42212987|NCT03589807|76028439|FG002|Overall Study|Enrolled but treatment not administered|0|||
42212988|NCT03589807|76028440|FG003|Overall Study|Enrolled but treatment not administered|0|||
42212989|NCT03589807|76028441|FG004|Overall Study|Enrolled but treatment not administered|1|||
42212990|NCT03589807|76028442|FG005|Overall Study|Enrolled but treatment not administered|0|||
42212991|NCT03544333|76028461|FG000|Overall Study|Withdrawal by Subject|1|||
42212992|NCT03544333|76028462|FG001|Overall Study|Withdrawal by Subject|0|||
42212993|NCT03560245|76028470|FG000|Overall Study|Withdrawal by Subject|3|||
42212994|NCT03560245|76028471|FG001|Overall Study|Withdrawal by Subject|2|||
42212995|NCT03560245|76028470|FG000|Overall Study|Adverse Event|1|||
42212996|NCT03560245|76028471|FG001|Overall Study|Adverse Event|1|||
42212997|NCT03560245|76028470|FG000|Overall Study|Protocol Violation|1|||
42212998|NCT03560245|76028471|FG001|Overall Study|Protocol Violation|0|||
42212999|NCT03560245|76028470|FG000|Overall Study|Death|0|||
42213000|NCT03560245|76028471|FG001|Overall Study|Death|1|||
42213001|NCT03560245|76028470|FG000|Overall Study|Lost to Follow-up|0|||
42213002|NCT03560245|76028471|FG001|Overall Study|Lost to Follow-up|1|||
42213003|NCT03560245|76028470|FG000|Overall Study|Physician Decision|0|||
42213004|NCT03560245|76028471|FG001|Overall Study|Physician Decision|1|||
42213005|NCT03560245|76028470|FG000|Overall Study|Other|0|||
42213006|NCT03560245|76028471|FG001|Overall Study|Other|1|||
42213007|NCT00707434|76028479|FG000|Overall Study|Adverse Event|1|||
42213008|NCT03054428|76028486|FG000|Overall Study|Physician Decision|0|||
42213009|NCT03054428|76028487|FG001|Overall Study|Physician Decision|1|||
42213010|NCT03054428|76028488|FG002|Overall Study|Physician Decision|1|||
42213011|NCT03054428|76028486|FG000|Overall Study|Lack of Efficacy|3|||
42213012|NCT03054428|76028487|FG001|Overall Study|Lack of Efficacy|1|||
42213013|NCT03054428|76028488|FG002|Overall Study|Lack of Efficacy|0|||
42213014|NCT03054428|76028486|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
42213015|NCT03054428|76028487|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
42213016|NCT03054428|76028488|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
42213017|NCT03054428|76028486|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
42213018|NCT03054428|76028487|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
42213019|NCT03054428|76028488|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
42213020|NCT03054428|76028486|FG000|Overall Study|Transitioned to OLE study|76|||
42213021|NCT03054428|76028487|FG001|Overall Study|Transitioned to OLE study|76|||
42213022|NCT03054428|76028488|FG002|Overall Study|Transitioned to OLE study|73|||
42213023|NCT03054428|76028486|FG000|Overall Study|Withdrawal by Subject|3|||
42213024|NCT03054428|76028487|FG001|Overall Study|Withdrawal by Subject|2|||
42213025|NCT03054428|76028488|FG002|Overall Study|Withdrawal by Subject|3|||
42301835|NCT02501473|76136967|FG007|Overall Study|Reason not specified|0|||
41976078|NCT04453202|75779007|FG002|Overall Study|Death|0|||
42213026|NCT03054428|76028486|FG000|Overall Study|Lost to Follow-up|0|||
42213027|NCT03054428|76028487|FG001|Overall Study|Lost to Follow-up|0|||
42213028|NCT03054428|76028488|FG002|Overall Study|Lost to Follow-up|1|||
42213029|NCT03558997|76028500|FG000|Overall Study|Adverse Event|0|||
42213030|NCT03558997|76028501|FG001|Overall Study|Adverse Event|2|||
42213031|NCT03558997|76028502|FG002|Overall Study|Adverse Event|5|||
42213032|NCT03558997|76028503|FG003|Overall Study|Adverse Event|1|||
42213033|NCT03558997|76028500|FG000|Overall Study|Physician Decision|0|||
42213034|NCT03558997|76028501|FG001|Overall Study|Physician Decision|0|||
42213035|NCT03558997|76028502|FG002|Overall Study|Physician Decision|1|||
42213036|NCT03558997|76028503|FG003|Overall Study|Physician Decision|0|||
42213037|NCT03558997|76028500|FG000|Overall Study|Withdrawal by Subject|1|||
42213038|NCT03558997|76028501|FG001|Overall Study|Withdrawal by Subject|0|||
42213039|NCT03558997|76028502|FG002|Overall Study|Withdrawal by Subject|1|||
42213040|NCT03558997|76028503|FG003|Overall Study|Withdrawal by Subject|1|||
42213041|NCT03558997|76028500|FG000|Overall Study|Lost to Follow-up|0|||
42213042|NCT03558997|76028501|FG001|Overall Study|Lost to Follow-up|0|||
42213043|NCT03558997|76028502|FG002|Overall Study|Lost to Follow-up|1|||
42213044|NCT03558997|76028503|FG003|Overall Study|Lost to Follow-up|0|||
42213045|NCT03052400|76028518|FG000|Overall Study|Lost to Follow-up|1|||
42213046|NCT03052400|76028519|FG001|Overall Study|Lost to Follow-up|0|||
42213047|NCT03052400|76028518|FG000|Overall Study|Withdrawal by Subject|0|||
42213048|NCT03052400|76028519|FG001|Overall Study|Withdrawal by Subject|1|||
42213049|NCT03538951|76028527|FG000|Overall Study|Withdrawal by Subject|1|||
42213050|NCT03538951|76028528|FG001|Overall Study|Withdrawal by Subject|2|||
42213051|NCT03052322|76028536|FG000|Overall Study|Other un-specified|1|||
42213052|NCT03052322|76028537|FG001|Overall Study|Other un-specified|2|||
42213053|NCT03052322|76028536|FG000|Overall Study|Withdrawal by Subject|10|||
42213054|NCT03052322|76028537|FG001|Overall Study|Withdrawal by Subject|9|||
42213055|NCT03052322|76028536|FG000|Overall Study|Death|0|||
42213056|NCT03052322|76028537|FG001|Overall Study|Death|2|||
42213057|NCT03052322|76028536|FG000|Overall Study|Lack of Efficacy|1|||
42213058|NCT03052322|76028537|FG001|Overall Study|Lack of Efficacy|2|||
42213059|NCT03052322|76028536|FG000|Overall Study|Protocol Violation|1|||
42213060|NCT03052322|76028537|FG001|Overall Study|Protocol Violation|0|||
42213061|NCT03052322|76028536|FG000|Overall Study|Lost to Follow-up|2|||
42213062|NCT03052322|76028537|FG001|Overall Study|Lost to Follow-up|4|||
42213063|NCT03052322|76028536|FG000|Overall Study|Adverse Event|6|||
42213064|NCT03052322|76028537|FG001|Overall Study|Adverse Event|13|||
42213065|NCT03521791|76028545|FG000|Overall Study|Protocol Violation|7|||
42213066|NCT03521791|76028546|FG001|Overall Study|Protocol Violation|17|||
42213067|NCT03521635|76028554|FG000|Overall Study|Adverse Event|1|||
42213068|NCT03521635|76028555|FG001|Overall Study|Adverse Event|1|||
42213069|NCT03521635|76028554|FG000|Overall Study|Refused to complete study visit|1|||
42213070|NCT03521635|76028555|FG001|Overall Study|Refused to complete study visit|0|||
42213071|NCT03521635|76028554|FG000|Overall Study|Refused to continue trial medication|2|||
42213072|NCT03521635|76028555|FG001|Overall Study|Refused to continue trial medication|2|||
42213073|NCT03521635|76028554|FG000|Overall Study|Lost to Follow-up|0|||
42213074|NCT03521635|76028555|FG001|Overall Study|Lost to Follow-up|1|||
42213075|NCT03521635|76028554|FG000|Overall Study|Meet exclusion criteria|0|||
42213076|NCT03521635|76028555|FG001|Overall Study|Meet exclusion criteria|1|||
42213077|NCT03521635|76028554|FG000|Overall Study|Patient not taken study medicine|0|||
42213078|NCT03521635|76028555|FG001|Overall Study|Patient not taken study medicine|1|||
42213079|NCT03170544|76028573|FG000|Part 1|Lost to Follow-up|1|||
42213080|NCT03170544|76028574|FG001|Part 1|Lost to Follow-up|0|||
42213081|NCT03170544|76028575|FG002|Part 1|Lost to Follow-up|0|||
42213082|NCT03170544|76028576|FG003|Part 1|Lost to Follow-up|0|||
42213083|NCT03170544|76028577|FG004|Part 1|Lost to Follow-up|0|||
42213084|NCT03170544|76028578|FG005|Part 1|Lost to Follow-up|0|||
42213085|NCT03170544|76028579|FG006|Part 1|Lost to Follow-up|0|||
42213086|NCT03170544|76028580|FG007|Part 1|Lost to Follow-up|0|||
42213087|NCT03170544|76028581|FG008|Part 1|Lost to Follow-up|0|||
42213088|NCT03170544|76028582|FG009|Part 1|Lost to Follow-up|0|||
42213089|NCT03170544|76028583|FG010|Part 1|Lost to Follow-up|0|||
42213090|NCT03170544|76028584|FG011|Part 1|Lost to Follow-up|0|||
42213091|NCT03170544|76028573|FG000|Part 1|Not treated|0|||
41976079|NCT04453202|75779008|FG003|Overall Study|Death|0|||
41976080|NCT04453202|75779009|FG004|Overall Study|Death|0|||
41976081|NCT04453202|75779010|FG005|Overall Study|Death|0|||
42128134|NCT00432159|75938725|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
42128135|NCT00519194|75938737|FG000|Overall Study|Withdrawal by Subject|9|||
42128136|NCT00519194|75938737|FG000|Overall Study|Death|9|||
42128137|NCT00519194|75938737|FG000|Overall Study|Lost to Follow-up|3|||
42128138|NCT00431847|75938745|FG000|Overall Study|completion of less than two study visits|6|||
42128139|NCT00431847|75938746|FG001|Overall Study|completion of less than two study visits|3|||
42128140|NCT00431847|75938747|FG002|Overall Study|completion of less than two study visits|4|||
42128141|NCT00431847|75938748|FG003|Overall Study|completion of less than two study visits|14|||
42128142|NCT00431847|75938749|FG004|Overall Study|completion of less than two study visits|0|||
42128143|NCT00431847|75938745|FG000|Overall Study|Protocol Violation|0|||
42128144|NCT00431847|75938746|FG001|Overall Study|Protocol Violation|0|||
42128145|NCT00431847|75938747|FG002|Overall Study|Protocol Violation|0|||
42128146|NCT00431847|75938748|FG003|Overall Study|Protocol Violation|0|||
42128147|NCT00431847|75938749|FG004|Overall Study|Protocol Violation|1|||
42128148|NCT00431067|75938759|FG000|Overall Study|Other Adverse Event|9|||
42213092|NCT03170544|76028574|FG001|Part 1|Not treated|0|||
42213093|NCT03170544|76028575|FG002|Part 1|Not treated|0|||
42213094|NCT03170544|76028576|FG003|Part 1|Not treated|1|||
42128149|NCT00431067|75938759|FG000|Overall Study|Progressive disease|30|||
42213095|NCT03170544|76028577|FG004|Part 1|Not treated|0|||
42213096|NCT03170544|76028578|FG005|Part 1|Not treated|0|||
42213097|NCT03170544|76028579|FG006|Part 1|Not treated|0|||
42213098|NCT03170544|76028580|FG007|Part 1|Not treated|0|||
42213099|NCT03170544|76028581|FG008|Part 1|Not treated|0|||
42213100|NCT03170544|76028582|FG009|Part 1|Not treated|0|||
42213101|NCT03170544|76028583|FG010|Part 1|Not treated|0|||
42213102|NCT03170544|76028584|FG011|Part 1|Not treated|0|||
42213103|NCT03582943|76028669|FG000|Allocated to Groups|Withdrawal by Subject|1|||
42213104|NCT03582943|76028670|FG001|Allocated to Groups|Withdrawal by Subject|1|||
42213105|NCT03582943|76028669|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
42213106|NCT03582943|76028670|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
42213107|NCT03582943|76028669|FG000|Analyzed|Protocol Violation|4|||
42213108|NCT03582943|76028670|FG001|Analyzed|Protocol Violation|1|||
42213109|NCT03532009|76028678|FG000|Overall Study|Other|1|||
42213110|NCT03532009|76028679|FG001|Overall Study|Other|1|||
42213111|NCT03532009|76028678|FG000|Overall Study|Death|1|||
42213112|NCT03532009|76028679|FG001|Overall Study|Death|1|||
42213113|NCT03532009|76028678|FG000|Overall Study|Withdrawal by Patient|0|||
42213114|NCT03532009|76028679|FG001|Overall Study|Withdrawal by Patient|2|||
42213115|NCT03520387|76028690|FG000|Pre-Randomization|Withdrawal by Subject|1|||
42213116|NCT03520387|76028691|FG001|Pre-Randomization|Withdrawal by Subject|0|||
42213117|NCT03520387|76028692|FG002|Pre-Randomization|Withdrawal by Subject|0|||
42213118|NCT03520387|76028693|FG003|Pre-Randomization|Withdrawal by Subject|0|||
42213119|NCT03520387|76028694|FG004|Pre-Randomization|Withdrawal by Subject|0|||
42213120|NCT03520387|76028690|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
42213121|NCT03520387|76028691|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
42213122|NCT03520387|76028692|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
42213123|NCT03520387|76028693|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
42213124|NCT03520387|76028694|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
42213125|NCT03170232|76028707|FG000|Overall Study|Adverse Event|0|||
42213126|NCT03170232|76028708|FG001|Overall Study|Adverse Event|1|||
42213127|NCT03170232|76028707|FG000|Overall Study|Protocol Violation|0|||
42213128|NCT03170232|76028708|FG001|Overall Study|Protocol Violation|1|||
42213129|NCT03170232|76028707|FG000|Overall Study|Lack of Efficacy|0|||
42213130|NCT03170232|76028708|FG001|Overall Study|Lack of Efficacy|1|||
42213131|NCT03170232|76028707|FG000|Overall Study|Study closed/terminated|26|||
42213132|NCT03170232|76028708|FG001|Overall Study|Study closed/terminated|23|||
42213133|NCT03170232|76028707|FG000|Overall Study|Lost to Follow-up|1|||
42213134|NCT03170232|76028708|FG001|Overall Study|Lost to Follow-up|0|||
42213135|NCT03170232|76028707|FG000|Overall Study|Withdrawal by Subject|0|||
42213136|NCT03170232|76028708|FG001|Overall Study|Withdrawal by Subject|1|||
42213137|NCT03519919|76028714|FG000|Overall Study|Withdrawal by Subject|1|||
42213138|NCT03519919|76028714|FG000|Overall Study|Lack of Efficacy|1|||
42213139|NCT03519919|76028714|FG000|Overall Study|Screen Failure|1|||
42213140|NCT03478969|76028747|FG000|Overall Study|Withdrawal by Subject|4|||
42213141|NCT03478969|76028748|FG001|Overall Study|Withdrawal by Subject|7|||
42213142|NCT03478969|76028749|FG002|Overall Study|Withdrawal by Subject|6|||
42213143|NCT03478969|76028747|FG000|Overall Study|Adverse Event|2|||
42213144|NCT03478969|76028748|FG001|Overall Study|Adverse Event|0|||
42213145|NCT03478969|76028749|FG002|Overall Study|Adverse Event|1|||
42213146|NCT03478969|76028747|FG000|Overall Study|Pregnancy|1|||
42213147|NCT03478969|76028748|FG001|Overall Study|Pregnancy|0|||
42213148|NCT03478969|76028749|FG002|Overall Study|Pregnancy|0|||
42213149|NCT03478969|76028747|FG000|Overall Study|Personal Reasons|1|||
42213150|NCT03478969|76028748|FG001|Overall Study|Personal Reasons|0|||
42213151|NCT03478969|76028749|FG002|Overall Study|Personal Reasons|1|||
42213152|NCT03478969|76028747|FG000|Overall Study|Covid-19|1|||
42213153|NCT03478969|76028748|FG001|Overall Study|Covid-19|4|||
42213154|NCT03478969|76028749|FG002|Overall Study|Covid-19|3|||
42213155|NCT03478969|76028747|FG000|Overall Study|Multiple Reasons|0|||
42213156|NCT03478969|76028748|FG001|Overall Study|Multiple Reasons|1|||
42213157|NCT03478969|76028749|FG002|Overall Study|Multiple Reasons|1|||
42213158|NCT03478969|76028747|FG000|Overall Study|Eligibility Criteria|0|||
42213159|NCT03478969|76028748|FG001|Overall Study|Eligibility Criteria|0|||
42213160|NCT03478969|76028749|FG002|Overall Study|Eligibility Criteria|5|||
42213161|NCT03478969|76028747|FG000|Overall Study|Lost to Follow-up|0|||
42128150|NCT00431067|75938759|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
42128151|NCT00430989|75938765|FG000|Overall Study|Lost to Follow-up|2|||
42128152|NCT00430989|75938766|FG001|Overall Study|Lost to Follow-up|3|||
42128153|NCT00430989|75938765|FG000|Overall Study|Withdrawal by Subject|15|||
42128154|NCT00430989|75938766|FG001|Overall Study|Withdrawal by Subject|14|||
42128155|NCT00430989|75938765|FG000|Overall Study|Protocol Violation|30|||
42128156|NCT00430989|75938766|FG001|Overall Study|Protocol Violation|37|||
42128157|NCT00430989|75938765|FG000|Overall Study|Not eligible|13|||
42128158|NCT00430989|75938766|FG001|Overall Study|Not eligible|6|||
42213162|NCT03478969|76028748|FG001|Overall Study|Lost to Follow-up|0|||
42213163|NCT03478969|76028749|FG002|Overall Study|Lost to Follow-up|1|||
42213164|NCT04823949|76028780|FG000|Overall Study|Withdrawal by Subject|0|||
42213165|NCT04823949|76028781|FG001|Overall Study|Withdrawal by Subject|4|||
42213166|NCT04823949|76028780|FG000|Overall Study|Physician Decision|0|||
42213167|NCT04823949|76028781|FG001|Overall Study|Physician Decision|1|||
42213168|NCT04499482|76028796|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
42128159|NCT00430755|75938774|FG000|Overall Study|Withdrawal by Subject|53|||
42213169|NCT04408794|76028815|FG000|Overall Study|Adverse Event|43|||
42213170|NCT04408794|76028815|FG000|Overall Study|Infrequent study drug usage|43|||
42213171|NCT04408794|76028815|FG000|Overall Study|Lack of Efficacy|61|||
42213172|NCT04408794|76028815|FG000|Overall Study|Lost to Follow-up|33|||
42213173|NCT04408794|76028815|FG000|Overall Study|Non-compliance|6|||
42213174|NCT04408794|76028815|FG000|Overall Study|Physician Decision|1|||
42213175|NCT04408794|76028815|FG000|Overall Study|Pregnancy|6|||
42213176|NCT04408794|76028815|FG000|Overall Study|Protocol Deviation|9|||
42213177|NCT04408794|76028815|FG000|Overall Study|Sheehan-STS Result|1|||
42213178|NCT04408794|76028815|FG000|Overall Study|Withdrawal by Subject|57|||
42213179|NCT04408794|76028815|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
42213180|NCT04408794|76028815|FG000|Overall Study|Never Treated Migraine|5|||
42213181|NCT04354168|76028848|FG000|Overall Study|Lost to Follow-up|22|||
42213182|NCT04305405|76028854|FG000|Overall Study|Withdrawal by parent/guardian|0|||
42213183|NCT04305405|76028855|FG001|Overall Study|Withdrawal by parent/guardian|1|||
42213184|NCT03543410|76028873|FG000|Overall Study|Adverse Event|10|||
42213185|NCT03543410|76028874|FG001|Overall Study|Adverse Event|8|||
42213186|NCT03543410|76028875|FG002|Overall Study|Adverse Event|2|||
42213187|NCT03543410|76028873|FG000|Overall Study|Lack of Efficacy|0|||
42213188|NCT03543410|76028874|FG001|Overall Study|Lack of Efficacy|1|||
42213189|NCT03543410|76028875|FG002|Overall Study|Lack of Efficacy|0|||
42213190|NCT03543410|76028873|FG000|Overall Study|Lost to Follow-up|0|||
42213191|NCT03543410|76028874|FG001|Overall Study|Lost to Follow-up|1|||
42213192|NCT03543410|76028875|FG002|Overall Study|Lost to Follow-up|0|||
42213193|NCT03543410|76028873|FG000|Overall Study|Withdrawal by Subject|5|||
42213194|NCT03543410|76028874|FG001|Overall Study|Withdrawal by Subject|2|||
42213195|NCT03543410|76028875|FG002|Overall Study|Withdrawal by Subject|8|||
42213196|NCT03543410|76028873|FG000|Overall Study|Protocol Violation|0|||
42213197|NCT03543410|76028874|FG001|Overall Study|Protocol Violation|1|||
42213198|NCT03543410|76028875|FG002|Overall Study|Protocol Violation|0|||
42213199|NCT03543410|76028873|FG000|Overall Study|Due to COVID-19|4|||
42213200|NCT03543410|76028874|FG001|Overall Study|Due to COVID-19|0|||
42213201|NCT03543410|76028875|FG002|Overall Study|Due to COVID-19|2|||
42213202|NCT03543410|76028873|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
42213203|NCT03543410|76028874|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
42213204|NCT03543410|76028875|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
42213205|NCT03543410|76028873|FG000|Overall Study|Not Due to COVID-19|2|||
42213206|NCT03543410|76028874|FG001|Overall Study|Not Due to COVID-19|0|||
42213207|NCT03543410|76028875|FG002|Overall Study|Not Due to COVID-19|1|||
42213208|NCT02908074|76028889|FG000|Overall Study|sponsor/ICON decision|0|||
42213209|NCT02908074|76028890|FG001|Overall Study|sponsor/ICON decision|0|||
42213210|NCT02908074|76028891|FG002|Overall Study|sponsor/ICON decision|1|||
42213211|NCT02908074|76028892|FG003|Overall Study|sponsor/ICON decision|0|||
42213212|NCT02908074|76028893|FG004|Overall Study|sponsor/ICON decision|0|||
42213213|NCT02908074|76028894|FG005|Overall Study|sponsor/ICON decision|0|||
42213214|NCT02908074|76028889|FG000|Overall Study|Protocol Violation|0|||
42213215|NCT02908074|76028890|FG001|Overall Study|Protocol Violation|1|||
42213216|NCT02908074|76028891|FG002|Overall Study|Protocol Violation|0|||
42213217|NCT02908074|76028892|FG003|Overall Study|Protocol Violation|0|||
42213218|NCT02908074|76028893|FG004|Overall Study|Protocol Violation|0|||
42213219|NCT02908074|76028894|FG005|Overall Study|Protocol Violation|0|||
42213220|NCT02908074|76028889|FG000|Overall Study|Adverse Event|5|||
42213221|NCT02908074|76028890|FG001|Overall Study|Adverse Event|2|||
42213222|NCT02908074|76028891|FG002|Overall Study|Adverse Event|0|||
42301836|NCT02501161|76136985|FG000|Overall Study|Adverse Event|2|||
42213223|NCT02908074|76028892|FG003|Overall Study|Adverse Event|0|||
42213224|NCT02908074|76028893|FG004|Overall Study|Adverse Event|1|||
42213225|NCT02908074|76028894|FG005|Overall Study|Adverse Event|0|||
42213226|NCT02908074|76028889|FG000|Overall Study|AESI|1|||
42213227|NCT02908074|76028890|FG001|Overall Study|AESI|0|||
42213228|NCT02908074|76028891|FG002|Overall Study|AESI|1|||
42213229|NCT02908074|76028892|FG003|Overall Study|AESI|0|||
42213230|NCT02908074|76028893|FG004|Overall Study|AESI|1|||
42213231|NCT02908074|76028894|FG005|Overall Study|AESI|0|||
42213232|NCT02908074|76028889|FG000|Overall Study|Discontinuation criteria per protocol|0|||
42213233|NCT02908074|76028890|FG001|Overall Study|Discontinuation criteria per protocol|0|||
42213234|NCT02908074|76028891|FG002|Overall Study|Discontinuation criteria per protocol|1|||
42213235|NCT02908074|76028892|FG003|Overall Study|Discontinuation criteria per protocol|0|||
42213236|NCT02908074|76028893|FG004|Overall Study|Discontinuation criteria per protocol|0|||
42213237|NCT02908074|76028894|FG005|Overall Study|Discontinuation criteria per protocol|1|||
42213238|NCT02908074|76028889|FG000|Overall Study|Withdrawal by Subject|3|||
42301837|NCT02501161|76136986|FG001|Overall Study|Adverse Event|6|||
42213239|NCT02908074|76028890|FG001|Overall Study|Withdrawal by Subject|2|||
42213240|NCT02908074|76028891|FG002|Overall Study|Withdrawal by Subject|2|||
42301838|NCT02501161|76136985|FG000|Overall Study|Lost to Follow-up|7|||
42213241|NCT02908074|76028892|FG003|Overall Study|Withdrawal by Subject|2|||
42213242|NCT02908074|76028893|FG004|Overall Study|Withdrawal by Subject|2|||
42301839|NCT02501161|76136986|FG001|Overall Study|Lost to Follow-up|4|||
42213243|NCT02908074|76028894|FG005|Overall Study|Withdrawal by Subject|2|||
42213244|NCT02908074|76028889|FG000|Overall Study|Lost to Follow-up|0|||
42213245|NCT02908074|76028890|FG001|Overall Study|Lost to Follow-up|1|||
42213246|NCT02908074|76028891|FG002|Overall Study|Lost to Follow-up|1|||
42213247|NCT02908074|76028892|FG003|Overall Study|Lost to Follow-up|1|||
42213248|NCT02908074|76028893|FG004|Overall Study|Lost to Follow-up|0|||
42213249|NCT02908074|76028894|FG005|Overall Study|Lost to Follow-up|1|||
42213250|NCT02907359|76028913|FG000|Overall Study|Death|234|||
42213251|NCT02907359|76028914|FG001|Overall Study|Death|117|||
42213252|NCT02907359|76028913|FG000|Overall Study|Withdrawal by Subject|6|||
42213253|NCT02907359|76028914|FG001|Overall Study|Withdrawal by Subject|11|||
42213254|NCT02907359|76028913|FG000|Overall Study|Lost to Follow-up|1|||
42213255|NCT02907359|76028914|FG001|Overall Study|Lost to Follow-up|0|||
42213256|NCT02714205|76028922|FG000|Overall Study|Cannot tolerate medication|1|||
42213257|NCT02714205|76028923|FG001|Overall Study|Cannot tolerate medication|0|||
42213258|NCT02714205|76028922|FG000|Overall Study|Adverse Event|2|||
42213259|NCT02714205|76028923|FG001|Overall Study|Adverse Event|0|||
42213260|NCT02714205|76028922|FG000|Overall Study|Too busy|1|||
42213261|NCT02714205|76028923|FG001|Overall Study|Too busy|0|||
42213262|NCT02714205|76028922|FG000|Overall Study|Incomplete outcome data|0|||
42213263|NCT02714205|76028923|FG001|Overall Study|Incomplete outcome data|1|||
42213264|NCT00583752|76028947|FG000|Overall Study|Lost to Follow-up|5|||
42213265|NCT00583752|76028948|FG001|Overall Study|Lost to Follow-up|5|||
42213266|NCT03170154|76028966|FG000|Overall Study|Lost to Follow-up|4|||
42213267|NCT03170154|76028966|FG000|Overall Study|Death|2|||
42213268|NCT03170154|76028966|FG000|Overall Study|Withdrawal by Subject|2|||
42213269|NCT03518125|76028981|FG000|Overall Study|Lost to Follow-up|0|||
42213270|NCT03518125|76028982|FG001|Overall Study|Lost to Follow-up|2|||
42213271|NCT03518125|76028983|FG002|Overall Study|Lost to Follow-up|0|||
42213272|NCT03518125|76028984|FG003|Overall Study|Lost to Follow-up|0|||
42213273|NCT03518125|76028985|FG004|Overall Study|Lost to Follow-up|3|||
42213274|NCT03518125|76028986|FG005|Overall Study|Lost to Follow-up|5|||
42213275|NCT03518125|76028981|FG000|Overall Study|Physician Decision|0|||
42213276|NCT03518125|76028982|FG001|Overall Study|Physician Decision|1|||
42213277|NCT03518125|76028983|FG002|Overall Study|Physician Decision|0|||
42213278|NCT03518125|76028984|FG003|Overall Study|Physician Decision|0|||
42213279|NCT03518125|76028985|FG004|Overall Study|Physician Decision|0|||
42213280|NCT03518125|76028986|FG005|Overall Study|Physician Decision|0|||
42213281|NCT03518125|76028981|FG000|Overall Study|Withdrawal by Subject|1|||
42213282|NCT03518125|76028982|FG001|Overall Study|Withdrawal by Subject|1|||
42213283|NCT03518125|76028983|FG002|Overall Study|Withdrawal by Subject|0|||
42213284|NCT03518125|76028984|FG003|Overall Study|Withdrawal by Subject|1|||
42213285|NCT03518125|76028985|FG004|Overall Study|Withdrawal by Subject|1|||
42213286|NCT03518125|76028986|FG005|Overall Study|Withdrawal by Subject|3|||
42213287|NCT03518125|76028981|FG000|Overall Study|Missed Day 394 Visit|1|||
42213288|NCT03518125|76028982|FG001|Overall Study|Missed Day 394 Visit|0|||
42213289|NCT03518125|76028983|FG002|Overall Study|Missed Day 394 Visit|0|||
42213290|NCT03518125|76028984|FG003|Overall Study|Missed Day 394 Visit|0|||
42213291|NCT03518125|76028985|FG004|Overall Study|Missed Day 394 Visit|0|||
42213292|NCT03518125|76028986|FG005|Overall Study|Missed Day 394 Visit|0|||
42213293|NCT03169530|76029003|FG000|Overall Study|Study ended by NIH|15|||
42213294|NCT03169530|76029004|FG001|Overall Study|Study ended by NIH|17|||
42213295|NCT03478891|76029022|FG000|Overall Study|Enrolled, but product never administered|0|||
42213296|NCT03478891|76029023|FG001|Overall Study|Enrolled, but product never administered|0|||
42213297|NCT03478891|76029024|FG002|Overall Study|Enrolled, but product never administered|1|||
42213298|NCT03478891|76029022|FG000|Overall Study|Moved from area|0|||
42213299|NCT03478891|76029023|FG001|Overall Study|Moved from area|0|||
42213300|NCT03478891|76029024|FG002|Overall Study|Moved from area|1|||
42213301|NCT03478891|76029022|FG000|Overall Study|Lost to Follow-up|1|||
42213302|NCT03478891|76029023|FG001|Overall Study|Lost to Follow-up|0|||
42213303|NCT03478891|76029024|FG002|Overall Study|Lost to Follow-up|1|||
42213304|NCT01585103|76029036|FG000|Overall Study|Unable to swallow Cytosponge|6|||
42213305|NCT03168906|76029042|FG000|Overall Study|Lack of Efficacy|6|||
42213306|NCT03168906|76029043|FG001|Overall Study|Lack of Efficacy|6|||
42213307|NCT00706966|76029050|FG000|Overall Study|Adverse Event|1|||
42213308|NCT03478657|76029084|FG000|Overall Study|Withdrawal by Subject|0|||
42213309|NCT03478657|76029085|FG001|Overall Study|Withdrawal by Subject|1|||
42213310|NCT03515941|76029093|FG000|Overall Study|Adverse Event|1|||
42213311|NCT03515941|76029094|FG001|Overall Study|Adverse Event|0|||
42213312|NCT03011034|76029102|FG000|Overall Study|Adverse Event|1|||
42213313|NCT03011034|76029103|FG001|Overall Study|Adverse Event|0|||
42213314|NCT03515629|76029111|FG000|Overall Study|Death|0|||
42213315|NCT03515629|76029112|FG001|Overall Study|Death|1|||
42213316|NCT03515629|76029113|FG002|Overall Study|Death|1|||
42213317|NCT03515629|76029111|FG000|Overall Study|Progressive disease|0|||
42213318|NCT03515629|76029112|FG001|Overall Study|Progressive disease|1|||
42213319|NCT03515629|76029113|FG002|Overall Study|Progressive disease|0|||
42213320|NCT03512353|76029122|FG000|Overall Study|Sponsor Decision|3|||
42213321|NCT03512353|76029122|FG000|Overall Study|Death|1|||
42213322|NCT03512275|76029130|FG000|Overall Study|Withdrawal by Subject|1|||
42213323|NCT03512275|76029131|FG001|Overall Study|Withdrawal by Subject|3|||
42213324|NCT03512275|76029130|FG000|Overall Study|Physician Decision|0|||
42213325|NCT03512275|76029131|FG001|Overall Study|Physician Decision|1|||
42213326|NCT03512275|76029130|FG000|Overall Study|Lost to Follow-up|0|||
42213327|NCT03512275|76029131|FG001|Overall Study|Lost to Follow-up|3|||
42213328|NCT03512275|76029130|FG000|Overall Study|Other|1|||
42213329|NCT03512275|76029131|FG001|Overall Study|Other|0|||
42213330|NCT03473197|76029137|FG000|Overall Study|Adverse Event|4|||
42213331|NCT03473197|76029137|FG000|Overall Study|Lost to Follow-up|1|||
42213332|NCT03473197|76029137|FG000|Overall Study|Withdrawal by Subject|5|||
42213333|NCT03511105|76029143|FG000|Overall Study|Adverse Event|1|||
42213334|NCT03511105|76029144|FG001|Overall Study|Adverse Event|0|||
42213335|NCT03511105|76029143|FG000|Overall Study|Withdrew consent|1|||
42213336|NCT03511105|76029144|FG001|Overall Study|Withdrew consent|0|||
42213337|NCT03510715|76029164|FG000|Overall Study|Adverse Event|1|||
42213338|NCT03510715|76029165|FG001|Overall Study|Adverse Event|0|||
42213339|NCT03508843|76029172|FG000|Overall Study|Withdrawal by Subject|1|||
42213340|NCT03508843|76029172|FG000|Overall Study|technical difficulties|2|||
42213341|NCT03508609|76029176|FG000|Overall Study|Withdrawal by Subject|1|||
42213342|NCT03054350|76029186|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
42213343|NCT03054350|76029187|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
42213344|NCT03054350|76029188|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
42213345|NCT03054350|76029189|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
42213346|NCT03054350|76029190|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
42213347|NCT03054350|76029191|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
42213348|NCT03054350|76029186|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
42213349|NCT03054350|76029187|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
42213350|NCT03054350|76029188|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
42301840|NCT02501161|76136985|FG000|Overall Study|Withdrawal by Subject|10|||
42301841|NCT02501161|76136986|FG001|Overall Study|Withdrawal by Subject|15|||
41976082|NCT04453202|75779011|FG006|Overall Study|Death|0|||
41976083|NCT04453202|75779012|FG007|Overall Study|Death|0|||
41976084|NCT04453202|75779013|FG008|Overall Study|Death|0|||
41976085|NCT04453202|75779014|FG009|Overall Study|Death|1|||
41976086|NCT04453202|75779015|FG010|Overall Study|Death|0|||
41976087|NCT04453202|75779005|FG000|Overall Study|Lost to Follow-up|0|||
41976088|NCT04453202|75779006|FG001|Overall Study|Lost to Follow-up|1|||
41976089|NCT04453202|75779007|FG002|Overall Study|Lost to Follow-up|0|||
41976090|NCT04453202|75779008|FG003|Overall Study|Lost to Follow-up|1|||
41976091|NCT04453202|75779009|FG004|Overall Study|Lost to Follow-up|0|||
41976092|NCT04453202|75779010|FG005|Overall Study|Lost to Follow-up|0|||
41976093|NCT04453202|75779011|FG006|Overall Study|Lost to Follow-up|0|||
41976094|NCT04453202|75779012|FG007|Overall Study|Lost to Follow-up|0|||
41976095|NCT04453202|75779013|FG008|Overall Study|Lost to Follow-up|0|||
41976096|NCT04453202|75779014|FG009|Overall Study|Lost to Follow-up|1|||
41976097|NCT04453202|75779015|FG010|Overall Study|Lost to Follow-up|1|||
41976098|NCT04453202|75779005|FG000|Overall Study|Withdrawal by Subject|1|||
41976099|NCT04453202|75779006|FG001|Overall Study|Withdrawal by Subject|2|||
41976100|NCT04453202|75779007|FG002|Overall Study|Withdrawal by Subject|1|||
41976101|NCT04453202|75779008|FG003|Overall Study|Withdrawal by Subject|2|||
41976102|NCT04453202|75779009|FG004|Overall Study|Withdrawal by Subject|1|||
41976103|NCT04453202|75779010|FG005|Overall Study|Withdrawal by Subject|1|||
42028407|NCT00910858|75836848|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
42028408|NCT00910858|75836849|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
42028409|NCT00910858|75836850|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
42028410|NCT00910858|75836848|FG000|Monotherapy Phase|Protocol Violation|1|||
42028411|NCT00910858|75836849|FG001|Monotherapy Phase|Protocol Violation|0|||
42028412|NCT00910858|75836850|FG002|Monotherapy Phase|Protocol Violation|0|||
42128160|NCT00518882|75938780|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
42128161|NCT00518882|75938781|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
42128162|NCT00518882|75938780|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
42128163|NCT00518882|75938781|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
42128164|NCT00518882|75938780|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
42128165|NCT00518882|75938781|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
42128166|NCT00518882|75938780|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
42128167|NCT00518882|75938781|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
42128168|NCT00518882|75938780|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
42128169|NCT00518882|75938781|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
42128170|NCT00518882|75938780|FG000|Double-Blind, Week 0-26|Subject decision|1|||
42128171|NCT00518882|75938781|FG001|Double-Blind, Week 0-26|Subject decision|1|||
42301842|NCT02501161|76136985|FG000|Overall Study|Other|3|||
41976104|NCT04453202|75779011|FG006|Overall Study|Withdrawal by Subject|0|||
42028413|NCT00910858|75836848|FG000|Monotherapy Phase|Other|3|||
42128172|NCT00518882|75938780|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
42301843|NCT02501161|76136986|FG001|Overall Study|Other|0|||
42301844|NCT02500537|76136994|FG000|Overall Study|Death|2|||
42301845|NCT02500537|76136995|FG001|Overall Study|Death|0|||
42301846|NCT02500537|76136994|FG000|Overall Study|Lost to Follow-up|0|||
42301847|NCT02500537|76136995|FG001|Overall Study|Lost to Follow-up|1|||
42301848|NCT02500537|76136994|FG000|Overall Study|Withdrawal by Subject|1|||
42301849|NCT02500537|76136995|FG001|Overall Study|Withdrawal by Subject|0|||
42301850|NCT02498821|76137004|FG000|Overall Study|Screen failure|3|||
42301851|NCT02498821|76137005|FG001|Overall Study|Screen failure|5|||
42301852|NCT02313909|76137013|FG000|Overall Study|Consent withdrawn by participant|33|||
42301853|NCT02313909|76137014|FG001|Overall Study|Consent withdrawn by participant|33|||
42301854|NCT02313909|76137013|FG000|Overall Study|Lost to Follow-up|24|||
42301855|NCT02313909|76137014|FG001|Overall Study|Lost to Follow-up|17|||
42301856|NCT02287467|76137022|FG000|Overall Study|Protocol Violation|12|||
42213351|NCT03054350|76029189|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
42213352|NCT03054350|76029190|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
42213353|NCT03054350|76029191|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
42213354|NCT03054350|76029186|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
42213355|NCT03054350|76029187|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
42213356|NCT03054350|76029188|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
42213357|NCT03054350|76029189|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
42213358|NCT03054350|76029190|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
42213359|NCT03054350|76029191|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
42213360|NCT03054350|76029186|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
42213361|NCT03054350|76029187|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
42213362|NCT03054350|76029188|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
42213363|NCT03054350|76029189|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
42213364|NCT03054350|76029190|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
42213365|NCT03054350|76029191|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
42213366|NCT03528577|76029222|FG000|Sequence 1|Failed Spirometry|1|||
42213367|NCT03528577|76029222|FG000|Sequence 1|Restricted medication|1|||
42213368|NCT03528577|76029222|FG000|Sequence 2|Adverse Event|1|||
42213369|NCT03528577|76029222|FG000|Sequence 2|Withdrawal by Subject|1|||
42213370|NCT03528577|76029222|FG000|Sequence 2|Failed Spirometry|1|||
42213371|NCT03528577|76029222|FG000|Sequence 3|Failed Spirometry|1|||
42213372|NCT03528577|76029222|FG000|Sequence 4|Failed Spirometry|2|||
42213373|NCT03528577|76029222|FG000|Sequence 4|Adverse Event|1|||
42213374|NCT00706654|76029232|FG000|Conversion Phase|Lost to Follow-up|4|||
42213375|NCT00706654|76029233|FG001|Conversion Phase|Lost to Follow-up|0|||
42213376|NCT00706654|76029234|FG002|Conversion Phase|Lost to Follow-up|0|||
42213377|NCT00706654|76029235|FG003|Conversion Phase|Lost to Follow-up|0|||
42213378|NCT00706654|76029232|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
42213379|NCT00706654|76029233|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
42213380|NCT00706654|76029234|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
42213381|NCT00706654|76029235|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
42213382|NCT00706654|76029232|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
41976105|NCT04453202|75779012|FG007|Overall Study|Withdrawal by Subject|0|||
42213383|NCT00706654|76029233|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
42213384|NCT00706654|76029234|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
42213385|NCT00706654|76029235|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
42213386|NCT00706654|76029232|FG000|Conversion Phase|Withdrawn by Investigator|14|||
42213387|NCT00706654|76029233|FG001|Conversion Phase|Withdrawn by Investigator|0|||
42213388|NCT00706654|76029234|FG002|Conversion Phase|Withdrawn by Investigator|0|||
42213389|NCT00706654|76029235|FG003|Conversion Phase|Withdrawn by Investigator|0|||
42213390|NCT00706654|76029232|FG000|Conversion Phase|Withdrew Consent|38|||
42213391|NCT00706654|76029233|FG001|Conversion Phase|Withdrew Consent|0|||
42213392|NCT00706654|76029234|FG002|Conversion Phase|Withdrew Consent|0|||
41976106|NCT04453202|75779013|FG008|Overall Study|Withdrawal by Subject|0|||
41976107|NCT04453202|75779014|FG009|Overall Study|Withdrawal by Subject|1|||
41976108|NCT04453202|75779015|FG010|Overall Study|Withdrawal by Subject|0|||
41976109|NCT04453202|75779005|FG000|Overall Study|Adverse Event|0|||
41976110|NCT04453202|75779006|FG001|Overall Study|Adverse Event|0|||
41976111|NCT04453202|75779007|FG002|Overall Study|Adverse Event|0|||
42213393|NCT00706654|76029235|FG003|Conversion Phase|Withdrew Consent|0|||
42301857|NCT02287467|76137023|FG001|Overall Study|Protocol Violation|9|||
42301858|NCT02287233|76137035|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
41976112|NCT04453202|75779008|FG003|Overall Study|Adverse Event|0|||
42213394|NCT00706654|76029232|FG000|Conversion Phase|Adverse Event|18|||
42213395|NCT00706654|76029233|FG001|Conversion Phase|Adverse Event|0|||
42213396|NCT00706654|76029234|FG002|Conversion Phase|Adverse Event|0|||
42213397|NCT00706654|76029235|FG003|Conversion Phase|Adverse Event|0|||
42213398|NCT00706654|76029232|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
42301859|NCT02287233|76137036|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
41976113|NCT04453202|75779009|FG004|Overall Study|Adverse Event|0|||
41976114|NCT04453202|75779010|FG005|Overall Study|Adverse Event|1|||
41976115|NCT04453202|75779011|FG006|Overall Study|Adverse Event|0|||
41976116|NCT04453202|75779012|FG007|Overall Study|Adverse Event|0|||
41976117|NCT04453202|75779013|FG008|Overall Study|Adverse Event|0|||
41976118|NCT04453202|75779014|FG009|Overall Study|Adverse Event|0|||
41976119|NCT04453202|75779015|FG010|Overall Study|Adverse Event|0|||
41976120|NCT04436289|75779043|FG000|Overall Study|Death prior to hospital discharge|8|||
41976121|NCT04436289|75779044|FG001|Overall Study|Death prior to hospital discharge|5|||
41976122|NCT04436289|75779045|FG002|Overall Study|Death prior to hospital discharge|0|||
41976123|NCT04436289|75779046|FG003|Overall Study|Death prior to hospital discharge|1|||
41976124|NCT04436289|75779043|FG000|Overall Study|Withdrawal by Subject|0|||
41976125|NCT04436289|75779044|FG001|Overall Study|Withdrawal by Subject|1|||
41976126|NCT04436289|75779045|FG002|Overall Study|Withdrawal by Subject|4|||
41976127|NCT04436289|75779046|FG003|Overall Study|Withdrawal by Subject|0|||
41976128|NCT04436289|75779043|FG000|Overall Study|Extended hospital stay|0|||
41976129|NCT04436289|75779044|FG001|Overall Study|Extended hospital stay|1|||
41976130|NCT04436289|75779045|FG002|Overall Study|Extended hospital stay|0|||
41976131|NCT04436289|75779046|FG003|Overall Study|Extended hospital stay|0|||
41976132|NCT04436289|75779043|FG000|Overall Study|Lost to Follow-up|0|||
41976133|NCT04436289|75779044|FG001|Overall Study|Lost to Follow-up|4|||
41976134|NCT04436289|75779045|FG002|Overall Study|Lost to Follow-up|1|||
41976135|NCT04436289|75779046|FG003|Overall Study|Lost to Follow-up|3|||
41976136|NCT04396795|75779061|FG000|Month 1|Lost to Follow-up|2|||
41976137|NCT04396795|75779062|FG001|Month 1|Lost to Follow-up|3|||
41976138|NCT04396795|75779061|FG000|Month 3|Lost to Follow-up|1|||
41976139|NCT04396795|75779062|FG001|Month 3|Lost to Follow-up|3|||
41976140|NCT04396795|75779061|FG000|Month 6|Lost to Follow-up|3|||
41976141|NCT04396795|75779062|FG001|Month 6|Lost to Follow-up|3|||
41976142|NCT04211766|75779070|FG000|Overall Study|Withdrawal by Subject|5|||
41976143|NCT04211766|75779071|FG001|Overall Study|Withdrawal by Subject|1|||
41976144|NCT03773562|75779119|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
41976145|NCT03773562|75779119|FG000|Overall Study|Lost to Follow-up|10|||
41976146|NCT03773562|75779119|FG000|Overall Study|Withdrawal by Subject|1|||
41976147|NCT03706456|75779132|FG000|Overall Study|Lack of Efficacy|1|||
41976148|NCT03706456|75779132|FG000|Overall Study|Ongoing|21|||
41976149|NCT03599141|75779146|FG000|Overall Study|Lost to Follow-up|3|||
41976150|NCT03599141|75779147|FG001|Overall Study|Lost to Follow-up|1|||
41976151|NCT03525678|75779156|FG000|Overall Study|Withdrawal by Subject|8|||
41976152|NCT03525678|75779157|FG001|Overall Study|Withdrawal by Subject|2|||
41976153|NCT03525678|75779158|FG002|Overall Study|Withdrawal by Subject|2|||
41976154|NCT03525678|75779156|FG000|Overall Study|Physician Decision|2|||
41976155|NCT03525678|75779157|FG001|Overall Study|Physician Decision|4|||
41976156|NCT03525678|75779158|FG002|Overall Study|Physician Decision|0|||
41976157|NCT03525678|75779156|FG000|Overall Study|Lost to Follow-up|2|||
41976158|NCT03525678|75779157|FG001|Overall Study|Lost to Follow-up|1|||
41976159|NCT03525678|75779158|FG002|Overall Study|Lost to Follow-up|2|||
41976160|NCT03525678|75779156|FG000|Overall Study|Death|70|||
41976161|NCT03525678|75779157|FG001|Overall Study|Death|80|||
41976162|NCT03525678|75779158|FG002|Overall Study|Death|16|||
41976163|NCT03525678|75779156|FG000|Overall Study|other reasons|14|||
41976164|NCT03525678|75779157|FG001|Overall Study|other reasons|10|||
41976165|NCT03525678|75779158|FG002|Overall Study|other reasons|5|||
41976166|NCT03525678|75779156|FG000|Overall Study|ongoing at the time of analysis|1|||
41976167|NCT03525678|75779157|FG001|Overall Study|ongoing at the time of analysis|2|||
41976168|NCT03525678|75779158|FG002|Overall Study|ongoing at the time of analysis|0|||
41976169|NCT03439514|75779181|FG000|Double-Blind Treatment Period|Other|4|||
41976170|NCT03439514|75779182|FG001|Double-Blind Treatment Period|Other|1|||
41976171|NCT03439514|75779181|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
41976172|NCT03439514|75779182|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
41976173|NCT03439514|75779181|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
41976174|NCT03439514|75779182|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
41976175|NCT03439514|75779181|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
41976176|NCT03439514|75779182|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
41976177|NCT03439514|75779181|FG000|Double-Blind Treatment Period|Death|1|||
42213399|NCT00706654|76029233|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
42213400|NCT00706654|76029234|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
42213401|NCT00706654|76029235|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
41976178|NCT03439514|75779182|FG001|Double-Blind Treatment Period|Death|2|||
41976179|NCT03272828|75779194|FG000|Overall Study|Lost to Follow-up|7|||
41976180|NCT03272828|75779195|FG001|Overall Study|Lost to Follow-up|7|||
41976181|NCT03272828|75779194|FG000|Overall Study|Withdrawal by Subject|2|||
41976182|NCT03272828|75779195|FG001|Overall Study|Withdrawal by Subject|0|||
41976183|NCT03272828|75779194|FG000|Overall Study|Deceased|1|||
41976184|NCT03272828|75779195|FG001|Overall Study|Deceased|1|||
41976185|NCT03272828|75779194|FG000|Overall Study|Failed implant|1|||
41976186|NCT03272828|75779195|FG001|Overall Study|Failed implant|2|||
41976187|NCT03250273|75779207|FG000|Overall Study|Disease Progression|2|||
42213402|NCT00706654|76029232|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
42213403|NCT00706654|76029233|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
42213404|NCT00706654|76029234|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
42213405|NCT00706654|76029235|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
42213406|NCT00706654|76029232|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
42213407|NCT00706654|76029233|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
42213408|NCT00706654|76029234|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
42213409|NCT00706654|76029235|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
42213410|NCT00706654|76029232|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
42213411|NCT00706654|76029233|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
42213412|NCT00706654|76029234|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
42213413|NCT00706654|76029235|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
42213414|NCT00706654|76029232|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
42213415|NCT00706654|76029233|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
42213416|NCT00706654|76029234|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
42213417|NCT00706654|76029235|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
42213418|NCT00706654|76029232|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
41976188|NCT03250273|75779208|FG001|Overall Study|Disease Progression|11|||
41976189|NCT03250273|75779207|FG000|Overall Study|Death|0|||
41976190|NCT03250273|75779208|FG001|Overall Study|Death|1|||
41976191|NCT03122886|75779227|FG000|Overall Study|Withdrawal by Subject|1|||
41976192|NCT03122886|75779228|FG001|Overall Study|Withdrawal by Subject|2|||
41976193|NCT02910401|75779242|FG000|Overall Study|Study closure Study closure|0|||
41976194|NCT02910401|75779243|FG001|Overall Study|Study closure Study closure|0|||
41976195|NCT02910401|75779244|FG002|Overall Study|Study closure Study closure|2|||
41976196|NCT02910401|75779242|FG000|Overall Study|Physician Decision|1|||
41976197|NCT02910401|75779243|FG001|Overall Study|Physician Decision|0|||
41976198|NCT02910401|75779244|FG002|Overall Study|Physician Decision|0|||
41976199|NCT02864953|75779254|FG000|Overall Study|Adverse Event|22|||
41976200|NCT02864953|75779255|FG001|Overall Study|Adverse Event|19|||
41976201|NCT02864953|75779254|FG000|Overall Study|Withdrawal by Subject|1|||
41976202|NCT02864953|75779255|FG001|Overall Study|Withdrawal by Subject|0|||
41976203|NCT02864953|75779254|FG000|Overall Study|Physician Decision|4|||
41976204|NCT02864953|75779255|FG001|Overall Study|Physician Decision|2|||
41976205|NCT02864953|75779254|FG000|Overall Study|Death|3|||
41976206|NCT02864953|75779255|FG001|Overall Study|Death|13|||
41976207|NCT02864953|75779254|FG000|Overall Study|Reason not specified|14|||
41976208|NCT02864953|75779255|FG001|Overall Study|Reason not specified|12|||
41976209|NCT02864953|75779254|FG000|Overall Study|Withdrew Prior to Dosing|9|||
41976210|NCT02864953|75779255|FG001|Overall Study|Withdrew Prior to Dosing|8|||
41976211|NCT02609503|75779283|FG000|Overall Study|Adverse Event|1|||
41976212|NCT02609503|75779283|FG000|Overall Study|Death|1|||
41976213|NCT02609503|75779283|FG000|Overall Study|Withdrawal by Subject|1|||
41976214|NCT02609503|75779283|FG000|Overall Study|Disease progression|1|||
41976215|NCT02437110|75779315|FG000|Screening|Lost to Follow-up|3|||
41976216|NCT02437110|75779315|FG000|Screening|Physician Decision|1|||
41976217|NCT02437110|75779315|FG000|ART|Adverse Event|3|||
42213419|NCT00706654|76029233|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
41976218|NCT02437110|75779315|FG000|ART|Protocol Violation|3|||
42128173|NCT00518882|75938781|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
41976219|NCT02437110|75779315|FG000|ART|Withdrawal by Subject|4|||
41976220|NCT02437110|75779315|FG000|ART|Lost to follow-up prior to start of intervention|1|||
41976221|NCT02437110|75779315|FG000|ART|Physician decision prior to start of intervention|2|||
42128174|NCT00518882|75938780|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
42128175|NCT00518882|75938781|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
42128176|NCT00518882|75938780|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
42128177|NCT00518882|75938781|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
42128178|NCT00518882|75938780|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
42128179|NCT00518882|75938781|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
41976222|NCT02437110|75779315|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
41976223|NCT02437110|75779315|FG000|Post-ART|Lost to Follow-up|3|||
41976224|NCT02437110|75779315|FG000|Post-ART|Protocol Violation|4|||
42128180|NCT00518882|75938780|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
42128181|NCT00518882|75938781|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
42213420|NCT00706654|76029234|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
42213421|NCT00706654|76029235|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
42213422|NCT00706654|76029232|FG000|Oral Stabilization Phase|Withdrew consent|55|||
42213423|NCT00706654|76029233|FG001|Oral Stabilization Phase|Withdrew consent|0|||
42213424|NCT00706654|76029234|FG002|Oral Stabilization Phase|Withdrew consent|0|||
42213425|NCT00706654|76029235|FG003|Oral Stabilization Phase|Withdrew consent|0|||
42213426|NCT00706654|76029232|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
42213427|NCT00706654|76029233|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
42213428|NCT00706654|76029234|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
42213429|NCT00706654|76029235|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
42213430|NCT00706654|76029232|FG000|Oral Stabilization Phase|Adverse Event|21|||
42213431|NCT00706654|76029233|FG001|Oral Stabilization Phase|Adverse Event|0|||
42213432|NCT00706654|76029234|FG002|Oral Stabilization Phase|Adverse Event|0|||
42213433|NCT00706654|76029235|FG003|Oral Stabilization Phase|Adverse Event|0|||
42213434|NCT00706654|76029232|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
42213435|NCT00706654|76029233|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
42213436|NCT00706654|76029234|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
42213437|NCT00706654|76029235|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
42213438|NCT00706654|76029232|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
41976225|NCT02437110|75779315|FG000|Post-ART|Withdrawal by Subject|3|||
42213439|NCT00706654|76029233|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
42213440|NCT00706654|76029234|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
42213441|NCT00706654|76029235|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
41976226|NCT02268851|75779327|FG000|Overall Study|Death|0|||
41976227|NCT02268851|75779328|FG001|Overall Study|Death|0|||
41976228|NCT02268851|75779329|FG002|Overall Study|Death|0|||
41976229|NCT02268851|75779330|FG003|Overall Study|Death|1|||
41976230|NCT02268851|75779331|FG004|Overall Study|Death|2|||
41976231|NCT02268851|75779332|FG005|Overall Study|Death|1|||
41976232|NCT02268851|75779327|FG000|Overall Study|Adverse Event|0|||
41976233|NCT02268851|75779328|FG001|Overall Study|Adverse Event|0|||
41976234|NCT02268851|75779329|FG002|Overall Study|Adverse Event|0|||
41976235|NCT02268851|75779330|FG003|Overall Study|Adverse Event|0|||
41976236|NCT02268851|75779331|FG004|Overall Study|Adverse Event|2|||
41976237|NCT02268851|75779332|FG005|Overall Study|Adverse Event|2|||
41976238|NCT02268851|75779327|FG000|Overall Study|Withdrawal by Subject|0|||
41976239|NCT02268851|75779328|FG001|Overall Study|Withdrawal by Subject|0|||
41976240|NCT02268851|75779329|FG002|Overall Study|Withdrawal by Subject|0|||
41976241|NCT02268851|75779330|FG003|Overall Study|Withdrawal by Subject|2|||
41976242|NCT02268851|75779331|FG004|Overall Study|Withdrawal by Subject|0|||
41976243|NCT02268851|75779332|FG005|Overall Study|Withdrawal by Subject|1|||
41976244|NCT02268851|75779327|FG000|Overall Study|Progressive Disease|1|||
41976245|NCT02268851|75779328|FG001|Overall Study|Progressive Disease|3|||
41976246|NCT02268851|75779329|FG002|Overall Study|Progressive Disease|0|||
41976247|NCT02268851|75779330|FG003|Overall Study|Progressive Disease|0|||
41976248|NCT02268851|75779331|FG004|Overall Study|Progressive Disease|1|||
41976249|NCT02268851|75779332|FG005|Overall Study|Progressive Disease|4|||
41976250|NCT02268851|75779327|FG000|Overall Study|Physician Decision|0|||
41976251|NCT02268851|75779328|FG001|Overall Study|Physician Decision|0|||
41976252|NCT02268851|75779329|FG002|Overall Study|Physician Decision|1|||
41976253|NCT02268851|75779330|FG003|Overall Study|Physician Decision|0|||
41976254|NCT02268851|75779331|FG004|Overall Study|Physician Decision|0|||
41976255|NCT02268851|75779332|FG005|Overall Study|Physician Decision|1|||
41976256|NCT02268851|75779327|FG000|Overall Study|Patient Compliance|0|||
41976257|NCT02268851|75779328|FG001|Overall Study|Patient Compliance|0|||
41976258|NCT02268851|75779329|FG002|Overall Study|Patient Compliance|0|||
41976259|NCT02268851|75779330|FG003|Overall Study|Patient Compliance|0|||
41976260|NCT02268851|75779331|FG004|Overall Study|Patient Compliance|1|||
41976261|NCT02268851|75779332|FG005|Overall Study|Patient Compliance|1|||
41976262|NCT02268851|75779327|FG000|Overall Study|Co-Morbid Condition|0|||
41976263|NCT02268851|75779328|FG001|Overall Study|Co-Morbid Condition|0|||
41976264|NCT02268851|75779329|FG002|Overall Study|Co-Morbid Condition|0|||
41976265|NCT02268851|75779330|FG003|Overall Study|Co-Morbid Condition|0|||
41976266|NCT02268851|75779331|FG004|Overall Study|Co-Morbid Condition|1|||
41976267|NCT02268851|75779332|FG005|Overall Study|Co-Morbid Condition|1|||
41976268|NCT02136134|75779348|FG000|Overall Study|Death|170|||
41976269|NCT02136134|75779349|FG001|Overall Study|Death|148|||
42213442|NCT00706654|76029232|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
42213443|NCT00706654|76029233|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
42213444|NCT00706654|76029234|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
42213445|NCT00706654|76029235|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
42213446|NCT00706654|76029232|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
42213447|NCT00706654|76029233|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
42213448|NCT00706654|76029234|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
41976270|NCT02136134|75779348|FG000|Overall Study|Withdrawal by Subject|19|||
41976271|NCT02136134|75779349|FG001|Overall Study|Withdrawal by Subject|10|||
41976272|NCT02136134|75779348|FG000|Overall Study|Lost to Follow-up|3|||
41976273|NCT02136134|75779349|FG001|Overall Study|Lost to Follow-up|3|||
41976274|NCT02136134|75779348|FG000|Overall Study|Uspecified|55|||
41976275|NCT02136134|75779349|FG001|Overall Study|Uspecified|90|||
41976276|NCT01846663|75779358|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
41976277|NCT01846663|75779359|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
41976278|NCT01846663|75779358|FG000|Overall Study|Withdrawal by Subject|1|||
41976279|NCT01846663|75779359|FG001|Overall Study|Withdrawal by Subject|0|||
41976280|NCT01846663|75779358|FG000|Overall Study|Adverse Event|1|||
41976281|NCT01846663|75779359|FG001|Overall Study|Adverse Event|2|||
41976282|NCT01659151|75779365|FG000|Overall Study|Inadequate TIL growth|1|||
41976283|NCT04847141|75779486|FG000|Overall Study|Adverse Event|1|||
41976284|NCT04847141|75779487|FG001|Overall Study|Adverse Event|0|||
41976285|NCT04847141|75779488|FG002|Overall Study|Adverse Event|1|||
41976286|NCT04847141|75779486|FG000|Overall Study|Withdrawal by Subject|2|||
41976287|NCT04847141|75779487|FG001|Overall Study|Withdrawal by Subject|4|||
41976288|NCT04847141|75779488|FG002|Overall Study|Withdrawal by Subject|3|||
41976289|NCT04847141|75779486|FG000|Overall Study|Lost to Follow-up|7|||
41976290|NCT04847141|75779487|FG001|Overall Study|Lost to Follow-up|5|||
41976291|NCT04847141|75779488|FG002|Overall Study|Lost to Follow-up|7|||
41976292|NCT04847141|75779486|FG000|Overall Study|Reason not Specified|0|||
41976293|NCT04847141|75779487|FG001|Overall Study|Reason not Specified|1|||
41976294|NCT04847141|75779488|FG002|Overall Study|Reason not Specified|0|||
41976295|NCT01349829|75779498|FG000|Overall Study|Lost to Follow-up|4|||
42301860|NCT02287233|76137037|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
41976296|NCT01349829|75779499|FG001|Overall Study|Lost to Follow-up|8|||
41976297|NCT01349829|75779498|FG000|Overall Study|Consent withdrawal|3|||
41976298|NCT01349829|75779499|FG001|Overall Study|Consent withdrawal|8|||
41976299|NCT01349829|75779498|FG000|Overall Study|Migrated/moved|2|||
41976300|NCT01349829|75779499|FG001|Overall Study|Migrated/moved|7|||
41976301|NCT01350128|75779507|FG000|Overall Study|Withdrawal by Subject|3|||
41976302|NCT01350128|75779507|FG000|Overall Study|Protocol discontinuation criteria|8|||
41976303|NCT01350128|75779507|FG000|Overall Study|Physician Decision|1|||
41976304|NCT01350128|75779507|FG000|Overall Study|Lost to Follow-up|2|||
41976305|NCT03893825|75779566|FG000|Overall Study|Death|2|||
41976306|NCT03893825|75779567|FG001|Overall Study|Death|1|||
41976307|NCT03893825|75779566|FG000|Overall Study|Adverse Event|0|||
41976308|NCT03893825|75779567|FG001|Overall Study|Adverse Event|2|||
41976309|NCT03893825|75779566|FG000|Overall Study|Withdrawal by Subject|19|||
41976310|NCT03893825|75779567|FG001|Overall Study|Withdrawal by Subject|21|||
41976311|NCT03893825|75779566|FG000|Overall Study|Protocol deviation|1|||
41976312|NCT03893825|75779567|FG001|Overall Study|Protocol deviation|0|||
41976313|NCT03893825|75779566|FG000|Overall Study|Lost to Follow-up|10|||
41976314|NCT03893825|75779567|FG001|Overall Study|Lost to Follow-up|10|||
41976315|NCT03893825|75779566|FG000|Overall Study|Other than specified|7|||
41976316|NCT03893825|75779567|FG001|Overall Study|Other than specified|6|||
41976317|NCT03890666|75779575|FG000|Overall Study|Withdrawal by Subject|0|||
41976318|NCT03890666|75779576|FG001|Overall Study|Withdrawal by Subject|1|||
41976319|NCT03890666|75779575|FG000|Overall Study|Protocol deviation|1|||
41976320|NCT03890666|75779576|FG001|Overall Study|Protocol deviation|4|||
41976321|NCT03890666|75779575|FG000|Overall Study|Lost to Follow-up|2|||
41976322|NCT03890666|75779576|FG001|Overall Study|Lost to Follow-up|5|||
41976323|NCT03890666|75779575|FG000|Overall Study|Other than specified|1|||
41976324|NCT03890666|75779576|FG001|Overall Study|Other than specified|8|||
41976325|NCT03090737|75779614|FG000|Overall Study|Other reasons|1|||
41976326|NCT03090737|75779614|FG000|Overall Study|Completed treatment as per protocol|17|||
41976327|NCT03090737|75779614|FG000|Overall Study|Maximum clinical benefit|2|||
41976328|NCT03090737|75779614|FG000|Overall Study|Adverse event unrelated to study drug|7|||
41976329|NCT03090737|75779614|FG000|Overall Study|Study drug toxicity|4|||
41976330|NCT03090737|75779614|FG000|Overall Study|Disease progression|98|||
41976331|NCT03004976|75779659|FG000|Overall Study|Lost to Follow-up|7|||
41976332|NCT03004976|75779660|FG001|Overall Study|Lost to Follow-up|5|||
41976333|NCT03004976|75779659|FG000|Overall Study|Physician Decision|1|||
41976334|NCT03004976|75779660|FG001|Overall Study|Physician Decision|0|||
41976335|NCT03004976|75779659|FG000|Overall Study|Withdrawal by Subject|1|||
41976336|NCT03004976|75779660|FG001|Overall Study|Withdrawal by Subject|0|||
41976337|NCT03004976|75779659|FG000|Overall Study|Death|4|||
41976338|NCT03004976|75779660|FG001|Overall Study|Death|1|||
42128182|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
42128183|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
42128184|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
42128185|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
41976339|NCT02985866|75779668|FG000|Overall Study|Poor CGM data|1|||
41976340|NCT02985866|75779669|FG001|Overall Study|Poor CGM data|1|||
41976341|NCT02762981|75779694|FG000|Overall Study|Adverse Event|2|||
41976342|NCT02762981|75779695|FG001|Overall Study|Adverse Event|3|||
41976343|NCT02762981|75779696|FG002|Overall Study|Adverse Event|1|||
41976344|NCT02762981|75779697|FG003|Overall Study|Adverse Event|1|||
41976345|NCT02762981|75779698|FG004|Overall Study|Adverse Event|3|||
41976346|NCT02762981|75779694|FG000|Overall Study|Physician Decision|0|||
41976347|NCT02762981|75779695|FG001|Overall Study|Physician Decision|1|||
41976348|NCT02762981|75779696|FG002|Overall Study|Physician Decision|0|||
41976349|NCT02762981|75779697|FG003|Overall Study|Physician Decision|0|||
41976350|NCT02762981|75779698|FG004|Overall Study|Physician Decision|1|||
41976351|NCT02762981|75779694|FG000|Overall Study|Disease progression|11|||
41976352|NCT02762981|75779695|FG001|Overall Study|Disease progression|23|||
41976353|NCT02762981|75779696|FG002|Overall Study|Disease progression|4|||
41976354|NCT02762981|75779697|FG003|Overall Study|Disease progression|10|||
41976355|NCT02762981|75779698|FG004|Overall Study|Disease progression|1|||
41976356|NCT02762981|75779694|FG000|Overall Study|Enrolled not treated|1|||
41976357|NCT02762981|75779695|FG001|Overall Study|Enrolled not treated|5|||
41976358|NCT02762981|75779696|FG002|Overall Study|Enrolled not treated|0|||
41976359|NCT02762981|75779697|FG003|Overall Study|Enrolled not treated|2|||
41976360|NCT02762981|75779698|FG004|Overall Study|Enrolled not treated|0|||
41976361|NCT02762981|75779694|FG000|Overall Study|Other|2|||
41976362|NCT02762981|75779695|FG001|Overall Study|Other|3|||
41976363|NCT02762981|75779696|FG002|Overall Study|Other|1|||
41976364|NCT02762981|75779697|FG003|Overall Study|Other|0|||
41976365|NCT02762981|75779698|FG004|Overall Study|Other|0|||
41976366|NCT02762981|75779694|FG000|Overall Study|Missing|1|||
42213449|NCT00706654|76029235|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
42213450|NCT00706654|76029232|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
42213451|NCT00706654|76029233|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
42213452|NCT00706654|76029234|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
42213453|NCT00706654|76029235|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
42213454|NCT00706654|76029232|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
42213455|NCT00706654|76029233|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
42213456|NCT00706654|76029234|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
42213457|NCT00706654|76029235|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
42213458|NCT00706654|76029232|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
42213459|NCT00706654|76029233|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
42213460|NCT00706654|76029234|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
42213461|NCT00706654|76029235|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
42213462|NCT00706654|76029232|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
42213463|NCT00706654|76029233|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
42213464|NCT00706654|76029234|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
42213465|NCT00706654|76029235|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
42213466|NCT00706654|76029232|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
42213467|NCT00706654|76029233|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
42213468|NCT00706654|76029234|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
42213469|NCT00706654|76029235|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
42213470|NCT00706654|76029232|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
42213471|NCT00706654|76029233|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
42213472|NCT00706654|76029234|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
42213473|NCT00706654|76029235|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
42213474|NCT03471871|76029247|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
42213475|NCT03471871|76029248|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
42213476|NCT03471871|76029249|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
42213477|NCT03471871|76029250|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
42213478|NCT03471871|76029251|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
42213479|NCT03471871|76029247|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
42213480|NCT03471871|76029248|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
42213481|NCT03471871|76029249|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
41976367|NCT02762981|75779695|FG001|Overall Study|Missing|0|||
41976368|NCT02762981|75779696|FG002|Overall Study|Missing|0|||
42213482|NCT03471871|76029250|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
42213483|NCT03471871|76029251|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
41976369|NCT02762981|75779697|FG003|Overall Study|Missing|0|||
41976370|NCT02762981|75779698|FG004|Overall Study|Missing|0|||
41976371|NCT02762981|75779694|FG000|Overall Study|Withdrawal by Subject|0|||
41976372|NCT02762981|75779695|FG001|Overall Study|Withdrawal by Subject|5|||
41976373|NCT02762981|75779696|FG002|Overall Study|Withdrawal by Subject|1|||
41976374|NCT02762981|75779697|FG003|Overall Study|Withdrawal by Subject|3|||
41976375|NCT02762981|75779698|FG004|Overall Study|Withdrawal by Subject|0|||
42213484|NCT03471871|76029247|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
42213485|NCT03471871|76029248|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
42213486|NCT03471871|76029249|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
42213487|NCT03471871|76029250|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
42213488|NCT03471871|76029251|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
42213489|NCT03471871|76029247|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
42213490|NCT03471871|76029248|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
42213491|NCT03471871|76029249|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
42213492|NCT03471871|76029250|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
42213493|NCT03471871|76029251|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
42213494|NCT03471871|76029247|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
42213495|NCT03471871|76029248|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
42213496|NCT03471871|76029249|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
42213497|NCT03471871|76029250|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
42213498|NCT03471871|76029251|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
42213499|NCT01957176|76029269|FG000|Overall Study|Adverse Event|2|||
42213500|NCT01957176|76029270|FG001|Overall Study|Adverse Event|0|||
42213501|NCT01957176|76029269|FG000|Overall Study|Physician Decision|2|||
42213502|NCT01957176|76029270|FG001|Overall Study|Physician Decision|1|||
42213503|NCT01957176|76029269|FG000|Overall Study|Withdrawal by Subject|1|||
42213504|NCT01957176|76029270|FG001|Overall Study|Withdrawal by Subject|0|||
42213505|NCT03527173|76029279|FG000|Overall Study|Lost to Follow-up|4|||
42213506|NCT03527173|76029280|FG001|Overall Study|Lost to Follow-up|2|||
42213507|NCT03527173|76029279|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
42213508|NCT03527173|76029280|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
42213509|NCT03527173|76029279|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
42213510|NCT03527173|76029280|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
42213511|NCT03527173|76029279|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
42213512|NCT03527173|76029280|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
42213513|NCT00707980|76029286|FG000|Overall Study|Adverse Event|49|||
42213514|NCT00707980|76029286|FG000|Overall Study|Lack of Efficacy|35|||
42213515|NCT00707980|76029286|FG000|Overall Study|Non-Compliance with Study Drug|28|||
42213516|NCT00707980|76029286|FG000|Overall Study|Protocol Deviations|19|||
42213517|NCT00707980|76029286|FG000|Overall Study|Withdrawal of Consent|81|||
42213518|NCT00707980|76029286|FG000|Overall Study|Lost to Follow-up|59|||
42213519|NCT00707980|76029286|FG000|Overall Study|Other|39|||
42213520|NCT03506425|76029293|FG000|Overall Study|Adverse Event|1|||
42213521|NCT03506425|76029294|FG001|Overall Study|Adverse Event|3|||
42213522|NCT03506425|76029295|FG002|Overall Study|Adverse Event|0|||
42213523|NCT03506425|76029293|FG000|Overall Study|Death|1|||
42213524|NCT03506425|76029294|FG001|Overall Study|Death|0|||
42213525|NCT03506425|76029295|FG002|Overall Study|Death|0|||
42213526|NCT03506425|76029293|FG000|Overall Study|Withdrawal by Subject|0|||
42213527|NCT03506425|76029294|FG001|Overall Study|Withdrawal by Subject|0|||
42213528|NCT03506425|76029295|FG002|Overall Study|Withdrawal by Subject|1|||
42213529|NCT03051620|76029304|FG000|Overall Study|Lost to Follow-up|6|||
42213530|NCT03051620|76029304|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
42213531|NCT03053492|76029310|FG000|Overall Study|Adverse Event|1|||
42213532|NCT03053492|76029311|FG001|Overall Study|Adverse Event|1|||
42213533|NCT03053492|76029310|FG000|Overall Study|Withdrawal by Subject|7|||
42213534|NCT03053492|76029311|FG001|Overall Study|Withdrawal by Subject|5|||
42213535|NCT03801707|76029317|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
42213536|NCT04239872|76029321|FG000|Overall Study|Lost to Follow-up|0|||
42213537|NCT04239872|76029322|FG001|Overall Study|Lost to Follow-up|1|||
42213538|NCT03164772|76029330|FG000|Overall Study|Death|4|||
42213539|NCT03164772|76029331|FG001|Overall Study|Death|2|||
42213540|NCT03164772|76029330|FG000|Overall Study|Adverse Event|1|||
42213541|NCT03164772|76029331|FG001|Overall Study|Adverse Event|4|||
42213542|NCT03164772|76029330|FG000|Overall Study|Progressive Disease|11|||
42213543|NCT03164772|76029331|FG001|Overall Study|Progressive Disease|21|||
42213544|NCT03164772|76029330|FG000|Overall Study|Physician Decision|2|||
42213545|NCT03164772|76029331|FG001|Overall Study|Physician Decision|0|||
42213546|NCT03164772|76029330|FG000|Overall Study|Withdrawal by Subject|0|||
42213547|NCT03164772|76029331|FG001|Overall Study|Withdrawal by Subject|4|||
42213548|NCT03050450|76029354|FG000|Overall Study|Physician Decision|1|||
42213549|NCT03050450|76029355|FG001|Overall Study|Physician Decision|0|||
42213550|NCT03050450|76029356|FG002|Overall Study|Physician Decision|0|||
42213551|NCT03050450|76029357|FG003|Overall Study|Physician Decision|0|||
42213552|NCT03050450|76029358|FG004|Overall Study|Physician Decision|0|||
42213553|NCT03505021|76029372|FG000|Overall Study|Protocol Violation|1|||
42213554|NCT03505021|76029373|FG001|Overall Study|Protocol Violation|0|||
42213555|NCT03505021|76029372|FG000|Overall Study|Death|9|||
42213556|NCT03505021|76029373|FG001|Overall Study|Death|8|||
42213557|NCT03505021|76029372|FG000|Overall Study|Consent withdrawn by subject|6|||
42213558|NCT03505021|76029373|FG001|Overall Study|Consent withdrawn by subject|1|||
42213559|NCT03505021|76029372|FG000|Overall Study|Lost to Follow-up|5|||
42213560|NCT03505021|76029373|FG001|Overall Study|Lost to Follow-up|3|||
42213561|NCT03505021|76029372|FG000|Overall Study|Adverse Event|26|||
42213562|NCT03505021|76029373|FG001|Overall Study|Adverse Event|9|||
42213563|NCT03505021|76029372|FG000|Overall Study|Disease progression|33|||
42213564|NCT03505021|76029373|FG001|Overall Study|Disease progression|17|||
42213565|NCT03505021|76029372|FG000|Overall Study|Other|11|||
42213566|NCT03505021|76029373|FG001|Overall Study|Other|5|||
42213567|NCT03505021|76029372|FG000|Overall Study|Personal reason|21|||
42213568|NCT03505021|76029373|FG001|Overall Study|Personal reason|12|||
42213569|NCT03050372|76029379|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
42213570|NCT03050372|76029380|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
42213571|NCT03050372|76029379|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
42213572|NCT03050372|76029380|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
42213573|NCT03470545|76029387|FG000|Overall Study|Death|0|||
42213574|NCT03470545|76029388|FG001|Overall Study|Death|1|||
42213575|NCT03470545|76029387|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
42213576|NCT03470545|76029388|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
42213577|NCT03470545|76029387|FG000|Overall Study|Adverse Event|2|||
42213578|NCT03470545|76029388|FG001|Overall Study|Adverse Event|0|||
42213579|NCT03470545|76029387|FG000|Overall Study|Withdrawal by Subject|1|||
42213580|NCT03470545|76029388|FG001|Overall Study|Withdrawal by Subject|1|||
42213581|NCT03470545|76029387|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
42213582|NCT03470545|76029388|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
42213583|NCT03163446|76029397|FG000|Overall Study|Unable to return for Day 180 visit|2|||
42213584|NCT03163446|76029398|FG001|Overall Study|Unable to return for Day 180 visit|0|||
42213585|NCT03163446|76029397|FG000|Overall Study|Withdrawal by Subject|2|||
42213586|NCT03163446|76029398|FG001|Overall Study|Withdrawal by Subject|6|||
42213587|NCT03163446|76029397|FG000|Overall Study|Death|16|||
42213588|NCT03163446|76029398|FG001|Overall Study|Death|5|||
41976376|NCT00001832|75779778|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
41976377|NCT00001832|75779779|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
41976378|NCT00001832|75779780|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
41976379|NCT00001832|75779781|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
41976380|NCT00001832|75779782|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
41976381|NCT00001832|75779783|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
41976382|NCT00001832|75779784|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
41976383|NCT00001832|75779785|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
41976384|NCT00001832|75779786|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
41976385|NCT00001832|75779787|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
41976386|NCT00001832|75779788|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
41976387|NCT00001832|75779789|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
42213589|NCT03163446|76029397|FG000|Overall Study|Lost to Follow-up|6|||
42213590|NCT03163446|76029398|FG001|Overall Study|Lost to Follow-up|5|||
42213591|NCT03163446|76029397|FG000|Overall Study|Physician Decision|1|||
42213592|NCT03163446|76029398|FG001|Overall Study|Physician Decision|1|||
42213593|NCT03163446|76029397|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
42213594|NCT03163446|76029398|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
42213595|NCT03722485|76029412|FG000|Overall Study|Withdrawal by Subject|1|||
42213596|NCT03722485|76029413|FG001|Overall Study|Withdrawal by Subject|0|||
42213597|NCT03722485|76029412|FG000|Overall Study|Adverse Event|0|||
42213598|NCT03722485|76029413|FG001|Overall Study|Adverse Event|2|||
42213599|NCT03722485|76029412|FG000|Overall Study|subject discharged prior to study completion|1|||
41976388|NCT00001832|75779790|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
41976389|NCT00001832|75779791|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
41976390|NCT00001832|75779792|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
41976391|NCT00001832|75779778|FG000|Treatment Period|Death during treatment|0|||
41976392|NCT00001832|75779779|FG001|Treatment Period|Death during treatment|0|||
41976393|NCT00001832|75779780|FG002|Treatment Period|Death during treatment|0|||
41976394|NCT00001832|75779781|FG003|Treatment Period|Death during treatment|0|||
41976395|NCT00001832|75779782|FG004|Treatment Period|Death during treatment|0|||
41976396|NCT00001832|75779783|FG005|Treatment Period|Death during treatment|1|||
41976397|NCT00001832|75779784|FG006|Treatment Period|Death during treatment|0|||
41976398|NCT00001832|75779785|FG007|Treatment Period|Death during treatment|0|||
41976399|NCT00001832|75779786|FG008|Treatment Period|Death during treatment|0|||
42128186|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
42128187|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
42128188|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
42213600|NCT03722485|76029413|FG001|Overall Study|subject discharged prior to study completion|5|||
42213601|NCT03722485|76029412|FG000|Overall Study|eligibility criteria not met|2|||
42213602|NCT03722485|76029413|FG001|Overall Study|eligibility criteria not met|0|||
42213603|NCT03047720|76029447|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
42213604|NCT03047720|76029448|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
42213605|NCT03626168|76029473|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
42213606|NCT03626168|76029474|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
42213607|NCT03626168|76029473|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
42213608|NCT03626168|76029474|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
42213609|NCT03626168|76029473|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
42213610|NCT03626168|76029474|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
42213611|NCT02966873|76029482|FG000|Overall Study|Lost to Follow-up|16|||
42213612|NCT02966873|76029483|FG001|Overall Study|Lost to Follow-up|15|||
42213613|NCT01389024|76029491|FG000|Overall Study|Withdrawal by Subject|0|||
42213614|NCT01389024|76029492|FG001|Overall Study|Withdrawal by Subject|1|||
42213615|NCT01389024|76029491|FG000|Overall Study|Lost to Follow-up|1|||
42213616|NCT01389024|76029492|FG001|Overall Study|Lost to Follow-up|0|||
42213617|NCT03050060|76029502|FG000|Overall Study|Adverse Event|7|||
42213618|NCT03050060|76029502|FG000|Overall Study|Withdrawal by Subject|1|||
42213619|NCT03050060|76029502|FG000|Overall Study|Progression|7|||
42213620|NCT00706342|76029515|FG000|Overall Study|Adverse Event|3|||
42213621|NCT00706342|76029515|FG000|Overall Study|Not responding to treatment|2|||
42213622|NCT00706342|76029515|FG000|Overall Study|Withdrawn due to failure to respond|1|||
42213623|NCT00706342|76029515|FG000|Overall Study|Death|1|||
42213624|NCT00706342|76029515|FG000|Overall Study|Withdrew from the study on his own.|1|||
42213625|NCT00706342|76029515|FG000|Overall Study|Investigator discretion|2|||
42213626|NCT00706342|76029515|FG000|Overall Study|Non-responder Week 12|1|||
42213627|NCT00706342|76029515|FG000|Overall Study|Ongoing|6|||
42213628|NCT00706342|76029515|FG000|Overall Study|WIthdrawal of consent|1|||
42213629|NCT03049748|76029521|FG000|Overall Study|Lost to Follow-up|1|||
42213630|NCT03049748|76029522|FG001|Overall Study|Lost to Follow-up|0|||
42213631|NCT03049748|76029521|FG000|Overall Study|Death|3|||
42213632|NCT03049748|76029522|FG001|Overall Study|Death|0|||
42213633|NCT03049748|76029521|FG000|Overall Study|Withdrawal by Subject|0|||
42213634|NCT03049748|76029522|FG001|Overall Study|Withdrawal by Subject|3|||
42213635|NCT03049748|76029521|FG000|Overall Study|Protocol Violation|0|||
42213636|NCT03049748|76029522|FG001|Overall Study|Protocol Violation|2|||
42213637|NCT03049748|76029521|FG000|Overall Study|Moved out of state (relocation)|0|||
42213638|NCT03049748|76029522|FG001|Overall Study|Moved out of state (relocation)|1|||
42213639|NCT03501277|76029536|FG000|Intervention Period 1 (4 Days)|Other|0|||
42213640|NCT03501277|76029537|FG001|Intervention Period 1 (4 Days)|Other|0|||
42213641|NCT03501277|76029538|FG002|Intervention Period 1 (4 Days)|Other|1|||
42213642|NCT03501277|76029539|FG003|Intervention Period 1 (4 Days)|Other|0|||
42213643|NCT03501277|76029536|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
42213644|NCT03501277|76029537|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
42213645|NCT03501277|76029538|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
41976400|NCT00001832|75779787|FG009|Treatment Period|Death during treatment|0|||
42128189|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
42128190|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
42128191|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
42128192|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
42128193|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
42213646|NCT03501277|76029539|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
41976401|NCT00001832|75779788|FG010|Treatment Period|Death during treatment|0|||
41976402|NCT00001832|75779789|FG011|Treatment Period|Death during treatment|0|||
41976403|NCT00001832|75779790|FG012|Treatment Period|Death during treatment|0|||
41976404|NCT00001832|75779791|FG013|Treatment Period|Death during treatment|0|||
42213647|NCT03501277|76029536|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
42213648|NCT03501277|76029537|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
42213649|NCT03501277|76029538|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
42213650|NCT03501277|76029539|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
42213651|NCT03501277|76029536|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
42213652|NCT03501277|76029537|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
42213653|NCT03501277|76029538|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
42213654|NCT03501277|76029539|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
42213655|NCT03500419|76029551|FG000|Overall Study|Withdrawal by Subject|2|||
41976405|NCT00001832|75779792|FG014|Treatment Period|Death during treatment|0|||
41976406|NCT00001832|75779778|FG000|Treatment Period|Not treated|0|||
41976407|NCT00001832|75779779|FG001|Treatment Period|Not treated|0|||
41976408|NCT00001832|75779780|FG002|Treatment Period|Not treated|0|||
41976409|NCT00001832|75779781|FG003|Treatment Period|Not treated|0|||
41976410|NCT00001832|75779782|FG004|Treatment Period|Not treated|0|||
41976411|NCT00001832|75779783|FG005|Treatment Period|Not treated|0|||
41976412|NCT00001832|75779784|FG006|Treatment Period|Not treated|0|||
41976413|NCT00001832|75779785|FG007|Treatment Period|Not treated|1|||
41976414|NCT00001832|75779786|FG008|Treatment Period|Not treated|0|||
42213656|NCT03500419|76029552|FG001|Overall Study|Withdrawal by Subject|25|||
42213657|NCT03500341|76029558|FG000|Overall Study|Withdrawn prior to Completion|2|||
42213658|NCT01316900|76029579|FG000|Overall Study|Adverse Event|10|||
42213659|NCT01316900|76029580|FG001|Overall Study|Adverse Event|10|||
42213660|NCT01316900|76029581|FG002|Overall Study|Adverse Event|15|||
42213661|NCT01316900|76029582|FG003|Overall Study|Adverse Event|9|||
42213662|NCT01316900|76029579|FG000|Overall Study|Lack of Efficacy|17|||
42213663|NCT01316900|76029580|FG001|Overall Study|Lack of Efficacy|9|||
42213664|NCT01316900|76029581|FG002|Overall Study|Lack of Efficacy|5|||
42213665|NCT01316900|76029582|FG003|Overall Study|Lack of Efficacy|7|||
42213666|NCT01316900|76029579|FG000|Overall Study|Protocol Violation|7|||
42213667|NCT01316900|76029580|FG001|Overall Study|Protocol Violation|1|||
42213668|NCT01316900|76029581|FG002|Overall Study|Protocol Violation|4|||
42213669|NCT01316900|76029582|FG003|Overall Study|Protocol Violation|0|||
42213670|NCT01316900|76029579|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
42213671|NCT01316900|76029580|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
42213672|NCT01316900|76029581|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
42213673|NCT01316900|76029582|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
42213674|NCT01316900|76029579|FG000|Overall Study|Lost to Follow-up|1|||
42213675|NCT01316900|76029580|FG001|Overall Study|Lost to Follow-up|0|||
42213676|NCT01316900|76029581|FG002|Overall Study|Lost to Follow-up|1|||
42213677|NCT01316900|76029582|FG003|Overall Study|Lost to Follow-up|1|||
42213678|NCT01316900|76029579|FG000|Overall Study|Withdrawal by Subject|7|||
42213679|NCT01316900|76029580|FG001|Overall Study|Withdrawal by Subject|8|||
42213680|NCT01316900|76029581|FG002|Overall Study|Withdrawal by Subject|6|||
42213681|NCT01316900|76029582|FG003|Overall Study|Withdrawal by Subject|9|||
42213682|NCT03499873|76029595|FG000|Overall Study|Withdrawal by Subject|4|||
42213683|NCT03499873|76029596|FG001|Overall Study|Withdrawal by Subject|6|||
42213684|NCT03499873|76029597|FG002|Overall Study|Withdrawal by Subject|1|||
41976415|NCT00001832|75779787|FG009|Treatment Period|Not treated|0|||
41976416|NCT00001832|75779788|FG010|Treatment Period|Not treated|0|||
41976417|NCT00001832|75779789|FG011|Treatment Period|Not treated|0|||
42128194|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
42128195|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
42128196|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
42128197|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
42128198|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
42128199|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
42128200|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
42128201|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
42128202|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
42128203|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
42128204|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
42128205|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
42128206|NCT00518882|75938780|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
42213685|NCT03499873|76029595|FG000|Overall Study|Subjects condition worsened|0|||
42213686|NCT03499873|76029596|FG001|Overall Study|Subjects condition worsened|3|||
42213687|NCT03499873|76029597|FG002|Overall Study|Subjects condition worsened|11|||
42213688|NCT03499873|76029595|FG000|Overall Study|Adverse Event|8|||
42213689|NCT03499873|76029596|FG001|Overall Study|Adverse Event|3|||
42213690|NCT03499873|76029597|FG002|Overall Study|Adverse Event|6|||
41976418|NCT00001832|75779790|FG012|Treatment Period|Not treated|0|||
41976419|NCT00001832|75779791|FG013|Treatment Period|Not treated|0|||
41976420|NCT00001832|75779792|FG014|Treatment Period|Not treated|0|||
41976421|NCT01349816|75780017|FG000|Overall Study|Withdrawal by Subject|4|||
41976422|NCT01349816|75780017|FG000|Overall Study|Physician Decision|1|||
41976423|NCT01349816|75780017|FG000|Overall Study|Adverse Event|14|||
41976424|NCT01349816|75780017|FG000|Overall Study|Lost to Follow-up|2|||
41976425|NCT01349816|75780017|FG000|Overall Study|Protocol Violation|1|||
41976426|NCT01349816|75780017|FG000|Overall Study|Protocol-specified criteria|8|||
41976427|NCT05201807|75780196|FG000|Overall Study|Adverse Event|1|||
41976428|NCT05201807|75780196|FG000|Overall Study|COVID-19 Related|1|||
41976429|NCT04978337|75780202|FG000|Overall Study|Withdrawal by Subject|0|||
41976430|NCT04978337|75780203|FG001|Overall Study|Withdrawal by Subject|1|||
41976431|NCT04828707|75780212|FG000|Overall Study|Lost to Follow-up|3|||
41976432|NCT04828707|75780213|FG001|Overall Study|Lost to Follow-up|2|||
41976433|NCT04828707|75780212|FG000|Overall Study|Withdrawal by Subject|2|||
41976434|NCT04828707|75780213|FG001|Overall Study|Withdrawal by Subject|1|||
41976435|NCT04629534|75780221|FG000|Overall Study|Physician Decision|1|||
41976436|NCT04629534|75780222|FG001|Overall Study|Physician Decision|0|||
42213691|NCT03499873|76029595|FG000|Overall Study|Physician Decision|1|||
42213692|NCT03499873|76029596|FG001|Overall Study|Physician Decision|0|||
42213693|NCT03499873|76029597|FG002|Overall Study|Physician Decision|0|||
42213694|NCT03499873|76029595|FG000|Overall Study|Administrative reasons|0|||
42213695|NCT03499873|76029596|FG001|Overall Study|Administrative reasons|1|||
42213696|NCT03499873|76029597|FG002|Overall Study|Administrative reasons|0|||
42213697|NCT03499873|76029595|FG000|Overall Study|Concomitant therapy|5|||
42213698|NCT03499873|76029596|FG001|Overall Study|Concomitant therapy|4|||
41976437|NCT04629534|75780221|FG000|Overall Study|Protocol Violation|0|||
41976438|NCT04629534|75780222|FG001|Overall Study|Protocol Violation|2|||
42213699|NCT03499873|76029597|FG002|Overall Study|Concomitant therapy|7|||
42213700|NCT03499873|76029595|FG000|Overall Study|Miscellaneous|1|||
42213701|NCT03499873|76029596|FG001|Overall Study|Miscellaneous|2|||
42213702|NCT03499873|76029597|FG002|Overall Study|Miscellaneous|2|||
42213703|NCT03499873|76029595|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
42213704|NCT03499873|76029596|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
42213705|NCT03499873|76029597|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
42213706|NCT03467971|76029607|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42213707|NCT03467971|76029608|FG001|Treatment Period 2|Withdrawal by Subject|1|||
42213708|NCT03049280|76029624|FG000|Overall Study|Physician Decision|1|||
42213709|NCT03048500|76029630|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
42213710|NCT03048500|76029630|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
42213711|NCT03048500|76029630|FG000|Reached 1st Response/Continued Treatment|Death|1|||
42213712|NCT03048500|76029630|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
42213713|NCT03048500|76029630|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
42213714|NCT03048500|76029630|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
42213715|NCT03048500|76029630|FG000|Follow up for 3 Years|Death|12|||
42213716|NCT00908076|76029636|FG000|Overall Study|Lack of Efficacy|1|||
41976439|NCT04481191|75780234|FG000|Overall Study|Withdrawn by parent/guardian|15|||
42128207|NCT00518882|75938781|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
42128208|NCT00518336|75938789|FG000|Year 7|Lost to Follow-up|2|||
42128209|NCT00518336|75938790|FG001|Year 7|Lost to Follow-up|0|||
42128210|NCT00518336|75938789|FG000|Year 7|Could not attend in time|0|||
42128211|NCT00518336|75938790|FG001|Year 7|Could not attend in time|3|||
42128212|NCT00518336|75938789|FG000|Year 8|Lost to Follow-up|1|||
42128213|NCT00518336|75938790|FG001|Year 8|Lost to Follow-up|1|||
42128214|NCT00518336|75938789|FG000|Year 8|Could not attend in time|0|||
42128215|NCT00518336|75938790|FG001|Year 8|Could not attend in time|1|||
42128216|NCT00518336|75938789|FG000|Year 9|Migrated/moved from study area|1|||
42128217|NCT00518336|75938790|FG001|Year 9|Migrated/moved from study area|1|||
42128218|NCT00518336|75938789|FG000|Year 9|Lost to Follow-up|3|||
42128219|NCT00518336|75938790|FG001|Year 9|Lost to Follow-up|0|||
42128220|NCT00518336|75938789|FG000|Year 9|Personal reasons|1|||
42128221|NCT00518336|75938790|FG001|Year 9|Personal reasons|0|||
42128222|NCT00518180|75938799|FG000|Overall Study|Withdrawal by Subject|29|||
42128223|NCT00518180|75938800|FG001|Overall Study|Withdrawal by Subject|30|||
42128224|NCT00518180|75938801|FG002|Overall Study|Withdrawal by Subject|42|||
42128225|NCT00518180|75938799|FG000|Overall Study|Lost to Follow-up|30|||
42128226|NCT00518180|75938800|FG001|Overall Study|Lost to Follow-up|28|||
42128227|NCT00518180|75938801|FG002|Overall Study|Lost to Follow-up|34|||
42128228|NCT00518180|75938799|FG000|Overall Study|Administrative reason|0|||
42128229|NCT00518180|75938800|FG001|Overall Study|Administrative reason|2|||
42213717|NCT00908076|76029637|FG001|Overall Study|Lack of Efficacy|1|||
42128230|NCT00518180|75938801|FG002|Overall Study|Administrative reason|2|||
41976440|NCT04481191|75780235|FG001|Overall Study|Withdrawn by parent/guardian|10|||
41976441|NCT03695185|75780258|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
41976442|NCT03695185|75780258|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
42128231|NCT00518180|75938799|FG000|Overall Study|Protocol Violation|5|||
41976443|NCT03695185|75780258|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
41976444|NCT03695185|75780258|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
42128232|NCT00518180|75938800|FG001|Overall Study|Protocol Violation|7|||
42128233|NCT00518180|75938801|FG002|Overall Study|Protocol Violation|4|||
42213718|NCT03467425|76029645|FG000|Overall Study|Adverse Event|9|||
42213719|NCT03467425|76029646|FG001|Overall Study|Adverse Event|9|||
42213720|NCT03467425|76029645|FG000|Overall Study|Lack of Efficacy|3|||
42213721|NCT03467425|76029646|FG001|Overall Study|Lack of Efficacy|1|||
42213722|NCT03467425|76029645|FG000|Overall Study|Protocol Violation|0|||
42213723|NCT03467425|76029646|FG001|Overall Study|Protocol Violation|1|||
42213724|NCT03467425|76029645|FG000|Overall Study|Lost to Follow-up|18|||
42213725|NCT03467425|76029646|FG001|Overall Study|Lost to Follow-up|25|||
41976445|NCT03695185|75780258|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
41976446|NCT03695185|75780258|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
41976447|NCT03596164|75780265|FG000|Overall Study|Adverse Event|0|||
41976448|NCT03596164|75780266|FG001|Overall Study|Adverse Event|1|||
41976449|NCT03596164|75780265|FG000|Overall Study|Death|1|||
41976450|NCT03596164|75780266|FG001|Overall Study|Death|0|||
41976451|NCT02990468|75780277|FG000|Phase 2: MTD|Change in treatment|0|||
41976452|NCT02990468|75780278|FG001|Phase 2: MTD|Change in treatment|0|||
41976453|NCT02990468|75780279|FG002|Phase 2: MTD|Change in treatment|1|||
41976454|NCT02855944|75780289|FG000|Period 1: Treatment|Ongoing|14|||
41976455|NCT02855944|75780290|FG001|Period 1: Treatment|Ongoing|0|||
41976456|NCT02855944|75780289|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
41976457|NCT02855944|75780290|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
41976458|NCT02855944|75780289|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
41976459|NCT02855944|75780290|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
41976460|NCT02681055|75780297|FG000|Weeks 5-12|Adverse Event|1|||
41976461|NCT02409342|75780304|FG000|Overall Study|Death|211|||
41976462|NCT02409342|75780305|FG001|Overall Study|Death|201|||
41976463|NCT02409342|75780304|FG000|Overall Study|Withdrawal by Subject|24|||
41976464|NCT02409342|75780305|FG001|Overall Study|Withdrawal by Subject|17|||
41976465|NCT02409342|75780304|FG000|Overall Study|Study Terminated By Sponsor|48|||
41976466|NCT02409342|75780305|FG001|Overall Study|Study Terminated By Sponsor|59|||
41976467|NCT02409342|75780304|FG000|Overall Study|Lost to Follow-up|3|||
41976468|NCT02409342|75780305|FG001|Overall Study|Lost to Follow-up|5|||
41976469|NCT02409342|75780304|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
41976470|NCT02409342|75780305|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
41976471|NCT02409342|75780304|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
41976472|NCT02409342|75780305|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
41976473|NCT02409342|75780304|FG000|Overall Study|Sponsor Decision|1|||
41976474|NCT02409342|75780305|FG001|Overall Study|Sponsor Decision|0|||
41976475|NCT02336503|75780317|FG000|Overall Study|Lost to Follow-up|0|||
41976476|NCT02336503|75780318|FG001|Overall Study|Lost to Follow-up|3|||
41976477|NCT02336503|75780319|FG002|Overall Study|Lost to Follow-up|0|||
41976478|NCT02336503|75780320|FG003|Overall Study|Lost to Follow-up|2|||
41976479|NCT02336503|75780317|FG000|Overall Study|Withdrawal by Subject|2|||
41976480|NCT02336503|75780318|FG001|Overall Study|Withdrawal by Subject|0|||
41976481|NCT02336503|75780319|FG002|Overall Study|Withdrawal by Subject|0|||
41976482|NCT02336503|75780320|FG003|Overall Study|Withdrawal by Subject|4|||
41976483|NCT02336503|75780317|FG000|Overall Study|Adverse Event|0|||
41976484|NCT02336503|75780318|FG001|Overall Study|Adverse Event|0|||
41976485|NCT02336503|75780319|FG002|Overall Study|Adverse Event|1|||
41976486|NCT02336503|75780320|FG003|Overall Study|Adverse Event|0|||
41976487|NCT02255409|75780336|FG000|Overall Study|Administrative Reason|3|||
41976488|NCT02255409|75780337|FG001|Overall Study|Administrative Reason|7|||
41976489|NCT02255409|75780336|FG000|Overall Study|Withdrawal by Subject|1|||
41976490|NCT02255409|75780337|FG001|Overall Study|Withdrawal by Subject|5|||
41976491|NCT02255409|75780336|FG000|Overall Study|Lost to Follow-up|10|||
42128234|NCT00518180|75938799|FG000|Overall Study|Unable to classify|0|||
42128235|NCT00518180|75938800|FG001|Overall Study|Unable to classify|2|||
42128236|NCT00518180|75938801|FG002|Overall Study|Unable to classify|0|||
42128237|NCT00518180|75938799|FG000|Overall Study|Adverse Event|1|||
42128238|NCT00518180|75938800|FG001|Overall Study|Adverse Event|0|||
42128239|NCT00518180|75938801|FG002|Overall Study|Adverse Event|0|||
42128240|NCT00525902|75938818|FG000|Overall Study|Lack of Efficacy|1|||
42128241|NCT00525824|75938826|FG000|Overall Study|Adverse Event|7|||
42128242|NCT00525824|75938827|FG001|Overall Study|Adverse Event|11|||
42128243|NCT00525824|75938828|FG002|Overall Study|Adverse Event|6|||
41976492|NCT02255409|75780337|FG001|Overall Study|Lost to Follow-up|19|||
41976493|NCT00630032|75780368|FG000|Overall Study|Death|55|||
41976494|NCT00630032|75780369|FG001|Overall Study|Death|49|||
42128244|NCT00525824|75938829|FG003|Overall Study|Adverse Event|7|||
42128245|NCT00525824|75938826|FG000|Overall Study|Withdrawal by Subject|5|||
41976495|NCT00630032|75780368|FG000|Overall Study|Withdrawal by Subject|3|||
41976496|NCT00630032|75780369|FG001|Overall Study|Withdrawal by Subject|2|||
41976497|NCT00630032|75780368|FG000|Overall Study|Lost to Follow-up|18|||
41976498|NCT00630032|75780369|FG001|Overall Study|Lost to Follow-up|31|||
41976499|NCT00630032|75780368|FG000|Overall Study|Protocol Violation|1|||
41976500|NCT00630032|75780369|FG001|Overall Study|Protocol Violation|0|||
42128246|NCT00525824|75938827|FG001|Overall Study|Withdrawal by Subject|9|||
42213726|NCT03467425|76029645|FG000|Overall Study|Physician Decision|2|||
42213727|NCT03467425|76029646|FG001|Overall Study|Physician Decision|1|||
42213728|NCT03467425|76029645|FG000|Overall Study|Withdrawal by Subject|15|||
42213729|NCT03467425|76029646|FG001|Overall Study|Withdrawal by Subject|17|||
42213730|NCT02886702|76029655|FG000|Overall Study|Other|4|||
42213731|NCT02886702|76029656|FG001|Overall Study|Other|3|||
42213732|NCT02886702|76029657|FG002|Overall Study|Other|9|||
42213733|NCT02886702|76029655|FG000|Overall Study|Withdrawal by Subject|24|||
42213734|NCT02886702|76029656|FG001|Overall Study|Withdrawal by Subject|18|||
42213735|NCT02886702|76029657|FG002|Overall Study|Withdrawal by Subject|22|||
42213736|NCT02886702|76029655|FG000|Overall Study|Significant Worsening of Condition|0|||
42213737|NCT02886702|76029656|FG001|Overall Study|Significant Worsening of Condition|1|||
42213738|NCT02886702|76029657|FG002|Overall Study|Significant Worsening of Condition|0|||
42213739|NCT02886702|76029655|FG000|Overall Study|Protocol Violation|2|||
42213740|NCT02886702|76029656|FG001|Overall Study|Protocol Violation|2|||
42213741|NCT02886702|76029657|FG002|Overall Study|Protocol Violation|1|||
42213742|NCT02886702|76029655|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42213743|NCT02886702|76029656|FG001|Overall Study|Non-Compliance With Study Drug|1|||
42213744|NCT02886702|76029657|FG002|Overall Study|Non-Compliance With Study Drug|4|||
42213745|NCT02886702|76029655|FG000|Overall Study|Lost to Follow-up|11|||
42213746|NCT02886702|76029656|FG001|Overall Study|Lost to Follow-up|13|||
42213747|NCT02886702|76029657|FG002|Overall Study|Lost to Follow-up|8|||
42213748|NCT02886702|76029655|FG000|Overall Study|Lack of Efficacy|3|||
42213749|NCT02886702|76029656|FG001|Overall Study|Lack of Efficacy|4|||
42213750|NCT02886702|76029657|FG002|Overall Study|Lack of Efficacy|5|||
42213751|NCT02886702|76029655|FG000|Overall Study|Adverse Event|4|||
42213752|NCT02886702|76029656|FG001|Overall Study|Adverse Event|9|||
42213753|NCT02886702|76029657|FG002|Overall Study|Adverse Event|3|||
42213754|NCT02886702|76029655|FG000|Overall Study|Administrative Reasons|0|||
42213755|NCT02886702|76029656|FG001|Overall Study|Administrative Reasons|0|||
42213756|NCT02886702|76029657|FG002|Overall Study|Administrative Reasons|1|||
42213757|NCT03498313|76029671|FG000|Experimental Period 1|Adverse Event|1|||
41976501|NCT00630032|75780368|FG000|Overall Study|Patient has moved|1|||
41976502|NCT00630032|75780369|FG001|Overall Study|Patient has moved|1|||
41976503|NCT00630032|75780368|FG000|Overall Study|Disease progression|1|||
41976504|NCT00630032|75780369|FG001|Overall Study|Disease progression|1|||
41976505|NCT00630032|75780368|FG000|Overall Study|End of monitoring in US centers|11|||
41976506|NCT00630032|75780369|FG001|Overall Study|End of monitoring in US centers|11|||
41976507|NCT00465517|75780377|FG000|Overall Study|Adverse Event|7|||
41976508|NCT00465517|75780378|FG001|Overall Study|Adverse Event|3|||
41976509|NCT00465517|75780377|FG000|Overall Study|Lost to Follow-up|1|||
41976510|NCT00465517|75780378|FG001|Overall Study|Lost to Follow-up|0|||
41976511|NCT00465517|75780377|FG000|Overall Study|Withdrawal by Subject|4|||
41976512|NCT00465517|75780378|FG001|Overall Study|Withdrawal by Subject|1|||
41976513|NCT05050578|75780386|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
41976514|NCT05050578|75780387|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
41976515|NCT05050578|75780386|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
42213758|NCT03498313|76029672|FG001|Experimental Period 1|Adverse Event|0|||
42213759|NCT03498313|76029673|FG002|Experimental Period 1|Adverse Event|0|||
42213760|NCT03498313|76029674|FG003|Experimental Period 1|Adverse Event|1|||
42213761|NCT03498313|76029675|FG004|Experimental Period 1|Adverse Event|0|||
42213762|NCT03498313|76029676|FG005|Experimental Period 1|Adverse Event|0|||
42213763|NCT03498313|76029671|FG000|Experimental Period 1|Withdrawal by Subject|0|||
42213764|NCT03498313|76029672|FG001|Experimental Period 1|Withdrawal by Subject|1|||
42213765|NCT03498313|76029673|FG002|Experimental Period 1|Withdrawal by Subject|0|||
42213766|NCT03498313|76029674|FG003|Experimental Period 1|Withdrawal by Subject|0|||
42213767|NCT03498313|76029675|FG004|Experimental Period 1|Withdrawal by Subject|0|||
42213768|NCT03498313|76029676|FG005|Experimental Period 1|Withdrawal by Subject|0|||
42213769|NCT03498313|76029671|FG000|Washout Period 1|Anovulation|1|||
42213770|NCT03498313|76029672|FG001|Washout Period 1|Anovulation|0|||
42213771|NCT03498313|76029673|FG002|Washout Period 1|Anovulation|0|||
42213772|NCT03498313|76029674|FG003|Washout Period 1|Anovulation|0|||
42213773|NCT03498313|76029675|FG004|Washout Period 1|Anovulation|0|||
42213774|NCT03498313|76029676|FG005|Washout Period 1|Anovulation|0|||
42213775|NCT03498313|76029671|FG000|Washout Period 1|Withdrawal by Subject|0|||
42213776|NCT03498313|76029672|FG001|Washout Period 1|Withdrawal by Subject|3|||
42213777|NCT03498313|76029673|FG002|Washout Period 1|Withdrawal by Subject|0|||
42213778|NCT03498313|76029674|FG003|Washout Period 1|Withdrawal by Subject|1|||
42213779|NCT03498313|76029675|FG004|Washout Period 1|Withdrawal by Subject|0|||
42213780|NCT03498313|76029676|FG005|Washout Period 1|Withdrawal by Subject|1|||
42213781|NCT03498313|76029671|FG000|Experimental Period 2|Adverse Event|0|||
42213782|NCT03498313|76029672|FG001|Experimental Period 2|Adverse Event|0|||
42213783|NCT03498313|76029673|FG002|Experimental Period 2|Adverse Event|0|||
42213784|NCT03498313|76029674|FG003|Experimental Period 2|Adverse Event|0|||
42213785|NCT03498313|76029675|FG004|Experimental Period 2|Adverse Event|1|||
42213786|NCT03498313|76029676|FG005|Experimental Period 2|Adverse Event|2|||
42213787|NCT03498313|76029671|FG000|Washout Period 2|Physician Decision|1|||
42213788|NCT03498313|76029672|FG001|Washout Period 2|Physician Decision|0|||
42213789|NCT03498313|76029673|FG002|Washout Period 2|Physician Decision|0|||
42213790|NCT03498313|76029674|FG003|Washout Period 2|Physician Decision|1|||
42213791|NCT03498313|76029675|FG004|Washout Period 2|Physician Decision|0|||
42213792|NCT03498313|76029676|FG005|Washout Period 2|Physician Decision|1|||
42213793|NCT03498313|76029671|FG000|Washout Period 2|Withdrawal by Subject|3|||
42213794|NCT03498313|76029672|FG001|Washout Period 2|Withdrawal by Subject|2|||
42213795|NCT03498313|76029673|FG002|Washout Period 2|Withdrawal by Subject|0|||
42213796|NCT03498313|76029674|FG003|Washout Period 2|Withdrawal by Subject|0|||
42213797|NCT03498313|76029675|FG004|Washout Period 2|Withdrawal by Subject|2|||
42213798|NCT03498313|76029676|FG005|Washout Period 2|Withdrawal by Subject|0|||
42213799|NCT03498313|76029671|FG000|Washout Period 2|Anovulation|0|||
42213800|NCT03498313|76029672|FG001|Washout Period 2|Anovulation|0|||
42213801|NCT03498313|76029673|FG002|Washout Period 2|Anovulation|0|||
42213802|NCT03498313|76029674|FG003|Washout Period 2|Anovulation|0|||
42213803|NCT03498313|76029675|FG004|Washout Period 2|Anovulation|0|||
42213804|NCT03498313|76029676|FG005|Washout Period 2|Anovulation|1|||
42213805|NCT02601014|76029686|FG000|Overall Study|Adverse Event|3|||
42213806|NCT02601014|76029687|FG001|Overall Study|Adverse Event|3|||
42213807|NCT02601014|76029686|FG000|Overall Study|Death|3|||
42213808|NCT02601014|76029687|FG001|Overall Study|Death|1|||
42213809|NCT02601014|76029686|FG000|Overall Study|Disease progression|4|||
42213810|NCT02601014|76029687|FG001|Overall Study|Disease progression|8|||
42213811|NCT01307046|76029695|FG000|Overall Study|Adverse Event|3|||
42213812|NCT01307046|76029696|FG001|Overall Study|Adverse Event|3|||
42213813|NCT01307046|76029695|FG000|Overall Study|Lack of Efficacy|0|||
42213814|NCT01307046|76029696|FG001|Overall Study|Lack of Efficacy|2|||
42213815|NCT01307046|76029695|FG000|Overall Study|Physician Decision|2|||
42213816|NCT01307046|76029696|FG001|Overall Study|Physician Decision|0|||
42213817|NCT01307046|76029695|FG000|Overall Study|Withdrawal by Subject|1|||
42213818|NCT01307046|76029696|FG001|Overall Study|Withdrawal by Subject|1|||
42213819|NCT01307046|76029695|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
42213820|NCT01307046|76029696|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
42213821|NCT01307046|76029695|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
42213822|NCT01307046|76029696|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
42213823|NCT03495817|76029702|FG000|26 Week Open Label|Adverse Event|3|||
42213824|NCT03495817|76029702|FG000|26 Week Open Label|Withdrawal by Subject|4|||
42213825|NCT03495817|76029702|FG000|26 Week Open Label|Lost to Follow-up|1|||
42213826|NCT03495817|76029702|FG000|26 Week Extension|Lost to Follow-up|2|||
42213827|NCT02886624|76029706|FG000|12-week Post Treatment Follow-up|Death|1|||
42213828|NCT02886624|76029706|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
42213829|NCT02963766|76029713|FG000|Double-Blind Period|Adverse Event|1|||
42213830|NCT02963766|76029714|FG001|Double-Blind Period|Adverse Event|0|||
42213831|NCT02963766|76029715|FG002|Double-Blind Period|Adverse Event|1|||
42301861|NCT02287233|76137035|FG000|Overall Study|Adverse Event Related to Progression|0|||
42213832|NCT02963766|76029713|FG000|Double-Blind Period|Physician Decision|1|||
42213833|NCT02963766|76029714|FG001|Double-Blind Period|Physician Decision|0|||
42213834|NCT02963766|76029715|FG002|Double-Blind Period|Physician Decision|0|||
42213835|NCT02963766|76029713|FG000|Double-Blind Period|Withdrawal by Subject|1|||
42213836|NCT02963766|76029714|FG001|Double-Blind Period|Withdrawal by Subject|1|||
42213837|NCT02963766|76029715|FG002|Double-Blind Period|Withdrawal by Subject|0|||
42213838|NCT02963766|76029713|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
42213839|NCT02963766|76029714|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
42213840|NCT02963766|76029715|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
42213841|NCT02963766|76029713|FG000|Double-Blind Period|Protocol Violation|1|||
42213842|NCT02963766|76029714|FG001|Double-Blind Period|Protocol Violation|0|||
42213843|NCT02963766|76029715|FG002|Double-Blind Period|Protocol Violation|0|||
42213844|NCT02963766|76029713|FG000|Double-Blind Period|Lost to Follow-up|0|||
42213845|NCT02963766|76029714|FG001|Double-Blind Period|Lost to Follow-up|1|||
41976516|NCT05050578|75780387|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
41976517|NCT05050578|75780386|FG000|Period 2, 30 Days|Protocol Violation|0|||
41976518|NCT05050578|75780387|FG001|Period 2, 30 Days|Protocol Violation|1|||
41976519|NCT04490278|75780396|FG000|Overall Study|Lost to Follow-up|6|||
41976520|NCT04004221|75780400|FG000|Overall Study|Death|89|||
41976521|NCT04004221|75780400|FG000|Overall Study|Withdrawal by Subject|5|||
41976522|NCT04004221|75780400|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
41976523|NCT04004221|75780400|FG000|Overall Study|Sponsor Decision|9|||
41976524|NCT04004221|75780400|FG000|Overall Study|Participant refused to enter LTE|1|||
41976525|NCT03775512|75780406|FG000|Overall Study|Death|1|||
41976526|NCT03775512|75780407|FG001|Overall Study|Death|1|||
41976527|NCT03775512|75780406|FG000|Overall Study|Withdrawal by Subject|7|||
41976528|NCT03775512|75780407|FG001|Overall Study|Withdrawal by Subject|4|||
41976529|NCT03775512|75780406|FG000|Overall Study|Lost to Follow-up|5|||
41976530|NCT03775512|75780407|FG001|Overall Study|Lost to Follow-up|5|||
41976531|NCT03775512|75780406|FG000|Overall Study|Excluded before Catheter insertion|14|||
41976532|NCT03775512|75780407|FG001|Overall Study|Excluded before Catheter insertion|5|||
41976533|NCT03775512|75780406|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
41976534|NCT03775512|75780407|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
41976535|NCT03775512|75780406|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
42028414|NCT00910858|75836849|FG001|Monotherapy Phase|Other|4|||
42028415|NCT00910858|75836850|FG002|Monotherapy Phase|Other|2|||
42028416|NCT00910858|75836848|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
42028417|NCT00910858|75836849|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
42028418|NCT00910858|75836850|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
42028419|NCT00910858|75836848|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
42028420|NCT00910858|75836849|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
42028421|NCT00910858|75836850|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
42128247|NCT00525824|75938828|FG002|Overall Study|Withdrawal by Subject|3|||
42128248|NCT00525824|75938829|FG003|Overall Study|Withdrawal by Subject|4|||
42128249|NCT00525824|75938826|FG000|Overall Study|Lost to Follow-up|4|||
42128250|NCT00525824|75938827|FG001|Overall Study|Lost to Follow-up|2|||
41976536|NCT03775512|75780407|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
41976537|NCT03620747|75780413|FG000|Overall Study|Participant decision|7|||
41976538|NCT03620747|75780413|FG000|Overall Study|Adverse Event|6|||
41976539|NCT03620747|75780413|FG000|Overall Study|Lack of Efficacy|1|||
41976540|NCT03620747|75780413|FG000|Overall Study|Poor compliance to protocol|2|||
41976541|NCT03620747|75780413|FG000|Overall Study|Other-unspecified|3|||
42128251|NCT00525824|75938828|FG002|Overall Study|Lost to Follow-up|4|||
42128252|NCT00525824|75938829|FG003|Overall Study|Lost to Follow-up|0|||
42128253|NCT00525824|75938826|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
42128254|NCT00525824|75938827|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
42128255|NCT00525824|75938828|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
42128256|NCT00525824|75938829|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
42128257|NCT00525824|75938826|FG000|Overall Study|Severe non-compliance|0|||
42128258|NCT00525824|75938827|FG001|Overall Study|Severe non-compliance|1|||
42128259|NCT00525824|75938828|FG002|Overall Study|Severe non-compliance|1|||
42213846|NCT02963766|76029715|FG002|Double-Blind Period|Lost to Follow-up|0|||
41976542|NCT03338790|75780438|FG000|Overall Study|Disease Progression|65|||
41976543|NCT03338790|75780439|FG001|Overall Study|Disease Progression|43|||
41976544|NCT03338790|75780440|FG002|Overall Study|Disease Progression|50|||
42028422|NCT00910858|75836848|FG000|Combined Treatment Phase|Protocol Violation|1|||
42028423|NCT00910858|75836849|FG001|Combined Treatment Phase|Protocol Violation|0|||
42028424|NCT00910858|75836850|FG002|Combined Treatment Phase|Protocol Violation|0|||
42028425|NCT00910858|75836848|FG000|Combined Treatment Phase|Other|0|||
42128260|NCT00525824|75938829|FG003|Overall Study|Severe non-compliance|1|||
42128261|NCT00525824|75938826|FG000|Overall Study|Safety reasons|1|||
42128262|NCT00525824|75938827|FG001|Overall Study|Safety reasons|0|||
42213847|NCT02963766|76029713|FG000|Open Label Extension (OLE)|Physician Decision|1|||
42213848|NCT02963766|76029714|FG001|Open Label Extension (OLE)|Physician Decision|2|||
42213849|NCT02963766|76029715|FG002|Open Label Extension (OLE)|Physician Decision|2|||
42213850|NCT02963766|76029713|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
42213851|NCT02963766|76029714|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
42213852|NCT02963766|76029715|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
42213853|NCT04839965|76029735|FG000|Overall Study|Death|6|||
42213854|NCT04839965|76029736|FG001|Overall Study|Death|6|||
42213855|NCT04839965|76029735|FG000|Overall Study|Lost to Follow-up|1|||
42213856|NCT04839965|76029736|FG001|Overall Study|Lost to Follow-up|0|||
42213857|NCT03466099|76029745|FG000|Overall Study|Adverse Event|1|||
42213858|NCT03466099|76029746|FG001|Overall Study|Adverse Event|1|||
42213859|NCT03466099|76029747|FG002|Overall Study|Adverse Event|1|||
42213860|NCT03466099|76029745|FG000|Overall Study|Withdrawal by Subject|2|||
42213861|NCT03466099|76029746|FG001|Overall Study|Withdrawal by Subject|3|||
42213862|NCT03466099|76029747|FG002|Overall Study|Withdrawal by Subject|1|||
42213863|NCT03466099|76029745|FG000|Overall Study|Use of rescue medication|8|||
42213864|NCT03466099|76029746|FG001|Overall Study|Use of rescue medication|9|||
42213865|NCT03466099|76029747|FG002|Overall Study|Use of rescue medication|13|||
42213866|NCT03466099|76029745|FG000|Overall Study|Rescued without meeting criteria|4|||
42213867|NCT03466099|76029746|FG001|Overall Study|Rescued without meeting criteria|1|||
42213868|NCT03466099|76029747|FG002|Overall Study|Rescued without meeting criteria|1|||
42213869|NCT03466099|76029745|FG000|Overall Study|Subject compliance|2|||
42213870|NCT03466099|76029746|FG001|Overall Study|Subject compliance|0|||
42213871|NCT03466099|76029747|FG002|Overall Study|Subject compliance|0|||
42213872|NCT03466099|76029745|FG000|Overall Study|Worsening disease|0|||
42213873|NCT03466099|76029746|FG001|Overall Study|Worsening disease|0|||
42213874|NCT03466099|76029747|FG002|Overall Study|Worsening disease|1|||
42213875|NCT00739674|76029757|FG000|Overall Study|Screening failures|19|||
42213876|NCT00739674|76029758|FG001|Overall Study|Screening failures|17|||
42213877|NCT00739674|76029757|FG000|Overall Study|Site 212 removal|19|||
42213878|NCT00739674|76029758|FG001|Overall Study|Site 212 removal|13|||
42213879|NCT00739674|76029757|FG000|Overall Study|No follow-up data|33|||
42213880|NCT00739674|76029758|FG001|Overall Study|No follow-up data|18|||
42213881|NCT00739674|76029757|FG000|Overall Study|Dietician consultation >30 days|1|||
42213882|NCT00739674|76029758|FG001|Overall Study|Dietician consultation >30 days|9|||
42213883|NCT00739674|76029757|FG000|Overall Study|Adverse Event|22|||
42213884|NCT00739674|76029758|FG001|Overall Study|Adverse Event|13|||
42213885|NCT00739674|76029757|FG000|Overall Study|Death|1|||
42213886|NCT00739674|76029758|FG001|Overall Study|Death|0|||
42213887|NCT00739674|76029757|FG000|Overall Study|Lack of Efficacy|1|||
42213888|NCT00739674|76029758|FG001|Overall Study|Lack of Efficacy|0|||
42213889|NCT00739674|76029757|FG000|Overall Study|Lost to Follow-up|52|||
41976545|NCT03338790|75780441|FG003|Overall Study|Disease Progression|37|||
41976546|NCT03338790|75780438|FG000|Overall Study|Study Drug Toxicity|9|||
41976547|NCT03338790|75780439|FG001|Overall Study|Study Drug Toxicity|8|||
41976548|NCT03338790|75780440|FG002|Overall Study|Study Drug Toxicity|15|||
41976549|NCT03338790|75780441|FG003|Overall Study|Study Drug Toxicity|0|||
41976550|NCT03338790|75780438|FG000|Overall Study|Death|1|||
41976551|NCT03338790|75780439|FG001|Overall Study|Death|1|||
41976552|NCT03338790|75780440|FG002|Overall Study|Death|1|||
41976553|NCT03338790|75780441|FG003|Overall Study|Death|0|||
41976554|NCT03338790|75780438|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
41976555|NCT03338790|75780439|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
41976556|NCT03338790|75780440|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
42213890|NCT00739674|76029758|FG001|Overall Study|Lost to Follow-up|30|||
42213891|NCT00739674|76029757|FG000|Overall Study|Protocol Violation|5|||
42213892|NCT00739674|76029758|FG001|Overall Study|Protocol Violation|5|||
42213893|NCT00739674|76029757|FG000|Overall Study|Withdrawal by Subject|9|||
42213894|NCT00739674|76029758|FG001|Overall Study|Withdrawal by Subject|9|||
42213895|NCT00739674|76029757|FG000|Overall Study|Reason missing|2|||
42213896|NCT00739674|76029758|FG001|Overall Study|Reason missing|0|||
42213897|NCT00739674|76029757|FG000|Overall Study|Clinic closed|6|||
42213898|NCT00739674|76029758|FG001|Overall Study|Clinic closed|4|||
42213899|NCT00739674|76029757|FG000|Overall Study|Patient moved|3|||
42213900|NCT00739674|76029758|FG001|Overall Study|Patient moved|2|||
41976557|NCT03338790|75780441|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
41976558|NCT03338790|75780438|FG000|Overall Study|Participant request to discontinue study treatment|3|||
41976559|NCT03338790|75780439|FG001|Overall Study|Participant request to discontinue study treatment|3|||
41976560|NCT03338790|75780440|FG002|Overall Study|Participant request to discontinue study treatment|2|||
41976561|NCT03338790|75780441|FG003|Overall Study|Participant request to discontinue study treatment|1|||
41976562|NCT03338790|75780438|FG000|Overall Study|Poor/non-compliance|0|||
41976563|NCT03338790|75780439|FG001|Overall Study|Poor/non-compliance|1|||
41976564|NCT03338790|75780440|FG002|Overall Study|Poor/non-compliance|0|||
41976565|NCT03338790|75780441|FG003|Overall Study|Poor/non-compliance|0|||
42213901|NCT00739674|76029757|FG000|Overall Study|Non compliant|4|||
42213902|NCT00739674|76029758|FG001|Overall Study|Non compliant|0|||
42213903|NCT00739674|76029757|FG000|Overall Study|Unable to attend visit|3|||
42213904|NCT00739674|76029758|FG001|Overall Study|Unable to attend visit|1|||
42213905|NCT00739674|76029757|FG000|Overall Study|Home monitoring off meds|1|||
42213906|NCT00739674|76029758|FG001|Overall Study|Home monitoring off meds|0|||
42213907|NCT00739674|76029757|FG000|Overall Study|Erectile dysfunction|0|||
42213908|NCT00739674|76029758|FG001|Overall Study|Erectile dysfunction|1|||
42213909|NCT03494725|76029766|FG000|Overall Study|Withdrawal by Subject|0|||
42213910|NCT03494725|76029767|FG001|Overall Study|Withdrawal by Subject|2|||
42213911|NCT03494725|76029766|FG000|Overall Study|Antibiotic use|1|||
42213912|NCT03494725|76029767|FG001|Overall Study|Antibiotic use|0|||
42213913|NCT00705718|76029781|FG000|Overall Study|Death|6|||
42213914|NCT00705718|76029782|FG001|Overall Study|Death|6|||
42213915|NCT00705718|76029781|FG000|Overall Study|Not due for Visit|0|||
42213916|NCT00705718|76029782|FG001|Overall Study|Not due for Visit|12|||
42213917|NCT00705718|76029781|FG000|Overall Study|Follow up not done|1|||
42213918|NCT00705718|76029782|FG001|Overall Study|Follow up not done|4|||
42213919|NCT03435211|76029788|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
42213920|NCT03465709|76029801|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
42213921|NCT03465709|76029801|FG000|Overall Study|Withdrawal by Subject|3|||
42213922|NCT03435055|76029807|FG000|Screening|Physician Decision|2|||
42213923|NCT03435055|76029807|FG000|Received Intervention|Did not complete nitrous administration|3|||
42213924|NCT03434977|76029820|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
42213925|NCT03434977|76029821|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
42213926|NCT03434119|76029829|FG000|Overall Study|Randomized but not treated|1|||
42213927|NCT03434119|76029830|FG001|Overall Study|Randomized but not treated|0|||
42301862|NCT02287233|76137036|FG001|Overall Study|Adverse Event Related to Progression|2|||
42301863|NCT02287233|76137037|FG002|Overall Study|Adverse Event Related to Progression|8|||
42301864|NCT02287233|76137035|FG000|Overall Study|Physician Decision|1|||
41976566|NCT03338790|75780438|FG000|Overall Study|Participant withdrew consent|1|||
42128263|NCT00525824|75938828|FG002|Overall Study|Safety reasons|1|||
42128264|NCT00525824|75938829|FG003|Overall Study|Safety reasons|0|||
42128265|NCT00525824|75938826|FG000|Overall Study|Other|1|||
42128266|NCT00525824|75938827|FG001|Overall Study|Other|3|||
42128267|NCT00525824|75938828|FG002|Overall Study|Other|3|||
42128268|NCT00525824|75938829|FG003|Overall Study|Other|1|||
42128269|NCT00525590|75938843|FG000|Overall Study|Adverse Event|3|||
42128270|NCT00525590|75938843|FG000|Overall Study|Physician Decision|3|||
42128271|NCT00525590|75938843|FG000|Overall Study|Withdrawal by Subject|16|||
42128272|NCT00525590|75938843|FG000|Overall Study|Lost to Follow-up|1|||
42128273|NCT00525590|75938843|FG000|Overall Study|Death|9|||
42128274|NCT00525590|75938843|FG000|Overall Study|Other|13|||
42128275|NCT00430677|75938850|FG000|Short-term Period|Death|1|||
42128276|NCT00430677|75938851|FG001|Short-term Period|Death|1|||
42128277|NCT00430677|75938852|FG002|Short-term Period|Death|5|||
42128278|NCT00430677|75938850|FG000|Short-term Period|Adverse Event|15|||
42128279|NCT00430677|75938851|FG001|Short-term Period|Adverse Event|13|||
42128280|NCT00430677|75938852|FG002|Short-term Period|Adverse Event|9|||
42128281|NCT00430677|75938850|FG000|Short-term Period|Lack of Efficacy|5|||
42128282|NCT00430677|75938851|FG001|Short-term Period|Lack of Efficacy|6|||
42128283|NCT00430677|75938852|FG002|Short-term Period|Lack of Efficacy|4|||
42128284|NCT00430677|75938850|FG000|Short-term Period|Withdrawal by Subject|1|||
42128285|NCT00430677|75938851|FG001|Short-term Period|Withdrawal by Subject|1|||
42128286|NCT00430677|75938852|FG002|Short-term Period|Withdrawal by Subject|2|||
42128287|NCT00430677|75938850|FG000|Short-term Period|Participant no longer met study criteria|1|||
42128288|NCT00430677|75938851|FG001|Short-term Period|Participant no longer met study criteria|1|||
42128289|NCT00430677|75938852|FG002|Short-term Period|Participant no longer met study criteria|2|||
42128290|NCT00430677|75938850|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
42128291|NCT00430677|75938851|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
42128292|NCT00430677|75938852|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
42128293|NCT00430677|75938850|FG000|Short-term Period|Pregnancy|0|||
42128294|NCT00430677|75938851|FG001|Short-term Period|Pregnancy|2|||
42128295|NCT00430677|75938852|FG002|Short-term Period|Pregnancy|0|||
42128296|NCT00430677|75938850|FG000|Long-term Extension Period|Death|1|||
42128297|NCT00430677|75938851|FG001|Long-term Extension Period|Death|0|||
42128298|NCT00430677|75938852|FG002|Long-term Extension Period|Death|0|||
42128299|NCT00430677|75938850|FG000|Long-term Extension Period|Adverse Event|3|||
42128300|NCT00430677|75938851|FG001|Long-term Extension Period|Adverse Event|2|||
42128301|NCT00430677|75938852|FG002|Long-term Extension Period|Adverse Event|5|||
42128302|NCT00430677|75938850|FG000|Long-term Extension Period|Lack of Efficacy|5|||
42128303|NCT00430677|75938851|FG001|Long-term Extension Period|Lack of Efficacy|3|||
42213928|NCT03434119|76029829|FG000|Overall Study|Adverse Event|1|||
42213929|NCT03434119|76029830|FG001|Overall Study|Adverse Event|0|||
42213930|NCT03434119|76029829|FG000|Overall Study|Poor Compliance to Protocol|0|||
42213931|NCT03434119|76029830|FG001|Overall Study|Poor Compliance to Protocol|1|||
42213932|NCT03434119|76029829|FG000|Overall Study|Study Terminated by Sponsor|91|||
42128304|NCT00430677|75938852|FG002|Long-term Extension Period|Lack of Efficacy|8|||
42128305|NCT00430677|75938850|FG000|Long-term Extension Period|Lost to Follow-up|1|||
42128306|NCT00430677|75938851|FG001|Long-term Extension Period|Lost to Follow-up|1|||
42301865|NCT02287233|76137036|FG001|Overall Study|Physician Decision|2|||
42301866|NCT02287233|76137037|FG002|Overall Study|Physician Decision|4|||
42301867|NCT02287233|76137035|FG000|Overall Study|Progressive Disease with Death|0|||
41976567|NCT03338790|75780439|FG001|Overall Study|Participant withdrew consent|0|||
41976568|NCT03338790|75780440|FG002|Overall Study|Participant withdrew consent|1|||
41976569|NCT03338790|75780441|FG003|Overall Study|Participant withdrew consent|1|||
41976570|NCT03338790|75780438|FG000|Overall Study|Other reasons|0|||
41976571|NCT03338790|75780439|FG001|Overall Study|Other reasons|5|||
41976572|NCT03338790|75780440|FG002|Overall Study|Other reasons|0|||
41976573|NCT03338790|75780441|FG003|Overall Study|Other reasons|2|||
41976574|NCT03338790|75780438|FG000|Overall Study|Not reported|0|||
41976575|NCT03338790|75780439|FG001|Overall Study|Not reported|0|||
41976576|NCT03338790|75780440|FG002|Overall Study|Not reported|1|||
41976577|NCT03338790|75780441|FG003|Overall Study|Not reported|0|||
41976578|NCT03338790|75780438|FG000|Overall Study|Completed treatment period|1|||
41976579|NCT03338790|75780439|FG001|Overall Study|Completed treatment period|2|||
41976580|NCT03338790|75780440|FG002|Overall Study|Completed treatment period|0|||
42028426|NCT00910858|75836849|FG001|Combined Treatment Phase|Other|2|||
42128307|NCT00430677|75938852|FG002|Long-term Extension Period|Lost to Follow-up|1|||
42128308|NCT00430677|75938850|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
42128309|NCT00430677|75938851|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
42128310|NCT00430677|75938852|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
42128311|NCT00430677|75938850|FG000|Long-term Extension Period|Pregnancy|1|||
42128312|NCT00430677|75938851|FG001|Long-term Extension Period|Pregnancy|1|||
42128313|NCT00430677|75938852|FG002|Long-term Extension Period|Pregnancy|0|||
42128314|NCT00430677|75938850|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
42128315|NCT00430677|75938851|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
42128316|NCT00430677|75938852|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
42128317|NCT00430677|75938850|FG000|Long-term Extension Period|Other|2|||
42128318|NCT00430677|75938851|FG001|Long-term Extension Period|Other|1|||
42128319|NCT00430677|75938852|FG002|Long-term Extension Period|Other|1|||
42128320|NCT00430677|75938850|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
42128321|NCT00430677|75938851|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
42128322|NCT00430677|75938852|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
42128323|NCT00525512|75938880|FG000|Double-Blind Phase|Adverse Event|48|||
42128324|NCT00525512|75938881|FG001|Double-Blind Phase|Adverse Event|28|||
42128325|NCT00525512|75938882|FG002|Double-Blind Phase|Adverse Event|0|||
42128326|NCT00525512|75938883|FG003|Double-Blind Phase|Adverse Event|0|||
42128327|NCT00525512|75938880|FG000|Double-Blind Phase|Protocol Violation|3|||
42128328|NCT00525512|75938881|FG001|Double-Blind Phase|Protocol Violation|1|||
42128329|NCT00525512|75938882|FG002|Double-Blind Phase|Protocol Violation|0|||
42128330|NCT00525512|75938883|FG003|Double-Blind Phase|Protocol Violation|0|||
42128331|NCT00525512|75938880|FG000|Double-Blind Phase|Lost to Follow-up|3|||
42128332|NCT00525512|75938881|FG001|Double-Blind Phase|Lost to Follow-up|7|||
42128333|NCT00525512|75938882|FG002|Double-Blind Phase|Lost to Follow-up|0|||
42128334|NCT00525512|75938883|FG003|Double-Blind Phase|Lost to Follow-up|0|||
42128335|NCT00525512|75938880|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
42128336|NCT00525512|75938881|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
42128337|NCT00525512|75938882|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
42128338|NCT00525512|75938883|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
42128339|NCT00525512|75938880|FG000|Double-Blind Phase|Lack of Efficacy|13|||
42128340|NCT00525512|75938881|FG001|Double-Blind Phase|Lack of Efficacy|5|||
42128341|NCT00525512|75938882|FG002|Double-Blind Phase|Lack of Efficacy|0|||
42128342|NCT00525512|75938883|FG003|Double-Blind Phase|Lack of Efficacy|0|||
42128343|NCT00525512|75938880|FG000|Double-Blind Phase|Other reason (not specified)|12|||
42128344|NCT00525512|75938881|FG001|Double-Blind Phase|Other reason (not specified)|13|||
42128345|NCT00525512|75938882|FG002|Double-Blind Phase|Other reason (not specified)|0|||
42128346|NCT00525512|75938883|FG003|Double-Blind Phase|Other reason (not specified)|0|||
42128347|NCT00525512|75938880|FG000|Open-Label Phase|Adverse Event|0|||
42128348|NCT00525512|75938881|FG001|Open-Label Phase|Adverse Event|0|||
42128349|NCT00525512|75938882|FG002|Open-Label Phase|Adverse Event|1|||
42128350|NCT00525512|75938883|FG003|Open-Label Phase|Adverse Event|0|||
42128351|NCT00525512|75938880|FG000|Open-Label Phase|Lost to Follow-up|0|||
42128352|NCT00525512|75938881|FG001|Open-Label Phase|Lost to Follow-up|0|||
42128353|NCT00525512|75938882|FG002|Open-Label Phase|Lost to Follow-up|1|||
42128354|NCT00525512|75938883|FG003|Open-Label Phase|Lost to Follow-up|0|||
42128355|NCT00525512|75938880|FG000|Open-Label Phase|Other reason (not specified)|0|||
42128356|NCT00525512|75938881|FG001|Open-Label Phase|Other reason (not specified)|0|||
42128357|NCT00525512|75938882|FG002|Open-Label Phase|Other reason (not specified)|4|||
42128358|NCT00525512|75938883|FG003|Open-Label Phase|Other reason (not specified)|5|||
42128359|NCT00517634|75938895|FG000|Second Treatment Period|Withdrawal by Subject|0|||
41976581|NCT03338790|75780441|FG003|Overall Study|Completed treatment period|0|||
42128360|NCT00517634|75938896|FG001|Second Treatment Period|Withdrawal by Subject|0|||
41976582|NCT02954536|75780468|FG000|Overall Study|Adverse Event|2|||
42213933|NCT03434119|76029830|FG001|Overall Study|Study Terminated by Sponsor|102|||
42213934|NCT03434119|76029829|FG000|Overall Study|Withdrawal by Subject|7|||
42213935|NCT03434119|76029830|FG001|Overall Study|Withdrawal by Subject|5|||
42213936|NCT03434119|76029829|FG000|Overall Study|Other than specified|7|||
42213937|NCT03434119|76029830|FG001|Overall Study|Other than specified|5|||
42213938|NCT00378378|76029839|FG000|Overall Study|Withdrawal by Subject|0|||
42213939|NCT00378378|76029840|FG001|Overall Study|Withdrawal by Subject|1|||
42213940|NCT00378378|76029841|FG002|Overall Study|Withdrawal by Subject|0|||
42213941|NCT00378378|76029839|FG000|Overall Study|Treatment Failure|0|||
42213942|NCT00378378|76029840|FG001|Overall Study|Treatment Failure|0|||
42213943|NCT00378378|76029841|FG002|Overall Study|Treatment Failure|1|||
42213944|NCT00378378|76029839|FG000|Overall Study|Non-compliance with protocol|0|||
42213945|NCT00378378|76029840|FG001|Overall Study|Non-compliance with protocol|0|||
42213946|NCT00378378|76029841|FG002|Overall Study|Non-compliance with protocol|1|||
42213947|NCT03490981|76029851|FG000|Overall Study|Lost to Follow-up|1|||
42213948|NCT03490981|76029852|FG001|Overall Study|Lost to Follow-up|2|||
42213949|NCT03160716|76029858|FG000|Overall Study|Lost to Follow-up|1|||
42213950|NCT03713021|76029862|FG000|Overall Study|Did not have CT sim scan available|6|||
42213951|NCT03713021|76029862|FG000|Overall Study|Not eligible|4|||
42213952|NCT03713021|76029862|FG000|Overall Study|Issues with TraceIT markers|5|||
42213953|NCT03160560|76029870|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
42213954|NCT03160560|76029871|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
42213955|NCT03160560|76029872|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
42213956|NCT03160560|76029873|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
42213957|NCT03160560|76029870|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
42213958|NCT03160560|76029871|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
42213959|NCT03160560|76029872|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
42213960|NCT03160560|76029873|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
42213961|NCT03489343|76029890|FG000|Overall Study|Documented progressive disease|1|||
42213962|NCT03489343|76029891|FG001|Overall Study|Documented progressive disease|0|||
42213963|NCT03489343|76029892|FG002|Overall Study|Documented progressive disease|3|||
42213964|NCT03489343|76029893|FG003|Overall Study|Documented progressive disease|1|||
42213965|NCT03489343|76029894|FG004|Overall Study|Documented progressive disease|3|||
42213966|NCT03489343|76029895|FG005|Overall Study|Documented progressive disease|5|||
42213967|NCT03489343|76029896|FG006|Overall Study|Documented progressive disease|4|||
42213968|NCT03489343|76029890|FG000|Overall Study|Adverse Event|0|||
42213969|NCT03489343|76029891|FG001|Overall Study|Adverse Event|1|||
42213970|NCT03489343|76029892|FG002|Overall Study|Adverse Event|0|||
42213971|NCT03489343|76029893|FG003|Overall Study|Adverse Event|0|||
42213972|NCT03489343|76029894|FG004|Overall Study|Adverse Event|0|||
41976583|NCT02954536|75780468|FG000|Overall Study|Death|12|||
41976584|NCT02919670|75780474|FG000|Overall Study|Only 17 participants met compliance|43|||
42213973|NCT03489343|76029895|FG005|Overall Study|Adverse Event|1|||
42213974|NCT03489343|76029896|FG006|Overall Study|Adverse Event|0|||
42213975|NCT03489343|76029890|FG000|Overall Study|Withdrawal by Subject|0|||
42213976|NCT03489343|76029891|FG001|Overall Study|Withdrawal by Subject|0|||
42213977|NCT03489343|76029892|FG002|Overall Study|Withdrawal by Subject|0|||
41976585|NCT02919670|75780475|FG001|Overall Study|Only 17 participants met compliance|39|||
41976586|NCT02250326|75780574|FG000|Treatment Period|Death|1|||
41976587|NCT02250326|75780575|FG001|Treatment Period|Death|12|||
41976588|NCT02250326|75780576|FG002|Treatment Period|Death|2|||
41976589|NCT02250326|75780574|FG000|Treatment Period|Adverse Event|8|||
41976590|NCT02250326|75780575|FG001|Treatment Period|Adverse Event|4|||
41976591|NCT02250326|75780576|FG002|Treatment Period|Adverse Event|8|||
41976592|NCT02250326|75780574|FG000|Treatment Period|Progressive Disease|42|||
41976593|NCT02250326|75780575|FG001|Treatment Period|Progressive Disease|36|||
41976594|NCT02250326|75780576|FG002|Treatment Period|Progressive Disease|45|||
41976595|NCT02250326|75780574|FG000|Treatment Period|Symptomatic Deterioration|9|||
41976596|NCT02250326|75780575|FG001|Treatment Period|Symptomatic Deterioration|4|||
41976597|NCT02250326|75780576|FG002|Treatment Period|Symptomatic Deterioration|10|||
41976598|NCT02250326|75780574|FG000|Treatment Period|Withdrawal by Subject|11|||
41976599|NCT02250326|75780575|FG001|Treatment Period|Withdrawal by Subject|5|||
41976600|NCT02250326|75780576|FG002|Treatment Period|Withdrawal by Subject|4|||
41976601|NCT02250326|75780574|FG000|Treatment Period|Miscellaneous|8|||
42128361|NCT00517634|75938897|FG002|Second Treatment Period|Withdrawal by Subject|0|||
42128362|NCT00517634|75938898|FG003|Second Treatment Period|Withdrawal by Subject|0|||
42128363|NCT00517634|75938899|FG004|Second Treatment Period|Withdrawal by Subject|1|||
42128364|NCT00517634|75938900|FG005|Second Treatment Period|Withdrawal by Subject|0|||
42128365|NCT03683576|75938912|FG000|Overall Study|Withdrawal by Subject|2|||
42128366|NCT03683576|75938913|FG001|Overall Study|Withdrawal by Subject|0|||
42128367|NCT03683576|75938914|FG002|Overall Study|Withdrawal by Subject|8|||
42128368|NCT03683576|75938915|FG003|Overall Study|Withdrawal by Subject|3|||
42128369|NCT03683576|75938912|FG000|Overall Study|Adverse Event|3|||
42128370|NCT03683576|75938913|FG001|Overall Study|Adverse Event|0|||
42128371|NCT03683576|75938914|FG002|Overall Study|Adverse Event|0|||
42128372|NCT03683576|75938915|FG003|Overall Study|Adverse Event|4|||
42128373|NCT03683576|75938912|FG000|Overall Study|Lack of Efficacy|1|||
42128374|NCT03683576|75938913|FG001|Overall Study|Lack of Efficacy|0|||
42128375|NCT03683576|75938914|FG002|Overall Study|Lack of Efficacy|1|||
42128376|NCT03683576|75938915|FG003|Overall Study|Lack of Efficacy|1|||
42128377|NCT03683576|75938912|FG000|Overall Study|Lost to Follow-up|0|||
42128378|NCT03683576|75938913|FG001|Overall Study|Lost to Follow-up|1|||
42128379|NCT03683576|75938914|FG002|Overall Study|Lost to Follow-up|2|||
42128380|NCT03683576|75938915|FG003|Overall Study|Lost to Follow-up|0|||
42128381|NCT03683576|75938912|FG000|Overall Study|Other, Not Specified|0|||
42128382|NCT03683576|75938913|FG001|Overall Study|Other, Not Specified|2|||
42128383|NCT03683576|75938914|FG002|Overall Study|Other, Not Specified|0|||
42128384|NCT03683576|75938915|FG003|Overall Study|Other, Not Specified|0|||
42128385|NCT03683576|75938912|FG000|Overall Study|Protocol Violation|0|||
42128386|NCT03683576|75938913|FG001|Overall Study|Protocol Violation|1|||
42128387|NCT03683576|75938914|FG002|Overall Study|Protocol Violation|1|||
42128388|NCT03683576|75938915|FG003|Overall Study|Protocol Violation|0|||
42128389|NCT03863834|75938925|FG000|Overall Study|Lost to Follow-up|3|||
42128390|NCT00430521|75938937|FG000|Overall Study|Adverse Event|0|||
42128391|NCT00430521|75938938|FG001|Overall Study|Adverse Event|0|||
42213978|NCT03489343|76029893|FG003|Overall Study|Withdrawal by Subject|1|||
41976602|NCT02250326|75780575|FG001|Treatment Period|Miscellaneous|2|||
41976603|NCT02250326|75780576|FG002|Treatment Period|Miscellaneous|7|||
41976604|NCT02250326|75780574|FG000|Treatment Period|Randomized or assigned; not treated|2|||
41976605|NCT02250326|75780575|FG001|Treatment Period|Randomized or assigned; not treated|1|||
41976606|NCT02250326|75780576|FG002|Treatment Period|Randomized or assigned; not treated|1|||
41976607|NCT02250326|75780574|FG000|Follow-Up Period|Death|46|||
41976608|NCT02250326|75780575|FG001|Follow-Up Period|Death|26|||
41976609|NCT02250326|75780576|FG002|Follow-Up Period|Death|32|||
41976610|NCT02250326|75780574|FG000|Follow-Up Period|Unknown or Missing|2|||
41976611|NCT02250326|75780575|FG001|Follow-Up Period|Unknown or Missing|3|||
41976612|NCT02250326|75780576|FG002|Follow-Up Period|Unknown or Missing|3|||
41976613|NCT02250326|75780574|FG000|Follow-Up Period|Lost to Follow-up|1|||
41976614|NCT02250326|75780575|FG001|Follow-Up Period|Lost to Follow-up|1|||
41976615|NCT02250326|75780576|FG002|Follow-Up Period|Lost to Follow-up|3|||
41976616|NCT01567722|75780588|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
41976617|NCT01567722|75780589|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
41976618|NCT01567722|75780590|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
41976619|NCT01567722|75780588|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
41976620|NCT01567722|75780589|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
41976621|NCT01567722|75780590|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
41976622|NCT01567722|75780588|FG000|Overall Study|Protocol closure by the OCG|2|||
41976623|NCT01567722|75780589|FG001|Overall Study|Protocol closure by the OCG|0|||
41976624|NCT01567722|75780590|FG002|Overall Study|Protocol closure by the OCG|0|||
41976625|NCT01567722|75780588|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
41976626|NCT01567722|75780589|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
41976627|NCT01567722|75780590|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
41976628|NCT01349790|75780615|FG000|Overall Study|Investigator Judgement|3|||
41976629|NCT01349790|75780615|FG000|Overall Study|Death|2|||
41976630|NCT01349790|75780615|FG000|Overall Study|Withdrawal by Patient|2|||
41976631|NCT01349790|75780615|FG000|Overall Study|Adverse Event|1|||
41976632|NCT01349790|75780615|FG000|Overall Study|Lost to Follow-up|1|||
41976633|NCT01349595|75780621|FG000|Overall Study|Lack of funding|2|||
41976634|NCT01349595|75780622|FG001|Overall Study|Lack of funding|2|||
41976635|NCT01349673|75780632|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
41976636|NCT01349673|75780632|FG000|Overall Study|No Longer Qualified For Study|1|||
41976637|NCT01349673|75780632|FG000|Overall Study|Site Closure|10|||
41976638|NCT01349673|75780632|FG000|Overall Study|Withdrawal by Subject|21|||
41976639|NCT01349673|75780632|FG000|Overall Study|Lost to Follow-up|6|||
41976640|NCT01349673|75780632|FG000|Overall Study|Adverse Event|17|||
41976641|NCT01349673|75780632|FG000|Overall Study|Study Terminated By Sponsor|50|||
41976642|NCT01349673|75780632|FG000|Overall Study|Lack of Efficacy|8|||
41976643|NCT04725682|75780662|FG000|Overall Study|Withdrawal by Subject|7|||
41976644|NCT04725682|75780663|FG001|Overall Study|Withdrawal by Subject|5|||
41976645|NCT04725682|75780662|FG000|Overall Study|Failed to comply with the requirements|2|||
41976646|NCT04725682|75780663|FG001|Overall Study|Failed to comply with the requirements|1|||
41976647|NCT04725682|75780662|FG000|Overall Study|Adverse Event|1|||
41976648|NCT04725682|75780663|FG001|Overall Study|Adverse Event|1|||
41976649|NCT04725682|75780662|FG000|Overall Study|Death|0|||
41976650|NCT04725682|75780663|FG001|Overall Study|Death|1|||
42128392|NCT00430521|75938939|FG002|Overall Study|Adverse Event|0|||
42128393|NCT00430521|75938940|FG003|Overall Study|Adverse Event|0|||
42128394|NCT00430521|75938941|FG004|Overall Study|Adverse Event|0|||
42128395|NCT00430521|75938942|FG005|Overall Study|Adverse Event|2|||
42128396|NCT00430521|75938943|FG006|Overall Study|Adverse Event|1|||
42128397|NCT00430521|75938944|FG007|Overall Study|Adverse Event|0|||
42128398|NCT00430521|75938937|FG000|Overall Study|Lost to Follow-up|7|||
42213979|NCT03489343|76029894|FG004|Overall Study|Withdrawal by Subject|0|||
42213980|NCT03489343|76029895|FG005|Overall Study|Withdrawal by Subject|1|||
41976651|NCT01349660|75780695|FG000|Overall Study|Still Receiving Study Treatment|0|||
41976652|NCT01349660|75780696|FG001|Overall Study|Still Receiving Study Treatment|0|||
41976653|NCT01349660|75780697|FG002|Overall Study|Still Receiving Study Treatment|1|||
42128399|NCT00430521|75938938|FG001|Overall Study|Lost to Follow-up|8|||
42028427|NCT00910858|75836850|FG002|Combined Treatment Phase|Other|1|||
42128400|NCT00430521|75938939|FG002|Overall Study|Lost to Follow-up|3|||
42213981|NCT03489343|76029896|FG006|Overall Study|Withdrawal by Subject|1|||
42213982|NCT03489343|76029890|FG000|Overall Study|Clinical progression|0|||
42213983|NCT03489343|76029891|FG001|Overall Study|Clinical progression|0|||
42301868|NCT02287233|76137036|FG001|Overall Study|Progressive Disease with Death|0|||
41976654|NCT01349660|75780695|FG000|Overall Study|Disease Progression|2|||
41976655|NCT01349660|75780696|FG001|Overall Study|Disease Progression|4|||
41976656|NCT01349660|75780697|FG002|Overall Study|Disease Progression|50|||
41976657|NCT01349660|75780695|FG000|Overall Study|Adverse Event|1|||
41976658|NCT01349660|75780696|FG001|Overall Study|Adverse Event|1|||
41976659|NCT01349660|75780697|FG002|Overall Study|Adverse Event|12|||
41976660|NCT01349660|75780695|FG000|Overall Study|Withdrawal by Subject|2|||
42213984|NCT03489343|76029892|FG002|Overall Study|Clinical progression|0|||
41976661|NCT01349660|75780696|FG001|Overall Study|Withdrawal by Subject|0|||
41976662|NCT01349660|75780697|FG002|Overall Study|Withdrawal by Subject|9|||
41976663|NCT01349660|75780695|FG000|Overall Study|Death|1|||
41976664|NCT01349660|75780696|FG001|Overall Study|Death|1|||
41976665|NCT01349660|75780697|FG002|Overall Study|Death|0|||
41976666|NCT01349660|75780695|FG000|Overall Study|Non-Permitted Interventions|0|||
42213985|NCT03489343|76029893|FG003|Overall Study|Clinical progression|1|||
42213986|NCT03489343|76029894|FG004|Overall Study|Clinical progression|0|||
42213987|NCT03489343|76029895|FG005|Overall Study|Clinical progression|0|||
42213988|NCT03489343|76029896|FG006|Overall Study|Clinical progression|1|||
42213989|NCT03489109|76029914|FG000|Overall Study|Lost to Follow-up|1|||
42213990|NCT03489109|76029915|FG001|Overall Study|Lost to Follow-up|2|||
42213991|NCT03709823|76029927|FG000|Overall Study|Adverse Event|0|||
42213992|NCT03709823|76029928|FG001|Overall Study|Adverse Event|0|||
42213993|NCT03709823|76029929|FG002|Overall Study|Adverse Event|1|||
42213994|NCT03709823|76029930|FG003|Overall Study|Adverse Event|0|||
42213995|NCT03709823|76029931|FG004|Overall Study|Adverse Event|0|||
42213996|NCT03709823|76029932|FG005|Overall Study|Adverse Event|0|||
42213997|NCT03709823|76029927|FG000|Overall Study|Lost to Follow-up|2|||
42213998|NCT03709823|76029928|FG001|Overall Study|Lost to Follow-up|2|||
42213999|NCT03709823|76029929|FG002|Overall Study|Lost to Follow-up|2|||
42214000|NCT03709823|76029930|FG003|Overall Study|Lost to Follow-up|1|||
42214001|NCT03709823|76029931|FG004|Overall Study|Lost to Follow-up|1|||
42214002|NCT03709823|76029932|FG005|Overall Study|Lost to Follow-up|0|||
42214003|NCT03709823|76029927|FG000|Overall Study|Withdrawal by Subject|1|||
42214004|NCT03709823|76029928|FG001|Overall Study|Withdrawal by Subject|3|||
42214005|NCT03709823|76029929|FG002|Overall Study|Withdrawal by Subject|0|||
42214006|NCT03709823|76029930|FG003|Overall Study|Withdrawal by Subject|0|||
42214007|NCT03709823|76029931|FG004|Overall Study|Withdrawal by Subject|0|||
42214008|NCT03709823|76029932|FG005|Overall Study|Withdrawal by Subject|0|||
42214009|NCT03709823|76029927|FG000|Overall Study|Other, Not Specified|0|||
42214010|NCT03709823|76029928|FG001|Overall Study|Other, Not Specified|0|||
42214011|NCT03709823|76029929|FG002|Overall Study|Other, Not Specified|0|||
42301869|NCT02287233|76137037|FG002|Overall Study|Progressive Disease with Death|10|||
42301870|NCT02287233|76137035|FG000|Overall Study|Progressive Disease Without Death|2|||
42301871|NCT02287233|76137036|FG001|Overall Study|Progressive Disease Without Death|3|||
42301872|NCT02287233|76137037|FG002|Overall Study|Progressive Disease Without Death|20|||
42301873|NCT02287233|76137035|FG000|Overall Study|Withdrawal by Subject|1|||
42301874|NCT02287233|76137036|FG001|Overall Study|Withdrawal by Subject|1|||
41976667|NCT01349660|75780696|FG001|Overall Study|Non-Permitted Interventions|0|||
41976668|NCT01349660|75780697|FG002|Overall Study|Non-Permitted Interventions|2|||
41976669|NCT01349660|75780695|FG000|Overall Study|Study Compliance|0|||
41976670|NCT01349660|75780696|FG001|Overall Study|Study Compliance|0|||
41976671|NCT01349660|75780697|FG002|Overall Study|Study Compliance|1|||
42028428|NCT00598975|75836868|FG000|Overall Study|Adverse Event|1|||
42301875|NCT02287233|76137037|FG002|Overall Study|Withdrawal by Subject|7|||
42301876|NCT02287233|76137035|FG000|Overall Study|Other|3|||
42301877|NCT02287233|76137036|FG001|Overall Study|Other|0|||
42301878|NCT02287233|76137037|FG002|Overall Study|Other|15|||
42301879|NCT02287233|76137035|FG000|Overall Study|Did Not Receive Treatment|0|||
42301880|NCT02287233|76137036|FG001|Overall Study|Did Not Receive Treatment|0|||
42301881|NCT02287233|76137037|FG002|Overall Study|Did Not Receive Treatment|2|||
42301882|NCT01646385|76137050|FG000|Overall Study|Death|202|||
42301883|NCT01646385|76137051|FG001|Overall Study|Death|222|||
42301884|NCT01646385|76137050|FG000|Overall Study|Switched to alternate biologic|636|||
42301885|NCT01646385|76137051|FG001|Overall Study|Switched to alternate biologic|649|||
42301886|NCT02286843|76137057|FG000|Overall Study|Not Treated|4|||
42301887|NCT02286843|76137057|FG000|Overall Study|Protocol Violation|1|||
41976672|NCT01349660|75780695|FG000|Overall Study|Declining Performance Status|0|||
41976673|NCT01349660|75780696|FG001|Overall Study|Declining Performance Status|0|||
41976674|NCT01349660|75780697|FG002|Overall Study|Declining Performance Status|1|||
42214012|NCT03709823|76029930|FG003|Overall Study|Other, Not Specified|1|||
42214013|NCT03709823|76029931|FG004|Overall Study|Other, Not Specified|0|||
42214014|NCT03709823|76029932|FG005|Overall Study|Other, Not Specified|0|||
42214015|NCT03488563|76029952|FG000|Overall Study|Lost to Follow-up|7|||
42214016|NCT03488563|76029953|FG001|Overall Study|Lost to Follow-up|6|||
42214017|NCT03488563|76029954|FG002|Overall Study|Lost to Follow-up|7|||
42214018|NCT03488563|76029952|FG000|Overall Study|Withdrawal by Subject|8|||
42214019|NCT03488563|76029953|FG001|Overall Study|Withdrawal by Subject|7|||
41976675|NCT01349569|75780716|FG000|Overall Study|Lack of Efficacy|4|||
42128401|NCT00430521|75938940|FG003|Overall Study|Lost to Follow-up|5|||
42128402|NCT00430521|75938941|FG004|Overall Study|Lost to Follow-up|5|||
42128403|NCT00430521|75938942|FG005|Overall Study|Lost to Follow-up|2|||
42128404|NCT00430521|75938943|FG006|Overall Study|Lost to Follow-up|8|||
42128405|NCT00430521|75938944|FG007|Overall Study|Lost to Follow-up|10|||
42128406|NCT00430521|75938937|FG000|Overall Study|Pregnancy|0|||
42128407|NCT00430521|75938938|FG001|Overall Study|Pregnancy|0|||
42128408|NCT00430521|75938939|FG002|Overall Study|Pregnancy|0|||
42128409|NCT00430521|75938940|FG003|Overall Study|Pregnancy|0|||
42128410|NCT00430521|75938941|FG004|Overall Study|Pregnancy|0|||
42128411|NCT00430521|75938942|FG005|Overall Study|Pregnancy|0|||
42128412|NCT00430521|75938943|FG006|Overall Study|Pregnancy|1|||
42128413|NCT00430521|75938944|FG007|Overall Study|Pregnancy|0|||
42128414|NCT00430521|75938937|FG000|Overall Study|Vaccine Expired|0|||
42128415|NCT00430521|75938938|FG001|Overall Study|Vaccine Expired|0|||
42128416|NCT00430521|75938939|FG002|Overall Study|Vaccine Expired|0|||
42128417|NCT00430521|75938940|FG003|Overall Study|Vaccine Expired|0|||
42128418|NCT00430521|75938941|FG004|Overall Study|Vaccine Expired|0|||
42128419|NCT00430521|75938942|FG005|Overall Study|Vaccine Expired|1|||
42128420|NCT00430521|75938943|FG006|Overall Study|Vaccine Expired|0|||
42128421|NCT00430521|75938944|FG007|Overall Study|Vaccine Expired|0|||
42128422|NCT00430521|75938937|FG000|Overall Study|Protocol Violation|1|||
42128423|NCT00430521|75938938|FG001|Overall Study|Protocol Violation|0|||
42128424|NCT00430521|75938939|FG002|Overall Study|Protocol Violation|0|||
42128425|NCT00430521|75938940|FG003|Overall Study|Protocol Violation|0|||
42128426|NCT00430521|75938941|FG004|Overall Study|Protocol Violation|0|||
42128427|NCT00430521|75938942|FG005|Overall Study|Protocol Violation|0|||
42128428|NCT00430521|75938943|FG006|Overall Study|Protocol Violation|0|||
42128429|NCT00430521|75938944|FG007|Overall Study|Protocol Violation|0|||
42128430|NCT00430521|75938937|FG000|Overall Study|Withdrawal by Subject|3|||
42128431|NCT00430521|75938938|FG001|Overall Study|Withdrawal by Subject|1|||
42128432|NCT00430521|75938939|FG002|Overall Study|Withdrawal by Subject|0|||
41976676|NCT05221749|75780767|FG000|Overall Study|Lost to Follow-up|2|||
41976677|NCT05221749|75780768|FG001|Overall Study|Lost to Follow-up|3|||
41976678|NCT04965389|75780822|FG000|Overall Study|Other reasons|1|||
41976679|NCT04965389|75780823|FG001|Overall Study|Other reasons|0|||
41976680|NCT04965389|75780824|FG002|Overall Study|Other reasons|0|||
42128433|NCT00430521|75938940|FG003|Overall Study|Withdrawal by Subject|3|||
42128434|NCT00430521|75938941|FG004|Overall Study|Withdrawal by Subject|0|||
42128435|NCT00430521|75938942|FG005|Overall Study|Withdrawal by Subject|0|||
42128436|NCT00430521|75938943|FG006|Overall Study|Withdrawal by Subject|0|||
42128437|NCT00430521|75938944|FG007|Overall Study|Withdrawal by Subject|2|||
42128438|NCT00429663|75938977|FG000|Overall Study|Lost to Follow-up|24|||
41976681|NCT04965389|75780825|FG003|Overall Study|Other reasons|0|||
41976682|NCT04965389|75780822|FG000|Overall Study|Participant withdrew consent|0|||
42128439|NCT00429663|75938978|FG001|Overall Study|Lost to Follow-up|31|||
42128440|NCT00429663|75938977|FG000|Overall Study|Physician Decision|6|||
42128441|NCT00429663|75938978|FG001|Overall Study|Physician Decision|3|||
42028429|NCT00598975|75836869|FG001|Overall Study|Adverse Event|1|||
42028430|NCT00598975|75836868|FG000|Overall Study|Brain metastases|1|||
42028431|NCT00598975|75836869|FG001|Overall Study|Brain metastases|0|||
42028432|NCT00598975|75836868|FG000|Overall Study|Withdrawal by Subject|1|||
42028433|NCT00598975|75836869|FG001|Overall Study|Withdrawal by Subject|1|||
42028434|NCT00598975|75836868|FG000|Overall Study|Withdrawal of consent|0|||
42028435|NCT00598975|75836869|FG001|Overall Study|Withdrawal of consent|1|||
42028436|NCT00598975|75836868|FG000|Overall Study|Disease progression|8|||
42028437|NCT00598975|75836869|FG001|Overall Study|Disease progression|3|||
42028438|NCT00598975|75836868|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
42028439|NCT00598975|75836869|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
42028440|NCT00957021|75836877|FG000|Overall Study|Death|5|||
42028441|NCT00957021|75836877|FG000|Overall Study|Lost to Follow-up|8|||
42301888|NCT02286843|76137057|FG000|Overall Study|Withdrawal by Subject|1|||
42301889|NCT02282163|76137061|FG000|Overall Study|Protocol Violation|1|||
41976683|NCT04965389|75780823|FG001|Overall Study|Participant withdrew consent|1|||
41976684|NCT04965389|75780824|FG002|Overall Study|Participant withdrew consent|0|||
41976685|NCT04965389|75780825|FG003|Overall Study|Participant withdrew consent|0|||
41976686|NCT04965389|75780822|FG000|Overall Study|Poor/Non-compliance|0|||
41976687|NCT04965389|75780823|FG001|Overall Study|Poor/Non-compliance|1|||
41976688|NCT04965389|75780824|FG002|Overall Study|Poor/Non-compliance|0|||
41976689|NCT04965389|75780825|FG003|Overall Study|Poor/Non-compliance|0|||
41976690|NCT04935931|75780842|FG000|Overall Study|Withdrawal by Subject|1|||
41976691|NCT04839393|75780854|FG000|Overall Study|Adverse Event|0|||
41976692|NCT04839393|75780855|FG001|Overall Study|Adverse Event|0|||
41976693|NCT04839393|75780856|FG002|Overall Study|Adverse Event|2|||
41976694|NCT04839393|75780854|FG000|Overall Study|Withdrawal by participant|0|||
41976695|NCT04839393|75780855|FG001|Overall Study|Withdrawal by participant|0|||
41976696|NCT04839393|75780856|FG002|Overall Study|Withdrawal by participant|1|||
41976697|NCT04677712|75780923|FG000|Overall Study|Lost to Follow-up|0|||
41976698|NCT04677712|75780924|FG001|Overall Study|Lost to Follow-up|1|||
41976699|NCT04677712|75780925|FG002|Overall Study|Lost to Follow-up|0|||
41976700|NCT04677712|75780926|FG003|Overall Study|Lost to Follow-up|0|||
41976701|NCT04677712|75780927|FG004|Overall Study|Lost to Follow-up|0|||
41976702|NCT04677712|75780928|FG005|Overall Study|Lost to Follow-up|0|||
41976703|NCT04630002|75780951|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
41976704|NCT04630002|75780952|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
41976705|NCT04630002|75780953|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
41976706|NCT04630002|75780951|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
41976707|NCT04630002|75780952|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
41976708|NCT04630002|75780953|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
41976709|NCT04630002|75780951|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
41976710|NCT04630002|75780952|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
41976711|NCT04630002|75780953|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
41976712|NCT04630002|75780951|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
41976713|NCT04630002|75780952|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
41976714|NCT04630002|75780953|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
41976715|NCT04630002|75780951|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
41976716|NCT04630002|75780952|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
42128442|NCT00429663|75938977|FG000|Overall Study|Withdrawal by Subject|2|||
42128443|NCT00429663|75938978|FG001|Overall Study|Withdrawal by Subject|5|||
42128444|NCT00429663|75938977|FG000|Overall Study|Death|4|||
42128445|NCT00429663|75938978|FG001|Overall Study|Death|0|||
42128446|NCT00429585|75938986|FG000|Overall Study|Death|1|||
42128447|NCT00429585|75938987|FG001|Overall Study|Death|0|||
42128448|NCT00429585|75938986|FG000|Overall Study|Lost to Follow-up|27|||
42301890|NCT02281773|76137079|FG000|Overall Study|Adverse Event|6|||
42301891|NCT02281773|76137080|FG001|Overall Study|Adverse Event|1|||
41976717|NCT04630002|75780953|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
41976718|NCT04630002|75780951|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
41976719|NCT04630002|75780952|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
41976720|NCT04630002|75780953|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
41976721|NCT04630002|75780951|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
41976722|NCT04630002|75780952|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
41976723|NCT04630002|75780953|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
42028442|NCT00957021|75836877|FG000|Overall Study|Withdrawal by Subject|34|||
42028443|NCT00957021|75836877|FG000|Overall Study|No 2 yr ROM data|35|||
42028444|NCT00957021|75836877|FG000|Overall Study|Revised study component by 2 yr visit|8|||
42028445|NCT00957021|75836877|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
42128449|NCT00429585|75938987|FG001|Overall Study|Lost to Follow-up|20|||
42128450|NCT00429585|75938986|FG000|Overall Study|Physician Decision|2|||
42128451|NCT00429585|75938987|FG001|Overall Study|Physician Decision|0|||
42128452|NCT05822921|75938995|FG000|Overall Study|Lost to Follow-up|1|||
42128453|NCT05822921|75938996|FG001|Overall Study|Lost to Follow-up|1|||
42128454|NCT05094154|75939008|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
42128455|NCT05094154|75939009|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
42128456|NCT05094154|75939008|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
42128457|NCT05094154|75939009|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
42128458|NCT04530448|75939038|FG000|Overall Study|Physician Decision|3|||
42128459|NCT04530448|75939039|FG001|Overall Study|Physician Decision|0|||
42128460|NCT04476030|75939047|FG000|Overall Study|Withdrawal by Subject|20|||
42128461|NCT04476030|75939048|FG001|Overall Study|Withdrawal by Subject|16|||
42128462|NCT04476030|75939047|FG000|Overall Study|Adverse Event|10|||
42128463|NCT04476030|75939048|FG001|Overall Study|Adverse Event|11|||
42128464|NCT04476030|75939047|FG000|Overall Study|Lost to Follow-up|7|||
42128465|NCT04476030|75939048|FG001|Overall Study|Lost to Follow-up|4|||
42128466|NCT04476030|75939047|FG000|Overall Study|Physician Decision|1|||
42128467|NCT04476030|75939048|FG001|Overall Study|Physician Decision|1|||
42128468|NCT04476030|75939047|FG000|Overall Study|Protocol Deviation|2|||
42128469|NCT04476030|75939048|FG001|Overall Study|Protocol Deviation|0|||
42128470|NCT04476030|75939047|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
42128471|NCT04476030|75939048|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
42128472|NCT04476030|75939047|FG000|Overall Study|Randomized but not Dosed|2|||
42128473|NCT04476030|75939048|FG001|Overall Study|Randomized but not Dosed|8|||
42128474|NCT04431453|75939077|FG000|Overall Study|Withdrew Consent|0|||
42128475|NCT04431453|75939078|FG001|Overall Study|Withdrew Consent|1|||
42128476|NCT04431453|75939079|FG002|Overall Study|Withdrew Consent|0|||
42128477|NCT04431453|75939080|FG003|Overall Study|Withdrew Consent|2|||
42128478|NCT04431453|75939081|FG004|Overall Study|Withdrew Consent|0|||
42128479|NCT04431453|75939082|FG005|Overall Study|Withdrew Consent|0|||
42128480|NCT04431453|75939083|FG006|Overall Study|Withdrew Consent|0|||
42128481|NCT04431453|75939084|FG007|Overall Study|Withdrew Consent|0|||
42128482|NCT04431453|75939077|FG000|Overall Study|Death|1|||
42128483|NCT04431453|75939078|FG001|Overall Study|Death|0|||
42128484|NCT04431453|75939079|FG002|Overall Study|Death|0|||
42128485|NCT04431453|75939080|FG003|Overall Study|Death|0|||
42128486|NCT04431453|75939081|FG004|Overall Study|Death|0|||
42128487|NCT04431453|75939082|FG005|Overall Study|Death|0|||
42128488|NCT04431453|75939083|FG006|Overall Study|Death|0|||
42128489|NCT04431453|75939084|FG007|Overall Study|Death|1|||
42128490|NCT04431453|75939077|FG000|Overall Study|Lost to Follow-up|0|||
42128491|NCT04431453|75939078|FG001|Overall Study|Lost to Follow-up|0|||
42128492|NCT04431453|75939079|FG002|Overall Study|Lost to Follow-up|1|||
42128493|NCT04431453|75939080|FG003|Overall Study|Lost to Follow-up|1|||
42128494|NCT04431453|75939081|FG004|Overall Study|Lost to Follow-up|0|||
42128495|NCT04431453|75939082|FG005|Overall Study|Lost to Follow-up|0|||
42128496|NCT04431453|75939083|FG006|Overall Study|Lost to Follow-up|0|||
41976724|NCT04630002|75780951|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
42128497|NCT04431453|75939084|FG007|Overall Study|Lost to Follow-up|0|||
42128498|NCT04431453|75939077|FG000|Overall Study|Enrolled but Never Treated|0|||
42128499|NCT04431453|75939078|FG001|Overall Study|Enrolled but Never Treated|0|||
42128500|NCT04431453|75939079|FG002|Overall Study|Enrolled but Never Treated|0|||
42128501|NCT04431453|75939080|FG003|Overall Study|Enrolled but Never Treated|0|||
41976725|NCT04630002|75780952|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
42128502|NCT04431453|75939081|FG004|Overall Study|Enrolled but Never Treated|1|||
42128503|NCT04431453|75939082|FG005|Overall Study|Enrolled but Never Treated|0|||
42214020|NCT03488563|76029954|FG002|Overall Study|Withdrawal by Subject|7|||
42214021|NCT03488563|76029952|FG000|Overall Study|Physician Decision|0|||
42214022|NCT03488563|76029953|FG001|Overall Study|Physician Decision|0|||
42214023|NCT03488563|76029954|FG002|Overall Study|Physician Decision|1|||
42214024|NCT03488563|76029952|FG000|Overall Study|Protocol Violation|3|||
42214025|NCT03488563|76029953|FG001|Overall Study|Protocol Violation|2|||
42214026|NCT03488563|76029954|FG002|Overall Study|Protocol Violation|6|||
42214027|NCT03488563|76029952|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
42214028|NCT03488563|76029953|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
42214029|NCT03488563|76029954|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
42214030|NCT03488563|76029952|FG000|Overall Study|Use of prohibited medication|2|||
42214031|NCT03488563|76029953|FG001|Overall Study|Use of prohibited medication|0|||
42214032|NCT03488563|76029954|FG002|Overall Study|Use of prohibited medication|0|||
42214033|NCT03488563|76029952|FG000|Overall Study|Adverse Event|1|||
42214034|NCT03488563|76029953|FG001|Overall Study|Adverse Event|0|||
42214035|NCT03488563|76029954|FG002|Overall Study|Adverse Event|1|||
42214036|NCT03488563|76029952|FG000|Overall Study|Subject returned for ET visit|0|||
42301892|NCT02281773|76137081|FG002|Overall Study|Adverse Event|4|||
42301893|NCT02281773|76137082|FG003|Overall Study|Adverse Event|8|||
42301894|NCT02281773|76137083|FG004|Overall Study|Adverse Event|9|||
42301895|NCT02281773|76137079|FG000|Overall Study|Protocol Violation|1|||
42301896|NCT02281773|76137080|FG001|Overall Study|Protocol Violation|0|||
42301897|NCT02281773|76137081|FG002|Overall Study|Protocol Violation|0|||
42301898|NCT02281773|76137082|FG003|Overall Study|Protocol Violation|2|||
42301899|NCT02281773|76137083|FG004|Overall Study|Protocol Violation|2|||
42301900|NCT02281773|76137079|FG000|Overall Study|Lost to Follow-up|2|||
42301901|NCT02281773|76137080|FG001|Overall Study|Lost to Follow-up|2|||
42301902|NCT02281773|76137081|FG002|Overall Study|Lost to Follow-up|6|||
42301903|NCT02281773|76137082|FG003|Overall Study|Lost to Follow-up|2|||
42301904|NCT02281773|76137083|FG004|Overall Study|Lost to Follow-up|10|||
42301905|NCT02281773|76137079|FG000|Overall Study|Withdrawal by Subject|2|||
42301906|NCT02281773|76137080|FG001|Overall Study|Withdrawal by Subject|8|||
42301907|NCT02281773|76137081|FG002|Overall Study|Withdrawal by Subject|6|||
42301908|NCT02281773|76137082|FG003|Overall Study|Withdrawal by Subject|6|||
42301909|NCT02281773|76137083|FG004|Overall Study|Withdrawal by Subject|8|||
42301910|NCT02281773|76137079|FG000|Overall Study|Other Reason|0|||
42301911|NCT02281773|76137080|FG001|Overall Study|Other Reason|4|||
42301912|NCT02281773|76137081|FG002|Overall Study|Other Reason|2|||
42301913|NCT02281773|76137082|FG003|Overall Study|Other Reason|3|||
42301914|NCT02281773|76137083|FG004|Overall Study|Other Reason|1|||
42301915|NCT02285361|76137095|FG000|Overall Study|Protocol Violation|43|||
42301916|NCT02285361|76137095|FG000|Overall Study|Lost to Follow-up|5|||
42301917|NCT02285361|76137095|FG000|Overall Study|Not taken GIOTRIF|2|||
42301918|NCT02285361|76137095|FG000|Overall Study|Consented prior to the contract date|1|||
42301919|NCT02354235|76137101|FG000|Overall Study|Adverse Event|2|||
42301920|NCT02354235|76137102|FG001|Overall Study|Adverse Event|2|||
42301921|NCT02354235|76137101|FG000|Overall Study|Physician Decision|0|||
42301922|NCT02354235|76137102|FG001|Overall Study|Physician Decision|1|||
42214037|NCT03488563|76029953|FG001|Overall Study|Subject returned for ET visit|1|||
42214038|NCT03488563|76029954|FG002|Overall Study|Subject returned for ET visit|0|||
42214039|NCT03488563|76029952|FG000|Overall Study|Sponsor's decision|0|||
42301923|NCT02354235|76137101|FG000|Overall Study|Withdrawal by Subject|1|||
42301924|NCT02354235|76137102|FG001|Overall Study|Withdrawal by Subject|3|||
41976726|NCT04630002|75780953|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
41976727|NCT04576923|75780986|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
42214040|NCT03488563|76029953|FG001|Overall Study|Sponsor's decision|0|||
42214041|NCT03488563|76029954|FG002|Overall Study|Sponsor's decision|1|||
42214042|NCT00706030|76029968|FG000|Overall Study|Disease Progression|4|||
42214043|NCT00706030|76029969|FG001|Overall Study|Disease Progression|6|||
42214044|NCT00706030|76029970|FG002|Overall Study|Disease Progression|46|||
42214045|NCT00706030|76029971|FG003|Overall Study|Disease Progression|12|||
42214046|NCT00706030|76029968|FG000|Overall Study|Adverse Event|1|||
42214047|NCT00706030|76029969|FG001|Overall Study|Adverse Event|0|||
42214048|NCT00706030|76029970|FG002|Overall Study|Adverse Event|4|||
42214049|NCT00706030|76029971|FG003|Overall Study|Adverse Event|2|||
42214050|NCT00706030|76029968|FG000|Overall Study|Withdrawal by Subject|1|||
42214051|NCT00706030|76029969|FG001|Overall Study|Withdrawal by Subject|0|||
42214052|NCT00706030|76029970|FG002|Overall Study|Withdrawal by Subject|2|||
42214053|NCT00706030|76029971|FG003|Overall Study|Withdrawal by Subject|0|||
42214054|NCT00706030|76029968|FG000|Overall Study|Physician Decision|0|||
42214055|NCT00706030|76029969|FG001|Overall Study|Physician Decision|0|||
42214056|NCT00706030|76029970|FG002|Overall Study|Physician Decision|2|||
42214057|NCT00706030|76029971|FG003|Overall Study|Physician Decision|0|||
42214058|NCT00706030|76029968|FG000|Overall Study|Not recorded|0|||
42214059|NCT00706030|76029969|FG001|Overall Study|Not recorded|0|||
42214060|NCT00706030|76029970|FG002|Overall Study|Not recorded|2|||
42214061|NCT00706030|76029971|FG003|Overall Study|Not recorded|0|||
42214062|NCT00706030|76029968|FG000|Overall Study|Protocol Violation|0|||
42214063|NCT00706030|76029969|FG001|Overall Study|Protocol Violation|0|||
42214064|NCT00706030|76029970|FG002|Overall Study|Protocol Violation|1|||
42214065|NCT00706030|76029971|FG003|Overall Study|Protocol Violation|1|||
42214066|NCT00706030|76029968|FG000|Overall Study|Failed to return|0|||
42214067|NCT00706030|76029969|FG001|Overall Study|Failed to return|0|||
42214068|NCT00706030|76029970|FG002|Overall Study|Failed to return|1|||
42214069|NCT00706030|76029971|FG003|Overall Study|Failed to return|0|||
42214070|NCT00706030|76029968|FG000|Overall Study|Symptomatic Deterioration|0|||
42214071|NCT00706030|76029969|FG001|Overall Study|Symptomatic Deterioration|0|||
42214072|NCT00706030|76029970|FG002|Overall Study|Symptomatic Deterioration|1|||
42214073|NCT00706030|76029971|FG003|Overall Study|Symptomatic Deterioration|0|||
42214074|NCT00706030|76029968|FG000|Overall Study|No treatment received|0|||
42214075|NCT00706030|76029969|FG001|Overall Study|No treatment received|0|||
42214076|NCT00706030|76029970|FG002|Overall Study|No treatment received|0|||
42214077|NCT00706030|76029971|FG003|Overall Study|No treatment received|1|||
42214078|NCT00706030|76029968|FG000|Overall Study|Death|0|||
42214079|NCT00706030|76029969|FG001|Overall Study|Death|0|||
42214080|NCT00706030|76029970|FG002|Overall Study|Death|1|||
42214081|NCT00706030|76029971|FG003|Overall Study|Death|0|||
42214082|NCT03488251|76029986|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
42214083|NCT03488251|76029987|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
42214084|NCT03488251|76029988|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
42214085|NCT03488251|76029989|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
42214086|NCT03488251|76029986|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
42214087|NCT03488251|76029987|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
42214088|NCT03488251|76029988|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
42214089|NCT03488251|76029989|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
42214090|NCT03488251|76029986|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
42214091|NCT03488251|76029987|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
42214092|NCT03488251|76029988|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
42214093|NCT03488251|76029989|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
42214094|NCT03488251|76029986|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
42214095|NCT03488251|76029987|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
42301925|NCT02354235|76137101|FG000|Overall Study|Conflict with the stopping criteria|0|||
41976728|NCT04526197|75781000|FG000|Period 1|Adverse Event|0|||
42214096|NCT03488251|76029988|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
42214097|NCT03488251|76029989|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
42214098|NCT03488251|76029986|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
42214099|NCT03488251|76029987|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
42214100|NCT03488251|76029988|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
42214101|NCT03488251|76029989|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
42214102|NCT02727322|76030002|FG000|Overall Study|Withdrawal by Subject|1|||
42214103|NCT02727322|76030003|FG001|Overall Study|Withdrawal by Subject|1|||
42214104|NCT02727322|76030002|FG000|Overall Study|Protocol Violation|1|||
42214105|NCT02727322|76030003|FG001|Overall Study|Protocol Violation|0|||
42214106|NCT03431857|76030013|FG000|Overall Study|Death|6|||
42214107|NCT03431857|76030013|FG000|Overall Study|Lost to Follow-up|41|||
42214108|NCT03431857|76030013|FG000|Overall Study|Adverse Event|6|||
42214109|NCT03431857|76030013|FG000|Overall Study|Withdrawal by Subject|1|||
42214110|NCT03487549|76030019|FG000|Overall Study|Protocol Violation|0|||
42214111|NCT03487549|76030020|FG001|Overall Study|Protocol Violation|1|||
42214112|NCT03487549|76030019|FG000|Overall Study|Lost to Follow-up|2|||
42214113|NCT03487549|76030020|FG001|Overall Study|Lost to Follow-up|1|||
42214114|NCT03487549|76030019|FG000|Overall Study|Withdrawal by Subject|2|||
42214115|NCT03487549|76030020|FG001|Overall Study|Withdrawal by Subject|0|||
42214116|NCT03464383|76030029|FG000|Overall Study|Lost to Follow-up|1|||
42214117|NCT03464383|76030030|FG001|Overall Study|Lost to Follow-up|0|||
42214118|NCT03464383|76030031|FG002|Overall Study|Lost to Follow-up|0|||
42214119|NCT03464383|76030029|FG000|Overall Study|Withdrawal by Subject|0|||
42214120|NCT03464383|76030030|FG001|Overall Study|Withdrawal by Subject|1|||
42214121|NCT03464383|76030031|FG002|Overall Study|Withdrawal by Subject|0|||
42214122|NCT01444092|76030040|FG000|Overall Study|Adverse Event|8|||
42214123|NCT01444092|76030040|FG000|Overall Study|Protocol Violation|1|||
42214124|NCT01444092|76030040|FG000|Overall Study|Withdrawal by Subject|1|||
42214125|NCT01444092|76030040|FG000|Overall Study|Other Eligibility criteria|7|||
42214126|NCT01265784|76030047|FG000|Overall Study|Lost to Follow-up|5|||
42214127|NCT01265784|76030048|FG001|Overall Study|Lost to Follow-up|3|||
42214128|NCT01265784|76030049|FG002|Overall Study|Lost to Follow-up|2|||
42214129|NCT01265784|76030047|FG000|Overall Study|Withdrawal by Subject|0|||
42214130|NCT01265784|76030048|FG001|Overall Study|Withdrawal by Subject|5|||
42214131|NCT01265784|76030049|FG002|Overall Study|Withdrawal by Subject|0|||
42214132|NCT01265784|76030047|FG000|Overall Study|Physician Decision|1|||
42214133|NCT01265784|76030048|FG001|Overall Study|Physician Decision|0|||
42214134|NCT01265784|76030049|FG002|Overall Study|Physician Decision|1|||
42214135|NCT01265784|76030047|FG000|Overall Study|Adverse Event|1|||
42214136|NCT01265784|76030048|FG001|Overall Study|Adverse Event|0|||
42214137|NCT01265784|76030049|FG002|Overall Study|Adverse Event|0|||
42214138|NCT01265784|76030047|FG000|Overall Study|Death|3|||
42214139|NCT01265784|76030048|FG001|Overall Study|Death|0|||
42214140|NCT01265784|76030049|FG002|Overall Study|Death|0|||
42214141|NCT01265784|76030047|FG000|Overall Study|Protocol Violation|2|||
42214142|NCT01265784|76030048|FG001|Overall Study|Protocol Violation|0|||
42214143|NCT01265784|76030049|FG002|Overall Study|Protocol Violation|0|||
42214144|NCT01265784|76030047|FG000|Overall Study|Incorrectly Randomized|0|||
42214145|NCT01265784|76030048|FG001|Overall Study|Incorrectly Randomized|0|||
42214146|NCT01265784|76030049|FG002|Overall Study|Incorrectly Randomized|1|||
42214147|NCT03156504|76030057|FG000|Overall Study|Withdrawal by Subject|1|||
42214148|NCT03159468|76030067|FG000|Overall Study|Withdrawal by Subject|0|||
42214149|NCT03159468|76030068|FG001|Overall Study|Withdrawal by Subject|0|||
42214150|NCT03159468|76030069|FG002|Overall Study|Withdrawal by Subject|3|||
42214151|NCT03159468|76030070|FG003|Overall Study|Withdrawal by Subject|0|||
42214152|NCT03159468|76030071|FG004|Overall Study|Withdrawal by Subject|0|||
42214153|NCT03159468|76030072|FG005|Overall Study|Withdrawal by Subject|0|||
42214154|NCT03430063|76030089|FG000|Overall Study|Adverse Event|0|||
42214155|NCT03430063|76030090|FG001|Overall Study|Adverse Event|1|||
41976729|NCT04526197|75781001|FG001|Period 1|Adverse Event|1|||
42214156|NCT03430063|76030091|FG002|Overall Study|Adverse Event|0|||
42214157|NCT03430063|76030089|FG000|Overall Study|Death|3|||
42214158|NCT03430063|76030090|FG001|Overall Study|Death|2|||
42214159|NCT03430063|76030091|FG002|Overall Study|Death|3|||
42214160|NCT03430063|76030089|FG000|Overall Study|Lost to Follow-up|0|||
42214161|NCT03430063|76030090|FG001|Overall Study|Lost to Follow-up|1|||
42214162|NCT03430063|76030091|FG002|Overall Study|Lost to Follow-up|0|||
42214163|NCT03430063|76030089|FG000|Overall Study|Withdrawal by Subject|0|||
42214164|NCT03430063|76030090|FG001|Overall Study|Withdrawal by Subject|0|||
42214165|NCT03430063|76030091|FG002|Overall Study|Withdrawal by Subject|1|||
42214166|NCT03430063|76030089|FG000|Overall Study|Withdrawal of consent|3|||
42214167|NCT03430063|76030090|FG001|Overall Study|Withdrawal of consent|1|||
42214168|NCT03430063|76030091|FG002|Overall Study|Withdrawal of consent|2|||
42214169|NCT03430063|76030089|FG000|Overall Study|Progressive disease|1|||
42214170|NCT03430063|76030090|FG001|Overall Study|Progressive disease|2|||
42214171|NCT03430063|76030091|FG002|Overall Study|Progressive disease|1|||
42214172|NCT03430063|76030089|FG000|Overall Study|Other un-specified|1|||
42214173|NCT03430063|76030090|FG001|Overall Study|Other un-specified|1|||
42214174|NCT03430063|76030091|FG002|Overall Study|Other un-specified|0|||
42214175|NCT03430063|76030089|FG000|Overall Study|Randomized, but never treated|0|||
42214176|NCT03430063|76030090|FG001|Overall Study|Randomized, but never treated|0|||
42214177|NCT03430063|76030091|FG002|Overall Study|Randomized, but never treated|1|||
42214178|NCT03158220|76030102|FG000|Overall Study|Screen Failure|0|||
42214179|NCT03158220|76030103|FG001|Overall Study|Screen Failure|1|||
42214180|NCT03158220|76030102|FG000|Overall Study|Withdrawal by Subject|8|||
42214181|NCT03158220|76030103|FG001|Overall Study|Withdrawal by Subject|9|||
42214182|NCT03158220|76030102|FG000|Overall Study|Status unknown|0|||
42214183|NCT03158220|76030103|FG001|Overall Study|Status unknown|1|||
42214184|NCT03158220|76030102|FG000|Overall Study|Lost to Follow-up|8|||
42214185|NCT03158220|76030103|FG001|Overall Study|Lost to Follow-up|5|||
42214186|NCT03158220|76030102|FG000|Overall Study|Physician Decision|1|||
42214187|NCT03158220|76030103|FG001|Overall Study|Physician Decision|0|||
42214188|NCT03156270|76030109|FG000|Overall Study|Failed pre-treatment screening|1|||
42214189|NCT03156270|76030109|FG000|Overall Study|Lost to Follow-up|1|||
41976730|NCT04526197|75781000|FG000|Period 1|Withdrawal by Subject|1|||
41976731|NCT04526197|75781001|FG001|Period 1|Withdrawal by Subject|0|||
41976732|NCT04526197|75781000|FG000|Period 2|Adverse Event|0|||
41976733|NCT04526197|75781001|FG001|Period 2|Adverse Event|1|||
41976734|NCT04526197|75781000|FG000|Period 2|Withdrawal by Subject|0|||
41976735|NCT04526197|75781001|FG001|Period 2|Withdrawal by Subject|1|||
41976736|NCT04412668|75781011|FG000|Overall Study|Death - multiple comorbidities|2|||
41976737|NCT04412668|75781012|FG001|Overall Study|Death - multiple comorbidities|0|||
41976738|NCT04412668|75781013|FG002|Overall Study|Death - multiple comorbidities|0|||
41976739|NCT04412668|75781011|FG000|Overall Study|Withdrawal by Subject|3|||
41976740|NCT04412668|75781012|FG001|Overall Study|Withdrawal by Subject|0|||
41976741|NCT04412668|75781013|FG002|Overall Study|Withdrawal by Subject|0|||
41976742|NCT04412668|75781011|FG000|Overall Study|Other than Specified|2|||
41976743|NCT04412668|75781012|FG001|Overall Study|Other than Specified|0|||
42128504|NCT04431453|75939083|FG006|Overall Study|Enrolled but Never Treated|0|||
42128505|NCT04431453|75939084|FG007|Overall Study|Enrolled but Never Treated|0|||
42128506|NCT04382612|75939108|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
42214190|NCT03429049|76030117|FG000|Overall Study|Adverse Event|2|||
42214191|NCT03429049|76030118|FG001|Overall Study|Adverse Event|3|||
42214192|NCT03429049|76030117|FG000|Overall Study|Death|0|||
42214193|NCT03429049|76030118|FG001|Overall Study|Death|1|||
42214194|NCT03429049|76030117|FG000|Overall Study|Lack of Efficacy|4|||
42214195|NCT03429049|76030118|FG001|Overall Study|Lack of Efficacy|2|||
42214196|NCT03429049|76030117|FG000|Overall Study|Lost to Follow-up|9|||
42214197|NCT03429049|76030118|FG001|Overall Study|Lost to Follow-up|8|||
42214198|NCT03429049|76030117|FG000|Overall Study|Physician Decision|1|||
42214199|NCT03429049|76030118|FG001|Overall Study|Physician Decision|0|||
42214200|NCT03429049|76030117|FG000|Overall Study|Protocol Violation|3|||
42214201|NCT03429049|76030118|FG001|Overall Study|Protocol Violation|0|||
42214202|NCT03429049|76030117|FG000|Overall Study|Sponsor Decision|2|||
42214203|NCT03429049|76030118|FG001|Overall Study|Sponsor Decision|0|||
42214204|NCT03429049|76030117|FG000|Overall Study|Withdrawal by Subject|4|||
42214205|NCT03429049|76030118|FG001|Overall Study|Withdrawal by Subject|20|||
42214206|NCT03429049|76030117|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
42214207|NCT03429049|76030118|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
42128507|NCT04158687|75939120|FG000|Overall Study|Adverse Event|2|||
42128508|NCT04158687|75939121|FG001|Overall Study|Adverse Event|3|||
42128509|NCT04158687|75939122|FG002|Overall Study|Adverse Event|0|||
42214208|NCT03428815|76030126|FG000|Overall Study|Lost to Follow-up|2|||
41976744|NCT04412668|75781013|FG002|Overall Study|Other than Specified|0|||
42128510|NCT04158687|75939123|FG003|Overall Study|Adverse Event|3|||
42128511|NCT04158687|75939120|FG000|Overall Study|Lost to Follow-up|5|||
42214209|NCT03428815|76030127|FG001|Overall Study|Lost to Follow-up|2|||
42214210|NCT03428815|76030126|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
42214211|NCT03428815|76030127|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
42214212|NCT03428815|76030126|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
42214213|NCT03428815|76030127|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
42214214|NCT03155724|76030133|FG000|Overall Study|Death|3|||
41976745|NCT04360551|75781023|FG000|Overall Study|Withdrawal by Subject|1|||
41976746|NCT04360551|75781024|FG001|Overall Study|Withdrawal by Subject|0|||
42128512|NCT04158687|75939121|FG001|Overall Study|Lost to Follow-up|12|||
42128513|NCT04158687|75939122|FG002|Overall Study|Lost to Follow-up|4|||
42214215|NCT03155724|76030133|FG000|Overall Study|Physician Decision|1|||
42214216|NCT03155724|76030133|FG000|Overall Study|Study closure|7|||
42214217|NCT03426787|76030137|FG000|Overall Study|Withdrawal by Subject|6|||
42214218|NCT03426787|76030137|FG000|Overall Study|Lost to Follow-up|7|||
42214219|NCT03426787|76030137|FG000|Overall Study|Unrelated to intervention death|1|||
42214220|NCT03426631|76030147|FG000|Overall Study|Lost to Follow-up|0|||
42214221|NCT03426631|76030148|FG001|Overall Study|Lost to Follow-up|1|||
42214222|NCT03484429|76030156|FG000|Overall Study|Withdrawal by Subject|1|||
42214223|NCT03484429|76030157|FG001|Overall Study|Withdrawal by Subject|0|||
42214224|NCT03484429|76030156|FG000|Overall Study|Adverse Event|2|||
42214225|NCT03484429|76030157|FG001|Overall Study|Adverse Event|0|||
42214226|NCT03484273|76030163|FG000|Overall Study|Equipment Malfunction|1|||
42214227|NCT03484273|76030163|FG000|Overall Study|Data excluded from analysis|1|||
42214228|NCT02724592|76030177|FG000|Overall Study|Lost to Follow-up|4|||
42214229|NCT02724592|76030178|FG001|Overall Study|Lost to Follow-up|1|||
42214230|NCT03154476|76030186|FG000|Overall Study|Lost to Follow-up|4|||
42214231|NCT03154476|76030187|FG001|Overall Study|Lost to Follow-up|4|||
42214232|NCT02726074|76030193|FG000|Overall Study|Withdrawal by Subject|4|||
42214233|NCT02726074|76030193|FG000|Overall Study|Adverse Event|14|||
42214234|NCT02726074|76030193|FG000|Overall Study|Protocol Violation|3|||
41976747|NCT04299087|75781032|FG000|Overall Study|Lost to Follow-up|2|||
41976748|NCT04299087|75781033|FG001|Overall Study|Lost to Follow-up|1|||
41976749|NCT04288778|75781039|FG000|Overall Study|Withdrawal by Subject|2|||
41976750|NCT04288778|75781039|FG000|Overall Study|Adverse Event|5|||
41976751|NCT04288778|75781039|FG000|Overall Study|Non-Compliance With Study Drug|1|||
41976752|NCT04288778|75781039|FG000|Overall Study|Other|1|||
41976753|NCT04288778|75781039|FG000|Overall Study|Started but not treated|2|||
41976754|NCT04233164|75781058|FG000|Overall Study|Unable to obtain specimen|0|||
41976755|NCT04233164|75781059|FG001|Overall Study|Unable to obtain specimen|1|||
41976756|NCT04147195|75781075|FG000|Overall Study|Adverse Event|0|||
41976757|NCT04147195|75781076|FG001|Overall Study|Adverse Event|3|||
41976758|NCT04147195|75781075|FG000|Overall Study|Study Terminated by Sponsor|4|||
41976759|NCT04147195|75781076|FG001|Overall Study|Study Terminated by Sponsor|2|||
41976760|NCT04147195|75781075|FG000|Overall Study|Withdrawal by Subject|0|||
41976761|NCT04147195|75781076|FG001|Overall Study|Withdrawal by Subject|1|||
41976762|NCT04092816|75781089|FG000|Overall Study|Lost to Follow-up|1|||
41976763|NCT04092816|75781090|FG001|Overall Study|Lost to Follow-up|2|||
41976764|NCT03985878|75781107|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
41976765|NCT03985878|75781107|FG000|Overall Study|Study Terminated by Sponsor|12|||
41976766|NCT03985878|75781107|FG000|Overall Study|Withdrawal by Subject|1|||
42214235|NCT02726074|76030193|FG000|Overall Study|Lost to Follow-up|2|||
42214236|NCT02726074|76030193|FG000|Overall Study|Others|3|||
41976767|NCT03774394|75781189|FG000|Overall Study|Withdrawal by Subject|2|||
42214237|NCT03482635|76030201|FG000|Overall Study|Lack of Efficacy|0|||
42214238|NCT03482635|76030202|FG001|Overall Study|Lack of Efficacy|0|||
42214239|NCT03482635|76030203|FG002|Overall Study|Lack of Efficacy|1|||
42214240|NCT03482635|76030204|FG003|Overall Study|Lack of Efficacy|3|||
42214241|NCT03482635|76030201|FG000|Overall Study|Adverse Event|2|||
42214242|NCT03482635|76030202|FG001|Overall Study|Adverse Event|2|||
41976768|NCT03774394|75781190|FG001|Overall Study|Withdrawal by Subject|0|||
41976769|NCT03765788|75781198|FG000|Overall Study|Subject decision|2|||
41976770|NCT03765788|75781199|FG001|Overall Study|Subject decision|3|||
41976771|NCT03765788|75781198|FG000|Overall Study|Physician Decision|2|||
41976772|NCT03765788|75781199|FG001|Overall Study|Physician Decision|4|||
41976773|NCT03765788|75781198|FG000|Overall Study|Death|0|||
42128514|NCT04158687|75939123|FG003|Overall Study|Lost to Follow-up|5|||
42128515|NCT04158687|75939120|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
42128516|NCT04158687|75939121|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
42128517|NCT04158687|75939122|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
42128518|NCT04158687|75939123|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
42128519|NCT04158687|75939120|FG000|Overall Study|Non-Compliance with Study Medication|2|||
42128520|NCT04158687|75939121|FG001|Overall Study|Non-Compliance with Study Medication|2|||
42128521|NCT04158687|75939122|FG002|Overall Study|Non-Compliance with Study Medication|3|||
42128522|NCT04158687|75939123|FG003|Overall Study|Non-Compliance with Study Medication|0|||
42128523|NCT04158687|75939120|FG000|Overall Study|Investigator Decision|0|||
42128524|NCT04158687|75939121|FG001|Overall Study|Investigator Decision|0|||
42128525|NCT04158687|75939122|FG002|Overall Study|Investigator Decision|2|||
42128526|NCT04158687|75939123|FG003|Overall Study|Investigator Decision|0|||
42128527|NCT04158687|75939120|FG000|Overall Study|Protocol Violation|0|||
42128528|NCT04158687|75939121|FG001|Overall Study|Protocol Violation|2|||
42128529|NCT04158687|75939122|FG002|Overall Study|Protocol Violation|1|||
42128530|NCT04158687|75939123|FG003|Overall Study|Protocol Violation|0|||
42214243|NCT03482635|76030203|FG002|Overall Study|Adverse Event|0|||
42214244|NCT03482635|76030204|FG003|Overall Study|Adverse Event|3|||
42214245|NCT03482635|76030201|FG000|Overall Study|Withdrawal by Subject|2|||
42214246|NCT03482635|76030202|FG001|Overall Study|Withdrawal by Subject|1|||
42214247|NCT03482635|76030203|FG002|Overall Study|Withdrawal by Subject|0|||
42214248|NCT03482635|76030204|FG003|Overall Study|Withdrawal by Subject|1|||
41976774|NCT03765788|75781199|FG001|Overall Study|Death|1|||
42214249|NCT03482635|76030201|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
42214250|NCT03482635|76030202|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
42214251|NCT03482635|76030203|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
42214252|NCT03482635|76030204|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
42214253|NCT03482635|76030201|FG000|Overall Study|Not treated|0|||
42214254|NCT03482635|76030202|FG001|Overall Study|Not treated|0|||
42214255|NCT03482635|76030203|FG002|Overall Study|Not treated|0|||
42214256|NCT03482635|76030204|FG003|Overall Study|Not treated|1|||
42301926|NCT02354235|76137102|FG001|Overall Study|Conflict with the stopping criteria|1|||
42301927|NCT02280291|76137112|FG000|Overall Study|Lost to Follow-up|2|||
42214257|NCT03712787|76030218|FG000|Overall Study|Adverse Event|2|||
42214258|NCT03712787|76030219|FG001|Overall Study|Adverse Event|3|||
41976775|NCT03765788|75781198|FG000|Overall Study|Lost to Follow-up|1|||
41976776|NCT03765788|75781199|FG001|Overall Study|Lost to Follow-up|0|||
41976777|NCT03692403|75781210|FG000|Overall Study|Withdrawal by Subject|1|||
41976778|NCT03692403|75781211|FG001|Overall Study|Withdrawal by Subject|0|||
41976779|NCT03692403|75781212|FG002|Overall Study|Withdrawal by Subject|1|||
41976780|NCT03692403|75781213|FG003|Overall Study|Withdrawal by Subject|0|||
41976781|NCT03692403|75781210|FG000|Overall Study|Adverse Event|0|||
42128531|NCT04158687|75939120|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
42128532|NCT04158687|75939121|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
42128533|NCT04158687|75939122|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
42128534|NCT04158687|75939123|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
42128535|NCT04158687|75939120|FG000|Overall Study|Reason not Specified|3|||
42128536|NCT04158687|75939121|FG001|Overall Study|Reason not Specified|2|||
42128537|NCT04158687|75939122|FG002|Overall Study|Reason not Specified|4|||
42128538|NCT04158687|75939123|FG003|Overall Study|Reason not Specified|4|||
42128539|NCT04090749|75939136|FG000|Open Label Pilot|Lost to Follow-up|1|||
42128540|NCT04090749|75939137|FG001|Open Label Pilot|Lost to Follow-up|0|||
42128541|NCT04090749|75939138|FG002|Open Label Pilot|Lost to Follow-up|0|||
42128542|NCT04090749|75939136|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
42128543|NCT04090749|75939137|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
42128544|NCT04090749|75939138|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
42128545|NCT04090749|75939136|FG000|Pilot Trial|Lost to Follow-up|0|||
42128546|NCT04090749|75939137|FG001|Pilot Trial|Lost to Follow-up|1|||
42128547|NCT04090749|75939138|FG002|Pilot Trial|Lost to Follow-up|1|||
42128548|NCT04076059|75939148|FG000|Double Blind Phase|Progressive disease|22|||
42128549|NCT04076059|75939149|FG001|Double Blind Phase|Progressive disease|26|||
42128550|NCT04076059|75939150|FG002|Double Blind Phase|Progressive disease|0|||
42128551|NCT04076059|75939148|FG000|Double Blind Phase|Withdrawal by Subject|4|||
42128552|NCT04076059|75939149|FG001|Double Blind Phase|Withdrawal by Subject|11|||
42128553|NCT04076059|75939150|FG002|Double Blind Phase|Withdrawal by Subject|0|||
42128554|NCT04076059|75939148|FG000|Double Blind Phase|Death|1|||
42128555|NCT04076059|75939149|FG001|Double Blind Phase|Death|1|||
42128556|NCT04076059|75939150|FG002|Double Blind Phase|Death|0|||
42214259|NCT03712787|76030220|FG002|Overall Study|Adverse Event|0|||
42214260|NCT03712787|76030221|FG003|Overall Study|Adverse Event|4|||
42214261|NCT03712787|76030218|FG000|Overall Study|Withdrawal by Subject|4|||
41976782|NCT03692403|75781211|FG001|Overall Study|Adverse Event|0|||
42028446|NCT00957021|75836877|FG000|Overall Study|Surgery Cancelled|9|||
42214262|NCT03712787|76030219|FG001|Overall Study|Withdrawal by Subject|14|||
42214263|NCT03712787|76030220|FG002|Overall Study|Withdrawal by Subject|12|||
42214264|NCT03712787|76030221|FG003|Overall Study|Withdrawal by Subject|8|||
42214265|NCT03712787|76030218|FG000|Overall Study|Lost to Follow-up|1|||
42214266|NCT03712787|76030219|FG001|Overall Study|Lost to Follow-up|1|||
42214267|NCT03712787|76030220|FG002|Overall Study|Lost to Follow-up|2|||
42214268|NCT03712787|76030221|FG003|Overall Study|Lost to Follow-up|1|||
42214269|NCT03712787|76030218|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
42214270|NCT03712787|76030219|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
42214271|NCT03712787|76030220|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
42214272|NCT03712787|76030221|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
42214273|NCT03712787|76030218|FG000|Overall Study|COVID-19 Infection|0|||
42214274|NCT03712787|76030219|FG001|Overall Study|COVID-19 Infection|1|||
42214275|NCT03712787|76030220|FG002|Overall Study|COVID-19 Infection|0|||
42214276|NCT03712787|76030221|FG003|Overall Study|COVID-19 Infection|0|||
42214277|NCT03712787|76030218|FG000|Overall Study|Other, Not Specified|79|||
42214278|NCT03712787|76030219|FG001|Overall Study|Other, Not Specified|77|||
42214279|NCT03712787|76030220|FG002|Overall Study|Other, Not Specified|74|||
42214280|NCT03712787|76030221|FG003|Overall Study|Other, Not Specified|78|||
42214281|NCT03048422|76030253|FG000|Overall Study|Death|1|||
42214282|NCT03048422|76030254|FG001|Overall Study|Death|0|||
42214283|NCT03048422|76030255|FG002|Overall Study|Death|0|||
42214284|NCT03048422|76030253|FG000|Overall Study|Lost to Follow-up|5|||
42214285|NCT03048422|76030254|FG001|Overall Study|Lost to Follow-up|0|||
42214286|NCT03048422|76030255|FG002|Overall Study|Lost to Follow-up|1|||
42214287|NCT03048422|76030253|FG000|Overall Study|Withdrawal by Subject|5|||
42214288|NCT03048422|76030254|FG001|Overall Study|Withdrawal by Subject|7|||
42214289|NCT03048422|76030255|FG002|Overall Study|Withdrawal by Subject|4|||
42214290|NCT03048422|76030253|FG000|Overall Study|Moved|3|||
42214291|NCT03048422|76030254|FG001|Overall Study|Moved|2|||
42214292|NCT03048422|76030255|FG002|Overall Study|Moved|2|||
42214293|NCT03048422|76030253|FG000|Overall Study|Noncompliant with Study Requirements|2|||
42214294|NCT03048422|76030254|FG001|Overall Study|Noncompliant with Study Requirements|1|||
42214295|NCT03048422|76030255|FG002|Overall Study|Noncompliant with Study Requirements|2|||
42214296|NCT03048422|76030253|FG000|Overall Study|Not Able to Get to Clinic|1|||
42214297|NCT03048422|76030254|FG001|Overall Study|Not Able to Get to Clinic|0|||
42214298|NCT03048422|76030255|FG002|Overall Study|Not Able to Get to Clinic|0|||
42214299|NCT04664855|76030275|FG000|Overall Study|Withdrawal by Subject|0|||
42214300|NCT04664855|76030276|FG001|Overall Study|Withdrawal by Subject|2|||
42214301|NCT04664153|76030286|FG000|Overall Study|Lack of Efficacy|0|||
42214302|NCT04664153|76030287|FG001|Overall Study|Lack of Efficacy|0|||
42214303|NCT04664153|76030288|FG002|Overall Study|Lack of Efficacy|1|||
42214304|NCT04664153|76030289|FG003|Overall Study|Lack of Efficacy|0|||
42214305|NCT04664153|76030286|FG000|Overall Study|Physician Decision|0|||
42214306|NCT04664153|76030287|FG001|Overall Study|Physician Decision|0|||
42214307|NCT04664153|76030288|FG002|Overall Study|Physician Decision|1|||
42214308|NCT04664153|76030289|FG003|Overall Study|Physician Decision|0|||
42214309|NCT04664153|76030286|FG000|Overall Study|Withdrawal by Subject|3|||
42214310|NCT04664153|76030287|FG001|Overall Study|Withdrawal by Subject|2|||
42214311|NCT04664153|76030288|FG002|Overall Study|Withdrawal by Subject|1|||
42214312|NCT04664153|76030289|FG003|Overall Study|Withdrawal by Subject|2|||
42214313|NCT04664153|76030286|FG000|Overall Study|Other|0|||
42214314|NCT04664153|76030287|FG001|Overall Study|Other|1|||
42214315|NCT04664153|76030288|FG002|Overall Study|Other|0|||
42301928|NCT02280291|76137113|FG001|Overall Study|Lost to Follow-up|1|||
42128557|NCT04076059|75939148|FG000|Double Blind Phase|Lost to Follow-up|1|||
42128558|NCT04076059|75939149|FG001|Double Blind Phase|Lost to Follow-up|0|||
42128559|NCT04076059|75939150|FG002|Double Blind Phase|Lost to Follow-up|0|||
42128560|NCT04076059|75939148|FG000|Double Blind Phase|Adverse Event|5|||
42128561|NCT04076059|75939149|FG001|Double Blind Phase|Adverse Event|1|||
42128562|NCT04076059|75939150|FG002|Double Blind Phase|Adverse Event|0|||
42128563|NCT04076059|75939148|FG000|Double Blind Phase|Ongoing Participants|82|||
42128564|NCT04076059|75939149|FG001|Double Blind Phase|Ongoing Participants|18|||
42128565|NCT04076059|75939150|FG002|Double Blind Phase|Ongoing Participants|0|||
42128566|NCT04076059|75939148|FG000|Double Blind Phase|Miscellaneous|3|||
42128567|NCT04076059|75939149|FG001|Double Blind Phase|Miscellaneous|1|||
42128568|NCT04076059|75939150|FG002|Double Blind Phase|Miscellaneous|0|||
42128569|NCT04076059|75939148|FG000|Double Blind Phase|Protocol Deviation|1|||
42214316|NCT04664153|76030289|FG003|Overall Study|Other|0|||
42214317|NCT04664153|76030286|FG000|Overall Study|Adverse Event|4|||
42214318|NCT04664153|76030287|FG001|Overall Study|Adverse Event|0|||
42214319|NCT04664153|76030288|FG002|Overall Study|Adverse Event|1|||
42214320|NCT04664153|76030289|FG003|Overall Study|Adverse Event|0|||
42214321|NCT04663295|76030301|FG000|Run-in Period|Withdrawal by Subject|3|||
42214322|NCT04663295|76030301|FG000|Overall Study Period|Pregnancy|1|||
42214323|NCT04663295|76030301|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
42214324|NCT04228445|76030312|FG000|Overall Study|Lost to Follow-up|1|||
42214325|NCT04228445|76030313|FG001|Overall Study|Lost to Follow-up|1|||
42214326|NCT04228445|76030312|FG000|Overall Study|Physician Decision|1|||
42214327|NCT04228445|76030313|FG001|Overall Study|Physician Decision|2|||
42214328|NCT04228445|76030312|FG000|Overall Study|Withdrawal by Subject|0|||
42214329|NCT04228445|76030313|FG001|Overall Study|Withdrawal by Subject|1|||
42214330|NCT04228445|76030312|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
42214331|NCT04228445|76030313|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
42214332|NCT04641299|76030325|FG000|Overall Study|Adverse Event|0|||
42214333|NCT04641299|76030326|FG001|Overall Study|Adverse Event|0|||
42214334|NCT04641299|76030327|FG002|Overall Study|Adverse Event|2|||
42214335|NCT04641299|76030328|FG003|Overall Study|Adverse Event|0|||
42214336|NCT04641299|76030325|FG000|Overall Study|Lost to Follow-up|0|||
42214337|NCT04641299|76030326|FG001|Overall Study|Lost to Follow-up|1|||
42214338|NCT04641299|76030327|FG002|Overall Study|Lost to Follow-up|0|||
42214339|NCT04641299|76030328|FG003|Overall Study|Lost to Follow-up|0|||
42214340|NCT04641299|76030325|FG000|Overall Study|Withdrawal by Subject|1|||
42214341|NCT04641299|76030326|FG001|Overall Study|Withdrawal by Subject|0|||
42214342|NCT04641299|76030327|FG002|Overall Study|Withdrawal by Subject|0|||
41976783|NCT03692403|75781212|FG002|Overall Study|Adverse Event|0|||
41976784|NCT03692403|75781213|FG003|Overall Study|Adverse Event|1|||
41976785|NCT03692403|75781210|FG000|Overall Study|Pregnancy|0|||
41976786|NCT03692403|75781211|FG001|Overall Study|Pregnancy|1|||
41976787|NCT03692403|75781212|FG002|Overall Study|Pregnancy|0|||
41976788|NCT03692403|75781213|FG003|Overall Study|Pregnancy|0|||
41976789|NCT03692403|75781210|FG000|Overall Study|Other|0|||
41976790|NCT03692403|75781211|FG001|Overall Study|Other|0|||
41976791|NCT03692403|75781212|FG002|Overall Study|Other|1|||
41976792|NCT03692403|75781213|FG003|Overall Study|Other|0|||
41976793|NCT03654651|75781228|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
41976794|NCT03654651|75781229|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
41976795|NCT03649230|75781236|FG000|Overall Study|Adverse Event|12|||
41976796|NCT03649230|75781236|FG000|Overall Study|Death|8|||
41976797|NCT03649230|75781236|FG000|Overall Study|Withdrawal by Subject|6|||
41976798|NCT03649230|75781236|FG000|Overall Study|Physician Decision|5|||
41976799|NCT03649230|75781236|FG000|Overall Study|Disease progression|5|||
41976800|NCT03649230|75781236|FG000|Overall Study|Switched to non-HEC|5|||
41976801|NCT03649230|75781236|FG000|Overall Study|Chemotherapy discontinued|4|||
41976802|NCT03649230|75781236|FG000|Overall Study|Received only 3 HEC cycles|4|||
41976803|NCT03649230|75781236|FG000|Overall Study|Screen Failure|3|||
41976804|NCT03649230|75781236|FG000|Overall Study|Patient stopped treatment|2|||
41976805|NCT03649230|75781236|FG000|Overall Study|Protocol Violation|1|||
41976806|NCT03649230|75781236|FG000|Overall Study|Non-compliance|1|||
41976807|NCT03649230|75781236|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
41976808|NCT03626545|75781247|FG000|Overall Study|Progressive disease|3|||
41976809|NCT03626545|75781248|FG001|Overall Study|Progressive disease|82|||
41976810|NCT03626545|75781249|FG002|Overall Study|Progressive disease|85|||
41976811|NCT03626545|75781247|FG000|Overall Study|Adverse Event|3|||
41976812|NCT03626545|75781248|FG001|Overall Study|Adverse Event|13|||
41976813|NCT03626545|75781249|FG002|Overall Study|Adverse Event|10|||
41976814|NCT03626545|75781247|FG000|Overall Study|Physician Decision|1|||
41976815|NCT03626545|75781248|FG001|Overall Study|Physician Decision|18|||
41976816|NCT03626545|75781249|FG002|Overall Study|Physician Decision|14|||
41976817|NCT03626545|75781247|FG000|Overall Study|Subject Decision|0|||
41976818|NCT03626545|75781248|FG001|Overall Study|Subject Decision|5|||
41976819|NCT03626545|75781249|FG002|Overall Study|Subject Decision|5|||
41976820|NCT03626545|75781247|FG000|Overall Study|Death|1|||
41976821|NCT03626545|75781248|FG001|Overall Study|Death|1|||
41976822|NCT03626545|75781249|FG002|Overall Study|Death|1|||
41976823|NCT03626545|75781247|FG000|Overall Study|Protocol Deviation|0|||
41976824|NCT03626545|75781248|FG001|Overall Study|Protocol Deviation|1|||
41976825|NCT03626545|75781249|FG002|Overall Study|Protocol Deviation|1|||
42214343|NCT04641299|76030328|FG003|Overall Study|Withdrawal by Subject|0|||
42214344|NCT04641299|76030325|FG000|Overall Study|Reason not given|1|||
42214345|NCT04641299|76030326|FG001|Overall Study|Reason not given|0|||
41976826|NCT03626545|75781247|FG000|Overall Study|Guardian Decision|0|||
41976827|NCT03626545|75781248|FG001|Overall Study|Guardian Decision|0|||
41976828|NCT03626545|75781249|FG002|Overall Study|Guardian Decision|1|||
41976829|NCT03575143|75781266|FG000|Overall Study|Lost to Follow-up|0|||
41976830|NCT03575143|75781267|FG001|Overall Study|Lost to Follow-up|0|||
41976831|NCT03575143|75781268|FG002|Overall Study|Lost to Follow-up|4|||
41976832|NCT03575143|75781266|FG000|Overall Study|Withdrawal by Subject|0|||
41976833|NCT03575143|75781267|FG001|Overall Study|Withdrawal by Subject|0|||
41976834|NCT03575143|75781268|FG002|Overall Study|Withdrawal by Subject|5|||
42214346|NCT04641299|76030327|FG002|Overall Study|Reason not given|0|||
42214347|NCT04641299|76030328|FG003|Overall Study|Reason not given|0|||
41976835|NCT03575143|75781266|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
41976836|NCT03575143|75781267|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
42010623|NCT00993265|75817739|FG001|Overall Study|Changed dose of concomitant drug|0|||
42214348|NCT03703817|76030344|FG000|Overall Study|Not meeting eligibility criteria|7|||
42214349|NCT03703817|76030345|FG001|Overall Study|Not meeting eligibility criteria|4|||
42214350|NCT03698591|76030353|FG000|Overall Study|Withdrawal by Subject|2|||
42214351|NCT03698591|76030354|FG001|Overall Study|Withdrawal by Subject|2|||
42214352|NCT03698591|76030353|FG000|Overall Study|Failed drug screen|1|||
42214353|NCT03698591|76030354|FG001|Overall Study|Failed drug screen|1|||
42214354|NCT03698591|76030353|FG000|Overall Study|Failed health screen|0|||
42214355|NCT03698591|76030354|FG001|Overall Study|Failed health screen|1|||
42214356|NCT03698591|76030353|FG000|Overall Study|Ineligible for financial compensation|1|||
42214357|NCT03698591|76030354|FG001|Overall Study|Ineligible for financial compensation|0|||
42214358|NCT03698591|76030353|FG000|Overall Study|Equipment Error|1|||
42214359|NCT03698591|76030354|FG001|Overall Study|Equipment Error|0|||
42214360|NCT03698591|76030353|FG000|Overall Study|Could not establish TMS dosage|0|||
42214361|NCT03698591|76030354|FG001|Overall Study|Could not establish TMS dosage|1|||
42214362|NCT04606199|76030360|FG000|Overall Study|Withdrawal by Subject|2|||
42214363|NCT05085665|76030366|FG000|Overall Study|Physician Decision|2|||
42214364|NCT05017493|76030372|FG000|Overall Study|Withdrawal by Subject|26|||
42214365|NCT05017493|76030373|FG001|Overall Study|Withdrawal by Subject|0|||
42214366|NCT05017493|76030372|FG000|Overall Study|Physician Decision|15|||
42214367|NCT05017493|76030373|FG001|Overall Study|Physician Decision|0|||
42214368|NCT05017493|76030372|FG000|Overall Study|Protocol Violation|81|||
42214369|NCT05017493|76030373|FG001|Overall Study|Protocol Violation|0|||
42214370|NCT04599803|76030379|FG000|Overall Study|Withdrawal by Subject|5|||
42214371|NCT04599803|76030379|FG000|Overall Study|Lost to Follow-up|26|||
42214372|NCT05002985|76030383|FG000|Overall Study|Withdrawal by Subject|1|||
42214373|NCT04580303|76030389|FG000|Overall Study|Adverse Event|0|||
42214374|NCT04580303|76030390|FG001|Overall Study|Adverse Event|1|||
42214375|NCT04580303|76030391|FG002|Overall Study|Adverse Event|0|||
42214376|NCT04580303|76030392|FG003|Overall Study|Adverse Event|0|||
42214377|NCT04580303|76030389|FG000|Overall Study|Withdrawal by Subject|0|||
42214378|NCT04580303|76030390|FG001|Overall Study|Withdrawal by Subject|0|||
42214379|NCT04580303|76030391|FG002|Overall Study|Withdrawal by Subject|1|||
42214380|NCT04580303|76030392|FG003|Overall Study|Withdrawal by Subject|0|||
42214381|NCT04577183|76030402|FG000|Overall Study|Death|1|||
42214382|NCT04577183|76030402|FG000|Overall Study|Withdrawal by Subject|3|||
42214383|NCT04577183|76030402|FG000|Overall Study|Early termination|2|||
42214384|NCT04574999|76030408|FG000|Overall Study|Adverse Event|1|||
42214385|NCT04574999|76030409|FG001|Overall Study|Adverse Event|0|||
42214386|NCT04574999|76030408|FG000|Overall Study|Lack of Efficacy|2|||
41976837|NCT03575143|75781268|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
41976838|NCT03548064|75781286|FG000|Overall Study|Withdrawal by Subject|0|||
41976839|NCT03548064|75781287|FG001|Overall Study|Withdrawal by Subject|0|||
41976840|NCT03548064|75781288|FG002|Overall Study|Withdrawal by Subject|0|||
41976841|NCT03548064|75781289|FG003|Overall Study|Withdrawal by Subject|1|||
41976842|NCT03548064|75781290|FG004|Overall Study|Withdrawal by Subject|0|||
41976843|NCT03548064|75781291|FG005|Overall Study|Withdrawal by Subject|0|||
41976844|NCT03548064|75781292|FG006|Overall Study|Withdrawal by Subject|0|||
41976845|NCT03548064|75781293|FG007|Overall Study|Withdrawal by Subject|0|||
41976846|NCT03548064|75781286|FG000|Overall Study|Lost to Follow-up|0|||
41976847|NCT03548064|75781287|FG001|Overall Study|Lost to Follow-up|0|||
41976848|NCT03548064|75781288|FG002|Overall Study|Lost to Follow-up|0|||
41976849|NCT03548064|75781289|FG003|Overall Study|Lost to Follow-up|0|||
41976850|NCT03548064|75781290|FG004|Overall Study|Lost to Follow-up|2|||
41976851|NCT03548064|75781291|FG005|Overall Study|Lost to Follow-up|0|||
41976852|NCT03548064|75781292|FG006|Overall Study|Lost to Follow-up|0|||
41976853|NCT03548064|75781293|FG007|Overall Study|Lost to Follow-up|0|||
41976854|NCT03548064|75781286|FG000|Overall Study|Covid-19 Pandemic|0|||
41976855|NCT03548064|75781287|FG001|Overall Study|Covid-19 Pandemic|0|||
41976856|NCT03548064|75781288|FG002|Overall Study|Covid-19 Pandemic|0|||
41976857|NCT03548064|75781289|FG003|Overall Study|Covid-19 Pandemic|0|||
41976858|NCT03548064|75781290|FG004|Overall Study|Covid-19 Pandemic|10|||
41976859|NCT03548064|75781291|FG005|Overall Study|Covid-19 Pandemic|3|||
41976860|NCT03548064|75781292|FG006|Overall Study|Covid-19 Pandemic|0|||
41976861|NCT03548064|75781293|FG007|Overall Study|Covid-19 Pandemic|0|||
41976862|NCT03512197|75781319|FG000|Overall Study|Guardian decision|1|||
41976863|NCT03512197|75781320|FG001|Overall Study|Guardian decision|1|||
41976864|NCT03512197|75781319|FG000|Overall Study|Lack of Efficacy|19|||
41976865|NCT03512197|75781320|FG001|Overall Study|Lack of Efficacy|11|||
41976866|NCT03512197|75781319|FG000|Overall Study|New Therapy for Study Indication|16|||
41976867|NCT03512197|75781320|FG001|Overall Study|New Therapy for Study Indication|16|||
41976868|NCT03512197|75781319|FG000|Overall Study|Physician Decision|60|||
41976869|NCT03512197|75781320|FG001|Overall Study|Physician Decision|60|||
41976870|NCT03512197|75781319|FG000|Overall Study|Protocol Violation|0|||
41976871|NCT03512197|75781320|FG001|Overall Study|Protocol Violation|2|||
41976872|NCT03512197|75781319|FG000|Overall Study|Terminated by Sponsored|46|||
41976873|NCT03512197|75781320|FG001|Overall Study|Terminated by Sponsored|50|||
41976874|NCT03512197|75781319|FG000|Overall Study|Subject Decision|15|||
41976875|NCT03512197|75781320|FG001|Overall Study|Subject Decision|12|||
41976876|NCT03512197|75781319|FG000|Overall Study|Withdrawal of informed consent|20|||
41976877|NCT03512197|75781320|FG001|Overall Study|Withdrawal of informed consent|14|||
41976878|NCT03512197|75781319|FG000|Overall Study|Adverse Event|30|||
41976879|NCT03512197|75781320|FG001|Overall Study|Adverse Event|34|||
41976880|NCT03512197|75781319|FG000|Overall Study|Death|14|||
41976881|NCT03512197|75781320|FG001|Overall Study|Death|9|||
41976882|NCT03512197|75781319|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
41976883|NCT03512197|75781320|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
41976884|NCT03512197|75781319|FG000|Overall Study|Missing|3|||
41976885|NCT03512197|75781320|FG001|Overall Study|Missing|13|||
41976886|NCT03502330|75781340|FG000|Overall Study|Adverse Event|2|||
41976887|NCT03502330|75781341|FG001|Overall Study|Adverse Event|1|||
41976888|NCT03502330|75781342|FG002|Overall Study|Adverse Event|0|||
41976889|NCT03502330|75781343|FG003|Overall Study|Adverse Event|0|||
41976890|NCT03502330|75781344|FG004|Overall Study|Adverse Event|1|||
41976891|NCT03502330|75781345|FG005|Overall Study|Adverse Event|0|||
41976892|NCT03502330|75781346|FG006|Overall Study|Adverse Event|1|||
41976893|NCT03502330|75781347|FG007|Overall Study|Adverse Event|1|||
41976894|NCT03502330|75781348|FG008|Overall Study|Adverse Event|0|||
41976895|NCT03502330|75781340|FG000|Overall Study|Lack of Efficacy|1|||
41976896|NCT03502330|75781341|FG001|Overall Study|Lack of Efficacy|5|||
42214387|NCT04574999|76030409|FG001|Overall Study|Lack of Efficacy|3|||
42214388|NCT04574999|76030408|FG000|Overall Study|Protocol Violation|1|||
42214389|NCT04574999|76030409|FG001|Overall Study|Protocol Violation|0|||
42214390|NCT04574999|76030408|FG000|Overall Study|Withdrawal by Subject|2|||
42214391|NCT04574999|76030409|FG001|Overall Study|Withdrawal by Subject|2|||
42028447|NCT00957021|75836877|FG000|Overall Study|Termination due to language issue|2|||
42028448|NCT01124604|75836884|FG000|Overall Study|Adverse Event|10|||
42214392|NCT04574999|76030408|FG000|Overall Study|Lost to Follow-up|1|||
41976897|NCT03502330|75781342|FG002|Overall Study|Lack of Efficacy|3|||
41976898|NCT03502330|75781343|FG003|Overall Study|Lack of Efficacy|5|||
41976899|NCT03502330|75781344|FG004|Overall Study|Lack of Efficacy|1|||
41976900|NCT03502330|75781345|FG005|Overall Study|Lack of Efficacy|5|||
41976901|NCT03502330|75781346|FG006|Overall Study|Lack of Efficacy|5|||
42214393|NCT04574999|76030409|FG001|Overall Study|Lost to Follow-up|0|||
41976902|NCT03502330|75781347|FG007|Overall Study|Lack of Efficacy|6|||
41976903|NCT03502330|75781348|FG008|Overall Study|Lack of Efficacy|0|||
41976904|NCT03502330|75781340|FG000|Overall Study|Physician Decision|0|||
41976905|NCT03502330|75781341|FG001|Overall Study|Physician Decision|0|||
41976906|NCT03502330|75781342|FG002|Overall Study|Physician Decision|0|||
42214394|NCT04574999|76030408|FG000|Overall Study|Personal problems|1|||
42214395|NCT04574999|76030409|FG001|Overall Study|Personal problems|0|||
42214396|NCT04574999|76030408|FG000|Overall Study|Previous planned surgery|1|||
42214397|NCT04574999|76030409|FG001|Overall Study|Previous planned surgery|0|||
42214398|NCT04565249|76030419|FG000|Overall Study|Death|0|||
42214399|NCT04565249|76030420|FG001|Overall Study|Death|0|||
42214400|NCT04565249|76030421|FG002|Overall Study|Death|0|||
42214401|NCT04565249|76030422|FG003|Overall Study|Death|1|||
42214402|NCT04942925|76030434|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
42214403|NCT04942925|76030435|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
42214404|NCT04942925|76030434|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
42214405|NCT04942925|76030435|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
42214406|NCT04854707|76030447|FG000|Overall Study|Lack of Efficacy|78|||
42214407|NCT04854707|76030448|FG001|Overall Study|Lack of Efficacy|59|||
42214408|NCT04854707|76030449|FG002|Overall Study|Lack of Efficacy|30|||
42214409|NCT04557371|76030464|FG000|Overall Study|Covid-19-related|0|||
42214410|NCT04557371|76030465|FG001|Overall Study|Covid-19-related|1|||
42214411|NCT04557371|76030466|FG002|Overall Study|Covid-19-related|0|||
42214412|NCT04557371|76030464|FG000|Overall Study|Withdrawal by Subject|0|||
42214413|NCT04557371|76030465|FG001|Overall Study|Withdrawal by Subject|1|||
42214414|NCT04557371|76030466|FG002|Overall Study|Withdrawal by Subject|0|||
42214415|NCT04557371|76030464|FG000|Overall Study|Adverse Event|1|||
42214416|NCT04557371|76030465|FG001|Overall Study|Adverse Event|0|||
42128570|NCT04076059|75939149|FG001|Double Blind Phase|Protocol Deviation|1|||
42128571|NCT04076059|75939150|FG002|Double Blind Phase|Protocol Deviation|0|||
42128572|NCT04076059|75939148|FG000|Double Blind Phase|Did not take study drug|1|||
42128573|NCT04076059|75939149|FG001|Double Blind Phase|Did not take study drug|1|||
42128574|NCT04076059|75939150|FG002|Double Blind Phase|Did not take study drug|0|||
42128575|NCT04076059|75939148|FG000|Open Label Phase|Progressive disease|0|||
42214417|NCT04557371|76030466|FG002|Overall Study|Adverse Event|0|||
42214418|NCT04821245|76030474|FG000|Overall Study|Withdrawal by Subject|3|||
42214419|NCT04821245|76030474|FG000|Overall Study|Physician Decision|1|||
42214420|NCT04821245|76030474|FG000|Overall Study|Protocol Violation|5|||
42214421|NCT04539275|76030482|FG000|Overall Study|Death|2|||
42214422|NCT04539275|76030483|FG001|Overall Study|Death|4|||
42214423|NCT04539275|76030482|FG000|Overall Study|Lost to Follow-up|1|||
42214424|NCT04539275|76030483|FG001|Overall Study|Lost to Follow-up|1|||
42214425|NCT04539275|76030482|FG000|Overall Study|Withdrawal by Subject|3|||
42214426|NCT04539275|76030483|FG001|Overall Study|Withdrawal by Subject|0|||
42214427|NCT04784897|76030492|FG000|Overall Study|Death|4|||
42214428|NCT04784897|76030493|FG001|Overall Study|Death|2|||
42214429|NCT04784897|76030494|FG002|Overall Study|Death|1|||
41976907|NCT03502330|75781343|FG003|Overall Study|Physician Decision|0|||
41976908|NCT03502330|75781344|FG004|Overall Study|Physician Decision|1|||
41976909|NCT03502330|75781345|FG005|Overall Study|Physician Decision|0|||
41976910|NCT03502330|75781346|FG006|Overall Study|Physician Decision|0|||
41976911|NCT03502330|75781347|FG007|Overall Study|Physician Decision|0|||
41976912|NCT03502330|75781348|FG008|Overall Study|Physician Decision|0|||
41976913|NCT03502330|75781340|FG000|Overall Study|Withdrawal by Subject|0|||
42128576|NCT04076059|75939149|FG001|Open Label Phase|Progressive disease|0|||
42128577|NCT04076059|75939150|FG002|Open Label Phase|Progressive disease|7|||
42128578|NCT04076059|75939148|FG000|Open Label Phase|Withdrawal by Subject|0|||
42128579|NCT04076059|75939149|FG001|Open Label Phase|Withdrawal by Subject|0|||
42128580|NCT04076059|75939150|FG002|Open Label Phase|Withdrawal by Subject|3|||
42128581|NCT04076059|75939148|FG000|Open Label Phase|Death|0|||
42128582|NCT04076059|75939149|FG001|Open Label Phase|Death|0|||
42214430|NCT04784897|76030492|FG000|Overall Study|Withdrawal by Subject|0|||
42214431|NCT04784897|76030493|FG001|Overall Study|Withdrawal by Subject|0|||
42214432|NCT04784897|76030494|FG002|Overall Study|Withdrawal by Subject|1|||
42214433|NCT04532099|76030508|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
42214434|NCT04532099|76030509|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
42214435|NCT04532099|76030510|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
42214436|NCT03041792|76030524|FG000|Overall Study|Adverse Event|4|||
42214437|NCT03041792|76030525|FG001|Overall Study|Adverse Event|0|||
41976914|NCT03502330|75781341|FG001|Overall Study|Withdrawal by Subject|0|||
41976915|NCT03502330|75781342|FG002|Overall Study|Withdrawal by Subject|0|||
42128583|NCT04076059|75939150|FG002|Open Label Phase|Death|2|||
42214438|NCT03041792|76030524|FG000|Overall Study|Death in the family|0|||
42214439|NCT03041792|76030525|FG001|Overall Study|Death in the family|2|||
42214440|NCT03041792|76030524|FG000|Overall Study|Randomized but not treated|0|||
42214441|NCT03041792|76030525|FG001|Overall Study|Randomized but not treated|1|||
42214442|NCT04507763|76030531|FG000|Overall Study|Participants did not meet entrance criteria|201|||
42214443|NCT03045302|76030538|FG000|Overall Study|Pre-treatment adverse event|1|||
41976916|NCT03502330|75781343|FG003|Overall Study|Withdrawal by Subject|0|||
42214444|NCT00705484|76030544|FG000|Overall Study|Adverse Event|28|||
42214445|NCT00705484|76030545|FG001|Overall Study|Adverse Event|27|||
42214446|NCT00705484|76030544|FG000|Overall Study|Lost to Follow-up|169|||
42214447|NCT00705484|76030545|FG001|Overall Study|Lost to Follow-up|250|||
42214448|NCT00705484|76030544|FG000|Overall Study|Withdrawal by Subject|96|||
42214449|NCT00705484|76030545|FG001|Overall Study|Withdrawal by Subject|72|||
42214450|NCT00705484|76030544|FG000|Overall Study|Administrative|89|||
42214451|NCT00705484|76030545|FG001|Overall Study|Administrative|59|||
42214452|NCT04523831|76030555|FG000|Overall Study|Lost to Follow-up|15|||
42214453|NCT04523831|76030556|FG001|Overall Study|Lost to Follow-up|17|||
42214454|NCT04523831|76030555|FG000|Overall Study|Death|0|||
42214455|NCT04523831|76030556|FG001|Overall Study|Death|3|||
42214456|NCT04523831|76030555|FG000|Overall Study|Adverse Event|2|||
42214457|NCT04523831|76030556|FG001|Overall Study|Adverse Event|0|||
42214458|NCT04707664|76030567|FG000|Overall Study|Adverse Event|2|||
42214459|NCT04707664|76030568|FG001|Overall Study|Adverse Event|0|||
42214460|NCT04707664|76030567|FG000|Overall Study|Death|1|||
42214461|NCT04707664|76030568|FG001|Overall Study|Death|2|||
42214462|NCT04707664|76030567|FG000|Overall Study|Withdrawal by Subject|13|||
42214463|NCT04707664|76030568|FG001|Overall Study|Withdrawal by Subject|21|||
42214464|NCT04707664|76030567|FG000|Overall Study|Lost to Follow-up|11|||
42214465|NCT04707664|76030568|FG001|Overall Study|Lost to Follow-up|13|||
42214466|NCT04707664|76030567|FG000|Overall Study|Not treated|2|||
42214467|NCT04707664|76030568|FG001|Overall Study|Not treated|0|||
42214468|NCT01316276|76030574|FG000|Overall Study|Death|1|||
42214469|NCT01316276|76030574|FG000|Overall Study|Adverse Event|19|||
41976917|NCT03502330|75781344|FG004|Overall Study|Withdrawal by Subject|0|||
41976918|NCT03502330|75781345|FG005|Overall Study|Withdrawal by Subject|1|||
41976919|NCT03502330|75781346|FG006|Overall Study|Withdrawal by Subject|0|||
41976920|NCT03502330|75781347|FG007|Overall Study|Withdrawal by Subject|1|||
41976921|NCT03502330|75781348|FG008|Overall Study|Withdrawal by Subject|0|||
42214470|NCT01316276|76030574|FG000|Overall Study|Withdrawal of consent|24|||
41976922|NCT03502330|75781340|FG000|Overall Study|Death|0|||
41976923|NCT03502330|75781341|FG001|Overall Study|Death|0|||
42214471|NCT01316276|76030574|FG000|Overall Study|Lost to Follow-up|1|||
42214472|NCT01316276|76030574|FG000|Overall Study|Other|22|||
42214473|NCT04668989|76030579|FG000|First Intervention|Covid-19 related self-isolation|0|||
42214474|NCT04668989|76030580|FG001|First Intervention|Covid-19 related self-isolation|1|||
42301929|NCT02280291|76137114|FG002|Overall Study|Lost to Follow-up|3|||
42214475|NCT04668989|76030579|FG000|Second Intervention|Adverse Event|0|||
42214476|NCT04668989|76030580|FG001|Second Intervention|Adverse Event|1|||
42214477|NCT03700385|76030586|FG000|Overall Study|Lost to Follow-up|1|||
41976924|NCT03502330|75781342|FG002|Overall Study|Death|0|||
41976925|NCT03502330|75781343|FG003|Overall Study|Death|0|||
42128584|NCT04076059|75939148|FG000|Open Label Phase|Ongoing Participants|0|||
42128585|NCT04076059|75939149|FG001|Open Label Phase|Ongoing Participants|0|||
42128586|NCT04076059|75939150|FG002|Open Label Phase|Ongoing Participants|11|||
42128587|NCT04047420|75939157|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
42128588|NCT04047420|75939157|FG000|Washout Period|Refused Participation|2|||
42128589|NCT04003636|75939166|FG000|Overall Study|Death|409|||
42128590|NCT04003636|75939167|FG001|Overall Study|Death|443|||
42128591|NCT04003636|75939166|FG000|Overall Study|Lost to Follow-up|0|||
42128592|NCT04003636|75939167|FG001|Overall Study|Lost to Follow-up|1|||
42128593|NCT04003636|75939166|FG000|Overall Study|Withdrawal by Subject|5|||
42128594|NCT04003636|75939167|FG001|Overall Study|Withdrawal by Subject|2|||
42128595|NCT04003636|75939166|FG000|Overall Study|Participant On-going|119|||
42128596|NCT04003636|75939167|FG001|Overall Study|Participant On-going|90|||
42128597|NCT03958045|75939174|FG000|Overall Study|Withdrawal by Subject|1|||
41976926|NCT03502330|75781344|FG004|Overall Study|Death|0|||
42214478|NCT04498403|76030592|FG000|Overall Study|Adverse Event|1|||
42214479|NCT04498403|76030593|FG001|Overall Study|Adverse Event|0|||
42214480|NCT04498403|76030592|FG000|Overall Study|Study Terminated By Sponsor|29|||
42214481|NCT04498403|76030593|FG001|Overall Study|Study Terminated By Sponsor|10|||
42214482|NCT04362137|76030601|FG000|Overall Study|Death|9|||
42214483|NCT04362137|76030602|FG001|Overall Study|Death|3|||
42214484|NCT04362137|76030601|FG000|Overall Study|Patient decision|6|||
42214485|NCT04362137|76030602|FG001|Overall Study|Patient decision|3|||
42214486|NCT04362137|76030601|FG000|Overall Study|Adverse Event|1|||
42214487|NCT04362137|76030602|FG001|Overall Study|Adverse Event|0|||
42214488|NCT04362137|76030601|FG000|Overall Study|Lost to Follow-up|1|||
42214489|NCT04362137|76030602|FG001|Overall Study|Lost to Follow-up|0|||
42214490|NCT04362137|76030601|FG000|Overall Study|Protocol deviation|1|||
42214491|NCT04362137|76030602|FG001|Overall Study|Protocol deviation|0|||
42214492|NCT05099380|76030610|FG000|Overall Study|Subject enrolled in error|1|||
42214493|NCT05099380|76030611|FG001|Overall Study|Subject enrolled in error|0|||
42214494|NCT05099380|76030610|FG000|Overall Study|Study Procedure|1|||
42214495|NCT05099380|76030611|FG001|Overall Study|Study Procedure|0|||
42214496|NCT05099380|76030610|FG000|Overall Study|Protocol Violation|1|||
42214497|NCT05099380|76030611|FG001|Overall Study|Protocol Violation|0|||
42214498|NCT05099380|76030610|FG000|Overall Study|Adverse Event|1|||
42214499|NCT05099380|76030611|FG001|Overall Study|Adverse Event|1|||
42214500|NCT05099380|76030610|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
42214501|NCT05099380|76030611|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
42214502|NCT03614728|76030621|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
42214503|NCT03614728|76030622|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
42214504|NCT03614728|76030623|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
42214505|NCT03614728|76030624|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
42214506|NCT03614728|76030621|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
42214507|NCT03614728|76030622|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
42214508|NCT03614728|76030623|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
42214509|NCT03614728|76030624|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
42214510|NCT03154086|76030647|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214511|NCT03154086|76030648|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214512|NCT03154086|76030649|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214513|NCT03154086|76030650|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
42214514|NCT03154086|76030651|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214515|NCT03154086|76030652|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214516|NCT03154086|76030653|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214517|NCT03154086|76030654|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214518|NCT03154086|76030655|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214519|NCT03154086|76030656|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214520|NCT03154086|76030657|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214521|NCT03154086|76030658|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214522|NCT03154086|76030659|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214523|NCT03154086|76030660|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42128598|NCT03806179|75939180|FG000|Overall Study|Progressive disease|0|||
42128599|NCT03806179|75939181|FG001|Overall Study|Progressive disease|2|||
42128600|NCT03759587|75939187|FG000|Overall Study|Adverse Event|5|||
42128601|NCT03759587|75939187|FG000|Overall Study|Progressive Disease|10|||
42128602|NCT03759587|75939187|FG000|Overall Study|Site Terminated by Sponsor|3|||
42128603|NCT03759587|75939187|FG000|Overall Study|Withdrawal by Subject|1|||
42128604|NCT03735121|75939209|FG000|Overall Study|Death|3|||
42128605|NCT03735121|75939210|FG001|Overall Study|Death|6|||
42128606|NCT03735121|75939211|FG002|Overall Study|Death|8|||
42128607|NCT03735121|75939212|FG003|Overall Study|Death|37|||
42128608|NCT03735121|75939213|FG004|Overall Study|Death|86|||
42128609|NCT03735121|75939209|FG000|Overall Study|Withdrawal by Subject|1|||
42128610|NCT03735121|75939210|FG001|Overall Study|Withdrawal by Subject|1|||
42128611|NCT03735121|75939211|FG002|Overall Study|Withdrawal by Subject|3|||
42128612|NCT03735121|75939212|FG003|Overall Study|Withdrawal by Subject|4|||
42128613|NCT03735121|75939213|FG004|Overall Study|Withdrawal by Subject|2|||
42128614|NCT03735121|75939209|FG000|Overall Study|Progressive Disease|0|||
42214524|NCT03154086|76030661|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
42214525|NCT03154086|76030647|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214526|NCT03154086|76030648|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
42301930|NCT02280291|76137115|FG003|Overall Study|Lost to Follow-up|8|||
42214527|NCT03154086|76030649|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42128615|NCT03735121|75939210|FG001|Overall Study|Progressive Disease|0|||
42128616|NCT03735121|75939211|FG002|Overall Study|Progressive Disease|1|||
42128617|NCT03735121|75939212|FG003|Overall Study|Progressive Disease|0|||
42128618|NCT03735121|75939213|FG004|Overall Study|Progressive Disease|0|||
42128619|NCT03735121|75939209|FG000|Overall Study|Lost to Follow-up|0|||
42214528|NCT03154086|76030650|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214529|NCT03154086|76030651|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214530|NCT03154086|76030652|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214531|NCT03154086|76030653|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214532|NCT03154086|76030654|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214533|NCT03154086|76030655|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214534|NCT03154086|76030656|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214535|NCT03154086|76030657|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214536|NCT03154086|76030658|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214537|NCT03154086|76030659|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214538|NCT03154086|76030660|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214539|NCT03154086|76030661|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
42214540|NCT03154086|76030647|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214541|NCT03154086|76030648|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214542|NCT03154086|76030649|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
42214543|NCT03154086|76030650|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214544|NCT03154086|76030651|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214545|NCT03154086|76030652|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214546|NCT03154086|76030653|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214547|NCT03154086|76030654|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214548|NCT03154086|76030655|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214549|NCT03154086|76030656|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214550|NCT03154086|76030657|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214551|NCT03154086|76030658|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214552|NCT03154086|76030659|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214553|NCT03154086|76030660|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214554|NCT03154086|76030661|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
42214555|NCT03154086|76030647|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
42214556|NCT03154086|76030648|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214557|NCT03154086|76030649|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214558|NCT03154086|76030650|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214559|NCT03154086|76030651|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214560|NCT03154086|76030652|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214561|NCT03154086|76030653|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214562|NCT03154086|76030654|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214563|NCT03154086|76030655|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214564|NCT03154086|76030656|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214565|NCT03154086|76030657|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214566|NCT03154086|76030658|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214567|NCT03154086|76030659|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214568|NCT03154086|76030660|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214569|NCT03154086|76030661|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
42214570|NCT03154086|76030647|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
41976927|NCT03502330|75781345|FG005|Overall Study|Death|0|||
42128620|NCT03735121|75939210|FG001|Overall Study|Lost to Follow-up|0|||
42128621|NCT03735121|75939211|FG002|Overall Study|Lost to Follow-up|0|||
42128622|NCT03735121|75939212|FG003|Overall Study|Lost to Follow-up|0|||
42128623|NCT03735121|75939213|FG004|Overall Study|Lost to Follow-up|1|||
42128624|NCT03735121|75939209|FG000|Overall Study|Ongoing|3|||
42128625|NCT03735121|75939210|FG001|Overall Study|Ongoing|3|||
42128626|NCT03735121|75939211|FG002|Overall Study|Ongoing|26|||
42128627|NCT03735121|75939212|FG003|Overall Study|Ongoing|83|||
42214571|NCT03154086|76030648|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
42214572|NCT03154086|76030649|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
42214573|NCT03154086|76030650|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
42214574|NCT03154086|76030651|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
42214575|NCT03154086|76030652|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
42214576|NCT03154086|76030653|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
42214577|NCT03154086|76030654|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
42214578|NCT03154086|76030655|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
42214579|NCT03154086|76030656|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
42214580|NCT03154086|76030657|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
42214581|NCT03154086|76030658|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
41976928|NCT03502330|75781346|FG006|Overall Study|Death|2|||
42128628|NCT03735121|75939213|FG004|Overall Study|Ongoing|158|||
42128629|NCT03730194|75939239|FG000|First Stage Treatment|Withdrawal by Subject|1|||
42128630|NCT03730194|75939240|FG001|First Stage Treatment|Withdrawal by Subject|1|||
42128631|NCT03730194|75939241|FG002|First Stage Treatment|Withdrawal by Subject|0|||
42128632|NCT03730194|75939242|FG003|First Stage Treatment|Withdrawal by Subject|0|||
42128633|NCT03730194|75939243|FG004|First Stage Treatment|Withdrawal by Subject|0|||
42128634|NCT03730194|75939244|FG005|First Stage Treatment|Withdrawal by Subject|0|||
42128635|NCT03730194|75939239|FG000|First Stage Treatment|Protocol Violation|3|||
42128636|NCT03730194|75939240|FG001|First Stage Treatment|Protocol Violation|3|||
42128637|NCT03730194|75939241|FG002|First Stage Treatment|Protocol Violation|0|||
42128638|NCT03730194|75939242|FG003|First Stage Treatment|Protocol Violation|0|||
42128639|NCT03730194|75939243|FG004|First Stage Treatment|Protocol Violation|0|||
42128640|NCT03730194|75939244|FG005|First Stage Treatment|Protocol Violation|0|||
42128641|NCT03559400|75939253|FG000|Overall Study|Lost to Follow-up|9|||
42128642|NCT03559400|75939254|FG001|Overall Study|Lost to Follow-up|7|||
42128643|NCT03559400|75939253|FG000|Overall Study|Death|0|||
42128644|NCT03559400|75939254|FG001|Overall Study|Death|2|||
42128645|NCT03483012|75939261|FG000|Overall Study|Lack of Efficacy|6|||
42128646|NCT03231709|75939271|FG000|Treatment Period 1|Reason not Specified|0|||
42128647|NCT03231709|75939272|FG001|Treatment Period 1|Reason not Specified|1|||
42128648|NCT03231709|75939271|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
42128649|NCT03231709|75939272|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
42214582|NCT03154086|76030659|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
41976929|NCT03502330|75781347|FG007|Overall Study|Death|0|||
42214583|NCT03154086|76030660|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
42214584|NCT03154086|76030661|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
42214585|NCT03154086|76030647|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214586|NCT03154086|76030648|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214587|NCT03154086|76030649|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214588|NCT03154086|76030650|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214589|NCT03154086|76030651|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
41976930|NCT03502330|75781348|FG008|Overall Study|Death|0|||
41976931|NCT03460756|75781370|FG000|Overall Study|Adverse Event|0|||
41976932|NCT03460756|75781371|FG001|Overall Study|Adverse Event|0|||
41976933|NCT03460756|75781372|FG002|Overall Study|Adverse Event|0|||
41976934|NCT03460756|75781373|FG003|Overall Study|Adverse Event|1|||
41976935|NCT03460756|75781370|FG000|Overall Study|Lack of Efficacy|0|||
42214590|NCT03154086|76030652|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214591|NCT03154086|76030653|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214592|NCT03154086|76030654|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
42214593|NCT03154086|76030655|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214594|NCT03154086|76030656|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214595|NCT03154086|76030657|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214596|NCT03154086|76030658|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214597|NCT03154086|76030659|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
41976936|NCT03460756|75781371|FG001|Overall Study|Lack of Efficacy|0|||
41976937|NCT03460756|75781372|FG002|Overall Study|Lack of Efficacy|0|||
41976938|NCT03460756|75781373|FG003|Overall Study|Lack of Efficacy|2|||
41976939|NCT03460756|75781370|FG000|Overall Study|Lost to Follow-up|0|||
42128670|NCT03014479|75939302|FG000|Overall Study|Adverse Event|0|||
42128671|NCT03014479|75939303|FG001|Overall Study|Adverse Event|1|||
42128672|NCT03014479|75939302|FG000|Overall Study|Voluntary Withdrawal|0|||
42128673|NCT03014479|75939303|FG001|Overall Study|Voluntary Withdrawal|2|||
42128674|NCT03014479|75939302|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
41976940|NCT03460756|75781371|FG001|Overall Study|Lost to Follow-up|1|||
41976941|NCT03460756|75781372|FG002|Overall Study|Lost to Follow-up|2|||
41976942|NCT03460756|75781373|FG003|Overall Study|Lost to Follow-up|1|||
41976943|NCT03460756|75781370|FG000|Overall Study|Pregnancy|0|||
42214598|NCT03154086|76030660|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214599|NCT03154086|76030661|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
42214600|NCT03154086|76030647|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
42214601|NCT03154086|76030648|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
42214602|NCT03154086|76030649|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
42214603|NCT03154086|76030650|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
42214604|NCT03154086|76030651|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
42214605|NCT03154086|76030652|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
42214606|NCT03154086|76030653|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
42214607|NCT03154086|76030654|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
42214608|NCT03154086|76030655|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
42214609|NCT03154086|76030656|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
42214610|NCT03154086|76030657|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
42214611|NCT03154086|76030658|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
42214612|NCT03154086|76030659|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
42214613|NCT03154086|76030660|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
41976944|NCT03460756|75781371|FG001|Overall Study|Pregnancy|0|||
41976945|NCT03460756|75781372|FG002|Overall Study|Pregnancy|0|||
41976946|NCT03460756|75781373|FG003|Overall Study|Pregnancy|1|||
41976947|NCT03460756|75781370|FG000|Overall Study|Protocol Violation|0|||
41976948|NCT03460756|75781371|FG001|Overall Study|Protocol Violation|0|||
41976949|NCT03460756|75781372|FG002|Overall Study|Protocol Violation|0|||
42128675|NCT03014479|75939303|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
42128676|NCT02937818|75939313|FG000|Overall Study|Participants decision|1|||
42128677|NCT02937818|75939314|FG001|Overall Study|Participants decision|0|||
42128678|NCT02937818|75939315|FG002|Overall Study|Participants decision|1|||
42128679|NCT02937818|75939316|FG003|Overall Study|Participants decision|1|||
42214614|NCT03154086|76030661|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
42214615|NCT02723344|76030719|FG000|Overall Study|Lost to Follow-up|0|||
42214616|NCT02723344|76030720|FG001|Overall Study|Lost to Follow-up|4|||
42214617|NCT02723188|76030729|FG000|Overall Study|Withdrawal by Subject|1|||
42214618|NCT02723188|76030730|FG001|Overall Study|Withdrawal by Subject|0|||
42214619|NCT02723188|76030731|FG002|Overall Study|Withdrawal by Subject|0|||
42214620|NCT00705406|76030741|FG000|Overall Study|Lost to Follow-up|3|||
42214621|NCT00705406|76030742|FG001|Overall Study|Lost to Follow-up|3|||
42214622|NCT00705406|76030741|FG000|Overall Study|Did not receive study drug|1|||
42214623|NCT00705406|76030742|FG001|Overall Study|Did not receive study drug|2|||
42214624|NCT03155178|76030753|FG000|Overall Study|Did not meet treatment day baseline|7|||
42214625|NCT03155178|76030754|FG001|Overall Study|Did not meet treatment day baseline|7|||
42214626|NCT03155178|76030755|FG002|Overall Study|Did not meet treatment day baseline|7|||
42214627|NCT03155178|76030756|FG003|Overall Study|Did not meet treatment day baseline|7|||
42214628|NCT00705250|76030780|FG000|Overall Study|Withdrawal by Subject|1|||
42214629|NCT00705250|76030780|FG000|Overall Study|Patient died in car accident|1|||
42214630|NCT05553600|76030786|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
42214631|NCT05553600|76030787|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
42214632|NCT05553600|76030788|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
42214633|NCT05553600|76030789|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
42214634|NCT05553600|76030786|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
42214635|NCT05553600|76030787|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
42214636|NCT05553600|76030788|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
42214637|NCT05553600|76030789|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
42214638|NCT05553600|76030786|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
42128680|NCT02937818|75939313|FG000|Overall Study|Adverse Event|2|||
42128681|NCT02937818|75939314|FG001|Overall Study|Adverse Event|4|||
42128682|NCT02937818|75939315|FG002|Overall Study|Adverse Event|1|||
42128683|NCT02937818|75939316|FG003|Overall Study|Adverse Event|1|||
42128684|NCT02937818|75939313|FG000|Overall Study|Disease progression|17|||
42214639|NCT05553600|76030787|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
41976950|NCT03460756|75781373|FG003|Overall Study|Protocol Violation|1|||
41976951|NCT03460756|75781370|FG000|Overall Study|Withdrawal by Subject|0|||
41976952|NCT03460756|75781371|FG001|Overall Study|Withdrawal by Subject|4|||
41976953|NCT03460756|75781372|FG002|Overall Study|Withdrawal by Subject|7|||
41976954|NCT03460756|75781373|FG003|Overall Study|Withdrawal by Subject|3|||
41976955|NCT03459443|75781385|FG000|Overall Study|Lack of Efficacy|3|||
42214640|NCT05553600|76030788|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
42214641|NCT05553600|76030789|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
42301931|NCT02280291|76137112|FG000|Overall Study|Protocol Violation|1|||
41976956|NCT03459443|75781385|FG000|Overall Study|Adverse Event|1|||
42128685|NCT02937818|75939314|FG001|Overall Study|Disease progression|14|||
42128686|NCT02937818|75939315|FG002|Overall Study|Disease progression|7|||
42214642|NCT05553600|76030786|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
42214643|NCT05553600|76030787|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
42214644|NCT05553600|76030788|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
42214645|NCT05553600|76030789|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
42214646|NCT05553600|76030786|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
42214647|NCT05553600|76030787|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
42214648|NCT05553600|76030788|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
42214649|NCT05553600|76030789|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
42214650|NCT05553600|76030786|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
42214651|NCT05553600|76030787|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
42214652|NCT05553600|76030788|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
42214653|NCT05553600|76030789|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
42214654|NCT05553600|76030786|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
42214655|NCT05553600|76030787|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
42214656|NCT05553600|76030788|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
42214657|NCT05553600|76030789|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
42214658|NCT05553600|76030786|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
42214659|NCT05553600|76030787|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
42214660|NCT05553600|76030788|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
42214661|NCT05553600|76030789|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
42214662|NCT05553600|76030786|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
42214663|NCT05553600|76030787|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
42214664|NCT05553600|76030788|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
42214665|NCT05553600|76030789|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
42214666|NCT05553600|76030786|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
42214667|NCT05553600|76030787|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
42214668|NCT05553600|76030788|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
42214669|NCT05553600|76030789|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
42214670|NCT05553600|76030786|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
42214671|NCT05553600|76030787|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
42214672|NCT05553600|76030788|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
42214673|NCT05553600|76030789|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
42214674|NCT05553600|76030786|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
42214675|NCT05553600|76030787|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
42214676|NCT05553600|76030788|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
42214677|NCT05553600|76030789|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
42214678|NCT05451329|76030803|FG000|Overall Study|Adverse Event|1|||
42214679|NCT05451329|76030804|FG001|Overall Study|Adverse Event|1|||
42214680|NCT05451329|76030805|FG002|Overall Study|Adverse Event|0|||
42214681|NCT05451329|76030803|FG000|Overall Study|Withdrawal by Subject|1|||
42214682|NCT05451329|76030804|FG001|Overall Study|Withdrawal by Subject|0|||
42214683|NCT05451329|76030805|FG002|Overall Study|Withdrawal by Subject|0|||
42214684|NCT05451329|76030803|FG000|Overall Study|Investigational Product Lot exchange|1|||
42214685|NCT05451329|76030804|FG001|Overall Study|Investigational Product Lot exchange|1|||
42214686|NCT05451329|76030805|FG002|Overall Study|Investigational Product Lot exchange|0|||
42214687|NCT05013905|76030833|FG000|Overall Study|Adverse Event|1|||
42214688|NCT05013905|76030833|FG000|Overall Study|Lack of Efficacy|1|||
42214689|NCT04887506|76030843|FG000|Overall Study|Death|1|||
42214690|NCT04887506|76030844|FG001|Overall Study|Death|1|||
42214691|NCT04887506|76030843|FG000|Overall Study|Withdrawal by Subject|0|||
42214692|NCT04887506|76030844|FG001|Overall Study|Withdrawal by Subject|3|||
42214693|NCT04887506|76030843|FG000|Overall Study|Adverse Event|4|||
42214694|NCT04887506|76030844|FG001|Overall Study|Adverse Event|3|||
42214695|NCT04887506|76030843|FG000|Overall Study|Other - Not Reported|1|||
42214696|NCT04887506|76030844|FG001|Overall Study|Other - Not Reported|1|||
41976957|NCT03459443|75781385|FG000|Overall Study|Sponsor's decision to close the study|18|||
42214697|NCT04872569|76030854|FG000|Overall Study|Withdrawal by Subject|2|||
42272605|NCT02282020|76102863|FG000|Overall Study|Objective Disease Progression|128|||
41976958|NCT03316885|75781398|FG000|Overall Study|Adverse Event|1|||
42214698|NCT04871776|76030862|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
42214699|NCT04871776|76030863|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
42214700|NCT04871776|76030864|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
42214701|NCT04871776|76030862|FG000|Overall Study|Did not meet eligibility criteria|1|||
42214702|NCT04871776|76030863|FG001|Overall Study|Did not meet eligibility criteria|1|||
42214703|NCT04871776|76030864|FG002|Overall Study|Did not meet eligibility criteria|1|||
42214704|NCT04854642|76030872|FG000|Overall Study|Adverse Event|1|||
42214705|NCT04854642|76030873|FG001|Overall Study|Adverse Event|2|||
42214706|NCT04854642|76030872|FG000|Overall Study|Withdrawal by Subject|0|||
42214707|NCT04854642|76030873|FG001|Overall Study|Withdrawal by Subject|1|||
42214708|NCT04832971|76030885|FG000|Overall Study|Death|1|||
42214709|NCT04832971|76030886|FG001|Overall Study|Death|0|||
42214710|NCT04832971|76030887|FG002|Overall Study|Death|0|||
42214711|NCT04832971|76030888|FG003|Overall Study|Death|0|||
42214712|NCT04832971|76030885|FG000|Overall Study|Lost to Follow-up|1|||
42214713|NCT04832971|76030886|FG001|Overall Study|Lost to Follow-up|1|||
42214714|NCT04832971|76030887|FG002|Overall Study|Lost to Follow-up|1|||
42214715|NCT04832971|76030888|FG003|Overall Study|Lost to Follow-up|0|||
42214716|NCT04832971|76030885|FG000|Overall Study|Withdrawal by Subject|1|||
42214717|NCT04832971|76030886|FG001|Overall Study|Withdrawal by Subject|3|||
42214718|NCT04832971|76030887|FG002|Overall Study|Withdrawal by Subject|2|||
42214719|NCT04832971|76030888|FG003|Overall Study|Withdrawal by Subject|2|||
42214720|NCT04832971|76030885|FG000|Overall Study|Other, Not Specified|0|||
42214721|NCT04832971|76030886|FG001|Overall Study|Other, Not Specified|0|||
42214722|NCT04832971|76030887|FG002|Overall Study|Other, Not Specified|1|||
42214723|NCT04832971|76030888|FG003|Overall Study|Other, Not Specified|0|||
42214724|NCT04824521|76030900|FG000|Overall Study|Lost to Follow-up|1|||
42214725|NCT04718194|76030906|FG000|Overall Study|Withdrawal by Subject|3|||
42214726|NCT04718194|76030907|FG001|Overall Study|Withdrawal by Subject|0|||
42214727|NCT04718194|76030906|FG000|Overall Study|Lost to Follow-up|3|||
41976959|NCT03316885|75781398|FG000|Overall Study|Death|10|||
41976960|NCT03316885|75781398|FG000|Overall Study|Lost to Follow-up|4|||
42214728|NCT04718194|76030907|FG001|Overall Study|Lost to Follow-up|0|||
42214729|NCT04706091|76030915|FG000|Treatment 2|Withdrawal by Subject|1|||
42214730|NCT04706091|76030916|FG001|Treatment 2|Withdrawal by Subject|0|||
41976961|NCT03316885|75781398|FG000|Overall Study|Withdrawal by Subject|9|||
41976962|NCT03316885|75781398|FG000|Overall Study|COVID related|8|||
41976963|NCT03259074|75781434|FG000|Overall Study|Adverse Event|9|||
41976964|NCT03259074|75781435|FG001|Overall Study|Adverse Event|12|||
41976965|NCT03259074|75781436|FG002|Overall Study|Adverse Event|8|||
41976966|NCT03259074|75781434|FG000|Overall Study|Death|1|||
41976967|NCT03259074|75781435|FG001|Overall Study|Death|1|||
41976968|NCT03259074|75781436|FG002|Overall Study|Death|3|||
41976969|NCT03259074|75781434|FG000|Overall Study|Lost to Follow-up|2|||
41976970|NCT03259074|75781435|FG001|Overall Study|Lost to Follow-up|4|||
41976971|NCT03259074|75781436|FG002|Overall Study|Lost to Follow-up|3|||
41976972|NCT03259074|75781434|FG000|Overall Study|New Therapy For Study Indication|1|||
41976973|NCT03259074|75781435|FG001|Overall Study|New Therapy For Study Indication|2|||
41976974|NCT03259074|75781436|FG002|Overall Study|New Therapy For Study Indication|2|||
41976975|NCT03259074|75781434|FG000|Overall Study|Physician Decision|4|||
41976976|NCT03259074|75781435|FG001|Overall Study|Physician Decision|12|||
41976977|NCT03259074|75781436|FG002|Overall Study|Physician Decision|10|||
41976978|NCT03259074|75781434|FG000|Overall Study|Pregnancy|1|||
42214731|NCT04669691|76030928|FG000|Overall Study|Death|0|||
42214732|NCT04669691|76030929|FG001|Overall Study|Death|1|||
42214733|NCT04669691|76030930|FG002|Overall Study|Death|0|||
42214734|NCT04669691|76030931|FG003|Overall Study|Death|0|||
42214735|NCT04669691|76030932|FG004|Overall Study|Death|0|||
42214736|NCT04669691|76030933|FG005|Overall Study|Death|0|||
42214737|NCT04610580|76030947|FG000|Two-way Crossover Period|Adverse Event|1|||
42214738|NCT04610580|76030948|FG001|Two-way Crossover Period|Adverse Event|0|||
41976979|NCT03259074|75781435|FG001|Overall Study|Pregnancy|1|||
41976980|NCT03259074|75781436|FG002|Overall Study|Pregnancy|0|||
41976981|NCT03259074|75781434|FG000|Overall Study|Progressive Disease|1|||
42214739|NCT04610580|76030949|FG002|Two-way Crossover Period|Adverse Event|0|||
42214740|NCT04610580|76030950|FG003|Two-way Crossover Period|Adverse Event|0|||
42214741|NCT04610580|76030951|FG004|Two-way Crossover Period|Adverse Event|0|||
42214742|NCT04610580|76030952|FG005|Two-way Crossover Period|Adverse Event|0|||
42214743|NCT04610580|76030947|FG000|Two-way Crossover Period|Physician Decision|1|||
41976982|NCT03259074|75781435|FG001|Overall Study|Progressive Disease|0|||
41976983|NCT03259074|75781436|FG002|Overall Study|Progressive Disease|0|||
41976984|NCT03259074|75781434|FG000|Overall Study|Protocol Deviation|1|||
41976985|NCT03259074|75781435|FG001|Overall Study|Protocol Deviation|1|||
41976986|NCT03259074|75781436|FG002|Overall Study|Protocol Deviation|3|||
41976987|NCT03259074|75781434|FG000|Overall Study|Subject/Guardian Decision|13|||
41976988|NCT03259074|75781435|FG001|Overall Study|Subject/Guardian Decision|16|||
41976989|NCT03259074|75781436|FG002|Overall Study|Subject/Guardian Decision|14|||
42214744|NCT04610580|76030948|FG001|Two-way Crossover Period|Physician Decision|0|||
42214745|NCT04610580|76030949|FG002|Two-way Crossover Period|Physician Decision|0|||
42214746|NCT04610580|76030950|FG003|Two-way Crossover Period|Physician Decision|0|||
42214747|NCT04610580|76030951|FG004|Two-way Crossover Period|Physician Decision|0|||
42214748|NCT04610580|76030952|FG005|Two-way Crossover Period|Physician Decision|0|||
42214749|NCT04610580|76030947|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
42214750|NCT04610580|76030948|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
42214751|NCT04610580|76030949|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
42214752|NCT04610580|76030950|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
42214753|NCT04610580|76030951|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
42214754|NCT04610580|76030952|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
42214755|NCT04610580|76030947|FG000|Two-way Crossover Period|Other than specified|0|||
42214756|NCT04610580|76030948|FG001|Two-way Crossover Period|Other than specified|1|||
42214757|NCT04610580|76030949|FG002|Two-way Crossover Period|Other than specified|0|||
42214758|NCT04610580|76030950|FG003|Two-way Crossover Period|Other than specified|0|||
42214759|NCT04610580|76030951|FG004|Two-way Crossover Period|Other than specified|0|||
42214760|NCT04610580|76030952|FG005|Two-way Crossover Period|Other than specified|0|||
42214761|NCT04610580|76030947|FG000|Washout Before Extension Period|Other than specified|0|||
42214762|NCT04610580|76030948|FG001|Washout Before Extension Period|Other than specified|1|||
42214763|NCT04610580|76030949|FG002|Washout Before Extension Period|Other than specified|0|||
42214764|NCT04610580|76030950|FG003|Washout Before Extension Period|Other than specified|0|||
42214765|NCT04610580|76030951|FG004|Washout Before Extension Period|Other than specified|0|||
42214766|NCT04610580|76030952|FG005|Washout Before Extension Period|Other than specified|0|||
42214767|NCT04610580|76030947|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
42214768|NCT04610580|76030948|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
42214769|NCT04610580|76030949|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
42214770|NCT04610580|76030950|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
42214771|NCT04610580|76030951|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
42214772|NCT04610580|76030952|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
42214773|NCT04610580|76030947|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
42214774|NCT04610580|76030948|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
42214775|NCT04610580|76030949|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
42214776|NCT04610580|76030950|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
42214777|NCT04610580|76030951|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
42214778|NCT04610580|76030952|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
42214779|NCT04359758|76031005|FG000|Overall Study|Protocol Violation|3|||
42214780|NCT04359758|76031006|FG001|Overall Study|Protocol Violation|2|||
42214781|NCT04186871|76031029|FG000|Overall Study|Lack of Efficacy|0|||
42214782|NCT04186871|76031030|FG001|Overall Study|Lack of Efficacy|1|||
42214783|NCT04186871|76031031|FG002|Overall Study|Lack of Efficacy|0|||
42214784|NCT04186871|76031032|FG003|Overall Study|Lack of Efficacy|0|||
42214785|NCT04186871|76031033|FG004|Overall Study|Lack of Efficacy|1|||
42214786|NCT04186871|76031034|FG005|Overall Study|Lack of Efficacy|1|||
42214787|NCT04186871|76031029|FG000|Overall Study|Adverse Event|1|||
42214788|NCT04186871|76031030|FG001|Overall Study|Adverse Event|1|||
42214789|NCT04186871|76031031|FG002|Overall Study|Adverse Event|0|||
42214790|NCT04186871|76031032|FG003|Overall Study|Adverse Event|0|||
42214791|NCT04186871|76031033|FG004|Overall Study|Adverse Event|0|||
42214792|NCT04186871|76031034|FG005|Overall Study|Adverse Event|2|||
42214793|NCT04186871|76031029|FG000|Overall Study|Study terminated by sponsor|1|||
42214794|NCT04186871|76031030|FG001|Overall Study|Study terminated by sponsor|2|||
42214795|NCT04186871|76031031|FG002|Overall Study|Study terminated by sponsor|0|||
42214796|NCT04186871|76031032|FG003|Overall Study|Study terminated by sponsor|1|||
41976990|NCT03159104|75781446|FG000|Overall Study|Violation of inclusion criteria|1|||
42214797|NCT04186871|76031033|FG004|Overall Study|Study terminated by sponsor|0|||
42214798|NCT04186871|76031034|FG005|Overall Study|Study terminated by sponsor|0|||
42214799|NCT04186871|76031029|FG000|Overall Study|Other reasons|0|||
42214800|NCT04186871|76031030|FG001|Overall Study|Other reasons|0|||
42214801|NCT04186871|76031031|FG002|Overall Study|Other reasons|0|||
42214802|NCT04186871|76031032|FG003|Overall Study|Other reasons|0|||
42214803|NCT04186871|76031033|FG004|Overall Study|Other reasons|0|||
42214804|NCT04186871|76031034|FG005|Overall Study|Other reasons|1|||
41976991|NCT03159104|75781447|FG001|Overall Study|Violation of inclusion criteria|2|||
41976992|NCT03149237|75781455|FG000|Overall Study|Withdrawal by Subject|4|||
41976993|NCT03149237|75781456|FG001|Overall Study|Withdrawal by Subject|5|||
41976994|NCT03132467|75781462|FG000|Overall Study|Adverse Event|2|||
41976995|NCT03132467|75781462|FG000|Overall Study|Withdrawal by Subject|2|||
42128687|NCT02937818|75939316|FG003|Overall Study|Disease progression|18|||
42128688|NCT02937818|75939313|FG000|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|1|||
42214805|NCT04186871|76031029|FG000|Overall Study|Withdrawal by Subject|0|||
42214806|NCT04186871|76031030|FG001|Overall Study|Withdrawal by Subject|0|||
42214807|NCT04186871|76031031|FG002|Overall Study|Withdrawal by Subject|0|||
42214808|NCT04186871|76031032|FG003|Overall Study|Withdrawal by Subject|0|||
42214809|NCT04186871|76031033|FG004|Overall Study|Withdrawal by Subject|0|||
42214810|NCT04186871|76031034|FG005|Overall Study|Withdrawal by Subject|1|||
42214811|NCT04186871|76031029|FG000|Overall Study|Lost to Follow-up|0|||
42214812|NCT04186871|76031030|FG001|Overall Study|Lost to Follow-up|0|||
42214813|NCT04186871|76031031|FG002|Overall Study|Lost to Follow-up|0|||
42214814|NCT04186871|76031032|FG003|Overall Study|Lost to Follow-up|0|||
42214815|NCT04186871|76031033|FG004|Overall Study|Lost to Follow-up|0|||
42214816|NCT04186871|76031034|FG005|Overall Study|Lost to Follow-up|1|||
42214817|NCT04058366|76031049|FG000|Overall Study|Adverse Event|14|||
42214818|NCT04058366|76031049|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
42214819|NCT04058366|76031049|FG000|Overall Study|Commercial drug is available for participants|6|||
42214820|NCT04058366|76031049|FG000|Overall Study|Death|1|||
42214821|NCT04058366|76031049|FG000|Overall Study|Other non-compliance|2|||
42214822|NCT04058366|76031049|FG000|Overall Study|Other|6|||
42128689|NCT02937818|75939314|FG001|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|2|||
42128690|NCT02937818|75939315|FG002|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
42128691|NCT02937818|75939316|FG003|Overall Study|Participants ongoing durvalumab at Data cut off (DCO)|0|||
42214823|NCT03840902|76031108|FG000|Overall Study|Randomized but not treated|1|||
42214824|NCT03840902|76031109|FG001|Overall Study|Randomized but not treated|1|||
42214825|NCT03820986|76031117|FG000|Overall Study|Death|177|||
42214826|NCT03820986|76031118|FG001|Overall Study|Death|156|||
42214827|NCT03820986|76031117|FG000|Overall Study|Lost to Follow-up|0|||
42214828|NCT03820986|76031118|FG001|Overall Study|Lost to Follow-up|1|||
42214829|NCT03820986|76031117|FG000|Overall Study|Withdrawal by Subject|8|||
42214830|NCT03820986|76031118|FG001|Overall Study|Withdrawal by Subject|3|||
42214831|NCT03820986|76031117|FG000|Overall Study|Ongoing|149|||
42128692|NCT02937818|75939313|FG000|Overall Study|Condition under investigation worsened|0|||
42128693|NCT02937818|75939314|FG001|Overall Study|Condition under investigation worsened|0|||
42128694|NCT02937818|75939315|FG002|Overall Study|Condition under investigation worsened|1|||
42128695|NCT02937818|75939316|FG003|Overall Study|Condition under investigation worsened|0|||
42128696|NCT02937818|75939313|FG000|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
42128697|NCT02937818|75939314|FG001|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
42128698|NCT02937818|75939315|FG002|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|0|||
42128699|NCT02937818|75939316|FG003|Overall Study|Participants ongoing ceralasertib and olaparib at DCO|1|||
42128700|NCT02864394|75939340|FG000|Overall Study|Death|184|||
42128701|NCT02864394|75939341|FG001|Overall Study|Death|189|||
42128702|NCT02864394|75939340|FG000|Overall Study|Lost to Follow-up|0|||
42128703|NCT02864394|75939341|FG001|Overall Study|Lost to Follow-up|2|||
42128704|NCT02864394|75939340|FG000|Overall Study|Sponsor Decision|26|||
42128705|NCT02864394|75939341|FG001|Overall Study|Sponsor Decision|11|||
42128706|NCT02864394|75939340|FG000|Overall Study|Withdrawal by Subject|3|||
42128707|NCT02864394|75939341|FG001|Overall Study|Withdrawal by Subject|10|||
42128708|NCT02773849|75939354|FG000|Overall Study|Adverse Event|3|||
42128709|NCT02773849|75939354|FG000|Overall Study|Lack of Efficacy|89|||
42128710|NCT02773849|75939354|FG000|Overall Study|Withdrawal by Subject|1|||
42128711|NCT02773849|75939354|FG000|Overall Study|Withdrawal of Consent|1|||
41976996|NCT03127852|75781469|FG000|Overall Study|Withdrawal by Subject|4|||
42214832|NCT03820986|76031118|FG001|Overall Study|Ongoing|180|||
42214833|NCT03775486|76031128|FG000|Initial Therapy Phase|Other reason provided|0|||
42214834|NCT03775486|76031129|FG001|Initial Therapy Phase|Other reason provided|15|||
42214835|NCT03775486|76031128|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
42301932|NCT02280291|76137113|FG001|Overall Study|Protocol Violation|0|||
42214836|NCT03775486|76031129|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
42214837|NCT03775486|76031128|FG000|Initial Therapy Phase|Protocol Violation|0|||
42214838|NCT03775486|76031129|FG001|Initial Therapy Phase|Protocol Violation|2|||
42214839|NCT03775486|76031128|FG000|Initial Therapy Phase|Adverse Event|0|||
42214840|NCT03775486|76031129|FG001|Initial Therapy Phase|Adverse Event|34|||
42214841|NCT03775486|76031128|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
42214842|NCT03775486|76031129|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
42214843|NCT03775486|76031128|FG000|Maintenance Phase|Withdrawal by Subject|13|||
42214844|NCT03775486|76031129|FG001|Maintenance Phase|Withdrawal by Subject|12|||
42214845|NCT03775486|76031128|FG000|Maintenance Phase|Death|44|||
42214846|NCT03775486|76031129|FG001|Maintenance Phase|Death|45|||
42214847|NCT03675737|76031147|FG000|Overall Study|Death|593|||
42214848|NCT03675737|76031148|FG001|Overall Study|Death|660|||
42214849|NCT03675737|76031147|FG000|Overall Study|Lost to Follow-up|1|||
42214850|NCT03675737|76031148|FG001|Overall Study|Lost to Follow-up|5|||
42214851|NCT03675737|76031147|FG000|Overall Study|Physician Decision|1|||
42214852|NCT03675737|76031148|FG001|Overall Study|Physician Decision|0|||
42214853|NCT03675737|76031147|FG000|Overall Study|Withdrawal by Subject|14|||
42214854|NCT03675737|76031148|FG001|Overall Study|Withdrawal by Subject|12|||
42214855|NCT03675737|76031147|FG000|Overall Study|Ongoing in Study|181|||
42214856|NCT03675737|76031148|FG001|Overall Study|Ongoing in Study|112|||
42214857|NCT03651271|76031160|FG000|Overall Study|Death|4|||
42214858|NCT03651271|76031161|FG001|Overall Study|Death|37|||
42214859|NCT03651271|76031162|FG002|Overall Study|Death|0|||
42214860|NCT03651271|76031163|FG003|Overall Study|Death|2|||
42214861|NCT03651271|76031164|FG004|Overall Study|Death|6|||
42214862|NCT03651271|76031160|FG000|Overall Study|Lost to Follow-up|1|||
42214863|NCT03651271|76031161|FG001|Overall Study|Lost to Follow-up|5|||
42214864|NCT03651271|76031162|FG002|Overall Study|Lost to Follow-up|0|||
42214865|NCT03651271|76031163|FG003|Overall Study|Lost to Follow-up|1|||
42214866|NCT03651271|76031164|FG004|Overall Study|Lost to Follow-up|0|||
42214867|NCT03651271|76031160|FG000|Overall Study|Physician Decision|0|||
42214868|NCT03651271|76031161|FG001|Overall Study|Physician Decision|2|||
42214869|NCT03651271|76031162|FG002|Overall Study|Physician Decision|0|||
42214870|NCT03651271|76031163|FG003|Overall Study|Physician Decision|0|||
42214871|NCT03651271|76031164|FG004|Overall Study|Physician Decision|0|||
42214872|NCT03651271|76031160|FG000|Overall Study|Withdrawal by Subject|1|||
42214873|NCT03651271|76031161|FG001|Overall Study|Withdrawal by Subject|15|||
42214874|NCT03651271|76031162|FG002|Overall Study|Withdrawal by Subject|0|||
42214875|NCT03651271|76031163|FG003|Overall Study|Withdrawal by Subject|0|||
42214876|NCT03651271|76031164|FG004|Overall Study|Withdrawal by Subject|1|||
42214877|NCT03651271|76031160|FG000|Overall Study|Patient medically unable to continue|0|||
42214878|NCT03651271|76031161|FG001|Overall Study|Patient medically unable to continue|0|||
41976997|NCT03127852|75781470|FG001|Overall Study|Withdrawal by Subject|1|||
41976998|NCT03127852|75781469|FG000|Overall Study|Death|1|||
41976999|NCT03127852|75781470|FG001|Overall Study|Death|1|||
41977000|NCT03107793|75781476|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
41977001|NCT03107793|75781477|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
41977002|NCT03107793|75781478|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
41977003|NCT03107793|75781479|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
41977004|NCT03107793|75781480|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
41977005|NCT03107793|75781476|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
42128712|NCT02516241|75939376|FG000|Overall Study|Death|255|||
42128713|NCT02516241|75939377|FG001|Overall Study|Death|262|||
42128714|NCT02516241|75939378|FG002|Overall Study|Death|270|||
42128715|NCT02516241|75939376|FG000|Overall Study|Lost to Follow-up|1|||
42128716|NCT02516241|75939377|FG001|Overall Study|Lost to Follow-up|1|||
42128717|NCT02516241|75939378|FG002|Overall Study|Lost to Follow-up|3|||
42128718|NCT02516241|75939376|FG000|Overall Study|Withdrawal by Subject|2|||
42128719|NCT02516241|75939377|FG001|Overall Study|Withdrawal by Subject|7|||
42128720|NCT02516241|75939378|FG002|Overall Study|Withdrawal by Subject|12|||
42128721|NCT02516241|75939376|FG000|Overall Study|participants ongoing at data cut-off|84|||
42128722|NCT02516241|75939377|FG001|Overall Study|participants ongoing at data cut-off|76|||
42128723|NCT02516241|75939378|FG002|Overall Study|participants ongoing at data cut-off|59|||
42128724|NCT02162810|75939406|FG000|Overall Study|Protocol Violation|1|||
42214879|NCT03651271|76031162|FG002|Overall Study|Patient medically unable to continue|0|||
42128725|NCT02162810|75939407|FG001|Overall Study|Protocol Violation|0|||
42214880|NCT03651271|76031163|FG003|Overall Study|Patient medically unable to continue|1|||
42214881|NCT03651271|76031164|FG004|Overall Study|Patient medically unable to continue|0|||
42214882|NCT03643562|76031181|FG000|Overall Study|Adverse Event|1|||
41977006|NCT03107793|75781477|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
42028449|NCT01124604|75836885|FG001|Overall Study|Adverse Event|1|||
42128726|NCT02162810|75939406|FG000|Overall Study|patients did not report compliance|4|||
42214883|NCT03643562|76031182|FG001|Overall Study|Adverse Event|0|||
41977007|NCT03107793|75781478|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
42128727|NCT02162810|75939407|FG001|Overall Study|patients did not report compliance|1|||
42128728|NCT02040857|75939413|FG000|Overall Study|Adverse Event|14|||
42214884|NCT03643562|76031181|FG000|Overall Study|Lack of Efficacy|0|||
42214885|NCT03643562|76031182|FG001|Overall Study|Lack of Efficacy|1|||
42214886|NCT03643562|76031181|FG000|Overall Study|Physician Decision|0|||
42214887|NCT03643562|76031182|FG001|Overall Study|Physician Decision|1|||
42214888|NCT03643562|76031181|FG000|Overall Study|Study Terminated by Sponsor|2|||
41977008|NCT03107793|75781479|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
41977009|NCT03107793|75781480|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
42214889|NCT03643562|76031182|FG001|Overall Study|Study Terminated by Sponsor|10|||
42214890|NCT03643562|76031181|FG000|Overall Study|Withdrawal by Subject|2|||
42214891|NCT03643562|76031182|FG001|Overall Study|Withdrawal by Subject|2|||
42214892|NCT03643562|76031181|FG000|Overall Study|Other than specified|3|||
42214893|NCT03643562|76031182|FG001|Overall Study|Other than specified|2|||
42214894|NCT03635567|76031190|FG000|Overall Study|Lost to Follow-up|0|||
42214895|NCT03635567|76031191|FG001|Overall Study|Lost to Follow-up|2|||
42214896|NCT03635567|76031190|FG000|Overall Study|Withdrawal by Subject|9|||
42214897|NCT03635567|76031191|FG001|Overall Study|Withdrawal by Subject|10|||
42214898|NCT03635567|76031190|FG000|Overall Study|Ongoing in Study|125|||
42214899|NCT03635567|76031191|FG001|Overall Study|Ongoing in Study|76|||
41977010|NCT03107793|75781476|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
41977011|NCT03107793|75781477|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
41977012|NCT03107793|75781478|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
41977013|NCT03107793|75781479|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
41977014|NCT03107793|75781480|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
41977015|NCT03107793|75781476|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
41977016|NCT03107793|75781477|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
41977017|NCT03107793|75781478|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42214900|NCT03635567|76031190|FG000|Overall Study|Death|174|||
41977018|NCT03107793|75781479|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
41977019|NCT03107793|75781480|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
41977020|NCT03107793|75781476|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
41977021|NCT03107793|75781477|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
41977022|NCT03107793|75781478|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
41977023|NCT03107793|75781479|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
41977024|NCT03107793|75781480|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
41977025|NCT03107793|75781476|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
41977026|NCT03107793|75781477|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
41977027|NCT03107793|75781478|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
41977028|NCT03107793|75781479|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
41977029|NCT03107793|75781480|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
41977030|NCT03107793|75781476|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
41977031|NCT03107793|75781477|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
41977032|NCT03107793|75781478|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
41977033|NCT03107793|75781479|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
41977034|NCT03107793|75781480|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
41977035|NCT03107793|75781476|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
41977036|NCT03107793|75781477|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
41977037|NCT03107793|75781478|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
41977038|NCT03107793|75781479|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
41977039|NCT03107793|75781480|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
41977040|NCT03107793|75781476|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
41977041|NCT03107793|75781477|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
41977042|NCT03107793|75781478|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
41977043|NCT03107793|75781479|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
41977044|NCT03107793|75781480|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
41977045|NCT03107793|75781476|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
41977046|NCT03107793|75781477|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
41977047|NCT03107793|75781478|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
41977048|NCT03107793|75781479|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
41977049|NCT03107793|75781480|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
41977050|NCT03107793|75781476|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
41977051|NCT03107793|75781477|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
41977052|NCT03107793|75781478|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
41977053|NCT03107793|75781479|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
41977054|NCT03107793|75781480|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
42214901|NCT03635567|76031191|FG001|Overall Study|Death|221|||
42214902|NCT03606486|76031198|FG000|Overall Study|Unable to collect sample|5|||
42214903|NCT03578536|76031202|FG000|Overall Study|Lost to Follow-up|1|||
42214904|NCT03564496|76031209|FG000|Overall Study|Withdrawal by Subject|1|||
42214905|NCT03564496|76031210|FG001|Overall Study|Withdrawal by Subject|1|||
42214906|NCT03564496|76031211|FG002|Overall Study|Withdrawal by Subject|0|||
42301933|NCT02280291|76137114|FG002|Overall Study|Protocol Violation|0|||
42301934|NCT02280291|76137115|FG003|Overall Study|Protocol Violation|0|||
42301935|NCT02280291|76137112|FG000|Overall Study|Other|1|||
42301936|NCT02280291|76137113|FG001|Overall Study|Other|1|||
42301937|NCT02280291|76137114|FG002|Overall Study|Other|0|||
42301938|NCT02280291|76137115|FG003|Overall Study|Other|0|||
42301939|NCT02284893|76137129|FG000|26 Week (Short Term)|Adverse Event|1|||
42128729|NCT02040857|75939413|FG000|Overall Study|Physician Decision|5|||
42128730|NCT02040857|75939413|FG000|Overall Study|Withdrawal by Subject|31|||
42128731|NCT02040857|75939413|FG000|Overall Study|patient non-compliance|3|||
42128732|NCT02040857|75939413|FG000|Overall Study|Lost to Follow-up|2|||
42128733|NCT02040857|75939413|FG000|Overall Study|recurrence|4|||
42128734|NCT02040857|75939413|FG000|Overall Study|ineligible|1|||
42128735|NCT01709435|75939426|FG000|Overall Study|Adverse Event|1|||
42128736|NCT01709435|75939427|FG001|Overall Study|Adverse Event|1|||
42128737|NCT01709435|75939428|FG002|Overall Study|Adverse Event|1|||
42128738|NCT01709435|75939429|FG003|Overall Study|Adverse Event|0|||
42128739|NCT01709435|75939430|FG004|Overall Study|Adverse Event|0|||
42128740|NCT01709435|75939431|FG005|Overall Study|Adverse Event|1|||
42128741|NCT01709435|75939426|FG000|Overall Study|Lack of Efficacy|5|||
42128742|NCT01709435|75939427|FG001|Overall Study|Lack of Efficacy|7|||
42128743|NCT01709435|75939428|FG002|Overall Study|Lack of Efficacy|2|||
42128744|NCT01709435|75939429|FG003|Overall Study|Lack of Efficacy|2|||
42128745|NCT01709435|75939430|FG004|Overall Study|Lack of Efficacy|6|||
42128746|NCT01709435|75939431|FG005|Overall Study|Lack of Efficacy|3|||
42128747|NCT01709435|75939426|FG000|Overall Study|Physician Decision|0|||
42128748|NCT01709435|75939427|FG001|Overall Study|Physician Decision|1|||
42128749|NCT01709435|75939428|FG002|Overall Study|Physician Decision|0|||
42128750|NCT01709435|75939429|FG003|Overall Study|Physician Decision|1|||
42128751|NCT01709435|75939430|FG004|Overall Study|Physician Decision|2|||
42128752|NCT01709435|75939431|FG005|Overall Study|Physician Decision|0|||
42128753|NCT01709435|75939426|FG000|Overall Study|Withdrawal by Subject|0|||
42128754|NCT01709435|75939427|FG001|Overall Study|Withdrawal by Subject|0|||
42128755|NCT01709435|75939428|FG002|Overall Study|Withdrawal by Subject|3|||
42128756|NCT01709435|75939429|FG003|Overall Study|Withdrawal by Subject|0|||
42301940|NCT02284893|76137130|FG001|26 Week (Short Term)|Adverse Event|9|||
42028450|NCT01124604|75836884|FG000|Overall Study|Lack of Efficacy|1|||
42028451|NCT01124604|75836885|FG001|Overall Study|Lack of Efficacy|0|||
42128757|NCT01709435|75939430|FG004|Overall Study|Withdrawal by Subject|2|||
42128758|NCT01709435|75939431|FG005|Overall Study|Withdrawal by Subject|2|||
42128759|NCT01358877|75939449|FG000|Overall Study|Death|80|||
42128760|NCT01358877|75939450|FG001|Overall Study|Death|89|||
42301941|NCT02284893|76137129|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
42214907|NCT03564496|76031209|FG000|Overall Study|Screen failure|0|||
42214908|NCT03564496|76031210|FG001|Overall Study|Screen failure|3|||
42214909|NCT03564496|76031211|FG002|Overall Study|Screen failure|0|||
42214910|NCT03562247|76031226|FG000|Overall Study|Lost to Follow-up|3|||
42214911|NCT03562247|76031227|FG001|Overall Study|Lost to Follow-up|1|||
42214912|NCT03562247|76031228|FG002|Overall Study|Lost to Follow-up|1|||
42214913|NCT03515837|76031238|FG000|Overall Study|Death|214|||
42214914|NCT03515837|76031239|FG001|Overall Study|Death|221|||
42214915|NCT03515837|76031238|FG000|Overall Study|Lost to Follow-up|0|||
42214916|NCT03515837|76031239|FG001|Overall Study|Lost to Follow-up|1|||
42214917|NCT03515837|76031238|FG000|Overall Study|Ongoing|31|||
42214918|NCT03515837|76031239|FG001|Overall Study|Ongoing|21|||
42214919|NCT03515837|76031238|FG000|Overall Study|Withdrawal by Subject|0|||
42214920|NCT03515837|76031239|FG001|Overall Study|Withdrawal by Subject|4|||
42214921|NCT03443973|76031252|FG000|Double-blind Treatment Period|Adverse Event|5|||
42214922|NCT03443973|76031253|FG001|Double-blind Treatment Period|Adverse Event|19|||
42214923|NCT03443973|76031254|FG002|Double-blind Treatment Period|Adverse Event|0|||
42214924|NCT03443973|76031255|FG003|Double-blind Treatment Period|Adverse Event|0|||
42214925|NCT03443973|76031252|FG000|Double-blind Treatment Period|Death|5|||
42214926|NCT03443973|76031253|FG001|Double-blind Treatment Period|Death|7|||
41977055|NCT03107793|75781476|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
42214927|NCT03443973|76031254|FG002|Double-blind Treatment Period|Death|0|||
41977056|NCT03107793|75781477|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
41977057|NCT03107793|75781478|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
41977058|NCT03107793|75781479|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
41977059|NCT03107793|75781480|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
41977060|NCT03107793|75781476|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
41977061|NCT03107793|75781477|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
41977062|NCT03107793|75781478|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
41977063|NCT03107793|75781479|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
41977064|NCT03107793|75781480|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
41977065|NCT03107793|75781476|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
41977066|NCT03107793|75781477|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
41977067|NCT03107793|75781478|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
41977068|NCT03107793|75781479|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
41977069|NCT03107793|75781480|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
41977070|NCT03107793|75781476|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
41977071|NCT03107793|75781477|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
41977072|NCT03107793|75781478|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
41977073|NCT03107793|75781479|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
41977074|NCT03107793|75781480|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
41977075|NCT03107793|75781476|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
41977076|NCT03107793|75781477|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
41977077|NCT03107793|75781478|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
41977078|NCT03107793|75781479|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
41977079|NCT03107793|75781480|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
41977080|NCT03107793|75781476|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
41977081|NCT03107793|75781477|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
41977082|NCT03107793|75781478|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
41977083|NCT03107793|75781479|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
41977084|NCT03107793|75781480|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
42214928|NCT03443973|76031255|FG003|Double-blind Treatment Period|Death|0|||
42214929|NCT03443973|76031252|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
42301942|NCT02284893|76137130|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
42301943|NCT02284893|76137129|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
42301944|NCT02284893|76137130|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
42301945|NCT02284893|76137129|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
42301946|NCT02284893|76137130|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
42301947|NCT02284893|76137129|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
42301948|NCT02284893|76137130|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
42301949|NCT02284893|76137129|FG000|26 Week (Short Term)|Other|1|||
42301950|NCT02284893|76137130|FG001|26 Week (Short Term)|Other|1|||
42301951|NCT02284893|76137129|FG000|52 Week (Long Term)|Adverse Event|3|||
42214930|NCT03443973|76031253|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
42301952|NCT02284893|76137130|FG001|52 Week (Long Term)|Adverse Event|1|||
42301953|NCT02284893|76137129|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
42214931|NCT03443973|76031254|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
42214932|NCT03443973|76031255|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
42214933|NCT03443973|76031252|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
42214934|NCT03443973|76031253|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
42214935|NCT03443973|76031254|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
42214936|NCT03443973|76031255|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
42214937|NCT03443973|76031252|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
42214938|NCT03443973|76031253|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
42214939|NCT03443973|76031254|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
42214940|NCT03443973|76031255|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
42214941|NCT03443973|76031252|FG000|Double-blind Treatment Period|Physician Decision|5|||
42214942|NCT03443973|76031253|FG001|Double-blind Treatment Period|Physician Decision|6|||
42214943|NCT03443973|76031254|FG002|Double-blind Treatment Period|Physician Decision|0|||
42214944|NCT03443973|76031255|FG003|Double-blind Treatment Period|Physician Decision|0|||
42214945|NCT03443973|76031252|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
42214946|NCT03443973|76031253|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
42214947|NCT03443973|76031254|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
42214948|NCT03443973|76031255|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
42214949|NCT03443973|76031252|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
42214950|NCT03443973|76031253|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
42214951|NCT03443973|76031254|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
42214952|NCT03443973|76031255|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
42214953|NCT03443973|76031252|FG000|Open-label Extension Period|Reason Not Specified|0|||
42214954|NCT03443973|76031253|FG001|Open-label Extension Period|Reason Not Specified|0|||
42214955|NCT03443973|76031254|FG002|Open-label Extension Period|Reason Not Specified|3|||
42214956|NCT03443973|76031255|FG003|Open-label Extension Period|Reason Not Specified|0|||
42214957|NCT03443973|76031252|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
42214958|NCT03443973|76031253|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
42214959|NCT03443973|76031254|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
42214960|NCT03443973|76031255|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
42214961|NCT03361306|76031319|FG000|Overall Study|Death|5|||
42214962|NCT03361306|76031319|FG000|Overall Study|Still On Study (on study treatment)|3|||
42214963|NCT03361306|76031319|FG000|Overall Study|Still On Study (in follow up)|7|||
42214964|NCT03325439|76031323|FG000|Overall Study|Ineligibility|3|||
42214965|NCT03246347|76031335|FG000|Overall Study|On Study|23|||
42214966|NCT03141177|76031342|FG000|Overall Study|Death|62|||
42214967|NCT03141177|76031343|FG001|Overall Study|Death|13|||
42214968|NCT03141177|76031344|FG002|Overall Study|Death|84|||
42214969|NCT03141177|76031342|FG000|Overall Study|Participant withdrew consent|9|||
42214970|NCT03141177|76031343|FG001|Overall Study|Participant withdrew consent|2|||
42214971|NCT03141177|76031344|FG002|Overall Study|Participant withdrew consent|13|||
42214972|NCT03141177|76031342|FG000|Overall Study|Not reported|1|||
42214973|NCT03141177|76031343|FG001|Overall Study|Not reported|0|||
42214974|NCT03141177|76031344|FG002|Overall Study|Not reported|1|||
42214975|NCT03141177|76031342|FG000|Overall Study|Lost to Follow-up|2|||
42214976|NCT03141177|76031343|FG001|Overall Study|Lost to Follow-up|1|||
42214977|NCT03141177|76031344|FG002|Overall Study|Lost to Follow-up|1|||
42214978|NCT03141177|76031342|FG000|Overall Study|Other reasons|4|||
42214979|NCT03141177|76031343|FG001|Overall Study|Other reasons|0|||
42214980|NCT03141177|76031344|FG002|Overall Study|Other reasons|11|||
42214981|NCT03141177|76031342|FG000|Overall Study|Participants did not start treatment period|3|||
42214982|NCT03141177|76031343|FG001|Overall Study|Participants did not start treatment period|0|||
42214983|NCT03141177|76031344|FG002|Overall Study|Participants did not start treatment period|8|||
42272606|NCT02282020|76102864|FG001|Overall Study|Objective Disease Progression|30|||
42272607|NCT02282020|76102863|FG000|Overall Study|Adverse Event|18|||
42272608|NCT02282020|76102864|FG001|Overall Study|Adverse Event|15|||
41977085|NCT03107793|75781476|FG000|Extension Period (Week 48- Week 104)|Death|0|||
41977086|NCT03107793|75781477|FG001|Extension Period (Week 48- Week 104)|Death|0|||
41977087|NCT03107793|75781478|FG002|Extension Period (Week 48- Week 104)|Death|0|||
41977088|NCT03107793|75781479|FG003|Extension Period (Week 48- Week 104)|Death|0|||
41977089|NCT03107793|75781480|FG004|Extension Period (Week 48- Week 104)|Death|1|||
41977090|NCT03107793|75781476|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
41977091|NCT03107793|75781477|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
41977092|NCT03107793|75781478|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
42272609|NCT02282020|76102863|FG000|Overall Study|Withdrawal by Subject|7|||
42272610|NCT02282020|76102864|FG001|Overall Study|Withdrawal by Subject|10|||
42272611|NCT02282020|76102863|FG000|Overall Study|Miscellaneous|5|||
42272612|NCT02282020|76102864|FG001|Overall Study|Miscellaneous|19|||
42272613|NCT02282020|76102863|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
42272614|NCT02282020|76102864|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
42272615|NCT02282020|76102863|FG000|Overall Study|Developed Discontinuation Criteria|0|||
42301954|NCT02284893|76137130|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
42301955|NCT02284893|76137129|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
41977093|NCT03107793|75781479|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
42214984|NCT03035864|76031355|FG000|Treatment Period|Adverse Event|1|||
42214985|NCT03035864|76031356|FG001|Treatment Period|Adverse Event|0|||
42214986|NCT03035864|76031355|FG000|Treatment Period|Other|3|||
42214987|NCT03035864|76031356|FG001|Treatment Period|Other|1|||
42214988|NCT03035864|76031355|FG000|Follow-up Period|Adverse Event|1|||
42214989|NCT03035864|76031356|FG001|Follow-up Period|Adverse Event|0|||
42214990|NCT03035864|76031355|FG000|Follow-up Period|Lost to Follow-up|6|||
42214991|NCT03035864|76031356|FG001|Follow-up Period|Lost to Follow-up|2|||
42214992|NCT03035864|76031355|FG000|Follow-up Period|Physician Decision|1|||
42214993|NCT03035864|76031356|FG001|Follow-up Period|Physician Decision|0|||
42214994|NCT03035864|76031355|FG000|Follow-up Period|Other|3|||
42214995|NCT03035864|76031356|FG001|Follow-up Period|Other|2|||
42214996|NCT02889809|76031368|FG000|Overall Study|Withdrawal by Subject|30|||
42214997|NCT02889809|76031369|FG001|Overall Study|Withdrawal by Subject|21|||
42214998|NCT02889809|76031368|FG000|Overall Study|Lost to Follow-up|1|||
42214999|NCT02889809|76031369|FG001|Overall Study|Lost to Follow-up|1|||
42215000|NCT02889809|76031368|FG000|Overall Study|Site Closed|12|||
42215001|NCT02889809|76031369|FG001|Overall Study|Site Closed|11|||
42215002|NCT02759107|76031393|FG000|Overall Study|Adverse Event|0|||
42215003|NCT02759107|76031394|FG001|Overall Study|Adverse Event|0|||
42215004|NCT02759107|76031395|FG002|Overall Study|Adverse Event|0|||
42215005|NCT02759107|76031396|FG003|Overall Study|Adverse Event|0|||
42215006|NCT02759107|76031397|FG004|Overall Study|Adverse Event|0|||
42215007|NCT02759107|76031398|FG005|Overall Study|Adverse Event|0|||
42215008|NCT02759107|76031399|FG006|Overall Study|Adverse Event|0|||
42215009|NCT02759107|76031400|FG007|Overall Study|Adverse Event|0|||
42215010|NCT02759107|76031401|FG008|Overall Study|Adverse Event|0|||
42215011|NCT02759107|76031402|FG009|Overall Study|Adverse Event|0|||
42215012|NCT02759107|76031403|FG010|Overall Study|Adverse Event|0|||
42215013|NCT02759107|76031404|FG011|Overall Study|Adverse Event|0|||
42215014|NCT02759107|76031405|FG012|Overall Study|Adverse Event|2|||
42215015|NCT02759107|76031406|FG013|Overall Study|Adverse Event|0|||
42215016|NCT02759107|76031407|FG014|Overall Study|Adverse Event|0|||
42215017|NCT02759107|76031408|FG015|Overall Study|Adverse Event|1|||
42215018|NCT02759107|76031409|FG016|Overall Study|Adverse Event|0|||
42215019|NCT02759107|76031410|FG017|Overall Study|Adverse Event|2|||
42215020|NCT02759107|76031393|FG000|Overall Study|Scheduling Conflict|0|||
42215021|NCT02759107|76031394|FG001|Overall Study|Scheduling Conflict|0|||
42215022|NCT02759107|76031395|FG002|Overall Study|Scheduling Conflict|0|||
42215023|NCT02759107|76031396|FG003|Overall Study|Scheduling Conflict|0|||
42215024|NCT02759107|76031397|FG004|Overall Study|Scheduling Conflict|0|||
42215025|NCT02759107|76031398|FG005|Overall Study|Scheduling Conflict|0|||
42215026|NCT02759107|76031399|FG006|Overall Study|Scheduling Conflict|0|||
42215027|NCT02759107|76031400|FG007|Overall Study|Scheduling Conflict|0|||
42028452|NCT01124604|75836884|FG000|Overall Study|Withdrawal by Subject|4|||
42028453|NCT01124604|75836885|FG001|Overall Study|Withdrawal by Subject|0|||
42028454|NCT01124604|75836884|FG000|Overall Study|Disease Progression|0|||
42128761|NCT01358877|75939449|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
42128762|NCT01358877|75939450|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
42128763|NCT01358877|75939449|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
42128764|NCT01358877|75939450|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
42128765|NCT01358877|75939449|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
42128766|NCT01358877|75939450|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
42128767|NCT01358877|75939449|FG000|Overall Study|Other|142|||
42128768|NCT01358877|75939450|FG001|Overall Study|Other|129|||
42128769|NCT00643279|75939482|FG000|Overall Study|Death|13|||
42128770|NCT00643279|75939483|FG001|Overall Study|Death|11|||
42215028|NCT02759107|76031401|FG008|Overall Study|Scheduling Conflict|0|||
42215029|NCT02759107|76031402|FG009|Overall Study|Scheduling Conflict|1|||
42215030|NCT02759107|76031403|FG010|Overall Study|Scheduling Conflict|0|||
42215031|NCT02759107|76031404|FG011|Overall Study|Scheduling Conflict|0|||
42215032|NCT02759107|76031405|FG012|Overall Study|Scheduling Conflict|0|||
42215033|NCT02759107|76031406|FG013|Overall Study|Scheduling Conflict|0|||
42215034|NCT02759107|76031407|FG014|Overall Study|Scheduling Conflict|0|||
42215035|NCT02759107|76031408|FG015|Overall Study|Scheduling Conflict|0|||
42215036|NCT02759107|76031409|FG016|Overall Study|Scheduling Conflict|0|||
42215037|NCT02759107|76031410|FG017|Overall Study|Scheduling Conflict|0|||
42215038|NCT02658968|76031456|FG000|Received Rituximab|Adverse Event|0|||
42215039|NCT02658968|76031457|FG001|Received Rituximab|Adverse Event|0|||
42215040|NCT02658968|76031458|FG002|Received Rituximab|Adverse Event|0|||
42215041|NCT02658968|76031459|FG003|Received Rituximab|Adverse Event|0|||
42215042|NCT02658968|76031460|FG004|Received Rituximab|Adverse Event|1|||
42215043|NCT02658968|76031456|FG000|Received Rituximab|Progressive disease|0|||
42215044|NCT02658968|76031457|FG001|Received Rituximab|Progressive disease|0|||
42215045|NCT02658968|76031458|FG002|Received Rituximab|Progressive disease|0|||
42215046|NCT02658968|76031459|FG003|Received Rituximab|Progressive disease|0|||
41977094|NCT03107793|75781480|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
41977095|NCT03107793|75781476|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
41977096|NCT03107793|75781477|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
41977097|NCT03107793|75781478|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
41977098|NCT03107793|75781479|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
41977099|NCT03107793|75781480|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
41977100|NCT03107793|75781476|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
41977101|NCT03107793|75781477|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
41977102|NCT03107793|75781478|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
41977103|NCT03107793|75781479|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
42215047|NCT02658968|76031460|FG004|Received Rituximab|Progressive disease|1|||
42215048|NCT02658968|76031456|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
42215049|NCT02658968|76031457|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
42215050|NCT02658968|76031458|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
42215051|NCT02658968|76031459|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
42215052|NCT02658968|76031460|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
42215053|NCT02658968|76031456|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
42215054|NCT02658968|76031457|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
42215055|NCT02658968|76031458|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
42215056|NCT02658968|76031459|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
41977104|NCT03107793|75781480|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
41977105|NCT03107793|75781476|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
41977106|NCT03107793|75781477|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
41977107|NCT03107793|75781478|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
41977108|NCT03107793|75781479|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
41977109|NCT03107793|75781480|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
41977110|NCT03107793|75781476|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
41977111|NCT03107793|75781477|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
41977112|NCT03107793|75781478|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
41977113|NCT03107793|75781479|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
41977114|NCT03107793|75781480|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
41977115|NCT03107793|75781476|FG000|Extension Period (Week 48- Week 104)|Other|0|||
41977116|NCT03107793|75781477|FG001|Extension Period (Week 48- Week 104)|Other|0|||
41977117|NCT03107793|75781478|FG002|Extension Period (Week 48- Week 104)|Other|0|||
41977118|NCT03107793|75781479|FG003|Extension Period (Week 48- Week 104)|Other|1|||
41977119|NCT03107793|75781480|FG004|Extension Period (Week 48- Week 104)|Other|3|||
41977120|NCT03107793|75781476|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
41977121|NCT03107793|75781477|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
41977122|NCT03107793|75781478|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
41977123|NCT03107793|75781479|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
42128771|NCT00643279|75939482|FG000|Overall Study|Withdrawal by Subject|3|||
42128772|NCT00643279|75939483|FG001|Overall Study|Withdrawal by Subject|0|||
42128773|NCT00643279|75939482|FG000|Overall Study|Lost to Follow-up|0|||
42128774|NCT00643279|75939483|FG001|Overall Study|Lost to Follow-up|1|||
42128775|NCT00643279|75939482|FG000|Overall Study|Physician Decision|0|||
42128776|NCT00643279|75939483|FG001|Overall Study|Physician Decision|1|||
42128777|NCT05607043|75939503|FG000|Overall Study|Lost to Follow-up|2|||
42128778|NCT04550221|75939530|FG000|Overall Study|Lost to Follow-up|0|||
42128779|NCT04550221|75939531|FG001|Overall Study|Lost to Follow-up|4|||
42128780|NCT04550221|75939530|FG000|Overall Study|Withdrawn|3|||
42128781|NCT04550221|75939531|FG001|Overall Study|Withdrawn|0|||
42215057|NCT02658968|76031460|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
42128782|NCT04550221|75939530|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
42128783|NCT04550221|75939531|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
42128784|NCT04193176|75939552|FG000|Overall Study|Withdrawal by Subject|6|||
42215058|NCT02658968|76031456|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
42215059|NCT02658968|76031457|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
42215060|NCT02658968|76031458|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
42215061|NCT02658968|76031459|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
42215062|NCT02658968|76031460|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
42215063|NCT02658968|76031456|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
42215064|NCT02658968|76031457|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
42215065|NCT02658968|76031458|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
42215066|NCT02658968|76031459|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
42215067|NCT02658968|76031460|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
42215068|NCT02658968|76031456|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
42215069|NCT02658968|76031457|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
42215070|NCT02658968|76031458|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
42215071|NCT02658968|76031459|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
42215072|NCT02658968|76031460|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
42215073|NCT02441803|76031487|FG000|Overall Study|Physician Decision|0|||
42215074|NCT02441803|76031488|FG001|Overall Study|Physician Decision|2|||
42215075|NCT02441803|76031489|FG002|Overall Study|Physician Decision|2|||
42215076|NCT02385110|76031508|FG000|Overall Study|Early Death|1|||
42215077|NCT02385110|76031509|FG001|Overall Study|Early Death|0|||
42215078|NCT02138110|76031515|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
42215079|NCT02138110|76031515|FG000|Overall Scaffold Implantation|Death|3|||
42215080|NCT01898793|76031526|FG000|Overall Study|Death|2|||
42215081|NCT01898793|76031527|FG001|Overall Study|Death|1|||
42215082|NCT01898793|76031528|FG002|Overall Study|Death|4|||
42215083|NCT01898793|76031529|FG003|Overall Study|Death|0|||
42215084|NCT01898793|76031530|FG004|Overall Study|Death|0|||
42215085|NCT01898793|76031531|FG005|Overall Study|Death|0|||
42215086|NCT01898793|76031532|FG006|Overall Study|Death|0|||
42215087|NCT01857934|76031551|FG000|Overall Study|Relapse or progression|2|||
42215088|NCT01857934|76031551|FG000|Overall Study|Unacceptable toxicity|3|||
42215089|NCT01857934|76031551|FG000|Overall Study|Unwillingness or inability to comply|2|||
42215090|NCT01857934|76031551|FG000|Overall Study|Physician Decision|3|||
42215091|NCT01757665|76031577|FG000|Overall Study|Still on Study - Visit Completed|240|||
42215092|NCT01757665|76031578|FG001|Overall Study|Still on Study - Visit Completed|30|||
42215093|NCT01757665|76031577|FG000|Overall Study|Still on Study - Visit Pending|398|||
42215094|NCT01757665|76031578|FG001|Overall Study|Still on Study - Visit Pending|40|||
42215095|NCT01757665|76031577|FG000|Overall Study|Still on Study - Missed Visit|14|||
42215096|NCT01757665|76031578|FG001|Overall Study|Still on Study - Missed Visit|1|||
42215097|NCT01757665|76031577|FG000|Overall Study|Death|25|||
42215098|NCT01757665|76031578|FG001|Overall Study|Death|8|||
42215099|NCT01757665|76031577|FG000|Overall Study|Explant|1|||
42215100|NCT01757665|76031578|FG001|Overall Study|Explant|2|||
42215101|NCT01757665|76031577|FG000|Overall Study|Withdrawal by Subject|10|||
42215102|NCT01757665|76031578|FG001|Overall Study|Withdrawal by Subject|0|||
42215103|NCT01757665|76031577|FG000|Overall Study|Lost to Follow-up|1|||
42215104|NCT01757665|76031578|FG001|Overall Study|Lost to Follow-up|1|||
42215105|NCT01757665|76031577|FG000|Overall Study|Not Implanted with Device|5|||
42215106|NCT01757665|76031578|FG001|Overall Study|Not Implanted with Device|1|||
42215107|NCT01459497|76031614|FG000|Overall Study|Inability to meet trial constraints.|1|||
42215108|NCT01459497|76031615|FG001|Overall Study|Inability to meet trial constraints.|0|||
42215109|NCT01459497|76031614|FG000|Overall Study|Physician Decision|1|||
42215110|NCT01459497|76031615|FG001|Overall Study|Physician Decision|1|||
42215111|NCT01459497|76031614|FG000|Overall Study|Hospitalization.|0|||
42215112|NCT01459497|76031615|FG001|Overall Study|Hospitalization.|3|||
42215113|NCT01459497|76031614|FG000|Overall Study|Disease progression.|0|||
42215114|NCT01459497|76031615|FG001|Overall Study|Disease progression.|1|||
42215115|NCT01275677|76031623|FG000|Overall Study|Not at risk for recurrence.|1|||
42215116|NCT01275677|76031624|FG001|Overall Study|Not at risk for recurrence.|1|||
42215117|NCT01275677|76031623|FG000|Overall Study|No follow-up|26|||
42215118|NCT01275677|76031624|FG001|Overall Study|No follow-up|37|||
42215119|NCT01275677|76031623|FG000|Overall Study|No clinical follow up.|1|||
41977124|NCT03107793|75781480|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
42215120|NCT01275677|76031624|FG001|Overall Study|No clinical follow up.|4|||
42215121|NCT01063751|76031630|FG000|Overall Study|Site terminated|45|||
42215122|NCT01063751|76031630|FG000|Overall Study|Lost to Follow-up|28|||
42215123|NCT01063751|76031630|FG000|Overall Study|Withdrawal by Subject|25|||
42215124|NCT01063751|76031630|FG000|Overall Study|Revision|6|||
42215125|NCT01063751|76031630|FG000|Overall Study|Death|12|||
42215126|NCT01063751|76031630|FG000|Overall Study|Physician Decision|4|||
42215127|NCT01063751|76031630|FG000|Overall Study|Active|91|||
42301956|NCT02284893|76137130|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
41977125|NCT03013543|75781499|FG000|Overall Study|Withdrawal by Subject|0|||
42215128|NCT00680901|76031637|FG000|Overall Study|Lost to Follow-up|8|||
42215129|NCT00680901|76031638|FG001|Overall Study|Lost to Follow-up|8|||
42215130|NCT00680901|76031637|FG000|Overall Study|Withdrawal by Subject|4|||
42215131|NCT00680901|76031638|FG001|Overall Study|Withdrawal by Subject|13|||
42215132|NCT00680901|76031637|FG000|Overall Study|Physician Decision|0|||
42215133|NCT00680901|76031638|FG001|Overall Study|Physician Decision|1|||
42215134|NCT00680901|76031637|FG000|Overall Study|Ongoing: On Study Treatment|16|||
42215135|NCT00680901|76031638|FG001|Overall Study|Ongoing: On Study Treatment|13|||
42215136|NCT00680901|76031637|FG000|Overall Study|Ongoing: In Follow Up|45|||
42215137|NCT00680901|76031638|FG001|Overall Study|Ongoing: In Follow Up|41|||
42215138|NCT00601900|76031646|FG000|Overall Study|Withdrawal by Subject|0|||
42215139|NCT00601900|76031647|FG001|Overall Study|Withdrawal by Subject|3|||
42215140|NCT00557193|76031653|FG000|Induction|Adverse Event|2|||
42215141|NCT00557193|76031654|FG001|Induction|Adverse Event|0|||
42215142|NCT00557193|76031655|FG002|Induction|Adverse Event|0|||
42215143|NCT00557193|76031656|FG003|Induction|Adverse Event|0|||
42215144|NCT00557193|76031657|FG004|Induction|Adverse Event|0|||
42215145|NCT00557193|76031658|FG005|Induction|Adverse Event|0|||
42215146|NCT00557193|76031653|FG000|Induction|Death|6|||
42215147|NCT00557193|76031654|FG001|Induction|Death|0|||
42215148|NCT00557193|76031655|FG002|Induction|Death|0|||
42215149|NCT00557193|76031656|FG003|Induction|Death|0|||
42215150|NCT00557193|76031657|FG004|Induction|Death|0|||
42215151|NCT00557193|76031658|FG005|Induction|Death|0|||
42215152|NCT00557193|76031653|FG000|Induction|Physician Decision|3|||
42215153|NCT00557193|76031654|FG001|Induction|Physician Decision|0|||
42215154|NCT00557193|76031655|FG002|Induction|Physician Decision|0|||
42215155|NCT00557193|76031656|FG003|Induction|Physician Decision|0|||
42215156|NCT00557193|76031657|FG004|Induction|Physician Decision|0|||
42215157|NCT00557193|76031658|FG005|Induction|Physician Decision|0|||
42215158|NCT00557193|76031653|FG000|Induction|Withdrawal by Subject|1|||
42215159|NCT00557193|76031654|FG001|Induction|Withdrawal by Subject|0|||
42215160|NCT00557193|76031655|FG002|Induction|Withdrawal by Subject|0|||
42215161|NCT00557193|76031656|FG003|Induction|Withdrawal by Subject|0|||
42215162|NCT00557193|76031657|FG004|Induction|Withdrawal by Subject|0|||
42215163|NCT00557193|76031658|FG005|Induction|Withdrawal by Subject|0|||
42215164|NCT00557193|76031653|FG000|Induction|Refusal of Further Protocol Therapy|2|||
42215165|NCT00557193|76031654|FG001|Induction|Refusal of Further Protocol Therapy|0|||
42215166|NCT00557193|76031655|FG002|Induction|Refusal of Further Protocol Therapy|0|||
42215167|NCT00557193|76031656|FG003|Induction|Refusal of Further Protocol Therapy|0|||
42215168|NCT00557193|76031657|FG004|Induction|Refusal of Further Protocol Therapy|0|||
42215169|NCT00557193|76031658|FG005|Induction|Refusal of Further Protocol Therapy|0|||
42215170|NCT00557193|76031653|FG000|Induction|Ineligible|8|||
42215171|NCT00557193|76031654|FG001|Induction|Ineligible|0|||
42215172|NCT00557193|76031655|FG002|Induction|Ineligible|0|||
42215173|NCT00557193|76031656|FG003|Induction|Ineligible|0|||
42215174|NCT00557193|76031657|FG004|Induction|Ineligible|0|||
42215175|NCT00557193|76031658|FG005|Induction|Ineligible|0|||
42215176|NCT00557193|76031653|FG000|Induction|Inevaluable for post Induction|2|||
42215177|NCT00557193|76031654|FG001|Induction|Inevaluable for post Induction|0|||
42215178|NCT00557193|76031655|FG002|Induction|Inevaluable for post Induction|0|||
42215179|NCT00557193|76031656|FG003|Induction|Inevaluable for post Induction|0|||
42215180|NCT00557193|76031657|FG004|Induction|Inevaluable for post Induction|0|||
42215181|NCT00557193|76031658|FG005|Induction|Inevaluable for post Induction|0|||
42215182|NCT00557193|76031653|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
42215183|NCT00557193|76031654|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
42215184|NCT00557193|76031655|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
42215185|NCT00557193|76031656|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
42215186|NCT00557193|76031657|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
42215187|NCT00557193|76031658|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
42215188|NCT00557193|76031653|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
41977126|NCT03013543|75781500|FG001|Overall Study|Withdrawal by Subject|2|||
41977127|NCT03013543|75781501|FG002|Overall Study|Withdrawal by Subject|0|||
41977128|NCT03013543|75781502|FG003|Overall Study|Withdrawal by Subject|5|||
41977129|NCT03013543|75781503|FG004|Overall Study|Withdrawal by Subject|6|||
42215189|NCT00557193|76031654|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
42215190|NCT00557193|76031655|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
42215191|NCT00557193|76031656|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
42215192|NCT00557193|76031657|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
42215193|NCT00557193|76031658|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
42215194|NCT00557193|76031653|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
42215195|NCT00557193|76031654|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
42215196|NCT00557193|76031655|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
42215197|NCT00557193|76031656|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
42215198|NCT00557193|76031657|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
42215199|NCT00557193|76031658|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
42215200|NCT00557193|76031653|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
42215201|NCT00557193|76031654|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
41977130|NCT03013543|75781504|FG005|Overall Study|Withdrawal by Subject|2|||
41977131|NCT03013543|75781505|FG006|Overall Study|Withdrawal by Subject|3|||
41977132|NCT03013543|75781506|FG007|Overall Study|Withdrawal by Subject|1|||
41977133|NCT03013543|75781507|FG008|Overall Study|Withdrawal by Subject|0|||
42215202|NCT00557193|76031655|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
42215203|NCT00557193|76031656|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
42215204|NCT00557193|76031657|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
42215205|NCT00557193|76031658|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
42215206|NCT00557193|76031653|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
42215207|NCT00557193|76031654|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
42215208|NCT00557193|76031655|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
42215209|NCT00557193|76031656|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
42215210|NCT00557193|76031657|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
42215211|NCT00557193|76031658|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
42215212|NCT00557193|76031653|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
42215213|NCT00557193|76031654|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
42215214|NCT00557193|76031655|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
42215215|NCT00557193|76031656|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
42215216|NCT00557193|76031657|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
42215217|NCT00557193|76031658|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
42215218|NCT00557193|76031653|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
42215219|NCT00557193|76031654|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
42215220|NCT00557193|76031655|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
42215221|NCT00557193|76031656|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
42215222|NCT00557193|76031657|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
42215223|NCT00557193|76031658|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
42215224|NCT00557193|76031653|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
42215225|NCT00557193|76031654|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
42215226|NCT00557193|76031655|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
42215227|NCT00557193|76031656|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
42215228|NCT00557193|76031657|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
42215229|NCT00557193|76031658|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
42215230|NCT00557193|76031653|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
42215231|NCT00557193|76031654|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
42215232|NCT00557193|76031655|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
42215233|NCT00557193|76031656|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
42215234|NCT00557193|76031657|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
42215235|NCT00557193|76031658|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
42215236|NCT00186888|76031711|FG000|Overall Study|Toxicity|0|||
42215237|NCT00186888|76031712|FG001|Overall Study|Toxicity|1|||
42215238|NCT00186888|76031713|FG002|Overall Study|Toxicity|0|||
42215239|NCT00186888|76031711|FG000|Overall Study|Relapse or progression of disease|4|||
42215240|NCT00186888|76031712|FG001|Overall Study|Relapse or progression of disease|2|||
42215241|NCT00186888|76031713|FG002|Overall Study|Relapse or progression of disease|0|||
42215242|NCT03078192|76031750|FG000|Overall Study|Withdrawal by Subject|2|||
42215243|NCT03078192|76031751|FG001|Overall Study|Withdrawal by Subject|1|||
42215244|NCT03078192|76031750|FG000|Overall Study|screen failure|0|||
42215245|NCT03078192|76031751|FG001|Overall Study|screen failure|3|||
42215246|NCT00703846|76031757|FG000|Overall Study|Adverse Event|8|||
42215247|NCT00703846|76031757|FG000|Overall Study|Lost to Follow-up|55|||
42215248|NCT00703846|76031757|FG000|Overall Study|Lack of Efficacy|15|||
42215249|NCT00703846|76031757|FG000|Overall Study|Noncompliance with Study Treatment|2|||
42215250|NCT00703846|76031757|FG000|Overall Study|Withdrawal by Subject|40|||
42215251|NCT00703846|76031757|FG000|Overall Study|Death|1|||
42215252|NCT00703846|76031757|FG000|Overall Study|Other|14|||
42215253|NCT00703846|76031757|FG000|Overall Study|Did Not Receive Study Drug|2|||
42215254|NCT05372575|76031767|FG000|Overall Study|Protocol Violation|7|||
42215255|NCT05372575|76031768|FG001|Overall Study|Protocol Violation|16|||
42215256|NCT05132127|76031779|FG000|Overall Study|Adverse Event|1|||
42215257|NCT04969276|76031806|FG000|Overall Study|Protocol Deviation|0|||
42215258|NCT04969276|76031807|FG001|Overall Study|Protocol Deviation|1|||
42215259|NCT04969276|76031808|FG002|Overall Study|Protocol Deviation|0|||
42215260|NCT04969276|76031806|FG000|Overall Study|Withdrawal by Subject|1|||
42215261|NCT04969276|76031807|FG001|Overall Study|Withdrawal by Subject|10|||
42215262|NCT04969276|76031808|FG002|Overall Study|Withdrawal by Subject|0|||
42215263|NCT04969276|76031806|FG000|Overall Study|Lost to Follow-up|0|||
41977134|NCT03013543|75781508|FG009|Overall Study|Withdrawal by Subject|4|||
41977135|NCT03013543|75781499|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
42215264|NCT04969276|76031807|FG001|Overall Study|Lost to Follow-up|1|||
42215265|NCT04969276|76031808|FG002|Overall Study|Lost to Follow-up|0|||
42215266|NCT04969224|76031816|FG000|Overall Study|Adverse Event|1|||
42215267|NCT04969224|76031816|FG000|Overall Study|Enrolled but never dosed|1|||
42215268|NCT04507126|76031842|FG000|Overall Study|Withdrawal by Subject|1|||
42215269|NCT04507126|76031842|FG000|Overall Study|Protocol Violation|2|||
42215270|NCT04507126|76031842|FG000|Overall Study|Physician Decision|1|||
42215271|NCT04498832|76031849|FG000|Overall Study|Adverse Event|1|||
42215272|NCT04498832|76031850|FG001|Overall Study|Adverse Event|3|||
42215273|NCT04498832|76031849|FG000|Overall Study|Withdrawal by Subject|0|||
42215274|NCT04498832|76031850|FG001|Overall Study|Withdrawal by Subject|1|||
42215275|NCT04490018|76031859|FG000|Overall Study|Protocol Violation|0|||
42215276|NCT04490018|76031860|FG001|Overall Study|Protocol Violation|2|||
42215277|NCT04490018|76031861|FG002|Overall Study|Protocol Violation|1|||
42215278|NCT04490018|76031859|FG000|Overall Study|Lost to Follow-up|2|||
42215279|NCT04490018|76031860|FG001|Overall Study|Lost to Follow-up|2|||
42215280|NCT04490018|76031861|FG002|Overall Study|Lost to Follow-up|0|||
42215281|NCT04490018|76031859|FG000|Overall Study|Withdrawal by Subject|2|||
42215282|NCT04490018|76031860|FG001|Overall Study|Withdrawal by Subject|1|||
42215283|NCT04490018|76031861|FG002|Overall Study|Withdrawal by Subject|0|||
42215284|NCT04490018|76031859|FG000|Overall Study|Withdrawal by parent/guardian|2|||
42215285|NCT04490018|76031860|FG001|Overall Study|Withdrawal by parent/guardian|3|||
42215286|NCT04490018|76031861|FG002|Overall Study|Withdrawal by parent/guardian|0|||
42215287|NCT03672461|76031912|FG000|Overall Study|COVID Related|4|||
42215288|NCT03672461|76031913|FG001|Overall Study|COVID Related|2|||
42215289|NCT03672461|76031912|FG000|Overall Study|Adverse Event|2|||
42215290|NCT03672461|76031913|FG001|Overall Study|Adverse Event|0|||
42215291|NCT03672461|76031912|FG000|Overall Study|Serious Adverse Event|0|||
42215292|NCT03672461|76031913|FG001|Overall Study|Serious Adverse Event|1|||
42215293|NCT03672461|76031912|FG000|Overall Study|Too Busy|3|||
42215294|NCT03672461|76031913|FG001|Overall Study|Too Busy|1|||
42215295|NCT03672461|76031912|FG000|Overall Study|Lost to Follow-up|1|||
42215296|NCT03672461|76031913|FG001|Overall Study|Lost to Follow-up|2|||
42215297|NCT03672461|76031912|FG000|Overall Study|Family|2|||
42215298|NCT03672461|76031913|FG001|Overall Study|Family|2|||
42215299|NCT03672461|76031912|FG000|Overall Study|No remote technology access|0|||
41977136|NCT03013543|75781500|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
41977137|NCT03013543|75781501|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
41977138|NCT03013543|75781502|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
41977139|NCT03013543|75781503|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
41977140|NCT03013543|75781504|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
41977141|NCT03013543|75781505|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
41977142|NCT03013543|75781506|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
41977143|NCT03013543|75781507|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
41977144|NCT03013543|75781508|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
41977145|NCT03013543|75781499|FG000|Overall Study|Other|0|||
41977146|NCT03013543|75781500|FG001|Overall Study|Other|0|||
41977147|NCT03013543|75781501|FG002|Overall Study|Other|2|||
42028455|NCT01124604|75836885|FG001|Overall Study|Disease Progression|1|||
42028456|NCT00909844|75836891|FG000|Overall Study|Adverse Event|1|||
42028457|NCT00909844|75836891|FG000|Overall Study|Withdrawal by Subject|1|||
42128785|NCT04193176|75939553|FG001|Overall Study|Withdrawal by Subject|10|||
42128786|NCT05384834|75939559|FG000|Overall Study|Lost to Follow-up|43|||
42128787|NCT05384834|75939559|FG000|Overall Study|Withdrawal by Subject|5|||
42128788|NCT05101486|75939566|FG000|Overall Study|Death|1|||
42128789|NCT05101486|75939567|FG001|Overall Study|Death|0|||
42128790|NCT05101486|75939568|FG002|Overall Study|Death|1|||
42128791|NCT05101486|75939566|FG000|Overall Study|Lost to Follow-up|12|||
42128792|NCT05101486|75939567|FG001|Overall Study|Lost to Follow-up|8|||
42128793|NCT05101486|75939568|FG002|Overall Study|Lost to Follow-up|17|||
42128794|NCT05101486|75939566|FG000|Overall Study|Physician Decision|1|||
42128795|NCT05101486|75939567|FG001|Overall Study|Physician Decision|0|||
42215300|NCT03672461|76031913|FG001|Overall Study|No remote technology access|1|||
42215301|NCT03672461|76031912|FG000|Overall Study|Withdrawal by Subject|1|||
42215302|NCT03672461|76031913|FG001|Overall Study|Withdrawal by Subject|0|||
42215303|NCT03672461|76031912|FG000|Overall Study|Cannot tolerate intervention|1|||
42215304|NCT03672461|76031913|FG001|Overall Study|Cannot tolerate intervention|0|||
42215305|NCT03672461|76031912|FG000|Overall Study|Incomplete outcome data|6|||
42215306|NCT03672461|76031913|FG001|Overall Study|Incomplete outcome data|1|||
42028458|NCT00909844|75836891|FG000|Overall Study|Lost to Follow-up|2|||
42215307|NCT03611556|76031926|FG000|Overall Study|Death|7|||
42215308|NCT03611556|76031927|FG001|Overall Study|Death|7|||
42215309|NCT03611556|76031928|FG002|Overall Study|Death|3|||
42215310|NCT03611556|76031929|FG003|Overall Study|Death|8|||
41977148|NCT03013543|75781502|FG003|Overall Study|Other|0|||
42128796|NCT05101486|75939568|FG002|Overall Study|Physician Decision|0|||
42128797|NCT05101486|75939566|FG000|Overall Study|Protocol Violation|0|||
42215311|NCT03611556|76031930|FG004|Overall Study|Death|47|||
42215312|NCT03611556|76031931|FG005|Overall Study|Death|32|||
42215313|NCT03611556|76031932|FG006|Overall Study|Death|53|||
42215314|NCT03611556|76031926|FG000|Overall Study|Withdrawal by Subject|0|||
42215315|NCT03611556|76031927|FG001|Overall Study|Withdrawal by Subject|0|||
42215316|NCT03611556|76031928|FG002|Overall Study|Withdrawal by Subject|0|||
42215317|NCT03611556|76031929|FG003|Overall Study|Withdrawal by Subject|0|||
42215318|NCT03611556|76031930|FG004|Overall Study|Withdrawal by Subject|4|||
42215319|NCT03611556|76031931|FG005|Overall Study|Withdrawal by Subject|2|||
42215320|NCT03611556|76031932|FG006|Overall Study|Withdrawal by Subject|4|||
42215321|NCT03611556|76031926|FG000|Overall Study|Sponsor decision|0|||
42215322|NCT03611556|76031927|FG001|Overall Study|Sponsor decision|0|||
42215323|NCT03611556|76031928|FG002|Overall Study|Sponsor decision|0|||
42215324|NCT03611556|76031929|FG003|Overall Study|Sponsor decision|0|||
42215325|NCT03611556|76031930|FG004|Overall Study|Sponsor decision|9|||
42215326|NCT03611556|76031931|FG005|Overall Study|Sponsor decision|4|||
42215327|NCT03611556|76031932|FG006|Overall Study|Sponsor decision|12|||
42215328|NCT03611556|76031926|FG000|Overall Study|Reasons|0|||
42215329|NCT03611556|76031927|FG001|Overall Study|Reasons|0|||
42215330|NCT03611556|76031928|FG002|Overall Study|Reasons|0|||
42215331|NCT03611556|76031929|FG003|Overall Study|Reasons|0|||
42215332|NCT03611556|76031930|FG004|Overall Study|Reasons|2|||
42215333|NCT03611556|76031931|FG005|Overall Study|Reasons|0|||
42215334|NCT03611556|76031932|FG006|Overall Study|Reasons|1|||
42215335|NCT03309813|76031983|FG000|Main Randomized Study|Withdrawal by Subject|1|||
42215336|NCT03309813|76031984|FG001|Main Randomized Study|Withdrawal by Subject|0|||
42215337|NCT02273388|76032037|FG000|Overall Study|Adverse Event|0|||
42215338|NCT02273388|76032038|FG001|Overall Study|Adverse Event|0|||
42215339|NCT02273388|76032039|FG002|Overall Study|Adverse Event|0|||
42215340|NCT02273388|76032040|FG003|Overall Study|Adverse Event|0|||
42215341|NCT02273388|76032041|FG004|Overall Study|Adverse Event|0|||
42215342|NCT02273388|76032042|FG005|Overall Study|Adverse Event|0|||
42215343|NCT02273388|76032043|FG006|Overall Study|Adverse Event|1|||
42215344|NCT02273388|76032044|FG007|Overall Study|Adverse Event|2|||
42215345|NCT02273388|76032045|FG008|Overall Study|Adverse Event|0|||
42215346|NCT02273388|76032046|FG009|Overall Study|Adverse Event|0|||
42215347|NCT02273388|76032047|FG010|Overall Study|Adverse Event|0|||
42215348|NCT02273388|76032048|FG011|Overall Study|Adverse Event|0|||
42215349|NCT02273388|76032037|FG000|Overall Study|Adverse Event study disease worse|4|||
42215350|NCT02273388|76032038|FG001|Overall Study|Adverse Event study disease worse|3|||
42215351|NCT02273388|76032039|FG002|Overall Study|Adverse Event study disease worse|3|||
42215352|NCT02273388|76032040|FG003|Overall Study|Adverse Event study disease worse|2|||
42215353|NCT02273388|76032041|FG004|Overall Study|Adverse Event study disease worse|4|||
42215354|NCT02273388|76032042|FG005|Overall Study|Adverse Event study disease worse|3|||
42215355|NCT02273388|76032043|FG006|Overall Study|Adverse Event study disease worse|14|||
41977149|NCT03013543|75781503|FG004|Overall Study|Other|2|||
42215356|NCT02273388|76032044|FG007|Overall Study|Adverse Event study disease worse|6|||
42215357|NCT02273388|76032045|FG008|Overall Study|Adverse Event study disease worse|6|||
42215358|NCT02273388|76032046|FG009|Overall Study|Adverse Event study disease worse|5|||
42215359|NCT02273388|76032047|FG010|Overall Study|Adverse Event study disease worse|10|||
42215360|NCT02273388|76032048|FG011|Overall Study|Adverse Event study disease worse|1|||
41977150|NCT03013543|75781504|FG005|Overall Study|Other|0|||
41977151|NCT03013543|75781505|FG006|Overall Study|Other|0|||
41977152|NCT03013543|75781506|FG007|Overall Study|Other|0|||
41977153|NCT03013543|75781507|FG008|Overall Study|Other|1|||
41977154|NCT03013543|75781508|FG009|Overall Study|Other|0|||
41977155|NCT03013543|75781499|FG000|Overall Study|Adverse Event|0|||
41977156|NCT03013543|75781500|FG001|Overall Study|Adverse Event|0|||
41977157|NCT03013543|75781501|FG002|Overall Study|Adverse Event|0|||
41977158|NCT03013543|75781502|FG003|Overall Study|Adverse Event|3|||
42028459|NCT01124448|75836898|FG000|Overall Study|Lost to Follow-up|0|||
42215361|NCT02273388|76032037|FG000|Overall Study|Sponsor decision|0|||
42215362|NCT02273388|76032038|FG001|Overall Study|Sponsor decision|0|||
42215363|NCT02273388|76032039|FG002|Overall Study|Sponsor decision|0|||
42215364|NCT02273388|76032040|FG003|Overall Study|Sponsor decision|0|||
42215365|NCT02273388|76032041|FG004|Overall Study|Sponsor decision|0|||
42215366|NCT02273388|76032042|FG005|Overall Study|Sponsor decision|0|||
42215367|NCT02273388|76032043|FG006|Overall Study|Sponsor decision|0|||
42215368|NCT02273388|76032044|FG007|Overall Study|Sponsor decision|0|||
41977159|NCT03013543|75781503|FG004|Overall Study|Adverse Event|2|||
41977160|NCT03013543|75781504|FG005|Overall Study|Adverse Event|1|||
42215369|NCT02273388|76032045|FG008|Overall Study|Sponsor decision|0|||
42215370|NCT02273388|76032046|FG009|Overall Study|Sponsor decision|0|||
42215371|NCT02273388|76032047|FG010|Overall Study|Sponsor decision|0|||
42215372|NCT02273388|76032048|FG011|Overall Study|Sponsor decision|1|||
42215373|NCT02272790|76032083|FG000|Overall Study|Physician Decision|0|||
42215374|NCT02272790|76032084|FG001|Overall Study|Physician Decision|1|||
41977161|NCT03013543|75781505|FG006|Overall Study|Adverse Event|3|||
41977162|NCT03013543|75781506|FG007|Overall Study|Adverse Event|8|||
41977163|NCT03013543|75781507|FG008|Overall Study|Adverse Event|0|||
42215375|NCT02272790|76032085|FG002|Overall Study|Physician Decision|0|||
42215376|NCT02272790|76032086|FG003|Overall Study|Physician Decision|0|||
42215377|NCT02272790|76032087|FG004|Overall Study|Physician Decision|0|||
42215378|NCT02272790|76032088|FG005|Overall Study|Physician Decision|0|||
42215379|NCT02100956|76032110|FG000|At Least One Week Between Injections|Adverse Event|0|||
42215380|NCT02100956|76032111|FG001|At Least One Week Between Injections|Adverse Event|1|||
42215381|NCT01438411|76032117|FG000|Overall Study|Adverse Event|8|||
42215382|NCT01438411|76032117|FG000|Overall Study|Lost to Follow-up|1|||
42215383|NCT01438411|76032117|FG000|Overall Study|Lack of Efficacy|1|||
42215384|NCT01438411|76032117|FG000|Overall Study|Withdrawal by Subject|3|||
42215385|NCT01302834|76032123|FG000|Overall Study|Protocol Violation|17|||
42215386|NCT01302834|76032124|FG001|Overall Study|Protocol Violation|23|||
42215387|NCT01302834|76032123|FG000|Overall Study|HIV positive|1|||
42215388|NCT01302834|76032124|FG001|Overall Study|HIV positive|3|||
42215389|NCT01153698|76032130|FG000|Overall Study|Adverse Event|12|||
42215390|NCT01153698|76032130|FG000|Overall Study|Lost to Follow-up|4|||
42215391|NCT01153698|76032130|FG000|Overall Study|Withdrawal by Subject|2|||
42215392|NCT01153698|76032130|FG000|Overall Study|Switch to other anticoagulants|4|||
42215393|NCT01153698|76032130|FG000|Overall Study|Other|2|||
42215394|NCT01153698|76032130|FG000|Overall Study|Not treated with Pradaxa|5|||
42215395|NCT00804856|76032163|FG000|Overall Study|Progressive Disease|3|||
42215396|NCT00804856|76032164|FG001|Overall Study|Progressive Disease|2|||
42215397|NCT00804856|76032165|FG002|Overall Study|Progressive Disease|4|||
42215398|NCT00804856|76032166|FG003|Overall Study|Progressive Disease|6|||
42215399|NCT00804856|76032167|FG004|Overall Study|Progressive Disease|4|||
42215400|NCT00804856|76032168|FG005|Overall Study|Progressive Disease|1|||
42215401|NCT00804856|76032169|FG006|Overall Study|Progressive Disease|8|||
41977164|NCT03013543|75781508|FG009|Overall Study|Adverse Event|2|||
42215402|NCT00804856|76032170|FG007|Overall Study|Progressive Disease|2|||
42215403|NCT00804856|76032171|FG008|Overall Study|Progressive Disease|4|||
42215404|NCT00804856|76032172|FG009|Overall Study|Progressive Disease|5|||
42215405|NCT00804856|76032173|FG010|Overall Study|Progressive Disease|12|||
42215406|NCT00804856|76032174|FG011|Overall Study|Progressive Disease|2|||
42215407|NCT00804856|76032175|FG012|Overall Study|Progressive Disease|2|||
42215408|NCT00804856|76032176|FG013|Overall Study|Progressive Disease|26|||
42215409|NCT00804856|76032177|FG014|Overall Study|Progressive Disease|20|||
42215410|NCT00804856|76032163|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215411|NCT00804856|76032164|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215412|NCT00804856|76032165|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215413|NCT00804856|76032166|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215414|NCT00804856|76032167|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
42215415|NCT00804856|76032168|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215416|NCT00804856|76032169|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215417|NCT00804856|76032170|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215418|NCT00804856|76032171|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215419|NCT00804856|76032172|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215420|NCT00804856|76032173|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215421|NCT00804856|76032174|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215422|NCT00804856|76032175|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215423|NCT00804856|76032176|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42215424|NCT00804856|76032177|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
42215425|NCT00804856|76032163|FG000|Overall Study|Other Adverse Event|1|||
42215426|NCT00804856|76032164|FG001|Overall Study|Other Adverse Event|1|||
42215427|NCT00804856|76032165|FG002|Overall Study|Other Adverse Event|1|||
42215428|NCT00804856|76032166|FG003|Overall Study|Other Adverse Event|2|||
42215429|NCT00804856|76032167|FG004|Overall Study|Other Adverse Event|2|||
42215430|NCT00804856|76032168|FG005|Overall Study|Other Adverse Event|1|||
42215431|NCT00804856|76032169|FG006|Overall Study|Other Adverse Event|3|||
42215432|NCT00804856|76032170|FG007|Overall Study|Other Adverse Event|0|||
42215433|NCT00804856|76032171|FG008|Overall Study|Other Adverse Event|0|||
42215434|NCT00804856|76032172|FG009|Overall Study|Other Adverse Event|1|||
42215435|NCT00804856|76032173|FG010|Overall Study|Other Adverse Event|5|||
42215436|NCT00804856|76032174|FG011|Overall Study|Other Adverse Event|2|||
42215437|NCT00804856|76032175|FG012|Overall Study|Other Adverse Event|0|||
42215438|NCT00804856|76032176|FG013|Overall Study|Other Adverse Event|6|||
42215439|NCT00804856|76032177|FG014|Overall Study|Other Adverse Event|13|||
42215440|NCT00804856|76032163|FG000|Overall Study|Non compliance with protocol|0|||
42215441|NCT00804856|76032164|FG001|Overall Study|Non compliance with protocol|0|||
42215442|NCT00804856|76032165|FG002|Overall Study|Non compliance with protocol|0|||
42215443|NCT00804856|76032166|FG003|Overall Study|Non compliance with protocol|0|||
42215444|NCT00804856|76032167|FG004|Overall Study|Non compliance with protocol|0|||
42215445|NCT00804856|76032168|FG005|Overall Study|Non compliance with protocol|0|||
42215446|NCT00804856|76032169|FG006|Overall Study|Non compliance with protocol|0|||
42215447|NCT00804856|76032170|FG007|Overall Study|Non compliance with protocol|0|||
42215448|NCT00804856|76032171|FG008|Overall Study|Non compliance with protocol|0|||
42215449|NCT00804856|76032172|FG009|Overall Study|Non compliance with protocol|0|||
42215450|NCT00804856|76032173|FG010|Overall Study|Non compliance with protocol|0|||
42215451|NCT00804856|76032174|FG011|Overall Study|Non compliance with protocol|0|||
42215452|NCT00804856|76032175|FG012|Overall Study|Non compliance with protocol|0|||
42215453|NCT00804856|76032176|FG013|Overall Study|Non compliance with protocol|2|||
42215454|NCT00804856|76032177|FG014|Overall Study|Non compliance with protocol|0|||
42215455|NCT00804856|76032163|FG000|Overall Study|Refused to continue medication|0|||
42215456|NCT00804856|76032164|FG001|Overall Study|Refused to continue medication|0|||
42215457|NCT00804856|76032165|FG002|Overall Study|Refused to continue medication|0|||
42215458|NCT00804856|76032166|FG003|Overall Study|Refused to continue medication|1|||
42215459|NCT00804856|76032167|FG004|Overall Study|Refused to continue medication|1|||
42215460|NCT00804856|76032168|FG005|Overall Study|Refused to continue medication|0|||
42215461|NCT00804856|76032169|FG006|Overall Study|Refused to continue medication|0|||
42215462|NCT00804856|76032170|FG007|Overall Study|Refused to continue medication|0|||
42215463|NCT00804856|76032171|FG008|Overall Study|Refused to continue medication|0|||
42215464|NCT00804856|76032172|FG009|Overall Study|Refused to continue medication|0|||
42215465|NCT00804856|76032173|FG010|Overall Study|Refused to continue medication|3|||
42215466|NCT00804856|76032174|FG011|Overall Study|Refused to continue medication|0|||
42215467|NCT00804856|76032175|FG012|Overall Study|Refused to continue medication|1|||
42215468|NCT00804856|76032176|FG013|Overall Study|Refused to continue medication|1|||
42215469|NCT00804856|76032177|FG014|Overall Study|Refused to continue medication|5|||
42215470|NCT00804856|76032163|FG000|Overall Study|Other reason than listed above|0|||
42215471|NCT00804856|76032164|FG001|Overall Study|Other reason than listed above|0|||
42215472|NCT00804856|76032165|FG002|Overall Study|Other reason than listed above|0|||
42215473|NCT00804856|76032166|FG003|Overall Study|Other reason than listed above|0|||
42215474|NCT00804856|76032167|FG004|Overall Study|Other reason than listed above|0|||
42215475|NCT00804856|76032168|FG005|Overall Study|Other reason than listed above|1|||
42215476|NCT00804856|76032169|FG006|Overall Study|Other reason than listed above|0|||
42215477|NCT00804856|76032170|FG007|Overall Study|Other reason than listed above|0|||
42215478|NCT00804856|76032171|FG008|Overall Study|Other reason than listed above|1|||
42215479|NCT00804856|76032172|FG009|Overall Study|Other reason than listed above|0|||
42215480|NCT00804856|76032173|FG010|Overall Study|Other reason than listed above|3|||
42215481|NCT00804856|76032174|FG011|Overall Study|Other reason than listed above|1|||
42215482|NCT00804856|76032175|FG012|Overall Study|Other reason than listed above|1|||
42215483|NCT00804856|76032176|FG013|Overall Study|Other reason than listed above|10|||
42215484|NCT00804856|76032177|FG014|Overall Study|Other reason than listed above|3|||
42215485|NCT01314872|76032265|FG000|Treatment Period 1|Protocol Violation|2|||
42215486|NCT01314872|76032266|FG001|Treatment Period 1|Protocol Violation|1|||
42215487|NCT01314872|76032267|FG002|Treatment Period 1|Protocol Violation|1|||
42215488|NCT01314872|76032268|FG003|Treatment Period 1|Protocol Violation|0|||
42215489|NCT01314872|76032269|FG004|Treatment Period 1|Protocol Violation|1|||
42215490|NCT01314872|76032270|FG005|Treatment Period 1|Protocol Violation|0|||
41977165|NCT03013543|75781499|FG000|Overall Study|Death|0|||
41977166|NCT03013543|75781500|FG001|Overall Study|Death|0|||
42215491|NCT01314872|76032271|FG006|Treatment Period 1|Protocol Violation|0|||
42215492|NCT01314872|76032272|FG007|Treatment Period 1|Protocol Violation|0|||
42215493|NCT01314872|76032273|FG008|Treatment Period 1|Protocol Violation|0|||
42215494|NCT01314872|76032274|FG009|Treatment Period 1|Protocol Violation|1|||
42215495|NCT01314872|76032275|FG010|Treatment Period 1|Protocol Violation|1|||
42215496|NCT01314872|76032276|FG011|Treatment Period 1|Protocol Violation|0|||
42215497|NCT01314872|76032277|FG012|Treatment Period 1|Protocol Violation|0|||
42215498|NCT01314872|76032278|FG013|Treatment Period 1|Protocol Violation|0|||
42215499|NCT01314872|76032279|FG014|Treatment Period 1|Protocol Violation|0|||
42215500|NCT01314872|76032265|FG000|Treatment Period 1|Physician Decision|0|||
42215501|NCT01314872|76032266|FG001|Treatment Period 1|Physician Decision|1|||
42215502|NCT01314872|76032267|FG002|Treatment Period 1|Physician Decision|0|||
42215503|NCT01314872|76032268|FG003|Treatment Period 1|Physician Decision|1|||
42215504|NCT01314872|76032269|FG004|Treatment Period 1|Physician Decision|0|||
42215505|NCT01314872|76032270|FG005|Treatment Period 1|Physician Decision|0|||
42215506|NCT01314872|76032271|FG006|Treatment Period 1|Physician Decision|0|||
42215507|NCT01314872|76032272|FG007|Treatment Period 1|Physician Decision|0|||
42215508|NCT01314872|76032273|FG008|Treatment Period 1|Physician Decision|0|||
42215509|NCT01314872|76032274|FG009|Treatment Period 1|Physician Decision|1|||
42215510|NCT01314872|76032275|FG010|Treatment Period 1|Physician Decision|0|||
42215511|NCT01314872|76032276|FG011|Treatment Period 1|Physician Decision|0|||
42215512|NCT01314872|76032277|FG012|Treatment Period 1|Physician Decision|0|||
42215513|NCT01314872|76032278|FG013|Treatment Period 1|Physician Decision|0|||
42215514|NCT01314872|76032279|FG014|Treatment Period 1|Physician Decision|0|||
41977167|NCT03013543|75781501|FG002|Overall Study|Death|0|||
41977168|NCT03013543|75781502|FG003|Overall Study|Death|1|||
41977169|NCT03013543|75781503|FG004|Overall Study|Death|0|||
41977170|NCT03013543|75781504|FG005|Overall Study|Death|0|||
41977171|NCT03013543|75781505|FG006|Overall Study|Death|0|||
41977172|NCT03013543|75781506|FG007|Overall Study|Death|0|||
41977173|NCT03013543|75781507|FG008|Overall Study|Death|0|||
42028460|NCT01124448|75836899|FG001|Overall Study|Lost to Follow-up|3|||
42028461|NCT01124448|75836898|FG000|Overall Study|Protocol Violation|2|||
42028462|NCT01124448|75836899|FG001|Overall Study|Protocol Violation|0|||
42028463|NCT01124292|75836908|FG000|Overall Study|Lost to Follow-up|2|||
42028464|NCT01124292|75836909|FG001|Overall Study|Lost to Follow-up|4|||
42028465|NCT01124292|75836910|FG002|Overall Study|Lost to Follow-up|3|||
42128798|NCT05101486|75939567|FG001|Overall Study|Protocol Violation|0|||
42128799|NCT05101486|75939568|FG002|Overall Study|Protocol Violation|1|||
42128800|NCT05101486|75939566|FG000|Overall Study|Withdrawal by Subject|5|||
42128801|NCT05101486|75939567|FG001|Overall Study|Withdrawal by Subject|2|||
42128802|NCT05101486|75939568|FG002|Overall Study|Withdrawal by Subject|4|||
42128803|NCT05101486|75939566|FG000|Overall Study|Randomized but not vaccinated|1|||
42128804|NCT05101486|75939567|FG001|Overall Study|Randomized but not vaccinated|1|||
42215515|NCT01314872|76032265|FG000|Treatment Period 1|Lack of Efficacy|1|||
42215516|NCT01314872|76032266|FG001|Treatment Period 1|Lack of Efficacy|0|||
42215517|NCT01314872|76032267|FG002|Treatment Period 1|Lack of Efficacy|0|||
42215518|NCT01314872|76032268|FG003|Treatment Period 1|Lack of Efficacy|0|||
42215519|NCT01314872|76032269|FG004|Treatment Period 1|Lack of Efficacy|0|||
42215520|NCT01314872|76032270|FG005|Treatment Period 1|Lack of Efficacy|1|||
42215521|NCT01314872|76032271|FG006|Treatment Period 1|Lack of Efficacy|0|||
42215522|NCT01314872|76032272|FG007|Treatment Period 1|Lack of Efficacy|2|||
42128805|NCT05101486|75939568|FG002|Overall Study|Randomized but not vaccinated|1|||
42215523|NCT01314872|76032273|FG008|Treatment Period 1|Lack of Efficacy|0|||
42215524|NCT01314872|76032274|FG009|Treatment Period 1|Lack of Efficacy|0|||
41977174|NCT03013543|75781508|FG009|Overall Study|Death|0|||
42215525|NCT01314872|76032275|FG010|Treatment Period 1|Lack of Efficacy|0|||
41977175|NCT03013543|75781499|FG000|Overall Study|Lack of Efficacy|0|||
41977176|NCT03013543|75781500|FG001|Overall Study|Lack of Efficacy|0|||
41977177|NCT03013543|75781501|FG002|Overall Study|Lack of Efficacy|0|||
42215526|NCT01314872|76032276|FG011|Treatment Period 1|Lack of Efficacy|0|||
42215527|NCT01314872|76032277|FG012|Treatment Period 1|Lack of Efficacy|0|||
42215528|NCT01314872|76032278|FG013|Treatment Period 1|Lack of Efficacy|0|||
42215529|NCT01314872|76032279|FG014|Treatment Period 1|Lack of Efficacy|0|||
42215530|NCT01314872|76032265|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
42215531|NCT01314872|76032266|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
42215532|NCT01314872|76032267|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
42215533|NCT01314872|76032268|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
42215534|NCT01314872|76032269|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
42215535|NCT01314872|76032270|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
42215536|NCT01314872|76032271|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
42215537|NCT01314872|76032272|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
42215538|NCT01314872|76032273|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
42215539|NCT01314872|76032274|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
42215540|NCT01314872|76032275|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
42215541|NCT01314872|76032276|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
42215542|NCT01314872|76032277|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
42215543|NCT01314872|76032278|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
42215544|NCT01314872|76032279|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
42215545|NCT01314872|76032265|FG000|Treatment Period 1|Withdrawal by Subject|3|||
42215546|NCT01314872|76032266|FG001|Treatment Period 1|Withdrawal by Subject|1|||
42215547|NCT01314872|76032267|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42215548|NCT01314872|76032268|FG003|Treatment Period 1|Withdrawal by Subject|2|||
42215549|NCT01314872|76032269|FG004|Treatment Period 1|Withdrawal by Subject|3|||
42215550|NCT01314872|76032270|FG005|Treatment Period 1|Withdrawal by Subject|1|||
42215551|NCT01314872|76032271|FG006|Treatment Period 1|Withdrawal by Subject|3|||
42215552|NCT01314872|76032272|FG007|Treatment Period 1|Withdrawal by Subject|2|||
42215553|NCT01314872|76032273|FG008|Treatment Period 1|Withdrawal by Subject|2|||
42215554|NCT01314872|76032274|FG009|Treatment Period 1|Withdrawal by Subject|2|||
42215555|NCT01314872|76032275|FG010|Treatment Period 1|Withdrawal by Subject|1|||
42215556|NCT01314872|76032276|FG011|Treatment Period 1|Withdrawal by Subject|0|||
42215557|NCT01314872|76032277|FG012|Treatment Period 1|Withdrawal by Subject|0|||
42215558|NCT01314872|76032278|FG013|Treatment Period 1|Withdrawal by Subject|0|||
42215559|NCT01314872|76032279|FG014|Treatment Period 1|Withdrawal by Subject|0|||
42215560|NCT01314872|76032265|FG000|Treatment Period 1|Lost to Follow-up|0|||
42215561|NCT01314872|76032266|FG001|Treatment Period 1|Lost to Follow-up|1|||
42215562|NCT01314872|76032267|FG002|Treatment Period 1|Lost to Follow-up|2|||
42215563|NCT01314872|76032268|FG003|Treatment Period 1|Lost to Follow-up|2|||
42215564|NCT01314872|76032269|FG004|Treatment Period 1|Lost to Follow-up|1|||
42215565|NCT01314872|76032270|FG005|Treatment Period 1|Lost to Follow-up|1|||
42215566|NCT01314872|76032271|FG006|Treatment Period 1|Lost to Follow-up|1|||
42215567|NCT01314872|76032272|FG007|Treatment Period 1|Lost to Follow-up|1|||
42215568|NCT01314872|76032273|FG008|Treatment Period 1|Lost to Follow-up|1|||
42215569|NCT01314872|76032274|FG009|Treatment Period 1|Lost to Follow-up|0|||
42215570|NCT01314872|76032275|FG010|Treatment Period 1|Lost to Follow-up|0|||
42215571|NCT01314872|76032276|FG011|Treatment Period 1|Lost to Follow-up|0|||
42215572|NCT01314872|76032277|FG012|Treatment Period 1|Lost to Follow-up|0|||
42215573|NCT01314872|76032278|FG013|Treatment Period 1|Lost to Follow-up|0|||
42215574|NCT01314872|76032279|FG014|Treatment Period 1|Lost to Follow-up|0|||
42215575|NCT01314872|76032265|FG000|Period 2|Protocol Violation|0|||
42215576|NCT01314872|76032266|FG001|Period 2|Protocol Violation|0|||
42215577|NCT01314872|76032267|FG002|Period 2|Protocol Violation|0|||
42215578|NCT01314872|76032268|FG003|Period 2|Protocol Violation|0|||
42215579|NCT01314872|76032269|FG004|Period 2|Protocol Violation|0|||
42215580|NCT01314872|76032270|FG005|Period 2|Protocol Violation|0|||
42215581|NCT01314872|76032271|FG006|Period 2|Protocol Violation|0|||
42215582|NCT01314872|76032272|FG007|Period 2|Protocol Violation|0|||
42215583|NCT01314872|76032273|FG008|Period 2|Protocol Violation|0|||
42215584|NCT01314872|76032274|FG009|Period 2|Protocol Violation|0|||
42215585|NCT01314872|76032275|FG010|Period 2|Protocol Violation|0|||
42215586|NCT01314872|76032276|FG011|Period 2|Protocol Violation|3|||
42215587|NCT01314872|76032277|FG012|Period 2|Protocol Violation|3|||
42215588|NCT01314872|76032278|FG013|Period 2|Protocol Violation|2|||
42215589|NCT01314872|76032279|FG014|Period 2|Protocol Violation|0|||
42215590|NCT01314872|76032265|FG000|Period 2|Non-compliance with study drug|0|||
41977178|NCT03013543|75781502|FG003|Overall Study|Lack of Efficacy|1|||
41977179|NCT03013543|75781503|FG004|Overall Study|Lack of Efficacy|0|||
41977180|NCT03013543|75781504|FG005|Overall Study|Lack of Efficacy|0|||
41977181|NCT03013543|75781505|FG006|Overall Study|Lack of Efficacy|0|||
41977182|NCT03013543|75781506|FG007|Overall Study|Lack of Efficacy|0|||
41977183|NCT03013543|75781507|FG008|Overall Study|Lack of Efficacy|0|||
42215591|NCT01314872|76032266|FG001|Period 2|Non-compliance with study drug|0|||
42215592|NCT01314872|76032267|FG002|Period 2|Non-compliance with study drug|0|||
42215593|NCT01314872|76032268|FG003|Period 2|Non-compliance with study drug|0|||
42215594|NCT01314872|76032269|FG004|Period 2|Non-compliance with study drug|0|||
42215595|NCT01314872|76032270|FG005|Period 2|Non-compliance with study drug|0|||
42215596|NCT01314872|76032271|FG006|Period 2|Non-compliance with study drug|0|||
42215597|NCT01314872|76032272|FG007|Period 2|Non-compliance with study drug|0|||
42215598|NCT01314872|76032273|FG008|Period 2|Non-compliance with study drug|0|||
42215599|NCT01314872|76032274|FG009|Period 2|Non-compliance with study drug|0|||
42215600|NCT01314872|76032275|FG010|Period 2|Non-compliance with study drug|0|||
42215601|NCT01314872|76032276|FG011|Period 2|Non-compliance with study drug|3|||
42215602|NCT01314872|76032277|FG012|Period 2|Non-compliance with study drug|3|||
42215603|NCT01314872|76032278|FG013|Period 2|Non-compliance with study drug|1|||
42215604|NCT01314872|76032279|FG014|Period 2|Non-compliance with study drug|2|||
42215605|NCT01314872|76032265|FG000|Period 2|Lack of Efficacy|0|||
42215606|NCT01314872|76032266|FG001|Period 2|Lack of Efficacy|0|||
42215607|NCT01314872|76032267|FG002|Period 2|Lack of Efficacy|0|||
42215608|NCT01314872|76032268|FG003|Period 2|Lack of Efficacy|0|||
42215609|NCT01314872|76032269|FG004|Period 2|Lack of Efficacy|0|||
42215610|NCT01314872|76032270|FG005|Period 2|Lack of Efficacy|0|||
42215611|NCT01314872|76032271|FG006|Period 2|Lack of Efficacy|0|||
42215612|NCT01314872|76032272|FG007|Period 2|Lack of Efficacy|0|||
42215613|NCT01314872|76032273|FG008|Period 2|Lack of Efficacy|0|||
42215614|NCT01314872|76032274|FG009|Period 2|Lack of Efficacy|0|||
42215615|NCT01314872|76032275|FG010|Period 2|Lack of Efficacy|0|||
42215616|NCT01314872|76032276|FG011|Period 2|Lack of Efficacy|7|||
42215617|NCT01314872|76032277|FG012|Period 2|Lack of Efficacy|12|||
42215618|NCT01314872|76032278|FG013|Period 2|Lack of Efficacy|9|||
42215619|NCT01314872|76032279|FG014|Period 2|Lack of Efficacy|2|||
42215620|NCT01314872|76032265|FG000|Period 2|Pregnancy|0|||
42215621|NCT01314872|76032266|FG001|Period 2|Pregnancy|0|||
42215622|NCT01314872|76032267|FG002|Period 2|Pregnancy|0|||
42215623|NCT01314872|76032268|FG003|Period 2|Pregnancy|0|||
42215624|NCT01314872|76032269|FG004|Period 2|Pregnancy|0|||
42215625|NCT01314872|76032270|FG005|Period 2|Pregnancy|0|||
42215626|NCT01314872|76032271|FG006|Period 2|Pregnancy|0|||
42215627|NCT01314872|76032272|FG007|Period 2|Pregnancy|0|||
42215628|NCT01314872|76032273|FG008|Period 2|Pregnancy|0|||
42215629|NCT01314872|76032274|FG009|Period 2|Pregnancy|0|||
42215630|NCT01314872|76032275|FG010|Period 2|Pregnancy|0|||
42215631|NCT01314872|76032276|FG011|Period 2|Pregnancy|0|||
42215632|NCT01314872|76032277|FG012|Period 2|Pregnancy|0|||
42215633|NCT01314872|76032278|FG013|Period 2|Pregnancy|0|||
42215634|NCT01314872|76032279|FG014|Period 2|Pregnancy|1|||
42215635|NCT01314872|76032265|FG000|Period 2|Study terminated by Sponsor|0|||
42215636|NCT01314872|76032266|FG001|Period 2|Study terminated by Sponsor|0|||
41977184|NCT03013543|75781508|FG009|Overall Study|Lack of Efficacy|0|||
42215637|NCT01314872|76032267|FG002|Period 2|Study terminated by Sponsor|0|||
42215638|NCT01314872|76032268|FG003|Period 2|Study terminated by Sponsor|0|||
42215639|NCT01314872|76032269|FG004|Period 2|Study terminated by Sponsor|0|||
42215640|NCT01314872|76032270|FG005|Period 2|Study terminated by Sponsor|0|||
42215641|NCT01314872|76032271|FG006|Period 2|Study terminated by Sponsor|0|||
42215642|NCT01314872|76032272|FG007|Period 2|Study terminated by Sponsor|0|||
42215643|NCT01314872|76032273|FG008|Period 2|Study terminated by Sponsor|0|||
42215644|NCT01314872|76032274|FG009|Period 2|Study terminated by Sponsor|0|||
42215645|NCT01314872|76032275|FG010|Period 2|Study terminated by Sponsor|0|||
42215646|NCT01314872|76032276|FG011|Period 2|Study terminated by Sponsor|2|||
42215647|NCT01314872|76032277|FG012|Period 2|Study terminated by Sponsor|2|||
42215648|NCT01314872|76032278|FG013|Period 2|Study terminated by Sponsor|3|||
42215649|NCT01314872|76032279|FG014|Period 2|Study terminated by Sponsor|0|||
42215650|NCT01314872|76032265|FG000|Period 2|Adverse event, non-fatal|0|||
42215651|NCT01314872|76032266|FG001|Period 2|Adverse event, non-fatal|0|||
42215652|NCT01314872|76032267|FG002|Period 2|Adverse event, non-fatal|0|||
42215653|NCT01314872|76032268|FG003|Period 2|Adverse event, non-fatal|0|||
42215654|NCT01314872|76032269|FG004|Period 2|Adverse event, non-fatal|0|||
42215655|NCT01314872|76032270|FG005|Period 2|Adverse event, non-fatal|0|||
42215656|NCT01314872|76032271|FG006|Period 2|Adverse event, non-fatal|0|||
42215657|NCT01314872|76032272|FG007|Period 2|Adverse event, non-fatal|0|||
42215658|NCT01314872|76032273|FG008|Period 2|Adverse event, non-fatal|0|||
42215659|NCT01314872|76032274|FG009|Period 2|Adverse event, non-fatal|0|||
42215660|NCT01314872|76032275|FG010|Period 2|Adverse event, non-fatal|0|||
42215661|NCT01314872|76032276|FG011|Period 2|Adverse event, non-fatal|13|||
42215662|NCT01314872|76032277|FG012|Period 2|Adverse event, non-fatal|16|||
42215663|NCT01314872|76032278|FG013|Period 2|Adverse event, non-fatal|24|||
42215664|NCT01314872|76032279|FG014|Period 2|Adverse event, non-fatal|9|||
42215665|NCT01314872|76032265|FG000|Period 2|Withdrawal by Subject|0|||
42215666|NCT01314872|76032266|FG001|Period 2|Withdrawal by Subject|0|||
42215667|NCT01314872|76032267|FG002|Period 2|Withdrawal by Subject|0|||
42215668|NCT01314872|76032268|FG003|Period 2|Withdrawal by Subject|0|||
42215669|NCT01314872|76032269|FG004|Period 2|Withdrawal by Subject|0|||
42215670|NCT01314872|76032270|FG005|Period 2|Withdrawal by Subject|0|||
42215671|NCT01314872|76032271|FG006|Period 2|Withdrawal by Subject|0|||
42215672|NCT01314872|76032272|FG007|Period 2|Withdrawal by Subject|0|||
42215673|NCT01314872|76032273|FG008|Period 2|Withdrawal by Subject|0|||
42215674|NCT01314872|76032274|FG009|Period 2|Withdrawal by Subject|0|||
42215675|NCT01314872|76032275|FG010|Period 2|Withdrawal by Subject|0|||
42215676|NCT01314872|76032276|FG011|Period 2|Withdrawal by Subject|14|||
42215677|NCT01314872|76032277|FG012|Period 2|Withdrawal by Subject|17|||
42215678|NCT01314872|76032278|FG013|Period 2|Withdrawal by Subject|12|||
42215679|NCT01314872|76032279|FG014|Period 2|Withdrawal by Subject|4|||
42215680|NCT01314872|76032265|FG000|Period 2|Lost to Follow-up|0|||
42215681|NCT01314872|76032266|FG001|Period 2|Lost to Follow-up|0|||
42215682|NCT01314872|76032267|FG002|Period 2|Lost to Follow-up|0|||
42215683|NCT01314872|76032268|FG003|Period 2|Lost to Follow-up|0|||
42215684|NCT01314872|76032269|FG004|Period 2|Lost to Follow-up|0|||
42215685|NCT01314872|76032270|FG005|Period 2|Lost to Follow-up|0|||
42215686|NCT01314872|76032271|FG006|Period 2|Lost to Follow-up|0|||
42215687|NCT01314872|76032272|FG007|Period 2|Lost to Follow-up|0|||
42215688|NCT01314872|76032273|FG008|Period 2|Lost to Follow-up|0|||
42301957|NCT02284893|76137129|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
41977185|NCT03013543|75781499|FG000|Overall Study|Lost to Follow-up|0|||
41977186|NCT03013543|75781500|FG001|Overall Study|Lost to Follow-up|0|||
41977187|NCT03013543|75781501|FG002|Overall Study|Lost to Follow-up|0|||
41977188|NCT03013543|75781502|FG003|Overall Study|Lost to Follow-up|1|||
41977189|NCT03013543|75781503|FG004|Overall Study|Lost to Follow-up|0|||
41977190|NCT03013543|75781504|FG005|Overall Study|Lost to Follow-up|0|||
42028466|NCT01124292|75836908|FG000|Overall Study|Physician Decision|0|||
42128806|NCT05083585|75939578|FG000|Overall Study|Death|1|||
42128807|NCT05083585|75939579|FG001|Overall Study|Death|1|||
42128808|NCT05083585|75939578|FG000|Overall Study|Lost to Follow-up|1|||
42128809|NCT05083585|75939579|FG001|Overall Study|Lost to Follow-up|1|||
42128810|NCT05083585|75939578|FG000|Overall Study|Withdrawal by Subject|2|||
42128811|NCT05083585|75939579|FG001|Overall Study|Withdrawal by Subject|0|||
42128812|NCT05083585|75939578|FG000|Overall Study|Randomized but not vaccinated|2|||
42128813|NCT05083585|75939579|FG001|Overall Study|Randomized but not vaccinated|0|||
42128814|NCT05071313|75939587|FG000|Overall Study|Lost to Follow-up|17|||
42215689|NCT01314872|76032274|FG009|Period 2|Lost to Follow-up|0|||
42215690|NCT01314872|76032275|FG010|Period 2|Lost to Follow-up|0|||
42215691|NCT01314872|76032276|FG011|Period 2|Lost to Follow-up|6|||
42215692|NCT01314872|76032277|FG012|Period 2|Lost to Follow-up|7|||
42215693|NCT01314872|76032278|FG013|Period 2|Lost to Follow-up|2|||
42215694|NCT01314872|76032279|FG014|Period 2|Lost to Follow-up|6|||
41977191|NCT03013543|75781505|FG006|Overall Study|Lost to Follow-up|1|||
41977192|NCT03013543|75781506|FG007|Overall Study|Lost to Follow-up|0|||
42215695|NCT00703924|76032313|FG000|Overall Study|Withdrawal by Subject|1|||
42215696|NCT00703924|76032314|FG001|Overall Study|Withdrawal by Subject|1|||
42128815|NCT05071313|75939588|FG001|Overall Study|Lost to Follow-up|10|||
42215697|NCT03152526|76032326|FG000|Overall Study|Withdrawal by Subject|0|||
42215698|NCT03152526|76032327|FG001|Overall Study|Withdrawal by Subject|1|||
42215699|NCT03149328|76032335|FG000|Overall Study|Withdrawal by Subject|30|||
42215700|NCT03149328|76032336|FG001|Overall Study|Withdrawal by Subject|26|||
41977193|NCT03013543|75781507|FG008|Overall Study|Lost to Follow-up|0|||
41977194|NCT03013543|75781508|FG009|Overall Study|Lost to Follow-up|2|||
42028467|NCT01124292|75836909|FG001|Overall Study|Physician Decision|3|||
42215701|NCT03149328|76032335|FG000|Overall Study|Changed Dialysis Modality|18|||
41977195|NCT03013543|75781499|FG000|Overall Study|Non-Compliance With Study Drug|0|||
41977196|NCT03013543|75781500|FG001|Overall Study|Non-Compliance With Study Drug|0|||
41977197|NCT03013543|75781501|FG002|Overall Study|Non-Compliance With Study Drug|0|||
41977198|NCT03013543|75781502|FG003|Overall Study|Non-Compliance With Study Drug|0|||
41977199|NCT03013543|75781503|FG004|Overall Study|Non-Compliance With Study Drug|0|||
41977200|NCT03013543|75781504|FG005|Overall Study|Non-Compliance With Study Drug|0|||
41977201|NCT03013543|75781505|FG006|Overall Study|Non-Compliance With Study Drug|0|||
41977202|NCT03013543|75781506|FG007|Overall Study|Non-Compliance With Study Drug|0|||
41977203|NCT03013543|75781507|FG008|Overall Study|Non-Compliance With Study Drug|1|||
41977204|NCT03013543|75781508|FG009|Overall Study|Non-Compliance With Study Drug|0|||
41977205|NCT03013543|75781499|FG000|Overall Study|Physician Decision|0|||
41977206|NCT03013543|75781500|FG001|Overall Study|Physician Decision|0|||
41977207|NCT03013543|75781501|FG002|Overall Study|Physician Decision|0|||
41977208|NCT03013543|75781502|FG003|Overall Study|Physician Decision|0|||
41977209|NCT03013543|75781503|FG004|Overall Study|Physician Decision|1|||
41977210|NCT03013543|75781504|FG005|Overall Study|Physician Decision|0|||
41977211|NCT03013543|75781505|FG006|Overall Study|Physician Decision|0|||
41977212|NCT03013543|75781506|FG007|Overall Study|Physician Decision|0|||
41977213|NCT03013543|75781507|FG008|Overall Study|Physician Decision|0|||
41977214|NCT03013543|75781508|FG009|Overall Study|Physician Decision|0|||
41977215|NCT03013543|75781499|FG000|Overall Study|Protocol Violation|0|||
41977216|NCT03013543|75781500|FG001|Overall Study|Protocol Violation|0|||
41977217|NCT03013543|75781501|FG002|Overall Study|Protocol Violation|0|||
41977218|NCT03013543|75781502|FG003|Overall Study|Protocol Violation|0|||
41977219|NCT03013543|75781503|FG004|Overall Study|Protocol Violation|0|||
41977220|NCT03013543|75781504|FG005|Overall Study|Protocol Violation|0|||
41977221|NCT03013543|75781505|FG006|Overall Study|Protocol Violation|0|||
41977222|NCT03013543|75781506|FG007|Overall Study|Protocol Violation|0|||
41977223|NCT03013543|75781507|FG008|Overall Study|Protocol Violation|0|||
41977224|NCT03013543|75781508|FG009|Overall Study|Protocol Violation|1|||
41977225|NCT02811549|75781534|FG000|Overall Study|Lost to Follow-up|1|||
41977226|NCT02811549|75781534|FG000|Overall Study|Withdrawal by Subject|3|||
41977227|NCT02811549|75781534|FG000|Overall Study|Subject screen failed|4|||
41977228|NCT02811549|75781534|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
41977229|NCT02426125|75781562|FG000|Overall Study|Lost to Follow-up|14|||
41977230|NCT02426125|75781563|FG001|Overall Study|Lost to Follow-up|12|||
41977231|NCT02426125|75781562|FG000|Overall Study|Withdrawal by Subject|13|||
41977232|NCT02426125|75781563|FG001|Overall Study|Withdrawal by Subject|14|||
41977233|NCT02426125|75781562|FG000|Overall Study|Death|185|||
41977234|NCT02426125|75781563|FG001|Overall Study|Death|200|||
41977235|NCT02426125|75781562|FG000|Overall Study|Randomized, But Never Treated|5|||
42028468|NCT01124292|75836910|FG002|Overall Study|Physician Decision|2|||
42028469|NCT01124292|75836908|FG000|Overall Study|Withdrawal by Subject|0|||
42028470|NCT01124292|75836909|FG001|Overall Study|Withdrawal by Subject|6|||
42128816|NCT05071313|75939587|FG000|Overall Study|Physician Decision|1|||
42028471|NCT01124292|75836910|FG002|Overall Study|Withdrawal by Subject|2|||
42028472|NCT01124292|75836908|FG000|Overall Study|medical issue unrelated to the study|0|||
42128817|NCT05071313|75939588|FG001|Overall Study|Physician Decision|6|||
42128818|NCT05071313|75939587|FG000|Overall Study|Death|1|||
42128819|NCT05071313|75939588|FG001|Overall Study|Death|0|||
42128820|NCT05071313|75939587|FG000|Overall Study|Withdrawal by Subject|10|||
42128821|NCT05071313|75939588|FG001|Overall Study|Withdrawal by Subject|15|||
42128822|NCT05071313|75939587|FG000|Overall Study|Other|1|||
42128823|NCT05071313|75939588|FG001|Overall Study|Other|0|||
41977236|NCT02426125|75781563|FG001|Overall Study|Randomized, But Never Treated|2|||
41977237|NCT02331277|75781591|FG000|Overall Study|Withdrawal by Subject|1|||
41977238|NCT02331277|75781592|FG001|Overall Study|Withdrawal by Subject|0|||
41977239|NCT02120365|75781610|FG000|Overall Study|Withdrawal by Subject|0|||
41977240|NCT02120365|75781611|FG001|Overall Study|Withdrawal by Subject|0|||
41977241|NCT02120365|75781612|FG002|Overall Study|Withdrawal by Subject|2|||
41977242|NCT02120365|75781613|FG003|Overall Study|Withdrawal by Subject|4|||
41977243|NCT02120365|75781614|FG004|Overall Study|Withdrawal by Subject|0|||
42128824|NCT05071313|75939587|FG000|Overall Study|Randomized but not vaccinated|4|||
42215702|NCT03149328|76032336|FG001|Overall Study|Changed Dialysis Modality|1|||
41977244|NCT02120365|75781615|FG005|Overall Study|Withdrawal by Subject|2|||
41977245|NCT01854775|75781656|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
41977246|NCT01854775|75781657|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
41977247|NCT01854775|75781658|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
41977248|NCT01854775|75781656|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
41977249|NCT01854775|75781657|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
41977250|NCT01854775|75781658|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
41977251|NCT01854775|75781656|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
41977252|NCT01854775|75781657|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
42128825|NCT05071313|75939588|FG001|Overall Study|Randomized but not vaccinated|2|||
42128826|NCT05019729|75939616|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
42128827|NCT05019729|75939617|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
42128828|NCT05019729|75939618|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
42128829|NCT05019729|75939619|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
42128830|NCT05019729|75939620|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
42128831|NCT05019729|75939621|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
42128832|NCT04544475|75939669|FG000|Overall Study|Withdrawal by Subject|1|||
42128833|NCT04544475|75939670|FG001|Overall Study|Withdrawal by Subject|3|||
41977253|NCT01854775|75781658|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
41977254|NCT01854775|75781656|FG000|Extension Phase|Pregnancy|3|||
41977255|NCT01854775|75781657|FG001|Extension Phase|Pregnancy|0|||
41977256|NCT01854775|75781658|FG002|Extension Phase|Pregnancy|0|||
41977257|NCT01854775|75781656|FG000|Extension Phase|Investigator's Discretion|1|||
41977258|NCT01854775|75781657|FG001|Extension Phase|Investigator's Discretion|0|||
41977259|NCT01854775|75781658|FG002|Extension Phase|Investigator's Discretion|0|||
41977260|NCT01854775|75781656|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
42128834|NCT04045613|75939701|FG000|Overall Study|Adverse Event|2|||
42128835|NCT04045613|75939702|FG001|Overall Study|Adverse Event|2|||
42128836|NCT04045613|75939703|FG002|Overall Study|Adverse Event|1|||
42128837|NCT04045613|75939704|FG003|Overall Study|Adverse Event|1|||
42128838|NCT04045613|75939705|FG004|Overall Study|Adverse Event|0|||
42128839|NCT04045613|75939706|FG005|Overall Study|Adverse Event|0|||
42128840|NCT04045613|75939707|FG006|Overall Study|Adverse Event|1|||
42128841|NCT04045613|75939701|FG000|Overall Study|Withdrawal by Subject|0|||
42215703|NCT03149328|76032335|FG000|Overall Study|Transplant|9|||
41977261|NCT01854775|75781657|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
41977262|NCT01854775|75781658|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
42128842|NCT04045613|75939702|FG001|Overall Study|Withdrawal by Subject|5|||
42215704|NCT03149328|76032336|FG001|Overall Study|Transplant|1|||
42215705|NCT03149328|76032335|FG000|Overall Study|Lost to Follow-up|25|||
42215706|NCT03149328|76032336|FG001|Overall Study|Lost to Follow-up|16|||
42215707|NCT03149328|76032335|FG000|Overall Study|Left Study Site|1|||
42215708|NCT03149328|76032336|FG001|Overall Study|Left Study Site|2|||
42215709|NCT03149328|76032335|FG000|Overall Study|Language Barrier|1|||
42215710|NCT03149328|76032336|FG001|Overall Study|Language Barrier|0|||
42215711|NCT04296942|76032385|FG000|Overall Study|Study closure by sponsor|1|||
42215712|NCT04296942|76032386|FG001|Overall Study|Study closure by sponsor|0|||
42215713|NCT04296942|76032387|FG002|Overall Study|Study closure by sponsor|0|||
42215714|NCT01315028|76032443|FG000|Overall Study|Lost to Follow-up|1|||
42215715|NCT01315028|76032444|FG001|Overall Study|Lost to Follow-up|0|||
42215716|NCT01315028|76032443|FG000|Overall Study|Death|0|||
42215717|NCT01315028|76032444|FG001|Overall Study|Death|1|||
42215718|NCT02720536|76032450|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
42215719|NCT02720536|76032450|FG000|Overall Study|PR - pregnancy|2|||
42215720|NCT02720536|76032450|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
42215721|NCT02720536|76032450|FG000|Overall Study|PR - death|1|||
42215722|NCT02720536|76032450|FG000|Overall Study|PR - adverse event|1|||
42215723|NCT02720536|76032450|FG000|Overall Study|PR - abnormal lab value(s)|1|||
42215724|NCT02720536|76032450|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
42215725|NCT03168438|76032462|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
42215726|NCT03168438|76032463|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
42215727|NCT03137784|76032470|FG000|Overall Study|Adverse Event|1|||
42215728|NCT03137784|76032471|FG001|Overall Study|Adverse Event|1|||
41977263|NCT01854775|75781656|FG000|Extension Phase|Lost to Follow-up|2|||
41977264|NCT01854775|75781657|FG001|Extension Phase|Lost to Follow-up|0|||
41977265|NCT01854775|75781658|FG002|Extension Phase|Lost to Follow-up|0|||
41977266|NCT01854775|75781656|FG000|Extension Phase|Still on Study|32|||
41977267|NCT01854775|75781657|FG001|Extension Phase|Still on Study|47|||
41977268|NCT01854775|75781658|FG002|Extension Phase|Still on Study|18|||
41977269|NCT00938340|75781711|FG000|Overall Study|Withdrawal by Subject|3|||
42215729|NCT03137784|76032472|FG002|Overall Study|Adverse Event|0|||
42215730|NCT03137784|76032473|FG003|Overall Study|Adverse Event|0|||
42215731|NCT03137784|76032474|FG004|Overall Study|Adverse Event|0|||
42215732|NCT03137784|76032475|FG005|Overall Study|Adverse Event|0|||
42215733|NCT03137784|76032470|FG000|Overall Study|Subject/guardian decision|1|||
42215734|NCT03137784|76032471|FG001|Overall Study|Subject/guardian decision|0|||
41977270|NCT00938340|75781711|FG000|Overall Study|Protocol Violation|1|||
41977271|NCT00938340|75781711|FG000|Overall Study|Adverse Event|1|||
41977272|NCT00539643|75781768|FG000|Overall Study|Adverse Event|1|||
42215735|NCT03137784|76032472|FG002|Overall Study|Subject/guardian decision|0|||
41977273|NCT00539643|75781769|FG001|Overall Study|Adverse Event|0|||
41977274|NCT00539643|75781768|FG000|Overall Study|Death|2|||
41977275|NCT00539643|75781769|FG001|Overall Study|Death|1|||
41977276|NCT00539643|75781768|FG000|Overall Study|Physician Decision|3|||
41977277|NCT00539643|75781769|FG001|Overall Study|Physician Decision|1|||
41977278|NCT00539643|75781768|FG000|Overall Study|Withdrawal by Subject|0|||
41977279|NCT00539643|75781769|FG001|Overall Study|Withdrawal by Subject|1|||
41977280|NCT00039130|75781784|FG000|Overall Study|Adverse Event|11|||
41977281|NCT00039130|75781784|FG000|Overall Study|Death|9|||
41977282|NCT00039130|75781784|FG000|Overall Study|Withdrawal by Subject|3|||
42128843|NCT04045613|75939703|FG002|Overall Study|Withdrawal by Subject|0|||
42128844|NCT04045613|75939704|FG003|Overall Study|Withdrawal by Subject|0|||
42128845|NCT04045613|75939705|FG004|Overall Study|Withdrawal by Subject|0|||
42128846|NCT04045613|75939706|FG005|Overall Study|Withdrawal by Subject|1|||
42128847|NCT04045613|75939707|FG006|Overall Study|Withdrawal by Subject|0|||
42128848|NCT04045613|75939701|FG000|Overall Study|Physician Decision|2|||
42128849|NCT04045613|75939702|FG001|Overall Study|Physician Decision|0|||
42128850|NCT04045613|75939703|FG002|Overall Study|Physician Decision|0|||
42128851|NCT04045613|75939704|FG003|Overall Study|Physician Decision|0|||
42128852|NCT04045613|75939705|FG004|Overall Study|Physician Decision|1|||
42128853|NCT04045613|75939706|FG005|Overall Study|Physician Decision|0|||
42128854|NCT04045613|75939707|FG006|Overall Study|Physician Decision|0|||
42128855|NCT04045613|75939701|FG000|Overall Study|Death|3|||
42128856|NCT04045613|75939702|FG001|Overall Study|Death|0|||
42128857|NCT04045613|75939703|FG002|Overall Study|Death|0|||
42215736|NCT03137784|76032473|FG003|Overall Study|Subject/guardian decision|0|||
42215737|NCT03137784|76032474|FG004|Overall Study|Subject/guardian decision|0|||
42215738|NCT03137784|76032475|FG005|Overall Study|Subject/guardian decision|0|||
42215739|NCT03137784|76032470|FG000|Overall Study|Non-compliance with study treatment|0|||
42215740|NCT03137784|76032471|FG001|Overall Study|Non-compliance with study treatment|0|||
42215741|NCT03137784|76032472|FG002|Overall Study|Non-compliance with study treatment|0|||
41977283|NCT00039130|75781784|FG000|Overall Study|Progression|2|||
41977284|NCT00039130|75781784|FG000|Overall Study|Subsequent treatment|2|||
41977285|NCT00039130|75781784|FG000|Overall Study|Physician Decision|3|||
42128858|NCT04045613|75939704|FG003|Overall Study|Death|0|||
42128859|NCT04045613|75939705|FG004|Overall Study|Death|0|||
42128860|NCT04045613|75939706|FG005|Overall Study|Death|0|||
41977286|NCT00005957|75781790|FG000|Overall Study|No treated|3|||
42215742|NCT03137784|76032473|FG003|Overall Study|Non-compliance with study treatment|0|||
41977287|NCT00005957|75781791|FG001|Overall Study|No treated|9|||
41977288|NCT00005957|75781790|FG000|Overall Study|Crossover to the other arm|5|||
41977289|NCT00005957|75781791|FG001|Overall Study|Crossover to the other arm|19|||
41977290|NCT04920916|75781877|FG000|Phase IIa 60 Day Study|Death|2|||
41977291|NCT04920916|75781878|FG001|Phase IIa 60 Day Study|Death|5|||
41977292|NCT04920916|75781877|FG000|1 Year Follow up (Phone Call)|Death|1|||
41977293|NCT04920916|75781878|FG001|1 Year Follow up (Phone Call)|Death|3|||
41977294|NCT04920916|75781877|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
41977295|NCT04920916|75781878|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
41977296|NCT04419493|75781891|FG000|Wash-out After Period 1|Adverse Event|1|||
41977297|NCT04419493|75781892|FG001|Wash-out After Period 1|Adverse Event|2|||
41977298|NCT04419493|75781893|FG002|Wash-out After Period 1|Adverse Event|1|||
41977299|NCT04419493|75781894|FG003|Wash-out After Period 1|Adverse Event|0|||
41977300|NCT04147611|75781922|FG000|Overall Study|Physician Decision|0|||
41977301|NCT04147611|75781923|FG001|Overall Study|Physician Decision|1|||
41977302|NCT03603964|75781954|FG000|Overall Study|Death|9|||
41977303|NCT03603964|75781954|FG000|Overall Study|Withdrawal by participant|7|||
41977304|NCT03603964|75781954|FG000|Overall Study|Study terminated by Sponsor|19|||
41977305|NCT03191864|75781974|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
42215743|NCT03137784|76032474|FG004|Overall Study|Non-compliance with study treatment|1|||
42215744|NCT03137784|76032475|FG005|Overall Study|Non-compliance with study treatment|0|||
42215745|NCT01314716|76032485|FG000|Double-Blind Phase|Randomized but not treated|1|||
42215746|NCT01314716|76032486|FG001|Double-Blind Phase|Randomized but not treated|1|||
42215747|NCT01314716|76032485|FG000|Double-Blind Phase|Adverse Event|10|||
42215748|NCT01314716|76032486|FG001|Double-Blind Phase|Adverse Event|4|||
42215749|NCT01314716|76032485|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
42215750|NCT01314716|76032486|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
42215751|NCT01314716|76032485|FG000|Double-Blind Phase|Lost to Follow-up|0|||
42215752|NCT01314716|76032486|FG001|Double-Blind Phase|Lost to Follow-up|1|||
42215753|NCT01314716|76032485|FG000|Double-Blind Phase|Sponsor request|1|||
42215754|NCT01314716|76032486|FG001|Double-Blind Phase|Sponsor request|2|||
42215755|NCT01314716|76032485|FG000|Double-Blind Phase|Physician Decision|0|||
42215756|NCT01314716|76032486|FG001|Double-Blind Phase|Physician Decision|1|||
42215757|NCT01314716|76032485|FG000|Open-Label Phase|Adverse Event|4|||
42215758|NCT01314716|76032486|FG001|Open-Label Phase|Adverse Event|6|||
42215759|NCT01314716|76032485|FG000|Open-Label Phase|Withdrawal by Subject|1|||
42215760|NCT01314716|76032486|FG001|Open-Label Phase|Withdrawal by Subject|2|||
42215761|NCT01314716|76032485|FG000|Open-Label Phase|Physician Decision|5|||
42215762|NCT01314716|76032486|FG001|Open-Label Phase|Physician Decision|4|||
42215763|NCT03144180|76032496|FG000|Overall Study|STAT Delivery|1|||
42215764|NCT03144180|76032497|FG001|Overall Study|STAT Delivery|1|||
42215765|NCT03144180|76032496|FG000|Overall Study|Provider forgot to fill out forms|1|||
42301958|NCT02284893|76137130|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
42301959|NCT02284893|76137129|FG000|52 Week (Long Term)|Non-Compliance|2|||
42215766|NCT03144180|76032497|FG001|Overall Study|Provider forgot to fill out forms|3|||
42301960|NCT02284893|76137130|FG001|52 Week (Long Term)|Non-Compliance|3|||
42301961|NCT02284347|76137136|FG000|Overall Study|Lost to Follow-up|2|||
42301962|NCT02284347|76137136|FG000|Overall Study|Withdrawn prior to treatment|1|||
42301963|NCT02279043|76137143|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
42301964|NCT02279043|76137144|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
42301965|NCT02279043|76137145|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
42301966|NCT02279043|76137143|FG000|Overall Study|Lost to Follow-up|46|||
41977306|NCT03191864|75781975|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
41977307|NCT03191864|75781976|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
41977308|NCT03191864|75781977|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
42215767|NCT03144180|76032496|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
41977309|NCT03191864|75781978|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
41977310|NCT03191864|75781979|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
41977311|NCT03191864|75781974|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
41977312|NCT03191864|75781975|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
41977313|NCT03191864|75781976|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
41977314|NCT03191864|75781977|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
41977315|NCT03191864|75781978|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
41977316|NCT03191864|75781979|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
41977317|NCT03191864|75781974|FG000|Baseline Symptom Assessment|Adverse Event|0|||
41977318|NCT03191864|75781975|FG001|Baseline Symptom Assessment|Adverse Event|0|||
41977319|NCT03191864|75781976|FG002|Baseline Symptom Assessment|Adverse Event|0|||
41977320|NCT03191864|75781977|FG003|Baseline Symptom Assessment|Adverse Event|0|||
41977321|NCT03191864|75781978|FG004|Baseline Symptom Assessment|Adverse Event|0|||
41977322|NCT03191864|75781979|FG005|Baseline Symptom Assessment|Adverse Event|2|||
41977323|NCT03191864|75781974|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
41977324|NCT03191864|75781975|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
41977325|NCT03191864|75781976|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
41977326|NCT03191864|75781977|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
41977327|NCT03191864|75781978|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
41977328|NCT03191864|75781979|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
41977329|NCT03191864|75781974|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
41977330|NCT03191864|75781975|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
41977331|NCT03191864|75781976|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
41977332|NCT03191864|75781977|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
41977333|NCT03191864|75781978|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
41977334|NCT03191864|75781979|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
41977335|NCT03191864|75781974|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
41977336|NCT03191864|75781975|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
41977337|NCT03191864|75781976|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
41977338|NCT03191864|75781977|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
41977339|NCT03191864|75781978|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
41977340|NCT03191864|75781979|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
41977341|NCT03191864|75781974|FG000|Part 1 - Induction|Adverse Event|0|||
41977342|NCT03191864|75781975|FG001|Part 1 - Induction|Adverse Event|2|||
41977343|NCT03191864|75781976|FG002|Part 1 - Induction|Adverse Event|0|||
41977344|NCT03191864|75781977|FG003|Part 1 - Induction|Adverse Event|1|||
41977345|NCT03191864|75781978|FG004|Part 1 - Induction|Adverse Event|0|||
41977346|NCT03191864|75781979|FG005|Part 1 - Induction|Adverse Event|2|||
41977347|NCT03191864|75781974|FG000|Part 1 - Induction|Randomized but never dosed|0|||
41977348|NCT03191864|75781975|FG001|Part 1 - Induction|Randomized but never dosed|0|||
41977349|NCT03191864|75781976|FG002|Part 1 - Induction|Randomized but never dosed|1|||
41977350|NCT03191864|75781977|FG003|Part 1 - Induction|Randomized but never dosed|0|||
41977351|NCT03191864|75781978|FG004|Part 1 - Induction|Randomized but never dosed|0|||
41977352|NCT03191864|75781979|FG005|Part 1 - Induction|Randomized but never dosed|0|||
41977353|NCT03191864|75781974|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
41977354|NCT03191864|75781975|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
41977355|NCT03191864|75781976|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
41977356|NCT03191864|75781977|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
41977357|NCT03191864|75781978|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
41977358|NCT03191864|75781979|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
41977359|NCT03191864|75781974|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
41977360|NCT03191864|75781975|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
41977361|NCT03191864|75781976|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
41977362|NCT03191864|75781977|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
41977363|NCT03191864|75781978|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
41977364|NCT03191864|75781979|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
41977365|NCT03191864|75781974|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
41977366|NCT03191864|75781975|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
41977367|NCT03191864|75781976|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
41977368|NCT03191864|75781977|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
41977369|NCT03191864|75781978|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
41977370|NCT03191864|75781979|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
41977371|NCT03191864|75781974|FG000|Part 2 - Maintenance|Physician Decision|1|||
41977372|NCT03191864|75781975|FG001|Part 2 - Maintenance|Physician Decision|0|||
41977373|NCT03191864|75781976|FG002|Part 2 - Maintenance|Physician Decision|0|||
41977374|NCT03191864|75781977|FG003|Part 2 - Maintenance|Physician Decision|0|||
41977375|NCT03191864|75781978|FG004|Part 2 - Maintenance|Physician Decision|0|||
42128861|NCT04045613|75939707|FG006|Overall Study|Death|1|||
41977376|NCT03191864|75781979|FG005|Part 2 - Maintenance|Physician Decision|0|||
41977377|NCT03191864|75781974|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
41977378|NCT03191864|75781975|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
41977379|NCT03191864|75781976|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
42215768|NCT03144180|76032497|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
42215769|NCT03144180|76032496|FG000|Overall Study|Scrub tech removed tube cap|0|||
42215770|NCT03144180|76032497|FG001|Overall Study|Scrub tech removed tube cap|1|||
42215771|NCT01465334|76032507|FG000|Overall Study|Disease Progression|1|||
42215772|NCT01465334|76032508|FG001|Overall Study|Disease Progression|0|||
42215773|NCT01465334|76032507|FG000|Overall Study|Adverse Event|1|||
42215774|NCT01465334|76032508|FG001|Overall Study|Adverse Event|0|||
42215775|NCT01465334|76032507|FG000|Overall Study|Richter's transformation|0|||
42215776|NCT01465334|76032508|FG001|Overall Study|Richter's transformation|3|||
42215777|NCT01465334|76032507|FG000|Overall Study|Refractory Disease|0|||
42215778|NCT01465334|76032508|FG001|Overall Study|Refractory Disease|3|||
42215779|NCT00702208|76032514|FG000|Overall Study|Lost to Follow-up|28|||
42215780|NCT00702208|76032514|FG000|Overall Study|Did not self-lavage|1|||
42215781|NCT00702208|76032514|FG000|Overall Study|Unsatisfactory colposcopy|2|||
42215782|NCT02718898|76032531|FG000|Blinded Treatment Period|Adverse Event|5|||
42215783|NCT02718898|76032532|FG001|Blinded Treatment Period|Adverse Event|1|||
42215784|NCT02718898|76032533|FG002|Blinded Treatment Period|Adverse Event|0|||
41977380|NCT03191864|75781977|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
42215785|NCT02718898|76032534|FG003|Blinded Treatment Period|Adverse Event|0|||
42215786|NCT02718898|76032535|FG004|Blinded Treatment Period|Adverse Event|0|||
41977381|NCT03191864|75781978|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
41977382|NCT03191864|75781979|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
41977383|NCT03191864|75781974|FG000|Part 2 - Maintenance|Adverse Event|0|||
41977384|NCT03191864|75781975|FG001|Part 2 - Maintenance|Adverse Event|0|||
41977385|NCT03191864|75781976|FG002|Part 2 - Maintenance|Adverse Event|0|||
41977386|NCT03191864|75781977|FG003|Part 2 - Maintenance|Adverse Event|0|||
41977387|NCT03191864|75781978|FG004|Part 2 - Maintenance|Adverse Event|1|||
41977388|NCT03191864|75781979|FG005|Part 2 - Maintenance|Adverse Event|0|||
41977389|NCT03191864|75781974|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
41977390|NCT03191864|75781975|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
41977391|NCT03191864|75781976|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
41977392|NCT03191864|75781977|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
41977393|NCT03191864|75781978|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
42128862|NCT04045613|75939701|FG000|Overall Study|Other reasons|0|||
42128863|NCT04045613|75939702|FG001|Overall Study|Other reasons|1|||
42128864|NCT04045613|75939703|FG002|Overall Study|Other reasons|0|||
42128865|NCT04045613|75939704|FG003|Overall Study|Other reasons|0|||
42128866|NCT04045613|75939705|FG004|Overall Study|Other reasons|0|||
42128867|NCT04045613|75939706|FG005|Overall Study|Other reasons|0|||
42128868|NCT04045613|75939707|FG006|Overall Study|Other reasons|1|||
42128869|NCT04045613|75939701|FG000|Overall Study|Progressive disease: Clinical progression|1|||
42128870|NCT04045613|75939702|FG001|Overall Study|Progressive disease: Clinical progression|0|||
42128871|NCT04045613|75939703|FG002|Overall Study|Progressive disease: Clinical progression|3|||
42128872|NCT04045613|75939704|FG003|Overall Study|Progressive disease: Clinical progression|1|||
42128873|NCT04045613|75939705|FG004|Overall Study|Progressive disease: Clinical progression|1|||
42128874|NCT04045613|75939706|FG005|Overall Study|Progressive disease: Clinical progression|3|||
42128875|NCT04045613|75939707|FG006|Overall Study|Progressive disease: Clinical progression|3|||
42128876|NCT04045613|75939701|FG000|Overall Study|Progressive disease: Radiological progression|24|||
42128877|NCT04045613|75939702|FG001|Overall Study|Progressive disease: Radiological progression|6|||
41977394|NCT03191864|75781979|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
42128878|NCT04045613|75939703|FG002|Overall Study|Progressive disease: Radiological progression|8|||
42128879|NCT04045613|75939704|FG003|Overall Study|Progressive disease: Radiological progression|0|||
42215787|NCT02718898|76032536|FG005|Blinded Treatment Period|Adverse Event|0|||
42215788|NCT02718898|76032537|FG006|Blinded Treatment Period|Adverse Event|0|||
42215789|NCT02718898|76032531|FG000|Blinded Treatment Period|Physician Decision|1|||
41977395|NCT03191864|75781974|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
41977396|NCT03191864|75781975|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
42128880|NCT04045613|75939705|FG004|Overall Study|Progressive disease: Radiological progression|6|||
42215790|NCT02718898|76032532|FG001|Blinded Treatment Period|Physician Decision|0|||
42128881|NCT04045613|75939706|FG005|Overall Study|Progressive disease: Radiological progression|6|||
41977397|NCT03191864|75781976|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
41977398|NCT03191864|75781977|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
41977399|NCT03191864|75781978|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
41977400|NCT03191864|75781979|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
41977401|NCT02636725|75782043|FG000|Baseline|Adverse Event|1|||
41977402|NCT02636725|75782043|FG000|Baseline|Lack of Efficacy|2|||
41977403|NCT02573493|75782051|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
42028473|NCT01124292|75836909|FG001|Overall Study|medical issue unrelated to the study|0|||
42028474|NCT01124292|75836910|FG002|Overall Study|medical issue unrelated to the study|2|||
42028475|NCT01124292|75836908|FG000|Overall Study|piercing track closed|0|||
42028476|NCT01124292|75836909|FG001|Overall Study|piercing track closed|2|||
42215791|NCT02718898|76032533|FG002|Blinded Treatment Period|Physician Decision|0|||
42215792|NCT02718898|76032534|FG003|Blinded Treatment Period|Physician Decision|0|||
42215793|NCT02718898|76032535|FG004|Blinded Treatment Period|Physician Decision|0|||
42215794|NCT02718898|76032536|FG005|Blinded Treatment Period|Physician Decision|0|||
42215795|NCT02718898|76032537|FG006|Blinded Treatment Period|Physician Decision|0|||
42028477|NCT01124292|75836910|FG002|Overall Study|piercing track closed|1|||
42215796|NCT02718898|76032531|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
42215797|NCT02718898|76032532|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
42215798|NCT02718898|76032533|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
42215799|NCT02718898|76032534|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
42215800|NCT02718898|76032535|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
42215801|NCT02718898|76032536|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
42215802|NCT02718898|76032537|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
42215803|NCT02718898|76032531|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
42215804|NCT02718898|76032532|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
42215805|NCT02718898|76032533|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
42215806|NCT02718898|76032534|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
42215807|NCT02718898|76032535|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
42215808|NCT02718898|76032536|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
42215809|NCT02718898|76032537|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
42215810|NCT02718898|76032531|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
42215811|NCT02718898|76032532|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
42215812|NCT02718898|76032533|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
42215813|NCT02718898|76032534|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
42215814|NCT02718898|76032535|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
42215815|NCT02718898|76032536|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
42215816|NCT02718898|76032537|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
42215817|NCT02718898|76032531|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
42215818|NCT02718898|76032532|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
42215819|NCT02718898|76032533|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
42215820|NCT02718898|76032534|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
42215821|NCT02718898|76032535|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
42215822|NCT02718898|76032536|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
42215823|NCT02718898|76032537|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
42215824|NCT02718898|76032531|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
42215825|NCT02718898|76032532|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
42215826|NCT02718898|76032533|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
42215827|NCT02718898|76032534|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
42215828|NCT02718898|76032535|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
42215829|NCT02718898|76032536|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
42215830|NCT02718898|76032537|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
42215831|NCT02718898|76032531|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
42215832|NCT02718898|76032532|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
42215833|NCT02718898|76032533|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
42301967|NCT02279043|76137144|FG001|Overall Study|Lost to Follow-up|88|||
42301968|NCT02279043|76137145|FG002|Overall Study|Lost to Follow-up|0|||
42301969|NCT02283411|76137151|FG000|Overall Study|Withdrawal by Subject|3|||
42301970|NCT02283411|76137151|FG000|Overall Study|Screen Failed|28|||
42301971|NCT02351817|76137155|FG000|Period 1|Adverse Event|1|||
42301972|NCT02351817|76137156|FG001|Period 1|Adverse Event|2|||
42301973|NCT02351817|76137155|FG000|Period 1|Lack of Efficacy|0|||
42301974|NCT02351817|76137156|FG001|Period 1|Lack of Efficacy|1|||
41977404|NCT02573493|75782052|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
41977405|NCT02573493|75782053|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
41977406|NCT02573493|75782054|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
41977407|NCT02327078|75782087|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
42215834|NCT02718898|76032534|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
42215835|NCT02718898|76032535|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
42215836|NCT02718898|76032536|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
42215837|NCT02718898|76032537|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
42215838|NCT02718898|76032531|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
42215839|NCT02718898|76032532|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
42215840|NCT02718898|76032533|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
41977408|NCT02327078|75782088|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
41977409|NCT02327078|75782089|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
42028478|NCT01136772|75836923|FG000|Overall Study|Adverse Event|15|||
42215841|NCT02718898|76032534|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
42215842|NCT02718898|76032535|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
42215843|NCT02718898|76032536|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
42215844|NCT02718898|76032537|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
42215845|NCT02718898|76032531|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
42215846|NCT02718898|76032532|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
42215847|NCT02718898|76032533|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
42215848|NCT02718898|76032534|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
42215849|NCT02718898|76032535|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
42215850|NCT02718898|76032536|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
42215851|NCT02718898|76032537|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
42215852|NCT02718898|76032531|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
42215853|NCT02718898|76032532|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
42215854|NCT02718898|76032533|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
42215855|NCT02718898|76032534|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
42215856|NCT02718898|76032535|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
42301975|NCT02351817|76137155|FG000|Period 2|Adverse Event|0|||
42301976|NCT02351817|76137156|FG001|Period 2|Adverse Event|2|||
42301977|NCT02351817|76137155|FG000|Period 2|Protocol Violation|1|||
42301978|NCT02351817|76137156|FG001|Period 2|Protocol Violation|0|||
42301979|NCT02351349|76137165|FG000|Overall Study|Withdrawal by Subject|2|||
42301980|NCT02351349|76137166|FG001|Overall Study|Withdrawal by Subject|3|||
42301981|NCT02484547|76137180|FG000|Placebo-Controlled Period|Adverse Event|10|||
42301982|NCT02484547|76137181|FG001|Placebo-Controlled Period|Adverse Event|13|||
42301983|NCT02484547|76137182|FG002|Placebo-Controlled Period|Adverse Event|20|||
42301984|NCT02484547|76137183|FG003|Placebo-Controlled Period|Adverse Event|0|||
42301985|NCT02484547|76137184|FG004|Placebo-Controlled Period|Adverse Event|0|||
42301986|NCT02484547|76137185|FG005|Placebo-Controlled Period|Adverse Event|0|||
42301987|NCT02484547|76137186|FG006|Placebo-Controlled Period|Adverse Event|0|||
42301988|NCT02484547|76137180|FG000|Placebo-Controlled Period|Change of Treatment|0|||
42215857|NCT02718898|76032536|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
42215858|NCT02718898|76032537|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
42215859|NCT02718898|76032531|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
42215860|NCT02718898|76032532|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
42215861|NCT02718898|76032533|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
42215862|NCT02718898|76032534|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
42215863|NCT02718898|76032535|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
42215864|NCT02718898|76032536|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
42215865|NCT02718898|76032537|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
42215866|NCT02718898|76032531|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
42215867|NCT02718898|76032532|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
42215868|NCT02718898|76032533|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
42215869|NCT02718898|76032534|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
42215870|NCT02718898|76032535|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
42215871|NCT02718898|76032536|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
42215872|NCT02718898|76032537|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
42215873|NCT03143166|76032554|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
42215874|NCT02879994|76032560|FG000|Overall Study|off treatment early|7|||
42215875|NCT02879994|76032560|FG000|Overall Study|Adverse Event|2|||
42215876|NCT02879994|76032560|FG000|Overall Study|Death|2|||
42215877|NCT03142932|76032566|FG000|Overall Study|Lost to Follow-up|2|||
42215878|NCT03142932|76032567|FG001|Overall Study|Lost to Follow-up|11|||
42215879|NCT00702052|76032573|FG000|Overall Study|Adverse Event|23|||
41977410|NCT02327078|75782090|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
41977411|NCT02327078|75782091|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
41977412|NCT02327078|75782092|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
42215880|NCT00702052|76032573|FG000|Overall Study|Disease Progression|30|||
42215881|NCT00702052|76032573|FG000|Overall Study|Withdrawal by Subject|5|||
42215882|NCT03140280|76032577|FG000|Overall Study|Physician Decision|5|||
42215883|NCT03136380|76032583|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
42215884|NCT03136380|76032584|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
42215885|NCT03136380|76032585|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
41977413|NCT02327078|75782093|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
41977414|NCT02327078|75782094|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
41977415|NCT02327078|75782095|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
41977416|NCT02327078|75782087|FG000|Overall Study|Death|2|||
41977417|NCT02327078|75782088|FG001|Overall Study|Death|4|||
41977418|NCT02327078|75782089|FG002|Overall Study|Death|10|||
41977419|NCT02327078|75782090|FG003|Overall Study|Death|6|||
41977420|NCT02327078|75782091|FG004|Overall Study|Death|4|||
41977421|NCT02327078|75782092|FG005|Overall Study|Death|3|||
41977422|NCT02327078|75782093|FG006|Overall Study|Death|2|||
41977423|NCT02327078|75782094|FG007|Overall Study|Death|51|||
41977424|NCT02327078|75782095|FG008|Overall Study|Death|97|||
41977425|NCT02327078|75782087|FG000|Overall Study|Lost to Follow-up|0|||
41977426|NCT02327078|75782088|FG001|Overall Study|Lost to Follow-up|1|||
41977427|NCT02327078|75782089|FG002|Overall Study|Lost to Follow-up|1|||
41977428|NCT02327078|75782090|FG003|Overall Study|Lost to Follow-up|0|||
41977429|NCT02327078|75782091|FG004|Overall Study|Lost to Follow-up|0|||
41977430|NCT02327078|75782092|FG005|Overall Study|Lost to Follow-up|0|||
41977431|NCT02327078|75782093|FG006|Overall Study|Lost to Follow-up|0|||
41977432|NCT02327078|75782094|FG007|Overall Study|Lost to Follow-up|2|||
42028479|NCT01136772|75836924|FG001|Overall Study|Adverse Event|14|||
42028480|NCT01136772|75836923|FG000|Overall Study|Lack of Efficacy|42|||
42215886|NCT03136380|76032586|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
42215887|NCT03136380|76032587|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
42215888|NCT03136068|76032607|FG000|Overall Study|Lost to Follow-up|1|||
42215889|NCT03136068|76032608|FG001|Overall Study|Lost to Follow-up|1|||
42215890|NCT03136068|76032607|FG000|Overall Study|Protocol Violation|1|||
42215891|NCT03136068|76032608|FG001|Overall Study|Protocol Violation|0|||
42215892|NCT02585232|76032616|FG000|Overall Study|Lost to Follow-up|8|||
42215893|NCT02585232|76032617|FG001|Overall Study|Lost to Follow-up|8|||
41977433|NCT02327078|75782095|FG008|Overall Study|Lost to Follow-up|5|||
41977434|NCT02327078|75782087|FG000|Overall Study|Site Terminated by Sponsor|1|||
41977435|NCT02327078|75782088|FG001|Overall Study|Site Terminated by Sponsor|0|||
41977436|NCT02327078|75782089|FG002|Overall Study|Site Terminated by Sponsor|1|||
41977437|NCT02327078|75782090|FG003|Overall Study|Site Terminated by Sponsor|4|||
41977438|NCT02327078|75782091|FG004|Overall Study|Site Terminated by Sponsor|0|||
41977439|NCT02327078|75782092|FG005|Overall Study|Site Terminated by Sponsor|0|||
41977440|NCT02327078|75782093|FG006|Overall Study|Site Terminated by Sponsor|0|||
41977441|NCT02327078|75782094|FG007|Overall Study|Site Terminated by Sponsor|11|||
41977442|NCT02327078|75782095|FG008|Overall Study|Site Terminated by Sponsor|25|||
41977443|NCT02327078|75782087|FG000|Overall Study|Physician Decision|0|||
41977444|NCT02327078|75782088|FG001|Overall Study|Physician Decision|0|||
41977445|NCT02327078|75782089|FG002|Overall Study|Physician Decision|0|||
42128882|NCT04045613|75939707|FG006|Overall Study|Progressive disease: Radiological progression|11|||
42215894|NCT02585232|76032616|FG000|Overall Study|Withdrawal by Subject|4|||
42128883|NCT03964207|75939737|FG000|First Treatment|Withdrawal by Subject|1|||
42128884|NCT03964207|75939738|FG001|First Treatment|Withdrawal by Subject|2|||
42215895|NCT02585232|76032617|FG001|Overall Study|Withdrawal by Subject|8|||
42215896|NCT03377790|76032646|FG000|Overall Study|Withdrawal by Subject|1|||
42215897|NCT03377790|76032647|FG001|Overall Study|Withdrawal by Subject|0|||
42215898|NCT03377790|76032646|FG000|Overall Study|Adverse Event|1|||
42215899|NCT03377790|76032647|FG001|Overall Study|Adverse Event|0|||
42215900|NCT03377790|76032646|FG000|Overall Study|Lost to Follow-up|0|||
42215901|NCT03377790|76032647|FG001|Overall Study|Lost to Follow-up|2|||
42215902|NCT03377790|76032646|FG000|Overall Study|Randomized but not treated|1|||
42215903|NCT03377790|76032647|FG001|Overall Study|Randomized but not treated|0|||
42215904|NCT03377790|76032646|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
42215905|NCT03377790|76032647|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
42215906|NCT02717494|76032656|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
42215907|NCT02717494|76032657|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
42215908|NCT02717494|76032658|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
42215909|NCT02717494|76032656|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
42215910|NCT02717494|76032657|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
42215911|NCT02717494|76032658|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
42215912|NCT02717494|76032656|FG000|First Intervention (Step 1)|Death|0|||
42215913|NCT02717494|76032657|FG001|First Intervention (Step 1)|Death|0|||
42215914|NCT02717494|76032658|FG002|First Intervention (Step 1)|Death|1|||
42215915|NCT02717494|76032656|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
42215916|NCT02717494|76032657|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
41977446|NCT02327078|75782090|FG003|Overall Study|Physician Decision|1|||
41977447|NCT02327078|75782091|FG004|Overall Study|Physician Decision|0|||
42128885|NCT03964207|75939737|FG000|First Treatment|Protocol Violation|1|||
42128886|NCT03964207|75939738|FG001|First Treatment|Protocol Violation|0|||
42128887|NCT03964207|75939737|FG000|First Treatment|Lost to Follow-up|1|||
42128888|NCT03964207|75939738|FG001|First Treatment|Lost to Follow-up|0|||
42215917|NCT02717494|76032658|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
42215918|NCT01844856|76032686|FG000|Overall Study|Lost to Follow-up|15|||
41977448|NCT02327078|75782092|FG005|Overall Study|Physician Decision|0|||
41977449|NCT02327078|75782093|FG006|Overall Study|Physician Decision|0|||
42215919|NCT01844856|76032687|FG001|Overall Study|Lost to Follow-up|3|||
41977450|NCT02327078|75782094|FG007|Overall Study|Physician Decision|0|||
41977451|NCT02327078|75782095|FG008|Overall Study|Physician Decision|1|||
42128889|NCT03964207|75939737|FG000|Second Treatment|Lost to Follow-up|0|||
42215920|NCT01844856|76032686|FG000|Overall Study|Adverse Event|3|||
42215921|NCT01844856|76032687|FG001|Overall Study|Adverse Event|6|||
42215922|NCT01844856|76032686|FG000|Overall Study|Withdrawal by Subject|3|||
41977452|NCT02327078|75782087|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
41977453|NCT02327078|75782088|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
41977454|NCT02327078|75782089|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
41977455|NCT02327078|75782090|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
41977456|NCT02327078|75782091|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
41977457|NCT02327078|75782092|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
42215923|NCT01844856|76032687|FG001|Overall Study|Withdrawal by Subject|2|||
42215924|NCT01844856|76032686|FG000|Overall Study|Noncompliance|2|||
42215925|NCT01844856|76032687|FG001|Overall Study|Noncompliance|3|||
42215926|NCT01844856|76032686|FG000|Overall Study|Enterococcus Resistant|0|||
42215927|NCT01844856|76032687|FG001|Overall Study|Enterococcus Resistant|1|||
42215928|NCT01844856|76032686|FG000|Overall Study|Inadvertently Not Scheduled|1|||
42215929|NCT01844856|76032687|FG001|Overall Study|Inadvertently Not Scheduled|0|||
42215930|NCT01844856|76032686|FG000|Overall Study|Randomized but was a Screen Failure|0|||
42215931|NCT01844856|76032687|FG001|Overall Study|Randomized but was a Screen Failure|1|||
42215932|NCT03135210|76032723|FG000|Overall Study|Death|0|||
42215933|NCT03135210|76032724|FG001|Overall Study|Death|1|||
42215934|NCT00701662|76032730|FG000|Overall Study|Lack of Efficacy|1|||
42215935|NCT02878590|76032734|FG000|Overall Study|Withdrawal by Subject|2|||
42215936|NCT04634409|76032765|FG000|Overall Study|Death|0|||
42215937|NCT04634409|76032766|FG001|Overall Study|Death|0|||
42215938|NCT04634409|76032767|FG002|Overall Study|Death|0|||
42215939|NCT04634409|76032768|FG003|Overall Study|Death|0|||
42215940|NCT04634409|76032769|FG004|Overall Study|Death|0|||
42215941|NCT04634409|76032770|FG005|Overall Study|Death|0|||
42215942|NCT04634409|76032771|FG006|Overall Study|Death|0|||
42215943|NCT04634409|76032772|FG007|Overall Study|Death|0|||
42215944|NCT04634409|76032773|FG008|Overall Study|Death|0|||
42215945|NCT04634409|76032774|FG009|Overall Study|Death|0|||
42215946|NCT04634409|76032775|FG010|Overall Study|Death|1|||
42215947|NCT04634409|76032776|FG011|Overall Study|Death|0|||
42215948|NCT04634409|76032777|FG012|Overall Study|Death|1|||
42215949|NCT04634409|76032778|FG013|Overall Study|Death|0|||
42215950|NCT04634409|76032779|FG014|Overall Study|Death|0|||
42215951|NCT04634409|76032780|FG015|Overall Study|Death|0|||
42215952|NCT04634409|76032781|FG016|Overall Study|Death|0|||
41977458|NCT02327078|75782093|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
42128890|NCT03964207|75939738|FG001|Second Treatment|Lost to Follow-up|1|||
42215953|NCT04634409|76032782|FG017|Overall Study|Death|0|||
42215954|NCT04634409|76032783|FG018|Overall Study|Death|0|||
42215955|NCT04634409|76032784|FG019|Overall Study|Death|0|||
42215956|NCT04634409|76032785|FG020|Overall Study|Death|0|||
42128891|NCT03964207|75939737|FG000|Second Treatment|Adverse Event|1|||
42128892|NCT03964207|75939738|FG001|Second Treatment|Adverse Event|2|||
42128893|NCT03947255|75939747|FG000|Overall Study|Study Closure by Sponsor|2|||
42128894|NCT03947255|75939748|FG001|Overall Study|Study Closure by Sponsor|2|||
41977459|NCT02327078|75782094|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
41977460|NCT02327078|75782095|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
42128895|NCT03947255|75939747|FG000|Overall Study|Withdrawal by Subject|2|||
42128896|NCT03947255|75939748|FG001|Overall Study|Withdrawal by Subject|2|||
42128897|NCT03947255|75939747|FG000|Overall Study|Lost to Follow-up|2|||
42215957|NCT04634409|76032786|FG021|Overall Study|Death|0|||
42215958|NCT04634409|76032787|FG022|Overall Study|Death|0|||
42215959|NCT04634409|76032788|FG023|Overall Study|Death|0|||
42215960|NCT04634409|76032789|FG024|Overall Study|Death|0|||
42215961|NCT04634409|76032790|FG025|Overall Study|Death|0|||
42215962|NCT04634409|76032791|FG026|Overall Study|Death|0|||
42215963|NCT04634409|76032765|FG000|Overall Study|Adverse Event|0|||
42215964|NCT04634409|76032766|FG001|Overall Study|Adverse Event|0|||
42215965|NCT04634409|76032767|FG002|Overall Study|Adverse Event|1|||
42215966|NCT04634409|76032768|FG003|Overall Study|Adverse Event|0|||
42215967|NCT04634409|76032769|FG004|Overall Study|Adverse Event|0|||
42215968|NCT04634409|76032770|FG005|Overall Study|Adverse Event|1|||
42215969|NCT04634409|76032771|FG006|Overall Study|Adverse Event|0|||
42215970|NCT04634409|76032772|FG007|Overall Study|Adverse Event|0|||
42215971|NCT04634409|76032773|FG008|Overall Study|Adverse Event|0|||
42215972|NCT04634409|76032774|FG009|Overall Study|Adverse Event|0|||
42215973|NCT04634409|76032775|FG010|Overall Study|Adverse Event|0|||
42215974|NCT04634409|76032776|FG011|Overall Study|Adverse Event|0|||
42215975|NCT04634409|76032777|FG012|Overall Study|Adverse Event|0|||
42215976|NCT04634409|76032778|FG013|Overall Study|Adverse Event|0|||
42215977|NCT04634409|76032779|FG014|Overall Study|Adverse Event|0|||
42215978|NCT04634409|76032780|FG015|Overall Study|Adverse Event|0|||
42215979|NCT04634409|76032781|FG016|Overall Study|Adverse Event|0|||
42215980|NCT04634409|76032782|FG017|Overall Study|Adverse Event|0|||
42215981|NCT04634409|76032783|FG018|Overall Study|Adverse Event|0|||
42215982|NCT04634409|76032784|FG019|Overall Study|Adverse Event|0|||
42215983|NCT04634409|76032785|FG020|Overall Study|Adverse Event|0|||
42215984|NCT04634409|76032786|FG021|Overall Study|Adverse Event|0|||
42215985|NCT04634409|76032787|FG022|Overall Study|Adverse Event|0|||
42215986|NCT04634409|76032788|FG023|Overall Study|Adverse Event|0|||
42215987|NCT04634409|76032789|FG024|Overall Study|Adverse Event|0|||
42215988|NCT04634409|76032790|FG025|Overall Study|Adverse Event|0|||
42215989|NCT04634409|76032791|FG026|Overall Study|Adverse Event|0|||
42215990|NCT04634409|76032765|FG000|Overall Study|Lost to Follow-up|3|||
42215991|NCT04634409|76032766|FG001|Overall Study|Lost to Follow-up|1|||
42215992|NCT04634409|76032767|FG002|Overall Study|Lost to Follow-up|1|||
42215993|NCT04634409|76032768|FG003|Overall Study|Lost to Follow-up|3|||
42215994|NCT04634409|76032769|FG004|Overall Study|Lost to Follow-up|1|||
42128898|NCT03947255|75939748|FG001|Overall Study|Lost to Follow-up|0|||
42128899|NCT03947255|75939747|FG000|Overall Study|Death|0|||
42128900|NCT03947255|75939748|FG001|Overall Study|Death|2|||
42215995|NCT04634409|76032770|FG005|Overall Study|Lost to Follow-up|1|||
42215996|NCT04634409|76032771|FG006|Overall Study|Lost to Follow-up|1|||
42215997|NCT04634409|76032772|FG007|Overall Study|Lost to Follow-up|3|||
42215998|NCT04634409|76032773|FG008|Overall Study|Lost to Follow-up|3|||
42215999|NCT04634409|76032774|FG009|Overall Study|Lost to Follow-up|11|||
42216000|NCT04634409|76032775|FG010|Overall Study|Lost to Follow-up|8|||
42216001|NCT04634409|76032776|FG011|Overall Study|Lost to Follow-up|15|||
42216002|NCT04634409|76032777|FG012|Overall Study|Lost to Follow-up|3|||
42216003|NCT04634409|76032778|FG013|Overall Study|Lost to Follow-up|2|||
42216004|NCT04634409|76032779|FG014|Overall Study|Lost to Follow-up|7|||
42216005|NCT04634409|76032780|FG015|Overall Study|Lost to Follow-up|0|||
42216006|NCT04634409|76032781|FG016|Overall Study|Lost to Follow-up|0|||
42216007|NCT04634409|76032782|FG017|Overall Study|Lost to Follow-up|0|||
42216008|NCT04634409|76032783|FG018|Overall Study|Lost to Follow-up|0|||
42216009|NCT04634409|76032784|FG019|Overall Study|Lost to Follow-up|0|||
41977461|NCT02327078|75782087|FG000|Overall Study|Reason not Specified|0|||
41977462|NCT02327078|75782088|FG001|Overall Study|Reason not Specified|0|||
41977463|NCT02327078|75782089|FG002|Overall Study|Reason not Specified|0|||
42128901|NCT03929757|75939756|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
42128902|NCT03929757|75939757|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
42128903|NCT03929757|75939758|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
42128904|NCT03929757|75939756|FG000|Main Study: Up to Day 365|Other|1|||
42128905|NCT03929757|75939757|FG001|Main Study: Up to Day 365|Other|0|||
42128906|NCT03929757|75939758|FG002|Main Study: Up to Day 365|Other|0|||
42128907|NCT03929757|75939756|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
42216010|NCT04634409|76032785|FG020|Overall Study|Lost to Follow-up|0|||
41977464|NCT02327078|75782090|FG003|Overall Study|Reason not Specified|0|||
41977465|NCT02327078|75782091|FG004|Overall Study|Reason not Specified|0|||
41977466|NCT02327078|75782092|FG005|Overall Study|Reason not Specified|0|||
42216011|NCT04634409|76032786|FG021|Overall Study|Lost to Follow-up|0|||
42216012|NCT04634409|76032787|FG022|Overall Study|Lost to Follow-up|0|||
42128908|NCT03929757|75939757|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
42216013|NCT04634409|76032788|FG023|Overall Study|Lost to Follow-up|0|||
42216014|NCT04634409|76032789|FG024|Overall Study|Lost to Follow-up|0|||
42216015|NCT04634409|76032790|FG025|Overall Study|Lost to Follow-up|0|||
42216016|NCT04634409|76032791|FG026|Overall Study|Lost to Follow-up|0|||
42216017|NCT04634409|76032765|FG000|Overall Study|Withdrawal by Subject|3|||
42216018|NCT04634409|76032766|FG001|Overall Study|Withdrawal by Subject|1|||
42216019|NCT04634409|76032767|FG002|Overall Study|Withdrawal by Subject|6|||
42216020|NCT04634409|76032768|FG003|Overall Study|Withdrawal by Subject|4|||
41977467|NCT02327078|75782093|FG006|Overall Study|Reason not Specified|0|||
41977468|NCT02327078|75782094|FG007|Overall Study|Reason not Specified|5|||
41977469|NCT02327078|75782095|FG008|Overall Study|Reason not Specified|12|||
41977470|NCT02304458|75782138|FG000|Overall Study|Adverse Event|0|||
41977471|NCT02304458|75782139|FG001|Overall Study|Adverse Event|0|||
42128909|NCT03929757|75939758|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
42128910|NCT03748823|75939767|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
42128911|NCT03748823|75939768|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
41977472|NCT02304458|75782140|FG002|Overall Study|Adverse Event|7|||
41977473|NCT02304458|75782141|FG003|Overall Study|Adverse Event|0|||
41977474|NCT02304458|75782142|FG004|Overall Study|Adverse Event|0|||
41977475|NCT02304458|75782143|FG005|Overall Study|Adverse Event|0|||
41977476|NCT02304458|75782144|FG006|Overall Study|Adverse Event|3|||
41977477|NCT02304458|75782145|FG007|Overall Study|Adverse Event|4|||
41977478|NCT02304458|75782138|FG000|Overall Study|Death|0|||
41977479|NCT02304458|75782139|FG001|Overall Study|Death|0|||
41977480|NCT02304458|75782140|FG002|Overall Study|Death|2|||
41977481|NCT02304458|75782141|FG003|Overall Study|Death|0|||
41977482|NCT02304458|75782142|FG004|Overall Study|Death|0|||
41977483|NCT02304458|75782143|FG005|Overall Study|Death|0|||
41977484|NCT02304458|75782144|FG006|Overall Study|Death|1|||
41977485|NCT02304458|75782145|FG007|Overall Study|Death|0|||
41977486|NCT02304458|75782138|FG000|Overall Study|Lack of Efficacy|4|||
41977487|NCT02304458|75782139|FG001|Overall Study|Lack of Efficacy|6|||
41977488|NCT02304458|75782140|FG002|Overall Study|Lack of Efficacy|38|||
41977489|NCT02304458|75782141|FG003|Overall Study|Lack of Efficacy|5|||
41977490|NCT02304458|75782142|FG004|Overall Study|Lack of Efficacy|6|||
41977491|NCT02304458|75782143|FG005|Overall Study|Lack of Efficacy|6|||
41977492|NCT02304458|75782144|FG006|Overall Study|Lack of Efficacy|21|||
41977493|NCT02304458|75782145|FG007|Overall Study|Lack of Efficacy|4|||
41977494|NCT02304458|75782138|FG000|Overall Study|Physician Decision|2|||
41977495|NCT02304458|75782139|FG001|Overall Study|Physician Decision|0|||
41977496|NCT02304458|75782140|FG002|Overall Study|Physician Decision|16|||
41977497|NCT02304458|75782141|FG003|Overall Study|Physician Decision|1|||
41977498|NCT02304458|75782142|FG004|Overall Study|Physician Decision|0|||
42128912|NCT03748823|75939767|FG000|Extension Period|Withdrawal by Subject|1|||
42128913|NCT03748823|75939768|FG001|Extension Period|Withdrawal by Subject|2|||
42128914|NCT03748823|75939767|FG000|Extension Period|Death|0|||
42128915|NCT03748823|75939768|FG001|Extension Period|Death|1|||
42301989|NCT02484547|76137181|FG001|Placebo-Controlled Period|Change of Treatment|0|||
42301990|NCT02484547|76137182|FG002|Placebo-Controlled Period|Change of Treatment|1|||
41977499|NCT02304458|75782143|FG005|Overall Study|Physician Decision|0|||
41977500|NCT02304458|75782144|FG006|Overall Study|Physician Decision|3|||
41977501|NCT02304458|75782145|FG007|Overall Study|Physician Decision|0|||
41977502|NCT02304458|75782138|FG000|Overall Study|Protocol Violation|0|||
41977503|NCT02304458|75782139|FG001|Overall Study|Protocol Violation|0|||
41977504|NCT02304458|75782140|FG002|Overall Study|Protocol Violation|1|||
41977505|NCT02304458|75782141|FG003|Overall Study|Protocol Violation|0|||
41977506|NCT02304458|75782142|FG004|Overall Study|Protocol Violation|0|||
41977507|NCT02304458|75782143|FG005|Overall Study|Protocol Violation|0|||
41977508|NCT02304458|75782144|FG006|Overall Study|Protocol Violation|0|||
41977509|NCT02304458|75782145|FG007|Overall Study|Protocol Violation|0|||
41977510|NCT02304458|75782138|FG000|Overall Study|Withdrawal by Subject|1|||
41977511|NCT02304458|75782139|FG001|Overall Study|Withdrawal by Subject|0|||
42128916|NCT03748823|75939767|FG000|Extension Period|Protocol Violation|1|||
41977512|NCT02304458|75782140|FG002|Overall Study|Withdrawal by Subject|7|||
41977513|NCT02304458|75782141|FG003|Overall Study|Withdrawal by Subject|0|||
41977514|NCT02304458|75782142|FG004|Overall Study|Withdrawal by Subject|0|||
41977515|NCT02304458|75782143|FG005|Overall Study|Withdrawal by Subject|0|||
41977516|NCT02304458|75782144|FG006|Overall Study|Withdrawal by Subject|1|||
41977517|NCT02304458|75782145|FG007|Overall Study|Withdrawal by Subject|0|||
42216021|NCT04634409|76032769|FG004|Overall Study|Withdrawal by Subject|2|||
42216022|NCT04634409|76032770|FG005|Overall Study|Withdrawal by Subject|0|||
42216023|NCT04634409|76032771|FG006|Overall Study|Withdrawal by Subject|0|||
42216024|NCT04634409|76032772|FG007|Overall Study|Withdrawal by Subject|2|||
42216025|NCT04634409|76032773|FG008|Overall Study|Withdrawal by Subject|3|||
42216026|NCT04634409|76032774|FG009|Overall Study|Withdrawal by Subject|2|||
42216027|NCT04634409|76032775|FG010|Overall Study|Withdrawal by Subject|3|||
42216028|NCT04634409|76032776|FG011|Overall Study|Withdrawal by Subject|2|||
42216029|NCT04634409|76032777|FG012|Overall Study|Withdrawal by Subject|2|||
42216030|NCT04634409|76032778|FG013|Overall Study|Withdrawal by Subject|1|||
42216031|NCT04634409|76032779|FG014|Overall Study|Withdrawal by Subject|5|||
42216032|NCT04634409|76032780|FG015|Overall Study|Withdrawal by Subject|0|||
42216033|NCT04634409|76032781|FG016|Overall Study|Withdrawal by Subject|0|||
42216034|NCT04634409|76032782|FG017|Overall Study|Withdrawal by Subject|1|||
42216035|NCT04634409|76032783|FG018|Overall Study|Withdrawal by Subject|0|||
42216036|NCT04634409|76032784|FG019|Overall Study|Withdrawal by Subject|0|||
42216037|NCT04634409|76032785|FG020|Overall Study|Withdrawal by Subject|0|||
42216038|NCT04634409|76032786|FG021|Overall Study|Withdrawal by Subject|0|||
42216039|NCT04634409|76032787|FG022|Overall Study|Withdrawal by Subject|0|||
42216040|NCT04634409|76032788|FG023|Overall Study|Withdrawal by Subject|1|||
42216041|NCT04634409|76032789|FG024|Overall Study|Withdrawal by Subject|0|||
42216042|NCT04634409|76032790|FG025|Overall Study|Withdrawal by Subject|0|||
42216043|NCT04634409|76032791|FG026|Overall Study|Withdrawal by Subject|0|||
42216044|NCT04634409|76032765|FG000|Overall Study|Other - As reported by Investigator|1|||
42216045|NCT04634409|76032766|FG001|Overall Study|Other - As reported by Investigator|0|||
42216046|NCT04634409|76032767|FG002|Overall Study|Other - As reported by Investigator|0|||
42216047|NCT04634409|76032768|FG003|Overall Study|Other - As reported by Investigator|0|||
42216048|NCT04634409|76032769|FG004|Overall Study|Other - As reported by Investigator|0|||
42216049|NCT04634409|76032770|FG005|Overall Study|Other - As reported by Investigator|0|||
42216050|NCT04634409|76032771|FG006|Overall Study|Other - As reported by Investigator|0|||
42216051|NCT04634409|76032772|FG007|Overall Study|Other - As reported by Investigator|6|||
42216052|NCT04634409|76032773|FG008|Overall Study|Other - As reported by Investigator|4|||
42216053|NCT04634409|76032774|FG009|Overall Study|Other - As reported by Investigator|0|||
42216054|NCT04634409|76032775|FG010|Overall Study|Other - As reported by Investigator|1|||
42216055|NCT04634409|76032776|FG011|Overall Study|Other - As reported by Investigator|2|||
42216056|NCT04634409|76032777|FG012|Overall Study|Other - As reported by Investigator|2|||
42216057|NCT04634409|76032778|FG013|Overall Study|Other - As reported by Investigator|1|||
42216058|NCT04634409|76032779|FG014|Overall Study|Other - As reported by Investigator|0|||
42216059|NCT04634409|76032780|FG015|Overall Study|Other - As reported by Investigator|0|||
42216060|NCT04634409|76032781|FG016|Overall Study|Other - As reported by Investigator|0|||
42216061|NCT04634409|76032782|FG017|Overall Study|Other - As reported by Investigator|0|||
42216062|NCT04634409|76032783|FG018|Overall Study|Other - As reported by Investigator|0|||
42216063|NCT04634409|76032784|FG019|Overall Study|Other - As reported by Investigator|0|||
42216064|NCT04634409|76032785|FG020|Overall Study|Other - As reported by Investigator|0|||
42216065|NCT04634409|76032786|FG021|Overall Study|Other - As reported by Investigator|0|||
42216066|NCT04634409|76032787|FG022|Overall Study|Other - As reported by Investigator|0|||
42216067|NCT04634409|76032788|FG023|Overall Study|Other - As reported by Investigator|0|||
42216068|NCT04634409|76032789|FG024|Overall Study|Other - As reported by Investigator|0|||
42216069|NCT04634409|76032790|FG025|Overall Study|Other - As reported by Investigator|0|||
42216070|NCT04634409|76032791|FG026|Overall Study|Other - As reported by Investigator|0|||
42216071|NCT00005780|76032869|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
42216072|NCT01978938|76032878|FG000|Overall Study|Lost to Follow-up|12|||
42216073|NCT01978938|76032879|FG001|Overall Study|Lost to Follow-up|6|||
42216074|NCT01978938|76032878|FG000|Overall Study|Withdrawal by Subject|8|||
42216075|NCT01978938|76032879|FG001|Overall Study|Withdrawal by Subject|4|||
41977518|NCT02187224|75782181|FG000|Overall Study|Did not show up for test day|1|||
41977519|NCT02187224|75782182|FG001|Overall Study|Did not show up for test day|0|||
42216076|NCT01978938|76032878|FG000|Overall Study|Adverse Event, non-fatal|2|||
42216077|NCT01978938|76032879|FG001|Overall Study|Adverse Event, non-fatal|1|||
42216078|NCT01978938|76032878|FG000|Overall Study|Participant noncompliance|1|||
42301991|NCT02484547|76137183|FG003|Placebo-Controlled Period|Change of Treatment|0|||
42216079|NCT01978938|76032879|FG001|Overall Study|Participant noncompliance|1|||
42216080|NCT01978938|76032878|FG000|Overall Study|Did not meet inclusion criteria|0|||
42216081|NCT01978938|76032879|FG001|Overall Study|Did not meet inclusion criteria|1|||
42216082|NCT01978938|76032878|FG000|Overall Study|Previously scheduled procedure|0|||
42216083|NCT01978938|76032879|FG001|Overall Study|Previously scheduled procedure|1|||
42216084|NCT03041090|76032887|FG000|Overall Study|technical error|0|||
42216085|NCT03041090|76032888|FG001|Overall Study|technical error|3|||
42216086|NCT00116142|76032896|FG000|Overall Study|Adverse Event|8|||
42216087|NCT00116142|76032897|FG001|Overall Study|Adverse Event|7|||
42216088|NCT00116142|76032896|FG000|Overall Study|Protocol Violation|2|||
42216089|NCT00116142|76032897|FG001|Overall Study|Protocol Violation|1|||
42216090|NCT00116142|76032896|FG000|Overall Study|Withdrawal by Subject|5|||
42216091|NCT00116142|76032897|FG001|Overall Study|Withdrawal by Subject|5|||
42216092|NCT00116142|76032896|FG000|Overall Study|Physician Decision|3|||
42216093|NCT00116142|76032897|FG001|Overall Study|Physician Decision|1|||
42216094|NCT00116142|76032896|FG000|Overall Study|Delayed Radiation Therapy|1|||
42216095|NCT00116142|76032897|FG001|Overall Study|Delayed Radiation Therapy|0|||
42216096|NCT00116142|76032896|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
42216097|NCT00116142|76032897|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
42028481|NCT01136772|75836924|FG001|Overall Study|Lack of Efficacy|39|||
42216098|NCT00116142|76032896|FG000|Overall Study|Patient stopped due to depression|0|||
42216099|NCT00116142|76032897|FG001|Overall Study|Patient stopped due to depression|1|||
42301992|NCT02484547|76137184|FG004|Placebo-Controlled Period|Change of Treatment|0|||
42216100|NCT00116142|76032896|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
41977520|NCT02176226|75782192|FG000|Overall Study|Lost to Follow-up|3|||
41977521|NCT02176226|75782192|FG000|Overall Study|Withdrew prior to treatment|6|||
41977522|NCT01958021|75782198|FG000|Overall Study|Progressive disease|87|||
41977523|NCT01958021|75782199|FG001|Overall Study|Progressive disease|146|||
41977524|NCT01958021|75782198|FG000|Overall Study|Adverse Event|25|||
41977525|NCT01958021|75782199|FG001|Overall Study|Adverse Event|7|||
41977526|NCT01958021|75782198|FG000|Overall Study|Subject/guardian decision|12|||
41977527|NCT01958021|75782199|FG001|Overall Study|Subject/guardian decision|13|||
41977528|NCT01958021|75782198|FG000|Overall Study|Physician Decision|10|||
41977529|NCT01958021|75782199|FG001|Overall Study|Physician Decision|13|||
41977530|NCT01958021|75782198|FG000|Overall Study|Protocol Violation|3|||
41977531|NCT01958021|75782199|FG001|Overall Study|Protocol Violation|1|||
41977532|NCT01958021|75782198|FG000|Overall Study|Death|2|||
41977533|NCT01958021|75782199|FG001|Overall Study|Death|0|||
41977534|NCT05059600|75782205|FG000|Overall Study|Enrolled but not Treated|10|||
41977535|NCT04608448|75782218|FG000|Overall Study|Withdrawal by Subject|1|||
41977536|NCT04608448|75782218|FG000|Overall Study|Adverse Event|1|||
41977537|NCT04530344|75782228|FG000|Overall Study|Lost to Follow-up|3|||
41977538|NCT04530344|75782229|FG001|Overall Study|Lost to Follow-up|3|||
41977539|NCT04530344|75782230|FG002|Overall Study|Lost to Follow-up|3|||
41977540|NCT04530344|75782231|FG003|Overall Study|Lost to Follow-up|10|||
41977541|NCT04530344|75782228|FG000|Overall Study|Withdrawal by Subject|14|||
41977542|NCT04530344|75782229|FG001|Overall Study|Withdrawal by Subject|5|||
41977543|NCT04530344|75782230|FG002|Overall Study|Withdrawal by Subject|18|||
41977544|NCT04530344|75782231|FG003|Overall Study|Withdrawal by Subject|33|||
41977545|NCT04530344|75782228|FG000|Overall Study|Adverse Event|0|||
41977546|NCT04530344|75782229|FG001|Overall Study|Adverse Event|0|||
41977547|NCT04530344|75782230|FG002|Overall Study|Adverse Event|0|||
41977548|NCT04530344|75782231|FG003|Overall Study|Adverse Event|1|||
41977549|NCT04530344|75782228|FG000|Overall Study|Lack of Efficacy|0|||
41977550|NCT04530344|75782229|FG001|Overall Study|Lack of Efficacy|0|||
41977551|NCT04530344|75782230|FG002|Overall Study|Lack of Efficacy|0|||
41977552|NCT04530344|75782231|FG003|Overall Study|Lack of Efficacy|1|||
41977553|NCT04530344|75782228|FG000|Overall Study|Physician Decision|0|||
41977554|NCT04530344|75782229|FG001|Overall Study|Physician Decision|0|||
41977555|NCT04530344|75782230|FG002|Overall Study|Physician Decision|1|||
41977556|NCT04530344|75782231|FG003|Overall Study|Physician Decision|1|||
41977557|NCT04530344|75782228|FG000|Overall Study|Pregnancy|0|||
41977558|NCT04530344|75782229|FG001|Overall Study|Pregnancy|0|||
41977559|NCT04530344|75782230|FG002|Overall Study|Pregnancy|2|||
41977560|NCT04530344|75782231|FG003|Overall Study|Pregnancy|1|||
41977561|NCT04530344|75782228|FG000|Overall Study|Protocol Violation|0|||
41977562|NCT04530344|75782229|FG001|Overall Study|Protocol Violation|0|||
41977563|NCT04530344|75782230|FG002|Overall Study|Protocol Violation|0|||
41977564|NCT04530344|75782231|FG003|Overall Study|Protocol Violation|1|||
41977565|NCT04530344|75782228|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
41977566|NCT04530344|75782229|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
41977567|NCT04530344|75782230|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
41977568|NCT04530344|75782231|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
41977569|NCT04530344|75782228|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
41977570|NCT04530344|75782229|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
41977571|NCT04530344|75782230|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
41977572|NCT04530344|75782231|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
41977573|NCT04530344|75782228|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
41977574|NCT04530344|75782229|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
41977575|NCT04530344|75782230|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
41977576|NCT04530344|75782231|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
41977577|NCT04530344|75782228|FG000|Overall Study|Personal Reasons|0|||
41977578|NCT04530344|75782229|FG001|Overall Study|Personal Reasons|0|||
41977579|NCT04530344|75782230|FG002|Overall Study|Personal Reasons|0|||
41977580|NCT04530344|75782231|FG003|Overall Study|Personal Reasons|1|||
41977581|NCT04530344|75782228|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
41977582|NCT04530344|75782229|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
41977583|NCT04530344|75782230|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
41977584|NCT04530344|75782231|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
41977585|NCT04058886|75782256|FG000|Overall Study|Withdrawal by Subject|4|||
41977586|NCT04058886|75782256|FG000|Overall Study|Inadequate deafness interpreter service|1|||
41977587|NCT03704194|75782279|FG000|Overall Study|Withdrawal by Subject|0|||
41977588|NCT03704194|75782280|FG001|Overall Study|Withdrawal by Subject|1|||
41977589|NCT03451422|75782294|FG000|Overall Study|Lost to Follow-up|0|||
41977590|NCT03451422|75782295|FG001|Overall Study|Lost to Follow-up|0|||
41977591|NCT03451422|75782296|FG002|Overall Study|Lost to Follow-up|0|||
41977592|NCT03451422|75782297|FG003|Overall Study|Lost to Follow-up|0|||
41977593|NCT03451422|75782298|FG004|Overall Study|Lost to Follow-up|0|||
41977594|NCT03451422|75782299|FG005|Overall Study|Lost to Follow-up|1|||
41977595|NCT03451422|75782294|FG000|Overall Study|Decision by sponsor|1|||
41977596|NCT03451422|75782295|FG001|Overall Study|Decision by sponsor|0|||
41977597|NCT03451422|75782296|FG002|Overall Study|Decision by sponsor|1|||
41977598|NCT03451422|75782297|FG003|Overall Study|Decision by sponsor|0|||
41977599|NCT03451422|75782298|FG004|Overall Study|Decision by sponsor|0|||
41977600|NCT03451422|75782299|FG005|Overall Study|Decision by sponsor|0|||
41977601|NCT03451422|75782294|FG000|Overall Study|Withdrawal by Subject|0|||
41977602|NCT03451422|75782295|FG001|Overall Study|Withdrawal by Subject|0|||
41977603|NCT03451422|75782296|FG002|Overall Study|Withdrawal by Subject|2|||
41977604|NCT03451422|75782297|FG003|Overall Study|Withdrawal by Subject|3|||
41977605|NCT03451422|75782298|FG004|Overall Study|Withdrawal by Subject|2|||
41977606|NCT03451422|75782299|FG005|Overall Study|Withdrawal by Subject|1|||
42128917|NCT03748823|75939768|FG001|Extension Period|Protocol Violation|0|||
42128918|NCT03748823|75939767|FG000|Extension Period|Ongoing in the Extension Period|41|||
42128919|NCT03748823|75939768|FG001|Extension Period|Ongoing in the Extension Period|84|||
42216101|NCT00116142|76032897|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
42216102|NCT00116142|76032896|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
42216103|NCT00116142|76032897|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
42216104|NCT00116142|76032896|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
42216105|NCT00116142|76032897|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
42216106|NCT03135522|76032908|FG000|Overall Study|Adverse Event|1|||
42216107|NCT03135522|76032909|FG001|Overall Study|Adverse Event|0|||
42216108|NCT02875080|76032932|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
42216109|NCT02875080|76032933|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
42216110|NCT02875080|76032934|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
42216111|NCT03129360|76032945|FG000|Overall Study|Did not meet entry criteria|0|||
42216112|NCT03129360|76032946|FG001|Overall Study|Did not meet entry criteria|2|||
42216113|NCT03129360|76032947|FG002|Overall Study|Did not meet entry criteria|1|||
42216114|NCT03129360|76032945|FG000|Overall Study|Excluded due to motion in scanner|1|||
42216115|NCT03129360|76032946|FG001|Overall Study|Excluded due to motion in scanner|0|||
42216116|NCT03129360|76032947|FG002|Overall Study|Excluded due to motion in scanner|0|||
42216117|NCT03165045|76032955|FG000|Visit 1|No registration after visit 1|9|||
42216118|NCT03165045|76032955|FG000|Visit 1|No treatment documented|10|||
42216119|NCT03165045|76032955|FG000|Visit 1|No visit 1|10|||
42216120|NCT03165045|76032955|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
42216121|NCT03165045|76032955|FG000|Visit 2|No available total CCQ score at all|29|||
42216122|NCT03165045|76032955|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
42216123|NCT01928199|76032963|FG000|Overall Study|Lost to Follow-up|2|||
42216124|NCT01928199|76032964|FG001|Overall Study|Lost to Follow-up|1|||
42216125|NCT01928199|76032963|FG000|Overall Study|Withdrawal by Subject|3|||
42216126|NCT01928199|76032964|FG001|Overall Study|Withdrawal by Subject|5|||
42301993|NCT02484547|76137185|FG005|Placebo-Controlled Period|Change of Treatment|0|||
42301994|NCT02484547|76137186|FG006|Placebo-Controlled Period|Change of Treatment|0|||
42301995|NCT02484547|76137180|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
42301996|NCT02484547|76137181|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
42301997|NCT02484547|76137182|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
42301998|NCT02484547|76137183|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
42301999|NCT02484547|76137184|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
42302000|NCT02484547|76137185|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
42302001|NCT02484547|76137186|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
42302002|NCT02484547|76137180|FG000|Placebo-Controlled Period|Death|5|||
42302003|NCT02484547|76137181|FG001|Placebo-Controlled Period|Death|0|||
42302004|NCT02484547|76137182|FG002|Placebo-Controlled Period|Death|6|||
42302005|NCT02484547|76137183|FG003|Placebo-Controlled Period|Death|0|||
42302006|NCT02484547|76137184|FG004|Placebo-Controlled Period|Death|0|||
41977607|NCT03446573|75782320|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
41977608|NCT03446573|75782321|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
41977609|NCT03446573|75782320|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
42128920|NCT03548558|75939791|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
42128921|NCT03548558|75939792|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
42128922|NCT03548558|75939793|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
42128923|NCT03548558|75939794|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
42128924|NCT03548558|75939795|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
42216127|NCT03128892|76032970|FG000|Overall Study|Withdrawal by Subject|2|||
41977610|NCT03446573|75782321|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
42128925|NCT03548558|75939796|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
41977611|NCT03446573|75782320|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
42216128|NCT03128892|76032970|FG000|Overall Study|Physician Decision|1|||
42216129|NCT03039686|76032986|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
42216130|NCT03039686|76032987|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
41977612|NCT03446573|75782321|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
41977613|NCT03446573|75782320|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
42216131|NCT03039686|76032988|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
42216132|NCT03039686|76032986|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
42216133|NCT03039686|76032987|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
42216134|NCT03039686|76032988|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
42216135|NCT03039686|76032986|FG000|Double-blind Period|Withdrawal by Subject|2|||
42216136|NCT03039686|76032987|FG001|Double-blind Period|Withdrawal by Subject|2|||
42216137|NCT03039686|76032988|FG002|Double-blind Period|Withdrawal by Subject|1|||
42216138|NCT03039686|76032986|FG000|Double-blind Period|Death|0|||
42216139|NCT03039686|76032987|FG001|Double-blind Period|Death|0|||
42216140|NCT03039686|76032988|FG002|Double-blind Period|Death|1|||
42216141|NCT03039686|76032986|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
42216142|NCT03039686|76032987|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
42216143|NCT03039686|76032988|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
42216144|NCT03039686|76032986|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
42216145|NCT03039686|76032987|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
42216146|NCT03039686|76032988|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
42216147|NCT03039686|76032986|FG000|Open Label Period|Withdrawal by Subject|0|||
42216148|NCT03039686|76032987|FG001|Open Label Period|Withdrawal by Subject|3|||
42216149|NCT03039686|76032988|FG002|Open Label Period|Withdrawal by Subject|1|||
42216150|NCT01822275|76033006|FG000|Overall Study|Withdrawal by Subject|3|||
41977614|NCT03446573|75782321|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
41977615|NCT03446573|75782320|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
41977616|NCT03446573|75782321|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
41977617|NCT03446573|75782320|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
41977618|NCT03446573|75782321|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
41977619|NCT03446573|75782320|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
41977620|NCT03446573|75782321|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
41977621|NCT03446573|75782320|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
41977622|NCT03446573|75782321|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
41977623|NCT03446573|75782320|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
41977624|NCT03446573|75782321|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
41977625|NCT03446573|75782320|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
41977626|NCT03446573|75782321|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
41977627|NCT03446573|75782320|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
41977628|NCT03446573|75782321|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
41977629|NCT03446573|75782320|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
41977630|NCT03446573|75782321|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
41977631|NCT03446573|75782320|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
42028482|NCT01136772|75836923|FG000|Overall Study|Administrative|14|||
42028483|NCT01136772|75836924|FG001|Overall Study|Administrative|12|||
42028484|NCT01136772|75836923|FG000|Overall Study|Withdrawal by Subject|33|||
42302007|NCT02484547|76137185|FG005|Placebo-Controlled Period|Death|0|||
42302008|NCT02484547|76137186|FG006|Placebo-Controlled Period|Death|0|||
42302009|NCT02484547|76137180|FG000|Placebo-Controlled Period|Disease Progression|2|||
42302010|NCT02484547|76137181|FG001|Placebo-Controlled Period|Disease Progression|0|||
42302011|NCT02484547|76137182|FG002|Placebo-Controlled Period|Disease Progression|1|||
42302012|NCT02484547|76137183|FG003|Placebo-Controlled Period|Disease Progression|0|||
42302013|NCT02484547|76137184|FG004|Placebo-Controlled Period|Disease Progression|0|||
42302014|NCT02484547|76137185|FG005|Placebo-Controlled Period|Disease Progression|0|||
42302015|NCT02484547|76137186|FG006|Placebo-Controlled Period|Disease Progression|0|||
42302016|NCT02484547|76137180|FG000|Placebo-Controlled Period|Investigator Decision|2|||
42302017|NCT02484547|76137181|FG001|Placebo-Controlled Period|Investigator Decision|2|||
42302018|NCT02484547|76137182|FG002|Placebo-Controlled Period|Investigator Decision|5|||
42302019|NCT02484547|76137183|FG003|Placebo-Controlled Period|Investigator Decision|0|||
42302020|NCT02484547|76137184|FG004|Placebo-Controlled Period|Investigator Decision|0|||
42216151|NCT01822275|76033006|FG000|Overall Study|Adverse Event|3|||
42302021|NCT02484547|76137185|FG005|Placebo-Controlled Period|Investigator Decision|0|||
41977632|NCT03446573|75782321|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
41977633|NCT03422536|75782339|FG000|Randomized|Physician Decision|1|||
41977634|NCT03422536|75782340|FG001|Randomized|Physician Decision|1|||
41977635|NCT03422536|75782339|FG000|Allocation - Received Intervention|Disease progression|19|||
41977636|NCT03422536|75782340|FG001|Allocation - Received Intervention|Disease progression|25|||
41977637|NCT03422536|75782339|FG000|Allocation - Received Intervention|Death|1|||
41977638|NCT03422536|75782340|FG001|Allocation - Received Intervention|Death|3|||
42216152|NCT01822275|76033006|FG000|Overall Study|Progression|14|||
42216153|NCT01822275|76033006|FG000|Overall Study|Physician Decision|2|||
41977639|NCT03422536|75782339|FG000|Allocation - Received Intervention|Adverse Event|1|||
41977640|NCT03422536|75782340|FG001|Allocation - Received Intervention|Adverse Event|0|||
41977641|NCT03422536|75782339|FG000|Allocation - Received Intervention|Physician Decision|1|||
42216154|NCT01656434|76033018|FG000|Overall Study|Adverse Event|199|||
42216155|NCT01656434|76033019|FG001|Overall Study|Adverse Event|63|||
42216156|NCT01656434|76033018|FG000|Overall Study|Enrollment terminated at trial site|2|||
42216157|NCT01656434|76033019|FG001|Overall Study|Enrollment terminated at trial site|0|||
42216158|NCT01656434|76033018|FG000|Overall Study|Lost to Follow-up|309|||
42216159|NCT01656434|76033019|FG001|Overall Study|Lost to Follow-up|76|||
42216160|NCT01656434|76033018|FG000|Overall Study|Site discontinued study participation|24|||
42216161|NCT01656434|76033019|FG001|Overall Study|Site discontinued study participation|9|||
42216162|NCT01656434|76033018|FG000|Overall Study|Screen failure|2|||
42216163|NCT01656434|76033019|FG001|Overall Study|Screen failure|0|||
42216164|NCT01656434|76033018|FG000|Overall Study|Protocol Violation|7|||
42216165|NCT01656434|76033019|FG001|Overall Study|Protocol Violation|0|||
42216166|NCT01656434|76033018|FG000|Overall Study|Pregnancy wish|18|||
42216167|NCT01656434|76033019|FG001|Overall Study|Pregnancy wish|6|||
42216168|NCT01656434|76033018|FG000|Overall Study|Pregnancy|45|||
42216169|NCT01656434|76033019|FG001|Overall Study|Pregnancy|10|||
42216170|NCT01656434|76033018|FG000|Overall Study|Physician Decision|7|||
42216171|NCT01656434|76033019|FG001|Overall Study|Physician Decision|2|||
42216172|NCT01656434|76033018|FG000|Overall Study|Non-compliance with study drug|48|||
42216173|NCT01656434|76033019|FG001|Overall Study|Non-compliance with study drug|9|||
42216174|NCT01656434|76033018|FG000|Overall Study|Study terminated by sponsor|1501|||
42216175|NCT01656434|76033019|FG001|Overall Study|Study terminated by sponsor|348|||
42216176|NCT01656434|76033018|FG000|Overall Study|Participant discontinued; drug related|13|||
42216177|NCT01656434|76033019|FG001|Overall Study|Participant discontinued; drug related|4|||
42216178|NCT01656434|76033018|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
42216179|NCT01656434|76033019|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
42216180|NCT01656434|76033018|FG000|Overall Study|Non-compliance with protocol|39|||
42216181|NCT01656434|76033019|FG001|Overall Study|Non-compliance with protocol|15|||
41977642|NCT03422536|75782340|FG001|Allocation - Received Intervention|Physician Decision|1|||
41977643|NCT03422536|75782339|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
42028485|NCT01136772|75836924|FG001|Overall Study|Withdrawal by Subject|36|||
42216182|NCT01656434|76033018|FG000|Overall Study|Participant moved|40|||
42216183|NCT01656434|76033019|FG001|Overall Study|Participant moved|12|||
42216184|NCT01656434|76033018|FG000|Overall Study|Participant withdrew consent|28|||
42216185|NCT01656434|76033019|FG001|Overall Study|Participant withdrew consent|9|||
41977644|NCT03422536|75782340|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
41977645|NCT03422536|75782339|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
41977646|NCT03422536|75782340|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
42216186|NCT01656434|76033018|FG000|Overall Study|Withdrawal by Subject|64|||
42216187|NCT01656434|76033019|FG001|Overall Study|Withdrawal by Subject|7|||
42216188|NCT02931396|76033027|FG000|Overall Study|Lost to Follow-up|3|||
42216189|NCT02931396|76033028|FG001|Overall Study|Lost to Follow-up|0|||
42216190|NCT02931396|76033027|FG000|Overall Study|Withdrawal by Subject|2|||
42216191|NCT02931396|76033028|FG001|Overall Study|Withdrawal by Subject|0|||
42216192|NCT03037580|76033036|FG000|Overall Study|Withdrawal by Subject|3|||
42216193|NCT03037580|76033037|FG001|Overall Study|Withdrawal by Subject|0|||
42216194|NCT03037580|76033036|FG000|Overall Study|Adverse Event|1|||
42216195|NCT03037580|76033037|FG001|Overall Study|Adverse Event|0|||
42216196|NCT03037580|76033036|FG000|Overall Study|Study Terminated by Sponsor|12|||
42216197|NCT03037580|76033037|FG001|Overall Study|Study Terminated by Sponsor|15|||
42216198|NCT03037580|76033036|FG000|Overall Study|Death|0|||
42216199|NCT03037580|76033037|FG001|Overall Study|Death|1|||
42216200|NCT00897104|76033046|FG000|Overall Study|Lost to Follow-up|12|||
42216201|NCT00897104|76033047|FG001|Overall Study|Lost to Follow-up|17|||
42216202|NCT00897104|76033048|FG002|Overall Study|Lost to Follow-up|2|||
42216203|NCT00897104|76033046|FG000|Overall Study|Pregnancy|0|||
42216204|NCT00897104|76033047|FG001|Overall Study|Pregnancy|1|||
42216205|NCT00897104|76033048|FG002|Overall Study|Pregnancy|0|||
42216206|NCT00897104|76033046|FG000|Overall Study|Protocol Violation|0|||
42216207|NCT00897104|76033047|FG001|Overall Study|Protocol Violation|1|||
42216208|NCT00897104|76033048|FG002|Overall Study|Protocol Violation|0|||
42216209|NCT00897104|76033046|FG000|Overall Study|Withdrawal by Subject|23|||
42216210|NCT00897104|76033047|FG001|Overall Study|Withdrawal by Subject|27|||
42216211|NCT00897104|76033048|FG002|Overall Study|Withdrawal by Subject|3|||
42216212|NCT00897104|76033046|FG000|Overall Study|Abnormal Prestudy Labs|2|||
42216213|NCT00897104|76033047|FG001|Overall Study|Abnormal Prestudy Labs|0|||
42216214|NCT00897104|76033048|FG002|Overall Study|Abnormal Prestudy Labs|0|||
42216215|NCT00897104|76033046|FG000|Overall Study|Abnormal Baseline ECG|2|||
42216216|NCT00897104|76033047|FG001|Overall Study|Abnormal Baseline ECG|2|||
42216217|NCT00897104|76033048|FG002|Overall Study|Abnormal Baseline ECG|0|||
42216218|NCT00897104|76033046|FG000|Overall Study|Need for Concom. Med.|0|||
42216219|NCT00897104|76033047|FG001|Overall Study|Need for Concom. Med.|1|||
42216220|NCT00897104|76033048|FG002|Overall Study|Need for Concom. Med.|1|||
42216221|NCT00897104|76033046|FG000|Overall Study|Lack of Migraine Attack|20|||
42216222|NCT00897104|76033047|FG001|Overall Study|Lack of Migraine Attack|22|||
42216223|NCT00897104|76033048|FG002|Overall Study|Lack of Migraine Attack|1|||
42216224|NCT00897104|76033046|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
42216225|NCT00897104|76033047|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
41977647|NCT03228394|75782354|FG000|Overall Study|Lost to Follow-up|0|||
41977648|NCT03228394|75782355|FG001|Overall Study|Lost to Follow-up|0|||
41977649|NCT03228394|75782356|FG002|Overall Study|Lost to Follow-up|1|||
41977650|NCT03228394|75782357|FG003|Overall Study|Lost to Follow-up|1|||
41977651|NCT03228394|75782358|FG004|Overall Study|Lost to Follow-up|0|||
41977652|NCT03228394|75782359|FG005|Overall Study|Lost to Follow-up|0|||
41977653|NCT03228394|75782360|FG006|Overall Study|Lost to Follow-up|2|||
41977654|NCT03228394|75782361|FG007|Overall Study|Lost to Follow-up|0|||
42216226|NCT00897104|76033048|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
42216227|NCT00897104|76033046|FG000|Overall Study|Other|3|||
42216228|NCT00897104|76033047|FG001|Overall Study|Other|0|||
42216229|NCT00897104|76033048|FG002|Overall Study|Other|0|||
42216230|NCT00897104|76033046|FG000|Overall Study|Protocol Violation|1|||
41977655|NCT03228394|75782354|FG000|Overall Study|Withdrawal by Subject|0|||
41977656|NCT03228394|75782355|FG001|Overall Study|Withdrawal by Subject|0|||
41977657|NCT03228394|75782356|FG002|Overall Study|Withdrawal by Subject|1|||
42216231|NCT00897104|76033047|FG001|Overall Study|Protocol Violation|0|||
42216232|NCT00897104|76033048|FG002|Overall Study|Protocol Violation|0|||
42216233|NCT00897104|76033046|FG000|Overall Study|Withdrawal by Subject|0|||
42216234|NCT00897104|76033047|FG001|Overall Study|Withdrawal by Subject|0|||
42216235|NCT00897104|76033048|FG002|Overall Study|Withdrawal by Subject|1|||
42216236|NCT01339689|76033058|FG000|Overall Study|Adverse Event|1|||
42216237|NCT01339689|76033059|FG001|Overall Study|Adverse Event|2|||
42216238|NCT01339689|76033058|FG000|Overall Study|Lost to Follow-up|9|||
41977658|NCT03228394|75782357|FG003|Overall Study|Withdrawal by Subject|0|||
41977659|NCT03228394|75782358|FG004|Overall Study|Withdrawal by Subject|0|||
41977660|NCT03228394|75782359|FG005|Overall Study|Withdrawal by Subject|0|||
41977661|NCT03228394|75782360|FG006|Overall Study|Withdrawal by Subject|1|||
41977662|NCT03228394|75782361|FG007|Overall Study|Withdrawal by Subject|3|||
41977663|NCT03228394|75782354|FG000|Overall Study|Protocol Violation|0|||
41977664|NCT03228394|75782355|FG001|Overall Study|Protocol Violation|0|||
41977665|NCT03228394|75782356|FG002|Overall Study|Protocol Violation|0|||
41977666|NCT03228394|75782357|FG003|Overall Study|Protocol Violation|1|||
41977667|NCT03228394|75782358|FG004|Overall Study|Protocol Violation|0|||
41977668|NCT03228394|75782359|FG005|Overall Study|Protocol Violation|0|||
41977669|NCT03228394|75782360|FG006|Overall Study|Protocol Violation|0|||
41977670|NCT03228394|75782361|FG007|Overall Study|Protocol Violation|0|||
41977671|NCT03228394|75782354|FG000|Overall Study|Physician Decision|0|||
41977672|NCT03228394|75782355|FG001|Overall Study|Physician Decision|0|||
41977673|NCT03228394|75782356|FG002|Overall Study|Physician Decision|0|||
41977674|NCT03228394|75782357|FG003|Overall Study|Physician Decision|0|||
41977675|NCT03228394|75782358|FG004|Overall Study|Physician Decision|0|||
41977676|NCT03228394|75782359|FG005|Overall Study|Physician Decision|0|||
41977677|NCT03228394|75782360|FG006|Overall Study|Physician Decision|1|||
41977678|NCT03228394|75782361|FG007|Overall Study|Physician Decision|0|||
41977679|NCT03228394|75782354|FG000|Overall Study|Noncompliance|0|||
41977680|NCT03228394|75782355|FG001|Overall Study|Noncompliance|0|||
41977681|NCT03228394|75782356|FG002|Overall Study|Noncompliance|0|||
41977682|NCT03228394|75782357|FG003|Overall Study|Noncompliance|0|||
41977683|NCT03228394|75782358|FG004|Overall Study|Noncompliance|0|||
41977684|NCT03228394|75782359|FG005|Overall Study|Noncompliance|0|||
41977685|NCT03228394|75782360|FG006|Overall Study|Noncompliance|1|||
41977686|NCT03228394|75782361|FG007|Overall Study|Noncompliance|0|||
41977687|NCT03008070|75782383|FG000|Overall Study|Adverse Event|3|||
41977688|NCT03008070|75782384|FG001|Overall Study|Adverse Event|3|||
41977689|NCT03008070|75782385|FG002|Overall Study|Adverse Event|3|||
41977690|NCT03008070|75782383|FG000|Overall Study|Lost to Follow-up|1|||
41977691|NCT03008070|75782384|FG001|Overall Study|Lost to Follow-up|1|||
41977692|NCT03008070|75782385|FG002|Overall Study|Lost to Follow-up|0|||
41977693|NCT03008070|75782383|FG000|Overall Study|Non compliance|0|||
41977694|NCT03008070|75782384|FG001|Overall Study|Non compliance|1|||
41977695|NCT03008070|75782385|FG002|Overall Study|Non compliance|1|||
41977696|NCT03008070|75782383|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
41977697|NCT03008070|75782384|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
41977698|NCT03008070|75782385|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
41977699|NCT03008070|75782383|FG000|Overall Study|Withdrawal by Subject|2|||
41977700|NCT03008070|75782384|FG001|Overall Study|Withdrawal by Subject|0|||
41977701|NCT03008070|75782385|FG002|Overall Study|Withdrawal by Subject|1|||
41977702|NCT03008070|75782383|FG000|Overall Study|Use of prohibited drug|0|||
41977703|NCT03008070|75782384|FG001|Overall Study|Use of prohibited drug|0|||
41977704|NCT03008070|75782385|FG002|Overall Study|Use of prohibited drug|2|||
41977705|NCT02979353|75782397|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
41977706|NCT02979353|75782398|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
41977707|NCT02979353|75782397|FG000|Overall Study|Withdrawal by Subject|16|||
41977708|NCT02979353|75782398|FG001|Overall Study|Withdrawal by Subject|12|||
41977709|NCT02979353|75782397|FG000|Overall Study|Death|10|||
41977710|NCT02979353|75782398|FG001|Overall Study|Death|11|||
41977711|NCT02979353|75782397|FG000|Overall Study|Transfer to Hospice Care|19|||
41977712|NCT02979353|75782398|FG001|Overall Study|Transfer to Hospice Care|14|||
41977713|NCT02979353|75782397|FG000|Overall Study|Lost to Follow-up|1|||
41977714|NCT02979353|75782398|FG001|Overall Study|Lost to Follow-up|5|||
41977715|NCT02633397|75782417|FG000|Overall Study|Adverse Event|8|||
41977716|NCT02633397|75782418|FG001|Overall Study|Adverse Event|8|||
41977717|NCT02633397|75782417|FG000|Overall Study|Study Burden|4|||
41977718|NCT02633397|75782418|FG001|Overall Study|Study Burden|1|||
41977719|NCT02633397|75782417|FG000|Overall Study|Treatment interruption|2|||
41977720|NCT02633397|75782418|FG001|Overall Study|Treatment interruption|5|||
41977721|NCT02633397|75782417|FG000|Overall Study|Death|2|||
41977722|NCT02633397|75782418|FG001|Overall Study|Death|2|||
41977723|NCT02633397|75782417|FG000|Overall Study|Physician Decision|0|||
41977724|NCT02633397|75782418|FG001|Overall Study|Physician Decision|1|||
41977725|NCT02592707|75782428|FG000|Overall Study|Consent Withdrawn|0|||
41977726|NCT02592707|75782429|FG001|Overall Study|Consent Withdrawn|1|||
41977727|NCT02592707|75782430|FG002|Overall Study|Consent Withdrawn|2|||
41977728|NCT02592707|75782431|FG003|Overall Study|Consent Withdrawn|0|||
41977729|NCT02592707|75782428|FG000|Overall Study|Death|1|||
41977730|NCT02592707|75782429|FG001|Overall Study|Death|0|||
41977731|NCT02592707|75782430|FG002|Overall Study|Death|0|||
41977732|NCT02592707|75782431|FG003|Overall Study|Death|0|||
41977733|NCT02592707|75782428|FG000|Overall Study|Progressive Disease|4|||
41977734|NCT02592707|75782429|FG001|Overall Study|Progressive Disease|4|||
41977735|NCT02592707|75782430|FG002|Overall Study|Progressive Disease|3|||
41977736|NCT02592707|75782431|FG003|Overall Study|Progressive Disease|3|||
41977737|NCT02592707|75782428|FG000|Overall Study|Other|0|||
42128926|NCT03548558|75939797|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
42128927|NCT03548558|75939791|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
42128928|NCT03548558|75939792|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
42216239|NCT01339689|76033059|FG001|Overall Study|Lost to Follow-up|3|||
42216240|NCT01339689|76033058|FG000|Overall Study|Withdrawal by Subject|3|||
42216241|NCT01339689|76033059|FG001|Overall Study|Withdrawal by Subject|0|||
42216242|NCT01339689|76033058|FG000|Overall Study|Noncompliance|1|||
42216243|NCT01339689|76033059|FG001|Overall Study|Noncompliance|0|||
42216244|NCT01339689|76033058|FG000|Overall Study|Relocated out of area|0|||
42216245|NCT01339689|76033059|FG001|Overall Study|Relocated out of area|1|||
42216246|NCT01339689|76033058|FG000|Overall Study|Other|2|||
42216247|NCT01339689|76033059|FG001|Overall Study|Other|2|||
42216248|NCT01339689|76033058|FG000|Overall Study|multiple reasons|1|||
42216249|NCT01339689|76033059|FG001|Overall Study|multiple reasons|1|||
42216250|NCT03038126|76033067|FG000|Overall Study|Death|1|||
42216251|NCT03038126|76033068|FG001|Overall Study|Death|1|||
42216252|NCT03038126|76033067|FG000|Overall Study|Withdrawal by Subject|5|||
42216253|NCT03038126|76033068|FG001|Overall Study|Withdrawal by Subject|0|||
42216254|NCT03038126|76033067|FG000|Overall Study|Lost to Follow-up|0|||
42216255|NCT03038126|76033068|FG001|Overall Study|Lost to Follow-up|1|||
42216256|NCT03038126|76033067|FG000|Overall Study|Long Term Hospitalization|2|||
42216257|NCT03038126|76033068|FG001|Overall Study|Long Term Hospitalization|0|||
42216258|NCT03038126|76033067|FG000|Overall Study|Too Ill to Participate|1|||
42216259|NCT03038126|76033068|FG001|Overall Study|Too Ill to Participate|2|||
42216260|NCT00696878|76033074|FG000|Overall Study|Adverse Event|8|||
42216261|NCT00696878|76033074|FG000|Overall Study|Withdrawal by Subject|87|||
42216262|NCT00696878|76033074|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
42216263|NCT00696878|76033074|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
42216264|NCT00696878|76033074|FG000|Overall Study|Trial stopped|32|||
42216265|NCT00696878|76033074|FG000|Overall Study|Other reason (not specified)|55|||
42216266|NCT00696800|76033080|FG000|Overall Study|Adverse Event|16|||
42216267|NCT00696800|76033081|FG001|Overall Study|Adverse Event|3|||
42216268|NCT00696800|76033080|FG000|Overall Study|Insufficient compliance with medication|2|||
42216269|NCT00696800|76033081|FG001|Overall Study|Insufficient compliance with medication|1|||
42216270|NCT00696800|76033080|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
42216271|NCT00696800|76033081|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
42216272|NCT00696800|76033080|FG000|Overall Study|Insufficient ovarian response|4|||
42216273|NCT00696800|76033081|FG001|Overall Study|Insufficient ovarian response|1|||
42216274|NCT00696800|76033080|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
42216275|NCT00696800|76033081|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
42216276|NCT00696800|76033080|FG000|Overall Study|Too high ovarian response|6|||
42216277|NCT00696800|76033081|FG001|Overall Study|Too high ovarian response|1|||
42216278|NCT00696800|76033080|FG000|Overall Study|No/too few/bad quality oocytes|4|||
42216279|NCT00696800|76033081|FG001|Overall Study|No/too few/bad quality oocytes|3|||
42216280|NCT00696800|76033080|FG000|Overall Study|No/abnormal fertilization|11|||
42216281|NCT00696800|76033081|FG001|Overall Study|No/abnormal fertilization|13|||
42216282|NCT00696800|76033080|FG000|Overall Study|No/too few/bad quality embryos|24|||
42216283|NCT00696800|76033081|FG001|Overall Study|No/too few/bad quality embryos|18|||
42216284|NCT00696800|76033080|FG000|Overall Study|Other Reasons|5|||
42216285|NCT00696800|76033081|FG001|Overall Study|Other Reasons|3|||
42216286|NCT00696800|76033080|FG000|Overall Study|Not treated|1|||
42216287|NCT00696800|76033081|FG001|Overall Study|Not treated|2|||
42216288|NCT00289874|76033089|FG000|Overall Study|Adverse Event|1|||
42216289|NCT00289874|76033090|FG001|Overall Study|Adverse Event|5|||
42216290|NCT00289874|76033089|FG000|Overall Study|Lost to Follow-up|1|||
42216291|NCT00289874|76033090|FG001|Overall Study|Lost to Follow-up|1|||
42128929|NCT03548558|75939793|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
42128930|NCT03548558|75939794|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
41977738|NCT02592707|75782429|FG001|Overall Study|Other|0|||
41977739|NCT02592707|75782430|FG002|Overall Study|Other|1|||
41977740|NCT02592707|75782431|FG003|Overall Study|Other|2|||
41977741|NCT02592707|75782428|FG000|Overall Study|Never entered LTFU period|1|||
42216292|NCT00289874|76033089|FG000|Overall Study|Protocol Violation|3|||
41977742|NCT02592707|75782429|FG001|Overall Study|Never entered LTFU period|0|||
42128931|NCT03548558|75939795|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
42216293|NCT00289874|76033090|FG001|Overall Study|Protocol Violation|2|||
42216294|NCT00289874|76033089|FG000|Overall Study|Did not meet eligibility|1|||
42216295|NCT00289874|76033090|FG001|Overall Study|Did not meet eligibility|0|||
42216296|NCT00245570|76033096|FG000|Washout Between Periods III and IV|Adverse Event|0|||
42216297|NCT00245570|76033097|FG001|Washout Between Periods III and IV|Adverse Event|1|||
42216298|NCT00245570|76033098|FG002|Washout Between Periods III and IV|Adverse Event|0|||
42216299|NCT00245570|76033099|FG003|Washout Between Periods III and IV|Adverse Event|0|||
41977743|NCT02592707|75782430|FG002|Overall Study|Never entered LTFU period|0|||
41977744|NCT02592707|75782431|FG003|Overall Study|Never entered LTFU period|2|||
41977745|NCT01423812|75782459|FG000|Overall Study|Lost to Follow-up|2|||
41977746|NCT01423812|75782460|FG001|Overall Study|Lost to Follow-up|2|||
41977747|NCT01423812|75782459|FG000|Overall Study|Withdrawal by Subject|1|||
41977748|NCT01423812|75782460|FG001|Overall Study|Withdrawal by Subject|2|||
41977749|NCT00965718|75782468|FG000|Overall Study|Withdrawal by Subject|4|||
41977750|NCT00792740|75782483|FG000|Overall Study|Disease Worsening|3|||
41977751|NCT00792740|75782484|FG001|Overall Study|Disease Worsening|2|||
41977752|NCT00792740|75782483|FG000|Overall Study|Personal Reason|1|||
41977753|NCT00792740|75782484|FG001|Overall Study|Personal Reason|0|||
41977754|NCT00792740|75782483|FG000|Overall Study|Adverse Event|1|||
41977755|NCT00792740|75782484|FG001|Overall Study|Adverse Event|3|||
41977756|NCT00792740|75782483|FG000|Overall Study|Patient's withdrawal of consent|0|||
41977757|NCT00792740|75782484|FG001|Overall Study|Patient's withdrawal of consent|1|||
41977758|NCT00792740|75782483|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
41977759|NCT00792740|75782484|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
41977760|NCT00792740|75782483|FG000|Overall Study|Other reasons|0|||
41977761|NCT00792740|75782484|FG001|Overall Study|Other reasons|1|||
41977762|NCT00567580|75782503|FG000|Overall Study|Protocol Violation|28|||
41977763|NCT00567580|75782504|FG001|Overall Study|Protocol Violation|24|||
41977764|NCT00567580|75782505|FG002|Overall Study|Protocol Violation|24|||
41977765|NCT01058863|75782516|FG000|Overall Study|Lost to Follow-up|1|||
41977766|NCT01058863|75782516|FG000|Overall Study|Withdrawal by Subject|1|||
41977767|NCT01058863|75782516|FG000|Overall Study|Sponsor requested withdrawal|1|||
41977768|NCT01058863|75782516|FG000|Overall Study|Randomized in error|1|||
41977769|NCT01058395|75782531|FG000|Overall Study|Death|2|||
41977770|NCT01058395|75782532|FG001|Overall Study|Death|1|||
41977771|NCT01058395|75782531|FG000|Overall Study|Lost to Follow-up|1|||
41977772|NCT01058395|75782532|FG001|Overall Study|Lost to Follow-up|0|||
41977773|NCT01058356|75782538|FG000|Overall Study|Adverse Event|5|||
41977774|NCT01058356|75782538|FG000|Overall Study|Administration of contraindicated drugs|12|||
41977775|NCT01058356|75782538|FG000|Overall Study|Withdrawal by Subject|21|||
41977776|NCT01058356|75782538|FG000|Overall Study|Lost to Follow-up|4|||
41977777|NCT01058005|75782545|FG000|Overall Study|Adverse Event|0|||
41977778|NCT01058005|75782546|FG001|Overall Study|Adverse Event|2|||
41977779|NCT01058005|75782547|FG002|Overall Study|Adverse Event|1|||
41977780|NCT01058005|75782545|FG000|Overall Study|Physician Decision|2|||
41977781|NCT01058005|75782546|FG001|Overall Study|Physician Decision|2|||
41977782|NCT01058005|75782547|FG002|Overall Study|Physician Decision|0|||
41977783|NCT01058005|75782545|FG000|Overall Study|Withdrawal by Subject|4|||
41977784|NCT01058005|75782546|FG001|Overall Study|Withdrawal by Subject|5|||
41977785|NCT01058005|75782547|FG002|Overall Study|Withdrawal by Subject|11|||
41977786|NCT01058005|75782545|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
41977787|NCT01058005|75782546|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
41977788|NCT01058005|75782547|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
41977789|NCT01058005|75782545|FG000|Overall Study|Reason Missing|5|||
41977790|NCT01058005|75782546|FG001|Overall Study|Reason Missing|3|||
41977791|NCT01058005|75782547|FG002|Overall Study|Reason Missing|1|||
41977792|NCT01056640|75782557|FG000|Overall Study|Withdrawal by Subject|11|||
41977793|NCT01056640|75782558|FG001|Overall Study|Withdrawal by Subject|8|||
41977794|NCT01056640|75782557|FG000|Overall Study|Death|15|||
41977795|NCT01056640|75782558|FG001|Overall Study|Death|4|||
41977796|NCT01056484|75782566|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
41977797|NCT01056484|75782567|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
41977798|NCT01056484|75782566|FG000|Randomized Controlled Trial|Physician Decision|1|||
41977799|NCT01056484|75782567|FG001|Randomized Controlled Trial|Physician Decision|0|||
41977800|NCT01056484|75782566|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
41977801|NCT01056484|75782567|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
41977802|NCT01055314|75782576|FG000|Overall Study|Adverse Event|7|||
42128932|NCT03548558|75939796|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
42216300|NCT00245570|76033100|FG004|Washout Between Periods III and IV|Adverse Event|0|||
41977803|NCT01055314|75782577|FG001|Overall Study|Adverse Event|4|||
41977804|NCT01055314|75782576|FG000|Overall Study|Death|2|||
41977805|NCT01055314|75782577|FG001|Overall Study|Death|1|||
41977806|NCT01055314|75782576|FG000|Overall Study|Lack of Efficacy|11|||
41977807|NCT01055314|75782577|FG001|Overall Study|Lack of Efficacy|19|||
41977808|NCT01055314|75782576|FG000|Overall Study|Physician Decision|10|||
41977809|NCT01055314|75782577|FG001|Overall Study|Physician Decision|5|||
41977810|NCT01055314|75782576|FG000|Overall Study|Withdrawal by Subject|1|||
41977811|NCT01055314|75782577|FG001|Overall Study|Withdrawal by Subject|0|||
41977812|NCT01055314|75782576|FG000|Overall Study|Ineligible|3|||
41977813|NCT01055314|75782577|FG001|Overall Study|Ineligible|5|||
41977814|NCT01055314|75782576|FG000|Overall Study|Refusal of further protocol therapy|10|||
41977815|NCT01055314|75782577|FG001|Overall Study|Refusal of further protocol therapy|4|||
41977816|NCT01055314|75782576|FG000|Overall Study|No treatment|1|||
41977817|NCT01055314|75782577|FG001|Overall Study|No treatment|0|||
41977818|NCT01055197|75782586|FG000|Overall Study|Protocol Violation|7|||
41977819|NCT01055197|75782587|FG001|Overall Study|Protocol Violation|2|||
42302022|NCT02484547|76137186|FG006|Placebo-Controlled Period|Investigator Decision|0|||
42302023|NCT02484547|76137180|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
42302024|NCT02484547|76137181|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
42302025|NCT02484547|76137182|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
42302026|NCT02484547|76137183|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
42302027|NCT02484547|76137184|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
42302028|NCT02484547|76137185|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
42302029|NCT02484547|76137186|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
42302030|NCT02484547|76137180|FG000|Placebo-Controlled Period|Relocation|1|||
42302031|NCT02484547|76137181|FG001|Placebo-Controlled Period|Relocation|1|||
42216301|NCT00245570|76033101|FG005|Washout Between Periods III and IV|Adverse Event|0|||
42216302|NCT04638660|76033137|FG000|Overall Study|Withdrawal by Subject|2|||
42216303|NCT04638660|76033138|FG001|Overall Study|Withdrawal by Subject|0|||
42216304|NCT04638660|76033137|FG000|Overall Study|Lost to Follow-up|1|||
42302032|NCT02484547|76137182|FG002|Placebo-Controlled Period|Relocation|1|||
42302033|NCT02484547|76137183|FG003|Placebo-Controlled Period|Relocation|0|||
42302034|NCT02484547|76137184|FG004|Placebo-Controlled Period|Relocation|0|||
42302035|NCT02484547|76137185|FG005|Placebo-Controlled Period|Relocation|0|||
42302036|NCT02484547|76137186|FG006|Placebo-Controlled Period|Relocation|0|||
42216305|NCT04638660|76033138|FG001|Overall Study|Lost to Follow-up|0|||
42216306|NCT04367480|76033147|FG000|Overall Study|Adverse Event|1|||
42216307|NCT04367480|76033148|FG001|Overall Study|Adverse Event|1|||
42216308|NCT04367480|76033147|FG000|Overall Study|Death|1|||
42216309|NCT04367480|76033148|FG001|Overall Study|Death|0|||
42216310|NCT04367480|76033147|FG000|Overall Study|Lost to Follow-up|1|||
42216311|NCT04367480|76033148|FG001|Overall Study|Lost to Follow-up|1|||
42216312|NCT04367480|76033147|FG000|Overall Study|Withdrawal by Subject|0|||
42216313|NCT04367480|76033148|FG001|Overall Study|Withdrawal by Subject|3|||
42028486|NCT01136772|75836923|FG000|Overall Study|Did not receive injection|10|||
42302037|NCT02484547|76137180|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
42302038|NCT02484547|76137181|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
42302039|NCT02484547|76137182|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
42302040|NCT02484547|76137183|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
42302041|NCT02484547|76137184|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
42302042|NCT02484547|76137185|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
42128933|NCT03548558|75939797|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
42128934|NCT03548558|75939791|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
42128935|NCT03548558|75939792|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
42128936|NCT03548558|75939793|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
42128937|NCT03548558|75939794|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
42128938|NCT03548558|75939795|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
42128939|NCT03548558|75939796|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
42128940|NCT03548558|75939797|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
42128941|NCT03548558|75939791|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
42128942|NCT03548558|75939792|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
42128943|NCT03548558|75939793|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
42128944|NCT03548558|75939794|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
42128945|NCT03548558|75939795|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
42128946|NCT03548558|75939796|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
42128947|NCT03548558|75939797|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
42128948|NCT03548558|75939791|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
42128949|NCT03548558|75939792|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
42128950|NCT03548558|75939793|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
42128951|NCT03548558|75939794|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
42128952|NCT03548558|75939795|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
42216314|NCT04367480|76033147|FG000|Overall Study|App glitch during the study|1|||
42216315|NCT04367480|76033148|FG001|Overall Study|App glitch during the study|0|||
42216316|NCT04367480|76033147|FG000|Overall Study|Device Distribution Error|0|||
42216317|NCT04367480|76033148|FG001|Overall Study|Device Distribution Error|2|||
42216318|NCT04367480|76033147|FG000|Overall Study|Ineligible after Randomization|0|||
42302043|NCT02484547|76137186|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
42302044|NCT02484547|76137180|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
42216319|NCT04367480|76033148|FG001|Overall Study|Ineligible after Randomization|1|||
42216320|NCT04367480|76033147|FG000|Overall Study|Other Medical Reasons|0|||
42302045|NCT02484547|76137181|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
42128953|NCT03548558|75939796|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
42128954|NCT03548558|75939797|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
42128955|NCT03548558|75939791|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
42128956|NCT03548558|75939792|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
42128957|NCT03548558|75939793|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
42128958|NCT03548558|75939794|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
42128959|NCT03548558|75939795|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
42128960|NCT03548558|75939796|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
42128961|NCT03548558|75939797|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
42128962|NCT03364673|75939859|FG000|Overall Study|Withdrawal by Subject|2|||
42128963|NCT03364673|75939859|FG000|Overall Study|Injury unrelated to study|3|||
42128964|NCT03330405|75939874|FG000|Overall Study|Other|1|||
42216321|NCT04367480|76033148|FG001|Overall Study|Other Medical Reasons|2|||
42216322|NCT04137731|76033171|FG000|Overall Study|Surgery Cancellation|1|||
42216323|NCT04137731|76033172|FG001|Overall Study|Surgery Cancellation|2|||
41977820|NCT01055197|75782586|FG000|Overall Study|Withdrawal by Subject|2|||
42128965|NCT03330405|75939875|FG001|Overall Study|Other|3|||
42128966|NCT03330405|75939876|FG002|Overall Study|Other|1|||
42128967|NCT03330405|75939877|FG003|Overall Study|Other|0|||
42128968|NCT03330405|75939878|FG004|Overall Study|Other|2|||
42128969|NCT03330405|75939879|FG005|Overall Study|Other|0|||
42128970|NCT03330405|75939880|FG006|Overall Study|Other|1|||
42128971|NCT03330405|75939881|FG007|Overall Study|Other|0|||
42128972|NCT03330405|75939882|FG008|Overall Study|Other|0|||
42128973|NCT03330405|75939883|FG009|Overall Study|Other|0|||
42128974|NCT03330405|75939884|FG010|Overall Study|Other|0|||
42128975|NCT03330405|75939874|FG000|Overall Study|Progressive disease|8|||
41977821|NCT01055197|75782587|FG001|Overall Study|Withdrawal by Subject|0|||
41977822|NCT01054885|75782599|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
42128976|NCT03330405|75939875|FG001|Overall Study|Progressive disease|27|||
42128977|NCT03330405|75939876|FG002|Overall Study|Progressive disease|4|||
42128978|NCT03330405|75939877|FG003|Overall Study|Progressive disease|18|||
42128979|NCT03330405|75939878|FG004|Overall Study|Progressive disease|16|||
42128980|NCT03330405|75939879|FG005|Overall Study|Progressive disease|14|||
42128981|NCT03330405|75939880|FG006|Overall Study|Progressive disease|7|||
42128982|NCT03330405|75939881|FG007|Overall Study|Progressive disease|29|||
42128983|NCT03330405|75939882|FG008|Overall Study|Progressive disease|9|||
42128984|NCT03330405|75939883|FG009|Overall Study|Progressive disease|11|||
42128985|NCT03330405|75939884|FG010|Overall Study|Progressive disease|5|||
42128986|NCT03330405|75939874|FG000|Overall Study|Withdrawal by Subject|1|||
42128987|NCT03330405|75939875|FG001|Overall Study|Withdrawal by Subject|4|||
42128988|NCT03330405|75939876|FG002|Overall Study|Withdrawal by Subject|0|||
42128989|NCT03330405|75939877|FG003|Overall Study|Withdrawal by Subject|1|||
42128990|NCT03330405|75939878|FG004|Overall Study|Withdrawal by Subject|1|||
42128991|NCT03330405|75939879|FG005|Overall Study|Withdrawal by Subject|1|||
42128992|NCT03330405|75939880|FG006|Overall Study|Withdrawal by Subject|0|||
42128993|NCT03330405|75939881|FG007|Overall Study|Withdrawal by Subject|2|||
42128994|NCT03330405|75939882|FG008|Overall Study|Withdrawal by Subject|2|||
42128995|NCT03330405|75939883|FG009|Overall Study|Withdrawal by Subject|1|||
42128996|NCT03330405|75939884|FG010|Overall Study|Withdrawal by Subject|1|||
42128997|NCT03330405|75939874|FG000|Overall Study|Global deterioration of health status|2|||
42128998|NCT03330405|75939875|FG001|Overall Study|Global deterioration of health status|3|||
42128999|NCT03330405|75939876|FG002|Overall Study|Global deterioration of health status|0|||
42129000|NCT03330405|75939877|FG003|Overall Study|Global deterioration of health status|2|||
42129001|NCT03330405|75939878|FG004|Overall Study|Global deterioration of health status|3|||
42129002|NCT03330405|75939879|FG005|Overall Study|Global deterioration of health status|3|||
42129003|NCT03330405|75939880|FG006|Overall Study|Global deterioration of health status|0|||
42129004|NCT03330405|75939881|FG007|Overall Study|Global deterioration of health status|2|||
42129005|NCT03330405|75939882|FG008|Overall Study|Global deterioration of health status|8|||
42129006|NCT03330405|75939883|FG009|Overall Study|Global deterioration of health status|4|||
42129007|NCT03330405|75939884|FG010|Overall Study|Global deterioration of health status|1|||
42129008|NCT03330405|75939874|FG000|Overall Study|Adverse Event|0|||
41977823|NCT01054885|75782600|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
41977824|NCT01054885|75782601|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
42129009|NCT03330405|75939875|FG001|Overall Study|Adverse Event|1|||
42129010|NCT03330405|75939876|FG002|Overall Study|Adverse Event|0|||
42129011|NCT03330405|75939877|FG003|Overall Study|Adverse Event|1|||
42129012|NCT03330405|75939878|FG004|Overall Study|Adverse Event|1|||
42129013|NCT03330405|75939879|FG005|Overall Study|Adverse Event|1|||
41977825|NCT01054885|75782602|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
42129014|NCT03330405|75939880|FG006|Overall Study|Adverse Event|3|||
42129015|NCT03330405|75939881|FG007|Overall Study|Adverse Event|4|||
42129016|NCT03330405|75939882|FG008|Overall Study|Adverse Event|2|||
41977826|NCT01054885|75782603|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
41977827|NCT01054885|75782604|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
41977828|NCT01054885|75782605|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
41977829|NCT01054885|75782599|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
41977830|NCT01054885|75782600|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
41977831|NCT01054885|75782601|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
41977832|NCT01054885|75782602|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
41977833|NCT01054885|75782603|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
41977834|NCT01054885|75782604|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
41977835|NCT01054885|75782605|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
41977836|NCT01054885|75782599|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
41977837|NCT01054885|75782600|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
41977838|NCT01054885|75782601|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
41977839|NCT01054885|75782602|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
42129017|NCT03330405|75939883|FG009|Overall Study|Adverse Event|2|||
42216324|NCT04137731|76033171|FG000|Overall Study|Withdrawal by Subject|2|||
42216325|NCT04137731|76033172|FG001|Overall Study|Withdrawal by Subject|0|||
42216326|NCT04137731|76033171|FG000|Overall Study|Protocol Violation|0|||
42216327|NCT04137731|76033172|FG001|Overall Study|Protocol Violation|1|||
42216328|NCT04088760|76033187|FG000|Overall Study|Physician Decision|1|||
42216329|NCT03813238|76033206|FG000|Overall Study|Adverse Event|0|||
42216330|NCT03813238|76033207|FG001|Overall Study|Adverse Event|6|||
42216331|NCT03813238|76033206|FG000|Overall Study|Withdrawal by parent/guardian|0|||
42216332|NCT03813238|76033207|FG001|Overall Study|Withdrawal by parent/guardian|2|||
42216333|NCT03813238|76033206|FG000|Overall Study|Lost to Follow-up|0|||
42216334|NCT03813238|76033207|FG001|Overall Study|Lost to Follow-up|1|||
42216335|NCT03813238|76033206|FG000|Overall Study|Other than specified|1|||
42216336|NCT03813238|76033207|FG001|Overall Study|Other than specified|2|||
42216337|NCT03737240|76033215|FG000|Overall Study|Lost to Follow-up|16|||
42216338|NCT03737240|76033216|FG001|Overall Study|Lost to Follow-up|15|||
42216339|NCT03532178|76033224|FG000|First Period|Withdrawal by Subject|1|||
42216340|NCT03532178|76033225|FG001|First Period|Withdrawal by Subject|3|||
42216341|NCT03532178|76033224|FG000|First Period|technical issues in data collection Technical issues|0|||
42216342|NCT03532178|76033225|FG001|First Period|technical issues in data collection Technical issues|1|||
42216343|NCT03532178|76033224|FG000|Second Period|Withdrawal by Subject|1|||
42216344|NCT03532178|76033225|FG001|Second Period|Withdrawal by Subject|1|||
42216345|NCT03532178|76033224|FG000|Second Period|Technical issues|0|||
42216346|NCT03532178|76033225|FG001|Second Period|Technical issues|1|||
42216347|NCT03526549|76033233|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
42216348|NCT03526549|76033234|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
42216349|NCT03526549|76033233|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
42216350|NCT03526549|76033234|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
42216351|NCT03526549|76033233|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
42216352|NCT03526549|76033234|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
42216353|NCT03526549|76033233|FG000|Open-label Phase|Adverse Event|4|||
42216354|NCT03526549|76033234|FG001|Open-label Phase|Adverse Event|0|||
42216355|NCT03526549|76033233|FG000|Open-label Phase|Withdrawal by Subject|54|||
42216356|NCT03526549|76033234|FG001|Open-label Phase|Withdrawal by Subject|0|||
42216357|NCT03526549|76033233|FG000|Open-label Phase|Lost to Follow-up|35|||
42216358|NCT03526549|76033234|FG001|Open-label Phase|Lost to Follow-up|0|||
42216359|NCT03526549|76033233|FG000|Open-label Phase|Other than Specified|5|||
42216360|NCT03526549|76033234|FG001|Open-label Phase|Other than Specified|0|||
42216361|NCT03449901|76033248|FG000|Overall Study|Progression|57|||
42216362|NCT03449901|76033249|FG001|Overall Study|Progression|12|||
42302046|NCT02484547|76137182|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
41977840|NCT01054885|75782603|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
41977841|NCT01054885|75782604|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
42129018|NCT03330405|75939884|FG010|Overall Study|Adverse Event|2|||
42129019|NCT03330405|75939874|FG000|Overall Study|Death|0|||
42129020|NCT03330405|75939875|FG001|Overall Study|Death|4|||
42129021|NCT03330405|75939876|FG002|Overall Study|Death|0|||
42129022|NCT03330405|75939877|FG003|Overall Study|Death|0|||
42129023|NCT03330405|75939878|FG004|Overall Study|Death|0|||
42129024|NCT03330405|75939879|FG005|Overall Study|Death|1|||
42129025|NCT03330405|75939880|FG006|Overall Study|Death|0|||
42216363|NCT03449901|76033248|FG000|Overall Study|Adverse Event|3|||
42216364|NCT03449901|76033249|FG001|Overall Study|Adverse Event|0|||
42216365|NCT03449901|76033248|FG000|Overall Study|Death|6|||
42216366|NCT03449901|76033249|FG001|Overall Study|Death|2|||
42216367|NCT03449901|76033248|FG000|Overall Study|Withdrawal by Subject|12|||
41977842|NCT01054885|75782605|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
42129026|NCT03330405|75939881|FG007|Overall Study|Death|2|||
42129027|NCT03330405|75939882|FG008|Overall Study|Death|0|||
41977843|NCT01054885|75782599|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
41977844|NCT01054885|75782600|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
41977845|NCT01054885|75782601|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
41977846|NCT01054885|75782602|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
41977847|NCT01054885|75782603|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
41977848|NCT01054885|75782604|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
41977849|NCT01054885|75782605|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
41977850|NCT01054885|75782599|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
42216368|NCT03449901|76033249|FG001|Overall Study|Withdrawal by Subject|1|||
42216369|NCT03449901|76033248|FG000|Overall Study|Physician Decision|1|||
42216370|NCT03449901|76033249|FG001|Overall Study|Physician Decision|0|||
42216371|NCT03449901|76033248|FG000|Overall Study|Patient elected for surgical intervention|1|||
42216372|NCT03449901|76033249|FG001|Overall Study|Patient elected for surgical intervention|0|||
42216373|NCT03449901|76033248|FG000|Overall Study|Patient off for other complicating disease|1|||
42216374|NCT03449901|76033249|FG001|Overall Study|Patient off for other complicating disease|0|||
42216375|NCT03435380|76033264|FG000|Overall Study|Death|1|||
42216376|NCT03435380|76033265|FG001|Overall Study|Death|2|||
42216377|NCT03435380|76033266|FG002|Overall Study|Death|1|||
42216378|NCT03435380|76033264|FG000|Overall Study|Lost to Follow-up|12|||
42216379|NCT03435380|76033265|FG001|Overall Study|Lost to Follow-up|8|||
42216380|NCT03435380|76033266|FG002|Overall Study|Lost to Follow-up|6|||
42216381|NCT03435380|76033264|FG000|Overall Study|Physician Decision|1|||
42216382|NCT03435380|76033265|FG001|Overall Study|Physician Decision|0|||
42216383|NCT03435380|76033266|FG002|Overall Study|Physician Decision|0|||
42216384|NCT03435380|76033264|FG000|Overall Study|Withdrawal by Subject|0|||
42216385|NCT03435380|76033265|FG001|Overall Study|Withdrawal by Subject|1|||
42216386|NCT03435380|76033266|FG002|Overall Study|Withdrawal by Subject|1|||
42216387|NCT03435380|76033264|FG000|Overall Study|Ineligible|0|||
42216388|NCT03435380|76033265|FG001|Overall Study|Ineligible|1|||
42216389|NCT03435380|76033266|FG002|Overall Study|Ineligible|1|||
42216390|NCT03363659|76033274|FG000|Overall Study|Adverse Event|1|||
42216391|NCT03363659|76033274|FG000|Overall Study|Screen fail|1|||
42216392|NCT03363659|76033274|FG000|Overall Study|Withdrawal by Subject|1|||
42216393|NCT03299166|76033280|FG000|Overall Study|Adverse Event|9|||
42216394|NCT03299166|76033281|FG001|Overall Study|Adverse Event|4|||
42216395|NCT03299166|76033280|FG000|Overall Study|Withdrawal by Subject|6|||
42216396|NCT03299166|76033281|FG001|Overall Study|Withdrawal by Subject|5|||
42216397|NCT03299166|76033280|FG000|Overall Study|Physician Decision|1|||
42216398|NCT03299166|76033281|FG001|Overall Study|Physician Decision|1|||
42216399|NCT03299166|76033280|FG000|Overall Study|Sponsor Decision|3|||
42216400|NCT03299166|76033281|FG001|Overall Study|Sponsor Decision|0|||
42216401|NCT03299166|76033280|FG000|Overall Study|Lost to Follow-up|2|||
42216402|NCT03299166|76033281|FG001|Overall Study|Lost to Follow-up|4|||
42216403|NCT03299166|76033280|FG000|Overall Study|Randomization Error|0|||
42216404|NCT03299166|76033281|FG001|Overall Study|Randomization Error|1|||
42216405|NCT03299166|76033280|FG000|Overall Study|Subject unable to return due to COVID|1|||
42302047|NCT02484547|76137183|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
41977851|NCT01054885|75782600|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
41977852|NCT01054885|75782601|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
41977853|NCT01054885|75782602|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
42129028|NCT03330405|75939883|FG009|Overall Study|Death|0|||
42129029|NCT03330405|75939884|FG010|Overall Study|Death|0|||
42129030|NCT03330405|75939874|FG000|Overall Study|Physician Decision|0|||
42129031|NCT03330405|75939875|FG001|Overall Study|Physician Decision|0|||
42129032|NCT03330405|75939876|FG002|Overall Study|Physician Decision|0|||
42129033|NCT03330405|75939877|FG003|Overall Study|Physician Decision|0|||
42129034|NCT03330405|75939878|FG004|Overall Study|Physician Decision|0|||
42129035|NCT03330405|75939879|FG005|Overall Study|Physician Decision|0|||
42129036|NCT03330405|75939880|FG006|Overall Study|Physician Decision|0|||
42129037|NCT03330405|75939881|FG007|Overall Study|Physician Decision|1|||
42129038|NCT03330405|75939882|FG008|Overall Study|Physician Decision|0|||
42129039|NCT03330405|75939883|FG009|Overall Study|Physician Decision|0|||
42129040|NCT03330405|75939884|FG010|Overall Study|Physician Decision|0|||
42129041|NCT02683239|75940029|FG000|Overall Study|Protocol Violation|35|||
42129042|NCT02683239|75940030|FG001|Overall Study|Protocol Violation|23|||
42129043|NCT02683239|75940031|FG002|Overall Study|Protocol Violation|26|||
42129044|NCT02683239|75940032|FG003|Overall Study|Protocol Violation|4|||
42216406|NCT03299166|76033281|FG001|Overall Study|Subject unable to return due to COVID|0|||
42216407|NCT03299166|76033280|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
42216408|NCT03299166|76033281|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
42129045|NCT02683239|75940033|FG004|Overall Study|Protocol Violation|35|||
42129046|NCT02683239|75940034|FG005|Overall Study|Protocol Violation|4|||
42129047|NCT02683239|75940035|FG006|Overall Study|Protocol Violation|5|||
42216409|NCT03204812|76033287|FG000|Overall Study|Adverse Event|3|||
42216410|NCT03201250|76033294|FG000|Overall Study|screen failures|3|||
42216411|NCT03201250|76033295|FG001|Overall Study|screen failures|0|||
42216412|NCT03201250|76033296|FG002|Overall Study|screen failures|0|||
42216413|NCT03149029|76033307|FG000|Overall Study|Adverse Event|2|||
42216414|NCT03149029|76033308|FG001|Overall Study|Adverse Event|0|||
42216415|NCT02853305|76033318|FG000|Overall Study|Death|287|||
42216416|NCT02853305|76033319|FG001|Overall Study|Death|249|||
42216417|NCT02853305|76033320|FG002|Overall Study|Death|300|||
42216418|NCT02853305|76033318|FG000|Overall Study|Withdrawal by Subject|2|||
42216419|NCT02853305|76033319|FG001|Overall Study|Withdrawal by Subject|8|||
42216420|NCT02853305|76033320|FG002|Overall Study|Withdrawal by Subject|3|||
42216421|NCT02853305|76033318|FG000|Overall Study|Transferred to Extension Study|46|||
42216422|NCT02853305|76033319|FG001|Overall Study|Transferred to Extension Study|30|||
42216423|NCT02853305|76033320|FG002|Overall Study|Transferred to Extension Study|25|||
42216424|NCT02853305|76033318|FG000|Overall Study|Did Not Continue on Extension Study|16|||
41977854|NCT01054885|75782603|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
41977855|NCT01054885|75782604|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
41977856|NCT01054885|75782605|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
42216425|NCT02853305|76033319|FG001|Overall Study|Did Not Continue on Extension Study|20|||
42216426|NCT02853305|76033320|FG002|Overall Study|Did Not Continue on Extension Study|24|||
42216427|NCT02524275|76033330|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
42216428|NCT02499120|76033336|FG000|Overall Study|Death|52|||
42216429|NCT02499120|76033337|FG001|Overall Study|Death|43|||
42216430|NCT02499120|76033336|FG000|Overall Study|Lost to Follow-up|1|||
42216431|NCT02499120|76033337|FG001|Overall Study|Lost to Follow-up|2|||
42216432|NCT02499120|76033336|FG000|Overall Study|Participant refused further follow-up|1|||
42216433|NCT02499120|76033337|FG001|Overall Study|Participant refused further follow-up|0|||
42216434|NCT02499120|76033336|FG000|Overall Study|Withdrawal by Subject|2|||
42216435|NCT02499120|76033337|FG001|Overall Study|Withdrawal by Subject|5|||
42216436|NCT02499120|76033336|FG000|Overall Study|Other|9|||
42216437|NCT02499120|76033337|FG001|Overall Study|Other|10|||
42216438|NCT02227992|76033345|FG000|Overall Study|Lost to Follow-up|1|||
42216439|NCT02227992|76033346|FG001|Overall Study|Lost to Follow-up|1|||
42216440|NCT01027143|76033358|FG000|Overall Study|Lost to Follow-up|9|||
42216441|NCT01027143|76033359|FG001|Overall Study|Lost to Follow-up|4|||
42216442|NCT00981656|76033365|FG000|Overall Study|Protocol Violation|1|||
42216443|NCT00981656|76033365|FG000|Overall Study|Did not start protocol treatment|2|||
42216444|NCT00895622|76033372|FG000|Overall Study|Protocol Violation|5|||
42216445|NCT00895622|76033373|FG001|Overall Study|Protocol Violation|4|||
42216446|NCT00895622|76033374|FG002|Overall Study|Protocol Violation|4|||
42216447|NCT00847535|76033390|FG000|Overall Study|Withdrawal by Subject|2|||
42216448|NCT00847535|76033391|FG001|Overall Study|Withdrawal by Subject|1|||
42216449|NCT00847535|76033392|FG002|Overall Study|Withdrawal by Subject|1|||
42216450|NCT00847535|76033390|FG000|Overall Study|Lost to Follow-up|0|||
42216451|NCT00847535|76033391|FG001|Overall Study|Lost to Follow-up|1|||
42216452|NCT00847535|76033392|FG002|Overall Study|Lost to Follow-up|0|||
42216453|NCT00539591|76033404|FG000|Overall Study|Toxicity|3|||
42216454|NCT00539591|76033405|FG001|Overall Study|Toxicity|0|||
42216455|NCT00539591|76033406|FG002|Overall Study|Toxicity|0|||
42216456|NCT00539591|76033404|FG000|Overall Study|Disease progression|2|||
42216457|NCT00539591|76033405|FG001|Overall Study|Disease progression|2|||
41977857|NCT01054885|75782599|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
42216458|NCT00539591|76033406|FG002|Overall Study|Disease progression|3|||
42216459|NCT03512210|76033446|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
41977858|NCT01054885|75782600|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
42216460|NCT03512210|76033446|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
41977859|NCT01054885|75782601|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
42216461|NCT03512210|76033446|FG000|Step 2:Post-MINMON|Death|2|||
42216462|NCT03512210|76033446|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
42216463|NCT03512210|76033446|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
42216464|NCT00383721|76033455|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
42216465|NCT00383721|76033456|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
42216466|NCT00383721|76033457|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
41977860|NCT01054885|75782602|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
41977861|NCT01054885|75782603|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
42028487|NCT01136772|75836924|FG001|Overall Study|Did not receive injection|7|||
42216467|NCT00383721|76033458|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
42216468|NCT00383721|76033459|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
42216469|NCT00383721|76033455|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
42216470|NCT00383721|76033456|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
42216471|NCT00383721|76033457|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
42216472|NCT00383721|76033458|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
41977862|NCT01054885|75782604|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
41977863|NCT01054885|75782605|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
41977864|NCT01054885|75782599|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
42216473|NCT00383721|76033459|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
42216474|NCT00383721|76033455|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
42129048|NCT02683239|75940029|FG000|Overall Study|Adverse Event|64|||
42129049|NCT02683239|75940030|FG001|Overall Study|Adverse Event|39|||
41977865|NCT01054885|75782600|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
41977866|NCT01054885|75782601|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
41977867|NCT01054885|75782602|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
41977868|NCT01054885|75782603|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
41977869|NCT01054885|75782604|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
41977870|NCT01054885|75782605|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
41977871|NCT01054885|75782599|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
41977872|NCT01054885|75782600|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
41977873|NCT01054885|75782601|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
41977874|NCT01054885|75782602|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
41977875|NCT01054885|75782603|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
41977876|NCT01054885|75782604|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
41977877|NCT01054885|75782605|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
41977878|NCT01054885|75782599|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
41977879|NCT01054885|75782600|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
41977880|NCT01054885|75782601|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
42129050|NCT02683239|75940031|FG002|Overall Study|Adverse Event|42|||
42129051|NCT02683239|75940032|FG003|Overall Study|Adverse Event|16|||
42129052|NCT02683239|75940033|FG004|Overall Study|Adverse Event|189|||
42129053|NCT02683239|75940034|FG005|Overall Study|Adverse Event|9|||
42129054|NCT02683239|75940035|FG006|Overall Study|Adverse Event|9|||
42129055|NCT02683239|75940029|FG000|Overall Study|Physician Decision|38|||
42129056|NCT02683239|75940030|FG001|Overall Study|Physician Decision|19|||
42129057|NCT02683239|75940031|FG002|Overall Study|Physician Decision|14|||
42129058|NCT02683239|75940032|FG003|Overall Study|Physician Decision|73|||
42129059|NCT02683239|75940033|FG004|Overall Study|Physician Decision|143|||
42129060|NCT02683239|75940034|FG005|Overall Study|Physician Decision|14|||
42129061|NCT02683239|75940035|FG006|Overall Study|Physician Decision|15|||
42129062|NCT02683239|75940029|FG000|Overall Study|Withdrawal by Subject|187|||
42129063|NCT02683239|75940030|FG001|Overall Study|Withdrawal by Subject|99|||
42129064|NCT02683239|75940031|FG002|Overall Study|Withdrawal by Subject|91|||
42129065|NCT02683239|75940032|FG003|Overall Study|Withdrawal by Subject|18|||
42129066|NCT02683239|75940033|FG004|Overall Study|Withdrawal by Subject|248|||
42129067|NCT02683239|75940034|FG005|Overall Study|Withdrawal by Subject|22|||
42129068|NCT02683239|75940035|FG006|Overall Study|Withdrawal by Subject|28|||
42129069|NCT02683239|75940029|FG000|Overall Study|Lost to Follow-up|77|||
42129070|NCT02683239|75940030|FG001|Overall Study|Lost to Follow-up|24|||
42129071|NCT02683239|75940031|FG002|Overall Study|Lost to Follow-up|25|||
42129072|NCT02683239|75940032|FG003|Overall Study|Lost to Follow-up|7|||
42129073|NCT02683239|75940033|FG004|Overall Study|Lost to Follow-up|88|||
42129074|NCT02683239|75940034|FG005|Overall Study|Lost to Follow-up|8|||
42129075|NCT02683239|75940035|FG006|Overall Study|Lost to Follow-up|11|||
42129076|NCT02683239|75940029|FG000|Overall Study|Death|9|||
42129077|NCT02683239|75940030|FG001|Overall Study|Death|5|||
42129078|NCT02683239|75940031|FG002|Overall Study|Death|8|||
42129079|NCT02683239|75940032|FG003|Overall Study|Death|0|||
42129080|NCT02683239|75940033|FG004|Overall Study|Death|12|||
42129081|NCT02683239|75940034|FG005|Overall Study|Death|1|||
42129082|NCT02683239|75940035|FG006|Overall Study|Death|0|||
42129083|NCT02683239|75940029|FG000|Overall Study|Lack of Efficacy|50|||
42129084|NCT02683239|75940030|FG001|Overall Study|Lack of Efficacy|23|||
42129085|NCT02683239|75940031|FG002|Overall Study|Lack of Efficacy|12|||
42129086|NCT02683239|75940032|FG003|Overall Study|Lack of Efficacy|2|||
42216475|NCT00383721|76033456|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
42216476|NCT00383721|76033457|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
42129087|NCT02683239|75940033|FG004|Overall Study|Lack of Efficacy|29|||
42129088|NCT02683239|75940034|FG005|Overall Study|Lack of Efficacy|2|||
42129089|NCT02683239|75940035|FG006|Overall Study|Lack of Efficacy|3|||
42129090|NCT02683239|75940029|FG000|Overall Study|Missing data|0|||
42129091|NCT02683239|75940030|FG001|Overall Study|Missing data|1|||
42216477|NCT00383721|76033458|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
41977881|NCT01054885|75782602|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
41977882|NCT01054885|75782603|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
41977883|NCT01054885|75782604|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
42129092|NCT02683239|75940031|FG002|Overall Study|Missing data|1|||
42129093|NCT02683239|75940032|FG003|Overall Study|Missing data|0|||
42129094|NCT02683239|75940033|FG004|Overall Study|Missing data|1|||
42129095|NCT02683239|75940034|FG005|Overall Study|Missing data|0|||
42129096|NCT02683239|75940035|FG006|Overall Study|Missing data|0|||
42129097|NCT02097134|75940051|FG000|Overall Study|Physician Decision|4|||
42216478|NCT00383721|76033459|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
42216479|NCT00383721|76033455|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
42216480|NCT00383721|76033456|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
42129098|NCT02097134|75940051|FG000|Overall Study|Non-Protocol Therapy|1|||
42129099|NCT02097134|75940051|FG000|Overall Study|Progressive Disease|3|||
42129100|NCT02097134|75940051|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
42129101|NCT01859130|75940056|FG000|Overall Study|Death|4|||
42129102|NCT01859130|75940056|FG000|Overall Study|Lost to Follow-up|16|||
42129103|NCT01859130|75940056|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
42129104|NCT01859130|75940056|FG000|Overall Study|Physician Decision|6|||
42129105|NCT01859130|75940056|FG000|Overall Study|Withdrawal by Subject|17|||
42129106|NCT01859130|75940056|FG000|Overall Study|Adverse Event|11|||
42129107|NCT01174043|75940073|FG000|Overall Study|Disease progression|5|||
42129108|NCT01174043|75940073|FG000|Overall Study|Adverse Event|3|||
42129109|NCT01174043|75940073|FG000|Overall Study|Death|1|||
42129110|NCT01174043|75940073|FG000|Overall Study|Withdrawal by Subject|2|||
42129111|NCT04050982|75940079|FG000|Overall Study|Did not meet eligibility criteria|0|||
42129112|NCT04050982|75940080|FG001|Overall Study|Did not meet eligibility criteria|1|||
42129113|NCT04050982|75940081|FG002|Overall Study|Did not meet eligibility criteria|0|||
42129114|NCT04050982|75940079|FG000|Overall Study|Withdrawal by Subject|1|||
42129115|NCT04050982|75940080|FG001|Overall Study|Withdrawal by Subject|0|||
42129116|NCT04050982|75940081|FG002|Overall Study|Withdrawal by Subject|0|||
42129117|NCT04050982|75940079|FG000|Overall Study|Unable to enroll on platform|1|||
42129118|NCT04050982|75940080|FG001|Overall Study|Unable to enroll on platform|0|||
42129119|NCT04050982|75940081|FG002|Overall Study|Unable to enroll on platform|0|||
42129120|NCT03905265|75940091|FG000|Overall Study|Withdrawal by Subject|1|||
42129121|NCT03905265|75940092|FG001|Overall Study|Withdrawal by Subject|1|||
42302048|NCT02484547|76137184|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
42302049|NCT02484547|76137185|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
42302050|NCT02484547|76137186|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
42302051|NCT02484547|76137180|FG000|Placebo-Controlled Period|Reason not Specified|216|||
42302052|NCT02484547|76137181|FG001|Placebo-Controlled Period|Reason not Specified|194|||
42302053|NCT02484547|76137182|FG002|Placebo-Controlled Period|Reason not Specified|183|||
42302054|NCT02484547|76137183|FG003|Placebo-Controlled Period|Reason not Specified|0|||
42302055|NCT02484547|76137184|FG004|Placebo-Controlled Period|Reason not Specified|0|||
42302056|NCT02484547|76137185|FG005|Placebo-Controlled Period|Reason not Specified|0|||
42302057|NCT02484547|76137186|FG006|Placebo-Controlled Period|Reason not Specified|0|||
42302058|NCT02484547|76137180|FG000|Long-Term Extension Period|Adverse Event|0|||
42302059|NCT02484547|76137181|FG001|Long-Term Extension Period|Adverse Event|0|||
42302060|NCT02484547|76137182|FG002|Long-Term Extension Period|Adverse Event|0|||
42129122|NCT03905265|75940093|FG002|Overall Study|Withdrawal by Subject|0|||
42129123|NCT03905265|75940094|FG003|Overall Study|Withdrawal by Subject|0|||
42129124|NCT03848845|75940107|FG000|Overall Study|Lost to Follow-up|0|||
42129125|NCT03848845|75940108|FG001|Overall Study|Lost to Follow-up|1|||
42129126|NCT03848845|75940109|FG002|Overall Study|Lost to Follow-up|0|||
42129127|NCT03848845|75940107|FG000|Overall Study|Withdrawal by Subject|3|||
42129128|NCT03848845|75940108|FG001|Overall Study|Withdrawal by Subject|2|||
42216481|NCT00383721|76033457|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
42216482|NCT00383721|76033458|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
42216483|NCT00383721|76033459|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
42216484|NCT00383721|76033455|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
42216485|NCT00383721|76033456|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
42216486|NCT00383721|76033457|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
42216487|NCT00383721|76033458|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
42216488|NCT00383721|76033459|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
42216489|NCT00383721|76033455|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
42216490|NCT00383721|76033456|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
42216491|NCT00383721|76033457|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
42216492|NCT00383721|76033458|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
42216493|NCT00383721|76033459|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
42216494|NCT00383721|76033455|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
42216495|NCT00383721|76033456|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
42302061|NCT02484547|76137183|FG003|Long-Term Extension Period|Adverse Event|0|||
42302062|NCT02484547|76137184|FG004|Long-Term Extension Period|Adverse Event|1|||
42302063|NCT02484547|76137185|FG005|Long-Term Extension Period|Adverse Event|3|||
42129129|NCT03848845|75940109|FG002|Overall Study|Withdrawal by Subject|6|||
42129130|NCT03848845|75940107|FG000|Overall Study|In Follow-up|0|||
42129131|NCT03848845|75940108|FG001|Overall Study|In Follow-up|1|||
42129132|NCT03848845|75940109|FG002|Overall Study|In Follow-up|12|||
42302064|NCT02484547|76137186|FG006|Long-Term Extension Period|Adverse Event|2|||
42302065|NCT02484547|76137180|FG000|Long-Term Extension Period|Death|0|||
42302066|NCT02484547|76137181|FG001|Long-Term Extension Period|Death|0|||
42302067|NCT02484547|76137182|FG002|Long-Term Extension Period|Death|0|||
42302068|NCT02484547|76137183|FG003|Long-Term Extension Period|Death|0|||
42302069|NCT02484547|76137184|FG004|Long-Term Extension Period|Death|0|||
42302070|NCT02484547|76137185|FG005|Long-Term Extension Period|Death|3|||
42216496|NCT00383721|76033457|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
42216497|NCT00383721|76033458|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
42216498|NCT00383721|76033459|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
42216499|NCT00383721|76033455|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
42216500|NCT00383721|76033456|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
42216501|NCT00383721|76033457|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
42216502|NCT00383721|76033458|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
42216503|NCT00383721|76033459|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
42216504|NCT00383721|76033455|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
42216505|NCT00383721|76033456|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
42216506|NCT00383721|76033457|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
42216507|NCT00383721|76033458|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
42216508|NCT00383721|76033459|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
42216509|NCT00383721|76033455|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
42216510|NCT00383721|76033456|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
42216511|NCT00383721|76033457|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
42216512|NCT00383721|76033458|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
42216513|NCT00383721|76033459|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
42216514|NCT00383721|76033455|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
42216515|NCT00383721|76033456|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
42216516|NCT00383721|76033457|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
42216517|NCT00383721|76033458|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
42216518|NCT00383721|76033459|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
42216519|NCT00383721|76033455|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
42216520|NCT00383721|76033456|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
42216521|NCT00383721|76033457|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
42216522|NCT00383721|76033458|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
42216523|NCT00383721|76033459|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
42216524|NCT00383721|76033455|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
42216525|NCT00383721|76033456|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
42216526|NCT00383721|76033457|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
42216527|NCT00383721|76033458|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
42216528|NCT00383721|76033459|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
42216529|NCT00383721|76033455|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
42216530|NCT00383721|76033456|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
42216531|NCT00383721|76033457|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
42216532|NCT00383721|76033458|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
42216533|NCT00383721|76033459|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
42216534|NCT00383721|76033455|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
42302071|NCT02484547|76137186|FG006|Long-Term Extension Period|Death|0|||
42302072|NCT02484547|76137180|FG000|Long-Term Extension Period|Disease Progression|0|||
42302073|NCT02484547|76137181|FG001|Long-Term Extension Period|Disease Progression|0|||
42302074|NCT02484547|76137182|FG002|Long-Term Extension Period|Disease Progression|0|||
42302075|NCT02484547|76137183|FG003|Long-Term Extension Period|Disease Progression|0|||
42302076|NCT02484547|76137184|FG004|Long-Term Extension Period|Disease Progression|2|||
42302077|NCT02484547|76137185|FG005|Long-Term Extension Period|Disease Progression|4|||
42302078|NCT02484547|76137186|FG006|Long-Term Extension Period|Disease Progression|0|||
42302079|NCT02484547|76137180|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
42302080|NCT02484547|76137181|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
42302081|NCT02484547|76137182|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
42302082|NCT02484547|76137183|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
42302083|NCT02484547|76137184|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
42302084|NCT02484547|76137185|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
42302085|NCT02484547|76137186|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
42302086|NCT02484547|76137180|FG000|Long-Term Extension Period|Loss of Capacity|0|||
42216535|NCT00383721|76033456|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
42302087|NCT02484547|76137181|FG001|Long-Term Extension Period|Loss of Capacity|0|||
42302088|NCT02484547|76137182|FG002|Long-Term Extension Period|Loss of Capacity|0|||
42302089|NCT02484547|76137183|FG003|Long-Term Extension Period|Loss of Capacity|0|||
42302090|NCT02484547|76137184|FG004|Long-Term Extension Period|Loss of Capacity|1|||
42302091|NCT02484547|76137185|FG005|Long-Term Extension Period|Loss of Capacity|0|||
42302092|NCT02484547|76137186|FG006|Long-Term Extension Period|Loss of Capacity|0|||
42302093|NCT02484547|76137180|FG000|Long-Term Extension Period|Change of Treatment|0|||
42302094|NCT02484547|76137181|FG001|Long-Term Extension Period|Change of Treatment|0|||
42302095|NCT02484547|76137182|FG002|Long-Term Extension Period|Change of Treatment|0|||
42302096|NCT02484547|76137183|FG003|Long-Term Extension Period|Change of Treatment|0|||
42302097|NCT02484547|76137184|FG004|Long-Term Extension Period|Change of Treatment|0|||
42302098|NCT02484547|76137185|FG005|Long-Term Extension Period|Change of Treatment|0|||
42302099|NCT02484547|76137186|FG006|Long-Term Extension Period|Change of Treatment|1|||
42302100|NCT02484547|76137180|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
42302101|NCT02484547|76137181|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
42216536|NCT00383721|76033457|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
42216537|NCT00383721|76033458|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
42216538|NCT00383721|76033459|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
42216539|NCT00383721|76033455|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
42216540|NCT00383721|76033456|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
42216541|NCT00383721|76033457|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
42216542|NCT00383721|76033458|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
42216543|NCT00383721|76033459|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
42216544|NCT00383721|76033455|FG000|26-Week Treatment Safety Extension|Administrative|1|||
42216545|NCT00383721|76033456|FG001|26-Week Treatment Safety Extension|Administrative|2|||
42216546|NCT00383721|76033457|FG002|26-Week Treatment Safety Extension|Administrative|3|||
42216547|NCT00383721|76033458|FG003|26-Week Treatment Safety Extension|Administrative|1|||
42216548|NCT00383721|76033459|FG004|26-Week Treatment Safety Extension|Administrative|0|||
42216549|NCT03035942|76033487|FG000|Overall Study|Adverse Event|8|||
42216550|NCT03035942|76033488|FG001|Overall Study|Adverse Event|4|||
42216551|NCT03035942|76033489|FG002|Overall Study|Adverse Event|5|||
42216552|NCT02616146|76033501|FG000|Overall Study|Adverse Event|64|||
42216553|NCT02616146|76033502|FG001|Overall Study|Adverse Event|24|||
42216554|NCT02616146|76033501|FG000|Overall Study|Lost to Follow-up|23|||
42216555|NCT02616146|76033502|FG001|Overall Study|Lost to Follow-up|13|||
42216556|NCT02616146|76033501|FG000|Overall Study|Non-compliance with study protocol|2|||
42216557|NCT02616146|76033502|FG001|Overall Study|Non-compliance with study protocol|0|||
42216558|NCT02616146|76033501|FG000|Overall Study|Non-compliance with study drug|4|||
42216559|NCT02616146|76033502|FG001|Overall Study|Non-compliance with study drug|2|||
42216560|NCT02616146|76033501|FG000|Overall Study|Pregnancy|2|||
42216561|NCT02616146|76033502|FG001|Overall Study|Pregnancy|2|||
42216562|NCT02616146|76033501|FG000|Overall Study|Pregnancy wish|3|||
42216563|NCT02616146|76033502|FG001|Overall Study|Pregnancy wish|0|||
42216564|NCT02616146|76033501|FG000|Overall Study|Protocol Violation|6|||
42216565|NCT02616146|76033502|FG001|Overall Study|Protocol Violation|3|||
42216566|NCT02616146|76033501|FG000|Overall Study|Study terminated by sponsor|1372|||
42216567|NCT02616146|76033502|FG001|Overall Study|Study terminated by sponsor|432|||
42216568|NCT02616146|76033501|FG000|Overall Study|Participant moved|4|||
42216569|NCT02616146|76033502|FG001|Overall Study|Participant moved|3|||
42216570|NCT02616146|76033501|FG000|Overall Study|Withdrawal by Subject|30|||
42216571|NCT02616146|76033502|FG001|Overall Study|Withdrawal by Subject|24|||
42216572|NCT02616146|76033501|FG000|Overall Study|Physician Decision|2|||
42216573|NCT02616146|76033502|FG001|Overall Study|Physician Decision|1|||
42216574|NCT04850313|76033510|FG000|Overall Study|Withdrawal by Subject|0|||
42216575|NCT04850313|76033511|FG001|Overall Study|Withdrawal by Subject|1|||
42216576|NCT02885181|76033529|FG000|Overall Study|Investigator's Discretion|0|||
42216577|NCT02885181|76033530|FG001|Overall Study|Investigator's Discretion|1|||
42216578|NCT02885181|76033531|FG002|Overall Study|Investigator's Discretion|0|||
42216579|NCT02885181|76033532|FG003|Overall Study|Investigator's Discretion|1|||
42216580|NCT02885181|76033529|FG000|Overall Study|Adverse Event|0|||
42216581|NCT02885181|76033530|FG001|Overall Study|Adverse Event|0|||
42302102|NCT02484547|76137182|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
42302103|NCT02484547|76137183|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
42216582|NCT02885181|76033531|FG002|Overall Study|Adverse Event|0|||
42216583|NCT02885181|76033532|FG003|Overall Study|Adverse Event|1|||
42302104|NCT02484547|76137184|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
42216584|NCT02885181|76033529|FG000|Overall Study|Withdrawal by Subject|0|||
42216585|NCT02885181|76033530|FG001|Overall Study|Withdrawal by Subject|0|||
42216586|NCT02885181|76033531|FG002|Overall Study|Withdrawal by Subject|0|||
42302105|NCT02484547|76137185|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
42216587|NCT02885181|76033532|FG003|Overall Study|Withdrawal by Subject|1|||
42216588|NCT02884089|76033546|FG000|Period 1|Dosing error|2|||
42216589|NCT02884089|76033547|FG001|Period 1|Dosing error|2|||
42216590|NCT02884089|76033548|FG002|Period 1|Dosing error|0|||
42216591|NCT02884089|76033549|FG003|Period 1|Dosing error|0|||
42216592|NCT02884089|76033546|FG000|Washout Period 1|Lost to Follow-up|0|||
42216593|NCT02884089|76033547|FG001|Washout Period 1|Lost to Follow-up|1|||
42216594|NCT02884089|76033548|FG002|Washout Period 1|Lost to Follow-up|0|||
42216595|NCT02884089|76033549|FG003|Washout Period 1|Lost to Follow-up|1|||
42216596|NCT02884089|76033546|FG000|Washout Period 1|Withdrawal by Subject|0|||
42216597|NCT02884089|76033547|FG001|Washout Period 1|Withdrawal by Subject|1|||
42216598|NCT02884089|76033548|FG002|Washout Period 1|Withdrawal by Subject|0|||
42216599|NCT02884089|76033549|FG003|Washout Period 1|Withdrawal by Subject|0|||
42216600|NCT02884089|76033546|FG000|Period 2|Adverse Event|1|||
42216601|NCT02884089|76033547|FG001|Period 2|Adverse Event|0|||
42302106|NCT02484547|76137186|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
42302107|NCT02484547|76137180|FG000|Long-Term Extension Period|Investigator Decision|0|||
42302108|NCT02484547|76137181|FG001|Long-Term Extension Period|Investigator Decision|0|||
42302109|NCT02484547|76137182|FG002|Long-Term Extension Period|Investigator Decision|0|||
42302110|NCT02484547|76137183|FG003|Long-Term Extension Period|Investigator Decision|2|||
42302111|NCT02484547|76137184|FG004|Long-Term Extension Period|Investigator Decision|1|||
42302112|NCT02484547|76137185|FG005|Long-Term Extension Period|Investigator Decision|0|||
42302113|NCT02484547|76137186|FG006|Long-Term Extension Period|Investigator Decision|1|||
42302114|NCT02484547|76137180|FG000|Long-Term Extension Period|Relocation|0|||
42216602|NCT02884089|76033548|FG002|Period 2|Adverse Event|0|||
42216603|NCT02884089|76033549|FG003|Period 2|Adverse Event|0|||
42216604|NCT02884089|76033546|FG000|Period 3|Withdrawal by Subject|0|||
42216605|NCT02884089|76033547|FG001|Period 3|Withdrawal by Subject|0|||
42216606|NCT02884089|76033548|FG002|Period 3|Withdrawal by Subject|1|||
42216607|NCT02884089|76033549|FG003|Period 3|Withdrawal by Subject|0|||
42216608|NCT02884089|76033546|FG000|Washout Period 3|Withdrawal by Subject|0|||
42216609|NCT02884089|76033547|FG001|Washout Period 3|Withdrawal by Subject|0|||
42216610|NCT02884089|76033548|FG002|Washout Period 3|Withdrawal by Subject|1|||
42216611|NCT02884089|76033549|FG003|Washout Period 3|Withdrawal by Subject|0|||
42216612|NCT02884089|76033546|FG000|Washout Period 3|Lost to Follow-up|0|||
42216613|NCT02884089|76033547|FG001|Washout Period 3|Lost to Follow-up|0|||
42216614|NCT02884089|76033548|FG002|Washout Period 3|Lost to Follow-up|0|||
42216615|NCT02884089|76033549|FG003|Washout Period 3|Lost to Follow-up|1|||
42216616|NCT02884089|76033546|FG000|Period 4|Withdrawal by Subject|0|||
42216617|NCT02884089|76033547|FG001|Period 4|Withdrawal by Subject|1|||
42216618|NCT02884089|76033548|FG002|Period 4|Withdrawal by Subject|0|||
42216619|NCT02884089|76033549|FG003|Period 4|Withdrawal by Subject|0|||
42216620|NCT02884089|76033546|FG000|Period 4|Lost to Follow-up|1|||
42216621|NCT02884089|76033547|FG001|Period 4|Lost to Follow-up|0|||
42216622|NCT02884089|76033548|FG002|Period 4|Lost to Follow-up|0|||
42216623|NCT02884089|76033549|FG003|Period 4|Lost to Follow-up|0|||
42216624|NCT02884089|76033546|FG000|Follow-up Visit|Withdrawal by Subject|1|||
42216625|NCT02884089|76033547|FG001|Follow-up Visit|Withdrawal by Subject|0|||
42216626|NCT02884089|76033548|FG002|Follow-up Visit|Withdrawal by Subject|0|||
42216627|NCT02884089|76033549|FG003|Follow-up Visit|Withdrawal by Subject|1|||
42216628|NCT02809677|76033559|FG000|Overall Study|Withdrawal by Subject|8|||
42216629|NCT02881047|76033564|FG000|Overall Study|Adverse Event|1|||
42216630|NCT02881047|76033564|FG000|Overall Study|Withdrawal by Subject|1|||
42216631|NCT03157089|76033570|FG000|Overall Study|Treated only with pembrolizumab|1|||
42216632|NCT03157089|76033571|FG001|Overall Study|Treated only with pembrolizumab|0|||
42216633|NCT03157089|76033570|FG000|Overall Study|Adverse Event|5|||
42216634|NCT03157089|76033571|FG001|Overall Study|Adverse Event|4|||
42216635|NCT03157089|76033570|FG000|Overall Study|Progressive disease|6|||
42028488|NCT01136772|75836923|FG000|Overall Study|Did not follow up after first injection|2|||
42028489|NCT01136772|75836924|FG001|Overall Study|Did not follow up after first injection|2|||
42028490|NCT00909532|75836932|FG000|Overall Study|Adverse Event|4|||
42028491|NCT00909532|75836933|FG001|Overall Study|Adverse Event|1|||
42216636|NCT03157089|76033571|FG001|Overall Study|Progressive disease|8|||
42216637|NCT03158727|76033580|FG000|Overall Study|Withdrawal by Subject|2|||
42216638|NCT03158727|76033581|FG001|Overall Study|Withdrawal by Subject|6|||
42216639|NCT03158727|76033580|FG000|Overall Study|Death|11|||
42302115|NCT02484547|76137181|FG001|Long-Term Extension Period|Relocation|0|||
42216640|NCT03158727|76033581|FG001|Overall Study|Death|12|||
42216641|NCT03158727|76033580|FG000|Overall Study|Lost to Follow-up|1|||
42216642|NCT03158727|76033581|FG001|Overall Study|Lost to Follow-up|0|||
42216643|NCT03158727|76033580|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
42216644|NCT03158727|76033581|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
42302116|NCT02484547|76137182|FG002|Long-Term Extension Period|Relocation|0|||
42302117|NCT02484547|76137183|FG003|Long-Term Extension Period|Relocation|1|||
42302118|NCT02484547|76137184|FG004|Long-Term Extension Period|Relocation|1|||
42216645|NCT03158727|76033580|FG000|Overall Study|Visit 11 not done by mistake|0|||
42216646|NCT03158727|76033581|FG001|Overall Study|Visit 11 not done by mistake|1|||
42216647|NCT03158727|76033580|FG000|Overall Study|Enrolled, not treated|1|||
42216648|NCT03158727|76033581|FG001|Overall Study|Enrolled, not treated|0|||
42216649|NCT00089895|76033589|FG000|Overall Study|Consent Withdrawn|11|||
42216650|NCT00089895|76033590|FG001|Overall Study|Consent Withdrawn|14|||
42216651|NCT00089895|76033589|FG000|Overall Study|Technical reason|7|||
42216652|NCT00089895|76033590|FG001|Overall Study|Technical reason|2|||
42216653|NCT00089895|76033589|FG000|Overall Study|Surgery|0|||
42216654|NCT00089895|76033590|FG001|Overall Study|Surgery|1|||
42216655|NCT00089895|76033589|FG000|Overall Study|Bleeding|0|||
42216656|NCT00089895|76033590|FG001|Overall Study|Bleeding|2|||
42216657|NCT00089895|76033589|FG000|Overall Study|Physician Decision|3|||
42216658|NCT00089895|76033590|FG001|Overall Study|Physician Decision|7|||
42216659|NCT00089895|76033589|FG000|Overall Study|Exclusion criteria met|6|||
42216660|NCT00089895|76033590|FG001|Overall Study|Exclusion criteria met|6|||
42216661|NCT00089895|76033589|FG000|Overall Study|Not otherwise specified|4|||
42216662|NCT00089895|76033590|FG001|Overall Study|Not otherwise specified|8|||
42216663|NCT00089895|76033589|FG000|Overall Study|Missing|4|||
42216664|NCT00089895|76033590|FG001|Overall Study|Missing|2|||
42216665|NCT02714218|76033599|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
42216666|NCT02714218|76033600|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
42216667|NCT02714218|76033601|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
42216668|NCT02714218|76033599|FG000|Pre-Treatment Period|Other reasons|0|||
42216669|NCT02714218|76033600|FG001|Pre-Treatment Period|Other reasons|1|||
42216670|NCT02714218|76033601|FG002|Pre-Treatment Period|Other reasons|0|||
42216671|NCT02714218|76033599|FG000|Treatment Period|Disease Progression|55|||
42216672|NCT02714218|76033600|FG001|Treatment Period|Disease Progression|52|||
42216673|NCT02714218|76033601|FG002|Treatment Period|Disease Progression|14|||
42216674|NCT02714218|76033599|FG000|Treatment Period|Study drug toxicity|46|||
42216675|NCT02714218|76033600|FG001|Treatment Period|Study drug toxicity|70|||
42216676|NCT02714218|76033601|FG002|Treatment Period|Study drug toxicity|6|||
42216677|NCT02714218|76033599|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
42216678|NCT02714218|76033600|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
42216679|NCT02714218|76033601|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
42216680|NCT02714218|76033599|FG000|Treatment Period|Request to discontinue treatment|1|||
42216681|NCT02714218|76033600|FG001|Treatment Period|Request to discontinue treatment|4|||
42216682|NCT02714218|76033601|FG002|Treatment Period|Request to discontinue treatment|1|||
42216683|NCT02714218|76033599|FG000|Treatment Period|Participant withdrew consent|2|||
42216684|NCT02714218|76033600|FG001|Treatment Period|Participant withdrew consent|2|||
42216685|NCT02714218|76033601|FG002|Treatment Period|Participant withdrew consent|0|||
42216686|NCT02714218|76033599|FG000|Treatment Period|Maximum clinical benefit|4|||
42216687|NCT02714218|76033600|FG001|Treatment Period|Maximum clinical benefit|2|||
42216688|NCT02714218|76033601|FG002|Treatment Period|Maximum clinical benefit|0|||
42302119|NCT02484547|76137185|FG005|Long-Term Extension Period|Relocation|0|||
42216689|NCT02714218|76033599|FG000|Treatment Period|Administrative reason by sponsor|2|||
42302120|NCT02484547|76137186|FG006|Long-Term Extension Period|Relocation|0|||
42302121|NCT02484547|76137180|FG000|Long-Term Extension Period|Study Visit Burden|0|||
42302122|NCT02484547|76137181|FG001|Long-Term Extension Period|Study Visit Burden|0|||
42302123|NCT02484547|76137182|FG002|Long-Term Extension Period|Study Visit Burden|0|||
42302124|NCT02484547|76137183|FG003|Long-Term Extension Period|Study Visit Burden|2|||
42302125|NCT02484547|76137184|FG004|Long-Term Extension Period|Study Visit Burden|0|||
42302126|NCT02484547|76137185|FG005|Long-Term Extension Period|Study Visit Burden|0|||
42302127|NCT02484547|76137186|FG006|Long-Term Extension Period|Study Visit Burden|3|||
42302128|NCT02484547|76137180|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
42302129|NCT02484547|76137181|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
42302130|NCT02484547|76137182|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
42302131|NCT02484547|76137183|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
41977884|NCT01054885|75782605|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
42216690|NCT02714218|76033600|FG001|Treatment Period|Administrative reason by sponsor|1|||
42302132|NCT02484547|76137184|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
41977885|NCT01054885|75782599|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
41977886|NCT01054885|75782600|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
41977887|NCT01054885|75782601|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
41977888|NCT01054885|75782602|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
41977889|NCT01054885|75782603|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
41977890|NCT01054885|75782604|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
42216691|NCT02714218|76033601|FG002|Treatment Period|Administrative reason by sponsor|0|||
42216692|NCT02714218|76033599|FG000|Treatment Period|Other reasons|6|||
42216693|NCT02714218|76033600|FG001|Treatment Period|Other reasons|6|||
42216694|NCT02714218|76033601|FG002|Treatment Period|Other reasons|0|||
42216695|NCT02714218|76033599|FG000|Treatment Period|Completed treatment as per protocol|36|||
42216696|NCT02714218|76033600|FG001|Treatment Period|Completed treatment as per protocol|27|||
42216697|NCT02714218|76033601|FG002|Treatment Period|Completed treatment as per protocol|3|||
42216698|NCT02714218|76033599|FG000|Treatment Period|Not reported|9|||
42216699|NCT02714218|76033600|FG001|Treatment Period|Not reported|6|||
42216700|NCT02714218|76033601|FG002|Treatment Period|Not reported|0|||
42216701|NCT03154047|76033608|FG000|Overall Study|Death|1|||
42216702|NCT03154047|76033608|FG000|Overall Study|Study terminated by sponsor|76|||
42216703|NCT03154047|76033608|FG000|Overall Study|Withdrawal by Subject|3|||
42216704|NCT03156621|76033614|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
42216705|NCT03156621|76033615|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
42216706|NCT03156621|76033614|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
42216707|NCT03156621|76033615|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
42216708|NCT03156543|76033626|FG000|Overall Study|Withdrawal by Subject|1|||
42216709|NCT03156543|76033627|FG001|Overall Study|Withdrawal by Subject|0|||
42216710|NCT02713594|76033635|FG000|Overall Study|Withdrawal by Subject|32|||
42216711|NCT02713594|76033636|FG001|Overall Study|Withdrawal by Subject|22|||
42216712|NCT02713594|76033635|FG000|Overall Study|Lost to Follow-up|358|||
42216713|NCT02713594|76033636|FG001|Overall Study|Lost to Follow-up|374|||
42216714|NCT03152019|76033646|FG000|Overall Study|Adverse Event|0|||
42216715|NCT03152019|76033647|FG001|Overall Study|Adverse Event|1|||
42216716|NCT02714062|76033660|FG000|Overall Study|Adverse Event|0|||
42216717|NCT02714062|76033661|FG001|Overall Study|Adverse Event|0|||
42216718|NCT02714062|76033662|FG002|Overall Study|Adverse Event|2|||
42216719|NCT02714062|76033660|FG000|Overall Study|Withdrawal by Subject|1|||
41977891|NCT01054885|75782605|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
41977892|NCT01054885|75782599|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
41977893|NCT01054885|75782600|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
41977894|NCT01054885|75782601|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
41977895|NCT01054885|75782602|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
41977896|NCT01054885|75782603|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
41977897|NCT01054885|75782604|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
41977898|NCT01054885|75782605|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
41977899|NCT01054885|75782599|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
41977900|NCT01054885|75782600|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
41977901|NCT01054885|75782601|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
41977902|NCT01054885|75782602|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
41977903|NCT01054885|75782603|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
41977904|NCT01054885|75782604|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
41977905|NCT01054885|75782605|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
41977906|NCT01054885|75782599|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
41977907|NCT01054885|75782600|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
41977908|NCT01054885|75782601|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
41977909|NCT01054885|75782602|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
41977910|NCT01054885|75782603|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
41977911|NCT01054885|75782604|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
41977912|NCT01054885|75782605|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
41977913|NCT01054885|75782599|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
41977914|NCT01054885|75782600|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
41977915|NCT01054885|75782601|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
41977916|NCT01054885|75782602|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
41977917|NCT01054885|75782603|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
41977918|NCT01054885|75782604|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
41977919|NCT01054885|75782605|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
41977920|NCT01054885|75782599|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
41977921|NCT01054885|75782600|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
41977922|NCT01054885|75782601|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
41977923|NCT01054885|75782602|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
41977924|NCT01054885|75782603|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
41977925|NCT01054885|75782604|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
42028492|NCT00909532|75836932|FG000|Overall Study|Pregnancy|0|||
42028493|NCT00909532|75836933|FG001|Overall Study|Pregnancy|1|||
42216720|NCT02714062|76033661|FG001|Overall Study|Withdrawal by Subject|0|||
42216721|NCT02714062|76033662|FG002|Overall Study|Withdrawal by Subject|1|||
42216722|NCT02714062|76033660|FG000|Overall Study|Protocol Violation|0|||
42216723|NCT02714062|76033661|FG001|Overall Study|Protocol Violation|1|||
42216724|NCT02714062|76033662|FG002|Overall Study|Protocol Violation|0|||
42216725|NCT03151395|76033672|FG000|Overall Study|Adverse Event|2|||
42216726|NCT03151395|76033672|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
42216727|NCT03151395|76033672|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
42216728|NCT03151395|76033672|FG000|Overall Study|Unspecified reason|4|||
42216729|NCT02713828|76033678|FG000|Overall Study|Death|2|||
42216730|NCT02713828|76033679|FG001|Overall Study|Death|0|||
42216731|NCT02713828|76033678|FG000|Overall Study|Withdrawal by Subject|1|||
42216732|NCT02713828|76033679|FG001|Overall Study|Withdrawal by Subject|0|||
42216733|NCT02713828|76033678|FG000|Overall Study|study terminated but patient allowed to|2|||
42216734|NCT02713828|76033679|FG001|Overall Study|study terminated but patient allowed to|0|||
42216735|NCT02875860|76033686|FG000|Overall Study|Withdrawal by Subject|0|||
42216736|NCT02875860|76033687|FG001|Overall Study|Withdrawal by Subject|1|||
42216737|NCT02875392|76033695|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
42216738|NCT02875392|76033696|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
42216739|NCT03127644|76033705|FG000|Overall Study|Study-specific withdrawal criteria|0|||
42216740|NCT03127644|76033706|FG001|Overall Study|Study-specific withdrawal criteria|0|||
42216741|NCT03127644|76033707|FG002|Overall Study|Study-specific withdrawal criteria|2|||
42216742|NCT03965962|76033721|FG000|Overall Study|Adverse Event|1|||
42216743|NCT03965962|76033722|FG001|Overall Study|Adverse Event|0|||
42216744|NCT03965962|76033723|FG002|Overall Study|Adverse Event|0|||
42216745|NCT03965962|76033724|FG003|Overall Study|Adverse Event|0|||
42216746|NCT03965962|76033721|FG000|Overall Study|Protocol Violation|21|||
42216747|NCT03965962|76033722|FG001|Overall Study|Protocol Violation|4|||
42216748|NCT03965962|76033723|FG002|Overall Study|Protocol Violation|10|||
42216749|NCT03965962|76033724|FG003|Overall Study|Protocol Violation|5|||
42216750|NCT03965962|76033721|FG000|Overall Study|Lost to Follow-up|0|||
42216751|NCT03965962|76033722|FG001|Overall Study|Lost to Follow-up|1|||
42216752|NCT03965962|76033723|FG002|Overall Study|Lost to Follow-up|0|||
42216753|NCT03965962|76033724|FG003|Overall Study|Lost to Follow-up|0|||
42216754|NCT03965962|76033721|FG000|Overall Study|Withdrawal by Subject|3|||
42216755|NCT03965962|76033722|FG001|Overall Study|Withdrawal by Subject|0|||
42216756|NCT03965962|76033723|FG002|Overall Study|Withdrawal by Subject|0|||
42216757|NCT03965962|76033724|FG003|Overall Study|Withdrawal by Subject|1|||
42216758|NCT03151551|76033736|FG000|Open-Label Treatment Period|Adverse Event|0|||
42216759|NCT03151551|76033737|FG001|Open-Label Treatment Period|Adverse Event|2|||
42216760|NCT03151551|76033736|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
42216761|NCT03151551|76033737|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
42216762|NCT03151551|76033736|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
42216763|NCT03151551|76033737|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
42216764|NCT03151551|76033736|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
42216765|NCT03151551|76033737|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
42216766|NCT03151551|76033736|FG000|Open-Label Treatment Period|Physician Decision|3|||
41977926|NCT01054885|75782605|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
41977927|NCT01054846|75782622|FG000|Overall Study|Lost to Follow-up|76|||
41977928|NCT01054846|75782623|FG001|Overall Study|Lost to Follow-up|17|||
41977929|NCT01054729|75782632|FG000|Overall Study|Randomized but Not Treated|0|||
41977930|NCT01054729|75782633|FG001|Overall Study|Randomized but Not Treated|1|||
41977931|NCT01054729|75782634|FG002|Overall Study|Randomized but Not Treated|0|||
41977932|NCT01054729|75782635|FG003|Overall Study|Randomized but Not Treated|0|||
41977933|NCT01054729|75782632|FG000|Overall Study|Adverse Event|1|||
41977934|NCT01054729|75782633|FG001|Overall Study|Adverse Event|1|||
41977935|NCT01054729|75782634|FG002|Overall Study|Adverse Event|2|||
41977936|NCT01054729|75782635|FG003|Overall Study|Adverse Event|1|||
41977937|NCT01054729|75782632|FG000|Overall Study|Withdrawal by Subject|1|||
41977938|NCT01054729|75782633|FG001|Overall Study|Withdrawal by Subject|0|||
41977939|NCT01054729|75782634|FG002|Overall Study|Withdrawal by Subject|1|||
41977940|NCT01054729|75782635|FG003|Overall Study|Withdrawal by Subject|0|||
42129133|NCT03848845|75940107|FG000|Overall Study|On Study Treatment|0|||
42129134|NCT03848845|75940108|FG001|Overall Study|On Study Treatment|0|||
42129135|NCT03848845|75940109|FG002|Overall Study|On Study Treatment|4|||
42129136|NCT03848845|75940107|FG000|Overall Study|Physician Decision|0|||
42129137|NCT03848845|75940108|FG001|Overall Study|Physician Decision|0|||
42129138|NCT03848845|75940109|FG002|Overall Study|Physician Decision|1|||
42129139|NCT03742037|75940122|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
42129140|NCT03742037|75940123|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
42129141|NCT03742037|75940124|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
42129142|NCT03742037|75940125|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
42129143|NCT03742037|75940126|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
42129144|NCT03742037|75940127|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
42216767|NCT03151551|76033737|FG001|Open-Label Treatment Period|Physician Decision|0|||
42216768|NCT03151551|76033736|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
42216769|NCT03151551|76033737|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
42216770|NCT03151551|76033736|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
42216771|NCT03151551|76033737|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
42216772|NCT03151551|76033736|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
41977941|NCT01054729|75782632|FG000|Overall Study|Lost to Follow-up|0|||
41977942|NCT01054729|75782633|FG001|Overall Study|Lost to Follow-up|1|||
41977943|NCT01054729|75782634|FG002|Overall Study|Lost to Follow-up|0|||
41977944|NCT01054729|75782635|FG003|Overall Study|Lost to Follow-up|0|||
41977945|NCT01054729|75782632|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
41977946|NCT01054729|75782633|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
41977947|NCT01054729|75782634|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
41977948|NCT01054729|75782635|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
41977949|NCT01054729|75782632|FG000|Overall Study|Non-responder|1|||
41977950|NCT01054729|75782633|FG001|Overall Study|Non-responder|0|||
42216773|NCT03151551|76033737|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
42216774|NCT03151551|76033736|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
42216775|NCT03151551|76033737|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
42216776|NCT03151551|76033736|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
42216777|NCT03151551|76033737|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
42216778|NCT03147495|76033747|FG000|Overall Study|Physician Decision|0|||
42216779|NCT03147495|76033748|FG001|Overall Study|Physician Decision|6|||
42216780|NCT03126786|76033756|FG000|Overall Study|Adverse Event|3|||
42216781|NCT03126786|76033757|FG001|Overall Study|Adverse Event|0|||
42216782|NCT03126786|76033756|FG000|Overall Study|Lost to Follow-up|0|||
42216783|NCT03126786|76033757|FG001|Overall Study|Lost to Follow-up|1|||
42216784|NCT03126786|76033756|FG000|Overall Study|Withdrawal by Subject|3|||
42216785|NCT03126786|76033757|FG001|Overall Study|Withdrawal by Subject|1|||
42216786|NCT03146403|76033765|FG000|Overall Study|Withdrawal by Subject|0|||
42216787|NCT03146403|76033766|FG001|Overall Study|Withdrawal by Subject|3|||
42216788|NCT03146403|76033765|FG000|Overall Study|Lost to Follow-up|2|||
42216789|NCT03146403|76033766|FG001|Overall Study|Lost to Follow-up|0|||
42216790|NCT02713204|76033775|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
42216791|NCT02713204|76033776|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
42216792|NCT02713204|76033777|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
42216793|NCT02713204|76033778|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
42216794|NCT02713204|76033779|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
42216795|NCT02713204|76033780|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
42216796|NCT02713204|76033781|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
42216797|NCT02713204|76033782|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
42216798|NCT02713204|76033775|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42216799|NCT02713204|76033776|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42216800|NCT02713204|76033777|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
42216801|NCT02713204|76033778|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42216802|NCT02713204|76033779|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42216803|NCT02713204|76033780|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42216804|NCT02713204|76033781|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42216805|NCT02713204|76033782|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42216806|NCT02713204|76033775|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42302133|NCT02484547|76137185|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
42302134|NCT02484547|76137186|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
41977951|NCT01054729|75782634|FG002|Overall Study|Non-responder|1|||
41977952|NCT01054729|75782635|FG003|Overall Study|Non-responder|1|||
41977953|NCT01054729|75782632|FG000|Overall Study|PEG/RBV Non-responder|1|||
41977954|NCT01054729|75782633|FG001|Overall Study|PEG/RBV Non-responder|0|||
41977955|NCT01054729|75782634|FG002|Overall Study|PEG/RBV Non-responder|1|||
41977956|NCT01054729|75782635|FG003|Overall Study|PEG/RBV Non-responder|0|||
41977957|NCT01054729|75782632|FG000|Overall Study|Personal/Obligations|0|||
42028494|NCT00909532|75836932|FG000|Overall Study|Prohibited Medication|2|||
42028495|NCT00909532|75836933|FG001|Overall Study|Prohibited Medication|1|||
42028496|NCT00909532|75836932|FG000|Overall Study|Withdrawal of Consent|1|||
42028497|NCT00909532|75836933|FG001|Overall Study|Withdrawal of Consent|1|||
42028498|NCT00909532|75836932|FG000|Overall Study|Noncompliance with Study Requirements|0|||
42028499|NCT00909532|75836933|FG001|Overall Study|Noncompliance with Study Requirements|2|||
42028500|NCT00909532|75836932|FG000|Overall Study|Physician Decision|1|||
42028501|NCT00909532|75836933|FG001|Overall Study|Physician Decision|0|||
42028502|NCT00909532|75836932|FG000|Overall Study|Wrong Genotype|1|||
42028503|NCT00909532|75836933|FG001|Overall Study|Wrong Genotype|0|||
42028504|NCT00909532|75836932|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
42028505|NCT00909532|75836933|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
42028506|NCT01136382|75836942|FG000|Overall Study|Other|8|||
42028507|NCT01136382|75836943|FG001|Overall Study|Other|3|||
42028508|NCT01136382|75836942|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
42216807|NCT02713204|76033776|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
42216808|NCT02713204|76033777|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42216809|NCT02713204|76033778|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42302135|NCT02484547|76137180|FG000|Long-Term Extension Period|Reason not Specified|0|||
42216810|NCT02713204|76033779|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
41977958|NCT01054729|75782633|FG001|Overall Study|Personal/Obligations|1|||
41977959|NCT01054729|75782634|FG002|Overall Study|Personal/Obligations|0|||
41977960|NCT01054729|75782635|FG003|Overall Study|Personal/Obligations|0|||
42216811|NCT02713204|76033780|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42216812|NCT02713204|76033781|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42216813|NCT02713204|76033782|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42216814|NCT02713204|76033775|FG000|From Week 12 up to Week 36|Adverse Event|1|||
42216815|NCT02713204|76033776|FG001|From Week 12 up to Week 36|Adverse Event|0|||
42216816|NCT02713204|76033777|FG002|From Week 12 up to Week 36|Adverse Event|0|||
42216817|NCT02713204|76033778|FG003|From Week 12 up to Week 36|Adverse Event|1|||
42216818|NCT02713204|76033779|FG004|From Week 12 up to Week 36|Adverse Event|1|||
42216819|NCT02713204|76033780|FG005|From Week 12 up to Week 36|Adverse Event|0|||
42216820|NCT02713204|76033781|FG006|From Week 12 up to Week 36|Adverse Event|2|||
42216821|NCT02713204|76033782|FG007|From Week 12 up to Week 36|Adverse Event|1|||
42216822|NCT02713204|76033775|FG000|From Week 12 up to Week 36|Death|0|||
42216823|NCT02713204|76033776|FG001|From Week 12 up to Week 36|Death|0|||
42216824|NCT02713204|76033777|FG002|From Week 12 up to Week 36|Death|0|||
42216825|NCT02713204|76033778|FG003|From Week 12 up to Week 36|Death|1|||
42216826|NCT02713204|76033779|FG004|From Week 12 up to Week 36|Death|0|||
42216827|NCT02713204|76033780|FG005|From Week 12 up to Week 36|Death|1|||
42216828|NCT02713204|76033781|FG006|From Week 12 up to Week 36|Death|0|||
42216829|NCT02713204|76033782|FG007|From Week 12 up to Week 36|Death|3|||
42216830|NCT02713204|76033775|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
42216831|NCT02713204|76033776|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
42216832|NCT02713204|76033777|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
42216833|NCT02713204|76033778|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
42216834|NCT02713204|76033779|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
42216835|NCT02713204|76033780|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
42216836|NCT02713204|76033781|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
42216837|NCT02713204|76033782|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
42216838|NCT02713204|76033775|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
42216839|NCT02713204|76033776|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
42216840|NCT02713204|76033777|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
42216841|NCT02713204|76033778|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
42216842|NCT02713204|76033779|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
42216843|NCT02713204|76033780|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
42216844|NCT02713204|76033781|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
42216845|NCT02713204|76033782|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
42216846|NCT03695172|76033802|FG000|Overall Study|Withdrawal by Subject|1|||
42216847|NCT03695172|76033803|FG001|Overall Study|Withdrawal by Subject|1|||
42216848|NCT03695172|76033804|FG002|Overall Study|Withdrawal by Subject|0|||
42216849|NCT03721107|76033816|FG000|Overall Study|Adverse Event|1|||
42216850|NCT03721107|76033817|FG001|Overall Study|Adverse Event|1|||
42216851|NCT03721107|76033818|FG002|Overall Study|Adverse Event|6|||
42216852|NCT03721107|76033819|FG003|Overall Study|Adverse Event|5|||
42216853|NCT03721107|76033816|FG000|Overall Study|Lost to Follow-up|2|||
42216854|NCT03721107|76033817|FG001|Overall Study|Lost to Follow-up|0|||
42216855|NCT03721107|76033818|FG002|Overall Study|Lost to Follow-up|3|||
42216856|NCT03721107|76033819|FG003|Overall Study|Lost to Follow-up|0|||
42216857|NCT03721107|76033816|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
42216858|NCT03721107|76033817|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
42216859|NCT03721107|76033818|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
42216860|NCT03721107|76033819|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
42216861|NCT03721107|76033816|FG000|Overall Study|Physician Decision|0|||
42216862|NCT03721107|76033817|FG001|Overall Study|Physician Decision|1|||
42216863|NCT03721107|76033818|FG002|Overall Study|Physician Decision|0|||
42216864|NCT03721107|76033819|FG003|Overall Study|Physician Decision|0|||
42129145|NCT03742037|75940128|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
42129146|NCT03742037|75940122|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
42129147|NCT03742037|75940123|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
42129148|NCT03742037|75940124|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
42129149|NCT03742037|75940125|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
42129150|NCT03742037|75940126|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
42129151|NCT03742037|75940127|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
42216865|NCT03721107|76033816|FG000|Overall Study|Pregnancy|0|||
42216866|NCT03721107|76033817|FG001|Overall Study|Pregnancy|0|||
42216867|NCT03721107|76033818|FG002|Overall Study|Pregnancy|1|||
42216868|NCT03721107|76033819|FG003|Overall Study|Pregnancy|0|||
42216869|NCT03721107|76033816|FG000|Overall Study|Withdrawal by Subject|1|||
42216870|NCT03721107|76033817|FG001|Overall Study|Withdrawal by Subject|1|||
42216871|NCT03721107|76033818|FG002|Overall Study|Withdrawal by Subject|5|||
42216872|NCT03721107|76033819|FG003|Overall Study|Withdrawal by Subject|5|||
42216873|NCT03721107|76033816|FG000|Overall Study|Other|1|||
42216874|NCT03721107|76033817|FG001|Overall Study|Other|0|||
42216875|NCT03721107|76033818|FG002|Overall Study|Other|0|||
42216876|NCT03721107|76033819|FG003|Overall Study|Other|1|||
42216877|NCT03052920|76033838|FG000|Overall Study|Withdrawal by Subject|1|||
42216878|NCT02930226|76033848|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
42216879|NCT02930226|76033849|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
42216880|NCT02930226|76033850|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
42216881|NCT02930226|76033851|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
42216882|NCT02930226|76033852|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
42216883|NCT02930226|76033853|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
42216884|NCT02722434|76033890|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
42216885|NCT02722434|76033891|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
42216886|NCT02722434|76033890|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
42216887|NCT02722434|76033891|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
42216888|NCT03539601|76033901|FG000|Overall Study|Withdraw by parent/guardian|1|||
42216889|NCT03539601|76033902|FG001|Overall Study|Withdraw by parent/guardian|0|||
42216890|NCT03539601|76033903|FG002|Overall Study|Withdraw by parent/guardian|1|||
42216891|NCT03539601|76033904|FG003|Overall Study|Withdraw by parent/guardian|0|||
42216892|NCT03539601|76033901|FG000|Overall Study|Adverse Event|0|||
42216893|NCT03539601|76033902|FG001|Overall Study|Adverse Event|2|||
42216894|NCT03539601|76033903|FG002|Overall Study|Adverse Event|0|||
42216895|NCT03539601|76033904|FG003|Overall Study|Adverse Event|0|||
42216896|NCT03539601|76033901|FG000|Overall Study|Lost to Follow-up|2|||
41977961|NCT01054729|75782632|FG000|Overall Study|Subject moved|0|||
41977962|NCT01054729|75782633|FG001|Overall Study|Subject moved|0|||
41977963|NCT01054729|75782634|FG002|Overall Study|Subject moved|1|||
41977964|NCT01054729|75782635|FG003|Overall Study|Subject moved|0|||
41977965|NCT01054729|75782632|FG000|Overall Study|Lack of Efficacy|0|||
41977966|NCT01054729|75782633|FG001|Overall Study|Lack of Efficacy|0|||
42129152|NCT03742037|75940128|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
42129153|NCT03742037|75940122|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
42129154|NCT03742037|75940123|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
42129155|NCT03742037|75940124|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
42129156|NCT03742037|75940125|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
42129157|NCT03742037|75940126|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
42129158|NCT03742037|75940127|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
42129159|NCT03742037|75940128|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
42129160|NCT03742037|75940122|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
42129161|NCT03742037|75940123|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
42129162|NCT03742037|75940124|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
42129163|NCT03742037|75940125|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
42129164|NCT03742037|75940126|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
42129165|NCT03742037|75940127|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
42129166|NCT03742037|75940128|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
42129167|NCT03742037|75940122|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
42129168|NCT03742037|75940123|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
42129169|NCT03742037|75940124|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
42129170|NCT03742037|75940125|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
42129171|NCT03742037|75940126|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
42129172|NCT03742037|75940127|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
42129173|NCT03742037|75940128|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
42129174|NCT03742037|75940122|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
42129175|NCT03742037|75940123|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
42129176|NCT03742037|75940124|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
42129177|NCT03742037|75940125|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
42129178|NCT03742037|75940126|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
42129179|NCT03742037|75940127|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
42129180|NCT03742037|75940128|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
42129181|NCT03742037|75940122|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
42216897|NCT03539601|76033902|FG001|Overall Study|Lost to Follow-up|4|||
42216898|NCT03539601|76033903|FG002|Overall Study|Lost to Follow-up|5|||
42216899|NCT03539601|76033904|FG003|Overall Study|Lost to Follow-up|0|||
42216900|NCT03539601|76033901|FG000|Overall Study|Withdrawal by Subject|2|||
42216901|NCT03539601|76033902|FG001|Overall Study|Withdrawal by Subject|0|||
41977967|NCT01054729|75782634|FG002|Overall Study|Lack of Efficacy|0|||
41977968|NCT01054729|75782635|FG003|Overall Study|Lack of Efficacy|1|||
41977969|NCT01054573|75782649|FG000|Overall Study|Adverse Event|1|||
41977970|NCT01054573|75782650|FG001|Overall Study|Adverse Event|0|||
42216902|NCT03539601|76033903|FG002|Overall Study|Withdrawal by Subject|0|||
42216903|NCT03539601|76033904|FG003|Overall Study|Withdrawal by Subject|1|||
41977971|NCT01054573|75782651|FG002|Overall Study|Adverse Event|1|||
41977972|NCT01054573|75782652|FG003|Overall Study|Adverse Event|1|||
41977973|NCT01054573|75782649|FG000|Overall Study|Lost to Follow-up|0|||
41977974|NCT01054573|75782650|FG001|Overall Study|Lost to Follow-up|2|||
41977975|NCT01054573|75782651|FG002|Overall Study|Lost to Follow-up|0|||
41977976|NCT01054573|75782652|FG003|Overall Study|Lost to Follow-up|0|||
41977977|NCT01054573|75782649|FG000|Overall Study|Withdrawal by Subject|0|||
41977978|NCT01054573|75782650|FG001|Overall Study|Withdrawal by Subject|2|||
41977979|NCT01054573|75782651|FG002|Overall Study|Withdrawal by Subject|2|||
41977980|NCT01054573|75782652|FG003|Overall Study|Withdrawal by Subject|1|||
41977981|NCT01054456|75782671|FG000|Overall Study|Other|1|||
41977982|NCT01054300|75782677|FG000|Period 1|Adverse Event|1|||
41977983|NCT01054300|75782678|FG001|Period 1|Adverse Event|0|||
41977984|NCT01054300|75782679|FG002|Period 1|Adverse Event|0|||
41977985|NCT01054300|75782680|FG003|Period 1|Adverse Event|0|||
41977986|NCT01054300|75782677|FG000|Period 2|Withdrawal by Subject|0|||
41977987|NCT01054300|75782678|FG001|Period 2|Withdrawal by Subject|0|||
41977988|NCT01054300|75782679|FG002|Period 2|Withdrawal by Subject|1|||
41977989|NCT01054300|75782680|FG003|Period 2|Withdrawal by Subject|0|||
42216904|NCT03539601|76033901|FG000|Overall Study|Randomized but not treated|1|||
42216905|NCT03539601|76033902|FG001|Overall Study|Randomized but not treated|1|||
42216906|NCT03539601|76033903|FG002|Overall Study|Randomized but not treated|0|||
42216907|NCT03539601|76033904|FG003|Overall Study|Randomized but not treated|0|||
42216908|NCT00700804|76033924|FG000|Overall Study|Withdrawal by Subject|1|||
42216909|NCT00700804|76033925|FG001|Overall Study|Withdrawal by Subject|2|||
42216910|NCT00700804|76033924|FG000|Overall Study|Protocol Violation|1|||
42216911|NCT00700804|76033925|FG001|Overall Study|Protocol Violation|1|||
42216912|NCT00700804|76033924|FG000|Overall Study|Loose Stools|1|||
42216913|NCT00700804|76033925|FG001|Overall Study|Loose Stools|1|||
42216914|NCT02903823|76033931|FG000|Overall Study|Physician Decision|5|||
42216915|NCT02903823|76033931|FG000|Overall Study|Could not advance catheter|1|||
42216916|NCT02903823|76033931|FG000|Overall Study|Catheter dislodgement|1|||
42216917|NCT00832455|76033960|FG000|Overall Study|Adverse Event|13|||
42216918|NCT00832455|76033960|FG000|Overall Study|Lost to Follow-up|26|||
42216919|NCT00832455|76033960|FG000|Overall Study|Protocol Violation|4|||
42216920|NCT00832455|76033960|FG000|Overall Study|Withdrawal by Subject|17|||
42216921|NCT00832455|76033960|FG000|Overall Study|Screening Failure|2|||
41977990|NCT01053988|75782695|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
42216922|NCT00832455|76033960|FG000|Overall Study|Stopped Medication|4|||
42216923|NCT00832455|76033960|FG000|Overall Study|Parent misunderstood study|1|||
42216924|NCT00832455|76033960|FG000|Overall Study|Parent dissatisfied|1|||
42216925|NCT00832455|76033960|FG000|Overall Study|No improvement|3|||
42216926|NCT00832455|76033960|FG000|Overall Study|Patient moved|1|||
42216927|NCT00687531|76033973|FG000|Overall Study|Did not meet protocol eligibility|104|||
42216928|NCT00687531|76033973|FG000|Overall Study|Adverse Event|5|||
42216929|NCT00687531|76033973|FG000|Overall Study|Lost to Follow-up|26|||
42216930|NCT00423579|76033979|FG000|Overall Study|Lost to Follow-up|3|||
42216931|NCT00423579|76033980|FG001|Overall Study|Lost to Follow-up|0|||
42216932|NCT00423579|76033979|FG000|Overall Study|Protocol Violation|1|||
42216933|NCT00423579|76033980|FG001|Overall Study|Protocol Violation|3|||
41977991|NCT01053988|75782696|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
41977992|NCT01053988|75782697|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
41977993|NCT01053988|75782698|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
42129182|NCT03742037|75940123|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
42129183|NCT03742037|75940124|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
42129184|NCT03742037|75940125|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
42129185|NCT03742037|75940126|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
42129186|NCT03742037|75940127|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
42129187|NCT03742037|75940128|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
42129188|NCT03742037|75940122|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
42129189|NCT03742037|75940123|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
42129190|NCT03742037|75940124|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
42129191|NCT03742037|75940125|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
42129192|NCT03742037|75940126|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
42129193|NCT03742037|75940127|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
42129194|NCT03742037|75940128|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
42216934|NCT00423579|76033979|FG000|Overall Study|Diagnosis of diabetes|0|||
41977994|NCT01053988|75782699|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
41977995|NCT01053988|75782700|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
42129195|NCT03742037|75940122|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
42216935|NCT00423579|76033980|FG001|Overall Study|Diagnosis of diabetes|1|||
42216936|NCT03268005|76033988|FG000|Overall Study|Death|2|||
42216937|NCT03268005|76033989|FG001|Overall Study|Death|1|||
42216938|NCT03268005|76033988|FG000|Overall Study|Lost to Follow-up|2|||
42216939|NCT03268005|76033989|FG001|Overall Study|Lost to Follow-up|2|||
41977996|NCT01053988|75782695|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
42216940|NCT03268005|76033988|FG000|Overall Study|Withdrawal by Subject|11|||
42216941|NCT03268005|76033989|FG001|Overall Study|Withdrawal by Subject|11|||
42216942|NCT03149055|76033995|FG000|Overall Study|Not treated|4|||
42216943|NCT03137121|76034010|FG000|Overall Study|Withdrawal by Subject|0|||
42216944|NCT03137121|76034011|FG001|Overall Study|Withdrawal by Subject|1|||
42216945|NCT00700570|76034054|FG000|Overall Study|Adverse Event|2|||
42216946|NCT00700570|76034055|FG001|Overall Study|Adverse Event|6|||
42216947|NCT00700570|76034054|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
42216948|NCT00700570|76034055|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
42216949|NCT00700570|76034054|FG000|Overall Study|Disease Progression|8|||
42216950|NCT00700570|76034055|FG001|Overall Study|Disease Progression|11|||
42216951|NCT00700570|76034054|FG000|Overall Study|Withdrawal by Subject|1|||
42216952|NCT00700570|76034055|FG001|Overall Study|Withdrawal by Subject|6|||
42216953|NCT02874924|76034073|FG000|Overall Study|Adverse Event|2|||
42216954|NCT02874924|76034074|FG001|Overall Study|Adverse Event|0|||
42216955|NCT02874924|76034075|FG002|Overall Study|Adverse Event|0|||
42216956|NCT02874924|76034073|FG000|Overall Study|Withdrawal by Subject|1|||
42216957|NCT02874924|76034074|FG001|Overall Study|Withdrawal by Subject|0|||
42216958|NCT02874924|76034075|FG002|Overall Study|Withdrawal by Subject|0|||
42216959|NCT04425863|76034086|FG000|Overall Study|Death|0|||
42216960|NCT04425863|76034087|FG001|Overall Study|Death|0|||
42216961|NCT04425863|76034088|FG002|Overall Study|Death|1|||
42216962|NCT04360187|76034110|FG000|Double-Blind Treatment|Adverse Event|9|||
42216963|NCT04360187|76034111|FG001|Double-Blind Treatment|Adverse Event|11|||
42216964|NCT04360187|76034110|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
42216965|NCT04360187|76034111|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
42216966|NCT04360187|76034110|FG000|Double-Blind Treatment|Physician Decision|1|||
42216967|NCT04360187|76034111|FG001|Double-Blind Treatment|Physician Decision|0|||
42216968|NCT04360187|76034110|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
42216969|NCT04360187|76034111|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
42216970|NCT04360187|76034110|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
42216971|NCT04360187|76034111|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
42216972|NCT04360187|76034110|FG000|Follow-Up|Lost to Follow-up|1|||
42216973|NCT04360187|76034111|FG001|Follow-Up|Lost to Follow-up|0|||
42216974|NCT04498169|76034119|FG000|Study Completion|Adverse Event|1|||
42216975|NCT04498169|76034120|FG001|Study Completion|Adverse Event|1|||
42216976|NCT03695393|76034128|FG000|Overall Study|Death|3|||
42216977|NCT03695393|76034129|FG001|Overall Study|Death|1|||
42216978|NCT03695393|76034128|FG000|Overall Study|Lost to Follow-up|0|||
42216979|NCT03695393|76034129|FG001|Overall Study|Lost to Follow-up|1|||
42216980|NCT03694925|76034138|FG000|Overall Study|Inadequate laboratory testing|0|||
42216981|NCT03694925|76034139|FG001|Overall Study|Inadequate laboratory testing|3|||
42216982|NCT03694925|76034140|FG002|Overall Study|Inadequate laboratory testing|0|||
42216983|NCT04258020|76034152|FG000|Overall Study|Withdrawal by Subject|1|||
42216984|NCT04258020|76034153|FG001|Overall Study|Withdrawal by Subject|0|||
42216985|NCT04495283|76034162|FG000|Overall Study|Physician Decision|0|||
42216986|NCT04495283|76034163|FG001|Overall Study|Physician Decision|0|||
42216987|NCT04495283|76034164|FG002|Overall Study|Physician Decision|1|||
42216988|NCT04495283|76034162|FG000|Overall Study|Withdrawal by Subject|0|||
42216989|NCT04495283|76034163|FG001|Overall Study|Withdrawal by Subject|1|||
42216990|NCT04495283|76034164|FG002|Overall Study|Withdrawal by Subject|1|||
42216991|NCT04495283|76034162|FG000|Overall Study|Other|1|||
42216992|NCT04495283|76034163|FG001|Overall Study|Other|0|||
42216993|NCT04495283|76034164|FG002|Overall Study|Other|1|||
42216994|NCT03117738|76034177|FG000|Overall Study|Withdrawal by Subject|3|||
42216995|NCT03117738|76034178|FG001|Overall Study|Withdrawal by Subject|1|||
42216996|NCT03117738|76034177|FG000|Overall Study|Lost to Follow-up|1|||
42216997|NCT03117738|76034178|FG001|Overall Study|Lost to Follow-up|4|||
42216998|NCT04234464|76034186|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
42216999|NCT04234464|76034187|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
42028509|NCT01136382|75836943|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
42217000|NCT03123588|76034195|FG000|Overall Study|Study Terminated by Sponsor|2|||
42217001|NCT03123588|76034196|FG001|Overall Study|Study Terminated by Sponsor|5|||
42217002|NCT03123588|76034195|FG000|Overall Study|Withdrawal by Subject|1|||
42217003|NCT03123588|76034196|FG001|Overall Study|Withdrawal by Subject|0|||
42217004|NCT03123588|76034195|FG000|Overall Study|Adverse Event|1|||
42217005|NCT03123588|76034196|FG001|Overall Study|Adverse Event|0|||
42217006|NCT03123588|76034195|FG000|Overall Study|Physician Decision|2|||
42217007|NCT03123588|76034196|FG001|Overall Study|Physician Decision|1|||
42028510|NCT01136382|75836942|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
42028511|NCT01136382|75836943|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
42217008|NCT03123354|76034203|FG000|Overall Study|Physician Decision|6|||
42217009|NCT04421027|76034209|FG000|Treatment Period|Adverse Event|5|||
42217010|NCT04421027|76034210|FG001|Treatment Period|Adverse Event|3|||
42217011|NCT04421027|76034211|FG002|Treatment Period|Adverse Event|0|||
42217012|NCT04421027|76034212|FG003|Treatment Period|Adverse Event|0|||
42217013|NCT04421027|76034209|FG000|Treatment Period|Death|98|||
42217014|NCT04421027|76034210|FG001|Treatment Period|Death|61|||
42217015|NCT04421027|76034211|FG002|Treatment Period|Death|0|||
42217016|NCT04421027|76034212|FG003|Treatment Period|Death|0|||
42217017|NCT04421027|76034209|FG000|Treatment Period|Lost to Follow-up|22|||
42217018|NCT04421027|76034210|FG001|Treatment Period|Lost to Follow-up|20|||
42217019|NCT04421027|76034211|FG002|Treatment Period|Lost to Follow-up|0|||
42217020|NCT04421027|76034212|FG003|Treatment Period|Lost to Follow-up|0|||
42217021|NCT04421027|76034209|FG000|Treatment Period|Other-Unknown|15|||
42217022|NCT04421027|76034210|FG001|Treatment Period|Other-Unknown|9|||
42217023|NCT04421027|76034211|FG002|Treatment Period|Other-Unknown|0|||
42217024|NCT04421027|76034212|FG003|Treatment Period|Other-Unknown|0|||
42217025|NCT04421027|76034209|FG000|Treatment Period|Physician Decision|1|||
42217026|NCT04421027|76034210|FG001|Treatment Period|Physician Decision|1|||
42217027|NCT04421027|76034211|FG002|Treatment Period|Physician Decision|0|||
42217028|NCT04421027|76034212|FG003|Treatment Period|Physician Decision|0|||
42217029|NCT04421027|76034209|FG000|Treatment Period|Withdrawal by Subject|7|||
42217030|NCT04421027|76034210|FG001|Treatment Period|Withdrawal by Subject|12|||
42217031|NCT04421027|76034211|FG002|Treatment Period|Withdrawal by Subject|0|||
42217032|NCT04421027|76034212|FG003|Treatment Period|Withdrawal by Subject|0|||
42217033|NCT04421027|76034209|FG000|Treatment Period|Randomized Not Dosed|9|||
42217034|NCT04421027|76034210|FG001|Treatment Period|Randomized Not Dosed|14|||
42217035|NCT04421027|76034211|FG002|Treatment Period|Randomized Not Dosed|0|||
41977997|NCT01053988|75782696|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
41977998|NCT01053988|75782697|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
42217036|NCT04421027|76034212|FG003|Treatment Period|Randomized Not Dosed|0|||
41977999|NCT01053988|75782698|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
41978000|NCT01053988|75782699|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
41978001|NCT01053988|75782700|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
41978002|NCT01053988|75782695|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
41978003|NCT01053988|75782696|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
41978004|NCT01053988|75782697|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
41978005|NCT01053988|75782698|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
41978006|NCT01053988|75782699|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
41978007|NCT01053988|75782700|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
41978008|NCT01053988|75782695|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
41978009|NCT01053988|75782696|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
41978010|NCT01053988|75782697|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
41978011|NCT01053988|75782698|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
41978012|NCT01053988|75782699|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
41978013|NCT01053988|75782700|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
41978014|NCT01053988|75782695|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
41978015|NCT01053988|75782696|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
41978016|NCT01053988|75782697|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
41978017|NCT01053988|75782698|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
41978018|NCT01053988|75782699|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
42217037|NCT04421027|76034209|FG000|Follow-Up Period|Adverse Event|0|||
42217038|NCT04421027|76034210|FG001|Follow-Up Period|Adverse Event|0|||
42217039|NCT04421027|76034211|FG002|Follow-Up Period|Adverse Event|0|||
42217040|NCT04421027|76034212|FG003|Follow-Up Period|Adverse Event|3|||
42217041|NCT04421027|76034209|FG000|Follow-Up Period|Death|0|||
42217042|NCT04421027|76034210|FG001|Follow-Up Period|Death|0|||
42217043|NCT04421027|76034211|FG002|Follow-Up Period|Death|16|||
42217044|NCT04421027|76034212|FG003|Follow-Up Period|Death|17|||
42217045|NCT04421027|76034209|FG000|Follow-Up Period|Lost to Follow-up|0|||
42217046|NCT04421027|76034210|FG001|Follow-Up Period|Lost to Follow-up|0|||
42217047|NCT04421027|76034211|FG002|Follow-Up Period|Lost to Follow-up|7|||
42217048|NCT04421027|76034212|FG003|Follow-Up Period|Lost to Follow-up|7|||
42217049|NCT04421027|76034209|FG000|Follow-Up Period|Protocol Deviation|0|||
42217050|NCT04421027|76034210|FG001|Follow-Up Period|Protocol Deviation|0|||
42028512|NCT01136382|75836942|FG000|Overall Study|Withdrawal by Subject|4|||
42028513|NCT01136382|75836943|FG001|Overall Study|Withdrawal by Subject|1|||
42217051|NCT04421027|76034211|FG002|Follow-Up Period|Protocol Deviation|1|||
42217052|NCT04421027|76034212|FG003|Follow-Up Period|Protocol Deviation|0|||
42217053|NCT04421027|76034209|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
42217054|NCT04421027|76034210|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
42217055|NCT04421027|76034211|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
42217056|NCT04421027|76034212|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
42217057|NCT04421027|76034209|FG000|Follow-Up Period|Left message, participant did not call back|0|||
42217058|NCT04421027|76034210|FG001|Follow-Up Period|Left message, participant did not call back|0|||
42217059|NCT04421027|76034211|FG002|Follow-Up Period|Left message, participant did not call back|0|||
42217060|NCT04421027|76034212|FG003|Follow-Up Period|Left message, participant did not call back|1|||
42217061|NCT04421027|76034209|FG000|Follow-Up Period|Participant died|0|||
42217062|NCT04421027|76034210|FG001|Follow-Up Period|Participant died|0|||
42217063|NCT04421027|76034211|FG002|Follow-Up Period|Participant died|0|||
42217064|NCT04421027|76034212|FG003|Follow-Up Period|Participant died|1|||
42217065|NCT04421027|76034209|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
42217066|NCT04421027|76034210|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
42217067|NCT04421027|76034211|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
42217068|NCT04421027|76034212|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
42217069|NCT04419311|76034222|FG000|Overall Study|Lost to Follow-up|1|||
42217070|NCT04419311|76034223|FG001|Overall Study|Lost to Follow-up|0|||
42217071|NCT04411667|76034233|FG000|Overall Study|Physician Decision|1|||
42217072|NCT04411667|76034234|FG001|Overall Study|Physician Decision|0|||
42217073|NCT04358549|76034242|FG000|Overall Study|Adverse Event|0|||
42217074|NCT04358549|76034243|FG001|Overall Study|Adverse Event|1|||
42217075|NCT04358549|76034242|FG000|Overall Study|Death|1|||
42217076|NCT04358549|76034243|FG001|Overall Study|Death|0|||
42217077|NCT04358549|76034242|FG000|Overall Study|Lost to Follow-up|2|||
42217078|NCT04358549|76034243|FG001|Overall Study|Lost to Follow-up|1|||
42217079|NCT04358549|76034242|FG000|Overall Study|Withdrawal by Subject|6|||
42217080|NCT04358549|76034243|FG001|Overall Study|Withdrawal by Subject|6|||
42217081|NCT04358549|76034242|FG000|Overall Study|Start remdesivir|1|||
42217082|NCT04358549|76034243|FG001|Overall Study|Start remdesivir|0|||
42217083|NCT00700180|76034251|FG000|Overall Study|Death|99|||
42217084|NCT00700180|76034252|FG001|Overall Study|Death|114|||
42217085|NCT00700180|76034251|FG000|Overall Study|Alive on treatment|5|||
42217086|NCT00700180|76034252|FG001|Overall Study|Alive on treatment|3|||
42217087|NCT00700180|76034251|FG000|Overall Study|Alive in follow-up|46|||
42217088|NCT00700180|76034252|FG001|Overall Study|Alive in follow-up|27|||
42217089|NCT00700180|76034251|FG000|Overall Study|Lost to Follow-up|4|||
42217090|NCT00700180|76034252|FG001|Overall Study|Lost to Follow-up|5|||
42217091|NCT00238420|76034260|FG000|Overall Study|Protocol Violation|1|||
42217092|NCT00238420|76034261|FG001|Overall Study|Protocol Violation|1|||
42217093|NCT04492475|76034269|FG000|Overall Study|Enrolled but not treated|8|||
42217094|NCT04492475|76034270|FG001|Overall Study|Enrolled but not treated|8|||
42217095|NCT04492475|76034269|FG000|Overall Study|Withdrawal by Subject|4|||
42217096|NCT04492475|76034270|FG001|Overall Study|Withdrawal by Subject|0|||
42217097|NCT04492475|76034269|FG000|Overall Study|Became ineligible after enrollment|2|||
42217098|NCT04492475|76034270|FG001|Overall Study|Became ineligible after enrollment|0|||
42217099|NCT04486235|76034285|FG000|Overall Study|Pregnancy|1|||
42129196|NCT03742037|75940123|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
42129197|NCT03742037|75940124|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
42129198|NCT03742037|75940125|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
42129199|NCT03742037|75940126|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
42129200|NCT03742037|75940127|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
42129201|NCT03742037|75940128|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
42129202|NCT03742037|75940122|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
42129203|NCT03742037|75940123|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
42129204|NCT03742037|75940124|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
42129205|NCT03742037|75940125|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
42129206|NCT03742037|75940126|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
42129207|NCT03742037|75940127|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
42129208|NCT03742037|75940128|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
42129209|NCT03742037|75940122|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
42129210|NCT03742037|75940123|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
42129211|NCT03742037|75940124|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
42129212|NCT03742037|75940125|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
42129213|NCT03742037|75940126|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
42217100|NCT04486235|76034286|FG001|Overall Study|Pregnancy|0|||
42217101|NCT04486235|76034285|FG000|Overall Study|Lost to Follow-up|1|||
42217102|NCT04486235|76034286|FG001|Overall Study|Lost to Follow-up|0|||
42217103|NCT04358081|76034296|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
42217104|NCT04358081|76034297|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
42217105|NCT04358081|76034298|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
42217106|NCT04358081|76034296|FG000|Treatment Phase of Study|Adverse Event|1|||
42217107|NCT04358081|76034297|FG001|Treatment Phase of Study|Adverse Event|0|||
42217108|NCT04358081|76034298|FG002|Treatment Phase of Study|Adverse Event|1|||
42217109|NCT04358081|76034296|FG000|Treatment Phase of Study|Physician Decision|2|||
42217110|NCT04358081|76034297|FG001|Treatment Phase of Study|Physician Decision|0|||
42217111|NCT04358081|76034298|FG002|Treatment Phase of Study|Physician Decision|1|||
42217112|NCT04358081|76034296|FG000|Treatment Phase of Study|Protocol Violation|1|||
42217113|NCT04358081|76034297|FG001|Treatment Phase of Study|Protocol Violation|0|||
42217114|NCT04358081|76034298|FG002|Treatment Phase of Study|Protocol Violation|0|||
42217115|NCT04358081|76034296|FG000|Study Completion Phase|Death|0|||
42217116|NCT04358081|76034297|FG001|Study Completion Phase|Death|0|||
42217117|NCT04358081|76034298|FG002|Study Completion Phase|Death|1|||
42217118|NCT04358081|76034296|FG000|Study Completion Phase|Lost to Follow-up|1|||
42217119|NCT04358081|76034297|FG001|Study Completion Phase|Lost to Follow-up|0|||
42217120|NCT04358081|76034298|FG002|Study Completion Phase|Lost to Follow-up|1|||
42217121|NCT04355663|76034311|FG000|Overall Study|Physician Decision|2|||
42217122|NCT04355663|76034312|FG001|Overall Study|Physician Decision|7|||
42217123|NCT04355663|76034313|FG002|Overall Study|Physician Decision|0|||
42217124|NCT04355663|76034311|FG000|Overall Study|Adverse Event|0|||
42217125|NCT04355663|76034312|FG001|Overall Study|Adverse Event|0|||
42217126|NCT04355663|76034313|FG002|Overall Study|Adverse Event|1|||
42217127|NCT04355663|76034311|FG000|Overall Study|Withdrawal by Subject|0|||
42217128|NCT04355663|76034312|FG001|Overall Study|Withdrawal by Subject|8|||
42217129|NCT04355663|76034313|FG002|Overall Study|Withdrawal by Subject|3|||
42217130|NCT04345367|76034323|FG000|Overall Study|Other|3|||
42217131|NCT04345367|76034324|FG001|Overall Study|Other|4|||
42217132|NCT04345367|76034323|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
42217133|NCT04345367|76034324|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
42217134|NCT04345367|76034323|FG000|Overall Study|Withdrawal by Subject|11|||
42217135|NCT04345367|76034324|FG001|Overall Study|Withdrawal by Subject|11|||
42217136|NCT04345367|76034323|FG000|Overall Study|Protocol Violation|4|||
42217137|NCT04345367|76034324|FG001|Overall Study|Protocol Violation|3|||
42217138|NCT04345367|76034323|FG000|Overall Study|Lost to Follow-up|2|||
42217139|NCT04345367|76034324|FG001|Overall Study|Lost to Follow-up|4|||
42217140|NCT04345367|76034323|FG000|Overall Study|Lack of Efficacy|2|||
42217141|NCT04345367|76034324|FG001|Overall Study|Lack of Efficacy|0|||
42217142|NCT04345367|76034323|FG000|Overall Study|Death|2|||
42217143|NCT04345367|76034324|FG001|Overall Study|Death|0|||
42217144|NCT04345367|76034323|FG000|Overall Study|Adverse Event|10|||
42217145|NCT04345367|76034324|FG001|Overall Study|Adverse Event|9|||
42217146|NCT04404725|76034330|FG000|First Intervention|Withdrawal by Subject|0|||
41978019|NCT01053988|75782700|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
41978020|NCT01053988|75782695|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
41978021|NCT01053988|75782696|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
41978022|NCT01053988|75782697|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
42129214|NCT03742037|75940127|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
42129215|NCT03742037|75940128|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
42129216|NCT03742037|75940122|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
42129217|NCT03742037|75940123|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
42129218|NCT03742037|75940124|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
42129219|NCT03742037|75940125|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
42129220|NCT03742037|75940126|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
42129221|NCT03742037|75940127|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
42217147|NCT04404725|76034331|FG001|First Intervention|Withdrawal by Subject|2|||
42217148|NCT04404725|76034330|FG000|Second Intervention|Adverse Event|1|||
42217149|NCT04404725|76034331|FG001|Second Intervention|Adverse Event|1|||
41978023|NCT01053988|75782698|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
42217150|NCT04404725|76034330|FG000|Second Intervention|Withdrawal by Subject|0|||
42217151|NCT04404725|76034331|FG001|Second Intervention|Withdrawal by Subject|1|||
42217152|NCT04343261|76034337|FG000|Overall Study|Adverse Event|1|||
42217153|NCT04343261|76034337|FG000|Overall Study|received inadequate amount of antibodies|7|||
42217154|NCT04336475|76034343|FG000|Overall Study|pain|1|||
42217155|NCT04336475|76034344|FG001|Overall Study|pain|0|||
42217156|NCT04336475|76034343|FG000|Overall Study|upper respiratory infection|1|||
42217157|NCT04336475|76034344|FG001|Overall Study|upper respiratory infection|0|||
42217158|NCT04336475|76034343|FG000|Overall Study|Lost to Follow-up|0|||
42217159|NCT04336475|76034344|FG001|Overall Study|Lost to Follow-up|2|||
42217160|NCT04335929|76034350|FG000|Overall Study|Lost to Follow-up|10|||
42217161|NCT04333199|76034357|FG000|Evaluated Patients|Lost to Follow-up|0|||
42217162|NCT04333199|76034358|FG001|Evaluated Patients|Lost to Follow-up|1|||
42028514|NCT00912028|75836952|FG000|Overall Study|Lost to Follow-up|2|||
42129222|NCT03742037|75940128|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
42129223|NCT03742037|75940122|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
42129224|NCT03742037|75940123|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
42129225|NCT03742037|75940124|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
42129226|NCT03742037|75940125|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
42129227|NCT03742037|75940126|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
42129228|NCT03742037|75940127|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
42129229|NCT03742037|75940128|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
42217163|NCT04333199|76034359|FG002|Evaluated Patients|Lost to Follow-up|2|||
42217164|NCT04332419|76034368|FG000|Overall Study|Withdrawal by Subject|1|||
42217165|NCT04330157|76034372|FG000|Overall Study|Protocol Violation|4|||
42217166|NCT04330157|76034372|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
42217167|NCT04329923|76034387|FG000|Overall Study|Withdrawal by Subject|1|||
42302136|NCT02484547|76137181|FG001|Long-Term Extension Period|Reason not Specified|0|||
41978024|NCT01053988|75782699|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
41978025|NCT01053988|75782700|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
41978026|NCT01053988|75782695|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
41978027|NCT01053988|75782696|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
41978028|NCT01053988|75782697|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
41978029|NCT01053988|75782698|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
41978030|NCT01053988|75782699|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
41978031|NCT01053988|75782700|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
42028515|NCT00912028|75836953|FG001|Overall Study|Lost to Follow-up|3|||
42217168|NCT04329923|76034388|FG001|Overall Study|Withdrawal by Subject|4|||
42217169|NCT04329923|76034389|FG002|Overall Study|Withdrawal by Subject|1|||
42217170|NCT04329923|76034390|FG003|Overall Study|Withdrawal by Subject|1|||
42217171|NCT04329923|76034391|FG004|Overall Study|Withdrawal by Subject|1|||
42217172|NCT04329923|76034392|FG005|Overall Study|Withdrawal by Subject|1|||
42217173|NCT04329923|76034387|FG000|Overall Study|early termination of study|0|||
42217174|NCT04329923|76034388|FG001|Overall Study|early termination of study|0|||
42217175|NCT04329923|76034389|FG002|Overall Study|early termination of study|0|||
42217176|NCT04329923|76034390|FG003|Overall Study|early termination of study|0|||
42217177|NCT04329923|76034391|FG004|Overall Study|early termination of study|1|||
42217178|NCT04329923|76034392|FG005|Overall Study|early termination of study|2|||
42217179|NCT04329923|76034387|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
42217180|NCT04329923|76034388|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
42217181|NCT04329923|76034389|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
42217182|NCT04329923|76034390|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
42217183|NCT04329923|76034391|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
42217184|NCT04329923|76034392|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
42217185|NCT04403399|76034408|FG000|Period 2|Physician Decision|0|||
42217186|NCT04403399|76034409|FG001|Period 2|Physician Decision|1|||
42217187|NCT04401293|76034417|FG000|Overall Study|Withdrawal by Subject|1|||
42217188|NCT04401293|76034418|FG001|Overall Study|Withdrawal by Subject|3|||
42217189|NCT04319159|76034426|FG000|Overall Study|Screening failure|13|||
42217190|NCT04319159|76034426|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
42217191|NCT04319159|76034426|FG000|Overall Study|Withdrawal by Subject|1|||
42217192|NCT04318535|76034432|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
42217193|NCT04318535|76034433|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
42217194|NCT04318535|76034434|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
42217195|NCT04454567|76034445|FG000|Overall Study|Study Terminated by Sponsor|1|||
42217196|NCT04454567|76034446|FG001|Overall Study|Study Terminated by Sponsor|1|||
42217197|NCT04449341|76034454|FG000|Overall Study|Protocol Violation|1|||
42217198|NCT04449341|76034455|FG001|Overall Study|Protocol Violation|0|||
42217199|NCT04448561|76034463|FG000|Overall Study|Noncompliance|1|||
42217200|NCT04448561|76034464|FG001|Overall Study|Noncompliance|0|||
42217201|NCT04308239|76034480|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
42217202|NCT04308239|76034481|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
42217203|NCT04308239|76034480|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
42217204|NCT04308239|76034481|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
42217205|NCT04308239|76034480|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
42217206|NCT04308239|76034481|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
42217207|NCT04308239|76034480|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
42217208|NCT04308239|76034481|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
42217209|NCT04302545|76034493|FG000|Overall Study|Lost to Follow-up|3|||
42217210|NCT04302545|76034494|FG001|Overall Study|Lost to Follow-up|4|||
42217211|NCT04297241|76034511|FG000|Overall Study|Withdrawal by Subject|1|||
42217212|NCT04297241|76034511|FG000|Overall Study|Adverse Event|1|||
42217213|NCT04297241|76034511|FG000|Overall Study|Physician Decision|3|||
42217214|NCT04292171|76034527|FG000|Overall Study|Pharmacy error|2|||
42217215|NCT04292171|76034528|FG001|Overall Study|Pharmacy error|0|||
42217216|NCT04292171|76034527|FG000|Overall Study|Delivered prior to procedure|0|||
42217217|NCT04292171|76034528|FG001|Overall Study|Delivered prior to procedure|1|||
42217218|NCT04393493|76034536|FG000|First 4 Days of Intervention|Early improvement|5|||
42217219|NCT04393493|76034537|FG001|First 4 Days of Intervention|Early improvement|7|||
42217220|NCT04280705|76034547|FG000|Overall Study|Enrolled but not treated|4|||
41978032|NCT01053988|75782695|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
41978033|NCT01053988|75782696|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
41978034|NCT01053988|75782697|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
42028516|NCT00912028|75836954|FG002|Overall Study|Lost to Follow-up|0|||
42217221|NCT04280705|76034548|FG001|Overall Study|Enrolled but not treated|10|||
42217222|NCT04280705|76034547|FG000|Overall Study|Physician Decision|1|||
42217223|NCT04280705|76034548|FG001|Overall Study|Physician Decision|0|||
42217224|NCT04280705|76034547|FG000|Overall Study|Withdrawal by Subject|7|||
42217225|NCT04280705|76034548|FG001|Overall Study|Withdrawal by Subject|9|||
42217226|NCT04280705|76034547|FG000|Overall Study|Adverse Event|0|||
42217227|NCT04280705|76034548|FG001|Overall Study|Adverse Event|4|||
42217228|NCT04280705|76034547|FG000|Overall Study|Transferred to another hospital|1|||
42217229|NCT04280705|76034548|FG001|Overall Study|Transferred to another hospital|1|||
42217230|NCT02077166|76034561|FG000|Overall Study|Death|6|||
42217231|NCT02077166|76034562|FG001|Overall Study|Death|7|||
42217232|NCT02077166|76034563|FG002|Overall Study|Death|5|||
42217233|NCT02077166|76034564|FG003|Overall Study|Death|6|||
42217234|NCT02077166|76034565|FG004|Overall Study|Death|4|||
42217235|NCT02077166|76034566|FG005|Overall Study|Death|32|||
42217236|NCT02077166|76034567|FG006|Overall Study|Death|22|||
42217237|NCT02077166|76034561|FG000|Overall Study|Study Closure by Sponsor|3|||
42217238|NCT02077166|76034562|FG001|Overall Study|Study Closure by Sponsor|0|||
42217239|NCT02077166|76034563|FG002|Overall Study|Study Closure by Sponsor|2|||
42217240|NCT02077166|76034564|FG003|Overall Study|Study Closure by Sponsor|2|||
42217241|NCT02077166|76034565|FG004|Overall Study|Study Closure by Sponsor|2|||
42217242|NCT02077166|76034566|FG005|Overall Study|Study Closure by Sponsor|12|||
42217243|NCT02077166|76034567|FG006|Overall Study|Study Closure by Sponsor|4|||
42217244|NCT02077166|76034561|FG000|Overall Study|Lost to Follow-up|0|||
42217245|NCT02077166|76034562|FG001|Overall Study|Lost to Follow-up|0|||
42217246|NCT02077166|76034563|FG002|Overall Study|Lost to Follow-up|0|||
42217247|NCT02077166|76034564|FG003|Overall Study|Lost to Follow-up|0|||
42217248|NCT02077166|76034565|FG004|Overall Study|Lost to Follow-up|0|||
42217249|NCT02077166|76034566|FG005|Overall Study|Lost to Follow-up|1|||
42217250|NCT02077166|76034567|FG006|Overall Study|Lost to Follow-up|0|||
42217251|NCT02077166|76034561|FG000|Overall Study|Withdrawal by Subject|3|||
42217252|NCT02077166|76034562|FG001|Overall Study|Withdrawal by Subject|0|||
42217253|NCT02077166|76034563|FG002|Overall Study|Withdrawal by Subject|1|||
42217254|NCT02077166|76034564|FG003|Overall Study|Withdrawal by Subject|1|||
42217255|NCT02077166|76034565|FG004|Overall Study|Withdrawal by Subject|1|||
42217256|NCT02077166|76034566|FG005|Overall Study|Withdrawal by Subject|3|||
42217257|NCT02077166|76034567|FG006|Overall Study|Withdrawal by Subject|0|||
42217258|NCT02077166|76034561|FG000|Overall Study|Other, Not Specified|0|||
42217259|NCT02077166|76034562|FG001|Overall Study|Other, Not Specified|0|||
42217260|NCT02077166|76034563|FG002|Overall Study|Other, Not Specified|1|||
42217261|NCT02077166|76034564|FG003|Overall Study|Other, Not Specified|0|||
42217262|NCT02077166|76034565|FG004|Overall Study|Other, Not Specified|1|||
42217263|NCT02077166|76034566|FG005|Overall Study|Other, Not Specified|7|||
42217264|NCT02077166|76034567|FG006|Overall Study|Other, Not Specified|8|||
42217265|NCT04273217|76034594|FG000|Overall Study|Lost to Follow-up|0|||
42217266|NCT04273217|76034595|FG001|Overall Study|Lost to Follow-up|0|||
42217267|NCT04273217|76034596|FG002|Overall Study|Lost to Follow-up|0|||
42217268|NCT04273217|76034597|FG003|Overall Study|Lost to Follow-up|0|||
42217269|NCT04273217|76034598|FG004|Overall Study|Lost to Follow-up|0|||
42217270|NCT04273217|76034599|FG005|Overall Study|Lost to Follow-up|1|||
42217271|NCT04273217|76034594|FG000|Overall Study|Participant non-compliance|0|||
42217272|NCT04273217|76034595|FG001|Overall Study|Participant non-compliance|0|||
42217273|NCT04273217|76034596|FG002|Overall Study|Participant non-compliance|0|||
42217274|NCT04273217|76034597|FG003|Overall Study|Participant non-compliance|0|||
42217275|NCT04273217|76034598|FG004|Overall Study|Participant non-compliance|1|||
42217276|NCT04273217|76034599|FG005|Overall Study|Participant non-compliance|0|||
42217277|NCT04273217|76034594|FG000|Overall Study|Positive urine drug screen|1|||
42217278|NCT04273217|76034595|FG001|Overall Study|Positive urine drug screen|0|||
42217279|NCT04273217|76034596|FG002|Overall Study|Positive urine drug screen|1|||
42217280|NCT04273217|76034597|FG003|Overall Study|Positive urine drug screen|0|||
42217281|NCT04273217|76034598|FG004|Overall Study|Positive urine drug screen|0|||
42217282|NCT04273217|76034599|FG005|Overall Study|Positive urine drug screen|1|||
42217283|NCT04384523|76034619|FG000|Overall Study|Lost to Follow-up|0|||
42217284|NCT04384523|76034620|FG001|Overall Study|Lost to Follow-up|0|||
42217285|NCT04384523|76034621|FG002|Overall Study|Lost to Follow-up|0|||
42028517|NCT00912028|75836955|FG003|Overall Study|Lost to Follow-up|1|||
42028518|NCT00912028|75836956|FG004|Overall Study|Lost to Follow-up|3|||
42028519|NCT00912028|75836952|FG000|Overall Study|Withdrawal by Subject|3|||
42129230|NCT03742037|75940122|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
42129231|NCT03742037|75940123|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
42129232|NCT03742037|75940124|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
42129233|NCT03742037|75940125|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
42129234|NCT03742037|75940126|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
42129235|NCT03742037|75940127|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
42129236|NCT03742037|75940128|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
42137798|NCT00334113|75948172|FG000|Overall Study|Withdrawal by Subject|0|||
42217286|NCT04384523|76034622|FG003|Overall Study|Lost to Follow-up|0|||
42217287|NCT04384523|76034623|FG004|Overall Study|Lost to Follow-up|0|||
42217288|NCT04384523|76034624|FG005|Overall Study|Lost to Follow-up|1|||
42217289|NCT04384523|76034619|FG000|Overall Study|Protocol Violation|0|||
42217290|NCT04384523|76034620|FG001|Overall Study|Protocol Violation|1|||
42217291|NCT04384523|76034621|FG002|Overall Study|Protocol Violation|0|||
42217292|NCT04384523|76034622|FG003|Overall Study|Protocol Violation|0|||
42217293|NCT04384523|76034623|FG004|Overall Study|Protocol Violation|0|||
42217294|NCT04384523|76034624|FG005|Overall Study|Protocol Violation|0|||
42217295|NCT04384523|76034619|FG000|Overall Study|Withdrawal by Subject|1|||
42217296|NCT04384523|76034620|FG001|Overall Study|Withdrawal by Subject|0|||
42129237|NCT03742037|75940122|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
42129238|NCT03742037|75940123|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
42129239|NCT03742037|75940124|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
42129240|NCT03742037|75940125|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
42217297|NCT04384523|76034621|FG002|Overall Study|Withdrawal by Subject|0|||
42217298|NCT04384523|76034622|FG003|Overall Study|Withdrawal by Subject|0|||
42217299|NCT04384523|76034623|FG004|Overall Study|Withdrawal by Subject|0|||
42217300|NCT04384523|76034624|FG005|Overall Study|Withdrawal by Subject|0|||
42217301|NCT04382651|76034659|FG000|Overall Study|Death|26|||
42217302|NCT04382651|76034660|FG001|Overall Study|Death|23|||
42217303|NCT04382651|76034659|FG000|Overall Study|Lost to Follow-up|3|||
42217304|NCT04382651|76034660|FG001|Overall Study|Lost to Follow-up|4|||
42217305|NCT04382651|76034659|FG000|Overall Study|Withdrawal by Subject|2|||
42217306|NCT04382651|76034660|FG001|Overall Study|Withdrawal by Subject|0|||
42217307|NCT04382651|76034659|FG000|Overall Study|Physician Decision|0|||
42217308|NCT04382651|76034660|FG001|Overall Study|Physician Decision|1|||
42217309|NCT03442088|76034672|FG000|Overall Study|Adverse Event|1|||
42217310|NCT03442088|76034672|FG000|Overall Study|Lack of Efficacy|2|||
42217311|NCT03442088|76034672|FG000|Overall Study|Lost to Follow-up|2|||
42217312|NCT04223687|76034678|FG000|Overall Study|Missing primary outcome|1|||
42217313|NCT04223687|76034679|FG001|Overall Study|Missing primary outcome|0|||
42217314|NCT03722576|76034685|FG000|Overall Study|Withdrawal by Subject|3|||
42217315|NCT03722576|76034685|FG000|Overall Study|Adverse Event|2|||
42217316|NCT03722576|76034685|FG000|Overall Study|Physician Decision|1|||
42217317|NCT03722576|76034685|FG000|Overall Study|Lost to Follow-up|1|||
42217318|NCT03693989|76034691|FG000|Overall Study|Protocol Violation|3|||
42217319|NCT03693989|76034692|FG001|Overall Study|Protocol Violation|4|||
42217320|NCT04206293|76034698|FG000|Overall Study|Consent withdrawal|1|||
42217321|NCT02727998|76034705|FG000|Overall Study|Lost to Follow-up|3|||
42217322|NCT02727998|76034706|FG001|Overall Study|Lost to Follow-up|3|||
42217323|NCT02727998|76034705|FG000|Overall Study|Withdrawal by Subject|0|||
42217324|NCT02727998|76034706|FG001|Overall Study|Withdrawal by Subject|1|||
42217325|NCT04366349|76034718|FG000|Overall Study|Withdrawal by Subject|1|||
42217326|NCT04366349|76034719|FG001|Overall Study|Withdrawal by Subject|0|||
42217327|NCT04366349|76034720|FG002|Overall Study|Withdrawal by Subject|0|||
42217328|NCT04366349|76034721|FG003|Overall Study|Withdrawal by Subject|0|||
42217329|NCT04366349|76034722|FG004|Overall Study|Withdrawal by Subject|0|||
42217330|NCT04366349|76034723|FG005|Overall Study|Withdrawal by Subject|0|||
42217331|NCT04179461|76034741|FG000|Overall Study|Lost to Follow-up|4|||
42217332|NCT04017611|76034745|FG000|Overall Study|Withdrawn prior to completion|1|||
42217333|NCT04172831|76034760|FG000|Overall Study|Adverse Event|21|||
42217334|NCT04172831|76034761|FG001|Overall Study|Adverse Event|9|||
42217335|NCT04172831|76034760|FG000|Overall Study|Lack of Efficacy|2|||
42217336|NCT04172831|76034761|FG001|Overall Study|Lack of Efficacy|8|||
42217337|NCT04172831|76034760|FG000|Overall Study|Physician Decision|0|||
42217338|NCT04172831|76034761|FG001|Overall Study|Physician Decision|1|||
42217339|NCT04172831|76034760|FG000|Overall Study|Withdrawal by Subject|12|||
42217340|NCT04172831|76034761|FG001|Overall Study|Withdrawal by Subject|11|||
42217341|NCT04172831|76034760|FG000|Overall Study|Lost to Follow-up|4|||
42217342|NCT04172831|76034761|FG001|Overall Study|Lost to Follow-up|9|||
42217343|NCT04172831|76034760|FG000|Overall Study|COVID-19 related crisis|3|||
42217344|NCT04172831|76034761|FG001|Overall Study|COVID-19 related crisis|3|||
42217345|NCT04172831|76034760|FG000|Overall Study|Subject non-compliance|1|||
42217346|NCT04172831|76034761|FG001|Overall Study|Subject non-compliance|1|||
42217347|NCT04172831|76034760|FG000|Overall Study|Family emergency|1|||
42217348|NCT04172831|76034761|FG001|Overall Study|Family emergency|0|||
42217349|NCT04165031|76034778|FG000|Overall Study|Adverse Event|1|||
42217350|NCT04165031|76034779|FG001|Overall Study|Adverse Event|1|||
42217351|NCT04165031|76034780|FG002|Overall Study|Adverse Event|0|||
42217352|NCT04165031|76034781|FG003|Overall Study|Adverse Event|0|||
42217353|NCT04165031|76034782|FG004|Overall Study|Adverse Event|0|||
42217354|NCT04165031|76034783|FG005|Overall Study|Adverse Event|0|||
42217355|NCT04165031|76034778|FG000|Overall Study|Withdrawal by Subject|0|||
42217356|NCT04165031|76034779|FG001|Overall Study|Withdrawal by Subject|0|||
42217357|NCT04165031|76034780|FG002|Overall Study|Withdrawal by Subject|1|||
42217358|NCT04165031|76034781|FG003|Overall Study|Withdrawal by Subject|0|||
42217359|NCT04165031|76034782|FG004|Overall Study|Withdrawal by Subject|0|||
42217360|NCT04165031|76034783|FG005|Overall Study|Withdrawal by Subject|0|||
42217361|NCT02712424|76034800|FG000|Overall Study|Lost to Follow-up|34|||
42217362|NCT02712424|76034801|FG001|Overall Study|Lost to Follow-up|32|||
42217363|NCT02968004|76034809|FG000|Overall Study|Adverse Event|1|||
42217364|NCT02968004|76034810|FG001|Overall Study|Adverse Event|0|||
42217365|NCT02968004|76034809|FG000|Overall Study|Withdrawal by Subject|0|||
42217366|NCT02968004|76034810|FG001|Overall Study|Withdrawal by Subject|1|||
42217367|NCT03034772|76034818|FG000|Overall Study|Adverse Event|0|||
42217368|NCT03034772|76034819|FG001|Overall Study|Adverse Event|1|||
42217369|NCT03034772|76034818|FG000|Overall Study|Withdrawal by Subject|0|||
42217370|NCT03034772|76034819|FG001|Overall Study|Withdrawal by Subject|1|||
42217371|NCT03032198|76034825|FG000|Overall Study|Screen Fail|1|||
42217372|NCT02431364|76034834|FG000|Overall Study|Adverse Event|0|||
42217373|NCT02431364|76034835|FG001|Overall Study|Adverse Event|1|||
42217374|NCT02431364|76034836|FG002|Overall Study|Adverse Event|0|||
42217375|NCT02431364|76034837|FG003|Overall Study|Adverse Event|0|||
42217376|NCT02431364|76034838|FG004|Overall Study|Adverse Event|0|||
42217377|NCT02431364|76034834|FG000|Overall Study|Randomized but never treated|0|||
42217378|NCT02431364|76034835|FG001|Overall Study|Randomized but never treated|0|||
42217379|NCT02431364|76034836|FG002|Overall Study|Randomized but never treated|0|||
42217380|NCT02431364|76034837|FG003|Overall Study|Randomized but never treated|1|||
42217381|NCT02431364|76034838|FG004|Overall Study|Randomized but never treated|0|||
42217382|NCT03034460|76034856|FG000|Overall Study|Adverse Event|0|||
42217383|NCT03034460|76034857|FG001|Overall Study|Adverse Event|1|||
42217384|NCT03034460|76034856|FG000|Overall Study|Withdrawal by Subject|2|||
42217385|NCT03034460|76034857|FG001|Overall Study|Withdrawal by Subject|2|||
42217386|NCT03034460|76034856|FG000|Overall Study|Personal Reasons|1|||
42217387|NCT03034460|76034857|FG001|Overall Study|Personal Reasons|0|||
42217388|NCT04162769|76034870|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
42217389|NCT04162769|76034871|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
42217390|NCT04162769|76034872|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
42217391|NCT04162769|76034873|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
42217392|NCT04162769|76034870|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
42217393|NCT04162769|76034871|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
42217394|NCT04162769|76034872|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
42217395|NCT04162769|76034873|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
42217396|NCT04162769|76034870|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
42217397|NCT04162769|76034871|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
42217398|NCT04162769|76034872|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
42217399|NCT04162769|76034873|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
42217400|NCT04162769|76034870|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
42217401|NCT04162769|76034871|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
42217402|NCT04162769|76034872|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
42217403|NCT04162769|76034873|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
42217404|NCT04162769|76034870|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
42217405|NCT04162769|76034871|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
42217406|NCT04162769|76034872|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
42217407|NCT04162769|76034873|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
42217408|NCT04162769|76034870|FG000|Double-blind Treatment (12-Week)|Other|0|||
42217409|NCT04162769|76034871|FG001|Double-blind Treatment (12-Week)|Other|1|||
42217410|NCT04162769|76034872|FG002|Double-blind Treatment (12-Week)|Other|1|||
42217411|NCT04162769|76034873|FG003|Double-blind Treatment (12-Week)|Other|0|||
42217412|NCT04162769|76034870|FG000|OLE Period (52-Week)|Adverse Event|0|||
42217413|NCT04162769|76034871|FG001|OLE Period (52-Week)|Adverse Event|0|||
42217414|NCT04162769|76034872|FG002|OLE Period (52-Week)|Adverse Event|0|||
42217415|NCT04162769|76034873|FG003|OLE Period (52-Week)|Adverse Event|5|||
42217416|NCT04162769|76034870|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
42217417|NCT04162769|76034871|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
42217418|NCT04162769|76034872|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
42217419|NCT04162769|76034873|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
42217420|NCT04162769|76034870|FG000|OLE Period (52-Week)|Physician Decision|0|||
42217421|NCT04162769|76034871|FG001|OLE Period (52-Week)|Physician Decision|0|||
42217422|NCT04162769|76034872|FG002|OLE Period (52-Week)|Physician Decision|0|||
42217423|NCT04162769|76034873|FG003|OLE Period (52-Week)|Physician Decision|1|||
42129241|NCT03742037|75940126|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
42129242|NCT03742037|75940127|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
42129243|NCT03742037|75940128|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
42129244|NCT03714815|75940145|FG000|Overall Study|Physician Decision|2|||
42129245|NCT03714815|75940145|FG000|Overall Study|Withdrawal by Subject|2|||
42129246|NCT03714815|75940145|FG000|Overall Study|Death|11|||
42129247|NCT03640312|75940155|FG000|Overall Study|Lost to Follow-up|3|||
42129248|NCT03640312|75940156|FG001|Overall Study|Lost to Follow-up|6|||
42129249|NCT02254278|75940177|FG000|Overall Study|Protocol Violation|1|||
42129250|NCT02254278|75940178|FG001|Overall Study|Protocol Violation|1|||
42129251|NCT01998841|75940190|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
42129252|NCT01998841|75940191|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
42129253|NCT01998841|75940192|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
42129254|NCT01998841|75940193|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
42129255|NCT01998841|75940194|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
42129256|NCT01998841|75940190|FG000|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
42129257|NCT01998841|75940191|FG001|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
42129258|NCT01998841|75940192|FG002|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|0|||
42129259|NCT01998841|75940193|FG003|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|147|||
42129260|NCT01998841|75940194|FG004|Study Period B|Ongoing in the Study at the Time of Primary Completion Date|72|||
42129261|NCT01607879|75940204|FG000|Overall Study|Death|1|||
42129262|NCT01607879|75940205|FG001|Overall Study|Death|0|||
42129263|NCT00352027|75940216|FG000|Overall Study|Progressive disease|3|||
42129264|NCT00440271|75940258|FG000|Overall Study|Protocol Violation|1|||
42129265|NCT00440271|75940259|FG001|Overall Study|Protocol Violation|1|||
42129266|NCT00440271|75940258|FG000|Overall Study|Adverse Event|0|||
42129267|NCT00440271|75940259|FG001|Overall Study|Adverse Event|1|||
42129268|NCT00440271|75940258|FG000|Overall Study|Lost to Follow-up|1|||
42129269|NCT00440271|75940259|FG001|Overall Study|Lost to Follow-up|0|||
42129270|NCT00440271|75940258|FG000|Overall Study|Withdrawal by Subject|0|||
42129271|NCT00440271|75940259|FG001|Overall Study|Withdrawal by Subject|2|||
42129272|NCT00440271|75940258|FG000|Overall Study|Lack of Efficacy|0|||
42129273|NCT00440271|75940259|FG001|Overall Study|Lack of Efficacy|1|||
42129274|NCT00440271|75940258|FG000|Overall Study|Due to closure of trial|8|||
42129275|NCT00440271|75940259|FG001|Overall Study|Due to closure of trial|10|||
42129276|NCT00440271|75940258|FG000|Overall Study|Other|2|||
42129277|NCT00440271|75940259|FG001|Overall Study|Other|0|||
42129278|NCT00346216|75940268|FG000|Overall Study|Other|181|||
42129279|NCT00346216|75940269|FG001|Overall Study|Other|231|||
42129280|NCT00346216|75940270|FG002|Overall Study|Other|205|||
42129281|NCT00346216|75940268|FG000|Overall Study|No longer willing to participate|600|||
42129282|NCT00346216|75940269|FG001|Overall Study|No longer willing to participate|606|||
42129283|NCT00346216|75940270|FG002|Overall Study|No longer willing to participate|585|||
42129284|NCT00346216|75940268|FG000|Overall Study|Withdrawal by Subject|661|||
42129285|NCT00346216|75940269|FG001|Overall Study|Withdrawal by Subject|692|||
42129286|NCT00346216|75940270|FG002|Overall Study|Withdrawal by Subject|651|||
42129287|NCT00346216|75940268|FG000|Overall Study|Lost to Follow-up|611|||
42129288|NCT00346216|75940269|FG001|Overall Study|Lost to Follow-up|588|||
42129289|NCT00346216|75940270|FG002|Overall Study|Lost to Follow-up|542|||
42129290|NCT00346216|75940268|FG000|Overall Study|Physician Decision|80|||
42129291|NCT00346216|75940269|FG001|Overall Study|Physician Decision|76|||
42129292|NCT00346216|75940270|FG002|Overall Study|Physician Decision|59|||
42129293|NCT00346216|75940268|FG000|Overall Study|Does not meet entrance criteria|13|||
42129294|NCT00346216|75940269|FG001|Overall Study|Does not meet entrance criteria|10|||
42129295|NCT00346216|75940270|FG002|Overall Study|Does not meet entrance criteria|8|||
42129296|NCT00346216|75940268|FG000|Overall Study|Death|189|||
42129297|NCT00346216|75940269|FG001|Overall Study|Death|192|||
42217424|NCT04162769|76034870|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
42217425|NCT04162769|76034871|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
42217426|NCT04162769|76034872|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
42217427|NCT04162769|76034873|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
42028520|NCT00912028|75836953|FG001|Overall Study|Withdrawal by Subject|0|||
42129298|NCT00346216|75940270|FG002|Overall Study|Death|228|||
42129299|NCT00346216|75940268|FG000|Overall Study|Study terminated by sponsor|11|||
42129300|NCT00346216|75940269|FG001|Overall Study|Study terminated by sponsor|4|||
42129301|NCT00346216|75940270|FG002|Overall Study|Study terminated by sponsor|8|||
42129302|NCT00346216|75940268|FG000|Overall Study|Missing Subject Summary Status|62|||
42129303|NCT00346216|75940269|FG001|Overall Study|Missing Subject Summary Status|61|||
42129304|NCT00346216|75940270|FG002|Overall Study|Missing Subject Summary Status|62|||
42129305|NCT00417963|75940278|FG000|Overall Study|Lost to Follow-up|3|||
42217428|NCT04162769|76034870|FG000|OLE Period (52-Week)|Protocol deviation|0|||
42217429|NCT04162769|76034871|FG001|OLE Period (52-Week)|Protocol deviation|0|||
42217430|NCT04162769|76034872|FG002|OLE Period (52-Week)|Protocol deviation|0|||
42217431|NCT04162769|76034873|FG003|OLE Period (52-Week)|Protocol deviation|2|||
42217432|NCT04161131|76034884|FG000|Overall Study|Ineligible|2|||
42217433|NCT04161131|76034884|FG000|Overall Study|Lost to Follow-up|4|||
42217434|NCT04155047|76034890|FG000|Overall Study|Adverse Event|1|||
42217435|NCT04155047|76034891|FG001|Overall Study|Adverse Event|0|||
42217436|NCT04155047|76034890|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
42217437|NCT04155047|76034891|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
42217438|NCT04152083|76034899|FG000|Overall Study|Lost to Follow-up|2|||
42217439|NCT04152083|76034900|FG001|Overall Study|Lost to Follow-up|1|||
42217440|NCT04152083|76034899|FG000|Overall Study|Adverse Event|1|||
42217441|NCT04152083|76034900|FG001|Overall Study|Adverse Event|0|||
42217442|NCT04152083|76034899|FG000|Overall Study|Randomized but not treated|3|||
42217443|NCT04152083|76034900|FG001|Overall Study|Randomized but not treated|2|||
42217444|NCT02711956|76034921|FG000|Overall Study|Adverse Event|0|||
42217445|NCT02711956|76034922|FG001|Overall Study|Adverse Event|0|||
42217446|NCT02711956|76034923|FG002|Overall Study|Adverse Event|0|||
42217447|NCT02711956|76034924|FG003|Overall Study|Adverse Event|1|||
42217448|NCT02711956|76034925|FG004|Overall Study|Adverse Event|2|||
42217449|NCT02711956|76034926|FG005|Overall Study|Adverse Event|0|||
42217450|NCT02711956|76034927|FG006|Overall Study|Adverse Event|0|||
42217451|NCT02711956|76034928|FG007|Overall Study|Adverse Event|1|||
42217452|NCT02711956|76034929|FG008|Overall Study|Adverse Event|1|||
42217453|NCT02711956|76034930|FG009|Overall Study|Adverse Event|1|||
42217454|NCT02711956|76034931|FG010|Overall Study|Adverse Event|1|||
42217455|NCT02711956|76034932|FG011|Overall Study|Adverse Event|0|||
42217456|NCT02711956|76034933|FG012|Overall Study|Adverse Event|0|||
42217457|NCT02711956|76034934|FG013|Overall Study|Adverse Event|0|||
42217458|NCT02711956|76034935|FG014|Overall Study|Adverse Event|2|||
42217459|NCT02711956|76034921|FG000|Overall Study|Physician Decision|0|||
42217460|NCT02711956|76034922|FG001|Overall Study|Physician Decision|0|||
42217461|NCT02711956|76034923|FG002|Overall Study|Physician Decision|0|||
42217462|NCT02711956|76034924|FG003|Overall Study|Physician Decision|2|||
42217463|NCT02711956|76034925|FG004|Overall Study|Physician Decision|0|||
42217464|NCT02711956|76034926|FG005|Overall Study|Physician Decision|0|||
42217465|NCT02711956|76034927|FG006|Overall Study|Physician Decision|0|||
42217466|NCT02711956|76034928|FG007|Overall Study|Physician Decision|0|||
42217467|NCT02711956|76034929|FG008|Overall Study|Physician Decision|0|||
41978035|NCT01053988|75782698|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
41978036|NCT01053988|75782699|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
41978037|NCT01053988|75782700|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
41978038|NCT01053988|75782695|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
41978039|NCT01053988|75782696|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
42217468|NCT02711956|76034930|FG009|Overall Study|Physician Decision|0|||
42217469|NCT02711956|76034931|FG010|Overall Study|Physician Decision|0|||
42217470|NCT02711956|76034932|FG011|Overall Study|Physician Decision|0|||
42217471|NCT02711956|76034933|FG012|Overall Study|Physician Decision|0|||
42217472|NCT02711956|76034934|FG013|Overall Study|Physician Decision|0|||
42217473|NCT02711956|76034935|FG014|Overall Study|Physician Decision|0|||
42217474|NCT02711956|76034921|FG000|Overall Study|Withdrawal by Subject|0|||
42217475|NCT02711956|76034922|FG001|Overall Study|Withdrawal by Subject|0|||
42217476|NCT02711956|76034923|FG002|Overall Study|Withdrawal by Subject|0|||
42217477|NCT02711956|76034924|FG003|Overall Study|Withdrawal by Subject|0|||
42217478|NCT02711956|76034925|FG004|Overall Study|Withdrawal by Subject|0|||
42217479|NCT02711956|76034926|FG005|Overall Study|Withdrawal by Subject|0|||
42217480|NCT02711956|76034927|FG006|Overall Study|Withdrawal by Subject|1|||
42217481|NCT02711956|76034928|FG007|Overall Study|Withdrawal by Subject|0|||
42217482|NCT02711956|76034929|FG008|Overall Study|Withdrawal by Subject|0|||
42217483|NCT02711956|76034930|FG009|Overall Study|Withdrawal by Subject|0|||
42217484|NCT02711956|76034931|FG010|Overall Study|Withdrawal by Subject|0|||
42217485|NCT02711956|76034932|FG011|Overall Study|Withdrawal by Subject|1|||
42217486|NCT02711956|76034933|FG012|Overall Study|Withdrawal by Subject|6|||
42217487|NCT02711956|76034934|FG013|Overall Study|Withdrawal by Subject|0|||
42217488|NCT02711956|76034935|FG014|Overall Study|Withdrawal by Subject|1|||
42217489|NCT02711956|76034921|FG000|Overall Study|Clinical progression|1|||
42217490|NCT02711956|76034922|FG001|Overall Study|Clinical progression|0|||
42217491|NCT02711956|76034923|FG002|Overall Study|Clinical progression|0|||
42217492|NCT02711956|76034924|FG003|Overall Study|Clinical progression|0|||
42217493|NCT02711956|76034925|FG004|Overall Study|Clinical progression|0|||
42217494|NCT02711956|76034926|FG005|Overall Study|Clinical progression|0|||
42217495|NCT02711956|76034927|FG006|Overall Study|Clinical progression|1|||
42217496|NCT02711956|76034928|FG007|Overall Study|Clinical progression|0|||
42217497|NCT02711956|76034929|FG008|Overall Study|Clinical progression|1|||
42217498|NCT02711956|76034930|FG009|Overall Study|Clinical progression|0|||
42217499|NCT02711956|76034931|FG010|Overall Study|Clinical progression|0|||
42217500|NCT02711956|76034932|FG011|Overall Study|Clinical progression|2|||
42217501|NCT02711956|76034933|FG012|Overall Study|Clinical progression|4|||
42217502|NCT02711956|76034934|FG013|Overall Study|Clinical progression|1|||
42217503|NCT02711956|76034935|FG014|Overall Study|Clinical progression|1|||
42217504|NCT02711956|76034921|FG000|Overall Study|Radiographic progression|1|||
42217505|NCT02711956|76034922|FG001|Overall Study|Radiographic progression|1|||
42217506|NCT02711956|76034923|FG002|Overall Study|Radiographic progression|2|||
42217507|NCT02711956|76034924|FG003|Overall Study|Radiographic progression|0|||
42217508|NCT02711956|76034925|FG004|Overall Study|Radiographic progression|1|||
41978040|NCT01053988|75782697|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
41978041|NCT01053988|75782698|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
42217509|NCT02711956|76034926|FG005|Overall Study|Radiographic progression|0|||
42217510|NCT02711956|76034927|FG006|Overall Study|Radiographic progression|0|||
42217511|NCT02711956|76034928|FG007|Overall Study|Radiographic progression|0|||
42217512|NCT02711956|76034929|FG008|Overall Study|Radiographic progression|2|||
42217513|NCT02711956|76034930|FG009|Overall Study|Radiographic progression|1|||
42217514|NCT02711956|76034931|FG010|Overall Study|Radiographic progression|0|||
41978042|NCT01053988|75782699|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
41978043|NCT01053988|75782700|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
41978044|NCT01053988|75782695|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
41978045|NCT01053988|75782696|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
41978046|NCT01053988|75782697|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
41978047|NCT01053988|75782698|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
41978048|NCT01053988|75782699|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
41978049|NCT01053988|75782700|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
41978050|NCT01053988|75782695|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
41978051|NCT01053988|75782696|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
41978052|NCT01053988|75782697|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
41978053|NCT01053988|75782698|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
41978054|NCT01053988|75782699|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
42028521|NCT00912028|75836954|FG002|Overall Study|Withdrawal by Subject|0|||
42028522|NCT00912028|75836955|FG003|Overall Study|Withdrawal by Subject|0|||
42028523|NCT00912028|75836956|FG004|Overall Study|Withdrawal by Subject|0|||
42028524|NCT02731729|75836968|FG000|Overall Study|Death|2|||
42129306|NCT00417963|75940278|FG000|Overall Study|Withdrawal by Subject|18|||
42129307|NCT00417963|75940278|FG000|Overall Study|Death|17|||
42129308|NCT00417963|75940278|FG000|Overall Study|Study device could not be deployed|3|||
42129309|NCT00429273|75940290|FG000|Overall Study|Lost to Follow-up|1|||
42129310|NCT00429273|75940291|FG001|Overall Study|Lost to Follow-up|2|||
42129311|NCT00429273|75940292|FG002|Overall Study|Lost to Follow-up|2|||
42129312|NCT00429273|75940290|FG000|Overall Study|Physician Decision|6|||
42129313|NCT00429273|75940291|FG001|Overall Study|Physician Decision|5|||
42129314|NCT00429273|75940292|FG002|Overall Study|Physician Decision|5|||
42217515|NCT02711956|76034932|FG011|Overall Study|Radiographic progression|5|||
42217516|NCT02711956|76034933|FG012|Overall Study|Radiographic progression|3|||
42217517|NCT02711956|76034934|FG013|Overall Study|Radiographic progression|0|||
42217518|NCT02711956|76034935|FG014|Overall Study|Radiographic progression|1|||
42217519|NCT02711956|76034921|FG000|Overall Study|PSA progression with clinical progression|0|||
42217520|NCT02711956|76034922|FG001|Overall Study|PSA progression with clinical progression|0|||
42217521|NCT02711956|76034923|FG002|Overall Study|PSA progression with clinical progression|0|||
42217522|NCT02711956|76034924|FG003|Overall Study|PSA progression with clinical progression|0|||
42217523|NCT02711956|76034925|FG004|Overall Study|PSA progression with clinical progression|1|||
42217524|NCT02711956|76034926|FG005|Overall Study|PSA progression with clinical progression|0|||
42217525|NCT02711956|76034927|FG006|Overall Study|PSA progression with clinical progression|0|||
42217526|NCT02711956|76034928|FG007|Overall Study|PSA progression with clinical progression|0|||
42217527|NCT02711956|76034929|FG008|Overall Study|PSA progression with clinical progression|0|||
42217528|NCT02711956|76034930|FG009|Overall Study|PSA progression with clinical progression|0|||
42217529|NCT02711956|76034931|FG010|Overall Study|PSA progression with clinical progression|0|||
42217530|NCT02711956|76034932|FG011|Overall Study|PSA progression with clinical progression|0|||
42217531|NCT02711956|76034933|FG012|Overall Study|PSA progression with clinical progression|1|||
42217532|NCT02711956|76034934|FG013|Overall Study|PSA progression with clinical progression|1|||
42217533|NCT02711956|76034935|FG014|Overall Study|PSA progression with clinical progression|0|||
42217534|NCT02711956|76034921|FG000|Overall Study|PSA progression with radiographic progression|0|||
42217535|NCT02711956|76034922|FG001|Overall Study|PSA progression with radiographic progression|1|||
42217536|NCT02711956|76034923|FG002|Overall Study|PSA progression with radiographic progression|0|||
42217537|NCT02711956|76034924|FG003|Overall Study|PSA progression with radiographic progression|0|||
42217538|NCT02711956|76034925|FG004|Overall Study|PSA progression with radiographic progression|0|||
42217539|NCT02711956|76034926|FG005|Overall Study|PSA progression with radiographic progression|2|||
42217540|NCT02711956|76034927|FG006|Overall Study|PSA progression with radiographic progression|2|||
42217541|NCT02711956|76034928|FG007|Overall Study|PSA progression with radiographic progression|1|||
42217542|NCT02711956|76034929|FG008|Overall Study|PSA progression with radiographic progression|0|||
42217543|NCT02711956|76034930|FG009|Overall Study|PSA progression with radiographic progression|1|||
42217544|NCT02711956|76034931|FG010|Overall Study|PSA progression with radiographic progression|0|||
42217545|NCT02711956|76034932|FG011|Overall Study|PSA progression with radiographic progression|1|||
42217546|NCT02711956|76034933|FG012|Overall Study|PSA progression with radiographic progression|2|||
42217547|NCT02711956|76034934|FG013|Overall Study|PSA progression with radiographic progression|3|||
42217548|NCT02711956|76034935|FG014|Overall Study|PSA progression with radiographic progression|3|||
42217549|NCT04149353|76034976|FG000|Overall Study|Study terminated|1|||
42217550|NCT02711800|76034981|FG000|Overall Study|Lost to Follow-up|1|||
42217551|NCT02711800|76034981|FG000|Overall Study|Withdrawal by Subject|1|||
42302137|NCT02484547|76137182|FG002|Long-Term Extension Period|Reason not Specified|0|||
42302138|NCT02484547|76137183|FG003|Long-Term Extension Period|Reason not Specified|119|||
42302139|NCT02484547|76137184|FG004|Long-Term Extension Period|Reason not Specified|117|||
42302140|NCT02484547|76137185|FG005|Long-Term Extension Period|Reason not Specified|223|||
41978055|NCT01053988|75782700|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
41978056|NCT01053988|75782695|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
41978057|NCT01053988|75782696|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
41978058|NCT01053988|75782697|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
41978059|NCT01053988|75782698|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
41978060|NCT01053988|75782699|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
41978061|NCT01053988|75782700|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
41978062|NCT01053988|75782695|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
41978063|NCT01053988|75782696|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
41978064|NCT01053988|75782697|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
41978065|NCT01053988|75782698|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
41978066|NCT01053988|75782699|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
41978067|NCT01053988|75782700|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
41978068|NCT01053988|75782695|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
41978069|NCT01053988|75782696|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
42028525|NCT02731729|75836969|FG001|Overall Study|Death|2|||
42028526|NCT02731729|75836968|FG000|Overall Study|Study terminated by Sponsor|6|||
42129315|NCT00429273|75940290|FG000|Overall Study|Adverse Event|1|||
42129316|NCT00429273|75940291|FG001|Overall Study|Adverse Event|1|||
42129317|NCT00429273|75940292|FG002|Overall Study|Adverse Event|2|||
42129318|NCT00359632|75940302|FG000|Overall Study|Death|2|||
42129319|NCT00359632|75940303|FG001|Overall Study|Death|0|||
42129320|NCT00359632|75940302|FG000|Overall Study|Adverse Event|1|||
42129321|NCT00359632|75940303|FG001|Overall Study|Adverse Event|0|||
42129322|NCT00359632|75940302|FG000|Overall Study|Non-compliance with visit schedule|1|||
42129323|NCT00359632|75940303|FG001|Overall Study|Non-compliance with visit schedule|0|||
42129324|NCT00417885|75940309|FG000|Overall Study|Adverse Event|1|||
42129325|NCT00417885|75940309|FG000|Overall Study|Objective Progression or Relapse|3|||
42129326|NCT00417885|75940309|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
42129327|NCT04488770|75940326|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42217552|NCT03031496|76034985|FG000|Period 1|Adverse Event|2|||
42217553|NCT03031496|76034986|FG001|Period 1|Adverse Event|0|||
42217554|NCT03031496|76034985|FG000|Period 1|Withdrawal by Subject|0|||
42217555|NCT03031496|76034986|FG001|Period 1|Withdrawal by Subject|2|||
42217556|NCT02659020|76034999|FG000|Overall Study|Adverse Event|0|||
42217557|NCT02659020|76035000|FG001|Overall Study|Adverse Event|0|||
42217558|NCT02659020|76035001|FG002|Overall Study|Adverse Event|0|||
42217559|NCT02659020|76035002|FG003|Overall Study|Adverse Event|2|||
42217560|NCT02659020|76035003|FG004|Overall Study|Adverse Event|0|||
42217561|NCT02659020|76035004|FG005|Overall Study|Adverse Event|0|||
42217562|NCT02659020|76035005|FG006|Overall Study|Adverse Event|2|||
42217563|NCT02659020|76034999|FG000|Overall Study|Lost to Follow-up|1|||
42217564|NCT02659020|76035000|FG001|Overall Study|Lost to Follow-up|2|||
42217565|NCT02659020|76035001|FG002|Overall Study|Lost to Follow-up|1|||
42217566|NCT02659020|76035002|FG003|Overall Study|Lost to Follow-up|6|||
42217567|NCT02659020|76035003|FG004|Overall Study|Lost to Follow-up|1|||
42217568|NCT02659020|76035004|FG005|Overall Study|Lost to Follow-up|5|||
42217569|NCT02659020|76035005|FG006|Overall Study|Lost to Follow-up|0|||
42217570|NCT02659020|76034999|FG000|Overall Study|Physician Decision|0|||
42217571|NCT02659020|76035000|FG001|Overall Study|Physician Decision|0|||
42217572|NCT02659020|76035001|FG002|Overall Study|Physician Decision|0|||
42217573|NCT02659020|76035002|FG003|Overall Study|Physician Decision|1|||
42217574|NCT02659020|76035003|FG004|Overall Study|Physician Decision|1|||
42217575|NCT02659020|76035004|FG005|Overall Study|Physician Decision|0|||
42217576|NCT02659020|76035005|FG006|Overall Study|Physician Decision|1|||
42217577|NCT02659020|76034999|FG000|Overall Study|Withdrawal by Subject|2|||
42217578|NCT02659020|76035000|FG001|Overall Study|Withdrawal by Subject|1|||
42217579|NCT02659020|76035001|FG002|Overall Study|Withdrawal by Subject|0|||
42217580|NCT02659020|76035002|FG003|Overall Study|Withdrawal by Subject|3|||
42217581|NCT02659020|76035003|FG004|Overall Study|Withdrawal by Subject|3|||
42217582|NCT02659020|76035004|FG005|Overall Study|Withdrawal by Subject|6|||
42217583|NCT02659020|76035005|FG006|Overall Study|Withdrawal by Subject|3|||
42217584|NCT02659020|76034999|FG000|Overall Study|Progressive Disease|0|||
42028527|NCT02731729|75836969|FG001|Overall Study|Study terminated by Sponsor|6|||
42129328|NCT04488770|75940327|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42129329|NCT04488770|75940328|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42129330|NCT04488770|75940329|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
42129331|NCT04488770|75940330|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42129332|NCT04488770|75940331|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42129333|NCT04488770|75940332|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42129334|NCT04488770|75940333|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42129335|NCT04488770|75940334|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42129336|NCT04488770|75940335|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42129337|NCT04488770|75940336|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42129338|NCT04488770|75940337|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42129339|NCT04488770|75940338|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
42129340|NCT04488770|75940326|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
42129341|NCT04488770|75940327|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129342|NCT04488770|75940328|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129343|NCT04488770|75940329|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129344|NCT04488770|75940330|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129345|NCT04488770|75940331|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129346|NCT04488770|75940332|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129347|NCT04488770|75940333|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129348|NCT04488770|75940334|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129349|NCT04488770|75940335|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129350|NCT04488770|75940336|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129351|NCT04488770|75940337|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129352|NCT04488770|75940338|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
42129353|NCT04488770|75940326|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42129354|NCT04488770|75940327|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42217585|NCT02659020|76035000|FG001|Overall Study|Progressive Disease|0|||
42217586|NCT02659020|76035001|FG002|Overall Study|Progressive Disease|0|||
42217587|NCT02659020|76035002|FG003|Overall Study|Progressive Disease|4|||
42217588|NCT02659020|76035003|FG004|Overall Study|Progressive Disease|1|||
42217589|NCT02659020|76035004|FG005|Overall Study|Progressive Disease|0|||
42217590|NCT02659020|76035005|FG006|Overall Study|Progressive Disease|2|||
42028528|NCT02731729|75836968|FG000|Overall Study|Withdrawal by Subject|1|||
42217591|NCT03482011|76035030|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
42217592|NCT03482011|76035031|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
42217593|NCT03482011|76035032|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
42217594|NCT03482011|76035033|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
42217595|NCT03482011|76035034|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
42217596|NCT03482011|76035035|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
42217597|NCT03482011|76035036|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
42217598|NCT03482011|76035037|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
42217599|NCT03482011|76035030|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
42217600|NCT03482011|76035031|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
42217601|NCT03482011|76035032|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42217602|NCT03482011|76035033|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42217603|NCT03482011|76035034|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42217604|NCT03482011|76035035|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42217605|NCT03482011|76035036|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42217606|NCT03482011|76035037|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42217607|NCT03482011|76035030|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
42217608|NCT03482011|76035031|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
42217609|NCT03482011|76035032|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
42217610|NCT03482011|76035033|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
42217611|NCT03482011|76035034|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
42217612|NCT03482011|76035035|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
42217613|NCT03482011|76035036|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
42217614|NCT03482011|76035037|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
42217615|NCT03482011|76035030|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
42217616|NCT03482011|76035031|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
41978070|NCT01053988|75782697|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
41978071|NCT01053988|75782698|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
41978072|NCT01053988|75782699|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
41978073|NCT01053988|75782700|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
41978074|NCT01053247|75782715|FG000|Overall Study|Withdrawal by Subject|9|||
41978075|NCT01053247|75782716|FG001|Overall Study|Withdrawal by Subject|4|||
41978076|NCT01053247|75782717|FG002|Overall Study|Withdrawal by Subject|15|||
41978077|NCT01053247|75782715|FG000|Overall Study|Lack of Efficacy|1|||
41978078|NCT01053247|75782716|FG001|Overall Study|Lack of Efficacy|0|||
41978079|NCT01053247|75782717|FG002|Overall Study|Lack of Efficacy|1|||
41978080|NCT01053247|75782715|FG000|Overall Study|Protocol Violation|2|||
41978081|NCT01053247|75782716|FG001|Overall Study|Protocol Violation|1|||
41978082|NCT01053247|75782717|FG002|Overall Study|Protocol Violation|2|||
41978083|NCT01053247|75782715|FG000|Overall Study|Lost to Follow-up|8|||
41978084|NCT01053247|75782716|FG001|Overall Study|Lost to Follow-up|5|||
41978085|NCT01053247|75782717|FG002|Overall Study|Lost to Follow-up|7|||
41978086|NCT01053247|75782715|FG000|Overall Study|Adverse Event|0|||
41978087|NCT01053247|75782716|FG001|Overall Study|Adverse Event|9|||
41978088|NCT01053247|75782717|FG002|Overall Study|Adverse Event|3|||
41978089|NCT01052662|75782728|FG000|Overall Study|Lost to Follow-up|15|||
41978090|NCT01052662|75782729|FG001|Overall Study|Lost to Follow-up|13|||
41978091|NCT01052662|75782730|FG002|Overall Study|Lost to Follow-up|18|||
41978092|NCT01052662|75782728|FG000|Overall Study|Withdrawal by Subject|3|||
41978093|NCT01052662|75782729|FG001|Overall Study|Withdrawal by Subject|2|||
41978094|NCT01052662|75782730|FG002|Overall Study|Withdrawal by Subject|1|||
41978095|NCT01052662|75782728|FG000|Overall Study|Pharmacy issue|1|||
41978096|NCT01052662|75782729|FG001|Overall Study|Pharmacy issue|3|||
41978097|NCT01052662|75782730|FG002|Overall Study|Pharmacy issue|3|||
41978098|NCT01052662|75782728|FG000|Overall Study|Adverse Event|1|||
41978099|NCT01052662|75782729|FG001|Overall Study|Adverse Event|1|||
41978100|NCT01052662|75782730|FG002|Overall Study|Adverse Event|0|||
41978101|NCT01052662|75782728|FG000|Overall Study|Legal Problem|2|||
41978102|NCT01052662|75782729|FG001|Overall Study|Legal Problem|0|||
41978103|NCT01052662|75782730|FG002|Overall Study|Legal Problem|0|||
41978104|NCT01052662|75782728|FG000|Overall Study|Administrative|0|||
41978105|NCT01052662|75782729|FG001|Overall Study|Administrative|3|||
41978106|NCT01052662|75782730|FG002|Overall Study|Administrative|0|||
41978107|NCT01052116|75782740|FG000|Overall Study|Lost to Follow-up|11|||
41978108|NCT01052116|75782741|FG001|Overall Study|Lost to Follow-up|17|||
41978109|NCT01052116|75782740|FG000|Overall Study|Withdrawal by Subject|3|||
41978110|NCT01052116|75782741|FG001|Overall Study|Withdrawal by Subject|6|||
41978111|NCT01052116|75782740|FG000|Overall Study|Spirometry not performed|0|||
41978112|NCT01052116|75782741|FG001|Overall Study|Spirometry not performed|4|||
41978113|NCT01052077|75782749|FG000|Phase A|Lost to Follow-up|22|||
41978114|NCT01052077|75782750|FG001|Phase A|Lost to Follow-up|0|||
41978115|NCT01052077|75782751|FG002|Phase A|Lost to Follow-up|0|||
41978116|NCT01052077|75782752|FG003|Phase A|Lost to Follow-up|0|||
42217617|NCT03482011|76035032|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
41978117|NCT01052077|75782749|FG000|Phase A|Adverse Event|32|||
42217618|NCT03482011|76035033|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
41978118|NCT01052077|75782750|FG001|Phase A|Adverse Event|0|||
41978119|NCT01052077|75782751|FG002|Phase A|Adverse Event|0|||
41978120|NCT01052077|75782752|FG003|Phase A|Adverse Event|0|||
41978121|NCT01052077|75782749|FG000|Phase A|Met Withdrawal Criteria|26|||
41978122|NCT01052077|75782750|FG001|Phase A|Met Withdrawal Criteria|0|||
41978123|NCT01052077|75782751|FG002|Phase A|Met Withdrawal Criteria|0|||
41978124|NCT01052077|75782752|FG003|Phase A|Met Withdrawal Criteria|0|||
41978125|NCT01052077|75782749|FG000|Phase A|Physician Decision|10|||
41978126|NCT01052077|75782750|FG001|Phase A|Physician Decision|0|||
41978127|NCT01052077|75782751|FG002|Phase A|Physician Decision|0|||
41978128|NCT01052077|75782752|FG003|Phase A|Physician Decision|0|||
41978129|NCT01052077|75782749|FG000|Phase A|Withdrawal by Subject|29|||
41978130|NCT01052077|75782750|FG001|Phase A|Withdrawal by Subject|0|||
41978131|NCT01052077|75782751|FG002|Phase A|Withdrawal by Subject|0|||
41978132|NCT01052077|75782752|FG003|Phase A|Withdrawal by Subject|0|||
41978133|NCT01052077|75782749|FG000|Phase A|Protocol Deviation|27|||
41978134|NCT01052077|75782750|FG001|Phase A|Protocol Deviation|0|||
41978135|NCT01052077|75782751|FG002|Phase A|Protocol Deviation|0|||
41978136|NCT01052077|75782752|FG003|Phase A|Protocol Deviation|0|||
41978137|NCT01052077|75782749|FG000|Phase B|Lost to Follow-up|0|||
41978138|NCT01052077|75782750|FG001|Phase B|Lost to Follow-up|2|||
41978139|NCT01052077|75782751|FG002|Phase B|Lost to Follow-up|3|||
41978140|NCT01052077|75782752|FG003|Phase B|Lost to Follow-up|0|||
41978141|NCT01052077|75782749|FG000|Phase B|Adverse Event|0|||
41978142|NCT01052077|75782750|FG001|Phase B|Adverse Event|9|||
42217619|NCT03482011|76035034|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
42217620|NCT03482011|76035035|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
42217621|NCT03482011|76035036|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
42217622|NCT03482011|76035037|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
42217623|NCT03482011|76035030|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
42217624|NCT03482011|76035031|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
42217625|NCT03482011|76035032|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42217626|NCT03482011|76035033|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
41978143|NCT01052077|75782751|FG002|Phase B|Adverse Event|2|||
41978144|NCT01052077|75782752|FG003|Phase B|Adverse Event|0|||
41978145|NCT01052077|75782749|FG000|Phase B|Met Withdrawal Criteria|0|||
41978146|NCT01052077|75782750|FG001|Phase B|Met Withdrawal Criteria|2|||
41978147|NCT01052077|75782751|FG002|Phase B|Met Withdrawal Criteria|1|||
41978148|NCT01052077|75782752|FG003|Phase B|Met Withdrawal Criteria|0|||
41978149|NCT01052077|75782749|FG000|Phase B|Physician Decision|0|||
41978150|NCT01052077|75782750|FG001|Phase B|Physician Decision|1|||
41978151|NCT01052077|75782751|FG002|Phase B|Physician Decision|1|||
41978152|NCT01052077|75782752|FG003|Phase B|Physician Decision|0|||
41978153|NCT01052077|75782749|FG000|Phase B|Withdrawal by Subject|0|||
41978154|NCT01052077|75782750|FG001|Phase B|Withdrawal by Subject|0|||
41978155|NCT01052077|75782751|FG002|Phase B|Withdrawal by Subject|5|||
41978156|NCT01052077|75782752|FG003|Phase B|Withdrawal by Subject|0|||
42217627|NCT03482011|76035034|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42217628|NCT03482011|76035035|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42217629|NCT03482011|76035036|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42217630|NCT03482011|76035037|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42217631|NCT03482011|76035030|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
42217632|NCT03482011|76035031|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
42217633|NCT03482011|76035032|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
42217634|NCT03482011|76035033|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
42217635|NCT03482011|76035034|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
42217636|NCT03482011|76035035|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
42217637|NCT03482011|76035036|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
42217638|NCT03482011|76035037|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
42217639|NCT03482011|76035030|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
42217640|NCT03482011|76035031|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
41978157|NCT01052077|75782749|FG000|Phase B|Protocol Deviation|0|||
41978158|NCT01052077|75782750|FG001|Phase B|Protocol Deviation|3|||
41978159|NCT01052077|75782751|FG002|Phase B|Protocol Deviation|4|||
41978160|NCT01052077|75782752|FG003|Phase B|Protocol Deviation|0|||
41978161|NCT01052077|75782749|FG000|Phase B|Lack of Efficacy|0|||
41978162|NCT01052077|75782750|FG001|Phase B|Lack of Efficacy|1|||
41978163|NCT01052077|75782751|FG002|Phase B|Lack of Efficacy|0|||
42028529|NCT02731729|75836969|FG001|Overall Study|Withdrawal by Subject|0|||
41978164|NCT01052077|75782752|FG003|Phase B|Lack of Efficacy|0|||
41978165|NCT01052077|75782749|FG000|Phase A+|Lost to Follow-up|0|||
41978166|NCT01052077|75782750|FG001|Phase A+|Lost to Follow-up|0|||
41978167|NCT01052077|75782751|FG002|Phase A+|Lost to Follow-up|0|||
41978168|NCT01052077|75782752|FG003|Phase A+|Lost to Follow-up|8|||
41978169|NCT01052077|75782749|FG000|Phase A+|Adverse Event|0|||
41978170|NCT01052077|75782750|FG001|Phase A+|Adverse Event|0|||
41978171|NCT01052077|75782751|FG002|Phase A+|Adverse Event|0|||
41978172|NCT01052077|75782752|FG003|Phase A+|Adverse Event|4|||
41978173|NCT01052077|75782749|FG000|Phase A+|Met Withdrawal Criteria|0|||
42217641|NCT03482011|76035032|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
42217642|NCT03482011|76035033|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
42217643|NCT03482011|76035034|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
42217644|NCT03482011|76035035|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
42217645|NCT03482011|76035036|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
42217646|NCT03482011|76035037|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
42217647|NCT03482011|76035030|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42217648|NCT03482011|76035031|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42217649|NCT03482011|76035032|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42217650|NCT03482011|76035033|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42217651|NCT03482011|76035034|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
42217652|NCT03482011|76035035|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42217653|NCT03482011|76035036|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42217654|NCT03482011|76035037|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
42217655|NCT03482011|76035030|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
42217656|NCT03482011|76035031|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
42217657|NCT03482011|76035032|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
42217658|NCT03482011|76035033|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
42217659|NCT03482011|76035034|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
42217660|NCT03482011|76035035|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
42217661|NCT03482011|76035036|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
42217662|NCT03482011|76035037|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
42217663|NCT03482011|76035030|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42217664|NCT03482011|76035031|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42217665|NCT03482011|76035032|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42217666|NCT03482011|76035033|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
42217667|NCT03482011|76035034|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
42217668|NCT03482011|76035035|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
42217669|NCT03482011|76035036|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
42217670|NCT03482011|76035037|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
42217671|NCT03482011|76035030|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
42217672|NCT03482011|76035031|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
42217673|NCT03482011|76035032|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
42217674|NCT03482011|76035033|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
42217675|NCT03482011|76035034|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
42217676|NCT03482011|76035035|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
42217677|NCT03482011|76035036|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
42217678|NCT03482011|76035037|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
42217679|NCT03482011|76035030|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
42217680|NCT03482011|76035031|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
42217681|NCT03482011|76035032|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
42217682|NCT03482011|76035033|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
42217683|NCT03482011|76035034|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
42217684|NCT03482011|76035035|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
42217685|NCT03482011|76035036|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
42217686|NCT03482011|76035037|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
42217687|NCT03482011|76035030|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
42217688|NCT03482011|76035031|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
42217689|NCT03482011|76035032|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
42217690|NCT03482011|76035033|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
42217691|NCT03482011|76035034|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
42217692|NCT03482011|76035035|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
42217693|NCT03482011|76035036|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
42217694|NCT03482011|76035037|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
42217695|NCT03482011|76035030|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
42217696|NCT03482011|76035031|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
42217697|NCT03482011|76035032|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
42217698|NCT03482011|76035033|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
42217699|NCT03482011|76035034|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
42217700|NCT03482011|76035035|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
42217701|NCT03482011|76035036|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
42217702|NCT03482011|76035037|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
42217703|NCT03482011|76035030|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
42217704|NCT03482011|76035031|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
42217705|NCT03482011|76035032|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
42217706|NCT03482011|76035033|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
42217707|NCT03482011|76035034|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
42217708|NCT03482011|76035035|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
42217709|NCT03482011|76035036|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
42217710|NCT03482011|76035037|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
42217711|NCT03481309|76035068|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
42217712|NCT03481309|76035069|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
42217713|NCT03481309|76035070|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
42217714|NCT03481309|76035071|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
41978174|NCT01052077|75782750|FG001|Phase A+|Met Withdrawal Criteria|0|||
41978175|NCT01052077|75782751|FG002|Phase A+|Met Withdrawal Criteria|0|||
41978176|NCT01052077|75782752|FG003|Phase A+|Met Withdrawal Criteria|2|||
41978177|NCT01052077|75782749|FG000|Phase A+|Withdrawal by Subject|0|||
41978178|NCT01052077|75782750|FG001|Phase A+|Withdrawal by Subject|0|||
41978179|NCT01052077|75782751|FG002|Phase A+|Withdrawal by Subject|0|||
41978180|NCT01052077|75782752|FG003|Phase A+|Withdrawal by Subject|7|||
41978181|NCT01052038|75782761|FG000|Overall Study|Lost to Follow-up|2|||
41978182|NCT01052038|75782762|FG001|Overall Study|Lost to Follow-up|3|||
41978183|NCT01052038|75782763|FG002|Overall Study|Lost to Follow-up|1|||
41978184|NCT01052038|75782761|FG000|Overall Study|Protocol Violation|2|||
41978185|NCT01052038|75782762|FG001|Overall Study|Protocol Violation|3|||
41978186|NCT01052038|75782763|FG002|Overall Study|Protocol Violation|3|||
41978187|NCT01051960|75782771|FG000|Overall Study|Adverse Event|1|||
41978188|NCT01051921|75782775|FG000|Overall Study|Physician Decision|9|||
41978189|NCT01051921|75782775|FG000|Overall Study|Adverse Event|8|||
41978190|NCT01051921|75782775|FG000|Overall Study|Withdrawal by Subject|7|||
41978191|NCT01051921|75782775|FG000|Overall Study|Lost to Follow-up|4|||
41978192|NCT01051921|75782775|FG000|Overall Study|virological failure|1|||
41978193|NCT01051921|75782775|FG000|Overall Study|patient moved|1|||
41978194|NCT01051063|75782781|FG000|Overall Study|Death|2|||
41978195|NCT01051063|75782782|FG001|Overall Study|Death|2|||
41978196|NCT01051063|75782781|FG000|Overall Study|Withdrawal by Subject|1|||
41978197|NCT01051063|75782782|FG001|Overall Study|Withdrawal by Subject|1|||
41978198|NCT01051063|75782781|FG000|Overall Study|Termination of the study|5|||
41978199|NCT01051063|75782782|FG001|Overall Study|Termination of the study|0|||
41978200|NCT01051063|75782781|FG000|Overall Study|Moved from the study site area|1|||
41978201|NCT01051063|75782782|FG001|Overall Study|Moved from the study site area|0|||
41978202|NCT01051063|75782781|FG000|Overall Study|Other|1|||
41978203|NCT01051063|75782782|FG001|Overall Study|Other|0|||
41978204|NCT01051063|75782781|FG000|Overall Study|Lost to Follow-up|0|||
41978205|NCT01051063|75782782|FG001|Overall Study|Lost to Follow-up|1|||
41978206|NCT01050790|75782789|FG000|Overall Study|Adverse Event|1|||
41978207|NCT01050673|75782796|FG000|Overall Study|Physician Decision|4|||
41978208|NCT01050673|75782797|FG001|Overall Study|Physician Decision|5|||
41978209|NCT01050205|75782805|FG000|Overall Study|Lost to Follow-up|7|||
41978210|NCT01050205|75782806|FG001|Overall Study|Lost to Follow-up|1|||
41978211|NCT01050205|75782805|FG000|Overall Study|Withdrawal by Subject|1|||
41978212|NCT01050205|75782806|FG001|Overall Study|Withdrawal by Subject|1|||
41978213|NCT01050205|75782805|FG000|Overall Study|Relocated from area|1|||
41978214|NCT01050205|75782806|FG001|Overall Study|Relocated from area|2|||
41978215|NCT01050205|75782805|FG000|Overall Study|Discontinued Intervention|2|||
41978216|NCT01050205|75782806|FG001|Overall Study|Discontinued Intervention|0|||
42129355|NCT04488770|75940328|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42129356|NCT04488770|75940329|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42129357|NCT04488770|75940330|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42129358|NCT04488770|75940331|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
42129359|NCT04488770|75940332|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
42129360|NCT04488770|75940333|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42129361|NCT04488770|75940334|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42129362|NCT04488770|75940335|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42129363|NCT04488770|75940336|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42129364|NCT04488770|75940337|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42129365|NCT04488770|75940338|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42129366|NCT04488770|75940326|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42129367|NCT04488770|75940327|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42217715|NCT03481309|76035072|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
41978217|NCT01059448|75782816|FG000|Overall Study|Adverse Event|1|||
41978218|NCT01059448|75782817|FG001|Overall Study|Adverse Event|3|||
42217716|NCT03481309|76035073|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
41978219|NCT01059448|75782818|FG002|Overall Study|Adverse Event|0|||
41978220|NCT01059448|75782819|FG003|Overall Study|Adverse Event|1|||
41978221|NCT01059448|75782816|FG000|Overall Study|Withdrawal by Subject|2|||
41978222|NCT01059448|75782817|FG001|Overall Study|Withdrawal by Subject|0|||
41978223|NCT01059448|75782818|FG002|Overall Study|Withdrawal by Subject|2|||
41978224|NCT01059448|75782819|FG003|Overall Study|Withdrawal by Subject|4|||
41978225|NCT01059448|75782816|FG000|Overall Study|Disease Progression|2|||
41978226|NCT01059448|75782817|FG001|Overall Study|Disease Progression|1|||
41978227|NCT01059448|75782818|FG002|Overall Study|Disease Progression|4|||
41978228|NCT01059448|75782819|FG003|Overall Study|Disease Progression|2|||
41978229|NCT01059448|75782816|FG000|Overall Study|Administrative Decision|43|||
42217717|NCT03480841|76035081|FG000|Overall Study|Lost to Follow-up|2|||
42217718|NCT02709538|76035088|FG000|Overall Study|Adverse Event|13|||
42217719|NCT02709538|76035089|FG001|Overall Study|Adverse Event|2|||
42217720|NCT02709538|76035090|FG002|Overall Study|Adverse Event|3|||
42217721|NCT02709538|76035088|FG000|Overall Study|Lack of Efficacy|1|||
42217722|NCT02709538|76035089|FG001|Overall Study|Lack of Efficacy|0|||
42217723|NCT02709538|76035090|FG002|Overall Study|Lack of Efficacy|0|||
42217724|NCT02709538|76035088|FG000|Overall Study|Lost to Follow-up|24|||
42217725|NCT02709538|76035089|FG001|Overall Study|Lost to Follow-up|8|||
42217726|NCT02709538|76035090|FG002|Overall Study|Lost to Follow-up|4|||
42217727|NCT02709538|76035088|FG000|Overall Study|Physician Decision|1|||
42217728|NCT02709538|76035089|FG001|Overall Study|Physician Decision|0|||
42217729|NCT02709538|76035090|FG002|Overall Study|Physician Decision|0|||
42217730|NCT02709538|76035088|FG000|Overall Study|Withdrawal by Subject|40|||
42217731|NCT02709538|76035089|FG001|Overall Study|Withdrawal by Subject|7|||
42217732|NCT02709538|76035090|FG002|Overall Study|Withdrawal by Subject|4|||
42217733|NCT02709538|76035088|FG000|Overall Study|Non-compliance with study procedures|5|||
42217734|NCT02709538|76035089|FG001|Overall Study|Non-compliance with study procedures|0|||
42217735|NCT02709538|76035090|FG002|Overall Study|Non-compliance with study procedures|0|||
42217736|NCT02709538|76035088|FG000|Overall Study|Non-compliance with study drug|2|||
42217737|NCT02709538|76035089|FG001|Overall Study|Non-compliance with study drug|0|||
42217738|NCT02709538|76035090|FG002|Overall Study|Non-compliance with study drug|0|||
42217739|NCT02709538|76035088|FG000|Overall Study|Protocol deviation|10|||
42217740|NCT02709538|76035089|FG001|Overall Study|Protocol deviation|4|||
42217741|NCT02709538|76035090|FG002|Overall Study|Protocol deviation|4|||
42217742|NCT02709538|76035088|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
42217743|NCT02709538|76035089|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
42217744|NCT02709538|76035090|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
42217745|NCT02709538|76035088|FG000|Overall Study|Other|16|||
42217746|NCT02709538|76035089|FG001|Overall Study|Other|7|||
42217747|NCT02709538|76035090|FG002|Overall Study|Other|5|||
42217748|NCT03789318|76035103|FG000|Overall Study|Adverse Event|0|||
42217749|NCT03789318|76035104|FG001|Overall Study|Adverse Event|0|||
42217750|NCT03789318|76035105|FG002|Overall Study|Adverse Event|1|||
42217751|NCT03789318|76035106|FG003|Overall Study|Adverse Event|1|||
41978230|NCT01059448|75782817|FG001|Overall Study|Administrative Decision|49|||
42217752|NCT03789318|76035107|FG004|Overall Study|Adverse Event|0|||
42217753|NCT03789318|76035103|FG000|Overall Study|Lost to Follow-up|0|||
42217754|NCT03789318|76035104|FG001|Overall Study|Lost to Follow-up|0|||
42217755|NCT03789318|76035105|FG002|Overall Study|Lost to Follow-up|1|||
42217756|NCT03789318|76035106|FG003|Overall Study|Lost to Follow-up|0|||
42217757|NCT03789318|76035107|FG004|Overall Study|Lost to Follow-up|0|||
42217758|NCT03789318|76035103|FG000|Overall Study|Withdrawal by Subject|0|||
42217759|NCT03789318|76035104|FG001|Overall Study|Withdrawal by Subject|0|||
42217760|NCT03789318|76035105|FG002|Overall Study|Withdrawal by Subject|1|||
42217761|NCT03789318|76035106|FG003|Overall Study|Withdrawal by Subject|0|||
42217762|NCT03789318|76035107|FG004|Overall Study|Withdrawal by Subject|0|||
42217763|NCT00511134|76035125|FG000|Overall Study|Withdrawal by Subject|0|||
42217764|NCT00511134|76035126|FG001|Overall Study|Withdrawal by Subject|2|||
42217765|NCT01372384|76035132|FG000|Overall Study|Progression of disease|3|||
42217766|NCT03115476|76035139|FG000|LP0084-1369|Death|1|||
42217767|NCT03115476|76035140|FG001|LP0084-1369|Death|0|||
42217768|NCT03115476|76035141|FG002|LP0084-1369|Death|2|||
42217769|NCT03115476|76035139|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
42217770|NCT03115476|76035140|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
42217771|NCT03115476|76035141|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
42217772|NCT03480763|76035151|FG000|Overall Study|Withdrawal by Subject|18|||
42217773|NCT03480763|76035152|FG001|Overall Study|Withdrawal by Subject|10|||
41978231|NCT01059448|75782818|FG002|Overall Study|Administrative Decision|45|||
41978232|NCT01059448|75782819|FG003|Overall Study|Administrative Decision|46|||
41978233|NCT01059448|75782816|FG000|Overall Study|Lost to Follow-up|0|||
42129368|NCT04488770|75940328|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42129369|NCT04488770|75940329|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42129370|NCT04488770|75940330|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
42129371|NCT04488770|75940331|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42129372|NCT04488770|75940332|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42129373|NCT04488770|75940333|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42129374|NCT04488770|75940334|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42217774|NCT03480763|76035151|FG000|Overall Study|Lost to Follow-up|4|||
42217775|NCT03480763|76035152|FG001|Overall Study|Lost to Follow-up|7|||
42217776|NCT03480763|76035151|FG000|Overall Study|non-study pneumococcal vaccine|1|||
42217777|NCT03480763|76035152|FG001|Overall Study|non-study pneumococcal vaccine|0|||
42217778|NCT03480763|76035151|FG000|Overall Study|oncological treatment|0|||
42217779|NCT03480763|76035152|FG001|Overall Study|oncological treatment|2|||
42217780|NCT03480763|76035151|FG000|Overall Study|pain with vaccination|1|||
42217781|NCT03480763|76035152|FG001|Overall Study|pain with vaccination|0|||
42217782|NCT03123120|76035166|FG000|Overall Study|Lost to Follow-up|0|||
42217783|NCT03123120|76035167|FG001|Overall Study|Lost to Follow-up|1|||
42217784|NCT03123120|76035166|FG000|Overall Study|Withdrawal by Subject|0|||
42217785|NCT03123120|76035167|FG001|Overall Study|Withdrawal by Subject|1|||
42217786|NCT01319994|76035177|FG000|Overall Study|Protocol Violation|7|||
42217787|NCT01319994|76035178|FG001|Overall Study|Protocol Violation|6|||
42217788|NCT03453151|76035188|FG000|Overall Study|Withdrawal by Subject|1|||
41978234|NCT01059448|75782817|FG001|Overall Study|Lost to Follow-up|0|||
41978235|NCT01059448|75782818|FG002|Overall Study|Lost to Follow-up|2|||
41978236|NCT01059448|75782819|FG003|Overall Study|Lost to Follow-up|0|||
41978237|NCT01059448|75782816|FG000|Overall Study|Death|0|||
42217789|NCT03453151|76035188|FG000|Overall Study|Physician Decision|3|||
42217790|NCT03452527|76035194|FG000|Overall Study|Withdrawal by Subject|1|||
42217791|NCT03452527|76035195|FG001|Overall Study|Withdrawal by Subject|1|||
42217792|NCT03452527|76035194|FG000|Overall Study|Study Terminated|2|||
42217793|NCT03452527|76035195|FG001|Overall Study|Study Terminated|3|||
42217794|NCT03028142|76035201|FG000|Overall Study|Adverse Event|1|||
42217795|NCT03028142|76035202|FG001|Overall Study|Adverse Event|1|||
42217796|NCT03028142|76035203|FG002|Overall Study|Adverse Event|0|||
42217797|NCT03028142|76035204|FG003|Overall Study|Adverse Event|0|||
42217798|NCT03028142|76035205|FG004|Overall Study|Adverse Event|0|||
42217799|NCT03028142|76035206|FG005|Overall Study|Adverse Event|1|||
41978238|NCT01059448|75782817|FG001|Overall Study|Death|1|||
41978239|NCT01059448|75782818|FG002|Overall Study|Death|0|||
42217800|NCT03028142|76035201|FG000|Overall Study|Withdrawal by Subject|0|||
42217801|NCT03028142|76035202|FG001|Overall Study|Withdrawal by Subject|0|||
42217802|NCT03028142|76035203|FG002|Overall Study|Withdrawal by Subject|0|||
42217803|NCT03028142|76035204|FG003|Overall Study|Withdrawal by Subject|0|||
42217804|NCT03028142|76035205|FG004|Overall Study|Withdrawal by Subject|1|||
42217805|NCT03028142|76035206|FG005|Overall Study|Withdrawal by Subject|0|||
42217806|NCT02708524|76035219|FG000|Overall Study|Adverse Event|0|||
42217807|NCT02708524|76035220|FG001|Overall Study|Adverse Event|1|||
42217808|NCT02708524|76035221|FG002|Overall Study|Adverse Event|0|||
42217809|NCT02708524|76035222|FG003|Overall Study|Adverse Event|0|||
42217810|NCT02708524|76035219|FG000|Overall Study|Lens Discomfort|1|||
42217811|NCT02708524|76035220|FG001|Overall Study|Lens Discomfort|0|||
42217812|NCT02708524|76035221|FG002|Overall Study|Lens Discomfort|1|||
42217813|NCT02708524|76035222|FG003|Overall Study|Lens Discomfort|0|||
42217814|NCT02708524|76035219|FG000|Overall Study|Lost to Follow-up|1|||
41978240|NCT01059448|75782819|FG003|Overall Study|Death|0|||
41978241|NCT01059448|75782816|FG000|Overall Study|Other|1|||
41978242|NCT01059448|75782817|FG001|Overall Study|Other|1|||
41978243|NCT01059448|75782818|FG002|Overall Study|Other|0|||
41978244|NCT01059448|75782819|FG003|Overall Study|Other|1|||
42217815|NCT02708524|76035220|FG001|Overall Study|Lost to Follow-up|1|||
42217816|NCT02708524|76035221|FG002|Overall Study|Lost to Follow-up|1|||
42217817|NCT02708524|76035222|FG003|Overall Study|Lost to Follow-up|0|||
42217818|NCT02708524|76035219|FG000|Overall Study|Protocol Violation|0|||
42217819|NCT02708524|76035220|FG001|Overall Study|Protocol Violation|1|||
42217820|NCT02708524|76035221|FG002|Overall Study|Protocol Violation|0|||
42217821|NCT02708524|76035222|FG003|Overall Study|Protocol Violation|0|||
42217822|NCT02708524|76035219|FG000|Overall Study|Withdrawal by Subject|1|||
42217823|NCT02708524|76035220|FG001|Overall Study|Withdrawal by Subject|1|||
42217824|NCT02708524|76035221|FG002|Overall Study|Withdrawal by Subject|0|||
42217825|NCT02708524|76035222|FG003|Overall Study|Withdrawal by Subject|0|||
41978245|NCT01058707|75782840|FG000|Overall Study|Disease Progression|15|||
41978246|NCT01058707|75782841|FG001|Overall Study|Disease Progression|20|||
41978247|NCT01058707|75782842|FG002|Overall Study|Disease Progression|20|||
41978248|NCT01058707|75782843|FG003|Overall Study|Disease Progression|15|||
41978249|NCT01058707|75782844|FG004|Overall Study|Disease Progression|23|||
41978250|NCT01058707|75782845|FG005|Overall Study|Disease Progression|10|||
41978251|NCT01058707|75782846|FG006|Overall Study|Disease Progression|12|||
42302141|NCT02484547|76137186|FG006|Long-Term Extension Period|Reason not Specified|231|||
42302142|NCT02517541|76137198|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
42302143|NCT02517541|76137198|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
41978252|NCT01058707|75782840|FG000|Overall Study|Adverse Event|11|||
41978253|NCT01058707|75782841|FG001|Overall Study|Adverse Event|4|||
41978254|NCT01058707|75782842|FG002|Overall Study|Adverse Event|7|||
41978255|NCT01058707|75782843|FG003|Overall Study|Adverse Event|6|||
42217826|NCT02708524|76035219|FG000|Overall Study|Dispensed incorrect study lens|0|||
42217827|NCT02708524|76035220|FG001|Overall Study|Dispensed incorrect study lens|1|||
41978256|NCT01058707|75782844|FG004|Overall Study|Adverse Event|7|||
41978257|NCT01058707|75782845|FG005|Overall Study|Adverse Event|3|||
42217828|NCT02708524|76035221|FG002|Overall Study|Dispensed incorrect study lens|1|||
42217829|NCT02708524|76035222|FG003|Overall Study|Dispensed incorrect study lens|0|||
42217830|NCT02708524|76035219|FG000|Overall Study|Did not wear lens at final visit|0|||
42217831|NCT02708524|76035220|FG001|Overall Study|Did not wear lens at final visit|1|||
41978258|NCT01058707|75782846|FG006|Overall Study|Adverse Event|1|||
42217832|NCT02708524|76035221|FG002|Overall Study|Did not wear lens at final visit|0|||
42217833|NCT02708524|76035222|FG003|Overall Study|Did not wear lens at final visit|0|||
42217834|NCT02708524|76035219|FG000|Overall Study|Subject lost study lens|1|||
42217835|NCT02708524|76035220|FG001|Overall Study|Subject lost study lens|0|||
42217836|NCT02708524|76035221|FG002|Overall Study|Subject lost study lens|0|||
42217837|NCT02708524|76035222|FG003|Overall Study|Subject lost study lens|0|||
42217838|NCT03418675|76035234|FG000|Overall Study|Lost to Follow-up|13|||
42217839|NCT03418675|76035235|FG001|Overall Study|Lost to Follow-up|10|||
42217840|NCT03418675|76035234|FG000|Overall Study|Adverse Event|2|||
42217841|NCT03418675|76035235|FG001|Overall Study|Adverse Event|0|||
42217842|NCT03417505|76035252|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
42217843|NCT03417505|76035253|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
42217844|NCT02953639|76035262|FG000|Overall Study|Adverse Event|2|||
42217845|NCT02953639|76035263|FG001|Overall Study|Adverse Event|0|||
42217846|NCT02953639|76035264|FG002|Overall Study|Adverse Event|1|||
42217847|NCT02953639|76035262|FG000|Overall Study|Lost to Follow-up|8|||
42217848|NCT02953639|76035263|FG001|Overall Study|Lost to Follow-up|4|||
42217849|NCT02953639|76035264|FG002|Overall Study|Lost to Follow-up|3|||
42217850|NCT02953639|76035262|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42217851|NCT02953639|76035263|FG001|Overall Study|Non-Compliance With Study Drug|2|||
42217852|NCT02953639|76035264|FG002|Overall Study|Non-Compliance With Study Drug|1|||
42217853|NCT02953639|76035262|FG000|Overall Study|Multiple Reasons|1|||
42217854|NCT02953639|76035263|FG001|Overall Study|Multiple Reasons|0|||
42217855|NCT02953639|76035264|FG002|Overall Study|Multiple Reasons|1|||
42217856|NCT02953639|76035262|FG000|Overall Study|Physician Decision|1|||
41978259|NCT01058707|75782840|FG000|Overall Study|Subject Decision|5|||
41978260|NCT01058707|75782841|FG001|Overall Study|Subject Decision|3|||
42129375|NCT04488770|75940335|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42129376|NCT04488770|75940336|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42129377|NCT04488770|75940337|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42129378|NCT04488770|75940338|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
42129379|NCT00525044|75940384|FG000|Overall Study|Lost to Follow-up|0|||
42129380|NCT00525044|75940385|FG001|Overall Study|Lost to Follow-up|1|||
42129381|NCT00355342|75940393|FG000|Overall Study|Adverse Event|13|||
42129382|NCT00355342|75940394|FG001|Overall Study|Adverse Event|15|||
42129383|NCT00355342|75940393|FG000|Overall Study|Lost to Follow-up|4|||
42129384|NCT00355342|75940394|FG001|Overall Study|Lost to Follow-up|2|||
42129385|NCT00355342|75940393|FG000|Overall Study|Withdrawal by Subject|14|||
42129386|NCT00355342|75940394|FG001|Overall Study|Withdrawal by Subject|11|||
42129387|NCT00355342|75940393|FG000|Overall Study|Sponsor terminated study|2|||
42129388|NCT00355342|75940394|FG001|Overall Study|Sponsor terminated study|2|||
42129389|NCT00355342|75940393|FG000|Overall Study|Overcompliant-PI discretion|1|||
42129390|NCT00355342|75940394|FG001|Overall Study|Overcompliant-PI discretion|0|||
42129391|NCT00355342|75940393|FG000|Overall Study|Use of prohibited medication|1|||
42129392|NCT00355342|75940394|FG001|Overall Study|Use of prohibited medication|0|||
42129393|NCT00355342|75940393|FG000|Overall Study|COPD exacerbation|1|||
42129394|NCT00355342|75940394|FG001|Overall Study|COPD exacerbation|1|||
42129395|NCT00355342|75940393|FG000|Overall Study|Dispensed wrong study drug kit|1|||
42129396|NCT00355342|75940394|FG001|Overall Study|Dispensed wrong study drug kit|0|||
42129397|NCT00355342|75940393|FG000|Overall Study|Non-compliance with Dexa scans|1|||
42129398|NCT00355342|75940394|FG001|Overall Study|Non-compliance with Dexa scans|0|||
42129399|NCT00355342|75940393|FG000|Overall Study|Withdrawal by participant and physician|1|||
42129400|NCT00355342|75940394|FG001|Overall Study|Withdrawal by participant and physician|0|||
42129401|NCT00355342|75940393|FG000|Overall Study|Participant relocated|0|||
42129402|NCT00355342|75940394|FG001|Overall Study|Participant relocated|1|||
42129403|NCT00355342|75940393|FG000|Overall Study|Participant discontinued study drug|0|||
42129404|NCT00355342|75940394|FG001|Overall Study|Participant discontinued study drug|1|||
42129405|NCT00355342|75940393|FG000|Overall Study|Study management|0|||
42129406|NCT00355342|75940394|FG001|Overall Study|Study management|1|||
42129407|NCT00355342|75940393|FG000|Overall Study|Protocol Violation|0|||
41978261|NCT01058707|75782842|FG002|Overall Study|Subject Decision|3|||
42129408|NCT00355342|75940394|FG001|Overall Study|Protocol Violation|1|||
42129409|NCT00355342|75940393|FG000|Overall Study|Use of protocol excluded medication|0|||
42217857|NCT02953639|76035263|FG001|Overall Study|Physician Decision|0|||
41978262|NCT01058707|75782843|FG003|Overall Study|Subject Decision|1|||
41978263|NCT01058707|75782844|FG004|Overall Study|Subject Decision|2|||
42217858|NCT02953639|76035264|FG002|Overall Study|Physician Decision|0|||
42217859|NCT02953639|76035262|FG000|Overall Study|Withdrawal by Subject|7|||
42217860|NCT02953639|76035263|FG001|Overall Study|Withdrawal by Subject|8|||
42217861|NCT02953639|76035264|FG002|Overall Study|Withdrawal by Subject|10|||
42217862|NCT02953639|76035262|FG000|Overall Study|Completed or Discontinued information is missing|1|||
42217863|NCT02953639|76035263|FG001|Overall Study|Completed or Discontinued information is missing|0|||
42217864|NCT02953639|76035264|FG002|Overall Study|Completed or Discontinued information is missing|0|||
42217865|NCT04147715|76035286|FG000|Overall Study|Adverse Event|0|||
41978264|NCT01058707|75782845|FG005|Overall Study|Subject Decision|3|||
41978265|NCT01058707|75782846|FG006|Overall Study|Subject Decision|6|||
41978266|NCT01058707|75782840|FG000|Overall Study|Lost to Follow-up|0|||
41978267|NCT01058707|75782841|FG001|Overall Study|Lost to Follow-up|0|||
41978268|NCT01058707|75782842|FG002|Overall Study|Lost to Follow-up|1|||
41978269|NCT01058707|75782843|FG003|Overall Study|Lost to Follow-up|0|||
41978270|NCT01058707|75782844|FG004|Overall Study|Lost to Follow-up|0|||
42217866|NCT04147715|76035287|FG001|Overall Study|Adverse Event|0|||
42217867|NCT04147715|76035288|FG002|Overall Study|Adverse Event|0|||
42217868|NCT04147715|76035289|FG003|Overall Study|Adverse Event|0|||
42217869|NCT04147715|76035290|FG004|Overall Study|Adverse Event|0|||
42217870|NCT04147715|76035291|FG005|Overall Study|Adverse Event|0|||
42217871|NCT04147715|76035292|FG006|Overall Study|Adverse Event|0|||
42217872|NCT04147715|76035293|FG007|Overall Study|Adverse Event|2|||
42217873|NCT04147715|76035294|FG008|Overall Study|Adverse Event|1|||
42217874|NCT04147715|76035295|FG009|Overall Study|Adverse Event|0|||
42217875|NCT04147715|76035296|FG010|Overall Study|Adverse Event|0|||
42217876|NCT04147715|76035297|FG011|Overall Study|Adverse Event|0|||
42217877|NCT02452554|76035384|FG000|Overall Study|Death|2|||
42217878|NCT02452554|76035385|FG001|Overall Study|Death|1|||
42217879|NCT02452554|76035386|FG002|Overall Study|Death|0|||
42217880|NCT02452554|76035387|FG003|Overall Study|Death|0|||
42217881|NCT02452554|76035388|FG004|Overall Study|Death|0|||
42028530|NCT01119066|75836979|FG000|Overall Study|Withdrawal by Subject|4|||
42028531|NCT01119066|75836980|FG001|Overall Study|Withdrawal by Subject|6|||
42028532|NCT01119066|75836981|FG002|Overall Study|Withdrawal by Subject|0|||
42028533|NCT01119066|75836982|FG003|Overall Study|Withdrawal by Subject|0|||
42129410|NCT00355342|75940394|FG001|Overall Study|Use of protocol excluded medication|1|||
42129411|NCT01573754|75940402|FG000|Overall Study|Noncompliance or remission not achieved|3|||
42129412|NCT01573754|75940403|FG001|Overall Study|Noncompliance or remission not achieved|15|||
42129413|NCT00355264|75940409|FG000|Extension (Variable Duration)|Adverse Event|1|||
42129414|NCT00355264|75940409|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
42129415|NCT00355030|75940420|FG000|Study Period 1 Treatment|Adverse Event|1|||
42129416|NCT00355030|75940421|FG001|Study Period 1 Treatment|Adverse Event|1|||
42129417|NCT00355030|75940420|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
42129418|NCT00355030|75940421|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
42129419|NCT00355030|75940420|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
42129420|NCT00355030|75940421|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
42129421|NCT00355030|75940420|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
42129422|NCT00355030|75940421|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
42129423|NCT00355030|75940420|FG000|Study Period 1 Treatment|Physician Decision|0|||
42129424|NCT00355030|75940421|FG001|Study Period 1 Treatment|Physician Decision|1|||
42129425|NCT00355030|75940420|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
42129426|NCT00355030|75940421|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
42129427|NCT00355030|75940420|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
42129428|NCT00355030|75940421|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
42129429|NCT00355030|75940420|FG000|Study Period 1 Treatment|Other|2|||
42129430|NCT00355030|75940421|FG001|Study Period 1 Treatment|Other|6|||
42129431|NCT00355030|75940420|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
42129432|NCT00355030|75940421|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
42129433|NCT00355030|75940420|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
42129434|NCT00355030|75940421|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
42129435|NCT00354172|75940427|FG000|Overall Study|Did not receive transplant|1|||
42129436|NCT00345592|75940433|FG000|Overall Study|Death|14|||
42129437|NCT00345592|75940434|FG001|Overall Study|Death|16|||
42129438|NCT00345592|75940433|FG000|Overall Study|Withdrawal by Subject|11|||
42129439|NCT00345592|75940434|FG001|Overall Study|Withdrawal by Subject|8|||
42129440|NCT00353704|75940442|FG000|Overall Study|Protocol Violation|3|||
42129441|NCT00353704|75940443|FG001|Overall Study|Protocol Violation|1|||
42217882|NCT02452554|76035389|FG005|Overall Study|Death|0|||
42129442|NCT00512252|75940452|FG000|Overall Study|Lost to Follow-up|0|||
42129443|NCT00512252|75940453|FG001|Overall Study|Lost to Follow-up|0|||
42217883|NCT02452554|76035384|FG000|Overall Study|Lack of Efficacy|13|||
41978271|NCT01058707|75782845|FG005|Overall Study|Lost to Follow-up|0|||
42129444|NCT00512252|75940454|FG002|Overall Study|Lost to Follow-up|1|||
42217884|NCT02452554|76035385|FG001|Overall Study|Lack of Efficacy|14|||
42217885|NCT02452554|76035386|FG002|Overall Study|Lack of Efficacy|9|||
42217886|NCT02452554|76035387|FG003|Overall Study|Lack of Efficacy|1|||
42217887|NCT02452554|76035388|FG004|Overall Study|Lack of Efficacy|5|||
42217888|NCT02452554|76035389|FG005|Overall Study|Lack of Efficacy|8|||
42217889|NCT02452554|76035384|FG000|Overall Study|Physician Decision|0|||
42217890|NCT02452554|76035385|FG001|Overall Study|Physician Decision|1|||
42217891|NCT02452554|76035386|FG002|Overall Study|Physician Decision|0|||
42217892|NCT02452554|76035387|FG003|Overall Study|Physician Decision|0|||
42217893|NCT02452554|76035388|FG004|Overall Study|Physician Decision|0|||
42217894|NCT02452554|76035389|FG005|Overall Study|Physician Decision|0|||
42217895|NCT02452554|76035384|FG000|Overall Study|Withdrawal by Subject|1|||
42217896|NCT02452554|76035385|FG001|Overall Study|Withdrawal by Subject|0|||
42217897|NCT02452554|76035386|FG002|Overall Study|Withdrawal by Subject|2|||
42217898|NCT02452554|76035387|FG003|Overall Study|Withdrawal by Subject|0|||
42217899|NCT02452554|76035388|FG004|Overall Study|Withdrawal by Subject|0|||
42217900|NCT02452554|76035389|FG005|Overall Study|Withdrawal by Subject|1|||
42217901|NCT02452554|76035384|FG000|Overall Study|Ineligible|0|||
42217902|NCT02452554|76035385|FG001|Overall Study|Ineligible|1|||
42217903|NCT02452554|76035386|FG002|Overall Study|Ineligible|0|||
42217904|NCT02452554|76035387|FG003|Overall Study|Ineligible|0|||
42217905|NCT02452554|76035388|FG004|Overall Study|Ineligible|0|||
42217906|NCT02452554|76035389|FG005|Overall Study|Ineligible|0|||
42217907|NCT02452554|76035384|FG000|Overall Study|Never Received Treatment|1|||
42217908|NCT02452554|76035385|FG001|Overall Study|Never Received Treatment|0|||
42217909|NCT02452554|76035386|FG002|Overall Study|Never Received Treatment|0|||
42217910|NCT02452554|76035387|FG003|Overall Study|Never Received Treatment|0|||
42217911|NCT02452554|76035388|FG004|Overall Study|Never Received Treatment|0|||
42217912|NCT02452554|76035389|FG005|Overall Study|Never Received Treatment|0|||
42217913|NCT04009577|76035408|FG000|Core Study|Adverse Event|1|||
42217914|NCT04009577|76035409|FG001|Core Study|Adverse Event|0|||
42217915|NCT04009577|76035410|FG002|Core Study|Adverse Event|2|||
42217916|NCT04009577|76035411|FG003|Core Study|Adverse Event|4|||
42217917|NCT04009577|76035408|FG000|Core Study|Withdrawal by Subject|0|||
42217918|NCT04009577|76035409|FG001|Core Study|Withdrawal by Subject|0|||
42217919|NCT04009577|76035410|FG002|Core Study|Withdrawal by Subject|2|||
42217920|NCT04009577|76035411|FG003|Core Study|Withdrawal by Subject|0|||
42217921|NCT04009577|76035408|FG000|Core Study|Other|0|||
42217922|NCT04009577|76035409|FG001|Core Study|Other|0|||
42217923|NCT04009577|76035410|FG002|Core Study|Other|0|||
42217924|NCT04009577|76035411|FG003|Core Study|Other|1|||
42217925|NCT04009577|76035408|FG000|Extension Phase|Adverse Event|0|||
42217926|NCT04009577|76035409|FG001|Extension Phase|Adverse Event|0|||
42217927|NCT04009577|76035410|FG002|Extension Phase|Adverse Event|0|||
42217928|NCT04009577|76035411|FG003|Extension Phase|Adverse Event|1|||
42217929|NCT04009577|76035408|FG000|Extension Phase|Inadequate therapeutic effect|0|||
42217930|NCT04009577|76035409|FG001|Extension Phase|Inadequate therapeutic effect|0|||
42217931|NCT04009577|76035410|FG002|Extension Phase|Inadequate therapeutic effect|1|||
42217932|NCT04009577|76035411|FG003|Extension Phase|Inadequate therapeutic effect|0|||
42217933|NCT04009577|76035408|FG000|Extension Phase|Withdrawal by Subject|0|||
42217934|NCT04009577|76035409|FG001|Extension Phase|Withdrawal by Subject|0|||
42217935|NCT04009577|76035410|FG002|Extension Phase|Withdrawal by Subject|1|||
42217936|NCT04009577|76035411|FG003|Extension Phase|Withdrawal by Subject|0|||
42217937|NCT04009577|76035408|FG000|Extension Phase|Not Treated|0|||
42217938|NCT04009577|76035409|FG001|Extension Phase|Not Treated|0|||
42217939|NCT04009577|76035410|FG002|Extension Phase|Not Treated|2|||
42217940|NCT04009577|76035411|FG003|Extension Phase|Not Treated|0|||
42217941|NCT04146467|76035439|FG000|Overall Study|Adverse Event|0|||
42217942|NCT04146467|76035440|FG001|Overall Study|Adverse Event|1|||
42217943|NCT04146467|76035439|FG000|Overall Study|Lost to Follow-up|0|||
42217944|NCT04146467|76035440|FG001|Overall Study|Lost to Follow-up|2|||
42217945|NCT02705716|76035451|FG000|Overall Study|Adverse Event|0|||
42217946|NCT02705716|76035452|FG001|Overall Study|Adverse Event|1|||
42217947|NCT02705716|76035451|FG000|Overall Study|Protocol Violation|3|||
42217948|NCT02705716|76035452|FG001|Overall Study|Protocol Violation|0|||
42217949|NCT02705716|76035451|FG000|Overall Study|Withdrawal of Consent|1|||
42217950|NCT02705716|76035452|FG001|Overall Study|Withdrawal of Consent|1|||
42217951|NCT04138043|76035460|FG000|Overall Study|Withdrawal by Subject|0|||
42217952|NCT04138043|76035461|FG001|Overall Study|Withdrawal by Subject|1|||
42217953|NCT03443713|76035480|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
42217954|NCT03443713|76035481|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
42028534|NCT01119066|75836979|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
42028535|NCT01119066|75836980|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
42217955|NCT03443713|76035482|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
42217956|NCT04133519|76035496|FG000|Overall Study|Withdrawal by Subject|5|||
42217957|NCT04133519|76035497|FG001|Overall Study|Withdrawal by Subject|4|||
42217958|NCT04133519|76035496|FG000|Overall Study|Protocol Violation|0|||
42217959|NCT04133519|76035497|FG001|Overall Study|Protocol Violation|1|||
42217960|NCT04133519|76035496|FG000|Overall Study|Never started treatment|1|||
42217961|NCT04133519|76035497|FG001|Overall Study|Never started treatment|1|||
42217962|NCT04007159|76035503|FG000|Induction Phase|(missed study visits)|16|||
42217963|NCT04007159|76035503|FG000|Induction Phase|Withdrawal by Subject|4|||
42217964|NCT04007159|76035503|FG000|Induction Phase|Adverse Event|2|||
42217965|NCT04007159|76035503|FG000|Challenge Phase|missed study visits|3|||
42217966|NCT03119688|76035514|FG000|Overall Study|Adverse Event|4|||
42217967|NCT03389893|76035533|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
42217968|NCT03389893|76035534|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
42217969|NCT03389893|76035535|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
42217970|NCT03389893|76035536|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
42217971|NCT03389893|76035533|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
42217972|NCT03389893|76035534|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
42217973|NCT03389893|76035535|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
42217974|NCT03389893|76035536|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
42217975|NCT03389893|76035533|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
42217976|NCT03389893|76035534|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
42217977|NCT03389893|76035535|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
42217978|NCT03389893|76035536|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
42217979|NCT03389893|76035533|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
42217980|NCT03389893|76035534|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
42217981|NCT03389893|76035535|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
42217982|NCT03389893|76035536|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
42217983|NCT04128293|76035546|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
42217984|NCT04128293|76035547|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
42217985|NCT04128293|76035548|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
42217986|NCT04128293|76035549|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
41978272|NCT01058707|75782846|FG006|Overall Study|Lost to Follow-up|0|||
42217987|NCT00787176|76035568|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
42217988|NCT00787176|76035569|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
42217989|NCT00787176|76035570|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
42217990|NCT00787176|76035571|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
41978273|NCT01058707|75782840|FG000|Overall Study|Reason Not Specified|0|||
42217991|NCT03691571|76035584|FG000|Overall Study|Withdrawal by Subject|9|||
42217992|NCT03691571|76035585|FG001|Overall Study|Withdrawal by Subject|2|||
42217993|NCT03113916|76035594|FG000|Overall Study|Withdrawal by Subject|9|||
42217994|NCT03113916|76035595|FG001|Overall Study|Withdrawal by Subject|7|||
42217995|NCT03113916|76035594|FG000|Overall Study|Pregnancy|1|||
42217996|NCT03113916|76035595|FG001|Overall Study|Pregnancy|3|||
42217997|NCT03113916|76035594|FG000|Overall Study|Lost to Follow-up|1|||
42217998|NCT03113916|76035595|FG001|Overall Study|Lost to Follow-up|2|||
42217999|NCT02925494|76035610|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
42218000|NCT02925494|76035611|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
42218001|NCT02925494|76035612|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
42218002|NCT02925494|76035613|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
42218003|NCT02925494|76035610|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
42218004|NCT02925494|76035611|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
42218005|NCT02925494|76035612|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
42218006|NCT02925494|76035613|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
42218007|NCT02925494|76035610|FG000|Post-Treatment Follow-Up Period|Other|1|||
42218008|NCT02925494|76035611|FG001|Post-Treatment Follow-Up Period|Other|4|||
42218009|NCT02925494|76035612|FG002|Post-Treatment Follow-Up Period|Other|3|||
42218010|NCT02925494|76035613|FG003|Post-Treatment Follow-Up Period|Other|6|||
42218011|NCT02925494|76035610|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
42218012|NCT02925494|76035611|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
42218013|NCT02925494|76035612|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
42218014|NCT02925494|76035613|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
42218015|NCT02925494|76035610|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
42218016|NCT02925494|76035611|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
42218017|NCT02925494|76035612|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
42218018|NCT02925494|76035613|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
42218019|NCT02925494|76035610|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
42218020|NCT02925494|76035611|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
42218021|NCT02925494|76035612|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
42218022|NCT02925494|76035613|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
42218023|NCT02925494|76035610|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
42218024|NCT02925494|76035611|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
42218025|NCT02925494|76035612|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
42028536|NCT01119066|75836981|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
42028537|NCT01119066|75836982|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
42218026|NCT02925494|76035613|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
42218027|NCT04006145|76035626|FG000|Overall Study|Lost to Follow-up|0|||
42218028|NCT04006145|76035627|FG001|Overall Study|Lost to Follow-up|1|||
42028538|NCT01119066|75836979|FG000|Overall Study|Relapse identified before transplant|1|||
42129445|NCT00512252|75940452|FG000|Overall Study|Protocol Violation|0|||
42129446|NCT00512252|75940453|FG001|Overall Study|Protocol Violation|0|||
42129447|NCT00512252|75940454|FG002|Overall Study|Protocol Violation|1|||
42129448|NCT00512252|75940452|FG000|Overall Study|Death|0|||
42129449|NCT00512252|75940453|FG001|Overall Study|Death|0|||
42129450|NCT00512252|75940454|FG002|Overall Study|Death|1|||
42129451|NCT00516386|75940469|FG000|Overall Study|not interested in the study|4|||
42218029|NCT04006145|76035626|FG000|Overall Study|Other|1|||
42218030|NCT04006145|76035627|FG001|Overall Study|Other|2|||
42218031|NCT03386773|76035635|FG000|Overall Study|Lost to Follow-up|24|||
42218032|NCT03386773|76035636|FG001|Overall Study|Lost to Follow-up|33|||
42218033|NCT03386773|76035635|FG000|Overall Study|Withdrawal by Subject|3|||
42218034|NCT03386773|76035636|FG001|Overall Study|Withdrawal by Subject|2|||
42129452|NCT00516386|75940469|FG000|Overall Study|Lost to Follow-up|2|||
42129453|NCT00524420|75940475|FG000|Overall Study|Lack of Efficacy|1|||
42129454|NCT00524420|75940476|FG001|Overall Study|Lack of Efficacy|0|||
42218035|NCT04126343|76035648|FG000|Overall Study|Adverse Event|0|||
42218036|NCT04126343|76035649|FG001|Overall Study|Adverse Event|0|||
42218037|NCT04126343|76035650|FG002|Overall Study|Adverse Event|0|||
42218038|NCT04126343|76035651|FG003|Overall Study|Adverse Event|0|||
42218039|NCT04126343|76035652|FG004|Overall Study|Adverse Event|0|||
42218040|NCT04126343|76035653|FG005|Overall Study|Adverse Event|1|||
42218041|NCT04126343|76035648|FG000|Overall Study|Withdrawal by Subject|0|||
42218042|NCT04126343|76035649|FG001|Overall Study|Withdrawal by Subject|0|||
42218043|NCT04126343|76035650|FG002|Overall Study|Withdrawal by Subject|0|||
42129455|NCT00512096|75940484|FG000|Overall Study|Adverse Event|2|||
42129456|NCT00512096|75940484|FG000|Overall Study|Withdrawal by Subject|2|||
42129457|NCT00512096|75940484|FG000|Overall Study|Lack of Efficacy|3|||
42129458|NCT00524030|75940490|FG000|Overall Study|Lack of Efficacy|10|||
42129459|NCT00524030|75940491|FG001|Overall Study|Lack of Efficacy|24|||
42129460|NCT00524030|75940490|FG000|Overall Study|Lost to Follow-up|0|||
42129461|NCT00524030|75940491|FG001|Overall Study|Lost to Follow-up|2|||
42129462|NCT00524030|75940490|FG000|Overall Study|Withdrawal by Subject|3|||
42129463|NCT00524030|75940491|FG001|Overall Study|Withdrawal by Subject|8|||
42129464|NCT00524030|75940490|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
42129465|NCT00524030|75940491|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
42129466|NCT00524030|75940490|FG000|Overall Study|Protocol Violation|0|||
42129467|NCT00524030|75940491|FG001|Overall Study|Protocol Violation|1|||
42129468|NCT00524030|75940490|FG000|Overall Study|Pregnancy|1|||
42129469|NCT00524030|75940491|FG001|Overall Study|Pregnancy|0|||
42129470|NCT00524030|75940490|FG000|Overall Study|Adverse Event|3|||
42129471|NCT00524030|75940491|FG001|Overall Study|Adverse Event|21|||
42129472|NCT00524030|75940490|FG000|Overall Study|Death|0|||
42129473|NCT00524030|75940491|FG001|Overall Study|Death|1|||
42129474|NCT00523718|75940500|FG000|Overall Study|Withdrawal by Subject|1|||
42129475|NCT00523718|75940501|FG001|Overall Study|Withdrawal by Subject|0|||
42129476|NCT00523718|75940500|FG000|Overall Study|Protocol Violation|2|||
42129477|NCT00523718|75940501|FG001|Overall Study|Protocol Violation|0|||
42129478|NCT00523640|75940507|FG000|Overall Study|Death|1|||
42129479|NCT00345358|75940515|FG000|Primary Vaccination Phase|Other|0|||
42129480|NCT00345358|75940516|FG001|Primary Vaccination Phase|Other|1|||
42129481|NCT00345358|75940517|FG002|Primary Vaccination Phase|Other|1|||
42129482|NCT00345358|75940518|FG003|Primary Vaccination Phase|Other|0|||
42129483|NCT00345358|75940515|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
42129484|NCT00345358|75940516|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
42129485|NCT00345358|75940517|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
42129486|NCT00345358|75940518|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
42129487|NCT00345358|75940515|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
42129488|NCT00345358|75940516|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
42129489|NCT00345358|75940517|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
42129490|NCT00345358|75940518|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
42129491|NCT00345358|75940515|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
41978274|NCT01058707|75782841|FG001|Overall Study|Reason Not Specified|3|||
41978275|NCT01058707|75782842|FG002|Overall Study|Reason Not Specified|2|||
42218044|NCT04126343|76035651|FG003|Overall Study|Withdrawal by Subject|1|||
42218045|NCT04126343|76035652|FG004|Overall Study|Withdrawal by Subject|0|||
42218046|NCT04126343|76035653|FG005|Overall Study|Withdrawal by Subject|0|||
42218047|NCT04126343|76035648|FG000|Overall Study|Related to COVID-19 pandemic|3|||
42218048|NCT04126343|76035649|FG001|Overall Study|Related to COVID-19 pandemic|4|||
42218049|NCT04126343|76035650|FG002|Overall Study|Related to COVID-19 pandemic|3|||
42218050|NCT04126343|76035651|FG003|Overall Study|Related to COVID-19 pandemic|3|||
42218051|NCT04126343|76035652|FG004|Overall Study|Related to COVID-19 pandemic|3|||
42218052|NCT04126343|76035653|FG005|Overall Study|Related to COVID-19 pandemic|3|||
42218053|NCT02952313|76035668|FG000|Primary Endpoint|Lost to Follow-up|4|||
42218054|NCT02952313|76035668|FG000|Primary Endpoint|Withdrawal by Subject|1|||
42218055|NCT02952313|76035668|FG000|Primary Endpoint|Lack of Efficacy|1|||
42218056|NCT02952313|76035668|FG000|Primary Endpoint|Missed visit|1|||
42218057|NCT02952313|76035668|FG000|Long-term Follow-up|Lost to Follow-up|12|||
42218058|NCT02952313|76035668|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
42218059|NCT02952313|76035668|FG000|Long-term Follow-up|Lack of Efficacy|6|||
42218060|NCT02952313|76035668|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
42218061|NCT02952313|76035668|FG000|Long-term Follow-up|Physician Decision|1|||
42218062|NCT02952313|76035668|FG000|Long-term Follow-up|Death|1|||
42218063|NCT03119610|76035675|FG000|Overall Study|Adverse Event|1|||
42218064|NCT03119610|76035676|FG001|Overall Study|Adverse Event|0|||
42218065|NCT03119610|76035675|FG000|Overall Study|Lost to Follow-up|0|||
42218066|NCT03119610|76035676|FG001|Overall Study|Lost to Follow-up|1|||
42218067|NCT04005755|76035682|FG000|Overall Study|Adverse Event|6|||
42218068|NCT04005755|76035682|FG000|Overall Study|Physician Decision|3|||
42218069|NCT04005755|76035682|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
42218070|NCT04005755|76035682|FG000|Overall Study|Withdrawal by Subject|3|||
42218071|NCT04005755|76035682|FG000|Overall Study|Lost to Follow-up|1|||
42218072|NCT03442777|76035689|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
42218073|NCT03442777|76035690|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
42218074|NCT03442777|76035691|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
42218075|NCT03401749|76035700|FG000|Overall Study|Lost to Follow-up|20|||
42218076|NCT03401749|76035701|FG001|Overall Study|Lost to Follow-up|16|||
42218077|NCT03401749|76035702|FG002|Overall Study|Lost to Follow-up|26|||
42218078|NCT03029624|76035710|FG000|Overall Study|Adverse Event|1|||
42218079|NCT03029624|76035710|FG000|Overall Study|Withdrawal by Subject|1|||
42218080|NCT03029624|76035710|FG000|Overall Study|Lack of Efficacy|1|||
42218081|NCT03029624|76035710|FG000|Overall Study|MRI need|2|||
42218082|NCT02952001|76035718|FG000|Overall Study|Adverse Event|3|||
42218083|NCT02952001|76035719|FG001|Overall Study|Adverse Event|0|||
42302144|NCT02517541|76137198|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
42302145|NCT02517541|76137198|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
42302146|NCT02517541|76137198|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
42302147|NCT02517541|76137198|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
42302148|NCT02496091|76137204|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
42302149|NCT02483611|76137212|FG000|Overall Study|Protocol Violation|0|||
42302150|NCT02483611|76137213|FG001|Overall Study|Protocol Violation|0|||
42302151|NCT02483611|76137214|FG002|Overall Study|Protocol Violation|1|||
42302152|NCT02483533|76137224|FG000|Overall Study|Lack of Efficacy|50|||
42302153|NCT02483533|76137225|FG001|Overall Study|Lack of Efficacy|50|||
42302154|NCT02482129|76137233|FG000|Overall Study|Adverse Event-prior to treatment|0|||
41978276|NCT01058707|75782843|FG003|Overall Study|Reason Not Specified|0|||
41978277|NCT01058707|75782844|FG004|Overall Study|Reason Not Specified|7|||
42218084|NCT02952001|76035718|FG000|Overall Study|Prohibited therapy|10|||
42302155|NCT02482129|76137234|FG001|Overall Study|Adverse Event-prior to treatment|1|||
41978278|NCT01058707|75782845|FG005|Overall Study|Reason Not Specified|1|||
41978279|NCT01058707|75782846|FG006|Overall Study|Reason Not Specified|7|||
42028539|NCT01119066|75836980|FG001|Overall Study|Relapse identified before transplant|0|||
42028540|NCT01119066|75836981|FG002|Overall Study|Relapse identified before transplant|0|||
42028541|NCT01119066|75836982|FG003|Overall Study|Relapse identified before transplant|0|||
42028542|NCT01119066|75836979|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
42028543|NCT01119066|75836980|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
42028544|NCT01119066|75836981|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
42028545|NCT01119066|75836982|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
42028546|NCT01119066|75836979|FG000|Overall Study|Relapse identified before transplant|0|||
42028547|NCT01119066|75836980|FG001|Overall Study|Relapse identified before transplant|4|||
42028548|NCT01119066|75836981|FG002|Overall Study|Relapse identified before transplant|0|||
42028549|NCT01119066|75836982|FG003|Overall Study|Relapse identified before transplant|0|||
42028550|NCT00910624|75836996|FG000|Treatment Phase|Adverse Event|2|||
41978280|NCT01054144|75782884|FG000|Overall Study|Death|2|||
41978281|NCT03276052|75782891|FG000|Overall Study|Withdrawal by Subject|5|||
41978282|NCT03276052|75782891|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
41978283|NCT00105586|75782901|FG000|Overall Study|Adverse Event|4|||
41978284|NCT00105586|75782902|FG001|Overall Study|Adverse Event|3|||
41978285|NCT00105586|75782901|FG000|Overall Study|Physician Decision|13|||
41978286|NCT00105586|75782902|FG001|Overall Study|Physician Decision|13|||
42028551|NCT00910624|75836997|FG001|Treatment Phase|Adverse Event|6|||
42028552|NCT00910624|75836998|FG002|Treatment Phase|Adverse Event|6|||
42028553|NCT00910624|75836999|FG003|Treatment Phase|Adverse Event|0|||
42028554|NCT00910624|75836996|FG000|Treatment Phase|Treatment Failure|23|||
42028555|NCT00910624|75836997|FG001|Treatment Phase|Treatment Failure|10|||
42028556|NCT00910624|75836998|FG002|Treatment Phase|Treatment Failure|0|||
42028557|NCT00910624|75836999|FG003|Treatment Phase|Treatment Failure|0|||
42028558|NCT00910624|75836996|FG000|Treatment Phase|Lost to Follow-up|0|||
42028559|NCT00910624|75836997|FG001|Treatment Phase|Lost to Follow-up|0|||
42028560|NCT00910624|75836998|FG002|Treatment Phase|Lost to Follow-up|1|||
42028561|NCT00910624|75836999|FG003|Treatment Phase|Lost to Follow-up|0|||
41978287|NCT01059643|75782910|FG000|Overall Study|Adverse Event|3|||
41978288|NCT01059643|75782910|FG000|Overall Study|Withdrawal by Subject|2|||
41978289|NCT01059643|75782910|FG000|Overall Study|Physician Decision|1|||
42028562|NCT00910624|75836996|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
42028563|NCT00910624|75836997|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
41978290|NCT01059565|75782919|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
41978291|NCT01059565|75782920|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
41978292|NCT01059565|75782919|FG000|24-Week Randomized Phase|Adverse Event|5|||
42218085|NCT02952001|76035719|FG001|Overall Study|Prohibited therapy|3|||
41978293|NCT01059565|75782920|FG001|24-Week Randomized Phase|Adverse Event|0|||
41978294|NCT01059565|75782919|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
41978295|NCT01059565|75782920|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
41978296|NCT01059565|75782919|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
41978297|NCT01059565|75782920|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
41978298|NCT01059565|75782919|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
41978299|NCT01059565|75782920|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
41978300|NCT01059565|75782919|FG000|24-Week Open-Label Phase|Adverse Event|2|||
41978301|NCT01059565|75782920|FG001|24-Week Open-Label Phase|Adverse Event|0|||
41978302|NCT01059565|75782919|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
41978303|NCT01059565|75782920|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
41978304|NCT01059565|75782919|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
41978305|NCT01059565|75782920|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
41978306|NCT01059565|75782919|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
41978307|NCT01059565|75782920|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
41978308|NCT01059565|75782919|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
41978309|NCT01059565|75782920|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
41978310|NCT01059565|75782919|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
41978311|NCT01059565|75782920|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
41978312|NCT01059526|75782930|FG000|Overall Study|Patient enrolled but not treated|20|||
41978313|NCT01059526|75782931|FG001|Overall Study|Patient enrolled but not treated|17|||
41978314|NCT01059526|75782930|FG000|Overall Study|Adverse Event|2|||
41978315|NCT01059526|75782931|FG001|Overall Study|Adverse Event|2|||
41978316|NCT01059526|75782930|FG000|Overall Study|Protocol Violation|0|||
41978317|NCT01059526|75782931|FG001|Overall Study|Protocol Violation|1|||
41978318|NCT01059526|75782930|FG000|Overall Study|Withdrawal by Subject|3|||
41978319|NCT01059526|75782931|FG001|Overall Study|Withdrawal by Subject|1|||
41978320|NCT01059526|75782930|FG000|Overall Study|Lost to Follow-up|4|||
41978321|NCT01059526|75782931|FG001|Overall Study|Lost to Follow-up|1|||
41978322|NCT01059526|75782930|FG000|Overall Study|Patient found to be dermatographic|1|||
41978323|NCT01059526|75782931|FG001|Overall Study|Patient found to be dermatographic|0|||
41978324|NCT03277261|75782939|FG000|Overall Study|Adverse Event|17|||
41978325|NCT03277261|75782940|FG001|Overall Study|Adverse Event|1|||
41978326|NCT03277261|75782939|FG000|Overall Study|Participant Withdrawal of Consent|6|||
41978327|NCT03277261|75782940|FG001|Overall Study|Participant Withdrawal of Consent|15|||
41978328|NCT03277261|75782939|FG000|Overall Study|Investigator / Sponsor Decision|4|||
41978329|NCT03277261|75782940|FG001|Overall Study|Investigator / Sponsor Decision|2|||
41978330|NCT03277261|75782939|FG000|Overall Study|Pregnancy|2|||
41978331|NCT03277261|75782940|FG001|Overall Study|Pregnancy|0|||
41978332|NCT03277261|75782939|FG000|Overall Study|Lost to Follow-up|2|||
41978333|NCT03277261|75782940|FG001|Overall Study|Lost to Follow-up|2|||
41978334|NCT03277261|75782939|FG000|Overall Study|Lack of Efficacy|2|||
41978335|NCT03277261|75782940|FG001|Overall Study|Lack of Efficacy|2|||
41978336|NCT03277261|75782939|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
41978337|NCT03277261|75782940|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
41978338|NCT03277690|75782962|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
41978339|NCT03277690|75782963|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
41978340|NCT03277690|75782962|FG000|Dose Titration and Maintenance|Physician Decision|1|||
41978341|NCT03277690|75782963|FG001|Dose Titration and Maintenance|Physician Decision|0|||
41978342|NCT03277690|75782962|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
41978343|NCT03277690|75782963|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
41978344|NCT03277690|75782962|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
41978345|NCT03277690|75782963|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
41978346|NCT03277690|75782962|FG000|Dose Titration and Maintenance|Adverse Event|15|||
41978347|NCT03277690|75782963|FG001|Dose Titration and Maintenance|Adverse Event|0|||
41978348|NCT03277690|75782962|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
41978349|NCT03277690|75782963|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
41978350|NCT03277690|75782962|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
41978351|NCT03277690|75782963|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
41978352|NCT03271021|75782972|FG000|Overall Study|Adverse Event|3|||
41978353|NCT03271021|75782973|FG001|Overall Study|Adverse Event|2|||
41978354|NCT03271021|75782972|FG000|Overall Study|Withdrawal by Subject|36|||
41978355|NCT03271021|75782973|FG001|Overall Study|Withdrawal by Subject|53|||
41978356|NCT03271021|75782972|FG000|Overall Study|Lost to Follow-up|34|||
41978357|NCT03271021|75782973|FG001|Overall Study|Lost to Follow-up|39|||
41978358|NCT03271021|75782972|FG000|Overall Study|Protocol Violation|6|||
41978359|NCT03271021|75782973|FG001|Overall Study|Protocol Violation|4|||
41978360|NCT03271021|75782972|FG000|Overall Study|Abnormal Lab Results|1|||
41978361|NCT03271021|75782973|FG001|Overall Study|Abnormal Lab Results|0|||
41978362|NCT03271021|75782972|FG000|Overall Study|Miscellaneous|9|||
41978363|NCT03271021|75782973|FG001|Overall Study|Miscellaneous|8|||
41978364|NCT01249651|75782994|FG000|Overall Study|Withdrawal by Subject|4|||
41978365|NCT01249651|75782994|FG000|Overall Study|Adverse Event|1|||
41978366|NCT01249651|75782994|FG000|Overall Study|Protocol Violation|1|||
42028564|NCT00910624|75836998|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
42129492|NCT00345358|75940516|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
42129493|NCT00345358|75940517|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
41978367|NCT01249651|75782994|FG000|Overall Study|Sponsor Decision|1|||
41978368|NCT01249417|75783001|FG000|Randomised Population|Study treatment not received|0|||
41978369|NCT01249417|75783002|FG001|Randomised Population|Study treatment not received|0|||
42129494|NCT00345358|75940518|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
42129495|NCT00345358|75940515|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
42129496|NCT00345358|75940516|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
41978370|NCT01249417|75783003|FG002|Randomised Population|Study treatment not received|2|||
41978371|NCT01249417|75783001|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
41978372|NCT01249417|75783002|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
41978373|NCT01249417|75783003|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
41978374|NCT01249417|75783001|FG000|Treatment Phase - ITT Population|Other|0|||
41978375|NCT01249417|75783002|FG001|Treatment Phase - ITT Population|Other|0|||
41978376|NCT01249417|75783003|FG002|Treatment Phase - ITT Population|Other|1|||
41978377|NCT01249417|75783001|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
41978378|NCT01249417|75783002|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
41978379|NCT01249417|75783003|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
41978380|NCT01249417|75783001|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
41978381|NCT01249417|75783002|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
42129497|NCT00345358|75940517|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
42129498|NCT00345358|75940518|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
41978382|NCT01249417|75783003|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
41978383|NCT01249417|75783001|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
41978384|NCT01249417|75783002|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
41978385|NCT01249417|75783003|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
41978386|NCT01249261|75783013|FG000|Overall Study|Withdrawal by Subject|1|||
42129499|NCT00345358|75940515|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
42218086|NCT02952001|76035718|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
42218087|NCT02952001|76035719|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
42218088|NCT04123067|76035728|FG000|Overall Study|Lost to Follow-up|0|||
42218089|NCT04123067|76035729|FG001|Overall Study|Lost to Follow-up|1|||
42218090|NCT04117607|76035738|FG000|Overall Study|Early Termination|0|||
42218091|NCT04117607|76035739|FG001|Overall Study|Early Termination|1|||
42218092|NCT04117607|76035740|FG002|Overall Study|Early Termination|0|||
42218093|NCT04117607|76035741|FG003|Overall Study|Early Termination|0|||
42218094|NCT04117607|76035742|FG004|Overall Study|Early Termination|0|||
42218095|NCT04117607|76035743|FG005|Overall Study|Early Termination|0|||
42218096|NCT04117607|76035744|FG006|Overall Study|Early Termination|1|||
42218097|NCT04117607|76035745|FG007|Overall Study|Early Termination|0|||
42218098|NCT04117607|76035746|FG008|Overall Study|Early Termination|0|||
42218099|NCT04117607|76035747|FG009|Overall Study|Early Termination|0|||
42218100|NCT04117607|76035748|FG010|Overall Study|Early Termination|0|||
42218101|NCT04117607|76035749|FG011|Overall Study|Early Termination|0|||
42218102|NCT04117607|76035750|FG012|Overall Study|Early Termination|0|||
42218103|NCT04117607|76035751|FG013|Overall Study|Early Termination|0|||
42218104|NCT04112303|76035767|FG000|Overall Study|Death|1|||
42218105|NCT03998189|76035773|FG000|Overall Study|Lack of Efficacy|0|||
42218106|NCT03998189|76035774|FG001|Overall Study|Lack of Efficacy|1|||
42218107|NCT04099277|76035780|FG000|Overall Study|Physician Decision|1|||
42218108|NCT04099277|76035780|FG000|Overall Study|Withdrawal by Subject|1|||
42272616|NCT02282020|76102864|FG001|Overall Study|Developed Discontinuation Criteria|2|||
42272617|NCT02282020|76102863|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
42272618|NCT02282020|76102864|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
42272619|NCT02281552|76102880|FG000|Overall Study|Medication error|1|||
42272620|NCT02281552|76102881|FG001|Overall Study|Medication error|0|||
42272621|NCT02281552|76102880|FG000|Overall Study|Insufficient clinical response|0|||
42272622|NCT02281552|76102881|FG001|Overall Study|Insufficient clinical response|1|||
42272623|NCT02281552|76102880|FG000|Overall Study|Adverse Event|3|||
42272624|NCT02281552|76102881|FG001|Overall Study|Adverse Event|9|||
42272625|NCT00890591|76102887|FG000|Overall Study|Lack of Efficacy|20|||
42272626|NCT02284906|76102896|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
42272627|NCT02284906|76102897|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
42272628|NCT02284906|76102898|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
42272629|NCT02284906|76102896|FG000|Overall Study|Major Protocol Deviation|0|||
42272630|NCT02284906|76102897|FG001|Overall Study|Major Protocol Deviation|1|||
42272631|NCT02284906|76102898|FG002|Overall Study|Major Protocol Deviation|0|||
42272632|NCT02284906|76102896|FG000|Overall Study|Voluntary Withdrawal|2|||
42272633|NCT02284906|76102897|FG001|Overall Study|Voluntary Withdrawal|4|||
42272634|NCT02284906|76102898|FG002|Overall Study|Voluntary Withdrawal|5|||
42272635|NCT02284906|76102896|FG000|Overall Study|Study Termination|0|||
42272636|NCT02284906|76102897|FG001|Overall Study|Study Termination|11|||
42272637|NCT02284906|76102898|FG002|Overall Study|Study Termination|14|||
42272638|NCT02284906|76102896|FG000|Overall Study|Reason not Specified|1|||
42272639|NCT02284906|76102897|FG001|Overall Study|Reason not Specified|1|||
42272640|NCT02284906|76102898|FG002|Overall Study|Reason not Specified|0|||
42272641|NCT02879305|76102908|FG000|Overall Study|Investigator Site Closed|55|||
42129500|NCT00345358|75940516|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
42129501|NCT00345358|75940517|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
42129502|NCT00345358|75940518|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
42129503|NCT03869684|75940531|FG000|Overall Study|Adverse Event|0|||
42129504|NCT03869684|75940532|FG001|Overall Study|Adverse Event|3|||
42129505|NCT03869684|75940533|FG002|Overall Study|Adverse Event|1|||
42129506|NCT03869684|75940531|FG000|Overall Study|Withdrawal by Subject|1|||
42129507|NCT03869684|75940532|FG001|Overall Study|Withdrawal by Subject|0|||
42129508|NCT03869684|75940533|FG002|Overall Study|Withdrawal by Subject|0|||
42129509|NCT03869684|75940531|FG000|Overall Study|Lost to Follow-up|1|||
42129510|NCT03869684|75940532|FG001|Overall Study|Lost to Follow-up|0|||
42129511|NCT03869684|75940533|FG002|Overall Study|Lost to Follow-up|0|||
42129512|NCT03869684|75940531|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
42272642|NCT02879305|76102909|FG001|Overall Study|Investigator Site Closed|57|||
42272643|NCT02879305|76102908|FG000|Overall Study|Withdrawal by Subject|44|||
42272644|NCT02879305|76102909|FG001|Overall Study|Withdrawal by Subject|42|||
42272645|NCT02879305|76102908|FG000|Overall Study|Lost to Follow-up|17|||
42272646|NCT02879305|76102909|FG001|Overall Study|Lost to Follow-up|12|||
41978387|NCT01249261|75783014|FG001|Overall Study|Withdrawal by Subject|0|||
42272647|NCT02879305|76102908|FG000|Overall Study|Other|1|||
42272648|NCT02879305|76102909|FG001|Overall Study|Other|0|||
42218109|NCT03990389|76035786|FG000|Overall Study|Lost to Follow-up|3|||
42218110|NCT03990389|76035787|FG001|Overall Study|Lost to Follow-up|0|||
42218111|NCT03988907|76035795|FG000|Overall Study|Unable to complete visit|0|||
42218112|NCT03988907|76035796|FG001|Overall Study|Unable to complete visit|1|||
42218113|NCT03987191|76035810|FG000|Overall Study|COVID-19 related research disruption|0|||
42218114|NCT03987191|76035811|FG001|Overall Study|COVID-19 related research disruption|2|||
42218115|NCT04098809|76035819|FG000|Overall Study|Withdrawal by Subject|1|||
42218116|NCT04098809|76035820|FG001|Overall Study|Withdrawal by Subject|3|||
42218117|NCT04098809|76035819|FG000|Overall Study|Physician Decision|2|||
42218118|NCT04098809|76035820|FG001|Overall Study|Physician Decision|1|||
42218119|NCT03122184|76035828|FG000|Overall Study|Lost to Follow-up|4|||
42218120|NCT03122184|76035829|FG001|Overall Study|Lost to Follow-up|6|||
42218121|NCT03122184|76035828|FG000|Overall Study|Withdrawal by Subject|3|||
42218122|NCT03122184|76035829|FG001|Overall Study|Withdrawal by Subject|0|||
42218123|NCT03122184|76035828|FG000|Overall Study|Terminated due to cognitive problem|1|||
42218124|NCT03122184|76035829|FG001|Overall Study|Terminated due to cognitive problem|0|||
42218125|NCT04091087|76035854|FG000|Overall Study|Not treated|1|||
42218126|NCT04091087|76035855|FG001|Overall Study|Not treated|0|||
42218127|NCT04091087|76035854|FG000|Overall Study|Adverse Event|4|||
42218128|NCT04091087|76035855|FG001|Overall Study|Adverse Event|4|||
42218129|NCT04091087|76035854|FG000|Overall Study|Protocol Violation|0|||
42129513|NCT03869684|75940532|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
42129514|NCT03869684|75940533|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
42218130|NCT04091087|76035855|FG001|Overall Study|Protocol Violation|1|||
42218131|NCT04091087|76035854|FG000|Overall Study|Withdrawal by Subject|5|||
42218132|NCT04091087|76035855|FG001|Overall Study|Withdrawal by Subject|2|||
42218133|NCT03400033|76035873|FG000|Overall Study|Withdrawal by Subject|1|||
42218134|NCT03400033|76035874|FG001|Overall Study|Withdrawal by Subject|2|||
42218135|NCT04089761|76035889|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
42218136|NCT04089761|76035889|FG000|"Run In Phase"|Lost to Follow-up|1|||
42218137|NCT04089761|76035889|FG000|"Treatment Phase"|No evaluable data|5|||
42218138|NCT04089761|76035889|FG000|"Treatment Phase"|Lost to Follow-up|1|||
42218139|NCT03118518|76035895|FG000|Overall Study|Early Exit after treatment|2|||
42218140|NCT03118518|76035896|FG001|Overall Study|Early Exit after treatment|8|||
42218141|NCT03118518|76035895|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
42218142|NCT03118518|76035896|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
42218143|NCT03984305|76035904|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
42218144|NCT03984305|76035905|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
42218145|NCT03984305|76035904|FG000|Overall Study|Withdrawal by Subject|3|||
42218146|NCT03984305|76035905|FG001|Overall Study|Withdrawal by Subject|3|||
42218147|NCT03984305|76035904|FG000|Overall Study|Lost to Follow-up|1|||
42218148|NCT03984305|76035905|FG001|Overall Study|Lost to Follow-up|0|||
42218149|NCT03397771|76035913|FG000|Overall Study|2 erroneously randomized, never treated|3|||
42218150|NCT03397771|76035914|FG001|Overall Study|2 erroneously randomized, never treated|1|||
42218151|NCT03397771|76035913|FG000|Overall Study|Withdrawal by Subject|1|||
42218152|NCT03397771|76035914|FG001|Overall Study|Withdrawal by Subject|3|||
42218153|NCT03397771|76035913|FG000|Overall Study|Protocol Violation|2|||
42218154|NCT03397771|76035914|FG001|Overall Study|Protocol Violation|2|||
42218155|NCT03397771|76035913|FG000|Overall Study|Adverse Event|2|||
42218156|NCT03397771|76035914|FG001|Overall Study|Adverse Event|1|||
42218157|NCT02876835|76035922|FG000|Treatment Period (51.1 Month)|Other|1|||
42218158|NCT02876835|76035923|FG001|Treatment Period (51.1 Month)|Other|0|||
42218159|NCT02876835|76035922|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
42218160|NCT02876835|76035923|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
42218161|NCT02876835|76035922|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
42218162|NCT02876835|76035923|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
42218163|NCT02876835|76035922|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
42129515|NCT00516074|75940543|FG000|Overall Study|Adverse Event|0|||
42129516|NCT00516074|75940544|FG001|Overall Study|Adverse Event|1|||
42129517|NCT00516074|75940543|FG000|Overall Study|Subject Decision|4|||
42129518|NCT00516074|75940544|FG001|Overall Study|Subject Decision|2|||
42129519|NCT00516074|75940543|FG000|Overall Study|Loss of Glucose Control|2|||
42129520|NCT00516074|75940544|FG001|Overall Study|Loss of Glucose Control|0|||
42129521|NCT00515294|75940554|FG000|Overall Study|Lost to Follow-up|3|||
42218164|NCT02876835|76035923|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
42218165|NCT04086641|76035932|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
42129522|NCT00515294|75940555|FG001|Overall Study|Lost to Follow-up|2|||
42129523|NCT00515294|75940556|FG002|Overall Study|Lost to Follow-up|3|||
42129524|NCT00515294|75940557|FG003|Overall Study|Lost to Follow-up|1|||
42218166|NCT04086641|76035933|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
42218167|NCT03503318|76035942|FG000|Overall Study|Death|1|||
42218168|NCT03503318|76035943|FG001|Overall Study|Death|0|||
42218169|NCT03503318|76035944|FG002|Overall Study|Death|4|||
42218170|NCT03503318|76035942|FG000|Overall Study|Adverse Event|3|||
42218171|NCT03503318|76035943|FG001|Overall Study|Adverse Event|4|||
42218172|NCT03503318|76035944|FG002|Overall Study|Adverse Event|2|||
42218173|NCT03503318|76035942|FG000|Overall Study|Withdrawal by Subject|12|||
42218174|NCT03503318|76035943|FG001|Overall Study|Withdrawal by Subject|17|||
42218175|NCT03503318|76035944|FG002|Overall Study|Withdrawal by Subject|16|||
42218176|NCT03503318|76035942|FG000|Overall Study|Protocol Violation|5|||
42218177|NCT03503318|76035943|FG001|Overall Study|Protocol Violation|0|||
42218178|NCT03503318|76035944|FG002|Overall Study|Protocol Violation|3|||
42218179|NCT03503318|76035942|FG000|Overall Study|Lost to Follow-up|17|||
42218180|NCT03503318|76035943|FG001|Overall Study|Lost to Follow-up|15|||
42218181|NCT03503318|76035944|FG002|Overall Study|Lost to Follow-up|12|||
42218182|NCT03503318|76035942|FG000|Overall Study|Other than specified|1|||
42218183|NCT03503318|76035943|FG001|Overall Study|Other than specified|3|||
42218184|NCT03503318|76035944|FG002|Overall Study|Other than specified|3|||
42218185|NCT03396913|76035954|FG000|Overall Study|Lost to Follow-up|0|||
42218186|NCT03396913|76035955|FG001|Overall Study|Lost to Follow-up|6|||
42218187|NCT03982433|76035961|FG000|Overall Study|Lost to Follow-up|1|||
42218188|NCT03396835|76035965|FG000|Overall Study|Withdrawn prior to completion|1|||
42218189|NCT03396835|76035965|FG000|Overall Study|Did not meet criteria for data analysis|1|||
42218190|NCT03121950|76035971|FG000|Overall Study|Withdrawal by Subject|11|||
42218191|NCT03121950|76035972|FG001|Overall Study|Withdrawal by Subject|2|||
42218192|NCT03395353|76035980|FG000|Overall Study|Adverse Event|20|||
42218193|NCT03395353|76035980|FG000|Overall Study|Protocol Violation|1|||
42218194|NCT03395353|76035980|FG000|Overall Study|Lack of Efficacy|3|||
42218195|NCT03395353|76035980|FG000|Overall Study|Withdrawal by Subject|24|||
42218196|NCT03395353|76035980|FG000|Overall Study|Discontinued visit|1|||
42218197|NCT03395353|76035980|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
42218198|NCT03395353|76035980|FG000|Overall Study|Physician Decision|4|||
42218199|NCT03395353|76035980|FG000|Overall Study|Early termination of overall study|33|||
42218200|NCT04082663|76035988|FG000|Overall Study|Adverse Event|6|||
42218201|NCT04082663|76035988|FG000|Overall Study|Lost to Follow-up|1|||
42218202|NCT03682367|76035994|FG000|Overall Study|Protocol Violation|2|||
42218203|NCT03682367|76035995|FG001|Overall Study|Protocol Violation|1|||
42218204|NCT03682367|76035994|FG000|Overall Study|Closed Study Early|0|||
42218205|NCT03682367|76035995|FG001|Overall Study|Closed Study Early|3|||
42218206|NCT03681353|76036001|FG000|Overall Study|Lost to Follow-up|2|||
42218207|NCT03681353|76036001|FG000|Overall Study|Withdrawal by Subject|3|||
42218208|NCT03681353|76036001|FG000|Overall Study|withdrawn by PI|2|||
42218209|NCT03394885|76036005|FG000|Overall Study|Adverse Event|4|||
42218210|NCT03394885|76036005|FG000|Overall Study|Lack of Efficacy|1|||
42218211|NCT03394885|76036005|FG000|Overall Study|Physician Decision|1|||
42218212|NCT03394885|76036005|FG000|Overall Study|Withdrawal by Subject|8|||
42218213|NCT03394885|76036005|FG000|Overall Study|Alternative Therapy|1|||
42218214|NCT02877927|76036011|FG000|Overall Study|Adverse Event|1|||
42129525|NCT00515294|75940554|FG000|Overall Study|Driver simulator problems|1|||
42129526|NCT00515294|75940555|FG001|Overall Study|Driver simulator problems|1|||
42129527|NCT00515294|75940556|FG002|Overall Study|Driver simulator problems|1|||
42129528|NCT00515294|75940557|FG003|Overall Study|Driver simulator problems|3|||
42129529|NCT00515294|75940554|FG000|Overall Study|Caffeine amount inaccurate|5|||
42129530|NCT00515294|75940555|FG001|Overall Study|Caffeine amount inaccurate|0|||
42129531|NCT00515294|75940556|FG002|Overall Study|Caffeine amount inaccurate|7|||
42129532|NCT00515294|75940557|FG003|Overall Study|Caffeine amount inaccurate|0|||
42129533|NCT00345046|75940570|FG000|Overall Study|Protocol Violation|1|||
42129534|NCT00345046|75940571|FG001|Overall Study|Protocol Violation|1|||
42218215|NCT02877927|76036012|FG001|Overall Study|Adverse Event|0|||
42218216|NCT02877927|76036011|FG000|Overall Study|Lost to Follow-up|37|||
42218217|NCT02877927|76036012|FG001|Overall Study|Lost to Follow-up|38|||
42218218|NCT02877927|76036011|FG000|Overall Study|Withdrawal by Subject|11|||
42218219|NCT02877927|76036012|FG001|Overall Study|Withdrawal by Subject|12|||
42218220|NCT02877927|76036011|FG000|Overall Study|Physician Decision|0|||
42218221|NCT02877927|76036012|FG001|Overall Study|Physician Decision|1|||
42218222|NCT02877927|76036011|FG000|Overall Study|Missed EOT/PTE Visit|5|||
42218223|NCT02877927|76036012|FG001|Overall Study|Missed EOT/PTE Visit|6|||
42129535|NCT00345046|75940572|FG002|Overall Study|Protocol Violation|2|||
42218224|NCT02706886|76036027|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
42218225|NCT02706886|76036028|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
42218226|NCT02706886|76036029|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
42218227|NCT02706886|76036030|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
42218228|NCT02706886|76036031|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
42218229|NCT02706886|76036032|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
42218230|NCT02706886|76036033|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
42218231|NCT02706886|76036034|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
42218232|NCT02706886|76036035|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
42218233|NCT04069715|76036089|FG000|Overall Study|Lost to Follow-up|1|||
42218234|NCT04069715|76036090|FG001|Overall Study|Lost to Follow-up|1|||
41978388|NCT01248949|75783030|FG000|Overall Study|Lost to Follow-up|2|||
41978389|NCT01248949|75783031|FG001|Overall Study|Lost to Follow-up|2|||
41978390|NCT01248949|75783032|FG002|Overall Study|Lost to Follow-up|2|||
41978391|NCT01248949|75783033|FG003|Overall Study|Lost to Follow-up|1|||
41978392|NCT01248949|75783034|FG004|Overall Study|Lost to Follow-up|0|||
41978393|NCT01248949|75783030|FG000|Overall Study|Withdrawal by Subject|5|||
41978394|NCT01248949|75783031|FG001|Overall Study|Withdrawal by Subject|3|||
41978395|NCT01248949|75783032|FG002|Overall Study|Withdrawal by Subject|11|||
41978396|NCT01248949|75783033|FG003|Overall Study|Withdrawal by Subject|3|||
41978397|NCT01248949|75783034|FG004|Overall Study|Withdrawal by Subject|1|||
41978398|NCT01248949|75783030|FG000|Overall Study|Death|22|||
41978399|NCT01248949|75783031|FG001|Overall Study|Death|7|||
41978400|NCT01248949|75783032|FG002|Overall Study|Death|21|||
41978401|NCT01248949|75783033|FG003|Overall Study|Death|6|||
41978402|NCT01248949|75783034|FG004|Overall Study|Death|2|||
41978403|NCT01248949|75783030|FG000|Overall Study|Alternative Therapy|1|||
41978404|NCT01248949|75783031|FG001|Overall Study|Alternative Therapy|0|||
41978405|NCT01248949|75783032|FG002|Overall Study|Alternative Therapy|0|||
41978406|NCT01248949|75783033|FG003|Overall Study|Alternative Therapy|0|||
41978407|NCT01248949|75783034|FG004|Overall Study|Alternative Therapy|0|||
41978408|NCT01248949|75783030|FG000|Overall Study|Alternative Therapy.|1|||
41978409|NCT01248949|75783031|FG001|Overall Study|Alternative Therapy.|0|||
41978410|NCT01248949|75783032|FG002|Overall Study|Alternative Therapy.|0|||
41978411|NCT01248949|75783033|FG003|Overall Study|Alternative Therapy.|0|||
41978412|NCT01248949|75783034|FG004|Overall Study|Alternative Therapy.|0|||
41978413|NCT01248949|75783030|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
41978414|NCT01248949|75783031|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
41978415|NCT01248949|75783032|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
41978416|NCT01248949|75783033|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
41978417|NCT01248949|75783034|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
41978418|NCT01248949|75783030|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
41978419|NCT01248949|75783031|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
41978420|NCT01248949|75783032|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
41978421|NCT01248949|75783033|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
41978422|NCT01248949|75783034|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
41978423|NCT01248949|75783030|FG000|Overall Study|Participant Went To Hospice|0|||
41978424|NCT01248949|75783031|FG001|Overall Study|Participant Went To Hospice|0|||
41978425|NCT01248949|75783032|FG002|Overall Study|Participant Went To Hospice|1|||
42129536|NCT00515216|75940580|FG000|Overall Study|Withdrawal by Subject|1|||
42129537|NCT00522626|75940585|FG000|Overall Study|Lost to Follow-up|7|||
42129538|NCT00440193|75940591|FG000|Treatment Period|Adverse Event|74|||
42129539|NCT00440193|75940592|FG001|Treatment Period|Adverse Event|67|||
42129540|NCT00440193|75940591|FG000|Treatment Period|Death|19|||
42129541|NCT00440193|75940592|FG001|Treatment Period|Death|22|||
42129542|NCT00440193|75940591|FG000|Treatment Period|Lack of Efficacy|0|||
42129543|NCT00440193|75940592|FG001|Treatment Period|Lack of Efficacy|1|||
42129544|NCT00440193|75940591|FG000|Treatment Period|Lost to Follow-up|12|||
42129545|NCT00440193|75940592|FG001|Treatment Period|Lost to Follow-up|18|||
42129546|NCT00440193|75940591|FG000|Treatment Period|Physician Decision|3|||
42129547|NCT00440193|75940592|FG001|Treatment Period|Physician Decision|6|||
42218235|NCT04069715|76036089|FG000|Overall Study|Physician Decision|1|||
42129548|NCT00440193|75940591|FG000|Treatment Period|Protocol Violation|16|||
42129549|NCT00440193|75940592|FG001|Treatment Period|Protocol Violation|19|||
42218236|NCT04069715|76036090|FG001|Overall Study|Physician Decision|1|||
42218237|NCT04069715|76036089|FG000|Overall Study|Withdrawal by Subject|3|||
41978426|NCT01248949|75783033|FG003|Overall Study|Participant Went To Hospice|0|||
41978427|NCT01248949|75783034|FG004|Overall Study|Participant Went To Hospice|0|||
41978428|NCT01248949|75783030|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
41978429|NCT01248949|75783031|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
41978430|NCT01248949|75783032|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
41978431|NCT01248949|75783033|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
41978432|NCT01248949|75783034|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
42218238|NCT04069715|76036090|FG001|Overall Study|Withdrawal by Subject|3|||
42129550|NCT00440193|75940591|FG000|Treatment Period|Withdrawal by Subject|36|||
41978433|NCT01248949|75783030|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
41978434|NCT01248949|75783031|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
41978435|NCT01248949|75783032|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
41978436|NCT01248949|75783033|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
41978437|NCT01248949|75783034|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
41978438|NCT01248949|75783030|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
41978439|NCT01248949|75783031|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
41978440|NCT01248949|75783032|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
41978441|NCT01248949|75783033|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
41978442|NCT01248949|75783034|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
41978443|NCT01248949|75783030|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
41978444|NCT01248949|75783031|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
41978445|NCT01248949|75783032|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
41978446|NCT01248949|75783033|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
41978447|NCT01248949|75783034|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
41978448|NCT01248793|75783048|FG000|Overall Study|Lost to Follow-up|0|||
41978449|NCT01248793|75783049|FG001|Overall Study|Lost to Follow-up|1|||
41978450|NCT01248793|75783048|FG000|Overall Study|Adverse Event|1|||
41978451|NCT01248793|75783049|FG001|Overall Study|Adverse Event|1|||
41978452|NCT01248793|75783048|FG000|Overall Study|Protocol Violation|0|||
41978453|NCT01248793|75783049|FG001|Overall Study|Protocol Violation|1|||
41978454|NCT01248793|75783048|FG000|Overall Study|Withdrawal by Subject|3|||
41978455|NCT01248793|75783049|FG001|Overall Study|Withdrawal by Subject|3|||
42129551|NCT00440193|75940592|FG001|Treatment Period|Withdrawal by Subject|77|||
42218239|NCT03681119|76036098|FG000|Overall Study|No specific reason|4|||
42218240|NCT03681119|76036099|FG001|Overall Study|No specific reason|0|||
42218241|NCT03681119|76036098|FG000|Overall Study|Sickness|2|||
42218242|NCT03681119|76036099|FG001|Overall Study|Sickness|0|||
42218243|NCT03111108|76036105|FG000|Overall Study|Death|0|||
42218244|NCT03111108|76036106|FG001|Overall Study|Death|1|||
42218245|NCT03111108|76036105|FG000|Overall Study|Withdrawal by Subject|1|||
42218246|NCT03111108|76036106|FG001|Overall Study|Withdrawal by Subject|0|||
42218247|NCT03677375|76036112|FG000|Overall Study|Incomplete procedure|8|||
42218248|NCT03677375|76036112|FG000|Overall Study|Adverse Event|3|||
42218249|NCT03677375|76036112|FG000|Overall Study|Physician Decision|1|||
42218250|NCT00702520|76036118|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
42218251|NCT00702520|76036119|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
42218252|NCT00702520|76036120|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
42218253|NCT00702520|76036121|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
42218254|NCT00702520|76036118|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
42218255|NCT00702520|76036119|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
42218256|NCT00702520|76036120|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
42218257|NCT00702520|76036121|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
42218258|NCT00702520|76036118|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
42218259|NCT00702520|76036119|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
42218260|NCT00702520|76036120|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
42218261|NCT00702520|76036121|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
42218262|NCT04067141|76036131|FG000|First Intervention|Withdrawal by Subject|0|||
42218263|NCT04067141|76036132|FG001|First Intervention|Withdrawal by Subject|1|||
42218264|NCT04067141|76036131|FG000|Second Intervention|Adverse Event|0|||
42218265|NCT04067141|76036132|FG001|Second Intervention|Adverse Event|2|||
42218266|NCT02876601|76036142|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
42218267|NCT02876601|76036143|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
42218268|NCT02876601|76036144|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
42129552|NCT00440193|75940591|FG000|Treatment Period|Clinical endpoint reached|28|||
42129553|NCT00440193|75940592|FG001|Treatment Period|Clinical endpoint reached|25|||
42129554|NCT00440193|75940591|FG000|Treatment Period|Study terminated by sponsor|102|||
42129555|NCT00440193|75940592|FG001|Treatment Period|Study terminated by sponsor|94|||
42129556|NCT00440193|75940591|FG000|Treatment Period|Protocol driven decision point|2|||
42129557|NCT00440193|75940592|FG001|Treatment Period|Protocol driven decision point|2|||
42129558|NCT00440193|75940591|FG000|Treatment Period|Switch to commercial drug|0|||
42129559|NCT00440193|75940592|FG001|Treatment Period|Switch to commercial drug|2|||
42129560|NCT00440193|75940591|FG000|Treatment Period|Technical problems|1|||
42218269|NCT02876601|76036145|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
42218270|NCT04054193|76036190|FG000|Cycle 1|Physician Decision|1|||
41978456|NCT01248364|75783059|FG000|Overall Study|Adverse Event|0|||
41978457|NCT01248364|75783060|FG001|Overall Study|Adverse Event|1|||
41978458|NCT01248364|75783061|FG002|Overall Study|Adverse Event|0|||
42129561|NCT00440193|75940592|FG001|Treatment Period|Technical problems|1|||
42129562|NCT00440193|75940591|FG000|Treatment Period|Participant convenience|5|||
42218271|NCT04054193|76036190|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
42218272|NCT04054193|76036190|FG000|Cycle 1|Allocated but not treated|3|||
41978459|NCT01248364|75783062|FG003|Overall Study|Adverse Event|0|||
41978460|NCT01248130|75783074|FG000|Overall Study|Protocol Violation|1|||
41978461|NCT01248130|75783075|FG001|Overall Study|Protocol Violation|0|||
41978462|NCT01248130|75783074|FG000|Overall Study|Ineligible|1|||
41978463|NCT01248130|75783075|FG001|Overall Study|Ineligible|0|||
41978464|NCT01248013|75783081|FG000|Overall Study|Withdrawal by Subject|14|||
41978465|NCT01247350|75783090|FG000|Overall Study|Adverse Event|0|||
41978466|NCT01247350|75783091|FG001|Overall Study|Adverse Event|0|||
41978467|NCT01247350|75783092|FG002|Overall Study|Adverse Event|1|||
41978468|NCT01247350|75783093|FG003|Overall Study|Adverse Event|0|||
41978469|NCT01247350|75783094|FG004|Overall Study|Adverse Event|0|||
41978470|NCT01247350|75783090|FG000|Overall Study|Withdrawal by Subject|0|||
41978471|NCT01247350|75783091|FG001|Overall Study|Withdrawal by Subject|0|||
41978472|NCT01247350|75783092|FG002|Overall Study|Withdrawal by Subject|0|||
41978473|NCT01247350|75783093|FG003|Overall Study|Withdrawal by Subject|1|||
41978474|NCT01247350|75783094|FG004|Overall Study|Withdrawal by Subject|0|||
41978475|NCT01247350|75783090|FG000|Overall Study|Entry criteria not met|0|||
41978476|NCT01247350|75783091|FG001|Overall Study|Entry criteria not met|0|||
42028565|NCT00910624|75836999|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
42028566|NCT00910624|75836996|FG000|Treatment Phase|Withdrawal by Subject|2|||
42028567|NCT00910624|75836997|FG001|Treatment Phase|Withdrawal by Subject|1|||
42028568|NCT00910624|75836998|FG002|Treatment Phase|Withdrawal by Subject|0|||
42028569|NCT00910624|75836999|FG003|Treatment Phase|Withdrawal by Subject|0|||
42028570|NCT00910624|75836996|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
42302156|NCT02482129|76137233|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
42129563|NCT00440193|75940592|FG001|Treatment Period|Participant convenience|2|||
42129564|NCT00440193|75940591|FG000|Treatment Period|Participant did not receive treatment|7|||
42129565|NCT00440193|75940592|FG001|Treatment Period|Participant did not receive treatment|13|||
42129566|NCT00440193|75940591|FG000|Treatment Period|Site closed by investigator|0|||
42129567|NCT00440193|75940592|FG001|Treatment Period|Site closed by investigator|2|||
41978477|NCT01247350|75783092|FG002|Overall Study|Entry criteria not met|0|||
41978478|NCT01247350|75783093|FG003|Overall Study|Entry criteria not met|0|||
41978479|NCT01247350|75783094|FG004|Overall Study|Entry criteria not met|1|||
42028571|NCT00910624|75836997|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
42302157|NCT02482129|76137234|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
41978480|NCT01246999|75783124|FG000|Overall Study|Lost to Follow-up|0|||
42129568|NCT00440193|75940591|FG000|Observational Period|Adverse Event|2|||
42129569|NCT00440193|75940592|FG001|Observational Period|Adverse Event|2|||
42129570|NCT00440193|75940591|FG000|Observational Period|Death|15|||
42129571|NCT00440193|75940592|FG001|Observational Period|Death|20|||
42129572|NCT00440193|75940591|FG000|Observational Period|Lost to Follow-up|12|||
41978481|NCT01246999|75783125|FG001|Overall Study|Lost to Follow-up|1|||
41978482|NCT01246999|75783126|FG002|Overall Study|Lost to Follow-up|0|||
41978483|NCT01246999|75783127|FG003|Overall Study|Lost to Follow-up|0|||
41978484|NCT01246999|75783124|FG000|Overall Study|Withdrawal by Subject|0|||
41978485|NCT01246999|75783125|FG001|Overall Study|Withdrawal by Subject|0|||
41978486|NCT01246999|75783126|FG002|Overall Study|Withdrawal by Subject|0|||
41978487|NCT01246999|75783127|FG003|Overall Study|Withdrawal by Subject|2|||
41978488|NCT01245751|75783149|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
41978489|NCT01245751|75783150|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
41978490|NCT01245751|75783151|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
41978491|NCT01245751|75783152|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
41978492|NCT01245751|75783149|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
41978493|NCT01245751|75783150|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
41978494|NCT01245751|75783151|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
41978495|NCT01245751|75783152|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
41978496|NCT01245751|75783149|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
41978497|NCT01245751|75783150|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
41978498|NCT01245751|75783151|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
41978499|NCT01245751|75783152|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
41978500|NCT01245673|75783163|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
41978501|NCT01245283|75783170|FG000|Overall Study|Lost to Follow-up|14|||
41978502|NCT01245283|75783171|FG001|Overall Study|Lost to Follow-up|11|||
41978503|NCT01245283|75783172|FG002|Overall Study|Lost to Follow-up|11|||
41978504|NCT01245049|75783185|FG000|Overall Study|Migrated/moved from study area|0|||
41978505|NCT01245049|75783186|FG001|Overall Study|Migrated/moved from study area|1|||
41978506|NCT01245049|75783185|FG000|Overall Study|Withdrawal by Subject|0|||
41978507|NCT01245049|75783186|FG001|Overall Study|Withdrawal by Subject|1|||
41978508|NCT01245049|75783185|FG000|Overall Study|Lost to Follow-up|1|||
41978509|NCT01245049|75783186|FG001|Overall Study|Lost to Follow-up|2|||
41978510|NCT01244893|75783192|FG000|Baseline|Protocol Violation|0|||
41978511|NCT01244893|75783193|FG001|Baseline|Protocol Violation|1|||
41978512|NCT01244893|75783192|FG000|1-Week Follow Up|Lost to Follow-up|1|||
41978513|NCT01244893|75783193|FG001|1-Week Follow Up|Lost to Follow-up|0|||
41978514|NCT01244815|75783208|FG000|Overall Study|Not Treated|0|||
41978515|NCT01244815|75783209|FG001|Overall Study|Not Treated|1|||
41978516|NCT01244815|75783210|FG002|Overall Study|Not Treated|0|||
41978517|NCT01244815|75783211|FG003|Overall Study|Not Treated|0|||
41978518|NCT01244815|75783208|FG000|Overall Study|Adverse Event|4|||
41978519|NCT01244815|75783209|FG001|Overall Study|Adverse Event|7|||
41978520|NCT01244815|75783210|FG002|Overall Study|Adverse Event|5|||
41978521|NCT01244815|75783211|FG003|Overall Study|Adverse Event|5|||
41978522|NCT01244815|75783208|FG000|Overall Study|Treatment Failure|0|||
41978523|NCT01244815|75783209|FG001|Overall Study|Treatment Failure|0|||
41978524|NCT01244815|75783210|FG002|Overall Study|Treatment Failure|0|||
41978525|NCT01244815|75783211|FG003|Overall Study|Treatment Failure|1|||
41978526|NCT01244815|75783208|FG000|Overall Study|Lost to Follow-up|3|||
41978527|NCT01244815|75783209|FG001|Overall Study|Lost to Follow-up|2|||
41978528|NCT01244815|75783210|FG002|Overall Study|Lost to Follow-up|3|||
41978529|NCT01244815|75783211|FG003|Overall Study|Lost to Follow-up|2|||
41978530|NCT01244815|75783208|FG000|Overall Study|Withdrawal by Subject|0|||
41978531|NCT01244815|75783209|FG001|Overall Study|Withdrawal by Subject|2|||
41978532|NCT01244815|75783210|FG002|Overall Study|Withdrawal by Subject|0|||
41978533|NCT01244815|75783211|FG003|Overall Study|Withdrawal by Subject|3|||
41978534|NCT01244815|75783208|FG000|Overall Study|Protocol Violation|7|||
41978535|NCT01244815|75783209|FG001|Overall Study|Protocol Violation|4|||
41978536|NCT01244815|75783210|FG002|Overall Study|Protocol Violation|3|||
41978537|NCT01244815|75783211|FG003|Overall Study|Protocol Violation|1|||
41978538|NCT01244815|75783208|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
41978539|NCT01244815|75783209|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
41978540|NCT01244815|75783210|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
41978541|NCT01244815|75783211|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
41978542|NCT01244425|75783223|FG000|Overall Study|Withdrawal by Subject|2|||
41978543|NCT01244425|75783224|FG001|Overall Study|Withdrawal by Subject|2|||
41978544|NCT01244425|75783223|FG000|Overall Study|Adverse Event|1|||
41978545|NCT01244425|75783224|FG001|Overall Study|Adverse Event|1|||
41978546|NCT01244191|75783240|FG000|Overall Study|Progressive disease|295|||
41978547|NCT01244191|75783241|FG001|Overall Study|Progressive disease|350|||
41978548|NCT01244191|75783240|FG000|Overall Study|Clinical disease progression|54|||
41978549|NCT01244191|75783241|FG001|Overall Study|Clinical disease progression|36|||
41978550|NCT01244191|75783240|FG000|Overall Study|Adverse Event|65|||
41978551|NCT01244191|75783241|FG001|Overall Study|Adverse Event|48|||
41978552|NCT01244191|75783240|FG000|Overall Study|Death|22|||
41978553|NCT01244191|75783241|FG001|Overall Study|Death|29|||
41978554|NCT01244191|75783240|FG000|Overall Study|Lost to Follow-up|0|||
41978555|NCT01244191|75783241|FG001|Overall Study|Lost to Follow-up|2|||
41978556|NCT01244191|75783240|FG000|Overall Study|Protocol Violation|1|||
41978557|NCT01244191|75783241|FG001|Overall Study|Protocol Violation|2|||
41978558|NCT01244191|75783240|FG000|Overall Study|Withdrawal by Subject|31|||
41978559|NCT01244191|75783241|FG001|Overall Study|Withdrawal by Subject|23|||
41978560|NCT01244191|75783240|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
41978561|NCT01244191|75783241|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
41978562|NCT01244035|75783247|FG000|Part 1: Period 1|Adverse Event|0|||
41978563|NCT01244035|75783248|FG001|Part 1: Period 1|Adverse Event|0|||
41978564|NCT01244035|75783249|FG002|Part 1: Period 1|Adverse Event|0|||
41978565|NCT01244035|75783250|FG003|Part 1: Period 1|Adverse Event|0|||
41978566|NCT01244035|75783251|FG004|Part 1: Period 1|Adverse Event|0|||
41978567|NCT01244035|75783252|FG005|Part 1: Period 1|Adverse Event|1|||
41978568|NCT01244035|75783247|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
41978569|NCT01244035|75783248|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
41978570|NCT01244035|75783249|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
41978571|NCT01244035|75783250|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
41978572|NCT01244035|75783251|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
42129573|NCT00440193|75940592|FG001|Observational Period|Lost to Follow-up|8|||
42218273|NCT04054193|76036190|FG000|Cycles 2-3|Physician Decision|2|||
42218274|NCT04054193|76036190|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
41978573|NCT01244035|75783252|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
41978574|NCT01244035|75783247|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
41978575|NCT01244035|75783248|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
41978576|NCT01244035|75783249|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
41978577|NCT01244035|75783250|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
41978578|NCT01244035|75783251|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
41978579|NCT01244035|75783252|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
41978580|NCT01244035|75783247|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
41978581|NCT01244035|75783248|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
41978582|NCT01244035|75783249|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
41978583|NCT01244035|75783250|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
41978584|NCT01244035|75783251|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
41978585|NCT01244035|75783252|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
42218275|NCT04054193|76036190|FG000|Cycles 2-3|Various reasons|17|||
42218276|NCT03394027|76036198|FG000|Overall Study|Ineligible|3|||
42218277|NCT03394027|76036199|FG001|Overall Study|Ineligible|1|||
42218278|NCT03394027|76036200|FG002|Overall Study|Ineligible|3|||
42218279|NCT03394027|76036198|FG000|Overall Study|Participant declined to participate before treatment started|0|||
42218280|NCT03394027|76036199|FG001|Overall Study|Participant declined to participate before treatment started|0|||
42218281|NCT03394027|76036200|FG002|Overall Study|Participant declined to participate before treatment started|1|||
42218282|NCT03136107|76036226|FG000|Overall Study|Other (Not specified)|1|||
42218283|NCT02916056|76036234|FG000|Overall Study|Adverse Event|6|||
42218284|NCT02916056|76036234|FG000|Overall Study|Lost to Follow-up|1|||
41978586|NCT01244035|75783247|FG000|Part 1: Period 3|Adverse Event|0|||
42129574|NCT00440193|75940591|FG000|Observational Period|Protocol Violation|1|||
42129575|NCT00440193|75940592|FG001|Observational Period|Protocol Violation|0|||
42129576|NCT00440193|75940591|FG000|Observational Period|Withdrawal by Subject|11|||
42129577|NCT00440193|75940592|FG001|Observational Period|Withdrawal by Subject|8|||
42129578|NCT00440193|75940591|FG000|Observational Period|Physician Decision|1|||
42129579|NCT00440193|75940592|FG001|Observational Period|Physician Decision|0|||
42129580|NCT00440193|75940591|FG000|Observational Period|Clinical endpoint reached|1|||
42129581|NCT00440193|75940592|FG001|Observational Period|Clinical endpoint reached|0|||
42129582|NCT00440193|75940591|FG000|Observational Period|Participant convenience|2|||
42129583|NCT00440193|75940592|FG001|Observational Period|Participant convenience|0|||
42129584|NCT00511472|75940600|FG000|Overall Study|Clinical Adverse Event|1|||
42218285|NCT02916056|76036234|FG000|Overall Study|Other|12|||
42218286|NCT02916056|76036234|FG000|Overall Study|Protocol Violation|1|||
41978587|NCT01244035|75783248|FG001|Part 1: Period 3|Adverse Event|0|||
41978588|NCT01244035|75783249|FG002|Part 1: Period 3|Adverse Event|0|||
41978589|NCT01244035|75783250|FG003|Part 1: Period 3|Adverse Event|0|||
41978590|NCT01244035|75783251|FG004|Part 1: Period 3|Adverse Event|0|||
41978591|NCT01244035|75783252|FG005|Part 1: Period 3|Adverse Event|1|||
41978592|NCT01244035|75783247|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
41978593|NCT01244035|75783248|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
41978594|NCT01244035|75783249|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
41978595|NCT01244035|75783250|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
41978596|NCT01244035|75783251|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
41978597|NCT01244035|75783252|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
41978598|NCT01244035|75783247|FG000|Part 1: Period 3|Protocol Deviation|0|||
41978599|NCT01244035|75783248|FG001|Part 1: Period 3|Protocol Deviation|1|||
41978600|NCT01244035|75783249|FG002|Part 1: Period 3|Protocol Deviation|0|||
41978601|NCT01244035|75783250|FG003|Part 1: Period 3|Protocol Deviation|0|||
41978602|NCT01244035|75783251|FG004|Part 1: Period 3|Protocol Deviation|0|||
41978603|NCT01244035|75783252|FG005|Part 1: Period 3|Protocol Deviation|0|||
41978604|NCT01243762|75783288|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
41978605|NCT01243762|75783289|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
41978606|NCT01243762|75783290|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
41978607|NCT01243762|75783291|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
41978608|NCT01243762|75783292|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
41978609|NCT01243762|75783293|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
41978610|NCT01243762|75783294|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
41978611|NCT01243762|75783288|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
41978612|NCT01243762|75783289|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
41978613|NCT01243762|75783290|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
41978614|NCT01243762|75783291|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
41978615|NCT01243762|75783292|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
41978616|NCT01243762|75783293|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
41978617|NCT01243762|75783294|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
41978618|NCT01243762|75783288|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
41978619|NCT01243762|75783289|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
41978620|NCT01243762|75783290|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
41978621|NCT01243762|75783291|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
41978622|NCT01243762|75783292|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
41978623|NCT01243762|75783293|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
41978624|NCT01243762|75783294|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
41978625|NCT01243762|75783288|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
41978626|NCT01243762|75783289|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
41978627|NCT01243762|75783290|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
41978628|NCT01243762|75783291|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
41978629|NCT01243762|75783292|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
41978630|NCT01243762|75783293|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
41978631|NCT01243762|75783294|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
41978632|NCT01243762|75783288|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
41978633|NCT01243762|75783289|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
41978634|NCT01243762|75783290|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
41978635|NCT01243762|75783291|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
41978636|NCT01243762|75783292|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
41978637|NCT01243762|75783293|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
41978638|NCT01243762|75783294|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
41978639|NCT01243762|75783288|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
41978640|NCT01243762|75783289|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
41978641|NCT01243762|75783290|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
41978642|NCT01243762|75783291|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
41978643|NCT01243762|75783292|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
41978644|NCT01243762|75783293|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
41978645|NCT01243762|75783294|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
41978646|NCT01243762|75783288|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
41978647|NCT01243762|75783289|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
41978648|NCT01243762|75783290|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
41978649|NCT01243762|75783291|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
41978650|NCT01243762|75783292|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
41978651|NCT01243762|75783293|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
41978652|NCT01243762|75783294|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
41978653|NCT01243762|75783288|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
41978654|NCT01243762|75783289|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
41978655|NCT01243762|75783290|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
41978656|NCT01243762|75783291|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
41978657|NCT01243762|75783292|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
42218287|NCT02916056|76036234|FG000|Overall Study|Withdrawal by Subject|8|||
42218288|NCT02916056|76036234|FG000|Overall Study|Study Terminated by Sponsor|269|||
42218289|NCT03384745|76036244|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
41978658|NCT01243762|75783293|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
41978659|NCT01243762|75783294|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
41978660|NCT01243411|75783313|FG000|Overall Study|Withdrawal by Subject|18|||
41978661|NCT01243411|75783313|FG000|Overall Study|Lost to Follow-up|10|||
42218290|NCT03384745|76036245|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
41978662|NCT01243411|75783313|FG000|Overall Study|Adverse Event|5|||
41978663|NCT01243411|75783313|FG000|Overall Study|Other|8|||
41978664|NCT01243177|75783319|FG000|Overall Study|Lack of Efficacy|47|||
41978665|NCT01243177|75783320|FG001|Overall Study|Lack of Efficacy|31|||
41978666|NCT01243177|75783319|FG000|Overall Study|Protocol Violation|11|||
41978667|NCT01243177|75783320|FG001|Overall Study|Protocol Violation|10|||
41978668|NCT01243177|75783319|FG000|Overall Study|Lost to Follow-up|15|||
41978669|NCT01243177|75783320|FG001|Overall Study|Lost to Follow-up|18|||
41978670|NCT01243177|75783319|FG000|Overall Study|Withdrawal by Subject|46|||
41978671|NCT01243177|75783320|FG001|Overall Study|Withdrawal by Subject|38|||
41978672|NCT01243177|75783319|FG000|Overall Study|AE, serious fatal|0|||
41978673|NCT01243177|75783320|FG001|Overall Study|AE, serious fatal|1|||
41978674|NCT01243177|75783319|FG000|Overall Study|SAE, non-fatal|7|||
41978675|NCT01243177|75783320|FG001|Overall Study|SAE, non-fatal|9|||
41978676|NCT01243177|75783319|FG000|Overall Study|AE, non-serious non-fatal|40|||
41978677|NCT01243177|75783320|FG001|Overall Study|AE, non-serious non-fatal|58|||
41978678|NCT01243177|75783319|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
41978679|NCT01243177|75783320|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
41978680|NCT01243177|75783319|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
41978681|NCT01243177|75783320|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
41978682|NCT01243177|75783319|FG000|Overall Study|Other Reason|11|||
42218291|NCT03384745|76036246|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
42218292|NCT03384745|76036247|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
42218293|NCT03384745|76036248|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
42218294|NCT03384745|76036249|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
42218295|NCT03384745|76036244|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
42218296|NCT03384745|76036245|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
41978683|NCT01243177|75783320|FG001|Overall Study|Other Reason|12|||
41978684|NCT01242748|75783328|FG000|Overall Study|Adverse Event|10|||
41978685|NCT01242748|75783329|FG001|Overall Study|Adverse Event|5|||
41978686|NCT01242748|75783328|FG000|Overall Study|Lost to Follow-up|6|||
41978687|NCT01242748|75783329|FG001|Overall Study|Lost to Follow-up|2|||
41978688|NCT01242748|75783328|FG000|Overall Study|Physician Decision|3|||
41978689|NCT01242748|75783329|FG001|Overall Study|Physician Decision|2|||
41978690|NCT01242748|75783328|FG000|Overall Study|Protocol Violation|1|||
41978691|NCT01242748|75783329|FG001|Overall Study|Protocol Violation|0|||
41978692|NCT01242748|75783328|FG000|Overall Study|Withdrawal by Subject|10|||
41978693|NCT01242748|75783329|FG001|Overall Study|Withdrawal by Subject|2|||
41978694|NCT01242748|75783328|FG000|Overall Study|Miscellaneous reasons|8|||
41978695|NCT01242748|75783329|FG001|Overall Study|Miscellaneous reasons|3|||
41978696|NCT01242514|75783338|FG000|Overall Study|e.g., project closure|1042|||
41978697|NCT01242514|75783339|FG001|Overall Study|e.g., project closure|305|||
41978698|NCT01242514|75783340|FG002|Overall Study|e.g., project closure|171|||
41978699|NCT01242514|75783338|FG000|Overall Study|Subject decision|33|||
41978700|NCT01242514|75783339|FG001|Overall Study|Subject decision|8|||
41978701|NCT01242514|75783340|FG002|Overall Study|Subject decision|2|||
41978702|NCT01242514|75783338|FG000|Overall Study|Severe non-compliance to protocol|5|||
42218297|NCT03384745|76036246|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
41978703|NCT01242514|75783339|FG001|Overall Study|Severe non-compliance to protocol|2|||
41978704|NCT01242514|75783340|FG002|Overall Study|Severe non-compliance to protocol|1|||
41978705|NCT01242514|75783338|FG000|Overall Study|Lack of therapeutic response|99|||
41978706|NCT01242514|75783339|FG001|Overall Study|Lack of therapeutic response|16|||
41978707|NCT01242514|75783340|FG002|Overall Study|Lack of therapeutic response|10|||
41978708|NCT01242514|75783338|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
41978709|NCT01242514|75783339|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
41978710|NCT01242514|75783340|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
41978711|NCT01242514|75783338|FG000|Overall Study|Lost to Follow-up|14|||
41978712|NCT01242514|75783339|FG001|Overall Study|Lost to Follow-up|5|||
41978713|NCT01242514|75783340|FG002|Overall Study|Lost to Follow-up|4|||
41978714|NCT01242514|75783338|FG000|Overall Study|Adverse Event|129|||
41978715|NCT01242514|75783339|FG001|Overall Study|Adverse Event|18|||
41978716|NCT01242514|75783340|FG002|Overall Study|Adverse Event|19|||
42129585|NCT00511472|75940601|FG001|Overall Study|Clinical Adverse Event|2|||
42129586|NCT00511472|75940600|FG000|Overall Study|Laboratory Adverse Event|0|||
42129587|NCT00511472|75940601|FG001|Overall Study|Laboratory Adverse Event|2|||
42129588|NCT00511472|75940600|FG000|Overall Study|Not reported|2|||
42302158|NCT02482129|76137233|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
41978717|NCT01242085|75783351|FG000|Overall Study|Withdrawal by Subject|4|||
41978718|NCT01242085|75783352|FG001|Overall Study|Withdrawal by Subject|2|||
41978719|NCT01242085|75783353|FG002|Overall Study|Withdrawal by Subject|0|||
42302159|NCT02482129|76137234|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
41978720|NCT01242085|75783351|FG000|Overall Study|medically unable to have surgery|4|||
41978721|NCT01242085|75783352|FG001|Overall Study|medically unable to have surgery|5|||
41978722|NCT01242085|75783353|FG002|Overall Study|medically unable to have surgery|0|||
41978723|NCT01241461|75783361|FG000|Overall Study|Progressive Disease|3|||
41978724|NCT01241461|75783362|FG001|Overall Study|Progressive Disease|6|||
41978725|NCT01240135|75783374|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
41978726|NCT01240135|75783375|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
41978727|NCT01240135|75783374|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
41978728|NCT01240135|75783375|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
41978729|NCT01247701|75783381|FG000|Overall Study|Death|2|||
41978730|NCT01247701|75783381|FG000|Overall Study|Relapsed|8|||
41978731|NCT01248247|75783389|FG000|Overall Study|Adverse Event|2|||
41978732|NCT01248247|75783390|FG001|Overall Study|Adverse Event|4|||
41978733|NCT01248247|75783391|FG002|Overall Study|Adverse Event|4|||
41978734|NCT01248247|75783392|FG003|Overall Study|Adverse Event|2|||
41978735|NCT01248247|75783389|FG000|Overall Study|Death|0|||
41978736|NCT01248247|75783390|FG001|Overall Study|Death|1|||
41978737|NCT01248247|75783391|FG002|Overall Study|Death|4|||
41978738|NCT01248247|75783392|FG003|Overall Study|Death|7|||
41978739|NCT01248247|75783389|FG000|Overall Study|Lost to Follow-up|0|||
41978740|NCT01248247|75783390|FG001|Overall Study|Lost to Follow-up|1|||
41978741|NCT01248247|75783391|FG002|Overall Study|Lost to Follow-up|1|||
41978742|NCT01248247|75783392|FG003|Overall Study|Lost to Follow-up|0|||
41978743|NCT01248247|75783389|FG000|Overall Study|Alternative treatment|0|||
41978744|NCT01248247|75783390|FG001|Overall Study|Alternative treatment|1|||
41978745|NCT01248247|75783391|FG002|Overall Study|Alternative treatment|0|||
41978746|NCT01248247|75783392|FG003|Overall Study|Alternative treatment|0|||
41978747|NCT01248247|75783389|FG000|Overall Study|Other|2|||
41978748|NCT01248247|75783390|FG001|Overall Study|Other|8|||
41978749|NCT01248247|75783391|FG002|Overall Study|Other|8|||
41978750|NCT01248247|75783392|FG003|Overall Study|Other|5|||
41978751|NCT01248247|75783389|FG000|Overall Study|Progression|18|||
41978752|NCT01248247|75783390|FG001|Overall Study|Progression|27|||
41978753|NCT01248247|75783391|FG002|Overall Study|Progression|56|||
41978754|NCT01248247|75783392|FG003|Overall Study|Progression|44|||
41978755|NCT01248247|75783389|FG000|Overall Study|Refuse further treatment|0|||
41978756|NCT01248247|75783390|FG001|Overall Study|Refuse further treatment|0|||
41978757|NCT01248247|75783391|FG002|Overall Study|Refuse further treatment|1|||
41978758|NCT01248247|75783392|FG003|Overall Study|Refuse further treatment|2|||
41978759|NCT01248247|75783389|FG000|Overall Study|Complicating disease|0|||
41978760|NCT01248247|75783390|FG001|Overall Study|Complicating disease|0|||
41978761|NCT01248247|75783391|FG002|Overall Study|Complicating disease|1|||
41978762|NCT01248247|75783392|FG003|Overall Study|Complicating disease|1|||
41978763|NCT02598583|75783404|FG000|Extension Period|Withdrawal by Subject|1|||
41978764|NCT02598583|75783405|FG001|Extension Period|Withdrawal by Subject|0|||
41978765|NCT05172050|75783481|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
41978766|NCT05172050|75783482|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
41978767|NCT05172050|75783483|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
41978768|NCT05172050|75783481|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
41978769|NCT05172050|75783482|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
41978770|NCT05172050|75783483|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
41978771|NCT05172050|75783481|FG000|Overall Study|Other|2|||
41978772|NCT05172050|75783482|FG001|Overall Study|Other|2|||
41978773|NCT05172050|75783483|FG002|Overall Study|Other|1|||
41978774|NCT04924062|75783496|FG000|Overall Study|Death|49|||
41978775|NCT04924062|75783497|FG001|Overall Study|Death|63|||
41978776|NCT04924062|75783496|FG000|Overall Study|Participant On-going|26|||
41978777|NCT04924062|75783497|FG001|Overall Study|Participant On-going|20|||
41978778|NCT04826484|75783505|FG000|Overall Study|Lost to Follow-up|2|||
41978779|NCT04826484|75783506|FG001|Overall Study|Lost to Follow-up|0|||
41978780|NCT04820842|75783515|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
41978781|NCT04820842|75783516|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
41978782|NCT04820842|75783517|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
41978783|NCT04820842|75783518|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
41978784|NCT04820842|75783519|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
41978785|NCT04820842|75783520|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
41978786|NCT04820842|75783521|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
41978787|NCT04820842|75783515|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
41978788|NCT04820842|75783516|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
41978789|NCT04820842|75783517|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
41978790|NCT04820842|75783518|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
41978791|NCT04820842|75783519|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
42129589|NCT00511472|75940601|FG001|Overall Study|Not reported|2|||
41978792|NCT04820842|75783520|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
41978793|NCT04820842|75783521|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
41978794|NCT04820842|75783515|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
41978795|NCT04820842|75783516|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
41978796|NCT04820842|75783517|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
41978797|NCT04820842|75783518|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
41978798|NCT04820842|75783519|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
41978799|NCT04820842|75783520|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
41978800|NCT04820842|75783521|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
41978801|NCT04820842|75783515|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
41978802|NCT04820842|75783516|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
41978803|NCT04820842|75783517|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
42010478|NCT00993499|75817615|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
42010479|NCT00993499|75817616|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
42010480|NCT00993499|75817611|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
42010481|NCT00993499|75817612|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
42218298|NCT03384745|76036247|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
42218299|NCT03384745|76036248|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
42218300|NCT03384745|76036249|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
42129590|NCT00514904|75940618|FG000|Overall Study|Withdrawal by Subject|3|||
42129591|NCT00514904|75940619|FG001|Overall Study|Withdrawal by Subject|2|||
42129592|NCT00514904|75940618|FG000|Overall Study|Lost to Follow-up|21|||
42129593|NCT00514904|75940619|FG001|Overall Study|Lost to Follow-up|3|||
42129594|NCT00440115|75940628|FG000|Overall Study|Death|7|||
42129595|NCT00440115|75940629|FG001|Overall Study|Death|9|||
42129596|NCT00440115|75940630|FG002|Overall Study|Death|5|||
42129597|NCT00440115|75940628|FG000|Overall Study|Incarceration|0|||
42129598|NCT00440115|75940629|FG001|Overall Study|Incarceration|2|||
42129599|NCT00440115|75940630|FG002|Overall Study|Incarceration|1|||
42129600|NCT00440037|75940638|FG000|Overall Study|Withdrawal by Subject|6|||
42129601|NCT00440037|75940638|FG000|Overall Study|Administrative decision|3|||
42129602|NCT00417027|75940645|FG000|Overall Study|Protocol Violation|0|||
42129603|NCT00417027|75940646|FG001|Overall Study|Protocol Violation|5|||
42129604|NCT00417027|75940647|FG002|Overall Study|Protocol Violation|5|||
42129605|NCT00416949|75940655|FG000|Overall Study|Patients refused to participate|5|||
42129606|NCT00416715|75940659|FG000|Overall Study|Not evaluable for joint aches|7|||
42129607|NCT00416715|75940659|FG000|Overall Study|Vitamin D levels not evaluable|8|||
42129608|NCT00406029|75940671|FG000|Overall Study|Adverse Event|12|||
42129609|NCT00406029|75940672|FG001|Overall Study|Adverse Event|2|||
42129610|NCT00406029|75940673|FG002|Overall Study|Adverse Event|5|||
42129611|NCT00406029|75940674|FG003|Overall Study|Adverse Event|10|||
42129612|NCT00406029|75940675|FG004|Overall Study|Adverse Event|7|||
42129613|NCT00406029|75940671|FG000|Overall Study|Withdrawal by Subject|3|||
42129614|NCT00406029|75940672|FG001|Overall Study|Withdrawal by Subject|4|||
42129615|NCT00406029|75940673|FG002|Overall Study|Withdrawal by Subject|2|||
42129616|NCT00406029|75940674|FG003|Overall Study|Withdrawal by Subject|2|||
42129617|NCT00406029|75940675|FG004|Overall Study|Withdrawal by Subject|0|||
42129618|NCT00406029|75940671|FG000|Overall Study|Protocol Violation|1|||
42129619|NCT00406029|75940672|FG001|Overall Study|Protocol Violation|2|||
42129620|NCT00406029|75940673|FG002|Overall Study|Protocol Violation|0|||
42129621|NCT00406029|75940674|FG003|Overall Study|Protocol Violation|2|||
42129622|NCT00406029|75940675|FG004|Overall Study|Protocol Violation|0|||
42129623|NCT00406029|75940671|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
42129624|NCT00406029|75940672|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
42129625|NCT00406029|75940673|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
42129626|NCT00406029|75940674|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
42129627|NCT00406029|75940675|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
42129628|NCT00406029|75940671|FG000|Overall Study|Randomized in Error|0|||
42129629|NCT00406029|75940672|FG001|Overall Study|Randomized in Error|0|||
42129630|NCT00406029|75940673|FG002|Overall Study|Randomized in Error|2|||
42129631|NCT00406029|75940674|FG003|Overall Study|Randomized in Error|3|||
42028572|NCT00910624|75836998|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
42218301|NCT03384745|76036244|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
42218302|NCT03384745|76036245|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
42129632|NCT00406029|75940675|FG004|Overall Study|Randomized in Error|1|||
42129633|NCT00514514|75940690|FG000|Pre-phase|Death|10|||
42129634|NCT00514514|75940691|FG001|Pre-phase|Death|0|||
42129635|NCT00514514|75940692|FG002|Pre-phase|Death|0|||
42129636|NCT00514514|75940690|FG000|Pre-phase|administrative problems|2|||
42129637|NCT00514514|75940691|FG001|Pre-phase|administrative problems|0|||
42129638|NCT00514514|75940692|FG002|Pre-phase|administrative problems|0|||
42129639|NCT00514514|75940690|FG000|Pre-phase|Protocol Violation|6|||
42129640|NCT00514514|75940691|FG001|Pre-phase|Protocol Violation|0|||
42129641|NCT00514514|75940692|FG002|Pre-phase|Protocol Violation|0|||
42129642|NCT00514514|75940690|FG000|Pre-phase|condition no longer requires study drug|7|||
42129643|NCT00514514|75940691|FG001|Pre-phase|condition no longer requires study drug|0|||
42129644|NCT00514514|75940692|FG002|Pre-phase|condition no longer requires study drug|0|||
42129645|NCT00514514|75940690|FG000|Pre-phase|abnormal test procedure results|15|||
42129646|NCT00514514|75940691|FG001|Pre-phase|abnormal test procedure results|0|||
42129647|NCT00514514|75940692|FG002|Pre-phase|abnormal test procedure results|0|||
42129648|NCT00514514|75940690|FG000|Pre-phase|Lost to Follow-up|2|||
42129649|NCT00514514|75940691|FG001|Pre-phase|Lost to Follow-up|0|||
42129650|NCT00514514|75940692|FG002|Pre-phase|Lost to Follow-up|0|||
42129651|NCT00514514|75940690|FG000|Pre-phase|abnormal lab values|23|||
42129652|NCT00514514|75940691|FG001|Pre-phase|abnormal lab values|0|||
42129653|NCT00514514|75940692|FG002|Pre-phase|abnormal lab values|0|||
42129654|NCT00514514|75940690|FG000|Pre-phase|Lack of Efficacy|35|||
42129655|NCT00514514|75940691|FG001|Pre-phase|Lack of Efficacy|0|||
42129656|NCT00514514|75940692|FG002|Pre-phase|Lack of Efficacy|0|||
42129657|NCT00514514|75940690|FG000|Pre-phase|Adverse Event|137|||
42129658|NCT00514514|75940691|FG001|Pre-phase|Adverse Event|0|||
42129659|NCT00514514|75940692|FG002|Pre-phase|Adverse Event|0|||
42129660|NCT00514514|75940690|FG000|Pre-phase|Withdrawal by Subject|66|||
42129661|NCT00514514|75940691|FG001|Pre-phase|Withdrawal by Subject|0|||
42129662|NCT00514514|75940692|FG002|Pre-phase|Withdrawal by Subject|0|||
42129663|NCT00514514|75940690|FG000|Randomized - 9 Month|Death|3|||
42129664|NCT00514514|75940691|FG001|Randomized - 9 Month|Death|2|||
42129665|NCT00514514|75940692|FG002|Randomized - 9 Month|Death|2|||
42129666|NCT00514514|75940690|FG000|Randomized - 9 Month|Administrative problems|1|||
42129667|NCT00514514|75940691|FG001|Randomized - 9 Month|Administrative problems|1|||
42129668|NCT00514514|75940692|FG002|Randomized - 9 Month|Administrative problems|2|||
42129669|NCT00514514|75940690|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
42129670|NCT00514514|75940691|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
42129671|NCT00514514|75940692|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
42129672|NCT00514514|75940690|FG000|Randomized - 9 Month|Protocol Violation|1|||
42129673|NCT00514514|75940691|FG001|Randomized - 9 Month|Protocol Violation|1|||
42129674|NCT00514514|75940692|FG002|Randomized - 9 Month|Protocol Violation|0|||
42129675|NCT00514514|75940690|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
42129676|NCT00514514|75940691|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
42129677|NCT00514514|75940692|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
42129678|NCT00514514|75940690|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
42129679|NCT00514514|75940691|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
42129680|NCT00514514|75940692|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
42129681|NCT00514514|75940690|FG000|Randomized - 9 Month|Adverse Event|25|||
42129682|NCT00514514|75940691|FG001|Randomized - 9 Month|Adverse Event|44|||
42129683|NCT00514514|75940692|FG002|Randomized - 9 Month|Adverse Event|27|||
42129684|NCT00514514|75940690|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
42129685|NCT00514514|75940691|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
42129686|NCT00514514|75940692|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
42129687|NCT00514514|75940690|FG000|Extension - 4 Years|Lost to Follow-up|12|||
42218303|NCT03384745|76036246|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
42218304|NCT03384745|76036247|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
42272649|NCT02281318|76102917|FG000|Overall Study|Adverse Event|2|||
42129688|NCT00514514|75940691|FG001|Extension - 4 Years|Lost to Follow-up|10|||
42129689|NCT00514514|75940692|FG002|Extension - 4 Years|Lost to Follow-up|9|||
42129690|NCT00514514|75940690|FG000|Extension - 4 Years|Administrative problems|3|||
42129691|NCT00514514|75940691|FG001|Extension - 4 Years|Administrative problems|1|||
42129692|NCT00514514|75940692|FG002|Extension - 4 Years|Administrative problems|1|||
42129693|NCT00514514|75940690|FG000|Extension - 4 Years|Death|8|||
42129694|NCT00514514|75940691|FG001|Extension - 4 Years|Death|3|||
42129695|NCT00514514|75940692|FG002|Extension - 4 Years|Death|6|||
42129696|NCT00514514|75940690|FG000|Extension - 4 Years|Adverse Event|9|||
42129697|NCT00514514|75940691|FG001|Extension - 4 Years|Adverse Event|6|||
42129698|NCT00514514|75940692|FG002|Extension - 4 Years|Adverse Event|3|||
42129699|NCT00405639|75940702|FG000|Overall Study|Withdrawal by Subject|1|||
42129700|NCT00405639|75940703|FG001|Overall Study|Withdrawal by Subject|0|||
42129701|NCT00405639|75940702|FG000|Overall Study|Adverse Event|1|||
42129702|NCT00405639|75940703|FG001|Overall Study|Adverse Event|0|||
42129703|NCT00405639|75940702|FG000|Overall Study|Seizure prior to receiving BNP|1|||
42129704|NCT00405639|75940703|FG001|Overall Study|Seizure prior to receiving BNP|0|||
42129705|NCT00439725|75940711|FG000|Treatment Period|Withdrawal by Subject|22|||
42129706|NCT00439725|75940712|FG001|Treatment Period|Withdrawal by Subject|19|||
42129707|NCT00439725|75940711|FG000|Treatment Period|Study terminated by sponsor|156|||
41978804|NCT04820842|75783518|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
41978805|NCT04820842|75783519|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
42129708|NCT00439725|75940712|FG001|Treatment Period|Study terminated by sponsor|148|||
42218305|NCT03384745|76036248|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
42218306|NCT03384745|76036249|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
42218307|NCT03384745|76036244|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
42218308|NCT03384745|76036245|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
42218309|NCT03384745|76036246|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
42218310|NCT03384745|76036247|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
42218311|NCT03384745|76036248|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
42218312|NCT03384745|76036249|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
42218313|NCT03384745|76036244|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
42218314|NCT03384745|76036245|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
42218315|NCT03384745|76036246|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
42218316|NCT03384745|76036247|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
42218317|NCT03384745|76036248|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
42218318|NCT03384745|76036249|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
42218319|NCT03384745|76036244|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
41978806|NCT04820842|75783520|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
41978807|NCT04820842|75783521|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
41978808|NCT04744285|75783551|FG000|Overall Study|Withdrawal by Subject|1|||
41978809|NCT04744285|75783552|FG001|Overall Study|Withdrawal by Subject|1|||
41978810|NCT04744285|75783553|FG002|Overall Study|Withdrawal by Subject|2|||
41978811|NCT04744285|75783554|FG003|Overall Study|Withdrawal by Subject|1|||
41978812|NCT04737187|75783566|FG000|Overall Study|Continuing the study on treatment|32|||
41978813|NCT04737187|75783567|FG001|Overall Study|Continuing the study on treatment|4|||
41978814|NCT04737187|75783566|FG000|Overall Study|Radiological Progressive Disease|145|||
41978815|NCT04737187|75783567|FG001|Overall Study|Radiological Progressive Disease|146|||
41978816|NCT04737187|75783566|FG000|Overall Study|Clinical Progressive Disease|20|||
41978817|NCT04737187|75783567|FG001|Overall Study|Clinical Progressive Disease|20|||
41978818|NCT04737187|75783566|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
41978819|NCT04737187|75783567|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
41978820|NCT04737187|75783566|FG000|Overall Study|Adverse Event|16|||
41978821|NCT04737187|75783567|FG001|Overall Study|Adverse Event|16|||
41978822|NCT04737187|75783566|FG000|Overall Study|Physician Decision|2|||
41978823|NCT04737187|75783567|FG001|Overall Study|Physician Decision|0|||
41978824|NCT04737187|75783566|FG000|Overall Study|Withdrawal by Subject|5|||
41978825|NCT04737187|75783567|FG001|Overall Study|Withdrawal by Subject|8|||
41978826|NCT04737031|75783577|FG000|Overall Study|Patients who did not have a treatment visit|0|||
41978827|NCT04737031|75783578|FG001|Overall Study|Patients who did not have a treatment visit|31|||
41978828|NCT04737031|75783579|FG002|Overall Study|Patients who did not have a treatment visit|93|||
41978829|NCT04737031|75783580|FG003|Overall Study|Patients who did not have a treatment visit|227|||
41978830|NCT04555044|75783592|FG000|Overall Study|Adverse Event|0|||
41978831|NCT04555044|75783593|FG001|Overall Study|Adverse Event|1|||
41978832|NCT04492722|75783624|FG000|Overall Study|Adverse Event|7|||
41978833|NCT04492722|75783625|FG001|Overall Study|Adverse Event|2|||
41978834|NCT04492722|75783626|FG002|Overall Study|Adverse Event|3|||
41978835|NCT04492722|75783627|FG003|Overall Study|Adverse Event|0|||
42129709|NCT00439725|75940711|FG000|Treatment Period|Site closed by investigator|1|||
42129710|NCT00439725|75940712|FG001|Treatment Period|Site closed by investigator|2|||
42129711|NCT00439725|75940711|FG000|Treatment Period|Adverse Event|39|||
42129712|NCT00439725|75940712|FG001|Treatment Period|Adverse Event|18|||
42129713|NCT00439725|75940711|FG000|Treatment Period|Physician Decision|1|||
42129714|NCT00439725|75940712|FG001|Treatment Period|Physician Decision|1|||
41978836|NCT04492722|75783624|FG000|Overall Study|Death|0|||
41978837|NCT04492722|75783625|FG001|Overall Study|Death|0|||
41978838|NCT04492722|75783626|FG002|Overall Study|Death|0|||
41978839|NCT04492722|75783627|FG003|Overall Study|Death|1|||
41978840|NCT04492722|75783624|FG000|Overall Study|Lost to Follow-up|0|||
41978841|NCT04492722|75783625|FG001|Overall Study|Lost to Follow-up|1|||
41978842|NCT04492722|75783626|FG002|Overall Study|Lost to Follow-up|0|||
41978843|NCT04492722|75783627|FG003|Overall Study|Lost to Follow-up|1|||
42129715|NCT00439725|75940711|FG000|Treatment Period|Protocol Violation|2|||
42129716|NCT00439725|75940712|FG001|Treatment Period|Protocol Violation|1|||
42129717|NCT00439725|75940711|FG000|Treatment Period|Clinical endpoint reached|6|||
42129718|NCT00439725|75940712|FG001|Treatment Period|Clinical endpoint reached|50|||
42129719|NCT00439725|75940711|FG000|Treatment Period|Technical problems|1|||
42129720|NCT00439725|75940712|FG001|Treatment Period|Technical problems|0|||
42129721|NCT00439725|75940711|FG000|Treatment Period|Lost to Follow-up|1|||
42129722|NCT00439725|75940712|FG001|Treatment Period|Lost to Follow-up|1|||
42129723|NCT00439725|75940711|FG000|Treatment Period|Participant convenience|1|||
42129724|NCT00439725|75940712|FG001|Treatment Period|Participant convenience|0|||
42129725|NCT00439725|75940711|FG000|Treatment Period|Protocol driven decision point|1|||
42129726|NCT00439725|75940712|FG001|Treatment Period|Protocol driven decision point|1|||
42129727|NCT00439725|75940711|FG000|Treatment Period|Death|1|||
42129728|NCT00439725|75940712|FG001|Treatment Period|Death|1|||
42129729|NCT00439725|75940711|FG000|Treatment Period|Participant did not receive treatment|4|||
42129730|NCT00439725|75940712|FG001|Treatment Period|Participant did not receive treatment|4|||
42129731|NCT00439725|75940711|FG000|Observational Period|Withdrawal by Subject|2|||
42129732|NCT00439725|75940712|FG001|Observational Period|Withdrawal by Subject|2|||
42129733|NCT00439725|75940711|FG000|Observational Period|Lost to Follow-up|0|||
42129734|NCT00439725|75940712|FG001|Observational Period|Lost to Follow-up|1|||
42129735|NCT00439725|75940711|FG000|Observational Period|Death|0|||
42129736|NCT00439725|75940712|FG001|Observational Period|Death|2|||
42218320|NCT03384745|76036245|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
42218321|NCT03384745|76036246|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
42218322|NCT03384745|76036247|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
42302160|NCT02482129|76137233|FG000|Overall Study|Criteria not met-prior to treatment|1|||
42218323|NCT03384745|76036248|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
42218324|NCT03384745|76036249|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
42218325|NCT03384745|76036244|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
42218326|NCT03384745|76036245|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
42302161|NCT02482129|76137234|FG001|Overall Study|Criteria not met-prior to treatment|0|||
42302162|NCT02482129|76137233|FG000|Overall Study|Adverse Event|1|||
42302163|NCT02482129|76137234|FG001|Overall Study|Adverse Event|0|||
42302164|NCT02482129|76137233|FG000|Overall Study|Withdrawal by Subject|2|||
42129737|NCT00439725|75940711|FG000|Observational Period|Study termination by sponsor|1|||
42129738|NCT00439725|75940712|FG001|Observational Period|Study termination by sponsor|1|||
42302165|NCT02482129|76137234|FG001|Overall Study|Withdrawal by Subject|0|||
42129739|NCT00439725|75940711|FG000|Observational Period|Clinical endpoint reached|3|||
42129740|NCT00439725|75940712|FG001|Observational Period|Clinical endpoint reached|1|||
42129741|NCT00439725|75940711|FG000|Observational Period|Technical problems|1|||
42129742|NCT00439725|75940712|FG001|Observational Period|Technical problems|0|||
42129743|NCT00439725|75940711|FG000|Observational Period|Participant convenience|1|||
42129744|NCT00439725|75940712|FG001|Observational Period|Participant convenience|0|||
42129745|NCT00521586|75940720|FG000|Initial Vaccination (Year 0)|Subject request|8|||
42129746|NCT00521586|75940721|FG001|Initial Vaccination (Year 0)|Subject request|11|||
42129747|NCT00521586|75940720|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
42129748|NCT00521586|75940721|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
42129749|NCT00521586|75940720|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
42129750|NCT00521586|75940721|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
42129751|NCT00521586|75940720|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
42129752|NCT00521586|75940721|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
42129753|NCT00521586|75940720|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
42218327|NCT03384745|76036246|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
42218328|NCT03384745|76036247|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
42218329|NCT03384745|76036248|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
42218330|NCT03384745|76036249|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
42129754|NCT00521586|75940721|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
42129755|NCT00521586|75940720|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
42129756|NCT00521586|75940721|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
41978844|NCT04492722|75783624|FG000|Overall Study|Physician Decision|0|||
41978845|NCT04492722|75783625|FG001|Overall Study|Physician Decision|3|||
41978846|NCT04492722|75783626|FG002|Overall Study|Physician Decision|1|||
41978847|NCT04492722|75783627|FG003|Overall Study|Physician Decision|1|||
41978848|NCT04492722|75783624|FG000|Overall Study|Withdrawal by Subject|6|||
41978849|NCT04492722|75783625|FG001|Overall Study|Withdrawal by Subject|6|||
41978850|NCT04492722|75783626|FG002|Overall Study|Withdrawal by Subject|0|||
41978851|NCT04492722|75783627|FG003|Overall Study|Withdrawal by Subject|3|||
41978852|NCT04492722|75783624|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
41978853|NCT04492722|75783625|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
41978854|NCT04492722|75783626|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
41978855|NCT04492722|75783627|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
41978856|NCT04492722|75783624|FG000|Overall Study|Due to Covid-19 pandemic|7|||
41978857|NCT04492722|75783625|FG001|Overall Study|Due to Covid-19 pandemic|3|||
41978858|NCT04492722|75783626|FG002|Overall Study|Due to Covid-19 pandemic|7|||
41978859|NCT04492722|75783627|FG003|Overall Study|Due to Covid-19 pandemic|6|||
41978860|NCT04492722|75783624|FG000|Overall Study|Failure to meet randomisation criteria|2|||
41978861|NCT04492722|75783625|FG001|Overall Study|Failure to meet randomisation criteria|3|||
41978862|NCT04492722|75783626|FG002|Overall Study|Failure to meet randomisation criteria|4|||
41978863|NCT04492722|75783627|FG003|Overall Study|Failure to meet randomisation criteria|2|||
41978864|NCT04492722|75783624|FG000|Overall Study|Early termination from the study|54|||
41978865|NCT04492722|75783625|FG001|Overall Study|Early termination from the study|51|||
41978866|NCT04492722|75783626|FG002|Overall Study|Early termination from the study|50|||
41978867|NCT04492722|75783627|FG003|Overall Study|Early termination from the study|50|||
42129757|NCT00521586|75940720|FG000|Initial Vaccination (Year 0)|Death|1|||
42129758|NCT00521586|75940721|FG001|Initial Vaccination (Year 0)|Death|0|||
41978868|NCT04492722|75783624|FG000|Overall Study|Missing|3|||
41978869|NCT04492722|75783625|FG001|Overall Study|Missing|0|||
42129759|NCT00521586|75940720|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
42129760|NCT00521586|75940721|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
41978870|NCT04492722|75783626|FG002|Overall Study|Missing|0|||
41978871|NCT04492722|75783627|FG003|Overall Study|Missing|5|||
41978872|NCT04492722|75783624|FG000|Overall Study|Participants who did not receive treatment|0|||
41978873|NCT04492722|75783625|FG001|Overall Study|Participants who did not receive treatment|1|||
41978874|NCT04492722|75783626|FG002|Overall Study|Participants who did not receive treatment|4|||
41978875|NCT04492722|75783627|FG003|Overall Study|Participants who did not receive treatment|0|||
41978876|NCT04466618|75783639|FG000|Overall Study|Withdrawal by Subject|0|||
41978877|NCT04466618|75783640|FG001|Overall Study|Withdrawal by Subject|1|||
41978878|NCT04271735|75783652|FG000|Overall Study|Physician Decision|2|||
41978879|NCT04271735|75783653|FG001|Overall Study|Physician Decision|0|||
41978880|NCT04221373|75783661|FG000|Overall Study|Physician Decision|4|||
41978881|NCT04221373|75783662|FG001|Overall Study|Physician Decision|0|||
41978882|NCT04206605|75783670|FG000|Overall Study|Adverse Event|0|||
41978883|NCT04206605|75783671|FG001|Overall Study|Adverse Event|1|||
41978884|NCT04206605|75783670|FG000|Overall Study|Withdrawal by Subject|1|||
42218331|NCT03384745|76036244|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
42218332|NCT03384745|76036245|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
42218333|NCT03384745|76036246|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
42218334|NCT03384745|76036247|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
42218335|NCT03384745|76036248|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
42218336|NCT03384745|76036249|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
42218337|NCT03384745|76036244|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
42218338|NCT03384745|76036245|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
42218339|NCT03384745|76036246|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
42218340|NCT03384745|76036247|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
42218341|NCT03384745|76036248|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
41978885|NCT04206605|75783671|FG001|Overall Study|Withdrawal by Subject|0|||
42218342|NCT03384745|76036249|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
42218343|NCT03384745|76036244|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
42218344|NCT03384745|76036245|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
42218345|NCT03384745|76036246|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
41978886|NCT04177212|75783681|FG000|Overall Study|Withdrawal by Subject|9|||
41978887|NCT04177212|75783682|FG001|Overall Study|Withdrawal by Subject|7|||
41978888|NCT04177212|75783681|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
41978889|NCT04177212|75783682|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
41978890|NCT04177212|75783681|FG000|Overall Study|Physician Decision|1|||
41978891|NCT04177212|75783682|FG001|Overall Study|Physician Decision|0|||
41978892|NCT04177212|75783681|FG000|Overall Study|Lost to Follow-up|0|||
41978893|NCT04177212|75783682|FG001|Overall Study|Lost to Follow-up|3|||
41978894|NCT04177212|75783681|FG000|Overall Study|Adverse Event|0|||
41978895|NCT04177212|75783682|FG001|Overall Study|Adverse Event|1|||
41978896|NCT04177212|75783681|FG000|Overall Study|Other|1|||
41978897|NCT04177212|75783682|FG001|Overall Study|Other|2|||
41978898|NCT04065841|75783698|FG000|Overall Study|Adverse Event|4|||
41978899|NCT04065841|75783699|FG001|Overall Study|Adverse Event|2|||
41978900|NCT04065841|75783700|FG002|Overall Study|Adverse Event|10|||
42028573|NCT00910624|75836999|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
42028574|NCT00910624|75836996|FG000|Follow-Up Phase|Adverse Event|0|||
42028575|NCT00910624|75836997|FG001|Follow-Up Phase|Adverse Event|0|||
42028576|NCT00910624|75836998|FG002|Follow-Up Phase|Adverse Event|1|||
42028577|NCT00910624|75836999|FG003|Follow-Up Phase|Adverse Event|0|||
42129761|NCT00521586|75940720|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
42129762|NCT00521586|75940721|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
42129763|NCT00521586|75940720|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
42129764|NCT00521586|75940721|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
42129765|NCT00521586|75940720|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
42129766|NCT00521586|75940721|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
42129767|NCT00521586|75940720|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
42129768|NCT00521586|75940721|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
42129769|NCT00521586|75940720|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
42129770|NCT00521586|75940721|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
42129771|NCT00521586|75940720|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
41978901|NCT04065841|75783701|FG003|Overall Study|Adverse Event|1|||
41978902|NCT04065841|75783698|FG000|Overall Study|Lost to Follow-up|1|||
41978903|NCT04065841|75783699|FG001|Overall Study|Lost to Follow-up|2|||
41978904|NCT04065841|75783700|FG002|Overall Study|Lost to Follow-up|2|||
41978905|NCT04065841|75783701|FG003|Overall Study|Lost to Follow-up|2|||
42028578|NCT00910624|75836996|FG000|Follow-Up Phase|Lost to Follow-up|3|||
41978906|NCT04065841|75783698|FG000|Overall Study|Physician Decision|1|||
41978907|NCT04065841|75783699|FG001|Overall Study|Physician Decision|0|||
41978908|NCT04065841|75783700|FG002|Overall Study|Physician Decision|0|||
41978909|NCT04065841|75783701|FG003|Overall Study|Physician Decision|0|||
41978910|NCT04065841|75783698|FG000|Overall Study|Protocol Violation|0|||
41978911|NCT04065841|75783699|FG001|Overall Study|Protocol Violation|1|||
41978912|NCT04065841|75783700|FG002|Overall Study|Protocol Violation|0|||
41978913|NCT04065841|75783701|FG003|Overall Study|Protocol Violation|0|||
41978914|NCT04065841|75783698|FG000|Overall Study|Study terminated by Sponsor|22|||
41978915|NCT04065841|75783699|FG001|Overall Study|Study terminated by Sponsor|16|||
41978916|NCT04065841|75783700|FG002|Overall Study|Study terminated by Sponsor|28|||
41978917|NCT04065841|75783701|FG003|Overall Study|Study terminated by Sponsor|17|||
41978918|NCT04065841|75783698|FG000|Overall Study|Withdrawal by Subject|1|||
41978919|NCT04065841|75783699|FG001|Overall Study|Withdrawal by Subject|1|||
41978920|NCT04065841|75783700|FG002|Overall Study|Withdrawal by Subject|2|||
41978921|NCT04065841|75783701|FG003|Overall Study|Withdrawal by Subject|0|||
41978922|NCT04045132|75783714|FG000|Overall Study|Lost to Follow-up|3|||
41978923|NCT04045132|75783715|FG001|Overall Study|Lost to Follow-up|6|||
41978924|NCT03912831|75783738|FG000|Overall Study|Death|1|||
41978925|NCT03912831|75783739|FG001|Overall Study|Death|1|||
41978926|NCT03912831|75783740|FG002|Overall Study|Death|1|||
41978927|NCT03912831|75783741|FG003|Overall Study|Death|1|||
41978928|NCT03912831|75783742|FG004|Overall Study|Death|1|||
41978929|NCT03912831|75783743|FG005|Overall Study|Death|1|||
41978930|NCT03912831|75783738|FG000|Overall Study|Reason not Specified|0|||
41978931|NCT03912831|75783739|FG001|Overall Study|Reason not Specified|0|||
41978932|NCT03912831|75783740|FG002|Overall Study|Reason not Specified|0|||
41978933|NCT03912831|75783741|FG003|Overall Study|Reason not Specified|0|||
41978934|NCT03912831|75783742|FG004|Overall Study|Reason not Specified|1|||
41978935|NCT03912831|75783743|FG005|Overall Study|Reason not Specified|0|||
41978936|NCT03912831|75783738|FG000|Overall Study|Withdrawal by Participant|0|||
41978937|NCT03912831|75783739|FG001|Overall Study|Withdrawal by Participant|0|||
41978938|NCT03912831|75783740|FG002|Overall Study|Withdrawal by Participant|0|||
41978939|NCT03912831|75783741|FG003|Overall Study|Withdrawal by Participant|0|||
41978940|NCT03912831|75783742|FG004|Overall Study|Withdrawal by Participant|1|||
41978941|NCT03912831|75783743|FG005|Overall Study|Withdrawal by Participant|0|||
41978942|NCT03655262|75783783|FG000|Overall Study|Withdrawal by Subject|0|||
41978943|NCT03655262|75783784|FG001|Overall Study|Withdrawal by Subject|0|||
41978944|NCT03655262|75783785|FG002|Overall Study|Withdrawal by Subject|1|||
41978945|NCT03524612|75783805|FG000|Overall Study|Lack of Efficacy|10|||
41978946|NCT03524612|75783805|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
41978947|NCT03524612|75783805|FG000|Overall Study|Adverse Event|10|||
42129772|NCT00521586|75940721|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
42129773|NCT00521586|75940720|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
41978948|NCT03524612|75783805|FG000|Overall Study|Withdrawal by Subject|7|||
41978949|NCT03524612|75783805|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
41978950|NCT03524612|75783805|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
41978951|NCT03524612|75783805|FG000|Overall Study|New therapy for study indication|6|||
41978952|NCT03524612|75783805|FG000|Overall Study|Death|3|||
41978953|NCT03524612|75783805|FG000|Overall Study|Lost to Follow-up|2|||
41978954|NCT03524612|75783805|FG000|Overall Study|Protocol Violation|1|||
41978955|NCT03495453|75783812|FG000|Overall Study|Withdrawal by Subject|0|||
41978956|NCT03495453|75783813|FG001|Overall Study|Withdrawal by Subject|1|||
41978957|NCT03473743|75783827|FG000|Overall Study|Withdrawal by Subject|0|||
41978958|NCT03473743|75783828|FG001|Overall Study|Withdrawal by Subject|0|||
41978959|NCT03473743|75783829|FG002|Overall Study|Withdrawal by Subject|0|||
41978960|NCT03473743|75783830|FG003|Overall Study|Withdrawal by Subject|0|||
41978961|NCT03473743|75783831|FG004|Overall Study|Withdrawal by Subject|0|||
41978962|NCT03473743|75783832|FG005|Overall Study|Withdrawal by Subject|0|||
41978963|NCT03473743|75783833|FG006|Overall Study|Withdrawal by Subject|0|||
42218346|NCT03384745|76036247|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
41978964|NCT03473743|75783834|FG007|Overall Study|Withdrawal by Subject|3|||
42129774|NCT00521586|75940721|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
42129775|NCT00521586|75940720|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
42218347|NCT03384745|76036248|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
42218348|NCT03384745|76036249|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
42218349|NCT03384745|76036244|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
42218350|NCT03384745|76036245|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
42218351|NCT03384745|76036246|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
42218352|NCT03384745|76036247|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
42218353|NCT03384745|76036248|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
42218354|NCT03384745|76036249|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
42218355|NCT03383887|76036269|FG000|Overall Study|Lost to Follow-up|0|||
42218356|NCT03383887|76036270|FG001|Overall Study|Lost to Follow-up|1|||
42218357|NCT03379753|76036278|FG000|Overall Study|Withdrawal by Subject|2|||
42218358|NCT03379753|76036279|FG001|Overall Study|Withdrawal by Subject|1|||
42218359|NCT03379753|76036278|FG000|Overall Study|not having correct procedure|1|||
42218360|NCT03379753|76036279|FG001|Overall Study|not having correct procedure|2|||
42218361|NCT03379753|76036278|FG000|Overall Study|No primary outcome|12|||
42218362|NCT03379753|76036279|FG001|Overall Study|No primary outcome|22|||
42218363|NCT03379675|76036288|FG000|Overall Study|Lost to Follow-up|0|||
42218364|NCT03379675|76036289|FG001|Overall Study|Lost to Follow-up|1|||
42218365|NCT03379675|76036290|FG002|Overall Study|Lost to Follow-up|0|||
42218366|NCT03379675|76036288|FG000|Overall Study|Adverse Event|2|||
42218367|NCT03379675|76036289|FG001|Overall Study|Adverse Event|0|||
42218368|NCT03379675|76036290|FG002|Overall Study|Adverse Event|0|||
42218369|NCT03379675|76036288|FG000|Overall Study|Withdrawal by Subject|2|||
42218370|NCT03379675|76036289|FG001|Overall Study|Withdrawal by Subject|1|||
42218371|NCT03379675|76036290|FG002|Overall Study|Withdrawal by Subject|2|||
42218372|NCT02930889|76036298|FG000|Overall Study|Lost to Follow-up|2|||
42218373|NCT02930889|76036298|FG000|Overall Study|Withdrawal by Subject|6|||
42218374|NCT02930889|76036298|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
42218375|NCT02875977|76036304|FG000|Overall Study|Lost to Follow-up|42|||
42218376|NCT02875977|76036305|FG001|Overall Study|Lost to Follow-up|29|||
42218377|NCT02703532|76036324|FG000|Overall Study|Withdrawal by Subject|0|||
42218378|NCT02703532|76036325|FG001|Overall Study|Withdrawal by Subject|1|||
42129776|NCT00521586|75940721|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
42129777|NCT00521586|75940720|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
42129778|NCT00521586|75940721|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
42129779|NCT00521586|75940720|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
42129780|NCT00521586|75940721|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
42129781|NCT00521586|75940720|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
42129782|NCT00521586|75940721|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
42129783|NCT00515502|75940739|FG000|Treatment Period 1|Adverse Event|0|||
42218379|NCT02703532|76036326|FG002|Overall Study|Withdrawal by Subject|0|||
42218380|NCT02703532|76036327|FG003|Overall Study|Withdrawal by Subject|1|||
42218381|NCT02703532|76036324|FG000|Overall Study|Lost to Follow-up|2|||
42218382|NCT02703532|76036325|FG001|Overall Study|Lost to Follow-up|0|||
42218383|NCT02703532|76036326|FG002|Overall Study|Lost to Follow-up|2|||
42218384|NCT02703532|76036327|FG003|Overall Study|Lost to Follow-up|0|||
42218385|NCT02930343|76036360|FG000|Overall Study|Lost to Follow-up|9|||
42218386|NCT02930343|76036361|FG001|Overall Study|Lost to Follow-up|7|||
42218387|NCT02703454|76036369|FG000|Overall Study|Not treated|1|||
41978965|NCT03473743|75783827|FG000|Overall Study|Other|0|||
42218388|NCT02703454|76036370|FG001|Overall Study|Not treated|3|||
42218389|NCT02703454|76036369|FG000|Overall Study|Withdrawal by Subject|4|||
42218390|NCT02703454|76036370|FG001|Overall Study|Withdrawal by Subject|3|||
42218391|NCT02703454|76036369|FG000|Overall Study|Lost to Follow-up|1|||
42218392|NCT02703454|76036370|FG001|Overall Study|Lost to Follow-up|2|||
42218393|NCT02703454|76036369|FG000|Overall Study|Study discontinuation|5|||
42218394|NCT02703454|76036370|FG001|Overall Study|Study discontinuation|8|||
42218395|NCT03103542|76036376|FG000|Overall Study|Physician Decision|2|||
42218396|NCT03103542|76036376|FG000|Overall Study|Adverse Event|2|||
41978966|NCT03473743|75783828|FG001|Overall Study|Other|0|||
41978967|NCT03473743|75783829|FG002|Overall Study|Other|0|||
41978968|NCT03473743|75783830|FG003|Overall Study|Other|1|||
42129784|NCT00515502|75940740|FG001|Treatment Period 1|Adverse Event|0|||
41978969|NCT03473743|75783831|FG004|Overall Study|Other|0|||
41978970|NCT03473743|75783832|FG005|Overall Study|Other|0|||
41978971|NCT03473743|75783833|FG006|Overall Study|Other|0|||
41978972|NCT03473743|75783834|FG007|Overall Study|Other|0|||
42129785|NCT00515502|75940741|FG002|Treatment Period 1|Adverse Event|0|||
41978973|NCT03473743|75783827|FG000|Overall Study|Ongoing|0|||
41978974|NCT03473743|75783828|FG001|Overall Study|Ongoing|0|||
41978975|NCT03473743|75783829|FG002|Overall Study|Ongoing|6|||
41978976|NCT03473743|75783830|FG003|Overall Study|Ongoing|8|||
41978977|NCT03473743|75783831|FG004|Overall Study|Ongoing|1|||
41978978|NCT03473743|75783832|FG005|Overall Study|Ongoing|1|||
41978979|NCT03473743|75783833|FG006|Overall Study|Ongoing|22|||
41978980|NCT03473743|75783834|FG007|Overall Study|Ongoing|24|||
41978981|NCT03473743|75783827|FG000|Overall Study|Randomized but not treated|0|||
41978982|NCT03473743|75783828|FG001|Overall Study|Randomized but not treated|0|||
41978983|NCT03473743|75783829|FG002|Overall Study|Randomized but not treated|0|||
41978984|NCT03473743|75783830|FG003|Overall Study|Randomized but not treated|0|||
41978985|NCT03473743|75783831|FG004|Overall Study|Randomized but not treated|0|||
41978986|NCT03473743|75783832|FG005|Overall Study|Randomized but not treated|0|||
41978987|NCT03473743|75783833|FG006|Overall Study|Randomized but not treated|1|||
41978988|NCT03473743|75783834|FG007|Overall Study|Randomized but not treated|1|||
42218397|NCT03103542|76036376|FG000|Overall Study|Other|2|||
42218398|NCT03103542|76036376|FG000|Overall Study|Withdrawal by Subject|1|||
42218399|NCT03376321|76036403|FG000|Overall Study|Other|5|||
42218400|NCT03376321|76036404|FG001|Overall Study|Other|1|||
42218401|NCT03376321|76036403|FG000|Overall Study|Withdrawal by Subject|8|||
42218402|NCT03376321|76036404|FG001|Overall Study|Withdrawal by Subject|14|||
41978989|NCT03212794|75783854|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
42218403|NCT03376321|76036403|FG000|Overall Study|Lost to Follow-up|1|||
42218404|NCT03376321|76036404|FG001|Overall Study|Lost to Follow-up|7|||
42218405|NCT03376321|76036403|FG000|Overall Study|Death|4|||
42218406|NCT03376321|76036404|FG001|Overall Study|Death|0|||
42218407|NCT03376321|76036403|FG000|Overall Study|Randomized, not treated|5|||
42218408|NCT03376321|76036404|FG001|Overall Study|Randomized, not treated|3|||
42218409|NCT03374995|76036412|FG000|Overall Study|Withdrawal by Subject|0|||
42218410|NCT03374995|76036413|FG001|Overall Study|Withdrawal by Subject|1|||
42218411|NCT02828982|76036419|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
42218412|NCT02828982|76036420|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
42218413|NCT03133767|76036430|FG000|Overall Study|Lost to Follow-up|38|||
42218414|NCT03133767|76036431|FG001|Overall Study|Lost to Follow-up|24|||
42218415|NCT03133767|76036430|FG000|Overall Study|Protocol Violation|0|||
42218416|NCT03133767|76036431|FG001|Overall Study|Protocol Violation|1|||
42218417|NCT03391765|76036441|FG000|Overall Study|Adverse Event|2|||
42218418|NCT03391765|76036442|FG001|Overall Study|Adverse Event|0|||
42218419|NCT03391765|76036443|FG002|Overall Study|Adverse Event|0|||
42218420|NCT03391765|76036444|FG003|Overall Study|Adverse Event|2|||
42218421|NCT03391765|76036441|FG000|Overall Study|Withdrew consent|5|||
42218422|NCT03391765|76036442|FG001|Overall Study|Withdrew consent|7|||
42218423|NCT03391765|76036443|FG002|Overall Study|Withdrew consent|2|||
42218424|NCT03391765|76036444|FG003|Overall Study|Withdrew consent|5|||
42218425|NCT03391765|76036441|FG000|Overall Study|Other, not specified|44|||
42218426|NCT03391765|76036442|FG001|Overall Study|Other, not specified|38|||
42218427|NCT03391765|76036443|FG002|Overall Study|Other, not specified|21|||
42218428|NCT03391765|76036444|FG003|Overall Study|Other, not specified|16|||
41978990|NCT03212794|75783855|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
41978991|NCT03212794|75783854|FG000|Overall Study|Lost to Follow-up|5|||
41978992|NCT03212794|75783855|FG001|Overall Study|Lost to Follow-up|6|||
41978993|NCT03212794|75783854|FG000|Overall Study|Incarcerated; unable to participate|2|||
41978994|NCT03212794|75783855|FG001|Overall Study|Incarcerated; unable to participate|0|||
41978995|NCT03212794|75783854|FG000|Overall Study|Withdrawal by Subject|1|||
41978996|NCT03212794|75783855|FG001|Overall Study|Withdrawal by Subject|0|||
41978997|NCT03212794|75783854|FG000|Overall Study|Death|0|||
41978998|NCT03212794|75783855|FG001|Overall Study|Death|1|||
41978999|NCT03212794|75783854|FG000|Overall Study|Found to be ineligible after allocation|0|||
41979000|NCT03212794|75783855|FG001|Overall Study|Found to be ineligible after allocation|1|||
41979001|NCT03212794|75783854|FG000|Overall Study|Relocated out of area|2|||
41979002|NCT03212794|75783855|FG001|Overall Study|Relocated out of area|0|||
41979003|NCT03200574|75783861|FG000|Overall Study|Death|4|||
42218429|NCT02802228|76036456|FG000|Overall Study|Withdrawal by Subject|2|||
42218430|NCT02802228|76036457|FG001|Overall Study|Withdrawal by Subject|0|||
42218431|NCT02802228|76036456|FG000|Overall Study|Lost to Follow-up|1|||
42218432|NCT02802228|76036457|FG001|Overall Study|Lost to Follow-up|0|||
42218433|NCT02802228|76036456|FG000|Overall Study|Adverse Event|1|||
42218434|NCT02802228|76036457|FG001|Overall Study|Adverse Event|0|||
42218435|NCT02802228|76036456|FG000|Overall Study|Physician Decision|1|||
41979004|NCT03200574|75783861|FG000|Overall Study|Withdrawal by Subject|8|||
41979005|NCT03200574|75783861|FG000|Overall Study|Long-Term need for anticoagulation|1|||
41979006|NCT03200574|75783861|FG000|Overall Study|Relocation|2|||
41979007|NCT03200574|75783861|FG000|Overall Study|Lost to Follow-up|2|||
41979008|NCT03194958|75783878|FG000|Overall Study|Death|0|||
41979009|NCT03194958|75783879|FG001|Overall Study|Death|1|||
41979010|NCT03194958|75783880|FG002|Overall Study|Death|1|||
41979011|NCT03194958|75783881|FG003|Overall Study|Death|1|||
41979012|NCT03194958|75783878|FG000|Overall Study|Withdrawal by Subject|24|||
41979013|NCT03194958|75783879|FG001|Overall Study|Withdrawal by Subject|27|||
41979014|NCT03194958|75783880|FG002|Overall Study|Withdrawal by Subject|7|||
41979015|NCT03194958|75783881|FG003|Overall Study|Withdrawal by Subject|22|||
41979016|NCT03194958|75783878|FG000|Overall Study|Lost to Follow-up|168|||
41979017|NCT03194958|75783879|FG001|Overall Study|Lost to Follow-up|196|||
41979018|NCT03194958|75783880|FG002|Overall Study|Lost to Follow-up|174|||
41979019|NCT03194958|75783881|FG003|Overall Study|Lost to Follow-up|186|||
41979020|NCT03123783|75783898|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
41979021|NCT03123783|75783899|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
41979022|NCT03123783|75783900|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
41979023|NCT03123783|75783901|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
41979024|NCT03123783|75783902|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
41979025|NCT03123783|75783903|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
41979026|NCT03123783|75783904|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
41979027|NCT03123783|75783898|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
41979028|NCT03123783|75783899|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
41979029|NCT03123783|75783900|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
42218436|NCT02802228|76036457|FG001|Overall Study|Physician Decision|0|||
42129786|NCT00515502|75940742|FG003|Treatment Period 1|Adverse Event|0|||
42302166|NCT02482129|76137233|FG000|Overall Study|Criteria not met|1|||
42129787|NCT00515502|75940743|FG004|Treatment Period 1|Adverse Event|0|||
41979030|NCT03123783|75783901|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
41979031|NCT03123783|75783902|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
41979032|NCT03123783|75783903|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
41979033|NCT03123783|75783904|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
41979034|NCT03123783|75783898|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
41979035|NCT03123783|75783899|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
41979036|NCT03123783|75783900|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
41979037|NCT03123783|75783901|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
41979038|NCT03123783|75783902|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
41979039|NCT03123783|75783903|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
41979040|NCT03123783|75783904|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
41979041|NCT03123783|75783898|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
41979042|NCT03123783|75783899|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
41979043|NCT03123783|75783900|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
41979044|NCT03123783|75783901|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
41979045|NCT03123783|75783902|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
41979046|NCT03123783|75783903|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
41979047|NCT03123783|75783904|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
41979048|NCT03003962|75783945|FG000|Overall Study|Withdrawal by Subject|5|||
42129788|NCT00515502|75940744|FG005|Treatment Period 1|Adverse Event|0|||
42302167|NCT02482129|76137234|FG001|Overall Study|Criteria not met|0|||
42302168|NCT02495857|76137245|FG000|Overall Study|Adverse Event|5|||
42129789|NCT00515502|75940745|FG006|Treatment Period 1|Adverse Event|1|||
41979049|NCT03003962|75783946|FG001|Overall Study|Withdrawal by Subject|17|||
41979050|NCT03003962|75783945|FG000|Overall Study|Death|274|||
41979051|NCT03003962|75783946|FG001|Overall Study|Death|277|||
42218437|NCT03130257|76036466|FG000|Overall Study|Withdrawal by Subject|1|||
42218438|NCT03130257|76036467|FG001|Overall Study|Withdrawal by Subject|0|||
42218439|NCT03130257|76036468|FG002|Overall Study|Withdrawal by Subject|2|||
42218440|NCT03674177|76036480|FG000|Overall Study|Lost to Follow-up|2|||
42218441|NCT03674177|76036481|FG001|Overall Study|Lost to Follow-up|1|||
42218442|NCT03674177|76036482|FG002|Overall Study|Lost to Follow-up|0|||
42218443|NCT03674177|76036483|FG003|Overall Study|Lost to Follow-up|2|||
42218444|NCT03354637|76036509|FG000|Double-blind Period|Protocol Violation|2|||
42218445|NCT03354637|76036510|FG001|Double-blind Period|Protocol Violation|0|||
42218446|NCT03354637|76036511|FG002|Double-blind Period|Protocol Violation|0|||
42218447|NCT03354637|76036509|FG000|Double-blind Period|Adverse Event|1|||
42218448|NCT03354637|76036510|FG001|Double-blind Period|Adverse Event|2|||
42218449|NCT03354637|76036511|FG002|Double-blind Period|Adverse Event|0|||
42218450|NCT03354637|76036509|FG000|Double-blind Period|Lost to Follow-up|3|||
42218451|NCT03354637|76036510|FG001|Double-blind Period|Lost to Follow-up|4|||
42218452|NCT03354637|76036511|FG002|Double-blind Period|Lost to Follow-up|3|||
42218453|NCT03354637|76036509|FG000|Double-blind Period|Withdrawal by Subject|10|||
42218454|NCT03354637|76036510|FG001|Double-blind Period|Withdrawal by Subject|6|||
42218455|NCT03354637|76036511|FG002|Double-blind Period|Withdrawal by Subject|4|||
42218456|NCT03354637|76036509|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
42302169|NCT02495857|76137246|FG001|Overall Study|Adverse Event|0|||
42129790|NCT00515502|75940746|FG007|Treatment Period 1|Adverse Event|0|||
42129791|NCT00515502|75940747|FG008|Treatment Period 1|Adverse Event|1|||
42129792|NCT00515502|75940748|FG009|Treatment Period 1|Adverse Event|0|||
42129793|NCT00515502|75940749|FG010|Treatment Period 1|Adverse Event|0|||
42129794|NCT00515502|75940750|FG011|Treatment Period 1|Adverse Event|1|||
42129795|NCT00515502|75940739|FG000|Treatment Period 2|Adverse Event|0|||
42129796|NCT00515502|75940740|FG001|Treatment Period 2|Adverse Event|1|||
42129797|NCT00515502|75940741|FG002|Treatment Period 2|Adverse Event|0|||
42129798|NCT00515502|75940742|FG003|Treatment Period 2|Adverse Event|0|||
42129799|NCT00515502|75940743|FG004|Treatment Period 2|Adverse Event|0|||
42129800|NCT00515502|75940744|FG005|Treatment Period 2|Adverse Event|0|||
42129801|NCT00515502|75940745|FG006|Treatment Period 2|Adverse Event|0|||
42129802|NCT00515502|75940746|FG007|Treatment Period 2|Adverse Event|0|||
42129803|NCT00515502|75940747|FG008|Treatment Period 2|Adverse Event|0|||
42129804|NCT00515502|75940748|FG009|Treatment Period 2|Adverse Event|0|||
42129805|NCT00515502|75940749|FG010|Treatment Period 2|Adverse Event|0|||
42129806|NCT00515502|75940750|FG011|Treatment Period 2|Adverse Event|0|||
42129807|NCT00439647|75940769|FG000|Overall Study|Withdrawal by Subject|25|||
42129808|NCT00439647|75940770|FG001|Overall Study|Withdrawal by Subject|22|||
42129809|NCT00439647|75940769|FG000|Overall Study|Death|15|||
42129810|NCT00439647|75940770|FG001|Overall Study|Death|18|||
42129811|NCT00439647|75940769|FG000|Overall Study|Adverse Event|11|||
42129812|NCT00439647|75940770|FG001|Overall Study|Adverse Event|11|||
42129813|NCT00439647|75940769|FG000|Overall Study|Lost to Follow-up|4|||
42129814|NCT00439647|75940770|FG001|Overall Study|Lost to Follow-up|12|||
42129815|NCT00439647|75940769|FG000|Overall Study|Protocol Violation|3|||
42129816|NCT00439647|75940770|FG001|Overall Study|Protocol Violation|4|||
41979052|NCT03003962|75783945|FG000|Overall Study|Participants ongoing at DCO|55|||
41979053|NCT03003962|75783946|FG001|Overall Study|Participants ongoing at DCO|40|||
41979054|NCT02943408|75783956|FG000|Overall Study|Lost to Follow-up|7|||
41979055|NCT02943408|75783957|FG001|Overall Study|Lost to Follow-up|1|||
42129817|NCT00439647|75940769|FG000|Overall Study|Lack of Efficacy|0|||
42129818|NCT00439647|75940770|FG001|Overall Study|Lack of Efficacy|4|||
42129819|NCT00515112|75940778|FG000|Overall Study|Death|0|||
42129820|NCT00515112|75940779|FG001|Overall Study|Death|1|||
42129821|NCT00515112|75940778|FG000|Overall Study|The study was terminated|3|||
42129822|NCT00515112|75940779|FG001|Overall Study|The study was terminated|2|||
42129823|NCT00404547|75940787|FG000|Overall Study|Adverse Event|39|||
42129824|NCT00404547|75940788|FG001|Overall Study|Adverse Event|6|||
42218457|NCT03354637|76036510|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
42218458|NCT03354637|76036511|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
42218459|NCT03354637|76036509|FG000|Open Label Extension|Adverse Event|0|||
42218460|NCT03354637|76036510|FG001|Open Label Extension|Adverse Event|0|||
42129825|NCT00404547|75940787|FG000|Overall Study|Withdrawal by Subject|19|||
42129826|NCT00404547|75940788|FG001|Overall Study|Withdrawal by Subject|2|||
42129827|NCT00404547|75940787|FG000|Overall Study|Protocol Violation|0|||
42129828|NCT00404547|75940788|FG001|Overall Study|Protocol Violation|1|||
42129829|NCT00404547|75940787|FG000|Overall Study|Lost to Follow-up|20|||
41979056|NCT02943408|75783956|FG000|Overall Study|Withdrawal by Subject|0|||
41979057|NCT02943408|75783957|FG001|Overall Study|Withdrawal by Subject|1|||
41979058|NCT02728102|75783966|FG000|Overall Study|Death|3|||
42129830|NCT00404547|75940788|FG001|Overall Study|Lost to Follow-up|9|||
41979059|NCT02728102|75783967|FG001|Overall Study|Death|0|||
41979060|NCT02728102|75783968|FG002|Overall Study|Death|1|||
41979061|NCT02728102|75783966|FG000|Overall Study|Withdrawal by Subject|0|||
41979062|NCT02728102|75783967|FG001|Overall Study|Withdrawal by Subject|2|||
42272650|NCT02281318|76102918|FG001|Overall Study|Adverse Event|2|||
41979063|NCT02728102|75783968|FG002|Overall Study|Withdrawal by Subject|3|||
42218461|NCT03354637|76036511|FG002|Open Label Extension|Adverse Event|1|||
42218462|NCT03354637|76036509|FG000|Open Label Extension|Lost to Follow-up|0|||
42218463|NCT03354637|76036510|FG001|Open Label Extension|Lost to Follow-up|0|||
42218464|NCT03354637|76036511|FG002|Open Label Extension|Lost to Follow-up|2|||
42218465|NCT03354637|76036509|FG000|Open Label Extension|Withdrawal by Subject|0|||
42218466|NCT03354637|76036510|FG001|Open Label Extension|Withdrawal by Subject|0|||
42218467|NCT03354637|76036511|FG002|Open Label Extension|Withdrawal by Subject|5|||
42302170|NCT02495857|76137247|FG002|Overall Study|Adverse Event|1|||
42218468|NCT03354637|76036509|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
42218469|NCT03354637|76036510|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
42028579|NCT00910624|75836997|FG001|Follow-Up Phase|Lost to Follow-up|1|||
42028580|NCT00910624|75836998|FG002|Follow-Up Phase|Lost to Follow-up|2|||
42028581|NCT00910624|75836999|FG003|Follow-Up Phase|Lost to Follow-up|0|||
42028582|NCT00910624|75836996|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
42028583|NCT00910624|75836997|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
42028584|NCT00910624|75836998|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
42028585|NCT00910624|75836999|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
42028586|NCT00910624|75836996|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
42028587|NCT00910624|75836997|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
42028588|NCT00910624|75836998|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
42028589|NCT00910624|75836999|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
42028590|NCT00910624|75836996|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
42028591|NCT00910624|75836997|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
42028592|NCT00910624|75836998|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
42028593|NCT00910624|75836999|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
42028594|NCT00910624|75836996|FG000|Follow-Up Phase|Administrative|0|||
42028595|NCT00910624|75836997|FG001|Follow-Up Phase|Administrative|1|||
42028596|NCT00910624|75836998|FG002|Follow-Up Phase|Administrative|1|||
42028597|NCT00910624|75836999|FG003|Follow-Up Phase|Administrative|0|||
42218470|NCT03354637|76036511|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
42218471|NCT03354637|76036509|FG000|Open Label Extension|Subject Noncompliance|0|||
42028598|NCT01123980|75837013|FG000|Overall Study|Adverse Event|1|||
42028599|NCT01123980|75837014|FG001|Overall Study|Adverse Event|1|||
42028600|NCT01123980|75837013|FG000|Overall Study|Lack of Efficacy|1|||
42218472|NCT03354637|76036510|FG001|Open Label Extension|Subject Noncompliance|0|||
41979064|NCT02728102|75783966|FG000|Overall Study|Physician Decision|1|||
41979065|NCT02728102|75783967|FG001|Overall Study|Physician Decision|1|||
41979066|NCT02728102|75783968|FG002|Overall Study|Physician Decision|0|||
41979067|NCT02728102|75783966|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
41979068|NCT02728102|75783967|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
41979069|NCT02728102|75783968|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
41979070|NCT02728102|75783966|FG000|Overall Study|Covid|0|||
41979071|NCT02728102|75783967|FG001|Overall Study|Covid|0|||
41979072|NCT02728102|75783968|FG002|Overall Study|Covid|1|||
41979073|NCT02660580|75783979|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
41979074|NCT02660580|75783980|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
41979075|NCT02660580|75783981|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
41979076|NCT02660580|75783982|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
41979077|NCT02660580|75783983|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
41979078|NCT02660580|75783979|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
41979079|NCT02660580|75783980|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
41979080|NCT02660580|75783981|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
41979081|NCT02660580|75783982|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
41979082|NCT02660580|75783983|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
41979083|NCT02660580|75783979|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
41979084|NCT02660580|75783980|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
41979085|NCT02660580|75783981|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
41979086|NCT02660580|75783982|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
41979087|NCT02660580|75783983|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
41979088|NCT02660580|75783979|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
41979089|NCT02660580|75783980|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
41979090|NCT02660580|75783981|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
41979091|NCT02660580|75783982|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
41979092|NCT02660580|75783983|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
41979093|NCT02660580|75783979|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
41979094|NCT02660580|75783980|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
41979095|NCT02660580|75783981|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
41979096|NCT02660580|75783982|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
41979097|NCT02660580|75783983|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
41979098|NCT02660580|75783979|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
41979099|NCT02660580|75783980|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
41979100|NCT02660580|75783981|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
41979101|NCT02660580|75783982|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
41979102|NCT02660580|75783983|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
41979103|NCT02660580|75783979|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
41979104|NCT02660580|75783980|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
41979105|NCT02660580|75783981|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
41979106|NCT02660580|75783982|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
41979107|NCT02660580|75783983|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
42218473|NCT03354637|76036511|FG002|Open Label Extension|Subject Noncompliance|1|||
41979108|NCT02660580|75783979|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
41979109|NCT02660580|75783980|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
41979110|NCT02660580|75783981|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
42218474|NCT03354637|76036509|FG000|Open Label Extension|Lack of Efficacy|0|||
42218475|NCT03354637|76036510|FG001|Open Label Extension|Lack of Efficacy|0|||
42218476|NCT03354637|76036511|FG002|Open Label Extension|Lack of Efficacy|1|||
42218477|NCT03354637|76036509|FG000|Open Label Extension|Physician Decision|0|||
42218478|NCT03354637|76036510|FG001|Open Label Extension|Physician Decision|0|||
42218479|NCT03354637|76036511|FG002|Open Label Extension|Physician Decision|1|||
42218480|NCT04053023|76036522|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
42218481|NCT04053023|76036523|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
42218482|NCT03352453|76036535|FG000|Overall Study|Miscellaneous Reasons|1|||
42218483|NCT03352453|76036536|FG001|Overall Study|Miscellaneous Reasons|2|||
42218484|NCT03352453|76036535|FG000|Overall Study|Lack of Efficacy|1|||
42218485|NCT03352453|76036536|FG001|Overall Study|Lack of Efficacy|0|||
42218486|NCT03352453|76036535|FG000|Overall Study|Withdrawal by Subject|8|||
42218487|NCT03352453|76036536|FG001|Overall Study|Withdrawal by Subject|14|||
42218488|NCT03352453|76036535|FG000|Overall Study|Study Terminated by Sponsor|2|||
42218489|NCT03352453|76036536|FG001|Overall Study|Study Terminated by Sponsor|1|||
42218490|NCT03352453|76036535|FG000|Overall Study|Protocol Deviation|1|||
42218491|NCT03352453|76036536|FG001|Overall Study|Protocol Deviation|0|||
42218492|NCT03352453|76036535|FG000|Overall Study|Lost to Follow-up|7|||
41979111|NCT02660580|75783982|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
42218493|NCT03352453|76036536|FG001|Overall Study|Lost to Follow-up|6|||
42218494|NCT03352453|76036535|FG000|Overall Study|Adverse Event|2|||
42218495|NCT03352453|76036536|FG001|Overall Study|Adverse Event|9|||
42218496|NCT03128931|76036542|FG000|Overall Study|Physician Decision|1|||
42218497|NCT03128931|76036542|FG000|Overall Study|Equipment Issues|3|||
41979112|NCT02660580|75783983|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
41979113|NCT02660580|75783979|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
41979114|NCT02660580|75783980|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
41979115|NCT02660580|75783981|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
41979116|NCT02660580|75783982|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
41979117|NCT02660580|75783983|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
41979118|NCT02660580|75783979|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
41979119|NCT02660580|75783980|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
41979120|NCT02660580|75783981|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
41979121|NCT02660580|75783982|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
41979122|NCT02660580|75783983|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
41979123|NCT02660580|75783979|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
41979124|NCT02660580|75783980|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
41979125|NCT02660580|75783981|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
41979126|NCT02660580|75783982|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
42028601|NCT01123980|75837014|FG001|Overall Study|Lack of Efficacy|0|||
42218498|NCT03107052|76036549|FG000|Overall Study|Adverse Event|6|||
42218499|NCT03107052|76036550|FG001|Overall Study|Adverse Event|1|||
42218500|NCT03107052|76036551|FG002|Overall Study|Adverse Event|2|||
42218501|NCT03107052|76036549|FG000|Overall Study|Withdrawal by Subject|9|||
42218502|NCT03107052|76036550|FG001|Overall Study|Withdrawal by Subject|5|||
41979127|NCT02660580|75783983|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
42028602|NCT01123980|75837013|FG000|Overall Study|Physician Decision|0|||
42028603|NCT01123980|75837014|FG001|Overall Study|Physician Decision|1|||
42028604|NCT01123980|75837013|FG000|Overall Study|Lost to Follow-up|0|||
42218503|NCT03107052|76036551|FG002|Overall Study|Withdrawal by Subject|8|||
42218504|NCT03107052|76036549|FG000|Overall Study|Protocol Violation|6|||
42218505|NCT03107052|76036550|FG001|Overall Study|Protocol Violation|0|||
42218506|NCT03107052|76036551|FG002|Overall Study|Protocol Violation|3|||
42028605|NCT01123980|75837014|FG001|Overall Study|Lost to Follow-up|6|||
42218507|NCT03107052|76036549|FG000|Overall Study|Lost to Follow-up|4|||
42218508|NCT03107052|76036550|FG001|Overall Study|Lost to Follow-up|0|||
42218509|NCT03107052|76036551|FG002|Overall Study|Lost to Follow-up|1|||
42218510|NCT03107052|76036549|FG000|Overall Study|Lack of Efficacy|23|||
42218511|NCT03107052|76036550|FG001|Overall Study|Lack of Efficacy|7|||
42218512|NCT03107052|76036551|FG002|Overall Study|Lack of Efficacy|4|||
42218513|NCT03107052|76036549|FG000|Overall Study|Other than specified|4|||
41979128|NCT02660580|75783979|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
41979129|NCT02660580|75783980|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
41979130|NCT02660580|75783981|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
41979131|NCT02660580|75783982|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
41979132|NCT02660580|75783983|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
41979133|NCT02660580|75783979|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
41979134|NCT02660580|75783980|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
41979135|NCT02660580|75783981|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
41979136|NCT02660580|75783982|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
41979137|NCT02660580|75783983|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
41979138|NCT02600897|75784011|FG000|Overall Study|Death|1|||
41979139|NCT02600897|75784012|FG001|Overall Study|Death|2|||
41979140|NCT02600897|75784013|FG002|Overall Study|Death|1|||
41979141|NCT02600897|75784014|FG003|Overall Study|Death|2|||
41979142|NCT02600897|75784015|FG004|Overall Study|Death|3|||
41979143|NCT02600897|75784016|FG005|Overall Study|Death|2|||
41979144|NCT02600897|75784017|FG006|Overall Study|Death|10|||
41979145|NCT02600897|75784018|FG007|Overall Study|Death|7|||
41979146|NCT02600897|75784019|FG008|Overall Study|Death|20|||
41979147|NCT02600897|75784011|FG000|Overall Study|Lost to Follow-up|1|||
41979148|NCT02600897|75784012|FG001|Overall Study|Lost to Follow-up|0|||
41979149|NCT02600897|75784013|FG002|Overall Study|Lost to Follow-up|0|||
41979150|NCT02600897|75784014|FG003|Overall Study|Lost to Follow-up|0|||
41979151|NCT02600897|75784015|FG004|Overall Study|Lost to Follow-up|0|||
41979152|NCT02600897|75784016|FG005|Overall Study|Lost to Follow-up|0|||
41979153|NCT02600897|75784017|FG006|Overall Study|Lost to Follow-up|0|||
41979154|NCT02600897|75784018|FG007|Overall Study|Lost to Follow-up|1|||
41979155|NCT02600897|75784019|FG008|Overall Study|Lost to Follow-up|0|||
41979156|NCT02600897|75784011|FG000|Overall Study|Withdrawal by Subject|0|||
41979157|NCT02600897|75784012|FG001|Overall Study|Withdrawal by Subject|0|||
41979158|NCT02600897|75784013|FG002|Overall Study|Withdrawal by Subject|0|||
41979159|NCT02600897|75784014|FG003|Overall Study|Withdrawal by Subject|0|||
41979160|NCT02600897|75784015|FG004|Overall Study|Withdrawal by Subject|0|||
41979161|NCT02600897|75784016|FG005|Overall Study|Withdrawal by Subject|0|||
41979162|NCT02600897|75784017|FG006|Overall Study|Withdrawal by Subject|0|||
41979163|NCT02600897|75784018|FG007|Overall Study|Withdrawal by Subject|4|||
41979164|NCT02600897|75784019|FG008|Overall Study|Withdrawal by Subject|2|||
41979165|NCT02600897|75784011|FG000|Overall Study|Reason Not Specified|0|||
41979166|NCT02600897|75784012|FG001|Overall Study|Reason Not Specified|0|||
41979167|NCT02600897|75784013|FG002|Overall Study|Reason Not Specified|0|||
41979168|NCT02600897|75784014|FG003|Overall Study|Reason Not Specified|0|||
41979169|NCT02600897|75784015|FG004|Overall Study|Reason Not Specified|0|||
41979170|NCT02600897|75784016|FG005|Overall Study|Reason Not Specified|0|||
41979171|NCT02600897|75784017|FG006|Overall Study|Reason Not Specified|0|||
41979172|NCT02600897|75784018|FG007|Overall Study|Reason Not Specified|0|||
41979173|NCT02600897|75784019|FG008|Overall Study|Reason Not Specified|1|||
41979174|NCT02399215|75784048|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
41979175|NCT02399215|75784048|FG000|Overall Study|Withdrawal by Subject|1|||
41979176|NCT02365649|75784058|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
41979177|NCT02365649|75784059|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
41979178|NCT02365649|75784060|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
41979179|NCT02365649|75784061|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
41979180|NCT02365649|75784062|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
41979181|NCT02365649|75784063|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
41979182|NCT02365649|75784064|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
41979183|NCT02365649|75784065|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
41979184|NCT02365649|75784066|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
41979185|NCT02365649|75784067|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
41979186|NCT02365649|75784058|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
41979187|NCT02365649|75784059|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
41979188|NCT02365649|75784060|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
41979189|NCT02365649|75784061|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
41979190|NCT02365649|75784062|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
41979191|NCT02365649|75784063|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
41979192|NCT02365649|75784064|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
42218514|NCT03107052|76036550|FG001|Overall Study|Other than specified|2|||
42218515|NCT03107052|76036551|FG002|Overall Study|Other than specified|0|||
42218516|NCT03107052|76036549|FG000|Overall Study|Study terminated due to futility|67|||
42218517|NCT03107052|76036550|FG001|Overall Study|Study terminated due to futility|31|||
42218518|NCT03107052|76036551|FG002|Overall Study|Study terminated due to futility|23|||
42218519|NCT04050371|76036561|FG000|Overall Study|Withdrawal by Subject|1|||
42218520|NCT04050371|76036562|FG001|Overall Study|Withdrawal by Subject|0|||
42218521|NCT04447287|76036571|FG000|Period 1: Run-in Period|Adverse Event|3|||
42218522|NCT04447287|76036572|FG001|Period 1: Run-in Period|Adverse Event|0|||
42218523|NCT04447287|76036573|FG002|Period 1: Run-in Period|Adverse Event|0|||
42218524|NCT04447287|76036571|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
42302171|NCT02495857|76137245|FG000|Overall Study|Withdrawal by Subject|9|||
41979193|NCT02365649|75784065|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
41979194|NCT02365649|75784066|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
41979195|NCT02365649|75784067|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
41979196|NCT02365649|75784058|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
41979197|NCT02365649|75784059|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
41979198|NCT02365649|75784060|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
42129831|NCT00404547|75940787|FG000|Overall Study|Lack of compliance|5|||
42129832|NCT00404547|75940788|FG001|Overall Study|Lack of compliance|1|||
42129833|NCT00404547|75940787|FG000|Overall Study|Other|4|||
42129834|NCT00404547|75940788|FG001|Overall Study|Other|0|||
42129835|NCT00404547|75940787|FG000|Overall Study|Reason not stated|3|||
42129836|NCT00404547|75940788|FG001|Overall Study|Reason not stated|6|||
42129837|NCT00515034|75940798|FG000|Overall Study|Adverse Event|2|||
42129838|NCT00515034|75940799|FG001|Overall Study|Adverse Event|0|||
42129839|NCT00515034|75940800|FG002|Overall Study|Adverse Event|1|||
42129840|NCT00515034|75940801|FG003|Overall Study|Adverse Event|0|||
42129841|NCT00515034|75940798|FG000|Overall Study|Death|4|||
42129842|NCT00515034|75940799|FG001|Overall Study|Death|2|||
42129843|NCT00515034|75940800|FG002|Overall Study|Death|1|||
42129844|NCT00515034|75940801|FG003|Overall Study|Death|3|||
42302172|NCT02495857|76137246|FG001|Overall Study|Withdrawal by Subject|6|||
41979199|NCT02365649|75784061|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
41979200|NCT02365649|75784062|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
42129845|NCT00515034|75940798|FG000|Overall Study|Withdrawal by Subject|1|||
42129846|NCT00515034|75940799|FG001|Overall Study|Withdrawal by Subject|0|||
42129847|NCT00515034|75940800|FG002|Overall Study|Withdrawal by Subject|3|||
42218525|NCT04447287|76036572|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
42218526|NCT04447287|76036573|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
41979201|NCT02365649|75784063|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
41979202|NCT02365649|75784064|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
41979203|NCT02365649|75784065|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
41979204|NCT02365649|75784066|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
41979205|NCT02365649|75784067|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
41979206|NCT02365649|75784058|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
41979207|NCT02365649|75784059|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
41979208|NCT02365649|75784060|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
41979209|NCT02365649|75784061|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
41979210|NCT02365649|75784062|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
41979211|NCT02365649|75784063|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
42028606|NCT01123980|75837013|FG000|Overall Study|Protocol Violation|6|||
41979212|NCT02365649|75784064|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
41979213|NCT02365649|75784065|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
41979214|NCT02365649|75784066|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
41979215|NCT02365649|75784067|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
41979216|NCT02365649|75784058|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
41979217|NCT02365649|75784059|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
41979218|NCT02365649|75784060|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
41979219|NCT02365649|75784061|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
41979220|NCT02365649|75784062|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
41979221|NCT02365649|75784063|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
41979222|NCT02365649|75784064|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
41979223|NCT02365649|75784065|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
41979224|NCT02365649|75784066|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
41979225|NCT02365649|75784067|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
41979226|NCT02365649|75784058|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
41979227|NCT02365649|75784059|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
41979228|NCT02365649|75784060|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
41979229|NCT02365649|75784061|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
41979230|NCT02365649|75784062|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
41979231|NCT02365649|75784063|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
41979232|NCT02365649|75784064|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
41979233|NCT02365649|75784065|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
41979234|NCT02365649|75784066|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
41979235|NCT02365649|75784067|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
41979236|NCT02365649|75784058|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
41979237|NCT02365649|75784059|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
41979238|NCT02365649|75784060|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
42129848|NCT00515034|75940801|FG003|Overall Study|Withdrawal by Subject|0|||
42129849|NCT00515034|75940798|FG000|Overall Study|Physician Decision|0|||
42129850|NCT00515034|75940799|FG001|Overall Study|Physician Decision|0|||
42129851|NCT00515034|75940800|FG002|Overall Study|Physician Decision|1|||
42129852|NCT00515034|75940801|FG003|Overall Study|Physician Decision|1|||
41979239|NCT02365649|75784061|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
41979240|NCT02365649|75784062|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
41979241|NCT02365649|75784063|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
41979242|NCT02365649|75784064|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
41979243|NCT02365649|75784065|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
41979244|NCT02365649|75784066|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
41979245|NCT02365649|75784067|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
41979246|NCT02365649|75784058|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
41979247|NCT02365649|75784059|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
41979248|NCT02365649|75784060|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
41979249|NCT02365649|75784061|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
41979250|NCT02365649|75784062|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
41979251|NCT02365649|75784063|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
41979252|NCT02365649|75784064|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
41979253|NCT02365649|75784065|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
41979254|NCT02365649|75784066|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
41979255|NCT02365649|75784067|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
41979256|NCT02365649|75784058|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
41979257|NCT02365649|75784059|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
41979258|NCT02365649|75784060|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
41979259|NCT02365649|75784061|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
41979260|NCT02365649|75784062|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
41979261|NCT02365649|75784063|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
41979262|NCT02365649|75784064|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
41979263|NCT02365649|75784065|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
42028607|NCT01123980|75837014|FG001|Overall Study|Protocol Violation|6|||
42218527|NCT04447287|76036571|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
42218528|NCT04447287|76036572|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
42218529|NCT04447287|76036573|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
42218530|NCT01879319|76036594|FG000|Overall Study|Withdrawal by Subject|1|||
42218531|NCT01879319|76036595|FG001|Overall Study|Withdrawal by Subject|0|||
42218532|NCT01879319|76036594|FG000|Overall Study|Lost to Follow-up|1|||
42218533|NCT01879319|76036595|FG001|Overall Study|Lost to Follow-up|5|||
42218534|NCT03102918|76036603|FG000|Overall Study|Protocol Violation|1|||
42218535|NCT03102918|76036604|FG001|Overall Study|Protocol Violation|0|||
42218536|NCT03128307|76036610|FG000|Overall Study|Lost to Follow-up|29|||
42218537|NCT03128307|76036610|FG000|Overall Study|Withdrawal by Subject|5|||
42218538|NCT03102762|76036616|FG000|Overall Study|Lost to Follow-up|1|||
42218539|NCT03102762|76036617|FG001|Overall Study|Lost to Follow-up|0|||
42218540|NCT01346475|76036630|FG000|First Intervention|Lost to Follow-up|4|||
42218541|NCT01346475|76036631|FG001|First Intervention|Lost to Follow-up|3|||
42218542|NCT01338636|76036637|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
42218543|NCT00322218|76036643|FG000|Overall Study|Death|3|||
42218544|NCT00322218|76036644|FG001|Overall Study|Death|6|||
42218545|NCT02873754|76036650|FG000|Overall Study|Lost to Follow-up|5|||
42218546|NCT02873754|76036650|FG000|Overall Study|Couldn't complete study procedures|1|||
42218547|NCT03287414|76036656|FG000|Treatment Epoch|Adverse Event|0|||
42218548|NCT03287414|76036657|FG001|Treatment Epoch|Adverse Event|1|||
42218549|NCT03287414|76036656|FG000|Treatment Epoch|Study terminated by sponsor|2|||
42218550|NCT03287414|76036657|FG001|Treatment Epoch|Study terminated by sponsor|2|||
42218551|NCT03287414|76036656|FG000|Treatment Epoch|Subject/Guardian decision|4|||
42218552|NCT03287414|76036657|FG001|Treatment Epoch|Subject/Guardian decision|0|||
42218553|NCT03287414|76036656|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
42218554|NCT03287414|76036657|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
42218555|NCT03287414|76036656|FG000|Treatment Epoch|Withdrawal by Subject|1|||
42218556|NCT03287414|76036657|FG001|Treatment Epoch|Withdrawal by Subject|0|||
42218557|NCT03287414|76036656|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
42218558|NCT03287414|76036657|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
42218559|NCT03287414|76036656|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
42218560|NCT03287414|76036657|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
42218561|NCT03101592|76036687|FG000|Overall Study|participant files could not be located|111|||
42218562|NCT03101592|76036688|FG001|Overall Study|participant files could not be located|170|||
42218563|NCT03101592|76036689|FG002|Overall Study|participant files could not be located|118|||
42218564|NCT04046939|76036707|FG000|Primary Assessment Period|Adverse Event|1|||
42218565|NCT04046939|76036708|FG001|Primary Assessment Period|Adverse Event|0|||
42218566|NCT04046939|76036709|FG002|Primary Assessment Period|Adverse Event|0|||
42218567|NCT04046939|76036710|FG003|Primary Assessment Period|Adverse Event|0|||
42218568|NCT04046939|76036707|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
42218569|NCT04046939|76036708|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
42218570|NCT04046939|76036709|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
42218571|NCT04046939|76036710|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
42218572|NCT04046939|76036707|FG000|Primary Assessment Period|Physician Decision|0|||
42218573|NCT04046939|76036708|FG001|Primary Assessment Period|Physician Decision|0|||
42218574|NCT04046939|76036709|FG002|Primary Assessment Period|Physician Decision|1|||
42218575|NCT04046939|76036710|FG003|Primary Assessment Period|Physician Decision|0|||
42218576|NCT04046939|76036707|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
42218577|NCT04046939|76036708|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
42218578|NCT04046939|76036709|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
42218579|NCT04046939|76036710|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
42218580|NCT04042103|76036726|FG000|Overall Study|Lost to Follow-up|1|||
42218581|NCT04042103|76036726|FG000|Overall Study|Withdrawal by Subject|1|||
42218582|NCT02955797|76036734|FG000|Overall Study|Protocol Violation|1|||
42218583|NCT02955797|76036735|FG001|Overall Study|Protocol Violation|0|||
42218584|NCT02955797|76036736|FG002|Overall Study|Protocol Violation|0|||
42302173|NCT02495857|76137247|FG002|Overall Study|Withdrawal by Subject|10|||
42302174|NCT02495857|76137245|FG000|Overall Study|Physician Decision|0|||
42302175|NCT02495857|76137246|FG001|Overall Study|Physician Decision|1|||
42218585|NCT02955797|76036737|FG003|Overall Study|Protocol Violation|1|||
42218586|NCT02955797|76036734|FG000|Overall Study|Withdrawal by Subject|2|||
42218587|NCT02955797|76036735|FG001|Overall Study|Withdrawal by Subject|2|||
42218588|NCT02955797|76036736|FG002|Overall Study|Withdrawal by Subject|0|||
42218589|NCT02955797|76036737|FG003|Overall Study|Withdrawal by Subject|1|||
42302176|NCT02495857|76137247|FG002|Overall Study|Physician Decision|0|||
42218590|NCT02955797|76036734|FG000|Overall Study|Lost to Follow-up|0|||
42129853|NCT00515034|75940798|FG000|Overall Study|Other|1|||
42129854|NCT00515034|75940799|FG001|Overall Study|Other|0|||
42129855|NCT00515034|75940800|FG002|Overall Study|Other|2|||
42218591|NCT02955797|76036735|FG001|Overall Study|Lost to Follow-up|1|||
42129856|NCT00515034|75940801|FG003|Overall Study|Other|1|||
42129857|NCT00404235|75940813|FG000|Overall Study|Withdrawal by Subject|1|||
42129858|NCT00404235|75940814|FG001|Overall Study|Withdrawal by Subject|2|||
42129859|NCT00404079|75940822|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
42129860|NCT00404079|75940823|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
42218592|NCT02955797|76036736|FG002|Overall Study|Lost to Follow-up|0|||
42218593|NCT02955797|76036737|FG003|Overall Study|Lost to Follow-up|0|||
42218594|NCT03101514|76036750|FG000|Overall Study|Withdrawal by Subject|4|||
42218595|NCT03101514|76036750|FG000|Overall Study|Protocol Violation|2|||
42218596|NCT03101514|76036750|FG000|Overall Study|patient's information was incomplete|1|||
42218597|NCT02702518|76036756|FG000|Overall Study|Lost to Follow-up|3|||
42218598|NCT02702518|76036757|FG001|Overall Study|Lost to Follow-up|4|||
42218599|NCT04039503|76036767|FG000|Overall Study|Adverse Event|3|||
42218600|NCT04039503|76036768|FG001|Overall Study|Adverse Event|0|||
42218601|NCT04039503|76036769|FG002|Overall Study|Adverse Event|2|||
42129861|NCT00403845|75940829|FG000|Treatment Period 1|Subject withdrew consent|1|||
42129862|NCT00403845|75940830|FG001|Treatment Period 1|Subject withdrew consent|0|||
42129863|NCT00403845|75940831|FG002|Treatment Period 1|Subject withdrew consent|0|||
42129864|NCT00403845|75940832|FG003|Treatment Period 1|Subject withdrew consent|0|||
42129865|NCT00403845|75940829|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
42129866|NCT00403845|75940830|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
42129867|NCT00403845|75940831|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
42129868|NCT00403845|75940832|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
42129869|NCT00403845|75940829|FG000|Treatment Period 2|Subject withdrew consent|1|||
42218602|NCT04039503|76036770|FG003|Overall Study|Adverse Event|0|||
42218603|NCT04039503|76036767|FG000|Overall Study|Lost to Follow-up|0|||
42302177|NCT02495857|76137245|FG000|Overall Study|Protocol Violation|1|||
42302178|NCT02495857|76137246|FG001|Overall Study|Protocol Violation|1|||
42218604|NCT04039503|76036768|FG001|Overall Study|Lost to Follow-up|0|||
42218605|NCT04039503|76036769|FG002|Overall Study|Lost to Follow-up|1|||
42218606|NCT04039503|76036770|FG003|Overall Study|Lost to Follow-up|0|||
42218607|NCT04039503|76036767|FG000|Overall Study|Protocol Violation|0|||
42218608|NCT04039503|76036768|FG001|Overall Study|Protocol Violation|1|||
42218609|NCT04039503|76036769|FG002|Overall Study|Protocol Violation|2|||
42218610|NCT04039503|76036770|FG003|Overall Study|Protocol Violation|1|||
42218611|NCT04039503|76036767|FG000|Overall Study|Withdrawal by Subject|4|||
42218612|NCT04039503|76036768|FG001|Overall Study|Withdrawal by Subject|3|||
42218613|NCT04039503|76036769|FG002|Overall Study|Withdrawal by Subject|5|||
42218614|NCT04039503|76036770|FG003|Overall Study|Withdrawal by Subject|2|||
42218615|NCT03131895|76036807|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
42218616|NCT03131895|76036808|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
42218617|NCT03131895|76036809|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
42218618|NCT03131895|76036810|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
42218619|NCT03131895|76036807|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
42218620|NCT03131895|76036808|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
42218621|NCT03131895|76036809|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
42218622|NCT03131895|76036810|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
42218623|NCT03131895|76036807|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
42218624|NCT03131895|76036808|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
42218625|NCT03131895|76036809|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
42218626|NCT03131895|76036810|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
42218627|NCT03131895|76036807|FG000|Washout Period (at Least 5 Days)|Other|0|||
42218628|NCT03131895|76036808|FG001|Washout Period (at Least 5 Days)|Other|0|||
42218629|NCT03131895|76036809|FG002|Washout Period (at Least 5 Days)|Other|2|||
42218630|NCT03131895|76036810|FG003|Washout Period (at Least 5 Days)|Other|0|||
42218631|NCT03131895|76036807|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
42218632|NCT03131895|76036808|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
42218633|NCT03131895|76036809|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
42218634|NCT03131895|76036810|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
42218635|NCT03131895|76036807|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
42218636|NCT03131895|76036808|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
42218637|NCT03131895|76036809|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
42218638|NCT03131895|76036810|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
42218639|NCT04039919|76036825|FG000|Treatment Period 1|Withdrawal by Subject|1|||
42218640|NCT04039919|76036826|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42218641|NCT04039919|76036827|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42302179|NCT02495857|76137247|FG002|Overall Study|Protocol Violation|2|||
42302180|NCT02495857|76137245|FG000|Overall Study|Lost to Follow-up|4|||
42302181|NCT02495857|76137246|FG001|Overall Study|Lost to Follow-up|5|||
41979264|NCT02365649|75784066|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
41979265|NCT02365649|75784067|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
41979266|NCT02365649|75784058|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
41979267|NCT02365649|75784059|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
41979268|NCT02365649|75784060|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
42302182|NCT02495857|76137247|FG002|Overall Study|Lost to Follow-up|3|||
42302183|NCT02495857|76137245|FG000|Overall Study|Other|3|||
41979269|NCT02365649|75784061|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
42218642|NCT04039919|76036828|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42218643|NCT04039919|76036829|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42218644|NCT04039919|76036825|FG000|Treatment Period 1|Sponsor's decision|0|||
42218645|NCT04039919|76036826|FG001|Treatment Period 1|Sponsor's decision|0|||
42218646|NCT04039919|76036827|FG002|Treatment Period 1|Sponsor's decision|0|||
42218647|NCT04039919|76036828|FG003|Treatment Period 1|Sponsor's decision|0|||
42218648|NCT04039919|76036829|FG004|Treatment Period 1|Sponsor's decision|16|||
42218649|NCT04039919|76036825|FG000|Treatment Period 5|Withdrawal by Subject|1|||
41979270|NCT02365649|75784062|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
41979271|NCT02365649|75784063|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
41979272|NCT02365649|75784064|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
42129870|NCT00403845|75940830|FG001|Treatment Period 2|Subject withdrew consent|0|||
42129871|NCT00403845|75940831|FG002|Treatment Period 2|Subject withdrew consent|0|||
42129872|NCT00403845|75940832|FG003|Treatment Period 2|Subject withdrew consent|0|||
42129873|NCT00403845|75940829|FG000|Treatment Period 3|Subject withdrew consent|0|||
42129874|NCT00403845|75940830|FG001|Treatment Period 3|Subject withdrew consent|0|||
42129875|NCT00403845|75940831|FG002|Treatment Period 3|Subject withdrew consent|0|||
42129876|NCT00403845|75940832|FG003|Treatment Period 3|Subject withdrew consent|1|||
42129877|NCT00403845|75940829|FG000|Treatment Period 3|Adverse Event|0|||
42129878|NCT00403845|75940830|FG001|Treatment Period 3|Adverse Event|0|||
42129879|NCT00403845|75940831|FG002|Treatment Period 3|Adverse Event|0|||
42129880|NCT00403845|75940832|FG003|Treatment Period 3|Adverse Event|1|||
42129881|NCT00509262|75940844|FG000|Overall Study|Adverse Event|16|||
42129882|NCT00509262|75940845|FG001|Overall Study|Adverse Event|18|||
42218650|NCT04039919|76036826|FG001|Treatment Period 5|Withdrawal by Subject|0|||
42218651|NCT04039919|76036827|FG002|Treatment Period 5|Withdrawal by Subject|0|||
42218652|NCT04039919|76036828|FG003|Treatment Period 5|Withdrawal by Subject|0|||
42218653|NCT04039919|76036829|FG004|Treatment Period 5|Withdrawal by Subject|0|||
42218654|NCT04035473|76036865|FG000|Screening/Baseline|Death|0|||
42218655|NCT04035473|76036866|FG001|Screening/Baseline|Death|1|||
42218656|NCT04035473|76036865|FG000|Screening/Baseline|Adverse Event|0|||
42218657|NCT04035473|76036866|FG001|Screening/Baseline|Adverse Event|1|||
42218658|NCT04035473|76036865|FG000|Follow-up Period|Adverse Event|2|||
42218659|NCT04035473|76036866|FG001|Follow-up Period|Adverse Event|0|||
42218660|NCT04032977|76036874|FG000|Overall Study|Withdrawal by Subject|6|||
42218661|NCT04032977|76036875|FG001|Overall Study|Withdrawal by Subject|1|||
42218662|NCT04032977|76036874|FG000|Overall Study|Lost to Follow-up|2|||
42218663|NCT04032977|76036875|FG001|Overall Study|Lost to Follow-up|7|||
42218664|NCT04032977|76036874|FG000|Overall Study|Pregnancy|1|||
42218665|NCT04032977|76036875|FG001|Overall Study|Pregnancy|0|||
41979273|NCT02365649|75784065|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
41979274|NCT02365649|75784066|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
41979275|NCT02365649|75784067|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
41979276|NCT02365649|75784058|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
41979277|NCT02365649|75784059|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
41979278|NCT02365649|75784060|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
41979279|NCT02365649|75784061|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
42129883|NCT00509262|75940844|FG000|Overall Study|Other|2|||
42129884|NCT00509262|75940845|FG001|Overall Study|Other|2|||
42129885|NCT00509262|75940844|FG000|Overall Study|Lack of Efficacy|1|||
42129886|NCT00509262|75940845|FG001|Overall Study|Lack of Efficacy|0|||
42218666|NCT04030247|76036881|FG000|Overall Study|Withdrawal by Subject|4|||
42218667|NCT04030247|76036881|FG000|Overall Study|Lost to Follow-up|13|||
42218668|NCT02915978|76036888|FG000|Overall Study|Adverse Event|2|||
42218669|NCT02915978|76036889|FG001|Overall Study|Adverse Event|1|||
42218670|NCT02915978|76036890|FG002|Overall Study|Adverse Event|0|||
42218671|NCT02701192|76036898|FG000|Overall Study|Protocol Violation|2|||
42218672|NCT02701192|76036898|FG000|Overall Study|Lost to Follow-up|4|||
41979280|NCT02365649|75784062|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
41979281|NCT02365649|75784063|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
41979282|NCT02365649|75784064|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
41979283|NCT02365649|75784065|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
41979284|NCT02365649|75784066|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
41979285|NCT02365649|75784067|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
41979286|NCT02365649|75784058|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
41979287|NCT02365649|75784059|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
41979288|NCT02365649|75784060|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
41979289|NCT02365649|75784061|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
41979290|NCT02365649|75784062|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
41979291|NCT02365649|75784063|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
41979292|NCT02365649|75784064|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
41979293|NCT02365649|75784065|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
41979294|NCT02365649|75784066|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
41979295|NCT02365649|75784067|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
41979296|NCT02110225|75784109|FG000|Overall Study|Lost to Follow-up|0|||
41979297|NCT02110225|75784110|FG001|Overall Study|Lost to Follow-up|1|||
41979298|NCT02110225|75784111|FG002|Overall Study|Lost to Follow-up|0|||
41979299|NCT02016820|75784122|FG000|Overall Study|Lost to Follow-up|2|||
41979300|NCT02016820|75784123|FG001|Overall Study|Lost to Follow-up|4|||
41979301|NCT01902173|75784135|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
41979302|NCT01902173|75784136|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
41979303|NCT01902173|75784137|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
41979304|NCT01902173|75784138|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
41979305|NCT01902173|75784139|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
41979306|NCT01902173|75784140|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
41979307|NCT01902173|75784135|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
41979308|NCT01902173|75784136|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
41979309|NCT01902173|75784137|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
41979310|NCT01902173|75784138|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
41979311|NCT01902173|75784139|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
41979312|NCT01902173|75784140|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
41979313|NCT01902173|75784135|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
41979314|NCT01902173|75784136|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
42302184|NCT02495857|76137246|FG001|Overall Study|Other|3|||
42218673|NCT03101358|76036906|FG000|Overall Study|Non-compliance with study schedule|1|||
42218674|NCT03101358|76036907|FG001|Overall Study|Non-compliance with study schedule|0|||
42218675|NCT03101358|76036908|FG002|Overall Study|Non-compliance with study schedule|0|||
42218676|NCT03101358|76036909|FG003|Overall Study|Non-compliance with study schedule|1|||
42218677|NCT03101358|76036906|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
42218678|NCT03101358|76036907|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
42272651|NCT02281318|76102917|FG000|Overall Study|Lack of Efficacy|2|||
42218679|NCT03101358|76036908|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
42218680|NCT03101358|76036909|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
42218681|NCT03101358|76036906|FG000|Overall Study|Physician Decision|1|||
42218682|NCT03101358|76036907|FG001|Overall Study|Physician Decision|0|||
42218683|NCT03101358|76036908|FG002|Overall Study|Physician Decision|0|||
41979315|NCT01902173|75784137|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
41979316|NCT01902173|75784138|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
42218684|NCT03101358|76036909|FG003|Overall Study|Physician Decision|3|||
42218685|NCT03101358|76036906|FG000|Overall Study|Adverse Event|0|||
42218686|NCT03101358|76036907|FG001|Overall Study|Adverse Event|0|||
42218687|NCT03101358|76036908|FG002|Overall Study|Adverse Event|1|||
42218688|NCT03101358|76036909|FG003|Overall Study|Adverse Event|0|||
42218689|NCT03101358|76036906|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
42218690|NCT03101358|76036907|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
42218691|NCT03101358|76036908|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
42218692|NCT03101358|76036909|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
42218693|NCT03101358|76036906|FG000|Overall Study|Lost to Follow-up|1|||
42218694|NCT03101358|76036907|FG001|Overall Study|Lost to Follow-up|0|||
42218695|NCT03101358|76036908|FG002|Overall Study|Lost to Follow-up|0|||
42218696|NCT03101358|76036909|FG003|Overall Study|Lost to Follow-up|1|||
42218697|NCT03657095|76036922|FG000|Overall Study|Withdrawal by Subject|1|||
42218698|NCT03657095|76036923|FG001|Overall Study|Withdrawal by Subject|1|||
42218699|NCT03657095|76036922|FG000|Overall Study|Adverse Event|0|||
42218700|NCT03657095|76036923|FG001|Overall Study|Adverse Event|3|||
42218701|NCT03657095|76036922|FG000|Overall Study|Study Terminated by Sponsor|58|||
42218702|NCT03657095|76036923|FG001|Overall Study|Study Terminated by Sponsor|49|||
42218703|NCT03100344|76036933|FG000|Overall Study|Adverse Event|0|||
42218704|NCT03100344|76036934|FG001|Overall Study|Adverse Event|3|||
42218705|NCT03100344|76036935|FG002|Overall Study|Adverse Event|2|||
42218706|NCT03100344|76036936|FG003|Overall Study|Adverse Event|3|||
42218707|NCT03100344|76036933|FG000|Overall Study|Lack of Efficacy|2|||
42218708|NCT03100344|76036934|FG001|Overall Study|Lack of Efficacy|0|||
42218709|NCT03100344|76036935|FG002|Overall Study|Lack of Efficacy|0|||
42218710|NCT03100344|76036936|FG003|Overall Study|Lack of Efficacy|0|||
42218711|NCT03100344|76036933|FG000|Overall Study|Protocol Violation|1|||
42218712|NCT03100344|76036934|FG001|Overall Study|Protocol Violation|0|||
42218713|NCT03100344|76036935|FG002|Overall Study|Protocol Violation|0|||
42218714|NCT03100344|76036936|FG003|Overall Study|Protocol Violation|0|||
42218715|NCT03100344|76036933|FG000|Overall Study|Withdrawal by Subject|10|||
42218716|NCT03100344|76036934|FG001|Overall Study|Withdrawal by Subject|7|||
42218717|NCT03100344|76036935|FG002|Overall Study|Withdrawal by Subject|4|||
42218718|NCT03100344|76036936|FG003|Overall Study|Withdrawal by Subject|8|||
42218719|NCT03100344|76036933|FG000|Overall Study|Lost to Follow-up|1|||
42218720|NCT03100344|76036934|FG001|Overall Study|Lost to Follow-up|1|||
42218721|NCT03100344|76036935|FG002|Overall Study|Lost to Follow-up|1|||
42218722|NCT03100344|76036936|FG003|Overall Study|Lost to Follow-up|1|||
42218723|NCT02951533|76036949|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
42218724|NCT02951533|76036950|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
42218725|NCT02951533|76036951|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
42302185|NCT02495857|76137247|FG002|Overall Study|Other|2|||
42129887|NCT00509262|75940844|FG000|Overall Study|Lost to Follow-up|1|||
42129888|NCT00509262|75940845|FG001|Overall Study|Lost to Follow-up|6|||
42129889|NCT00509262|75940844|FG000|Overall Study|Physician Decision|1|||
42129890|NCT00509262|75940845|FG001|Overall Study|Physician Decision|3|||
42129891|NCT00509262|75940844|FG000|Overall Study|Protocol Violation|2|||
42129892|NCT00509262|75940845|FG001|Overall Study|Protocol Violation|2|||
42129893|NCT00509262|75940844|FG000|Overall Study|Withdrawal by Subject|24|||
42129894|NCT00509262|75940845|FG001|Overall Study|Withdrawal by Subject|11|||
42129895|NCT00607997|75940855|FG000|Overall Study|Lack of Efficacy|6|||
42129896|NCT00607997|75940856|FG001|Overall Study|Lack of Efficacy|20|||
42218726|NCT02951533|76036949|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
42218727|NCT02951533|76036950|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
41979317|NCT01902173|75784139|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
42129897|NCT00607997|75940857|FG002|Overall Study|Lack of Efficacy|14|||
42129898|NCT00607997|75940858|FG003|Overall Study|Lack of Efficacy|10|||
42218728|NCT02951533|76036951|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
42218729|NCT02951533|76036949|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
42218730|NCT02951533|76036950|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
42218731|NCT02951533|76036951|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
42218732|NCT02951533|76036949|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
42218733|NCT02951533|76036950|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
42218734|NCT02951533|76036951|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
41979318|NCT01902173|75784140|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
41979319|NCT01902173|75784135|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
41979320|NCT01902173|75784136|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
41979321|NCT01902173|75784137|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
41979322|NCT01902173|75784138|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
41979323|NCT01902173|75784139|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
41979324|NCT01902173|75784140|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
41979325|NCT01902173|75784135|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
41979326|NCT01902173|75784136|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
41979327|NCT01902173|75784137|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
41979328|NCT01902173|75784138|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
41979329|NCT01902173|75784139|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
41979330|NCT01902173|75784140|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
41979331|NCT01902173|75784135|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
41979332|NCT01902173|75784136|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
41979333|NCT01902173|75784137|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
41979334|NCT01902173|75784138|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
41979335|NCT01902173|75784139|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
42129899|NCT00607997|75940855|FG000|Overall Study|Death|8|||
42129900|NCT00607997|75940856|FG001|Overall Study|Death|5|||
42218735|NCT02951533|76036949|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
42129901|NCT00607997|75940857|FG002|Overall Study|Death|2|||
42129902|NCT00607997|75940858|FG003|Overall Study|Death|5|||
41979336|NCT01902173|75784140|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
41979337|NCT01902173|75784135|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
41979338|NCT01902173|75784136|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
41979339|NCT01902173|75784137|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
41979340|NCT01902173|75784138|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
41979341|NCT01902173|75784139|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
41979342|NCT01902173|75784140|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
41979343|NCT01902173|75784135|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
41979344|NCT01902173|75784136|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
41979345|NCT01902173|75784137|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
41979346|NCT01902173|75784138|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
41979347|NCT01902173|75784139|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
41979348|NCT01902173|75784140|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
41979349|NCT01902173|75784135|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
42218736|NCT02951533|76036950|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
42218737|NCT02951533|76036951|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
42218738|NCT02951533|76036949|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
42218739|NCT02951533|76036950|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
42218740|NCT02951533|76036951|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
42218741|NCT02951533|76036949|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
42218742|NCT02951533|76036950|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
42218743|NCT02951533|76036951|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
42218744|NCT02951533|76036949|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
42218745|NCT02951533|76036950|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
42218746|NCT02951533|76036951|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
42218747|NCT02951533|76036949|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
42302186|NCT02495389|76137255|FG000|Overall Study|Withdrawal by Subject|40|||
42218748|NCT02951533|76036950|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
41979350|NCT01902173|75784136|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
41979351|NCT01902173|75784137|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
42129903|NCT00607997|75940855|FG000|Overall Study|Adverse Event|3|||
42218749|NCT02951533|76036951|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
41979352|NCT01902173|75784138|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
41979353|NCT01902173|75784139|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
41979354|NCT01902173|75784140|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
41979355|NCT01902173|75784135|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
41979356|NCT01902173|75784136|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
41979357|NCT01902173|75784137|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
42218750|NCT02951533|76036949|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
42218751|NCT02951533|76036950|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
42218752|NCT02951533|76036951|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
42218753|NCT02951533|76036949|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
42218754|NCT02951533|76036950|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
42218755|NCT02951533|76036951|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
42218756|NCT02700412|76036968|FG000|Overall Study|Adverse Event|6|||
42218757|NCT02700412|76036968|FG000|Overall Study|Death|1|||
42218758|NCT02700412|76036968|FG000|Overall Study|Lack of Efficacy|19|||
42218759|NCT02700412|76036968|FG000|Overall Study|Protocol Violation|5|||
42218760|NCT02700412|76036968|FG000|Overall Study|Withdrawal by Subject|2|||
42218761|NCT03665441|76036974|FG000|Overall Study|survival follow up ongoing|23|||
42218762|NCT03665441|76036975|FG001|Overall Study|survival follow up ongoing|0|||
42218763|NCT03665441|76036974|FG000|Overall Study|Patients ongoing on treatment|9|||
42218764|NCT03665441|76036975|FG001|Overall Study|Patients ongoing on treatment|6|||
42218765|NCT03665441|76036974|FG000|Overall Study|Randomized but not treated|7|||
42218766|NCT03665441|76036975|FG001|Overall Study|Randomized but not treated|11|||
42218767|NCT02699866|76036981|FG000|Overall Study|Withdrawal by Subject|3|||
42218768|NCT02699866|76036981|FG000|Overall Study|Physician Decision|2|||
42218769|NCT02699866|76036981|FG000|Overall Study|Adverse Event|3|||
42218770|NCT03663569|76036985|FG000|Overall Study|Discontinuation of study|11|||
42218771|NCT03663569|76036985|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
42218772|NCT03663569|76036985|FG000|Overall Study|Deceased patient|6|||
42218773|NCT03663569|76036985|FG000|Overall Study|Lost to Follow-up|18|||
42218774|NCT03663569|76036985|FG000|Overall Study|Withdrawal of consent|5|||
42218775|NCT03663569|76036985|FG000|Overall Study|Patient's request|11|||
42218776|NCT03663569|76036985|FG000|Overall Study|Adverse Event|4|||
42218777|NCT03663569|76036985|FG000|Overall Study|Not come to second visit|3|||
42218778|NCT03663569|76036985|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
42218779|NCT03663569|76036985|FG000|Overall Study|Serious adverse event|1|||
42218780|NCT03596762|76036994|FG000|Overall Study|Protocol Violation|0|||
41979358|NCT01902173|75784138|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
41979359|NCT01902173|75784139|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
41979360|NCT01902173|75784140|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
42218781|NCT03596762|76036995|FG001|Overall Study|Protocol Violation|0|||
42218782|NCT03596762|76036996|FG002|Overall Study|Protocol Violation|0|||
42218783|NCT03596762|76036997|FG003|Overall Study|Protocol Violation|0|||
42218784|NCT03596762|76036998|FG004|Overall Study|Protocol Violation|1|||
42218785|NCT03596762|76036994|FG000|Overall Study|Adverse Event|2|||
42028608|NCT01123980|75837013|FG000|Overall Study|Withdrawal by Subject|5|||
42218786|NCT03596762|76036995|FG001|Overall Study|Adverse Event|0|||
42218787|NCT03596762|76036996|FG002|Overall Study|Adverse Event|1|||
42218788|NCT03596762|76036997|FG003|Overall Study|Adverse Event|0|||
42218789|NCT03596762|76036998|FG004|Overall Study|Adverse Event|5|||
41979361|NCT01902173|75784135|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
41979362|NCT01902173|75784136|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
41979363|NCT01902173|75784137|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
41979364|NCT01902173|75784138|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
41979365|NCT01902173|75784139|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
41979366|NCT01902173|75784140|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
41979367|NCT01902173|75784135|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
41979368|NCT01902173|75784136|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
41979369|NCT01902173|75784137|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
41979370|NCT01902173|75784138|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
41979371|NCT01902173|75784139|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
41979372|NCT01902173|75784140|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
41979373|NCT01902173|75784135|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
41979374|NCT01902173|75784136|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
41979375|NCT01902173|75784137|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
41979376|NCT01902173|75784138|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
41979377|NCT01902173|75784139|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
41979378|NCT01902173|75784140|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
41979379|NCT01902173|75784135|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
41979380|NCT01902173|75784136|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
41979381|NCT01902173|75784137|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
42218790|NCT03596762|76036994|FG000|Overall Study|Withdrawal by Subject|2|||
42218791|NCT03596762|76036995|FG001|Overall Study|Withdrawal by Subject|1|||
42218792|NCT03596762|76036996|FG002|Overall Study|Withdrawal by Subject|0|||
42218793|NCT03596762|76036997|FG003|Overall Study|Withdrawal by Subject|1|||
42272652|NCT02281318|76102918|FG001|Overall Study|Lack of Efficacy|0|||
41979382|NCT01902173|75784138|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
42218794|NCT03596762|76036998|FG004|Overall Study|Withdrawal by Subject|1|||
42218795|NCT03663179|76037016|FG000|Overall Study|Withdrawal by Subject|2|||
42218796|NCT03663179|76037017|FG001|Overall Study|Withdrawal by Subject|0|||
42218797|NCT03663179|76037016|FG000|Overall Study|Lost to Follow-up|1|||
42218798|NCT03663179|76037017|FG001|Overall Study|Lost to Follow-up|1|||
42218799|NCT03663179|76037016|FG000|Overall Study|Revealed exclusionary condition|1|||
42218800|NCT03663179|76037017|FG001|Overall Study|Revealed exclusionary condition|0|||
42218801|NCT03662789|76037025|FG000|Overall Study|Lost to Follow-up|1|||
42218802|NCT03662789|76037026|FG001|Overall Study|Lost to Follow-up|2|||
42218803|NCT03662789|76037025|FG000|Overall Study|Could not perform treadmill test|4|||
42218804|NCT03662789|76037026|FG001|Overall Study|Could not perform treadmill test|4|||
42218805|NCT03662789|76037025|FG000|Overall Study|Death|0|||
42218806|NCT03662789|76037026|FG001|Overall Study|Death|1|||
42218807|NCT03658889|76037034|FG000|Overall Study|Protocol Violation|2|||
42218808|NCT03658889|76037035|FG001|Overall Study|Protocol Violation|0|||
42218809|NCT03655691|76037043|FG000|Overall Study|Adverse Event|0|||
42218810|NCT03655691|76037044|FG001|Overall Study|Adverse Event|0|||
42218811|NCT03655691|76037045|FG002|Overall Study|Adverse Event|1|||
42218812|NCT03655691|76037043|FG000|Overall Study|Lost to Follow-up|1|||
42218813|NCT03655691|76037044|FG001|Overall Study|Lost to Follow-up|1|||
42218814|NCT03655691|76037045|FG002|Overall Study|Lost to Follow-up|2|||
42218815|NCT03655691|76037043|FG000|Overall Study|Protocol Violation|0|||
42218816|NCT03655691|76037044|FG001|Overall Study|Protocol Violation|1|||
42218817|NCT03655691|76037045|FG002|Overall Study|Protocol Violation|0|||
42218818|NCT03655691|76037043|FG000|Overall Study|Withdrawal by Subject|1|||
42218819|NCT03655691|76037044|FG001|Overall Study|Withdrawal by Subject|1|||
42218820|NCT03655691|76037045|FG002|Overall Study|Withdrawal by Subject|0|||
42218821|NCT03658811|76037053|FG000|Overall Study|Lost to Follow-up|3|||
42218822|NCT03631355|76037063|FG000|Overall Study|Lost to Follow-up|1|||
42218823|NCT03631355|76037064|FG001|Overall Study|Lost to Follow-up|2|||
41979383|NCT01902173|75784139|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
41979384|NCT01902173|75784140|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
41979385|NCT01756456|75784188|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
41979386|NCT01756456|75784189|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
41979387|NCT01756456|75784190|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
41979388|NCT01756456|75784191|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
41979389|NCT01756456|75784192|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
41979390|NCT01756456|75784193|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
41979391|NCT01756456|75784188|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
41979392|NCT01756456|75784189|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
41979393|NCT01756456|75784190|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
41979394|NCT01756456|75784191|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
41979395|NCT01756456|75784192|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
41979396|NCT01756456|75784193|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
41979397|NCT01756456|75784188|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
41979398|NCT01756456|75784189|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
41979399|NCT01756456|75784190|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
41979400|NCT01756456|75784191|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
41979401|NCT01756456|75784192|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
41979402|NCT01756456|75784193|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
41979403|NCT01756456|75784188|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
42028609|NCT01123980|75837014|FG001|Overall Study|Withdrawal by Subject|3|||
42129904|NCT00607997|75940856|FG001|Overall Study|Adverse Event|1|||
42129905|NCT00607997|75940857|FG002|Overall Study|Adverse Event|2|||
42129906|NCT00607997|75940858|FG003|Overall Study|Adverse Event|0|||
42129907|NCT00607997|75940855|FG000|Overall Study|Physician Decision|4|||
42129908|NCT00607997|75940856|FG001|Overall Study|Physician Decision|1|||
42129909|NCT00607997|75940857|FG002|Overall Study|Physician Decision|0|||
42129910|NCT00607997|75940858|FG003|Overall Study|Physician Decision|0|||
42129911|NCT00607997|75940855|FG000|Overall Study|Relapse, recurrent illness|4|||
42129912|NCT00607997|75940856|FG001|Overall Study|Relapse, recurrent illness|0|||
42129913|NCT00607997|75940857|FG002|Overall Study|Relapse, recurrent illness|2|||
42218824|NCT03629249|76037073|FG000|Overall Study|Study terminated by sponsor|197|||
42218825|NCT03629249|76037074|FG001|Overall Study|Study terminated by sponsor|197|||
42218826|NCT03629249|76037075|FG002|Overall Study|Study terminated by sponsor|194|||
42218827|NCT03629249|76037073|FG000|Overall Study|Protocol deviation|0|||
42218828|NCT03629249|76037074|FG001|Overall Study|Protocol deviation|2|||
42218829|NCT03629249|76037075|FG002|Overall Study|Protocol deviation|5|||
42218830|NCT03629249|76037073|FG000|Overall Study|Subject decision|1|||
42218831|NCT03629249|76037074|FG001|Overall Study|Subject decision|1|||
42218832|NCT03629249|76037075|FG002|Overall Study|Subject decision|3|||
42218833|NCT03629249|76037073|FG000|Overall Study|Adverse Event|1|||
42218834|NCT03629249|76037074|FG001|Overall Study|Adverse Event|1|||
42218835|NCT03629249|76037075|FG002|Overall Study|Adverse Event|0|||
41979404|NCT01756456|75784189|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
41979405|NCT01756456|75784190|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
41979406|NCT01756456|75784191|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
42218836|NCT03629249|76037073|FG000|Overall Study|Death|1|||
42218837|NCT03629249|76037074|FG001|Overall Study|Death|0|||
41979407|NCT01756456|75784192|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
41979408|NCT01756456|75784193|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
41979409|NCT01756456|75784188|FG000|Treatment Period: Phase I/II|Other causes|0|||
41979410|NCT01756456|75784189|FG001|Treatment Period: Phase I/II|Other causes|0|||
42028610|NCT01123980|75837013|FG000|Overall Study|Unclassified|6|||
42218838|NCT03629249|76037075|FG002|Overall Study|Death|0|||
42218839|NCT03629249|76037073|FG000|Overall Study|Physician Decision|1|||
42218840|NCT03629249|76037074|FG001|Overall Study|Physician Decision|0|||
42218841|NCT03629249|76037075|FG002|Overall Study|Physician Decision|0|||
42218842|NCT03628781|76037085|FG000|Overall Study|Lost to Follow-up|16|||
42129914|NCT00607997|75940858|FG003|Overall Study|Relapse, recurrent illness|0|||
42129915|NCT00607997|75940855|FG000|Overall Study|Other without explanation|2|||
42129916|NCT00607997|75940856|FG001|Overall Study|Other without explanation|0|||
42129917|NCT00607997|75940857|FG002|Overall Study|Other without explanation|4|||
42129918|NCT00607997|75940858|FG003|Overall Study|Other without explanation|1|||
42129919|NCT00509106|75940875|FG000|Overall Study|Adverse Event|3|||
42129920|NCT00509106|75940876|FG001|Overall Study|Adverse Event|2|||
42129921|NCT00509106|75940875|FG000|Overall Study|Noncompliance|0|||
42129922|NCT00509106|75940876|FG001|Overall Study|Noncompliance|1|||
42129923|NCT00509106|75940875|FG000|Overall Study|At the request of sponsor/investigator|1|||
42218843|NCT03628781|76037086|FG001|Overall Study|Lost to Follow-up|8|||
42028611|NCT01123980|75837014|FG001|Overall Study|Unclassified|7|||
42129924|NCT00509106|75940876|FG001|Overall Study|At the request of sponsor/investigator|2|||
42218844|NCT03628781|76037085|FG000|Overall Study|Withdrawal by Subject|16|||
42218845|NCT03628781|76037086|FG001|Overall Study|Withdrawal by Subject|1|||
42218846|NCT03371251|76037098|FG000|Overall Study|Withdrawal by Subject|1|||
42218847|NCT03371251|76037099|FG001|Overall Study|Withdrawal by Subject|0|||
42218848|NCT03371251|76037100|FG002|Overall Study|Withdrawal by Subject|1|||
42218849|NCT03371251|76037101|FG003|Overall Study|Withdrawal by Subject|0|||
41979411|NCT01756456|75784190|FG002|Treatment Period: Phase I/II|Other causes|0|||
41979412|NCT01756456|75784191|FG003|Treatment Period: Phase I/II|Other causes|1|||
41979413|NCT01756456|75784192|FG004|Treatment Period: Phase I/II|Other causes|2|||
41979414|NCT01756456|75784193|FG005|Treatment Period: Phase I/II|Other causes|2|||
41979415|NCT01756456|75784188|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
41979416|NCT01756456|75784189|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
41979417|NCT01756456|75784190|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
41979418|NCT01756456|75784191|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
41979419|NCT01756456|75784192|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
41979420|NCT01756456|75784193|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
41979421|NCT01756456|75784188|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
42218850|NCT03371251|76037102|FG004|Overall Study|Withdrawal by Subject|2|||
42218851|NCT03371251|76037103|FG005|Overall Study|Withdrawal by Subject|2|||
42010624|NCT00993265|75817738|FG000|Overall Study|Non-compliant with study medication|1|||
41979422|NCT01756456|75784189|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
41979423|NCT01756456|75784190|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
41979424|NCT01756456|75784191|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
41979425|NCT01756456|75784192|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
41979426|NCT01756456|75784193|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
42218852|NCT03371251|76037098|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
42218853|NCT03371251|76037099|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
42218854|NCT03371251|76037100|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
42218855|NCT03371251|76037101|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
42218856|NCT03371251|76037102|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
42218857|NCT03371251|76037103|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
42218858|NCT03371251|76037098|FG000|Overall Study|Adverse Event|0|||
42218859|NCT03371251|76037099|FG001|Overall Study|Adverse Event|0|||
42218860|NCT03371251|76037100|FG002|Overall Study|Adverse Event|0|||
42218861|NCT03371251|76037101|FG003|Overall Study|Adverse Event|0|||
42218862|NCT03371251|76037102|FG004|Overall Study|Adverse Event|1|||
42218863|NCT03371251|76037103|FG005|Overall Study|Adverse Event|0|||
42218864|NCT03371251|76037098|FG000|Overall Study|Decision by Sponsor|0|||
42218865|NCT03371251|76037099|FG001|Overall Study|Decision by Sponsor|0|||
42218866|NCT03371251|76037100|FG002|Overall Study|Decision by Sponsor|0|||
42218867|NCT03371251|76037101|FG003|Overall Study|Decision by Sponsor|0|||
42218868|NCT03371251|76037102|FG004|Overall Study|Decision by Sponsor|2|||
42218869|NCT03371251|76037103|FG005|Overall Study|Decision by Sponsor|0|||
41979427|NCT01756456|75784188|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
41979428|NCT01756456|75784189|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
41979429|NCT01756456|75784190|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
42129925|NCT00509106|75940875|FG000|Overall Study|Withdrew consent|4|||
42129926|NCT00509106|75940876|FG001|Overall Study|Withdrew consent|8|||
42129927|NCT00509106|75940875|FG000|Overall Study|Lost to Follow-up|16|||
42129928|NCT00509106|75940876|FG001|Overall Study|Lost to Follow-up|10|||
42129929|NCT00509106|75940875|FG000|Overall Study|Other|1|||
42129930|NCT00509106|75940876|FG001|Overall Study|Other|0|||
42129931|NCT00509106|75940875|FG000|Overall Study|Death|6|||
42129932|NCT00509106|75940876|FG001|Overall Study|Death|6|||
42129933|NCT00607919|75940884|FG000|Acute Phase|Adverse Event|9|||
42129934|NCT00607919|75940885|FG001|Acute Phase|Adverse Event|2|||
42129935|NCT00607919|75940884|FG000|Acute Phase|Entry Criteria Not Met|1|||
42129936|NCT00607919|75940885|FG001|Acute Phase|Entry Criteria Not Met|1|||
42129937|NCT00607919|75940884|FG000|Acute Phase|Lack of Efficacy|1|||
42129938|NCT00607919|75940885|FG001|Acute Phase|Lack of Efficacy|2|||
42129939|NCT00607919|75940884|FG000|Acute Phase|Lost to Follow-up|9|||
42129940|NCT00607919|75940885|FG001|Acute Phase|Lost to Follow-up|3|||
42129941|NCT00607919|75940884|FG000|Acute Phase|Parent/Caregiver Decision|6|||
42129942|NCT00607919|75940885|FG001|Acute Phase|Parent/Caregiver Decision|4|||
42129943|NCT00607919|75940884|FG000|Acute Phase|Protocol Violation|5|||
42129944|NCT00607919|75940885|FG001|Acute Phase|Protocol Violation|1|||
42129945|NCT00607919|75940884|FG000|Acute Phase|Withdrawal by Subject|3|||
42129946|NCT00607919|75940885|FG001|Acute Phase|Withdrawal by Subject|3|||
42129947|NCT00607919|75940884|FG000|Open-Label Phase|Adverse Event|1|||
42129948|NCT00607919|75940885|FG001|Open-Label Phase|Adverse Event|5|||
42129949|NCT00607919|75940884|FG000|Open-Label Phase|Lost to Follow-up|4|||
42129950|NCT00607919|75940885|FG001|Open-Label Phase|Lost to Follow-up|1|||
42129951|NCT00607919|75940884|FG000|Open-Label Phase|Protocol Violation|2|||
42129952|NCT00607919|75940885|FG001|Open-Label Phase|Protocol Violation|2|||
42129953|NCT00607919|75940884|FG000|Open-Label Phase|Withdrawal by Subject|2|||
42218870|NCT03370471|76037122|FG000|Overall Study|Withdrawal by Subject|6|||
41979430|NCT01756456|75784191|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
41979431|NCT01756456|75784192|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
41979432|NCT01756456|75784193|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
41979433|NCT01756456|75784188|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
41979434|NCT01756456|75784189|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
41979435|NCT01756456|75784190|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
41979436|NCT01756456|75784191|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
41979437|NCT01756456|75784192|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
41979438|NCT01756456|75784193|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
41979439|NCT01756456|75784188|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
41979440|NCT01756456|75784189|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
41979441|NCT01756456|75784190|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
41979442|NCT01756456|75784191|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
41979443|NCT01756456|75784192|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
41979444|NCT01756456|75784193|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
41979445|NCT01756456|75784188|FG000|Follow Up Period Phase I/II|Other causes|0|||
41979446|NCT01756456|75784189|FG001|Follow Up Period Phase I/II|Other causes|0|||
41979447|NCT01756456|75784190|FG002|Follow Up Period Phase I/II|Other causes|0|||
41979448|NCT01756456|75784191|FG003|Follow Up Period Phase I/II|Other causes|1|||
41979449|NCT01756456|75784192|FG004|Follow Up Period Phase I/II|Other causes|3|||
41979450|NCT01756456|75784193|FG005|Follow Up Period Phase I/II|Other causes|5|||
41979451|NCT01477333|75784269|FG000|Overall Study|Adverse Event|1|||
41979452|NCT01477333|75784269|FG000|Overall Study|Withdrawal by Subject|1|||
41979453|NCT01477333|75784269|FG000|Overall Study|Clinical Deterioration|1|||
41979454|NCT01262625|75784291|FG000|Overall Study|Administrative Error|1|||
41979455|NCT01262625|75784292|FG001|Overall Study|Administrative Error|1|||
41979456|NCT01262625|75784291|FG000|Overall Study|Site Closed|1|||
42218871|NCT03370471|76037123|FG001|Overall Study|Withdrawal by Subject|1|||
42218872|NCT03370471|76037122|FG000|Overall Study|Unable to access veins for blood draw|0|||
42218873|NCT03370471|76037123|FG001|Overall Study|Unable to access veins for blood draw|1|||
42218874|NCT03370471|76037122|FG000|Overall Study|Screen fail|1|||
42218875|NCT03370471|76037123|FG001|Overall Study|Screen fail|0|||
42218876|NCT03349645|76037131|FG000|Overall Study|Sponsor Terminated Study|75|||
42218877|NCT03349645|76037131|FG000|Overall Study|Withdrawal by Subject|4|||
42218878|NCT03349645|76037131|FG000|Overall Study|Protocol Violation|1|||
42218879|NCT03349645|76037131|FG000|Overall Study|Other|2|||
42218880|NCT03349333|76037135|FG000|Overall Study|Progression of Disease|36|||
42218881|NCT03349333|76037135|FG000|Overall Study|Adverse Event|11|||
42218882|NCT03349333|76037135|FG000|Overall Study|Other|6|||
42218883|NCT03349333|76037135|FG000|Overall Study|Withdrawal by Subject|5|||
42218884|NCT03349333|76037135|FG000|Overall Study|Conditions interfere with participation|2|||
42218885|NCT03349333|76037135|FG000|Overall Study|Physician Decision|2|||
42218886|NCT03349333|76037135|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
42218887|NCT03349333|76037135|FG000|Overall Study|Patients in treatment less than 24 month|8|||
42218888|NCT03349099|76037141|FG000|Overall Study|Physician Decision|3|||
42218889|NCT03349099|76037142|FG001|Overall Study|Physician Decision|4|||
42218890|NCT03349099|76037141|FG000|Overall Study|Stone migrated from the kidney|1|||
42218891|NCT03349099|76037142|FG001|Overall Study|Stone migrated from the kidney|0|||
42218892|NCT03348163|76037150|FG000|Overall Study|Withdrawal by Subject|2|||
42218893|NCT03348163|76037151|FG001|Overall Study|Withdrawal by Subject|0|||
42129954|NCT00607919|75940885|FG001|Open-Label Phase|Withdrawal by Subject|2|||
42129955|NCT00607919|75940884|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
42129956|NCT00607919|75940885|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
42129957|NCT00344968|75940896|FG000|Overall Study|Adverse Event|5|||
42129958|NCT00344968|75940897|FG001|Overall Study|Adverse Event|4|||
42129959|NCT00344968|75940898|FG002|Overall Study|Adverse Event|15|||
42129960|NCT00344968|75940896|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
42129961|NCT00344968|75940897|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
42129962|NCT00344968|75940898|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
42129963|NCT00344968|75940896|FG000|Overall Study|Protocol Violation|2|||
42129964|NCT00344968|75940897|FG001|Overall Study|Protocol Violation|2|||
42129965|NCT00344968|75940898|FG002|Overall Study|Protocol Violation|5|||
42129966|NCT00344968|75940896|FG000|Overall Study|Withdrawal by Subject|14|||
42129967|NCT00344968|75940897|FG001|Overall Study|Withdrawal by Subject|31|||
42129968|NCT00344968|75940898|FG002|Overall Study|Withdrawal by Subject|27|||
42129969|NCT00344968|75940896|FG000|Overall Study|Lost to Follow-up|24|||
42129970|NCT00344968|75940897|FG001|Overall Study|Lost to Follow-up|37|||
42129971|NCT00344968|75940898|FG002|Overall Study|Lost to Follow-up|37|||
42129972|NCT00344968|75940896|FG000|Overall Study|Death|11|||
42129973|NCT00344968|75940897|FG001|Overall Study|Death|27|||
42129974|NCT00344968|75940898|FG002|Overall Study|Death|31|||
42129975|NCT00344968|75940896|FG000|Overall Study|Other|0|||
42129976|NCT00344968|75940897|FG001|Overall Study|Other|1|||
42129977|NCT00344968|75940898|FG002|Overall Study|Other|0|||
42129978|NCT00509028|75940909|FG000|Overall Study|Adverse Event|2|||
42129979|NCT00509028|75940910|FG001|Overall Study|Adverse Event|0|||
42129980|NCT00509028|75940909|FG000|Overall Study|Withdrawal by Subject|4|||
42129981|NCT00509028|75940910|FG001|Overall Study|Withdrawal by Subject|3|||
42129982|NCT00509028|75940909|FG000|Overall Study|Lost to Follow-up|0|||
42218894|NCT03347695|76037159|FG000|Overall Study|Death|0|||
41979457|NCT01262625|75784292|FG001|Overall Study|Site Closed|0|||
41979458|NCT01116648|75784341|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
41979459|NCT01116648|75784342|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
41979460|NCT01116648|75784343|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
41979461|NCT01116648|75784344|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
41979462|NCT01116648|75784345|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
41979463|NCT01116648|75784346|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
41979464|NCT01116648|75784347|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
41979465|NCT01116648|75784348|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
41979466|NCT01116648|75784349|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
41979467|NCT01116648|75784350|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
41979468|NCT01116648|75784351|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
41979469|NCT01116648|75784352|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
41979470|NCT01116648|75784353|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
41979471|NCT01116648|75784354|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
41979472|NCT01116648|75784355|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
41979473|NCT04831736|75784396|FG000|Overall Study|Withdrawal by Subject|0|||
41979474|NCT04831736|75784397|FG001|Overall Study|Withdrawal by Subject|1|||
41979475|NCT04583956|75784412|FG000|Overall Study|Death|9|||
41979476|NCT04583956|75784413|FG001|Overall Study|Death|11|||
41979477|NCT04583956|75784412|FG000|Overall Study|Lost to Follow-up|7|||
41979478|NCT04583956|75784413|FG001|Overall Study|Lost to Follow-up|9|||
41979479|NCT04583956|75784412|FG000|Overall Study|Protocol Violation|2|||
41979480|NCT04583956|75784413|FG001|Overall Study|Protocol Violation|0|||
41979481|NCT04583956|75784412|FG000|Overall Study|Withdrawal by Subject|0|||
41979482|NCT04583956|75784413|FG001|Overall Study|Withdrawal by Subject|2|||
41979483|NCT04583956|75784412|FG000|Overall Study|Randomized but not dosed|2|||
41979484|NCT04583956|75784413|FG001|Overall Study|Randomized but not dosed|3|||
41979485|NCT04583956|75784412|FG000|Overall Study|Withdrawal of consent before product administration|1|||
41979486|NCT04583956|75784413|FG001|Overall Study|Withdrawal of consent before product administration|0|||
41979487|NCT04463680|75784429|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
41979488|NCT04463680|75784429|FG000|Overall Study|Not eligible due to implant duration of use|1|||
41979489|NCT04463680|75784429|FG000|Overall Study|Withdrawal by Subject|3|||
41979490|NCT04449029|75784441|FG000|Overall Study|Adverse Event|0|||
41979491|NCT04449029|75784442|FG001|Overall Study|Adverse Event|1|||
41979492|NCT04449029|75784443|FG002|Overall Study|Adverse Event|1|||
41979493|NCT04449029|75784444|FG003|Overall Study|Adverse Event|0|||
41979494|NCT04449029|75784445|FG004|Overall Study|Adverse Event|1|||
41979495|NCT04449029|75784446|FG005|Overall Study|Adverse Event|0|||
41979496|NCT04449029|75784447|FG006|Overall Study|Adverse Event|1|||
41979497|NCT04449029|75784448|FG007|Overall Study|Adverse Event|0|||
41979498|NCT04449029|75784441|FG000|Overall Study|Lost to Follow-up|0|||
41979499|NCT04449029|75784442|FG001|Overall Study|Lost to Follow-up|1|||
41979500|NCT04449029|75784443|FG002|Overall Study|Lost to Follow-up|0|||
41979501|NCT04449029|75784444|FG003|Overall Study|Lost to Follow-up|0|||
41979502|NCT04449029|75784445|FG004|Overall Study|Lost to Follow-up|0|||
41979503|NCT04449029|75784446|FG005|Overall Study|Lost to Follow-up|0|||
41979504|NCT04449029|75784447|FG006|Overall Study|Lost to Follow-up|0|||
41979505|NCT04449029|75784448|FG007|Overall Study|Lost to Follow-up|0|||
41979506|NCT04449029|75784441|FG000|Overall Study|Protocol Violation|0|||
41979507|NCT04449029|75784442|FG001|Overall Study|Protocol Violation|1|||
41979508|NCT04449029|75784443|FG002|Overall Study|Protocol Violation|0|||
41979509|NCT04449029|75784444|FG003|Overall Study|Protocol Violation|0|||
41979510|NCT04449029|75784445|FG004|Overall Study|Protocol Violation|0|||
41979511|NCT04449029|75784446|FG005|Overall Study|Protocol Violation|0|||
42028612|NCT01118520|75837023|FG000|Overall Study|AAA repair|9|||
42218895|NCT03347695|76037160|FG001|Overall Study|Death|4|||
42218896|NCT03347695|76037159|FG000|Overall Study|Lost to Follow-up|0|||
42218897|NCT03347695|76037160|FG001|Overall Study|Lost to Follow-up|1|||
42218898|NCT02892019|76037170|FG000|Overall Study|randomized but not treated|0|||
42218899|NCT02892019|76037171|FG001|Overall Study|randomized but not treated|1|||
42218900|NCT02892019|76037170|FG000|Overall Study|Withdrawal by Subject|0|||
42218901|NCT02892019|76037171|FG001|Overall Study|Withdrawal by Subject|1|||
42218902|NCT02892019|76037170|FG000|Overall Study|Adverse Event|1|||
42218903|NCT02892019|76037171|FG001|Overall Study|Adverse Event|1|||
42218904|NCT03365791|76037177|FG000|Overall Study|Adverse Event|5|||
42218905|NCT03365791|76037177|FG000|Overall Study|Death|1|||
42218906|NCT03365791|76037177|FG000|Overall Study|Lost to Follow-up|1|||
42218907|NCT03365791|76037177|FG000|Overall Study|Physician Decision|9|||
42218908|NCT03365791|76037177|FG000|Overall Study|Progressive disease|51|||
42218909|NCT03365791|76037177|FG000|Overall Study|Subject/guardian decision|5|||
42218910|NCT03365011|76037184|FG000|Overall Study|Withdrawal by Subject|1|||
42218911|NCT03365011|76037185|FG001|Overall Study|Withdrawal by Subject|2|||
42218912|NCT03627767|76037194|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
42218913|NCT03627767|76037195|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
42218914|NCT03627767|76037196|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
42218915|NCT03627767|76037197|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
42218916|NCT03627767|76037198|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
42218917|NCT03627767|76037194|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
42218918|NCT03627767|76037195|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
42218919|NCT03627767|76037196|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
42218920|NCT03627767|76037197|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
42218921|NCT03627767|76037198|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
42218922|NCT03627767|76037194|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
42218923|NCT03627767|76037195|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
42218924|NCT03627767|76037196|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
42218925|NCT03627767|76037197|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
42218926|NCT03627767|76037198|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
42218927|NCT03627767|76037194|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
42218928|NCT03627767|76037195|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
42218929|NCT03627767|76037196|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
42218930|NCT03627767|76037197|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
42218931|NCT03627767|76037198|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
42218932|NCT03627767|76037194|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
42218933|NCT03627767|76037195|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
42218934|NCT03627767|76037196|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
42218935|NCT03627767|76037197|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
42218936|NCT03627767|76037198|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
42272653|NCT02281318|76102917|FG000|Overall Study|Lost to Follow-up|2|||
41979512|NCT04449029|75784447|FG006|Overall Study|Protocol Violation|0|||
41979513|NCT04449029|75784448|FG007|Overall Study|Protocol Violation|0|||
41979514|NCT04449029|75784441|FG000|Overall Study|Physician Decision|0|||
41979515|NCT04449029|75784442|FG001|Overall Study|Physician Decision|0|||
41979516|NCT04449029|75784443|FG002|Overall Study|Physician Decision|0|||
41979517|NCT04449029|75784444|FG003|Overall Study|Physician Decision|0|||
41979518|NCT04449029|75784445|FG004|Overall Study|Physician Decision|0|||
41979519|NCT04449029|75784446|FG005|Overall Study|Physician Decision|1|||
41979520|NCT04449029|75784447|FG006|Overall Study|Physician Decision|0|||
41979521|NCT04449029|75784448|FG007|Overall Study|Physician Decision|0|||
41979522|NCT04449029|75784441|FG000|Overall Study|Withdrawal by Subject|3|||
41979523|NCT04449029|75784442|FG001|Overall Study|Withdrawal by Subject|0|||
41979524|NCT04449029|75784443|FG002|Overall Study|Withdrawal by Subject|1|||
41979525|NCT04449029|75784444|FG003|Overall Study|Withdrawal by Subject|1|||
41979526|NCT04449029|75784445|FG004|Overall Study|Withdrawal by Subject|5|||
41979527|NCT04449029|75784446|FG005|Overall Study|Withdrawal by Subject|1|||
42129983|NCT00509028|75940910|FG001|Overall Study|Lost to Follow-up|1|||
41979528|NCT04449029|75784447|FG006|Overall Study|Withdrawal by Subject|4|||
41979529|NCT04449029|75784448|FG007|Overall Study|Withdrawal by Subject|0|||
41979530|NCT04193202|75784478|FG000|Overall Study|Adverse Event|2|||
41979531|NCT04193202|75784479|FG001|Overall Study|Adverse Event|1|||
41979532|NCT04193202|75784478|FG000|Overall Study|Death|0|||
41979533|NCT04193202|75784479|FG001|Overall Study|Death|1|||
41979534|NCT04193202|75784478|FG000|Overall Study|Physician Decision|1|||
41979535|NCT04193202|75784479|FG001|Overall Study|Physician Decision|1|||
41979536|NCT04193202|75784478|FG000|Overall Study|Protocol Violation|2|||
41979537|NCT04193202|75784479|FG001|Overall Study|Protocol Violation|2|||
41979538|NCT04193202|75784478|FG000|Overall Study|Withdrawal by Subject|11|||
41979539|NCT04193202|75784479|FG001|Overall Study|Withdrawal by Subject|5|||
41979540|NCT04159935|75784487|FG000|Overall Study|Study terminated due to COVID-19|1|||
41979541|NCT04159935|75784488|FG001|Overall Study|Study terminated due to COVID-19|3|||
41979542|NCT03871543|75784512|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
41979543|NCT03871543|75784512|FG000|Period 1|Investigator Error|1|||
41979544|NCT03871543|75784512|FG000|Period 1|Protocol Violation|2|||
41979545|NCT03871543|75784512|FG000|Period 1|COVID-19 Related|1|||
41979546|NCT03871543|75784512|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
41979547|NCT03871543|75784512|FG000|Period 1|Withdrawal by Subject|10|||
41979548|NCT03871543|75784512|FG000|Period 2|Adverse Event|1|||
41979549|NCT03871543|75784512|FG000|Period 2|Withdrawal by Subject|1|||
41979550|NCT03843125|75784524|FG000|Overall Study|Adverse Event|17|||
41979551|NCT03843125|75784525|FG001|Overall Study|Adverse Event|13|||
41979552|NCT03843125|75784526|FG002|Overall Study|Adverse Event|5|||
41979553|NCT03843125|75784527|FG003|Overall Study|Adverse Event|9|||
41979554|NCT03843125|75784524|FG000|Overall Study|Death|0|||
42218937|NCT03627767|76037194|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
42218938|NCT03627767|76037195|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
42218939|NCT03627767|76037196|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
42218940|NCT03627767|76037197|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
42218941|NCT03627767|76037198|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
42218942|NCT03627767|76037194|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
42218943|NCT03627767|76037195|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
42218944|NCT03627767|76037196|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
42218945|NCT03627767|76037197|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
42218946|NCT03627767|76037198|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
42218947|NCT03627767|76037194|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
42218948|NCT03627767|76037195|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
42218949|NCT03627767|76037196|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
42218950|NCT03627767|76037197|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
42218951|NCT03627767|76037198|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
42218952|NCT03627767|76037194|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
42218953|NCT03627767|76037195|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
42218954|NCT03627767|76037196|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
42218955|NCT03627767|76037197|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
42218956|NCT03627767|76037198|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
42218957|NCT03627767|76037194|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
42218958|NCT03627767|76037195|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
42218959|NCT03627767|76037196|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
42218960|NCT03627767|76037197|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
42218961|NCT03627767|76037198|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
42218962|NCT03627767|76037194|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
42218963|NCT03627767|76037195|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
42218964|NCT03627767|76037196|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
42218965|NCT03627767|76037197|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
42218966|NCT03627767|76037198|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
42218967|NCT03627767|76037194|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
42218968|NCT03627767|76037195|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
42218969|NCT03627767|76037196|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
42218970|NCT03627767|76037197|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
42218971|NCT03627767|76037198|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
42218972|NCT03627767|76037194|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
42218973|NCT03627767|76037195|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
42218974|NCT03627767|76037196|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
42218975|NCT03627767|76037197|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
42218976|NCT03627767|76037198|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
42302187|NCT02495233|76137261|FG000|Overall Study|Miscellaneous|0|||
42302188|NCT02495233|76137262|FG001|Overall Study|Miscellaneous|1|||
42302189|NCT02495077|76137270|FG000|Overall Study|Adverse Event|0|||
41979555|NCT03843125|75784525|FG001|Overall Study|Death|6|||
42129984|NCT00509028|75940909|FG000|Overall Study|Protocol Violation|4|||
42129985|NCT00509028|75940910|FG001|Overall Study|Protocol Violation|2|||
42129986|NCT00509028|75940909|FG000|Overall Study|Non-compliance|2|||
42129987|NCT00509028|75940910|FG001|Overall Study|Non-compliance|1|||
42129988|NCT00352846|75940918|FG000|Overall Study|Disease progression|0|||
42129989|NCT00352846|75940919|FG001|Overall Study|Disease progression|2|||
42129990|NCT00352846|75940918|FG000|Overall Study|Withdrawal by Subject|3|||
42129991|NCT00352846|75940919|FG001|Overall Study|Withdrawal by Subject|8|||
42129992|NCT00352846|75940918|FG000|Overall Study|Ineligible|3|||
42129993|NCT00352846|75940919|FG001|Overall Study|Ineligible|2|||
42129994|NCT00352846|75940918|FG000|Overall Study|Non-compliance|2|||
42129995|NCT00352846|75940919|FG001|Overall Study|Non-compliance|0|||
42129996|NCT00352846|75940918|FG000|Overall Study|Death|0|||
42129997|NCT00352846|75940919|FG001|Overall Study|Death|1|||
42129998|NCT00508872|75940925|FG000|Overall Study|Lost to Follow-up|1|||
42302190|NCT02495077|76137271|FG001|Overall Study|Adverse Event|1|||
42129999|NCT00508872|75940925|FG000|Overall Study|Physician Decision|1|||
41979556|NCT03843125|75784526|FG002|Overall Study|Death|2|||
42130000|NCT00508482|75940932|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
42130001|NCT00508482|75940933|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
42130002|NCT00508482|75940934|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
42130003|NCT00508482|75940932|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
42130004|NCT00508482|75940933|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
42130005|NCT00508482|75940934|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
42218977|NCT03627767|76037194|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
42218978|NCT03627767|76037195|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
42028613|NCT01118520|75837024|FG001|Overall Study|AAA repair|7|||
42028614|NCT01118520|75837025|FG002|Overall Study|AAA repair|9|||
42028615|NCT01118520|75837023|FG000|Overall Study|Adverse Event|3|||
41979557|NCT03843125|75784527|FG003|Overall Study|Death|0|||
41979558|NCT03843125|75784524|FG000|Overall Study|Lack of Efficacy|14|||
41979559|NCT03843125|75784525|FG001|Overall Study|Lack of Efficacy|11|||
41979560|NCT03843125|75784526|FG002|Overall Study|Lack of Efficacy|9|||
41979561|NCT03843125|75784527|FG003|Overall Study|Lack of Efficacy|4|||
41979562|NCT03843125|75784524|FG000|Overall Study|Lost to Follow-up|3|||
41979563|NCT03843125|75784525|FG001|Overall Study|Lost to Follow-up|4|||
41979564|NCT03843125|75784526|FG002|Overall Study|Lost to Follow-up|0|||
41979565|NCT03843125|75784527|FG003|Overall Study|Lost to Follow-up|2|||
41979566|NCT03843125|75784524|FG000|Overall Study|Other|12|||
41979567|NCT03843125|75784525|FG001|Overall Study|Other|14|||
41979568|NCT03843125|75784526|FG002|Overall Study|Other|3|||
41979569|NCT03843125|75784527|FG003|Overall Study|Other|4|||
41979570|NCT03843125|75784524|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
41979571|NCT03843125|75784525|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
41979572|NCT03843125|75784526|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
41979573|NCT03843125|75784527|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
41979574|NCT03843125|75784524|FG000|Overall Study|Study Terminated by Sponsor|318|||
41979575|NCT03843125|75784525|FG001|Overall Study|Study Terminated by Sponsor|318|||
42218979|NCT03627767|76037196|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
42218980|NCT03627767|76037197|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
42218981|NCT03627767|76037198|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
42218982|NCT03627767|76037194|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
42218983|NCT03627767|76037195|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
42218984|NCT03627767|76037196|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
42218985|NCT03627767|76037197|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
42218986|NCT03627767|76037198|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
42218987|NCT03627767|76037194|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
42218988|NCT03627767|76037195|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
42218989|NCT03627767|76037196|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
42218990|NCT03627767|76037197|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
42218991|NCT03627767|76037198|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
42218992|NCT03627767|76037194|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
42218993|NCT03627767|76037195|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
42218994|NCT03627767|76037196|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
42218995|NCT03627767|76037197|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
42218996|NCT03627767|76037198|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
42218997|NCT03627767|76037194|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
42218998|NCT03627767|76037195|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
42218999|NCT03627767|76037196|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
42219000|NCT03627767|76037197|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
41979576|NCT03843125|75784526|FG002|Overall Study|Study Terminated by Sponsor|163|||
42219001|NCT03627767|76037198|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
42219002|NCT03627767|76037194|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
42272654|NCT02281318|76102918|FG001|Overall Study|Lost to Follow-up|1|||
41979577|NCT03843125|75784527|FG003|Overall Study|Study Terminated by Sponsor|163|||
41979578|NCT03843125|75784524|FG000|Overall Study|Withdrawal by Subject|23|||
41979579|NCT03843125|75784525|FG001|Overall Study|Withdrawal by Subject|12|||
41979580|NCT03843125|75784526|FG002|Overall Study|Withdrawal by Subject|6|||
41979581|NCT03843125|75784527|FG003|Overall Study|Withdrawal by Subject|9|||
41979582|NCT03843125|75784524|FG000|Overall Study|Missing data|0|||
41979583|NCT03843125|75784525|FG001|Overall Study|Missing data|1|||
41979584|NCT03843125|75784526|FG002|Overall Study|Missing data|1|||
41979585|NCT03843125|75784527|FG003|Overall Study|Missing data|0|||
41979586|NCT03603509|75784540|FG000|Overall Study|Lost to Follow-up|3|||
41979587|NCT03603509|75784541|FG001|Overall Study|Lost to Follow-up|4|||
41979588|NCT03066258|75784565|FG000|Overall Study|Death|1|||
41979589|NCT03066258|75784566|FG001|Overall Study|Death|0|||
41979590|NCT03066258|75784567|FG002|Overall Study|Death|0|||
41979591|NCT03066258|75784568|FG003|Overall Study|Death|0|||
41979592|NCT03066258|75784569|FG004|Overall Study|Death|1|||
41979593|NCT03024255|75784585|FG000|Overall Study|Adverse Event|1|||
41979594|NCT03024255|75784586|FG001|Overall Study|Adverse Event|4|||
41979595|NCT03024255|75784587|FG002|Overall Study|Adverse Event|8|||
41979596|NCT03024255|75784588|FG003|Overall Study|Adverse Event|0|||
42028616|NCT01118520|75837024|FG001|Overall Study|Adverse Event|3|||
42028617|NCT01118520|75837025|FG002|Overall Study|Adverse Event|3|||
41979597|NCT03024255|75784585|FG000|Overall Study|Withdrawal by Subject|3|||
41979598|NCT03024255|75784586|FG001|Overall Study|Withdrawal by Subject|1|||
41979599|NCT03024255|75784587|FG002|Overall Study|Withdrawal by Subject|0|||
41979600|NCT03024255|75784588|FG003|Overall Study|Withdrawal by Subject|3|||
41979601|NCT03024255|75784585|FG000|Overall Study|Protocol Violation|0|||
41979602|NCT03024255|75784586|FG001|Overall Study|Protocol Violation|0|||
41979603|NCT03024255|75784587|FG002|Overall Study|Protocol Violation|2|||
41979604|NCT03024255|75784588|FG003|Overall Study|Protocol Violation|0|||
41979605|NCT03024255|75784585|FG000|Overall Study|Lost to Follow-up|1|||
41979606|NCT03024255|75784586|FG001|Overall Study|Lost to Follow-up|2|||
41979607|NCT03024255|75784587|FG002|Overall Study|Lost to Follow-up|1|||
41979608|NCT03024255|75784588|FG003|Overall Study|Lost to Follow-up|1|||
41979609|NCT03024255|75784585|FG000|Overall Study|Lack of Efficacy|1|||
41979610|NCT03024255|75784586|FG001|Overall Study|Lack of Efficacy|0|||
42028618|NCT01118520|75837023|FG000|Overall Study|Withdrawal by Subject|8|||
42028619|NCT01118520|75837024|FG001|Overall Study|Withdrawal by Subject|13|||
42028620|NCT01118520|75837025|FG002|Overall Study|Withdrawal by Subject|8|||
41979611|NCT03024255|75784587|FG002|Overall Study|Lack of Efficacy|0|||
41979612|NCT03024255|75784588|FG003|Overall Study|Lack of Efficacy|0|||
41979613|NCT03024255|75784585|FG000|Overall Study|Protocol Noncompliance|1|||
41979614|NCT03024255|75784586|FG001|Overall Study|Protocol Noncompliance|1|||
42219003|NCT03627767|76037195|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
42219004|NCT03627767|76037196|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
41979615|NCT03024255|75784587|FG002|Overall Study|Protocol Noncompliance|0|||
41979616|NCT03024255|75784588|FG003|Overall Study|Protocol Noncompliance|1|||
42219005|NCT03627767|76037197|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
41979617|NCT01252953|75784611|FG000|Overall Study|Withdrawal by Subject|16|||
41979618|NCT01252953|75784612|FG001|Overall Study|Withdrawal by Subject|17|||
41979619|NCT01252953|75784611|FG000|Overall Study|Lost to Follow-up|22|||
41979620|NCT01252953|75784612|FG001|Overall Study|Lost to Follow-up|21|||
41979621|NCT01234480|75784619|FG000|Overall Study|Pregnancy|88|||
41979622|NCT01234480|75784619|FG000|Overall Study|>36/Normal History|50|||
41979623|NCT01234480|75784619|FG000|Overall Study|Age|3|||
42130006|NCT00508482|75940932|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
42130007|NCT00508482|75940933|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
42130008|NCT00508482|75940934|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
42219006|NCT03627767|76037198|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
42219007|NCT03627767|76037194|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
42130009|NCT00344500|75940945|FG000|Overall Study|Adverse Event|6|||
42130010|NCT00344500|75940946|FG001|Overall Study|Adverse Event|2|||
42130011|NCT00344500|75940947|FG002|Overall Study|Adverse Event|0|||
42130012|NCT00344500|75940945|FG000|Overall Study|Lost to Follow-up|5|||
42130013|NCT00344500|75940946|FG001|Overall Study|Lost to Follow-up|13|||
42130014|NCT00344500|75940947|FG002|Overall Study|Lost to Follow-up|1|||
42130015|NCT00344500|75940945|FG000|Overall Study|Withdrawal by Subject|7|||
42130016|NCT00344500|75940946|FG001|Overall Study|Withdrawal by Subject|10|||
42219008|NCT03627767|76037195|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
42219009|NCT03627767|76037196|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
42219010|NCT03627767|76037197|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
42219011|NCT03627767|76037198|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
41979624|NCT01234480|75784619|FG000|Overall Study|HPV Vaccine History|28|||
41979625|NCT01234480|75784619|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
41979626|NCT01234480|75784619|FG000|Overall Study|Hysterectomy|2|||
42130017|NCT00344500|75940947|FG002|Overall Study|Withdrawal by Subject|0|||
41979627|NCT01234480|75784619|FG000|Overall Study|Hysterectomy post enrollment|1|||
41979628|NCT01234480|75784619|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
42130018|NCT00344500|75940945|FG000|Overall Study|Protocol Violation|4|||
42302191|NCT02495077|76137272|FG002|Overall Study|Adverse Event|1|||
41979629|NCT01234480|75784619|FG000|Overall Study|Informed Consent Form Violation|30|||
42219012|NCT03627065|76037209|FG000|Overall Study|Study Terminated by sponsor|1|||
41979630|NCT01234480|75784619|FG000|Overall Study|Incorrect Visit|3|||
42219013|NCT03627065|76037209|FG000|Overall Study|Withdrawal by Subject|2|||
42219014|NCT02142738|76037215|FG000|Overall Study|Adverse Event|13|||
42219015|NCT02142738|76037216|FG001|Overall Study|Adverse Event|9|||
42219016|NCT02142738|76037215|FG000|Overall Study|Death|92|||
42219017|NCT02142738|76037216|FG001|Overall Study|Death|112|||
42219018|NCT02142738|76037215|FG000|Overall Study|Lost to Follow-up|0|||
42219019|NCT02142738|76037216|FG001|Overall Study|Lost to Follow-up|3|||
42219020|NCT02142738|76037215|FG000|Overall Study|Withdrawal by Subject|6|||
42219021|NCT02142738|76037216|FG001|Overall Study|Withdrawal by Subject|7|||
42219022|NCT02142738|76037215|FG000|Overall Study|Follow up ended by sponsor|43|||
42219023|NCT02142738|76037216|FG001|Overall Study|Follow up ended by sponsor|20|||
42219024|NCT03617861|76037227|FG000|Second Intervention (1 Day)|Adverse Event|0|||
42219025|NCT03617861|76037228|FG001|Second Intervention (1 Day)|Adverse Event|0|||
42219026|NCT03617861|76037229|FG002|Second Intervention (1 Day)|Adverse Event|1|||
42219027|NCT03617861|76037230|FG003|Second Intervention (1 Day)|Adverse Event|0|||
42219028|NCT03614975|76037242|FG000|Overall Study|Physician Decision|7|||
42219029|NCT03614975|76037243|FG001|Overall Study|Physician Decision|5|||
42219030|NCT03614975|76037242|FG000|Overall Study|Withdrawal by Subject|2|||
42219031|NCT03614975|76037243|FG001|Overall Study|Withdrawal by Subject|2|||
42219032|NCT03614975|76037242|FG000|Overall Study|Specimens not in lab batch shipment|1|||
42219033|NCT03614975|76037243|FG001|Overall Study|Specimens not in lab batch shipment|1|||
42219034|NCT03613649|76037261|FG000|Second Treatment|Lost to Follow-up|0|||
42219035|NCT03613649|76037262|FG001|Second Treatment|Lost to Follow-up|0|||
42219036|NCT03613649|76037263|FG002|Second Treatment|Lost to Follow-up|1|||
42219037|NCT03613649|76037264|FG003|Second Treatment|Lost to Follow-up|0|||
42219038|NCT03613649|76037265|FG004|Second Treatment|Lost to Follow-up|0|||
42219039|NCT03613649|76037266|FG005|Second Treatment|Lost to Follow-up|0|||
42219040|NCT03613649|76037267|FG006|Second Treatment|Lost to Follow-up|0|||
42219041|NCT03613649|76037268|FG007|Second Treatment|Lost to Follow-up|0|||
42219042|NCT03613649|76037269|FG008|Second Treatment|Lost to Follow-up|0|||
42219043|NCT03613649|76037270|FG009|Second Treatment|Lost to Follow-up|0|||
41979631|NCT01234480|75784619|FG000|Overall Study|No Florida Lab License|20|||
41979632|NCT01234480|75784619|FG000|Overall Study|Out of Window|42|||
41979633|NCT01234480|75784619|FG000|Overall Study|Sample Processing/Storage|92|||
41979634|NCT01234480|75784619|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
41979635|NCT01234480|75784619|FG000|Overall Study|Site/Subject non-compliance|44|||
41979636|NCT01234480|75784619|FG000|Overall Study|Missing Sample|9|||
41979637|NCT00877851|75784628|FG000|Overall Study|Lost to Follow-up|5|||
41979638|NCT00877851|75784629|FG001|Overall Study|Lost to Follow-up|5|||
41979639|NCT00877851|75784628|FG000|Overall Study|computer problem|3|||
41979640|NCT00877851|75784629|FG001|Overall Study|computer problem|0|||
41979641|NCT00877851|75784628|FG000|Overall Study|no longer interested in participating|1|||
42219044|NCT03613649|76037271|FG010|Second Treatment|Lost to Follow-up|0|||
42219045|NCT03613649|76037272|FG011|Second Treatment|Lost to Follow-up|0|||
42219046|NCT03613649|76037261|FG000|Second Treatment|Withdrawal by Subject|0|||
42219047|NCT03613649|76037262|FG001|Second Treatment|Withdrawal by Subject|0|||
41979642|NCT00877851|75784629|FG001|Overall Study|no longer interested in participating|0|||
42219048|NCT03613649|76037263|FG002|Second Treatment|Withdrawal by Subject|0|||
42219049|NCT03613649|76037264|FG003|Second Treatment|Withdrawal by Subject|0|||
41979643|NCT00837616|75784637|FG000|Overall Study|Withdrawal by Subject|0|||
41979644|NCT00837616|75784638|FG001|Overall Study|Withdrawal by Subject|1|||
41979645|NCT00176254|75784644|FG000|Overall Study|Lost to Follow-up|1|||
41979646|NCT03083873|75784657|FG000|Overall Study|Death|6|||
41979647|NCT03083873|75784658|FG001|Overall Study|Death|15|||
41979648|NCT03083873|75784659|FG002|Overall Study|Death|13|||
41979649|NCT03083873|75784660|FG003|Overall Study|Death|9|||
41979650|NCT03083873|75784661|FG004|Overall Study|Death|0|||
41979651|NCT03083873|75784657|FG000|Overall Study|Sponsor Terminated Study|0|||
41979652|NCT03083873|75784658|FG001|Overall Study|Sponsor Terminated Study|1|||
41979653|NCT03083873|75784659|FG002|Overall Study|Sponsor Terminated Study|2|||
42130019|NCT00344500|75940946|FG001|Overall Study|Protocol Violation|7|||
42130020|NCT00344500|75940947|FG002|Overall Study|Protocol Violation|1|||
41979654|NCT03083873|75784660|FG003|Overall Study|Sponsor Terminated Study|3|||
42130021|NCT00344500|75940945|FG000|Overall Study|Not Noted|1|||
41979655|NCT03083873|75784661|FG004|Overall Study|Sponsor Terminated Study|0|||
41979656|NCT03083873|75784657|FG000|Overall Study|Lost to Follow-up|0|||
41979657|NCT03083873|75784658|FG001|Overall Study|Lost to Follow-up|1|||
41979658|NCT03083873|75784659|FG002|Overall Study|Lost to Follow-up|1|||
41979659|NCT03083873|75784660|FG003|Overall Study|Lost to Follow-up|0|||
41979660|NCT03083873|75784661|FG004|Overall Study|Lost to Follow-up|0|||
41979661|NCT03083873|75784657|FG000|Overall Study|Withdrawal by Subject|2|||
41979662|NCT03083873|75784658|FG001|Overall Study|Withdrawal by Subject|0|||
41979663|NCT03083873|75784659|FG002|Overall Study|Withdrawal by Subject|0|||
41979664|NCT03083873|75784660|FG003|Overall Study|Withdrawal by Subject|0|||
41979665|NCT03083873|75784661|FG004|Overall Study|Withdrawal by Subject|0|||
41979666|NCT03083873|75784657|FG000|Overall Study|Did Not Receive TIL|2|||
41979667|NCT03083873|75784658|FG001|Overall Study|Did Not Receive TIL|5|||
41979668|NCT03083873|75784659|FG002|Overall Study|Did Not Receive TIL|3|||
41979669|NCT03083873|75784660|FG003|Overall Study|Did Not Receive TIL|1|||
41979670|NCT03083873|75784661|FG004|Overall Study|Did Not Receive TIL|0|||
41979671|NCT04834726|75784695|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
41979672|NCT04834726|75784696|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
41979673|NCT04834726|75784697|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
41979674|NCT04834726|75784698|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
41979675|NCT04834726|75784699|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
41979676|NCT04834726|75784700|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
41979677|NCT04834726|75784701|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
41979678|NCT04834726|75784702|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
42130022|NCT00344500|75940946|FG001|Overall Study|Not Noted|3|||
41979679|NCT04834726|75784703|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
41979680|NCT04732949|75784719|FG000|Overall Study|Withdrawal by Subject|23|||
42302192|NCT02495077|76137273|FG003|Overall Study|Adverse Event|0|||
42302193|NCT02495077|76137270|FG000|Overall Study|Death|3|||
42302194|NCT02495077|76137271|FG001|Overall Study|Death|5|||
42302195|NCT02495077|76137272|FG002|Overall Study|Death|0|||
42302196|NCT02495077|76137273|FG003|Overall Study|Death|0|||
41979681|NCT04732949|75784720|FG001|Overall Study|Withdrawal by Subject|27|||
41979682|NCT04732949|75784719|FG000|Overall Study|Protocol Violation|0|||
41979683|NCT04732949|75784720|FG001|Overall Study|Protocol Violation|1|||
41979684|NCT04732949|75784719|FG000|Overall Study|Non-compliance|0|||
41979685|NCT04732949|75784720|FG001|Overall Study|Non-compliance|2|||
41979686|NCT04732949|75784719|FG000|Overall Study|Physician Decision|2|||
41979687|NCT04732949|75784720|FG001|Overall Study|Physician Decision|1|||
41979688|NCT04732949|75784719|FG000|Overall Study|Serious adverse event (Fatal)|16|||
41979689|NCT04732949|75784720|FG001|Overall Study|Serious adverse event (Fatal)|18|||
41979690|NCT04732949|75784719|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
41979691|NCT04732949|75784720|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
41979692|NCT04732949|75784719|FG000|Overall Study|Non-serious adverse event|1|||
41979693|NCT04732949|75784720|FG001|Overall Study|Non-serious adverse event|3|||
41979694|NCT04732949|75784719|FG000|Overall Study|Lost to Follow-up|26|||
41979695|NCT04732949|75784720|FG001|Overall Study|Lost to Follow-up|27|||
41979696|NCT04732949|75784719|FG000|Overall Study|Other|6|||
41979697|NCT04732949|75784720|FG001|Overall Study|Other|3|||
41979698|NCT04235504|75784775|FG000|Study Phase|Withdrawal by Subject|5|||
41979699|NCT04235504|75784776|FG001|Study Phase|Withdrawal by Subject|2|||
41979700|NCT04235504|75784777|FG002|Study Phase|Withdrawal by Subject|0|||
41979701|NCT04235504|75784778|FG003|Study Phase|Withdrawal by Subject|0|||
41979702|NCT04235504|75784775|FG000|Continuation Phase|Withdrawal by Subject|0|||
41979703|NCT04235504|75784776|FG001|Continuation Phase|Withdrawal by Subject|4|||
41979704|NCT04235504|75784777|FG002|Continuation Phase|Withdrawal by Subject|0|||
41979705|NCT04235504|75784778|FG003|Continuation Phase|Withdrawal by Subject|0|||
41979706|NCT04235504|75784775|FG000|Continuation Phase|Adverse Event|0|||
41979707|NCT04235504|75784776|FG001|Continuation Phase|Adverse Event|1|||
41979708|NCT04235504|75784777|FG002|Continuation Phase|Adverse Event|0|||
41979709|NCT04235504|75784778|FG003|Continuation Phase|Adverse Event|0|||
41979710|NCT04235504|75784775|FG000|Continuation Phase|Physician Decision|1|||
41979711|NCT04235504|75784776|FG001|Continuation Phase|Physician Decision|2|||
41979712|NCT04235504|75784777|FG002|Continuation Phase|Physician Decision|1|||
41979713|NCT04235504|75784778|FG003|Continuation Phase|Physician Decision|0|||
41979714|NCT04172987|75784793|FG000|Lead In Period|Adverse Event|1|||
41979715|NCT04172987|75784793|FG000|Lead In Period|Protocol Violation|1|||
41979716|NCT04172987|75784793|FG000|Period 1|Physician Decision|1|||
41979717|NCT04172987|75784793|FG000|Period 2|Adverse Event|5|||
42130023|NCT00344500|75940947|FG002|Overall Study|Not Noted|0|||
41979718|NCT04172987|75784793|FG000|Period 2|Dosing Termination by Sponsor|4|||
42130024|NCT00344032|75940956|FG000|Overall Study|Adverse Event|0|||
41979719|NCT03705832|75784802|FG000|Overall Study|Physician Decision|0|||
41979720|NCT03705832|75784803|FG001|Overall Study|Physician Decision|1|||
41979721|NCT03705832|75784802|FG000|Overall Study|Withdrawal by Subject|1|||
41979722|NCT03705832|75784803|FG001|Overall Study|Withdrawal by Subject|0|||
41979723|NCT03447743|75784809|FG000|Overall Study|Withdrawal by Subject|2|||
41979724|NCT03447743|75784809|FG000|Overall Study|Lost to Follow-up|3|||
41979725|NCT03447743|75784809|FG000|Overall Study|Adverse Event|1|||
41979726|NCT03447743|75784809|FG000|Overall Study|Did not meet criteria to continue|1|||
42302197|NCT02495077|76137270|FG000|Overall Study|Lost to Follow-up|6|||
42219050|NCT03613649|76037265|FG004|Second Treatment|Withdrawal by Subject|1|||
42219051|NCT03613649|76037266|FG005|Second Treatment|Withdrawal by Subject|0|||
42219052|NCT03613649|76037267|FG006|Second Treatment|Withdrawal by Subject|0|||
42219053|NCT03613649|76037268|FG007|Second Treatment|Withdrawal by Subject|0|||
42219054|NCT03613649|76037269|FG008|Second Treatment|Withdrawal by Subject|0|||
42219055|NCT03613649|76037270|FG009|Second Treatment|Withdrawal by Subject|0|||
42219056|NCT03613649|76037271|FG010|Second Treatment|Withdrawal by Subject|0|||
42219057|NCT03613649|76037272|FG011|Second Treatment|Withdrawal by Subject|0|||
42219058|NCT03613649|76037261|FG000|Third Treatment|Lost to Follow-up|0|||
42219059|NCT03613649|76037262|FG001|Third Treatment|Lost to Follow-up|0|||
42219060|NCT03613649|76037263|FG002|Third Treatment|Lost to Follow-up|0|||
42219061|NCT03613649|76037264|FG003|Third Treatment|Lost to Follow-up|0|||
42219062|NCT03613649|76037265|FG004|Third Treatment|Lost to Follow-up|1|||
42219063|NCT03613649|76037266|FG005|Third Treatment|Lost to Follow-up|0|||
42219064|NCT03613649|76037267|FG006|Third Treatment|Lost to Follow-up|0|||
42219065|NCT03613649|76037268|FG007|Third Treatment|Lost to Follow-up|0|||
42219066|NCT03613649|76037269|FG008|Third Treatment|Lost to Follow-up|0|||
42219067|NCT03613649|76037270|FG009|Third Treatment|Lost to Follow-up|0|||
42219068|NCT03613649|76037271|FG010|Third Treatment|Lost to Follow-up|0|||
42219069|NCT03613649|76037272|FG011|Third Treatment|Lost to Follow-up|1|||
42219070|NCT03613649|76037261|FG000|Third Treatment|Protocol Violation|0|||
42219071|NCT03613649|76037262|FG001|Third Treatment|Protocol Violation|0|||
42219072|NCT03613649|76037263|FG002|Third Treatment|Protocol Violation|0|||
42219073|NCT03613649|76037264|FG003|Third Treatment|Protocol Violation|0|||
42219074|NCT03613649|76037265|FG004|Third Treatment|Protocol Violation|0|||
42219075|NCT03613649|76037266|FG005|Third Treatment|Protocol Violation|0|||
42219076|NCT03613649|76037267|FG006|Third Treatment|Protocol Violation|1|||
42219077|NCT03613649|76037268|FG007|Third Treatment|Protocol Violation|0|||
42219078|NCT03613649|76037269|FG008|Third Treatment|Protocol Violation|0|||
42219079|NCT03613649|76037270|FG009|Third Treatment|Protocol Violation|0|||
42219080|NCT03613649|76037271|FG010|Third Treatment|Protocol Violation|0|||
42219081|NCT03613649|76037272|FG011|Third Treatment|Protocol Violation|1|||
42219082|NCT03613649|76037261|FG000|Fourth Treatment|Protocol Violation|1|||
42219083|NCT03613649|76037262|FG001|Fourth Treatment|Protocol Violation|0|||
42219084|NCT03613649|76037263|FG002|Fourth Treatment|Protocol Violation|0|||
42219085|NCT03613649|76037264|FG003|Fourth Treatment|Protocol Violation|0|||
42219086|NCT03613649|76037265|FG004|Fourth Treatment|Protocol Violation|1|||
42219087|NCT03613649|76037266|FG005|Fourth Treatment|Protocol Violation|0|||
42219088|NCT03613649|76037267|FG006|Fourth Treatment|Protocol Violation|0|||
42219089|NCT03613649|76037268|FG007|Fourth Treatment|Protocol Violation|0|||
42219090|NCT03613649|76037269|FG008|Fourth Treatment|Protocol Violation|0|||
42219091|NCT03613649|76037270|FG009|Fourth Treatment|Protocol Violation|0|||
42219092|NCT03613649|76037271|FG010|Fourth Treatment|Protocol Violation|0|||
42219093|NCT03613649|76037272|FG011|Fourth Treatment|Protocol Violation|0|||
42219094|NCT03613649|76037261|FG000|Fourth Treatment|Physician Decision|0|||
42219095|NCT03613649|76037262|FG001|Fourth Treatment|Physician Decision|0|||
42219096|NCT03613649|76037263|FG002|Fourth Treatment|Physician Decision|0|||
42219097|NCT03613649|76037264|FG003|Fourth Treatment|Physician Decision|0|||
42219098|NCT03613649|76037265|FG004|Fourth Treatment|Physician Decision|0|||
42219099|NCT03613649|76037266|FG005|Fourth Treatment|Physician Decision|0|||
42219100|NCT03613649|76037267|FG006|Fourth Treatment|Physician Decision|1|||
42219101|NCT03613649|76037268|FG007|Fourth Treatment|Physician Decision|0|||
42219102|NCT03613649|76037269|FG008|Fourth Treatment|Physician Decision|0|||
42219103|NCT03613649|76037270|FG009|Fourth Treatment|Physician Decision|0|||
42219104|NCT03613649|76037271|FG010|Fourth Treatment|Physician Decision|0|||
42219105|NCT03613649|76037272|FG011|Fourth Treatment|Physician Decision|0|||
42219106|NCT03096288|76037294|FG000|Overall Study|Withdrawal by Subject|0|||
42219107|NCT03096288|76037295|FG001|Overall Study|Withdrawal by Subject|1|||
42219108|NCT03096288|76037296|FG002|Overall Study|Withdrawal by Subject|0|||
42219109|NCT03096288|76037297|FG003|Overall Study|Withdrawal by Subject|1|||
42219110|NCT03611075|76037316|FG000|Overall Study|Physician Decision|0|||
42219111|NCT03611075|76037317|FG001|Overall Study|Physician Decision|1|||
42219112|NCT03611075|76037318|FG002|Overall Study|Physician Decision|1|||
41979727|NCT03433755|75784817|FG000|Overall Study|Lost to Follow-up|1|||
42219113|NCT03611075|76037319|FG003|Overall Study|Physician Decision|0|||
42219114|NCT03611075|76037320|FG004|Overall Study|Physician Decision|0|||
42219115|NCT03611075|76037321|FG005|Overall Study|Physician Decision|0|||
42219116|NCT03611075|76037322|FG006|Overall Study|Physician Decision|0|||
42219117|NCT03611075|76037323|FG007|Overall Study|Physician Decision|0|||
41979728|NCT03433755|75784818|FG001|Overall Study|Lost to Follow-up|0|||
42302198|NCT02495077|76137271|FG001|Overall Study|Lost to Follow-up|4|||
42219118|NCT03611075|76037324|FG008|Overall Study|Physician Decision|0|||
42219119|NCT03611075|76037316|FG000|Overall Study|Lost to Follow-up|1|||
42219120|NCT03611075|76037317|FG001|Overall Study|Lost to Follow-up|0|||
42219121|NCT03611075|76037318|FG002|Overall Study|Lost to Follow-up|0|||
42219122|NCT03611075|76037319|FG003|Overall Study|Lost to Follow-up|2|||
42219123|NCT03611075|76037320|FG004|Overall Study|Lost to Follow-up|0|||
42219124|NCT03611075|76037321|FG005|Overall Study|Lost to Follow-up|0|||
42219125|NCT03611075|76037322|FG006|Overall Study|Lost to Follow-up|0|||
42219126|NCT03611075|76037323|FG007|Overall Study|Lost to Follow-up|0|||
42219127|NCT03611075|76037324|FG008|Overall Study|Lost to Follow-up|0|||
42219128|NCT03611075|76037316|FG000|Overall Study|Withdrawal by Subject|0|||
42219129|NCT03611075|76037317|FG001|Overall Study|Withdrawal by Subject|1|||
42219130|NCT03611075|76037318|FG002|Overall Study|Withdrawal by Subject|1|||
42219131|NCT03611075|76037319|FG003|Overall Study|Withdrawal by Subject|1|||
42219132|NCT03611075|76037320|FG004|Overall Study|Withdrawal by Subject|0|||
42219133|NCT03611075|76037321|FG005|Overall Study|Withdrawal by Subject|0|||
42219134|NCT03611075|76037322|FG006|Overall Study|Withdrawal by Subject|1|||
42219135|NCT03611075|76037323|FG007|Overall Study|Withdrawal by Subject|0|||
42219136|NCT03611075|76037324|FG008|Overall Study|Withdrawal by Subject|0|||
42219137|NCT03611075|76037316|FG000|Overall Study|Reason unknown|0|||
42219138|NCT03611075|76037317|FG001|Overall Study|Reason unknown|0|||
42219139|NCT03611075|76037318|FG002|Overall Study|Reason unknown|0|||
42219140|NCT03611075|76037319|FG003|Overall Study|Reason unknown|1|||
42219141|NCT03611075|76037320|FG004|Overall Study|Reason unknown|0|||
42302199|NCT02495077|76137272|FG002|Overall Study|Lost to Follow-up|0|||
42302200|NCT02495077|76137273|FG003|Overall Study|Lost to Follow-up|0|||
41979729|NCT03433755|75784819|FG002|Overall Study|Lost to Follow-up|0|||
42219142|NCT03611075|76037321|FG005|Overall Study|Reason unknown|0|||
42219143|NCT03611075|76037322|FG006|Overall Study|Reason unknown|1|||
42219144|NCT03611075|76037323|FG007|Overall Study|Reason unknown|0|||
42219145|NCT03611075|76037324|FG008|Overall Study|Reason unknown|0|||
42219146|NCT03095508|76037369|FG000|Overall Study|Adverse Event|0|||
42219147|NCT03095508|76037370|FG001|Overall Study|Adverse Event|1|||
42219148|NCT03607487|76037380|FG000|Overall Study|Withdrawal by Subject|2|||
42302201|NCT02495077|76137270|FG000|Overall Study|Physician Decision|2|||
42219149|NCT03607487|76037381|FG001|Overall Study|Withdrawal by Subject|0|||
42219150|NCT03607487|76037382|FG002|Overall Study|Withdrawal by Subject|0|||
42219151|NCT03607487|76037383|FG003|Overall Study|Withdrawal by Subject|1|||
42219152|NCT03605693|76037397|FG000|Overall Study|Lost to Follow-up|4|||
42219153|NCT03605693|76037398|FG001|Overall Study|Lost to Follow-up|0|||
42219154|NCT03605693|76037397|FG000|Overall Study|Physician Decision|1|||
42219155|NCT03605693|76037398|FG001|Overall Study|Physician Decision|0|||
42219156|NCT03605303|76037404|FG000|Period 1|Study Terminated|2|||
42219157|NCT03605303|76037405|FG001|Period 1|Study Terminated|1|||
42130025|NCT00344032|75940957|FG001|Overall Study|Adverse Event|1|||
42130026|NCT00344032|75940956|FG000|Overall Study|Withdrawal by Subject|6|||
42130027|NCT00344032|75940957|FG001|Overall Study|Withdrawal by Subject|2|||
41979730|NCT03433755|75784820|FG003|Overall Study|Lost to Follow-up|0|||
41979731|NCT03433755|75784817|FG000|Overall Study|Decision by Sponsor|1|||
41979732|NCT03433755|75784818|FG001|Overall Study|Decision by Sponsor|0|||
41979733|NCT03433755|75784819|FG002|Overall Study|Decision by Sponsor|0|||
41979734|NCT03433755|75784820|FG003|Overall Study|Decision by Sponsor|0|||
41979735|NCT03406507|75784843|FG000|Extension Period|Lack of Efficacy|0|||
41979736|NCT03406507|75784844|FG001|Extension Period|Lack of Efficacy|1|||
41979737|NCT03283150|75784853|FG000|Overall Study|Withdrawal by Subject|6|||
41979738|NCT03283150|75784854|FG001|Overall Study|Withdrawal by Subject|0|||
41979739|NCT03283150|75784855|FG002|Overall Study|Withdrawal by Subject|0|||
41979740|NCT03218917|75784866|FG000|Overall Study|Adverse Event|3|||
41979741|NCT03218917|75784867|FG001|Overall Study|Adverse Event|3|||
41979742|NCT03218917|75784868|FG002|Overall Study|Adverse Event|2|||
41979743|NCT03218917|75784866|FG000|Overall Study|Subject withdrew consent|2|||
41979744|NCT03218917|75784867|FG001|Overall Study|Subject withdrew consent|4|||
41979745|NCT03218917|75784868|FG002|Overall Study|Subject withdrew consent|10|||
41979746|NCT03218917|75784866|FG000|Overall Study|Physician Decision|0|||
41979747|NCT03218917|75784867|FG001|Overall Study|Physician Decision|1|||
41979748|NCT03218917|75784868|FG002|Overall Study|Physician Decision|1|||
42028621|NCT01135992|75837033|FG000|Overall Study|Adverse Event|1|||
41979749|NCT03218917|75784866|FG000|Overall Study|Lost to Follow-up|1|||
41979750|NCT03218917|75784867|FG001|Overall Study|Lost to Follow-up|0|||
41979751|NCT03218917|75784868|FG002|Overall Study|Lost to Follow-up|0|||
42028622|NCT01135992|75837033|FG000|Overall Study|Lack of Efficacy|1|||
42028623|NCT01135992|75837033|FG000|Overall Study|Protocol Violation|2|||
42028624|NCT01135992|75837033|FG000|Overall Study|Withdrawal criteria|10|||
42028625|NCT01135992|75837033|FG000|Overall Study|Unclassified|7|||
42219158|NCT03604523|76037413|FG000|Overall Study|Physician Decision|1|||
42219159|NCT03604523|76037414|FG001|Overall Study|Physician Decision|0|||
42219160|NCT03602339|76037420|FG000|Overall Study|Withdrawal by Subject|9|||
42219161|NCT03602339|76037420|FG000|Overall Study|Physician Decision|2|||
42219162|NCT03602339|76037420|FG000|Overall Study|Other reason|4|||
42219163|NCT03653429|76037429|FG000|Overall Study|Physician Decision|4|||
42219164|NCT03653429|76037430|FG001|Overall Study|Physician Decision|10|||
42219165|NCT03601715|76037439|FG000|Second Intervention|Lost to Follow-up|1|||
41979752|NCT03218917|75784866|FG000|Overall Study|Reason Missing|0|||
41979753|NCT03218917|75784867|FG001|Overall Study|Reason Missing|2|||
41979754|NCT03218917|75784868|FG002|Overall Study|Reason Missing|0|||
41979755|NCT03218917|75784866|FG000|Overall Study|Death|0|||
41979756|NCT03218917|75784867|FG001|Overall Study|Death|1|||
41979757|NCT03218917|75784868|FG002|Overall Study|Death|0|||
41979758|NCT03218917|75784866|FG000|Overall Study|Non-Compliance with Study Drug|0|||
41979759|NCT03218917|75784867|FG001|Overall Study|Non-Compliance with Study Drug|1|||
41979760|NCT03218917|75784868|FG002|Overall Study|Non-Compliance with Study Drug|0|||
41979761|NCT03056040|75784879|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
41979762|NCT03056040|75784880|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
42219166|NCT03601715|76037440|FG001|Second Intervention|Lost to Follow-up|1|||
42219167|NCT03601715|76037441|FG002|Second Intervention|Lost to Follow-up|0|||
42219168|NCT03594227|76037457|FG000|Overall Study|Adverse Event|2|||
41979763|NCT03056040|75784879|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
42219169|NCT03594227|76037458|FG001|Overall Study|Adverse Event|1|||
42219170|NCT03594227|76037459|FG002|Overall Study|Adverse Event|0|||
42219171|NCT03594227|76037460|FG003|Overall Study|Adverse Event|2|||
42219172|NCT03594227|76037457|FG000|Overall Study|Lost to Follow-up|1|||
42219173|NCT03594227|76037458|FG001|Overall Study|Lost to Follow-up|1|||
42219174|NCT03594227|76037459|FG002|Overall Study|Lost to Follow-up|1|||
42219175|NCT03594227|76037460|FG003|Overall Study|Lost to Follow-up|0|||
42219176|NCT03594227|76037457|FG000|Overall Study|Withdrawal by Subject|1|||
42219177|NCT03594227|76037458|FG001|Overall Study|Withdrawal by Subject|1|||
42219178|NCT03594227|76037459|FG002|Overall Study|Withdrawal by Subject|1|||
42219179|NCT03594227|76037460|FG003|Overall Study|Withdrawal by Subject|1|||
42219180|NCT03594227|76037457|FG000|Overall Study|Pregnancy|0|||
41979764|NCT03056040|75784880|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
41979765|NCT03056040|75784879|FG000|Primary Evaluation Period|Pregnancy|0|||
41979766|NCT03056040|75784880|FG001|Primary Evaluation Period|Pregnancy|1|||
41979767|NCT03056040|75784879|FG000|Extension Period|Physician Decision|3|||
42130028|NCT00344032|75940956|FG000|Overall Study|Lost to Follow-up|4|||
42130029|NCT00344032|75940957|FG001|Overall Study|Lost to Follow-up|6|||
42130030|NCT00344032|75940956|FG000|Overall Study|Physician Decision|4|||
42219181|NCT03594227|76037458|FG001|Overall Study|Pregnancy|1|||
42219182|NCT03594227|76037459|FG002|Overall Study|Pregnancy|0|||
42219183|NCT03594227|76037460|FG003|Overall Study|Pregnancy|0|||
42302202|NCT02495077|76137271|FG001|Overall Study|Physician Decision|1|||
42302203|NCT02495077|76137272|FG002|Overall Study|Physician Decision|4|||
42302204|NCT02495077|76137273|FG003|Overall Study|Physician Decision|0|||
41979768|NCT03056040|75784880|FG001|Extension Period|Physician Decision|3|||
41979769|NCT03056040|75784879|FG000|Extension Period|Lost to Follow-up|0|||
42130031|NCT00344032|75940957|FG001|Overall Study|Physician Decision|1|||
42130032|NCT00607373|75940965|FG000|Treatment Period|Adverse Event|0|||
42130033|NCT00607373|75940966|FG001|Treatment Period|Adverse Event|4|||
42130034|NCT00607373|75940965|FG000|Treatment Period|Physician Decision|0|||
42130035|NCT00607373|75940966|FG001|Treatment Period|Physician Decision|1|||
42130036|NCT00607373|75940965|FG000|Treatment Period|Withdrawal by Subject|0|||
42130037|NCT00607373|75940966|FG001|Treatment Period|Withdrawal by Subject|1|||
42130038|NCT00607373|75940965|FG000|Follow-up Period|Other|0|||
42130039|NCT00607373|75940966|FG001|Follow-up Period|Other|1|||
42130040|NCT00607373|75940965|FG000|Follow-up Period|Protocol Violation|0|||
42130041|NCT00607373|75940966|FG001|Follow-up Period|Protocol Violation|1|||
42130042|NCT00607373|75940965|FG000|Follow-up Period|Withdrawal by Subject|1|||
41979770|NCT03056040|75784880|FG001|Extension Period|Lost to Follow-up|1|||
42130043|NCT00607373|75940966|FG001|Follow-up Period|Withdrawal by Subject|3|||
42130044|NCT00508404|75940972|FG000|Overall Study|Ongoing at Data Cut-off|12|||
42130045|NCT00508404|75940972|FG000|Overall Study|Adverse Event|2|||
42130046|NCT00508404|75940972|FG000|Overall Study|Death|16|||
42219184|NCT03594227|76037457|FG000|Overall Study|Sponsor Decision|0|||
42219185|NCT03594227|76037458|FG001|Overall Study|Sponsor Decision|0|||
42219186|NCT03594227|76037459|FG002|Overall Study|Sponsor Decision|0|||
42219187|NCT03594227|76037460|FG003|Overall Study|Sponsor Decision|1|||
42219188|NCT03594227|76037457|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
42219189|NCT03594227|76037458|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
42219190|NCT03594227|76037459|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
42219191|NCT03594227|76037460|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
41979771|NCT03056040|75784879|FG000|Extension Period|Death|0|||
42219192|NCT03098550|76037484|FG000|Overall Study|Disease Progression|30|||
41979772|NCT03056040|75784880|FG001|Extension Period|Death|3|||
42302205|NCT02495077|76137270|FG000|Overall Study|Protocol Violation|0|||
41979773|NCT03056040|75784879|FG000|Extension Period|Withdrawal by Subject|1|||
41979774|NCT03056040|75784880|FG001|Extension Period|Withdrawal by Subject|0|||
41979775|NCT03021499|75784891|FG000|Overall Study|Adverse Event|1|||
41979776|NCT03021499|75784892|FG001|Overall Study|Adverse Event|0|||
41979777|NCT03021499|75784891|FG000|Overall Study|Death|1|||
41979778|NCT03021499|75784892|FG001|Overall Study|Death|5|||
41979779|NCT03021499|75784891|FG000|Overall Study|Lack of Efficacy|0|||
41979780|NCT03021499|75784892|FG001|Overall Study|Lack of Efficacy|1|||
41979781|NCT03021499|75784891|FG000|Overall Study|Lost to Follow-up|1|||
41979782|NCT03021499|75784892|FG001|Overall Study|Lost to Follow-up|3|||
41979783|NCT03021499|75784891|FG000|Overall Study|Physician Decision|2|||
41979784|NCT03021499|75784892|FG001|Overall Study|Physician Decision|3|||
41979785|NCT03021499|75784891|FG000|Overall Study|Pregnancy|1|||
41979786|NCT03021499|75784892|FG001|Overall Study|Pregnancy|0|||
41979787|NCT03021499|75784891|FG000|Overall Study|Withdrawal by Subject|7|||
41979788|NCT03021499|75784892|FG001|Overall Study|Withdrawal by Subject|14|||
41979789|NCT03021499|75784891|FG000|Overall Study|Prohibited medication required|1|||
42219193|NCT03098550|76037485|FG001|Overall Study|Disease Progression|19|||
42219194|NCT03098550|76037486|FG002|Overall Study|Disease Progression|41|||
42219195|NCT03098550|76037484|FG000|Overall Study|Study Drug Toxicity|2|||
42219196|NCT03098550|76037485|FG001|Overall Study|Study Drug Toxicity|1|||
42219197|NCT03098550|76037486|FG002|Overall Study|Study Drug Toxicity|0|||
42219198|NCT03098550|76037484|FG000|Overall Study|Death|1|||
42219199|NCT03098550|76037485|FG001|Overall Study|Death|0|||
42219200|NCT03098550|76037486|FG002|Overall Study|Death|0|||
42219201|NCT03098550|76037484|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
42219202|NCT03098550|76037485|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
42219203|NCT03098550|76037486|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
42219204|NCT03098550|76037484|FG000|Overall Study|Administrative reason by sponsor|0|||
42219205|NCT03098550|76037485|FG001|Overall Study|Administrative reason by sponsor|0|||
42219206|NCT03098550|76037486|FG002|Overall Study|Administrative reason by sponsor|1|||
42219207|NCT03098550|76037484|FG000|Overall Study|Other reasons|2|||
42219208|NCT03098550|76037485|FG001|Overall Study|Other reasons|0|||
42219209|NCT03098550|76037486|FG002|Overall Study|Other reasons|0|||
42219210|NCT03095118|76037498|FG000|Overall Study|Adverse Event|1|||
42219211|NCT03095118|76037498|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
42219212|NCT03594071|76037502|FG000|Overall Study|Re-operation|3|||
42219213|NCT03594071|76037502|FG000|Overall Study|Missed visit|2|||
42219214|NCT02696902|76037509|FG000|Overall Study|Lost to Follow-up|0|||
42219215|NCT02696902|76037510|FG001|Overall Study|Lost to Follow-up|1|||
41979790|NCT03021499|75784892|FG001|Overall Study|Prohibited medication required|0|||
41979791|NCT03021499|75784891|FG000|Overall Study|Protocol non-compliance|1|||
42219216|NCT02696902|76037511|FG002|Overall Study|Lost to Follow-up|1|||
41979792|NCT03021499|75784892|FG001|Overall Study|Protocol non-compliance|1|||
42219217|NCT02696902|76037509|FG000|Overall Study|Withdrawal by Subject|0|||
42219218|NCT02696902|76037510|FG001|Overall Study|Withdrawal by Subject|0|||
42219219|NCT02696902|76037511|FG002|Overall Study|Withdrawal by Subject|1|||
42219220|NCT02696902|76037509|FG000|Overall Study|Death|19|||
41979793|NCT03021499|75784891|FG000|Overall Study|None of the above|0|||
41979794|NCT03021499|75784892|FG001|Overall Study|None of the above|4|||
41979795|NCT03021499|75784891|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
41979796|NCT03021499|75784892|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
41979797|NCT02726581|75784921|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
41979798|NCT02726581|75784922|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
41979799|NCT02726581|75784923|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
41979800|NCT02726581|75784921|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
41979801|NCT02726581|75784922|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
41979802|NCT02726581|75784923|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
41979803|NCT02726581|75784921|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
41979804|NCT02726581|75784922|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41979805|NCT02726581|75784923|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
41979806|NCT02726581|75784921|FG000|Treatment Period|Disease progression|47|||
41979807|NCT02726581|75784922|FG001|Treatment Period|Disease progression|50|||
41979808|NCT02726581|75784923|FG002|Treatment Period|Disease progression|16|||
41979809|NCT02726581|75784921|FG000|Treatment Period|Other reasons|9|||
41979810|NCT02726581|75784922|FG001|Treatment Period|Other reasons|8|||
41979811|NCT02726581|75784923|FG002|Treatment Period|Other reasons|2|||
41979812|NCT02726581|75784921|FG000|Treatment Period|Study drug toxicity|6|||
41979813|NCT02726581|75784922|FG001|Treatment Period|Study drug toxicity|3|||
41979814|NCT02726581|75784923|FG002|Treatment Period|Study drug toxicity|2|||
41979815|NCT02726581|75784921|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
42130047|NCT00508404|75940972|FG000|Overall Study|Physician Decision|2|||
42302206|NCT02495077|76137271|FG001|Overall Study|Protocol Violation|1|||
41979816|NCT02726581|75784922|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
42028626|NCT00959049|75837043|FG000|Overall Study|Adverse Event|1|||
42028627|NCT00959049|75837044|FG001|Overall Study|Adverse Event|0|||
41979817|NCT02726581|75784923|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
41979818|NCT02726581|75784921|FG000|Treatment Period|Participant withdrew consent|3|||
41979819|NCT02726581|75784922|FG001|Treatment Period|Participant withdrew consent|1|||
41979820|NCT02726581|75784923|FG002|Treatment Period|Participant withdrew consent|1|||
41979821|NCT02726581|75784921|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
41979822|NCT02726581|75784922|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
41979823|NCT02726581|75784923|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
41979824|NCT02726581|75784921|FG000|Treatment Period|Maximum clinical benefit|0|||
41979825|NCT02726581|75784922|FG001|Treatment Period|Maximum clinical benefit|2|||
41979826|NCT02726581|75784923|FG002|Treatment Period|Maximum clinical benefit|0|||
41979827|NCT02726581|75784921|FG000|Treatment Period|Death|1|||
41979828|NCT02726581|75784922|FG001|Treatment Period|Death|0|||
41979829|NCT02726581|75784923|FG002|Treatment Period|Death|0|||
41979830|NCT02726581|75784921|FG000|Treatment Period|Poor/non-compliance|1|||
41979831|NCT02726581|75784922|FG001|Treatment Period|Poor/non-compliance|0|||
41979832|NCT02726581|75784923|FG002|Treatment Period|Poor/non-compliance|0|||
41979833|NCT02726581|75784921|FG000|Treatment Period|Participant no longer meets study criteria|0|||
41979834|NCT02726581|75784922|FG001|Treatment Period|Participant no longer meets study criteria|1|||
41979835|NCT02726581|75784923|FG002|Treatment Period|Participant no longer meets study criteria|0|||
41979836|NCT02700048|75784933|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
41979837|NCT02700048|75784934|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
41979838|NCT02425904|75784951|FG000|Overall Study|Lost to Follow-up|1|||
41979839|NCT02425904|75784952|FG001|Overall Study|Lost to Follow-up|0|||
41979840|NCT02425904|75784951|FG000|Overall Study|Withdrawal by Subject|2|||
42130048|NCT00508404|75940972|FG000|Overall Study|Withdrawal by Subject|3|||
42130049|NCT00508404|75940972|FG000|Overall Study|Protocol-specified Criteria|2|||
42130050|NCT00508404|75940972|FG000|Overall Study|Lost to Follow-up|2|||
42130051|NCT00508404|75940972|FG000|Overall Study|Other - Not Specified|3|||
42219221|NCT02696902|76037510|FG001|Overall Study|Death|3|||
41979841|NCT02425904|75784952|FG001|Overall Study|Withdrawal by Subject|0|||
41979842|NCT02425904|75784951|FG000|Overall Study|Death|0|||
41979843|NCT02425904|75784952|FG001|Overall Study|Death|3|||
41979844|NCT01964989|75784974|FG000|Overall Study|Protocol Violation|3|||
41979845|NCT01964989|75784975|FG001|Overall Study|Protocol Violation|4|||
41979846|NCT01964989|75784974|FG000|Overall Study|Administrative Reason|103|||
41979847|NCT01964989|75784975|FG001|Overall Study|Administrative Reason|95|||
41979848|NCT01964989|75784974|FG000|Overall Study|Adverse Event|0|||
41979849|NCT01964989|75784975|FG001|Overall Study|Adverse Event|1|||
41979850|NCT01964989|75784974|FG000|Overall Study|Death|1|||
41979851|NCT01964989|75784975|FG001|Overall Study|Death|3|||
41979852|NCT01964989|75784974|FG000|Overall Study|Withdrawal by Subject|156|||
41979853|NCT01964989|75784975|FG001|Overall Study|Withdrawal by Subject|160|||
41979854|NCT01964989|75784974|FG000|Overall Study|Lost to Follow-up|254|||
41979855|NCT01964989|75784975|FG001|Overall Study|Lost to Follow-up|232|||
41979856|NCT01964989|75784974|FG000|Overall Study|Other|267|||
41979857|NCT01964989|75784975|FG001|Overall Study|Other|252|||
41979858|NCT01575860|75785003|FG000|Overall Study|Withdrawal by Subject|1|||
41979859|NCT01575860|75785003|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
41979860|NCT01416831|75785010|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
41979861|NCT01416831|75785011|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
41979862|NCT00382070|75785032|FG000|Overall Study|No follow up data mapped to Other|17|||
41979863|NCT00382070|75785033|FG001|Overall Study|No follow up data mapped to Other|19|||
41979864|NCT00382070|75785032|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
41979865|NCT00382070|75785033|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
41979866|NCT00382070|75785032|FG000|Overall Study|No clinical assessment|9|||
41979867|NCT00382070|75785033|FG001|Overall Study|No clinical assessment|11|||
41979868|NCT02921269|75785064|FG000|Overall Study|Did not complete DLT period|1|||
41979869|NCT04303559|75785103|FG000|Overall Study|Study closed due to poor enrollment.|1|||
41979870|NCT03784820|75785109|FG000|Overall Study|Lost to Follow-up|5|||
41979871|NCT03784820|75785110|FG001|Overall Study|Lost to Follow-up|5|||
41979872|NCT03784820|75785111|FG002|Overall Study|Lost to Follow-up|3|||
41979873|NCT03784820|75785112|FG003|Overall Study|Lost to Follow-up|3|||
41979874|NCT03769675|75785120|FG000|Overall Study|Lost to Follow-up|1|||
41979875|NCT03729245|75785126|FG000|Overall Study|Lost to Follow-up|5|||
42219222|NCT02696902|76037511|FG002|Overall Study|Death|24|||
41979876|NCT03729245|75785127|FG001|Overall Study|Lost to Follow-up|6|||
41979877|NCT03729245|75785126|FG000|Overall Study|Withdrawal by Subject|16|||
41979878|NCT03729245|75785127|FG001|Overall Study|Withdrawal by Subject|19|||
41979879|NCT03729245|75785126|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
41979880|NCT03729245|75785127|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
41979881|NCT03311711|75785147|FG000|Overall Study|Death|1|||
41979882|NCT03311711|75785148|FG001|Overall Study|Death|0|||
41979883|NCT03311711|75785149|FG002|Overall Study|Death|0|||
41979884|NCT03311711|75785150|FG003|Overall Study|Death|0|||
41979885|NCT03311711|75785151|FG004|Overall Study|Death|0|||
41979886|NCT03311711|75785152|FG005|Overall Study|Death|0|||
41979887|NCT03311711|75785153|FG006|Overall Study|Death|1|||
41979888|NCT03311711|75785154|FG007|Overall Study|Death|0|||
41979889|NCT03311711|75785155|FG008|Overall Study|Death|1|||
41979890|NCT03311711|75785156|FG009|Overall Study|Death|0|||
41979891|NCT03311711|75785147|FG000|Overall Study|Death of dyad partner|0|||
41979892|NCT03311711|75785148|FG001|Overall Study|Death of dyad partner|1|||
41979893|NCT03311711|75785149|FG002|Overall Study|Death of dyad partner|0|||
41979894|NCT03311711|75785150|FG003|Overall Study|Death of dyad partner|0|||
41979895|NCT03311711|75785151|FG004|Overall Study|Death of dyad partner|0|||
42130052|NCT00352690|75940979|FG000|Overall Study|Determined to be ineligible|2|||
41979896|NCT03311711|75785152|FG005|Overall Study|Death of dyad partner|0|||
41979897|NCT03311711|75785153|FG006|Overall Study|Death of dyad partner|0|||
42130053|NCT00352690|75940980|FG001|Overall Study|Determined to be ineligible|0|||
42219223|NCT02696902|76037509|FG000|Overall Study|Participant not fit post-randomization|0|||
41979898|NCT03311711|75785154|FG007|Overall Study|Death of dyad partner|1|||
41979899|NCT03311711|75785155|FG008|Overall Study|Death of dyad partner|0|||
41979900|NCT03311711|75785156|FG009|Overall Study|Death of dyad partner|1|||
41979901|NCT03311711|75785147|FG000|Overall Study|Lost to Follow-up|2|||
41979902|NCT03311711|75785148|FG001|Overall Study|Lost to Follow-up|2|||
41979903|NCT03311711|75785149|FG002|Overall Study|Lost to Follow-up|0|||
41979904|NCT03311711|75785150|FG003|Overall Study|Lost to Follow-up|0|||
41979905|NCT03311711|75785151|FG004|Overall Study|Lost to Follow-up|0|||
41979906|NCT03311711|75785152|FG005|Overall Study|Lost to Follow-up|0|||
41979907|NCT03311711|75785153|FG006|Overall Study|Lost to Follow-up|1|||
41979908|NCT03311711|75785154|FG007|Overall Study|Lost to Follow-up|1|||
41979909|NCT03311711|75785155|FG008|Overall Study|Lost to Follow-up|0|||
41979910|NCT03311711|75785156|FG009|Overall Study|Lost to Follow-up|0|||
41979911|NCT03311711|75785147|FG000|Overall Study|Withdrawal by Subject|1|||
42028628|NCT00959049|75837045|FG002|Overall Study|Adverse Event|0|||
42028629|NCT00959049|75837046|FG003|Overall Study|Adverse Event|0|||
41979912|NCT03311711|75785148|FG001|Overall Study|Withdrawal by Subject|1|||
41979913|NCT03311711|75785149|FG002|Overall Study|Withdrawal by Subject|0|||
41979914|NCT03311711|75785150|FG003|Overall Study|Withdrawal by Subject|0|||
41979915|NCT03311711|75785151|FG004|Overall Study|Withdrawal by Subject|0|||
41979916|NCT03311711|75785152|FG005|Overall Study|Withdrawal by Subject|0|||
41979917|NCT03311711|75785153|FG006|Overall Study|Withdrawal by Subject|3|||
41979918|NCT03311711|75785154|FG007|Overall Study|Withdrawal by Subject|3|||
41979919|NCT03311711|75785155|FG008|Overall Study|Withdrawal by Subject|0|||
41979920|NCT03311711|75785156|FG009|Overall Study|Withdrawal by Subject|0|||
42272655|NCT02281318|76102917|FG000|Overall Study|Physician Decision|2|||
41979921|NCT03270891|75785186|FG000|Overall Study|Lost to Follow-up|3|||
41979922|NCT03270891|75785187|FG001|Overall Study|Lost to Follow-up|6|||
41979923|NCT03270891|75785188|FG002|Overall Study|Lost to Follow-up|0|||
41979924|NCT03270891|75785186|FG000|Overall Study|Withdrawal by Subject|1|||
41979925|NCT03270891|75785187|FG001|Overall Study|Withdrawal by Subject|0|||
41979926|NCT03270891|75785188|FG002|Overall Study|Withdrawal by Subject|0|||
41979927|NCT03270891|75785186|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
41979928|NCT03270891|75785187|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
41979929|NCT03270891|75785188|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
41979930|NCT02992743|75785196|FG000|Overall Study|Withdrawal by Subject|1|||
41979931|NCT02992743|75785197|FG001|Overall Study|Withdrawal by Subject|1|||
41979932|NCT02992743|75785196|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
42130054|NCT00609245|75940986|FG000|Overall Study|Adverse Event|1|||
42130055|NCT00343642|75940995|FG000|Overall Study|Lost to Follow-up|0|||
42130056|NCT00343642|75940996|FG001|Overall Study|Lost to Follow-up|1|||
42130057|NCT00343642|75940997|FG002|Overall Study|Lost to Follow-up|0|||
42130058|NCT00343642|75940995|FG000|Overall Study|Pregnancy|1|||
42130059|NCT00343642|75940996|FG001|Overall Study|Pregnancy|0|||
42130060|NCT00343642|75940997|FG002|Overall Study|Pregnancy|2|||
42130061|NCT00343642|75940995|FG000|Overall Study|Withdrawal by Subject|2|||
42130062|NCT00343642|75940996|FG001|Overall Study|Withdrawal by Subject|3|||
42130063|NCT00343642|75940997|FG002|Overall Study|Withdrawal by Subject|4|||
42130064|NCT00343642|75940995|FG000|Overall Study|Adverse Event|0|||
42130065|NCT00343642|75940996|FG001|Overall Study|Adverse Event|0|||
42130066|NCT00343642|75940997|FG002|Overall Study|Adverse Event|1|||
42130067|NCT00343642|75940995|FG000|Overall Study|Flare up|6|||
42130068|NCT00343642|75940996|FG001|Overall Study|Flare up|4|||
42130069|NCT00343642|75940997|FG002|Overall Study|Flare up|0|||
42130070|NCT00609167|75941010|FG000|Overall Study|Withdrawal by Subject|1|||
42130071|NCT00609167|75941011|FG001|Overall Study|Withdrawal by Subject|0|||
42130072|NCT00609167|75941010|FG000|Overall Study|Lack of Efficacy|1|||
42130073|NCT00609167|75941011|FG001|Overall Study|Lack of Efficacy|0|||
42130074|NCT00609167|75941010|FG000|Overall Study|Adverse Event|5|||
42130075|NCT00609167|75941011|FG001|Overall Study|Adverse Event|1|||
42130076|NCT00609167|75941010|FG000|Overall Study|Disease Progression|1|||
42130077|NCT00609167|75941011|FG001|Overall Study|Disease Progression|0|||
42130078|NCT00609167|75941010|FG000|Overall Study|Stem Cell Transplant|0|||
42130079|NCT00609167|75941011|FG001|Overall Study|Stem Cell Transplant|6|||
42130080|NCT00606281|75941019|FG000|Overall Study|Adverse Event|11|||
42130081|NCT00606281|75941020|FG001|Overall Study|Adverse Event|12|||
42130082|NCT00606281|75941019|FG000|Overall Study|Death|1|||
42130083|NCT00606281|75941020|FG001|Overall Study|Death|0|||
42130084|NCT00606281|75941019|FG000|Overall Study|Lack of Efficacy|28|||
42130085|NCT00606281|75941020|FG001|Overall Study|Lack of Efficacy|35|||
42130086|NCT00606281|75941019|FG000|Overall Study|Physician Decision|0|||
42130087|NCT00606281|75941020|FG001|Overall Study|Physician Decision|1|||
42130088|NCT00606281|75941019|FG000|Overall Study|Protocol Violation|3|||
42130089|NCT00606281|75941020|FG001|Overall Study|Protocol Violation|3|||
42130090|NCT00606281|75941019|FG000|Overall Study|Withdrawal by Subject|11|||
42130091|NCT00606281|75941020|FG001|Overall Study|Withdrawal by Subject|13|||
42130092|NCT00606281|75941019|FG000|Overall Study|Progression to depressive phase|1|||
42130093|NCT00606281|75941020|FG001|Overall Study|Progression to depressive phase|1|||
42130094|NCT00606281|75941019|FG000|Overall Study|Change of residence or other commitments|1|||
41979933|NCT02992743|75785197|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
41979934|NCT02992743|75785196|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
41979935|NCT02992743|75785197|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
41979936|NCT02992743|75785196|FG000|Overall Study|No measurable disease|1|||
41979937|NCT02992743|75785197|FG001|Overall Study|No measurable disease|0|||
41979938|NCT02992743|75785196|FG000|Overall Study|Lost to Follow-up|0|||
41979939|NCT02992743|75785197|FG001|Overall Study|Lost to Follow-up|1|||
42130095|NCT00606281|75941020|FG001|Overall Study|Change of residence or other commitments|1|||
42130096|NCT00506142|75941028|FG000|Overall Study|Adverse Event|8|||
41979940|NCT02853344|75785205|FG000|Overall Study|Lost to Follow-up|1|||
41979941|NCT02853344|75785206|FG001|Overall Study|Lost to Follow-up|1|||
41979942|NCT02853344|75785205|FG000|Overall Study|Withdrawal by Subject|2|||
41979943|NCT02853344|75785206|FG001|Overall Study|Withdrawal by Subject|4|||
42130097|NCT00506142|75941029|FG001|Overall Study|Adverse Event|7|||
42130098|NCT00506142|75941028|FG000|Overall Study|Lack of Efficacy|21|||
42130099|NCT00506142|75941029|FG001|Overall Study|Lack of Efficacy|7|||
42130100|NCT00506142|75941028|FG000|Overall Study|Withdrawal by Subject|4|||
42130101|NCT00506142|75941029|FG001|Overall Study|Withdrawal by Subject|5|||
42130102|NCT00506142|75941028|FG000|Overall Study|Physician Decision|1|||
41979944|NCT02853344|75785205|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
41979945|NCT02853344|75785206|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
41979946|NCT02853344|75785205|FG000|Overall Study|Death|70|||
41979947|NCT02853344|75785206|FG001|Overall Study|Death|112|||
41979948|NCT02739620|75785217|FG000|Overall Study|Lost to Follow-up|3|||
41979949|NCT02739620|75785218|FG001|Overall Study|Lost to Follow-up|1|||
41979950|NCT02739620|75785217|FG000|Overall Study|Adverse Event|0|||
41979951|NCT02739620|75785218|FG001|Overall Study|Adverse Event|1|||
41979952|NCT02675426|75785227|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
41979953|NCT02675426|75785228|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
41979954|NCT02675426|75785229|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
41979955|NCT02675426|75785230|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
41979956|NCT02675426|75785227|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
41979957|NCT02675426|75785228|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
41979958|NCT02675426|75785229|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
41979959|NCT02675426|75785230|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
41979960|NCT02675426|75785227|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
41979961|NCT02675426|75785228|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
41979962|NCT02675426|75785229|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
41979963|NCT02675426|75785230|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
41979964|NCT02675426|75785227|FG000|Period 1: Week 1 to Week 12|Other|2|||
41979965|NCT02675426|75785228|FG001|Period 1: Week 1 to Week 12|Other|1|||
41979966|NCT02675426|75785229|FG002|Period 1: Week 1 to Week 12|Other|0|||
42302207|NCT02495077|76137272|FG002|Overall Study|Protocol Violation|0|||
41979967|NCT02675426|75785230|FG003|Period 1: Week 1 to Week 12|Other|2|||
41979968|NCT02675426|75785227|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
41979969|NCT02675426|75785228|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
41979970|NCT02675426|75785229|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
41979971|NCT02675426|75785230|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
41979972|NCT02675426|75785227|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
41979973|NCT02675426|75785228|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
41979974|NCT02675426|75785229|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
41979975|NCT02675426|75785230|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
41979976|NCT02675426|75785227|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
41979977|NCT02675426|75785228|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
41979978|NCT02675426|75785229|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
42302208|NCT02495077|76137273|FG003|Overall Study|Protocol Violation|0|||
41979979|NCT02675426|75785230|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
41979980|NCT02675426|75785227|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
41979981|NCT02675426|75785228|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
41979982|NCT02675426|75785229|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
41979983|NCT02675426|75785230|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
42130103|NCT00506142|75941029|FG001|Overall Study|Physician Decision|0|||
42219224|NCT02696902|76037510|FG001|Overall Study|Participant not fit post-randomization|0|||
42219225|NCT02696902|76037511|FG002|Overall Study|Participant not fit post-randomization|1|||
42219226|NCT02696902|76037509|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
42219227|NCT02696902|76037510|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
42130104|NCT00506142|75941028|FG000|Overall Study|New health condition|1|||
42130105|NCT00506142|75941029|FG001|Overall Study|New health condition|0|||
42130106|NCT00514020|75941035|FG000|Overall Study|Adverse Event|6|||
42130107|NCT00514020|75941035|FG000|Overall Study|Withdrawal by Subject|3|||
42130108|NCT00514020|75941035|FG000|Overall Study|Physician Decision|1|||
42130109|NCT00514020|75941035|FG000|Overall Study|disease progression|9|||
42130110|NCT00514020|75941035|FG000|Overall Study|other complicating disease|2|||
42130111|NCT00514020|75941035|FG000|Overall Study|patient went to radiation treatment|1|||
42130112|NCT00514020|75941035|FG000|Overall Study|"patients moved to the no tx group"|6|||
42130113|NCT00513708|75941042|FG000|Overall Study|Lost to Follow-up|4|||
42130114|NCT00513708|75941043|FG001|Overall Study|Lost to Follow-up|4|||
42130115|NCT00513708|75941044|FG002|Overall Study|Lost to Follow-up|4|||
42130116|NCT00513474|75941054|FG000|Overall Study|Death|6|||
42130117|NCT00513474|75941055|FG001|Overall Study|Death|9|||
42130118|NCT00513474|75941054|FG000|Overall Study|Participant Withdrew Consent|1|||
42130119|NCT00513474|75941055|FG001|Overall Study|Participant Withdrew Consent|0|||
42130120|NCT00505752|75941065|FG000|Overall Study|Adverse Event|1|||
42130121|NCT00505752|75941066|FG001|Overall Study|Adverse Event|0|||
42130122|NCT00505752|75941067|FG002|Overall Study|Adverse Event|1|||
42130123|NCT00505752|75941068|FG003|Overall Study|Adverse Event|0|||
42130124|NCT00505752|75941065|FG000|Overall Study|Lost to Follow-up|1|||
42130125|NCT00505752|75941066|FG001|Overall Study|Lost to Follow-up|0|||
42130126|NCT00505752|75941067|FG002|Overall Study|Lost to Follow-up|0|||
42130127|NCT00505752|75941068|FG003|Overall Study|Lost to Follow-up|0|||
42130128|NCT00505752|75941065|FG000|Overall Study|Lack of ovarian response|1|||
42130129|NCT00505752|75941066|FG001|Overall Study|Lack of ovarian response|3|||
42130130|NCT00505752|75941067|FG002|Overall Study|Lack of ovarian response|0|||
42130131|NCT00505752|75941068|FG003|Overall Study|Lack of ovarian response|0|||
42130132|NCT00505752|75941065|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
42130133|NCT00505752|75941066|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
42130134|NCT00505752|75941067|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
42130135|NCT00505752|75941068|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
42130136|NCT00505752|75941065|FG000|Overall Study|No oocytes retrieved|0|||
42130137|NCT00505752|75941066|FG001|Overall Study|No oocytes retrieved|2|||
42130138|NCT00505752|75941067|FG002|Overall Study|No oocytes retrieved|0|||
42130139|NCT00505752|75941068|FG003|Overall Study|No oocytes retrieved|1|||
42130140|NCT00505752|75941065|FG000|Overall Study|No Fertilization|1|||
42219228|NCT02696902|76037511|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
42219229|NCT02696902|76037509|FG000|Overall Study|Principal investigator's decision|1|||
42130141|NCT00505752|75941066|FG001|Overall Study|No Fertilization|1|||
42219230|NCT02696902|76037510|FG001|Overall Study|Principal investigator's decision|0|||
42130142|NCT00505752|75941067|FG002|Overall Study|No Fertilization|2|||
42130143|NCT00505752|75941068|FG003|Overall Study|No Fertilization|1|||
42130144|NCT00505752|75941065|FG000|Overall Study|All embryos/blastocysts discarded|0|||
42130145|NCT00505752|75941066|FG001|Overall Study|All embryos/blastocysts discarded|0|||
41979984|NCT02675426|75785227|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
41979985|NCT02675426|75785228|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
41979986|NCT02675426|75785229|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
41979987|NCT02675426|75785230|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
41979988|NCT02675426|75785227|FG000|Period 2: Week 12 to Week 260|Other|8|||
41979989|NCT02675426|75785228|FG001|Period 2: Week 12 to Week 260|Other|12|||
41979990|NCT02675426|75785229|FG002|Period 2: Week 12 to Week 260|Other|23|||
41979991|NCT02675426|75785230|FG003|Period 2: Week 12 to Week 260|Other|15|||
41979992|NCT02060721|75785271|FG000|Overall Study|Lost to Follow-up|1|||
41979993|NCT02060721|75785271|FG000|Overall Study|Physician Decision|2|||
41979994|NCT02060721|75785271|FG000|Overall Study|Death|14|||
41979995|NCT02060721|75785271|FG000|Overall Study|Withdrawal by Subject|2|||
41979996|NCT02060721|75785271|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
41979997|NCT01527149|75785275|FG000|Overall Study|Death|2|||
41979998|NCT01359956|75785283|FG000|Overall Study|Death|58|||
41979999|NCT01359956|75785284|FG001|Overall Study|Death|60|||
41980000|NCT01359956|75785285|FG002|Overall Study|Death|66|||
41980001|NCT01359956|75785286|FG003|Overall Study|Death|57|||
41980002|NCT01359956|75785283|FG000|Overall Study|Lost to Follow-up|3|||
41980003|NCT01359956|75785284|FG001|Overall Study|Lost to Follow-up|4|||
41980004|NCT01359956|75785285|FG002|Overall Study|Lost to Follow-up|1|||
41980005|NCT01359956|75785286|FG003|Overall Study|Lost to Follow-up|1|||
41980006|NCT01306045|75785299|FG000|Met General Eligibility Criteria|Screen failures|193|||
41980007|NCT01306045|75785300|FG001|Met General Eligibility Criteria|Screen failures|11|||
41980008|NCT01306045|75785301|FG002|Met General Eligibility Criteria|Screen failures|8|||
41980009|NCT05121480|75785350|FG000|Overall Study|Lack of Efficacy|2|||
41980010|NCT05121480|75785351|FG001|Overall Study|Lack of Efficacy|2|||
41980011|NCT05121480|75785352|FG002|Overall Study|Lack of Efficacy|1|||
41980012|NCT05121480|75785353|FG003|Overall Study|Lack of Efficacy|4|||
41980013|NCT05121480|75785354|FG004|Overall Study|Lack of Efficacy|0|||
41980014|NCT05121480|75785355|FG005|Overall Study|Lack of Efficacy|1|||
41980015|NCT05121480|75785356|FG006|Overall Study|Lack of Efficacy|0|||
41980016|NCT05121480|75785357|FG007|Overall Study|Lack of Efficacy|2|||
41980017|NCT05121480|75785350|FG000|Overall Study|Treatment Failure|0|||
41980018|NCT05121480|75785351|FG001|Overall Study|Treatment Failure|2|||
41980019|NCT05121480|75785352|FG002|Overall Study|Treatment Failure|0|||
41980020|NCT05121480|75785353|FG003|Overall Study|Treatment Failure|1|||
41980021|NCT05121480|75785354|FG004|Overall Study|Treatment Failure|0|||
41980022|NCT05121480|75785355|FG005|Overall Study|Treatment Failure|0|||
41980023|NCT05121480|75785356|FG006|Overall Study|Treatment Failure|0|||
41980024|NCT05121480|75785357|FG007|Overall Study|Treatment Failure|0|||
41980025|NCT05121480|75785350|FG000|Overall Study|Adverse Event|0|||
41980026|NCT05121480|75785351|FG001|Overall Study|Adverse Event|1|||
41980027|NCT05121480|75785352|FG002|Overall Study|Adverse Event|0|||
41980028|NCT05121480|75785353|FG003|Overall Study|Adverse Event|5|||
41980029|NCT05121480|75785354|FG004|Overall Study|Adverse Event|3|||
41980030|NCT05121480|75785355|FG005|Overall Study|Adverse Event|2|||
41980031|NCT05121480|75785356|FG006|Overall Study|Adverse Event|0|||
41980032|NCT05121480|75785357|FG007|Overall Study|Adverse Event|4|||
41980033|NCT05121480|75785350|FG000|Overall Study|Withdrawal by Subject|4|||
41980034|NCT05121480|75785351|FG001|Overall Study|Withdrawal by Subject|9|||
41980035|NCT05121480|75785352|FG002|Overall Study|Withdrawal by Subject|1|||
41980036|NCT05121480|75785353|FG003|Overall Study|Withdrawal by Subject|8|||
41980037|NCT05121480|75785354|FG004|Overall Study|Withdrawal by Subject|0|||
41980038|NCT05121480|75785355|FG005|Overall Study|Withdrawal by Subject|9|||
41980039|NCT05121480|75785356|FG006|Overall Study|Withdrawal by Subject|0|||
41980040|NCT05121480|75785357|FG007|Overall Study|Withdrawal by Subject|4|||
41980041|NCT05121480|75785350|FG000|Overall Study|Non-compliance with the protocol|0|||
42130146|NCT00505752|75941067|FG002|Overall Study|All embryos/blastocysts discarded|1|||
42130147|NCT00505752|75941068|FG003|Overall Study|All embryos/blastocysts discarded|1|||
42130148|NCT00505752|75941065|FG000|Overall Study|Other|1|||
42130149|NCT00505752|75941066|FG001|Overall Study|Other|2|||
42130150|NCT00505752|75941067|FG002|Overall Study|Other|1|||
42130151|NCT00505752|75941068|FG003|Overall Study|Other|2|||
42130152|NCT03601637|75941080|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
42130153|NCT03601637|75941081|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
41980042|NCT05121480|75785351|FG001|Overall Study|Non-compliance with the protocol|0|||
41980043|NCT05121480|75785352|FG002|Overall Study|Non-compliance with the protocol|0|||
41980044|NCT05121480|75785353|FG003|Overall Study|Non-compliance with the protocol|0|||
42130154|NCT03601637|75941080|FG000|Overall Study|Adverse Event|1|||
42130155|NCT03601637|75941081|FG001|Overall Study|Adverse Event|1|||
41980045|NCT05121480|75785354|FG004|Overall Study|Non-compliance with the protocol|1|||
41980046|NCT05121480|75785355|FG005|Overall Study|Non-compliance with the protocol|6|||
41980047|NCT05121480|75785356|FG006|Overall Study|Non-compliance with the protocol|0|||
42028630|NCT00959049|75837047|FG004|Overall Study|Adverse Event|0|||
42130156|NCT03601637|75941080|FG000|Overall Study|Other|0|||
42130157|NCT03601637|75941081|FG001|Overall Study|Other|1|||
41980048|NCT05121480|75785357|FG007|Overall Study|Non-compliance with the protocol|1|||
41980049|NCT05121480|75785350|FG000|Overall Study|Lost to Follow-up|0|||
41980050|NCT05121480|75785351|FG001|Overall Study|Lost to Follow-up|4|||
41980051|NCT05121480|75785352|FG002|Overall Study|Lost to Follow-up|1|||
41980052|NCT05121480|75785353|FG003|Overall Study|Lost to Follow-up|3|||
41980053|NCT05121480|75785354|FG004|Overall Study|Lost to Follow-up|1|||
41980054|NCT05121480|75785355|FG005|Overall Study|Lost to Follow-up|1|||
41980055|NCT05121480|75785356|FG006|Overall Study|Lost to Follow-up|1|||
41980056|NCT05121480|75785357|FG007|Overall Study|Lost to Follow-up|4|||
41980057|NCT05121480|75785350|FG000|Overall Study|Physician Decision|0|||
41980058|NCT05121480|75785351|FG001|Overall Study|Physician Decision|0|||
41980059|NCT05121480|75785352|FG002|Overall Study|Physician Decision|0|||
41980060|NCT05121480|75785353|FG003|Overall Study|Physician Decision|0|||
41980061|NCT05121480|75785354|FG004|Overall Study|Physician Decision|0|||
42130158|NCT00343252|75941096|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
42130159|NCT00343252|75941097|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
42130160|NCT00343252|75941096|FG000|6 Months (All Treated Participants)|Death|0|||
42219231|NCT02696902|76037511|FG002|Overall Study|Principal investigator's decision|0|||
42219232|NCT02696902|76037509|FG000|Overall Study|Sponsor's decision|1|||
42130161|NCT00343252|75941097|FG001|6 Months (All Treated Participants)|Death|2|||
42219233|NCT02696902|76037510|FG001|Overall Study|Sponsor's decision|0|||
42219234|NCT02696902|76037511|FG002|Overall Study|Sponsor's decision|0|||
42219235|NCT02696902|76037509|FG000|Overall Study|Transferred to other hospital|1|||
42219236|NCT02696902|76037510|FG001|Overall Study|Transferred to other hospital|0|||
42219237|NCT02696902|76037511|FG002|Overall Study|Transferred to other hospital|0|||
42219238|NCT02694562|76037521|FG000|Overall Study|Death|8|||
42219239|NCT02694562|76037521|FG000|Overall Study|Protocol Violation|4|||
42219240|NCT02694562|76037521|FG000|Overall Study|Lost to Follow-up|3|||
42219241|NCT02694562|76037521|FG000|Overall Study|Screen Failure|2|||
42219242|NCT02694562|76037521|FG000|Overall Study|Physician Decision|1|||
42219243|NCT02874534|76037527|FG000|Overall Study|Withdrawal by Subject|5|||
42219244|NCT02874534|76037528|FG001|Overall Study|Withdrawal by Subject|8|||
42219245|NCT02874534|76037527|FG000|Overall Study|Lost to Follow-up|2|||
42219246|NCT02874534|76037528|FG001|Overall Study|Lost to Follow-up|2|||
42219247|NCT02874534|76037527|FG000|Overall Study|Ongoing in study|1|||
42219248|NCT02874534|76037528|FG001|Overall Study|Ongoing in study|1|||
42219249|NCT03097614|76037534|FG000|Overall Study|Adverse Event|3|||
42219250|NCT03364309|76037541|FG000|Induction Period|Adverse Event|4|||
42219251|NCT03364309|76037542|FG001|Induction Period|Adverse Event|0|||
42219252|NCT03364309|76037543|FG002|Induction Period|Adverse Event|1|||
42219253|NCT03364309|76037544|FG003|Induction Period|Adverse Event|0|||
42219254|NCT03364309|76037545|FG004|Induction Period|Adverse Event|0|||
42219255|NCT03364309|76037546|FG005|Induction Period|Adverse Event|0|||
42219256|NCT03364309|76037547|FG006|Induction Period|Adverse Event|0|||
42219257|NCT03364309|76037548|FG007|Induction Period|Adverse Event|0|||
42219258|NCT03364309|76037549|FG008|Induction Period|Adverse Event|0|||
42219259|NCT03364309|76037550|FG009|Induction Period|Adverse Event|0|||
42219260|NCT03364309|76037551|FG010|Induction Period|Adverse Event|0|||
42219261|NCT03364309|76037552|FG011|Induction Period|Adverse Event|0|||
42219262|NCT03364309|76037553|FG012|Induction Period|Adverse Event|0|||
42219263|NCT03364309|76037554|FG013|Induction Period|Adverse Event|0|||
42219264|NCT03364309|76037555|FG014|Induction Period|Adverse Event|0|||
42219265|NCT03364309|76037556|FG015|Induction Period|Adverse Event|0|||
42219266|NCT03364309|76037557|FG016|Induction Period|Adverse Event|0|||
42219267|NCT03364309|76037558|FG017|Induction Period|Adverse Event|0|||
42219268|NCT03364309|76037559|FG018|Induction Period|Adverse Event|0|||
42130162|NCT00343252|75941096|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
42130163|NCT00343252|75941097|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
42130164|NCT00343252|75941096|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
42130165|NCT00343252|75941097|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
42130166|NCT00343252|75941096|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
42130167|NCT00343252|75941097|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
42219269|NCT03364309|76037541|FG000|Induction Period|Withdrawal by Subject|1|||
42219270|NCT03364309|76037542|FG001|Induction Period|Withdrawal by Subject|3|||
42219271|NCT03364309|76037543|FG002|Induction Period|Withdrawal by Subject|0|||
42219272|NCT03364309|76037544|FG003|Induction Period|Withdrawal by Subject|0|||
42219273|NCT03364309|76037545|FG004|Induction Period|Withdrawal by Subject|0|||
41980062|NCT05121480|75785355|FG005|Overall Study|Physician Decision|1|||
41980063|NCT05121480|75785356|FG006|Overall Study|Physician Decision|0|||
41980064|NCT05121480|75785357|FG007|Overall Study|Physician Decision|1|||
42219274|NCT03364309|76037546|FG005|Induction Period|Withdrawal by Subject|0|||
42219275|NCT03364309|76037547|FG006|Induction Period|Withdrawal by Subject|0|||
42219276|NCT03364309|76037548|FG007|Induction Period|Withdrawal by Subject|0|||
42219277|NCT03364309|76037549|FG008|Induction Period|Withdrawal by Subject|0|||
41980065|NCT05121480|75785350|FG000|Overall Study|Other Reason|0|||
42219278|NCT03364309|76037550|FG009|Induction Period|Withdrawal by Subject|0|||
42219279|NCT03364309|76037551|FG010|Induction Period|Withdrawal by Subject|0|||
42219280|NCT03364309|76037552|FG011|Induction Period|Withdrawal by Subject|0|||
42219281|NCT03364309|76037553|FG012|Induction Period|Withdrawal by Subject|0|||
42219282|NCT03364309|76037554|FG013|Induction Period|Withdrawal by Subject|0|||
42219283|NCT03364309|76037555|FG014|Induction Period|Withdrawal by Subject|0|||
42219284|NCT03364309|76037556|FG015|Induction Period|Withdrawal by Subject|0|||
42219285|NCT03364309|76037557|FG016|Induction Period|Withdrawal by Subject|0|||
42219286|NCT03364309|76037558|FG017|Induction Period|Withdrawal by Subject|0|||
42219287|NCT03364309|76037559|FG018|Induction Period|Withdrawal by Subject|0|||
42219288|NCT03364309|76037541|FG000|Induction Period|Lost to Follow-up|1|||
42219289|NCT03364309|76037542|FG001|Induction Period|Lost to Follow-up|0|||
42219290|NCT03364309|76037543|FG002|Induction Period|Lost to Follow-up|0|||
42219291|NCT03364309|76037544|FG003|Induction Period|Lost to Follow-up|0|||
42219292|NCT03364309|76037545|FG004|Induction Period|Lost to Follow-up|0|||
41980066|NCT05121480|75785351|FG001|Overall Study|Other Reason|0|||
41980067|NCT05121480|75785352|FG002|Overall Study|Other Reason|0|||
41980068|NCT05121480|75785353|FG003|Overall Study|Other Reason|0|||
41980069|NCT05121480|75785354|FG004|Overall Study|Other Reason|0|||
41980070|NCT05121480|75785355|FG005|Overall Study|Other Reason|1|||
41980071|NCT05121480|75785356|FG006|Overall Study|Other Reason|1|||
41980072|NCT05121480|75785357|FG007|Overall Study|Other Reason|1|||
41980073|NCT04772755|75785383|FG000|Overall Study|Withdrawal by Subject|1|||
41980074|NCT04772755|75785384|FG001|Overall Study|Withdrawal by Subject|0|||
41980075|NCT04772755|75785383|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
41980076|NCT04772755|75785384|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
41980077|NCT04590040|75785394|FG000|Treatment Period|Lost to Follow-up|2|||
41980078|NCT04590040|75785395|FG001|Treatment Period|Lost to Follow-up|5|||
41980079|NCT04590040|75785396|FG002|Treatment Period|Lost to Follow-up|0|||
41980080|NCT04590040|75785394|FG000|Treatment Period|Physician Decision|0|||
41980081|NCT04590040|75785395|FG001|Treatment Period|Physician Decision|0|||
41980082|NCT04590040|75785396|FG002|Treatment Period|Physician Decision|2|||
41980083|NCT04430335|75785414|FG000|Overall Study|Withdrawal by Subject|1|||
41980084|NCT03690427|75785427|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
41980085|NCT03690427|75785428|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
41980086|NCT03658668|75785437|FG000|Overall Study|Time Commitment|1|||
41980087|NCT03658668|75785438|FG001|Overall Study|Time Commitment|1|||
41980088|NCT03469934|75785446|FG000|Overall Study|Withdrawal by Subject|0|||
41980089|NCT03469934|75785447|FG001|Overall Study|Withdrawal by Subject|1|||
41980090|NCT03004404|75785464|FG000|Period 2|Adverse Event|0|||
41980091|NCT03004404|75785465|FG001|Period 2|Adverse Event|0|||
41980092|NCT03004404|75785466|FG002|Period 2|Adverse Event|0|||
41980093|NCT03004404|75785467|FG003|Period 2|Adverse Event|0|||
41980094|NCT03004404|75785468|FG004|Period 2|Adverse Event|0|||
41980095|NCT03004404|75785469|FG005|Period 2|Adverse Event|0|||
41980096|NCT03004404|75785470|FG006|Period 2|Adverse Event|0|||
41980097|NCT03004404|75785471|FG007|Period 2|Adverse Event|0|||
41980098|NCT03004404|75785472|FG008|Period 2|Adverse Event|1|||
41980099|NCT03004404|75785473|FG009|Period 2|Adverse Event|0|||
41980100|NCT03004404|75785474|FG010|Period 2|Adverse Event|0|||
41980101|NCT03004404|75785475|FG011|Period 2|Adverse Event|0|||
41980102|NCT03004404|75785476|FG012|Period 2|Adverse Event|0|||
42130168|NCT00343252|75941096|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
42130169|NCT00343252|75941097|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
42130170|NCT00343252|75941096|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
42130171|NCT00343252|75941097|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
42130172|NCT00343252|75941096|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
42130173|NCT00343252|75941097|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
42130174|NCT00343252|75941096|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
42130175|NCT00343252|75941097|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
42130176|NCT00343252|75941096|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
42219293|NCT03364309|76037546|FG005|Induction Period|Lost to Follow-up|0|||
42219294|NCT03364309|76037547|FG006|Induction Period|Lost to Follow-up|0|||
42219295|NCT03364309|76037548|FG007|Induction Period|Lost to Follow-up|0|||
42219296|NCT03364309|76037549|FG008|Induction Period|Lost to Follow-up|0|||
42219297|NCT03364309|76037550|FG009|Induction Period|Lost to Follow-up|0|||
41980103|NCT03004404|75785477|FG013|Period 2|Adverse Event|0|||
41980104|NCT03004404|75785478|FG014|Period 2|Adverse Event|0|||
41980105|NCT03004404|75785479|FG015|Period 2|Adverse Event|1|||
41980106|NCT02512965|75785546|FG000|Overall Study|Withdrawal by Subject|0|||
41980107|NCT02512965|75785547|FG001|Overall Study|Withdrawal by Subject|4|||
41980108|NCT02335268|75785555|FG000|Overall Study|Physician Decision|5|||
41980109|NCT02335268|75785556|FG001|Overall Study|Physician Decision|1|||
41980110|NCT02335268|75785555|FG000|Overall Study|Lack of Efficacy|2|||
41980111|NCT02335268|75785556|FG001|Overall Study|Lack of Efficacy|1|||
41980112|NCT02335268|75785555|FG000|Overall Study|Adverse Event|5|||
41980113|NCT02335268|75785556|FG001|Overall Study|Adverse Event|2|||
41980114|NCT02335268|75785555|FG000|Overall Study|increase blasts|2|||
41980115|NCT02335268|75785556|FG001|Overall Study|increase blasts|0|||
41980116|NCT02335268|75785555|FG000|Overall Study|Withdrawal by Subject|3|||
41980117|NCT02335268|75785556|FG001|Overall Study|Withdrawal by Subject|2|||
41980118|NCT01029002|75785578|FG000|Overall Study|Lost to Follow-up|2|||
41980119|NCT01029002|75785579|FG001|Overall Study|Lost to Follow-up|4|||
41980120|NCT01011478|75785587|FG000|Overall Study|No follow up data|12|||
41980121|NCT01011478|75785588|FG001|Overall Study|No follow up data|7|||
41980122|NCT00546260|75785596|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
41980123|NCT00546260|75785597|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
41980124|NCT02896192|75785620|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
41980125|NCT02896192|75785620|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
41980126|NCT02896192|75785620|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
41980127|NCT01356940|75785636|FG000|First Intervention (28 Days)|Adverse Event|1|||
41980128|NCT01356940|75785637|FG001|First Intervention (28 Days)|Adverse Event|0|||
41980129|NCT01356940|75785636|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
41980130|NCT01356940|75785637|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
41980131|NCT01330030|75785656|FG000|Overall Study|Lost to Follow-up|16|||
41980132|NCT01330030|75785657|FG001|Overall Study|Lost to Follow-up|17|||
41980133|NCT00477295|75785772|FG000|Overall Study|Adverse Event|31|||
41980134|NCT00477295|75785773|FG001|Overall Study|Adverse Event|35|||
41980135|NCT00477295|75785772|FG000|Overall Study|Withdrawal by Subject|35|||
41980136|NCT00477295|75785773|FG001|Overall Study|Withdrawal by Subject|24|||
41980137|NCT00477295|75785772|FG000|Overall Study|Lack of Efficacy|23|||
41980138|NCT00477295|75785773|FG001|Overall Study|Lack of Efficacy|23|||
41980139|NCT00477295|75785772|FG000|Overall Study|Protocol Violation|3|||
41980140|NCT00477295|75785773|FG001|Overall Study|Protocol Violation|8|||
41980141|NCT00477295|75785772|FG000|Overall Study|Physician Decision|4|||
41980142|NCT00477295|75785773|FG001|Overall Study|Physician Decision|5|||
41980143|NCT00477295|75785772|FG000|Overall Study|Lost to Follow-up|21|||
41980144|NCT00477295|75785773|FG001|Overall Study|Lost to Follow-up|11|||
41980145|NCT00477295|75785772|FG000|Overall Study|Other|4|||
41980146|NCT00477295|75785773|FG001|Overall Study|Other|3|||
41980147|NCT00476593|75785785|FG000|Overall Study|Lost to Follow-up|10|||
41980148|NCT00476593|75785786|FG001|Overall Study|Lost to Follow-up|2|||
41980149|NCT00476593|75785787|FG002|Overall Study|Lost to Follow-up|8|||
41980150|NCT00476593|75785788|FG003|Overall Study|Lost to Follow-up|22|||
42130177|NCT00343252|75941097|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
42130178|NCT00343252|75941096|FG000|12 Months (All Treated Participants)|Death|3|||
42130179|NCT00343252|75941097|FG001|12 Months (All Treated Participants)|Death|3|||
42219298|NCT03364309|76037551|FG010|Induction Period|Lost to Follow-up|0|||
42219299|NCT03364309|76037552|FG011|Induction Period|Lost to Follow-up|0|||
42219300|NCT03364309|76037553|FG012|Induction Period|Lost to Follow-up|0|||
42219301|NCT03364309|76037554|FG013|Induction Period|Lost to Follow-up|0|||
42219302|NCT03364309|76037555|FG014|Induction Period|Lost to Follow-up|0|||
42219303|NCT03364309|76037556|FG015|Induction Period|Lost to Follow-up|0|||
42219304|NCT03364309|76037557|FG016|Induction Period|Lost to Follow-up|0|||
42219305|NCT03364309|76037558|FG017|Induction Period|Lost to Follow-up|0|||
42219306|NCT03364309|76037559|FG018|Induction Period|Lost to Follow-up|0|||
42219307|NCT03364309|76037541|FG000|Induction Period|Physician Decision|0|||
42219308|NCT03364309|76037542|FG001|Induction Period|Physician Decision|1|||
42219309|NCT03364309|76037543|FG002|Induction Period|Physician Decision|0|||
42219310|NCT03364309|76037544|FG003|Induction Period|Physician Decision|0|||
42219311|NCT03364309|76037545|FG004|Induction Period|Physician Decision|0|||
42130180|NCT00343252|75941096|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
42130181|NCT00343252|75941097|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
42130182|NCT00343252|75941096|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
42130183|NCT00343252|75941097|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
42130184|NCT00343252|75941096|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
42130185|NCT00343252|75941097|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
42130186|NCT00343252|75941096|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
42219312|NCT03364309|76037546|FG005|Induction Period|Physician Decision|0|||
42219313|NCT03364309|76037547|FG006|Induction Period|Physician Decision|0|||
41980151|NCT00476476|75785800|FG000|Overall Study|Adverse Event|2|||
41980152|NCT00476476|75785801|FG001|Overall Study|Adverse Event|7|||
41980153|NCT00476476|75785800|FG000|Overall Study|Progressive Disease|0|||
41980154|NCT00476476|75785801|FG001|Overall Study|Progressive Disease|17|||
41980155|NCT00476086|75785806|FG000|Overall Study|Alternative therapy|1|||
41980156|NCT00476086|75785806|FG000|Overall Study|Progressive Disease|4|||
41980157|NCT00476047|75785812|FG000|Overall Study|Lost to Follow-up|1|||
41980158|NCT00476008|75785820|FG000|Overall Study|Adverse Event|4|||
41980159|NCT00476008|75785821|FG001|Overall Study|Adverse Event|4|||
41980160|NCT00476008|75785820|FG000|Overall Study|Placebo concerns|2|||
41980161|NCT00476008|75785821|FG001|Overall Study|Placebo concerns|2|||
41980162|NCT00476008|75785820|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
41980163|NCT00476008|75785821|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
41980164|NCT00476008|75785820|FG000|Overall Study|Withdrawal by Subject|0|||
41980165|NCT00476008|75785821|FG001|Overall Study|Withdrawal by Subject|1|||
41980166|NCT00476008|75785820|FG000|Overall Study|Death|1|||
41980167|NCT00476008|75785821|FG001|Overall Study|Death|0|||
41980168|NCT00475735|75785837|FG000|Treatment Period 1|Adverse Event|2|||
41980169|NCT00475735|75785838|FG001|Treatment Period 1|Adverse Event|0|||
41980170|NCT00475735|75785839|FG002|Treatment Period 1|Adverse Event|0|||
41980171|NCT00475735|75785840|FG003|Treatment Period 1|Adverse Event|0|||
41980172|NCT00475735|75785841|FG004|Treatment Period 1|Adverse Event|0|||
41980173|NCT00475735|75785842|FG005|Treatment Period 1|Adverse Event|0|||
41980174|NCT00475735|75785837|FG000|Treatment Period 1|Lack of Efficacy|1|||
41980175|NCT00475735|75785838|FG001|Treatment Period 1|Lack of Efficacy|0|||
41980176|NCT00475735|75785839|FG002|Treatment Period 1|Lack of Efficacy|0|||
41980177|NCT00475735|75785840|FG003|Treatment Period 1|Lack of Efficacy|0|||
41980178|NCT00475735|75785841|FG004|Treatment Period 1|Lack of Efficacy|0|||
41980179|NCT00475735|75785842|FG005|Treatment Period 1|Lack of Efficacy|0|||
41980180|NCT00475735|75785837|FG000|Treatment Period 1|Lost to Follow-up|0|||
41980181|NCT00475735|75785838|FG001|Treatment Period 1|Lost to Follow-up|0|||
41980182|NCT00475735|75785839|FG002|Treatment Period 1|Lost to Follow-up|0|||
41980183|NCT00475735|75785840|FG003|Treatment Period 1|Lost to Follow-up|0|||
41980184|NCT00475735|75785841|FG004|Treatment Period 1|Lost to Follow-up|0|||
41980185|NCT00475735|75785842|FG005|Treatment Period 1|Lost to Follow-up|1|||
41980186|NCT00475735|75785837|FG000|Treatment Period 1|Protocol Violation|0|||
41980187|NCT00475735|75785838|FG001|Treatment Period 1|Protocol Violation|0|||
41980188|NCT00475735|75785839|FG002|Treatment Period 1|Protocol Violation|0|||
41980189|NCT00475735|75785840|FG003|Treatment Period 1|Protocol Violation|1|||
41980190|NCT00475735|75785841|FG004|Treatment Period 1|Protocol Violation|0|||
41980191|NCT00475735|75785842|FG005|Treatment Period 1|Protocol Violation|0|||
41980192|NCT00475735|75785837|FG000|Treatment Period 1|Withdrawal by Subject|1|||
41980193|NCT00475735|75785838|FG001|Treatment Period 1|Withdrawal by Subject|1|||
41980194|NCT00475735|75785839|FG002|Treatment Period 1|Withdrawal by Subject|0|||
41980195|NCT00475735|75785840|FG003|Treatment Period 1|Withdrawal by Subject|0|||
41980196|NCT00475735|75785841|FG004|Treatment Period 1|Withdrawal by Subject|0|||
41980197|NCT00475735|75785842|FG005|Treatment Period 1|Withdrawal by Subject|0|||
41980198|NCT00475735|75785837|FG000|Treatment Period 1|DC due to AE but continuing|0|||
41980199|NCT00475735|75785838|FG001|Treatment Period 1|DC due to AE but continuing|0|||
41980200|NCT00475735|75785839|FG002|Treatment Period 1|DC due to AE but continuing|0|||
41980201|NCT00475735|75785840|FG003|Treatment Period 1|DC due to AE but continuing|1|||
41980202|NCT00475735|75785841|FG004|Treatment Period 1|DC due to AE but continuing|2|||
41980203|NCT00475735|75785842|FG005|Treatment Period 1|DC due to AE but continuing|2|||
41980204|NCT00475735|75785837|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
41980205|NCT00475735|75785838|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
41980206|NCT00475735|75785839|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
41980207|NCT00475735|75785840|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
42028631|NCT00959049|75837048|FG005|Overall Study|Adverse Event|0|||
41980208|NCT00475735|75785841|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
41980209|NCT00475735|75785842|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
41980210|NCT00475735|75785837|FG000|Treatment Washout|Lost to Follow-up|0|||
42028632|NCT00959049|75837043|FG000|Overall Study|Lost to Follow-up|17|||
41980211|NCT00475735|75785838|FG001|Treatment Washout|Lost to Follow-up|1|||
41980212|NCT00475735|75785839|FG002|Treatment Washout|Lost to Follow-up|0|||
41980213|NCT00475735|75785840|FG003|Treatment Washout|Lost to Follow-up|0|||
41980214|NCT00475735|75785841|FG004|Treatment Washout|Lost to Follow-up|0|||
41980215|NCT00475735|75785842|FG005|Treatment Washout|Lost to Follow-up|0|||
41980216|NCT00475735|75785837|FG000|Treatment Washout|Protocol Violation|0|||
41980217|NCT00475735|75785838|FG001|Treatment Washout|Protocol Violation|1|||
41980218|NCT00475735|75785839|FG002|Treatment Washout|Protocol Violation|0|||
41980219|NCT00475735|75785840|FG003|Treatment Washout|Protocol Violation|0|||
41980220|NCT00475735|75785841|FG004|Treatment Washout|Protocol Violation|0|||
41980221|NCT00475735|75785842|FG005|Treatment Washout|Protocol Violation|0|||
41980222|NCT00475735|75785837|FG000|Treatment Period 2|Adverse Event|0|||
41980223|NCT00475735|75785838|FG001|Treatment Period 2|Adverse Event|1|||
41980224|NCT00475735|75785839|FG002|Treatment Period 2|Adverse Event|0|||
41980225|NCT00475735|75785840|FG003|Treatment Period 2|Adverse Event|2|||
41980226|NCT00475735|75785841|FG004|Treatment Period 2|Adverse Event|0|||
41980227|NCT00475735|75785842|FG005|Treatment Period 2|Adverse Event|0|||
41980228|NCT00475735|75785837|FG000|Treatment Period 2|Lack of Efficacy|0|||
41980229|NCT00475735|75785838|FG001|Treatment Period 2|Lack of Efficacy|0|||
41980230|NCT00475735|75785839|FG002|Treatment Period 2|Lack of Efficacy|0|||
41980231|NCT00475735|75785840|FG003|Treatment Period 2|Lack of Efficacy|0|||
41980232|NCT00475735|75785841|FG004|Treatment Period 2|Lack of Efficacy|0|||
41980233|NCT00475735|75785842|FG005|Treatment Period 2|Lack of Efficacy|1|||
41980234|NCT00475735|75785837|FG000|Treatment Period 2|Withdrawal by Subject|0|||
41980235|NCT00475735|75785838|FG001|Treatment Period 2|Withdrawal by Subject|0|||
41980236|NCT00475735|75785839|FG002|Treatment Period 2|Withdrawal by Subject|0|||
41980237|NCT00475735|75785840|FG003|Treatment Period 2|Withdrawal by Subject|0|||
41980238|NCT00475735|75785841|FG004|Treatment Period 2|Withdrawal by Subject|1|||
41980239|NCT00475735|75785842|FG005|Treatment Period 2|Withdrawal by Subject|0|||
41980240|NCT00475657|75785850|FG000|Overall Study|Death|1|||
41980241|NCT00475657|75785850|FG000|Overall Study|Sponsor's Decision|3|||
41980242|NCT00475423|75785854|FG000|Overall Study|Protocol Violation|5|||
41980243|NCT00475423|75785854|FG000|Overall Study|Adverse Event|4|||
41980244|NCT00475423|75785854|FG000|Overall Study|Withdrawal by Subject|6|||
41980245|NCT00475423|75785854|FG000|Overall Study|Lack of Efficacy|8|||
41980246|NCT00475423|75785854|FG000|Overall Study|Death|1|||
41980247|NCT00475423|75785854|FG000|Overall Study|Reason not specified|1|||
41980248|NCT00475423|75785854|FG000|Overall Study|Lost to Follow-up|7|||
41980249|NCT00475306|75785862|FG000|Overall Study|Protocol Violation|1|||
41980250|NCT00475306|75785863|FG001|Overall Study|Protocol Violation|1|||
41980251|NCT00475306|75785864|FG002|Overall Study|Protocol Violation|0|||
41980252|NCT00475306|75785865|FG003|Overall Study|Protocol Violation|1|||
41980253|NCT00475228|75785877|FG000|Overall Study|Lost to Follow-up|17|||
41980254|NCT00475228|75785878|FG001|Overall Study|Lost to Follow-up|17|||
41980255|NCT05186311|75785906|FG000|Part A: Serum|Withdrawal by Subject|1|||
41980256|NCT04854434|75785914|FG000|Overall Study|Death|1|||
42219314|NCT03364309|76037548|FG007|Induction Period|Physician Decision|0|||
42219315|NCT03364309|76037549|FG008|Induction Period|Physician Decision|0|||
42219316|NCT03364309|76037550|FG009|Induction Period|Physician Decision|0|||
42219317|NCT03364309|76037551|FG010|Induction Period|Physician Decision|0|||
42219318|NCT03364309|76037552|FG011|Induction Period|Physician Decision|0|||
42219319|NCT03364309|76037553|FG012|Induction Period|Physician Decision|0|||
42219320|NCT03364309|76037554|FG013|Induction Period|Physician Decision|0|||
41980257|NCT04854434|75785915|FG001|Overall Study|Death|3|||
42130187|NCT00343252|75941097|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
42130188|NCT00343252|75941096|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
42130189|NCT00343252|75941097|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
42130190|NCT00343252|75941096|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
42130191|NCT00343252|75941097|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
42130192|NCT00343252|75941096|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
42130193|NCT00343252|75941097|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
42130194|NCT00343252|75941096|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
42130195|NCT00343252|75941097|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
42130196|NCT00343252|75941096|FG000|18 Months (All Treated Participants)|Death|4|||
42130197|NCT00343252|75941097|FG001|18 Months (All Treated Participants)|Death|5|||
42130198|NCT00343252|75941096|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
42130199|NCT00343252|75941097|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
42130200|NCT00343252|75941096|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
42219321|NCT03364309|76037555|FG014|Induction Period|Physician Decision|0|||
41980258|NCT04854434|75785916|FG002|Overall Study|Death|4|||
41980259|NCT04854434|75785914|FG000|Overall Study|Study Terminated by Sponsor|2|||
41980260|NCT04854434|75785915|FG001|Overall Study|Study Terminated by Sponsor|0|||
41980261|NCT04854434|75785916|FG002|Overall Study|Study Terminated by Sponsor|0|||
41980262|NCT04854434|75785914|FG000|Overall Study|Other|1|||
42219322|NCT03364309|76037556|FG015|Induction Period|Physician Decision|0|||
41980263|NCT04854434|75785915|FG001|Overall Study|Other|1|||
41980264|NCT04854434|75785916|FG002|Overall Study|Other|0|||
41980265|NCT03797014|75785951|FG000|Overall Study|Withdrawal by Subject|1|||
41980266|NCT03797014|75785951|FG000|Overall Study|Lost to Follow-up|1|||
41980267|NCT03797014|75785951|FG000|Overall Study|Protocol Violation|1|||
41980268|NCT03596450|75785957|FG000|Overall Study|Death|4|||
41980269|NCT03596450|75785958|FG001|Overall Study|Death|4|||
41980270|NCT03596450|75785957|FG000|Overall Study|Protocol Violation|7|||
41980271|NCT03596450|75785958|FG001|Overall Study|Protocol Violation|12|||
41980272|NCT03596450|75785957|FG000|Overall Study|Lost to Follow-up|7|||
41980273|NCT03596450|75785958|FG001|Overall Study|Lost to Follow-up|6|||
41980274|NCT03596450|75785957|FG000|Overall Study|Adverse Event|9|||
41980275|NCT03596450|75785958|FG001|Overall Study|Adverse Event|6|||
41980276|NCT03596450|75785957|FG000|Overall Study|Withdrawal by Subject|16|||
41980277|NCT03596450|75785958|FG001|Overall Study|Withdrawal by Subject|9|||
41980278|NCT03596450|75785957|FG000|Overall Study|Accidentally Randomized|2|||
41980279|NCT03596450|75785958|FG001|Overall Study|Accidentally Randomized|0|||
41980280|NCT03596450|75785957|FG000|Overall Study|Other reasons|21|||
41980281|NCT03596450|75785958|FG001|Overall Study|Other reasons|22|||
41980282|NCT03596450|75785957|FG000|Overall Study|Missed the Year 1 study visit|56|||
41980283|NCT03596450|75785958|FG001|Overall Study|Missed the Year 1 study visit|50|||
41980284|NCT03300817|75785973|FG000|Overall Study|Withdrawal by Subject|1|||
41980285|NCT03300817|75785973|FG000|Overall Study|Adverse Event|1|||
41980286|NCT03300817|75785973|FG000|Overall Study|Subject Found to be Ineligible|2|||
41980287|NCT02948842|75786003|FG000|Overall Study|Withdrawal by Subject|4|||
41980288|NCT02782468|75786011|FG000|Overall Study|Progressive Disease|2|||
41980289|NCT02782468|75786012|FG001|Overall Study|Progressive Disease|5|||
41980290|NCT02782468|75786013|FG002|Overall Study|Progressive Disease|0|||
41980291|NCT02782468|75786014|FG003|Overall Study|Progressive Disease|4|||
41980292|NCT02782468|75786011|FG000|Overall Study|Adverse Event|0|||
41980293|NCT02782468|75786012|FG001|Overall Study|Adverse Event|2|||
41980294|NCT02782468|75786013|FG002|Overall Study|Adverse Event|2|||
41980295|NCT02782468|75786014|FG003|Overall Study|Adverse Event|3|||
41980296|NCT02782468|75786011|FG000|Overall Study|Other|0|||
41980297|NCT02782468|75786012|FG001|Overall Study|Other|0|||
41980298|NCT02782468|75786013|FG002|Overall Study|Other|1|||
41980299|NCT02782468|75786014|FG003|Overall Study|Other|1|||
41980300|NCT02782468|75786011|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
41980301|NCT02782468|75786012|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
41980302|NCT02782468|75786013|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
41980303|NCT02782468|75786014|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
41980304|NCT02782468|75786011|FG000|Overall Study|Symptomatic Deterioration|0|||
41980305|NCT02782468|75786012|FG001|Overall Study|Symptomatic Deterioration|0|||
41980306|NCT02782468|75786013|FG002|Overall Study|Symptomatic Deterioration|0|||
41980307|NCT02782468|75786014|FG003|Overall Study|Symptomatic Deterioration|1|||
41980308|NCT02782468|75786011|FG000|Overall Study|Withdrawal by Subject|1|||
41980309|NCT02782468|75786012|FG001|Overall Study|Withdrawal by Subject|0|||
41980310|NCT02782468|75786013|FG002|Overall Study|Withdrawal by Subject|0|||
41980311|NCT02782468|75786014|FG003|Overall Study|Withdrawal by Subject|0|||
41980312|NCT02563769|75786036|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
41980313|NCT02563769|75786037|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
41980314|NCT02563769|75786038|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
41980315|NCT02420717|75786074|FG000|Overall Study|Did not receive all study medication|2|||
41980316|NCT02420717|75786075|FG001|Overall Study|Did not receive all study medication|0|||
41980317|NCT02420717|75786076|FG002|Overall Study|Did not receive all study medication|0|||
41980318|NCT02126579|75786109|FG000|Overall Study|disease progression|0|||
41980319|NCT02126579|75786110|FG001|Overall Study|disease progression|0|||
41980320|NCT02126579|75786111|FG002|Overall Study|disease progression|0|||
41980321|NCT02126579|75786112|FG003|Overall Study|disease progression|1|||
42130201|NCT00343252|75941097|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
42130202|NCT00343252|75941096|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
41980322|NCT02126579|75786113|FG004|Overall Study|disease progression|0|||
41980323|NCT02126579|75786114|FG005|Overall Study|disease progression|0|||
41980324|NCT02126579|75786115|FG006|Overall Study|disease progression|1|||
41980325|NCT01970306|75786133|FG000|Overall Study|Not eligible|3|||
41980326|NCT01970306|75786133|FG000|Overall Study|Not able to be treated|9|||
41980327|NCT01574274|75786139|FG000|Overall Study|Ineligible|0|||
41980328|NCT01574274|75786140|FG001|Overall Study|Ineligible|1|||
41980329|NCT01574274|75786139|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
42272656|NCT02281318|76102918|FG001|Overall Study|Physician Decision|0|||
41980330|NCT01574274|75786140|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
41980331|NCT01574274|75786139|FG000|Overall Study|Ph+ B-ALL|3|||
41980332|NCT01574274|75786140|FG001|Overall Study|Ph+ B-ALL|4|||
41980333|NCT01574274|75786139|FG000|Overall Study|Induction Death|2|||
41980334|NCT01574274|75786140|FG001|Overall Study|Induction Death|0|||
41980335|NCT01574274|75786139|FG000|Overall Study|Induction Failure|4|||
41980336|NCT01574274|75786140|FG001|Overall Study|Induction Failure|1|||
41980337|NCT01574274|75786139|FG000|Overall Study|Adverse Event|16|||
41980338|NCT01574274|75786140|FG001|Overall Study|Adverse Event|13|||
41980339|NCT01574274|75786139|FG000|Overall Study|Remission Death|1|||
41980340|NCT01574274|75786140|FG001|Overall Study|Remission Death|0|||
41980341|NCT01574274|75786139|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
41980342|NCT01574274|75786140|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
41980343|NCT01574274|75786139|FG000|Overall Study|Other, unknown|3|||
41980344|NCT01574274|75786140|FG001|Overall Study|Other, unknown|2|||
41980345|NCT01268514|75786150|FG000|Overall Study|Adverse Event|20|||
41980346|NCT01268514|75786150|FG000|Overall Study|Death|8|||
41980347|NCT01268514|75786150|FG000|Overall Study|Lost to Follow-up|5|||
41980348|NCT01268514|75786150|FG000|Overall Study|Withdrawal by Subject|3|||
41980349|NCT01268514|75786150|FG000|Overall Study|Withdrawal by Surgeon|5|||
41980350|NCT00625586|75786156|FG000|Overall Study|Adverse Event|1|||
41980351|NCT00625586|75786156|FG000|Overall Study|Progressive disease|1|||
41980352|NCT00400946|75786165|FG000|Overall Study|Ineligible|0|||
41980353|NCT00400946|75786166|FG001|Overall Study|Ineligible|0|||
41980354|NCT00400946|75786167|FG002|Overall Study|Ineligible|0|||
41980355|NCT00400946|75786168|FG003|Overall Study|Ineligible|5|||
41980356|NCT00400946|75786169|FG004|Overall Study|Ineligible|1|||
41980357|NCT00400946|75786165|FG000|Overall Study|Induction Failure|0|||
41980358|NCT00400946|75786166|FG001|Overall Study|Induction Failure|0|||
41980359|NCT00400946|75786167|FG002|Overall Study|Induction Failure|0|||
41980360|NCT00400946|75786168|FG003|Overall Study|Induction Failure|11|||
41980361|NCT00400946|75786169|FG004|Overall Study|Induction Failure|8|||
41980362|NCT00400946|75786165|FG000|Overall Study|Induction Death|0|||
41980363|NCT00400946|75786166|FG001|Overall Study|Induction Death|0|||
41980364|NCT00400946|75786167|FG002|Overall Study|Induction Death|0|||
41980365|NCT00400946|75786168|FG003|Overall Study|Induction Death|13|||
41980366|NCT00400946|75786169|FG004|Overall Study|Induction Death|3|||
41980367|NCT00400946|75786165|FG000|Overall Study|Lost to Follow-up|1|||
41980368|NCT00400946|75786166|FG001|Overall Study|Lost to Follow-up|1|||
41980369|NCT00400946|75786167|FG002|Overall Study|Lost to Follow-up|0|||
41980370|NCT00400946|75786168|FG003|Overall Study|Lost to Follow-up|0|||
41980371|NCT00400946|75786169|FG004|Overall Study|Lost to Follow-up|1|||
41980372|NCT00400946|75786165|FG000|Overall Study|Remission Death|1|||
41980373|NCT00400946|75786166|FG001|Overall Study|Remission Death|1|||
41980374|NCT00400946|75786167|FG002|Overall Study|Remission Death|0|||
41980375|NCT00400946|75786168|FG003|Overall Study|Remission Death|0|||
41980376|NCT00400946|75786169|FG004|Overall Study|Remission Death|1|||
41980377|NCT00400946|75786165|FG000|Overall Study|Relapse|9|||
41980378|NCT00400946|75786166|FG001|Overall Study|Relapse|2|||
41980379|NCT00400946|75786167|FG002|Overall Study|Relapse|1|||
41980380|NCT00400946|75786168|FG003|Overall Study|Relapse|1|||
41980381|NCT00400946|75786169|FG004|Overall Study|Relapse|5|||
41980382|NCT00400946|75786165|FG000|Overall Study|Transplant in CR1|0|||
41980383|NCT00400946|75786166|FG001|Overall Study|Transplant in CR1|0|||
41980384|NCT00400946|75786167|FG002|Overall Study|Transplant in CR1|0|||
41980385|NCT00400946|75786168|FG003|Overall Study|Transplant in CR1|10|||
41980386|NCT00400946|75786169|FG004|Overall Study|Transplant in CR1|1|||
41980387|NCT00400946|75786165|FG000|Overall Study|Withdrawal by Subject|2|||
41980388|NCT00400946|75786166|FG001|Overall Study|Withdrawal by Subject|5|||
41980389|NCT00400946|75786167|FG002|Overall Study|Withdrawal by Subject|1|||
41980390|NCT00400946|75786168|FG003|Overall Study|Withdrawal by Subject|5|||
41980391|NCT00400946|75786169|FG004|Overall Study|Withdrawal by Subject|8|||
42219323|NCT03364309|76037557|FG016|Induction Period|Physician Decision|0|||
41980392|NCT00400946|75786165|FG000|Overall Study|Clinical|1|||
41980393|NCT00400946|75786166|FG001|Overall Study|Clinical|2|||
42219324|NCT03364309|76037558|FG017|Induction Period|Physician Decision|0|||
42219325|NCT03364309|76037559|FG018|Induction Period|Physician Decision|0|||
42219326|NCT03364309|76037541|FG000|Maintenance Period|Withdrawal by Subject|0|||
42219327|NCT03364309|76037542|FG001|Maintenance Period|Withdrawal by Subject|0|||
41980394|NCT00400946|75786167|FG002|Overall Study|Clinical|0|||
41980395|NCT00400946|75786168|FG003|Overall Study|Clinical|2|||
41980396|NCT00400946|75786169|FG004|Overall Study|Clinical|9|||
41980397|NCT00400946|75786165|FG000|Overall Study|Other|0|||
41980398|NCT00400946|75786166|FG001|Overall Study|Other|0|||
41980399|NCT00400946|75786167|FG002|Overall Study|Other|0|||
41980400|NCT00400946|75786168|FG003|Overall Study|Other|0|||
41980401|NCT00400946|75786169|FG004|Overall Study|Other|1|||
41980402|NCT00475033|75786189|FG000|Infant Series|Failed to return|3|||
41980403|NCT00475033|75786190|FG001|Infant Series|Failed to return|4|||
41980404|NCT00475033|75786189|FG000|Infant Series|Parent or legal guardian request|1|||
41980405|NCT00475033|75786190|FG001|Infant Series|Parent or legal guardian request|5|||
41980406|NCT00475033|75786189|FG000|Infant Series|Protocol Violation|1|||
41980407|NCT00475033|75786190|FG001|Infant Series|Protocol Violation|2|||
41980408|NCT00475033|75786189|FG000|Infant Series|Lost to Follow-up|2|||
41980409|NCT00475033|75786190|FG001|Infant Series|Lost to Follow-up|0|||
41980410|NCT00475033|75786189|FG000|Infant Series|Adverse Event|0|||
41980411|NCT00475033|75786190|FG001|Infant Series|Adverse Event|2|||
42219328|NCT03364309|76037543|FG002|Maintenance Period|Withdrawal by Subject|0|||
41980412|NCT00475033|75786189|FG000|After the Infant Series|Adverse Event|0|||
41980413|NCT00475033|75786190|FG001|After the Infant Series|Adverse Event|4|||
41980414|NCT00475033|75786189|FG000|After the Infant Series|Parent or legal guardian request|2|||
41980415|NCT00475033|75786190|FG001|After the Infant Series|Parent or legal guardian request|2|||
41980416|NCT00475033|75786189|FG000|After the Infant Series|Failed to return|2|||
41980417|NCT00475033|75786190|FG001|After the Infant Series|Failed to return|1|||
41980418|NCT00475033|75786189|FG000|After the Infant Series|Protocol Violation|1|||
41980419|NCT00475033|75786190|FG001|After the Infant Series|Protocol Violation|0|||
41980420|NCT00475033|75786189|FG000|After the Infant Series|Lost to Follow-up|1|||
41980421|NCT00475033|75786190|FG001|After the Infant Series|Lost to Follow-up|0|||
41980422|NCT00475033|75786189|FG000|After the Infant Series|Other|0|||
41980423|NCT00475033|75786190|FG001|After the Infant Series|Other|1|||
41980424|NCT00475033|75786189|FG000|Toddler Dose|Parent or legal guardian request|2|||
41980425|NCT00475033|75786190|FG001|Toddler Dose|Parent or legal guardian request|0|||
41980426|NCT00475033|75786189|FG000|Toddler Dose|Failed to return|1|||
41980427|NCT00475033|75786190|FG001|Toddler Dose|Failed to return|0|||
41980428|NCT00475033|75786189|FG000|Toddler Dose|Lost to Follow-up|1|||
41980429|NCT00475033|75786190|FG001|Toddler Dose|Lost to Follow-up|0|||
41980430|NCT00474994|75786203|FG000|Overall Study|Patient Not treated|1|||
42028633|NCT00959049|75837044|FG001|Overall Study|Lost to Follow-up|5|||
42219329|NCT03364309|76037544|FG003|Maintenance Period|Withdrawal by Subject|1|||
42219330|NCT03364309|76037545|FG004|Maintenance Period|Withdrawal by Subject|3|||
42219331|NCT03364309|76037546|FG005|Maintenance Period|Withdrawal by Subject|1|||
42219332|NCT03364309|76037547|FG006|Maintenance Period|Withdrawal by Subject|3|||
42219333|NCT03364309|76037548|FG007|Maintenance Period|Withdrawal by Subject|0|||
42028634|NCT00959049|75837045|FG002|Overall Study|Lost to Follow-up|1|||
42028635|NCT00959049|75837046|FG003|Overall Study|Lost to Follow-up|10|||
42028636|NCT00959049|75837047|FG004|Overall Study|Lost to Follow-up|9|||
42130203|NCT00343252|75941097|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
42219334|NCT03364309|76037549|FG008|Maintenance Period|Withdrawal by Subject|1|||
42219335|NCT03364309|76037550|FG009|Maintenance Period|Withdrawal by Subject|1|||
42219336|NCT03364309|76037551|FG010|Maintenance Period|Withdrawal by Subject|2|||
42219337|NCT03364309|76037552|FG011|Maintenance Period|Withdrawal by Subject|0|||
42219338|NCT03364309|76037553|FG012|Maintenance Period|Withdrawal by Subject|0|||
42219339|NCT03364309|76037554|FG013|Maintenance Period|Withdrawal by Subject|0|||
42219340|NCT03364309|76037555|FG014|Maintenance Period|Withdrawal by Subject|0|||
42219341|NCT03364309|76037556|FG015|Maintenance Period|Withdrawal by Subject|0|||
42219342|NCT03364309|76037557|FG016|Maintenance Period|Withdrawal by Subject|0|||
42219343|NCT03364309|76037558|FG017|Maintenance Period|Withdrawal by Subject|0|||
42219344|NCT03364309|76037559|FG018|Maintenance Period|Withdrawal by Subject|0|||
42219345|NCT03364309|76037541|FG000|Maintenance Period|Adverse Event|0|||
42219346|NCT03364309|76037542|FG001|Maintenance Period|Adverse Event|0|||
42219347|NCT03364309|76037543|FG002|Maintenance Period|Adverse Event|0|||
42219348|NCT03364309|76037544|FG003|Maintenance Period|Adverse Event|0|||
42219349|NCT03364309|76037545|FG004|Maintenance Period|Adverse Event|2|||
42219350|NCT03364309|76037546|FG005|Maintenance Period|Adverse Event|0|||
42219351|NCT03364309|76037547|FG006|Maintenance Period|Adverse Event|3|||
42219352|NCT03364309|76037548|FG007|Maintenance Period|Adverse Event|0|||
42219353|NCT03364309|76037549|FG008|Maintenance Period|Adverse Event|1|||
42219354|NCT03364309|76037550|FG009|Maintenance Period|Adverse Event|0|||
42219355|NCT03364309|76037551|FG010|Maintenance Period|Adverse Event|2|||
42219356|NCT03364309|76037552|FG011|Maintenance Period|Adverse Event|0|||
42219357|NCT03364309|76037553|FG012|Maintenance Period|Adverse Event|0|||
42219358|NCT03364309|76037554|FG013|Maintenance Period|Adverse Event|0|||
42219359|NCT03364309|76037555|FG014|Maintenance Period|Adverse Event|0|||
42028637|NCT00959049|75837048|FG005|Overall Study|Lost to Follow-up|1|||
42130204|NCT00343252|75941096|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
42130205|NCT00343252|75941097|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
42130206|NCT00343252|75941096|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
42130207|NCT00343252|75941097|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
42130208|NCT00343252|75941096|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
42130209|NCT00343252|75941097|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
42130210|NCT00343252|75941096|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
42130211|NCT00343252|75941097|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
42219360|NCT03364309|76037556|FG015|Maintenance Period|Adverse Event|0|||
41980431|NCT00474994|75786203|FG000|Overall Study|Patient evaluable for toxicity only|3|||
42028638|NCT00959049|75837043|FG000|Overall Study|Contraindicated medication|0|||
42219361|NCT03364309|76037557|FG016|Maintenance Period|Adverse Event|0|||
42219362|NCT03364309|76037558|FG017|Maintenance Period|Adverse Event|0|||
42219363|NCT03364309|76037559|FG018|Maintenance Period|Adverse Event|0|||
42219364|NCT03364309|76037541|FG000|Maintenance Period|Relapsed|0|||
42219365|NCT03364309|76037542|FG001|Maintenance Period|Relapsed|0|||
42219366|NCT03364309|76037543|FG002|Maintenance Period|Relapsed|0|||
42219367|NCT03364309|76037544|FG003|Maintenance Period|Relapsed|43|||
42219368|NCT03364309|76037545|FG004|Maintenance Period|Relapsed|7|||
42219369|NCT03364309|76037546|FG005|Maintenance Period|Relapsed|45|||
42219370|NCT03364309|76037547|FG006|Maintenance Period|Relapsed|10|||
41980432|NCT00474994|75786203|FG000|Overall Study|Patient found to be ineligible|1|||
42219371|NCT03364309|76037548|FG007|Maintenance Period|Relapsed|2|||
42219372|NCT03364309|76037549|FG008|Maintenance Period|Relapsed|0|||
42219373|NCT03364309|76037550|FG009|Maintenance Period|Relapsed|0|||
41980433|NCT00474955|75786207|FG000|Overall Study|Adverse Event|2|||
41980434|NCT00474955|75786207|FG000|Overall Study|Drug unavailability|1|||
41980435|NCT00474955|75786207|FG000|Overall Study|Personal reasons|5|||
41980436|NCT00474487|75786215|FG000|Overall Study|Withdrawal by Subject|6|||
41980437|NCT00474487|75786216|FG001|Overall Study|Withdrawal by Subject|0|||
41980438|NCT00474487|75786217|FG002|Overall Study|Withdrawal by Subject|0|||
41980439|NCT00474487|75786218|FG003|Overall Study|Withdrawal by Subject|0|||
41980440|NCT00474487|75786215|FG000|Overall Study|Lost to Follow-up|20|||
41980441|NCT00474487|75786216|FG001|Overall Study|Lost to Follow-up|1|||
41980442|NCT00474487|75786217|FG002|Overall Study|Lost to Follow-up|7|||
41980443|NCT00474487|75786218|FG003|Overall Study|Lost to Follow-up|0|||
41980444|NCT00474487|75786215|FG000|Overall Study|Inappropriate enrollment|4|||
41980445|NCT00474487|75786216|FG001|Overall Study|Inappropriate enrollment|0|||
41980446|NCT00474487|75786217|FG002|Overall Study|Inappropriate enrollment|7|||
41980447|NCT00474487|75786218|FG003|Overall Study|Inappropriate enrollment|0|||
41980448|NCT00474487|75786215|FG000|Overall Study|Death|0|||
41980449|NCT00474487|75786216|FG001|Overall Study|Death|1|||
41980450|NCT00474487|75786217|FG002|Overall Study|Death|0|||
41980451|NCT00474487|75786218|FG003|Overall Study|Death|0|||
41980452|NCT00474253|75786230|FG000|Overall Study|Withdrew consent|2|||
41980453|NCT00474253|75786231|FG001|Overall Study|Withdrew consent|0|||
41980454|NCT00474253|75786230|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
41980455|NCT00474253|75786231|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
41980456|NCT00474253|75786230|FG000|Overall Study|Lost to Follow-up|1|||
41980457|NCT00474253|75786231|FG001|Overall Study|Lost to Follow-up|0|||
41980458|NCT00474253|75786230|FG000|Overall Study|Discharged prior to study completion|0|||
41980459|NCT00474253|75786231|FG001|Overall Study|Discharged prior to study completion|1|||
41980460|NCT00474058|75786239|FG000|Overall Study|Adverse Event|11|||
41980461|NCT00474058|75786240|FG001|Overall Study|Adverse Event|6|||
41980462|NCT00474058|75786239|FG000|Overall Study|Lack of Efficacy|0|||
41980463|NCT00474058|75786240|FG001|Overall Study|Lack of Efficacy|4|||
41980464|NCT00474058|75786239|FG000|Overall Study|Withdrawal by Subject|11|||
41980465|NCT00474058|75786240|FG001|Overall Study|Withdrawal by Subject|7|||
41980466|NCT00474058|75786239|FG000|Overall Study|Other|2|||
41980467|NCT00474058|75786240|FG001|Overall Study|Other|0|||
41980468|NCT00473824|75786248|FG000|Overall Study|Virologic Breakthrough|1|||
41980469|NCT00473824|75786249|FG001|Overall Study|Virologic Breakthrough|0|||
41980470|NCT00473824|75786248|FG000|Overall Study|Adverse Event|1|||
41980471|NCT00473824|75786249|FG001|Overall Study|Adverse Event|0|||
41980472|NCT00473824|75786248|FG000|Overall Study|Death|1|||
41980473|NCT00473824|75786249|FG001|Overall Study|Death|0|||
41980474|NCT00473824|75786248|FG000|Overall Study|Lost to Follow-up|1|||
41980475|NCT00473824|75786249|FG001|Overall Study|Lost to Follow-up|0|||
41980476|NCT00473824|75786248|FG000|Overall Study|Withdrawal by physician|1|||
41980477|NCT00473824|75786249|FG001|Overall Study|Withdrawal by physician|0|||
41980478|NCT00473746|75786260|FG000|Period 1 (Phase 1)|Adverse Event|1|||
41980479|NCT00473746|75786261|FG001|Period 1 (Phase 1)|Adverse Event|0|||
41980480|NCT00473746|75786262|FG002|Period 1 (Phase 1)|Adverse Event|0|||
41980481|NCT00473746|75786263|FG003|Period 1 (Phase 1)|Adverse Event|0|||
41980482|NCT00473746|75786264|FG004|Period 1 (Phase 1)|Adverse Event|0|||
41980483|NCT00473746|75786260|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
41980484|NCT00473746|75786261|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
41980485|NCT00473746|75786262|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
41980486|NCT00473746|75786263|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
41980487|NCT00473746|75786264|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
41980488|NCT00473746|75786260|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
41980489|NCT00473746|75786261|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
41980490|NCT00473746|75786262|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
42219374|NCT03364309|76037551|FG010|Maintenance Period|Relapsed|0|||
41980491|NCT00473746|75786263|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
41980492|NCT00473746|75786264|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
41980493|NCT00473746|75786260|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
41980494|NCT00473746|75786261|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
41980495|NCT00473746|75786262|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
41980496|NCT00473746|75786263|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
41980497|NCT00473746|75786264|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
41980498|NCT00473746|75786260|FG000|Period 1 (Phase 1)|Reason not specified|0|||
42219375|NCT03364309|76037552|FG011|Maintenance Period|Relapsed|0|||
42219376|NCT03364309|76037553|FG012|Maintenance Period|Relapsed|0|||
41980499|NCT00473746|75786261|FG001|Period 1 (Phase 1)|Reason not specified|1|||
41980500|NCT00473746|75786262|FG002|Period 1 (Phase 1)|Reason not specified|0|||
41980501|NCT00473746|75786263|FG003|Period 1 (Phase 1)|Reason not specified|0|||
41980502|NCT00473746|75786264|FG004|Period 1 (Phase 1)|Reason not specified|0|||
41980503|NCT00473746|75786260|FG000|Period 2 (Phase 2)|Adverse Event|0|||
41980504|NCT00473746|75786261|FG001|Period 2 (Phase 2)|Adverse Event|0|||
41980505|NCT00473746|75786262|FG002|Period 2 (Phase 2)|Adverse Event|0|||
41980506|NCT00473746|75786263|FG003|Period 2 (Phase 2)|Adverse Event|0|||
41980507|NCT00473746|75786264|FG004|Period 2 (Phase 2)|Adverse Event|3|||
41980508|NCT00473746|75786260|FG000|Period 2 (Phase 2)|Death|0|||
41980509|NCT00473746|75786261|FG001|Period 2 (Phase 2)|Death|0|||
41980510|NCT00473746|75786262|FG002|Period 2 (Phase 2)|Death|0|||
41980511|NCT00473746|75786263|FG003|Period 2 (Phase 2)|Death|0|||
41980512|NCT00473746|75786264|FG004|Period 2 (Phase 2)|Death|1|||
41980513|NCT00473746|75786260|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
41980514|NCT00473746|75786261|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
41980515|NCT00473746|75786262|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
41980516|NCT00473746|75786263|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
41980517|NCT00473746|75786264|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
41980518|NCT00473746|75786260|FG000|Period 2 (Phase 2)|Reason not specified|0|||
41980519|NCT00473746|75786261|FG001|Period 2 (Phase 2)|Reason not specified|0|||
41980520|NCT00473746|75786262|FG002|Period 2 (Phase 2)|Reason not specified|0|||
41980521|NCT00473746|75786263|FG003|Period 2 (Phase 2)|Reason not specified|0|||
41980522|NCT00473746|75786264|FG004|Period 2 (Phase 2)|Reason not specified|3|||
41980523|NCT00473668|75786281|FG000|Overall Study|Withdrawal by Subject|0|||
41980524|NCT00473668|75786282|FG001|Overall Study|Withdrawal by Subject|2|||
41980525|NCT00473668|75786283|FG002|Overall Study|Withdrawal by Subject|0|||
41980526|NCT00473668|75786281|FG000|Overall Study|Migrated/moved from study area|3|||
41980527|NCT00473668|75786282|FG001|Overall Study|Migrated/moved from study area|2|||
41980528|NCT00473668|75786283|FG002|Overall Study|Migrated/moved from study area|0|||
41980529|NCT00473668|75786281|FG000|Overall Study|Lost to Follow-up|0|||
41980530|NCT00473668|75786282|FG001|Overall Study|Lost to Follow-up|4|||
41980531|NCT00473668|75786283|FG002|Overall Study|Lost to Follow-up|6|||
41980532|NCT00473668|75786281|FG000|Overall Study|Other|2|||
41980533|NCT00473668|75786282|FG001|Overall Study|Other|3|||
41980534|NCT00473668|75786283|FG002|Overall Study|Other|4|||
41980535|NCT00473590|75786293|FG000|Overall Study|Adverse Event|3|||
41980536|NCT00473590|75786294|FG001|Overall Study|Adverse Event|3|||
41980537|NCT00473590|75786293|FG000|Overall Study|Death|4|||
41980538|NCT00473590|75786294|FG001|Overall Study|Death|2|||
41980539|NCT00473590|75786293|FG000|Overall Study|Progression not resulting in death|24|||
41980540|NCT00473590|75786294|FG001|Overall Study|Progression not resulting in death|20|||
41980541|NCT00473590|75786293|FG000|Overall Study|Non-protocol-specified therapy|7|||
41980542|NCT00473590|75786294|FG001|Overall Study|Non-protocol-specified therapy|5|||
41980543|NCT00473590|75786293|FG000|Overall Study|Physician Decision|2|||
41980544|NCT00473590|75786294|FG001|Overall Study|Physician Decision|4|||
41980545|NCT00473590|75786293|FG000|Overall Study|Withdrawal by Subject|5|||
41980546|NCT00473590|75786294|FG001|Overall Study|Withdrawal by Subject|3|||
41980547|NCT00473590|75786293|FG000|Overall Study|Other|0|||
41980548|NCT00473590|75786294|FG001|Overall Study|Other|1|||
41980549|NCT00473512|75786305|FG000|Period 1 (Phase 1)|Adverse Event|0|||
41980550|NCT00473512|75786306|FG001|Period 1 (Phase 1)|Adverse Event|0|||
41980551|NCT00473512|75786307|FG002|Period 1 (Phase 1)|Adverse Event|0|||
41980552|NCT00473512|75786308|FG003|Period 1 (Phase 1)|Adverse Event|5|||
41980553|NCT00473512|75786309|FG004|Period 1 (Phase 1)|Adverse Event|0|||
41980554|NCT00473512|75786305|FG000|Period 1 (Phase 1)|Death|0|||
41980555|NCT00473512|75786306|FG001|Period 1 (Phase 1)|Death|0|||
41980556|NCT00473512|75786307|FG002|Period 1 (Phase 1)|Death|0|||
41980557|NCT00473512|75786308|FG003|Period 1 (Phase 1)|Death|1|||
41980558|NCT00473512|75786309|FG004|Period 1 (Phase 1)|Death|0|||
41980559|NCT00473512|75786305|FG000|Period 1 (Phase 1)|Disease Progression|1|||
41980560|NCT00473512|75786306|FG001|Period 1 (Phase 1)|Disease Progression|1|||
41980561|NCT00473512|75786307|FG002|Period 1 (Phase 1)|Disease Progression|0|||
42130212|NCT00342628|75941106|FG000|Overall Study|Withdrawal by Subject|19|||
42130213|NCT00342628|75941107|FG001|Overall Study|Withdrawal by Subject|19|||
42130214|NCT00342628|75941108|FG002|Overall Study|Withdrawal by Subject|18|||
41980562|NCT00473512|75786308|FG003|Period 1 (Phase 1)|Disease Progression|10|||
41980563|NCT00473512|75786309|FG004|Period 1 (Phase 1)|Disease Progression|1|||
41980564|NCT00473512|75786305|FG000|Period 1 (Phase 1)|Other|0|||
41980565|NCT00473512|75786306|FG001|Period 1 (Phase 1)|Other|0|||
41980566|NCT00473512|75786307|FG002|Period 1 (Phase 1)|Other|0|||
41980567|NCT00473512|75786308|FG003|Period 1 (Phase 1)|Other|1|||
41980568|NCT00473512|75786309|FG004|Period 1 (Phase 1)|Other|0|||
41980569|NCT00473512|75786305|FG000|Period 2 (Phase 2)|Adverse Event|0|||
41980570|NCT00473512|75786306|FG001|Period 2 (Phase 2)|Adverse Event|0|||
41980571|NCT00473512|75786307|FG002|Period 2 (Phase 2)|Adverse Event|0|||
41980572|NCT00473512|75786308|FG003|Period 2 (Phase 2)|Adverse Event|1|||
42130215|NCT00342628|75941106|FG000|Overall Study|Death|1|||
42130216|NCT00342628|75941107|FG001|Overall Study|Death|1|||
42130217|NCT00342628|75941108|FG002|Overall Study|Death|0|||
41980573|NCT00473512|75786309|FG004|Period 2 (Phase 2)|Adverse Event|0|||
41980574|NCT00473512|75786305|FG000|Period 2 (Phase 2)|Death|0|||
41980575|NCT00473512|75786306|FG001|Period 2 (Phase 2)|Death|0|||
41980576|NCT00473512|75786307|FG002|Period 2 (Phase 2)|Death|0|||
41980577|NCT00473512|75786308|FG003|Period 2 (Phase 2)|Death|1|||
41980578|NCT00473512|75786309|FG004|Period 2 (Phase 2)|Death|1|||
41980579|NCT00473512|75786305|FG000|Period 2 (Phase 2)|Disease Progression|0|||
41980580|NCT00473512|75786306|FG001|Period 2 (Phase 2)|Disease Progression|2|||
41980581|NCT00473512|75786307|FG002|Period 2 (Phase 2)|Disease Progression|2|||
41980582|NCT00473512|75786308|FG003|Period 2 (Phase 2)|Disease Progression|17|||
41980583|NCT00473512|75786309|FG004|Period 2 (Phase 2)|Disease Progression|1|||
41980584|NCT00473512|75786305|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
41980585|NCT00473512|75786306|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
41980586|NCT00473512|75786307|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
41980587|NCT00473512|75786308|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
41980588|NCT00473512|75786309|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
41980589|NCT00473512|75786305|FG000|Period 2 (Phase 2)|Other|1|||
41980590|NCT00473512|75786306|FG001|Period 2 (Phase 2)|Other|0|||
41980591|NCT00473512|75786307|FG002|Period 2 (Phase 2)|Other|0|||
41980592|NCT00473512|75786308|FG003|Period 2 (Phase 2)|Other|3|||
41980593|NCT00473512|75786309|FG004|Period 2 (Phase 2)|Other|0|||
41980594|NCT00473434|75786329|FG000|Overall Study|Physician Decision|3|||
41980595|NCT00473434|75786329|FG000|Overall Study|Withdrawal by Subject|9|||
41980596|NCT00473434|75786329|FG000|Overall Study|Compliance|3|||
41980597|NCT00473434|75786329|FG000|Overall Study|Lack of Efficacy|3|||
41980598|NCT00473434|75786329|FG000|Overall Study|Adverse Event|3|||
41980599|NCT00473434|75786329|FG000|Overall Study|Patient was selling medication to others|1|||
41980600|NCT00473434|75786329|FG000|Overall Study|Safety evaluation|1|||
41980601|NCT00473434|75786329|FG000|Overall Study|Reason not specified|6|||
41980602|NCT00473434|75786329|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
41980603|NCT00473434|75786329|FG000|Overall Study|Switching to trial medication|1|||
41980604|NCT00473434|75786329|FG000|Overall Study|No longer required|1|||
41980605|NCT00473083|75786349|FG000|Overall Study|Adverse Event|1|||
41980606|NCT00473083|75786350|FG001|Overall Study|Adverse Event|0|||
41980607|NCT00473083|75786351|FG002|Overall Study|Adverse Event|0|||
41980608|NCT00472420|75786362|FG000|Induction Treatment Period|Physician Decision|9|||
41980609|NCT00472420|75786362|FG000|Induction Treatment Period|Adverse Event|3|||
41980610|NCT00472420|75786362|FG000|Induction Treatment Period|Non-compliance|1|||
41980611|NCT00472420|75786362|FG000|Induction Treatment Period|Death|3|||
41980612|NCT00472420|75786362|FG000|Follow-up Period|Death|5|||
41980613|NCT00472420|75786362|FG000|Follow-up Period|Physician Decision|9|||
41980614|NCT00472420|75786362|FG000|Follow-up Period|Lost to Follow-up|2|||
41980615|NCT00472420|75786362|FG000|Follow-up Period|Protocol Violation|1|||
41980616|NCT00472303|75786368|FG000|Titration Phase|Adverse Event|22|||
41980617|NCT00472303|75786369|FG001|Titration Phase|Adverse Event|12|||
41980618|NCT00472303|75786370|FG002|Titration Phase|Adverse Event|0|||
41980619|NCT00472303|75786368|FG000|Titration Phase|Death|4|||
41980620|NCT00472303|75786369|FG001|Titration Phase|Death|2|||
41980621|NCT00472303|75786370|FG002|Titration Phase|Death|0|||
41980622|NCT00472303|75786368|FG000|Titration Phase|Lack of Efficacy|10|||
41980623|NCT00472303|75786369|FG001|Titration Phase|Lack of Efficacy|0|||
41980624|NCT00472303|75786370|FG002|Titration Phase|Lack of Efficacy|0|||
41980625|NCT00472303|75786368|FG000|Titration Phase|Withdrawal by Subject|16|||
41980626|NCT00472303|75786369|FG001|Titration Phase|Withdrawal by Subject|13|||
41980627|NCT00472303|75786370|FG002|Titration Phase|Withdrawal by Subject|0|||
41980628|NCT00472303|75786368|FG000|Titration Phase|Trial Medication non-compliant|4|||
41980629|NCT00472303|75786369|FG001|Titration Phase|Trial Medication non-compliant|1|||
41980630|NCT00472303|75786370|FG002|Titration Phase|Trial Medication non-compliant|0|||
41980631|NCT00472303|75786368|FG000|Titration Phase|Other|3|||
41980632|NCT00472303|75786369|FG001|Titration Phase|Other|1|||
41980633|NCT00472303|75786370|FG002|Titration Phase|Other|0|||
41980634|NCT00472303|75786368|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
41980635|NCT00472303|75786369|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
42130218|NCT00342628|75941106|FG000|Overall Study|moved residence|0|||
42130219|NCT00342628|75941107|FG001|Overall Study|moved residence|1|||
41980636|NCT00472303|75786370|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
41980637|NCT00472303|75786368|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
41980638|NCT00472303|75786369|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
41980639|NCT00472303|75786370|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
41980640|NCT00472303|75786368|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
41980641|NCT00472303|75786369|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
41980642|NCT00472303|75786370|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
41980643|NCT00472303|75786368|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
42130220|NCT00342628|75941108|FG002|Overall Study|moved residence|1|||
41980644|NCT00472303|75786369|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
41980645|NCT00472303|75786370|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
41980646|NCT00472303|75786368|FG000|Discontinuations After Titration Phase|Other|5|||
41980647|NCT00472303|75786369|FG001|Discontinuations After Titration Phase|Other|0|||
41980648|NCT00472303|75786370|FG002|Discontinuations After Titration Phase|Other|0|||
41980649|NCT00472303|75786368|FG000|Maintenance Phase|Adverse Event|5|||
41980650|NCT00472303|75786369|FG001|Maintenance Phase|Adverse Event|6|||
41980651|NCT00472303|75786370|FG002|Maintenance Phase|Adverse Event|6|||
41980652|NCT00472303|75786368|FG000|Maintenance Phase|Death|3|||
41980653|NCT00472303|75786369|FG001|Maintenance Phase|Death|0|||
41980654|NCT00472303|75786370|FG002|Maintenance Phase|Death|2|||
41980655|NCT00472303|75786368|FG000|Maintenance Phase|Lack of Efficacy|2|||
41980656|NCT00472303|75786369|FG001|Maintenance Phase|Lack of Efficacy|2|||
41980657|NCT00472303|75786370|FG002|Maintenance Phase|Lack of Efficacy|4|||
42219377|NCT03364309|76037554|FG013|Maintenance Period|Relapsed|0|||
42219378|NCT03364309|76037555|FG014|Maintenance Period|Relapsed|0|||
42219379|NCT03364309|76037556|FG015|Maintenance Period|Relapsed|0|||
42219380|NCT03364309|76037557|FG016|Maintenance Period|Relapsed|0|||
42219381|NCT03364309|76037558|FG017|Maintenance Period|Relapsed|0|||
42219382|NCT03364309|76037559|FG018|Maintenance Period|Relapsed|0|||
42219383|NCT03364309|76037541|FG000|Maintenance Period|Lack of Efficacy|0|||
42219384|NCT03364309|76037542|FG001|Maintenance Period|Lack of Efficacy|0|||
42219385|NCT03364309|76037543|FG002|Maintenance Period|Lack of Efficacy|0|||
42219386|NCT03364309|76037544|FG003|Maintenance Period|Lack of Efficacy|0|||
42219387|NCT03364309|76037545|FG004|Maintenance Period|Lack of Efficacy|0|||
42219388|NCT03364309|76037546|FG005|Maintenance Period|Lack of Efficacy|0|||
42219389|NCT03364309|76037547|FG006|Maintenance Period|Lack of Efficacy|0|||
42219390|NCT03364309|76037548|FG007|Maintenance Period|Lack of Efficacy|0|||
42219391|NCT03364309|76037549|FG008|Maintenance Period|Lack of Efficacy|1|||
42219392|NCT03364309|76037550|FG009|Maintenance Period|Lack of Efficacy|3|||
42219393|NCT03364309|76037551|FG010|Maintenance Period|Lack of Efficacy|2|||
41980658|NCT00472303|75786368|FG000|Maintenance Phase|Withdrawal by Subject|6|||
41980659|NCT00472303|75786369|FG001|Maintenance Phase|Withdrawal by Subject|7|||
41980660|NCT00472303|75786370|FG002|Maintenance Phase|Withdrawal by Subject|3|||
41980661|NCT00472303|75786368|FG000|Maintenance Phase|Trial medication non-compliant|0|||
41980662|NCT00472303|75786369|FG001|Maintenance Phase|Trial medication non-compliant|0|||
41980663|NCT00472303|75786370|FG002|Maintenance Phase|Trial medication non-compliant|1|||
41980664|NCT00472303|75786368|FG000|Maintenance Phase|Resolution of pain|0|||
41980665|NCT00472303|75786369|FG001|Maintenance Phase|Resolution of pain|0|||
41980666|NCT00472303|75786370|FG002|Maintenance Phase|Resolution of pain|1|||
41980667|NCT00472303|75786368|FG000|Maintenance Phase|Other|1|||
41980668|NCT00472303|75786369|FG001|Maintenance Phase|Other|1|||
41980669|NCT00472303|75786370|FG002|Maintenance Phase|Other|0|||
41980670|NCT00471718|75786398|FG000|Overall Study|Adverse Event|3|||
41980671|NCT00471718|75786398|FG000|Overall Study|other complicating disease|1|||
41980672|NCT00471718|75786398|FG000|Overall Study|disease progression|22|||
41980673|NCT00471718|75786398|FG000|Overall Study|Withdrawal by Subject|1|||
41980674|NCT00471445|75786408|FG000|Overall Study|Withdrawal by Subject|1|||
41980675|NCT00471445|75786409|FG001|Overall Study|Withdrawal by Subject|1|||
41980676|NCT00471445|75786408|FG000|Overall Study|Ineligible|1|||
41980677|NCT00471445|75786409|FG001|Overall Study|Ineligible|0|||
41980678|NCT00471445|75786408|FG000|Overall Study|Protocol Violation|0|||
42130221|NCT00505284|75941121|FG000|Overall Study|Adverse Event|3|||
42130222|NCT00505284|75941122|FG001|Overall Study|Adverse Event|7|||
42130223|NCT00505284|75941123|FG002|Overall Study|Adverse Event|9|||
42130224|NCT00505284|75941124|FG003|Overall Study|Adverse Event|14|||
42130225|NCT00505284|75941125|FG004|Overall Study|Adverse Event|22|||
42130226|NCT00505284|75941121|FG000|Overall Study|Protocol Violation|0|||
42130227|NCT00505284|75941122|FG001|Overall Study|Protocol Violation|1|||
42130228|NCT00505284|75941123|FG002|Overall Study|Protocol Violation|1|||
42130229|NCT00505284|75941124|FG003|Overall Study|Protocol Violation|0|||
42130230|NCT00505284|75941125|FG004|Overall Study|Protocol Violation|0|||
42130231|NCT00505284|75941121|FG000|Overall Study|Withdrawal by Subject|2|||
42130232|NCT00505284|75941122|FG001|Overall Study|Withdrawal by Subject|6|||
42130233|NCT00505284|75941123|FG002|Overall Study|Withdrawal by Subject|1|||
42130234|NCT00505284|75941124|FG003|Overall Study|Withdrawal by Subject|0|||
42130235|NCT00505284|75941125|FG004|Overall Study|Withdrawal by Subject|6|||
42130236|NCT00505284|75941121|FG000|Overall Study|Lack of Efficacy|0|||
41980679|NCT00471445|75786409|FG001|Overall Study|Protocol Violation|1|||
41980680|NCT00471328|75786417|FG000|Core Phase|Adverse Event|18|||
41980681|NCT00471328|75786418|FG001|Core Phase|Adverse Event|6|||
41980682|NCT00471328|75786417|FG000|Core Phase|Death|8|||
41980683|NCT00471328|75786418|FG001|Core Phase|Death|4|||
42130237|NCT00505284|75941122|FG001|Overall Study|Lack of Efficacy|1|||
42130238|NCT00505284|75941123|FG002|Overall Study|Lack of Efficacy|1|||
42219394|NCT03364309|76037552|FG011|Maintenance Period|Lack of Efficacy|0|||
42219395|NCT03364309|76037553|FG012|Maintenance Period|Lack of Efficacy|0|||
42219396|NCT03364309|76037554|FG013|Maintenance Period|Lack of Efficacy|0|||
41980684|NCT00471328|75786417|FG000|Core Phase|Withdrawal by Subject|2|||
41980685|NCT00471328|75786418|FG001|Core Phase|Withdrawal by Subject|2|||
41980686|NCT00471328|75786417|FG000|Core Phase|Abnormal laboratory value|1|||
41980687|NCT00471328|75786418|FG001|Core Phase|Abnormal laboratory value|0|||
41980688|NCT00471328|75786417|FG000|Core Phase|Disease Progression|78|||
41980689|NCT00471328|75786418|FG001|Core Phase|Disease Progression|53|||
41980690|NCT00471328|75786417|FG000|Core Phase|Administrative Problem|0|||
41980691|NCT00471328|75786418|FG001|Core Phase|Administrative Problem|1|||
41980692|NCT00471328|75786417|FG000|Core Phase|Protocol Deviation|0|||
41980693|NCT00471328|75786418|FG001|Core Phase|Protocol Deviation|1|||
41980694|NCT00471328|75786417|FG000|Extension Phase|Adverse Event|3|||
41980695|NCT00471328|75786418|FG001|Extension Phase|Adverse Event|12|||
41980696|NCT00471328|75786417|FG000|Extension Phase|Withdrawal by Subject|0|||
41980697|NCT00471328|75786418|FG001|Extension Phase|Withdrawal by Subject|2|||
41980698|NCT00471328|75786417|FG000|Extension Phase|Death|1|||
41980699|NCT00471328|75786418|FG001|Extension Phase|Death|7|||
41980700|NCT00471328|75786417|FG000|Extension Phase|Protocol Deviation|3|||
41980701|NCT00471328|75786418|FG001|Extension Phase|Protocol Deviation|1|||
41980702|NCT00471328|75786417|FG000|Extension Phase|Treatment duration as per protocol|0|||
41980703|NCT00471328|75786418|FG001|Extension Phase|Treatment duration as per protocol|1|||
41980704|NCT00471328|75786417|FG000|Extension Phase|Disease Progression|32|||
41980705|NCT00471328|75786418|FG001|Extension Phase|Disease Progression|44|||
41980706|NCT00471328|75786417|FG000|Extension Phase|New cancer Therapy|1|||
41980707|NCT00471328|75786418|FG001|Extension Phase|New cancer Therapy|0|||
41980708|NCT00471328|75786417|FG000|Extension Phase|Administrative Problem|1|||
41980709|NCT00471328|75786418|FG001|Extension Phase|Administrative Problem|0|||
41980710|NCT00470470|75786426|FG000|Overall Study|Adverse Event|2|||
41980711|NCT00470470|75786426|FG000|Overall Study|Death|2|||
41980712|NCT00470470|75786426|FG000|Overall Study|Not treated|1|||
41980713|NCT00470275|75786430|FG000|Overall Study|Death|1|||
41980714|NCT00470275|75786430|FG000|Overall Study|Lack of Efficacy|7|||
41980715|NCT00470275|75786430|FG000|Overall Study|Withdrawal by Subject|2|||
41980716|NCT00470158|75786439|FG000|Overall Study|Death|0|||
41980717|NCT00470158|75786440|FG001|Overall Study|Death|0|||
41980718|NCT00470158|75786441|FG002|Overall Study|Death|0|||
41980719|NCT00470158|75786442|FG003|Overall Study|Death|0|||
41980720|NCT00470158|75786443|FG004|Overall Study|Death|2|||
41980721|NCT00470158|75786439|FG000|Overall Study|Lost to Follow-up|7|||
41980722|NCT00470158|75786440|FG001|Overall Study|Lost to Follow-up|8|||
41980723|NCT00470158|75786441|FG002|Overall Study|Lost to Follow-up|8|||
41980724|NCT00470158|75786442|FG003|Overall Study|Lost to Follow-up|5|||
41980725|NCT00470158|75786443|FG004|Overall Study|Lost to Follow-up|4|||
41980726|NCT00470158|75786439|FG000|Overall Study|Protocol Violation|1|||
41980727|NCT00470158|75786440|FG001|Overall Study|Protocol Violation|0|||
41980728|NCT00470158|75786441|FG002|Overall Study|Protocol Violation|0|||
41980729|NCT00470158|75786442|FG003|Overall Study|Protocol Violation|0|||
41980730|NCT00470158|75786443|FG004|Overall Study|Protocol Violation|0|||
41980731|NCT00475540|75786457|FG000|36 Months|Lost to Follow-up|4|||
41980732|NCT00475540|75786458|FG001|36 Months|Lost to Follow-up|4|||
41980733|NCT00475540|75786457|FG000|36 Months|Death|1|||
41980734|NCT00475540|75786458|FG001|36 Months|Death|2|||
41980735|NCT00475540|75786457|FG000|36 Months|Censored due to reoperation|3|||
41980736|NCT00475540|75786458|FG001|36 Months|Censored due to reoperation|0|||
41980737|NCT00472186|75786466|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
41980738|NCT00472186|75786467|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
41980739|NCT00479713|75786477|FG000|Overall Study|Adverse Event|8|||
41980740|NCT00479713|75786478|FG001|Overall Study|Adverse Event|6|||
41980741|NCT00479713|75786477|FG000|Overall Study|Death|1|||
42028639|NCT00959049|75837044|FG001|Overall Study|Contraindicated medication|0|||
41980742|NCT00479713|75786478|FG001|Overall Study|Death|0|||
41980743|NCT00479713|75786477|FG000|Overall Study|Lost to Follow-up|0|||
41980744|NCT00479713|75786478|FG001|Overall Study|Lost to Follow-up|1|||
41980745|NCT00479713|75786477|FG000|Overall Study|Protocol Violation|0|||
42028640|NCT00959049|75837045|FG002|Overall Study|Contraindicated medication|0|||
42028641|NCT00959049|75837046|FG003|Overall Study|Contraindicated medication|1|||
42130239|NCT00505284|75941124|FG003|Overall Study|Lack of Efficacy|1|||
41980746|NCT00479713|75786478|FG001|Overall Study|Protocol Violation|1|||
41980747|NCT00479713|75786477|FG000|Overall Study|Withdrawal by Subject|4|||
41980748|NCT00479713|75786478|FG001|Overall Study|Withdrawal by Subject|1|||
41980749|NCT00474526|75786510|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
41980750|NCT00474526|75786511|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
41980751|NCT00474526|75786512|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
41980752|NCT00474526|75786513|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
41980753|NCT00474526|75786514|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
41980754|NCT00474526|75786515|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
41980755|NCT00474526|75786516|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
41980756|NCT00474526|75786517|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
41980757|NCT00474526|75786518|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
41980758|NCT00474526|75786519|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
41980759|NCT00474526|75786520|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
41980760|NCT00474526|75786521|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
41980761|NCT00474526|75786522|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
41980762|NCT00474526|75786523|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
41980763|NCT00474526|75786524|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
41980764|NCT00474526|75786525|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
41980765|NCT00474526|75786526|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
41980766|NCT00474526|75786510|FG000|Overall Study|Adverse Event|2|||
41980767|NCT00474526|75786511|FG001|Overall Study|Adverse Event|0|||
41980768|NCT00474526|75786512|FG002|Overall Study|Adverse Event|2|||
41980769|NCT00474526|75786513|FG003|Overall Study|Adverse Event|4|||
41980770|NCT00474526|75786514|FG004|Overall Study|Adverse Event|2|||
41980771|NCT00474526|75786515|FG005|Overall Study|Adverse Event|1|||
41980772|NCT00474526|75786516|FG006|Overall Study|Adverse Event|1|||
41980773|NCT00474526|75786517|FG007|Overall Study|Adverse Event|0|||
41980774|NCT00474526|75786518|FG008|Overall Study|Adverse Event|0|||
41980775|NCT00474526|75786519|FG009|Overall Study|Adverse Event|0|||
41980776|NCT00474526|75786520|FG010|Overall Study|Adverse Event|0|||
41980777|NCT00474526|75786521|FG011|Overall Study|Adverse Event|0|||
41980778|NCT00474526|75786522|FG012|Overall Study|Adverse Event|0|||
41980779|NCT00474526|75786523|FG013|Overall Study|Adverse Event|0|||
41980780|NCT00474526|75786524|FG014|Overall Study|Adverse Event|1|||
41980781|NCT00474526|75786525|FG015|Overall Study|Adverse Event|1|||
41980782|NCT00474526|75786526|FG016|Overall Study|Adverse Event|0|||
41980783|NCT00474526|75786510|FG000|Overall Study|Death|0|||
41980784|NCT00474526|75786511|FG001|Overall Study|Death|0|||
41980785|NCT00474526|75786512|FG002|Overall Study|Death|0|||
41980786|NCT00474526|75786513|FG003|Overall Study|Death|0|||
41980787|NCT00474526|75786514|FG004|Overall Study|Death|0|||
41980788|NCT00474526|75786515|FG005|Overall Study|Death|0|||
41980789|NCT00474526|75786516|FG006|Overall Study|Death|0|||
41980790|NCT00474526|75786517|FG007|Overall Study|Death|0|||
41980791|NCT00474526|75786518|FG008|Overall Study|Death|0|||
42130240|NCT00505284|75941125|FG004|Overall Study|Lack of Efficacy|1|||
42130241|NCT00505284|75941121|FG000|Overall Study|Physician Decision|0|||
42219397|NCT03364309|76037555|FG014|Maintenance Period|Lack of Efficacy|0|||
42219398|NCT03364309|76037556|FG015|Maintenance Period|Lack of Efficacy|0|||
42130242|NCT00505284|75941122|FG001|Overall Study|Physician Decision|1|||
42130243|NCT00505284|75941123|FG002|Overall Study|Physician Decision|0|||
42130244|NCT00505284|75941124|FG003|Overall Study|Physician Decision|0|||
42130245|NCT00505284|75941125|FG004|Overall Study|Physician Decision|0|||
42130246|NCT00505284|75941121|FG000|Overall Study|Other|5|||
42130247|NCT00505284|75941122|FG001|Overall Study|Other|0|||
42130248|NCT00505284|75941123|FG002|Overall Study|Other|0|||
42130249|NCT00505284|75941124|FG003|Overall Study|Other|4|||
42130250|NCT00505284|75941125|FG004|Overall Study|Other|4|||
42130251|NCT00337168|75941137|FG000|Overall Study|Death|5|||
42130252|NCT00337168|75941137|FG000|Overall Study|Not protocol specified|2|||
42130253|NCT00337168|75941137|FG000|Overall Study|Did not start therapy|1|||
42130254|NCT00606905|75941144|FG000|Overall Study|No Pregnancy|9|||
42130255|NCT00606905|75941145|FG001|Overall Study|No Pregnancy|6|||
42130256|NCT00606905|75941144|FG000|Overall Study|Non-Index Pregnancy|1|||
42130257|NCT00606905|75941145|FG001|Overall Study|Non-Index Pregnancy|4|||
42130258|NCT00606905|75941144|FG000|Overall Study|Withdrew|5|||
42130259|NCT00606905|75941145|FG001|Overall Study|Withdrew|5|||
42130260|NCT00606593|75941151|FG000|Overall Study|Adverse Event|0|||
42130261|NCT00606593|75941152|FG001|Overall Study|Adverse Event|0|||
41980792|NCT00474526|75786519|FG009|Overall Study|Death|0|||
41980793|NCT00474526|75786520|FG010|Overall Study|Death|0|||
42130262|NCT00606593|75941153|FG002|Overall Study|Adverse Event|0|||
41980794|NCT00474526|75786521|FG011|Overall Study|Death|0|||
41980795|NCT00474526|75786522|FG012|Overall Study|Death|0|||
41980796|NCT00474526|75786523|FG013|Overall Study|Death|3|||
41980797|NCT00474526|75786524|FG014|Overall Study|Death|0|||
41980798|NCT00474526|75786525|FG015|Overall Study|Death|0|||
42130263|NCT00606593|75941154|FG003|Overall Study|Adverse Event|1|||
42130264|NCT00606593|75941155|FG004|Overall Study|Adverse Event|1|||
42130265|NCT00606593|75941156|FG005|Overall Study|Adverse Event|0|||
41980799|NCT00474526|75786526|FG016|Overall Study|Death|0|||
41980800|NCT00474526|75786510|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
42130266|NCT00606593|75941157|FG006|Overall Study|Adverse Event|1|||
42130267|NCT00606593|75941158|FG007|Overall Study|Adverse Event|2|||
41980801|NCT00474526|75786511|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
41980802|NCT00474526|75786512|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
41980803|NCT00474526|75786513|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
41980804|NCT00474526|75786514|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
41980805|NCT00474526|75786515|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
41980806|NCT00474526|75786516|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
41980807|NCT00474526|75786517|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
41980808|NCT00474526|75786518|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
41980809|NCT00474526|75786519|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
41980810|NCT00474526|75786520|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
41980811|NCT00474526|75786521|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
41980812|NCT00474526|75786522|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
41980813|NCT00474526|75786523|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
41980814|NCT00474526|75786524|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
41980815|NCT00474526|75786525|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
41980816|NCT00474526|75786526|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
41980817|NCT00474526|75786510|FG000|Overall Study|Lost to Follow-up|8|||
41980818|NCT00474526|75786511|FG001|Overall Study|Lost to Follow-up|6|||
41980819|NCT00474526|75786512|FG002|Overall Study|Lost to Follow-up|13|||
41980820|NCT00474526|75786513|FG003|Overall Study|Lost to Follow-up|29|||
41980821|NCT00474526|75786514|FG004|Overall Study|Lost to Follow-up|11|||
41980822|NCT00474526|75786515|FG005|Overall Study|Lost to Follow-up|5|||
41980823|NCT00474526|75786516|FG006|Overall Study|Lost to Follow-up|8|||
41980824|NCT00474526|75786517|FG007|Overall Study|Lost to Follow-up|1|||
41980825|NCT00474526|75786518|FG008|Overall Study|Lost to Follow-up|0|||
41980826|NCT00474526|75786519|FG009|Overall Study|Lost to Follow-up|6|||
41980827|NCT00474526|75786520|FG010|Overall Study|Lost to Follow-up|2|||
41980828|NCT00474526|75786521|FG011|Overall Study|Lost to Follow-up|4|||
41980829|NCT00474526|75786522|FG012|Overall Study|Lost to Follow-up|6|||
41980830|NCT00474526|75786523|FG013|Overall Study|Lost to Follow-up|74|||
41980831|NCT00474526|75786524|FG014|Overall Study|Lost to Follow-up|29|||
41980832|NCT00474526|75786525|FG015|Overall Study|Lost to Follow-up|4|||
41980833|NCT00474526|75786526|FG016|Overall Study|Lost to Follow-up|5|||
41980834|NCT00474526|75786510|FG000|Overall Study|Protocol Violation|2|||
41980835|NCT00474526|75786511|FG001|Overall Study|Protocol Violation|6|||
41980836|NCT00474526|75786512|FG002|Overall Study|Protocol Violation|4|||
41980837|NCT00474526|75786513|FG003|Overall Study|Protocol Violation|12|||
41980838|NCT00474526|75786514|FG004|Overall Study|Protocol Violation|3|||
41980839|NCT00474526|75786515|FG005|Overall Study|Protocol Violation|1|||
41980840|NCT00474526|75786516|FG006|Overall Study|Protocol Violation|3|||
41980841|NCT00474526|75786517|FG007|Overall Study|Protocol Violation|0|||
41980842|NCT00474526|75786518|FG008|Overall Study|Protocol Violation|0|||
41980843|NCT00474526|75786519|FG009|Overall Study|Protocol Violation|4|||
41980844|NCT00474526|75786520|FG010|Overall Study|Protocol Violation|2|||
41980845|NCT00474526|75786521|FG011|Overall Study|Protocol Violation|2|||
41980846|NCT00474526|75786522|FG012|Overall Study|Protocol Violation|4|||
41980847|NCT00474526|75786523|FG013|Overall Study|Protocol Violation|19|||
41980848|NCT00474526|75786524|FG014|Overall Study|Protocol Violation|9|||
41980849|NCT00474526|75786525|FG015|Overall Study|Protocol Violation|6|||
41980850|NCT00474526|75786526|FG016|Overall Study|Protocol Violation|2|||
41980851|NCT00474526|75786510|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
41980852|NCT00474526|75786511|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
41980853|NCT00474526|75786512|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
41980854|NCT00474526|75786513|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
41980855|NCT00474526|75786514|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
41980856|NCT00474526|75786515|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
41980857|NCT00474526|75786516|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
41980858|NCT00474526|75786517|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
41980859|NCT00474526|75786518|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
41980860|NCT00474526|75786519|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
41980861|NCT00474526|75786520|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
42130268|NCT00606593|75941159|FG008|Overall Study|Adverse Event|1|||
41980862|NCT00474526|75786521|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
41980863|NCT00474526|75786522|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
41980864|NCT00474526|75786523|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
41980865|NCT00474526|75786524|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
41980866|NCT00474526|75786525|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
41980867|NCT00474526|75786526|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
41980868|NCT00474526|75786510|FG000|Overall Study|Withdrawal by Subject|9|||
41980869|NCT00474526|75786511|FG001|Overall Study|Withdrawal by Subject|24|||
41980870|NCT00474526|75786512|FG002|Overall Study|Withdrawal by Subject|21|||
41980871|NCT00474526|75786513|FG003|Overall Study|Withdrawal by Subject|52|||
41980872|NCT00474526|75786514|FG004|Overall Study|Withdrawal by Subject|38|||
41980873|NCT00474526|75786515|FG005|Overall Study|Withdrawal by Subject|6|||
41980874|NCT00474526|75786516|FG006|Overall Study|Withdrawal by Subject|12|||
41980875|NCT00474526|75786517|FG007|Overall Study|Withdrawal by Subject|4|||
41980876|NCT00474526|75786518|FG008|Overall Study|Withdrawal by Subject|4|||
41980877|NCT00474526|75786519|FG009|Overall Study|Withdrawal by Subject|13|||
41980878|NCT00474526|75786520|FG010|Overall Study|Withdrawal by Subject|5|||
41980879|NCT00474526|75786521|FG011|Overall Study|Withdrawal by Subject|4|||
41980880|NCT00474526|75786522|FG012|Overall Study|Withdrawal by Subject|4|||
41980881|NCT00474526|75786523|FG013|Overall Study|Withdrawal by Subject|37|||
41980882|NCT00474526|75786524|FG014|Overall Study|Withdrawal by Subject|22|||
41980883|NCT00474526|75786525|FG015|Overall Study|Withdrawal by Subject|1|||
41980884|NCT00474526|75786526|FG016|Overall Study|Withdrawal by Subject|1|||
41980885|NCT00478426|75786612|FG000|Overall Study|Withdrawal by Subject|1|||
41980886|NCT00477412|75786620|FG000|Overall Study|Death|0|||
41980887|NCT00477412|75786621|FG001|Overall Study|Death|0|||
41980888|NCT00477412|75786622|FG002|Overall Study|Death|0|||
41980889|NCT00477412|75786623|FG003|Overall Study|Death|4|||
41980890|NCT00477412|75786620|FG000|Overall Study|Lost to Follow-up|0|||
41980891|NCT00477412|75786621|FG001|Overall Study|Lost to Follow-up|0|||
41980892|NCT00477412|75786622|FG002|Overall Study|Lost to Follow-up|0|||
41980893|NCT00477412|75786623|FG003|Overall Study|Lost to Follow-up|1|||
41980894|NCT00477412|75786620|FG000|Overall Study|Withdrawal by Subject|0|||
41980895|NCT00477412|75786621|FG001|Overall Study|Withdrawal by Subject|0|||
41980896|NCT00477412|75786622|FG002|Overall Study|Withdrawal by Subject|0|||
41980897|NCT00477412|75786623|FG003|Overall Study|Withdrawal by Subject|2|||
41980898|NCT00477412|75786620|FG000|Overall Study|Second Malignancy|0|||
42219399|NCT03364309|76037557|FG016|Maintenance Period|Lack of Efficacy|0|||
42219400|NCT03364309|76037558|FG017|Maintenance Period|Lack of Efficacy|0|||
42219401|NCT03364309|76037559|FG018|Maintenance Period|Lack of Efficacy|0|||
42219402|NCT03364309|76037541|FG000|Maintenance Period|Death|0|||
42219403|NCT03364309|76037542|FG001|Maintenance Period|Death|0|||
42219404|NCT03364309|76037543|FG002|Maintenance Period|Death|0|||
42219405|NCT03364309|76037544|FG003|Maintenance Period|Death|0|||
42219406|NCT03364309|76037545|FG004|Maintenance Period|Death|0|||
42219407|NCT03364309|76037546|FG005|Maintenance Period|Death|0|||
42219408|NCT03364309|76037547|FG006|Maintenance Period|Death|0|||
42219409|NCT03364309|76037548|FG007|Maintenance Period|Death|0|||
42219410|NCT03364309|76037549|FG008|Maintenance Period|Death|1|||
42219411|NCT03364309|76037550|FG009|Maintenance Period|Death|0|||
42219412|NCT03364309|76037551|FG010|Maintenance Period|Death|0|||
42219413|NCT03364309|76037552|FG011|Maintenance Period|Death|0|||
42219414|NCT03364309|76037553|FG012|Maintenance Period|Death|0|||
42219415|NCT03364309|76037554|FG013|Maintenance Period|Death|0|||
42219416|NCT03364309|76037555|FG014|Maintenance Period|Death|0|||
42219417|NCT03364309|76037556|FG015|Maintenance Period|Death|0|||
42219418|NCT03364309|76037557|FG016|Maintenance Period|Death|0|||
42219419|NCT03364309|76037558|FG017|Maintenance Period|Death|0|||
42219420|NCT03364309|76037559|FG018|Maintenance Period|Death|0|||
42219421|NCT03364309|76037541|FG000|Maintenance Period|Lost to Follow-up|0|||
42219422|NCT03364309|76037542|FG001|Maintenance Period|Lost to Follow-up|0|||
42219423|NCT03364309|76037543|FG002|Maintenance Period|Lost to Follow-up|0|||
42219424|NCT03364309|76037544|FG003|Maintenance Period|Lost to Follow-up|0|||
42219425|NCT03364309|76037545|FG004|Maintenance Period|Lost to Follow-up|0|||
42219426|NCT03364309|76037546|FG005|Maintenance Period|Lost to Follow-up|0|||
41980899|NCT00477412|75786621|FG001|Overall Study|Second Malignancy|0|||
41980900|NCT00477412|75786622|FG002|Overall Study|Second Malignancy|0|||
41980901|NCT00477412|75786623|FG003|Overall Study|Second Malignancy|1|||
41980902|NCT00477412|75786620|FG000|Overall Study|Adverse Event|1|||
41980903|NCT00477412|75786621|FG001|Overall Study|Adverse Event|0|||
41980904|NCT00477412|75786622|FG002|Overall Study|Adverse Event|1|||
41980905|NCT00477412|75786623|FG003|Overall Study|Adverse Event|0|||
41980906|NCT01089556|75786633|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
41980907|NCT01089556|75786634|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
41980908|NCT01089556|75786635|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
42219427|NCT03364309|76037547|FG006|Maintenance Period|Lost to Follow-up|0|||
42219428|NCT03364309|76037548|FG007|Maintenance Period|Lost to Follow-up|0|||
41980909|NCT01089556|75786636|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
41980910|NCT01089556|75786637|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
41980911|NCT01089556|75786638|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
41980912|NCT01089556|75786633|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
41980913|NCT01089556|75786634|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
41980914|NCT01089556|75786635|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
41980915|NCT01089556|75786636|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
42219429|NCT03364309|76037549|FG008|Maintenance Period|Lost to Follow-up|1|||
42219430|NCT03364309|76037550|FG009|Maintenance Period|Lost to Follow-up|0|||
42219431|NCT03364309|76037551|FG010|Maintenance Period|Lost to Follow-up|0|||
42219432|NCT03364309|76037552|FG011|Maintenance Period|Lost to Follow-up|0|||
42219433|NCT03364309|76037553|FG012|Maintenance Period|Lost to Follow-up|0|||
42219434|NCT03364309|76037554|FG013|Maintenance Period|Lost to Follow-up|0|||
42219435|NCT03364309|76037555|FG014|Maintenance Period|Lost to Follow-up|0|||
42219436|NCT03364309|76037556|FG015|Maintenance Period|Lost to Follow-up|0|||
41980916|NCT01089556|75786637|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
41980917|NCT01089556|75786638|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
41980918|NCT01089556|75786633|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
41980919|NCT01089556|75786634|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
41980920|NCT01089556|75786635|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
41980921|NCT01089556|75786636|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
41980922|NCT01089556|75786637|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
41980923|NCT01089556|75786638|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
41980924|NCT01089556|75786633|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
41980925|NCT01089556|75786634|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
41980926|NCT01089556|75786635|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
41980927|NCT01089556|75786636|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
41980928|NCT01089556|75786637|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
41980929|NCT01089556|75786638|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
41980930|NCT01089556|75786633|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
41980931|NCT01089556|75786634|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
41980932|NCT01089556|75786635|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
41980933|NCT01089556|75786636|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
41980934|NCT01089556|75786637|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
41980935|NCT01089556|75786638|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
41980936|NCT01089556|75786633|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
41980937|NCT01089556|75786634|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
41980938|NCT01089556|75786635|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
41980939|NCT01089556|75786636|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
41980940|NCT01089556|75786637|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
41980941|NCT01089556|75786638|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
41980942|NCT01089556|75786633|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
41980943|NCT01089556|75786634|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
41980944|NCT01089556|75786635|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
41980945|NCT01089556|75786636|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
41980946|NCT01089556|75786637|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
41980947|NCT01089556|75786638|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
41980948|NCT01089556|75786633|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
41980949|NCT01089556|75786634|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
41980950|NCT01089556|75786635|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
41980951|NCT01089556|75786636|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
41980952|NCT01089556|75786637|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
41980953|NCT01089556|75786638|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
41980954|NCT01089556|75786633|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
41980955|NCT01089556|75786634|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
41980956|NCT01089556|75786635|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
41980957|NCT01089556|75786636|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
41980958|NCT01089556|75786637|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
41980959|NCT01089556|75786638|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
41980960|NCT01089556|75786633|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
41980961|NCT01089556|75786634|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
41980962|NCT01089556|75786635|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
42219437|NCT03364309|76037557|FG016|Maintenance Period|Lost to Follow-up|0|||
41980963|NCT01089556|75786636|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
41980964|NCT01089556|75786637|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
41980965|NCT01089556|75786638|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
41980966|NCT01089556|75786633|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
41980967|NCT01089556|75786634|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
41980968|NCT01089556|75786635|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
41980969|NCT01089556|75786636|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
41980970|NCT01089556|75786637|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
41980971|NCT01089556|75786638|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
41980972|NCT01089556|75786633|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
42130269|NCT00606593|75941160|FG009|Overall Study|Adverse Event|0|||
42130270|NCT00606593|75941151|FG000|Overall Study|Withdrawal of consent|1|||
42130271|NCT00606593|75941152|FG001|Overall Study|Withdrawal of consent|0|||
42130272|NCT00606593|75941153|FG002|Overall Study|Withdrawal of consent|1|||
42130273|NCT00606593|75941154|FG003|Overall Study|Withdrawal of consent|0|||
42130274|NCT00606593|75941155|FG004|Overall Study|Withdrawal of consent|0|||
42130275|NCT00606593|75941156|FG005|Overall Study|Withdrawal of consent|0|||
42130276|NCT00606593|75941157|FG006|Overall Study|Withdrawal of consent|0|||
42130277|NCT00606593|75941158|FG007|Overall Study|Withdrawal of consent|0|||
42130278|NCT00606593|75941159|FG008|Overall Study|Withdrawal of consent|0|||
41980973|NCT01089556|75786634|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
42130279|NCT00606593|75941160|FG009|Overall Study|Withdrawal of consent|0|||
41980974|NCT01089556|75786635|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
41980975|NCT01089556|75786636|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
41980976|NCT01089556|75786637|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
41980977|NCT01089556|75786638|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
41980978|NCT01089556|75786633|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
41980979|NCT01089556|75786634|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
41980980|NCT01089556|75786635|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
41980981|NCT01089556|75786636|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
41980982|NCT01089556|75786637|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
41980983|NCT01089556|75786638|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
41980984|NCT01089556|75786633|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
41980985|NCT01089556|75786634|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
42219438|NCT03364309|76037558|FG017|Maintenance Period|Lost to Follow-up|0|||
42219439|NCT03364309|76037559|FG018|Maintenance Period|Lost to Follow-up|0|||
42219440|NCT03364309|76037541|FG000|Maintenance Period|Miscellaneous|0|||
42219441|NCT03364309|76037542|FG001|Maintenance Period|Miscellaneous|0|||
42219442|NCT03364309|76037543|FG002|Maintenance Period|Miscellaneous|0|||
42219443|NCT03364309|76037544|FG003|Maintenance Period|Miscellaneous|0|||
42219444|NCT03364309|76037545|FG004|Maintenance Period|Miscellaneous|0|||
42219445|NCT03364309|76037546|FG005|Maintenance Period|Miscellaneous|0|||
42219446|NCT03364309|76037547|FG006|Maintenance Period|Miscellaneous|0|||
42219447|NCT03364309|76037548|FG007|Maintenance Period|Miscellaneous|0|||
42219448|NCT03364309|76037549|FG008|Maintenance Period|Miscellaneous|1|||
42219449|NCT03364309|76037550|FG009|Maintenance Period|Miscellaneous|0|||
42219450|NCT03364309|76037551|FG010|Maintenance Period|Miscellaneous|0|||
42219451|NCT03364309|76037552|FG011|Maintenance Period|Miscellaneous|0|||
41980986|NCT01089556|75786635|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
41980987|NCT01089556|75786636|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
41980988|NCT01089556|75786637|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
41980989|NCT01089556|75786638|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
41980990|NCT01089556|75786633|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
41980991|NCT01089556|75786634|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
42219452|NCT03364309|76037553|FG012|Maintenance Period|Miscellaneous|0|||
42219453|NCT03364309|76037554|FG013|Maintenance Period|Miscellaneous|0|||
42219454|NCT03364309|76037555|FG014|Maintenance Period|Miscellaneous|0|||
42219455|NCT03364309|76037556|FG015|Maintenance Period|Miscellaneous|0|||
42219456|NCT03364309|76037557|FG016|Maintenance Period|Miscellaneous|0|||
42219457|NCT03364309|76037558|FG017|Maintenance Period|Miscellaneous|0|||
42219458|NCT03364309|76037559|FG018|Maintenance Period|Miscellaneous|0|||
42219459|NCT03364309|76037541|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219460|NCT03364309|76037542|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219461|NCT03364309|76037543|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219462|NCT03364309|76037544|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219463|NCT03364309|76037545|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219464|NCT03364309|76037546|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219465|NCT03364309|76037547|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219466|NCT03364309|76037548|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219467|NCT03364309|76037549|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219468|NCT03364309|76037550|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219469|NCT03364309|76037551|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219470|NCT03364309|76037552|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219471|NCT03364309|76037553|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219472|NCT03364309|76037554|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
42219473|NCT03364309|76037555|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
42219474|NCT03364309|76037556|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
42219475|NCT03364309|76037557|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219476|NCT03364309|76037558|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219477|NCT03364309|76037559|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
42219478|NCT03364309|76037541|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219479|NCT03364309|76037542|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219480|NCT03364309|76037543|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219481|NCT03364309|76037544|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
41980992|NCT01089556|75786635|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
41980993|NCT01089556|75786636|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
41980994|NCT01089556|75786637|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
42028642|NCT00959049|75837047|FG004|Overall Study|Contraindicated medication|0|||
42219482|NCT03364309|76037545|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219483|NCT03364309|76037546|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219484|NCT03364309|76037547|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219485|NCT03364309|76037548|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219486|NCT03364309|76037549|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
41980995|NCT01089556|75786638|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
41980996|NCT01089127|75786656|FG000|Overall Study|Adverse Event|5|||
41980997|NCT01089127|75786657|FG001|Overall Study|Adverse Event|1|||
41980998|NCT01089127|75786658|FG002|Overall Study|Adverse Event|1|||
41980999|NCT01089127|75786659|FG003|Overall Study|Adverse Event|0|||
41981000|NCT01089127|75786660|FG004|Overall Study|Adverse Event|0|||
41981001|NCT01089127|75786661|FG005|Overall Study|Adverse Event|1|||
41981002|NCT01089127|75786656|FG000|Overall Study|Subject withdrew consent|0|||
41981003|NCT01089127|75786657|FG001|Overall Study|Subject withdrew consent|1|||
41981004|NCT01089127|75786658|FG002|Overall Study|Subject withdrew consent|1|||
41981005|NCT01089127|75786659|FG003|Overall Study|Subject withdrew consent|1|||
41981006|NCT01089127|75786660|FG004|Overall Study|Subject withdrew consent|0|||
41981007|NCT01089127|75786661|FG005|Overall Study|Subject withdrew consent|2|||
41981008|NCT01089127|75786656|FG000|Overall Study|Abnormal test procedure result(s)|2|||
41981009|NCT01089127|75786657|FG001|Overall Study|Abnormal test procedure result(s)|1|||
41981010|NCT01089127|75786658|FG002|Overall Study|Abnormal test procedure result(s)|0|||
41981011|NCT01089127|75786659|FG003|Overall Study|Abnormal test procedure result(s)|0|||
41981012|NCT01089127|75786660|FG004|Overall Study|Abnormal test procedure result(s)|0|||
41981013|NCT01089127|75786661|FG005|Overall Study|Abnormal test procedure result(s)|0|||
41981014|NCT01089127|75786656|FG000|Overall Study|Lost to Follow-up|1|||
41981015|NCT01089127|75786657|FG001|Overall Study|Lost to Follow-up|1|||
41981016|NCT01089127|75786658|FG002|Overall Study|Lost to Follow-up|0|||
41981017|NCT01089127|75786659|FG003|Overall Study|Lost to Follow-up|0|||
41981018|NCT01089127|75786660|FG004|Overall Study|Lost to Follow-up|1|||
41981019|NCT01089127|75786661|FG005|Overall Study|Lost to Follow-up|0|||
41981020|NCT01089127|75786656|FG000|Overall Study|Protocol deviation|0|||
41981021|NCT01089127|75786657|FG001|Overall Study|Protocol deviation|1|||
41981022|NCT01089127|75786658|FG002|Overall Study|Protocol deviation|0|||
41981023|NCT01089127|75786659|FG003|Overall Study|Protocol deviation|0|||
41981024|NCT01089127|75786660|FG004|Overall Study|Protocol deviation|1|||
41981025|NCT01089127|75786661|FG005|Overall Study|Protocol deviation|0|||
41981026|NCT01087957|75786677|FG000|Overall Study|Death|2|||
41981027|NCT01087957|75786678|FG001|Overall Study|Death|2|||
41981028|NCT01087957|75786677|FG000|Overall Study|Lost to Follow-up|3|||
41981029|NCT01087957|75786678|FG001|Overall Study|Lost to Follow-up|4|||
41981030|NCT01087957|75786677|FG000|Overall Study|Protocol Violation|13|||
41981031|NCT01087957|75786678|FG001|Overall Study|Protocol Violation|25|||
41981032|NCT01087957|75786677|FG000|Overall Study|Withdrawal by Subject|18|||
41981033|NCT01087957|75786678|FG001|Overall Study|Withdrawal by Subject|15|||
41981034|NCT01087957|75786677|FG000|Overall Study|Physician Decision|5|||
41981035|NCT01087957|75786678|FG001|Overall Study|Physician Decision|9|||
41981036|NCT01087723|75786686|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
41981037|NCT01087723|75786687|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
41981038|NCT01087723|75786686|FG000|Overall Study|Withdrawal by Subject|10|||
41981039|NCT01087723|75786687|FG001|Overall Study|Withdrawal by Subject|13|||
41981040|NCT01087723|75786686|FG000|Overall Study|Physician Decision|2|||
41981041|NCT01087723|75786687|FG001|Overall Study|Physician Decision|0|||
41981042|NCT01087723|75786686|FG000|Overall Study|Lost to Follow-up|1|||
41981043|NCT01087723|75786687|FG001|Overall Study|Lost to Follow-up|4|||
41981044|NCT01087723|75786686|FG000|Overall Study|Reason Not Specified|1|||
41981045|NCT01087723|75786687|FG001|Overall Study|Reason Not Specified|2|||
41981046|NCT01087528|75786693|FG000|Overall Study|Withdrawal by Subject|1|||
41981047|NCT01087528|75786693|FG000|Overall Study|Incomplete CE procedure|6|||
41981048|NCT01085812|75786699|FG000|Open-Label Period|Adverse Event|0|||
41981049|NCT01085812|75786700|FG001|Open-Label Period|Adverse Event|80|||
41981050|NCT01085812|75786699|FG000|Open-Label Period|Lack of Efficacy|0|||
41981051|NCT01085812|75786700|FG001|Open-Label Period|Lack of Efficacy|26|||
41981052|NCT01085812|75786699|FG000|Open-Label Period|Protocol Violation|0|||
41981053|NCT01085812|75786700|FG001|Open-Label Period|Protocol Violation|39|||
41981054|NCT01085812|75786699|FG000|Open-Label Period|Withdrawal by Subject|0|||
41981055|NCT01085812|75786700|FG001|Open-Label Period|Withdrawal by Subject|53|||
41981056|NCT01085812|75786699|FG000|Open-Label Period|Lost to Follow-up|0|||
41981057|NCT01085812|75786700|FG001|Open-Label Period|Lost to Follow-up|42|||
41981058|NCT01085812|75786699|FG000|Double-Blind Period|Adverse Event|3|||
42219487|NCT03364309|76037550|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219488|NCT03364309|76037551|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219489|NCT03364309|76037552|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
41981059|NCT01085812|75786700|FG001|Double-Blind Period|Adverse Event|8|||
41981060|NCT01085812|75786699|FG000|Double-Blind Period|Protocol Violation|2|||
41981061|NCT01085812|75786700|FG001|Double-Blind Period|Protocol Violation|7|||
41981062|NCT01085812|75786699|FG000|Double-Blind Period|Withdrawal by Subject|11|||
41981063|NCT01085812|75786700|FG001|Double-Blind Period|Withdrawal by Subject|24|||
41981064|NCT01085812|75786699|FG000|Double-Blind Period|Lost to Follow-up|5|||
41981065|NCT01085812|75786700|FG001|Double-Blind Period|Lost to Follow-up|17|||
41981066|NCT01085812|75786699|FG000|Double-Blind Period|Other Reasons|0|||
41981067|NCT01085812|75786700|FG001|Double-Blind Period|Other Reasons|2|||
41981068|NCT01085812|75786699|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
41981069|NCT01085812|75786700|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
41981070|NCT01085812|75786699|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
41981071|NCT01085812|75786700|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
41981072|NCT01085812|75786699|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
41981073|NCT01085812|75786700|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
41981074|NCT01085812|75786699|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
41981075|NCT01085812|75786700|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
41981076|NCT01085812|75786699|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
41981077|NCT01085812|75786700|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
41981078|NCT01085734|75786709|FG000|Overall Study|Adverse Event|0|||
41981079|NCT01085734|75786710|FG001|Overall Study|Adverse Event|2|||
41981080|NCT01085734|75786709|FG000|Overall Study|Death|1|||
41981081|NCT01085734|75786710|FG001|Overall Study|Death|0|||
41981082|NCT01085734|75786709|FG000|Overall Study|Lost to Follow-up|0|||
41981083|NCT01085734|75786710|FG001|Overall Study|Lost to Follow-up|1|||
41981084|NCT01085734|75786709|FG000|Overall Study|Withdrawal by Subject|0|||
41981085|NCT01085734|75786710|FG001|Overall Study|Withdrawal by Subject|1|||
41981086|NCT01084603|75786717|FG000|Baseline|Withdrawal by Subject|2|||
41981087|NCT01084603|75786717|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
41981088|NCT01084603|75786717|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
41981089|NCT01084603|75786717|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
41981090|NCT01084603|75786717|FG000|Washout Period 4|Adverse Event|1|||
41981091|NCT01084174|75786732|FG000|Overall Study|gastrointestinal symptoms|1|||
41981092|NCT01084174|75786733|FG001|Overall Study|gastrointestinal symptoms|1|||
41981093|NCT01084174|75786732|FG000|Overall Study|Eosinophilic esophagitis|0|||
41981094|NCT01084174|75786733|FG001|Overall Study|Eosinophilic esophagitis|1|||
41981095|NCT01084174|75786732|FG000|Overall Study|Anaphylaxis|0|||
42219490|NCT03364309|76037553|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219491|NCT03364309|76037554|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219492|NCT03364309|76037555|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
42219493|NCT03364309|76037556|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219494|NCT03364309|76037557|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219495|NCT03364309|76037558|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219496|NCT03364309|76037559|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
42219497|NCT03364309|76037541|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
42219498|NCT03364309|76037542|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
42219499|NCT03364309|76037543|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
42219500|NCT03364309|76037544|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
42219501|NCT03364309|76037545|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
41981096|NCT01084174|75786733|FG001|Overall Study|Anaphylaxis|1|||
41981097|NCT01084174|75786732|FG000|Overall Study|Participant noncompliance|0|||
41981098|NCT01084174|75786733|FG001|Overall Study|Participant noncompliance|1|||
41981099|NCT01084135|75786743|FG000|20 Week|Physician Decision|0|||
41981100|NCT01084135|75786744|FG001|20 Week|Physician Decision|1|||
41981101|NCT01083316|75786752|FG000|Overall Study|Adverse Event|2|||
41981102|NCT01083316|75786752|FG000|Overall Study|Withdrawal by Subject|1|||
41981103|NCT01083160|75786757|FG000|Overall Study|Adverse Event|1|||
41981104|NCT01083121|75786761|FG000|Overall Study|Use of Humira outside the approved label|81|||
41981105|NCT01082614|75786771|FG000|Overall Study|Adverse Event|1|||
41981106|NCT01082614|75786772|FG001|Overall Study|Adverse Event|4|||
41981107|NCT01082614|75786771|FG000|Overall Study|Equipment Malfunction|0|||
41981108|NCT01082614|75786772|FG001|Overall Study|Equipment Malfunction|1|||
42219502|NCT03364309|76037546|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
41981109|NCT01082614|75786771|FG000|Overall Study|Physician Decision|2|||
42219503|NCT03364309|76037547|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
42219504|NCT03364309|76037548|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
41981110|NCT01082614|75786772|FG001|Overall Study|Physician Decision|0|||
41981111|NCT01081873|75786778|FG000|Overall Study|Death|86|||
42028643|NCT00959049|75837048|FG005|Overall Study|Contraindicated medication|0|||
41981112|NCT01081873|75786778|FG000|Overall Study|Withdrawal by Subject|10|||
41981113|NCT01081873|75786778|FG000|Overall Study|Lost to Follow-up|142|||
41981114|NCT01081873|75786778|FG000|Overall Study|Progression of prostate cancer|13|||
41981115|NCT01081873|75786778|FG000|Overall Study|Other|47|||
41981116|NCT01081795|75786810|FG000|Overall Study|Adverse Event|18|||
41981117|NCT01081795|75786811|FG001|Overall Study|Adverse Event|23|||
41981118|NCT01081795|75786812|FG002|Overall Study|Adverse Event|6|||
41981119|NCT01081795|75786810|FG000|Overall Study|Lack of Efficacy|7|||
41981120|NCT01081795|75786811|FG001|Overall Study|Lack of Efficacy|5|||
41981121|NCT01081795|75786812|FG002|Overall Study|Lack of Efficacy|19|||
41981122|NCT01081795|75786810|FG000|Overall Study|Subject's schedule|1|||
41981123|NCT01081795|75786811|FG001|Overall Study|Subject's schedule|1|||
41981124|NCT01081795|75786812|FG002|Overall Study|Subject's schedule|2|||
41981125|NCT01081795|75786810|FG000|Overall Study|Revocation of informed consent|2|||
42302209|NCT02495077|76137270|FG000|Overall Study|Screen Failure|0|||
42302210|NCT02495077|76137271|FG001|Overall Study|Screen Failure|0|||
42219505|NCT03364309|76037549|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
42219506|NCT03364309|76037550|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
42219507|NCT03364309|76037551|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
42219508|NCT03364309|76037552|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
42219509|NCT03364309|76037553|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
42219510|NCT03364309|76037554|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
42219511|NCT03364309|76037555|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
42219512|NCT03364309|76037556|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
42219513|NCT03364309|76037557|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
42219514|NCT03364309|76037558|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
42219515|NCT03364309|76037559|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
42219516|NCT03364309|76037541|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219517|NCT03364309|76037542|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219518|NCT03364309|76037543|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219519|NCT03364309|76037544|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219520|NCT03364309|76037545|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219521|NCT03364309|76037546|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219522|NCT03364309|76037547|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219523|NCT03364309|76037548|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219524|NCT03364309|76037549|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219525|NCT03364309|76037550|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219526|NCT03364309|76037551|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219527|NCT03364309|76037552|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219528|NCT03364309|76037553|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219529|NCT03364309|76037554|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219530|NCT03364309|76037555|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219531|NCT03364309|76037556|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42219532|NCT03364309|76037557|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
42219533|NCT03364309|76037558|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
42219534|NCT03364309|76037559|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
42219535|NCT03364309|76037541|FG000|Post-Treatment Followup Period|Adverse Event|0|||
42219536|NCT03364309|76037542|FG001|Post-Treatment Followup Period|Adverse Event|0|||
42219537|NCT03364309|76037543|FG002|Post-Treatment Followup Period|Adverse Event|0|||
42219538|NCT03364309|76037544|FG003|Post-Treatment Followup Period|Adverse Event|0|||
42219539|NCT03364309|76037545|FG004|Post-Treatment Followup Period|Adverse Event|0|||
42219540|NCT03364309|76037546|FG005|Post-Treatment Followup Period|Adverse Event|0|||
42219541|NCT03364309|76037547|FG006|Post-Treatment Followup Period|Adverse Event|0|||
42219542|NCT03364309|76037548|FG007|Post-Treatment Followup Period|Adverse Event|0|||
42219543|NCT03364309|76037549|FG008|Post-Treatment Followup Period|Adverse Event|0|||
42219544|NCT03364309|76037550|FG009|Post-Treatment Followup Period|Adverse Event|0|||
42219545|NCT03364309|76037551|FG010|Post-Treatment Followup Period|Adverse Event|0|||
42219546|NCT03364309|76037552|FG011|Post-Treatment Followup Period|Adverse Event|0|||
42219547|NCT03364309|76037553|FG012|Post-Treatment Followup Period|Adverse Event|0|||
42219548|NCT03364309|76037554|FG013|Post-Treatment Followup Period|Adverse Event|0|||
42219549|NCT03364309|76037555|FG014|Post-Treatment Followup Period|Adverse Event|0|||
42219550|NCT03364309|76037556|FG015|Post-Treatment Followup Period|Adverse Event|0|||
42219551|NCT03364309|76037557|FG016|Post-Treatment Followup Period|Adverse Event|2|||
42302211|NCT02495077|76137272|FG002|Overall Study|Screen Failure|0|||
41981126|NCT01081795|75786811|FG001|Overall Study|Revocation of informed consent|0|||
41981127|NCT01081795|75786812|FG002|Overall Study|Revocation of informed consent|0|||
42302212|NCT02495077|76137273|FG003|Overall Study|Screen Failure|48|||
41981128|NCT01081795|75786810|FG000|Overall Study|Ineligible for participation|1|||
41981129|NCT01081795|75786811|FG001|Overall Study|Ineligible for participation|0|||
41981130|NCT01081795|75786812|FG002|Overall Study|Ineligible for participation|0|||
41981131|NCT01081795|75786810|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
41981132|NCT01081795|75786811|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
41981133|NCT01081795|75786812|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
41981134|NCT01081795|75786810|FG000|Overall Study|Using drug with restricted days of use|2|||
41981135|NCT01081795|75786811|FG001|Overall Study|Using drug with restricted days of use|3|||
41981136|NCT01081795|75786812|FG002|Overall Study|Using drug with restricted days of use|2|||
41981137|NCT01081795|75786810|FG000|Overall Study|Other|1|||
41981138|NCT01081795|75786811|FG001|Overall Study|Other|2|||
41981139|NCT01081795|75786812|FG002|Overall Study|Other|0|||
41981140|NCT01081678|75786824|FG000|Overall Study|Ineligibility Determined|0|||
41981141|NCT01081678|75786825|FG001|Overall Study|Ineligibility Determined|0|||
41981142|NCT01081678|75786826|FG002|Overall Study|Ineligibility Determined|1|||
41981143|NCT01081678|75786827|FG003|Overall Study|Ineligibility Determined|1|||
41981144|NCT01081678|75786824|FG000|Overall Study|Noncompliance|3|||
41981145|NCT01081678|75786825|FG001|Overall Study|Noncompliance|4|||
41981146|NCT01081678|75786826|FG002|Overall Study|Noncompliance|5|||
41981147|NCT01081678|75786827|FG003|Overall Study|Noncompliance|2|||
41981148|NCT01081678|75786824|FG000|Overall Study|Adverse Event|2|||
41981149|NCT01081678|75786825|FG001|Overall Study|Adverse Event|1|||
41981150|NCT01081678|75786826|FG002|Overall Study|Adverse Event|2|||
41981151|NCT01081678|75786827|FG003|Overall Study|Adverse Event|2|||
41981152|NCT01081678|75786824|FG000|Overall Study|Withdrawal by Subject|15|||
41981153|NCT01081678|75786825|FG001|Overall Study|Withdrawal by Subject|7|||
41981154|NCT01081678|75786826|FG002|Overall Study|Withdrawal by Subject|17|||
41981155|NCT01081678|75786827|FG003|Overall Study|Withdrawal by Subject|14|||
41981156|NCT01081678|75786824|FG000|Overall Study|Administrative Decision|1|||
41981157|NCT01081678|75786825|FG001|Overall Study|Administrative Decision|0|||
41981158|NCT01081678|75786826|FG002|Overall Study|Administrative Decision|0|||
41981159|NCT01081678|75786827|FG003|Overall Study|Administrative Decision|1|||
41981160|NCT01081678|75786824|FG000|Overall Study|Lost to Follow-up|4|||
41981161|NCT01081678|75786825|FG001|Overall Study|Lost to Follow-up|1|||
41981162|NCT01081678|75786826|FG002|Overall Study|Lost to Follow-up|4|||
41981163|NCT01081678|75786827|FG003|Overall Study|Lost to Follow-up|3|||
41981164|NCT01081678|75786824|FG000|Overall Study|Death|2|||
41981165|NCT01081678|75786825|FG001|Overall Study|Death|2|||
41981166|NCT01081678|75786826|FG002|Overall Study|Death|2|||
41981167|NCT01081678|75786827|FG003|Overall Study|Death|6|||
41981168|NCT01081678|75786824|FG000|Overall Study|Other|0|||
41981169|NCT01081678|75786825|FG001|Overall Study|Other|1|||
41981170|NCT01081678|75786826|FG002|Overall Study|Other|0|||
41981171|NCT01081678|75786827|FG003|Overall Study|Other|0|||
41981172|NCT01081249|75786837|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
41981173|NCT01081249|75786838|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
41981174|NCT01081132|75786846|FG000|Overall Study|Lack of Efficacy|25|||
41981175|NCT01081132|75786847|FG001|Overall Study|Lack of Efficacy|9|||
41981176|NCT01081132|75786846|FG000|Overall Study|Withdrawal by Subject|13|||
41981177|NCT01081132|75786847|FG001|Overall Study|Withdrawal by Subject|16|||
41981178|NCT01081132|75786846|FG000|Overall Study|Lost to Follow-up|4|||
41981179|NCT01081132|75786847|FG001|Overall Study|Lost to Follow-up|11|||
41981180|NCT01081132|75786846|FG000|Overall Study|Adverse Event|3|||
41981181|NCT01081132|75786847|FG001|Overall Study|Adverse Event|9|||
41981182|NCT01081132|75786846|FG000|Overall Study|Non Compliance|4|||
41981183|NCT01081132|75786847|FG001|Overall Study|Non Compliance|2|||
41981184|NCT01081132|75786846|FG000|Overall Study|Lack Of Compliance|0|||
41981185|NCT01081132|75786847|FG001|Overall Study|Lack Of Compliance|1|||
41981186|NCT01081132|75786846|FG000|Overall Study|Missed Visits|1|||
41981187|NCT01081132|75786847|FG001|Overall Study|Missed Visits|1|||
41981188|NCT01081132|75786846|FG000|Overall Study|Stopped Taking Meds|2|||
41981189|NCT01081132|75786847|FG001|Overall Study|Stopped Taking Meds|0|||
42302213|NCT02495077|76137270|FG000|Overall Study|Withdrawal by Subject|7|||
42302214|NCT02495077|76137271|FG001|Overall Study|Withdrawal by Subject|7|||
42302215|NCT02495077|76137272|FG002|Overall Study|Withdrawal by Subject|7|||
41981190|NCT01081132|75786846|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
41981191|NCT01081132|75786847|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
41981192|NCT01081132|75786846|FG000|Overall Study|Declined Taper Phase|0|||
41981193|NCT01081132|75786847|FG001|Overall Study|Declined Taper Phase|1|||
41981194|NCT01081132|75786846|FG000|Overall Study|Protocol Violation|3|||
41981195|NCT01081132|75786847|FG001|Overall Study|Protocol Violation|1|||
41981196|NCT01080625|75786856|FG000|Overall Study|Physician Decision|0|||
41981197|NCT01080625|75786857|FG001|Overall Study|Physician Decision|2|||
41981198|NCT01080625|75786858|FG002|Overall Study|Physician Decision|1|||
41981199|NCT01059903|75786868|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
41981200|NCT01059903|75786869|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
41981201|NCT05562011|75786904|FG000|Overall Study|Withdrawal by Subject|3|||
42028644|NCT00959049|75837043|FG000|Overall Study|Withdrawal by Subject|0|||
41981202|NCT05562011|75786904|FG000|Overall Study|Lost to Follow-up|1|||
41981203|NCT05562011|75786904|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
41981204|NCT05562011|75786904|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
41981205|NCT05562011|75786904|FG000|Overall Study|Device malfunction|13|||
41981206|NCT05089708|75786963|FG000|Overall Study|Lost to Follow-up|9|||
41981207|NCT05089708|75786964|FG001|Overall Study|Lost to Follow-up|7|||
41981208|NCT05089708|75786963|FG000|Overall Study|Withdrawal by Subject|3|||
41981209|NCT05089708|75786964|FG001|Overall Study|Withdrawal by Subject|1|||
41981210|NCT05089708|75786963|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
41981211|NCT05089708|75786964|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
41981212|NCT05089708|75786963|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
41981213|NCT05089708|75786964|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
41981214|NCT04642638|75787016|FG000|Overall Study|Withdrawal by Subject|23|||
41981215|NCT04642638|75787017|FG001|Overall Study|Withdrawal by Subject|29|||
41981216|NCT04642638|75787018|FG002|Overall Study|Withdrawal by Subject|9|||
41981217|NCT04642638|75787019|FG003|Overall Study|Withdrawal by Subject|7|||
41981218|NCT04642638|75787020|FG004|Overall Study|Withdrawal by Subject|61|||
41981219|NCT04642638|75787021|FG005|Overall Study|Withdrawal by Subject|27|||
41981220|NCT04642638|75787016|FG000|Overall Study|Lost to Follow-up|17|||
41981221|NCT04642638|75787017|FG001|Overall Study|Lost to Follow-up|18|||
41981222|NCT04642638|75787018|FG002|Overall Study|Lost to Follow-up|5|||
41981223|NCT04642638|75787019|FG003|Overall Study|Lost to Follow-up|5|||
41981224|NCT04642638|75787020|FG004|Overall Study|Lost to Follow-up|6|||
41981225|NCT04642638|75787021|FG005|Overall Study|Lost to Follow-up|3|||
41981226|NCT04642638|75787016|FG000|Overall Study|Adverse Event|0|||
41981227|NCT04642638|75787017|FG001|Overall Study|Adverse Event|0|||
41981228|NCT04642638|75787018|FG002|Overall Study|Adverse Event|1|||
41981229|NCT04642638|75787019|FG003|Overall Study|Adverse Event|0|||
41981230|NCT04642638|75787020|FG004|Overall Study|Adverse Event|10|||
41981231|NCT04642638|75787021|FG005|Overall Study|Adverse Event|3|||
41981232|NCT04642638|75787016|FG000|Overall Study|Reason Not Specified|1|||
41981233|NCT04642638|75787017|FG001|Overall Study|Reason Not Specified|4|||
41981234|NCT04642638|75787018|FG002|Overall Study|Reason Not Specified|0|||
41981235|NCT04642638|75787019|FG003|Overall Study|Reason Not Specified|0|||
41981236|NCT04642638|75787020|FG004|Overall Study|Reason Not Specified|38|||
41981237|NCT04642638|75787021|FG005|Overall Study|Reason Not Specified|16|||
41981238|NCT04642638|75787016|FG000|Overall Study|Physician Decision|0|||
41981239|NCT04642638|75787017|FG001|Overall Study|Physician Decision|0|||
41981240|NCT04642638|75787018|FG002|Overall Study|Physician Decision|0|||
41981241|NCT04642638|75787019|FG003|Overall Study|Physician Decision|0|||
41981242|NCT04642638|75787020|FG004|Overall Study|Physician Decision|2|||
41981243|NCT04642638|75787021|FG005|Overall Study|Physician Decision|1|||
41981244|NCT04642638|75787016|FG000|Overall Study|Protocol Deviation|0|||
41981245|NCT04642638|75787017|FG001|Overall Study|Protocol Deviation|0|||
41981246|NCT04642638|75787018|FG002|Overall Study|Protocol Deviation|0|||
41981247|NCT04642638|75787019|FG003|Overall Study|Protocol Deviation|0|||
41981248|NCT04642638|75787020|FG004|Overall Study|Protocol Deviation|1|||
41981249|NCT04642638|75787021|FG005|Overall Study|Protocol Deviation|3|||
41981250|NCT04642638|75787016|FG000|Overall Study|Study Terminated|0|||
41981251|NCT04642638|75787017|FG001|Overall Study|Study Terminated|0|||
41981252|NCT04642638|75787018|FG002|Overall Study|Study Terminated|0|||
41981253|NCT04642638|75787019|FG003|Overall Study|Study Terminated|0|||
41981254|NCT04642638|75787020|FG004|Overall Study|Study Terminated|484|||
41981255|NCT04642638|75787021|FG005|Overall Study|Study Terminated|250|||
41981256|NCT04642638|75787016|FG000|Overall Study|Pregnancy|0|||
41981257|NCT04642638|75787017|FG001|Overall Study|Pregnancy|0|||
41981258|NCT04642638|75787018|FG002|Overall Study|Pregnancy|0|||
41981259|NCT04642638|75787019|FG003|Overall Study|Pregnancy|0|||
41981260|NCT04642638|75787020|FG004|Overall Study|Pregnancy|1|||
41981261|NCT04642638|75787021|FG005|Overall Study|Pregnancy|0|||
41981262|NCT04634825|75787039|FG000|Overall Study|Death|10|||
41981263|NCT04634825|75787040|FG001|Overall Study|Death|3|||
41981264|NCT04634825|75787039|FG000|Overall Study|Lost to Follow-up|1|||
41981265|NCT04634825|75787040|FG001|Overall Study|Lost to Follow-up|0|||
41981266|NCT04634825|75787039|FG000|Overall Study|Study terminated by sponsor|35|||
41981267|NCT04634825|75787040|FG001|Overall Study|Study terminated by sponsor|11|||
41981268|NCT04634825|75787039|FG000|Overall Study|Withdrawal by Subject|2|||
41981269|NCT04634825|75787040|FG001|Overall Study|Withdrawal by Subject|0|||
41981270|NCT04398537|75787054|FG000|Overall Study|Physician Decision|10|||
41981271|NCT04398537|75787055|FG001|Overall Study|Physician Decision|15|||
41981272|NCT04176939|75787075|FG000|Overall Study|Adverse Event|7|||
41981273|NCT04176939|75787075|FG000|Overall Study|Unspecified reason|2|||
41981274|NCT04176939|75787075|FG000|Overall Study|Migrated/Moved from the study area|1|||
41981275|NCT04176939|75787075|FG000|Overall Study|Withdrawal by Subject|4|||
41981276|NCT04176939|75787075|FG000|Overall Study|In follow-up|54|||
41981277|NCT04146909|75787081|FG000|Overall Study|Withdrawal by Subject|3|||
42219552|NCT03364309|76037558|FG017|Post-Treatment Followup Period|Adverse Event|6|||
42219553|NCT03364309|76037559|FG018|Post-Treatment Followup Period|Adverse Event|1|||
42219554|NCT03364309|76037541|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219555|NCT03364309|76037542|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219556|NCT03364309|76037543|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219557|NCT03364309|76037544|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219558|NCT03364309|76037545|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219559|NCT03364309|76037546|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219560|NCT03364309|76037547|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219561|NCT03364309|76037548|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219562|NCT03364309|76037549|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219563|NCT03364309|76037550|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219564|NCT03364309|76037551|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219565|NCT03364309|76037552|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219566|NCT03364309|76037553|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219567|NCT03364309|76037554|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219568|NCT03364309|76037555|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219569|NCT03364309|76037556|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219570|NCT03364309|76037557|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219571|NCT03364309|76037558|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
42219572|NCT03364309|76037559|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
42219573|NCT03364309|76037541|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
42219574|NCT03364309|76037542|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
42219575|NCT03364309|76037543|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
42219576|NCT03364309|76037544|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
42219577|NCT03364309|76037545|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
42219578|NCT03364309|76037546|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
42219579|NCT03364309|76037547|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
42219580|NCT03364309|76037548|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
42219581|NCT03364309|76037549|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
42219582|NCT03364309|76037550|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
42219583|NCT03364309|76037551|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
42219584|NCT03364309|76037552|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
42219585|NCT03364309|76037553|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
42219586|NCT03364309|76037554|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
42219587|NCT03364309|76037555|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
42219588|NCT03364309|76037556|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
42219589|NCT03364309|76037557|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
42219590|NCT03364309|76037558|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
42219591|NCT03364309|76037559|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
42219592|NCT03334903|76037585|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
42219593|NCT03334903|76037586|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
42219594|NCT03334903|76037585|FG000|Overall Study|Protocol Violation|1|||
42219595|NCT03334903|76037586|FG001|Overall Study|Protocol Violation|3|||
42219596|NCT03334903|76037585|FG000|Overall Study|Surgery postponed|1|||
42219597|NCT03334903|76037586|FG001|Overall Study|Surgery postponed|0|||
42219598|NCT03334903|76037585|FG000|Overall Study|Adverse Event|1|||
42219599|NCT03334903|76037586|FG001|Overall Study|Adverse Event|1|||
42219600|NCT03334903|76037585|FG000|Overall Study|Withdrawal by Subject|0|||
42219601|NCT03334903|76037586|FG001|Overall Study|Withdrawal by Subject|1|||
42219602|NCT01353664|76037592|FG000|Overall Study|Other|3|||
42219603|NCT01353664|76037592|FG000|Overall Study|Disease Progression|16|||
42219604|NCT02694328|76037598|FG000|Overall Study|Adverse Event|27|||
42219605|NCT02694328|76037599|FG001|Overall Study|Adverse Event|33|||
42219606|NCT02694328|76037598|FG000|Overall Study|Withdrawal by Subject|27|||
42130280|NCT00606593|75941151|FG000|Overall Study|Administrative/Other|0|||
42130281|NCT00606593|75941152|FG001|Overall Study|Administrative/Other|0|||
42130282|NCT00606593|75941153|FG002|Overall Study|Administrative/Other|1|||
42130283|NCT00606593|75941154|FG003|Overall Study|Administrative/Other|0|||
42130284|NCT00606593|75941155|FG004|Overall Study|Administrative/Other|0|||
42130285|NCT00606593|75941156|FG005|Overall Study|Administrative/Other|0|||
42130286|NCT00606593|75941157|FG006|Overall Study|Administrative/Other|0|||
42130287|NCT00606593|75941158|FG007|Overall Study|Administrative/Other|0|||
42130288|NCT00606593|75941159|FG008|Overall Study|Administrative/Other|0|||
42130289|NCT00606593|75941160|FG009|Overall Study|Administrative/Other|0|||
42130290|NCT00605267|75941175|FG000|Overall Study|Adverse Event|0|||
42130291|NCT00605267|75941176|FG001|Overall Study|Adverse Event|1|||
42130292|NCT00605267|75941175|FG000|Overall Study|Lack of Efficacy|1|||
42130293|NCT00605267|75941176|FG001|Overall Study|Lack of Efficacy|5|||
42130294|NCT00605267|75941175|FG000|Overall Study|Withdrawal by Subject|2|||
41981278|NCT04146909|75787081|FG000|Overall Study|Did not qualify after consented|1|||
41981279|NCT03894891|75787103|FG000|Overall Study|Withdrawal by Subject|1|||
41981280|NCT03894891|75787103|FG000|Overall Study|Completed protocol treatment per protocol|5|||
41981281|NCT03863080|75787110|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
41981282|NCT03863080|75787111|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
41981283|NCT03863080|75787112|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
41981284|NCT03863080|75787113|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
41981285|NCT03863080|75787110|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
41981286|NCT03863080|75787111|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
41981287|NCT03863080|75787112|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
41981288|NCT03863080|75787113|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
41981289|NCT03863080|75787110|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
41981290|NCT03863080|75787111|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
41981291|NCT03863080|75787112|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
42028645|NCT00959049|75837044|FG001|Overall Study|Withdrawal by Subject|2|||
42028646|NCT00959049|75837045|FG002|Overall Study|Withdrawal by Subject|0|||
42028647|NCT00959049|75837046|FG003|Overall Study|Withdrawal by Subject|0|||
42028648|NCT00959049|75837047|FG004|Overall Study|Withdrawal by Subject|0|||
42028649|NCT00959049|75837048|FG005|Overall Study|Withdrawal by Subject|0|||
42028650|NCT00956943|75837075|FG000|Overall Study|Lost to Follow-up|9|||
41981292|NCT03863080|75787113|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
41981293|NCT03834493|75787128|FG000|Overall Study|Participants Ongoing|311|||
41981294|NCT03834493|75787129|FG001|Overall Study|Participants Ongoing|324|||
41981295|NCT03834493|75787128|FG000|Overall Study|Withdrawal by Subject|20|||
41981296|NCT03834493|75787129|FG001|Overall Study|Withdrawal by Subject|17|||
41981297|NCT03834493|75787128|FG000|Overall Study|Physician Decision|1|||
41981298|NCT03834493|75787129|FG001|Overall Study|Physician Decision|0|||
42028651|NCT00956943|75837076|FG001|Overall Study|Lost to Follow-up|10|||
42028652|NCT00958893|75837082|FG000|Overall Study|Study prematurely terminated|4|||
42028653|NCT01135914|75837089|FG000|Overall Study|Withdrawal by Subject|1|||
42028654|NCT01135914|75837090|FG001|Overall Study|Withdrawal by Subject|3|||
42028655|NCT01135914|75837091|FG002|Overall Study|Withdrawal by Subject|6|||
42028656|NCT01135914|75837089|FG000|Overall Study|Lost to Follow-up|1|||
42028657|NCT01135914|75837090|FG001|Overall Study|Lost to Follow-up|0|||
42028658|NCT01135914|75837091|FG002|Overall Study|Lost to Follow-up|1|||
42028659|NCT01135914|75837089|FG000|Overall Study|Protocol Violation|0|||
42028660|NCT01135914|75837090|FG001|Overall Study|Protocol Violation|0|||
42028661|NCT01135914|75837091|FG002|Overall Study|Protocol Violation|3|||
42028662|NCT01135914|75837089|FG000|Overall Study|Lack of Efficacy|2|||
42028663|NCT01135914|75837090|FG001|Overall Study|Lack of Efficacy|1|||
42028664|NCT01135914|75837091|FG002|Overall Study|Lack of Efficacy|10|||
42028665|NCT01135914|75837089|FG000|Overall Study|Adverse Event|0|||
41981299|NCT03834493|75787128|FG000|Overall Study|Death|289|||
42028666|NCT01135914|75837090|FG001|Overall Study|Adverse Event|1|||
42028667|NCT01135914|75837091|FG002|Overall Study|Adverse Event|2|||
42028668|NCT00907738|75837104|FG000|Overall Study|Adverse Event|2|||
42028669|NCT00907738|75837105|FG001|Overall Study|Adverse Event|0|||
42028670|NCT00907738|75837106|FG002|Overall Study|Adverse Event|1|||
42028671|NCT00907738|75837107|FG003|Overall Study|Adverse Event|0|||
42028672|NCT00907738|75837108|FG004|Overall Study|Adverse Event|0|||
42028673|NCT00907738|75837104|FG000|Overall Study|not specified or withdrew consent|3|||
42028674|NCT00907738|75837105|FG001|Overall Study|not specified or withdrew consent|0|||
42302216|NCT02495077|76137273|FG003|Overall Study|Withdrawal by Subject|0|||
42302217|NCT02495077|76137270|FG000|Overall Study|Covid-19 research restrictions|1|||
41981300|NCT03834493|75787129|FG001|Overall Study|Death|282|||
41981301|NCT03569891|75787136|FG000|Lead-in|Ineligible during lead-in|8|||
41981302|NCT03569891|75787136|FG000|Lead-in|Withdrawal by Subject|3|||
42028675|NCT00907738|75837106|FG002|Overall Study|not specified or withdrew consent|0|||
42028676|NCT00907738|75837107|FG003|Overall Study|not specified or withdrew consent|0|||
42028677|NCT00907738|75837108|FG004|Overall Study|not specified or withdrew consent|0|||
42028678|NCT00907738|75837104|FG000|Overall Study|Disease progression|8|||
42028679|NCT00907738|75837105|FG001|Overall Study|Disease progression|1|||
42028680|NCT00907738|75837106|FG002|Overall Study|Disease progression|6|||
42028681|NCT00907738|75837107|FG003|Overall Study|Disease progression|4|||
42028682|NCT00907738|75837108|FG004|Overall Study|Disease progression|2|||
41981303|NCT03569891|75787136|FG000|Lead-in|Risks related to COVID-19|2|||
42028683|NCT01123356|75837124|FG000|Overall Study|Adverse Event|2|||
42028684|NCT01123356|75837124|FG000|Overall Study|Lack of Efficacy|4|||
42028685|NCT01123356|75837124|FG000|Overall Study|Withdrawal by Subject|1|||
42028686|NCT00908596|75837133|FG000|Overall Study|Other reasons|46|||
42028687|NCT00908596|75837134|FG001|Overall Study|Other reasons|6|||
41981304|NCT03569891|75787136|FG000|AMT-061|Adverse Event|1|||
41981305|NCT03483103|75787145|FG000|Pre-Treatment Phase|Other reasons|1|||
41981306|NCT03483103|75787145|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
41981307|NCT03483103|75787145|FG000|Pre-Treatment Phase|Disease-related complications|1|||
41981308|NCT03483103|75787145|FG000|Pre-Treatment Phase|Death|5|||
41981309|NCT03483103|75787145|FG000|Treatment Phase|Withdrawal by Subject|7|||
41981310|NCT03483103|75787145|FG000|Treatment Phase|Other reasons|1|||
41981311|NCT03483103|75787145|FG000|Treatment Phase|Death|23|||
41981312|NCT03483103|75787145|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
41981313|NCT03483103|75787145|FG000|Treatment Phase|Received nonconforming product|1|||
41981314|NCT03412747|75787161|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
41981315|NCT03412747|75787162|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
42028688|NCT00908596|75837135|FG002|Overall Study|Other reasons|2|||
41981316|NCT03412747|75787163|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
41981317|NCT03412747|75787161|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
41981318|NCT03412747|75787162|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
41981319|NCT03412747|75787163|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
41981320|NCT03412747|75787161|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
41981321|NCT03412747|75787162|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
41981322|NCT03412747|75787163|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
41981323|NCT03412747|75787161|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
41981324|NCT03412747|75787162|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
41981325|NCT03412747|75787163|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
41981326|NCT03412747|75787161|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
41981327|NCT03412747|75787162|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
41981328|NCT03412747|75787163|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
41981329|NCT03412747|75787161|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
41981330|NCT03412747|75787162|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
41981331|NCT03412747|75787163|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
41981332|NCT03412747|75787161|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
41981333|NCT03412747|75787162|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
42028689|NCT00908596|75837136|FG003|Overall Study|Other reasons|0|||
42028690|NCT00908596|75837133|FG000|Overall Study|Lost to Follow-up|0|||
42028691|NCT00908596|75837134|FG001|Overall Study|Lost to Follow-up|1|||
42028692|NCT00908596|75837135|FG002|Overall Study|Lost to Follow-up|12|||
42028693|NCT00908596|75837136|FG003|Overall Study|Lost to Follow-up|4|||
42028694|NCT00908596|75837133|FG000|Overall Study|Death|0|||
42028695|NCT00908596|75837134|FG001|Overall Study|Death|5|||
42028696|NCT00908596|75837135|FG002|Overall Study|Death|57|||
42028697|NCT00908596|75837136|FG003|Overall Study|Death|32|||
42028698|NCT00908596|75837133|FG000|Overall Study|Protocol Violation|1|||
42028699|NCT00908596|75837134|FG001|Overall Study|Protocol Violation|0|||
42028700|NCT00908596|75837135|FG002|Overall Study|Protocol Violation|0|||
42028701|NCT00908596|75837136|FG003|Overall Study|Protocol Violation|0|||
42028702|NCT00908596|75837133|FG000|Overall Study|Withdrawal by Subject|0|||
42028703|NCT00908596|75837134|FG001|Overall Study|Withdrawal by Subject|1|||
42028704|NCT00908596|75837135|FG002|Overall Study|Withdrawal by Subject|3|||
41981334|NCT03412747|75787163|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
41981335|NCT03412747|75787161|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
41981336|NCT03412747|75787162|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
41981337|NCT03412747|75787163|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
41981338|NCT03412747|75787161|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
41981339|NCT03412747|75787162|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
42028705|NCT00908596|75837136|FG003|Overall Study|Withdrawal by Subject|1|||
42028706|NCT01118052|75837146|FG000|Overall Study|Never treated|2|||
42130295|NCT00605267|75941176|FG001|Overall Study|Withdrawal by Subject|3|||
42130296|NCT00605813|75941182|FG000|Overall Study|Protocol Violation|25|||
42028707|NCT01123200|75837156|FG000|Overall Study|Withdrawal by Subject|1|||
42028708|NCT00955617|75837160|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
42028709|NCT00955617|75837161|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
41981340|NCT03412747|75787163|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
41981341|NCT03412747|75787161|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
41981342|NCT03412747|75787162|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
41981343|NCT03412747|75787163|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
41981344|NCT03412747|75787161|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
41981345|NCT03412747|75787162|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
41981346|NCT03412747|75787163|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
41981347|NCT03412747|75787161|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
41981348|NCT03412747|75787162|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
41981349|NCT03412747|75787163|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
41981350|NCT03412747|75787161|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
41981351|NCT03412747|75787162|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
41981352|NCT03412747|75787163|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
41981353|NCT03412747|75787161|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
41981354|NCT03412747|75787162|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
41981355|NCT03412747|75787163|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
41981356|NCT03412747|75787161|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
41981357|NCT03412747|75787162|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
42028710|NCT00955617|75837160|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
42028711|NCT00955617|75837161|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
42028712|NCT00955617|75837160|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
42028713|NCT00955617|75837161|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
42028714|NCT00955617|75837160|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
42028715|NCT00955617|75837161|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
42028716|NCT00958347|75837167|FG000|Overall Study|Death|43|||
42028717|NCT00958347|75837167|FG000|Overall Study|Withdrawal by Subject|23|||
42028718|NCT00958347|75837167|FG000|Overall Study|Lost to Follow-up|15|||
42028719|NCT00958347|75837167|FG000|Overall Study|revision/removal|10|||
42028720|NCT00958347|75837167|FG000|Overall Study|study termination|135|||
42028721|NCT00958191|75837171|FG000|Overall Study|Death|4|||
42028722|NCT00958191|75837171|FG000|Overall Study|Lost to Follow-up|5|||
42028723|NCT00958191|75837171|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
42028724|NCT00958191|75837171|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
42028725|NCT00958191|75837171|FG000|Overall Study|Revision of study device|4|||
42028726|NCT00958191|75837171|FG000|Overall Study|Site termination|11|||
42028727|NCT00958191|75837171|FG000|Overall Study|No 5 yr x-rays|56|||
42028728|NCT00960843|75837179|FG000|Overall Study|Lost to Follow-up|2|||
42028729|NCT00960843|75837180|FG001|Overall Study|Lost to Follow-up|0|||
42028730|NCT00960843|75837179|FG000|Overall Study|Protocol Violation|0|||
42028731|NCT00960843|75837180|FG001|Overall Study|Protocol Violation|4|||
42028732|NCT00960843|75837179|FG000|Overall Study|Repeated needle dislodgment|0|||
42028733|NCT00960843|75837180|FG001|Overall Study|Repeated needle dislodgment|1|||
42028734|NCT01605253|75837188|FG000|Overall Study|Physician Decision|3|||
42028735|NCT01605253|75837189|FG001|Overall Study|Physician Decision|2|||
42028736|NCT01605253|75837188|FG000|Overall Study|Lost to Follow-up|3|||
42028737|NCT01605253|75837189|FG001|Overall Study|Lost to Follow-up|1|||
42028738|NCT00955305|75837199|FG000|Overall Study|Disease progression|39|||
42028739|NCT00955305|75837200|FG001|Overall Study|Disease progression|41|||
42028740|NCT00955305|75837199|FG000|Overall Study|Adverse Event|22|||
42028741|NCT00955305|75837200|FG001|Overall Study|Adverse Event|22|||
42028742|NCT00955305|75837199|FG000|Overall Study|Death|2|||
42028743|NCT00955305|75837200|FG001|Overall Study|Death|1|||
42028744|NCT00955305|75837199|FG000|Overall Study|Withdrawal by Subject|5|||
42028745|NCT00955305|75837200|FG001|Overall Study|Withdrawal by Subject|4|||
41981358|NCT03412747|75787163|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
41981359|NCT03412747|75787161|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
41981360|NCT03412747|75787162|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
41981361|NCT03412747|75787163|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
41981362|NCT03410992|75787183|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
42028746|NCT00955305|75837199|FG000|Overall Study|Alternative therapy|4|||
42028747|NCT00955305|75837200|FG001|Overall Study|Alternative therapy|0|||
42028748|NCT00955305|75837199|FG000|Overall Study|Other complicating disease|2|||
42028749|NCT00955305|75837200|FG001|Overall Study|Other complicating disease|4|||
42028750|NCT00955305|75837199|FG000|Overall Study|Physician Decision|1|||
42028751|NCT00955305|75837200|FG001|Overall Study|Physician Decision|0|||
42028752|NCT00955305|75837199|FG000|Overall Study|Continued presence of residual disease|0|||
42028753|NCT00955305|75837200|FG001|Overall Study|Continued presence of residual disease|1|||
42028754|NCT00955305|75837199|FG000|Overall Study|Functional decline|2|||
42028755|NCT00955305|75837200|FG001|Overall Study|Functional decline|0|||
42028756|NCT00955305|75837199|FG000|Overall Study|Maximum response achieved|0|||
42028757|NCT00955305|75837200|FG001|Overall Study|Maximum response achieved|1|||
42028758|NCT00955305|75837199|FG000|Overall Study|Lost to Follow-up|0|||
42028759|NCT00955305|75837200|FG001|Overall Study|Lost to Follow-up|1|||
42028760|NCT00955305|75837199|FG000|Overall Study|No off-treatment reason submitted|1|||
42028761|NCT00955305|75837200|FG001|Overall Study|No off-treatment reason submitted|0|||
42028762|NCT00955305|75837199|FG000|Overall Study|Never started protocol treatment|5|||
42028763|NCT00955305|75837200|FG001|Overall Study|Never started protocol treatment|5|||
42028764|NCT00955305|75837199|FG000|Overall Study|Ineligible|5|||
42028765|NCT00955305|75837200|FG001|Overall Study|Ineligible|7|||
42028766|NCT00598585|75837208|FG000|Overall Study|Lost to Follow-up|1|||
42028767|NCT00598585|75837209|FG001|Overall Study|Lost to Follow-up|0|||
42028768|NCT00953667|75837215|FG000|Overall Study|Lost to Follow-up|11|||
42028769|NCT00953667|75837215|FG000|Overall Study|Physician Decision|35|||
42028770|NCT00953667|75837215|FG000|Overall Study|Withdrawal by Subject|63|||
42028771|NCT00953667|75837215|FG000|Overall Study|Adverse Event|10|||
42028772|NCT00953667|75837215|FG000|Overall Study|poor venous access,unable to draw blood|4|||
42028773|NCT00883129|75837221|FG000|Overall Study|Adverse Event|7|||
42130297|NCT00604721|75941195|FG000|Overall Study|Physician Decision|1|||
41981363|NCT03410992|75787184|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
41981364|NCT03410992|75787185|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
41981365|NCT03410992|75787186|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
41981366|NCT03410992|75787187|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
41981367|NCT03410992|75787188|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
41981368|NCT03410992|75787189|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
41981369|NCT03410992|75787190|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
41981370|NCT03410992|75787191|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
41981371|NCT03410992|75787192|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
42028774|NCT00883129|75837222|FG001|Overall Study|Adverse Event|15|||
42130298|NCT00604721|75941195|FG000|Overall Study|Withdrawal by Subject|1|||
42028775|NCT00883129|75837221|FG000|Overall Study|Withdrawal by Subject|8|||
42028776|NCT00883129|75837222|FG001|Overall Study|Withdrawal by Subject|9|||
42028777|NCT00883129|75837221|FG000|Overall Study|Non-compliance|3|||
42028778|NCT00883129|75837222|FG001|Overall Study|Non-compliance|6|||
42130299|NCT00605657|75941200|FG000|Overall Study|Adverse Event|1|||
42130300|NCT00605657|75941200|FG000|Overall Study|Protocol Violation|1|||
42130301|NCT00604565|75941206|FG000|Overall Study|Study terminated|0|||
42130302|NCT00604565|75941207|FG001|Overall Study|Study terminated|3|||
42028779|NCT00883129|75837221|FG000|Overall Study|Lost to Follow-up|1|||
42130303|NCT00605345|75941215|FG000|Overall Study|Withdrawal by Subject|1|||
42028780|NCT00883129|75837222|FG001|Overall Study|Lost to Follow-up|2|||
42028781|NCT00883129|75837221|FG000|Overall Study|Death|1|||
42028782|NCT00883129|75837222|FG001|Overall Study|Death|2|||
42028783|NCT00883129|75837221|FG000|Overall Study|Defined Treatment Failure|0|||
42028784|NCT00883129|75837222|FG001|Overall Study|Defined Treatment Failure|2|||
42028785|NCT00905632|75837253|FG000|Overall Study|Adverse Event|0|||
42028786|NCT00905632|75837254|FG001|Overall Study|Adverse Event|0|||
42028787|NCT00905632|75837255|FG002|Overall Study|Adverse Event|0|||
42028788|NCT00905632|75837256|FG003|Overall Study|Adverse Event|0|||
42028789|NCT00905632|75837257|FG004|Overall Study|Adverse Event|0|||
42028790|NCT00905632|75837258|FG005|Overall Study|Adverse Event|1|||
42028791|NCT00905632|75837259|FG006|Overall Study|Adverse Event|4|||
42028792|NCT00954447|75837284|FG000|Overall Study|Adverse Event|33|||
42028793|NCT00954447|75837285|FG001|Overall Study|Adverse Event|25|||
42028794|NCT00954447|75837284|FG000|Overall Study|Lack of Efficacy|17|||
42028795|NCT00954447|75837285|FG001|Overall Study|Lack of Efficacy|3|||
42028796|NCT00954447|75837284|FG000|Overall Study|Protocol Violation|5|||
42028797|NCT00954447|75837285|FG001|Overall Study|Protocol Violation|7|||
42028798|NCT00954447|75837284|FG000|Overall Study|Lost to Follow-up|8|||
42028799|NCT00954447|75837285|FG001|Overall Study|Lost to Follow-up|14|||
42028800|NCT00954447|75837284|FG000|Overall Study|Withdrawal by Subject|26|||
42028801|NCT00954447|75837285|FG001|Overall Study|Withdrawal by Subject|21|||
42028802|NCT00954447|75837284|FG000|Overall Study|Other|21|||
42028803|NCT00954447|75837285|FG001|Overall Study|Other|18|||
42028804|NCT00904150|75837293|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
42028805|NCT00904150|75837294|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
42028806|NCT00904150|75837293|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
42028807|NCT00904150|75837294|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
42028808|NCT00903760|75837302|FG000|Overall Study|Disease Progression/Death|8|||
42028809|NCT00903760|75837303|FG001|Overall Study|Disease Progression/Death|6|||
42028810|NCT00903760|75837302|FG000|Overall Study|Stem Cell Transplant|8|||
42028811|NCT00903760|75837303|FG001|Overall Study|Stem Cell Transplant|4|||
42028812|NCT00903760|75837302|FG000|Overall Study|Physician Decision|1|||
42028813|NCT00903760|75837303|FG001|Overall Study|Physician Decision|2|||
42028814|NCT00903760|75837302|FG000|Overall Study|Death|0|||
42028815|NCT00903760|75837303|FG001|Overall Study|Death|1|||
42028816|NCT00903760|75837302|FG000|Overall Study|Lost to Follow-up|1|||
42028817|NCT00903760|75837303|FG001|Overall Study|Lost to Follow-up|0|||
42130304|NCT00605345|75941216|FG001|Overall Study|Withdrawal by Subject|0|||
42130305|NCT00605345|75941215|FG000|Overall Study|Adverse Event|0|||
42130306|NCT00605345|75941216|FG001|Overall Study|Adverse Event|1|||
41981372|NCT03410992|75787193|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
41981373|NCT03410992|75787183|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
41981374|NCT03410992|75787184|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
41981375|NCT03410992|75787185|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
41981376|NCT03410992|75787186|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
41981377|NCT03410992|75787187|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
41981378|NCT03410992|75787188|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
41981379|NCT03410992|75787189|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
41981380|NCT03410992|75787190|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
41981381|NCT03410992|75787191|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
41981382|NCT03410992|75787192|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
41981383|NCT03410992|75787193|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
42028818|NCT00903760|75837302|FG000|Overall Study|Withdrawal by Subject|1|||
42028819|NCT00903760|75837303|FG001|Overall Study|Withdrawal by Subject|2|||
42028820|NCT00903760|75837302|FG000|Overall Study|Off treatment for long period|0|||
42028821|NCT00903760|75837303|FG001|Overall Study|Off treatment for long period|1|||
42028822|NCT00883051|75837314|FG000|Overall Study|Lost to Follow-up|0|||
42028823|NCT00883051|75837315|FG001|Overall Study|Lost to Follow-up|0|||
42028824|NCT00883051|75837316|FG002|Overall Study|Lost to Follow-up|0|||
42028825|NCT00883051|75837317|FG003|Overall Study|Lost to Follow-up|0|||
42130307|NCT00605345|75941215|FG000|Overall Study|Protocol Violation|0|||
42130308|NCT00605345|75941216|FG001|Overall Study|Protocol Violation|2|||
42028826|NCT00883051|75837318|FG004|Overall Study|Lost to Follow-up|1|||
42028827|NCT00883051|75837314|FG000|Overall Study|Did not use study medication|24|||
42028828|NCT00883051|75837315|FG001|Overall Study|Did not use study medication|22|||
42028829|NCT00883051|75837316|FG002|Overall Study|Did not use study medication|29|||
42028830|NCT00883051|75837317|FG003|Overall Study|Did not use study medication|29|||
42028831|NCT00883051|75837318|FG004|Overall Study|Did not use study medication|17|||
42028832|NCT00903682|75837332|FG000|Overall Study|Adverse Event|6|||
42028833|NCT00903682|75837333|FG001|Overall Study|Adverse Event|13|||
42028834|NCT00903682|75837332|FG000|Overall Study|Lost to Follow-up|1|||
42028835|NCT00903682|75837333|FG001|Overall Study|Lost to Follow-up|0|||
42028836|NCT00903682|75837332|FG000|Overall Study|Withdrawal by Subject|5|||
42028837|NCT00903682|75837333|FG001|Overall Study|Withdrawal by Subject|0|||
42028838|NCT00903682|75837332|FG000|Overall Study|Pregnancy|0|||
42028839|NCT00903682|75837333|FG001|Overall Study|Pregnancy|1|||
42028840|NCT00903682|75837332|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
42028841|NCT00903682|75837333|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
42028842|NCT00903682|75837332|FG000|Overall Study|Subject Non-Compliant|1|||
42028843|NCT00903682|75837333|FG001|Overall Study|Subject Non-Compliant|0|||
42028844|NCT00903682|75837332|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
42028845|NCT00903682|75837333|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
42028846|NCT00903682|75837332|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
42028847|NCT00903682|75837333|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
42028848|NCT01117428|75837345|FG000|Overall Study|Lack of Efficacy|1|||
42028849|NCT01117428|75837346|FG001|Overall Study|Lack of Efficacy|0|||
42028850|NCT01117428|75837347|FG002|Overall Study|Lack of Efficacy|0|||
42028851|NCT01117428|75837348|FG003|Overall Study|Lack of Efficacy|0|||
42028852|NCT01117428|75837349|FG004|Overall Study|Lack of Efficacy|0|||
42028853|NCT01117428|75837350|FG005|Overall Study|Lack of Efficacy|0|||
42028854|NCT01117428|75837345|FG000|Overall Study|Adverse Event|4|||
42028855|NCT01117428|75837346|FG001|Overall Study|Adverse Event|0|||
42028856|NCT01117428|75837347|FG002|Overall Study|Adverse Event|0|||
42028857|NCT01117428|75837348|FG003|Overall Study|Adverse Event|0|||
42028858|NCT01117428|75837349|FG004|Overall Study|Adverse Event|1|||
42028859|NCT01117428|75837350|FG005|Overall Study|Adverse Event|2|||
42028860|NCT01117428|75837345|FG000|Overall Study|Death|0|||
42028861|NCT01117428|75837346|FG001|Overall Study|Death|1|||
42028862|NCT01117428|75837347|FG002|Overall Study|Death|2|||
42028863|NCT01117428|75837348|FG003|Overall Study|Death|0|||
42028864|NCT01117428|75837349|FG004|Overall Study|Death|0|||
42028865|NCT01117428|75837350|FG005|Overall Study|Death|1|||
42028866|NCT01117428|75837345|FG000|Overall Study|Physician Decision|0|||
42028867|NCT01117428|75837346|FG001|Overall Study|Physician Decision|1|||
42028868|NCT01117428|75837347|FG002|Overall Study|Physician Decision|0|||
42028869|NCT01117428|75837348|FG003|Overall Study|Physician Decision|0|||
42028870|NCT01117428|75837349|FG004|Overall Study|Physician Decision|0|||
42028871|NCT01117428|75837350|FG005|Overall Study|Physician Decision|0|||
42028872|NCT01117428|75837345|FG000|Overall Study|Withdrawal by Subject|0|||
42028873|NCT01117428|75837346|FG001|Overall Study|Withdrawal by Subject|0|||
42028874|NCT01117428|75837347|FG002|Overall Study|Withdrawal by Subject|1|||
42028875|NCT01117428|75837348|FG003|Overall Study|Withdrawal by Subject|0|||
42028876|NCT01117428|75837349|FG004|Overall Study|Withdrawal by Subject|0|||
42028877|NCT01117428|75837350|FG005|Overall Study|Withdrawal by Subject|0|||
42028878|NCT01117428|75837345|FG000|Overall Study|Progressive disease|15|||
42028879|NCT01117428|75837346|FG001|Overall Study|Progressive disease|27|||
42028880|NCT01117428|75837347|FG002|Overall Study|Progressive disease|10|||
42028881|NCT01117428|75837348|FG003|Overall Study|Progressive disease|12|||
42028882|NCT01117428|75837349|FG004|Overall Study|Progressive disease|16|||
42028883|NCT01117428|75837350|FG005|Overall Study|Progressive disease|17|||
42028884|NCT00655681|75837368|FG000|Overall Study|Lost to Follow-up|1|||
42028885|NCT00655681|75837369|FG001|Overall Study|Lost to Follow-up|1|||
42028886|NCT01135524|75837388|FG000|Overall Study|Withdrawal by Subject|14|||
42028887|NCT01135524|75837388|FG000|Overall Study|Adverse Event|20|||
42028888|NCT01135524|75837388|FG000|Overall Study|Lost to Follow-up|3|||
42028889|NCT01135524|75837388|FG000|Overall Study|Administrative|151|||
42130309|NCT00604175|75941225|FG000|Entry Through Week 28|Death|2|||
42219607|NCT02694328|76037599|FG001|Overall Study|Withdrawal by Subject|23|||
42219608|NCT02694328|76037598|FG000|Overall Study|Lost to Follow-up|26|||
42028890|NCT01135524|75837388|FG000|Overall Study|Lack of Efficacy|8|||
42028891|NCT00948675|75837394|FG000|Overall Study|Lost to Follow-up|1|||
42028892|NCT00948675|75837395|FG001|Overall Study|Lost to Follow-up|0|||
42028893|NCT00903370|75837403|FG000|Overall Study|Death|13|||
42028894|NCT00903370|75837404|FG001|Overall Study|Death|10|||
42028895|NCT00903370|75837403|FG000|Overall Study|Withdrawal by Subject|9|||
42028896|NCT00903370|75837404|FG001|Overall Study|Withdrawal by Subject|6|||
42028897|NCT00903370|75837403|FG000|Overall Study|Lost to Follow-up|6|||
42028898|NCT00903370|75837404|FG001|Overall Study|Lost to Follow-up|8|||
42028899|NCT01110408|75837412|FG000|Overall Study|Protocol Violation|1|||
42219609|NCT02694328|76037599|FG001|Overall Study|Lost to Follow-up|22|||
42028900|NCT01110408|75837413|FG001|Overall Study|Protocol Violation|0|||
42028901|NCT00953043|75837421|FG000|Overall Study|Withdrawal by Subject|4|||
42028902|NCT00953043|75837422|FG001|Overall Study|Withdrawal by Subject|0|||
42028903|NCT00953043|75837421|FG000|Overall Study|Physician Decision|0|||
42028904|NCT00953043|75837422|FG001|Overall Study|Physician Decision|2|||
42028905|NCT01135134|75837430|FG000|Overall Study|Adverse Event|1|||
42028906|NCT01135134|75837431|FG001|Overall Study|Adverse Event|1|||
42028907|NCT01135134|75837430|FG000|Overall Study|Did not meet protocol eligibility|1|||
42028908|NCT01135134|75837431|FG001|Overall Study|Did not meet protocol eligibility|0|||
42028909|NCT00948441|75837439|FG000|Overall Study|no longer meet inclusion criteria|1|||
42028910|NCT00948441|75837440|FG001|Overall Study|no longer meet inclusion criteria|4|||
42028911|NCT01117350|75837450|FG000|Comparative Period|Not Treated|5|||
42028912|NCT01117350|75837451|FG001|Comparative Period|Not Treated|8|||
42028913|NCT01117350|75837450|FG000|Comparative Period|Adverse Event|6|||
42028914|NCT01117350|75837451|FG001|Comparative Period|Adverse Event|33|||
42028915|NCT01117350|75837450|FG000|Comparative Period|Lost to Follow-up|11|||
42028916|NCT01117350|75837451|FG001|Comparative Period|Lost to Follow-up|7|||
42028917|NCT01117350|75837450|FG000|Comparative Period|Withdrawal by Subject|9|||
42028918|NCT01117350|75837451|FG001|Comparative Period|Withdrawal by Subject|13|||
42028919|NCT01117350|75837450|FG000|Comparative Period|Protocol Violation|8|||
42028920|NCT01117350|75837451|FG001|Comparative Period|Protocol Violation|12|||
42028921|NCT01117350|75837450|FG000|Comparative Period|Lack of Efficacy|1|||
42028922|NCT01117350|75837451|FG001|Comparative Period|Lack of Efficacy|0|||
41981384|NCT03410992|75787183|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
41981385|NCT03410992|75787184|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
41981386|NCT03410992|75787185|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
42028923|NCT01117350|75837450|FG000|Comparative Period|Physician Decision|0|||
42028924|NCT01117350|75837451|FG001|Comparative Period|Physician Decision|1|||
42028925|NCT01117350|75837450|FG000|Comparative Period|Move to another city/country|2|||
42028926|NCT01117350|75837451|FG001|Comparative Period|Move to another city/country|1|||
42028927|NCT01117350|75837450|FG000|Extension Period|Not included in extension, not treated|0|||
42028928|NCT01117350|75837451|FG001|Extension Period|Not included in extension, not treated|50|||
42028929|NCT01117350|75837450|FG000|Extension Period|Adverse Event|0|||
42028930|NCT01117350|75837451|FG001|Extension Period|Adverse Event|2|||
42028931|NCT01117350|75837450|FG000|Extension Period|Protocol Violation|0|||
42028932|NCT01117350|75837451|FG001|Extension Period|Protocol Violation|2|||
42028933|NCT01117350|75837450|FG000|Extension Period|Lost to Follow-up|0|||
42028934|NCT01117350|75837451|FG001|Extension Period|Lost to Follow-up|2|||
42028935|NCT01117350|75837450|FG000|Extension Period|Withdrawal by Subject|0|||
42028936|NCT01117350|75837451|FG001|Extension Period|Withdrawal by Subject|3|||
42028937|NCT01117350|75837450|FG000|Extension Period|Lack of Efficacy|0|||
42028938|NCT01117350|75837451|FG001|Extension Period|Lack of Efficacy|2|||
42028939|NCT01117350|75837450|FG000|Extension Period|Inclusion criteria not respected|0|||
42028940|NCT01117350|75837451|FG001|Extension Period|Inclusion criteria not respected|1|||
42028941|NCT01117350|75837450|FG000|Extension Period|Prohibited medication|0|||
42028942|NCT01117350|75837451|FG001|Extension Period|Prohibited medication|1|||
42028943|NCT00952731|75837462|FG000|Overall Study|Drug supply expired|1|||
42028944|NCT00952731|75837463|FG001|Overall Study|Drug supply expired|0|||
42028945|NCT00947427|75837471|FG000|Overall Study|Withdrawal by Subject|1|||
42028946|NCT00947427|75837472|FG001|Overall Study|Withdrawal by Subject|3|||
42028947|NCT00947427|75837471|FG000|Overall Study|Protocol Violation|0|||
42028948|NCT00947427|75837472|FG001|Overall Study|Protocol Violation|1|||
41981387|NCT03410992|75787186|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
41981388|NCT03410992|75787187|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
41981389|NCT03410992|75787188|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
41981390|NCT03410992|75787189|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
41981391|NCT03410992|75787190|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
41981392|NCT03410992|75787191|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
41981393|NCT03410992|75787192|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
41981394|NCT03410992|75787193|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
41981395|NCT03410992|75787183|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
41981396|NCT03410992|75787184|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
42028949|NCT01116882|75837480|FG000|30-day|Lost to Follow-up|50|||
42028950|NCT01116882|75837481|FG001|30-day|Lost to Follow-up|21|||
42028951|NCT01116882|75837480|FG000|30-day|Withdrawal by Subject|2|||
42028952|NCT01116882|75837481|FG001|30-day|Withdrawal by Subject|4|||
42028953|NCT01116882|75837480|FG000|30-day|Other Reasons|16|||
42028954|NCT01116882|75837481|FG001|30-day|Other Reasons|6|||
42028955|NCT01116882|75837480|FG000|12-month|Lost to Follow-up|111|||
42028956|NCT01116882|75837481|FG001|12-month|Lost to Follow-up|42|||
42028957|NCT01116882|75837480|FG000|12-month|Other Reasons|151|||
42028958|NCT01116882|75837481|FG001|12-month|Other Reasons|49|||
42028959|NCT01116882|75837480|FG000|12-month|Withdrawal by Subject|5|||
42028960|NCT01116882|75837481|FG001|12-month|Withdrawal by Subject|8|||
42028961|NCT00953745|75837492|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
42028962|NCT00953745|75837493|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
42028963|NCT00953745|75837492|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
42028964|NCT00953745|75837493|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
42028965|NCT00953745|75837492|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
42028966|NCT00953745|75837493|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
42028967|NCT00953745|75837492|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
42028968|NCT00953745|75837493|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
42028969|NCT00953745|75837492|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
42028970|NCT00953745|75837493|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
42028971|NCT00953745|75837492|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
42028972|NCT00953745|75837493|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
42028973|NCT00902746|75837510|FG000|Overall Study|Protocol Violation|7|||
42028974|NCT00902746|75837510|FG000|Overall Study|Withdrawal by Subject|16|||
42028975|NCT00902746|75837510|FG000|Overall Study|Adverse Event|8|||
42028976|NCT00902746|75837510|FG000|Overall Study|Lost to Follow-up|3|||
42028977|NCT00902746|75837510|FG000|Overall Study|Physician Decision|2|||
42028978|NCT00902668|75837523|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
42028979|NCT00947349|75837531|FG000|Triple Treatment Combination Period|Adverse Event|0|||
42028980|NCT00947349|75837532|FG001|Triple Treatment Combination Period|Adverse Event|1|||
42028981|NCT00947349|75837533|FG002|Triple Treatment Combination Period|Adverse Event|0|||
42028982|NCT00947349|75837534|FG003|Triple Treatment Combination Period|Adverse Event|0|||
42028983|NCT00947349|75837531|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
42028984|NCT00947349|75837532|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
42028985|NCT00947349|75837533|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
42028986|NCT00947349|75837534|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
42028987|NCT00947349|75837531|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
42028988|NCT00947349|75837532|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
42028989|NCT00947349|75837533|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
42028990|NCT00947349|75837534|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
42028991|NCT00947349|75837531|FG000|Overall Study Standard of Care|Other|0|||
42028992|NCT00947349|75837532|FG001|Overall Study Standard of Care|Other|0|||
42028993|NCT00947349|75837533|FG002|Overall Study Standard of Care|Other|0|||
42028994|NCT00947349|75837534|FG003|Overall Study Standard of Care|Other|1|||
42028995|NCT00947193|75837562|FG000|Overall Study|Lost to Follow-up|1|||
42219610|NCT02694328|76037598|FG000|Overall Study|Noncompliant with study drug|11|||
42219611|NCT02694328|76037599|FG001|Overall Study|Noncompliant with study drug|8|||
42219612|NCT02694328|76037598|FG000|Overall Study|Incarceration|1|||
42219613|NCT02694328|76037599|FG001|Overall Study|Incarceration|1|||
42219614|NCT02694328|76037598|FG000|Overall Study|Lack of Efficacy|1|||
41981397|NCT03410992|75787185|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
41981398|NCT03410992|75787186|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
41981399|NCT03410992|75787187|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
41981400|NCT03410992|75787188|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
41981401|NCT03410992|75787189|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
41981402|NCT03410992|75787190|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
41981403|NCT03410992|75787191|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
41981404|NCT03410992|75787192|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
41981405|NCT03410992|75787193|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
41981406|NCT03410992|75787183|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
41981407|NCT03410992|75787184|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
41981408|NCT03410992|75787185|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
42028996|NCT00947193|75837563|FG001|Overall Study|Lost to Follow-up|0|||
42028997|NCT00947193|75837562|FG000|Overall Study|Withdrawal by Subject|1|||
42028998|NCT00947193|75837563|FG001|Overall Study|Withdrawal by Subject|0|||
42028999|NCT00947193|75837562|FG000|Overall Study|Factor VIII >1%|1|||
42029000|NCT00947193|75837563|FG001|Overall Study|Factor VIII >1%|0|||
42130310|NCT00604175|75941226|FG001|Entry Through Week 28|Death|0|||
42130311|NCT00604175|75941227|FG002|Entry Through Week 28|Death|0|||
42130312|NCT00604175|75941225|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
42130313|NCT00604175|75941226|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
42130314|NCT00604175|75941227|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
42130315|NCT00604175|75941225|FG000|Entry Through Week 28|Lost to Follow-up|4|||
42130316|NCT00604175|75941226|FG001|Entry Through Week 28|Lost to Follow-up|3|||
42130317|NCT00604175|75941227|FG002|Entry Through Week 28|Lost to Follow-up|0|||
42130318|NCT00604175|75941225|FG000|Entry Through Week 28|Ineligible|1|||
42130319|NCT00604175|75941226|FG001|Entry Through Week 28|Ineligible|0|||
42130320|NCT00604175|75941227|FG002|Entry Through Week 28|Ineligible|0|||
42130321|NCT00604175|75941225|FG000|Entry Through Week 28|Did not start intervention|2|||
42130322|NCT00604175|75941226|FG001|Entry Through Week 28|Did not start intervention|0|||
42130323|NCT00604175|75941227|FG002|Entry Through Week 28|Did not start intervention|1|||
42219615|NCT02694328|76037599|FG001|Overall Study|Lack of Efficacy|2|||
42219616|NCT02694328|76037598|FG000|Overall Study|Pregnancy|1|||
42219617|NCT02694328|76037599|FG001|Overall Study|Pregnancy|1|||
42219618|NCT02694328|76037598|FG000|Overall Study|Protocol Violation|6|||
42219619|NCT02694328|76037599|FG001|Overall Study|Protocol Violation|5|||
42219620|NCT02694328|76037598|FG000|Overall Study|Abnormal Laboratory Value|0|||
42219621|NCT02694328|76037599|FG001|Overall Study|Abnormal Laboratory Value|3|||
42219622|NCT03334747|76037614|FG000|Treatment Phase|Technical problems|0|||
42219623|NCT03334747|76037615|FG001|Treatment Phase|Technical problems|0|||
42219624|NCT03334747|76037616|FG002|Treatment Phase|Technical problems|0|||
42219625|NCT03334747|76037617|FG003|Treatment Phase|Technical problems|0|||
42219626|NCT03334747|76037618|FG004|Treatment Phase|Technical problems|1|||
42219627|NCT03334747|76037619|FG005|Treatment Phase|Technical problems|0|||
42219628|NCT03334747|76037620|FG006|Treatment Phase|Technical problems|0|||
42219629|NCT03334747|76037621|FG007|Treatment Phase|Technical problems|0|||
42219630|NCT03334747|76037622|FG008|Treatment Phase|Technical problems|0|||
42219631|NCT03334747|76037614|FG000|Treatment Phase|Subject/guardian decision|1|||
42219632|NCT03334747|76037615|FG001|Treatment Phase|Subject/guardian decision|0|||
42219633|NCT03334747|76037616|FG002|Treatment Phase|Subject/guardian decision|0|||
42029001|NCT00947115|75837571|FG000|Overall Study|Missed reporting interval|3|||
42029002|NCT00947115|75837572|FG001|Overall Study|Missed reporting interval|4|||
42029003|NCT00947115|75837573|FG002|Overall Study|Missed reporting interval|2|||
42029004|NCT00947115|75837571|FG000|Overall Study|Physician Decision|0|||
42029005|NCT00947115|75837572|FG001|Overall Study|Physician Decision|2|||
42029006|NCT00947115|75837573|FG002|Overall Study|Physician Decision|0|||
42029007|NCT00947115|75837571|FG000|Overall Study|Death|0|||
42029008|NCT00947115|75837572|FG001|Overall Study|Death|1|||
42029009|NCT00947115|75837573|FG002|Overall Study|Death|1|||
42029010|NCT00947115|75837571|FG000|Overall Study|Migrated from study area|2|||
42219634|NCT03334747|76037617|FG003|Treatment Phase|Subject/guardian decision|0|||
42219635|NCT03334747|76037618|FG004|Treatment Phase|Subject/guardian decision|0|||
42219636|NCT03334747|76037619|FG005|Treatment Phase|Subject/guardian decision|1|||
42219637|NCT03334747|76037620|FG006|Treatment Phase|Subject/guardian decision|0|||
42219638|NCT03334747|76037621|FG007|Treatment Phase|Subject/guardian decision|0|||
42219639|NCT03334747|76037622|FG008|Treatment Phase|Subject/guardian decision|0|||
42219640|NCT03334747|76037614|FG000|Follow-Up Phase|Subject/guardian decision|0|||
42219641|NCT03334747|76037615|FG001|Follow-Up Phase|Subject/guardian decision|0|||
42219642|NCT03334747|76037616|FG002|Follow-Up Phase|Subject/guardian decision|0|||
42219643|NCT03334747|76037617|FG003|Follow-Up Phase|Subject/guardian decision|0|||
41981409|NCT03410992|75787186|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
41981410|NCT03410992|75787187|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
41981411|NCT03410992|75787188|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
41981412|NCT03410992|75787189|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
41981413|NCT03410992|75787190|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
41981414|NCT03410992|75787191|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
41981415|NCT03410992|75787192|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
41981416|NCT03410992|75787193|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
42029011|NCT00947115|75837572|FG001|Overall Study|Migrated from study area|0|||
42029012|NCT00947115|75837573|FG002|Overall Study|Migrated from study area|0|||
42029013|NCT00947115|75837571|FG000|Overall Study|Withdrawal by Subject|1|||
42029014|NCT00947115|75837572|FG001|Overall Study|Withdrawal by Subject|3|||
42029015|NCT00947115|75837573|FG002|Overall Study|Withdrawal by Subject|4|||
42029016|NCT00947115|75837571|FG000|Overall Study|Lost to Follow-up|11|||
42029017|NCT00947115|75837572|FG001|Overall Study|Lost to Follow-up|12|||
42029018|NCT00947115|75837573|FG002|Overall Study|Lost to Follow-up|8|||
42029019|NCT00952419|75837584|FG000|Overall Study|Adverse Event|2|||
42029020|NCT00952419|75837585|FG001|Overall Study|Adverse Event|0|||
42029021|NCT00952419|75837586|FG002|Overall Study|Adverse Event|0|||
42219644|NCT03334747|76037618|FG004|Follow-Up Phase|Subject/guardian decision|0|||
42219645|NCT03334747|76037619|FG005|Follow-Up Phase|Subject/guardian decision|0|||
41981417|NCT03410992|75787183|FG000|Week 16 Assessment|Incorrect escapers|0|||
41981418|NCT03410992|75787184|FG001|Week 16 Assessment|Incorrect escapers|6|||
42219646|NCT03334747|76037620|FG006|Follow-Up Phase|Subject/guardian decision|1|||
42219647|NCT03334747|76037621|FG007|Follow-Up Phase|Subject/guardian decision|0|||
42219648|NCT03334747|76037622|FG008|Follow-Up Phase|Subject/guardian decision|1|||
42219649|NCT03346759|76037644|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
42219650|NCT03346759|76037645|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
41981419|NCT03410992|75787185|FG002|Week 16 Assessment|Incorrect escapers|0|||
42029022|NCT00952419|75837584|FG000|Overall Study|Protocol Violation|3|||
42029023|NCT00952419|75837585|FG001|Overall Study|Protocol Violation|7|||
42029024|NCT00952419|75837586|FG002|Overall Study|Protocol Violation|0|||
42029025|NCT00952419|75837584|FG000|Overall Study|Withdrawal by Subject|1|||
42029026|NCT00952419|75837585|FG001|Overall Study|Withdrawal by Subject|3|||
42029027|NCT00952419|75837586|FG002|Overall Study|Withdrawal by Subject|0|||
42029028|NCT00902278|75837599|FG000|Overall Study|Physician Decision|1|||
42219651|NCT03346759|76037644|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
42029029|NCT00902278|75837600|FG001|Overall Study|Physician Decision|0|||
42029030|NCT00902278|75837601|FG002|Overall Study|Physician Decision|2|||
42029031|NCT00902278|75837602|FG003|Overall Study|Physician Decision|0|||
42029032|NCT00902278|75837603|FG004|Overall Study|Physician Decision|1|||
42029033|NCT00902278|75837599|FG000|Overall Study|Lost to Follow-up|3|||
42029034|NCT00902278|75837600|FG001|Overall Study|Lost to Follow-up|2|||
42219652|NCT03346759|76037645|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
42219653|NCT03346759|76037644|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
42219654|NCT03346759|76037645|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
42219655|NCT03361423|76037654|FG000|Overall Study|Withdrawal by Subject|4|||
41981420|NCT03410992|75787186|FG003|Week 16 Assessment|Incorrect escapers|0|||
41981421|NCT03410992|75787187|FG004|Week 16 Assessment|Incorrect escapers|0|||
41981422|NCT03410992|75787188|FG005|Week 16 Assessment|Incorrect escapers|0|||
41981423|NCT03410992|75787189|FG006|Week 16 Assessment|Incorrect escapers|0|||
41981424|NCT03410992|75787190|FG007|Week 16 Assessment|Incorrect escapers|0|||
41981425|NCT03410992|75787191|FG008|Week 16 Assessment|Incorrect escapers|0|||
41981426|NCT03410992|75787192|FG009|Week 16 Assessment|Incorrect escapers|0|||
41981427|NCT03410992|75787193|FG010|Week 16 Assessment|Incorrect escapers|0|||
41981428|NCT03410992|75787183|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
41981429|NCT03410992|75787184|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
41981430|NCT03410992|75787185|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
41981431|NCT03410992|75787186|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
41981432|NCT03410992|75787187|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
41981433|NCT03410992|75787188|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
41981434|NCT03410992|75787189|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
41981435|NCT03410992|75787190|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
41981436|NCT03410992|75787191|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
41981437|NCT03410992|75787192|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
41981438|NCT03410992|75787193|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
41981439|NCT03410992|75787183|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
41981440|NCT03410992|75787184|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
41981441|NCT03410992|75787185|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
41981442|NCT03410992|75787186|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
41981443|NCT03410992|75787187|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
42029035|NCT00902278|75837601|FG002|Overall Study|Lost to Follow-up|3|||
42029036|NCT00902278|75837602|FG003|Overall Study|Lost to Follow-up|0|||
42029037|NCT00902278|75837603|FG004|Overall Study|Lost to Follow-up|1|||
42029038|NCT01998633|75837617|FG000|Overall Study|Death|1|||
42029039|NCT00952341|75837627|FG000|Cycle 1|Adverse Event|4|||
42029040|NCT00952341|75837628|FG001|Cycle 1|Adverse Event|1|||
42029041|NCT00952341|75837627|FG000|Cycle 1|Withdrawal by Subject|3|||
42029042|NCT00952341|75837628|FG001|Cycle 1|Withdrawal by Subject|8|||
42029043|NCT00952341|75837627|FG000|Cycle 1|Protocol Violation|2|||
42029044|NCT00952341|75837628|FG001|Cycle 1|Protocol Violation|1|||
42130324|NCT00604175|75941225|FG000|Week 29 Through Week 72|Death|0|||
42130325|NCT00604175|75941226|FG001|Week 29 Through Week 72|Death|0|||
42130326|NCT00604175|75941227|FG002|Week 29 Through Week 72|Death|1|||
42130327|NCT00604175|75941225|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
42130328|NCT00604175|75941226|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
42130329|NCT00604175|75941227|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
42130330|NCT00604175|75941225|FG000|Week 29 Through Week 72|Site closure|0|||
42130331|NCT00604175|75941226|FG001|Week 29 Through Week 72|Site closure|1|||
42130332|NCT00604175|75941227|FG002|Week 29 Through Week 72|Site closure|0|||
42130333|NCT00604175|75941225|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
42130334|NCT00604175|75941226|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
42130335|NCT00604175|75941227|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
42130336|NCT00605189|75941262|FG000|Overall Study|Adverse Event|1|||
42130337|NCT00605189|75941263|FG001|Overall Study|Adverse Event|0|||
42130338|NCT00605189|75941264|FG002|Overall Study|Adverse Event|0|||
42130339|NCT00605189|75941262|FG000|Overall Study|Other|2|||
42130340|NCT00605189|75941263|FG001|Overall Study|Other|2|||
42130341|NCT00605189|75941264|FG002|Overall Study|Other|0|||
42130342|NCT00340834|75941277|FG000|Core Phase of Study|Adverse Event|26|||
42130343|NCT00340834|75941278|FG001|Core Phase of Study|Adverse Event|9|||
42130344|NCT00340834|75941279|FG002|Core Phase of Study|Adverse Event|9|||
42130345|NCT00340834|75941280|FG003|Core Phase of Study|Adverse Event|0|||
42130346|NCT00340834|75941281|FG004|Core Phase of Study|Adverse Event|0|||
42130347|NCT00340834|75941277|FG000|Core Phase of Study|Withdrawal by Subject|11|||
42130348|NCT00340834|75941278|FG001|Core Phase of Study|Withdrawal by Subject|9|||
42130349|NCT00340834|75941279|FG002|Core Phase of Study|Withdrawal by Subject|16|||
42130350|NCT00340834|75941280|FG003|Core Phase of Study|Withdrawal by Subject|0|||
42130351|NCT00340834|75941281|FG004|Core Phase of Study|Withdrawal by Subject|0|||
42130352|NCT00340834|75941277|FG000|Core Phase of Study|Administrative Problems|6|||
42130353|NCT00340834|75941278|FG001|Core Phase of Study|Administrative Problems|2|||
41981444|NCT03410992|75787188|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
41981445|NCT03410992|75787189|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
41981446|NCT03410992|75787190|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
41981447|NCT03410992|75787191|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
41981448|NCT03410992|75787192|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
41981449|NCT03410992|75787193|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
41981450|NCT03410992|75787183|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
41981451|NCT03410992|75787184|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
41981452|NCT03410992|75787185|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
41981453|NCT03410992|75787186|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
41981454|NCT03410992|75787187|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
41981455|NCT03410992|75787188|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
41981456|NCT03410992|75787189|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
41981457|NCT03410992|75787190|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
41981458|NCT03410992|75787191|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
41981459|NCT03410992|75787192|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
41981460|NCT03410992|75787193|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
41981461|NCT03410992|75787183|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
41981462|NCT03410992|75787184|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
41981463|NCT03410992|75787185|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
41981464|NCT03410992|75787186|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
41981465|NCT03410992|75787187|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
41981466|NCT03410992|75787188|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
41981467|NCT03410992|75787189|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
41981468|NCT03410992|75787190|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
41981469|NCT03410992|75787191|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
41981470|NCT03410992|75787192|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
41981471|NCT03410992|75787193|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
41981472|NCT03410992|75787183|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
41981473|NCT03410992|75787184|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
41981474|NCT03410992|75787185|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
41981475|NCT03410992|75787186|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
41981476|NCT03410992|75787187|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
41981477|NCT03410992|75787188|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
41981478|NCT03410992|75787189|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
41981479|NCT03410992|75787190|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
41981480|NCT03410992|75787191|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
41981481|NCT03410992|75787192|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
41981482|NCT03410992|75787193|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
41981483|NCT03410992|75787183|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
41981484|NCT03410992|75787184|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
41981485|NCT03410992|75787185|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
41981486|NCT03410992|75787186|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
41981487|NCT03410992|75787187|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
41981488|NCT03410992|75787188|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
41981489|NCT03410992|75787189|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
41981490|NCT03410992|75787190|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
41981491|NCT03410992|75787191|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
41981492|NCT03410992|75787192|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
41981493|NCT03410992|75787193|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
41981494|NCT03370913|75787223|FG000|Overall Study|Death|1|||
41981495|NCT03370913|75787223|FG000|Overall Study|Lost to Follow-up|1|||
41981496|NCT03342404|75787229|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
41981497|NCT03342404|75787230|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
41981498|NCT03342404|75787229|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
41981499|NCT03342404|75787230|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
41981500|NCT03342404|75787229|FG000|Blinded Treatment Phase|Adverse Event|5|||
41981501|NCT03342404|75787230|FG001|Blinded Treatment Phase|Adverse Event|4|||
42130354|NCT00340834|75941279|FG002|Core Phase of Study|Administrative Problems|7|||
42130355|NCT00340834|75941280|FG003|Core Phase of Study|Administrative Problems|0|||
42130356|NCT00340834|75941281|FG004|Core Phase of Study|Administrative Problems|0|||
42219656|NCT03361423|76037655|FG001|Overall Study|Withdrawal by Subject|3|||
41981502|NCT03342404|75787229|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
41981503|NCT03342404|75787230|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
42029045|NCT00952341|75837627|FG000|Cycle 1|Lost to Follow-up|11|||
42130357|NCT00340834|75941277|FG000|Core Phase of Study|Lack of Efficacy|3|||
42130358|NCT00340834|75941278|FG001|Core Phase of Study|Lack of Efficacy|3|||
41981504|NCT03342404|75787229|FG000|Blinded Treatment Phase|Other reasons|1|||
41981505|NCT03342404|75787230|FG001|Blinded Treatment Phase|Other reasons|0|||
41981506|NCT03342404|75787229|FG000|Blinded Treatment Phase|Physician Decision|1|||
41981507|NCT03342404|75787230|FG001|Blinded Treatment Phase|Physician Decision|0|||
41981508|NCT03342404|75787229|FG000|Blinded Treatment Phase|Death|1|||
41981509|NCT03342404|75787230|FG001|Blinded Treatment Phase|Death|0|||
41981510|NCT03342404|75787229|FG000|Open-Label Phase|Lost to Follow-up|0|||
41981511|NCT03342404|75787230|FG001|Open-Label Phase|Lost to Follow-up|1|||
42130359|NCT00340834|75941279|FG002|Core Phase of Study|Lack of Efficacy|7|||
42219657|NCT03361423|76037654|FG000|Overall Study|Did not treat|19|||
42219658|NCT03361423|76037655|FG001|Overall Study|Did not treat|18|||
42219659|NCT03361423|76037654|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
42219660|NCT03361423|76037655|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
42219661|NCT03361423|76037654|FG000|Overall Study|Missing data|4|||
41981512|NCT03342404|75787229|FG000|Open-Label Phase|Other reasons|0|||
41981513|NCT03342404|75787230|FG001|Open-Label Phase|Other reasons|1|||
41981514|NCT03342404|75787229|FG000|Open-Label Phase|Adverse Event|0|||
41981515|NCT03342404|75787230|FG001|Open-Label Phase|Adverse Event|3|||
41981516|NCT03342404|75787229|FG000|Open-Label Phase|Withdrawal by Subject|0|||
41981517|NCT03342404|75787230|FG001|Open-Label Phase|Withdrawal by Subject|6|||
41981518|NCT03213457|75787249|FG000|Overall Study|Not Treated|1|||
41981519|NCT03213457|75787250|FG001|Overall Study|Not Treated|1|||
41981520|NCT03213457|75787251|FG002|Overall Study|Not Treated|0|||
41981521|NCT03213457|75787249|FG000|Overall Study|Adverse Event|16|||
41981522|NCT03213457|75787250|FG001|Overall Study|Adverse Event|9|||
41981523|NCT03213457|75787251|FG002|Overall Study|Adverse Event|41|||
41981524|NCT03213457|75787249|FG000|Overall Study|Non-Compliance With Study Drug|1|||
41981525|NCT03213457|75787250|FG001|Overall Study|Non-Compliance With Study Drug|2|||
41981526|NCT03213457|75787251|FG002|Overall Study|Non-Compliance With Study Drug|7|||
41981527|NCT03213457|75787249|FG000|Overall Study|Non-Compliance Other, Not Specified|0|||
41981528|NCT03213457|75787250|FG001|Overall Study|Non-Compliance Other, Not Specified|1|||
41981529|NCT03213457|75787251|FG002|Overall Study|Non-Compliance Other, Not Specified|5|||
41981530|NCT03213457|75787249|FG000|Overall Study|Withdrawal by Subject|18|||
41981531|NCT03213457|75787250|FG001|Overall Study|Withdrawal by Subject|7|||
41981532|NCT03213457|75787251|FG002|Overall Study|Withdrawal by Subject|35|||
41981533|NCT03213457|75787249|FG000|Overall Study|Lost to Follow-up|12|||
41981534|NCT03213457|75787250|FG001|Overall Study|Lost to Follow-up|12|||
41981535|NCT03213457|75787251|FG002|Overall Study|Lost to Follow-up|33|||
41981536|NCT03213457|75787249|FG000|Overall Study|Pregnancy|11|||
41981537|NCT03213457|75787250|FG001|Overall Study|Pregnancy|0|||
41981538|NCT03213457|75787251|FG002|Overall Study|Pregnancy|7|||
41981539|NCT03213457|75787249|FG000|Overall Study|Protocol Violation|1|||
41981540|NCT03213457|75787250|FG001|Overall Study|Protocol Violation|1|||
41981541|NCT03213457|75787251|FG002|Overall Study|Protocol Violation|6|||
42029046|NCT00952341|75837628|FG001|Cycle 1|Lost to Follow-up|2|||
42130360|NCT00340834|75941280|FG003|Core Phase of Study|Lack of Efficacy|0|||
42130361|NCT00340834|75941281|FG004|Core Phase of Study|Lack of Efficacy|0|||
42130362|NCT00340834|75941277|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
42130363|NCT00340834|75941278|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
42130364|NCT00340834|75941279|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
42130365|NCT00340834|75941280|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
42130366|NCT00340834|75941281|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
42130367|NCT00340834|75941277|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
42130368|NCT00340834|75941278|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
42130369|NCT00340834|75941279|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
42130370|NCT00340834|75941280|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
42130371|NCT00340834|75941281|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
42130372|NCT00340834|75941277|FG000|Core Phase of Study|Lost to Follow-up|1|||
42130373|NCT00340834|75941278|FG001|Core Phase of Study|Lost to Follow-up|1|||
42130374|NCT00340834|75941279|FG002|Core Phase of Study|Lost to Follow-up|4|||
42130375|NCT00340834|75941280|FG003|Core Phase of Study|Lost to Follow-up|0|||
42130376|NCT00340834|75941281|FG004|Core Phase of Study|Lost to Follow-up|0|||
42029047|NCT00952341|75837627|FG000|Cycle 1|Physician Decision|0|||
41981542|NCT03213457|75787249|FG000|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|4|||
41981543|NCT03213457|75787250|FG001|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|0|||
41981544|NCT03213457|75787251|FG002|Overall Study|Requires Surgery/Invasive Intervention for Endometriosis Treatment|2|||
41981545|NCT03213457|75787249|FG000|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
41981546|NCT03213457|75787250|FG001|Overall Study|Dual Energy X-Ray Absorptiometry Finding|1|||
42219662|NCT03361423|76037655|FG001|Overall Study|Missing data|1|||
42219663|NCT02693002|76037663|FG000|Overall Study|Withdrawal by Subject|1|||
42219664|NCT02693002|76037664|FG001|Overall Study|Withdrawal by Subject|0|||
42219665|NCT03093870|76037673|FG000|Overall Study|Withdrawal by Subject|2|||
42219666|NCT03093870|76037674|FG001|Overall Study|Withdrawal by Subject|6|||
42219667|NCT03093870|76037675|FG002|Overall Study|Withdrawal by Subject|5|||
42219668|NCT03093870|76037673|FG000|Overall Study|Death|1|||
42219669|NCT03093870|76037674|FG001|Overall Study|Death|35|||
42219670|NCT03093870|76037675|FG002|Overall Study|Death|35|||
42219671|NCT03093870|76037673|FG000|Overall Study|Radiographic disease progression|10|||
42219672|NCT03093870|76037674|FG001|Overall Study|Radiographic disease progression|0|||
42219673|NCT03093870|76037675|FG002|Overall Study|Radiographic disease progression|0|||
42219674|NCT03093870|76037673|FG000|Overall Study|Clinical disease progression|1|||
42219675|NCT03093870|76037674|FG001|Overall Study|Clinical disease progression|0|||
42219676|NCT03093870|76037675|FG002|Overall Study|Clinical disease progression|0|||
42219677|NCT03093870|76037673|FG000|Overall Study|Physician Decision|2|||
42219678|NCT03093870|76037674|FG001|Overall Study|Physician Decision|0|||
42219679|NCT03093870|76037675|FG002|Overall Study|Physician Decision|0|||
42219680|NCT03093870|76037673|FG000|Overall Study|Adverse Event|7|||
42219681|NCT03093870|76037674|FG001|Overall Study|Adverse Event|0|||
41981547|NCT03213457|75787251|FG002|Overall Study|Dual Energy X-Ray Absorptiometry Finding|3|||
41981548|NCT03213457|75787249|FG000|Overall Study|Lack of Efficacy|12|||
41981549|NCT03213457|75787250|FG001|Overall Study|Lack of Efficacy|2|||
41981550|NCT03213457|75787251|FG002|Overall Study|Lack of Efficacy|9|||
41981551|NCT03213457|75787249|FG000|Overall Study|Other, Not Specified|11|||
41981552|NCT03213457|75787250|FG001|Overall Study|Other, Not Specified|3|||
41981553|NCT03213457|75787251|FG002|Overall Study|Other, Not Specified|26|||
41981554|NCT03198078|75787262|FG000|Overall Study|Adverse Event|0|||
41981555|NCT03198078|75787263|FG001|Overall Study|Adverse Event|1|||
41981556|NCT03198078|75787264|FG002|Overall Study|Adverse Event|2|||
41981557|NCT03198078|75787262|FG000|Overall Study|Lack of Efficacy|0|||
41981558|NCT03198078|75787263|FG001|Overall Study|Lack of Efficacy|0|||
41981559|NCT03198078|75787264|FG002|Overall Study|Lack of Efficacy|3|||
41981560|NCT03198078|75787262|FG000|Overall Study|Lost to Follow-up|1|||
41981561|NCT03198078|75787263|FG001|Overall Study|Lost to Follow-up|0|||
41981562|NCT03198078|75787264|FG002|Overall Study|Lost to Follow-up|0|||
42219682|NCT03093870|76037675|FG002|Overall Study|Adverse Event|0|||
41981563|NCT03198078|75787262|FG000|Overall Study|Pregnancy|0|||
41981564|NCT03198078|75787263|FG001|Overall Study|Pregnancy|1|||
41981565|NCT03198078|75787264|FG002|Overall Study|Pregnancy|0|||
41981566|NCT03198078|75787262|FG000|Overall Study|Withdrawal by Subject|1|||
41981567|NCT03198078|75787263|FG001|Overall Study|Withdrawal by Subject|0|||
41981568|NCT03198078|75787264|FG002|Overall Study|Withdrawal by Subject|2|||
41981569|NCT03198078|75787262|FG000|Overall Study|Withdrawal by Caregiver|1|||
41981570|NCT03198078|75787263|FG001|Overall Study|Withdrawal by Caregiver|3|||
41981571|NCT03198078|75787264|FG002|Overall Study|Withdrawal by Caregiver|5|||
41981572|NCT02808650|75787288|FG000|Overall Study|Death|0|||
41981573|NCT02808650|75787289|FG001|Overall Study|Death|0|||
41981574|NCT02808650|75787290|FG002|Overall Study|Death|0|||
41981575|NCT02808650|75787291|FG003|Overall Study|Death|0|||
41981576|NCT02808650|75787292|FG004|Overall Study|Death|1|||
41981577|NCT02808650|75787288|FG000|Overall Study|Lack of Efficacy|5|||
41981578|NCT02808650|75787289|FG001|Overall Study|Lack of Efficacy|5|||
42130377|NCT00340834|75941277|FG000|Core Phase of Study|Death|2|||
42130378|NCT00340834|75941278|FG001|Core Phase of Study|Death|0|||
42130379|NCT00340834|75941279|FG002|Core Phase of Study|Death|0|||
42130380|NCT00340834|75941280|FG003|Core Phase of Study|Death|0|||
42130381|NCT00340834|75941281|FG004|Core Phase of Study|Death|0|||
42130382|NCT00340834|75941277|FG000|Core Phase of Study|Protocol Violation|0|||
42130383|NCT00340834|75941278|FG001|Core Phase of Study|Protocol Violation|0|||
42130384|NCT00340834|75941279|FG002|Core Phase of Study|Protocol Violation|2|||
42130385|NCT00340834|75941280|FG003|Core Phase of Study|Protocol Violation|0|||
42130386|NCT00340834|75941281|FG004|Core Phase of Study|Protocol Violation|0|||
42219683|NCT03093870|76037673|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
42219684|NCT03093870|76037674|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
42219685|NCT03093870|76037675|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
41981579|NCT02808650|75787290|FG002|Overall Study|Lack of Efficacy|6|||
41981580|NCT02808650|75787291|FG003|Overall Study|Lack of Efficacy|5|||
41981581|NCT02808650|75787292|FG004|Overall Study|Lack of Efficacy|4|||
41981582|NCT02808650|75787288|FG000|Overall Study|Physician Decision|1|||
41981583|NCT02808650|75787289|FG001|Overall Study|Physician Decision|1|||
41981584|NCT02808650|75787290|FG002|Overall Study|Physician Decision|0|||
41981585|NCT02808650|75787291|FG003|Overall Study|Physician Decision|0|||
41981586|NCT02808650|75787292|FG004|Overall Study|Physician Decision|0|||
41981587|NCT02808650|75787288|FG000|Overall Study|Withdrawal by Subject|0|||
41981588|NCT02808650|75787289|FG001|Overall Study|Withdrawal by Subject|0|||
42219686|NCT03093870|76037673|FG000|Overall Study|Lost to Follow-up|0|||
42219687|NCT03093870|76037674|FG001|Overall Study|Lost to Follow-up|0|||
42219688|NCT03093870|76037675|FG002|Overall Study|Lost to Follow-up|1|||
42219689|NCT03346057|76037698|FG000|Overall Study|Death|1|||
42219690|NCT03346057|76037699|FG001|Overall Study|Death|2|||
42219691|NCT03346057|76037700|FG002|Overall Study|Death|0|||
42219692|NCT03346057|76037701|FG003|Overall Study|Death|0|||
42219693|NCT03346057|76037698|FG000|Overall Study|Lost to Follow-up|0|||
42219694|NCT03346057|76037699|FG001|Overall Study|Lost to Follow-up|2|||
42219695|NCT03346057|76037700|FG002|Overall Study|Lost to Follow-up|1|||
41981589|NCT02808650|75787290|FG002|Overall Study|Withdrawal by Subject|0|||
41981590|NCT02808650|75787291|FG003|Overall Study|Withdrawal by Subject|1|||
42219696|NCT03346057|76037701|FG003|Overall Study|Lost to Follow-up|0|||
42219697|NCT03346057|76037698|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
41981591|NCT02808650|75787292|FG004|Overall Study|Withdrawal by Subject|1|||
41981592|NCT02677896|75787307|FG000|Double Blind Period (up to 35 Months)|Death|113|||
41981593|NCT02677896|75787308|FG001|Double Blind Period (up to 35 Months)|Death|189|||
41981594|NCT02677896|75787307|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
42219698|NCT03346057|76037699|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
42219699|NCT03346057|76037700|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
42219700|NCT03346057|76037701|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
42219701|NCT03346057|76037698|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
42219702|NCT03346057|76037699|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
42219703|NCT03346057|76037700|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
42219704|NCT03346057|76037701|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
42219705|NCT03346057|76037698|FG000|Overall Study|Physician Decision|3|||
42219706|NCT03346057|76037699|FG001|Overall Study|Physician Decision|2|||
41981595|NCT02677896|75787308|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
41981596|NCT02677896|75787307|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
41981597|NCT02677896|75787308|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
41981598|NCT02677896|75787307|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
41981599|NCT02677896|75787308|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
42029048|NCT00952341|75837628|FG001|Cycle 1|Physician Decision|1|||
42130387|NCT00340834|75941277|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
42130388|NCT00340834|75941278|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
42130389|NCT00340834|75941279|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
42130390|NCT00340834|75941280|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
42130391|NCT00340834|75941281|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
42130392|NCT00340834|75941277|FG000|Extension Phase of Study|Subject withdrew consent|26|||
42130393|NCT00340834|75941278|FG001|Extension Phase of Study|Subject withdrew consent|31|||
42130394|NCT00340834|75941279|FG002|Extension Phase of Study|Subject withdrew consent|0|||
42130395|NCT00340834|75941280|FG003|Extension Phase of Study|Subject withdrew consent|12|||
42130396|NCT00340834|75941281|FG004|Extension Phase of Study|Subject withdrew consent|15|||
42130397|NCT00340834|75941277|FG000|Extension Phase of Study|Adverse Event|21|||
42130398|NCT00340834|75941278|FG001|Extension Phase of Study|Adverse Event|22|||
42130399|NCT00340834|75941279|FG002|Extension Phase of Study|Adverse Event|0|||
42130400|NCT00340834|75941280|FG003|Extension Phase of Study|Adverse Event|19|||
42130401|NCT00340834|75941281|FG004|Extension Phase of Study|Adverse Event|7|||
42130402|NCT00340834|75941277|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
42130403|NCT00340834|75941278|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
42130404|NCT00340834|75941279|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
42130405|NCT00340834|75941280|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
42130406|NCT00340834|75941281|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
42130407|NCT00340834|75941277|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
42130408|NCT00340834|75941278|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
42130409|NCT00340834|75941279|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
42130410|NCT00340834|75941280|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
42130411|NCT00340834|75941281|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
42130412|NCT00340834|75941277|FG000|Extension Phase of Study|Lost to Follow-up|1|||
42130413|NCT00340834|75941278|FG001|Extension Phase of Study|Lost to Follow-up|1|||
42130414|NCT00340834|75941279|FG002|Extension Phase of Study|Lost to Follow-up|0|||
42130415|NCT00340834|75941280|FG003|Extension Phase of Study|Lost to Follow-up|2|||
42130416|NCT00340834|75941281|FG004|Extension Phase of Study|Lost to Follow-up|3|||
42219707|NCT03346057|76037700|FG002|Overall Study|Physician Decision|0|||
42219708|NCT03346057|76037701|FG003|Overall Study|Physician Decision|2|||
42219709|NCT03346057|76037698|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
42029049|NCT00952341|75837627|FG000|Cycle 2|Withdrawal by Subject|1|||
42029050|NCT00952341|75837628|FG001|Cycle 2|Withdrawal by Subject|1|||
42302218|NCT02495077|76137271|FG001|Overall Study|Covid-19 research restrictions|0|||
42029051|NCT00952341|75837627|FG000|Cycle 2|Protocol Violation|1|||
42029052|NCT00952341|75837628|FG001|Cycle 2|Protocol Violation|0|||
42219710|NCT03346057|76037699|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
42219711|NCT03346057|76037700|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
42219712|NCT03346057|76037701|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
42219713|NCT03346057|76037698|FG000|Overall Study|Withdrawal by Subject|1|||
42219714|NCT03346057|76037699|FG001|Overall Study|Withdrawal by Subject|0|||
42219715|NCT03346057|76037700|FG002|Overall Study|Withdrawal by Subject|0|||
42219716|NCT03346057|76037701|FG003|Overall Study|Withdrawal by Subject|0|||
42219717|NCT03345979|76037713|FG000|Overall Study|Withdrawal by Subject|20|||
42219718|NCT03345979|76037714|FG001|Overall Study|Withdrawal by Subject|31|||
42219719|NCT03345979|76037713|FG000|Overall Study|Adverse Event|10|||
42219720|NCT03345979|76037714|FG001|Overall Study|Adverse Event|11|||
42219721|NCT03345979|76037713|FG000|Overall Study|Lost to Follow-up|8|||
42219722|NCT03345979|76037714|FG001|Overall Study|Lost to Follow-up|9|||
42219723|NCT03345979|76037713|FG000|Overall Study|Lack of Efficacy|4|||
42219724|NCT03345979|76037714|FG001|Overall Study|Lack of Efficacy|2|||
42219725|NCT03345979|76037713|FG000|Overall Study|Protocol Violation|1|||
42219726|NCT03345979|76037714|FG001|Overall Study|Protocol Violation|3|||
42219727|NCT03345979|76037713|FG000|Overall Study|Physician Decision|0|||
42219728|NCT03345979|76037714|FG001|Overall Study|Physician Decision|2|||
42219729|NCT02696434|76037722|FG000|Overall Study|Adverse Event|3|||
42219730|NCT02696434|76037723|FG001|Overall Study|Adverse Event|1|||
42219731|NCT02696434|76037722|FG000|Overall Study|Lost to Follow-up|5|||
42219732|NCT02696434|76037723|FG001|Overall Study|Lost to Follow-up|4|||
42219733|NCT02696434|76037722|FG000|Overall Study|Withdrawal by Subject|14|||
42219734|NCT02696434|76037723|FG001|Overall Study|Withdrawal by Subject|12|||
42219735|NCT02696434|76037722|FG000|Overall Study|Physician Decision|0|||
42219736|NCT02696434|76037723|FG001|Overall Study|Physician Decision|1|||
42219737|NCT03345901|76037729|FG000|Overall Study|The study was terminated|18|||
42219738|NCT02950831|76037734|FG000|Overall Study|Lost to Follow-up|1|||
42219739|NCT02950831|76037734|FG000|Overall Study|Withdrawal by Subject|3|||
42219740|NCT02950831|76037734|FG000|Overall Study|stimulation trail failure|5|||
42219741|NCT03593681|76037738|FG000|Overall Study|Inadequate sample collected|12|||
42219742|NCT03593681|76037738|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
42219743|NCT03593681|76037738|FG000|Overall Study|Protocol Violation|3|||
42219744|NCT03593681|76037738|FG000|Overall Study|Withdrawal by Subject|3|||
42219745|NCT03593681|76037738|FG000|Overall Study|Procedure not attempted|3|||
42219746|NCT03593681|76037738|FG000|Overall Study|Adverse Event|2|||
42219747|NCT03593681|76037738|FG000|Overall Study|Physician Decision|1|||
42219748|NCT03592745|76037761|FG000|Overall Study|Adverse Event|0|||
42219749|NCT03592745|76037762|FG001|Overall Study|Adverse Event|2|||
42219750|NCT03592745|76037761|FG000|Overall Study|Lost to Follow-up|2|||
42219751|NCT03592745|76037762|FG001|Overall Study|Lost to Follow-up|0|||
42219752|NCT03592745|76037761|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
42219753|NCT03592745|76037762|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
42219754|NCT03592277|76037770|FG000|Overall Study|Withdrawal by Subject|6|||
42219755|NCT03592277|76037771|FG001|Overall Study|Withdrawal by Subject|8|||
42219756|NCT03401112|76037782|FG000|Overall Study|Adverse Event|1|||
42219757|NCT03401112|76037783|FG001|Overall Study|Adverse Event|2|||
42219758|NCT03401112|76037784|FG002|Overall Study|Adverse Event|3|||
42219759|NCT03401112|76037785|FG003|Overall Study|Adverse Event|2|||
42219760|NCT03401112|76037786|FG004|Overall Study|Adverse Event|0|||
42219761|NCT03401112|76037782|FG000|Overall Study|Lost to Follow-up|1|||
42219762|NCT03401112|76037783|FG001|Overall Study|Lost to Follow-up|0|||
42219763|NCT03401112|76037784|FG002|Overall Study|Lost to Follow-up|0|||
42219764|NCT03401112|76037785|FG003|Overall Study|Lost to Follow-up|0|||
42219765|NCT03401112|76037786|FG004|Overall Study|Lost to Follow-up|0|||
42219766|NCT03401112|76037782|FG000|Overall Study|Noncompliance|1|||
42219767|NCT03401112|76037783|FG001|Overall Study|Noncompliance|2|||
42219768|NCT03401112|76037784|FG002|Overall Study|Noncompliance|3|||
42219769|NCT03401112|76037785|FG003|Overall Study|Noncompliance|0|||
42219770|NCT03401112|76037786|FG004|Overall Study|Noncompliance|0|||
42219771|NCT03401112|76037782|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
42219772|NCT03401112|76037783|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
42219773|NCT03401112|76037784|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
42219774|NCT03401112|76037785|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
42219775|NCT03401112|76037786|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
42219776|NCT03401112|76037782|FG000|Overall Study|Withdrawal by Subject|0|||
42219777|NCT03401112|76037783|FG001|Overall Study|Withdrawal by Subject|3|||
42219778|NCT03401112|76037784|FG002|Overall Study|Withdrawal by Subject|2|||
42219779|NCT03401112|76037785|FG003|Overall Study|Withdrawal by Subject|1|||
42219780|NCT03401112|76037786|FG004|Overall Study|Withdrawal by Subject|0|||
42219781|NCT03401112|76037782|FG000|Overall Study|Physician Decision|0|||
42219782|NCT03401112|76037783|FG001|Overall Study|Physician Decision|0|||
42029053|NCT00952341|75837627|FG000|Cycle 2|Lost to Follow-up|6|||
42029054|NCT00952341|75837628|FG001|Cycle 2|Lost to Follow-up|9|||
41981600|NCT02677896|75787307|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
41981601|NCT02677896|75787308|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
41981602|NCT02677896|75787307|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
42219783|NCT03401112|76037784|FG002|Overall Study|Physician Decision|0|||
42219784|NCT03401112|76037785|FG003|Overall Study|Physician Decision|2|||
42219785|NCT03401112|76037786|FG004|Overall Study|Physician Decision|0|||
42219786|NCT03401112|76037782|FG000|Overall Study|Study was Terminated by Sponsor|0|||
42219787|NCT03401112|76037783|FG001|Overall Study|Study was Terminated by Sponsor|0|||
42219788|NCT03401112|76037784|FG002|Overall Study|Study was Terminated by Sponsor|0|||
42219789|NCT03401112|76037785|FG003|Overall Study|Study was Terminated by Sponsor|1|||
42219790|NCT03401112|76037786|FG004|Overall Study|Study was Terminated by Sponsor|0|||
42219791|NCT03401112|76037782|FG000|Overall Study|Day 1 Assessment not Done|1|||
42219792|NCT03401112|76037783|FG001|Overall Study|Day 1 Assessment not Done|0|||
42219793|NCT03401112|76037784|FG002|Overall Study|Day 1 Assessment not Done|0|||
42219794|NCT03401112|76037785|FG003|Overall Study|Day 1 Assessment not Done|0|||
42219795|NCT03401112|76037786|FG004|Overall Study|Day 1 Assessment not Done|0|||
42219796|NCT03401112|76037782|FG000|Overall Study|Not Dosed|0|||
42219797|NCT03401112|76037783|FG001|Overall Study|Not Dosed|0|||
42219798|NCT03401112|76037784|FG002|Overall Study|Not Dosed|1|||
42219799|NCT03401112|76037785|FG003|Overall Study|Not Dosed|0|||
42219800|NCT03401112|76037786|FG004|Overall Study|Not Dosed|0|||
42219801|NCT03401112|76037782|FG000|Overall Study|Missed Clinical Visit|0|||
42219802|NCT03401112|76037783|FG001|Overall Study|Missed Clinical Visit|0|||
42219803|NCT03401112|76037784|FG002|Overall Study|Missed Clinical Visit|1|||
42219804|NCT03401112|76037785|FG003|Overall Study|Missed Clinical Visit|0|||
42219805|NCT03401112|76037786|FG004|Overall Study|Missed Clinical Visit|0|||
42219806|NCT03401112|76037782|FG000|Overall Study|Missed Doses|0|||
41981603|NCT02677896|75787308|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
41981604|NCT02677896|75787307|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
41981605|NCT02677896|75787308|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
41981606|NCT02677896|75787307|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
41981607|NCT02677896|75787308|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
41981608|NCT02677896|75787307|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
41981609|NCT02677896|75787308|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
41981610|NCT02677896|75787307|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
41981611|NCT02677896|75787308|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
41981612|NCT02677896|75787307|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
41981613|NCT02677896|75787308|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
42130417|NCT00340834|75941277|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
42130418|NCT00340834|75941278|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
42130419|NCT00340834|75941279|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
42130420|NCT00340834|75941280|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
42130421|NCT00340834|75941281|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
42130422|NCT00340834|75941277|FG000|Extension Phase of Study|Administrative problems|3|||
42130423|NCT00340834|75941278|FG001|Extension Phase of Study|Administrative problems|0|||
42130424|NCT00340834|75941279|FG002|Extension Phase of Study|Administrative problems|0|||
42130425|NCT00340834|75941280|FG003|Extension Phase of Study|Administrative problems|1|||
42130426|NCT00340834|75941281|FG004|Extension Phase of Study|Administrative problems|1|||
42130427|NCT00340834|75941277|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
42130428|NCT00340834|75941278|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
42130429|NCT00340834|75941279|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
42130430|NCT00340834|75941280|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
42130431|NCT00340834|75941281|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
42130432|NCT00340834|75941277|FG000|Extension Phase of Study|Protocol Violation|3|||
42130433|NCT00340834|75941278|FG001|Extension Phase of Study|Protocol Violation|0|||
42130434|NCT00340834|75941279|FG002|Extension Phase of Study|Protocol Violation|0|||
42219807|NCT03401112|76037783|FG001|Overall Study|Missed Doses|0|||
42219808|NCT03401112|76037784|FG002|Overall Study|Missed Doses|1|||
41981614|NCT02677896|75787307|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
42219809|NCT03401112|76037785|FG003|Overall Study|Missed Doses|0|||
42219810|NCT03401112|76037786|FG004|Overall Study|Missed Doses|0|||
42219811|NCT02697916|76037815|FG000|Overall Study|Death|357|||
42219812|NCT02697916|76037816|FG001|Overall Study|Death|315|||
42219813|NCT02697916|76037815|FG000|Overall Study|Withdrawal by Subject|221|||
42219814|NCT02697916|76037816|FG001|Overall Study|Withdrawal by Subject|393|||
42219815|NCT03359473|76037835|FG000|Overall Study|Adverse Event|0|||
42219816|NCT03359473|76037836|FG001|Overall Study|Adverse Event|2|||
42219817|NCT03359473|76037837|FG002|Overall Study|Adverse Event|5|||
42219818|NCT03359473|76037838|FG003|Overall Study|Adverse Event|3|||
42219819|NCT03359473|76037835|FG000|Overall Study|Lost to Follow-up|0|||
42219820|NCT03359473|76037836|FG001|Overall Study|Lost to Follow-up|1|||
42219821|NCT03359473|76037837|FG002|Overall Study|Lost to Follow-up|0|||
42219822|NCT03359473|76037838|FG003|Overall Study|Lost to Follow-up|0|||
42219823|NCT03359473|76037835|FG000|Overall Study|Physician Decision|0|||
42302219|NCT02495077|76137272|FG002|Overall Study|Covid-19 research restrictions|0|||
41981615|NCT02677896|75787308|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
41981616|NCT02677896|75787307|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
41981617|NCT02677896|75787308|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
41981618|NCT02677896|75787307|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
41981619|NCT02677896|75787308|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
41981620|NCT02630693|75787317|FG000|Overall Study|No receive treatment|0|||
41981621|NCT02630693|75787318|FG001|Overall Study|No receive treatment|1|||
41981622|NCT02626338|75787327|FG000|Overall Study|Lack of Efficacy|3|||
41981623|NCT02626338|75787328|FG001|Overall Study|Lack of Efficacy|2|||
41981624|NCT02626338|75787329|FG002|Overall Study|Lack of Efficacy|0|||
41981625|NCT02603146|75787341|FG000|Overall Study|Lost to Follow-up|5|||
41981626|NCT02603146|75787342|FG001|Overall Study|Lost to Follow-up|6|||
41981627|NCT02603146|75787341|FG000|Overall Study|Withdrawal by Subject|8|||
41981628|NCT02603146|75787342|FG001|Overall Study|Withdrawal by Subject|10|||
41981629|NCT02603146|75787341|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
41981630|NCT02603146|75787342|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
41981631|NCT02603146|75787341|FG000|Overall Study|Participant moved|2|||
41981632|NCT02603146|75787342|FG001|Overall Study|Participant moved|0|||
41981633|NCT02603146|75787341|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
41981634|NCT02603146|75787342|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
41981635|NCT01723774|75787412|FG000|Neoadjuvant|Ki67 > 10%|4|||
41981636|NCT01723774|75787413|FG001|Neoadjuvant|Ki67 > 10%|0|||
41981637|NCT01723774|75787414|FG002|Neoadjuvant|Ki67 > 10%|10|||
41981638|NCT01723774|75787415|FG003|Neoadjuvant|Ki67 > 10%|0|||
41981639|NCT01723774|75787412|FG000|Neoadjuvant|Withdrawal by Subject|3|||
41981640|NCT01723774|75787413|FG001|Neoadjuvant|Withdrawal by Subject|1|||
41981641|NCT01723774|75787414|FG002|Neoadjuvant|Withdrawal by Subject|0|||
41981642|NCT01723774|75787415|FG003|Neoadjuvant|Withdrawal by Subject|0|||
41981643|NCT01723774|75787412|FG000|Neoadjuvant|Disease progression|0|||
41981644|NCT01723774|75787413|FG001|Neoadjuvant|Disease progression|1|||
41981645|NCT01723774|75787414|FG002|Neoadjuvant|Disease progression|1|||
41981646|NCT01723774|75787415|FG003|Neoadjuvant|Disease progression|0|||
41981647|NCT01723774|75787412|FG000|Neoadjuvant|Adverse Event|0|||
41981648|NCT01723774|75787413|FG001|Neoadjuvant|Adverse Event|1|||
41981649|NCT01723774|75787414|FG002|Neoadjuvant|Adverse Event|2|||
41981650|NCT01723774|75787415|FG003|Neoadjuvant|Adverse Event|0|||
41981651|NCT01723774|75787412|FG000|Neoadjuvant|High estradiol|0|||
41981652|NCT01723774|75787413|FG001|Neoadjuvant|High estradiol|1|||
41981653|NCT01723774|75787414|FG002|Neoadjuvant|High estradiol|0|||
41981654|NCT01723774|75787415|FG003|Neoadjuvant|High estradiol|0|||
41981655|NCT01012817|75787452|FG000|Overall Study|Withdrawal by Subject|0|||
41981656|NCT01012817|75787453|FG001|Overall Study|Withdrawal by Subject|0|||
41981657|NCT01012817|75787454|FG002|Overall Study|Withdrawal by Subject|0|||
41981658|NCT01012817|75787455|FG003|Overall Study|Withdrawal by Subject|1|||
41981659|NCT01012817|75787456|FG004|Overall Study|Withdrawal by Subject|0|||
41981660|NCT01012817|75787457|FG005|Overall Study|Withdrawal by Subject|0|||
42130435|NCT00340834|75941280|FG003|Extension Phase of Study|Protocol Violation|0|||
42130436|NCT00340834|75941281|FG004|Extension Phase of Study|Protocol Violation|0|||
42130437|NCT00340834|75941277|FG000|Extension Phase of Study|Death|0|||
42130438|NCT00340834|75941278|FG001|Extension Phase of Study|Death|0|||
41981661|NCT01012817|75787458|FG006|Overall Study|Withdrawal by Subject|0|||
42130439|NCT00340834|75941279|FG002|Extension Phase of Study|Death|0|||
42130440|NCT00340834|75941280|FG003|Extension Phase of Study|Death|0|||
42130441|NCT00340834|75941281|FG004|Extension Phase of Study|Death|1|||
42130442|NCT00603941|75941294|FG000|Overall Study|Disease progression|6|||
41981662|NCT01012817|75787459|FG007|Overall Study|Withdrawal by Subject|1|||
41981663|NCT01012817|75787460|FG008|Overall Study|Withdrawal by Subject|0|||
41981664|NCT01012817|75787461|FG009|Overall Study|Withdrawal by Subject|0|||
41981665|NCT01012817|75787462|FG010|Overall Study|Withdrawal by Subject|1|||
41981666|NCT01012817|75787463|FG011|Overall Study|Withdrawal by Subject|1|||
41981667|NCT01012817|75787464|FG012|Overall Study|Withdrawal by Subject|0|||
41981668|NCT01012817|75787465|FG013|Overall Study|Withdrawal by Subject|1|||
41981669|NCT01012817|75787452|FG000|Overall Study|Adverse Event|0|||
42130443|NCT00603941|75941295|FG001|Overall Study|Disease progression|7|||
42130444|NCT00603941|75941296|FG002|Overall Study|Disease progression|1|||
41981670|NCT01012817|75787453|FG001|Overall Study|Adverse Event|0|||
41981671|NCT01012817|75787454|FG002|Overall Study|Adverse Event|0|||
41981672|NCT01012817|75787455|FG003|Overall Study|Adverse Event|0|||
41981673|NCT01012817|75787456|FG004|Overall Study|Adverse Event|0|||
41981674|NCT01012817|75787457|FG005|Overall Study|Adverse Event|1|||
41981675|NCT01012817|75787458|FG006|Overall Study|Adverse Event|0|||
41981676|NCT01012817|75787459|FG007|Overall Study|Adverse Event|0|||
41981677|NCT01012817|75787460|FG008|Overall Study|Adverse Event|0|||
41981678|NCT01012817|75787461|FG009|Overall Study|Adverse Event|0|||
41981679|NCT01012817|75787462|FG010|Overall Study|Adverse Event|1|||
41981680|NCT01012817|75787463|FG011|Overall Study|Adverse Event|0|||
41981681|NCT01012817|75787464|FG012|Overall Study|Adverse Event|0|||
41981682|NCT01012817|75787465|FG013|Overall Study|Adverse Event|1|||
42130445|NCT00603941|75941294|FG000|Overall Study|Adverse Event|1|||
42130446|NCT00603941|75941295|FG001|Overall Study|Adverse Event|0|||
42130447|NCT00603941|75941296|FG002|Overall Study|Adverse Event|1|||
42130448|NCT00603941|75941294|FG000|Overall Study|Physician Decision|0|||
42130449|NCT00603941|75941295|FG001|Overall Study|Physician Decision|1|||
42130450|NCT00603941|75941296|FG002|Overall Study|Physician Decision|0|||
42130451|NCT00603941|75941294|FG000|Overall Study|Withdrawal by Subject|0|||
42219824|NCT03359473|76037836|FG001|Overall Study|Physician Decision|1|||
42219825|NCT03359473|76037837|FG002|Overall Study|Physician Decision|0|||
42219826|NCT03359473|76037838|FG003|Overall Study|Physician Decision|1|||
42219827|NCT03359473|76037835|FG000|Overall Study|Withdrawal by Subject|1|||
42219828|NCT03359473|76037836|FG001|Overall Study|Withdrawal by Subject|2|||
42219829|NCT03359473|76037837|FG002|Overall Study|Withdrawal by Subject|1|||
42130452|NCT00603941|75941295|FG001|Overall Study|Withdrawal by Subject|2|||
42130453|NCT00603941|75941296|FG002|Overall Study|Withdrawal by Subject|0|||
42130454|NCT00340678|75941309|FG000|Overall Study|Lost to Follow-up|1|||
42130455|NCT00340678|75941310|FG001|Overall Study|Lost to Follow-up|0|||
42130456|NCT00340678|75941311|FG002|Overall Study|Lost to Follow-up|0|||
42130457|NCT00340678|75941312|FG003|Overall Study|Lost to Follow-up|0|||
42130458|NCT00336544|75941322|FG000|Overall Study|Lack of Efficacy|8|||
42130459|NCT00336544|75941323|FG001|Overall Study|Lack of Efficacy|5|||
42130460|NCT00336544|75941322|FG000|Overall Study|Adverse Event|4|||
42130461|NCT00336544|75941323|FG001|Overall Study|Adverse Event|9|||
42219830|NCT03359473|76037838|FG003|Overall Study|Withdrawal by Subject|0|||
42219831|NCT03359473|76037835|FG000|Overall Study|Protocol-defined stopping criteria|1|||
42219832|NCT03359473|76037836|FG001|Overall Study|Protocol-defined stopping criteria|0|||
42219833|NCT03359473|76037837|FG002|Overall Study|Protocol-defined stopping criteria|0|||
42219834|NCT03359473|76037838|FG003|Overall Study|Protocol-defined stopping criteria|1|||
42219835|NCT03589469|76037851|FG000|Overall Study|Withdrawal by Subject|8|||
42219836|NCT03589469|76037851|FG000|Overall Study|Physician Decision|20|||
42219837|NCT03589469|76037851|FG000|Overall Study|Death|97|||
42219838|NCT03589469|76037851|FG000|Overall Study|Lost to Follow-up|8|||
42219839|NCT03589469|76037851|FG000|Overall Study|Miscellaneous|1|||
42219840|NCT03359395|76037857|FG000|First Intervention A / B|Withdrawal by Subject|1|||
42219841|NCT03359395|76037858|FG001|First Intervention A / B|Withdrawal by Subject|0|||
42219842|NCT03359395|76037857|FG000|First Intervention A / B|Lost to Follow-up|2|||
42219843|NCT03359395|76037858|FG001|First Intervention A / B|Lost to Follow-up|3|||
42219844|NCT03359395|76037857|FG000|Second Intervention B/A|Exclusion criteria|0|||
42219845|NCT03359395|76037858|FG001|Second Intervention B/A|Exclusion criteria|1|||
42219846|NCT03359395|76037857|FG000|Second Intervention B/A|Lost to Follow-up|3|||
42219847|NCT03359395|76037858|FG001|Second Intervention B/A|Lost to Follow-up|2|||
42219848|NCT03586427|76037869|FG000|Overall Study|Lost to Follow-up|0|||
42219849|NCT03586427|76037870|FG001|Overall Study|Lost to Follow-up|3|||
42219850|NCT03586427|76037871|FG002|Overall Study|Lost to Follow-up|1|||
42219851|NCT03586427|76037872|FG003|Overall Study|Lost to Follow-up|3|||
42219852|NCT03586427|76037873|FG004|Overall Study|Lost to Follow-up|3|||
42219853|NCT03586427|76037869|FG000|Overall Study|Withdrawal by Subject|0|||
42219854|NCT03586427|76037870|FG001|Overall Study|Withdrawal by Subject|1|||
42219855|NCT03586427|76037871|FG002|Overall Study|Withdrawal by Subject|2|||
42219856|NCT03586427|76037872|FG003|Overall Study|Withdrawal by Subject|1|||
42219857|NCT03586427|76037873|FG004|Overall Study|Withdrawal by Subject|1|||
42219858|NCT03586427|76037869|FG000|Overall Study|Adverse Event|0|||
42219859|NCT03586427|76037870|FG001|Overall Study|Adverse Event|0|||
42219860|NCT03586427|76037871|FG002|Overall Study|Adverse Event|1|||
42219861|NCT03586427|76037872|FG003|Overall Study|Adverse Event|0|||
42219862|NCT03586427|76037873|FG004|Overall Study|Adverse Event|0|||
42219863|NCT03586427|76037869|FG000|Overall Study|Protocol Violation|0|||
42219864|NCT03586427|76037870|FG001|Overall Study|Protocol Violation|0|||
42219865|NCT03586427|76037871|FG002|Overall Study|Protocol Violation|1|||
42219866|NCT03586427|76037872|FG003|Overall Study|Protocol Violation|0|||
42219867|NCT03586427|76037873|FG004|Overall Study|Protocol Violation|1|||
41981683|NCT00920582|75787499|FG000|Overall Study|Lost to Follow-up|5|||
41981684|NCT00920582|75787500|FG001|Overall Study|Lost to Follow-up|1|||
42130462|NCT00336544|75941322|FG000|Overall Study|Withdrawal by Subject|4|||
42130463|NCT00336544|75941323|FG001|Overall Study|Withdrawal by Subject|3|||
42130464|NCT00336544|75941322|FG000|Overall Study|Other|3|||
42219868|NCT03586427|76037869|FG000|Overall Study|Noncompliance with study drug|0|||
41981685|NCT00920582|75787501|FG002|Overall Study|Lost to Follow-up|2|||
41981686|NCT00920582|75787502|FG003|Overall Study|Lost to Follow-up|0|||
41981687|NCT00920582|75787499|FG000|Overall Study|Withdrawal by Subject|5|||
41981688|NCT00920582|75787500|FG001|Overall Study|Withdrawal by Subject|4|||
41981689|NCT00920582|75787501|FG002|Overall Study|Withdrawal by Subject|6|||
41981690|NCT00920582|75787502|FG003|Overall Study|Withdrawal by Subject|3|||
41981691|NCT00920582|75787499|FG000|Overall Study|Protocol Violation|1|||
41981692|NCT00920582|75787500|FG001|Overall Study|Protocol Violation|0|||
41981693|NCT00920582|75787501|FG002|Overall Study|Protocol Violation|0|||
41981694|NCT00920582|75787502|FG003|Overall Study|Protocol Violation|0|||
41981695|NCT00920582|75787499|FG000|Overall Study|Other|2|||
41981696|NCT00920582|75787500|FG001|Overall Study|Other|1|||
41981697|NCT00920582|75787501|FG002|Overall Study|Other|3|||
41981698|NCT00920582|75787502|FG003|Overall Study|Other|2|||
41981699|NCT00199888|75787551|FG000|Overall Study|Lost to Follow-up|1|||
41981700|NCT00199849|75787558|FG000|Overall Study|Unrelated illness or complication|0|||
41981701|NCT00199849|75787559|FG001|Overall Study|Unrelated illness or complication|1|||
41981702|NCT00199849|75787560|FG002|Overall Study|Unrelated illness or complication|0|||
41981703|NCT00199849|75787558|FG000|Overall Study|Progressive disease requiring intervention|0|||
41981704|NCT00199849|75787559|FG001|Overall Study|Progressive disease requiring intervention|0|||
41981705|NCT00199849|75787560|FG002|Overall Study|Progressive disease requiring intervention|1|||
41981706|NCT00199849|75787558|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
41981707|NCT00199849|75787559|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
41981708|NCT00199849|75787560|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
41981709|NCT00199381|75787568|FG000|Overall Study|Withdrawal by Subject|38|||
41981710|NCT00199381|75787568|FG000|Overall Study|Adverse Event|73|||
41981711|NCT00199381|75787568|FG000|Overall Study|Protocol Violation|6|||
41981712|NCT00199381|75787568|FG000|Overall Study|Lack of Efficacy|27|||
41981713|NCT00199381|75787568|FG000|Overall Study|Not including due to early termination|37|||
41981714|NCT00199381|75787568|FG000|Overall Study|Study termination by Sponsor|323|||
41981715|NCT00198133|75787574|FG000|Overall Study|Disease progression|2|||
41981716|NCT00198133|75787575|FG001|Overall Study|Disease progression|5|||
41981717|NCT00198133|75787574|FG000|Overall Study|Adverse Event|1|||
41981718|NCT00198133|75787575|FG001|Overall Study|Adverse Event|3|||
41981719|NCT00198133|75787574|FG000|Overall Study|Withdrawal by Subject|1|||
41981720|NCT00198133|75787575|FG001|Overall Study|Withdrawal by Subject|0|||
41981721|NCT00198133|75787574|FG000|Overall Study|Physician Decision|1|||
41981722|NCT00198133|75787575|FG001|Overall Study|Physician Decision|0|||
41981723|NCT00197236|75787584|FG000|Overall Study|Adverse Event|1|||
41981724|NCT00197236|75787585|FG001|Overall Study|Adverse Event|0|||
41981725|NCT00197236|75787586|FG002|Overall Study|Adverse Event|1|||
41981726|NCT00197236|75787584|FG000|Overall Study|Lost to Follow-up|5|||
41981727|NCT00197236|75787585|FG001|Overall Study|Lost to Follow-up|14|||
41981728|NCT00197236|75787586|FG002|Overall Study|Lost to Follow-up|6|||
41981729|NCT00197236|75787584|FG000|Overall Study|Protocol Violation|0|||
41981730|NCT00197236|75787585|FG001|Overall Study|Protocol Violation|0|||
41981731|NCT00197236|75787586|FG002|Overall Study|Protocol Violation|1|||
41981732|NCT00197236|75787584|FG000|Overall Study|Withdrawal by Subject|7|||
41981733|NCT00197236|75787585|FG001|Overall Study|Withdrawal by Subject|3|||
41981734|NCT00197236|75787586|FG002|Overall Study|Withdrawal by Subject|11|||
41981735|NCT00197236|75787584|FG000|Overall Study|Study drug/medication expiration|1|||
41981736|NCT00197236|75787585|FG001|Overall Study|Study drug/medication expiration|0|||
41981737|NCT00197236|75787586|FG002|Overall Study|Study drug/medication expiration|3|||
41981738|NCT00197236|75787584|FG000|Overall Study|Returned out of specified time window|0|||
41981739|NCT00197236|75787585|FG001|Overall Study|Returned out of specified time window|0|||
41981740|NCT00197236|75787586|FG002|Overall Study|Returned out of specified time window|1|||
41981741|NCT00197002|75787600|FG000|Overall Study|Adverse Event|0|||
41981742|NCT00197002|75787601|FG001|Overall Study|Adverse Event|1|||
41981743|NCT00197002|75787602|FG002|Overall Study|Adverse Event|0|||
41981744|NCT00197002|75787600|FG000|Overall Study|Protocol Violation|1|||
41981745|NCT00197002|75787601|FG001|Overall Study|Protocol Violation|0|||
41981746|NCT00197002|75787602|FG002|Overall Study|Protocol Violation|2|||
41981747|NCT00197002|75787600|FG000|Overall Study|Withdrawal by Subject|9|||
41981748|NCT00197002|75787601|FG001|Overall Study|Withdrawal by Subject|5|||
41981749|NCT00197002|75787602|FG002|Overall Study|Withdrawal by Subject|7|||
41981750|NCT00197002|75787600|FG000|Overall Study|Migrated/moved from study area|3|||
41981751|NCT00197002|75787601|FG001|Overall Study|Migrated/moved from study area|5|||
41981752|NCT00197002|75787602|FG002|Overall Study|Migrated/moved from study area|1|||
41981753|NCT00197002|75787600|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
41981754|NCT00197002|75787601|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
41981755|NCT00197002|75787602|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
41981756|NCT00197002|75787600|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
41981757|NCT00197002|75787601|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
41981758|NCT00197002|75787602|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
41981759|NCT00197002|75787600|FG000|Overall Study|Others|3|||
42219869|NCT03586427|76037870|FG001|Overall Study|Noncompliance with study drug|0|||
42219870|NCT03586427|76037871|FG002|Overall Study|Noncompliance with study drug|1|||
42219871|NCT03586427|76037872|FG003|Overall Study|Noncompliance with study drug|0|||
42219872|NCT03586427|76037873|FG004|Overall Study|Noncompliance with study drug|0|||
42219873|NCT03648983|76037890|FG000|Overall Study|Study was terminated due to PI departure|95|||
42219874|NCT02695420|76037899|FG000|Overall Study|Death|0|||
42219875|NCT02695420|76037900|FG001|Overall Study|Death|1|||
42219876|NCT02695420|76037901|FG002|Overall Study|Death|0|||
41981760|NCT00197002|75787601|FG001|Overall Study|Others|1|||
41981761|NCT00197002|75787602|FG002|Overall Study|Others|1|||
42219877|NCT02695420|76037902|FG003|Overall Study|Death|0|||
42219878|NCT03358147|76037920|FG000|Overall Study|Withdrawal by Subject|13|||
42219879|NCT03358147|76037921|FG001|Overall Study|Withdrawal by Subject|19|||
42219880|NCT03358147|76037922|FG002|Overall Study|Withdrawal by Subject|16|||
42219881|NCT03358147|76037923|FG003|Overall Study|Withdrawal by Subject|10|||
42219882|NCT03358147|76037924|FG004|Overall Study|Withdrawal by Subject|5|||
42219883|NCT03358147|76037920|FG000|Overall Study|Adverse Event|3|||
41981762|NCT00196105|75787616|FG000|Overall Study|Lost to Follow-up|4|||
41981763|NCT00196105|75787617|FG001|Overall Study|Lost to Follow-up|5|||
41981764|NCT00196105|75787618|FG002|Overall Study|Lost to Follow-up|7|||
41981765|NCT00195715|75787626|FG000|Overall Study|Adverse Event|122|||
41981766|NCT00195715|75787626|FG000|Overall Study|Withdrawal by Subject|58|||
42219884|NCT03358147|76037921|FG001|Overall Study|Adverse Event|9|||
42219885|NCT03358147|76037922|FG002|Overall Study|Adverse Event|7|||
42219886|NCT03358147|76037923|FG003|Overall Study|Adverse Event|5|||
42219887|NCT03358147|76037924|FG004|Overall Study|Adverse Event|2|||
42219888|NCT03358147|76037920|FG000|Overall Study|Lost to Follow-up|4|||
42219889|NCT03358147|76037921|FG001|Overall Study|Lost to Follow-up|3|||
42219890|NCT03358147|76037922|FG002|Overall Study|Lost to Follow-up|7|||
42219891|NCT03358147|76037923|FG003|Overall Study|Lost to Follow-up|6|||
42219892|NCT03358147|76037924|FG004|Overall Study|Lost to Follow-up|4|||
42219893|NCT03358147|76037920|FG000|Overall Study|Major Protocol Deviation|11|||
42219894|NCT03358147|76037921|FG001|Overall Study|Major Protocol Deviation|3|||
42219895|NCT03358147|76037922|FG002|Overall Study|Major Protocol Deviation|2|||
42219896|NCT03358147|76037923|FG003|Overall Study|Major Protocol Deviation|3|||
42219897|NCT03358147|76037924|FG004|Overall Study|Major Protocol Deviation|1|||
42219898|NCT03358147|76037920|FG000|Overall Study|Protocol specified criteria|2|||
42219899|NCT03358147|76037921|FG001|Overall Study|Protocol specified criteria|3|||
42219900|NCT03358147|76037922|FG002|Overall Study|Protocol specified criteria|0|||
42219901|NCT03358147|76037923|FG003|Overall Study|Protocol specified criteria|3|||
42219902|NCT03358147|76037924|FG004|Overall Study|Protocol specified criteria|1|||
42219903|NCT03358147|76037920|FG000|Overall Study|Physician Decision|1|||
42219904|NCT03358147|76037921|FG001|Overall Study|Physician Decision|0|||
42219905|NCT03358147|76037922|FG002|Overall Study|Physician Decision|1|||
42302220|NCT02495077|76137273|FG003|Overall Study|Covid-19 research restrictions|0|||
42029055|NCT00952341|75837627|FG000|Cycle 2|Physician Decision|1|||
42029056|NCT00952341|75837628|FG001|Cycle 2|Physician Decision|1|||
42029057|NCT00952341|75837627|FG000|Cycle 2|Progressive Disease|0|||
42029058|NCT00952341|75837628|FG001|Cycle 2|Progressive Disease|1|||
42029059|NCT00946881|75837634|FG000|First Treatment|Withdrawal by Subject|1|||
42029060|NCT00946881|75837634|FG000|First Treatment|Patient relocated to another state|1|||
42029061|NCT00946881|75837634|FG000|Retreatment|Withdrawal by Subject|1|||
42029062|NCT01214642|75837671|FG000|Overall Study|Progressive Disease|3|||
42029063|NCT01214642|75837672|FG001|Overall Study|Progressive Disease|2|||
42029064|NCT01214642|75837673|FG002|Overall Study|Progressive Disease|3|||
42029065|NCT01214642|75837674|FG003|Overall Study|Progressive Disease|5|||
42029066|NCT01214642|75837675|FG004|Overall Study|Progressive Disease|5|||
42029067|NCT01214642|75837676|FG005|Overall Study|Progressive Disease|3|||
42029068|NCT01214642|75837677|FG006|Overall Study|Progressive Disease|5|||
42029069|NCT01214642|75837678|FG007|Overall Study|Progressive Disease|3|||
42029070|NCT01214642|75837679|FG008|Overall Study|Progressive Disease|10|||
42029071|NCT01214642|75837680|FG009|Overall Study|Progressive Disease|2|||
42029072|NCT01214642|75837681|FG010|Overall Study|Progressive Disease|1|||
42029073|NCT01214642|75837682|FG011|Overall Study|Progressive Disease|4|||
41981767|NCT00195715|75787626|FG000|Overall Study|Lost to Follow-up|27|||
42029074|NCT01214642|75837671|FG000|Overall Study|Adverse Event|0|||
42029075|NCT01214642|75837672|FG001|Overall Study|Adverse Event|1|||
42029076|NCT01214642|75837673|FG002|Overall Study|Adverse Event|0|||
42219906|NCT03358147|76037923|FG003|Overall Study|Physician Decision|6|||
42029077|NCT01214642|75837674|FG003|Overall Study|Adverse Event|0|||
42219907|NCT03358147|76037924|FG004|Overall Study|Physician Decision|1|||
42302221|NCT02495077|76137270|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
41981768|NCT00195715|75787626|FG000|Overall Study|Protocol Violation|13|||
42029078|NCT01214642|75837675|FG004|Overall Study|Adverse Event|0|||
42029079|NCT01214642|75837676|FG005|Overall Study|Adverse Event|0|||
42029080|NCT01214642|75837677|FG006|Overall Study|Adverse Event|1|||
42029081|NCT01214642|75837678|FG007|Overall Study|Adverse Event|0|||
42219908|NCT03358147|76037920|FG000|Overall Study|Administrative reasons|0|||
42219909|NCT03358147|76037921|FG001|Overall Study|Administrative reasons|1|||
42029082|NCT01214642|75837679|FG008|Overall Study|Adverse Event|0|||
42029083|NCT01214642|75837680|FG009|Overall Study|Adverse Event|1|||
42029084|NCT01214642|75837681|FG010|Overall Study|Adverse Event|1|||
42029085|NCT01214642|75837682|FG011|Overall Study|Adverse Event|0|||
42029086|NCT01214642|75837671|FG000|Overall Study|Death|0|||
42029087|NCT01214642|75837672|FG001|Overall Study|Death|0|||
42029088|NCT01214642|75837673|FG002|Overall Study|Death|1|||
41981769|NCT00195715|75787626|FG000|Overall Study|Lack of Efficacy|93|||
41981770|NCT00195715|75787626|FG000|Overall Study|Pregnancy|14|||
42029089|NCT01214642|75837674|FG003|Overall Study|Death|0|||
42029090|NCT01214642|75837675|FG004|Overall Study|Death|0|||
42029091|NCT01214642|75837676|FG005|Overall Study|Death|0|||
42029092|NCT01214642|75837677|FG006|Overall Study|Death|0|||
42029093|NCT01214642|75837678|FG007|Overall Study|Death|0|||
42029094|NCT01214642|75837679|FG008|Overall Study|Death|0|||
42029095|NCT01214642|75837680|FG009|Overall Study|Death|0|||
42029096|NCT01214642|75837681|FG010|Overall Study|Death|1|||
42029097|NCT01214642|75837682|FG011|Overall Study|Death|0|||
42029098|NCT01214642|75837671|FG000|Overall Study|Withdrawal by Subject|0|||
42029099|NCT01214642|75837672|FG001|Overall Study|Withdrawal by Subject|0|||
42029100|NCT01214642|75837673|FG002|Overall Study|Withdrawal by Subject|1|||
42029101|NCT01214642|75837674|FG003|Overall Study|Withdrawal by Subject|0|||
42029102|NCT01214642|75837675|FG004|Overall Study|Withdrawal by Subject|0|||
41981771|NCT00195715|75787626|FG000|Overall Study|Investigative site closure|8|||
41981772|NCT00195715|75787626|FG000|Overall Study|Subject moved/relocated|7|||
41981773|NCT00195715|75787626|FG000|Overall Study|Subject non-compliance|6|||
41981774|NCT00195715|75787626|FG000|Overall Study|Subject started commercial Humira|5|||
41981775|NCT00195715|75787626|FG000|Overall Study|Subject choice|3|||
41981776|NCT00195715|75787626|FG000|Overall Study|Loss of response/no improvement|3|||
41981777|NCT00195715|75787626|FG000|Overall Study|Sponsor stopped study|1|||
41981778|NCT00195715|75787626|FG000|Overall Study|Administrative reasons|2|||
41981779|NCT00195715|75787626|FG000|Overall Study|Investigator's decision|2|||
41981780|NCT00195715|75787626|FG000|Overall Study|Subject wants to get pregnant|4|||
41981781|NCT00195715|75787626|FG000|Overall Study|Use of prohibited medication|2|||
41981782|NCT00195715|75787626|FG000|Overall Study|Planned surgery|2|||
41981783|NCT00195715|75787626|FG000|Overall Study|Increased infection rate|1|||
41981784|NCT00195715|75787626|FG000|Overall Study|Ineligible|1|||
41981785|NCT00195715|75787626|FG000|Overall Study|Colonic stricture|1|||
41981786|NCT00195715|75787626|FG000|Overall Study|Sponsor discontinued trial|1|||
41981787|NCT00195715|75787626|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
41981788|NCT00195676|75787630|FG000|Period O - Open-label Treatment|Adverse Event|82|||
41981789|NCT00195676|75787630|FG000|Period O - Open-label Treatment|Death|6|||
41981790|NCT00195676|75787630|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
42029103|NCT01214642|75837676|FG005|Overall Study|Withdrawal by Subject|0|||
42029104|NCT01214642|75837677|FG006|Overall Study|Withdrawal by Subject|0|||
42029105|NCT01214642|75837678|FG007|Overall Study|Withdrawal by Subject|0|||
42029106|NCT01214642|75837679|FG008|Overall Study|Withdrawal by Subject|3|||
42029107|NCT01214642|75837680|FG009|Overall Study|Withdrawal by Subject|1|||
42029108|NCT01214642|75837681|FG010|Overall Study|Withdrawal by Subject|1|||
42130465|NCT00336544|75941323|FG001|Overall Study|Other|5|||
42130466|NCT00605033|75941331|FG000|Overall Study|Adverse Event|2|||
41981791|NCT00195676|75787630|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
41981792|NCT00195676|75787630|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
41981793|NCT00195676|75787630|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
41981794|NCT00195676|75787630|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
41981795|NCT00195676|75787630|FG000|Period O - Open-label Treatment|Other reasons|68|||
41981796|NCT00195676|75787630|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
42029109|NCT01214642|75837682|FG011|Overall Study|Withdrawal by Subject|0|||
42029110|NCT01214642|75837671|FG000|Overall Study|Physician Decision|0|||
42029111|NCT01214642|75837672|FG001|Overall Study|Physician Decision|0|||
42130467|NCT00605033|75941332|FG001|Overall Study|Adverse Event|2|||
42130468|NCT00605033|75941331|FG000|Overall Study|Lost to Follow-up|1|||
42130469|NCT00605033|75941332|FG001|Overall Study|Lost to Follow-up|1|||
42130470|NCT00605033|75941331|FG000|Overall Study|Withdrawal by Subject|3|||
41981797|NCT00195676|75787630|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
41981798|NCT00195676|75787630|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
42219910|NCT03358147|76037922|FG002|Overall Study|Administrative reasons|0|||
41981799|NCT00195676|75787630|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
41981800|NCT00195676|75787630|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
42029112|NCT01214642|75837673|FG002|Overall Study|Physician Decision|1|||
42029113|NCT01214642|75837674|FG003|Overall Study|Physician Decision|1|||
42029114|NCT01214642|75837675|FG004|Overall Study|Physician Decision|1|||
42029115|NCT01214642|75837676|FG005|Overall Study|Physician Decision|0|||
42029116|NCT01214642|75837677|FG006|Overall Study|Physician Decision|0|||
42029117|NCT01214642|75837678|FG007|Overall Study|Physician Decision|0|||
42029118|NCT01214642|75837679|FG008|Overall Study|Physician Decision|0|||
42130471|NCT00605033|75941332|FG001|Overall Study|Withdrawal by Subject|4|||
41981801|NCT00195676|75787630|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
41981802|NCT00195676|75787630|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
41981803|NCT00195676|75787630|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
41981804|NCT00195676|75787630|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
41981805|NCT00195676|75787630|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
41981806|NCT00195676|75787630|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
41981807|NCT00195676|75787630|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
41981808|NCT00195676|75787630|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
41981809|NCT00194077|75787640|FG000|Overall Study|Lack of Efficacy|22|||
42029119|NCT01214642|75837680|FG009|Overall Study|Physician Decision|0|||
42029120|NCT01214642|75837681|FG010|Overall Study|Physician Decision|0|||
42029121|NCT01214642|75837682|FG011|Overall Study|Physician Decision|2|||
42029122|NCT01214252|75837725|FG000|Overall Study|Not eligible per protocol|82|||
42029123|NCT01214174|75837733|FG000|Overall Study|Withdrawal by Subject|0|||
42029124|NCT01214174|75837734|FG001|Overall Study|Withdrawal by Subject|0|||
42029125|NCT01214174|75837735|FG002|Overall Study|Withdrawal by Subject|1|||
42029126|NCT00901342|75837743|FG000|Overall Study|Adverse Event|1|||
42029127|NCT00901342|75837743|FG000|Overall Study|Death|4|||
42130472|NCT00605033|75941331|FG000|Overall Study|Protocol Violation|1|||
42130473|NCT00605033|75941332|FG001|Overall Study|Protocol Violation|1|||
42219911|NCT03358147|76037923|FG003|Overall Study|Administrative reasons|3|||
42219912|NCT03358147|76037924|FG004|Overall Study|Administrative reasons|0|||
42219913|NCT03358147|76037920|FG000|Overall Study|Lack of Efficacy|0|||
42219914|NCT03358147|76037921|FG001|Overall Study|Lack of Efficacy|1|||
42219915|NCT03358147|76037922|FG002|Overall Study|Lack of Efficacy|1|||
42219916|NCT03358147|76037923|FG003|Overall Study|Lack of Efficacy|0|||
42219917|NCT03358147|76037924|FG004|Overall Study|Lack of Efficacy|0|||
42219918|NCT03093402|76037940|FG000|Overall Study|Lost to Follow-up|1|||
42219919|NCT03093402|76037941|FG001|Overall Study|Lost to Follow-up|0|||
42219920|NCT03093402|76037942|FG002|Overall Study|Lost to Follow-up|0|||
42219921|NCT03093402|76037943|FG003|Overall Study|Lost to Follow-up|0|||
42219922|NCT03093402|76037940|FG000|Overall Study|Withdrawal by Subject|3|||
42219923|NCT03093402|76037941|FG001|Overall Study|Withdrawal by Subject|3|||
42219924|NCT03093402|76037942|FG002|Overall Study|Withdrawal by Subject|0|||
42219925|NCT03093402|76037943|FG003|Overall Study|Withdrawal by Subject|1|||
42219926|NCT03093402|76037940|FG000|Overall Study|Withdrew prior to dosing|2|||
42219927|NCT03093402|76037941|FG001|Overall Study|Withdrew prior to dosing|1|||
42219928|NCT03093402|76037942|FG002|Overall Study|Withdrew prior to dosing|2|||
42219929|NCT03093402|76037943|FG003|Overall Study|Withdrew prior to dosing|3|||
42219930|NCT03093402|76037940|FG000|Overall Study|Ineligible for study|1|||
42219931|NCT03093402|76037941|FG001|Overall Study|Ineligible for study|0|||
42219932|NCT03093402|76037942|FG002|Overall Study|Ineligible for study|0|||
42219933|NCT03093402|76037943|FG003|Overall Study|Ineligible for study|0|||
42219934|NCT03093402|76037940|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
42219935|NCT03093402|76037941|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
42219936|NCT03093402|76037942|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
42219937|NCT03093402|76037943|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
42219938|NCT03585959|76037953|FG000|Overall Study|Physician Decision|1|||
42219939|NCT03585959|76037953|FG000|Overall Study|Unsuccessful Procedure|2|||
42219940|NCT03584789|76037962|FG000|Overall Study|refused EHR permission|19|||
41981810|NCT00194077|75787641|FG001|Overall Study|Lack of Efficacy|29|||
41981811|NCT00194077|75787640|FG000|Overall Study|Study nonadherence|1|||
42029128|NCT00901342|75837743|FG000|Overall Study|Disease progression|1|||
42029129|NCT00901342|75837743|FG000|Overall Study|Withdrawal by Subject|9|||
42130474|NCT00339040|75941340|FG000|Stage I|Not able to attend clinic|1|||
42130475|NCT00339040|75941341|FG001|Stage I|Not able to attend clinic|0|||
42130476|NCT00339040|75941340|FG000|Stage I|Protocol Violation|1|||
42130477|NCT00339040|75941341|FG001|Stage I|Protocol Violation|1|||
42130478|NCT00339040|75941340|FG000|Stage II|Lost to Follow-up|3|||
42130479|NCT00339040|75941341|FG001|Stage II|Lost to Follow-up|0|||
42130480|NCT00339040|75941340|FG000|Stage II|Withdrawal by Subject|1|||
42130481|NCT00339040|75941341|FG001|Stage II|Withdrawal by Subject|2|||
42130482|NCT00339040|75941340|FG000|Stage II|Protocol Violation|3|||
42130483|NCT00339040|75941341|FG001|Stage II|Protocol Violation|0|||
42130484|NCT00339040|75941340|FG000|Stage II|Not able to attend clinic|1|||
42130485|NCT00339040|75941341|FG001|Stage II|Not able to attend clinic|0|||
42130486|NCT00339040|75941340|FG000|Stage II|Site closing|2|||
42219941|NCT03584789|76037963|FG001|Overall Study|refused EHR permission|28|||
41981812|NCT00194077|75787641|FG001|Overall Study|Study nonadherence|0|||
41981813|NCT00194077|75787640|FG000|Overall Study|Withdrawal by Subject|1|||
42029130|NCT00901186|75837749|FG000|Overall Study|Lack of Efficacy|0|||
42029131|NCT00901186|75837750|FG001|Overall Study|Lack of Efficacy|1|||
42029132|NCT00901186|75837749|FG000|Overall Study|Abnormal laboratory values|0|||
42130487|NCT00339040|75941341|FG001|Stage II|Site closing|0|||
42130488|NCT00338962|75941351|FG000|Overall Study|Lost to Follow-up|3|||
42130489|NCT00338962|75941352|FG001|Overall Study|Lost to Follow-up|3|||
41981814|NCT00194077|75787641|FG001|Overall Study|Withdrawal by Subject|1|||
41981815|NCT00193609|75787647|FG000|Overall Study|Lack of Efficacy|2|||
41981816|NCT00193609|75787647|FG000|Overall Study|Adverse Event|2|||
41981817|NCT00193180|75787651|FG000|Overall Study|Lack of Efficacy|1|||
41981818|NCT00193180|75787651|FG000|Overall Study|Adverse Event|8|||
41981819|NCT00193180|75787651|FG000|Overall Study|Protocol Violation|1|||
41981820|NCT00193063|75787656|FG000|Overall Study|Lack of Efficacy|3|||
42130490|NCT00338962|75941353|FG002|Overall Study|Lost to Follow-up|2|||
42130491|NCT00338962|75941354|FG003|Overall Study|Lost to Follow-up|3|||
42029133|NCT00901186|75837750|FG001|Overall Study|Abnormal laboratory values|1|||
42029134|NCT00901186|75837749|FG000|Overall Study|Lost to Follow-up|2|||
42029135|NCT00901186|75837750|FG001|Overall Study|Lost to Follow-up|0|||
42130492|NCT00338962|75941351|FG000|Overall Study|Withdrawal by Subject|1|||
42130493|NCT00338962|75941352|FG001|Overall Study|Withdrawal by Subject|0|||
42130494|NCT00338962|75941353|FG002|Overall Study|Withdrawal by Subject|0|||
42130495|NCT00338962|75941354|FG003|Overall Study|Withdrawal by Subject|0|||
42130496|NCT00338962|75941351|FG000|Overall Study|No Transportation|2|||
42130497|NCT00338962|75941352|FG001|Overall Study|No Transportation|0|||
42130498|NCT00338962|75941353|FG002|Overall Study|No Transportation|0|||
42130499|NCT00338962|75941354|FG003|Overall Study|No Transportation|0|||
42130500|NCT00338962|75941351|FG000|Overall Study|Time Constraint|2|||
42130501|NCT00338962|75941352|FG001|Overall Study|Time Constraint|0|||
42130502|NCT00338962|75941353|FG002|Overall Study|Time Constraint|0|||
42130503|NCT00338962|75941354|FG003|Overall Study|Time Constraint|0|||
42130504|NCT00338962|75941351|FG000|Overall Study|Moved|0|||
42130505|NCT00338962|75941352|FG001|Overall Study|Moved|1|||
42130506|NCT00338962|75941353|FG002|Overall Study|Moved|0|||
42130507|NCT00338962|75941354|FG003|Overall Study|Moved|0|||
42130508|NCT00338962|75941351|FG000|Overall Study|Adverse Event|0|||
42130509|NCT00338962|75941352|FG001|Overall Study|Adverse Event|0|||
42130510|NCT00338962|75941353|FG002|Overall Study|Adverse Event|2|||
42130511|NCT00338962|75941354|FG003|Overall Study|Adverse Event|0|||
42029136|NCT00901186|75837749|FG000|Overall Study|Adverse Event|2|||
42029137|NCT00901186|75837750|FG001|Overall Study|Adverse Event|4|||
42029138|NCT00901186|75837749|FG000|Overall Study|Administration problems|0|||
42029139|NCT00901186|75837750|FG001|Overall Study|Administration problems|1|||
42029140|NCT00901186|75837749|FG000|Overall Study|Protocol deviations|5|||
42029141|NCT00901186|75837750|FG001|Overall Study|Protocol deviations|4|||
42029142|NCT01213472|75837756|FG000|Overall Study|Recurrence/Progressive disease|25|||
42029143|NCT01213472|75837756|FG000|Overall Study|Withdrawal by Subject|1|||
42029144|NCT01213472|75837756|FG000|Overall Study|Physician Decision|1|||
42029145|NCT00900796|75837760|FG000|Phase 1|Lacked sufficient information|4|||
42029146|NCT00900796|75837760|FG000|Phase 1|Missing information at Week 16|7|||
41981821|NCT00193063|75787656|FG000|Overall Study|Adverse Event|1|||
42130512|NCT00338962|75941351|FG000|Overall Study|Poor Compliance|0|||
42130513|NCT00338962|75941352|FG001|Overall Study|Poor Compliance|0|||
42130514|NCT00338962|75941353|FG002|Overall Study|Poor Compliance|2|||
42130515|NCT00338962|75941354|FG003|Overall Study|Poor Compliance|0|||
42130516|NCT00568061|75941366|FG000|Overall Study|Inclusion / exclusion criteria|5|||
42130517|NCT00568061|75941367|FG001|Overall Study|Inclusion / exclusion criteria|1|||
42130518|NCT00568061|75941366|FG000|Overall Study|Adverse Event|0|||
41981822|NCT00191854|75787663|FG000|Overall Study|Death|26|||
42029147|NCT00900796|75837760|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
42130519|NCT00568061|75941367|FG001|Overall Study|Adverse Event|1|||
42130520|NCT00338884|75941374|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
42130521|NCT00338884|75941374|FG000|Overall Study|Adverse Event|14|||
42130522|NCT00338884|75941374|FG000|Overall Study|Death|8|||
41981823|NCT00191854|75787664|FG001|Overall Study|Death|23|||
41981824|NCT00191854|75787665|FG002|Overall Study|Death|29|||
41981825|NCT00191854|75787663|FG000|Overall Study|Lost to Follow-up|7|||
42029148|NCT00900796|75837760|FG000|Phase 2|Lost to Follow-up|5|||
42029149|NCT01213082|75837768|FG000|Overall Study|Lost to Follow-up|6|||
42029150|NCT01213082|75837769|FG001|Overall Study|Lost to Follow-up|7|||
42130523|NCT00338884|75941374|FG000|Overall Study|Other|4|||
41981826|NCT00191854|75787664|FG001|Overall Study|Lost to Follow-up|5|||
41981827|NCT00191854|75787665|FG002|Overall Study|Lost to Follow-up|5|||
42029151|NCT01213082|75837770|FG002|Overall Study|Lost to Follow-up|4|||
42029152|NCT01213082|75837768|FG000|Overall Study|Physician Decision|0|||
42029153|NCT01213082|75837769|FG001|Overall Study|Physician Decision|0|||
42029154|NCT01213082|75837770|FG002|Overall Study|Physician Decision|1|||
42029155|NCT00885703|75837785|FG000|Overall Study|Death|9|||
42029156|NCT00885703|75837786|FG001|Overall Study|Death|7|||
42029157|NCT00885703|75837787|FG002|Overall Study|Death|8|||
42029158|NCT00885703|75837788|FG003|Overall Study|Death|7|||
42029159|NCT00885703|75837789|FG004|Overall Study|Death|7|||
42029160|NCT00885703|75837790|FG005|Overall Study|Death|8|||
42029161|NCT00885703|75837791|FG006|Overall Study|Death|4|||
42029162|NCT00885703|75837785|FG000|Overall Study|Lost to Follow-up|0|||
42029163|NCT00885703|75837786|FG001|Overall Study|Lost to Follow-up|0|||
42029164|NCT00885703|75837787|FG002|Overall Study|Lost to Follow-up|1|||
42029165|NCT00885703|75837788|FG003|Overall Study|Lost to Follow-up|0|||
42029166|NCT00885703|75837789|FG004|Overall Study|Lost to Follow-up|0|||
42029167|NCT00885703|75837790|FG005|Overall Study|Lost to Follow-up|1|||
42029168|NCT00885703|75837791|FG006|Overall Study|Lost to Follow-up|0|||
42029169|NCT00885703|75837785|FG000|Overall Study|Withdrawal by Subject|0|||
42029170|NCT00885703|75837786|FG001|Overall Study|Withdrawal by Subject|0|||
42029171|NCT00885703|75837787|FG002|Overall Study|Withdrawal by Subject|0|||
42219942|NCT03584789|76037964|FG002|Overall Study|refused EHR permission|23|||
42219943|NCT03584789|76037962|FG000|Overall Study|patients tied to a provider who retired|0|||
42219944|NCT03584789|76037963|FG001|Overall Study|patients tied to a provider who retired|0|||
42219945|NCT03584789|76037964|FG002|Overall Study|patients tied to a provider who retired|3|||
42219946|NCT03343639|76037974|FG000|Overall Study|Withdrawal by Subject|10|||
42219947|NCT03343639|76037975|FG001|Overall Study|Withdrawal by Subject|6|||
42219948|NCT03343639|76037974|FG000|Overall Study|Lost to Follow-up|4|||
42219949|NCT03343639|76037975|FG001|Overall Study|Lost to Follow-up|5|||
42219950|NCT03343639|76037974|FG000|Overall Study|Protocol Violation|0|||
42219951|NCT03343639|76037975|FG001|Overall Study|Protocol Violation|1|||
42219952|NCT03647267|76037983|FG000|Overall Study|Lost to Follow-up|1|||
42219953|NCT03647267|76037984|FG001|Overall Study|Lost to Follow-up|0|||
42219954|NCT03356977|76037992|FG000|Overall Study|Lost to Follow-up|3|||
42219955|NCT03356977|76037992|FG000|Overall Study|Withdrawal by parent/guardian|2|||
42219956|NCT02690974|76037996|FG000|Overall Study|Adverse Event|16|||
42219957|NCT02690974|76037996|FG000|Overall Study|Death|9|||
42219958|NCT02690974|76037996|FG000|Overall Study|Subject/guardian decision|4|||
42219959|NCT02690974|76037996|FG000|Overall Study|Lost to Follow-up|3|||
42219960|NCT02690974|76037996|FG000|Overall Study|Withdrawal of Informed Consent|3|||
42219961|NCT02690974|76037996|FG000|Overall Study|Physician Decision|2|||
42219962|NCT02690974|76037996|FG000|Overall Study|Non-compliance with study treatment|1|||
42219963|NCT02690974|76037996|FG000|Overall Study|Protocol-defined stopping criteria|1|||
42219964|NCT02690974|76037996|FG000|Overall Study|Protocol Deviation|1|||
42219965|NCT03093324|76038002|FG000|Overall Study|Adverse Event|4|||
41981828|NCT00191854|75787663|FG000|Overall Study|Withdrawal by Subject|4|||
41981829|NCT00191854|75787664|FG001|Overall Study|Withdrawal by Subject|2|||
41981830|NCT00191854|75787665|FG002|Overall Study|Withdrawal by Subject|3|||
41981831|NCT00191854|75787663|FG000|Overall Study|Sponsor Decision|0|||
41981832|NCT00191854|75787664|FG001|Overall Study|Sponsor Decision|0|||
41981833|NCT00191854|75787665|FG002|Overall Study|Sponsor Decision|1|||
41981834|NCT00191854|75787663|FG000|Overall Study|Screen Failure|0|||
41981835|NCT00191854|75787664|FG001|Overall Study|Screen Failure|0|||
41981836|NCT00191854|75787665|FG002|Overall Study|Screen Failure|1|||
42029172|NCT00885703|75837788|FG003|Overall Study|Withdrawal by Subject|1|||
42029173|NCT00885703|75837789|FG004|Overall Study|Withdrawal by Subject|3|||
42219966|NCT03093324|76038003|FG001|Overall Study|Adverse Event|15|||
42219967|NCT03093324|76038002|FG000|Overall Study|Lost to Follow-up|1|||
42219968|NCT03093324|76038003|FG001|Overall Study|Lost to Follow-up|0|||
42219969|NCT03093324|76038002|FG000|Overall Study|Protocol Deviation|2|||
42219970|NCT03093324|76038003|FG001|Overall Study|Protocol Deviation|2|||
42219971|NCT03093324|76038002|FG000|Overall Study|Withdrawal by Subject|2|||
42029174|NCT00885703|75837790|FG005|Overall Study|Withdrawal by Subject|1|||
42029175|NCT00885703|75837791|FG006|Overall Study|Withdrawal by Subject|1|||
42029176|NCT00885703|75837785|FG000|Overall Study|Ineligible (no CM)|1|||
42029177|NCT00885703|75837786|FG001|Overall Study|Ineligible (no CM)|3|||
42029178|NCT00885703|75837787|FG002|Overall Study|Ineligible (no CM)|2|||
42029179|NCT00885703|75837788|FG003|Overall Study|Ineligible (no CM)|1|||
42029180|NCT00885703|75837789|FG004|Overall Study|Ineligible (no CM)|2|||
42302222|NCT02495077|76137271|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
42029181|NCT00885703|75837790|FG005|Overall Study|Ineligible (no CM)|3|||
41981837|NCT00191815|75787673|FG000|Overall Study|Adverse Event|2|||
41981838|NCT00191815|75787673|FG000|Overall Study|Disease progression or relapse|24|||
41981839|NCT00191815|75787673|FG000|Overall Study|Death|2|||
42219972|NCT03093324|76038003|FG001|Overall Study|Withdrawal by Subject|2|||
42029182|NCT00885703|75837791|FG006|Overall Study|Ineligible (no CM)|1|||
42029183|NCT00901576|75837817|FG000|Second Intervention|Withdrawal by Subject|0|||
42029184|NCT00901576|75837818|FG001|Second Intervention|Withdrawal by Subject|0|||
42029185|NCT00901576|75837819|FG002|Second Intervention|Withdrawal by Subject|0|||
42029186|NCT00901576|75837820|FG003|Second Intervention|Withdrawal by Subject|1|||
42029187|NCT00901576|75837821|FG004|Second Intervention|Withdrawal by Subject|0|||
42029188|NCT00901576|75837822|FG005|Second Intervention|Withdrawal by Subject|1|||
42029189|NCT00901576|75837817|FG000|Second Intervention|Physician Decision|1|||
42029190|NCT00901576|75837818|FG001|Second Intervention|Physician Decision|0|||
42029191|NCT00901576|75837819|FG002|Second Intervention|Physician Decision|0|||
42029192|NCT00901576|75837820|FG003|Second Intervention|Physician Decision|0|||
42029193|NCT00901576|75837821|FG004|Second Intervention|Physician Decision|0|||
42029194|NCT00901576|75837822|FG005|Second Intervention|Physician Decision|0|||
42029195|NCT00882583|75837832|FG000|Overall Study|Physician Decision|1|||
42029196|NCT00882583|75837833|FG001|Overall Study|Physician Decision|0|||
42029197|NCT00882583|75837832|FG000|Overall Study|Adverse Event|0|||
42029198|NCT00882583|75837833|FG001|Overall Study|Adverse Event|1|||
42029199|NCT00900562|75837841|FG000|Overall Study|Progressive disease|9|||
42029200|NCT00900562|75837842|FG001|Overall Study|Progressive disease|5|||
42029201|NCT00900562|75837841|FG000|Overall Study|Toxicity|1|||
42029202|NCT00900562|75837842|FG001|Overall Study|Toxicity|0|||
42029203|NCT00900562|75837841|FG000|Overall Study|Death|1|||
42029204|NCT00900562|75837842|FG001|Overall Study|Death|1|||
42029205|NCT00900562|75837841|FG000|Overall Study|Withdrawal by Subject|0|||
42029206|NCT00900562|75837842|FG001|Overall Study|Withdrawal by Subject|1|||
42029207|NCT00900562|75837841|FG000|Overall Study|Unrelated adverse event|1|||
42029208|NCT00900562|75837842|FG001|Overall Study|Unrelated adverse event|0|||
42029209|NCT00599521|75837851|FG000|Overall Study|Lack of Efficacy|4|||
42029210|NCT00599521|75837852|FG001|Overall Study|Lack of Efficacy|8|||
42029211|NCT00599521|75837851|FG000|Overall Study|Adverse Event|4|||
42029212|NCT00599521|75837852|FG001|Overall Study|Adverse Event|1|||
42029213|NCT00599521|75837851|FG000|Overall Study|Withdrawal by Subject|28|||
42029214|NCT00599521|75837852|FG001|Overall Study|Withdrawal by Subject|34|||
42029215|NCT00599521|75837851|FG000|Overall Study|Protocol Violation|1|||
42029216|NCT00599521|75837852|FG001|Overall Study|Protocol Violation|1|||
42029217|NCT00599521|75837851|FG000|Overall Study|Lost to Follow-up|23|||
42029218|NCT00599521|75837852|FG001|Overall Study|Lost to Follow-up|23|||
42029219|NCT00599521|75837851|FG000|Overall Study|Pregnancy|0|||
42029220|NCT00599521|75837852|FG001|Overall Study|Pregnancy|2|||
42029221|NCT00882115|75837858|FG000|Overall Study|Withdrawal by Subject|3|||
42029222|NCT00882115|75837858|FG000|Overall Study|did not respond to DEP challe|6|||
42029223|NCT00881959|75837864|FG000|Overall Study|Lost to Follow-up|2|||
42029224|NCT00881959|75837865|FG001|Overall Study|Lost to Follow-up|4|||
42029225|NCT00884377|75837873|FG000|Overall Study|Withdrawal by Subject|1|||
42029226|NCT00884377|75837874|FG001|Overall Study|Withdrawal by Subject|0|||
42029227|NCT00884377|75837873|FG000|Overall Study|Could not confirm diagnosis|1|||
42029228|NCT00884377|75837874|FG001|Overall Study|Could not confirm diagnosis|0|||
42130524|NCT00338884|75941374|FG000|Overall Study|Global Deterioration of Health Status|3|||
41981840|NCT00191815|75787673|FG000|Overall Study|Protocol Violation|3|||
41981841|NCT00191815|75787673|FG000|Overall Study|Physician Decision|2|||
41981842|NCT00191815|75787673|FG000|Overall Study|Withdrawal by Subject|7|||
41981843|NCT00191386|75787677|FG000|Overall Study|Adverse Event|16|||
41981844|NCT00191386|75787677|FG000|Overall Study|Lost to Follow-up|1|||
41981845|NCT00191386|75787677|FG000|Overall Study|Entry Criteria Exclusion|3|||
41981846|NCT00191386|75787677|FG000|Overall Study|Protocol Violation|18|||
41981847|NCT00191386|75787677|FG000|Overall Study|Withdrawal by Subject|96|||
41981848|NCT00191386|75787677|FG000|Overall Study|Physician Decision|11|||
41981849|NCT00191386|75787677|FG000|Overall Study|Lack of Efficacy|15|||
41981850|NCT00191308|75787681|FG000|Overall Study|Adverse Event|1|||
41981851|NCT00191269|75787687|FG000|Overall Study|Protocol Violation|0|||
41981852|NCT00191269|75787688|FG001|Overall Study|Protocol Violation|2|||
42029229|NCT00884377|75837873|FG000|Overall Study|Physician Decision|0|||
42029230|NCT00884377|75837874|FG001|Overall Study|Physician Decision|1|||
42029231|NCT00884221|75837888|FG000|Overall Study|Withdrawal by Subject|0|||
42029232|NCT00884221|75837889|FG001|Overall Study|Withdrawal by Subject|3|||
42029233|NCT00884221|75837888|FG000|Overall Study|Adverse Event|6|||
42029234|NCT00884221|75837889|FG001|Overall Study|Adverse Event|3|||
42029235|NCT00884221|75837888|FG000|Overall Study|Protocol Violation|16|||
42029236|NCT00884221|75837889|FG001|Overall Study|Protocol Violation|13|||
42029237|NCT00884221|75837888|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
42130525|NCT00338884|75941374|FG000|Overall Study|Withdrawal by Subject|3|||
42130526|NCT00338884|75941374|FG000|Overall Study|Lost to Follow-up|1|||
41981853|NCT00191269|75787687|FG000|Overall Study|Adverse Event|1|||
41981854|NCT00191269|75787688|FG001|Overall Study|Adverse Event|4|||
41981855|NCT00191269|75787687|FG000|Overall Study|Progression of Disease|4|||
41981856|NCT00191269|75787688|FG001|Overall Study|Progression of Disease|42|||
42029238|NCT00884221|75837889|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
42029239|NCT00899548|75837910|FG000|Overall Study|Physician Decision|3|||
42029240|NCT00899392|75837920|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
42029241|NCT00899392|75837921|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
42219973|NCT03584009|76038011|FG000|Overall Study|Death|25|||
42219974|NCT03584009|76038012|FG001|Overall Study|Death|18|||
42219975|NCT03584009|76038011|FG000|Overall Study|Lost to Follow-up|0|||
42219976|NCT03584009|76038012|FG001|Overall Study|Lost to Follow-up|1|||
41981857|NCT00191269|75787687|FG000|Overall Study|Lack of Efficacy|1|||
41981858|NCT00191269|75787688|FG001|Overall Study|Lack of Efficacy|5|||
41981859|NCT00191269|75787687|FG000|Overall Study|Withdrawal by Subject|0|||
41981860|NCT00191269|75787688|FG001|Overall Study|Withdrawal by Subject|1|||
42219977|NCT03584009|76038011|FG000|Overall Study|Physician Decision|1|||
42219978|NCT03584009|76038012|FG001|Overall Study|Physician Decision|1|||
42219979|NCT03584009|76038011|FG000|Overall Study|Study Terminated by Sponsor|22|||
42219980|NCT03584009|76038012|FG001|Overall Study|Study Terminated by Sponsor|30|||
42219981|NCT03584009|76038011|FG000|Overall Study|Withdrawal by Subject|3|||
42219982|NCT03584009|76038012|FG001|Overall Study|Withdrawal by Subject|2|||
42219983|NCT04167462|76038023|FG000|Overall Study|Other reasons|3|||
42219984|NCT04167462|76038024|FG001|Overall Study|Other reasons|2|||
42219985|NCT04167462|76038023|FG000|Overall Study|Withdrawal by Subject|6|||
42219986|NCT04167462|76038024|FG001|Overall Study|Withdrawal by Subject|7|||
42219987|NCT04167462|76038023|FG000|Overall Study|Adverse Event|4|||
42219988|NCT04167462|76038024|FG001|Overall Study|Adverse Event|0|||
42219989|NCT04167462|76038023|FG000|Overall Study|Pregnancy|1|||
42219990|NCT04167462|76038024|FG001|Overall Study|Pregnancy|0|||
42219991|NCT04167462|76038023|FG000|Overall Study|Lack of Efficacy|0|||
42219992|NCT04167462|76038024|FG001|Overall Study|Lack of Efficacy|1|||
42219993|NCT03583385|76038031|FG000|Treatment Period 1|Withdrawal by Subject|1|||
42219994|NCT03583385|76038032|FG001|Treatment Period 1|Withdrawal by Subject|1|||
42219995|NCT03583385|76038031|FG000|Treatment Period 2|Adverse Event|1|||
42219996|NCT03583385|76038032|FG001|Treatment Period 2|Adverse Event|0|||
42219997|NCT04350372|76038038|FG000|Overall Study|Death|1|||
42219998|NCT02949973|76038042|FG000|Overall Study|Physician Decision|1|||
42219999|NCT02948959|76038048|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
41981861|NCT00191269|75787687|FG000|Overall Study|Pathologic Aggrevation|0|||
41981862|NCT00191269|75787688|FG001|Overall Study|Pathologic Aggrevation|1|||
41981863|NCT00191269|75787687|FG000|Overall Study|Physician Decision|0|||
41981864|NCT00191269|75787688|FG001|Overall Study|Physician Decision|3|||
41981865|NCT00191191|75787697|FG000|Overall Study|Entry Criteria Exclusion|2|||
41981866|NCT00191191|75787698|FG001|Overall Study|Entry Criteria Exclusion|0|||
41981867|NCT00191191|75787697|FG000|Overall Study|Treated with Another Systemic Agent|1|||
42029242|NCT00690898|75837927|FG000|SCREENING|Screen failure|18|||
42130527|NCT00338884|75941374|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
42130528|NCT00338806|75941380|FG000|Acute Phase|Withdrawal by Subject|0|||
42130529|NCT00338806|75941381|FG001|Acute Phase|Withdrawal by Subject|1|||
42130530|NCT00338806|75941380|FG000|Follow-up|Lost to Follow-up|1|||
42130531|NCT00338806|75941381|FG001|Follow-up|Lost to Follow-up|3|||
42130532|NCT03038100|75941391|FG000|Overall Study|Death|289|||
42130533|NCT03038100|75941392|FG001|Overall Study|Death|272|||
42130534|NCT03038100|75941391|FG000|Overall Study|Lost to Follow-up|9|||
42130535|NCT03038100|75941392|FG001|Overall Study|Lost to Follow-up|10|||
42130536|NCT03038100|75941391|FG000|Overall Study|Protocol Deviation|1|||
42130537|NCT03038100|75941392|FG001|Overall Study|Protocol Deviation|4|||
42130538|NCT03038100|75941391|FG000|Overall Study|Withdrawal by Subject|45|||
42130539|NCT03038100|75941392|FG001|Overall Study|Withdrawal by Subject|51|||
42130540|NCT03038100|75941391|FG000|Overall Study|Study Terminated By Sponsor|305|||
42130541|NCT03038100|75941392|FG001|Overall Study|Study Terminated By Sponsor|311|||
42130542|NCT03038100|75941391|FG000|Overall Study|Physician Decision|1|||
42130543|NCT03038100|75941392|FG001|Overall Study|Physician Decision|3|||
42130544|NCT00338728|75941399|FG000|Overall Study|Screen Failure|14|||
42130545|NCT00336856|75941403|FG000|Overall Study|Withdrawal by Subject|3|||
42130546|NCT00336856|75941403|FG000|Overall Study|Found ineligible at time of analysis|1|||
42130547|NCT00566501|75941409|FG000|Overall Study|Adverse Event|68|||
42130548|NCT00566501|75941410|FG001|Overall Study|Adverse Event|59|||
42130549|NCT00566501|75941409|FG000|Overall Study|Medication Non-compliance|5|||
42130550|NCT00566501|75941410|FG001|Overall Study|Medication Non-compliance|0|||
42130551|NCT00566501|75941409|FG000|Overall Study|Protocol Violation|2|||
42130552|NCT00566501|75941410|FG001|Overall Study|Protocol Violation|2|||
42220000|NCT02948959|76038049|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
42220001|NCT02948959|76038048|FG000|52 Weeks Treatment Period|Adverse Event|2|||
42220002|NCT02948959|76038049|FG001|52 Weeks Treatment Period|Adverse Event|5|||
42220003|NCT02948959|76038048|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
42130553|NCT00566501|75941409|FG000|Overall Study|Request of Investigator or Sponsor|6|||
42130554|NCT00566501|75941410|FG001|Overall Study|Request of Investigator or Sponsor|7|||
42130555|NCT00566501|75941409|FG000|Overall Study|Withdrawal by Subject|33|||
42220004|NCT02948959|76038049|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
42272657|NCT02281318|76102917|FG000|Overall Study|Withdrawal by Subject|6|||
41981868|NCT00191191|75787698|FG001|Overall Study|Treated with Another Systemic Agent|1|||
41981869|NCT00191191|75787697|FG000|Overall Study|Adverse Event|11|||
41981870|NCT00191191|75787698|FG001|Overall Study|Adverse Event|21|||
41981871|NCT00191191|75787697|FG000|Overall Study|Progressive Disease|84|||
41981872|NCT00191191|75787698|FG001|Overall Study|Progressive Disease|72|||
41981873|NCT00191191|75787697|FG000|Overall Study|Toxicity After Dose Reduction|7|||
41981874|NCT00191191|75787698|FG001|Overall Study|Toxicity After Dose Reduction|8|||
41981875|NCT00191191|75787697|FG000|Overall Study|Family/Caregiver Decision|5|||
41981876|NCT00191191|75787698|FG001|Overall Study|Family/Caregiver Decision|7|||
41981877|NCT00191191|75787697|FG000|Overall Study|Lost to Follow-up|1|||
41981878|NCT00191191|75787698|FG001|Overall Study|Lost to Follow-up|0|||
41981879|NCT00191191|75787697|FG000|Overall Study|Physician Decision|3|||
41981880|NCT00191191|75787698|FG001|Overall Study|Physician Decision|2|||
41981881|NCT00191191|75787697|FG000|Overall Study|Good Clinical Practice Violation|0|||
41981882|NCT00191191|75787698|FG001|Overall Study|Good Clinical Practice Violation|1|||
41981883|NCT00191152|75787706|FG000|Initial Treatment|Adverse Event|43|||
41981884|NCT00191152|75787707|FG001|Initial Treatment|Adverse Event|67|||
41981885|NCT00191152|75787706|FG000|Initial Treatment|Physician Decision|40|||
41981886|NCT00191152|75787707|FG001|Initial Treatment|Physician Decision|31|||
41981887|NCT00191152|75787706|FG000|Initial Treatment|Withdrawal by Subject|40|||
41981888|NCT00191152|75787707|FG001|Initial Treatment|Withdrawal by Subject|28|||
41981889|NCT00191152|75787706|FG000|Initial Treatment|Lost to Follow-up|0|||
41981890|NCT00191152|75787707|FG001|Initial Treatment|Lost to Follow-up|6|||
41981891|NCT00191152|75787706|FG000|Initial Treatment|Other|18|||
41981892|NCT00191152|75787707|FG001|Initial Treatment|Other|21|||
41981893|NCT00191152|75787706|FG000|Crossover Treatment|Adverse Event|8|||
41981894|NCT00191152|75787707|FG001|Crossover Treatment|Adverse Event|8|||
41981895|NCT00191152|75787706|FG000|Crossover Treatment|Physician Decision|7|||
41981896|NCT00191152|75787707|FG001|Crossover Treatment|Physician Decision|7|||
41981897|NCT00191152|75787706|FG000|Crossover Treatment|Withdrawal by Subject|6|||
41981898|NCT00191152|75787707|FG001|Crossover Treatment|Withdrawal by Subject|9|||
41981899|NCT00191152|75787706|FG000|Crossover Treatment|Lost to Follow-up|2|||
41981900|NCT00191152|75787707|FG001|Crossover Treatment|Lost to Follow-up|1|||
41981901|NCT00191152|75787706|FG000|Crossover Treatment|Other|4|||
41981902|NCT00191152|75787707|FG001|Crossover Treatment|Other|3|||
41981903|NCT00190684|75787725|FG000|Overall Study|Adverse Event|86|||
41981904|NCT00190684|75787725|FG000|Overall Study|Satisfactory response|80|||
41981905|NCT00190684|75787725|FG000|Overall Study|Lack of efficacy|204|||
41981906|NCT00190684|75787725|FG000|Overall Study|Lost to Follow-up|232|||
41981907|NCT00190684|75787725|FG000|Overall Study|Patient moved|60|||
41981908|NCT00190684|75787725|FG000|Overall Study|Patient Decision|432|||
41981909|NCT00190684|75787725|FG000|Overall Study|Clinical relapse|67|||
41981910|NCT00190684|75787725|FG000|Overall Study|Sponsor's decision|17|||
41981911|NCT00190684|75787725|FG000|Overall Study|Physician Decision|84|||
41981912|NCT00190684|75787725|FG000|Overall Study|Protocol Violation|123|||
41981913|NCT00190684|75787725|FG000|Overall Study|Study Period III Completed|103|||
41981914|NCT00190684|75787725|FG000|Overall Study|Study Period V Completed|1|||
41981915|NCT00179959|75787736|FG000|Overall Study|Lost to Follow-up|3|||
41981916|NCT00179959|75787737|FG001|Overall Study|Lost to Follow-up|1|||
41981917|NCT00179959|75787736|FG000|Overall Study|Withdrawal by Subject|3|||
41981918|NCT00179959|75787737|FG001|Overall Study|Withdrawal by Subject|2|||
41981919|NCT00179647|75787743|FG000|Overall Study|Adverse Event|294|||
41981920|NCT00179647|75787743|FG000|Overall Study|Lack of Efficacy|478|||
41981921|NCT00179647|75787743|FG000|Overall Study|Withdrawal by Subject|83|||
41981922|NCT00179647|75787743|FG000|Overall Study|Lost to Follow-up|4|||
41981923|NCT00179647|75787743|FG000|Overall Study|Death|94|||
41981924|NCT00179647|75787743|FG000|Overall Study|Other|960|||
41981925|NCT00179413|75787749|FG000|Overall Study|Adverse Event|38|||
41981926|NCT00179413|75787750|FG001|Overall Study|Adverse Event|20|||
41981927|NCT00179413|75787749|FG000|Overall Study|Withdrawal by Subject|87|||
41981928|NCT00179413|75787750|FG001|Overall Study|Withdrawal by Subject|95|||
41981929|NCT00178633|75787756|FG000|Overall Study|Lost to Follow-up|6|||
41981930|NCT00178399|75787761|FG000|Overall Study|Physician Decision|4|||
41981931|NCT00178399|75787761|FG000|Overall Study|Withdrawal by Subject|8|||
41981932|NCT00178399|75787761|FG000|Overall Study|Lost to Follow-up|1|||
41981933|NCT00178126|75787768|FG000|Overall Study|Lost to Follow-up|21|||
41981934|NCT00178126|75787769|FG001|Overall Study|Lost to Follow-up|21|||
41981935|NCT00178126|75787768|FG000|Overall Study|did not receive intervention|4|||
41981936|NCT00178126|75787769|FG001|Overall Study|did not receive intervention|6|||
41981937|NCT00177307|75787775|FG000|Overall Study|Withdrawal by Subject|1|||
41981938|NCT00176605|75787783|FG000|Overall Study|Withdrawal by Subject|2|||
41981939|NCT00176488|75787787|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
41981940|NCT00175825|75787795|FG000|Overall Study|Adverse Event|3|||
41981941|NCT00175825|75787796|FG001|Overall Study|Adverse Event|2|||
41981942|NCT00175825|75787797|FG002|Overall Study|Adverse Event|1|||
41981943|NCT00175825|75787798|FG003|Overall Study|Adverse Event|1|||
41981944|NCT00175825|75787795|FG000|Overall Study|Lost to Follow-up|1|||
41981945|NCT00175825|75787796|FG001|Overall Study|Lost to Follow-up|2|||
41981946|NCT00175825|75787797|FG002|Overall Study|Lost to Follow-up|0|||
41981947|NCT00175825|75787798|FG003|Overall Study|Lost to Follow-up|0|||
41981948|NCT00175825|75787795|FG000|Overall Study|Withdrawal by Subject|1|||
41981949|NCT00175825|75787796|FG001|Overall Study|Withdrawal by Subject|0|||
41981950|NCT00175825|75787797|FG002|Overall Study|Withdrawal by Subject|0|||
41981951|NCT00175825|75787798|FG003|Overall Study|Withdrawal by Subject|0|||
41981952|NCT00174967|75787812|FG000|Overall Study|Adverse Event|1|||
41981953|NCT00174967|75787813|FG001|Overall Study|Adverse Event|2|||
41981954|NCT00174967|75787814|FG002|Overall Study|Adverse Event|2|||
41981955|NCT00174967|75787815|FG003|Overall Study|Adverse Event|1|||
41981956|NCT00174967|75787812|FG000|Overall Study|Gout Flare|0|||
41981957|NCT00174967|75787813|FG001|Overall Study|Gout Flare|0|||
41981958|NCT00174967|75787814|FG002|Overall Study|Gout Flare|0|||
41981959|NCT00174967|75787815|FG003|Overall Study|Gout Flare|1|||
41981960|NCT00174967|75787812|FG000|Overall Study|Other|0|||
41981961|NCT00174967|75787813|FG001|Overall Study|Other|1|||
41981962|NCT00174967|75787814|FG002|Overall Study|Other|0|||
41981963|NCT00174967|75787815|FG003|Overall Study|Other|0|||
41981964|NCT00174265|75787827|FG000|Overall Study|Adverse Event|7|||
41981965|NCT00174265|75787828|FG001|Overall Study|Adverse Event|4|||
41981966|NCT00174265|75787827|FG000|Overall Study|Lack of Efficacy|2|||
41981967|NCT00174265|75787828|FG001|Overall Study|Lack of Efficacy|2|||
41981968|NCT00174265|75787827|FG000|Overall Study|Withdrawal by Subject|3|||
41981969|NCT00174265|75787828|FG001|Overall Study|Withdrawal by Subject|5|||
41981970|NCT00174265|75787827|FG000|Overall Study|Lost to Follow-up|1|||
41981971|NCT00174265|75787828|FG001|Overall Study|Lost to Follow-up|0|||
41981972|NCT00174265|75787827|FG000|Overall Study|Other (Not specified)|16|||
41981973|NCT00174265|75787828|FG001|Overall Study|Other (Not specified)|10|||
41981974|NCT00172042|75787836|FG000|Overall Study|Adverse Event|27|||
41981975|NCT00172042|75787837|FG001|Overall Study|Adverse Event|13|||
41981976|NCT00172042|75787836|FG000|Overall Study|Abnormal laboratory value(s)|5|||
41981977|NCT00172042|75787837|FG001|Overall Study|Abnormal laboratory value(s)|1|||
41981978|NCT00172042|75787836|FG000|Overall Study|Abnormal test procedure(s)|0|||
41981979|NCT00172042|75787837|FG001|Overall Study|Abnormal test procedure(s)|3|||
41981980|NCT00172042|75787836|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
41981981|NCT00172042|75787837|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
41981982|NCT00172042|75787836|FG000|Overall Study|Patient no longer requires study drug|10|||
41981983|NCT00172042|75787837|FG001|Overall Study|Patient no longer requires study drug|8|||
41981984|NCT00172042|75787836|FG000|Overall Study|Protocol Violation|8|||
41981985|NCT00172042|75787837|FG001|Overall Study|Protocol Violation|7|||
41981986|NCT00172042|75787836|FG000|Overall Study|Withdrawal by Subject|37|||
41981987|NCT00172042|75787837|FG001|Overall Study|Withdrawal by Subject|25|||
41981988|NCT00172042|75787836|FG000|Overall Study|Lost to Follow-up|3|||
41981989|NCT00172042|75787837|FG001|Overall Study|Lost to Follow-up|5|||
41981990|NCT00172042|75787836|FG000|Overall Study|Administrative problems|13|||
41981991|NCT00172042|75787837|FG001|Overall Study|Administrative problems|10|||
41981992|NCT00172042|75787836|FG000|Overall Study|Death|42|||
41981993|NCT00172042|75787837|FG001|Overall Study|Death|42|||
41981994|NCT00171925|75787845|FG000|Overall Study|Adverse Event|10|||
41981995|NCT00171925|75787846|FG001|Overall Study|Adverse Event|6|||
41981996|NCT00171925|75787845|FG000|Overall Study|Protocol Violation|1|||
41981997|NCT00171925|75787846|FG001|Overall Study|Protocol Violation|1|||
41981998|NCT00171925|75787845|FG000|Overall Study|Withdrawal by Subject|6|||
41981999|NCT00171925|75787846|FG001|Overall Study|Withdrawal by Subject|9|||
41982000|NCT00171925|75787845|FG000|Overall Study|Lost to Follow-up|2|||
41982001|NCT00171925|75787846|FG001|Overall Study|Lost to Follow-up|2|||
41982002|NCT00171925|75787845|FG000|Overall Study|Administrative problems|10|||
41982003|NCT00171925|75787846|FG001|Overall Study|Administrative problems|11|||
41982004|NCT00171925|75787845|FG000|Overall Study|Death|1|||
41982005|NCT00171925|75787846|FG001|Overall Study|Death|2|||
41982006|NCT00171340|75787854|FG000|Overall Study|Adverse Event|46|||
41982007|NCT00171340|75787855|FG001|Overall Study|Adverse Event|42|||
41982008|NCT00171340|75787854|FG000|Overall Study|Lack of Efficacy|29|||
41982009|NCT00171340|75787855|FG001|Overall Study|Lack of Efficacy|41|||
41982010|NCT00171340|75787854|FG000|Overall Study|Protocol Violation|7|||
41982011|NCT00171340|75787855|FG001|Overall Study|Protocol Violation|8|||
41982012|NCT00171340|75787854|FG000|Overall Study|Withdrawal by Subject|22|||
41982013|NCT00171340|75787855|FG001|Overall Study|Withdrawal by Subject|19|||
41982014|NCT00171340|75787854|FG000|Overall Study|Lost to Follow-up|0|||
41982015|NCT00171340|75787855|FG001|Overall Study|Lost to Follow-up|5|||
41982016|NCT00171340|75787854|FG000|Overall Study|Abnormal Laboratory Results|2|||
41982017|NCT00171340|75787855|FG001|Overall Study|Abnormal Laboratory Results|0|||
41982018|NCT00171340|75787854|FG000|Overall Study|Abnormal Test Procedure Results|6|||
41982019|NCT00171340|75787855|FG001|Overall Study|Abnormal Test Procedure Results|11|||
41982020|NCT00171340|75787854|FG000|Overall Study|No Longer Required Study Drug|1|||
41982021|NCT00171340|75787855|FG001|Overall Study|No Longer Required Study Drug|1|||
41982022|NCT00171340|75787854|FG000|Overall Study|Administrative Problems|5|||
41982023|NCT00171340|75787855|FG001|Overall Study|Administrative Problems|2|||
41982024|NCT00171340|75787854|FG000|Overall Study|Death|6|||
41982025|NCT00171340|75787855|FG001|Overall Study|Death|6|||
41982026|NCT00171301|75787865|FG000|Overall Study|Death|1|||
41982027|NCT00171301|75787866|FG001|Overall Study|Death|2|||
41982028|NCT00171301|75787865|FG000|Overall Study|Adverse Event|1|||
41982029|NCT00171301|75787866|FG001|Overall Study|Adverse Event|2|||
41982030|NCT00171301|75787865|FG000|Overall Study|Lost to Follow-up|6|||
41982031|NCT00171301|75787866|FG001|Overall Study|Lost to Follow-up|2|||
41982032|NCT00171301|75787865|FG000|Overall Study|Protocol Violation|0|||
41982033|NCT00171301|75787866|FG001|Overall Study|Protocol Violation|2|||
41982034|NCT00171301|75787865|FG000|Overall Study|Withdrawal by Subject|0|||
41982035|NCT00171301|75787866|FG001|Overall Study|Withdrawal by Subject|1|||
41982036|NCT00171223|75787876|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
41982037|NCT00171223|75787877|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
41982038|NCT00171223|75787878|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
41982039|NCT00171223|75787876|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
41982040|NCT00171223|75787877|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
41982041|NCT00171223|75787878|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
41982042|NCT00171223|75787876|FG000|Overall Study|Abnormal Procedure|1|||
41982043|NCT00171223|75787877|FG001|Overall Study|Abnormal Procedure|0|||
41982044|NCT00171223|75787878|FG002|Overall Study|Abnormal Procedure|0|||
41982045|NCT00171223|75787876|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
41982046|NCT00171223|75787877|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
41982047|NCT00171223|75787878|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
41982048|NCT00171223|75787876|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
41982049|NCT00171223|75787877|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
41982050|NCT00171223|75787878|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
41982051|NCT00171223|75787876|FG000|Overall Study|Protocol Violation|2|||
41982052|NCT00171223|75787877|FG001|Overall Study|Protocol Violation|2|||
41982053|NCT00171223|75787878|FG002|Overall Study|Protocol Violation|3|||
41982054|NCT00171223|75787876|FG000|Overall Study|Participant Withdrew Consent|12|||
41982055|NCT00171223|75787877|FG001|Overall Study|Participant Withdrew Consent|21|||
41982056|NCT00171223|75787878|FG002|Overall Study|Participant Withdrew Consent|15|||
41982057|NCT00171223|75787876|FG000|Overall Study|Lost to Follow-up|5|||
41982058|NCT00171223|75787877|FG001|Overall Study|Lost to Follow-up|2|||
41982059|NCT00171223|75787878|FG002|Overall Study|Lost to Follow-up|3|||
41982060|NCT00171223|75787876|FG000|Overall Study|Administrative Problems|4|||
41982061|NCT00171223|75787877|FG001|Overall Study|Administrative Problems|7|||
41982062|NCT00171223|75787878|FG002|Overall Study|Administrative Problems|6|||
41982063|NCT00171223|75787876|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
41982064|NCT00171223|75787877|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
41982065|NCT00171223|75787878|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
41982066|NCT00171223|75787876|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
41982067|NCT00171223|75787877|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
41982068|NCT00171223|75787878|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
41982069|NCT00479674|75787884|FG000|Overall Study|Adverse Event|18|||
41982070|NCT00479674|75787884|FG000|Overall Study|Withdrawal by Subject|6|||
41982071|NCT00479674|75787884|FG000|Overall Study|Physician Decision|14|||
41982072|NCT00479674|75787884|FG000|Overall Study|none provided|3|||
41982073|NCT00479401|75787891|FG000|Overall Study|Adverse Event|24|||
41982074|NCT00479401|75787892|FG001|Overall Study|Adverse Event|20|||
41982075|NCT00479401|75787893|FG002|Overall Study|Adverse Event|4|||
41982076|NCT00479401|75787891|FG000|Overall Study|Lack of Efficacy|2|||
41982077|NCT00479401|75787892|FG001|Overall Study|Lack of Efficacy|2|||
41982078|NCT00479401|75787893|FG002|Overall Study|Lack of Efficacy|4|||
41982079|NCT00479401|75787891|FG000|Overall Study|Protocol Violation|2|||
41982080|NCT00479401|75787892|FG001|Overall Study|Protocol Violation|1|||
41982081|NCT00479401|75787893|FG002|Overall Study|Protocol Violation|1|||
41982082|NCT00479401|75787891|FG000|Overall Study|Lost to Follow-up|1|||
41982083|NCT00479401|75787892|FG001|Overall Study|Lost to Follow-up|1|||
41982084|NCT00479401|75787893|FG002|Overall Study|Lost to Follow-up|1|||
41982085|NCT00479401|75787891|FG000|Overall Study|Withdrawal by Subject|16|||
41982086|NCT00479401|75787892|FG001|Overall Study|Withdrawal by Subject|10|||
41982087|NCT00479401|75787893|FG002|Overall Study|Withdrawal by Subject|2|||
41982088|NCT00479401|75787891|FG000|Overall Study|Exclusion criteria, relocation|4|||
41982089|NCT00479401|75787892|FG001|Overall Study|Exclusion criteria, relocation|3|||
41982090|NCT00479401|75787893|FG002|Overall Study|Exclusion criteria, relocation|0|||
41982091|NCT00478777|75787901|FG000|Overall Study|Adverse Event|29|||
41982092|NCT00478777|75787901|FG000|Overall Study|Lack of Efficacy|23|||
41982093|NCT00478777|75787901|FG000|Overall Study|Withdrawal by Subject|4|||
41982094|NCT00478777|75787901|FG000|Overall Study|Death|3|||
41982095|NCT00478777|75787901|FG000|Overall Study|Protocol Violation|3|||
41982096|NCT00478777|75787901|FG000|Overall Study|Lost to Follow-up|3|||
41982097|NCT00478777|75787901|FG000|Overall Study|Physician Decision|1|||
41982098|NCT00478777|75787901|FG000|Overall Study|Intolerance of therapy|1|||
41982099|NCT00478777|75787901|FG000|Overall Study|Lack of compliance|1|||
41982100|NCT00478777|75787901|FG000|Overall Study|Lymphocytes infusion|1|||
41982101|NCT00478777|75787901|FG000|Overall Study|End of therapy|2|||
41982102|NCT00478777|75787901|FG000|Overall Study|Not treated with lenalidomide|6|||
41982103|NCT00477607|75787907|FG000|Overall Study|Lost to Follow-up|7|||
41982104|NCT00477607|75787908|FG001|Overall Study|Lost to Follow-up|7|||
41982105|NCT00477490|75787919|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
41982106|NCT00477490|75787920|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
41982107|NCT00477490|75787921|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
41982108|NCT00477490|75787922|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
41982109|NCT00477490|75787923|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
41982110|NCT00477490|75787924|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
41982111|NCT00477490|75787925|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
41982112|NCT00477490|75787926|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
41982113|NCT00477490|75787927|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
41982114|NCT00477490|75787919|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
41982115|NCT00477490|75787920|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
41982116|NCT00477490|75787921|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
41982117|NCT00477490|75787922|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
41982118|NCT00477490|75787923|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
41982119|NCT00477490|75787924|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
41982120|NCT00477490|75787925|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
41982121|NCT00477490|75787926|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
41982122|NCT00477490|75787927|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
41982123|NCT00477490|75787919|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
41982124|NCT00477490|75787920|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
41982125|NCT00477490|75787921|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
41982126|NCT00477490|75787922|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
41982127|NCT00477490|75787923|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
41982128|NCT00477490|75787924|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
41982129|NCT00477490|75787925|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
41982130|NCT00477490|75787926|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
41982131|NCT00477490|75787927|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
41982132|NCT00477490|75787919|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
41982133|NCT00477490|75787920|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
41982134|NCT00477490|75787921|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
41982135|NCT00477490|75787922|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
41982136|NCT00477490|75787923|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
41982137|NCT00477490|75787924|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
41982138|NCT00477490|75787925|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
41982139|NCT00477490|75787926|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
41982140|NCT00477490|75787927|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
41982141|NCT00477490|75787919|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
41982142|NCT00477490|75787920|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
41982143|NCT00477490|75787921|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
41982144|NCT00477490|75787922|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
41982145|NCT00477490|75787923|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
41982146|NCT00477490|75787924|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
41982147|NCT00477490|75787925|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
41982148|NCT00477490|75787926|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
41982149|NCT00477490|75787927|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
41982150|NCT00477490|75787919|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
41982151|NCT00477490|75787920|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
41982152|NCT00477490|75787921|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
41982153|NCT00477490|75787922|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
41982154|NCT00477490|75787923|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
41982155|NCT00477490|75787924|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
41982156|NCT00477490|75787925|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
41982157|NCT00477490|75787926|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
41982158|NCT00477490|75787927|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
41982159|NCT00477490|75787919|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
41982160|NCT00477490|75787920|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
41982161|NCT00477490|75787921|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
41982162|NCT00477490|75787922|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
41982163|NCT00477490|75787923|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
41982164|NCT00477490|75787924|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
41982165|NCT00477490|75787925|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
41982166|NCT00477490|75787926|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
41982167|NCT00477490|75787927|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
41982168|NCT00477490|75787919|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
41982169|NCT00477490|75787920|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
41982170|NCT00477490|75787921|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
41982171|NCT00477490|75787922|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
41982172|NCT00477490|75787923|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
41982173|NCT00477490|75787924|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
41982174|NCT00477490|75787925|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
41982175|NCT00477490|75787926|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
41982176|NCT00477490|75787927|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
41982177|NCT00477490|75787919|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
41982178|NCT00477490|75787920|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
41982179|NCT00477490|75787921|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
41982180|NCT00477490|75787922|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
41982181|NCT00477490|75787923|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
41982182|NCT00477490|75787924|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
41982183|NCT00477490|75787925|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
41982184|NCT00477490|75787926|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
41982185|NCT00477490|75787927|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
41982186|NCT00477490|75787919|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
41982187|NCT00477490|75787920|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
41982188|NCT00477490|75787921|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
41982189|NCT00477490|75787922|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
41982190|NCT00477490|75787923|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
41982191|NCT00477490|75787924|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
41982192|NCT00477490|75787925|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
41982193|NCT00477490|75787926|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
41982194|NCT00477490|75787927|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
41982195|NCT00477490|75787919|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
41982196|NCT00477490|75787920|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
41982197|NCT00477490|75787921|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
41982198|NCT00477490|75787922|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
41982199|NCT00477490|75787923|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
41982200|NCT00477490|75787924|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
41982201|NCT00477490|75787925|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
41982202|NCT00477490|75787926|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
41982203|NCT00477490|75787927|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
41982204|NCT00477490|75787919|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
41982205|NCT00477490|75787920|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
41982206|NCT00477490|75787921|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
41982207|NCT00477490|75787922|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
41982208|NCT00477490|75787923|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
41982209|NCT00477490|75787924|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
41982210|NCT00477490|75787925|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
41982211|NCT00477490|75787926|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
41982212|NCT00477490|75787927|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
41982213|NCT00477490|75787919|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
41982214|NCT00477490|75787920|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
41982215|NCT00477490|75787921|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
41982216|NCT00477490|75787922|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
41982217|NCT00477490|75787923|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
41982218|NCT00477490|75787924|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
42130556|NCT00566501|75941410|FG001|Overall Study|Withdrawal by Subject|30|||
42130557|NCT00566501|75941409|FG000|Overall Study|Lack of Efficacy|8|||
41982219|NCT00477490|75787925|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
41982220|NCT00477490|75787926|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
41982221|NCT00477490|75787927|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
41982222|NCT00477490|75787919|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
41982223|NCT00477490|75787920|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
41982224|NCT00477490|75787921|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
42130558|NCT00566501|75941410|FG001|Overall Study|Lack of Efficacy|3|||
42130559|NCT00566501|75941409|FG000|Overall Study|Other|25|||
42130560|NCT00566501|75941410|FG001|Overall Study|Other|21|||
42220005|NCT02948959|76038048|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
42272658|NCT02281318|76102918|FG001|Overall Study|Withdrawal by Subject|2|||
41982225|NCT00477490|75787922|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
41982226|NCT00477490|75787923|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
41982227|NCT00477490|75787924|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
41982228|NCT00477490|75787925|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
41982229|NCT00477490|75787926|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
41982230|NCT00477490|75787927|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
41982231|NCT00477334|75787957|FG000|Overall Study|Discontinued prior to taking study drug|106|||
41982232|NCT00477334|75787958|FG001|Overall Study|Discontinued prior to taking study drug|53|||
41982233|NCT00477334|75787957|FG000|Overall Study|Adverse Event|1|||
41982234|NCT00477334|75787958|FG001|Overall Study|Adverse Event|2|||
41982235|NCT00477334|75787957|FG000|Overall Study|Withdrawal by Subject|2|||
41982236|NCT00477334|75787958|FG001|Overall Study|Withdrawal by Subject|1|||
41982237|NCT00477334|75787957|FG000|Overall Study|Lost to Follow-up|15|||
41982238|NCT00477334|75787958|FG001|Overall Study|Lost to Follow-up|4|||
41982239|NCT00477334|75787957|FG000|Overall Study|Administrative Problems|39|||
41982240|NCT00477334|75787958|FG001|Overall Study|Administrative Problems|15|||
41982241|NCT00477334|75787957|FG000|Overall Study|Protocol Violation|7|||
41982242|NCT00477334|75787958|FG001|Overall Study|Protocol Violation|1|||
41982243|NCT04536727|75788037|FG000|Overall Study|Lost to Follow-up|1|||
41982244|NCT04536727|75788038|FG001|Overall Study|Lost to Follow-up|1|||
41982245|NCT04536727|75788037|FG000|Overall Study|Death|0|||
41982246|NCT04536727|75788038|FG001|Overall Study|Death|1|||
41982247|NCT04971967|75788099|FG000|Overall Study|Lost to Follow-up|6|||
41982248|NCT04971967|75788100|FG001|Overall Study|Lost to Follow-up|7|||
41982249|NCT04716881|75788114|FG000|Overall Study|Adverse Event|1|||
41982250|NCT04716881|75788114|FG000|Overall Study|Lost to Follow-up|1|||
41982251|NCT04582266|75788131|FG000|Overall Study|Lost to Follow-up|7|||
41982252|NCT04582266|75788132|FG001|Overall Study|Lost to Follow-up|5|||
41982253|NCT04582266|75788131|FG000|Overall Study|Withdrawal by Subject|1|||
41982254|NCT04582266|75788132|FG001|Overall Study|Withdrawal by Subject|0|||
41982255|NCT04582266|75788131|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
41982256|NCT04582266|75788132|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
41982257|NCT04459338|75788142|FG000|Overall Study|Loss of IV during study|1|||
41982258|NCT04459338|75788143|FG001|Overall Study|Loss of IV during study|0|||
41982259|NCT03740048|75788189|FG000|Overall Study|Withdrawal by Subject|1|||
41982260|NCT03740048|75788190|FG001|Overall Study|Withdrawal by Subject|1|||
41982261|NCT03740048|75788189|FG000|Overall Study|Death|1|||
41982262|NCT03740048|75788190|FG001|Overall Study|Death|6|||
41982263|NCT03740048|75788189|FG000|Overall Study|Switched to thrice-weekly HD|2|||
41982264|NCT03740048|75788190|FG001|Overall Study|Switched to thrice-weekly HD|0|||
41982265|NCT03740048|75788189|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
41982266|NCT03740048|75788190|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
41982267|NCT03740048|75788189|FG000|Overall Study|Lost to Follow-up|0|||
41982268|NCT03740048|75788190|FG001|Overall Study|Lost to Follow-up|1|||
41982269|NCT03740048|75788189|FG000|Overall Study|Non-compliance with HD|0|||
41982270|NCT03740048|75788190|FG001|Overall Study|Non-compliance with HD|1|||
41982271|NCT03373760|75788267|FG000|Overall Study|Adverse Event|8|||
41982272|NCT03373760|75788267|FG000|Overall Study|Disease Progression|46|||
41982273|NCT03373760|75788267|FG000|Overall Study|Death|4|||
41982274|NCT03324880|75788276|FG000|Overall Study|Adverse Event|0|||
41982275|NCT03324880|75788277|FG001|Overall Study|Adverse Event|2|||
41982276|NCT03324880|75788276|FG000|Overall Study|Withdrawal by Subject|2|||
41982277|NCT03324880|75788277|FG001|Overall Study|Withdrawal by Subject|2|||
41982278|NCT03324880|75788276|FG000|Overall Study|Lost to Follow-up|0|||
42029243|NCT00690898|75837927|FG000|TREATMENT|Adverse Event|3|||
42029244|NCT00690898|75837927|FG000|TREATMENT|Lack of Efficacy|18|||
42220006|NCT02948959|76038049|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
42220007|NCT02948959|76038048|FG000|52 Weeks Treatment Period|Randomized by error|0|||
42220008|NCT02948959|76038049|FG001|52 Weeks Treatment Period|Randomized by error|5|||
42220009|NCT02948959|76038048|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
42220010|NCT02948959|76038049|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
42220011|NCT02948959|76038048|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
42302223|NCT02495077|76137272|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
42302224|NCT02495077|76137273|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
41982279|NCT03324880|75788277|FG001|Overall Study|Lost to Follow-up|1|||
41982280|NCT03324880|75788276|FG000|Overall Study|Product Recall|0|||
41982281|NCT03324880|75788277|FG001|Overall Study|Product Recall|1|||
41982282|NCT03053440|75788287|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
41982283|NCT03053440|75788288|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
41982284|NCT03053440|75788287|FG000|Overall Study|Death|18|||
41982285|NCT03053440|75788288|FG001|Overall Study|Death|14|||
42029245|NCT00690898|75837927|FG000|TREATMENT|Withdrawal by Subject|4|||
42220012|NCT02948959|76038049|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
41982286|NCT03053440|75788287|FG000|Overall Study|Withdrawal by Subject|9|||
41982287|NCT03053440|75788288|FG001|Overall Study|Withdrawal by Subject|8|||
41982288|NCT03053440|75788287|FG000|Overall Study|Lost to Follow-up|1|||
41982289|NCT03053440|75788288|FG001|Overall Study|Lost to Follow-up|0|||
41982290|NCT03053440|75788287|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
41982291|NCT03053440|75788288|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
41982292|NCT03053440|75788287|FG000|Overall Study|Physician Decision|2|||
41982293|NCT03053440|75788288|FG001|Overall Study|Physician Decision|1|||
41982294|NCT03053440|75788287|FG000|Overall Study|Participant Randomized but died before dosing|1|||
41982295|NCT03053440|75788288|FG001|Overall Study|Participant Randomized but died before dosing|0|||
41982296|NCT02985684|75788295|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
41982297|NCT02985684|75788295|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
41982298|NCT02985684|75788295|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
41982299|NCT02949934|75788334|FG000|Natural Drinking Period|Adverse Event|1|||
41982300|NCT02949934|75788335|FG001|Natural Drinking Period|Adverse Event|0|||
41982301|NCT02949934|75788336|FG002|Natural Drinking Period|Adverse Event|0|||
41982302|NCT02949934|75788337|FG003|Natural Drinking Period|Adverse Event|1|||
41982303|NCT02949934|75788338|FG004|Natural Drinking Period|Adverse Event|0|||
41982304|NCT02949934|75788339|FG005|Natural Drinking Period|Adverse Event|0|||
41982305|NCT02949934|75788334|FG000|Natural Drinking Period|Lost to Follow-up|0|||
41982306|NCT02949934|75788335|FG001|Natural Drinking Period|Lost to Follow-up|0|||
41982307|NCT02949934|75788336|FG002|Natural Drinking Period|Lost to Follow-up|0|||
41982308|NCT02949934|75788337|FG003|Natural Drinking Period|Lost to Follow-up|0|||
41982309|NCT02949934|75788338|FG004|Natural Drinking Period|Lost to Follow-up|1|||
41982310|NCT02949934|75788339|FG005|Natural Drinking Period|Lost to Follow-up|0|||
41982311|NCT02949934|75788334|FG000|Neuroimaging|Protocol Violation|2|||
41982312|NCT02949934|75788335|FG001|Neuroimaging|Protocol Violation|0|||
41982313|NCT02949934|75788336|FG002|Neuroimaging|Protocol Violation|0|||
41982314|NCT02949934|75788337|FG003|Neuroimaging|Protocol Violation|0|||
41982315|NCT02949934|75788338|FG004|Neuroimaging|Protocol Violation|1|||
41982316|NCT02949934|75788339|FG005|Neuroimaging|Protocol Violation|0|||
41982317|NCT02949934|75788334|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
41982318|NCT02949934|75788335|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
41982319|NCT02949934|75788336|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
41982320|NCT02949934|75788337|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
41982321|NCT02949934|75788338|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
41982322|NCT02949934|75788339|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
41982323|NCT02949934|75788334|FG000|Neuroimaging|Not scanned|0|||
41982324|NCT02949934|75788335|FG001|Neuroimaging|Not scanned|0|||
41982325|NCT02949934|75788336|FG002|Neuroimaging|Not scanned|1|||
41982326|NCT02949934|75788337|FG003|Neuroimaging|Not scanned|0|||
41982327|NCT02949934|75788338|FG004|Neuroimaging|Not scanned|0|||
41982328|NCT02949934|75788339|FG005|Neuroimaging|Not scanned|2|||
41982329|NCT02949934|75788334|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
41982330|NCT02949934|75788335|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
41982331|NCT02949934|75788336|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
41982332|NCT02949934|75788337|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
41982333|NCT02949934|75788338|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
41982334|NCT02949934|75788339|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
41982335|NCT02949934|75788334|FG000|Bar Laboratory|Adverse Event|1|||
41982336|NCT02949934|75788335|FG001|Bar Laboratory|Adverse Event|0|||
42029246|NCT00690898|75837927|FG000|TREATMENT|Other (not otherwise specified)|1|||
42029247|NCT00895414|75837931|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
41982337|NCT02949934|75788336|FG002|Bar Laboratory|Adverse Event|2|||
41982338|NCT02949934|75788337|FG003|Bar Laboratory|Adverse Event|0|||
41982339|NCT02949934|75788338|FG004|Bar Laboratory|Adverse Event|1|||
41982340|NCT02949934|75788339|FG005|Bar Laboratory|Adverse Event|0|||
41982341|NCT02949934|75788334|FG000|Bar Laboratory|Protocol Violation|0|||
41982342|NCT02949934|75788335|FG001|Bar Laboratory|Protocol Violation|0|||
41982343|NCT02949934|75788336|FG002|Bar Laboratory|Protocol Violation|0|||
41982344|NCT02949934|75788337|FG003|Bar Laboratory|Protocol Violation|1|||
41982345|NCT02949934|75788338|FG004|Bar Laboratory|Protocol Violation|0|||
41982346|NCT02949934|75788339|FG005|Bar Laboratory|Protocol Violation|0|||
41982347|NCT02935634|75788371|FG000|Randomization|Participant withdrew consent|0|||
41982348|NCT02935634|75788372|FG001|Randomization|Participant withdrew consent|1|||
41982349|NCT02935634|75788373|FG002|Randomization|Participant withdrew consent|0|||
41982350|NCT02935634|75788374|FG003|Randomization|Participant withdrew consent|0|||
41982351|NCT02935634|75788375|FG004|Randomization|Participant withdrew consent|0|||
41982352|NCT02935634|75788376|FG005|Randomization|Participant withdrew consent|0|||
41982353|NCT02935634|75788371|FG000|Randomization|Death|2|||
41982354|NCT02935634|75788372|FG001|Randomization|Death|1|||
41982355|NCT02935634|75788373|FG002|Randomization|Death|1|||
41982356|NCT02935634|75788374|FG003|Randomization|Death|0|||
41982357|NCT02935634|75788375|FG004|Randomization|Death|0|||
41982358|NCT02935634|75788376|FG005|Randomization|Death|0|||
41982359|NCT02935634|75788371|FG000|Randomization|Other reasons|0|||
41982360|NCT02935634|75788372|FG001|Randomization|Other reasons|2|||
41982361|NCT02935634|75788373|FG002|Randomization|Other reasons|2|||
41982362|NCT02935634|75788374|FG003|Randomization|Other reasons|0|||
41982363|NCT02935634|75788375|FG004|Randomization|Other reasons|0|||
41982364|NCT02935634|75788376|FG005|Randomization|Other reasons|0|||
41982365|NCT02935634|75788371|FG000|Treatment: Track 1|Disease progression|15|||
41982366|NCT02935634|75788372|FG001|Treatment: Track 1|Disease progression|17|||
41982367|NCT02935634|75788373|FG002|Treatment: Track 1|Disease progression|28|||
41982368|NCT02935634|75788374|FG003|Treatment: Track 1|Disease progression|4|||
41982369|NCT02935634|75788375|FG004|Treatment: Track 1|Disease progression|6|||
41982370|NCT02935634|75788376|FG005|Treatment: Track 1|Disease progression|2|||
41982371|NCT02935634|75788371|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
41982372|NCT02935634|75788372|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
41982373|NCT02935634|75788373|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
41982374|NCT02935634|75788374|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
41982375|NCT02935634|75788375|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
41982376|NCT02935634|75788376|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
41982377|NCT02935634|75788371|FG000|Treatment: Track 1|Lost to Follow-up|1|||
41982378|NCT02935634|75788372|FG001|Treatment: Track 1|Lost to Follow-up|0|||
42029248|NCT00895414|75837932|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
42029249|NCT00895414|75837931|FG000|First Intervention (14 Days)|Physician Decision|0|||
42029250|NCT00895414|75837932|FG001|First Intervention (14 Days)|Physician Decision|1|||
42029251|NCT01212770|75837941|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
42029252|NCT01212770|75837942|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
42220013|NCT02948959|76038048|FG000|52 Weeks Treatment Period|Change of residence location|0|||
42220014|NCT02948959|76038049|FG001|52 Weeks Treatment Period|Change of residence location|1|||
42220015|NCT02948959|76038048|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
42220016|NCT02948959|76038049|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
42220017|NCT02948959|76038048|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
42220018|NCT02948959|76038049|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
42220019|NCT02948959|76038048|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
42220020|NCT02948959|76038049|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
42220021|NCT02948959|76038048|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
42220022|NCT02948959|76038049|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
42220023|NCT02948959|76038048|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
42220024|NCT02948959|76038049|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
42220025|NCT02948959|76038048|FG000|12 Weeks Follow-up Period|Study site closure|1|||
42220026|NCT02948959|76038049|FG001|12 Weeks Follow-up Period|Study site closure|0|||
42220027|NCT03582215|76038071|FG000|Overall Study|Adverse Event|1|||
42220028|NCT03582215|76038072|FG001|Overall Study|Adverse Event|0|||
42220029|NCT03582215|76038073|FG002|Overall Study|Adverse Event|0|||
42220030|NCT03582215|76038074|FG003|Overall Study|Adverse Event|0|||
42220031|NCT03582215|76038075|FG004|Overall Study|Adverse Event|0|||
42220032|NCT03582215|76038076|FG005|Overall Study|Adverse Event|0|||
41982379|NCT02935634|75788373|FG002|Treatment: Track 1|Lost to Follow-up|0|||
41982380|NCT02935634|75788374|FG003|Treatment: Track 1|Lost to Follow-up|0|||
42220033|NCT03582215|76038077|FG006|Overall Study|Adverse Event|2|||
42220034|NCT03582215|76038078|FG007|Overall Study|Adverse Event|2|||
42220035|NCT03089580|76038107|FG000|Overall Study|Lost to Follow-up|2|||
42220036|NCT03645395|76038117|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
42220037|NCT03645395|76038118|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
42220038|NCT03645395|76038119|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
42220039|NCT03645395|76038120|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
42302225|NCT02495077|76137270|FG000|Overall Study|Incarcerated|0|||
41982381|NCT02935634|75788375|FG004|Treatment: Track 1|Lost to Follow-up|0|||
41982382|NCT02935634|75788376|FG005|Treatment: Track 1|Lost to Follow-up|0|||
41982383|NCT02935634|75788371|FG000|Treatment: Track 1|Study drug toxicity|2|||
41982384|NCT02935634|75788372|FG001|Treatment: Track 1|Study drug toxicity|1|||
41982385|NCT02935634|75788373|FG002|Treatment: Track 1|Study drug toxicity|3|||
41982386|NCT02935634|75788374|FG003|Treatment: Track 1|Study drug toxicity|0|||
41982387|NCT02935634|75788375|FG004|Treatment: Track 1|Study drug toxicity|0|||
42029253|NCT01212770|75837943|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
42029254|NCT01212770|75837944|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42029255|NCT01212770|75837945|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42029256|NCT01212770|75837946|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42029257|NCT01212770|75837947|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42029258|NCT01212770|75837948|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42029259|NCT01212770|75837949|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42029260|NCT01212770|75837941|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
42029261|NCT01212770|75837942|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
42029262|NCT01212770|75837943|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
42029263|NCT01212770|75837944|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42029264|NCT01212770|75837945|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42029265|NCT01212770|75837946|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42220040|NCT03645395|76038117|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
42220041|NCT03645395|76038118|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
41982388|NCT02935634|75788376|FG005|Treatment: Track 1|Study drug toxicity|1|||
41982389|NCT02935634|75788371|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
41982390|NCT02935634|75788372|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
41982391|NCT02935634|75788373|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
41982392|NCT02935634|75788374|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
41982393|NCT02935634|75788375|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
41982394|NCT02935634|75788376|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
42029266|NCT01212770|75837947|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42029267|NCT01212770|75837948|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42029268|NCT01212770|75837949|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42029269|NCT01212770|75837941|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
42029270|NCT01212770|75837942|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
42029271|NCT01212770|75837943|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
42029272|NCT01212770|75837944|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42029273|NCT01212770|75837945|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42029274|NCT01212770|75837946|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42029275|NCT01212770|75837947|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42029276|NCT01212770|75837948|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42029277|NCT01212770|75837949|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42029278|NCT01212770|75837941|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
42029279|NCT01212770|75837942|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42029280|NCT01212770|75837943|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
42029281|NCT01212770|75837944|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42029282|NCT01212770|75837945|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42029283|NCT01212770|75837946|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42029284|NCT01212770|75837947|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42029285|NCT01212770|75837948|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42029286|NCT01212770|75837949|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42029287|NCT01212770|75837941|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42029288|NCT01212770|75837942|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42029289|NCT01212770|75837943|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
42130561|NCT00504894|75941419|FG000|Overall Study|fMRI technical problems|1|||
42130562|NCT00504894|75941420|FG001|Overall Study|fMRI technical problems|1|||
42130563|NCT00504894|75941421|FG002|Overall Study|fMRI technical problems|0|||
42130564|NCT00504894|75941419|FG000|Overall Study|Withdrawal by Subject|0|||
42130565|NCT00504894|75941420|FG001|Overall Study|Withdrawal by Subject|1|||
42130566|NCT00504894|75941421|FG002|Overall Study|Withdrawal by Subject|0|||
42220042|NCT03645395|76038119|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
41982395|NCT02935634|75788371|FG000|Treatment: Track 1|Participant withdrew consent|2|||
42029290|NCT01212770|75837944|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42029291|NCT01212770|75837945|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42029292|NCT01212770|75837946|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42029293|NCT01212770|75837947|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42029294|NCT01212770|75837948|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42130567|NCT00504894|75941419|FG000|Overall Study|Infusion technical problems|0|||
42130568|NCT00504894|75941420|FG001|Overall Study|Infusion technical problems|1|||
42130569|NCT00504894|75941421|FG002|Overall Study|Infusion technical problems|0|||
42220043|NCT03645395|76038120|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
42220044|NCT03645395|76038117|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
42220045|NCT03645395|76038118|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
42220046|NCT03645395|76038119|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
42220047|NCT03645395|76038120|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
42220048|NCT03645395|76038117|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
42220049|NCT03645395|76038118|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
42220050|NCT03645395|76038119|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
42220051|NCT03645395|76038120|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
42220052|NCT03342469|76038133|FG000|Overall Study|Withdrawal by Subject|0|||
42220053|NCT03342469|76038134|FG001|Overall Study|Withdrawal by Subject|1|||
42220054|NCT03342469|76038135|FG002|Overall Study|Withdrawal by Subject|0|||
42220055|NCT03342469|76038136|FG003|Overall Study|Withdrawal by Subject|0|||
42220056|NCT03581825|76038147|FG000|Period 1|Lens Discomfort|1|||
42220057|NCT03581825|76038148|FG001|Period 1|Lens Discomfort|0|||
42220058|NCT03581825|76038147|FG000|Period 2|Unsatisfactory Vision to Test|0|||
42220059|NCT03581825|76038148|FG001|Period 2|Unsatisfactory Vision to Test|1|||
41982396|NCT02935634|75788372|FG001|Treatment: Track 1|Participant withdrew consent|0|||
41982397|NCT02935634|75788373|FG002|Treatment: Track 1|Participant withdrew consent|1|||
41982398|NCT02935634|75788374|FG003|Treatment: Track 1|Participant withdrew consent|0|||
42220060|NCT03342001|76038154|FG000|Overall Study|Adverse Event|1|||
42220061|NCT03342001|76038154|FG000|Overall Study|Lost to Follow-up|1|||
42220062|NCT03341923|76038158|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
42220063|NCT03341923|76038159|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
42220064|NCT03579719|76038167|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
42220065|NCT03341533|76038173|FG000|Overall Study|Withdrawal by Subject|1|||
42220066|NCT03341533|76038174|FG001|Overall Study|Withdrawal by Subject|1|||
42220067|NCT03341533|76038173|FG000|Overall Study|Not eligible after randomization|2|||
42220068|NCT03341533|76038174|FG001|Overall Study|Not eligible after randomization|1|||
42220069|NCT02688088|76038180|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
42220070|NCT02688088|76038181|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
42220071|NCT02688088|76038182|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
42220072|NCT02688088|76038183|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
42220073|NCT02688088|76038184|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
42220074|NCT02688088|76038180|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
42220075|NCT02688088|76038181|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
42220076|NCT02688088|76038182|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
42220077|NCT02688088|76038183|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
42220078|NCT02688088|76038184|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
42220079|NCT02688088|76038180|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
42220080|NCT02688088|76038181|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
42220081|NCT02688088|76038182|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
42220082|NCT02688088|76038183|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
42220083|NCT02688088|76038184|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
42220084|NCT02688088|76038180|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
42220085|NCT02688088|76038181|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
42220086|NCT02688088|76038182|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
42220087|NCT02688088|76038183|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
42220088|NCT02688088|76038184|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
42302226|NCT02495077|76137271|FG001|Overall Study|Incarcerated|1|||
42302227|NCT02495077|76137272|FG002|Overall Study|Incarcerated|0|||
42302228|NCT02495077|76137273|FG003|Overall Study|Incarcerated|0|||
41982399|NCT02935634|75788375|FG004|Treatment: Track 1|Participant withdrew consent|1|||
41982400|NCT02935634|75788376|FG005|Treatment: Track 1|Participant withdrew consent|0|||
41982401|NCT02935634|75788371|FG000|Treatment: Track 1|Other reasons|0|||
41982402|NCT02935634|75788372|FG001|Treatment: Track 1|Other reasons|0|||
41982403|NCT02935634|75788373|FG002|Treatment: Track 1|Other reasons|2|||
41982404|NCT02935634|75788374|FG003|Treatment: Track 1|Other reasons|0|||
41982405|NCT02935634|75788375|FG004|Treatment: Track 1|Other reasons|0|||
41982406|NCT02935634|75788376|FG005|Treatment: Track 1|Other reasons|0|||
41982407|NCT02935634|75788371|FG000|Treatment: Track 2|Disease progression|13|||
41982408|NCT02935634|75788372|FG001|Treatment: Track 2|Disease progression|26|||
41982409|NCT02935634|75788373|FG002|Treatment: Track 2|Disease progression|20|||
41982410|NCT02935634|75788374|FG003|Treatment: Track 2|Disease progression|5|||
42029295|NCT01212770|75837949|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42029296|NCT01212770|75837941|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
42029297|NCT01212770|75837942|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
41982411|NCT02935634|75788375|FG004|Treatment: Track 2|Disease progression|1|||
41982412|NCT02935634|75788376|FG005|Treatment: Track 2|Disease progression|4|||
42029298|NCT01212770|75837943|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
42130570|NCT00504894|75941419|FG000|Overall Study|poor subject data|2|||
42029299|NCT01212770|75837944|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
42029300|NCT01212770|75837945|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
42029301|NCT01212770|75837946|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
42029302|NCT01212770|75837947|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
42029303|NCT01212770|75837948|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
42029304|NCT01212770|75837949|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
42029305|NCT01212770|75837941|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
42029306|NCT01212770|75837942|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
41982413|NCT02935634|75788371|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
41982414|NCT02935634|75788372|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
41982415|NCT02935634|75788373|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
41982416|NCT02935634|75788374|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
42029307|NCT01212770|75837943|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
42029308|NCT01212770|75837944|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
42029309|NCT01212770|75837945|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
42029310|NCT01212770|75837946|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
42029311|NCT01212770|75837947|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
42029312|NCT01212770|75837948|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
42029313|NCT01212770|75837949|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
42029314|NCT01212770|75837941|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
42029315|NCT01212770|75837942|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
42029316|NCT01212770|75837943|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
42029317|NCT01212770|75837944|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
42029318|NCT01212770|75837945|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
42029319|NCT01212770|75837946|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
42029320|NCT01212770|75837947|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
42029321|NCT01212770|75837948|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
42029322|NCT01212770|75837949|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
42029323|NCT01212770|75837941|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
42029324|NCT01212770|75837942|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
42029325|NCT01212770|75837943|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
42029326|NCT01212770|75837944|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
42029327|NCT01212770|75837945|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
42029328|NCT01212770|75837946|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
42029329|NCT01212770|75837947|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
42029330|NCT01212770|75837948|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
42029331|NCT01212770|75837949|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
42029332|NCT01212770|75837941|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
42029333|NCT01212770|75837942|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
42029334|NCT01212770|75837943|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
42029335|NCT01212770|75837944|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
42029336|NCT01212770|75837945|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
42029337|NCT01212770|75837946|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
42029338|NCT01212770|75837947|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
42029339|NCT01212770|75837948|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
42029340|NCT01212770|75837949|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
42029341|NCT01212770|75837941|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
42029342|NCT01212770|75837942|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
42029343|NCT01212770|75837943|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
42029344|NCT01212770|75837944|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
42029345|NCT01212770|75837945|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
42029346|NCT01212770|75837946|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
42029347|NCT01212770|75837947|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
42029348|NCT01212770|75837948|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
42029349|NCT01212770|75837949|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
42029350|NCT01212770|75837941|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
41982417|NCT02935634|75788375|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
41982418|NCT02935634|75788376|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
41982419|NCT02935634|75788371|FG000|Treatment: Track 2|Study drug toxicity|7|||
41982420|NCT02935634|75788372|FG001|Treatment: Track 2|Study drug toxicity|3|||
41982421|NCT02935634|75788373|FG002|Treatment: Track 2|Study drug toxicity|0|||
42029351|NCT01212770|75837942|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
42029352|NCT01212770|75837943|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
42029353|NCT01212770|75837944|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
42029354|NCT01212770|75837945|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
42029355|NCT01212770|75837946|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
42029356|NCT01212770|75837947|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
42029357|NCT01212770|75837948|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
42029358|NCT01212770|75837949|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
42029359|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
42029360|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
42029361|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
42029362|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
42029363|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
42029364|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
42029365|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
42029366|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
42029367|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
42029368|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
42029369|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
42029370|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
42029371|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
42029372|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
42029373|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
41982422|NCT02935634|75788374|FG003|Treatment: Track 2|Study drug toxicity|0|||
41982423|NCT02935634|75788375|FG004|Treatment: Track 2|Study drug toxicity|0|||
42029374|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
42029375|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
42029376|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
42029377|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
42029378|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
42029379|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
42029380|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
42029381|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
42029382|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
42029383|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
42029384|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
42029385|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
42029386|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
42029387|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
42029388|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
42029389|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
42029390|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
42130571|NCT00504894|75941420|FG001|Overall Study|poor subject data|0|||
42130572|NCT00504894|75941421|FG002|Overall Study|poor subject data|0|||
42130573|NCT00513240|75941431|FG000|Overall Study|Did not have intended surgery|3|||
41982424|NCT02935634|75788376|FG005|Treatment: Track 2|Study drug toxicity|0|||
41982425|NCT02935634|75788371|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
41982426|NCT02935634|75788372|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
41982427|NCT02935634|75788373|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
41982428|NCT02935634|75788374|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
41982429|NCT02935634|75788375|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
41982430|NCT02935634|75788376|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
41982431|NCT02935634|75788371|FG000|Treatment: Track 2|Participant withdrew consent|0|||
42130574|NCT00513240|75941432|FG001|Overall Study|Did not have intended surgery|0|||
42130575|NCT00513240|75941431|FG000|Overall Study|Death|3|||
42130576|NCT00513240|75941432|FG001|Overall Study|Death|3|||
42130577|NCT00513240|75941431|FG000|Overall Study|Withdrawal by Subject|7|||
42130578|NCT00513240|75941432|FG001|Overall Study|Withdrawal by Subject|4|||
42130579|NCT00504426|75941445|FG000|Overall Study|Adverse Event|0|||
42130580|NCT00504426|75941446|FG001|Overall Study|Adverse Event|0|||
42130581|NCT00504426|75941447|FG002|Overall Study|Adverse Event|2|||
42130582|NCT00504426|75941448|FG003|Overall Study|Adverse Event|0|||
42130583|NCT00504426|75941445|FG000|Overall Study|Protocol Violation|1|||
42130584|NCT00504426|75941446|FG001|Overall Study|Protocol Violation|1|||
42130585|NCT00504426|75941447|FG002|Overall Study|Protocol Violation|2|||
42130586|NCT00504426|75941448|FG003|Overall Study|Protocol Violation|0|||
42130587|NCT00504426|75941445|FG000|Overall Study|Withdrawal by Subject|2|||
42130588|NCT00504426|75941446|FG001|Overall Study|Withdrawal by Subject|0|||
42130589|NCT00504426|75941447|FG002|Overall Study|Withdrawal by Subject|0|||
42302229|NCT02495077|76137270|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
42302230|NCT02495077|76137271|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
42130590|NCT00504426|75941448|FG003|Overall Study|Withdrawal by Subject|0|||
42302231|NCT02495077|76137272|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
42029391|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
42029392|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
42029393|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
42029394|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
42302232|NCT02495077|76137273|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
42302233|NCT02495077|76137270|FG000|Overall Study|Timing of transplant and randomization|0|||
42302234|NCT02495077|76137271|FG001|Overall Study|Timing of transplant and randomization|0|||
42302235|NCT02495077|76137272|FG002|Overall Study|Timing of transplant and randomization|5|||
42302236|NCT02495077|76137273|FG003|Overall Study|Timing of transplant and randomization|0|||
42302237|NCT02278341|76137281|FG000|Overall Study|Randomized but never received study drug|1|||
42302238|NCT02278341|76137282|FG001|Overall Study|Randomized but never received study drug|1|||
42302239|NCT02278341|76137281|FG000|Overall Study|Adverse Event|3|||
42302240|NCT02278341|76137282|FG001|Overall Study|Adverse Event|0|||
42302241|NCT02278341|76137281|FG000|Overall Study|Death|68|||
42029395|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
42029396|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
42029397|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
42029398|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
42029399|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
42029400|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
42029401|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
42029402|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
42029403|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
42029404|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42029405|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
42029406|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
42029407|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42029408|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42029409|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42029410|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42130591|NCT00504348|75941461|FG000|Overall Study|Adverse Event|3|||
42302242|NCT02278341|76137282|FG001|Overall Study|Death|56|||
42130592|NCT00504348|75941461|FG000|Overall Study|Lack of Efficacy|4|||
42130593|NCT00504348|75941461|FG000|Overall Study|Physician Decision|1|||
42130594|NCT00507546|75941467|FG000|Overall Study|Withdrawal by Subject|1|||
41982432|NCT02935634|75788372|FG001|Treatment: Track 2|Participant withdrew consent|1|||
42130595|NCT00507546|75941468|FG001|Overall Study|Withdrawal by Subject|0|||
41982433|NCT02935634|75788373|FG002|Treatment: Track 2|Participant withdrew consent|1|||
41982434|NCT02935634|75788374|FG003|Treatment: Track 2|Participant withdrew consent|0|||
41982435|NCT02935634|75788375|FG004|Treatment: Track 2|Participant withdrew consent|1|||
41982436|NCT02935634|75788376|FG005|Treatment: Track 2|Participant withdrew consent|0|||
41982437|NCT02864992|75788405|FG000|Overall Study|still on treatment|15|||
41982438|NCT02864992|75788406|FG001|Overall Study|still on treatment|1|||
41982439|NCT02864992|75788407|FG002|Overall Study|still on treatment|33|||
41982440|NCT02684578|75788415|FG000|Overall Study|Withdrawal by Subject|10|||
42130596|NCT00507546|75941467|FG000|Overall Study|Protocol Violation|1|||
42302243|NCT02278341|76137281|FG000|Overall Study|Withdrawal by Subject|30|||
41982441|NCT02684578|75788416|FG001|Overall Study|Withdrawal by Subject|7|||
42029411|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42130597|NCT00507546|75941468|FG001|Overall Study|Protocol Violation|0|||
42130598|NCT00507546|75941467|FG000|Overall Study|Physician Decision|0|||
42130599|NCT00507546|75941468|FG001|Overall Study|Physician Decision|1|||
42130600|NCT00567593|75941476|FG000|Overall Study|Adverse Event|1|||
42130601|NCT00567593|75941476|FG000|Overall Study|Physician Decision|1|||
42130602|NCT00335764|75941485|FG000|Overall Study|wrong histology|1|||
42130603|NCT00335764|75941486|FG001|Overall Study|wrong histology|0|||
42220089|NCT02688088|76038180|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
42220090|NCT02688088|76038181|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
42220091|NCT02688088|76038182|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
42220092|NCT02688088|76038183|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
42220093|NCT02688088|76038184|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
42220094|NCT02688088|76038180|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
42220095|NCT02688088|76038181|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
42220096|NCT02688088|76038182|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
42302244|NCT02278341|76137282|FG001|Overall Study|Withdrawal by Subject|19|||
42302245|NCT02278341|76137281|FG000|Overall Study|Lost to Follow-up|0|||
42302246|NCT02278341|76137282|FG001|Overall Study|Lost to Follow-up|1|||
41982442|NCT02684578|75788415|FG000|Overall Study|Lost to Follow-up|0|||
41982443|NCT02684578|75788416|FG001|Overall Study|Lost to Follow-up|3|||
42130604|NCT00335764|75941487|FG002|Overall Study|wrong histology|0|||
42130605|NCT00335764|75941488|FG003|Overall Study|wrong histology|0|||
41982444|NCT02684578|75788415|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
41982445|NCT02684578|75788416|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
41982446|NCT02684578|75788415|FG000|Overall Study|Missing follow-up data|0|||
41982447|NCT02684578|75788416|FG001|Overall Study|Missing follow-up data|1|||
41982448|NCT02612129|75788424|FG000|Single Dose Treatment Period|Screening Failure|1|||
41982449|NCT02612129|75788425|FG001|Single Dose Treatment Period|Screening Failure|0|||
41982450|NCT02612129|75788426|FG002|Single Dose Treatment Period|Screening Failure|0|||
41982451|NCT02612129|75788424|FG000|Continuous Treatment Period|Early Escape|0|||
41982452|NCT02612129|75788425|FG001|Continuous Treatment Period|Early Escape|2|||
41982453|NCT02612129|75788426|FG002|Continuous Treatment Period|Early Escape|0|||
41982454|NCT02612129|75788424|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
41982455|NCT02612129|75788425|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
41982456|NCT02612129|75788426|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
41982457|NCT02612129|75788424|FG000|Continuous Treatment Period|Safety Reasons|0|||
41982458|NCT02612129|75788425|FG001|Continuous Treatment Period|Safety Reasons|3|||
41982459|NCT02612129|75788426|FG002|Continuous Treatment Period|Safety Reasons|0|||
41982460|NCT02612129|75788424|FG000|Continuous Treatment Period|Death|0|||
41982461|NCT02612129|75788425|FG001|Continuous Treatment Period|Death|1|||
41982462|NCT02612129|75788426|FG002|Continuous Treatment Period|Death|0|||
41982463|NCT02612129|75788424|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
41982464|NCT02612129|75788425|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
41982465|NCT02612129|75788426|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
41982466|NCT02580305|75788436|FG000|Overall Study|Adverse Event|15|||
41982467|NCT02580305|75788437|FG001|Overall Study|Adverse Event|19|||
41982468|NCT02580305|75788438|FG002|Overall Study|Adverse Event|10|||
41982469|NCT02580305|75788436|FG000|Overall Study|Lack of Efficacy|5|||
41982470|NCT02580305|75788437|FG001|Overall Study|Lack of Efficacy|0|||
41982471|NCT02580305|75788438|FG002|Overall Study|Lack of Efficacy|2|||
41982472|NCT02580305|75788436|FG000|Overall Study|Protocol Violation|4|||
41982473|NCT02580305|75788437|FG001|Overall Study|Protocol Violation|9|||
41982474|NCT02580305|75788438|FG002|Overall Study|Protocol Violation|6|||
41982475|NCT02580305|75788436|FG000|Overall Study|Lost to Follow-up|4|||
41982476|NCT02580305|75788437|FG001|Overall Study|Lost to Follow-up|4|||
41982477|NCT02580305|75788438|FG002|Overall Study|Lost to Follow-up|2|||
41982478|NCT02580305|75788436|FG000|Overall Study|Withdrawal by Subject|11|||
41982479|NCT02580305|75788437|FG001|Overall Study|Withdrawal by Subject|9|||
41982480|NCT02580305|75788438|FG002|Overall Study|Withdrawal by Subject|7|||
41982481|NCT02580305|75788436|FG000|Overall Study|Randomized in error and never treated|4|||
41982482|NCT02580305|75788437|FG001|Overall Study|Randomized in error and never treated|8|||
41982483|NCT02580305|75788438|FG002|Overall Study|Randomized in error and never treated|5|||
41982484|NCT02054741|75788457|FG000|Overall Study|Protocol Violation|13|||
41982485|NCT02054741|75788458|FG001|Overall Study|Protocol Violation|2|||
41982486|NCT02054741|75788457|FG000|Overall Study|Withdrawal by Subject|10|||
41982487|NCT02054741|75788458|FG001|Overall Study|Withdrawal by Subject|5|||
41982488|NCT02054741|75788457|FG000|Overall Study|Death|94|||
41982489|NCT02054741|75788458|FG001|Overall Study|Death|90|||
41982490|NCT02054741|75788457|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
41982491|NCT02054741|75788458|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
41982492|NCT01555463|75788466|FG000|Treatment|Adverse Event|6|||
41982493|NCT01555463|75788467|FG001|Treatment|Adverse Event|12|||
41982494|NCT01555463|75788466|FG000|Treatment|Withdrawal by Subject|24|||
41982495|NCT01555463|75788467|FG001|Treatment|Withdrawal by Subject|36|||
41982496|NCT01555463|75788466|FG000|Treatment|Lost to Follow-up|28|||
41982497|NCT01555463|75788467|FG001|Treatment|Lost to Follow-up|23|||
41982498|NCT01555463|75788466|FG000|Treatment|Protocol Violation|4|||
42130606|NCT00335764|75941489|FG004|Overall Study|wrong histology|1|||
42130607|NCT00567359|75941525|FG000|Overall Study|Withdrawal by Subject|1|||
42130608|NCT00492726|75941531|FG000|Overall Study|Adverse Event|10|||
42130609|NCT00492726|75941532|FG001|Overall Study|Adverse Event|6|||
42130610|NCT00492726|75941531|FG000|Overall Study|Death|7|||
42220097|NCT02688088|76038183|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
41982499|NCT01555463|75788467|FG001|Treatment|Protocol Violation|5|||
41982500|NCT01555463|75788466|FG000|Treatment|Other reason|2|||
41982501|NCT01555463|75788467|FG001|Treatment|Other reason|3|||
41982502|NCT01555463|75788466|FG000|Follow up|Adverse Event|2|||
41982503|NCT01555463|75788467|FG001|Follow up|Adverse Event|5|||
41982504|NCT01555463|75788466|FG000|Follow up|Death|0|||
41982505|NCT01555463|75788467|FG001|Follow up|Death|1|||
41982506|NCT01555463|75788466|FG000|Follow up|Withdrawal by Subject|22|||
41982507|NCT01555463|75788467|FG001|Follow up|Withdrawal by Subject|22|||
41982508|NCT01555463|75788466|FG000|Follow up|Lost to Follow-up|9|||
41982509|NCT01555463|75788467|FG001|Follow up|Lost to Follow-up|10|||
41982510|NCT01555463|75788466|FG000|Follow up|Protocol Violation|2|||
41982511|NCT01555463|75788467|FG001|Follow up|Protocol Violation|4|||
41982512|NCT01555463|75788466|FG000|Follow up|Other reason|3|||
41982513|NCT01555463|75788467|FG001|Follow up|Other reason|3|||
41982514|NCT02277106|75788543|FG000|Stage 2|Adverse Event|0|||
41982515|NCT02277106|75788544|FG001|Stage 2|Adverse Event|0|||
42220098|NCT02688088|76038184|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
42220099|NCT02688088|76038180|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
42220100|NCT02688088|76038181|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
42220101|NCT02688088|76038182|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
42220102|NCT02688088|76038183|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
41982516|NCT02277106|75788545|FG002|Stage 2|Adverse Event|1|||
42220103|NCT02688088|76038184|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
42220104|NCT02688088|76038180|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
42220105|NCT02688088|76038181|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
42220106|NCT02688088|76038182|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
42220107|NCT02688088|76038183|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
42220108|NCT02688088|76038184|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
42220109|NCT02688088|76038180|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
42220110|NCT02688088|76038181|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
42220111|NCT02688088|76038182|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
42220112|NCT02688088|76038183|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
42220113|NCT02688088|76038184|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
42220114|NCT03641651|76038209|FG000|Overall Study|organizational issues at one study site|1|||
42220115|NCT03341299|76038213|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
42220116|NCT03341299|76038214|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
42220117|NCT03341299|76038215|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
42220118|NCT03341299|76038216|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
42220119|NCT02949271|76038230|FG000|Overall Study|Lack of Efficacy|5|||
42220120|NCT02949271|76038231|FG001|Overall Study|Lack of Efficacy|4|||
42220121|NCT02949271|76038230|FG000|Overall Study|Lost to Follow-up|3|||
42220122|NCT02949271|76038231|FG001|Overall Study|Lost to Follow-up|6|||
42220123|NCT02949271|76038230|FG000|Overall Study|Physician Decision|5|||
42220124|NCT02949271|76038231|FG001|Overall Study|Physician Decision|5|||
42220125|NCT02949271|76038230|FG000|Overall Study|Protocol Violation|6|||
42220126|NCT02949271|76038231|FG001|Overall Study|Protocol Violation|3|||
42220127|NCT02949271|76038230|FG000|Overall Study|Withdrawal by Subject|1|||
42220128|NCT02949271|76038231|FG001|Overall Study|Withdrawal by Subject|0|||
41982517|NCT02215096|75788568|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
42029412|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
42220129|NCT02949271|76038230|FG000|Overall Study|Delivered prior to intervention|7|||
42302247|NCT02278341|76137281|FG000|Overall Study|Physician Decision|1|||
41982518|NCT02215096|75788569|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
41982519|NCT02215096|75788570|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
41982520|NCT02215096|75788571|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
41982521|NCT02215096|75788572|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
41982522|NCT02215096|75788568|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
42130611|NCT00492726|75941532|FG001|Overall Study|Death|2|||
42130612|NCT00492726|75941531|FG000|Overall Study|Lack of Efficacy|0|||
42130613|NCT00492726|75941532|FG001|Overall Study|Lack of Efficacy|2|||
42130614|NCT00492726|75941531|FG000|Overall Study|Lost to Follow-up|27|||
42130615|NCT00492726|75941532|FG001|Overall Study|Lost to Follow-up|19|||
42130616|NCT00492726|75941531|FG000|Overall Study|Physician Decision|0|||
42130617|NCT00492726|75941532|FG001|Overall Study|Physician Decision|1|||
42130618|NCT00492726|75941531|FG000|Overall Study|Withdrawal by Subject|6|||
42130619|NCT00492726|75941532|FG001|Overall Study|Withdrawal by Subject|3|||
42130620|NCT00492726|75941531|FG000|Overall Study|Non compliant with study medication|0|||
42130621|NCT00492726|75941532|FG001|Overall Study|Non compliant with study medication|3|||
42130622|NCT00309946|75941538|FG000|Overall Study|Withdrawal by Subject|1|||
42130623|NCT00492648|75941544|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
42130624|NCT00492648|75941545|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
42130625|NCT00506922|75941556|FG000|Overall Study|Physician Decision|0|||
42130626|NCT00506922|75941557|FG001|Overall Study|Physician Decision|0|||
42130627|NCT00506922|75941558|FG002|Overall Study|Physician Decision|0|||
42130628|NCT00506922|75941559|FG003|Overall Study|Physician Decision|2|||
42130629|NCT00506922|75941560|FG004|Overall Study|Physician Decision|0|||
42130630|NCT00506922|75941556|FG000|Overall Study|Withdrawal by Subject|0|||
42130631|NCT00506922|75941557|FG001|Overall Study|Withdrawal by Subject|0|||
42130632|NCT00506922|75941558|FG002|Overall Study|Withdrawal by Subject|0|||
42130633|NCT00506922|75941559|FG003|Overall Study|Withdrawal by Subject|0|||
42130634|NCT00506922|75941560|FG004|Overall Study|Withdrawal by Subject|1|||
42130635|NCT00492024|75941570|FG000|Treatment|Adverse Event|3|||
41982523|NCT02215096|75788569|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
41982524|NCT02215096|75788570|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
41982525|NCT02215096|75788571|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
41982526|NCT02215096|75788572|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
41982527|NCT02215096|75788568|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
41982528|NCT02215096|75788569|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
41982529|NCT02215096|75788570|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
41982530|NCT02215096|75788571|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
41982531|NCT02215096|75788572|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
41982532|NCT02215096|75788568|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
41982533|NCT02215096|75788569|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
41982534|NCT02215096|75788570|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
41982535|NCT02215096|75788571|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
41982536|NCT02215096|75788572|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
41982537|NCT03189862|75788607|FG000|Overall Study|Withdrawal by Subject|1|||
41982538|NCT03189862|75788608|FG001|Overall Study|Withdrawal by Subject|0|||
41982539|NCT03189862|75788607|FG000|Overall Study|Lost to Follow-up|54|||
41982540|NCT03189862|75788608|FG001|Overall Study|Lost to Follow-up|62|||
41982541|NCT00107614|75788636|FG000|Overall Study|Physician Decision|10|||
41982542|NCT00107614|75788636|FG000|Overall Study|Death|2|||
41982543|NCT00107380|75788640|FG000|Overall Study|Adverse Event|7|||
41982544|NCT00107380|75788640|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
41982545|NCT00107380|75788640|FG000|Overall Study|Progression/relapse|4|||
41982546|NCT00107380|75788640|FG000|Overall Study|Death|3|||
41982547|NCT00107380|75788640|FG000|Overall Study|Other - not protocol specified|7|||
41982548|NCT00107380|75788640|FG000|Overall Study|Ineligible|2|||
41982549|NCT01340014|75788647|FG000|Period 1, First 7 Days|Adverse Event|1|||
41982550|NCT01340014|75788648|FG001|Period 1, First 7 Days|Adverse Event|0|||
41982551|NCT01340014|75788647|FG000|Period 1, First 7 Days|Personal Reasons|1|||
41982552|NCT01340014|75788648|FG001|Period 1, First 7 Days|Personal Reasons|0|||
41982553|NCT01340014|75788647|FG000|Period 2, Second 7 Days|Adverse Event|0|||
41982554|NCT01340014|75788648|FG001|Period 2, Second 7 Days|Adverse Event|1|||
41982555|NCT01339897|75788658|FG000|Overall Study|Adverse Event|1|||
41982556|NCT01339897|75788659|FG001|Overall Study|Adverse Event|0|||
41982557|NCT01339897|75788660|FG002|Overall Study|Adverse Event|0|||
41982558|NCT01339897|75788661|FG003|Overall Study|Adverse Event|1|||
41982559|NCT01339429|75788673|FG000|Overall Study|Withdrawal by Subject|1|||
41982560|NCT01339429|75788673|FG000|Overall Study|Physician Decision|3|||
41982561|NCT01339390|75788679|FG000|Overall Study|Death|32|||
41982562|NCT01339390|75788680|FG001|Overall Study|Death|29|||
41982563|NCT01339390|75788679|FG000|Overall Study|Lost to Follow-up|125|||
41982564|NCT01339390|75788680|FG001|Overall Study|Lost to Follow-up|127|||
41982565|NCT01339273|75788688|FG000|Overall Study|Lost to Follow-up|8|||
41982566|NCT01339273|75788689|FG001|Overall Study|Lost to Follow-up|8|||
41982567|NCT01334866|75788695|FG000|Overall Study|Withdrawal by Subject|10|||
41982568|NCT01334866|75788695|FG000|Overall Study|Lost to Follow-up|3|||
41982569|NCT01334866|75788695|FG000|Overall Study|Physician Decision|3|||
41982570|NCT01334866|75788695|FG000|Overall Study|medically necessary prior to procedure|2|||
41982571|NCT01334866|75788695|FG000|Overall Study|medically necessary post-procedure|1|||
41982572|NCT01334710|75788701|FG000|Overall Study|Trial was terminated|3|||
41982573|NCT01334554|75788708|FG000|Overall Study|Adverse Event|4|||
41982574|NCT01334554|75788709|FG001|Overall Study|Adverse Event|2|||
41982575|NCT01332799|75788719|FG000|Overall Study|Insufficient funding|10|||
41982576|NCT01332799|75788720|FG001|Overall Study|Insufficient funding|10|||
41982577|NCT01332331|75788728|FG000|Overall Study|Lost to Follow-up|0|||
41982578|NCT01332331|75788729|FG001|Overall Study|Lost to Follow-up|1|||
41982579|NCT01332331|75788728|FG000|Overall Study|Adverse Event|1|||
41982580|NCT01332331|75788729|FG001|Overall Study|Adverse Event|1|||
41982581|NCT01332331|75788728|FG000|Overall Study|Physician Decision|1|||
41982582|NCT01332331|75788729|FG001|Overall Study|Physician Decision|0|||
41982583|NCT01332292|75788736|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
41982584|NCT01332292|75788737|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
41982585|NCT01332292|75788736|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
41982586|NCT01332292|75788737|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
41982587|NCT01332292|75788736|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
41982588|NCT01332292|75788737|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
41982589|NCT01332019|75788747|FG000|Overall Study|Was Not Dosed|1|||
41982590|NCT01332019|75788748|FG001|Overall Study|Was Not Dosed|0|||
41982591|NCT01332019|75788747|FG000|Overall Study|Other|16|||
41982592|NCT01332019|75788748|FG001|Overall Study|Other|18|||
41982593|NCT01332019|75788747|FG000|Overall Study|Death|2|||
41982594|NCT01332019|75788748|FG001|Overall Study|Death|1|||
41982595|NCT01332019|75788747|FG000|Overall Study|Physician Decision|4|||
41982596|NCT01332019|75788748|FG001|Overall Study|Physician Decision|3|||
41982597|NCT01332019|75788747|FG000|Overall Study|Withdrawal by Subject|73|||
42029413|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
42029414|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
42029415|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
42029416|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
42029417|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
42029418|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
42029419|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
42029420|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
42029421|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
42029422|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
42029423|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
42029424|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
42029425|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
42029426|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
42029427|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
42029428|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
42130636|NCT00492024|75941571|FG001|Treatment|Adverse Event|1|||
42130637|NCT00492024|75941570|FG000|Treatment|Lack of Efficacy|21|||
42130638|NCT00492024|75941571|FG001|Treatment|Lack of Efficacy|20|||
42220130|NCT02949271|76038231|FG001|Overall Study|Delivered prior to intervention|9|||
42220131|NCT02949271|76038230|FG000|Overall Study|Outside the window for cervical dilation|2|||
42220132|NCT02949271|76038231|FG001|Overall Study|Outside the window for cervical dilation|3|||
42220133|NCT03640559|76038239|FG000|Overall Study|Physician Decision|1|||
42220134|NCT03640559|76038240|FG001|Overall Study|Physician Decision|1|||
42220135|NCT03640559|76038239|FG000|Overall Study|Withdrawal by Subject|1|||
42220136|NCT03640559|76038240|FG001|Overall Study|Withdrawal by Subject|0|||
42220137|NCT03339583|76038248|FG000|First Intervention (14 Days)|Adverse Event|1|||
42220138|NCT03339583|76038249|FG001|First Intervention (14 Days)|Adverse Event|0|||
42220139|NCT03339583|76038248|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
42220140|NCT03339583|76038249|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
42220141|NCT03339583|76038248|FG000|Second Intervention (14 Days)|Adverse Event|0|||
42220142|NCT03339583|76038249|FG001|Second Intervention (14 Days)|Adverse Event|1|||
42220143|NCT03339583|76038248|FG000|Follow-up (14 Days)|Physician Decision|6|||
42220144|NCT03339583|76038249|FG001|Follow-up (14 Days)|Physician Decision|3|||
42220145|NCT03639779|76038257|FG000|Overall Study|Lost to Follow-up|1|||
42220146|NCT03575975|76038266|FG000|Overall Study|Lost to Follow-up|1|||
42220147|NCT03575975|76038267|FG001|Overall Study|Lost to Follow-up|0|||
42220148|NCT03575975|76038268|FG002|Overall Study|Lost to Follow-up|0|||
42220149|NCT03636893|76038276|FG000|Overall Study|Death|0|||
42220150|NCT03636893|76038277|FG001|Overall Study|Death|1|||
42220151|NCT03636893|76038276|FG000|Overall Study|Protocol Violation|0|||
42220152|NCT03636893|76038277|FG001|Overall Study|Protocol Violation|3|||
42220153|NCT03636893|76038276|FG000|Overall Study|Withdrawal by Subject|1|||
42220154|NCT03636893|76038277|FG001|Overall Study|Withdrawal by Subject|2|||
42220155|NCT03636893|76038276|FG000|Overall Study|Refusal to surgery|4|||
42220156|NCT03636893|76038277|FG001|Overall Study|Refusal to surgery|3|||
42220157|NCT03636893|76038276|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
42220158|NCT03636893|76038277|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
42220159|NCT03636893|76038276|FG000|Overall Study|Adverse Event|1|||
42220160|NCT03636893|76038277|FG001|Overall Study|Adverse Event|1|||
42220161|NCT01353586|76038285|FG000|Overall Study|Procedure terminated prior to ablation|3|||
42220162|NCT01353586|76038286|FG001|Overall Study|Procedure terminated prior to ablation|0|||
42220163|NCT01353586|76038285|FG000|Overall Study|Never had insertion of study catheter|4|||
42220164|NCT01353586|76038286|FG001|Overall Study|Never had insertion of study catheter|1|||
42220165|NCT01353586|76038285|FG000|Overall Study|Neurological exam not done|0|||
42220166|NCT01353586|76038286|FG001|Overall Study|Neurological exam not done|1|||
42220167|NCT03091920|76038298|FG000|Overall Study|Adverse Event|0|||
42220168|NCT03091920|76038299|FG001|Overall Study|Adverse Event|1|||
42130639|NCT00492024|75941570|FG000|Treatment|Lost to Follow-up|3|||
42130640|NCT00492024|75941571|FG001|Treatment|Lost to Follow-up|1|||
42130641|NCT00492024|75941570|FG000|Treatment|Withdrawal by Subject|2|||
42130642|NCT00492024|75941571|FG001|Treatment|Withdrawal by Subject|0|||
42130643|NCT00492024|75941570|FG000|Follow up|Lack of Efficacy|0|||
42130644|NCT00492024|75941571|FG001|Follow up|Lack of Efficacy|1|||
42130645|NCT00492024|75941570|FG000|Follow up|Lost to Follow-up|1|||
42029429|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
42029430|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
42130646|NCT00492024|75941571|FG001|Follow up|Lost to Follow-up|1|||
42130647|NCT00491556|75941579|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
42130648|NCT00491556|75941580|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
42220169|NCT03091920|76038300|FG002|Overall Study|Adverse Event|0|||
42220170|NCT03338569|76038316|FG000|Overall Study|Physician Decision|8|||
42220171|NCT03338569|76038317|FG001|Overall Study|Physician Decision|3|||
42029431|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
42029432|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
42029433|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
42029434|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
42029435|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
42029436|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
42029437|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
42029438|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
42029439|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
42029440|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42029441|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
42029442|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42029443|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42029444|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42029445|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42029446|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42029447|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42029448|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42029449|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
41982598|NCT01332019|75788748|FG001|Overall Study|Withdrawal by Subject|71|||
42029450|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
42029451|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
42029452|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
42029453|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
42029454|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
42029455|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
42029456|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
42029457|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
42029458|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
42029459|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
42029460|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
42029461|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
42029462|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
41982599|NCT01332019|75788747|FG000|Overall Study|Lost to Follow-up|4|||
41982600|NCT01332019|75788748|FG001|Overall Study|Lost to Follow-up|7|||
41982601|NCT01332019|75788747|FG000|Overall Study|Adverse Event|13|||
41982602|NCT01332019|75788748|FG001|Overall Study|Adverse Event|22|||
42029463|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
42029464|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
42029465|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
42029466|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
42029467|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42029468|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
42029469|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
42029470|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42029471|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42029472|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42029473|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42220172|NCT03338569|76038316|FG000|Overall Study|Withdrawal by Subject|0|||
41982603|NCT01331239|75788756|FG000|Part II: Core Study|Adverse Event|0|||
41982604|NCT01331239|75788757|FG001|Part II: Core Study|Adverse Event|3|||
41982605|NCT01331239|75788758|FG002|Part II: Core Study|Adverse Event|0|||
41982606|NCT01331239|75788756|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
41982607|NCT01331239|75788757|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
41982608|NCT01331239|75788758|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
41982609|NCT01331239|75788756|FG000|Part II: Core Study|Withdrawal by Subject|0|||
41982610|NCT01331239|75788757|FG001|Part II: Core Study|Withdrawal by Subject|2|||
41982611|NCT01331239|75788758|FG002|Part II: Core Study|Withdrawal by Subject|0|||
41982612|NCT01331239|75788756|FG000|Part II: Core Study|Administrative problems|0|||
41982613|NCT01331239|75788757|FG001|Part II: Core Study|Administrative problems|1|||
41982614|NCT01331239|75788758|FG002|Part II: Core Study|Administrative problems|0|||
42029474|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42130649|NCT00491556|75941579|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
42130650|NCT00491556|75941580|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
41982615|NCT01331161|75788776|FG000|Overall Study|Physician Decision|1|||
42130651|NCT00491556|75941579|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
42130652|NCT00491556|75941580|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
42220173|NCT03338569|76038317|FG001|Overall Study|Withdrawal by Subject|1|||
41982616|NCT01331161|75788777|FG001|Overall Study|Physician Decision|0|||
41982617|NCT01331161|75788776|FG000|Overall Study|Lost to Follow-up|0|||
42029475|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
42029476|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42029477|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
42029478|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
42029479|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42029480|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42029481|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42029482|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42029483|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
42029484|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42029485|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
42029486|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
42029487|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
42029488|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
42029489|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
42029490|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
42029491|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
42029492|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
42029493|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
42029494|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42029495|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
42029496|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
42029497|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42029498|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42029499|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42029500|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42029501|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42029502|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42029503|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42029504|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42029505|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
42029506|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42029507|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42029508|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42029509|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42029510|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42029511|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42029512|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42029513|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
42029514|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42029515|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42029516|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42029517|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42029518|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42029519|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42029520|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
42029521|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
42029522|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
42029523|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
42029524|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
42029525|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
42029526|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
42029527|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
42029528|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
42029529|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
42029530|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42029531|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42029532|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
42029533|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42029534|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42029535|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42029536|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42029537|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42029538|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42029539|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42029540|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42220174|NCT03338569|76038316|FG000|Overall Study|Lost to Follow-up|0|||
42029541|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
42029542|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42029543|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42029544|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42029545|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42029546|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42029547|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
42029548|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42029549|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42029550|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
42029551|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42029552|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42029553|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42029554|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42029555|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42029556|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42029557|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42029558|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
42029559|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
42029560|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42029561|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42029562|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42029563|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42029564|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
42029565|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42029566|NCT01212770|75837941|FG000|Long-term Safety Phase (Year 5)|Death|0|||
42029567|NCT01212770|75837942|FG001|Long-term Safety Phase (Year 5)|Death|0|||
42029568|NCT01212770|75837943|FG002|Long-term Safety Phase (Year 5)|Death|0|||
42029569|NCT01212770|75837944|FG003|Long-term Safety Phase (Year 5)|Death|0|||
42029570|NCT01212770|75837945|FG004|Long-term Safety Phase (Year 5)|Death|0|||
42029571|NCT01212770|75837946|FG005|Long-term Safety Phase (Year 5)|Death|0|||
42029572|NCT01212770|75837947|FG006|Long-term Safety Phase (Year 5)|Death|0|||
42029573|NCT01212770|75837948|FG007|Long-term Safety Phase (Year 5)|Death|1|||
41982618|NCT01331161|75788777|FG001|Overall Study|Lost to Follow-up|1|||
41982619|NCT01331161|75788776|FG000|Overall Study|Pregnancy|0|||
41982620|NCT01331161|75788777|FG001|Overall Study|Pregnancy|1|||
41982621|NCT01331005|75788787|FG000|Overall Study|Lost to Follow-up|2|||
41982622|NCT01331005|75788788|FG001|Overall Study|Lost to Follow-up|1|||
41982623|NCT01331005|75788787|FG000|Overall Study|Withdrawal by Subject|2|||
41982624|NCT01331005|75788788|FG001|Overall Study|Withdrawal by Subject|3|||
41982625|NCT01330459|75788796|FG000|Overall Study|Physician Decision|0|||
42029574|NCT01212770|75837949|FG008|Long-term Safety Phase (Year 5)|Death|0|||
42029575|NCT00598273|75837974|FG000|Overall Study|Adverse Event|4|||
42029576|NCT00598273|75837975|FG001|Overall Study|Adverse Event|5|||
42029577|NCT00598273|75837976|FG002|Overall Study|Adverse Event|2|||
42029578|NCT00598273|75837974|FG000|Overall Study|Death|6|||
42029579|NCT00598273|75837975|FG001|Overall Study|Death|12|||
42029580|NCT00598273|75837976|FG002|Overall Study|Death|8|||
42029581|NCT00598273|75837974|FG000|Overall Study|Lost to Follow-up|8|||
42029582|NCT00598273|75837975|FG001|Overall Study|Lost to Follow-up|3|||
42029583|NCT00598273|75837976|FG002|Overall Study|Lost to Follow-up|5|||
42029584|NCT00598273|75837974|FG000|Overall Study|Physician Decision|0|||
42029585|NCT00598273|75837975|FG001|Overall Study|Physician Decision|0|||
42029586|NCT00598273|75837976|FG002|Overall Study|Physician Decision|1|||
42029587|NCT00598273|75837974|FG000|Overall Study|Withdrawal by Subject|12|||
42029588|NCT00598273|75837975|FG001|Overall Study|Withdrawal by Subject|10|||
42029589|NCT00598273|75837976|FG002|Overall Study|Withdrawal by Subject|10|||
42029590|NCT00598273|75837974|FG000|Overall Study|Noncompliance|3|||
42029591|NCT00598273|75837975|FG001|Overall Study|Noncompliance|2|||
42220175|NCT03338569|76038317|FG001|Overall Study|Lost to Follow-up|1|||
42220176|NCT03338023|76038325|FG000|Overall Study|Withdrawal by Subject|3|||
42220177|NCT03338023|76038326|FG001|Overall Study|Withdrawal by Subject|4|||
42220178|NCT03338023|76038325|FG000|Overall Study|Protocol Violation|3|||
42220179|NCT03338023|76038326|FG001|Overall Study|Protocol Violation|3|||
41982626|NCT01330459|75788797|FG001|Overall Study|Physician Decision|2|||
41982627|NCT01330381|75788807|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
41982628|NCT01330381|75788808|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
42029592|NCT00598273|75837976|FG002|Overall Study|Noncompliance|3|||
42029593|NCT00598273|75837974|FG000|Overall Study|Relocation|0|||
42029594|NCT00598273|75837975|FG001|Overall Study|Relocation|2|||
42029595|NCT00598273|75837976|FG002|Overall Study|Relocation|4|||
42029596|NCT00598273|75837974|FG000|Overall Study|Renal transplant|1|||
42029597|NCT00598273|75837975|FG001|Overall Study|Renal transplant|0|||
42029598|NCT00598273|75837976|FG002|Overall Study|Renal transplant|1|||
42220180|NCT03338023|76038325|FG000|Overall Study|Lost to Follow-up|2|||
42029599|NCT00598273|75837974|FG000|Overall Study|Site elected to close|1|||
42029600|NCT00598273|75837975|FG001|Overall Study|Site elected to close|0|||
42029601|NCT00598273|75837976|FG002|Overall Study|Site elected to close|0|||
42029602|NCT00598273|75837974|FG000|Overall Study|Started dialysis|6|||
42029603|NCT00598273|75837975|FG001|Overall Study|Started dialysis|4|||
42029604|NCT00598273|75837976|FG002|Overall Study|Started dialysis|5|||
42029605|NCT01211522|75837987|FG000|Overall Study|Withdrawal by Subject|3|||
42029606|NCT01211522|75837988|FG001|Overall Study|Withdrawal by Subject|7|||
42029607|NCT01211522|75837989|FG002|Overall Study|Withdrawal by Subject|5|||
42029608|NCT01211288|75837999|FG000|Overall Study|Lost to Follow-up|1|||
41982629|NCT01330381|75788809|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
41982630|NCT01330381|75788807|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
41982631|NCT01330381|75788808|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
42029609|NCT01211288|75838000|FG001|Overall Study|Lost to Follow-up|1|||
42029610|NCT00883753|75838008|FG000|Overall Study|Adverse Event|37|||
42029611|NCT00883753|75838008|FG000|Overall Study|Death|2|||
42029612|NCT00883753|75838008|FG000|Overall Study|Insufficient therapeutic response|16|||
42130653|NCT00491556|75941579|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
42130654|NCT00491556|75941580|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
42130655|NCT00491556|75941579|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
42130656|NCT00491556|75941580|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
42220181|NCT03338023|76038326|FG001|Overall Study|Lost to Follow-up|1|||
42220182|NCT03338023|76038325|FG000|Overall Study|Physician Decision|1|||
42220183|NCT03338023|76038326|FG001|Overall Study|Physician Decision|2|||
42220184|NCT03337477|76038334|FG000|Overall Study|not categorized into the listed ones|11|||
42220185|NCT03337477|76038335|FG001|Overall Study|not categorized into the listed ones|9|||
42220186|NCT03337477|76038334|FG000|Overall Study|Withdrawal by Subject|0|||
42220187|NCT03337477|76038335|FG001|Overall Study|Withdrawal by Subject|1|||
42220188|NCT03337477|76038334|FG000|Overall Study|Death|0|||
42220189|NCT03337477|76038335|FG001|Overall Study|Death|1|||
42220190|NCT03337477|76038334|FG000|Overall Study|Lost to Follow-up|0|||
42220191|NCT03337477|76038335|FG001|Overall Study|Lost to Follow-up|2|||
42220192|NCT02687542|76038348|FG000|Overall Study|Medication error without associated AEs|0|||
42220193|NCT02687542|76038349|FG001|Overall Study|Medication error without associated AEs|0|||
42220194|NCT02687542|76038350|FG002|Overall Study|Medication error without associated AEs|0|||
42220195|NCT02687542|76038351|FG003|Overall Study|Medication error without associated AEs|0|||
42220196|NCT02687542|76038352|FG004|Overall Study|Medication error without associated AEs|1|||
42220197|NCT02687542|76038348|FG000|Overall Study|Lost to Follow-up|0|||
42220198|NCT02687542|76038349|FG001|Overall Study|Lost to Follow-up|0|||
42220199|NCT02687542|76038350|FG002|Overall Study|Lost to Follow-up|0|||
42220200|NCT02687542|76038351|FG003|Overall Study|Lost to Follow-up|0|||
42220201|NCT02687542|76038352|FG004|Overall Study|Lost to Follow-up|1|||
42220202|NCT02687542|76038348|FG000|Overall Study|Protocol Violation|0|||
42220203|NCT02687542|76038349|FG001|Overall Study|Protocol Violation|1|||
42220204|NCT02687542|76038350|FG002|Overall Study|Protocol Violation|0|||
42220205|NCT02687542|76038351|FG003|Overall Study|Protocol Violation|0|||
42220206|NCT02687542|76038352|FG004|Overall Study|Protocol Violation|0|||
42220207|NCT02687542|76038348|FG000|Overall Study|Other|5|||
42220208|NCT02687542|76038349|FG001|Overall Study|Other|9|||
41982632|NCT01330381|75788809|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
41982633|NCT01330381|75788807|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
41982634|NCT01330381|75788808|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
42130657|NCT00491556|75941579|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
42130658|NCT00491556|75941580|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
42130659|NCT00491556|75941579|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
42130660|NCT00491556|75941580|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
42220209|NCT02687542|76038350|FG002|Overall Study|Other|10|||
42220210|NCT02687542|76038351|FG003|Overall Study|Other|6|||
42220211|NCT02687542|76038352|FG004|Overall Study|Other|5|||
42220212|NCT02687542|76038348|FG000|Overall Study|Adverse Event|3|||
42220213|NCT02687542|76038349|FG001|Overall Study|Adverse Event|1|||
41982635|NCT01330381|75788809|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
42029613|NCT00883753|75838008|FG000|Overall Study|Lost to Follow-up|4|||
42029614|NCT00883753|75838008|FG000|Overall Study|Violation of selection criteria at entry|7|||
42220214|NCT02687542|76038350|FG002|Overall Study|Adverse Event|3|||
42220215|NCT02687542|76038351|FG003|Overall Study|Adverse Event|2|||
42220216|NCT02687542|76038352|FG004|Overall Study|Adverse Event|9|||
42220217|NCT02687542|76038348|FG000|Overall Study|Withdrawal by Subject|0|||
42220218|NCT02687542|76038349|FG001|Overall Study|Withdrawal by Subject|1|||
42220219|NCT02687542|76038350|FG002|Overall Study|Withdrawal by Subject|1|||
42220220|NCT02687542|76038351|FG003|Overall Study|Withdrawal by Subject|2|||
42220221|NCT02687542|76038352|FG004|Overall Study|Withdrawal by Subject|4|||
42029615|NCT00883753|75838008|FG000|Overall Study|Protocol Violation|2|||
42029616|NCT00883753|75838008|FG000|Overall Study|Refused treatment|4|||
42130661|NCT00491556|75941579|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
42130662|NCT00491556|75941580|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
42130663|NCT00491556|75941579|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
42130664|NCT00491556|75941580|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
42130665|NCT00491556|75941579|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
42130666|NCT00491556|75941580|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
42130667|NCT00491556|75941579|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
42130668|NCT00491556|75941580|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
42130669|NCT00491556|75941579|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
42130670|NCT00491556|75941580|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
42130671|NCT00491556|75941579|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
42130672|NCT00491556|75941580|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
42130673|NCT00491556|75941579|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
42130674|NCT00491556|75941580|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
42130675|NCT00491556|75941579|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
42130676|NCT00491556|75941580|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
42130677|NCT00491556|75941579|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
42220222|NCT03336619|76038366|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
42220223|NCT03336619|76038367|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
42220224|NCT03336619|76038366|FG000|Overall Study|Withdrawal by Subject|17|||
42220225|NCT03336619|76038367|FG001|Overall Study|Withdrawal by Subject|16|||
42220226|NCT03336619|76038366|FG000|Overall Study|Adverse Event|2|||
42220227|NCT03336619|76038367|FG001|Overall Study|Adverse Event|5|||
42220228|NCT03336619|76038366|FG000|Overall Study|Physician Decision|3|||
42220229|NCT03336619|76038367|FG001|Overall Study|Physician Decision|0|||
42220230|NCT01353508|76038389|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
42220231|NCT01353508|76038390|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
42220232|NCT01353508|76038391|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
42220233|NCT01353508|76038392|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
42220234|NCT01353508|76038389|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
42220235|NCT01353508|76038390|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
42220236|NCT01353508|76038391|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
42220237|NCT01353508|76038392|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
42220238|NCT03636269|76038404|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
42220239|NCT03636269|76038405|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
42220240|NCT03636269|76038406|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
42220241|NCT03636269|76038404|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
41982636|NCT01330381|75788807|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
41982637|NCT01330381|75788808|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
41982638|NCT01330381|75788809|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
41982639|NCT01330381|75788807|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
41982640|NCT01330381|75788808|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
41982641|NCT01330381|75788809|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
41982642|NCT01330381|75788807|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
41982643|NCT01330381|75788808|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
41982644|NCT01330381|75788809|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
41982645|NCT01330381|75788807|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
41982646|NCT01330381|75788808|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
41982647|NCT01330381|75788809|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
41982648|NCT01330381|75788807|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
41982649|NCT01330381|75788808|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
41982650|NCT01330381|75788809|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
41982651|NCT01330381|75788807|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
41982652|NCT01330381|75788808|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
41982653|NCT01330381|75788809|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
41982654|NCT01330381|75788807|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
41982655|NCT01330381|75788808|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
41982656|NCT01330381|75788809|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
41982657|NCT01330303|75788818|FG000|Period 1|Adverse Event|1|||
41982658|NCT01330303|75788819|FG001|Period 1|Adverse Event|0|||
41982659|NCT01330303|75788818|FG000|Period 1|Protocol Violation|0|||
41982660|NCT01330303|75788819|FG001|Period 1|Protocol Violation|1|||
41982661|NCT01330303|75788818|FG000|Period 1|Withdrawal by Subject|0|||
41982662|NCT01330303|75788819|FG001|Period 1|Withdrawal by Subject|1|||
42130678|NCT00491556|75941580|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
42220242|NCT03636269|76038405|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
42220243|NCT03636269|76038406|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
42220244|NCT03636269|76038404|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
42220245|NCT03636269|76038405|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
42220246|NCT03636269|76038406|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
42220247|NCT03636269|76038404|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
42220248|NCT03636269|76038405|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
42220249|NCT03636269|76038406|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
42220250|NCT03636269|76038404|FG000|Period 1: Double-blind Phase|Other|6|||
42220251|NCT03636269|76038405|FG001|Period 1: Double-blind Phase|Other|3|||
42220252|NCT03636269|76038406|FG002|Period 1: Double-blind Phase|Other|0|||
42220253|NCT03636269|76038404|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
42220254|NCT03636269|76038405|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
42220255|NCT03636269|76038406|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
42220256|NCT03636269|76038404|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
42220257|NCT03636269|76038405|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
42220258|NCT03636269|76038406|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
42220259|NCT03636269|76038404|FG000|Period 2: Open-label Phase|Adverse Event|0|||
42220260|NCT03636269|76038405|FG001|Period 2: Open-label Phase|Adverse Event|0|||
42220261|NCT03636269|76038406|FG002|Period 2: Open-label Phase|Adverse Event|21|||
42220262|NCT03636269|76038404|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
42220263|NCT03636269|76038405|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
42220264|NCT03636269|76038406|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
42220265|NCT03636269|76038404|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
42220266|NCT03636269|76038405|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
42220267|NCT03636269|76038406|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
42220268|NCT03636269|76038404|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
42220269|NCT03636269|76038405|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
42220270|NCT03636269|76038406|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
42220271|NCT03636269|76038404|FG000|Period 2: Open-label Phase|Administrative|0|||
42220272|NCT03636269|76038405|FG001|Period 2: Open-label Phase|Administrative|0|||
42220273|NCT03636269|76038406|FG002|Period 2: Open-label Phase|Administrative|36|||
42220274|NCT03636269|76038404|FG000|Period 2: Open-label Phase|Other|0|||
42220275|NCT03636269|76038405|FG001|Period 2: Open-label Phase|Other|0|||
42220276|NCT03636269|76038406|FG002|Period 2: Open-label Phase|Other|9|||
42220277|NCT03636269|76038404|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
42220278|NCT03636269|76038405|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
42220279|NCT03636269|76038406|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
42220280|NCT02685202|76038415|FG000|Overall Study|Lost to Follow-up|9|||
42220281|NCT03087786|76038421|FG000|Overall Study|Withdrawal by Subject|2|||
42220282|NCT03087786|76038422|FG001|Overall Study|Withdrawal by Subject|0|||
42220283|NCT03635957|76038428|FG000|Run-In Period|Lost to Follow-up|1|||
42220284|NCT03635957|76038428|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
42220285|NCT01353274|76038433|FG000|Overall Study|No case report form (CRF) collected|28|||
42220286|NCT02690194|76038440|FG000|Overall Study|Withdrawal by Subject|1|||
42220287|NCT02690194|76038441|FG001|Overall Study|Withdrawal by Subject|4|||
42130679|NCT00491556|75941579|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
42130680|NCT00491556|75941580|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
42130681|NCT00491556|75941579|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
42130682|NCT00491556|75941580|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
42130683|NCT00491556|75941579|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
42130684|NCT00491556|75941580|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
42130685|NCT00491556|75941579|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
42130686|NCT00491556|75941580|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
42130687|NCT00506454|75941588|FG000|Overall Study|Withdrawal by Subject|1|||
42130688|NCT00506454|75941589|FG001|Overall Study|Withdrawal by Subject|1|||
42130689|NCT00485472|75941597|FG000|Overall Study|Adverse Event|8|||
42130690|NCT00485472|75941598|FG001|Overall Study|Adverse Event|5|||
42130691|NCT00485472|75941597|FG000|Overall Study|Lack of Efficacy|5|||
42130692|NCT00485472|75941598|FG001|Overall Study|Lack of Efficacy|4|||
42220288|NCT02690194|76038442|FG002|Overall Study|Withdrawal by Subject|0|||
42220289|NCT02684344|76038452|FG000|Overall Study|Withdrawal by Subject|0|||
42220290|NCT02684344|76038453|FG001|Overall Study|Withdrawal by Subject|1|||
42130693|NCT00485472|75941597|FG000|Overall Study|Withdrawal by Subject|1|||
42220291|NCT02683876|76038461|FG000|Overall Study|samples damaged during shipping|2|||
42220292|NCT02683876|76038462|FG001|Overall Study|samples damaged during shipping|0|||
42029617|NCT00883753|75838008|FG000|Overall Study|Withdrew consent|10|||
42130694|NCT00485472|75941598|FG001|Overall Study|Withdrawal by Subject|0|||
42220293|NCT03974100|76038472|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
42220294|NCT03974100|76038473|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
42220295|NCT03974100|76038474|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
42220296|NCT03974100|76038475|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
42130695|NCT00485472|75941597|FG000|Overall Study|Protocol Violation|0|||
42130696|NCT00485472|75941598|FG001|Overall Study|Protocol Violation|1|||
42130697|NCT00485472|75941597|FG000|Overall Study|Other|2|||
42130698|NCT00485472|75941598|FG001|Overall Study|Other|1|||
42130699|NCT00485472|75941597|FG000|Overall Study|Lost to Follow-up|0|||
42130700|NCT00485472|75941598|FG001|Overall Study|Lost to Follow-up|1|||
42130701|NCT00491400|75941606|FG000|Overall Study|Withdrawal by Subject|5|||
42130702|NCT00491400|75941607|FG001|Overall Study|Withdrawal by Subject|4|||
42130703|NCT00491322|75941617|FG000|Overall Study|Protocol Violation|1|||
41982663|NCT01330108|75788826|FG000|Overall Study|Withdrawal by Subject|4|||
41982664|NCT04543409|75788840|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
41982665|NCT04543409|75788841|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
41982666|NCT04543409|75788840|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
41982667|NCT04543409|75788841|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
42220297|NCT03974100|76038476|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
42220298|NCT03974100|76038472|FG000|TP1 - Day 1 to Week 52|Death|1|||
42130704|NCT00491322|75941618|FG001|Overall Study|Protocol Violation|0|||
41982668|NCT04543409|75788840|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
41982669|NCT04543409|75788841|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
41982670|NCT04543409|75788840|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
41982671|NCT04543409|75788841|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
41982672|NCT04543409|75788840|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
41982673|NCT04543409|75788841|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
41982674|NCT04543409|75788840|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
41982675|NCT04543409|75788841|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
41982676|NCT04543409|75788840|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
41982677|NCT04543409|75788841|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
41982678|NCT04543409|75788840|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
41982679|NCT04543409|75788841|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
41982680|NCT04543409|75788840|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
41982681|NCT04543409|75788841|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
41982682|NCT04543409|75788840|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
41982683|NCT04543409|75788841|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
41982684|NCT04543409|75788840|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
41982685|NCT04543409|75788841|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
41982686|NCT04434937|75788848|FG000|Overall Study|Death|4|||
41982687|NCT04434937|75788848|FG000|Overall Study|Withdrawal by Subject|1|||
41982688|NCT04434937|75788848|FG000|Overall Study|"Captured as Other in Database"|1|||
41982689|NCT04434937|75788848|FG000|Overall Study|Ongoing|36|||
41982690|NCT04030143|75788884|FG000|Overall Study|Adverse Event|5|||
41982691|NCT04030143|75788885|FG001|Overall Study|Adverse Event|10|||
41982692|NCT04030143|75788884|FG000|Overall Study|Lost to Follow-up|3|||
41982693|NCT04030143|75788885|FG001|Overall Study|Lost to Follow-up|7|||
41982694|NCT04030143|75788884|FG000|Overall Study|Protocol Deviation|2|||
41982695|NCT04030143|75788885|FG001|Overall Study|Protocol Deviation|2|||
41982696|NCT04030143|75788884|FG000|Overall Study|Withdrawal by Subject|16|||
42029618|NCT00883753|75838008|FG000|Overall Study|Investigator's decision|17|||
42130705|NCT00491322|75941617|FG000|Overall Study|Pregnancy|0|||
42130706|NCT00491322|75941618|FG001|Overall Study|Pregnancy|1|||
42130707|NCT00502320|75941626|FG000|Overall Study|Lost to Follow-up|1|||
42130708|NCT00502320|75941627|FG001|Overall Study|Lost to Follow-up|1|||
42130709|NCT00502320|75941626|FG000|Overall Study|Withdrew Consent|1|||
42130710|NCT00502320|75941627|FG001|Overall Study|Withdrew Consent|0|||
42130711|NCT00502320|75941626|FG000|Overall Study|No longer met criteria|1|||
42029619|NCT00883753|75838008|FG000|Overall Study|Administrative/Other|8|||
42130712|NCT00502320|75941627|FG001|Overall Study|No longer met criteria|0|||
42130713|NCT00502320|75941626|FG000|Overall Study|Screen Failure|0|||
42220299|NCT03974100|76038473|FG001|TP1 - Day 1 to Week 52|Death|0|||
42220300|NCT03974100|76038474|FG002|TP1 - Day 1 to Week 52|Death|0|||
42220301|NCT03974100|76038475|FG003|TP1 - Day 1 to Week 52|Death|0|||
42302248|NCT02278341|76137282|FG001|Overall Study|Physician Decision|1|||
42130714|NCT00502320|75941627|FG001|Overall Study|Screen Failure|1|||
42130715|NCT00502320|75941626|FG000|Overall Study|Adverse Event|3|||
42130716|NCT00502320|75941627|FG001|Overall Study|Adverse Event|5|||
42130717|NCT02567825|75941635|FG000|Overall Study|No follow-up post-randomization|5|||
42130718|NCT02567825|75941636|FG001|Overall Study|No follow-up post-randomization|1|||
42220302|NCT03974100|76038476|FG004|TP1 - Day 1 to Week 52|Death|0|||
42220303|NCT03974100|76038472|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
42220304|NCT03974100|76038473|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
42220305|NCT03974100|76038474|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
42220306|NCT03974100|76038475|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
42220307|NCT03974100|76038476|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
42220308|NCT03974100|76038472|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
42220309|NCT03974100|76038473|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
42220310|NCT03974100|76038474|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
42220311|NCT03974100|76038475|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
42220312|NCT03974100|76038476|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
42220313|NCT03974100|76038472|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
42220314|NCT03974100|76038473|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
42220315|NCT03974100|76038474|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
42220316|NCT03974100|76038475|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
42220317|NCT03974100|76038476|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
42220318|NCT03974100|76038472|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
42220319|NCT03974100|76038473|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
42220320|NCT03974100|76038474|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
42220321|NCT03974100|76038475|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
42220322|NCT03974100|76038476|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
42220323|NCT03974100|76038472|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
42220324|NCT03974100|76038473|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
42220325|NCT03974100|76038474|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
42220326|NCT03974100|76038475|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
42220327|NCT03974100|76038476|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
42220328|NCT02689804|76038490|FG000|Overall Study|Withdrawal by Subject|2|||
42220329|NCT02689804|76038491|FG001|Overall Study|Withdrawal by Subject|0|||
42220330|NCT02946931|76038500|FG000|Overall Study|Did not require collection of CRFs|588|||
42220331|NCT02946931|76038500|FG000|Overall Study|Other than listed|37|||
42220332|NCT02946931|76038500|FG000|Overall Study|Discharge from hospital|118|||
42220333|NCT02946931|76038500|FG000|Overall Study|Adverse Event|81|||
42220334|NCT02946931|76038500|FG000|Overall Study|CRFs not valid|1|||
42220335|NCT02946931|76038500|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
41982697|NCT04030143|75788885|FG001|Overall Study|Withdrawal by Subject|18|||
42220336|NCT02689492|76038504|FG000|Overall Study|Lost to Follow-up|61|||
42220337|NCT02689492|76038504|FG000|Overall Study|Withdrawal by Subject|11|||
41982698|NCT04030143|75788884|FG000|Overall Study|Physician Decision|1|||
42220338|NCT02689492|76038504|FG000|Overall Study|Death|9|||
42220339|NCT02689492|76038504|FG000|Overall Study|Physician Decision|2|||
42220340|NCT02689492|76038504|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
42220341|NCT02689492|76038504|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
42220342|NCT02689492|76038504|FG000|Overall Study|Other than listed|1|||
42220343|NCT01374568|76038522|FG000|Overall Study|Lab unable to analyze BTM|0|||
42220344|NCT01374568|76038523|FG001|Overall Study|Lab unable to analyze BTM|2|||
42220345|NCT02682784|76038533|FG000|Overall Study|Withdrawal by Subject|0|||
42220346|NCT02682784|76038534|FG001|Overall Study|Withdrawal by Subject|2|||
42220347|NCT02682784|76038535|FG002|Overall Study|Withdrawal by Subject|1|||
41982699|NCT04030143|75788885|FG001|Overall Study|Physician Decision|1|||
41982700|NCT04030143|75788884|FG000|Overall Study|Due to Covid-19|2|||
41982701|NCT04030143|75788885|FG001|Overall Study|Due to Covid-19|3|||
42130719|NCT02567825|75941635|FG000|Overall Study|Follow-up less than 23 months|16|||
42130720|NCT02567825|75941636|FG001|Overall Study|Follow-up less than 23 months|20|||
42130721|NCT00490776|75941642|FG000|Overall Study|Withdrawal by Subject|1|||
42130722|NCT00490776|75941642|FG000|Overall Study|Administrative Problems|1|||
42130723|NCT00490776|75941642|FG000|Overall Study|Death|1|||
42130724|NCT00490776|75941642|FG000|Overall Study|New Cancer Therapy|1|||
42130725|NCT00490776|75941642|FG000|Overall Study|Disease Progression|5|||
42130726|NCT00566735|75941648|FG000|Overall Study|Withdrawal by Subject|0|||
42130727|NCT00566735|75941649|FG001|Overall Study|Withdrawal by Subject|1|||
42130728|NCT00566735|75941648|FG000|Overall Study|Refused neuropsychological testing|2|||
42130729|NCT00566735|75941649|FG001|Overall Study|Refused neuropsychological testing|5|||
42130730|NCT00566735|75941648|FG000|Overall Study|Switched into a manic episode|0|||
42220348|NCT02682784|76038536|FG003|Overall Study|Withdrawal by Subject|2|||
42220349|NCT02682784|76038533|FG000|Overall Study|Physician Decision|1|||
41982702|NCT04030143|75788884|FG000|Overall Study|Not Due to Covid-19|1|||
42220350|NCT02682784|76038534|FG001|Overall Study|Physician Decision|0|||
42220351|NCT02682784|76038535|FG002|Overall Study|Physician Decision|1|||
42220352|NCT02682784|76038536|FG003|Overall Study|Physician Decision|1|||
42220353|NCT03387852|76038550|FG000|Overall Study|Adverse event (AE)|3|||
42220354|NCT03387852|76038551|FG001|Overall Study|Adverse event (AE)|0|||
42220355|NCT03387852|76038552|FG002|Overall Study|Adverse event (AE)|2|||
42220356|NCT03387852|76038553|FG003|Overall Study|Adverse event (AE)|0|||
41982703|NCT04030143|75788885|FG001|Overall Study|Not Due to Covid-19|1|||
42220357|NCT03387852|76038550|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
42130731|NCT00566735|75941649|FG001|Overall Study|Switched into a manic episode|1|||
42220358|NCT03387852|76038551|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
42220359|NCT03387852|76038552|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
42220360|NCT03387852|76038553|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
42220361|NCT03387852|76038550|FG000|Overall Study|Withdrawal by participant|1|||
42220362|NCT03387852|76038551|FG001|Overall Study|Withdrawal by participant|1|||
42220363|NCT03387852|76038552|FG002|Overall Study|Withdrawal by participant|3|||
41982704|NCT03934931|75788900|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
41982705|NCT03934931|75788901|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
42029620|NCT01210664|75838015|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
42029621|NCT01210664|75838016|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
42029622|NCT01210664|75838017|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
42029623|NCT01210664|75838018|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
42029624|NCT01210664|75838015|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
42029625|NCT01210664|75838016|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
42029626|NCT01210664|75838017|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
42029627|NCT01210664|75838018|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
42029628|NCT01210664|75838015|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
42029629|NCT01210664|75838016|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
42029630|NCT01210664|75838017|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
42029631|NCT01210664|75838018|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
41982706|NCT03934931|75788902|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
41982707|NCT03927144|75788912|FG000|Core Phase|Adverse Event|9|||
41982708|NCT03927144|75788913|FG001|Core Phase|Adverse Event|5|||
41982709|NCT03927144|75788912|FG000|Core Phase|Lost to Follow-up|3|||
41982710|NCT03927144|75788913|FG001|Core Phase|Lost to Follow-up|2|||
41982711|NCT03927144|75788912|FG000|Core Phase|New Therapy for Study Indication|0|||
41982712|NCT03927144|75788913|FG001|Core Phase|New Therapy for Study Indication|1|||
41982713|NCT03927144|75788912|FG000|Core Phase|No Longer Clinically Benefiting|4|||
41982714|NCT03927144|75788913|FG001|Core Phase|No Longer Clinically Benefiting|4|||
41982715|NCT03927144|75788912|FG000|Core Phase|Physician Decision|2|||
41982716|NCT03927144|75788913|FG001|Core Phase|Physician Decision|8|||
41982717|NCT03927144|75788912|FG000|Core Phase|Protocol Violation|2|||
41982718|NCT03927144|75788913|FG001|Core Phase|Protocol Violation|2|||
41982719|NCT03927144|75788912|FG000|Core Phase|Withdrawal by Subject|16|||
41982720|NCT03927144|75788913|FG001|Core Phase|Withdrawal by Subject|40|||
41982721|NCT03927144|75788912|FG000|Extension Phase|Adverse Event|2|||
41982722|NCT03927144|75788913|FG001|Extension Phase|Adverse Event|1|||
41982723|NCT03927144|75788912|FG000|Extension Phase|No longer clinically benefiting|4|||
41982724|NCT03927144|75788913|FG001|Extension Phase|No longer clinically benefiting|5|||
41982725|NCT03927144|75788912|FG000|Extension Phase|Pregnancy|1|||
41982726|NCT03927144|75788913|FG001|Extension Phase|Pregnancy|0|||
41982727|NCT03927144|75788912|FG000|Extension Phase|Protocol Violation|0|||
41982728|NCT03927144|75788913|FG001|Extension Phase|Protocol Violation|1|||
41982729|NCT03927144|75788912|FG000|Extension Phase|Withdrawal by Subject|8|||
41982730|NCT03927144|75788913|FG001|Extension Phase|Withdrawal by Subject|3|||
41982731|NCT03859973|75788923|FG000|Overall Study|Other reason than listed|3|||
41982732|NCT03859973|75788924|FG001|Overall Study|Other reason than listed|2|||
41982733|NCT03859973|75788923|FG000|Overall Study|COVID-19 related, not due to AE|3|||
41982734|NCT03859973|75788924|FG001|Overall Study|COVID-19 related, not due to AE|4|||
41982735|NCT03859973|75788923|FG000|Overall Study|Withdrawal by Subject|8|||
41982736|NCT03859973|75788924|FG001|Overall Study|Withdrawal by Subject|9|||
42029632|NCT00881569|75838030|FG000|Overall Study|Disease progression|1|||
42029633|NCT00881569|75838031|FG001|Overall Study|Disease progression|1|||
42029634|NCT00881335|75838039|FG000|Overall Study|Lost to Follow-up|3|||
41982737|NCT03859973|75788923|FG000|Overall Study|Lost to Follow-up|2|||
41982738|NCT03859973|75788924|FG001|Overall Study|Lost to Follow-up|3|||
41982739|NCT03859973|75788923|FG000|Overall Study|Protocol Violation|1|||
41982740|NCT03859973|75788924|FG001|Overall Study|Protocol Violation|3|||
41982741|NCT03859973|75788923|FG000|Overall Study|Adverse Event|3|||
42029635|NCT00881335|75838040|FG001|Overall Study|Lost to Follow-up|2|||
42130732|NCT00566111|75941657|FG000|Overall Study|Adverse Event|0|||
42130733|NCT00566111|75941658|FG001|Overall Study|Adverse Event|2|||
42130734|NCT00514046|75941673|FG000|Overall Study|transferred to another protocol|2|||
42130735|NCT00514046|75941674|FG001|Overall Study|transferred to another protocol|1|||
42130736|NCT00514046|75941675|FG002|Overall Study|transferred to another protocol|3|||
42130737|NCT00514046|75941676|FG003|Overall Study|transferred to another protocol|0|||
42130738|NCT00514046|75941677|FG004|Overall Study|transferred to another protocol|1|||
42130739|NCT00514046|75941678|FG005|Overall Study|transferred to another protocol|0|||
42130740|NCT00514046|75941679|FG006|Overall Study|transferred to another protocol|0|||
42130741|NCT00514046|75941680|FG007|Overall Study|transferred to another protocol|0|||
42130742|NCT00514046|75941681|FG008|Overall Study|transferred to another protocol|0|||
41982742|NCT03859973|75788924|FG001|Overall Study|Adverse Event|5|||
41982743|NCT03761394|75788934|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
42220364|NCT03387852|76038553|FG003|Overall Study|Withdrawal by participant|2|||
41982744|NCT03761394|75788935|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
41982745|NCT03761394|75788936|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
41982746|NCT03761394|75788937|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
41982747|NCT03761394|75788934|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
41982748|NCT03761394|75788935|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
41982749|NCT03761394|75788936|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
41982750|NCT03761394|75788937|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
42220365|NCT03387852|76038550|FG000|Overall Study|Other- Unspecified|1|||
42220366|NCT03387852|76038551|FG001|Overall Study|Other- Unspecified|1|||
42220367|NCT03387852|76038552|FG002|Overall Study|Other- Unspecified|2|||
42220368|NCT03387852|76038553|FG003|Overall Study|Other- Unspecified|1|||
42220369|NCT03387852|76038550|FG000|Overall Study|Poor compliance to protocol|0|||
42220370|NCT03387852|76038551|FG001|Overall Study|Poor compliance to protocol|0|||
42220371|NCT03387852|76038552|FG002|Overall Study|Poor compliance to protocol|0|||
42220372|NCT03387852|76038553|FG003|Overall Study|Poor compliance to protocol|1|||
42220373|NCT03387852|76038550|FG000|Overall Study|Randomized and not treated|0|||
42220374|NCT03387852|76038551|FG001|Overall Study|Randomized and not treated|0|||
42220375|NCT03387852|76038552|FG002|Overall Study|Randomized and not treated|0|||
42220376|NCT03387852|76038553|FG003|Overall Study|Randomized and not treated|1|||
42220377|NCT02679274|76038566|FG000|Overall Study|Withdrawal by Subject|1|||
42220378|NCT02679274|76038567|FG001|Overall Study|Withdrawal by Subject|0|||
42220379|NCT04969861|76038575|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
42220380|NCT04969861|76038576|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
42220381|NCT02678416|76038584|FG000|Part 1|Withdrawal by Subject|1|||
42220382|NCT02678416|76038584|FG000|Part 2|Adverse Event|2|||
42220383|NCT02678416|76038584|FG000|Part 2|Withdrawal by Subject|1|||
42220384|NCT02680834|76038604|FG000|Overall Study|Physician Decision|5|||
42220385|NCT02680834|76038605|FG001|Overall Study|Physician Decision|2|||
42220386|NCT02680834|76038604|FG000|Overall Study|Withdrawal by Subject|6|||
42220387|NCT02680834|76038605|FG001|Overall Study|Withdrawal by Subject|0|||
42220388|NCT02680834|76038604|FG000|Overall Study|Lost to Follow-up|0|||
42220389|NCT02680834|76038605|FG001|Overall Study|Lost to Follow-up|1|||
42220390|NCT03343704|76038613|FG000|Overall Study|Refused to complete follow up|0|||
42220391|NCT03343704|76038614|FG001|Overall Study|Refused to complete follow up|1|||
42220392|NCT03343704|76038613|FG000|Overall Study|Death|0|||
42220393|NCT03343704|76038614|FG001|Overall Study|Death|1|||
41982751|NCT03761394|75788934|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
41982752|NCT03761394|75788935|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
41982753|NCT03761394|75788936|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
41982754|NCT03761394|75788937|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
41982755|NCT03761394|75788934|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
41982756|NCT03761394|75788935|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
41982757|NCT03761394|75788936|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
41982758|NCT03761394|75788937|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
41982759|NCT03699020|75788949|FG000|Overall Study|Withdrawal by Subject|3|||
41982760|NCT03699020|75788950|FG001|Overall Study|Withdrawal by Subject|2|||
41982761|NCT03661723|75788988|FG000|Overall Study|Disease Progression|4|||
41982762|NCT03661723|75788989|FG001|Overall Study|Disease Progression|24|||
41982763|NCT03661723|75788990|FG002|Overall Study|Disease Progression|4|||
41982764|NCT03661723|75788991|FG003|Overall Study|Disease Progression|19|||
41982765|NCT03661723|75788988|FG000|Overall Study|Withdrawal by Subject|1|||
41982766|NCT03661723|75788989|FG001|Overall Study|Withdrawal by Subject|0|||
41982767|NCT03661723|75788990|FG002|Overall Study|Withdrawal by Subject|2|||
41982768|NCT03661723|75788991|FG003|Overall Study|Withdrawal by Subject|4|||
41982769|NCT03661723|75788988|FG000|Overall Study|Physician Decision|1|||
41982770|NCT03661723|75788989|FG001|Overall Study|Physician Decision|0|||
41982771|NCT03661723|75788990|FG002|Overall Study|Physician Decision|0|||
41982772|NCT03661723|75788991|FG003|Overall Study|Physician Decision|0|||
42220394|NCT03343704|76038613|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
42220395|NCT03343704|76038614|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
42220396|NCT02680756|76038624|FG000|Overall Study|Adverse Event|10|||
42220397|NCT02680756|76038625|FG001|Overall Study|Adverse Event|2|||
42220398|NCT02680756|76038624|FG000|Overall Study|Lost to Follow-up|7|||
41982773|NCT03661723|75788988|FG000|Overall Study|Clinical Deterioration|0|||
41982774|NCT03661723|75788989|FG001|Overall Study|Clinical Deterioration|0|||
42029636|NCT00879775|75838057|FG000|Overall Study|Lost to Follow-up|2|||
42220399|NCT02680756|76038625|FG001|Overall Study|Lost to Follow-up|6|||
42220400|NCT02680756|76038624|FG000|Overall Study|Withdrawal by Subject|5|||
42220401|NCT02680756|76038625|FG001|Overall Study|Withdrawal by Subject|5|||
42220402|NCT02680756|76038624|FG000|Overall Study|Physician Decision|4|||
42220403|NCT02680756|76038625|FG001|Overall Study|Physician Decision|1|||
41982775|NCT03661723|75788990|FG002|Overall Study|Clinical Deterioration|0|||
42220404|NCT02680756|76038624|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
42220405|NCT02680756|76038625|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
42220406|NCT02680756|76038624|FG000|Overall Study|Blood transfusion for any reason|0|||
42220407|NCT02680756|76038625|FG001|Overall Study|Blood transfusion for any reason|1|||
42220408|NCT02680756|76038624|FG000|Overall Study|Death|1|||
42220409|NCT02680756|76038625|FG001|Overall Study|Death|0|||
42220410|NCT02680756|76038624|FG000|Overall Study|Protocol Violation|1|||
42220411|NCT02680756|76038625|FG001|Overall Study|Protocol Violation|0|||
42220412|NCT02680756|76038624|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
42220413|NCT02680756|76038625|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
42220414|NCT02680756|76038624|FG000|Overall Study|None of above or not recorded|3|||
42220415|NCT02680756|76038625|FG001|Overall Study|None of above or not recorded|2|||
42220416|NCT03086460|76038631|FG000|Study Participants|Lost to Follow-up|2|||
42220417|NCT03086460|76038631|FG000|Study Participants|Protocol Violation|1|||
42220418|NCT03086460|76038631|FG000|Study Participants|Withdrawal by Subject|6|||
42220419|NCT03086460|76038631|FG000|Treatment A|Lost to Follow-up|1|||
42220420|NCT03086460|76038631|FG000|Treatment A|Protocol Violation|1|||
42220421|NCT03086460|76038631|FG000|Treatment A|Withdrawal by Subject|2|||
42220422|NCT03086460|76038631|FG000|Treatment C|Withdrawal by Subject|2|||
42220423|NCT03086460|76038631|FG000|Treatment E|Lost to Follow-up|1|||
42220424|NCT03086460|76038631|FG000|Treatment E|Withdrawal by Subject|3|||
42220425|NCT02677714|76038657|FG000|Overall Study|Withdrawal by Subject|2|||
42220426|NCT02677714|76038658|FG001|Overall Study|Withdrawal by Subject|0|||
42220427|NCT02677324|76038664|FG000|Overall Study|Disease Progression|6|||
42220428|NCT02677324|76038664|FG000|Overall Study|Inability to Swallow pills|1|||
42029637|NCT00879775|75838058|FG001|Overall Study|Lost to Follow-up|1|||
42029638|NCT00894790|75838066|FG000|Overall Study|Protocol Violation|0|||
42029639|NCT00894790|75838067|FG001|Overall Study|Protocol Violation|1|||
42029640|NCT00894790|75838066|FG000|Overall Study|Lost to Follow-up|0|||
42029641|NCT00894790|75838067|FG001|Overall Study|Lost to Follow-up|1|||
42029642|NCT00894790|75838066|FG000|Overall Study|Did not meet entrance criteria|1|||
42029643|NCT00894790|75838067|FG001|Overall Study|Did not meet entrance criteria|0|||
42029644|NCT00879229|75838075|FG000|Overall Study|Study terminated by Sponsor|13|||
42029645|NCT00879229|75838076|FG001|Overall Study|Study terminated by Sponsor|12|||
42130743|NCT00514046|75941673|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
42130744|NCT00514046|75941674|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
42130745|NCT00514046|75941675|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
42130746|NCT00514046|75941676|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
42130747|NCT00514046|75941677|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
42130748|NCT00514046|75941678|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
42130749|NCT00514046|75941679|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
42130750|NCT00514046|75941680|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
42130751|NCT00514046|75941681|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
42130752|NCT00514046|75941673|FG000|Overall Study|Disease progression on study|0|||
42130753|NCT00514046|75941674|FG001|Overall Study|Disease progression on study|0|||
42130754|NCT00514046|75941675|FG002|Overall Study|Disease progression on study|2|||
42130755|NCT00514046|75941676|FG003|Overall Study|Disease progression on study|0|||
42130756|NCT00514046|75941677|FG004|Overall Study|Disease progression on study|0|||
42130757|NCT00514046|75941678|FG005|Overall Study|Disease progression on study|1|||
42130758|NCT00514046|75941679|FG006|Overall Study|Disease progression on study|0|||
42130759|NCT00514046|75941680|FG007|Overall Study|Disease progression on study|0|||
42130760|NCT00514046|75941681|FG008|Overall Study|Disease progression on study|0|||
42130761|NCT00564629|75941705|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
42130762|NCT00564629|75941706|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
42130763|NCT00564395|75941712|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
42130764|NCT00564395|75941713|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
42130765|NCT00564395|75941712|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
42130766|NCT00564395|75941713|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
42130767|NCT00502242|75941721|FG000|Overall Study|Lack of Efficacy|1|||
42130768|NCT00502242|75941722|FG001|Overall Study|Lack of Efficacy|11|||
42130769|NCT00502242|75941721|FG000|Overall Study|Adverse Event|31|||
42130770|NCT00502242|75941722|FG001|Overall Study|Adverse Event|20|||
42130771|NCT00502242|75941721|FG000|Overall Study|Physician Decision|2|||
42130772|NCT00502242|75941722|FG001|Overall Study|Physician Decision|3|||
42130773|NCT00502242|75941721|FG000|Overall Study|Other - Unspecified|8|||
42130774|NCT00502242|75941722|FG001|Overall Study|Other - Unspecified|14|||
42029646|NCT00879229|75838075|FG000|Overall Study|Death|4|||
42220429|NCT02677324|76038664|FG000|Overall Study|Non-compliance|1|||
42220430|NCT02677324|76038664|FG000|Overall Study|Lack of Efficacy|1|||
42220431|NCT02677324|76038664|FG000|Overall Study|Medical insurance coverage|1|||
42220432|NCT02677324|76038664|FG000|Overall Study|Adverse Event|1|||
42029647|NCT00879229|75838076|FG001|Overall Study|Death|2|||
42029648|NCT00879229|75838075|FG000|Overall Study|Adverse Event|2|||
42029649|NCT00879229|75838076|FG001|Overall Study|Adverse Event|0|||
42029650|NCT00879229|75838075|FG000|Overall Study|Withdrawal by Subject|1|||
42220433|NCT02677324|76038664|FG000|Overall Study|IgM Myeloma diagnosis|1|||
42220434|NCT01971008|76038672|FG000|Overall Study|Protocol Violation|2|||
42220435|NCT01971008|76038673|FG001|Overall Study|Protocol Violation|1|||
42220436|NCT01374178|76038682|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
42220437|NCT01374178|76038683|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
42220438|NCT01374178|76038682|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
42220439|NCT01374178|76038683|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
42220440|NCT03025542|76038691|FG000|Overall Study|Adverse Event|0|||
42220441|NCT03025542|76038692|FG001|Overall Study|Adverse Event|2|||
42220442|NCT03025542|76038691|FG000|Overall Study|Lost to Follow-up|1|||
42220443|NCT03025542|76038692|FG001|Overall Study|Lost to Follow-up|0|||
42220444|NCT03025542|76038691|FG000|Overall Study|Withdrawal by Subject|1|||
42029651|NCT00879229|75838076|FG001|Overall Study|Withdrawal by Subject|0|||
42029652|NCT00879229|75838075|FG000|Overall Study|Clinical status did not improve|1|||
42029653|NCT00879229|75838076|FG001|Overall Study|Clinical status did not improve|0|||
42220445|NCT03025542|76038692|FG001|Overall Study|Withdrawal by Subject|0|||
42220446|NCT03022370|76038706|FG000|Overall Study|Death|6|||
42220447|NCT03022370|76038707|FG001|Overall Study|Death|12|||
42220448|NCT03022370|76038706|FG000|Overall Study|Lost to Follow-up|174|||
42220449|NCT03022370|76038707|FG001|Overall Study|Lost to Follow-up|109|||
42220450|NCT03021668|76038719|FG000|Overall Study|Physician Decision|0|||
42220451|NCT03021668|76038720|FG001|Overall Study|Physician Decision|1|||
42220452|NCT03020888|76038726|FG000|Overall Study|Physician Decision|4|||
42220453|NCT03020888|76038726|FG000|Overall Study|Withdrawal by Subject|6|||
42220454|NCT03020888|76038726|FG000|Overall Study|Insurance coverage|2|||
42220455|NCT03020888|76038726|FG000|Overall Study|Lost to Follow-up|1|||
42220456|NCT02250300|76038734|FG000|Expansion Phase|Death|6|||
42220457|NCT02250300|76038735|FG001|Expansion Phase|Death|7|||
42220458|NCT02250300|76038736|FG002|Expansion Phase|Death|0|||
42220459|NCT02250300|76038737|FG003|Expansion Phase|Death|0|||
42220460|NCT03020966|76038750|FG000|Overall Study|Withdrawal by Subject|2|||
42302249|NCT02278341|76137281|FG000|Overall Study|Miscellaneous|15|||
42302250|NCT02278341|76137282|FG001|Overall Study|Miscellaneous|14|||
42130775|NCT00502242|75941721|FG000|Overall Study|Protocol Violation|3|||
42130776|NCT00502242|75941722|FG001|Overall Study|Protocol Violation|1|||
42130777|NCT00502242|75941721|FG000|Overall Study|Withdrawal by Subject|6|||
42130778|NCT00502242|75941722|FG001|Overall Study|Withdrawal by Subject|7|||
42130779|NCT03972137|75941732|FG000|Overall Study|Lost to Follow-up|2|||
42130780|NCT03972137|75941732|FG000|Overall Study|Withdrawal by Subject|4|||
42130781|NCT00490698|75941748|FG000|Overall Study|Withdrawal by Subject|1|||
42130782|NCT00490698|75941748|FG000|Overall Study|Disease Progression|7|||
42130783|NCT00490698|75941748|FG000|Overall Study|Physician Decision|2|||
42130784|NCT03855228|75941756|FG000|Overall Study|Adverse Event|2|||
42130785|NCT03855228|75941757|FG001|Overall Study|Adverse Event|4|||
42130786|NCT03855228|75941758|FG002|Overall Study|Adverse Event|4|||
42130787|NCT03855228|75941759|FG003|Overall Study|Adverse Event|8|||
42130788|NCT03855228|75941756|FG000|Overall Study|Treatment Failure|1|||
42130789|NCT03855228|75941757|FG001|Overall Study|Treatment Failure|2|||
42130790|NCT03855228|75941758|FG002|Overall Study|Treatment Failure|1|||
42130791|NCT03855228|75941759|FG003|Overall Study|Treatment Failure|8|||
42130792|NCT03855228|75941756|FG000|Overall Study|Lost to Follow-up|0|||
42130793|NCT03855228|75941757|FG001|Overall Study|Lost to Follow-up|0|||
42130794|NCT03855228|75941758|FG002|Overall Study|Lost to Follow-up|0|||
42130795|NCT03855228|75941759|FG003|Overall Study|Lost to Follow-up|1|||
42130796|NCT03855228|75941756|FG000|Overall Study|Protocol Violation|0|||
42130797|NCT03855228|75941757|FG001|Overall Study|Protocol Violation|1|||
42130798|NCT03855228|75941758|FG002|Overall Study|Protocol Violation|2|||
42130799|NCT03855228|75941759|FG003|Overall Study|Protocol Violation|1|||
42130800|NCT03855228|75941756|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
42220461|NCT03020966|76038751|FG001|Overall Study|Withdrawal by Subject|0|||
42220462|NCT03020576|76038759|FG000|Overall Study|Withdrawal by Subject|1|||
42302251|NCT02282631|76137291|FG000|Overall Study|Lost to Follow-up|2|||
42302252|NCT02282631|76137292|FG001|Overall Study|Lost to Follow-up|0|||
42029654|NCT00879229|75838075|FG000|Overall Study|Other|1|||
42029655|NCT00879229|75838076|FG001|Overall Study|Other|0|||
42130801|NCT03855228|75941757|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
42130802|NCT03855228|75941758|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
42130803|NCT03855228|75941759|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
42130804|NCT00511238|75941771|FG000|Overall Study|Adverse Event|13|||
42220463|NCT03020576|76038760|FG001|Overall Study|Withdrawal by Subject|2|||
42220464|NCT03017612|76038766|FG000|Overall Study|Adverse Event|2|||
42220465|NCT03635099|76038778|FG000|Period 1|Adverse Event|1|||
42220466|NCT03635099|76038779|FG001|Period 1|Adverse Event|0|||
42130805|NCT00511238|75941772|FG001|Overall Study|Adverse Event|33|||
42220467|NCT03635099|76038780|FG002|Period 1|Adverse Event|0|||
42220468|NCT03635099|76038781|FG003|Period 1|Adverse Event|1|||
42302253|NCT02278263|76137307|FG000|Overall Study|Protocol Violation|7|||
42220469|NCT03635099|76038782|FG004|Period 1|Adverse Event|0|||
42220470|NCT03635099|76038783|FG005|Period 1|Adverse Event|0|||
42220471|NCT03635099|76038784|FG006|Period 1|Adverse Event|0|||
42220472|NCT03635099|76038785|FG007|Period 1|Adverse Event|0|||
42220473|NCT03635099|76038778|FG000|Period 1|Protocol Violation|0|||
42220474|NCT03635099|76038779|FG001|Period 1|Protocol Violation|0|||
42220475|NCT03635099|76038780|FG002|Period 1|Protocol Violation|1|||
42220476|NCT03635099|76038781|FG003|Period 1|Protocol Violation|0|||
42220477|NCT03635099|76038782|FG004|Period 1|Protocol Violation|0|||
42220478|NCT03635099|76038783|FG005|Period 1|Protocol Violation|0|||
42220479|NCT03635099|76038784|FG006|Period 1|Protocol Violation|0|||
42220480|NCT03635099|76038785|FG007|Period 1|Protocol Violation|0|||
42220481|NCT03635099|76038778|FG000|Period 1|Lost to Follow-up|0|||
42220482|NCT03635099|76038779|FG001|Period 1|Lost to Follow-up|0|||
42220483|NCT03635099|76038780|FG002|Period 1|Lost to Follow-up|1|||
42220484|NCT03635099|76038781|FG003|Period 1|Lost to Follow-up|2|||
42220485|NCT03635099|76038782|FG004|Period 1|Lost to Follow-up|1|||
42220486|NCT03635099|76038783|FG005|Period 1|Lost to Follow-up|0|||
42220487|NCT03635099|76038784|FG006|Period 1|Lost to Follow-up|1|||
42220488|NCT03635099|76038785|FG007|Period 1|Lost to Follow-up|2|||
42220489|NCT03635099|76038778|FG000|Period 1|Withdrawal by Subject|3|||
42220490|NCT03635099|76038779|FG001|Period 1|Withdrawal by Subject|3|||
42220491|NCT03635099|76038780|FG002|Period 1|Withdrawal by Subject|5|||
42220492|NCT03635099|76038781|FG003|Period 1|Withdrawal by Subject|2|||
42220493|NCT03635099|76038782|FG004|Period 1|Withdrawal by Subject|2|||
42220494|NCT03635099|76038783|FG005|Period 1|Withdrawal by Subject|0|||
42220495|NCT03635099|76038784|FG006|Period 1|Withdrawal by Subject|3|||
42220496|NCT03635099|76038785|FG007|Period 1|Withdrawal by Subject|0|||
42220497|NCT03635099|76038778|FG000|Period 1|History of suicidal ideation|0|||
42220498|NCT03635099|76038779|FG001|Period 1|History of suicidal ideation|0|||
42220499|NCT03635099|76038780|FG002|Period 1|History of suicidal ideation|1|||
42220500|NCT03635099|76038781|FG003|Period 1|History of suicidal ideation|0|||
42220501|NCT03635099|76038782|FG004|Period 1|History of suicidal ideation|0|||
42220502|NCT03635099|76038783|FG005|Period 1|History of suicidal ideation|0|||
42220503|NCT03635099|76038784|FG006|Period 1|History of suicidal ideation|0|||
42220504|NCT03635099|76038785|FG007|Period 1|History of suicidal ideation|0|||
42220505|NCT03635099|76038778|FG000|Period 1|pursue other treatment options|0|||
42220506|NCT03635099|76038779|FG001|Period 1|pursue other treatment options|0|||
42220507|NCT03635099|76038780|FG002|Period 1|pursue other treatment options|0|||
42220508|NCT03635099|76038781|FG003|Period 1|pursue other treatment options|0|||
42220509|NCT03635099|76038782|FG004|Period 1|pursue other treatment options|0|||
42220510|NCT03635099|76038783|FG005|Period 1|pursue other treatment options|1|||
42220511|NCT03635099|76038784|FG006|Period 1|pursue other treatment options|0|||
42220512|NCT03635099|76038785|FG007|Period 1|pursue other treatment options|0|||
42220513|NCT03635099|76038778|FG000|Not Eligible for Period 2|Pregnancy|0|||
42220514|NCT03635099|76038779|FG001|Not Eligible for Period 2|Pregnancy|0|||
42220515|NCT03635099|76038780|FG002|Not Eligible for Period 2|Pregnancy|0|||
42220516|NCT03635099|76038781|FG003|Not Eligible for Period 2|Pregnancy|1|||
42220517|NCT03635099|76038782|FG004|Not Eligible for Period 2|Pregnancy|0|||
42220518|NCT03635099|76038783|FG005|Not Eligible for Period 2|Pregnancy|0|||
42220519|NCT03635099|76038784|FG006|Not Eligible for Period 2|Pregnancy|0|||
42220520|NCT03635099|76038785|FG007|Not Eligible for Period 2|Pregnancy|0|||
42220521|NCT03635099|76038778|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
42220522|NCT03635099|76038779|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
42220523|NCT03635099|76038780|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
42220524|NCT03635099|76038781|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
42220525|NCT03635099|76038782|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
42220526|NCT03635099|76038783|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
42220527|NCT03635099|76038784|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
42220528|NCT03635099|76038785|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
42220529|NCT03635099|76038778|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
42220530|NCT03635099|76038779|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
42220531|NCT03635099|76038780|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
42220532|NCT03635099|76038781|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
42220533|NCT03635099|76038782|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
42220534|NCT03635099|76038783|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
42029656|NCT00878995|75838084|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
42220535|NCT03635099|76038784|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
42220536|NCT03635099|76038785|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
42220537|NCT03635099|76038778|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
42220538|NCT03635099|76038779|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
42220539|NCT03635099|76038780|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
42220540|NCT03635099|76038781|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
42220541|NCT03635099|76038782|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
42220542|NCT03635099|76038783|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
42220543|NCT03635099|76038784|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
42220544|NCT03635099|76038785|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
42220545|NCT03635099|76038778|FG000|Period 2|Adverse Event|0|||
42220546|NCT03635099|76038779|FG001|Period 2|Adverse Event|0|||
42220547|NCT03635099|76038780|FG002|Period 2|Adverse Event|1|||
42220548|NCT03635099|76038781|FG003|Period 2|Adverse Event|0|||
42220549|NCT03635099|76038782|FG004|Period 2|Adverse Event|1|||
42220550|NCT03635099|76038783|FG005|Period 2|Adverse Event|0|||
42220551|NCT03635099|76038784|FG006|Period 2|Adverse Event|0|||
42220552|NCT03635099|76038785|FG007|Period 2|Adverse Event|0|||
42220553|NCT03635099|76038778|FG000|Period 2|Lost to Follow-up|0|||
42220554|NCT03635099|76038779|FG001|Period 2|Lost to Follow-up|0|||
42220555|NCT03635099|76038780|FG002|Period 2|Lost to Follow-up|1|||
42220556|NCT03635099|76038781|FG003|Period 2|Lost to Follow-up|0|||
42220557|NCT03635099|76038782|FG004|Period 2|Lost to Follow-up|4|||
42220558|NCT03635099|76038783|FG005|Period 2|Lost to Follow-up|0|||
42220559|NCT03635099|76038784|FG006|Period 2|Lost to Follow-up|0|||
42220560|NCT03635099|76038785|FG007|Period 2|Lost to Follow-up|0|||
42220561|NCT03635099|76038778|FG000|Period 2|Withdrawal by Subject|0|||
42220562|NCT03635099|76038779|FG001|Period 2|Withdrawal by Subject|0|||
42220563|NCT03635099|76038780|FG002|Period 2|Withdrawal by Subject|7|||
42220564|NCT03635099|76038781|FG003|Period 2|Withdrawal by Subject|4|||
42220565|NCT03635099|76038782|FG004|Period 2|Withdrawal by Subject|7|||
42220566|NCT03635099|76038783|FG005|Period 2|Withdrawal by Subject|0|||
42220567|NCT03635099|76038784|FG006|Period 2|Withdrawal by Subject|0|||
42220568|NCT03635099|76038785|FG007|Period 2|Withdrawal by Subject|0|||
42220569|NCT02108652|76038811|FG000|Overall Study|Death|226|||
42220570|NCT02108652|76038811|FG000|Overall Study|Lost to Follow-up|2|||
42220571|NCT02108652|76038811|FG000|Overall Study|Withdrawal by Subject|8|||
42220572|NCT02108652|76038811|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|74|||
42220573|NCT03634085|76038817|FG000|Overall Study|Adverse Event|1|||
42220574|NCT03634085|76038818|FG001|Overall Study|Adverse Event|0|||
42220575|NCT03634085|76038817|FG000|Overall Study|Withdrawal by Subject|0|||
42220576|NCT03634085|76038818|FG001|Overall Study|Withdrawal by Subject|2|||
42220577|NCT02676778|76038834|FG000|Overall Study|Disease Progression|7|||
42220578|NCT02676778|76038835|FG001|Overall Study|Disease Progression|3|||
42220579|NCT02676778|76038836|FG002|Overall Study|Disease Progression|1|||
42220580|NCT02676778|76038834|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
42220581|NCT02676778|76038835|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
42220582|NCT02676778|76038836|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
42220583|NCT02676778|76038834|FG000|Overall Study|Withdrawal by Subject|3|||
42220584|NCT02676778|76038835|FG001|Overall Study|Withdrawal by Subject|2|||
41982776|NCT03661723|75788991|FG003|Overall Study|Clinical Deterioration|1|||
41982777|NCT03414983|75789012|FG000|Pre-Treatment|Other reasons|1|||
41982778|NCT03414983|75789013|FG001|Pre-Treatment|Other reasons|0|||
41982779|NCT03414983|75789012|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
41982780|NCT03414983|75789013|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
41982781|NCT03414983|75789012|FG000|Pre-Treatment|Participant withdrew consent|1|||
41982782|NCT03414983|75789013|FG001|Pre-Treatment|Participant withdrew consent|3|||
41982783|NCT03414983|75789012|FG000|Treatment|Participant withdrew consent|4|||
41982784|NCT03414983|75789013|FG001|Treatment|Participant withdrew consent|3|||
41982785|NCT03414983|75789012|FG000|Treatment|Participant request to discontinue study treatment|8|||
41982786|NCT03414983|75789013|FG001|Treatment|Participant request to discontinue study treatment|10|||
41982787|NCT03414983|75789012|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
41982788|NCT03414983|75789013|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
41982789|NCT03414983|75789012|FG000|Treatment|Death|0|||
41982790|NCT03414983|75789013|FG001|Treatment|Death|1|||
41982791|NCT03414983|75789012|FG000|Treatment|Study Drug Toxicity|10|||
41982792|NCT03414983|75789013|FG001|Treatment|Study Drug Toxicity|5|||
42220585|NCT02676778|76038836|FG002|Overall Study|Withdrawal by Subject|0|||
42220586|NCT02676778|76038834|FG000|Overall Study|Other|4|||
42220587|NCT02676778|76038835|FG001|Overall Study|Other|3|||
42220588|NCT02676778|76038836|FG002|Overall Study|Other|0|||
42302254|NCT02278263|76137308|FG001|Overall Study|Protocol Violation|0|||
41982793|NCT03414983|75789012|FG000|Treatment|Disease Progression|75|||
41982794|NCT03414983|75789013|FG001|Treatment|Disease Progression|29|||
41982795|NCT03414983|75789012|FG000|Treatment|Not reported|1|||
42220589|NCT02676778|76038834|FG000|Overall Study|Adverse Event|2|||
42220590|NCT02676778|76038835|FG001|Overall Study|Adverse Event|3|||
42220591|NCT02676778|76038836|FG002|Overall Study|Adverse Event|0|||
42220592|NCT02946385|76038851|FG000|Overall Study|Lost to Follow-up|0|||
42220593|NCT02946385|76038852|FG001|Overall Study|Lost to Follow-up|0|||
42220594|NCT02946385|76038853|FG002|Overall Study|Lost to Follow-up|3|||
42220595|NCT02946385|76038854|FG003|Overall Study|Lost to Follow-up|0|||
42220596|NCT02946385|76038855|FG004|Overall Study|Lost to Follow-up|2|||
42220597|NCT02946385|76038856|FG005|Overall Study|Lost to Follow-up|1|||
42220598|NCT02694718|76038876|FG000|Overall Study|Death|1|||
42220599|NCT02694718|76038876|FG000|Overall Study|Withdrawal by Subject|1|||
42220600|NCT02944513|76038882|FG000|Overall Study|Withdrawal by Subject|4|||
42220601|NCT02944513|76038883|FG001|Overall Study|Withdrawal by Subject|1|||
42220602|NCT03018938|76038911|FG000|Overall Study|Death|0|||
42220603|NCT03018938|76038912|FG001|Overall Study|Death|1|||
42220604|NCT03018938|76038911|FG000|Overall Study|Lost to Follow-up|21|||
42220605|NCT03018938|76038912|FG001|Overall Study|Lost to Follow-up|32|||
42220606|NCT03018938|76038911|FG000|Overall Study|Withdrawal by Subject|38|||
42220607|NCT03018938|76038912|FG001|Overall Study|Withdrawal by Subject|45|||
42220608|NCT03018938|76038911|FG000|Overall Study|Physician Decision|3|||
42220609|NCT03018938|76038912|FG001|Overall Study|Physician Decision|2|||
42220610|NCT03018938|76038911|FG000|Overall Study|Sponsor Decision|0|||
42220611|NCT03018938|76038912|FG001|Overall Study|Sponsor Decision|1|||
42220612|NCT03018938|76038911|FG000|Overall Study|Screen failure-After randomization|4|||
42220613|NCT03018938|76038912|FG001|Overall Study|Screen failure-After randomization|2|||
42220614|NCT03018938|76038911|FG000|Overall Study|Not recorded|0|||
42220615|NCT03018938|76038912|FG001|Overall Study|Not recorded|2|||
42220616|NCT02943577|76038920|FG000|Overall Study|Protocol Violation|0|||
42220617|NCT02943577|76038921|FG001|Overall Study|Protocol Violation|1|||
42220618|NCT02943577|76038920|FG000|Overall Study|Adverse Event|3|||
42220619|NCT02943577|76038921|FG001|Overall Study|Adverse Event|2|||
42220620|NCT02943577|76038920|FG000|Overall Study|Lost to Follow-up|0|||
42220621|NCT02943577|76038921|FG001|Overall Study|Lost to Follow-up|1|||
42220622|NCT02943577|76038920|FG000|Overall Study|Withdrawal by Subject|1|||
42220623|NCT02943577|76038921|FG001|Overall Study|Withdrawal by Subject|1|||
42220624|NCT02943577|76038920|FG000|Overall Study|Pregnancy|1|||
42220625|NCT02943577|76038921|FG001|Overall Study|Pregnancy|0|||
42220626|NCT03016598|76038929|FG000|Overall Study|Lost to Follow-up|0|||
42220627|NCT03016598|76038930|FG001|Overall Study|Lost to Follow-up|2|||
42220628|NCT03017846|76038936|FG000|Overall Study|Lost to Follow-up|3|||
42220629|NCT03017846|76038936|FG000|Overall Study|Adverse Event|2|||
42220630|NCT03014180|76038942|FG000|Overall Study|Protocol Violation|2|||
42220631|NCT03011840|76038952|FG000|Overall Study|Not received PIL in post PIL phase|0|||
42220632|NCT03011840|76038953|FG001|Overall Study|Not received PIL in post PIL phase|21|||
42220633|NCT02942485|76038961|FG000|Overall Study|Lost to Follow-up|1|||
42220634|NCT02942485|76038962|FG001|Overall Study|Lost to Follow-up|0|||
42220635|NCT02942407|76038970|FG000|Overall Study|Lost to Follow-up|3|||
42220636|NCT02942407|76038971|FG001|Overall Study|Lost to Follow-up|2|||
42220637|NCT02942407|76038970|FG000|Overall Study|Withdrawal by Subject|7|||
42302255|NCT02278263|76137309|FG002|Overall Study|Protocol Violation|9|||
42302256|NCT02349789|76137320|FG000|Overall Study|Withdrawal by Subject|2|||
41982796|NCT03414983|75789013|FG001|Treatment|Not reported|0|||
41982797|NCT03414983|75789012|FG000|Treatment|Other reasons|3|||
41982798|NCT03414983|75789013|FG001|Treatment|Other reasons|2|||
41982799|NCT03414983|75789012|FG000|Treatment|Poor/non-compliance|2|||
41982800|NCT03414983|75789013|FG001|Treatment|Poor/non-compliance|0|||
41982801|NCT03414983|75789012|FG000|Treatment|Maximum clinical benefit|5|||
41982802|NCT03414983|75789013|FG001|Treatment|Maximum clinical benefit|9|||
41982803|NCT03414983|75789012|FG000|Treatment|Lost to Follow-up|0|||
41982804|NCT03414983|75789013|FG001|Treatment|Lost to Follow-up|1|||
41982805|NCT03414983|75789012|FG000|Treatment|Administrative reasons by sponsor|1|||
41982806|NCT03414983|75789013|FG001|Treatment|Administrative reasons by sponsor|0|||
41982807|NCT02986659|75789047|FG000|First Intervention Period|Adverse Event|3|||
41982808|NCT02986659|75789048|FG001|First Intervention Period|Adverse Event|1|||
41982809|NCT02986659|75789047|FG000|First Intervention Period|Lost to Follow-up|1|||
41982810|NCT02986659|75789048|FG001|First Intervention Period|Lost to Follow-up|0|||
41982811|NCT02986659|75789047|FG000|First Intervention Period|Withdrawal by Subject|0|||
41982812|NCT02986659|75789048|FG001|First Intervention Period|Withdrawal by Subject|1|||
41982813|NCT02986659|75789047|FG000|Second Intervention Period|Adverse Event|0|||
41982814|NCT02986659|75789048|FG001|Second Intervention Period|Adverse Event|6|||
41982815|NCT02933489|75789056|FG000|Overall Study|Ineligible|3|||
41982816|NCT02933489|75789057|FG001|Overall Study|Ineligible|3|||
41982817|NCT02933489|75789056|FG000|Overall Study|Withdrawal by Subject|27|||
41982818|NCT02933489|75789057|FG001|Overall Study|Withdrawal by Subject|18|||
42029657|NCT00878995|75838085|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
42220638|NCT02942407|76038971|FG001|Overall Study|Withdrawal by Subject|9|||
41982819|NCT02933489|75789056|FG000|Overall Study|Unable to complete exams (other)|14|||
41982820|NCT02933489|75789057|FG001|Overall Study|Unable to complete exams (other)|7|||
41982821|NCT02743806|75789075|FG000|Overall Study|Adverse Event|9|||
42220639|NCT02942407|76038970|FG000|Overall Study|Death|16|||
42220640|NCT02942407|76038971|FG001|Overall Study|Death|13|||
42220641|NCT03009344|76038985|FG000|Overall Study|Lack of Efficacy|5|||
42220642|NCT03009344|76038985|FG000|Overall Study|Withdrawal by Subject|1|||
42220643|NCT03009344|76038985|FG000|Overall Study|Adverse Event|1|||
42220644|NCT03322423|76038989|FG000|Period 1|Subject no longer eligible|0|||
42220645|NCT03322423|76038990|FG001|Period 1|Subject no longer eligible|1|||
42220646|NCT03322423|76038989|FG000|Period 1|Withdrawal by Subject|0|||
42220647|NCT03322423|76038990|FG001|Period 1|Withdrawal by Subject|1|||
42220648|NCT03322423|76038989|FG000|Period 1|Incorrect Lens Dispensed|1|||
42220649|NCT03322423|76038990|FG001|Period 1|Incorrect Lens Dispensed|0|||
42220650|NCT03322423|76038989|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
42220651|NCT03322423|76038990|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
42220652|NCT03322423|76038989|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
42220653|NCT03322423|76038990|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
42220654|NCT03322423|76038989|FG000|Period 2|Protocol Violation|1|||
42220655|NCT03322423|76038990|FG001|Period 2|Protocol Violation|0|||
42220656|NCT03322423|76038989|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
42220657|NCT03322423|76038990|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
42220658|NCT03007472|76038996|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
42220659|NCT03007472|76038996|FG000|Overall Study|Death|2|||
42220660|NCT03007472|76038996|FG000|Overall Study|Loss to Follow Up|1|||
42220661|NCT03321721|76039003|FG000|Overall Study|Lost to Follow-up|4|||
42220662|NCT03321721|76039004|FG001|Overall Study|Lost to Follow-up|8|||
42220663|NCT03321721|76039005|FG002|Overall Study|Lost to Follow-up|11|||
42220664|NCT03015116|76039017|FG000|Overall Study|Lost to Follow-up|3|||
42220665|NCT03015116|76039018|FG001|Overall Study|Lost to Follow-up|0|||
42220666|NCT03015116|76039019|FG002|Overall Study|Lost to Follow-up|2|||
42220667|NCT03015116|76039017|FG000|Overall Study|Withdrawal by Subject|3|||
42220668|NCT03015116|76039018|FG001|Overall Study|Withdrawal by Subject|1|||
42220669|NCT03015116|76039019|FG002|Overall Study|Withdrawal by Subject|0|||
42220670|NCT03015116|76039017|FG000|Overall Study|Subject has New Medical Status|1|||
42220671|NCT03015116|76039018|FG001|Overall Study|Subject has New Medical Status|0|||
42220672|NCT03015116|76039019|FG002|Overall Study|Subject has New Medical Status|0|||
42220673|NCT03015116|76039017|FG000|Overall Study|Physician Decision|0|||
41982822|NCT02743806|75789075|FG000|Overall Study|Lost to Follow-up|8|||
41982823|NCT02743806|75789075|FG000|Overall Study|Voluntary Withdrawal|54|||
42220674|NCT03015116|76039018|FG001|Overall Study|Physician Decision|1|||
42220675|NCT03015116|76039019|FG002|Overall Study|Physician Decision|0|||
42220676|NCT03006458|76039029|FG000|First Intervention|Unsatisfied Vision|0|||
42220677|NCT03006458|76039030|FG001|First Intervention|Unsatisfied Vision|3|||
42220678|NCT03320941|76039041|FG000|Overall Study|subject/guardian decision|0|||
42220679|NCT03320941|76039042|FG001|Overall Study|subject/guardian decision|0|||
42220680|NCT03320941|76039043|FG002|Overall Study|subject/guardian decision|0|||
42220681|NCT03320941|76039044|FG003|Overall Study|subject/guardian decision|1|||
42220682|NCT03320941|76039045|FG004|Overall Study|subject/guardian decision|0|||
42220683|NCT03005288|76039059|FG000|Overall Study|Withdrawal by Subject|7|||
42220684|NCT03005288|76039060|FG001|Overall Study|Withdrawal by Subject|5|||
42220685|NCT03005288|76039059|FG000|Overall Study|Lost to Follow-up|0|||
42220686|NCT03005288|76039060|FG001|Overall Study|Lost to Follow-up|1|||
42220687|NCT03005288|76039059|FG000|Overall Study|Adverse Event|5|||
41982824|NCT02743806|75789075|FG000|Overall Study|Study Termination|65|||
41982825|NCT02743806|75789075|FG000|Overall Study|Pregnancy|6|||
41982826|NCT02743806|75789075|FG000|Overall Study|No Longer Clinically Benefiting|27|||
41982827|NCT02743806|75789075|FG000|Overall Study|Reason Not Specified|12|||
41982828|NCT02668653|75789081|FG000|Overall Study|Refractory disease|41|||
41982829|NCT02668653|75789082|FG001|Overall Study|Refractory disease|70|||
41982830|NCT02668653|75789081|FG000|Overall Study|Relapse|44|||
41982831|NCT02668653|75789082|FG001|Overall Study|Relapse|65|||
41982832|NCT02668653|75789081|FG000|Overall Study|Adverse Event|58|||
41982833|NCT02668653|75789082|FG001|Overall Study|Adverse Event|23|||
41982834|NCT02668653|75789081|FG000|Overall Study|Subject decision to stop study drug|25|||
41982835|NCT02668653|75789082|FG001|Overall Study|Subject decision to stop study drug|23|||
41982836|NCT02668653|75789081|FG000|Overall Study|Other reasons not specified|16|||
41982837|NCT02668653|75789082|FG001|Overall Study|Other reasons not specified|11|||
41982838|NCT02668653|75789081|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
41982839|NCT02668653|75789082|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
42029658|NCT00879697|75838093|FG000|Overall Study|Physician Decision|2|||
42220688|NCT03005288|76039060|FG001|Overall Study|Adverse Event|0|||
42220689|NCT03005288|76039059|FG000|Overall Study|Protocol deviation|0|||
42220690|NCT03005288|76039060|FG001|Overall Study|Protocol deviation|1|||
42220691|NCT03005288|76039059|FG000|Overall Study|Physician Decision|0|||
42220692|NCT03005288|76039060|FG001|Overall Study|Physician Decision|1|||
42220693|NCT03003494|76039066|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
42220694|NCT03559699|76039070|FG000|Overall Study|Withdrawal by Subject|6|||
41982840|NCT02668653|75789081|FG000|Overall Study|Investigator decision|10|||
42220695|NCT03559699|76039070|FG000|Overall Study|Lost to Follow-up|1|||
41982841|NCT02668653|75789082|FG001|Overall Study|Investigator decision|7|||
41982842|NCT02668653|75789081|FG000|Overall Study|Failure to meet continuation criteria|5|||
41982843|NCT02668653|75789082|FG001|Overall Study|Failure to meet continuation criteria|12|||
42220696|NCT03085758|76039077|FG000|Overall Study|Death|26|||
42220697|NCT03085758|76039078|FG001|Overall Study|Death|24|||
42220698|NCT03085758|76039079|FG002|Overall Study|Death|53|||
42220699|NCT03085758|76039077|FG000|Overall Study|Lost to Follow-up|1|||
42220700|NCT03085758|76039078|FG001|Overall Study|Lost to Follow-up|1|||
42220701|NCT03085758|76039079|FG002|Overall Study|Lost to Follow-up|1|||
42220702|NCT03085758|76039077|FG000|Overall Study|Withdrawal by Subject|2|||
42220703|NCT03085758|76039078|FG001|Overall Study|Withdrawal by Subject|2|||
42220704|NCT03085758|76039079|FG002|Overall Study|Withdrawal by Subject|1|||
42220705|NCT03085758|76039077|FG000|Overall Study|Refusal to recall it up to day 90|0|||
42220706|NCT03085758|76039078|FG001|Overall Study|Refusal to recall it up to day 90|0|||
42220707|NCT03085758|76039079|FG002|Overall Study|Refusal to recall it up to day 90|1|||
42220708|NCT03085758|76039077|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
42220709|NCT03085758|76039078|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
42220710|NCT03085758|76039079|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
42220711|NCT03935880|76039103|FG000|Overall Study|Lost to Follow-up|0|||
42220712|NCT03935880|76039104|FG001|Overall Study|Lost to Follow-up|1|||
42220713|NCT03315793|76039112|FG000|Overall Study|Adverse Event|4|||
42220714|NCT03315793|76039113|FG001|Overall Study|Adverse Event|2|||
42220715|NCT03315793|76039112|FG000|Overall Study|Protocol Deviation|1|||
42220716|NCT03315793|76039113|FG001|Overall Study|Protocol Deviation|0|||
42220717|NCT03315793|76039112|FG000|Overall Study|Difficult for regular visit|0|||
42220718|NCT03315793|76039113|FG001|Overall Study|Difficult for regular visit|1|||
42220719|NCT02676466|76039129|FG000|Overall Study|Death|0|||
42220720|NCT02676466|76039130|FG001|Overall Study|Death|2|||
42220721|NCT02676466|76039131|FG002|Overall Study|Death|1|||
42220722|NCT02676466|76039132|FG003|Overall Study|Death|0|||
42220723|NCT02676466|76039133|FG004|Overall Study|Death|0|||
42220724|NCT02676466|76039134|FG005|Overall Study|Death|0|||
42220725|NCT02676466|76039135|FG006|Overall Study|Death|0|||
42220726|NCT02676466|76039136|FG007|Overall Study|Death|0|||
42220727|NCT02676466|76039129|FG000|Overall Study|Withdrawal by Subject|4|||
42220728|NCT02676466|76039130|FG001|Overall Study|Withdrawal by Subject|3|||
42220729|NCT02676466|76039131|FG002|Overall Study|Withdrawal by Subject|1|||
42220730|NCT02676466|76039132|FG003|Overall Study|Withdrawal by Subject|0|||
42220731|NCT02676466|76039133|FG004|Overall Study|Withdrawal by Subject|3|||
42220732|NCT02676466|76039134|FG005|Overall Study|Withdrawal by Subject|1|||
42220733|NCT02676466|76039135|FG006|Overall Study|Withdrawal by Subject|1|||
42220734|NCT02676466|76039136|FG007|Overall Study|Withdrawal by Subject|1|||
42220735|NCT03633695|76039160|FG000|Overall Study|Lost to Follow-up|4|||
42220736|NCT03633695|76039161|FG001|Overall Study|Lost to Follow-up|5|||
42220737|NCT03633695|76039160|FG000|Overall Study|Discontinued|8|||
42220738|NCT03633695|76039161|FG001|Overall Study|Discontinued|4|||
42220739|NCT03314233|76039183|FG000|Overall Study|No longer eligible at time of delivery|1|||
42220740|NCT02675998|76039191|FG000|8-Week Treatment Period|Adverse Event|6|||
42220741|NCT02675998|76039192|FG001|8-Week Treatment Period|Adverse Event|5|||
42220742|NCT02675998|76039193|FG002|8-Week Treatment Period|Adverse Event|6|||
42220743|NCT02675998|76039194|FG003|8-Week Treatment Period|Adverse Event|0|||
42220744|NCT02675998|76039191|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
42220745|NCT02675998|76039192|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
42220746|NCT02675998|76039193|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
42220747|NCT02675998|76039194|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
42220748|NCT02675998|76039191|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
42220749|NCT02675998|76039192|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
42220750|NCT02675998|76039193|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
42220751|NCT02675998|76039194|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
41982844|NCT02668653|75789081|FG000|Overall Study|Lost to Follow-up|1|||
41982845|NCT02668653|75789082|FG001|Overall Study|Lost to Follow-up|0|||
42220752|NCT02675998|76039191|FG000|8-Week Treatment Period|Physician Decision|1|||
41982846|NCT02668653|75789081|FG000|Overall Study|Pregnancy|0|||
41982847|NCT02668653|75789082|FG001|Overall Study|Pregnancy|1|||
41982848|NCT02668653|75789081|FG000|Overall Study|Death|0|||
41982849|NCT02668653|75789082|FG001|Overall Study|Death|1|||
41982850|NCT02649972|75789088|FG000|Overall Study|Not treated|1|||
41982851|NCT02437318|75789103|FG000|Overall Study|Progressive disease|173|||
41982852|NCT02437318|75789104|FG001|Overall Study|Progressive disease|208|||
42220753|NCT02675998|76039192|FG001|8-Week Treatment Period|Physician Decision|0|||
42220754|NCT02675998|76039193|FG002|8-Week Treatment Period|Physician Decision|2|||
41982853|NCT02437318|75789103|FG000|Overall Study|Subject/guardian decision|22|||
41982854|NCT02437318|75789104|FG001|Overall Study|Subject/guardian decision|10|||
41982855|NCT02437318|75789103|FG000|Overall Study|Physician Decision|11|||
42220755|NCT02675998|76039194|FG003|8-Week Treatment Period|Physician Decision|0|||
42220756|NCT02675998|76039191|FG000|8-Week Treatment Period|GI side Effects|1|||
42220757|NCT02675998|76039192|FG001|8-Week Treatment Period|GI side Effects|4|||
42220758|NCT02675998|76039193|FG002|8-Week Treatment Period|GI side Effects|2|||
42220759|NCT02675998|76039194|FG003|8-Week Treatment Period|GI side Effects|0|||
42220760|NCT02675998|76039191|FG000|8-Week Treatment Period|Protocol Violation|1|||
42220761|NCT02675998|76039192|FG001|8-Week Treatment Period|Protocol Violation|1|||
42220762|NCT02675998|76039193|FG002|8-Week Treatment Period|Protocol Violation|1|||
42220763|NCT02675998|76039194|FG003|8-Week Treatment Period|Protocol Violation|0|||
42220764|NCT02675998|76039191|FG000|8-Week Treatment Period|Other|3|||
42220765|NCT02675998|76039192|FG001|8-Week Treatment Period|Other|1|||
42220766|NCT02675998|76039193|FG002|8-Week Treatment Period|Other|2|||
42220767|NCT02675998|76039194|FG003|8-Week Treatment Period|Other|0|||
42220768|NCT02675998|76039191|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
42220769|NCT02675998|76039192|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
42220770|NCT02675998|76039193|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
42220771|NCT02675998|76039194|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
42220772|NCT02675998|76039191|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
42220773|NCT02675998|76039192|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
42220774|NCT02675998|76039193|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
42220775|NCT02675998|76039194|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
42220776|NCT02675998|76039191|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
42220777|NCT02675998|76039192|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
42220778|NCT02675998|76039193|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
42220779|NCT02675998|76039194|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
42220780|NCT02675998|76039191|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
42220781|NCT02675998|76039192|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
42220782|NCT02675998|76039193|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
42220783|NCT02675998|76039194|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
42220784|NCT02675998|76039191|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
42220785|NCT02675998|76039192|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
42220786|NCT02675998|76039193|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
42220787|NCT02675998|76039194|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
42220788|NCT02674204|76039210|FG000|Overall Study|Adverse Event|1|||
42220789|NCT02674204|76039211|FG001|Overall Study|Adverse Event|0|||
42220790|NCT02941627|76039217|FG000|Overall Study|Death|1|||
42220791|NCT02941627|76039217|FG000|Overall Study|Surgical failure|1|||
42220792|NCT02941627|76039217|FG000|Overall Study|cholesteatoma prevented implantation|1|||
42220793|NCT03521934|76039229|FG000|Overall Study|Death|65|||
42220794|NCT03521934|76039230|FG001|Overall Study|Death|73|||
42220795|NCT03521934|76039229|FG000|Overall Study|Withdrawal by Subject|18|||
42220796|NCT03521934|76039230|FG001|Overall Study|Withdrawal by Subject|23|||
42220797|NCT03521934|76039229|FG000|Overall Study|Site Terminated by Sponsor|39|||
42220798|NCT03521934|76039230|FG001|Overall Study|Site Terminated by Sponsor|35|||
42220799|NCT03521934|76039229|FG000|Overall Study|Study Terminated by Sponsor|483|||
42220800|NCT03521934|76039230|FG001|Overall Study|Study Terminated by Sponsor|477|||
42220801|NCT03521934|76039229|FG000|Overall Study|Reason not Specified|3|||
42220802|NCT03521934|76039230|FG001|Overall Study|Reason not Specified|6|||
42220803|NCT03434353|76039241|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
42220804|NCT03434353|76039242|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
42220805|NCT03434353|76039243|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
42220806|NCT03434353|76039244|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
42220807|NCT03434353|76039245|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
42220808|NCT03434353|76039241|FG000|Overall Study|Withdrew consent|1|||
42220809|NCT03434353|76039242|FG001|Overall Study|Withdrew consent|0|||
42220810|NCT03434353|76039243|FG002|Overall Study|Withdrew consent|3|||
42220811|NCT03434353|76039244|FG003|Overall Study|Withdrew consent|0|||
42220812|NCT03434353|76039245|FG004|Overall Study|Withdrew consent|0|||
42220813|NCT03434353|76039241|FG000|Overall Study|Adverse Event|1|||
42220814|NCT03434353|76039242|FG001|Overall Study|Adverse Event|0|||
42220815|NCT03434353|76039243|FG002|Overall Study|Adverse Event|0|||
42220816|NCT03434353|76039244|FG003|Overall Study|Adverse Event|0|||
42220817|NCT03434353|76039245|FG004|Overall Study|Adverse Event|1|||
42220818|NCT03434353|76039241|FG000|Overall Study|Lost to Follow-up|2|||
42220819|NCT03434353|76039242|FG001|Overall Study|Lost to Follow-up|0|||
42220820|NCT03434353|76039243|FG002|Overall Study|Lost to Follow-up|0|||
42220821|NCT03434353|76039244|FG003|Overall Study|Lost to Follow-up|0|||
42220822|NCT03434353|76039245|FG004|Overall Study|Lost to Follow-up|0|||
42220823|NCT02914184|76039261|FG000|Overall Study|Lost to Follow-up|7|||
42220824|NCT02914184|76039262|FG001|Overall Study|Lost to Follow-up|10|||
42220825|NCT02914184|76039263|FG002|Overall Study|Lost to Follow-up|8|||
42220826|NCT02914184|76039264|FG003|Overall Study|Lost to Follow-up|7|||
42220827|NCT02914184|76039261|FG000|Overall Study|Withdrawal by Subject|4|||
42220828|NCT02914184|76039262|FG001|Overall Study|Withdrawal by Subject|2|||
42220829|NCT02914184|76039263|FG002|Overall Study|Withdrawal by Subject|7|||
42220830|NCT02914184|76039264|FG003|Overall Study|Withdrawal by Subject|3|||
42220831|NCT02914184|76039261|FG000|Overall Study|Other|1|||
42220832|NCT02914184|76039262|FG001|Overall Study|Other|0|||
42220833|NCT02914184|76039263|FG002|Overall Study|Other|0|||
42220834|NCT02914184|76039264|FG003|Overall Study|Other|0|||
42220835|NCT02914184|76039261|FG000|Overall Study|Migrated/moved from the study area|2|||
42220836|NCT02914184|76039262|FG001|Overall Study|Migrated/moved from the study area|1|||
42220837|NCT02914184|76039263|FG002|Overall Study|Migrated/moved from the study area|2|||
42029659|NCT00879697|75838094|FG001|Overall Study|Physician Decision|2|||
42029660|NCT00894556|75838103|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
42220838|NCT02914184|76039264|FG003|Overall Study|Migrated/moved from the study area|1|||
42220839|NCT03633227|76039278|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
42220840|NCT03633227|76039279|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
42220841|NCT03633227|76039278|FG000|Double Blind (DB), up to Week 48|Death|2|||
42220842|NCT03633227|76039279|FG001|Double Blind (DB), up to Week 48|Death|1|||
42220843|NCT03633227|76039278|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
42220844|NCT03633227|76039279|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
42220845|NCT03633227|76039278|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
42220846|NCT03633227|76039279|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
42220847|NCT03633227|76039278|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
42220848|NCT03633227|76039279|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
42220849|NCT03633227|76039278|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
42220850|NCT03633227|76039279|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
42220851|NCT03633227|76039278|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
42220852|NCT03633227|76039279|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
42220853|NCT03633227|76039278|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
42220854|NCT03633227|76039279|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
42220855|NCT03633227|76039278|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
42220856|NCT03633227|76039279|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
42220857|NCT03633227|76039278|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
42220858|NCT03633227|76039279|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
42220859|NCT03633227|76039278|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
42220860|NCT03633227|76039279|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
42220861|NCT03633227|76039278|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
42220862|NCT03633227|76039279|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
42220863|NCT02913326|76039292|FG000|Overall Study|Reason not listed|0|||
42220864|NCT02913326|76039293|FG001|Overall Study|Reason not listed|1|||
42220865|NCT02913326|76039292|FG000|Overall Study|Lost to Follow-up|0|||
42220866|NCT02913326|76039293|FG001|Overall Study|Lost to Follow-up|1|||
42220867|NCT02913326|76039292|FG000|Overall Study|Adverse Event|1|||
42220868|NCT02913326|76039293|FG001|Overall Study|Adverse Event|0|||
42220869|NCT02912468|76039301|FG000|Overall Study|Adverse Event|3|||
42220870|NCT02912468|76039302|FG001|Overall Study|Adverse Event|2|||
42220871|NCT02912468|76039301|FG000|Overall Study|Withdrawal by Subject|6|||
42220872|NCT02912468|76039302|FG001|Overall Study|Withdrawal by Subject|2|||
42220873|NCT02912468|76039301|FG000|Overall Study|Randomized and not treated|0|||
42220874|NCT02912468|76039302|FG001|Overall Study|Randomized and not treated|1|||
42220875|NCT04438499|76039309|FG000|Overall Study|Lack of Efficacy|2|||
42220876|NCT00002874|76039315|FG000|Overall Study|Withdrawal by Subject|1|||
42220877|NCT00002874|76039316|FG001|Overall Study|Withdrawal by Subject|1|||
42220878|NCT00002874|76039315|FG000|Overall Study|Protocol Violation|44|||
42220879|NCT00002874|76039316|FG001|Overall Study|Protocol Violation|34|||
42220880|NCT03001076|76039324|FG000|Overall Study|Withdrawal by patient|2|||
42220881|NCT03001076|76039325|FG001|Overall Study|Withdrawal by patient|0|||
42220882|NCT03001076|76039324|FG000|Overall Study|Other|1|||
42220883|NCT03001076|76039325|FG001|Overall Study|Other|0|||
42220884|NCT03001076|76039324|FG000|Overall Study|Adverse Event|3|||
42220885|NCT03001076|76039325|FG001|Overall Study|Adverse Event|3|||
42220886|NCT03001076|76039324|FG000|Overall Study|Sponsor decision|1|||
42220887|NCT03001076|76039325|FG001|Overall Study|Sponsor decision|0|||
42220888|NCT03001076|76039324|FG000|Overall Study|Lost to Follow-up|0|||
42220889|NCT03001076|76039325|FG001|Overall Study|Lost to Follow-up|2|||
42220890|NCT03555305|76039331|FG000|Period 1|Physician Decision|0|||
42220891|NCT03555305|76039332|FG001|Period 1|Physician Decision|1|||
42029661|NCT00894556|75838104|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
42029662|NCT00894556|75838105|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
42029663|NCT00894556|75838106|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
42029664|NCT00894556|75838103|FG000|Treatment Phase|Lost to Follow-up|2|||
42029665|NCT00894556|75838104|FG001|Treatment Phase|Lost to Follow-up|3|||
42029666|NCT00894556|75838105|FG002|Treatment Phase|Lost to Follow-up|1|||
42220892|NCT03555305|76039331|FG000|Period 1|Adverse Event|0|||
42220893|NCT03555305|76039332|FG001|Period 1|Adverse Event|1|||
42220894|NCT03553823|76039340|FG000|Overall Study|Physician Decision|0|||
42220895|NCT03553823|76039341|FG001|Overall Study|Physician Decision|1|||
42220896|NCT03000686|76039349|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
42220897|NCT03000686|76039350|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
42220898|NCT03000686|76039351|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
42220899|NCT03000686|76039352|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
42220900|NCT02493660|76039370|FG000|Overall Study|Physician Decision|0|||
42220901|NCT02493660|76039371|FG001|Overall Study|Physician Decision|1|||
42220902|NCT02493660|76039370|FG000|Overall Study|Adverse Event|4|||
42220903|NCT02493660|76039371|FG001|Overall Study|Adverse Event|2|||
42220904|NCT02493660|76039370|FG000|Overall Study|Withdrawal by Subject|2|||
42220905|NCT02493660|76039371|FG001|Overall Study|Withdrawal by Subject|3|||
42220906|NCT02493660|76039370|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
42220907|NCT02493660|76039371|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
42220908|NCT02493660|76039370|FG000|Overall Study|Protocol Violation|0|||
42029667|NCT00894556|75838106|FG003|Treatment Phase|Lost to Follow-up|0|||
42029668|NCT00894556|75838103|FG000|Treatment Phase|Lack of Qualifying Event|2|||
42029669|NCT00894556|75838104|FG001|Treatment Phase|Lack of Qualifying Event|1|||
42029670|NCT00894556|75838105|FG002|Treatment Phase|Lack of Qualifying Event|0|||
42029671|NCT00894556|75838106|FG003|Treatment Phase|Lack of Qualifying Event|0|||
42029672|NCT01210352|75838122|FG000|Overall Study|Adverse Event|0|||
42220909|NCT02493660|76039371|FG001|Overall Study|Protocol Violation|1|||
42220910|NCT02493660|76039370|FG000|Overall Study|Death|0|||
42029673|NCT01210352|75838123|FG001|Overall Study|Adverse Event|0|||
42029674|NCT01210352|75838124|FG002|Overall Study|Adverse Event|0|||
42220911|NCT02493660|76039371|FG001|Overall Study|Death|1|||
42220912|NCT02493660|76039370|FG000|Overall Study|Lost to Follow-up|2|||
42220913|NCT02493660|76039371|FG001|Overall Study|Lost to Follow-up|4|||
42220914|NCT03552029|76039381|FG000|Overall Study|Death|3|||
42220915|NCT03552029|76039382|FG001|Overall Study|Death|0|||
42220916|NCT03552029|76039381|FG000|Overall Study|Adverse Event|1|||
42220917|NCT03552029|76039382|FG001|Overall Study|Adverse Event|0|||
42220918|NCT03552029|76039381|FG000|Overall Study|Lack of Efficacy|0|||
42220919|NCT03552029|76039382|FG001|Overall Study|Lack of Efficacy|2|||
42220920|NCT03552029|76039381|FG000|Overall Study|Physician Decision|0|||
42220921|NCT03552029|76039382|FG001|Overall Study|Physician Decision|1|||
42220922|NCT03552029|76039381|FG000|Overall Study|Study terminated by Sponsor|0|||
42220923|NCT03552029|76039382|FG001|Overall Study|Study terminated by Sponsor|1|||
42220924|NCT03552029|76039381|FG000|Overall Study|Other|0|||
42220925|NCT03552029|76039382|FG001|Overall Study|Other|2|||
42220926|NCT05395104|76039388|FG000|Overall Study|Met Liver Stopping Criteria|1|||
42220927|NCT05395104|76039388|FG000|Overall Study|Withdrawal by Subject|1|||
42220928|NCT05327491|76039394|FG000|Periods 1 & 2|Miscellaneous|0|||
42220929|NCT05327491|76039395|FG001|Periods 1 & 2|Miscellaneous|1|||
42220930|NCT05327491|76039396|FG002|Periods 1 & 2|Miscellaneous|0|||
42220931|NCT05327491|76039397|FG003|Periods 1 & 2|Miscellaneous|0|||
42220932|NCT05327491|76039394|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
42220933|NCT05327491|76039395|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
42220934|NCT05327491|76039396|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
42220935|NCT05327491|76039397|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
42220936|NCT05299892|76039415|FG000|Overall Study|Withdrawal by Subject|2|||
42220937|NCT04983940|76039420|FG000|Overall Study|Lost to Follow-up|14|||
42220938|NCT04983940|76039420|FG000|Overall Study|Lack of Efficacy|2|||
42220939|NCT04966910|76039428|FG000|Baseline|Participant did not complete measure|0|||
42220940|NCT04966910|76039429|FG001|Baseline|Participant did not complete measure|0|||
42220941|NCT04966910|76039430|FG002|Baseline|Participant did not complete measure|1|||
42220942|NCT04966910|76039431|FG003|Baseline|Participant did not complete measure|0|||
42220943|NCT04966910|76039428|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
42220944|NCT04966910|76039429|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
42220945|NCT04966910|76039430|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
41982856|NCT02437318|75789104|FG001|Overall Study|Physician Decision|10|||
41982857|NCT02437318|75789103|FG000|Overall Study|Adverse Event|14|||
41982858|NCT02437318|75789104|FG001|Overall Study|Adverse Event|3|||
41982859|NCT02437318|75789103|FG000|Overall Study|Death|4|||
41982860|NCT02437318|75789104|FG001|Overall Study|Death|4|||
41982861|NCT02437318|75789103|FG000|Overall Study|Protocol Violation|5|||
41982862|NCT02437318|75789104|FG001|Overall Study|Protocol Violation|6|||
41982863|NCT02437318|75789103|FG000|Overall Study|Untreated|0|||
41982864|NCT02437318|75789104|FG001|Overall Study|Untreated|1|||
41982865|NCT02305238|75789113|FG000|Overall Study|Death|2|||
41982866|NCT02305238|75789114|FG001|Overall Study|Death|1|||
41982867|NCT02305238|75789115|FG002|Overall Study|Death|0|||
41982868|NCT02305238|75789113|FG000|Overall Study|Progressive disease|4|||
41982869|NCT02305238|75789114|FG001|Overall Study|Progressive disease|4|||
42029675|NCT01210352|75838125|FG003|Overall Study|Adverse Event|0|||
42029676|NCT01210352|75838126|FG004|Overall Study|Adverse Event|0|||
42029677|NCT01210352|75838127|FG005|Overall Study|Adverse Event|0|||
42220946|NCT04966910|76039431|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
42220947|NCT04966910|76039428|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
42220948|NCT04966910|76039429|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
42220949|NCT04966910|76039430|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
42220950|NCT04966910|76039431|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
42220951|NCT04966910|76039428|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
42220952|NCT04966910|76039429|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
42220953|NCT04966910|76039430|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
42220954|NCT04966910|76039431|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
42220955|NCT04900038|76039447|FG000|Overall Study|Adverse Event|1|||
42220956|NCT04900038|76039448|FG001|Overall Study|Adverse Event|0|||
42220957|NCT04900038|76039449|FG002|Overall Study|Adverse Event|1|||
42220958|NCT04900038|76039450|FG003|Overall Study|Adverse Event|1|||
42220959|NCT04900038|76039447|FG000|Overall Study|Withdrawal by Subject|0|||
42220960|NCT04900038|76039448|FG001|Overall Study|Withdrawal by Subject|1|||
42220961|NCT04900038|76039449|FG002|Overall Study|Withdrawal by Subject|0|||
42220962|NCT04900038|76039450|FG003|Overall Study|Withdrawal by Subject|0|||
42220963|NCT04900038|76039447|FG000|Overall Study|Study terminated by sponsor|18|||
42220964|NCT04900038|76039448|FG001|Overall Study|Study terminated by sponsor|15|||
42220965|NCT04900038|76039449|FG002|Overall Study|Study terminated by sponsor|17|||
42302257|NCT02349711|76137326|FG000|Overall Study|Withdrawal by Subject|2|||
41982870|NCT02305238|75789115|FG002|Overall Study|Progressive disease|0|||
41982871|NCT02305238|75789113|FG000|Overall Study|Logistical difficulties|1|||
41982872|NCT02305238|75789114|FG001|Overall Study|Logistical difficulties|3|||
41982873|NCT02305238|75789115|FG002|Overall Study|Logistical difficulties|0|||
42130806|NCT00511238|75941771|FG000|Overall Study|Withdrawal by Subject|2|||
42130807|NCT00511238|75941772|FG001|Overall Study|Withdrawal by Subject|22|||
42130808|NCT00511238|75941771|FG000|Overall Study|Progressive Disease|23|||
42130809|NCT00511238|75941772|FG001|Overall Study|Progressive Disease|157|||
42130810|NCT00511238|75941771|FG000|Overall Study|various reasons|4|||
42130811|NCT00511238|75941772|FG001|Overall Study|various reasons|14|||
41982874|NCT02305238|75789113|FG000|Overall Study|Protocol Violation|0|||
41982875|NCT02305238|75789114|FG001|Overall Study|Protocol Violation|3|||
41982876|NCT02305238|75789115|FG002|Overall Study|Protocol Violation|0|||
42130812|NCT00513500|75941790|FG000|Overall Study|Lost to Follow-up|35|||
42130813|NCT00513500|75941791|FG001|Overall Study|Lost to Follow-up|39|||
42130814|NCT00513500|75941790|FG000|Overall Study|Death|2|||
42130815|NCT00513500|75941791|FG001|Overall Study|Death|1|||
42130816|NCT00513500|75941790|FG000|Overall Study|Hospitalized|4|||
42130817|NCT00513500|75941791|FG001|Overall Study|Hospitalized|14|||
42130818|NCT03969719|75941800|FG000|Overall Study|Other reasons not specified|1|||
42130819|NCT03969719|75941801|FG001|Overall Study|Other reasons not specified|1|||
42130820|NCT03969719|75941802|FG002|Overall Study|Other reasons not specified|3|||
42130821|NCT03969719|75941800|FG000|Overall Study|Withdrawal by Subject|2|||
42130822|NCT03969719|75941801|FG001|Overall Study|Withdrawal by Subject|3|||
42029678|NCT01210352|75838128|FG006|Overall Study|Adverse Event|0|||
42029679|NCT01210352|75838129|FG007|Overall Study|Adverse Event|2|||
42130823|NCT03969719|75941802|FG002|Overall Study|Withdrawal by Subject|2|||
42130824|NCT03969719|75941800|FG000|Overall Study|Protocol Violation|1|||
42130825|NCT03969719|75941801|FG001|Overall Study|Protocol Violation|2|||
42130826|NCT03969719|75941802|FG002|Overall Study|Protocol Violation|0|||
42220966|NCT04900038|76039450|FG003|Overall Study|Study terminated by sponsor|14|||
41982877|NCT02305238|75789113|FG000|Overall Study|Physician Decision|2|||
41982878|NCT02305238|75789114|FG001|Overall Study|Physician Decision|1|||
42220967|NCT04900038|76039447|FG000|Overall Study|Protocol Deviation|1|||
42220968|NCT04900038|76039448|FG001|Overall Study|Protocol Deviation|1|||
42029680|NCT01210352|75838130|FG008|Overall Study|Adverse Event|1|||
42220969|NCT04900038|76039449|FG002|Overall Study|Protocol Deviation|0|||
42220970|NCT04900038|76039450|FG003|Overall Study|Protocol Deviation|0|||
42220971|NCT04900038|76039447|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
42220972|NCT04900038|76039448|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
42220973|NCT04900038|76039449|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
42220974|NCT04900038|76039450|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
42220975|NCT04900038|76039447|FG000|Overall Study|Lost to Follow-up|0|||
42220976|NCT04900038|76039448|FG001|Overall Study|Lost to Follow-up|0|||
42220977|NCT04900038|76039449|FG002|Overall Study|Lost to Follow-up|0|||
42220978|NCT04900038|76039450|FG003|Overall Study|Lost to Follow-up|1|||
42220979|NCT04880642|76039462|FG000|Randomization|Withdrawal by Subject|2|||
42029681|NCT01210352|75838122|FG000|Overall Study|Lack of Efficacy|0|||
42029682|NCT01210352|75838123|FG001|Overall Study|Lack of Efficacy|0|||
42029683|NCT01210352|75838124|FG002|Overall Study|Lack of Efficacy|0|||
42029684|NCT01210352|75838125|FG003|Overall Study|Lack of Efficacy|0|||
42029685|NCT01210352|75838126|FG004|Overall Study|Lack of Efficacy|0|||
42220980|NCT04880642|76039463|FG001|Randomization|Withdrawal by Subject|3|||
42220981|NCT04880642|76039462|FG000|Treatment Period|Adverse Event|0|||
42220982|NCT04880642|76039463|FG001|Treatment Period|Adverse Event|1|||
42220983|NCT04880642|76039462|FG000|Treatment Period|Death|6|||
42220984|NCT04880642|76039463|FG001|Treatment Period|Death|6|||
42029686|NCT01210352|75838127|FG005|Overall Study|Lack of Efficacy|0|||
42220985|NCT04880642|76039462|FG000|Treatment Period|Lost to Follow-up|1|||
42220986|NCT04880642|76039463|FG001|Treatment Period|Lost to Follow-up|0|||
42220987|NCT04880642|76039462|FG000|Treatment Period|Protocol Violation|0|||
42220988|NCT04880642|76039463|FG001|Treatment Period|Protocol Violation|1|||
42220989|NCT04880642|76039462|FG000|Treatment Period|Withdrawal by Subject|5|||
42220990|NCT04880642|76039463|FG001|Treatment Period|Withdrawal by Subject|3|||
42220991|NCT04880642|76039462|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
42220992|NCT04880642|76039463|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
42220993|NCT04880642|76039462|FG000|Follow-up|Death|4|||
42220994|NCT04880642|76039463|FG001|Follow-up|Death|3|||
42220995|NCT04880642|76039462|FG000|Follow-up|Withdrawal by Subject|1|||
42220996|NCT04880642|76039463|FG001|Follow-up|Withdrawal by Subject|0|||
42220997|NCT04578535|76039475|FG000|Overall Study|Lost to Follow-up|1|||
42220998|NCT04578535|76039476|FG001|Overall Study|Lost to Follow-up|0|||
42220999|NCT04578535|76039477|FG002|Overall Study|Lost to Follow-up|0|||
42029687|NCT01210352|75838128|FG006|Overall Study|Lack of Efficacy|1|||
42029688|NCT01210352|75838129|FG007|Overall Study|Lack of Efficacy|0|||
42029689|NCT01210352|75838130|FG008|Overall Study|Lack of Efficacy|0|||
42029690|NCT01210352|75838122|FG000|Overall Study|Physician Decision|0|||
42029691|NCT01210352|75838123|FG001|Overall Study|Physician Decision|0|||
42130827|NCT03969719|75941800|FG000|Overall Study|Adverse Event|0|||
42130828|NCT03969719|75941801|FG001|Overall Study|Adverse Event|2|||
42130829|NCT03969719|75941802|FG002|Overall Study|Adverse Event|0|||
42130830|NCT03969719|75941800|FG000|Overall Study|Lost to Follow-up|0|||
42130831|NCT03969719|75941801|FG001|Overall Study|Lost to Follow-up|1|||
42130832|NCT03969719|75941802|FG002|Overall Study|Lost to Follow-up|0|||
42130833|NCT00511004|75941813|FG000|Overall Study|Lost to Follow-up|0|||
42130834|NCT00511004|75941814|FG001|Overall Study|Lost to Follow-up|0|||
42130835|NCT00511004|75941815|FG002|Overall Study|Lost to Follow-up|4|||
42130836|NCT02877134|75941842|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
42130837|NCT02877134|75941843|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
42130838|NCT02877134|75941844|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
42130839|NCT02877134|75941845|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
42130840|NCT02877134|75941846|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
42130841|NCT02877134|75941847|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
42130842|NCT02877134|75941848|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
42130843|NCT02877134|75941849|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
42130844|NCT02877134|75941850|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
42130845|NCT02877134|75941851|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
42130846|NCT02877134|75941852|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
42130847|NCT02877134|75941853|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
42130848|NCT02877134|75941842|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
42130849|NCT02877134|75941843|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
42221000|NCT04578535|76039478|FG003|Overall Study|Lost to Follow-up|1|||
42221001|NCT04578535|76039479|FG004|Overall Study|Lost to Follow-up|0|||
42029692|NCT01210352|75838124|FG002|Overall Study|Physician Decision|0|||
42130850|NCT02877134|75941844|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
42221002|NCT04578535|76039480|FG005|Overall Study|Lost to Follow-up|2|||
42130851|NCT02877134|75941845|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
42130852|NCT02877134|75941846|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
42221003|NCT04578535|76039475|FG000|Overall Study|Pregnancy|1|||
42029693|NCT01210352|75838125|FG003|Overall Study|Physician Decision|0|||
42221004|NCT04578535|76039476|FG001|Overall Study|Pregnancy|0|||
42221005|NCT04578535|76039477|FG002|Overall Study|Pregnancy|0|||
42221006|NCT04578535|76039478|FG003|Overall Study|Pregnancy|0|||
42221007|NCT04578535|76039479|FG004|Overall Study|Pregnancy|0|||
42221008|NCT04578535|76039480|FG005|Overall Study|Pregnancy|0|||
42221009|NCT04578535|76039475|FG000|Overall Study|Withdrawal by Subject|0|||
42221010|NCT04578535|76039476|FG001|Overall Study|Withdrawal by Subject|0|||
42221011|NCT04578535|76039477|FG002|Overall Study|Withdrawal by Subject|0|||
42221012|NCT04578535|76039478|FG003|Overall Study|Withdrawal by Subject|1|||
42221013|NCT04578535|76039479|FG004|Overall Study|Withdrawal by Subject|1|||
42221014|NCT04578535|76039480|FG005|Overall Study|Withdrawal by Subject|5|||
42221015|NCT04578535|76039475|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
42221016|NCT04578535|76039476|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
42221017|NCT04578535|76039477|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
42221018|NCT04578535|76039478|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
42221019|NCT04578535|76039479|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
42221020|NCT04578535|76039480|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
42221021|NCT04574362|76039500|FG000|Overall Study|Other|0|||
42221022|NCT04574362|76039501|FG001|Overall Study|Other|5|||
42221023|NCT04574362|76039500|FG000|Overall Study|COVID-19|0|||
42221024|NCT04574362|76039501|FG001|Overall Study|COVID-19|1|||
42221025|NCT04574362|76039500|FG000|Overall Study|Adverse Event|1|||
42221026|NCT04574362|76039501|FG001|Overall Study|Adverse Event|1|||
42221027|NCT04574362|76039500|FG000|Overall Study|Withdrawal by Subject|2|||
42221028|NCT04574362|76039501|FG001|Overall Study|Withdrawal by Subject|4|||
42221029|NCT04574362|76039500|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
42221030|NCT04574362|76039501|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
42221031|NCT04574362|76039500|FG000|Overall Study|Participant refused to come to the hospital|1|||
42221032|NCT04574362|76039501|FG001|Overall Study|Participant refused to come to the hospital|0|||
42221033|NCT04574362|76039500|FG000|Overall Study|Participant refused the visit|1|||
42221034|NCT04574362|76039501|FG001|Overall Study|Participant refused the visit|0|||
42221035|NCT04574362|76039500|FG000|Overall Study|Participant quit early because of business trip|1|||
42221036|NCT04574362|76039501|FG001|Overall Study|Participant quit early because of business trip|0|||
42221037|NCT04470908|76039507|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
42221038|NCT04399837|76039521|FG000|Overall Study|Other than listed|0|||
42221039|NCT04399837|76039522|FG001|Overall Study|Other than listed|2|||
42221040|NCT04399837|76039523|FG002|Overall Study|Other than listed|2|||
42221041|NCT04399837|76039524|FG003|Overall Study|Other than listed|3|||
42221042|NCT04399837|76039521|FG000|Overall Study|Withdrawal by Subject|1|||
42221043|NCT04399837|76039522|FG001|Overall Study|Withdrawal by Subject|2|||
42221044|NCT04399837|76039523|FG002|Overall Study|Withdrawal by Subject|1|||
42221045|NCT04399837|76039524|FG003|Overall Study|Withdrawal by Subject|1|||
42221046|NCT04364269|76039547|FG000|Overall Study|Adverse Event|1|||
42221047|NCT04364269|76039548|FG001|Overall Study|Adverse Event|0|||
42221048|NCT04364269|76039549|FG002|Overall Study|Adverse Event|0|||
42221049|NCT04364269|76039547|FG000|Overall Study|Withdrawal by Subject|0|||
42221050|NCT04364269|76039548|FG001|Overall Study|Withdrawal by Subject|1|||
42221051|NCT04364269|76039549|FG002|Overall Study|Withdrawal by Subject|0|||
42221052|NCT04299048|76039557|FG000|Overall Study|Death|1|||
42221053|NCT04299048|76039557|FG000|Overall Study|Global deterioration of health status|2|||
42221054|NCT04299048|76039557|FG000|Overall Study|Enrolled and not treated|1|||
42221055|NCT04152200|76039563|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
42221056|NCT04152200|76039564|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
42221057|NCT03905694|76039598|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
41982879|NCT02305238|75789115|FG002|Overall Study|Physician Decision|0|||
42130853|NCT02877134|75941847|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
42130854|NCT02877134|75941848|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
42130855|NCT02877134|75941849|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
42130856|NCT02877134|75941850|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
42130857|NCT02877134|75941851|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
42130858|NCT02877134|75941852|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
42130859|NCT02877134|75941853|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
42130860|NCT02877134|75941842|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
42130861|NCT02877134|75941843|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
42221058|NCT03681184|76039604|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
41982880|NCT02305238|75789113|FG000|Overall Study|Adverse Event|4|||
41982881|NCT02305238|75789114|FG001|Overall Study|Adverse Event|2|||
41982882|NCT02305238|75789115|FG002|Overall Study|Adverse Event|0|||
41982883|NCT02305238|75789113|FG000|Overall Study|Withdrawal by Subject|3|||
41982884|NCT02305238|75789114|FG001|Overall Study|Withdrawal by Subject|4|||
41982885|NCT02305238|75789115|FG002|Overall Study|Withdrawal by Subject|0|||
42221059|NCT03681184|76039605|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
42221060|NCT03681184|76039604|FG000|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|12|||
42221061|NCT03681184|76039605|FG001|3-Month Blinded Extension Period|Remained in this Period at Time of Data Cut|23|||
42221062|NCT03681184|76039604|FG000|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
42221063|NCT03681184|76039605|FG001|Open-Label Extension Period|Remained in this Period at Time of Data Cut|1|||
42221064|NCT03673462|76039613|FG000|Overall Study|Adverse Event|11|||
42221065|NCT03673462|76039614|FG001|Overall Study|Adverse Event|1|||
42221066|NCT03673462|76039613|FG000|Overall Study|Protocol Violation|25|||
42221067|NCT03673462|76039614|FG001|Overall Study|Protocol Violation|11|||
42221068|NCT03673462|76039613|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
42221069|NCT03673462|76039614|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
42221070|NCT03673462|76039613|FG000|Overall Study|Lost to Follow-up|102|||
42221071|NCT03673462|76039614|FG001|Overall Study|Lost to Follow-up|19|||
42221072|NCT03432364|76039623|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
42221073|NCT03307785|76039639|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
42221074|NCT03307785|76039640|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
42221075|NCT03307785|76039641|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
42221076|NCT03307785|76039642|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
42221077|NCT03307785|76039643|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
42221078|NCT03307785|76039644|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
42221079|NCT03307785|76039645|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
42221080|NCT03307785|76039646|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
42221081|NCT03307785|76039647|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
42221082|NCT03307785|76039648|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
42221083|NCT03307785|76039649|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
42221084|NCT03307785|76039639|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
42221085|NCT03307785|76039640|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
42221086|NCT03307785|76039641|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
42221087|NCT03307785|76039642|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
42221088|NCT03307785|76039643|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
42221089|NCT03307785|76039644|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
42221090|NCT03307785|76039645|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
42221091|NCT03307785|76039646|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
42221092|NCT03307785|76039647|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
42221093|NCT03307785|76039648|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
42221094|NCT03307785|76039649|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
42221095|NCT03307785|76039639|FG000|Part A: Up to 28.5 Months|Death|4|||
42221096|NCT03307785|76039640|FG001|Part A: Up to 28.5 Months|Death|4|||
42221097|NCT03307785|76039641|FG002|Part A: Up to 28.5 Months|Death|0|||
42221098|NCT03307785|76039642|FG003|Part A: Up to 28.5 Months|Death|0|||
42221099|NCT03307785|76039643|FG004|Part A: Up to 28.5 Months|Death|0|||
42221100|NCT03307785|76039644|FG005|Part A: Up to 28.5 Months|Death|0|||
42221101|NCT03307785|76039645|FG006|Part A: Up to 28.5 Months|Death|0|||
42221102|NCT03307785|76039646|FG007|Part A: Up to 28.5 Months|Death|0|||
42221103|NCT03307785|76039647|FG008|Part A: Up to 28.5 Months|Death|0|||
42221104|NCT03307785|76039648|FG009|Part A: Up to 28.5 Months|Death|0|||
42221105|NCT03307785|76039649|FG010|Part A: Up to 28.5 Months|Death|0|||
42221106|NCT03307785|76039639|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
42221107|NCT03307785|76039640|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
42221108|NCT03307785|76039641|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
42221109|NCT03307785|76039642|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
42221110|NCT03307785|76039643|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
42221111|NCT03307785|76039644|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
42221112|NCT03307785|76039645|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
42029694|NCT01210352|75838126|FG004|Overall Study|Physician Decision|0|||
42130862|NCT02877134|75941844|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
42130863|NCT02877134|75941845|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
42130864|NCT02877134|75941846|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
42130865|NCT02877134|75941847|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
42130866|NCT02877134|75941848|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
42130867|NCT02877134|75941849|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
42221113|NCT03307785|76039646|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
42221114|NCT03307785|76039647|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
42221115|NCT03307785|76039648|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
42221116|NCT03307785|76039649|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
42029695|NCT01210352|75838127|FG005|Overall Study|Physician Decision|0|||
42130868|NCT02877134|75941850|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
42221117|NCT03307785|76039639|FG000|Part B: Up to 28.5 Months|Disease progression|0|||
42221118|NCT03307785|76039640|FG001|Part B: Up to 28.5 Months|Disease progression|0|||
42221119|NCT03307785|76039641|FG002|Part B: Up to 28.5 Months|Disease progression|1|||
42221120|NCT03307785|76039642|FG003|Part B: Up to 28.5 Months|Disease progression|0|||
42221121|NCT03307785|76039643|FG004|Part B: Up to 28.5 Months|Disease progression|0|||
42221122|NCT03307785|76039644|FG005|Part B: Up to 28.5 Months|Disease progression|0|||
42221123|NCT03307785|76039645|FG006|Part B: Up to 28.5 Months|Disease progression|0|||
42221124|NCT03307785|76039646|FG007|Part B: Up to 28.5 Months|Disease progression|0|||
42221125|NCT03307785|76039647|FG008|Part B: Up to 28.5 Months|Disease progression|0|||
42221126|NCT03307785|76039648|FG009|Part B: Up to 28.5 Months|Disease progression|0|||
42221127|NCT03307785|76039649|FG010|Part B: Up to 28.5 Months|Disease progression|0|||
42221128|NCT03307785|76039639|FG000|Part B: Up to 28.5 Months|Physician Decision|0|||
42221129|NCT03307785|76039640|FG001|Part B: Up to 28.5 Months|Physician Decision|0|||
42221130|NCT03307785|76039641|FG002|Part B: Up to 28.5 Months|Physician Decision|1|||
42221131|NCT03307785|76039642|FG003|Part B: Up to 28.5 Months|Physician Decision|0|||
42221132|NCT03307785|76039643|FG004|Part B: Up to 28.5 Months|Physician Decision|0|||
42221133|NCT03307785|76039644|FG005|Part B: Up to 28.5 Months|Physician Decision|0|||
42221134|NCT03307785|76039645|FG006|Part B: Up to 28.5 Months|Physician Decision|0|||
42221135|NCT03307785|76039646|FG007|Part B: Up to 28.5 Months|Physician Decision|0|||
42221136|NCT03307785|76039647|FG008|Part B: Up to 28.5 Months|Physician Decision|0|||
42221137|NCT03307785|76039648|FG009|Part B: Up to 28.5 Months|Physician Decision|0|||
42221138|NCT03307785|76039649|FG010|Part B: Up to 28.5 Months|Physician Decision|0|||
42221139|NCT03307785|76039639|FG000|Part B: Up to 28.5 Months|Death|0|||
42221140|NCT03307785|76039640|FG001|Part B: Up to 28.5 Months|Death|0|||
42221141|NCT03307785|76039641|FG002|Part B: Up to 28.5 Months|Death|7|||
42221142|NCT03307785|76039642|FG003|Part B: Up to 28.5 Months|Death|0|||
42221143|NCT03307785|76039643|FG004|Part B: Up to 28.5 Months|Death|0|||
42221144|NCT03307785|76039644|FG005|Part B: Up to 28.5 Months|Death|0|||
42221145|NCT03307785|76039645|FG006|Part B: Up to 28.5 Months|Death|0|||
42221146|NCT03307785|76039646|FG007|Part B: Up to 28.5 Months|Death|0|||
42221147|NCT03307785|76039647|FG008|Part B: Up to 28.5 Months|Death|0|||
42221148|NCT03307785|76039648|FG009|Part B: Up to 28.5 Months|Death|0|||
42221149|NCT03307785|76039649|FG010|Part B: Up to 28.5 Months|Death|0|||
42221150|NCT03307785|76039639|FG000|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
42221151|NCT03307785|76039640|FG001|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
42221152|NCT03307785|76039641|FG002|Part B: Up to 28.5 Months|Withdrawal by Subject|1|||
42221153|NCT03307785|76039642|FG003|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
42221154|NCT03307785|76039643|FG004|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
42221155|NCT03307785|76039644|FG005|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
42221156|NCT03307785|76039645|FG006|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
42221157|NCT03307785|76039646|FG007|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
42221158|NCT03307785|76039647|FG008|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
42221159|NCT03307785|76039648|FG009|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
42221160|NCT03307785|76039649|FG010|Part B: Up to 28.5 Months|Withdrawal by Subject|0|||
42221161|NCT03307785|76039639|FG000|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
42029696|NCT01210352|75838128|FG006|Overall Study|Physician Decision|0|||
42029697|NCT01210352|75838129|FG007|Overall Study|Physician Decision|1|||
42221162|NCT03307785|76039640|FG001|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
42221163|NCT03307785|76039641|FG002|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|4|||
42221164|NCT03307785|76039642|FG003|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
42221165|NCT03307785|76039643|FG004|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
42221166|NCT03307785|76039644|FG005|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
42221167|NCT03307785|76039645|FG006|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
42221168|NCT03307785|76039646|FG007|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
42221169|NCT03307785|76039647|FG008|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
42221170|NCT03307785|76039648|FG009|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
42221171|NCT03307785|76039649|FG010|Part B: Up to 28.5 Months|Ongoing With Treatment in the Study|0|||
42221172|NCT03307785|76039639|FG000|Part C: Up to 22.5 Months|Disease progression|0|||
42221173|NCT03307785|76039640|FG001|Part C: Up to 22.5 Months|Disease progression|0|||
42221174|NCT03307785|76039641|FG002|Part C: Up to 22.5 Months|Disease progression|0|||
42221175|NCT03307785|76039642|FG003|Part C: Up to 22.5 Months|Disease progression|0|||
42221176|NCT03307785|76039643|FG004|Part C: Up to 22.5 Months|Disease progression|1|||
42221177|NCT03307785|76039644|FG005|Part C: Up to 22.5 Months|Disease progression|0|||
42029698|NCT01210352|75838130|FG008|Overall Study|Physician Decision|2|||
42029699|NCT01210352|75838122|FG000|Overall Study|Withdrawal by Subject|0|||
42029700|NCT01210352|75838123|FG001|Overall Study|Withdrawal by Subject|0|||
42029701|NCT01210352|75838124|FG002|Overall Study|Withdrawal by Subject|1|||
42029702|NCT01210352|75838125|FG003|Overall Study|Withdrawal by Subject|0|||
42029703|NCT01210352|75838126|FG004|Overall Study|Withdrawal by Subject|0|||
42029704|NCT01210352|75838127|FG005|Overall Study|Withdrawal by Subject|0|||
42221178|NCT03307785|76039645|FG006|Part C: Up to 22.5 Months|Disease progression|0|||
42221179|NCT03307785|76039646|FG007|Part C: Up to 22.5 Months|Disease progression|0|||
42221180|NCT03307785|76039647|FG008|Part C: Up to 22.5 Months|Disease progression|0|||
42221181|NCT03307785|76039648|FG009|Part C: Up to 22.5 Months|Disease progression|0|||
42221182|NCT03307785|76039649|FG010|Part C: Up to 22.5 Months|Disease progression|0|||
42221183|NCT03307785|76039639|FG000|Part C: Up to 22.5 Months|Physician Decision|0|||
42221184|NCT03307785|76039640|FG001|Part C: Up to 22.5 Months|Physician Decision|0|||
42221185|NCT03307785|76039641|FG002|Part C: Up to 22.5 Months|Physician Decision|0|||
42221186|NCT03307785|76039642|FG003|Part C: Up to 22.5 Months|Physician Decision|3|||
42221187|NCT03307785|76039643|FG004|Part C: Up to 22.5 Months|Physician Decision|1|||
42221188|NCT03307785|76039644|FG005|Part C: Up to 22.5 Months|Physician Decision|0|||
42221189|NCT03307785|76039645|FG006|Part C: Up to 22.5 Months|Physician Decision|0|||
42221190|NCT03307785|76039646|FG007|Part C: Up to 22.5 Months|Physician Decision|0|||
42221191|NCT03307785|76039647|FG008|Part C: Up to 22.5 Months|Physician Decision|0|||
42221192|NCT03307785|76039648|FG009|Part C: Up to 22.5 Months|Physician Decision|0|||
42221193|NCT03307785|76039649|FG010|Part C: Up to 22.5 Months|Physician Decision|0|||
42221194|NCT03307785|76039639|FG000|Part C: Up to 22.5 Months|Death|0|||
42221195|NCT03307785|76039640|FG001|Part C: Up to 22.5 Months|Death|0|||
42221196|NCT03307785|76039641|FG002|Part C: Up to 22.5 Months|Death|0|||
42221197|NCT03307785|76039642|FG003|Part C: Up to 22.5 Months|Death|1|||
42221198|NCT03307785|76039643|FG004|Part C: Up to 22.5 Months|Death|4|||
42221199|NCT03307785|76039644|FG005|Part C: Up to 22.5 Months|Death|0|||
42221200|NCT03307785|76039645|FG006|Part C: Up to 22.5 Months|Death|0|||
42221201|NCT03307785|76039646|FG007|Part C: Up to 22.5 Months|Death|0|||
42221202|NCT03307785|76039647|FG008|Part C: Up to 22.5 Months|Death|0|||
42221203|NCT03307785|76039648|FG009|Part C: Up to 22.5 Months|Death|0|||
42221204|NCT03307785|76039649|FG010|Part C: Up to 22.5 Months|Death|0|||
42221205|NCT03307785|76039639|FG000|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
42221206|NCT03307785|76039640|FG001|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
42221207|NCT03307785|76039641|FG002|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
42221208|NCT03307785|76039642|FG003|Part C: Up to 22.5 Months|Withdrawal by Subject|1|||
42221209|NCT03307785|76039643|FG004|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
42221210|NCT03307785|76039644|FG005|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
42221211|NCT03307785|76039645|FG006|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
42221212|NCT03307785|76039646|FG007|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
42221213|NCT03307785|76039647|FG008|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
42221214|NCT03307785|76039648|FG009|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
42221215|NCT03307785|76039649|FG010|Part C: Up to 22.5 Months|Withdrawal by Subject|0|||
42221216|NCT03307785|76039639|FG000|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
42221217|NCT03307785|76039640|FG001|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
42221218|NCT03307785|76039641|FG002|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
42221219|NCT03307785|76039642|FG003|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
42221220|NCT03307785|76039643|FG004|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|1|||
42221221|NCT03307785|76039644|FG005|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
42221222|NCT03307785|76039645|FG006|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
42221223|NCT03307785|76039646|FG007|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
42221224|NCT03307785|76039647|FG008|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
42221225|NCT03307785|76039648|FG009|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
42221226|NCT03307785|76039649|FG010|Part C: Up to 22.5 Months|Ongoing With Treatment in the Study|0|||
42221227|NCT03307785|76039639|FG000|Part D: Up to 9.5 Months|Physician Decision|0|||
41982886|NCT02305238|75789113|FG000|Overall Study|Randomized failure|0|||
41982887|NCT02305238|75789114|FG001|Overall Study|Randomized failure|0|||
41982888|NCT02305238|75789115|FG002|Overall Study|Randomized failure|8|||
41982889|NCT02305238|75789113|FG000|Overall Study|Required procedure failed|0|||
41982890|NCT02305238|75789114|FG001|Overall Study|Required procedure failed|1|||
41982891|NCT02305238|75789115|FG002|Overall Study|Required procedure failed|0|||
41982892|NCT02175004|75789124|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
41982893|NCT02175004|75789125|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
41982894|NCT02175004|75789124|FG000|Overall Study|Investigator Judgment|1|||
41982895|NCT02175004|75789125|FG001|Overall Study|Investigator Judgment|4|||
41982896|NCT02175004|75789124|FG000|Overall Study|Voluntary Withdrawal|6|||
41982897|NCT02175004|75789125|FG001|Overall Study|Voluntary Withdrawal|19|||
41982898|NCT02175004|75789124|FG000|Overall Study|Liver Transplant|1|||
42029705|NCT01210352|75838128|FG006|Overall Study|Withdrawal by Subject|1|||
42221228|NCT03307785|76039640|FG001|Part D: Up to 9.5 Months|Physician Decision|0|||
42221229|NCT03307785|76039641|FG002|Part D: Up to 9.5 Months|Physician Decision|0|||
42221230|NCT03307785|76039642|FG003|Part D: Up to 9.5 Months|Physician Decision|0|||
42221231|NCT03307785|76039643|FG004|Part D: Up to 9.5 Months|Physician Decision|0|||
42221232|NCT03307785|76039644|FG005|Part D: Up to 9.5 Months|Physician Decision|1|||
42221233|NCT03307785|76039645|FG006|Part D: Up to 9.5 Months|Physician Decision|0|||
42221234|NCT03307785|76039646|FG007|Part D: Up to 9.5 Months|Physician Decision|0|||
42221235|NCT03307785|76039647|FG008|Part D: Up to 9.5 Months|Physician Decision|0|||
42221236|NCT03307785|76039648|FG009|Part D: Up to 9.5 Months|Physician Decision|0|||
42221237|NCT03307785|76039649|FG010|Part D: Up to 9.5 Months|Physician Decision|0|||
42221238|NCT03307785|76039639|FG000|Part D: Up to 9.5 Months|Death|0|||
42221239|NCT03307785|76039640|FG001|Part D: Up to 9.5 Months|Death|0|||
42221240|NCT03307785|76039641|FG002|Part D: Up to 9.5 Months|Death|0|||
42221241|NCT03307785|76039642|FG003|Part D: Up to 9.5 Months|Death|0|||
42221242|NCT03307785|76039643|FG004|Part D: Up to 9.5 Months|Death|0|||
42221243|NCT03307785|76039644|FG005|Part D: Up to 9.5 Months|Death|1|||
42221244|NCT03307785|76039645|FG006|Part D: Up to 9.5 Months|Death|0|||
42221245|NCT03307785|76039646|FG007|Part D: Up to 9.5 Months|Death|0|||
42221246|NCT03307785|76039647|FG008|Part D: Up to 9.5 Months|Death|0|||
42221247|NCT03307785|76039648|FG009|Part D: Up to 9.5 Months|Death|0|||
42221248|NCT03307785|76039649|FG010|Part D: Up to 9.5 Months|Death|0|||
42221249|NCT03307785|76039639|FG000|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
42221250|NCT03307785|76039640|FG001|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
42221251|NCT03307785|76039641|FG002|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
42221252|NCT03307785|76039642|FG003|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
42221253|NCT03307785|76039643|FG004|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
42221254|NCT03307785|76039644|FG005|Part D: Up to 9.5 Months|Withdrawal by Subject|1|||
42221255|NCT03307785|76039645|FG006|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
42221256|NCT03307785|76039646|FG007|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
42221257|NCT03307785|76039647|FG008|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
42221258|NCT03307785|76039648|FG009|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
42221259|NCT03307785|76039649|FG010|Part D: Up to 9.5 Months|Withdrawal by Subject|0|||
42221260|NCT03307785|76039639|FG000|Part E: Up to 4.4 Months|Death|0|||
42221261|NCT03307785|76039640|FG001|Part E: Up to 4.4 Months|Death|0|||
42221262|NCT03307785|76039641|FG002|Part E: Up to 4.4 Months|Death|0|||
42221263|NCT03307785|76039642|FG003|Part E: Up to 4.4 Months|Death|0|||
42221264|NCT03307785|76039643|FG004|Part E: Up to 4.4 Months|Death|0|||
42221265|NCT03307785|76039644|FG005|Part E: Up to 4.4 Months|Death|0|||
42221266|NCT03307785|76039645|FG006|Part E: Up to 4.4 Months|Death|1|||
42221267|NCT03307785|76039646|FG007|Part E: Up to 4.4 Months|Death|0|||
42221268|NCT03307785|76039647|FG008|Part E: Up to 4.4 Months|Death|0|||
42221269|NCT03307785|76039648|FG009|Part E: Up to 4.4 Months|Death|0|||
42221270|NCT03307785|76039649|FG010|Part E: Up to 4.4 Months|Death|0|||
42221271|NCT03307785|76039639|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
42221272|NCT03307785|76039640|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
42221273|NCT03307785|76039641|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
42221274|NCT03307785|76039642|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
42221275|NCT03307785|76039643|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
42221276|NCT03307785|76039644|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
42221277|NCT03307785|76039645|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
42221278|NCT03307785|76039646|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
42221279|NCT03307785|76039647|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
42221280|NCT03307785|76039648|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
42221281|NCT03307785|76039649|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
41982899|NCT02175004|75789125|FG001|Overall Study|Liver Transplant|0|||
41982900|NCT02175004|75789124|FG000|Overall Study|Disease Progression|1|||
41982901|NCT02175004|75789125|FG001|Overall Study|Disease Progression|0|||
42221282|NCT03307785|76039639|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
42221283|NCT03307785|76039640|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
42221284|NCT03307785|76039641|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
42221285|NCT03307785|76039642|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
42221286|NCT03307785|76039643|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
41982902|NCT02175004|75789124|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
42130869|NCT02877134|75941851|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
42130870|NCT02877134|75941852|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
42130871|NCT02877134|75941853|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
42130872|NCT02877134|75941842|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
42130873|NCT02877134|75941843|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
42130874|NCT02877134|75941844|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
42130875|NCT02877134|75941845|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
42221287|NCT03307785|76039644|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
41982903|NCT02175004|75789125|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
42221288|NCT03307785|76039645|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
42221289|NCT03307785|76039646|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
42221290|NCT03307785|76039647|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
42221291|NCT03307785|76039648|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
42221292|NCT03307785|76039649|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
42221293|NCT03199040|76039672|FG000|Overall Study|Lack of Efficacy|2|||
42221294|NCT03199040|76039673|FG001|Overall Study|Lack of Efficacy|0|||
42221295|NCT03199040|76039672|FG000|Overall Study|Withdrawal by Subject|2|||
42221296|NCT03199040|76039673|FG001|Overall Study|Withdrawal by Subject|0|||
42221297|NCT03199040|76039672|FG000|Overall Study|Adverse Event|0|||
42221298|NCT03199040|76039673|FG001|Overall Study|Adverse Event|1|||
42221299|NCT03072238|76039681|FG000|Overall Study|Withdrawal by Subject|30|||
42221300|NCT03072238|76039682|FG001|Overall Study|Withdrawal by Subject|51|||
42221301|NCT03072238|76039681|FG000|Overall Study|Lost to Follow-up|7|||
42221302|NCT03072238|76039682|FG001|Overall Study|Lost to Follow-up|4|||
42221303|NCT03072238|76039681|FG000|Overall Study|Physician Decision|1|||
42221304|NCT03072238|76039682|FG001|Overall Study|Physician Decision|3|||
42221305|NCT03072238|76039681|FG000|Overall Study|Death|139|||
42221306|NCT03072238|76039682|FG001|Overall Study|Death|121|||
42221307|NCT03072238|76039681|FG000|Overall Study|Other|0|||
42221308|NCT03072238|76039682|FG001|Overall Study|Other|1|||
42221309|NCT03072238|76039681|FG000|Overall Study|Ongoing on study|377|||
42221310|NCT03072238|76039682|FG001|Overall Study|Ongoing on study|367|||
42221311|NCT02970318|76039691|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
42221312|NCT02970318|76039692|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
42221313|NCT02970318|76039693|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
42221314|NCT02970318|76039694|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
42221315|NCT02970318|76039691|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
42221316|NCT02970318|76039692|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
42221317|NCT02970318|76039693|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
42221318|NCT02970318|76039694|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
42221319|NCT02970318|76039691|FG000|Overall for Arm A & Main for Arm B|Death|41|||
42221320|NCT02970318|76039692|FG001|Overall for Arm A & Main for Arm B|Death|33|||
42221321|NCT02970318|76039693|FG002|Overall for Arm A & Main for Arm B|Death|0|||
42221322|NCT02970318|76039694|FG003|Overall for Arm A & Main for Arm B|Death|0|||
42221323|NCT02970318|76039691|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
42221324|NCT02970318|76039692|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
42221325|NCT02970318|76039693|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
42221326|NCT02970318|76039694|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
42221327|NCT02970318|76039691|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
42221328|NCT02970318|76039692|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
42130876|NCT02877134|75941846|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
42130877|NCT02877134|75941847|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
42130878|NCT02877134|75941848|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
42130879|NCT02877134|75941849|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
42221329|NCT02970318|76039693|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
42221330|NCT02970318|76039694|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
42130880|NCT02877134|75941850|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
42130881|NCT02877134|75941851|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
42130882|NCT02877134|75941852|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
42221331|NCT02970318|76039691|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
42221332|NCT02970318|76039692|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
42221333|NCT02970318|76039693|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
42221334|NCT02970318|76039694|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
42221335|NCT02970318|76039691|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
42221336|NCT02970318|76039692|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
42221337|NCT02970318|76039693|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
42221338|NCT02970318|76039694|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
42221339|NCT02408549|76039828|FG000|Overall Study|Adverse Event|15|||
42221340|NCT02408549|76039828|FG000|Overall Study|Death|4|||
42221341|NCT02408549|76039828|FG000|Overall Study|Lack of Efficacy|17|||
42221342|NCT02408549|76039828|FG000|Overall Study|Protocol Violation|4|||
41982904|NCT02075840|75789133|FG000|Overall Study|Withdrawal by Subject|13|||
41982905|NCT02075840|75789134|FG001|Overall Study|Withdrawal by Subject|22|||
41982906|NCT02075840|75789133|FG000|Overall Study|Reason not specified|1|||
41982907|NCT02075840|75789134|FG001|Overall Study|Reason not specified|0|||
41982908|NCT02075840|75789133|FG000|Overall Study|Adverse Event|0|||
41982909|NCT02075840|75789134|FG001|Overall Study|Adverse Event|2|||
41982910|NCT02075840|75789133|FG000|Overall Study|Death|35|||
41982911|NCT02075840|75789134|FG001|Overall Study|Death|40|||
41982912|NCT02075840|75789133|FG000|Overall Study|Lost to Follow-up|3|||
41982913|NCT02075840|75789134|FG001|Overall Study|Lost to Follow-up|2|||
41982914|NCT02075840|75789133|FG000|Overall Study|Physician Decision|1|||
42221343|NCT02408549|76039828|FG000|Overall Study|Lost to Follow-up|6|||
42221344|NCT02408549|76039828|FG000|Overall Study|Consent withdrawn|30|||
42221345|NCT02408549|76039828|FG000|Overall Study|Neurology research program closing at site|1|||
42221346|NCT02408549|76039828|FG000|Overall Study|Site closure|1|||
42221347|NCT02408549|76039828|FG000|Overall Study|Pregnancy|1|||
42029706|NCT01210352|75838129|FG007|Overall Study|Withdrawal by Subject|0|||
42130883|NCT02877134|75941853|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
42130884|NCT02877134|75941842|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
42221348|NCT02408549|76039828|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
42221349|NCT02408549|76039828|FG000|Overall Study|Subject moved to another place, far from site|1|||
42221350|NCT02408549|76039828|FG000|Overall Study|Study terminated at site|1|||
42221351|NCT02242942|76039835|FG000|Overall Study|Death|17|||
42221352|NCT02242942|76039836|FG001|Overall Study|Death|20|||
42221353|NCT02242942|76039837|FG002|Overall Study|Death|2|||
42221354|NCT02242942|76039835|FG000|Overall Study|Physician Decision|1|||
42221355|NCT02242942|76039836|FG001|Overall Study|Physician Decision|0|||
42221356|NCT02242942|76039837|FG002|Overall Study|Physician Decision|0|||
42221357|NCT02242942|76039835|FG000|Overall Study|Withdrawal by Subject|8|||
42221358|NCT02242942|76039836|FG001|Overall Study|Withdrawal by Subject|10|||
42221359|NCT02242942|76039837|FG002|Overall Study|Withdrawal by Subject|0|||
42221360|NCT02242942|76039835|FG000|Overall Study|On-going in Study|190|||
42221361|NCT02242942|76039836|FG001|Overall Study|On-going in Study|186|||
42221362|NCT02242942|76039837|FG002|Overall Study|On-going in Study|11|||
42221363|NCT01523002|76039858|FG000|Period 1|Withdrawal by Subject|1|||
42221364|NCT01523002|76039859|FG001|Period 1|Withdrawal by Subject|3|||
42221365|NCT01523002|76039858|FG000|Period 1|Lost to Follow-up|1|||
42221366|NCT01523002|76039859|FG001|Period 1|Lost to Follow-up|0|||
42221367|NCT01523002|76039858|FG000|Period 1|Adverse Event|0|||
42221368|NCT01523002|76039859|FG001|Period 1|Adverse Event|8|||
42221369|NCT01523002|76039858|FG000|Period 2|Withdrawal by Subject|4|||
42221370|NCT01523002|76039859|FG001|Period 2|Withdrawal by Subject|1|||
42221371|NCT01523002|76039858|FG000|Period 2|Adverse Event|2|||
42221372|NCT01523002|76039859|FG001|Period 2|Adverse Event|5|||
42221373|NCT01523002|76039858|FG000|Period 3|Withdrawal by Subject|1|||
42221374|NCT01523002|76039859|FG001|Period 3|Withdrawal by Subject|0|||
42221375|NCT01523002|76039858|FG000|Period 3|Adverse Event|3|||
42221376|NCT01523002|76039859|FG001|Period 3|Adverse Event|0|||
42221377|NCT00489307|76039867|FG000|Overall Study|Death|1|||
42221378|NCT00489307|76039868|FG001|Overall Study|Death|1|||
42221379|NCT00489307|76039867|FG000|Overall Study|Lost to Follow-up|2|||
42221380|NCT00489307|76039868|FG001|Overall Study|Lost to Follow-up|2|||
42221381|NCT00489307|76039867|FG000|Overall Study|Physician Decision|1|||
42221382|NCT00489307|76039868|FG001|Overall Study|Physician Decision|0|||
42221383|NCT00489307|76039867|FG000|Overall Study|Withdrawal by Subject|2|||
42221384|NCT00489307|76039868|FG001|Overall Study|Withdrawal by Subject|4|||
42221385|NCT00489307|76039867|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
42221386|NCT00489307|76039868|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
42221387|NCT00489307|76039867|FG000|Overall Study|Surgery after assignment|1|||
42221388|NCT00489307|76039868|FG001|Overall Study|Surgery after assignment|0|||
41982915|NCT02075840|75789134|FG001|Overall Study|Physician Decision|3|||
41982916|NCT02075840|75789133|FG000|Overall Study|Ongoing at CCOD|99|||
41982917|NCT02075840|75789134|FG001|Overall Study|Ongoing at CCOD|82|||
41982918|NCT01059825|75789146|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
41982919|NCT01059825|75789147|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
42130885|NCT02877134|75941843|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
42130886|NCT02877134|75941844|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
42130887|NCT02877134|75941845|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
41982920|NCT01059825|75789148|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
41982921|NCT01059825|75789149|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
41982922|NCT01059825|75789150|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
42130888|NCT02877134|75941846|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
41982923|NCT01059825|75789151|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
42130889|NCT02877134|75941847|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
42130890|NCT02877134|75941848|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
42130891|NCT02877134|75941849|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
42130892|NCT02877134|75941850|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
42130893|NCT02877134|75941851|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
42130894|NCT02877134|75941852|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
42130895|NCT02877134|75941853|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
42221389|NCT00489307|76039867|FG000|Overall Study|Did not fill up the forms|2|||
42221390|NCT00489307|76039868|FG001|Overall Study|Did not fill up the forms|1|||
42221391|NCT00489307|76039867|FG000|Overall Study|Patient or family refusal|5|||
42221392|NCT00489307|76039868|FG001|Overall Study|Patient or family refusal|9|||
42221393|NCT03521141|76039877|FG000|Overall Study|Death|1|||
42221394|NCT03521141|76039878|FG001|Overall Study|Death|0|||
42221395|NCT03521141|76039879|FG002|Overall Study|Death|1|||
42221396|NCT02997176|76039891|FG000|Overall Study|Adverse Event|0|||
42221397|NCT02997176|76039892|FG001|Overall Study|Adverse Event|0|||
42221398|NCT02997176|76039893|FG002|Overall Study|Adverse Event|0|||
42221399|NCT02997176|76039894|FG003|Overall Study|Adverse Event|8|||
42221400|NCT02997176|76039891|FG000|Overall Study|Progressive Disease|1|||
42221401|NCT02997176|76039892|FG001|Overall Study|Progressive Disease|0|||
42221402|NCT02997176|76039893|FG002|Overall Study|Progressive Disease|1|||
42221403|NCT02997176|76039894|FG003|Overall Study|Progressive Disease|1|||
42221404|NCT02997176|76039891|FG000|Overall Study|Death|0|||
42221405|NCT02997176|76039892|FG001|Overall Study|Death|0|||
42221406|NCT02997176|76039893|FG002|Overall Study|Death|1|||
42221407|NCT02997176|76039894|FG003|Overall Study|Death|1|||
42221408|NCT02997176|76039891|FG000|Overall Study|Withdrawal by Subject|0|||
42221409|NCT02997176|76039892|FG001|Overall Study|Withdrawal by Subject|2|||
42221410|NCT02997176|76039893|FG002|Overall Study|Withdrawal by Subject|0|||
42221411|NCT02997176|76039894|FG003|Overall Study|Withdrawal by Subject|1|||
42221412|NCT03000452|76039904|FG000|Treatment Period|Death|1|||
42221413|NCT03000452|76039904|FG000|Treatment Period|Progressive Disease (PD)|14|||
42221414|NCT03000452|76039904|FG000|Treatment Period|Physician Decision|1|||
42221415|NCT03000452|76039904|FG000|Treatment Period|Miscellaneous|2|||
42221416|NCT03000452|76039904|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
42221417|NCT03000452|76039904|FG000|Follow-Up Period|Death|3|||
42221418|NCT03000452|76039904|FG000|Follow-Up Period|Withdrawal by Subject|3|||
42221419|NCT01373164|76039913|FG000|Overall Study|Lost to Follow-up|0|||
42221420|NCT01373164|76039914|FG001|Overall Study|Lost to Follow-up|0|||
42221421|NCT01373164|76039915|FG002|Overall Study|Lost to Follow-up|1|||
42221422|NCT01373164|76039916|FG003|Overall Study|Lost to Follow-up|2|||
42221423|NCT01373164|76039917|FG004|Overall Study|Lost to Follow-up|0|||
42221424|NCT01373164|76039913|FG000|Overall Study|Withdrawal by Subject|0|||
42221425|NCT01373164|76039914|FG001|Overall Study|Withdrawal by Subject|1|||
42221426|NCT01373164|76039915|FG002|Overall Study|Withdrawal by Subject|0|||
42221427|NCT01373164|76039916|FG003|Overall Study|Withdrawal by Subject|10|||
42221428|NCT01373164|76039917|FG004|Overall Study|Withdrawal by Subject|2|||
42221429|NCT02999984|76039932|FG000|Overall Study|Treatment Failure|1|||
42221430|NCT03550313|76039939|FG000|Overall Study|Adverse Event|0|||
42221431|NCT03550313|76039940|FG001|Overall Study|Adverse Event|1|||
42221432|NCT03550313|76039941|FG002|Overall Study|Adverse Event|0|||
42221433|NCT03550313|76039939|FG000|Overall Study|Lost to Follow-up|5|||
42221434|NCT03550313|76039940|FG001|Overall Study|Lost to Follow-up|7|||
42221435|NCT03550313|76039941|FG002|Overall Study|Lost to Follow-up|12|||
42221436|NCT03550313|76039939|FG000|Overall Study|Study terminated by sponsor|44|||
42221437|NCT03550313|76039940|FG001|Overall Study|Study terminated by sponsor|37|||
42221438|NCT03550313|76039941|FG002|Overall Study|Study terminated by sponsor|48|||
42221439|NCT03550313|76039939|FG000|Overall Study|No longer met eligibility criteria|3|||
42221440|NCT03550313|76039940|FG001|Overall Study|No longer met eligibility criteria|5|||
42221441|NCT03550313|76039941|FG002|Overall Study|No longer met eligibility criteria|6|||
42221442|NCT03550313|76039939|FG000|Overall Study|Withdrawal by parent/guardian|20|||
42221443|NCT03550313|76039940|FG001|Overall Study|Withdrawal by parent/guardian|18|||
42221444|NCT03550313|76039941|FG002|Overall Study|Withdrawal by parent/guardian|26|||
42221445|NCT03550313|76039939|FG000|Overall Study|Other|4|||
42221446|NCT03550313|76039940|FG001|Overall Study|Other|2|||
42221447|NCT03550313|76039941|FG002|Overall Study|Other|2|||
42221448|NCT03550313|76039939|FG000|Overall Study|Randomized but not vaccinated|3|||
42221449|NCT03550313|76039940|FG001|Overall Study|Randomized but not vaccinated|23|||
42221450|NCT03550313|76039941|FG002|Overall Study|Randomized but not vaccinated|2|||
42221451|NCT03550313|76039939|FG000|Overall Study|Sites terminated due to quality issues|18|||
42221452|NCT03550313|76039940|FG001|Overall Study|Sites terminated due to quality issues|17|||
42221453|NCT03550313|76039941|FG002|Overall Study|Sites terminated due to quality issues|18|||
42221454|NCT03312907|76039953|FG000|Overall Study|Adverse Event|1|||
42221455|NCT03312907|76039954|FG001|Overall Study|Adverse Event|6|||
42221456|NCT03312907|76039955|FG002|Overall Study|Adverse Event|1|||
42221457|NCT03312907|76039953|FG000|Overall Study|Protocol Violation|2|||
42221458|NCT03312907|76039954|FG001|Overall Study|Protocol Violation|3|||
42221459|NCT03312907|76039955|FG002|Overall Study|Protocol Violation|4|||
42221460|NCT03312907|76039953|FG000|Overall Study|Lost to Follow-up|2|||
42029707|NCT01210352|75838130|FG008|Overall Study|Withdrawal by Subject|1|||
42221461|NCT03312907|76039954|FG001|Overall Study|Lost to Follow-up|3|||
42221462|NCT03312907|76039955|FG002|Overall Study|Lost to Follow-up|2|||
42221463|NCT03312907|76039953|FG000|Overall Study|Physician Decision|3|||
42221464|NCT03312907|76039954|FG001|Overall Study|Physician Decision|4|||
42221465|NCT03312907|76039955|FG002|Overall Study|Physician Decision|2|||
42221466|NCT03312907|76039953|FG000|Overall Study|Withdrawal by Subject|9|||
42221467|NCT03312907|76039954|FG001|Overall Study|Withdrawal by Subject|14|||
42221468|NCT03312907|76039955|FG002|Overall Study|Withdrawal by Subject|10|||
42221469|NCT02999672|76039965|FG000|Overall Study|Death|0|||
42221470|NCT02999672|76039966|FG001|Overall Study|Death|1|||
42221471|NCT02999672|76039965|FG000|Overall Study|Study Terminated by Sponsor|0|||
42221472|NCT02999672|76039966|FG001|Overall Study|Study Terminated by Sponsor|1|||
42221473|NCT02999672|76039965|FG000|Overall Study|Progressive Disease|9|||
42221474|NCT02999672|76039966|FG001|Overall Study|Progressive Disease|5|||
42221475|NCT02999672|76039965|FG000|Overall Study|Adverse Event|4|||
42029708|NCT01210352|75838122|FG000|Overall Study|Patient Discharged Early|0|||
42130896|NCT02877134|75941842|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
42221476|NCT02999672|76039966|FG001|Overall Study|Adverse Event|0|||
42221477|NCT01911676|76039976|FG000|Period 1 of Study|Withdrawal by Subject|4|||
42221478|NCT01911676|76039977|FG001|Period 1 of Study|Withdrawal by Subject|2|||
42221479|NCT01911676|76039978|FG002|Period 1 of Study|Withdrawal by Subject|1|||
42221480|NCT01911676|76039979|FG003|Period 1 of Study|Withdrawal by Subject|2|||
42221481|NCT01911676|76039976|FG000|Period 1 of Study|Physician Decision|2|||
42221482|NCT01911676|76039977|FG001|Period 1 of Study|Physician Decision|0|||
42221483|NCT01911676|76039978|FG002|Period 1 of Study|Physician Decision|0|||
42221484|NCT01911676|76039979|FG003|Period 1 of Study|Physician Decision|1|||
42221485|NCT01911676|76039976|FG000|Period 2 of Study|Physician Decision|2|||
42221486|NCT01911676|76039977|FG001|Period 2 of Study|Physician Decision|0|||
42221487|NCT01911676|76039978|FG002|Period 2 of Study|Physician Decision|0|||
42221488|NCT01911676|76039979|FG003|Period 2 of Study|Physician Decision|1|||
42221489|NCT01911676|76039976|FG000|Period 2 of Study|Lost to Follow-up|0|||
42221490|NCT01911676|76039977|FG001|Period 2 of Study|Lost to Follow-up|0|||
42221491|NCT01911676|76039978|FG002|Period 2 of Study|Lost to Follow-up|0|||
42221492|NCT01911676|76039979|FG003|Period 2 of Study|Lost to Follow-up|1|||
42221493|NCT03573323|76039996|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
42221494|NCT03573323|76039997|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
42221495|NCT03573323|76039996|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
42221496|NCT03573323|76039997|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
42221497|NCT03573323|76039996|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
42221498|NCT03573323|76039997|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
42221499|NCT03573323|76039996|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
42221500|NCT03573323|76039997|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
42221501|NCT03573323|76039996|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
42221502|NCT03573323|76039997|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
42221503|NCT03573323|76039996|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
42221504|NCT03573323|76039997|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
42221505|NCT03573323|76039996|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
42221506|NCT03573323|76039997|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
42221507|NCT03573323|76039996|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
42221508|NCT03573323|76039997|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
42221509|NCT03573323|76039996|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
42221510|NCT03573323|76039997|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
42221511|NCT03573323|76039996|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
42221512|NCT03573323|76039997|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
42221513|NCT03573323|76039996|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
42221514|NCT03573323|76039997|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
42221515|NCT03573323|76039996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
42221516|NCT03573323|76039997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
42221517|NCT03573323|76039996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
42221518|NCT03573323|76039997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
42221519|NCT03573323|76039996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
42221520|NCT03573323|76039997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
42221521|NCT03573323|76039996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
42221522|NCT03573323|76039997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
42221523|NCT03573323|76039996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
42221524|NCT03573323|76039997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
42302258|NCT02349711|76137327|FG001|Overall Study|Withdrawal by Subject|1|||
42130897|NCT02877134|75941843|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
42130898|NCT02877134|75941844|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
42130899|NCT02877134|75941845|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
42130900|NCT02877134|75941846|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
42130901|NCT02877134|75941847|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
42130902|NCT02877134|75941848|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
42130903|NCT02877134|75941849|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
42130904|NCT02877134|75941850|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
42130905|NCT02877134|75941851|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
42130906|NCT02877134|75941852|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
42130907|NCT02877134|75941853|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
42221525|NCT03573323|76039996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
42221526|NCT03573323|76039997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
42221527|NCT03573323|76039996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
42221528|NCT03573323|76039997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
42221529|NCT03573323|76039996|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
42221530|NCT03573323|76039997|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
42221531|NCT03306043|76040023|FG000|Overall Study|Adverse Event|1|||
42221532|NCT03306043|76040023|FG000|Overall Study|Lost to Follow-up|1|||
42221533|NCT03306043|76040023|FG000|Overall Study|Withdrawal by Subject|2|||
42221534|NCT01069172|76040027|FG000|Overall Study|Withdrawal by Subject|1|||
42221535|NCT01069172|76040028|FG001|Overall Study|Withdrawal by Subject|0|||
42221536|NCT02911688|76040037|FG000|Washout|Lost to Follow-up|1|||
42221537|NCT02911688|76040038|FG001|Washout|Lost to Follow-up|1|||
42221538|NCT02911688|76040037|FG000|Washout|Withdrawal by Subject|0|||
42221539|NCT02911688|76040038|FG001|Washout|Withdrawal by Subject|1|||
42221540|NCT02670928|76040048|FG000|Overall Study|Adverse Event|3|||
42221541|NCT02670928|76040049|FG001|Overall Study|Adverse Event|1|||
42221542|NCT02670928|76040048|FG000|Overall Study|Withdrawal by Subject|4|||
42221543|NCT02670928|76040049|FG001|Overall Study|Withdrawal by Subject|0|||
42221544|NCT02670928|76040048|FG000|Overall Study|Lost to Follow-up|1|||
42221545|NCT02670928|76040049|FG001|Overall Study|Lost to Follow-up|0|||
42221546|NCT02670928|76040048|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
42221547|NCT02670928|76040049|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
42221548|NCT03305809|76040059|FG000|Overall Study|Adverse Event|2|||
42221549|NCT03305809|76040060|FG001|Overall Study|Adverse Event|2|||
42221550|NCT03305809|76040061|FG002|Overall Study|Adverse Event|6|||
42221551|NCT03305809|76040062|FG003|Overall Study|Adverse Event|6|||
42221552|NCT03305809|76040059|FG000|Overall Study|Death|0|||
42221553|NCT03305809|76040060|FG001|Overall Study|Death|0|||
42221554|NCT03305809|76040061|FG002|Overall Study|Death|1|||
42221555|NCT03305809|76040062|FG003|Overall Study|Death|1|||
42221556|NCT03305809|76040059|FG000|Overall Study|Lost to Follow-up|1|||
42221557|NCT03305809|76040060|FG001|Overall Study|Lost to Follow-up|2|||
42221558|NCT03305809|76040061|FG002|Overall Study|Lost to Follow-up|0|||
42221559|NCT03305809|76040062|FG003|Overall Study|Lost to Follow-up|0|||
42221560|NCT03305809|76040059|FG000|Overall Study|Sponsor Decision|1|||
42302259|NCT02349711|76137326|FG000|Overall Study|Lost to Follow-up|1|||
41982924|NCT01059825|75789152|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
41982925|NCT01059825|75789146|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
41982926|NCT01059825|75789147|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
41982927|NCT01059825|75789148|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
41982928|NCT01059825|75789149|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
41982929|NCT01059825|75789150|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
41982930|NCT01059825|75789151|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
41982931|NCT01059825|75789152|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
41982932|NCT01059825|75789146|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
41982933|NCT01059825|75789147|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
41982934|NCT01059825|75789148|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
41982935|NCT01059825|75789149|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
41982936|NCT01059825|75789150|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
41982937|NCT01059825|75789151|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
41982938|NCT01059825|75789152|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
41982939|NCT01059825|75789146|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
41982940|NCT01059825|75789147|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
41982941|NCT01059825|75789148|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
41982942|NCT01059825|75789149|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
41982943|NCT01059825|75789150|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
41982944|NCT01059825|75789151|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
41982945|NCT01059825|75789152|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
42221561|NCT03305809|76040060|FG001|Overall Study|Sponsor Decision|0|||
42221562|NCT03305809|76040061|FG002|Overall Study|Sponsor Decision|1|||
42221563|NCT03305809|76040062|FG003|Overall Study|Sponsor Decision|8|||
42221564|NCT03305809|76040059|FG000|Overall Study|Physician Decision|0|||
42221565|NCT03305809|76040060|FG001|Overall Study|Physician Decision|0|||
42221566|NCT03305809|76040061|FG002|Overall Study|Physician Decision|2|||
42221567|NCT03305809|76040062|FG003|Overall Study|Physician Decision|4|||
42221568|NCT03305809|76040059|FG000|Overall Study|Progressive Disease|0|||
42221569|NCT03305809|76040060|FG001|Overall Study|Progressive Disease|0|||
42029709|NCT01210352|75838123|FG001|Overall Study|Patient Discharged Early|0|||
42029710|NCT01210352|75838124|FG002|Overall Study|Patient Discharged Early|1|||
42029711|NCT01210352|75838125|FG003|Overall Study|Patient Discharged Early|0|||
42029712|NCT01210352|75838126|FG004|Overall Study|Patient Discharged Early|0|||
42029713|NCT01210352|75838127|FG005|Overall Study|Patient Discharged Early|0|||
42029714|NCT01210352|75838128|FG006|Overall Study|Patient Discharged Early|0|||
42029715|NCT01210352|75838129|FG007|Overall Study|Patient Discharged Early|0|||
42029716|NCT01210352|75838130|FG008|Overall Study|Patient Discharged Early|0|||
42221570|NCT03305809|76040061|FG002|Overall Study|Progressive Disease|1|||
42221571|NCT03305809|76040062|FG003|Overall Study|Progressive Disease|0|||
42221572|NCT03305809|76040059|FG000|Overall Study|Protocol Violation|1|||
42221573|NCT03305809|76040060|FG001|Overall Study|Protocol Violation|0|||
42221574|NCT03305809|76040061|FG002|Overall Study|Protocol Violation|2|||
42221575|NCT03305809|76040062|FG003|Overall Study|Protocol Violation|3|||
42221576|NCT03305809|76040059|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
42221577|NCT03305809|76040060|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
42221578|NCT03305809|76040061|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
42221579|NCT03305809|76040062|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
42221580|NCT03305809|76040059|FG000|Overall Study|Withdrawal by Subject|2|||
42221581|NCT03305809|76040060|FG001|Overall Study|Withdrawal by Subject|4|||
42221582|NCT03305809|76040061|FG002|Overall Study|Withdrawal by Subject|5|||
42221583|NCT03305809|76040062|FG003|Overall Study|Withdrawal by Subject|2|||
42221584|NCT03305809|76040059|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
42221585|NCT03305809|76040060|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
42221586|NCT03305809|76040061|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
42221587|NCT03305809|76040062|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
42221588|NCT02994056|76040075|FG000|Overall Study|Death|8|||
42221589|NCT02994056|76040075|FG000|Overall Study|Withdrew Consent|1|||
41982946|NCT01059825|75789146|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
41982947|NCT01059825|75789147|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
42221590|NCT03548051|76040094|FG000|Overall Study|Death|1|||
42302260|NCT02349711|76137327|FG001|Overall Study|Lost to Follow-up|1|||
41982948|NCT01059825|75789148|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
41982949|NCT01059825|75789149|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
41982950|NCT01059825|75789150|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
41982951|NCT01059825|75789151|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
41982952|NCT01059825|75789152|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
41982953|NCT01059825|75789146|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
41982954|NCT01059825|75789147|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
41982955|NCT01059825|75789148|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
41982956|NCT01059825|75789149|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
41982957|NCT01059825|75789150|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
42029717|NCT01210118|75838237|FG000|Overall Study|Lost to Follow-up|1|||
42029718|NCT01210118|75838238|FG001|Overall Study|Lost to Follow-up|1|||
42029719|NCT01210118|75838237|FG000|Overall Study|Protocol Violation|1|||
42130908|NCT02877134|75941842|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
42130909|NCT02877134|75941843|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
42130910|NCT02877134|75941844|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
42130911|NCT02877134|75941845|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
42130912|NCT02877134|75941846|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
42130913|NCT02877134|75941847|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
42130914|NCT02877134|75941848|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
42130915|NCT02877134|75941849|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
42130916|NCT02877134|75941850|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
42130917|NCT02877134|75941851|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
42130918|NCT02877134|75941852|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
42130919|NCT02877134|75941853|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
42130920|NCT02877134|75941842|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
42130921|NCT02877134|75941843|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
42130922|NCT02877134|75941844|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
42130923|NCT02877134|75941845|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
42130924|NCT02877134|75941846|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
42130925|NCT02877134|75941847|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
42221591|NCT03548051|76040095|FG001|Overall Study|Death|1|||
42221592|NCT03548051|76040094|FG000|Overall Study|Withdrawal by Subject|1|||
42221593|NCT03548051|76040095|FG001|Overall Study|Withdrawal by Subject|0|||
42221594|NCT03305731|76040101|FG000|Overall Study|Protocol Violation|1|||
42221595|NCT03305575|76040107|FG000|Overall Study|Physician Decision|1|||
42221596|NCT03305575|76040108|FG001|Overall Study|Physician Decision|0|||
42221597|NCT02993822|76040118|FG000|Overall Study|Lack of Efficacy|1|||
42221598|NCT02993822|76040119|FG001|Overall Study|Lack of Efficacy|1|||
41982958|NCT01059825|75789151|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
41982959|NCT01059825|75789152|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
42221599|NCT02993822|76040120|FG002|Overall Study|Lack of Efficacy|0|||
42221600|NCT02993822|76040121|FG003|Overall Study|Lack of Efficacy|0|||
42221601|NCT02993822|76040118|FG000|Overall Study|Protocol Violation|1|||
42221602|NCT02993822|76040119|FG001|Overall Study|Protocol Violation|0|||
42221603|NCT02993822|76040120|FG002|Overall Study|Protocol Violation|0|||
42221604|NCT02993822|76040121|FG003|Overall Study|Protocol Violation|0|||
42221605|NCT02993822|76040118|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
42221606|NCT02993822|76040119|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
42221607|NCT02993822|76040120|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
42221608|NCT02993822|76040121|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
42221609|NCT02993822|76040118|FG000|Overall Study|Adverse Event|3|||
42221610|NCT02993822|76040119|FG001|Overall Study|Adverse Event|1|||
42221611|NCT02993822|76040120|FG002|Overall Study|Adverse Event|7|||
42221612|NCT02993822|76040121|FG003|Overall Study|Adverse Event|0|||
42221613|NCT02993822|76040118|FG000|Overall Study|Withdrawal by Subject|4|||
42221614|NCT02993822|76040119|FG001|Overall Study|Withdrawal by Subject|2|||
42221615|NCT02993822|76040120|FG002|Overall Study|Withdrawal by Subject|2|||
42221616|NCT02993822|76040121|FG003|Overall Study|Withdrawal by Subject|3|||
42221617|NCT02993822|76040118|FG000|Overall Study|Lost to Follow-up|1|||
42221618|NCT02993822|76040119|FG001|Overall Study|Lost to Follow-up|0|||
42221619|NCT02993822|76040120|FG002|Overall Study|Lost to Follow-up|1|||
42221620|NCT02993822|76040121|FG003|Overall Study|Lost to Follow-up|0|||
42221621|NCT01068860|76040141|FG000|Overall Study|Withdrawal by Subject|0|||
42221622|NCT01068860|76040142|FG001|Overall Study|Withdrawal by Subject|0|||
42221623|NCT01068860|76040143|FG002|Overall Study|Withdrawal by Subject|0|||
42221624|NCT01068860|76040144|FG003|Overall Study|Withdrawal by Subject|0|||
42221625|NCT01068860|76040145|FG004|Overall Study|Withdrawal by Subject|0|||
42221626|NCT01068860|76040146|FG005|Overall Study|Withdrawal by Subject|2|||
42221627|NCT01068860|76040147|FG006|Overall Study|Withdrawal by Subject|0|||
42221628|NCT01068860|76040148|FG007|Overall Study|Withdrawal by Subject|0|||
42221629|NCT01068860|76040149|FG008|Overall Study|Withdrawal by Subject|0|||
42221630|NCT01068860|76040150|FG009|Overall Study|Withdrawal by Subject|3|||
42221631|NCT01068860|76040141|FG000|Overall Study|Administrative problems; misrandomized|0|||
42221632|NCT01068860|76040142|FG001|Overall Study|Administrative problems; misrandomized|0|||
42221633|NCT01068860|76040143|FG002|Overall Study|Administrative problems; misrandomized|0|||
42221634|NCT01068860|76040144|FG003|Overall Study|Administrative problems; misrandomized|1|||
42221635|NCT01068860|76040145|FG004|Overall Study|Administrative problems; misrandomized|0|||
42221636|NCT01068860|76040146|FG005|Overall Study|Administrative problems; misrandomized|0|||
42221637|NCT01068860|76040147|FG006|Overall Study|Administrative problems; misrandomized|0|||
42221638|NCT01068860|76040148|FG007|Overall Study|Administrative problems; misrandomized|0|||
42221639|NCT01068860|76040149|FG008|Overall Study|Administrative problems; misrandomized|0|||
42221640|NCT01068860|76040150|FG009|Overall Study|Administrative problems; misrandomized|1|||
42221641|NCT01068860|76040141|FG000|Overall Study|Lost to Follow-up|0|||
42221642|NCT01068860|76040142|FG001|Overall Study|Lost to Follow-up|1|||
42221643|NCT01068860|76040143|FG002|Overall Study|Lost to Follow-up|0|||
42221644|NCT01068860|76040144|FG003|Overall Study|Lost to Follow-up|0|||
41982960|NCT01059825|75789146|FG000|Treatment Period|Lost to Follow-up|2|||
41982961|NCT01059825|75789147|FG001|Treatment Period|Lost to Follow-up|1|||
41982962|NCT01059825|75789148|FG002|Treatment Period|Lost to Follow-up|0|||
42221645|NCT01068860|76040145|FG004|Overall Study|Lost to Follow-up|0|||
42221646|NCT01068860|76040146|FG005|Overall Study|Lost to Follow-up|0|||
41982963|NCT01059825|75789149|FG003|Treatment Period|Lost to Follow-up|1|||
42029720|NCT01210118|75838238|FG001|Overall Study|Protocol Violation|1|||
42221647|NCT01068860|76040147|FG006|Overall Study|Lost to Follow-up|0|||
42221648|NCT01068860|76040148|FG007|Overall Study|Lost to Follow-up|0|||
42221649|NCT01068860|76040149|FG008|Overall Study|Lost to Follow-up|0|||
42221650|NCT01068860|76040150|FG009|Overall Study|Lost to Follow-up|0|||
42221651|NCT02989610|76040172|FG000|Overall Study|Withdrawal/Other reasons|39|||
41982964|NCT01059825|75789150|FG004|Treatment Period|Lost to Follow-up|2|||
41982965|NCT01059825|75789151|FG005|Treatment Period|Lost to Follow-up|0|||
41982966|NCT01059825|75789152|FG006|Treatment Period|Lost to Follow-up|0|||
42221652|NCT01372774|76040178|FG000|Overall Study|Withdrawal prior to treatment|4|||
42221653|NCT01372774|76040179|FG001|Overall Study|Withdrawal prior to treatment|5|||
42221654|NCT02670538|76040190|FG000|Overall Study|Withdrawal of Consent|8|||
42221655|NCT02670538|76040191|FG001|Overall Study|Withdrawal of Consent|6|||
42221656|NCT02670538|76040192|FG002|Overall Study|Withdrawal of Consent|5|||
42221657|NCT02670538|76040190|FG000|Overall Study|Lost to Follow-up|8|||
42221658|NCT02670538|76040191|FG001|Overall Study|Lost to Follow-up|12|||
42221659|NCT02670538|76040192|FG002|Overall Study|Lost to Follow-up|7|||
42221660|NCT02670538|76040190|FG000|Overall Study|Adverse Event|5|||
42221661|NCT02670538|76040191|FG001|Overall Study|Adverse Event|5|||
42221662|NCT02670538|76040192|FG002|Overall Study|Adverse Event|11|||
42221663|NCT02670538|76040190|FG000|Overall Study|Lack of Efficacy|7|||
42221664|NCT02670538|76040191|FG001|Overall Study|Lack of Efficacy|1|||
42221665|NCT02670538|76040192|FG002|Overall Study|Lack of Efficacy|2|||
42221666|NCT02670538|76040190|FG000|Overall Study|Protocol Violation|3|||
42221667|NCT02670538|76040191|FG001|Overall Study|Protocol Violation|4|||
42221668|NCT02670538|76040192|FG002|Overall Study|Protocol Violation|1|||
42221669|NCT02670538|76040190|FG000|Overall Study|Noncompliance with Study Drug|1|||
42221670|NCT02670538|76040191|FG001|Overall Study|Noncompliance with Study Drug|3|||
42221671|NCT02670538|76040192|FG002|Overall Study|Noncompliance with Study Drug|2|||
42221672|NCT02670538|76040190|FG000|Overall Study|Other Miscellaneous Reasons|0|||
42221673|NCT02670538|76040191|FG001|Overall Study|Other Miscellaneous Reasons|1|||
42221674|NCT02670538|76040192|FG002|Overall Study|Other Miscellaneous Reasons|2|||
42221675|NCT03547583|76040203|FG000|Overall Study|Adverse Event|16|||
42221676|NCT03547583|76040204|FG001|Overall Study|Adverse Event|11|||
42221677|NCT03547583|76040205|FG002|Overall Study|Adverse Event|10|||
42221678|NCT03547583|76040203|FG000|Overall Study|Death|11|||
42221679|NCT03547583|76040204|FG001|Overall Study|Death|7|||
42221680|NCT03547583|76040205|FG002|Overall Study|Death|4|||
42221681|NCT03547583|76040203|FG000|Overall Study|Lost to Follow-up|1|||
42221682|NCT03547583|76040204|FG001|Overall Study|Lost to Follow-up|0|||
42221683|NCT03547583|76040205|FG002|Overall Study|Lost to Follow-up|0|||
42221684|NCT03547583|76040203|FG000|Overall Study|Non-compliance with study drug|0|||
42221685|NCT03547583|76040204|FG001|Overall Study|Non-compliance with study drug|0|||
42221686|NCT03547583|76040205|FG002|Overall Study|Non-compliance with study drug|1|||
42221687|NCT03547583|76040203|FG000|Overall Study|Physician Decision|1|||
42221688|NCT03547583|76040204|FG001|Overall Study|Physician Decision|0|||
42221689|NCT03547583|76040205|FG002|Overall Study|Physician Decision|3|||
42221690|NCT03547583|76040203|FG000|Overall Study|Protocol Violation|2|||
42221691|NCT03547583|76040204|FG001|Overall Study|Protocol Violation|1|||
41982967|NCT01059825|75789146|FG000|Treatment Period|Withdrawal by Subject|3|||
41982968|NCT01059825|75789147|FG001|Treatment Period|Withdrawal by Subject|0|||
41982969|NCT01059825|75789148|FG002|Treatment Period|Withdrawal by Subject|1|||
42221692|NCT03547583|76040205|FG002|Overall Study|Protocol Violation|1|||
42221693|NCT03547583|76040203|FG000|Overall Study|Withdrawal by Subject|12|||
42221694|NCT03547583|76040204|FG001|Overall Study|Withdrawal by Subject|19|||
42221695|NCT03547583|76040205|FG002|Overall Study|Withdrawal by Subject|10|||
42221696|NCT03547583|76040203|FG000|Overall Study|Other|2|||
42221697|NCT03547583|76040204|FG001|Overall Study|Other|2|||
42221698|NCT03547583|76040205|FG002|Overall Study|Other|3|||
42221699|NCT02670382|76040216|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
42221700|NCT02670382|76040217|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
42221701|NCT02991482|76040227|FG000|Overall Study|Disease progression|56|||
42221702|NCT02991482|76040228|FG001|Overall Study|Disease progression|47|||
42221703|NCT02991482|76040227|FG000|Overall Study|Death|4|||
41982970|NCT01059825|75789149|FG003|Treatment Period|Withdrawal by Subject|5|||
41982971|NCT01059825|75789150|FG004|Treatment Period|Withdrawal by Subject|4|||
41982972|NCT01059825|75789151|FG005|Treatment Period|Withdrawal by Subject|1|||
41982973|NCT01059825|75789152|FG006|Treatment Period|Withdrawal by Subject|0|||
41982974|NCT01059825|75789146|FG000|Treatment Period|Other reason not specified|1|||
41982975|NCT01059825|75789147|FG001|Treatment Period|Other reason not specified|2|||
41982976|NCT01059825|75789148|FG002|Treatment Period|Other reason not specified|1|||
42029721|NCT01210118|75838237|FG000|Overall Study|Spontaneous abortion|1|||
42221704|NCT02991482|76040228|FG001|Overall Study|Death|4|||
42221705|NCT02991482|76040227|FG000|Overall Study|Adverse Event|1|||
42221706|NCT02991482|76040228|FG001|Overall Study|Adverse Event|6|||
42221707|NCT02991482|76040227|FG000|Overall Study|Patient decision|1|||
41982977|NCT01059825|75789149|FG003|Treatment Period|Other reason not specified|2|||
41982978|NCT01059825|75789150|FG004|Treatment Period|Other reason not specified|0|||
41982979|NCT01059825|75789151|FG005|Treatment Period|Other reason not specified|0|||
42221708|NCT02991482|76040228|FG001|Overall Study|Patient decision|1|||
42221709|NCT02991482|76040227|FG000|Overall Study|Physician Decision|0|||
42221710|NCT02991482|76040228|FG001|Overall Study|Physician Decision|6|||
42221711|NCT02991482|76040227|FG000|Overall Study|Clinical deterioration|1|||
42221712|NCT02991482|76040228|FG001|Overall Study|Clinical deterioration|0|||
42221713|NCT02991482|76040227|FG000|Overall Study|Patient feeling too unwell|1|||
42221714|NCT02991482|76040228|FG001|Overall Study|Patient feeling too unwell|0|||
42221715|NCT02991482|76040227|FG000|Overall Study|Worsening of performance status|0|||
42221716|NCT02991482|76040228|FG001|Overall Study|Worsening of performance status|1|||
41982980|NCT01059825|75789152|FG006|Treatment Period|Other reason not specified|0|||
41982981|NCT01059825|75789146|FG000|Treatment Period|Protocol Violation|0|||
41982982|NCT01059825|75789147|FG001|Treatment Period|Protocol Violation|0|||
41982983|NCT01059825|75789148|FG002|Treatment Period|Protocol Violation|1|||
41982984|NCT01059825|75789149|FG003|Treatment Period|Protocol Violation|1|||
41982985|NCT01059825|75789150|FG004|Treatment Period|Protocol Violation|1|||
41982986|NCT01059825|75789151|FG005|Treatment Period|Protocol Violation|1|||
41982987|NCT01059825|75789152|FG006|Treatment Period|Protocol Violation|0|||
41982988|NCT01059825|75789146|FG000|Treatment Period|Adverse event related to study drug|1|||
41982989|NCT01059825|75789147|FG001|Treatment Period|Adverse event related to study drug|0|||
41982990|NCT01059825|75789148|FG002|Treatment Period|Adverse event related to study drug|1|||
41982991|NCT01059825|75789149|FG003|Treatment Period|Adverse event related to study drug|1|||
41982992|NCT01059825|75789150|FG004|Treatment Period|Adverse event related to study drug|0|||
41982993|NCT01059825|75789151|FG005|Treatment Period|Adverse event related to study drug|0|||
41982994|NCT01059825|75789152|FG006|Treatment Period|Adverse event related to study drug|0|||
41982995|NCT01059825|75789146|FG000|Treatment Period|Insufficient clinical response|3|||
41982996|NCT01059825|75789147|FG001|Treatment Period|Insufficient clinical response|0|||
41982997|NCT01059825|75789148|FG002|Treatment Period|Insufficient clinical response|0|||
42130926|NCT02877134|75941848|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
42130927|NCT02877134|75941849|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
42130928|NCT02877134|75941850|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
42130929|NCT02877134|75941851|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
41982998|NCT01059825|75789149|FG003|Treatment Period|Insufficient clinical response|0|||
42130930|NCT02877134|75941852|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
42130931|NCT02877134|75941853|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
42130932|NCT00563381|75941879|FG000|Overall Study|Adverse Event|264|||
42130933|NCT00563381|75941880|FG001|Overall Study|Adverse Event|292|||
42130934|NCT00563381|75941879|FG000|Overall Study|Protocol Violation|66|||
42130935|NCT00563381|75941880|FG001|Overall Study|Protocol Violation|74|||
42130936|NCT00563381|75941879|FG000|Overall Study|Lost to Follow-up|7|||
42130937|NCT00563381|75941880|FG001|Overall Study|Lost to Follow-up|15|||
42130938|NCT00563381|75941879|FG000|Overall Study|Withdrawal by Subject|192|||
42130939|NCT00563381|75941880|FG001|Overall Study|Withdrawal by Subject|209|||
42130940|NCT00563381|75941879|FG000|Overall Study|Lack of Efficacy|32|||
42130941|NCT00563381|75941880|FG001|Overall Study|Lack of Efficacy|24|||
42130942|NCT00563381|75941879|FG000|Overall Study|Individual different reasons|24|||
42130943|NCT00563381|75941880|FG001|Overall Study|Individual different reasons|34|||
42130944|NCT00512798|75941888|FG000|Overall Study|Death|0|||
42130945|NCT00512798|75941889|FG001|Overall Study|Death|3|||
42130946|NCT00512798|75941888|FG000|Overall Study|Adverse Event|2|||
42130947|NCT00512798|75941889|FG001|Overall Study|Adverse Event|4|||
42130948|NCT00512798|75941888|FG000|Overall Study|Progression of disease|14|||
42130949|NCT00512798|75941889|FG001|Overall Study|Progression of disease|20|||
42130950|NCT00512798|75941888|FG000|Overall Study|Withdrawal by Subject|3|||
42130951|NCT00512798|75941889|FG001|Overall Study|Withdrawal by Subject|0|||
42130952|NCT00565721|75941896|FG000|Overall Study|Screen Failure|2|||
42130953|NCT00565721|75941896|FG000|Overall Study|Lost to Follow-up|6|||
42130954|NCT00565721|75941896|FG000|Overall Study|Technical Problems|1|||
42130955|NCT00565721|75941896|FG000|Overall Study|Physician Decision|2|||
42130956|NCT00565721|75941896|FG000|Overall Study|Other reasons|6|||
42130957|NCT00561977|75941926|FG000|Overall Study|Withdrawal by Subject|0|||
42130958|NCT00561977|75941927|FG001|Overall Study|Withdrawal by Subject|2|||
42130959|NCT00561977|75941928|FG002|Overall Study|Withdrawal by Subject|1|||
42130960|NCT00561977|75941926|FG000|Overall Study|Pregnancy|0|||
42130961|NCT00561977|75941927|FG001|Overall Study|Pregnancy|1|||
42130962|NCT00561977|75941928|FG002|Overall Study|Pregnancy|1|||
42130963|NCT00561821|75941940|FG000|Overall Study|Not treated|0|||
42130964|NCT00561821|75941941|FG001|Overall Study|Not treated|0|||
42130965|NCT00561821|75941942|FG002|Overall Study|Not treated|1|||
42130966|NCT00561821|75941943|FG003|Overall Study|Not treated|0|||
41982999|NCT01059825|75789150|FG004|Treatment Period|Insufficient clinical response|0|||
41983000|NCT01059825|75789151|FG005|Treatment Period|Insufficient clinical response|0|||
42130967|NCT00561821|75941940|FG000|Overall Study|Withdrawal by Subject|0|||
42130968|NCT00561821|75941941|FG001|Overall Study|Withdrawal by Subject|1|||
42130969|NCT00561821|75941942|FG002|Overall Study|Withdrawal by Subject|0|||
42130970|NCT00561821|75941943|FG003|Overall Study|Withdrawal by Subject|2|||
42130971|NCT00561821|75941940|FG000|Overall Study|Reasons not related to trial|2|||
42221717|NCT02991482|76040227|FG000|Overall Study|Death prior to study drug initiation|1|||
42221718|NCT02991482|76040228|FG001|Overall Study|Death prior to study drug initiation|0|||
42221719|NCT02991482|76040227|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
42221720|NCT02991482|76040228|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
42221721|NCT02674750|76040237|FG000|Overall Study|Death|4|||
42221722|NCT02674750|76040238|FG001|Overall Study|Death|5|||
42221723|NCT02674750|76040239|FG002|Overall Study|Death|8|||
42221724|NCT02674750|76040237|FG000|Overall Study|Lost to Follow-up|0|||
42221725|NCT02674750|76040238|FG001|Overall Study|Lost to Follow-up|8|||
42221726|NCT02674750|76040239|FG002|Overall Study|Lost to Follow-up|0|||
42221727|NCT02674750|76040237|FG000|Overall Study|Lack of Efficacy|1|||
42221728|NCT02674750|76040238|FG001|Overall Study|Lack of Efficacy|17|||
42221729|NCT02674750|76040239|FG002|Overall Study|Lack of Efficacy|3|||
42221730|NCT02674750|76040237|FG000|Overall Study|Withdrawal by Subject|0|||
42221731|NCT02674750|76040238|FG001|Overall Study|Withdrawal by Subject|7|||
42221732|NCT02674750|76040239|FG002|Overall Study|Withdrawal by Subject|1|||
42221733|NCT02674750|76040237|FG000|Overall Study|Other|0|||
42221734|NCT02674750|76040238|FG001|Overall Study|Other|8|||
42221735|NCT02674750|76040239|FG002|Overall Study|Other|0|||
42221736|NCT02987972|76040268|FG000|Overall Study|Adverse Event|1|||
42221737|NCT02987972|76040269|FG001|Overall Study|Adverse Event|1|||
42221738|NCT02987972|76040270|FG002|Overall Study|Adverse Event|0|||
42221739|NCT02987972|76040268|FG000|Overall Study|Death|1|||
42221740|NCT02987972|76040269|FG001|Overall Study|Death|0|||
42221741|NCT02987972|76040270|FG002|Overall Study|Death|0|||
42221742|NCT02987972|76040268|FG000|Overall Study|Lack of Efficacy|9|||
42221743|NCT02987972|76040269|FG001|Overall Study|Lack of Efficacy|12|||
42221744|NCT02987972|76040270|FG002|Overall Study|Lack of Efficacy|12|||
42221745|NCT02987972|76040268|FG000|Overall Study|Lost to Follow-up|7|||
42221746|NCT02987972|76040269|FG001|Overall Study|Lost to Follow-up|8|||
42221747|NCT02987972|76040270|FG002|Overall Study|Lost to Follow-up|4|||
42221748|NCT02987972|76040268|FG000|Overall Study|Physician Decision|1|||
42221749|NCT02987972|76040269|FG001|Overall Study|Physician Decision|6|||
42221750|NCT02987972|76040270|FG002|Overall Study|Physician Decision|0|||
42029722|NCT01210118|75838238|FG001|Overall Study|Spontaneous abortion|3|||
42029723|NCT01208870|75838249|FG000|Overall Study|Lost to Follow-up|2|||
42029724|NCT01208870|75838250|FG001|Overall Study|Lost to Follow-up|8|||
42029725|NCT00880555|75838261|FG000|Overall Study|Physician Decision|0|||
42029726|NCT00880555|75838262|FG001|Overall Study|Physician Decision|8|||
42029727|NCT00880555|75838263|FG002|Overall Study|Physician Decision|0|||
42029728|NCT00880555|75838264|FG003|Overall Study|Physician Decision|2|||
42029729|NCT00880555|75838265|FG004|Overall Study|Physician Decision|1|||
42029730|NCT00880555|75838266|FG005|Overall Study|Physician Decision|0|||
42029731|NCT00880555|75838261|FG000|Overall Study|Withdrawal by Subject|1|||
42029732|NCT00880555|75838262|FG001|Overall Study|Withdrawal by Subject|1|||
42029733|NCT00880555|75838263|FG002|Overall Study|Withdrawal by Subject|0|||
42029734|NCT00880555|75838264|FG003|Overall Study|Withdrawal by Subject|0|||
42029735|NCT00880555|75838265|FG004|Overall Study|Withdrawal by Subject|0|||
42029736|NCT00880555|75838266|FG005|Overall Study|Withdrawal by Subject|0|||
42221751|NCT02987972|76040268|FG000|Overall Study|Protocol Violation|2|||
42221752|NCT02987972|76040269|FG001|Overall Study|Protocol Violation|1|||
41983001|NCT01059825|75789152|FG006|Treatment Period|Insufficient clinical response|0|||
41983002|NCT01059825|75789146|FG000|Treatment Period|Adverse event not related to study drug|0|||
41983003|NCT01059825|75789147|FG001|Treatment Period|Adverse event not related to study drug|1|||
41983004|NCT01059825|75789148|FG002|Treatment Period|Adverse event not related to study drug|2|||
41983005|NCT01059825|75789149|FG003|Treatment Period|Adverse event not related to study drug|1|||
41983006|NCT01059825|75789150|FG004|Treatment Period|Adverse event not related to study drug|1|||
41983007|NCT01059825|75789151|FG005|Treatment Period|Adverse event not related to study drug|1|||
41983008|NCT01059825|75789152|FG006|Treatment Period|Adverse event not related to study drug|0|||
41983009|NCT03439839|75789179|FG000|Overall Study|Death|3|||
42221753|NCT02987972|76040270|FG002|Overall Study|Protocol Violation|5|||
42221754|NCT02987972|76040268|FG000|Overall Study|Withdrawal by Subject|22|||
42221755|NCT02987972|76040269|FG001|Overall Study|Withdrawal by Subject|17|||
42029737|NCT00880555|75838261|FG000|Overall Study|Lack of resources (hired rater)|9|||
42221756|NCT02987972|76040270|FG002|Overall Study|Withdrawal by Subject|21|||
42221757|NCT01372618|76040278|FG000|Overall Study|PI Died. Study Terminated|9|||
42029738|NCT00880555|75838262|FG001|Overall Study|Lack of resources (hired rater)|7|||
42029739|NCT00880555|75838263|FG002|Overall Study|Lack of resources (hired rater)|5|||
42029740|NCT00880555|75838264|FG003|Overall Study|Lack of resources (hired rater)|0|||
42029741|NCT00880555|75838265|FG004|Overall Study|Lack of resources (hired rater)|0|||
42029742|NCT00880555|75838266|FG005|Overall Study|Lack of resources (hired rater)|0|||
42029743|NCT00880555|75838261|FG000|Overall Study|Death|0|||
42029744|NCT00880555|75838262|FG001|Overall Study|Death|0|||
42029745|NCT00880555|75838263|FG002|Overall Study|Death|0|||
42029746|NCT00880555|75838264|FG003|Overall Study|Death|0|||
42029747|NCT00880555|75838265|FG004|Overall Study|Death|0|||
42029748|NCT00880555|75838266|FG005|Overall Study|Death|1|||
42221758|NCT03304873|76040284|FG000|Overall Study|Lost to Follow-up|1|||
42221759|NCT03304873|76040285|FG001|Overall Study|Lost to Follow-up|8|||
42221760|NCT02669758|76040291|FG000|Overall Study|Withdrawal by Subject|43|||
42221761|NCT02669758|76040291|FG000|Overall Study|Lost to Follow-up|19|||
42221762|NCT02669758|76040291|FG000|Overall Study|Adverse Event|16|||
42221763|NCT02669758|76040291|FG000|Overall Study|Non-Compliance with Study Drug|8|||
42221764|NCT02669758|76040291|FG000|Overall Study|Lack of Efficacy|5|||
42221765|NCT02669758|76040291|FG000|Overall Study|Pregnancy|1|||
42221766|NCT02669758|76040291|FG000|Overall Study|Study noncompliance|1|||
42221767|NCT02669758|76040291|FG000|Overall Study|Protocol Violation|1|||
42221768|NCT02987660|76040297|FG000|Overall Study|Study terminated by sponsor|10|||
42221769|NCT02987660|76040298|FG001|Overall Study|Study terminated by sponsor|10|||
42221770|NCT04528069|76040304|FG000|Overall Study|Adverse Event|1|||
42221771|NCT04528069|76040304|FG000|Overall Study|Lost to Follow-up|1|||
42221772|NCT04528069|76040304|FG000|Overall Study|Patient Unable to Come|1|||
42221773|NCT04528069|76040304|FG000|Overall Study|Patient Unable to Attend|1|||
42221774|NCT03303469|76040320|FG000|Overall Study|Lost to Follow-up|2|||
42221775|NCT02990000|76040326|FG000|Overall Study|Failed to provide data beyond baseline|36|||
42221776|NCT02990000|76040327|FG001|Overall Study|Failed to provide data beyond baseline|34|||
42221777|NCT01068626|76040335|FG000|Overall Study|Adverse Event|3|||
42221778|NCT01068626|76040336|FG001|Overall Study|Adverse Event|0|||
42221779|NCT01068626|76040335|FG000|Overall Study|Withdrawal by Subject|0|||
42221780|NCT01068626|76040336|FG001|Overall Study|Withdrawal by Subject|2|||
42221781|NCT02921750|76040344|FG000|Overall Study|Adverse Event|1|||
42221782|NCT02921750|76040345|FG001|Overall Study|Adverse Event|2|||
42221783|NCT02921750|76040344|FG000|Overall Study|Withdrawal by Subject|1|||
42221784|NCT02921750|76040345|FG001|Overall Study|Withdrawal by Subject|1|||
42221785|NCT02921750|76040344|FG000|Overall Study|Lost to Follow-up|3|||
42221786|NCT02921750|76040345|FG001|Overall Study|Lost to Follow-up|3|||
42221787|NCT02921750|76040344|FG000|Overall Study|Wound healed|3|||
42221788|NCT02921750|76040345|FG001|Overall Study|Wound healed|3|||
42221789|NCT02921750|76040344|FG000|Overall Study|Serious Adverse Event|1|||
42221790|NCT02921750|76040345|FG001|Overall Study|Serious Adverse Event|2|||
42221791|NCT02920970|76040354|FG000|First Intervention|Protocol Violation|0|||
42221792|NCT02920970|76040355|FG001|First Intervention|Protocol Violation|1|||
42221793|NCT02920970|76040354|FG000|First Intervention|Adverse Event|0|||
42221794|NCT02920970|76040355|FG001|First Intervention|Adverse Event|1|||
42221795|NCT02920970|76040354|FG000|Second Intervention|Poor Lens Fit|1|||
42221796|NCT02920970|76040355|FG001|Second Intervention|Poor Lens Fit|0|||
42221797|NCT01068158|76040365|FG000|Overall Study|Withdrawal by Subject|1|||
42221798|NCT01068158|76040366|FG001|Overall Study|Withdrawal by Subject|2|||
42221799|NCT01068158|76040365|FG000|Overall Study|Lost to Follow-up|7|||
42221800|NCT01068158|76040366|FG001|Overall Study|Lost to Follow-up|0|||
42221801|NCT01068158|76040365|FG000|Overall Study|Protocol Violation|0|||
42221802|NCT01068158|76040366|FG001|Overall Study|Protocol Violation|2|||
42221803|NCT03303079|76040375|FG000|Overall Study|Adverse Event|0|||
42221804|NCT03303079|76040376|FG001|Overall Study|Adverse Event|1|||
42221805|NCT03303079|76040377|FG002|Overall Study|Adverse Event|3|||
42221806|NCT03303079|76040375|FG000|Overall Study|Protocol Violation|5|||
42221807|NCT03303079|76040376|FG001|Overall Study|Protocol Violation|4|||
42221808|NCT03303079|76040377|FG002|Overall Study|Protocol Violation|7|||
42221809|NCT03303079|76040375|FG000|Overall Study|Withdrawal by Subject|2|||
42221810|NCT03303079|76040376|FG001|Overall Study|Withdrawal by Subject|4|||
42221811|NCT03303079|76040377|FG002|Overall Study|Withdrawal by Subject|2|||
42221812|NCT03303079|76040375|FG000|Overall Study|Other than specified|0|||
42221813|NCT03303079|76040376|FG001|Overall Study|Other than specified|2|||
42221814|NCT03303079|76040377|FG002|Overall Study|Other than specified|0|||
42221815|NCT01067846|76040387|FG000|Overall Study|Lost to Follow-up|17|||
42221816|NCT01067846|76040388|FG001|Overall Study|Lost to Follow-up|19|||
42221817|NCT01067846|76040387|FG000|Overall Study|Withdrawal by Subject|1|||
42221818|NCT01067846|76040388|FG001|Overall Study|Withdrawal by Subject|0|||
42029749|NCT00880555|75838261|FG000|Overall Study|Lost to Follow-up|0|||
42221819|NCT01067846|76040387|FG000|Overall Study|participation in other tx study|1|||
42221820|NCT01067846|76040388|FG001|Overall Study|participation in other tx study|0|||
42221821|NCT03311659|76040394|FG000|Overall Study|Protocol Violation|1|||
42221822|NCT03874234|76040411|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42029750|NCT00880555|75838262|FG001|Overall Study|Lost to Follow-up|1|||
42221823|NCT03874234|76040412|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42221824|NCT03874234|76040413|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42221825|NCT03874234|76040414|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
42221826|NCT03874234|76040415|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42221827|NCT03874234|76040416|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42221828|NCT03874234|76040417|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42221829|NCT03874234|76040418|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42221830|NCT03874234|76040419|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42221831|NCT03874234|76040420|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42221832|NCT03874234|76040421|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42221833|NCT03874234|76040422|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42221834|NCT03874234|76040423|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
42221835|NCT03874234|76040411|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
42221836|NCT03874234|76040412|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221837|NCT03874234|76040413|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221838|NCT03874234|76040414|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221839|NCT03874234|76040415|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221840|NCT03874234|76040416|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221841|NCT03874234|76040417|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221842|NCT03874234|76040418|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221843|NCT03874234|76040419|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221844|NCT03874234|76040420|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221845|NCT03874234|76040421|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221846|NCT03874234|76040422|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221847|NCT03874234|76040423|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
42221848|NCT03874234|76040411|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
42221849|NCT03874234|76040412|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
42221850|NCT03874234|76040413|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
42221851|NCT03874234|76040414|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
42221852|NCT03874234|76040415|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
42221853|NCT03874234|76040416|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
42221854|NCT03874234|76040417|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
42221855|NCT03874234|76040418|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
42221856|NCT03874234|76040419|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
42221857|NCT03874234|76040420|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
41983010|NCT03439839|75789180|FG001|Overall Study|Death|0|||
41983011|NCT04618770|75789244|FG000|Overall Study|Censored from Analysis|12|||
41983012|NCT04618770|75789244|FG000|Overall Study|Early Termination|25|||
41983013|NCT04568603|75789248|FG000|Overall Study|Physician Decision|1|||
41983014|NCT04544709|75789253|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
41983015|NCT04528732|75789262|FG000|Overall Study|Death|1|||
41983016|NCT04528732|75789263|FG001|Overall Study|Death|0|||
41983017|NCT04528732|75789264|FG002|Overall Study|Death|1|||
41983018|NCT04528732|75789262|FG000|Overall Study|Lost to Follow-up|0|||
41983019|NCT04528732|75789263|FG001|Overall Study|Lost to Follow-up|1|||
41983020|NCT04528732|75789264|FG002|Overall Study|Lost to Follow-up|2|||
41983021|NCT04505540|75789277|FG000|Baseline|Protocol Violation|10|||
42221858|NCT03874234|76040421|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
42221859|NCT03874234|76040422|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
42221860|NCT03874234|76040423|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
42302261|NCT02494921|76137338|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
42221861|NCT03874234|76040411|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42302262|NCT02494921|76137339|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
41983022|NCT04505540|75789277|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
42029751|NCT00880555|75838263|FG002|Overall Study|Lost to Follow-up|0|||
42029752|NCT00880555|75838264|FG003|Overall Study|Lost to Follow-up|0|||
42221862|NCT03874234|76040412|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42221863|NCT03874234|76040413|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42221864|NCT03874234|76040414|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42221865|NCT03874234|76040415|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
42221866|NCT03874234|76040416|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42221867|NCT03874234|76040417|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42221868|NCT03874234|76040418|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42221869|NCT03874234|76040419|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42221870|NCT03874234|76040420|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42221871|NCT03874234|76040421|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42221872|NCT03874234|76040422|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42221873|NCT03874234|76040423|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
42221874|NCT03874234|76040411|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
42221875|NCT03874234|76040412|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
42221876|NCT03874234|76040413|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
42221877|NCT03874234|76040414|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
42221878|NCT03874234|76040415|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
42221879|NCT03874234|76040416|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
42221880|NCT03874234|76040417|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
42221881|NCT03874234|76040418|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
42221882|NCT03874234|76040419|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
41983023|NCT04505540|75789277|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
42221883|NCT03874234|76040420|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
41983024|NCT04505540|75789277|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
41983025|NCT04505540|75789277|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
41983026|NCT04505540|75789277|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
41983027|NCT04505540|75789277|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
41983028|NCT04505540|75789277|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
41983029|NCT04505540|75789277|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
41983030|NCT04505540|75789277|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
41983031|NCT04505540|75789277|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
41983032|NCT04505540|75789277|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
41983033|NCT04505540|75789277|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
42130972|NCT00561821|75941941|FG001|Overall Study|Reasons not related to trial|1|||
42130973|NCT00561821|75941942|FG002|Overall Study|Reasons not related to trial|0|||
42130974|NCT00561821|75941943|FG003|Overall Study|Reasons not related to trial|0|||
42130975|NCT00561821|75941940|FG000|Overall Study|Other (reason not specified)|1|||
42130976|NCT00561821|75941941|FG001|Overall Study|Other (reason not specified)|1|||
42130977|NCT00561821|75941942|FG002|Overall Study|Other (reason not specified)|0|||
42130978|NCT00561821|75941943|FG003|Overall Study|Other (reason not specified)|0|||
42130979|NCT00561821|75941940|FG000|Overall Study|Adverse Event|2|||
42130980|NCT00561821|75941941|FG001|Overall Study|Adverse Event|3|||
42221884|NCT03874234|76040421|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
42221885|NCT03874234|76040422|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
42221886|NCT03874234|76040423|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
42221887|NCT03874234|76040411|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
42130981|NCT00561821|75941942|FG002|Overall Study|Adverse Event|1|||
42221888|NCT03874234|76040412|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
42221889|NCT03874234|76040413|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
42221890|NCT03874234|76040414|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
42221891|NCT03874234|76040415|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
42221892|NCT03874234|76040416|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
42221893|NCT03874234|76040417|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
42221894|NCT03874234|76040418|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
42221895|NCT03874234|76040419|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
42221896|NCT03874234|76040420|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
42221897|NCT03874234|76040421|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
42221898|NCT03874234|76040422|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
42221899|NCT03874234|76040423|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
42221900|NCT03874234|76040411|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221901|NCT03874234|76040412|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221902|NCT03874234|76040413|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221903|NCT03874234|76040414|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221904|NCT03874234|76040415|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221905|NCT03874234|76040416|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221906|NCT03874234|76040417|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
42221907|NCT03874234|76040418|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221908|NCT03874234|76040419|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221909|NCT03874234|76040420|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221910|NCT03874234|76040421|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221911|NCT03874234|76040422|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221912|NCT03874234|76040423|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
42221913|NCT03874234|76040411|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221914|NCT03874234|76040412|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221915|NCT03874234|76040413|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221916|NCT03874234|76040414|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221917|NCT03874234|76040415|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
42221918|NCT03874234|76040416|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221919|NCT03874234|76040417|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221920|NCT03874234|76040418|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221921|NCT03874234|76040419|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221922|NCT03874234|76040420|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221923|NCT03874234|76040421|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221924|NCT03874234|76040422|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221925|NCT03874234|76040423|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
42221926|NCT02985398|76040459|FG000|Overall Study|Adverse Event|1|||
42221927|NCT02985398|76040459|FG000|Overall Study|Lost to Follow-up|4|||
42221928|NCT02985398|76040459|FG000|Overall Study|Withdrawal by Subject|8|||
42221929|NCT02985398|76040459|FG000|Overall Study|Study Burden|9|||
42221930|NCT03310723|76040465|FG000|Overall Study|Withdrawal by Subject|0|||
42221931|NCT03310723|76040466|FG001|Overall Study|Withdrawal by Subject|1|||
41983034|NCT04455815|75789283|FG000|Randomisation Phase|Adverse Event|1|||
41983035|NCT04455815|75789284|FG001|Randomisation Phase|Adverse Event|0|||
41983036|NCT04455815|75789283|FG000|Treatment Phase|Adverse Event|0|||
41983037|NCT04455815|75789284|FG001|Treatment Phase|Adverse Event|1|||
41983038|NCT04455815|75789283|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
41983039|NCT04455815|75789284|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
41983040|NCT04455815|75789283|FG000|Treatment Phase|Withdrawal by Subject|1|||
41983041|NCT04455815|75789284|FG001|Treatment Phase|Withdrawal by Subject|1|||
41983042|NCT04220411|75789294|FG000|Overall Study|Adverse Event|0|||
41983043|NCT04220411|75789295|FG001|Overall Study|Adverse Event|0|||
41983044|NCT04220411|75789296|FG002|Overall Study|Adverse Event|0|||
41983045|NCT04220411|75789297|FG003|Overall Study|Adverse Event|1|||
41983046|NCT04194489|75789309|FG000|Overall Study|Withdrawal by Subject|5|||
41983047|NCT04194489|75789309|FG000|Overall Study|Lost to Follow-up|48|||
41983048|NCT04194450|75789313|FG000|Overall Study|not eligible|1|||
41983049|NCT04194450|75789314|FG001|Overall Study|not eligible|0|||
41983050|NCT04158739|75789321|FG000|Overall Study|Adverse Event|1|||
41983051|NCT04158739|75789322|FG001|Overall Study|Adverse Event|0|||
41983052|NCT04158739|75789321|FG000|Overall Study|Death|0|||
41983053|NCT04158739|75789322|FG001|Overall Study|Death|1|||
41983054|NCT04158739|75789321|FG000|Overall Study|Lack of Efficacy|3|||
41983055|NCT04158739|75789322|FG001|Overall Study|Lack of Efficacy|7|||
41983056|NCT04158739|75789321|FG000|Overall Study|Physician Decision|0|||
42221932|NCT03310723|76040465|FG000|Overall Study|Protocol Violation|0|||
42221933|NCT03310723|76040466|FG001|Overall Study|Protocol Violation|2|||
42221934|NCT02663674|76040474|FG000|Overall Study|Lost to Follow-up|5|||
41983057|NCT04158739|75789322|FG001|Overall Study|Physician Decision|1|||
41983058|NCT04158739|75789321|FG000|Overall Study|Withdrawal by Subject|3|||
41983059|NCT04158739|75789322|FG001|Overall Study|Withdrawal by Subject|0|||
41983060|NCT04123093|75789332|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
42221935|NCT02663674|76040475|FG001|Overall Study|Lost to Follow-up|4|||
42221936|NCT02663674|76040474|FG000|Overall Study|Withdrawal by Subject|1|||
42221937|NCT02663674|76040475|FG001|Overall Study|Withdrawal by Subject|4|||
42221938|NCT02663674|76040474|FG000|Overall Study|Physician Decision|1|||
42221939|NCT02663674|76040475|FG001|Overall Study|Physician Decision|1|||
42221940|NCT02663674|76040474|FG000|Overall Study|Other Event (Health Related)|0|||
42221941|NCT02663674|76040475|FG001|Overall Study|Other Event (Health Related)|1|||
42221942|NCT02908880|76040481|FG000|Overall Study|Lost to Follow-up|4|||
42221943|NCT02908880|76040481|FG000|Overall Study|Explantation of the device|1|||
42221944|NCT02908880|76040481|FG000|Overall Study|Withdrawal by Subject|17|||
42221945|NCT02908880|76040481|FG000|Overall Study|Death|5|||
42221946|NCT03310411|76040485|FG000|Period 1|Adverse Event|0|||
42221947|NCT03310411|76040486|FG001|Period 1|Adverse Event|0|||
42221948|NCT03310411|76040487|FG002|Period 1|Adverse Event|0|||
42221949|NCT03310411|76040488|FG003|Period 1|Adverse Event|1|||
42221950|NCT03301831|76040506|FG000|Overall Study|Lost to Follow-up|5|||
42221951|NCT03301831|76040507|FG001|Overall Study|Lost to Follow-up|3|||
42221952|NCT03301831|76040506|FG000|Overall Study|Protocol Violation|4|||
42221953|NCT03301831|76040507|FG001|Overall Study|Protocol Violation|0|||
42221954|NCT03301831|76040506|FG000|Overall Study|Withdrawal by Subject|11|||
42221955|NCT03301831|76040507|FG001|Overall Study|Withdrawal by Subject|0|||
42221956|NCT02909504|76040513|FG000|Overall Study|Adverse Event|2|||
42221957|NCT02909504|76040513|FG000|Overall Study|Lack of Efficacy|3|||
42221958|NCT02909504|76040513|FG000|Overall Study|Withdrawal by Subject|4|||
42221959|NCT02909504|76040513|FG000|Overall Study|Pregnancy|1|||
42221960|NCT02909504|76040513|FG000|Overall Study|Subject moved|1|||
42221961|NCT02909504|76040513|FG000|Overall Study|Lost to Follow-up|1|||
42221962|NCT02199691|76040522|FG000|Overall Study|Protocol Violation|3|||
42221963|NCT02199691|76040523|FG001|Overall Study|Protocol Violation|3|||
42221964|NCT02199691|76040524|FG002|Overall Study|Protocol Violation|6|||
42221965|NCT02199691|76040525|FG003|Overall Study|Protocol Violation|7|||
42221966|NCT02199691|76040522|FG000|Overall Study|Withdrawal by Subject|5|||
42221967|NCT02199691|76040523|FG001|Overall Study|Withdrawal by Subject|3|||
42221968|NCT02199691|76040524|FG002|Overall Study|Withdrawal by Subject|12|||
42221969|NCT02199691|76040525|FG003|Overall Study|Withdrawal by Subject|13|||
42221970|NCT02199691|76040522|FG000|Overall Study|Lost to Follow-up|2|||
42221971|NCT02199691|76040523|FG001|Overall Study|Lost to Follow-up|1|||
42221972|NCT02199691|76040524|FG002|Overall Study|Lost to Follow-up|9|||
42221973|NCT02199691|76040525|FG003|Overall Study|Lost to Follow-up|10|||
42221974|NCT03299881|76040539|FG000|Overall Study|Study Termination|17|||
42221975|NCT03299881|76040540|FG001|Overall Study|Study Termination|13|||
42221976|NCT03299101|76040546|FG000|Overall Study|Lost to Follow-up|1|||
42221977|NCT03299101|76040546|FG000|Overall Study|Withdrawal by Subject|5|||
42221978|NCT03299101|76040546|FG000|Overall Study|Surgery was changed|3|||
42221979|NCT03299101|76040546|FG000|Overall Study|Not enough time to complete prehab|1|||
42221980|NCT02663128|76040552|FG000|Period 2|Physician Decision|0|||
42221981|NCT02663128|76040553|FG001|Period 2|Physician Decision|0|||
42221982|NCT02663128|76040554|FG002|Period 2|Physician Decision|0|||
42221983|NCT02663128|76040555|FG003|Period 2|Physician Decision|0|||
42221984|NCT02663128|76040556|FG004|Period 2|Physician Decision|1|||
42221985|NCT02663128|76040557|FG005|Period 2|Physician Decision|0|||
42221986|NCT03298867|76040568|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
42221987|NCT03298867|76040569|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
42221988|NCT03298867|76040568|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
42221989|NCT03298867|76040569|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
41983061|NCT04123093|75789333|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
41983062|NCT04123093|75789332|FG000|Phase 2|Physician Decision|0|||
41983063|NCT04123093|75789333|FG001|Phase 2|Physician Decision|1|||
41983064|NCT04123093|75789332|FG000|Phase 2|Withdrawal by Subject|0|||
41983065|NCT04123093|75789333|FG001|Phase 2|Withdrawal by Subject|1|||
41983066|NCT03538301|75789395|FG000|Overall Study|Adverse Event|1|||
42221990|NCT03298867|76040568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
42221991|NCT03298867|76040569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
42221992|NCT03298867|76040568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
42221993|NCT03298867|76040569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
42221994|NCT03298867|76040568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
42221995|NCT03298867|76040569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
42221996|NCT03298867|76040568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
42221997|NCT03298867|76040569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
42221998|NCT03298867|76040568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
42221999|NCT03298867|76040569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
42222000|NCT03298867|76040568|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
42029753|NCT00880555|75838265|FG004|Overall Study|Lost to Follow-up|0|||
42130982|NCT00561821|75941943|FG003|Overall Study|Adverse Event|1|||
42130983|NCT00558701|75941955|FG000|Overall Study|Protocol Deviations|1|||
42130984|NCT00558701|75941956|FG001|Overall Study|Protocol Deviations|4|||
42222001|NCT03298867|76040569|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
42222002|NCT03298867|76040568|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
42222003|NCT03298867|76040569|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
42222004|NCT02906930|76040579|FG000|Overall Study|Withdrawal by Subject|0|||
42222005|NCT02906930|76040580|FG001|Overall Study|Withdrawal by Subject|5|||
42222006|NCT02906930|76040581|FG002|Overall Study|Withdrawal by Subject|5|||
42222007|NCT02906930|76040582|FG003|Overall Study|Withdrawal by Subject|4|||
42222008|NCT02906930|76040579|FG000|Overall Study|Lost to Follow-up|5|||
42222009|NCT02906930|76040580|FG001|Overall Study|Lost to Follow-up|7|||
42222010|NCT02906930|76040581|FG002|Overall Study|Lost to Follow-up|5|||
42222011|NCT02906930|76040582|FG003|Overall Study|Lost to Follow-up|2|||
42222012|NCT02906930|76040579|FG000|Overall Study|Death|0|||
42222013|NCT02906930|76040580|FG001|Overall Study|Death|0|||
42222014|NCT02906930|76040581|FG002|Overall Study|Death|1|||
42222015|NCT02906930|76040582|FG003|Overall Study|Death|0|||
42222016|NCT02906930|76040579|FG000|Overall Study|Other|1|||
42222017|NCT02906930|76040580|FG001|Overall Study|Other|2|||
42222018|NCT02906930|76040581|FG002|Overall Study|Other|1|||
42222019|NCT02906930|76040582|FG003|Overall Study|Other|2|||
42222020|NCT02983604|76040596|FG000|Overall Study|Enrolled but not Treated|0|||
42222021|NCT02983604|76040597|FG001|Overall Study|Enrolled but not Treated|0|||
42222022|NCT02983604|76040598|FG002|Overall Study|Enrolled but not Treated|1|||
42222023|NCT02983604|76040599|FG003|Overall Study|Enrolled but not Treated|0|||
42222024|NCT02662582|76040611|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
41983067|NCT03538301|75789396|FG001|Overall Study|Adverse Event|4|||
42130985|NCT03684044|75941964|FG000|Overall Study|Adverse Event|3|||
42130986|NCT03684044|75941965|FG001|Overall Study|Adverse Event|0|||
42130987|NCT03684044|75941964|FG000|Overall Study|Death|4|||
42130988|NCT03684044|75941965|FG001|Overall Study|Death|7|||
42130989|NCT03684044|75941964|FG000|Overall Study|Lost to Follow-up|3|||
42130990|NCT03684044|75941965|FG001|Overall Study|Lost to Follow-up|2|||
42130991|NCT03684044|75941964|FG000|Overall Study|Patient Not Available|0|||
42130992|NCT03684044|75941965|FG001|Overall Study|Patient Not Available|2|||
42130993|NCT03684044|75941964|FG000|Overall Study|Physician Decision|1|||
42130994|NCT03684044|75941965|FG001|Overall Study|Physician Decision|0|||
42130995|NCT03684044|75941964|FG000|Overall Study|Withdrawal by Subject|11|||
42130996|NCT03684044|75941965|FG001|Overall Study|Withdrawal by Subject|9|||
42130997|NCT00510692|75941973|FG000|Overall Study|Adverse Event|1|||
42130998|NCT00510692|75941974|FG001|Overall Study|Adverse Event|3|||
42130999|NCT00510692|75941973|FG000|Overall Study|Withdrawal by Subject|1|||
41983068|NCT03538301|75789397|FG002|Overall Study|Adverse Event|4|||
41983069|NCT03538301|75789395|FG000|Overall Study|Death|1|||
41983070|NCT03538301|75789396|FG001|Overall Study|Death|1|||
41983071|NCT03538301|75789397|FG002|Overall Study|Death|0|||
41983072|NCT03538301|75789395|FG000|Overall Study|Physician Decision|0|||
41983073|NCT03538301|75789396|FG001|Overall Study|Physician Decision|1|||
41983074|NCT03538301|75789397|FG002|Overall Study|Physician Decision|0|||
41983075|NCT03538301|75789395|FG000|Overall Study|Protocol Violation|0|||
41983076|NCT03538301|75789396|FG001|Overall Study|Protocol Violation|0|||
41983077|NCT03538301|75789397|FG002|Overall Study|Protocol Violation|1|||
41983078|NCT03538301|75789395|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
41983079|NCT03538301|75789396|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
42029754|NCT00880555|75838266|FG005|Overall Study|Lost to Follow-up|0|||
42029755|NCT01208402|75838279|FG000|Overall Study|Withdrawal by Subject|1|||
42029756|NCT01208402|75838280|FG001|Overall Study|Withdrawal by Subject|0|||
42131000|NCT00510692|75941974|FG001|Overall Study|Withdrawal by Subject|0|||
42131001|NCT00335452|75941986|FG000|Overall Study|Death|156|||
42131002|NCT00335452|75941987|FG001|Overall Study|Death|144|||
42131003|NCT00335452|75941988|FG002|Overall Study|Death|158|||
42222025|NCT02662582|76040612|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
42131004|NCT00335452|75941989|FG003|Overall Study|Death|129|||
42131005|NCT00335452|75941986|FG000|Overall Study|Lost to Follow-up|2|||
42131006|NCT00335452|75941987|FG001|Overall Study|Lost to Follow-up|3|||
42131007|NCT00335452|75941988|FG002|Overall Study|Lost to Follow-up|1|||
42222026|NCT02662582|76040611|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
42222027|NCT02662582|76040612|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
42222028|NCT02662582|76040611|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
42222029|NCT02662582|76040612|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
42222030|NCT02662582|76040611|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
42222031|NCT02662582|76040612|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
42222032|NCT02908100|76040622|FG000|Overall Study|Adverse Event|7|||
42222033|NCT02908100|76040623|FG001|Overall Study|Adverse Event|6|||
42222034|NCT02908100|76040624|FG002|Overall Study|Adverse Event|9|||
42222035|NCT02908100|76040622|FG000|Overall Study|Death|2|||
42222036|NCT02908100|76040623|FG001|Overall Study|Death|0|||
42222037|NCT02908100|76040624|FG002|Overall Study|Death|0|||
42222038|NCT02908100|76040622|FG000|Overall Study|Lack of Efficacy|2|||
42222039|NCT02908100|76040623|FG001|Overall Study|Lack of Efficacy|3|||
42222040|NCT02908100|76040624|FG002|Overall Study|Lack of Efficacy|3|||
42222041|NCT02908100|76040622|FG000|Overall Study|Lost to Follow-up|0|||
42222042|NCT02908100|76040623|FG001|Overall Study|Lost to Follow-up|1|||
42222043|NCT02908100|76040624|FG002|Overall Study|Lost to Follow-up|2|||
42222044|NCT02908100|76040622|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42222045|NCT02908100|76040623|FG001|Overall Study|Non-Compliance With Study Drug|1|||
42222046|NCT02908100|76040624|FG002|Overall Study|Non-Compliance With Study Drug|2|||
42222047|NCT02908100|76040622|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
42222048|NCT02908100|76040623|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
42222049|NCT02908100|76040624|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
42222050|NCT02908100|76040622|FG000|Overall Study|Physician Decision|0|||
42222051|NCT02908100|76040623|FG001|Overall Study|Physician Decision|1|||
42222052|NCT02908100|76040624|FG002|Overall Study|Physician Decision|0|||
42222053|NCT02908100|76040622|FG000|Overall Study|Pregnancy|1|||
42222054|NCT02908100|76040623|FG001|Overall Study|Pregnancy|2|||
42222055|NCT02908100|76040624|FG002|Overall Study|Pregnancy|0|||
42222056|NCT02908100|76040622|FG000|Overall Study|Withdrawal by Subject|8|||
42222057|NCT02908100|76040623|FG001|Overall Study|Withdrawal by Subject|7|||
42222058|NCT02908100|76040624|FG002|Overall Study|Withdrawal by Subject|5|||
42222059|NCT02908100|76040622|FG000|Overall Study|Randomised in Error|1|||
42222060|NCT02908100|76040623|FG001|Overall Study|Randomised in Error|0|||
42222061|NCT02908100|76040624|FG002|Overall Study|Randomised in Error|0|||
42222062|NCT02982590|76040648|FG000|Overall Study|Lost to Follow-up|0|||
42222063|NCT02982590|76040649|FG001|Overall Study|Lost to Follow-up|1|||
42222064|NCT02982590|76040648|FG000|Overall Study|Death|4|||
42222065|NCT02982590|76040649|FG001|Overall Study|Death|0|||
42222066|NCT03310021|76040675|FG000|Overall Study|Withdrawal by Subject|0|||
42222067|NCT03310021|76040676|FG001|Overall Study|Withdrawal by Subject|0|||
42222068|NCT03310021|76040677|FG002|Overall Study|Withdrawal by Subject|0|||
42222069|NCT03310021|76040678|FG003|Overall Study|Withdrawal by Subject|0|||
42222070|NCT03310021|76040679|FG004|Overall Study|Withdrawal by Subject|0|||
42222071|NCT03310021|76040680|FG005|Overall Study|Withdrawal by Subject|0|||
42131008|NCT00335452|75941989|FG003|Overall Study|Lost to Follow-up|2|||
42131009|NCT00522548|75942006|FG000|Overall Study|Adverse Event|2|||
42131010|NCT00522548|75942007|FG001|Overall Study|Adverse Event|2|||
42131011|NCT00522548|75942006|FG000|Overall Study|Withdrawal by Subject|0|||
42131012|NCT00522548|75942007|FG001|Overall Study|Withdrawal by Subject|2|||
42131013|NCT00522392|75942015|FG000|Overall Study|Disease progression|0|||
42131014|NCT00522392|75942016|FG001|Overall Study|Disease progression|3|||
42131015|NCT00522392|75942015|FG000|Overall Study|Adverse Event|7|||
42131016|NCT00522392|75942016|FG001|Overall Study|Adverse Event|7|||
42131017|NCT00522392|75942015|FG000|Overall Study|Withdrawal by Subject|1|||
42131018|NCT00522392|75942016|FG001|Overall Study|Withdrawal by Subject|1|||
42131019|NCT00522392|75942015|FG000|Overall Study|Physician Decision|0|||
42131020|NCT00522392|75942016|FG001|Overall Study|Physician Decision|1|||
42131021|NCT00522392|75942015|FG000|Overall Study|Non-compliance|0|||
42131022|NCT00522392|75942016|FG001|Overall Study|Non-compliance|1|||
42131023|NCT00309244|75942024|FG000|Overall Study|Adverse Event|29|||
42131024|NCT00309244|75942025|FG001|Overall Study|Adverse Event|12|||
42131025|NCT00309244|75942024|FG000|Overall Study|Lost to Follow-up|6|||
42131026|NCT00309244|75942025|FG001|Overall Study|Lost to Follow-up|22|||
42131027|NCT00309244|75942024|FG000|Overall Study|Physician Decision|5|||
42131028|NCT00309244|75942025|FG001|Overall Study|Physician Decision|8|||
42131029|NCT00309244|75942024|FG000|Overall Study|Protocol Violation|6|||
42131030|NCT00309244|75942025|FG001|Overall Study|Protocol Violation|3|||
42131031|NCT00309244|75942024|FG000|Overall Study|Withdrawal by Subject|50|||
42131032|NCT00309244|75942025|FG001|Overall Study|Withdrawal by Subject|32|||
42131033|NCT00309244|75942024|FG000|Overall Study|Various|7|||
42131034|NCT00309244|75942025|FG001|Overall Study|Various|7|||
42131035|NCT00309244|75942024|FG000|Overall Study|Randomized but not dosed|11|||
42131036|NCT00309244|75942025|FG001|Overall Study|Randomized but not dosed|12|||
42222072|NCT03310021|76040681|FG006|Overall Study|Withdrawal by Subject|1|||
42131037|NCT00309244|75942024|FG000|Overall Study|Death|4|||
42222073|NCT03310021|76040682|FG007|Overall Study|Withdrawal by Subject|0|||
42222074|NCT03310021|76040683|FG008|Overall Study|Withdrawal by Subject|0|||
42222075|NCT03310021|76040684|FG009|Overall Study|Withdrawal by Subject|0|||
42222076|NCT03310021|76040685|FG010|Overall Study|Withdrawal by Subject|0|||
42222077|NCT03310021|76040686|FG011|Overall Study|Withdrawal by Subject|0|||
42222078|NCT03310021|76040687|FG012|Overall Study|Withdrawal by Subject|0|||
42222079|NCT03310021|76040688|FG013|Overall Study|Withdrawal by Subject|0|||
42222080|NCT03310021|76040689|FG014|Overall Study|Withdrawal by Subject|0|||
42222081|NCT03310021|76040690|FG015|Overall Study|Withdrawal by Subject|0|||
42222082|NCT03310021|76040691|FG016|Overall Study|Withdrawal by Subject|0|||
42222083|NCT03310021|76040692|FG017|Overall Study|Withdrawal by Subject|0|||
42222084|NCT03310021|76040693|FG018|Overall Study|Withdrawal by Subject|0|||
42222085|NCT03310021|76040694|FG019|Overall Study|Withdrawal by Subject|0|||
42222086|NCT03310021|76040675|FG000|Overall Study|Lost to Follow-up|0|||
42222087|NCT03310021|76040676|FG001|Overall Study|Lost to Follow-up|0|||
42222088|NCT03310021|76040677|FG002|Overall Study|Lost to Follow-up|0|||
42222089|NCT03310021|76040678|FG003|Overall Study|Lost to Follow-up|0|||
42222090|NCT03310021|76040679|FG004|Overall Study|Lost to Follow-up|0|||
42222091|NCT03310021|76040680|FG005|Overall Study|Lost to Follow-up|0|||
42222092|NCT03310021|76040681|FG006|Overall Study|Lost to Follow-up|0|||
42222093|NCT03310021|76040682|FG007|Overall Study|Lost to Follow-up|0|||
42222094|NCT03310021|76040683|FG008|Overall Study|Lost to Follow-up|0|||
42222095|NCT03310021|76040684|FG009|Overall Study|Lost to Follow-up|0|||
42222096|NCT03310021|76040685|FG010|Overall Study|Lost to Follow-up|1|||
42222097|NCT03310021|76040686|FG011|Overall Study|Lost to Follow-up|0|||
42222098|NCT03310021|76040687|FG012|Overall Study|Lost to Follow-up|0|||
42222099|NCT03310021|76040688|FG013|Overall Study|Lost to Follow-up|0|||
42222100|NCT03310021|76040689|FG014|Overall Study|Lost to Follow-up|0|||
42222101|NCT03310021|76040690|FG015|Overall Study|Lost to Follow-up|0|||
42222102|NCT03310021|76040691|FG016|Overall Study|Lost to Follow-up|0|||
42222103|NCT03310021|76040692|FG017|Overall Study|Lost to Follow-up|0|||
42222104|NCT03310021|76040693|FG018|Overall Study|Lost to Follow-up|0|||
42222105|NCT03310021|76040694|FG019|Overall Study|Lost to Follow-up|0|||
42222106|NCT03333109|76040739|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
42222107|NCT03333109|76040740|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
42222108|NCT03333109|76040741|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
42222109|NCT03333109|76040739|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
42222110|NCT03333109|76040740|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
42222111|NCT03333109|76040741|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
42222112|NCT03333109|76040739|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
42222113|NCT03333109|76040740|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
42222114|NCT03333109|76040741|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
42222115|NCT03333109|76040739|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
42131038|NCT00309244|75942025|FG001|Overall Study|Death|1|||
42131039|NCT00483756|75942034|FG000|Overall Study|Death|2|||
42131040|NCT00483756|75942035|FG001|Overall Study|Death|0|||
42222116|NCT03333109|76040740|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
42222117|NCT03333109|76040741|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
42222118|NCT03333109|76040739|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
42222119|NCT03333109|76040740|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
42222120|NCT03333109|76040741|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
42222121|NCT03333109|76040739|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
42222122|NCT03333109|76040740|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
42222123|NCT03333109|76040741|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
42222124|NCT03333109|76040739|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
42222125|NCT03333109|76040740|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
42222126|NCT03333109|76040741|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
42222127|NCT03333109|76040739|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
42222128|NCT03333109|76040740|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
42222129|NCT03333109|76040741|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
42222130|NCT02940223|76040751|FG000|Overall Study|Failed Requirement|2|||
42222131|NCT02940223|76040752|FG001|Overall Study|Failed Requirement|0|||
41983080|NCT03538301|75789397|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
41983081|NCT03485157|75789407|FG000|Double Blind Phase|Lost to Follow-up|4|||
41983082|NCT03485157|75789408|FG001|Double Blind Phase|Lost to Follow-up|4|||
42131041|NCT00483756|75942036|FG002|Overall Study|Death|1|||
42131042|NCT00483756|75942034|FG000|Overall Study|Adverse Event|19|||
42131043|NCT00483756|75942035|FG001|Overall Study|Adverse Event|38|||
42131044|NCT00483756|75942036|FG002|Overall Study|Adverse Event|40|||
42131045|NCT00483756|75942034|FG000|Overall Study|Lack of Efficacy|1|||
42131046|NCT00483756|75942035|FG001|Overall Study|Lack of Efficacy|0|||
42131047|NCT00483756|75942036|FG002|Overall Study|Lack of Efficacy|0|||
42131048|NCT00483756|75942034|FG000|Overall Study|Lost to Follow-up|3|||
42222132|NCT03295201|76040760|FG000|Overall Study|Lost to Follow-up|1|||
42222133|NCT03295201|76040761|FG001|Overall Study|Lost to Follow-up|1|||
42222134|NCT03295201|76040760|FG000|Overall Study|Hospital admission|0|||
42222135|NCT03295201|76040761|FG001|Overall Study|Hospital admission|1|||
42302263|NCT02494921|76137340|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
42222136|NCT03293485|76040767|FG000|Overall Study|Death|1|||
42222137|NCT03293485|76040767|FG000|Overall Study|Screen Failure|2|||
42222138|NCT03293485|76040767|FG000|Overall Study|Withdrawal by Subject|2|||
42222139|NCT03309943|76040775|FG000|Overall Study|Withdrawal by Subject|0|||
42222140|NCT03309943|76040776|FG001|Overall Study|Withdrawal by Subject|1|||
42222141|NCT03309943|76040775|FG000|Overall Study|Inappropriate behavior towards staff|0|||
42222142|NCT03309943|76040776|FG001|Overall Study|Inappropriate behavior towards staff|1|||
42222143|NCT01732627|76040784|FG000|Overall Study|Withdrawal by Subject|1|||
41983083|NCT03485157|75789407|FG000|Double Blind Phase|Adverse Event|2|||
41983084|NCT03485157|75789408|FG001|Double Blind Phase|Adverse Event|1|||
41983085|NCT03485157|75789407|FG000|Double Blind Phase|Withdrawal by Subject|6|||
41983086|NCT03485157|75789408|FG001|Double Blind Phase|Withdrawal by Subject|9|||
41983087|NCT03485157|75789407|FG000|Double Blind Phase|Removal by PI|3|||
41983088|NCT03485157|75789408|FG001|Double Blind Phase|Removal by PI|7|||
41983089|NCT03485157|75789407|FG000|Open Label Phase|Lost to Follow-up|1|||
41983090|NCT03485157|75789408|FG001|Open Label Phase|Lost to Follow-up|2|||
41983091|NCT03485157|75789407|FG000|Open Label Phase|Adverse Event|0|||
41983092|NCT03485157|75789408|FG001|Open Label Phase|Adverse Event|1|||
41983093|NCT03485157|75789407|FG000|Open Label Phase|Withdrawal by Subject|1|||
42131049|NCT00483756|75942035|FG001|Overall Study|Lost to Follow-up|1|||
42131050|NCT00483756|75942036|FG002|Overall Study|Lost to Follow-up|0|||
42131051|NCT00483756|75942034|FG000|Overall Study|Withdrawal by Subject|5|||
42131052|NCT00483756|75942035|FG001|Overall Study|Withdrawal by Subject|3|||
42131053|NCT00483756|75942036|FG002|Overall Study|Withdrawal by Subject|4|||
42131054|NCT00483756|75942034|FG000|Overall Study|Other|2|||
42131055|NCT00483756|75942035|FG001|Overall Study|Other|4|||
42131056|NCT00483756|75942036|FG002|Overall Study|Other|3|||
42131057|NCT00483756|75942034|FG000|Overall Study|Randomized, Not Treated|1|||
42131058|NCT00483756|75942035|FG001|Overall Study|Randomized, Not Treated|4|||
42131059|NCT00483756|75942036|FG002|Overall Study|Randomized, Not Treated|4|||
42131060|NCT00309166|75942046|FG000|Overall Study|Adverse event, non-fatal|1|||
42131061|NCT00309166|75942047|FG001|Overall Study|Adverse event, non-fatal|0|||
42131062|NCT00309166|75942046|FG000|Overall Study|Withdrawal by Subject|4|||
42131063|NCT00309166|75942047|FG001|Overall Study|Withdrawal by Subject|3|||
42131064|NCT00501852|75942053|FG000|Overall Study|Adverse Event|3|||
42131065|NCT00501852|75942053|FG000|Overall Study|Withdrawal by Subject|2|||
42131066|NCT00482274|75942067|FG000|Overall Study|Adverse Event|1|||
42131067|NCT00490542|75942073|FG000|Overall Study|Lost to Follow-up|3|||
42131068|NCT00490542|75942074|FG001|Overall Study|Lost to Follow-up|0|||
42131069|NCT00490542|75942073|FG000|Overall Study|Adverse Event|3|||
42131070|NCT00490542|75942074|FG001|Overall Study|Adverse Event|3|||
42131071|NCT00490542|75942073|FG000|Overall Study|Lack of Efficacy|1|||
42131072|NCT00490542|75942074|FG001|Overall Study|Lack of Efficacy|1|||
42131073|NCT00501540|75942080|FG000|Overall Study|Death|5|||
42131074|NCT00322348|75942086|FG000|Overall Study|Adverse Event|0|||
42131075|NCT00322348|75942087|FG001|Overall Study|Adverse Event|1|||
42131076|NCT00322348|75942086|FG000|Overall Study|Withdrawal by Subject|1|||
42131077|NCT00322348|75942087|FG001|Overall Study|Withdrawal by Subject|4|||
42131078|NCT00322348|75942086|FG000|Overall Study|Lost to Follow-up|1|||
42131079|NCT00322348|75942087|FG001|Overall Study|Lost to Follow-up|0|||
42131080|NCT00322348|75942086|FG000|Overall Study|Death|0|||
42131081|NCT00322348|75942087|FG001|Overall Study|Death|2|||
42131082|NCT00322348|75942086|FG000|Overall Study|Disease Progression|30|||
42131083|NCT00322348|75942087|FG001|Overall Study|Disease Progression|25|||
42131084|NCT00322348|75942086|FG000|Overall Study|Reasons not specified|5|||
42131085|NCT00322348|75942087|FG001|Overall Study|Reasons not specified|1|||
42131086|NCT00501228|75942093|FG000|Overall Study|Withdrawal by Subject|1|||
42131087|NCT00308620|75942100|FG000|Overall Study|Death|1|||
42131088|NCT00308620|75942101|FG001|Overall Study|Death|1|||
42131089|NCT00308620|75942102|FG002|Overall Study|Death|0|||
42131090|NCT00308620|75942100|FG000|Overall Study|Lost to Follow-up|0|||
42131091|NCT00308620|75942101|FG001|Overall Study|Lost to Follow-up|0|||
42131092|NCT00308620|75942102|FG002|Overall Study|Lost to Follow-up|1|||
42131093|NCT00492752|75942112|FG000|Double Blind Treatment|Death|13|||
42131094|NCT00492752|75942113|FG001|Double Blind Treatment|Death|0|||
42131095|NCT00492752|75942114|FG002|Double Blind Treatment|Death|2|||
42131096|NCT00492752|75942115|FG003|Double Blind Treatment|Death|0|||
42131097|NCT00492752|75942112|FG000|Double Blind Treatment|Adverse Event|1|||
42029757|NCT01208324|75838290|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
42131098|NCT00492752|75942113|FG001|Double Blind Treatment|Adverse Event|0|||
42131099|NCT00492752|75942114|FG002|Double Blind Treatment|Adverse Event|0|||
42131100|NCT00492752|75942115|FG003|Double Blind Treatment|Adverse Event|0|||
42131101|NCT00492752|75942112|FG000|Double Blind Treatment|Protocol Violation|0|||
42131102|NCT00492752|75942113|FG001|Double Blind Treatment|Protocol Violation|0|||
42131103|NCT00492752|75942114|FG002|Double Blind Treatment|Protocol Violation|1|||
42131104|NCT00492752|75942115|FG003|Double Blind Treatment|Protocol Violation|0|||
42131105|NCT00492752|75942112|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
41983094|NCT03485157|75789408|FG001|Open Label Phase|Withdrawal by Subject|2|||
42222144|NCT01732627|76040785|FG001|Overall Study|Withdrawal by Subject|0|||
42222145|NCT03307837|76040797|FG000|Overall Study|Withdrawal by Subject|0|||
42222146|NCT03307837|76040798|FG001|Overall Study|Withdrawal by Subject|0|||
42222147|NCT03307837|76040799|FG002|Overall Study|Withdrawal by Subject|1|||
42222148|NCT03307837|76040800|FG003|Overall Study|Withdrawal by Subject|0|||
42222149|NCT03307837|76040801|FG004|Overall Study|Withdrawal by Subject|0|||
42222150|NCT03307837|76040802|FG005|Overall Study|Withdrawal by Subject|1|||
42222151|NCT03307837|76040797|FG000|Overall Study|Lost to Follow-up|1|||
42222152|NCT03307837|76040798|FG001|Overall Study|Lost to Follow-up|1|||
42222153|NCT03307837|76040799|FG002|Overall Study|Lost to Follow-up|0|||
42222154|NCT03307837|76040800|FG003|Overall Study|Lost to Follow-up|0|||
42222155|NCT03307837|76040801|FG004|Overall Study|Lost to Follow-up|0|||
42222156|NCT03307837|76040802|FG005|Overall Study|Lost to Follow-up|1|||
42131106|NCT00492752|75942113|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
42131107|NCT00492752|75942114|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
42131108|NCT00492752|75942115|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
42131109|NCT00492752|75942112|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
42131110|NCT00492752|75942113|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
42131111|NCT00492752|75942114|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
42131112|NCT00492752|75942115|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
42131113|NCT00492752|75942112|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
42131114|NCT00492752|75942113|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
42131115|NCT00492752|75942114|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
42131116|NCT00492752|75942115|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
42131117|NCT00492752|75942112|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
42131118|NCT00492752|75942113|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
42131119|NCT00492752|75942114|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
42131120|NCT00492752|75942115|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
42131121|NCT00492752|75942112|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
42131122|NCT00492752|75942113|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
42131123|NCT00492752|75942114|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
42131124|NCT00492752|75942115|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
42131125|NCT00492752|75942112|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
42131126|NCT00492752|75942113|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
42131127|NCT00492752|75942114|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
42131128|NCT00492752|75942115|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
42131129|NCT00492752|75942112|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
42131130|NCT00492752|75942113|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
42131131|NCT00492752|75942114|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
42131132|NCT00492752|75942115|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
42131133|NCT00492752|75942112|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
42131134|NCT00492752|75942113|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
42131135|NCT00492752|75942114|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
42131136|NCT00492752|75942115|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
42131137|NCT00308308|75942124|FG000|Overall Study|Adverse Event|17|||
42131138|NCT00308308|75942125|FG001|Overall Study|Adverse Event|2|||
42131139|NCT00308308|75942124|FG000|Overall Study|Lost to Follow-up|5|||
42131140|NCT00308308|75942125|FG001|Overall Study|Lost to Follow-up|5|||
42131141|NCT00308308|75942124|FG000|Overall Study|Physician Decision|15|||
42131142|NCT00308308|75942125|FG001|Overall Study|Physician Decision|7|||
42131143|NCT00308308|75942124|FG000|Overall Study|Protocol Violation|3|||
42131144|NCT00308308|75942125|FG001|Overall Study|Protocol Violation|14|||
42131145|NCT00308308|75942124|FG000|Overall Study|Withdrawal by Subject|47|||
42131146|NCT00308308|75942125|FG001|Overall Study|Withdrawal by Subject|19|||
42131147|NCT00308308|75942124|FG000|Overall Study|Various|7|||
42131148|NCT00308308|75942125|FG001|Overall Study|Various|5|||
42131149|NCT00308308|75942124|FG000|Overall Study|Randomized but not dosed|8|||
42222157|NCT03331315|76040823|FG000|Overall Study|Physician Decision|18|||
42222158|NCT03331315|76040824|FG001|Overall Study|Physician Decision|14|||
42029758|NCT01208324|75838291|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
42029759|NCT01208324|75838292|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
42029760|NCT01208324|75838293|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
42029761|NCT00880399|75838306|FG000|Overall Study|Adverse Event|4|||
42222159|NCT03329989|76040832|FG000|Overall Study|Withdrawal by Subject|9|||
42222160|NCT03329989|76040832|FG000|Overall Study|Lost to Follow-up|8|||
42222161|NCT03329989|76040832|FG000|Overall Study|Adverse Event|5|||
42222162|NCT03329989|76040832|FG000|Overall Study|Protocol Violation|1|||
42222163|NCT03287869|76040838|FG000|Overall Study|Adverse Event|14|||
42222164|NCT03287869|76040839|FG001|Overall Study|Adverse Event|12|||
42222165|NCT03287869|76040838|FG000|Overall Study|Lack of Efficacy|1|||
42222166|NCT03287869|76040839|FG001|Overall Study|Lack of Efficacy|0|||
42222167|NCT03287869|76040838|FG000|Overall Study|Lost to Follow-up|13|||
42222168|NCT03287869|76040839|FG001|Overall Study|Lost to Follow-up|19|||
42222169|NCT03287869|76040838|FG000|Overall Study|Non-Compliance With Study Drug|5|||
42222170|NCT03287869|76040839|FG001|Overall Study|Non-Compliance With Study Drug|9|||
42222171|NCT03287869|76040838|FG000|Overall Study|Progressive Disease|1|||
42222172|NCT03287869|76040839|FG001|Overall Study|Progressive Disease|0|||
42222173|NCT03287869|76040838|FG000|Overall Study|Protocol Deviation|2|||
42222174|NCT03287869|76040839|FG001|Overall Study|Protocol Deviation|1|||
42222175|NCT03287869|76040838|FG000|Overall Study|Withdrawal by Subject|36|||
42222176|NCT03287869|76040839|FG001|Overall Study|Withdrawal by Subject|43|||
42222177|NCT03287869|76040838|FG000|Overall Study|Early Closure of the Site|0|||
42222178|NCT03287869|76040839|FG001|Overall Study|Early Closure of the Site|1|||
42222179|NCT03287869|76040838|FG000|Overall Study|Physician Decision|5|||
42222180|NCT03287869|76040839|FG001|Overall Study|Physician Decision|5|||
42222181|NCT03287869|76040838|FG000|Overall Study|Reason not Specified|6|||
42029762|NCT00880399|75838307|FG001|Overall Study|Adverse Event|6|||
42029763|NCT00880399|75838308|FG002|Overall Study|Adverse Event|5|||
42029764|NCT00880399|75838306|FG000|Overall Study|Lack of Efficacy|1|||
42029765|NCT00880399|75838307|FG001|Overall Study|Lack of Efficacy|4|||
42029766|NCT00880399|75838308|FG002|Overall Study|Lack of Efficacy|2|||
42029767|NCT00880399|75838306|FG000|Overall Study|Protocol Violation|4|||
42029768|NCT00880399|75838307|FG001|Overall Study|Protocol Violation|4|||
42029769|NCT00880399|75838308|FG002|Overall Study|Protocol Violation|6|||
42029770|NCT00880399|75838306|FG000|Overall Study|Study closed/terminated|3|||
42029771|NCT00880399|75838307|FG001|Overall Study|Study closed/terminated|7|||
42029772|NCT00880399|75838308|FG002|Overall Study|Study closed/terminated|4|||
42029773|NCT00880399|75838306|FG000|Overall Study|Lost to Follow-up|8|||
42029774|NCT00880399|75838307|FG001|Overall Study|Lost to Follow-up|5|||
42029775|NCT00880399|75838308|FG002|Overall Study|Lost to Follow-up|3|||
42029776|NCT00880399|75838306|FG000|Overall Study|Physician Decision|5|||
42029777|NCT00880399|75838307|FG001|Overall Study|Physician Decision|0|||
42029778|NCT00880399|75838308|FG002|Overall Study|Physician Decision|3|||
42029779|NCT00880399|75838306|FG000|Overall Study|Withdrawal by Subject|6|||
42029780|NCT00880399|75838307|FG001|Overall Study|Withdrawal by Subject|3|||
42029781|NCT00880399|75838308|FG002|Overall Study|Withdrawal by Subject|3|||
42029782|NCT01207388|75838316|FG000|Overall Study|Death|67|||
42029783|NCT01207388|75838316|FG000|Overall Study|Withdrawal by Subject|1|||
42029784|NCT01206764|75838328|FG000|Overall Study|Adverse Event|20|||
42029785|NCT01206764|75838328|FG000|Overall Study|Abnormal laboratory value|2|||
42029786|NCT01206764|75838328|FG000|Overall Study|Abnormal test procedure result|1|||
42029787|NCT01206764|75838328|FG000|Overall Study|Patient withdrew consent|5|||
42029788|NCT01206764|75838328|FG000|Overall Study|Lost to Follow-up|6|||
42222182|NCT03287869|76040839|FG001|Overall Study|Reason not Specified|3|||
42222183|NCT02661490|76040850|FG000|Overall Study|Lost to Follow-up|0|||
42222184|NCT02661490|76040851|FG001|Overall Study|Lost to Follow-up|1|||
42222185|NCT02661490|76040852|FG002|Overall Study|Lost to Follow-up|0|||
42222186|NCT02661490|76040853|FG003|Overall Study|Lost to Follow-up|0|||
42222187|NCT02661490|76040854|FG004|Overall Study|Lost to Follow-up|2|||
42222188|NCT02661490|76040850|FG000|Overall Study|Withdrawal by Subject|2|||
42222189|NCT02661490|76040851|FG001|Overall Study|Withdrawal by Subject|0|||
42222190|NCT02661490|76040852|FG002|Overall Study|Withdrawal by Subject|2|||
42222191|NCT02661490|76040853|FG003|Overall Study|Withdrawal by Subject|0|||
42222192|NCT02661490|76040854|FG004|Overall Study|Withdrawal by Subject|0|||
42222193|NCT02661490|76040850|FG000|Overall Study|Death|1|||
42222194|NCT02661490|76040851|FG001|Overall Study|Death|1|||
42222195|NCT02661490|76040852|FG002|Overall Study|Death|0|||
42222196|NCT02661490|76040853|FG003|Overall Study|Death|1|||
42222197|NCT02661490|76040854|FG004|Overall Study|Death|0|||
42222198|NCT02661490|76040850|FG000|Overall Study|Reason not Specified|0|||
42222199|NCT02661490|76040851|FG001|Overall Study|Reason not Specified|0|||
42222200|NCT02661490|76040852|FG002|Overall Study|Reason not Specified|0|||
42222201|NCT02661490|76040853|FG003|Overall Study|Reason not Specified|0|||
42222202|NCT02661490|76040854|FG004|Overall Study|Reason not Specified|1|||
42222203|NCT03287791|76040869|FG000|Overall Study|Insufficient Therapeutic Response|0|||
42222204|NCT03287791|76040870|FG001|Overall Study|Insufficient Therapeutic Response|0|||
42222205|NCT03287791|76040871|FG002|Overall Study|Insufficient Therapeutic Response|1|||
42222206|NCT03287791|76040869|FG000|Overall Study|Adverse Event|0|||
42222207|NCT03287791|76040870|FG001|Overall Study|Adverse Event|4|||
42222208|NCT03287791|76040871|FG002|Overall Study|Adverse Event|3|||
42222209|NCT03287791|76040869|FG000|Overall Study|Withdrawal by Subject|12|||
42222210|NCT03287791|76040870|FG001|Overall Study|Withdrawal by Subject|12|||
42222211|NCT03287791|76040871|FG002|Overall Study|Withdrawal by Subject|17|||
42222212|NCT03287791|76040869|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
42222213|NCT03287791|76040870|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
42222214|NCT03287791|76040871|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
42222215|NCT03287791|76040869|FG000|Overall Study|Lost to Follow-up|8|||
42222216|NCT03287791|76040870|FG001|Overall Study|Lost to Follow-up|14|||
42222217|NCT03287791|76040871|FG002|Overall Study|Lost to Follow-up|11|||
42222218|NCT03287791|76040869|FG000|Overall Study|Protocol Violation|7|||
42222219|NCT03287791|76040870|FG001|Overall Study|Protocol Violation|2|||
42222220|NCT03287791|76040871|FG002|Overall Study|Protocol Violation|1|||
42222221|NCT03287791|76040869|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
42222222|NCT03287791|76040870|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
42222223|NCT03287791|76040871|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
42222224|NCT03287791|76040869|FG000|Overall Study|Too much time between 2 visits|0|||
42222225|NCT03287791|76040870|FG001|Overall Study|Too much time between 2 visits|1|||
42222226|NCT03287791|76040871|FG002|Overall Study|Too much time between 2 visits|0|||
42222227|NCT03287791|76040869|FG000|Overall Study|Non-compliance|0|||
42222228|NCT03287791|76040870|FG001|Overall Study|Non-compliance|1|||
42222229|NCT03287791|76040871|FG002|Overall Study|Non-compliance|0|||
42222230|NCT03287791|76040869|FG000|Overall Study|Did not meet inclusion criteria|1|||
42222231|NCT03287791|76040870|FG001|Overall Study|Did not meet inclusion criteria|0|||
42222232|NCT03287791|76040871|FG002|Overall Study|Did not meet inclusion criteria|0|||
42222233|NCT03287635|76040879|FG000|Overall Study|Lost to Follow-up|5|||
42222234|NCT03287635|76040879|FG000|Overall Study|Withdrawal by Subject|1|||
42222235|NCT03287635|76040879|FG000|Overall Study|Physician Decision|1|||
42222236|NCT03287089|76040885|FG000|Overall Study|Lost to Follow-up|0|||
42222237|NCT03287089|76040886|FG001|Overall Study|Lost to Follow-up|2|||
42222238|NCT03287089|76040885|FG000|Overall Study|Physician Decision|0|||
42222239|NCT03287089|76040886|FG001|Overall Study|Physician Decision|2|||
42222240|NCT03287089|76040885|FG000|Overall Study|Withdrawal by Subject|0|||
42222241|NCT03287089|76040886|FG001|Overall Study|Withdrawal by Subject|2|||
42222242|NCT03286543|76040894|FG000|Consented|Screen failure before randomization|2|||
42222243|NCT03286543|76040895|FG001|Consented|Screen failure before randomization|0|||
42222244|NCT03286543|76040896|FG002|Consented|Screen failure before randomization|0|||
42222245|NCT03286543|76040894|FG000|Consented|Screen failure before enrollment|4|||
42222246|NCT03286543|76040895|FG001|Consented|Screen failure before enrollment|0|||
42222247|NCT03286543|76040896|FG002|Consented|Screen failure before enrollment|0|||
42222248|NCT03286543|76040894|FG000|Consented|TKA cancelled after enrollment|1|||
42222249|NCT03286543|76040895|FG001|Consented|TKA cancelled after enrollment|0|||
42222250|NCT03286543|76040896|FG002|Consented|TKA cancelled after enrollment|0|||
42222251|NCT03286543|76040894|FG000|Consented|Withdrawn from study|12|||
42222252|NCT03286543|76040895|FG001|Consented|Withdrawn from study|0|||
42222253|NCT03286543|76040896|FG002|Consented|Withdrawn from study|0|||
42222254|NCT03286543|76040894|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
42222255|NCT03286543|76040895|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
42222256|NCT03286543|76040896|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
42222257|NCT03286543|76040894|FG000|Study Enrollment|Withdrawn from study|0|||
42222258|NCT03286543|76040895|FG001|Study Enrollment|Withdrawn from study|6|||
42222259|NCT03286543|76040896|FG002|Study Enrollment|Withdrawn from study|6|||
42222260|NCT03306433|76040902|FG000|Overall Study|Lost to Follow-up|3|||
42222261|NCT03306433|76040902|FG000|Overall Study|Patient did not have teeth extracted|1|||
42222262|NCT03306433|76040902|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
42222263|NCT02940691|76040910|FG000|Overall Study|Lost to Follow-up|5|||
42222264|NCT02940691|76040910|FG000|Overall Study|Incarceration|1|||
42222265|NCT03306277|76040948|FG000|Overall Study|Death|1|||
42222266|NCT03306277|76040948|FG000|Overall Study|Adverse Event|1|||
42222267|NCT03306277|76040948|FG000|Overall Study|Withdrawal by Subject|1|||
42222268|NCT03130959|76040962|FG000|Overall Study|Disease progression|19|||
42222269|NCT03130959|76040963|FG001|Overall Study|Disease progression|7|||
42222270|NCT03130959|76040964|FG002|Overall Study|Disease progression|12|||
42222271|NCT03130959|76040965|FG003|Overall Study|Disease progression|7|||
42222272|NCT03130959|76040966|FG004|Overall Study|Disease progression|12|||
42222273|NCT03130959|76040967|FG005|Overall Study|Disease progression|3|||
42222274|NCT03130959|76040968|FG006|Overall Study|Disease progression|6|||
42222275|NCT03130959|76040969|FG007|Overall Study|Disease progression|3|||
42222276|NCT03130959|76040970|FG008|Overall Study|Disease progression|15|||
42222277|NCT03130959|76040971|FG009|Overall Study|Disease progression|8|||
42222278|NCT03130959|76040962|FG000|Overall Study|Study drug toxicity|2|||
42302264|NCT02494921|76137341|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
42222279|NCT03130959|76040963|FG001|Overall Study|Study drug toxicity|2|||
42222280|NCT03130959|76040964|FG002|Overall Study|Study drug toxicity|1|||
42222281|NCT03130959|76040965|FG003|Overall Study|Study drug toxicity|2|||
42222282|NCT03130959|76040966|FG004|Overall Study|Study drug toxicity|1|||
42222283|NCT03130959|76040967|FG005|Overall Study|Study drug toxicity|1|||
42222284|NCT03130959|76040968|FG006|Overall Study|Study drug toxicity|3|||
42222285|NCT03130959|76040969|FG007|Overall Study|Study drug toxicity|0|||
42222286|NCT03130959|76040970|FG008|Overall Study|Study drug toxicity|3|||
42222287|NCT03130959|76040971|FG009|Overall Study|Study drug toxicity|3|||
42222288|NCT03130959|76040962|FG000|Overall Study|Other reasons|0|||
42222289|NCT03130959|76040963|FG001|Overall Study|Other reasons|0|||
42222290|NCT03130959|76040964|FG002|Overall Study|Other reasons|0|||
42222291|NCT03130959|76040965|FG003|Overall Study|Other reasons|0|||
42222292|NCT03130959|76040966|FG004|Overall Study|Other reasons|0|||
42222293|NCT03130959|76040967|FG005|Overall Study|Other reasons|1|||
42222294|NCT03130959|76040968|FG006|Overall Study|Other reasons|1|||
42222295|NCT03130959|76040969|FG007|Overall Study|Other reasons|0|||
42222296|NCT03130959|76040970|FG008|Overall Study|Other reasons|0|||
42222297|NCT03130959|76040971|FG009|Overall Study|Other reasons|0|||
42222298|NCT03130959|76040962|FG000|Overall Study|Subject request to discontinue therapy|0|||
42222299|NCT03130959|76040963|FG001|Overall Study|Subject request to discontinue therapy|0|||
42222300|NCT03130959|76040964|FG002|Overall Study|Subject request to discontinue therapy|1|||
42222301|NCT03130959|76040965|FG003|Overall Study|Subject request to discontinue therapy|1|||
42222302|NCT03130959|76040966|FG004|Overall Study|Subject request to discontinue therapy|0|||
42222303|NCT03130959|76040967|FG005|Overall Study|Subject request to discontinue therapy|0|||
42222304|NCT03130959|76040968|FG006|Overall Study|Subject request to discontinue therapy|1|||
42222305|NCT03130959|76040969|FG007|Overall Study|Subject request to discontinue therapy|1|||
42222306|NCT03130959|76040970|FG008|Overall Study|Subject request to discontinue therapy|0|||
42222307|NCT03130959|76040971|FG009|Overall Study|Subject request to discontinue therapy|0|||
42222308|NCT03130959|76040962|FG000|Overall Study|Not reported|0|||
42222309|NCT03130959|76040963|FG001|Overall Study|Not reported|0|||
42222310|NCT03130959|76040964|FG002|Overall Study|Not reported|0|||
42222311|NCT03130959|76040965|FG003|Overall Study|Not reported|1|||
42222312|NCT03130959|76040966|FG004|Overall Study|Not reported|0|||
42222313|NCT03130959|76040967|FG005|Overall Study|Not reported|1|||
42222314|NCT03130959|76040968|FG006|Overall Study|Not reported|0|||
42222315|NCT03130959|76040969|FG007|Overall Study|Not reported|0|||
42222316|NCT03130959|76040970|FG008|Overall Study|Not reported|0|||
42222317|NCT03130959|76040971|FG009|Overall Study|Not reported|1|||
42222318|NCT03130959|76040962|FG000|Overall Study|Adverse Event unrelated to drug|0|||
42222319|NCT03130959|76040963|FG001|Overall Study|Adverse Event unrelated to drug|0|||
42222320|NCT03130959|76040964|FG002|Overall Study|Adverse Event unrelated to drug|1|||
42222321|NCT03130959|76040965|FG003|Overall Study|Adverse Event unrelated to drug|1|||
42222322|NCT03130959|76040966|FG004|Overall Study|Adverse Event unrelated to drug|1|||
42222323|NCT03130959|76040967|FG005|Overall Study|Adverse Event unrelated to drug|0|||
42222324|NCT03130959|76040968|FG006|Overall Study|Adverse Event unrelated to drug|1|||
42222325|NCT03130959|76040969|FG007|Overall Study|Adverse Event unrelated to drug|0|||
42222326|NCT03130959|76040970|FG008|Overall Study|Adverse Event unrelated to drug|1|||
42222327|NCT03130959|76040971|FG009|Overall Study|Adverse Event unrelated to drug|1|||
42222328|NCT03130959|76040962|FG000|Overall Study|Participant withdrew consent|0|||
42222329|NCT03130959|76040963|FG001|Overall Study|Participant withdrew consent|1|||
42222330|NCT03130959|76040964|FG002|Overall Study|Participant withdrew consent|0|||
42222331|NCT03130959|76040965|FG003|Overall Study|Participant withdrew consent|2|||
42222332|NCT03130959|76040966|FG004|Overall Study|Participant withdrew consent|1|||
42222333|NCT03130959|76040967|FG005|Overall Study|Participant withdrew consent|0|||
42222334|NCT03130959|76040968|FG006|Overall Study|Participant withdrew consent|0|||
42222335|NCT03130959|76040969|FG007|Overall Study|Participant withdrew consent|0|||
42222336|NCT03130959|76040970|FG008|Overall Study|Participant withdrew consent|0|||
42222337|NCT03130959|76040971|FG009|Overall Study|Participant withdrew consent|2|||
42222338|NCT03130959|76040962|FG000|Overall Study|Administrative reason by sponsor|1|||
42222339|NCT03130959|76040963|FG001|Overall Study|Administrative reason by sponsor|0|||
42222340|NCT03130959|76040964|FG002|Overall Study|Administrative reason by sponsor|1|||
42302265|NCT02494921|76137342|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
42222341|NCT03130959|76040965|FG003|Overall Study|Administrative reason by sponsor|0|||
42222342|NCT03130959|76040966|FG004|Overall Study|Administrative reason by sponsor|0|||
42222343|NCT03130959|76040967|FG005|Overall Study|Administrative reason by sponsor|0|||
42222344|NCT03130959|76040968|FG006|Overall Study|Administrative reason by sponsor|0|||
42222345|NCT03130959|76040969|FG007|Overall Study|Administrative reason by sponsor|0|||
42222346|NCT03130959|76040970|FG008|Overall Study|Administrative reason by sponsor|0|||
42222347|NCT03130959|76040971|FG009|Overall Study|Administrative reason by sponsor|0|||
42222348|NCT03130959|76040962|FG000|Overall Study|Lost to Follow-up|1|||
42222349|NCT03130959|76040963|FG001|Overall Study|Lost to Follow-up|0|||
42222350|NCT03130959|76040964|FG002|Overall Study|Lost to Follow-up|0|||
42029789|NCT01206764|75838328|FG000|Overall Study|Death|11|||
42222351|NCT03130959|76040965|FG003|Overall Study|Lost to Follow-up|0|||
42222352|NCT03130959|76040966|FG004|Overall Study|Lost to Follow-up|0|||
42222353|NCT03130959|76040967|FG005|Overall Study|Lost to Follow-up|0|||
42222354|NCT03130959|76040968|FG006|Overall Study|Lost to Follow-up|0|||
42222355|NCT03130959|76040969|FG007|Overall Study|Lost to Follow-up|0|||
42222356|NCT03130959|76040970|FG008|Overall Study|Lost to Follow-up|0|||
42222357|NCT03130959|76040971|FG009|Overall Study|Lost to Follow-up|0|||
42222358|NCT03124407|76041010|FG000|Overall Study|Lost to Follow-up|1|||
42222359|NCT03124407|76041011|FG001|Overall Study|Lost to Follow-up|0|||
42222360|NCT03124407|76041012|FG002|Overall Study|Lost to Follow-up|0|||
42222361|NCT03124407|76041013|FG003|Overall Study|Lost to Follow-up|0|||
42222362|NCT03124407|76041010|FG000|Overall Study|Adverse Event|0|||
42222363|NCT03124407|76041011|FG001|Overall Study|Adverse Event|0|||
42222364|NCT03124407|76041012|FG002|Overall Study|Adverse Event|1|||
42222365|NCT03124407|76041013|FG003|Overall Study|Adverse Event|0|||
42222366|NCT02929407|76041027|FG000|Overall Study|Adverse Event|1|||
42222367|NCT03123939|76041031|FG000|Overall Study|Lack of Efficacy|6|||
42222368|NCT03123939|76041031|FG000|Overall Study|Death|5|||
42222369|NCT03123939|76041031|FG000|Overall Study|Physician Decision|2|||
42222370|NCT03123939|76041031|FG000|Overall Study|Subject/guardian decision|2|||
42222371|NCT03123939|76041031|FG000|Overall Study|Lost to Follow-up|1|||
42222372|NCT03123939|76041031|FG000|Overall Study|New therapy for study indication|1|||
42222373|NCT03123939|76041031|FG000|Overall Study|Protocol deviation|1|||
42222374|NCT03123939|76041031|FG000|Overall Study|Progressive disease|18|||
42222375|NCT03123939|76041031|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
42222376|NCT03123939|76041031|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
42222377|NCT03123861|76041046|FG000|Overall Study|Protocol Violation|1|||
42222378|NCT03123861|76041047|FG001|Overall Study|Protocol Violation|1|||
42222379|NCT03123861|76041046|FG000|Overall Study|Withdrawal by Subject|2|||
42222380|NCT03123861|76041047|FG001|Overall Study|Withdrawal by Subject|2|||
42222381|NCT03123471|76041055|FG000|Placebo-controlled Phase|Adverse Event|3|||
42222382|NCT03123471|76041056|FG001|Placebo-controlled Phase|Adverse Event|8|||
42222383|NCT03123471|76041055|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
42222384|NCT03123471|76041056|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
42222385|NCT03123471|76041055|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
42222386|NCT03123471|76041056|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
42222387|NCT03123471|76041055|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
42222388|NCT03123471|76041056|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
42302266|NCT02494921|76137338|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
42029790|NCT01206764|75838328|FG000|Overall Study|New cancer therapy|2|||
42029791|NCT01206764|75838328|FG000|Overall Study|Disease progression|88|||
42029792|NCT01206764|75838328|FG000|Overall Study|Protocol deviation|3|||
42029793|NCT00894322|75838335|FG000|Overall Study|Withdrawal by Subject|1|||
42029794|NCT00894322|75838336|FG001|Overall Study|Withdrawal by Subject|0|||
42029795|NCT00894322|75838337|FG002|Overall Study|Withdrawal by Subject|0|||
42029796|NCT00596635|75838350|FG000|Overall Study|Lost to Follow-up|0|||
42029797|NCT00596635|75838351|FG001|Overall Study|Lost to Follow-up|2|||
42029798|NCT00596635|75838352|FG002|Overall Study|Lost to Follow-up|0|||
42029799|NCT00596635|75838350|FG000|Overall Study|Treatment for symptomatic UTI|4|||
42222389|NCT03123471|76041055|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
42222390|NCT03123471|76041056|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
42222391|NCT03123471|76041055|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
42222392|NCT03123471|76041056|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
42222393|NCT03123471|76041055|FG000|Placebo-controlled Phase|Miscellaneous|0|||
42222394|NCT03123471|76041056|FG001|Placebo-controlled Phase|Miscellaneous|1|||
42222395|NCT03123471|76041055|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
42222396|NCT03123471|76041056|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
42222397|NCT03123471|76041055|FG000|Apremilast Extension Phase|Adverse Event|1|||
42222398|NCT03123471|76041056|FG001|Apremilast Extension Phase|Adverse Event|5|||
41983095|NCT03485157|75789407|FG000|Open Label Phase|Removal by PI|2|||
41983096|NCT03485157|75789408|FG001|Open Label Phase|Removal by PI|0|||
41983097|NCT03383692|75789417|FG000|Overall Study|Progressive disease as per RECIST|3|||
41983098|NCT03383692|75789418|FG001|Overall Study|Progressive disease as per RECIST|3|||
41983099|NCT03383692|75789417|FG000|Overall Study|Clinical progression|0|||
41983100|NCT03383692|75789418|FG001|Overall Study|Clinical progression|1|||
41983101|NCT03383692|75789417|FG000|Overall Study|Adverse Event|3|||
41983102|NCT03383692|75789418|FG001|Overall Study|Adverse Event|0|||
41983103|NCT03048019|75789437|FG000|Overall Study|Adverse Event|1|||
42222399|NCT03123471|76041055|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
42222400|NCT03123471|76041056|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
42222401|NCT03123471|76041055|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
41983104|NCT03048019|75789438|FG001|Overall Study|Adverse Event|0|||
42222402|NCT03123471|76041056|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
42222403|NCT02661178|76041083|FG000|Part 1|Protocol Violation|1|||
42222404|NCT02661178|76041084|FG001|Part 1|Protocol Violation|0|||
42222405|NCT02661178|76041085|FG002|Part 1|Protocol Violation|0|||
42222406|NCT02661178|76041086|FG003|Part 1|Protocol Violation|0|||
42222407|NCT02661178|76041087|FG004|Part 1|Protocol Violation|0|||
42222408|NCT02661178|76041088|FG005|Part 1|Protocol Violation|0|||
42222409|NCT02661178|76041089|FG006|Part 1|Protocol Violation|0|||
42222410|NCT02661178|76041090|FG007|Part 1|Protocol Violation|0|||
42029800|NCT00596635|75838351|FG001|Overall Study|Treatment for symptomatic UTI|6|||
42029801|NCT00596635|75838352|FG002|Overall Study|Treatment for symptomatic UTI|3|||
42029802|NCT00596635|75838350|FG000|Overall Study|Hip fracture|2|||
42029803|NCT00596635|75838351|FG001|Overall Study|Hip fracture|3|||
42029804|NCT00596635|75838352|FG002|Overall Study|Hip fracture|3|||
42029805|NCT00596635|75838350|FG000|Overall Study|Could not provide urine specimen|1|||
42222411|NCT02661178|76041091|FG008|Part 1|Protocol Violation|0|||
42222412|NCT02661178|76041092|FG009|Part 1|Protocol Violation|0|||
42222413|NCT02661178|76041093|FG010|Part 1|Protocol Violation|0|||
42222414|NCT02661178|76041094|FG011|Part 1|Protocol Violation|0|||
42222415|NCT02661178|76041095|FG012|Part 1|Protocol Violation|0|||
42222416|NCT02661178|76041096|FG013|Part 1|Protocol Violation|0|||
42029806|NCT00596635|75838351|FG001|Overall Study|Could not provide urine specimen|2|||
42029807|NCT00596635|75838352|FG002|Overall Study|Could not provide urine specimen|2|||
42029808|NCT00894166|75838368|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
42029809|NCT00894166|75838369|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
42222417|NCT02661178|76041097|FG014|Part 1|Protocol Violation|0|||
42222418|NCT02660944|76041149|FG000|Overall Study|Adverse Event|3|||
42222419|NCT02660944|76041150|FG001|Overall Study|Adverse Event|4|||
42222420|NCT02660944|76041149|FG000|Overall Study|Physician Decision|3|||
41983105|NCT02998645|75789444|FG000|Treatment Period 1|Adverse Event|6|||
41983106|NCT02998645|75789444|FG000|Treatment Period 1|Death|5|||
42029810|NCT00894166|75838370|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
42029811|NCT00894166|75838371|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
42029812|NCT00894166|75838372|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
42029813|NCT00894166|75838373|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
42029814|NCT00894166|75838374|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
42029815|NCT00894166|75838375|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
42029816|NCT00894166|75838368|FG000|Overall Study|Death|0|||
42029817|NCT00894166|75838369|FG001|Overall Study|Death|0|||
42029818|NCT00894166|75838370|FG002|Overall Study|Death|0|||
42029819|NCT00894166|75838371|FG003|Overall Study|Death|1|||
42029820|NCT00894166|75838372|FG004|Overall Study|Death|0|||
42131150|NCT00308308|75942125|FG001|Overall Study|Randomized but not dosed|16|||
42131151|NCT00308308|75942124|FG000|Overall Study|Other|1|||
42131152|NCT00308308|75942125|FG001|Overall Study|Other|0|||
42131153|NCT00505934|75942131|FG000|Overall Study|Adverse Event|1|||
42131154|NCT00505934|75942131|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
42131155|NCT00505934|75942131|FG000|Overall Study|Other: IV dose needed to be changed|1|||
42131156|NCT00505778|75942137|FG000|Overall Study|Adverse Event|2|||
42131157|NCT00505778|75942138|FG001|Overall Study|Adverse Event|7|||
42131158|NCT00505778|75942137|FG000|Overall Study|Physician Decision|8|||
42131159|NCT00505778|75942138|FG001|Overall Study|Physician Decision|14|||
42222421|NCT02660944|76041150|FG001|Overall Study|Physician Decision|1|||
42222422|NCT02660944|76041149|FG000|Overall Study|Withdrawal by Subject|5|||
42222423|NCT02660944|76041150|FG001|Overall Study|Withdrawal by Subject|3|||
41983107|NCT02998645|75789444|FG000|Treatment Period 1|Technical Problems|4|||
41983108|NCT02998645|75789444|FG000|Treatment Period 1|Lack of Efficacy|2|||
41983109|NCT02998645|75789444|FG000|Treatment Period 1|Progressive disease|1|||
42029821|NCT00894166|75838373|FG005|Overall Study|Death|0|||
42131160|NCT00505778|75942137|FG000|Overall Study|Lost to Follow-up|17|||
42222424|NCT02660944|76041149|FG000|Overall Study|Lost to Follow-up|4|||
42222425|NCT02660944|76041150|FG001|Overall Study|Lost to Follow-up|1|||
42222426|NCT02660944|76041149|FG000|Overall Study|Subject schedule|0|||
42222427|NCT02660944|76041150|FG001|Overall Study|Subject schedule|1|||
42222428|NCT02660944|76041149|FG000|Overall Study|Exclusion criteria met|2|||
42029822|NCT00894166|75838374|FG006|Overall Study|Death|0|||
42029823|NCT00894166|75838375|FG007|Overall Study|Death|0|||
42029824|NCT00880165|75838400|FG000|Overall Study|Withdrawal by Subject|27|||
42029825|NCT00880165|75838401|FG001|Overall Study|Withdrawal by Subject|23|||
42029826|NCT00880165|75838400|FG000|Overall Study|Not diagnosed with OSA|14|||
42029827|NCT00880165|75838401|FG001|Overall Study|Not diagnosed with OSA|8|||
42029828|NCT00880165|75838400|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
42029829|NCT00880165|75838401|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
42029830|NCT00880165|75838400|FG000|Overall Study|Lost to follow|9|||
42222429|NCT02660944|76041150|FG001|Overall Study|Exclusion criteria met|0|||
42222430|NCT02975336|76041160|FG000|DBPC (52 Weeks)|Adverse Event|16|||
42222431|NCT02975336|76041161|FG001|DBPC (52 Weeks)|Adverse Event|17|||
42222432|NCT02975336|76041162|FG002|DBPC (52 Weeks)|Adverse Event|13|||
42222433|NCT02975336|76041163|FG003|DBPC (52 Weeks)|Adverse Event|18|||
42222434|NCT02975336|76041164|FG004|DBPC (52 Weeks)|Adverse Event|0|||
42222435|NCT02975336|76041165|FG005|DBPC (52 Weeks)|Adverse Event|0|||
42222436|NCT02975336|76041166|FG006|DBPC (52 Weeks)|Adverse Event|0|||
42222437|NCT02975336|76041167|FG007|DBPC (52 Weeks)|Adverse Event|0|||
42222438|NCT02975336|76041160|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
42222439|NCT02975336|76041161|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
42222440|NCT02975336|76041162|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
42222441|NCT02975336|76041163|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
42222442|NCT02975336|76041164|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
42222443|NCT02975336|76041165|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
42222444|NCT02975336|76041166|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
42222445|NCT02975336|76041167|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
42222446|NCT02975336|76041160|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
42222447|NCT02975336|76041161|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
42222448|NCT02975336|76041162|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
42222449|NCT02975336|76041163|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
42222450|NCT02975336|76041164|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
42222451|NCT02975336|76041165|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
41983110|NCT02998645|75789444|FG000|Treatment Period 1|Subject/guardian decision|1|||
42222452|NCT02975336|76041166|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
42222453|NCT02975336|76041167|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
41983111|NCT02998645|75789444|FG000|Treatment Period 2|Lack of Efficacy|5|||
42222454|NCT02975336|76041160|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
42222455|NCT02975336|76041161|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
42222456|NCT02975336|76041162|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
42222457|NCT02975336|76041163|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
42222458|NCT02975336|76041164|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
42222459|NCT02975336|76041165|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
42222460|NCT02975336|76041166|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
42222461|NCT02975336|76041167|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
42222462|NCT02975336|76041160|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
42222463|NCT02975336|76041161|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
42222464|NCT02975336|76041162|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
42222465|NCT02975336|76041163|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
42222466|NCT02975336|76041164|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
42222467|NCT02975336|76041165|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
42222468|NCT02975336|76041166|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
42222469|NCT02975336|76041167|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
42222470|NCT02975336|76041160|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
42222471|NCT02975336|76041161|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
42222472|NCT02975336|76041162|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
42302267|NCT02494921|76137339|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
41983112|NCT02998645|75789444|FG000|Treatment Period 2|Adverse Event|2|||
41983113|NCT02998645|75789444|FG000|Treatment Period 2|Progressive disease|2|||
41983114|NCT02998645|75789444|FG000|Treatment Period 2|Physician Decision|1|||
41983115|NCT02094261|75789457|FG000|Overall Study|Death|24|||
42029831|NCT00880165|75838401|FG001|Overall Study|Lost to follow|15|||
42029832|NCT01165229|75838409|FG000|Overall Study|Serious Adverse Event|456|||
42029833|NCT01165229|75838410|FG001|Overall Study|Serious Adverse Event|487|||
42029834|NCT01165229|75838409|FG000|Overall Study|Non-Serious Adverse Event|47|||
42222473|NCT02975336|76041163|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
42222474|NCT02975336|76041164|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
41983116|NCT02094261|75789457|FG000|Overall Study|Lost to Follow-up|1|||
42222475|NCT02975336|76041165|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
42222476|NCT02975336|76041166|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
42222477|NCT02975336|76041167|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
42222478|NCT02975336|76041160|FG000|LTE (104 Weeks)|Adverse Event|0|||
41983117|NCT02094261|75789457|FG000|Overall Study|Withdrawal by Subject|4|||
41983118|NCT02094261|75789457|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
41983119|NCT02074553|75789468|FG000|Intervention Period 1|Family Emergency|0|||
41983120|NCT02074553|75789469|FG001|Intervention Period 1|Family Emergency|0|||
41983121|NCT02074553|75789470|FG002|Intervention Period 1|Family Emergency|0|||
42222479|NCT02975336|76041161|FG001|LTE (104 Weeks)|Adverse Event|0|||
42222480|NCT02975336|76041162|FG002|LTE (104 Weeks)|Adverse Event|0|||
42222481|NCT02975336|76041163|FG003|LTE (104 Weeks)|Adverse Event|0|||
42222482|NCT02975336|76041164|FG004|LTE (104 Weeks)|Adverse Event|7|||
42222483|NCT02975336|76041165|FG005|LTE (104 Weeks)|Adverse Event|4|||
42222484|NCT02975336|76041166|FG006|LTE (104 Weeks)|Adverse Event|2|||
42222485|NCT02975336|76041167|FG007|LTE (104 Weeks)|Adverse Event|0|||
42222486|NCT02975336|76041160|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
42222487|NCT02975336|76041161|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
42222488|NCT02975336|76041162|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
42222489|NCT02975336|76041163|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
42222490|NCT02975336|76041164|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
42222491|NCT02975336|76041165|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
41983122|NCT02074553|75789471|FG003|Intervention Period 1|Family Emergency|1|||
41983123|NCT02074553|75789472|FG004|Intervention Period 1|Family Emergency|0|||
41983124|NCT02074553|75789473|FG005|Intervention Period 1|Family Emergency|0|||
41983125|NCT02074553|75789474|FG006|Intervention Period 1|Family Emergency|0|||
42131161|NCT00505778|75942138|FG001|Overall Study|Lost to Follow-up|23|||
42131162|NCT00505778|75942137|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
42131163|NCT00505778|75942138|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
42131164|NCT00505778|75942137|FG000|Overall Study|Protocol Violation|7|||
42131165|NCT00505778|75942138|FG001|Overall Study|Protocol Violation|9|||
42131166|NCT00505778|75942137|FG000|Overall Study|Withdrawal by Subject|29|||
42131167|NCT00505778|75942138|FG001|Overall Study|Withdrawal by Subject|14|||
42131168|NCT00505778|75942137|FG000|Overall Study|Relapse|65|||
42131169|NCT00505778|75942138|FG001|Overall Study|Relapse|65|||
42131170|NCT00505778|75942137|FG000|Overall Study|Took No Study Drug|2|||
42131171|NCT00505778|75942138|FG001|Overall Study|Took No Study Drug|2|||
42131172|NCT00308074|75942144|FG000|Overall Study|Withdrawal by Subject|1|||
42131173|NCT00500760|75942150|FG000|Overall Study|Death|32|||
42131174|NCT00500760|75942151|FG001|Overall Study|Death|15|||
42131175|NCT00500760|75942150|FG000|Overall Study|Withdrawal by Subject|5|||
42131176|NCT00500760|75942151|FG001|Overall Study|Withdrawal by Subject|7|||
42131177|NCT00500760|75942150|FG000|Overall Study|Administrative decision|2|||
42131178|NCT00500760|75942151|FG001|Overall Study|Administrative decision|0|||
42131179|NCT00500760|75942150|FG000|Overall Study|Lost to Follow-up|3|||
42131180|NCT00500760|75942151|FG001|Overall Study|Lost to Follow-up|0|||
42131181|NCT00500760|75942150|FG000|Overall Study|Other|1|||
42131182|NCT00500760|75942151|FG001|Overall Study|Other|2|||
42131183|NCT00505622|75942160|FG000|Overall Study|Adverse Event|5|||
42131184|NCT00505622|75942161|FG001|Overall Study|Adverse Event|6|||
42131185|NCT00505622|75942162|FG002|Overall Study|Adverse Event|4|||
42131186|NCT00505622|75942160|FG000|Overall Study|Protocol Violation|1|||
42131187|NCT00505622|75942161|FG001|Overall Study|Protocol Violation|1|||
42131188|NCT00505622|75942162|FG002|Overall Study|Protocol Violation|0|||
42131189|NCT00505622|75942160|FG000|Overall Study|Withdrawal by Subject|0|||
42131190|NCT00505622|75942161|FG001|Overall Study|Withdrawal by Subject|3|||
42131191|NCT00505622|75942162|FG002|Overall Study|Withdrawal by Subject|2|||
42131192|NCT00505622|75942160|FG000|Overall Study|Study termination by sponsor|115|||
42131193|NCT00505622|75942161|FG001|Overall Study|Study termination by sponsor|98|||
42131194|NCT00505622|75942162|FG002|Overall Study|Study termination by sponsor|90|||
42131195|NCT03851094|75942172|FG000|Overall Study|Withdrawal by Subject|0|||
42131196|NCT03851094|75942173|FG001|Overall Study|Withdrawal by Subject|1|||
42131197|NCT03851094|75942172|FG000|Overall Study|Participant lost device|0|||
42131198|NCT03851094|75942173|FG001|Overall Study|Participant lost device|1|||
42131199|NCT03851094|75942172|FG000|Overall Study|Participant returned device|0|||
42131200|NCT03851094|75942173|FG001|Overall Study|Participant returned device|2|||
42131201|NCT00505076|75942184|FG000|Overall Study|Adverse Event|1|||
42131202|NCT00505076|75942185|FG001|Overall Study|Adverse Event|0|||
42131203|NCT00505076|75942186|FG002|Overall Study|Adverse Event|1|||
42131204|NCT00505076|75942184|FG000|Overall Study|Protocol Violation|2|||
42131205|NCT00505076|75942185|FG001|Overall Study|Protocol Violation|1|||
42131206|NCT00505076|75942186|FG002|Overall Study|Protocol Violation|2|||
42131207|NCT00505076|75942184|FG000|Overall Study|Withdrawal by Subject|0|||
42131208|NCT00505076|75942185|FG001|Overall Study|Withdrawal by Subject|1|||
42131209|NCT00505076|75942186|FG002|Overall Study|Withdrawal by Subject|2|||
42131210|NCT00307684|75942194|FG000|Open Label Phase|Lack of Efficacy|0|||
42222492|NCT02975336|76041166|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
42222493|NCT02975336|76041167|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
42131211|NCT00307684|75942195|FG001|Open Label Phase|Lack of Efficacy|0|||
42131212|NCT00307684|75942196|FG002|Open Label Phase|Lack of Efficacy|3|||
42131213|NCT00307684|75942194|FG000|Open Label Phase|Adverse Event|0|||
42131214|NCT00307684|75942195|FG001|Open Label Phase|Adverse Event|0|||
42131215|NCT00307684|75942196|FG002|Open Label Phase|Adverse Event|16|||
42131216|NCT00307684|75942194|FG000|Open Label Phase|Withdrawal by Subject|0|||
42131217|NCT00307684|75942195|FG001|Open Label Phase|Withdrawal by Subject|0|||
42222494|NCT02975336|76041160|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
42222495|NCT02975336|76041161|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
42222496|NCT02975336|76041162|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
42222497|NCT02975336|76041163|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
42222498|NCT02975336|76041164|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
42222499|NCT02975336|76041165|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
42222500|NCT02975336|76041166|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
42222501|NCT02975336|76041167|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
42222502|NCT02975336|76041160|FG000|LTE (104 Weeks)|Other|0|||
42222503|NCT02975336|76041161|FG001|LTE (104 Weeks)|Other|0|||
42222504|NCT02975336|76041162|FG002|LTE (104 Weeks)|Other|0|||
42222505|NCT02975336|76041163|FG003|LTE (104 Weeks)|Other|0|||
42029835|NCT01165229|75838410|FG001|Overall Study|Non-Serious Adverse Event|15|||
42029836|NCT01165229|75838409|FG000|Overall Study|Protocol Violation|6|||
42029837|NCT01165229|75838410|FG001|Overall Study|Protocol Violation|8|||
42131218|NCT00307684|75942196|FG002|Open Label Phase|Withdrawal by Subject|15|||
42131219|NCT00307684|75942194|FG000|Open Label Phase|Lost to Follow-up|0|||
42131220|NCT00307684|75942195|FG001|Open Label Phase|Lost to Follow-up|0|||
42131221|NCT00307684|75942196|FG002|Open Label Phase|Lost to Follow-up|11|||
42131222|NCT00307684|75942194|FG000|Open Label Phase|non compliance|0|||
42131223|NCT00307684|75942195|FG001|Open Label Phase|non compliance|0|||
42131224|NCT00307684|75942196|FG002|Open Label Phase|non compliance|5|||
42131225|NCT00307684|75942194|FG000|Open Label Phase|other|0|||
42131226|NCT00307684|75942195|FG001|Open Label Phase|other|0|||
42131227|NCT00307684|75942196|FG002|Open Label Phase|other|6|||
42131228|NCT00307684|75942194|FG000|Double Blind Phase|Lack of Efficacy|2|||
42131229|NCT00307684|75942195|FG001|Double Blind Phase|Lack of Efficacy|5|||
42131230|NCT00307684|75942196|FG002|Double Blind Phase|Lack of Efficacy|0|||
42131231|NCT00489918|75942209|FG000|Overall Study|Withdrawal by Subject|2|||
42131232|NCT00489918|75942210|FG001|Overall Study|Withdrawal by Subject|1|||
42131233|NCT00489918|75942211|FG002|Overall Study|Withdrawal by Subject|1|||
42131234|NCT00489918|75942212|FG003|Overall Study|Withdrawal by Subject|0|||
42131235|NCT00489918|75942213|FG004|Overall Study|Withdrawal by Subject|1|||
42131236|NCT00489918|75942209|FG000|Overall Study|Adverse Event|0|||
42131237|NCT00489918|75942210|FG001|Overall Study|Adverse Event|1|||
42131238|NCT00489918|75942211|FG002|Overall Study|Adverse Event|1|||
42131239|NCT00489918|75942212|FG003|Overall Study|Adverse Event|0|||
42131240|NCT00489918|75942213|FG004|Overall Study|Adverse Event|0|||
42131241|NCT00489918|75942209|FG000|Overall Study|Lost to Follow-up|0|||
42131242|NCT00489918|75942210|FG001|Overall Study|Lost to Follow-up|0|||
42131243|NCT00489918|75942211|FG002|Overall Study|Lost to Follow-up|1|||
42131244|NCT00489918|75942212|FG003|Overall Study|Lost to Follow-up|1|||
42131245|NCT00489918|75942213|FG004|Overall Study|Lost to Follow-up|0|||
42131246|NCT00489918|75942209|FG000|Overall Study|Physician Decision|0|||
42131247|NCT00489918|75942210|FG001|Overall Study|Physician Decision|0|||
42131248|NCT00489918|75942211|FG002|Overall Study|Physician Decision|1|||
42131249|NCT00489918|75942212|FG003|Overall Study|Physician Decision|0|||
42131250|NCT00489918|75942213|FG004|Overall Study|Physician Decision|0|||
42131251|NCT00307294|75942225|FG000|Overall Study|Withdrawal by Subject|1|||
42131252|NCT03963401|75942236|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
42131253|NCT03963401|75942237|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
42131254|NCT03963401|75942238|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
42131255|NCT03963401|75942239|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
42131256|NCT03963401|75942240|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
42131257|NCT03963401|75942241|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
42131258|NCT03963401|75942236|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
42131259|NCT03963401|75942237|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
42131260|NCT03963401|75942238|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
42131261|NCT03963401|75942239|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
42131262|NCT03963401|75942240|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
42131263|NCT03963401|75942241|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
42131264|NCT03963401|75942236|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
42131265|NCT03963401|75942237|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
42131266|NCT03963401|75942238|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
42131267|NCT03963401|75942239|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
42222506|NCT02975336|76041164|FG004|LTE (104 Weeks)|Other|55|||
42222507|NCT02975336|76041165|FG005|LTE (104 Weeks)|Other|63|||
42131268|NCT03963401|75942240|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
42131269|NCT03963401|75942241|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
42131270|NCT03963401|75942236|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
42131271|NCT03963401|75942237|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
42131272|NCT03963401|75942238|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
42131273|NCT03963401|75942239|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
42131274|NCT03963401|75942240|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
42222508|NCT02975336|76041166|FG006|LTE (104 Weeks)|Other|76|||
42222509|NCT02975336|76041167|FG007|LTE (104 Weeks)|Other|72|||
42222510|NCT03124563|76041183|FG000|Overall Study|Lost to Follow-up|1|||
42222511|NCT03124563|76041184|FG001|Overall Study|Lost to Follow-up|1|||
42222512|NCT03124563|76041183|FG000|Overall Study|Withdrawal by Subject|1|||
42222513|NCT03124563|76041184|FG001|Overall Study|Withdrawal by Subject|1|||
42222514|NCT03079869|76041192|FG000|Overall Study|Adverse Event|6|||
42222515|NCT03079869|76041193|FG001|Overall Study|Adverse Event|8|||
42222516|NCT03079869|76041192|FG000|Overall Study|Withdrawal by Subject|4|||
42222517|NCT03079869|76041193|FG001|Overall Study|Withdrawal by Subject|1|||
42222518|NCT03079869|76041192|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
42222519|NCT03079869|76041193|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
42222520|NCT03085914|76041206|FG000|Overall Study|Death|6|||
42222521|NCT03085914|76041207|FG001|Overall Study|Death|6|||
42222522|NCT03085914|76041208|FG002|Overall Study|Death|4|||
42222523|NCT03085914|76041209|FG003|Overall Study|Death|1|||
42222524|NCT03085914|76041210|FG004|Overall Study|Death|5|||
42222525|NCT03085914|76041211|FG005|Overall Study|Death|2|||
42222526|NCT03085914|76041212|FG006|Overall Study|Death|2|||
42222527|NCT03085914|76041206|FG000|Overall Study|Withdrawal by Subject|1|||
42222528|NCT03085914|76041207|FG001|Overall Study|Withdrawal by Subject|1|||
42222529|NCT03085914|76041208|FG002|Overall Study|Withdrawal by Subject|2|||
42222530|NCT03085914|76041209|FG003|Overall Study|Withdrawal by Subject|2|||
42222531|NCT03085914|76041210|FG004|Overall Study|Withdrawal by Subject|2|||
42222532|NCT03085914|76041211|FG005|Overall Study|Withdrawal by Subject|0|||
42222533|NCT03085914|76041212|FG006|Overall Study|Withdrawal by Subject|1|||
42222534|NCT03085914|76041206|FG000|Overall Study|Lost to Follow-up|0|||
42222535|NCT03085914|76041207|FG001|Overall Study|Lost to Follow-up|0|||
42222536|NCT03085914|76041208|FG002|Overall Study|Lost to Follow-up|1|||
42222537|NCT03085914|76041209|FG003|Overall Study|Lost to Follow-up|0|||
42222538|NCT03085914|76041210|FG004|Overall Study|Lost to Follow-up|0|||
42222539|NCT03085914|76041211|FG005|Overall Study|Lost to Follow-up|1|||
42222540|NCT03085914|76041212|FG006|Overall Study|Lost to Follow-up|1|||
42222541|NCT03085914|76041206|FG000|Overall Study|Reason was not specified,|2|||
42222542|NCT03085914|76041207|FG001|Overall Study|Reason was not specified,|2|||
42222543|NCT03085914|76041208|FG002|Overall Study|Reason was not specified,|2|||
42222544|NCT03085914|76041209|FG003|Overall Study|Reason was not specified,|3|||
42222545|NCT03085914|76041210|FG004|Overall Study|Reason was not specified,|3|||
42222546|NCT03085914|76041211|FG005|Overall Study|Reason was not specified,|3|||
42222547|NCT03085914|76041212|FG006|Overall Study|Reason was not specified,|6|||
42222548|NCT03085914|76041206|FG000|Overall Study|Progressive Disease|0|||
42222549|NCT03085914|76041207|FG001|Overall Study|Progressive Disease|0|||
42222550|NCT03085914|76041208|FG002|Overall Study|Progressive Disease|2|||
42222551|NCT03085914|76041209|FG003|Overall Study|Progressive Disease|2|||
42222552|NCT03085914|76041210|FG004|Overall Study|Progressive Disease|1|||
42222553|NCT03085914|76041211|FG005|Overall Study|Progressive Disease|1|||
42222554|NCT03085914|76041212|FG006|Overall Study|Progressive Disease|1|||
42222555|NCT03085914|76041206|FG000|Overall Study|Study Terminated by the Sponsor|0|||
42222556|NCT03085914|76041207|FG001|Overall Study|Study Terminated by the Sponsor|0|||
42222557|NCT03085914|76041208|FG002|Overall Study|Study Terminated by the Sponsor|0|||
42222558|NCT03085914|76041209|FG003|Overall Study|Study Terminated by the Sponsor|1|||
42222559|NCT03085914|76041210|FG004|Overall Study|Study Terminated by the Sponsor|2|||
42222560|NCT03085914|76041211|FG005|Overall Study|Study Terminated by the Sponsor|1|||
42222561|NCT03085914|76041212|FG006|Overall Study|Study Terminated by the Sponsor|0|||
42222562|NCT03078582|76041240|FG000|Overall Study|Adverse Event|0|||
42222563|NCT03078582|76041241|FG001|Overall Study|Adverse Event|8|||
42222564|NCT03077724|76041249|FG000|Overall Study|Lost to Follow-up|5|||
42302268|NCT02494921|76137340|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
42029838|NCT01165229|75838409|FG000|Overall Study|Withdrawal by Subject|387|||
42131275|NCT03963401|75942241|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
42131276|NCT03963401|75942236|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
42131277|NCT03963401|75942237|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
42131278|NCT03963401|75942238|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
42131279|NCT03963401|75942239|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
42131280|NCT03963401|75942240|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
42131281|NCT03963401|75942241|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
42131282|NCT03963401|75942236|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
42131283|NCT03963401|75942237|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
42131284|NCT03963401|75942238|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
42131285|NCT03963401|75942239|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
42131286|NCT03963401|75942240|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
42222565|NCT03077724|76041250|FG001|Overall Study|Lost to Follow-up|1|||
42222566|NCT03077724|76041249|FG000|Overall Study|Withdrawal by Subject|3|||
42222567|NCT03077724|76041250|FG001|Overall Study|Withdrawal by Subject|1|||
42222568|NCT00979212|76041258|FG000|Overall Study|Protocol Violation|1|||
42222569|NCT00979212|76041259|FG001|Overall Study|Protocol Violation|8|||
42222570|NCT00979212|76041258|FG000|Overall Study|No protocol therapy received|1|||
42222571|NCT00979212|76041259|FG001|Overall Study|No protocol therapy received|0|||
42222572|NCT03080454|76041265|FG000|Baseline|Adverse Event|2|||
42222573|NCT03080454|76041265|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
42222574|NCT03080454|76041265|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
42131287|NCT03963401|75942241|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
42131288|NCT03963401|75942236|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
42222575|NCT02981342|76041289|FG000|Overall Study|Adverse Event|0|||
42222576|NCT02981342|76041290|FG001|Overall Study|Adverse Event|0|||
42222577|NCT02981342|76041291|FG002|Overall Study|Adverse Event|0|||
42222578|NCT02981342|76041292|FG003|Overall Study|Adverse Event|1|||
42222579|NCT02981342|76041289|FG000|Overall Study|Death|0|||
42222580|NCT02981342|76041290|FG001|Overall Study|Death|9|||
42222581|NCT02981342|76041291|FG002|Overall Study|Death|9|||
42222582|NCT02981342|76041292|FG003|Overall Study|Death|4|||
42222583|NCT02981342|76041289|FG000|Overall Study|Withdrawal by Subject|0|||
42222584|NCT02981342|76041290|FG001|Overall Study|Withdrawal by Subject|0|||
42222585|NCT02981342|76041291|FG002|Overall Study|Withdrawal by Subject|3|||
42222586|NCT02981342|76041292|FG003|Overall Study|Withdrawal by Subject|1|||
42222587|NCT02981342|76041289|FG000|Overall Study|Study closed by sponsor|0|||
42222588|NCT02981342|76041290|FG001|Overall Study|Study closed by sponsor|0|||
42222589|NCT02981342|76041291|FG002|Overall Study|Study closed by sponsor|1|||
42222590|NCT02981342|76041292|FG003|Overall Study|Study closed by sponsor|1|||
42222591|NCT02981342|76041289|FG000|Overall Study|Randomized, Never Treated|0|||
42222592|NCT02981342|76041290|FG001|Overall Study|Randomized, Never Treated|1|||
42222593|NCT02981342|76041291|FG002|Overall Study|Randomized, Never Treated|0|||
42222594|NCT02981342|76041292|FG003|Overall Study|Randomized, Never Treated|7|||
42222595|NCT02981342|76041289|FG000|Overall Study|Lost to Follow-up|0|||
42222596|NCT02981342|76041290|FG001|Overall Study|Lost to Follow-up|1|||
42222597|NCT02981342|76041291|FG002|Overall Study|Lost to Follow-up|0|||
42222598|NCT02981342|76041292|FG003|Overall Study|Lost to Follow-up|0|||
42222599|NCT02794246|76041304|FG000|Overall Study|Withdrawal by Subject|2|||
42222600|NCT02794246|76041304|FG000|Overall Study|Physician Decision|4|||
42222601|NCT03428100|76041312|FG000|Overall Study|Adverse Event|1|||
42222602|NCT03428100|76041313|FG001|Overall Study|Adverse Event|0|||
42222603|NCT03428100|76041314|FG002|Overall Study|Adverse Event|3|||
42222604|NCT03428100|76041315|FG003|Overall Study|Adverse Event|1|||
42222605|NCT03428100|76041312|FG000|Overall Study|Lack of Efficacy|16|||
42222606|NCT03428100|76041313|FG001|Overall Study|Lack of Efficacy|10|||
42222607|NCT03428100|76041314|FG002|Overall Study|Lack of Efficacy|7|||
42222608|NCT03428100|76041315|FG003|Overall Study|Lack of Efficacy|6|||
42222609|NCT03428100|76041312|FG000|Overall Study|Protocol Deviation|0|||
42222610|NCT03428100|76041313|FG001|Overall Study|Protocol Deviation|2|||
42222611|NCT03428100|76041314|FG002|Overall Study|Protocol Deviation|2|||
42222612|NCT03428100|76041315|FG003|Overall Study|Protocol Deviation|0|||
42222613|NCT03428100|76041312|FG000|Overall Study|Withdrawal by Subject|4|||
42222614|NCT03428100|76041313|FG001|Overall Study|Withdrawal by Subject|0|||
42222615|NCT03428100|76041314|FG002|Overall Study|Withdrawal by Subject|0|||
42222616|NCT03428100|76041315|FG003|Overall Study|Withdrawal by Subject|0|||
42222617|NCT03428100|76041312|FG000|Overall Study|Physician Decision|0|||
41983126|NCT02074553|75789475|FG007|Intervention Period 1|Family Emergency|0|||
41983127|NCT02074553|75789468|FG000|Washout Period 1|Adverse Event|1|||
41983128|NCT02074553|75789469|FG001|Washout Period 1|Adverse Event|0|||
41983129|NCT02074553|75789470|FG002|Washout Period 1|Adverse Event|0|||
41983130|NCT02074553|75789471|FG003|Washout Period 1|Adverse Event|0|||
41983131|NCT02074553|75789472|FG004|Washout Period 1|Adverse Event|0|||
41983132|NCT02074553|75789473|FG005|Washout Period 1|Adverse Event|0|||
41983133|NCT02074553|75789474|FG006|Washout Period 1|Adverse Event|0|||
42131289|NCT03963401|75942237|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
42131290|NCT03963401|75942238|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
42131291|NCT03963401|75942239|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
42131292|NCT03963401|75942240|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
42131293|NCT03963401|75942241|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
42131294|NCT03963401|75942236|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
42131295|NCT03963401|75942237|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
42131296|NCT03963401|75942238|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
42131297|NCT03963401|75942239|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
42131298|NCT03963401|75942240|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
42222618|NCT03428100|76041313|FG001|Overall Study|Physician Decision|1|||
42222619|NCT03428100|76041314|FG002|Overall Study|Physician Decision|0|||
42222620|NCT03428100|76041315|FG003|Overall Study|Physician Decision|0|||
42222621|NCT02980874|76041337|FG000|Overall Study|Adverse Event|2|||
42222622|NCT02980874|76041338|FG001|Overall Study|Adverse Event|7|||
42302269|NCT02494921|76137341|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
41983134|NCT02074553|75789475|FG007|Washout Period 1|Adverse Event|0|||
41983135|NCT02074553|75789468|FG000|Washout Period 1|Physician Decision|0|||
42222623|NCT02980874|76041337|FG000|Overall Study|Withdrawal by Subject|7|||
42222624|NCT02980874|76041338|FG001|Overall Study|Withdrawal by Subject|2|||
42222625|NCT02980874|76041337|FG000|Overall Study|Lost to Follow-up|5|||
42222626|NCT02980874|76041338|FG001|Overall Study|Lost to Follow-up|5|||
42222627|NCT02980874|76041337|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
42222628|NCT02980874|76041338|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
42222629|NCT02980874|76041337|FG000|Overall Study|Unknown study completion status|1|||
42222630|NCT02980874|76041338|FG001|Overall Study|Unknown study completion status|0|||
42222631|NCT01066052|76041346|FG000|Overall Study|Enrolled But Not Treated|3|||
42222632|NCT01066052|76041347|FG001|Overall Study|Enrolled But Not Treated|0|||
42222633|NCT03077646|76041355|FG000|Overall Study|Lost to Follow-up|29|||
42222634|NCT03077646|76041356|FG001|Overall Study|Lost to Follow-up|30|||
42222635|NCT03077646|76041357|FG002|Overall Study|Lost to Follow-up|31|||
42222636|NCT02892149|76041367|FG000|Overall Study|Death|262|||
42222637|NCT02892149|76041368|FG001|Overall Study|Death|278|||
42222638|NCT02892149|76041367|FG000|Overall Study|Withdrawal by Subject|53|||
42222639|NCT02892149|76041368|FG001|Overall Study|Withdrawal by Subject|47|||
42222640|NCT02892149|76041367|FG000|Overall Study|Lost to Follow-up|37|||
42222641|NCT02892149|76041368|FG001|Overall Study|Lost to Follow-up|31|||
42222642|NCT04187092|76041376|FG000|Overall Study|Lost to Follow-up|1|||
42222643|NCT04187092|76041377|FG001|Overall Study|Lost to Follow-up|1|||
42222644|NCT04187092|76041376|FG000|Overall Study|Withdrawal by Subject|1|||
42222645|NCT04187092|76041377|FG001|Overall Study|Withdrawal by Subject|1|||
42222646|NCT04187092|76041376|FG000|Overall Study|Adverse Event|0|||
42222647|NCT04187092|76041377|FG001|Overall Study|Adverse Event|1|||
42222648|NCT02896127|76041385|FG000|COMPLETED WEEK 52|Adverse Event|9|||
41983136|NCT02074553|75789469|FG001|Washout Period 1|Physician Decision|0|||
42222649|NCT02896127|76041386|FG001|COMPLETED WEEK 52|Adverse Event|2|||
41983137|NCT02074553|75789470|FG002|Washout Period 1|Physician Decision|0|||
41983138|NCT02074553|75789471|FG003|Washout Period 1|Physician Decision|1|||
41983139|NCT02074553|75789472|FG004|Washout Period 1|Physician Decision|0|||
41983140|NCT02074553|75789473|FG005|Washout Period 1|Physician Decision|0|||
41983141|NCT02074553|75789474|FG006|Washout Period 1|Physician Decision|0|||
41983142|NCT02074553|75789475|FG007|Washout Period 1|Physician Decision|0|||
41983143|NCT02074553|75789468|FG000|Washout Period 1|Other|0|||
41983144|NCT02074553|75789469|FG001|Washout Period 1|Other|0|||
41983145|NCT02074553|75789470|FG002|Washout Period 1|Other|0|||
42029839|NCT01165229|75838410|FG001|Overall Study|Withdrawal by Subject|396|||
42029840|NCT01165229|75838409|FG000|Overall Study|Migrated/moved from study area|51|||
42029841|NCT01165229|75838410|FG001|Overall Study|Migrated/moved from study area|46|||
42029842|NCT01165229|75838409|FG000|Overall Study|Lost to Follow-up|123|||
42029843|NCT01165229|75838410|FG001|Overall Study|Lost to Follow-up|133|||
42029844|NCT01165229|75838409|FG000|Overall Study|Suspected HZ Episode|2|||
42029845|NCT01165229|75838410|FG001|Overall Study|Suspected HZ Episode|2|||
42029846|NCT01165229|75838409|FG000|Overall Study|No reason from the subject|108|||
42029847|NCT01165229|75838410|FG001|Overall Study|No reason from the subject|102|||
42029848|NCT01165229|75838409|FG000|Overall Study|Unknown completion status|0|||
42029849|NCT01165229|75838410|FG001|Overall Study|Unknown completion status|1|||
42029850|NCT00596011|75838448|FG000|Overall Study|Withdrawal by Subject|2|||
42029851|NCT00596011|75838449|FG001|Overall Study|Withdrawal by Subject|3|||
42029852|NCT00596011|75838448|FG000|Overall Study|Adverse Event|11|||
41983146|NCT02074553|75789471|FG003|Washout Period 1|Other|0|||
41983147|NCT02074553|75789472|FG004|Washout Period 1|Other|0|||
41983148|NCT02074553|75789473|FG005|Washout Period 1|Other|1|||
41983149|NCT02074553|75789474|FG006|Washout Period 1|Other|0|||
41983150|NCT02074553|75789475|FG007|Washout Period 1|Other|0|||
41983151|NCT02074553|75789468|FG000|Washout Period 2|Adverse Event|0|||
42029853|NCT00596011|75838449|FG001|Overall Study|Adverse Event|7|||
42029854|NCT01163747|75838457|FG000|Overall Study|Adverse Event|0|||
42029855|NCT01163747|75838458|FG001|Overall Study|Adverse Event|5|||
42029856|NCT01163747|75838457|FG000|Overall Study|Insufficient Therapeutic Response|0|||
42131299|NCT03963401|75942241|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
42131300|NCT03963401|75942236|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
42131301|NCT03963401|75942237|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
42131302|NCT03963401|75942238|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
42131303|NCT03963401|75942239|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
42131304|NCT03963401|75942240|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
42131305|NCT03963401|75942241|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
42131306|NCT03963401|75942236|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
42137799|NCT00334113|75948173|FG001|Overall Study|Withdrawal by Subject|1|||
42222650|NCT02896127|76041385|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
42222651|NCT02896127|76041386|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
41983152|NCT02074553|75789469|FG001|Washout Period 2|Adverse Event|0|||
42222652|NCT02896127|76041385|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
42222653|NCT02896127|76041386|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
41983153|NCT02074553|75789470|FG002|Washout Period 2|Adverse Event|0|||
41983154|NCT02074553|75789471|FG003|Washout Period 2|Adverse Event|0|||
42222654|NCT02896127|76041385|FG000|COMPLETED WEEK 52|Physician Decision|1|||
42222655|NCT02896127|76041386|FG001|COMPLETED WEEK 52|Physician Decision|1|||
42222656|NCT02896127|76041385|FG000|COMPLETED WEEK 52|Pregnancy|2|||
42222657|NCT02896127|76041386|FG001|COMPLETED WEEK 52|Pregnancy|0|||
42222658|NCT02896127|76041385|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
42222659|NCT02896127|76041386|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
41983155|NCT02074553|75789472|FG004|Washout Period 2|Adverse Event|0|||
41983156|NCT02074553|75789473|FG005|Washout Period 2|Adverse Event|0|||
41983157|NCT02074553|75789474|FG006|Washout Period 2|Adverse Event|1|||
41983158|NCT02074553|75789475|FG007|Washout Period 2|Adverse Event|0|||
41983159|NCT02074553|75789468|FG000|Washout Period 2|Physician Decision|0|||
42131307|NCT03963401|75942237|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
42131308|NCT03963401|75942238|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
42131309|NCT03963401|75942239|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
42131310|NCT03963401|75942240|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
42131311|NCT03963401|75942241|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
42131312|NCT03963401|75942236|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
42131313|NCT03963401|75942237|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
42131314|NCT03963401|75942238|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
42131315|NCT03963401|75942239|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
42131316|NCT03963401|75942240|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
42131317|NCT03963401|75942241|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
42131318|NCT00334282|75942261|FG000|Overall Study|Lost to Follow-up|11|||
42131319|NCT00334282|75942262|FG001|Overall Study|Lost to Follow-up|5|||
42131320|NCT00334282|75942261|FG000|Overall Study|Withdrawal by Subject|17|||
42131321|NCT00334282|75942262|FG001|Overall Study|Withdrawal by Subject|3|||
42131322|NCT00334282|75942261|FG000|Overall Study|Death|194|||
42131323|NCT00334282|75942262|FG001|Overall Study|Death|100|||
42131324|NCT00306670|75942274|FG000|Overall Study|patients recruited; Genentech, the st|0|||
42131325|NCT00306670|75942275|FG001|Overall Study|patients recruited; Genentech, the st|2|||
42131326|NCT00306592|75942281|FG000|Overall Study|Adverse Event|8|||
42131327|NCT00306592|75942282|FG001|Overall Study|Adverse Event|15|||
42131328|NCT00306592|75942281|FG000|Overall Study|Lost to Follow-up|1|||
42131329|NCT00306592|75942282|FG001|Overall Study|Lost to Follow-up|0|||
42131330|NCT00306592|75942281|FG000|Overall Study|Noncompliance|0|||
42131331|NCT00306592|75942282|FG001|Overall Study|Noncompliance|2|||
42131332|NCT00306592|75942281|FG000|Overall Study|Persistent Antibodies|6|||
42131333|NCT00306592|75942282|FG001|Overall Study|Persistent Antibodies|3|||
42131334|NCT00306592|75942281|FG000|Overall Study|Voluntary|10|||
42131335|NCT00306592|75942282|FG001|Overall Study|Voluntary|6|||
42131336|NCT00306592|75942281|FG000|Overall Study|Other|5|||
42131337|NCT00306592|75942282|FG001|Overall Study|Other|10|||
42131338|NCT00306592|75942281|FG000|Overall Study|Other|1|||
42131339|NCT00306592|75942282|FG001|Overall Study|Other|2|||
42131340|NCT00306592|75942281|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
42131341|NCT00306592|75942282|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
42131342|NCT00321646|75942286|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
42131343|NCT00321646|75942286|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
42131344|NCT00321646|75942286|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
42131345|NCT00403767|75942292|FG000|Overall Study|Adverse Event|993|||
42131346|NCT00403767|75942293|FG001|Overall Study|Adverse Event|919|||
42131347|NCT00403767|75942292|FG000|Overall Study|Non-compliant with study medication|134|||
42131348|NCT00403767|75942293|FG001|Overall Study|Non-compliant with study medication|164|||
42131349|NCT00403767|75942292|FG000|Overall Study|Consent withdrawn|671|||
42131350|NCT00403767|75942293|FG001|Overall Study|Consent withdrawn|673|||
42131351|NCT00403767|75942292|FG000|Overall Study|Investigator dec./not protocol-related|191|||
42131352|NCT00403767|75942293|FG001|Overall Study|Investigator dec./not protocol-related|178|||
42131353|NCT00403767|75942292|FG000|Overall Study|Lost to Follow-up|6|||
42131354|NCT00403767|75942293|FG001|Overall Study|Lost to Follow-up|8|||
42131355|NCT00403767|75942292|FG000|Overall Study|Protocol Violation|142|||
42131356|NCT00403767|75942293|FG001|Overall Study|Protocol Violation|124|||
42131357|NCT00403767|75942292|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
42131358|NCT00403767|75942293|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
42131359|NCT00403767|75942292|FG000|Overall Study|Study terminated by sponsor|82|||
42222660|NCT02896127|76041385|FG000|COMPLETED WEEK 52|Technical problems|1|||
42131360|NCT00403767|75942293|FG001|Overall Study|Study terminated by sponsor|69|||
42131361|NCT00403767|75942292|FG000|Overall Study|Missing/incomplete data|1|||
42131362|NCT00403767|75942293|FG001|Overall Study|Missing/incomplete data|1|||
42131363|NCT00492284|75942303|FG000|Overall Study|Adverse Event|0|||
42131364|NCT00492284|75942304|FG001|Overall Study|Adverse Event|1|||
42131365|NCT00492284|75942305|FG002|Overall Study|Adverse Event|1|||
42131366|NCT00492284|75942306|FG003|Overall Study|Adverse Event|2|||
42131367|NCT00492284|75942303|FG000|Overall Study|Lost to Follow-up|0|||
42222661|NCT02896127|76041386|FG001|COMPLETED WEEK 52|Technical problems|0|||
42222662|NCT02896127|76041385|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
42222663|NCT02896127|76041386|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
42222664|NCT02896127|76041385|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
42222665|NCT02896127|76041386|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
42222666|NCT02896127|76041385|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
42222667|NCT02896127|76041386|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
42222668|NCT02896127|76041385|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
42222669|NCT02896127|76041386|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
42222670|NCT02896127|76041385|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
42222671|NCT02896127|76041386|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
42222672|NCT03546647|76041392|FG000|Overall Study|Adverse Event|1|||
42222673|NCT03546647|76041393|FG001|Overall Study|Adverse Event|0|||
42222674|NCT03077412|76041402|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
42222675|NCT03077412|76041403|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
42222676|NCT03077412|76041404|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
42222677|NCT03077412|76041402|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
42222678|NCT03077412|76041403|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
42222679|NCT03077412|76041404|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
42222680|NCT03077412|76041402|FG000|Overall Study|Adverse Event|1|||
42222681|NCT03077412|76041403|FG001|Overall Study|Adverse Event|2|||
42222682|NCT03077412|76041404|FG002|Overall Study|Adverse Event|2|||
42222683|NCT03077412|76041402|FG000|Overall Study|Investigator's Discretion|0|||
42222684|NCT03077412|76041403|FG001|Overall Study|Investigator's Discretion|1|||
42222685|NCT03077412|76041404|FG002|Overall Study|Investigator's Discretion|1|||
42222686|NCT03077412|76041402|FG000|Overall Study|Withdrew Consent|0|||
42222687|NCT03077412|76041403|FG001|Overall Study|Withdrew Consent|2|||
42222688|NCT03077412|76041404|FG002|Overall Study|Withdrew Consent|0|||
42222689|NCT03544229|76041416|FG000|Overall Study|Adverse Event|1|||
42222690|NCT03544229|76041417|FG001|Overall Study|Adverse Event|0|||
42222691|NCT03544229|76041418|FG002|Overall Study|Adverse Event|1|||
42222692|NCT03544229|76041419|FG003|Overall Study|Adverse Event|0|||
42222693|NCT03544229|76041416|FG000|Overall Study|Protocol Deviation|0|||
42222694|NCT03544229|76041417|FG001|Overall Study|Protocol Deviation|0|||
42222695|NCT03544229|76041418|FG002|Overall Study|Protocol Deviation|1|||
42222696|NCT03544229|76041419|FG003|Overall Study|Protocol Deviation|0|||
42222697|NCT03544229|76041416|FG000|Overall Study|Lost to Follow-up|3|||
42222698|NCT03544229|76041417|FG001|Overall Study|Lost to Follow-up|0|||
42222699|NCT03544229|76041418|FG002|Overall Study|Lost to Follow-up|0|||
42222700|NCT03544229|76041419|FG003|Overall Study|Lost to Follow-up|2|||
42222701|NCT03544229|76041416|FG000|Overall Study|Voluntary Withdrawal|2|||
42222702|NCT03544229|76041417|FG001|Overall Study|Voluntary Withdrawal|1|||
42222703|NCT03544229|76041418|FG002|Overall Study|Voluntary Withdrawal|3|||
42222704|NCT03544229|76041419|FG003|Overall Study|Voluntary Withdrawal|0|||
42222705|NCT03544229|76041416|FG000|Overall Study|Lack of Efficacy|0|||
42222706|NCT03544229|76041417|FG001|Overall Study|Lack of Efficacy|1|||
42222707|NCT03544229|76041418|FG002|Overall Study|Lack of Efficacy|0|||
42222708|NCT03544229|76041419|FG003|Overall Study|Lack of Efficacy|0|||
42222709|NCT03078816|76041429|FG000|Overall Study|Withdrawal by Subject|1|||
42222710|NCT03510455|76041433|FG000|Overall Study|Physician Decision|1|||
42222711|NCT03509675|76041441|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
42222712|NCT03509675|76041442|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
42131368|NCT00492284|75942304|FG001|Overall Study|Lost to Follow-up|0|||
42131369|NCT00492284|75942305|FG002|Overall Study|Lost to Follow-up|3|||
42131370|NCT00492284|75942306|FG003|Overall Study|Lost to Follow-up|1|||
42131371|NCT00492284|75942303|FG000|Overall Study|Death|0|||
42131372|NCT00492284|75942304|FG001|Overall Study|Death|3|||
42131373|NCT00492284|75942305|FG002|Overall Study|Death|2|||
42131374|NCT00492284|75942306|FG003|Overall Study|Death|5|||
42131375|NCT00492284|75942303|FG000|Overall Study|Withdrawal by Subject|1|||
42131376|NCT00492284|75942304|FG001|Overall Study|Withdrawal by Subject|0|||
42131377|NCT00492284|75942305|FG002|Overall Study|Withdrawal by Subject|0|||
42222713|NCT03509675|76041441|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
42222714|NCT03509675|76041442|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
42222715|NCT03509675|76041441|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
42222716|NCT03509675|76041442|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
42222717|NCT03509675|76041441|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
42222718|NCT03509675|76041442|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
42222719|NCT03509207|76041448|FG000|Overall Study|Death|2|||
42222720|NCT03543137|76041452|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
42222721|NCT03543137|76041453|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
42222722|NCT03543137|76041452|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
42222723|NCT03543137|76041453|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
42131378|NCT00492284|75942306|FG003|Overall Study|Withdrawal by Subject|2|||
42131379|NCT00510458|75942316|FG000|Overall Study|5 year not evaluable/missed|21|||
42222724|NCT03543137|76041452|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
42222725|NCT03543137|76041453|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
41983160|NCT02074553|75789469|FG001|Washout Period 2|Physician Decision|0|||
41983161|NCT02074553|75789470|FG002|Washout Period 2|Physician Decision|0|||
41983162|NCT02074553|75789471|FG003|Washout Period 2|Physician Decision|0|||
41983163|NCT02074553|75789472|FG004|Washout Period 2|Physician Decision|0|||
41983164|NCT02074553|75789473|FG005|Washout Period 2|Physician Decision|1|||
41983165|NCT02074553|75789474|FG006|Washout Period 2|Physician Decision|0|||
41983166|NCT02074553|75789475|FG007|Washout Period 2|Physician Decision|0|||
41983167|NCT02074553|75789468|FG000|Washout Period 2|Lost to Follow-up|0|||
41983168|NCT02074553|75789469|FG001|Washout Period 2|Lost to Follow-up|0|||
41983169|NCT02074553|75789470|FG002|Washout Period 2|Lost to Follow-up|1|||
41983170|NCT02074553|75789471|FG003|Washout Period 2|Lost to Follow-up|0|||
41983171|NCT02074553|75789472|FG004|Washout Period 2|Lost to Follow-up|0|||
41983172|NCT02074553|75789473|FG005|Washout Period 2|Lost to Follow-up|0|||
41983173|NCT02074553|75789474|FG006|Washout Period 2|Lost to Follow-up|0|||
41983174|NCT02074553|75789475|FG007|Washout Period 2|Lost to Follow-up|0|||
41983175|NCT02074553|75789468|FG000|Washout Period 3|Physician Decision|0|||
41983176|NCT02074553|75789469|FG001|Washout Period 3|Physician Decision|0|||
41983177|NCT02074553|75789470|FG002|Washout Period 3|Physician Decision|0|||
42029857|NCT01163747|75838458|FG001|Overall Study|Insufficient Therapeutic Response|1|||
42029858|NCT01163747|75838457|FG000|Overall Study|Protocol Violation|0|||
42029859|NCT01163747|75838458|FG001|Overall Study|Protocol Violation|1|||
42029860|NCT01163747|75838457|FG000|Overall Study|Refused Treatment|6|||
42029861|NCT01163747|75838458|FG001|Overall Study|Refused Treatment|4|||
42131380|NCT00510458|75942316|FG000|Overall Study|Death|1|||
42131381|NCT00510458|75942316|FG000|Overall Study|Terminated|14|||
42131382|NCT00510458|75942316|FG000|Overall Study|Lost to Follow-up|6|||
42131383|NCT00510458|75942316|FG000|Overall Study|Withdrawal by Subject|3|||
41983178|NCT02074553|75789471|FG003|Washout Period 3|Physician Decision|0|||
42131384|NCT00510458|75942316|FG000|Overall Study|Revision|2|||
42131385|NCT00414765|75942323|FG000|Overall Study|Adverse Event|5|||
42131386|NCT00414765|75942324|FG001|Overall Study|Adverse Event|9|||
42131387|NCT00414765|75942323|FG000|Overall Study|Withdrawal by Subject|1|||
42131388|NCT00414765|75942324|FG001|Overall Study|Withdrawal by Subject|1|||
42131389|NCT00414765|75942323|FG000|Overall Study|Disease Progression|0|||
42222726|NCT02895347|76041463|FG000|Overall Study|Withdrawal by Subject|3|||
42222727|NCT02895347|76041464|FG001|Overall Study|Withdrawal by Subject|1|||
42222728|NCT03539549|76041471|FG000|Overall Study|Adverse Event|12|||
41983179|NCT02074553|75789472|FG004|Washout Period 3|Physician Decision|0|||
41983180|NCT02074553|75789473|FG005|Washout Period 3|Physician Decision|0|||
41983181|NCT02074553|75789474|FG006|Washout Period 3|Physician Decision|0|||
42029862|NCT01163279|75838466|FG000|Overall Study|Withdrawal by Subject|2|||
42131390|NCT00414765|75942324|FG001|Overall Study|Disease Progression|1|||
42131391|NCT00500682|75942332|FG000|Overall Study|Adverse Event|37|||
42222729|NCT03539549|76041471|FG000|Overall Study|Lost to Follow-up|1|||
42222730|NCT03539549|76041471|FG000|Overall Study|Death|2|||
42222731|NCT03539549|76041471|FG000|Overall Study|Progressive Disease|1|||
42222732|NCT03539549|76041471|FG000|Overall Study|Reason not Specified|1|||
42222733|NCT03506477|76041477|FG000|Overall Study|Withdrawal by Subject|1|||
42222734|NCT03506477|76041478|FG001|Overall Study|Withdrawal by Subject|0|||
42222735|NCT03073980|76041487|FG000|Overall Study|Lost to Follow-up|10|||
42222736|NCT03073980|76041488|FG001|Overall Study|Lost to Follow-up|2|||
42222737|NCT03073980|76041489|FG002|Overall Study|Lost to Follow-up|9|||
42222738|NCT03073980|76041487|FG000|Overall Study|No post-procedure data|0|||
42222739|NCT03073980|76041488|FG001|Overall Study|No post-procedure data|0|||
42222740|NCT03073980|76041489|FG002|Overall Study|No post-procedure data|2|||
42222741|NCT03930186|76041501|FG000|Weeks 0 to 16|Adverse Event|6|||
42222742|NCT03930186|76041501|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
42222743|NCT03930186|76041501|FG000|Weeks 16 to 32|Adverse Event|1|||
42222744|NCT03930186|76041501|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
42222745|NCT03504917|76041507|FG000|Blinded Treatment Period|Protocol Violation|1|||
42222746|NCT03504917|76041508|FG001|Blinded Treatment Period|Protocol Violation|0|||
42222747|NCT03504917|76041507|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
42222748|NCT03504917|76041508|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
42222749|NCT03504917|76041507|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
42222750|NCT03504917|76041508|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
42222751|NCT03504917|76041507|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
42222752|NCT03504917|76041508|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
42222753|NCT03504917|76041507|FG000|Blinded Treatment Period|Adverse Event|4|||
42222754|NCT03504917|76041508|FG001|Blinded Treatment Period|Adverse Event|4|||
42222755|NCT03504917|76041507|FG000|Blinded Treatment Period|Physician Decision|1|||
42222756|NCT03504917|76041508|FG001|Blinded Treatment Period|Physician Decision|0|||
42222757|NCT03504917|76041507|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
42222758|NCT03504917|76041508|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
42222759|NCT03504917|76041507|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
42222760|NCT03504917|76041508|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
42222761|NCT03504917|76041507|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
42222762|NCT03504917|76041508|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
42222763|NCT03504917|76041507|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
42222764|NCT03504917|76041508|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
42222765|NCT03504917|76041507|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
42222766|NCT03504917|76041508|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
42222767|NCT03504917|76041507|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
42222768|NCT03504917|76041508|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
42222769|NCT03504917|76041507|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
42222770|NCT03504917|76041508|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
42222771|NCT03504917|76041507|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
42222772|NCT03504917|76041508|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
42222773|NCT03504917|76041507|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
42222774|NCT03504917|76041508|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
42222775|NCT03504917|76041507|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
42222776|NCT03504917|76041508|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
42222777|NCT03536663|76041520|FG000|Endexo|Protocol Violation|1|||
42222778|NCT03565211|76041529|FG000|Overall Study|Withdrawal by Subject|2|||
41983182|NCT02074553|75789475|FG007|Washout Period 3|Physician Decision|1|||
41983183|NCT01664598|75789493|FG000|Overall Study|Sponsor Decision|1|||
41983184|NCT01664598|75789493|FG000|Overall Study|Withdrawal of Informed Consent|4|||
41983185|NCT01664598|75789493|FG000|Overall Study|Adverse Event|1|||
41983186|NCT01280682|75789503|FG000|Overall Study|Lost to Follow-up|0|||
41983187|NCT01280682|75789504|FG001|Overall Study|Lost to Follow-up|6|||
41983188|NCT01280682|75789503|FG000|Overall Study|Withdrawal by Subject|0|||
41983189|NCT01280682|75789504|FG001|Overall Study|Withdrawal by Subject|7|||
41983190|NCT01050218|75789521|FG000|Overall Study|Adverse Event|37|||
41983191|NCT01050218|75789521|FG000|Overall Study|Lack of Efficacy|8|||
41983192|NCT01050218|75789521|FG000|Overall Study|Protocol Violation|3|||
41983193|NCT01050218|75789521|FG000|Overall Study|Withdrawal by Subject|18|||
42222779|NCT03565211|76041529|FG000|Overall Study|Lost to Follow-up|1|||
42222780|NCT03565211|76041529|FG000|Overall Study|Adverse Event|44|||
42222781|NCT03565211|76041529|FG000|Overall Study|Personal issues|1|||
42222782|NCT03531905|76041536|FG000|Overall Study|Withdrawal by Subject|3|||
41983194|NCT01050218|75789521|FG000|Overall Study|Discontinued by sponsor|18|||
41983195|NCT01050218|75789521|FG000|Overall Study|Compliance|2|||
41983196|NCT01050218|75789521|FG000|Overall Study|Failed to return|7|||
41983197|NCT01050218|75789521|FG000|Overall Study|Serious Adverse Event|1|||
41983198|NCT01050218|75789521|FG000|Overall Study|Family emergency|1|||
42222783|NCT03531905|76041537|FG001|Overall Study|Withdrawal by Subject|3|||
42222784|NCT03531905|76041538|FG002|Overall Study|Withdrawal by Subject|2|||
42222785|NCT03531905|76041536|FG000|Overall Study|Lost to Follow-up|2|||
42222786|NCT03531905|76041537|FG001|Overall Study|Lost to Follow-up|2|||
42222787|NCT03531905|76041538|FG002|Overall Study|Lost to Follow-up|1|||
42222788|NCT03531905|76041536|FG000|Overall Study|Participant was out of town|1|||
42222789|NCT03531905|76041537|FG001|Overall Study|Participant was out of town|0|||
42222790|NCT03531905|76041538|FG002|Overall Study|Participant was out of town|0|||
42222791|NCT03531905|76041536|FG000|Overall Study|Could not speak with the participant|1|||
42222792|NCT03531905|76041537|FG001|Overall Study|Could not speak with the participant|0|||
42222793|NCT03531905|76041538|FG002|Overall Study|Could not speak with the participant|0|||
42222794|NCT03531827|76041548|FG000|Overall Study|Adverse Event|2|||
42222795|NCT03531827|76041549|FG001|Overall Study|Adverse Event|0|||
42222796|NCT03531827|76041548|FG000|Overall Study|Progressive disease|1|||
42222797|NCT03531827|76041549|FG001|Overall Study|Progressive disease|0|||
42222798|NCT03530345|76041578|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
42222799|NCT03530345|76041579|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
42222800|NCT03530345|76041578|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
42222801|NCT03530345|76041579|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
42222802|NCT03530345|76041578|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
42222803|NCT03530345|76041579|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
42222804|NCT03530345|76041578|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
42222805|NCT03530345|76041579|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
42222806|NCT03500159|76041593|FG000|Overall Study|Study Terminated|2|||
42222807|NCT03500159|76041594|FG001|Overall Study|Study Terminated|1|||
42222808|NCT03785340|76041602|FG000|Overall Study|Lost to Follow-up|2|||
42222809|NCT03785340|76041603|FG001|Overall Study|Lost to Follow-up|0|||
42222810|NCT03785340|76041602|FG000|Overall Study|Adverse Event|1|||
42222811|NCT03785340|76041603|FG001|Overall Study|Adverse Event|0|||
42222812|NCT03499067|76041609|FG000|First Intervention|Physician Decision|2|||
42222813|NCT03499067|76041610|FG001|First Intervention|Physician Decision|1|||
42222814|NCT03499067|76041609|FG000|First Intervention|Withdrawal by Subject|3|||
42222815|NCT03499067|76041610|FG001|First Intervention|Withdrawal by Subject|6|||
42222816|NCT03562481|76041618|FG000|First Intervention|Lost to Follow-up|1|||
42222817|NCT03562481|76041619|FG001|First Intervention|Lost to Follow-up|0|||
42222818|NCT03529409|76041645|FG000|Randomized|Lost to Follow-up|0|||
42222819|NCT03529409|76041646|FG001|Randomized|Lost to Follow-up|0|||
42222820|NCT03529409|76041647|FG002|Randomized|Lost to Follow-up|4|||
42222821|NCT03529409|76041645|FG000|Randomized|Excluded|0|||
42222822|NCT03529409|76041646|FG001|Randomized|Excluded|0|||
42222823|NCT03529409|76041647|FG002|Randomized|Excluded|1|||
42222824|NCT03529409|76041645|FG000|Post-treatment Assessment|Death|1|||
42222825|NCT03529409|76041646|FG001|Post-treatment Assessment|Death|0|||
42222826|NCT03529409|76041647|FG002|Post-treatment Assessment|Death|0|||
42222827|NCT03529409|76041645|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
42222828|NCT03529409|76041646|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
42222829|NCT03529409|76041647|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
42222830|NCT03529409|76041645|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
42222831|NCT03529409|76041646|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
42222832|NCT03529409|76041647|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
42222833|NCT03529409|76041645|FG000|Follow-up Assessment|Death|1|||
42222834|NCT03529409|76041646|FG001|Follow-up Assessment|Death|0|||
42222835|NCT03529409|76041647|FG002|Follow-up Assessment|Death|0|||
42222836|NCT03529409|76041645|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
42222837|NCT03529409|76041646|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
42222838|NCT03529409|76041647|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
42222839|NCT03498287|76041656|FG000|Overall Study|Withdrawal by Subject|3|||
42222840|NCT03498287|76041657|FG001|Overall Study|Withdrawal by Subject|0|||
42222841|NCT03498287|76041656|FG000|Overall Study|Protocol Violation|0|||
41983199|NCT00679029|75789525|FG000|Overall Study|Adverse Event|3|||
41983200|NCT00679029|75789525|FG000|Overall Study|Withdrawal by Subject|1|||
42222842|NCT03498287|76041657|FG001|Overall Study|Protocol Violation|4|||
42222843|NCT03498287|76041656|FG000|Overall Study|Adverse Event|0|||
42222844|NCT03498287|76041657|FG001|Overall Study|Adverse Event|1|||
42222845|NCT03497429|76041665|FG000|Overall Study|Progressive disease|3|||
42222846|NCT03497429|76041666|FG001|Overall Study|Progressive disease|4|||
42222847|NCT03497429|76041665|FG000|Overall Study|Adverse Event|0|||
42222848|NCT03497429|76041666|FG001|Overall Study|Adverse Event|2|||
42222849|NCT03497039|76041674|FG000|Overall Study|Withdrawal by Subject|1|||
42302270|NCT02494921|76137342|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
42222850|NCT03497039|76041675|FG001|Overall Study|Withdrawal by Subject|0|||
42222851|NCT03497039|76041674|FG000|Overall Study|Protocol Violation|0|||
42222852|NCT03497039|76041675|FG001|Overall Study|Protocol Violation|1|||
42222853|NCT03495869|76041694|FG000|Overall Study|Lost to Follow-up|4|||
42222854|NCT03495869|76041695|FG001|Overall Study|Lost to Follow-up|17|||
42222855|NCT03495869|76041696|FG002|Overall Study|Lost to Follow-up|8|||
42222856|NCT03495869|76041697|FG003|Overall Study|Lost to Follow-up|14|||
42222857|NCT03495869|76041694|FG000|Overall Study|Withdrawal by Subject|0|||
42222858|NCT03495869|76041695|FG001|Overall Study|Withdrawal by Subject|3|||
42222859|NCT03495869|76041696|FG002|Overall Study|Withdrawal by Subject|0|||
42222860|NCT03495869|76041697|FG003|Overall Study|Withdrawal by Subject|3|||
42222861|NCT03495869|76041694|FG000|Overall Study|Dropped from study|0|||
42222862|NCT03495869|76041695|FG001|Overall Study|Dropped from study|7|||
42222863|NCT03495869|76041696|FG002|Overall Study|Dropped from study|2|||
42222864|NCT03495869|76041697|FG003|Overall Study|Dropped from study|4|||
42222865|NCT03071094|76041718|FG000|Overall Study|Death|1|||
42222866|NCT03071094|76041719|FG001|Overall Study|Death|1|||
42222867|NCT03071094|76041718|FG000|Overall Study|Adverse Event|1|||
42222868|NCT03071094|76041719|FG001|Overall Study|Adverse Event|0|||
42222869|NCT03559517|76041728|FG000|Overall Study|Withdrawal by Subject|1|||
42222870|NCT03559517|76041729|FG001|Overall Study|Withdrawal by Subject|0|||
42222871|NCT03559517|76041730|FG002|Overall Study|Withdrawal by Subject|0|||
42222872|NCT02509494|76041747|FG000|Overall Study|Lost to Follow-up|8|||
42222873|NCT02509494|76041748|FG001|Overall Study|Lost to Follow-up|47|||
42222874|NCT02509494|76041749|FG002|Overall Study|Lost to Follow-up|19|||
42222875|NCT02509494|76041750|FG003|Overall Study|Lost to Follow-up|6|||
42222876|NCT02509494|76041751|FG004|Overall Study|Lost to Follow-up|3|||
42222877|NCT02509494|76041752|FG005|Overall Study|Lost to Follow-up|3|||
42222878|NCT02509494|76041753|FG006|Overall Study|Lost to Follow-up|1|||
42222879|NCT02509494|76041754|FG007|Overall Study|Lost to Follow-up|3|||
42222880|NCT02509494|76041755|FG008|Overall Study|Lost to Follow-up|1|||
42222881|NCT02509494|76041747|FG000|Overall Study|Physician Decision|2|||
42222882|NCT02509494|76041748|FG001|Overall Study|Physician Decision|1|||
42222883|NCT02509494|76041749|FG002|Overall Study|Physician Decision|0|||
42222884|NCT02509494|76041750|FG003|Overall Study|Physician Decision|0|||
42222885|NCT02509494|76041751|FG004|Overall Study|Physician Decision|0|||
42222886|NCT02509494|76041752|FG005|Overall Study|Physician Decision|0|||
42222887|NCT02509494|76041753|FG006|Overall Study|Physician Decision|0|||
41983201|NCT00679029|75789525|FG000|Overall Study|Lost to Follow-up|1|||
41983202|NCT00195429|75789531|FG000|Overall Study|Adverse Event|2|||
41983203|NCT00195429|75789532|FG001|Overall Study|Adverse Event|4|||
41983204|NCT00195429|75789531|FG000|Overall Study|Lack of Efficacy|2|||
41983205|NCT00195429|75789532|FG001|Overall Study|Lack of Efficacy|1|||
41983206|NCT00195429|75789531|FG000|Overall Study|Lost to Follow-up|1|||
42222888|NCT02509494|76041754|FG007|Overall Study|Physician Decision|0|||
42222889|NCT02509494|76041755|FG008|Overall Study|Physician Decision|0|||
42222890|NCT02509494|76041747|FG000|Overall Study|Withdrawal by Subject|4|||
42222891|NCT02509494|76041748|FG001|Overall Study|Withdrawal by Subject|17|||
42222892|NCT02509494|76041749|FG002|Overall Study|Withdrawal by Subject|7|||
42222893|NCT02509494|76041750|FG003|Overall Study|Withdrawal by Subject|5|||
42222894|NCT02509494|76041751|FG004|Overall Study|Withdrawal by Subject|0|||
42222895|NCT02509494|76041752|FG005|Overall Study|Withdrawal by Subject|6|||
42222896|NCT02509494|76041753|FG006|Overall Study|Withdrawal by Subject|1|||
42222897|NCT02509494|76041754|FG007|Overall Study|Withdrawal by Subject|2|||
42222898|NCT02509494|76041755|FG008|Overall Study|Withdrawal by Subject|1|||
42222899|NCT02509494|76041747|FG000|Overall Study|Death|0|||
41983207|NCT00195429|75789532|FG001|Overall Study|Lost to Follow-up|0|||
41983208|NCT01059773|75789540|FG000|Overall Study|Adverse Event|2|||
41983209|NCT01059773|75789541|FG001|Overall Study|Adverse Event|2|||
41983210|NCT01059773|75789540|FG000|Overall Study|Withdrawal by Subject|1|||
41983211|NCT01059773|75789541|FG001|Overall Study|Withdrawal by Subject|5|||
41983212|NCT01059773|75789540|FG000|Overall Study|Lost to Follow-up|1|||
42222900|NCT02509494|76041748|FG001|Overall Study|Death|1|||
42222901|NCT02509494|76041749|FG002|Overall Study|Death|0|||
42222902|NCT02509494|76041750|FG003|Overall Study|Death|0|||
42222903|NCT02509494|76041751|FG004|Overall Study|Death|1|||
42222904|NCT02509494|76041752|FG005|Overall Study|Death|0|||
42222905|NCT02509494|76041753|FG006|Overall Study|Death|0|||
42222906|NCT02509494|76041754|FG007|Overall Study|Death|1|||
42222907|NCT02509494|76041755|FG008|Overall Study|Death|0|||
42222908|NCT02509494|76041747|FG000|Overall Study|Other|0|||
42302271|NCT02494921|76137338|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
41983213|NCT01059773|75789541|FG001|Overall Study|Lost to Follow-up|1|||
41983214|NCT01059773|75789540|FG000|Overall Study|Pregnancy|1|||
41983215|NCT01059773|75789541|FG001|Overall Study|Pregnancy|1|||
41983216|NCT01059773|75789540|FG000|Overall Study|Protocol Violation|6|||
42222909|NCT02509494|76041748|FG001|Overall Study|Other|4|||
42222910|NCT02509494|76041749|FG002|Overall Study|Other|5|||
42222911|NCT02509494|76041750|FG003|Overall Study|Other|0|||
42222912|NCT02509494|76041751|FG004|Overall Study|Other|0|||
42222913|NCT02509494|76041752|FG005|Overall Study|Other|0|||
41983217|NCT01059773|75789541|FG001|Overall Study|Protocol Violation|2|||
41983218|NCT01059773|75789540|FG000|Overall Study|Physician Decision|5|||
42222914|NCT02509494|76041753|FG006|Overall Study|Other|0|||
42222915|NCT02509494|76041754|FG007|Overall Study|Other|0|||
42222916|NCT02509494|76041755|FG008|Overall Study|Other|0|||
42029863|NCT01163279|75838467|FG001|Overall Study|Withdrawal by Subject|0|||
42029864|NCT01162499|75838474|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
42029865|NCT01162499|75838475|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
42029866|NCT01206140|75838485|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
42029867|NCT01206140|75838486|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
42029868|NCT01162421|75838494|FG000|Overall Study|Did not receive study drug|2|||
42029869|NCT01162421|75838495|FG001|Overall Study|Did not receive study drug|1|||
42029870|NCT01162421|75838494|FG000|Overall Study|Adverse Event|2|||
42029871|NCT01162421|75838495|FG001|Overall Study|Adverse Event|5|||
42029872|NCT01162421|75838494|FG000|Overall Study|Lost to Follow-up|0|||
42029873|NCT01162421|75838495|FG001|Overall Study|Lost to Follow-up|2|||
42029874|NCT01162421|75838494|FG000|Overall Study|Lack of Efficacy|2|||
42029875|NCT01162421|75838495|FG001|Overall Study|Lack of Efficacy|2|||
42029876|NCT01162421|75838494|FG000|Overall Study|Other|2|||
42029877|NCT01162421|75838495|FG001|Overall Study|Other|3|||
42029878|NCT01162343|75838501|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
42029879|NCT01162343|75838501|FG000|Overall Study|Refused psychiatrist assessment|12|||
42029880|NCT01188551|75838509|FG000|Overall Study|Pharmacy issues|1|||
42029881|NCT01188551|75838510|FG001|Overall Study|Pharmacy issues|0|||
42029882|NCT01188551|75838511|FG002|Overall Study|Pharmacy issues|0|||
42029883|NCT01188551|75838512|FG003|Overall Study|Pharmacy issues|0|||
42029884|NCT01161407|75838524|FG000|Overall Study|Protocol Violation|3|||
42029885|NCT01161407|75838525|FG001|Overall Study|Protocol Violation|1|||
42222917|NCT02509494|76041747|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42222918|NCT02509494|76041748|FG001|Overall Study|Non-Compliance With Study Drug|11|||
42222919|NCT02509494|76041749|FG002|Overall Study|Non-Compliance With Study Drug|7|||
42222920|NCT02509494|76041750|FG003|Overall Study|Non-Compliance With Study Drug|0|||
42029886|NCT01161173|75838531|FG000|Overall Study|Protocol Violation|13|||
42029887|NCT01161173|75838531|FG000|Overall Study|Lost to Follow-up|7|||
42029888|NCT01161173|75838531|FG000|Overall Study|Progressive Disease|82|||
42029889|NCT01161173|75838531|FG000|Overall Study|Withdrawal of Consent|5|||
42029890|NCT01161173|75838531|FG000|Overall Study|Unacceptable Toxicity|21|||
42029891|NCT01161173|75838531|FG000|Overall Study|Death|194|||
42029892|NCT01161173|75838531|FG000|Overall Study|End of Study|2|||
42029893|NCT01161173|75838531|FG000|Overall Study|Reasons Not Specified|23|||
42029894|NCT01159769|75838535|FG000|Overall Study|Adverse Event|1|||
42029895|NCT01159691|75838539|FG000|Overall Study|Lost to Follow-up|2|||
42029896|NCT01159691|75838539|FG000|Overall Study|Unknown reasons|1|||
42029897|NCT01159691|75838539|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
42029898|NCT01159691|75838539|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
42222921|NCT02509494|76041751|FG004|Overall Study|Non-Compliance With Study Drug|1|||
42222922|NCT02509494|76041752|FG005|Overall Study|Non-Compliance With Study Drug|2|||
42222923|NCT02509494|76041753|FG006|Overall Study|Non-Compliance With Study Drug|1|||
42222924|NCT02509494|76041754|FG007|Overall Study|Non-Compliance With Study Drug|1|||
42222925|NCT02509494|76041755|FG008|Overall Study|Non-Compliance With Study Drug|0|||
41983219|NCT01059773|75789541|FG001|Overall Study|Physician Decision|4|||
41983220|NCT01059773|75789540|FG000|Overall Study|Lack of Efficacy|3|||
41983221|NCT01059773|75789541|FG001|Overall Study|Lack of Efficacy|3|||
41983222|NCT01059773|75789540|FG000|Overall Study|Death|0|||
41983223|NCT01059773|75789541|FG001|Overall Study|Death|1|||
41983224|NCT01059773|75789540|FG000|Overall Study|Malignancy including squamous cell skin|0|||
41983225|NCT01059773|75789541|FG001|Overall Study|Malignancy including squamous cell skin|1|||
41983226|NCT01059773|75789540|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
41983227|NCT01059773|75789541|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
41983228|NCT01059773|75789540|FG000|Overall Study|Other|1|||
41983229|NCT01059773|75789541|FG001|Overall Study|Other|3|||
41983230|NCT01059318|75789552|FG000|Core Study (26 Week)|Adverse Event|3|||
41983231|NCT01059318|75789552|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
41983232|NCT01059318|75789552|FG000|Extension (36 Week)|Adverse Event|3|||
41983233|NCT01058655|75789563|FG000|Overall Study|Withdrawal by Subject|1|||
42029899|NCT01159691|75838539|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
42029900|NCT01159691|75838539|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
42029901|NCT01159691|75838539|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
42029902|NCT01159691|75838539|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
42222926|NCT03493451|76041792|FG000|Overall Study|Death|11|||
41983234|NCT01058655|75789564|FG001|Overall Study|Withdrawal by Subject|0|||
41983235|NCT01058655|75789565|FG002|Overall Study|Withdrawal by Subject|3|||
42029903|NCT01157897|75838547|FG000|Overall Study|Lost to Follow-up|2|||
41983236|NCT01058655|75789566|FG003|Overall Study|Withdrawal by Subject|4|||
42222927|NCT03493451|76041793|FG001|Overall Study|Death|26|||
41983237|NCT01058655|75789563|FG000|Overall Study|Prolonged Treatment Delay|0|||
42029904|NCT01157897|75838548|FG001|Overall Study|Lost to Follow-up|0|||
42029905|NCT01157897|75838549|FG002|Overall Study|Lost to Follow-up|0|||
42029906|NCT01157897|75838550|FG003|Overall Study|Lost to Follow-up|1|||
42029907|NCT01157897|75838547|FG000|Overall Study|Relocated|0|||
42029908|NCT01157897|75838548|FG001|Overall Study|Relocated|2|||
42222928|NCT03493451|76041794|FG002|Overall Study|Death|3|||
42222929|NCT03493451|76041792|FG000|Overall Study|Lost to Follow-up|1|||
42222930|NCT03493451|76041793|FG001|Overall Study|Lost to Follow-up|4|||
42222931|NCT03493451|76041794|FG002|Overall Study|Lost to Follow-up|1|||
42222932|NCT03493451|76041792|FG000|Overall Study|Withdrawal by Subject|1|||
42222933|NCT03493451|76041793|FG001|Overall Study|Withdrawal by Subject|1|||
42222934|NCT03493451|76041794|FG002|Overall Study|Withdrawal by Subject|2|||
42222935|NCT03493451|76041792|FG000|Overall Study|Progressive Disease|1|||
42222936|NCT03493451|76041793|FG001|Overall Study|Progressive Disease|0|||
42222937|NCT03493451|76041794|FG002|Overall Study|Progressive Disease|0|||
42222938|NCT03493451|76041792|FG000|Overall Study|Transferred to long term extension study|8|||
42222939|NCT03493451|76041793|FG001|Overall Study|Transferred to long term extension study|13|||
42222940|NCT03493451|76041794|FG002|Overall Study|Transferred to long term extension study|5|||
42222941|NCT03492281|76041805|FG000|Overall Study|Withdrawal by Subject|21|||
42222942|NCT03492281|76041806|FG001|Overall Study|Withdrawal by Subject|14|||
42222943|NCT03492281|76041807|FG002|Overall Study|Withdrawal by Subject|13|||
42222944|NCT03492281|76041805|FG000|Overall Study|Lost to Follow-up|14|||
42222945|NCT03492281|76041806|FG001|Overall Study|Lost to Follow-up|15|||
42222946|NCT03492281|76041807|FG002|Overall Study|Lost to Follow-up|10|||
42222947|NCT03492281|76041805|FG000|Overall Study|Adverse Event|6|||
42222948|NCT03492281|76041806|FG001|Overall Study|Adverse Event|8|||
42222949|NCT03492281|76041807|FG002|Overall Study|Adverse Event|13|||
42222950|NCT03492281|76041805|FG000|Overall Study|Lack of Efficacy|3|||
42222951|NCT03492281|76041806|FG001|Overall Study|Lack of Efficacy|0|||
42222952|NCT03492281|76041807|FG002|Overall Study|Lack of Efficacy|1|||
42222953|NCT03492281|76041805|FG000|Overall Study|Physician Decision|1|||
42222954|NCT03492281|76041806|FG001|Overall Study|Physician Decision|0|||
42222955|NCT03492281|76041807|FG002|Overall Study|Physician Decision|3|||
42222956|NCT03492281|76041805|FG000|Overall Study|Protocol Violation|0|||
42222957|NCT03492281|76041806|FG001|Overall Study|Protocol Violation|2|||
42222958|NCT03492281|76041807|FG002|Overall Study|Protocol Violation|1|||
42222959|NCT03492281|76041805|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
42222960|NCT03492281|76041806|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
42222961|NCT03492281|76041807|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
42222962|NCT03492281|76041805|FG000|Overall Study|Death|0|||
42222963|NCT03492281|76041806|FG001|Overall Study|Death|0|||
42222964|NCT03492281|76041807|FG002|Overall Study|Death|1|||
42222965|NCT03492281|76041805|FG000|Overall Study|Captured as Other in Database|8|||
42222966|NCT03492281|76041806|FG001|Overall Study|Captured as Other in Database|6|||
42222967|NCT03492281|76041807|FG002|Overall Study|Captured as Other in Database|3|||
42222968|NCT03070782|76041824|FG000|Overall Study|Adverse Event|3|||
42222969|NCT03070782|76041825|FG001|Overall Study|Adverse Event|0|||
42222970|NCT03070782|76041826|FG002|Overall Study|Adverse Event|3|||
41983238|NCT01058655|75789564|FG001|Overall Study|Prolonged Treatment Delay|0|||
41983239|NCT01058655|75789565|FG002|Overall Study|Prolonged Treatment Delay|0|||
41983240|NCT01058655|75789566|FG003|Overall Study|Prolonged Treatment Delay|2|||
41983241|NCT01058655|75789563|FG000|Overall Study|Symptomatic Deterioration|0|||
41983242|NCT01058655|75789564|FG001|Overall Study|Symptomatic Deterioration|0|||
41983243|NCT01058655|75789565|FG002|Overall Study|Symptomatic Deterioration|0|||
41983244|NCT01058655|75789566|FG003|Overall Study|Symptomatic Deterioration|1|||
41983245|NCT01058655|75789563|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
42029909|NCT01157897|75838549|FG002|Overall Study|Relocated|0|||
42029910|NCT01157897|75838550|FG003|Overall Study|Relocated|0|||
42029911|NCT01185821|75838565|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42029912|NCT01185821|75838566|FG001|Overall Study|Abnormal laboratory value(s)|2|||
42131392|NCT00500682|75942333|FG001|Overall Study|Adverse Event|29|||
42131393|NCT00500682|75942332|FG000|Overall Study|Death|25|||
42131394|NCT00500682|75942333|FG001|Overall Study|Death|16|||
42131395|NCT00500682|75942332|FG000|Overall Study|Lost to Follow-up|11|||
42131396|NCT00500682|75942333|FG001|Overall Study|Lost to Follow-up|11|||
42131397|NCT00500682|75942332|FG000|Overall Study|Physician Decision|6|||
42131398|NCT00500682|75942333|FG001|Overall Study|Physician Decision|10|||
42131399|NCT00500682|75942332|FG000|Overall Study|Pregnancy|2|||
42131400|NCT00500682|75942333|FG001|Overall Study|Pregnancy|0|||
42131401|NCT00500682|75942332|FG000|Overall Study|Protocol Violation|1|||
42222971|NCT03070782|76041827|FG003|Overall Study|Adverse Event|1|||
42222972|NCT03070782|76041828|FG004|Overall Study|Adverse Event|6|||
42222973|NCT03070782|76041829|FG005|Overall Study|Adverse Event|2|||
42222974|NCT03070782|76041824|FG000|Overall Study|Withdrawal by Subject|2|||
41983246|NCT01058655|75789564|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
41983247|NCT01058655|75789565|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
41983248|NCT01058655|75789566|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
41983249|NCT01058655|75789563|FG000|Overall Study|Death|0|||
41983250|NCT01058655|75789564|FG001|Overall Study|Death|1|||
41983251|NCT01058655|75789565|FG002|Overall Study|Death|1|||
41983252|NCT01058655|75789566|FG003|Overall Study|Death|0|||
41983253|NCT01058655|75789563|FG000|Overall Study|Disease Progression|1|||
42222975|NCT03070782|76041825|FG001|Overall Study|Withdrawal by Subject|1|||
42222976|NCT03070782|76041826|FG002|Overall Study|Withdrawal by Subject|1|||
42222977|NCT03070782|76041827|FG003|Overall Study|Withdrawal by Subject|0|||
42222978|NCT03070782|76041828|FG004|Overall Study|Withdrawal by Subject|4|||
42222979|NCT03070782|76041829|FG005|Overall Study|Withdrawal by Subject|3|||
42222980|NCT03070782|76041824|FG000|Overall Study|Reason Not Specified|2|||
41983254|NCT01058655|75789564|FG001|Overall Study|Disease Progression|2|||
41983255|NCT01058655|75789565|FG002|Overall Study|Disease Progression|4|||
42029913|NCT01185821|75838567|FG002|Overall Study|Abnormal laboratory value(s)|1|||
42029914|NCT01185821|75838568|FG003|Overall Study|Abnormal laboratory value(s)|0|||
42029915|NCT01185821|75838569|FG004|Overall Study|Abnormal laboratory value(s)|0|||
42029916|NCT01185821|75838565|FG000|Overall Study|Protocol Violation|0|||
42029917|NCT01185821|75838566|FG001|Overall Study|Protocol Violation|0|||
42029918|NCT01185821|75838567|FG002|Overall Study|Protocol Violation|0|||
42222981|NCT03070782|76041825|FG001|Overall Study|Reason Not Specified|0|||
42222982|NCT03070782|76041826|FG002|Overall Study|Reason Not Specified|0|||
42222983|NCT03070782|76041827|FG003|Overall Study|Reason Not Specified|1|||
42222984|NCT03070782|76041828|FG004|Overall Study|Reason Not Specified|2|||
42222985|NCT03070782|76041829|FG005|Overall Study|Reason Not Specified|1|||
42222986|NCT03070782|76041824|FG000|Overall Study|Ineligibility|0|||
42222987|NCT03070782|76041825|FG001|Overall Study|Ineligibility|0|||
42222988|NCT03070782|76041826|FG002|Overall Study|Ineligibility|0|||
42222989|NCT03070782|76041827|FG003|Overall Study|Ineligibility|1|||
42222990|NCT03070782|76041828|FG004|Overall Study|Ineligibility|0|||
42222991|NCT03070782|76041829|FG005|Overall Study|Ineligibility|1|||
42222992|NCT03070782|76041824|FG000|Overall Study|Pregnancy|0|||
42222993|NCT03070782|76041825|FG001|Overall Study|Pregnancy|0|||
42222994|NCT03070782|76041826|FG002|Overall Study|Pregnancy|0|||
42222995|NCT03070782|76041827|FG003|Overall Study|Pregnancy|1|||
42222996|NCT03070782|76041828|FG004|Overall Study|Pregnancy|0|||
42222997|NCT03070782|76041829|FG005|Overall Study|Pregnancy|0|||
42222998|NCT03070782|76041824|FG000|Overall Study|Investigator Judgement|0|||
42222999|NCT03070782|76041825|FG001|Overall Study|Investigator Judgement|0|||
42223000|NCT03070782|76041826|FG002|Overall Study|Investigator Judgement|0|||
42223001|NCT03070782|76041827|FG003|Overall Study|Investigator Judgement|1|||
42223002|NCT03070782|76041828|FG004|Overall Study|Investigator Judgement|0|||
42223003|NCT03070782|76041829|FG005|Overall Study|Investigator Judgement|0|||
42302272|NCT02494921|76137339|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
41983256|NCT01058655|75789566|FG003|Overall Study|Disease Progression|24|||
42029919|NCT01185821|75838568|FG003|Overall Study|Protocol Violation|1|||
42131402|NCT00500682|75942333|FG001|Overall Study|Protocol Violation|3|||
42131403|NCT00500682|75942332|FG000|Overall Study|Withdrawal by Subject|80|||
42131404|NCT00500682|75942333|FG001|Overall Study|Withdrawal by Subject|74|||
42131405|NCT00500682|75942332|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
42131406|NCT00500682|75942333|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
42131407|NCT00500370|75942341|FG000|Overall Study|Adverse Event|9|||
42131408|NCT00500370|75942342|FG001|Overall Study|Adverse Event|3|||
42131409|NCT00500370|75942341|FG000|Overall Study|Lost to Follow-up|10|||
42131410|NCT00500370|75942342|FG001|Overall Study|Lost to Follow-up|10|||
42131411|NCT00500370|75942341|FG000|Overall Study|Protocol Violation|2|||
42131412|NCT00500370|75942342|FG001|Overall Study|Protocol Violation|4|||
42131413|NCT00500370|75942341|FG000|Overall Study|Sponsor Decision|2|||
42131414|NCT00500370|75942342|FG001|Overall Study|Sponsor Decision|0|||
42131415|NCT00500370|75942341|FG000|Overall Study|Subject Decision|10|||
42131416|NCT00500370|75942342|FG001|Overall Study|Subject Decision|17|||
41983257|NCT01058655|75789563|FG000|Overall Study|Other|0|||
42029920|NCT01185821|75838569|FG004|Overall Study|Protocol Violation|1|||
42223004|NCT03525119|76041865|FG000|Overall Study|Adverse Event|0|||
42223005|NCT03525119|76041866|FG001|Overall Study|Adverse Event|1|||
42223006|NCT03525119|76041867|FG002|Overall Study|Adverse Event|0|||
42223007|NCT03525119|76041865|FG000|Overall Study|Lost to Follow-up|32|||
42223008|NCT03525119|76041866|FG001|Overall Study|Lost to Follow-up|33|||
42131417|NCT00320788|75942353|FG000|Overall Study|Adverse Event|0|||
41983258|NCT01058655|75789564|FG001|Overall Study|Other|0|||
42131418|NCT00320788|75942354|FG001|Overall Study|Adverse Event|0|||
42131419|NCT00320788|75942355|FG002|Overall Study|Adverse Event|0|||
42223009|NCT03525119|76041867|FG002|Overall Study|Lost to Follow-up|37|||
42223010|NCT03525119|76041865|FG000|Overall Study|Withdrawal by Subject|5|||
42223011|NCT03525119|76041866|FG001|Overall Study|Withdrawal by Subject|4|||
42223012|NCT03525119|76041867|FG002|Overall Study|Withdrawal by Subject|2|||
42223013|NCT03525119|76041865|FG000|Overall Study|Reason not Specified|2|||
42223014|NCT03525119|76041866|FG001|Overall Study|Reason not Specified|1|||
42223015|NCT03525119|76041867|FG002|Overall Study|Reason not Specified|2|||
42223016|NCT03525119|76041865|FG000|Overall Study|Randomized but not Vaccinated|1|||
42223017|NCT03525119|76041866|FG001|Overall Study|Randomized but not Vaccinated|0|||
42223018|NCT03525119|76041867|FG002|Overall Study|Randomized but not Vaccinated|2|||
42223019|NCT03558503|76041875|FG000|Overall Study|Adverse Event|1|||
42223020|NCT03558503|76041875|FG000|Overall Study|Death|1|||
42223021|NCT03558503|76041875|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
42223022|NCT03489863|76041881|FG000|Overall Study|Withdrawal by Subject|0|||
42223023|NCT03489863|76041882|FG001|Overall Study|Withdrawal by Subject|1|||
42223024|NCT03489551|76041888|FG000|Overall Study|Withdrawal by Subject|2|||
42223025|NCT03557801|76041895|FG000|Overall Study|Protocol Violation|1|||
42223026|NCT03557801|76041896|FG001|Overall Study|Protocol Violation|0|||
42223027|NCT03557801|76041897|FG002|Overall Study|Protocol Violation|0|||
42223028|NCT03557801|76041895|FG000|Overall Study|Withdrawal by Subject|1|||
42223029|NCT03557801|76041896|FG001|Overall Study|Withdrawal by Subject|0|||
42223030|NCT03557801|76041897|FG002|Overall Study|Withdrawal by Subject|3|||
42223031|NCT03557801|76041895|FG000|Overall Study|Lost to Follow-up|0|||
42223032|NCT03557801|76041896|FG001|Overall Study|Lost to Follow-up|1|||
42223033|NCT03557801|76041897|FG002|Overall Study|Lost to Follow-up|0|||
42223034|NCT04210180|76041905|FG000|Overall Study|Withdrawal by Subject|2|||
42223035|NCT03523871|76041909|FG000|Overall Study|Death|1|||
42223036|NCT03523715|76041915|FG000|Overall Study|Lost to Follow-up|11|||
42223037|NCT03523715|76041916|FG001|Overall Study|Lost to Follow-up|14|||
42223038|NCT03523715|76041915|FG000|Overall Study|Did not meet inclusion criteria|1|||
42223039|NCT03523715|76041916|FG001|Overall Study|Did not meet inclusion criteria|0|||
42223040|NCT03523715|76041915|FG000|Overall Study|Internally inconsistent reporting|0|||
42223041|NCT03523715|76041916|FG001|Overall Study|Internally inconsistent reporting|2|||
42223042|NCT03980730|76041924|FG000|Overall Study|Study Terminated by Sponsor|0|||
42223043|NCT03980730|76041925|FG001|Overall Study|Study Terminated by Sponsor|3|||
42223044|NCT03980730|76041924|FG000|Overall Study|Adverse Event|2|||
42223045|NCT03980730|76041925|FG001|Overall Study|Adverse Event|0|||
42223046|NCT03980730|76041924|FG000|Overall Study|Sponsor Request|0|||
42223047|NCT03980730|76041925|FG001|Overall Study|Sponsor Request|1|||
42223048|NCT03523091|76041933|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
42223049|NCT03523091|76041934|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
42223050|NCT03523091|76041933|FG000|Overall Study|Withdrawal by Subject|0|||
42223051|NCT03523091|76041934|FG001|Overall Study|Withdrawal by Subject|3|||
42223052|NCT03523091|76041933|FG000|Overall Study|Increase Botox dose|0|||
42223053|NCT03523091|76041934|FG001|Overall Study|Increase Botox dose|1|||
42223054|NCT03438383|76041955|FG000|Overall Study|Protocol Violation|9|||
42223055|NCT03438383|76041956|FG001|Overall Study|Protocol Violation|3|||
42223056|NCT03478787|76041964|FG000|Overall Study|Adverse Event|5|||
41983259|NCT01058655|75789565|FG002|Overall Study|Other|0|||
41983260|NCT01058655|75789566|FG003|Overall Study|Other|4|||
41983261|NCT01058421|75789579|FG000|1 Month Outcomes|Death|10|||
41983262|NCT01058421|75789580|FG001|1 Month Outcomes|Death|6|||
41983263|NCT01058421|75789579|FG000|1 Month Outcomes|Lost to Follow-up|8|||
41983264|NCT01058421|75789580|FG001|1 Month Outcomes|Lost to Follow-up|7|||
41983265|NCT01058421|75789579|FG000|1 Month Outcomes|Remained in Hospital|5|||
41983266|NCT01058421|75789580|FG001|1 Month Outcomes|Remained in Hospital|12|||
42131420|NCT00320788|75942356|FG003|Overall Study|Adverse Event|1|||
42131421|NCT00320788|75942357|FG004|Overall Study|Adverse Event|0|||
42131422|NCT00320788|75942353|FG000|Overall Study|Death|0|||
42131423|NCT00320788|75942354|FG001|Overall Study|Death|0|||
42131424|NCT00320788|75942355|FG002|Overall Study|Death|1|||
42131425|NCT00320788|75942356|FG003|Overall Study|Death|0|||
42131426|NCT00320788|75942357|FG004|Overall Study|Death|1|||
42131427|NCT00320788|75942353|FG000|Overall Study|Lost to Follow-up|0|||
42131428|NCT00320788|75942354|FG001|Overall Study|Lost to Follow-up|2|||
42131429|NCT00320788|75942355|FG002|Overall Study|Lost to Follow-up|1|||
42131430|NCT00320788|75942356|FG003|Overall Study|Lost to Follow-up|0|||
42223057|NCT03478787|76041965|FG001|Overall Study|Adverse Event|1|||
41983267|NCT01058421|75789579|FG000|1 Month Outcomes|Remained in Other Facility|16|||
42131431|NCT00320788|75942357|FG004|Overall Study|Lost to Follow-up|0|||
42223058|NCT03478787|76041964|FG000|Overall Study|Protocol Violation|3|||
42223059|NCT03478787|76041965|FG001|Overall Study|Protocol Violation|0|||
42223060|NCT03478787|76041964|FG000|Overall Study|Lack of Efficacy|7|||
42223061|NCT03478787|76041965|FG001|Overall Study|Lack of Efficacy|1|||
42223062|NCT03478787|76041964|FG000|Overall Study|Lost to Follow-up|9|||
42223063|NCT03478787|76041965|FG001|Overall Study|Lost to Follow-up|5|||
42223064|NCT03478787|76041964|FG000|Overall Study|Withdrawal by Subject|2|||
42223065|NCT03478787|76041965|FG001|Overall Study|Withdrawal by Subject|6|||
42223066|NCT03478787|76041964|FG000|Overall Study|Other, Not Specified|3|||
42223067|NCT03478787|76041965|FG001|Overall Study|Other, Not Specified|0|||
42223068|NCT03488927|76041974|FG000|Overall Study|Withdrawal by Subject|44|||
42223069|NCT03488927|76041975|FG001|Overall Study|Withdrawal by Subject|118|||
42223070|NCT03488927|76041976|FG002|Overall Study|Withdrawal by Subject|217|||
42223071|NCT03437447|76041987|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42029921|NCT01185821|75838565|FG000|Overall Study|Abnormal test procedure result|0|||
42029922|NCT01185821|75838566|FG001|Overall Study|Abnormal test procedure result|0|||
42029923|NCT01185821|75838567|FG002|Overall Study|Abnormal test procedure result|0|||
42029924|NCT01185821|75838568|FG003|Overall Study|Abnormal test procedure result|0|||
42029925|NCT01185821|75838569|FG004|Overall Study|Abnormal test procedure result|1|||
42029926|NCT01185821|75838565|FG000|Overall Study|Death|0|||
42029927|NCT01185821|75838566|FG001|Overall Study|Death|1|||
42029928|NCT01185821|75838567|FG002|Overall Study|Death|0|||
42029929|NCT01185821|75838568|FG003|Overall Study|Death|0|||
42029930|NCT01185821|75838569|FG004|Overall Study|Death|0|||
42029931|NCT01185821|75838565|FG000|Overall Study|Condition no longer required study drug|0|||
42029932|NCT01185821|75838566|FG001|Overall Study|Condition no longer required study drug|0|||
42029933|NCT01185821|75838567|FG002|Overall Study|Condition no longer required study drug|0|||
42029934|NCT01185821|75838568|FG003|Overall Study|Condition no longer required study drug|0|||
42029935|NCT01185821|75838569|FG004|Overall Study|Condition no longer required study drug|1|||
42029936|NCT01185821|75838565|FG000|Overall Study|Adverse Event|2|||
42029937|NCT01185821|75838566|FG001|Overall Study|Adverse Event|3|||
42029938|NCT01185821|75838567|FG002|Overall Study|Adverse Event|1|||
42029939|NCT01185821|75838568|FG003|Overall Study|Adverse Event|2|||
42029940|NCT01185821|75838569|FG004|Overall Study|Adverse Event|5|||
42029941|NCT01185821|75838565|FG000|Overall Study|Lack of Efficacy|0|||
42029942|NCT01185821|75838566|FG001|Overall Study|Lack of Efficacy|0|||
42029943|NCT01185821|75838567|FG002|Overall Study|Lack of Efficacy|3|||
42029944|NCT01185821|75838568|FG003|Overall Study|Lack of Efficacy|0|||
42029945|NCT01185821|75838569|FG004|Overall Study|Lack of Efficacy|9|||
42029946|NCT01185821|75838565|FG000|Overall Study|Withdrawal by Subject|3|||
42029947|NCT01185821|75838566|FG001|Overall Study|Withdrawal by Subject|2|||
42029948|NCT01185821|75838567|FG002|Overall Study|Withdrawal by Subject|2|||
42029949|NCT01185821|75838568|FG003|Overall Study|Withdrawal by Subject|1|||
42223072|NCT03437447|76041988|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42223073|NCT03437447|76041989|FG002|Treatment Period 1|Withdrawal by Subject|1|||
42223074|NCT03487445|76042012|FG000|Randomization|Not treated for administrative reasons|1|||
42223075|NCT03487445|76042013|FG001|Randomization|Not treated for administrative reasons|0|||
42223076|NCT02109172|76042019|FG000|Overall Study|Withdrawal by Subject|1|||
42223077|NCT02109172|76042020|FG001|Overall Study|Withdrawal by Subject|0|||
42223078|NCT02109172|76042021|FG002|Overall Study|Withdrawal by Subject|0|||
42223079|NCT02109172|76042022|FG003|Overall Study|Withdrawal by Subject|1|||
42223080|NCT02109172|76042023|FG004|Overall Study|Withdrawal by Subject|0|||
42223081|NCT02109172|76042024|FG005|Overall Study|Withdrawal by Subject|0|||
42223082|NCT02109172|76042019|FG000|Overall Study|Adverse Event|0|||
41983268|NCT01058421|75789580|FG001|1 Month Outcomes|Remained in Other Facility|17|||
41983269|NCT01058421|75789579|FG000|3 Month Outcomes|Death|3|||
41983270|NCT01058421|75789580|FG001|3 Month Outcomes|Death|5|||
41983271|NCT01058421|75789579|FG000|3 Month Outcomes|Lost to Follow-up|12|||
41983272|NCT01058421|75789580|FG001|3 Month Outcomes|Lost to Follow-up|11|||
41983273|NCT01058421|75789579|FG000|3 Month Outcomes|Remained in Hospital|0|||
41983274|NCT01058421|75789580|FG001|3 Month Outcomes|Remained in Hospital|2|||
41983275|NCT01058421|75789579|FG000|3 Month Outcomes|Remained in Other Facility|5|||
41983276|NCT01058421|75789580|FG001|3 Month Outcomes|Remained in Other Facility|8|||
41983277|NCT01058421|75789579|FG000|6 Month Outcomes|Death|2|||
42223083|NCT02109172|76042020|FG001|Overall Study|Adverse Event|0|||
42223084|NCT02109172|76042021|FG002|Overall Study|Adverse Event|1|||
41983278|NCT01058421|75789580|FG001|6 Month Outcomes|Death|2|||
42223085|NCT02109172|76042022|FG003|Overall Study|Adverse Event|0|||
42029950|NCT01185821|75838569|FG004|Overall Study|Withdrawal by Subject|3|||
42029951|NCT01185821|75838565|FG000|Overall Study|Lost to Follow-up|1|||
42223086|NCT02109172|76042023|FG004|Overall Study|Adverse Event|0|||
41983279|NCT01058421|75789579|FG000|6 Month Outcomes|Lost to Follow-up|16|||
41983280|NCT01058421|75789580|FG001|6 Month Outcomes|Lost to Follow-up|21|||
41983281|NCT01058421|75789579|FG000|6 Month Outcomes|Remained in Other Facility|1|||
42029952|NCT01185821|75838566|FG001|Overall Study|Lost to Follow-up|1|||
42029953|NCT01185821|75838567|FG002|Overall Study|Lost to Follow-up|2|||
42029954|NCT01185821|75838568|FG003|Overall Study|Lost to Follow-up|1|||
42223087|NCT02109172|76042024|FG005|Overall Study|Adverse Event|1|||
42223088|NCT02109172|76042019|FG000|Overall Study|Death|0|||
42223089|NCT02109172|76042020|FG001|Overall Study|Death|0|||
42223090|NCT02109172|76042021|FG002|Overall Study|Death|0|||
42223091|NCT02109172|76042022|FG003|Overall Study|Death|0|||
42223092|NCT02109172|76042023|FG004|Overall Study|Death|1|||
42223093|NCT02109172|76042024|FG005|Overall Study|Death|0|||
42223094|NCT02974868|76042035|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
42223095|NCT02974868|76042036|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
42223096|NCT02974868|76042037|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
42223097|NCT02974868|76042038|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
42223098|NCT02974868|76042035|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
42223099|NCT02974868|76042036|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
42223100|NCT02974868|76042037|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
42223101|NCT02974868|76042038|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
42223102|NCT02974868|76042035|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
42223103|NCT02974868|76042036|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
42223104|NCT02974868|76042037|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
42223105|NCT02974868|76042038|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
42223106|NCT02974868|76042035|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
42223107|NCT02974868|76042036|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
42223108|NCT02974868|76042037|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
42223109|NCT02974868|76042038|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
42223110|NCT03486899|76042083|FG000|Overall Study|Lost to Follow-up|4|||
42223111|NCT03486899|76042084|FG001|Overall Study|Lost to Follow-up|1|||
42223112|NCT03486899|76042085|FG002|Overall Study|Lost to Follow-up|4|||
42223113|NCT03486899|76042086|FG003|Overall Study|Lost to Follow-up|3|||
42223114|NCT03486899|76042083|FG000|Overall Study|Death|1|||
42223115|NCT03486899|76042084|FG001|Overall Study|Death|0|||
42223116|NCT03486899|76042085|FG002|Overall Study|Death|0|||
42223117|NCT03486899|76042086|FG003|Overall Study|Death|1|||
42223118|NCT03486899|76042083|FG000|Overall Study|Adverse Event|0|||
42223119|NCT03486899|76042084|FG001|Overall Study|Adverse Event|2|||
42223120|NCT03486899|76042085|FG002|Overall Study|Adverse Event|0|||
42223121|NCT03486899|76042086|FG003|Overall Study|Adverse Event|2|||
42223122|NCT03486899|76042083|FG000|Overall Study|Withdrawal by Subject|3|||
42223123|NCT03486899|76042084|FG001|Overall Study|Withdrawal by Subject|7|||
42223124|NCT03486899|76042085|FG002|Overall Study|Withdrawal by Subject|4|||
42223125|NCT03486899|76042086|FG003|Overall Study|Withdrawal by Subject|3|||
42223126|NCT03486899|76042083|FG000|Overall Study|Other Reasons|0|||
42223127|NCT03486899|76042084|FG001|Overall Study|Other Reasons|1|||
42223128|NCT03486899|76042085|FG002|Overall Study|Other Reasons|0|||
42223129|NCT03486899|76042086|FG003|Overall Study|Other Reasons|1|||
42223130|NCT02918552|76042098|FG000|Overall Study|Failed Pharmacokinetics|1|||
42223131|NCT02918552|76042099|FG001|Overall Study|Failed Pharmacokinetics|0|||
42223132|NCT02918552|76042098|FG000|Overall Study|Withdrawal by Subject|0|||
42223133|NCT02918552|76042099|FG001|Overall Study|Withdrawal by Subject|1|||
42223134|NCT02918552|76042098|FG000|Overall Study|Lost to Follow-up|0|||
42223135|NCT02918552|76042099|FG001|Overall Study|Lost to Follow-up|1|||
42223136|NCT03485495|76042107|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
42223137|NCT03485495|76042108|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
42223138|NCT01065818|76042114|FG000|Overall Study|Withdrawal by Subject|1|||
42223139|NCT01065818|76042114|FG000|Overall Study|Not a candidate for surgery|1|||
42223140|NCT03483623|76042118|FG000|Overall Study|43 complete sets achieved|1|||
42223141|NCT02318277|76042130|FG000|Overall Study|Physician Decision|0|||
42223142|NCT02318277|76042131|FG001|Overall Study|Physician Decision|0|||
42223143|NCT02318277|76042132|FG002|Overall Study|Physician Decision|0|||
42223144|NCT02318277|76042133|FG003|Overall Study|Physician Decision|0|||
42223145|NCT02318277|76042134|FG004|Overall Study|Physician Decision|0|||
42223146|NCT02318277|76042135|FG005|Overall Study|Physician Decision|0|||
42223147|NCT02318277|76042136|FG006|Overall Study|Physician Decision|0|||
42223148|NCT02318277|76042137|FG007|Overall Study|Physician Decision|1|||
42302273|NCT02494921|76137340|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
42029955|NCT01185821|75838569|FG004|Overall Study|Lost to Follow-up|2|||
42223149|NCT02318277|76042130|FG000|Overall Study|Other|0|||
42223150|NCT02318277|76042131|FG001|Overall Study|Other|0|||
42223151|NCT02318277|76042132|FG002|Overall Study|Other|0|||
42223152|NCT02318277|76042133|FG003|Overall Study|Other|0|||
42223153|NCT02318277|76042134|FG004|Overall Study|Other|0|||
42223154|NCT02318277|76042135|FG005|Overall Study|Other|0|||
42223155|NCT02318277|76042136|FG006|Overall Study|Other|1|||
42029956|NCT01185821|75838565|FG000|Overall Study|Administrative problems|0|||
42029957|NCT01185821|75838566|FG001|Overall Study|Administrative problems|0|||
42029958|NCT01185821|75838567|FG002|Overall Study|Administrative problems|1|||
42029959|NCT01185821|75838568|FG003|Overall Study|Administrative problems|1|||
42029960|NCT01185821|75838569|FG004|Overall Study|Administrative problems|2|||
42029961|NCT00893464|75838591|FG000|Overall Study|Did not complete therapy/experience PD|0|||
42029962|NCT00893464|75838592|FG001|Overall Study|Did not complete therapy/experience PD|0|||
42029963|NCT00893464|75838593|FG002|Overall Study|Did not complete therapy/experience PD|0|||
42029964|NCT00893464|75838594|FG003|Overall Study|Did not complete therapy/experience PD|0|||
42029965|NCT00893464|75838595|FG004|Overall Study|Did not complete therapy/experience PD|0|||
42029966|NCT00893464|75838596|FG005|Overall Study|Did not complete therapy/experience PD|0|||
42029967|NCT00893464|75838597|FG006|Overall Study|Did not complete therapy/experience PD|2|||
42029968|NCT00893464|75838598|FG007|Overall Study|Did not complete therapy/experience PD|2|||
42029969|NCT00891904|75838621|FG000|Overall Study|Death|1|||
42029970|NCT00891904|75838621|FG000|Overall Study|Adverse Event|1|||
42223156|NCT02318277|76042137|FG007|Overall Study|Other|0|||
42223157|NCT02318277|76042130|FG000|Overall Study|Withdrawal by Subject|0|||
42223158|NCT02318277|76042131|FG001|Overall Study|Withdrawal by Subject|0|||
42223159|NCT02318277|76042132|FG002|Overall Study|Withdrawal by Subject|1|||
42223160|NCT02318277|76042133|FG003|Overall Study|Withdrawal by Subject|0|||
42223161|NCT02318277|76042134|FG004|Overall Study|Withdrawal by Subject|1|||
42223162|NCT02318277|76042135|FG005|Overall Study|Withdrawal by Subject|1|||
42223163|NCT02318277|76042136|FG006|Overall Study|Withdrawal by Subject|6|||
42223164|NCT02318277|76042137|FG007|Overall Study|Withdrawal by Subject|14|||
42223165|NCT02318277|76042130|FG000|Overall Study|Participant trial terminated by sponsor|0|||
42223166|NCT02318277|76042131|FG001|Overall Study|Participant trial terminated by sponsor|0|||
42223167|NCT02318277|76042132|FG002|Overall Study|Participant trial terminated by sponsor|1|||
42223168|NCT02318277|76042133|FG003|Overall Study|Participant trial terminated by sponsor|0|||
42223169|NCT02318277|76042134|FG004|Overall Study|Participant trial terminated by sponsor|1|||
42223170|NCT02318277|76042135|FG005|Overall Study|Participant trial terminated by sponsor|2|||
42223171|NCT02318277|76042136|FG006|Overall Study|Participant trial terminated by sponsor|5|||
42223172|NCT02318277|76042137|FG007|Overall Study|Participant trial terminated by sponsor|16|||
42223173|NCT02318277|76042130|FG000|Overall Study|Lost to Follow-up|1|||
42223174|NCT02318277|76042131|FG001|Overall Study|Lost to Follow-up|0|||
42223175|NCT02318277|76042132|FG002|Overall Study|Lost to Follow-up|1|||
42223176|NCT02318277|76042133|FG003|Overall Study|Lost to Follow-up|0|||
42223177|NCT02318277|76042134|FG004|Overall Study|Lost to Follow-up|0|||
42223178|NCT02318277|76042135|FG005|Overall Study|Lost to Follow-up|0|||
42223179|NCT02318277|76042136|FG006|Overall Study|Lost to Follow-up|3|||
42223180|NCT02318277|76042137|FG007|Overall Study|Lost to Follow-up|4|||
42223181|NCT02318277|76042130|FG000|Overall Study|Death|5|||
42223182|NCT02318277|76042131|FG001|Overall Study|Death|3|||
42223183|NCT02318277|76042132|FG002|Overall Study|Death|1|||
42223184|NCT02318277|76042133|FG003|Overall Study|Death|4|||
42223185|NCT02318277|76042134|FG004|Overall Study|Death|6|||
42223186|NCT02318277|76042135|FG005|Overall Study|Death|5|||
42223187|NCT02318277|76042136|FG006|Overall Study|Death|34|||
42223188|NCT02318277|76042137|FG007|Overall Study|Death|58|||
42223189|NCT02318277|76042130|FG000|Overall Study|Transitioned to Hospice|0|||
42223190|NCT02318277|76042131|FG001|Overall Study|Transitioned to Hospice|0|||
42223191|NCT02318277|76042132|FG002|Overall Study|Transitioned to Hospice|0|||
42223192|NCT02318277|76042133|FG003|Overall Study|Transitioned to Hospice|0|||
42223193|NCT02318277|76042134|FG004|Overall Study|Transitioned to Hospice|0|||
42223194|NCT02318277|76042135|FG005|Overall Study|Transitioned to Hospice|1|||
42223195|NCT02318277|76042136|FG006|Overall Study|Transitioned to Hospice|0|||
42223196|NCT02318277|76042137|FG007|Overall Study|Transitioned to Hospice|0|||
42223197|NCT01063868|76042182|FG000|Overall Study|Adverse Event|9|||
42029971|NCT01157351|75838627|FG000|Overall Study|Adverse Event|5|||
42029972|NCT01157351|75838628|FG001|Overall Study|Adverse Event|4|||
42029973|NCT01157351|75838627|FG000|Overall Study|Death|1|||
42029974|NCT01157351|75838628|FG001|Overall Study|Death|0|||
42223198|NCT01063868|76042183|FG001|Overall Study|Adverse Event|7|||
42223199|NCT01063868|76042182|FG000|Overall Study|Withdrawal by Subject|3|||
42223200|NCT01063868|76042183|FG001|Overall Study|Withdrawal by Subject|1|||
42223201|NCT01063868|76042182|FG000|Overall Study|Study Terminated By Sponsor|23|||
42223202|NCT01063868|76042183|FG001|Overall Study|Study Terminated By Sponsor|4|||
42223203|NCT02974088|76042191|FG000|Overall Study|Lost to Follow-up|0|||
42223204|NCT02974088|76042192|FG001|Overall Study|Lost to Follow-up|2|||
42029975|NCT01157351|75838627|FG000|Overall Study|Lost to Follow-up|53|||
42029976|NCT01157351|75838628|FG001|Overall Study|Lost to Follow-up|55|||
42029977|NCT01157351|75838627|FG000|Overall Study|Withdrawal by Subject|37|||
42223205|NCT02974088|76042191|FG000|Overall Study|Adverse Event|0|||
42223206|NCT02974088|76042192|FG001|Overall Study|Adverse Event|1|||
42223207|NCT02385045|76042198|FG000|Overall Study|Endoscopy could not be completed|4|||
42223208|NCT02974010|76042206|FG000|Overall Study|Lost to Follow-up|3|||
42223209|NCT02974010|76042207|FG001|Overall Study|Lost to Follow-up|1|||
42223210|NCT02974010|76042208|FG002|Overall Study|Lost to Follow-up|0|||
42223211|NCT02974010|76042209|FG003|Overall Study|Lost to Follow-up|0|||
42223212|NCT02974010|76042206|FG000|Overall Study|Withdrawal by Subject|2|||
42223213|NCT02974010|76042207|FG001|Overall Study|Withdrawal by Subject|1|||
42223214|NCT02974010|76042208|FG002|Overall Study|Withdrawal by Subject|0|||
42223215|NCT02974010|76042209|FG003|Overall Study|Withdrawal by Subject|0|||
42223216|NCT02974010|76042206|FG000|Overall Study|Adverse Event|0|||
42223217|NCT02974010|76042207|FG001|Overall Study|Adverse Event|1|||
42223218|NCT02974010|76042208|FG002|Overall Study|Adverse Event|0|||
42223219|NCT02974010|76042209|FG003|Overall Study|Adverse Event|0|||
42223220|NCT02974010|76042206|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
42223221|NCT02974010|76042207|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
42223222|NCT02974010|76042208|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
42302274|NCT02494921|76137341|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
42302275|NCT02494921|76137342|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
41983282|NCT01058421|75789580|FG001|6 Month Outcomes|Remained in Other Facility|3|||
41983283|NCT01058304|75789588|FG000|Overall Study|Withdrawal by Subject|8|||
41983284|NCT01058304|75789589|FG001|Overall Study|Withdrawal by Subject|5|||
41983285|NCT01058304|75789588|FG000|Overall Study|Lost to Follow-up|13|||
41983286|NCT01058304|75789589|FG001|Overall Study|Lost to Follow-up|16|||
41983287|NCT01058304|75789588|FG000|Overall Study|Developed exclusion criterion|6|||
41983288|NCT01058304|75789589|FG001|Overall Study|Developed exclusion criterion|12|||
41983289|NCT01058265|75789597|FG000|Overall Study|Lost to Follow-up|11|||
41983290|NCT01058265|75789598|FG001|Overall Study|Lost to Follow-up|12|||
41983291|NCT01057251|75789606|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
42131432|NCT00320788|75942353|FG000|Overall Study|Decision by the Sponsor|1|||
42131433|NCT00320788|75942354|FG001|Overall Study|Decision by the Sponsor|1|||
42131434|NCT00320788|75942355|FG002|Overall Study|Decision by the Sponsor|0|||
42131435|NCT00320788|75942356|FG003|Overall Study|Decision by the Sponsor|0|||
42131436|NCT00320788|75942357|FG004|Overall Study|Decision by the Sponsor|1|||
42131437|NCT00320788|75942353|FG000|Overall Study|Other|1|||
42131438|NCT00320788|75942354|FG001|Overall Study|Other|2|||
42131439|NCT00320788|75942355|FG002|Overall Study|Other|1|||
42131440|NCT00320788|75942356|FG003|Overall Study|Other|1|||
42131441|NCT00320788|75942357|FG004|Overall Study|Other|1|||
42131442|NCT00320788|75942353|FG000|Overall Study|Physician Decision|1|||
42223223|NCT02974010|76042209|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
42223224|NCT02974010|76042206|FG000|Overall Study|Lack of Efficacy|0|||
42223225|NCT02974010|76042207|FG001|Overall Study|Lack of Efficacy|0|||
42223226|NCT02974010|76042208|FG002|Overall Study|Lack of Efficacy|1|||
42223227|NCT02974010|76042209|FG003|Overall Study|Lack of Efficacy|0|||
42223228|NCT02030938|76042219|FG000|Overall Study|Lost to Follow-up|4|||
41983292|NCT01057251|75789607|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
42223229|NCT02030938|76042219|FG000|Overall Study|Withdrawal by Subject|1|||
42223230|NCT03122535|76042227|FG000|Overall Study|Lost to Follow-up|68|||
42223231|NCT03122535|76042228|FG001|Overall Study|Lost to Follow-up|68|||
42223232|NCT03122535|76042227|FG000|Overall Study|Physician Decision|3|||
42223233|NCT03122535|76042228|FG001|Overall Study|Physician Decision|3|||
42223234|NCT03122535|76042227|FG000|Overall Study|Withdrawal by Subject|2|||
42223235|NCT03122535|76042228|FG001|Overall Study|Withdrawal by Subject|2|||
42223236|NCT01061606|76042234|FG000|Overall Study|Adverse Event|1|||
42223237|NCT01061606|76042234|FG000|Overall Study|Death|1|||
42223238|NCT01061606|76042234|FG000|Overall Study|Disease Progression|4|||
42223239|NCT01061606|76042234|FG000|Overall Study|alternative therapy|2|||
42223240|NCT03122457|76042238|FG000|Overall Study|Withdrawal by Subject|6|||
42223241|NCT03482453|76042254|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
42223242|NCT03482453|76042255|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
42223243|NCT03482453|76042256|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
42223244|NCT03482453|76042257|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
42223245|NCT03482453|76042258|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
42223246|NCT03482453|76042259|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
42223247|NCT03482453|76042260|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
42223248|NCT03482453|76042261|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
42223249|NCT03482453|76042262|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
42223250|NCT03482453|76042263|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
42223251|NCT03482453|76042264|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
42223252|NCT03482453|76042265|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
42223253|NCT03480425|76042301|FG000|Overall Study|Force transducer technical failure|1|||
42223254|NCT03472547|76042305|FG000|Overall Study|Withdrawal by Subject|30|||
42223255|NCT00799396|76042309|FG000|Clopidogrel Treatment|Adverse Event|6|||
42223256|NCT00799396|76042309|FG000|Clopidogrel Treatment|Physician Decision|5|||
42223257|NCT00799396|76042309|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
42223258|NCT00799396|76042309|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
42223259|NCT00799396|76042309|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
42223260|NCT03469349|76042315|FG000|Overall Study|Withdrawal by Subject|1|||
42223261|NCT03469349|76042316|FG001|Overall Study|Withdrawal by Subject|3|||
42223262|NCT03469349|76042315|FG000|Overall Study|Progressive Disease|0|||
42223263|NCT03469349|76042316|FG001|Overall Study|Progressive Disease|1|||
42223264|NCT03469349|76042315|FG000|Overall Study|Lost to Follow-up|2|||
42223265|NCT03469349|76042316|FG001|Overall Study|Lost to Follow-up|2|||
42223266|NCT03469349|76042315|FG000|Overall Study|Adverse Event|2|||
42223267|NCT03469349|76042316|FG001|Overall Study|Adverse Event|4|||
42223268|NCT03467945|76042326|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42223269|NCT03467945|76042327|FG001|Treatment Period 2|Withdrawal by Subject|1|||
42223270|NCT03467945|76042328|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42223271|NCT03467945|76042329|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42223272|NCT03467945|76042326|FG000|Treatment Period 3|Withdrawal by Subject|1|||
42223273|NCT03467945|76042327|FG001|Treatment Period 3|Withdrawal by Subject|0|||
42223274|NCT03467945|76042328|FG002|Treatment Period 3|Withdrawal by Subject|2|||
42223275|NCT03467945|76042329|FG003|Treatment Period 3|Withdrawal by Subject|1|||
42223276|NCT00069238|76042340|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
42223277|NCT00069238|76042341|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
42223278|NCT00069238|76042342|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
42223279|NCT00069238|76042340|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
42302276|NCT01653847|76137362|FG000|Overall Study|Withdrawal by Subject|1|||
42302277|NCT01653847|76137363|FG001|Overall Study|Withdrawal by Subject|0|||
42302278|NCT02493751|76137371|FG000|Overall Study|Withdrawal by Subject|2|||
41983293|NCT01057251|75789606|FG000|Overall Study|Adverse Event|4|||
41983294|NCT01057251|75789607|FG001|Overall Study|Adverse Event|2|||
41983295|NCT01057251|75789606|FG000|Overall Study|Lack of Efficacy|2|||
41983296|NCT01057251|75789607|FG001|Overall Study|Lack of Efficacy|11|||
41983297|NCT01057251|75789606|FG000|Overall Study|Protocol Violation|6|||
41983298|NCT01057251|75789607|FG001|Overall Study|Protocol Violation|2|||
41983299|NCT01057251|75789606|FG000|Overall Study|Withdrawal by Subject|4|||
41983300|NCT01057251|75789607|FG001|Overall Study|Withdrawal by Subject|5|||
42223280|NCT00069238|76042341|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
42223281|NCT00069238|76042342|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
42223282|NCT00069238|76042340|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
42223283|NCT00069238|76042341|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
41983301|NCT01057251|75789606|FG000|Overall Study|Lost to Follow-up|7|||
42223284|NCT00069238|76042342|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
42223285|NCT03435497|76042349|FG000|Overall Study|Lost to Follow-up|1|||
42223286|NCT03435497|76042350|FG001|Overall Study|Lost to Follow-up|0|||
42223287|NCT03435497|76042349|FG000|Overall Study|Death|1|||
42223288|NCT03435497|76042350|FG001|Overall Study|Death|0|||
42223289|NCT03435497|76042349|FG000|Overall Study|Withdrawal by Subject|0|||
42223290|NCT03435497|76042350|FG001|Overall Study|Withdrawal by Subject|4|||
42223291|NCT03435497|76042349|FG000|Overall Study|Wrong survey administered|0|||
42223292|NCT03435497|76042350|FG001|Overall Study|Wrong survey administered|2|||
42223293|NCT03073200|76042359|FG000|Double Blind Treatment Period|Protocol Violation|1|||
41983302|NCT01057251|75789607|FG001|Overall Study|Lost to Follow-up|6|||
41983303|NCT01057251|75789606|FG000|Overall Study|Other Reason|1|||
42223294|NCT03073200|76042360|FG001|Double Blind Treatment Period|Protocol Violation|0|||
41983304|NCT01057251|75789607|FG001|Overall Study|Other Reason|1|||
41983305|NCT01056822|75789615|FG000|Overall Study|Adverse Event|0|||
41983306|NCT01056822|75789616|FG001|Overall Study|Adverse Event|1|||
41983307|NCT01056822|75789615|FG000|Overall Study|Protocol Violation|6|||
42223295|NCT03073200|76042361|FG002|Double Blind Treatment Period|Protocol Violation|0|||
42223296|NCT03073200|76042362|FG003|Double Blind Treatment Period|Protocol Violation|0|||
42223297|NCT03073200|76042363|FG004|Double Blind Treatment Period|Protocol Violation|0|||
42223298|NCT03073200|76042364|FG005|Double Blind Treatment Period|Protocol Violation|0|||
42223299|NCT03073200|76042365|FG006|Double Blind Treatment Period|Protocol Violation|0|||
42223300|NCT03073200|76042366|FG007|Double Blind Treatment Period|Protocol Violation|0|||
42223301|NCT03073200|76042367|FG008|Double Blind Treatment Period|Protocol Violation|0|||
42223302|NCT03073200|76042368|FG009|Double Blind Treatment Period|Protocol Violation|0|||
42223303|NCT03073200|76042369|FG010|Double Blind Treatment Period|Protocol Violation|0|||
42223304|NCT03073200|76042370|FG011|Double Blind Treatment Period|Protocol Violation|0|||
42223305|NCT03073200|76042371|FG012|Double Blind Treatment Period|Protocol Violation|0|||
42223306|NCT03073200|76042372|FG013|Double Blind Treatment Period|Protocol Violation|0|||
42223307|NCT03073200|76042373|FG014|Double Blind Treatment Period|Protocol Violation|0|||
42223308|NCT03073200|76042359|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223309|NCT03073200|76042360|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
42223310|NCT03073200|76042361|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42302279|NCT02493751|76137372|FG001|Overall Study|Withdrawal by Subject|8|||
42302280|NCT02493751|76137371|FG000|Overall Study|Death|6|||
42302281|NCT02493751|76137372|FG001|Overall Study|Death|13|||
42302282|NCT02493751|76137371|FG000|Overall Study|Lost to Follow-up|2|||
42302283|NCT02493751|76137372|FG001|Overall Study|Lost to Follow-up|3|||
42302284|NCT02493751|76137371|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
42302285|NCT02493751|76137372|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
41983308|NCT01056822|75789616|FG001|Overall Study|Protocol Violation|5|||
41983309|NCT01056822|75789615|FG000|Overall Study|Withdrawal by Subject|1|||
41983310|NCT01056822|75789616|FG001|Overall Study|Withdrawal by Subject|1|||
41983311|NCT01056822|75789615|FG000|Overall Study|Lost to Follow-up|1|||
41983312|NCT01056822|75789616|FG001|Overall Study|Lost to Follow-up|0|||
41983313|NCT01051791|75789623|FG000|Overall Study|Failed screening|3|||
42302286|NCT02493517|76137381|FG000|Overall Study|Protocol Violation|1|||
42302287|NCT02493517|76137382|FG001|Overall Study|Protocol Violation|2|||
42302288|NCT02493517|76137381|FG000|Overall Study|Withdrawal by Subject|1|||
42302289|NCT02493517|76137382|FG001|Overall Study|Withdrawal by Subject|2|||
42302290|NCT02493517|76137381|FG000|Overall Study|Adverse Event|0|||
42302291|NCT02493517|76137382|FG001|Overall Study|Adverse Event|2|||
41983314|NCT01051791|75789623|FG000|Overall Study|Withdrawal by Subject|1|||
41983315|NCT01056510|75789635|FG000|Overall Study|Dropout Before Start of Treatment|1|||
42131443|NCT00320788|75942354|FG001|Overall Study|Physician Decision|1|||
42131444|NCT00320788|75942355|FG002|Overall Study|Physician Decision|0|||
42131445|NCT00320788|75942356|FG003|Overall Study|Physician Decision|0|||
42131446|NCT00320788|75942357|FG004|Overall Study|Physician Decision|0|||
42131447|NCT00320788|75942353|FG000|Overall Study|Protocol Violation|0|||
42131448|NCT00320788|75942354|FG001|Overall Study|Protocol Violation|0|||
42131449|NCT00320788|75942355|FG002|Overall Study|Protocol Violation|0|||
42131450|NCT00320788|75942356|FG003|Overall Study|Protocol Violation|0|||
42131451|NCT00320788|75942357|FG004|Overall Study|Protocol Violation|1|||
42131452|NCT00320788|75942353|FG000|Overall Study|Withdrawal by Subject|3|||
42131453|NCT00320788|75942354|FG001|Overall Study|Withdrawal by Subject|0|||
42131454|NCT00320788|75942355|FG002|Overall Study|Withdrawal by Subject|0|||
42131455|NCT00320788|75942356|FG003|Overall Study|Withdrawal by Subject|3|||
42131456|NCT00320788|75942357|FG004|Overall Study|Withdrawal by Subject|1|||
42223311|NCT03073200|76042362|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223312|NCT03073200|76042363|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223313|NCT03073200|76042364|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223314|NCT03073200|76042365|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223315|NCT03073200|76042366|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223316|NCT03073200|76042367|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223317|NCT03073200|76042368|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223318|NCT03073200|76042369|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223319|NCT03073200|76042370|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223320|NCT03073200|76042371|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223321|NCT03073200|76042372|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223322|NCT03073200|76042373|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
42223323|NCT03073200|76042359|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
42223324|NCT03073200|76042360|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223325|NCT03073200|76042361|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223326|NCT03073200|76042362|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223327|NCT03073200|76042363|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223328|NCT03073200|76042364|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223329|NCT03073200|76042365|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223330|NCT03073200|76042366|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223331|NCT03073200|76042367|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223332|NCT03073200|76042368|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223333|NCT03073200|76042369|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223334|NCT03073200|76042370|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223335|NCT03073200|76042371|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223336|NCT03073200|76042372|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223337|NCT03073200|76042373|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
42223338|NCT03073200|76042359|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223339|NCT03073200|76042360|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223340|NCT03073200|76042361|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223341|NCT03073200|76042362|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
42223342|NCT03073200|76042363|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
42223343|NCT03073200|76042364|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223344|NCT03073200|76042365|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223345|NCT03073200|76042366|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223346|NCT03073200|76042367|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223347|NCT03073200|76042368|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223348|NCT03073200|76042369|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223349|NCT03073200|76042370|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223350|NCT03073200|76042371|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223351|NCT03073200|76042372|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223352|NCT03073200|76042373|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
42223353|NCT03073200|76042359|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
42223354|NCT03073200|76042360|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
42223355|NCT03073200|76042361|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
42223356|NCT03073200|76042362|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
42223357|NCT03073200|76042363|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
42223358|NCT03073200|76042364|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
42223359|NCT03073200|76042365|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
42223360|NCT03073200|76042366|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
42223361|NCT03073200|76042367|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
42223362|NCT03073200|76042368|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
42223363|NCT03073200|76042369|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
42223364|NCT03073200|76042370|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
42223365|NCT03073200|76042371|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
42302292|NCT02493517|76137381|FG000|Overall Study|Missed study visit|0|||
42223366|NCT03073200|76042372|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
42223367|NCT03073200|76042373|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
42223368|NCT03073200|76042359|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223369|NCT03073200|76042360|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223370|NCT03073200|76042361|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223371|NCT03073200|76042362|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223372|NCT03073200|76042363|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
42223373|NCT03073200|76042364|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223374|NCT03073200|76042365|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223375|NCT03073200|76042366|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223376|NCT03073200|76042367|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223377|NCT03073200|76042368|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223378|NCT03073200|76042369|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223379|NCT03073200|76042370|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223380|NCT03073200|76042371|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223381|NCT03073200|76042372|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223382|NCT03073200|76042373|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
42223383|NCT03073200|76042359|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223384|NCT03073200|76042360|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223385|NCT03073200|76042361|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223386|NCT03073200|76042362|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
42223387|NCT03073200|76042363|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
42223388|NCT03073200|76042364|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223389|NCT03073200|76042365|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223390|NCT03073200|76042366|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223391|NCT03073200|76042367|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223392|NCT03073200|76042368|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223393|NCT03073200|76042369|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223394|NCT03073200|76042370|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223395|NCT03073200|76042371|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223396|NCT03073200|76042372|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223397|NCT03073200|76042373|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
42223398|NCT03073200|76042359|FG000|Extension Period|Lost to Follow-up|0|||
42223399|NCT03073200|76042360|FG001|Extension Period|Lost to Follow-up|0|||
42223400|NCT03073200|76042361|FG002|Extension Period|Lost to Follow-up|0|||
42223401|NCT03073200|76042362|FG003|Extension Period|Lost to Follow-up|0|||
42223402|NCT03073200|76042363|FG004|Extension Period|Lost to Follow-up|0|||
42223403|NCT03073200|76042364|FG005|Extension Period|Lost to Follow-up|0|||
42223404|NCT03073200|76042365|FG006|Extension Period|Lost to Follow-up|1|||
42223405|NCT03073200|76042366|FG007|Extension Period|Lost to Follow-up|1|||
42223406|NCT03073200|76042367|FG008|Extension Period|Lost to Follow-up|0|||
42223407|NCT03073200|76042368|FG009|Extension Period|Lost to Follow-up|0|||
42223408|NCT03073200|76042369|FG010|Extension Period|Lost to Follow-up|0|||
42223409|NCT03073200|76042370|FG011|Extension Period|Lost to Follow-up|0|||
42223410|NCT03073200|76042371|FG012|Extension Period|Lost to Follow-up|0|||
42223411|NCT03073200|76042372|FG013|Extension Period|Lost to Follow-up|0|||
42223412|NCT03073200|76042373|FG014|Extension Period|Lost to Follow-up|0|||
42223413|NCT03073200|76042359|FG000|Extension Period|Sponsor Decision|0|||
42223414|NCT03073200|76042360|FG001|Extension Period|Sponsor Decision|0|||
42223415|NCT03073200|76042361|FG002|Extension Period|Sponsor Decision|0|||
42223416|NCT03073200|76042362|FG003|Extension Period|Sponsor Decision|0|||
42223417|NCT03073200|76042363|FG004|Extension Period|Sponsor Decision|0|||
42223418|NCT03073200|76042364|FG005|Extension Period|Sponsor Decision|0|||
42223419|NCT03073200|76042365|FG006|Extension Period|Sponsor Decision|0|||
41983316|NCT01056510|75789636|FG001|Overall Study|Dropout Before Start of Treatment|1|||
41983317|NCT01056510|75789635|FG000|Overall Study|Withdrawal by Subject|4|||
41983318|NCT01056510|75789636|FG001|Overall Study|Withdrawal by Subject|2|||
41983319|NCT01056510|75789635|FG000|Overall Study|Death|29|||
41983320|NCT01056510|75789636|FG001|Overall Study|Death|34|||
41983321|NCT01056510|75789635|FG000|Overall Study|Noncompliance|1|||
41983322|NCT01056510|75789636|FG001|Overall Study|Noncompliance|3|||
41983323|NCT01056510|75789635|FG000|Overall Study|Physician Decision|4|||
41983324|NCT01056510|75789636|FG001|Overall Study|Physician Decision|5|||
41983325|NCT01056510|75789635|FG000|Overall Study|Lost to Follow-up|5|||
41983326|NCT01056510|75789636|FG001|Overall Study|Lost to Follow-up|6|||
42223420|NCT03073200|76042366|FG007|Extension Period|Sponsor Decision|0|||
42223421|NCT03073200|76042367|FG008|Extension Period|Sponsor Decision|1|||
42223422|NCT03073200|76042368|FG009|Extension Period|Sponsor Decision|0|||
42223423|NCT03073200|76042369|FG010|Extension Period|Sponsor Decision|0|||
42223424|NCT03073200|76042370|FG011|Extension Period|Sponsor Decision|0|||
41983327|NCT01056510|75789635|FG000|Overall Study|Other|10|||
42223425|NCT03073200|76042371|FG012|Extension Period|Sponsor Decision|0|||
41983328|NCT01056510|75789636|FG001|Overall Study|Other|12|||
42223426|NCT03073200|76042372|FG013|Extension Period|Sponsor Decision|0|||
42223427|NCT03073200|76042373|FG014|Extension Period|Sponsor Decision|0|||
42223428|NCT03073200|76042359|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
42223429|NCT03073200|76042360|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
42223430|NCT03073200|76042361|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
42223431|NCT03073200|76042362|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
42223432|NCT03073200|76042363|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
42223433|NCT03073200|76042364|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
42223434|NCT03073200|76042365|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
42223435|NCT03073200|76042366|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
42223436|NCT03073200|76042367|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
42223437|NCT03073200|76042368|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
42223438|NCT03073200|76042369|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
42223439|NCT03073200|76042370|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
42223440|NCT03073200|76042371|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
42223441|NCT03073200|76042372|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
42223442|NCT03073200|76042373|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
42223443|NCT03073200|76042359|FG000|Extension Period|Withdrawal by Subject|0|||
42223444|NCT03073200|76042360|FG001|Extension Period|Withdrawal by Subject|0|||
42223445|NCT03073200|76042361|FG002|Extension Period|Withdrawal by Subject|0|||
42223446|NCT03073200|76042362|FG003|Extension Period|Withdrawal by Subject|0|||
42223447|NCT03073200|76042363|FG004|Extension Period|Withdrawal by Subject|0|||
42223448|NCT03073200|76042364|FG005|Extension Period|Withdrawal by Subject|0|||
42131457|NCT00503984|75942377|FG000|Overall Study|Protocol Violation|0|||
42131458|NCT00503984|75942378|FG001|Overall Study|Protocol Violation|1|||
42131459|NCT00503984|75942379|FG002|Overall Study|Protocol Violation|0|||
42131460|NCT00503984|75942380|FG003|Overall Study|Protocol Violation|0|||
42131461|NCT00503984|75942381|FG004|Overall Study|Protocol Violation|0|||
42131462|NCT00503984|75942382|FG005|Overall Study|Protocol Violation|0|||
42131463|NCT00503984|75942377|FG000|Overall Study|Adverse Event|0|||
42131464|NCT00503984|75942378|FG001|Overall Study|Adverse Event|1|||
42131465|NCT00503984|75942379|FG002|Overall Study|Adverse Event|0|||
42131466|NCT00503984|75942380|FG003|Overall Study|Adverse Event|0|||
42131467|NCT00503984|75942381|FG004|Overall Study|Adverse Event|0|||
42131468|NCT00503984|75942382|FG005|Overall Study|Adverse Event|0|||
42131469|NCT00503984|75942377|FG000|Overall Study|Death|0|||
42131470|NCT00503984|75942378|FG001|Overall Study|Death|0|||
42223449|NCT03073200|76042365|FG006|Extension Period|Withdrawal by Subject|1|||
42223450|NCT03073200|76042366|FG007|Extension Period|Withdrawal by Subject|2|||
42223451|NCT03073200|76042367|FG008|Extension Period|Withdrawal by Subject|0|||
42223452|NCT03073200|76042368|FG009|Extension Period|Withdrawal by Subject|0|||
42223453|NCT03073200|76042369|FG010|Extension Period|Withdrawal by Subject|0|||
42223454|NCT03073200|76042370|FG011|Extension Period|Withdrawal by Subject|0|||
42223455|NCT03073200|76042371|FG012|Extension Period|Withdrawal by Subject|0|||
42223456|NCT03073200|76042372|FG013|Extension Period|Withdrawal by Subject|0|||
42223457|NCT03073200|76042373|FG014|Extension Period|Withdrawal by Subject|0|||
42223458|NCT03073200|76042359|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223459|NCT03073200|76042360|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223460|NCT03073200|76042361|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223461|NCT03073200|76042362|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223462|NCT03073200|76042363|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223463|NCT03073200|76042364|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223464|NCT03073200|76042365|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223465|NCT03073200|76042366|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223466|NCT03073200|76042367|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223467|NCT03073200|76042368|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223468|NCT03073200|76042369|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223469|NCT03073200|76042370|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
42223470|NCT03073200|76042371|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223471|NCT03073200|76042372|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223472|NCT03073200|76042373|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
42223473|NCT03073200|76042359|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42131471|NCT00503984|75942379|FG002|Overall Study|Death|0|||
42223474|NCT03073200|76042360|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42223475|NCT03073200|76042361|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42131472|NCT00503984|75942380|FG003|Overall Study|Death|0|||
42223476|NCT03073200|76042362|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42223477|NCT03073200|76042363|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42223478|NCT03073200|76042364|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42223479|NCT03073200|76042365|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
41983329|NCT01056510|75789635|FG000|Overall Study|Missing|0|||
41983330|NCT01056510|75789636|FG001|Overall Study|Missing|1|||
41983331|NCT01051323|75789644|FG000|Overall Study|Discontinuation of treatment|103|||
41983332|NCT01051323|75789644|FG000|Overall Study|Transplantation|28|||
41983333|NCT01051323|75789644|FG000|Overall Study|Dialysis dependency|22|||
42223480|NCT03073200|76042366|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42223481|NCT03073200|76042367|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42223482|NCT03073200|76042368|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42223483|NCT03073200|76042369|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42223484|NCT03073200|76042370|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
42223485|NCT03073200|76042371|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42223486|NCT03073200|76042372|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42223487|NCT03073200|76042373|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
42223488|NCT03073200|76042359|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223489|NCT03073200|76042360|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223490|NCT03073200|76042361|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223491|NCT03073200|76042362|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223492|NCT03073200|76042363|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223493|NCT03073200|76042364|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223494|NCT03073200|76042365|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223495|NCT03073200|76042366|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223496|NCT03073200|76042367|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223497|NCT03073200|76042368|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223498|NCT03073200|76042369|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
42223499|NCT03073200|76042370|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
42223500|NCT03073200|76042371|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223501|NCT03073200|76042372|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223502|NCT03073200|76042373|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42223503|NCT03073200|76042359|FG000|Randomized Withdrawal Period|Adverse Event|0|||
42223504|NCT03073200|76042360|FG001|Randomized Withdrawal Period|Adverse Event|0|||
42223505|NCT03073200|76042361|FG002|Randomized Withdrawal Period|Adverse Event|0|||
41983334|NCT01051323|75789644|FG000|Overall Study|Withdrawal by Subject|13|||
41983335|NCT01051323|75789644|FG000|Overall Study|Lost to Follow-up|31|||
42223506|NCT03073200|76042362|FG003|Randomized Withdrawal Period|Adverse Event|0|||
42223507|NCT03073200|76042363|FG004|Randomized Withdrawal Period|Adverse Event|0|||
42223508|NCT03073200|76042364|FG005|Randomized Withdrawal Period|Adverse Event|0|||
42223509|NCT03073200|76042365|FG006|Randomized Withdrawal Period|Adverse Event|0|||
42223510|NCT03073200|76042366|FG007|Randomized Withdrawal Period|Adverse Event|0|||
42302293|NCT02493517|76137382|FG001|Overall Study|Missed study visit|1|||
41983336|NCT01051323|75789644|FG000|Overall Study|Death|129|||
41983337|NCT01051323|75789644|FG000|Overall Study|Hospitalization|28|||
42223511|NCT03073200|76042367|FG008|Randomized Withdrawal Period|Adverse Event|0|||
42223512|NCT03073200|76042368|FG009|Randomized Withdrawal Period|Adverse Event|0|||
42223513|NCT03073200|76042369|FG010|Randomized Withdrawal Period|Adverse Event|1|||
42223514|NCT03073200|76042370|FG011|Randomized Withdrawal Period|Adverse Event|0|||
42223515|NCT03073200|76042371|FG012|Randomized Withdrawal Period|Adverse Event|0|||
42223516|NCT03073200|76042372|FG013|Randomized Withdrawal Period|Adverse Event|0|||
42223517|NCT03073200|76042373|FG014|Randomized Withdrawal Period|Adverse Event|0|||
42223518|NCT03073200|76042359|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223519|NCT03073200|76042360|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223520|NCT03073200|76042361|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223521|NCT03073200|76042362|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223522|NCT03073200|76042363|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223523|NCT03073200|76042364|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223524|NCT03073200|76042365|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223525|NCT03073200|76042366|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223526|NCT03073200|76042367|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223527|NCT03073200|76042368|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223528|NCT03073200|76042369|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223529|NCT03073200|76042370|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223530|NCT03073200|76042371|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223531|NCT03073200|76042372|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
42223532|NCT03073200|76042373|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
42223533|NCT03073200|76042359|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223534|NCT03073200|76042360|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223535|NCT03073200|76042361|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223536|NCT03073200|76042362|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223537|NCT03073200|76042363|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223538|NCT03073200|76042364|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223539|NCT03073200|76042365|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223540|NCT03073200|76042366|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223541|NCT03073200|76042367|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223542|NCT03073200|76042368|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223543|NCT03073200|76042369|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223544|NCT03073200|76042370|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223545|NCT03073200|76042371|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223546|NCT03073200|76042372|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
42223547|NCT03073200|76042373|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42223548|NCT03073200|76042359|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42223549|NCT03073200|76042360|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
41983338|NCT01051323|75789644|FG000|Overall Study|Other|148|||
41983339|NCT01051323|75789644|FG000|Overall Study|Missing|37|||
41983340|NCT01056276|75789654|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
41983341|NCT01056276|75789655|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
41983342|NCT01056276|75789654|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
41983343|NCT01056276|75789655|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
41983344|NCT01056276|75789654|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
41983345|NCT01056276|75789655|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
41983346|NCT01056276|75789654|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
41983347|NCT01056276|75789655|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
41983348|NCT01056276|75789654|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
41983349|NCT01056276|75789655|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
41983350|NCT01056276|75789654|FG000|Treatment Period-Cycles 1-8|Death|3|||
41983351|NCT01056276|75789655|FG001|Treatment Period-Cycles 1-8|Death|1|||
41983352|NCT01056276|75789654|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
41983353|NCT01056276|75789655|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
41983354|NCT01056276|75789654|FG000|Maintenance Therapy|Toxicity|0|||
41983355|NCT01056276|75789655|FG001|Maintenance Therapy|Toxicity|2|||
41983356|NCT01056276|75789654|FG000|Maintenance Therapy|Progressive Disease|0|||
42131473|NCT00503984|75942381|FG004|Overall Study|Death|1|||
42131474|NCT00503984|75942382|FG005|Overall Study|Death|0|||
42131475|NCT00565409|75942406|FG000|Period 1 Open Label|Adverse Event|17|||
42131476|NCT00565409|75942407|FG001|Period 1 Open Label|Adverse Event|0|||
42131477|NCT00565409|75942408|FG002|Period 1 Open Label|Adverse Event|0|||
42131478|NCT00565409|75942409|FG003|Period 1 Open Label|Adverse Event|0|||
42131479|NCT00565409|75942406|FG000|Period 1 Open Label|Death|2|||
42131480|NCT00565409|75942407|FG001|Period 1 Open Label|Death|0|||
42131481|NCT00565409|75942408|FG002|Period 1 Open Label|Death|0|||
42131482|NCT00565409|75942409|FG003|Period 1 Open Label|Death|0|||
42131483|NCT00565409|75942406|FG000|Period 1 Open Label|Lost to Follow-up|1|||
42131484|NCT00565409|75942407|FG001|Period 1 Open Label|Lost to Follow-up|0|||
42131485|NCT00565409|75942408|FG002|Period 1 Open Label|Lost to Follow-up|0|||
42223550|NCT03073200|76042361|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42223551|NCT03073200|76042362|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42223552|NCT03073200|76042363|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
41983357|NCT01056276|75789655|FG001|Maintenance Therapy|Progressive Disease|9|||
41983358|NCT01056276|75789654|FG000|Maintenance Therapy|Physician Decision|0|||
41983359|NCT01056276|75789655|FG001|Maintenance Therapy|Physician Decision|1|||
41983360|NCT01056276|75789654|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
41983361|NCT01056276|75789655|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
41983362|NCT01056276|75789654|FG000|Maintenance Therapy|Intercurrent Illness|0|||
41983363|NCT01056276|75789655|FG001|Maintenance Therapy|Intercurrent Illness|1|||
42223553|NCT03073200|76042364|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42223554|NCT03073200|76042365|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42223555|NCT03073200|76042366|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42029978|NCT01157351|75838628|FG001|Overall Study|Withdrawal by Subject|27|||
42223556|NCT03073200|76042367|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42223557|NCT03073200|76042368|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42223558|NCT03073200|76042369|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42029979|NCT01157351|75838627|FG000|Overall Study|Physician Decision|5|||
42223559|NCT03073200|76042370|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42223560|NCT03073200|76042371|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42223561|NCT03073200|76042372|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
42223562|NCT03073200|76042373|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
42223563|NCT03073200|76042359|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42223564|NCT03073200|76042360|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42223565|NCT03073200|76042361|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42223566|NCT03073200|76042362|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42029980|NCT01157351|75838628|FG001|Overall Study|Physician Decision|4|||
42029981|NCT01157351|75838627|FG000|Overall Study|Protocol Violation|0|||
42029982|NCT01157351|75838628|FG001|Overall Study|Protocol Violation|1|||
42029983|NCT01157351|75838627|FG000|Overall Study|Other|32|||
42029984|NCT01157351|75838628|FG001|Overall Study|Other|36|||
42029985|NCT01157351|75838627|FG000|Overall Study|Noncompliance with Study Drug|0|||
42029986|NCT01157351|75838628|FG001|Overall Study|Noncompliance with Study Drug|3|||
42029987|NCT01157351|75838627|FG000|Overall Study|Randomized but not Treated|4|||
42223567|NCT03073200|76042363|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42223568|NCT03073200|76042364|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42029988|NCT01157351|75838628|FG001|Overall Study|Randomized but not Treated|2|||
42223569|NCT03073200|76042365|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42223570|NCT03073200|76042366|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42223571|NCT03073200|76042367|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42223572|NCT03073200|76042368|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42223573|NCT03073200|76042369|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42223574|NCT03073200|76042370|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42029989|NCT01157117|75838637|FG000|Overall Study|Dosing Symptoms|0|||
42029990|NCT01157117|75838638|FG001|Overall Study|Dosing Symptoms|4|||
42029991|NCT01157117|75838639|FG002|Overall Study|Dosing Symptoms|0|||
42029992|NCT01157117|75838637|FG000|Overall Study|Withdrawal by Subject|4|||
42223575|NCT03073200|76042371|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
41983364|NCT01056276|75789654|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
41983365|NCT01056276|75789655|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
41983366|NCT01055886|75789668|FG000|Overall Study|Withdrawal by Subject|4|||
41983367|NCT01055886|75789669|FG001|Overall Study|Withdrawal by Subject|9|||
41983368|NCT01055886|75789668|FG000|Overall Study|Lost to Follow-up|1|||
41983369|NCT01055886|75789669|FG001|Overall Study|Lost to Follow-up|1|||
41983370|NCT01055886|75789668|FG000|Overall Study|Withdrawal by PI|0|||
41983371|NCT01055886|75789669|FG001|Overall Study|Withdrawal by PI|1|||
41983372|NCT01055613|75789677|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
42223576|NCT03073200|76042372|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
42223577|NCT03073200|76042373|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42223578|NCT03073200|76042359|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223579|NCT03073200|76042360|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
41983373|NCT01055613|75789678|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
41983374|NCT01055613|75789677|FG000|Overall Study|Unacceptable lens fit|1|||
42029993|NCT01157117|75838638|FG001|Overall Study|Withdrawal by Subject|1|||
42029994|NCT01157117|75838639|FG002|Overall Study|Withdrawal by Subject|1|||
42029995|NCT01157117|75838637|FG000|Overall Study|Lack of Efficacy|1|||
42223580|NCT03073200|76042361|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223581|NCT03073200|76042362|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223582|NCT03073200|76042363|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223583|NCT03073200|76042364|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223584|NCT03073200|76042365|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223585|NCT03073200|76042366|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223586|NCT03073200|76042367|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223587|NCT03073200|76042368|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223588|NCT03073200|76042369|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223589|NCT03073200|76042370|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223590|NCT03073200|76042371|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223591|NCT03073200|76042372|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
42223592|NCT03073200|76042373|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
42223593|NCT03073200|76042359|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223594|NCT03073200|76042360|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223595|NCT03073200|76042361|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223596|NCT03073200|76042362|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223597|NCT03073200|76042363|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223598|NCT03073200|76042364|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223599|NCT03073200|76042365|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223600|NCT03073200|76042366|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223601|NCT03073200|76042367|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223602|NCT03073200|76042368|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223603|NCT03073200|76042369|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223604|NCT03073200|76042370|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223605|NCT03073200|76042371|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223606|NCT03073200|76042372|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
42223607|NCT03073200|76042373|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
42223608|NCT03073200|76042359|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223609|NCT03073200|76042360|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223610|NCT03073200|76042361|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223611|NCT03073200|76042362|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223612|NCT03073200|76042363|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223613|NCT03073200|76042364|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223614|NCT03073200|76042365|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223615|NCT03073200|76042366|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223616|NCT03073200|76042367|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223617|NCT03073200|76042368|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223618|NCT03073200|76042369|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223619|NCT03073200|76042370|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223620|NCT03073200|76042371|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223621|NCT03073200|76042372|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
42223622|NCT03073200|76042373|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42223623|NCT03073200|76042359|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223624|NCT03073200|76042360|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223625|NCT03073200|76042361|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223626|NCT03073200|76042362|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223627|NCT03073200|76042363|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223628|NCT03073200|76042364|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42131486|NCT00565409|75942409|FG003|Period 1 Open Label|Lost to Follow-up|0|||
42131487|NCT00565409|75942406|FG000|Period 1 Open Label|Other|21|||
42131488|NCT00565409|75942407|FG001|Period 1 Open Label|Other|0|||
42131489|NCT00565409|75942408|FG002|Period 1 Open Label|Other|0|||
42131490|NCT00565409|75942409|FG003|Period 1 Open Label|Other|0|||
42131491|NCT00565409|75942406|FG000|Period 1 Open Label|Protocol Violation|14|||
42131492|NCT00565409|75942407|FG001|Period 1 Open Label|Protocol Violation|0|||
42131493|NCT00565409|75942408|FG002|Period 1 Open Label|Protocol Violation|0|||
42131494|NCT00565409|75942409|FG003|Period 1 Open Label|Protocol Violation|0|||
42131495|NCT00565409|75942406|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
42131496|NCT00565409|75942407|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
42223629|NCT03073200|76042365|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223630|NCT03073200|76042366|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223631|NCT03073200|76042367|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42131497|NCT00565409|75942408|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
42131498|NCT00565409|75942409|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
42131499|NCT00565409|75942406|FG000|Period 1 Open Label|no conclusion of participation record|1|||
42131500|NCT00565409|75942407|FG001|Period 1 Open Label|no conclusion of participation record|0|||
42223632|NCT03073200|76042368|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223633|NCT03073200|76042369|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223634|NCT03073200|76042370|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223635|NCT03073200|76042371|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223636|NCT03073200|76042372|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
42223637|NCT03073200|76042373|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
42223638|NCT03290781|76042402|FG000|Overall Study|Adverse Event|5|||
42223639|NCT03290781|76042403|FG001|Overall Study|Adverse Event|7|||
42223640|NCT03290781|76042404|FG002|Overall Study|Adverse Event|4|||
42223641|NCT03290781|76042405|FG003|Overall Study|Adverse Event|1|||
42223642|NCT03290781|76042406|FG004|Overall Study|Adverse Event|0|||
42223643|NCT03290781|76042407|FG005|Overall Study|Adverse Event|0|||
42223644|NCT03290781|76042408|FG006|Overall Study|Adverse Event|0|||
42223645|NCT03290781|76042402|FG000|Overall Study|Death|0|||
42223646|NCT03290781|76042403|FG001|Overall Study|Death|0|||
42223647|NCT03290781|76042404|FG002|Overall Study|Death|1|||
42223648|NCT03290781|76042405|FG003|Overall Study|Death|0|||
42223649|NCT03290781|76042406|FG004|Overall Study|Death|1|||
42223650|NCT03290781|76042407|FG005|Overall Study|Death|0|||
42223651|NCT03290781|76042408|FG006|Overall Study|Death|0|||
42223652|NCT03290781|76042402|FG000|Overall Study|Withdrawal by Subject|6|||
42223653|NCT03290781|76042403|FG001|Overall Study|Withdrawal by Subject|5|||
42223654|NCT03290781|76042404|FG002|Overall Study|Withdrawal by Subject|9|||
42223655|NCT03290781|76042405|FG003|Overall Study|Withdrawal by Subject|10|||
42223656|NCT03290781|76042406|FG004|Overall Study|Withdrawal by Subject|1|||
42223657|NCT03290781|76042407|FG005|Overall Study|Withdrawal by Subject|2|||
42223658|NCT03290781|76042408|FG006|Overall Study|Withdrawal by Subject|0|||
42223659|NCT03290781|76042402|FG000|Overall Study|Physician Decision|0|||
42223660|NCT03290781|76042403|FG001|Overall Study|Physician Decision|1|||
42223661|NCT03290781|76042404|FG002|Overall Study|Physician Decision|0|||
42223662|NCT03290781|76042405|FG003|Overall Study|Physician Decision|0|||
42223663|NCT03290781|76042406|FG004|Overall Study|Physician Decision|0|||
42223664|NCT03290781|76042407|FG005|Overall Study|Physician Decision|0|||
42223665|NCT03290781|76042408|FG006|Overall Study|Physician Decision|0|||
42223666|NCT03290781|76042402|FG000|Overall Study|Site Terminated by Sponsor|1|||
42223667|NCT03290781|76042403|FG001|Overall Study|Site Terminated by Sponsor|0|||
42223668|NCT03290781|76042404|FG002|Overall Study|Site Terminated by Sponsor|2|||
42223669|NCT03290781|76042405|FG003|Overall Study|Site Terminated by Sponsor|1|||
42223670|NCT03290781|76042406|FG004|Overall Study|Site Terminated by Sponsor|0|||
42131501|NCT00565409|75942408|FG002|Period 1 Open Label|no conclusion of participation record|0|||
41983375|NCT01055613|75789678|FG001|Overall Study|Unacceptable lens fit|0|||
42223671|NCT03290781|76042407|FG005|Overall Study|Site Terminated by Sponsor|0|||
42302294|NCT02493361|76137390|FG000|Overall Study|Withdrawal by Subject|3|||
41983376|NCT01055613|75789677|FG000|Overall Study|Discomfort|2|||
42131502|NCT00565409|75942409|FG003|Period 1 Open Label|no conclusion of participation record|0|||
42131503|NCT00565409|75942406|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
42131504|NCT00565409|75942407|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
42223672|NCT03290781|76042408|FG006|Overall Study|Site Terminated by Sponsor|0|||
42223673|NCT03290781|76042402|FG000|Overall Study|Lost to Follow-up|0|||
42223674|NCT03290781|76042403|FG001|Overall Study|Lost to Follow-up|0|||
42223675|NCT03290781|76042404|FG002|Overall Study|Lost to Follow-up|0|||
42223676|NCT03290781|76042405|FG003|Overall Study|Lost to Follow-up|1|||
42223677|NCT03290781|76042406|FG004|Overall Study|Lost to Follow-up|0|||
42223678|NCT03290781|76042407|FG005|Overall Study|Lost to Follow-up|0|||
42223679|NCT03290781|76042408|FG006|Overall Study|Lost to Follow-up|0|||
42223680|NCT03290781|76042402|FG000|Overall Study|Protocol Deviation|2|||
42223681|NCT03290781|76042403|FG001|Overall Study|Protocol Deviation|0|||
42223682|NCT03290781|76042404|FG002|Overall Study|Protocol Deviation|0|||
42223683|NCT03290781|76042405|FG003|Overall Study|Protocol Deviation|1|||
42223684|NCT03290781|76042406|FG004|Overall Study|Protocol Deviation|0|||
42223685|NCT03290781|76042407|FG005|Overall Study|Protocol Deviation|0|||
42223686|NCT03290781|76042408|FG006|Overall Study|Protocol Deviation|0|||
42223687|NCT03290781|76042402|FG000|Overall Study|Disease Relapse|32|||
42223688|NCT03290781|76042403|FG001|Overall Study|Disease Relapse|5|||
42223689|NCT03290781|76042404|FG002|Overall Study|Disease Relapse|38|||
42223690|NCT03290781|76042405|FG003|Overall Study|Disease Relapse|7|||
42223691|NCT03290781|76042406|FG004|Overall Study|Disease Relapse|3|||
42223692|NCT03290781|76042407|FG005|Overall Study|Disease Relapse|1|||
42223693|NCT03290781|76042408|FG006|Overall Study|Disease Relapse|4|||
42223694|NCT03290781|76042402|FG000|Overall Study|Other|3|||
42223695|NCT03290781|76042403|FG001|Overall Study|Other|0|||
42223696|NCT03290781|76042404|FG002|Overall Study|Other|2|||
42223697|NCT03290781|76042405|FG003|Overall Study|Other|2|||
42223698|NCT03290781|76042406|FG004|Overall Study|Other|0|||
42223699|NCT03290781|76042407|FG005|Overall Study|Other|0|||
42223700|NCT03290781|76042408|FG006|Overall Study|Other|0|||
42223701|NCT03466073|76042437|FG000|Overall Study|Death|1|||
42223702|NCT03466073|76042438|FG001|Overall Study|Death|0|||
42223703|NCT03466073|76042439|FG002|Overall Study|Death|0|||
42223704|NCT03466073|76042440|FG003|Overall Study|Death|0|||
42223705|NCT03466073|76042441|FG004|Overall Study|Death|0|||
42223706|NCT03466073|76042442|FG005|Overall Study|Death|1|||
42223707|NCT03412019|76042465|FG000|Overall Study|Withdrawal by Subject|1|||
42223708|NCT03412019|76042466|FG001|Overall Study|Withdrawal by Subject|1|||
42223709|NCT03070002|76042472|FG000|Follow up for 2 Years|Death|1|||
42223710|NCT02918318|76042480|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
42223711|NCT02918318|76042481|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
42223712|NCT02918318|76042482|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
42223713|NCT02918318|76042483|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
42223714|NCT02918318|76042484|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
42223715|NCT02918318|76042480|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
42223716|NCT02918318|76042481|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
42223717|NCT02918318|76042482|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
42223718|NCT02918318|76042483|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
42223719|NCT02918318|76042484|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
42223720|NCT02918318|76042480|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
42223721|NCT02918318|76042481|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
42223722|NCT02918318|76042482|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
42223723|NCT02918318|76042483|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
42223724|NCT02918318|76042484|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
42223725|NCT02918318|76042480|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
42223726|NCT02918318|76042481|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
42223727|NCT02918318|76042482|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
42223728|NCT02918318|76042483|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
42223729|NCT02918318|76042484|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
42223730|NCT02918318|76042480|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
42223731|NCT02918318|76042481|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
42223732|NCT02918318|76042482|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
42223733|NCT02918318|76042483|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
42223734|NCT02918318|76042484|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
42223735|NCT02918318|76042480|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
42223736|NCT02918318|76042481|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
41983377|NCT01055613|75789678|FG001|Overall Study|Discomfort|1|||
41983378|NCT01055613|75789677|FG000|Overall Study|Lost to Follow-up|1|||
42223737|NCT02918318|76042482|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
42223738|NCT02918318|76042483|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
42223739|NCT02918318|76042484|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
42223740|NCT02918318|76042480|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
42223741|NCT02918318|76042481|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
42223742|NCT02918318|76042482|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
42223743|NCT02918318|76042483|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
42223744|NCT02918318|76042484|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
42223745|NCT02918318|76042480|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
42223746|NCT02918318|76042481|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
42223747|NCT02918318|76042482|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
42223748|NCT02918318|76042483|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
42223749|NCT02918318|76042484|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
42223750|NCT02918318|76042480|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
42223751|NCT02918318|76042481|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
42223752|NCT02918318|76042482|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
42223753|NCT02918318|76042483|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
42223754|NCT02918318|76042484|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
42223755|NCT02918318|76042480|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
42223756|NCT02918318|76042481|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
42223757|NCT02918318|76042482|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
42223758|NCT02918318|76042483|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
42223759|NCT02918318|76042484|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
42223760|NCT02918318|76042480|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
42223761|NCT02918318|76042481|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
42223762|NCT02918318|76042482|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
42223763|NCT02918318|76042483|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
42223764|NCT02918318|76042484|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
42223765|NCT02918318|76042480|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
42223766|NCT02918318|76042481|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
42223767|NCT02918318|76042482|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
42223768|NCT02918318|76042483|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
42223769|NCT02918318|76042484|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
42223770|NCT03411863|76042529|FG000|Overall Study|Withdrawal by Subject|3|||
42223771|NCT03411863|76042530|FG001|Overall Study|Withdrawal by Subject|1|||
42223772|NCT03411863|76042529|FG000|Overall Study|Physician Decision|0|||
42223773|NCT03411863|76042530|FG001|Overall Study|Physician Decision|1|||
42223774|NCT01065350|76042539|FG000|Overall Study|Received incorrect drug allocation|0|||
42223775|NCT01065350|76042540|FG001|Overall Study|Received incorrect drug allocation|1|||
42223776|NCT03434249|76042548|FG000|Overall Study|Adverse Event|1|||
42223777|NCT03434249|76042549|FG001|Overall Study|Adverse Event|0|||
42223778|NCT03434249|76042548|FG000|Overall Study|Lost to Follow-up|0|||
42223779|NCT03434249|76042549|FG001|Overall Study|Lost to Follow-up|1|||
42223780|NCT03434249|76042548|FG000|Overall Study|Non-compliance of family|2|||
42223781|NCT03434249|76042549|FG001|Overall Study|Non-compliance of family|1|||
42223782|NCT03434249|76042548|FG000|Overall Study|Difficulties in completing daily diary|2|||
42223783|NCT03434249|76042549|FG001|Overall Study|Difficulties in completing daily diary|1|||
42223784|NCT03114969|76042564|FG000|Overall Study|Lost to Follow-up|0|||
42223785|NCT03114969|76042565|FG001|Overall Study|Lost to Follow-up|0|||
42223786|NCT03114969|76042566|FG002|Overall Study|Lost to Follow-up|3|||
42223787|NCT03114969|76042567|FG003|Overall Study|Lost to Follow-up|2|||
42223788|NCT03114969|76042568|FG004|Overall Study|Lost to Follow-up|0|||
42223789|NCT03114969|76042569|FG005|Overall Study|Lost to Follow-up|0|||
42223790|NCT03114969|76042570|FG006|Overall Study|Lost to Follow-up|0|||
42223791|NCT03114969|76042571|FG007|Overall Study|Lost to Follow-up|0|||
42223792|NCT03114969|76042572|FG008|Overall Study|Lost to Follow-up|0|||
42223793|NCT03114969|76042564|FG000|Overall Study|Adverse Event|0|||
42223794|NCT03114969|76042565|FG001|Overall Study|Adverse Event|0|||
42223795|NCT03114969|76042566|FG002|Overall Study|Adverse Event|1|||
41983379|NCT01055613|75789678|FG001|Overall Study|Lost to Follow-up|1|||
41983380|NCT01055613|75789677|FG000|Overall Study|Protocol Violation|1|||
41983381|NCT01055613|75789678|FG001|Overall Study|Protocol Violation|1|||
41983382|NCT01055613|75789677|FG000|Overall Study|Subject Disinterest|1|||
41983383|NCT01055613|75789678|FG001|Overall Study|Subject Disinterest|1|||
41983384|NCT01055457|75789694|FG000|Overall Study|Lost to Follow-up|0|||
41983385|NCT01055457|75789695|FG001|Overall Study|Lost to Follow-up|1|||
41983386|NCT01055457|75789696|FG002|Overall Study|Lost to Follow-up|0|||
41983387|NCT01055457|75789697|FG003|Overall Study|Lost to Follow-up|0|||
42223796|NCT03114969|76042567|FG003|Overall Study|Adverse Event|0|||
42223797|NCT03114969|76042568|FG004|Overall Study|Adverse Event|0|||
42223798|NCT03114969|76042569|FG005|Overall Study|Adverse Event|1|||
42223799|NCT03114969|76042570|FG006|Overall Study|Adverse Event|1|||
42223800|NCT03114969|76042571|FG007|Overall Study|Adverse Event|0|||
42223801|NCT03114969|76042572|FG008|Overall Study|Adverse Event|2|||
42223802|NCT02046096|76042601|FG000|Overall Study|Death|28|||
41983388|NCT01055457|75789698|FG004|Overall Study|Lost to Follow-up|0|||
41983389|NCT01055457|75789699|FG005|Overall Study|Lost to Follow-up|1|||
41983390|NCT01055457|75789700|FG006|Overall Study|Lost to Follow-up|0|||
42223803|NCT02046096|76042602|FG001|Overall Study|Death|45|||
42223804|NCT02046096|76042601|FG000|Overall Study|Lost to Follow-up|9|||
42223805|NCT02046096|76042602|FG001|Overall Study|Lost to Follow-up|20|||
42223806|NCT02046096|76042601|FG000|Overall Study|Withdrawal by Subject|5|||
42223807|NCT02046096|76042602|FG001|Overall Study|Withdrawal by Subject|17|||
42223808|NCT02046096|76042601|FG000|Overall Study|Other endpoint|2|||
42223809|NCT02046096|76042602|FG001|Overall Study|Other endpoint|19|||
42223810|NCT03463577|76042616|FG000|Overall Study|Lost to Follow-up|238|||
42223811|NCT03463577|76042617|FG001|Overall Study|Lost to Follow-up|435|||
42223812|NCT03463577|76042618|FG002|Overall Study|Lost to Follow-up|0|||
42223813|NCT03463577|76042619|FG003|Overall Study|Lost to Follow-up|0|||
42223814|NCT03463577|76042620|FG004|Overall Study|Lost to Follow-up|0|||
42223815|NCT03463577|76042621|FG005|Overall Study|Lost to Follow-up|0|||
42223816|NCT03463577|76042616|FG000|Overall Study|With unknown pregnancy outcome|0|||
42223817|NCT03463577|76042617|FG001|Overall Study|With unknown pregnancy outcome|5|||
42223818|NCT03463577|76042618|FG002|Overall Study|With unknown pregnancy outcome|0|||
42223819|NCT03463577|76042619|FG003|Overall Study|With unknown pregnancy outcome|0|||
42223820|NCT03463577|76042620|FG004|Overall Study|With unknown pregnancy outcome|0|||
42223821|NCT03463577|76042621|FG005|Overall Study|With unknown pregnancy outcome|0|||
42223822|NCT03463577|76042616|FG000|Overall Study|Maternal death|2|||
42223823|NCT03463577|76042617|FG001|Overall Study|Maternal death|0|||
42223824|NCT03463577|76042618|FG002|Overall Study|Maternal death|0|||
42223825|NCT03463577|76042619|FG003|Overall Study|Maternal death|0|||
42223826|NCT03463577|76042620|FG004|Overall Study|Maternal death|0|||
42223827|NCT03463577|76042621|FG005|Overall Study|Maternal death|0|||
42223828|NCT03463577|76042616|FG000|Overall Study|Neonatal death|0|||
42223829|NCT03463577|76042617|FG001|Overall Study|Neonatal death|0|||
42223830|NCT03463577|76042618|FG002|Overall Study|Neonatal death|0|||
42223831|NCT03463577|76042619|FG003|Overall Study|Neonatal death|15|||
42223832|NCT03463577|76042620|FG004|Overall Study|Neonatal death|17|||
42223833|NCT03463577|76042621|FG005|Overall Study|Neonatal death|0|||
42223834|NCT03122145|76042637|FG000|Overall Study|Concurrent respiratory disease|3|||
42223835|NCT03122145|76042638|FG001|Overall Study|Concurrent respiratory disease|0|||
42223836|NCT03114657|76042646|FG000|Overall Study|Adverse Event|9|||
42223837|NCT03114657|76042647|FG001|Overall Study|Adverse Event|6|||
42223838|NCT03114657|76042646|FG000|Overall Study|Death|4|||
42223839|NCT03114657|76042647|FG001|Overall Study|Death|0|||
42223840|NCT03114657|76042646|FG000|Overall Study|Multiple Reasons|1|||
42223841|NCT03114657|76042647|FG001|Overall Study|Multiple Reasons|2|||
42223842|NCT03114657|76042646|FG000|Overall Study|Physician Decision|2|||
42223843|NCT03114657|76042647|FG001|Overall Study|Physician Decision|2|||
42223844|NCT03114657|76042646|FG000|Overall Study|Study Terminated By Sponsor|355|||
42223845|NCT03114657|76042647|FG001|Overall Study|Study Terminated By Sponsor|374|||
42223846|NCT03114657|76042646|FG000|Overall Study|Symptomatic Deterioration|0|||
42223847|NCT03114657|76042647|FG001|Overall Study|Symptomatic Deterioration|1|||
42223848|NCT03114657|76042646|FG000|Overall Study|Withdrawal by Subject|28|||
42223849|NCT03114657|76042647|FG001|Overall Study|Withdrawal by Subject|22|||
42223850|NCT02926950|76042656|FG000|Overall Study|Adverse Event|4|||
42223851|NCT02926950|76042657|FG001|Overall Study|Adverse Event|6|||
42223852|NCT02926950|76042656|FG000|Overall Study|At the participant's own request|21|||
42223853|NCT02926950|76042657|FG001|Overall Study|At the participant's own request|25|||
42223854|NCT02926950|76042656|FG000|Overall Study|Reason not Specified|17|||
42223855|NCT02926950|76042657|FG001|Overall Study|Reason not Specified|9|||
42223856|NCT02926950|76042656|FG000|Overall Study|Lost to Follow-up|7|||
42223857|NCT02926950|76042657|FG001|Overall Study|Lost to Follow-up|8|||
42223858|NCT03410693|76042666|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
42223859|NCT03410693|76042667|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
42223860|NCT03410693|76042666|FG000|Overall Study|Disc trt: Lost to follow up|0|||
42223861|NCT03410693|76042667|FG001|Overall Study|Disc trt: Lost to follow up|1|||
42302295|NCT02493127|76137396|FG000|Overall Study|Lost to Follow-up|1|||
42302296|NCT02493127|76137397|FG001|Overall Study|Lost to Follow-up|1|||
42302297|NCT02478463|76137405|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
42302298|NCT02478463|76137405|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
42302299|NCT02478463|76137405|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
42302300|NCT02491411|76137411|FG000|Overall Study|Physician Decision|4|||
42302301|NCT02517463|76137417|FG000|Overall Study|Lost to Follow-up|5|||
42223862|NCT03410693|76042666|FG000|Overall Study|Disc trt: radiological progression|58|||
42223863|NCT03410693|76042667|FG001|Overall Study|Disc trt: radiological progression|50|||
42223864|NCT03410693|76042666|FG000|Overall Study|Disc trt: Other|1|||
42223865|NCT03410693|76042667|FG001|Overall Study|Disc trt: Other|0|||
42223866|NCT03410693|76042666|FG000|Overall Study|Study drug never administered|1|||
42223867|NCT03410693|76042667|FG001|Overall Study|Study drug never administered|6|||
42223868|NCT03410693|76042666|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
42223869|NCT03410693|76042667|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
42223870|NCT03410693|76042666|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
42223871|NCT03410693|76042667|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
42223872|NCT03410693|76042666|FG000|Overall Study|Disc trt: Physician decision|0|||
42223873|NCT03410693|76042667|FG001|Overall Study|Disc trt: Physician decision|5|||
42302302|NCT02517463|76137418|FG001|Overall Study|Lost to Follow-up|2|||
42223874|NCT03410693|76042666|FG000|Overall Study|Disc trt: clinical progression|1|||
42223875|NCT03410693|76042667|FG001|Overall Study|Disc trt: clinical progression|5|||
42223876|NCT03410693|76042666|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
42223877|NCT03410693|76042667|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
42223878|NCT01064414|76042682|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
42223879|NCT01064414|76042683|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
42223880|NCT01064414|76042684|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
42223881|NCT01064414|76042682|FG000|Core Period: Baseline to Week 26|Death|0|||
42223882|NCT01064414|76042683|FG001|Core Period: Baseline to Week 26|Death|1|||
42223883|NCT01064414|76042684|FG002|Core Period: Baseline to Week 26|Death|0|||
42223884|NCT01064414|76042682|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
42223885|NCT01064414|76042683|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
42223886|NCT01064414|76042684|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
42223887|NCT01064414|76042682|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
42223888|NCT01064414|76042683|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
42223889|NCT01064414|76042684|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
42223890|NCT01064414|76042682|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
42223891|NCT01064414|76042683|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
42223892|NCT01064414|76042684|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
42223893|NCT01064414|76042682|FG000|Core Period: Baseline to Week 26|Other|4|||
42223894|NCT01064414|76042683|FG001|Core Period: Baseline to Week 26|Other|7|||
42223895|NCT01064414|76042684|FG002|Core Period: Baseline to Week 26|Other|2|||
42223896|NCT01064414|76042682|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
42223897|NCT01064414|76042683|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
42223898|NCT01064414|76042684|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
42223899|NCT01064414|76042682|FG000|Extension Period: Week 26 to Week 52|Death|0|||
42223900|NCT01064414|76042683|FG001|Extension Period: Week 26 to Week 52|Death|1|||
42223901|NCT01064414|76042684|FG002|Extension Period: Week 26 to Week 52|Death|0|||
42223902|NCT01064414|76042682|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
42223903|NCT01064414|76042683|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
42223904|NCT01064414|76042684|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
42223905|NCT01064414|76042682|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
42223906|NCT01064414|76042683|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
42223907|NCT01064414|76042684|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
42223908|NCT01064414|76042682|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
42223909|NCT01064414|76042683|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
42223910|NCT01064414|76042684|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
42223911|NCT01064414|76042682|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
42223912|NCT01064414|76042683|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
42223913|NCT01064414|76042684|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
42223914|NCT01064414|76042682|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
42223915|NCT01064414|76042683|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
42223916|NCT01064414|76042684|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
42223917|NCT01064414|76042682|FG000|Extension Period: Week 26 to Week 52|Other|5|||
42223918|NCT01064414|76042683|FG001|Extension Period: Week 26 to Week 52|Other|2|||
42223919|NCT01064414|76042684|FG002|Extension Period: Week 26 to Week 52|Other|1|||
42223920|NCT03433703|76042695|FG000|Overall Study|Study terminated by Sponsor|2|||
42223921|NCT03463031|76042705|FG000|Overall Study|Withdrawal by Subject|4|||
42223922|NCT03463031|76042706|FG001|Overall Study|Withdrawal by Subject|2|||
42223923|NCT03463031|76042705|FG000|Overall Study|Investigator/Sponsor Decision|0|||
42223924|NCT03463031|76042706|FG001|Overall Study|Investigator/Sponsor Decision|1|||
42223925|NCT03463031|76042705|FG000|Overall Study|Lost to Follow-up|1|||
42223926|NCT03463031|76042706|FG001|Overall Study|Lost to Follow-up|1|||
42223927|NCT03463031|76042705|FG000|Overall Study|Adverse Event|4|||
42223928|NCT03463031|76042706|FG001|Overall Study|Adverse Event|1|||
42223929|NCT03463031|76042705|FG000|Overall Study|Use of prohibited medication by subject|1|||
41983391|NCT01055457|75789701|FG007|Overall Study|Lost to Follow-up|0|||
41983392|NCT01055457|75789702|FG008|Overall Study|Lost to Follow-up|0|||
41983393|NCT01055457|75789703|FG009|Overall Study|Lost to Follow-up|0|||
41983394|NCT01055457|75789694|FG000|Overall Study|Protocol Violation|0|||
41983395|NCT01055457|75789695|FG001|Overall Study|Protocol Violation|0|||
41983396|NCT01055457|75789696|FG002|Overall Study|Protocol Violation|1|||
41983397|NCT01055457|75789697|FG003|Overall Study|Protocol Violation|1|||
42223930|NCT03463031|76042706|FG001|Overall Study|Use of prohibited medication by subject|0|||
41983398|NCT01055457|75789698|FG004|Overall Study|Protocol Violation|1|||
41983399|NCT01055457|75789699|FG005|Overall Study|Protocol Violation|2|||
41983400|NCT01055457|75789700|FG006|Overall Study|Protocol Violation|1|||
42223931|NCT03462641|76042714|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
42223932|NCT03462641|76042715|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
42223933|NCT03462641|76042714|FG000|Visit 2|Withdrawal by Subject|0|||
42223934|NCT03462641|76042715|FG001|Visit 2|Withdrawal by Subject|1|||
42223935|NCT02974634|76042725|FG000|Overall Study|Advanced disease|12|||
42223936|NCT02974634|76042726|FG001|Overall Study|Advanced disease|3|||
42223937|NCT02974634|76042725|FG000|Overall Study|Noncompliance|3|||
42223938|NCT02974634|76042726|FG001|Overall Study|Noncompliance|7|||
42223939|NCT02974634|76042725|FG000|Overall Study|intervention technology related issues|5|||
42223940|NCT02974634|76042726|FG001|Overall Study|intervention technology related issues|0|||
42223941|NCT02974634|76042725|FG000|Overall Study|Death|8|||
42223942|NCT02974634|76042726|FG001|Overall Study|Death|11|||
42223943|NCT01060670|76042735|FG000|Run In|screen failure|0|||
42223944|NCT01060670|76042736|FG001|Run In|screen failure|238|||
42223945|NCT02971670|76042748|FG000|Overall Study|Withdrawal by Subject|4|||
42223946|NCT02971670|76042749|FG001|Overall Study|Withdrawal by Subject|1|||
42223947|NCT02971670|76042750|FG002|Overall Study|Withdrawal by Subject|1|||
42223948|NCT02971670|76042751|FG003|Overall Study|Withdrawal by Subject|2|||
42223949|NCT02971202|76042764|FG000|Overall Study|Pregnancy|1|||
42223950|NCT02971202|76042765|FG001|Overall Study|Pregnancy|0|||
42223951|NCT02971202|76042766|FG002|Overall Study|Pregnancy|0|||
42223952|NCT02971202|76042764|FG000|Overall Study|screen fail after consent|1|||
42223953|NCT02971202|76042765|FG001|Overall Study|screen fail after consent|0|||
41983401|NCT01055457|75789701|FG007|Overall Study|Protocol Violation|0|||
41983402|NCT01055457|75789702|FG008|Overall Study|Protocol Violation|0|||
41983403|NCT01055457|75789703|FG009|Overall Study|Protocol Violation|1|||
41983404|NCT01055457|75789694|FG000|Overall Study|Subject Disinterest|0|||
41983405|NCT01055457|75789695|FG001|Overall Study|Subject Disinterest|0|||
41983406|NCT01055457|75789696|FG002|Overall Study|Subject Disinterest|0|||
41983407|NCT01055457|75789697|FG003|Overall Study|Subject Disinterest|0|||
41983408|NCT01055457|75789698|FG004|Overall Study|Subject Disinterest|0|||
42223954|NCT02971202|76042766|FG002|Overall Study|screen fail after consent|1|||
42223955|NCT02926638|76042776|FG000|Overall Study|Progression|2|||
42223956|NCT02926638|76042777|FG001|Overall Study|Progression|5|||
42223957|NCT02926638|76042776|FG000|Overall Study|Ineligible|1|||
42223958|NCT02926638|76042777|FG001|Overall Study|Ineligible|0|||
42223959|NCT02926638|76042776|FG000|Overall Study|Not protocol specified|1|||
42223960|NCT02926638|76042777|FG001|Overall Study|Not protocol specified|0|||
42223961|NCT02903030|76042785|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
42223962|NCT02903030|76042786|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
42223963|NCT02969408|76042795|FG000|Overall Study|Adverse Event|2|||
42223964|NCT02969408|76042795|FG000|Overall Study|Withdrawal by Subject|8|||
42223965|NCT02969408|76042795|FG000|Overall Study|Lost to Follow-up|4|||
42223966|NCT02969408|76042795|FG000|Overall Study|Protocol Violation|1|||
42223967|NCT02969408|76042795|FG000|Overall Study|Other than specified|1|||
42223968|NCT03462563|76042801|FG000|Overall Study|Death|1|||
42223969|NCT03462563|76042802|FG001|Overall Study|Death|1|||
42223970|NCT03462563|76042801|FG000|Overall Study|Termination of study|2|||
42223971|NCT03462563|76042802|FG001|Overall Study|Termination of study|1|||
42223972|NCT03462563|76042801|FG000|Overall Study|Adverse Event|1|||
42223973|NCT03462563|76042802|FG001|Overall Study|Adverse Event|3|||
42223974|NCT03462563|76042801|FG000|Overall Study|Unspecified reason|10|||
42223975|NCT03462563|76042802|FG001|Overall Study|Unspecified reason|12|||
42223976|NCT03462563|76042801|FG000|Overall Study|Physician Decision|1|||
42223977|NCT03462563|76042802|FG001|Overall Study|Physician Decision|0|||
42223978|NCT01060124|76042808|FG000|Overall Study|Other|16|||
42302303|NCT02516605|76137429|FG000|Overall Study|Protocol Violation|0|||
42302304|NCT02516605|76137430|FG001|Overall Study|Protocol Violation|0|||
41983409|NCT01055457|75789699|FG005|Overall Study|Subject Disinterest|0|||
41983410|NCT01055457|75789700|FG006|Overall Study|Subject Disinterest|0|||
42131505|NCT00565409|75942408|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
42131506|NCT00565409|75942409|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
42131507|NCT00565409|75942406|FG000|Period 2 Double-Blind|Adverse Event|0|||
42131508|NCT00565409|75942407|FG001|Period 2 Double-Blind|Adverse Event|7|||
42131509|NCT00565409|75942408|FG002|Period 2 Double-Blind|Adverse Event|4|||
42131510|NCT00565409|75942409|FG003|Period 2 Double-Blind|Adverse Event|5|||
42131511|NCT00565409|75942406|FG000|Period 2 Double-Blind|Death|0|||
42131512|NCT00565409|75942407|FG001|Period 2 Double-Blind|Death|2|||
42131513|NCT00565409|75942408|FG002|Period 2 Double-Blind|Death|0|||
42131514|NCT00565409|75942409|FG003|Period 2 Double-Blind|Death|0|||
42131515|NCT00565409|75942406|FG000|Period 2 Double-Blind|Protocol Violation|0|||
42131516|NCT00565409|75942407|FG001|Period 2 Double-Blind|Protocol Violation|4|||
42131517|NCT00565409|75942408|FG002|Period 2 Double-Blind|Protocol Violation|6|||
42131518|NCT00565409|75942409|FG003|Period 2 Double-Blind|Protocol Violation|2|||
42131519|NCT00565409|75942406|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
42223979|NCT01060124|76042808|FG000|Overall Study|Adverse Event|14|||
42223980|NCT01060124|76042808|FG000|Overall Study|Withdrawal by Subject|7|||
42223981|NCT03461003|76042814|FG000|Overall Study|Lost to Follow-up|2|||
42223982|NCT03461003|76042815|FG001|Overall Study|Lost to Follow-up|2|||
42223983|NCT03461003|76042814|FG000|Overall Study|Withdrawal by Subject|3|||
42223984|NCT03461003|76042815|FG001|Overall Study|Withdrawal by Subject|1|||
42223985|NCT02904902|76042821|FG000|Overall Study|Withdrawal by Subject|1|||
42223986|NCT04425720|76042827|FG000|Overall Study|Withdrawal by Subject|0|||
42223987|NCT04425720|76042828|FG001|Overall Study|Withdrawal by Subject|20|||
42223988|NCT02904512|76042837|FG000|Overall Study|Withdrawal by Subject|1|||
42223989|NCT02904512|76042838|FG001|Overall Study|Withdrawal by Subject|0|||
42223990|NCT02904512|76042837|FG000|Overall Study|Transferred to ICU|1|||
42223991|NCT02904512|76042838|FG001|Overall Study|Transferred to ICU|0|||
42223992|NCT02904512|76042837|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
42223993|NCT02904512|76042838|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
42223994|NCT02904200|76042844|FG000|Overall Study|Withdrawal by Subject|1|||
42223995|NCT02904200|76042845|FG001|Overall Study|Withdrawal by Subject|0|||
41983411|NCT01055457|75789701|FG007|Overall Study|Subject Disinterest|1|||
42223996|NCT03432533|76042851|FG000|Overall Study|Lost to Follow-up|1|||
42223997|NCT03432533|76042852|FG001|Overall Study|Lost to Follow-up|2|||
42223998|NCT03432533|76042851|FG000|Overall Study|Withdrawal by Subject|14|||
42223999|NCT03432533|76042852|FG001|Overall Study|Withdrawal by Subject|9|||
42224000|NCT02901548|76042858|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
42224001|NCT02903966|76042864|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
42224002|NCT02903966|76042865|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
42224003|NCT02903966|76042864|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
42224004|NCT02903966|76042865|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
42224005|NCT02903966|76042864|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
42224006|NCT02903966|76042865|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
42224007|NCT03457727|76042881|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
42224008|NCT03457727|76042882|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
42224009|NCT03457727|76042883|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
42224010|NCT03457727|76042884|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
42224011|NCT03431441|76042916|FG000|Overall Study|Withdrawal by Subject|2|||
42224012|NCT03431441|76042916|FG000|Overall Study|Adverse Event|2|||
42224013|NCT03431441|76042916|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
42224014|NCT03457103|76042922|FG000|Overall Study|illness/hospitalization|4|||
42224015|NCT03457103|76042923|FG001|Overall Study|illness/hospitalization|2|||
42224016|NCT03457103|76042922|FG000|Overall Study|Lost to Follow-up|2|||
42224017|NCT03457103|76042923|FG001|Overall Study|Lost to Follow-up|1|||
42224018|NCT03457103|76042922|FG000|Overall Study|Withdrawal by Subject|1|||
42224019|NCT03457103|76042923|FG001|Overall Study|Withdrawal by Subject|2|||
42224020|NCT03457103|76042922|FG000|Overall Study|financial/ insurance issues|1|||
42224021|NCT03457103|76042923|FG001|Overall Study|financial/ insurance issues|1|||
42224022|NCT03455543|76042931|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
42224023|NCT03455543|76042932|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
42302305|NCT02516605|76137431|FG002|Overall Study|Protocol Violation|0|||
41983412|NCT01055457|75789702|FG008|Overall Study|Subject Disinterest|0|||
41983413|NCT01055457|75789703|FG009|Overall Study|Subject Disinterest|0|||
41983414|NCT01055457|75789694|FG000|Overall Study|Subject Ineligible|1|||
41983415|NCT01055457|75789695|FG001|Overall Study|Subject Ineligible|0|||
41983416|NCT01055457|75789696|FG002|Overall Study|Subject Ineligible|1|||
41983417|NCT01055457|75789697|FG003|Overall Study|Subject Ineligible|0|||
41983418|NCT01055457|75789698|FG004|Overall Study|Subject Ineligible|1|||
41983419|NCT01055457|75789699|FG005|Overall Study|Subject Ineligible|0|||
41983420|NCT01055457|75789700|FG006|Overall Study|Subject Ineligible|0|||
41983421|NCT01055457|75789701|FG007|Overall Study|Subject Ineligible|0|||
41983422|NCT01055457|75789702|FG008|Overall Study|Subject Ineligible|0|||
41983423|NCT01055457|75789703|FG009|Overall Study|Subject Ineligible|0|||
41983424|NCT01055457|75789694|FG000|Overall Study|Discomfort|0|||
41983425|NCT01055457|75789695|FG001|Overall Study|Discomfort|0|||
41983426|NCT01055457|75789696|FG002|Overall Study|Discomfort|0|||
41983427|NCT01055457|75789697|FG003|Overall Study|Discomfort|0|||
42302306|NCT02516605|76137432|FG003|Overall Study|Protocol Violation|0|||
42131520|NCT00565409|75942407|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
42131521|NCT00565409|75942408|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
42131522|NCT00565409|75942409|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
42131523|NCT00565409|75942406|FG000|Period 2 Double-Blind|Other|0|||
42131524|NCT00565409|75942407|FG001|Period 2 Double-Blind|Other|4|||
42131525|NCT00565409|75942408|FG002|Period 2 Double-Blind|Other|5|||
42131526|NCT00565409|75942409|FG003|Period 2 Double-Blind|Other|9|||
42131527|NCT00565409|75942406|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
41983428|NCT01055457|75789698|FG004|Overall Study|Discomfort|1|||
41983429|NCT01055457|75789699|FG005|Overall Study|Discomfort|0|||
41983430|NCT01055457|75789700|FG006|Overall Study|Discomfort|0|||
41983431|NCT01055457|75789701|FG007|Overall Study|Discomfort|0|||
42224024|NCT03455543|76042933|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
42224025|NCT03455543|76042931|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
42224026|NCT03455543|76042932|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
42224027|NCT03455543|76042933|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
42224028|NCT03455543|76042931|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
42224029|NCT03455543|76042932|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
42224030|NCT03455543|76042933|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
42224031|NCT03455543|76042931|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
42224032|NCT03455543|76042932|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
42224033|NCT03455543|76042933|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
42224034|NCT03455543|76042931|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
42224035|NCT03455543|76042932|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
42224036|NCT03455543|76042933|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
42224037|NCT03455543|76042931|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
42224038|NCT03455543|76042932|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
42224039|NCT03455543|76042933|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
42224040|NCT03455543|76042931|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
42224041|NCT03455543|76042932|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
42224042|NCT03455543|76042933|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
42224043|NCT03455543|76042931|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
42224044|NCT03455543|76042932|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
42224045|NCT03455543|76042933|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
42224046|NCT03455543|76042931|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
42224047|NCT03455543|76042932|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
42224048|NCT03455543|76042933|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
42224049|NCT03068754|76042943|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
42224050|NCT03068754|76042944|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
42224051|NCT03068754|76042945|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
42224052|NCT03068754|76042946|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
42224053|NCT03068754|76042943|FG000|Randomized Treatment Period (RTP)|Death|2|||
42224054|NCT03068754|76042944|FG001|Randomized Treatment Period (RTP)|Death|2|||
42224055|NCT03068754|76042945|FG002|Randomized Treatment Period (RTP)|Death|0|||
42224056|NCT03068754|76042946|FG003|Randomized Treatment Period (RTP)|Death|0|||
42224057|NCT03068754|76042943|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
42224058|NCT03068754|76042944|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
42224059|NCT03068754|76042945|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
42224060|NCT03068754|76042946|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
42224061|NCT03068754|76042943|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
42224062|NCT03068754|76042944|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
42224063|NCT03068754|76042945|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
42224064|NCT03068754|76042946|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
42224065|NCT03068754|76042943|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
42224066|NCT03068754|76042944|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
42224067|NCT03068754|76042945|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
42224068|NCT03068754|76042946|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
42224069|NCT03068754|76042943|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
42224070|NCT03068754|76042944|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
42224071|NCT03068754|76042945|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
42224072|NCT03068754|76042946|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
42224073|NCT03068754|76042943|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
42224074|NCT03068754|76042944|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
42224075|NCT03068754|76042945|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
42224076|NCT03068754|76042946|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
42224077|NCT03068754|76042943|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
42224078|NCT03068754|76042944|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
42224079|NCT03068754|76042945|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
42302307|NCT02516605|76137433|FG004|Overall Study|Protocol Violation|1|||
42224080|NCT03068754|76042946|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
42224081|NCT03068754|76042943|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
42224082|NCT03068754|76042944|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
42224083|NCT03068754|76042945|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
42224084|NCT03068754|76042946|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
42224085|NCT03068754|76042943|FG000|Open Label Extension Period (OLE)|Death|0|||
42224086|NCT03068754|76042944|FG001|Open Label Extension Period (OLE)|Death|0|||
42224087|NCT03068754|76042945|FG002|Open Label Extension Period (OLE)|Death|0|||
42224088|NCT03068754|76042946|FG003|Open Label Extension Period (OLE)|Death|1|||
42224089|NCT03068754|76042943|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
42224090|NCT03068754|76042944|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
42224091|NCT03068754|76042945|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
42224092|NCT03068754|76042946|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
42224093|NCT03068754|76042943|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
42224094|NCT03068754|76042944|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
42224095|NCT03068754|76042945|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
42224096|NCT03068754|76042946|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
42224097|NCT03068754|76042943|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
42224098|NCT03068754|76042944|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
42224099|NCT03068754|76042945|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
42224100|NCT03068754|76042946|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
42224101|NCT03068754|76042943|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
42029996|NCT01157117|75838638|FG001|Overall Study|Lack of Efficacy|1|||
42029997|NCT01157117|75838639|FG002|Overall Study|Lack of Efficacy|0|||
42029998|NCT01157117|75838637|FG000|Overall Study|Lost to Follow-up|0|||
42029999|NCT01157117|75838638|FG001|Overall Study|Lost to Follow-up|0|||
42224102|NCT03068754|76042944|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
42224103|NCT03068754|76042945|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
42224104|NCT03068754|76042946|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
42224105|NCT02965820|76042956|FG000|Period 2, Second 30 Days|Adverse Event|1|||
42224106|NCT02965820|76042957|FG001|Period 2, Second 30 Days|Adverse Event|1|||
42224107|NCT03430895|76042963|FG000|Overall Study|Not Treated|2|||
42224108|NCT03452189|76042967|FG000|First Intervention (3 Months)|Adverse Event|1|||
42224109|NCT03452189|76042968|FG001|First Intervention (3 Months)|Adverse Event|0|||
42224110|NCT03452189|76042967|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
42224111|NCT03452189|76042968|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
42224112|NCT03451721|76042974|FG000|Overall Study|Death|1|||
42224113|NCT00603954|76042980|FG000|Overall Study|Protocol Violation|1|||
42224114|NCT00603954|76042981|FG001|Overall Study|Protocol Violation|2|||
42224115|NCT03427619|76042988|FG000|Overall Study|Physician Decision|3|||
42224116|NCT03427619|76042988|FG000|Overall Study|Withdrawal by Subject|4|||
42224117|NCT03427619|76042988|FG000|Overall Study|Lost to Follow-up|5|||
42224118|NCT03427619|76042988|FG000|Overall Study|Administrative|4|||
42224119|NCT03427619|76042988|FG000|Overall Study|Other|2|||
42224120|NCT03427619|76042988|FG000|Overall Study|Unknown or Missing Completion Status|48|||
42224121|NCT03407729|76042994|FG000|Overall Study|Lost to Follow-up|2|||
42224122|NCT03407729|76042995|FG001|Overall Study|Lost to Follow-up|0|||
42224123|NCT03407729|76042994|FG000|Overall Study|Unable to schedule|0|||
42224124|NCT03407729|76042995|FG001|Overall Study|Unable to schedule|3|||
42224125|NCT02435433|76043006|FG000|Overall Study|Withdrawal by Subject|2|||
42224126|NCT02435433|76043007|FG001|Overall Study|Withdrawal by Subject|3|||
42224127|NCT02435433|76043008|FG002|Overall Study|Withdrawal by Subject|1|||
42224128|NCT02435433|76043009|FG003|Overall Study|Withdrawal by Subject|0|||
42224129|NCT02435433|76043010|FG004|Overall Study|Withdrawal by Subject|0|||
42224130|NCT02435433|76043006|FG000|Overall Study|Lost to Follow-up|2|||
42224131|NCT02435433|76043007|FG001|Overall Study|Lost to Follow-up|2|||
42224132|NCT02435433|76043008|FG002|Overall Study|Lost to Follow-up|4|||
42224133|NCT02435433|76043009|FG003|Overall Study|Lost to Follow-up|1|||
42224134|NCT02435433|76043010|FG004|Overall Study|Lost to Follow-up|0|||
42131528|NCT00565409|75942407|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
42224135|NCT03120351|76043023|FG000|Overall Study|Physician Decision|1|||
42224136|NCT03120351|76043024|FG001|Overall Study|Physician Decision|1|||
42030000|NCT01157117|75838639|FG002|Overall Study|Lost to Follow-up|1|||
42131529|NCT00565409|75942408|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
42131530|NCT00565409|75942409|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
42131531|NCT00394251|75942421|FG000|Overall Study|Adverse Event|7|||
42131532|NCT00394251|75942422|FG001|Overall Study|Adverse Event|5|||
42131533|NCT00394251|75942421|FG000|Overall Study|Unacceptable Toxicity|20|||
42131534|NCT00394251|75942422|FG001|Overall Study|Unacceptable Toxicity|18|||
42131535|NCT00394251|75942421|FG000|Overall Study|Physician Decision|1|||
42131536|NCT00394251|75942422|FG001|Overall Study|Physician Decision|1|||
42131537|NCT00394251|75942421|FG000|Overall Study|Protocol Violation|0|||
42224137|NCT02354703|76043034|FG000|Overall Study|Withdrawal by Subject|1|||
42224138|NCT02354703|76043035|FG001|Overall Study|Withdrawal by Subject|1|||
42224139|NCT02354703|76043036|FG002|Overall Study|Withdrawal by Subject|1|||
42224140|NCT02354703|76043037|FG003|Overall Study|Withdrawal by Subject|1|||
42224141|NCT02354703|76043034|FG000|Overall Study|Lost to Follow-up|2|||
42224142|NCT02354703|76043035|FG001|Overall Study|Lost to Follow-up|7|||
42224143|NCT02354703|76043036|FG002|Overall Study|Lost to Follow-up|9|||
42224144|NCT02354703|76043037|FG003|Overall Study|Lost to Follow-up|2|||
42030001|NCT01157117|75838637|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
42030002|NCT01157117|75838638|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
42030003|NCT01157117|75838639|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
42030004|NCT00891202|75838649|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
42030005|NCT00891202|75838650|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
42030006|NCT00891202|75838651|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
42030007|NCT00891202|75838652|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
42030008|NCT00891202|75838649|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
42030009|NCT00891202|75838650|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
42030010|NCT00891202|75838651|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
42030011|NCT00891202|75838652|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
42030012|NCT00891202|75838649|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
42224145|NCT02354703|76043034|FG000|Overall Study|Adverse Event|0|||
42224146|NCT02354703|76043035|FG001|Overall Study|Adverse Event|0|||
42224147|NCT02354703|76043036|FG002|Overall Study|Adverse Event|1|||
42224148|NCT02354703|76043037|FG003|Overall Study|Adverse Event|0|||
42224149|NCT00384111|76043053|FG000|Overall Study|Disease Progression|3|||
42224150|NCT00384111|76043053|FG000|Overall Study|Adverse Event|1|||
42224151|NCT00384111|76043053|FG000|Overall Study|Investigator Decision|3|||
42224152|NCT00384111|76043053|FG000|Overall Study|Study Terminated by the Sponsor|19|||
42224153|NCT03113409|76043057|FG000|Overall Study|Withdrawal by Subject|5|||
42224154|NCT03113409|76043058|FG001|Overall Study|Withdrawal by Subject|0|||
42224155|NCT03113409|76043059|FG002|Overall Study|Withdrawal by Subject|0|||
42224156|NCT01319877|76043065|FG000|Overall Study|Lost to Follow-up|100|||
42224157|NCT01319877|76043066|FG001|Overall Study|Lost to Follow-up|37|||
42224158|NCT01319877|76043065|FG000|Overall Study|Physician Decision|2|||
42224159|NCT01319877|76043066|FG001|Overall Study|Physician Decision|0|||
42224160|NCT01319877|76043065|FG000|Overall Study|Disease Progression|2|||
42224161|NCT01319877|76043066|FG001|Overall Study|Disease Progression|2|||
42224162|NCT01319877|76043065|FG000|Overall Study|Withdrawal by Subject|0|||
41983432|NCT01055457|75789702|FG008|Overall Study|Discomfort|0|||
41983433|NCT01055457|75789703|FG009|Overall Study|Discomfort|0|||
41983434|NCT01055457|75789694|FG000|Overall Study|Pregnancy|0|||
41983435|NCT01055457|75789695|FG001|Overall Study|Pregnancy|0|||
41983436|NCT01055457|75789696|FG002|Overall Study|Pregnancy|0|||
41983437|NCT01055457|75789697|FG003|Overall Study|Pregnancy|1|||
41983438|NCT01055457|75789698|FG004|Overall Study|Pregnancy|0|||
41983439|NCT01055457|75789699|FG005|Overall Study|Pregnancy|0|||
41983440|NCT01055457|75789700|FG006|Overall Study|Pregnancy|0|||
42030013|NCT00891202|75838650|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
42030014|NCT00891202|75838651|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
42030015|NCT00891202|75838652|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
42030016|NCT00891202|75838649|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
42224163|NCT01319877|76043066|FG001|Overall Study|Withdrawal by Subject|1|||
41983441|NCT01055457|75789701|FG007|Overall Study|Pregnancy|0|||
41983442|NCT01055457|75789702|FG008|Overall Study|Pregnancy|0|||
41983443|NCT01055457|75789703|FG009|Overall Study|Pregnancy|0|||
41983444|NCT01055457|75789694|FG000|Overall Study|Adverse Event|0|||
41983445|NCT01055457|75789695|FG001|Overall Study|Adverse Event|0|||
41983446|NCT01055457|75789696|FG002|Overall Study|Adverse Event|0|||
41983447|NCT01055457|75789697|FG003|Overall Study|Adverse Event|1|||
41983448|NCT01055457|75789698|FG004|Overall Study|Adverse Event|0|||
41983449|NCT01055457|75789699|FG005|Overall Study|Adverse Event|0|||
41983450|NCT01055457|75789700|FG006|Overall Study|Adverse Event|0|||
42224164|NCT01319877|76043065|FG000|Overall Study|Reason Not Specified|4|||
41983451|NCT01055457|75789701|FG007|Overall Study|Adverse Event|0|||
41983452|NCT01055457|75789702|FG008|Overall Study|Adverse Event|0|||
42224165|NCT01319877|76043066|FG001|Overall Study|Reason Not Specified|5|||
41983453|NCT01055457|75789703|FG009|Overall Study|Adverse Event|0|||
41983454|NCT01055028|75789727|FG000|Screening|Screen Failure|1|||
41983455|NCT01055028|75789728|FG001|Screening|Screen Failure|1|||
41983456|NCT01055028|75789727|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
42030017|NCT00891202|75838650|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
42224166|NCT03427073|76043079|FG000|Overall Study|Disease Progression|1|||
42224167|NCT03427073|76043080|FG001|Overall Study|Disease Progression|1|||
41983457|NCT01055028|75789728|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
41983458|NCT01055028|75789727|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
41983459|NCT01055028|75789728|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
41983460|NCT01055028|75789727|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
41983461|NCT01055028|75789728|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
41983462|NCT01050816|75789760|FG000|Overall Study|Lost to Follow-up|2|||
41983463|NCT01050816|75789760|FG000|Overall Study|patient's refusal|2|||
41983464|NCT01054560|75789766|FG000|Overall Study|Death|10|||
41983465|NCT01054560|75789767|FG001|Overall Study|Death|21|||
41983466|NCT01054560|75789766|FG000|Overall Study|Lost to Follow-up|2|||
41983467|NCT01054560|75789767|FG001|Overall Study|Lost to Follow-up|5|||
41983468|NCT01054560|75789766|FG000|Overall Study|Withdrawal by Subject|0|||
41983469|NCT01054560|75789767|FG001|Overall Study|Withdrawal by Subject|2|||
41983470|NCT01054560|75789766|FG000|Overall Study|Physician Decision|1|||
41983471|NCT01054560|75789767|FG001|Overall Study|Physician Decision|0|||
41983472|NCT01054443|75789779|FG000|Overall Study|Withdrawal by Subject|0|||
41983473|NCT01054443|75789780|FG001|Overall Study|Withdrawal by Subject|0|||
41983474|NCT01054443|75789781|FG002|Overall Study|Withdrawal by Subject|0|||
42030018|NCT00891202|75838651|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
42030019|NCT00891202|75838652|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
42030020|NCT01185509|75838662|FG000|Overall Study|Progression/Relapse|9|||
42030021|NCT01185509|75838663|FG001|Overall Study|Progression/Relapse|15|||
42030022|NCT01185509|75838662|FG000|Overall Study|Physician Decision|2|||
42030023|NCT01185509|75838663|FG001|Overall Study|Physician Decision|2|||
42030024|NCT01185509|75838662|FG000|Overall Study|Withdrawal by Subject|0|||
42030025|NCT01185509|75838663|FG001|Overall Study|Withdrawal by Subject|1|||
42030026|NCT01185509|75838662|FG000|Overall Study|Death|0|||
42030027|NCT01185509|75838663|FG001|Overall Study|Death|1|||
42030028|NCT01185509|75838662|FG000|Overall Study|Intercurrent Illness|0|||
42030029|NCT01185509|75838663|FG001|Overall Study|Intercurrent Illness|1|||
42030030|NCT00891046|75838675|FG000|Overall Study|Protocol Violation|1|||
42030031|NCT00891046|75838676|FG001|Overall Study|Protocol Violation|1|||
42030032|NCT00891046|75838677|FG002|Overall Study|Protocol Violation|0|||
42030033|NCT00891046|75838678|FG003|Overall Study|Protocol Violation|0|||
42030034|NCT00891046|75838679|FG004|Overall Study|Protocol Violation|1|||
42030035|NCT00891046|75838675|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
42030036|NCT00891046|75838676|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42030037|NCT00891046|75838677|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
42030038|NCT00891046|75838678|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
42030039|NCT00891046|75838679|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
42030040|NCT00891046|75838675|FG000|Overall Study|Administrative problems|0|||
42030041|NCT00891046|75838676|FG001|Overall Study|Administrative problems|0|||
42030042|NCT00891046|75838677|FG002|Overall Study|Administrative problems|0|||
42030043|NCT00891046|75838678|FG003|Overall Study|Administrative problems|0|||
42030044|NCT00891046|75838679|FG004|Overall Study|Administrative problems|1|||
42030045|NCT00891046|75838675|FG000|Overall Study|Participant no longer required drug|0|||
42030046|NCT00891046|75838676|FG001|Overall Study|Participant no longer required drug|2|||
42030047|NCT00891046|75838677|FG002|Overall Study|Participant no longer required drug|0|||
41983475|NCT01054443|75789782|FG003|Overall Study|Withdrawal by Subject|1|||
41983476|NCT01050543|75789797|FG000|Overall Study|Withdrawal by Subject|0|||
41983477|NCT01050543|75789798|FG001|Overall Study|Withdrawal by Subject|2|||
41983478|NCT01050543|75789797|FG000|Overall Study|Protocol Violation|0|||
41983479|NCT01050543|75789798|FG001|Overall Study|Protocol Violation|1|||
41983480|NCT01050543|75789797|FG000|Overall Study|Administrative|4|||
41983481|NCT01050543|75789798|FG001|Overall Study|Administrative|1|||
41983482|NCT01051557|75789811|FG000|Overall Study|Physician Decision|1|||
41983483|NCT01051557|75789812|FG001|Overall Study|Physician Decision|0|||
41983484|NCT01051557|75789813|FG002|Overall Study|Physician Decision|0|||
41983485|NCT01051557|75789814|FG003|Overall Study|Physician Decision|0|||
41983486|NCT01051557|75789815|FG004|Overall Study|Physician Decision|0|||
41983487|NCT01051557|75789816|FG005|Overall Study|Physician Decision|0|||
42030048|NCT00891046|75838678|FG003|Overall Study|Participant no longer required drug|0|||
42030049|NCT00891046|75838679|FG004|Overall Study|Participant no longer required drug|1|||
42030050|NCT00891046|75838675|FG000|Overall Study|Adverse Event|4|||
42030051|NCT00891046|75838676|FG001|Overall Study|Adverse Event|3|||
42030052|NCT00891046|75838677|FG002|Overall Study|Adverse Event|2|||
42030053|NCT00891046|75838678|FG003|Overall Study|Adverse Event|0|||
42302308|NCT02516605|76137429|FG000|Overall Study|Withdrawal by Subject|0|||
42030054|NCT00891046|75838679|FG004|Overall Study|Adverse Event|14|||
42030055|NCT00891046|75838675|FG000|Overall Study|Withdrawal by Subject|2|||
42302309|NCT02516605|76137430|FG001|Overall Study|Withdrawal by Subject|0|||
41983488|NCT01051557|75789817|FG006|Overall Study|Physician Decision|0|||
41983489|NCT01051557|75789811|FG000|Overall Study|disease progression|3|||
41983490|NCT01051557|75789812|FG001|Overall Study|disease progression|3|||
41983491|NCT01051557|75789813|FG002|Overall Study|disease progression|5|||
42030056|NCT00891046|75838676|FG001|Overall Study|Withdrawal by Subject|1|||
42302310|NCT02516605|76137431|FG002|Overall Study|Withdrawal by Subject|0|||
41983492|NCT01051557|75789814|FG003|Overall Study|disease progression|2|||
41983493|NCT01051557|75789815|FG004|Overall Study|disease progression|4|||
41983494|NCT01051557|75789816|FG005|Overall Study|disease progression|3|||
41983495|NCT01051557|75789817|FG006|Overall Study|disease progression|1|||
41983496|NCT01051557|75789811|FG000|Overall Study|Withdrawal by Subject|0|||
41983497|NCT01051557|75789812|FG001|Overall Study|Withdrawal by Subject|0|||
41983498|NCT01051557|75789813|FG002|Overall Study|Withdrawal by Subject|1|||
41983499|NCT01051557|75789814|FG003|Overall Study|Withdrawal by Subject|0|||
41983500|NCT01051557|75789815|FG004|Overall Study|Withdrawal by Subject|2|||
41983501|NCT01051557|75789816|FG005|Overall Study|Withdrawal by Subject|0|||
41983502|NCT01051557|75789817|FG006|Overall Study|Withdrawal by Subject|1|||
41983503|NCT01051557|75789811|FG000|Overall Study|Adverse Event|0|||
41983504|NCT01051557|75789812|FG001|Overall Study|Adverse Event|0|||
41983505|NCT01051557|75789813|FG002|Overall Study|Adverse Event|0|||
41983506|NCT01051557|75789814|FG003|Overall Study|Adverse Event|1|||
41983507|NCT01051557|75789815|FG004|Overall Study|Adverse Event|1|||
41983508|NCT01051557|75789816|FG005|Overall Study|Adverse Event|3|||
41983509|NCT01051557|75789817|FG006|Overall Study|Adverse Event|4|||
41983510|NCT01054170|75789836|FG000|Overall Study|Protocol Violation|1|||
41983511|NCT01054170|75789837|FG001|Overall Study|Protocol Violation|0|||
41983512|NCT01054170|75789836|FG000|Overall Study|Withdrawal by Subject|3|||
41983513|NCT01054170|75789837|FG001|Overall Study|Withdrawal by Subject|2|||
41983514|NCT01054170|75789836|FG000|Overall Study|Adverse Event|0|||
41983515|NCT01054170|75789837|FG001|Overall Study|Adverse Event|4|||
41983516|NCT01053741|75789845|FG000|2nd Study Intervention|Physician Decision|0|||
41983517|NCT01053741|75789846|FG001|2nd Study Intervention|Physician Decision|1|||
41983518|NCT01052493|75789852|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
41983519|NCT01052493|75789853|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
41983520|NCT01052493|75789854|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
41983521|NCT01052103|75789869|FG000|Overall Study|Adverse Event|10|||
41983522|NCT01052103|75789870|FG001|Overall Study|Adverse Event|6|||
41983523|NCT01052103|75789869|FG000|Overall Study|Entry Criteria Not Met|3|||
41983524|NCT01052103|75789870|FG001|Overall Study|Entry Criteria Not Met|1|||
41983525|NCT01052103|75789869|FG000|Overall Study|Lost to Follow-up|3|||
41983526|NCT01052103|75789870|FG001|Overall Study|Lost to Follow-up|5|||
41983527|NCT01052103|75789869|FG000|Overall Study|Protocol Violation|10|||
41983528|NCT01052103|75789870|FG001|Overall Study|Protocol Violation|4|||
41983529|NCT01052103|75789869|FG000|Overall Study|Scheduling conflict|2|||
42224168|NCT03427073|76043081|FG002|Overall Study|Disease Progression|1|||
42224169|NCT03427073|76043082|FG003|Overall Study|Disease Progression|3|||
42224170|NCT03427073|76043083|FG004|Overall Study|Disease Progression|3|||
42224171|NCT03427073|76043084|FG005|Overall Study|Disease Progression|4|||
42224172|NCT03427073|76043085|FG006|Overall Study|Disease Progression|2|||
42224173|NCT03427073|76043086|FG007|Overall Study|Disease Progression|3|||
42224174|NCT03427073|76043079|FG000|Overall Study|Physician Decision|0|||
42224175|NCT03427073|76043080|FG001|Overall Study|Physician Decision|0|||
42224176|NCT03427073|76043081|FG002|Overall Study|Physician Decision|0|||
42224177|NCT03427073|76043082|FG003|Overall Study|Physician Decision|0|||
42224178|NCT03427073|76043083|FG004|Overall Study|Physician Decision|0|||
42224179|NCT03427073|76043084|FG005|Overall Study|Physician Decision|0|||
42224180|NCT03427073|76043085|FG006|Overall Study|Physician Decision|1|||
42224181|NCT03427073|76043086|FG007|Overall Study|Physician Decision|1|||
42224182|NCT03066804|76043106|FG000|Overall Study|Physician Decision|0|||
42224183|NCT03066804|76043107|FG001|Overall Study|Physician Decision|4|||
42224184|NCT03066804|76043106|FG000|Overall Study|Death|23|||
42224185|NCT03066804|76043107|FG001|Overall Study|Death|17|||
42224186|NCT03066804|76043106|FG000|Overall Study|Withdrawal by Subject|19|||
42224187|NCT03066804|76043107|FG001|Overall Study|Withdrawal by Subject|25|||
42224188|NCT03066804|76043106|FG000|Overall Study|Lost to Follow-up|2|||
42224189|NCT03066804|76043107|FG001|Overall Study|Lost to Follow-up|0|||
42224190|NCT03066804|76043106|FG000|Overall Study|Adverse Event|2|||
42224191|NCT03066804|76043107|FG001|Overall Study|Adverse Event|3|||
41983530|NCT01052103|75789870|FG001|Overall Study|Scheduling conflict|1|||
41983531|NCT01052103|75789869|FG000|Overall Study|Sponsor Decision|2|||
41983532|NCT01052103|75789870|FG001|Overall Study|Sponsor Decision|0|||
42224192|NCT03066804|76043106|FG000|Overall Study|Technical problems|5|||
42224193|NCT03066804|76043107|FG001|Overall Study|Technical problems|1|||
42224194|NCT02954237|76043114|FG000|Overall Study|Withdrawal by Subject|25|||
42224195|NCT02954237|76043114|FG000|Overall Study|Missed visit|16|||
42224196|NCT02954237|76043114|FG000|Overall Study|Death|2|||
42302311|NCT02516605|76137432|FG003|Overall Study|Withdrawal by Subject|1|||
42224197|NCT04250337|76043120|FG000|Overall Study|Adverse Event|0|||
42224198|NCT04250337|76043121|FG001|Overall Study|Adverse Event|3|||
41983533|NCT01052103|75789869|FG000|Overall Study|Withdrawal by Subject|3|||
41983534|NCT01052103|75789870|FG001|Overall Study|Withdrawal by Subject|6|||
41983535|NCT01052103|75789869|FG000|Overall Study|Perceived Lack of Efficacy|1|||
41983536|NCT01052103|75789870|FG001|Overall Study|Perceived Lack of Efficacy|0|||
41983537|NCT01051986|75789879|FG000|Overall Study|Death|1|||
41983538|NCT01051986|75789880|FG001|Overall Study|Death|0|||
41983539|NCT01051986|75789879|FG000|Overall Study|Withdrawal by Subject|2|||
41983540|NCT01051986|75789880|FG001|Overall Study|Withdrawal by Subject|1|||
42224199|NCT04250337|76043120|FG000|Overall Study|Lack of Efficacy|1|||
42030057|NCT00891046|75838677|FG002|Overall Study|Withdrawal by Subject|2|||
42030058|NCT00891046|75838678|FG003|Overall Study|Withdrawal by Subject|1|||
42030059|NCT00891046|75838679|FG004|Overall Study|Withdrawal by Subject|1|||
42030060|NCT00891046|75838675|FG000|Overall Study|Lost to Follow-up|0|||
42030061|NCT00891046|75838676|FG001|Overall Study|Lost to Follow-up|0|||
42030062|NCT00891046|75838677|FG002|Overall Study|Lost to Follow-up|0|||
42030063|NCT00891046|75838678|FG003|Overall Study|Lost to Follow-up|0|||
42030064|NCT00891046|75838679|FG004|Overall Study|Lost to Follow-up|1|||
42030065|NCT00889720|75838706|FG000|Overall Study|Withdrawal by Subject|4|||
42030066|NCT00889720|75838706|FG000|Overall Study|Other|4|||
42030067|NCT00880087|75838712|FG000|Overall Study|Lost to Follow-up|0|||
42030068|NCT00880087|75838713|FG001|Overall Study|Lost to Follow-up|2|||
42030069|NCT00889252|75838721|FG000|Overall Study|Adverse Event|2|||
42030070|NCT00889252|75838722|FG001|Overall Study|Adverse Event|4|||
42030071|NCT00889252|75838721|FG000|Overall Study|Withdrawal by Subject|3|||
42030072|NCT00889252|75838722|FG001|Overall Study|Withdrawal by Subject|0|||
42030073|NCT00889252|75838721|FG000|Overall Study|Protocol Violation|2|||
42030074|NCT00889252|75838722|FG001|Overall Study|Protocol Violation|0|||
42030075|NCT01110330|75838731|FG000|Overall Study|Adverse Event|0|||
42030076|NCT01110330|75838732|FG001|Overall Study|Adverse Event|4|||
42030077|NCT01110330|75838733|FG002|Overall Study|Adverse Event|3|||
42030078|NCT01110330|75838731|FG000|Overall Study|Lack of Efficacy|3|||
42030079|NCT01110330|75838732|FG001|Overall Study|Lack of Efficacy|1|||
42030080|NCT01110330|75838733|FG002|Overall Study|Lack of Efficacy|1|||
42030081|NCT01110330|75838731|FG000|Overall Study|Lost to Follow-up|9|||
42030082|NCT01110330|75838732|FG001|Overall Study|Lost to Follow-up|10|||
42030083|NCT01110330|75838733|FG002|Overall Study|Lost to Follow-up|15|||
42030084|NCT01110330|75838731|FG000|Overall Study|Physician Decision|0|||
42030085|NCT01110330|75838732|FG001|Overall Study|Physician Decision|1|||
42030086|NCT01110330|75838733|FG002|Overall Study|Physician Decision|0|||
42224200|NCT04250337|76043121|FG001|Overall Study|Lack of Efficacy|3|||
42224201|NCT04250337|76043120|FG000|Overall Study|Physician Decision|1|||
42224202|NCT04250337|76043121|FG001|Overall Study|Physician Decision|0|||
42224203|NCT04250337|76043120|FG000|Overall Study|Protocol Deviation|2|||
42224204|NCT04250337|76043121|FG001|Overall Study|Protocol Deviation|2|||
42224205|NCT04250337|76043120|FG000|Overall Study|Withdrawal by Subject|4|||
42224206|NCT04250337|76043121|FG001|Overall Study|Withdrawal by Subject|3|||
42224207|NCT03118947|76043128|FG000|Overall Study|Adverse Event|7|||
42224208|NCT03118947|76043128|FG000|Overall Study|Death|3|||
42224209|NCT03118947|76043128|FG000|Overall Study|Lack of Efficacy|4|||
42224210|NCT03118947|76043128|FG000|Overall Study|Non-compliance with study drug|1|||
42224211|NCT03118947|76043128|FG000|Overall Study|Protocol Violation|2|||
41983541|NCT01051986|75789879|FG000|Overall Study|Protocol Violation|2|||
41983542|NCT01051986|75789880|FG001|Overall Study|Protocol Violation|3|||
41983543|NCT03279978|75789896|FG000|Overall Study|Withdrawal by Subject|0|||
41983544|NCT03279978|75789897|FG001|Overall Study|Withdrawal by Subject|1|||
41983545|NCT03279978|75789898|FG002|Overall Study|Withdrawal by Subject|0|||
41983546|NCT03279978|75789899|FG003|Overall Study|Withdrawal by Subject|0|||
41983547|NCT03279978|75789900|FG004|Overall Study|Withdrawal by Subject|0|||
41983548|NCT03279978|75789901|FG005|Overall Study|Withdrawal by Subject|0|||
41983549|NCT03279978|75789902|FG006|Overall Study|Withdrawal by Subject|0|||
41983550|NCT03279978|75789903|FG007|Overall Study|Withdrawal by Subject|0|||
41983551|NCT03279978|75789904|FG008|Overall Study|Withdrawal by Subject|0|||
41983552|NCT03279978|75789905|FG009|Overall Study|Withdrawal by Subject|1|||
42030087|NCT01110330|75838731|FG000|Overall Study|Protocol Violation|2|||
42030088|NCT01110330|75838732|FG001|Overall Study|Protocol Violation|0|||
42030089|NCT01110330|75838733|FG002|Overall Study|Protocol Violation|4|||
42030090|NCT01110330|75838731|FG000|Overall Study|Withdrawal by Subject|0|||
42030091|NCT01110330|75838732|FG001|Overall Study|Withdrawal by Subject|6|||
42030092|NCT01110330|75838733|FG002|Overall Study|Withdrawal by Subject|2|||
42030093|NCT01110330|75838731|FG000|Overall Study|Other|1|||
42131538|NCT00394251|75942422|FG001|Overall Study|Protocol Violation|1|||
42131539|NCT00394251|75942421|FG000|Overall Study|Withdrawal by Subject|7|||
42131540|NCT00394251|75942422|FG001|Overall Study|Withdrawal by Subject|11|||
42131541|NCT00394251|75942421|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
42131542|NCT00394251|75942422|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
42131543|NCT00394095|75942434|FG000|Overall Study|Adverse Event|1|||
42131544|NCT00394095|75942435|FG001|Overall Study|Adverse Event|0|||
42131545|NCT00503906|75942442|FG000|Overall Study|Withdrawal by Subject|1|||
42131546|NCT00305110|75942447|FG000|Overall Study|Missing data|29|||
42131547|NCT00491894|75942451|FG000|Overall Study|Adverse Event|14|||
42131548|NCT00491894|75942451|FG000|Overall Study|Withdrawal by Subject|5|||
42131549|NCT00491894|75942451|FG000|Overall Study|Death|3|||
42131550|NCT00491894|75942451|FG000|Overall Study|Lost to Follow-up|3|||
42224212|NCT03118947|76043128|FG000|Overall Study|Withdrawal by Subject|3|||
42030094|NCT01110330|75838732|FG001|Overall Study|Other|1|||
42131551|NCT00491894|75942451|FG000|Overall Study|Lack of Efficacy|2|||
42224213|NCT03118947|76043128|FG000|Overall Study|Withdrawal by caregiver|3|||
42224214|NCT03118947|76043128|FG000|Overall Study|Change in patient's living situation|4|||
41983553|NCT03279978|75789896|FG000|Overall Study|Lost to Follow-up|1|||
41983554|NCT03279978|75789897|FG001|Overall Study|Lost to Follow-up|0|||
41983555|NCT03279978|75789898|FG002|Overall Study|Lost to Follow-up|1|||
41983556|NCT03279978|75789899|FG003|Overall Study|Lost to Follow-up|0|||
41983557|NCT03279978|75789900|FG004|Overall Study|Lost to Follow-up|0|||
41983558|NCT03279978|75789901|FG005|Overall Study|Lost to Follow-up|0|||
41983559|NCT03279978|75789902|FG006|Overall Study|Lost to Follow-up|0|||
41983560|NCT03279978|75789903|FG007|Overall Study|Lost to Follow-up|0|||
41983561|NCT03279978|75789904|FG008|Overall Study|Lost to Follow-up|0|||
41983562|NCT03279978|75789905|FG009|Overall Study|Lost to Follow-up|0|||
41983563|NCT03279978|75789896|FG000|Overall Study|Other than stated above|0|||
42030095|NCT01110330|75838733|FG002|Overall Study|Other|1|||
42030096|NCT00596947|75838743|FG000|Overall Study|study halted due to low enrollment|5|||
42030097|NCT00596947|75838744|FG001|Overall Study|study halted due to low enrollment|3|||
42030098|NCT00596947|75838743|FG000|Overall Study|Lost to Follow-up|1|||
42030099|NCT00596947|75838744|FG001|Overall Study|Lost to Follow-up|0|||
42030100|NCT00888940|75838752|FG000|Overall Study|Adverse Event|12|||
42030101|NCT00888940|75838753|FG001|Overall Study|Adverse Event|3|||
42030102|NCT00888940|75838752|FG000|Overall Study|Lost to Follow-up|5|||
42030103|NCT00888940|75838753|FG001|Overall Study|Lost to Follow-up|5|||
42030104|NCT00888940|75838752|FG000|Overall Study|Randomized Not Treated|11|||
42030105|NCT00888940|75838753|FG001|Overall Study|Randomized Not Treated|13|||
42030106|NCT00595621|75838761|FG000|Open Label Run in|Adverse Event|1|||
42030107|NCT00595621|75838762|FG001|Open Label Run in|Adverse Event|0|||
42030108|NCT00595621|75838761|FG000|Open Label Run in|Physician Decision|1|||
42030109|NCT00595621|75838762|FG001|Open Label Run in|Physician Decision|0|||
42030110|NCT00595621|75838761|FG000|Open Label Run in|Withdrawal by Subject|1|||
42030111|NCT00595621|75838762|FG001|Open Label Run in|Withdrawal by Subject|0|||
42030112|NCT00595621|75838761|FG000|Randomization and Study|Adverse Event|2|||
42030113|NCT00595621|75838762|FG001|Randomization and Study|Adverse Event|0|||
42030114|NCT00595621|75838761|FG000|Randomization and Study|Withdrawal by Subject|0|||
42030115|NCT00595621|75838762|FG001|Randomization and Study|Withdrawal by Subject|1|||
42030116|NCT00888238|75838769|FG000|Washout Period After Period 2|Adverse Event|0|||
42030117|NCT00888238|75838770|FG001|Washout Period After Period 2|Adverse Event|0|||
42030118|NCT00888238|75838771|FG002|Washout Period After Period 2|Adverse Event|1|||
42030119|NCT00595465|75838780|FG000|Overall Study|Adverse Event|4|||
42030120|NCT00595465|75838781|FG001|Overall Study|Adverse Event|3|||
42030121|NCT00595465|75838782|FG002|Overall Study|Adverse Event|3|||
42030122|NCT00595465|75838780|FG000|Overall Study|Pregnancy|0|||
42030123|NCT00595465|75838781|FG001|Overall Study|Pregnancy|0|||
42030124|NCT00595465|75838782|FG002|Overall Study|Pregnancy|1|||
42030125|NCT00595465|75838780|FG000|Overall Study|Protocol Violation|2|||
42030126|NCT00595465|75838781|FG001|Overall Study|Protocol Violation|1|||
42030127|NCT00595465|75838782|FG002|Overall Study|Protocol Violation|0|||
42030128|NCT00595465|75838780|FG000|Overall Study|Lost to Follow-up|0|||
42030129|NCT00595465|75838781|FG001|Overall Study|Lost to Follow-up|0|||
42030130|NCT00595465|75838782|FG002|Overall Study|Lost to Follow-up|2|||
42030131|NCT00595465|75838780|FG000|Overall Study|administrative reason|0|||
42030132|NCT00595465|75838781|FG001|Overall Study|administrative reason|0|||
42030133|NCT00595465|75838782|FG002|Overall Study|administrative reason|1|||
42030134|NCT01205438|75838793|FG000|Overall Study|Adverse Event|19|||
42030135|NCT01205438|75838794|FG001|Overall Study|Adverse Event|17|||
42030136|NCT01205438|75838795|FG002|Overall Study|Adverse Event|24|||
42030137|NCT01205438|75838793|FG000|Overall Study|Death|1|||
42030138|NCT01205438|75838794|FG001|Overall Study|Death|1|||
41983564|NCT03279978|75789897|FG001|Overall Study|Other than stated above|0|||
41983565|NCT03279978|75789898|FG002|Overall Study|Other than stated above|0|||
41983566|NCT03279978|75789899|FG003|Overall Study|Other than stated above|0|||
41983567|NCT03279978|75789900|FG004|Overall Study|Other than stated above|0|||
41983568|NCT03279978|75789901|FG005|Overall Study|Other than stated above|0|||
42030139|NCT01205438|75838795|FG002|Overall Study|Death|3|||
42030140|NCT01205438|75838793|FG000|Overall Study|Entry Criteria Not Met|16|||
42030141|NCT01205438|75838794|FG001|Overall Study|Entry Criteria Not Met|15|||
42030142|NCT01205438|75838795|FG002|Overall Study|Entry Criteria Not Met|13|||
42030143|NCT01205438|75838793|FG000|Overall Study|Lack of Efficacy|14|||
42030144|NCT01205438|75838794|FG001|Overall Study|Lack of Efficacy|11|||
42030145|NCT01205438|75838795|FG002|Overall Study|Lack of Efficacy|14|||
42030146|NCT01205438|75838793|FG000|Overall Study|Lost to Follow-up|6|||
42030147|NCT01205438|75838794|FG001|Overall Study|Lost to Follow-up|7|||
42030148|NCT01205438|75838795|FG002|Overall Study|Lost to Follow-up|8|||
42030149|NCT01205438|75838793|FG000|Overall Study|Withdrawal by Subject|19|||
42030150|NCT01205438|75838794|FG001|Overall Study|Withdrawal by Subject|25|||
42030151|NCT01205438|75838795|FG002|Overall Study|Withdrawal by Subject|19|||
42030152|NCT01205438|75838793|FG000|Overall Study|Physician Decision|0|||
42030153|NCT01205438|75838794|FG001|Overall Study|Physician Decision|3|||
42030154|NCT01205438|75838795|FG002|Overall Study|Physician Decision|2|||
42030155|NCT01205438|75838793|FG000|Overall Study|Protocol Violation|2|||
42030156|NCT01205438|75838794|FG001|Overall Study|Protocol Violation|7|||
42030157|NCT01205438|75838795|FG002|Overall Study|Protocol Violation|4|||
42030158|NCT01205438|75838793|FG000|Overall Study|Sponsor Decision|0|||
42030159|NCT01205438|75838794|FG001|Overall Study|Sponsor Decision|1|||
42030160|NCT01205438|75838795|FG002|Overall Study|Sponsor Decision|1|||
42030161|NCT01104870|75838809|FG000|Overall Study|Adverse Event|1|||
42030162|NCT01104870|75838810|FG001|Overall Study|Adverse Event|1|||
42030163|NCT01104870|75838811|FG002|Overall Study|Adverse Event|0|||
42030164|NCT01104870|75838809|FG000|Overall Study|Death|0|||
42030165|NCT01104870|75838810|FG001|Overall Study|Death|0|||
42030166|NCT01104870|75838811|FG002|Overall Study|Death|1|||
42030167|NCT01104870|75838809|FG000|Overall Study|Withdrawal by Subject|0|||
42030168|NCT01104870|75838810|FG001|Overall Study|Withdrawal by Subject|0|||
42030169|NCT01104870|75838811|FG002|Overall Study|Withdrawal by Subject|1|||
41983569|NCT03279978|75789902|FG006|Overall Study|Other than stated above|1|||
41983570|NCT03279978|75789903|FG007|Overall Study|Other than stated above|0|||
41983571|NCT03279978|75789904|FG008|Overall Study|Other than stated above|0|||
41983572|NCT03279978|75789905|FG009|Overall Study|Other than stated above|0|||
41983573|NCT00105534|75789938|FG000|Overall Study|Adverse Event|2|||
41983574|NCT00105534|75789939|FG001|Overall Study|Adverse Event|5|||
41983575|NCT00105534|75789938|FG000|Overall Study|Protocol Violation|1|||
41983576|NCT00105534|75789939|FG001|Overall Study|Protocol Violation|4|||
41983577|NCT00105534|75789938|FG000|Overall Study|Withdrawal by Subject|6|||
41983578|NCT00105534|75789939|FG001|Overall Study|Withdrawal by Subject|6|||
42030170|NCT01104792|75838819|FG000|Overall Study|Adverse Event|77|||
42030171|NCT01104792|75838819|FG000|Overall Study|Insufficient Therapeutic Response|22|||
42030172|NCT01104792|75838819|FG000|Overall Study|Protocol Violation|45|||
42030173|NCT01104792|75838819|FG000|Overall Study|Withdrawal of Consent|179|||
42030174|NCT01104792|75838819|FG000|Overall Study|Lost to Follow-up|43|||
42030175|NCT01104792|75838819|FG000|Overall Study|Reasons Not Specified|27|||
42030176|NCT01104792|75838819|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
42030177|NCT01205126|75838825|FG000|Titration Phase|Adverse Event|5|||
42030178|NCT01205126|75838826|FG001|Titration Phase|Adverse Event|3|||
42030179|NCT01205126|75838825|FG000|Titration Phase|Withdrawal by Subject|5|||
42030180|NCT01205126|75838826|FG001|Titration Phase|Withdrawal by Subject|5|||
42030181|NCT01205126|75838825|FG000|Titration Phase|Lost to Follow-up|2|||
42030182|NCT01205126|75838826|FG001|Titration Phase|Lost to Follow-up|2|||
42030183|NCT01205126|75838825|FG000|Titration Phase|No stable titration dose|1|||
42030184|NCT01205126|75838826|FG001|Titration Phase|No stable titration dose|0|||
42030185|NCT01205126|75838825|FG000|Titration Phase|More than maximum dosage required|2|||
42030186|NCT01205126|75838826|FG001|Titration Phase|More than maximum dosage required|3|||
41983579|NCT00105534|75789938|FG000|Overall Study|Lost to Follow-up|5|||
41983580|NCT00105534|75789939|FG001|Overall Study|Lost to Follow-up|1|||
41983581|NCT00105534|75789938|FG000|Overall Study|Lack of Efficacy|7|||
42030187|NCT01205126|75838825|FG000|Titration Phase|Other|8|||
42030188|NCT01205126|75838826|FG001|Titration Phase|Other|6|||
42030189|NCT01205126|75838825|FG000|Between Titration & Maintenance Phase|Other|0|||
42030190|NCT01205126|75838826|FG001|Between Titration & Maintenance Phase|Other|4|||
42030191|NCT01205126|75838825|FG000|Maintenance Phase|Adverse Event|3|||
42030192|NCT01205126|75838826|FG001|Maintenance Phase|Adverse Event|7|||
42030193|NCT01205126|75838825|FG000|Maintenance Phase|Death|4|||
42030194|NCT01205126|75838826|FG001|Maintenance Phase|Death|4|||
42030195|NCT01205126|75838825|FG000|Maintenance Phase|More than the maximum dosage required|5|||
42030196|NCT01205126|75838826|FG001|Maintenance Phase|More than the maximum dosage required|5|||
42030197|NCT01205126|75838825|FG000|Maintenance Phase|Prohibited drugs used|1|||
42030198|NCT01205126|75838826|FG001|Maintenance Phase|Prohibited drugs used|0|||
42030199|NCT01205126|75838825|FG000|Maintenance Phase|Other|11|||
42030200|NCT01205126|75838826|FG001|Maintenance Phase|Other|8|||
42030201|NCT01205126|75838825|FG000|Maintenance Phase|Lost to Follow-up|5|||
42030202|NCT01205126|75838826|FG001|Maintenance Phase|Lost to Follow-up|5|||
42030203|NCT01205126|75838825|FG000|Maintenance Phase|Withdrawal by Subject|8|||
42030204|NCT01205126|75838826|FG001|Maintenance Phase|Withdrawal by Subject|11|||
42030205|NCT00946647|75838837|FG000|Phase 1 Part|Adverse Event|2|||
42030206|NCT00946647|75838838|FG001|Phase 1 Part|Adverse Event|5|||
42030207|NCT00946647|75838839|FG002|Phase 1 Part|Adverse Event|3|||
42030208|NCT00946647|75838840|FG003|Phase 1 Part|Adverse Event|0|||
42030209|NCT00946647|75838841|FG004|Phase 1 Part|Adverse Event|0|||
42030210|NCT00946647|75838837|FG000|Phase 1 Part|Disease progression|3|||
42030211|NCT00946647|75838838|FG001|Phase 1 Part|Disease progression|6|||
42030212|NCT00946647|75838839|FG002|Phase 1 Part|Disease progression|1|||
42030213|NCT00946647|75838840|FG003|Phase 1 Part|Disease progression|0|||
42030214|NCT00946647|75838841|FG004|Phase 1 Part|Disease progression|0|||
42030215|NCT00946647|75838837|FG000|Phase 1 Part|Withdrawal by Subject|1|||
42030216|NCT00946647|75838838|FG001|Phase 1 Part|Withdrawal by Subject|4|||
41983582|NCT00105534|75789939|FG001|Overall Study|Lack of Efficacy|15|||
41983583|NCT00105534|75789938|FG000|Overall Study|Treatment unmasked|1|||
41983584|NCT00105534|75789939|FG001|Overall Study|Treatment unmasked|0|||
41983585|NCT00105534|75789938|FG000|Overall Study|Other Reason|0|||
41983586|NCT00105534|75789939|FG001|Overall Study|Other Reason|2|||
41983587|NCT00105183|75789948|FG000|Overall Study|Death|19|||
41983588|NCT00105183|75789949|FG001|Overall Study|Death|13|||
41983589|NCT00105183|75789950|FG002|Overall Study|Death|15|||
42224215|NCT03118947|76043128|FG000|Overall Study|Lost to Follow-up|2|||
42224216|NCT03953079|76043135|FG000|Core Study|Withdrawal by Subject|1|||
42224217|NCT03953079|76043136|FG001|Core Study|Withdrawal by Subject|2|||
42224218|NCT03953079|76043137|FG002|Core Study|Withdrawal by Subject|1|||
42224219|NCT03953079|76043135|FG000|Core Study|COVID-19|0|||
41983590|NCT00105183|75789948|FG000|Overall Study|Withdrawal by Subject|1|||
41983591|NCT00105183|75789949|FG001|Overall Study|Withdrawal by Subject|1|||
41983592|NCT00105183|75789950|FG002|Overall Study|Withdrawal by Subject|4|||
42030217|NCT00946647|75838839|FG002|Phase 1 Part|Withdrawal by Subject|3|||
42030218|NCT00946647|75838840|FG003|Phase 1 Part|Withdrawal by Subject|0|||
42030219|NCT00946647|75838841|FG004|Phase 1 Part|Withdrawal by Subject|0|||
42030220|NCT00946647|75838837|FG000|Phase 1 Part|Abnormal values|0|||
42030221|NCT00946647|75838838|FG001|Phase 1 Part|Abnormal values|2|||
42030222|NCT00946647|75838839|FG002|Phase 1 Part|Abnormal values|0|||
42030223|NCT00946647|75838840|FG003|Phase 1 Part|Abnormal values|0|||
42030224|NCT00946647|75838841|FG004|Phase 1 Part|Abnormal values|0|||
42030225|NCT00946647|75838837|FG000|Phase 1 Part|Reason missing|0|||
42030226|NCT00946647|75838838|FG001|Phase 1 Part|Reason missing|1|||
41983593|NCT00105183|75789948|FG000|Overall Study|Physician Decision|1|||
41983594|NCT00105183|75789949|FG001|Overall Study|Physician Decision|2|||
41983595|NCT00105183|75789950|FG002|Overall Study|Physician Decision|3|||
41983596|NCT00105183|75789948|FG000|Overall Study|Lost to Follow-up|0|||
42030227|NCT00946647|75838839|FG002|Phase 1 Part|Reason missing|0|||
42030228|NCT00946647|75838840|FG003|Phase 1 Part|Reason missing|0|||
42030229|NCT00946647|75838841|FG004|Phase 1 Part|Reason missing|0|||
42030230|NCT00946647|75838837|FG000|Phase ll Part|Untreated|0|||
42224220|NCT03953079|76043136|FG001|Core Study|COVID-19|1|||
41983597|NCT00105183|75789949|FG001|Overall Study|Lost to Follow-up|1|||
41983598|NCT00105183|75789950|FG002|Overall Study|Lost to Follow-up|1|||
41983599|NCT00105183|75789948|FG000|Overall Study|Other reason|1|||
42030231|NCT00946647|75838838|FG001|Phase ll Part|Untreated|0|||
42030232|NCT00946647|75838839|FG002|Phase ll Part|Untreated|0|||
42030233|NCT00946647|75838840|FG003|Phase ll Part|Untreated|0|||
42224221|NCT03953079|76043137|FG002|Core Study|COVID-19|0|||
41983600|NCT00105183|75789949|FG001|Overall Study|Other reason|2|||
41983601|NCT00105183|75789950|FG002|Overall Study|Other reason|0|||
41983602|NCT01059617|75789962|FG000|Overall Study|Other|7|||
41983603|NCT01059617|75789963|FG001|Overall Study|Other|1|||
41983604|NCT01059617|75789964|FG002|Overall Study|Other|8|||
41983605|NCT01059617|75789965|FG003|Overall Study|Other|6|||
41983606|NCT01059344|75789985|FG000|Overall Study|Adverse Event|12|||
41983607|NCT01059344|75789986|FG001|Overall Study|Adverse Event|30|||
41983608|NCT01059344|75789985|FG000|Overall Study|Withdrawal by Subject|6|||
41983609|NCT01059344|75789986|FG001|Overall Study|Withdrawal by Subject|9|||
41983610|NCT01059344|75789985|FG000|Overall Study|Lost to Follow-up|1|||
41983611|NCT01059344|75789986|FG001|Overall Study|Lost to Follow-up|1|||
41983612|NCT01059344|75789985|FG000|Overall Study|Other|3|||
41983613|NCT01059344|75789986|FG001|Overall Study|Other|6|||
41983614|NCT01058369|75789994|FG000|Overall Study|Adverse Event|1|||
41983615|NCT01058369|75789994|FG000|Overall Study|Early termination study|1|||
41983616|NCT01057433|75789998|FG000|Overall Study|Adverse Event|1|||
41983617|NCT01057394|75790002|FG000|Overall Study|Not eligible|0|||
41983618|NCT01057394|75790003|FG001|Overall Study|Not eligible|2|||
41983619|NCT01058642|75790011|FG000|Treatment Period 1|Adverse Event|0|||
41983620|NCT01058642|75790012|FG001|Treatment Period 1|Adverse Event|1|||
41983621|NCT01058642|75790013|FG002|Treatment Period 1|Adverse Event|1|||
41983622|NCT01058642|75790014|FG003|Treatment Period 1|Adverse Event|0|||
41983623|NCT01058642|75790011|FG000|Treatment Period 1|Physician Decision|0|||
41983624|NCT01058642|75790012|FG001|Treatment Period 1|Physician Decision|0|||
41983625|NCT01058642|75790013|FG002|Treatment Period 1|Physician Decision|1|||
41983626|NCT01058642|75790014|FG003|Treatment Period 1|Physician Decision|0|||
41983627|NCT01058642|75790011|FG000|Treatment Period 1|Withdrawal by Subject|1|||
41983628|NCT01058642|75790012|FG001|Treatment Period 1|Withdrawal by Subject|0|||
41983629|NCT01058642|75790013|FG002|Treatment Period 1|Withdrawal by Subject|0|||
41983630|NCT01058642|75790014|FG003|Treatment Period 1|Withdrawal by Subject|0|||
41983631|NCT01058642|75790011|FG000|Treatment Period 1|Lack of Efficacy|0|||
41983632|NCT01058642|75790012|FG001|Treatment Period 1|Lack of Efficacy|0|||
41983633|NCT01058642|75790013|FG002|Treatment Period 1|Lack of Efficacy|0|||
41983634|NCT01058642|75790014|FG003|Treatment Period 1|Lack of Efficacy|1|||
41983635|NCT01058642|75790011|FG000|Treatment Period 1|Protocol Violation|0|||
41983636|NCT01058642|75790012|FG001|Treatment Period 1|Protocol Violation|0|||
41983637|NCT01058642|75790013|FG002|Treatment Period 1|Protocol Violation|0|||
41983638|NCT01058642|75790014|FG003|Treatment Period 1|Protocol Violation|1|||
41983639|NCT01058642|75790011|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
41983640|NCT01058642|75790012|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
41983641|NCT01058642|75790013|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
41983642|NCT01058642|75790014|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
41983643|NCT01056653|75790025|FG000|Overall Study|Lost to Follow-up|0|||
41983644|NCT01056653|75790026|FG001|Overall Study|Lost to Follow-up|0|||
41983645|NCT01056653|75790027|FG002|Overall Study|Lost to Follow-up|2|||
41983646|NCT01056536|75790039|FG000|Overall Study|Lost to Follow-up|202|||
41983647|NCT01056536|75790040|FG001|Overall Study|Lost to Follow-up|116|||
41983648|NCT01056536|75790041|FG002|Overall Study|Lost to Follow-up|248|||
41983649|NCT01056380|75790051|FG000|Overall Study|Lost to Follow-up|2|||
41983650|NCT01056380|75790052|FG001|Overall Study|Lost to Follow-up|3|||
41983651|NCT01055834|75790062|FG000|Treatment Period I|Adverse Event|1|||
41983652|NCT01055834|75790063|FG001|Treatment Period I|Adverse Event|0|||
41983653|NCT01055639|75790074|FG000|Overall Study|Adverse Event|0|||
41983654|NCT01055639|75790075|FG001|Overall Study|Adverse Event|1|||
41983655|NCT01055639|75790074|FG000|Overall Study|Lack of Efficacy|0|||
41983656|NCT01055639|75790075|FG001|Overall Study|Lack of Efficacy|1|||
41983657|NCT01055639|75790074|FG000|Overall Study|Lost to Follow-up|8|||
41983658|NCT01055639|75790075|FG001|Overall Study|Lost to Follow-up|11|||
41983659|NCT01055639|75790074|FG000|Overall Study|Protocol Violation|5|||
41983660|NCT01055639|75790075|FG001|Overall Study|Protocol Violation|5|||
41983661|NCT01055639|75790074|FG000|Overall Study|Withdrawal by Subject|8|||
41983662|NCT01055639|75790075|FG001|Overall Study|Withdrawal by Subject|11|||
41983663|NCT01055132|75790090|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
41983664|NCT01055132|75790091|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
41983665|NCT01055132|75790090|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
41983666|NCT01055132|75790091|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
41983667|NCT01054976|75790101|FG000|Overall Study|Adverse Event|16|||
41983668|NCT01054976|75790101|FG000|Overall Study|Uncooperative participations to study|7|||
41983669|NCT01054976|75790101|FG000|Overall Study|Withdrawal by Subject|4|||
41983670|NCT01054976|75790101|FG000|Overall Study|Other|8|||
41983671|NCT05490771|75790135|FG000|Overall Study|Disease progression|18|||
41983672|NCT05490771|75790135|FG000|Overall Study|Adverse Event|3|||
41983673|NCT05490771|75790135|FG000|Overall Study|Other complicating disease|1|||
41983674|NCT05490771|75790135|FG000|Overall Study|Withdrawal by Subject|3|||
42030234|NCT00946647|75838841|FG004|Phase ll Part|Untreated|2|||
42030235|NCT00946647|75838837|FG000|Phase ll Part|Adverse Event|0|||
42030236|NCT00946647|75838838|FG001|Phase ll Part|Adverse Event|0|||
42030237|NCT00946647|75838839|FG002|Phase ll Part|Adverse Event|0|||
42030238|NCT00946647|75838840|FG003|Phase ll Part|Adverse Event|10|||
42030239|NCT00946647|75838841|FG004|Phase ll Part|Adverse Event|6|||
42030240|NCT00946647|75838837|FG000|Phase ll Part|Withdrawal by Subject|0|||
42030241|NCT00946647|75838838|FG001|Phase ll Part|Withdrawal by Subject|0|||
42030242|NCT00946647|75838839|FG002|Phase ll Part|Withdrawal by Subject|0|||
42030243|NCT00946647|75838840|FG003|Phase ll Part|Withdrawal by Subject|8|||
42030244|NCT00946647|75838841|FG004|Phase ll Part|Withdrawal by Subject|6|||
42030245|NCT00946647|75838837|FG000|Phase ll Part|Administrative problems|0|||
42030246|NCT00946647|75838838|FG001|Phase ll Part|Administrative problems|0|||
42030247|NCT00946647|75838839|FG002|Phase ll Part|Administrative problems|0|||
42030248|NCT00946647|75838840|FG003|Phase ll Part|Administrative problems|3|||
42030249|NCT00946647|75838841|FG004|Phase ll Part|Administrative problems|8|||
42030250|NCT00946647|75838837|FG000|Phase ll Part|Death|0|||
42030251|NCT00946647|75838838|FG001|Phase ll Part|Death|0|||
42030252|NCT00946647|75838839|FG002|Phase ll Part|Death|0|||
42030253|NCT00946647|75838840|FG003|Phase ll Part|Death|7|||
42030254|NCT00946647|75838841|FG004|Phase ll Part|Death|4|||
42030255|NCT00946647|75838837|FG000|Phase ll Part|Disease progression|0|||
42030256|NCT00946647|75838838|FG001|Phase ll Part|Disease progression|0|||
42030257|NCT00946647|75838839|FG002|Phase ll Part|Disease progression|0|||
42030258|NCT00946647|75838840|FG003|Phase ll Part|Disease progression|6|||
42030259|NCT00946647|75838841|FG004|Phase ll Part|Disease progression|14|||
42030260|NCT00946647|75838837|FG000|Phase ll Part|Protocol Violation|0|||
42030261|NCT00946647|75838838|FG001|Phase ll Part|Protocol Violation|0|||
42030262|NCT00946647|75838839|FG002|Phase ll Part|Protocol Violation|0|||
42030263|NCT00946647|75838840|FG003|Phase ll Part|Protocol Violation|4|||
42030264|NCT00946647|75838841|FG004|Phase ll Part|Protocol Violation|2|||
42030265|NCT00946647|75838837|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
42030266|NCT00946647|75838838|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
42030267|NCT00946647|75838839|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
42030268|NCT00946647|75838840|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
42030269|NCT00946647|75838841|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
42030270|NCT00946101|75838856|FG000|Overall Study|Lost to Follow-up|2|||
42030271|NCT00946101|75838857|FG001|Overall Study|Lost to Follow-up|1|||
42030272|NCT00946101|75838856|FG000|Overall Study|Withdrawal of consent|2|||
42030273|NCT00946101|75838857|FG001|Overall Study|Withdrawal of consent|0|||
42030274|NCT00946101|75838856|FG000|Overall Study|Physician Decision|0|||
42030275|NCT00946101|75838857|FG001|Overall Study|Physician Decision|1|||
42224222|NCT03953079|76043135|FG000|Core Study|Difficulties leaving the house|0|||
42224223|NCT03953079|76043136|FG001|Core Study|Difficulties leaving the house|1|||
42224224|NCT03953079|76043137|FG002|Core Study|Difficulties leaving the house|0|||
42224225|NCT03953079|76043135|FG000|Extension Study|Withdrawal by Subject|1|||
42224226|NCT03953079|76043136|FG001|Extension Study|Withdrawal by Subject|0|||
42224227|NCT03953079|76043137|FG002|Extension Study|Withdrawal by Subject|0|||
42224228|NCT03953079|76043135|FG000|Extension Study|Received Rescue Treatment|5|||
42224229|NCT03953079|76043136|FG001|Extension Study|Received Rescue Treatment|6|||
42224230|NCT03953079|76043137|FG002|Extension Study|Received Rescue Treatment|5|||
42224231|NCT03885999|76043150|FG000|Overall Study|Adverse Event|1|||
41983675|NCT05490771|75790135|FG000|Overall Study|Physician Decision|1|||
41983676|NCT05490771|75790135|FG000|Overall Study|Still on treatment|2|||
41983677|NCT05490771|75790135|FG000|Overall Study|Never start protocol therapy|5|||
41983678|NCT05490771|75790135|FG000|Overall Study|Ineligible|2|||
41983679|NCT05480514|75790139|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
41983680|NCT05480514|75790140|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
41983681|NCT05480514|75790139|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
41983682|NCT05480514|75790140|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
41983683|NCT05480514|75790139|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
41983684|NCT05480514|75790140|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
42224232|NCT03108027|76043164|FG000|Period 1|Subject/Guardian Decision|0|||
41983685|NCT05480514|75790139|FG000|Period 1|Covid-19 Related|1|||
41983686|NCT05480514|75790140|FG001|Period 1|Covid-19 Related|0|||
42030276|NCT01109940|75838871|FG000|Overall Study|Administrative problems|2|||
42224233|NCT03108027|76043165|FG001|Period 1|Subject/Guardian Decision|0|||
42030277|NCT01109940|75838872|FG001|Overall Study|Administrative problems|0|||
42030278|NCT01109940|75838873|FG002|Overall Study|Administrative problems|0|||
42030279|NCT01109940|75838874|FG003|Overall Study|Administrative problems|0|||
41983687|NCT05480514|75790139|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
42030280|NCT01109940|75838871|FG000|Overall Study|Serious Adverse Event|2|||
42030281|NCT01109940|75838872|FG001|Overall Study|Serious Adverse Event|1|||
42030282|NCT01109940|75838873|FG002|Overall Study|Serious Adverse Event|0|||
42030283|NCT01109940|75838874|FG003|Overall Study|Serious Adverse Event|0|||
42224234|NCT03108027|76043166|FG002|Period 1|Subject/Guardian Decision|0|||
42224235|NCT03108027|76043167|FG003|Period 1|Subject/Guardian Decision|2|||
42030284|NCT01109940|75838871|FG000|Overall Study|Lost to Follow-up|1|||
42030285|NCT01109940|75838872|FG001|Overall Study|Lost to Follow-up|0|||
42030286|NCT01109940|75838873|FG002|Overall Study|Lost to Follow-up|0|||
42030287|NCT01109940|75838874|FG003|Overall Study|Lost to Follow-up|0|||
42030288|NCT01109940|75838871|FG000|Overall Study|Patient withdrew consent|1|||
42030289|NCT01109940|75838872|FG001|Overall Study|Patient withdrew consent|1|||
42030290|NCT01109940|75838873|FG002|Overall Study|Patient withdrew consent|0|||
42030291|NCT01109940|75838874|FG003|Overall Study|Patient withdrew consent|0|||
42030292|NCT01109940|75838871|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
42030293|NCT01109940|75838872|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42030294|NCT01109940|75838873|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
42030295|NCT01109940|75838874|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
42030296|NCT00595309|75838884|FG000|Overall Study|Lost to Follow-up|1|||
42030297|NCT00595309|75838884|FG000|Overall Study|planned vaccination against yellow fever|1|||
42030298|NCT00595309|75838884|FG000|Overall Study|acute infection after V0|1|||
42030299|NCT00595309|75838884|FG000|Overall Study|personal reason|1|||
42030300|NCT00595075|75838890|FG000|Overall Study|Withdrawal by Subject|1|||
42030301|NCT00595075|75838891|FG001|Overall Study|Withdrawal by Subject|0|||
42030302|NCT00887224|75838900|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
42030303|NCT00887224|75838901|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
42030304|NCT00887224|75838902|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
42030305|NCT00887224|75838900|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
42030306|NCT00887224|75838901|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
42030307|NCT00887224|75838902|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
42030308|NCT00887224|75838900|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
42030309|NCT00887224|75838901|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
42030310|NCT00887224|75838902|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
42030311|NCT00887224|75838900|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
42030312|NCT00887224|75838901|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
42030313|NCT00887224|75838902|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
42030314|NCT00887224|75838900|FG000|Open-label Response (OLR) Phase|Other|1|||
42030315|NCT00887224|75838901|FG001|Open-label Response (OLR) Phase|Other|0|||
42030316|NCT00887224|75838902|FG002|Open-label Response (OLR) Phase|Other|0|||
42030317|NCT00887224|75838900|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
42030318|NCT00887224|75838901|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
42030319|NCT00887224|75838902|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
42030320|NCT00887224|75838900|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
42030321|NCT00887224|75838901|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
42030322|NCT00887224|75838902|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
42030323|NCT00887224|75838900|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
42030324|NCT00887224|75838901|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
42224236|NCT03108027|76043168|FG004|Period 1|Subject/Guardian Decision|0|||
42224237|NCT03108027|76043169|FG005|Period 1|Subject/Guardian Decision|0|||
42131552|NCT00491894|75942451|FG000|Overall Study|Other-Failed to meet any criteria|2|||
42131553|NCT00491894|75942451|FG000|Overall Study|Physician Decision|2|||
42131554|NCT00491894|75942451|FG000|Overall Study|Protocol Violation|2|||
42224238|NCT03108027|76043164|FG000|Period 3|Adverse Event|0|||
41983688|NCT05480514|75790140|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
41983689|NCT05379920|75790150|FG000|Overall Study|Lost to Follow-up|0|||
41983690|NCT05379920|75790151|FG001|Overall Study|Lost to Follow-up|5|||
41983691|NCT05379920|75790152|FG002|Overall Study|Lost to Follow-up|0|||
41983692|NCT05379920|75790153|FG003|Overall Study|Lost to Follow-up|0|||
41983693|NCT05327816|75790172|FG000|Overall Study|Lost to Follow-up|1|||
41983694|NCT05327816|75790173|FG001|Overall Study|Lost to Follow-up|0|||
41983695|NCT05327816|75790174|FG002|Overall Study|Lost to Follow-up|0|||
41983696|NCT05327816|75790175|FG003|Overall Study|Lost to Follow-up|0|||
41983697|NCT05327816|75790176|FG004|Overall Study|Lost to Follow-up|0|||
41983698|NCT05327816|75790177|FG005|Overall Study|Lost to Follow-up|0|||
41983699|NCT05327816|75790178|FG006|Overall Study|Lost to Follow-up|0|||
41983700|NCT05327816|75790179|FG007|Overall Study|Lost to Follow-up|0|||
41983701|NCT05327816|75790180|FG008|Overall Study|Lost to Follow-up|0|||
41983702|NCT05327816|75790181|FG009|Overall Study|Lost to Follow-up|1|||
41983703|NCT05327816|75790182|FG010|Overall Study|Lost to Follow-up|0|||
42030325|NCT00887224|75838902|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
42030326|NCT00887224|75838900|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
42030327|NCT00887224|75838901|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
42030328|NCT00887224|75838902|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
41983704|NCT05327816|75790172|FG000|Overall Study|Withdrawal by Subject|0|||
42030329|NCT00887224|75838900|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
42131555|NCT00491894|75942451|FG000|Overall Study|Other-Intake of prohibited medication|1|||
42224239|NCT03108027|76043165|FG001|Period 3|Adverse Event|1|||
41983705|NCT05327816|75790173|FG001|Overall Study|Withdrawal by Subject|0|||
41983706|NCT05327816|75790174|FG002|Overall Study|Withdrawal by Subject|0|||
41983707|NCT05327816|75790175|FG003|Overall Study|Withdrawal by Subject|0|||
42030330|NCT00887224|75838901|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
42030331|NCT00887224|75838902|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
42030332|NCT00887224|75838900|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
42030333|NCT00887224|75838901|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
42030334|NCT00887224|75838902|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
42030335|NCT00887224|75838900|FG000|Open-label Stability (OLS) Phase|Other|1|||
42030336|NCT00887224|75838901|FG001|Open-label Stability (OLS) Phase|Other|0|||
42030337|NCT00887224|75838902|FG002|Open-label Stability (OLS) Phase|Other|0|||
42030338|NCT00887224|75838900|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
42030339|NCT00887224|75838901|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
42030340|NCT00887224|75838902|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
42030341|NCT00887224|75838900|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
42030342|NCT00887224|75838901|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
42030343|NCT00887224|75838902|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
42030344|NCT00887224|75838900|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
42030345|NCT00887224|75838901|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
42030346|NCT00887224|75838902|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
42030347|NCT00887224|75838900|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
42030348|NCT00887224|75838901|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
42030349|NCT00887224|75838902|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
42030350|NCT00887224|75838900|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
41983708|NCT05327816|75790176|FG004|Overall Study|Withdrawal by Subject|1|||
41983709|NCT05327816|75790177|FG005|Overall Study|Withdrawal by Subject|1|||
41983710|NCT05327816|75790178|FG006|Overall Study|Withdrawal by Subject|0|||
41983711|NCT05327816|75790179|FG007|Overall Study|Withdrawal by Subject|0|||
41983712|NCT05327816|75790180|FG008|Overall Study|Withdrawal by Subject|0|||
41983713|NCT05327816|75790181|FG009|Overall Study|Withdrawal by Subject|0|||
41983714|NCT05327816|75790182|FG010|Overall Study|Withdrawal by Subject|0|||
41983715|NCT05327816|75790172|FG000|Overall Study|Study Terminated by Sponsor|11|||
41983716|NCT05327816|75790173|FG001|Overall Study|Study Terminated by Sponsor|12|||
41983717|NCT05327816|75790174|FG002|Overall Study|Study Terminated by Sponsor|12|||
41983718|NCT05327816|75790175|FG003|Overall Study|Study Terminated by Sponsor|12|||
41983719|NCT05327816|75790176|FG004|Overall Study|Study Terminated by Sponsor|11|||
41983720|NCT05327816|75790177|FG005|Overall Study|Study Terminated by Sponsor|11|||
41983721|NCT05327816|75790178|FG006|Overall Study|Study Terminated by Sponsor|11|||
41983722|NCT05327816|75790179|FG007|Overall Study|Study Terminated by Sponsor|11|||
41983723|NCT05327816|75790180|FG008|Overall Study|Study Terminated by Sponsor|11|||
42030351|NCT00887224|75838901|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
42030352|NCT00887224|75838902|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
42030353|NCT00887224|75838900|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
42030354|NCT00887224|75838901|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
42224240|NCT03108027|76043166|FG002|Period 3|Adverse Event|0|||
42224241|NCT03108027|76043167|FG003|Period 3|Adverse Event|0|||
42224242|NCT03108027|76043168|FG004|Period 3|Adverse Event|0|||
42224243|NCT03108027|76043169|FG005|Period 3|Adverse Event|0|||
42224244|NCT03107715|76043185|FG000|Overall Study|did not deliver at the home hospital|4|||
42224245|NCT03107715|76043186|FG001|Overall Study|did not deliver at the home hospital|6|||
42224246|NCT03107715|76043185|FG000|Overall Study|infant stillborn|0|||
42224247|NCT03107715|76043186|FG001|Overall Study|infant stillborn|1|||
42224248|NCT03567057|76043195|FG000|Overall Study|Adverse Event|56|||
42224249|NCT03567057|76043196|FG001|Overall Study|Adverse Event|53|||
42224250|NCT03567057|76043197|FG002|Overall Study|Adverse Event|28|||
42224251|NCT03567057|76043195|FG000|Overall Study|Withdrawal by Subject|22|||
42224252|NCT03567057|76043196|FG001|Overall Study|Withdrawal by Subject|24|||
42224253|NCT03567057|76043197|FG002|Overall Study|Withdrawal by Subject|13|||
42224254|NCT03567057|76043195|FG000|Overall Study|Lost to Follow-up|3|||
42224255|NCT03567057|76043196|FG001|Overall Study|Lost to Follow-up|5|||
42030355|NCT00887224|75838902|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
42224256|NCT03567057|76043197|FG002|Overall Study|Lost to Follow-up|2|||
42224257|NCT03567057|76043195|FG000|Overall Study|COVID-19 pandemic|4|||
42224258|NCT03567057|76043196|FG001|Overall Study|COVID-19 pandemic|3|||
42224259|NCT03567057|76043197|FG002|Overall Study|COVID-19 pandemic|0|||
42030356|NCT00887224|75838900|FG000|OL Taper Phase / OL Follow Up|Other|30|||
42030357|NCT00887224|75838901|FG001|OL Taper Phase / OL Follow Up|Other|0|||
42224260|NCT03567057|76043195|FG000|Overall Study|Non-compliance with study drug|4|||
42224261|NCT03567057|76043196|FG001|Overall Study|Non-compliance with study drug|2|||
42224262|NCT03567057|76043197|FG002|Overall Study|Non-compliance with study drug|0|||
42302312|NCT02516605|76137433|FG004|Overall Study|Withdrawal by Subject|0|||
41983724|NCT05327816|75790181|FG009|Overall Study|Study Terminated by Sponsor|11|||
41983725|NCT05327816|75790182|FG010|Overall Study|Study Terminated by Sponsor|12|||
42224263|NCT03567057|76043195|FG000|Overall Study|Lack of Efficacy|3|||
41983726|NCT05327816|75790172|FG000|Overall Study|Randomized but not treated|0|||
41983727|NCT05327816|75790173|FG001|Overall Study|Randomized but not treated|0|||
42224264|NCT03567057|76043196|FG001|Overall Study|Lack of Efficacy|0|||
42224265|NCT03567057|76043197|FG002|Overall Study|Lack of Efficacy|1|||
42030358|NCT00887224|75838902|FG002|OL Taper Phase / OL Follow Up|Other|0|||
42030359|NCT00887224|75838900|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
42030360|NCT00887224|75838901|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
42030361|NCT00887224|75838902|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
42030362|NCT00887224|75838900|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
42030363|NCT00887224|75838901|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
42030364|NCT00887224|75838902|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
42030365|NCT00887224|75838900|FG000|Double-blind (DB) Phase|Adverse Event|0|||
41983728|NCT05327816|75790174|FG002|Overall Study|Randomized but not treated|0|||
41983729|NCT05327816|75790175|FG003|Overall Study|Randomized but not treated|0|||
41983730|NCT05327816|75790176|FG004|Overall Study|Randomized but not treated|0|||
41983731|NCT05327816|75790177|FG005|Overall Study|Randomized but not treated|0|||
41983732|NCT05327816|75790178|FG006|Overall Study|Randomized but not treated|1|||
42030366|NCT00887224|75838901|FG001|Double-blind (DB) Phase|Adverse Event|7|||
42030367|NCT00887224|75838902|FG002|Double-blind (DB) Phase|Adverse Event|2|||
42030368|NCT00887224|75838900|FG000|Double-blind (DB) Phase|Failed to return|0|||
42030369|NCT00887224|75838901|FG001|Double-blind (DB) Phase|Failed to return|2|||
42030370|NCT00887224|75838902|FG002|Double-blind (DB) Phase|Failed to return|2|||
42030371|NCT00887224|75838900|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
42030372|NCT00887224|75838901|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
42030373|NCT00887224|75838902|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
42030374|NCT00887224|75838900|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
42030375|NCT00887224|75838901|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
42131556|NCT00491504|75942459|FG000|Overall Study|Adverse Event|0|||
42131557|NCT00491504|75942460|FG001|Overall Study|Adverse Event|1|||
41983733|NCT05327816|75790179|FG007|Overall Study|Randomized but not treated|1|||
41983734|NCT05327816|75790180|FG008|Overall Study|Randomized but not treated|1|||
41983735|NCT05327816|75790181|FG009|Overall Study|Randomized but not treated|0|||
41983736|NCT05327816|75790182|FG010|Overall Study|Randomized but not treated|0|||
41983737|NCT05227027|75790208|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
41983738|NCT05227027|75790209|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
41983739|NCT05124210|75790230|FG000|Overall Study|Lost to Follow-up|1|||
41983740|NCT05124210|75790231|FG001|Overall Study|Lost to Follow-up|0|||
41983741|NCT05124210|75790230|FG000|Overall Study|Withdrawal by Subject|1|||
41983742|NCT05124210|75790231|FG001|Overall Study|Withdrawal by Subject|0|||
41983743|NCT05041062|75790246|FG000|Overall Study|Adverse Event|2|||
41983744|NCT04800315|75790294|FG000|Randomization|Did not receive study treatment|1|||
41983745|NCT04800315|75790295|FG001|Randomization|Did not receive study treatment|0|||
41983746|NCT04800315|75790296|FG002|Randomization|Did not receive study treatment|0|||
41983747|NCT04800315|75790297|FG003|Randomization|Did not receive study treatment|0|||
41983748|NCT04800315|75790294|FG000|Treatment Period|Adverse Event|4|||
41983749|NCT04800315|75790295|FG001|Treatment Period|Adverse Event|2|||
41983750|NCT04800315|75790296|FG002|Treatment Period|Adverse Event|1|||
41983751|NCT04800315|75790297|FG003|Treatment Period|Adverse Event|2|||
42030376|NCT00887224|75838902|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
42030377|NCT00887224|75838900|FG000|Double-blind (DB) Phase|Other|0|||
42030378|NCT00887224|75838901|FG001|Double-blind (DB) Phase|Other|2|||
42030379|NCT00887224|75838902|FG002|Double-blind (DB) Phase|Other|0|||
42030380|NCT00887224|75838900|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
42131558|NCT00491504|75942461|FG002|Overall Study|Adverse Event|0|||
42131559|NCT00491504|75942462|FG003|Overall Study|Adverse Event|0|||
42131560|NCT00491504|75942459|FG000|Overall Study|Withdrawal by Subject|0|||
42131561|NCT00491504|75942460|FG001|Overall Study|Withdrawal by Subject|0|||
42131562|NCT00491504|75942461|FG002|Overall Study|Withdrawal by Subject|1|||
42131563|NCT00491504|75942462|FG003|Overall Study|Withdrawal by Subject|2|||
42131564|NCT00491504|75942459|FG000|Overall Study|Protocol Violation|0|||
42131565|NCT00491504|75942460|FG001|Overall Study|Protocol Violation|0|||
42131566|NCT00491504|75942461|FG002|Overall Study|Protocol Violation|3|||
42131567|NCT00491504|75942462|FG003|Overall Study|Protocol Violation|2|||
42131568|NCT00500292|75942473|FG000|Overall Study|Adverse Event|3|||
42131569|NCT00500292|75942474|FG001|Overall Study|Adverse Event|6|||
42131570|NCT00500292|75942475|FG002|Overall Study|Adverse Event|4|||
42131571|NCT00500292|75942473|FG000|Overall Study|Condition under investigation worsened|21|||
42131572|NCT00500292|75942474|FG001|Overall Study|Condition under investigation worsened|23|||
42131573|NCT00500292|75942475|FG002|Overall Study|Condition under investigation worsened|19|||
42131574|NCT00500292|75942473|FG000|Overall Study|Withdrawal by Subject|0|||
42131575|NCT00500292|75942474|FG001|Overall Study|Withdrawal by Subject|1|||
42131576|NCT00500292|75942475|FG002|Overall Study|Withdrawal by Subject|0|||
42224266|NCT03567057|76043195|FG000|Overall Study|Death|1|||
42030381|NCT00887224|75838901|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
42030382|NCT00887224|75838902|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
42030383|NCT00887224|75838900|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
42224267|NCT03567057|76043196|FG001|Overall Study|Death|0|||
42224268|NCT03567057|76043197|FG002|Overall Study|Death|0|||
42224269|NCT03567057|76043195|FG000|Overall Study|Physician Decision|1|||
41983752|NCT04800315|75790294|FG000|Treatment Period|Lack of Efficacy|1|||
42224270|NCT03567057|76043196|FG001|Overall Study|Physician Decision|0|||
42224271|NCT03567057|76043197|FG002|Overall Study|Physician Decision|0|||
42224272|NCT03567057|76043195|FG000|Overall Study|Unstable medical condition|1|||
42224273|NCT03567057|76043196|FG001|Overall Study|Unstable medical condition|0|||
42224274|NCT03567057|76043197|FG002|Overall Study|Unstable medical condition|0|||
42224275|NCT03567057|76043195|FG000|Overall Study|Medical history event|0|||
42224276|NCT03567057|76043196|FG001|Overall Study|Medical history event|0|||
42224277|NCT03567057|76043197|FG002|Overall Study|Medical history event|1|||
42224278|NCT03567057|76043195|FG000|Overall Study|Other|0|||
42224279|NCT03567057|76043196|FG001|Overall Study|Other|0|||
42224280|NCT03567057|76043197|FG002|Overall Study|Other|1|||
42224281|NCT04388787|76043205|FG000|Blinded Period|Patient could not follow instructions|1|||
42224282|NCT04388787|76043205|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
42224283|NCT03057600|76043217|FG000|Overall Study|Adverse Event|0|||
42224284|NCT03057600|76043218|FG001|Overall Study|Adverse Event|0|||
42224285|NCT03057600|76043219|FG002|Overall Study|Adverse Event|4|||
42224286|NCT03057600|76043220|FG003|Overall Study|Adverse Event|0|||
42224287|NCT03057600|76043217|FG000|Overall Study|Radiologic Disease Progression|8|||
42224288|NCT03057600|76043218|FG001|Overall Study|Radiologic Disease Progression|7|||
42224289|NCT03057600|76043219|FG002|Overall Study|Radiologic Disease Progression|13|||
42224290|NCT03057600|76043220|FG003|Overall Study|Radiologic Disease Progression|10|||
42224291|NCT03057600|76043217|FG000|Overall Study|Symptomatic Deterioration|0|||
42224292|NCT03057600|76043218|FG001|Overall Study|Symptomatic Deterioration|1|||
42224293|NCT03057600|76043219|FG002|Overall Study|Symptomatic Deterioration|1|||
42224294|NCT03057600|76043220|FG003|Overall Study|Symptomatic Deterioration|0|||
41983753|NCT04800315|75790295|FG001|Treatment Period|Lack of Efficacy|0|||
41983754|NCT04800315|75790296|FG002|Treatment Period|Lack of Efficacy|0|||
42224295|NCT03057600|76043217|FG000|Overall Study|Investigator Decision|0|||
42224296|NCT03057600|76043218|FG001|Overall Study|Investigator Decision|0|||
41983755|NCT04800315|75790297|FG003|Treatment Period|Lack of Efficacy|3|||
41983756|NCT04800315|75790294|FG000|Treatment Period|Lost to Follow-up|0|||
41983757|NCT04800315|75790295|FG001|Treatment Period|Lost to Follow-up|1|||
41983758|NCT04800315|75790296|FG002|Treatment Period|Lost to Follow-up|2|||
41983759|NCT04800315|75790297|FG003|Treatment Period|Lost to Follow-up|2|||
41983760|NCT04800315|75790294|FG000|Treatment Period|Withdrawal by participant|0|||
41983761|NCT04800315|75790295|FG001|Treatment Period|Withdrawal by participant|0|||
41983762|NCT04800315|75790296|FG002|Treatment Period|Withdrawal by participant|0|||
41983763|NCT04800315|75790297|FG003|Treatment Period|Withdrawal by participant|4|||
41983764|NCT04800315|75790294|FG000|Treatment Period|Other Reasons|0|||
41983765|NCT04800315|75790295|FG001|Treatment Period|Other Reasons|2|||
41983766|NCT04800315|75790296|FG002|Treatment Period|Other Reasons|0|||
41983767|NCT04800315|75790297|FG003|Treatment Period|Other Reasons|1|||
41983768|NCT04768114|75790309|FG000|Overall Study|Lost to Follow-up|5|||
41983769|NCT04768114|75790310|FG001|Overall Study|Lost to Follow-up|10|||
41983770|NCT04768114|75790309|FG000|Overall Study|Withdrawal by Subject|0|||
41983771|NCT04768114|75790310|FG001|Overall Study|Withdrawal by Subject|1|||
41983772|NCT04547192|75790343|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
41983773|NCT04547192|75790344|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
41983774|NCT04547192|75790345|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
41983775|NCT04547192|75790346|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
42030384|NCT00887224|75838901|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
42030385|NCT00887224|75838902|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
41983776|NCT04547192|75790343|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
42030386|NCT00887224|75838900|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
42030387|NCT00887224|75838901|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
42030388|NCT00887224|75838902|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
42030389|NCT00887224|75838900|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
41983777|NCT04547192|75790344|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
42030390|NCT00887224|75838901|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
42030391|NCT00887224|75838902|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
42030392|NCT00887224|75838900|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
42030393|NCT00887224|75838901|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
42030394|NCT00887224|75838902|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
42030395|NCT00887224|75838900|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
42030396|NCT00887224|75838901|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
42030397|NCT00887224|75838902|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
42030398|NCT00887224|75838900|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
42030399|NCT00887224|75838901|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
41983778|NCT04547192|75790345|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
41983779|NCT04547192|75790346|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
41983780|NCT04547192|75790343|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
41983781|NCT04547192|75790344|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
41983782|NCT04547192|75790345|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
41983783|NCT04547192|75790346|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
41983784|NCT04547192|75790343|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
41983785|NCT04547192|75790344|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
41983786|NCT04547192|75790345|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
41983787|NCT04547192|75790346|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
41983788|NCT04547192|75790343|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
41983789|NCT04547192|75790344|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
41983790|NCT04547192|75790345|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
41983791|NCT04547192|75790346|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
41983792|NCT04514510|75790356|FG000|Overall Study|Lost to Follow-up|0|||
41983793|NCT04514510|75790357|FG001|Overall Study|Lost to Follow-up|1|||
41983794|NCT04514510|75790356|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
41983795|NCT04514510|75790357|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
41983796|NCT04439123|75790373|FG000|Overall Study|Adverse Event|11|||
41983797|NCT04439123|75790373|FG000|Overall Study|Death|1|||
41983798|NCT04439123|75790373|FG000|Overall Study|Disease progression|19|||
41983799|NCT04439123|75790373|FG000|Overall Study|Withdrawal by Subject|2|||
41983800|NCT04439123|75790373|FG000|Overall Study|Still on treatment|2|||
41983801|NCT04325828|75790381|FG000|Overall Study|Ongoing|26|||
41983802|NCT04283461|75790417|FG000|Overall Study|Enrolled in separate trial|0|||
41983803|NCT04283461|75790418|FG001|Overall Study|Enrolled in separate trial|0|||
42030400|NCT00887224|75838902|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
42030401|NCT00887224|75838900|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
42030402|NCT00887224|75838901|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
42030403|NCT00887224|75838902|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
42030404|NCT00887224|75838900|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
42030405|NCT00887224|75838901|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
42030406|NCT00887224|75838902|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
42030407|NCT01109316|75838920|FG000|Study Period 1|Adverse Event|0|||
42030408|NCT01109316|75838921|FG001|Study Period 1|Adverse Event|0|||
42030409|NCT01109316|75838922|FG002|Study Period 1|Adverse Event|1|||
42030410|NCT01109316|75838923|FG003|Study Period 1|Adverse Event|0|||
42030411|NCT01109316|75838924|FG004|Study Period 1|Adverse Event|0|||
42030412|NCT01109316|75838925|FG005|Study Period 1|Adverse Event|0|||
42030413|NCT01109316|75838920|FG000|Study Period 1|Lost to Follow-up|0|||
42030414|NCT01109316|75838921|FG001|Study Period 1|Lost to Follow-up|0|||
42030415|NCT01109316|75838922|FG002|Study Period 1|Lost to Follow-up|1|||
42030416|NCT01109316|75838923|FG003|Study Period 1|Lost to Follow-up|1|||
41983804|NCT04283461|75790419|FG002|Overall Study|Enrolled in separate trial|8|||
41983805|NCT04283461|75790420|FG003|Overall Study|Enrolled in separate trial|13|||
41983806|NCT04283461|75790421|FG004|Overall Study|Enrolled in separate trial|12|||
42302313|NCT02490475|76137453|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
42302314|NCT02490475|76137454|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
41983807|NCT04283461|75790422|FG005|Overall Study|Enrolled in separate trial|0|||
42302315|NCT02490475|76137455|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
42302316|NCT02490475|76137456|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
42302317|NCT02490475|76137453|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
42030417|NCT01109316|75838924|FG004|Study Period 1|Lost to Follow-up|0|||
42030418|NCT01109316|75838925|FG005|Study Period 1|Lost to Follow-up|0|||
42030419|NCT01109316|75838920|FG000|Study Period 1|Withdrawal by Subject|0|||
41983808|NCT04283461|75790423|FG006|Overall Study|Enrolled in separate trial|0|||
41983809|NCT04283461|75790424|FG007|Overall Study|Enrolled in separate trial|8|||
42030420|NCT01109316|75838921|FG001|Study Period 1|Withdrawal by Subject|0|||
42030421|NCT01109316|75838922|FG002|Study Period 1|Withdrawal by Subject|1|||
41983810|NCT04283461|75790425|FG008|Overall Study|Enrolled in separate trial|0|||
41983811|NCT04283461|75790426|FG009|Overall Study|Enrolled in separate trial|0|||
41983812|NCT04283461|75790427|FG010|Overall Study|Enrolled in separate trial|0|||
41983813|NCT04283461|75790428|FG011|Overall Study|Enrolled in separate trial|7|||
41983814|NCT04283461|75790429|FG012|Overall Study|Enrolled in separate trial|0|||
41983815|NCT04213079|75790462|FG000|Overall Study|Lost to Follow-up|0|||
41983816|NCT04213079|75790463|FG001|Overall Study|Lost to Follow-up|2|||
41983817|NCT04102189|75790493|FG000|Overall Study|Withdrawal by Subject|1|||
41983818|NCT04102189|75790494|FG001|Overall Study|Withdrawal by Subject|2|||
41983819|NCT04102189|75790493|FG000|Overall Study|Withdrawal by parent/guardian|0|||
41983820|NCT04102189|75790494|FG001|Overall Study|Withdrawal by parent/guardian|1|||
41983821|NCT04102189|75790493|FG000|Overall Study|Lost to Follow-up|1|||
41983822|NCT04102189|75790494|FG001|Overall Study|Lost to Follow-up|0|||
41983823|NCT04034927|75790502|FG000|Overall Study|Adverse Event|4|||
41983824|NCT04034927|75790503|FG001|Overall Study|Adverse Event|9|||
41983825|NCT04034927|75790502|FG000|Overall Study|Death|0|||
41983826|NCT04034927|75790503|FG001|Overall Study|Death|1|||
41983827|NCT04034927|75790502|FG000|Overall Study|Withdrawal by Subject|0|||
41983828|NCT04034927|75790503|FG001|Overall Study|Withdrawal by Subject|3|||
41983829|NCT04034927|75790502|FG000|Overall Study|Still on Treatment|2|||
41983830|NCT04034927|75790503|FG001|Overall Study|Still on Treatment|1|||
41983831|NCT04034927|75790502|FG000|Overall Study|Other|1|||
41983832|NCT04034927|75790503|FG001|Overall Study|Other|1|||
41983833|NCT04025580|75790525|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
42030422|NCT01109316|75838923|FG003|Study Period 1|Withdrawal by Subject|0|||
42030423|NCT01109316|75838924|FG004|Study Period 1|Withdrawal by Subject|2|||
42030424|NCT01109316|75838925|FG005|Study Period 1|Withdrawal by Subject|0|||
42030425|NCT01109316|75838920|FG000|Study Period 1|Sponsor Decision|0|||
42030426|NCT01109316|75838921|FG001|Study Period 1|Sponsor Decision|0|||
42030427|NCT01109316|75838922|FG002|Study Period 1|Sponsor Decision|0|||
41983834|NCT04025580|75790526|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
42030428|NCT01109316|75838923|FG003|Study Period 1|Sponsor Decision|0|||
42030429|NCT01109316|75838924|FG004|Study Period 1|Sponsor Decision|0|||
42030430|NCT01109316|75838925|FG005|Study Period 1|Sponsor Decision|2|||
41983835|NCT04025580|75790527|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
41983836|NCT03982368|75790537|FG000|Overall Study|Adverse Event|6|||
41983837|NCT03982368|75790538|FG001|Overall Study|Adverse Event|4|||
41983838|NCT03982368|75790539|FG002|Overall Study|Adverse Event|3|||
41983839|NCT03982368|75790537|FG000|Overall Study|Lost to Follow-up|2|||
41983840|NCT03982368|75790538|FG001|Overall Study|Lost to Follow-up|1|||
41983841|NCT03982368|75790539|FG002|Overall Study|Lost to Follow-up|0|||
41983842|NCT03982368|75790537|FG000|Overall Study|Withdrawal by Subject|1|||
41983843|NCT03982368|75790538|FG001|Overall Study|Withdrawal by Subject|2|||
41983844|NCT03982368|75790539|FG002|Overall Study|Withdrawal by Subject|0|||
41983845|NCT03982368|75790537|FG000|Overall Study|unknow|4|||
42030431|NCT01109316|75838920|FG000|Study Period 2|Entry Criteria Not Met|0|||
42030432|NCT01109316|75838921|FG001|Study Period 2|Entry Criteria Not Met|1|||
42030433|NCT01109316|75838922|FG002|Study Period 2|Entry Criteria Not Met|0|||
42030434|NCT01109316|75838923|FG003|Study Period 2|Entry Criteria Not Met|0|||
42030435|NCT01109316|75838924|FG004|Study Period 2|Entry Criteria Not Met|0|||
42030436|NCT01109316|75838925|FG005|Study Period 2|Entry Criteria Not Met|0|||
42030437|NCT01109316|75838920|FG000|Study Period 2|Physician Decision|0|||
42030438|NCT01109316|75838921|FG001|Study Period 2|Physician Decision|0|||
42030439|NCT01109316|75838922|FG002|Study Period 2|Physician Decision|0|||
42030440|NCT01109316|75838923|FG003|Study Period 2|Physician Decision|1|||
42030441|NCT01109316|75838924|FG004|Study Period 2|Physician Decision|0|||
42030442|NCT01109316|75838925|FG005|Study Period 2|Physician Decision|0|||
42030443|NCT01109316|75838920|FG000|Study Period 2|Protocol Violation|1|||
41983846|NCT03982368|75790538|FG001|Overall Study|unknow|0|||
41983847|NCT03982368|75790539|FG002|Overall Study|unknow|2|||
41983848|NCT03934684|75790552|FG000|Overall Study|Participants continuing in study|11|||
41983849|NCT03934684|75790553|FG001|Overall Study|Participants continuing in study|4|||
42030444|NCT01109316|75838921|FG001|Study Period 2|Protocol Violation|0|||
42030445|NCT01109316|75838922|FG002|Study Period 2|Protocol Violation|0|||
42030446|NCT01109316|75838923|FG003|Study Period 2|Protocol Violation|0|||
42030447|NCT01109316|75838924|FG004|Study Period 2|Protocol Violation|0|||
42030448|NCT01109316|75838925|FG005|Study Period 2|Protocol Violation|0|||
42030449|NCT01109316|75838920|FG000|Study Period 2|Withdrawal by Subject|0|||
42030450|NCT01109316|75838921|FG001|Study Period 2|Withdrawal by Subject|0|||
42030451|NCT01109316|75838922|FG002|Study Period 2|Withdrawal by Subject|1|||
42030452|NCT01109316|75838923|FG003|Study Period 2|Withdrawal by Subject|0|||
42030453|NCT01109316|75838924|FG004|Study Period 2|Withdrawal by Subject|0|||
42030454|NCT01109316|75838925|FG005|Study Period 2|Withdrawal by Subject|1|||
42030455|NCT01109316|75838920|FG000|Study Period 3|Lost to Follow-up|0|||
41983850|NCT03934684|75790552|FG000|Overall Study|Discontinuation of carfilzomib|20|||
41983851|NCT03934684|75790553|FG001|Overall Study|Discontinuation of carfilzomib|30|||
41983852|NCT03934684|75790552|FG000|Overall Study|Death|2|||
42030456|NCT01109316|75838921|FG001|Study Period 3|Lost to Follow-up|0|||
42030457|NCT01109316|75838922|FG002|Study Period 3|Lost to Follow-up|0|||
42030458|NCT01109316|75838923|FG003|Study Period 3|Lost to Follow-up|0|||
42030459|NCT01109316|75838924|FG004|Study Period 3|Lost to Follow-up|1|||
42030460|NCT01109316|75838925|FG005|Study Period 3|Lost to Follow-up|0|||
42030461|NCT01109316|75838920|FG000|Study Period 3|Withdrawal by Subject|1|||
42030462|NCT01109316|75838921|FG001|Study Period 3|Withdrawal by Subject|0|||
42030463|NCT01109316|75838922|FG002|Study Period 3|Withdrawal by Subject|0|||
42030464|NCT01109316|75838923|FG003|Study Period 3|Withdrawal by Subject|0|||
42030465|NCT01109316|75838924|FG004|Study Period 3|Withdrawal by Subject|1|||
42030466|NCT01109316|75838925|FG005|Study Period 3|Withdrawal by Subject|0|||
42030467|NCT00887068|75838935|FG000|Overall Study|Withdrawal by Subject|2|||
42030468|NCT00887068|75838936|FG001|Overall Study|Withdrawal by Subject|0|||
42030469|NCT00887068|75838935|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
42030470|NCT00887068|75838936|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
42030471|NCT00941031|75838946|FG000|Induction Period|Lack of Efficacy|2|||
42030472|NCT00941031|75838947|FG001|Induction Period|Lack of Efficacy|1|||
42030473|NCT00941031|75838948|FG002|Induction Period|Lack of Efficacy|0|||
42030474|NCT00941031|75838949|FG003|Induction Period|Lack of Efficacy|5|||
42030475|NCT00941031|75838950|FG004|Induction Period|Lack of Efficacy|0|||
42030476|NCT00941031|75838951|FG005|Induction Period|Lack of Efficacy|0|||
42030477|NCT00941031|75838952|FG006|Induction Period|Lack of Efficacy|0|||
42030478|NCT00941031|75838946|FG000|Induction Period|Withdrawal by Subject|1|||
42030479|NCT00941031|75838947|FG001|Induction Period|Withdrawal by Subject|2|||
42030480|NCT00941031|75838948|FG002|Induction Period|Withdrawal by Subject|2|||
42030481|NCT00941031|75838949|FG003|Induction Period|Withdrawal by Subject|2|||
42030482|NCT00941031|75838950|FG004|Induction Period|Withdrawal by Subject|0|||
42030483|NCT00941031|75838951|FG005|Induction Period|Withdrawal by Subject|0|||
42030484|NCT00941031|75838952|FG006|Induction Period|Withdrawal by Subject|0|||
42030485|NCT00941031|75838946|FG000|Induction Period|Adminstative Problems|1|||
42030486|NCT00941031|75838947|FG001|Induction Period|Adminstative Problems|1|||
42030487|NCT00941031|75838948|FG002|Induction Period|Adminstative Problems|1|||
42030488|NCT00941031|75838949|FG003|Induction Period|Adminstative Problems|0|||
42030489|NCT00941031|75838950|FG004|Induction Period|Adminstative Problems|0|||
42030490|NCT00941031|75838951|FG005|Induction Period|Adminstative Problems|0|||
42030491|NCT00941031|75838952|FG006|Induction Period|Adminstative Problems|0|||
42030492|NCT00941031|75838946|FG000|Induction Period|Adverse Event|1|||
42030493|NCT00941031|75838947|FG001|Induction Period|Adverse Event|0|||
42030494|NCT00941031|75838948|FG002|Induction Period|Adverse Event|3|||
42030495|NCT00941031|75838949|FG003|Induction Period|Adverse Event|2|||
42030496|NCT00941031|75838950|FG004|Induction Period|Adverse Event|0|||
42030497|NCT00941031|75838951|FG005|Induction Period|Adverse Event|0|||
42030498|NCT00941031|75838952|FG006|Induction Period|Adverse Event|0|||
42030499|NCT00941031|75838946|FG000|Maintenance Period|Withdrawal by Subject|0|||
42030500|NCT00941031|75838947|FG001|Maintenance Period|Withdrawal by Subject|0|||
42030501|NCT00941031|75838948|FG002|Maintenance Period|Withdrawal by Subject|0|||
42030502|NCT00941031|75838949|FG003|Maintenance Period|Withdrawal by Subject|0|||
42030503|NCT00941031|75838950|FG004|Maintenance Period|Withdrawal by Subject|6|||
42030504|NCT00941031|75838951|FG005|Maintenance Period|Withdrawal by Subject|2|||
42131577|NCT00500292|75942473|FG000|Overall Study|Other|1|||
42131578|NCT00500292|75942474|FG001|Overall Study|Other|1|||
42131579|NCT00500292|75942475|FG002|Overall Study|Other|4|||
41983853|NCT03934684|75790553|FG001|Overall Study|Death|2|||
41983854|NCT03934684|75790552|FG000|Overall Study|Lost to Follow-up|2|||
41983855|NCT03934684|75790553|FG001|Overall Study|Lost to Follow-up|5|||
41983856|NCT03934684|75790552|FG000|Overall Study|Withdrawal by Subject|7|||
41983857|NCT03934684|75790553|FG001|Overall Study|Withdrawal by Subject|8|||
41983858|NCT03880019|75790570|FG000|Overall Study|Competing disease|1|||
41983859|NCT03818035|75790574|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
41983860|NCT03818035|75790575|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
41983861|NCT03818035|75790576|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
41983862|NCT03818035|75790577|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
41983863|NCT03818035|75790574|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
41983864|NCT03818035|75790575|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
41983865|NCT03818035|75790576|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
42030505|NCT00941031|75838952|FG006|Maintenance Period|Withdrawal by Subject|13|||
42030506|NCT00941031|75838946|FG000|Maintenance Period|Administrative Problems|0|||
42030507|NCT00941031|75838947|FG001|Maintenance Period|Administrative Problems|0|||
42030508|NCT00941031|75838948|FG002|Maintenance Period|Administrative Problems|0|||
42030509|NCT00941031|75838949|FG003|Maintenance Period|Administrative Problems|0|||
42030510|NCT00941031|75838950|FG004|Maintenance Period|Administrative Problems|1|||
42030511|NCT00941031|75838951|FG005|Maintenance Period|Administrative Problems|0|||
42030512|NCT00941031|75838952|FG006|Maintenance Period|Administrative Problems|1|||
42030513|NCT00941031|75838946|FG000|Maintenance Period|Protocol Violation|0|||
42030514|NCT00941031|75838947|FG001|Maintenance Period|Protocol Violation|0|||
42030515|NCT00941031|75838948|FG002|Maintenance Period|Protocol Violation|0|||
42131580|NCT00499746|75942483|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
41983866|NCT03818035|75790577|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
41983867|NCT03818035|75790574|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
41983868|NCT03818035|75790575|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
41983869|NCT03818035|75790576|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
42030516|NCT00941031|75838949|FG003|Maintenance Period|Protocol Violation|0|||
42030517|NCT00941031|75838950|FG004|Maintenance Period|Protocol Violation|0|||
42030518|NCT00941031|75838951|FG005|Maintenance Period|Protocol Violation|0|||
42030519|NCT00941031|75838952|FG006|Maintenance Period|Protocol Violation|1|||
42030520|NCT00941031|75838946|FG000|Maintenance Period|Adverse Event|0|||
42030521|NCT00941031|75838947|FG001|Maintenance Period|Adverse Event|0|||
42030522|NCT00941031|75838948|FG002|Maintenance Period|Adverse Event|0|||
42030523|NCT00941031|75838949|FG003|Maintenance Period|Adverse Event|0|||
41983870|NCT03818035|75790577|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
41983871|NCT03818035|75790574|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
41983872|NCT03818035|75790575|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
41983873|NCT03818035|75790576|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
41983874|NCT03818035|75790577|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
41983875|NCT03818035|75790574|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
41983876|NCT03818035|75790575|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
41983877|NCT03818035|75790576|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
41983878|NCT03818035|75790577|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
42030524|NCT00941031|75838950|FG004|Maintenance Period|Adverse Event|0|||
42030525|NCT00941031|75838951|FG005|Maintenance Period|Adverse Event|2|||
42030526|NCT00941031|75838952|FG006|Maintenance Period|Adverse Event|8|||
42030527|NCT00941031|75838946|FG000|Maintenance Period|Lost to Follow-up|0|||
42030528|NCT00941031|75838947|FG001|Maintenance Period|Lost to Follow-up|0|||
42030529|NCT00941031|75838948|FG002|Maintenance Period|Lost to Follow-up|0|||
42030530|NCT00941031|75838949|FG003|Maintenance Period|Lost to Follow-up|0|||
42030531|NCT00941031|75838950|FG004|Maintenance Period|Lost to Follow-up|2|||
42030532|NCT00941031|75838951|FG005|Maintenance Period|Lost to Follow-up|2|||
42030533|NCT00941031|75838952|FG006|Maintenance Period|Lost to Follow-up|7|||
42030534|NCT00941031|75838946|FG000|Maintenance Period|Lack of Efficacy|0|||
41983879|NCT03818035|75790574|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
41983880|NCT03818035|75790575|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
41983881|NCT03818035|75790576|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
41983882|NCT03818035|75790577|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
41983883|NCT03818035|75790574|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
41983884|NCT03818035|75790575|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
41983885|NCT03818035|75790576|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
41983886|NCT03818035|75790577|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
41983887|NCT03818035|75790574|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
41983888|NCT03818035|75790575|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
41983889|NCT03818035|75790576|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
41983890|NCT03818035|75790577|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
41983891|NCT03818035|75790574|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
41983892|NCT03818035|75790575|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
41983893|NCT03818035|75790576|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
41983894|NCT03818035|75790577|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
41983895|NCT03818035|75790574|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
41983896|NCT03818035|75790575|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
41983897|NCT03818035|75790576|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
41983898|NCT03818035|75790577|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
41983899|NCT03818035|75790574|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
41983900|NCT03818035|75790575|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
41983901|NCT03818035|75790576|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
41983902|NCT03818035|75790577|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
41983903|NCT03818035|75790574|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
41983904|NCT03818035|75790575|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
41983905|NCT03818035|75790576|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
41983906|NCT03818035|75790577|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
41983907|NCT03818035|75790574|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
41983908|NCT03818035|75790575|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
41983909|NCT03818035|75790576|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
41983910|NCT03818035|75790577|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
41983911|NCT03818035|75790574|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
41983912|NCT03818035|75790575|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
41983913|NCT03818035|75790576|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
41983914|NCT03818035|75790577|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
41983915|NCT03818035|75790574|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
41983916|NCT03818035|75790575|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
41983917|NCT03818035|75790576|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
41983918|NCT03818035|75790577|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
41983919|NCT03748641|75790591|FG000|Overall Study|Ongoing|155|||
41983920|NCT03748641|75790592|FG001|Overall Study|Ongoing|148|||
41983921|NCT03748641|75790593|FG002|Overall Study|Ongoing|66|||
41983922|NCT03748641|75790594|FG003|Overall Study|Ongoing|79|||
41983923|NCT03748641|75790595|FG004|Overall Study|Ongoing|84|||
41983924|NCT03748641|75790591|FG000|Overall Study|Death|54|||
41983925|NCT03748641|75790592|FG001|Overall Study|Death|59|||
41983926|NCT03748641|75790593|FG002|Overall Study|Death|51|||
41983927|NCT03748641|75790594|FG003|Overall Study|Death|42|||
41983928|NCT03748641|75790595|FG004|Overall Study|Death|9|||
41983929|NCT03748641|75790591|FG000|Overall Study|Lost to Follow-up|0|||
41983930|NCT03748641|75790592|FG001|Overall Study|Lost to Follow-up|2|||
41983931|NCT03748641|75790593|FG002|Overall Study|Lost to Follow-up|1|||
41983932|NCT03748641|75790594|FG003|Overall Study|Lost to Follow-up|0|||
41983933|NCT03748641|75790595|FG004|Overall Study|Lost to Follow-up|0|||
41983934|NCT03748641|75790591|FG000|Overall Study|Withdrawal by Subject|3|||
41983935|NCT03748641|75790592|FG001|Overall Study|Withdrawal by Subject|2|||
41983936|NCT03748641|75790593|FG002|Overall Study|Withdrawal by Subject|5|||
41983937|NCT03748641|75790594|FG003|Overall Study|Withdrawal by Subject|3|||
41983938|NCT03748641|75790595|FG004|Overall Study|Withdrawal by Subject|2|||
41983939|NCT03737994|75790609|FG000|Overall Study|Withdrawal by Subject|0|||
41983940|NCT03737994|75790610|FG001|Overall Study|Withdrawal by Subject|0|||
41983941|NCT03737994|75790611|FG002|Overall Study|Withdrawal by Subject|0|||
42030535|NCT00941031|75838947|FG001|Maintenance Period|Lack of Efficacy|0|||
41983942|NCT03737994|75790612|FG003|Overall Study|Withdrawal by Subject|0|||
41983943|NCT03737994|75790613|FG004|Overall Study|Withdrawal by Subject|0|||
41983944|NCT03737994|75790614|FG005|Overall Study|Withdrawal by Subject|0|||
41983945|NCT03737994|75790615|FG006|Overall Study|Withdrawal by Subject|1|||
41983946|NCT03698019|75790637|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
41983947|NCT03698019|75790638|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
41983948|NCT03698019|75790637|FG000|Step 1: Registration|Withdrawal by Subject|7|||
42131581|NCT00499746|75942483|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
42131582|NCT00499746|75942483|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
41983949|NCT03698019|75790638|FG001|Step 1: Registration|Withdrawal by Subject|2|||
41983950|NCT03698019|75790637|FG000|Step 1: Registration|Toxicity|0|||
41983951|NCT03698019|75790638|FG001|Step 1: Registration|Toxicity|1|||
41983952|NCT03698019|75790637|FG000|Step 1: Registration|Disease Progression|0|||
41983953|NCT03698019|75790638|FG001|Step 1: Registration|Disease Progression|12|||
41983954|NCT03698019|75790637|FG000|Step 1: Registration|Co-morbidities|0|||
41983955|NCT03698019|75790638|FG001|Step 1: Registration|Co-morbidities|1|||
41983956|NCT03698019|75790637|FG000|Step 1: Registration|Scheduling Issues|1|||
41983957|NCT03698019|75790638|FG001|Step 1: Registration|Scheduling Issues|0|||
41983958|NCT03698019|75790637|FG000|Step 1: Registration|Participant Refusal|0|||
41983959|NCT03698019|75790638|FG001|Step 1: Registration|Participant Refusal|1|||
41983960|NCT03698019|75790637|FG000|Step 2: Surgery|Participant Refusal|2|||
41983961|NCT03698019|75790638|FG001|Step 2: Surgery|Participant Refusal|1|||
41983962|NCT03698019|75790637|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
41983963|NCT03698019|75790638|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
41983964|NCT03698019|75790637|FG000|Step 2: Surgery|Metastatic Disease|16|||
41983965|NCT03698019|75790638|FG001|Step 2: Surgery|Metastatic Disease|9|||
41983966|NCT03698019|75790637|FG000|Step 2: Surgery|Residual Disease|2|||
41983967|NCT03698019|75790638|FG001|Step 2: Surgery|Residual Disease|1|||
41983968|NCT03698019|75790637|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
41983969|NCT03698019|75790638|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
41983970|NCT03698019|75790637|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
41983971|NCT03698019|75790638|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
41983972|NCT03698019|75790637|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
41983973|NCT03698019|75790638|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
41983974|NCT03698019|75790637|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
41983975|NCT03698019|75790638|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
41983976|NCT03698019|75790637|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
41983977|NCT03698019|75790638|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
41983978|NCT03698019|75790637|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
41983979|NCT03698019|75790638|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
41983980|NCT03698019|75790637|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
41983981|NCT03698019|75790638|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
41983982|NCT03698019|75790637|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
41983983|NCT03698019|75790638|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
41983984|NCT03674112|75790648|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
41983985|NCT03674112|75790649|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
41983986|NCT03674112|75790648|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
41983987|NCT03674112|75790649|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
41983988|NCT03674112|75790648|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
41983989|NCT03674112|75790649|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
41983990|NCT03674112|75790648|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
41983991|NCT03674112|75790649|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
41983992|NCT03674112|75790648|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
41983993|NCT03674112|75790649|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
41983994|NCT03674112|75790648|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
41983995|NCT03674112|75790649|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
41983996|NCT03674112|75790648|FG000|Follow-Up Period (≥3 Years)|Death|2|||
41983997|NCT03674112|75790649|FG001|Follow-Up Period (≥3 Years)|Death|0|||
41983998|NCT03674112|75790648|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
41983999|NCT03674112|75790649|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
41984000|NCT03673501|75790681|FG000|Overall Study|Participants ongoing.|36|||
41984001|NCT03673501|75790682|FG001|Overall Study|Participants ongoing.|24|||
41984002|NCT03517722|75790699|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
42131583|NCT00499746|75942483|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
42131584|NCT00489216|75942497|FG000|Overall Study|Adverse Event|1|||
41984003|NCT03517722|75790700|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
41984004|NCT03517722|75790699|FG000|Double Blind Period: Week 0-52|Death|0|||
41984005|NCT03517722|75790700|FG001|Double Blind Period: Week 0-52|Death|4|||
41984006|NCT03517722|75790699|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
41984007|NCT03517722|75790700|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
41984008|NCT03517722|75790699|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
42030536|NCT00941031|75838948|FG002|Maintenance Period|Lack of Efficacy|0|||
42030537|NCT00941031|75838949|FG003|Maintenance Period|Lack of Efficacy|0|||
42030538|NCT00941031|75838950|FG004|Maintenance Period|Lack of Efficacy|0|||
42030539|NCT00941031|75838951|FG005|Maintenance Period|Lack of Efficacy|0|||
42030540|NCT00941031|75838952|FG006|Maintenance Period|Lack of Efficacy|13|||
42030541|NCT00886834|75838973|FG000|Overall Study|Protocol Violation|0|||
42030542|NCT00886834|75838974|FG001|Overall Study|Protocol Violation|3|||
42030543|NCT00880009|75838980|FG000|Overall Study|Study terminated by sponsor|14|||
42030544|NCT00880009|75838980|FG000|Overall Study|Withdrawal by Subject|1|||
42030545|NCT00880009|75838980|FG000|Overall Study|Protocol Violation|1|||
42030546|NCT01104636|75838987|FG000|Overall Study|Lack of Efficacy|43|||
42030547|NCT01104636|75838987|FG000|Overall Study|Lost to Follow-up|24|||
42030548|NCT01104636|75838987|FG000|Overall Study|Withdrawal by Subject|4|||
42030549|NCT01104636|75838987|FG000|Overall Study|Other|43|||
42030550|NCT01104636|75838987|FG000|Overall Study|Study terminated by sponsor|1|||
42030551|NCT01104636|75838987|FG000|Overall Study|Pregnancy|2|||
42030552|NCT01104636|75838987|FG000|Overall Study|Adverse Event|40|||
42030553|NCT01104636|75838987|FG000|Overall Study|Ongoing|21|||
42030554|NCT01104558|75838991|FG000|Overall Study|Protocol Violation|6|||
42030555|NCT01104558|75838991|FG000|Overall Study|Missing of primary efficacy assessment|10|||
42030556|NCT01104558|75838991|FG000|Overall Study|Missing of genetic analysis results|1|||
42030557|NCT00886288|75838997|FG000|Overall Study|no respect of the 12 weeks period|657|||
42030558|NCT00886288|75838998|FG001|Overall Study|no respect of the 12 weeks period|227|||
42030559|NCT00886288|75838997|FG000|Overall Study|Lost to Follow-up|86|||
42030560|NCT00886288|75838998|FG001|Overall Study|Lost to Follow-up|0|||
42030561|NCT01204658|75839010|FG000|Primary Phase|Adverse Event|0|||
42030562|NCT01204658|75839011|FG001|Primary Phase|Adverse Event|0|||
42030563|NCT01204658|75839012|FG002|Primary Phase|Adverse Event|1|||
42030564|NCT01204658|75839013|FG003|Primary Phase|Adverse Event|0|||
42030565|NCT00951483|75839028|FG000|Overall Study|Physician Decision|4|||
42030566|NCT00951483|75839029|FG001|Overall Study|Physician Decision|0|||
42030567|NCT00951483|75839028|FG000|Overall Study|Withdrawal by Subject|15|||
42030568|NCT00951483|75839029|FG001|Overall Study|Withdrawal by Subject|0|||
41984009|NCT03517722|75790700|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
41984010|NCT03517722|75790699|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
41984011|NCT03517722|75790700|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
41984012|NCT03517722|75790699|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
41984013|NCT03517722|75790700|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
41984014|NCT03517722|75790699|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
41984015|NCT03517722|75790700|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
41984016|NCT03517722|75790699|FG000|Double Blind Period: Week 0-52|Other|4|||
41984017|NCT03517722|75790700|FG001|Double Blind Period: Week 0-52|Other|3|||
41984018|NCT03517722|75790699|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
41984019|NCT03517722|75790700|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
41984020|NCT03517722|75790699|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
41984021|NCT03517722|75790700|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
41984022|NCT03517722|75790699|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
41984023|NCT03517722|75790700|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
41984024|NCT03517722|75790699|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
41984025|NCT03517722|75790700|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
41984026|NCT03517722|75790699|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
41984027|NCT03517722|75790700|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
41984028|NCT03258593|75790739|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
41984029|NCT03258593|75790740|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
41984030|NCT03258593|75790741|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
41984031|NCT03258593|75790742|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
41984032|NCT03258593|75790739|FG000|Run-In Maintenance Phase|Disease progression|3|||
41984033|NCT03258593|75790740|FG001|Run-In Maintenance Phase|Disease progression|0|||
41984034|NCT03258593|75790741|FG002|Run-In Maintenance Phase|Disease progression|0|||
42030569|NCT01104246|75839037|FG000|Overall Study|Withdrawal by Subject|1|||
42030570|NCT01104246|75839037|FG000|Overall Study|did not meet inclusion criteria|4|||
42030571|NCT01103778|75839041|FG000|Overall Study|Lost to Follow-up|1|||
42030572|NCT01103778|75839041|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
42030573|NCT01103778|75839041|FG000|Overall Study|Screen failure|1|||
42030574|NCT01103466|75839047|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
42030575|NCT01103466|75839048|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
42030576|NCT01103466|75839049|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
42030577|NCT01103466|75839047|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
42030578|NCT01103466|75839048|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
42030579|NCT01103466|75839049|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
42030580|NCT01103466|75839047|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
42030581|NCT01103466|75839048|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
42030582|NCT01103466|75839049|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
42030583|NCT01103466|75839047|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
42030584|NCT01103466|75839048|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
42030585|NCT01103466|75839049|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
42030586|NCT01103466|75839047|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
42030587|NCT01103466|75839048|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
42030588|NCT01103466|75839049|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
42030589|NCT01103466|75839047|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
42030590|NCT01103466|75839048|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
42030591|NCT01103466|75839049|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
42030592|NCT00945945|75839059|FG000|Overall Study|Adverse Event|15|||
42030593|NCT00945945|75839060|FG001|Overall Study|Adverse Event|35|||
42030594|NCT00945945|75839059|FG000|Overall Study|Withdrawal by Subject|7|||
42030595|NCT00945945|75839060|FG001|Overall Study|Withdrawal by Subject|10|||
42030596|NCT00945945|75839059|FG000|Overall Study|Lost to Follow-up|4|||
42030597|NCT00945945|75839060|FG001|Overall Study|Lost to Follow-up|5|||
42030598|NCT00945945|75839059|FG000|Overall Study|Lack of Efficacy|6|||
42030599|NCT00945945|75839060|FG001|Overall Study|Lack of Efficacy|2|||
42030600|NCT00945945|75839059|FG000|Overall Study|Protocol Violation|4|||
42030601|NCT00945945|75839060|FG001|Overall Study|Protocol Violation|2|||
42030602|NCT00945945|75839059|FG000|Overall Study|Entry Criteria Not Met|0|||
42030603|NCT00945945|75839060|FG001|Overall Study|Entry Criteria Not Met|1|||
42030604|NCT01203956|75839066|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
42030605|NCT01203956|75839067|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
42030606|NCT01103232|75839076|FG000|Overall Study|Withdrawal by Subject|1|||
42030607|NCT01103232|75839077|FG001|Overall Study|Withdrawal by Subject|1|||
42030608|NCT01103232|75839076|FG000|Overall Study|Protocol Violation|0|||
42030609|NCT01103232|75839077|FG001|Overall Study|Protocol Violation|1|||
42030610|NCT01112982|75839083|FG000|Overall Study|Withdrawal by Subject|1|||
42030611|NCT01112982|75839083|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
42030612|NCT01203878|75839093|FG000|Overall Study|Withdrawal by Subject|0|||
42030613|NCT01203878|75839094|FG001|Overall Study|Withdrawal by Subject|0|||
42030614|NCT01203878|75839095|FG002|Overall Study|Withdrawal by Subject|1|||
42030615|NCT01203878|75839093|FG000|Overall Study|Adverse Event|0|||
42030616|NCT01203878|75839094|FG001|Overall Study|Adverse Event|0|||
42030617|NCT01203878|75839095|FG002|Overall Study|Adverse Event|2|||
42030618|NCT01112514|75839102|FG000|Overall Study|Lost to Follow-up|1|||
42131585|NCT00499590|75942504|FG000|Overall Study|Study Terminated|112|||
42302318|NCT02490475|76137454|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
42302319|NCT02490475|76137455|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
42302320|NCT02490475|76137456|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
42302321|NCT02490475|76137453|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
42302322|NCT02490475|76137454|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
41984035|NCT03258593|75790742|FG003|Run-In Maintenance Phase|Disease progression|0|||
41984036|NCT03258593|75790739|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
41984037|NCT03258593|75790740|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
41984038|NCT03258593|75790741|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
41984039|NCT03258593|75790742|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
41984040|NCT03258593|75790739|FG000|Expansion Maintenance Phase|Physician Decision|0|||
41984041|NCT03258593|75790740|FG001|Expansion Maintenance Phase|Physician Decision|1|||
41984042|NCT03258593|75790741|FG002|Expansion Maintenance Phase|Physician Decision|0|||
42030619|NCT01203098|75839109|FG000|Overall Study|Adverse Event|3|||
42030620|NCT01203098|75839110|FG001|Overall Study|Adverse Event|1|||
42030621|NCT01203098|75839111|FG002|Overall Study|Adverse Event|7|||
42030622|NCT01203098|75839109|FG000|Overall Study|Lost to Follow-up|0|||
42030623|NCT01203098|75839110|FG001|Overall Study|Lost to Follow-up|0|||
42030624|NCT01203098|75839111|FG002|Overall Study|Lost to Follow-up|1|||
42030625|NCT01203098|75839109|FG000|Overall Study|Physician Decision|2|||
42030626|NCT01203098|75839110|FG001|Overall Study|Physician Decision|2|||
42030627|NCT01203098|75839111|FG002|Overall Study|Physician Decision|0|||
42131586|NCT00499590|75942505|FG001|Overall Study|Study Terminated|112|||
41984043|NCT03258593|75790742|FG003|Expansion Maintenance Phase|Physician Decision|0|||
41984044|NCT03201458|75790755|FG000|Overall Study|No longer eligible|2|||
41984045|NCT03201458|75790756|FG001|Overall Study|No longer eligible|5|||
41984046|NCT03201458|75790755|FG000|Overall Study|Health event before starting|1|||
41984047|NCT03201458|75790756|FG001|Overall Study|Health event before starting|0|||
41984048|NCT03201458|75790755|FG000|Overall Study|Physician Decision|1|||
41984049|NCT03201458|75790756|FG001|Overall Study|Physician Decision|0|||
41984050|NCT02924129|75790789|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
41984051|NCT02924129|75790790|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
41984052|NCT02924129|75790789|FG000|Overall Study|Withdrawal by Subject|2|||
41984053|NCT02924129|75790790|FG001|Overall Study|Withdrawal by Subject|2|||
41984054|NCT02924129|75790789|FG000|Overall Study|Physician Decision|1|||
41984055|NCT02924129|75790790|FG001|Overall Study|Physician Decision|0|||
41984056|NCT02924129|75790789|FG000|Overall Study|Missed Visit|0|||
41984057|NCT02924129|75790790|FG001|Overall Study|Missed Visit|1|||
41984058|NCT02824263|75790798|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
41984059|NCT02824263|75790799|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
41984060|NCT02824263|75790798|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
41984061|NCT02824263|75790799|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
41984062|NCT02814838|75790807|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
41984063|NCT02814838|75790808|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
41984064|NCT02814838|75790807|FG000|Overall Study|Consent withdrawal|1|||
41984065|NCT02814838|75790808|FG001|Overall Study|Consent withdrawal|1|||
41984066|NCT02724878|75790814|FG000|Overall Study|Still on Active Therapy|15|||
41984067|NCT02724878|75790814|FG000|Overall Study|Disease Progression|31|||
41984068|NCT02724878|75790814|FG000|Overall Study|Toxicity|5|||
41984069|NCT02724878|75790814|FG000|Overall Study|Death|1|||
42030628|NCT01203098|75839109|FG000|Overall Study|Withdrawal by Subject|1|||
42030629|NCT01203098|75839110|FG001|Overall Study|Withdrawal by Subject|1|||
42030630|NCT01203098|75839111|FG002|Overall Study|Withdrawal by Subject|3|||
42030631|NCT00945555|75839119|FG000|Overall Study|Referred to another hospital|5|||
42030632|NCT00945555|75839119|FG000|Overall Study|Worsening condition, intensive care unit|1|||
42030633|NCT00945555|75839119|FG000|Overall Study|Withdrawal by Subject|2|||
41984070|NCT02724878|75790814|FG000|Overall Study|Withdrawal by Subject|4|||
41984071|NCT02724878|75790814|FG000|Overall Study|Lost to Follow-up|2|||
41984072|NCT02724878|75790814|FG000|Overall Study|Protocol Violation|1|||
41984073|NCT02724878|75790814|FG000|Overall Study|Ineligible for Study Drug|5|||
41984074|NCT02724878|75790814|FG000|Overall Study|not started|1|||
41984075|NCT02661464|75790822|FG000|Overall Study|Lost to Follow-up|28|||
41984076|NCT02661464|75790823|FG001|Overall Study|Lost to Follow-up|0|||
41984077|NCT02661464|75790824|FG002|Overall Study|Lost to Follow-up|0|||
41984078|NCT02661464|75790825|FG003|Overall Study|Lost to Follow-up|0|||
41984079|NCT02661464|75790822|FG000|Overall Study|Withdrawal by Subject|3|||
41984080|NCT02661464|75790823|FG001|Overall Study|Withdrawal by Subject|1|||
41984081|NCT02661464|75790824|FG002|Overall Study|Withdrawal by Subject|0|||
41984082|NCT02661464|75790825|FG003|Overall Study|Withdrawal by Subject|0|||
41984083|NCT02661464|75790822|FG000|Overall Study|Participants terminated prematurely|288|||
41984084|NCT02661464|75790823|FG001|Overall Study|Participants terminated prematurely|52|||
41984085|NCT02661464|75790824|FG002|Overall Study|Participants terminated prematurely|1|||
41984086|NCT02661464|75790825|FG003|Overall Study|Participants terminated prematurely|1|||
41984087|NCT02661464|75790822|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
41984088|NCT02661464|75790823|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
41984089|NCT02661464|75790824|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
41984090|NCT02661464|75790825|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
41984091|NCT02618408|75790847|FG000|Overall Study|Withdrawal by Subject|1|||
41984092|NCT02618408|75790848|FG001|Overall Study|Withdrawal by Subject|0|||
41984093|NCT02618408|75790849|FG002|Overall Study|Withdrawal by Subject|4|||
41984094|NCT02618408|75790847|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
41984095|NCT02618408|75790848|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
41984096|NCT02618408|75790849|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
41984097|NCT02618408|75790847|FG000|Overall Study|Lost to Follow-up|4|||
41984098|NCT02618408|75790848|FG001|Overall Study|Lost to Follow-up|2|||
42030634|NCT00945555|75839119|FG000|Overall Study|Participant continued treatment at home|1|||
42030635|NCT00945555|75839119|FG000|Overall Study|Death|18|||
42131587|NCT00499590|75942506|FG002|Overall Study|Study Terminated|112|||
41984099|NCT02618408|75790849|FG002|Overall Study|Lost to Follow-up|6|||
41984100|NCT02618408|75790847|FG000|Overall Study|Adverse Event|4|||
41984101|NCT02618408|75790848|FG001|Overall Study|Adverse Event|0|||
41984102|NCT02618408|75790849|FG002|Overall Study|Adverse Event|10|||
41984103|NCT02618408|75790847|FG000|Overall Study|Physician Decision|1|||
41984104|NCT02618408|75790848|FG001|Overall Study|Physician Decision|1|||
41984105|NCT02618408|75790849|FG002|Overall Study|Physician Decision|2|||
41984106|NCT02618408|75790847|FG000|Overall Study|Protocol Violation|1|||
41984107|NCT02618408|75790848|FG001|Overall Study|Protocol Violation|1|||
42030636|NCT00945555|75839119|FG000|Overall Study|Other|1|||
41984108|NCT02618408|75790849|FG002|Overall Study|Protocol Violation|2|||
41984109|NCT02618408|75790847|FG000|Overall Study|Other, Multiple Categories|0|||
41984110|NCT02618408|75790848|FG001|Overall Study|Other, Multiple Categories|0|||
41984111|NCT02618408|75790849|FG002|Overall Study|Other, Multiple Categories|4|||
41984112|NCT02499172|75790864|FG000|Overall Study|Financial reason|0|||
41984113|NCT02499172|75790865|FG001|Overall Study|Financial reason|0|||
41984114|NCT02499172|75790866|FG002|Overall Study|Financial reason|523|||
41984115|NCT02499172|75790867|FG003|Overall Study|Financial reason|436|||
41984116|NCT02499172|75790864|FG000|Overall Study|Lost to Follow-up|65|||
41984117|NCT02499172|75790865|FG001|Overall Study|Lost to Follow-up|64|||
41984118|NCT02499172|75790866|FG002|Overall Study|Lost to Follow-up|0|||
41984119|NCT02499172|75790867|FG003|Overall Study|Lost to Follow-up|0|||
41984120|NCT02446600|75790881|FG000|Overall Study|Never treated|20|||
41984121|NCT02446600|75790882|FG001|Overall Study|Never treated|2|||
42030637|NCT01108458|75839123|FG000|Overall Study|Withdrawal by Subject|1|||
42030638|NCT01108068|75839129|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
42030639|NCT01108068|75839130|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
42030640|NCT01201850|75839137|FG000|Overall Study|Tumor progression|4|||
42030641|NCT00951171|75839143|FG000|Overall Study|Adverse Event|2|||
42030642|NCT00951171|75839144|FG001|Overall Study|Adverse Event|0|||
42030643|NCT01200992|75839152|FG000|Overall Study|Study terminated early|35|||
42030644|NCT01200992|75839153|FG001|Overall Study|Study terminated early|41|||
42030645|NCT01200992|75839152|FG000|Overall Study|Randomized but not treated|2|||
42030646|NCT01200992|75839153|FG001|Overall Study|Randomized but not treated|0|||
42030647|NCT00878215|75839165|FG000|Overall Study|Determined to be ineligible|0|||
42030648|NCT00878215|75839166|FG001|Overall Study|Determined to be ineligible|10|||
42030649|NCT00878215|75839167|FG002|Overall Study|Determined to be ineligible|0|||
42030650|NCT00878215|75839168|FG003|Overall Study|Determined to be ineligible|0|||
42030651|NCT01200758|75839180|FG000|Stage I|Death|0|||
42030652|NCT01200758|75839181|FG001|Stage I|Death|1|||
42030653|NCT01200758|75839182|FG002|Stage I|Death|0|||
42030654|NCT01200758|75839183|FG003|Stage I|Death|0|||
42030655|NCT01200758|75839180|FG000|Stage I|Physician Decision|1|||
41984122|NCT02446600|75790883|FG002|Overall Study|Never treated|6|||
41984123|NCT02446600|75790884|FG003|Overall Study|Never treated|0|||
42030656|NCT01200758|75839181|FG001|Stage I|Physician Decision|1|||
42030657|NCT01200758|75839182|FG002|Stage I|Physician Decision|0|||
42030658|NCT01200758|75839183|FG003|Stage I|Physician Decision|0|||
42030659|NCT01200758|75839180|FG000|Stage I|Lack of Efficacy|2|||
42030660|NCT01200758|75839181|FG001|Stage I|Lack of Efficacy|1|||
42030661|NCT01200758|75839182|FG002|Stage I|Lack of Efficacy|0|||
42030662|NCT01200758|75839183|FG003|Stage I|Lack of Efficacy|0|||
42030663|NCT01200758|75839180|FG000|Stage I|Adverse Event|5|||
42030664|NCT01200758|75839181|FG001|Stage I|Adverse Event|5|||
42030665|NCT01200758|75839182|FG002|Stage I|Adverse Event|0|||
42030666|NCT01200758|75839183|FG003|Stage I|Adverse Event|0|||
42030667|NCT01200758|75839180|FG000|Stage I|Withdrawal by Subject|1|||
42030668|NCT01200758|75839181|FG001|Stage I|Withdrawal by Subject|2|||
42030669|NCT01200758|75839182|FG002|Stage I|Withdrawal by Subject|0|||
42030670|NCT01200758|75839183|FG003|Stage I|Withdrawal by Subject|0|||
42030671|NCT01200758|75839180|FG000|Stage I|Disease Progression|9|||
42030672|NCT01200758|75839181|FG001|Stage I|Disease Progression|7|||
42030673|NCT01200758|75839182|FG002|Stage I|Disease Progression|0|||
42030674|NCT01200758|75839183|FG003|Stage I|Disease Progression|0|||
42030675|NCT01200758|75839180|FG000|Stage 2|Disease Progression|0|||
42030676|NCT01200758|75839181|FG001|Stage 2|Disease Progression|0|||
42030677|NCT01200758|75839182|FG002|Stage 2|Disease Progression|16|||
42030678|NCT01200758|75839183|FG003|Stage 2|Disease Progression|21|||
42030679|NCT01200758|75839180|FG000|Stage 2|Lack of Efficacy|0|||
42030680|NCT01200758|75839181|FG001|Stage 2|Lack of Efficacy|0|||
42224297|NCT03057600|76043219|FG002|Overall Study|Investigator Decision|1|||
41984124|NCT02446600|75790881|FG000|Overall Study|Withdrawal by Subject|19|||
42030681|NCT01200758|75839182|FG002|Stage 2|Lack of Efficacy|4|||
42030682|NCT01200758|75839183|FG003|Stage 2|Lack of Efficacy|2|||
42224298|NCT03057600|76043220|FG003|Overall Study|Investigator Decision|0|||
42224299|NCT03057600|76043217|FG000|Overall Study|Study Termination by Sponsor|0|||
42224300|NCT03057600|76043218|FG001|Overall Study|Study Termination by Sponsor|0|||
42224301|NCT03057600|76043219|FG002|Overall Study|Study Termination by Sponsor|0|||
41984125|NCT02446600|75790882|FG001|Overall Study|Withdrawal by Subject|5|||
41984126|NCT02446600|75790883|FG002|Overall Study|Withdrawal by Subject|17|||
41984127|NCT02446600|75790884|FG003|Overall Study|Withdrawal by Subject|0|||
41984128|NCT02446600|75790881|FG000|Overall Study|Ineligible|1|||
42030683|NCT01200758|75839180|FG000|Stage 2|Physician Decision|0|||
42030684|NCT01200758|75839181|FG001|Stage 2|Physician Decision|0|||
42030685|NCT01200758|75839182|FG002|Stage 2|Physician Decision|5|||
42030686|NCT01200758|75839183|FG003|Stage 2|Physician Decision|7|||
42030687|NCT01200758|75839180|FG000|Stage 2|Adverse Event|0|||
42030688|NCT01200758|75839181|FG001|Stage 2|Adverse Event|0|||
42030689|NCT01200758|75839182|FG002|Stage 2|Adverse Event|5|||
42030690|NCT01200758|75839183|FG003|Stage 2|Adverse Event|9|||
42030691|NCT01200758|75839180|FG000|Stage 2|Withdrawal by Subject|0|||
42030692|NCT01200758|75839181|FG001|Stage 2|Withdrawal by Subject|0|||
42030693|NCT01200758|75839182|FG002|Stage 2|Withdrawal by Subject|4|||
42030694|NCT01200758|75839183|FG003|Stage 2|Withdrawal by Subject|1|||
42030695|NCT01200758|75839180|FG000|Stage 2|Lost to Follow-up|0|||
42030696|NCT01200758|75839181|FG001|Stage 2|Lost to Follow-up|0|||
42030697|NCT01200758|75839182|FG002|Stage 2|Lost to Follow-up|3|||
42030698|NCT01200758|75839183|FG003|Stage 2|Lost to Follow-up|1|||
42030699|NCT01200758|75839180|FG000|Stage 2|Protocol Violation|0|||
42030700|NCT01200758|75839181|FG001|Stage 2|Protocol Violation|0|||
42030701|NCT01200758|75839182|FG002|Stage 2|Protocol Violation|1|||
42030702|NCT01200758|75839183|FG003|Stage 2|Protocol Violation|4|||
42030703|NCT01200758|75839180|FG000|Stage 2|Death|0|||
42030704|NCT01200758|75839181|FG001|Stage 2|Death|0|||
42030705|NCT01200758|75839182|FG002|Stage 2|Death|3|||
42030706|NCT01200758|75839183|FG003|Stage 2|Death|5|||
42030707|NCT00876343|75839198|FG000|Overall Study|Adverse Event|7|||
42030708|NCT00876343|75839199|FG001|Overall Study|Adverse Event|8|||
42030709|NCT00876343|75839200|FG002|Overall Study|Adverse Event|2|||
42030710|NCT00876343|75839198|FG000|Overall Study|Withdrawal by Subject|4|||
42030711|NCT00876343|75839199|FG001|Overall Study|Withdrawal by Subject|4|||
42030712|NCT00876343|75839200|FG002|Overall Study|Withdrawal by Subject|3|||
42030713|NCT00876343|75839198|FG000|Overall Study|Lack of Efficacy|0|||
42030714|NCT00876343|75839199|FG001|Overall Study|Lack of Efficacy|0|||
42030715|NCT00876343|75839200|FG002|Overall Study|Lack of Efficacy|1|||
42030716|NCT00876343|75839198|FG000|Overall Study|Protocol Violation|4|||
42030717|NCT00876343|75839199|FG001|Overall Study|Protocol Violation|1|||
42030718|NCT00876343|75839200|FG002|Overall Study|Protocol Violation|1|||
42030719|NCT00876343|75839198|FG000|Overall Study|Physician Decision|0|||
42030720|NCT00876343|75839199|FG001|Overall Study|Physician Decision|1|||
42030721|NCT00876343|75839200|FG002|Overall Study|Physician Decision|1|||
42030722|NCT00876343|75839198|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
42030723|NCT00876343|75839199|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
42030724|NCT00876343|75839200|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
42030725|NCT00876343|75839198|FG000|Overall Study|Change of residence or other commitments|2|||
42030726|NCT00876343|75839199|FG001|Overall Study|Change of residence or other commitments|2|||
42030727|NCT00876343|75839200|FG002|Overall Study|Change of residence or other commitments|3|||
42030728|NCT01107912|75839212|FG000|Period 1|Adverse Event|0|||
42030729|NCT01107912|75839213|FG001|Period 1|Adverse Event|0|||
42030730|NCT01107912|75839214|FG002|Period 1|Adverse Event|0|||
42030731|NCT01107912|75839215|FG003|Period 1|Adverse Event|0|||
42030732|NCT01107912|75839216|FG004|Period 1|Adverse Event|2|||
42030733|NCT01107912|75839217|FG005|Period 1|Adverse Event|0|||
42030734|NCT01107912|75839212|FG000|Period 1|Physician Decision|0|||
42030735|NCT01107912|75839213|FG001|Period 1|Physician Decision|0|||
42030736|NCT01107912|75839214|FG002|Period 1|Physician Decision|0|||
42030737|NCT01107912|75839215|FG003|Period 1|Physician Decision|0|||
42030738|NCT01107912|75839216|FG004|Period 1|Physician Decision|1|||
42030739|NCT01107912|75839217|FG005|Period 1|Physician Decision|0|||
42030740|NCT01107912|75839212|FG000|Period 1|Withdrawal by Subject|1|||
42030741|NCT01107912|75839213|FG001|Period 1|Withdrawal by Subject|0|||
42030742|NCT01107912|75839214|FG002|Period 1|Withdrawal by Subject|0|||
42030743|NCT01107912|75839215|FG003|Period 1|Withdrawal by Subject|0|||
42030744|NCT01107912|75839216|FG004|Period 1|Withdrawal by Subject|0|||
42030745|NCT01107912|75839217|FG005|Period 1|Withdrawal by Subject|0|||
42030746|NCT01107912|75839212|FG000|Period 2|Physician Decision|0|||
42030747|NCT01107912|75839213|FG001|Period 2|Physician Decision|0|||
42030748|NCT01107912|75839214|FG002|Period 2|Physician Decision|1|||
42030749|NCT01107912|75839215|FG003|Period 2|Physician Decision|0|||
42030750|NCT01107912|75839216|FG004|Period 2|Physician Decision|0|||
42030751|NCT01107912|75839217|FG005|Period 2|Physician Decision|0|||
42030752|NCT01107912|75839212|FG000|Period 3|Adverse Event|0|||
42030753|NCT01107912|75839213|FG001|Period 3|Adverse Event|1|||
42030754|NCT01107912|75839214|FG002|Period 3|Adverse Event|1|||
42030755|NCT01107912|75839215|FG003|Period 3|Adverse Event|0|||
42030756|NCT01107912|75839216|FG004|Period 3|Adverse Event|0|||
42030757|NCT01107912|75839217|FG005|Period 3|Adverse Event|0|||
42030758|NCT01107912|75839212|FG000|Period 3|Withdrawal by Subject|0|||
42030759|NCT01107912|75839213|FG001|Period 3|Withdrawal by Subject|0|||
42030760|NCT01107912|75839214|FG002|Period 3|Withdrawal by Subject|0|||
42030761|NCT01107912|75839215|FG003|Period 3|Withdrawal by Subject|1|||
42030762|NCT01107912|75839216|FG004|Period 3|Withdrawal by Subject|0|||
42030763|NCT01107912|75839217|FG005|Period 3|Withdrawal by Subject|0|||
42030764|NCT01200524|75839235|FG000|Overall Study|Withdrawal by Subject|1|||
42030765|NCT01200524|75839236|FG001|Overall Study|Withdrawal by Subject|1|||
42030766|NCT01200524|75839237|FG002|Overall Study|Withdrawal by Subject|3|||
42030767|NCT01200524|75839235|FG000|Overall Study|Adverse Event|1|||
42030768|NCT01200524|75839236|FG001|Overall Study|Adverse Event|0|||
42030769|NCT01200524|75839237|FG002|Overall Study|Adverse Event|0|||
42030770|NCT01200524|75839235|FG000|Overall Study|Non availability of study nurse|0|||
42030771|NCT01200524|75839236|FG001|Overall Study|Non availability of study nurse|0|||
42030772|NCT01200524|75839237|FG002|Overall Study|Non availability of study nurse|1|||
42030773|NCT01100034|75839245|FG000|Overall Study|Lost to Follow-up|11|||
42030774|NCT01100034|75839245|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
42030775|NCT01100034|75839245|FG000|Overall Study|Withdrawal by Subject|4|||
42030776|NCT01100034|75839245|FG000|Overall Study|Sponsor decision|21|||
42030777|NCT01100034|75839245|FG000|Overall Study|Participated in another clinical trial|1|||
42030778|NCT01100034|75839245|FG000|Overall Study|Participants moved to another hospital|4|||
42030779|NCT01100034|75839245|FG000|Overall Study|Site closed due to non-responsiveness|1|||
42030780|NCT00876265|75839249|FG000|Overall Study|Miscellaneous reasons|4|||
42030781|NCT00876265|75839249|FG000|Overall Study|Lost to Follow-up|6|||
42030782|NCT00876265|75839249|FG000|Overall Study|Withdrawal by Subject|2|||
42030783|NCT01107444|75839257|FG000|Overall Study|Withdrawal by Subject|8|||
42030784|NCT01107444|75839258|FG001|Overall Study|Withdrawal by Subject|12|||
42030785|NCT01107444|75839257|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
42030786|NCT01107444|75839258|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
42030787|NCT00876187|75839272|FG000|Overall Study|Adverse Event|14|||
42030788|NCT00876187|75839273|FG001|Overall Study|Adverse Event|12|||
42030789|NCT00876187|75839274|FG002|Overall Study|Adverse Event|19|||
42030790|NCT00876187|75839275|FG003|Overall Study|Adverse Event|29|||
42030791|NCT00876187|75839276|FG004|Overall Study|Adverse Event|10|||
42030792|NCT00876187|75839272|FG000|Overall Study|Lack of Efficacy|59|||
42030793|NCT00876187|75839273|FG001|Overall Study|Lack of Efficacy|34|||
42030794|NCT00876187|75839274|FG002|Overall Study|Lack of Efficacy|45|||
42030795|NCT00876187|75839275|FG003|Overall Study|Lack of Efficacy|34|||
42030796|NCT00876187|75839276|FG004|Overall Study|Lack of Efficacy|59|||
42030797|NCT00876187|75839272|FG000|Overall Study|Lost to Follow-up|9|||
42030798|NCT00876187|75839273|FG001|Overall Study|Lost to Follow-up|10|||
41984129|NCT02446600|75790882|FG001|Overall Study|Ineligible|4|||
41984130|NCT02446600|75790883|FG002|Overall Study|Ineligible|4|||
41984131|NCT02446600|75790884|FG003|Overall Study|Ineligible|1|||
41984132|NCT02446600|75790881|FG000|Overall Study|Duplicate Enrollment|0|||
41984133|NCT02446600|75790882|FG001|Overall Study|Duplicate Enrollment|1|||
41984134|NCT02446600|75790883|FG002|Overall Study|Duplicate Enrollment|0|||
41984135|NCT02446600|75790884|FG003|Overall Study|Duplicate Enrollment|0|||
41984136|NCT02323880|75790906|FG000|Overall Study|Adverse Event|2|||
42030799|NCT00876187|75839274|FG002|Overall Study|Lost to Follow-up|8|||
42030800|NCT00876187|75839275|FG003|Overall Study|Lost to Follow-up|8|||
42030801|NCT00876187|75839276|FG004|Overall Study|Lost to Follow-up|11|||
42030802|NCT00876187|75839272|FG000|Overall Study|Protocol Violation|6|||
42030803|NCT00876187|75839273|FG001|Overall Study|Protocol Violation|7|||
42030804|NCT00876187|75839274|FG002|Overall Study|Protocol Violation|7|||
42030805|NCT00876187|75839275|FG003|Overall Study|Protocol Violation|6|||
42030806|NCT00876187|75839276|FG004|Overall Study|Protocol Violation|3|||
42030807|NCT00876187|75839272|FG000|Overall Study|Withdrawal by Subject|16|||
41984137|NCT02323880|75790907|FG001|Overall Study|Adverse Event|0|||
41984138|NCT02323880|75790908|FG002|Overall Study|Adverse Event|1|||
41984139|NCT02323880|75790909|FG003|Overall Study|Adverse Event|1|||
41984140|NCT02323880|75790910|FG004|Overall Study|Adverse Event|1|||
41984141|NCT02323880|75790911|FG005|Overall Study|Adverse Event|0|||
41984142|NCT02323880|75790912|FG006|Overall Study|Adverse Event|1|||
41984143|NCT02323880|75790913|FG007|Overall Study|Adverse Event|0|||
41984144|NCT02323880|75790906|FG000|Overall Study|Death|0|||
41984145|NCT02323880|75790907|FG001|Overall Study|Death|0|||
41984146|NCT02323880|75790908|FG002|Overall Study|Death|0|||
41984147|NCT02323880|75790909|FG003|Overall Study|Death|0|||
41984148|NCT02323880|75790910|FG004|Overall Study|Death|0|||
41984149|NCT02323880|75790911|FG005|Overall Study|Death|1|||
42030808|NCT00876187|75839273|FG001|Overall Study|Withdrawal by Subject|26|||
42030809|NCT00876187|75839274|FG002|Overall Study|Withdrawal by Subject|32|||
42030810|NCT00876187|75839275|FG003|Overall Study|Withdrawal by Subject|38|||
42030811|NCT00876187|75839276|FG004|Overall Study|Withdrawal by Subject|37|||
42030812|NCT00876187|75839272|FG000|Overall Study|Entered extension study|101|||
42030813|NCT00876187|75839273|FG001|Overall Study|Entered extension study|120|||
41984150|NCT02323880|75790912|FG006|Overall Study|Death|0|||
42030814|NCT00876187|75839274|FG002|Overall Study|Entered extension study|156|||
42030815|NCT00876187|75839275|FG003|Overall Study|Entered extension study|151|||
42030816|NCT00876187|75839276|FG004|Overall Study|Entered extension study|144|||
42131588|NCT00499590|75942504|FG000|Overall Study|Not treated|1|||
41984151|NCT02323880|75790913|FG007|Overall Study|Death|0|||
41984152|NCT02323880|75790906|FG000|Overall Study|Lack of Efficacy|4|||
41984153|NCT02323880|75790907|FG001|Overall Study|Lack of Efficacy|11|||
42030817|NCT00876187|75839272|FG000|Overall Study|Randomized but not treated|3|||
42030818|NCT00876187|75839273|FG001|Overall Study|Randomized but not treated|1|||
42030819|NCT00876187|75839274|FG002|Overall Study|Randomized but not treated|3|||
42030820|NCT00876187|75839275|FG003|Overall Study|Randomized but not treated|2|||
42030821|NCT00876187|75839276|FG004|Overall Study|Randomized but not treated|3|||
42030822|NCT00876187|75839272|FG000|Overall Study|Other|2|||
42030823|NCT00876187|75839273|FG001|Overall Study|Other|5|||
41984154|NCT02323880|75790908|FG002|Overall Study|Lack of Efficacy|5|||
41984155|NCT02323880|75790909|FG003|Overall Study|Lack of Efficacy|5|||
42030824|NCT00876187|75839274|FG002|Overall Study|Other|9|||
42030825|NCT00876187|75839275|FG003|Overall Study|Other|7|||
42030826|NCT00876187|75839276|FG004|Overall Study|Other|4|||
42030827|NCT01102374|75839293|FG000|Overall Study|Death|9|||
42030828|NCT01102374|75839294|FG001|Overall Study|Death|13|||
42030829|NCT01102374|75839293|FG000|Overall Study|Lost to Follow-up|7|||
42030830|NCT01102374|75839294|FG001|Overall Study|Lost to Follow-up|6|||
42030831|NCT01106976|75839300|FG000|Overall Study|Lost to Follow-up|8|||
42030832|NCT00875485|75839306|FG000|Challenge Dose Epoch|Pregnancy|1|||
42030833|NCT00875485|75839307|FG001|Challenge Dose Epoch|Pregnancy|0|||
42030834|NCT04547140|75839315|FG000|Overall Study|Adverse Event|0|||
42030835|NCT04547140|75839316|FG001|Overall Study|Adverse Event|1|||
42030836|NCT04547140|75839315|FG000|Overall Study|Withdrawal by Subject|0|||
42030837|NCT04547140|75839316|FG001|Overall Study|Withdrawal by Subject|1|||
42030838|NCT04547140|75839315|FG000|Overall Study|Lost to Follow-up|3|||
42030839|NCT04547140|75839316|FG001|Overall Study|Lost to Follow-up|1|||
42030840|NCT04547140|75839315|FG000|Overall Study|Death|2|||
42030841|NCT04547140|75839316|FG001|Overall Study|Death|1|||
42030842|NCT04547140|75839315|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
42030843|NCT04547140|75839316|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
42030844|NCT04547140|75839315|FG000|Overall Study|Pregnancy|1|||
42030845|NCT04547140|75839316|FG001|Overall Study|Pregnancy|0|||
42030846|NCT04547140|75839315|FG000|Overall Study|Reason Not Specified|4|||
42030847|NCT04547140|75839316|FG001|Overall Study|Reason Not Specified|1|||
42030848|NCT01098474|75839328|FG000|Active Phase|Other|0|||
42030849|NCT01098474|75839329|FG001|Active Phase|Other|0|||
42030850|NCT01098474|75839330|FG002|Active Phase|Other|3|||
42030851|NCT01098474|75839331|FG003|Active Phase|Other|0|||
42030852|NCT01098474|75839332|FG004|Active Phase|Other|0|||
42030853|NCT01098474|75839333|FG005|Active Phase|Other|0|||
42030854|NCT01098474|75839328|FG000|Active Phase|Withdrawal by Subject|1|||
42030855|NCT01098474|75839329|FG001|Active Phase|Withdrawal by Subject|1|||
42030856|NCT01098474|75839330|FG002|Active Phase|Withdrawal by Subject|2|||
42030857|NCT01098474|75839331|FG003|Active Phase|Withdrawal by Subject|0|||
42030858|NCT01098474|75839332|FG004|Active Phase|Withdrawal by Subject|0|||
42030859|NCT01098474|75839333|FG005|Active Phase|Withdrawal by Subject|0|||
42030860|NCT01098474|75839328|FG000|Active Phase|Lost to Follow-up|1|||
42030861|NCT01098474|75839329|FG001|Active Phase|Lost to Follow-up|0|||
42030862|NCT01098474|75839330|FG002|Active Phase|Lost to Follow-up|0|||
42030863|NCT01098474|75839331|FG003|Active Phase|Lost to Follow-up|0|||
41984156|NCT02323880|75790910|FG004|Overall Study|Lack of Efficacy|4|||
41984157|NCT02323880|75790911|FG005|Overall Study|Lack of Efficacy|8|||
41984158|NCT02323880|75790912|FG006|Overall Study|Lack of Efficacy|4|||
41984159|NCT02323880|75790913|FG007|Overall Study|Lack of Efficacy|6|||
41984160|NCT02323880|75790906|FG000|Overall Study|Physician Decision|0|||
41984161|NCT02323880|75790907|FG001|Overall Study|Physician Decision|0|||
41984162|NCT02323880|75790908|FG002|Overall Study|Physician Decision|0|||
41984163|NCT02323880|75790909|FG003|Overall Study|Physician Decision|0|||
41984164|NCT02323880|75790910|FG004|Overall Study|Physician Decision|1|||
42030864|NCT01098474|75839332|FG004|Active Phase|Lost to Follow-up|0|||
42030865|NCT01098474|75839333|FG005|Active Phase|Lost to Follow-up|0|||
42030866|NCT01098474|75839328|FG000|Follow Up Phase|Travelled out of study area|0|||
42030867|NCT01098474|75839329|FG001|Follow Up Phase|Travelled out of study area|0|||
42030868|NCT01098474|75839330|FG002|Follow Up Phase|Travelled out of study area|0|||
42030869|NCT01098474|75839331|FG003|Follow Up Phase|Travelled out of study area|0|||
42030870|NCT01098474|75839332|FG004|Follow Up Phase|Travelled out of study area|1|||
42030871|NCT01098474|75839333|FG005|Follow Up Phase|Travelled out of study area|0|||
42030872|NCT01098474|75839328|FG000|Follow Up Phase|Other|0|||
41984165|NCT02323880|75790911|FG005|Overall Study|Physician Decision|1|||
41984166|NCT02323880|75790912|FG006|Overall Study|Physician Decision|1|||
41984167|NCT02323880|75790913|FG007|Overall Study|Physician Decision|0|||
42030873|NCT01098474|75839329|FG001|Follow Up Phase|Other|0|||
42030874|NCT01098474|75839330|FG002|Follow Up Phase|Other|0|||
42030875|NCT01098474|75839331|FG003|Follow Up Phase|Other|0|||
42030876|NCT01098474|75839332|FG004|Follow Up Phase|Other|0|||
42030877|NCT01098474|75839333|FG005|Follow Up Phase|Other|4|||
42030878|NCT01098474|75839328|FG000|Follow Up Phase|Withdrawal by Subject|0|||
41984168|NCT02323880|75790906|FG000|Overall Study|Withdrawal by Subject|0|||
41984169|NCT02323880|75790907|FG001|Overall Study|Withdrawal by Subject|2|||
41984170|NCT02323880|75790908|FG002|Overall Study|Withdrawal by Subject|0|||
42030879|NCT01098474|75839329|FG001|Follow Up Phase|Withdrawal by Subject|0|||
42030880|NCT01098474|75839330|FG002|Follow Up Phase|Withdrawal by Subject|0|||
42030881|NCT01098474|75839331|FG003|Follow Up Phase|Withdrawal by Subject|2|||
42030882|NCT01098474|75839332|FG004|Follow Up Phase|Withdrawal by Subject|0|||
42030883|NCT01098474|75839333|FG005|Follow Up Phase|Withdrawal by Subject|1|||
42030884|NCT01098474|75839328|FG000|Follow Up Phase|Lost to Follow-up|0|||
42030885|NCT01098474|75839329|FG001|Follow Up Phase|Lost to Follow-up|0|||
42030886|NCT01098474|75839330|FG002|Follow Up Phase|Lost to Follow-up|0|||
42030887|NCT01098474|75839331|FG003|Follow Up Phase|Lost to Follow-up|0|||
42030888|NCT01098474|75839332|FG004|Follow Up Phase|Lost to Follow-up|1|||
42030889|NCT01098474|75839333|FG005|Follow Up Phase|Lost to Follow-up|0|||
42030890|NCT00876733|75839361|FG000|Overall Study|Adverse Event|34|||
42030891|NCT00876733|75839362|FG001|Overall Study|Adverse Event|20|||
42030892|NCT00876733|75839363|FG002|Overall Study|Adverse Event|10|||
42030893|NCT00876733|75839364|FG003|Overall Study|Adverse Event|3|||
42030894|NCT00876733|75839361|FG000|Overall Study|Lack of Efficacy|17|||
42030895|NCT00876733|75839362|FG001|Overall Study|Lack of Efficacy|9|||
42030896|NCT00876733|75839363|FG002|Overall Study|Lack of Efficacy|10|||
42030897|NCT00876733|75839364|FG003|Overall Study|Lack of Efficacy|1|||
42030898|NCT00876733|75839361|FG000|Overall Study|Lost to Follow-up|26|||
42030899|NCT00876733|75839362|FG001|Overall Study|Lost to Follow-up|10|||
42030900|NCT00876733|75839363|FG002|Overall Study|Lost to Follow-up|3|||
42030901|NCT00876733|75839364|FG003|Overall Study|Lost to Follow-up|2|||
42030902|NCT00876733|75839361|FG000|Overall Study|Data not available|14|||
42030903|NCT00876733|75839362|FG001|Overall Study|Data not available|3|||
42030904|NCT00876733|75839363|FG002|Overall Study|Data not available|7|||
42030905|NCT00876733|75839364|FG003|Overall Study|Data not available|1|||
42030906|NCT00875017|75839384|FG000|First Intervention|Withdrawal by Subject|1|||
42030907|NCT00875017|75839385|FG001|First Intervention|Withdrawal by Subject|0|||
42030908|NCT00875017|75839386|FG002|First Intervention|Withdrawal by Subject|1|||
42030909|NCT00875017|75839387|FG003|First Intervention|Withdrawal by Subject|0|||
42030910|NCT00875017|75839388|FG004|First Intervention|Withdrawal by Subject|0|||
42030911|NCT00875017|75839389|FG005|First Intervention|Withdrawal by Subject|0|||
42030912|NCT00875017|75839384|FG000|First Intervention|Adverse Event|0|||
42030913|NCT00875017|75839385|FG001|First Intervention|Adverse Event|0|||
42030914|NCT00875017|75839386|FG002|First Intervention|Adverse Event|0|||
42030915|NCT00875017|75839387|FG003|First Intervention|Adverse Event|1|||
42030916|NCT00875017|75839388|FG004|First Intervention|Adverse Event|0|||
42030917|NCT00875017|75839389|FG005|First Intervention|Adverse Event|0|||
42030918|NCT00875017|75839384|FG000|First Intervention|Problems collecting rectal effluent|1|||
42030919|NCT00875017|75839385|FG001|First Intervention|Problems collecting rectal effluent|0|||
42030920|NCT00875017|75839386|FG002|First Intervention|Problems collecting rectal effluent|0|||
42030921|NCT00875017|75839387|FG003|First Intervention|Problems collecting rectal effluent|0|||
42030922|NCT00875017|75839388|FG004|First Intervention|Problems collecting rectal effluent|0|||
42030923|NCT00875017|75839389|FG005|First Intervention|Problems collecting rectal effluent|0|||
42030924|NCT00875017|75839384|FG000|First Intervention|Intolerance to nasogastric tube|0|||
42030925|NCT00875017|75839385|FG001|First Intervention|Intolerance to nasogastric tube|0|||
42030926|NCT00875017|75839386|FG002|First Intervention|Intolerance to nasogastric tube|0|||
42030927|NCT00875017|75839387|FG003|First Intervention|Intolerance to nasogastric tube|0|||
42030928|NCT00875017|75839388|FG004|First Intervention|Intolerance to nasogastric tube|1|||
42030929|NCT00875017|75839389|FG005|First Intervention|Intolerance to nasogastric tube|0|||
42030930|NCT00875017|75839384|FG000|Washout|Problem collecting rectal effluent|0|||
42030931|NCT00875017|75839385|FG001|Washout|Problem collecting rectal effluent|0|||
42302323|NCT02490475|76137455|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
41984171|NCT02323880|75790909|FG003|Overall Study|Withdrawal by Subject|0|||
41984172|NCT02323880|75790910|FG004|Overall Study|Withdrawal by Subject|0|||
41984173|NCT02323880|75790911|FG005|Overall Study|Withdrawal by Subject|0|||
41984174|NCT02323880|75790912|FG006|Overall Study|Withdrawal by Subject|0|||
41984175|NCT02323880|75790913|FG007|Overall Study|Withdrawal by Subject|0|||
41984176|NCT02143414|75790953|FG000|Induction|Adverse Event|1|||
41984177|NCT02143414|75790954|FG001|Induction|Adverse Event|2|||
41984178|NCT02143414|75790953|FG000|Induction|Death|1|||
42030932|NCT00875017|75839386|FG002|Washout|Problem collecting rectal effluent|1|||
42030933|NCT00875017|75839387|FG003|Washout|Problem collecting rectal effluent|0|||
42030934|NCT00875017|75839388|FG004|Washout|Problem collecting rectal effluent|0|||
42030935|NCT00875017|75839389|FG005|Washout|Problem collecting rectal effluent|0|||
42131589|NCT00499590|75942505|FG001|Overall Study|Not treated|0|||
42131590|NCT00499590|75942506|FG002|Overall Study|Not treated|1|||
42131591|NCT00510146|75942517|FG000|Double-Blind Treatment|Adverse Event|30|||
42131592|NCT00510146|75942518|FG001|Double-Blind Treatment|Adverse Event|13|||
42302324|NCT02490475|76137456|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
41984179|NCT02143414|75790954|FG001|Induction|Death|2|||
41984180|NCT02143414|75790953|FG000|Induction|Patient refusal|1|||
41984181|NCT02143414|75790954|FG001|Induction|Patient refusal|1|||
41984182|NCT02143414|75790953|FG000|Induction|Refractory|1|||
42030936|NCT00875017|75839384|FG000|Second Intervention|Adverse Event|0|||
41984183|NCT02143414|75790954|FG001|Induction|Refractory|0|||
42030937|NCT00875017|75839385|FG001|Second Intervention|Adverse Event|0|||
42030938|NCT00875017|75839386|FG002|Second Intervention|Adverse Event|0|||
42030939|NCT00875017|75839387|FG003|Second Intervention|Adverse Event|1|||
42030940|NCT00875017|75839388|FG004|Second Intervention|Adverse Event|0|||
42030941|NCT00875017|75839389|FG005|Second Intervention|Adverse Event|0|||
42030942|NCT00875017|75839384|FG000|Washout|Problems collecting rectal effluent|0|||
42030943|NCT00875017|75839385|FG001|Washout|Problems collecting rectal effluent|1|||
42030944|NCT00875017|75839386|FG002|Washout|Problems collecting rectal effluent|0|||
42030945|NCT00875017|75839387|FG003|Washout|Problems collecting rectal effluent|0|||
42030946|NCT00875017|75839388|FG004|Washout|Problems collecting rectal effluent|0|||
42030947|NCT00875017|75839389|FG005|Washout|Problems collecting rectal effluent|0|||
42030948|NCT00875017|75839384|FG000|Third Intervention|Adverse Event|0|||
42030949|NCT00875017|75839385|FG001|Third Intervention|Adverse Event|1|||
42030950|NCT00875017|75839386|FG002|Third Intervention|Adverse Event|1|||
42030951|NCT00875017|75839387|FG003|Third Intervention|Adverse Event|0|||
42030952|NCT00875017|75839388|FG004|Third Intervention|Adverse Event|0|||
42030953|NCT00875017|75839389|FG005|Third Intervention|Adverse Event|0|||
42030954|NCT00875017|75839384|FG000|Washout|Withdrawal by Subject|0|||
42030955|NCT00875017|75839385|FG001|Washout|Withdrawal by Subject|0|||
42030956|NCT00875017|75839386|FG002|Washout|Withdrawal by Subject|0|||
42030957|NCT00875017|75839387|FG003|Washout|Withdrawal by Subject|0|||
42030958|NCT00875017|75839388|FG004|Washout|Withdrawal by Subject|1|||
42030959|NCT00875017|75839389|FG005|Washout|Withdrawal by Subject|0|||
42030960|NCT00875017|75839384|FG000|Fourth Intervention|Inability to comply with fasting|0|||
42030961|NCT00875017|75839385|FG001|Fourth Intervention|Inability to comply with fasting|0|||
42030962|NCT00875017|75839386|FG002|Fourth Intervention|Inability to comply with fasting|0|||
42030963|NCT00875017|75839387|FG003|Fourth Intervention|Inability to comply with fasting|0|||
42030964|NCT00875017|75839388|FG004|Fourth Intervention|Inability to comply with fasting|0|||
42030965|NCT00875017|75839389|FG005|Fourth Intervention|Inability to comply with fasting|1|||
42030966|NCT00875797|75839414|FG000|Overall Study|Protocol Violation|6|||
42030967|NCT00875797|75839415|FG001|Overall Study|Protocol Violation|3|||
42030968|NCT00874939|75839441|FG000|Overall Study|Study terminated|4|||
42030969|NCT00875563|75839451|FG000|Overall Study|Death|4|||
42030970|NCT00875563|75839451|FG000|Overall Study|Withdrawal by Subject|7|||
42030971|NCT00875563|75839451|FG000|Overall Study|No long-term (3-5 year) consent|6|||
42030972|NCT00875563|75839451|FG000|Overall Study|Still be eligible for follow-up|7|||
42030973|NCT01155869|75839457|FG000|Overall Study|Lost to Follow-up|3|||
42030974|NCT01155869|75839458|FG001|Overall Study|Lost to Follow-up|1|||
42030975|NCT01185353|75839469|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
42030976|NCT01185353|75839470|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
42030977|NCT01185353|75839471|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
42030978|NCT01185353|75839472|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
42030979|NCT01185353|75839473|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
42030980|NCT01185353|75839474|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
42030981|NCT01185353|75839475|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
42030982|NCT01185353|75839476|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
42030983|NCT01185353|75839477|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
42030984|NCT01185353|75839478|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
42030985|NCT01185353|75839469|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
42030986|NCT01185353|75839470|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
42030987|NCT01185353|75839471|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
42030988|NCT01185353|75839472|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
42030989|NCT01185353|75839473|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
42030990|NCT01185353|75839474|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
42030991|NCT01185353|75839475|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
42030992|NCT01185353|75839476|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
42030993|NCT01185353|75839477|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
42030994|NCT01185353|75839478|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
42030995|NCT01185353|75839469|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
42030996|NCT01185353|75839470|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
42030997|NCT01185353|75839471|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
42030998|NCT01185353|75839472|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
42030999|NCT01185353|75839473|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
42031000|NCT01185353|75839474|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
42031001|NCT01185353|75839475|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
42031002|NCT01185353|75839476|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
42031003|NCT01185353|75839477|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
42031004|NCT01185353|75839478|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
42031005|NCT01185353|75839469|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
42031006|NCT01185353|75839470|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
42031007|NCT01185353|75839471|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
42031008|NCT01185353|75839472|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
42031009|NCT01185353|75839473|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
42031010|NCT01185353|75839474|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
42031011|NCT01185353|75839475|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
42031012|NCT01185353|75839476|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
42031013|NCT01185353|75839477|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
42031014|NCT01185353|75839478|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
42031015|NCT01185353|75839469|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
42031016|NCT01185353|75839470|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
42031017|NCT01185353|75839471|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
42031018|NCT01185353|75839472|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
42031019|NCT01185353|75839473|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
42031020|NCT01185353|75839474|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
42031021|NCT01185353|75839475|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
42031022|NCT01185353|75839476|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
42031023|NCT01185353|75839477|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
42031024|NCT01185353|75839478|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
42031025|NCT01185353|75839469|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
42031026|NCT01185353|75839470|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
42031027|NCT01185353|75839471|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
42031028|NCT01185353|75839472|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
42031029|NCT01185353|75839473|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
42031030|NCT01185353|75839474|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
42031031|NCT01185353|75839475|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
42031032|NCT01185353|75839476|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
42031033|NCT01185353|75839477|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
42031034|NCT01185353|75839478|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
42031035|NCT01185353|75839469|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
42031036|NCT01185353|75839470|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
42031037|NCT01185353|75839471|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
42031038|NCT01185353|75839472|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
42031039|NCT01185353|75839473|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
42031040|NCT01185353|75839474|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
42031041|NCT01185353|75839475|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
42031042|NCT01185353|75839476|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
42031043|NCT01185353|75839477|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
42031044|NCT01185353|75839478|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
42031045|NCT01185353|75839469|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
42031046|NCT01185353|75839470|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
42031047|NCT01185353|75839471|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
42031048|NCT01185353|75839472|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
42031049|NCT01185353|75839473|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
42031050|NCT01185353|75839474|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
42031051|NCT01185353|75839475|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
42031052|NCT01185353|75839476|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
42031053|NCT01185353|75839477|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
42031054|NCT01185353|75839478|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
42031055|NCT01185353|75839469|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
42031056|NCT01185353|75839470|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
42031057|NCT01185353|75839471|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
42031058|NCT01185353|75839472|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
42031059|NCT01185353|75839473|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
42031060|NCT01185353|75839474|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
41984184|NCT02143414|75790953|FG000|Induction|Began alternative treatment|1|||
41984185|NCT02143414|75790954|FG001|Induction|Began alternative treatment|0|||
41984186|NCT02143414|75790953|FG000|Induction|Ineligible for postremission|5|||
41984187|NCT02143414|75790954|FG001|Induction|Ineligible for postremission|1|||
41984188|NCT02143414|75790953|FG000|Post-remission|Adverse Event|0|||
41984189|NCT02143414|75790954|FG001|Post-remission|Adverse Event|2|||
41984190|NCT02143414|75790953|FG000|Post-remission|Disease progression/relapse|5|||
41984191|NCT02143414|75790954|FG001|Post-remission|Disease progression/relapse|0|||
41984192|NCT02143414|75790953|FG000|Maintenance|Adverse Event|4|||
41984193|NCT02143414|75790954|FG001|Maintenance|Adverse Event|6|||
42031061|NCT01185353|75839475|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
42031062|NCT01185353|75839476|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
42224302|NCT03057600|76043220|FG003|Overall Study|Study Termination by Sponsor|2|||
42224303|NCT03057600|76043217|FG000|Overall Study|Withdrawal by Subject|0|||
42224304|NCT03057600|76043218|FG001|Overall Study|Withdrawal by Subject|1|||
41984194|NCT02143414|75790953|FG000|Maintenance|Disease progression/relapse|3|||
41984195|NCT02143414|75790954|FG001|Maintenance|Disease progression/relapse|2|||
41984196|NCT02143414|75790953|FG000|Maintenance|Patient refusal|2|||
41984197|NCT02143414|75790954|FG001|Maintenance|Patient refusal|1|||
41984198|NCT02143414|75790953|FG000|Maintenance|Physician Decision|1|||
41984199|NCT02143414|75790954|FG001|Maintenance|Physician Decision|0|||
41984200|NCT02143414|75790953|FG000|Maintenance|Death|0|||
42224305|NCT03057600|76043219|FG002|Overall Study|Withdrawal by Subject|0|||
42224306|NCT03057600|76043220|FG003|Overall Study|Withdrawal by Subject|0|||
42224307|NCT03057600|76043217|FG000|Overall Study|Other, Not Specified|1|||
42224308|NCT03057600|76043218|FG001|Overall Study|Other, Not Specified|1|||
42224309|NCT03057600|76043219|FG002|Overall Study|Other, Not Specified|1|||
41984201|NCT02143414|75790954|FG001|Maintenance|Death|1|||
41984202|NCT02143414|75790953|FG000|Maintenance|On protocol treatment|0|||
41984203|NCT02143414|75790954|FG001|Maintenance|On protocol treatment|6|||
41984204|NCT02115282|75790973|FG000|Overall Study|Disease progression during treatment|216|||
41984205|NCT02115282|75790974|FG001|Overall Study|Disease progression during treatment|229|||
41984206|NCT02115282|75790973|FG000|Overall Study|Adverse Event|49|||
41984207|NCT02115282|75790974|FG001|Overall Study|Adverse Event|23|||
41984208|NCT02115282|75790973|FG000|Overall Study|Death|1|||
41984209|NCT02115282|75790974|FG001|Overall Study|Death|3|||
41984210|NCT02115282|75790973|FG000|Overall Study|Alternative therapy|1|||
41984211|NCT02115282|75790974|FG001|Overall Study|Alternative therapy|1|||
41984212|NCT02115282|75790973|FG000|Overall Study|Complicating disease|0|||
41984213|NCT02115282|75790974|FG001|Overall Study|Complicating disease|3|||
41984214|NCT02115282|75790973|FG000|Overall Study|Withdrawal by Subject|12|||
41984215|NCT02115282|75790974|FG001|Overall Study|Withdrawal by Subject|10|||
41984216|NCT02115282|75790973|FG000|Overall Study|Symptomatic progression/deterioration|7|||
41984217|NCT02115282|75790974|FG001|Overall Study|Symptomatic progression/deterioration|18|||
41984218|NCT02115282|75790973|FG000|Overall Study|Non-compliance|5|||
41984219|NCT02115282|75790974|FG001|Overall Study|Non-compliance|1|||
41984220|NCT02115282|75790973|FG000|Overall Study|Protocol Violation|2|||
41984221|NCT02115282|75790974|FG001|Overall Study|Protocol Violation|2|||
41984222|NCT02115282|75790973|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
41984223|NCT02115282|75790974|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
41984224|NCT02115282|75790973|FG000|Overall Study|Not start protocol therapy|9|||
41984225|NCT02115282|75790974|FG001|Overall Study|Not start protocol therapy|10|||
41984226|NCT01991977|75790982|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
41984227|NCT01991977|75790982|FG000|Overall Study|Withdrew after start of treatment|5|||
41984228|NCT01922076|75790999|FG000|Overall Study|Adverse Event|0|||
41984229|NCT01922076|75791000|FG001|Overall Study|Adverse Event|0|||
41984230|NCT01922076|75791001|FG002|Overall Study|Adverse Event|0|||
41984231|NCT01922076|75791002|FG003|Overall Study|Adverse Event|0|||
41984232|NCT01922076|75791003|FG004|Overall Study|Adverse Event|1|||
41984233|NCT01922076|75791004|FG005|Overall Study|Adverse Event|0|||
41984234|NCT01922076|75791005|FG006|Overall Study|Adverse Event|0|||
41984235|NCT01922076|75790999|FG000|Overall Study|Physician Decision|0|||
41984236|NCT01922076|75791000|FG001|Overall Study|Physician Decision|0|||
41984237|NCT01922076|75791001|FG002|Overall Study|Physician Decision|1|||
41984238|NCT01922076|75791002|FG003|Overall Study|Physician Decision|0|||
41984239|NCT01922076|75791003|FG004|Overall Study|Physician Decision|0|||
41984240|NCT01922076|75791004|FG005|Overall Study|Physician Decision|0|||
41984241|NCT01922076|75791005|FG006|Overall Study|Physician Decision|0|||
41984242|NCT01922076|75790999|FG000|Overall Study|Withdrawal by Subject|0|||
41984243|NCT01922076|75791000|FG001|Overall Study|Withdrawal by Subject|0|||
41984244|NCT01922076|75791001|FG002|Overall Study|Withdrawal by Subject|0|||
41984245|NCT01922076|75791002|FG003|Overall Study|Withdrawal by Subject|1|||
41984246|NCT01922076|75791003|FG004|Overall Study|Withdrawal by Subject|0|||
41984247|NCT01922076|75791004|FG005|Overall Study|Withdrawal by Subject|1|||
41984248|NCT01922076|75791005|FG006|Overall Study|Withdrawal by Subject|1|||
41984249|NCT01854554|75791024|FG000|Overall Study|Denial of Insurance Coverage|12|||
41984250|NCT01854554|75791025|FG001|Overall Study|Denial of Insurance Coverage|0|||
41984251|NCT01854554|75791024|FG000|Overall Study|Decided to get treatment locally|1|||
41984252|NCT01854554|75791025|FG001|Overall Study|Decided to get treatment locally|5|||
41984253|NCT01854554|75791024|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
41984254|NCT01854554|75791025|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
41984255|NCT01854554|75791024|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
41984256|NCT01854554|75791025|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
42031063|NCT01185353|75839477|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
42031064|NCT01185353|75839478|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
42031065|NCT01185353|75839469|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
41984257|NCT01854554|75791024|FG000|Overall Study|Progression|0|||
41984258|NCT01854554|75791025|FG001|Overall Study|Progression|1|||
41984259|NCT01854554|75791024|FG000|Overall Study|Lost to Follow-up|0|||
41984260|NCT01854554|75791025|FG001|Overall Study|Lost to Follow-up|1|||
41984261|NCT01817959|75791033|FG000|Overall Study|Graft loss|1|||
41984262|NCT01817959|75791034|FG001|Overall Study|Graft loss|1|||
41984263|NCT01817959|75791033|FG000|Overall Study|forbidden medication|1|||
41984264|NCT01817959|75791034|FG001|Overall Study|forbidden medication|1|||
41984265|NCT01817959|75791033|FG000|Overall Study|Adverse Event|1|||
41984266|NCT01817959|75791034|FG001|Overall Study|Adverse Event|0|||
41984267|NCT01817959|75791033|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
42031066|NCT01185353|75839470|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
42031067|NCT01185353|75839471|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
42031068|NCT01185353|75839472|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
42031069|NCT01185353|75839473|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
42031070|NCT01185353|75839474|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
42031071|NCT01185353|75839475|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
42031072|NCT01185353|75839476|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
42031073|NCT01185353|75839477|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
42031074|NCT01185353|75839478|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
42031075|NCT01185353|75839469|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
42031076|NCT01185353|75839470|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
42031077|NCT01185353|75839471|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
42031078|NCT01185353|75839472|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
42031079|NCT01185353|75839473|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
42031080|NCT01185353|75839474|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
42031081|NCT01185353|75839475|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
42031082|NCT01185353|75839476|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
42031083|NCT01185353|75839477|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
42031084|NCT01185353|75839478|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
42031085|NCT01185353|75839469|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
42031086|NCT01185353|75839470|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
42031087|NCT01185353|75839471|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
42031088|NCT01185353|75839472|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
42031089|NCT01185353|75839473|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
42031090|NCT01185353|75839474|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
42031091|NCT01185353|75839475|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
42031092|NCT01185353|75839476|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
42031093|NCT01185353|75839477|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
42031094|NCT01185353|75839478|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
42031095|NCT01185353|75839469|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
42031096|NCT01185353|75839470|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
42031097|NCT01185353|75839471|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
42031098|NCT01185353|75839472|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
42031099|NCT01185353|75839473|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
42031100|NCT01185353|75839474|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
42031101|NCT01185353|75839475|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
42031102|NCT01185353|75839476|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
42031103|NCT01185353|75839477|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
42031104|NCT01185353|75839478|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
42031105|NCT01185353|75839469|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
42031106|NCT01185353|75839470|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
42031107|NCT01185353|75839471|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
42031108|NCT01185353|75839472|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
42031109|NCT01185353|75839473|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
42031110|NCT01185353|75839474|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
42131593|NCT00510146|75942517|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
42131594|NCT00510146|75942518|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
42131595|NCT00510146|75942517|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
41984268|NCT01817959|75791034|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
41984269|NCT01755195|75791040|FG000|Overall Study|Participant noncompliance|2|||
41984270|NCT01755195|75791040|FG000|Overall Study|Switched to alternative treatment|4|||
41984271|NCT01755195|75791040|FG000|Overall Study|Withdrawal by Subject|1|||
41984272|NCT01755195|75791040|FG000|Overall Study|Participant refused to start treatment|1|||
41984273|NCT01755195|75791040|FG000|Overall Study|Participant has been consented for another trial|1|||
41984274|NCT01755195|75791040|FG000|Overall Study|Refused further treatment|3|||
41984275|NCT01755195|75791040|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
41984276|NCT01263769|75791051|FG000|Overall Study|Non-Compliant with treatment|1|||
41984277|NCT01004978|75791064|FG000|Overall Study|Disease progression|31|||
41984278|NCT01004978|75791065|FG001|Overall Study|Disease progression|48|||
41984279|NCT01004978|75791064|FG000|Overall Study|Adverse Event|42|||
41984280|NCT01004978|75791065|FG001|Overall Study|Adverse Event|22|||
41984281|NCT01004978|75791064|FG000|Overall Study|Death|3|||
42131596|NCT00510146|75942518|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
41984282|NCT01004978|75791065|FG001|Overall Study|Death|2|||
41984283|NCT01004978|75791064|FG000|Overall Study|Withdrawal by Subject|16|||
41984284|NCT01004978|75791065|FG001|Overall Study|Withdrawal by Subject|16|||
42031111|NCT01185353|75839475|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
42131597|NCT00510146|75942517|FG000|Double-Blind Treatment|Physician Decision|6|||
42131598|NCT00510146|75942518|FG001|Double-Blind Treatment|Physician Decision|0|||
41984285|NCT01004978|75791064|FG000|Overall Study|Alternative therapy|4|||
41984286|NCT01004978|75791065|FG001|Overall Study|Alternative therapy|8|||
41984287|NCT01004978|75791064|FG000|Overall Study|Physician Decision|6|||
41984288|NCT01004978|75791065|FG001|Overall Study|Physician Decision|3|||
41984289|NCT01004978|75791064|FG000|Overall Study|Other complicating disease|2|||
41984290|NCT01004978|75791065|FG001|Overall Study|Other complicating disease|2|||
41984291|NCT01004978|75791064|FG000|Overall Study|Protocol Violation|2|||
41984292|NCT01004978|75791065|FG001|Overall Study|Protocol Violation|3|||
41984293|NCT01004978|75791064|FG000|Overall Study|Non-compliance|3|||
41984294|NCT01004978|75791065|FG001|Overall Study|Non-compliance|2|||
41984295|NCT01004978|75791064|FG000|Overall Study|Ineligible|1|||
41984296|NCT01004978|75791065|FG001|Overall Study|Ineligible|0|||
41984297|NCT01004978|75791064|FG000|Overall Study|Unblinded|0|||
41984298|NCT01004978|75791065|FG001|Overall Study|Unblinded|1|||
41984299|NCT01004978|75791064|FG000|Overall Study|Performance status worsening|0|||
41984300|NCT01004978|75791065|FG001|Overall Study|Performance status worsening|1|||
41984301|NCT01004978|75791064|FG000|Overall Study|Never started treatment|8|||
41984302|NCT01004978|75791065|FG001|Overall Study|Never started treatment|9|||
41984303|NCT00947531|75791073|FG000|Overall Study|Withdrawal by Subject|10|||
41984304|NCT00947531|75791074|FG001|Overall Study|Withdrawal by Subject|7|||
41984305|NCT00947531|75791073|FG000|Overall Study|Administrative Reason|0|||
41984306|NCT00947531|75791074|FG001|Overall Study|Administrative Reason|1|||
41984307|NCT00947531|75791073|FG000|Overall Study|Adverse Event|2|||
41984308|NCT00947531|75791074|FG001|Overall Study|Adverse Event|2|||
41984309|NCT00947531|75791073|FG000|Overall Study|Lack of Efficacy|1|||
41984310|NCT00947531|75791074|FG001|Overall Study|Lack of Efficacy|0|||
41984311|NCT00947531|75791073|FG000|Overall Study|Other|1|||
41984312|NCT00947531|75791074|FG001|Overall Study|Other|1|||
41984313|NCT00643604|75791080|FG000|Overall Study|Death|1|||
41984314|NCT00447382|75791086|FG000|Overall Study|Adverse Event|1|||
41984315|NCT00447382|75791087|FG001|Overall Study|Adverse Event|1|||
41984316|NCT00447382|75791086|FG000|Overall Study|Lack of Efficacy|1|||
41984317|NCT00447382|75791087|FG001|Overall Study|Lack of Efficacy|0|||
41984318|NCT00447382|75791086|FG000|Overall Study|Protocol Violation|2|||
41984319|NCT00447382|75791087|FG001|Overall Study|Protocol Violation|0|||
41984320|NCT00447382|75791086|FG000|Overall Study|Unclassified|2|||
41984321|NCT00447382|75791087|FG001|Overall Study|Unclassified|5|||
41984322|NCT00135668|75791121|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
41984323|NCT00135668|75791122|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
41984324|NCT00135668|75791123|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
41984325|NCT00135668|75791124|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
41984326|NCT00066703|75791155|FG000|Overall Study|Adverse Event|80|||
41984327|NCT00066703|75791156|FG001|Overall Study|Adverse Event|111|||
41984328|NCT00066703|75791155|FG000|Overall Study|Death|3|||
41984329|NCT00066703|75791156|FG001|Overall Study|Death|0|||
41984330|NCT00066703|75791155|FG000|Overall Study|Lack of Efficacy|114|||
41984331|NCT00066703|75791156|FG001|Overall Study|Lack of Efficacy|69|||
41984332|NCT00066703|75791155|FG000|Overall Study|Lost to Follow-up|31|||
41984333|NCT00066703|75791156|FG001|Overall Study|Lost to Follow-up|28|||
41984334|NCT00066703|75791155|FG000|Overall Study|Withdrawal by Subject|38|||
41984335|NCT00066703|75791156|FG001|Overall Study|Withdrawal by Subject|63|||
41984336|NCT00066703|75791155|FG000|Overall Study|Treatment ongoing|346|||
41984337|NCT00066703|75791156|FG001|Overall Study|Treatment ongoing|311|||
41984338|NCT00066690|75791165|FG000|Overall Study|Adverse Event|145|||
41984339|NCT00066690|75791166|FG001|Overall Study|Adverse Event|58|||
41984340|NCT00066690|75791167|FG002|Overall Study|Adverse Event|126|||
41984341|NCT00066690|75791165|FG000|Overall Study|Death|3|||
41984342|NCT00066690|75791166|FG001|Overall Study|Death|0|||
41984343|NCT00066690|75791167|FG002|Overall Study|Death|2|||
41984344|NCT00066690|75791165|FG000|Overall Study|Lack of Efficacy|114|||
41984345|NCT00066690|75791166|FG001|Overall Study|Lack of Efficacy|110|||
41984346|NCT00066690|75791167|FG002|Overall Study|Lack of Efficacy|76|||
41984347|NCT00066690|75791165|FG000|Overall Study|Lost to Follow-up|40|||
41984348|NCT00066690|75791166|FG001|Overall Study|Lost to Follow-up|21|||
41984349|NCT00066690|75791167|FG002|Overall Study|Lost to Follow-up|29|||
41984350|NCT00066690|75791165|FG000|Overall Study|Withdrawal by Subject|50|||
41984351|NCT00066690|75791166|FG001|Overall Study|Withdrawal by Subject|55|||
41984352|NCT00066690|75791167|FG002|Overall Study|Withdrawal by Subject|49|||
41984353|NCT00066690|75791165|FG000|Overall Study|Treatment Ongoing|246|||
41984354|NCT00066690|75791166|FG001|Overall Study|Treatment Ongoing|278|||
41984355|NCT00066690|75791167|FG002|Overall Study|Treatment Ongoing|282|||
41984356|NCT01053962|75791183|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
41984357|NCT01053962|75791184|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
41984358|NCT01053962|75791185|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
41984359|NCT01053962|75791186|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
41984360|NCT01053962|75791187|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
41984361|NCT01053962|75791183|FG000|Pretreatment Period|Venipuncture Failure|0|||
42031112|NCT01185353|75839476|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
41984362|NCT01053962|75791184|FG001|Pretreatment Period|Venipuncture Failure|0|||
41984363|NCT01053962|75791185|FG002|Pretreatment Period|Venipuncture Failure|1|||
41984364|NCT01053962|75791186|FG003|Pretreatment Period|Venipuncture Failure|0|||
41984365|NCT01053962|75791187|FG004|Pretreatment Period|Venipuncture Failure|0|||
41984366|NCT01053962|75791183|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
41984367|NCT01053962|75791184|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
41984368|NCT01053962|75791185|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
42031113|NCT01185353|75839477|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
42031114|NCT01185353|75839478|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
42031115|NCT01185353|75839469|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
42031116|NCT01185353|75839470|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
42031117|NCT01185353|75839471|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
42031118|NCT01185353|75839472|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
42224310|NCT03057600|76043220|FG003|Overall Study|Other, Not Specified|1|||
42224311|NCT03371823|76043250|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
42224312|NCT03371823|76043251|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
42224313|NCT02966301|76043266|FG000|Overall Study|Death|2|||
42224314|NCT02966301|76043266|FG000|Overall Study|Withdrawal by Subject|1|||
42224315|NCT03107091|76043270|FG000|Overall Study|Physician Decision|1|||
42224316|NCT03065400|76043284|FG000|Overall Study|Adverse Event|1|||
42224317|NCT03065400|76043284|FG000|Overall Study|Physician Decision|3|||
42224318|NCT03065400|76043284|FG000|Overall Study|Withdrawal by Subject|1|||
42224319|NCT03065400|76043284|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
42224320|NCT03085095|76043290|FG000|Overall Study|Adverse Event|23|||
42224321|NCT03085095|76043291|FG001|Overall Study|Adverse Event|8|||
42224322|NCT03085095|76043290|FG000|Overall Study|Protocol Violation|0|||
42224323|NCT03085095|76043291|FG001|Overall Study|Protocol Violation|1|||
42224324|NCT03085095|76043290|FG000|Overall Study|Lost to Follow-up|2|||
42224325|NCT03085095|76043291|FG001|Overall Study|Lost to Follow-up|1|||
42224326|NCT03085095|76043290|FG000|Overall Study|Withdrawal by Subject|17|||
42224327|NCT03085095|76043291|FG001|Overall Study|Withdrawal by Subject|6|||
42224328|NCT03085095|76043290|FG000|Overall Study|Physician Decision|9|||
42224329|NCT03085095|76043291|FG001|Overall Study|Physician Decision|3|||
42224330|NCT03085095|76043290|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
42224331|NCT03085095|76043291|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
42224332|NCT03085095|76043290|FG000|Overall Study|Did not Receive Study Drug|2|||
42224333|NCT03085095|76043291|FG001|Overall Study|Did not Receive Study Drug|2|||
42224334|NCT03085095|76043290|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
42224335|NCT03085095|76043291|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
42224336|NCT04097301|76043300|FG000|Overall Study|Death|1|||
42224337|NCT04097301|76043300|FG000|Overall Study|Withdrawal by Subject|1|||
42224338|NCT04097301|76043300|FG000|Overall Study|Screening Failure|5|||
42224339|NCT02276547|76043306|FG000|Overall Study|Death|2|||
42224340|NCT02276547|76043306|FG000|Overall Study|Explant|2|||
42224341|NCT02966834|76043316|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
42224342|NCT02966834|76043317|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
42224343|NCT02966834|76043318|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
42224344|NCT02966834|76043319|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
42224345|NCT02966834|76043320|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
42224346|NCT02966834|76043321|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
42224347|NCT02966834|76043316|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
42224348|NCT02966834|76043317|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
42224349|NCT02966834|76043318|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
42224350|NCT02966834|76043319|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
42224351|NCT02966834|76043320|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
42224352|NCT02966834|76043321|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
42224353|NCT02966834|76043316|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
42224354|NCT02966834|76043317|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
42224355|NCT02966834|76043318|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
42224356|NCT02966834|76043319|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
42224357|NCT02966834|76043320|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
42224358|NCT02966834|76043321|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
42224359|NCT02966834|76043316|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
42224360|NCT02966834|76043317|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
42224361|NCT02966834|76043318|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
42224362|NCT02966834|76043319|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
42224363|NCT02966834|76043320|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
42224364|NCT02966834|76043321|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
42031119|NCT01185353|75839473|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
42031120|NCT01185353|75839474|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
42031121|NCT01185353|75839475|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
42031122|NCT01185353|75839476|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
42031123|NCT01185353|75839477|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
42031124|NCT01185353|75839478|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
42031125|NCT01185353|75839469|FG000|Part C (Weeks 24 Through 76)|Death|0|||
42031126|NCT01185353|75839470|FG001|Part C (Weeks 24 Through 76)|Death|0|||
42031127|NCT01185353|75839471|FG002|Part C (Weeks 24 Through 76)|Death|0|||
42031128|NCT01185353|75839472|FG003|Part C (Weeks 24 Through 76)|Death|0|||
42031129|NCT01185353|75839473|FG004|Part C (Weeks 24 Through 76)|Death|0|||
42031130|NCT01185353|75839474|FG005|Part C (Weeks 24 Through 76)|Death|0|||
42031131|NCT01185353|75839475|FG006|Part C (Weeks 24 Through 76)|Death|0|||
42031132|NCT01185353|75839476|FG007|Part C (Weeks 24 Through 76)|Death|0|||
42031133|NCT01185353|75839477|FG008|Part C (Weeks 24 Through 76)|Death|0|||
42031134|NCT01185353|75839478|FG009|Part C (Weeks 24 Through 76)|Death|1|||
42031135|NCT01185353|75839469|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
42031136|NCT01185353|75839470|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
42031137|NCT01185353|75839471|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
42031138|NCT01185353|75839472|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
42031139|NCT01185353|75839473|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
42031140|NCT01185353|75839474|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
42031141|NCT01185353|75839475|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
42031142|NCT01185353|75839476|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
42031143|NCT01185353|75839477|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
42031144|NCT01185353|75839478|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
42031145|NCT01185353|75839469|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
42031146|NCT01185353|75839470|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
42031147|NCT01185353|75839471|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
42031148|NCT01185353|75839472|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
42031149|NCT01185353|75839473|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
42031150|NCT01185353|75839474|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
42031151|NCT01185353|75839475|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
42031152|NCT01185353|75839476|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
42031153|NCT01185353|75839477|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
42031154|NCT01185353|75839478|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
42031155|NCT01185353|75839469|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
42031156|NCT01185353|75839470|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
42031157|NCT01185353|75839471|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
42031158|NCT01185353|75839472|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
42031159|NCT01185353|75839473|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
42031160|NCT01185353|75839474|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
42031161|NCT01185353|75839475|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
42031162|NCT01185353|75839476|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
42031163|NCT01185353|75839477|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
42031164|NCT01185353|75839478|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
42031165|NCT01185353|75839469|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
42031166|NCT01185353|75839470|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
42031167|NCT01185353|75839471|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
42031168|NCT01185353|75839472|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
42031169|NCT01185353|75839473|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
42031170|NCT01185353|75839474|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
42031171|NCT01185353|75839475|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
42031172|NCT01185353|75839476|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
42031173|NCT01185353|75839477|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
42131599|NCT00510146|75942517|FG000|Double-Blind Treatment|Protocol Violation|1|||
41984369|NCT01053962|75791186|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
41984370|NCT01053962|75791187|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
41984371|NCT01053962|75791183|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
41984372|NCT01053962|75791184|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
41984373|NCT01053962|75791185|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
41984374|NCT01053962|75791186|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
41984375|NCT01053962|75791187|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
41984376|NCT01053962|75791183|FG000|Treatment Period|Lack of Efficacy|0|||
41984377|NCT01053962|75791184|FG001|Treatment Period|Lack of Efficacy|0|||
41984378|NCT01053962|75791185|FG002|Treatment Period|Lack of Efficacy|0|||
41984379|NCT01053962|75791186|FG003|Treatment Period|Lack of Efficacy|0|||
41984380|NCT01053962|75791187|FG004|Treatment Period|Lack of Efficacy|1|||
41984381|NCT01053962|75791183|FG000|Treatment Period|Adverse Event|0|||
41984382|NCT01053962|75791184|FG001|Treatment Period|Adverse Event|0|||
41984383|NCT01053962|75791185|FG002|Treatment Period|Adverse Event|0|||
42031174|NCT01185353|75839478|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
42031175|NCT01185353|75839469|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
42031176|NCT01185353|75839470|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
42031177|NCT01185353|75839471|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
42031178|NCT01185353|75839472|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
42031179|NCT01185353|75839473|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
42031180|NCT01185353|75839474|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
42031181|NCT01185353|75839475|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
42031182|NCT01185353|75839476|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
42031183|NCT01185353|75839477|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
42031184|NCT01185353|75839478|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
42031185|NCT01185353|75839469|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
42031186|NCT01185353|75839470|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
42031187|NCT01185353|75839471|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
42031188|NCT01185353|75839472|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
42031189|NCT01185353|75839473|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
42031190|NCT01185353|75839474|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
42031191|NCT01185353|75839475|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
42031192|NCT01185353|75839476|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
42031193|NCT01185353|75839477|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
42031194|NCT01185353|75839478|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
42031195|NCT01098240|75839517|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
42031196|NCT01098240|75839518|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
41984384|NCT01053962|75791186|FG003|Treatment Period|Adverse Event|0|||
41984385|NCT01053962|75791187|FG004|Treatment Period|Adverse Event|1|||
41984386|NCT01053962|75791183|FG000|Treatment Period|Withdrawal by Subject|0|||
41984387|NCT01053962|75791184|FG001|Treatment Period|Withdrawal by Subject|0|||
41984388|NCT01053962|75791185|FG002|Treatment Period|Withdrawal by Subject|0|||
41984389|NCT01053962|75791186|FG003|Treatment Period|Withdrawal by Subject|0|||
41984390|NCT01053962|75791187|FG004|Treatment Period|Withdrawal by Subject|1|||
41984391|NCT01053962|75791183|FG000|Treatment Period|Noncompliance with protocol|1|||
41984392|NCT01053962|75791184|FG001|Treatment Period|Noncompliance with protocol|0|||
41984393|NCT01053962|75791185|FG002|Treatment Period|Noncompliance with protocol|0|||
41984394|NCT01053962|75791186|FG003|Treatment Period|Noncompliance with protocol|0|||
41984395|NCT01053962|75791187|FG004|Treatment Period|Noncompliance with protocol|0|||
41984396|NCT01053221|75791206|FG000|Overall Study|The study was closed prematurely|5|||
41984397|NCT01053221|75791207|FG001|Overall Study|The study was closed prematurely|9|||
41984398|NCT01052012|75791219|FG000|Overall Study|Not treated|2|||
41984399|NCT01052012|75791220|FG001|Overall Study|Not treated|5|||
41984400|NCT01052012|75791221|FG002|Overall Study|Not treated|0|||
41984401|NCT01052012|75791222|FG003|Overall Study|Not treated|0|||
41984402|NCT01052012|75791223|FG004|Overall Study|Not treated|11|||
41984403|NCT01052012|75791224|FG005|Overall Study|Not treated|8|||
42031197|NCT01098240|75839519|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
42031198|NCT01098240|75839517|FG000|Open-Label Phase|Protocol Violation|4|||
42031199|NCT01098240|75839518|FG001|Open-Label Phase|Protocol Violation|0|||
42131600|NCT00510146|75942518|FG001|Double-Blind Treatment|Protocol Violation|2|||
41984404|NCT01052012|75791219|FG000|Overall Study|Adverse Event|1|||
41984405|NCT01052012|75791220|FG001|Overall Study|Adverse Event|0|||
41984406|NCT01052012|75791221|FG002|Overall Study|Adverse Event|0|||
42031200|NCT01098240|75839519|FG002|Open-Label Phase|Protocol Violation|0|||
42031201|NCT01098240|75839517|FG000|Open-Label Phase|Lost to Follow-up|13|||
42031202|NCT01098240|75839518|FG001|Open-Label Phase|Lost to Follow-up|0|||
42031203|NCT01098240|75839519|FG002|Open-Label Phase|Lost to Follow-up|0|||
42031204|NCT01098240|75839517|FG000|Open-Label Phase|Other|19|||
42031205|NCT01098240|75839518|FG001|Open-Label Phase|Other|0|||
42031206|NCT01098240|75839519|FG002|Open-Label Phase|Other|0|||
42031207|NCT01098240|75839517|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
42031208|NCT01098240|75839518|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
42031209|NCT01098240|75839519|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
42031210|NCT01098240|75839517|FG000|Open-Label Phase|Pregnancy|1|||
42031211|NCT01098240|75839518|FG001|Open-Label Phase|Pregnancy|0|||
42031212|NCT01098240|75839519|FG002|Open-Label Phase|Pregnancy|0|||
42031213|NCT01098240|75839517|FG000|Open-Label Phase|Withdrawal by Subject|9|||
42031214|NCT01098240|75839518|FG001|Open-Label Phase|Withdrawal by Subject|0|||
42031215|NCT01098240|75839519|FG002|Open-Label Phase|Withdrawal by Subject|0|||
42031216|NCT01098240|75839517|FG000|Open-Label Phase|Adverse Event|12|||
42031217|NCT01098240|75839518|FG001|Open-Label Phase|Adverse Event|0|||
42031218|NCT01098240|75839519|FG002|Open-Label Phase|Adverse Event|0|||
42031219|NCT01098240|75839517|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
42031220|NCT01098240|75839518|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
42031221|NCT01098240|75839519|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
42031222|NCT01098240|75839517|FG000|Double-Blind Phase|Protocol Violation|0|||
42031223|NCT01098240|75839518|FG001|Double-Blind Phase|Protocol Violation|2|||
42031224|NCT01098240|75839519|FG002|Double-Blind Phase|Protocol Violation|4|||
42031225|NCT01098240|75839517|FG000|Double-Blind Phase|Lost to Follow-up|0|||
42031226|NCT01098240|75839518|FG001|Double-Blind Phase|Lost to Follow-up|2|||
42031227|NCT01098240|75839519|FG002|Double-Blind Phase|Lost to Follow-up|0|||
42031228|NCT01098240|75839517|FG000|Double-Blind Phase|Other|0|||
42031229|NCT01098240|75839518|FG001|Double-Blind Phase|Other|2|||
42031230|NCT01098240|75839519|FG002|Double-Blind Phase|Other|2|||
42031231|NCT01098240|75839517|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
42031232|NCT01098240|75839518|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
42031233|NCT01098240|75839519|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
42031234|NCT01098240|75839517|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
42031235|NCT01098240|75839518|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
42031236|NCT01098240|75839519|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
42031237|NCT01098240|75839517|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
42031238|NCT01098240|75839518|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
42031239|NCT01098240|75839519|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
42031240|NCT01098240|75839517|FG000|Double-Blind Phase|Adverse Event|0|||
42031241|NCT01098240|75839518|FG001|Double-Blind Phase|Adverse Event|3|||
42031242|NCT01098240|75839519|FG002|Double-Blind Phase|Adverse Event|3|||
42031243|NCT01098162|75839526|FG000|Overall Study|Adverse Event|37|||
42031244|NCT01098162|75839526|FG000|Overall Study|Lack of Efficacy|4|||
42031245|NCT01098162|75839526|FG000|Overall Study|Wish of Patient|7|||
42031246|NCT01098162|75839526|FG000|Overall Study|Lost to Follow-up|9|||
42031247|NCT01098162|75839526|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
42031248|NCT01098162|75839526|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
42031249|NCT01098162|75839526|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
42031250|NCT01098162|75839526|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
42224365|NCT02966834|76043316|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
42131601|NCT00510146|75942517|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
42131602|NCT00510146|75942518|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
42131603|NCT00510146|75942517|FG000|Double-Blind Treatment|Clinical Relapse|0|||
42131604|NCT00510146|75942518|FG001|Double-Blind Treatment|Clinical Relapse|1|||
42131605|NCT00510146|75942517|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
42224366|NCT02966834|76043317|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
42131606|NCT00510146|75942518|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
42031251|NCT01098162|75839526|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
42031252|NCT01098162|75839526|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
42031253|NCT01098162|75839526|FG000|Overall Study|Other Reason|1|||
42031254|NCT01098162|75839526|FG000|Overall Study|Reason Unknown|26|||
42031255|NCT01097694|75839532|FG000|Overall Study|Adverse Event|5|||
42031256|NCT01097694|75839533|FG001|Overall Study|Adverse Event|0|||
42031257|NCT01097694|75839532|FG000|Overall Study|Lost to Follow-up|0|||
42031258|NCT01097694|75839533|FG001|Overall Study|Lost to Follow-up|3|||
42031259|NCT01097694|75839532|FG000|Overall Study|Withdrawal by Subject|3|||
42031260|NCT01097694|75839533|FG001|Overall Study|Withdrawal by Subject|1|||
42031261|NCT01102140|75839541|FG000|Overall Study|Lost to Follow-up|1|||
42031262|NCT01102140|75839542|FG001|Overall Study|Lost to Follow-up|0|||
42031263|NCT01102140|75839541|FG000|Overall Study|Investigator terminated study|2|||
42031264|NCT01102140|75839542|FG001|Overall Study|Investigator terminated study|2|||
42031265|NCT00874549|75839554|FG000|Overall Study|Adverse Event|0|||
42031266|NCT00874549|75839555|FG001|Overall Study|Adverse Event|0|||
42031267|NCT00874549|75839556|FG002|Overall Study|Adverse Event|1|||
42031268|NCT00874549|75839557|FG003|Overall Study|Adverse Event|0|||
42031269|NCT00874549|75839554|FG000|Overall Study|Protocol Violation|1|||
42031270|NCT00874549|75839555|FG001|Overall Study|Protocol Violation|0|||
42031271|NCT00874549|75839556|FG002|Overall Study|Protocol Violation|2|||
42031272|NCT00874549|75839557|FG003|Overall Study|Protocol Violation|1|||
42031273|NCT00874549|75839554|FG000|Overall Study|Lost to Follow-up|0|||
42031274|NCT00874549|75839555|FG001|Overall Study|Lost to Follow-up|0|||
42031275|NCT00874549|75839556|FG002|Overall Study|Lost to Follow-up|1|||
42031276|NCT00874549|75839557|FG003|Overall Study|Lost to Follow-up|0|||
42031277|NCT00874549|75839554|FG000|Overall Study|Withdrawal by Subject|0|||
42031278|NCT00874549|75839555|FG001|Overall Study|Withdrawal by Subject|1|||
42031279|NCT00874549|75839556|FG002|Overall Study|Withdrawal by Subject|0|||
42031280|NCT00874549|75839557|FG003|Overall Study|Withdrawal by Subject|1|||
42031281|NCT01155479|75839572|FG000|Part I|Adverse Event|13|||
42031282|NCT01155479|75839573|FG001|Part I|Adverse Event|8|||
42031283|NCT01155479|75839574|FG002|Part I|Adverse Event|18|||
42031284|NCT01155479|75839575|FG003|Part I|Adverse Event|7|||
42031285|NCT01155479|75839576|FG004|Part I|Adverse Event|6|||
41984407|NCT01052012|75791222|FG003|Overall Study|Adverse Event|1|||
41984408|NCT01052012|75791223|FG004|Overall Study|Adverse Event|0|||
41984409|NCT01052012|75791224|FG005|Overall Study|Adverse Event|0|||
41984410|NCT01052012|75791219|FG000|Overall Study|Lost to Follow-up|0|||
41984411|NCT01052012|75791220|FG001|Overall Study|Lost to Follow-up|0|||
41984412|NCT01052012|75791221|FG002|Overall Study|Lost to Follow-up|0|||
41984413|NCT01052012|75791222|FG003|Overall Study|Lost to Follow-up|0|||
41984414|NCT01052012|75791223|FG004|Overall Study|Lost to Follow-up|1|||
41984415|NCT01052012|75791224|FG005|Overall Study|Lost to Follow-up|0|||
41984416|NCT01052012|75791219|FG000|Overall Study|Withdrawal by Subject|1|||
41984417|NCT01052012|75791220|FG001|Overall Study|Withdrawal by Subject|1|||
42031286|NCT01155479|75839572|FG000|Part I|Administrative|2|||
42031287|NCT01155479|75839573|FG001|Part I|Administrative|2|||
42031288|NCT01155479|75839574|FG002|Part I|Administrative|2|||
41984418|NCT01052012|75791221|FG002|Overall Study|Withdrawal by Subject|0|||
41984419|NCT01052012|75791222|FG003|Overall Study|Withdrawal by Subject|0|||
41984420|NCT01052012|75791223|FG004|Overall Study|Withdrawal by Subject|3|||
42031289|NCT01155479|75839575|FG003|Part I|Administrative|0|||
42031290|NCT01155479|75839576|FG004|Part I|Administrative|0|||
42031291|NCT01155479|75839572|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
42031292|NCT01155479|75839573|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
42031293|NCT01155479|75839574|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
42031294|NCT01155479|75839575|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
42031295|NCT01155479|75839576|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
42031296|NCT01155479|75839572|FG000|Part I|Withdrawal by Subject|11|||
42031297|NCT01155479|75839573|FG001|Part I|Withdrawal by Subject|13|||
42031298|NCT01155479|75839574|FG002|Part I|Withdrawal by Subject|8|||
41984421|NCT01052012|75791224|FG005|Overall Study|Withdrawal by Subject|1|||
41984422|NCT01052012|75791219|FG000|Overall Study|Physician Decision|0|||
41984423|NCT01052012|75791220|FG001|Overall Study|Physician Decision|0|||
41984424|NCT01052012|75791221|FG002|Overall Study|Physician Decision|0|||
41984425|NCT01052012|75791222|FG003|Overall Study|Physician Decision|0|||
42031299|NCT01155479|75839575|FG003|Part I|Withdrawal by Subject|8|||
42031300|NCT01155479|75839576|FG004|Part I|Withdrawal by Subject|9|||
42031301|NCT01155479|75839572|FG000|Part I|Lost to Follow-up|0|||
42031302|NCT01155479|75839573|FG001|Part I|Lost to Follow-up|0|||
42031303|NCT01155479|75839574|FG002|Part I|Lost to Follow-up|1|||
42031304|NCT01155479|75839575|FG003|Part I|Lost to Follow-up|1|||
42031305|NCT01155479|75839576|FG004|Part I|Lost to Follow-up|0|||
41984426|NCT01052012|75791223|FG004|Overall Study|Physician Decision|0|||
41984427|NCT01052012|75791224|FG005|Overall Study|Physician Decision|1|||
41984428|NCT01052012|75791219|FG000|Overall Study|Other|0|||
41984429|NCT01052012|75791220|FG001|Overall Study|Other|0|||
41984430|NCT01052012|75791221|FG002|Overall Study|Other|0|||
41984431|NCT01052012|75791222|FG003|Overall Study|Other|0|||
41984432|NCT01052012|75791223|FG004|Overall Study|Other|1|||
41984433|NCT01052012|75791224|FG005|Overall Study|Other|0|||
42031306|NCT01155479|75839572|FG000|Part I|Treatment Failure|3|||
42031307|NCT01155479|75839573|FG001|Part I|Treatment Failure|0|||
42031308|NCT01155479|75839574|FG002|Part I|Treatment Failure|3|||
42031309|NCT01155479|75839575|FG003|Part I|Treatment Failure|1|||
42031310|NCT01155479|75839576|FG004|Part I|Treatment Failure|2|||
42031311|NCT01155479|75839572|FG000|Part I|Did Not Receive Treatment|4|||
42031312|NCT01155479|75839573|FG001|Part I|Did Not Receive Treatment|2|||
42031313|NCT01155479|75839574|FG002|Part I|Did Not Receive Treatment|2|||
42031314|NCT01155479|75839575|FG003|Part I|Did Not Receive Treatment|6|||
42031315|NCT01155479|75839576|FG004|Part I|Did Not Receive Treatment|1|||
42031316|NCT01155479|75839572|FG000|Part I|Non-Compliance with Protocol|2|||
42031317|NCT01155479|75839573|FG001|Part I|Non-Compliance with Protocol|1|||
42031318|NCT01155479|75839574|FG002|Part I|Non-Compliance with Protocol|3|||
42031319|NCT01155479|75839575|FG003|Part I|Non-Compliance with Protocol|3|||
41984434|NCT01051817|75791240|FG000|Overall Study|Adverse Event|0|||
41984435|NCT01051817|75791241|FG001|Overall Study|Adverse Event|2|||
42031320|NCT01155479|75839576|FG004|Part I|Non-Compliance with Protocol|2|||
42031321|NCT01155479|75839572|FG000|Part II|Adverse Event|7|||
42031322|NCT01155479|75839573|FG001|Part II|Adverse Event|6|||
42031323|NCT01155479|75839574|FG002|Part II|Adverse Event|8|||
42031324|NCT01155479|75839575|FG003|Part II|Adverse Event|3|||
42031325|NCT01155479|75839576|FG004|Part II|Adverse Event|4|||
42031326|NCT01155479|75839572|FG000|Part II|Administrative|43|||
42031327|NCT01155479|75839573|FG001|Part II|Administrative|49|||
42031328|NCT01155479|75839574|FG002|Part II|Administrative|36|||
42031329|NCT01155479|75839575|FG003|Part II|Administrative|38|||
42031330|NCT01155479|75839576|FG004|Part II|Administrative|46|||
42031331|NCT01155479|75839572|FG000|Part II|Withdrawal by Subject|8|||
42031332|NCT01155479|75839573|FG001|Part II|Withdrawal by Subject|4|||
42031333|NCT01155479|75839574|FG002|Part II|Withdrawal by Subject|12|||
42031334|NCT01155479|75839575|FG003|Part II|Withdrawal by Subject|7|||
42031335|NCT01155479|75839576|FG004|Part II|Withdrawal by Subject|3|||
42031336|NCT01155479|75839572|FG000|Part II|Lost to Follow-up|1|||
42031337|NCT01155479|75839573|FG001|Part II|Lost to Follow-up|0|||
42031338|NCT01155479|75839574|FG002|Part II|Lost to Follow-up|0|||
42031339|NCT01155479|75839575|FG003|Part II|Lost to Follow-up|0|||
42031340|NCT01155479|75839576|FG004|Part II|Lost to Follow-up|1|||
42224367|NCT02966834|76043318|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
42224368|NCT02966834|76043319|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
42224369|NCT02966834|76043320|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
42224370|NCT02966834|76043321|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
41984436|NCT01051817|75791240|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
41984437|NCT01051817|75791241|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
41984438|NCT01051817|75791240|FG000|Overall Study|Withdrawal by Subject|3|||
41984439|NCT01051817|75791241|FG001|Overall Study|Withdrawal by Subject|5|||
41984440|NCT01051817|75791240|FG000|Overall Study|Protocol Violation|0|||
42031341|NCT01155479|75839572|FG000|Part II|Treatment Failure|0|||
42031342|NCT01155479|75839573|FG001|Part II|Treatment Failure|1|||
42031343|NCT01155479|75839574|FG002|Part II|Treatment Failure|2|||
42031344|NCT01155479|75839575|FG003|Part II|Treatment Failure|0|||
42031345|NCT01155479|75839576|FG004|Part II|Treatment Failure|1|||
42031346|NCT01155479|75839572|FG000|Part II|Non-Compliance with Protocol|0|||
42031347|NCT01155479|75839573|FG001|Part II|Non-Compliance with Protocol|1|||
42031348|NCT01155479|75839574|FG002|Part II|Non-Compliance with Protocol|0|||
42031349|NCT01155479|75839575|FG003|Part II|Non-Compliance with Protocol|2|||
42031350|NCT01155479|75839576|FG004|Part II|Non-Compliance with Protocol|0|||
42031351|NCT01155323|75839604|FG000|First Intervention|exclusion criteria|1|||
42031352|NCT01155323|75839605|FG001|First Intervention|exclusion criteria|1|||
42031353|NCT01155323|75839604|FG000|Second Intervention|Lost to Follow-up|1|||
42031354|NCT01155323|75839605|FG001|Second Intervention|Lost to Follow-up|1|||
42031355|NCT01155167|75839613|FG000|Overall Study|Insufficient ultrasound data|2|||
42031356|NCT01155167|75839614|FG001|Overall Study|Insufficient ultrasound data|0|||
42031357|NCT01155167|75839613|FG000|Overall Study|Access site changed to femoral artery|1|||
42031358|NCT01155167|75839614|FG001|Overall Study|Access site changed to femoral artery|0|||
41984441|NCT01051817|75791241|FG001|Overall Study|Protocol Violation|1|||
41984442|NCT01327846|75791251|FG000|Core Phase|Subject decision (vital status: missing)|1|||
41984443|NCT01327846|75791252|FG001|Core Phase|Subject decision (vital status: missing)|2|||
41984444|NCT01327846|75791253|FG002|Core Phase|Subject decision (vital status: missing)|2|||
41984445|NCT01327846|75791254|FG003|Core Phase|Subject decision (vital status: missing)|1|||
42031359|NCT01106586|75839622|FG000|Overall Study|Adverse Event|9|||
42031360|NCT01106586|75839623|FG001|Overall Study|Adverse Event|15|||
42031361|NCT01106586|75839622|FG000|Overall Study|Death|1|||
42031362|NCT01106586|75839623|FG001|Overall Study|Death|3|||
42031363|NCT01106586|75839622|FG000|Overall Study|Pregnancy|2|||
42031364|NCT01106586|75839623|FG001|Overall Study|Pregnancy|2|||
42031365|NCT01106586|75839622|FG000|Overall Study|Lack of Efficacy|1|||
42031366|NCT01106586|75839623|FG001|Overall Study|Lack of Efficacy|0|||
42031367|NCT01106586|75839622|FG000|Overall Study|Investigator's Discretion|5|||
42031368|NCT01106586|75839623|FG001|Overall Study|Investigator's Discretion|8|||
42031369|NCT01106586|75839622|FG000|Overall Study|Withdrew Consent|18|||
42031370|NCT01106586|75839623|FG001|Overall Study|Withdrew Consent|30|||
42031371|NCT01106586|75839622|FG000|Overall Study|Lost to Follow-up|24|||
42031372|NCT01106586|75839623|FG001|Overall Study|Lost to Follow-up|20|||
42031373|NCT01106586|75839622|FG000|Overall Study|Participant Noncompliance|12|||
42031374|NCT01106586|75839623|FG001|Overall Study|Participant Noncompliance|10|||
42031375|NCT01106586|75839622|FG000|Overall Study|Protocol Violation|1|||
42031376|NCT01106586|75839623|FG001|Overall Study|Protocol Violation|0|||
42031377|NCT01106586|75839622|FG000|Overall Study|Participant Transferred to Another Study|212|||
42031378|NCT01106586|75839623|FG001|Overall Study|Participant Transferred to Another Study|197|||
42031379|NCT01155011|75839631|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
42031380|NCT01155011|75839632|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
42031381|NCT01155011|75839631|FG000|Baseline to 6 Months|investigator decision, moved|4|||
42031382|NCT01155011|75839632|FG001|Baseline to 6 Months|investigator decision, moved|5|||
42031383|NCT01155011|75839631|FG000|Baseline to 6 Months|Death|0|||
42031384|NCT01155011|75839632|FG001|Baseline to 6 Months|Death|1|||
42031385|NCT01155011|75839631|FG000|6 to 12 Months|Withdrawal by Subject|8|||
42031386|NCT01155011|75839632|FG001|6 to 12 Months|Withdrawal by Subject|5|||
42031387|NCT01155011|75839631|FG000|6 to 12 Months|Death|1|||
42031388|NCT01155011|75839632|FG001|6 to 12 Months|Death|5|||
42031389|NCT01106430|75839644|FG000|Overall Study|Adverse Event|8|||
42031390|NCT01106430|75839645|FG001|Overall Study|Adverse Event|10|||
42031391|NCT01106430|75839644|FG000|Overall Study|Lack of Efficacy|2|||
42031392|NCT01106430|75839645|FG001|Overall Study|Lack of Efficacy|13|||
42031393|NCT01106430|75839644|FG000|Overall Study|Lost to Follow-up|5|||
42031394|NCT01106430|75839645|FG001|Overall Study|Lost to Follow-up|1|||
42031395|NCT01106430|75839644|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
42031396|NCT01106430|75839645|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
42031397|NCT01106430|75839644|FG000|Overall Study|Moved Out Of State|0|||
42031398|NCT01106430|75839645|FG001|Overall Study|Moved Out Of State|1|||
42224371|NCT02966834|76043316|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
42224372|NCT02966834|76043317|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
42224373|NCT02966834|76043318|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
42224374|NCT02966834|76043319|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
42224375|NCT02966834|76043320|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
41984446|NCT01327846|75791251|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
41984447|NCT01327846|75791252|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
41984448|NCT01327846|75791253|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
41984449|NCT01327846|75791254|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
41984450|NCT01327846|75791251|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
42031399|NCT01106430|75839644|FG000|Overall Study|Refused To Take Medication|0|||
42031400|NCT01106430|75839645|FG001|Overall Study|Refused To Take Medication|1|||
42031401|NCT01106430|75839644|FG000|Overall Study|Noncompliance|0|||
42031402|NCT01106430|75839645|FG001|Overall Study|Noncompliance|1|||
42031403|NCT01106430|75839644|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
42031404|NCT01106430|75839645|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
42031405|NCT01106430|75839644|FG000|Overall Study|Previous Use Of Marijuana|1|||
42031406|NCT01106430|75839645|FG001|Overall Study|Previous Use Of Marijuana|0|||
42031407|NCT01106430|75839644|FG000|Overall Study|Protocol Violation|7|||
42031408|NCT01106430|75839645|FG001|Overall Study|Protocol Violation|2|||
42031409|NCT01106430|75839644|FG000|Overall Study|Withdrawal by Subject|8|||
42031410|NCT01106430|75839645|FG001|Overall Study|Withdrawal by Subject|4|||
42031411|NCT01154231|75839651|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
42031412|NCT01154231|75839651|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
42031413|NCT01154153|75839657|FG000|Overall Study|Poor compliance to protocol|2|||
42031414|NCT01154153|75839658|FG001|Overall Study|Poor compliance to protocol|0|||
42031415|NCT01154153|75839657|FG000|Overall Study|Unable to use labs|2|||
42031416|NCT01154153|75839658|FG001|Overall Study|Unable to use labs|3|||
41984451|NCT01327846|75791252|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
42031417|NCT01154153|75839657|FG000|Overall Study|Withdrew consent|1|||
42031418|NCT01154153|75839658|FG001|Overall Study|Withdrew consent|0|||
42031419|NCT00874237|75839664|FG000|Overall Study|Physician Decision|0|||
42031420|NCT00874237|75839665|FG001|Overall Study|Physician Decision|1|||
42031421|NCT00874237|75839666|FG002|Overall Study|Physician Decision|0|||
42031422|NCT00874237|75839667|FG003|Overall Study|Physician Decision|0|||
42031423|NCT00874237|75839668|FG004|Overall Study|Physician Decision|0|||
42031424|NCT00874237|75839669|FG005|Overall Study|Physician Decision|0|||
41984452|NCT01327846|75791253|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
41984453|NCT01327846|75791254|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
41984454|NCT01327846|75791251|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
42031425|NCT00874237|75839664|FG000|Overall Study|Withdrawal by Subject|0|||
42031426|NCT00874237|75839665|FG001|Overall Study|Withdrawal by Subject|0|||
42031427|NCT00874237|75839666|FG002|Overall Study|Withdrawal by Subject|1|||
42031428|NCT00874237|75839667|FG003|Overall Study|Withdrawal by Subject|0|||
42031429|NCT00874237|75839668|FG004|Overall Study|Withdrawal by Subject|0|||
42031430|NCT00874237|75839669|FG005|Overall Study|Withdrawal by Subject|0|||
42031431|NCT01153841|75839681|FG000|Overall Study|Adverse Event|1|||
42031432|NCT01153841|75839682|FG001|Overall Study|Adverse Event|0|||
42031433|NCT01153841|75839681|FG000|Overall Study|Withdrawal by Subject|1|||
42031434|NCT01153841|75839682|FG001|Overall Study|Withdrawal by Subject|0|||
42031435|NCT01153841|75839681|FG000|Overall Study|Protocol Violation|2|||
42031436|NCT01153841|75839682|FG001|Overall Study|Protocol Violation|0|||
42031437|NCT01153841|75839681|FG000|Overall Study|Lost to Follow-up|2|||
42031438|NCT01153841|75839682|FG001|Overall Study|Lost to Follow-up|0|||
42031439|NCT01153763|75839688|FG000|Overall Study|Study Closed|16|||
42031440|NCT01153763|75839688|FG000|Overall Study|Lost to Follow-up|1|||
42031441|NCT01153763|75839688|FG000|Overall Study|Physician Decision|2|||
42031442|NCT01153763|75839688|FG000|Overall Study|Withdrawal by Subject|2|||
42224376|NCT02966834|76043321|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
41984455|NCT01327846|75791252|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
41984456|NCT01327846|75791253|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
41984457|NCT01327846|75791254|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
41984458|NCT01327846|75791251|FG000|Core Phase|Lost to Follow-up|3|||
41984459|NCT01327846|75791252|FG001|Core Phase|Lost to Follow-up|3|||
41984460|NCT01327846|75791253|FG002|Core Phase|Lost to Follow-up|4|||
41984461|NCT01327846|75791254|FG003|Core Phase|Lost to Follow-up|5|||
41984462|NCT01327846|75791251|FG000|Extension Phase|Study terminated by sponsor|1073|||
41984463|NCT01327846|75791252|FG001|Extension Phase|Study terminated by sponsor|1124|||
41984464|NCT01327846|75791253|FG002|Extension Phase|Study terminated by sponsor|1067|||
41984465|NCT01327846|75791254|FG003|Extension Phase|Study terminated by sponsor|1660|||
41984466|NCT01327846|75791251|FG000|Extension Phase|Withdrawal by Subject|20|||
41984467|NCT01327846|75791252|FG001|Extension Phase|Withdrawal by Subject|13|||
41984468|NCT01327846|75791253|FG002|Extension Phase|Withdrawal by Subject|19|||
41984469|NCT01327846|75791254|FG003|Extension Phase|Withdrawal by Subject|37|||
41984470|NCT01327846|75791251|FG000|Extension Phase|Lost to Follow-up|4|||
42031443|NCT00871741|75839694|FG000|Overall Study|Premature study termination|9|||
42031444|NCT00871741|75839695|FG001|Overall Study|Premature study termination|7|||
42031445|NCT01152437|75839704|FG000|Overall Study|Other Adverse Event|8|||
42031446|NCT01152437|75839705|FG001|Overall Study|Other Adverse Event|1|||
41984471|NCT01327846|75791252|FG001|Extension Phase|Lost to Follow-up|3|||
41984472|NCT01327846|75791253|FG002|Extension Phase|Lost to Follow-up|4|||
41984473|NCT01327846|75791254|FG003|Extension Phase|Lost to Follow-up|7|||
41984474|NCT01327846|75791251|FG000|Extension Phase|Technical Problems|2|||
41984475|NCT01327846|75791252|FG001|Extension Phase|Technical Problems|4|||
41984476|NCT01327846|75791253|FG002|Extension Phase|Technical Problems|2|||
41984477|NCT01327846|75791254|FG003|Extension Phase|Technical Problems|2|||
42031447|NCT01152437|75839706|FG002|Overall Study|Other Adverse Event|7|||
42031448|NCT01152437|75839704|FG000|Overall Study|Not treated|0|||
42031449|NCT01152437|75839705|FG001|Overall Study|Not treated|1|||
42031450|NCT01152437|75839706|FG002|Overall Study|Not treated|2|||
42031451|NCT01152437|75839704|FG000|Overall Study|Progressive disease|27|||
42031452|NCT01152437|75839705|FG001|Overall Study|Progressive disease|13|||
42031453|NCT01152437|75839706|FG002|Overall Study|Progressive disease|32|||
42031454|NCT01152437|75839704|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
42224377|NCT03106077|76043370|FG000|Overall Study|Screen Failure|94|||
41984478|NCT01051739|75791267|FG000|Overall Study|Death|3|||
41984479|NCT01051739|75791268|FG001|Overall Study|Death|3|||
41984480|NCT01051739|75791267|FG000|Overall Study|Withdrawal by Subject|25|||
42031455|NCT01152437|75839705|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
42031456|NCT01152437|75839706|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
42031457|NCT01151579|75839718|FG000|Overall Study|Physician Decision|3|||
42031458|NCT01151579|75839719|FG001|Overall Study|Physician Decision|1|||
41984481|NCT01051739|75791268|FG001|Overall Study|Withdrawal by Subject|10|||
41984482|NCT01051661|75791280|FG000|Overall Study|Adverse Event|1|||
42031459|NCT01151579|75839718|FG000|Overall Study|Withdrawal by Subject|3|||
42031460|NCT01151579|75839719|FG001|Overall Study|Withdrawal by Subject|2|||
42031461|NCT01151579|75839718|FG000|Overall Study|Not meet inclusion criteria|6|||
42031462|NCT01151579|75839719|FG001|Overall Study|Not meet inclusion criteria|4|||
42031463|NCT01097616|75839728|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
42031464|NCT01097616|75839729|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
42031465|NCT01097616|75839730|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
42031466|NCT01097616|75839731|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
42031467|NCT01097616|75839732|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
42031468|NCT01097616|75839733|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
42031469|NCT01097616|75839734|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
42031470|NCT01097616|75839735|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
42031471|NCT01097616|75839728|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
42031472|NCT01097616|75839729|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
42031473|NCT01097616|75839730|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
42031474|NCT01097616|75839731|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
42031475|NCT01097616|75839732|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
42031476|NCT01097616|75839733|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
42031477|NCT01097616|75839734|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
42031478|NCT01097616|75839735|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
42031479|NCT01097616|75839728|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
42031480|NCT01097616|75839729|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
42031481|NCT01097616|75839730|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
42031482|NCT01097616|75839731|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
42031483|NCT01097616|75839732|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
42031484|NCT01097616|75839733|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
42031485|NCT01097616|75839734|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
42031486|NCT01097616|75839735|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
42031487|NCT01097616|75839728|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
42031488|NCT01097616|75839729|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
42031489|NCT01097616|75839730|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
42031490|NCT01097616|75839731|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
42031491|NCT01097616|75839732|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
42031492|NCT01097616|75839733|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
42031493|NCT01097616|75839734|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
42031494|NCT01097616|75839735|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
42031495|NCT01097616|75839728|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
42031496|NCT01097616|75839729|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
42031497|NCT01097616|75839730|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
42031498|NCT01097616|75839731|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
42031499|NCT01097616|75839732|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
42031500|NCT01097616|75839733|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
41984483|NCT01051661|75791281|FG001|Overall Study|Adverse Event|1|||
41984484|NCT01051661|75791282|FG002|Overall Study|Adverse Event|1|||
41984485|NCT01051661|75791283|FG003|Overall Study|Adverse Event|1|||
41984486|NCT01051661|75791284|FG004|Overall Study|Adverse Event|0|||
41984487|NCT01051661|75791285|FG005|Overall Study|Adverse Event|0|||
41984488|NCT01051661|75791280|FG000|Overall Study|Lost to Follow-up|13|||
41984489|NCT01051661|75791281|FG001|Overall Study|Lost to Follow-up|22|||
42031501|NCT01097616|75839734|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
42031502|NCT01097616|75839735|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
42224378|NCT03106077|76043371|FG001|Overall Study|Screen Failure|0|||
42031503|NCT01097616|75839728|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
42031504|NCT01097616|75839729|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
42031505|NCT01097616|75839730|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
42031506|NCT01097616|75839731|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
42031507|NCT01097616|75839732|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
42031508|NCT01097616|75839733|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
42031509|NCT01097616|75839734|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
42031510|NCT01097616|75839735|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
42031511|NCT01097616|75839728|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
42031512|NCT01097616|75839729|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
42031513|NCT01097616|75839730|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42031514|NCT01097616|75839731|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42031515|NCT01097616|75839732|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42031516|NCT01097616|75839733|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42031517|NCT01097616|75839734|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42031518|NCT01097616|75839735|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42031519|NCT01097616|75839728|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42031520|NCT01097616|75839729|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42031521|NCT01097616|75839730|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
42031522|NCT01097616|75839731|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42031523|NCT01097616|75839732|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42031524|NCT01097616|75839733|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42031525|NCT01097616|75839734|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42031526|NCT01097616|75839735|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42031527|NCT01097616|75839728|FG000|Optional DB EXT Phase|Adverse Event|0|||
42031528|NCT01097616|75839729|FG001|Optional DB EXT Phase|Adverse Event|7|||
42031529|NCT01097616|75839730|FG002|Optional DB EXT Phase|Adverse Event|2|||
42031530|NCT01097616|75839731|FG003|Optional DB EXT Phase|Adverse Event|0|||
42031531|NCT01097616|75839732|FG004|Optional DB EXT Phase|Adverse Event|0|||
42031532|NCT01097616|75839733|FG005|Optional DB EXT Phase|Adverse Event|0|||
42031533|NCT01097616|75839734|FG006|Optional DB EXT Phase|Adverse Event|0|||
42031534|NCT01097616|75839735|FG007|Optional DB EXT Phase|Adverse Event|0|||
42031535|NCT01097616|75839728|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
42031536|NCT01097616|75839729|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
42031537|NCT01097616|75839730|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
42031538|NCT01097616|75839731|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
42031539|NCT01097616|75839732|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
42031540|NCT01097616|75839733|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
42031541|NCT01097616|75839734|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
42031542|NCT01097616|75839735|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
42031543|NCT01097616|75839728|FG000|Optional DB EXT Phase|Protocol Violation|0|||
42031544|NCT01097616|75839729|FG001|Optional DB EXT Phase|Protocol Violation|2|||
42031545|NCT01097616|75839730|FG002|Optional DB EXT Phase|Protocol Violation|3|||
41984490|NCT01051661|75791282|FG002|Overall Study|Lost to Follow-up|15|||
41984491|NCT01051661|75791283|FG003|Overall Study|Lost to Follow-up|17|||
41984492|NCT01051661|75791284|FG004|Overall Study|Lost to Follow-up|10|||
41984493|NCT01051661|75791285|FG005|Overall Study|Lost to Follow-up|24|||
41984494|NCT01051661|75791280|FG000|Overall Study|Migrated/moved from study area|1|||
41984495|NCT01051661|75791281|FG001|Overall Study|Migrated/moved from study area|6|||
41984496|NCT01051661|75791282|FG002|Overall Study|Migrated/moved from study area|6|||
41984497|NCT01051661|75791283|FG003|Overall Study|Migrated/moved from study area|8|||
41984498|NCT01051661|75791284|FG004|Overall Study|Migrated/moved from study area|7|||
41984499|NCT01051661|75791285|FG005|Overall Study|Migrated/moved from study area|3|||
41984500|NCT01051661|75791280|FG000|Overall Study|Refused blood sampling|0|||
41984501|NCT01051661|75791281|FG001|Overall Study|Refused blood sampling|0|||
41984502|NCT01051661|75791282|FG002|Overall Study|Refused blood sampling|0|||
41984503|NCT01051661|75791283|FG003|Overall Study|Refused blood sampling|0|||
41984504|NCT01051661|75791284|FG004|Overall Study|Refused blood sampling|0|||
41984505|NCT01051661|75791285|FG005|Overall Study|Refused blood sampling|1|||
41984506|NCT01051661|75791280|FG000|Overall Study|Data not reliable|1|||
41984507|NCT01051661|75791281|FG001|Overall Study|Data not reliable|0|||
41984508|NCT01051661|75791282|FG002|Overall Study|Data not reliable|0|||
42031546|NCT01097616|75839731|FG003|Optional DB EXT Phase|Protocol Violation|0|||
42031547|NCT01097616|75839732|FG004|Optional DB EXT Phase|Protocol Violation|0|||
42031548|NCT01097616|75839733|FG005|Optional DB EXT Phase|Protocol Violation|0|||
42031549|NCT01097616|75839734|FG006|Optional DB EXT Phase|Protocol Violation|0|||
42031550|NCT01097616|75839735|FG007|Optional DB EXT Phase|Protocol Violation|0|||
42031551|NCT01097616|75839728|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
42031552|NCT01097616|75839729|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
42031553|NCT01097616|75839730|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
42031554|NCT01097616|75839731|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
42031555|NCT01097616|75839732|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
42031556|NCT01097616|75839733|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
42031557|NCT01097616|75839734|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
42031558|NCT01097616|75839735|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
42031559|NCT01097616|75839728|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
42031560|NCT01097616|75839729|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
42031561|NCT01097616|75839730|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
42031562|NCT01097616|75839731|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
42031563|NCT01097616|75839732|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
42031564|NCT01097616|75839733|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
42031565|NCT01097616|75839734|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
42031566|NCT01097616|75839735|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
42031567|NCT01097616|75839728|FG000|Optional DB EXT Phase|Physician Decision|1|||
42031568|NCT01097616|75839729|FG001|Optional DB EXT Phase|Physician Decision|0|||
42031569|NCT01097616|75839730|FG002|Optional DB EXT Phase|Physician Decision|0|||
42031570|NCT01097616|75839731|FG003|Optional DB EXT Phase|Physician Decision|0|||
42031571|NCT01097616|75839732|FG004|Optional DB EXT Phase|Physician Decision|0|||
42031572|NCT01097616|75839733|FG005|Optional DB EXT Phase|Physician Decision|0|||
42031573|NCT01097616|75839734|FG006|Optional DB EXT Phase|Physician Decision|0|||
42031574|NCT01097616|75839735|FG007|Optional DB EXT Phase|Physician Decision|0|||
42031575|NCT01097616|75839728|FG000|DB RO Phase|Adverse Event|0|||
42031576|NCT01097616|75839729|FG001|DB RO Phase|Adverse Event|0|||
42031577|NCT01097616|75839730|FG002|DB RO Phase|Adverse Event|0|||
42031578|NCT01097616|75839731|FG003|DB RO Phase|Adverse Event|0|||
42031579|NCT01097616|75839732|FG004|DB RO Phase|Adverse Event|0|||
42031580|NCT01097616|75839733|FG005|DB RO Phase|Adverse Event|0|||
42031581|NCT01097616|75839734|FG006|DB RO Phase|Adverse Event|1|||
42031582|NCT01097616|75839735|FG007|DB RO Phase|Adverse Event|0|||
42031583|NCT01097616|75839728|FG000|DB RO Phase|Withdrawal by Subject|0|||
42031584|NCT01097616|75839729|FG001|DB RO Phase|Withdrawal by Subject|0|||
42031585|NCT01097616|75839730|FG002|DB RO Phase|Withdrawal by Subject|0|||
42031586|NCT01097616|75839731|FG003|DB RO Phase|Withdrawal by Subject|0|||
42031587|NCT01097616|75839732|FG004|DB RO Phase|Withdrawal by Subject|0|||
42031588|NCT01097616|75839733|FG005|DB RO Phase|Withdrawal by Subject|1|||
42031589|NCT01097616|75839734|FG006|DB RO Phase|Withdrawal by Subject|0|||
42031590|NCT01097616|75839735|FG007|DB RO Phase|Withdrawal by Subject|0|||
42031591|NCT01097616|75839728|FG000|DB RO Phase|Lost to Follow-up|0|||
42031592|NCT01097616|75839729|FG001|DB RO Phase|Lost to Follow-up|0|||
42031593|NCT01097616|75839730|FG002|DB RO Phase|Lost to Follow-up|0|||
42031594|NCT01097616|75839731|FG003|DB RO Phase|Lost to Follow-up|1|||
42131607|NCT00510146|75942517|FG000|Open-Label Treatment|Adverse Event|22|||
42224379|NCT03105297|76043376|FG000|Baseline Phase (Day 1)|Other|21|||
42224380|NCT03105297|76043376|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
42224381|NCT03105297|76043376|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
41984509|NCT01051661|75791283|FG003|Overall Study|Data not reliable|0|||
41984510|NCT01051661|75791284|FG004|Overall Study|Data not reliable|0|||
41984511|NCT01051661|75791285|FG005|Overall Study|Data not reliable|1|||
41984512|NCT01051661|75791280|FG000|Overall Study|Unable to attend visit(s)|2|||
41984513|NCT01051661|75791281|FG001|Overall Study|Unable to attend visit(s)|4|||
41984514|NCT01051661|75791282|FG002|Overall Study|Unable to attend visit(s)|2|||
41984515|NCT01051661|75791283|FG003|Overall Study|Unable to attend visit(s)|1|||
41984516|NCT01051661|75791284|FG004|Overall Study|Unable to attend visit(s)|3|||
41984517|NCT01051661|75791285|FG005|Overall Study|Unable to attend visit(s)|2|||
41984518|NCT01051661|75791280|FG000|Overall Study|Consent not received from both parents|0|||
41984519|NCT01051661|75791281|FG001|Overall Study|Consent not received from both parents|0|||
41984520|NCT01051661|75791282|FG002|Overall Study|Consent not received from both parents|0|||
41984521|NCT01051661|75791283|FG003|Overall Study|Consent not received from both parents|0|||
41984522|NCT01051661|75791284|FG004|Overall Study|Consent not received from both parents|0|||
41984523|NCT01051661|75791285|FG005|Overall Study|Consent not received from both parents|1|||
41984524|NCT01051661|75791280|FG000|Overall Study|Failure to comply with protocol|0|||
41984525|NCT01051661|75791281|FG001|Overall Study|Failure to comply with protocol|0|||
42031595|NCT01097616|75839732|FG004|DB RO Phase|Lost to Follow-up|1|||
42031596|NCT01097616|75839733|FG005|DB RO Phase|Lost to Follow-up|0|||
42031597|NCT01097616|75839734|FG006|DB RO Phase|Lost to Follow-up|0|||
42031598|NCT01097616|75839735|FG007|DB RO Phase|Lost to Follow-up|1|||
42031599|NCT01097616|75839728|FG000|DB RO Phase|Not Treated in RO|0|||
42031600|NCT01097616|75839729|FG001|DB RO Phase|Not Treated in RO|0|||
42031601|NCT01097616|75839730|FG002|DB RO Phase|Not Treated in RO|0|||
42031602|NCT01097616|75839731|FG003|DB RO Phase|Not Treated in RO|0|||
42031603|NCT01097616|75839732|FG004|DB RO Phase|Not Treated in RO|0|||
42031604|NCT01097616|75839733|FG005|DB RO Phase|Not Treated in RO|1|||
42031605|NCT01097616|75839734|FG006|DB RO Phase|Not Treated in RO|0|||
42031606|NCT01097616|75839735|FG007|DB RO Phase|Not Treated in RO|0|||
42031607|NCT00871429|75839761|FG000|Overall Study|Lost to Follow-up|6|||
42031608|NCT00871429|75839761|FG000|Overall Study|Withdrawal by Subject|17|||
42031609|NCT00871429|75839761|FG000|Overall Study|Questionnaire not completed|1|||
42031610|NCT01151345|75839769|FG000|First Intervention Period|Protocol Violation|0|||
42031611|NCT01151345|75839770|FG001|First Intervention Period|Protocol Violation|1|||
42031612|NCT00593827|75839778|FG000|Overall Study|On Active Treatment/Pending|0|||
42031613|NCT00593827|75839779|FG001|Overall Study|On Active Treatment/Pending|2|||
42031614|NCT01150097|75839788|FG000|Months 24 to 36 Post-transplantation|Death|2|||
42031615|NCT01150097|75839789|FG001|Months 24 to 36 Post-transplantation|Death|0|||
42031616|NCT01150097|75839790|FG002|Months 24 to 36 Post-transplantation|Death|0|||
42031617|NCT01150097|75839788|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
42031618|NCT01150097|75839789|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
42031619|NCT01150097|75839790|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
42031620|NCT01150097|75839788|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
42031621|NCT01150097|75839789|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
42031622|NCT01150097|75839790|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
42031623|NCT01150097|75839788|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
42031624|NCT01150097|75839789|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
42031625|NCT01150097|75839790|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
42031626|NCT01150097|75839788|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
42031627|NCT01150097|75839789|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
42031628|NCT01150097|75839790|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
41984526|NCT01051661|75791282|FG002|Overall Study|Failure to comply with protocol|2|||
41984527|NCT01051661|75791283|FG003|Overall Study|Failure to comply with protocol|0|||
41984528|NCT01051661|75791284|FG004|Overall Study|Failure to comply with protocol|0|||
41984529|NCT01051661|75791285|FG005|Overall Study|Failure to comply with protocol|0|||
41984530|NCT01051661|75791280|FG000|Overall Study|Subject lost legal representation|0|||
41984531|NCT01051661|75791281|FG001|Overall Study|Subject lost legal representation|0|||
41984532|NCT01051661|75791282|FG002|Overall Study|Subject lost legal representation|0|||
41984533|NCT01051661|75791283|FG003|Overall Study|Subject lost legal representation|0|||
41984534|NCT01051661|75791284|FG004|Overall Study|Subject lost legal representation|1|||
41984535|NCT01051661|75791285|FG005|Overall Study|Subject lost legal representation|0|||
41984536|NCT01051661|75791280|FG000|Overall Study|Protocol Violation|0|||
41984537|NCT01051661|75791281|FG001|Overall Study|Protocol Violation|0|||
41984538|NCT01051661|75791282|FG002|Overall Study|Protocol Violation|0|||
41984539|NCT01051661|75791283|FG003|Overall Study|Protocol Violation|1|||
41984540|NCT01051661|75791284|FG004|Overall Study|Protocol Violation|2|||
41984541|NCT01051661|75791285|FG005|Overall Study|Protocol Violation|1|||
41984542|NCT01051661|75791280|FG000|Overall Study|Withdrawal by Subject|16|||
41984543|NCT01051661|75791281|FG001|Overall Study|Withdrawal by Subject|30|||
41984544|NCT01051661|75791282|FG002|Overall Study|Withdrawal by Subject|13|||
41984545|NCT01051661|75791283|FG003|Overall Study|Withdrawal by Subject|28|||
41984546|NCT01051661|75791284|FG004|Overall Study|Withdrawal by Subject|12|||
41984547|NCT01051661|75791285|FG005|Overall Study|Withdrawal by Subject|34|||
41984548|NCT01051466|75791322|FG000|Overall Study|Adverse Event|1|||
41984549|NCT01051466|75791323|FG001|Overall Study|Adverse Event|0|||
41984550|NCT01051466|75791322|FG000|Overall Study|Lost to Follow-up|1|||
41984551|NCT01051466|75791323|FG001|Overall Study|Lost to Follow-up|1|||
41984552|NCT01051466|75791322|FG000|Overall Study|Withdrawal by Subject|5|||
41984553|NCT01051466|75791323|FG001|Overall Study|Withdrawal by Subject|1|||
41984554|NCT01051466|75791322|FG000|Overall Study|Entry Criteria Not Met|0|||
41984555|NCT01051466|75791323|FG001|Overall Study|Entry Criteria Not Met|3|||
41984556|NCT01051466|75791322|FG000|Overall Study|Physician Decision|1|||
41984557|NCT01051466|75791323|FG001|Overall Study|Physician Decision|0|||
41984558|NCT01051349|75791337|FG000|Overall Study|Adverse Event|88|||
41984559|NCT01051349|75791337|FG000|Overall Study|Consent Withdrawn|54|||
41984560|NCT01051349|75791337|FG000|Overall Study|Investigator Decision|6|||
41984561|NCT01051349|75791337|FG000|Overall Study|Lost to Follow-up|6|||
41984562|NCT01051349|75791337|FG000|Overall Study|Subject non-compliance|7|||
41984563|NCT01051349|75791337|FG000|Overall Study|Reason not Specified|12|||
41984564|NCT01050998|75791349|FG000|Overall Study|Adverse Event|1|||
41984565|NCT01050998|75791350|FG001|Overall Study|Adverse Event|0|||
41984566|NCT01050998|75791351|FG002|Overall Study|Adverse Event|1|||
41984567|NCT01050998|75791352|FG003|Overall Study|Adverse Event|0|||
41984568|NCT01050998|75791353|FG004|Overall Study|Adverse Event|2|||
41984569|NCT01050998|75791349|FG000|Overall Study|Withdrawal by Subject|0|||
41984570|NCT01050998|75791350|FG001|Overall Study|Withdrawal by Subject|0|||
41984571|NCT01050998|75791351|FG002|Overall Study|Withdrawal by Subject|0|||
41984572|NCT01050998|75791352|FG003|Overall Study|Withdrawal by Subject|1|||
41984573|NCT01050998|75791353|FG004|Overall Study|Withdrawal by Subject|3|||
41984574|NCT01050998|75791349|FG000|Overall Study|Other|3|||
41984575|NCT01050998|75791350|FG001|Overall Study|Other|2|||
41984576|NCT01050998|75791351|FG002|Overall Study|Other|1|||
41984577|NCT01050998|75791352|FG003|Overall Study|Other|1|||
41984578|NCT01050998|75791353|FG004|Overall Study|Other|5|||
42031629|NCT01150097|75839788|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
42031630|NCT01150097|75839789|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
42224382|NCT03426995|76043406|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224383|NCT03426995|76043407|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224384|NCT03426995|76043408|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
42224385|NCT03426995|76043409|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224386|NCT03426995|76043410|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224387|NCT03426995|76043411|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224388|NCT03426995|76043412|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224389|NCT03426995|76043413|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224390|NCT03426995|76043414|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224391|NCT03426995|76043415|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224392|NCT03426995|76043416|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224393|NCT03426995|76043417|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224394|NCT03426995|76043418|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224395|NCT03426995|76043419|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224396|NCT03426995|76043420|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224397|NCT03426995|76043421|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224398|NCT03426995|76043422|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224399|NCT03426995|76043423|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224400|NCT03426995|76043424|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
42224401|NCT03426995|76043406|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224402|NCT03426995|76043407|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224403|NCT03426995|76043408|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224404|NCT03426995|76043409|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224405|NCT03426995|76043410|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224406|NCT03426995|76043411|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
42224407|NCT03426995|76043412|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224408|NCT03426995|76043413|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224409|NCT03426995|76043414|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224410|NCT03426995|76043415|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224411|NCT03426995|76043416|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224412|NCT03426995|76043417|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224413|NCT03426995|76043418|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224414|NCT03426995|76043419|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224415|NCT03426995|76043420|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224416|NCT03426995|76043421|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224417|NCT03426995|76043422|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224418|NCT03426995|76043423|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224419|NCT03426995|76043424|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
42224420|NCT03426995|76043406|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224421|NCT03426995|76043407|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224422|NCT03426995|76043408|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224423|NCT03426995|76043409|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224424|NCT03426995|76043410|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
42224425|NCT03426995|76043411|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
42224426|NCT03426995|76043412|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224427|NCT03426995|76043413|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224428|NCT03426995|76043414|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224429|NCT03426995|76043415|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224430|NCT03426995|76043416|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224431|NCT03426995|76043417|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224432|NCT03426995|76043418|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224433|NCT03426995|76043419|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224434|NCT03426995|76043420|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224435|NCT03426995|76043421|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
41984579|NCT01050998|75791349|FG000|Overall Study|Data integrity issues|0|||
41984580|NCT01050998|75791350|FG001|Overall Study|Data integrity issues|0|||
41984581|NCT01050998|75791351|FG002|Overall Study|Data integrity issues|1|||
41984582|NCT01050998|75791352|FG003|Overall Study|Data integrity issues|1|||
41984583|NCT01050998|75791353|FG004|Overall Study|Data integrity issues|4|||
41984584|NCT00106028|75791371|FG000|Overall Study|Adverse Event|3|||
41984585|NCT00106028|75791372|FG001|Overall Study|Adverse Event|2|||
41984586|NCT00106028|75791371|FG000|Overall Study|Protocol Violation|1|||
41984587|NCT00106028|75791372|FG001|Overall Study|Protocol Violation|1|||
41984588|NCT00106028|75791371|FG000|Overall Study|Withdrawal by Subject|2|||
41984589|NCT00106028|75791372|FG001|Overall Study|Withdrawal by Subject|8|||
41984590|NCT00106028|75791371|FG000|Overall Study|Lost to Follow-up|0|||
42031631|NCT01150097|75839790|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
42031632|NCT01150097|75839788|FG000|Months 24 to 48 Post-transplantation|Death|2|||
42031633|NCT01150097|75839789|FG001|Months 24 to 48 Post-transplantation|Death|0|||
42031634|NCT01150097|75839790|FG002|Months 24 to 48 Post-transplantation|Death|0|||
42031635|NCT01149863|75839800|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
42031636|NCT01149473|75839806|FG000|First Intervention|Adverse Event|1|||
42031637|NCT01149473|75839807|FG001|First Intervention|Adverse Event|1|||
42031638|NCT01149473|75839806|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
42031639|NCT01149473|75839807|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
42031640|NCT00872989|75839815|FG000|Overall Study|Adverse Event|7|||
42031641|NCT00872989|75839816|FG001|Overall Study|Adverse Event|15|||
42031642|NCT00872989|75839815|FG000|Overall Study|Withdrawal by Subject|8|||
42031643|NCT00872989|75839816|FG001|Overall Study|Withdrawal by Subject|5|||
42031644|NCT00872989|75839815|FG000|Overall Study|Progression/relapse|47|||
41984591|NCT00106028|75791372|FG001|Overall Study|Lost to Follow-up|1|||
41984592|NCT01050764|75791380|FG000|Overall Study|Death, before HSCT|1|||
41984593|NCT01050764|75791380|FG000|Overall Study|Donor mobilization failure, death|1|||
41984594|NCT01050764|75791380|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
41984595|NCT01050569|75791387|FG000|Overall Study|Lost to Follow-up|20|||
41984596|NCT01050569|75791388|FG001|Overall Study|Lost to Follow-up|14|||
41984597|NCT01050569|75791389|FG002|Overall Study|Lost to Follow-up|16|||
41984598|NCT01050569|75791387|FG000|Overall Study|Withdrawal by Subject|9|||
41984599|NCT01050569|75791388|FG001|Overall Study|Withdrawal by Subject|3|||
41984600|NCT01050569|75791389|FG002|Overall Study|Withdrawal by Subject|11|||
41984601|NCT01050569|75791387|FG000|Overall Study|Lack of Efficacy|5|||
41984602|NCT01050569|75791388|FG001|Overall Study|Lack of Efficacy|4|||
41984603|NCT01050569|75791389|FG002|Overall Study|Lack of Efficacy|3|||
41984604|NCT01050569|75791387|FG000|Overall Study|Adverse Event|1|||
41984605|NCT01050569|75791388|FG001|Overall Study|Adverse Event|0|||
41984606|NCT01050569|75791389|FG002|Overall Study|Adverse Event|0|||
41984607|NCT01050569|75791387|FG000|Overall Study|Physician Decision|3|||
41984608|NCT01050569|75791388|FG001|Overall Study|Physician Decision|3|||
41984609|NCT01050569|75791389|FG002|Overall Study|Physician Decision|3|||
41984610|NCT01050530|75791403|FG000|Overall Study|Adverse Event|6|||
41984611|NCT01050530|75791404|FG001|Overall Study|Adverse Event|3|||
41984612|NCT01050530|75791403|FG000|Overall Study|Lack of Efficacy|1|||
41984613|NCT01050530|75791404|FG001|Overall Study|Lack of Efficacy|4|||
41984614|NCT01050530|75791403|FG000|Overall Study|Withdrawal by Subject|0|||
41984615|NCT01050530|75791404|FG001|Overall Study|Withdrawal by Subject|3|||
41984616|NCT01050530|75791403|FG000|Overall Study|Protocol Violation|1|||
41984617|NCT01050530|75791404|FG001|Overall Study|Protocol Violation|0|||
41984618|NCT01050257|75791413|FG000|Overall Study|Adverse Event|4|||
41984619|NCT01050257|75791414|FG001|Overall Study|Adverse Event|4|||
41984620|NCT01050257|75791415|FG002|Overall Study|Adverse Event|2|||
41984621|NCT01050257|75791413|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
41984622|NCT01050257|75791414|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
41984623|NCT01050257|75791415|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
41984624|NCT01050257|75791413|FG000|Overall Study|Withdrawal by Subject|0|||
41984625|NCT01050257|75791414|FG001|Overall Study|Withdrawal by Subject|3|||
41984626|NCT01050257|75791415|FG002|Overall Study|Withdrawal by Subject|0|||
41984627|NCT01050257|75791413|FG000|Overall Study|No reason specified|0|||
41984628|NCT01050257|75791414|FG001|Overall Study|No reason specified|0|||
41984629|NCT01050257|75791415|FG002|Overall Study|No reason specified|2|||
41984630|NCT01050257|75791413|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
41984631|NCT01050257|75791414|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
41984632|NCT01050257|75791415|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
41984633|NCT01050257|75791413|FG000|Overall Study|Violation criteria|0|||
41984634|NCT01050257|75791414|FG001|Overall Study|Violation criteria|1|||
42031645|NCT00872989|75839816|FG001|Overall Study|Progression/relapse|35|||
42031646|NCT00872989|75839815|FG000|Overall Study|Not protocol specified|3|||
42031647|NCT00872989|75839816|FG001|Overall Study|Not protocol specified|8|||
42131608|NCT00510146|75942518|FG001|Open-Label Treatment|Adverse Event|8|||
41984635|NCT01050257|75791415|FG002|Overall Study|Violation criteria|0|||
41984636|NCT01050257|75791413|FG000|Overall Study|Failure to return|0|||
41984637|NCT01050257|75791414|FG001|Overall Study|Failure to return|2|||
41984638|NCT01050257|75791415|FG002|Overall Study|Failure to return|0|||
41984639|NCT01050257|75791413|FG000|Overall Study|Death|0|||
41984640|NCT01050257|75791414|FG001|Overall Study|Death|0|||
41984641|NCT01050257|75791415|FG002|Overall Study|Death|1|||
41984642|NCT01050062|75791425|FG000|Overall Study|Adverse Event|75|||
42031648|NCT01148771|75839830|FG000|Washout Period|Withdrawal by Subject|0|||
42031649|NCT01148771|75839831|FG001|Washout Period|Withdrawal by Subject|1|||
42031650|NCT01148693|75839843|FG000|Overall Study|Attempts for cannulation were failed|13|||
42031651|NCT01148693|75839844|FG001|Overall Study|Attempts for cannulation were failed|10|||
42031652|NCT00872599|75839850|FG000|Second Washout Period|Adverse Event|1|||
41984643|NCT01050062|75791426|FG001|Overall Study|Adverse Event|22|||
41984644|NCT01050062|75791425|FG000|Overall Study|Lost to Follow-up|83|||
41984645|NCT01050062|75791426|FG001|Overall Study|Lost to Follow-up|35|||
42031653|NCT00872599|75839851|FG001|Second Washout Period|Adverse Event|1|||
42031654|NCT01148537|75839860|FG000|Overall Study|Withdrawal by Subject|1|||
42031655|NCT01148537|75839861|FG001|Overall Study|Withdrawal by Subject|0|||
42031656|NCT01148537|75839862|FG002|Overall Study|Withdrawal by Subject|2|||
42031657|NCT01148537|75839860|FG000|Overall Study|Adverse Event|2|||
42031658|NCT01148537|75839861|FG001|Overall Study|Adverse Event|0|||
42031659|NCT01148537|75839862|FG002|Overall Study|Adverse Event|1|||
42031660|NCT01148459|75839873|FG000|Overall Study|Serious Adverse Event|5|||
42031661|NCT01148459|75839874|FG001|Overall Study|Serious Adverse Event|4|||
42224436|NCT03426995|76043422|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224437|NCT03426995|76043423|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224438|NCT03426995|76043424|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
42224439|NCT03426995|76043406|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224440|NCT03426995|76043407|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224441|NCT03426995|76043408|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224442|NCT03426995|76043409|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224443|NCT03426995|76043410|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42302325|NCT02490475|76137453|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
42302326|NCT02490475|76137454|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
42302327|NCT02490475|76137455|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
42302328|NCT02490475|76137456|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
42302329|NCT02490475|76137453|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
42302330|NCT02490475|76137454|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
42302331|NCT02490475|76137455|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
42302332|NCT02490475|76137456|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
42302333|NCT02490475|76137453|FG000|Period 2: Extension Phase|Refused Treatment|0|||
42302334|NCT02490475|76137454|FG001|Period 2: Extension Phase|Refused Treatment|0|||
42302335|NCT02490475|76137455|FG002|Period 2: Extension Phase|Refused Treatment|0|||
41984646|NCT01050062|75791425|FG000|Overall Study|Lack of Efficacy|22|||
41984647|NCT01050062|75791426|FG001|Overall Study|Lack of Efficacy|35|||
41984648|NCT01050062|75791425|FG000|Overall Study|Physician Decision|74|||
41984649|NCT01050062|75791426|FG001|Overall Study|Physician Decision|9|||
41984650|NCT01050062|75791425|FG000|Overall Study|Others|17|||
41984651|NCT01050062|75791426|FG001|Overall Study|Others|11|||
41984652|NCT00105989|75791444|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
41984653|NCT00105989|75791445|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
41984654|NCT00105989|75791444|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
41984655|NCT00105989|75791445|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
41984656|NCT00105989|75791444|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
41984657|NCT00105989|75791445|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
41984658|NCT00105989|75791444|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
41984659|NCT00105989|75791445|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
41984660|NCT00105989|75791444|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
41984661|NCT00105989|75791445|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
42031662|NCT01148459|75839873|FG000|Overall Study|Withdrawal by Subject|1|||
42031663|NCT01148459|75839874|FG001|Overall Study|Withdrawal by Subject|0|||
42031664|NCT01148459|75839873|FG000|Overall Study|Migrated/moved from study area|3|||
42031665|NCT01148459|75839874|FG001|Overall Study|Migrated/moved from study area|6|||
42131609|NCT00510146|75942517|FG000|Open-Label Treatment|Death|1|||
42031666|NCT01148459|75839873|FG000|Overall Study|Lost to Follow-up|2|||
42131610|NCT00510146|75942518|FG001|Open-Label Treatment|Death|1|||
42131611|NCT00510146|75942517|FG000|Open-Label Treatment|Lack of Efficacy|4|||
42131612|NCT00510146|75942518|FG001|Open-Label Treatment|Lack of Efficacy|0|||
42131613|NCT00510146|75942517|FG000|Open-Label Treatment|Lost to Follow-up|10|||
42131614|NCT00510146|75942518|FG001|Open-Label Treatment|Lost to Follow-up|1|||
42131615|NCT00510146|75942517|FG000|Open-Label Treatment|Physician Decision|3|||
42131616|NCT00510146|75942518|FG001|Open-Label Treatment|Physician Decision|1|||
42131617|NCT00510146|75942517|FG000|Open-Label Treatment|Protocol Violation|4|||
42131618|NCT00510146|75942518|FG001|Open-Label Treatment|Protocol Violation|2|||
42131619|NCT00510146|75942517|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
42131620|NCT00510146|75942518|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
42131621|NCT00510146|75942517|FG000|Open-Label Treatment|Clinical Relapse|1|||
42131622|NCT00510146|75942518|FG001|Open-Label Treatment|Clinical Relapse|1|||
42131623|NCT00510146|75942517|FG000|Open-Label Treatment|Sponsor Decision|2|||
42131624|NCT00510146|75942518|FG001|Open-Label Treatment|Sponsor Decision|0|||
42131625|NCT00480636|75942526|FG000|Overall Study|Death|12|||
42131626|NCT00480636|75942526|FG000|Overall Study|Lost to Follow-up|4|||
42131627|NCT00480636|75942526|FG000|Overall Study|Other|2|||
42131628|NCT00480636|75942526|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
42224444|NCT03426995|76043411|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224445|NCT03426995|76043412|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224446|NCT03426995|76043413|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224447|NCT03426995|76043414|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224448|NCT03426995|76043415|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224449|NCT03426995|76043416|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
42224450|NCT03426995|76043417|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224451|NCT03426995|76043418|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224452|NCT03426995|76043419|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224453|NCT03426995|76043420|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224454|NCT03426995|76043421|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224455|NCT03426995|76043422|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224456|NCT03426995|76043423|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224457|NCT03426995|76043424|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
42224458|NCT03426995|76043406|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224459|NCT03426995|76043407|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224460|NCT03426995|76043408|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224461|NCT03426995|76043409|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224462|NCT03426995|76043410|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224463|NCT03426995|76043411|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224464|NCT03426995|76043412|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224465|NCT03426995|76043413|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
42224466|NCT03426995|76043414|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224467|NCT03426995|76043415|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224468|NCT03426995|76043416|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224469|NCT03426995|76043417|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224470|NCT03426995|76043418|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224471|NCT03426995|76043419|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224472|NCT03426995|76043420|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224473|NCT03426995|76043421|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224474|NCT03426995|76043422|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224475|NCT03426995|76043423|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224476|NCT03426995|76043424|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
42224477|NCT03426995|76043406|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224478|NCT03426995|76043407|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224479|NCT03426995|76043408|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224480|NCT03426995|76043409|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224481|NCT03426995|76043410|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224482|NCT03426995|76043411|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224483|NCT03426995|76043412|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224484|NCT03426995|76043413|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224485|NCT03426995|76043414|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224486|NCT03426995|76043415|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224487|NCT03426995|76043416|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224488|NCT03426995|76043417|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224489|NCT03426995|76043418|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224490|NCT03426995|76043419|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224491|NCT03426995|76043420|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
42224492|NCT03426995|76043421|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
42224493|NCT03426995|76043422|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224494|NCT03426995|76043423|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224495|NCT03426995|76043424|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
42224496|NCT03426995|76043406|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224497|NCT03426995|76043407|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224498|NCT03426995|76043408|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224499|NCT03426995|76043409|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224500|NCT03426995|76043410|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42302336|NCT02490475|76137456|FG003|Period 2: Extension Phase|Refused Treatment|1|||
42302337|NCT02490475|76137453|FG000|Period 2: Extension Phase|Adverse Event|0|||
42302338|NCT02490475|76137454|FG001|Period 2: Extension Phase|Adverse Event|0|||
42224501|NCT03426995|76043411|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42302339|NCT02490475|76137455|FG002|Period 2: Extension Phase|Adverse Event|1|||
42224502|NCT03426995|76043412|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42302340|NCT02490475|76137456|FG003|Period 2: Extension Phase|Adverse Event|0|||
42302341|NCT02477839|76137479|FG000|Overall Study|Adverse Event|0|||
42302342|NCT02477839|76137480|FG001|Overall Study|Adverse Event|1|||
42302343|NCT02477839|76137479|FG000|Overall Study|Protocol Violation|0|||
42302344|NCT02477839|76137480|FG001|Overall Study|Protocol Violation|2|||
42302345|NCT02477839|76137479|FG000|Overall Study|Withdrawal by Subject|3|||
42302346|NCT02477839|76137480|FG001|Overall Study|Withdrawal by Subject|3|||
42302347|NCT02477839|76137479|FG000|Overall Study|Participant had PGS during V6|0|||
42302348|NCT02477839|76137480|FG001|Overall Study|Participant had PGS during V6|1|||
42302349|NCT02477839|76137479|FG000|Overall Study|Parents decided to stop medication|0|||
42302350|NCT02477839|76137480|FG001|Overall Study|Parents decided to stop medication|1|||
42302351|NCT02477839|76137479|FG000|Overall Study|Lack of tolerability|0|||
42302352|NCT02477839|76137480|FG001|Overall Study|Lack of tolerability|1|||
42302353|NCT02477839|76137479|FG000|Overall Study|Exclusion criterion|0|||
42302354|NCT02477839|76137480|FG001|Overall Study|Exclusion criterion|1|||
42302355|NCT02489773|76137490|FG000|Overall Study|Lost to Follow-up|4|||
42302356|NCT02489773|76137491|FG001|Overall Study|Lost to Follow-up|1|||
42302357|NCT02489773|76137490|FG000|Overall Study|Physician Decision|1|||
42302358|NCT02489773|76137491|FG001|Overall Study|Physician Decision|0|||
42302359|NCT02489773|76137490|FG000|Overall Study|Withdrawal by Subject|1|||
42302360|NCT02489773|76137491|FG001|Overall Study|Withdrawal by Subject|0|||
42302361|NCT02489773|76137490|FG000|Overall Study|Leave the country or the state|1|||
42302362|NCT02489773|76137491|FG001|Overall Study|Leave the country or the state|1|||
42302363|NCT02488915|76137497|FG000|Overall Study|Death|21|||
42302364|NCT02488915|76137497|FG000|Overall Study|Lost to Follow-up|4|||
42302365|NCT02488915|76137497|FG000|Overall Study|Withdrawal by Subject|1|||
42302366|NCT02488681|76137501|FG000|Overall Study|Implant unsuccessful|7|||
42302367|NCT02477605|76137507|FG000|Overall Study|Discontinued prior to treatment|1|||
42302368|NCT02477605|76137508|FG001|Overall Study|Discontinued prior to treatment|0|||
42302369|NCT02477605|76137507|FG000|Overall Study|Lost to Follow-up|0|||
42302370|NCT02477605|76137508|FG001|Overall Study|Lost to Follow-up|2|||
42302371|NCT02477605|76137507|FG000|Overall Study|Withdrawal by Subject|0|||
42302372|NCT02477605|76137508|FG001|Overall Study|Withdrawal by Subject|1|||
42302373|NCT02477605|76137507|FG000|Overall Study|Administered gas during surgery|0|||
42302374|NCT02477605|76137508|FG001|Overall Study|Administered gas during surgery|1|||
42302375|NCT02477527|76137518|FG000|Overall Study|Lost to Follow-up|2|||
42302376|NCT02477527|76137518|FG000|Overall Study|Withdrawal by Subject|1|||
42302377|NCT02477527|76137518|FG000|Overall Study|Screen Failure|3|||
42302378|NCT02477215|76137526|FG000|Dose Escalation Phase|Physician Decision|1|||
42302379|NCT02477215|76137527|FG001|Dose Escalation Phase|Physician Decision|2|||
42302380|NCT02477215|76137528|FG002|Dose Escalation Phase|Physician Decision|0|||
42302381|NCT02477215|76137526|FG000|Fixed Dose Phase|Physician Decision|0|||
42302382|NCT02477215|76137527|FG001|Fixed Dose Phase|Physician Decision|7|||
42302383|NCT02477215|76137528|FG002|Fixed Dose Phase|Physician Decision|0|||
42302384|NCT02487199|76137541|FG000|Overall Study|Withdrew Consent|0|||
42302385|NCT02487199|76137542|FG001|Overall Study|Withdrew Consent|1|||
42302386|NCT02475733|76137550|FG000|Overall Study|Withdrawal by Subject|1|||
42302387|NCT02475733|76137551|FG001|Overall Study|Withdrawal by Subject|0|||
42302388|NCT02475733|76137550|FG000|Overall Study|Physician Decision|1|||
42302389|NCT02475733|76137551|FG001|Overall Study|Physician Decision|0|||
42302390|NCT02486653|76137559|FG000|Overall Study|Withdrawal by Subject|1|||
42302391|NCT02486653|76137560|FG001|Overall Study|Withdrawal by Subject|3|||
42302392|NCT02486653|76137559|FG000|Overall Study|Protocol Violation|1|||
42302393|NCT02486653|76137560|FG001|Overall Study|Protocol Violation|0|||
42302394|NCT02486653|76137559|FG000|Overall Study|surgery cancelled|4|||
42302395|NCT02486653|76137560|FG001|Overall Study|surgery cancelled|1|||
42302396|NCT02475655|76137568|FG000|Overall Study|Lost to Follow-up|0|||
42302397|NCT02475655|76137569|FG001|Overall Study|Lost to Follow-up|1|||
42302398|NCT02475265|76137575|FG000|Overall Study|Physician Decision|1|||
42302399|NCT02475265|76137575|FG000|Overall Study|Withdrawal by Subject|2|||
42302400|NCT02485717|76137582|FG000|Overall Study|Lost to Follow-up|6|||
42302401|NCT02485717|76137583|FG001|Overall Study|Lost to Follow-up|0|||
42302402|NCT02485717|76137584|FG002|Overall Study|Lost to Follow-up|0|||
42302403|NCT02485717|76137582|FG000|Overall Study|Withdrawal by Subject|0|||
42302404|NCT02485717|76137583|FG001|Overall Study|Withdrawal by Subject|0|||
41984662|NCT00105989|75791444|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
41984663|NCT00105989|75791445|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
41984664|NCT00105989|75791444|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
41984665|NCT00105989|75791445|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
41984666|NCT00105989|75791444|FG000|Acute - Open Label: Week 0-10|Death|1|||
42302405|NCT02485717|76137584|FG002|Overall Study|Withdrawal by Subject|1|||
42302406|NCT02485717|76137582|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
42031667|NCT01148459|75839874|FG001|Overall Study|Lost to Follow-up|0|||
42302407|NCT02485717|76137583|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
42302408|NCT02485717|76137584|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
42302409|NCT02485717|76137582|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
42302410|NCT02485717|76137583|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
42302411|NCT02485717|76137584|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
42302412|NCT02451007|76137592|FG000|Overall Study|Withdrawal by Subject|4|||
42302413|NCT02451007|76137592|FG000|Overall Study|Adverse Event|1|||
42302414|NCT02451007|76137592|FG000|Overall Study|Disease Progression|2|||
42302415|NCT02485483|76137598|FG000|Overall Study|Depression at baseline|15|||
42302416|NCT02485483|76137599|FG001|Overall Study|Depression at baseline|0|||
42302417|NCT02485483|76137598|FG000|Overall Study|Discontinued after baseline|39|||
42302418|NCT02485483|76137599|FG001|Overall Study|Discontinued after baseline|0|||
42302419|NCT02473471|76137605|FG000|Overall Study|poor oral hygiene|2|||
42302420|NCT02473471|76137605|FG000|Overall Study|Lost to Follow-up|1|||
42302421|NCT02450539|76137617|FG000|Overall Study|Withdrawal by Subject|12|||
42302422|NCT02450539|76137618|FG001|Overall Study|Withdrawal by Subject|6|||
42302423|NCT02450539|76137617|FG000|Overall Study|Lost to Follow-up|4|||
42302424|NCT02450539|76137618|FG001|Overall Study|Lost to Follow-up|1|||
42302425|NCT02449915|76137629|FG000|Overall Study|Exclusion criteria - drug use|1|||
42302426|NCT02449915|76137630|FG001|Overall Study|Exclusion criteria - drug use|0|||
42302427|NCT02449915|76137629|FG000|Overall Study|Withdrawal by Subject|0|||
42302428|NCT02449915|76137630|FG001|Overall Study|Withdrawal by Subject|2|||
42302429|NCT02449915|76137629|FG000|Overall Study|Intraoperative surgical findings|1|||
42302430|NCT02449915|76137630|FG001|Overall Study|Intraoperative surgical findings|1|||
42302431|NCT02449915|76137629|FG000|Overall Study|Abnormal preop lab|0|||
41984667|NCT00105989|75791445|FG001|Acute - Open Label: Week 0-10|Death|0|||
41984668|NCT00105989|75791444|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
41984669|NCT00105989|75791445|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
41984670|NCT00105989|75791444|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
41984671|NCT00105989|75791445|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
41984672|NCT00105989|75791444|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
41984673|NCT00105989|75791445|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
41984674|NCT00105989|75791444|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
41984675|NCT00105989|75791445|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
41984676|NCT00105989|75791444|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
41984677|NCT00105989|75791445|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
41984678|NCT00105989|75791444|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
41984679|NCT00105989|75791445|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
41984680|NCT00105989|75791444|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
41984681|NCT00105989|75791445|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
41984682|NCT00105989|75791444|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
41984683|NCT00105989|75791445|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
41984684|NCT00105989|75791444|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
41984685|NCT00105989|75791445|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
41984686|NCT00105989|75791444|FG000|Continuation - Open Label:Week 10-34|Death|0|||
41984687|NCT00105989|75791445|FG001|Continuation - Open Label:Week 10-34|Death|0|||
41984688|NCT00105989|75791444|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
41984689|NCT00105989|75791445|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
41984690|NCT00105989|75791444|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
41984691|NCT00105989|75791445|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
41984692|NCT00105989|75791444|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
41984693|NCT00105989|75791445|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
41984694|NCT00105989|75791444|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
42224503|NCT03426995|76043413|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224504|NCT03426995|76043414|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224505|NCT03426995|76043415|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224506|NCT03426995|76043416|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224507|NCT03426995|76043417|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224508|NCT03426995|76043418|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224509|NCT03426995|76043419|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224510|NCT03426995|76043420|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
42224511|NCT03426995|76043421|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
41984695|NCT00105989|75791445|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
41984696|NCT00105989|75791444|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
41984697|NCT00105989|75791445|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
41984698|NCT00105989|75791444|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
42302432|NCT02449915|76137630|FG001|Overall Study|Abnormal preop lab|1|||
42302433|NCT02420119|76137636|FG000|Overall Study|insufficient laboratory data|5|||
42302434|NCT02473393|76137644|FG000|Overall Study|Adverse Event|0|||
42302435|NCT02473393|76137645|FG001|Overall Study|Adverse Event|0|||
42224512|NCT03426995|76043422|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224513|NCT03426995|76043423|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224514|NCT03426995|76043424|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
42224515|NCT03424265|76043473|FG000|Overall Study|screening failure|1|||
42224516|NCT03424265|76043474|FG001|Overall Study|screening failure|0|||
42224517|NCT03424265|76043473|FG000|Overall Study|Withdrawal by Subject|0|||
42224518|NCT03424265|76043474|FG001|Overall Study|Withdrawal by Subject|2|||
42224519|NCT03322566|76043483|FG000|Overall Study|Death|34|||
42224520|NCT03322566|76043484|FG001|Overall Study|Death|35|||
42224521|NCT03322566|76043485|FG002|Overall Study|Death|23|||
42224522|NCT03322566|76043483|FG000|Overall Study|Physician Decision|6|||
42224523|NCT03322566|76043484|FG001|Overall Study|Physician Decision|7|||
42224524|NCT03322566|76043485|FG002|Overall Study|Physician Decision|2|||
42224525|NCT03322566|76043483|FG000|Overall Study|Withdrawal by Subject|4|||
42224526|NCT03322566|76043484|FG001|Overall Study|Withdrawal by Subject|3|||
42224527|NCT03322566|76043485|FG002|Overall Study|Withdrawal by Subject|6|||
42224528|NCT03322566|76043483|FG000|Overall Study|Lost to Follow-up|0|||
42224529|NCT03322566|76043484|FG001|Overall Study|Lost to Follow-up|0|||
42224530|NCT03322566|76043485|FG002|Overall Study|Lost to Follow-up|1|||
42224531|NCT03322566|76043483|FG000|Overall Study|Study terminated by sponsor|1|||
42224532|NCT03322566|76043484|FG001|Overall Study|Study terminated by sponsor|0|||
42224533|NCT03322566|76043485|FG002|Overall Study|Study terminated by sponsor|1|||
42224534|NCT02969018|76043501|FG000|Overall Study|Adverse Event|2|||
42224535|NCT02969018|76043502|FG001|Overall Study|Adverse Event|4|||
42224536|NCT02969018|76043503|FG002|Overall Study|Adverse Event|1|||
42224537|NCT02969018|76043504|FG003|Overall Study|Adverse Event|2|||
42224538|NCT02969018|76043505|FG004|Overall Study|Adverse Event|0|||
42224539|NCT02969018|76043506|FG005|Overall Study|Adverse Event|1|||
42224540|NCT02969018|76043507|FG006|Overall Study|Adverse Event|2|||
42224541|NCT02969018|76043508|FG007|Overall Study|Adverse Event|0|||
42224542|NCT02969018|76043501|FG000|Overall Study|Lack of Efficacy|0|||
42224543|NCT02969018|76043502|FG001|Overall Study|Lack of Efficacy|1|||
42224544|NCT02969018|76043503|FG002|Overall Study|Lack of Efficacy|0|||
42224545|NCT02969018|76043504|FG003|Overall Study|Lack of Efficacy|0|||
41984699|NCT00105989|75791445|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
41984700|NCT00105989|75791444|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
42031668|NCT01148459|75839873|FG000|Overall Study|Refusal|1|||
42031669|NCT01148459|75839874|FG001|Overall Study|Refusal|0|||
42031670|NCT01148459|75839873|FG000|Overall Study|Failure to comply with study procedures|0|||
42031671|NCT01148459|75839874|FG001|Overall Study|Failure to comply with study procedures|1|||
41984701|NCT00105989|75791445|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
41984702|NCT00105989|75791444|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
41984703|NCT00105989|75791445|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
41984704|NCT00105989|75791444|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
41984705|NCT00105989|75791445|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
42031672|NCT00872521|75839883|FG000|Completed PAD Induction|Patient choice|0|||
42031673|NCT00872521|75839884|FG001|Completed PAD Induction|Patient choice|1|||
42031674|NCT00872521|75839885|FG002|Completed PAD Induction|Patient choice|0|||
42031675|NCT00872521|75839883|FG000|Completed PAD Induction|Disease progression|0|||
42031676|NCT00872521|75839884|FG001|Completed PAD Induction|Disease progression|2|||
42031677|NCT00872521|75839885|FG002|Completed PAD Induction|Disease progression|0|||
42031678|NCT00872521|75839883|FG000|Completed PAD Induction|Adverse Event|4|||
42031679|NCT00872521|75839884|FG001|Completed PAD Induction|Adverse Event|0|||
42031680|NCT00872521|75839885|FG002|Completed PAD Induction|Adverse Event|0|||
42031681|NCT00872521|75839883|FG000|Completed PAD Induction|Death|1|||
42031682|NCT00872521|75839884|FG001|Completed PAD Induction|Death|1|||
42031683|NCT00872521|75839885|FG002|Completed PAD Induction|Death|0|||
42224546|NCT02969018|76043505|FG004|Overall Study|Lack of Efficacy|1|||
42224547|NCT02969018|76043506|FG005|Overall Study|Lack of Efficacy|1|||
42224548|NCT02969018|76043507|FG006|Overall Study|Lack of Efficacy|1|||
42224549|NCT02969018|76043508|FG007|Overall Study|Lack of Efficacy|1|||
42224550|NCT02969018|76043501|FG000|Overall Study|Lost to Follow-up|1|||
42224551|NCT02969018|76043502|FG001|Overall Study|Lost to Follow-up|2|||
42224552|NCT02969018|76043503|FG002|Overall Study|Lost to Follow-up|2|||
41984706|NCT00105989|75791444|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
42224553|NCT02969018|76043504|FG003|Overall Study|Lost to Follow-up|0|||
41984707|NCT00105989|75791445|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
41984708|NCT00105989|75791444|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
41984709|NCT00105989|75791445|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
42031684|NCT00872521|75839883|FG000|Primary Endpoint Analysis|Other|1|||
42031685|NCT00872521|75839884|FG001|Primary Endpoint Analysis|Other|2|||
42031686|NCT00872521|75839885|FG002|Primary Endpoint Analysis|Other|0|||
42224554|NCT02969018|76043505|FG004|Overall Study|Lost to Follow-up|1|||
42224555|NCT02969018|76043506|FG005|Overall Study|Lost to Follow-up|1|||
42031687|NCT00872521|75839883|FG000|Primary Endpoint Analysis|Patient choice|0|||
42031688|NCT00872521|75839884|FG001|Primary Endpoint Analysis|Patient choice|1|||
42031689|NCT00872521|75839885|FG002|Primary Endpoint Analysis|Patient choice|0|||
42031690|NCT00872521|75839883|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
41984710|NCT00105989|75791444|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
41984711|NCT00105989|75791445|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
41984712|NCT03277248|75791463|FG000|Overall Study|Adverse Event|3|||
41984713|NCT03277248|75791464|FG001|Overall Study|Adverse Event|1|||
41984714|NCT03277248|75791463|FG000|Overall Study|Subject Withdrawal of Consent|6|||
41984715|NCT03277248|75791464|FG001|Overall Study|Subject Withdrawal of Consent|23|||
41984716|NCT03277248|75791463|FG000|Overall Study|Investigator/Sponsor Decision|2|||
41984717|NCT03277248|75791464|FG001|Overall Study|Investigator/Sponsor Decision|2|||
41984718|NCT03277248|75791463|FG000|Overall Study|Pregnancy|4|||
41984719|NCT03277248|75791464|FG001|Overall Study|Pregnancy|1|||
41984720|NCT03277248|75791463|FG000|Overall Study|Lost to Follow-up|0|||
41984721|NCT03277248|75791464|FG001|Overall Study|Lost to Follow-up|2|||
41984722|NCT03277248|75791463|FG000|Overall Study|Lack of Efficacy|0|||
41984723|NCT03277248|75791464|FG001|Overall Study|Lack of Efficacy|2|||
41984724|NCT03277248|75791463|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
41984725|NCT03277248|75791464|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
41984726|NCT03276780|75791472|FG000|Overall Study|Withdrawal by Subject|5|||
41984727|NCT03276780|75791473|FG001|Overall Study|Withdrawal by Subject|3|||
41984728|NCT03276780|75791472|FG000|Overall Study|Lost to Follow-up|3|||
41984729|NCT03276780|75791473|FG001|Overall Study|Lost to Follow-up|5|||
41984730|NCT03276780|75791472|FG000|Overall Study|Moved out of state|1|||
41984731|NCT03276780|75791473|FG001|Overall Study|Moved out of state|1|||
41984732|NCT03276780|75791472|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
41984733|NCT03276780|75791473|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
41984734|NCT03276780|75791472|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
41984735|NCT03276780|75791473|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
41984736|NCT03271047|75791489|FG000|Phase 1b: Dose Finding Period|Death|8|||
41984737|NCT03271047|75791490|FG001|Phase 1b: Dose Finding Period|Death|8|||
41984738|NCT03271047|75791491|FG002|Phase 1b: Dose Finding Period|Death|0|||
41984739|NCT03271047|75791492|FG003|Phase 1b: Dose Finding Period|Death|0|||
41984740|NCT03271047|75791489|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
41984741|NCT03271047|75791490|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
41984742|NCT03271047|75791491|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
41984743|NCT03271047|75791492|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
41984744|NCT03271047|75791489|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
41984745|NCT03271047|75791490|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
41984746|NCT03271047|75791491|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
41984747|NCT03271047|75791492|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
41984748|NCT03271047|75791489|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
41984749|NCT03271047|75791490|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
41984750|NCT03271047|75791491|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
41984751|NCT03271047|75791492|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
41984752|NCT03271047|75791489|FG000|Randomized Phase 2 Period|Other|0|||
41984753|NCT03271047|75791490|FG001|Randomized Phase 2 Period|Other|0|||
41984754|NCT03271047|75791491|FG002|Randomized Phase 2 Period|Other|0|||
41984755|NCT03271047|75791492|FG003|Randomized Phase 2 Period|Other|1|||
41984756|NCT03271047|75791489|FG000|Randomized Phase 2 Period|Death|0|||
41984757|NCT03271047|75791490|FG001|Randomized Phase 2 Period|Death|0|||
41984758|NCT03271047|75791491|FG002|Randomized Phase 2 Period|Death|20|||
42224556|NCT02969018|76043507|FG006|Overall Study|Lost to Follow-up|0|||
42224557|NCT02969018|76043508|FG007|Overall Study|Lost to Follow-up|1|||
41984759|NCT03271047|75791492|FG003|Randomized Phase 2 Period|Death|21|||
41984760|NCT03271047|75791489|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
41984761|NCT03271047|75791490|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
42031691|NCT00872521|75839884|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
42031692|NCT00872521|75839885|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
42031693|NCT00872521|75839883|FG000|Primary Endpoint Analysis|Patient response missing|0|||
42031694|NCT00872521|75839884|FG001|Primary Endpoint Analysis|Patient response missing|0|||
42031695|NCT00872521|75839885|FG002|Primary Endpoint Analysis|Patient response missing|1|||
42031696|NCT00872521|75839883|FG000|Completed 3-month Follow up|Other|0|||
42031697|NCT00872521|75839884|FG001|Completed 3-month Follow up|Other|2|||
42031698|NCT00872521|75839885|FG002|Completed 3-month Follow up|Other|0|||
42031699|NCT00872521|75839883|FG000|Completed 3-month Follow up|Physician Decision|0|||
42031700|NCT00872521|75839884|FG001|Completed 3-month Follow up|Physician Decision|1|||
42031701|NCT00872521|75839885|FG002|Completed 3-month Follow up|Physician Decision|0|||
42031702|NCT00872521|75839883|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
42031703|NCT00872521|75839884|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
42031704|NCT00872521|75839885|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
42031705|NCT01148225|75839904|FG000|Overall Study|Other|185|||
42224558|NCT02969018|76043501|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
42224559|NCT02969018|76043502|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
42224560|NCT02969018|76043503|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
42224561|NCT02969018|76043504|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
42224562|NCT02969018|76043505|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
42224563|NCT02969018|76043506|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
42224564|NCT02969018|76043507|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
42224565|NCT02969018|76043508|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
42224566|NCT02969018|76043501|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42224567|NCT02969018|76043502|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42224568|NCT02969018|76043503|FG002|Overall Study|Non-Compliance With Study Drug|0|||
42224569|NCT02969018|76043504|FG003|Overall Study|Non-Compliance With Study Drug|0|||
42224570|NCT02969018|76043505|FG004|Overall Study|Non-Compliance With Study Drug|0|||
42224571|NCT02969018|76043506|FG005|Overall Study|Non-Compliance With Study Drug|0|||
42224572|NCT02969018|76043507|FG006|Overall Study|Non-Compliance With Study Drug|0|||
42224573|NCT02969018|76043508|FG007|Overall Study|Non-Compliance With Study Drug|0|||
42224574|NCT02969018|76043501|FG000|Overall Study|Other|0|||
42224575|NCT02969018|76043502|FG001|Overall Study|Other|0|||
42224576|NCT02969018|76043503|FG002|Overall Study|Other|0|||
42224577|NCT02969018|76043504|FG003|Overall Study|Other|1|||
42224578|NCT02969018|76043505|FG004|Overall Study|Other|0|||
42224579|NCT02969018|76043506|FG005|Overall Study|Other|0|||
42224580|NCT02969018|76043507|FG006|Overall Study|Other|0|||
42224581|NCT02969018|76043508|FG007|Overall Study|Other|2|||
42224582|NCT02969018|76043501|FG000|Overall Study|Pregnancy|0|||
42224583|NCT02969018|76043502|FG001|Overall Study|Pregnancy|0|||
42224584|NCT02969018|76043503|FG002|Overall Study|Pregnancy|0|||
42224585|NCT02969018|76043504|FG003|Overall Study|Pregnancy|0|||
42031706|NCT01190891|75839913|FG000|Overall Study|Protocol Violation|1|||
42224586|NCT02969018|76043505|FG004|Overall Study|Pregnancy|0|||
42224587|NCT02969018|76043506|FG005|Overall Study|Pregnancy|1|||
42224588|NCT02969018|76043507|FG006|Overall Study|Pregnancy|0|||
42031707|NCT01190891|75839914|FG001|Overall Study|Protocol Violation|0|||
42031708|NCT01190891|75839913|FG000|Overall Study|Withdrawal by Subject|5|||
42031709|NCT01190891|75839914|FG001|Overall Study|Withdrawal by Subject|0|||
42031710|NCT00871975|75839920|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
42031711|NCT00871975|75839920|FG000|Overall Study|Catheters could not be inserted|1|||
42031712|NCT00871975|75839920|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
42031713|NCT00871975|75839920|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
42031714|NCT01190813|75839926|FG000|Overall Study|Lost to Follow-up|1|||
42031715|NCT01190813|75839927|FG001|Overall Study|Lost to Follow-up|2|||
42031716|NCT01190813|75839926|FG000|Overall Study|Withdrawal by Subject|2|||
42224589|NCT02969018|76043508|FG007|Overall Study|Pregnancy|0|||
42224590|NCT02969018|76043501|FG000|Overall Study|Protocol Violation|0|||
42031717|NCT01190813|75839927|FG001|Overall Study|Withdrawal by Subject|1|||
42031718|NCT01190813|75839926|FG000|Overall Study|Refused study treatment after randomized|1|||
42031719|NCT01190813|75839927|FG001|Overall Study|Refused study treatment after randomized|0|||
42224591|NCT02969018|76043502|FG001|Overall Study|Protocol Violation|0|||
42224592|NCT02969018|76043503|FG002|Overall Study|Protocol Violation|1|||
42224593|NCT02969018|76043504|FG003|Overall Study|Protocol Violation|1|||
42224594|NCT02969018|76043505|FG004|Overall Study|Protocol Violation|0|||
42224595|NCT02969018|76043506|FG005|Overall Study|Protocol Violation|0|||
42031720|NCT01190813|75839926|FG000|Overall Study|Adverse Event|0|||
42031721|NCT01190813|75839927|FG001|Overall Study|Adverse Event|1|||
42031722|NCT00870727|75839949|FG000|Overall Study|Lost to Follow-up|0|||
42031723|NCT00870727|75839950|FG001|Overall Study|Lost to Follow-up|1|||
42031724|NCT00870727|75839949|FG000|Overall Study|Lack of Efficacy|1|||
42031725|NCT00870727|75839950|FG001|Overall Study|Lack of Efficacy|3|||
42031726|NCT00870727|75839949|FG000|Overall Study|Adverse Event|0|||
42224596|NCT02969018|76043507|FG006|Overall Study|Protocol Violation|0|||
42224597|NCT02969018|76043508|FG007|Overall Study|Protocol Violation|0|||
42031727|NCT00870727|75839950|FG001|Overall Study|Adverse Event|1|||
42031728|NCT01147055|75839956|FG000|First Intervention Period|Lost to Follow-up|1|||
42031729|NCT01147055|75839957|FG001|First Intervention Period|Lost to Follow-up|0|||
42031730|NCT01146665|75839965|FG000|Overall Study|Withdrawal by Subject|10|||
42031731|NCT01146665|75839966|FG001|Overall Study|Withdrawal by Subject|16|||
42031732|NCT01145885|75839981|FG000|Overall Study|Progressive Disease|7|||
42031733|NCT01190267|75839993|FG000|Overall Study|Adverse Event|10|||
42031734|NCT01190267|75839994|FG001|Overall Study|Adverse Event|0|||
42031735|NCT01190267|75839993|FG000|Overall Study|Treatment Failure|8|||
42031736|NCT01190267|75839994|FG001|Overall Study|Treatment Failure|2|||
42031737|NCT01190267|75839993|FG000|Overall Study|Lost to Follow-up|2|||
42031738|NCT01190267|75839994|FG001|Overall Study|Lost to Follow-up|0|||
42031739|NCT01190267|75839993|FG000|Overall Study|Withdrawal by Subject|13|||
42031740|NCT01190267|75839994|FG001|Overall Study|Withdrawal by Subject|1|||
42031741|NCT01190267|75839993|FG000|Overall Study|Protocol Violation|8|||
42031742|NCT01190267|75839994|FG001|Overall Study|Protocol Violation|1|||
42224598|NCT02969018|76043501|FG000|Overall Study|Withdrawal by Subject|0|||
42224599|NCT02969018|76043502|FG001|Overall Study|Withdrawal by Subject|1|||
42224600|NCT02969018|76043503|FG002|Overall Study|Withdrawal by Subject|2|||
42224601|NCT02969018|76043504|FG003|Overall Study|Withdrawal by Subject|1|||
42224602|NCT02969018|76043505|FG004|Overall Study|Withdrawal by Subject|0|||
42224603|NCT02969018|76043506|FG005|Overall Study|Withdrawal by Subject|4|||
42224604|NCT02969018|76043507|FG006|Overall Study|Withdrawal by Subject|4|||
42224605|NCT02969018|76043508|FG007|Overall Study|Withdrawal by Subject|3|||
42224606|NCT01319721|76043531|FG000|Overall Study|Lost to Follow-up|1|||
42224607|NCT01319721|76043532|FG001|Overall Study|Lost to Follow-up|6|||
42224608|NCT02905032|76043541|FG000|Overall Study|Withdrawal by Subject|2|||
42224609|NCT02905032|76043542|FG001|Overall Study|Withdrawal by Subject|0|||
42224610|NCT02905032|76043543|FG002|Overall Study|Withdrawal by Subject|0|||
42031743|NCT00869089|75840000|FG000|Overall Study|Lost to Follow-up|1|||
42031744|NCT00869089|75840000|FG000|Overall Study|Withdrawal by Subject|1|||
42031745|NCT00869089|75840000|FG000|Overall Study|Screen Fail|1|||
42031746|NCT01190189|75840004|FG000|Overall Study|Lost to Follow-up|4|||
42031747|NCT01190189|75840004|FG000|Overall Study|Withdrawal by Subject|1|||
42031748|NCT01190189|75840004|FG000|Overall Study|Migrated/moved from study area|1|||
42031749|NCT00871117|75840010|FG000|Overall Study|Lost to Follow-up|5|||
42031750|NCT00871117|75840011|FG001|Overall Study|Lost to Follow-up|6|||
42031751|NCT00871117|75840010|FG000|Overall Study|Other|0|||
42031752|NCT00871117|75840011|FG001|Overall Study|Other|4|||
42031753|NCT00870103|75840018|FG000|Overall Study|Physician Decision|2|||
42031754|NCT00870103|75840018|FG000|Overall Study|Lost to Follow-up|2|||
42031755|NCT01145417|75840037|FG000|Overall Study|Death|1|||
42031756|NCT01145417|75840038|FG001|Overall Study|Death|0|||
42031757|NCT01145417|75840037|FG000|Overall Study|Lost to Follow-up|2|||
42031758|NCT01145417|75840038|FG001|Overall Study|Lost to Follow-up|1|||
42031759|NCT01145417|75840037|FG000|Overall Study|Withdrawal by Subject|1|||
42031760|NCT01145417|75840038|FG001|Overall Study|Withdrawal by Subject|2|||
42224611|NCT02905032|76043541|FG000|Overall Study|Protocol Violation|6|||
42224612|NCT02905032|76043542|FG001|Overall Study|Protocol Violation|12|||
42224613|NCT02905032|76043543|FG002|Overall Study|Protocol Violation|0|||
42224614|NCT03259425|76043550|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
42224615|NCT03101241|76043556|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
42224616|NCT03101241|76043557|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
41984762|NCT03271047|75791491|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
41984763|NCT03271047|75791492|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
41984764|NCT03271047|75791489|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
41984765|NCT03271047|75791490|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
41984766|NCT03271047|75791491|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
41984767|NCT03271047|75791492|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
41984768|NCT03271047|75791489|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
41984769|NCT03271047|75791490|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
41984770|NCT03271047|75791491|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
42031761|NCT01145417|75840037|FG000|Overall Study|Pregnancy|1|||
42031762|NCT01145417|75840038|FG001|Overall Study|Pregnancy|0|||
42031763|NCT01145417|75840037|FG000|Overall Study|Adverse Event|0|||
42224617|NCT03101241|76043556|FG000|Overall Study|Participant withdrew consent|3|||
42224618|NCT03101241|76043557|FG001|Overall Study|Participant withdrew consent|1|||
42302436|NCT02473393|76137646|FG002|Overall Study|Adverse Event|1|||
41984771|NCT03271047|75791492|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
42031764|NCT01145417|75840038|FG001|Overall Study|Adverse Event|1|||
42031765|NCT01145417|75840037|FG000|Overall Study|Study terminated by sponsor|35|||
42031766|NCT01145417|75840038|FG001|Overall Study|Study terminated by sponsor|43|||
42031767|NCT01145417|75840037|FG000|Overall Study|Other|1|||
42031768|NCT01145417|75840038|FG001|Overall Study|Other|0|||
42031769|NCT01144715|75840046|FG000|Overall Study|Lost to Follow-up|2|||
42031770|NCT01144715|75840047|FG001|Overall Study|Lost to Follow-up|1|||
42031771|NCT01144715|75840046|FG000|Overall Study|Withdrawal by Subject|2|||
42031772|NCT01144715|75840047|FG001|Overall Study|Withdrawal by Subject|1|||
42031773|NCT01144715|75840046|FG000|Overall Study|Adverse Event|0|||
42031774|NCT01144715|75840047|FG001|Overall Study|Adverse Event|1|||
42031775|NCT01189487|75840053|FG000|Overall Study|Lack of Efficacy|2|||
42031776|NCT01189487|75840053|FG000|Overall Study|Adverse Event|1|||
41984772|NCT03276936|75791506|FG000|Overall Study|Adverse Event|4|||
41984773|NCT03276936|75791507|FG001|Overall Study|Adverse Event|2|||
41984774|NCT03276936|75791506|FG000|Overall Study|Lost to Follow-up|16|||
41984775|NCT03276936|75791507|FG001|Overall Study|Lost to Follow-up|13|||
41984776|NCT03276936|75791506|FG000|Overall Study|Withdrawal by Subject|30|||
41984777|NCT03276936|75791507|FG001|Overall Study|Withdrawal by Subject|20|||
41984778|NCT03276936|75791506|FG000|Overall Study|Not mentioned|6|||
41984779|NCT03276936|75791507|FG001|Overall Study|Not mentioned|3|||
41984780|NCT00106002|75791513|FG000|Overall Study|Did not take any study drug|1|||
41984781|NCT00106002|75791513|FG000|Overall Study|Ineligible after Registration|1|||
41984782|NCT00105482|75791531|FG000|Overall Study|Adverse Event|1|||
41984783|NCT00105482|75791532|FG001|Overall Study|Adverse Event|1|||
41984784|NCT00105482|75791531|FG000|Overall Study|Lost to Follow-up|26|||
41984785|NCT00105482|75791532|FG001|Overall Study|Lost to Follow-up|17|||
42224619|NCT03101241|76043556|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
42224620|NCT03101241|76043557|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
42224621|NCT03101241|76043556|FG000|Overall Study|Lost to Follow-up|2|||
42224622|NCT03101241|76043557|FG001|Overall Study|Lost to Follow-up|0|||
42224623|NCT03101241|76043556|FG000|Overall Study|Lack of Efficacy|0|||
42224624|NCT03101241|76043557|FG001|Overall Study|Lack of Efficacy|1|||
42224625|NCT03101241|76043556|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
42224626|NCT03101241|76043557|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
42224627|NCT03061188|76043567|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
42224628|NCT03061188|76043568|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
42224629|NCT03061188|76043569|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
42224630|NCT03061188|76043570|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
42031777|NCT01106352|75840062|FG000|Overall Study|Subjects untreated|0|||
42031778|NCT01106352|75840063|FG001|Overall Study|Subjects untreated|0|||
42031779|NCT01106352|75840064|FG002|Overall Study|Subjects untreated|0|||
42031780|NCT01106352|75840065|FG003|Overall Study|Subjects untreated|3|||
42031781|NCT01106352|75840066|FG004|Overall Study|Subjects untreated|4|||
42224631|NCT03061188|76043567|FG000|On Follow-up for 3 Years|Death|0|||
42224632|NCT03061188|76043568|FG001|On Follow-up for 3 Years|Death|3|||
42224633|NCT03061188|76043569|FG002|On Follow-up for 3 Years|Death|5|||
42224634|NCT03061188|76043570|FG003|On Follow-up for 3 Years|Death|2|||
42224635|NCT03061188|76043567|FG000|On Follow-up for 3 Years|Still in follow-up|0|||
42224636|NCT03061188|76043568|FG001|On Follow-up for 3 Years|Still in follow-up|0|||
42224637|NCT03061188|76043569|FG002|On Follow-up for 3 Years|Still in follow-up|0|||
42224638|NCT03061188|76043570|FG003|On Follow-up for 3 Years|Still in follow-up|3|||
42224639|NCT03449147|76043588|FG000|52-week Treatment Period|Death|0|||
42224640|NCT03449147|76043589|FG001|52-week Treatment Period|Death|1|||
42224641|NCT03449147|76043590|FG002|52-week Treatment Period|Death|0|||
42224642|NCT03449147|76043588|FG000|52-week Treatment Period|Lost to Follow-up|6|||
42224643|NCT03449147|76043589|FG001|52-week Treatment Period|Lost to Follow-up|2|||
42224644|NCT03449147|76043590|FG002|52-week Treatment Period|Lost to Follow-up|5|||
42224645|NCT03449147|76043588|FG000|52-week Treatment Period|Other|0|||
42224646|NCT03449147|76043589|FG001|52-week Treatment Period|Other|1|||
42224647|NCT03449147|76043590|FG002|52-week Treatment Period|Other|2|||
42224648|NCT03449147|76043588|FG000|52-week Treatment Period|Physician Decision|1|||
42031782|NCT01106352|75840062|FG000|Overall Study|Sponsor Decision|1|||
42031783|NCT01106352|75840063|FG001|Overall Study|Sponsor Decision|0|||
42224649|NCT03449147|76043589|FG001|52-week Treatment Period|Physician Decision|0|||
42224650|NCT03449147|76043590|FG002|52-week Treatment Period|Physician Decision|3|||
42224651|NCT03449147|76043588|FG000|52-week Treatment Period|Screen Failure|1|||
42224652|NCT03449147|76043589|FG001|52-week Treatment Period|Screen Failure|2|||
42031784|NCT01106352|75840064|FG002|Overall Study|Sponsor Decision|0|||
42031785|NCT01106352|75840065|FG003|Overall Study|Sponsor Decision|0|||
42031786|NCT01106352|75840066|FG004|Overall Study|Sponsor Decision|0|||
42031787|NCT01106352|75840062|FG000|Overall Study|Too ill to come in for the visit|0|||
42224653|NCT03449147|76043590|FG002|52-week Treatment Period|Screen Failure|0|||
42224654|NCT03449147|76043588|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
41984786|NCT00105482|75791531|FG000|Overall Study|Withdrawal by Subject|0|||
41984787|NCT00105482|75791532|FG001|Overall Study|Withdrawal by Subject|1|||
41984788|NCT00105482|75791531|FG000|Overall Study|Lost Interest|29|||
41984789|NCT00105482|75791532|FG001|Overall Study|Lost Interest|32|||
41984790|NCT00105482|75791531|FG000|Overall Study|Scheduling Conflict|2|||
42031788|NCT01106352|75840063|FG001|Overall Study|Too ill to come in for the visit|0|||
42031789|NCT01106352|75840064|FG002|Overall Study|Too ill to come in for the visit|1|||
42031790|NCT01106352|75840065|FG003|Overall Study|Too ill to come in for the visit|0|||
42224655|NCT03449147|76043589|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
42224656|NCT03449147|76043590|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
42224657|NCT03449147|76043588|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
42224658|NCT03449147|76043589|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
42224659|NCT03449147|76043590|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
42224660|NCT03449147|76043588|FG000|12-Week Off-Treatment Durability Period|Other|0|||
42224661|NCT03449147|76043589|FG001|12-Week Off-Treatment Durability Period|Other|1|||
42224662|NCT03449147|76043590|FG002|12-Week Off-Treatment Durability Period|Other|0|||
42224663|NCT03423173|76043606|FG000|Overall Study|Randomized but not vaccinated|1|||
42224664|NCT03423173|76043607|FG001|Overall Study|Randomized but not vaccinated|0|||
42224665|NCT03423173|76043608|FG002|Overall Study|Randomized but not vaccinated|2|||
42224666|NCT03423173|76043609|FG003|Overall Study|Randomized but not vaccinated|1|||
42224667|NCT03423173|76043606|FG000|Overall Study|Adverse Event|1|||
42224668|NCT03423173|76043607|FG001|Overall Study|Adverse Event|1|||
42224669|NCT03423173|76043608|FG002|Overall Study|Adverse Event|1|||
42224670|NCT03423173|76043609|FG003|Overall Study|Adverse Event|1|||
42224671|NCT03423173|76043606|FG000|Overall Study|Lost to Follow-up|10|||
42224672|NCT03423173|76043607|FG001|Overall Study|Lost to Follow-up|19|||
42224673|NCT03423173|76043608|FG002|Overall Study|Lost to Follow-up|17|||
42224674|NCT03423173|76043609|FG003|Overall Study|Lost to Follow-up|22|||
42224675|NCT03423173|76043606|FG000|Overall Study|Withdrawal of consent|4|||
42224676|NCT03423173|76043607|FG001|Overall Study|Withdrawal of consent|10|||
42224677|NCT03423173|76043608|FG002|Overall Study|Withdrawal of consent|4|||
42224678|NCT03423173|76043609|FG003|Overall Study|Withdrawal of consent|5|||
42224679|NCT03423173|76043606|FG000|Overall Study|Death|1|||
42224680|NCT03423173|76043607|FG001|Overall Study|Death|0|||
42224681|NCT03423173|76043608|FG002|Overall Study|Death|0|||
42224682|NCT03423173|76043609|FG003|Overall Study|Death|0|||
42224683|NCT03423173|76043606|FG000|Overall Study|Reason not Specified|2|||
42224684|NCT03423173|76043607|FG001|Overall Study|Reason not Specified|5|||
42224685|NCT03423173|76043608|FG002|Overall Study|Reason not Specified|3|||
42224686|NCT03423173|76043609|FG003|Overall Study|Reason not Specified|1|||
42224687|NCT03447821|76043622|FG000|Overall Study|Withdrawal by Subject|1|||
42224688|NCT03447821|76043623|FG001|Overall Study|Withdrawal by Subject|1|||
42224689|NCT03447821|76043624|FG002|Overall Study|Withdrawal by Subject|0|||
42224690|NCT03447821|76043622|FG000|Overall Study|Lost to Follow-up|0|||
42224691|NCT03447821|76043623|FG001|Overall Study|Lost to Follow-up|0|||
42224692|NCT03447821|76043624|FG002|Overall Study|Lost to Follow-up|1|||
42224693|NCT03447353|76043638|FG000|Overall Study|Failure at Screening Visit|2|||
42224694|NCT03447353|76043638|FG000|Overall Study|Lost to Follow-up|4|||
42224695|NCT03447353|76043638|FG000|Overall Study|Scheduling Conflicts|3|||
42224696|NCT03447353|76043638|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
42224697|NCT03446885|76043648|FG000|Overall Study|Lost to Follow-up|1|||
42224698|NCT03446885|76043649|FG001|Overall Study|Lost to Follow-up|0|||
42224699|NCT03446885|76043648|FG000|Overall Study|Did not complete entire visit|1|||
42224700|NCT03446885|76043649|FG001|Overall Study|Did not complete entire visit|0|||
42224701|NCT00710970|76043657|FG000|Overall Study|Never took drug|3|||
42224702|NCT03421379|76043663|FG000|Period 1|Withdrawal by Subject|0|||
42224703|NCT03421379|76043664|FG001|Period 1|Withdrawal by Subject|1|||
42224704|NCT03421379|76043663|FG000|Period 1|Physician Decision|1|||
42224705|NCT03421379|76043664|FG001|Period 1|Physician Decision|1|||
42224706|NCT03421379|76043663|FG000|Period 1|Did not receive treatment|1|||
42224707|NCT03421379|76043664|FG001|Period 1|Did not receive treatment|2|||
42224708|NCT02900378|76043672|FG000|Randomization (Visit 2)|Adverse Event|14|||
42224709|NCT02900378|76043673|FG001|Randomization (Visit 2)|Adverse Event|11|||
42224710|NCT02900378|76043672|FG000|Randomization (Visit 2)|Death|1|||
42224711|NCT02900378|76043673|FG001|Randomization (Visit 2)|Death|4|||
42224712|NCT02900378|76043672|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
42224713|NCT02900378|76043673|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
42224714|NCT02900378|76043672|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
42224715|NCT02900378|76043673|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
42224716|NCT02900378|76043672|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
42224717|NCT02900378|76043673|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
42224718|NCT02900378|76043672|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
42224719|NCT02900378|76043673|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
42224720|NCT02900378|76043672|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
42224721|NCT02900378|76043673|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
42224722|NCT03058692|76043681|FG000|Overall Study|Lost to Follow-up|2|||
42224723|NCT03058692|76043682|FG001|Overall Study|Lost to Follow-up|1|||
42224724|NCT03058692|76043681|FG000|Overall Study|Withdrawal by Subject|1|||
42224725|NCT03058692|76043682|FG001|Overall Study|Withdrawal by Subject|1|||
42224726|NCT02964338|76043692|FG000|Overall Study|Sponsor terminated study for futility|12|||
42224727|NCT02964338|76043693|FG001|Overall Study|Sponsor terminated study for futility|15|||
42224728|NCT02964338|76043694|FG002|Overall Study|Sponsor terminated study for futility|14|||
42224729|NCT02964338|76043692|FG000|Overall Study|Lack of Efficacy|0|||
42224730|NCT02964338|76043693|FG001|Overall Study|Lack of Efficacy|3|||
42224731|NCT02964338|76043694|FG002|Overall Study|Lack of Efficacy|0|||
42224732|NCT02964338|76043692|FG000|Overall Study|Lost to Follow-up|1|||
42031791|NCT01106352|75840066|FG004|Overall Study|Too ill to come in for the visit|0|||
42031792|NCT01106352|75840062|FG000|Overall Study|Lost to Follow-up|0|||
42031793|NCT01106352|75840063|FG001|Overall Study|Lost to Follow-up|0|||
42031794|NCT01106352|75840064|FG002|Overall Study|Lost to Follow-up|0|||
42031795|NCT01106352|75840065|FG003|Overall Study|Lost to Follow-up|0|||
42031796|NCT01106352|75840066|FG004|Overall Study|Lost to Follow-up|1|||
42031797|NCT01106352|75840062|FG000|Overall Study|Death|0|||
42031798|NCT01106352|75840063|FG001|Overall Study|Death|0|||
42031799|NCT01106352|75840064|FG002|Overall Study|Death|1|||
42031800|NCT01106352|75840065|FG003|Overall Study|Death|3|||
42031801|NCT01106352|75840066|FG004|Overall Study|Death|1|||
42224733|NCT02964338|76043693|FG001|Overall Study|Lost to Follow-up|0|||
42224734|NCT02964338|76043694|FG002|Overall Study|Lost to Follow-up|3|||
42224735|NCT02964338|76043692|FG000|Overall Study|Protocol Violation|0|||
42224736|NCT02964338|76043693|FG001|Overall Study|Protocol Violation|1|||
42224737|NCT02964338|76043694|FG002|Overall Study|Protocol Violation|0|||
42224738|NCT02964338|76043692|FG000|Overall Study|Withdrawal by Subject|1|||
42031802|NCT01106352|75840062|FG000|Overall Study|Disease progression|0|||
42031803|NCT01106352|75840063|FG001|Overall Study|Disease progression|0|||
42031804|NCT01106352|75840064|FG002|Overall Study|Disease progression|0|||
42224739|NCT02964338|76043693|FG001|Overall Study|Withdrawal by Subject|3|||
42224740|NCT02964338|76043694|FG002|Overall Study|Withdrawal by Subject|1|||
42224741|NCT02964338|76043692|FG000|Overall Study|Adverse Event|2|||
42224742|NCT02964338|76043693|FG001|Overall Study|Adverse Event|1|||
42224743|NCT02964338|76043694|FG002|Overall Study|Adverse Event|1|||
42224744|NCT02964338|76043692|FG000|Overall Study|Non-compliant with e-diary|0|||
42224745|NCT02964338|76043693|FG001|Overall Study|Non-compliant with e-diary|1|||
42224746|NCT02964338|76043694|FG002|Overall Study|Non-compliant with e-diary|0|||
42224747|NCT02964338|76043692|FG000|Overall Study|Did not meet criteria|1|||
42224748|NCT02964338|76043693|FG001|Overall Study|Did not meet criteria|0|||
42224749|NCT02964338|76043694|FG002|Overall Study|Did not meet criteria|0|||
42224750|NCT03056352|76043702|FG000|Overall Study|Lost to Follow-up|1|||
42224751|NCT02898662|76043708|FG000|Overall Study|Adverse Event|1|||
42224752|NCT02898662|76043709|FG001|Overall Study|Adverse Event|0|||
42224753|NCT02898662|76043708|FG000|Overall Study|Loss of asthma control|23|||
42224754|NCT02898662|76043709|FG001|Overall Study|Loss of asthma control|24|||
42224755|NCT02898662|76043708|FG000|Overall Study|Withdrawal by Subject|4|||
42224756|NCT02898662|76043709|FG001|Overall Study|Withdrawal by Subject|1|||
42224757|NCT02898662|76043708|FG000|Overall Study|Technical issue|0|||
42224758|NCT02898662|76043709|FG001|Overall Study|Technical issue|1|||
42224759|NCT02898662|76043708|FG000|Overall Study|Randomized in error|0|||
42224760|NCT02898662|76043709|FG001|Overall Study|Randomized in error|1|||
42224761|NCT02898662|76043708|FG000|Overall Study|Subject decision|1|||
42224762|NCT02898662|76043709|FG001|Overall Study|Subject decision|0|||
42224763|NCT02898662|76043708|FG000|Overall Study|Other|0|||
42224764|NCT02898662|76043709|FG001|Overall Study|Other|1|||
42224765|NCT03055338|76043718|FG000|Overall Study|Lost to Follow-up|9|||
42224766|NCT03055338|76043719|FG001|Overall Study|Lost to Follow-up|2|||
42224767|NCT03055338|76043720|FG002|Overall Study|Lost to Follow-up|3|||
42224768|NCT03055338|76043718|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
42224769|NCT03055338|76043719|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
42224770|NCT03055338|76043720|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
42031805|NCT01106352|75840065|FG003|Overall Study|Disease progression|1|||
42031806|NCT01106352|75840066|FG004|Overall Study|Disease progression|0|||
42031807|NCT01106352|75840062|FG000|Overall Study|Withdrawal by Subject|0|||
42131629|NCT00499122|75942530|FG000|Overall Study|Withdrawal by Subject|2|||
42131630|NCT00393939|75942537|FG000|Overall Study|Protocol Violation|1|||
42131631|NCT00393939|75942538|FG001|Overall Study|Protocol Violation|1|||
42131632|NCT00393939|75942537|FG000|Overall Study|Lost to Follow-up|2|||
42131633|NCT00393939|75942538|FG001|Overall Study|Lost to Follow-up|4|||
42131634|NCT00393939|75942537|FG000|Overall Study|Death|10|||
42131635|NCT00393939|75942538|FG001|Overall Study|Death|4|||
42131636|NCT00393939|75942537|FG000|Overall Study|Sponsor|5|||
42224771|NCT03055338|76043718|FG000|Overall Study|Physician Decision|0|||
42224772|NCT03055338|76043719|FG001|Overall Study|Physician Decision|0|||
42224773|NCT03055338|76043720|FG002|Overall Study|Physician Decision|2|||
42224774|NCT03055338|76043718|FG000|Overall Study|Withdrawal by Subject|9|||
42224775|NCT03055338|76043719|FG001|Overall Study|Withdrawal by Subject|8|||
42224776|NCT03055338|76043720|FG002|Overall Study|Withdrawal by Subject|7|||
42224777|NCT03913130|76043728|FG000|Overall Study|Sponsor Decision|1|||
42031808|NCT01106352|75840063|FG001|Overall Study|Withdrawal by Subject|0|||
42031809|NCT01106352|75840064|FG002|Overall Study|Withdrawal by Subject|0|||
42031810|NCT01106352|75840065|FG003|Overall Study|Withdrawal by Subject|3|||
42031811|NCT01106352|75840066|FG004|Overall Study|Withdrawal by Subject|2|||
42031812|NCT01106352|75840062|FG000|Overall Study|Went on hospice|0|||
42131637|NCT00393939|75942538|FG001|Overall Study|Sponsor|13|||
42031813|NCT01106352|75840063|FG001|Overall Study|Went on hospice|0|||
42224778|NCT03419741|76043734|FG000|Overall Study|Adverse Event|1|||
42224779|NCT03419741|76043735|FG001|Overall Study|Adverse Event|0|||
42224780|NCT03419741|76043734|FG000|Overall Study|Withdrawal by Subject|1|||
42224781|NCT03419741|76043735|FG001|Overall Study|Withdrawal by Subject|2|||
42224782|NCT02896400|76043757|FG000|1 Month Follow-up|Lost to Follow-up|7|||
42224783|NCT02896400|76043758|FG001|1 Month Follow-up|Lost to Follow-up|7|||
42224784|NCT02896400|76043759|FG002|1 Month Follow-up|Lost to Follow-up|5|||
42224785|NCT02896400|76043760|FG003|1 Month Follow-up|Lost to Follow-up|8|||
42224786|NCT02896400|76043761|FG004|1 Month Follow-up|Lost to Follow-up|9|||
42224787|NCT02896400|76043762|FG005|1 Month Follow-up|Lost to Follow-up|6|||
42224788|NCT02896400|76043763|FG006|1 Month Follow-up|Lost to Follow-up|5|||
42224789|NCT02896400|76043764|FG007|1 Month Follow-up|Lost to Follow-up|6|||
42224790|NCT02896400|76043765|FG008|1 Month Follow-up|Lost to Follow-up|4|||
42224791|NCT02896400|76043766|FG009|1 Month Follow-up|Lost to Follow-up|7|||
42224792|NCT02896400|76043767|FG010|1 Month Follow-up|Lost to Follow-up|5|||
42224793|NCT02896400|76043768|FG011|1 Month Follow-up|Lost to Follow-up|5|||
42224794|NCT02896400|76043769|FG012|1 Month Follow-up|Lost to Follow-up|3|||
42224795|NCT02896400|76043770|FG013|1 Month Follow-up|Lost to Follow-up|4|||
42224796|NCT02896400|76043771|FG014|1 Month Follow-up|Lost to Follow-up|1|||
42224797|NCT02896400|76043772|FG015|1 Month Follow-up|Lost to Follow-up|2|||
41984791|NCT00105482|75791532|FG001|Overall Study|Scheduling Conflict|3|||
41984792|NCT00105482|75791531|FG000|Overall Study|Withdrawn by PI|1|||
41984793|NCT00105482|75791532|FG001|Overall Study|Withdrawn by PI|1|||
41984794|NCT01327651|75791547|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
41984795|NCT01327651|75791548|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
42224798|NCT02896400|76043757|FG000|1 Month Follow-up|Death|0|||
42224799|NCT02896400|76043758|FG001|1 Month Follow-up|Death|0|||
42224800|NCT02896400|76043759|FG002|1 Month Follow-up|Death|0|||
42224801|NCT02896400|76043760|FG003|1 Month Follow-up|Death|0|||
42224802|NCT02896400|76043761|FG004|1 Month Follow-up|Death|0|||
42224803|NCT02896400|76043762|FG005|1 Month Follow-up|Death|0|||
42224804|NCT02896400|76043763|FG006|1 Month Follow-up|Death|0|||
42224805|NCT02896400|76043764|FG007|1 Month Follow-up|Death|0|||
42224806|NCT02896400|76043765|FG008|1 Month Follow-up|Death|0|||
42224807|NCT02896400|76043766|FG009|1 Month Follow-up|Death|0|||
42224808|NCT02896400|76043767|FG010|1 Month Follow-up|Death|0|||
42224809|NCT02896400|76043768|FG011|1 Month Follow-up|Death|0|||
42031814|NCT01106352|75840064|FG002|Overall Study|Went on hospice|0|||
42031815|NCT01106352|75840065|FG003|Overall Study|Went on hospice|1|||
42224810|NCT02896400|76043769|FG012|1 Month Follow-up|Death|0|||
42224811|NCT02896400|76043770|FG013|1 Month Follow-up|Death|0|||
42224812|NCT02896400|76043771|FG014|1 Month Follow-up|Death|0|||
42224813|NCT02896400|76043772|FG015|1 Month Follow-up|Death|1|||
42224814|NCT02896400|76043757|FG000|3 Month Follow-up|Lost to Follow-up|6|||
42224815|NCT02896400|76043758|FG001|3 Month Follow-up|Lost to Follow-up|3|||
42224816|NCT02896400|76043759|FG002|3 Month Follow-up|Lost to Follow-up|6|||
42224817|NCT02896400|76043760|FG003|3 Month Follow-up|Lost to Follow-up|11|||
42224818|NCT02896400|76043761|FG004|3 Month Follow-up|Lost to Follow-up|12|||
42224819|NCT02896400|76043762|FG005|3 Month Follow-up|Lost to Follow-up|6|||
41984796|NCT01327651|75791549|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
41984797|NCT01327651|75791550|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
41984798|NCT01327651|75791551|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
41984799|NCT01327651|75791552|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
41984800|NCT01327651|75791553|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
41984801|NCT01327651|75791554|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
41984802|NCT01327651|75791555|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
41984803|NCT01327651|75791547|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
42031816|NCT01106352|75840066|FG004|Overall Study|Went on hospice|0|||
42031817|NCT01106352|75840062|FG000|Overall Study|Subject entered hospice|0|||
42031818|NCT01106352|75840063|FG001|Overall Study|Subject entered hospice|0|||
42031819|NCT01106352|75840064|FG002|Overall Study|Subject entered hospice|0|||
42031820|NCT01106352|75840065|FG003|Overall Study|Subject entered hospice|1|||
42224820|NCT02896400|76043763|FG006|3 Month Follow-up|Lost to Follow-up|4|||
42224821|NCT02896400|76043764|FG007|3 Month Follow-up|Lost to Follow-up|3|||
42224822|NCT02896400|76043765|FG008|3 Month Follow-up|Lost to Follow-up|6|||
42224823|NCT02896400|76043766|FG009|3 Month Follow-up|Lost to Follow-up|5|||
42224824|NCT02896400|76043767|FG010|3 Month Follow-up|Lost to Follow-up|6|||
42031821|NCT01106352|75840066|FG004|Overall Study|Subject entered hospice|0|||
42224825|NCT02896400|76043768|FG011|3 Month Follow-up|Lost to Follow-up|6|||
41984804|NCT01327651|75791548|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
41984805|NCT01327651|75791549|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
42031822|NCT01106352|75840062|FG000|Overall Study|Home hospice since July 2013|0|||
42031823|NCT01106352|75840063|FG001|Overall Study|Home hospice since July 2013|0|||
42224826|NCT02896400|76043769|FG012|3 Month Follow-up|Lost to Follow-up|3|||
42224827|NCT02896400|76043770|FG013|3 Month Follow-up|Lost to Follow-up|5|||
42224828|NCT02896400|76043771|FG014|3 Month Follow-up|Lost to Follow-up|3|||
42031824|NCT01106352|75840064|FG002|Overall Study|Home hospice since July 2013|0|||
42031825|NCT01106352|75840065|FG003|Overall Study|Home hospice since July 2013|1|||
42031826|NCT01106352|75840066|FG004|Overall Study|Home hospice since July 2013|0|||
42031827|NCT01144403|75840082|FG000|Overall Study|Lost to Follow-up|3|||
42031828|NCT01144403|75840082|FG000|Overall Study|Death|1|||
41984806|NCT01327651|75791550|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
41984807|NCT01327651|75791551|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
41984808|NCT01327651|75791552|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
41984809|NCT01327651|75791553|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
41984810|NCT01327651|75791554|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
41984811|NCT01327651|75791555|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
42031829|NCT01144403|75840082|FG000|Overall Study|Adverse Event|1|||
42031830|NCT01143389|75840089|FG000|Overall Study|Lost to Follow-up|26|||
42031831|NCT01143389|75840090|FG001|Overall Study|Lost to Follow-up|25|||
42031832|NCT00868231|75840096|FG000|Treatment Period 1|Adverse Event|0|||
42031833|NCT00868231|75840097|FG001|Treatment Period 1|Adverse Event|0|||
42031834|NCT00868231|75840098|FG002|Treatment Period 1|Adverse Event|0|||
42031835|NCT00868231|75840099|FG003|Treatment Period 1|Adverse Event|0|||
42031836|NCT00868231|75840100|FG004|Treatment Period 1|Adverse Event|1|||
42031837|NCT00868231|75840101|FG005|Treatment Period 1|Adverse Event|0|||
42031838|NCT00868231|75840096|FG000|Treatment Period 2|Adverse Event|1|||
42031839|NCT00868231|75840097|FG001|Treatment Period 2|Adverse Event|0|||
42031840|NCT00868231|75840098|FG002|Treatment Period 2|Adverse Event|0|||
42031841|NCT00868231|75840099|FG003|Treatment Period 2|Adverse Event|0|||
42031842|NCT00868231|75840100|FG004|Treatment Period 2|Adverse Event|0|||
42031843|NCT00868231|75840101|FG005|Treatment Period 2|Adverse Event|0|||
42031844|NCT00868231|75840096|FG000|Treatment Period 3|Adverse Event|0|||
42031845|NCT00868231|75840097|FG001|Treatment Period 3|Adverse Event|0|||
42031846|NCT00868231|75840098|FG002|Treatment Period 3|Adverse Event|1|||
42031847|NCT00868231|75840099|FG003|Treatment Period 3|Adverse Event|0|||
42031848|NCT00868231|75840100|FG004|Treatment Period 3|Adverse Event|0|||
42031849|NCT00868231|75840101|FG005|Treatment Period 3|Adverse Event|0|||
42031850|NCT01143077|75840112|FG000|Overall Study|Lack of Efficacy|0|||
42031851|NCT01143077|75840113|FG001|Overall Study|Lack of Efficacy|2|||
42031852|NCT01143077|75840114|FG002|Overall Study|Lack of Efficacy|1|||
42031853|NCT01143077|75840112|FG000|Overall Study|Adverse Event|5|||
42031854|NCT01143077|75840113|FG001|Overall Study|Adverse Event|6|||
42031855|NCT01143077|75840114|FG002|Overall Study|Adverse Event|5|||
42031856|NCT01143077|75840112|FG000|Overall Study|Lost to Follow-up|2|||
42031857|NCT01143077|75840113|FG001|Overall Study|Lost to Follow-up|3|||
42224829|NCT02896400|76043772|FG015|3 Month Follow-up|Lost to Follow-up|2|||
42224830|NCT02896400|76043757|FG000|3 Month Follow-up|Death|0|||
42224831|NCT02896400|76043758|FG001|3 Month Follow-up|Death|0|||
42224832|NCT02896400|76043759|FG002|3 Month Follow-up|Death|0|||
42224833|NCT02896400|76043760|FG003|3 Month Follow-up|Death|0|||
42224834|NCT02896400|76043761|FG004|3 Month Follow-up|Death|0|||
42224835|NCT02896400|76043762|FG005|3 Month Follow-up|Death|0|||
42224836|NCT02896400|76043763|FG006|3 Month Follow-up|Death|0|||
42224837|NCT02896400|76043764|FG007|3 Month Follow-up|Death|0|||
42224838|NCT02896400|76043765|FG008|3 Month Follow-up|Death|0|||
42224839|NCT02896400|76043766|FG009|3 Month Follow-up|Death|0|||
42224840|NCT02896400|76043767|FG010|3 Month Follow-up|Death|0|||
42224841|NCT02896400|76043768|FG011|3 Month Follow-up|Death|0|||
42224842|NCT02896400|76043769|FG012|3 Month Follow-up|Death|0|||
42224843|NCT02896400|76043770|FG013|3 Month Follow-up|Death|1|||
42224844|NCT02896400|76043771|FG014|3 Month Follow-up|Death|1|||
42224845|NCT02896400|76043772|FG015|3 Month Follow-up|Death|0|||
42224846|NCT02896400|76043757|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
42224847|NCT02896400|76043758|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
42031858|NCT01143077|75840114|FG002|Overall Study|Lost to Follow-up|4|||
42031859|NCT01143077|75840112|FG000|Overall Study|Protocol Violation|2|||
42031860|NCT01143077|75840113|FG001|Overall Study|Protocol Violation|0|||
42224848|NCT02896400|76043759|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
42224849|NCT02896400|76043760|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
42224850|NCT02896400|76043761|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
42224851|NCT02896400|76043762|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
42224852|NCT02896400|76043763|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
42224853|NCT02896400|76043764|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
42224854|NCT02896400|76043765|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
42031861|NCT01143077|75840114|FG002|Overall Study|Protocol Violation|0|||
42031862|NCT01143077|75840112|FG000|Overall Study|Withdrawal by Subject|4|||
42031863|NCT01143077|75840113|FG001|Overall Study|Withdrawal by Subject|3|||
42031864|NCT01143077|75840114|FG002|Overall Study|Withdrawal by Subject|3|||
42031865|NCT01143077|75840112|FG000|Overall Study|Non-compliance with study drug|0|||
42031866|NCT01143077|75840113|FG001|Overall Study|Non-compliance with study drug|1|||
42031867|NCT01143077|75840114|FG002|Overall Study|Non-compliance with study drug|1|||
42031868|NCT01143077|75840112|FG000|Overall Study|Administrative|1|||
42224855|NCT02896400|76043766|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
42224856|NCT02896400|76043767|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
42224857|NCT02896400|76043768|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
42224858|NCT02896400|76043769|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
42224859|NCT02896400|76043770|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
42224860|NCT02896400|76043771|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
42224861|NCT02896400|76043772|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
42224862|NCT02896400|76043757|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
42224863|NCT02896400|76043758|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
42224864|NCT02896400|76043759|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
42224865|NCT02896400|76043760|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
41984812|NCT01327651|75791547|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
41984813|NCT01327651|75791548|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
41984814|NCT01327651|75791549|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
41984815|NCT01327651|75791550|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
42224866|NCT02896400|76043761|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
42224867|NCT02896400|76043762|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
42224868|NCT02896400|76043763|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
42224869|NCT02896400|76043764|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
42224870|NCT02896400|76043765|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
42224871|NCT02896400|76043766|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
41984816|NCT01327651|75791551|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
41984817|NCT01327651|75791552|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
41984818|NCT01327651|75791553|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
41984819|NCT01327651|75791554|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
41984820|NCT01327651|75791555|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
41984821|NCT01327651|75791547|FG000|Post Study Follow-up|Lost to Follow-up|0|||
41984822|NCT01327651|75791548|FG001|Post Study Follow-up|Lost to Follow-up|1|||
41984823|NCT01327651|75791549|FG002|Post Study Follow-up|Lost to Follow-up|1|||
41984824|NCT01327651|75791550|FG003|Post Study Follow-up|Lost to Follow-up|0|||
41984825|NCT01327651|75791551|FG004|Post Study Follow-up|Lost to Follow-up|0|||
41984826|NCT01327651|75791552|FG005|Post Study Follow-up|Lost to Follow-up|0|||
41984827|NCT01327651|75791553|FG006|Post Study Follow-up|Lost to Follow-up|4|||
42224872|NCT02896400|76043767|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
42224873|NCT02896400|76043768|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
42224874|NCT02896400|76043769|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
42224875|NCT02896400|76043770|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
42224876|NCT02896400|76043771|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
42224877|NCT02896400|76043772|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
42224878|NCT03405935|76043798|FG000|Overall Study|Adverse Event|3|||
42224879|NCT03405935|76043798|FG000|Overall Study|Death|2|||
42224880|NCT03405935|76043798|FG000|Overall Study|Withdrawal by Subject|1|||
42224881|NCT03405935|76043798|FG000|Overall Study|Lost to Follow-up|2|||
42224882|NCT03055260|76043804|FG000|Overall Study|Withdrawal by Subject|1|||
42224883|NCT03055260|76043805|FG001|Overall Study|Withdrawal by Subject|0|||
42224884|NCT03404843|76043813|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
42224885|NCT03404843|76043814|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
42224886|NCT03444155|76043838|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
42302437|NCT02473393|76137647|FG003|Overall Study|Adverse Event|0|||
41984828|NCT01327651|75791554|FG007|Post Study Follow-up|Lost to Follow-up|1|||
41984829|NCT01327651|75791555|FG008|Post Study Follow-up|Lost to Follow-up|2|||
41984830|NCT00105443|75791596|FG000|Double-Blind Treatment|Adverse Event|1|||
42031869|NCT01143077|75840113|FG001|Overall Study|Administrative|0|||
42031870|NCT01143077|75840114|FG002|Overall Study|Administrative|0|||
41984831|NCT00105443|75791597|FG001|Double-Blind Treatment|Adverse Event|0|||
42224887|NCT03444155|76043839|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
42224888|NCT02898116|76043845|FG000|Overall Study|Adverse Event|1|||
42224889|NCT02898116|76043845|FG000|Overall Study|Progressive disease|1|||
42224890|NCT03658304|76043849|FG000|Overall Study|participants still on follow up|8|||
42224891|NCT03422159|76043855|FG000|Overall Study|Exclusion due to terminal disease|2|||
42224892|NCT03422159|76043856|FG001|Overall Study|Exclusion due to terminal disease|1|||
42224893|NCT03403751|76043866|FG000|Overall Study|Death|5|||
42224894|NCT03403751|76043867|FG001|Overall Study|Death|6|||
42224895|NCT03403751|76043866|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
42224896|NCT03403751|76043867|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
42224897|NCT02297412|76043877|FG000|Overall Study|Canceled|1|||
42224898|NCT02297412|76043878|FG001|Overall Study|Canceled|1|||
42224899|NCT03418727|76043887|FG000|Overall Study|Adverse Event|1|||
42224900|NCT03418727|76043888|FG001|Overall Study|Adverse Event|2|||
42224901|NCT03418727|76043889|FG002|Overall Study|Adverse Event|0|||
42224902|NCT03418727|76043887|FG000|Overall Study|Withdrawal by Subject|0|||
42224903|NCT03418727|76043888|FG001|Overall Study|Withdrawal by Subject|0|||
42224904|NCT03418727|76043889|FG002|Overall Study|Withdrawal by Subject|2|||
42224905|NCT03418571|76043899|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
42224906|NCT03418571|76043900|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
42224907|NCT03402893|76043906|FG000|Overall Study|Withdrawal by Subject|1|||
42224908|NCT03442985|76043914|FG000|Overall Study|Sponsor Request|55|||
42224909|NCT03442985|76043915|FG001|Overall Study|Sponsor Request|60|||
42224910|NCT03442985|76043916|FG002|Overall Study|Sponsor Request|54|||
42224911|NCT03442985|76043914|FG000|Overall Study|Lost to Follow-up|5|||
42224912|NCT03442985|76043915|FG001|Overall Study|Lost to Follow-up|2|||
42224913|NCT03442985|76043916|FG002|Overall Study|Lost to Follow-up|7|||
42224914|NCT03442985|76043914|FG000|Overall Study|Withdrawal by Subject|2|||
42224915|NCT03442985|76043915|FG001|Overall Study|Withdrawal by Subject|3|||
42224916|NCT03442985|76043916|FG002|Overall Study|Withdrawal by Subject|4|||
42224917|NCT03442985|76043914|FG000|Overall Study|Adverse Event|0|||
42224918|NCT03442985|76043915|FG001|Overall Study|Adverse Event|1|||
42224919|NCT03442985|76043916|FG002|Overall Study|Adverse Event|0|||
42224920|NCT01318122|76043928|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
42224921|NCT01318122|76043929|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
42224922|NCT01318122|76043930|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
42224923|NCT01318122|76043931|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
42224924|NCT01318122|76043928|FG000|Enrolled - Long-Term Extension Study|Other|1|||
42224925|NCT01318122|76043929|FG001|Enrolled - Long-Term Extension Study|Other|0|||
42224926|NCT01318122|76043930|FG002|Enrolled - Long-Term Extension Study|Other|0|||
42224927|NCT01318122|76043931|FG003|Enrolled - Long-Term Extension Study|Other|0|||
42224928|NCT01318122|76043928|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
42224929|NCT01318122|76043929|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
42224930|NCT01318122|76043930|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
42224931|NCT01318122|76043931|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
42224932|NCT01318122|76043928|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
42224933|NCT01318122|76043929|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
42224934|NCT01318122|76043930|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
42224935|NCT01318122|76043931|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
42224936|NCT01318122|76043928|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
42224937|NCT01318122|76043929|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
42224938|NCT01318122|76043930|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
42224939|NCT01318122|76043931|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
42224940|NCT01318122|76043928|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
42224941|NCT01318122|76043929|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
42224942|NCT01318122|76043930|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
42224943|NCT01318122|76043931|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
42224944|NCT02954159|76043939|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
42224945|NCT02954159|76043940|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
42224946|NCT02954159|76043939|FG000|Overall Study|Withdrawal by Subject|0|||
42224947|NCT02954159|76043940|FG001|Overall Study|Withdrawal by Subject|1|||
42224948|NCT03442829|76043948|FG000|Overall Study|Scheduling clash|3|||
42224949|NCT03442829|76043949|FG001|Overall Study|Scheduling clash|1|||
42224950|NCT03442829|76043948|FG000|Overall Study|Illness unrelated to study|1|||
42224951|NCT03442829|76043949|FG001|Overall Study|Illness unrelated to study|1|||
42224952|NCT03442595|76043957|FG000|Overall Study|Lost to Follow-up|94|||
42224953|NCT03442595|76043958|FG001|Overall Study|Lost to Follow-up|0|||
42224954|NCT03440411|76043967|FG000|Overall Study|Adverse Event|0|||
42224955|NCT03440411|76043968|FG001|Overall Study|Adverse Event|0|||
42224956|NCT03440411|76043969|FG002|Overall Study|Adverse Event|1|||
42224957|NCT03440411|76043970|FG003|Overall Study|Adverse Event|0|||
42224958|NCT03440411|76043967|FG000|Overall Study|PD|2|||
42224959|NCT03440411|76043968|FG001|Overall Study|PD|1|||
42224960|NCT03440411|76043969|FG002|Overall Study|PD|1|||
42224961|NCT03440411|76043970|FG003|Overall Study|PD|1|||
42224962|NCT03440411|76043967|FG000|Overall Study|Withdrawal by Subject|1|||
42224963|NCT03440411|76043968|FG001|Overall Study|Withdrawal by Subject|0|||
42224964|NCT03440411|76043969|FG002|Overall Study|Withdrawal by Subject|0|||
42224965|NCT03440411|76043970|FG003|Overall Study|Withdrawal by Subject|0|||
42224966|NCT03440411|76043967|FG000|Overall Study|Closed study by sponsor|0|||
42224967|NCT03440411|76043968|FG001|Overall Study|Closed study by sponsor|0|||
42224968|NCT03440411|76043969|FG002|Overall Study|Closed study by sponsor|0|||
42224969|NCT03440411|76043970|FG003|Overall Study|Closed study by sponsor|1|||
42224970|NCT03438539|76043991|FG000|Overall Study|Lost to Follow-up|8|||
42224971|NCT03438539|76043992|FG001|Overall Study|Lost to Follow-up|4|||
42224972|NCT03438539|76043993|FG002|Overall Study|Lost to Follow-up|10|||
42224973|NCT03438539|76043994|FG003|Overall Study|Lost to Follow-up|9|||
42224974|NCT03438539|76043995|FG004|Overall Study|Lost to Follow-up|3|||
42224975|NCT03438539|76043996|FG005|Overall Study|Lost to Follow-up|8|||
42224976|NCT03400787|76044012|FG000|Overall Study|Lost to Follow-up|1|||
42224977|NCT03400787|76044013|FG001|Overall Study|Lost to Follow-up|0|||
42031871|NCT01143077|75840112|FG000|Overall Study|Principal Investigator Decision|2|||
42031872|NCT01143077|75840113|FG001|Overall Study|Principal Investigator Decision|0|||
42224978|NCT03400787|76044012|FG000|Overall Study|Death|1|||
42224979|NCT03400787|76044013|FG001|Overall Study|Death|0|||
41984832|NCT00105443|75791598|FG002|Double-Blind Treatment|Adverse Event|0|||
41984833|NCT00105443|75791599|FG003|Double-Blind Treatment|Adverse Event|0|||
41984834|NCT00105443|75791596|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
41984835|NCT00105443|75791597|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
41984836|NCT00105443|75791598|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
41984837|NCT00105443|75791599|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
41984838|NCT00105443|75791596|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
41984839|NCT00105443|75791597|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
41984840|NCT00105443|75791598|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
41984841|NCT00105443|75791599|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
41984842|NCT00105443|75791596|FG000|Double-Blind Treatment|Physician Decision|1|||
41984843|NCT00105443|75791597|FG001|Double-Blind Treatment|Physician Decision|0|||
41984844|NCT00105443|75791598|FG002|Double-Blind Treatment|Physician Decision|2|||
41984845|NCT00105443|75791599|FG003|Double-Blind Treatment|Physician Decision|0|||
41984846|NCT00105443|75791596|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
41984847|NCT00105443|75791597|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
41984848|NCT00105443|75791598|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
41984849|NCT00105443|75791599|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
41984850|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
41984851|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
41984852|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
41984853|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
41984854|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
41984855|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
41984856|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
42031873|NCT01143077|75840114|FG002|Overall Study|Principal Investigator Decision|1|||
42224980|NCT03400787|76044012|FG000|Overall Study|Protocol Violation|0|||
42224981|NCT03400787|76044013|FG001|Overall Study|Protocol Violation|2|||
42224982|NCT03400787|76044012|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
42224983|NCT03400787|76044013|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
42224984|NCT03417245|76044021|FG000|Overall Study|Adverse Event|1|||
42224985|NCT03417245|76044022|FG001|Overall Study|Adverse Event|0|||
41984857|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
41984858|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
41984859|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
42031874|NCT01096446|75840124|FG000|Overall Study|Death|1|||
42224986|NCT03417245|76044021|FG000|Overall Study|Protocol Violation|1|||
42224987|NCT03417245|76044022|FG001|Overall Study|Protocol Violation|0|||
42224988|NCT03417245|76044021|FG000|Overall Study|Withdrawal by Subject|1|||
42224989|NCT03417245|76044022|FG001|Overall Study|Withdrawal by Subject|1|||
42224990|NCT03389555|76044030|FG000|Overall Study|Protocol Violation|1|||
42224991|NCT03389555|76044031|FG001|Overall Study|Protocol Violation|3|||
42224992|NCT03389555|76044030|FG000|Overall Study|Death|1|||
42224993|NCT03389555|76044031|FG001|Overall Study|Death|0|||
42224994|NCT03395639|76044039|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
42224995|NCT03395639|76044040|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
42224996|NCT03395639|76044041|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
42224997|NCT03395639|76044039|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
42224998|NCT03395639|76044040|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
42224999|NCT03395639|76044041|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
42225000|NCT03395639|76044039|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
42225001|NCT03395639|76044040|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
42225002|NCT03395639|76044041|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
42225003|NCT03395639|76044039|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
42225004|NCT03395639|76044040|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
42225005|NCT03395639|76044041|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
42225006|NCT03395639|76044039|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
42225007|NCT03395639|76044040|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
42225008|NCT03395639|76044041|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
42225009|NCT03353922|76044048|FG000|Overall Study|Withdrawal by Subject|1|||
42225010|NCT03353922|76044049|FG001|Overall Study|Withdrawal by Subject|0|||
42225011|NCT03353922|76044050|FG002|Overall Study|Withdrawal by Subject|1|||
42225012|NCT03353922|76044051|FG003|Overall Study|Withdrawal by Subject|1|||
42225013|NCT03353922|76044052|FG004|Overall Study|Withdrawal by Subject|0|||
42225014|NCT03353922|76044053|FG005|Overall Study|Withdrawal by Subject|0|||
42225015|NCT03353922|76044048|FG000|Overall Study|Adverse Event|0|||
42225016|NCT03353922|76044049|FG001|Overall Study|Adverse Event|1|||
42225017|NCT03353922|76044050|FG002|Overall Study|Adverse Event|0|||
42225018|NCT03353922|76044051|FG003|Overall Study|Adverse Event|0|||
42225019|NCT03353922|76044052|FG004|Overall Study|Adverse Event|0|||
42225020|NCT03353922|76044053|FG005|Overall Study|Adverse Event|0|||
42225021|NCT03387683|76044066|FG000|Overall Study|In receipt of disallowed medication|1|||
42225022|NCT03387683|76044067|FG001|Overall Study|In receipt of disallowed medication|0|||
42225023|NCT03387683|76044066|FG000|Overall Study|Did not receive treatment|1|||
42225024|NCT03387683|76044067|FG001|Overall Study|Did not receive treatment|0|||
42225025|NCT03387059|76044075|FG000|Overall Study|Study termination|5|||
42225026|NCT03387059|76044076|FG001|Overall Study|Study termination|4|||
42225027|NCT02942004|76044085|FG000|Overall Study|Withdrawal by Subject|0|||
42225028|NCT02942004|76044086|FG001|Overall Study|Withdrawal by Subject|2|||
42225029|NCT02942004|76044087|FG002|Overall Study|Withdrawal by Subject|3|||
42225030|NCT02942004|76044085|FG000|Overall Study|Lost to Follow-up|1|||
42225031|NCT02942004|76044086|FG001|Overall Study|Lost to Follow-up|1|||
42225032|NCT02942004|76044087|FG002|Overall Study|Lost to Follow-up|2|||
42225033|NCT02942004|76044085|FG000|Overall Study|Randomized but not dosed|3|||
42225034|NCT02942004|76044086|FG001|Overall Study|Randomized but not dosed|9|||
42225035|NCT02942004|76044087|FG002|Overall Study|Randomized but not dosed|4|||
42225036|NCT03394391|76044097|FG000|Overall Study|Lost to Follow-up|1|||
42225037|NCT03394391|76044098|FG001|Overall Study|Lost to Follow-up|2|||
42225038|NCT03386435|76044106|FG000|Overall Study|Protocol Violation|5|||
42225039|NCT03386435|76044107|FG001|Overall Study|Protocol Violation|7|||
42225040|NCT02726880|76044115|FG000|Overall Study|Withdrawal by Subject|2|||
42225041|NCT02726880|76044116|FG001|Overall Study|Withdrawal by Subject|0|||
42225042|NCT02726880|76044115|FG000|Overall Study|Lost to Follow-up|1|||
42225043|NCT02726880|76044116|FG001|Overall Study|Lost to Follow-up|3|||
42225044|NCT03275389|76044133|FG000|Overall Study|Lost to Follow-up|10|||
42225045|NCT03275389|76044134|FG001|Overall Study|Lost to Follow-up|10|||
42225046|NCT03275389|76044135|FG002|Overall Study|Lost to Follow-up|19|||
42225047|NCT03275389|76044136|FG003|Overall Study|Lost to Follow-up|12|||
42225048|NCT03275389|76044137|FG004|Overall Study|Lost to Follow-up|11|||
42225049|NCT03275389|76044138|FG005|Overall Study|Lost to Follow-up|12|||
42225050|NCT03275389|76044139|FG006|Overall Study|Lost to Follow-up|21|||
42225051|NCT03275389|76044140|FG007|Overall Study|Lost to Follow-up|15|||
42225052|NCT03275389|76044141|FG008|Overall Study|Lost to Follow-up|12|||
42225053|NCT03275389|76044142|FG009|Overall Study|Lost to Follow-up|14|||
42225054|NCT03275389|76044133|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
42225055|NCT03275389|76044134|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
42225056|NCT03275389|76044135|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
42225057|NCT03275389|76044136|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
42225058|NCT03275389|76044137|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
42225059|NCT03275389|76044138|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
42225060|NCT03275389|76044139|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
42225061|NCT03275389|76044140|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
42225062|NCT03275389|76044141|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
42225063|NCT03275389|76044142|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
42225064|NCT03275389|76044133|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
42225065|NCT03275389|76044134|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
42225066|NCT03275389|76044135|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
42225067|NCT03275389|76044136|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
42225068|NCT03275389|76044137|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
42225069|NCT03275389|76044138|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
42225070|NCT03275389|76044139|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
42225071|NCT03275389|76044140|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
42225072|NCT03275389|76044141|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
41984860|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
41984861|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
41984862|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
41984863|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
41984864|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
41984865|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
41984866|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
41984867|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
42031875|NCT01096446|75840125|FG001|Overall Study|Death|0|||
42031876|NCT01096446|75840124|FG000|Overall Study|Protocol Violation|2|||
42031877|NCT01096446|75840125|FG001|Overall Study|Protocol Violation|0|||
42031878|NCT00864721|75840130|FG000|Overall Study|Patient request|11|||
42031879|NCT00864721|75840130|FG000|Overall Study|Hospitalized|1|||
42031880|NCT00864721|75840130|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
42031881|NCT00864721|75840130|FG000|Overall Study|Adverse Event|21|||
42031882|NCT01095666|75840137|FG000|Overall Study|Lack of Efficacy|0|||
42031883|NCT01095666|75840138|FG001|Overall Study|Lack of Efficacy|0|||
42031884|NCT01095666|75840139|FG002|Overall Study|Lack of Efficacy|1|||
42031885|NCT01095666|75840137|FG000|Overall Study|Adverse Event|2|||
42031886|NCT01095666|75840138|FG001|Overall Study|Adverse Event|1|||
42031887|NCT01095666|75840139|FG002|Overall Study|Adverse Event|3|||
42031888|NCT01095666|75840137|FG000|Overall Study|Lost to Follow-up|2|||
42031889|NCT01095666|75840138|FG001|Overall Study|Lost to Follow-up|2|||
42031890|NCT01095666|75840139|FG002|Overall Study|Lost to Follow-up|0|||
42031891|NCT01095666|75840137|FG000|Overall Study|Withdrawal by Subject|6|||
42031892|NCT01095666|75840138|FG001|Overall Study|Withdrawal by Subject|6|||
42031893|NCT01095666|75840139|FG002|Overall Study|Withdrawal by Subject|1|||
42031894|NCT01095666|75840137|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
42031895|NCT01095666|75840138|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
42031896|NCT01095666|75840139|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
42225073|NCT03275389|76044142|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
42225074|NCT03275389|76044133|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42225075|NCT03275389|76044134|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
42225076|NCT03275389|76044135|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
41984868|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
42031897|NCT01100658|75840147|FG000|Overall Study|Withdrawal by Subject|1|||
42031898|NCT01100502|75840153|FG000|Overall Study|Withdrawal by Subject|18|||
42225077|NCT03275389|76044136|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
42225078|NCT03275389|76044137|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42225079|NCT03275389|76044138|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
41984869|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
42031899|NCT01100502|75840154|FG001|Overall Study|Withdrawal by Subject|25|||
42031900|NCT01100502|75840153|FG000|Overall Study|Lost to Follow-up|13|||
42031901|NCT01100502|75840154|FG001|Overall Study|Lost to Follow-up|28|||
42031902|NCT01100502|75840153|FG000|Overall Study|Site request to end participation in study|0|||
42031903|NCT01100502|75840154|FG001|Overall Study|Site request to end participation in study|1|||
42031904|NCT01100502|75840153|FG000|Overall Study|Death|45|||
42031905|NCT01100502|75840154|FG001|Overall Study|Death|40|||
42031906|NCT01094886|75840160|FG000|Overall Study|Adverse Event|2|||
42031907|NCT01094886|75840160|FG000|Overall Study|Withdrawal by Subject|5|||
42031908|NCT01094808|75840167|FG000|Overall Study|Withdrawal by Subject|1|||
42031909|NCT01094808|75840168|FG001|Overall Study|Withdrawal by Subject|1|||
42031910|NCT01094808|75840169|FG002|Overall Study|Withdrawal by Subject|0|||
42031911|NCT00864253|75840179|FG000|Overall Study|Adverse Event|56|||
42031912|NCT00864253|75840180|FG001|Overall Study|Adverse Event|11|||
42225080|NCT03275389|76044139|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
42225081|NCT03275389|76044140|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42225082|NCT03275389|76044141|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42225083|NCT03275389|76044142|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42225084|NCT03275389|76044133|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
42225085|NCT03275389|76044134|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
42225086|NCT03275389|76044135|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
42225087|NCT03275389|76044136|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
42225088|NCT03275389|76044137|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
42225089|NCT03275389|76044138|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
42225090|NCT03275389|76044139|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
42225091|NCT03275389|76044140|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
42225092|NCT03275389|76044141|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
42225093|NCT03275389|76044142|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
42225094|NCT03275389|76044133|FG000|Overall Study|Other|0|||
42225095|NCT03275389|76044134|FG001|Overall Study|Other|4|||
42225096|NCT03275389|76044135|FG002|Overall Study|Other|3|||
42225097|NCT03275389|76044136|FG003|Overall Study|Other|2|||
42225098|NCT03275389|76044137|FG004|Overall Study|Other|2|||
41984870|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
41984871|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
42225099|NCT03275389|76044138|FG005|Overall Study|Other|2|||
42225100|NCT03275389|76044139|FG006|Overall Study|Other|0|||
42225101|NCT03275389|76044140|FG007|Overall Study|Other|0|||
42225102|NCT03275389|76044141|FG008|Overall Study|Other|1|||
42225103|NCT03275389|76044142|FG009|Overall Study|Other|0|||
42225104|NCT03414359|76044166|FG000|Overall Study|Lack of Efficacy|1|||
42225105|NCT03414359|76044167|FG001|Overall Study|Lack of Efficacy|1|||
42225106|NCT03414359|76044166|FG000|Overall Study|Protocol Violation|0|||
42225107|NCT03414359|76044167|FG001|Overall Study|Protocol Violation|1|||
42225108|NCT03285295|76044178|FG000|Alinity s HBsAg|Protocol Violation|11|||
41984872|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
41984873|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
41984874|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
41984875|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
41984876|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
41984877|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
41984878|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
41984879|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
41984880|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
41984881|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
42225109|NCT03285295|76044179|FG001|Alinity s HBsAg|Protocol Violation|0|||
42225110|NCT03285295|76044180|FG002|Alinity s HBsAg|Protocol Violation|0|||
42225111|NCT03285295|76044181|FG003|Alinity s HBsAg|Protocol Violation|0|||
42225112|NCT03285295|76044182|FG004|Alinity s HBsAg|Protocol Violation|0|||
42225113|NCT03285295|76044178|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
42225114|NCT03285295|76044179|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
42225115|NCT03285295|76044180|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
42225116|NCT03285295|76044181|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
42225117|NCT03285295|76044182|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
42031913|NCT00864253|75840179|FG000|Overall Study|Unrelated Adverse Event|3|||
42031914|NCT00864253|75840180|FG001|Overall Study|Unrelated Adverse Event|1|||
42225118|NCT03285295|76044178|FG000|Alinity s HBsAg|No Results Generated|74|||
42225119|NCT03285295|76044179|FG001|Alinity s HBsAg|No Results Generated|6|||
42225120|NCT03285295|76044180|FG002|Alinity s HBsAg|No Results Generated|0|||
42225121|NCT03285295|76044181|FG003|Alinity s HBsAg|No Results Generated|0|||
42225122|NCT03285295|76044182|FG004|Alinity s HBsAg|No Results Generated|0|||
42225123|NCT03285295|76044178|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
42225124|NCT03285295|76044179|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
42225125|NCT03285295|76044180|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
42225126|NCT03285295|76044181|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
42225127|NCT03285295|76044182|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
42225128|NCT03285295|76044178|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
42225129|NCT03285295|76044179|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
42225130|NCT03285295|76044180|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
42225131|NCT03285295|76044181|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
42225132|NCT03285295|76044182|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
42225133|NCT03285295|76044178|FG000|Alinity s HTLV I/II|No Results Generated|70|||
42225134|NCT03285295|76044179|FG001|Alinity s HTLV I/II|No Results Generated|0|||
42225135|NCT03285295|76044180|FG002|Alinity s HTLV I/II|No Results Generated|0|||
42225136|NCT03285295|76044181|FG003|Alinity s HTLV I/II|No Results Generated|0|||
42225137|NCT03285295|76044182|FG004|Alinity s HTLV I/II|No Results Generated|0|||
42225138|NCT03285295|76044178|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
42225139|NCT03285295|76044179|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
42225140|NCT03285295|76044180|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
42225141|NCT03285295|76044181|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
42225142|NCT03285295|76044182|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
42225143|NCT03285295|76044178|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
42225144|NCT03285295|76044179|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
42225145|NCT03285295|76044180|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
42225146|NCT03285295|76044181|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
42225147|NCT03285295|76044182|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
42225148|NCT03285295|76044178|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
42225149|NCT03285295|76044179|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
42225150|NCT03285295|76044180|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
42225151|NCT03285295|76044181|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
42225152|NCT03285295|76044182|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
42225153|NCT03285295|76044178|FG000|Alinity s Anti-HCV|No Results Generated|71|||
42225154|NCT03285295|76044179|FG001|Alinity s Anti-HCV|No Results Generated|0|||
42225155|NCT03285295|76044180|FG002|Alinity s Anti-HCV|No Results Generated|0|||
42225156|NCT03285295|76044181|FG003|Alinity s Anti-HCV|No Results Generated|0|||
42225157|NCT03285295|76044182|FG004|Alinity s Anti-HCV|No Results Generated|0|||
42225158|NCT03285295|76044178|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
42225159|NCT03285295|76044179|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
42225160|NCT03285295|76044180|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
42225161|NCT03285295|76044181|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
42225162|NCT03285295|76044182|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
42225163|NCT03285295|76044178|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
42225164|NCT03285295|76044179|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
42225165|NCT03285295|76044180|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
42225166|NCT03285295|76044181|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
42225167|NCT03285295|76044182|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
42225168|NCT03285295|76044178|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
42225169|NCT03285295|76044179|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
42225170|NCT03285295|76044180|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
42225171|NCT03285295|76044181|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
42225172|NCT03285295|76044182|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
42225173|NCT03285295|76044178|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
42225174|NCT03285295|76044179|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
42225175|NCT03285295|76044180|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
42225176|NCT03285295|76044181|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
42225177|NCT03285295|76044182|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
42302438|NCT02473393|76137644|FG000|Overall Study|Withdrawal by Subject|0|||
41984882|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
41984883|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
41984884|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
41984885|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
41984886|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
41984887|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
41984888|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
41984889|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
42031915|NCT00864253|75840179|FG000|Overall Study|Physician Decision|11|||
42225178|NCT03285295|76044178|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
42225179|NCT03285295|76044179|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
42031916|NCT00864253|75840180|FG001|Overall Study|Physician Decision|15|||
42031917|NCT00864253|75840179|FG000|Overall Study|Protocol Violation|0|||
42225180|NCT03285295|76044180|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
42225181|NCT03285295|76044181|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
42225182|NCT03285295|76044182|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
42225183|NCT03285295|76044178|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
42225184|NCT03285295|76044179|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
42225185|NCT03285295|76044180|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
42225186|NCT03285295|76044181|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
42225187|NCT03285295|76044182|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
42225188|NCT03285295|76044178|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
42225189|NCT03285295|76044179|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
42225190|NCT03285295|76044180|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
42225191|NCT03285295|76044181|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
42225192|NCT03285295|76044182|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
42225193|NCT03285295|76044178|FG000|Alinity s Anti-HBc|No Results Generated|70|||
42225194|NCT03285295|76044179|FG001|Alinity s Anti-HBc|No Results Generated|0|||
42225195|NCT03285295|76044180|FG002|Alinity s Anti-HBc|No Results Generated|0|||
42225196|NCT03285295|76044181|FG003|Alinity s Anti-HBc|No Results Generated|0|||
42225197|NCT03285295|76044182|FG004|Alinity s Anti-HBc|No Results Generated|0|||
42225198|NCT03285295|76044178|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
42225199|NCT03285295|76044179|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
42225200|NCT03285295|76044180|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
42225201|NCT03285295|76044181|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
42225202|NCT03285295|76044182|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
42225203|NCT03285295|76044178|FG000|Alinity s Chagas|Protocol Violation|76|||
42225204|NCT03285295|76044179|FG001|Alinity s Chagas|Protocol Violation|0|||
42225205|NCT03285295|76044180|FG002|Alinity s Chagas|Protocol Violation|0|||
42225206|NCT03285295|76044181|FG003|Alinity s Chagas|Protocol Violation|0|||
42225207|NCT03285295|76044182|FG004|Alinity s Chagas|Protocol Violation|0|||
42225208|NCT03285295|76044178|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
42225209|NCT03285295|76044179|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
42225210|NCT03285295|76044180|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
42225211|NCT03285295|76044181|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
42225212|NCT03285295|76044182|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
42225213|NCT03285295|76044178|FG000|Alinity s Chagas|No Results Generated|105|||
42225214|NCT03285295|76044179|FG001|Alinity s Chagas|No Results Generated|0|||
42225215|NCT03285295|76044180|FG002|Alinity s Chagas|No Results Generated|0|||
41984890|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
41984891|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
41984892|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
41984893|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
41984894|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
41984895|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
41984896|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
41984897|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
41984898|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
41984899|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
41984900|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
41984901|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
41984902|NCT00105443|75791596|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
41984903|NCT00105443|75791597|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
41984904|NCT00105443|75791598|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
41984905|NCT00105443|75791599|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
42031918|NCT00864253|75840180|FG001|Overall Study|Protocol Violation|2|||
42031919|NCT00864253|75840179|FG000|Overall Study|Lost to Follow-up|1|||
42031920|NCT00864253|75840180|FG001|Overall Study|Lost to Follow-up|1|||
42225216|NCT03285295|76044181|FG003|Alinity s Chagas|No Results Generated|0|||
42225217|NCT03285295|76044182|FG004|Alinity s Chagas|No Results Generated|0|||
42225218|NCT03285295|76044178|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
42225219|NCT03285295|76044179|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
42225220|NCT03285295|76044180|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
42225221|NCT03285295|76044181|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
42225222|NCT03285295|76044182|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
42225223|NCT02583048|76044214|FG000|Overall Study|Withdrawal by Subject|0|||
42225224|NCT02583048|76044215|FG001|Overall Study|Withdrawal by Subject|1|||
42225225|NCT02583048|76044216|FG002|Overall Study|Withdrawal by Subject|0|||
42225226|NCT02583048|76044214|FG000|Overall Study|Failed to meet eligibility criterion|0|||
42225227|NCT02583048|76044215|FG001|Overall Study|Failed to meet eligibility criterion|0|||
42225228|NCT02583048|76044216|FG002|Overall Study|Failed to meet eligibility criterion|1|||
42225229|NCT02939599|76044229|FG000|Overall Study|Adverse Event|1|||
42225230|NCT02939599|76044230|FG001|Overall Study|Adverse Event|0|||
42225231|NCT02939599|76044229|FG000|Overall Study|Study Terminated By Sponsor|2|||
42225232|NCT02939599|76044230|FG001|Overall Study|Study Terminated By Sponsor|2|||
42225233|NCT01318512|76044237|FG000|Maintenance Period (6 Months)|Death|2|||
42225234|NCT01318512|76044237|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
42225235|NCT03274687|76044258|FG000|Overall Study|Protocol Violation|1|||
42225236|NCT03274687|76044259|FG001|Overall Study|Protocol Violation|1|||
42225237|NCT04651218|76044265|FG000|Overall Study|Withdrawal by Subject|0|||
42225238|NCT04651218|76044266|FG001|Overall Study|Withdrawal by Subject|2|||
42225239|NCT03274453|76044276|FG000|Overall Study|Lost to Follow-up|2|||
42225240|NCT03274453|76044277|FG001|Overall Study|Lost to Follow-up|5|||
42225241|NCT03274453|76044278|FG002|Overall Study|Lost to Follow-up|4|||
42225242|NCT03274453|76044279|FG003|Overall Study|Lost to Follow-up|1|||
42225243|NCT03274453|76044276|FG000|Overall Study|Physician Decision|2|||
42225244|NCT03274453|76044277|FG001|Overall Study|Physician Decision|0|||
42225245|NCT03274453|76044278|FG002|Overall Study|Physician Decision|0|||
42225246|NCT03274453|76044279|FG003|Overall Study|Physician Decision|3|||
42225247|NCT03274453|76044276|FG000|Overall Study|Surgery Cancelled|0|||
42225248|NCT03274453|76044277|FG001|Overall Study|Surgery Cancelled|1|||
42225249|NCT03274453|76044278|FG002|Overall Study|Surgery Cancelled|0|||
42225250|NCT03274453|76044279|FG003|Overall Study|Surgery Cancelled|0|||
42225251|NCT03273907|76044289|FG000|Overall Study|Death|1|||
42225252|NCT03273907|76044289|FG000|Overall Study|Lost to Follow-up|4|||
42225253|NCT03273907|76044289|FG000|Overall Study|Withdrawal by Subject|2|||
42225254|NCT03273907|76044289|FG000|Overall Study|COVID 19|2|||
42225255|NCT00659646|76044311|FG000|Overall Study|Protocol Violation|12|||
42225256|NCT00659646|76044312|FG001|Overall Study|Protocol Violation|8|||
42225257|NCT00659646|76044311|FG000|Overall Study|Adverse Event|1|||
42225258|NCT00659646|76044312|FG001|Overall Study|Adverse Event|0|||
42225259|NCT00659646|76044311|FG000|Overall Study|Lost to Follow-up|1|||
42225260|NCT00659646|76044312|FG001|Overall Study|Lost to Follow-up|0|||
42225261|NCT00659646|76044311|FG000|Overall Study|protocol noncompliance after randomized|1|||
42225262|NCT00659646|76044312|FG001|Overall Study|protocol noncompliance after randomized|0|||
42225263|NCT02236572|76044320|FG000|Overall Study|Withdrawal by Subject|1|||
42225264|NCT02236572|76044320|FG000|Overall Study|Protocol Violation|1|||
42225265|NCT02236572|76044320|FG000|Overall Study|Lost to Follow-up|1|||
42225266|NCT03054870|76044324|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
42225267|NCT03054870|76044324|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
42225268|NCT03414047|76044343|FG000|Overall Study|Adverse Event|0|||
42225269|NCT03414047|76044344|FG001|Overall Study|Adverse Event|0|||
42225270|NCT03414047|76044345|FG002|Overall Study|Adverse Event|1|||
42225271|NCT03414047|76044346|FG003|Overall Study|Adverse Event|1|||
42225272|NCT03414047|76044343|FG000|Overall Study|Physician Decision|1|||
42225273|NCT03414047|76044344|FG001|Overall Study|Physician Decision|0|||
42225274|NCT03414047|76044345|FG002|Overall Study|Physician Decision|0|||
42225275|NCT03414047|76044346|FG003|Overall Study|Physician Decision|1|||
42225276|NCT03414047|76044343|FG000|Overall Study|Withdrawal by Subject|1|||
41984906|NCT01327612|75791615|FG000|Overall Study|Withdrawal by Subject|0|||
41984907|NCT01327612|75791616|FG001|Overall Study|Withdrawal by Subject|0|||
41984908|NCT01327612|75791617|FG002|Overall Study|Withdrawal by Subject|0|||
41984909|NCT01327612|75791618|FG003|Overall Study|Withdrawal by Subject|0|||
41984910|NCT01327612|75791619|FG004|Overall Study|Withdrawal by Subject|0|||
41984911|NCT01327612|75791620|FG005|Overall Study|Withdrawal by Subject|1|||
41984912|NCT01327612|75791621|FG006|Overall Study|Withdrawal by Subject|0|||
42225277|NCT03414047|76044344|FG001|Overall Study|Withdrawal by Subject|0|||
42225278|NCT03414047|76044345|FG002|Overall Study|Withdrawal by Subject|2|||
42225279|NCT03414047|76044346|FG003|Overall Study|Withdrawal by Subject|0|||
42225280|NCT03351335|76044360|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
42225281|NCT03351335|76044361|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
42225282|NCT03351335|76044362|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
42225283|NCT03055806|76044374|FG000|Overall Study|Adverse Event|0|||
42225284|NCT03055806|76044375|FG001|Overall Study|Adverse Event|0|||
42225285|NCT03055806|76044376|FG002|Overall Study|Adverse Event|1|||
42225286|NCT03055806|76044377|FG003|Overall Study|Adverse Event|1|||
42225287|NCT03055806|76044374|FG000|Overall Study|Lost to Follow-up|0|||
42225288|NCT03055806|76044375|FG001|Overall Study|Lost to Follow-up|3|||
42225289|NCT03055806|76044376|FG002|Overall Study|Lost to Follow-up|6|||
42225290|NCT03055806|76044377|FG003|Overall Study|Lost to Follow-up|7|||
41984913|NCT01327612|75791615|FG000|Overall Study|Disease Progression|1|||
42225291|NCT03055806|76044374|FG000|Overall Study|Physician Decision|1|||
42225292|NCT03055806|76044375|FG001|Overall Study|Physician Decision|0|||
42225293|NCT03055806|76044376|FG002|Overall Study|Physician Decision|0|||
42302439|NCT02473393|76137645|FG001|Overall Study|Withdrawal by Subject|0|||
42225294|NCT03055806|76044377|FG003|Overall Study|Physician Decision|1|||
42225295|NCT03055806|76044374|FG000|Overall Study|Protocol Violation|1|||
42031921|NCT00864253|75840179|FG000|Overall Study|Withdrawal by Subject|18|||
42031922|NCT00864253|75840180|FG001|Overall Study|Withdrawal by Subject|18|||
42031923|NCT00864253|75840179|FG000|Overall Study|Death|1|||
42031924|NCT00864253|75840180|FG001|Overall Study|Death|0|||
42031925|NCT00864253|75840179|FG000|Overall Study|Ongoing|2|||
42031926|NCT00864253|75840180|FG001|Overall Study|Ongoing|3|||
42031927|NCT00864253|75840179|FG000|Overall Study|Untreated|7|||
42031928|NCT00864253|75840180|FG001|Overall Study|Untreated|7|||
42031929|NCT01094730|75840188|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
42031930|NCT01094730|75840189|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
42031931|NCT01094730|75840188|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
42031932|NCT01094730|75840189|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
42031933|NCT01094730|75840188|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
42031934|NCT01094730|75840189|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
42031935|NCT01094730|75840188|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
42031936|NCT01094730|75840189|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
42031937|NCT01094730|75840188|FG000|Period 2 (14 Days)|Protocol Violation|2|||
42031938|NCT01094730|75840189|FG001|Period 2 (14 Days)|Protocol Violation|0|||
42031939|NCT01094730|75840188|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
42031940|NCT01094730|75840189|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
42031941|NCT01094730|75840188|FG000|Period 2 (14 Days)|Adverse Event|0|||
42031942|NCT01094730|75840189|FG001|Period 2 (14 Days)|Adverse Event|1|||
42031943|NCT01094730|75840188|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
42031944|NCT01094730|75840189|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
42031945|NCT00864097|75840204|FG000|Overall Study|Death|0|||
42031946|NCT00864097|75840205|FG001|Overall Study|Death|1|||
42225296|NCT03055806|76044375|FG001|Overall Study|Protocol Violation|0|||
42225297|NCT03055806|76044376|FG002|Overall Study|Protocol Violation|0|||
42225298|NCT03055806|76044377|FG003|Overall Study|Protocol Violation|0|||
42225299|NCT03055806|76044374|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
42225300|NCT03055806|76044375|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
42225301|NCT03055806|76044376|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
41984914|NCT01327612|75791616|FG001|Overall Study|Disease Progression|1|||
42031947|NCT00864097|75840206|FG002|Overall Study|Death|0|||
42031948|NCT00864097|75840207|FG003|Overall Study|Death|0|||
42225302|NCT03055806|76044377|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
42225303|NCT03055806|76044374|FG000|Overall Study|Withdrawal of consent to continue study|2|||
41984915|NCT01327612|75791617|FG002|Overall Study|Disease Progression|1|||
41984916|NCT01327612|75791618|FG003|Overall Study|Disease Progression|0|||
41984917|NCT01327612|75791619|FG004|Overall Study|Disease Progression|1|||
41984918|NCT01327612|75791620|FG005|Overall Study|Disease Progression|2|||
42031949|NCT00864097|75840204|FG000|Overall Study|Adverse Event|6|||
41984919|NCT01327612|75791621|FG006|Overall Study|Disease Progression|2|||
41984920|NCT01327612|75791615|FG000|Overall Study|Administrative Decision|0|||
41984921|NCT01327612|75791616|FG001|Overall Study|Administrative Decision|0|||
41984922|NCT01327612|75791617|FG002|Overall Study|Administrative Decision|0|||
41984923|NCT01327612|75791618|FG003|Overall Study|Administrative Decision|1|||
41984924|NCT01327612|75791619|FG004|Overall Study|Administrative Decision|0|||
41984925|NCT01327612|75791620|FG005|Overall Study|Administrative Decision|0|||
41984926|NCT01327612|75791621|FG006|Overall Study|Administrative Decision|0|||
41984927|NCT01327612|75791615|FG000|Overall Study|Death|0|||
41984928|NCT01327612|75791616|FG001|Overall Study|Death|0|||
41984929|NCT01327612|75791617|FG002|Overall Study|Death|0|||
41984930|NCT01327612|75791618|FG003|Overall Study|Death|0|||
41984931|NCT01327612|75791619|FG004|Overall Study|Death|1|||
42031950|NCT00864097|75840205|FG001|Overall Study|Adverse Event|8|||
42031951|NCT00864097|75840206|FG002|Overall Study|Adverse Event|11|||
42031952|NCT00864097|75840207|FG003|Overall Study|Adverse Event|9|||
42031953|NCT00864097|75840204|FG000|Overall Study|Lack of Efficacy|9|||
42031954|NCT00864097|75840205|FG001|Overall Study|Lack of Efficacy|3|||
42031955|NCT00864097|75840206|FG002|Overall Study|Lack of Efficacy|7|||
42031956|NCT00864097|75840207|FG003|Overall Study|Lack of Efficacy|2|||
42031957|NCT00864097|75840204|FG000|Overall Study|Lost to Follow-up|0|||
42031958|NCT00864097|75840205|FG001|Overall Study|Lost to Follow-up|1|||
42225304|NCT03055806|76044375|FG001|Overall Study|Withdrawal of consent to continue study|3|||
42225305|NCT03055806|76044376|FG002|Overall Study|Withdrawal of consent to continue study|4|||
42225306|NCT03055806|76044377|FG003|Overall Study|Withdrawal of consent to continue study|6|||
42225307|NCT03055806|76044374|FG000|Overall Study|Partner not willing to try intercourse|1|||
42225308|NCT03055806|76044375|FG001|Overall Study|Partner not willing to try intercourse|0|||
42225309|NCT03055806|76044376|FG002|Overall Study|Partner not willing to try intercourse|0|||
42225310|NCT03055806|76044377|FG003|Overall Study|Partner not willing to try intercourse|0|||
42225311|NCT04620798|76044389|FG000|Overall Study|Lost to Follow-up|126|||
42225312|NCT04620798|76044390|FG001|Overall Study|Lost to Follow-up|138|||
42225313|NCT03052764|76044398|FG000|Double-Blind Treatment Period|Adverse Event|2|||
42225314|NCT03052764|76044399|FG001|Double-Blind Treatment Period|Adverse Event|0|||
42225315|NCT03052764|76044398|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
42225316|NCT03052764|76044399|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
42225317|NCT03052764|76044398|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
42225318|NCT03052764|76044399|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
42225319|NCT03052764|76044398|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
42225320|NCT03052764|76044399|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
42225321|NCT03052764|76044398|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
42225322|NCT03052764|76044399|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
42225323|NCT02951819|76044409|FG000|Overall Study|Death|9|||
42225324|NCT02951819|76044410|FG001|Overall Study|Death|7|||
42225325|NCT02951819|76044409|FG000|Overall Study|Withdrawal by Subject|3|||
42225326|NCT02951819|76044410|FG001|Overall Study|Withdrawal by Subject|0|||
42225327|NCT02951819|76044409|FG000|Overall Study|Adverse Event|1|||
42225328|NCT02951819|76044410|FG001|Overall Study|Adverse Event|0|||
42225329|NCT02951819|76044409|FG000|Overall Study|Lack of Efficacy|4|||
42225330|NCT02951819|76044410|FG001|Overall Study|Lack of Efficacy|0|||
42225331|NCT02951819|76044409|FG000|Overall Study|Lost to Follow-up|1|||
42225332|NCT02951819|76044410|FG001|Overall Study|Lost to Follow-up|0|||
41984932|NCT01327612|75791620|FG005|Overall Study|Death|0|||
42225333|NCT02951819|76044409|FG000|Overall Study|Progressive Disease|1|||
42225334|NCT02951819|76044410|FG001|Overall Study|Progressive Disease|0|||
42225335|NCT02951819|76044409|FG000|Overall Study|Other|9|||
42225336|NCT02951819|76044410|FG001|Overall Study|Other|0|||
42225337|NCT03383783|76044416|FG000|Overall Study|Withdrawal by Subject|2|||
42225338|NCT03334721|76044434|FG000|Overall Study|Withdrawal by Subject|1|||
42225339|NCT03334721|76044435|FG001|Overall Study|Withdrawal by Subject|0|||
42225340|NCT03334721|76044434|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
42225341|NCT03334721|76044435|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
42225342|NCT03515551|76044448|FG000|Overall Study|Death|4|||
42225343|NCT03515551|76044449|FG001|Overall Study|Death|1|||
42225344|NCT03515551|76044450|FG002|Overall Study|Death|2|||
42225345|NCT03515551|76044451|FG003|Overall Study|Death|2|||
42225346|NCT03515551|76044452|FG004|Overall Study|Death|2|||
42225347|NCT03515551|76044453|FG005|Overall Study|Death|4|||
42225348|NCT03515551|76044454|FG006|Overall Study|Death|1|||
42225349|NCT03515551|76044448|FG000|Overall Study|Lost to Follow-up|0|||
42225350|NCT03515551|76044449|FG001|Overall Study|Lost to Follow-up|0|||
41984933|NCT01327612|75791621|FG006|Overall Study|Death|0|||
41984934|NCT01327573|75791640|FG000|Overall Study|Physician Decision|3|||
41984935|NCT01327573|75791641|FG001|Overall Study|Physician Decision|1|||
41984936|NCT01327495|75791654|FG000|Overall Study|Adverse Event|2|||
41984937|NCT01327495|75791655|FG001|Overall Study|Adverse Event|1|||
41984938|NCT01327495|75791656|FG002|Overall Study|Adverse Event|1|||
41984939|NCT01327495|75791657|FG003|Overall Study|Adverse Event|0|||
42031959|NCT00864097|75840206|FG002|Overall Study|Lost to Follow-up|0|||
42225351|NCT03515551|76044450|FG002|Overall Study|Lost to Follow-up|1|||
42225352|NCT03515551|76044451|FG003|Overall Study|Lost to Follow-up|0|||
42225353|NCT03515551|76044452|FG004|Overall Study|Lost to Follow-up|0|||
42225354|NCT03515551|76044453|FG005|Overall Study|Lost to Follow-up|0|||
42225355|NCT03515551|76044454|FG006|Overall Study|Lost to Follow-up|0|||
42225356|NCT03515551|76044448|FG000|Overall Study|Withdrawal by Subject|0|||
42225357|NCT03515551|76044449|FG001|Overall Study|Withdrawal by Subject|1|||
42225358|NCT03515551|76044450|FG002|Overall Study|Withdrawal by Subject|0|||
42225359|NCT03515551|76044451|FG003|Overall Study|Withdrawal by Subject|0|||
42225360|NCT03515551|76044452|FG004|Overall Study|Withdrawal by Subject|0|||
42225361|NCT03515551|76044453|FG005|Overall Study|Withdrawal by Subject|0|||
42225362|NCT03515551|76044454|FG006|Overall Study|Withdrawal by Subject|1|||
42225363|NCT03515551|76044448|FG000|Overall Study|Study ended by sponsor|0|||
42225364|NCT03515551|76044449|FG001|Overall Study|Study ended by sponsor|0|||
42225365|NCT03515551|76044450|FG002|Overall Study|Study ended by sponsor|2|||
42225366|NCT03515551|76044451|FG003|Overall Study|Study ended by sponsor|1|||
42225367|NCT03515551|76044452|FG004|Overall Study|Study ended by sponsor|3|||
41984940|NCT01327495|75791658|FG004|Overall Study|Adverse Event|0|||
41984941|NCT01327495|75791659|FG005|Overall Study|Adverse Event|2|||
41984942|NCT01327495|75791654|FG000|Overall Study|Withdrawal by Subject|0|||
41984943|NCT01327495|75791655|FG001|Overall Study|Withdrawal by Subject|1|||
41984944|NCT01327495|75791656|FG002|Overall Study|Withdrawal by Subject|1|||
41984945|NCT01327495|75791657|FG003|Overall Study|Withdrawal by Subject|0|||
41984946|NCT01327495|75791658|FG004|Overall Study|Withdrawal by Subject|1|||
41984947|NCT01327495|75791659|FG005|Overall Study|Withdrawal by Subject|0|||
41984948|NCT01327495|75791654|FG000|Overall Study|Physician Decision|0|||
41984949|NCT01327495|75791655|FG001|Overall Study|Physician Decision|0|||
41984950|NCT01327495|75791656|FG002|Overall Study|Physician Decision|0|||
41984951|NCT01327495|75791657|FG003|Overall Study|Physician Decision|0|||
41984952|NCT01327495|75791658|FG004|Overall Study|Physician Decision|2|||
41984953|NCT01327495|75791659|FG005|Overall Study|Physician Decision|0|||
41984954|NCT01327339|75791679|FG000|Overall Study|Protocol Violation|8|||
41984955|NCT01327300|75791683|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
42225368|NCT03515551|76044453|FG005|Overall Study|Study ended by sponsor|0|||
42225369|NCT03515551|76044454|FG006|Overall Study|Study ended by sponsor|3|||
42225370|NCT03515551|76044448|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
42225371|NCT03515551|76044449|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
42225372|NCT03515551|76044450|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
42225373|NCT03515551|76044451|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
42225374|NCT03515551|76044452|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
42225375|NCT03515551|76044453|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
42225376|NCT03515551|76044454|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
42225377|NCT03380429|76044480|FG000|Overall Study|Physician Decision|0|||
42225378|NCT03380429|76044481|FG001|Overall Study|Physician Decision|1|||
42225379|NCT03380429|76044482|FG002|Overall Study|Physician Decision|0|||
42225380|NCT03380429|76044483|FG003|Overall Study|Physician Decision|1|||
42225381|NCT03380429|76044484|FG004|Overall Study|Physician Decision|1|||
42225382|NCT03380429|76044480|FG000|Overall Study|Withdrawal by Subject|3|||
42225383|NCT03380429|76044481|FG001|Overall Study|Withdrawal by Subject|3|||
42225384|NCT03380429|76044482|FG002|Overall Study|Withdrawal by Subject|5|||
42225385|NCT03380429|76044483|FG003|Overall Study|Withdrawal by Subject|2|||
42225386|NCT03380429|76044484|FG004|Overall Study|Withdrawal by Subject|1|||
42225387|NCT03380429|76044480|FG000|Overall Study|Lost to Follow-up|0|||
42225388|NCT03380429|76044481|FG001|Overall Study|Lost to Follow-up|2|||
42225389|NCT03380429|76044482|FG002|Overall Study|Lost to Follow-up|4|||
42225390|NCT03380429|76044483|FG003|Overall Study|Lost to Follow-up|3|||
42225391|NCT03380429|76044484|FG004|Overall Study|Lost to Follow-up|1|||
42225392|NCT03380429|76044480|FG000|Overall Study|Protocol Violation|1|||
42225393|NCT03380429|76044481|FG001|Overall Study|Protocol Violation|0|||
42225394|NCT03380429|76044482|FG002|Overall Study|Protocol Violation|1|||
42225395|NCT03380429|76044483|FG003|Overall Study|Protocol Violation|0|||
42225396|NCT03380429|76044484|FG004|Overall Study|Protocol Violation|1|||
42225397|NCT03380429|76044480|FG000|Overall Study|Lack of Efficacy|0|||
42225398|NCT03380429|76044481|FG001|Overall Study|Lack of Efficacy|0|||
42225399|NCT03380429|76044482|FG002|Overall Study|Lack of Efficacy|0|||
42225400|NCT03380429|76044483|FG003|Overall Study|Lack of Efficacy|2|||
42225401|NCT03380429|76044484|FG004|Overall Study|Lack of Efficacy|1|||
42225402|NCT03380429|76044480|FG000|Overall Study|Adverse Event|1|||
42225403|NCT03380429|76044481|FG001|Overall Study|Adverse Event|1|||
42225404|NCT03380429|76044482|FG002|Overall Study|Adverse Event|1|||
42225405|NCT03380429|76044483|FG003|Overall Study|Adverse Event|2|||
42225406|NCT03380429|76044484|FG004|Overall Study|Adverse Event|0|||
42225407|NCT03280615|76044503|FG000|Overall Study|Lost to Follow-up|1|||
42225408|NCT03280615|76044504|FG001|Overall Study|Lost to Follow-up|2|||
42225409|NCT03280615|76044503|FG000|Overall Study|Adverse Event|1|||
42225410|NCT03280615|76044504|FG001|Overall Study|Adverse Event|1|||
42225411|NCT03280615|76044503|FG000|Overall Study|Withdrawal by Subject|2|||
42225412|NCT03280615|76044504|FG001|Overall Study|Withdrawal by Subject|2|||
42225413|NCT03280537|76044512|FG000|Overall Study|Withdrawal by Subject|2|||
42225414|NCT03280537|76044513|FG001|Overall Study|Withdrawal by Subject|4|||
41984956|NCT01327300|75791684|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
42225415|NCT03280381|76044521|FG000|Overall Study|Physician Decision|0|||
42225416|NCT03280381|76044522|FG001|Overall Study|Physician Decision|2|||
42225417|NCT03270085|76044531|FG000|Overall Study|Withdrawal by Subject|1|||
42225418|NCT03270085|76044532|FG001|Overall Study|Withdrawal by Subject|0|||
42225419|NCT03267511|76044542|FG000|Overall Study|Lost to Follow-up|0|||
42225420|NCT03267511|76044543|FG001|Overall Study|Lost to Follow-up|0|||
42225421|NCT03267511|76044544|FG002|Overall Study|Lost to Follow-up|0|||
42225422|NCT03267511|76044545|FG003|Overall Study|Lost to Follow-up|1|||
42225423|NCT03379259|76044572|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
42225424|NCT03379259|76044573|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
41984957|NCT01379521|75791702|FG000|Overall Study -Treatment Period|Adverse Event|3|||
41984958|NCT01379521|75791703|FG001|Overall Study -Treatment Period|Adverse Event|0|||
42225425|NCT03379259|76044574|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
41984959|NCT01379521|75791702|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
41984960|NCT01379521|75791703|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
42225426|NCT03379259|76044575|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
42225427|NCT03379259|76044576|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
42225428|NCT03379259|76044577|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
42225429|NCT03379259|76044572|FG000|Overall Study|Death|0|||
42225430|NCT03379259|76044573|FG001|Overall Study|Death|1|||
42225431|NCT03379259|76044574|FG002|Overall Study|Death|2|||
42225432|NCT03379259|76044575|FG003|Overall Study|Death|1|||
42225433|NCT03379259|76044576|FG004|Overall Study|Death|4|||
42225434|NCT03379259|76044577|FG005|Overall Study|Death|2|||
42225435|NCT03379259|76044572|FG000|Overall Study|Withdrawal by Subject|0|||
42225436|NCT03379259|76044573|FG001|Overall Study|Withdrawal by Subject|0|||
42225437|NCT03379259|76044574|FG002|Overall Study|Withdrawal by Subject|1|||
42225438|NCT03379259|76044575|FG003|Overall Study|Withdrawal by Subject|0|||
42225439|NCT03379259|76044576|FG004|Overall Study|Withdrawal by Subject|2|||
42225440|NCT03379259|76044577|FG005|Overall Study|Withdrawal by Subject|0|||
42225441|NCT03379259|76044572|FG000|Overall Study|Study terminated by sponsor|0|||
42225442|NCT03379259|76044573|FG001|Overall Study|Study terminated by sponsor|0|||
42225443|NCT03379259|76044574|FG002|Overall Study|Study terminated by sponsor|0|||
42031960|NCT00864097|75840207|FG003|Overall Study|Lost to Follow-up|1|||
42225444|NCT03379259|76044575|FG003|Overall Study|Study terminated by sponsor|1|||
42225445|NCT03379259|76044576|FG004|Overall Study|Study terminated by sponsor|1|||
42225446|NCT03379259|76044577|FG005|Overall Study|Study terminated by sponsor|4|||
42225447|NCT03379259|76044572|FG000|Overall Study|Disease progression|0|||
42225448|NCT03379259|76044573|FG001|Overall Study|Disease progression|0|||
42225449|NCT03379259|76044574|FG002|Overall Study|Disease progression|0|||
42225450|NCT03379259|76044575|FG003|Overall Study|Disease progression|1|||
42225451|NCT03379259|76044576|FG004|Overall Study|Disease progression|0|||
42225452|NCT03379259|76044577|FG005|Overall Study|Disease progression|1|||
42225453|NCT03379259|76044572|FG000|Overall Study|Lost to Follow-up|0|||
42225454|NCT03379259|76044573|FG001|Overall Study|Lost to Follow-up|0|||
42225455|NCT03379259|76044574|FG002|Overall Study|Lost to Follow-up|0|||
42225456|NCT03379259|76044575|FG003|Overall Study|Lost to Follow-up|0|||
42225457|NCT03379259|76044576|FG004|Overall Study|Lost to Follow-up|1|||
42225458|NCT03379259|76044577|FG005|Overall Study|Lost to Follow-up|0|||
42225459|NCT03379259|76044572|FG000|Overall Study|Deteriorating condition|0|||
42225460|NCT03379259|76044573|FG001|Overall Study|Deteriorating condition|0|||
42225461|NCT03379259|76044574|FG002|Overall Study|Deteriorating condition|0|||
42225462|NCT03379259|76044575|FG003|Overall Study|Deteriorating condition|0|||
42225463|NCT03379259|76044576|FG004|Overall Study|Deteriorating condition|1|||
42225464|NCT03379259|76044577|FG005|Overall Study|Deteriorating condition|0|||
42225465|NCT03328897|76044597|FG000|Randomized-treatment Epoch|Adverse Event|4|||
42225466|NCT03328897|76044598|FG001|Randomized-treatment Epoch|Adverse Event|1|||
42225467|NCT03328897|76044599|FG002|Randomized-treatment Epoch|Adverse Event|1|||
42225468|NCT03328897|76044597|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
42225469|NCT03328897|76044598|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
42225470|NCT03328897|76044599|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
42225471|NCT03328897|76044597|FG000|Randomized-treatment Epoch|Pregnancy|3|||
42225472|NCT03328897|76044598|FG001|Randomized-treatment Epoch|Pregnancy|0|||
42225473|NCT03328897|76044599|FG002|Randomized-treatment Epoch|Pregnancy|0|||
42225474|NCT03328897|76044597|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
42225475|NCT03328897|76044598|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
42031961|NCT00864097|75840204|FG000|Overall Study|Withdrawal by Subject|15|||
42031962|NCT00864097|75840205|FG001|Overall Study|Withdrawal by Subject|11|||
42031963|NCT00864097|75840206|FG002|Overall Study|Withdrawal by Subject|11|||
42031964|NCT00864097|75840207|FG003|Overall Study|Withdrawal by Subject|12|||
42031965|NCT00864097|75840204|FG000|Overall Study|Protocol Violation|2|||
42031966|NCT00864097|75840205|FG001|Overall Study|Protocol Violation|1|||
42031967|NCT00864097|75840206|FG002|Overall Study|Protocol Violation|0|||
42031968|NCT00864097|75840207|FG003|Overall Study|Protocol Violation|1|||
42031969|NCT00864097|75840204|FG000|Overall Study|Terminated by sponsor|105|||
42031970|NCT00864097|75840205|FG001|Overall Study|Terminated by sponsor|112|||
42031971|NCT00864097|75840206|FG002|Overall Study|Terminated by sponsor|102|||
42225476|NCT03328897|76044599|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
42225477|NCT03328897|76044597|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
42031972|NCT00864097|75840207|FG003|Overall Study|Terminated by sponsor|99|||
42031973|NCT00864097|75840204|FG000|Overall Study|Randomized but not treated|2|||
42031974|NCT00864097|75840205|FG001|Overall Study|Randomized but not treated|0|||
42031975|NCT00864097|75840206|FG002|Overall Study|Randomized but not treated|1|||
42225478|NCT03328897|76044598|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
42225479|NCT03328897|76044599|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
42225480|NCT03328897|76044597|FG000|Follow-up Epoch|Adverse Event|4|||
42225481|NCT03328897|76044598|FG001|Follow-up Epoch|Adverse Event|0|||
42225482|NCT03328897|76044599|FG002|Follow-up Epoch|Adverse Event|1|||
42225483|NCT03328897|76044597|FG000|Follow-up Epoch|Lack of Efficacy|1|||
42225484|NCT03328897|76044598|FG001|Follow-up Epoch|Lack of Efficacy|1|||
42225485|NCT03328897|76044599|FG002|Follow-up Epoch|Lack of Efficacy|1|||
42225486|NCT03328897|76044597|FG000|Follow-up Epoch|Lost to Follow-up|0|||
42225487|NCT03328897|76044598|FG001|Follow-up Epoch|Lost to Follow-up|1|||
42225488|NCT03328897|76044599|FG002|Follow-up Epoch|Lost to Follow-up|0|||
42225489|NCT03328897|76044597|FG000|Follow-up Epoch|Pregnancy|1|||
42225490|NCT03328897|76044598|FG001|Follow-up Epoch|Pregnancy|0|||
42225491|NCT03328897|76044599|FG002|Follow-up Epoch|Pregnancy|0|||
42225492|NCT03328897|76044597|FG000|Follow-up Epoch|Patient/guardian decision|2|||
42225493|NCT03328897|76044598|FG001|Follow-up Epoch|Patient/guardian decision|1|||
42225494|NCT03328897|76044599|FG002|Follow-up Epoch|Patient/guardian decision|0|||
42225495|NCT03266107|76044607|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
42225496|NCT03266107|76044607|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
42225497|NCT03266107|76044607|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
42225498|NCT03266107|76044607|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
42225499|NCT03378635|76044616|FG000|Overall Study|Adverse Event|1|||
42225500|NCT03378635|76044617|FG001|Overall Study|Adverse Event|0|||
42225501|NCT03378635|76044618|FG002|Overall Study|Adverse Event|0|||
42225502|NCT03378635|76044616|FG000|Overall Study|Withdrawal by Subject|1|||
42225503|NCT03378635|76044617|FG001|Overall Study|Withdrawal by Subject|0|||
42225504|NCT03378635|76044618|FG002|Overall Study|Withdrawal by Subject|0|||
42225505|NCT03326869|76044629|FG000|Overall Study|Study data has been lost to natural disa|1|||
42225506|NCT03326869|76044630|FG001|Overall Study|Study data has been lost to natural disa|1|||
42225507|NCT03334409|76044642|FG000|Overall Study|Did not meet inclusion criteria|1|||
42225508|NCT03334409|76044643|FG001|Overall Study|Did not meet inclusion criteria|0|||
42225509|NCT02891915|76044651|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
42225510|NCT02891915|76044652|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
42225511|NCT02891915|76044651|FG000|Overall Study|Withdrawal by Subject|3|||
42225512|NCT02891915|76044652|FG001|Overall Study|Withdrawal by Subject|3|||
42225513|NCT02891915|76044651|FG000|Overall Study|Became Ineligible After Enrollment|2|||
42225514|NCT02891915|76044652|FG001|Overall Study|Became Ineligible After Enrollment|1|||
42225515|NCT02891915|76044651|FG000|Overall Study|Lost to Follow-up|1|||
42225516|NCT02891915|76044652|FG001|Overall Study|Lost to Follow-up|4|||
42225517|NCT02891915|76044651|FG000|Overall Study|Physician Decision|1|||
42225518|NCT02891915|76044652|FG001|Overall Study|Physician Decision|0|||
42225519|NCT02891681|76044661|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
42225520|NCT02891681|76044662|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
42225521|NCT02891681|76044663|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
42225522|NCT02891681|76044661|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
42225523|NCT02891681|76044662|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
42225524|NCT02891681|76044663|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
42225525|NCT02891681|76044661|FG000|Overall Study|Taken off study after first imaging appointment|1|||
42225526|NCT02891681|76044662|FG001|Overall Study|Taken off study after first imaging appointment|0|||
42225527|NCT02891681|76044663|FG002|Overall Study|Taken off study after first imaging appointment|0|||
42225528|NCT04671342|76044671|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
42225529|NCT04671342|76044671|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
42225530|NCT04671342|76044671|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
42225531|NCT04671342|76044671|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
42225532|NCT04671342|76044671|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
42225533|NCT04671342|76044671|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
42225534|NCT03051217|76044678|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
41984961|NCT01379521|75791702|FG000|Overall Study -Treatment Period|Disease Progression|23|||
41984962|NCT01379521|75791703|FG001|Overall Study -Treatment Period|Disease Progression|22|||
41984963|NCT01379521|75791702|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
41984964|NCT01379521|75791703|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
41984965|NCT01379521|75791702|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
41984966|NCT01379521|75791703|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
41984967|NCT01379521|75791702|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
42031976|NCT00864097|75840207|FG003|Overall Study|Randomized but not treated|0|||
42031977|NCT00864097|75840204|FG000|Overall Study|Other|0|||
42031978|NCT00864097|75840205|FG001|Overall Study|Other|0|||
42031979|NCT00864097|75840206|FG002|Overall Study|Other|0|||
42031980|NCT00864097|75840207|FG003|Overall Study|Other|1|||
42036445|NCT01017120|75844852|FG000|Overall Study|Withdrawal by Subject|39|||
42036446|NCT01017120|75844853|FG001|Overall Study|Withdrawal by Subject|21|||
42225535|NCT03051217|76044679|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42225536|NCT03051217|76044680|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
42225537|NCT03051217|76044681|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42225538|NCT03051217|76044682|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42225539|NCT03051217|76044683|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
41984968|NCT01379521|75791703|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
42036447|NCT01017120|75844852|FG000|Overall Study|Pregnancy|1|||
42036448|NCT01017120|75844853|FG001|Overall Study|Pregnancy|1|||
41984969|NCT01379521|75791702|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
41984970|NCT01379521|75791703|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
41984971|NCT01379521|75791702|FG000|Overall Study -Treatment Period|Death|2|||
41984972|NCT01379521|75791703|FG001|Overall Study -Treatment Period|Death|1|||
41984973|NCT01379521|75791702|FG000|Post-Treatment Evaluations|Disease Progression|22|||
41984974|NCT01379521|75791703|FG001|Post-Treatment Evaluations|Disease Progression|20|||
41984975|NCT01379521|75791702|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
42225540|NCT03051217|76044684|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42225541|NCT03051217|76044678|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
42225542|NCT03051217|76044679|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
42225543|NCT03051217|76044680|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
42225544|NCT03051217|76044681|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
42225545|NCT03051217|76044682|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
42225546|NCT03051217|76044683|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
42225547|NCT03051217|76044684|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
42225548|NCT03051217|76044678|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
42225549|NCT03051217|76044679|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
42225550|NCT03051217|76044680|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
42225551|NCT03051217|76044681|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42225552|NCT03051217|76044682|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42225553|NCT03051217|76044683|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42225554|NCT03051217|76044684|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42225555|NCT03051217|76044678|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
42225556|NCT03051217|76044679|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
42225557|NCT03051217|76044680|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
42225558|NCT03051217|76044681|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
42225559|NCT03051217|76044682|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
42225560|NCT03051217|76044683|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
42225561|NCT03051217|76044684|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
42225562|NCT03051217|76044678|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
42225563|NCT03051217|76044679|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
42225564|NCT03051217|76044680|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
42225565|NCT03051217|76044681|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
42225566|NCT03051217|76044682|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
42225567|NCT03051217|76044683|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
42225568|NCT03051217|76044684|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
42225569|NCT03051217|76044678|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
42225570|NCT03051217|76044679|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
42225571|NCT03051217|76044680|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
42225572|NCT03051217|76044681|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
42225573|NCT03051217|76044682|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
42225574|NCT03051217|76044683|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
42225575|NCT03051217|76044684|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
42225576|NCT03051217|76044678|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
42225577|NCT03051217|76044679|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
42225578|NCT03051217|76044680|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
41984976|NCT01379521|75791703|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
41984977|NCT01379521|75791702|FG000|Post-Treatment Evaluations|Death|1|||
41984978|NCT01379521|75791703|FG001|Post-Treatment Evaluations|Death|0|||
41984979|NCT01371994|75791711|FG000|Overall Study|Adverse Event|3|||
41984980|NCT01371994|75791712|FG001|Overall Study|Adverse Event|6|||
42225579|NCT03051217|76044681|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
42225580|NCT03051217|76044682|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
42225581|NCT03051217|76044683|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
42225582|NCT03051217|76044684|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
42225583|NCT03051217|76044678|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
42225584|NCT03051217|76044679|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
42225585|NCT03051217|76044680|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
42225586|NCT03051217|76044681|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
42225587|NCT03051217|76044682|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
42225588|NCT03051217|76044683|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
42225589|NCT03051217|76044684|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
41984981|NCT01371994|75791711|FG000|Overall Study|Lack of Efficacy|3|||
41984982|NCT01371994|75791712|FG001|Overall Study|Lack of Efficacy|0|||
41984983|NCT01371994|75791711|FG000|Overall Study|Withdrawal by Subject|13|||
42225590|NCT03046056|76044710|FG000|Overall Study|Non-responder at Week 10|6|||
42225591|NCT03046056|76044711|FG001|Overall Study|Non-responder at Week 10|6|||
42225592|NCT03046056|76044712|FG002|Overall Study|Non-responder at Week 10|4|||
42225593|NCT03046056|76044710|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
42225594|NCT03046056|76044711|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
42225595|NCT03046056|76044712|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
42225596|NCT03046056|76044710|FG000|Overall Study|Adverse Event|1|||
42225597|NCT03046056|76044711|FG001|Overall Study|Adverse Event|5|||
42225598|NCT03046056|76044712|FG002|Overall Study|Adverse Event|0|||
42225599|NCT03046056|76044710|FG000|Overall Study|Non-compliance With Study Drug|0|||
42225600|NCT03046056|76044711|FG001|Overall Study|Non-compliance With Study Drug|0|||
42225601|NCT03046056|76044712|FG002|Overall Study|Non-compliance With Study Drug|2|||
42225602|NCT03046056|76044710|FG000|Overall Study|Protocol Violation|1|||
42225603|NCT03046056|76044711|FG001|Overall Study|Protocol Violation|1|||
42225604|NCT03046056|76044712|FG002|Overall Study|Protocol Violation|0|||
42225605|NCT03046056|76044710|FG000|Overall Study|Investigator's Discretion|0|||
42225606|NCT03046056|76044711|FG001|Overall Study|Investigator's Discretion|1|||
42225607|NCT03046056|76044712|FG002|Overall Study|Investigator's Discretion|0|||
42225608|NCT03046056|76044710|FG000|Overall Study|Withdrew Consent|1|||
42225609|NCT03046056|76044711|FG001|Overall Study|Withdrew Consent|0|||
42225610|NCT03046056|76044712|FG002|Overall Study|Withdrew Consent|0|||
42225611|NCT02849587|76044723|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
42225612|NCT02849587|76044724|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
42225613|NCT02849587|76044725|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
42225614|NCT02849587|76044723|FG000|Overall Study|Withdrawal by Subject|0|||
42225615|NCT02849587|76044724|FG001|Overall Study|Withdrawal by Subject|1|||
42225616|NCT02849587|76044725|FG002|Overall Study|Withdrawal by Subject|0|||
42225617|NCT03347279|76044739|FG000|Overall Study|Withdrawal by Subject|8|||
42131638|NCT00393939|75942537|FG000|Overall Study|Objective progression or relapse|239|||
42131639|NCT00393939|75942538|FG001|Overall Study|Objective progression or relapse|223|||
42131640|NCT00393939|75942537|FG000|Overall Study|Withdrawal by Subject|2|||
42131641|NCT00393939|75942538|FG001|Overall Study|Withdrawal by Subject|7|||
42225618|NCT03347279|76044740|FG001|Overall Study|Withdrawal by Subject|15|||
42225619|NCT03347279|76044739|FG000|Overall Study|Death|0|||
42225620|NCT03347279|76044740|FG001|Overall Study|Death|2|||
42225621|NCT03347279|76044739|FG000|Overall Study|Lost to Follow-up|5|||
42225622|NCT03347279|76044740|FG001|Overall Study|Lost to Follow-up|2|||
42225623|NCT03347279|76044739|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
42225624|NCT03347279|76044740|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
42225625|NCT03262441|76044746|FG000|Overall Study|Withdrawal by Subject|1|||
41984984|NCT01371994|75791712|FG001|Overall Study|Withdrawal by Subject|7|||
41984985|NCT01371994|75791711|FG000|Overall Study|Lost to Follow-up|1|||
42225626|NCT04580394|76044750|FG000|First Intervention|Incorrectly Randomized|1|||
42225627|NCT04580394|76044750|FG000|First Intervention|Physician Decision|1|||
42225628|NCT04580394|76044750|FG000|First Intervention|Lost to Follow-up|1|||
42225629|NCT04580394|76044750|FG000|Washout (One Week)|Withdrawal by Subject|1|||
41984986|NCT01371994|75791712|FG001|Overall Study|Lost to Follow-up|1|||
41984987|NCT01371994|75791711|FG000|Overall Study|Protocol Violation|24|||
41984988|NCT01371994|75791712|FG001|Overall Study|Protocol Violation|17|||
41984989|NCT01371994|75791711|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
41984990|NCT01371994|75791712|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
41984991|NCT01371994|75791711|FG000|Overall Study|Physician Decision|1|||
41984992|NCT01371994|75791712|FG001|Overall Study|Physician Decision|1|||
41984993|NCT01371994|75791711|FG000|Overall Study|Miscellaneous Reasons|6|||
41984994|NCT01371994|75791712|FG001|Overall Study|Miscellaneous Reasons|4|||
41984995|NCT01371877|75791720|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
41984996|NCT01371877|75791721|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
41984997|NCT01371838|75791729|FG000|Overall Study|Withdrawal by Subject|27|||
41984998|NCT01371838|75791730|FG001|Overall Study|Withdrawal by Subject|33|||
41984999|NCT01371838|75791729|FG000|Overall Study|Lost to Follow-up|10|||
41985000|NCT01371838|75791730|FG001|Overall Study|Lost to Follow-up|20|||
41985001|NCT01371838|75791729|FG000|Overall Study|Death|3|||
41985002|NCT01371838|75791730|FG001|Overall Study|Death|4|||
41985003|NCT01371838|75791729|FG000|Overall Study|Protocol Violation|3|||
41985004|NCT01371838|75791730|FG001|Overall Study|Protocol Violation|0|||
41985005|NCT01371838|75791729|FG000|Overall Study|Investigator Decision|3|||
41985006|NCT01371838|75791730|FG001|Overall Study|Investigator Decision|8|||
42225630|NCT04580394|76044750|FG000|Washout (One Week)|Adverse Event|1|||
42225631|NCT04580394|76044750|FG000|Washout (One Week)|Withdrawal by Subject|2|||
41985007|NCT01371838|75791729|FG000|Overall Study|Last follow-up visit not conducted|2|||
41985008|NCT01371838|75791730|FG001|Overall Study|Last follow-up visit not conducted|0|||
41985009|NCT01371838|75791729|FG000|Overall Study|Lack of therapeutic response|0|||
42225632|NCT04580394|76044750|FG000|Third Intervention|Adverse Event|1|||
42225633|NCT04580394|76044750|FG000|Third Intervention|Withdrawal by Subject|1|||
42225634|NCT04580394|76044750|FG000|Washout (One Week)|Withdrawal by Subject|2|||
42225635|NCT02781727|76044762|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
42225636|NCT02781727|76044763|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
42225637|NCT02781727|76044762|FG000|Treatment Period|Withdrawal by Subject|1|||
42225638|NCT02781727|76044763|FG001|Treatment Period|Withdrawal by Subject|0|||
42225639|NCT02781727|76044762|FG000|Treatment Period|Lost to Follow-up|0|||
42225640|NCT02781727|76044763|FG001|Treatment Period|Lost to Follow-up|1|||
42225641|NCT01343082|76044769|FG000|The run-in Period|Not meeting criteria|3|||
42225642|NCT01343082|76044770|FG001|The run-in Period|Not meeting criteria|4|||
42225643|NCT01343082|76044771|FG002|The run-in Period|Not meeting criteria|5|||
42225644|NCT01343082|76044769|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
42225645|NCT01343082|76044770|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
42225646|NCT01343082|76044771|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
42225647|NCT01343082|76044769|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
42225648|NCT01343082|76044770|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
42225649|NCT01343082|76044771|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
42225650|NCT01343082|76044769|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
42225651|NCT01343082|76044770|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
42225652|NCT01343082|76044771|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
42225653|NCT01343082|76044769|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
42225654|NCT01343082|76044770|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
42225655|NCT01343082|76044771|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
42225656|NCT03374189|76044777|FG000|Overall Study|Lost to Follow-up|1|||
42225657|NCT03374189|76044778|FG001|Overall Study|Lost to Follow-up|0|||
42225658|NCT03261037|76044788|FG000|Overall Study|Withdrawal by Subject|2|||
42225659|NCT03261037|76044789|FG001|Overall Study|Withdrawal by Subject|13|||
42225660|NCT03261037|76044790|FG002|Overall Study|Withdrawal by Subject|0|||
42225661|NCT03261037|76044791|FG003|Overall Study|Withdrawal by Subject|18|||
42225662|NCT03261037|76044788|FG000|Overall Study|Non-compliance with study procedures|0|||
42225663|NCT03261037|76044789|FG001|Overall Study|Non-compliance with study procedures|2|||
42225664|NCT03261037|76044790|FG002|Overall Study|Non-compliance with study procedures|0|||
42225665|NCT03261037|76044791|FG003|Overall Study|Non-compliance with study procedures|6|||
42225666|NCT03261037|76044788|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
42225667|NCT03261037|76044789|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
42225668|NCT03261037|76044790|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
42225669|NCT03261037|76044791|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
42225670|NCT03261037|76044788|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
42225671|NCT03261037|76044789|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
42225672|NCT03261037|76044790|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
42031981|NCT01183013|75840224|FG000|Overall Study|Adverse Event|6|||
42031982|NCT01183013|75840225|FG001|Overall Study|Adverse Event|8|||
42031983|NCT01183013|75840226|FG002|Overall Study|Adverse Event|5|||
42031984|NCT01183013|75840227|FG003|Overall Study|Adverse Event|5|||
42031985|NCT01183013|75840228|FG004|Overall Study|Adverse Event|10|||
42031986|NCT01183013|75840229|FG005|Overall Study|Adverse Event|10|||
42225673|NCT03261037|76044791|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
42225674|NCT03261037|76044788|FG000|Overall Study|Diagnosed but protocol deviation|1|||
42225675|NCT03261037|76044789|FG001|Overall Study|Diagnosed but protocol deviation|0|||
42225676|NCT03261037|76044790|FG002|Overall Study|Diagnosed but protocol deviation|0|||
42225677|NCT03261037|76044791|FG003|Overall Study|Diagnosed but protocol deviation|0|||
42225678|NCT03261037|76044788|FG000|Overall Study|Participant did not want to continue the study|0|||
42225679|NCT03261037|76044789|FG001|Overall Study|Participant did not want to continue the study|1|||
42225680|NCT03261037|76044790|FG002|Overall Study|Participant did not want to continue the study|0|||
42225681|NCT03261037|76044791|FG003|Overall Study|Participant did not want to continue the study|0|||
42225682|NCT03261037|76044788|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
42225683|NCT03261037|76044789|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
42225684|NCT03261037|76044790|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
42031987|NCT01183013|75840230|FG006|Overall Study|Adverse Event|6|||
42225685|NCT03261037|76044791|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
42225686|NCT03261037|76044788|FG000|Overall Study|Participant presented clinical improvement|0|||
42225687|NCT03261037|76044789|FG001|Overall Study|Participant presented clinical improvement|2|||
42225688|NCT03261037|76044790|FG002|Overall Study|Participant presented clinical improvement|0|||
42225689|NCT03261037|76044791|FG003|Overall Study|Participant presented clinical improvement|0|||
42225690|NCT03261037|76044788|FG000|Overall Study|Technical difficulties|0|||
42031988|NCT01183013|75840224|FG000|Overall Study|Lack of Efficacy|3|||
42031989|NCT01183013|75840225|FG001|Overall Study|Lack of Efficacy|2|||
42225691|NCT03261037|76044789|FG001|Overall Study|Technical difficulties|0|||
42225692|NCT03261037|76044790|FG002|Overall Study|Technical difficulties|0|||
42225693|NCT03261037|76044791|FG003|Overall Study|Technical difficulties|1|||
42225694|NCT03261037|76044788|FG000|Overall Study|Equipment failed to work|0|||
42225695|NCT03261037|76044789|FG001|Overall Study|Equipment failed to work|0|||
42225696|NCT03261037|76044790|FG002|Overall Study|Equipment failed to work|0|||
42225697|NCT03261037|76044791|FG003|Overall Study|Equipment failed to work|1|||
42225698|NCT03261037|76044788|FG000|Overall Study|End of study for participant and no follow up|0|||
42225699|NCT03261037|76044789|FG001|Overall Study|End of study for participant and no follow up|0|||
42225700|NCT03261037|76044790|FG002|Overall Study|End of study for participant and no follow up|0|||
42225701|NCT03261037|76044791|FG003|Overall Study|End of study for participant and no follow up|1|||
42225702|NCT03261037|76044788|FG000|Overall Study|Participant was too weak to continue in study|1|||
42225703|NCT03261037|76044789|FG001|Overall Study|Participant was too weak to continue in study|0|||
42225704|NCT03261037|76044790|FG002|Overall Study|Participant was too weak to continue in study|0|||
42225705|NCT03261037|76044791|FG003|Overall Study|Participant was too weak to continue in study|0|||
42225706|NCT03372551|76044802|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
42225707|NCT03372551|76044803|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
42225708|NCT03326323|76044816|FG000|Overall Study|Unable to receive ANH protocol|3|||
42225709|NCT03259789|76044827|FG000|Overall Study|Adverse Event|3|||
42225710|NCT03259789|76044828|FG001|Overall Study|Adverse Event|2|||
42225711|NCT03259789|76044829|FG002|Overall Study|Adverse Event|1|||
42225712|NCT03259789|76044827|FG000|Overall Study|Withdrawal by Subject|9|||
42225713|NCT03259789|76044828|FG001|Overall Study|Withdrawal by Subject|5|||
42225714|NCT03259789|76044829|FG002|Overall Study|Withdrawal by Subject|1|||
42225715|NCT03259789|76044827|FG000|Overall Study|Lost to Follow-up|5|||
42225716|NCT03259789|76044828|FG001|Overall Study|Lost to Follow-up|9|||
42225717|NCT03259789|76044829|FG002|Overall Study|Lost to Follow-up|4|||
42225718|NCT03259789|76044827|FG000|Overall Study|Physician Decision|0|||
42225719|NCT03259789|76044828|FG001|Overall Study|Physician Decision|1|||
42225720|NCT03259789|76044829|FG002|Overall Study|Physician Decision|0|||
42225721|NCT03259555|76044840|FG000|Overall Study|Adverse Event|6|||
42225722|NCT03259555|76044841|FG001|Overall Study|Adverse Event|4|||
42225723|NCT03259555|76044840|FG000|Overall Study|Lack of Efficacy|6|||
42225724|NCT03259555|76044841|FG001|Overall Study|Lack of Efficacy|4|||
42225725|NCT03259555|76044840|FG000|Overall Study|Lost to Follow-up|0|||
42225726|NCT03259555|76044841|FG001|Overall Study|Lost to Follow-up|2|||
42225727|NCT03259555|76044840|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42225728|NCT03259555|76044841|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42225729|NCT03259555|76044840|FG000|Overall Study|Progressive Disease|0|||
42225730|NCT03259555|76044841|FG001|Overall Study|Progressive Disease|2|||
42225731|NCT03259555|76044840|FG000|Overall Study|Withdrawal by Subject|19|||
42225732|NCT03259555|76044841|FG001|Overall Study|Withdrawal by Subject|16|||
42225733|NCT03259555|76044840|FG000|Overall Study|Physician Decision|1|||
42225734|NCT03259555|76044841|FG001|Overall Study|Physician Decision|2|||
42225735|NCT03259555|76044840|FG000|Overall Study|Other|1|||
42225736|NCT03259555|76044841|FG001|Overall Study|Other|0|||
42225737|NCT03259087|76044852|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
42225738|NCT03259087|76044853|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
42225739|NCT03259087|76044854|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
42225740|NCT03259087|76044855|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
42225741|NCT03259087|76044856|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
42225742|NCT03259087|76044852|FG000|Period 2 of Part 2|Adverse Event|0|||
42225743|NCT03259087|76044853|FG001|Period 2 of Part 2|Adverse Event|0|||
42225744|NCT03259087|76044854|FG002|Period 2 of Part 2|Adverse Event|0|||
42225745|NCT03259087|76044855|FG003|Period 2 of Part 2|Adverse Event|0|||
42225746|NCT03259087|76044856|FG004|Period 2 of Part 2|Adverse Event|1|||
42225747|NCT03257995|76044878|FG000|Overall Study|Adverse Event|0|||
42225748|NCT03257995|76044879|FG001|Overall Study|Adverse Event|1|||
42225749|NCT03257995|76044880|FG002|Overall Study|Adverse Event|0|||
42225750|NCT03257995|76044881|FG003|Overall Study|Adverse Event|0|||
42225751|NCT03257995|76044882|FG004|Overall Study|Adverse Event|0|||
42225752|NCT03257995|76044883|FG005|Overall Study|Adverse Event|0|||
42131642|NCT00393939|75942537|FG000|Overall Study|Other|37|||
42225753|NCT03257995|76044878|FG000|Overall Study|Protocol deviation|0|||
42131643|NCT00393939|75942538|FG001|Overall Study|Other|45|||
42225754|NCT03257995|76044879|FG001|Overall Study|Protocol deviation|0|||
42225755|NCT03257995|76044880|FG002|Overall Study|Protocol deviation|0|||
42225756|NCT03257995|76044881|FG003|Overall Study|Protocol deviation|0|||
42225757|NCT03257995|76044882|FG004|Overall Study|Protocol deviation|0|||
42225758|NCT03257995|76044883|FG005|Overall Study|Protocol deviation|2|||
42225759|NCT03049488|76044901|FG000|Overall Study|Lost to Follow-up|1|||
42225760|NCT03049488|76044902|FG001|Overall Study|Lost to Follow-up|1|||
42225761|NCT03049488|76044903|FG002|Overall Study|Lost to Follow-up|0|||
42225762|NCT03049488|76044904|FG003|Overall Study|Lost to Follow-up|0|||
42225763|NCT03049488|76044905|FG004|Overall Study|Lost to Follow-up|0|||
42225764|NCT03049488|76044906|FG005|Overall Study|Lost to Follow-up|0|||
42225765|NCT03049488|76044901|FG000|Overall Study|Moved from Area|1|||
42225766|NCT03049488|76044902|FG001|Overall Study|Moved from Area|0|||
42225767|NCT03049488|76044903|FG002|Overall Study|Moved from Area|0|||
42225768|NCT03049488|76044904|FG003|Overall Study|Moved from Area|1|||
42225769|NCT03049488|76044905|FG004|Overall Study|Moved from Area|1|||
42225770|NCT03049488|76044906|FG005|Overall Study|Moved from Area|0|||
42225771|NCT03049488|76044901|FG000|Overall Study|Physician Decision|0|||
42225772|NCT03049488|76044902|FG001|Overall Study|Physician Decision|1|||
42225773|NCT03049488|76044903|FG002|Overall Study|Physician Decision|0|||
42225774|NCT03049488|76044904|FG003|Overall Study|Physician Decision|0|||
42225775|NCT03049488|76044905|FG004|Overall Study|Physician Decision|0|||
42225776|NCT03049488|76044906|FG005|Overall Study|Physician Decision|0|||
42225777|NCT03049488|76044901|FG000|Overall Study|Withdrawal by Subject|0|||
42225778|NCT03049488|76044902|FG001|Overall Study|Withdrawal by Subject|0|||
42225779|NCT03049488|76044903|FG002|Overall Study|Withdrawal by Subject|0|||
42225780|NCT03049488|76044904|FG003|Overall Study|Withdrawal by Subject|1|||
42225781|NCT03049488|76044905|FG004|Overall Study|Withdrawal by Subject|1|||
42225782|NCT03049488|76044906|FG005|Overall Study|Withdrawal by Subject|0|||
42225783|NCT03257371|76044921|FG000|Overall Study|Lost to Follow-up|1|||
42225784|NCT03242863|76044925|FG000|Study Week 1|Withdrawal by Subject|0|||
42225785|NCT03242863|76044926|FG001|Study Week 1|Withdrawal by Subject|1|||
42225786|NCT03242863|76044927|FG002|Study Week 1|Withdrawal by Subject|0|||
42225787|NCT03242863|76044928|FG003|Study Week 1|Withdrawal by Subject|0|||
42225788|NCT03242863|76044929|FG004|Study Week 1|Withdrawal by Subject|3|||
42225789|NCT03242863|76044930|FG005|Study Week 1|Withdrawal by Subject|0|||
42225790|NCT03044106|76044938|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
42225791|NCT03044106|76044939|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
42225792|NCT03043560|76044965|FG000|Overall Study|Discontinued Intervention|1|||
42225793|NCT03043560|76044966|FG001|Overall Study|Discontinued Intervention|2|||
42225794|NCT03043560|76044965|FG000|Overall Study|Lost to Follow-up|0|||
42225795|NCT03043560|76044966|FG001|Overall Study|Lost to Follow-up|1|||
42225796|NCT03255733|76044992|FG000|Overall Study|Lost to Follow-up|4|||
42225797|NCT03255655|76044998|FG000|Overall Study|Lost to Follow-up|7|||
42225798|NCT03255655|76044999|FG001|Overall Study|Lost to Follow-up|4|||
42225799|NCT02899988|76045009|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
42225800|NCT02899988|76045010|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
42225801|NCT02899988|76045011|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42225802|NCT02899988|76045012|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42225803|NCT02899988|76045013|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42225804|NCT02899988|76045014|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42225805|NCT02899988|76045015|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42225806|NCT02899988|76045016|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42225807|NCT02899988|76045017|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42225808|NCT02899988|76045018|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42225809|NCT02899988|76045019|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42225810|NCT02899988|76045009|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
42225811|NCT02899988|76045010|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
42225812|NCT02899988|76045011|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
42225813|NCT02899988|76045012|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
42225814|NCT02899988|76045013|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
42225815|NCT02899988|76045014|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
42225816|NCT02899988|76045015|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
42225817|NCT02899988|76045016|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
42225818|NCT02899988|76045017|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
42225819|NCT02899988|76045018|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
42225820|NCT02899988|76045019|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
42225821|NCT02899988|76045009|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
42225822|NCT02899988|76045010|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
41985010|NCT01371838|75791730|FG001|Overall Study|Lack of therapeutic response|1|||
41985011|NCT01371838|75791729|FG000|Overall Study|Surgery|1|||
41985012|NCT01371838|75791730|FG001|Overall Study|Surgery|0|||
41985013|NCT01371721|75791739|FG000|Overall Study|Adverse Event|5|||
41985014|NCT01371721|75791740|FG001|Overall Study|Adverse Event|4|||
41985015|NCT01371721|75791741|FG002|Overall Study|Adverse Event|5|||
41985016|NCT01371721|75791739|FG000|Overall Study|Protocol Violation|6|||
41985017|NCT01371721|75791740|FG001|Overall Study|Protocol Violation|4|||
42225823|NCT02899988|76045011|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
42225824|NCT02899988|76045012|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
42225825|NCT02899988|76045013|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
42225826|NCT02899988|76045014|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
42225827|NCT02899988|76045015|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
42225828|NCT02899988|76045016|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
42031990|NCT01183013|75840226|FG002|Overall Study|Lack of Efficacy|1|||
42031991|NCT01183013|75840227|FG003|Overall Study|Lack of Efficacy|2|||
42031992|NCT01183013|75840228|FG004|Overall Study|Lack of Efficacy|1|||
42031993|NCT01183013|75840229|FG005|Overall Study|Lack of Efficacy|2|||
42031994|NCT01183013|75840230|FG006|Overall Study|Lack of Efficacy|0|||
42031995|NCT01183013|75840224|FG000|Overall Study|Protocol Violation|5|||
42031996|NCT01183013|75840225|FG001|Overall Study|Protocol Violation|2|||
42225829|NCT02899988|76045017|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
42225830|NCT02899988|76045018|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
42225831|NCT02899988|76045019|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
42225832|NCT02899988|76045009|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
42225833|NCT02899988|76045010|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
42225834|NCT02899988|76045011|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
42225835|NCT02899988|76045012|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
42225836|NCT02899988|76045013|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
42225837|NCT02899988|76045014|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
42225838|NCT02899988|76045015|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
42225839|NCT02899988|76045016|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
42225840|NCT02899988|76045017|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
42225841|NCT02899988|76045018|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
42225842|NCT02899988|76045019|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
42225843|NCT02899988|76045009|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
42225844|NCT02899988|76045010|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
42225845|NCT02899988|76045011|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
42225846|NCT02899988|76045012|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
42225847|NCT02899988|76045013|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
42225848|NCT02899988|76045014|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
42225849|NCT02899988|76045015|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
42225850|NCT02899988|76045016|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
42225851|NCT02899988|76045017|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
42225852|NCT02899988|76045018|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
42225853|NCT02899988|76045019|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
42225854|NCT02899988|76045009|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
42225855|NCT02899988|76045010|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
42225856|NCT02899988|76045011|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
42225857|NCT02899988|76045012|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
42225858|NCT02899988|76045013|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
42225859|NCT02899988|76045014|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
42225860|NCT02899988|76045015|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
42225861|NCT02899988|76045016|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
42225862|NCT02899988|76045017|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
42225863|NCT02899988|76045018|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
42225864|NCT02899988|76045019|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
42225865|NCT02939131|76045053|FG000|Overall Study|Unable to get to clinic|6|||
42225866|NCT02939131|76045054|FG001|Overall Study|Unable to get to clinic|4|||
42225867|NCT02939131|76045053|FG000|Overall Study|Lost to Follow-up|2|||
42225868|NCT02939131|76045054|FG001|Overall Study|Lost to Follow-up|4|||
42225869|NCT02939131|76045053|FG000|Overall Study|severe debilitation|1|||
42225870|NCT02939131|76045054|FG001|Overall Study|severe debilitation|0|||
42225871|NCT02939131|76045053|FG000|Overall Study|Other|0|||
42225872|NCT02939131|76045054|FG001|Overall Study|Other|1|||
42302440|NCT02473393|76137646|FG002|Overall Study|Withdrawal by Subject|1|||
42302441|NCT02473393|76137647|FG003|Overall Study|Withdrawal by Subject|1|||
42302442|NCT02419573|76137659|FG000|Overall Study|Lost to Follow-up|3|||
42302443|NCT02419573|76137660|FG001|Overall Study|Lost to Follow-up|0|||
42302444|NCT02419573|76137659|FG000|Overall Study|Withdrawal by Subject|1|||
42302445|NCT02419573|76137660|FG001|Overall Study|Withdrawal by Subject|0|||
42302446|NCT02472847|76137668|FG000|Overall Study|Withdrawal by Subject|1|||
42302447|NCT02472847|76137669|FG001|Overall Study|Withdrawal by Subject|5|||
42302448|NCT02472145|76137678|FG000|Overall Study|Death|10|||
41985018|NCT01371721|75791741|FG002|Overall Study|Protocol Violation|5|||
41985019|NCT01371721|75791739|FG000|Overall Study|Lost to Follow-up|8|||
41985020|NCT01371721|75791740|FG001|Overall Study|Lost to Follow-up|2|||
41985021|NCT01371721|75791741|FG002|Overall Study|Lost to Follow-up|6|||
41985022|NCT01371721|75791739|FG000|Overall Study|Withdrawal by Subject|5|||
41985023|NCT01371721|75791740|FG001|Overall Study|Withdrawal by Subject|7|||
41985024|NCT01371721|75791741|FG002|Overall Study|Withdrawal by Subject|11|||
41985025|NCT01371721|75791739|FG000|Overall Study|Other|2|||
41985026|NCT01371721|75791740|FG001|Overall Study|Other|3|||
41985027|NCT01371721|75791741|FG002|Overall Study|Other|0|||
42031997|NCT01183013|75840226|FG002|Overall Study|Protocol Violation|4|||
42031998|NCT01183013|75840227|FG003|Overall Study|Protocol Violation|0|||
42031999|NCT01183013|75840228|FG004|Overall Study|Protocol Violation|4|||
42225873|NCT02939131|76045053|FG000|Overall Study|not willing to adhere to protocol|2|||
42225874|NCT02939131|76045054|FG001|Overall Study|not willing to adhere to protocol|0|||
42225875|NCT03345407|76045068|FG000|Overall Study|Withdrawal by Subject|11|||
42225876|NCT03345407|76045069|FG001|Overall Study|Withdrawal by Subject|1|||
42225877|NCT03345407|76045070|FG002|Overall Study|Withdrawal by Subject|5|||
42225878|NCT03345407|76045071|FG003|Overall Study|Withdrawal by Subject|6|||
42225879|NCT03345407|76045072|FG004|Overall Study|Withdrawal by Subject|3|||
42225880|NCT03345407|76045073|FG005|Overall Study|Withdrawal by Subject|6|||
42225881|NCT03345407|76045074|FG006|Overall Study|Withdrawal by Subject|16|||
42225882|NCT03345407|76045068|FG000|Overall Study|Physician Decision|3|||
42225883|NCT03345407|76045069|FG001|Overall Study|Physician Decision|1|||
42225884|NCT03345407|76045070|FG002|Overall Study|Physician Decision|0|||
42225885|NCT03345407|76045071|FG003|Overall Study|Physician Decision|0|||
42225886|NCT03345407|76045072|FG004|Overall Study|Physician Decision|1|||
42032000|NCT01183013|75840229|FG005|Overall Study|Protocol Violation|3|||
42032001|NCT01183013|75840230|FG006|Overall Study|Protocol Violation|3|||
42032002|NCT01183013|75840224|FG000|Overall Study|Lost to Follow-up|7|||
41985028|NCT01371721|75791739|FG000|Overall Study|Lack of Efficacy|2|||
41985029|NCT01371721|75791740|FG001|Overall Study|Lack of Efficacy|4|||
41985030|NCT01371721|75791741|FG002|Overall Study|Lack of Efficacy|3|||
41985031|NCT01371721|75791739|FG000|Overall Study|Randomized but not treated|1|||
41985032|NCT01371721|75791740|FG001|Overall Study|Randomized but not treated|0|||
41985033|NCT01371721|75791741|FG002|Overall Study|Randomized but not treated|0|||
42032003|NCT01183013|75840225|FG001|Overall Study|Lost to Follow-up|3|||
42032004|NCT01183013|75840226|FG002|Overall Study|Lost to Follow-up|4|||
42032005|NCT01183013|75840227|FG003|Overall Study|Lost to Follow-up|3|||
42032006|NCT01183013|75840228|FG004|Overall Study|Lost to Follow-up|2|||
42225887|NCT03345407|76045073|FG005|Overall Study|Physician Decision|2|||
42225888|NCT03345407|76045074|FG006|Overall Study|Physician Decision|3|||
42225889|NCT03345407|76045068|FG000|Overall Study|Lost to Follow-up|2|||
42225890|NCT03345407|76045069|FG001|Overall Study|Lost to Follow-up|0|||
42225891|NCT03345407|76045070|FG002|Overall Study|Lost to Follow-up|1|||
42225892|NCT03345407|76045071|FG003|Overall Study|Lost to Follow-up|0|||
42225893|NCT03345407|76045072|FG004|Overall Study|Lost to Follow-up|1|||
42225894|NCT03345407|76045073|FG005|Overall Study|Lost to Follow-up|2|||
42225895|NCT03345407|76045074|FG006|Overall Study|Lost to Follow-up|3|||
42225896|NCT03345407|76045068|FG000|Overall Study|Protocol-defined stopping criteria|9|||
42225897|NCT03345407|76045069|FG001|Overall Study|Protocol-defined stopping criteria|0|||
42225898|NCT03345407|76045070|FG002|Overall Study|Protocol-defined stopping criteria|0|||
42225899|NCT03345407|76045071|FG003|Overall Study|Protocol-defined stopping criteria|0|||
42225900|NCT03345407|76045072|FG004|Overall Study|Protocol-defined stopping criteria|2|||
42225901|NCT03345407|76045073|FG005|Overall Study|Protocol-defined stopping criteria|1|||
42225902|NCT03345407|76045074|FG006|Overall Study|Protocol-defined stopping criteria|1|||
42225903|NCT03345407|76045068|FG000|Overall Study|Protocol Violation|2|||
42225904|NCT03345407|76045069|FG001|Overall Study|Protocol Violation|0|||
42225905|NCT03345407|76045070|FG002|Overall Study|Protocol Violation|0|||
42225906|NCT03345407|76045071|FG003|Overall Study|Protocol Violation|0|||
42225907|NCT03345407|76045072|FG004|Overall Study|Protocol Violation|1|||
42225908|NCT03345407|76045073|FG005|Overall Study|Protocol Violation|0|||
42225909|NCT03345407|76045074|FG006|Overall Study|Protocol Violation|3|||
42225910|NCT03345407|76045068|FG000|Overall Study|Lack of Efficacy|1|||
42225911|NCT03345407|76045069|FG001|Overall Study|Lack of Efficacy|1|||
42225912|NCT03345407|76045070|FG002|Overall Study|Lack of Efficacy|1|||
42225913|NCT03345407|76045071|FG003|Overall Study|Lack of Efficacy|1|||
42225914|NCT03345407|76045072|FG004|Overall Study|Lack of Efficacy|1|||
42225915|NCT03345407|76045073|FG005|Overall Study|Lack of Efficacy|0|||
42225916|NCT03345407|76045074|FG006|Overall Study|Lack of Efficacy|3|||
42225917|NCT03345407|76045068|FG000|Overall Study|Adverse Event|4|||
42225918|NCT03345407|76045069|FG001|Overall Study|Adverse Event|0|||
42225919|NCT03345407|76045070|FG002|Overall Study|Adverse Event|5|||
41985034|NCT01366534|75791754|FG000|Overall Study|Lost to Follow-up|1|||
41985035|NCT01366534|75791755|FG001|Overall Study|Lost to Follow-up|0|||
41985036|NCT01366534|75791756|FG002|Overall Study|Lost to Follow-up|0|||
41985037|NCT01366534|75791754|FG000|Overall Study|Migrated|1|||
41985038|NCT01366534|75791755|FG001|Overall Study|Migrated|1|||
41985039|NCT01366534|75791756|FG002|Overall Study|Migrated|0|||
42032007|NCT01183013|75840229|FG005|Overall Study|Lost to Follow-up|6|||
42032008|NCT01183013|75840230|FG006|Overall Study|Lost to Follow-up|5|||
42225920|NCT03345407|76045071|FG003|Overall Study|Adverse Event|4|||
42225921|NCT03345407|76045072|FG004|Overall Study|Adverse Event|6|||
42225922|NCT03345407|76045073|FG005|Overall Study|Adverse Event|5|||
41985040|NCT01366534|75791754|FG000|Overall Study|Declined challenged|0|||
41985041|NCT01366534|75791755|FG001|Overall Study|Declined challenged|1|||
42225923|NCT03345407|76045074|FG006|Overall Study|Adverse Event|16|||
42225924|NCT03255187|76045098|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
42032009|NCT01183013|75840224|FG000|Overall Study|Withdrawal by Subject|9|||
42225925|NCT03255187|76045099|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
42225926|NCT03255187|76045098|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
42225927|NCT03255187|76045099|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
42225928|NCT02929329|76045107|FG000|Overall Study|Withdrawal by Subject|24|||
42225929|NCT02929329|76045108|FG001|Overall Study|Withdrawal by Subject|21|||
42225930|NCT02929329|76045107|FG000|Overall Study|Lost to Follow-up|26|||
42225931|NCT02929329|76045108|FG001|Overall Study|Lost to Follow-up|20|||
42225932|NCT02929329|76045107|FG000|Overall Study|Death|1054|||
42225933|NCT02929329|76045108|FG001|Overall Study|Death|1051|||
42225934|NCT03240133|76045121|FG000|Overall Study|Withdrawal by Subject|0|||
42225935|NCT03240133|76045122|FG001|Overall Study|Withdrawal by Subject|1|||
42225936|NCT03240133|76045123|FG002|Overall Study|Withdrawal by Subject|0|||
42225937|NCT03240133|76045121|FG000|Overall Study|Adverse Event|1|||
42225938|NCT03240133|76045122|FG001|Overall Study|Adverse Event|1|||
42225939|NCT03240133|76045123|FG002|Overall Study|Adverse Event|0|||
42225940|NCT03240133|76045121|FG000|Overall Study|Rash|1|||
42225941|NCT03240133|76045122|FG001|Overall Study|Rash|0|||
42225942|NCT03240133|76045123|FG002|Overall Study|Rash|0|||
42225943|NCT03240133|76045121|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
42225944|NCT03240133|76045122|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
42225945|NCT03240133|76045123|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
42225946|NCT03240133|76045121|FG000|Overall Study|Intercurrent illness.|0|||
42225947|NCT03240133|76045122|FG001|Overall Study|Intercurrent illness.|1|||
42225948|NCT03240133|76045123|FG002|Overall Study|Intercurrent illness.|0|||
42225949|NCT03240133|76045121|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
41985042|NCT01366534|75791756|FG002|Overall Study|Declined challenged|0|||
41985043|NCT01365910|75791764|FG000|Overall Study|Withdrawal by Subject|7|||
41985044|NCT01365910|75791764|FG000|Overall Study|disease progression|18|||
41985045|NCT01365910|75791764|FG000|Overall Study|Adverse Event|3|||
41985046|NCT01365910|75791764|FG000|Overall Study|other complicating disease|1|||
41985047|NCT01365910|75791764|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
42032010|NCT01183013|75840225|FG001|Overall Study|Withdrawal by Subject|13|||
42032011|NCT01183013|75840226|FG002|Overall Study|Withdrawal by Subject|10|||
42032012|NCT01183013|75840227|FG003|Overall Study|Withdrawal by Subject|8|||
42032013|NCT01183013|75840228|FG004|Overall Study|Withdrawal by Subject|7|||
42225950|NCT03240133|76045122|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
42225951|NCT03240133|76045123|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
42225952|NCT03372083|76045147|FG000|Overall Study|Adverse Event|3|||
42225953|NCT03372083|76045147|FG000|Overall Study|Physician Decision|1|||
42225954|NCT03372083|76045147|FG000|Overall Study|Withdrawal by Subject|1|||
42225955|NCT03044886|76045154|FG000|Overall Study|Lost to Follow-up|15|||
42225956|NCT03044886|76045155|FG001|Overall Study|Lost to Follow-up|10|||
42225957|NCT03044886|76045156|FG002|Overall Study|Lost to Follow-up|12|||
42225958|NCT02961764|76045166|FG000|Overall Study|Protocol Violation|0|||
42225959|NCT02961764|76045167|FG001|Overall Study|Protocol Violation|1|||
42225960|NCT02961764|76045166|FG000|Overall Study|Death|2|||
42225961|NCT02961764|76045167|FG001|Overall Study|Death|0|||
42225962|NCT02961764|76045166|FG000|Overall Study|Lost to Follow-up|35|||
42225963|NCT02961764|76045167|FG001|Overall Study|Lost to Follow-up|24|||
42225964|NCT02961764|76045166|FG000|Overall Study|Withdrawal by Subject|2|||
42225965|NCT02961764|76045167|FG001|Overall Study|Withdrawal by Subject|0|||
42225966|NCT03371459|76045173|FG000|Washout|Lost to Follow-up|0|||
42225967|NCT03371459|76045174|FG001|Washout|Lost to Follow-up|1|||
42225968|NCT02961920|76045182|FG000|Overall Study|did not achive stydy protocol schedule|1|||
42225969|NCT02961920|76045183|FG001|Overall Study|did not achive stydy protocol schedule|1|||
42225970|NCT03371381|76045189|FG000|Overall Study|Death|5|||
42225971|NCT03371381|76045189|FG000|Overall Study|Study terminated by sponsor|3|||
42225972|NCT03371381|76045189|FG000|Overall Study|Other|4|||
42225973|NCT03044730|76045193|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
42225974|NCT03044730|76045193|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
42225975|NCT03044730|76045193|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
42225976|NCT03044730|76045193|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
42032014|NCT01183013|75840229|FG005|Overall Study|Withdrawal by Subject|9|||
42032015|NCT01183013|75840230|FG006|Overall Study|Withdrawal by Subject|10|||
42032016|NCT01183013|75840224|FG000|Overall Study|Reasons other than stated above|15|||
42225977|NCT03044730|76045193|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
42225978|NCT03044730|76045193|FG000|Cycles 4 and Beyond|Adverse Event|1|||
41985048|NCT01365481|75791772|FG000|Overall Study|Adverse Event|6|||
41985049|NCT01365481|75791773|FG001|Overall Study|Adverse Event|9|||
42225979|NCT03044730|76045193|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
42225980|NCT03044730|76045193|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
42225981|NCT03044730|76045193|FG000|On Follow-up for 2 Years|Death|17|||
42225982|NCT02961374|76045198|FG000|Overall Study|Adverse Event|4|||
41985050|NCT01365481|75791774|FG002|Overall Study|Adverse Event|0|||
42032017|NCT01183013|75840225|FG001|Overall Study|Reasons other than stated above|11|||
42225983|NCT02951429|76045204|FG000|Overall Study|Adverse Event|3|||
42225984|NCT02951429|76045205|FG001|Overall Study|Adverse Event|7|||
42225985|NCT02951429|76045204|FG000|Overall Study|Death|28|||
42225986|NCT02951429|76045205|FG001|Overall Study|Death|36|||
42225987|NCT02951429|76045204|FG000|Overall Study|Lack of Efficacy|0|||
42225988|NCT02951429|76045205|FG001|Overall Study|Lack of Efficacy|1|||
42225989|NCT02951429|76045204|FG000|Overall Study|Lost to Follow-up|0|||
42225990|NCT02951429|76045205|FG001|Overall Study|Lost to Follow-up|1|||
42225991|NCT02951429|76045204|FG000|Overall Study|Lung Transplantation|9|||
42225992|NCT02951429|76045205|FG001|Overall Study|Lung Transplantation|6|||
42225993|NCT02951429|76045204|FG000|Overall Study|Other|1|||
42225994|NCT02951429|76045205|FG001|Overall Study|Other|3|||
42225995|NCT02951429|76045204|FG000|Overall Study|Progressive Disease|1|||
41985051|NCT01365481|75791775|FG003|Overall Study|Adverse Event|2|||
41985052|NCT01365481|75791772|FG000|Overall Study|Withdrawal by Subject|0|||
41985053|NCT01365481|75791773|FG001|Overall Study|Withdrawal by Subject|2|||
41985054|NCT01365481|75791774|FG002|Overall Study|Withdrawal by Subject|1|||
41985055|NCT01365481|75791775|FG003|Overall Study|Withdrawal by Subject|1|||
41985056|NCT01365481|75791772|FG000|Overall Study|Lost to Follow-up|1|||
42225996|NCT02951429|76045205|FG001|Overall Study|Progressive Disease|1|||
42225997|NCT02951429|76045204|FG000|Overall Study|Withdrawal by Subject|7|||
42225998|NCT02951429|76045205|FG001|Overall Study|Withdrawal by Subject|11|||
42225999|NCT02951429|76045204|FG000|Overall Study|Participant ongoing in the study|23|||
42302449|NCT02472145|76137679|FG001|Overall Study|Death|101|||
41985057|NCT01365481|75791773|FG001|Overall Study|Lost to Follow-up|1|||
41985058|NCT01365481|75791774|FG002|Overall Study|Lost to Follow-up|2|||
41985059|NCT01365481|75791775|FG003|Overall Study|Lost to Follow-up|3|||
41985060|NCT01365481|75791772|FG000|Overall Study|Abnormal laboratory value(s)|0|||
41985061|NCT01365481|75791773|FG001|Overall Study|Abnormal laboratory value(s)|1|||
41985062|NCT01365481|75791774|FG002|Overall Study|Abnormal laboratory value(s)|0|||
41985063|NCT01365481|75791775|FG003|Overall Study|Abnormal laboratory value(s)|0|||
41985064|NCT01365481|75791772|FG000|Overall Study|Administrative problems|0|||
41985065|NCT01365481|75791773|FG001|Overall Study|Administrative problems|1|||
41985066|NCT01365481|75791774|FG002|Overall Study|Administrative problems|0|||
41985067|NCT01365481|75791775|FG003|Overall Study|Administrative problems|0|||
41985068|NCT01365481|75791772|FG000|Overall Study|Protocol deviation|0|||
41985069|NCT01365481|75791773|FG001|Overall Study|Protocol deviation|1|||
41985070|NCT01365481|75791774|FG002|Overall Study|Protocol deviation|0|||
41985071|NCT01365481|75791775|FG003|Overall Study|Protocol deviation|1|||
41985072|NCT01365481|75791772|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
41985073|NCT01365481|75791773|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
41985074|NCT01365481|75791774|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
41985075|NCT01365481|75791775|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
41985076|NCT01357915|75791787|FG000|Overall Study|Lost to Follow-up|3|||
41985077|NCT01357915|75791788|FG001|Overall Study|Lost to Follow-up|0|||
41985078|NCT01350973|75791797|FG000|Overall Study|Adverse Event|4|||
41985079|NCT01350973|75791798|FG001|Overall Study|Adverse Event|7|||
41985080|NCT01350973|75791799|FG002|Overall Study|Adverse Event|7|||
41985081|NCT01350973|75791797|FG000|Overall Study|Voluntary Withdrawal|2|||
41985082|NCT01350973|75791798|FG001|Overall Study|Voluntary Withdrawal|1|||
41985083|NCT01350973|75791799|FG002|Overall Study|Voluntary Withdrawal|1|||
41985084|NCT01350544|75791809|FG000|Overall Study|Administrative Withdrawal|0|||
41985085|NCT01350544|75791810|FG001|Overall Study|Administrative Withdrawal|1|||
41985086|NCT01350544|75791809|FG000|Overall Study|Death|1|||
41985087|NCT01350544|75791810|FG001|Overall Study|Death|2|||
41985088|NCT01350544|75791809|FG000|Overall Study|Moved out of LA County|2|||
41985089|NCT01350544|75791810|FG001|Overall Study|Moved out of LA County|2|||
41985090|NCT01350544|75791809|FG000|Overall Study|Medical Issues|1|||
41985091|NCT01350544|75791810|FG001|Overall Study|Medical Issues|1|||
41985092|NCT01350544|75791809|FG000|Overall Study|Withdrawal by Subject|0|||
41985093|NCT01350544|75791810|FG001|Overall Study|Withdrawal by Subject|1|||
41985094|NCT01350544|75791809|FG000|Overall Study|Incarceration|1|||
41985095|NCT01350544|75791810|FG001|Overall Study|Incarceration|0|||
41985096|NCT01350544|75791809|FG000|Overall Study|Lost to Follow-up|18|||
41985097|NCT01350544|75791810|FG001|Overall Study|Lost to Follow-up|15|||
41985098|NCT01350505|75791816|FG000|Overall Study|Lost to Follow-up|4|||
41985099|NCT01350271|75791823|FG000|Overall Study|Lost to Follow-up|21|||
42131644|NCT00488982|75942544|FG000|Course 1|Physician Decision|0|||
42131645|NCT00488982|75942545|FG001|Course 1|Physician Decision|2|||
41985100|NCT01350271|75791824|FG001|Overall Study|Lost to Follow-up|17|||
42226000|NCT02951429|76045205|FG001|Overall Study|Participant ongoing in the study|17|||
42226001|NCT03343067|76045218|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
42302450|NCT02472145|76137680|FG002|Overall Study|Death|99|||
41985101|NCT01350271|75791825|FG002|Overall Study|Lost to Follow-up|26|||
41985102|NCT01348828|75791836|FG000|Overall Study|Death|20|||
41985103|NCT01348828|75791836|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
41985104|NCT01348828|75791836|FG000|Overall Study|Conversion|2|||
41985105|NCT01348828|75791836|FG000|Overall Study|missed visit|1|||
41985106|NCT01348789|75791840|FG000|Overall Study|Protocol Violation|2|||
41985107|NCT01348789|75791840|FG000|Overall Study|Withdrawal by Subject|2|||
41985108|NCT01342510|75791855|FG000|Overall Study|Protocol Violation|12|||
41985109|NCT01342510|75791856|FG001|Overall Study|Protocol Violation|6|||
41985110|NCT01342510|75791857|FG002|Overall Study|Protocol Violation|13|||
41985111|NCT01342510|75791858|FG003|Overall Study|Protocol Violation|11|||
41985112|NCT01340872|75791878|FG000|Double-blind Phase|Adverse Event|6|||
41985113|NCT01340872|75791879|FG001|Double-blind Phase|Adverse Event|4|||
41985114|NCT01340872|75791880|FG002|Double-blind Phase|Adverse Event|0|||
41985115|NCT01340872|75791881|FG003|Double-blind Phase|Adverse Event|0|||
41985116|NCT01340872|75791878|FG000|Double-blind Phase|Withdrawal by Subject|3|||
41985117|NCT01340872|75791879|FG001|Double-blind Phase|Withdrawal by Subject|5|||
42032018|NCT01183013|75840226|FG002|Overall Study|Reasons other than stated above|17|||
42032019|NCT01183013|75840227|FG003|Overall Study|Reasons other than stated above|12|||
42032020|NCT01183013|75840228|FG004|Overall Study|Reasons other than stated above|12|||
42032021|NCT01183013|75840229|FG005|Overall Study|Reasons other than stated above|15|||
42032022|NCT01183013|75840230|FG006|Overall Study|Reasons other than stated above|13|||
42032023|NCT01141283|75840254|FG000|Overall Study|Adverse Event|56|||
42032024|NCT01141283|75840254|FG000|Overall Study|Lost to Follow-up|4|||
42032025|NCT01141283|75840254|FG000|Overall Study|Withdrawal by Subject|14|||
42032026|NCT01141283|75840254|FG000|Overall Study|Administrative|4|||
42032027|NCT01141283|75840254|FG000|Overall Study|Lack of Efficacy|10|||
42032028|NCT00863707|75840260|FG000|Overall Study|Randomized, but drug not received|4|||
42032029|NCT00863707|75840261|FG001|Overall Study|Randomized, but drug not received|3|||
42032030|NCT01094184|75840269|FG000|Overall Study|Death|35|||
42032031|NCT01094184|75840270|FG001|Overall Study|Death|11|||
42032032|NCT01134731|75840279|FG000|Overall Study|Adverse Event|3|||
42032033|NCT01134731|75840280|FG001|Overall Study|Adverse Event|2|||
42032034|NCT01134731|75840281|FG002|Overall Study|Adverse Event|1|||
42032035|NCT01134731|75840279|FG000|Overall Study|Physician Decision|2|||
42032036|NCT01134731|75840280|FG001|Overall Study|Physician Decision|2|||
42032037|NCT01134731|75840281|FG002|Overall Study|Physician Decision|2|||
42032038|NCT01134731|75840279|FG000|Overall Study|Lack of Efficacy|0|||
42032039|NCT01134731|75840280|FG001|Overall Study|Lack of Efficacy|0|||
42032040|NCT01134731|75840281|FG002|Overall Study|Lack of Efficacy|1|||
41985118|NCT01340872|75791880|FG002|Double-blind Phase|Withdrawal by Subject|0|||
41985119|NCT01340872|75791881|FG003|Double-blind Phase|Withdrawal by Subject|0|||
42032041|NCT01134731|75840279|FG000|Overall Study|Withdrawal by Subject|3|||
42032042|NCT01134731|75840280|FG001|Overall Study|Withdrawal by Subject|3|||
42032043|NCT01134731|75840281|FG002|Overall Study|Withdrawal by Subject|1|||
42032044|NCT01134731|75840279|FG000|Overall Study|Lost to Follow-up|5|||
42032045|NCT01134731|75840280|FG001|Overall Study|Lost to Follow-up|4|||
42032046|NCT01134731|75840281|FG002|Overall Study|Lost to Follow-up|3|||
42032047|NCT01141205|75840292|FG000|Overall Study|Physician Decision|1|||
41985120|NCT01340872|75791878|FG000|Double-blind Phase|Lost to Follow-up|0|||
41985121|NCT01340872|75791879|FG001|Double-blind Phase|Lost to Follow-up|1|||
41985122|NCT01340872|75791880|FG002|Double-blind Phase|Lost to Follow-up|0|||
41985123|NCT01340872|75791881|FG003|Double-blind Phase|Lost to Follow-up|0|||
41985124|NCT01340872|75791878|FG000|Double-blind Phase|Protocol Violation|0|||
41985125|NCT01340872|75791879|FG001|Double-blind Phase|Protocol Violation|1|||
42226002|NCT03343067|76045219|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
42226003|NCT03343067|76045220|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
42226004|NCT03103503|76045228|FG000|Overall Study|Death|64|||
42226005|NCT03103503|76045228|FG000|Overall Study|Physician Decision|57|||
42226006|NCT03103503|76045228|FG000|Overall Study|Withdrawal by Subject|10|||
42226007|NCT03103503|76045228|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
42226008|NCT03103503|76045228|FG000|Overall Study|Lost to Follow-up|3|||
42032048|NCT01141205|75840293|FG001|Overall Study|Physician Decision|1|||
42032049|NCT01141205|75840292|FG000|Overall Study|Lost to Follow-up|1|||
42226009|NCT03103503|76045228|FG000|Overall Study|Study Closure|757|||
42226010|NCT02961218|76045234|FG000|Overall Study|Lost to Follow-up|0|||
41985126|NCT01340872|75791880|FG002|Double-blind Phase|Protocol Violation|0|||
41985127|NCT01340872|75791881|FG003|Double-blind Phase|Protocol Violation|0|||
41985128|NCT01340872|75791878|FG000|Open-label Phase|Physician Decision|0|||
42226011|NCT02961218|76045235|FG001|Overall Study|Lost to Follow-up|2|||
42226012|NCT02961218|76045234|FG000|Overall Study|Physician Decision|0|||
42032050|NCT01141205|75840293|FG001|Overall Study|Lost to Follow-up|0|||
42032051|NCT01141205|75840292|FG000|Overall Study|Withdrawal by Subject|1|||
42032052|NCT01141205|75840293|FG001|Overall Study|Withdrawal by Subject|1|||
42032053|NCT01140503|75840303|FG000|Overall Study|Withdrawal by Subject|1|||
42032054|NCT00863317|75840309|FG000|Overall Study|Lost to Follow-up|8|||
42226013|NCT02961218|76045235|FG001|Overall Study|Physician Decision|2|||
42226014|NCT02961218|76045234|FG000|Overall Study|Subject/Guardian Decision|3|||
41985129|NCT01340872|75791879|FG001|Open-label Phase|Physician Decision|0|||
41985130|NCT01340872|75791880|FG002|Open-label Phase|Physician Decision|2|||
41985131|NCT01340872|75791881|FG003|Open-label Phase|Physician Decision|1|||
41985132|NCT01340872|75791878|FG000|Open-label Phase|Pregnancy|0|||
41985133|NCT01340872|75791879|FG001|Open-label Phase|Pregnancy|0|||
42032055|NCT00863317|75840310|FG001|Overall Study|Lost to Follow-up|9|||
42032056|NCT01200368|75840319|FG000|Infant Series|Adverse Event|2|||
42226015|NCT02961218|76045235|FG001|Overall Study|Subject/Guardian Decision|1|||
42226016|NCT02949947|76045245|FG000|Overall Study|Non Compliance|0|||
42226017|NCT02949947|76045246|FG001|Overall Study|Non Compliance|1|||
42226018|NCT02949947|76045245|FG000|Overall Study|Insurance change|1|||
42226019|NCT02949947|76045246|FG001|Overall Study|Insurance change|0|||
42226020|NCT03341507|76045252|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
42226021|NCT01345058|76045258|FG000|Overall Study|Withdrawal by Subject|1|||
42226022|NCT01345058|76045259|FG001|Overall Study|Withdrawal by Subject|0|||
42226023|NCT01345058|76045258|FG000|Overall Study|Participant Reported Increase in Events|1|||
42226024|NCT01345058|76045259|FG001|Overall Study|Participant Reported Increase in Events|0|||
42226025|NCT01345058|76045258|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
42226026|NCT01345058|76045259|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
42226027|NCT01345058|76045258|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
42226028|NCT01345058|76045259|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
42226029|NCT01345058|76045258|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
42226030|NCT01345058|76045259|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
42226031|NCT01345292|76045268|FG000|Overall Study|Withdrawal by Subject|2|||
42226032|NCT01345292|76045269|FG001|Overall Study|Withdrawal by Subject|0|||
42226033|NCT01345292|76045270|FG002|Overall Study|Withdrawal by Subject|1|||
42226034|NCT03340961|76045282|FG000|Overall Study|Adverse Event|1|||
42226035|NCT03340961|76045283|FG001|Overall Study|Adverse Event|3|||
42226036|NCT03340961|76045284|FG002|Overall Study|Adverse Event|2|||
42226037|NCT03340961|76045285|FG003|Overall Study|Adverse Event|4|||
42226038|NCT03340961|76045282|FG000|Overall Study|Lost to Follow-up|0|||
42226039|NCT03340961|76045283|FG001|Overall Study|Lost to Follow-up|1|||
42226040|NCT03340961|76045284|FG002|Overall Study|Lost to Follow-up|0|||
42226041|NCT03340961|76045285|FG003|Overall Study|Lost to Follow-up|1|||
42226042|NCT03340961|76045282|FG000|Overall Study|Withdrawal by Subject|3|||
42226043|NCT03340961|76045283|FG001|Overall Study|Withdrawal by Subject|2|||
42226044|NCT03340961|76045284|FG002|Overall Study|Withdrawal by Subject|4|||
42226045|NCT03340961|76045285|FG003|Overall Study|Withdrawal by Subject|7|||
42226046|NCT03340961|76045282|FG000|Overall Study|Use of prohibited treatment|0|||
42226047|NCT03340961|76045283|FG001|Overall Study|Use of prohibited treatment|3|||
42226048|NCT03340961|76045284|FG002|Overall Study|Use of prohibited treatment|2|||
42226049|NCT03340961|76045285|FG003|Overall Study|Use of prohibited treatment|4|||
42226050|NCT03340961|76045282|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
42226051|NCT03340961|76045283|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
42226052|NCT03340961|76045284|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
42226053|NCT03340961|76045285|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
42226054|NCT03340961|76045282|FG000|Overall Study|Subject developed an exclusion criterion|0|||
42032057|NCT01200368|75840320|FG001|Infant Series|Adverse Event|2|||
42032058|NCT01200368|75840321|FG002|Infant Series|Adverse Event|3|||
42032059|NCT01200368|75840319|FG000|Infant Series|Withdrawal by Subject|0|||
42032060|NCT01200368|75840320|FG001|Infant Series|Withdrawal by Subject|2|||
42226055|NCT03340961|76045283|FG001|Overall Study|Subject developed an exclusion criterion|1|||
41985134|NCT01340872|75791880|FG002|Open-label Phase|Pregnancy|1|||
42226056|NCT03340961|76045284|FG002|Overall Study|Subject developed an exclusion criterion|0|||
42226057|NCT03340961|76045285|FG003|Overall Study|Subject developed an exclusion criterion|0|||
42226058|NCT03340961|76045282|FG000|Overall Study|Protocol Violation|1|||
42226059|NCT03340961|76045283|FG001|Overall Study|Protocol Violation|0|||
41985135|NCT01340872|75791881|FG003|Open-label Phase|Pregnancy|0|||
41985136|NCT01340872|75791878|FG000|Open-label Phase|Adverse Event|0|||
41985137|NCT01340872|75791879|FG001|Open-label Phase|Adverse Event|0|||
41985138|NCT01340872|75791880|FG002|Open-label Phase|Adverse Event|8|||
41985139|NCT01340872|75791881|FG003|Open-label Phase|Adverse Event|4|||
41985140|NCT01340872|75791878|FG000|Open-label Phase|Withdrawal by Subject|0|||
41985141|NCT01340872|75791879|FG001|Open-label Phase|Withdrawal by Subject|0|||
42032061|NCT01200368|75840321|FG002|Infant Series|Withdrawal by Subject|2|||
42032062|NCT01200368|75840319|FG000|Infant Series|Did not meet entrance criteria|0|||
42032063|NCT01200368|75840320|FG001|Infant Series|Did not meet entrance criteria|1|||
42226060|NCT03340961|76045284|FG002|Overall Study|Protocol Violation|1|||
42226061|NCT03340961|76045285|FG003|Overall Study|Protocol Violation|0|||
42226062|NCT03340961|76045282|FG000|Overall Study|Adverse Event|1|||
42226063|NCT03340961|76045283|FG001|Overall Study|Adverse Event|1|||
42226064|NCT03340961|76045284|FG002|Overall Study|Adverse Event|0|||
42131646|NCT00488982|75942546|FG002|Course 1|Physician Decision|4|||
42226065|NCT03340961|76045285|FG003|Overall Study|Adverse Event|0|||
42226066|NCT03340961|76045282|FG000|Overall Study|Lack of Efficacy|0|||
42226067|NCT03340961|76045283|FG001|Overall Study|Lack of Efficacy|0|||
42226068|NCT03340961|76045284|FG002|Overall Study|Lack of Efficacy|0|||
42226069|NCT03340961|76045285|FG003|Overall Study|Lack of Efficacy|1|||
42226070|NCT03340025|76045297|FG000|Overall Study|Lost to Follow-up|2|||
42226071|NCT03340025|76045298|FG001|Overall Study|Lost to Follow-up|2|||
41985142|NCT01340872|75791880|FG002|Open-label Phase|Withdrawal by Subject|1|||
42226072|NCT03339713|76045306|FG000|Overall Study|Lost to Follow-up|2|||
42226073|NCT03339713|76045307|FG001|Overall Study|Lost to Follow-up|1|||
42226074|NCT03339713|76045306|FG000|Overall Study|Protocol Violation|1|||
42226075|NCT03339713|76045307|FG001|Overall Study|Protocol Violation|0|||
42226076|NCT03339713|76045306|FG000|Overall Study|Withdrawal by Subject|1|||
42226077|NCT03339713|76045307|FG001|Overall Study|Withdrawal by Subject|1|||
42226078|NCT03254485|76045319|FG000|Overall Study|Adverse Event|3|||
42226079|NCT03254485|76045320|FG001|Overall Study|Adverse Event|0|||
42226080|NCT03254485|76045321|FG002|Overall Study|Adverse Event|0|||
42226081|NCT03254485|76045322|FG003|Overall Study|Adverse Event|6|||
42226082|NCT03254485|76045319|FG000|Overall Study|Protocol Violation|6|||
42226083|NCT03254485|76045320|FG001|Overall Study|Protocol Violation|0|||
42226084|NCT03254485|76045321|FG002|Overall Study|Protocol Violation|0|||
42226085|NCT03254485|76045322|FG003|Overall Study|Protocol Violation|2|||
42226086|NCT03254485|76045319|FG000|Overall Study|Withdrawal by Subject|1|||
42226087|NCT03254485|76045320|FG001|Overall Study|Withdrawal by Subject|0|||
42226088|NCT03254485|76045321|FG002|Overall Study|Withdrawal by Subject|0|||
42226089|NCT03254485|76045322|FG003|Overall Study|Withdrawal by Subject|4|||
42226090|NCT03254485|76045319|FG000|Overall Study|Death|0|||
42226091|NCT03254485|76045320|FG001|Overall Study|Death|0|||
42226092|NCT03254485|76045321|FG002|Overall Study|Death|0|||
42226093|NCT03254485|76045322|FG003|Overall Study|Death|1|||
42226094|NCT03254485|76045319|FG000|Overall Study|Lost to Follow-up|1|||
42226095|NCT03254485|76045320|FG001|Overall Study|Lost to Follow-up|0|||
42226096|NCT03254485|76045321|FG002|Overall Study|Lost to Follow-up|0|||
42226097|NCT03254485|76045322|FG003|Overall Study|Lost to Follow-up|0|||
42226098|NCT03254485|76045319|FG000|Overall Study|Other|1|||
42226099|NCT03254485|76045320|FG001|Overall Study|Other|0|||
42226100|NCT03254485|76045321|FG002|Overall Study|Other|0|||
42226101|NCT03254485|76045322|FG003|Overall Study|Other|2|||
42226102|NCT03339401|76045335|FG000|Overall Study|Death|2|||
42226103|NCT03339401|76045336|FG001|Overall Study|Death|1|||
42226104|NCT03339401|76045335|FG000|Overall Study|Withdrawal by Subject|2|||
42226105|NCT03339401|76045336|FG001|Overall Study|Withdrawal by Subject|0|||
42226106|NCT03339401|76045335|FG000|Overall Study|Study terminated|4|||
42226107|NCT03339401|76045336|FG001|Overall Study|Study terminated|3|||
42226108|NCT03339401|76045335|FG000|Overall Study|Investigator Decision|1|||
42226109|NCT03339401|76045336|FG001|Overall Study|Investigator Decision|0|||
42226110|NCT03370289|76045342|FG000|Overall Study|Screen Failure|1|||
42226111|NCT03370289|76045342|FG000|Overall Study|Sample Size Sufficient|4|||
42226112|NCT01344824|76045346|FG000|Overall Study|Adverse Event|15|||
42226113|NCT01344824|76045346|FG000|Overall Study|Withdrawal by Subject|6|||
42226114|NCT01344824|76045346|FG000|Overall Study|Other complicating disease|1|||
42226115|NCT01344824|76045346|FG000|Overall Study|Progression|15|||
42226116|NCT03339245|76045353|FG000|Overall Study|Adverse Event|1|||
42226117|NCT03339245|76045354|FG001|Overall Study|Adverse Event|1|||
42226118|NCT03339245|76045353|FG000|Overall Study|Withdrawal by Subject|1|||
42226119|NCT03339245|76045354|FG001|Overall Study|Withdrawal by Subject|0|||
42226120|NCT03044574|76045362|FG000|Overall Study|Lost to Follow-up|37|||
42226121|NCT03044574|76045363|FG001|Overall Study|Lost to Follow-up|45|||
42226122|NCT02959892|76045371|FG000|Overall Study|PET tracer synthesis failure|1|||
42226123|NCT02959892|76045372|FG001|Overall Study|PET tracer synthesis failure|0|||
42226124|NCT02959892|76045371|FG000|Overall Study|Study termination|0|||
42226125|NCT02959892|76045372|FG001|Overall Study|Study termination|1|||
42226126|NCT03252145|76045380|FG000|Overall Study|Withdrawal by Subject|1|||
42226127|NCT03252145|76045381|FG001|Overall Study|Withdrawal by Subject|0|||
42226128|NCT03252145|76045380|FG000|Overall Study|Complicating Disease|1|||
42226129|NCT03252145|76045381|FG001|Overall Study|Complicating Disease|2|||
42226130|NCT02959814|76045387|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
42226131|NCT02959814|76045387|FG000|Overall Study|Excluded based on anatomical criteria|2|||
42226132|NCT02959814|76045387|FG000|Overall Study|Protocol Violation|7|||
42226133|NCT02959814|76045387|FG000|Overall Study|FFR not measured|2|||
42226134|NCT02959814|76045387|FG000|Overall Study|In-procedure QFR not computed|6|||
42226135|NCT02959814|76045387|FG000|Overall Study|Excluded by FFR core-lab|24|||
42226136|NCT03666624|76045394|FG000|Overall Study|participant grieving over recent death of parent|1|||
41985143|NCT01340872|75791881|FG003|Open-label Phase|Withdrawal by Subject|6|||
41985144|NCT01340872|75791878|FG000|Open-label Phase|Worsening of IBD|0|||
42226137|NCT03666624|76045395|FG001|Overall Study|participant grieving over recent death of parent|0|||
42226138|NCT03368807|76045401|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
42226139|NCT03368807|76045401|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
42226140|NCT03368807|76045401|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
42226141|NCT03368807|76045401|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
42226142|NCT03338855|76045409|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
42226143|NCT03338855|76045410|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
42226144|NCT03367793|76045422|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
42226145|NCT03367793|76045423|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
42226146|NCT03367793|76045424|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
42226147|NCT03367793|76045425|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
42226148|NCT03367793|76045426|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
42226149|NCT03367793|76045427|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
42226150|NCT01347307|76045449|FG000|Overall Study|Death|0|||
42226151|NCT01347307|76045450|FG001|Overall Study|Death|4|||
42032064|NCT01200368|75840321|FG002|Infant Series|Did not meet entrance criteria|0|||
42226152|NCT01347307|76045449|FG000|Overall Study|Physician Decision|0|||
42226153|NCT01347307|76045450|FG001|Overall Study|Physician Decision|1|||
42226154|NCT03247543|76045507|FG000|Overall Study|Adverse Event|3|||
42226155|NCT03247543|76045508|FG001|Overall Study|Adverse Event|6|||
41985145|NCT01340872|75791879|FG001|Open-label Phase|Worsening of IBD|0|||
41985146|NCT01340872|75791880|FG002|Open-label Phase|Worsening of IBD|1|||
41985147|NCT01340872|75791881|FG003|Open-label Phase|Worsening of IBD|0|||
41985148|NCT01340794|75791895|FG000|Overall Study|Withdrawal by Subject|0|||
41985149|NCT01340794|75791896|FG001|Overall Study|Withdrawal by Subject|1|||
41985150|NCT01340482|75791907|FG000|Overall Study|Adverse Event|2|||
41985151|NCT01340482|75791908|FG001|Overall Study|Adverse Event|0|||
42302451|NCT02472145|76137678|FG000|Overall Study|Lost to Follow-up|0|||
42302452|NCT02472145|76137679|FG001|Overall Study|Lost to Follow-up|1|||
42226156|NCT03247543|76045509|FG002|Overall Study|Adverse Event|4|||
42226157|NCT03247543|76045507|FG000|Overall Study|Lost to Follow-up|10|||
42226158|NCT03247543|76045508|FG001|Overall Study|Lost to Follow-up|7|||
42226159|NCT03247543|76045509|FG002|Overall Study|Lost to Follow-up|8|||
42226160|NCT03247543|76045507|FG000|Overall Study|Consent withdrawn by caregiver|2|||
42226161|NCT03247543|76045508|FG001|Overall Study|Consent withdrawn by caregiver|2|||
42226162|NCT03247543|76045509|FG002|Overall Study|Consent withdrawn by caregiver|9|||
42226163|NCT03247543|76045507|FG000|Overall Study|Withdrawal by Subject|0|||
42226164|NCT03247543|76045508|FG001|Overall Study|Withdrawal by Subject|0|||
42226165|NCT03247543|76045509|FG002|Overall Study|Withdrawal by Subject|1|||
42226166|NCT03247543|76045507|FG000|Overall Study|Failure to Follow study procedures|1|||
42226167|NCT03247543|76045508|FG001|Overall Study|Failure to Follow study procedures|3|||
42226168|NCT03247543|76045509|FG002|Overall Study|Failure to Follow study procedures|1|||
42226169|NCT03247543|76045507|FG000|Overall Study|Lack of Efficacy|1|||
42226170|NCT03247543|76045508|FG001|Overall Study|Lack of Efficacy|0|||
42226171|NCT03247543|76045509|FG002|Overall Study|Lack of Efficacy|0|||
42226172|NCT03247543|76045507|FG000|Overall Study|Non-compliance with study visits|0|||
42226173|NCT03247543|76045508|FG001|Overall Study|Non-compliance with study visits|1|||
42226174|NCT03247543|76045509|FG002|Overall Study|Non-compliance with study visits|0|||
42226175|NCT01347073|76045519|FG000|Overall Study|Adverse Event|1|||
42226176|NCT01347073|76045519|FG000|Overall Study|Liver Transplant|1|||
42226177|NCT01315236|76045531|FG000|Double-blind Phase|Death|1|||
42302453|NCT02472145|76137680|FG002|Overall Study|Lost to Follow-up|0|||
42302454|NCT02472145|76137678|FG000|Overall Study|Withdrawal by Subject|0|||
42302455|NCT02472145|76137679|FG001|Overall Study|Withdrawal by Subject|9|||
42032065|NCT01200368|75840319|FG000|Infant Series|Randomized, not vaccinated|0|||
42032066|NCT01200368|75840320|FG001|Infant Series|Randomized, not vaccinated|1|||
42226178|NCT01315236|76045532|FG001|Double-blind Phase|Death|0|||
42226179|NCT01315236|76045531|FG000|Double-blind Phase|Adverse Event|1|||
42032067|NCT01200368|75840321|FG002|Infant Series|Randomized, not vaccinated|1|||
42131647|NCT00488982|75942544|FG000|Course 1|Withdrawal by Subject|0|||
42131648|NCT00488982|75942545|FG001|Course 1|Withdrawal by Subject|8|||
42131649|NCT00488982|75942546|FG002|Course 1|Withdrawal by Subject|2|||
42226180|NCT01315236|76045532|FG001|Double-blind Phase|Adverse Event|0|||
42226181|NCT01315236|76045531|FG000|Double-blind Phase|Withdrawal of Consent|1|||
42226182|NCT01315236|76045532|FG001|Double-blind Phase|Withdrawal of Consent|0|||
42226183|NCT01315236|76045531|FG000|Double-blind Phase|Lost to Follow-up|1|||
42226184|NCT01315236|76045532|FG001|Double-blind Phase|Lost to Follow-up|0|||
42226185|NCT01315236|76045531|FG000|Open-label Phase|Death|1|||
42302456|NCT02472145|76137680|FG002|Overall Study|Withdrawal by Subject|13|||
41985152|NCT01340482|75791909|FG002|Overall Study|Adverse Event|0|||
41985153|NCT01340209|75791922|FG000|Overall Study|Adverse Event|1|||
41985154|NCT01340209|75791923|FG001|Overall Study|Adverse Event|1|||
41985155|NCT01340209|75791924|FG002|Overall Study|Adverse Event|2|||
41985156|NCT01340209|75791922|FG000|Overall Study|Protocol Violation|1|||
41985157|NCT01340209|75791923|FG001|Overall Study|Protocol Violation|2|||
41985158|NCT01340209|75791924|FG002|Overall Study|Protocol Violation|1|||
41985159|NCT01340209|75791922|FG000|Overall Study|Withdrawal by Subject|0|||
42032068|NCT01200368|75840319|FG000|Infant Series|Other|1|||
42226186|NCT01315236|76045532|FG001|Open-label Phase|Death|0|||
42226187|NCT01315236|76045531|FG000|Open-label Phase|Adverse Event|0|||
42226188|NCT01315236|76045532|FG001|Open-label Phase|Adverse Event|1|||
42226189|NCT01315236|76045531|FG000|Open-label Phase|Other|0|||
42226190|NCT01315236|76045532|FG001|Open-label Phase|Other|1|||
42226191|NCT01315236|76045531|FG000|12-Month Follow-up Period|Death|0|||
42226192|NCT01315236|76045532|FG001|12-Month Follow-up Period|Death|1|||
42302457|NCT02472145|76137678|FG000|Overall Study|Sponsor decision|0|||
42032069|NCT01200368|75840320|FG001|Infant Series|Other|0|||
42032070|NCT01200368|75840321|FG002|Infant Series|Other|0|||
42032071|NCT01200368|75840319|FG000|After Infant Series|Adverse Event|6|||
42032072|NCT01200368|75840320|FG001|After Infant Series|Adverse Event|6|||
42032073|NCT01200368|75840321|FG002|After Infant Series|Adverse Event|3|||
42032074|NCT01200368|75840319|FG000|After Infant Series|Withdrawal by Subject|10|||
42032075|NCT01200368|75840320|FG001|After Infant Series|Withdrawal by Subject|8|||
42032076|NCT01200368|75840321|FG002|After Infant Series|Withdrawal by Subject|4|||
42032077|NCT01200368|75840319|FG000|After Infant Series|Lost to Follow-up|1|||
42226193|NCT01315236|76045531|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
42226194|NCT01315236|76045532|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
42226195|NCT03232567|76045544|FG000|Overall Study|Withdrawal by Subject|0|||
42226196|NCT03232567|76045545|FG001|Overall Study|Withdrawal by Subject|1|||
42226197|NCT03232567|76045546|FG002|Overall Study|Withdrawal by Subject|0|||
42226198|NCT03232567|76045547|FG003|Overall Study|Withdrawal by Subject|0|||
42226199|NCT01348490|76045557|FG000|Overall Study|Death|1|||
42226200|NCT01348490|76045557|FG000|Overall Study|Adverse Event|3|||
42226201|NCT01348490|76045557|FG000|Overall Study|Consent withdrawn|7|||
42226202|NCT01348490|76045557|FG000|Overall Study|Disease progression|3|||
42226203|NCT01348490|76045557|FG000|Overall Study|Lost to Follow-up|1|||
42226204|NCT01348490|76045557|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
42226205|NCT01348490|76045557|FG000|Overall Study|Other Unspecified|8|||
42226206|NCT03040674|76045578|FG000|Overall Study|Lost to Follow-up|225|||
42226207|NCT03040674|76045578|FG000|Overall Study|Death|23|||
42226208|NCT03232333|76045583|FG000|Overall Study|Infection or Osteomyelitis|9|||
42226209|NCT03232333|76045583|FG000|Overall Study|Lost to Follow-up|4|||
42226210|NCT03232333|76045583|FG000|Overall Study|Withdrawal by Subject|2|||
42226211|NCT03364049|76045591|FG000|Overall Study|Death|6|||
42226212|NCT03364049|76045592|FG001|Overall Study|Death|4|||
42226213|NCT03364049|76045593|FG002|Overall Study|Death|5|||
42226214|NCT03364049|76045594|FG003|Overall Study|Death|14|||
42226215|NCT03364049|76045591|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
42226216|NCT03364049|76045592|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
42226217|NCT03364049|76045593|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
42226218|NCT03364049|76045594|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
42226219|NCT03364049|76045591|FG000|Overall Study|Withdrawal by Subject|0|||
42226220|NCT03364049|76045592|FG001|Overall Study|Withdrawal by Subject|1|||
42226221|NCT03364049|76045593|FG002|Overall Study|Withdrawal by Subject|1|||
42226222|NCT03364049|76045594|FG003|Overall Study|Withdrawal by Subject|1|||
42226223|NCT03238963|76045606|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
42226224|NCT03238963|76045607|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
42226225|NCT03238963|76045606|FG000|Overall Study|Withdrawal by Subject|1|||
42226226|NCT03238963|76045607|FG001|Overall Study|Withdrawal by Subject|1|||
42032078|NCT01200368|75840320|FG001|After Infant Series|Lost to Follow-up|0|||
42032079|NCT01200368|75840321|FG002|After Infant Series|Lost to Follow-up|0|||
42032080|NCT01200368|75840319|FG000|After Infant Series|Other|1|||
42032081|NCT01200368|75840320|FG001|After Infant Series|Other|2|||
42032082|NCT01200368|75840321|FG002|After Infant Series|Other|2|||
42032083|NCT01200368|75840319|FG000|Toddler Dose|Adverse Event|0|||
42226227|NCT03238963|76045606|FG000|Overall Study|Lost to Follow-up|1|||
42226228|NCT03238963|76045607|FG001|Overall Study|Lost to Follow-up|0|||
42226229|NCT03238963|76045606|FG000|Overall Study|Protocol Violation|1|||
42226230|NCT03238963|76045607|FG001|Overall Study|Protocol Violation|1|||
42032084|NCT01200368|75840320|FG001|Toddler Dose|Adverse Event|3|||
42032085|NCT01200368|75840321|FG002|Toddler Dose|Adverse Event|1|||
42032086|NCT01079130|75840342|FG000|Overall Study|Adverse Event|1|||
42032087|NCT01079130|75840343|FG001|Overall Study|Adverse Event|1|||
42032088|NCT01079130|75840344|FG002|Overall Study|Adverse Event|0|||
42032089|NCT01079130|75840345|FG003|Overall Study|Adverse Event|1|||
42032090|NCT01079130|75840346|FG004|Overall Study|Adverse Event|5|||
42032091|NCT01079130|75840347|FG005|Overall Study|Adverse Event|1|||
42032092|NCT01079130|75840342|FG000|Overall Study|Administrative problems|1|||
42032093|NCT01079130|75840343|FG001|Overall Study|Administrative problems|3|||
42032094|NCT01079130|75840344|FG002|Overall Study|Administrative problems|0|||
42032095|NCT01079130|75840345|FG003|Overall Study|Administrative problems|0|||
42032096|NCT01079130|75840346|FG004|Overall Study|Administrative problems|0|||
42032097|NCT01079130|75840347|FG005|Overall Study|Administrative problems|1|||
42032098|NCT01079130|75840342|FG000|Overall Study|Withdrawal by Subject|0|||
42032099|NCT01079130|75840343|FG001|Overall Study|Withdrawal by Subject|1|||
42226231|NCT03238963|76045606|FG000|Overall Study|Adverse Event|1|||
42226232|NCT03238963|76045607|FG001|Overall Study|Adverse Event|0|||
42226233|NCT03337139|76045615|FG000|Phase I|Withdrawal by Subject|10|||
42226234|NCT03337139|76045616|FG001|Phase I|Withdrawal by Subject|0|||
42226235|NCT03042312|76045624|FG000|Overall Study|Administrative Reason|1|||
42226236|NCT03042312|76045625|FG001|Overall Study|Administrative Reason|1|||
42226237|NCT03042312|76045624|FG000|Overall Study|Adverse Event|0|||
42226238|NCT03042312|76045625|FG001|Overall Study|Adverse Event|1|||
42032100|NCT01079130|75840344|FG002|Overall Study|Withdrawal by Subject|0|||
42032101|NCT01079130|75840345|FG003|Overall Study|Withdrawal by Subject|0|||
42032102|NCT01079130|75840346|FG004|Overall Study|Withdrawal by Subject|1|||
42032103|NCT01079130|75840347|FG005|Overall Study|Withdrawal by Subject|3|||
42032104|NCT01079130|75840342|FG000|Overall Study|Protocol deviation|0|||
42226239|NCT03042312|76045624|FG000|Overall Study|Lost to Follow-up|1|||
42226240|NCT03042312|76045625|FG001|Overall Study|Lost to Follow-up|3|||
42226241|NCT03042312|76045624|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
42226242|NCT03042312|76045625|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
42226243|NCT03042312|76045624|FG000|Overall Study|Withdrawal by Subject|4|||
42032105|NCT01079130|75840343|FG001|Overall Study|Protocol deviation|2|||
42032106|NCT01079130|75840344|FG002|Overall Study|Protocol deviation|1|||
42032107|NCT01079130|75840345|FG003|Overall Study|Protocol deviation|2|||
42226244|NCT03042312|76045625|FG001|Overall Study|Withdrawal by Subject|5|||
42226245|NCT03360071|76045633|FG000|Overall Study|Lost to Follow-up|1|||
42226246|NCT03360071|76045634|FG001|Overall Study|Lost to Follow-up|0|||
42226247|NCT02949011|76045643|FG000|Overall Study|Adverse Event|6|||
42226248|NCT02949011|76045644|FG001|Overall Study|Adverse Event|7|||
42226249|NCT02949011|76045645|FG002|Overall Study|Adverse Event|3|||
42226250|NCT02949011|76045643|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
42226251|NCT02949011|76045644|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
42226252|NCT02949011|76045645|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
42226253|NCT02949011|76045643|FG000|Overall Study|Protocol Deviation|5|||
42226254|NCT02949011|76045644|FG001|Overall Study|Protocol Deviation|3|||
42226255|NCT02949011|76045645|FG002|Overall Study|Protocol Deviation|3|||
42302458|NCT02472145|76137679|FG001|Overall Study|Sponsor decision|3|||
41985160|NCT01340209|75791923|FG001|Overall Study|Withdrawal by Subject|0|||
41985161|NCT01340209|75791924|FG002|Overall Study|Withdrawal by Subject|1|||
42226256|NCT02949011|76045643|FG000|Overall Study|Lack of Efficacy|0|||
42226257|NCT02949011|76045644|FG001|Overall Study|Lack of Efficacy|2|||
42226258|NCT02949011|76045645|FG002|Overall Study|Lack of Efficacy|0|||
42226259|NCT02949011|76045643|FG000|Overall Study|Withdrawal by Subject|13|||
42226260|NCT02949011|76045644|FG001|Overall Study|Withdrawal by Subject|13|||
42226261|NCT02949011|76045645|FG002|Overall Study|Withdrawal by Subject|21|||
42226262|NCT02949011|76045643|FG000|Overall Study|Lost to Follow-up|7|||
42226263|NCT02949011|76045644|FG001|Overall Study|Lost to Follow-up|5|||
42226264|NCT02949011|76045645|FG002|Overall Study|Lost to Follow-up|5|||
42226265|NCT02949011|76045643|FG000|Overall Study|Death|0|||
42226266|NCT02949011|76045644|FG001|Overall Study|Death|0|||
42226267|NCT02949011|76045645|FG002|Overall Study|Death|1|||
42226268|NCT02949011|76045643|FG000|Overall Study|Miscellaneous|2|||
42226269|NCT02949011|76045644|FG001|Overall Study|Miscellaneous|4|||
42226270|NCT02949011|76045645|FG002|Overall Study|Miscellaneous|6|||
41985162|NCT01340209|75791922|FG000|Overall Study|Other reason not defined above|3|||
41985163|NCT01340209|75791923|FG001|Overall Study|Other reason not defined above|5|||
41985164|NCT01340209|75791924|FG002|Overall Study|Other reason not defined above|4|||
41985165|NCT01326910|75791934|FG000|Overall Study|Withdrawal by Subject|3|||
41985166|NCT01326910|75791935|FG001|Overall Study|Withdrawal by Subject|2|||
41985167|NCT01326910|75791934|FG000|Overall Study|Protocol Violation|1|||
41985168|NCT01326910|75791935|FG001|Overall Study|Protocol Violation|1|||
41985169|NCT01326481|75791941|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
41985170|NCT01325701|75791949|FG000|Overall Study|Adverse Event|12|||
41985171|NCT01325701|75791950|FG001|Overall Study|Adverse Event|0|||
41985172|NCT01325701|75791949|FG000|Overall Study|Protocol Violation|1|||
42032108|NCT01079130|75840346|FG004|Overall Study|Protocol deviation|0|||
42032109|NCT01079130|75840347|FG005|Overall Study|Protocol deviation|0|||
42032110|NCT01079130|75840342|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42032111|NCT01079130|75840343|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42032112|NCT01079130|75840344|FG002|Overall Study|Abnormal test procedure result(s)|0|||
42226271|NCT03357731|76045657|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
42226272|NCT03357731|76045658|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
42226273|NCT03357731|76045659|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
42226274|NCT03357731|76045660|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
42226275|NCT03357731|76045661|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
42302459|NCT02472145|76137680|FG002|Overall Study|Sponsor decision|2|||
41985173|NCT01325701|75791950|FG001|Overall Study|Protocol Violation|0|||
41985174|NCT01325701|75791949|FG000|Overall Study|Physician Decision|2|||
42226276|NCT03357731|76045662|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
42226277|NCT03357731|76045657|FG000|Overall Study|Acute bradycardia and hypotension|0|||
42226278|NCT03357731|76045658|FG001|Overall Study|Acute bradycardia and hypotension|0|||
41985175|NCT01325701|75791950|FG001|Overall Study|Physician Decision|2|||
41985176|NCT01325701|75791949|FG000|Overall Study|Withdrawal by Subject|2|||
42302460|NCT02472145|76137678|FG000|Overall Study|Other|0|||
41985177|NCT01325701|75791950|FG001|Overall Study|Withdrawal by Subject|1|||
41985178|NCT01325701|75791949|FG000|Overall Study|Rollerover Extension Study|4|||
42226279|NCT03357731|76045659|FG002|Overall Study|Acute bradycardia and hypotension|0|||
42226280|NCT03357731|76045660|FG003|Overall Study|Acute bradycardia and hypotension|1|||
42226281|NCT03357731|76045661|FG004|Overall Study|Acute bradycardia and hypotension|0|||
42226282|NCT03357731|76045662|FG005|Overall Study|Acute bradycardia and hypotension|0|||
42226283|NCT03357731|76045657|FG000|Overall Study|Adverse Event|0|||
42226284|NCT03357731|76045658|FG001|Overall Study|Adverse Event|0|||
42226285|NCT03357731|76045659|FG002|Overall Study|Adverse Event|0|||
42226286|NCT03357731|76045660|FG003|Overall Study|Adverse Event|0|||
42226287|NCT03357731|76045661|FG004|Overall Study|Adverse Event|0|||
42226288|NCT03357731|76045662|FG005|Overall Study|Adverse Event|1|||
42226289|NCT03357731|76045657|FG000|Overall Study|Hypotension|0|||
42226290|NCT03357731|76045658|FG001|Overall Study|Hypotension|0|||
42226291|NCT03357731|76045659|FG002|Overall Study|Hypotension|1|||
42226292|NCT03357731|76045660|FG003|Overall Study|Hypotension|1|||
42226293|NCT03357731|76045661|FG004|Overall Study|Hypotension|0|||
42226294|NCT03357731|76045662|FG005|Overall Study|Hypotension|0|||
42226295|NCT03357731|76045657|FG000|Overall Study|Lost to Follow-up|0|||
42226296|NCT03357731|76045658|FG001|Overall Study|Lost to Follow-up|0|||
42226297|NCT03357731|76045659|FG002|Overall Study|Lost to Follow-up|0|||
42226298|NCT03357731|76045660|FG003|Overall Study|Lost to Follow-up|1|||
42226299|NCT03357731|76045661|FG004|Overall Study|Lost to Follow-up|0|||
42226300|NCT03357731|76045662|FG005|Overall Study|Lost to Follow-up|0|||
42226301|NCT03357341|76045672|FG000|Overall Study|Withdrawal by Subject|3|||
42226302|NCT03357341|76045673|FG001|Overall Study|Withdrawal by Subject|6|||
42226303|NCT03357341|76045672|FG000|Overall Study|Lost to Follow-up|4|||
42226304|NCT03357341|76045673|FG001|Overall Study|Lost to Follow-up|5|||
42226305|NCT03357341|76045672|FG000|Overall Study|Death|0|||
42226306|NCT03357341|76045673|FG001|Overall Study|Death|1|||
42226307|NCT03039738|76045682|FG000|Overall Study|Incomplete data sets|54|||
42226308|NCT03039738|76045683|FG001|Overall Study|Incomplete data sets|0|||
42226309|NCT03036852|76045714|FG000|Overall Study|Death|2|||
42226310|NCT03036852|76045714|FG000|Overall Study|Lack of Efficacy|2|||
42226311|NCT03036852|76045714|FG000|Overall Study|Adverse Event|1|||
42226312|NCT03036852|76045714|FG000|Overall Study|Lost to Follow-up|1|||
42226313|NCT02945657|76045725|FG000|Overall Study|Adverse Event|1|||
42226314|NCT02945657|76045725|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
42226315|NCT02948777|76045730|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
42226316|NCT03324581|76045738|FG000|Overall Study|Adverse Event|18|||
42226317|NCT03324581|76045739|FG001|Overall Study|Adverse Event|11|||
42226318|NCT03324581|76045740|FG002|Overall Study|Adverse Event|7|||
42226319|NCT03324581|76045738|FG000|Overall Study|Lack of Efficacy|0|||
42226320|NCT03324581|76045739|FG001|Overall Study|Lack of Efficacy|1|||
42226321|NCT03324581|76045740|FG002|Overall Study|Lack of Efficacy|0|||
42226322|NCT03324581|76045738|FG000|Overall Study|Lost to Follow-up|5|||
42226323|NCT03324581|76045739|FG001|Overall Study|Lost to Follow-up|3|||
42226324|NCT03324581|76045740|FG002|Overall Study|Lost to Follow-up|6|||
42226325|NCT03324581|76045738|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
42226326|NCT03324581|76045739|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
42226327|NCT03324581|76045740|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
42226328|NCT03324581|76045738|FG000|Overall Study|Physician Decision|0|||
42226329|NCT03324581|76045739|FG001|Overall Study|Physician Decision|1|||
42226330|NCT03324581|76045740|FG002|Overall Study|Physician Decision|2|||
42226331|NCT03324581|76045738|FG000|Overall Study|Protocol Deviation|8|||
42302461|NCT02472145|76137679|FG001|Overall Study|Other|45|||
42302462|NCT02472145|76137680|FG002|Overall Study|Other|43|||
42131650|NCT00488982|75942544|FG000|Course 1|nonprotocol therapy|0|||
42131651|NCT00488982|75942545|FG001|Course 1|nonprotocol therapy|2|||
42131652|NCT00488982|75942546|FG002|Course 1|nonprotocol therapy|2|||
42131653|NCT00488982|75942544|FG000|Course 1|Adverse Event|0|||
42131654|NCT00488982|75942545|FG001|Course 1|Adverse Event|0|||
42131655|NCT00488982|75942546|FG002|Course 1|Adverse Event|6|||
42131656|NCT00488826|75942563|FG000|Overall Study|Withdrawal by Subject|40|||
42131657|NCT00488826|75942564|FG001|Overall Study|Withdrawal by Subject|35|||
42131658|NCT00488826|75942565|FG002|Overall Study|Withdrawal by Subject|19|||
42131659|NCT00488826|75942563|FG000|Overall Study|Protocol Violation|0|||
42131660|NCT00488826|75942564|FG001|Overall Study|Protocol Violation|0|||
42131661|NCT00488826|75942565|FG002|Overall Study|Protocol Violation|2|||
42131662|NCT00488826|75942563|FG000|Overall Study|Adverse Event|9|||
42131663|NCT00488826|75942564|FG001|Overall Study|Adverse Event|15|||
42226332|NCT03324581|76045739|FG001|Overall Study|Protocol Deviation|9|||
42226333|NCT03324581|76045740|FG002|Overall Study|Protocol Deviation|4|||
42302463|NCT02448043|76137689|FG000|Overall Study|Withdrawal by Subject|2|||
42131664|NCT00488826|75942565|FG002|Overall Study|Adverse Event|4|||
42226334|NCT03324581|76045738|FG000|Overall Study|Withdrawal by Subject|6|||
42226335|NCT03324581|76045739|FG001|Overall Study|Withdrawal by Subject|8|||
42226336|NCT03324581|76045740|FG002|Overall Study|Withdrawal by Subject|6|||
42226337|NCT03324581|76045738|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
42302464|NCT02448043|76137690|FG001|Overall Study|Withdrawal by Subject|2|||
42302465|NCT02448043|76137689|FG000|Overall Study|Protocol Violation|1|||
42032113|NCT01079130|75840345|FG003|Overall Study|Abnormal test procedure result(s)|0|||
42032114|NCT01079130|75840346|FG004|Overall Study|Abnormal test procedure result(s)|1|||
42032115|NCT01079130|75840347|FG005|Overall Study|Abnormal test procedure result(s)|0|||
42032116|NCT01079130|75840342|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42032117|NCT01079130|75840343|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42226338|NCT03324581|76045739|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
42226339|NCT03324581|76045740|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
42226340|NCT02943473|76045748|FG000|Overall Study|enrolled but not dosed|1|||
42226341|NCT02943473|76045748|FG000|Overall Study|screen failure|1|||
42226342|NCT02943473|76045748|FG000|Overall Study|Physician Decision|4|||
42226343|NCT03320369|76045752|FG000|Overall Study|Adverse Event|1|||
42226344|NCT03320369|76045752|FG000|Overall Study|Withdrawal by Subject|2|||
42226345|NCT02650895|76045762|FG000|Overall Study|Withdrawal by Subject|0|||
42226346|NCT02650895|76045763|FG001|Overall Study|Withdrawal by Subject|1|||
42226347|NCT02650895|76045764|FG002|Overall Study|Withdrawal by Subject|0|||
42226348|NCT02650895|76045765|FG003|Overall Study|Withdrawal by Subject|0|||
42226349|NCT02650895|76045766|FG004|Overall Study|Withdrawal by Subject|0|||
42226350|NCT02650895|76045767|FG005|Overall Study|Withdrawal by Subject|0|||
42226351|NCT03320057|76045786|FG000|Overall Study|Lost to Follow-up|4|||
42226352|NCT03320057|76045787|FG001|Overall Study|Lost to Follow-up|17|||
42226353|NCT03320057|76045786|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
42226354|NCT03320057|76045787|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
42226355|NCT03316547|76045795|FG000|Overall Study|Death|3|||
42226356|NCT03316547|76045796|FG001|Overall Study|Death|1|||
42226357|NCT03316547|76045795|FG000|Overall Study|Lost to Follow-up|6|||
42226358|NCT03316547|76045796|FG001|Overall Study|Lost to Follow-up|6|||
42226359|NCT03316547|76045795|FG000|Overall Study|Withdrawal by Subject|3|||
42226360|NCT03316547|76045796|FG001|Overall Study|Withdrawal by Subject|2|||
42226361|NCT03316547|76045795|FG000|Overall Study|Transfer to another hospital|6|||
42226362|NCT03316547|76045796|FG001|Overall Study|Transfer to another hospital|4|||
41985179|NCT01325701|75791950|FG001|Overall Study|Rollerover Extension Study|0|||
41985180|NCT01325623|75791957|FG000|Overall Study|Withdrawal by Subject|3|||
42226363|NCT03315689|76045819|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
42226364|NCT03315689|76045820|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
42226365|NCT03315689|76045819|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
42226366|NCT03315689|76045820|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
42226367|NCT03315689|76045819|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
42226368|NCT03315689|76045820|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
42226369|NCT03314519|76045830|FG000|Overall Study|Protocol Violation|3|||
41985181|NCT01325584|75791994|FG000|Overall Study|Death|1|||
41985182|NCT01325428|75791998|FG000|Part A|Progressive disease according to RECIST|9|||
41985183|NCT01325428|75791998|FG000|Part A|Clinical signs, symptoms of progression|2|||
41985184|NCT01325428|75791998|FG000|Part A|Other adverse event|1|||
41985185|NCT01325428|75791998|FG000|Part A|Refused continue taking trial medication|2|||
41985186|NCT01325428|75791998|FG000|Part A|Other reason not defined above|2|||
41985187|NCT01325428|75791998|FG000|Part B|Refused continue taking trial medication|2|||
41985188|NCT01325428|75791998|FG000|Part B|Other reason not defined above|1|||
42032118|NCT01079130|75840344|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
42131665|NCT00488826|75942563|FG000|Overall Study|Lost to Follow-up|5|||
42131666|NCT00488826|75942564|FG001|Overall Study|Lost to Follow-up|1|||
42131667|NCT00488826|75942565|FG002|Overall Study|Lost to Follow-up|0|||
42131668|NCT00488826|75942563|FG000|Overall Study|Protocol Deviations|2|||
42131669|NCT00488826|75942564|FG001|Overall Study|Protocol Deviations|1|||
42131670|NCT00488826|75942565|FG002|Overall Study|Protocol Deviations|1|||
42131671|NCT00393861|75942573|FG000|Overall Study|Adverse Event|2|||
42131672|NCT00393861|75942573|FG000|Overall Study|Disease Progression|24|||
42131673|NCT00480324|75942579|FG000|Overall Study|Adverse Event|1|||
42131674|NCT00480324|75942580|FG001|Overall Study|Adverse Event|1|||
42131675|NCT00480324|75942579|FG000|Overall Study|Protocol Violation|0|||
42131676|NCT00480324|75942580|FG001|Overall Study|Protocol Violation|1|||
42131677|NCT00480324|75942579|FG000|Overall Study|Withdrawal by Subject|14|||
42131678|NCT00480324|75942580|FG001|Overall Study|Withdrawal by Subject|5|||
42131679|NCT00480324|75942579|FG000|Overall Study|Lost to Follow-up|17|||
42131680|NCT00480324|75942580|FG001|Overall Study|Lost to Follow-up|8|||
42226370|NCT03314519|76045831|FG001|Overall Study|Protocol Violation|2|||
42226371|NCT03313037|76045843|FG000|Overall Study|Protocol Violation|4|||
42226372|NCT03313037|76045844|FG001|Overall Study|Protocol Violation|1|||
42226373|NCT03313037|76045843|FG000|Overall Study|Other|1|||
42226374|NCT03313037|76045844|FG001|Overall Study|Other|1|||
41985189|NCT01325350|75792012|FG000|Overall Study|Adverse Event|3|||
41985190|NCT01325350|75792013|FG001|Overall Study|Adverse Event|3|||
41985191|NCT01325350|75792014|FG002|Overall Study|Adverse Event|3|||
41985192|NCT01325350|75792015|FG003|Overall Study|Adverse Event|1|||
41985193|NCT01325350|75792016|FG004|Overall Study|Adverse Event|2|||
42226375|NCT03313037|76045843|FG000|Overall Study|Withdrawal by Subject|4|||
42226376|NCT03313037|76045844|FG001|Overall Study|Withdrawal by Subject|3|||
42226377|NCT03313037|76045843|FG000|Overall Study|No longer meets eligibility criteria|1|||
42226378|NCT03313037|76045844|FG001|Overall Study|No longer meets eligibility criteria|7|||
42226379|NCT03313037|76045843|FG000|Overall Study|Lost to Follow-up|9|||
42226380|NCT03313037|76045844|FG001|Overall Study|Lost to Follow-up|8|||
42226381|NCT03313037|76045843|FG000|Overall Study|Randomized but not treated|1|||
42226382|NCT03313037|76045844|FG001|Overall Study|Randomized but not treated|0|||
42226383|NCT02420795|76045853|FG000|Overall Study|Withdrawal by Subject|1|||
42226384|NCT02420795|76045854|FG001|Overall Study|Withdrawal by Subject|0|||
42226385|NCT02420795|76045855|FG002|Overall Study|Withdrawal by Subject|0|||
42226386|NCT02420795|76045853|FG000|Overall Study|Adverse Event|1|||
42226387|NCT02420795|76045854|FG001|Overall Study|Adverse Event|0|||
42226388|NCT02420795|76045855|FG002|Overall Study|Adverse Event|0|||
42226389|NCT02420795|76045853|FG000|Overall Study|Progressive disease|2|||
42226390|NCT02420795|76045854|FG001|Overall Study|Progressive disease|2|||
42226391|NCT02420795|76045855|FG002|Overall Study|Progressive disease|4|||
42226392|NCT02420795|76045853|FG000|Overall Study|Death|0|||
42226393|NCT02420795|76045854|FG001|Overall Study|Death|0|||
42226394|NCT02420795|76045855|FG002|Overall Study|Death|1|||
42226395|NCT03334175|76045867|FG000|Overall Study|Lost to Follow-up|0|||
42226396|NCT03334175|76045868|FG001|Overall Study|Lost to Follow-up|1|||
42226397|NCT02942771|76045879|FG000|Overall Study|Adverse Event|1|||
42226398|NCT02942771|76045880|FG001|Overall Study|Adverse Event|0|||
42226399|NCT02942771|76045881|FG002|Overall Study|Adverse Event|0|||
42226400|NCT02942771|76045882|FG003|Overall Study|Adverse Event|0|||
42226401|NCT02942771|76045883|FG004|Overall Study|Adverse Event|2|||
42226402|NCT02942771|76045879|FG000|Overall Study|Lost to Follow-up|1|||
42226403|NCT02942771|76045880|FG001|Overall Study|Lost to Follow-up|0|||
42226404|NCT02942771|76045881|FG002|Overall Study|Lost to Follow-up|0|||
42226405|NCT02942771|76045882|FG003|Overall Study|Lost to Follow-up|0|||
42226406|NCT02942771|76045883|FG004|Overall Study|Lost to Follow-up|0|||
42226407|NCT02942771|76045879|FG000|Overall Study|Withdrawal by Subject|1|||
42226408|NCT02942771|76045880|FG001|Overall Study|Withdrawal by Subject|0|||
42226409|NCT02942771|76045881|FG002|Overall Study|Withdrawal by Subject|0|||
42226410|NCT02942771|76045882|FG003|Overall Study|Withdrawal by Subject|0|||
42226411|NCT02942771|76045883|FG004|Overall Study|Withdrawal by Subject|2|||
42226412|NCT03036150|76045897|FG000|Overall Study|Withdrawal by Subject|8|||
42226413|NCT03036150|76045898|FG001|Overall Study|Withdrawal by Subject|3|||
42226414|NCT03036150|76045897|FG000|Overall Study|Lost to Follow-up|2|||
42226415|NCT03036150|76045898|FG001|Overall Study|Lost to Follow-up|2|||
42226416|NCT03332771|76045908|FG000|Overall Study|Adverse Event|6|||
42226417|NCT03332771|76045909|FG001|Overall Study|Adverse Event|4|||
42226418|NCT03332771|76045910|FG002|Overall Study|Adverse Event|1|||
42226419|NCT03332771|76045911|FG003|Overall Study|Adverse Event|3|||
42226420|NCT03332771|76045908|FG000|Overall Study|Poor Compliance to Protocol|0|||
42226421|NCT03332771|76045909|FG001|Overall Study|Poor Compliance to Protocol|1|||
42226422|NCT03332771|76045910|FG002|Overall Study|Poor Compliance to Protocol|0|||
42226423|NCT03332771|76045911|FG003|Overall Study|Poor Compliance to Protocol|1|||
42226424|NCT03332771|76045908|FG000|Overall Study|Lost to Follow-up|2|||
42226425|NCT03332771|76045909|FG001|Overall Study|Lost to Follow-up|2|||
42226426|NCT03332771|76045910|FG002|Overall Study|Lost to Follow-up|1|||
42226427|NCT03332771|76045911|FG003|Overall Study|Lost to Follow-up|2|||
42226428|NCT03332771|76045908|FG000|Overall Study|At the Participant's own request|20|||
42226429|NCT03332771|76045909|FG001|Overall Study|At the Participant's own request|26|||
42226430|NCT03332771|76045910|FG002|Overall Study|At the Participant's own request|14|||
42226431|NCT03332771|76045911|FG003|Overall Study|At the Participant's own request|23|||
42226432|NCT03332771|76045908|FG000|Overall Study|Reason Not Specified|6|||
42226433|NCT03332771|76045909|FG001|Overall Study|Reason Not Specified|18|||
41985194|NCT01325350|75792012|FG000|Overall Study|Pregnancy|0|||
41985195|NCT01325350|75792013|FG001|Overall Study|Pregnancy|0|||
41985196|NCT01325350|75792014|FG002|Overall Study|Pregnancy|1|||
41985197|NCT01325350|75792015|FG003|Overall Study|Pregnancy|0|||
42226434|NCT03332771|76045910|FG002|Overall Study|Reason Not Specified|16|||
42226435|NCT03332771|76045911|FG003|Overall Study|Reason Not Specified|19|||
42226436|NCT03310775|76045923|FG000|Overall Study|Lost to Follow-up|2|||
42226437|NCT03310775|76045924|FG001|Overall Study|Lost to Follow-up|3|||
42226438|NCT03310775|76045923|FG000|Overall Study|aggravation of depression|0|||
41985198|NCT01325350|75792016|FG004|Overall Study|Pregnancy|1|||
42226439|NCT03310775|76045924|FG001|Overall Study|aggravation of depression|1|||
42226440|NCT03330119|76045936|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
42226441|NCT03330119|76045937|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
42226442|NCT03040986|76045945|FG000|Overall Study|Hospice|1|||
42226443|NCT03040986|76045946|FG001|Overall Study|Hospice|0|||
42226444|NCT03040986|76045945|FG000|Overall Study|Adverse Event|2|||
42226445|NCT03040986|76045946|FG001|Overall Study|Adverse Event|1|||
41985199|NCT01325350|75792012|FG000|Overall Study|Lost to Follow-up|1|||
42032119|NCT01079130|75840345|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
42032120|NCT01079130|75840346|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
42032121|NCT01079130|75840347|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
42032122|NCT01079130|75840342|FG000|Overall Study|Lost to Follow-up|0|||
42032123|NCT01079130|75840343|FG001|Overall Study|Lost to Follow-up|0|||
42032124|NCT01079130|75840344|FG002|Overall Study|Lost to Follow-up|0|||
42032125|NCT01079130|75840345|FG003|Overall Study|Lost to Follow-up|0|||
42032126|NCT01079130|75840346|FG004|Overall Study|Lost to Follow-up|1|||
42032127|NCT01079130|75840347|FG005|Overall Study|Lost to Follow-up|0|||
42032128|NCT01078974|75840361|FG000|Overall Study|Adverse Event|3|||
42032129|NCT00869557|75840367|FG000|Randomized Phase|Lost to Follow-up|2|||
42032130|NCT00869557|75840368|FG001|Randomized Phase|Lost to Follow-up|1|||
42032131|NCT00869557|75840367|FG000|Randomized Phase|Investigator's Discretion|1|||
42032132|NCT00869557|75840368|FG001|Randomized Phase|Investigator's Discretion|0|||
42032133|NCT00869557|75840367|FG000|Randomized Phase|Withdrew Consent|0|||
42032134|NCT00869557|75840368|FG001|Randomized Phase|Withdrew Consent|1|||
42226446|NCT03040986|76045945|FG000|Overall Study|Disease progression on study|3|||
42226447|NCT03040986|76045946|FG001|Overall Study|Disease progression on study|1|||
42226448|NCT03039192|76045956|FG000|Overall Study|Lost to Follow-up|4|||
42131681|NCT00480324|75942579|FG000|Overall Study|Subject's mother pregnant|0|||
42131682|NCT00480324|75942580|FG001|Overall Study|Subject's mother pregnant|1|||
42131683|NCT00488592|75942586|FG000|Overall Study|Withdrawal by Subject|1|||
42131684|NCT00488592|75942586|FG000|Overall Study|Disease progression|1|||
42226449|NCT03039192|76045957|FG001|Overall Study|Lost to Follow-up|4|||
42226450|NCT03039192|76045956|FG000|Overall Study|Adverse event, serious fatal|0|||
42226451|NCT03039192|76045957|FG001|Overall Study|Adverse event, serious fatal|1|||
42226452|NCT03039192|76045956|FG000|Overall Study|Adverse event, non-fatal|0|||
42226453|NCT03039192|76045957|FG001|Overall Study|Adverse event, non-fatal|2|||
42226454|NCT03039192|76045956|FG000|Overall Study|Withdrawal by Subject|6|||
42226455|NCT03039192|76045957|FG001|Overall Study|Withdrawal by Subject|9|||
42032135|NCT00869557|75840367|FG000|Extension Phase|Adverse Event|2|||
42131685|NCT00488592|75942586|FG000|Overall Study|Enrolled but not treated|1|||
42131686|NCT00488514|75942590|FG000|Overall Study|Adverse Event|41|||
42131687|NCT00488514|75942590|FG000|Overall Study|Lost to Follow-up|44|||
42131688|NCT00488514|75942590|FG000|Overall Study|Protocol Violation|32|||
42131689|NCT00488514|75942590|FG000|Overall Study|Withdrawal by Subject|106|||
42131690|NCT00488514|75942590|FG000|Overall Study|Lack of Efficacy|28|||
42131691|NCT00488514|75942590|FG000|Overall Study|Did not meet criteria for treatment|30|||
42131692|NCT00488514|75942590|FG000|Overall Study|Postive drug screen|1|||
42131693|NCT00488514|75942590|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
42131694|NCT00488514|75942590|FG000|Overall Study|Investigator decision|1|||
42226456|NCT03039192|76045956|FG000|Overall Study|Discontinued from treatment phase|19|||
42226457|NCT03039192|76045957|FG001|Overall Study|Discontinued from treatment phase|12|||
42226458|NCT03039192|76045956|FG000|Overall Study|Other|3|||
42226459|NCT03039192|76045957|FG001|Overall Study|Other|2|||
42226460|NCT03698279|76045969|FG000|Overall Study|Withdrawal by parent/guardian|1|||
42226461|NCT03698279|76045970|FG001|Overall Study|Withdrawal by parent/guardian|1|||
42226462|NCT03698279|76045971|FG002|Overall Study|Withdrawal by parent/guardian|1|||
42226463|NCT03698279|76045972|FG003|Overall Study|Withdrawal by parent/guardian|1|||
42226464|NCT03698279|76045973|FG004|Overall Study|Withdrawal by parent/guardian|0|||
42226465|NCT03698279|76045974|FG005|Overall Study|Withdrawal by parent/guardian|0|||
42226466|NCT03698279|76045969|FG000|Overall Study|Protocol deviation|1|||
42226467|NCT03698279|76045970|FG001|Overall Study|Protocol deviation|0|||
42226468|NCT03698279|76045971|FG002|Overall Study|Protocol deviation|1|||
42226469|NCT03698279|76045972|FG003|Overall Study|Protocol deviation|0|||
41985200|NCT01325350|75792013|FG001|Overall Study|Lost to Follow-up|0|||
41985201|NCT01325350|75792014|FG002|Overall Study|Lost to Follow-up|5|||
41985202|NCT01325350|75792015|FG003|Overall Study|Lost to Follow-up|1|||
41985203|NCT01325350|75792016|FG004|Overall Study|Lost to Follow-up|5|||
41985204|NCT01325350|75792012|FG000|Overall Study|Personal Reasons|2|||
41985205|NCT01325350|75792013|FG001|Overall Study|Personal Reasons|1|||
41985206|NCT01325350|75792014|FG002|Overall Study|Personal Reasons|6|||
42032136|NCT00869557|75840368|FG001|Extension Phase|Adverse Event|2|||
42032137|NCT00869557|75840367|FG000|Extension Phase|Lack of Efficacy|1|||
42032138|NCT00869557|75840368|FG001|Extension Phase|Lack of Efficacy|0|||
42032139|NCT00869557|75840367|FG000|Extension Phase|Lost to Follow-up|3|||
42131695|NCT00488514|75942590|FG000|Overall Study|Participant had too few migraines|5|||
42226470|NCT03698279|76045973|FG004|Overall Study|Protocol deviation|0|||
42131696|NCT00488514|75942590|FG000|Overall Study|Increase in number of migraines|2|||
42226471|NCT03698279|76045974|FG005|Overall Study|Protocol deviation|0|||
42226472|NCT03698279|76045969|FG000|Overall Study|Withdrawal by Subject|0|||
41985207|NCT01325350|75792015|FG003|Overall Study|Personal Reasons|5|||
41985208|NCT01325350|75792016|FG004|Overall Study|Personal Reasons|3|||
42032140|NCT00869557|75840368|FG001|Extension Phase|Lost to Follow-up|1|||
42226473|NCT03698279|76045970|FG001|Overall Study|Withdrawal by Subject|0|||
42226474|NCT03698279|76045971|FG002|Overall Study|Withdrawal by Subject|1|||
42032141|NCT00869557|75840367|FG000|Extension Phase|Investigator's Discretion|2|||
41985209|NCT01325350|75792012|FG000|Overall Study|Protocol Violation|0|||
41985210|NCT01325350|75792013|FG001|Overall Study|Protocol Violation|0|||
41985211|NCT01325350|75792014|FG002|Overall Study|Protocol Violation|0|||
41985212|NCT01325350|75792015|FG003|Overall Study|Protocol Violation|1|||
41985213|NCT01325350|75792016|FG004|Overall Study|Protocol Violation|0|||
41985214|NCT01325350|75792012|FG000|Overall Study|Withdrawal by Subject|0|||
42226475|NCT03698279|76045972|FG003|Overall Study|Withdrawal by Subject|0|||
42226476|NCT03698279|76045973|FG004|Overall Study|Withdrawal by Subject|0|||
42226477|NCT03698279|76045974|FG005|Overall Study|Withdrawal by Subject|0|||
42226478|NCT03698279|76045969|FG000|Overall Study|Lost to Follow-up|3|||
42226479|NCT03698279|76045970|FG001|Overall Study|Lost to Follow-up|1|||
42226480|NCT03698279|76045971|FG002|Overall Study|Lost to Follow-up|4|||
42226481|NCT03698279|76045972|FG003|Overall Study|Lost to Follow-up|5|||
42226482|NCT03698279|76045973|FG004|Overall Study|Lost to Follow-up|0|||
42226483|NCT03698279|76045974|FG005|Overall Study|Lost to Follow-up|0|||
42226484|NCT01529034|76045993|FG000|Overall Study|Discontinued prior to study treatment|14|||
41985215|NCT01325350|75792013|FG001|Overall Study|Withdrawal by Subject|0|||
41985216|NCT01325350|75792014|FG002|Overall Study|Withdrawal by Subject|1|||
42032142|NCT00869557|75840368|FG001|Extension Phase|Investigator's Discretion|0|||
42032143|NCT00869557|75840367|FG000|Extension Phase|Withdrew Consent|2|||
42032144|NCT00869557|75840368|FG001|Extension Phase|Withdrew Consent|0|||
42032145|NCT01200290|75840375|FG000|Treatment Period|Adverse Event|1|||
42032146|NCT01200290|75840375|FG000|Post-Treatment Follow-Up Period|Death|2|||
42032147|NCT01134263|75840384|FG000|Overall Study|Serious adverse event|2|||
42032148|NCT01134263|75840385|FG001|Overall Study|Serious adverse event|1|||
42032149|NCT01134263|75840386|FG002|Overall Study|Serious adverse event|1|||
42226485|NCT01529034|76045993|FG000|Overall Study|Site closure|62|||
42226486|NCT01529034|76045993|FG000|Overall Study|Study termination|29|||
42226487|NCT01529034|76045993|FG000|Overall Study|Withdrawal by Subject|25|||
41985217|NCT01325350|75792015|FG003|Overall Study|Withdrawal by Subject|1|||
41985218|NCT01325350|75792016|FG004|Overall Study|Withdrawal by Subject|0|||
41985219|NCT01325350|75792012|FG000|Overall Study|Did Not Receive Treatment|0|||
41985220|NCT01325350|75792013|FG001|Overall Study|Did Not Receive Treatment|1|||
41985221|NCT01325350|75792014|FG002|Overall Study|Did Not Receive Treatment|1|||
41985222|NCT01325350|75792015|FG003|Overall Study|Did Not Receive Treatment|0|||
41985223|NCT01325350|75792016|FG004|Overall Study|Did Not Receive Treatment|1|||
41985224|NCT01324999|75792028|FG000|Overall Study|Adverse Event|3|||
41985225|NCT01324999|75792028|FG000|Overall Study|Withdrawal by Subject|2|||
41985226|NCT01324570|75792034|FG000|Overall Study|Adverse Event|4|||
41985227|NCT01324570|75792035|FG001|Overall Study|Adverse Event|7|||
41985228|NCT01324570|75792034|FG000|Overall Study|Withdrawal by Subject|0|||
41985229|NCT01324570|75792035|FG001|Overall Study|Withdrawal by Subject|3|||
41985230|NCT01324570|75792034|FG000|Overall Study|Lack of Efficacy|0|||
41985231|NCT01324570|75792035|FG001|Overall Study|Lack of Efficacy|1|||
41985232|NCT01324570|75792034|FG000|Overall Study|Confirmed or suspected diversion|0|||
41985233|NCT01324570|75792035|FG001|Overall Study|Confirmed or suspected diversion|1|||
41985234|NCT01324570|75792034|FG000|Overall Study|Administrative|0|||
41985235|NCT01324570|75792035|FG001|Overall Study|Administrative|2|||
41985236|NCT01324141|75792043|FG000|Overall Study|Declined to participate before treatment started|1|||
41985237|NCT01324141|75792043|FG000|Overall Study|Disease progression on study|1|||
41985238|NCT01324102|75792059|FG000|Overall Study|illness|1|||
41985239|NCT01324102|75792060|FG001|Overall Study|illness|6|||
41985240|NCT01324024|75792067|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
41985241|NCT01324024|75792068|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
41985242|NCT01323946|75792081|FG000|Overall Study|Lost to Follow-up|0|||
41985243|NCT01323946|75792082|FG001|Overall Study|Lost to Follow-up|1|||
41985244|NCT01323946|75792083|FG002|Overall Study|Lost to Follow-up|0|||
41985245|NCT01323946|75792081|FG000|Overall Study|Parents refused the last blood draw|1|||
41985246|NCT01323946|75792082|FG001|Overall Study|Parents refused the last blood draw|0|||
41985247|NCT01323946|75792083|FG002|Overall Study|Parents refused the last blood draw|0|||
41985248|NCT01323946|75792081|FG000|Overall Study|Withdrawal by Subject|2|||
42226488|NCT01529034|76045993|FG000|Overall Study|No treated SCs within protocol window|13|||
42226489|NCT01529034|76045993|FG000|Overall Study|Noncompliance|8|||
42226490|NCT01529034|76045993|FG000|Overall Study|Caregiver no longer available|7|||
41985249|NCT01323946|75792082|FG001|Overall Study|Withdrawal by Subject|2|||
41985250|NCT01323946|75792083|FG002|Overall Study|Withdrawal by Subject|0|||
41985251|NCT01323790|75792096|FG000|Overall Study|Other|3|||
41985252|NCT01323790|75792097|FG001|Overall Study|Other|2|||
41985253|NCT01323790|75792098|FG002|Overall Study|Other|1|||
41985254|NCT01323790|75792096|FG000|Overall Study|Lost to Follow-up|11|||
41985255|NCT01323790|75792097|FG001|Overall Study|Lost to Follow-up|9|||
41985256|NCT01323790|75792098|FG002|Overall Study|Lost to Follow-up|9|||
42032150|NCT01134263|75840387|FG003|Overall Study|Serious adverse event|1|||
42032151|NCT01134263|75840388|FG004|Overall Study|Serious adverse event|1|||
42226491|NCT01529034|76045993|FG000|Overall Study|Adverse Event|4|||
42226492|NCT01529034|76045993|FG000|Overall Study|Protocol Violation|4|||
42226493|NCT01529034|76045993|FG000|Overall Study|Lack of Efficacy|4|||
42226494|NCT01529034|76045993|FG000|Overall Study|Investigator no longer available|2|||
42226495|NCT01529034|76045993|FG000|Overall Study|Study drug not available|2|||
42226496|NCT03036072|76046000|FG000|Overall Study|Death|0|||
42226497|NCT03036072|76046001|FG001|Overall Study|Death|1|||
42226498|NCT03036072|76046000|FG000|Overall Study|Withdrawal by Subject|0|||
42226499|NCT03036072|76046001|FG001|Overall Study|Withdrawal by Subject|1|||
42226500|NCT03036072|76046000|FG000|Overall Study|Physician Decision|0|||
42226501|NCT03036072|76046001|FG001|Overall Study|Physician Decision|1|||
42226502|NCT03038880|76046010|FG000|Overall Study|Death|1|||
42226503|NCT03038880|76046011|FG001|Overall Study|Death|2|||
42226504|NCT03038880|76046012|FG002|Overall Study|Death|0|||
42226505|NCT03038880|76046010|FG000|Overall Study|Physician Decision|2|||
42226506|NCT03038880|76046011|FG001|Overall Study|Physician Decision|1|||
42226507|NCT03038880|76046012|FG002|Overall Study|Physician Decision|0|||
42226508|NCT03035916|76046023|FG000|Overall Study|Puncture failed|0|||
42226509|NCT03035916|76046024|FG001|Overall Study|Puncture failed|2|||
42226510|NCT03035916|76046025|FG002|Overall Study|Puncture failed|0|||
42226511|NCT01702571|76046035|FG000|Overall Study|Death|1067|||
42226512|NCT01702571|76046036|FG001|Overall Study|Death|76|||
42226513|NCT01702571|76046035|FG000|Overall Study|Lost to Follow-up|144|||
42226514|NCT01702571|76046036|FG001|Overall Study|Lost to Follow-up|10|||
42226515|NCT01702571|76046035|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
42226516|NCT01702571|76046036|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
42226517|NCT01702571|76046035|FG000|Overall Study|Investigator Decision|5|||
42226518|NCT01702571|76046036|FG001|Overall Study|Investigator Decision|0|||
42226519|NCT01702571|76046035|FG000|Overall Study|Not Classifiable|1|||
42226520|NCT01702571|76046036|FG001|Overall Study|Not Classifiable|0|||
42226521|NCT01702571|76046035|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
42226522|NCT01702571|76046036|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
42226523|NCT01702571|76046035|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
42226524|NCT01702571|76046036|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
42226525|NCT01702571|76046035|FG000|Overall Study|Progressive Disease|3|||
42226526|NCT01702571|76046036|FG001|Overall Study|Progressive Disease|0|||
42226527|NCT01702571|76046035|FG000|Overall Study|Protocol Violation|2|||
42226528|NCT01702571|76046036|FG001|Overall Study|Protocol Violation|0|||
42226529|NCT01702571|76046035|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
42226530|NCT01702571|76046036|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
42226531|NCT01702571|76046035|FG000|Overall Study|Termination By Sponsor|4|||
42226532|NCT01702571|76046036|FG001|Overall Study|Termination By Sponsor|0|||
42226533|NCT01702571|76046035|FG000|Overall Study|Withdrawal by Subject|177|||
42226534|NCT01702571|76046036|FG001|Overall Study|Withdrawal by Subject|29|||
42226535|NCT03231943|76046059|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
42226536|NCT03231943|76046060|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
42226537|NCT03231943|76046061|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
42226538|NCT03231943|76046062|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
42226539|NCT03231943|76046063|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
42226540|NCT03231943|76046064|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
42226541|NCT03231943|76046065|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
42226542|NCT03231943|76046066|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
42226543|NCT03231943|76046067|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
42226544|NCT03231943|76046068|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
42226545|NCT03231943|76046069|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
42226546|NCT03231943|76046070|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
42226547|NCT03231943|76046071|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
41985257|NCT01323790|75792096|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
41985258|NCT01323790|75792097|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
41985259|NCT01323790|75792098|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
41985260|NCT01323790|75792096|FG000|Overall Study|Lack of Efficacy|3|||
41985261|NCT01323790|75792097|FG001|Overall Study|Lack of Efficacy|0|||
41985262|NCT01323790|75792098|FG002|Overall Study|Lack of Efficacy|3|||
41985263|NCT01323790|75792096|FG000|Overall Study|Adverse Event|11|||
41985264|NCT01323790|75792097|FG001|Overall Study|Adverse Event|24|||
41985265|NCT01323790|75792098|FG002|Overall Study|Adverse Event|12|||
42226548|NCT03231943|76046059|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42226549|NCT03231943|76046060|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
42226550|NCT03231943|76046061|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42226551|NCT03231943|76046062|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42226552|NCT03231943|76046063|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42226553|NCT03231943|76046064|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42226554|NCT03231943|76046065|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42226555|NCT03231943|76046066|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42032152|NCT01134263|75840384|FG000|Overall Study|Other adverse event|1|||
42226556|NCT03231943|76046067|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42226557|NCT03231943|76046068|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42226558|NCT03231943|76046069|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42226559|NCT03231943|76046070|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42226560|NCT03231943|76046071|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
42226561|NCT03231943|76046059|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
42226562|NCT03231943|76046060|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226563|NCT03231943|76046061|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226564|NCT03231943|76046062|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226565|NCT03231943|76046063|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226566|NCT03231943|76046064|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226567|NCT03231943|76046065|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226568|NCT03231943|76046066|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226569|NCT03231943|76046067|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226570|NCT03231943|76046068|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226571|NCT03231943|76046069|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226572|NCT03231943|76046070|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226573|NCT03231943|76046071|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
42226574|NCT03231943|76046059|FG000|Part 2|Adverse Event|0|||
42226575|NCT03231943|76046060|FG001|Part 2|Adverse Event|0|||
42226576|NCT03231943|76046061|FG002|Part 2|Adverse Event|0|||
42226577|NCT03231943|76046062|FG003|Part 2|Adverse Event|0|||
42226578|NCT03231943|76046063|FG004|Part 2|Adverse Event|0|||
42226579|NCT03231943|76046064|FG005|Part 2|Adverse Event|0|||
42226580|NCT03231943|76046065|FG006|Part 2|Adverse Event|0|||
42226581|NCT03231943|76046066|FG007|Part 2|Adverse Event|0|||
42226582|NCT03231943|76046067|FG008|Part 2|Adverse Event|0|||
42226583|NCT03231943|76046068|FG009|Part 2|Adverse Event|0|||
42226584|NCT03231943|76046069|FG010|Part 2|Adverse Event|1|||
42226585|NCT03231943|76046070|FG011|Part 2|Adverse Event|0|||
42226586|NCT03231943|76046071|FG012|Part 2|Adverse Event|0|||
42226587|NCT03231943|76046059|FG000|Part 2|Withdrawal by Subject|0|||
42226588|NCT03231943|76046060|FG001|Part 2|Withdrawal by Subject|0|||
42226589|NCT03231943|76046061|FG002|Part 2|Withdrawal by Subject|0|||
42226590|NCT03231943|76046062|FG003|Part 2|Withdrawal by Subject|0|||
42226591|NCT03231943|76046063|FG004|Part 2|Withdrawal by Subject|0|||
42226592|NCT03231943|76046064|FG005|Part 2|Withdrawal by Subject|0|||
42226593|NCT03231943|76046065|FG006|Part 2|Withdrawal by Subject|0|||
42226594|NCT03231943|76046066|FG007|Part 2|Withdrawal by Subject|0|||
42226595|NCT03231943|76046067|FG008|Part 2|Withdrawal by Subject|0|||
42226596|NCT03231943|76046068|FG009|Part 2|Withdrawal by Subject|0|||
42226597|NCT03231943|76046069|FG010|Part 2|Withdrawal by Subject|0|||
42226598|NCT03231943|76046070|FG011|Part 2|Withdrawal by Subject|1|||
42226599|NCT03231943|76046071|FG012|Part 2|Withdrawal by Subject|0|||
42226600|NCT01578239|76046103|FG000|Treatment Period|Progressive Disease|19|||
42226601|NCT01578239|76046104|FG001|Treatment Period|Progressive Disease|64|||
42226602|NCT01578239|76046103|FG000|Treatment Period|Physician Decision|17|||
42226603|NCT01578239|76046104|FG001|Treatment Period|Physician Decision|17|||
42226604|NCT01578239|76046103|FG000|Treatment Period|Adverse Event|13|||
42226605|NCT01578239|76046104|FG001|Treatment Period|Adverse Event|10|||
42226606|NCT01578239|76046103|FG000|Treatment Period|Non-compliance|2|||
42226607|NCT01578239|76046104|FG001|Treatment Period|Non-compliance|0|||
42226608|NCT01578239|76046103|FG000|Treatment Period|Withdrawal by Subject|10|||
42226609|NCT01578239|76046104|FG001|Treatment Period|Withdrawal by Subject|9|||
42226610|NCT01578239|76046103|FG000|Treatment Period|Other|6|||
42226611|NCT01578239|76046104|FG001|Treatment Period|Other|1|||
42226612|NCT01578239|76046103|FG000|Long-term Follow-Up Period|Death|69|||
42226613|NCT01578239|76046104|FG001|Long-term Follow-Up Period|Death|64|||
42226614|NCT01578239|76046103|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
42226615|NCT01578239|76046104|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
42226616|NCT01578239|76046103|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
42226617|NCT01578239|76046104|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
42226618|NCT01578239|76046103|FG000|Long-term Follow-Up Period|Other|2|||
42226619|NCT01578239|76046104|FG001|Long-term Follow-Up Period|Other|2|||
42131697|NCT00488514|75942590|FG000|Overall Study|Increased use of concomitant medication|1|||
42131698|NCT00320710|75942614|FG000|Overall Study|Disease progression|24|||
42226620|NCT03241927|76046110|FG000|Overall Study|study terminated|1|||
42226621|NCT03241927|76046111|FG001|Overall Study|study terminated|0|||
42226622|NCT03329885|76046123|FG000|Overall Study|Sponsor discontinued the study early|0|||
42226623|NCT03329885|76046124|FG001|Overall Study|Sponsor discontinued the study early|0|||
42226624|NCT03329885|76046125|FG002|Overall Study|Sponsor discontinued the study early|0|||
42226625|NCT03329885|76046126|FG003|Overall Study|Sponsor discontinued the study early|0|||
42226626|NCT03329885|76046127|FG004|Overall Study|Sponsor discontinued the study early|0|||
42226627|NCT03329885|76046128|FG005|Overall Study|Sponsor discontinued the study early|0|||
42226628|NCT03329885|76046129|FG006|Overall Study|Sponsor discontinued the study early|1|||
42226629|NCT03329885|76046130|FG007|Overall Study|Sponsor discontinued the study early|1|||
42226630|NCT03329885|76046131|FG008|Overall Study|Sponsor discontinued the study early|0|||
42226631|NCT02941523|76046153|FG000|Monotherapy|Withdrawal by Subject|0|||
42226632|NCT02941523|76046154|FG001|Monotherapy|Withdrawal by Subject|1|||
42226633|NCT02941523|76046153|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
42226634|NCT02941523|76046154|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
42226635|NCT02941523|76046153|FG000|Carboplatin Combination Therapy|Death|1|||
42226636|NCT02941523|76046154|FG001|Carboplatin Combination Therapy|Death|2|||
42226637|NCT02941523|76046153|FG000|Carboplatin Combination Therapy|Disease progression|2|||
42226638|NCT02941523|76046154|FG001|Carboplatin Combination Therapy|Disease progression|0|||
42226639|NCT02941523|76046153|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
42226640|NCT02941523|76046154|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
42226641|NCT02938585|76046172|FG000|Overall Study|Withdrawal by parent or guardian|0|||
42226642|NCT02938585|76046173|FG001|Overall Study|Withdrawal by parent or guardian|1|||
42226643|NCT02938585|76046174|FG002|Overall Study|Withdrawal by parent or guardian|0|||
42226644|NCT02938585|76046175|FG003|Overall Study|Withdrawal by parent or guardian|0|||
42226645|NCT02938585|76046172|FG000|Overall Study|Withdrawal by Subject|0|||
42226646|NCT02938585|76046173|FG001|Overall Study|Withdrawal by Subject|0|||
42226647|NCT02938585|76046174|FG002|Overall Study|Withdrawal by Subject|0|||
42226648|NCT02938585|76046175|FG003|Overall Study|Withdrawal by Subject|5|||
42226649|NCT03229759|76046199|FG000|Overall Study|Screen Failure|30|||
42226650|NCT03228433|76046211|FG000|Overall Study|Lost to Follow-up|1|||
42226651|NCT03228433|76046212|FG001|Overall Study|Lost to Follow-up|0|||
42226652|NCT03228433|76046213|FG002|Overall Study|Lost to Follow-up|0|||
42226653|NCT03228433|76046214|FG003|Overall Study|Lost to Follow-up|0|||
42226654|NCT03228433|76046215|FG004|Overall Study|Lost to Follow-up|0|||
42226655|NCT03228433|76046216|FG005|Overall Study|Lost to Follow-up|0|||
42226656|NCT03228433|76046211|FG000|Overall Study|Positive alcohol test|0|||
42226657|NCT03228433|76046212|FG001|Overall Study|Positive alcohol test|0|||
42226658|NCT03228433|76046213|FG002|Overall Study|Positive alcohol test|0|||
42226659|NCT03228433|76046214|FG003|Overall Study|Positive alcohol test|1|||
42226660|NCT03228433|76046215|FG004|Overall Study|Positive alcohol test|0|||
42226661|NCT03228433|76046216|FG005|Overall Study|Positive alcohol test|0|||
42226662|NCT01496118|76046246|FG000|Overall Study|Disease progression|3|||
42226663|NCT01496118|76046247|FG001|Overall Study|Disease progression|2|||
42226664|NCT01496118|76046248|FG002|Overall Study|Disease progression|3|||
41985266|NCT01323790|75792096|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
41985267|NCT01323790|75792097|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
41985268|NCT01323790|75792098|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
41985269|NCT01323790|75792096|FG000|Overall Study|Withdrawal by Subject|23|||
41985270|NCT01323790|75792097|FG001|Overall Study|Withdrawal by Subject|20|||
41985271|NCT01323790|75792098|FG002|Overall Study|Withdrawal by Subject|13|||
41985272|NCT01323790|75792096|FG000|Overall Study|Did Not Receive Treatment|2|||
41985273|NCT01323790|75792097|FG001|Overall Study|Did Not Receive Treatment|0|||
41985274|NCT01323790|75792098|FG002|Overall Study|Did Not Receive Treatment|1|||
41985275|NCT01323790|75792096|FG000|Overall Study|Severe non-compliance with protocol|2|||
41985276|NCT01323790|75792097|FG001|Overall Study|Severe non-compliance with protocol|2|||
41985277|NCT01323790|75792098|FG002|Overall Study|Severe non-compliance with protocol|2|||
41985278|NCT01323673|75792108|FG000|Overall Study|Adverse Event|0|||
41985279|NCT01323673|75792109|FG001|Overall Study|Adverse Event|1|||
41985280|NCT01323673|75792108|FG000|Overall Study|Lost to Follow-up|0|||
41985281|NCT01323673|75792109|FG001|Overall Study|Lost to Follow-up|1|||
41985282|NCT01323673|75792108|FG000|Overall Study|Protocol Violation|1|||
41985283|NCT01323673|75792109|FG001|Overall Study|Protocol Violation|0|||
41985284|NCT01323673|75792108|FG000|Overall Study|Withdrawal by Subject|2|||
41985285|NCT01323673|75792109|FG001|Overall Study|Withdrawal by Subject|3|||
41985286|NCT01323634|75792117|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
41985287|NCT01323634|75792118|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
41985288|NCT01323634|75792119|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
42226665|NCT01496118|76046249|FG003|Overall Study|Disease progression|1|||
42226666|NCT01496118|76046250|FG004|Overall Study|Disease progression|2|||
42226667|NCT01496118|76046251|FG005|Overall Study|Disease progression|2|||
41985289|NCT01323634|75792117|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
41985290|NCT01323634|75792118|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
41985291|NCT01323634|75792119|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
41985292|NCT01323634|75792117|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
41985293|NCT01323634|75792118|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
41985294|NCT01323634|75792119|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
41985295|NCT01323634|75792117|FG000|2-week Run-in Period|Physician Decision|5|||
41985296|NCT01323634|75792118|FG001|2-week Run-in Period|Physician Decision|0|||
42131699|NCT00320710|75942615|FG001|Overall Study|Disease progression|19|||
41985297|NCT01323634|75792119|FG002|2-week Run-in Period|Physician Decision|0|||
42226668|NCT01496118|76046252|FG006|Overall Study|Disease progression|14|||
41985298|NCT01323634|75792117|FG000|2-week Run-in Period|Protocol Violation|1|||
41985299|NCT01323634|75792118|FG001|2-week Run-in Period|Protocol Violation|0|||
42226669|NCT01496118|76046253|FG007|Overall Study|Disease progression|10|||
41985300|NCT01323634|75792119|FG002|2-week Run-in Period|Protocol Violation|0|||
41985301|NCT01323634|75792117|FG000|2-week Run-in Period|Adverse Event|1|||
41985302|NCT01323634|75792118|FG001|2-week Run-in Period|Adverse Event|0|||
41985303|NCT01323634|75792119|FG002|2-week Run-in Period|Adverse Event|0|||
41985304|NCT01323634|75792117|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
41985305|NCT01323634|75792118|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
41985306|NCT01323634|75792119|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
41985307|NCT01323634|75792117|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
41985308|NCT01323634|75792118|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
41985309|NCT01323634|75792119|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
41985310|NCT01323634|75792117|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
41985311|NCT01323634|75792118|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
41985312|NCT01323634|75792119|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
41985313|NCT01323634|75792117|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
41985314|NCT01323634|75792118|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
41985315|NCT01323634|75792119|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
42032153|NCT01134263|75840385|FG001|Overall Study|Other adverse event|2|||
42032154|NCT01134263|75840386|FG002|Overall Study|Other adverse event|5|||
42032155|NCT01134263|75840387|FG003|Overall Study|Other adverse event|3|||
42032156|NCT01134263|75840388|FG004|Overall Study|Other adverse event|0|||
42032157|NCT01134263|75840384|FG000|Overall Study|Protocol Violation|8|||
42032158|NCT01134263|75840385|FG001|Overall Study|Protocol Violation|7|||
42032159|NCT01134263|75840386|FG002|Overall Study|Protocol Violation|2|||
42032160|NCT01134263|75840387|FG003|Overall Study|Protocol Violation|4|||
42032161|NCT01134263|75840388|FG004|Overall Study|Protocol Violation|2|||
42032162|NCT01134263|75840384|FG000|Overall Study|Lost to Follow-up|4|||
41985316|NCT01323634|75792117|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
41985317|NCT01323634|75792118|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
41985318|NCT01323634|75792119|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
41985319|NCT01323634|75792117|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
41985320|NCT01323634|75792118|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
41985321|NCT01323634|75792119|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
41985322|NCT01323634|75792117|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
41985323|NCT01323634|75792118|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
41985324|NCT01323634|75792119|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
41985325|NCT01323478|75792125|FG000|Overall Study|Adverse Event|7|||
41985326|NCT01323478|75792125|FG000|Overall Study|Lack of Efficacy|4|||
41985327|NCT01323478|75792125|FG000|Overall Study|Non-compliance With Study Product|3|||
41985328|NCT01323478|75792125|FG000|Overall Study|Protocol Violation|1|||
41985329|NCT01323478|75792125|FG000|Overall Study|Withdrawal of Consent|1|||
42032163|NCT01134263|75840385|FG001|Overall Study|Lost to Follow-up|3|||
42226670|NCT01496118|76046246|FG000|Overall Study|Physician Decision|0|||
41985330|NCT01323478|75792125|FG000|Overall Study|Administrative or Other Reasons|8|||
41985331|NCT01322386|75792131|FG000|Overall Study|Protocol Violation|0|||
41985332|NCT01322386|75792132|FG001|Overall Study|Protocol Violation|1|||
41985333|NCT01322386|75792131|FG000|Overall Study|Physician Decision|0|||
41985334|NCT01322386|75792132|FG001|Overall Study|Physician Decision|1|||
41985335|NCT01322347|75792142|FG000|Overall Study|Adverse Event|7|||
41985336|NCT01322347|75792143|FG001|Overall Study|Adverse Event|2|||
41985337|NCT01322347|75792142|FG000|Overall Study|Death|5|||
41985338|NCT01322347|75792143|FG001|Overall Study|Death|3|||
41985339|NCT01322347|75792142|FG000|Overall Study|Physician Decision|2|||
41985340|NCT01322347|75792143|FG001|Overall Study|Physician Decision|1|||
41985341|NCT01322347|75792142|FG000|Overall Study|Protocol Violation|5|||
41985342|NCT01322347|75792143|FG001|Overall Study|Protocol Violation|2|||
41985343|NCT01322347|75792142|FG000|Overall Study|Withdrawal by Subject|1|||
41985344|NCT01322347|75792143|FG001|Overall Study|Withdrawal by Subject|4|||
41985345|NCT01322347|75792142|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
41985346|NCT01322347|75792143|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
41985347|NCT01322347|75792142|FG000|Overall Study|blood transfusion|5|||
41985348|NCT01322347|75792143|FG001|Overall Study|blood transfusion|5|||
41985349|NCT01322347|75792142|FG000|Overall Study|sponsor decision|1|||
41985350|NCT01322347|75792143|FG001|Overall Study|sponsor decision|3|||
41985351|NCT01322347|75792142|FG000|Overall Study|ineligible|6|||
41985352|NCT01322347|75792143|FG001|Overall Study|ineligible|3|||
41985353|NCT01322347|75792142|FG000|Overall Study|kidney transplant|3|||
42032164|NCT01134263|75840386|FG002|Overall Study|Lost to Follow-up|5|||
42226671|NCT01496118|76046247|FG001|Overall Study|Physician Decision|0|||
41985354|NCT01322347|75792143|FG001|Overall Study|kidney transplant|1|||
41985355|NCT01322347|75792142|FG000|Overall Study|study drug withheld > 12 wks|0|||
42032165|NCT01134263|75840387|FG003|Overall Study|Lost to Follow-up|3|||
42032166|NCT01134263|75840388|FG004|Overall Study|Lost to Follow-up|1|||
42032167|NCT01134263|75840384|FG000|Overall Study|Withdrawal by Subject|8|||
42032168|NCT01134263|75840385|FG001|Overall Study|Withdrawal by Subject|6|||
42226672|NCT01496118|76046248|FG002|Overall Study|Physician Decision|0|||
42032169|NCT01134263|75840386|FG002|Overall Study|Withdrawal by Subject|16|||
42032170|NCT01134263|75840387|FG003|Overall Study|Withdrawal by Subject|7|||
42032171|NCT01134263|75840388|FG004|Overall Study|Withdrawal by Subject|5|||
42032172|NCT01134263|75840384|FG000|Overall Study|Enrolled, but not treated|1|||
42032173|NCT01134263|75840385|FG001|Overall Study|Enrolled, but not treated|1|||
42032174|NCT01134263|75840386|FG002|Overall Study|Enrolled, but not treated|0|||
42032175|NCT01134263|75840387|FG003|Overall Study|Enrolled, but not treated|1|||
42032176|NCT01134263|75840388|FG004|Overall Study|Enrolled, but not treated|0|||
42032177|NCT01199822|75840409|FG000|Overall Study|Investigator discontinued therapy|0|||
42032178|NCT01199822|75840410|FG001|Overall Study|Investigator discontinued therapy|1|||
42032179|NCT01199822|75840411|FG002|Overall Study|Investigator discontinued therapy|0|||
42032180|NCT01096056|75840428|FG000|Overall Study|Lost to Follow-up|0|||
42032181|NCT01096056|75840429|FG001|Overall Study|Lost to Follow-up|1|||
42032182|NCT00866359|75840437|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
42032183|NCT00866359|75840438|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
42032184|NCT00866359|75840439|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
42032185|NCT00866359|75840440|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
42032186|NCT00866359|75840437|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
42032187|NCT00866359|75840438|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
42032188|NCT00866359|75840439|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
42032189|NCT00866359|75840440|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
42032190|NCT00866359|75840437|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
42032191|NCT00866359|75840438|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
42032192|NCT00866359|75840439|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
42032193|NCT00866359|75840440|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
42032194|NCT00866359|75840437|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
42032195|NCT00866359|75840438|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
42032196|NCT00866359|75840439|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
42032197|NCT00866359|75840440|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
42032198|NCT00866359|75840437|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
42032199|NCT00866359|75840438|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
42032200|NCT00866359|75840439|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
42032201|NCT00866359|75840440|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
42032202|NCT00866359|75840437|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
42032203|NCT00866359|75840438|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
42032204|NCT00866359|75840439|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
42032205|NCT00866359|75840440|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
42032206|NCT01199198|75840469|FG000|Overall Study|Adverse Event|3|||
42032207|NCT01199198|75840470|FG001|Overall Study|Adverse Event|0|||
42032208|NCT01199198|75840469|FG000|Overall Study|Lost to Follow-up|1|||
42032209|NCT01199198|75840470|FG001|Overall Study|Lost to Follow-up|5|||
42032210|NCT01199198|75840469|FG000|Overall Study|Withdrawal by Subject|1|||
42032211|NCT01199198|75840470|FG001|Overall Study|Withdrawal by Subject|2|||
42032212|NCT01199198|75840469|FG000|Overall Study|ICU Transfer|1|||
42032213|NCT01199198|75840470|FG001|Overall Study|ICU Transfer|2|||
42032214|NCT01199198|75840469|FG000|Overall Study|Hospice-care transfer|1|||
42032215|NCT01199198|75840470|FG001|Overall Study|Hospice-care transfer|2|||
42032216|NCT01095978|75840476|FG000|Overall Study|Did not take Klacid SR|2|||
42032217|NCT01095978|75840476|FG000|Overall Study|Adverse Event|1|||
42032218|NCT01134107|75840484|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
42032219|NCT01134107|75840485|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
42032220|NCT01134107|75840484|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
42032221|NCT01134107|75840485|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
42032222|NCT01134107|75840484|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
42032223|NCT01134107|75840485|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
42032224|NCT01134107|75840484|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
42032225|NCT01134107|75840485|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
42032226|NCT01134107|75840484|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
42032227|NCT01134107|75840485|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
42032228|NCT01134107|75840484|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
42032229|NCT01134107|75840485|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
42032230|NCT01134107|75840484|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
42032231|NCT01134107|75840485|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
42032232|NCT01199042|75840491|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
42032233|NCT01199042|75840491|FG000|At Home (3 Months)|Lost to Follow-up|1|||
42032234|NCT01198574|75840504|FG000|Overall Study|Resigned from schools|4|||
42032235|NCT01198574|75840505|FG001|Overall Study|Resigned from schools|1|||
42032236|NCT01198574|75840506|FG002|Overall Study|Resigned from schools|1|||
42032237|NCT01198574|75840507|FG003|Overall Study|Resigned from schools|4|||
42032238|NCT01198028|75840517|FG000|Overall Study|Adverse Event|5|||
42032239|NCT01198028|75840517|FG000|Overall Study|Death|3|||
41985356|NCT01322347|75792143|FG001|Overall Study|study drug withheld > 12 wks|1|||
41985357|NCT01322347|75792142|FG000|Overall Study|moved/changed dialysis|2|||
41985358|NCT01322347|75792143|FG001|Overall Study|moved/changed dialysis|4|||
41985359|NCT01321879|75792150|FG000|Overall Study|Lack of Efficacy|5|||
41985360|NCT01321879|75792150|FG000|Overall Study|Adverse Event|5|||
41985361|NCT01321879|75792150|FG000|Overall Study|Death|3|||
41985362|NCT01321879|75792150|FG000|Overall Study|Withdrawal by Subject|1|||
41985363|NCT01321723|75792157|FG000|Overall Study|Adverse Event|3|||
42032240|NCT01198028|75840517|FG000|Overall Study|Physician Decision|2|||
42032241|NCT01197950|75840524|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
42032242|NCT01197950|75840525|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
42032243|NCT01197950|75840526|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
42032244|NCT01092780|75840534|FG000|Washout Period 1|Adverse Event|0|||
42032245|NCT01092780|75840535|FG001|Washout Period 1|Adverse Event|1|||
42032246|NCT01092780|75840536|FG002|Washout Period 1|Adverse Event|0|||
42032247|NCT01092780|75840537|FG003|Washout Period 1|Adverse Event|0|||
42032248|NCT01092780|75840534|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
42032249|NCT01092780|75840535|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
42032250|NCT01092780|75840536|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
42032251|NCT01092780|75840537|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
41985364|NCT01321723|75792158|FG001|Overall Study|Adverse Event|5|||
41985365|NCT01321723|75792159|FG002|Overall Study|Adverse Event|2|||
41985366|NCT01321723|75792157|FG000|Overall Study|Withdrawal by Subject|2|||
41985367|NCT01321723|75792158|FG001|Overall Study|Withdrawal by Subject|0|||
41985368|NCT01321723|75792159|FG002|Overall Study|Withdrawal by Subject|2|||
42032252|NCT01092780|75840534|FG000|Washout Period 2|Adverse Event|0|||
42032253|NCT01092780|75840535|FG001|Washout Period 2|Adverse Event|1|||
42032254|NCT01092780|75840536|FG002|Washout Period 2|Adverse Event|1|||
42032255|NCT01092780|75840537|FG003|Washout Period 2|Adverse Event|0|||
42032256|NCT01092546|75840547|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
42032257|NCT01197794|75840558|FG000|Overall Study|Adverse Event|3|||
42032258|NCT01197794|75840559|FG001|Overall Study|Adverse Event|2|||
42032259|NCT01197794|75840560|FG002|Overall Study|Adverse Event|4|||
42032260|NCT01197794|75840561|FG003|Overall Study|Adverse Event|4|||
42032261|NCT01197794|75840562|FG004|Overall Study|Adverse Event|4|||
42032262|NCT01197794|75840563|FG005|Overall Study|Adverse Event|2|||
42032263|NCT01197794|75840564|FG006|Overall Study|Adverse Event|3|||
42032264|NCT01197794|75840558|FG000|Overall Study|Protocol Violation|0|||
42032265|NCT01197794|75840559|FG001|Overall Study|Protocol Violation|0|||
42032266|NCT01197794|75840560|FG002|Overall Study|Protocol Violation|0|||
42032267|NCT01197794|75840561|FG003|Overall Study|Protocol Violation|0|||
42032268|NCT01197794|75840562|FG004|Overall Study|Protocol Violation|2|||
42032269|NCT01197794|75840563|FG005|Overall Study|Protocol Violation|0|||
42032270|NCT01197794|75840564|FG006|Overall Study|Protocol Violation|1|||
41985369|NCT01321606|75792169|FG000|Overall Study|Lost to Follow-up|0|||
41985370|NCT01321606|75792170|FG001|Overall Study|Lost to Follow-up|0|||
41985371|NCT01321606|75792171|FG002|Overall Study|Lost to Follow-up|0|||
41985372|NCT01321606|75792172|FG003|Overall Study|Lost to Follow-up|1|||
41985373|NCT01320943|75792184|FG000|Overall Study|Lost to Follow-up|1|||
41985374|NCT01320943|75792185|FG001|Overall Study|Lost to Follow-up|0|||
41985375|NCT01320943|75792184|FG000|Overall Study|Physician Decision|0|||
41985376|NCT01320943|75792185|FG001|Overall Study|Physician Decision|1|||
41985377|NCT01320943|75792184|FG000|Overall Study|Randomized but not Treated|0|||
42032271|NCT01197794|75840558|FG000|Overall Study|Development of study withdrawal criteria|3|||
42032272|NCT01197794|75840559|FG001|Overall Study|Development of study withdrawal criteria|0|||
42032273|NCT01197794|75840560|FG002|Overall Study|Development of study withdrawal criteria|0|||
42032274|NCT01197794|75840561|FG003|Overall Study|Development of study withdrawal criteria|1|||
42032275|NCT01197794|75840562|FG004|Overall Study|Development of study withdrawal criteria|0|||
42032276|NCT01197794|75840563|FG005|Overall Study|Development of study withdrawal criteria|0|||
42032277|NCT01197794|75840564|FG006|Overall Study|Development of study withdrawal criteria|1|||
42226673|NCT01496118|76046249|FG003|Overall Study|Physician Decision|0|||
42226674|NCT01496118|76046250|FG004|Overall Study|Physician Decision|1|||
42032278|NCT01197794|75840558|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
42032279|NCT01197794|75840559|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
42032280|NCT01197794|75840560|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
42032281|NCT01197794|75840561|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
42131700|NCT00320710|75942616|FG002|Overall Study|Disease progression|2|||
42226675|NCT01496118|76046251|FG005|Overall Study|Physician Decision|0|||
42226676|NCT01496118|76046252|FG006|Overall Study|Physician Decision|3|||
42226677|NCT01496118|76046253|FG007|Overall Study|Physician Decision|6|||
41985378|NCT01320943|75792185|FG001|Overall Study|Randomized but not Treated|1|||
41985379|NCT02482233|75792200|FG000|Overall Study|Lost to Follow-up|1|||
41985380|NCT02482233|75792201|FG001|Overall Study|Lost to Follow-up|1|||
41985381|NCT01320202|75792211|FG000|Overall Study|Adverse Event|5|||
41985382|NCT01320202|75792212|FG001|Overall Study|Adverse Event|5|||
42032282|NCT01197794|75840562|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
42032283|NCT01197794|75840563|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
42032284|NCT01197794|75840564|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
42032285|NCT01197794|75840558|FG000|Overall Study|Withdrawal by Subject|3|||
42032286|NCT01197794|75840559|FG001|Overall Study|Withdrawal by Subject|3|||
42032287|NCT01197794|75840560|FG002|Overall Study|Withdrawal by Subject|4|||
42032288|NCT01197794|75840561|FG003|Overall Study|Withdrawal by Subject|1|||
42032289|NCT01197794|75840562|FG004|Overall Study|Withdrawal by Subject|1|||
42032290|NCT01197794|75840563|FG005|Overall Study|Withdrawal by Subject|5|||
42032291|NCT01197794|75840564|FG006|Overall Study|Withdrawal by Subject|6|||
42032292|NCT01197794|75840558|FG000|Overall Study|Lost to Follow-up|1|||
42032293|NCT01197794|75840559|FG001|Overall Study|Lost to Follow-up|1|||
41985383|NCT01320202|75792211|FG000|Overall Study|Death|5|||
41985384|NCT01320202|75792212|FG001|Overall Study|Death|3|||
41985385|NCT01320202|75792211|FG000|Overall Study|Lost to Follow-up|1|||
41985386|NCT01320202|75792212|FG001|Overall Study|Lost to Follow-up|0|||
41985387|NCT01320202|75792211|FG000|Overall Study|Physician Decision|3|||
41985388|NCT01320202|75792212|FG001|Overall Study|Physician Decision|1|||
41985389|NCT01320202|75792211|FG000|Overall Study|Protocol Violation|2|||
41985390|NCT01320202|75792212|FG001|Overall Study|Protocol Violation|1|||
41985391|NCT01320202|75792211|FG000|Overall Study|Withdrawal by Subject|10|||
41985392|NCT01320202|75792212|FG001|Overall Study|Withdrawal by Subject|3|||
41985393|NCT01320202|75792211|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
41985394|NCT01320202|75792212|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
41985395|NCT01320202|75792211|FG000|Overall Study|kidney transplant|1|||
41985396|NCT01320202|75792212|FG001|Overall Study|kidney transplant|2|||
41985397|NCT01320202|75792211|FG000|Overall Study|blood transfusion|1|||
41985398|NCT01320202|75792212|FG001|Overall Study|blood transfusion|7|||
41985399|NCT01320202|75792211|FG000|Overall Study|moved/changed dialysis|5|||
41985400|NCT01320202|75792212|FG001|Overall Study|moved/changed dialysis|2|||
41985401|NCT01320202|75792211|FG000|Overall Study|sponsor request|2|||
41985402|NCT01320202|75792212|FG001|Overall Study|sponsor request|0|||
41985403|NCT01320202|75792211|FG000|Overall Study|ineligible|3|||
41985404|NCT01320202|75792212|FG001|Overall Study|ineligible|0|||
41985405|NCT01320202|75792211|FG000|Overall Study|regained renal function|1|||
41985406|NCT01320202|75792212|FG001|Overall Study|regained renal function|0|||
42010482|NCT00993499|75817613|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
42010483|NCT00993499|75817614|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
42010484|NCT00993499|75817615|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
42010485|NCT00993499|75817616|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
42010486|NCT00993499|75817611|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
42010487|NCT00993499|75817612|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
42010488|NCT00993499|75817613|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
42010489|NCT00993499|75817614|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
42010490|NCT00993499|75817615|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
42010491|NCT00993499|75817616|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
42010492|NCT00993499|75817611|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
42010493|NCT00993499|75817612|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
42010494|NCT00993499|75817613|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
42010495|NCT00993499|75817614|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
42010496|NCT00993499|75817615|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
42010497|NCT00993499|75817616|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
42010498|NCT00993499|75817611|FG000|Discontinued After Starting Course 3|DLT|1|||
42010499|NCT00993499|75817612|FG001|Discontinued After Starting Course 3|DLT|0|||
42010500|NCT00993499|75817613|FG002|Discontinued After Starting Course 3|DLT|2|||
42010501|NCT00993499|75817614|FG003|Discontinued After Starting Course 3|DLT|1|||
42010502|NCT00993499|75817615|FG004|Discontinued After Starting Course 3|DLT|0|||
42010503|NCT00993499|75817616|FG005|Discontinued After Starting Course 3|DLT|0|||
42010504|NCT00993499|75817611|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
42010505|NCT00993499|75817612|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
42010506|NCT00993499|75817613|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
42010507|NCT00993499|75817614|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
42010508|NCT00993499|75817615|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
42010509|NCT00993499|75817616|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
42010510|NCT01014442|75817632|FG000|Overall Study|Adverse Event|0|||
42010511|NCT01014442|75817633|FG001|Overall Study|Adverse Event|8|||
42010512|NCT01014442|75817632|FG000|Overall Study|Withdrawal by Subject|4|||
42010513|NCT01014442|75817633|FG001|Overall Study|Withdrawal by Subject|4|||
42032294|NCT01197794|75840560|FG002|Overall Study|Lost to Follow-up|0|||
42032295|NCT01197794|75840561|FG003|Overall Study|Lost to Follow-up|1|||
42032296|NCT01197794|75840562|FG004|Overall Study|Lost to Follow-up|0|||
42032297|NCT01197794|75840563|FG005|Overall Study|Lost to Follow-up|1|||
41985407|NCT01319383|75792221|FG000|Overall Study|No ex vivo or in vivo response|4|||
41985408|NCT01319383|75792222|FG001|Overall Study|No ex vivo or in vivo response|0|||
41985409|NCT01319383|75792221|FG000|Overall Study|Physician Decision|3|||
41985410|NCT01319383|75792222|FG001|Overall Study|Physician Decision|0|||
41985411|NCT01319383|75792221|FG000|Overall Study|Lack of Efficacy|5|||
41985412|NCT01319383|75792222|FG001|Overall Study|Lack of Efficacy|9|||
41985413|NCT01319383|75792221|FG000|Overall Study|No in vivo response to interval doses|0|||
41985414|NCT01319383|75792222|FG001|Overall Study|No in vivo response to interval doses|1|||
41985415|NCT01316614|75792239|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
41985416|NCT01316614|75792239|FG000|Overall Study|Cytology slides not available for review|4|||
41985417|NCT01316614|75792239|FG000|Overall Study|Cystic lesion|5|||
41985418|NCT01316614|75792239|FG000|Overall Study|Inadequate number of passes|2|||
41985419|NCT01316614|75792239|FG000|Overall Study|Medically unstable|1|||
41985420|NCT01316575|75792246|FG000|Overall Study|Withdrawal by Subject|2|||
41985421|NCT01316575|75792247|FG001|Overall Study|Withdrawal by Subject|0|||
41985422|NCT01316575|75792246|FG000|Overall Study|Required alternate treatment|0|||
41985423|NCT01316575|75792247|FG001|Overall Study|Required alternate treatment|1|||
41985424|NCT01315678|75792255|FG000|Overall Study|Withdrawal by Subject|7|||
41985425|NCT01315678|75792256|FG001|Overall Study|Withdrawal by Subject|3|||
41985426|NCT01315678|75792255|FG000|Overall Study|Adverse Event|3|||
41985427|NCT01315678|75792256|FG001|Overall Study|Adverse Event|1|||
41985428|NCT01315678|75792255|FG000|Overall Study|Lost to Follow-up|1|||
41985429|NCT01315678|75792256|FG001|Overall Study|Lost to Follow-up|0|||
41985430|NCT01315678|75792255|FG000|Overall Study|similar reason to those listed above|3|||
41985431|NCT01315678|75792256|FG001|Overall Study|similar reason to those listed above|2|||
41985432|NCT01315249|75792266|FG000|Overall Study|Adverse Event|22|||
42226678|NCT01496118|76046246|FG000|Overall Study|Adverse Event|1|||
42226679|NCT01496118|76046247|FG001|Overall Study|Adverse Event|1|||
42226680|NCT01496118|76046248|FG002|Overall Study|Adverse Event|0|||
42226681|NCT01496118|76046249|FG003|Overall Study|Adverse Event|0|||
42226682|NCT01496118|76046250|FG004|Overall Study|Adverse Event|0|||
42226683|NCT01496118|76046251|FG005|Overall Study|Adverse Event|0|||
42226684|NCT01496118|76046252|FG006|Overall Study|Adverse Event|6|||
42226685|NCT01496118|76046253|FG007|Overall Study|Adverse Event|10|||
42226686|NCT01496118|76046246|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
42226687|NCT01496118|76046247|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
41985433|NCT01315249|75792267|FG001|Overall Study|Adverse Event|26|||
42226688|NCT01496118|76046248|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
42226689|NCT01496118|76046249|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
42226690|NCT01496118|76046250|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
42226691|NCT01496118|76046251|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
42226692|NCT01496118|76046252|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
42226693|NCT01496118|76046253|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
42226694|NCT01496118|76046246|FG000|Overall Study|Death|0|||
41985434|NCT01315249|75792266|FG000|Overall Study|Withdrawal by Subject|11|||
41985435|NCT01315249|75792267|FG001|Overall Study|Withdrawal by Subject|10|||
41985436|NCT01315249|75792266|FG000|Overall Study|Protocol Violation|8|||
41985437|NCT01315249|75792267|FG001|Overall Study|Protocol Violation|5|||
41985438|NCT01315249|75792266|FG000|Overall Study|Abnormal test results|1|||
42226695|NCT01496118|76046247|FG001|Overall Study|Death|0|||
42226696|NCT01496118|76046248|FG002|Overall Study|Death|0|||
42226697|NCT01496118|76046249|FG003|Overall Study|Death|0|||
42226698|NCT01496118|76046250|FG004|Overall Study|Death|0|||
42226699|NCT01496118|76046251|FG005|Overall Study|Death|0|||
42226700|NCT01496118|76046252|FG006|Overall Study|Death|1|||
42226701|NCT01496118|76046253|FG007|Overall Study|Death|1|||
42226702|NCT01496118|76046246|FG000|Overall Study|Withdrawal by Subject|0|||
42226703|NCT01496118|76046247|FG001|Overall Study|Withdrawal by Subject|0|||
42226704|NCT01496118|76046248|FG002|Overall Study|Withdrawal by Subject|0|||
42226705|NCT01496118|76046249|FG003|Overall Study|Withdrawal by Subject|2|||
42226706|NCT01496118|76046250|FG004|Overall Study|Withdrawal by Subject|0|||
42226707|NCT01496118|76046251|FG005|Overall Study|Withdrawal by Subject|1|||
42226708|NCT01496118|76046252|FG006|Overall Study|Withdrawal by Subject|6|||
42226709|NCT01496118|76046253|FG007|Overall Study|Withdrawal by Subject|3|||
42226710|NCT02936869|76046273|FG000|Overall Study|Lost to Follow-up|1|||
42226711|NCT02936869|76046274|FG001|Overall Study|Lost to Follow-up|3|||
42226712|NCT02936869|76046273|FG000|Overall Study|Death|0|||
42226713|NCT02936869|76046274|FG001|Overall Study|Death|1|||
42226714|NCT02936869|76046273|FG000|Overall Study|Legal Case|0|||
42226715|NCT02936869|76046274|FG001|Overall Study|Legal Case|1|||
42226716|NCT02936869|76046273|FG000|Overall Study|Protocol Violation|1|||
42226717|NCT02936869|76046274|FG001|Overall Study|Protocol Violation|0|||
42226718|NCT03309605|76046289|FG000|Overall Study|Adverse Event|0|||
42226719|NCT03309605|76046290|FG001|Overall Study|Adverse Event|0|||
41985439|NCT01315249|75792267|FG001|Overall Study|Abnormal test results|2|||
41985440|NCT01315249|75792266|FG000|Overall Study|Administrative problems|1|||
41985441|NCT01315249|75792267|FG001|Overall Study|Administrative problems|0|||
41985442|NCT01315249|75792266|FG000|Overall Study|inability to use device|1|||
41985443|NCT01315249|75792267|FG001|Overall Study|inability to use device|0|||
42226720|NCT03309605|76046291|FG002|Overall Study|Adverse Event|0|||
42226721|NCT03309605|76046292|FG003|Overall Study|Adverse Event|1|||
42226722|NCT03309605|76046293|FG004|Overall Study|Adverse Event|0|||
42226723|NCT03309605|76046294|FG005|Overall Study|Adverse Event|0|||
42226724|NCT03309605|76046295|FG006|Overall Study|Adverse Event|2|||
42226725|NCT03309605|76046296|FG007|Overall Study|Adverse Event|1|||
42226726|NCT03309605|76046289|FG000|Overall Study|Withdrawal by Subject|0|||
42226727|NCT03309605|76046290|FG001|Overall Study|Withdrawal by Subject|0|||
42226728|NCT03309605|76046291|FG002|Overall Study|Withdrawal by Subject|0|||
42226729|NCT03309605|76046292|FG003|Overall Study|Withdrawal by Subject|0|||
42226730|NCT03309605|76046293|FG004|Overall Study|Withdrawal by Subject|1|||
42226731|NCT03309605|76046294|FG005|Overall Study|Withdrawal by Subject|0|||
42226732|NCT03309605|76046295|FG006|Overall Study|Withdrawal by Subject|1|||
42226733|NCT03309605|76046296|FG007|Overall Study|Withdrawal by Subject|1|||
42226734|NCT02936635|76046312|FG000|Overall Study|Adverse Event|43|||
42226735|NCT02936635|76046313|FG001|Overall Study|Adverse Event|25|||
42226736|NCT02936635|76046312|FG000|Overall Study|Progressive Disease|10|||
42226737|NCT02936635|76046313|FG001|Overall Study|Progressive Disease|18|||
42226738|NCT02936635|76046312|FG000|Overall Study|Sponsor Discretion|10|||
42226739|NCT02936635|76046313|FG001|Overall Study|Sponsor Discretion|16|||
42226740|NCT02936635|76046312|FG000|Overall Study|Death|9|||
42226741|NCT02936635|76046313|FG001|Overall Study|Death|15|||
42226742|NCT02936635|76046312|FG000|Overall Study|Withdrawal by Subject|8|||
42226743|NCT02936635|76046313|FG001|Overall Study|Withdrawal by Subject|15|||
42226744|NCT02936635|76046312|FG000|Overall Study|Physician Decision|2|||
42226745|NCT02936635|76046313|FG001|Overall Study|Physician Decision|9|||
42226746|NCT02936635|76046312|FG000|Overall Study|Lost to Follow-up|1|||
42226747|NCT02936635|76046313|FG001|Overall Study|Lost to Follow-up|2|||
42226748|NCT02936635|76046312|FG000|Overall Study|Protocol Violation|1|||
42226749|NCT02936635|76046313|FG001|Overall Study|Protocol Violation|0|||
42226750|NCT02936635|76046312|FG000|Overall Study|Lack of effect/Entry into other study|31|||
42226751|NCT02936635|76046313|FG001|Overall Study|Lack of effect/Entry into other study|65|||
42226752|NCT03227029|76046322|FG000|Overall Study|Child Wheezed (no treatment)|0|||
42226753|NCT03227029|76046323|FG001|Overall Study|Child Wheezed (no treatment)|1|||
41985444|NCT01315249|75792266|FG000|Overall Study|Lack of Efficacy|0|||
41985445|NCT01315249|75792267|FG001|Overall Study|Lack of Efficacy|1|||
41985446|NCT01315249|75792266|FG000|Overall Study|Lost to Follow-up|0|||
41985447|NCT01315249|75792267|FG001|Overall Study|Lost to Follow-up|2|||
42226754|NCT03227029|76046324|FG002|Overall Study|Child Wheezed (no treatment)|0|||
42226755|NCT03227029|76046322|FG000|Overall Study|No post RSV season visit due to COVID|3|||
41985448|NCT01315249|75792266|FG000|Overall Study|Death|0|||
41985449|NCT01315249|75792267|FG001|Overall Study|Death|1|||
42032298|NCT01197794|75840564|FG006|Overall Study|Lost to Follow-up|0|||
42226756|NCT03227029|76046323|FG001|Overall Study|No post RSV season visit due to COVID|3|||
42226757|NCT03227029|76046324|FG002|Overall Study|No post RSV season visit due to COVID|2|||
42226758|NCT03227029|76046322|FG000|Overall Study|Not able to get to clinic|0|||
42226759|NCT03227029|76046323|FG001|Overall Study|Not able to get to clinic|0|||
42226760|NCT03227029|76046324|FG002|Overall Study|Not able to get to clinic|1|||
42032299|NCT01197794|75840558|FG000|Overall Study|Other|1|||
42226761|NCT03227029|76046322|FG000|Overall Study|Withdrawal by Subject|1|||
42226762|NCT03227029|76046323|FG001|Overall Study|Withdrawal by Subject|0|||
42226763|NCT03227029|76046324|FG002|Overall Study|Withdrawal by Subject|0|||
42226764|NCT03227029|76046322|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
42226765|NCT03227029|76046323|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
41985450|NCT01315132|75792273|FG000|Overall Study|not treated due to disease progression|1|||
41985451|NCT01313767|75792279|FG000|Overall Study|Adverse Event|1|||
41985452|NCT01313767|75792280|FG001|Overall Study|Adverse Event|0|||
41985453|NCT01313767|75792279|FG000|Overall Study|Lost to Follow-up|1|||
41985454|NCT01313767|75792280|FG001|Overall Study|Lost to Follow-up|0|||
41985455|NCT01313767|75792279|FG000|Overall Study|Withdrawal by Subject|2|||
41985456|NCT01313767|75792280|FG001|Overall Study|Withdrawal by Subject|1|||
41985457|NCT01313767|75792279|FG000|Overall Study|Protocol Violation|3|||
41985458|NCT01313767|75792280|FG001|Overall Study|Protocol Violation|1|||
41985459|NCT01313728|75792286|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
41985460|NCT01313650|75792295|FG000|Overall Study|Adverse Event|9|||
41985461|NCT01313650|75792296|FG001|Overall Study|Adverse Event|34|||
41985462|NCT01313650|75792297|FG002|Overall Study|Adverse Event|24|||
41985463|NCT01313650|75792298|FG003|Overall Study|Adverse Event|23|||
41985464|NCT01313650|75792295|FG000|Overall Study|Lack of Efficacy|37|||
41985465|NCT01313650|75792296|FG001|Overall Study|Lack of Efficacy|20|||
41985466|NCT01313650|75792297|FG002|Overall Study|Lack of Efficacy|32|||
41985467|NCT01313650|75792298|FG003|Overall Study|Lack of Efficacy|20|||
41985468|NCT01313650|75792295|FG000|Overall Study|Lost to Follow-up|1|||
41985469|NCT01313650|75792296|FG001|Overall Study|Lost to Follow-up|0|||
41985470|NCT01313650|75792297|FG002|Overall Study|Lost to Follow-up|3|||
41985471|NCT01313650|75792298|FG003|Overall Study|Lost to Follow-up|2|||
41985472|NCT01313650|75792295|FG000|Overall Study|Withdrawal by Subject|16|||
41985473|NCT01313650|75792296|FG001|Overall Study|Withdrawal by Subject|20|||
42226766|NCT03227029|76046324|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
42226767|NCT03329573|76046336|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
42226768|NCT03329573|76046337|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
42226769|NCT03329573|76046338|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
42226770|NCT03329573|76046339|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
42226771|NCT03329573|76046336|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
42226772|NCT03329573|76046337|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
42226773|NCT03329573|76046338|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42226774|NCT03329573|76046339|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
42226775|NCT03329573|76046336|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
42226776|NCT03329573|76046337|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
42226777|NCT03329573|76046338|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
42226778|NCT03329573|76046339|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
42226779|NCT03329573|76046336|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
42226780|NCT03329573|76046337|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
42226781|NCT03329573|76046338|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
42226782|NCT03329573|76046339|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
42226783|NCT03308825|76046370|FG000|Overall Study|Lost to Follow-up|2|||
42226784|NCT03308825|76046371|FG001|Overall Study|Lost to Follow-up|2|||
42226785|NCT03308825|76046372|FG002|Overall Study|Lost to Follow-up|1|||
42226786|NCT03308825|76046373|FG003|Overall Study|Lost to Follow-up|0|||
42226787|NCT03308825|76046370|FG000|Overall Study|Protocol Violation|0|||
42226788|NCT03308825|76046371|FG001|Overall Study|Protocol Violation|2|||
42226789|NCT03308825|76046372|FG002|Overall Study|Protocol Violation|0|||
42226790|NCT03308825|76046373|FG003|Overall Study|Protocol Violation|0|||
42226791|NCT03328325|76046387|FG000|Overall Study|Lost to Follow-up|4|||
42226792|NCT03328325|76046387|FG000|Overall Study|Physician Decision|1|||
42226793|NCT03328325|76046387|FG000|Overall Study|Withdrawal by Subject|3|||
42226794|NCT03328325|76046387|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
42226795|NCT03305081|76046397|FG000|Overall Study|Lost to Follow-up|10|||
42226796|NCT03305081|76046398|FG001|Overall Study|Lost to Follow-up|15|||
41985474|NCT01313650|75792297|FG002|Overall Study|Withdrawal by Subject|15|||
41985475|NCT01313650|75792298|FG003|Overall Study|Withdrawal by Subject|15|||
41985476|NCT01313650|75792295|FG000|Overall Study|Protocol Violation|4|||
42226797|NCT03325673|76046416|FG000|Overall Study|Adverse Event|4|||
42226798|NCT03325673|76046417|FG001|Overall Study|Adverse Event|0|||
42226799|NCT03223909|76046426|FG000|Overall Study|Protocol Violation|48|||
42226800|NCT03223909|76046427|FG001|Overall Study|Protocol Violation|45|||
42226801|NCT03223909|76046428|FG002|Overall Study|Protocol Violation|16|||
41985477|NCT01313650|75792296|FG001|Overall Study|Protocol Violation|7|||
42226802|NCT03733925|76046436|FG000|Overall Study|Lost to Follow-up|1|||
41985478|NCT01313650|75792297|FG002|Overall Study|Protocol Violation|5|||
42226803|NCT03733925|76046436|FG000|Overall Study|Withdrawal by Subject|2|||
41985479|NCT01313650|75792298|FG003|Overall Study|Protocol Violation|6|||
42010514|NCT01014442|75817632|FG000|Overall Study|Protocol Violation|2|||
42226804|NCT03733925|76046436|FG000|Overall Study|Adverse Event|2|||
42226805|NCT03733925|76046436|FG000|Overall Study|Non-Compliance with Study Drug|1|||
42226806|NCT03649711|76046443|FG000|Overall Study|Adverse Event|0|||
42226807|NCT03649711|76046444|FG001|Overall Study|Adverse Event|1|||
42226808|NCT03649711|76046445|FG002|Overall Study|Adverse Event|0|||
42226809|NCT03649711|76046443|FG000|Overall Study|Kidney Transplant|1|||
42226810|NCT03649711|76046444|FG001|Overall Study|Kidney Transplant|0|||
42226811|NCT03649711|76046445|FG002|Overall Study|Kidney Transplant|0|||
42226812|NCT03303521|76046455|FG000|Overall Study|Withdrawal by Subject|2|||
42226813|NCT03303521|76046456|FG001|Overall Study|Withdrawal by Subject|0|||
42226814|NCT03303521|76046455|FG000|Overall Study|Death|1|||
42226815|NCT03303521|76046456|FG001|Overall Study|Death|0|||
42226816|NCT03303521|76046455|FG000|Overall Study|Kidney transplantation|0|||
42226817|NCT03303521|76046456|FG001|Overall Study|Kidney transplantation|1|||
42226818|NCT03303521|76046455|FG000|Overall Study|Investigational product discontinuation|0|||
42226819|NCT03303521|76046456|FG001|Overall Study|Investigational product discontinuation|1|||
42226820|NCT03303521|76046455|FG000|Overall Study|Transferred to non-study dialysis center|1|||
41985480|NCT01313650|75792295|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
41985481|NCT01313650|75792296|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
41985482|NCT01313650|75792297|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
41985483|NCT01313650|75792298|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
41985484|NCT01313299|75792311|FG000|Overall Study|Adverse Event|3|||
41985485|NCT01313299|75792312|FG001|Overall Study|Adverse Event|1|||
41985486|NCT01313299|75792313|FG002|Overall Study|Adverse Event|1|||
41985487|NCT01313299|75792311|FG000|Overall Study|Lost to Follow-up|1|||
41985488|NCT01313299|75792312|FG001|Overall Study|Lost to Follow-up|0|||
41985489|NCT01313299|75792313|FG002|Overall Study|Lost to Follow-up|0|||
42226821|NCT03303521|76046456|FG001|Overall Study|Transferred to non-study dialysis center|0|||
42226822|NCT03303521|76046455|FG000|Overall Study|Non-comliance to study protocol|0|||
42226823|NCT03303521|76046456|FG001|Overall Study|Non-comliance to study protocol|1|||
42226824|NCT03303521|76046455|FG000|Overall Study|Adverse Event|1|||
42226825|NCT03303521|76046456|FG001|Overall Study|Adverse Event|0|||
42226826|NCT03214081|76046462|FG000|Overall Study|Case Report Forms Uncollected|9|||
42226827|NCT03214081|76046462|FG000|Overall Study|Protocol Deviation|54|||
42226828|NCT02888171|76046468|FG000|Overall Study|Lost to Follow-up|2|||
42226829|NCT02888171|76046469|FG001|Overall Study|Lost to Follow-up|1|||
42226830|NCT02888171|76046468|FG000|Overall Study|Withdrawal by Subject|3|||
42226831|NCT02888171|76046469|FG001|Overall Study|Withdrawal by Subject|2|||
42226832|NCT02888171|76046468|FG000|Overall Study|Adverse Event|0|||
42226833|NCT02888171|76046469|FG001|Overall Study|Adverse Event|1|||
42226834|NCT02932891|76046475|FG000|Overall Study|Lost to Follow-up|2|||
42226835|NCT02932891|76046475|FG000|Overall Study|HPA Suppress|2|||
42226836|NCT03302975|76046479|FG000|Overall Study|Lost to Follow-up|4|||
42226837|NCT03212521|76046483|FG000|Overall Study|Adverse Event|1|||
41985490|NCT01313299|75792311|FG000|Overall Study|Protocol Violation|2|||
41985491|NCT01313299|75792312|FG001|Overall Study|Protocol Violation|0|||
41985492|NCT01313299|75792313|FG002|Overall Study|Protocol Violation|0|||
41985493|NCT01313299|75792311|FG000|Overall Study|Withdrawal by Subject|1|||
41985494|NCT01313299|75792312|FG001|Overall Study|Withdrawal by Subject|0|||
41985495|NCT01313299|75792313|FG002|Overall Study|Withdrawal by Subject|2|||
41985496|NCT01313299|75792311|FG000|Overall Study|Family reason and moved out of state|0|||
41985497|NCT01313299|75792312|FG001|Overall Study|Family reason and moved out of state|2|||
41985498|NCT01313299|75792313|FG002|Overall Study|Family reason and moved out of state|0|||
41985499|NCT01313299|75792311|FG000|Overall Study|Lack of subject compliance|0|||
41985500|NCT01313299|75792312|FG001|Overall Study|Lack of subject compliance|0|||
42032300|NCT01197794|75840559|FG001|Overall Study|Other|1|||
42131701|NCT00320710|75942614|FG000|Overall Study|Death|10|||
42226838|NCT03212521|76046483|FG000|Overall Study|Lost to Follow-up|4|||
42226839|NCT03212521|76046483|FG000|Overall Study|Withdrawal by Subject|1|||
42131702|NCT00320710|75942615|FG001|Overall Study|Death|7|||
42131703|NCT00320710|75942616|FG002|Overall Study|Death|1|||
42226840|NCT03212521|76046483|FG000|Overall Study|Other|1|||
42226841|NCT03212365|76046489|FG000|Overall Study|Discharged prior to Xa level|12|||
42226842|NCT03212365|76046490|FG001|Overall Study|Discharged prior to Xa level|8|||
42226843|NCT03212365|76046489|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
42226844|NCT03212365|76046490|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
41985501|NCT01313299|75792313|FG002|Overall Study|Lack of subject compliance|1|||
41985502|NCT01313221|75792324|FG000|Overall Study|Protocol Violation|0|||
41985503|NCT01313221|75792325|FG001|Overall Study|Protocol Violation|1|||
41985504|NCT01313221|75792326|FG002|Overall Study|Protocol Violation|1|||
41985505|NCT01313221|75792324|FG000|Overall Study|Non-compliance|3|||
41985506|NCT01313221|75792325|FG001|Overall Study|Non-compliance|0|||
41985507|NCT01313221|75792326|FG002|Overall Study|Non-compliance|2|||
41985508|NCT01313221|75792324|FG000|Overall Study|Withdrawal by Subject|2|||
41985509|NCT01313221|75792325|FG001|Overall Study|Withdrawal by Subject|3|||
41985510|NCT01313221|75792326|FG002|Overall Study|Withdrawal by Subject|5|||
42226845|NCT03212365|76046489|FG000|Overall Study|Refused study medication|3|||
42226846|NCT03212365|76046490|FG001|Overall Study|Refused study medication|0|||
42226847|NCT03212365|76046489|FG000|Overall Study|Initiated heparin infusion on floor|1|||
42226848|NCT03212365|76046490|FG001|Overall Study|Initiated heparin infusion on floor|1|||
42226849|NCT03212365|76046489|FG000|Overall Study|Unexpected return to OR|1|||
42226850|NCT03212365|76046490|FG001|Overall Study|Unexpected return to OR|1|||
41985511|NCT01313221|75792324|FG000|Overall Study|Requirement for alternative therapy|0|||
41985512|NCT01313221|75792325|FG001|Overall Study|Requirement for alternative therapy|1|||
41985513|NCT01313221|75792326|FG002|Overall Study|Requirement for alternative therapy|1|||
42032301|NCT01197794|75840560|FG002|Overall Study|Other|3|||
42032302|NCT01197794|75840561|FG003|Overall Study|Other|0|||
42032303|NCT01197794|75840562|FG004|Overall Study|Other|2|||
42226851|NCT03212365|76046489|FG000|Overall Study|Medication distribution error|1|||
42226852|NCT03212365|76046490|FG001|Overall Study|Medication distribution error|0|||
42226853|NCT03212365|76046489|FG000|Overall Study|Required epidural placement|1|||
42226854|NCT03212365|76046490|FG001|Overall Study|Required epidural placement|0|||
42226855|NCT03212365|76046489|FG000|Overall Study|Withdrawal by Subject|0|||
42226856|NCT03212365|76046490|FG001|Overall Study|Withdrawal by Subject|1|||
42226857|NCT03212365|76046489|FG000|Overall Study|developed acute renal failure|0|||
42032304|NCT01197794|75840563|FG005|Overall Study|Other|2|||
42032305|NCT01197794|75840564|FG006|Overall Study|Other|4|||
42032306|NCT01078662|75840586|FG000|Overall Study|Death|41|||
42032307|NCT01078662|75840587|FG001|Overall Study|Death|103|||
42032308|NCT01078662|75840588|FG002|Overall Study|Death|18|||
42032309|NCT01078662|75840589|FG003|Overall Study|Death|5|||
42032310|NCT01078662|75840590|FG004|Overall Study|Death|8|||
42032311|NCT01078662|75840586|FG000|Overall Study|Patients reached data cut-off|12|||
42032312|NCT01078662|75840587|FG001|Overall Study|Patients reached data cut-off|53|||
42032313|NCT01078662|75840588|FG002|Overall Study|Patients reached data cut-off|2|||
42032314|NCT01078662|75840589|FG003|Overall Study|Patients reached data cut-off|2|||
42032315|NCT01078662|75840590|FG004|Overall Study|Patients reached data cut-off|3|||
42032316|NCT01078662|75840586|FG000|Overall Study|Withdrawal by Subject|4|||
42032317|NCT01078662|75840587|FG001|Overall Study|Withdrawal by Subject|11|||
42032318|NCT01078662|75840588|FG002|Overall Study|Withdrawal by Subject|1|||
42032319|NCT01078662|75840589|FG003|Overall Study|Withdrawal by Subject|0|||
42032320|NCT01078662|75840590|FG004|Overall Study|Withdrawal by Subject|0|||
42032321|NCT01078662|75840586|FG000|Overall Study|Protocol Violation|0|||
42032322|NCT01078662|75840587|FG001|Overall Study|Protocol Violation|1|||
42032323|NCT01078662|75840588|FG002|Overall Study|Protocol Violation|0|||
42032324|NCT01078662|75840589|FG003|Overall Study|Protocol Violation|0|||
42032325|NCT01078662|75840590|FG004|Overall Study|Protocol Violation|0|||
42032326|NCT01078662|75840586|FG000|Overall Study|Lost to Follow-up|1|||
42032327|NCT01078662|75840587|FG001|Overall Study|Lost to Follow-up|0|||
42032328|NCT01078662|75840588|FG002|Overall Study|Lost to Follow-up|0|||
42032329|NCT01078662|75840589|FG003|Overall Study|Lost to Follow-up|0|||
42032330|NCT01078662|75840590|FG004|Overall Study|Lost to Follow-up|0|||
42032331|NCT01091454|75840599|FG000|Overall Study|Ineligible|1|||
42032332|NCT01140347|75840605|FG000|Overall Study|Lost to Follow-up|5|||
42032333|NCT01140347|75840606|FG001|Overall Study|Lost to Follow-up|6|||
42226858|NCT03212365|76046490|FG001|Overall Study|developed acute renal failure|1|||
41985514|NCT01313221|75792324|FG000|Overall Study|Lost to Follow-up|6|||
41985515|NCT01313221|75792325|FG001|Overall Study|Lost to Follow-up|3|||
41985516|NCT01313221|75792326|FG002|Overall Study|Lost to Follow-up|1|||
41985517|NCT01313221|75792324|FG000|Overall Study|Other|1|||
42032334|NCT01140347|75840605|FG000|Overall Study|Withdrawal by Subject|13|||
42032335|NCT01140347|75840606|FG001|Overall Study|Withdrawal by Subject|8|||
42032336|NCT01197560|75840614|FG000|Overall Study|Adverse Event|6|||
42032337|NCT01197560|75840615|FG001|Overall Study|Adverse Event|8|||
42032338|NCT01197560|75840614|FG000|Overall Study|Death|3|||
42032339|NCT01197560|75840615|FG001|Overall Study|Death|5|||
42032340|NCT01197560|75840614|FG000|Overall Study|Withdrawal by Subject|1|||
42032341|NCT01197560|75840615|FG001|Overall Study|Withdrawal by Subject|1|||
42032342|NCT01197560|75840614|FG000|Overall Study|Disease progression|40|||
42226859|NCT03273257|76046498|FG000|Overall Study|Death|0|||
42226860|NCT03273257|76046499|FG001|Overall Study|Death|1|||
42226861|NCT03273257|76046498|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
41985518|NCT01313221|75792325|FG001|Overall Study|Other|0|||
41985519|NCT01313221|75792326|FG002|Overall Study|Other|0|||
42032343|NCT01197560|75840615|FG001|Overall Study|Disease progression|35|||
41985520|NCT01313221|75792324|FG000|Overall Study|Adverse Event|0|||
41985521|NCT01313221|75792325|FG001|Overall Study|Adverse Event|0|||
41985522|NCT01313221|75792326|FG002|Overall Study|Adverse Event|7|||
41985523|NCT01313221|75792324|FG000|Overall Study|Disease progression|0|||
41985524|NCT01313221|75792325|FG001|Overall Study|Disease progression|0|||
41985525|NCT01313221|75792326|FG002|Overall Study|Disease progression|2|||
41985526|NCT01313221|75792324|FG000|Overall Study|Physician Decision|0|||
41985527|NCT01313221|75792325|FG001|Overall Study|Physician Decision|0|||
41985528|NCT01313221|75792326|FG002|Overall Study|Physician Decision|2|||
41985529|NCT01313221|75792324|FG000|Overall Study|Pregnancy|0|||
41985530|NCT01313221|75792325|FG001|Overall Study|Pregnancy|0|||
41985531|NCT01313221|75792326|FG002|Overall Study|Pregnancy|2|||
41985532|NCT01313182|75792336|FG000|Overall Study|Protocol Violation|66|||
41985533|NCT01313182|75792337|FG001|Overall Study|Protocol Violation|92|||
41985534|NCT01312909|75792346|FG000|Overall Study|Randomized but not treated|1|||
41985535|NCT01312909|75792347|FG001|Overall Study|Randomized but not treated|3|||
41985536|NCT01312909|75792348|FG002|Overall Study|Randomized but not treated|1|||
41985537|NCT01312909|75792346|FG000|Overall Study|Adverse Event|1|||
41985538|NCT01312909|75792347|FG001|Overall Study|Adverse Event|0|||
41985539|NCT01312909|75792348|FG002|Overall Study|Adverse Event|3|||
41985540|NCT01312909|75792346|FG000|Overall Study|Protocol Violation|2|||
41985541|NCT01312909|75792347|FG001|Overall Study|Protocol Violation|0|||
41985542|NCT01312909|75792348|FG002|Overall Study|Protocol Violation|2|||
41985543|NCT01312909|75792346|FG000|Overall Study|Other|9|||
41985544|NCT01312909|75792347|FG001|Overall Study|Other|6|||
41985545|NCT01312909|75792348|FG002|Overall Study|Other|11|||
41985546|NCT01312909|75792346|FG000|Overall Study|Withdrawal by Subject|8|||
41985547|NCT01312909|75792347|FG001|Overall Study|Withdrawal by Subject|10|||
41985548|NCT01312909|75792348|FG002|Overall Study|Withdrawal by Subject|7|||
41985549|NCT01312909|75792346|FG000|Overall Study|Lost to Follow-up|21|||
41985550|NCT01312909|75792347|FG001|Overall Study|Lost to Follow-up|17|||
41985551|NCT01312909|75792348|FG002|Overall Study|Lost to Follow-up|20|||
41985552|NCT01312909|75792346|FG000|Overall Study|Insufficient clinical response|0|||
41985553|NCT01312909|75792347|FG001|Overall Study|Insufficient clinical response|0|||
41985554|NCT01312909|75792348|FG002|Overall Study|Insufficient clinical response|1|||
41985555|NCT01312909|75792346|FG000|Overall Study|Entrance criteria not met|0|||
41985556|NCT01312909|75792347|FG001|Overall Study|Entrance criteria not met|0|||
41985557|NCT01312909|75792348|FG002|Overall Study|Entrance criteria not met|2|||
41985558|NCT01312129|75792358|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
41985559|NCT01312129|75792359|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
41985560|NCT01311661|75792365|FG000|Overall Study|Adverse Event|2|||
41985561|NCT01311661|75792365|FG000|Overall Study|Protocol Violation|3|||
41985562|NCT01311661|75792365|FG000|Overall Study|Withdrawal by Subject|2|||
41985563|NCT01311505|75792377|FG000|First Intervention Period|Protocol Violation|0|||
41985564|NCT01311505|75792378|FG001|First Intervention Period|Protocol Violation|1|||
41985565|NCT01310803|75792389|FG000|Overall Study|Subject terminated by Sponsor|1|||
41985566|NCT01310803|75792390|FG001|Overall Study|Subject terminated by Sponsor|0|||
41985567|NCT01310413|75792402|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
41985568|NCT01310413|75792403|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
41985569|NCT01310413|75792404|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
41985570|NCT01310413|75792405|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
41985571|NCT01310413|75792406|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
41985572|NCT01310413|75792407|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
41985573|NCT01310413|75792408|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
41985574|NCT01310413|75792402|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
41985575|NCT01310413|75792403|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
41985576|NCT01310413|75792404|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
41985577|NCT01310413|75792405|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
41985578|NCT01310413|75792406|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
41985579|NCT01310413|75792407|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
41985580|NCT01310413|75792408|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
41985581|NCT01310413|75792402|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
41985582|NCT01310413|75792403|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
41985583|NCT01310413|75792404|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
41985584|NCT01310413|75792405|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
41985585|NCT01310413|75792406|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
41985586|NCT01310413|75792407|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
41985587|NCT01310413|75792408|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
41985588|NCT01310413|75792402|FG000|Day 0 to Day 385|Other|1|||
41985589|NCT01310413|75792403|FG001|Day 0 to Day 385|Other|0|||
41985590|NCT01310413|75792404|FG002|Day 0 to Day 385|Other|3|||
41985591|NCT01310413|75792405|FG003|Day 0 to Day 385|Other|0|||
41985592|NCT01310413|75792406|FG004|Day 0 to Day 385|Other|0|||
41985593|NCT01310413|75792407|FG005|Day 0 to Day 385|Other|0|||
41985594|NCT01310413|75792408|FG006|Day 0 to Day 385|Other|0|||
41985595|NCT01310413|75792402|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
41985596|NCT01310413|75792403|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
42032344|NCT01197560|75840614|FG000|Overall Study|Miscellaneous|4|||
42032345|NCT01197560|75840615|FG001|Overall Study|Miscellaneous|3|||
42032346|NCT01197560|75840614|FG000|Overall Study|Missing|0|||
42032347|NCT01197560|75840615|FG001|Overall Study|Missing|1|||
42032348|NCT01133405|75840632|FG000|Period 1|Withdrawal by Subject|0|||
42032349|NCT01133405|75840633|FG001|Period 1|Withdrawal by Subject|1|||
42032350|NCT01133405|75840634|FG002|Period 1|Withdrawal by Subject|0|||
42032351|NCT01133405|75840635|FG003|Period 1|Withdrawal by Subject|1|||
42032352|NCT01133405|75840636|FG004|Period 1|Withdrawal by Subject|0|||
42032353|NCT01133405|75840637|FG005|Period 1|Withdrawal by Subject|1|||
42032354|NCT01133405|75840638|FG006|Period 1|Withdrawal by Subject|0|||
42032355|NCT01133405|75840639|FG007|Period 1|Withdrawal by Subject|0|||
42032356|NCT01133405|75840640|FG008|Period 1|Withdrawal by Subject|0|||
42032357|NCT01133405|75840641|FG009|Period 1|Withdrawal by Subject|0|||
42032358|NCT01133405|75840632|FG000|Period 1|Physician Decision|0|||
42032359|NCT01133405|75840633|FG001|Period 1|Physician Decision|0|||
41985597|NCT01310413|75792404|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
41985598|NCT01310413|75792405|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
41985599|NCT01310413|75792406|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
41985600|NCT01310413|75792407|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
41985601|NCT01310413|75792408|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
41985602|NCT01310413|75792402|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
41985603|NCT01310413|75792403|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
41985604|NCT01310413|75792404|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
41985605|NCT01310413|75792405|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
41985606|NCT01310413|75792406|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
41985607|NCT01310413|75792407|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
41985608|NCT01310413|75792408|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
41985609|NCT01309828|75792439|FG000|Overall Study|Adverse Event|10|||
41985610|NCT01309828|75792440|FG001|Overall Study|Adverse Event|11|||
41985611|NCT01309828|75792439|FG000|Overall Study|Voluntary Withdrawal|5|||
41985612|NCT01309828|75792440|FG001|Overall Study|Voluntary Withdrawal|4|||
41985613|NCT01309828|75792439|FG000|Overall Study|Major Protocol Deviation|0|||
41985614|NCT01309828|75792440|FG001|Overall Study|Major Protocol Deviation|1|||
41985615|NCT01309828|75792439|FG000|Overall Study|Other|1|||
41985616|NCT01309828|75792440|FG001|Overall Study|Other|0|||
41985617|NCT01309282|75792446|FG000|Overall Study|Lost to Follow-up|1|||
41985618|NCT01309243|75792452|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
42032360|NCT01133405|75840634|FG002|Period 1|Physician Decision|0|||
42032361|NCT01133405|75840635|FG003|Period 1|Physician Decision|1|||
42032362|NCT01133405|75840636|FG004|Period 1|Physician Decision|0|||
42032363|NCT01133405|75840637|FG005|Period 1|Physician Decision|0|||
42032364|NCT01133405|75840638|FG006|Period 1|Physician Decision|0|||
42032365|NCT01133405|75840639|FG007|Period 1|Physician Decision|0|||
42032366|NCT01133405|75840640|FG008|Period 1|Physician Decision|0|||
42032367|NCT01133405|75840641|FG009|Period 1|Physician Decision|0|||
42032368|NCT01133405|75840632|FG000|Period 1|Discontinued after randomization|1|||
42032369|NCT01133405|75840633|FG001|Period 1|Discontinued after randomization|0|||
42032370|NCT01133405|75840634|FG002|Period 1|Discontinued after randomization|0|||
42032371|NCT01133405|75840635|FG003|Period 1|Discontinued after randomization|0|||
42032372|NCT01133405|75840636|FG004|Period 1|Discontinued after randomization|0|||
42032373|NCT01133405|75840637|FG005|Period 1|Discontinued after randomization|0|||
42032374|NCT01133405|75840638|FG006|Period 1|Discontinued after randomization|1|||
42032375|NCT01133405|75840639|FG007|Period 1|Discontinued after randomization|0|||
42032376|NCT01133405|75840640|FG008|Period 1|Discontinued after randomization|0|||
42032377|NCT01133405|75840641|FG009|Period 1|Discontinued after randomization|0|||
42032378|NCT01133405|75840632|FG000|Period 1|Received drug only in period 2|0|||
42032379|NCT01133405|75840633|FG001|Period 1|Received drug only in period 2|1|||
42032380|NCT01133405|75840634|FG002|Period 1|Received drug only in period 2|0|||
42032381|NCT01133405|75840635|FG003|Period 1|Received drug only in period 2|2|||
42032382|NCT01133405|75840636|FG004|Period 1|Received drug only in period 2|0|||
42032383|NCT01133405|75840637|FG005|Period 1|Received drug only in period 2|1|||
42032384|NCT01133405|75840638|FG006|Period 1|Received drug only in period 2|0|||
42032385|NCT01133405|75840639|FG007|Period 1|Received drug only in period 2|0|||
42032386|NCT01133405|75840640|FG008|Period 1|Received drug only in period 2|0|||
42032387|NCT01133405|75840641|FG009|Period 1|Received drug only in period 2|0|||
42032388|NCT01133405|75840632|FG000|Period 1|Received drug only in period 3|0|||
42032389|NCT01133405|75840633|FG001|Period 1|Received drug only in period 3|1|||
42032390|NCT01133405|75840634|FG002|Period 1|Received drug only in period 3|1|||
42032391|NCT01133405|75840635|FG003|Period 1|Received drug only in period 3|0|||
42032392|NCT01133405|75840636|FG004|Period 1|Received drug only in period 3|0|||
42032393|NCT01133405|75840637|FG005|Period 1|Received drug only in period 3|0|||
42032394|NCT01133405|75840638|FG006|Period 1|Received drug only in period 3|0|||
42032395|NCT01133405|75840639|FG007|Period 1|Received drug only in period 3|0|||
42032396|NCT01133405|75840640|FG008|Period 1|Received drug only in period 3|0|||
42032397|NCT01133405|75840641|FG009|Period 1|Received drug only in period 3|0|||
42032398|NCT01133405|75840632|FG000|Period 2|Adverse Event|0|||
42032399|NCT01133405|75840633|FG001|Period 2|Adverse Event|0|||
42032400|NCT01133405|75840634|FG002|Period 2|Adverse Event|1|||
42032401|NCT01133405|75840635|FG003|Period 2|Adverse Event|0|||
42032402|NCT01133405|75840636|FG004|Period 2|Adverse Event|0|||
42032403|NCT01133405|75840637|FG005|Period 2|Adverse Event|0|||
42032404|NCT01133405|75840638|FG006|Period 2|Adverse Event|0|||
42032405|NCT01133405|75840639|FG007|Period 2|Adverse Event|0|||
42032406|NCT01133405|75840640|FG008|Period 2|Adverse Event|0|||
42032407|NCT01133405|75840641|FG009|Period 2|Adverse Event|0|||
42032408|NCT01133405|75840632|FG000|Period 2|Withdrawal by Subject|0|||
42032409|NCT01133405|75840633|FG001|Period 2|Withdrawal by Subject|0|||
42032410|NCT01133405|75840634|FG002|Period 2|Withdrawal by Subject|0|||
42032411|NCT01133405|75840635|FG003|Period 2|Withdrawal by Subject|1|||
42032412|NCT01133405|75840636|FG004|Period 2|Withdrawal by Subject|0|||
42032413|NCT01133405|75840637|FG005|Period 2|Withdrawal by Subject|1|||
42032414|NCT01133405|75840638|FG006|Period 2|Withdrawal by Subject|0|||
42032415|NCT01133405|75840639|FG007|Period 2|Withdrawal by Subject|0|||
42032416|NCT01133405|75840640|FG008|Period 2|Withdrawal by Subject|0|||
42032417|NCT01133405|75840641|FG009|Period 2|Withdrawal by Subject|0|||
42032418|NCT01133405|75840632|FG000|Period 2|Entry Criteria Not Met|0|||
42032419|NCT01133405|75840633|FG001|Period 2|Entry Criteria Not Met|1|||
42226862|NCT03273257|76046499|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
42226863|NCT03273257|76046498|FG000|Overall Study|Study terminated|3|||
42226864|NCT03273257|76046499|FG001|Overall Study|Study terminated|2|||
42226865|NCT04316741|76046507|FG000|Baseline Enrollment|Lost to Follow-up|1|||
42226866|NCT04316741|76046508|FG001|Baseline Enrollment|Lost to Follow-up|1|||
42226867|NCT04316741|76046507|FG000|Immediate Post-Test|Lost to Follow-up|5|||
42226868|NCT04316741|76046508|FG001|Immediate Post-Test|Lost to Follow-up|1|||
41985619|NCT01309243|75792453|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
41985620|NCT01309243|75792452|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
41985621|NCT01309243|75792453|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
41985622|NCT01309243|75792452|FG000|Randomized Phase Through Week 96|Death|0|||
41985623|NCT01309243|75792453|FG001|Randomized Phase Through Week 96|Death|1|||
41985624|NCT01309243|75792452|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
41985625|NCT01309243|75792453|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
41985626|NCT01309243|75792452|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
41985627|NCT01309243|75792453|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
41985628|NCT01309243|75792452|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
41985629|NCT01309243|75792453|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
41985630|NCT01309243|75792452|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
41985631|NCT01309243|75792453|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
41985632|NCT01309243|75792452|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
41985633|NCT01309243|75792453|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
41985634|NCT01309243|75792452|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
41985635|NCT01309243|75792453|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
41985636|NCT01309243|75792452|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
41985637|NCT01309243|75792453|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
41985638|NCT01309243|75792452|FG000|Extension Phase|Lost to Follow-up|6|||
41985639|NCT01309243|75792453|FG001|Extension Phase|Lost to Follow-up|0|||
41985640|NCT01309204|75792461|FG000|Overall Study|Adverse Event|48|||
41985641|NCT01309204|75792462|FG001|Overall Study|Adverse Event|58|||
41985642|NCT01309204|75792461|FG000|Overall Study|Lost to Follow-up|2|||
41985643|NCT01309204|75792462|FG001|Overall Study|Lost to Follow-up|2|||
41985644|NCT01309204|75792461|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
41985645|NCT01309204|75792462|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
41985646|NCT01309204|75792461|FG000|Overall Study|Inadequate control of IOP|4|||
41985647|NCT01309204|75792462|FG001|Overall Study|Inadequate control of IOP|4|||
41985648|NCT01309204|75792461|FG000|Overall Study|Other|4|||
41985649|NCT01309204|75792462|FG001|Overall Study|Other|1|||
41985650|NCT01309165|75792470|FG000|Overall Study|Lost to Follow-up|4|||
41985651|NCT01309165|75792471|FG001|Overall Study|Lost to Follow-up|3|||
42032420|NCT01133405|75840634|FG002|Period 2|Entry Criteria Not Met|0|||
42032421|NCT01133405|75840635|FG003|Period 2|Entry Criteria Not Met|0|||
41985652|NCT01309165|75792470|FG000|Overall Study|Return to work|1|||
41985653|NCT01309165|75792471|FG001|Overall Study|Return to work|2|||
41985654|NCT01309165|75792470|FG000|Overall Study|Left country|0|||
41985655|NCT01309165|75792471|FG001|Overall Study|Left country|1|||
41985656|NCT01309165|75792470|FG000|Overall Study|No transportation|0|||
42032422|NCT01133405|75840636|FG004|Period 2|Entry Criteria Not Met|0|||
42032423|NCT01133405|75840637|FG005|Period 2|Entry Criteria Not Met|0|||
42032424|NCT01133405|75840638|FG006|Period 2|Entry Criteria Not Met|0|||
42032425|NCT01133405|75840639|FG007|Period 2|Entry Criteria Not Met|0|||
42032426|NCT01133405|75840640|FG008|Period 2|Entry Criteria Not Met|0|||
42032427|NCT01133405|75840641|FG009|Period 2|Entry Criteria Not Met|0|||
42032428|NCT01133405|75840632|FG000|Period 2|Physician Decision|0|||
42226869|NCT04316741|76046507|FG000|1-month Post-test|Lost to Follow-up|7|||
42226870|NCT04316741|76046508|FG001|1-month Post-test|Lost to Follow-up|2|||
42226871|NCT04316741|76046507|FG000|3-month Follow-up|Lost to Follow-up|10|||
42226872|NCT04316741|76046508|FG001|3-month Follow-up|Lost to Follow-up|2|||
42226873|NCT03271307|76046518|FG000|Overall Study|Lost to Follow-up|0|||
42226874|NCT03271307|76046519|FG001|Overall Study|Lost to Follow-up|0|||
42226875|NCT03271307|76046520|FG002|Overall Study|Lost to Follow-up|0|||
42226876|NCT03271307|76046521|FG003|Overall Study|Lost to Follow-up|28|||
42226877|NCT03271307|76046522|FG004|Overall Study|Lost to Follow-up|91|||
42226878|NCT03271151|76046539|FG000|Overall Study|Lost to Follow-up|1|||
42226879|NCT03271151|76046540|FG001|Overall Study|Lost to Follow-up|3|||
42226880|NCT03271151|76046539|FG000|Overall Study|Withdrawal by Subject|1|||
42226881|NCT03271151|76046540|FG001|Overall Study|Withdrawal by Subject|0|||
42226882|NCT03245723|76046548|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
42226883|NCT03245723|76046549|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
42226884|NCT03245723|76046548|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
42226885|NCT03245723|76046549|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
42226886|NCT03245723|76046548|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
42226887|NCT03245723|76046549|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
42226888|NCT03245723|76046548|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
42226889|NCT03245723|76046549|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
42226890|NCT03301649|76046558|FG000|Overall Study|Need alternate therapy due to live lice|17|||
42226891|NCT03301649|76046559|FG001|Overall Study|Need alternate therapy due to live lice|25|||
42226892|NCT03301649|76046560|FG002|Overall Study|Need alternate therapy due to live lice|81|||
42226893|NCT03301649|76046558|FG000|Overall Study|Lost to Follow-up|11|||
42226894|NCT03301649|76046559|FG001|Overall Study|Lost to Follow-up|11|||
42226895|NCT03301649|76046560|FG002|Overall Study|Lost to Follow-up|3|||
42226896|NCT03301649|76046558|FG000|Overall Study|Protocol Violation|0|||
42226897|NCT03301649|76046559|FG001|Overall Study|Protocol Violation|1|||
42226898|NCT03301649|76046560|FG002|Overall Study|Protocol Violation|1|||
42226899|NCT03301649|76046558|FG000|Overall Study|Withdrawal by Subject|10|||
42226900|NCT03301649|76046559|FG001|Overall Study|Withdrawal by Subject|4|||
42226901|NCT03301649|76046560|FG002|Overall Study|Withdrawal by Subject|0|||
42226902|NCT03301649|76046558|FG000|Overall Study|Other than specified|5|||
42226903|NCT03301649|76046559|FG001|Overall Study|Other than specified|3|||
42226904|NCT03301649|76046560|FG002|Overall Study|Other than specified|0|||
42226905|NCT03222973|76046570|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
42226906|NCT03222973|76046571|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
42226907|NCT03222973|76046572|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
42226908|NCT03222973|76046573|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
42226909|NCT03222973|76046570|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
42226910|NCT03222973|76046571|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
42226911|NCT03222973|76046572|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
42226912|NCT03222973|76046573|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
42226913|NCT03222973|76046570|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
42226914|NCT03222973|76046571|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
42226915|NCT03222973|76046572|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
42226916|NCT03222973|76046573|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
42226917|NCT03222973|76046570|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
42226918|NCT03222973|76046571|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
42226919|NCT03222973|76046572|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
42226920|NCT03222973|76046573|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
42226921|NCT03222973|76046570|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
42226922|NCT03222973|76046571|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
42226923|NCT03222973|76046572|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
42226924|NCT03222973|76046573|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
42032429|NCT01133405|75840633|FG001|Period 2|Physician Decision|0|||
42032430|NCT01133405|75840634|FG002|Period 2|Physician Decision|0|||
42032431|NCT01133405|75840635|FG003|Period 2|Physician Decision|0|||
42032432|NCT01133405|75840636|FG004|Period 2|Physician Decision|0|||
42032433|NCT01133405|75840637|FG005|Period 2|Physician Decision|1|||
42226925|NCT03222973|76046570|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
42226926|NCT03222973|76046571|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
42226927|NCT03222973|76046572|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
42226928|NCT03222973|76046573|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
42226929|NCT03222973|76046570|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
42226930|NCT03222973|76046571|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
42226931|NCT03222973|76046572|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
42226932|NCT03222973|76046573|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
42226933|NCT03222973|76046570|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
42226934|NCT03222973|76046571|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
42226935|NCT03222973|76046572|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
42032434|NCT01133405|75840638|FG006|Period 2|Physician Decision|0|||
42226936|NCT03222973|76046573|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
42226937|NCT03222973|76046570|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
42226938|NCT03222973|76046571|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
42226939|NCT03222973|76046572|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
42226940|NCT03222973|76046573|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
42226941|NCT03222973|76046570|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
42226942|NCT03222973|76046571|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
42226943|NCT03222973|76046572|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
42226944|NCT03222973|76046573|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
42226945|NCT03222973|76046570|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
42226946|NCT03222973|76046571|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
42226947|NCT03222973|76046572|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
42226948|NCT03222973|76046573|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
42226949|NCT03222973|76046570|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
42226950|NCT03222973|76046571|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
42226951|NCT03222973|76046572|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
42226952|NCT03222973|76046573|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
42226953|NCT01144416|76046585|FG000|Intervention Period|Adverse Event|5|||
42226954|NCT01144416|76046586|FG001|Intervention Period|Adverse Event|6|||
42226955|NCT01144416|76046585|FG000|Intervention Period|Insufficient ovarian response|11|||
42226956|NCT01144416|76046586|FG001|Intervention Period|Insufficient ovarian response|17|||
42226957|NCT01144416|76046585|FG000|Intervention Period|Risk of OHSS|0|||
42226958|NCT01144416|76046586|FG001|Intervention Period|Risk of OHSS|1|||
42226959|NCT01144416|76046585|FG000|Intervention Period|Too high ovarian response|4|||
42226960|NCT01144416|76046586|FG001|Intervention Period|Too high ovarian response|2|||
42226961|NCT01144416|76046585|FG000|Intervention Period|No/too few/bad oocytes|7|||
42226962|NCT01144416|76046586|FG001|Intervention Period|No/too few/bad oocytes|5|||
42226963|NCT01144416|76046585|FG000|Intervention Period|No or abnormal fertilization|25|||
42226964|NCT01144416|76046586|FG001|Intervention Period|No or abnormal fertilization|10|||
42226965|NCT01144416|76046585|FG000|Intervention Period|No/too few/bad quality embryos|3|||
42226966|NCT01144416|76046586|FG001|Intervention Period|No/too few/bad quality embryos|3|||
42226967|NCT01144416|76046585|FG000|Intervention Period|Other|7|||
42226968|NCT01144416|76046586|FG001|Intervention Period|Other|5|||
42226969|NCT00335777|76046596|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
42226970|NCT00335777|76046596|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
42226971|NCT00335777|76046596|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
42226972|NCT00335777|76046596|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
42226973|NCT00335777|76046596|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
42226974|NCT01140048|76046601|FG000|Overall Study|Physician Decision|1|||
42226975|NCT01140048|76046601|FG000|Overall Study|Withdrawal by Subject|13|||
42226976|NCT01140048|76046601|FG000|Overall Study|Lost to Follow-up|31|||
42226977|NCT00972738|76046612|FG000|Overall Study|Adverse Event|7|||
42226978|NCT00972738|76046613|FG001|Overall Study|Adverse Event|1|||
42226979|NCT00972738|76046614|FG002|Overall Study|Adverse Event|8|||
42226980|NCT00972738|76046612|FG000|Overall Study|Protocol Violation|2|||
42226981|NCT00972738|76046613|FG001|Overall Study|Protocol Violation|1|||
42226982|NCT00972738|76046614|FG002|Overall Study|Protocol Violation|3|||
42226983|NCT00972738|76046612|FG000|Overall Study|Lost to Follow-up|1|||
42226984|NCT00972738|76046613|FG001|Overall Study|Lost to Follow-up|0|||
42226985|NCT00972738|76046614|FG002|Overall Study|Lost to Follow-up|1|||
42226986|NCT00972738|76046612|FG000|Overall Study|Lack of Efficacy|5|||
42226987|NCT00972738|76046613|FG001|Overall Study|Lack of Efficacy|1|||
42226988|NCT00972738|76046614|FG002|Overall Study|Lack of Efficacy|11|||
42226989|NCT00972738|76046612|FG000|Overall Study|Withdrawal by Subject|5|||
42226990|NCT00972738|76046613|FG001|Overall Study|Withdrawal by Subject|1|||
42226991|NCT00972738|76046614|FG002|Overall Study|Withdrawal by Subject|4|||
42226992|NCT00972738|76046612|FG000|Overall Study|Moved|0|||
42226993|NCT00972738|76046613|FG001|Overall Study|Moved|0|||
42226994|NCT00972738|76046614|FG002|Overall Study|Moved|1|||
42226995|NCT00972738|76046612|FG000|Overall Study|Other|1|||
42226996|NCT00972738|76046613|FG001|Overall Study|Other|2|||
42226997|NCT00972738|76046614|FG002|Overall Study|Other|1|||
42226998|NCT03243305|76046622|FG000|Overall Study|Lost to Follow-up|250|||
42226999|NCT03243305|76046622|FG000|Overall Study|Withdrawal by Subject|170|||
42227000|NCT03243305|76046622|FG000|Overall Study|Pregnancy|104|||
42227001|NCT03243305|76046622|FG000|Overall Study|Non-Compliance with Study Drug|38|||
42227002|NCT03243305|76046622|FG000|Overall Study|Adverse Event|23|||
42227003|NCT03243305|76046622|FG000|Overall Study|No sexually active|26|||
42227004|NCT03243305|76046622|FG000|Overall Study|Physician Decision|22|||
42227005|NCT03243305|76046622|FG000|Overall Study|Protocol Violation|22|||
42227006|NCT03243305|76046622|FG000|Overall Study|Study method no longer primary method|12|||
42227007|NCT03243305|76046622|FG000|Overall Study|Study Terminated by Sponsor|1|||
42227008|NCT03243305|76046622|FG000|Overall Study|Early terminations|267|||
42227009|NCT03222583|76046628|FG000|Overall Study|Withdrawal by Subject|3|||
42227010|NCT03222583|76046629|FG001|Overall Study|Withdrawal by Subject|3|||
42227011|NCT03222583|76046628|FG000|Overall Study|Lost to Follow-up|1|||
42227012|NCT03222583|76046629|FG001|Overall Study|Lost to Follow-up|0|||
42227013|NCT03222583|76046628|FG000|Overall Study|Other|1|||
42227014|NCT03222583|76046629|FG001|Overall Study|Other|3|||
42227015|NCT03295721|76046638|FG000|Overall Study|Adverse Event|1|||
42227016|NCT03295721|76046639|FG001|Overall Study|Adverse Event|0|||
42227017|NCT03295721|76046640|FG002|Overall Study|Adverse Event|0|||
42227018|NCT03295721|76046638|FG000|Overall Study|Lost to Follow-up|1|||
42227019|NCT03295721|76046639|FG001|Overall Study|Lost to Follow-up|1|||
42227020|NCT03295721|76046640|FG002|Overall Study|Lost to Follow-up|1|||
42227021|NCT03295721|76046638|FG000|Overall Study|Withdrawal by Subject|1|||
42227022|NCT03295721|76046639|FG001|Overall Study|Withdrawal by Subject|0|||
42227023|NCT03295721|76046640|FG002|Overall Study|Withdrawal by Subject|1|||
42227024|NCT03295721|76046638|FG000|Overall Study|Death|0|||
42227025|NCT03295721|76046639|FG001|Overall Study|Death|0|||
42227026|NCT03295721|76046640|FG002|Overall Study|Death|1|||
42227027|NCT00803790|76046651|FG000|Period 1|Adverse Event|0|||
42227028|NCT00803790|76046652|FG001|Period 1|Adverse Event|1|||
42227029|NCT00803790|76046653|FG002|Period 1|Adverse Event|0|||
42227030|NCT00803790|76046654|FG003|Period 1|Adverse Event|0|||
42227031|NCT00803790|76046651|FG000|Period 1|Lost to Follow-up|1|||
42227032|NCT00803790|76046652|FG001|Period 1|Lost to Follow-up|2|||
42227033|NCT00803790|76046653|FG002|Period 1|Lost to Follow-up|0|||
42227034|NCT00803790|76046654|FG003|Period 1|Lost to Follow-up|0|||
42227035|NCT00803790|76046651|FG000|Period 1|Withdrawal by Subject|8|||
42227036|NCT00803790|76046652|FG001|Period 1|Withdrawal by Subject|6|||
42227037|NCT00803790|76046653|FG002|Period 1|Withdrawal by Subject|0|||
42227038|NCT00803790|76046654|FG003|Period 1|Withdrawal by Subject|0|||
42227039|NCT00803790|76046651|FG000|Period 1|positive drug screen or personal reasons|0|||
42227040|NCT00803790|76046652|FG001|Period 1|positive drug screen or personal reasons|3|||
42227041|NCT00803790|76046653|FG002|Period 1|positive drug screen or personal reasons|0|||
42227042|NCT00803790|76046654|FG003|Period 1|positive drug screen or personal reasons|4|||
42227043|NCT00803790|76046651|FG000|Period 1|Protocol Violation|0|||
42227044|NCT00803790|76046652|FG001|Period 1|Protocol Violation|0|||
42227045|NCT00803790|76046653|FG002|Period 1|Protocol Violation|1|||
41985657|NCT01309165|75792471|FG001|Overall Study|No transportation|1|||
41985658|NCT01309165|75792470|FG000|Overall Study|Admitted to hospital for second stroke|1|||
41985659|NCT01309165|75792471|FG001|Overall Study|Admitted to hospital for second stroke|0|||
41985660|NCT01308853|75792478|FG000|Overall Study|Adverse Event|1|||
41985661|NCT01308853|75792478|FG000|Overall Study|Lost to Follow-up|2|||
42227046|NCT00803790|76046654|FG003|Period 1|Protocol Violation|0|||
42227047|NCT00803790|76046651|FG000|Period 2|Adverse Event|0|||
42227048|NCT00803790|76046652|FG001|Period 2|Adverse Event|0|||
42227049|NCT00803790|76046653|FG002|Period 2|Adverse Event|1|||
42227050|NCT00803790|76046654|FG003|Period 2|Adverse Event|1|||
42227051|NCT00803790|76046651|FG000|Period 2|Withdrawal by Subject|1|||
42227052|NCT00803790|76046652|FG001|Period 2|Withdrawal by Subject|0|||
42227053|NCT00803790|76046653|FG002|Period 2|Withdrawal by Subject|0|||
42227054|NCT00803790|76046654|FG003|Period 2|Withdrawal by Subject|0|||
42227055|NCT00803790|76046651|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
42227056|NCT00803790|76046652|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
42227057|NCT00803790|76046653|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
42227058|NCT00803790|76046654|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
42227059|NCT00250458|76046702|FG000|Overall Study|Lost to Follow-up|4|||
42227060|NCT00250458|76046703|FG001|Overall Study|Lost to Follow-up|2|||
42227061|NCT00250458|76046702|FG000|Overall Study|Protocol Violation|0|||
42227062|NCT00250458|76046703|FG001|Overall Study|Protocol Violation|1|||
42227063|NCT00250458|76046702|FG000|Overall Study|Withdrawal by Subject|4|||
41985662|NCT01308853|75792478|FG000|Overall Study|Insertion of permanent implants|1|||
41985663|NCT01308736|75792484|FG000|Overall Study|Did not attend a single session|6|||
41985664|NCT01308736|75792485|FG001|Overall Study|Did not attend a single session|5|||
41985665|NCT01308580|75792493|FG000|Overall Study|Lost to Follow-up|12|||
42227064|NCT00250458|76046703|FG001|Overall Study|Withdrawal by Subject|2|||
42227065|NCT00250458|76046702|FG000|Overall Study|Lack of Migraine Attack|20|||
42227066|NCT00250458|76046703|FG001|Overall Study|Lack of Migraine Attack|9|||
42227067|NCT00250458|76046702|FG000|Overall Study|Qualifying migraine but did not treat|3|||
42227068|NCT00250458|76046703|FG001|Overall Study|Qualifying migraine but did not treat|3|||
42227069|NCT00250458|76046702|FG000|Overall Study|Other|1|||
41985666|NCT01308580|75792494|FG001|Overall Study|Lost to Follow-up|7|||
41985667|NCT01308463|75792501|FG000|Overall Study|Study Discontinued|23|||
42227070|NCT00250458|76046703|FG001|Overall Study|Other|0|||
42227071|NCT01667133|76046721|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
42227072|NCT01667133|76046722|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
41985668|NCT01308463|75792501|FG000|Overall Study|Death|4|||
41985669|NCT01308463|75792501|FG000|Overall Study|Revision|2|||
42227073|NCT01667133|76046723|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
42227074|NCT01667133|76046724|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
42227075|NCT01667133|76046725|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
42227076|NCT01667133|76046726|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
42227077|NCT01667133|76046727|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
42227078|NCT01667133|76046728|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
42227079|NCT01667133|76046729|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
42227080|NCT01667133|76046730|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
42227081|NCT01667133|76046731|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
42227082|NCT01667133|76046732|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
42227083|NCT01667133|76046721|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
42227084|NCT01667133|76046722|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
42227085|NCT01667133|76046723|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
42227086|NCT01667133|76046724|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
42227087|NCT01667133|76046725|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
42227088|NCT01667133|76046726|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
42227089|NCT01667133|76046727|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
42227090|NCT01667133|76046728|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
42227091|NCT01667133|76046729|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
42227092|NCT01667133|76046730|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
42227093|NCT01667133|76046731|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
42227094|NCT01667133|76046732|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
42227095|NCT01667133|76046721|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
42227096|NCT01667133|76046722|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
42227097|NCT01667133|76046723|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
42227098|NCT01667133|76046724|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
42227099|NCT01667133|76046725|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
42227100|NCT01667133|76046726|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
42227101|NCT01667133|76046727|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
42227102|NCT01667133|76046728|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
42227103|NCT01667133|76046729|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
42227104|NCT01667133|76046730|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
42227105|NCT01667133|76046731|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
42227106|NCT01667133|76046732|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
42227107|NCT01667133|76046721|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
42227108|NCT01667133|76046722|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
42227109|NCT01667133|76046723|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
42227110|NCT01667133|76046724|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
42227111|NCT01667133|76046725|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
42227112|NCT01667133|76046726|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
42227113|NCT01667133|76046727|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
42227114|NCT01667133|76046728|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
42227115|NCT01667133|76046729|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
42227116|NCT01667133|76046730|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
42227117|NCT01667133|76046731|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
42227118|NCT01667133|76046732|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
42227119|NCT01667133|76046721|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
42227120|NCT01667133|76046722|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
42227121|NCT01667133|76046723|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
42227122|NCT01667133|76046724|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
42227123|NCT01667133|76046725|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
42227124|NCT01667133|76046726|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
42227125|NCT01667133|76046727|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
42227126|NCT01667133|76046728|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
42227127|NCT01667133|76046729|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
42227128|NCT01667133|76046730|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
42227129|NCT01667133|76046731|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
42227130|NCT01667133|76046732|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
42227131|NCT01667133|76046721|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
42227132|NCT01667133|76046722|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
42227133|NCT01667133|76046723|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
42227134|NCT01667133|76046724|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
42227135|NCT01667133|76046725|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
42227136|NCT01667133|76046726|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
42227137|NCT01667133|76046727|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
42227138|NCT01667133|76046728|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
42227139|NCT01667133|76046729|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
42227140|NCT01667133|76046730|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
42227141|NCT01667133|76046731|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
42227142|NCT01667133|76046732|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
42227143|NCT01667133|76046721|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
42227144|NCT01667133|76046722|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
42227145|NCT01667133|76046723|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
42227146|NCT01667133|76046724|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
42227147|NCT01667133|76046725|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
42227148|NCT01667133|76046726|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
42227149|NCT01667133|76046727|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
42227150|NCT01667133|76046728|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
42227151|NCT01667133|76046729|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
42227152|NCT01667133|76046730|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
42227153|NCT01667133|76046731|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
42227154|NCT01667133|76046732|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
42227155|NCT01667133|76046721|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
42227156|NCT01667133|76046722|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
42227157|NCT01667133|76046723|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
42227158|NCT01667133|76046724|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
42227159|NCT01667133|76046725|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
42227160|NCT01667133|76046726|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
42227161|NCT01667133|76046727|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
42227162|NCT01667133|76046728|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
42227163|NCT01667133|76046729|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
42227164|NCT01667133|76046730|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
42227165|NCT01667133|76046731|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
42227166|NCT01667133|76046732|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
42227167|NCT01667133|76046721|FG000|Phase 2: Dose-expansion|Death|0|||
42227168|NCT01667133|76046722|FG001|Phase 2: Dose-expansion|Death|0|||
42227169|NCT01667133|76046723|FG002|Phase 2: Dose-expansion|Death|0|||
42227170|NCT01667133|76046724|FG003|Phase 2: Dose-expansion|Death|0|||
42227171|NCT01667133|76046725|FG004|Phase 2: Dose-expansion|Death|0|||
42227172|NCT01667133|76046726|FG005|Phase 2: Dose-expansion|Death|0|||
42227173|NCT01667133|76046727|FG006|Phase 2: Dose-expansion|Death|0|||
42227174|NCT01667133|76046728|FG007|Phase 2: Dose-expansion|Death|0|||
42227175|NCT01667133|76046729|FG008|Phase 2: Dose-expansion|Death|0|||
42227176|NCT01667133|76046730|FG009|Phase 2: Dose-expansion|Death|1|||
41985670|NCT01308424|75792507|FG000|Baseline Eligibility|Screen Failures|71|||
41985671|NCT01308424|75792508|FG001|Baseline Eligibility|Screen Failures|0|||
41985672|NCT01308424|75792509|FG002|Baseline Eligibility|Screen Failures|0|||
41985673|NCT01308424|75792507|FG000|Randomization|Adverse Event|0|||
42227177|NCT01667133|76046731|FG010|Phase 2: Dose-expansion|Death|0|||
42227178|NCT01667133|76046732|FG011|Phase 2: Dose-expansion|Death|0|||
42227179|NCT01667133|76046721|FG000|Phase 2: Dose-expansion|Other|0|||
42227180|NCT01667133|76046722|FG001|Phase 2: Dose-expansion|Other|0|||
42227181|NCT01667133|76046723|FG002|Phase 2: Dose-expansion|Other|0|||
42227182|NCT01667133|76046724|FG003|Phase 2: Dose-expansion|Other|0|||
42227183|NCT01667133|76046725|FG004|Phase 2: Dose-expansion|Other|0|||
42227184|NCT01667133|76046726|FG005|Phase 2: Dose-expansion|Other|0|||
42227185|NCT01667133|76046727|FG006|Phase 2: Dose-expansion|Other|0|||
42227186|NCT01667133|76046728|FG007|Phase 2: Dose-expansion|Other|0|||
42227187|NCT01667133|76046729|FG008|Phase 2: Dose-expansion|Other|0|||
42227188|NCT01667133|76046730|FG009|Phase 2: Dose-expansion|Other|0|||
42227189|NCT01667133|76046731|FG010|Phase 2: Dose-expansion|Other|0|||
42227190|NCT01667133|76046732|FG011|Phase 2: Dose-expansion|Other|1|||
42227191|NCT01181778|76046793|FG000|Overall Study|Physician Decision|48|||
42227192|NCT00092118|76046801|FG000|Overall Study|Adverse Event|35|||
42227193|NCT00092118|76046802|FG001|Overall Study|Adverse Event|32|||
42227194|NCT00092118|76046801|FG000|Overall Study|Lack of Efficacy|12|||
42227195|NCT00092118|76046802|FG001|Overall Study|Lack of Efficacy|14|||
42227196|NCT00092118|76046801|FG000|Overall Study|Lost to Follow-up|4|||
42227197|NCT00092118|76046802|FG001|Overall Study|Lost to Follow-up|3|||
42227198|NCT00092118|76046801|FG000|Overall Study|Protocol Violation|23|||
42227199|NCT00092118|76046802|FG001|Overall Study|Protocol Violation|25|||
42227200|NCT00092118|76046801|FG000|Overall Study|Withdrawal by Subject|4|||
42227201|NCT00092118|76046802|FG001|Overall Study|Withdrawal by Subject|10|||
42227202|NCT00092118|76046801|FG000|Overall Study|Other|6|||
42227203|NCT00092118|76046802|FG001|Overall Study|Other|5|||
42227204|NCT03261947|76046813|FG000|Overall Study|Death|10|||
42227205|NCT03261947|76046814|FG001|Overall Study|Death|13|||
42227206|NCT03261947|76046815|FG002|Overall Study|Death|17|||
42227207|NCT03261947|76046816|FG003|Overall Study|Death|12|||
42227208|NCT03261947|76046817|FG004|Overall Study|Death|8|||
42227209|NCT03261947|76046813|FG000|Overall Study|Lost to Follow-up|0|||
42227210|NCT03261947|76046814|FG001|Overall Study|Lost to Follow-up|0|||
42227211|NCT03261947|76046815|FG002|Overall Study|Lost to Follow-up|2|||
42227212|NCT03261947|76046816|FG003|Overall Study|Lost to Follow-up|1|||
42227213|NCT03261947|76046817|FG004|Overall Study|Lost to Follow-up|0|||
42227214|NCT03261947|76046813|FG000|Overall Study|Withdrawal by Subject|0|||
42227215|NCT03261947|76046814|FG001|Overall Study|Withdrawal by Subject|0|||
42227216|NCT03261947|76046815|FG002|Overall Study|Withdrawal by Subject|3|||
42227217|NCT03261947|76046816|FG003|Overall Study|Withdrawal by Subject|0|||
42227218|NCT03261947|76046817|FG004|Overall Study|Withdrawal by Subject|1|||
42227219|NCT03261947|76046813|FG000|Overall Study|Site Terminated by Sponsor|0|||
42227220|NCT03261947|76046814|FG001|Overall Study|Site Terminated by Sponsor|0|||
42227221|NCT03261947|76046815|FG002|Overall Study|Site Terminated by Sponsor|4|||
42227222|NCT03261947|76046816|FG003|Overall Study|Site Terminated by Sponsor|7|||
42227223|NCT03261947|76046817|FG004|Overall Study|Site Terminated by Sponsor|5|||
42227224|NCT03261947|76046813|FG000|Overall Study|Reason not Specified|2|||
42227225|NCT03261947|76046814|FG001|Overall Study|Reason not Specified|0|||
42227226|NCT03261947|76046815|FG002|Overall Study|Reason not Specified|4|||
42227227|NCT03261947|76046816|FG003|Overall Study|Reason not Specified|1|||
42227228|NCT03261947|76046817|FG004|Overall Study|Reason not Specified|3|||
42227229|NCT03098979|76046848|FG000|Overall Study|Adverse Event|1|||
42227230|NCT03098979|76046849|FG001|Overall Study|Adverse Event|0|||
42227231|NCT03098979|76046850|FG002|Overall Study|Adverse Event|1|||
42227232|NCT03098979|76046851|FG003|Overall Study|Adverse Event|4|||
42227233|NCT03098979|76046852|FG004|Overall Study|Adverse Event|6|||
42227234|NCT03098979|76046853|FG005|Overall Study|Adverse Event|1|||
42227235|NCT03098979|76046848|FG000|Overall Study|Withdrawal by Subject|2|||
42227236|NCT03098979|76046849|FG001|Overall Study|Withdrawal by Subject|1|||
42227237|NCT03098979|76046850|FG002|Overall Study|Withdrawal by Subject|1|||
42227238|NCT03098979|76046851|FG003|Overall Study|Withdrawal by Subject|1|||
42227239|NCT03098979|76046852|FG004|Overall Study|Withdrawal by Subject|2|||
42227240|NCT03098979|76046853|FG005|Overall Study|Withdrawal by Subject|1|||
42227241|NCT03098979|76046848|FG000|Overall Study|Death|1|||
42227242|NCT03098979|76046849|FG001|Overall Study|Death|0|||
42227243|NCT03098979|76046850|FG002|Overall Study|Death|2|||
42227244|NCT03098979|76046851|FG003|Overall Study|Death|0|||
42227245|NCT03098979|76046852|FG004|Overall Study|Death|1|||
42227246|NCT03098979|76046853|FG005|Overall Study|Death|0|||
42227247|NCT03098979|76046848|FG000|Overall Study|Physician Decision|2|||
42227248|NCT03098979|76046849|FG001|Overall Study|Physician Decision|1|||
42227249|NCT03098979|76046850|FG002|Overall Study|Physician Decision|0|||
42227250|NCT03098979|76046851|FG003|Overall Study|Physician Decision|0|||
42227251|NCT03098979|76046852|FG004|Overall Study|Physician Decision|0|||
42227252|NCT03098979|76046853|FG005|Overall Study|Physician Decision|0|||
42227253|NCT03098979|76046848|FG000|Overall Study|Non-compliance|0|||
42227254|NCT03098979|76046849|FG001|Overall Study|Non-compliance|0|||
42227255|NCT03098979|76046850|FG002|Overall Study|Non-compliance|0|||
42227256|NCT03098979|76046851|FG003|Overall Study|Non-compliance|0|||
42227257|NCT03098979|76046852|FG004|Overall Study|Non-compliance|0|||
42227258|NCT03098979|76046853|FG005|Overall Study|Non-compliance|1|||
42227259|NCT03098979|76046848|FG000|Overall Study|Protocol Violation|0|||
42227260|NCT03098979|76046849|FG001|Overall Study|Protocol Violation|0|||
42227261|NCT03098979|76046850|FG002|Overall Study|Protocol Violation|0|||
42227262|NCT03098979|76046851|FG003|Overall Study|Protocol Violation|0|||
42227263|NCT03098979|76046852|FG004|Overall Study|Protocol Violation|0|||
42227264|NCT03098979|76046853|FG005|Overall Study|Protocol Violation|1|||
42227265|NCT03261167|76046869|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
42227266|NCT03261167|76046870|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
42227267|NCT03261167|76046869|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
42227268|NCT03261167|76046870|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
42227269|NCT03261167|76046869|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
42227270|NCT03261167|76046870|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
42227271|NCT03261167|76046869|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
42227272|NCT03261167|76046870|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
42227273|NCT03261167|76046869|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
42227274|NCT03261167|76046870|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
42227275|NCT03294941|76046884|FG000|Overall Study|Withdrawal by Subject|0|||
42131704|NCT00320710|75942614|FG000|Overall Study|Administrative problems|1|||
42227276|NCT03294941|76046885|FG001|Overall Study|Withdrawal by Subject|2|||
42227277|NCT03098433|76046892|FG000|Overall Study|Withdrawal by Subject|10|||
42227278|NCT03294317|76046897|FG000|Overall Study|Physician Decision|1|||
42227279|NCT03294317|76046897|FG000|Overall Study|Withdrawal by Subject|6|||
42227280|NCT03294317|76046897|FG000|Overall Study|Lost to Follow-up|1|||
42227281|NCT03294317|76046897|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
42227282|NCT03294317|76046897|FG000|Overall Study|Failed HB lead implant|8|||
42227283|NCT03294317|76046897|FG000|Overall Study|Received CRT instead|1|||
42227284|NCT03294317|76046897|FG000|Overall Study|Exited after lead revision|2|||
42227285|NCT03292913|76046903|FG000|Overall Study|Death|9|||
42227286|NCT03292913|76046904|FG001|Overall Study|Death|3|||
42227287|NCT03292913|76046903|FG000|Overall Study|Lost to Follow-up|49|||
42227288|NCT03292913|76046904|FG001|Overall Study|Lost to Follow-up|49|||
42227289|NCT03292913|76046903|FG000|Overall Study|Withdrawal by Subject|2|||
42227290|NCT03292913|76046904|FG001|Overall Study|Withdrawal by Subject|0|||
42227291|NCT03292913|76046903|FG000|Overall Study|Clinic closed due to COVID|22|||
42227292|NCT03292913|76046904|FG001|Overall Study|Clinic closed due to COVID|36|||
42227293|NCT03291587|76046916|FG000|Overall Study|Lost to Follow-up|62|||
42227294|NCT03291587|76046917|FG001|Overall Study|Lost to Follow-up|43|||
42227295|NCT03291587|76046916|FG000|Overall Study|Refused to Answer|5|||
42227296|NCT03291587|76046917|FG001|Overall Study|Refused to Answer|2|||
42227297|NCT03291587|76046916|FG000|Overall Study|Death|2|||
42227298|NCT03291587|76046917|FG001|Overall Study|Death|4|||
42227299|NCT03291587|76046916|FG000|Overall Study|Not interested in participating|8|||
42227300|NCT03291587|76046917|FG001|Overall Study|Not interested in participating|6|||
42227301|NCT03291587|76046916|FG000|Overall Study|Too busy to participate|4|||
42227302|NCT03291587|76046917|FG001|Overall Study|Too busy to participate|2|||
42227303|NCT03210961|76046948|FG000|Overall Study|Adverse Event|0|||
42227304|NCT03210961|76046949|FG001|Overall Study|Adverse Event|0|||
42227305|NCT03210961|76046950|FG002|Overall Study|Adverse Event|0|||
42227306|NCT03210961|76046951|FG003|Overall Study|Adverse Event|0|||
42227307|NCT03210961|76046952|FG004|Overall Study|Adverse Event|0|||
42227308|NCT03210961|76046953|FG005|Overall Study|Adverse Event|0|||
42227309|NCT03210961|76046954|FG006|Overall Study|Adverse Event|0|||
42227310|NCT03210961|76046955|FG007|Overall Study|Adverse Event|0|||
42227311|NCT03210961|76046956|FG008|Overall Study|Adverse Event|0|||
42227312|NCT03210961|76046957|FG009|Overall Study|Adverse Event|0|||
42227313|NCT03210961|76046958|FG010|Overall Study|Adverse Event|0|||
42227314|NCT03210961|76046959|FG011|Overall Study|Adverse Event|0|||
42227315|NCT03210961|76046960|FG012|Overall Study|Adverse Event|0|||
42227316|NCT03210961|76046961|FG013|Overall Study|Adverse Event|1|||
42227317|NCT03210961|76046962|FG014|Overall Study|Adverse Event|0|||
42227318|NCT03210961|76046948|FG000|Overall Study|Lost to Follow-up|0|||
42227319|NCT03210961|76046949|FG001|Overall Study|Lost to Follow-up|0|||
42227320|NCT03210961|76046950|FG002|Overall Study|Lost to Follow-up|0|||
42227321|NCT03210961|76046951|FG003|Overall Study|Lost to Follow-up|0|||
42227322|NCT03210961|76046952|FG004|Overall Study|Lost to Follow-up|0|||
42227323|NCT03210961|76046953|FG005|Overall Study|Lost to Follow-up|0|||
42227324|NCT03210961|76046954|FG006|Overall Study|Lost to Follow-up|0|||
42227325|NCT03210961|76046955|FG007|Overall Study|Lost to Follow-up|0|||
42227326|NCT03210961|76046956|FG008|Overall Study|Lost to Follow-up|0|||
42227327|NCT03210961|76046957|FG009|Overall Study|Lost to Follow-up|0|||
42227328|NCT03210961|76046958|FG010|Overall Study|Lost to Follow-up|0|||
42227329|NCT03210961|76046959|FG011|Overall Study|Lost to Follow-up|0|||
42227330|NCT03210961|76046960|FG012|Overall Study|Lost to Follow-up|0|||
42227331|NCT03210961|76046961|FG013|Overall Study|Lost to Follow-up|0|||
42227332|NCT03210961|76046962|FG014|Overall Study|Lost to Follow-up|1|||
42227333|NCT03210961|76046948|FG000|Overall Study|Withdrawal by Subject|0|||
42227334|NCT03210961|76046949|FG001|Overall Study|Withdrawal by Subject|0|||
42227335|NCT03210961|76046950|FG002|Overall Study|Withdrawal by Subject|0|||
42227336|NCT03210961|76046951|FG003|Overall Study|Withdrawal by Subject|0|||
42227337|NCT03210961|76046952|FG004|Overall Study|Withdrawal by Subject|0|||
42227338|NCT03210961|76046953|FG005|Overall Study|Withdrawal by Subject|0|||
42227339|NCT03210961|76046954|FG006|Overall Study|Withdrawal by Subject|0|||
42227340|NCT03210961|76046955|FG007|Overall Study|Withdrawal by Subject|0|||
41985674|NCT01308424|75792508|FG001|Randomization|Adverse Event|1|||
41985675|NCT01308424|75792509|FG002|Randomization|Adverse Event|1|||
41985676|NCT01308424|75792507|FG000|Randomization|Lost to Follow-up|0|||
41985677|NCT01308424|75792508|FG001|Randomization|Lost to Follow-up|1|||
41985678|NCT01308424|75792509|FG002|Randomization|Lost to Follow-up|0|||
41985679|NCT01308424|75792507|FG000|Randomization|Physician Decision|0|||
41985680|NCT01308424|75792508|FG001|Randomization|Physician Decision|1|||
41985681|NCT01308424|75792509|FG002|Randomization|Physician Decision|1|||
41985682|NCT01307800|75792520|FG000|Overall Study|Adverse Event|9|||
41985683|NCT01307800|75792521|FG001|Overall Study|Adverse Event|8|||
41985684|NCT01307800|75792522|FG002|Overall Study|Adverse Event|10|||
41985685|NCT01307800|75792523|FG003|Overall Study|Adverse Event|14|||
41985686|NCT01307800|75792520|FG000|Overall Study|Entry Criteria Not Met|0|||
41985687|NCT01307800|75792521|FG001|Overall Study|Entry Criteria Not Met|0|||
41985688|NCT01307800|75792522|FG002|Overall Study|Entry Criteria Not Met|0|||
41985689|NCT01307800|75792523|FG003|Overall Study|Entry Criteria Not Met|2|||
41985690|NCT01307800|75792520|FG000|Overall Study|Lost to Follow-up|5|||
42227341|NCT03210961|76046956|FG008|Overall Study|Withdrawal by Subject|0|||
42227342|NCT03210961|76046957|FG009|Overall Study|Withdrawal by Subject|0|||
42227343|NCT03210961|76046958|FG010|Overall Study|Withdrawal by Subject|0|||
42227344|NCT03210961|76046959|FG011|Overall Study|Withdrawal by Subject|0|||
42227345|NCT03210961|76046960|FG012|Overall Study|Withdrawal by Subject|0|||
42227346|NCT03210961|76046961|FG013|Overall Study|Withdrawal by Subject|0|||
42227347|NCT03210961|76046962|FG014|Overall Study|Withdrawal by Subject|1|||
42227348|NCT03210961|76046948|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227349|NCT03210961|76046949|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227350|NCT03210961|76046950|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227351|NCT03210961|76046951|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227352|NCT03210961|76046952|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227353|NCT03210961|76046953|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227354|NCT03210961|76046954|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227355|NCT03210961|76046955|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227356|NCT03210961|76046956|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227357|NCT03210961|76046957|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227358|NCT03210961|76046958|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227359|NCT03210961|76046959|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227360|NCT03210961|76046960|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227361|NCT03210961|76046961|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
42227362|NCT03210961|76046962|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
42227363|NCT03210961|76046948|FG000|Overall Study|Other|0|||
42227364|NCT03210961|76046949|FG001|Overall Study|Other|0|||
41985691|NCT01307800|75792521|FG001|Overall Study|Lost to Follow-up|6|||
41985692|NCT01307800|75792522|FG002|Overall Study|Lost to Follow-up|2|||
41985693|NCT01307800|75792523|FG003|Overall Study|Lost to Follow-up|8|||
41985694|NCT01307800|75792520|FG000|Overall Study|Perceived Lack of Efficacy|24|||
41985695|NCT01307800|75792521|FG001|Overall Study|Perceived Lack of Efficacy|23|||
41985696|NCT01307800|75792522|FG002|Overall Study|Perceived Lack of Efficacy|20|||
41985697|NCT01307800|75792523|FG003|Overall Study|Perceived Lack of Efficacy|33|||
41985698|NCT01307800|75792520|FG000|Overall Study|Protocol Violation|0|||
41985699|NCT01307800|75792521|FG001|Overall Study|Protocol Violation|3|||
42227365|NCT03210961|76046950|FG002|Overall Study|Other|0|||
42227366|NCT03210961|76046951|FG003|Overall Study|Other|1|||
42227367|NCT03210961|76046952|FG004|Overall Study|Other|0|||
42227368|NCT03210961|76046953|FG005|Overall Study|Other|0|||
42227369|NCT03210961|76046954|FG006|Overall Study|Other|1|||
42227370|NCT03210961|76046955|FG007|Overall Study|Other|0|||
42227371|NCT03210961|76046956|FG008|Overall Study|Other|0|||
42227372|NCT03210961|76046957|FG009|Overall Study|Other|0|||
41985700|NCT01307800|75792522|FG002|Overall Study|Protocol Violation|4|||
41985701|NCT01307800|75792523|FG003|Overall Study|Protocol Violation|5|||
42032435|NCT01133405|75840639|FG007|Period 2|Physician Decision|0|||
41985702|NCT01307800|75792520|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
41985703|NCT01307800|75792521|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
42227373|NCT03210961|76046958|FG010|Overall Study|Other|1|||
41985704|NCT01307800|75792522|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
41985705|NCT01307800|75792523|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
42227374|NCT03210961|76046959|FG011|Overall Study|Other|0|||
42227375|NCT03210961|76046960|FG012|Overall Study|Other|2|||
42227376|NCT03210961|76046961|FG013|Overall Study|Other|2|||
42227377|NCT03210961|76046962|FG014|Overall Study|Other|0|||
42227378|NCT03242759|76047015|FG000|Overall Study|Adverse Event|5|||
42227379|NCT03242759|76047016|FG001|Overall Study|Adverse Event|1|||
42227380|NCT03242759|76047015|FG000|Overall Study|Withdrawal by Subject|4|||
42227381|NCT03242759|76047016|FG001|Overall Study|Withdrawal by Subject|3|||
42227382|NCT03242759|76047015|FG000|Overall Study|Lost to Follow-up|3|||
42227383|NCT03242759|76047016|FG001|Overall Study|Lost to Follow-up|1|||
42227384|NCT03242759|76047015|FG000|Overall Study|Administrative problems|1|||
42227385|NCT03242759|76047016|FG001|Overall Study|Administrative problems|1|||
42227386|NCT03242759|76047015|FG000|Overall Study|Death|22|||
42227387|NCT03242759|76047016|FG001|Overall Study|Death|0|||
42227388|NCT03242759|76047015|FG000|Overall Study|Change visit schedule|0|||
42227389|NCT03242759|76047016|FG001|Overall Study|Change visit schedule|1|||
41985706|NCT01307800|75792520|FG000|Overall Study|Sponsor Decision|6|||
41985707|NCT01307800|75792521|FG001|Overall Study|Sponsor Decision|9|||
42227390|NCT03097029|76047022|FG000|Overall Study|Withdrawal by Subject|1|||
42227391|NCT03257813|76047028|FG000|Overall Study|Protocol Violation|6|||
42227392|NCT03257813|76047029|FG001|Overall Study|Protocol Violation|3|||
42227393|NCT03210259|76047040|FG000|12-Week Run-in Period|Adverse Event|1|||
42227394|NCT03210259|76047041|FG001|12-Week Run-in Period|Adverse Event|0|||
42227395|NCT03210259|76047042|FG002|12-Week Run-in Period|Adverse Event|0|||
42227396|NCT03210259|76047040|FG000|12-Week Run-in Period|Death|1|||
42227397|NCT03210259|76047041|FG001|12-Week Run-in Period|Death|0|||
42227398|NCT03210259|76047042|FG002|12-Week Run-in Period|Death|0|||
42227399|NCT03210259|76047040|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
42227400|NCT03210259|76047041|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
42227401|NCT03210259|76047042|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
42227402|NCT03210259|76047040|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
42227403|NCT03210259|76047041|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
42227404|NCT03210259|76047042|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
42227405|NCT03210259|76047040|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
42227406|NCT03210259|76047041|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
42227407|NCT03210259|76047042|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
42227408|NCT03210259|76047040|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
42227409|NCT03210259|76047041|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
42227410|NCT03210259|76047042|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
42227411|NCT03210259|76047040|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
42227412|NCT03210259|76047041|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
42227413|NCT03210259|76047042|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
42227414|NCT03210259|76047040|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
42227415|NCT03210259|76047041|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
41985708|NCT01307800|75792522|FG002|Overall Study|Sponsor Decision|12|||
42227416|NCT03210259|76047042|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
42227417|NCT03210259|76047040|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
42227418|NCT03210259|76047041|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
42227419|NCT03210259|76047042|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
42227420|NCT03210259|76047040|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
42227421|NCT03210259|76047041|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
42227422|NCT03210259|76047042|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
42227423|NCT03210259|76047040|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
42227424|NCT03210259|76047041|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
42227425|NCT03210259|76047042|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
42227426|NCT03257657|76047051|FG000|Overall Study|Lost to Follow-up|0|||
42227427|NCT03257657|76047052|FG001|Overall Study|Lost to Follow-up|3|||
42227428|NCT03257657|76047051|FG000|Overall Study|Withdrawn|0|||
42227429|NCT03257657|76047052|FG001|Overall Study|Withdrawn|1|||
42227430|NCT03257657|76047051|FG000|Overall Study|Noted not eligible right after enrolled|0|||
42227431|NCT03257657|76047052|FG001|Overall Study|Noted not eligible right after enrolled|1|||
42227432|NCT02496611|76047061|FG000|Overall Study|Lost to Follow-up|2|||
42227433|NCT02496611|76047062|FG001|Overall Study|Lost to Follow-up|1|||
42227434|NCT02496611|76047061|FG000|Overall Study|Withdrawal by Subject|5|||
42227435|NCT02496611|76047062|FG001|Overall Study|Withdrawal by Subject|2|||
42227436|NCT03237481|76047072|FG000|Overall Study|Lost to Follow-up|1|||
42227437|NCT03237481|76047073|FG001|Overall Study|Lost to Follow-up|0|||
42227438|NCT03237481|76047074|FG002|Overall Study|Lost to Follow-up|0|||
41985709|NCT01307800|75792523|FG003|Overall Study|Sponsor Decision|28|||
41985710|NCT01307800|75792520|FG000|Overall Study|Withdrawal by Subject|10|||
41985711|NCT01307800|75792521|FG001|Overall Study|Withdrawal by Subject|11|||
41985712|NCT01307800|75792522|FG002|Overall Study|Withdrawal by Subject|8|||
41985713|NCT01307800|75792523|FG003|Overall Study|Withdrawal by Subject|15|||
41985714|NCT01307800|75792520|FG000|Overall Study|Participant Moved|0|||
42227439|NCT03237481|76047072|FG000|Overall Study|Protocol Violation|1|||
42227440|NCT03237481|76047073|FG001|Overall Study|Protocol Violation|0|||
42227441|NCT03237481|76047074|FG002|Overall Study|Protocol Violation|0|||
42227442|NCT03237481|76047072|FG000|Overall Study|Withdrawal by Subject|3|||
42227443|NCT03237481|76047073|FG001|Overall Study|Withdrawal by Subject|2|||
42227444|NCT03237481|76047074|FG002|Overall Study|Withdrawal by Subject|1|||
42227445|NCT03222349|76047082|FG000|Overall Study|Treatment B not done|5|||
42227446|NCT03222349|76047083|FG001|Overall Study|Treatment B not done|0|||
42227447|NCT03222349|76047082|FG000|Overall Study|Lost to Follow-up|1|||
42227448|NCT03222349|76047083|FG001|Overall Study|Lost to Follow-up|2|||
42227449|NCT03222349|76047082|FG000|Overall Study|Withdrawal by Subject|1|||
42227450|NCT03222349|76047083|FG001|Overall Study|Withdrawal by Subject|0|||
42227451|NCT03222349|76047082|FG000|Overall Study|Treatment A not done|0|||
42227452|NCT03222349|76047083|FG001|Overall Study|Treatment A not done|5|||
42227453|NCT03222349|76047082|FG000|Overall Study|Study terminated by sponsor|1|||
42227454|NCT03222349|76047083|FG001|Overall Study|Study terminated by sponsor|0|||
42227455|NCT02927925|76047096|FG000|Overall Study|Death|16|||
42227456|NCT02927925|76047096|FG000|Overall Study|Physician Decision|1|||
42227457|NCT02927925|76047096|FG000|Overall Study|Withdrawal by Subject|11|||
42227458|NCT02927925|76047096|FG000|Overall Study|Other|3|||
42227459|NCT02927925|76047096|FG000|Overall Study|Disease progression at clinical cutoff|1|||
42227460|NCT03208933|76047100|FG000|Overall Study|Death|3|||
42227461|NCT03208933|76047100|FG000|Overall Study|Withdrawal by Subject|3|||
42227462|NCT03208933|76047100|FG000|Overall Study|Adverse Event|1|||
42227463|NCT03208933|76047100|FG000|Overall Study|Lost to Follow-up|2|||
42227464|NCT03208933|76047100|FG000|Overall Study|Physician Decision|3|||
42227465|NCT03208933|76047100|FG000|Overall Study|Protocol Violation|1|||
42227466|NCT03207763|76047106|FG000|Overall Study|Lost to Follow-up|1|||
42227467|NCT03207763|76047107|FG001|Overall Study|Lost to Follow-up|0|||
42227468|NCT04766034|76047126|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
42227469|NCT04766034|76047127|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
42227470|NCT04766034|76047128|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
42227471|NCT04766034|76047129|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
42227472|NCT04766034|76047130|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
42227473|NCT04766034|76047126|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
42227474|NCT04766034|76047127|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
42227475|NCT04766034|76047128|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
42227476|NCT04766034|76047129|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
42227477|NCT04766034|76047130|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
42227478|NCT04766034|76047126|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
42227479|NCT04766034|76047127|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
41985715|NCT01307800|75792521|FG001|Overall Study|Participant Moved|2|||
42227480|NCT04766034|76047128|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
42227481|NCT04766034|76047129|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
42227482|NCT04766034|76047130|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
41985716|NCT01307800|75792522|FG002|Overall Study|Participant Moved|1|||
42227483|NCT04766034|76047126|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
42227484|NCT04766034|76047127|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
42227485|NCT04766034|76047128|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
42227486|NCT04766034|76047129|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
42227487|NCT04766034|76047130|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
42227488|NCT03237013|76047145|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
42227489|NCT03237013|76047146|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
42227490|NCT03237013|76047147|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
42227491|NCT03236779|76047157|FG000|Overall Study|Lost to Follow-up|13|||
42227492|NCT03236779|76047158|FG001|Overall Study|Lost to Follow-up|21|||
42227493|NCT03096483|76047166|FG000|Overall Study|Withdrawal by site|1|||
42227494|NCT02932579|76047172|FG000|Overall Study|Withdrawal by Subject|4|||
42227495|NCT02932579|76047173|FG001|Overall Study|Withdrawal by Subject|1|||
42227496|NCT03207451|76047183|FG000|Overall Study|scheduling conflict|1|||
42227497|NCT03207451|76047184|FG001|Overall Study|scheduling conflict|0|||
42227498|NCT03207451|76047185|FG002|Overall Study|scheduling conflict|2|||
42227499|NCT03207451|76047186|FG003|Overall Study|scheduling conflict|2|||
42227500|NCT03207451|76047183|FG000|Overall Study|Adverse Event|0|||
42227501|NCT03207451|76047184|FG001|Overall Study|Adverse Event|0|||
42227502|NCT03207451|76047185|FG002|Overall Study|Adverse Event|0|||
42227503|NCT03207451|76047186|FG003|Overall Study|Adverse Event|1|||
42227504|NCT03350503|76047213|FG000|Overall Study|Adverse Event|5|||
42227505|NCT03350503|76047213|FG000|Overall Study|Withdrawal by Subject|5|||
42227506|NCT03350503|76047213|FG000|Overall Study|Continuation impossible due to move|4|||
42227507|NCT03350503|76047213|FG000|Overall Study|Physician Decision|3|||
42227508|NCT03288779|76047236|FG000|Overall Study|Withdrawal by Subject|3|||
42227509|NCT03206749|76047243|FG000|Overall Study|Withdrawal of consent|5|||
42227510|NCT03206749|76047244|FG001|Overall Study|Withdrawal of consent|3|||
42227511|NCT03206749|76047245|FG002|Overall Study|Withdrawal of consent|6|||
42227512|NCT03206749|76047243|FG000|Overall Study|Lost to Follow-up|0|||
42227513|NCT03206749|76047244|FG001|Overall Study|Lost to Follow-up|0|||
42227514|NCT03206749|76047245|FG002|Overall Study|Lost to Follow-up|1|||
42227515|NCT03255941|76047265|FG000|Overall Study|Not eligible or refused injection|37|||
42227516|NCT03255941|76047266|FG001|Overall Study|Not eligible or refused injection|44|||
42227517|NCT03255941|76047267|FG002|Overall Study|Not eligible or refused injection|5|||
42227518|NCT03255941|76047268|FG003|Overall Study|Not eligible or refused injection|6|||
42227519|NCT03255941|76047265|FG000|Overall Study|Did not complete exit interview|1|||
42227520|NCT03255941|76047266|FG001|Overall Study|Did not complete exit interview|2|||
42227521|NCT03255941|76047267|FG002|Overall Study|Did not complete exit interview|0|||
42227522|NCT03255941|76047268|FG003|Overall Study|Did not complete exit interview|0|||
42227523|NCT03255629|76047290|FG000|Overall Study|Adverse Event|1|||
42227524|NCT03255629|76047291|FG001|Overall Study|Adverse Event|0|||
42227525|NCT03255629|76047290|FG000|Overall Study|did not experience hypoglycemia|2|||
41985717|NCT01307800|75792523|FG003|Overall Study|Participant Moved|3|||
41985718|NCT01307449|75792537|FG000|Overall Study|Adverse Event|1|||
42227526|NCT03255629|76047291|FG001|Overall Study|did not experience hypoglycemia|1|||
42227527|NCT03031938|76047300|FG000|Overall Study|Death|1|||
42227528|NCT03031938|76047301|FG001|Overall Study|Death|0|||
42227529|NCT01137773|76047309|FG000|Overall Study|Death|3|||
42227530|NCT01137773|76047310|FG001|Overall Study|Death|3|||
42227531|NCT01137773|76047309|FG000|Overall Study|Lost to Follow-up|6|||
42227532|NCT01137773|76047310|FG001|Overall Study|Lost to Follow-up|0|||
42227533|NCT03094611|76047318|FG000|Overall Study|Lack of Efficacy|1|||
42227534|NCT03094611|76047318|FG000|Overall Study|Stem Cell Transplant|1|||
42227535|NCT04105725|76047342|FG000|Primary Intervention|Lost to Follow-up|0|||
42227536|NCT04105725|76047343|FG001|Primary Intervention|Lost to Follow-up|2|||
42227537|NCT04105725|76047342|FG000|Primary Intervention|Withdrawal by Subject|0|||
42227538|NCT04105725|76047343|FG001|Primary Intervention|Withdrawal by Subject|1|||
42227539|NCT04066023|76047352|FG000|Overall Study|Adverse Event|0|||
41985719|NCT01307449|75792538|FG001|Overall Study|Adverse Event|0|||
41985720|NCT01307449|75792539|FG002|Overall Study|Adverse Event|0|||
42227540|NCT04066023|76047353|FG001|Overall Study|Adverse Event|0|||
42227541|NCT04066023|76047354|FG002|Overall Study|Adverse Event|1|||
42227542|NCT04066023|76047352|FG000|Overall Study|Sponsor decision|3|||
42227543|NCT04066023|76047353|FG001|Overall Study|Sponsor decision|6|||
42227544|NCT04066023|76047354|FG002|Overall Study|Sponsor decision|2|||
42227545|NCT04066023|76047352|FG000|Overall Study|Physician Decision|0|||
42131705|NCT00320710|75942615|FG001|Overall Study|Administrative problems|2|||
42131706|NCT00320710|75942616|FG002|Overall Study|Administrative problems|0|||
42131707|NCT00320710|75942614|FG000|Overall Study|Withdrawal by Subject|20|||
42131708|NCT00320710|75942615|FG001|Overall Study|Withdrawal by Subject|26|||
42131709|NCT00320710|75942616|FG002|Overall Study|Withdrawal by Subject|1|||
42131710|NCT00320710|75942614|FG000|Overall Study|Protocol Violation|6|||
42227546|NCT04066023|76047353|FG001|Overall Study|Physician Decision|0|||
42227547|NCT04066023|76047354|FG002|Overall Study|Physician Decision|1|||
42227548|NCT04066023|76047352|FG000|Overall Study|Lost to Follow-up|0|||
42227549|NCT04066023|76047353|FG001|Overall Study|Lost to Follow-up|1|||
42227550|NCT04066023|76047354|FG002|Overall Study|Lost to Follow-up|1|||
42227551|NCT04066023|76047352|FG000|Overall Study|Noncompliance|0|||
41985721|NCT01307449|75792540|FG003|Overall Study|Adverse Event|0|||
41985722|NCT01307020|75792560|FG000|Overall Study|Lost to Follow-up|0|||
41985723|NCT01307020|75792561|FG001|Overall Study|Lost to Follow-up|0|||
41985724|NCT01307020|75792562|FG002|Overall Study|Lost to Follow-up|1|||
41985725|NCT01307020|75792563|FG003|Overall Study|Lost to Follow-up|1|||
41985726|NCT01307020|75792564|FG004|Overall Study|Lost to Follow-up|0|||
41985727|NCT01307020|75792565|FG005|Overall Study|Lost to Follow-up|0|||
41985728|NCT01307020|75792566|FG006|Overall Study|Lost to Follow-up|1|||
41985729|NCT01307020|75792567|FG007|Overall Study|Lost to Follow-up|0|||
41985730|NCT01307020|75792568|FG008|Overall Study|Lost to Follow-up|0|||
41985731|NCT01307020|75792569|FG009|Overall Study|Lost to Follow-up|0|||
41985732|NCT01307020|75792560|FG000|Overall Study|Electronic data capture failure|0|||
41985733|NCT01307020|75792561|FG001|Overall Study|Electronic data capture failure|1|||
41985734|NCT01307020|75792562|FG002|Overall Study|Electronic data capture failure|0|||
41985735|NCT01307020|75792563|FG003|Overall Study|Electronic data capture failure|0|||
41985736|NCT01307020|75792564|FG004|Overall Study|Electronic data capture failure|0|||
41985737|NCT01307020|75792565|FG005|Overall Study|Electronic data capture failure|0|||
41985738|NCT01307020|75792566|FG006|Overall Study|Electronic data capture failure|0|||
41985739|NCT01307020|75792567|FG007|Overall Study|Electronic data capture failure|0|||
41985740|NCT01307020|75792568|FG008|Overall Study|Electronic data capture failure|0|||
41985741|NCT01307020|75792569|FG009|Overall Study|Electronic data capture failure|0|||
41985742|NCT01306201|75792591|FG000|Overall Study|Arrhythmia|4|||
41985743|NCT01306201|75792591|FG000|Overall Study|Files could not be processed|3|||
41985744|NCT01306201|75792591|FG000|Overall Study|Files unreadable|3|||
41985745|NCT01306162|75792603|FG000|Period 1|Adverse Event|0|||
41985746|NCT01306162|75792604|FG001|Period 1|Adverse Event|0|||
41985747|NCT01306162|75792605|FG002|Period 1|Adverse Event|0|||
41985748|NCT01306162|75792606|FG003|Period 1|Adverse Event|1|||
41985749|NCT01306162|75792603|FG000|Washout 1|Non-compliance to protocol|0|||
41985750|NCT01306162|75792604|FG001|Washout 1|Non-compliance to protocol|1|||
41985751|NCT01306162|75792605|FG002|Washout 1|Non-compliance to protocol|0|||
41985752|NCT01306162|75792606|FG003|Washout 1|Non-compliance to protocol|0|||
41985753|NCT01305577|75792622|FG000|Overall Study|Adverse Event|2|||
41985754|NCT01305577|75792623|FG001|Overall Study|Adverse Event|2|||
41985755|NCT01305577|75792624|FG002|Overall Study|Adverse Event|1|||
41985756|NCT01305577|75792622|FG000|Overall Study|Withdrawal by Subject|7|||
41985757|NCT01305577|75792623|FG001|Overall Study|Withdrawal by Subject|5|||
41985758|NCT01305577|75792624|FG002|Overall Study|Withdrawal by Subject|6|||
41985759|NCT01305577|75792622|FG000|Overall Study|Lost to Follow-up|4|||
41985760|NCT01305577|75792623|FG001|Overall Study|Lost to Follow-up|3|||
41985761|NCT01305577|75792624|FG002|Overall Study|Lost to Follow-up|2|||
41985762|NCT01305577|75792622|FG000|Overall Study|Protocol Deviation|0|||
41985763|NCT01305577|75792623|FG001|Overall Study|Protocol Deviation|1|||
41985764|NCT01305577|75792624|FG002|Overall Study|Protocol Deviation|1|||
41985765|NCT01304329|75792632|FG000|Third Intervention (3 Days)|Adverse Event|0|||
41985766|NCT01304329|75792633|FG001|Third Intervention (3 Days)|Adverse Event|1|||
42032436|NCT01133405|75840640|FG008|Period 2|Physician Decision|0|||
42032437|NCT01133405|75840641|FG009|Period 2|Physician Decision|0|||
42032438|NCT01196078|75840673|FG000|Overall Study|Withdrawal by Subject|3|||
42032439|NCT01196078|75840674|FG001|Overall Study|Withdrawal by Subject|5|||
42032440|NCT01196078|75840673|FG000|Overall Study|Adverse Event|4|||
42032441|NCT01196078|75840674|FG001|Overall Study|Adverse Event|4|||
42032442|NCT01196078|75840673|FG000|Overall Study|Protocol Violation|2|||
42032443|NCT01196078|75840674|FG001|Overall Study|Protocol Violation|1|||
42131711|NCT00320710|75942615|FG001|Overall Study|Protocol Violation|5|||
42131712|NCT00320710|75942616|FG002|Overall Study|Protocol Violation|0|||
42131713|NCT00320710|75942614|FG000|Overall Study|Abnormal test procedure result(s)|2|||
42131714|NCT00320710|75942615|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42131715|NCT00320710|75942616|FG002|Overall Study|Abnormal test procedure result(s)|0|||
42227552|NCT04066023|76047353|FG001|Overall Study|Noncompliance|1|||
41985767|NCT01304329|75792634|FG002|Third Intervention (3 Days)|Adverse Event|0|||
41985768|NCT01304329|75792635|FG003|Third Intervention (3 Days)|Adverse Event|0|||
41985769|NCT01304329|75792636|FG004|Third Intervention (3 Days)|Adverse Event|0|||
41985770|NCT01304329|75792637|FG005|Third Intervention (3 Days)|Adverse Event|0|||
41985771|NCT01303861|75792650|FG000|Overall Study|Lost to Follow-up|34|||
41985772|NCT01303861|75792651|FG001|Overall Study|Lost to Follow-up|14|||
41985773|NCT01303861|75792652|FG002|Overall Study|Lost to Follow-up|27|||
41985774|NCT01303861|75792653|FG003|Overall Study|Lost to Follow-up|31|||
41985775|NCT01303861|75792650|FG000|Overall Study|Lack of Efficacy|3|||
41985776|NCT01303861|75792651|FG001|Overall Study|Lack of Efficacy|2|||
41985777|NCT01303861|75792652|FG002|Overall Study|Lack of Efficacy|1|||
41985778|NCT01303861|75792653|FG003|Overall Study|Lack of Efficacy|0|||
41985779|NCT01303861|75792650|FG000|Overall Study|Withdrawal by Subject|16|||
42032444|NCT01196078|75840673|FG000|Overall Study|Lack of Efficacy|17|||
42032445|NCT01196078|75840674|FG001|Overall Study|Lack of Efficacy|23|||
41985780|NCT01303861|75792651|FG001|Overall Study|Withdrawal by Subject|8|||
42227553|NCT04066023|76047354|FG002|Overall Study|Noncompliance|1|||
42227554|NCT03106987|76047366|FG000|Overall Study|Death|37|||
42227555|NCT03106987|76047367|FG001|Overall Study|Death|22|||
42227556|NCT03106987|76047368|FG002|Overall Study|Death|12|||
42227557|NCT03106987|76047369|FG003|Overall Study|Death|8|||
42227558|NCT03106987|76047366|FG000|Overall Study|Lost to Follow-up|2|||
42227559|NCT03106987|76047367|FG001|Overall Study|Lost to Follow-up|0|||
42227560|NCT03106987|76047368|FG002|Overall Study|Lost to Follow-up|2|||
42227561|NCT03106987|76047369|FG003|Overall Study|Lost to Follow-up|2|||
42227562|NCT03106987|76047366|FG000|Overall Study|Withdrawal by Subject|5|||
42227563|NCT03106987|76047367|FG001|Overall Study|Withdrawal by Subject|1|||
41985781|NCT01303861|75792652|FG002|Overall Study|Withdrawal by Subject|8|||
41985782|NCT01303861|75792653|FG003|Overall Study|Withdrawal by Subject|23|||
41985783|NCT01303861|75792650|FG000|Overall Study|Adverse Event|4|||
41985784|NCT01303861|75792651|FG001|Overall Study|Adverse Event|1|||
42302466|NCT02448043|76137690|FG001|Overall Study|Protocol Violation|2|||
42302467|NCT02447887|76137699|FG000|Overall Study|Study was terminated|3|||
42302468|NCT02471755|76137705|FG000|Overall Study|Withdrawal by Subject|1|||
42302469|NCT02471755|76137706|FG001|Overall Study|Withdrawal by Subject|0|||
42302470|NCT02471755|76137705|FG000|Overall Study|Lost to Follow-up|0|||
42302471|NCT02471755|76137706|FG001|Overall Study|Lost to Follow-up|1|||
42302472|NCT02470429|76137714|FG000|Overall Study|Adverse Event|1|||
42302473|NCT02470429|76137715|FG001|Overall Study|Adverse Event|0|||
42302474|NCT02470429|76137714|FG000|Overall Study|Withdrawal by Subject|1|||
42302475|NCT02470429|76137715|FG001|Overall Study|Withdrawal by Subject|0|||
41985785|NCT01303861|75792652|FG002|Overall Study|Adverse Event|0|||
41985786|NCT01303861|75792653|FG003|Overall Study|Adverse Event|5|||
41985787|NCT01303861|75792650|FG000|Overall Study|Pregnancy|1|||
42227564|NCT03106987|76047368|FG002|Overall Study|Withdrawal by Subject|4|||
42227565|NCT03106987|76047369|FG003|Overall Study|Withdrawal by Subject|1|||
42227566|NCT02932267|76047379|FG000|Overall Study|Withdrawal by Subject|3|||
42227567|NCT02932267|76047379|FG000|Overall Study|Lost to Follow-up|4|||
42227568|NCT02932267|76047379|FG000|Overall Study|Pregnancy|1|||
42227569|NCT03217591|76047386|FG000|Overall Study|Adverse Event|1|||
42227570|NCT03217591|76047387|FG001|Overall Study|Adverse Event|2|||
42227571|NCT03217591|76047388|FG002|Overall Study|Adverse Event|6|||
42227572|NCT03217591|76047386|FG000|Overall Study|Withdrawal by Subject|0|||
42227573|NCT03217591|76047387|FG001|Overall Study|Withdrawal by Subject|1|||
42227574|NCT03217591|76047388|FG002|Overall Study|Withdrawal by Subject|3|||
42227575|NCT03217591|76047386|FG000|Overall Study|Lost to Follow-up|1|||
42227576|NCT03217591|76047387|FG001|Overall Study|Lost to Follow-up|0|||
42227577|NCT03217591|76047388|FG002|Overall Study|Lost to Follow-up|0|||
42227578|NCT03217591|76047386|FG000|Overall Study|Protocol Violation|1|||
42227579|NCT03217591|76047387|FG001|Overall Study|Protocol Violation|0|||
42227580|NCT03217591|76047388|FG002|Overall Study|Protocol Violation|1|||
42227581|NCT03031782|76047397|FG000|Treatment Period 1|Lack of Efficacy|3|||
42227582|NCT03031782|76047398|FG001|Treatment Period 1|Lack of Efficacy|0|||
42227583|NCT03031782|76047399|FG002|Treatment Period 1|Lack of Efficacy|0|||
42227584|NCT03031782|76047400|FG003|Treatment Period 1|Lack of Efficacy|0|||
42227585|NCT03031782|76047401|FG004|Treatment Period 1|Lack of Efficacy|0|||
42227586|NCT03031782|76047397|FG000|Treatment Period 2|Physician Decision|0|||
42227587|NCT03031782|76047398|FG001|Treatment Period 2|Physician Decision|1|||
42227588|NCT03031782|76047399|FG002|Treatment Period 2|Physician Decision|0|||
42227589|NCT03031782|76047400|FG003|Treatment Period 2|Physician Decision|0|||
42227590|NCT03031782|76047401|FG004|Treatment Period 2|Physician Decision|3|||
41985788|NCT01303861|75792651|FG001|Overall Study|Pregnancy|0|||
41985789|NCT01303861|75792652|FG002|Overall Study|Pregnancy|0|||
41985790|NCT01303861|75792653|FG003|Overall Study|Pregnancy|0|||
41985791|NCT01303627|75792666|FG000|Overall Study|the failure while performing URS|0|||
41985792|NCT01303627|75792667|FG001|Overall Study|the failure while performing URS|1|||
42227591|NCT03031782|76047397|FG000|Treatment Period 2|Lack of Efficacy|0|||
42227592|NCT03031782|76047398|FG001|Treatment Period 2|Lack of Efficacy|1|||
42227593|NCT03031782|76047399|FG002|Treatment Period 2|Lack of Efficacy|0|||
42227594|NCT03031782|76047400|FG003|Treatment Period 2|Lack of Efficacy|0|||
42227595|NCT03031782|76047401|FG004|Treatment Period 2|Lack of Efficacy|1|||
41985793|NCT01303510|75792675|FG000|Overall Study|Lost to Follow-up|1|||
41985794|NCT01303510|75792676|FG001|Overall Study|Lost to Follow-up|0|||
41985795|NCT01303159|75792682|FG000|Overall Study|Death|16|||
42227596|NCT03031782|76047397|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42227597|NCT03031782|76047398|FG001|Treatment Period 2|Withdrawal by Subject|3|||
42227598|NCT03031782|76047399|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42227599|NCT03031782|76047400|FG003|Treatment Period 2|Withdrawal by Subject|0|||
41985796|NCT01303159|75792682|FG000|Overall Study|Study Termination|7|||
42227600|NCT03031782|76047401|FG004|Treatment Period 2|Withdrawal by Subject|1|||
42302476|NCT02447497|76137726|FG000|Overall Study|Did not meet treatment day baseline.|6|||
41985797|NCT01302964|75792688|FG000|Overall Study|Adverse Event|1|||
42227601|NCT03031782|76047397|FG000|Treatment Period 2|Adverse Event|0|||
42227602|NCT03031782|76047398|FG001|Treatment Period 2|Adverse Event|1|||
42227603|NCT03031782|76047399|FG002|Treatment Period 2|Adverse Event|2|||
42227604|NCT03031782|76047400|FG003|Treatment Period 2|Adverse Event|0|||
42227605|NCT03031782|76047401|FG004|Treatment Period 2|Adverse Event|0|||
42227606|NCT03031782|76047397|FG000|Treatment Period 3|Withdrawal by Subject|0|||
42227607|NCT03031782|76047398|FG001|Treatment Period 3|Withdrawal by Subject|0|||
42227608|NCT03031782|76047399|FG002|Treatment Period 3|Withdrawal by Subject|0|||
42227609|NCT03031782|76047400|FG003|Treatment Period 3|Withdrawal by Subject|1|||
42227610|NCT03031782|76047401|FG004|Treatment Period 3|Withdrawal by Subject|0|||
42227611|NCT03216265|76047418|FG000|Overall Study|Adverse Event|2|||
42227612|NCT03216265|76047419|FG001|Overall Study|Adverse Event|0|||
42227613|NCT03216265|76047420|FG002|Overall Study|Adverse Event|2|||
41985798|NCT01302964|75792689|FG001|Overall Study|Adverse Event|0|||
41985799|NCT01302691|75792697|FG000|Overall Study|Adverse Event|2|||
41985800|NCT01302691|75792698|FG001|Overall Study|Adverse Event|0|||
41985801|NCT01302691|75792697|FG000|Overall Study|Death|0|||
41985802|NCT01302691|75792698|FG001|Overall Study|Death|1|||
41985803|NCT01302691|75792697|FG000|Overall Study|Lost to Follow-up|1|||
41985804|NCT01302691|75792698|FG001|Overall Study|Lost to Follow-up|0|||
41985805|NCT01302691|75792697|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
41985806|NCT01302691|75792698|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
41985807|NCT01302691|75792697|FG000|Overall Study|Physician Decision|0|||
41985808|NCT01302691|75792698|FG001|Overall Study|Physician Decision|1|||
41985809|NCT01302691|75792697|FG000|Overall Study|Protocol Violation|1|||
41985810|NCT01302691|75792698|FG001|Overall Study|Protocol Violation|0|||
41985811|NCT01302418|75792704|FG000|Overall Study|Protocol Violation|9|||
41985812|NCT01302418|75792704|FG000|Overall Study|Non-evaluable|9|||
41985813|NCT01302067|75792711|FG000|Overall Study|Death|0|||
42227614|NCT03216265|76047418|FG000|Overall Study|Lost to Follow-up|0|||
42227615|NCT03216265|76047419|FG001|Overall Study|Lost to Follow-up|1|||
42227616|NCT03216265|76047420|FG002|Overall Study|Lost to Follow-up|0|||
41985814|NCT01302067|75792712|FG001|Overall Study|Death|0|||
41985815|NCT01302067|75792713|FG002|Overall Study|Death|1|||
41985816|NCT01302067|75792711|FG000|Overall Study|Physician Decision|9|||
42227617|NCT03216265|76047418|FG000|Overall Study|Withdrawal by Subject|0|||
41985817|NCT01302067|75792712|FG001|Overall Study|Physician Decision|5|||
42227618|NCT03216265|76047419|FG001|Overall Study|Withdrawal by Subject|0|||
42227619|NCT03216265|76047420|FG002|Overall Study|Withdrawal by Subject|1|||
41985818|NCT01302067|75792713|FG002|Overall Study|Physician Decision|14|||
41985819|NCT01302067|75792711|FG000|Overall Study|Lack of Efficacy|8|||
41985820|NCT01302067|75792712|FG001|Overall Study|Lack of Efficacy|4|||
41985821|NCT01302067|75792713|FG002|Overall Study|Lack of Efficacy|2|||
41985822|NCT01302067|75792711|FG000|Overall Study|Lost to Follow-up|9|||
41985823|NCT01302067|75792712|FG001|Overall Study|Lost to Follow-up|4|||
41985824|NCT01302067|75792713|FG002|Overall Study|Lost to Follow-up|15|||
41985825|NCT01302067|75792711|FG000|Overall Study|Withdrawal by Subject|13|||
41985826|NCT01302067|75792712|FG001|Overall Study|Withdrawal by Subject|6|||
41985827|NCT01302067|75792713|FG002|Overall Study|Withdrawal by Subject|10|||
41985828|NCT01302067|75792711|FG000|Overall Study|Other|1|||
41985829|NCT01302067|75792712|FG001|Overall Study|Other|1|||
41985830|NCT01302067|75792713|FG002|Overall Study|Other|3|||
41985831|NCT01302067|75792711|FG000|Overall Study|Protocol Violation|11|||
41985832|NCT01302067|75792712|FG001|Overall Study|Protocol Violation|0|||
41985833|NCT01302067|75792713|FG002|Overall Study|Protocol Violation|8|||
41985834|NCT01302067|75792711|FG000|Overall Study|Adverse Event|27|||
41985835|NCT01302067|75792712|FG001|Overall Study|Adverse Event|14|||
41985836|NCT01302067|75792713|FG002|Overall Study|Adverse Event|45|||
42131716|NCT00320710|75942614|FG000|Overall Study|Abnormal laboratory value(s)|12|||
42227620|NCT04486950|76047451|FG000|Overall Study|Lost to Follow-up|0|||
42227621|NCT04486950|76047452|FG001|Overall Study|Lost to Follow-up|0|||
42227622|NCT04486950|76047453|FG002|Overall Study|Lost to Follow-up|0|||
42227623|NCT04486950|76047454|FG003|Overall Study|Lost to Follow-up|0|||
42227624|NCT04486950|76047455|FG004|Overall Study|Lost to Follow-up|0|||
42227625|NCT04486950|76047456|FG005|Overall Study|Lost to Follow-up|1|||
42227626|NCT04486950|76047457|FG006|Overall Study|Lost to Follow-up|0|||
42227627|NCT04693416|76047479|FG000|Overall Study|Lost to Follow-up|13|||
42227628|NCT04693416|76047480|FG001|Overall Study|Lost to Follow-up|0|||
42227629|NCT00265941|76047488|FG000|Overall Study|Protocol Violation|22|||
42227630|NCT00265941|76047489|FG001|Overall Study|Protocol Violation|25|||
42227631|NCT00265941|76047488|FG000|Overall Study|Lost to Follow-up|1|||
42227632|NCT00265941|76047489|FG001|Overall Study|Lost to Follow-up|1|||
42227633|NCT03882957|76047503|FG000|Overall Study|Did not complete all three arms|1|||
42227634|NCT03201211|76047515|FG000|Overall Study|Adverse Event|1|||
42227635|NCT03201211|76047516|FG001|Overall Study|Adverse Event|0|||
42227636|NCT03201211|76047517|FG002|Overall Study|Adverse Event|0|||
42227637|NCT03201211|76047515|FG000|Overall Study|Protocol Violation|1|||
42227638|NCT03201211|76047516|FG001|Overall Study|Protocol Violation|0|||
42227639|NCT03201211|76047517|FG002|Overall Study|Protocol Violation|0|||
42227640|NCT03201211|76047515|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
42227641|NCT03201211|76047516|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
42227642|NCT03201211|76047517|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
42227643|NCT03201211|76047515|FG000|Overall Study|OTHER unknown reasons|0|||
42227644|NCT03201211|76047516|FG001|Overall Study|OTHER unknown reasons|1|||
42227645|NCT03201211|76047517|FG002|Overall Study|OTHER unknown reasons|0|||
42227646|NCT04633837|76047527|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
42227647|NCT04633837|76047528|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
42227648|NCT03029832|76047536|FG000|Overall Study|Safety Follow-Up Completed|2|||
41985837|NCT01301950|75792723|FG000|Overall Study|Surgery was cancelled by patient|0|||
41985838|NCT01301950|75792724|FG001|Overall Study|Surgery was cancelled by patient|1|||
41985839|NCT01301833|75792734|FG000|Overall Study|Adverse Event|7|||
41985840|NCT01301833|75792735|FG001|Overall Study|Adverse Event|5|||
41985841|NCT01301833|75792736|FG002|Overall Study|Adverse Event|5|||
41985842|NCT01301833|75792737|FG003|Overall Study|Adverse Event|5|||
41985843|NCT01301833|75792734|FG000|Overall Study|Lack of Efficacy|1|||
41985844|NCT01301833|75792735|FG001|Overall Study|Lack of Efficacy|1|||
41985845|NCT01301833|75792736|FG002|Overall Study|Lack of Efficacy|0|||
41985846|NCT01301833|75792737|FG003|Overall Study|Lack of Efficacy|0|||
41985847|NCT01301833|75792734|FG000|Overall Study|Physician Decision|3|||
41985848|NCT01301833|75792735|FG001|Overall Study|Physician Decision|1|||
42227649|NCT03029832|76047537|FG001|Overall Study|Safety Follow-Up Completed|0|||
42227650|NCT03029832|76047536|FG000|Overall Study|Death due to Disease Progression|1|||
42227651|NCT03029832|76047537|FG001|Overall Study|Death due to Disease Progression|0|||
42227652|NCT03029832|76047536|FG000|Overall Study|Study Terminated By Sponsor|1|||
42227653|NCT03029832|76047537|FG001|Overall Study|Study Terminated By Sponsor|1|||
42227654|NCT03089697|76047545|FG000|Overall Study|Adverse Event|1|||
42227655|NCT03089697|76047546|FG001|Overall Study|Adverse Event|2|||
42227656|NCT03089697|76047545|FG000|Overall Study|Withdrawal by Subject|1|||
42227657|NCT03089697|76047546|FG001|Overall Study|Withdrawal by Subject|0|||
42227658|NCT03199963|76047554|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
42227659|NCT03199963|76047555|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
42227660|NCT03199963|76047554|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
42227661|NCT03199963|76047555|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
42227662|NCT03199963|76047554|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
42227663|NCT03199963|76047555|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
42227664|NCT03199963|76047554|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
42227665|NCT03199963|76047555|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
42227666|NCT03199963|76047554|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
42227667|NCT03199963|76047555|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
42227668|NCT03199963|76047554|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
42227669|NCT03199963|76047555|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
42227670|NCT03883581|76047567|FG000|Overall Study|Withdrawal by Subject|4|||
42227671|NCT03029208|76047573|FG000|Overall Study|Withdrawal by Subject|2|||
42227672|NCT03029208|76047574|FG001|Overall Study|Withdrawal by Subject|3|||
42227673|NCT03029208|76047573|FG000|Overall Study|Lost to Follow-up|0|||
42227674|NCT03029208|76047574|FG001|Overall Study|Lost to Follow-up|1|||
42227675|NCT03198715|76047594|FG000|Overall Study|Death|0|||
42227676|NCT03198715|76047595|FG001|Overall Study|Death|0|||
42227677|NCT03198715|76047596|FG002|Overall Study|Death|1|||
42227678|NCT03198715|76047597|FG003|Overall Study|Death|0|||
42227679|NCT03198715|76047598|FG004|Overall Study|Death|2|||
42227680|NCT03198715|76047594|FG000|Overall Study|Other|0|||
42227681|NCT03198715|76047595|FG001|Overall Study|Other|1|||
42227682|NCT03198715|76047596|FG002|Overall Study|Other|1|||
42227683|NCT03198715|76047597|FG003|Overall Study|Other|0|||
42227684|NCT03198715|76047598|FG004|Overall Study|Other|0|||
42227685|NCT03088917|76047619|FG000|Overall Study|In care/cured elsewhere|15|||
42227686|NCT03088917|76047619|FG000|Overall Study|Refuse re-evaluation|13|||
42227687|NCT03088917|76047619|FG000|Overall Study|Contact not established|13|||
42227688|NCT03088917|76047619|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
42227689|NCT03088917|76047619|FG000|Overall Study|Moved outside study region|50|||
42227690|NCT03087513|76047625|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
41985849|NCT01301833|75792736|FG002|Overall Study|Physician Decision|1|||
41985850|NCT01301833|75792737|FG003|Overall Study|Physician Decision|0|||
41985851|NCT01301833|75792734|FG000|Overall Study|Withdrawal by Subject|3|||
41985852|NCT01301833|75792735|FG001|Overall Study|Withdrawal by Subject|1|||
41985853|NCT01301833|75792736|FG002|Overall Study|Withdrawal by Subject|1|||
41985854|NCT01301833|75792737|FG003|Overall Study|Withdrawal by Subject|2|||
42227691|NCT02917629|76047640|FG000|Overall Study|Withdrawal by Subject|0|||
42227692|NCT02917629|76047641|FG001|Overall Study|Withdrawal by Subject|1|||
42227693|NCT02927847|76047650|FG000|Overall Study|Lost to Follow-up|1|||
42227694|NCT02927847|76047651|FG001|Overall Study|Lost to Follow-up|0|||
42227695|NCT02927847|76047650|FG000|Overall Study|Withdrawal by Subject|4|||
42227696|NCT02927847|76047651|FG001|Overall Study|Withdrawal by Subject|2|||
42227697|NCT02927847|76047650|FG000|Overall Study|PI withdrawn due to missed visits|1|||
42227698|NCT02927847|76047651|FG001|Overall Study|PI withdrawn due to missed visits|1|||
42227699|NCT02960438|76047661|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
42227700|NCT02960438|76047662|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
42227701|NCT02960438|76047663|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
42227702|NCT02960438|76047664|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
42227703|NCT02960438|76047661|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
42227704|NCT02960438|76047662|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
42227705|NCT02960438|76047663|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
42227706|NCT02960438|76047664|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
42227707|NCT02960438|76047661|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
41985855|NCT01301833|75792734|FG000|Overall Study|Personal matter|1|||
41985856|NCT01301833|75792735|FG001|Overall Study|Personal matter|0|||
41985857|NCT01301833|75792736|FG002|Overall Study|Personal matter|0|||
41985858|NCT01301833|75792737|FG003|Overall Study|Personal matter|0|||
42227708|NCT02960438|76047662|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
42227709|NCT02960438|76047663|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
42227710|NCT02960438|76047664|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
42227711|NCT02960438|76047661|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
42227712|NCT02960438|76047662|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
42227713|NCT02960438|76047663|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
42227714|NCT02960438|76047664|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
42227715|NCT02960438|76047661|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
42227716|NCT02960438|76047662|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
42227717|NCT02960438|76047663|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
42227718|NCT02960438|76047664|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
42227719|NCT02960438|76047661|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
41985859|NCT01301092|75792750|FG000|Overall Study|Lost to Follow-up|0|||
41985860|NCT01301092|75792751|FG001|Overall Study|Lost to Follow-up|0|||
41985861|NCT01301092|75792752|FG002|Overall Study|Lost to Follow-up|1|||
42227720|NCT02960438|76047662|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
42227721|NCT02960438|76047663|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
42227722|NCT02960438|76047664|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
42227723|NCT02960438|76047661|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
42227724|NCT02960438|76047662|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
42227725|NCT02960438|76047663|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
42227726|NCT02960438|76047664|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
42227727|NCT02960438|76047661|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
42227728|NCT02960438|76047662|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
42227729|NCT02960438|76047663|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
42227730|NCT02960438|76047664|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
42227731|NCT02960438|76047661|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
42227732|NCT02960438|76047662|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
42227733|NCT02960438|76047663|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
42227734|NCT02960438|76047664|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
42227735|NCT02960438|76047661|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
42227736|NCT02960438|76047662|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
42227737|NCT02960438|76047663|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
42227738|NCT02960438|76047664|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
42227739|NCT02960438|76047661|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
42227740|NCT02960438|76047662|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
42227741|NCT02960438|76047663|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
42227742|NCT02960438|76047664|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
42227743|NCT02960438|76047661|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
42227744|NCT02960438|76047662|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
42227745|NCT02960438|76047663|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
42227746|NCT02960438|76047664|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
42227747|NCT02957942|76047684|FG000|Overall Study|Withdrawal by Subject|0|||
41985862|NCT01300819|75792767|FG000|Overall Study|Adverse Event|9|||
41985863|NCT01300819|75792768|FG001|Overall Study|Adverse Event|27|||
41985864|NCT01300819|75792767|FG000|Overall Study|Lack of Efficacy|2|||
41985865|NCT01300819|75792768|FG001|Overall Study|Lack of Efficacy|1|||
42227748|NCT02957942|76047685|FG001|Overall Study|Withdrawal by Subject|1|||
42227749|NCT02957942|76047684|FG000|Overall Study|Practicing experiment protocol|0|||
42227750|NCT02957942|76047685|FG001|Overall Study|Practicing experiment protocol|6|||
42227751|NCT02959970|76047693|FG000|Overall Study|Adverse Event|1|||
42227752|NCT02959970|76047694|FG001|Overall Study|Adverse Event|0|||
42227753|NCT02959970|76047693|FG000|Overall Study|Withdrawal by Subject|0|||
42227754|NCT02959970|76047694|FG001|Overall Study|Withdrawal by Subject|2|||
42227755|NCT02959970|76047693|FG000|Overall Study|Lost to Follow-up|1|||
42227756|NCT02959970|76047694|FG001|Overall Study|Lost to Follow-up|5|||
42227757|NCT05300763|76047727|FG000|Overall Study|Adverse Event|0|||
41985866|NCT01300819|75792767|FG000|Overall Study|Withdrawal by Subject|10|||
41985867|NCT01300819|75792768|FG001|Overall Study|Withdrawal by Subject|12|||
41985868|NCT01300819|75792767|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
41985869|NCT01300819|75792768|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
41985870|NCT01300819|75792767|FG000|Overall Study|Refusal to down titrate study drug|0|||
41985871|NCT01300819|75792768|FG001|Overall Study|Refusal to down titrate study drug|1|||
41985872|NCT01300819|75792767|FG000|Overall Study|Administrative reason|0|||
41985873|NCT01300819|75792768|FG001|Overall Study|Administrative reason|1|||
41985874|NCT01300819|75792767|FG000|Overall Study|Safety follow up not done by mistake|0|||
41985875|NCT01300819|75792768|FG001|Overall Study|Safety follow up not done by mistake|1|||
41985876|NCT01300819|75792767|FG000|Overall Study|Follow up call was not done|1|||
41985877|NCT01300819|75792768|FG001|Overall Study|Follow up call was not done|0|||
41985878|NCT01300741|75792774|FG000|Overall Study|Lens deposits|1|||
41985879|NCT01300741|75792774|FG000|Overall Study|Lost to Follow-up|1|||
41985880|NCT01300741|75792774|FG000|Overall Study|Discomfort|1|||
41985881|NCT01300546|75792782|FG000|Overall Study|Withdrawal by Subject|1|||
41985882|NCT01300546|75792783|FG001|Overall Study|Withdrawal by Subject|0|||
41985883|NCT01300546|75792782|FG000|Overall Study|Lost to Follow-up|0|||
42227758|NCT05300763|76047728|FG001|Overall Study|Adverse Event|1|||
42227759|NCT05300763|76047727|FG000|Overall Study|Major Protocol Deviation|1|||
41985884|NCT01300546|75792783|FG001|Overall Study|Lost to Follow-up|2|||
41985885|NCT01300546|75792782|FG000|Overall Study|Lack of Efficacy|0|||
41985886|NCT01300546|75792783|FG001|Overall Study|Lack of Efficacy|3|||
41985887|NCT01300546|75792782|FG000|Overall Study|Adverse Event|0|||
41985888|NCT01300546|75792783|FG001|Overall Study|Adverse Event|1|||
41985889|NCT01300351|75792791|FG000|Overall Study|Did not receive treatment|2|||
41985890|NCT01300351|75792792|FG001|Overall Study|Did not receive treatment|0|||
41985891|NCT01300351|75792791|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
41985892|NCT01300351|75792792|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
41985893|NCT01300351|75792791|FG000|Overall Study|Lost to Follow-up|0|||
41985894|NCT01300351|75792792|FG001|Overall Study|Lost to Follow-up|1|||
41985895|NCT01300351|75792791|FG000|Overall Study|Adverse Event|0|||
41985896|NCT01300351|75792792|FG001|Overall Study|Adverse Event|4|||
41985897|NCT01300351|75792791|FG000|Overall Study|Withdrawal by Subject|7|||
41985898|NCT01300351|75792792|FG001|Overall Study|Withdrawal by Subject|10|||
41985899|NCT01300234|75792800|FG000|Overall Study|Adverse Event|1|||
42227760|NCT05300763|76047728|FG001|Overall Study|Major Protocol Deviation|0|||
42227761|NCT05300763|76047727|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
42227762|NCT05300763|76047728|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
42227763|NCT01383135|76047738|FG000|Overall Study|Not Scanned / Imaged|1|||
42227764|NCT01383135|76047739|FG001|Overall Study|Not Scanned / Imaged|0|||
42227765|NCT01383135|76047740|FG002|Overall Study|Not Scanned / Imaged|1|||
42227766|NCT01383135|76047741|FG003|Overall Study|Not Scanned / Imaged|0|||
42227767|NCT02925312|76047754|FG000|Overall Study|Lost to Follow-up|25|||
42227768|NCT02925312|76047755|FG001|Overall Study|Lost to Follow-up|0|||
42227769|NCT02925312|76047754|FG000|Overall Study|Adverse Event|2|||
42227770|NCT02925312|76047755|FG001|Overall Study|Adverse Event|0|||
42227771|NCT03196297|76047770|FG000|Main Period|Withdrawal by Subject|4|||
42227772|NCT03196297|76047770|FG000|Extension Period|Withdrawal by Subject|1|||
42227773|NCT03196297|76047770|FG000|Extension Period|Lack of Efficacy|2|||
42227774|NCT03192475|76047788|FG000|Overall Study|Death|0|||
42227775|NCT03192475|76047789|FG001|Overall Study|Death|1|||
42227776|NCT03192475|76047788|FG000|Overall Study|Lost to Follow-up|13|||
42227777|NCT03192475|76047789|FG001|Overall Study|Lost to Follow-up|8|||
42227778|NCT03189745|76047798|FG000|Overall Study|Conflict in work schedule of participant|1|||
42227779|NCT03189745|76047799|FG001|Overall Study|Conflict in work schedule of participant|1|||
42227780|NCT03188263|76047807|FG000|Overall Study|Withdrawal by Subject|3|||
42227781|NCT03188263|76047808|FG001|Overall Study|Withdrawal by Subject|0|||
42227782|NCT03188263|76047807|FG000|Overall Study|Physician Decision|1|||
42227783|NCT03188263|76047808|FG001|Overall Study|Physician Decision|0|||
42227784|NCT03188185|76047816|FG000|Stage 1|Adverse Event|4|||
41985900|NCT01300234|75792801|FG001|Overall Study|Adverse Event|1|||
41985901|NCT01300234|75792800|FG000|Overall Study|Protocol Violation|2|||
41985902|NCT01300234|75792801|FG001|Overall Study|Protocol Violation|3|||
41985903|NCT01300234|75792800|FG000|Overall Study|Withdrawal by Subject|5|||
41985904|NCT01300234|75792801|FG001|Overall Study|Withdrawal by Subject|9|||
41985905|NCT01300234|75792800|FG000|Overall Study|Lost to Follow-up|14|||
41985906|NCT01300234|75792801|FG001|Overall Study|Lost to Follow-up|12|||
41985907|NCT01300234|75792800|FG000|Overall Study|Pregnancy|2|||
41985908|NCT01300234|75792801|FG001|Overall Study|Pregnancy|1|||
41985909|NCT01300234|75792800|FG000|Overall Study|Participant reached stopping critera|2|||
41985910|NCT01300234|75792801|FG001|Overall Study|Participant reached stopping critera|0|||
41985911|NCT01300234|75792800|FG000|Overall Study|Participant stopped medication|1|||
41985912|NCT01300234|75792801|FG001|Overall Study|Participant stopped medication|1|||
41985913|NCT01300234|75792800|FG000|Overall Study|Participant refused return to hospital|1|||
41985914|NCT01300234|75792801|FG001|Overall Study|Participant refused return to hospital|0|||
41985915|NCT01299961|75792818|FG000|Overall Study|Adverse Event|3|||
41985916|NCT01299961|75792818|FG000|Overall Study|Lack of Efficacy|2|||
41985917|NCT01299961|75792818|FG000|Overall Study|Lost to Follow-up|1|||
41985918|NCT01299805|75792824|FG000|Overall Study|Adverse Event|2|||
41985919|NCT01299805|75792825|FG001|Overall Study|Adverse Event|0|||
41985920|NCT01299766|75792833|FG000|Overall Study|Death|5|||
41985921|NCT01299766|75792834|FG001|Overall Study|Death|4|||
41985922|NCT01299766|75792833|FG000|Overall Study|Withdrawal by Subject|29|||
41985923|NCT01299766|75792834|FG001|Overall Study|Withdrawal by Subject|19|||
41985924|NCT01299727|75792843|FG000|Overall Study|Withdrawal by Subject|1|||
41985925|NCT01299727|75792844|FG001|Overall Study|Withdrawal by Subject|0|||
41985926|NCT01299727|75792845|FG002|Overall Study|Withdrawal by Subject|0|||
42227785|NCT03188185|76047817|FG001|Stage 1|Adverse Event|12|||
42227786|NCT03188185|76047818|FG002|Stage 1|Adverse Event|0|||
42227787|NCT03188185|76047819|FG003|Stage 1|Adverse Event|0|||
42227788|NCT03188185|76047816|FG000|Stage 1|Lack of Efficacy|0|||
42227789|NCT03188185|76047817|FG001|Stage 1|Lack of Efficacy|2|||
42227790|NCT03188185|76047818|FG002|Stage 1|Lack of Efficacy|0|||
42302477|NCT02447497|76137727|FG001|Overall Study|Did not meet treatment day baseline.|5|||
42227791|NCT03188185|76047819|FG003|Stage 1|Lack of Efficacy|0|||
42227792|NCT03188185|76047816|FG000|Stage 1|Lost to Follow-up|6|||
42227793|NCT03188185|76047817|FG001|Stage 1|Lost to Follow-up|1|||
42227794|NCT03188185|76047818|FG002|Stage 1|Lost to Follow-up|0|||
42227795|NCT03188185|76047819|FG003|Stage 1|Lost to Follow-up|0|||
42227796|NCT03188185|76047816|FG000|Stage 1|Withdrawal by Subject|9|||
42227797|NCT03188185|76047817|FG001|Stage 1|Withdrawal by Subject|0|||
42227798|NCT03188185|76047818|FG002|Stage 1|Withdrawal by Subject|0|||
42227799|NCT03188185|76047819|FG003|Stage 1|Withdrawal by Subject|0|||
42227800|NCT03188185|76047816|FG000|Stage 1|Identified as a professional patient|0|||
42227801|NCT03188185|76047817|FG001|Stage 1|Identified as a professional patient|1|||
42227802|NCT03188185|76047818|FG002|Stage 1|Identified as a professional patient|0|||
42227803|NCT03188185|76047819|FG003|Stage 1|Identified as a professional patient|0|||
42227804|NCT03188185|76047816|FG000|Stage 2|Adverse Event|0|||
42227805|NCT03188185|76047817|FG001|Stage 2|Adverse Event|0|||
42227806|NCT03188185|76047818|FG002|Stage 2|Adverse Event|2|||
42227807|NCT03188185|76047819|FG003|Stage 2|Adverse Event|4|||
42227808|NCT03188185|76047816|FG000|Stage 2|Lack of Efficacy|0|||
42227809|NCT03188185|76047817|FG001|Stage 2|Lack of Efficacy|0|||
42227810|NCT03188185|76047818|FG002|Stage 2|Lack of Efficacy|3|||
42227811|NCT03188185|76047819|FG003|Stage 2|Lack of Efficacy|0|||
42227812|NCT03188185|76047816|FG000|Stage 2|Lost to Follow-up|0|||
42227813|NCT03188185|76047817|FG001|Stage 2|Lost to Follow-up|0|||
42227814|NCT03188185|76047818|FG002|Stage 2|Lost to Follow-up|1|||
42227815|NCT03188185|76047819|FG003|Stage 2|Lost to Follow-up|0|||
42227816|NCT03188185|76047816|FG000|Stage 2|Physician Decision|0|||
42227817|NCT03188185|76047817|FG001|Stage 2|Physician Decision|0|||
42227818|NCT03188185|76047818|FG002|Stage 2|Physician Decision|0|||
42227819|NCT03188185|76047819|FG003|Stage 2|Physician Decision|1|||
42227820|NCT03188185|76047816|FG000|Stage 2|Withdrawal by Subject|0|||
42227821|NCT03188185|76047817|FG001|Stage 2|Withdrawal by Subject|0|||
42227822|NCT03188185|76047818|FG002|Stage 2|Withdrawal by Subject|3|||
42227823|NCT03188185|76047819|FG003|Stage 2|Withdrawal by Subject|1|||
42227824|NCT03186781|76047835|FG000|Overall Study|Lost to Follow-up|0|||
42227825|NCT03186781|76047836|FG001|Overall Study|Lost to Follow-up|0|||
42227826|NCT03186781|76047837|FG002|Overall Study|Lost to Follow-up|1|||
42227827|NCT03186781|76047838|FG003|Overall Study|Lost to Follow-up|0|||
42227828|NCT03186781|76047839|FG004|Overall Study|Lost to Follow-up|1|||
42227829|NCT03186781|76047840|FG005|Overall Study|Lost to Follow-up|0|||
42227830|NCT03186781|76047835|FG000|Overall Study|Moved from Area|0|||
42227831|NCT03186781|76047836|FG001|Overall Study|Moved from Area|0|||
42227832|NCT03186781|76047837|FG002|Overall Study|Moved from Area|0|||
41985927|NCT01299727|75792843|FG000|Overall Study|Adverse Event|0|||
41985928|NCT01299727|75792844|FG001|Overall Study|Adverse Event|0|||
41985929|NCT01299727|75792845|FG002|Overall Study|Adverse Event|1|||
41985930|NCT01299727|75792843|FG000|Overall Study|Completed the Treatment Period|3|||
41985931|NCT01299727|75792844|FG001|Overall Study|Completed the Treatment Period|4|||
42227833|NCT03186781|76047838|FG003|Overall Study|Moved from Area|0|||
42227834|NCT03186781|76047839|FG004|Overall Study|Moved from Area|1|||
42227835|NCT03186781|76047840|FG005|Overall Study|Moved from Area|0|||
42227836|NCT03186781|76047835|FG000|Overall Study|Withdrawal by Subject|0|||
42227837|NCT03186781|76047836|FG001|Overall Study|Withdrawal by Subject|0|||
42227838|NCT03186781|76047837|FG002|Overall Study|Withdrawal by Subject|0|||
42227839|NCT03186781|76047838|FG003|Overall Study|Withdrawal by Subject|0|||
42227840|NCT03186781|76047839|FG004|Overall Study|Withdrawal by Subject|1|||
42227841|NCT03186781|76047840|FG005|Overall Study|Withdrawal by Subject|0|||
42227842|NCT03184987|76047867|FG000|Overall Study|Withdrawal by Subject|0|||
42227843|NCT03184987|76047868|FG001|Overall Study|Withdrawal by Subject|1|||
41985932|NCT01299727|75792845|FG002|Overall Study|Completed the Treatment Period|3|||
41985933|NCT01299571|75792853|FG000|Overall Study|Protocol Violation|107|||
41985934|NCT01299376|75792860|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
41985935|NCT01299376|75792861|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
41985936|NCT01299376|75792860|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
42227844|NCT03184987|76047869|FG002|Overall Study|Withdrawal by Subject|2|||
42227845|NCT03184987|76047867|FG000|Overall Study|Physician Decision|0|||
42227846|NCT03184987|76047868|FG001|Overall Study|Physician Decision|0|||
42227847|NCT03184987|76047869|FG002|Overall Study|Physician Decision|1|||
42227848|NCT03184987|76047867|FG000|Overall Study|Adverse Event|1|||
42227849|NCT03184987|76047868|FG001|Overall Study|Adverse Event|0|||
42227850|NCT03184987|76047869|FG002|Overall Study|Adverse Event|1|||
42227851|NCT03184519|76047877|FG000|Overall Study|Lost to Follow-up|6|||
42227852|NCT03184519|76047877|FG000|Overall Study|Physician Decision|21|||
42227853|NCT03184441|76047881|FG000|Overall Study|Withdrawal by Subject|1|||
42227854|NCT03026166|76047890|FG000|Overall Study|Death|22|||
42227855|NCT03026166|76047891|FG001|Overall Study|Death|7|||
42227856|NCT03026166|76047890|FG000|Overall Study|Physician Decision|2|||
42227857|NCT03026166|76047891|FG001|Overall Study|Physician Decision|0|||
42227858|NCT03026166|76047890|FG000|Overall Study|Withdrawal by Subject|1|||
42227859|NCT03026166|76047891|FG001|Overall Study|Withdrawal by Subject|2|||
42227860|NCT03026166|76047890|FG000|Overall Study|Lost to Follow-up|1|||
42227861|NCT03026166|76047891|FG001|Overall Study|Lost to Follow-up|0|||
42227862|NCT03026166|76047890|FG000|Overall Study|Study Terminated by Sponsor|3|||
42227863|NCT03026166|76047891|FG001|Overall Study|Study Terminated by Sponsor|3|||
42227864|NCT03026166|76047890|FG000|Overall Study|Other|1|||
42227865|NCT03026166|76047891|FG001|Overall Study|Other|0|||
42227866|NCT03026088|76047897|FG000|Overall Study|Study termination|20|||
41985937|NCT01299376|75792861|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
41985938|NCT01299376|75792860|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
41985939|NCT01299376|75792861|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
41985940|NCT01299376|75792860|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
41985941|NCT01299376|75792861|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
41985942|NCT01299376|75792860|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
41985943|NCT01299376|75792861|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
41985944|NCT01299376|75792860|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
41985945|NCT01299376|75792861|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
41985946|NCT01299376|75792860|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
41985947|NCT01299376|75792861|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
41985948|NCT01299376|75792860|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
41985949|NCT01299376|75792861|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
41985950|NCT01299376|75792860|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
41985951|NCT01299376|75792861|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
41985952|NCT01299376|75792860|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
41985953|NCT01299376|75792861|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
41985954|NCT01299376|75792860|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
41985955|NCT01299376|75792861|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
41985956|NCT01299025|75792873|FG000|Overall Study|Withdrawal by Subject|2|||
41985957|NCT01299025|75792874|FG001|Overall Study|Withdrawal by Subject|1|||
41985958|NCT01299025|75792873|FG000|Overall Study|Lost to Follow-up|1|||
41985959|NCT01299025|75792874|FG001|Overall Study|Lost to Follow-up|0|||
41985960|NCT01298596|75792882|FG000|Overall Study|Withdrawal by Subject|1|||
41985961|NCT01298596|75792883|FG001|Overall Study|Withdrawal by Subject|1|||
41985962|NCT01298596|75792882|FG000|Overall Study|Death|5|||
41985963|NCT01298596|75792883|FG001|Overall Study|Death|3|||
41985964|NCT01298596|75792882|FG000|Overall Study|Lost to Follow-up|6|||
41985965|NCT01298596|75792883|FG001|Overall Study|Lost to Follow-up|14|||
41985966|NCT01298596|75792882|FG000|Overall Study|Referred for further management|16|||
41985967|NCT01298596|75792883|FG001|Overall Study|Referred for further management|15|||
41985968|NCT01298518|75792892|FG000|Overall Study|Withdrawal by Subject|0|||
41985969|NCT01298518|75792893|FG001|Overall Study|Withdrawal by Subject|0|||
41985970|NCT01298518|75792894|FG002|Overall Study|Withdrawal by Subject|1|||
41985971|NCT01298362|75792904|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
41985972|NCT01298362|75792905|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
41985973|NCT01297504|75792913|FG000|Overall Study|Invalid Consent|1|||
41985974|NCT01297504|75792913|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
41985975|NCT01297504|75792913|FG000|Overall Study|No Study Visits|4|||
41985976|NCT01297504|75792913|FG000|Overall Study|Death|3|||
41985977|NCT01297504|75792913|FG000|Overall Study|Lost to Follow-up|43|||
41985978|NCT01297504|75792913|FG000|Overall Study|Withdrawal by Subject|9|||
41985979|NCT01297504|75792913|FG000|Overall Study|Site Closure|3|||
41985980|NCT01297504|75792913|FG000|Overall Study|Protocol Violation|3|||
41985981|NCT01297465|75792923|FG000|Overall Study|Lack of Ovarian Response|1|||
41985982|NCT01297465|75792924|FG001|Overall Study|Lack of Ovarian Response|1|||
41985983|NCT01297465|75792923|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
41985984|NCT01297465|75792924|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
41985985|NCT01297465|75792923|FG000|Overall Study|No Oocytes Retrieved|1|||
42227867|NCT03181789|76047905|FG000|Overall Study|Withdrawal by Subject|0|||
42227868|NCT03181789|76047906|FG001|Overall Study|Withdrawal by Subject|1|||
42227869|NCT03181789|76047907|FG002|Overall Study|Withdrawal by Subject|1|||
42227870|NCT03181789|76047908|FG003|Overall Study|Withdrawal by Subject|0|||
41985986|NCT01297465|75792924|FG001|Overall Study|No Oocytes Retrieved|1|||
41985987|NCT01297465|75792923|FG000|Overall Study|Poor oocyte quality|0|||
41985988|NCT01297465|75792924|FG001|Overall Study|Poor oocyte quality|1|||
41985989|NCT01297465|75792923|FG000|Overall Study|No Fertilization|6|||
41985990|NCT01297465|75792924|FG001|Overall Study|No Fertilization|4|||
41985991|NCT01297465|75792923|FG000|Overall Study|All Embryos Discarded|0|||
41985992|NCT01297465|75792924|FG001|Overall Study|All Embryos Discarded|1|||
42227871|NCT03181789|76047905|FG000|Overall Study|Lost to Follow-up|7|||
42227872|NCT03181789|76047906|FG001|Overall Study|Lost to Follow-up|1|||
41985993|NCT01297465|75792923|FG000|Overall Study|Intention to Freeze all Embryos|0|||
41985994|NCT01297465|75792924|FG001|Overall Study|Intention to Freeze all Embryos|1|||
41985995|NCT01297309|75792930|FG000|Overall Study|Eligibility failure|2|||
41985996|NCT01297309|75792930|FG000|Overall Study|Screen failure|2|||
42227873|NCT03181789|76047907|FG002|Overall Study|Lost to Follow-up|0|||
42227874|NCT03181789|76047908|FG003|Overall Study|Lost to Follow-up|0|||
42227875|NCT03181789|76047905|FG000|Overall Study|Participant unable to adhere to visit|0|||
42227876|NCT03181789|76047906|FG001|Overall Study|Participant unable to adhere to visit|1|||
42227877|NCT03181789|76047907|FG002|Overall Study|Participant unable to adhere to visit|0|||
42227878|NCT03181789|76047908|FG003|Overall Study|Participant unable to adhere to visit|0|||
42227879|NCT03024606|76047920|FG000|Overall Study|Withdrawal by Subject|9|||
42227880|NCT03024606|76047921|FG001|Overall Study|Withdrawal by Subject|10|||
42227881|NCT03180619|76047930|FG000|Overall Study|Withdrew Consent|5|||
42227882|NCT03180619|76047931|FG001|Overall Study|Withdrew Consent|0|||
42227883|NCT03180619|76047932|FG002|Overall Study|Withdrew Consent|2|||
42227884|NCT03180619|76047930|FG000|Overall Study|Death|2|||
42227885|NCT03180619|76047931|FG001|Overall Study|Death|1|||
42227886|NCT03180619|76047932|FG002|Overall Study|Death|2|||
42227887|NCT03180619|76047930|FG000|Overall Study|Adverse Event|2|||
42227888|NCT03180619|76047931|FG001|Overall Study|Adverse Event|0|||
42227889|NCT03180619|76047932|FG002|Overall Study|Adverse Event|1|||
42227890|NCT03180619|76047930|FG000|Overall Study|Investigator's discretion|2|||
42227891|NCT03180619|76047931|FG001|Overall Study|Investigator's discretion|0|||
42227892|NCT03180619|76047932|FG002|Overall Study|Investigator's discretion|1|||
42227893|NCT02915874|76047949|FG000|Overall Study|Lost to Follow-up|5|||
42227894|NCT02915874|76047950|FG001|Overall Study|Lost to Follow-up|4|||
41985997|NCT01297309|75792930|FG000|Overall Study|Withdrawal by Subject|5|||
41985998|NCT01297309|75792930|FG000|Overall Study|Adverse Event|1|||
41985999|NCT01297309|75792930|FG000|Overall Study|Investigator Decision|2|||
41986000|NCT01297309|75792930|FG000|Overall Study|Death|1|||
41986001|NCT01297309|75792930|FG000|Overall Study|Participant not entering extensionperiod|1|||
41986002|NCT04518462|75792937|FG000|Overall Study|Withdrawal by Subject|0|||
41986003|NCT04518462|75792938|FG001|Overall Study|Withdrawal by Subject|0|||
41986004|NCT04518462|75792939|FG002|Overall Study|Withdrawal by Subject|1|||
41986005|NCT04518462|75792937|FG000|Overall Study|Physician Decision|1|||
41986006|NCT04518462|75792938|FG001|Overall Study|Physician Decision|1|||
41986007|NCT04518462|75792939|FG002|Overall Study|Physician Decision|0|||
41986008|NCT01297270|75792950|FG000|Overall Study|Adverse Event|19|||
41986009|NCT01297270|75792951|FG001|Overall Study|Adverse Event|32|||
41986010|NCT01297270|75792952|FG002|Overall Study|Adverse Event|5|||
41986011|NCT01297270|75792950|FG000|Overall Study|Lack of Efficacy|15|||
41986012|NCT01297270|75792951|FG001|Overall Study|Lack of Efficacy|17|||
41986013|NCT01297270|75792952|FG002|Overall Study|Lack of Efficacy|15|||
41986014|NCT01297270|75792950|FG000|Overall Study|Lost to Follow-up|1|||
41986015|NCT01297270|75792951|FG001|Overall Study|Lost to Follow-up|2|||
41986016|NCT01297270|75792952|FG002|Overall Study|Lost to Follow-up|1|||
41986017|NCT01297270|75792950|FG000|Overall Study|Protocol Violation|0|||
41986018|NCT01297270|75792951|FG001|Overall Study|Protocol Violation|2|||
41986019|NCT01297270|75792952|FG002|Overall Study|Protocol Violation|0|||
41986020|NCT01297270|75792950|FG000|Overall Study|Withdrawal by Subject|7|||
41986021|NCT01297270|75792951|FG001|Overall Study|Withdrawal by Subject|15|||
41986022|NCT01297270|75792952|FG002|Overall Study|Withdrawal by Subject|7|||
42227895|NCT02915874|76047949|FG000|Overall Study|Withdrawal by Subject|1|||
42227896|NCT02915874|76047950|FG001|Overall Study|Withdrawal by Subject|1|||
42227897|NCT02915874|76047949|FG000|Overall Study|Started New Anxiety Medication|0|||
42227898|NCT02915874|76047950|FG001|Overall Study|Started New Anxiety Medication|1|||
42227899|NCT03022578|76047956|FG000|Overall Study|Adverse Event|1|||
42227900|NCT03022578|76047956|FG000|Overall Study|Lack of Efficacy|2|||
42227901|NCT03022578|76047956|FG000|Overall Study|Withdrawal by Subject|1|||
42227902|NCT03022422|76047966|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
42227903|NCT03022422|76047967|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
42227904|NCT03022422|76047968|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
42227905|NCT03022422|76047969|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
42227906|NCT03022422|76047970|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
42227907|NCT03022422|76047971|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
42227908|NCT03023826|76047987|FG000|Period 1|Withdrawal by Subject|0|||
42227909|NCT03023826|76047988|FG001|Period 1|Withdrawal by Subject|0|||
41986023|NCT01297270|75792950|FG000|Overall Study|Other reason not defined above|3|||
41986024|NCT01297270|75792951|FG001|Overall Study|Other reason not defined above|3|||
41986025|NCT01297270|75792952|FG002|Overall Study|Other reason not defined above|1|||
42131717|NCT00320710|75942615|FG001|Overall Study|Abnormal laboratory value(s)|3|||
41986026|NCT01297270|75792950|FG000|Overall Study|Not treated|0|||
41986027|NCT01297270|75792951|FG001|Overall Study|Not treated|1|||
41986028|NCT01297270|75792952|FG002|Overall Study|Not treated|0|||
42227910|NCT03023826|76047989|FG002|Period 1|Withdrawal by Subject|0|||
42227911|NCT03023826|76047990|FG003|Period 1|Withdrawal by Subject|0|||
42227912|NCT03023826|76047991|FG004|Period 1|Withdrawal by Subject|1|||
42227913|NCT03023826|76047992|FG005|Period 1|Withdrawal by Subject|0|||
42227914|NCT03166735|76048005|FG000|Overall Study|Not Treated|1|||
42227915|NCT03166735|76048006|FG001|Overall Study|Not Treated|0|||
41986029|NCT01296568|75792960|FG000|Continued Access Phase|Lost to Follow-up|1|||
41986030|NCT01296568|75792960|FG000|Continued Access Phase|Withdrawal by Subject|1|||
42010515|NCT01014442|75817633|FG001|Overall Study|Protocol Violation|5|||
42227916|NCT03166735|76048007|FG002|Overall Study|Not Treated|0|||
42227917|NCT03166735|76048008|FG003|Overall Study|Not Treated|0|||
42227918|NCT03166735|76048009|FG004|Overall Study|Not Treated|0|||
42227919|NCT03166735|76048005|FG000|Overall Study|follow-up not completed as planned|0|||
42227920|NCT03166735|76048006|FG001|Overall Study|follow-up not completed as planned|1|||
42227921|NCT03166735|76048007|FG002|Overall Study|follow-up not completed as planned|1|||
42227922|NCT03166735|76048008|FG003|Overall Study|follow-up not completed as planned|0|||
42227923|NCT03166735|76048009|FG004|Overall Study|follow-up not completed as planned|1|||
42227924|NCT03166735|76048005|FG000|Overall Study|Withdrawal by Subject|0|||
42227925|NCT03166735|76048006|FG001|Overall Study|Withdrawal by Subject|0|||
42227926|NCT03166735|76048007|FG002|Overall Study|Withdrawal by Subject|1|||
42227927|NCT03166735|76048008|FG003|Overall Study|Withdrawal by Subject|1|||
42227928|NCT03166735|76048009|FG004|Overall Study|Withdrawal by Subject|2|||
42227929|NCT03166735|76048005|FG000|Overall Study|Lost to Follow-up|0|||
42227930|NCT03166735|76048006|FG001|Overall Study|Lost to Follow-up|2|||
42227931|NCT03166735|76048007|FG002|Overall Study|Lost to Follow-up|1|||
42227932|NCT03166735|76048008|FG003|Overall Study|Lost to Follow-up|0|||
42227933|NCT03166735|76048009|FG004|Overall Study|Lost to Follow-up|1|||
42227934|NCT03165955|76048022|FG000|Treatment|Withdrawal by Subject|3|||
42227935|NCT03165955|76048022|FG000|Treatment|Death|1|||
42227936|NCT03165955|76048022|FG000|Treatment|Adverse Event|1|||
42227937|NCT03165955|76048022|FG000|Treatment|Progressive disease|3|||
42227938|NCT03055494|76048028|FG000|Overall Study|Lost to Follow-up|6|||
42227939|NCT03055494|76048029|FG001|Overall Study|Lost to Follow-up|0|||
42227940|NCT03055494|76048028|FG000|Overall Study|Physician Decision|2|||
42227941|NCT03055494|76048029|FG001|Overall Study|Physician Decision|0|||
42227942|NCT03055494|76048028|FG000|Overall Study|Withdrawal by Subject|1|||
42227943|NCT03055494|76048029|FG001|Overall Study|Withdrawal by Subject|0|||
42227944|NCT03055494|76048028|FG000|Overall Study|Adverse Event|0|||
42227945|NCT03055494|76048029|FG001|Overall Study|Adverse Event|1|||
42227946|NCT03055494|76048028|FG000|Overall Study|Non-compliance with study treatment|1|||
42227947|NCT03055494|76048029|FG001|Overall Study|Non-compliance with study treatment|0|||
42227948|NCT02914548|76048039|FG000|Overall Study|Adverse Event|15|||
42227949|NCT02914548|76048040|FG001|Overall Study|Adverse Event|7|||
42227950|NCT02914548|76048041|FG002|Overall Study|Adverse Event|15|||
42227951|NCT02914548|76048039|FG000|Overall Study|Physician Decision|2|||
42227952|NCT02914548|76048040|FG001|Overall Study|Physician Decision|2|||
42227953|NCT02914548|76048041|FG002|Overall Study|Physician Decision|0|||
42227954|NCT02914548|76048039|FG000|Overall Study|Protocol Violation|1|||
42227955|NCT02914548|76048040|FG001|Overall Study|Protocol Violation|0|||
42227956|NCT02914548|76048041|FG002|Overall Study|Protocol Violation|0|||
42227957|NCT02914548|76048039|FG000|Overall Study|Withdrawal by Subject|3|||
42227958|NCT02914548|76048040|FG001|Overall Study|Withdrawal by Subject|4|||
42227959|NCT02914548|76048041|FG002|Overall Study|Withdrawal by Subject|4|||
42227960|NCT02914548|76048039|FG000|Overall Study|>40% of body surface area|0|||
42227961|NCT02914548|76048040|FG001|Overall Study|>40% of body surface area|1|||
42227962|NCT02914548|76048041|FG002|Overall Study|>40% of body surface area|1|||
42227963|NCT03165721|76048052|FG000|Overall Study|Refused further treatment|3|||
42227964|NCT03165721|76048053|FG001|Overall Study|Refused further treatment|0|||
42227965|NCT03165721|76048054|FG002|Overall Study|Refused further treatment|0|||
42227966|NCT03165721|76048052|FG000|Overall Study|Physician Decision|1|||
42227967|NCT03165721|76048053|FG001|Overall Study|Physician Decision|0|||
42227968|NCT03165721|76048054|FG002|Overall Study|Physician Decision|0|||
42227969|NCT02187198|76048070|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
42227970|NCT02187198|76048071|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
42227971|NCT02187198|76048070|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
42227972|NCT02187198|76048071|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
42227973|NCT02642029|76048077|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
42227974|NCT02642029|76048078|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
42227975|NCT02642029|76048079|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
42227976|NCT02642029|76048080|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
42227977|NCT02642029|76048081|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
42227978|NCT02642029|76048082|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
42227979|NCT02642029|76048077|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
42227980|NCT02642029|76048078|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
42227981|NCT02642029|76048079|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
42227982|NCT02642029|76048080|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
42227983|NCT02642029|76048081|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
42227984|NCT02642029|76048082|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
42227985|NCT02642029|76048077|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
42227986|NCT02642029|76048078|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
42227987|NCT02642029|76048079|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
42227988|NCT02642029|76048080|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
42227989|NCT02642029|76048081|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
42227990|NCT02642029|76048082|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
42227991|NCT02642029|76048077|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
42227992|NCT02642029|76048078|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
42227993|NCT02642029|76048079|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
42227994|NCT02642029|76048080|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
42227995|NCT02642029|76048081|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
42227996|NCT02642029|76048082|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
42227997|NCT02642029|76048077|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
42227998|NCT02642029|76048078|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
42227999|NCT02642029|76048079|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
42228000|NCT02642029|76048080|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
42228001|NCT02642029|76048081|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
42228002|NCT02642029|76048082|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
42228003|NCT02642029|76048077|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
42228004|NCT02642029|76048078|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
42228005|NCT02642029|76048079|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
42228006|NCT02642029|76048080|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
41986031|NCT01296568|75792960|FG000|Continued Access Phase|Disease Progression|1|||
41986032|NCT01296412|75792968|FG000|Overall Study|Adverse Event|8|||
41986033|NCT01296412|75792969|FG001|Overall Study|Adverse Event|29|||
41986034|NCT01296412|75792968|FG000|Overall Study|Lack of Efficacy|1|||
41986035|NCT01296412|75792969|FG001|Overall Study|Lack of Efficacy|0|||
41986036|NCT01296412|75792968|FG000|Overall Study|Lost to Follow-up|10|||
41986037|NCT01296412|75792969|FG001|Overall Study|Lost to Follow-up|7|||
41986038|NCT01296412|75792968|FG000|Overall Study|Non-compliance with study drug|1|||
41986039|NCT01296412|75792969|FG001|Overall Study|Non-compliance with study drug|2|||
41986040|NCT01296412|75792968|FG000|Overall Study|Other reason not specified|20|||
41986041|NCT01296412|75792969|FG001|Overall Study|Other reason not specified|15|||
41986042|NCT01296412|75792968|FG000|Overall Study|Physician Decision|1|||
41986043|NCT01296412|75792969|FG001|Overall Study|Physician Decision|3|||
41986044|NCT01296412|75792968|FG000|Overall Study|Pregnancy|0|||
41986045|NCT01296412|75792969|FG001|Overall Study|Pregnancy|1|||
41986046|NCT01296412|75792968|FG000|Overall Study|Withdrawal by Subject|10|||
41986047|NCT01296412|75792969|FG001|Overall Study|Withdrawal by Subject|13|||
41986048|NCT01295905|75792977|FG000|Overall Study|Did not meet inclusion criteria|1|||
41986049|NCT01295905|75792978|FG001|Overall Study|Did not meet inclusion criteria|0|||
41986050|NCT01295905|75792977|FG000|Overall Study|Met exclusion criteria|1|||
41986051|NCT01295905|75792978|FG001|Overall Study|Met exclusion criteria|0|||
42228007|NCT02642029|76048081|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
42228008|NCT02642029|76048082|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
42228009|NCT03178669|76048095|FG000|Overall Study|Adverse Event|4|||
42228010|NCT03178669|76048096|FG001|Overall Study|Adverse Event|1|||
42228011|NCT03178669|76048097|FG002|Overall Study|Adverse Event|4|||
42228012|NCT03178669|76048098|FG003|Overall Study|Adverse Event|2|||
42228013|NCT03178669|76048099|FG004|Overall Study|Adverse Event|2|||
42228014|NCT03178669|76048095|FG000|Overall Study|Lack of Efficacy|0|||
42228015|NCT03178669|76048096|FG001|Overall Study|Lack of Efficacy|0|||
42228016|NCT03178669|76048097|FG002|Overall Study|Lack of Efficacy|2|||
42228017|NCT03178669|76048098|FG003|Overall Study|Lack of Efficacy|0|||
42228018|NCT03178669|76048099|FG004|Overall Study|Lack of Efficacy|1|||
42228019|NCT03178669|76048095|FG000|Overall Study|Physician Decision|0|||
42228020|NCT03178669|76048096|FG001|Overall Study|Physician Decision|0|||
42228021|NCT03178669|76048097|FG002|Overall Study|Physician Decision|0|||
42228022|NCT03178669|76048098|FG003|Overall Study|Physician Decision|0|||
42228023|NCT03178669|76048099|FG004|Overall Study|Physician Decision|1|||
42228024|NCT03178669|76048095|FG000|Overall Study|Withdrawal by Subject|1|||
42228025|NCT03178669|76048096|FG001|Overall Study|Withdrawal by Subject|0|||
42228026|NCT03178669|76048097|FG002|Overall Study|Withdrawal by Subject|1|||
42228027|NCT03178669|76048098|FG003|Overall Study|Withdrawal by Subject|1|||
41986052|NCT02596035|75792987|FG000|Overall Study|Disease Progression|64|||
41986053|NCT02596035|75792988|FG001|Overall Study|Disease Progression|32|||
41986054|NCT02596035|75792989|FG002|Overall Study|Disease Progression|1|||
41986055|NCT02596035|75792987|FG000|Overall Study|study drug toxicity|12|||
41986056|NCT02596035|75792988|FG001|Overall Study|study drug toxicity|3|||
41986057|NCT02596035|75792989|FG002|Overall Study|study drug toxicity|0|||
41986058|NCT02596035|75792987|FG000|Overall Study|AE unrelated to study drug|5|||
41986059|NCT02596035|75792988|FG001|Overall Study|AE unrelated to study drug|2|||
41986060|NCT02596035|75792989|FG002|Overall Study|AE unrelated to study drug|0|||
42228028|NCT03178669|76048099|FG004|Overall Study|Withdrawal by Subject|0|||
42228029|NCT03178669|76048095|FG000|Overall Study|Lost to Follow-up|0|||
42228030|NCT03178669|76048096|FG001|Overall Study|Lost to Follow-up|0|||
42228031|NCT03178669|76048097|FG002|Overall Study|Lost to Follow-up|0|||
41986061|NCT02596035|75792987|FG000|Overall Study|participant request to discontinue study treatment|2|||
41986062|NCT02596035|75792988|FG001|Overall Study|participant request to discontinue study treatment|0|||
41986063|NCT02596035|75792989|FG002|Overall Study|participant request to discontinue study treatment|0|||
41986064|NCT02596035|75792987|FG000|Overall Study|participant withdrew consent|2|||
41986065|NCT02596035|75792988|FG001|Overall Study|participant withdrew consent|2|||
42032446|NCT01196078|75840673|FG000|Overall Study|Lost to Follow-up|1|||
42032447|NCT01196078|75840674|FG001|Overall Study|Lost to Follow-up|0|||
42032448|NCT01196078|75840673|FG000|Overall Study|Death|6|||
42032449|NCT01196078|75840674|FG001|Overall Study|Death|4|||
42032450|NCT01078584|75840680|FG000|Overall Study|Final Status Unknown|1073|||
42032451|NCT01078584|75840680|FG000|Overall Study|Lost to Follow-up|670|||
42032452|NCT01078584|75840680|FG000|Overall Study|Non-serious Adverse Event|577|||
42032453|NCT01078584|75840680|FG000|Overall Study|Withdrawal of Consent|244|||
42032454|NCT01078584|75840680|FG000|Overall Study|Physician Withdrew from Study|90|||
42032455|NCT01078584|75840680|FG000|Overall Study|Non-compliance|67|||
42032456|NCT01078584|75840680|FG000|Overall Study|Blood Pressure Controlled|49|||
42032457|NCT01078584|75840680|FG000|Overall Study|Physician Switched Medication|26|||
42032458|NCT01078584|75840680|FG000|Overall Study|Physician Discontinued Patient|12|||
42032459|NCT01078584|75840680|FG000|Overall Study|Lack of Efficacy|98|||
42032460|NCT01078584|75840680|FG000|Overall Study|Protocol Violation|75|||
42032461|NCT01078584|75840680|FG000|Overall Study|Serious Adverse Event|27|||
42032462|NCT01078584|75840680|FG000|Overall Study|Multiple Reasons|2|||
42032463|NCT01133171|75840700|FG000|Overall Study|Withdrawal by Subject|1|||
42032464|NCT01133171|75840701|FG001|Overall Study|Withdrawal by Subject|2|||
42032465|NCT01133171|75840702|FG002|Overall Study|Withdrawal by Subject|0|||
42131718|NCT00320710|75942616|FG002|Overall Study|Abnormal laboratory value(s)|0|||
42131719|NCT00320710|75942614|FG000|Overall Study|Adverse Event|18|||
42228032|NCT03178669|76048098|FG003|Overall Study|Lost to Follow-up|1|||
42228033|NCT03178669|76048099|FG004|Overall Study|Lost to Follow-up|0|||
42228034|NCT03178201|76048111|FG000|Overall Study|Off study|5|||
42228035|NCT03021642|76048115|FG000|Washout Period (21 Days)|Adverse Event|1|||
42228036|NCT03021642|76048116|FG001|Washout Period (21 Days)|Adverse Event|1|||
42228037|NCT03021564|76048124|FG000|Overall Study|Death|84|||
42228038|NCT03021564|76048125|FG001|Overall Study|Death|466|||
42228039|NCT03021564|76048124|FG000|Overall Study|Lost to Follow-up|0|||
42228040|NCT03021564|76048125|FG001|Overall Study|Lost to Follow-up|2|||
42228041|NCT03023046|76048135|FG000|Overall Study|Withdrawal by Subject|1|||
42228042|NCT03019458|76048143|FG000|Overall Study|Death|0|||
42228043|NCT03019458|76048144|FG001|Overall Study|Death|1|||
42228044|NCT02923830|76048154|FG000|Overall Study|Physician Decision|13|||
42228045|NCT02923830|76048155|FG001|Overall Study|Physician Decision|15|||
42228046|NCT03021018|76048164|FG000|Overall Study|Adverse Event|1|||
41986066|NCT02596035|75792989|FG002|Overall Study|participant withdrew consent|0|||
41986067|NCT02596035|75792987|FG000|Overall Study|Poor/Non Comlpiance|0|||
41986068|NCT02596035|75792988|FG001|Overall Study|Poor/Non Comlpiance|1|||
41986069|NCT02596035|75792989|FG002|Overall Study|Poor/Non Comlpiance|0|||
41986070|NCT02596035|75792987|FG000|Overall Study|participant no longer meets study criteria|1|||
41986071|NCT02596035|75792988|FG001|Overall Study|participant no longer meets study criteria|0|||
41986072|NCT02596035|75792989|FG002|Overall Study|participant no longer meets study criteria|0|||
41986073|NCT02596035|75792987|FG000|Overall Study|other reasons|11|||
41986074|NCT02596035|75792988|FG001|Overall Study|other reasons|4|||
41986075|NCT02596035|75792989|FG002|Overall Study|other reasons|0|||
41986076|NCT02595372|75792998|FG000|Overall Study|Adverse Event|6|||
41986077|NCT02595372|75792998|FG000|Overall Study|Physician Decision|2|||
41986078|NCT02595372|75792998|FG000|Overall Study|Disease Progression|1|||
42228047|NCT03021018|76048165|FG001|Overall Study|Adverse Event|0|||
42228048|NCT03021018|76048166|FG002|Overall Study|Adverse Event|0|||
42228049|NCT03021018|76048164|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
42228050|NCT03021018|76048165|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
42228051|NCT03021018|76048166|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
42228052|NCT02509507|76048183|FG000|Overall Study|Death|21|||
42228053|NCT02509507|76048184|FG001|Overall Study|Death|3|||
41986079|NCT04829916|75793035|FG000|Overall Study|Withdrawal by Subject|1|||
41986080|NCT04829916|75793036|FG001|Overall Study|Withdrawal by Subject|0|||
41986081|NCT04761822|75793048|FG000|Overall Study|Adverse Event|3|||
42228054|NCT02509507|76048185|FG002|Overall Study|Death|22|||
42228055|NCT02509507|76048186|FG003|Overall Study|Death|13|||
42302478|NCT02447497|76137728|FG002|Overall Study|Did not meet treatment day baseline.|2|||
41986082|NCT04761822|75793049|FG001|Overall Study|Adverse Event|1|||
41986083|NCT04761822|75793050|FG002|Overall Study|Adverse Event|1|||
42131720|NCT00320710|75942615|FG001|Overall Study|Adverse Event|14|||
42228056|NCT02509507|76048187|FG004|Overall Study|Death|6|||
42228057|NCT02509507|76048188|FG005|Overall Study|Death|9|||
42228058|NCT02509507|76048189|FG006|Overall Study|Death|4|||
42032466|NCT01195844|75840710|FG000|Overall Study|Fecal sample not collected|40|||
42032467|NCT01132547|75840726|FG000|Overall Study|Withdrawal by Subject|3|||
42032468|NCT01132547|75840727|FG001|Overall Study|Withdrawal by Subject|1|||
42228059|NCT02509507|76048190|FG007|Overall Study|Death|3|||
42228060|NCT02509507|76048191|FG008|Overall Study|Death|7|||
42228061|NCT02509507|76048183|FG000|Overall Study|Lost to Follow-up|0|||
42228062|NCT02509507|76048184|FG001|Overall Study|Lost to Follow-up|1|||
42228063|NCT02509507|76048185|FG002|Overall Study|Lost to Follow-up|0|||
41986084|NCT04761822|75793051|FG003|Overall Study|Adverse Event|3|||
41986085|NCT04761822|75793048|FG000|Overall Study|Lost to Follow-up|1|||
41986086|NCT04761822|75793049|FG001|Overall Study|Lost to Follow-up|0|||
41986087|NCT04761822|75793050|FG002|Overall Study|Lost to Follow-up|2|||
41986088|NCT04761822|75793051|FG003|Overall Study|Lost to Follow-up|3|||
41986089|NCT04761822|75793048|FG000|Overall Study|Physician Decision|0|||
41986090|NCT04761822|75793049|FG001|Overall Study|Physician Decision|1|||
41986091|NCT04761822|75793050|FG002|Overall Study|Physician Decision|0|||
41986092|NCT04761822|75793051|FG003|Overall Study|Physician Decision|0|||
41986093|NCT04761822|75793048|FG000|Overall Study|Withdrawal by Subject|3|||
41986094|NCT04761822|75793049|FG001|Overall Study|Withdrawal by Subject|8|||
41986095|NCT04761822|75793050|FG002|Overall Study|Withdrawal by Subject|1|||
41986096|NCT04761822|75793051|FG003|Overall Study|Withdrawal by Subject|11|||
41986097|NCT04761822|75793048|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
41986098|NCT04761822|75793049|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
41986099|NCT04761822|75793050|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
42228064|NCT02509507|76048186|FG003|Overall Study|Lost to Follow-up|0|||
42228065|NCT02509507|76048187|FG004|Overall Study|Lost to Follow-up|0|||
42228066|NCT02509507|76048188|FG005|Overall Study|Lost to Follow-up|1|||
42228067|NCT02509507|76048189|FG006|Overall Study|Lost to Follow-up|0|||
42228068|NCT02509507|76048190|FG007|Overall Study|Lost to Follow-up|0|||
42228069|NCT02509507|76048191|FG008|Overall Study|Lost to Follow-up|0|||
42228070|NCT02509507|76048183|FG000|Overall Study|Withdrawal by Subject|2|||
42228071|NCT02509507|76048184|FG001|Overall Study|Withdrawal by Subject|0|||
42228072|NCT02509507|76048185|FG002|Overall Study|Withdrawal by Subject|1|||
42228073|NCT02509507|76048186|FG003|Overall Study|Withdrawal by Subject|4|||
42228074|NCT02509507|76048187|FG004|Overall Study|Withdrawal by Subject|0|||
42228075|NCT02509507|76048188|FG005|Overall Study|Withdrawal by Subject|3|||
42228076|NCT02509507|76048189|FG006|Overall Study|Withdrawal by Subject|3|||
42228077|NCT02509507|76048190|FG007|Overall Study|Withdrawal by Subject|0|||
42228078|NCT02509507|76048191|FG008|Overall Study|Withdrawal by Subject|0|||
42228079|NCT02509507|76048183|FG000|Overall Study|Continuing Study|0|||
42228080|NCT02509507|76048184|FG001|Overall Study|Continuing Study|1|||
42228081|NCT02509507|76048185|FG002|Overall Study|Continuing Study|1|||
42228082|NCT02509507|76048186|FG003|Overall Study|Continuing Study|5|||
42228083|NCT02509507|76048187|FG004|Overall Study|Continuing Study|4|||
42228084|NCT02509507|76048188|FG005|Overall Study|Continuing Study|5|||
42228085|NCT02509507|76048189|FG006|Overall Study|Continuing Study|3|||
42228086|NCT02509507|76048190|FG007|Overall Study|Continuing Study|2|||
42228087|NCT02509507|76048191|FG008|Overall Study|Continuing Study|3|||
42228088|NCT03176407|76048216|FG000|Overall Study|Protocol Violation|1|||
42228089|NCT03176407|76048216|FG000|Overall Study|human failure|1|||
42228090|NCT03176407|76048216|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
42228091|NCT03175549|76048224|FG000|Overall Study|Lost to Follow-up|2|||
42228092|NCT03175549|76048225|FG001|Overall Study|Lost to Follow-up|2|||
42228093|NCT03175549|76048224|FG000|Overall Study|Medication non-compliance|2|||
42228094|NCT03175549|76048225|FG001|Overall Study|Medication non-compliance|2|||
42228095|NCT03174925|76048233|FG000|Overall Study|Elastographic images not retrievable|2|||
42228096|NCT03174925|76048233|FG000|Overall Study|Elastography image not interpretable|1|||
42228097|NCT02924688|76048243|FG000|Overall Study|Adverse Event|9|||
42228098|NCT02924688|76048244|FG001|Overall Study|Adverse Event|3|||
42228099|NCT02924688|76048245|FG002|Overall Study|Adverse Event|2|||
42228100|NCT02924688|76048246|FG003|Overall Study|Adverse Event|2|||
42228101|NCT02924688|76048247|FG004|Overall Study|Adverse Event|3|||
41986100|NCT04761822|75793051|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
42228102|NCT02924688|76048248|FG005|Overall Study|Adverse Event|2|||
42228103|NCT02924688|76048243|FG000|Overall Study|Lack of Efficacy|2|||
42228104|NCT02924688|76048244|FG001|Overall Study|Lack of Efficacy|3|||
42228105|NCT02924688|76048245|FG002|Overall Study|Lack of Efficacy|4|||
42228106|NCT02924688|76048246|FG003|Overall Study|Lack of Efficacy|2|||
42228107|NCT02924688|76048247|FG004|Overall Study|Lack of Efficacy|1|||
41986101|NCT04761822|75793048|FG000|Overall Study|Participant requested unblinding|0|||
41986102|NCT04761822|75793049|FG001|Overall Study|Participant requested unblinding|0|||
41986103|NCT04761822|75793050|FG002|Overall Study|Participant requested unblinding|0|||
41986104|NCT04761822|75793051|FG003|Overall Study|Participant requested unblinding|1|||
42228108|NCT02924688|76048248|FG005|Overall Study|Lack of Efficacy|1|||
42228109|NCT02924688|76048243|FG000|Overall Study|Protocol Violation|3|||
42228110|NCT02924688|76048244|FG001|Overall Study|Protocol Violation|7|||
42228111|NCT02924688|76048245|FG002|Overall Study|Protocol Violation|5|||
42228112|NCT02924688|76048246|FG003|Overall Study|Protocol Violation|6|||
42228113|NCT02924688|76048247|FG004|Overall Study|Protocol Violation|2|||
42228114|NCT02924688|76048248|FG005|Overall Study|Protocol Violation|2|||
41986105|NCT04596267|75793089|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
41986106|NCT04596267|75793090|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
42228115|NCT02924688|76048243|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
42228116|NCT02924688|76048244|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
42228117|NCT02924688|76048245|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
42228118|NCT02924688|76048246|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
42228119|NCT02924688|76048247|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
42228120|NCT02924688|76048248|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
42228121|NCT02924688|76048243|FG000|Overall Study|Lost to Follow-up|2|||
42228122|NCT02924688|76048244|FG001|Overall Study|Lost to Follow-up|4|||
41986107|NCT04596267|75793089|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
41986108|NCT04596267|75793090|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
41986109|NCT04439903|75793113|FG000|Overall Study|Withdrawal by Subject|2|||
41986110|NCT04439903|75793113|FG000|Overall Study|Screen Failure|1|||
41986111|NCT04280783|75793119|FG000|Overall Study|Family issues unrelated to the study.|1|||
41986112|NCT04280783|75793120|FG001|Overall Study|Family issues unrelated to the study.|0|||
41986113|NCT04280783|75793119|FG000|Overall Study|Withdrawal by Subject|0|||
41986114|NCT04280783|75793120|FG001|Overall Study|Withdrawal by Subject|1|||
41986115|NCT04177095|75793127|FG000|Overall Study|Withdrawal by Subject|3|||
41986116|NCT04177095|75793127|FG000|Overall Study|Screen Failure|3|||
41986117|NCT04177095|75793127|FG000|Overall Study|Problems with the Trugraf assay|1|||
41986118|NCT03799718|75793149|FG000|Overall Study|Adverse Event|2|||
42032469|NCT01132547|75840726|FG000|Overall Study|Death|1|||
42032470|NCT01132547|75840727|FG001|Overall Study|Death|0|||
42032471|NCT01194830|75840735|FG000|Overall Study|Adverse Event|3|||
42032472|NCT01194830|75840736|FG001|Overall Study|Adverse Event|2|||
42032473|NCT01194830|75840735|FG000|Overall Study|Protocol Violation|5|||
42228123|NCT02924688|76048245|FG002|Overall Study|Lost to Follow-up|2|||
42228124|NCT02924688|76048246|FG003|Overall Study|Lost to Follow-up|4|||
42228125|NCT02924688|76048247|FG004|Overall Study|Lost to Follow-up|2|||
42228126|NCT02924688|76048248|FG005|Overall Study|Lost to Follow-up|4|||
42228127|NCT02924688|76048243|FG000|Overall Study|Physician Decision|2|||
42228128|NCT02924688|76048244|FG001|Overall Study|Physician Decision|1|||
42228129|NCT02924688|76048245|FG002|Overall Study|Physician Decision|0|||
42228130|NCT02924688|76048246|FG003|Overall Study|Physician Decision|1|||
42228131|NCT02924688|76048247|FG004|Overall Study|Physician Decision|1|||
42228132|NCT02924688|76048248|FG005|Overall Study|Physician Decision|1|||
42228133|NCT02924688|76048243|FG000|Overall Study|Withdrawal by Subject|14|||
42228134|NCT02924688|76048244|FG001|Overall Study|Withdrawal by Subject|13|||
42228135|NCT02924688|76048245|FG002|Overall Study|Withdrawal by Subject|9|||
42228136|NCT02924688|76048246|FG003|Overall Study|Withdrawal by Subject|12|||
42228137|NCT02924688|76048247|FG004|Overall Study|Withdrawal by Subject|13|||
42228138|NCT02924688|76048248|FG005|Overall Study|Withdrawal by Subject|14|||
42228139|NCT03011892|76048271|FG000|Double Blind (DB) Period|Adverse Event|0|||
42228140|NCT03011892|76048272|FG001|Double Blind (DB) Period|Adverse Event|1|||
42228141|NCT03011892|76048273|FG002|Double Blind (DB) Period|Adverse Event|1|||
42228142|NCT03011892|76048274|FG003|Double Blind (DB) Period|Adverse Event|0|||
42228143|NCT03011892|76048275|FG004|Double Blind (DB) Period|Adverse Event|0|||
42228144|NCT03011892|76048276|FG005|Double Blind (DB) Period|Adverse Event|0|||
42228145|NCT03011892|76048277|FG006|Double Blind (DB) Period|Adverse Event|0|||
42228146|NCT03011892|76048278|FG007|Double Blind (DB) Period|Adverse Event|0|||
42228147|NCT03011892|76048279|FG008|Double Blind (DB) Period|Adverse Event|0|||
42228148|NCT03011892|76048280|FG009|Double Blind (DB) Period|Adverse Event|0|||
42228149|NCT03011892|76048281|FG010|Double Blind (DB) Period|Adverse Event|0|||
42228150|NCT03011892|76048282|FG011|Double Blind (DB) Period|Adverse Event|0|||
42228151|NCT03011892|76048271|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
42228152|NCT03011892|76048272|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
42228153|NCT03011892|76048273|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
42228154|NCT03011892|76048274|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
42228155|NCT03011892|76048275|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
42228156|NCT03011892|76048276|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
42228157|NCT03011892|76048277|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
42228158|NCT03011892|76048278|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
42228159|NCT03011892|76048279|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
42228160|NCT03011892|76048280|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
41986119|NCT03458728|75793184|FG000|Overall Study|Adverse Event|1|||
41986120|NCT03458728|75793185|FG001|Overall Study|Adverse Event|0|||
42131721|NCT00320710|75942616|FG002|Overall Study|Adverse Event|1|||
42228161|NCT03011892|76048281|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
42228162|NCT03011892|76048282|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
42228163|NCT03011892|76048271|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
42228164|NCT03011892|76048272|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
42228165|NCT03011892|76048273|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
42228166|NCT03011892|76048274|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
42228167|NCT03011892|76048275|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
42032474|NCT01194830|75840736|FG001|Overall Study|Protocol Violation|4|||
42032475|NCT01194830|75840735|FG000|Overall Study|Lost to Follow-up|9|||
42228168|NCT03011892|76048276|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
42228169|NCT03011892|76048277|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
42228170|NCT03011892|76048278|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
42228171|NCT03011892|76048279|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
42228172|NCT03011892|76048280|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
42228173|NCT03011892|76048281|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
42228174|NCT03011892|76048282|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
42228175|NCT03011892|76048271|FG000|Double Blind (DB) Period|Other|1|||
42228176|NCT03011892|76048272|FG001|Double Blind (DB) Period|Other|1|||
42228177|NCT03011892|76048273|FG002|Double Blind (DB) Period|Other|1|||
42228178|NCT03011892|76048274|FG003|Double Blind (DB) Period|Other|0|||
42228179|NCT03011892|76048275|FG004|Double Blind (DB) Period|Other|1|||
42228180|NCT03011892|76048276|FG005|Double Blind (DB) Period|Other|0|||
42228181|NCT03011892|76048277|FG006|Double Blind (DB) Period|Other|0|||
42228182|NCT03011892|76048278|FG007|Double Blind (DB) Period|Other|0|||
42228183|NCT03011892|76048279|FG008|Double Blind (DB) Period|Other|0|||
42228184|NCT03011892|76048280|FG009|Double Blind (DB) Period|Other|0|||
42228185|NCT03011892|76048281|FG010|Double Blind (DB) Period|Other|0|||
42228186|NCT03011892|76048282|FG011|Double Blind (DB) Period|Other|0|||
42228187|NCT03011892|76048271|FG000|Double Blind (DB) Period|Physician Decision|1|||
42228188|NCT03011892|76048272|FG001|Double Blind (DB) Period|Physician Decision|0|||
41986121|NCT03458728|75793184|FG000|Overall Study|Physician Decision|1|||
41986122|NCT03458728|75793185|FG001|Overall Study|Physician Decision|0|||
41986123|NCT03458728|75793184|FG000|Overall Study|Progressive disease - clinical assessment|1|||
41986124|NCT03458728|75793185|FG001|Overall Study|Progressive disease - clinical assessment|0|||
41986125|NCT03458728|75793184|FG000|Overall Study|Progressive disease - radiological progression|21|||
41986126|NCT03458728|75793185|FG001|Overall Study|Progressive disease - radiological progression|6|||
41986127|NCT03458728|75793184|FG000|Overall Study|Withdrawal by Subject|0|||
41986128|NCT03458728|75793185|FG001|Overall Study|Withdrawal by Subject|1|||
41986129|NCT03220035|75793193|FG000|Overall Study|Adverse Event|1|||
41986130|NCT03220035|75793193|FG000|Overall Study|Protocol Violation|1|||
41986131|NCT03220035|75793193|FG000|Overall Study|Progressive Disease|2|||
41986132|NCT03215706|75793199|FG000|Randomization|Adverse Event unrelated to study drug|1|||
41986133|NCT03215706|75793200|FG001|Randomization|Adverse Event unrelated to study drug|0|||
41986134|NCT03215706|75793199|FG000|Randomization|participant withdrew consent|1|||
41986135|NCT03215706|75793200|FG001|Randomization|participant withdrew consent|3|||
41986136|NCT03215706|75793199|FG000|Randomization|no longer meets study criteria|1|||
41986137|NCT03215706|75793200|FG001|Randomization|no longer meets study criteria|4|||
41986138|NCT03215706|75793199|FG000|Randomization|other reasons|0|||
42228189|NCT03011892|76048273|FG002|Double Blind (DB) Period|Physician Decision|1|||
42228190|NCT03011892|76048274|FG003|Double Blind (DB) Period|Physician Decision|0|||
42228191|NCT03011892|76048275|FG004|Double Blind (DB) Period|Physician Decision|0|||
42228192|NCT03011892|76048276|FG005|Double Blind (DB) Period|Physician Decision|0|||
42228193|NCT03011892|76048277|FG006|Double Blind (DB) Period|Physician Decision|0|||
41986139|NCT03215706|75793200|FG001|Randomization|other reasons|2|||
42228194|NCT03011892|76048278|FG007|Double Blind (DB) Period|Physician Decision|0|||
42228195|NCT03011892|76048279|FG008|Double Blind (DB) Period|Physician Decision|0|||
42228196|NCT03011892|76048280|FG009|Double Blind (DB) Period|Physician Decision|0|||
42228197|NCT03011892|76048281|FG010|Double Blind (DB) Period|Physician Decision|0|||
42228198|NCT03011892|76048282|FG011|Double Blind (DB) Period|Physician Decision|0|||
42228199|NCT03011892|76048271|FG000|Double Blind (DB) Period|Pregnancy|0|||
42228200|NCT03011892|76048272|FG001|Double Blind (DB) Period|Pregnancy|0|||
42228201|NCT03011892|76048273|FG002|Double Blind (DB) Period|Pregnancy|0|||
42228202|NCT03011892|76048274|FG003|Double Blind (DB) Period|Pregnancy|0|||
42228203|NCT03011892|76048275|FG004|Double Blind (DB) Period|Pregnancy|1|||
42228204|NCT03011892|76048276|FG005|Double Blind (DB) Period|Pregnancy|0|||
42228205|NCT03011892|76048277|FG006|Double Blind (DB) Period|Pregnancy|0|||
42228206|NCT03011892|76048278|FG007|Double Blind (DB) Period|Pregnancy|0|||
42228207|NCT03011892|76048279|FG008|Double Blind (DB) Period|Pregnancy|0|||
42228208|NCT03011892|76048280|FG009|Double Blind (DB) Period|Pregnancy|0|||
42228209|NCT03011892|76048281|FG010|Double Blind (DB) Period|Pregnancy|0|||
42228210|NCT03011892|76048282|FG011|Double Blind (DB) Period|Pregnancy|0|||
42228211|NCT03011892|76048271|FG000|Double Blind (DB) Period|Protocol Violation|1|||
41986140|NCT03215706|75793199|FG000|Treatment Period|Disease Progression|150|||
41986141|NCT03215706|75793200|FG001|Treatment Period|Disease Progression|142|||
42228212|NCT03011892|76048272|FG001|Double Blind (DB) Period|Protocol Violation|0|||
42228213|NCT03011892|76048273|FG002|Double Blind (DB) Period|Protocol Violation|0|||
42302479|NCT02447497|76137729|FG003|Overall Study|Did not meet treatment day baseline.|2|||
41986142|NCT03215706|75793199|FG000|Treatment Period|Study Drug Toxicity|53|||
41986143|NCT03215706|75793200|FG001|Treatment Period|Study Drug Toxicity|21|||
41986144|NCT03215706|75793199|FG000|Treatment Period|Death|2|||
42302480|NCT02447497|76137726|FG000|Overall Study|Dressing was compromised|0|||
42228214|NCT03011892|76048274|FG003|Double Blind (DB) Period|Protocol Violation|0|||
42228215|NCT03011892|76048275|FG004|Double Blind (DB) Period|Protocol Violation|0|||
42228216|NCT03011892|76048276|FG005|Double Blind (DB) Period|Protocol Violation|0|||
42228217|NCT03011892|76048277|FG006|Double Blind (DB) Period|Protocol Violation|0|||
42228218|NCT03011892|76048278|FG007|Double Blind (DB) Period|Protocol Violation|0|||
42228219|NCT03011892|76048279|FG008|Double Blind (DB) Period|Protocol Violation|0|||
42228220|NCT03011892|76048280|FG009|Double Blind (DB) Period|Protocol Violation|0|||
42228221|NCT03011892|76048281|FG010|Double Blind (DB) Period|Protocol Violation|0|||
42228222|NCT03011892|76048282|FG011|Double Blind (DB) Period|Protocol Violation|0|||
42228223|NCT03011892|76048271|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
42228224|NCT03011892|76048272|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
42228225|NCT03011892|76048273|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
42228226|NCT03011892|76048274|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
42131722|NCT00320710|75942614|FG000|Overall Study|Lost to Follow-up|1|||
42131723|NCT00320710|75942615|FG001|Overall Study|Lost to Follow-up|0|||
42228227|NCT03011892|76048275|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
42228228|NCT03011892|76048276|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
42228229|NCT03011892|76048277|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
42228230|NCT03011892|76048278|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
42228231|NCT03011892|76048279|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
42228232|NCT03011892|76048280|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
42228233|NCT03011892|76048281|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
42228234|NCT03011892|76048282|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
42228235|NCT03011892|76048271|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
42228236|NCT03011892|76048272|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
42228237|NCT03011892|76048273|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
42228238|NCT03011892|76048274|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
42228239|NCT03011892|76048275|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
42228240|NCT03011892|76048276|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
42228241|NCT03011892|76048277|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
42228242|NCT03011892|76048278|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
42228243|NCT03011892|76048279|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
42228244|NCT03011892|76048280|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
42228245|NCT03011892|76048281|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
42228246|NCT03011892|76048282|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
42228247|NCT03011892|76048271|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
42228248|NCT03011892|76048272|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
42228249|NCT03011892|76048273|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
42228250|NCT03011892|76048274|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
42228251|NCT03011892|76048275|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
42228252|NCT03011892|76048276|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
42228253|NCT03011892|76048277|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
42228254|NCT03011892|76048278|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
42228255|NCT03011892|76048279|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
42228256|NCT03011892|76048280|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
42228257|NCT03011892|76048281|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
42228258|NCT03011892|76048282|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
42228259|NCT03011892|76048271|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
42228260|NCT03011892|76048272|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
42228261|NCT03011892|76048273|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
42228262|NCT03011892|76048274|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
42228263|NCT03011892|76048275|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
42228264|NCT03011892|76048276|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
42228265|NCT03011892|76048277|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
42228266|NCT03011892|76048278|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
42228267|NCT03011892|76048279|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
42228268|NCT03011892|76048280|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
42228269|NCT03011892|76048281|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
42228270|NCT03011892|76048282|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
42228271|NCT03011892|76048271|FG000|Open Label (OL) Period|Reason not specified|0|||
42228272|NCT03011892|76048272|FG001|Open Label (OL) Period|Reason not specified|0|||
42228273|NCT03011892|76048273|FG002|Open Label (OL) Period|Reason not specified|0|||
42228274|NCT03011892|76048274|FG003|Open Label (OL) Period|Reason not specified|0|||
42228275|NCT03011892|76048275|FG004|Open Label (OL) Period|Reason not specified|0|||
42228276|NCT03011892|76048276|FG005|Open Label (OL) Period|Reason not specified|0|||
42131724|NCT00320710|75942616|FG002|Overall Study|Lost to Follow-up|0|||
42228277|NCT03011892|76048277|FG006|Open Label (OL) Period|Reason not specified|0|||
42228278|NCT03011892|76048278|FG007|Open Label (OL) Period|Reason not specified|1|||
42131725|NCT00320398|75942625|FG000|Overall Study|Adverse Event|1|||
42131726|NCT00320398|75942626|FG001|Overall Study|Adverse Event|4|||
42131727|NCT00320398|75942625|FG000|Overall Study|Other|1|||
42228279|NCT03011892|76048279|FG008|Open Label (OL) Period|Reason not specified|0|||
42228280|NCT03011892|76048280|FG009|Open Label (OL) Period|Reason not specified|0|||
42228281|NCT03011892|76048281|FG010|Open Label (OL) Period|Reason not specified|0|||
42228282|NCT03011892|76048282|FG011|Open Label (OL) Period|Reason not specified|0|||
42228283|NCT03017742|76048309|FG000|Overall Study|Protocol Violation|36|||
42228284|NCT03017742|76048309|FG000|Overall Study|Withdrawal by Subject|37|||
42228285|NCT03012828|76048319|FG000|Overall Study|Lost to Follow-up|1|||
42228286|NCT03012828|76048320|FG001|Overall Study|Lost to Follow-up|0|||
42228287|NCT03012828|76048321|FG002|Overall Study|Lost to Follow-up|1|||
42228288|NCT03012828|76048322|FG003|Overall Study|Lost to Follow-up|0|||
42228289|NCT03012828|76048323|FG004|Overall Study|Lost to Follow-up|1|||
42228290|NCT03012828|76048324|FG005|Overall Study|Lost to Follow-up|0|||
42228291|NCT03012828|76048319|FG000|Overall Study|Withdrawal by Subject|0|||
42228292|NCT03012828|76048320|FG001|Overall Study|Withdrawal by Subject|0|||
42228293|NCT03012828|76048321|FG002|Overall Study|Withdrawal by Subject|1|||
42228294|NCT03012828|76048322|FG003|Overall Study|Withdrawal by Subject|0|||
42228295|NCT03012828|76048323|FG004|Overall Study|Withdrawal by Subject|0|||
42228296|NCT03012828|76048324|FG005|Overall Study|Withdrawal by Subject|1|||
42228297|NCT03012828|76048319|FG000|Overall Study|Non-compliance with protocol|0|||
42228298|NCT03012828|76048320|FG001|Overall Study|Non-compliance with protocol|0|||
42228299|NCT03012828|76048321|FG002|Overall Study|Non-compliance with protocol|0|||
42228300|NCT03012828|76048322|FG003|Overall Study|Non-compliance with protocol|0|||
42228301|NCT03012828|76048323|FG004|Overall Study|Non-compliance with protocol|1|||
42228302|NCT03012828|76048324|FG005|Overall Study|Non-compliance with protocol|0|||
42228303|NCT03012828|76048319|FG000|Overall Study|Delay to last visit would delay DBL|0|||
42228304|NCT03012828|76048320|FG001|Overall Study|Delay to last visit would delay DBL|0|||
42228305|NCT03012828|76048321|FG002|Overall Study|Delay to last visit would delay DBL|0|||
42228306|NCT03012828|76048322|FG003|Overall Study|Delay to last visit would delay DBL|0|||
42228307|NCT03012828|76048323|FG004|Overall Study|Delay to last visit would delay DBL|0|||
42228308|NCT03012828|76048324|FG005|Overall Study|Delay to last visit would delay DBL|1|||
42228309|NCT03010254|76048342|FG000|Overall Study|Adverse Event|0|||
42228310|NCT03010254|76048343|FG001|Overall Study|Adverse Event|1|||
42228311|NCT03010254|76048342|FG000|Overall Study|Lost to Follow-up|4|||
42228312|NCT03010254|76048343|FG001|Overall Study|Lost to Follow-up|0|||
42228313|NCT03010254|76048342|FG000|Overall Study|Withdrawal by Subject|1|||
42228314|NCT03010254|76048343|FG001|Overall Study|Withdrawal by Subject|1|||
42228315|NCT03010254|76048342|FG000|Overall Study|Other|2|||
42228316|NCT03010254|76048343|FG001|Overall Study|Other|3|||
42228317|NCT03008460|76048358|FG000|Overall Study|Protocol deviation|0|||
42228318|NCT03008460|76048359|FG001|Overall Study|Protocol deviation|2|||
42228319|NCT03008460|76048358|FG000|Overall Study|Study drug not dispensed|0|||
42228320|NCT03008460|76048359|FG001|Overall Study|Study drug not dispensed|1|||
42228321|NCT03008460|76048358|FG000|Overall Study|Adverse Event|0|||
42228322|NCT03008460|76048359|FG001|Overall Study|Adverse Event|1|||
42228323|NCT03008460|76048358|FG000|Overall Study|Withdrawal by Subject|5|||
42228324|NCT03008460|76048359|FG001|Overall Study|Withdrawal by Subject|6|||
42228325|NCT03008460|76048358|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
42228326|NCT03008460|76048359|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
42228327|NCT03008460|76048358|FG000|Overall Study|End of study visit outside permitted time window|0|||
42228328|NCT03008460|76048359|FG001|Overall Study|End of study visit outside permitted time window|1|||
42228329|NCT03008460|76048358|FG000|Overall Study|Lost to Follow-up|1|||
42228330|NCT03008460|76048359|FG001|Overall Study|Lost to Follow-up|3|||
42228331|NCT02914236|76048365|FG000|Overall Study|Lost to Follow-up|1|||
42228332|NCT03003390|76048371|FG000|Overall Study|Physician Decision|2|||
42228333|NCT03003390|76048372|FG001|Overall Study|Physician Decision|0|||
42228334|NCT03003390|76048371|FG000|Overall Study|Parent refused intervention|2|||
42228335|NCT03003390|76048372|FG001|Overall Study|Parent refused intervention|0|||
42228336|NCT03003000|76048386|FG000|Overall Study|Adverse Event|1|||
42228337|NCT03003000|76048387|FG001|Overall Study|Adverse Event|2|||
42228338|NCT03003000|76048388|FG002|Overall Study|Adverse Event|3|||
42228339|NCT03003000|76048386|FG000|Overall Study|Lack of Efficacy|1|||
42228340|NCT03003000|76048387|FG001|Overall Study|Lack of Efficacy|0|||
42228341|NCT03003000|76048388|FG002|Overall Study|Lack of Efficacy|0|||
42228342|NCT03003000|76048386|FG000|Overall Study|Non-compliant with protocol|0|||
42228343|NCT03003000|76048387|FG001|Overall Study|Non-compliant with protocol|1|||
42228344|NCT03003000|76048388|FG002|Overall Study|Non-compliant with protocol|1|||
42228345|NCT03003000|76048386|FG000|Overall Study|Refused to continue medication|2|||
42228346|NCT03003000|76048387|FG001|Overall Study|Refused to continue medication|0|||
42228347|NCT03003000|76048388|FG002|Overall Study|Refused to continue medication|0|||
42228348|NCT03003000|76048386|FG000|Overall Study|Other than listed|1|||
42228349|NCT03003000|76048387|FG001|Overall Study|Other than listed|1|||
42228350|NCT03003000|76048388|FG002|Overall Study|Other than listed|1|||
42228351|NCT03002610|76048399|FG000|Overall Study|Withdrawal by Subject|6|||
42228352|NCT03002610|76048400|FG001|Overall Study|Withdrawal by Subject|25|||
42302481|NCT02447497|76137727|FG001|Overall Study|Dressing was compromised|1|||
42228353|NCT03002610|76048401|FG002|Overall Study|Withdrawal by Subject|13|||
42228354|NCT03005106|76048409|FG000|Overall Study|Lost to Follow-up|16|||
42228355|NCT03005106|76048409|FG000|Overall Study|Adverse Event|1|||
42228356|NCT03005106|76048409|FG000|Overall Study|Physician Decision|1|||
42228357|NCT03005106|76048409|FG000|Overall Study|Death|2|||
42228358|NCT01004861|76048426|FG000|Overall Study|Disease progression|3|||
41986145|NCT03215706|75793200|FG001|Treatment Period|Death|1|||
41986146|NCT03215706|75793199|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
41986147|NCT03215706|75793200|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
41986148|NCT03215706|75793199|FG000|Treatment Period|Request to D/C treatment|1|||
41986149|NCT03215706|75793200|FG001|Treatment Period|Request to D/C treatment|6|||
41986150|NCT03215706|75793199|FG000|Treatment Period|Participant withdrew consent|3|||
41986151|NCT03215706|75793200|FG001|Treatment Period|Participant withdrew consent|4|||
41986152|NCT03215706|75793199|FG000|Treatment Period|Lost to Follow-up|0|||
42228359|NCT01004861|76048427|FG001|Overall Study|Disease progression|4|||
42228360|NCT01004861|76048428|FG002|Overall Study|Disease progression|5|||
42228361|NCT01004861|76048429|FG003|Overall Study|Disease progression|4|||
42228362|NCT01004861|76048430|FG004|Overall Study|Disease progression|4|||
42228363|NCT01004861|76048431|FG005|Overall Study|Disease progression|4|||
42228364|NCT01004861|76048432|FG006|Overall Study|Disease progression|5|||
42228365|NCT01004861|76048433|FG007|Overall Study|Disease progression|1|||
42228366|NCT01004861|76048434|FG008|Overall Study|Disease progression|4|||
42228367|NCT01004861|76048435|FG009|Overall Study|Disease progression|7|||
42228368|NCT01004861|76048436|FG010|Overall Study|Disease progression|6|||
42228369|NCT01004861|76048437|FG011|Overall Study|Disease progression|3|||
42228370|NCT01004861|76048438|FG012|Overall Study|Disease progression|8|||
42228371|NCT01004861|76048426|FG000|Overall Study|Physician Decision|0|||
42228372|NCT01004861|76048427|FG001|Overall Study|Physician Decision|2|||
42228373|NCT01004861|76048428|FG002|Overall Study|Physician Decision|1|||
42228374|NCT01004861|76048429|FG003|Overall Study|Physician Decision|1|||
42228375|NCT01004861|76048430|FG004|Overall Study|Physician Decision|1|||
42228376|NCT01004861|76048431|FG005|Overall Study|Physician Decision|0|||
42228377|NCT01004861|76048432|FG006|Overall Study|Physician Decision|0|||
42228378|NCT01004861|76048433|FG007|Overall Study|Physician Decision|1|||
42228379|NCT01004861|76048434|FG008|Overall Study|Physician Decision|0|||
42228380|NCT01004861|76048435|FG009|Overall Study|Physician Decision|0|||
42228381|NCT01004861|76048436|FG010|Overall Study|Physician Decision|0|||
42228382|NCT01004861|76048437|FG011|Overall Study|Physician Decision|0|||
42228383|NCT01004861|76048438|FG012|Overall Study|Physician Decision|3|||
42228384|NCT01004861|76048426|FG000|Overall Study|Adverse Event|0|||
42228385|NCT01004861|76048427|FG001|Overall Study|Adverse Event|0|||
42228386|NCT01004861|76048428|FG002|Overall Study|Adverse Event|0|||
42228387|NCT01004861|76048429|FG003|Overall Study|Adverse Event|1|||
42228388|NCT01004861|76048430|FG004|Overall Study|Adverse Event|0|||
42228389|NCT01004861|76048431|FG005|Overall Study|Adverse Event|2|||
42228390|NCT01004861|76048432|FG006|Overall Study|Adverse Event|1|||
42228391|NCT01004861|76048433|FG007|Overall Study|Adverse Event|1|||
42228392|NCT01004861|76048434|FG008|Overall Study|Adverse Event|13|||
42228393|NCT01004861|76048435|FG009|Overall Study|Adverse Event|1|||
42228394|NCT01004861|76048436|FG010|Overall Study|Adverse Event|1|||
42228395|NCT01004861|76048437|FG011|Overall Study|Adverse Event|0|||
42228396|NCT01004861|76048438|FG012|Overall Study|Adverse Event|2|||
42228397|NCT01004861|76048426|FG000|Overall Study|Protocol Violation|0|||
42228398|NCT01004861|76048427|FG001|Overall Study|Protocol Violation|0|||
42228399|NCT01004861|76048428|FG002|Overall Study|Protocol Violation|0|||
42228400|NCT01004861|76048429|FG003|Overall Study|Protocol Violation|0|||
42228401|NCT01004861|76048430|FG004|Overall Study|Protocol Violation|1|||
42228402|NCT01004861|76048431|FG005|Overall Study|Protocol Violation|0|||
42228403|NCT01004861|76048432|FG006|Overall Study|Protocol Violation|0|||
42228404|NCT01004861|76048433|FG007|Overall Study|Protocol Violation|0|||
42228405|NCT01004861|76048434|FG008|Overall Study|Protocol Violation|0|||
42228406|NCT01004861|76048435|FG009|Overall Study|Protocol Violation|0|||
41986153|NCT03215706|75793200|FG001|Treatment Period|Lost to Follow-up|1|||
41986154|NCT03215706|75793199|FG000|Treatment Period|Other Reasons|4|||
42228407|NCT01004861|76048436|FG010|Overall Study|Protocol Violation|0|||
42228408|NCT01004861|76048437|FG011|Overall Study|Protocol Violation|0|||
41986155|NCT03215706|75793200|FG001|Treatment Period|Other Reasons|5|||
42228409|NCT01004861|76048438|FG012|Overall Study|Protocol Violation|0|||
42228410|NCT01004861|76048426|FG000|Overall Study|Lost to Follow-up|0|||
41986156|NCT03215706|75793199|FG000|Treatment Period|Ongoing in the treatment period|105|||
42228411|NCT01004861|76048427|FG001|Overall Study|Lost to Follow-up|0|||
42228412|NCT01004861|76048428|FG002|Overall Study|Lost to Follow-up|0|||
42228413|NCT01004861|76048429|FG003|Overall Study|Lost to Follow-up|0|||
42228414|NCT01004861|76048430|FG004|Overall Study|Lost to Follow-up|0|||
42228415|NCT01004861|76048431|FG005|Overall Study|Lost to Follow-up|0|||
42228416|NCT01004861|76048432|FG006|Overall Study|Lost to Follow-up|0|||
42228417|NCT01004861|76048433|FG007|Overall Study|Lost to Follow-up|1|||
42228418|NCT01004861|76048434|FG008|Overall Study|Lost to Follow-up|3|||
42228419|NCT01004861|76048435|FG009|Overall Study|Lost to Follow-up|0|||
42228420|NCT01004861|76048436|FG010|Overall Study|Lost to Follow-up|0|||
41986157|NCT03215706|75793200|FG001|Treatment Period|Ongoing in the treatment period|43|||
41986158|NCT03213691|75793206|FG000|Overall Study|Adverse Event|2|||
41986159|NCT03213691|75793206|FG000|Overall Study|Death|3|||
42228421|NCT01004861|76048437|FG011|Overall Study|Lost to Follow-up|1|||
42228422|NCT01004861|76048438|FG012|Overall Study|Lost to Follow-up|0|||
42228423|NCT01004861|76048426|FG000|Overall Study|Non-compliance|0|||
42228424|NCT01004861|76048427|FG001|Overall Study|Non-compliance|0|||
42228425|NCT01004861|76048428|FG002|Overall Study|Non-compliance|0|||
42228426|NCT01004861|76048429|FG003|Overall Study|Non-compliance|0|||
42228427|NCT01004861|76048430|FG004|Overall Study|Non-compliance|0|||
42228428|NCT01004861|76048431|FG005|Overall Study|Non-compliance|0|||
42228429|NCT01004861|76048432|FG006|Overall Study|Non-compliance|0|||
41986160|NCT03213691|75793206|FG000|Overall Study|Physician Decision|1|||
42228430|NCT01004861|76048433|FG007|Overall Study|Non-compliance|0|||
42228431|NCT01004861|76048434|FG008|Overall Study|Non-compliance|5|||
42228432|NCT01004861|76048435|FG009|Overall Study|Non-compliance|0|||
42228433|NCT01004861|76048436|FG010|Overall Study|Non-compliance|0|||
42228434|NCT01004861|76048437|FG011|Overall Study|Non-compliance|0|||
42228435|NCT01004861|76048438|FG012|Overall Study|Non-compliance|1|||
42228436|NCT01004861|76048426|FG000|Overall Study|Other|0|||
42228437|NCT01004861|76048427|FG001|Overall Study|Other|0|||
42228438|NCT01004861|76048428|FG002|Overall Study|Other|0|||
42228439|NCT01004861|76048429|FG003|Overall Study|Other|0|||
42228440|NCT01004861|76048430|FG004|Overall Study|Other|0|||
42228441|NCT01004861|76048431|FG005|Overall Study|Other|0|||
42228442|NCT01004861|76048432|FG006|Overall Study|Other|0|||
42228443|NCT01004861|76048433|FG007|Overall Study|Other|0|||
42228444|NCT01004861|76048434|FG008|Overall Study|Other|0|||
42228445|NCT01004861|76048435|FG009|Overall Study|Other|2|||
42228446|NCT01004861|76048436|FG010|Overall Study|Other|1|||
42228447|NCT01004861|76048437|FG011|Overall Study|Other|2|||
42228448|NCT01004861|76048438|FG012|Overall Study|Other|3|||
42228449|NCT01004861|76048426|FG000|Overall Study|Patient decision|0|||
42228450|NCT01004861|76048427|FG001|Overall Study|Patient decision|0|||
42228451|NCT01004861|76048428|FG002|Overall Study|Patient decision|0|||
42228452|NCT01004861|76048429|FG003|Overall Study|Patient decision|0|||
42228453|NCT01004861|76048430|FG004|Overall Study|Patient decision|1|||
42228454|NCT01004861|76048431|FG005|Overall Study|Patient decision|0|||
42228455|NCT01004861|76048432|FG006|Overall Study|Patient decision|1|||
42228456|NCT01004861|76048433|FG007|Overall Study|Patient decision|0|||
42228457|NCT01004861|76048434|FG008|Overall Study|Patient decision|7|||
42228458|NCT01004861|76048435|FG009|Overall Study|Patient decision|1|||
42228459|NCT01004861|76048436|FG010|Overall Study|Patient decision|1|||
42228460|NCT01004861|76048437|FG011|Overall Study|Patient decision|2|||
42228461|NCT01004861|76048438|FG012|Overall Study|Patient decision|3|||
42228462|NCT01004861|76048426|FG000|Overall Study|Transitioned to Phase 4 study|0|||
42228463|NCT01004861|76048427|FG001|Overall Study|Transitioned to Phase 4 study|0|||
42228464|NCT01004861|76048428|FG002|Overall Study|Transitioned to Phase 4 study|0|||
42228465|NCT01004861|76048429|FG003|Overall Study|Transitioned to Phase 4 study|0|||
42228466|NCT01004861|76048430|FG004|Overall Study|Transitioned to Phase 4 study|0|||
42228467|NCT01004861|76048431|FG005|Overall Study|Transitioned to Phase 4 study|0|||
42228468|NCT01004861|76048432|FG006|Overall Study|Transitioned to Phase 4 study|0|||
42228469|NCT01004861|76048433|FG007|Overall Study|Transitioned to Phase 4 study|0|||
42228470|NCT01004861|76048434|FG008|Overall Study|Transitioned to Phase 4 study|2|||
42228471|NCT01004861|76048435|FG009|Overall Study|Transitioned to Phase 4 study|0|||
42228472|NCT01004861|76048436|FG010|Overall Study|Transitioned to Phase 4 study|0|||
42228473|NCT01004861|76048437|FG011|Overall Study|Transitioned to Phase 4 study|0|||
42228474|NCT01004861|76048438|FG012|Overall Study|Transitioned to Phase 4 study|0|||
42228475|NCT01004861|76048426|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
42228476|NCT01004861|76048427|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
42228477|NCT01004861|76048428|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
42228478|NCT01004861|76048429|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
42228479|NCT01004861|76048430|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
42228480|NCT01004861|76048431|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
41986161|NCT03213691|75793206|FG000|Overall Study|Progressive Disease|14|||
42228481|NCT01004861|76048432|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
42228482|NCT01004861|76048433|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
42228483|NCT01004861|76048434|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
42228484|NCT01004861|76048435|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
42228485|NCT01004861|76048436|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
42302482|NCT02447497|76137728|FG002|Overall Study|Dressing was compromised|0|||
42302483|NCT02447497|76137729|FG003|Overall Study|Dressing was compromised|0|||
41986162|NCT03213691|75793206|FG000|Overall Study|Ineligible|1|||
42228486|NCT01004861|76048437|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
42228487|NCT01004861|76048438|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
42228488|NCT01004861|76048426|FG000|Overall Study|Patient withdrew|0|||
42228489|NCT01004861|76048427|FG001|Overall Study|Patient withdrew|0|||
42228490|NCT01004861|76048428|FG002|Overall Study|Patient withdrew|0|||
42228491|NCT01004861|76048429|FG003|Overall Study|Patient withdrew|0|||
42228492|NCT01004861|76048430|FG004|Overall Study|Patient withdrew|0|||
42228493|NCT01004861|76048431|FG005|Overall Study|Patient withdrew|0|||
42228494|NCT01004861|76048432|FG006|Overall Study|Patient withdrew|0|||
42228495|NCT01004861|76048433|FG007|Overall Study|Patient withdrew|0|||
42228496|NCT01004861|76048434|FG008|Overall Study|Patient withdrew|1|||
42228497|NCT01004861|76048435|FG009|Overall Study|Patient withdrew|0|||
42228498|NCT01004861|76048436|FG010|Overall Study|Patient withdrew|0|||
42228499|NCT01004861|76048437|FG011|Overall Study|Patient withdrew|0|||
42228500|NCT01004861|76048438|FG012|Overall Study|Patient withdrew|0|||
42228501|NCT01004861|76048426|FG000|Overall Study|Surgical resection|0|||
42228502|NCT01004861|76048427|FG001|Overall Study|Surgical resection|0|||
42228503|NCT01004861|76048428|FG002|Overall Study|Surgical resection|0|||
42228504|NCT01004861|76048429|FG003|Overall Study|Surgical resection|0|||
42228505|NCT01004861|76048430|FG004|Overall Study|Surgical resection|0|||
42228506|NCT01004861|76048431|FG005|Overall Study|Surgical resection|0|||
42228507|NCT01004861|76048432|FG006|Overall Study|Surgical resection|0|||
42228508|NCT01004861|76048433|FG007|Overall Study|Surgical resection|0|||
42228509|NCT01004861|76048434|FG008|Overall Study|Surgical resection|1|||
42228510|NCT01004861|76048435|FG009|Overall Study|Surgical resection|0|||
42228511|NCT01004861|76048436|FG010|Overall Study|Surgical resection|0|||
42228512|NCT01004861|76048437|FG011|Overall Study|Surgical resection|0|||
42228513|NCT01004861|76048438|FG012|Overall Study|Surgical resection|0|||
42228514|NCT01004861|76048426|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228515|NCT01004861|76048427|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228516|NCT01004861|76048428|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228517|NCT01004861|76048429|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228518|NCT01004861|76048430|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228519|NCT01004861|76048431|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228520|NCT01004861|76048432|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228521|NCT01004861|76048433|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228522|NCT01004861|76048434|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
42228523|NCT01004861|76048435|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228524|NCT01004861|76048436|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228525|NCT01004861|76048437|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228526|NCT01004861|76048438|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
42228527|NCT01004861|76048426|FG000|Overall Study|Study termination by Sponsor|0|||
42228528|NCT01004861|76048427|FG001|Overall Study|Study termination by Sponsor|0|||
42228529|NCT01004861|76048428|FG002|Overall Study|Study termination by Sponsor|0|||
42228530|NCT01004861|76048429|FG003|Overall Study|Study termination by Sponsor|0|||
42228531|NCT01004861|76048430|FG004|Overall Study|Study termination by Sponsor|0|||
42228532|NCT01004861|76048431|FG005|Overall Study|Study termination by Sponsor|0|||
42228533|NCT01004861|76048432|FG006|Overall Study|Study termination by Sponsor|0|||
42228534|NCT01004861|76048433|FG007|Overall Study|Study termination by Sponsor|0|||
42228535|NCT01004861|76048434|FG008|Overall Study|Study termination by Sponsor|1|||
42228536|NCT01004861|76048435|FG009|Overall Study|Study termination by Sponsor|0|||
42228537|NCT01004861|76048436|FG010|Overall Study|Study termination by Sponsor|0|||
42228538|NCT01004861|76048437|FG011|Overall Study|Study termination by Sponsor|0|||
42228539|NCT01004861|76048438|FG012|Overall Study|Study termination by Sponsor|0|||
42228540|NCT03254459|76048485|FG000|Overall Study|Adverse Event|7|||
42228541|NCT03254459|76048486|FG001|Overall Study|Adverse Event|20|||
42228542|NCT03254459|76048485|FG000|Overall Study|Withdrawal by Subject Consent|3|||
42228543|NCT03254459|76048486|FG001|Overall Study|Withdrawal by Subject Consent|1|||
42228544|NCT03254459|76048485|FG000|Overall Study|Lost to Follow-up|0|||
42228545|NCT03254459|76048486|FG001|Overall Study|Lost to Follow-up|1|||
42228546|NCT03254459|76048485|FG000|Overall Study|Miscellaneous|0|||
42228547|NCT03254459|76048486|FG001|Overall Study|Miscellaneous|1|||
42228548|NCT02736617|76048492|FG000|Treatment|Adverse Event|1|||
42228549|NCT02736617|76048492|FG000|Treatment|Lack of Efficacy|1|||
42228550|NCT02736617|76048492|FG000|Treatment|Withdrawal by Subject|1|||
42228551|NCT02736617|76048492|FG000|Maintenance|Lack of Efficacy|4|||
42228552|NCT02736617|76048492|FG000|Maintenance|Physician Decision|1|||
42228553|NCT03251963|76048499|FG000|Overall Study|inappropriate Xa level timing|6|||
42228554|NCT03251963|76048500|FG001|Overall Study|inappropriate Xa level timing|3|||
42228555|NCT03251963|76048499|FG000|Overall Study|no peak Xa level drawn|2|||
42228556|NCT03251963|76048500|FG001|Overall Study|no peak Xa level drawn|0|||
42228557|NCT03251963|76048499|FG000|Overall Study|bled prior to Xa level|1|||
42228558|NCT03251963|76048500|FG001|Overall Study|bled prior to Xa level|2|||
42228559|NCT03287219|76048508|FG000|Overall Study|Protocol Violation|0|||
42228560|NCT03287219|76048509|FG001|Overall Study|Protocol Violation|2|||
42228561|NCT03286751|76048548|FG000|Washout Period 1|Withdrawal by Subject|0|||
42228562|NCT03286751|76048549|FG001|Washout Period 1|Withdrawal by Subject|0|||
42228563|NCT03286751|76048550|FG002|Washout Period 1|Withdrawal by Subject|0|||
42228564|NCT03286751|76048551|FG003|Washout Period 1|Withdrawal by Subject|0|||
42228565|NCT03286751|76048552|FG004|Washout Period 1|Withdrawal by Subject|1|||
42228566|NCT03286751|76048553|FG005|Washout Period 1|Withdrawal by Subject|0|||
42228567|NCT03286751|76048548|FG000|Washout Period 2|Personal Reasons|0|||
42228568|NCT03286751|76048549|FG001|Washout Period 2|Personal Reasons|1|||
42228569|NCT03286751|76048550|FG002|Washout Period 2|Personal Reasons|0|||
42228570|NCT03286751|76048551|FG003|Washout Period 2|Personal Reasons|0|||
42228571|NCT03286751|76048552|FG004|Washout Period 2|Personal Reasons|0|||
42228572|NCT03286751|76048553|FG005|Washout Period 2|Personal Reasons|0|||
42228573|NCT03286751|76048548|FG000|Washout Period 5|Adverse Event|0|||
42228574|NCT03286751|76048549|FG001|Washout Period 5|Adverse Event|0|||
42228575|NCT03286751|76048550|FG002|Washout Period 5|Adverse Event|0|||
42228576|NCT03286751|76048551|FG003|Washout Period 5|Adverse Event|0|||
42228577|NCT03286751|76048552|FG004|Washout Period 5|Adverse Event|1|||
42228578|NCT03286751|76048553|FG005|Washout Period 5|Adverse Event|0|||
42228579|NCT03249935|76048567|FG000|Overall Study|Discharged from facility early|36|||
42228580|NCT03249935|76048567|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
42228581|NCT03249935|76048567|FG000|Overall Study|Protocol Violation|5|||
42228582|NCT03285113|76048573|FG000|Overall Study|Unable to implant leads|2|||
42228583|NCT03000348|76048583|FG000|Overall Study|Adverse Event|1|||
42228584|NCT03000348|76048584|FG001|Overall Study|Adverse Event|1|||
42228585|NCT03000348|76048585|FG002|Overall Study|Adverse Event|1|||
42228586|NCT03000348|76048586|FG003|Overall Study|Adverse Event|1|||
42228587|NCT03000348|76048587|FG004|Overall Study|Adverse Event|1|||
42228588|NCT03000348|76048588|FG005|Overall Study|Adverse Event|1|||
42228589|NCT03000348|76048583|FG000|Overall Study|Lost to Follow-up|0|||
42228590|NCT03000348|76048584|FG001|Overall Study|Lost to Follow-up|0|||
42228591|NCT03000348|76048585|FG002|Overall Study|Lost to Follow-up|1|||
42228592|NCT03000348|76048586|FG003|Overall Study|Lost to Follow-up|0|||
42228593|NCT03000348|76048587|FG004|Overall Study|Lost to Follow-up|0|||
42228594|NCT03000348|76048588|FG005|Overall Study|Lost to Follow-up|0|||
42228595|NCT03000348|76048583|FG000|Overall Study|Withdrawal by Subject|0|||
42228596|NCT03000348|76048584|FG001|Overall Study|Withdrawal by Subject|1|||
42228597|NCT03000348|76048585|FG002|Overall Study|Withdrawal by Subject|0|||
42228598|NCT03000348|76048586|FG003|Overall Study|Withdrawal by Subject|0|||
42228599|NCT03000348|76048587|FG004|Overall Study|Withdrawal by Subject|0|||
42228600|NCT03000348|76048588|FG005|Overall Study|Withdrawal by Subject|0|||
42228601|NCT03000348|76048583|FG000|Overall Study|Consent|0|||
42228602|NCT03000348|76048584|FG001|Overall Study|Consent|0|||
42228603|NCT03000348|76048585|FG002|Overall Study|Consent|0|||
42228604|NCT03000348|76048586|FG003|Overall Study|Consent|0|||
42228605|NCT03000348|76048587|FG004|Overall Study|Consent|1|||
42228606|NCT03000348|76048588|FG005|Overall Study|Consent|0|||
42228607|NCT03000348|76048583|FG000|Overall Study|Failure to expectorate sputum|1|||
42228608|NCT03000348|76048584|FG001|Overall Study|Failure to expectorate sputum|0|||
42228609|NCT03000348|76048585|FG002|Overall Study|Failure to expectorate sputum|1|||
42228610|NCT03000348|76048586|FG003|Overall Study|Failure to expectorate sputum|0|||
42228611|NCT03000348|76048587|FG004|Overall Study|Failure to expectorate sputum|1|||
42228612|NCT03000348|76048588|FG005|Overall Study|Failure to expectorate sputum|0|||
42228613|NCT03000348|76048583|FG000|Overall Study|No gram negative|1|||
42228614|NCT03000348|76048584|FG001|Overall Study|No gram negative|2|||
42228615|NCT03000348|76048585|FG002|Overall Study|No gram negative|1|||
42228616|NCT03000348|76048586|FG003|Overall Study|No gram negative|1|||
42228617|NCT03000348|76048587|FG004|Overall Study|No gram negative|1|||
42228618|NCT03000348|76048588|FG005|Overall Study|No gram negative|1|||
42228619|NCT03000348|76048583|FG000|Overall Study|Patient had no transport|0|||
41986163|NCT03213665|75793210|FG000|Overall Study|Adverse Event|1|||
41986164|NCT03213665|75793210|FG000|Overall Study|Physician Decision|2|||
41986165|NCT03213665|75793210|FG000|Overall Study|Withdrawal by Subject|3|||
42228620|NCT03000348|76048584|FG001|Overall Study|Patient had no transport|0|||
42228621|NCT03000348|76048585|FG002|Overall Study|Patient had no transport|0|||
42228622|NCT03000348|76048586|FG003|Overall Study|Patient had no transport|1|||
42228623|NCT03000348|76048587|FG004|Overall Study|Patient had no transport|0|||
42228624|NCT03000348|76048588|FG005|Overall Study|Patient had no transport|0|||
42228625|NCT03000348|76048583|FG000|Overall Study|Dosing|0|||
42228626|NCT03000348|76048584|FG001|Overall Study|Dosing|0|||
42228627|NCT03000348|76048585|FG002|Overall Study|Dosing|0|||
42228628|NCT03000348|76048586|FG003|Overall Study|Dosing|0|||
42228629|NCT03000348|76048587|FG004|Overall Study|Dosing|1|||
42228630|NCT03000348|76048588|FG005|Overall Study|Dosing|0|||
42228631|NCT03283709|76048607|FG000|Overall Study|trial terminated|0|||
42131728|NCT00320398|75942626|FG001|Overall Study|Other|0|||
42228632|NCT03283709|76048608|FG001|Overall Study|trial terminated|1|||
42228633|NCT03247673|76048617|FG000|Overall Study|Withdrawal by Subject|1|||
42228634|NCT03247673|76048618|FG001|Overall Study|Withdrawal by Subject|0|||
42228635|NCT03247673|76048619|FG002|Overall Study|Withdrawal by Subject|3|||
42228636|NCT03247673|76048617|FG000|Overall Study|Lost to Follow-up|0|||
42228637|NCT03247673|76048618|FG001|Overall Study|Lost to Follow-up|0|||
42228638|NCT03247673|76048619|FG002|Overall Study|Lost to Follow-up|1|||
42228639|NCT03247517|76048630|FG000|Overall Study|Adverse Event|0|||
42228640|NCT03247517|76048631|FG001|Overall Study|Adverse Event|4|||
42228641|NCT03247517|76048632|FG002|Overall Study|Adverse Event|2|||
42228642|NCT03247517|76048630|FG000|Overall Study|Lost to Follow-up|2|||
42228643|NCT03247517|76048631|FG001|Overall Study|Lost to Follow-up|6|||
42228644|NCT03247517|76048632|FG002|Overall Study|Lost to Follow-up|4|||
42228645|NCT03247517|76048630|FG000|Overall Study|Consent withdrawn by caregiver|1|||
42228646|NCT03247517|76048631|FG001|Overall Study|Consent withdrawn by caregiver|4|||
42228647|NCT03247517|76048632|FG002|Overall Study|Consent withdrawn by caregiver|7|||
42228648|NCT03247517|76048630|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
42228649|NCT03247517|76048631|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
42228650|NCT03247517|76048632|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
41986166|NCT03213665|75793210|FG000|Overall Study|Progressive Disease|13|||
42228651|NCT03247517|76048630|FG000|Overall Study|Protocol Violation|0|||
42228652|NCT03247517|76048631|FG001|Overall Study|Protocol Violation|2|||
42228653|NCT03247517|76048632|FG002|Overall Study|Protocol Violation|0|||
42228654|NCT03247517|76048630|FG000|Overall Study|Multiple reasons|3|||
42228655|NCT03247517|76048631|FG001|Overall Study|Multiple reasons|1|||
42228656|NCT03247517|76048632|FG002|Overall Study|Multiple reasons|0|||
42228657|NCT03283553|76048642|FG000|Patient Participant Flow|Death|5|||
42228658|NCT03283553|76048643|FG001|Patient Participant Flow|Death|10|||
42228659|NCT03283553|76048642|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
42228660|NCT03283553|76048643|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
42228661|NCT03283553|76048642|FG000|Patient Participant Flow|Lost to Follow-up|1|||
42228662|NCT03283553|76048643|FG001|Patient Participant Flow|Lost to Follow-up|1|||
42228663|NCT03283553|76048642|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
42228664|NCT03283553|76048643|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
42228665|NCT03283553|76048642|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
42228666|NCT03283553|76048643|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
42228667|NCT03283553|76048642|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
42228668|NCT03283553|76048643|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
42228669|NCT03283319|76048657|FG000|Overall Study|Lost to Follow-up|5|||
42228670|NCT03283319|76048658|FG001|Overall Study|Lost to Follow-up|4|||
42228671|NCT03283319|76048659|FG002|Overall Study|Lost to Follow-up|5|||
42228672|NCT03283319|76048660|FG003|Overall Study|Lost to Follow-up|5|||
42228673|NCT03283319|76048661|FG004|Overall Study|Lost to Follow-up|4|||
42228674|NCT03283319|76048662|FG005|Overall Study|Lost to Follow-up|3|||
42228675|NCT03283319|76048657|FG000|Overall Study|Withdrawal by Subject|2|||
42228676|NCT03283319|76048658|FG001|Overall Study|Withdrawal by Subject|2|||
42228677|NCT03283319|76048659|FG002|Overall Study|Withdrawal by Subject|2|||
42228678|NCT03283319|76048660|FG003|Overall Study|Withdrawal by Subject|1|||
42228679|NCT03283319|76048661|FG004|Overall Study|Withdrawal by Subject|0|||
41986167|NCT03151005|75793216|FG000|Overall Study|Lost to Follow-up|5|||
42228680|NCT03283319|76048662|FG005|Overall Study|Withdrawal by Subject|1|||
41986168|NCT03151005|75793217|FG001|Overall Study|Lost to Follow-up|5|||
41986169|NCT03143153|75793226|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
41986170|NCT03143153|75793227|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
41986171|NCT03143153|75793228|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
41986172|NCT03143153|75793226|FG000|Pre-Treatment|Participant withdrew consent|0|||
42228681|NCT03283319|76048657|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
42228682|NCT03283319|76048658|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
42228683|NCT03283319|76048659|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
42228684|NCT03283319|76048660|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
41986173|NCT03143153|75793227|FG001|Pre-Treatment|Participant withdrew consent|1|||
41986174|NCT03143153|75793228|FG002|Pre-Treatment|Participant withdrew consent|12|||
41986175|NCT03143153|75793226|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
41986176|NCT03143153|75793227|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
42228685|NCT03283319|76048661|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
42228686|NCT03283319|76048662|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
42228687|NCT03282227|76048676|FG000|Overall Study|Exposure Goals Achieved|60|||
42228688|NCT03282227|76048676|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
42228689|NCT03282227|76048676|FG000|Overall Study|Adverse Event|15|||
42228690|NCT03282227|76048676|FG000|Overall Study|Lost to Follow-up|21|||
41986177|NCT03143153|75793228|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
41986178|NCT03143153|75793226|FG000|Pre-Treatment|Other Reasons|1|||
41986179|NCT03143153|75793227|FG001|Pre-Treatment|Other Reasons|2|||
41986180|NCT03143153|75793228|FG002|Pre-Treatment|Other Reasons|1|||
41986181|NCT03143153|75793226|FG000|Pre-Treatment|Disease Progression|1|||
41986182|NCT03143153|75793227|FG001|Pre-Treatment|Disease Progression|1|||
41986183|NCT03143153|75793228|FG002|Pre-Treatment|Disease Progression|2|||
42228691|NCT03282227|76048676|FG000|Overall Study|Withdrawal by Subject|20|||
42228692|NCT03282227|76048676|FG000|Overall Study|Lack of Efficacy|12|||
42228693|NCT03282227|76048676|FG000|Overall Study|Sponsor decision|3|||
42228694|NCT03282227|76048676|FG000|Overall Study|Physician Decision|2|||
42228695|NCT03282227|76048676|FG000|Overall Study|Pregnancy|2|||
42228696|NCT03282227|76048676|FG000|Overall Study|Other|1|||
42228697|NCT03240575|76048684|FG000|Overall Study|Adverse Event|0|||
42228698|NCT03240575|76048685|FG001|Overall Study|Adverse Event|2|||
42228699|NCT03240575|76048686|FG002|Overall Study|Adverse Event|0|||
42228700|NCT03240575|76048687|FG003|Overall Study|Adverse Event|1|||
42228701|NCT03240575|76048684|FG000|Overall Study|Withdrawal by Subject|2|||
42228702|NCT03240575|76048685|FG001|Overall Study|Withdrawal by Subject|11|||
42228703|NCT03240575|76048686|FG002|Overall Study|Withdrawal by Subject|0|||
42228704|NCT03240575|76048687|FG003|Overall Study|Withdrawal by Subject|1|||
42228705|NCT03240575|76048684|FG000|Overall Study|Other|0|||
42228706|NCT03240575|76048685|FG001|Overall Study|Other|1|||
42228707|NCT03240575|76048686|FG002|Overall Study|Other|0|||
42228708|NCT03240575|76048687|FG003|Overall Study|Other|0|||
42228709|NCT03385265|76048699|FG000|Overall Study|Withdrawal by Subject|5|||
42228710|NCT03385265|76048700|FG001|Overall Study|Withdrawal by Subject|2|||
42228711|NCT03385265|76048701|FG002|Overall Study|Withdrawal by Subject|5|||
42228712|NCT03385265|76048702|FG003|Overall Study|Withdrawal by Subject|2|||
42228713|NCT03280121|76048714|FG000|Overall Study|Physician Decision|1|||
42228714|NCT03280121|76048714|FG000|Overall Study|Lost to Follow-up|1|||
41986184|NCT03143153|75793226|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
41986185|NCT03143153|75793227|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
41986186|NCT03143153|75793228|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
41986187|NCT03143153|75793226|FG000|Treatment|Disease progression|174|||
41986188|NCT03143153|75793227|FG001|Treatment|Disease progression|184|||
41986189|NCT03143153|75793228|FG002|Treatment|Disease progression|193|||
41986190|NCT03143153|75793226|FG000|Treatment|Study drug toxicity|59|||
41986191|NCT03143153|75793227|FG001|Treatment|Study drug toxicity|33|||
41986192|NCT03143153|75793228|FG002|Treatment|Study drug toxicity|40|||
41986193|NCT03143153|75793226|FG000|Treatment|Death|5|||
41986194|NCT03143153|75793227|FG001|Treatment|Death|3|||
41986195|NCT03143153|75793228|FG002|Treatment|Death|4|||
41986196|NCT03143153|75793226|FG000|Treatment|Adverse event unrelated to study drug|19|||
41986197|NCT03143153|75793227|FG001|Treatment|Adverse event unrelated to study drug|28|||
41986198|NCT03143153|75793228|FG002|Treatment|Adverse event unrelated to study drug|12|||
41986199|NCT03143153|75793226|FG000|Treatment|Participant request to discontinue study treatment|13|||
41986200|NCT03143153|75793227|FG001|Treatment|Participant request to discontinue study treatment|15|||
41986201|NCT03143153|75793228|FG002|Treatment|Participant request to discontinue study treatment|20|||
41986202|NCT03143153|75793226|FG000|Treatment|Participant withdrew consent|3|||
41986203|NCT03143153|75793227|FG001|Treatment|Participant withdrew consent|4|||
41986204|NCT03143153|75793228|FG002|Treatment|Participant withdrew consent|12|||
41986205|NCT03143153|75793226|FG000|Treatment|Pregnancy|1|||
41986206|NCT03143153|75793227|FG001|Treatment|Pregnancy|0|||
42228715|NCT03280121|76048714|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
42228716|NCT03233009|76048718|FG000|Overall Study|Lost to Follow-up|1|||
42228717|NCT04034225|76048733|FG000|Overall Study|Death|3|||
42228718|NCT04034225|76048733|FG000|Overall Study|Withdrawal by Subject|2|||
42228719|NCT04034225|76048733|FG000|Overall Study|Study termination by Sponsor|18|||
42228720|NCT04034225|76048733|FG000|Overall Study|Physician Decision|1|||
42228721|NCT04034225|76048733|FG000|Overall Study|Lack of Efficacy|1|||
42228722|NCT02999178|76048741|FG000|Overall Study|Adverse Event|85|||
42228723|NCT02999178|76048742|FG001|Overall Study|Adverse Event|62|||
42228724|NCT02999178|76048741|FG000|Overall Study|Protocol Violation|1|||
41986207|NCT03143153|75793228|FG002|Treatment|Pregnancy|0|||
41986208|NCT03143153|75793226|FG000|Treatment|Maximum clinical benefit|1|||
41986209|NCT03143153|75793227|FG001|Treatment|Maximum clinical benefit|3|||
42228725|NCT02999178|76048742|FG001|Overall Study|Protocol Violation|2|||
42228726|NCT02999178|76048741|FG000|Overall Study|Lost to Follow-up|0|||
42228727|NCT02999178|76048742|FG001|Overall Study|Lost to Follow-up|2|||
42228728|NCT02999178|76048741|FG000|Overall Study|Withdrawal by Subject|21|||
42228729|NCT02999178|76048742|FG001|Overall Study|Withdrawal by Subject|21|||
42228730|NCT02999178|76048741|FG000|Overall Study|Other reason not defined above|7|||
41986210|NCT03143153|75793228|FG002|Treatment|Maximum clinical benefit|4|||
41986211|NCT03143153|75793226|FG000|Treatment|Completed treatment as per Protocol|13|||
41986212|NCT03143153|75793227|FG001|Treatment|Completed treatment as per Protocol|8|||
41986213|NCT03143153|75793228|FG002|Treatment|Completed treatment as per Protocol|0|||
42228731|NCT02999178|76048742|FG001|Overall Study|Other reason not defined above|13|||
42228732|NCT02959190|76048754|FG000|Open Label|Adverse Event|5|||
41986214|NCT03143153|75793226|FG000|Treatment|Other reasons|12|||
41986215|NCT03143153|75793227|FG001|Treatment|Other reasons|7|||
41986216|NCT03143153|75793228|FG002|Treatment|Other reasons|15|||
41986217|NCT03143153|75793226|FG000|Treatment|Not reported|1|||
41986218|NCT03143153|75793227|FG001|Treatment|Not reported|0|||
41986219|NCT03143153|75793228|FG002|Treatment|Not reported|0|||
41986220|NCT03106779|75793238|FG000|Overall Study|Lack of Efficacy|33|||
41986221|NCT03106779|75793239|FG001|Overall Study|Lack of Efficacy|24|||
41986222|NCT03106779|75793238|FG000|Overall Study|Adverse Event|8|||
41986223|NCT03106779|75793239|FG001|Overall Study|Adverse Event|16|||
41986224|NCT03106779|75793238|FG000|Overall Study|Physician Decision|10|||
41986225|NCT03106779|75793239|FG001|Overall Study|Physician Decision|6|||
41986226|NCT03106779|75793238|FG000|Overall Study|Patient/guardian decision|4|||
41986227|NCT03106779|75793239|FG001|Overall Study|Patient/guardian decision|3|||
41986228|NCT03106779|75793238|FG000|Overall Study|Progressive disease|1|||
41986229|NCT03106779|75793239|FG001|Overall Study|Progressive disease|3|||
41986230|NCT03106779|75793238|FG000|Overall Study|Lost to Follow-up|1|||
41986231|NCT03106779|75793239|FG001|Overall Study|Lost to Follow-up|2|||
41986232|NCT03106779|75793238|FG000|Overall Study|Death|1|||
41986233|NCT03106779|75793239|FG001|Overall Study|Death|0|||
41986234|NCT03106779|75793238|FG000|Overall Study|Protocol Violation|1|||
41986235|NCT03106779|75793239|FG001|Overall Study|Protocol Violation|0|||
41986236|NCT03106779|75793238|FG000|Overall Study|Not treated|1|||
41986237|NCT03106779|75793239|FG001|Overall Study|Not treated|0|||
41986238|NCT02872116|75793248|FG000|Pre-Treatment|Disease Progression|0|||
41986239|NCT02872116|75793249|FG001|Pre-Treatment|Disease Progression|1|||
41986240|NCT02872116|75793250|FG002|Pre-Treatment|Disease Progression|0|||
41986241|NCT02872116|75793248|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
42228733|NCT02959190|76048755|FG001|Open Label|Adverse Event|7|||
42228734|NCT02959190|76048756|FG002|Open Label|Adverse Event|3|||
42228735|NCT02959190|76048757|FG003|Open Label|Adverse Event|4|||
42228736|NCT02959190|76048754|FG000|Open Label|Pregnancy|0|||
41986242|NCT02872116|75793249|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
42228737|NCT02959190|76048755|FG001|Open Label|Pregnancy|1|||
42228738|NCT02959190|76048756|FG002|Open Label|Pregnancy|0|||
42228739|NCT02959190|76048757|FG003|Open Label|Pregnancy|0|||
42228740|NCT02959190|76048754|FG000|Open Label|Withdrawal by Subject|2|||
42228741|NCT02959190|76048755|FG001|Open Label|Withdrawal by Subject|8|||
41986243|NCT02872116|75793250|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
41986244|NCT02872116|75793248|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
41986245|NCT02872116|75793249|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
41986246|NCT02872116|75793250|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
41986247|NCT02872116|75793248|FG000|Pre-Treatment|Participant withdrew consent|2|||
41986248|NCT02872116|75793249|FG001|Pre-Treatment|Participant withdrew consent|20|||
41986249|NCT02872116|75793250|FG002|Pre-Treatment|Participant withdrew consent|3|||
41986250|NCT02872116|75793248|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
41986251|NCT02872116|75793249|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
41986252|NCT02872116|75793250|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
41986253|NCT02872116|75793248|FG000|Pre-Treatment|Other reasons|1|||
41986254|NCT02872116|75793249|FG001|Pre-Treatment|Other reasons|2|||
41986255|NCT02872116|75793250|FG002|Pre-Treatment|Other reasons|2|||
41986256|NCT02872116|75793248|FG000|Treatment|Death|122|||
41986257|NCT02872116|75793249|FG001|Treatment|Death|94|||
41986258|NCT02872116|75793250|FG002|Treatment|Death|68|||
41986259|NCT02872116|75793248|FG000|Treatment|Lost to Follow-up|5|||
41986260|NCT02872116|75793249|FG001|Treatment|Lost to Follow-up|7|||
41986261|NCT02872116|75793250|FG002|Treatment|Lost to Follow-up|3|||
42228742|NCT02959190|76048756|FG002|Open Label|Withdrawal by Subject|0|||
41986262|NCT02872116|75793248|FG000|Treatment|Participant withdrew consent|20|||
41986263|NCT02872116|75793249|FG001|Treatment|Participant withdrew consent|40|||
41986264|NCT02872116|75793250|FG002|Treatment|Participant withdrew consent|8|||
41986265|NCT02872116|75793248|FG000|Treatment|Other reasons|12|||
41986266|NCT02872116|75793249|FG001|Treatment|Other reasons|12|||
41986267|NCT02872116|75793250|FG002|Treatment|Other reasons|5|||
41986268|NCT02828358|75793264|FG000|Overall Study|Physician Decision|7|||
41986269|NCT02828358|75793265|FG001|Overall Study|Physician Decision|1|||
41986270|NCT02828358|75793264|FG000|Overall Study|Treatment Failure|6|||
41986271|NCT02828358|75793265|FG001|Overall Study|Treatment Failure|0|||
41986272|NCT02828358|75793264|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
41986273|NCT02828358|75793265|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
42010516|NCT01014442|75817632|FG000|Overall Study|Lack of Compliance|0|||
42228743|NCT02959190|76048757|FG003|Open Label|Withdrawal by Subject|0|||
42228744|NCT02959190|76048754|FG000|Open Label|Physician Decision|0|||
42228745|NCT02959190|76048755|FG001|Open Label|Physician Decision|0|||
41986274|NCT02828358|75793264|FG000|Overall Study|Refusal of further protocol therapy|2|||
41986275|NCT02828358|75793265|FG001|Overall Study|Refusal of further protocol therapy|0|||
41986276|NCT02828358|75793264|FG000|Overall Study|Relapse|25|||
41986277|NCT02828358|75793265|FG001|Overall Study|Relapse|0|||
41986278|NCT02828358|75793264|FG000|Overall Study|Still on therapy|5|||
41986279|NCT02828358|75793265|FG001|Overall Study|Still on therapy|0|||
41986280|NCT02592824|75793272|FG000|Overall Study|Protocol Violation|5|||
41986281|NCT02592824|75793273|FG001|Overall Study|Protocol Violation|3|||
41986282|NCT02592824|75793272|FG000|Overall Study|Lost to Follow-up|2|||
41986283|NCT02592824|75793273|FG001|Overall Study|Lost to Follow-up|1|||
41986284|NCT02348112|75793292|FG000|Overall Study|Withdrawal by Subject|32|||
42228746|NCT02959190|76048756|FG002|Open Label|Physician Decision|1|||
42228747|NCT02959190|76048757|FG003|Open Label|Physician Decision|0|||
42228748|NCT02959190|76048754|FG000|Open Label|Protocol Violation|0|||
42228749|NCT02959190|76048755|FG001|Open Label|Protocol Violation|0|||
42228750|NCT02959190|76048756|FG002|Open Label|Protocol Violation|0|||
42228751|NCT02959190|76048757|FG003|Open Label|Protocol Violation|2|||
42228752|NCT02959190|76048754|FG000|Post Treatment Follow Up|Adverse Event|1|||
42228753|NCT02959190|76048755|FG001|Post Treatment Follow Up|Adverse Event|1|||
42228754|NCT02959190|76048756|FG002|Post Treatment Follow Up|Adverse Event|0|||
42228755|NCT02959190|76048757|FG003|Post Treatment Follow Up|Adverse Event|0|||
42228756|NCT02959190|76048754|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
42228757|NCT02959190|76048755|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
42228758|NCT02959190|76048756|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
42228759|NCT02959190|76048757|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
42228760|NCT01344356|76048778|FG000|Overall Study|Physician Decision|0|||
42228761|NCT01344356|76048779|FG001|Overall Study|Physician Decision|3|||
42228762|NCT01344356|76048778|FG000|Overall Study|Lost to Follow-up|0|||
42228763|NCT01344356|76048779|FG001|Overall Study|Lost to Follow-up|6|||
42228764|NCT02956460|76048805|FG000|Lens 1|Lost to Follow-up|1|||
42228765|NCT02956460|76048806|FG001|Lens 1|Lost to Follow-up|0|||
42228766|NCT02999100|76048818|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
42228767|NCT02999100|76048819|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
42228768|NCT02999100|76048820|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
42228769|NCT02999100|76048821|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
42228770|NCT02999100|76048822|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
42228771|NCT02999100|76048823|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
42228772|NCT02999100|76048818|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
42228773|NCT02999100|76048819|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
42228774|NCT02999100|76048820|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
42228775|NCT02999100|76048821|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
41986285|NCT02348112|75793293|FG001|Overall Study|Withdrawal by Subject|29|||
41986286|NCT02348112|75793292|FG000|Overall Study|Lost to Follow-up|24|||
41986287|NCT02348112|75793293|FG001|Overall Study|Lost to Follow-up|20|||
41986288|NCT02348112|75793292|FG000|Overall Study|Physician Decision|17|||
41986289|NCT02348112|75793293|FG001|Overall Study|Physician Decision|15|||
41986290|NCT02348112|75793292|FG000|Overall Study|Site closed due to PI leaving|0|||
41986291|NCT02348112|75793293|FG001|Overall Study|Site closed due to PI leaving|30|||
41986292|NCT02348112|75793292|FG000|Overall Study|Sponsor withdrawal|0|||
41986293|NCT02348112|75793293|FG001|Overall Study|Sponsor withdrawal|7|||
41986294|NCT02348112|75793292|FG000|Overall Study|Death|0|||
42228776|NCT02999100|76048822|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
42228777|NCT02999100|76048823|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
41986295|NCT02348112|75793293|FG001|Overall Study|Death|1|||
41986296|NCT02004691|75793327|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
41986297|NCT02004691|75793328|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
41986298|NCT02004691|75793327|FG000|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|1|||
42228778|NCT02999100|76048818|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
42302484|NCT02417935|76137749|FG000|Treatment Period|Adverse Event|12|||
41986299|NCT02004691|75793328|FG001|ETP: Ongoing From Week 52|Related to Coronavirus Disease (COVID-19)|0|||
41986300|NCT02004691|75793327|FG000|ETP: Ongoing From Week 52|Withdrawal by Subject|0|||
41986301|NCT02004691|75793328|FG001|ETP: Ongoing From Week 52|Withdrawal by Subject|1|||
41986302|NCT02004691|75793327|FG000|ETP: Ongoing From Week 52|Other|0|||
41986303|NCT02004691|75793328|FG001|ETP: Ongoing From Week 52|Other|1|||
41986304|NCT02004691|75793327|FG000|ETP: Ongoing From Week 52|Ongoing|16|||
41986305|NCT02004691|75793328|FG001|ETP: Ongoing From Week 52|Ongoing|16|||
42228779|NCT02999100|76048819|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
42302485|NCT02417935|76137750|FG001|Treatment Period|Adverse Event|10|||
42302486|NCT02417935|76137749|FG000|Treatment Period|Lost to Follow-up|1|||
41986306|NCT01248962|75793389|FG000|Overall Study|Withdrawal by Subject|1|||
41986307|NCT01248962|75793390|FG001|Overall Study|Withdrawal by Subject|1|||
42228780|NCT02999100|76048820|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
42228781|NCT02999100|76048821|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
42228782|NCT02999100|76048822|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
42228783|NCT02999100|76048823|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
41986308|NCT01248962|75793389|FG000|Overall Study|Adverse Event|2|||
41986309|NCT01248962|75793390|FG001|Overall Study|Adverse Event|1|||
41986310|NCT01248962|75793389|FG000|Overall Study|Complete Response after 4 Cycles|1|||
41986311|NCT01248962|75793390|FG001|Overall Study|Complete Response after 4 Cycles|0|||
41986312|NCT01248962|75793389|FG000|Overall Study|Complete Response after 3 Cycles|0|||
41986313|NCT01248962|75793390|FG001|Overall Study|Complete Response after 3 Cycles|1|||
41986314|NCT01248962|75793389|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
42228784|NCT02749370|76048845|FG000|Overall Study|Withdrawal by Subject|11|||
42228785|NCT02749370|76048845|FG000|Overall Study|Lost to Follow-up|3|||
42228786|NCT03607994|76048851|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
42228787|NCT03607994|76048852|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
42228788|NCT02996682|76048860|FG000|Overall Study|Death|0|||
42228789|NCT02996682|76048861|FG001|Overall Study|Death|3|||
42032476|NCT01194830|75840736|FG001|Overall Study|Lost to Follow-up|7|||
42032477|NCT01194830|75840735|FG000|Overall Study|Withdrawal by Subject|2|||
42032478|NCT01194830|75840736|FG001|Overall Study|Withdrawal by Subject|1|||
42032479|NCT01194830|75840735|FG000|Overall Study|Lack of Efficacy|1|||
42032480|NCT01194830|75840736|FG001|Overall Study|Lack of Efficacy|1|||
42032481|NCT01194830|75840735|FG000|Overall Study|Non-compliance issues|4|||
42228790|NCT02873702|76048869|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
42228791|NCT02873702|76048870|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
42228792|NCT02873702|76048871|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
42228793|NCT02873702|76048872|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
42228794|NCT02873702|76048869|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
42228795|NCT02873702|76048870|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
42228796|NCT02873702|76048871|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
41986315|NCT01248962|75793390|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
41986316|NCT01248455|75793397|FG000|Overall Study|switched to alternate treatment|1|||
41986317|NCT01247090|75793404|FG000|Overall Study|Physician Decision|1|||
41986318|NCT01247090|75793405|FG001|Overall Study|Physician Decision|0|||
41986319|NCT01247090|75793406|FG002|Overall Study|Physician Decision|0|||
41986320|NCT01247090|75793404|FG000|Overall Study|Withdrawal by Subject|0|||
41986321|NCT01247090|75793405|FG001|Overall Study|Withdrawal by Subject|1|||
41986322|NCT01247090|75793406|FG002|Overall Study|Withdrawal by Subject|0|||
41986323|NCT01249664|75793416|FG000|Overall Study|Withdrawal by Subject|5|||
41986324|NCT01249664|75793417|FG001|Overall Study|Withdrawal by Subject|0|||
41986325|NCT01249664|75793416|FG000|Overall Study|Adverse Event|1|||
42032482|NCT01194830|75840736|FG001|Overall Study|Non-compliance issues|4|||
41986326|NCT01249664|75793417|FG001|Overall Study|Adverse Event|0|||
41986327|NCT01249274|75793427|FG000|Overall Study|Lost to Follow-up|3|||
41986328|NCT01249274|75793428|FG001|Overall Study|Lost to Follow-up|4|||
41986329|NCT01249274|75793427|FG000|Overall Study|Received inpatient substance treatment|1|||
41986330|NCT01249274|75793428|FG001|Overall Study|Received inpatient substance treatment|2|||
41986331|NCT01249157|75793436|FG000|Overall Study|Withdrawal by Subject|1|||
41986332|NCT01249118|75793440|FG000|First Washout Period|Physician Decision|0|||
41986333|NCT01249118|75793441|FG001|First Washout Period|Physician Decision|1|||
41986334|NCT01249118|75793442|FG002|First Washout Period|Physician Decision|0|||
41986335|NCT01248884|75793452|FG000|Overall Study|Withdrawal by Subject|1|||
41986336|NCT01248884|75793453|FG001|Overall Study|Withdrawal by Subject|3|||
41986337|NCT01248884|75793454|FG002|Overall Study|Withdrawal by Subject|1|||
41986338|NCT01248884|75793452|FG000|Overall Study|Adverse Event|1|||
41986339|NCT01248884|75793453|FG001|Overall Study|Adverse Event|0|||
41986340|NCT01248884|75793454|FG002|Overall Study|Adverse Event|0|||
41986341|NCT01248728|75793466|FG000|Overall Study|Adverse Event|1|||
41986342|NCT01248728|75793467|FG001|Overall Study|Adverse Event|1|||
42032483|NCT01194830|75840735|FG000|Overall Study|Other Reason|12|||
42032484|NCT01194830|75840736|FG001|Overall Study|Other Reason|8|||
42032485|NCT01194440|75840742|FG000|Baseline (First Dose)|Reason not specified|4|||
42032486|NCT01194440|75840742|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
42032487|NCT01194440|75840742|FG000|Baseline (First Dose)|Change in therapy|1|||
42032488|NCT01194440|75840742|FG000|Baseline (First Dose)|Adverse Event|1|||
42032489|NCT01194440|75840742|FG000|6-months (2nd Dose)|Change in therapy|4|||
42228797|NCT02873702|76048872|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
42228798|NCT02873702|76048869|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
42032490|NCT00951015|75840751|FG000|Randomization Phase 96 Week|Adverse Event|1|||
42032491|NCT00951015|75840752|FG001|Randomization Phase 96 Week|Adverse Event|1|||
42032492|NCT00951015|75840753|FG002|Randomization Phase 96 Week|Adverse Event|2|||
42228799|NCT02873702|76048870|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
42228800|NCT02873702|76048871|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
41986343|NCT01248728|75793466|FG000|Overall Study|Withdrawal by Subject|2|||
41986344|NCT01248728|75793467|FG001|Overall Study|Withdrawal by Subject|1|||
41986345|NCT01248728|75793466|FG000|Overall Study|Lack of Efficacy|1|||
41986346|NCT01248728|75793467|FG001|Overall Study|Lack of Efficacy|0|||
41986347|NCT01246973|75793477|FG000|Overall Study|Other|38|||
42228801|NCT02873702|76048872|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
42228802|NCT02873702|76048869|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
42228803|NCT02873702|76048870|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
42228804|NCT02873702|76048871|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
42228805|NCT02873702|76048872|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
42228806|NCT02873702|76048869|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
42228807|NCT02873702|76048870|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
42228808|NCT02873702|76048871|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
42228809|NCT02873702|76048872|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
42228810|NCT02911116|76048884|FG000|Overall Study|Insufficient Therapeutic Response|1|||
42228811|NCT02911116|76048885|FG001|Overall Study|Insufficient Therapeutic Response|0|||
42302487|NCT02417935|76137750|FG001|Treatment Period|Lost to Follow-up|0|||
42302488|NCT02417935|76137749|FG000|Treatment Period|Entry Criteria not met|0|||
42302489|NCT02417935|76137750|FG001|Treatment Period|Entry Criteria not met|1|||
42302490|NCT02417935|76137749|FG000|Treatment Period|Protocol Violation|2|||
42302491|NCT02417935|76137750|FG001|Treatment Period|Protocol Violation|1|||
42302492|NCT02417935|76137749|FG000|Treatment Period|Withdrawal by Subject|3|||
42302493|NCT02417935|76137750|FG001|Treatment Period|Withdrawal by Subject|3|||
42302494|NCT02417935|76137749|FG000|Treatment Period|Physician Decision|3|||
42302495|NCT02417935|76137750|FG001|Treatment Period|Physician Decision|1|||
42302496|NCT02417233|76137759|FG000|Overall Study|Death|4|||
42302497|NCT02417233|76137760|FG001|Overall Study|Death|10|||
42302498|NCT02417233|76137761|FG002|Overall Study|Death|14|||
41986348|NCT01246973|75793478|FG001|Overall Study|Other|25|||
41986349|NCT01246973|75793477|FG000|Overall Study|Adverse Event|16|||
42228812|NCT02911116|76048884|FG000|Overall Study|Lost to Follow-up|0|||
42228813|NCT02911116|76048885|FG001|Overall Study|Lost to Follow-up|1|||
42228814|NCT02998554|76048893|FG000|Overall Study|Adverse Event|8|||
42228815|NCT02998554|76048894|FG001|Overall Study|Adverse Event|3|||
42228816|NCT02998554|76048893|FG000|Overall Study|Protocol deviation|1|||
42228817|NCT02998554|76048894|FG001|Overall Study|Protocol deviation|0|||
42228818|NCT02998554|76048893|FG000|Overall Study|Withdrawal by Subject|2|||
42228819|NCT02998554|76048894|FG001|Overall Study|Withdrawal by Subject|6|||
42228820|NCT02998554|76048893|FG000|Overall Study|Lost to Follow-up|0|||
42228821|NCT02998554|76048894|FG001|Overall Study|Lost to Follow-up|1|||
42228822|NCT02998554|76048893|FG000|Overall Study|Lack of Efficacy|0|||
42228823|NCT02998554|76048894|FG001|Overall Study|Lack of Efficacy|1|||
42228824|NCT02996448|76048902|FG000|Overall Study|Study terminated due to adverse effects|3|||
42228825|NCT02995980|76048907|FG000|Overall Study|Lost to Follow-up|14|||
42228826|NCT02872142|76048912|FG000|Overall Study|Adverse Event|2|||
42228827|NCT02872142|76048912|FG000|Overall Study|Death|1|||
42228828|NCT02872142|76048912|FG000|Overall Study|Participant Decision|3|||
42228829|NCT02994654|76048916|FG000|Overall Study|Lost to Follow-up|1|||
42228830|NCT02870972|76048926|FG000|Overall Study|Adverse Event|1|||
42228831|NCT02870972|76048927|FG001|Overall Study|Adverse Event|0|||
42228832|NCT02870972|76048928|FG002|Overall Study|Adverse Event|0|||
42228833|NCT02870972|76048929|FG003|Overall Study|Adverse Event|0|||
42228834|NCT02870972|76048930|FG004|Overall Study|Adverse Event|0|||
42228835|NCT03214367|76048950|FG000|Lead-in Period|Withdrawal by Subject|50|||
42228836|NCT03214367|76048951|FG001|Lead-in Period|Withdrawal by Subject|0|||
42228837|NCT03214367|76048952|FG002|Lead-in Period|Withdrawal by Subject|0|||
42228838|NCT03214367|76048953|FG003|Lead-in Period|Withdrawal by Subject|0|||
42228839|NCT03214367|76048954|FG004|Lead-in Period|Withdrawal by Subject|2|||
42228840|NCT03214367|76048955|FG005|Lead-in Period|Withdrawal by Subject|0|||
42228841|NCT03214367|76048956|FG006|Lead-in Period|Withdrawal by Subject|0|||
42228842|NCT03214367|76048957|FG007|Lead-in Period|Withdrawal by Subject|0|||
42228843|NCT03214367|76048950|FG000|Lead-in Period|Adverse Event|3|||
42228844|NCT03214367|76048951|FG001|Lead-in Period|Adverse Event|0|||
42228845|NCT03214367|76048952|FG002|Lead-in Period|Adverse Event|0|||
42228846|NCT03214367|76048953|FG003|Lead-in Period|Adverse Event|0|||
42228847|NCT03214367|76048954|FG004|Lead-in Period|Adverse Event|0|||
42228848|NCT03214367|76048955|FG005|Lead-in Period|Adverse Event|0|||
42228849|NCT03214367|76048956|FG006|Lead-in Period|Adverse Event|0|||
41986350|NCT01246973|75793478|FG001|Overall Study|Adverse Event|9|||
42228850|NCT03214367|76048957|FG007|Lead-in Period|Adverse Event|0|||
42228851|NCT03214367|76048950|FG000|Lead-in Period|Lost to Follow-up|12|||
42228852|NCT03214367|76048951|FG001|Lead-in Period|Lost to Follow-up|0|||
42228853|NCT03214367|76048952|FG002|Lead-in Period|Lost to Follow-up|0|||
42228854|NCT03214367|76048953|FG003|Lead-in Period|Lost to Follow-up|0|||
42228855|NCT03214367|76048954|FG004|Lead-in Period|Lost to Follow-up|0|||
42228856|NCT03214367|76048955|FG005|Lead-in Period|Lost to Follow-up|0|||
42228857|NCT03214367|76048956|FG006|Lead-in Period|Lost to Follow-up|0|||
42302499|NCT02417233|76137759|FG000|Overall Study|Lost to Follow-up|27|||
42302500|NCT02417233|76137760|FG001|Overall Study|Lost to Follow-up|39|||
42302501|NCT02417233|76137761|FG002|Overall Study|Lost to Follow-up|34|||
42010517|NCT01014442|75817633|FG001|Overall Study|Lack of Compliance|1|||
42302502|NCT02417233|76137759|FG000|Overall Study|Protocol Violation|2|||
42228858|NCT03214367|76048957|FG007|Lead-in Period|Lost to Follow-up|0|||
42228859|NCT03214367|76048950|FG000|Lead-in Period|Sponsor Decision|11|||
42228860|NCT03214367|76048951|FG001|Lead-in Period|Sponsor Decision|0|||
42228861|NCT03214367|76048952|FG002|Lead-in Period|Sponsor Decision|0|||
42228862|NCT03214367|76048953|FG003|Lead-in Period|Sponsor Decision|0|||
42228863|NCT03214367|76048954|FG004|Lead-in Period|Sponsor Decision|0|||
42228864|NCT03214367|76048955|FG005|Lead-in Period|Sponsor Decision|0|||
42228865|NCT03214367|76048956|FG006|Lead-in Period|Sponsor Decision|0|||
42228866|NCT03214367|76048957|FG007|Lead-in Period|Sponsor Decision|0|||
42228867|NCT03214367|76048950|FG000|Lead-in Period|Physician Decision|12|||
42228868|NCT03214367|76048951|FG001|Lead-in Period|Physician Decision|0|||
42228869|NCT03214367|76048952|FG002|Lead-in Period|Physician Decision|0|||
42228870|NCT03214367|76048953|FG003|Lead-in Period|Physician Decision|0|||
42228871|NCT03214367|76048954|FG004|Lead-in Period|Physician Decision|0|||
42228872|NCT03214367|76048955|FG005|Lead-in Period|Physician Decision|0|||
42228873|NCT03214367|76048956|FG006|Lead-in Period|Physician Decision|0|||
42228874|NCT03214367|76048957|FG007|Lead-in Period|Physician Decision|0|||
42228875|NCT03214367|76048950|FG000|Lead-in Period|Protocol Violation|5|||
42228876|NCT03214367|76048951|FG001|Lead-in Period|Protocol Violation|0|||
42228877|NCT03214367|76048952|FG002|Lead-in Period|Protocol Violation|0|||
41986351|NCT01246973|75793477|FG000|Overall Study|Withdrawal by Subject|7|||
41986352|NCT01246973|75793478|FG001|Overall Study|Withdrawal by Subject|13|||
41986353|NCT01246466|75793484|FG000|Overall Study|Death|1|||
41986354|NCT01246466|75793484|FG000|Overall Study|Withdrawal by Subject|1|||
41986355|NCT01245764|75793493|FG000|Study Phase A|Other|3|||
41986356|NCT01245764|75793494|FG001|Study Phase A|Other|2|||
41986357|NCT01245764|75793495|FG002|Study Phase A|Other|3|||
41986358|NCT01245764|75793496|FG003|Study Phase A|Other|1|||
41986359|NCT01245764|75793493|FG000|Study Phase A|Protocol Violation|6|||
41986360|NCT01245764|75793494|FG001|Study Phase A|Protocol Violation|3|||
41986361|NCT01245764|75793495|FG002|Study Phase A|Protocol Violation|2|||
41986362|NCT01245764|75793496|FG003|Study Phase A|Protocol Violation|2|||
41986363|NCT01245764|75793493|FG000|Study Phase A|Lost to Follow-up|0|||
41986364|NCT01245764|75793494|FG001|Study Phase A|Lost to Follow-up|0|||
41986365|NCT01245764|75793495|FG002|Study Phase A|Lost to Follow-up|5|||
41986366|NCT01245764|75793496|FG003|Study Phase A|Lost to Follow-up|0|||
41986367|NCT01245140|75793516|FG000|Overall Study|Adverse Event|1|||
41986368|NCT01245140|75793517|FG001|Overall Study|Adverse Event|3|||
41986369|NCT01245140|75793516|FG000|Overall Study|Lack of Efficacy|2|||
41986370|NCT01245140|75793517|FG001|Overall Study|Lack of Efficacy|4|||
41986371|NCT01245140|75793516|FG000|Overall Study|Protocol Violation|0|||
41986372|NCT01245140|75793517|FG001|Overall Study|Protocol Violation|1|||
41986373|NCT01245140|75793516|FG000|Overall Study|Withdrawal by Subject|0|||
41986374|NCT01245140|75793517|FG001|Overall Study|Withdrawal by Subject|1|||
41986375|NCT01245140|75793516|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
41986376|NCT01245140|75793517|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
41986377|NCT01245101|75793525|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
41986378|NCT01245101|75793526|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
41986379|NCT01245101|75793525|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
41986380|NCT01245101|75793526|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
41986381|NCT01245101|75793525|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
41986382|NCT01245101|75793526|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
41986383|NCT01245062|75793534|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
41986384|NCT01245062|75793535|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
41986385|NCT01245062|75793536|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
41986386|NCT01245062|75793534|FG000|Randomization and Crossover Phase|Physician Decision|2|||
41986387|NCT01245062|75793535|FG001|Randomization and Crossover Phase|Physician Decision|4|||
41986388|NCT01245062|75793536|FG002|Randomization and Crossover Phase|Physician Decision|0|||
41986389|NCT01245062|75793534|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
41986390|NCT01245062|75793535|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
41986391|NCT01245062|75793536|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
41986392|NCT01245062|75793534|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
41986393|NCT01245062|75793535|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
41986394|NCT01245062|75793536|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
41986395|NCT01245062|75793534|FG000|Cross-over Phase|Lost to Follow-up|0|||
41986396|NCT01245062|75793535|FG001|Cross-over Phase|Lost to Follow-up|0|||
41986397|NCT01245062|75793536|FG002|Cross-over Phase|Lost to Follow-up|1|||
42228878|NCT03214367|76048953|FG003|Lead-in Period|Protocol Violation|0|||
41986398|NCT01245062|75793534|FG000|Cross-over Phase|Physician Decision|0|||
41986399|NCT01245062|75793535|FG001|Cross-over Phase|Physician Decision|0|||
41986400|NCT01245062|75793536|FG002|Cross-over Phase|Physician Decision|1|||
41986401|NCT01245062|75793534|FG000|Cross-over Phase|Withdrew Consent|0|||
42228879|NCT03214367|76048954|FG004|Lead-in Period|Protocol Violation|0|||
42228880|NCT03214367|76048955|FG005|Lead-in Period|Protocol Violation|0|||
42228881|NCT03214367|76048956|FG006|Lead-in Period|Protocol Violation|0|||
42228882|NCT03214367|76048957|FG007|Lead-in Period|Protocol Violation|0|||
41986402|NCT01245062|75793535|FG001|Cross-over Phase|Withdrew Consent|0|||
41986403|NCT01245062|75793536|FG002|Cross-over Phase|Withdrew Consent|4|||
41986404|NCT01245062|75793534|FG000|Cross-over Phase|Study closed/ terminated|0|||
41986405|NCT01245062|75793535|FG001|Cross-over Phase|Study closed/ terminated|0|||
41986406|NCT01245062|75793536|FG002|Cross-over Phase|Study closed/ terminated|11|||
41986407|NCT01244984|75793547|FG000|Overall Study|Adverse Event|2|||
41986408|NCT01244984|75793548|FG001|Overall Study|Adverse Event|11|||
41986409|NCT01244984|75793549|FG002|Overall Study|Adverse Event|2|||
41986410|NCT01244984|75793547|FG000|Overall Study|Protocol Violation|1|||
42228883|NCT03214367|76048950|FG000|Lead-in Period|Treatment Interruption|1|||
42228884|NCT03214367|76048951|FG001|Lead-in Period|Treatment Interruption|0|||
42228885|NCT03214367|76048952|FG002|Lead-in Period|Treatment Interruption|0|||
42228886|NCT03214367|76048953|FG003|Lead-in Period|Treatment Interruption|0|||
42228887|NCT03214367|76048954|FG004|Lead-in Period|Treatment Interruption|0|||
42228888|NCT03214367|76048955|FG005|Lead-in Period|Treatment Interruption|0|||
42228889|NCT03214367|76048956|FG006|Lead-in Period|Treatment Interruption|0|||
42228890|NCT03214367|76048957|FG007|Lead-in Period|Treatment Interruption|0|||
42228891|NCT03214367|76048950|FG000|Treatment Period|Adverse Event|0|||
42228892|NCT03214367|76048951|FG001|Treatment Period|Adverse Event|1|||
42228893|NCT03214367|76048952|FG002|Treatment Period|Adverse Event|4|||
42228894|NCT03214367|76048953|FG003|Treatment Period|Adverse Event|2|||
42228895|NCT03214367|76048954|FG004|Treatment Period|Adverse Event|0|||
42228896|NCT03214367|76048955|FG005|Treatment Period|Adverse Event|0|||
42228897|NCT03214367|76048956|FG006|Treatment Period|Adverse Event|0|||
42228898|NCT03214367|76048957|FG007|Treatment Period|Adverse Event|0|||
42228899|NCT03214367|76048950|FG000|Treatment Period|Death|0|||
42228900|NCT03214367|76048951|FG001|Treatment Period|Death|1|||
42228901|NCT03214367|76048952|FG002|Treatment Period|Death|1|||
42032493|NCT00951015|75840754|FG003|Randomization Phase 96 Week|Adverse Event|5|||
42032494|NCT00951015|75840755|FG004|Randomization Phase 96 Week|Adverse Event|0|||
42032495|NCT00951015|75840751|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
42032496|NCT00951015|75840752|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
42032497|NCT00951015|75840753|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
42032498|NCT00951015|75840754|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
42032499|NCT00951015|75840755|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
42131729|NCT00498186|75942633|FG000|Overall Study|Protocol Violation|10|||
42228902|NCT03214367|76048953|FG003|Treatment Period|Death|1|||
42228903|NCT03214367|76048954|FG004|Treatment Period|Death|0|||
42228904|NCT03214367|76048955|FG005|Treatment Period|Death|0|||
41986411|NCT01244984|75793548|FG001|Overall Study|Protocol Violation|0|||
42228905|NCT03214367|76048956|FG006|Treatment Period|Death|0|||
42228906|NCT03214367|76048957|FG007|Treatment Period|Death|0|||
42228907|NCT03214367|76048950|FG000|Treatment Period|Lost to Follow-up|0|||
41986412|NCT01244984|75793549|FG002|Overall Study|Protocol Violation|0|||
41986413|NCT01244984|75793547|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
41986414|NCT01244984|75793548|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
41986415|NCT01244984|75793549|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
41986416|NCT01244984|75793547|FG000|Overall Study|Withdrawal by Subject|1|||
41986417|NCT01244984|75793548|FG001|Overall Study|Withdrawal by Subject|2|||
41986418|NCT01244984|75793549|FG002|Overall Study|Withdrawal by Subject|2|||
41986419|NCT01244516|75793561|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
41986420|NCT01244516|75793562|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
41986421|NCT01244516|75793563|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
41986422|NCT01244516|75793561|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
41986423|NCT01244516|75793562|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
42228908|NCT03214367|76048951|FG001|Treatment Period|Lost to Follow-up|5|||
42228909|NCT03214367|76048952|FG002|Treatment Period|Lost to Follow-up|3|||
42228910|NCT03214367|76048953|FG003|Treatment Period|Lost to Follow-up|2|||
42228911|NCT03214367|76048954|FG004|Treatment Period|Lost to Follow-up|0|||
41986424|NCT01244516|75793563|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
41986425|NCT01244516|75793561|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
42032500|NCT00951015|75840751|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
42032501|NCT00951015|75840752|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
42228912|NCT03214367|76048955|FG005|Treatment Period|Lost to Follow-up|2|||
42228913|NCT03214367|76048956|FG006|Treatment Period|Lost to Follow-up|1|||
42228914|NCT03214367|76048957|FG007|Treatment Period|Lost to Follow-up|0|||
42228915|NCT03214367|76048950|FG000|Treatment Period|Sponsor Decision|0|||
42228916|NCT03214367|76048951|FG001|Treatment Period|Sponsor Decision|3|||
42228917|NCT03214367|76048952|FG002|Treatment Period|Sponsor Decision|0|||
42228918|NCT03214367|76048953|FG003|Treatment Period|Sponsor Decision|0|||
42228919|NCT03214367|76048954|FG004|Treatment Period|Sponsor Decision|0|||
42032502|NCT00951015|75840753|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
42228920|NCT03214367|76048955|FG005|Treatment Period|Sponsor Decision|0|||
42228921|NCT03214367|76048956|FG006|Treatment Period|Sponsor Decision|0|||
42228922|NCT03214367|76048957|FG007|Treatment Period|Sponsor Decision|0|||
42228923|NCT03214367|76048950|FG000|Treatment Period|Physician Decision|0|||
42228924|NCT03214367|76048951|FG001|Treatment Period|Physician Decision|1|||
42228925|NCT03214367|76048952|FG002|Treatment Period|Physician Decision|2|||
42228926|NCT03214367|76048953|FG003|Treatment Period|Physician Decision|0|||
42228927|NCT03214367|76048954|FG004|Treatment Period|Physician Decision|0|||
42228928|NCT03214367|76048955|FG005|Treatment Period|Physician Decision|0|||
42228929|NCT03214367|76048956|FG006|Treatment Period|Physician Decision|0|||
42228930|NCT03214367|76048957|FG007|Treatment Period|Physician Decision|0|||
41986426|NCT01244516|75793562|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
41986427|NCT01244516|75793563|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
42228931|NCT03214367|76048950|FG000|Treatment Period|Protocol Violation|0|||
42228932|NCT03214367|76048951|FG001|Treatment Period|Protocol Violation|3|||
42228933|NCT03214367|76048952|FG002|Treatment Period|Protocol Violation|0|||
42228934|NCT03214367|76048953|FG003|Treatment Period|Protocol Violation|0|||
42228935|NCT03214367|76048954|FG004|Treatment Period|Protocol Violation|0|||
42228936|NCT03214367|76048955|FG005|Treatment Period|Protocol Violation|0|||
42228937|NCT03214367|76048956|FG006|Treatment Period|Protocol Violation|0|||
42228938|NCT03214367|76048957|FG007|Treatment Period|Protocol Violation|0|||
42228939|NCT03214367|76048950|FG000|Treatment Period|Withdrawal by Subject|0|||
42228940|NCT03214367|76048951|FG001|Treatment Period|Withdrawal by Subject|20|||
42228941|NCT03214367|76048952|FG002|Treatment Period|Withdrawal by Subject|23|||
42228942|NCT03214367|76048953|FG003|Treatment Period|Withdrawal by Subject|14|||
42228943|NCT03214367|76048954|FG004|Treatment Period|Withdrawal by Subject|0|||
42228944|NCT03214367|76048955|FG005|Treatment Period|Withdrawal by Subject|1|||
42228945|NCT03214367|76048956|FG006|Treatment Period|Withdrawal by Subject|1|||
42228946|NCT03214367|76048957|FG007|Treatment Period|Withdrawal by Subject|1|||
42228947|NCT02994108|76048973|FG000|Intervention Messages|Withdrawal by Subject|2|||
42228948|NCT02994108|76048974|FG001|Intervention Messages|Withdrawal by Subject|0|||
42228949|NCT02994108|76048973|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
42228950|NCT02994108|76048974|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
42228951|NCT02994108|76048973|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
42228952|NCT02994108|76048974|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
42228953|NCT02994108|76048973|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
42228954|NCT02994108|76048974|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
42228955|NCT03231371|76048981|FG000|Overall Study|Withdrawal by Subject|1|||
42228956|NCT03231371|76048981|FG000|Overall Study|chose or were ineligible to have MRI|12|||
42228957|NCT02870348|76048985|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
42228958|NCT03239873|76048991|FG000|Overall Study|Lost to Follow-up|15|||
42228959|NCT03239873|76048992|FG001|Overall Study|Lost to Follow-up|16|||
42228960|NCT03239873|76048991|FG000|Overall Study|Physician Decision|1|||
42228961|NCT03239873|76048992|FG001|Overall Study|Physician Decision|0|||
42228962|NCT03239873|76048991|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
42228963|NCT03239873|76048992|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
41986428|NCT01244516|75793561|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
41986429|NCT01244516|75793562|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
41986430|NCT01244516|75793563|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
42131730|NCT00498186|75942633|FG000|Overall Study|Lack of Efficacy|31|||
42131731|NCT00498186|75942633|FG000|Overall Study|Adverse Event|89|||
42131732|NCT00498186|75942633|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
42228964|NCT03239873|76048991|FG000|Overall Study|Withdrawal by Subject|2|||
42228965|NCT03239873|76048992|FG001|Overall Study|Withdrawal by Subject|0|||
42228966|NCT03239873|76048991|FG000|Overall Study|Contraindication to study medication|1|||
42228967|NCT03239873|76048992|FG001|Overall Study|Contraindication to study medication|0|||
41986431|NCT01244516|75793561|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
41986432|NCT01244516|75793562|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
41986433|NCT01244516|75793563|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
41986434|NCT01244516|75793561|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
41986435|NCT01244516|75793562|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
41986436|NCT01244516|75793563|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
41986437|NCT01244516|75793561|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
41986438|NCT01244516|75793562|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
41986439|NCT01244516|75793563|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
41986440|NCT01244126|75793575|FG000|Overall Study|Protocol Violation|3|||
41986441|NCT01244126|75793576|FG001|Overall Study|Protocol Violation|3|||
41986442|NCT01244126|75793577|FG002|Overall Study|Protocol Violation|9|||
42228968|NCT03239873|76048991|FG000|Overall Study|Protocol Violation|1|||
42228969|NCT03239873|76048992|FG001|Overall Study|Protocol Violation|0|||
42131733|NCT00498186|75942633|FG000|Overall Study|Withdrawal by Subject|18|||
42228970|NCT03213509|76049000|FG000|Overall Study|Did not consent for verbal autopsy|4|||
41986443|NCT01243892|75793587|FG000|Overall Study|Did not meet eligibility criteria|2|||
42010518|NCT01014442|75817632|FG000|Overall Study|Unspecified Reason|1|||
42228971|NCT03213509|76049001|FG001|Overall Study|Did not consent for verbal autopsy|5|||
42228972|NCT03239483|76049010|FG000|Overall Study|Lost to Follow-up|1|||
42228973|NCT03239483|76049011|FG001|Overall Study|Lost to Follow-up|0|||
42228974|NCT03239483|76049010|FG000|Overall Study|Withdrawal by Subject|1|||
42228975|NCT03239483|76049011|FG001|Overall Study|Withdrawal by Subject|0|||
42228976|NCT02868554|76049020|FG000|Overall Study|Lost to Follow-up|3|||
42228977|NCT02868554|76049021|FG001|Overall Study|Lost to Follow-up|0|||
42228978|NCT02868554|76049022|FG002|Overall Study|Lost to Follow-up|1|||
42228979|NCT01068912|76049033|FG000|Overall Study|Adverse Event|2|||
42228980|NCT01068912|76049034|FG001|Overall Study|Adverse Event|3|||
42228981|NCT01068912|76049035|FG002|Overall Study|Adverse Event|2|||
42228982|NCT01068912|76049033|FG000|Overall Study|Withdrawal by Subject|5|||
42228983|NCT01068912|76049034|FG001|Overall Study|Withdrawal by Subject|6|||
42228984|NCT01068912|76049035|FG002|Overall Study|Withdrawal by Subject|6|||
42228985|NCT01068912|76049033|FG000|Overall Study|Lost to Follow-up|3|||
42228986|NCT01068912|76049034|FG001|Overall Study|Lost to Follow-up|7|||
42228987|NCT01068912|76049035|FG002|Overall Study|Lost to Follow-up|3|||
42228988|NCT01068912|76049033|FG000|Overall Study|Protocol Violation|0|||
42228989|NCT01068912|76049034|FG001|Overall Study|Protocol Violation|2|||
42228990|NCT01068912|76049035|FG002|Overall Study|Protocol Violation|0|||
42228991|NCT01068912|76049033|FG000|Overall Study|aggravation influenza|1|||
42228992|NCT01068912|76049034|FG001|Overall Study|aggravation influenza|1|||
42228993|NCT01068912|76049035|FG002|Overall Study|aggravation influenza|1|||
42228994|NCT01068912|76049033|FG000|Overall Study|other underlying illness|0|||
42228995|NCT01068912|76049034|FG001|Overall Study|other underlying illness|3|||
42228996|NCT01068912|76049035|FG002|Overall Study|other underlying illness|3|||
42228997|NCT03229109|76049047|FG000|Overall Study|Withdrawal by Subject|0|||
42228998|NCT03229109|76049048|FG001|Overall Study|Withdrawal by Subject|0|||
42228999|NCT03229109|76049049|FG002|Overall Study|Withdrawal by Subject|0|||
42229000|NCT03229109|76049050|FG003|Overall Study|Withdrawal by Subject|1|||
42229001|NCT03212261|76049060|FG000|Overall Study|Became ineligible d/t tech|2|||
42229002|NCT03212261|76049060|FG000|Overall Study|Tech Trouble- No first study visit|1|||
42229003|NCT03212261|76049060|FG000|Overall Study|Lost to Follow-up|7|||
42229004|NCT03212261|76049060|FG000|Overall Study|Family Emergency|1|||
42229005|NCT03212261|76049060|FG000|Overall Study|Too busy/ No time|5|||
42229006|NCT02993250|76049067|FG000|Overall Study|Lost to Follow-up|0|||
42229007|NCT02993250|76049068|FG001|Overall Study|Lost to Follow-up|1|||
42229008|NCT02989194|76049077|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
42229009|NCT02989194|76049078|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
42229010|NCT02989194|76049079|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
42229011|NCT02989194|76049077|FG000|Overall Study|Lost to Follow-up|0|||
42229012|NCT02989194|76049078|FG001|Overall Study|Lost to Follow-up|1|||
42229013|NCT02989194|76049079|FG002|Overall Study|Lost to Follow-up|0|||
42229014|NCT02989194|76049077|FG000|Overall Study|Withdrawal by Subject|0|||
42229015|NCT02989194|76049078|FG001|Overall Study|Withdrawal by Subject|1|||
42229016|NCT02989194|76049079|FG002|Overall Study|Withdrawal by Subject|0|||
42229017|NCT02990910|76049100|FG000|Overall Study|Lack of Efficacy|6|||
42229018|NCT02990910|76049101|FG001|Overall Study|Lack of Efficacy|10|||
42229019|NCT03227861|76049107|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
42229020|NCT03227861|76049107|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
42229021|NCT03227861|76049107|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
42229022|NCT03227861|76049107|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
42229023|NCT03227861|76049107|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
42229024|NCT03227861|76049107|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
42229025|NCT03227861|76049107|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
42229026|NCT03227861|76049107|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
42229027|NCT03227861|76049107|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
42229028|NCT03227861|76049107|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
42229029|NCT01336712|76049113|FG000|Overall Study|Death|2|||
42229030|NCT01336712|76049113|FG000|Overall Study|Lack of Efficacy|1|||
42229031|NCT03208127|76049117|FG000|Overall Study|Death|1|||
42229032|NCT02865122|76049124|FG000|Overall Study|Adverse Event|1|||
42229033|NCT02865122|76049125|FG001|Overall Study|Adverse Event|0|||
42229034|NCT02865122|76049126|FG002|Overall Study|Adverse Event|0|||
42229035|NCT02864498|76049137|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
42229036|NCT02864498|76049138|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
42229037|NCT02864498|76049139|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
42229038|NCT02864498|76049137|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
42229039|NCT02864498|76049138|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
42229040|NCT02864498|76049139|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
42229041|NCT02864498|76049137|FG000|Overall Study|Investigator Discretion|0|||
42229042|NCT02864498|76049138|FG001|Overall Study|Investigator Discretion|2|||
42229043|NCT02864498|76049139|FG002|Overall Study|Investigator Discretion|1|||
42229044|NCT02864498|76049137|FG000|Overall Study|Lost to Follow-up|8|||
42229045|NCT02864498|76049138|FG001|Overall Study|Lost to Follow-up|6|||
42229046|NCT02864498|76049139|FG002|Overall Study|Lost to Follow-up|3|||
42229047|NCT02864498|76049137|FG000|Overall Study|Lack of Efficacy|5|||
42229048|NCT02864498|76049138|FG001|Overall Study|Lack of Efficacy|3|||
42229049|NCT02864498|76049139|FG002|Overall Study|Lack of Efficacy|3|||
42229050|NCT02864498|76049137|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
42229051|NCT02864498|76049138|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
42229052|NCT02864498|76049139|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
42229053|NCT02864498|76049137|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
42229054|NCT02864498|76049138|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
42229055|NCT02864498|76049139|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
42229056|NCT02864498|76049137|FG000|Overall Study|Subject moved out of the country.|0|||
42229057|NCT02864498|76049138|FG001|Overall Study|Subject moved out of the country.|0|||
42229058|NCT02864498|76049139|FG002|Overall Study|Subject moved out of the country.|1|||
42229059|NCT03238781|76049150|FG000|Overall Study|Adverse Event|1|||
42229060|NCT03238781|76049151|FG001|Overall Study|Adverse Event|1|||
42229061|NCT03238781|76049152|FG002|Overall Study|Adverse Event|2|||
42229062|NCT03238781|76049150|FG000|Overall Study|Lost to Follow-up|2|||
42229063|NCT03238781|76049151|FG001|Overall Study|Lost to Follow-up|1|||
42229064|NCT03238781|76049152|FG002|Overall Study|Lost to Follow-up|2|||
42229065|NCT03238781|76049150|FG000|Overall Study|Withdrawal by Subject|23|||
42229066|NCT03238781|76049151|FG001|Overall Study|Withdrawal by Subject|14|||
41986444|NCT01243892|75793588|FG001|Overall Study|Did not meet eligibility criteria|0|||
41986445|NCT01243775|75793594|FG000|Overall Study|Withdrawal by Subject|2|||
41986446|NCT01243268|75793598|FG000|Overall Study|Lost to Follow-up|4|||
41986447|NCT01243268|75793598|FG000|Overall Study|Protocol Violation|51|||
41986448|NCT01243268|75793598|FG000|Overall Study|Deviation with contract date|7|||
41986449|NCT01243268|75793598|FG000|Overall Study|Duplicate subject|2|||
41986450|NCT01242371|75793604|FG000|Overall Study|Withdrawal by Subject|2|||
41986451|NCT01242371|75793605|FG001|Overall Study|Withdrawal by Subject|2|||
41986452|NCT01242371|75793604|FG000|Overall Study|Protocol Violation|0|||
41986453|NCT01242371|75793605|FG001|Overall Study|Protocol Violation|3|||
41986454|NCT01242176|75793611|FG000|Washout Period of 7 Days|Adverse Event|0|||
41986455|NCT01242176|75793612|FG001|Washout Period of 7 Days|Adverse Event|2|||
42229067|NCT03238781|76049152|FG002|Overall Study|Withdrawal by Subject|16|||
42229068|NCT03238781|76049150|FG000|Overall Study|Decision by sponsor|0|||
42229069|NCT03238781|76049151|FG001|Overall Study|Decision by sponsor|1|||
42229070|NCT03238781|76049152|FG002|Overall Study|Decision by sponsor|0|||
42229071|NCT02097121|76049163|FG000|Overall Study|Other, not specified|4|||
42229072|NCT02097121|76049164|FG001|Overall Study|Other, not specified|2|||
42229073|NCT02097121|76049165|FG002|Overall Study|Other, not specified|3|||
42229074|NCT02097121|76049163|FG000|Overall Study|Lack of Efficacy|2|||
42229075|NCT02097121|76049164|FG001|Overall Study|Lack of Efficacy|1|||
42229076|NCT02097121|76049165|FG002|Overall Study|Lack of Efficacy|3|||
42229077|NCT02097121|76049163|FG000|Overall Study|Withdrawal by Subject|0|||
42229078|NCT02097121|76049164|FG001|Overall Study|Withdrawal by Subject|1|||
42229079|NCT02097121|76049165|FG002|Overall Study|Withdrawal by Subject|2|||
42229080|NCT02097121|76049163|FG000|Overall Study|Adverse Event|0|||
42229081|NCT02097121|76049164|FG001|Overall Study|Adverse Event|1|||
42229082|NCT02097121|76049165|FG002|Overall Study|Adverse Event|0|||
42229083|NCT02097121|76049163|FG000|Overall Study|Lost to Follow-up|1|||
42229084|NCT02097121|76049164|FG001|Overall Study|Lost to Follow-up|1|||
42229085|NCT02097121|76049165|FG002|Overall Study|Lost to Follow-up|2|||
42229086|NCT02747420|76049194|FG000|Overall Study|Lost to Follow-up|4|||
42229087|NCT02747420|76049195|FG001|Overall Study|Lost to Follow-up|2|||
42229088|NCT02747420|76049194|FG000|Overall Study|Withdrawal by Subject|3|||
42229089|NCT02747420|76049195|FG001|Overall Study|Withdrawal by Subject|2|||
42229090|NCT03238001|76049201|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
42229091|NCT03238001|76049201|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
42229092|NCT03238001|76049201|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
42229093|NCT03238001|76049201|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
42229094|NCT03238001|76049201|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
42229095|NCT03238001|76049201|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
41986456|NCT01242176|75793611|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
41986457|NCT01242176|75793612|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
41986458|NCT01242020|75793620|FG000|Overall Study|Withdrawal by Subject|2|||
42229096|NCT03238001|76049201|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
42229097|NCT03238001|76049201|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
42229098|NCT02747108|76049215|FG000|Overall Study|Death|2|||
42229099|NCT02747108|76049216|FG001|Overall Study|Death|2|||
41986459|NCT01242020|75793621|FG001|Overall Study|Withdrawal by Subject|0|||
41986460|NCT01242020|75793620|FG000|Overall Study|Failed screening|1|||
42229100|NCT02747108|76049215|FG000|Overall Study|Withdrawal by Subject|1|||
42229101|NCT02747108|76049216|FG001|Overall Study|Withdrawal by Subject|0|||
42229102|NCT02747108|76049215|FG000|Overall Study|Protocol Violation|2|||
42229103|NCT02747108|76049216|FG001|Overall Study|Protocol Violation|0|||
42131734|NCT00498186|75942633|FG000|Overall Study|Lost to Follow-up|3|||
42229104|NCT03226769|76049244|FG000|Overall Study|Withdrawal by Subject|0|||
42229105|NCT03226769|76049245|FG001|Overall Study|Withdrawal by Subject|1|||
42229106|NCT02864342|76049253|FG000|Overall Study|Eligibility Criteria Deviation|2|||
42229107|NCT02864342|76049254|FG001|Overall Study|Eligibility Criteria Deviation|3|||
42229108|NCT02864342|76049253|FG000|Overall Study|Withdrawal by Subject|4|||
42229109|NCT02864342|76049254|FG001|Overall Study|Withdrawal by Subject|2|||
42229110|NCT02864342|76049253|FG000|Overall Study|Device Technology Issue|6|||
42229111|NCT02864342|76049254|FG001|Overall Study|Device Technology Issue|7|||
42229112|NCT02864342|76049253|FG000|Overall Study|Death|0|||
42229113|NCT02864342|76049254|FG001|Overall Study|Death|1|||
42229114|NCT02864342|76049253|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
42229115|NCT02864342|76049254|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
42229116|NCT02864342|76049253|FG000|Overall Study|Lost to Follow-up|1|||
41986461|NCT01242020|75793621|FG001|Overall Study|Failed screening|0|||
42229117|NCT02864342|76049254|FG001|Overall Study|Lost to Follow-up|5|||
42229118|NCT02864342|76049253|FG000|Overall Study|Lost Device|1|||
41986462|NCT01241786|75793627|FG000|Overall Study|Lack of Efficacy|5|||
41986463|NCT01241318|75793634|FG000|Overall Study|Woman: false pregnancies|27|||
41986464|NCT01241318|75793635|FG001|Overall Study|Woman: false pregnancies|15|||
41986465|NCT01241318|75793634|FG000|Overall Study|Woman: miscarriage/abortion|46|||
41986466|NCT01241318|75793635|FG001|Overall Study|Woman: miscarriage/abortion|38|||
42131735|NCT00498186|75942633|FG000|Overall Study|Other|10|||
42131736|NCT00333970|75942639|FG000|Overall Study|Withdrawal by Subject|13|||
42131737|NCT00333970|75942640|FG001|Overall Study|Withdrawal by Subject|7|||
42131738|NCT00477594|75942648|FG000|Year 1 and Year 2|Adverse Event|4|||
42131739|NCT00477594|75942649|FG001|Year 1 and Year 2|Adverse Event|2|||
42131740|NCT00477594|75942648|FG000|Year 1 and Year 2|Physician Decision|2|||
42131741|NCT00477594|75942649|FG001|Year 1 and Year 2|Physician Decision|1|||
42131742|NCT00477594|75942648|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
42131743|NCT00477594|75942649|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
42131744|NCT00477594|75942648|FG000|Year 1 and Year 2|Other|1|||
42131745|NCT00477594|75942649|FG001|Year 1 and Year 2|Other|0|||
42131746|NCT00477594|75942648|FG000|Year 3|Adverse Event|1|||
42131747|NCT00477594|75942649|FG001|Year 3|Adverse Event|0|||
42229119|NCT02864342|76049254|FG001|Overall Study|Lost Device|0|||
41986467|NCT01241318|75793634|FG000|Overall Study|Withdrawal by Subject|175|||
41986468|NCT01241318|75793635|FG001|Overall Study|Withdrawal by Subject|46|||
41986469|NCT01241318|75793634|FG000|Overall Study|Lost to Follow-up|740|||
41986470|NCT01241318|75793635|FG001|Overall Study|Lost to Follow-up|455|||
41986471|NCT01241318|75793634|FG000|Overall Study|Death|2|||
41986472|NCT01241318|75793635|FG001|Overall Study|Death|4|||
41986473|NCT01241318|75793634|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
41986474|NCT01241318|75793635|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
41986475|NCT01241318|75793634|FG000|Overall Study|Woman: Stillborn infant|129|||
41986476|NCT01241318|75793635|FG001|Overall Study|Woman: Stillborn infant|146|||
41986477|NCT01241279|75793646|FG000|Overall Study|Lost to Follow-up|0|||
41986478|NCT01241279|75793647|FG001|Overall Study|Lost to Follow-up|1|||
41986479|NCT01241240|75793655|FG000|Overall Study|Adverse Event|5|||
41986480|NCT01241240|75793656|FG001|Overall Study|Adverse Event|4|||
41986481|NCT01241240|75793655|FG000|Overall Study|Lost to Follow-up|2|||
41986482|NCT01241240|75793656|FG001|Overall Study|Lost to Follow-up|4|||
41986483|NCT01241240|75793655|FG000|Overall Study|Personal Reasons|1|||
41986484|NCT01241240|75793656|FG001|Overall Study|Personal Reasons|1|||
41986485|NCT01240811|75793665|FG000|Overall Study|Physician Decision|0|||
41986486|NCT01240811|75793666|FG001|Overall Study|Physician Decision|1|||
41986487|NCT01240811|75793667|FG002|Overall Study|Physician Decision|0|||
41986488|NCT01240811|75793665|FG000|Overall Study|Withdrawal by Subject|0|||
41986489|NCT01240811|75793666|FG001|Overall Study|Withdrawal by Subject|0|||
41986490|NCT01240811|75793667|FG002|Overall Study|Withdrawal by Subject|1|||
41986491|NCT01240382|75793679|FG000|Overall Study|Adverse Event|2|||
41986492|NCT01240382|75793680|FG001|Overall Study|Adverse Event|1|||
41986493|NCT01240382|75793679|FG000|Overall Study|Lack of Efficacy|0|||
41986494|NCT01240382|75793680|FG001|Overall Study|Lack of Efficacy|2|||
41986495|NCT01240382|75793679|FG000|Overall Study|Fear of adverse events|0|||
41986496|NCT01240382|75793680|FG001|Overall Study|Fear of adverse events|1|||
42229120|NCT02864342|76049253|FG000|Overall Study|Adverse Event|1|||
41986497|NCT01244828|75793686|FG000|Overall Study|Adverse Event|37|||
41986498|NCT01244828|75793686|FG000|Overall Study|Withdrawal by Subject|31|||
41986499|NCT01244828|75793686|FG000|Overall Study|Lack of Efficacy|7|||
41986500|NCT01244828|75793686|FG000|Overall Study|Lost to Follow-up|2|||
41986501|NCT01244828|75793686|FG000|Overall Study|Other reason (not specified)|1|||
42131748|NCT00477594|75942648|FG000|Year 3|Withdrawal by Subject|1|||
42131749|NCT00477594|75942649|FG001|Year 3|Withdrawal by Subject|0|||
42229121|NCT02864342|76049254|FG001|Overall Study|Adverse Event|0|||
41986502|NCT01249833|75793692|FG000|Overall Study|Lost to Follow-up|0|||
42229122|NCT03237065|76049263|FG000|Overall Study|Adverse Event|0|||
42131750|NCT00477594|75942648|FG000|Follow-up Period|Withdrawal by Subject|2|||
42131751|NCT00477594|75942649|FG001|Follow-up Period|Withdrawal by Subject|1|||
42229123|NCT03237065|76049264|FG001|Overall Study|Adverse Event|2|||
42229124|NCT03237065|76049263|FG000|Overall Study|Protocol Violation|0|||
42229125|NCT03237065|76049264|FG001|Overall Study|Protocol Violation|1|||
42229126|NCT03237065|76049263|FG000|Overall Study|Withdrawal by Subject|3|||
42229127|NCT03237065|76049264|FG001|Overall Study|Withdrawal by Subject|0|||
42229128|NCT03237065|76049263|FG000|Overall Study|Lost to Follow-up|1|||
42229129|NCT03237065|76049264|FG001|Overall Study|Lost to Follow-up|0|||
42229130|NCT03237065|76049263|FG000|Overall Study|Unable to obtain venous access|0|||
42229131|NCT03237065|76049264|FG001|Overall Study|Unable to obtain venous access|1|||
42229132|NCT03171415|76049275|FG000|Overall Study|Lost to Follow-up|0|||
42229133|NCT03171415|76049276|FG001|Overall Study|Lost to Follow-up|0|||
42229134|NCT03171415|76049277|FG002|Overall Study|Lost to Follow-up|0|||
42229135|NCT03171415|76049278|FG003|Overall Study|Lost to Follow-up|0|||
42229136|NCT03171415|76049279|FG004|Overall Study|Lost to Follow-up|2|||
42229137|NCT03829241|76049304|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
42229138|NCT03829241|76049305|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
42229139|NCT03829241|76049304|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
41986503|NCT01249833|75793693|FG001|Overall Study|Lost to Follow-up|1|||
42229140|NCT03829241|76049305|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
42229141|NCT03829241|76049304|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
42229142|NCT03829241|76049305|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
42229143|NCT03829241|76049304|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
42229144|NCT03829241|76049305|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
42229145|NCT03829241|76049304|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
42229146|NCT03829241|76049305|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
42229147|NCT03829241|76049304|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
42229148|NCT03829241|76049305|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
42229149|NCT03829241|76049304|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
42229150|NCT03829241|76049305|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
42229151|NCT03829241|76049304|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
42229152|NCT03829241|76049305|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
42229153|NCT03829241|76049304|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
42229154|NCT03829241|76049305|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
42229155|NCT03829241|76049304|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
42229156|NCT03829241|76049305|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
42229157|NCT03829241|76049304|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
42229158|NCT03829241|76049305|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
42229159|NCT03829241|76049304|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
42229160|NCT03829241|76049305|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
42229161|NCT03829241|76049304|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
42229162|NCT03829241|76049305|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
42229163|NCT03829241|76049304|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
42229164|NCT03829241|76049305|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
42229165|NCT03164551|76049317|FG000|Overall Study|Imaging discontinued prior completion|8|||
41986504|NCT01249404|75793702|FG000|Overall Study|Study treatment not received|0|||
41986505|NCT01249404|75793703|FG001|Overall Study|Study treatment not received|1|||
41986506|NCT01249404|75793704|FG002|Overall Study|Study treatment not received|2|||
41986507|NCT01249404|75793702|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
41986508|NCT01249404|75793703|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
41986509|NCT01249404|75793704|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
41986510|NCT01249404|75793702|FG000|Overall Study|Adverse Event|2|||
41986511|NCT01249404|75793703|FG001|Overall Study|Adverse Event|2|||
41986512|NCT01249404|75793704|FG002|Overall Study|Adverse Event|2|||
41986513|NCT01249404|75793702|FG000|Overall Study|Withdrawal by Subject|2|||
41986514|NCT01249404|75793703|FG001|Overall Study|Withdrawal by Subject|2|||
41986515|NCT01249404|75793704|FG002|Overall Study|Withdrawal by Subject|0|||
41986516|NCT01249404|75793702|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
41986517|NCT01249404|75793703|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
42032503|NCT00951015|75840754|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
42032504|NCT00951015|75840755|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
42229166|NCT03164551|76049318|FG001|Overall Study|Imaging discontinued prior completion|0|||
42229167|NCT03164551|76049317|FG000|Overall Study|Participant was non-compliant|1|||
42229168|NCT03164551|76049318|FG001|Overall Study|Participant was non-compliant|0|||
42229169|NCT03164551|76049317|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
42229170|NCT03164551|76049318|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
42229171|NCT03164551|76049317|FG000|Overall Study|Other|8|||
42229172|NCT03164551|76049318|FG001|Overall Study|Other|2|||
42229173|NCT02863328|76049326|FG000|Overall Study|Lost to Follow-up|4|||
41986518|NCT01249404|75793704|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
42032505|NCT00951015|75840751|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
41986519|NCT01249404|75793702|FG000|Overall Study|Non compliance to visit schedule|0|||
41986520|NCT01249404|75793703|FG001|Overall Study|Non compliance to visit schedule|1|||
41986521|NCT01249404|75793704|FG002|Overall Study|Non compliance to visit schedule|0|||
42229174|NCT02863328|76049327|FG001|Overall Study|Lost to Follow-up|10|||
42229175|NCT02863328|76049326|FG000|Overall Study|Withdrawal by Subject|7|||
42229176|NCT02863328|76049327|FG001|Overall Study|Withdrawal by Subject|12|||
42229177|NCT02863328|76049326|FG000|Overall Study|Died|0|||
42229178|NCT02863328|76049327|FG001|Overall Study|Died|1|||
42229179|NCT03040141|76049336|FG000|Overall Study|Death|1|||
42229180|NCT03040141|76049337|FG001|Overall Study|Death|2|||
42229181|NCT03040141|76049338|FG002|Overall Study|Death|3|||
42229182|NCT03040141|76049336|FG000|Overall Study|Withdrawal by Subject|3|||
41986522|NCT01249365|75793712|FG000|Overall Study|Lost to Follow-up|1|||
41986523|NCT01249131|75793716|FG000|Washout Period of 10 Days|Adverse Event|0|||
42229183|NCT03040141|76049337|FG001|Overall Study|Withdrawal by Subject|1|||
42229184|NCT03040141|76049338|FG002|Overall Study|Withdrawal by Subject|1|||
42229185|NCT03040141|76049336|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
42229186|NCT03040141|76049337|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
42229187|NCT03040141|76049338|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
42229188|NCT03040141|76049336|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
42229189|NCT03040141|76049337|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
42229190|NCT03040141|76049338|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
42229191|NCT02937701|76049352|FG000|Day 1 to Week 22|Adverse Event|11|||
42229192|NCT02937701|76049353|FG001|Day 1 to Week 22|Adverse Event|14|||
42229193|NCT02937701|76049354|FG002|Day 1 to Week 22|Adverse Event|0|||
42229194|NCT02937701|76049355|FG003|Day 1 to Week 22|Adverse Event|0|||
42229195|NCT02937701|76049356|FG004|Day 1 to Week 22|Adverse Event|0|||
42229196|NCT02937701|76049352|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
42229197|NCT02937701|76049353|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
42229198|NCT02937701|76049354|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
42229199|NCT02937701|76049355|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
42229200|NCT02937701|76049356|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
42229201|NCT02937701|76049352|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
42229202|NCT02937701|76049353|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
42229203|NCT02937701|76049354|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
42229204|NCT02937701|76049355|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
42229205|NCT02937701|76049356|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
42229206|NCT02937701|76049352|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
42229207|NCT02937701|76049353|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
42229208|NCT02937701|76049354|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
42229209|NCT02937701|76049355|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
42229210|NCT02937701|76049356|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
42229211|NCT02937701|76049352|FG000|Day 1 to Week 22|Death|1|||
42229212|NCT02937701|76049353|FG001|Day 1 to Week 22|Death|1|||
42229213|NCT02937701|76049354|FG002|Day 1 to Week 22|Death|0|||
42229214|NCT02937701|76049355|FG003|Day 1 to Week 22|Death|0|||
42229215|NCT02937701|76049356|FG004|Day 1 to Week 22|Death|0|||
42229216|NCT02937701|76049352|FG000|Day 1 to Week 22|Protocol Violation|1|||
42229217|NCT02937701|76049353|FG001|Day 1 to Week 22|Protocol Violation|1|||
42229218|NCT02937701|76049354|FG002|Day 1 to Week 22|Protocol Violation|0|||
42229219|NCT02937701|76049355|FG003|Day 1 to Week 22|Protocol Violation|0|||
42229220|NCT02937701|76049356|FG004|Day 1 to Week 22|Protocol Violation|0|||
41986524|NCT01249131|75793717|FG001|Washout Period of 10 Days|Adverse Event|0|||
41986525|NCT01249131|75793718|FG002|Washout Period of 10 Days|Adverse Event|0|||
41986526|NCT01249131|75793719|FG003|Washout Period of 10 Days|Adverse Event|0|||
41986527|NCT01249131|75793720|FG004|Washout Period of 10 Days|Adverse Event|1|||
41986528|NCT01249131|75793721|FG005|Washout Period of 10 Days|Adverse Event|0|||
41986529|NCT01249092|75793729|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
41986530|NCT01249092|75793729|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
41986531|NCT01248936|75793735|FG000|Overall Study|Sponsor Decision|259|||
41986532|NCT01248936|75793735|FG000|Overall Study|Progression of Disease|50|||
41986533|NCT01248936|75793735|FG000|Overall Study|Death|26|||
42131752|NCT00477594|75942648|FG000|Follow-up Period|Other|1|||
42229221|NCT02937701|76049352|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
42229222|NCT02937701|76049353|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
42229223|NCT02937701|76049354|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
42229224|NCT02937701|76049355|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
42229225|NCT02937701|76049356|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
42229226|NCT02937701|76049352|FG000|Day 1 to Week 22|Physician Decision|2|||
42229227|NCT02937701|76049353|FG001|Day 1 to Week 22|Physician Decision|0|||
41986534|NCT01248936|75793735|FG000|Overall Study|Withdrawal of Consent|20|||
42229228|NCT02937701|76049354|FG002|Day 1 to Week 22|Physician Decision|0|||
42229229|NCT02937701|76049355|FG003|Day 1 to Week 22|Physician Decision|0|||
41986535|NCT01248936|75793735|FG000|Overall Study|Adverse Event|8|||
41986536|NCT01248936|75793735|FG000|Overall Study|Lost to Follow-up|7|||
41986537|NCT01248936|75793735|FG000|Overall Study|Refused Treatment|1|||
41986538|NCT01248936|75793735|FG000|Overall Study|Other reason|3|||
41986539|NCT01248780|75793742|FG000|Overall Study|Lack of Efficacy|2|||
41986540|NCT01248780|75793743|FG001|Overall Study|Lack of Efficacy|0|||
42229230|NCT02937701|76049356|FG004|Day 1 to Week 22|Physician Decision|0|||
42229231|NCT02937701|76049352|FG000|Day 1 to Week 22|Other|1|||
42229232|NCT02937701|76049353|FG001|Day 1 to Week 22|Other|0|||
42229233|NCT02937701|76049354|FG002|Day 1 to Week 22|Other|0|||
42229234|NCT02937701|76049355|FG003|Day 1 to Week 22|Other|0|||
42229235|NCT02937701|76049356|FG004|Day 1 to Week 22|Other|0|||
42229236|NCT02937701|76049352|FG000|Week 22 to Week 50|Adverse Event|0|||
42229237|NCT02937701|76049353|FG001|Week 22 to Week 50|Adverse Event|0|||
42229238|NCT02937701|76049354|FG002|Week 22 to Week 50|Adverse Event|10|||
42229239|NCT02937701|76049355|FG003|Week 22 to Week 50|Adverse Event|3|||
42229240|NCT02937701|76049356|FG004|Week 22 to Week 50|Adverse Event|3|||
42229241|NCT02937701|76049352|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
42229242|NCT02937701|76049353|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
42229243|NCT02937701|76049354|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
42229244|NCT02937701|76049355|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
42229245|NCT02937701|76049356|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
41986541|NCT01248780|75793742|FG000|Overall Study|Lost to Follow-up|0|||
41986542|NCT01248780|75793743|FG001|Overall Study|Lost to Follow-up|1|||
41986543|NCT01248780|75793742|FG000|Overall Study|Death|0|||
41986544|NCT01248780|75793743|FG001|Overall Study|Death|1|||
41986545|NCT01248780|75793742|FG000|Overall Study|Adverse Event|2|||
41986546|NCT01248780|75793743|FG001|Overall Study|Adverse Event|7|||
41986547|NCT01248780|75793742|FG000|Overall Study|Protocol Violation|1|||
41986548|NCT01248780|75793743|FG001|Overall Study|Protocol Violation|1|||
41986549|NCT01248780|75793742|FG000|Overall Study|Withdrawal by Subject|4|||
41986550|NCT01248780|75793743|FG001|Overall Study|Withdrawal by Subject|4|||
41986551|NCT01248780|75793742|FG000|Overall Study|Not treated|0|||
41986552|NCT01248780|75793743|FG001|Overall Study|Not treated|1|||
41986553|NCT01248468|75793752|FG000|Overall Study|Administrative problem|1|||
41986554|NCT01248468|75793753|FG001|Overall Study|Administrative problem|0|||
41986555|NCT01248468|75793754|FG002|Overall Study|Administrative problem|0|||
41986556|NCT01248468|75793752|FG000|Overall Study|Lost to Follow-up|9|||
41986557|NCT01248468|75793753|FG001|Overall Study|Lost to Follow-up|12|||
41986558|NCT01248468|75793754|FG002|Overall Study|Lost to Follow-up|4|||
41986559|NCT01248468|75793752|FG000|Overall Study|Pregnancy|1|||
41986560|NCT01248468|75793753|FG001|Overall Study|Pregnancy|0|||
41986561|NCT01248468|75793754|FG002|Overall Study|Pregnancy|0|||
41986562|NCT01248468|75793752|FG000|Overall Study|Withdrawal by Subject|4|||
41986563|NCT01248468|75793753|FG001|Overall Study|Withdrawal by Subject|2|||
41986564|NCT01248468|75793754|FG002|Overall Study|Withdrawal by Subject|0|||
41986565|NCT01247922|75793762|FG000|Overall Study|Disease progression|4|||
41986566|NCT01246206|75793766|FG000|Overall Study|Patient did not receive study regiments.|1|||
41986567|NCT01246011|75793773|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
41986568|NCT01246011|75793774|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
41986569|NCT01246011|75793775|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
41986570|NCT01246011|75793773|FG000|Overall Study|Withdrawal by Subject|0|||
41986571|NCT01246011|75793774|FG001|Overall Study|Withdrawal by Subject|0|||
41986572|NCT01246011|75793775|FG002|Overall Study|Withdrawal by Subject|1|||
41986573|NCT01244490|75793787|FG000|Overall Study|Lack of Efficacy|14|||
41986574|NCT01244490|75793788|FG001|Overall Study|Lack of Efficacy|5|||
41986575|NCT01244490|75793789|FG002|Overall Study|Lack of Efficacy|5|||
41986576|NCT01244490|75793787|FG000|Overall Study|Withdrawal by Subject|4|||
41986577|NCT01244490|75793788|FG001|Overall Study|Withdrawal by Subject|4|||
41986578|NCT01244490|75793789|FG002|Overall Study|Withdrawal by Subject|9|||
41986579|NCT01244490|75793787|FG000|Overall Study|Adverse Event|1|||
41986580|NCT01244490|75793788|FG001|Overall Study|Adverse Event|9|||
42229246|NCT02937701|76049352|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
41986581|NCT01244490|75793789|FG002|Overall Study|Adverse Event|5|||
41986582|NCT01244490|75793787|FG000|Overall Study|Lost to Follow-up|0|||
41986583|NCT01244490|75793788|FG001|Overall Study|Lost to Follow-up|6|||
41986584|NCT01244490|75793789|FG002|Overall Study|Lost to Follow-up|3|||
41986585|NCT01244490|75793787|FG000|Overall Study|Other|0|||
41986586|NCT01244490|75793788|FG001|Overall Study|Other|0|||
42229247|NCT02937701|76049353|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
42229248|NCT02937701|76049354|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
42229249|NCT02937701|76049355|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
42229250|NCT02937701|76049356|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
41986587|NCT01244490|75793789|FG002|Overall Study|Other|1|||
41986588|NCT01243944|75793799|FG000|Overall Study|Adverse Event|15|||
41986589|NCT01243944|75793800|FG001|Overall Study|Adverse Event|13|||
41986590|NCT01243944|75793799|FG000|Overall Study|Lost to Follow-up|2|||
41986591|NCT01243944|75793800|FG001|Overall Study|Lost to Follow-up|1|||
41986592|NCT01243944|75793799|FG000|Overall Study|Physician Decision|2|||
42229251|NCT02937701|76049352|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
42229252|NCT02937701|76049353|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
42229253|NCT02937701|76049354|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
41986593|NCT01243944|75793800|FG001|Overall Study|Physician Decision|7|||
41986594|NCT01243944|75793799|FG000|Overall Study|Disease progression|12|||
41986595|NCT01243944|75793800|FG001|Overall Study|Disease progression|11|||
41986596|NCT01243944|75793799|FG000|Overall Study|Protocol deviation|1|||
42229254|NCT02937701|76049355|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
42229255|NCT02937701|76049356|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
42229256|NCT02937701|76049352|FG000|Week 22 to Week 50|Physician Decision|0|||
42229257|NCT02937701|76049353|FG001|Week 22 to Week 50|Physician Decision|0|||
42229258|NCT02937701|76049354|FG002|Week 22 to Week 50|Physician Decision|2|||
42229259|NCT02937701|76049355|FG003|Week 22 to Week 50|Physician Decision|0|||
42229260|NCT02937701|76049356|FG004|Week 22 to Week 50|Physician Decision|1|||
42229261|NCT02937701|76049352|FG000|Week 22 to Week 50|Other|0|||
42229262|NCT02937701|76049353|FG001|Week 22 to Week 50|Other|0|||
42229263|NCT02937701|76049354|FG002|Week 22 to Week 50|Other|0|||
42229264|NCT02937701|76049355|FG003|Week 22 to Week 50|Other|0|||
42229265|NCT02937701|76049356|FG004|Week 22 to Week 50|Other|1|||
42229266|NCT03169153|76049368|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
42229267|NCT03169153|76049369|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
42229268|NCT03169153|76049368|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
42229269|NCT03169153|76049369|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
42229270|NCT03169153|76049368|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
42229271|NCT03169153|76049369|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
42229272|NCT03169153|76049368|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
41986597|NCT01243944|75793800|FG001|Overall Study|Protocol deviation|1|||
41986598|NCT01243944|75793799|FG000|Overall Study|Participant decision|10|||
41986599|NCT01243944|75793800|FG001|Overall Study|Participant decision|15|||
41986600|NCT01243944|75793799|FG000|Overall Study|Death|2|||
41986601|NCT01243944|75793800|FG001|Overall Study|Death|3|||
41986602|NCT01243944|75793799|FG000|Overall Study|Non-compliance with study treatment|1|||
41986603|NCT01243944|75793800|FG001|Overall Study|Non-compliance with study treatment|0|||
41986604|NCT01243242|75793809|FG000|Overall Study|Adverse Event|1|||
41986605|NCT01243242|75793810|FG001|Overall Study|Adverse Event|1|||
41986606|NCT01243242|75793809|FG000|Overall Study|Withdrawal by Subject|1|||
41986607|NCT01243242|75793810|FG001|Overall Study|Withdrawal by Subject|1|||
41986608|NCT01243242|75793809|FG000|Overall Study|Physician Decision|0|||
41986609|NCT01243242|75793810|FG001|Overall Study|Physician Decision|1|||
41986610|NCT01243242|75793809|FG000|Overall Study|sponsor decision|0|||
41986611|NCT01243242|75793810|FG001|Overall Study|sponsor decision|1|||
41986612|NCT01243242|75793809|FG000|Overall Study|non compliance|1|||
41986613|NCT01243242|75793810|FG001|Overall Study|non compliance|0|||
41986614|NCT01242813|75793816|FG000|Overall Study|Lost to Follow-up|2|||
41986615|NCT01242111|75793820|FG000|Overall Study|Adverse Event|1|||
41986616|NCT01242111|75793820|FG000|Overall Study|Withdrawal by Subject|1|||
41986617|NCT01242111|75793820|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
41986618|NCT01241604|75793824|FG000|Screening Period|Screen Failure|3|||
41986619|NCT01241604|75793825|FG001|Screening Period|Screen Failure|0|||
41986620|NCT01241604|75793826|FG002|Screening Period|Screen Failure|0|||
41986621|NCT01241292|75793835|FG000|Overall Study|Administrative Reason by Sponsor|1|||
41986622|NCT01241292|75793836|FG001|Overall Study|Administrative Reason by Sponsor|0|||
41986623|NCT01241292|75793835|FG000|Overall Study|Disease Progression|2|||
41986624|NCT01241292|75793836|FG001|Overall Study|Disease Progression|0|||
41986625|NCT01241292|75793835|FG000|Overall Study|Study Drug Toxicity|0|||
41986626|NCT01241292|75793836|FG001|Overall Study|Study Drug Toxicity|1|||
41986627|NCT01241292|75793835|FG000|Overall Study|Participant Discontinued Treatment|0|||
41986628|NCT01241292|75793836|FG001|Overall Study|Participant Discontinued Treatment|2|||
41986629|NCT01240863|75793848|FG000|Open-label Titration Period|Adverse Event|47|||
41986630|NCT01240863|75793849|FG001|Open-label Titration Period|Adverse Event|0|||
41986631|NCT01240863|75793850|FG002|Open-label Titration Period|Adverse Event|0|||
41986632|NCT01240863|75793848|FG000|Open-label Titration Period|Lack of Efficacy|19|||
42229273|NCT03169153|76049369|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
42229274|NCT03168919|76049375|FG000|Overall Study|Withdrawal by Subject|2|||
41986633|NCT01240863|75793849|FG001|Open-label Titration Period|Lack of Efficacy|0|||
42229275|NCT03205163|76049385|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
42229276|NCT03205163|76049386|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
41986634|NCT01240863|75793850|FG002|Open-label Titration Period|Lack of Efficacy|0|||
41986635|NCT01240863|75793848|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
41986636|NCT01240863|75793849|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
41986637|NCT01240863|75793850|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
41986638|NCT01240863|75793848|FG000|Open-label Titration Period|Protocol Violation|7|||
42131753|NCT00477594|75942649|FG001|Follow-up Period|Other|0|||
42229277|NCT01759537|76049401|FG000|Overall Study|Death|1|||
41986639|NCT01240863|75793849|FG001|Open-label Titration Period|Protocol Violation|0|||
41986640|NCT01240863|75793850|FG002|Open-label Titration Period|Protocol Violation|0|||
42229278|NCT01759537|76049402|FG001|Overall Study|Death|1|||
42229279|NCT01759537|76049401|FG000|Overall Study|Pregnancy|1|||
42229280|NCT01759537|76049402|FG001|Overall Study|Pregnancy|1|||
42229281|NCT01759537|76049401|FG000|Overall Study|Lost to Follow-up|9|||
42229282|NCT01759537|76049402|FG001|Overall Study|Lost to Follow-up|9|||
42229283|NCT01759537|76049401|FG000|Overall Study|Accident involving jaw fracture|1|||
42229284|NCT01759537|76049402|FG001|Overall Study|Accident involving jaw fracture|1|||
42229285|NCT01759537|76049401|FG000|Overall Study|Subcrestal implant too coronal|1|||
42229286|NCT01759537|76049402|FG001|Overall Study|Subcrestal implant too coronal|1|||
42229287|NCT03204539|76049410|FG000|Overall Study|Loss of funding|0|||
42229288|NCT03204539|76049411|FG001|Overall Study|Loss of funding|1|||
42229289|NCT03502681|76049428|FG000|Overall Study|Adverse Event|1|||
42229290|NCT03502681|76049429|FG001|Overall Study|Adverse Event|1|||
42229291|NCT03502681|76049428|FG000|Overall Study|Disease Progression|2|||
42229292|NCT03502681|76049429|FG001|Overall Study|Disease Progression|1|||
42229293|NCT02860130|76049436|FG000|Overall Study|Adverse Event|2|||
42229294|NCT02860130|76049437|FG001|Overall Study|Adverse Event|3|||
42229295|NCT02860130|76049436|FG000|Overall Study|Protocol Violation|1|||
42229296|NCT02860130|76049437|FG001|Overall Study|Protocol Violation|1|||
42229297|NCT02860130|76049436|FG000|Overall Study|Withdrawal by Subject|0|||
42229298|NCT02860130|76049437|FG001|Overall Study|Withdrawal by Subject|2|||
42229299|NCT02860130|76049436|FG000|Overall Study|Physician Decision|2|||
42229300|NCT02860130|76049437|FG001|Overall Study|Physician Decision|2|||
42229301|NCT02860130|76049436|FG000|Overall Study|Other|2|||
42229302|NCT02860130|76049437|FG001|Overall Study|Other|1|||
42229303|NCT02986854|76049446|FG000|Overall Study|Withdrawal by Subject|0|||
42229304|NCT02986854|76049447|FG001|Overall Study|Withdrawal by Subject|1|||
42229305|NCT02986854|76049448|FG002|Overall Study|Withdrawal by Subject|1|||
42229306|NCT02986854|76049446|FG000|Overall Study|Lost to Follow-up|3|||
42229307|NCT02986854|76049447|FG001|Overall Study|Lost to Follow-up|11|||
42229308|NCT02986854|76049448|FG002|Overall Study|Lost to Follow-up|2|||
42229309|NCT02887183|76049458|FG000|Overall Study|Adverse Event|44|||
42229310|NCT02887183|76049458|FG000|Overall Study|Death|30|||
42229311|NCT02887183|76049458|FG000|Overall Study|Pregnancy|1|||
42229312|NCT02887183|76049458|FG000|Overall Study|Protocol Violation|6|||
42229313|NCT02887183|76049458|FG000|Overall Study|Technical Problems|2|||
42229314|NCT02887183|76049458|FG000|Overall Study|Lost to Follow-up|13|||
42229315|NCT02887183|76049458|FG000|Overall Study|Physician Decision|10|||
42229316|NCT02887183|76049458|FG000|Overall Study|Withdrawal by Subject|35|||
42229317|NCT03167359|76049462|FG000|Overall Study|Physician Decision|1|||
42229318|NCT03167359|76049462|FG000|Overall Study|Lost to Follow-up|1|||
42229319|NCT01068600|76049468|FG000|Overall Study|Withdrawal by Subject|5|||
42229320|NCT01068600|76049469|FG001|Overall Study|Withdrawal by Subject|6|||
42229321|NCT01068600|76049468|FG000|Overall Study|Adverse Event|3|||
42229322|NCT01068600|76049469|FG001|Overall Study|Adverse Event|3|||
42229323|NCT01068600|76049468|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42229324|NCT01068600|76049469|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42229325|NCT01068600|76049468|FG000|Overall Study|Lost to Follow-up|1|||
42229326|NCT01068600|76049469|FG001|Overall Study|Lost to Follow-up|2|||
42229327|NCT01068600|76049468|FG000|Overall Study|Protocol deviation|1|||
42229328|NCT01068600|76049469|FG001|Overall Study|Protocol deviation|1|||
42229329|NCT01068600|76049468|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42229330|NCT01068600|76049469|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
42229331|NCT01068600|76049468|FG000|Overall Study|Administrative problems|0|||
42229332|NCT01068600|76049469|FG001|Overall Study|Administrative problems|1|||
42229333|NCT01067976|76049475|FG000|Overall Study|Study drug never administered|20|||
42229334|NCT01067976|76049475|FG000|Overall Study|Study prematurely discontinued|2|||
42229335|NCT02858492|76049497|FG000|Overall Study|Withdrawal by Subject|0|||
42229336|NCT02858492|76049498|FG001|Overall Study|Withdrawal by Subject|1|||
41986641|NCT01240863|75793848|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
42229337|NCT02858492|76049499|FG002|Overall Study|Withdrawal by Subject|0|||
42229338|NCT02858492|76049500|FG003|Overall Study|Withdrawal by Subject|1|||
42229339|NCT02858492|76049497|FG000|Overall Study|Adverse Event|0|||
42229340|NCT02858492|76049498|FG001|Overall Study|Adverse Event|0|||
42302503|NCT02417233|76137760|FG001|Overall Study|Protocol Violation|0|||
42229341|NCT02858492|76049499|FG002|Overall Study|Adverse Event|0|||
42229342|NCT02858492|76049500|FG003|Overall Study|Adverse Event|3|||
42229343|NCT02858492|76049497|FG000|Overall Study|Lack of Efficacy|0|||
42229344|NCT02858492|76049498|FG001|Overall Study|Lack of Efficacy|0|||
42229345|NCT02858492|76049499|FG002|Overall Study|Lack of Efficacy|0|||
42229346|NCT02858492|76049500|FG003|Overall Study|Lack of Efficacy|1|||
42229347|NCT02858492|76049497|FG000|Overall Study|Protocol defined stopping criteria|0|||
42229348|NCT02858492|76049498|FG001|Overall Study|Protocol defined stopping criteria|0|||
42229349|NCT02858492|76049499|FG002|Overall Study|Protocol defined stopping criteria|0|||
42229350|NCT02858492|76049500|FG003|Overall Study|Protocol defined stopping criteria|1|||
42229351|NCT01067508|76049514|FG000|Overall Study|Physician Decision|0|||
42229352|NCT01067508|76049515|FG001|Overall Study|Physician Decision|1|||
42229353|NCT01067508|76049514|FG000|Overall Study|Withdrawal by Subject|0|||
42229354|NCT01067508|76049515|FG001|Overall Study|Withdrawal by Subject|1|||
42229355|NCT01067352|76049524|FG000|Overall Study|Withdrawal by Subject|1|||
42229356|NCT01067352|76049525|FG001|Overall Study|Withdrawal by Subject|2|||
42229357|NCT01067352|76049526|FG002|Overall Study|Withdrawal by Subject|1|||
42229358|NCT01067352|76049524|FG000|Overall Study|Physician Decision|0|||
42229359|NCT01067352|76049525|FG001|Overall Study|Physician Decision|1|||
42229360|NCT01067352|76049526|FG002|Overall Study|Physician Decision|0|||
42229361|NCT02986074|76049534|FG000|First Trial Period|Adverse Event|1|||
42229362|NCT02986074|76049535|FG001|First Trial Period|Adverse Event|0|||
42229363|NCT02986074|76049536|FG002|First Trial Period|Adverse Event|0|||
42229364|NCT02986074|76049537|FG003|First Trial Period|Adverse Event|0|||
42229365|NCT02986074|76049534|FG000|Follow up Period|system explant|0|||
42229366|NCT02986074|76049535|FG001|Follow up Period|system explant|0|||
42229367|NCT02986074|76049536|FG002|Follow up Period|system explant|1|||
42229368|NCT02986074|76049537|FG003|Follow up Period|system explant|2|||
42229369|NCT02986074|76049534|FG000|Follow up Period|Physician Decision|0|||
42229370|NCT02986074|76049535|FG001|Follow up Period|Physician Decision|0|||
42229371|NCT02986074|76049536|FG002|Follow up Period|Physician Decision|0|||
42229372|NCT02986074|76049537|FG003|Follow up Period|Physician Decision|1|||
42229373|NCT02920242|76049545|FG000|Overall Study|Withdrawal by Subject|1|||
42229374|NCT02920242|76049546|FG001|Overall Study|Withdrawal by Subject|0|||
42229375|NCT02920242|76049547|FG002|Overall Study|Withdrawal by Subject|1|||
42229376|NCT02920242|76049545|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
42229377|NCT02920242|76049546|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
42229378|NCT02920242|76049547|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
42229379|NCT02985996|76049560|FG000|Overall Study|Withdrawal by Subject|0|||
42229380|NCT02985996|76049561|FG001|Overall Study|Withdrawal by Subject|0|||
42229381|NCT02985996|76049562|FG002|Overall Study|Withdrawal by Subject|1|||
42229382|NCT02985996|76049563|FG003|Overall Study|Withdrawal by Subject|0|||
42229383|NCT02985996|76049564|FG004|Overall Study|Withdrawal by Subject|0|||
42229384|NCT02985996|76049560|FG000|Overall Study|Protocol Violation|0|||
42229385|NCT02985996|76049561|FG001|Overall Study|Protocol Violation|1|||
42229386|NCT02985996|76049562|FG002|Overall Study|Protocol Violation|0|||
42229387|NCT02985996|76049563|FG003|Overall Study|Protocol Violation|0|||
42229388|NCT02985996|76049564|FG004|Overall Study|Protocol Violation|0|||
42229389|NCT03225833|76049586|FG000|Overall Study|Adverse Event|0|||
42229390|NCT03225833|76049587|FG001|Overall Study|Adverse Event|1|||
42229391|NCT03225833|76049588|FG002|Overall Study|Adverse Event|2|||
42229392|NCT03225833|76049589|FG003|Overall Study|Adverse Event|0|||
42229393|NCT03225833|76049590|FG004|Overall Study|Adverse Event|0|||
42229394|NCT03225833|76049591|FG005|Overall Study|Adverse Event|2|||
42229395|NCT03225833|76049586|FG000|Overall Study|Withdrawal by Subject|1|||
42229396|NCT03225833|76049587|FG001|Overall Study|Withdrawal by Subject|0|||
42229397|NCT03225833|76049588|FG002|Overall Study|Withdrawal by Subject|0|||
42229398|NCT03225833|76049589|FG003|Overall Study|Withdrawal by Subject|0|||
42229399|NCT03225833|76049590|FG004|Overall Study|Withdrawal by Subject|1|||
42229400|NCT03225833|76049591|FG005|Overall Study|Withdrawal by Subject|0|||
42229401|NCT03225833|76049586|FG000|Overall Study|Termination of Study by Sponsor|4|||
42229402|NCT03225833|76049587|FG001|Overall Study|Termination of Study by Sponsor|0|||
42229403|NCT03225833|76049588|FG002|Overall Study|Termination of Study by Sponsor|0|||
42229404|NCT03225833|76049589|FG003|Overall Study|Termination of Study by Sponsor|0|||
42229405|NCT03225833|76049590|FG004|Overall Study|Termination of Study by Sponsor|0|||
42229406|NCT03225833|76049591|FG005|Overall Study|Termination of Study by Sponsor|7|||
42229407|NCT03225833|76049586|FG000|Overall Study|Sponsor Decision|0|||
42229408|NCT03225833|76049587|FG001|Overall Study|Sponsor Decision|0|||
42229409|NCT03225833|76049588|FG002|Overall Study|Sponsor Decision|0|||
42229410|NCT03225833|76049589|FG003|Overall Study|Sponsor Decision|0|||
42229411|NCT03225833|76049590|FG004|Overall Study|Sponsor Decision|0|||
42229412|NCT03225833|76049591|FG005|Overall Study|Sponsor Decision|1|||
42229413|NCT03203447|76049612|FG000|Overall Study|Withdrawal by Subject|2|||
42229414|NCT03203447|76049613|FG001|Overall Study|Withdrawal by Subject|1|||
42229415|NCT03203447|76049612|FG000|Overall Study|Lost to Follow-up|1|||
42229416|NCT03203447|76049613|FG001|Overall Study|Lost to Follow-up|10|||
42229417|NCT03203447|76049612|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
42229418|NCT03203447|76049613|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
42229419|NCT02858726|76049623|FG000|Overall Study|Adverse Event|4|||
42229420|NCT02858726|76049624|FG001|Overall Study|Adverse Event|4|||
42229421|NCT02858726|76049625|FG002|Overall Study|Adverse Event|9|||
42229422|NCT02858726|76049626|FG003|Overall Study|Adverse Event|1|||
42229423|NCT02858726|76049623|FG000|Overall Study|Physician Decision|0|||
42229424|NCT02858726|76049624|FG001|Overall Study|Physician Decision|0|||
42229425|NCT02858726|76049625|FG002|Overall Study|Physician Decision|1|||
42229426|NCT02858726|76049626|FG003|Overall Study|Physician Decision|0|||
42229427|NCT02858726|76049623|FG000|Overall Study|Protocol Violation|0|||
42229428|NCT02858726|76049624|FG001|Overall Study|Protocol Violation|0|||
42229429|NCT02858726|76049625|FG002|Overall Study|Protocol Violation|0|||
42229430|NCT02858726|76049626|FG003|Overall Study|Protocol Violation|1|||
42229431|NCT02858726|76049623|FG000|Overall Study|Study Terminated by Sponsor|0|||
42229432|NCT02858726|76049624|FG001|Overall Study|Study Terminated by Sponsor|0|||
42229433|NCT02858726|76049625|FG002|Overall Study|Study Terminated by Sponsor|0|||
42229434|NCT02858726|76049626|FG003|Overall Study|Study Terminated by Sponsor|1|||
42229435|NCT02858726|76049623|FG000|Overall Study|Withdrawal by Subject|1|||
42229436|NCT02858726|76049624|FG001|Overall Study|Withdrawal by Subject|2|||
42229437|NCT02858726|76049625|FG002|Overall Study|Withdrawal by Subject|1|||
42229438|NCT02858726|76049626|FG003|Overall Study|Withdrawal by Subject|0|||
42229439|NCT02858726|76049623|FG000|Overall Study|Noncompliance|0|||
42229440|NCT02858726|76049624|FG001|Overall Study|Noncompliance|1|||
42229441|NCT02858726|76049625|FG002|Overall Study|Noncompliance|0|||
42229442|NCT02858726|76049626|FG003|Overall Study|Noncompliance|0|||
42229443|NCT03203291|76049640|FG000|Overall Study|Withdrawal by Subject|1|||
42229444|NCT01068678|76049646|FG000|Overall Study|Lack of Efficacy|3|||
42229445|NCT01068678|76049647|FG001|Overall Study|Lack of Efficacy|2|||
42229446|NCT01068678|76049646|FG000|Overall Study|Protocol Violation|5|||
42229447|NCT01068678|76049647|FG001|Overall Study|Protocol Violation|1|||
42229448|NCT01068678|76049646|FG000|Overall Study|Withdrawal criteria|12|||
42229449|NCT01068678|76049647|FG001|Overall Study|Withdrawal criteria|6|||
42229450|NCT01068678|76049646|FG000|Overall Study|Unclassified|18|||
42229451|NCT01068678|76049647|FG001|Overall Study|Unclassified|15|||
42229452|NCT03202511|76049653|FG000|Overall Study|Withdrawal by Subject|1|||
42229453|NCT03202511|76049654|FG001|Overall Study|Withdrawal by Subject|0|||
42229454|NCT02919696|76049675|FG000|Overall Study|Adverse Event|1|||
42229455|NCT02919696|76049676|FG001|Overall Study|Adverse Event|2|||
42229456|NCT02919696|76049675|FG000|Overall Study|Withdrawal by Subject|2|||
42229457|NCT02919696|76049676|FG001|Overall Study|Withdrawal by Subject|1|||
42229458|NCT02919696|76049675|FG000|Overall Study|Sponsor Decision|1|||
42229459|NCT02919696|76049676|FG001|Overall Study|Sponsor Decision|1|||
42229460|NCT02919696|76049675|FG000|Overall Study|Never Treated|0|||
42229461|NCT02919696|76049676|FG001|Overall Study|Never Treated|1|||
42229462|NCT02935673|76049691|FG000|Overall Study|Adverse Event|0|||
42229463|NCT02935673|76049692|FG001|Overall Study|Adverse Event|1|||
42229464|NCT02935673|76049693|FG002|Overall Study|Adverse Event|0|||
42229465|NCT02935673|76049691|FG000|Overall Study|Withdrawal by Subject|1|||
42229466|NCT02935673|76049692|FG001|Overall Study|Withdrawal by Subject|2|||
42229467|NCT02935673|76049693|FG002|Overall Study|Withdrawal by Subject|0|||
42229468|NCT03201809|76049705|FG000|Overall Study|Lost to Follow-up|2|||
42229469|NCT03201809|76049706|FG001|Overall Study|Lost to Follow-up|0|||
42229470|NCT02985450|76049717|FG000|Overall Study|Lost to Follow-up|7|||
42229471|NCT02908464|76049726|FG000|Overall Study|Withdrawal by Subject|2|||
42229472|NCT02908464|76049727|FG001|Overall Study|Withdrawal by Subject|1|||
42229473|NCT02908464|76049726|FG000|Overall Study|Found ineligible after randomization|0|||
42229474|NCT02908464|76049727|FG001|Overall Study|Found ineligible after randomization|2|||
42229475|NCT02907216|76049736|FG000|Overall Study|No benefit to be obtained by continuing|0|||
42229476|NCT02907216|76049737|FG001|Overall Study|No benefit to be obtained by continuing|1|||
42229477|NCT02907216|76049736|FG000|Overall Study|Withdrawal by Subject|1|||
42229478|NCT02907216|76049737|FG001|Overall Study|Withdrawal by Subject|0|||
42229479|NCT02984982|76049745|FG000|Overall Study|Adverse Event|2|||
42229480|NCT02984982|76049746|FG001|Overall Study|Adverse Event|5|||
42229481|NCT02984982|76049745|FG000|Overall Study|Poor Compliance to Protocol|4|||
42229482|NCT02984982|76049746|FG001|Overall Study|Poor Compliance to Protocol|4|||
42229483|NCT02984982|76049745|FG000|Overall Study|Withdrawal by Subject|2|||
42229484|NCT02984982|76049746|FG001|Overall Study|Withdrawal by Subject|0|||
42229485|NCT02984982|76049745|FG000|Overall Study|Randomized but not treated|0|||
42229486|NCT02984982|76049746|FG001|Overall Study|Randomized but not treated|1|||
42229487|NCT02981472|76049755|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
42229488|NCT02981472|76049756|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
42229489|NCT02981472|76049755|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
42229490|NCT02981472|76049756|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
42229491|NCT02981472|76049755|FG000|Treatment Period|Adverse Event|6|||
42229492|NCT02981472|76049756|FG001|Treatment Period|Adverse Event|1|||
42229493|NCT02981472|76049755|FG000|Treatment Period|Participant withdrew consent|1|||
42229494|NCT02981472|76049756|FG001|Treatment Period|Participant withdrew consent|0|||
42229495|NCT02981472|76049755|FG000|Treatment Period|Lost to Follow-up|0|||
42229496|NCT02981472|76049756|FG001|Treatment Period|Lost to Follow-up|1|||
42229497|NCT02982720|76049768|FG000|Overall Study|Adverse Event|3|||
42229498|NCT02982720|76049768|FG000|Overall Study|Death|1|||
42229499|NCT00849667|76049775|FG000|Overall Study|Withdrawal by Subject|16|||
41986642|NCT01240863|75793849|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
41986643|NCT01240863|75793850|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
41986644|NCT01240863|75793848|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
41986645|NCT01240863|75793849|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
41986646|NCT01240863|75793850|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
41986647|NCT01240863|75793848|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
41986648|NCT01240863|75793849|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
41986649|NCT01240863|75793850|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
42229500|NCT00849667|76049776|FG001|Overall Study|Withdrawal by Subject|33|||
41986650|NCT01240863|75793848|FG000|Open-label Titration Period|Other|7|||
41986651|NCT01240863|75793849|FG001|Open-label Titration Period|Other|0|||
41986652|NCT01240863|75793850|FG002|Open-label Titration Period|Other|0|||
41986653|NCT01240863|75793848|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
41986654|NCT01240863|75793849|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
41986655|NCT01240863|75793850|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
41986656|NCT01240863|75793848|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
41986657|NCT01240863|75793849|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
41986658|NCT01240863|75793850|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
41986659|NCT01240863|75793848|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
41986660|NCT01240863|75793849|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
41986661|NCT01240863|75793850|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
41986662|NCT01240863|75793848|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
42229501|NCT00849667|76049777|FG002|Overall Study|Withdrawal by Subject|35|||
42229502|NCT00849667|76049775|FG000|Overall Study|Lost to Follow-up|8|||
42229503|NCT00849667|76049776|FG001|Overall Study|Lost to Follow-up|8|||
42229504|NCT00849667|76049777|FG002|Overall Study|Lost to Follow-up|8|||
42229505|NCT00849667|76049775|FG000|Overall Study|Adverse Event|1|||
42229506|NCT00849667|76049776|FG001|Overall Study|Adverse Event|2|||
42229507|NCT00849667|76049777|FG002|Overall Study|Adverse Event|0|||
42229508|NCT00849667|76049775|FG000|Overall Study|Other|18|||
42229509|NCT00849667|76049776|FG001|Overall Study|Other|19|||
42229510|NCT00849667|76049777|FG002|Overall Study|Other|18|||
42229511|NCT00849667|76049775|FG000|Overall Study|Progressive disease|119|||
42229512|NCT00849667|76049776|FG001|Overall Study|Progressive disease|100|||
42229513|NCT00849667|76049777|FG002|Overall Study|Progressive disease|112|||
42229514|NCT00849667|76049775|FG000|Overall Study|Sponsor decision|208|||
42229515|NCT00849667|76049776|FG001|Overall Study|Sponsor decision|204|||
42032506|NCT00951015|75840752|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
42032507|NCT00951015|75840753|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
42032508|NCT00951015|75840754|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
42032509|NCT00951015|75840755|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
42229516|NCT00849667|76049777|FG002|Overall Study|Sponsor decision|190|||
42229517|NCT00849667|76049775|FG000|Overall Study|Investigator discretion|0|||
42229518|NCT00849667|76049776|FG001|Overall Study|Investigator discretion|0|||
42229519|NCT00849667|76049777|FG002|Overall Study|Investigator discretion|1|||
42229520|NCT03201419|76049796|FG000|Overall Study|Adverse Event|3|||
42229521|NCT03201419|76049797|FG001|Overall Study|Adverse Event|1|||
42229522|NCT03201419|76049798|FG002|Overall Study|Adverse Event|0|||
42229523|NCT03201419|76049799|FG003|Overall Study|Adverse Event|0|||
42229524|NCT03201419|76049800|FG004|Overall Study|Adverse Event|1|||
42229525|NCT03201419|76049801|FG005|Overall Study|Adverse Event|1|||
42229526|NCT03201419|76049802|FG006|Overall Study|Adverse Event|5|||
42229527|NCT03201419|76049803|FG007|Overall Study|Adverse Event|0|||
42229528|NCT03201419|76049804|FG008|Overall Study|Adverse Event|0|||
42229529|NCT03201419|76049796|FG000|Overall Study|Lost to Follow-up|1|||
42229530|NCT03201419|76049797|FG001|Overall Study|Lost to Follow-up|0|||
42229531|NCT03201419|76049798|FG002|Overall Study|Lost to Follow-up|0|||
42229532|NCT03201419|76049799|FG003|Overall Study|Lost to Follow-up|0|||
42229533|NCT03201419|76049800|FG004|Overall Study|Lost to Follow-up|0|||
42229534|NCT03201419|76049801|FG005|Overall Study|Lost to Follow-up|0|||
42229535|NCT03201419|76049802|FG006|Overall Study|Lost to Follow-up|0|||
42229536|NCT03201419|76049803|FG007|Overall Study|Lost to Follow-up|0|||
41986663|NCT01240863|75793849|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
42229537|NCT03201419|76049804|FG008|Overall Study|Lost to Follow-up|0|||
42229538|NCT03201419|76049796|FG000|Overall Study|Protocol Deviation|0|||
42229539|NCT03201419|76049797|FG001|Overall Study|Protocol Deviation|0|||
42229540|NCT03201419|76049798|FG002|Overall Study|Protocol Deviation|0|||
42229541|NCT03201419|76049799|FG003|Overall Study|Protocol Deviation|0|||
42229542|NCT03201419|76049800|FG004|Overall Study|Protocol Deviation|0|||
42229543|NCT03201419|76049801|FG005|Overall Study|Protocol Deviation|0|||
41986664|NCT01240863|75793850|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
42229544|NCT03201419|76049802|FG006|Overall Study|Protocol Deviation|1|||
42229545|NCT03201419|76049803|FG007|Overall Study|Protocol Deviation|0|||
42229546|NCT03201419|76049804|FG008|Overall Study|Protocol Deviation|0|||
42229547|NCT03201419|76049796|FG000|Overall Study|Withdrawal by Subject|4|||
42229548|NCT03201419|76049797|FG001|Overall Study|Withdrawal by Subject|2|||
42229549|NCT03201419|76049798|FG002|Overall Study|Withdrawal by Subject|1|||
42229550|NCT03201419|76049799|FG003|Overall Study|Withdrawal by Subject|0|||
42229551|NCT03201419|76049800|FG004|Overall Study|Withdrawal by Subject|0|||
42229552|NCT03201419|76049801|FG005|Overall Study|Withdrawal by Subject|0|||
42229553|NCT03201419|76049802|FG006|Overall Study|Withdrawal by Subject|0|||
42229554|NCT03201419|76049803|FG007|Overall Study|Withdrawal by Subject|1|||
42229555|NCT03201419|76049804|FG008|Overall Study|Withdrawal by Subject|2|||
42229556|NCT03201419|76049796|FG000|Overall Study|Other|0|||
42229557|NCT03201419|76049797|FG001|Overall Study|Other|0|||
42229558|NCT03201419|76049798|FG002|Overall Study|Other|1|||
42229559|NCT03201419|76049799|FG003|Overall Study|Other|0|||
42229560|NCT03201419|76049800|FG004|Overall Study|Other|0|||
42229561|NCT03201419|76049801|FG005|Overall Study|Other|0|||
42229562|NCT03201419|76049802|FG006|Overall Study|Other|0|||
42229563|NCT03201419|76049803|FG007|Overall Study|Other|0|||
42229564|NCT03201419|76049804|FG008|Overall Study|Other|0|||
42229565|NCT01764633|76049840|FG000|Overall Study|Withdrawal by Subject|105|||
42229566|NCT01764633|76049841|FG001|Overall Study|Withdrawal by Subject|88|||
42229567|NCT01764633|76049840|FG000|Overall Study|Lost to Follow-up|13|||
42229568|NCT01764633|76049841|FG001|Overall Study|Lost to Follow-up|5|||
42229569|NCT02924389|76049849|FG000|Overall Study|Lost to Follow-up|1|||
42229570|NCT02924389|76049850|FG001|Overall Study|Lost to Follow-up|0|||
42229571|NCT02924389|76049849|FG000|Overall Study|Physician Decision|2|||
42229572|NCT02924389|76049850|FG001|Overall Study|Physician Decision|0|||
42229573|NCT02924389|76049849|FG000|Overall Study|Withdrawal by Subject|3|||
42229574|NCT02924389|76049850|FG001|Overall Study|Withdrawal by Subject|0|||
42229575|NCT02924389|76049849|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
42229576|NCT02924389|76049850|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
42229577|NCT03235349|76049857|FG000|Overall Study|Adverse Event|1|||
42229578|NCT03235349|76049857|FG000|Overall Study|Other|1|||
42229579|NCT03235115|76049861|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
42229580|NCT03235115|76049862|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
42229581|NCT03235115|76049863|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
42229582|NCT03235115|76049864|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
42229583|NCT03235115|76049865|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
42229584|NCT03235115|76049866|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
42229585|NCT02923531|76049874|FG000|Overall Study|Adverse Event|4|||
42229586|NCT02923531|76049874|FG000|Overall Study|Clinical Deterioration|1|||
42229587|NCT02923531|76049874|FG000|Overall Study|Disease Progression|3|||
42229588|NCT02923531|76049874|FG000|Overall Study|Study Termination|1|||
42229589|NCT02934503|76049879|FG000|Overall Study|progression of disease|3|||
42229590|NCT02934503|76049879|FG000|Overall Study|Withdrawal by Subject|1|||
42229591|NCT02937545|76049885|FG000|Overall Study|Withdrawal by Subject|1|||
42229592|NCT02937545|76049886|FG001|Overall Study|Withdrawal by Subject|2|||
42229593|NCT02937545|76049887|FG002|Overall Study|Withdrawal by Subject|6|||
42229594|NCT02937545|76049888|FG003|Overall Study|Withdrawal by Subject|7|||
42229595|NCT02937545|76049885|FG000|Overall Study|Lost to Follow-up|1|||
42229596|NCT02937545|76049886|FG001|Overall Study|Lost to Follow-up|0|||
42229597|NCT02937545|76049887|FG002|Overall Study|Lost to Follow-up|0|||
42229598|NCT02937545|76049888|FG003|Overall Study|Lost to Follow-up|0|||
42229599|NCT03199391|76049899|FG000|Overall Study|Death|1|||
42229600|NCT03199391|76049899|FG000|Overall Study|Lost to Follow-up|3|||
42229601|NCT03199391|76049899|FG000|Overall Study|Adverse Event|2|||
42229602|NCT03199391|76049899|FG000|Overall Study|Withdrawal by Subject|10|||
42229603|NCT03198767|76049910|FG000|Overall Study|Protocol Violation|0|||
42229604|NCT03198767|76049911|FG001|Overall Study|Protocol Violation|0|||
42229605|NCT03198767|76049912|FG002|Overall Study|Protocol Violation|0|||
42229606|NCT03198767|76049913|FG003|Overall Study|Protocol Violation|6|||
42229607|NCT03198767|76049914|FG004|Overall Study|Protocol Violation|0|||
42229608|NCT03198767|76049915|FG005|Overall Study|Protocol Violation|0|||
42229609|NCT03198767|76049916|FG006|Overall Study|Protocol Violation|0|||
42229610|NCT03162055|76049933|FG000|Overall Study|Adverse Event|6|||
42229611|NCT03162055|76049934|FG001|Overall Study|Adverse Event|5|||
42229612|NCT03162055|76049933|FG000|Overall Study|Death|3|||
42229613|NCT03162055|76049934|FG001|Overall Study|Death|3|||
42302504|NCT02417233|76137761|FG002|Overall Study|Protocol Violation|2|||
41986665|NCT01240863|75793848|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
42229614|NCT03162055|76049933|FG000|Overall Study|Lost to Follow-up|0|||
42229615|NCT03162055|76049934|FG001|Overall Study|Lost to Follow-up|1|||
42229616|NCT03162055|76049933|FG000|Overall Study|Study-specific withdrawal criteria|22|||
42229617|NCT03162055|76049934|FG001|Overall Study|Study-specific withdrawal criteria|14|||
42229618|NCT03162055|76049933|FG000|Overall Study|Withdrawal by Subject|17|||
42229619|NCT03162055|76049934|FG001|Overall Study|Withdrawal by Subject|2|||
42229620|NCT03162055|76049933|FG000|Overall Study|Did not receive treatment|2|||
42229621|NCT03162055|76049934|FG001|Overall Study|Did not receive treatment|0|||
42229622|NCT03162055|76049933|FG000|Overall Study|Incorrect randomization|4|||
42229623|NCT03162055|76049934|FG001|Overall Study|Incorrect randomization|3|||
42229624|NCT03162055|76049933|FG000|Overall Study|Other|8|||
42229625|NCT03162055|76049934|FG001|Overall Study|Other|15|||
42229626|NCT02927145|76049947|FG000|Initial Recruitment|Withdrawal by Subject|0|||
42229627|NCT02927145|76049948|FG001|Initial Recruitment|Withdrawal by Subject|1|||
42229628|NCT02927145|76049949|FG002|Initial Recruitment|Withdrawal by Subject|1|||
42229629|NCT02927145|76049950|FG003|Initial Recruitment|Withdrawal by Subject|4|||
42229630|NCT02927145|76049951|FG004|Initial Recruitment|Withdrawal by Subject|1|||
42229631|NCT02927145|76049952|FG005|Initial Recruitment|Withdrawal by Subject|1|||
42229632|NCT02927145|76049953|FG006|Initial Recruitment|Withdrawal by Subject|0|||
42229633|NCT02927145|76049954|FG007|Initial Recruitment|Withdrawal by Subject|0|||
42229634|NCT02927145|76049955|FG008|Initial Recruitment|Withdrawal by Subject|2|||
42229635|NCT02927145|76049947|FG000|Initial Recruitment|Adverse Event|0|||
42229636|NCT02927145|76049948|FG001|Initial Recruitment|Adverse Event|0|||
42229637|NCT02927145|76049949|FG002|Initial Recruitment|Adverse Event|0|||
42229638|NCT02927145|76049950|FG003|Initial Recruitment|Adverse Event|0|||
42229639|NCT02927145|76049951|FG004|Initial Recruitment|Adverse Event|2|||
42229640|NCT02927145|76049952|FG005|Initial Recruitment|Adverse Event|0|||
42229641|NCT02927145|76049953|FG006|Initial Recruitment|Adverse Event|0|||
42229642|NCT02927145|76049954|FG007|Initial Recruitment|Adverse Event|0|||
42229643|NCT02927145|76049955|FG008|Initial Recruitment|Adverse Event|0|||
42229644|NCT02927145|76049947|FG000|Invitation for Additional Challenge|Pregnancy|0|||
42229645|NCT02927145|76049948|FG001|Invitation for Additional Challenge|Pregnancy|0|||
42229646|NCT02927145|76049949|FG002|Invitation for Additional Challenge|Pregnancy|0|||
42229647|NCT02927145|76049950|FG003|Invitation for Additional Challenge|Pregnancy|0|||
42229648|NCT02927145|76049951|FG004|Invitation for Additional Challenge|Pregnancy|0|||
42229649|NCT02927145|76049952|FG005|Invitation for Additional Challenge|Pregnancy|0|||
42229650|NCT02927145|76049953|FG006|Invitation for Additional Challenge|Pregnancy|1|||
42229651|NCT02927145|76049954|FG007|Invitation for Additional Challenge|Pregnancy|0|||
42229652|NCT02927145|76049955|FG008|Invitation for Additional Challenge|Pregnancy|0|||
42229653|NCT03688919|76049978|FG000|Overall Study|Lost to Follow-up|2|||
42229654|NCT03688919|76049979|FG001|Overall Study|Lost to Follow-up|1|||
42229655|NCT03688919|76049978|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
42229656|NCT03688919|76049979|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
42229657|NCT02888119|76050002|FG000|Overall Study|Lost to Follow-up|5|||
42229658|NCT02888119|76050003|FG001|Overall Study|Lost to Follow-up|4|||
42229659|NCT02888119|76050004|FG002|Overall Study|Lost to Follow-up|0|||
42229660|NCT03197129|76050013|FG000|Overall Study|did not answer the VPT: shyness|4|||
42229661|NCT03197129|76050014|FG001|Overall Study|did not answer the VPT: shyness|5|||
42229662|NCT03196973|76050023|FG000|Overall Study|Adverse Event|1|||
42229663|NCT03196973|76050024|FG001|Overall Study|Adverse Event|1|||
42229664|NCT03196973|76050025|FG002|Overall Study|Adverse Event|2|||
42229665|NCT03196973|76050023|FG000|Overall Study|Lack of Efficacy|2|||
42229666|NCT03196973|76050024|FG001|Overall Study|Lack of Efficacy|6|||
42229667|NCT03196973|76050025|FG002|Overall Study|Lack of Efficacy|1|||
42229668|NCT03196973|76050023|FG000|Overall Study|Lost to Follow-up|4|||
42229669|NCT03196973|76050024|FG001|Overall Study|Lost to Follow-up|3|||
42229670|NCT03196973|76050025|FG002|Overall Study|Lost to Follow-up|2|||
42229671|NCT03196973|76050023|FG000|Overall Study|Consent withdrawn|2|||
42229672|NCT03196973|76050024|FG001|Overall Study|Consent withdrawn|1|||
42229673|NCT03196973|76050025|FG002|Overall Study|Consent withdrawn|0|||
42229674|NCT03196973|76050023|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
42229675|NCT03196973|76050024|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
42229676|NCT03196973|76050025|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
42229677|NCT03196505|76050035|FG000|Overall Study|Physician Decision|26|||
42229678|NCT03196505|76050036|FG001|Overall Study|Physician Decision|26|||
42229679|NCT03196349|76050045|FG000|Overall Study|Did not receive study drug|0|||
42229680|NCT03196349|76050046|FG001|Overall Study|Did not receive study drug|1|||
42229681|NCT03196349|76050047|FG002|Overall Study|Did not receive study drug|2|||
42229682|NCT03196349|76050045|FG000|Overall Study|No data entered|2|||
42229683|NCT03196349|76050046|FG001|Overall Study|No data entered|4|||
42229684|NCT03196349|76050047|FG002|Overall Study|No data entered|0|||
42229685|NCT03196349|76050045|FG000|Overall Study|Study Terminated early|15|||
42229686|NCT03196349|76050046|FG001|Overall Study|Study Terminated early|9|||
42229687|NCT03196349|76050047|FG002|Overall Study|Study Terminated early|11|||
42229688|NCT02886715|76050058|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42229689|NCT02886715|76050059|FG001|Overall Study|Non-Compliance With Study Drug|2|||
42229690|NCT02886715|76050060|FG002|Overall Study|Non-Compliance With Study Drug|0|||
42229691|NCT02886715|76050058|FG000|Overall Study|Adverse Event|4|||
42229692|NCT02886715|76050059|FG001|Overall Study|Adverse Event|2|||
42229693|NCT02886715|76050060|FG002|Overall Study|Adverse Event|0|||
42229694|NCT02886715|76050058|FG000|Overall Study|Lack of Efficacy|0|||
42229695|NCT02886715|76050059|FG001|Overall Study|Lack of Efficacy|2|||
42229696|NCT02886715|76050060|FG002|Overall Study|Lack of Efficacy|1|||
42229697|NCT02886715|76050058|FG000|Overall Study|Lost to Follow-up|29|||
42229698|NCT02886715|76050059|FG001|Overall Study|Lost to Follow-up|26|||
42229699|NCT02886715|76050060|FG002|Overall Study|Lost to Follow-up|10|||
42229700|NCT02886715|76050058|FG000|Overall Study|Pregnancy|1|||
42229701|NCT02886715|76050059|FG001|Overall Study|Pregnancy|1|||
42229702|NCT02886715|76050060|FG002|Overall Study|Pregnancy|1|||
42229703|NCT02886715|76050058|FG000|Overall Study|Protocol Violation|3|||
42229704|NCT02886715|76050059|FG001|Overall Study|Protocol Violation|2|||
42229705|NCT02886715|76050060|FG002|Overall Study|Protocol Violation|1|||
42229706|NCT02886715|76050058|FG000|Overall Study|Withdrawal by Subject|20|||
42229707|NCT02886715|76050059|FG001|Overall Study|Withdrawal by Subject|18|||
42229708|NCT02886715|76050060|FG002|Overall Study|Withdrawal by Subject|5|||
42229709|NCT02886715|76050058|FG000|Overall Study|missing|7|||
42229710|NCT02886715|76050059|FG001|Overall Study|missing|2|||
42229711|NCT02886715|76050060|FG002|Overall Study|missing|2|||
42229712|NCT03085797|76050070|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
42229713|NCT03085797|76050071|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
42229714|NCT03085797|76050070|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
42229715|NCT03085797|76050071|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
42229716|NCT03085797|76050070|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
42229717|NCT03085797|76050071|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
42229718|NCT03157531|76050079|FG000|Overall Study|Death|2|||
42229719|NCT03157531|76050079|FG000|Overall Study|Lost to Follow-up|4|||
42229720|NCT03159091|76050085|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
42229721|NCT03159091|76050086|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
42229722|NCT03159091|76050085|FG000|Overall Study|Patient has taken no dose of study drug|0|||
42229723|NCT03159091|76050086|FG001|Overall Study|Patient has taken no dose of study drug|1|||
42229724|NCT03196193|76050094|FG000|Overall Study|Adverse Event|1|||
42229725|NCT03196193|76050095|FG001|Overall Study|Adverse Event|0|||
42229726|NCT03196193|76050094|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
42229727|NCT03196193|76050095|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
42229728|NCT03621761|76050104|FG000|Overall Study|Lost to Follow-up|1|||
42229729|NCT03621761|76050105|FG001|Overall Study|Lost to Follow-up|1|||
42229730|NCT03621761|76050106|FG002|Overall Study|Lost to Follow-up|2|||
42229731|NCT03621761|76050104|FG000|Overall Study|Withdrawal by Subject|2|||
42229732|NCT03621761|76050105|FG001|Overall Study|Withdrawal by Subject|1|||
42229733|NCT03621761|76050106|FG002|Overall Study|Withdrawal by Subject|1|||
42229734|NCT03621761|76050104|FG000|Overall Study|Became Ineligible|0|||
42229735|NCT03621761|76050105|FG001|Overall Study|Became Ineligible|2|||
42229736|NCT03621761|76050106|FG002|Overall Study|Became Ineligible|0|||
42229737|NCT03221387|76050114|FG000|Overall Study|Lost to Follow-up|1|||
42229738|NCT03221387|76050114|FG000|Overall Study|Lung transplant|1|||
42229739|NCT03318861|76050123|FG000|Overall Study|Death|2|||
42229740|NCT03318861|76050124|FG001|Overall Study|Death|3|||
42229741|NCT03318861|76050125|FG002|Overall Study|Death|3|||
42229742|NCT03318861|76050126|FG003|Overall Study|Death|2|||
42229743|NCT03318861|76050127|FG004|Overall Study|Death|2|||
42229744|NCT03318861|76050123|FG000|Overall Study|Enrolled But Never Treated|0|||
41986666|NCT01240863|75793849|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
41986667|NCT01240863|75793850|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
42229745|NCT03318861|76050124|FG001|Overall Study|Enrolled But Never Treated|1|||
42229746|NCT03318861|76050125|FG002|Overall Study|Enrolled But Never Treated|0|||
42229747|NCT03318861|76050126|FG003|Overall Study|Enrolled But Never Treated|1|||
42229748|NCT03318861|76050127|FG004|Overall Study|Enrolled But Never Treated|1|||
42229749|NCT03318861|76050123|FG000|Overall Study|Informed Consent Withdraw|0|||
42229750|NCT03318861|76050124|FG001|Overall Study|Informed Consent Withdraw|0|||
42229751|NCT03318861|76050125|FG002|Overall Study|Informed Consent Withdraw|0|||
42229752|NCT03318861|76050126|FG003|Overall Study|Informed Consent Withdraw|1|||
42229753|NCT03318861|76050127|FG004|Overall Study|Informed Consent Withdraw|0|||
42229754|NCT03318861|76050123|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
42229755|NCT03318861|76050124|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
42229756|NCT03318861|76050125|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
42229757|NCT03318861|76050126|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
42229758|NCT03318861|76050127|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
42229759|NCT03084315|76050142|FG000|Overall Study|Lost to Follow-up|8|||
42229760|NCT03084315|76050143|FG001|Overall Study|Lost to Follow-up|7|||
42229761|NCT03084315|76050142|FG000|Overall Study|Withdrawal by Subject|2|||
42229762|NCT03084315|76050143|FG001|Overall Study|Withdrawal by Subject|2|||
42229763|NCT03187301|76050149|FG000|Titration Period|Adverse Event|0|||
42229764|NCT03187301|76050150|FG001|Titration Period|Adverse Event|0|||
42229765|NCT03187301|76050151|FG002|Titration Period|Adverse Event|0|||
42229766|NCT03187301|76050152|FG003|Titration Period|Adverse Event|0|||
42229767|NCT03187301|76050153|FG004|Titration Period|Adverse Event|0|||
42229768|NCT03187301|76050154|FG005|Titration Period|Adverse Event|0|||
42229769|NCT03187301|76050155|FG006|Titration Period|Adverse Event|5|||
42229770|NCT03187301|76050149|FG000|Titration Period|Withdrawal by Subject|0|||
42229771|NCT03187301|76050150|FG001|Titration Period|Withdrawal by Subject|0|||
42229772|NCT03187301|76050151|FG002|Titration Period|Withdrawal by Subject|0|||
42229773|NCT03187301|76050152|FG003|Titration Period|Withdrawal by Subject|0|||
42229774|NCT03187301|76050153|FG004|Titration Period|Withdrawal by Subject|0|||
42229775|NCT03187301|76050154|FG005|Titration Period|Withdrawal by Subject|0|||
42229776|NCT03187301|76050155|FG006|Titration Period|Withdrawal by Subject|1|||
42229777|NCT03187301|76050149|FG000|Titration Period|Exclusion Criteria Met|0|||
42229778|NCT03187301|76050150|FG001|Titration Period|Exclusion Criteria Met|0|||
42229779|NCT03187301|76050151|FG002|Titration Period|Exclusion Criteria Met|0|||
42229780|NCT03187301|76050152|FG003|Titration Period|Exclusion Criteria Met|0|||
42229781|NCT03187301|76050153|FG004|Titration Period|Exclusion Criteria Met|0|||
42229782|NCT03187301|76050154|FG005|Titration Period|Exclusion Criteria Met|0|||
42229783|NCT03187301|76050155|FG006|Titration Period|Exclusion Criteria Met|1|||
42229784|NCT03187301|76050149|FG000|Pre-Intervention|Withdrawal by Subject|1|||
42229785|NCT03187301|76050150|FG001|Pre-Intervention|Withdrawal by Subject|0|||
42229786|NCT03187301|76050151|FG002|Pre-Intervention|Withdrawal by Subject|0|||
42229787|NCT03187301|76050152|FG003|Pre-Intervention|Withdrawal by Subject|0|||
42229788|NCT03187301|76050153|FG004|Pre-Intervention|Withdrawal by Subject|0|||
42229789|NCT03187301|76050154|FG005|Pre-Intervention|Withdrawal by Subject|0|||
42229790|NCT03187301|76050155|FG006|Pre-Intervention|Withdrawal by Subject|0|||
42229791|NCT02946047|76050180|FG000|Overall Study|Adverse Event|1|||
42229792|NCT02946047|76050181|FG001|Overall Study|Adverse Event|0|||
42229793|NCT02946047|76050182|FG002|Overall Study|Adverse Event|0|||
42229794|NCT02946047|76050183|FG003|Overall Study|Adverse Event|0|||
42229795|NCT03077919|76050195|FG000|Overall Study|Lost to Follow-up|4|||
42229796|NCT03077919|76050196|FG001|Overall Study|Lost to Follow-up|1|||
42229797|NCT03220217|76050205|FG000|Overall Study|Withdrawal by Subject|0|||
42229798|NCT03220217|76050206|FG001|Overall Study|Withdrawal by Subject|1|||
42229799|NCT03220217|76050207|FG002|Overall Study|Withdrawal by Subject|0|||
42229800|NCT03220217|76050205|FG000|Overall Study|Subject Missed Procedure|0|||
42229801|NCT03220217|76050206|FG001|Overall Study|Subject Missed Procedure|0|||
42229802|NCT03220217|76050207|FG002|Overall Study|Subject Missed Procedure|1|||
42229803|NCT03192137|76050238|FG000|Overall Study|Adverse Event|10|||
42229804|NCT03192137|76050239|FG001|Overall Study|Adverse Event|11|||
42229805|NCT03192137|76050238|FG000|Overall Study|Physician Decision|1|||
42229806|NCT03192137|76050239|FG001|Overall Study|Physician Decision|0|||
42229807|NCT03192137|76050238|FG000|Overall Study|Lack of Efficacy|20|||
41986668|NCT01240863|75793848|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
41986669|NCT01240863|75793849|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
41986670|NCT01240863|75793850|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
42229808|NCT03192137|76050239|FG001|Overall Study|Lack of Efficacy|37|||
42229809|NCT03192137|76050238|FG000|Overall Study|Withdrawal by Subject|3|||
42229810|NCT03192137|76050239|FG001|Overall Study|Withdrawal by Subject|3|||
42229811|NCT03192137|76050238|FG000|Overall Study|Protocol Violation|4|||
42229812|NCT03192137|76050239|FG001|Overall Study|Protocol Violation|3|||
42229813|NCT03192137|76050238|FG000|Overall Study|Surgery Cancelled|4|||
42229814|NCT03192137|76050239|FG001|Overall Study|Surgery Cancelled|1|||
42229815|NCT03192137|76050238|FG000|Overall Study|Other - Various Administrative Reasons|8|||
42229816|NCT03192137|76050239|FG001|Overall Study|Other - Various Administrative Reasons|3|||
42229817|NCT03881059|76050259|FG000|Treatment Period - Part A|Adverse Event|1|||
42229818|NCT03881059|76050260|FG001|Treatment Period - Part A|Adverse Event|3|||
42229819|NCT03881059|76050261|FG002|Treatment Period - Part A|Adverse Event|4|||
42229820|NCT03881059|76050259|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
42229821|NCT03881059|76050260|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
42229822|NCT03881059|76050261|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
42229823|NCT03881059|76050259|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
42229824|NCT03881059|76050260|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
42229825|NCT03881059|76050261|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
42229826|NCT03881059|76050259|FG000|Treatment Period - Part A|Other reasons|2|||
41986671|NCT01240863|75793848|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
41986672|NCT01240863|75793849|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
41986673|NCT01240863|75793850|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
42229827|NCT03881059|76050260|FG001|Treatment Period - Part A|Other reasons|1|||
42229828|NCT03881059|76050261|FG002|Treatment Period - Part A|Other reasons|0|||
42229829|NCT03881059|76050259|FG000|Treatment Period - Part B|Adverse Event|0|||
42229830|NCT03881059|76050260|FG001|Treatment Period - Part B|Adverse Event|0|||
41986674|NCT01240863|75793848|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
41986675|NCT01240863|75793849|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
41986676|NCT01240863|75793850|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
41986677|NCT01240746|75793865|FG000|Overall Study|Adverse Event|2|||
41986678|NCT01240746|75793866|FG001|Overall Study|Adverse Event|0|||
42131754|NCT00475722|75942657|FG000|Overall Study|Withdrawal by Subject|12|||
42131755|NCT00475722|75942658|FG001|Overall Study|Withdrawal by Subject|12|||
42229831|NCT03881059|76050261|FG002|Treatment Period - Part B|Adverse Event|3|||
42229832|NCT03881059|76050259|FG000|Treatment Period - Part B|Death|0|||
42229833|NCT03881059|76050260|FG001|Treatment Period - Part B|Death|1|||
42229834|NCT03881059|76050261|FG002|Treatment Period - Part B|Death|1|||
42229835|NCT03881059|76050259|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
42229836|NCT03881059|76050260|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
42229837|NCT03881059|76050261|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
42229838|NCT03881059|76050259|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
42229839|NCT03881059|76050260|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
42229840|NCT03881059|76050261|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
42229841|NCT03881059|76050259|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
42229842|NCT03881059|76050260|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
42229843|NCT03881059|76050261|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
42229844|NCT03881059|76050259|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
42229845|NCT03881059|76050260|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
42229846|NCT03881059|76050261|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
42229847|NCT03881059|76050259|FG000|Treatment Period - Part B|Other reasons|4|||
42229848|NCT03881059|76050260|FG001|Treatment Period - Part B|Other reasons|3|||
42229849|NCT03881059|76050261|FG002|Treatment Period - Part B|Other reasons|3|||
42229850|NCT02861534|76050276|FG000|Overall Study|Death|541|||
42229851|NCT02861534|76050277|FG001|Overall Study|Death|552|||
42229852|NCT02861534|76050276|FG000|Overall Study|Lost to Follow-up|14|||
42229853|NCT02861534|76050277|FG001|Overall Study|Lost to Follow-up|14|||
42229854|NCT02861534|76050276|FG000|Overall Study|Site Terminated by Sponsor|4|||
42229855|NCT02861534|76050277|FG001|Overall Study|Site Terminated by Sponsor|3|||
42229856|NCT02861534|76050276|FG000|Overall Study|Withdrawal by Subject|15|||
42229857|NCT02861534|76050277|FG001|Overall Study|Withdrawal by Subject|18|||
42229858|NCT03083847|76050318|FG000|Main|Physician Decision|0|||
42229859|NCT03083847|76050319|FG001|Main|Physician Decision|0|||
42229860|NCT03083847|76050320|FG002|Main|Physician Decision|0|||
42229861|NCT03083847|76050321|FG003|Main|Physician Decision|0|||
42302505|NCT02417233|76137759|FG000|Overall Study|Withdrawal by Subject|2|||
42302506|NCT02417233|76137760|FG001|Overall Study|Withdrawal by Subject|1|||
42302507|NCT02417233|76137761|FG002|Overall Study|Withdrawal by Subject|8|||
42302508|NCT02417233|76137759|FG000|Overall Study|Relocation out of study area|1|||
42302509|NCT02417233|76137760|FG001|Overall Study|Relocation out of study area|0|||
42302510|NCT02417233|76137761|FG002|Overall Study|Relocation out of study area|1|||
42302511|NCT02417233|76137759|FG000|Overall Study|Mentally unstable|0|||
42131756|NCT00475722|75942657|FG000|Overall Study|Protocol Violation|3|||
42131757|NCT00475722|75942658|FG001|Overall Study|Protocol Violation|0|||
42229862|NCT03083847|76050322|FG004|Main|Physician Decision|0|||
42229863|NCT03083847|76050323|FG005|Main|Physician Decision|1|||
42229864|NCT03083847|76050324|FG006|Main|Physician Decision|0|||
42229865|NCT03083847|76050325|FG007|Main|Physician Decision|0|||
42229866|NCT03083847|76050326|FG008|Main|Physician Decision|0|||
42229867|NCT03083847|76050327|FG009|Main|Physician Decision|0|||
42229868|NCT03083847|76050318|FG000|Main|Pregnancy|0|||
42229869|NCT03083847|76050319|FG001|Main|Pregnancy|0|||
42302512|NCT02417233|76137760|FG001|Overall Study|Mentally unstable|1|||
42302513|NCT02417233|76137761|FG002|Overall Study|Mentally unstable|0|||
41986679|NCT01240746|75793867|FG002|Overall Study|Adverse Event|10|||
41986680|NCT01240746|75793865|FG000|Overall Study|Lost to Follow-up|23|||
42229870|NCT03083847|76050320|FG002|Main|Pregnancy|0|||
42229871|NCT03083847|76050321|FG003|Main|Pregnancy|0|||
42229872|NCT03083847|76050322|FG004|Main|Pregnancy|0|||
42229873|NCT03083847|76050323|FG005|Main|Pregnancy|0|||
42229874|NCT03083847|76050324|FG006|Main|Pregnancy|0|||
42229875|NCT03083847|76050325|FG007|Main|Pregnancy|1|||
42229876|NCT03083847|76050326|FG008|Main|Pregnancy|0|||
42229877|NCT03083847|76050327|FG009|Main|Pregnancy|0|||
42229878|NCT03083847|76050318|FG000|Main|Adverse Event|0|||
42229879|NCT03083847|76050319|FG001|Main|Adverse Event|0|||
42229880|NCT03083847|76050320|FG002|Main|Adverse Event|0|||
42229881|NCT03083847|76050321|FG003|Main|Adverse Event|0|||
42229882|NCT03083847|76050322|FG004|Main|Adverse Event|0|||
42229883|NCT03083847|76050323|FG005|Main|Adverse Event|0|||
42229884|NCT03083847|76050324|FG006|Main|Adverse Event|0|||
42229885|NCT03083847|76050325|FG007|Main|Adverse Event|2|||
42229886|NCT03083847|76050326|FG008|Main|Adverse Event|0|||
42229887|NCT03083847|76050327|FG009|Main|Adverse Event|0|||
42229888|NCT03083847|76050318|FG000|Main|Withdrawal by Subject|0|||
42229889|NCT03083847|76050319|FG001|Main|Withdrawal by Subject|0|||
42229890|NCT03083847|76050320|FG002|Main|Withdrawal by Subject|0|||
42229891|NCT03083847|76050321|FG003|Main|Withdrawal by Subject|0|||
42229892|NCT03083847|76050322|FG004|Main|Withdrawal by Subject|0|||
42229893|NCT03083847|76050323|FG005|Main|Withdrawal by Subject|0|||
42229894|NCT03083847|76050324|FG006|Main|Withdrawal by Subject|1|||
42229895|NCT03083847|76050325|FG007|Main|Withdrawal by Subject|1|||
42229896|NCT03083847|76050326|FG008|Main|Withdrawal by Subject|0|||
42229897|NCT03083847|76050327|FG009|Main|Withdrawal by Subject|0|||
42229898|NCT03082677|76050355|FG000|Overall Study|Not Treated|2|||
42229899|NCT02858180|76050370|FG000|Overall Study|Lost to Follow-up|0|||
42229900|NCT02858180|76050371|FG001|Overall Study|Lost to Follow-up|2|||
42229901|NCT03082599|76050379|FG000|Overall Study|Lost to Follow-up|1|||
42229902|NCT03082599|76050380|FG001|Overall Study|Lost to Follow-up|0|||
42229903|NCT01346501|76050388|FG000|Overall Study|Initiated Other Biological Agents|3|||
42229904|NCT01346501|76050389|FG001|Overall Study|Initiated Other Biological Agents|1|||
42229905|NCT01346501|76050388|FG000|Overall Study|Other|8|||
42229906|NCT01346501|76050389|FG001|Overall Study|Other|12|||
42229907|NCT03160885|76050399|FG000|Initial Treatment Period|Not dosed|2|||
42229908|NCT03160885|76050400|FG001|Initial Treatment Period|Not dosed|0|||
42229909|NCT03160885|76050401|FG002|Initial Treatment Period|Not dosed|0|||
42229910|NCT03160885|76050402|FG003|Initial Treatment Period|Not dosed|0|||
42229911|NCT03160885|76050403|FG004|Initial Treatment Period|Not dosed|0|||
42229912|NCT03160885|76050404|FG005|Initial Treatment Period|Not dosed|0|||
42229913|NCT03160885|76050405|FG006|Initial Treatment Period|Not dosed|0|||
42229914|NCT03160885|76050399|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
41986681|NCT01240746|75793866|FG001|Overall Study|Lost to Follow-up|20|||
41986682|NCT01240746|75793867|FG002|Overall Study|Lost to Follow-up|102|||
41986683|NCT01240746|75793865|FG000|Overall Study|Protocol Violation|24|||
41986684|NCT01240746|75793866|FG001|Overall Study|Protocol Violation|15|||
41986685|NCT01240746|75793867|FG002|Overall Study|Protocol Violation|72|||
41986686|NCT01240746|75793865|FG000|Overall Study|Withdrawal by Subject|10|||
42131758|NCT00304954|75942668|FG000|Overall Study|Withdrawal by Subject|0|||
42229915|NCT03160885|76050400|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
42229916|NCT03160885|76050401|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
42229917|NCT03160885|76050402|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
42229918|NCT03160885|76050403|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
42229919|NCT03160885|76050404|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
42229920|NCT03160885|76050405|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
42229921|NCT03160885|76050399|FG000|Open-label Treatment|Not dosed|0|||
42131759|NCT00304954|75942669|FG001|Overall Study|Withdrawal by Subject|0|||
42131760|NCT00304954|75942670|FG002|Overall Study|Withdrawal by Subject|1|||
42131761|NCT00304954|75942671|FG003|Overall Study|Withdrawal by Subject|0|||
42131762|NCT00304954|75942668|FG000|Overall Study|Adverse Event|1|||
42229922|NCT03160885|76050400|FG001|Open-label Treatment|Not dosed|0|||
42229923|NCT03160885|76050401|FG002|Open-label Treatment|Not dosed|0|||
42229924|NCT03160885|76050402|FG003|Open-label Treatment|Not dosed|0|||
42229925|NCT03160885|76050403|FG004|Open-label Treatment|Not dosed|0|||
41986687|NCT01240746|75793866|FG001|Overall Study|Withdrawal by Subject|13|||
42131763|NCT00304954|75942669|FG001|Overall Study|Adverse Event|0|||
42229926|NCT03160885|76050404|FG005|Open-label Treatment|Not dosed|0|||
42229927|NCT03160885|76050405|FG006|Open-label Treatment|Not dosed|2|||
42229928|NCT03160885|76050399|FG000|Open-label Treatment|Discontinued IMP|0|||
42229929|NCT03160885|76050400|FG001|Open-label Treatment|Discontinued IMP|0|||
42229930|NCT03160885|76050401|FG002|Open-label Treatment|Discontinued IMP|0|||
42229931|NCT03160885|76050402|FG003|Open-label Treatment|Discontinued IMP|0|||
42229932|NCT03160885|76050403|FG004|Open-label Treatment|Discontinued IMP|0|||
42229933|NCT03160885|76050404|FG005|Open-label Treatment|Discontinued IMP|0|||
42229934|NCT03160885|76050405|FG006|Open-label Treatment|Discontinued IMP|131|||
42229935|NCT03160885|76050399|FG000|Open-label Treatment|Completed Week 50|0|||
42229936|NCT03160885|76050400|FG001|Open-label Treatment|Completed Week 50|0|||
42229937|NCT03160885|76050401|FG002|Open-label Treatment|Completed Week 50|0|||
42229938|NCT03160885|76050402|FG003|Open-label Treatment|Completed Week 50|0|||
42229939|NCT03160885|76050403|FG004|Open-label Treatment|Completed Week 50|0|||
42229940|NCT03160885|76050404|FG005|Open-label Treatment|Completed Week 50|0|||
42229941|NCT03160885|76050405|FG006|Open-label Treatment|Completed Week 50|4|||
42229942|NCT03160885|76050399|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
41986688|NCT01240746|75793867|FG002|Overall Study|Withdrawal by Subject|59|||
41986689|NCT01240590|75793880|FG000|Phase I|Refused further treatment|0|||
41986690|NCT01240590|75793881|FG001|Phase I|Refused further treatment|0|||
41986691|NCT01240590|75793882|FG002|Phase I|Refused further treatment|3|||
41986692|NCT01240590|75793883|FG003|Phase I|Refused further treatment|0|||
41986693|NCT01240590|75793884|FG004|Phase I|Refused further treatment|0|||
42229943|NCT03160885|76050400|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
42229944|NCT03160885|76050401|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
42229945|NCT03160885|76050402|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
42229946|NCT03160885|76050403|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
42229947|NCT03160885|76050404|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
42229948|NCT03160885|76050405|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
42229949|NCT03160885|76050399|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
41986694|NCT01240590|75793880|FG000|Phase II|Refused further treatment|0|||
41986695|NCT01240590|75793881|FG001|Phase II|Refused further treatment|0|||
41986696|NCT01240590|75793882|FG002|Phase II|Refused further treatment|0|||
42229950|NCT03160885|76050400|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
42229951|NCT03160885|76050401|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
42229952|NCT03160885|76050402|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
42229953|NCT03160885|76050403|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
42229954|NCT03160885|76050404|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
42229955|NCT03160885|76050405|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
41986697|NCT01240590|75793883|FG003|Phase II|Refused further treatment|2|||
41986698|NCT01240590|75793884|FG004|Phase II|Refused further treatment|1|||
41986699|NCT01240200|75793912|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
41986700|NCT01240200|75793913|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
41986701|NCT01356966|75793924|FG000|Overall Study|Withdrawal by Subject|1|||
41986702|NCT01356966|75793925|FG001|Overall Study|Withdrawal by Subject|2|||
41986703|NCT01356966|75793924|FG000|Overall Study|Physician Decision|1|||
41986704|NCT01356966|75793925|FG001|Overall Study|Physician Decision|0|||
41986705|NCT05289271|75793963|FG000|Overall Study|Mistakenly allocated, untreated|1|||
41986706|NCT05289271|75793964|FG001|Overall Study|Mistakenly allocated, untreated|0|||
41986707|NCT05080660|75794005|FG000|Overall Study|Adverse Event|4|||
41986708|NCT05080660|75794006|FG001|Overall Study|Adverse Event|0|||
41986709|NCT05080660|75794005|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
41986710|NCT05080660|75794006|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
41986711|NCT05080660|75794005|FG000|Overall Study|Physician Decision|1|||
41986712|NCT05080660|75794006|FG001|Overall Study|Physician Decision|0|||
41986713|NCT05080660|75794005|FG000|Overall Study|Protocol Deviation|2|||
41986714|NCT05080660|75794006|FG001|Overall Study|Protocol Deviation|0|||
42229956|NCT03160885|76050399|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
42229957|NCT03160885|76050400|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
42229958|NCT03160885|76050401|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
42229959|NCT03160885|76050402|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
42229960|NCT03160885|76050403|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
42229961|NCT03160885|76050404|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
42229962|NCT03160885|76050405|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
42229963|NCT03160885|76050399|FG000|Maintenance Treatment Period|Completed Week 50|0|||
42229964|NCT03160885|76050400|FG001|Maintenance Treatment Period|Completed Week 50|0|||
42229965|NCT03160885|76050401|FG002|Maintenance Treatment Period|Completed Week 50|1|||
42229966|NCT03160885|76050402|FG003|Maintenance Treatment Period|Completed Week 50|0|||
42229967|NCT03160885|76050403|FG004|Maintenance Treatment Period|Completed Week 50|0|||
42229968|NCT03160885|76050404|FG005|Maintenance Treatment Period|Completed Week 50|0|||
42229969|NCT03160885|76050405|FG006|Maintenance Treatment Period|Completed Week 50|0|||
41986715|NCT05080660|75794005|FG000|Overall Study|Withdrawal by Subject|5|||
41986716|NCT05080660|75794006|FG001|Overall Study|Withdrawal by Subject|2|||
41986717|NCT05005312|75794014|FG000|Overall Study|Enrolled, but not treated|0|||
41986718|NCT05005312|75794015|FG001|Overall Study|Enrolled, but not treated|1|||
41986719|NCT04867902|75794030|FG000|Overall Study|Lost to Follow-up|1|||
41986720|NCT04867902|75794030|FG000|Overall Study|Withdrawal by Subject|2|||
41986721|NCT04867902|75794030|FG000|Overall Study|Protocol Violation|1|||
42010519|NCT01014442|75817633|FG001|Overall Study|Unspecified Reason|1|||
42229970|NCT03181451|76050425|FG000|Overall Study|Adverse Event|0|||
42229971|NCT03181451|76050426|FG001|Overall Study|Adverse Event|1|||
42229972|NCT03181451|76050427|FG002|Overall Study|Adverse Event|0|||
42229973|NCT03181451|76050425|FG000|Overall Study|Withdrawal by Subject|0|||
42229974|NCT03181451|76050426|FG001|Overall Study|Withdrawal by Subject|1|||
42229975|NCT03181451|76050427|FG002|Overall Study|Withdrawal by Subject|0|||
42229976|NCT00406783|76050439|FG000|Overall Study|Adverse Event|4|||
42229977|NCT00406783|76050440|FG001|Overall Study|Adverse Event|4|||
42229978|NCT00406783|76050439|FG000|Overall Study|Treatment Failure|2|||
42229979|NCT00406783|76050440|FG001|Overall Study|Treatment Failure|3|||
42229980|NCT00406783|76050439|FG000|Overall Study|Lost to Follow-up|3|||
42229981|NCT00406783|76050440|FG001|Overall Study|Lost to Follow-up|0|||
42229982|NCT00406783|76050439|FG000|Overall Study|Withdrawal by Subject|1|||
42229983|NCT00406783|76050440|FG001|Overall Study|Withdrawal by Subject|4|||
42229984|NCT00406783|76050439|FG000|Overall Study|Protocol Violation|4|||
42229985|NCT00406783|76050440|FG001|Overall Study|Protocol Violation|4|||
42229986|NCT03179891|76050446|FG000|First Intervention|Withdrawal by Subject|1|||
42229987|NCT03179891|76050447|FG001|First Intervention|Withdrawal by Subject|1|||
42229988|NCT03179891|76050446|FG000|First Intervention|Unspecified reason|1|||
42229989|NCT03179891|76050447|FG001|First Intervention|Unspecified reason|0|||
42229990|NCT03179891|76050446|FG000|First Intervention|Protocol Violation|0|||
42229991|NCT03179891|76050447|FG001|First Intervention|Protocol Violation|1|||
42229992|NCT02973815|76050458|FG000|Post Intervention|Death|1|||
42229993|NCT02973815|76050459|FG001|Post Intervention|Death|0|||
42229994|NCT02973815|76050458|FG000|Post Intervention|Lost to Follow-up|7|||
42229995|NCT02973815|76050459|FG001|Post Intervention|Lost to Follow-up|24|||
42229996|NCT02973815|76050458|FG000|Follow-up|Lost to Follow-up|2|||
42229997|NCT02973815|76050459|FG001|Follow-up|Lost to Follow-up|0|||
42229998|NCT03160573|76050469|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
42229999|NCT03160573|76050470|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
42230000|NCT03160573|76050471|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
42230001|NCT03160573|76050472|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
42230002|NCT02736227|76050485|FG000|Overall Study|Withdrawal by Subject|0|||
42230003|NCT02736227|76050486|FG001|Overall Study|Withdrawal by Subject|0|||
42230004|NCT02736227|76050487|FG002|Overall Study|Withdrawal by Subject|1|||
42230005|NCT02736227|76050485|FG000|Overall Study|Physician Decision|0|||
42230006|NCT02736227|76050486|FG001|Overall Study|Physician Decision|0|||
42230007|NCT02736227|76050487|FG002|Overall Study|Physician Decision|5|||
42230008|NCT02736227|76050485|FG000|Overall Study|Non Compliant|0|||
42230009|NCT02736227|76050486|FG001|Overall Study|Non Compliant|0|||
42230010|NCT02736227|76050487|FG002|Overall Study|Non Compliant|2|||
42230011|NCT03176459|76050496|FG000|Overall Study|Lost to Follow-up|5|||
42230012|NCT03176459|76050497|FG001|Overall Study|Lost to Follow-up|7|||
42230013|NCT03155269|76050505|FG000|Overall Study|Withdrawal by Subject|4|||
42230014|NCT03155269|76050506|FG001|Overall Study|Withdrawal by Subject|5|||
42230015|NCT03155269|76050505|FG000|Overall Study|Lost to Follow-up|1|||
41986722|NCT04677179|75794037|FG000|Induction Treatment Period|Adverse Event|1|||
41986723|NCT04677179|75794038|FG001|Induction Treatment Period|Adverse Event|0|||
41986724|NCT04677179|75794039|FG002|Induction Treatment Period|Adverse Event|0|||
42230016|NCT03155269|76050506|FG001|Overall Study|Lost to Follow-up|2|||
42230017|NCT02906670|76050522|FG000|Cohort 1, QW|Radiological Progression|1|||
42230018|NCT02906670|76050523|FG001|Cohort 1, QW|Radiological Progression|0|||
42230019|NCT02906670|76050524|FG002|Cohort 1, QW|Radiological Progression|0|||
42230020|NCT02906670|76050525|FG003|Cohort 1, QW|Radiological Progression|0|||
42230021|NCT02906670|76050526|FG004|Cohort 1, QW|Radiological Progression|0|||
41986725|NCT04677179|75794040|FG003|Induction Treatment Period|Adverse Event|0|||
41986726|NCT04677179|75794041|FG004|Induction Treatment Period|Adverse Event|0|||
41986727|NCT04677179|75794042|FG005|Induction Treatment Period|Adverse Event|0|||
41986728|NCT04677179|75794043|FG006|Induction Treatment Period|Adverse Event|0|||
42032510|NCT00951015|75840751|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
42032511|NCT00951015|75840752|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
42032512|NCT00951015|75840753|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
42230022|NCT02906670|76050527|FG005|Cohort 1, QW|Radiological Progression|0|||
42230023|NCT02906670|76050528|FG006|Cohort 1, QW|Radiological Progression|0|||
42230024|NCT02906670|76050529|FG007|Cohort 1, QW|Radiological Progression|0|||
42230025|NCT02906670|76050530|FG008|Cohort 1, QW|Radiological Progression|0|||
42230026|NCT02906670|76050531|FG009|Cohort 1, QW|Radiological Progression|0|||
42230027|NCT02906670|76050522|FG000|Cohort 2, QW|Radiological Progression|0|||
42230028|NCT02906670|76050523|FG001|Cohort 2, QW|Radiological Progression|1|||
42230029|NCT02906670|76050524|FG002|Cohort 2, QW|Radiological Progression|0|||
42230030|NCT02906670|76050525|FG003|Cohort 2, QW|Radiological Progression|0|||
42230031|NCT02906670|76050526|FG004|Cohort 2, QW|Radiological Progression|0|||
42230032|NCT02906670|76050527|FG005|Cohort 2, QW|Radiological Progression|0|||
42230033|NCT02906670|76050528|FG006|Cohort 2, QW|Radiological Progression|0|||
42230034|NCT02906670|76050529|FG007|Cohort 2, QW|Radiological Progression|0|||
41986729|NCT04677179|75794044|FG007|Induction Treatment Period|Adverse Event|0|||
41986730|NCT04677179|75794045|FG008|Induction Treatment Period|Adverse Event|0|||
41986731|NCT04677179|75794046|FG009|Induction Treatment Period|Adverse Event|0|||
42230035|NCT02906670|76050530|FG008|Cohort 2, QW|Radiological Progression|0|||
42230036|NCT02906670|76050531|FG009|Cohort 2, QW|Radiological Progression|0|||
42230037|NCT02906670|76050522|FG000|Cohort 3, QW|Radiological Progression|0|||
42230038|NCT02906670|76050523|FG001|Cohort 3, QW|Radiological Progression|0|||
42230039|NCT02906670|76050524|FG002|Cohort 3, QW|Radiological Progression|2|||
42230040|NCT02906670|76050525|FG003|Cohort 3, QW|Radiological Progression|0|||
42230041|NCT02906670|76050526|FG004|Cohort 3, QW|Radiological Progression|0|||
42230042|NCT02906670|76050527|FG005|Cohort 3, QW|Radiological Progression|0|||
42230043|NCT02906670|76050528|FG006|Cohort 3, QW|Radiological Progression|0|||
42230044|NCT02906670|76050529|FG007|Cohort 3, QW|Radiological Progression|0|||
42230045|NCT02906670|76050530|FG008|Cohort 3, QW|Radiological Progression|0|||
42230046|NCT02906670|76050531|FG009|Cohort 3, QW|Radiological Progression|0|||
42230047|NCT02906670|76050522|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
42230048|NCT02906670|76050523|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
42230049|NCT02906670|76050524|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
42230050|NCT02906670|76050525|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
42230051|NCT02906670|76050526|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
42230052|NCT02906670|76050527|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
42230053|NCT02906670|76050528|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
42230054|NCT02906670|76050529|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
42230055|NCT02906670|76050530|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
42230056|NCT02906670|76050531|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
42230057|NCT02906670|76050522|FG000|Cohort 4, Q2W|Radiological Progression|0|||
42230058|NCT02906670|76050523|FG001|Cohort 4, Q2W|Radiological Progression|0|||
42230059|NCT02906670|76050524|FG002|Cohort 4, Q2W|Radiological Progression|0|||
42230060|NCT02906670|76050525|FG003|Cohort 4, Q2W|Radiological Progression|0|||
42230061|NCT02906670|76050526|FG004|Cohort 4, Q2W|Radiological Progression|0|||
42230062|NCT02906670|76050527|FG005|Cohort 4, Q2W|Radiological Progression|1|||
42230063|NCT02906670|76050528|FG006|Cohort 4, Q2W|Radiological Progression|0|||
42230064|NCT02906670|76050529|FG007|Cohort 4, Q2W|Radiological Progression|0|||
42230065|NCT02906670|76050530|FG008|Cohort 4, Q2W|Radiological Progression|0|||
42230066|NCT02906670|76050531|FG009|Cohort 4, Q2W|Radiological Progression|0|||
42230067|NCT02906670|76050522|FG000|Cohort 4, Q2W|Clinical Progression|0|||
42230068|NCT02906670|76050523|FG001|Cohort 4, Q2W|Clinical Progression|0|||
42230069|NCT02906670|76050524|FG002|Cohort 4, Q2W|Clinical Progression|0|||
42230070|NCT02906670|76050525|FG003|Cohort 4, Q2W|Clinical Progression|0|||
42230071|NCT02906670|76050526|FG004|Cohort 4, Q2W|Clinical Progression|0|||
42230072|NCT02906670|76050527|FG005|Cohort 4, Q2W|Clinical Progression|2|||
42230073|NCT02906670|76050528|FG006|Cohort 4, Q2W|Clinical Progression|0|||
42230074|NCT02906670|76050529|FG007|Cohort 4, Q2W|Clinical Progression|0|||
42230075|NCT02906670|76050530|FG008|Cohort 4, Q2W|Clinical Progression|0|||
42230076|NCT02906670|76050531|FG009|Cohort 4, Q2W|Clinical Progression|0|||
42230077|NCT02906670|76050522|FG000|Cohort 5, Q2W|Radiological Progression|0|||
42230078|NCT02906670|76050523|FG001|Cohort 5, Q2W|Radiological Progression|0|||
42230079|NCT02906670|76050524|FG002|Cohort 5, Q2W|Radiological Progression|0|||
42230080|NCT02906670|76050525|FG003|Cohort 5, Q2W|Radiological Progression|0|||
42230081|NCT02906670|76050526|FG004|Cohort 5, Q2W|Radiological Progression|0|||
42230082|NCT02906670|76050527|FG005|Cohort 5, Q2W|Radiological Progression|0|||
42230083|NCT02906670|76050528|FG006|Cohort 5, Q2W|Radiological Progression|4|||
42230084|NCT02906670|76050529|FG007|Cohort 5, Q2W|Radiological Progression|0|||
42230085|NCT02906670|76050530|FG008|Cohort 5, Q2W|Radiological Progression|0|||
42230086|NCT02906670|76050531|FG009|Cohort 5, Q2W|Radiological Progression|0|||
42230087|NCT02906670|76050522|FG000|Cohort 5, Q2W|Clinical Progression|0|||
42230088|NCT02906670|76050523|FG001|Cohort 5, Q2W|Clinical Progression|0|||
41986732|NCT04677179|75794037|FG000|Induction Treatment Period|Physician Decision|1|||
41986733|NCT04677179|75794038|FG001|Induction Treatment Period|Physician Decision|0|||
41986734|NCT04677179|75794039|FG002|Induction Treatment Period|Physician Decision|1|||
41986735|NCT04677179|75794040|FG003|Induction Treatment Period|Physician Decision|0|||
41986736|NCT04677179|75794041|FG004|Induction Treatment Period|Physician Decision|0|||
41986737|NCT04677179|75794042|FG005|Induction Treatment Period|Physician Decision|0|||
41986738|NCT04677179|75794043|FG006|Induction Treatment Period|Physician Decision|0|||
42230089|NCT02906670|76050524|FG002|Cohort 5, Q2W|Clinical Progression|0|||
41986739|NCT04677179|75794044|FG007|Induction Treatment Period|Physician Decision|0|||
42131764|NCT00304954|75942670|FG002|Overall Study|Adverse Event|0|||
42131765|NCT00304954|75942671|FG003|Overall Study|Adverse Event|0|||
42230090|NCT02906670|76050525|FG003|Cohort 5, Q2W|Clinical Progression|0|||
42230091|NCT02906670|76050526|FG004|Cohort 5, Q2W|Clinical Progression|0|||
42230092|NCT02906670|76050527|FG005|Cohort 5, Q2W|Clinical Progression|0|||
42230093|NCT02906670|76050528|FG006|Cohort 5, Q2W|Clinical Progression|1|||
42230094|NCT02906670|76050529|FG007|Cohort 5, Q2W|Clinical Progression|0|||
42230095|NCT02906670|76050530|FG008|Cohort 5, Q2W|Clinical Progression|0|||
42230096|NCT02906670|76050531|FG009|Cohort 5, Q2W|Clinical Progression|0|||
42230097|NCT02906670|76050522|FG000|Cohort 5, Q2W|Adverse Event|0|||
41986740|NCT04677179|75794045|FG008|Induction Treatment Period|Physician Decision|0|||
41986741|NCT04677179|75794046|FG009|Induction Treatment Period|Physician Decision|0|||
41986742|NCT04677179|75794037|FG000|Induction Treatment Period|Protocol Violation|0|||
41986743|NCT04677179|75794038|FG001|Induction Treatment Period|Protocol Violation|1|||
42230098|NCT02906670|76050523|FG001|Cohort 5, Q2W|Adverse Event|0|||
41986744|NCT04677179|75794039|FG002|Induction Treatment Period|Protocol Violation|0|||
41986745|NCT04677179|75794040|FG003|Induction Treatment Period|Protocol Violation|0|||
41986746|NCT04677179|75794041|FG004|Induction Treatment Period|Protocol Violation|0|||
41986747|NCT04677179|75794042|FG005|Induction Treatment Period|Protocol Violation|0|||
41986748|NCT04677179|75794043|FG006|Induction Treatment Period|Protocol Violation|0|||
41986749|NCT04677179|75794044|FG007|Induction Treatment Period|Protocol Violation|0|||
41986750|NCT04677179|75794045|FG008|Induction Treatment Period|Protocol Violation|0|||
41986751|NCT04677179|75794046|FG009|Induction Treatment Period|Protocol Violation|0|||
41986752|NCT04677179|75794037|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
42230099|NCT02906670|76050524|FG002|Cohort 5, Q2W|Adverse Event|0|||
42230100|NCT02906670|76050525|FG003|Cohort 5, Q2W|Adverse Event|0|||
42230101|NCT02906670|76050526|FG004|Cohort 5, Q2W|Adverse Event|0|||
42230102|NCT02906670|76050527|FG005|Cohort 5, Q2W|Adverse Event|0|||
42230103|NCT02906670|76050528|FG006|Cohort 5, Q2W|Adverse Event|1|||
42230104|NCT02906670|76050529|FG007|Cohort 5, Q2W|Adverse Event|0|||
42230105|NCT02906670|76050530|FG008|Cohort 5, Q2W|Adverse Event|0|||
42230106|NCT02906670|76050531|FG009|Cohort 5, Q2W|Adverse Event|0|||
42230107|NCT02906670|76050522|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
42230108|NCT02906670|76050523|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
42230109|NCT02906670|76050524|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
42230110|NCT02906670|76050525|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
42230111|NCT02906670|76050526|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
42230112|NCT02906670|76050527|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
42230113|NCT02906670|76050528|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
42230114|NCT02906670|76050529|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
42230115|NCT02906670|76050530|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
42230116|NCT02906670|76050531|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
42230117|NCT02906670|76050522|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
42230118|NCT02906670|76050523|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
42230119|NCT02906670|76050524|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
42230120|NCT02906670|76050525|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
42230121|NCT02906670|76050526|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
42230122|NCT02906670|76050527|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
42230123|NCT02906670|76050528|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
42230124|NCT02906670|76050529|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
42230125|NCT02906670|76050530|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
42230126|NCT02906670|76050531|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
42230127|NCT02906670|76050522|FG000|Cohort 5P, Q2W|Adverse Event|0|||
42230128|NCT02906670|76050523|FG001|Cohort 5P, Q2W|Adverse Event|0|||
42230129|NCT02906670|76050524|FG002|Cohort 5P, Q2W|Adverse Event|0|||
42230130|NCT02906670|76050525|FG003|Cohort 5P, Q2W|Adverse Event|0|||
42230131|NCT02906670|76050526|FG004|Cohort 5P, Q2W|Adverse Event|0|||
42230132|NCT02906670|76050527|FG005|Cohort 5P, Q2W|Adverse Event|0|||
42230133|NCT02906670|76050528|FG006|Cohort 5P, Q2W|Adverse Event|0|||
42230134|NCT02906670|76050529|FG007|Cohort 5P, Q2W|Adverse Event|1|||
42230135|NCT02906670|76050530|FG008|Cohort 5P, Q2W|Adverse Event|0|||
42230136|NCT02906670|76050531|FG009|Cohort 5P, Q2W|Adverse Event|0|||
42230137|NCT02906670|76050522|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
42230138|NCT02906670|76050523|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
42230139|NCT02906670|76050524|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
42230140|NCT02906670|76050525|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
42230141|NCT02906670|76050526|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
42230142|NCT02906670|76050527|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
42230143|NCT02906670|76050528|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
42230144|NCT02906670|76050529|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
42230145|NCT02906670|76050530|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
42230146|NCT02906670|76050531|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
42230147|NCT02906670|76050522|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
42230148|NCT02906670|76050523|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
42230149|NCT02906670|76050524|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
42230150|NCT02906670|76050525|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
42230151|NCT02906670|76050526|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
42230152|NCT02906670|76050527|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
42230153|NCT02906670|76050528|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
41986753|NCT04677179|75794038|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
42230154|NCT02906670|76050529|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
42230155|NCT02906670|76050530|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
41986754|NCT04677179|75794039|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
42230156|NCT02906670|76050531|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
42230157|NCT02906670|76050522|FG000|Cohort 4P, QW|Radiological Progression|0|||
42230158|NCT02906670|76050523|FG001|Cohort 4P, QW|Radiological Progression|0|||
42230159|NCT02906670|76050524|FG002|Cohort 4P, QW|Radiological Progression|0|||
41986755|NCT04677179|75794040|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
41986756|NCT04677179|75794041|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
41986757|NCT04677179|75794042|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
41986758|NCT04677179|75794043|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
41986759|NCT04677179|75794044|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
41986760|NCT04677179|75794045|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
41986761|NCT04677179|75794046|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
41986762|NCT04677179|75794037|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
41986763|NCT04677179|75794038|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
41986764|NCT04677179|75794039|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
41986765|NCT04677179|75794040|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
41986766|NCT04677179|75794041|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
41986767|NCT04677179|75794042|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
41986768|NCT04677179|75794043|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
41986769|NCT04677179|75794044|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
41986770|NCT04677179|75794045|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
41986771|NCT04677179|75794046|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
41986772|NCT04677179|75794037|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
41986773|NCT04677179|75794038|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
41986774|NCT04677179|75794039|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
41986775|NCT04677179|75794040|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
41986776|NCT04677179|75794041|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
41986777|NCT04677179|75794042|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
41986778|NCT04677179|75794043|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
41986779|NCT04677179|75794044|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
41986780|NCT04677179|75794045|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
41986781|NCT04677179|75794046|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
41986782|NCT04677179|75794037|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
41986783|NCT04677179|75794038|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
41986784|NCT04677179|75794039|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
41986785|NCT04677179|75794040|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
41986786|NCT04677179|75794041|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
41986787|NCT04677179|75794042|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
41986788|NCT04677179|75794043|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
41986789|NCT04677179|75794044|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
41986790|NCT04677179|75794045|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
41986791|NCT04677179|75794046|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
41986792|NCT04677179|75794037|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
41986793|NCT04677179|75794038|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
41986794|NCT04677179|75794039|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
41986795|NCT04677179|75794040|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
41986796|NCT04677179|75794041|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
41986797|NCT04677179|75794042|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
41986798|NCT04677179|75794043|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
41986799|NCT04677179|75794044|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
41986800|NCT04677179|75794045|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
41986801|NCT04677179|75794046|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
41986802|NCT04677179|75794037|FG000|Extension Treatment Period|Lack of Efficacy|0|||
41986803|NCT04677179|75794038|FG001|Extension Treatment Period|Lack of Efficacy|0|||
41986804|NCT04677179|75794039|FG002|Extension Treatment Period|Lack of Efficacy|0|||
41986805|NCT04677179|75794040|FG003|Extension Treatment Period|Lack of Efficacy|0|||
41986806|NCT04677179|75794041|FG004|Extension Treatment Period|Lack of Efficacy|0|||
41986807|NCT04677179|75794042|FG005|Extension Treatment Period|Lack of Efficacy|0|||
41986808|NCT04677179|75794043|FG006|Extension Treatment Period|Lack of Efficacy|6|||
41986809|NCT04677179|75794044|FG007|Extension Treatment Period|Lack of Efficacy|0|||
41986810|NCT04677179|75794045|FG008|Extension Treatment Period|Lack of Efficacy|0|||
41986811|NCT04677179|75794046|FG009|Extension Treatment Period|Lack of Efficacy|0|||
41986812|NCT04677179|75794037|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
41986813|NCT04677179|75794038|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
41986814|NCT04677179|75794039|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
41986815|NCT04677179|75794040|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
41986816|NCT04677179|75794041|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
41986817|NCT04677179|75794042|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
41986818|NCT04677179|75794043|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
41986819|NCT04677179|75794044|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
41986820|NCT04677179|75794045|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
41986821|NCT04677179|75794046|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
41986822|NCT04677179|75794037|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
42230160|NCT02906670|76050525|FG003|Cohort 4P, QW|Radiological Progression|3|||
42230161|NCT02906670|76050526|FG004|Cohort 4P, QW|Radiological Progression|0|||
42230162|NCT02906670|76050527|FG005|Cohort 4P, QW|Radiological Progression|0|||
41986823|NCT04677179|75794038|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
41986824|NCT04677179|75794039|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
42230163|NCT02906670|76050528|FG006|Cohort 4P, QW|Radiological Progression|0|||
42230164|NCT02906670|76050529|FG007|Cohort 4P, QW|Radiological Progression|0|||
42230165|NCT02906670|76050530|FG008|Cohort 4P, QW|Radiological Progression|0|||
42230166|NCT02906670|76050531|FG009|Cohort 4P, QW|Radiological Progression|0|||
42230167|NCT02906670|76050522|FG000|Cohort 7P, Q2W|Adverse Event|0|||
42230168|NCT02906670|76050523|FG001|Cohort 7P, Q2W|Adverse Event|0|||
42230169|NCT02906670|76050524|FG002|Cohort 7P, Q2W|Adverse Event|0|||
42230170|NCT02906670|76050525|FG003|Cohort 7P, Q2W|Adverse Event|0|||
42230171|NCT02906670|76050526|FG004|Cohort 7P, Q2W|Adverse Event|0|||
42230172|NCT02906670|76050527|FG005|Cohort 7P, Q2W|Adverse Event|0|||
42230173|NCT02906670|76050528|FG006|Cohort 7P, Q2W|Adverse Event|0|||
42230174|NCT02906670|76050529|FG007|Cohort 7P, Q2W|Adverse Event|0|||
41986825|NCT04677179|75794040|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
41986826|NCT04677179|75794041|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
42230175|NCT02906670|76050530|FG008|Cohort 7P, Q2W|Adverse Event|0|||
42230176|NCT02906670|76050531|FG009|Cohort 7P, Q2W|Adverse Event|1|||
42230177|NCT02906670|76050522|FG000|Cohort 7P, Q2W|Physician Decision|0|||
42230178|NCT02906670|76050523|FG001|Cohort 7P, Q2W|Physician Decision|0|||
42230179|NCT02906670|76050524|FG002|Cohort 7P, Q2W|Physician Decision|0|||
42230180|NCT02906670|76050525|FG003|Cohort 7P, Q2W|Physician Decision|0|||
42230181|NCT02906670|76050526|FG004|Cohort 7P, Q2W|Physician Decision|0|||
42230182|NCT02906670|76050527|FG005|Cohort 7P, Q2W|Physician Decision|0|||
42230183|NCT02906670|76050528|FG006|Cohort 7P, Q2W|Physician Decision|0|||
42230184|NCT02906670|76050529|FG007|Cohort 7P, Q2W|Physician Decision|0|||
42230185|NCT02906670|76050530|FG008|Cohort 7P, Q2W|Physician Decision|0|||
42230186|NCT02906670|76050531|FG009|Cohort 7P, Q2W|Physician Decision|1|||
42230187|NCT02906670|76050522|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
42230188|NCT02906670|76050523|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
42230189|NCT02906670|76050524|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
42230190|NCT02906670|76050525|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
42230191|NCT02906670|76050526|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
42230192|NCT02906670|76050527|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
42230193|NCT02906670|76050528|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
42230194|NCT02906670|76050529|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
42230195|NCT02906670|76050530|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
42230196|NCT02906670|76050531|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
42230197|NCT02906670|76050522|FG000|Cohort 5P, QW|Radiological Progression|0|||
42230198|NCT02906670|76050523|FG001|Cohort 5P, QW|Radiological Progression|0|||
42230199|NCT02906670|76050524|FG002|Cohort 5P, QW|Radiological Progression|0|||
42230200|NCT02906670|76050525|FG003|Cohort 5P, QW|Radiological Progression|0|||
42230201|NCT02906670|76050526|FG004|Cohort 5P, QW|Radiological Progression|3|||
42230202|NCT02906670|76050527|FG005|Cohort 5P, QW|Radiological Progression|0|||
42230203|NCT02906670|76050528|FG006|Cohort 5P, QW|Radiological Progression|0|||
42230204|NCT02906670|76050529|FG007|Cohort 5P, QW|Radiological Progression|0|||
42230205|NCT02906670|76050530|FG008|Cohort 5P, QW|Radiological Progression|0|||
42230206|NCT02906670|76050531|FG009|Cohort 5P, QW|Radiological Progression|0|||
42230207|NCT02906358|76050583|FG000|Overall Study|Withdrawal by Subject|10|||
42230208|NCT02906358|76050584|FG001|Overall Study|Withdrawal by Subject|7|||
42230209|NCT02906358|76050583|FG000|Overall Study|Lost to Follow-up|12|||
42230210|NCT02906358|76050584|FG001|Overall Study|Lost to Follow-up|15|||
42230211|NCT02186834|76050590|FG000|Dose Escalation|Death|0|||
42230212|NCT02186834|76050591|FG001|Dose Escalation|Death|0|||
42230213|NCT02186834|76050592|FG002|Dose Escalation|Death|0|||
42302514|NCT02447029|76137772|FG000|Overall Study|Withdrawal by Subject|3|||
41986827|NCT04677179|75794042|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
41986828|NCT04677179|75794043|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
41986829|NCT04677179|75794044|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
42010520|NCT00996307|75817647|FG000|Overall Study|Adverse Event|0|||
42230214|NCT02186834|76050593|FG003|Dose Escalation|Death|1|||
42230215|NCT02186834|76050594|FG004|Dose Escalation|Death|0|||
42230216|NCT02186834|76050595|FG005|Dose Escalation|Death|0|||
42302515|NCT02447029|76137773|FG001|Overall Study|Withdrawal by Subject|2|||
42302516|NCT02416453|76137790|FG000|Overall Study|Adverse Event|0|||
42302517|NCT02416453|76137791|FG001|Overall Study|Adverse Event|0|||
42230217|NCT02186834|76050590|FG000|Treatment at RP2D|Died prior to treatment|0|||
42230218|NCT02186834|76050591|FG001|Treatment at RP2D|Died prior to treatment|0|||
42230219|NCT02186834|76050592|FG002|Treatment at RP2D|Died prior to treatment|0|||
42230220|NCT02186834|76050593|FG003|Treatment at RP2D|Died prior to treatment|0|||
42230221|NCT02186834|76050594|FG004|Treatment at RP2D|Died prior to treatment|0|||
42302518|NCT02416453|76137792|FG002|Overall Study|Adverse Event|0|||
42302519|NCT02416453|76137793|FG003|Overall Study|Adverse Event|2|||
42230222|NCT02186834|76050595|FG005|Treatment at RP2D|Died prior to treatment|1|||
42230223|NCT03144687|76050606|FG000|Overall Study|Death|0|||
42230224|NCT03144687|76050607|FG001|Overall Study|Death|2|||
42230225|NCT03144687|76050606|FG000|Overall Study|Lost to Follow-up|0|||
42230226|NCT03144687|76050607|FG001|Overall Study|Lost to Follow-up|1|||
42230227|NCT03144687|76050606|FG000|Overall Study|Physician Decision|0|||
42230228|NCT03144687|76050607|FG001|Overall Study|Physician Decision|1|||
42230229|NCT03144687|76050606|FG000|Overall Study|Withdrawal by Subject|1|||
42230230|NCT03144687|76050607|FG001|Overall Study|Withdrawal by Subject|3|||
42230231|NCT03144687|76050606|FG000|Overall Study|Not Reported|2|||
42230232|NCT03144687|76050607|FG001|Overall Study|Not Reported|0|||
41986830|NCT04677179|75794045|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
41986831|NCT04677179|75794046|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
41986832|NCT04677179|75794037|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
41986833|NCT04677179|75794038|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
42230233|NCT03080961|76050617|FG000|Overall Study|Withdrawal by Subject|3|||
42230234|NCT02905266|76050641|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
42230235|NCT02905266|76050642|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
42230236|NCT02905266|76050641|FG000|Treatment Phase Part 1|Disease Progression|6|||
42230237|NCT02905266|76050642|FG001|Treatment Phase Part 1|Disease Progression|7|||
42230238|NCT02905266|76050641|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
42230239|NCT02905266|76050642|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
42230240|NCT02905266|76050641|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
42230241|NCT02905266|76050642|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
42230242|NCT02905266|76050641|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
42230243|NCT02905266|76050642|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
42230244|NCT02905266|76050641|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
42230245|NCT02905266|76050642|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
42230246|NCT02905266|76050641|FG000|Transition From Part 1 to Part 2|Death|0|||
42230247|NCT02905266|76050642|FG001|Transition From Part 1 to Part 2|Death|1|||
42230248|NCT02905266|76050641|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
42230249|NCT02905266|76050642|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
42230250|NCT02905266|76050641|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
42230251|NCT02905266|76050642|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
42230252|NCT02905266|76050641|FG000|Maintenance Phase Part 2|Disease Progression|9|||
42230253|NCT02905266|76050642|FG001|Maintenance Phase Part 2|Disease Progression|2|||
42230254|NCT02905266|76050641|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
42230255|NCT02905266|76050642|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
42230256|NCT02905266|76050641|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
42230257|NCT02905266|76050642|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
42230258|NCT02982018|76050650|FG000|Overall Study|Incorrect Lens Dispensed|1|||
42230259|NCT02982018|76050651|FG001|Overall Study|Incorrect Lens Dispensed|0|||
42230260|NCT02982018|76050650|FG000|Overall Study|Protocol Violation|1|||
42230261|NCT02982018|76050651|FG001|Overall Study|Protocol Violation|1|||
42230262|NCT02982018|76050650|FG000|Overall Study|Adverse Event|1|||
42230263|NCT02982018|76050651|FG001|Overall Study|Adverse Event|1|||
41986834|NCT04677179|75794039|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
41986835|NCT04677179|75794040|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
41986836|NCT04677179|75794041|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
41986837|NCT04677179|75794042|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
41986838|NCT04677179|75794043|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
41986839|NCT04677179|75794044|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
41986840|NCT04677179|75794045|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
41986841|NCT04677179|75794046|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
41986842|NCT04677179|75794037|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
41986843|NCT04677179|75794038|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
41986844|NCT04677179|75794039|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
41986845|NCT04677179|75794040|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
42131766|NCT00475176|75942689|FG000|Overall Study|Adverse Event|2|||
42230264|NCT02982018|76050650|FG000|Overall Study|Lens Discomfort|2|||
42230265|NCT02982018|76050651|FG001|Overall Study|Lens Discomfort|0|||
42230266|NCT02982018|76050650|FG000|Overall Study|Withdrawal by Subject|0|||
42230267|NCT02982018|76050651|FG001|Overall Study|Withdrawal by Subject|1|||
42230268|NCT03080493|76050659|FG000|Overall Study|Did not provide NRS pain results|1|||
42230269|NCT03080493|76050660|FG001|Overall Study|Did not provide NRS pain results|0|||
42230270|NCT03080493|76050659|FG000|Overall Study|Adverse Event|0|||
42230271|NCT03080493|76050660|FG001|Overall Study|Adverse Event|1|||
42230272|NCT03080493|76050659|FG000|Overall Study|Randomization error (parity group)|0|||
42230273|NCT03080493|76050660|FG001|Overall Study|Randomization error (parity group)|1|||
42230274|NCT01339910|76050668|FG000|Overall Study|Withdrawal by Subject|1|||
41986846|NCT04677179|75794041|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
42230275|NCT01339910|76050669|FG001|Overall Study|Withdrawal by Subject|0|||
42230276|NCT01339910|76050668|FG000|Overall Study|Physician Decision|1|||
42230277|NCT01339910|76050669|FG001|Overall Study|Physician Decision|0|||
42230278|NCT01339910|76050668|FG000|Overall Study|Disease relapse|1|||
42230279|NCT01339910|76050669|FG001|Overall Study|Disease relapse|4|||
42230280|NCT02981082|76050677|FG000|Overall Study|Withdrawal by Subject|2|||
42230281|NCT02981082|76050678|FG001|Overall Study|Withdrawal by Subject|0|||
42230282|NCT02981082|76050677|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
42230283|NCT02981082|76050678|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
42230284|NCT02981082|76050677|FG000|Overall Study|Adverse Event|0|||
42230285|NCT02981082|76050678|FG001|Overall Study|Adverse Event|1|||
42230286|NCT01066104|76050686|FG000|Overall Study|Adverse Event|1|||
42230287|NCT01066104|76050687|FG001|Overall Study|Adverse Event|1|||
42230288|NCT01066104|76050686|FG000|Overall Study|Protocol Violation|1|||
42230289|NCT01066104|76050687|FG001|Overall Study|Protocol Violation|0|||
42230290|NCT02736968|76050698|FG000|Overall Study|Lost to Follow-up|0|||
42230291|NCT02736968|76050699|FG001|Overall Study|Lost to Follow-up|0|||
42230292|NCT02736968|76050700|FG002|Overall Study|Lost to Follow-up|0|||
42230293|NCT02736968|76050701|FG003|Overall Study|Lost to Follow-up|0|||
42230294|NCT02736968|76050702|FG004|Overall Study|Lost to Follow-up|0|||
42230295|NCT02736968|76050703|FG005|Overall Study|Lost to Follow-up|0|||
42230296|NCT02736968|76050704|FG006|Overall Study|Lost to Follow-up|5|||
42230297|NCT02736968|76050705|FG007|Overall Study|Lost to Follow-up|2|||
42230298|NCT02736968|76050698|FG000|Overall Study|COVID-19 Pandemic|0|||
42230299|NCT02736968|76050699|FG001|Overall Study|COVID-19 Pandemic|0|||
42230300|NCT02736968|76050700|FG002|Overall Study|COVID-19 Pandemic|0|||
42230301|NCT02736968|76050701|FG003|Overall Study|COVID-19 Pandemic|0|||
42230302|NCT02736968|76050702|FG004|Overall Study|COVID-19 Pandemic|0|||
42230303|NCT02736968|76050703|FG005|Overall Study|COVID-19 Pandemic|0|||
42230304|NCT02736968|76050704|FG006|Overall Study|COVID-19 Pandemic|2|||
42230305|NCT02736968|76050705|FG007|Overall Study|COVID-19 Pandemic|0|||
42230306|NCT02736968|76050698|FG000|Overall Study|Withdrawal by Subject|0|||
42230307|NCT02736968|76050699|FG001|Overall Study|Withdrawal by Subject|0|||
42230308|NCT02736968|76050700|FG002|Overall Study|Withdrawal by Subject|0|||
42230309|NCT02736968|76050701|FG003|Overall Study|Withdrawal by Subject|0|||
42230310|NCT02736968|76050702|FG004|Overall Study|Withdrawal by Subject|0|||
42230311|NCT02736968|76050703|FG005|Overall Study|Withdrawal by Subject|0|||
42230312|NCT02736968|76050704|FG006|Overall Study|Withdrawal by Subject|1|||
42230313|NCT02736968|76050705|FG007|Overall Study|Withdrawal by Subject|0|||
42230314|NCT02980224|76050718|FG000|Overall Study|Adverse Event|4|||
42230315|NCT02980224|76050719|FG001|Overall Study|Adverse Event|1|||
42230316|NCT02980224|76050718|FG000|Overall Study|Withdrawal by Subject|0|||
42230317|NCT02980224|76050719|FG001|Overall Study|Withdrawal by Subject|2|||
42230318|NCT02591615|76050729|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
42230319|NCT02591615|76050730|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
42230320|NCT02591615|76050731|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
42230321|NCT02591615|76050732|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
42230322|NCT02591615|76050729|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
42230323|NCT02591615|76050730|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
42230324|NCT02591615|76050731|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
42230325|NCT02591615|76050732|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
42230326|NCT02591615|76050729|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
42230327|NCT02591615|76050730|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
42230328|NCT02591615|76050731|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
42230329|NCT02591615|76050732|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
42230330|NCT02591615|76050729|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
42230331|NCT02591615|76050730|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
42230332|NCT02591615|76050731|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
42230333|NCT02591615|76050732|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
42230334|NCT02591615|76050729|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
42230335|NCT02591615|76050730|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
42230336|NCT02591615|76050731|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
42230337|NCT02591615|76050732|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
42230338|NCT02591615|76050729|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
42230339|NCT02591615|76050730|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
42230340|NCT02591615|76050731|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
42230341|NCT02591615|76050732|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
42230342|NCT02591615|76050729|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
42230343|NCT02591615|76050730|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
42230344|NCT02591615|76050731|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
42230345|NCT02591615|76050732|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
42230346|NCT02591615|76050729|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
42230347|NCT02591615|76050730|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
42230348|NCT02591615|76050731|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
42230349|NCT02591615|76050732|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
42230350|NCT02591615|76050729|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
42230351|NCT02591615|76050730|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
42230352|NCT02591615|76050731|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
42230353|NCT02591615|76050732|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
42230354|NCT02591615|76050729|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
42230355|NCT02591615|76050730|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
42230356|NCT02591615|76050731|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
42230357|NCT02591615|76050732|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
42230358|NCT02591615|76050729|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
42230359|NCT02591615|76050730|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
42230360|NCT02591615|76050731|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
42230361|NCT02591615|76050732|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
42230362|NCT02591615|76050729|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
42230363|NCT02591615|76050730|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
42230364|NCT02591615|76050731|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
42230365|NCT02591615|76050732|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
42230366|NCT02591615|76050729|FG000|Maintenance MK-3475|Adverse Event|0|||
42230367|NCT02591615|76050730|FG001|Maintenance MK-3475|Adverse Event|3|||
42230368|NCT02591615|76050731|FG002|Maintenance MK-3475|Adverse Event|1|||
42230369|NCT02591615|76050732|FG003|Maintenance MK-3475|Adverse Event|2|||
42230370|NCT02591615|76050729|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
42230371|NCT02591615|76050730|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
42230372|NCT02591615|76050731|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
42230373|NCT02591615|76050732|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
42230374|NCT02591615|76050729|FG000|Maintenance MK-3475|Death|0|||
42230375|NCT02591615|76050730|FG001|Maintenance MK-3475|Death|1|||
42230376|NCT02591615|76050731|FG002|Maintenance MK-3475|Death|1|||
42230377|NCT02591615|76050732|FG003|Maintenance MK-3475|Death|0|||
42230378|NCT02591615|76050729|FG000|Maintenance MK-3475|Physician discretion|0|||
42230379|NCT02591615|76050730|FG001|Maintenance MK-3475|Physician discretion|0|||
42230380|NCT02591615|76050731|FG002|Maintenance MK-3475|Physician discretion|1|||
42230381|NCT02591615|76050732|FG003|Maintenance MK-3475|Physician discretion|0|||
42230382|NCT02591615|76050729|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
42230383|NCT02591615|76050730|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
42230384|NCT02591615|76050731|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
42230385|NCT02591615|76050732|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
42230386|NCT02591615|76050729|FG000|Maintenance MK-3475|In active treatment|2|||
42230387|NCT02591615|76050730|FG001|Maintenance MK-3475|In active treatment|0|||
42230388|NCT02591615|76050731|FG002|Maintenance MK-3475|In active treatment|0|||
42032513|NCT00951015|75840754|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
42032514|NCT00951015|75840755|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
42032515|NCT00951015|75840751|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
42032516|NCT00951015|75840752|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
42032517|NCT00951015|75840753|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
42032518|NCT00951015|75840754|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
42230389|NCT02591615|76050732|FG003|Maintenance MK-3475|In active treatment|1|||
42230390|NCT03077607|76050747|FG000|Period 1 (15 Days)|Adverse Event|1|||
42230391|NCT03077607|76050748|FG001|Period 1 (15 Days)|Adverse Event|0|||
42230392|NCT03077607|76050747|FG000|Period 1 (15 Days)|Death|1|||
42230393|NCT03077607|76050748|FG001|Period 1 (15 Days)|Death|0|||
42230394|NCT03077607|76050747|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
42230395|NCT03077607|76050748|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
42230396|NCT03077607|76050747|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
42230397|NCT03077607|76050748|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
42230398|NCT02977572|76050767|FG000|Overall Study|Exclusion criterion|2|||
42230399|NCT02977572|76050768|FG001|Overall Study|Exclusion criterion|2|||
42230400|NCT02746874|76050780|FG000|Overall Study|Withdrawal by Subject|0|||
42230401|NCT02746874|76050781|FG001|Overall Study|Withdrawal by Subject|1|||
41986847|NCT04677179|75794042|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
41986848|NCT04677179|75794043|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
41986849|NCT04677179|75794044|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
41986850|NCT04677179|75794045|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
41986851|NCT04677179|75794046|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
41986852|NCT04677179|75794037|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
41986853|NCT04677179|75794038|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
41986854|NCT04677179|75794039|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
42230402|NCT02746874|76050780|FG000|Overall Study|Surgery Date Changed|0|||
42230403|NCT02746874|76050781|FG001|Overall Study|Surgery Date Changed|2|||
42230404|NCT03217175|76050787|FG000|Overall Study|Physician Decision|4|||
42230405|NCT03217175|76050788|FG001|Overall Study|Physician Decision|1|||
42230406|NCT01062126|76050794|FG000|Overall Study|Death|209|||
42230407|NCT01062126|76050794|FG000|Overall Study|All Withdrawals|324|||
42230408|NCT02522429|76050798|FG000|Overall Study|Lost to Follow-up|8|||
42230409|NCT02522429|76050798|FG000|Overall Study|Adverse Event|2|||
42230410|NCT02522429|76050798|FG000|Overall Study|Death|1|||
42230411|NCT02522429|76050798|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
42230412|NCT02974140|76050802|FG000|Overall Study|Adverse Event|2|||
42230413|NCT02974140|76050802|FG000|Overall Study|Lost to Follow-up|1|||
42230414|NCT02974140|76050802|FG000|Overall Study|Study Terminated by Sponsor|36|||
42230415|NCT02974842|76050809|FG000|Overall Study|Withdrawal by Subject|4|||
42230416|NCT02974842|76050809|FG000|Overall Study|Screen failures|4|||
42230417|NCT03172481|76050815|FG000|Double-blind|Withdrawal by Subject|1|||
42230418|NCT03172481|76050816|FG001|Double-blind|Withdrawal by Subject|0|||
42230419|NCT02855450|76050824|FG000|Overall Study|Adverse Event|1|||
42230420|NCT02855450|76050825|FG001|Overall Study|Adverse Event|0|||
42230421|NCT02855450|76050824|FG000|Overall Study|Lost to Follow-up|4|||
42230422|NCT02855450|76050825|FG001|Overall Study|Lost to Follow-up|0|||
42230423|NCT03172325|76050833|FG000|Overall Study|Adverse Event|2|||
42230424|NCT03172325|76050834|FG001|Overall Study|Adverse Event|3|||
42230425|NCT03172325|76050833|FG000|Overall Study|Positive PPD|1|||
42230426|NCT03172325|76050834|FG001|Overall Study|Positive PPD|0|||
42230427|NCT03172325|76050833|FG000|Overall Study|Poor Compliance|1|||
42230428|NCT03172325|76050834|FG001|Overall Study|Poor Compliance|1|||
42230429|NCT03085017|76050842|FG000|Overall Study|Death|0|||
42230430|NCT03085017|76050843|FG001|Overall Study|Death|3|||
42230431|NCT03215771|76050849|FG000|Overall Study|Withdrawal by Subject|2|||
42230432|NCT03215771|76050849|FG000|Overall Study|Physician Decision|1|||
42230433|NCT02745392|76050858|FG000|Overall Study|Lost to Follow-up|0|||
42230434|NCT02745392|76050859|FG001|Overall Study|Lost to Follow-up|1|||
42230435|NCT02745392|76050860|FG002|Overall Study|Lost to Follow-up|0|||
42230436|NCT02745392|76050861|FG003|Overall Study|Lost to Follow-up|0|||
42230437|NCT03076515|76050873|FG000|Overall Study|DMC decision based on interim analysis|25|||
42230438|NCT03076515|76050874|FG001|Overall Study|DMC decision based on interim analysis|29|||
42230439|NCT03170609|76050887|FG000|Overall Study|Death|0|||
42230440|NCT03170609|76050888|FG001|Overall Study|Death|0|||
42230441|NCT03170609|76050889|FG002|Overall Study|Death|1|||
42230442|NCT03170609|76050890|FG003|Overall Study|Death|0|||
42230443|NCT03170609|76050891|FG004|Overall Study|Death|0|||
42230444|NCT03170609|76050892|FG005|Overall Study|Death|0|||
42230445|NCT03170609|76050893|FG006|Overall Study|Death|0|||
42230446|NCT03170609|76050887|FG000|Overall Study|Withdrawal by Subject|1|||
42230447|NCT03170609|76050888|FG001|Overall Study|Withdrawal by Subject|2|||
42230448|NCT03170609|76050889|FG002|Overall Study|Withdrawal by Subject|0|||
42230449|NCT03170609|76050890|FG003|Overall Study|Withdrawal by Subject|0|||
42230450|NCT03170609|76050891|FG004|Overall Study|Withdrawal by Subject|0|||
42230451|NCT03170609|76050892|FG005|Overall Study|Withdrawal by Subject|0|||
42230452|NCT03170609|76050893|FG006|Overall Study|Withdrawal by Subject|1|||
42230453|NCT03170609|76050887|FG000|Overall Study|Lost to Follow-up|1|||
42230454|NCT03170609|76050888|FG001|Overall Study|Lost to Follow-up|0|||
42230455|NCT03170609|76050889|FG002|Overall Study|Lost to Follow-up|5|||
42230456|NCT03170609|76050890|FG003|Overall Study|Lost to Follow-up|2|||
42230457|NCT03170609|76050891|FG004|Overall Study|Lost to Follow-up|1|||
41986855|NCT04677179|75794040|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
41986856|NCT04677179|75794041|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
41986857|NCT04677179|75794042|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
42230458|NCT03170609|76050892|FG005|Overall Study|Lost to Follow-up|1|||
41986858|NCT04677179|75794043|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
41986859|NCT04677179|75794044|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
41986860|NCT04677179|75794045|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
41986861|NCT04677179|75794046|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
41986862|NCT04677179|75794037|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
41986863|NCT04677179|75794038|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
41986864|NCT04677179|75794039|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
42032519|NCT00951015|75840755|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
42230459|NCT03170609|76050893|FG006|Overall Study|Lost to Follow-up|0|||
41986865|NCT04677179|75794040|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
42230460|NCT03170609|76050887|FG000|Overall Study|Other|1|||
42230461|NCT03170609|76050888|FG001|Overall Study|Other|0|||
42230462|NCT03170609|76050889|FG002|Overall Study|Other|0|||
42230463|NCT03170609|76050890|FG003|Overall Study|Other|0|||
42230464|NCT03170609|76050891|FG004|Overall Study|Other|0|||
42230465|NCT03170609|76050892|FG005|Overall Study|Other|1|||
42230466|NCT03170609|76050893|FG006|Overall Study|Other|0|||
42230467|NCT01141712|76050909|FG000|Overall Study|Disease progression|3|||
42230468|NCT03219333|76050919|FG000|Overall Study|Withdrawal by Subject|8|||
42230469|NCT03219333|76050920|FG001|Overall Study|Withdrawal by Subject|3|||
42230470|NCT03219333|76050919|FG000|Overall Study|Lost to Follow-up|1|||
42230471|NCT03219333|76050920|FG001|Overall Study|Lost to Follow-up|0|||
42230472|NCT03219333|76050919|FG000|Overall Study|Death|94|||
42230473|NCT03219333|76050920|FG001|Overall Study|Death|44|||
42230474|NCT03219333|76050919|FG000|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
42230475|NCT03219333|76050920|FG001|Overall Study|Includes 4 participants who were enrolled and never received study treatment.|2|||
42230476|NCT03168867|76050928|FG000|Overall Study|Withdrawal by Subject|1|||
42230477|NCT03168867|76050929|FG001|Overall Study|Withdrawal by Subject|5|||
42230478|NCT01064622|76050938|FG000|Randomized Phase II|Withdrawal by Subject|2|||
42230479|NCT01064622|76050939|FG001|Randomized Phase II|Withdrawal by Subject|2|||
42230480|NCT01064622|76050938|FG000|Randomized Phase II|Protocol Violation|0|||
42230481|NCT01064622|76050939|FG001|Randomized Phase II|Protocol Violation|1|||
42230482|NCT04163718|76050948|FG000|Overall Study|Study terminated|12|||
42230483|NCT01063764|76050952|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
42230484|NCT01063764|76050952|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
42230485|NCT01063764|76050952|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
42230486|NCT01063764|76050952|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
42230487|NCT01063764|76050952|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
42230488|NCT01063764|76050952|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
42230489|NCT01063764|76050952|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
42230490|NCT03075891|76050962|FG000|Overall Study|Withdrawal by Subject|3|||
42230491|NCT03075891|76050963|FG001|Overall Study|Withdrawal by Subject|6|||
42230492|NCT03075891|76050962|FG000|Overall Study|Lost to Follow-up|1|||
42230493|NCT03075891|76050963|FG001|Overall Study|Lost to Follow-up|0|||
42230494|NCT03075891|76050962|FG000|Overall Study|Pregnancy|3|||
42230495|NCT03075891|76050963|FG001|Overall Study|Pregnancy|1|||
42230496|NCT03075891|76050962|FG000|Overall Study|visits not performed (no time)|1|||
42230497|NCT03075891|76050963|FG001|Overall Study|visits not performed (no time)|0|||
42230498|NCT03075891|76050962|FG000|Overall Study|Drug abuse relapse issue|0|||
42230499|NCT03075891|76050963|FG001|Overall Study|Drug abuse relapse issue|1|||
42230500|NCT03075891|76050962|FG000|Overall Study|Participant requiring study withdrawal|0|||
42230501|NCT03075891|76050963|FG001|Overall Study|Participant requiring study withdrawal|1|||
42230502|NCT03075891|76050962|FG000|Overall Study|Adverse event, non-fatal|1|||
42230503|NCT03075891|76050963|FG001|Overall Study|Adverse event, non-fatal|4|||
42230504|NCT02013167|76050973|FG000|Overall Study|Withdrawal by Subject|15|||
42230505|NCT02013167|76050974|FG001|Overall Study|Withdrawal by Subject|14|||
42230506|NCT02013167|76050973|FG000|Overall Study|Sponsor Decision|1|||
42230507|NCT02013167|76050974|FG001|Overall Study|Sponsor Decision|3|||
42230508|NCT02013167|76050973|FG000|Overall Study|Lost to Follow-up|0|||
42230509|NCT02013167|76050974|FG001|Overall Study|Lost to Follow-up|1|||
42230510|NCT02013167|76050973|FG000|Overall Study|Death|85|||
42230511|NCT02013167|76050974|FG001|Overall Study|Death|160|||
42230512|NCT01063062|76050983|FG000|Overall Study|Patient withdrew consent|0|||
42230513|NCT01063062|76050984|FG001|Overall Study|Patient withdrew consent|1|||
42230514|NCT01063062|76050983|FG000|Overall Study|Adverse Event|2|||
42230515|NCT01063062|76050984|FG001|Overall Study|Adverse Event|4|||
42230516|NCT01063062|76050983|FG000|Overall Study|Protocol Violation|5|||
42230517|NCT01063062|76050984|FG001|Overall Study|Protocol Violation|4|||
42230518|NCT01063062|76050983|FG000|Overall Study|Investigator's request|1|||
42230519|NCT01063062|76050984|FG001|Overall Study|Investigator's request|0|||
42230520|NCT01063062|76050983|FG000|Overall Study|Lost to Follow-up|0|||
42230521|NCT01063062|76050984|FG001|Overall Study|Lost to Follow-up|2|||
42230522|NCT01063062|76050983|FG000|Overall Study|Miscellaneous reason|0|||
42230523|NCT01063062|76050984|FG001|Overall Study|Miscellaneous reason|1|||
42230524|NCT02973048|76050993|FG000|Overall Study|Epidural catheter insertion failure|1|||
42230525|NCT02973048|76050994|FG001|Overall Study|Epidural catheter insertion failure|0|||
42230526|NCT02973048|76050993|FG000|Overall Study|Withdrawal by Subject|0|||
42230527|NCT02973048|76050994|FG001|Overall Study|Withdrawal by Subject|3|||
42230528|NCT02932943|76051002|FG000|Overall Study|Lost to Follow-up|0|||
42230529|NCT02932943|76051003|FG001|Overall Study|Lost to Follow-up|2|||
42230530|NCT02932943|76051002|FG000|Overall Study|Adverse Event|2|||
42230531|NCT02932943|76051003|FG001|Overall Study|Adverse Event|2|||
42032520|NCT00951015|75840751|FG000|Open-label Phase|Adverse Event|0|||
42032521|NCT00951015|75840752|FG001|Open-label Phase|Adverse Event|0|||
42230532|NCT02932943|76051002|FG000|Overall Study|Withdrawal by Subject|3|||
42230533|NCT02932943|76051003|FG001|Overall Study|Withdrawal by Subject|3|||
42230534|NCT02972658|76051028|FG000|Overall Study|Adverse Event|0|||
42230535|NCT02972658|76051029|FG001|Overall Study|Adverse Event|3|||
42230536|NCT02972658|76051030|FG002|Overall Study|Adverse Event|0|||
42230537|NCT02972658|76051031|FG003|Overall Study|Adverse Event|2|||
42230538|NCT02972658|76051028|FG000|Overall Study|Other-determined by Investigator|1|||
42230539|NCT02972658|76051029|FG001|Overall Study|Other-determined by Investigator|1|||
42230540|NCT02972658|76051030|FG002|Overall Study|Other-determined by Investigator|0|||
42230541|NCT02972658|76051031|FG003|Overall Study|Other-determined by Investigator|0|||
42230542|NCT02972658|76051028|FG000|Overall Study|Death|0|||
42230543|NCT02972658|76051029|FG001|Overall Study|Death|0|||
42230544|NCT02972658|76051030|FG002|Overall Study|Death|0|||
42230545|NCT02972658|76051031|FG003|Overall Study|Death|1|||
42230546|NCT02972658|76051028|FG000|Overall Study|Lost to Follow-up|0|||
42230547|NCT02972658|76051029|FG001|Overall Study|Lost to Follow-up|1|||
42230548|NCT02972658|76051030|FG002|Overall Study|Lost to Follow-up|1|||
42230549|NCT02972658|76051031|FG003|Overall Study|Lost to Follow-up|2|||
42230550|NCT02972658|76051028|FG000|Overall Study|Progressive Disease|0|||
42230551|NCT02972658|76051029|FG001|Overall Study|Progressive Disease|1|||
42230552|NCT02972658|76051030|FG002|Overall Study|Progressive Disease|0|||
42230553|NCT02972658|76051031|FG003|Overall Study|Progressive Disease|1|||
42230554|NCT02972658|76051028|FG000|Overall Study|Withdrawal by Subject|4|||
42230555|NCT02972658|76051029|FG001|Overall Study|Withdrawal by Subject|4|||
41986866|NCT04677179|75794041|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
42230556|NCT02972658|76051030|FG002|Overall Study|Withdrawal by Subject|1|||
42230557|NCT02972658|76051031|FG003|Overall Study|Withdrawal by Subject|6|||
42230558|NCT02972658|76051028|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
42230559|NCT02972658|76051029|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
42230560|NCT02972658|76051030|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
42230561|NCT02972658|76051031|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
42230562|NCT02972658|76051028|FG000|Overall Study|Sponsor Decision|70|||
42230563|NCT02972658|76051029|FG001|Overall Study|Sponsor Decision|127|||
42230564|NCT02972658|76051030|FG002|Overall Study|Sponsor Decision|72|||
42230565|NCT02972658|76051031|FG003|Overall Study|Sponsor Decision|119|||
42230566|NCT02853032|76051043|FG000|Overall Study|Adverse Event|4|||
42230567|NCT02853032|76051044|FG001|Overall Study|Adverse Event|0|||
42230568|NCT02853032|76051043|FG000|Overall Study|Withdrawal by Subject|3|||
42230569|NCT02853032|76051044|FG001|Overall Study|Withdrawal by Subject|1|||
42230570|NCT02853032|76051043|FG000|Overall Study|Requested to withdraw from all treatment|2|||
42230571|NCT02853032|76051044|FG001|Overall Study|Requested to withdraw from all treatment|2|||
42230572|NCT02232087|76051052|FG000|Overall Study|Withdrawal by Subject|2|||
42230573|NCT02232087|76051053|FG001|Overall Study|Withdrawal by Subject|0|||
42230574|NCT02232087|76051054|FG002|Overall Study|Withdrawal by Subject|0|||
42230575|NCT02232087|76051055|FG003|Overall Study|Withdrawal by Subject|0|||
42230576|NCT02232087|76051056|FG004|Overall Study|Withdrawal by Subject|0|||
42230577|NCT02232087|76051057|FG005|Overall Study|Withdrawal by Subject|1|||
42230578|NCT02232087|76051052|FG000|Overall Study|poor inhalation technique|0|||
41986867|NCT04677179|75794042|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
41986868|NCT04677179|75794043|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
41986869|NCT04677179|75794044|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
41986870|NCT04677179|75794045|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
42032522|NCT00951015|75840753|FG002|Open-label Phase|Adverse Event|0|||
42032523|NCT00951015|75840754|FG003|Open-label Phase|Adverse Event|0|||
41986871|NCT04677179|75794046|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
41986872|NCT04677179|75794037|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
41986873|NCT04677179|75794038|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
41986874|NCT04677179|75794039|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
41986875|NCT04677179|75794040|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
41986876|NCT04677179|75794041|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
41986877|NCT04677179|75794042|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
41986878|NCT04677179|75794043|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
41986879|NCT04677179|75794044|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
41986880|NCT04677179|75794045|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
41986881|NCT04677179|75794046|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
42032524|NCT00951015|75840755|FG004|Open-label Phase|Adverse Event|3|||
42032525|NCT00951015|75840751|FG000|Open-label Phase|Lack of Efficacy|0|||
42032526|NCT00951015|75840752|FG001|Open-label Phase|Lack of Efficacy|0|||
42032527|NCT00951015|75840753|FG002|Open-label Phase|Lack of Efficacy|0|||
42032528|NCT00951015|75840754|FG003|Open-label Phase|Lack of Efficacy|0|||
42032529|NCT00951015|75840755|FG004|Open-label Phase|Lack of Efficacy|1|||
42032530|NCT00951015|75840751|FG000|Open-label Phase|Protocol Violation|0|||
42032531|NCT00951015|75840752|FG001|Open-label Phase|Protocol Violation|0|||
42032532|NCT00951015|75840753|FG002|Open-label Phase|Protocol Violation|0|||
42032533|NCT00951015|75840754|FG003|Open-label Phase|Protocol Violation|0|||
42032534|NCT00951015|75840755|FG004|Open-label Phase|Protocol Violation|12|||
42032535|NCT00951015|75840751|FG000|Open-label Phase|Lost to Follow-up|0|||
42230579|NCT02232087|76051053|FG001|Overall Study|poor inhalation technique|1|||
42230580|NCT02232087|76051054|FG002|Overall Study|poor inhalation technique|0|||
42230581|NCT02232087|76051055|FG003|Overall Study|poor inhalation technique|0|||
42230582|NCT02232087|76051056|FG004|Overall Study|poor inhalation technique|0|||
42032536|NCT00951015|75840752|FG001|Open-label Phase|Lost to Follow-up|0|||
42032537|NCT00951015|75840753|FG002|Open-label Phase|Lost to Follow-up|0|||
42131767|NCT00475176|75942689|FG000|Overall Study|Withdrawal by Subject|1|||
42131768|NCT00475176|75942689|FG000|Overall Study|Protocol Violation|1|||
42230583|NCT02232087|76051057|FG005|Overall Study|poor inhalation technique|2|||
42230584|NCT02232087|76051052|FG000|Overall Study|protocol stop criteria|0|||
42230585|NCT02232087|76051053|FG001|Overall Study|protocol stop criteria|1|||
42230586|NCT02232087|76051054|FG002|Overall Study|protocol stop criteria|0|||
42230587|NCT02232087|76051055|FG003|Overall Study|protocol stop criteria|1|||
42230588|NCT02232087|76051056|FG004|Overall Study|protocol stop criteria|0|||
42230589|NCT02232087|76051057|FG005|Overall Study|protocol stop criteria|0|||
42230590|NCT02232087|76051052|FG000|Overall Study|Adverse Event|0|||
42230591|NCT02232087|76051053|FG001|Overall Study|Adverse Event|0|||
42230592|NCT02232087|76051054|FG002|Overall Study|Adverse Event|0|||
42230593|NCT02232087|76051055|FG003|Overall Study|Adverse Event|0|||
42230594|NCT02232087|76051056|FG004|Overall Study|Adverse Event|1|||
42230595|NCT02232087|76051057|FG005|Overall Study|Adverse Event|0|||
42230596|NCT03168425|76051078|FG000|Overall Study|Lost to Follow-up|5|||
42230597|NCT03168425|76051079|FG001|Overall Study|Lost to Follow-up|8|||
42230598|NCT03168425|76051078|FG000|Overall Study|unable to confirm post op opioids|2|||
42230599|NCT03168425|76051079|FG001|Overall Study|unable to confirm post op opioids|3|||
42230600|NCT00004445|76051086|FG000|Overall Study|Physician Decision|2|||
42230601|NCT00004445|76051086|FG000|Overall Study|Withdrawal by Subject|1|||
42230602|NCT02972502|76051092|FG000|Overall Study|Lost to Follow-up|3|||
42230603|NCT02972502|76051093|FG001|Overall Study|Lost to Follow-up|1|||
42230604|NCT02972502|76051092|FG000|Overall Study|Withdrawal by Subject|1|||
42230605|NCT02972502|76051093|FG001|Overall Study|Withdrawal by Subject|1|||
42230606|NCT02971800|76051099|FG000|Overall Study|Protocol Violation|1|||
42230607|NCT02971800|76051099|FG000|Overall Study|Withdrawal by Subject|1|||
42230608|NCT02971800|76051099|FG000|Overall Study|Exclusion criteria prior intervention|1|||
42230609|NCT02971800|76051099|FG000|Overall Study|Number evaluable participant already reached|4|||
42230610|NCT03163667|76051105|FG000|Overall Study|Death|15|||
42230611|NCT03163667|76051106|FG001|Overall Study|Death|27|||
42230612|NCT03163667|76051105|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
42230613|NCT03163667|76051106|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
42230614|NCT03167411|76051114|FG000|Overall Study|Adverse Event|0|||
42230615|NCT03167411|76051115|FG001|Overall Study|Adverse Event|1|||
42230616|NCT01952847|76051125|FG000|Overall Study|Ineligible|1|||
42230617|NCT01952847|76051126|FG001|Overall Study|Ineligible|0|||
42230618|NCT01952847|76051127|FG002|Overall Study|Ineligible|0|||
42230619|NCT01952847|76051128|FG003|Overall Study|Ineligible|0|||
42230620|NCT01952847|76051125|FG000|Overall Study|Lack of Insurance Coverage|0|||
42230621|NCT01952847|76051126|FG001|Overall Study|Lack of Insurance Coverage|1|||
42230622|NCT01952847|76051127|FG002|Overall Study|Lack of Insurance Coverage|0|||
42230623|NCT01952847|76051128|FG003|Overall Study|Lack of Insurance Coverage|0|||
42230624|NCT01952847|76051125|FG000|Overall Study|Withdrawal by Subject|1|||
42230625|NCT01952847|76051126|FG001|Overall Study|Withdrawal by Subject|1|||
42230626|NCT01952847|76051127|FG002|Overall Study|Withdrawal by Subject|0|||
42230627|NCT01952847|76051128|FG003|Overall Study|Withdrawal by Subject|1|||
42230628|NCT01560585|76051140|FG000|Overall Study|Physician Decision|3|||
42230629|NCT03075501|76051147|FG000|Overall Study|Scheduling difficulties|15|||
42230630|NCT03075501|76051148|FG001|Overall Study|Scheduling difficulties|9|||
42230631|NCT02317991|76051155|FG000|Overall Study|Adverse Event|12|||
42230632|NCT02317991|76051155|FG000|Overall Study|Death|4|||
42230633|NCT02317991|76051155|FG000|Overall Study|Withdrawal by Subject|8|||
42230634|NCT02317991|76051155|FG000|Overall Study|Progressive Disease|41|||
42230635|NCT03075267|76051162|FG000|Overall Study|Protocol Violation|1|||
42230636|NCT03075267|76051163|FG001|Overall Study|Protocol Violation|0|||
42230637|NCT03075267|76051164|FG002|Overall Study|Protocol Violation|0|||
42230638|NCT03074331|76051172|FG000|Overall Study|Enrolled but Not Treated|1|||
42230639|NCT03074331|76051172|FG000|Overall Study|Lost to Follow-up|5|||
42302520|NCT02416453|76137794|FG004|Overall Study|Adverse Event|0|||
41986882|NCT04590937|75794063|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
41986883|NCT04576897|75794077|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
41986884|NCT04166435|75794109|FG000|Overall Study|2 patients ineligible for response|2|||
41986885|NCT04124965|75794115|FG000|Overall Study|Adverse event, non-fatal|3|||
41986886|NCT04124965|75794116|FG001|Overall Study|Adverse event, non-fatal|1|||
41986887|NCT04124965|75794115|FG000|Overall Study|Withdrawal by Subject|1|||
42230640|NCT03074331|76051172|FG000|Overall Study|Withdrew Consent|1|||
42230641|NCT02260193|76051179|FG000|Overall Study|Lack of Efficacy|0|||
42230642|NCT02260193|76051180|FG001|Overall Study|Lack of Efficacy|1|||
42230643|NCT02260193|76051181|FG002|Overall Study|Lack of Efficacy|6|||
42230644|NCT02260193|76051179|FG000|Overall Study|Adverse Event|3|||
42230645|NCT02260193|76051180|FG001|Overall Study|Adverse Event|4|||
42230646|NCT02260193|76051181|FG002|Overall Study|Adverse Event|1|||
42230647|NCT02260193|76051179|FG000|Overall Study|Protocol Violation|0|||
42230648|NCT02260193|76051180|FG001|Overall Study|Protocol Violation|4|||
41986888|NCT04124965|75794116|FG001|Overall Study|Withdrawal by Subject|1|||
41986889|NCT04124965|75794115|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
42230649|NCT02260193|76051181|FG002|Overall Study|Protocol Violation|0|||
42230650|NCT02260193|76051179|FG000|Overall Study|Withdrawal by Subject|3|||
42230651|NCT02260193|76051180|FG001|Overall Study|Withdrawal by Subject|0|||
42230652|NCT02260193|76051181|FG002|Overall Study|Withdrawal by Subject|2|||
42230653|NCT02260193|76051179|FG000|Overall Study|Kidney Transplantation|0|||
42230654|NCT02260193|76051180|FG001|Overall Study|Kidney Transplantation|0|||
42230655|NCT02260193|76051181|FG002|Overall Study|Kidney Transplantation|1|||
42230656|NCT02849678|76051191|FG000|Overall Study|Protocol Violation|3|||
42230657|NCT02849678|76051192|FG001|Overall Study|Protocol Violation|6|||
42230658|NCT01596257|76051200|FG000|Overall Study|Inadequate Collection|23|||
42230659|NCT01596257|76051201|FG001|Overall Study|Inadequate Collection|19|||
42230660|NCT04577781|76051211|FG000|Overall Study|Adverse Event|2|||
42230661|NCT04577781|76051212|FG001|Overall Study|Adverse Event|2|||
42230662|NCT04577781|76051211|FG000|Overall Study|Physician Decision|1|||
42230663|NCT04577781|76051212|FG001|Overall Study|Physician Decision|0|||
42230664|NCT02737826|76051219|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
42230665|NCT02737826|76051220|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
42230666|NCT02737826|76051221|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
42230667|NCT03070431|76051248|FG000|Overall Study|Withdrawal by Subject|2|||
42230668|NCT03070431|76051248|FG000|Overall Study|Lost to Follow-up|2|||
42230669|NCT01071395|76051259|FG000|Overall Study|Withdrawal by Subject|2|||
42230670|NCT01071395|76051260|FG001|Overall Study|Withdrawal by Subject|1|||
42230671|NCT01071395|76051259|FG000|Overall Study|Adverse Event|3|||
42230672|NCT01071395|76051260|FG001|Overall Study|Adverse Event|1|||
42230673|NCT02970942|76051270|FG000|Overall Study|Death|0|||
42230674|NCT02970942|76051271|FG001|Overall Study|Death|1|||
42230675|NCT02970942|76051272|FG002|Overall Study|Death|0|||
42230676|NCT02970942|76051273|FG003|Overall Study|Death|0|||
42230677|NCT02970942|76051270|FG000|Overall Study|Lost to Follow-up|1|||
42230678|NCT02970942|76051271|FG001|Overall Study|Lost to Follow-up|0|||
42230679|NCT02970942|76051272|FG002|Overall Study|Lost to Follow-up|2|||
42230680|NCT02970942|76051273|FG003|Overall Study|Lost to Follow-up|1|||
42230681|NCT02970942|76051270|FG000|Overall Study|Withdrawal by Subject|3|||
42230682|NCT02970942|76051271|FG001|Overall Study|Withdrawal by Subject|5|||
42230683|NCT02970942|76051272|FG002|Overall Study|Withdrawal by Subject|3|||
42230684|NCT02970942|76051273|FG003|Overall Study|Withdrawal by Subject|2|||
42230685|NCT03073005|76051287|FG000|Overall Study|Death|6|||
42230686|NCT03073005|76051288|FG001|Overall Study|Death|0|||
42230687|NCT03073005|76051289|FG002|Overall Study|Death|7|||
42230688|NCT03073005|76051290|FG003|Overall Study|Death|0|||
42230689|NCT03073005|76051287|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
42230690|NCT03073005|76051288|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
42230691|NCT03073005|76051289|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
42230692|NCT03073005|76051290|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
42230693|NCT03073005|76051287|FG000|Overall Study|Lost to Follow-up|2|||
42230694|NCT03073005|76051288|FG001|Overall Study|Lost to Follow-up|2|||
42230695|NCT03073005|76051289|FG002|Overall Study|Lost to Follow-up|1|||
42230696|NCT03073005|76051290|FG003|Overall Study|Lost to Follow-up|2|||
42230697|NCT03073005|76051287|FG000|Overall Study|Withdrawal by Subject|0|||
42230698|NCT03073005|76051288|FG001|Overall Study|Withdrawal by Subject|4|||
42230699|NCT03073005|76051289|FG002|Overall Study|Withdrawal by Subject|4|||
42230700|NCT03073005|76051290|FG003|Overall Study|Withdrawal by Subject|4|||
42230701|NCT02849171|76051303|FG000|Overall Study|Withdrawal by Subject|1|||
42230702|NCT02849171|76051303|FG000|Overall Study|Not treated|1|||
42230703|NCT02848664|76051316|FG000|Overall Study|Withdrawal by Subject|2|||
42230704|NCT02848664|76051316|FG000|Overall Study|Adverse Event|1|||
42230705|NCT02848664|76051316|FG000|Overall Study|no assistance for device training|1|||
42230706|NCT02969382|76051326|FG000|Overall Study|Adverse Event|8|||
42230707|NCT02969382|76051327|FG001|Overall Study|Adverse Event|10|||
42230708|NCT02969382|76051326|FG000|Overall Study|Lack of Efficacy|4|||
42230709|NCT02969382|76051327|FG001|Overall Study|Lack of Efficacy|5|||
42230710|NCT02969382|76051326|FG000|Overall Study|Death|0|||
42230711|NCT02969382|76051327|FG001|Overall Study|Death|1|||
42230712|NCT02969382|76051326|FG000|Overall Study|PROTOCOL DEVIATION|0|||
42230713|NCT02969382|76051327|FG001|Overall Study|PROTOCOL DEVIATION|1|||
42230714|NCT02969382|76051326|FG000|Overall Study|Withdrawal by Subject|14|||
42032538|NCT00951015|75840754|FG003|Open-label Phase|Lost to Follow-up|0|||
42230715|NCT02969382|76051327|FG001|Overall Study|Withdrawal by Subject|9|||
42230716|NCT01989104|76051338|FG000|Overall Study|Withdrawal by Subject|3|||
42230717|NCT01989104|76051339|FG001|Overall Study|Withdrawal by Subject|0|||
42230718|NCT01989104|76051340|FG002|Overall Study|Withdrawal by Subject|0|||
42230719|NCT01989104|76051341|FG003|Overall Study|Withdrawal by Subject|0|||
42230720|NCT01989104|76051342|FG004|Overall Study|Withdrawal by Subject|0|||
42230721|NCT02903238|76051354|FG000|Overall Study|Lost to Follow-up|4|||
42230722|NCT02847260|76051359|FG000|Overall Study|Adverse Event|3|||
42230723|NCT02847260|76051359|FG000|Overall Study|Withdrawal by Subject|2|||
42230724|NCT02847260|76051359|FG000|Overall Study|Clinical Deterioration|1|||
42230725|NCT02847260|76051359|FG000|Overall Study|Physician Decision|1|||
42230726|NCT02968563|76051365|FG000|Overall Study|Adverse Event|0|||
42230727|NCT02968563|76051366|FG001|Overall Study|Adverse Event|6|||
42230728|NCT02968563|76051365|FG000|Overall Study|Death|1|||
42230729|NCT02968563|76051366|FG001|Overall Study|Death|1|||
42230730|NCT02968563|76051365|FG000|Overall Study|Lost to Follow-up|0|||
42230731|NCT02968563|76051366|FG001|Overall Study|Lost to Follow-up|1|||
42230732|NCT02904096|76051374|FG000|Overall Study|Adverse Event|1|||
42230733|NCT02904096|76051375|FG001|Overall Study|Adverse Event|0|||
42230734|NCT02904096|76051374|FG000|Overall Study|Withdrawal by Subject|4|||
42230735|NCT02904096|76051375|FG001|Overall Study|Withdrawal by Subject|3|||
42230736|NCT02904096|76051374|FG000|Overall Study|Lost to Follow-up|10|||
42230737|NCT02904096|76051375|FG001|Overall Study|Lost to Follow-up|17|||
42230738|NCT02904096|76051374|FG000|Overall Study|Non-compliant|3|||
42230739|NCT02904096|76051375|FG001|Overall Study|Non-compliant|1|||
42230740|NCT02904096|76051374|FG000|Overall Study|Sponsor instructed|1|||
42230741|NCT02904096|76051375|FG001|Overall Study|Sponsor instructed|0|||
42230742|NCT03161405|76051385|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
42230743|NCT01813929|76051394|FG000|Overall Study|Withdrawal by Subject|0|||
42230744|NCT01813929|76051395|FG001|Overall Study|Withdrawal by Subject|1|||
42230745|NCT02901054|76051405|FG000|Overall Study|Physician Decision|1|||
42230746|NCT02901054|76051405|FG000|Overall Study|Withdrawal by Subject|3|||
42230747|NCT03068715|76051411|FG000|Overall Study|No longer met inclusion criteria|1|||
42230748|NCT03068715|76051412|FG001|Overall Study|No longer met inclusion criteria|0|||
42230749|NCT02966340|76051420|FG000|Overall Study|Adverse Event|0|||
42230750|NCT02966340|76051421|FG001|Overall Study|Adverse Event|1|||
42230751|NCT02966340|76051420|FG000|Overall Study|Lost to Follow-up|0|||
42230752|NCT02966340|76051421|FG001|Overall Study|Lost to Follow-up|1|||
42230753|NCT02966340|76051420|FG000|Overall Study|Withdrawal by Subject|1|||
42230754|NCT02966340|76051421|FG001|Overall Study|Withdrawal by Subject|0|||
42230755|NCT02966340|76051420|FG000|Overall Study|data acquisition error|1|||
42230756|NCT02966340|76051421|FG001|Overall Study|data acquisition error|0|||
42230757|NCT02966340|76051420|FG000|Overall Study|startle non-responder|1|||
42230758|NCT02966340|76051421|FG001|Overall Study|startle non-responder|1|||
42230759|NCT03067311|76051429|FG000|Overall Study|Lost to Follow-up|1|||
42230760|NCT03067311|76051430|FG001|Overall Study|Lost to Follow-up|1|||
42230761|NCT03067311|76051429|FG000|Overall Study|Moved away|1|||
42230762|NCT03067311|76051430|FG001|Overall Study|Moved away|1|||
42230763|NCT04380519|76051439|FG000|Overall Study|Withdrawal by Subject|4|||
42230764|NCT04380519|76051440|FG001|Overall Study|Withdrawal by Subject|0|||
42230765|NCT04380519|76051441|FG002|Overall Study|Withdrawal by Subject|1|||
42230766|NCT04380519|76051439|FG000|Overall Study|Death|14|||
42230767|NCT04380519|76051440|FG001|Overall Study|Death|9|||
42230768|NCT04380519|76051441|FG002|Overall Study|Death|6|||
42230769|NCT04380519|76051439|FG000|Overall Study|Adverse Event|0|||
42230770|NCT04380519|76051440|FG001|Overall Study|Adverse Event|1|||
42230771|NCT04380519|76051441|FG002|Overall Study|Adverse Event|0|||
42230772|NCT04380519|76051439|FG000|Overall Study|relatives' decision|0|||
42230773|NCT04380519|76051440|FG001|Overall Study|relatives' decision|1|||
42230774|NCT04380519|76051441|FG002|Overall Study|relatives' decision|0|||
42230775|NCT02847182|76051451|FG000|Overall Study|Withdrawal by Subject|0|||
42230776|NCT02847182|76051452|FG001|Overall Study|Withdrawal by Subject|1|||
42230777|NCT02846558|76051468|FG000|Overall Study|Adverse Event|1|||
42230778|NCT02846558|76051469|FG001|Overall Study|Adverse Event|0|||
42230779|NCT02846558|76051470|FG002|Overall Study|Adverse Event|0|||
42230780|NCT02846558|76051471|FG003|Overall Study|Adverse Event|0|||
42230781|NCT02846558|76051468|FG000|Overall Study|Withdrawal by Subject|5|||
42230782|NCT02846558|76051469|FG001|Overall Study|Withdrawal by Subject|4|||
42230783|NCT02846558|76051470|FG002|Overall Study|Withdrawal by Subject|2|||
42230784|NCT02846558|76051471|FG003|Overall Study|Withdrawal by Subject|2|||
42230785|NCT02846558|76051468|FG000|Overall Study|Lost to Follow-up|2|||
42230786|NCT02846558|76051469|FG001|Overall Study|Lost to Follow-up|0|||
42230787|NCT02846558|76051470|FG002|Overall Study|Lost to Follow-up|0|||
42230788|NCT02846558|76051471|FG003|Overall Study|Lost to Follow-up|0|||
42230789|NCT04362813|76051490|FG000|Overall Study|Death|12|||
41986890|NCT04124965|75794116|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
41986891|NCT04124965|75794115|FG000|Overall Study|Pregnancy|1|||
42230790|NCT04362813|76051491|FG001|Overall Study|Death|16|||
42230791|NCT04362813|76051490|FG000|Overall Study|Withdrawal by Subject|3|||
42230792|NCT04362813|76051491|FG001|Overall Study|Withdrawal by Subject|1|||
42230793|NCT04362813|76051490|FG000|Overall Study|Protocol Violation|0|||
42230794|NCT04362813|76051491|FG001|Overall Study|Protocol Violation|3|||
42230795|NCT04362813|76051490|FG000|Overall Study|Lost to Follow-up|1|||
42230796|NCT04362813|76051491|FG001|Overall Study|Lost to Follow-up|1|||
42230797|NCT04362813|76051490|FG000|Overall Study|Enrolled but did not receive treatment|2|||
41986892|NCT04124965|75794116|FG001|Overall Study|Pregnancy|0|||
42230798|NCT04362813|76051491|FG001|Overall Study|Enrolled but did not receive treatment|4|||
42230799|NCT02966028|76051500|FG000|Overall Study|Adverse Event|7|||
42230800|NCT02966028|76051501|FG001|Overall Study|Adverse Event|13|||
42230801|NCT02966028|76051502|FG002|Overall Study|Adverse Event|10|||
42230802|NCT02966028|76051500|FG000|Overall Study|Physician Decision|1|||
42230803|NCT02966028|76051501|FG001|Overall Study|Physician Decision|0|||
42230804|NCT02966028|76051502|FG002|Overall Study|Physician Decision|2|||
42230805|NCT02966028|76051500|FG000|Overall Study|Withdrawal by Subject|7|||
42230806|NCT02966028|76051501|FG001|Overall Study|Withdrawal by Subject|5|||
42230807|NCT02966028|76051502|FG002|Overall Study|Withdrawal by Subject|5|||
42230808|NCT02966028|76051500|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
42230809|NCT02966028|76051501|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
42230810|NCT02966028|76051502|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
42230811|NCT02925741|76051516|FG000|Overall Study|Withdrawal by Subject|11|||
42230812|NCT02925741|76051517|FG001|Overall Study|Withdrawal by Subject|0|||
42230813|NCT02964312|76051526|FG000|Overall Study|Lost to Follow-up|28|||
42230814|NCT02964312|76051526|FG000|Overall Study|Withdrawal by Subject|11|||
42230815|NCT02964312|76051526|FG000|Overall Study|Lack of Efficacy|10|||
42230816|NCT02964312|76051526|FG000|Overall Study|Did not consent to long-term FU|14|||
42230817|NCT02964312|76051526|FG000|Overall Study|Death|1|||
42230818|NCT02899962|76051550|FG000|Open-label Phase|Adverse Event|2|||
42230819|NCT02899962|76051551|FG001|Open-label Phase|Adverse Event|0|||
42230820|NCT02899962|76051552|FG002|Open-label Phase|Adverse Event|0|||
42230821|NCT02899962|76051550|FG000|Open-label Phase|Lost to Follow-up|9|||
42230822|NCT02899962|76051551|FG001|Open-label Phase|Lost to Follow-up|0|||
42230823|NCT02899962|76051552|FG002|Open-label Phase|Lost to Follow-up|0|||
42230824|NCT02899962|76051550|FG000|Open-label Phase|Other reasons|9|||
42230825|NCT02899962|76051551|FG001|Open-label Phase|Other reasons|0|||
42230826|NCT02899962|76051552|FG002|Open-label Phase|Other reasons|0|||
42230827|NCT02899962|76051550|FG000|Open-label Phase|Withdrawal by Subject|7|||
42230828|NCT02899962|76051551|FG001|Open-label Phase|Withdrawal by Subject|0|||
42230829|NCT02899962|76051552|FG002|Open-label Phase|Withdrawal by Subject|0|||
42230830|NCT02899962|76051550|FG000|Maintenance Phase|Adverse Event|0|||
42230831|NCT02899962|76051551|FG001|Maintenance Phase|Adverse Event|2|||
42230832|NCT02899962|76051552|FG002|Maintenance Phase|Adverse Event|1|||
42230833|NCT02899962|76051550|FG000|Maintenance Phase|Death|0|||
42230834|NCT02899962|76051551|FG001|Maintenance Phase|Death|0|||
42230835|NCT02899962|76051552|FG002|Maintenance Phase|Death|1|||
42230836|NCT02899962|76051550|FG000|Maintenance Phase|Lack of Efficacy|0|||
42230837|NCT02899962|76051551|FG001|Maintenance Phase|Lack of Efficacy|20|||
42230838|NCT02899962|76051552|FG002|Maintenance Phase|Lack of Efficacy|16|||
42230839|NCT02899962|76051550|FG000|Maintenance Phase|Lost to Follow-up|0|||
42230840|NCT02899962|76051551|FG001|Maintenance Phase|Lost to Follow-up|12|||
42230841|NCT02899962|76051552|FG002|Maintenance Phase|Lost to Follow-up|14|||
42230842|NCT02899962|76051550|FG000|Maintenance Phase|Other reasons|0|||
42230843|NCT02899962|76051551|FG001|Maintenance Phase|Other reasons|9|||
42230844|NCT02899962|76051552|FG002|Maintenance Phase|Other reasons|13|||
41986893|NCT04124965|75794115|FG000|Overall Study|Sponsor and participant decision|0|||
41986894|NCT04124965|75794116|FG001|Overall Study|Sponsor and participant decision|1|||
41986895|NCT04124965|75794115|FG000|Overall Study|Personal surgery|0|||
41986896|NCT04124965|75794116|FG001|Overall Study|Personal surgery|1|||
41986897|NCT04124965|75794115|FG000|Overall Study|Physician Decision|0|||
41986898|NCT04124965|75794116|FG001|Overall Study|Physician Decision|1|||
41986899|NCT04098068|75794122|FG000|Overall Study|Disease Progression|7|||
41986900|NCT04098068|75794122|FG000|Overall Study|Withdrawal by Subject|2|||
41986901|NCT04098068|75794122|FG000|Overall Study|New Cancer Diagnosis|1|||
41986902|NCT04021862|75794129|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
41986903|NCT04021862|75794130|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
41986904|NCT04021862|75794131|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
42230845|NCT02899962|76051550|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
42302521|NCT02416453|76137795|FG005|Overall Study|Adverse Event|1|||
42302522|NCT02416453|76137796|FG006|Overall Study|Adverse Event|0|||
42302523|NCT02416453|76137797|FG007|Overall Study|Adverse Event|0|||
42302524|NCT02416453|76137798|FG008|Overall Study|Adverse Event|0|||
42302525|NCT02416453|76137799|FG009|Overall Study|Adverse Event|0|||
42302526|NCT02416453|76137800|FG010|Overall Study|Adverse Event|0|||
42302527|NCT02416453|76137790|FG000|Overall Study|Lost to Follow-up|1|||
42302528|NCT02416453|76137791|FG001|Overall Study|Lost to Follow-up|3|||
42131769|NCT00414609|75942695|FG000|Core Study|Adverse Event|9|||
42230846|NCT02899962|76051551|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
42302529|NCT02416453|76137792|FG002|Overall Study|Lost to Follow-up|0|||
42302530|NCT02416453|76137793|FG003|Overall Study|Lost to Follow-up|8|||
41986905|NCT04021862|75794132|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
42230847|NCT02899962|76051552|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
42230848|NCT02899962|76051550|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
42230849|NCT02899962|76051551|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
42131770|NCT00414609|75942696|FG001|Core Study|Adverse Event|11|||
42230850|NCT02899962|76051552|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
42230851|NCT02899962|76051550|FG000|Maintenance Phase|Withdrawal by Subject|0|||
42230852|NCT02899962|76051551|FG001|Maintenance Phase|Withdrawal by Subject|30|||
42230853|NCT02899962|76051552|FG002|Maintenance Phase|Withdrawal by Subject|36|||
42302531|NCT02416453|76137794|FG004|Overall Study|Lost to Follow-up|0|||
42302532|NCT02416453|76137795|FG005|Overall Study|Lost to Follow-up|5|||
42230854|NCT02899338|76051561|FG000|Overall Study|Adverse Event|1|||
42230855|NCT02899338|76051562|FG001|Overall Study|Adverse Event|2|||
42230856|NCT02899338|76051561|FG000|Overall Study|Withdrawal by Subject|2|||
42230857|NCT02899338|76051562|FG001|Overall Study|Withdrawal by Subject|0|||
42230858|NCT03066609|76051571|FG000|INDUCTION|Pregnancy|0|||
42230859|NCT03066609|76051572|FG001|INDUCTION|Pregnancy|0|||
42230860|NCT03066609|76051573|FG002|INDUCTION|Pregnancy|1|||
42230861|NCT03066609|76051574|FG003|INDUCTION|Pregnancy|0|||
42230862|NCT03066609|76051571|FG000|INDUCTION|Lack of Efficacy|0|||
42230863|NCT03066609|76051572|FG001|INDUCTION|Lack of Efficacy|0|||
42230864|NCT03066609|76051573|FG002|INDUCTION|Lack of Efficacy|1|||
42230865|NCT03066609|76051574|FG003|INDUCTION|Lack of Efficacy|0|||
42230866|NCT03066609|76051571|FG000|INDUCTION|Adverse Event|2|||
42230867|NCT03066609|76051572|FG001|INDUCTION|Adverse Event|2|||
42230868|NCT03066609|76051573|FG002|INDUCTION|Adverse Event|0|||
42230869|NCT03066609|76051574|FG003|INDUCTION|Adverse Event|0|||
42230870|NCT03066609|76051571|FG000|MAINTENANCE|Adverse Event|0|||
42230871|NCT03066609|76051572|FG001|MAINTENANCE|Adverse Event|0|||
42230872|NCT03066609|76051573|FG002|MAINTENANCE|Adverse Event|0|||
42230873|NCT03066609|76051574|FG003|MAINTENANCE|Adverse Event|1|||
42230874|NCT03066609|76051571|FG000|MAINTENANCE|Withdrawal by Subject|4|||
42230875|NCT03066609|76051572|FG001|MAINTENANCE|Withdrawal by Subject|2|||
42230876|NCT03066609|76051573|FG002|MAINTENANCE|Withdrawal by Subject|1|||
42230877|NCT03066609|76051574|FG003|MAINTENANCE|Withdrawal by Subject|1|||
42230878|NCT03066609|76051571|FG000|MAINTENANCE|Lost to Follow-up|0|||
42230879|NCT03066609|76051572|FG001|MAINTENANCE|Lost to Follow-up|1|||
42230880|NCT03066609|76051573|FG002|MAINTENANCE|Lost to Follow-up|1|||
42230881|NCT03066609|76051574|FG003|MAINTENANCE|Lost to Follow-up|0|||
42230882|NCT03066609|76051571|FG000|MAINTENANCE|Pregnancy|1|||
42230883|NCT03066609|76051572|FG001|MAINTENANCE|Pregnancy|0|||
42230884|NCT03066609|76051573|FG002|MAINTENANCE|Pregnancy|0|||
42230885|NCT03066609|76051574|FG003|MAINTENANCE|Pregnancy|0|||
42230886|NCT03066609|76051571|FG000|MAINTENANCE|Lack of Efficacy|2|||
42230887|NCT03066609|76051572|FG001|MAINTENANCE|Lack of Efficacy|1|||
42230888|NCT03066609|76051573|FG002|MAINTENANCE|Lack of Efficacy|0|||
42230889|NCT03066609|76051574|FG003|MAINTENANCE|Lack of Efficacy|1|||
42230890|NCT03066609|76051571|FG000|OVERALL STUDY|Adverse Event|2|||
42230891|NCT03066609|76051572|FG001|OVERALL STUDY|Adverse Event|2|||
42230892|NCT03066609|76051573|FG002|OVERALL STUDY|Adverse Event|0|||
42230893|NCT03066609|76051574|FG003|OVERALL STUDY|Adverse Event|1|||
42230894|NCT03066609|76051571|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
42230895|NCT03066609|76051572|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
42230896|NCT03066609|76051573|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
42230897|NCT03066609|76051574|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
42230898|NCT03066609|76051571|FG000|OVERALL STUDY|Lost to Follow-up|1|||
42230899|NCT03066609|76051572|FG001|OVERALL STUDY|Lost to Follow-up|1|||
42230900|NCT03066609|76051573|FG002|OVERALL STUDY|Lost to Follow-up|1|||
42230901|NCT03066609|76051574|FG003|OVERALL STUDY|Lost to Follow-up|1|||
42302533|NCT02416453|76137796|FG006|Overall Study|Lost to Follow-up|1|||
42302534|NCT02416453|76137797|FG007|Overall Study|Lost to Follow-up|3|||
42230902|NCT03066609|76051571|FG000|OVERALL STUDY|Pregnancy|1|||
42230903|NCT03066609|76051572|FG001|OVERALL STUDY|Pregnancy|0|||
42230904|NCT03066609|76051573|FG002|OVERALL STUDY|Pregnancy|1|||
42230905|NCT03066609|76051574|FG003|OVERALL STUDY|Pregnancy|0|||
42230906|NCT03066609|76051571|FG000|OVERALL STUDY|Lack of Efficacy|2|||
42230907|NCT03066609|76051572|FG001|OVERALL STUDY|Lack of Efficacy|1|||
42230908|NCT03066609|76051573|FG002|OVERALL STUDY|Lack of Efficacy|1|||
42230909|NCT03066609|76051574|FG003|OVERALL STUDY|Lack of Efficacy|1|||
42230910|NCT03066609|76051571|FG000|OVERALL STUDY|discontinued follow up|0|||
42230911|NCT03066609|76051572|FG001|OVERALL STUDY|discontinued follow up|2|||
42230912|NCT03066609|76051573|FG002|OVERALL STUDY|discontinued follow up|0|||
42230913|NCT03066609|76051574|FG003|OVERALL STUDY|discontinued follow up|0|||
42230914|NCT02964234|76051591|FG000|Overall Study|Lost to Follow-up|22|||
42302535|NCT02416453|76137798|FG008|Overall Study|Lost to Follow-up|1|||
42230915|NCT02964234|76051592|FG001|Overall Study|Lost to Follow-up|13|||
42230916|NCT01345188|76051598|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
42230917|NCT01345188|76051598|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
42230918|NCT03852459|76051607|FG000|Overall Study|Adverse Event|2|||
42230919|NCT03852459|76051608|FG001|Overall Study|Adverse Event|2|||
42230920|NCT03852459|76051607|FG000|Overall Study|Withdrawal by Subject|1|||
42230921|NCT03852459|76051608|FG001|Overall Study|Withdrawal by Subject|1|||
42230922|NCT02896296|76051614|FG000|Overall Study|Adverse Event|1|||
42230923|NCT02896296|76051614|FG000|Overall Study|Lost to Follow-up|19|||
42230924|NCT02896296|76051614|FG000|Overall Study|Pregnancy|1|||
42230925|NCT02896296|76051614|FG000|Overall Study|Physician Decision|2|||
42230926|NCT02896296|76051614|FG000|Overall Study|Withdrawal by Subject|10|||
42230927|NCT02896296|76051614|FG000|Overall Study|Site closing|7|||
42230928|NCT02896296|76051614|FG000|Overall Study|Incarceration|1|||
42230929|NCT02896296|76051614|FG000|Overall Study|Relocation|1|||
42230930|NCT03740919|76051621|FG000|Lead-in Period|Lost to Follow-up|1|||
42230931|NCT03740919|76051622|FG001|Lead-in Period|Lost to Follow-up|0|||
42230932|NCT03740919|76051623|FG002|Lead-in Period|Lost to Follow-up|0|||
42230933|NCT03740919|76051624|FG003|Lead-in Period|Lost to Follow-up|0|||
42230934|NCT03740919|76051621|FG000|Lead-in Period|Physician Decision|2|||
42230935|NCT03740919|76051622|FG001|Lead-in Period|Physician Decision|0|||
42230936|NCT03740919|76051623|FG002|Lead-in Period|Physician Decision|0|||
42230937|NCT03740919|76051624|FG003|Lead-in Period|Physician Decision|0|||
42230938|NCT03740919|76051621|FG000|Lead-in Period|Protocol Violation|1|||
42230939|NCT03740919|76051622|FG001|Lead-in Period|Protocol Violation|0|||
42230940|NCT03740919|76051623|FG002|Lead-in Period|Protocol Violation|0|||
42230941|NCT03740919|76051624|FG003|Lead-in Period|Protocol Violation|0|||
42230942|NCT03740919|76051621|FG000|Lead-in Period|Withdrawal by Subject|10|||
42230943|NCT03740919|76051622|FG001|Lead-in Period|Withdrawal by Subject|0|||
42230944|NCT03740919|76051623|FG002|Lead-in Period|Withdrawal by Subject|0|||
42230945|NCT03740919|76051624|FG003|Lead-in Period|Withdrawal by Subject|0|||
42230946|NCT03740919|76051621|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
42230947|NCT03740919|76051622|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
42230948|NCT03740919|76051623|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
42230949|NCT03740919|76051624|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
42230950|NCT03740919|76051621|FG000|Lead-in Period|Study Task Too Burdensome|1|||
42230951|NCT03740919|76051622|FG001|Lead-in Period|Study Task Too Burdensome|0|||
42230952|NCT03740919|76051623|FG002|Lead-in Period|Study Task Too Burdensome|0|||
42230953|NCT03740919|76051624|FG003|Lead-in Period|Study Task Too Burdensome|0|||
42230954|NCT03740919|76051621|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
42230955|NCT03740919|76051622|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
42230956|NCT03740919|76051623|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
42230957|NCT03740919|76051624|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
42230958|NCT03740919|76051621|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
42230959|NCT03740919|76051622|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
42230960|NCT03740919|76051623|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
42230961|NCT03740919|76051624|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
42230962|NCT03740919|76051621|FG000|Treatment Period|Adverse Event|0|||
42230963|NCT03740919|76051622|FG001|Treatment Period|Adverse Event|0|||
42230964|NCT03740919|76051623|FG002|Treatment Period|Adverse Event|2|||
42230965|NCT03740919|76051624|FG003|Treatment Period|Adverse Event|0|||
42230966|NCT03740919|76051621|FG000|Treatment Period|Protocol Violation|0|||
42230967|NCT03740919|76051622|FG001|Treatment Period|Protocol Violation|1|||
42230968|NCT03740919|76051623|FG002|Treatment Period|Protocol Violation|0|||
42230969|NCT03740919|76051624|FG003|Treatment Period|Protocol Violation|0|||
42230970|NCT03740919|76051621|FG000|Treatment Period|Withdrawal by Subject|0|||
42230971|NCT03740919|76051622|FG001|Treatment Period|Withdrawal by Subject|7|||
42230972|NCT03740919|76051623|FG002|Treatment Period|Withdrawal by Subject|6|||
42230973|NCT03740919|76051624|FG003|Treatment Period|Withdrawal by Subject|2|||
42230974|NCT03740919|76051621|FG000|Treatment Period|Terminated by Sponsor|0|||
42230975|NCT03740919|76051622|FG001|Treatment Period|Terminated by Sponsor|1|||
42230976|NCT03740919|76051623|FG002|Treatment Period|Terminated by Sponsor|0|||
42230977|NCT03740919|76051624|FG003|Treatment Period|Terminated by Sponsor|0|||
42230978|NCT03740919|76051621|FG000|Treatment Period|Issue with Insulin Pump|0|||
42230979|NCT03740919|76051622|FG001|Treatment Period|Issue with Insulin Pump|1|||
42230980|NCT03740919|76051623|FG002|Treatment Period|Issue with Insulin Pump|0|||
42230981|NCT03740919|76051624|FG003|Treatment Period|Issue with Insulin Pump|0|||
42230982|NCT03740919|76051621|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
42230983|NCT03740919|76051622|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
42230984|NCT03740919|76051623|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
42230985|NCT03740919|76051624|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
42230986|NCT03740919|76051621|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
42230987|NCT03740919|76051622|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
42230988|NCT03740919|76051623|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
42230989|NCT03740919|76051624|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
42230990|NCT03740919|76051621|FG000|Treatment Period|Not Completing Diary|0|||
42230991|NCT03740919|76051622|FG001|Treatment Period|Not Completing Diary|0|||
42131771|NCT00414609|75942697|FG002|Core Study|Adverse Event|0|||
42230992|NCT03740919|76051623|FG002|Treatment Period|Not Completing Diary|1|||
42230993|NCT03740919|76051624|FG003|Treatment Period|Not Completing Diary|0|||
42230994|NCT03740919|76051621|FG000|Treatment Period|Insulin Painful to Participant|0|||
42230995|NCT03740919|76051622|FG001|Treatment Period|Insulin Painful to Participant|0|||
42230996|NCT03740919|76051623|FG002|Treatment Period|Insulin Painful to Participant|1|||
42230997|NCT03740919|76051624|FG003|Treatment Period|Insulin Painful to Participant|0|||
42230998|NCT01335685|76051639|FG000|Overall Study|Study Terminated by Sponsor|2|||
42230999|NCT01335685|76051640|FG001|Overall Study|Study Terminated by Sponsor|1|||
42231000|NCT01335685|76051641|FG002|Overall Study|Study Terminated by Sponsor|1|||
42231001|NCT01335685|76051642|FG003|Overall Study|Study Terminated by Sponsor|10|||
42231002|NCT01335685|76051643|FG004|Overall Study|Study Terminated by Sponsor|0|||
42231003|NCT01335685|76051644|FG005|Overall Study|Study Terminated by Sponsor|4|||
42231004|NCT01335685|76051645|FG006|Overall Study|Study Terminated by Sponsor|2|||
42231005|NCT01335685|76051646|FG007|Overall Study|Study Terminated by Sponsor|3|||
42231006|NCT01335685|76051639|FG000|Overall Study|Withdrawal by Subject|1|||
42231007|NCT01335685|76051640|FG001|Overall Study|Withdrawal by Subject|0|||
42231008|NCT01335685|76051641|FG002|Overall Study|Withdrawal by Subject|0|||
42231009|NCT01335685|76051642|FG003|Overall Study|Withdrawal by Subject|1|||
42231010|NCT01335685|76051643|FG004|Overall Study|Withdrawal by Subject|0|||
42231011|NCT01335685|76051644|FG005|Overall Study|Withdrawal by Subject|0|||
42231012|NCT01335685|76051645|FG006|Overall Study|Withdrawal by Subject|0|||
42231013|NCT01335685|76051646|FG007|Overall Study|Withdrawal by Subject|0|||
42231014|NCT01335685|76051639|FG000|Overall Study|Reason not Specified|0|||
42231015|NCT01335685|76051640|FG001|Overall Study|Reason not Specified|0|||
42231016|NCT01335685|76051641|FG002|Overall Study|Reason not Specified|1|||
42231017|NCT01335685|76051642|FG003|Overall Study|Reason not Specified|0|||
42231018|NCT01335685|76051643|FG004|Overall Study|Reason not Specified|0|||
42231019|NCT01335685|76051644|FG005|Overall Study|Reason not Specified|1|||
42231020|NCT01335685|76051645|FG006|Overall Study|Reason not Specified|0|||
42231021|NCT01335685|76051646|FG007|Overall Study|Reason not Specified|0|||
42231022|NCT02926209|76051669|FG000|Study Cohort|Poor Bowel Preparation|1|||
42231023|NCT02926209|76051670|FG001|Study Cohort|Poor Bowel Preparation|0|||
42231024|NCT03066999|76051679|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
42231025|NCT03066999|76051680|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
42231026|NCT02963922|76051694|FG000|Overall Study|Adverse Event|15|||
42231027|NCT02963922|76051695|FG001|Overall Study|Adverse Event|6|||
42231028|NCT02963922|76051694|FG000|Overall Study|Protocol deviation|6|||
42231029|NCT02963922|76051695|FG001|Overall Study|Protocol deviation|6|||
42231030|NCT02963922|76051694|FG000|Overall Study|Lack of Efficacy|1|||
42231031|NCT02963922|76051695|FG001|Overall Study|Lack of Efficacy|1|||
42231032|NCT02963922|76051694|FG000|Overall Study|Lost to Follow-up|2|||
42231033|NCT02963922|76051695|FG001|Overall Study|Lost to Follow-up|3|||
42231034|NCT02963922|76051694|FG000|Overall Study|Other|8|||
42231035|NCT02963922|76051695|FG001|Overall Study|Other|14|||
42231036|NCT02881567|76051701|FG000|Overall Study|Adverse Event|1|||
42231037|NCT02881567|76051701|FG000|Overall Study|Lost to Follow-up|3|||
42231038|NCT02881567|76051701|FG000|Overall Study|Consent withdrawn|1|||
42231039|NCT02881567|76051701|FG000|Overall Study|Investigator decision|1|||
42231040|NCT02881567|76051701|FG000|Overall Study|Study terminated by sponsor|9|||
42231041|NCT02881567|76051701|FG000|Overall Study|Reason not Specified|3|||
42231042|NCT02962674|76051705|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
42231043|NCT02962908|76051715|FG000|Overall Study|Lost to Follow-up|0|||
42231044|NCT02962908|76051716|FG001|Overall Study|Lost to Follow-up|3|||
42231045|NCT02962908|76051717|FG002|Overall Study|Lost to Follow-up|0|||
42231046|NCT02962908|76051718|FG003|Overall Study|Lost to Follow-up|1|||
42231047|NCT02962908|76051715|FG000|Overall Study|Withdrawal by Subject|0|||
42231048|NCT02962908|76051716|FG001|Overall Study|Withdrawal by Subject|3|||
42231049|NCT02962908|76051717|FG002|Overall Study|Withdrawal by Subject|0|||
42231050|NCT02962908|76051718|FG003|Overall Study|Withdrawal by Subject|2|||
42231051|NCT02962908|76051715|FG000|Overall Study|Protocol Violation|0|||
42231052|NCT02962908|76051716|FG001|Overall Study|Protocol Violation|1|||
42231053|NCT02962908|76051717|FG002|Overall Study|Protocol Violation|0|||
42231054|NCT02962908|76051718|FG003|Overall Study|Protocol Violation|0|||
42231055|NCT02962908|76051715|FG000|Overall Study|Physician Decision|0|||
42231056|NCT02962908|76051716|FG001|Overall Study|Physician Decision|1|||
42231057|NCT02962908|76051717|FG002|Overall Study|Physician Decision|0|||
42231058|NCT02962908|76051718|FG003|Overall Study|Physician Decision|0|||
42231059|NCT02962284|76051736|FG000|Overall Study|Death|2|||
42231060|NCT02962284|76051737|FG001|Overall Study|Death|0|||
42231061|NCT02962284|76051736|FG000|Overall Study|Progressive disease|2|||
42231062|NCT02962284|76051737|FG001|Overall Study|Progressive disease|3|||
42231063|NCT02962284|76051736|FG000|Overall Study|Withdrawal by Subject|1|||
42231064|NCT02962284|76051737|FG001|Overall Study|Withdrawal by Subject|0|||
42231065|NCT01344876|76051745|FG000|Overall Study|Adverse Event|0|||
42231066|NCT01344876|76051746|FG001|Overall Study|Adverse Event|0|||
42231067|NCT01344876|76051747|FG002|Overall Study|Adverse Event|0|||
42231068|NCT01344876|76051748|FG003|Overall Study|Adverse Event|0|||
42231069|NCT01344876|76051749|FG004|Overall Study|Adverse Event|1|||
42231070|NCT01344876|76051745|FG000|Overall Study|Withdrawal by Subject|0|||
42231071|NCT01344876|76051746|FG001|Overall Study|Withdrawal by Subject|0|||
42231072|NCT01344876|76051747|FG002|Overall Study|Withdrawal by Subject|1|||
42231073|NCT01344876|76051748|FG003|Overall Study|Withdrawal by Subject|0|||
42010521|NCT00996307|75817648|FG001|Overall Study|Adverse Event|1|||
42231074|NCT01344876|76051749|FG004|Overall Study|Withdrawal by Subject|0|||
42231075|NCT01344876|76051745|FG000|Overall Study|Definite progression of primary disease|1|||
42231076|NCT01344876|76051746|FG001|Overall Study|Definite progression of primary disease|0|||
42231077|NCT01344876|76051747|FG002|Overall Study|Definite progression of primary disease|0|||
42231078|NCT01344876|76051748|FG003|Overall Study|Definite progression of primary disease|3|||
42231079|NCT01344876|76051749|FG004|Overall Study|Definite progression of primary disease|0|||
42231080|NCT02846324|76051766|FG000|Overall Study|Other|1|||
42231081|NCT02846324|76051767|FG001|Overall Study|Other|0|||
42231082|NCT02846324|76051768|FG002|Overall Study|Other|0|||
42231083|NCT02846324|76051769|FG003|Overall Study|Other|0|||
42231084|NCT02846324|76051766|FG000|Overall Study|Withdrawal by Subject|1|||
42231085|NCT02846324|76051767|FG001|Overall Study|Withdrawal by Subject|0|||
42231086|NCT02846324|76051768|FG002|Overall Study|Withdrawal by Subject|4|||
42231087|NCT02846324|76051769|FG003|Overall Study|Withdrawal by Subject|0|||
42231088|NCT03161093|76051794|FG000|Overall Study|Protocol Violation|11|||
42231089|NCT03161093|76051795|FG001|Overall Study|Protocol Violation|14|||
42231090|NCT03161093|76051796|FG002|Overall Study|Protocol Violation|6|||
42231091|NCT03161093|76051797|FG003|Overall Study|Protocol Violation|13|||
42231092|NCT03161093|76051798|FG004|Overall Study|Protocol Violation|1|||
42231093|NCT03161093|76051799|FG005|Overall Study|Protocol Violation|0|||
42231094|NCT03161093|76051794|FG000|Overall Study|Adverse Event|5|||
42231095|NCT03161093|76051795|FG001|Overall Study|Adverse Event|21|||
42231096|NCT03161093|76051796|FG002|Overall Study|Adverse Event|16|||
42231097|NCT03161093|76051797|FG003|Overall Study|Adverse Event|35|||
42231098|NCT03161093|76051798|FG004|Overall Study|Adverse Event|2|||
42231099|NCT03161093|76051799|FG005|Overall Study|Adverse Event|1|||
42231100|NCT03161093|76051794|FG000|Overall Study|Lack of Efficacy|9|||
42231101|NCT03161093|76051795|FG001|Overall Study|Lack of Efficacy|13|||
42231102|NCT03161093|76051796|FG002|Overall Study|Lack of Efficacy|9|||
42231103|NCT03161093|76051797|FG003|Overall Study|Lack of Efficacy|24|||
42231104|NCT03161093|76051798|FG004|Overall Study|Lack of Efficacy|4|||
42231105|NCT03161093|76051799|FG005|Overall Study|Lack of Efficacy|1|||
42231106|NCT03161093|76051794|FG000|Overall Study|Physician Decision|0|||
42231107|NCT03161093|76051795|FG001|Overall Study|Physician Decision|1|||
42231108|NCT03161093|76051796|FG002|Overall Study|Physician Decision|0|||
42231109|NCT03161093|76051797|FG003|Overall Study|Physician Decision|2|||
42231110|NCT03161093|76051798|FG004|Overall Study|Physician Decision|17|||
42231111|NCT03161093|76051799|FG005|Overall Study|Physician Decision|15|||
42231112|NCT03161093|76051794|FG000|Overall Study|Withdrawal by Subject|24|||
42231113|NCT03161093|76051795|FG001|Overall Study|Withdrawal by Subject|73|||
42231114|NCT03161093|76051796|FG002|Overall Study|Withdrawal by Subject|44|||
42231115|NCT03161093|76051797|FG003|Overall Study|Withdrawal by Subject|97|||
42231116|NCT03161093|76051798|FG004|Overall Study|Withdrawal by Subject|11|||
42231117|NCT03161093|76051799|FG005|Overall Study|Withdrawal by Subject|10|||
42231118|NCT03161093|76051794|FG000|Overall Study|Lost to Follow-up|3|||
42231119|NCT03161093|76051795|FG001|Overall Study|Lost to Follow-up|12|||
42231120|NCT03161093|76051796|FG002|Overall Study|Lost to Follow-up|4|||
42231121|NCT03161093|76051797|FG003|Overall Study|Lost to Follow-up|7|||
42231122|NCT03161093|76051798|FG004|Overall Study|Lost to Follow-up|8|||
42231123|NCT03161093|76051799|FG005|Overall Study|Lost to Follow-up|13|||
42231124|NCT03161093|76051794|FG000|Overall Study|Death|3|||
41986906|NCT04021862|75794133|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
41986907|NCT04021862|75794134|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
41986908|NCT04021862|75794129|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
41986909|NCT04021862|75794130|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
41986910|NCT04021862|75794131|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
41986911|NCT04021862|75794132|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
41986912|NCT04021862|75794133|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
41986913|NCT04021862|75794134|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
41986914|NCT04021862|75794129|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
41986915|NCT04021862|75794130|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
41986916|NCT04021862|75794131|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
41986917|NCT04021862|75794132|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
41986918|NCT04021862|75794133|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
41986919|NCT04021862|75794134|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
42231125|NCT03161093|76051795|FG001|Overall Study|Death|9|||
42231126|NCT03161093|76051796|FG002|Overall Study|Death|7|||
42231127|NCT03161093|76051797|FG003|Overall Study|Death|9|||
42231128|NCT03161093|76051798|FG004|Overall Study|Death|0|||
42231129|NCT03161093|76051799|FG005|Overall Study|Death|0|||
42231130|NCT03161093|76051794|FG000|Overall Study|Unknown - Not reported|0|||
42231131|NCT03161093|76051795|FG001|Overall Study|Unknown - Not reported|1|||
42231132|NCT03161093|76051796|FG002|Overall Study|Unknown - Not reported|0|||
42231133|NCT03161093|76051797|FG003|Overall Study|Unknown - Not reported|0|||
42231134|NCT03161093|76051798|FG004|Overall Study|Unknown - Not reported|0|||
42231135|NCT03161093|76051799|FG005|Overall Study|Unknown - Not reported|1|||
42231136|NCT02847650|76051820|FG000|Overall Study|Adverse Event|2|||
42231137|NCT02847650|76051821|FG001|Overall Study|Adverse Event|4|||
42231138|NCT02847650|76051820|FG000|Overall Study|Lost to Follow-up|1|||
42231139|NCT02847650|76051821|FG001|Overall Study|Lost to Follow-up|0|||
42231140|NCT02847650|76051820|FG000|Overall Study|Protocol Violation|0|||
42231141|NCT02847650|76051821|FG001|Overall Study|Protocol Violation|1|||
42231142|NCT02847650|76051820|FG000|Overall Study|Withdrawal by Subject|1|||
42231143|NCT02847650|76051821|FG001|Overall Study|Withdrawal by Subject|1|||
42231144|NCT02847494|76051829|FG000|Overall Study|Lost to Follow-up|8|||
42231145|NCT02847494|76051830|FG001|Overall Study|Lost to Follow-up|5|||
42231146|NCT02554253|76051838|FG000|Overall Study|ineligible after enrollment|1|||
42231147|NCT02554253|76051839|FG001|Overall Study|ineligible after enrollment|0|||
42231148|NCT02554253|76051838|FG000|Overall Study|converted to transcatheter procedure|0|||
42231149|NCT02554253|76051839|FG001|Overall Study|converted to transcatheter procedure|1|||
42231150|NCT02554253|76051838|FG000|Overall Study|received both drugs|0|||
42231151|NCT02554253|76051839|FG001|Overall Study|received both drugs|1|||
42231152|NCT03157583|76051846|FG000|Overall Study|Other (did not meet study criteria)|1|||
42231153|NCT02842736|76051864|FG000|Overall Study|Lost to Follow-up|13|||
42231154|NCT02842736|76051864|FG000|Overall Study|Intervention for menstrual bleeding|17|||
42231155|NCT02842736|76051864|FG000|Overall Study|Withdrawal by Subject|4|||
42231156|NCT02842736|76051864|FG000|Overall Study|Pregnancy|3|||
42231157|NCT02842736|76051864|FG000|Overall Study|Hysterectomy for fibroids|2|||
42231158|NCT02842736|76051864|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
42231159|NCT02842736|76051864|FG000|Overall Study|IUD: Mirena|1|||
42231160|NCT01307033|76051870|FG000|8-week Double-blind Period|Adverse Event|2|||
42231161|NCT01307033|76051871|FG001|8-week Double-blind Period|Adverse Event|0|||
42231162|NCT01307033|76051872|FG002|8-week Double-blind Period|Adverse Event|0|||
42231163|NCT01307033|76051873|FG003|8-week Double-blind Period|Adverse Event|0|||
42231164|NCT01307033|76051870|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
42231165|NCT01307033|76051871|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
42231166|NCT01307033|76051872|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
42231167|NCT01307033|76051873|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
42231168|NCT01307033|76051870|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
42231169|NCT01307033|76051871|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
42231170|NCT01307033|76051872|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
42231171|NCT01307033|76051873|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
42231172|NCT01307033|76051870|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
42231173|NCT01307033|76051871|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
42231174|NCT01307033|76051872|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
42231175|NCT01307033|76051873|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
42231176|NCT01307033|76051870|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
42231177|NCT01307033|76051871|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
42231178|NCT01307033|76051872|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
42231179|NCT01307033|76051873|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
42231180|NCT01307033|76051870|FG000|44-week Open-label Extension|Adverse Event|0|||
42231181|NCT01307033|76051871|FG001|44-week Open-label Extension|Adverse Event|0|||
42231182|NCT01307033|76051872|FG002|44-week Open-label Extension|Adverse Event|2|||
42231183|NCT01307033|76051873|FG003|44-week Open-label Extension|Adverse Event|1|||
42231184|NCT01307033|76051870|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
42231185|NCT01307033|76051871|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
42231186|NCT01307033|76051872|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
42231187|NCT01307033|76051873|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
42231188|NCT01307033|76051870|FG000|44-week Open-label Extension|Physician Decision|0|||
42231189|NCT01307033|76051871|FG001|44-week Open-label Extension|Physician Decision|0|||
42231190|NCT01307033|76051872|FG002|44-week Open-label Extension|Physician Decision|1|||
42231191|NCT01307033|76051873|FG003|44-week Open-label Extension|Physician Decision|0|||
42231192|NCT01307033|76051870|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
42302536|NCT02416453|76137799|FG009|Overall Study|Lost to Follow-up|0|||
42302537|NCT02416453|76137800|FG010|Overall Study|Lost to Follow-up|0|||
41986920|NCT04021862|75794129|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
41986921|NCT04021862|75794130|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
41986922|NCT04021862|75794131|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
41986923|NCT04021862|75794132|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
42302538|NCT02416453|76137790|FG000|Overall Study|Physician Decision|0|||
42231193|NCT01307033|76051871|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
42231194|NCT01307033|76051872|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
42272659|NCT01657760|76102926|FG000|Overall Study|Withdrawal by Subject|0|||
42231195|NCT01307033|76051873|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
42231196|NCT01307033|76051870|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
42231197|NCT01307033|76051871|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
42231198|NCT01307033|76051872|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
42231199|NCT01307033|76051873|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
42231200|NCT01307033|76051870|FG000|44-week Open-label Extension|Death|0|||
42231201|NCT01307033|76051871|FG001|44-week Open-label Extension|Death|0|||
42231202|NCT01307033|76051872|FG002|44-week Open-label Extension|Death|0|||
42231203|NCT01307033|76051873|FG003|44-week Open-label Extension|Death|1|||
42231204|NCT02844920|76051885|FG000|Overall Study|Lost to Follow-up|2|||
42231205|NCT03158311|76051892|FG000|Overall Study|Subject/Guardian Decision|10|||
42231206|NCT03158311|76051893|FG001|Overall Study|Subject/Guardian Decision|6|||
42231207|NCT03158311|76051894|FG002|Overall Study|Subject/Guardian Decision|11|||
42231208|NCT03158311|76051892|FG000|Overall Study|Adverse Event|5|||
42231209|NCT03158311|76051893|FG001|Overall Study|Adverse Event|3|||
41986924|NCT04021862|75794133|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
41986925|NCT04021862|75794134|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
41986926|NCT04021862|75794129|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
41986927|NCT04021862|75794130|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
41986928|NCT04021862|75794131|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
42231210|NCT03158311|76051894|FG002|Overall Study|Adverse Event|3|||
42231211|NCT03158311|76051892|FG000|Overall Study|Techinical Problems|3|||
42231212|NCT03158311|76051893|FG001|Overall Study|Techinical Problems|1|||
42231213|NCT03158311|76051894|FG002|Overall Study|Techinical Problems|5|||
42231214|NCT03158311|76051892|FG000|Overall Study|Physician Decision|2|||
42231215|NCT03158311|76051893|FG001|Overall Study|Physician Decision|3|||
42231216|NCT03158311|76051894|FG002|Overall Study|Physician Decision|7|||
42231217|NCT03158311|76051892|FG000|Overall Study|Lost to Follow-up|1|||
42231218|NCT03158311|76051893|FG001|Overall Study|Lost to Follow-up|1|||
42231219|NCT03158311|76051894|FG002|Overall Study|Lost to Follow-up|1|||
42231220|NCT03158311|76051892|FG000|Overall Study|Sponsor decision|1|||
42231221|NCT03158311|76051893|FG001|Overall Study|Sponsor decision|0|||
42231222|NCT03158311|76051894|FG002|Overall Study|Sponsor decision|0|||
42231223|NCT03158311|76051892|FG000|Overall Study|Pregnancy|0|||
42231224|NCT03158311|76051893|FG001|Overall Study|Pregnancy|2|||
42231225|NCT03158311|76051894|FG002|Overall Study|Pregnancy|0|||
42231226|NCT03158311|76051892|FG000|Overall Study|Randomized in error|0|||
42231227|NCT03158311|76051893|FG001|Overall Study|Randomized in error|0|||
42231228|NCT03158311|76051894|FG002|Overall Study|Randomized in error|1|||
42231229|NCT01336621|76051906|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
42231230|NCT01336621|76051906|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
42231231|NCT01336621|76051906|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
42231232|NCT01336621|76051906|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
42231233|NCT01336621|76051906|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
42231234|NCT01336621|76051906|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
42231235|NCT01336621|76051906|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
42231236|NCT01336621|76051906|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
42231237|NCT01336621|76051906|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
42231238|NCT01336621|76051906|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
42231239|NCT01336621|76051906|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
42231240|NCT01336621|76051906|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
42231241|NCT01336621|76051906|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
42231242|NCT01336621|76051906|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
42231243|NCT00383435|76051918|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
42231244|NCT00383435|76051919|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
42231245|NCT00383435|76051920|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
41986929|NCT04021862|75794132|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
41986930|NCT04021862|75794133|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
41986931|NCT04021862|75794134|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
41986932|NCT04003155|75794151|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
41986933|NCT04003155|75794152|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
41986934|NCT04003155|75794153|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
41986935|NCT04003155|75794154|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
41986936|NCT04003155|75794155|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
41986937|NCT04003155|75794151|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
42231246|NCT00383435|76051921|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
42231247|NCT00383435|76051922|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
42231248|NCT00383435|76051918|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
41986938|NCT04003155|75794152|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
42010522|NCT00996307|75817649|FG002|Overall Study|Adverse Event|0|||
42231249|NCT00383435|76051919|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
42231250|NCT00383435|76051920|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
42231251|NCT00383435|76051921|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
42231252|NCT00383435|76051922|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
42231253|NCT00383435|76051918|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
41986939|NCT04003155|75794153|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
41986940|NCT04003155|75794154|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
42231254|NCT00383435|76051919|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
42231255|NCT00383435|76051920|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
42231256|NCT00383435|76051921|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
42231257|NCT00383435|76051922|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
42231258|NCT00383435|76051918|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
41986941|NCT04003155|75794155|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
41986942|NCT04003155|75794151|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
41986943|NCT04003155|75794152|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
41986944|NCT04003155|75794153|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
41986945|NCT04003155|75794154|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
41986946|NCT04003155|75794155|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
41986947|NCT04003155|75794151|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
41986948|NCT04003155|75794152|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
41986949|NCT04003155|75794153|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
41986950|NCT04003155|75794154|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
41986951|NCT04003155|75794155|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
41986952|NCT04003155|75794151|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
41986953|NCT04003155|75794152|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
41986954|NCT04003155|75794153|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
41986955|NCT04003155|75794154|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
41986956|NCT04003155|75794155|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
41986957|NCT04003155|75794151|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
41986958|NCT04003155|75794152|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
41986959|NCT04003155|75794153|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
41986960|NCT04003155|75794154|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
41986961|NCT04003155|75794155|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
41986962|NCT04003155|75794151|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
41986963|NCT04003155|75794152|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
41986964|NCT04003155|75794153|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
41986965|NCT04003155|75794154|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
41986966|NCT04003155|75794155|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
41986967|NCT04003155|75794151|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
41986968|NCT04003155|75794152|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
41986969|NCT04003155|75794153|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
41986970|NCT04003155|75794154|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
41986971|NCT04003155|75794155|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
41986972|NCT04003155|75794151|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
41986973|NCT04003155|75794152|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
41986974|NCT04003155|75794153|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
41986975|NCT04003155|75794154|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
42032539|NCT00951015|75840755|FG004|Open-label Phase|Lost to Follow-up|12|||
42032540|NCT00951015|75840751|FG000|Open-label Phase|Withdrawal by Subject|0|||
42231259|NCT00383435|76051919|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
42231260|NCT00383435|76051920|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
42231261|NCT00383435|76051921|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
42231262|NCT00383435|76051922|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
42231263|NCT00383435|76051918|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
42231264|NCT00383435|76051919|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
42231265|NCT00383435|76051920|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
42231266|NCT00383435|76051921|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
42231267|NCT00383435|76051922|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
42231268|NCT00383435|76051918|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
42231269|NCT00383435|76051919|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
42231270|NCT00383435|76051920|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
42231271|NCT00383435|76051921|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
42032541|NCT00951015|75840752|FG001|Open-label Phase|Withdrawal by Subject|0|||
42231272|NCT00383435|76051922|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
42231273|NCT00383435|76051918|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
42231274|NCT00383435|76051919|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
42231275|NCT00383435|76051920|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
42231276|NCT00383435|76051921|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
41986976|NCT04003155|75794155|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
42231277|NCT00383435|76051922|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
42231278|NCT00383435|76051918|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
42231279|NCT00383435|76051919|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
42032542|NCT00951015|75840753|FG002|Open-label Phase|Withdrawal by Subject|0|||
42231280|NCT00383435|76051920|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
42231281|NCT00383435|76051921|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
42231282|NCT00383435|76051922|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
42231283|NCT00383435|76051918|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
42231284|NCT00383435|76051919|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
42231285|NCT00383435|76051920|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
42231286|NCT00383435|76051921|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
42231287|NCT00383435|76051922|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
42231288|NCT00383435|76051918|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
42231289|NCT00383435|76051919|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
42231290|NCT00383435|76051920|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
42231291|NCT00383435|76051921|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
42231292|NCT00383435|76051922|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
42231293|NCT00383435|76051918|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
42231294|NCT00383435|76051919|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
42231295|NCT00383435|76051920|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
42231296|NCT00383435|76051921|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
42231297|NCT00383435|76051922|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
42231298|NCT00383435|76051918|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
42231299|NCT00383435|76051919|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
42231300|NCT00383435|76051920|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
42231301|NCT00383435|76051921|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
42231302|NCT00383435|76051922|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
42231303|NCT00383435|76051918|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
42231304|NCT00383435|76051919|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
42231305|NCT00383435|76051920|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
42231306|NCT00383435|76051921|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
42231307|NCT00383435|76051922|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
42231308|NCT00383435|76051918|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
42231309|NCT00383435|76051919|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
42231310|NCT00383435|76051920|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
42231311|NCT00383435|76051921|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
42231312|NCT00383435|76051922|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
42231313|NCT00383435|76051918|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
42231314|NCT00383435|76051919|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
42231315|NCT00383435|76051920|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
42231316|NCT00383435|76051921|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
42231317|NCT00383435|76051922|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
41986977|NCT04003142|75794176|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
41986978|NCT04003142|75794177|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
41986979|NCT04003142|75794178|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
41986980|NCT04003142|75794179|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
41986981|NCT04003142|75794180|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
41986982|NCT04003142|75794176|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
41986983|NCT04003142|75794177|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
41986984|NCT04003142|75794178|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
41986985|NCT04003142|75794179|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
41986986|NCT04003142|75794180|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
41986987|NCT04003142|75794176|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
41986988|NCT04003142|75794177|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
42231318|NCT00383435|76051918|FG000|26-Week Treatment Safety Extension|Administrative|1|||
42231319|NCT00383435|76051919|FG001|26-Week Treatment Safety Extension|Administrative|1|||
42231320|NCT00383435|76051920|FG002|26-Week Treatment Safety Extension|Administrative|0|||
42032543|NCT00951015|75840754|FG003|Open-label Phase|Withdrawal by Subject|0|||
41986989|NCT04003142|75794178|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
42032544|NCT00951015|75840755|FG004|Open-label Phase|Withdrawal by Subject|14|||
42032545|NCT00951015|75840751|FG000|Open-label Phase|Physician Decision|0|||
41986990|NCT04003142|75794179|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
41986991|NCT04003142|75794180|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
41986992|NCT04003142|75794176|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
41986993|NCT04003142|75794177|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
41986994|NCT04003142|75794178|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
41986995|NCT04003142|75794179|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
41986996|NCT04003142|75794180|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
41986997|NCT04003142|75794176|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
41986998|NCT04003142|75794177|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
41986999|NCT04003142|75794178|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
41987000|NCT04003142|75794179|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
41987001|NCT04003142|75794180|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
41987002|NCT04003142|75794176|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
41987003|NCT04003142|75794177|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
41987004|NCT04003142|75794178|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
41987005|NCT04003142|75794179|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
41987006|NCT04003142|75794180|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
41987007|NCT04003142|75794176|FG000|Extension Period (40 Weeks)|Death|0|||
41987008|NCT04003142|75794177|FG001|Extension Period (40 Weeks)|Death|0|||
41987009|NCT04003142|75794178|FG002|Extension Period (40 Weeks)|Death|0|||
42231321|NCT00383435|76051921|FG003|26-Week Treatment Safety Extension|Administrative|1|||
42231322|NCT00383435|76051922|FG004|26-Week Treatment Safety Extension|Administrative|0|||
42231323|NCT03157037|76051934|FG000|Overall Study|Death|1|||
42231324|NCT00381485|76051956|FG000|Open-Label Run-In Period|Adverse Event|9|||
42231325|NCT00381485|76051957|FG001|Open-Label Run-In Period|Adverse Event|0|||
42231326|NCT00381485|76051958|FG002|Open-Label Run-In Period|Adverse Event|0|||
42231327|NCT00381485|76051959|FG003|Open-Label Run-In Period|Adverse Event|0|||
42231328|NCT00381485|76051956|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
42231329|NCT00381485|76051957|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
42231330|NCT00381485|76051958|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
42231331|NCT00381485|76051959|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
42231332|NCT00381485|76051956|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
42231333|NCT00381485|76051957|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
42231334|NCT00381485|76051958|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
42231335|NCT00381485|76051959|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
42231336|NCT00381485|76051956|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
42231337|NCT00381485|76051957|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
42231338|NCT00381485|76051958|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
42231339|NCT00381485|76051959|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
42231340|NCT00381485|76051956|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
42231341|NCT00381485|76051957|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
42231342|NCT00381485|76051958|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
42231343|NCT00381485|76051959|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
42231344|NCT00381485|76051956|FG000|Open-Label Run-In Period|Treatment failure|1|||
42231345|NCT00381485|76051957|FG001|Open-Label Run-In Period|Treatment failure|0|||
42231346|NCT00381485|76051958|FG002|Open-Label Run-In Period|Treatment failure|0|||
42231347|NCT00381485|76051959|FG003|Open-Label Run-In Period|Treatment failure|0|||
42231348|NCT00381485|76051956|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42231349|NCT00381485|76051957|FG001|Double-Blind Treatment Period|Adverse Event|2|||
42231350|NCT00381485|76051958|FG002|Double-Blind Treatment Period|Adverse Event|2|||
42231351|NCT00381485|76051959|FG003|Double-Blind Treatment Period|Adverse Event|5|||
42231352|NCT00381485|76051956|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
42231353|NCT00381485|76051957|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
42231354|NCT00381485|76051958|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
42231355|NCT00381485|76051959|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
42231356|NCT00381485|76051956|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
42231357|NCT00381485|76051957|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
42231358|NCT00381485|76051958|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
42231359|NCT00381485|76051959|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
42231360|NCT00381485|76051956|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
41987010|NCT04003142|75794179|FG003|Extension Period (40 Weeks)|Death|0|||
42032546|NCT00951015|75840752|FG001|Open-label Phase|Physician Decision|0|||
42032547|NCT00951015|75840753|FG002|Open-label Phase|Physician Decision|0|||
42032548|NCT00951015|75840754|FG003|Open-label Phase|Physician Decision|0|||
42032549|NCT00951015|75840755|FG004|Open-label Phase|Physician Decision|8|||
41987011|NCT04003142|75794180|FG004|Extension Period (40 Weeks)|Death|1|||
42032550|NCT01139021|75840784|FG000|Overall Study|Adverse Event|0|||
42032551|NCT01139021|75840785|FG001|Overall Study|Adverse Event|0|||
42032552|NCT01139021|75840786|FG002|Overall Study|Adverse Event|0|||
42231361|NCT00381485|76051957|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
42231362|NCT00381485|76051958|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
42231363|NCT00381485|76051959|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
42231364|NCT00381485|76051956|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
42231365|NCT00381485|76051957|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
42231366|NCT00381485|76051958|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
42231367|NCT00381485|76051959|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
42231368|NCT00381485|76051956|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
42231369|NCT00381485|76051957|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
42231370|NCT00381485|76051958|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
42231371|NCT00381485|76051959|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
42231372|NCT00381485|76051956|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
42231373|NCT00381485|76051957|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
42231374|NCT00381485|76051958|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
42231375|NCT00381485|76051959|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
42231376|NCT00381485|76051956|FG000|Double-Blind Treatment Period|Administrative|0|||
42231377|NCT00381485|76051957|FG001|Double-Blind Treatment Period|Administrative|1|||
42231378|NCT00381485|76051958|FG002|Double-Blind Treatment Period|Administrative|0|||
42231379|NCT00381485|76051959|FG003|Double-Blind Treatment Period|Administrative|1|||
42231380|NCT02840474|76051970|FG000|Overall Study|Lost to Follow-up|1|||
42231381|NCT02840474|76051971|FG001|Overall Study|Lost to Follow-up|0|||
42231382|NCT03155945|76051979|FG000|Overall Study|Lost to Follow-up|0|||
42231383|NCT03155945|76051980|FG001|Overall Study|Lost to Follow-up|1|||
42231384|NCT03155945|76051979|FG000|Overall Study|Withdrawal by Subject|0|||
42231385|NCT03155945|76051980|FG001|Overall Study|Withdrawal by Subject|1|||
42231386|NCT03155945|76051979|FG000|Overall Study|Other Reason|0|||
42231387|NCT03155945|76051980|FG001|Overall Study|Other Reason|1|||
42231388|NCT03160703|76051990|FG000|Overall Study|Withdrawal by Subject|0|||
42231389|NCT03160703|76051991|FG001|Overall Study|Withdrawal by Subject|0|||
42231390|NCT03160703|76051992|FG002|Overall Study|Withdrawal by Subject|0|||
42231391|NCT03160703|76051993|FG003|Overall Study|Withdrawal by Subject|1|||
42231392|NCT03159611|76052005|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
42231393|NCT03159611|76052006|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
42231394|NCT03159611|76052005|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
42231395|NCT03159611|76052006|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
42231396|NCT03159611|76052005|FG000|Overall Study|Protocol Violation|7|||
42231397|NCT03159611|76052006|FG001|Overall Study|Protocol Violation|4|||
42231398|NCT03159611|76052005|FG000|Overall Study|Adverse Event|1|||
42231399|NCT03159611|76052006|FG001|Overall Study|Adverse Event|0|||
42231400|NCT03159611|76052005|FG000|Overall Study|Withdrawal by Subject|1|||
42231401|NCT03159611|76052006|FG001|Overall Study|Withdrawal by Subject|1|||
42231402|NCT03159611|76052005|FG000|Overall Study|Non-compliance with protocol requirement|3|||
42231403|NCT03159611|76052006|FG001|Overall Study|Non-compliance with protocol requirement|2|||
42231404|NCT03159611|76052005|FG000|Overall Study|Inability to perform procedures|1|||
42032553|NCT01139021|75840787|FG003|Overall Study|Adverse Event|0|||
42032554|NCT01139021|75840788|FG004|Overall Study|Adverse Event|1|||
41987012|NCT04003142|75794176|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
41987013|NCT04003142|75794177|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
41987014|NCT04003142|75794178|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
41987015|NCT04003142|75794179|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
41987016|NCT04003142|75794180|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
41987017|NCT04003142|75794176|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
41987018|NCT04003142|75794177|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
42032555|NCT01139021|75840789|FG005|Overall Study|Adverse Event|0|||
42032556|NCT01139021|75840784|FG000|Overall Study|Lost to Follow-up|0|||
42032557|NCT01139021|75840785|FG001|Overall Study|Lost to Follow-up|0|||
42032558|NCT01139021|75840786|FG002|Overall Study|Lost to Follow-up|0|||
42231405|NCT03159611|76052006|FG001|Overall Study|Inability to perform procedures|0|||
42231406|NCT03159455|76052018|FG000|Overall Study|Adverse Event|0|||
42231407|NCT03159455|76052019|FG001|Overall Study|Adverse Event|0|||
42231408|NCT03159455|76052020|FG002|Overall Study|Adverse Event|0|||
42231409|NCT03159455|76052021|FG003|Overall Study|Adverse Event|0|||
42231410|NCT03159455|76052022|FG004|Overall Study|Adverse Event|0|||
42231411|NCT03159455|76052023|FG005|Overall Study|Adverse Event|1|||
41987019|NCT04003142|75794178|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
42231412|NCT02838134|76052043|FG000|Overall Study|Lost to Follow-up|1|||
42231413|NCT02838134|76052044|FG001|Overall Study|Lost to Follow-up|2|||
41987020|NCT04003142|75794179|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
42231414|NCT02838134|76052043|FG000|Overall Study|logistic problems|1|||
41987021|NCT04003142|75794180|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
41987022|NCT04003142|75794176|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
42032559|NCT01139021|75840787|FG003|Overall Study|Lost to Follow-up|0|||
42032560|NCT01139021|75840788|FG004|Overall Study|Lost to Follow-up|2|||
42231415|NCT02838134|76052044|FG001|Overall Study|logistic problems|1|||
42231416|NCT03150589|76052052|FG000|Overall Study|Withdrawal by Subject|16|||
42231417|NCT03150589|76052053|FG001|Overall Study|Withdrawal by Subject|9|||
42231418|NCT03150589|76052052|FG000|Overall Study|Adverse Event|7|||
42231419|NCT03150589|76052053|FG001|Overall Study|Adverse Event|6|||
42231420|NCT03150589|76052052|FG000|Overall Study|Protocol Violation|4|||
42231421|NCT03150589|76052053|FG001|Overall Study|Protocol Violation|3|||
42231422|NCT03150589|76052052|FG000|Overall Study|Lost to Follow-up|3|||
42231423|NCT03150589|76052053|FG001|Overall Study|Lost to Follow-up|3|||
42231424|NCT03150589|76052052|FG000|Overall Study|Death|2|||
42231425|NCT03150589|76052053|FG001|Overall Study|Death|3|||
42231426|NCT03150589|76052052|FG000|Overall Study|IP non-compliance and other reasons|12|||
42231427|NCT03150589|76052053|FG001|Overall Study|IP non-compliance and other reasons|3|||
42231428|NCT02835092|76052062|FG000|Overall Study|Withdrawal by Subject|3|||
42231429|NCT02835092|76052063|FG001|Overall Study|Withdrawal by Subject|6|||
42231430|NCT02835092|76052064|FG002|Overall Study|Withdrawal by Subject|3|||
42231431|NCT02835092|76052062|FG000|Overall Study|Lost to Follow-up|0|||
42231432|NCT02835092|76052063|FG001|Overall Study|Lost to Follow-up|2|||
42231433|NCT02835092|76052064|FG002|Overall Study|Lost to Follow-up|0|||
42231434|NCT03145207|76052072|FG000|Overall Study|volunteer started taking allergy shots|1|||
42231435|NCT03145207|76052072|FG000|Overall Study|baseline blood pressure high|1|||
42231436|NCT02836652|76052089|FG000|Overall Study|Death|3|||
42231437|NCT02836652|76052090|FG001|Overall Study|Death|3|||
42231438|NCT02836652|76052089|FG000|Overall Study|Transplant/Explant|3|||
42231439|NCT02836652|76052090|FG001|Overall Study|Transplant/Explant|4|||
42231440|NCT02836652|76052089|FG000|Overall Study|Withdrawn|9|||
42231441|NCT02836652|76052090|FG001|Overall Study|Withdrawn|9|||
42231442|NCT02836652|76052089|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
42231443|NCT02836652|76052090|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
42231444|NCT02836496|76052098|FG000|Overall Study|Adverse Event|2|||
42231445|NCT02836496|76052099|FG001|Overall Study|Adverse Event|1|||
42231446|NCT02836496|76052098|FG000|Overall Study|Withdrawal by Subject|0|||
42231447|NCT02836496|76052099|FG001|Overall Study|Withdrawal by Subject|1|||
42231448|NCT04213807|76052108|FG000|Overall Study|Physician Decision|0|||
42231449|NCT04213807|76052109|FG001|Overall Study|Physician Decision|0|||
42231450|NCT04213807|76052110|FG002|Overall Study|Physician Decision|1|||
42231451|NCT00577577|76052129|FG000|Overall Study|Adverse Event|3|||
42231452|NCT00577577|76052130|FG001|Overall Study|Adverse Event|2|||
42231453|NCT00577577|76052129|FG000|Overall Study|Lost to Follow-up|1|||
42231454|NCT00577577|76052130|FG001|Overall Study|Lost to Follow-up|0|||
41987023|NCT04003142|75794177|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
41987024|NCT04003142|75794178|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
41987025|NCT04003142|75794179|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
41987026|NCT04003142|75794180|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
41987027|NCT04003142|75794176|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
41987028|NCT04003142|75794177|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
41987029|NCT04003142|75794178|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
41987030|NCT04003142|75794179|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
42032561|NCT01139021|75840789|FG005|Overall Study|Lost to Follow-up|0|||
42032562|NCT01139021|75840784|FG000|Overall Study|Protocol Violation|1|||
42032563|NCT01139021|75840785|FG001|Overall Study|Protocol Violation|0|||
42032564|NCT01139021|75840786|FG002|Overall Study|Protocol Violation|0|||
42032565|NCT01139021|75840787|FG003|Overall Study|Protocol Violation|0|||
42231455|NCT00577577|76052129|FG000|Overall Study|Protocol Violation|0|||
42231456|NCT00577577|76052130|FG001|Overall Study|Protocol Violation|3|||
42231457|NCT00577577|76052129|FG000|Overall Study|Transportation|1|||
42231458|NCT00577577|76052130|FG001|Overall Study|Transportation|0|||
42231459|NCT02833844|76052138|FG000|Double-Blind Period|Withdrawal by Subject|2|||
42231460|NCT02833844|76052139|FG001|Double-Blind Period|Withdrawal by Subject|3|||
42231461|NCT02833844|76052138|FG000|Double-Blind Period|Protocol Violation|0|||
42231462|NCT02833844|76052139|FG001|Double-Blind Period|Protocol Violation|4|||
42231463|NCT02833844|76052138|FG000|Open-Label Period|Death|0|||
42231464|NCT02833844|76052139|FG001|Open-Label Period|Death|2|||
42231465|NCT02833844|76052138|FG000|Open-Label Period|Lost to Follow-up|1|||
42032566|NCT01139021|75840788|FG004|Overall Study|Protocol Violation|2|||
42231466|NCT02833844|76052139|FG001|Open-Label Period|Lost to Follow-up|0|||
42231467|NCT02833844|76052138|FG000|Open-Label Period|Withdrawal by Subject|1|||
42231468|NCT02833844|76052139|FG001|Open-Label Period|Withdrawal by Subject|0|||
42231469|NCT01341782|76052149|FG000|Overall Study|Adverse Event|1|||
42231470|NCT01341782|76052150|FG001|Overall Study|Adverse Event|1|||
42231471|NCT01341782|76052149|FG000|Overall Study|Withdrawal by Subject|6|||
42231472|NCT01341782|76052150|FG001|Overall Study|Withdrawal by Subject|5|||
41987031|NCT04003142|75794180|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
42032567|NCT01139021|75840789|FG005|Overall Study|Protocol Violation|0|||
42032568|NCT01139021|75840784|FG000|Overall Study|Withdrawal by Subject|0|||
42231473|NCT01341782|76052149|FG000|Overall Study|Missed 3 consecutive doses|0|||
42231474|NCT01341782|76052150|FG001|Overall Study|Missed 3 consecutive doses|4|||
42231475|NCT01341782|76052149|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
42231476|NCT01341782|76052150|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
42231477|NCT01341782|76052149|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
42231478|NCT01341782|76052150|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
42231479|NCT01341782|76052149|FG000|Overall Study|Other|5|||
42231480|NCT01341782|76052150|FG001|Overall Study|Other|0|||
42231481|NCT01341470|76052162|FG000|Overall Study|Sponsor decision|0|||
42231482|NCT01341470|76052163|FG001|Overall Study|Sponsor decision|0|||
42231483|NCT01341470|76052164|FG002|Overall Study|Sponsor decision|1|||
42231484|NCT01341470|76052165|FG003|Overall Study|Sponsor decision|1|||
42231485|NCT01341470|76052166|FG004|Overall Study|Sponsor decision|0|||
42231486|NCT01341470|76052167|FG005|Overall Study|Sponsor decision|1|||
42231487|NCT03143101|76052186|FG000|Overall Study|Withdrawal by Subject|0|||
42231488|NCT03143101|76052187|FG001|Overall Study|Withdrawal by Subject|1|||
42231489|NCT03143101|76052188|FG002|Overall Study|Withdrawal by Subject|0|||
42231490|NCT03143101|76052186|FG000|Overall Study|Lost to Follow-up|2|||
42231491|NCT03143101|76052187|FG001|Overall Study|Lost to Follow-up|2|||
42231492|NCT03143101|76052188|FG002|Overall Study|Lost to Follow-up|0|||
42231493|NCT00871351|76052199|FG000|Overall Study|Withdrawal by Subject|1|||
42231494|NCT00871351|76052200|FG001|Overall Study|Withdrawal by Subject|0|||
42231495|NCT00871351|76052201|FG002|Overall Study|Withdrawal by Subject|0|||
42231496|NCT00871351|76052199|FG000|Overall Study|Adverse Event|3|||
42231497|NCT00871351|76052200|FG001|Overall Study|Adverse Event|1|||
42231498|NCT00871351|76052201|FG002|Overall Study|Adverse Event|0|||
42231499|NCT02745080|76052211|FG000|Overall Study|Adverse Event|13|||
42231500|NCT02745080|76052212|FG001|Overall Study|Adverse Event|21|||
42231501|NCT02745080|76052211|FG000|Overall Study|Lack of Efficacy|11|||
42231502|NCT02745080|76052212|FG001|Overall Study|Lack of Efficacy|23|||
42231503|NCT02745080|76052211|FG000|Overall Study|Lost to Follow-up|3|||
42231504|NCT02745080|76052212|FG001|Overall Study|Lost to Follow-up|3|||
42231505|NCT02745080|76052211|FG000|Overall Study|Physician Decision|3|||
42231506|NCT02745080|76052212|FG001|Overall Study|Physician Decision|0|||
42231507|NCT02745080|76052211|FG000|Overall Study|Protocol Violation|3|||
42231508|NCT02745080|76052212|FG001|Overall Study|Protocol Violation|1|||
42231509|NCT02745080|76052211|FG000|Overall Study|Withdrawal by Subject|22|||
42231510|NCT02745080|76052212|FG001|Overall Study|Withdrawal by Subject|41|||
42231511|NCT00521599|76052222|FG000|Overall Study|Adverse Event|5|||
42231512|NCT00521599|76052223|FG001|Overall Study|Adverse Event|7|||
42231513|NCT00521599|76052224|FG002|Overall Study|Adverse Event|6|||
42231514|NCT00521599|76052222|FG000|Overall Study|Treatment Failure|8|||
42231515|NCT00521599|76052223|FG001|Overall Study|Treatment Failure|9|||
42231516|NCT00521599|76052224|FG002|Overall Study|Treatment Failure|22|||
42231517|NCT00521599|76052222|FG000|Overall Study|Lost to Follow-up|2|||
42231518|NCT00521599|76052223|FG001|Overall Study|Lost to Follow-up|1|||
42231519|NCT00521599|76052224|FG002|Overall Study|Lost to Follow-up|2|||
42231520|NCT00521599|76052222|FG000|Overall Study|Withdrawal by Subject|3|||
42231521|NCT00521599|76052223|FG001|Overall Study|Withdrawal by Subject|5|||
42231522|NCT00521599|76052224|FG002|Overall Study|Withdrawal by Subject|1|||
42302539|NCT02416453|76137791|FG001|Overall Study|Physician Decision|0|||
41987032|NCT03971422|75794201|FG000|Overall Study|Lost to Follow-up|0|||
41987033|NCT03971422|75794202|FG001|Overall Study|Lost to Follow-up|1|||
41987034|NCT03971422|75794203|FG002|Overall Study|Lost to Follow-up|0|||
41987035|NCT03971422|75794201|FG000|Overall Study|Lack of Efficacy|5|||
41987036|NCT03971422|75794202|FG001|Overall Study|Lack of Efficacy|1|||
41987037|NCT03971422|75794203|FG002|Overall Study|Lack of Efficacy|1|||
41987038|NCT03971422|75794201|FG000|Overall Study|Adverse event, not fatal|2|||
41987039|NCT03971422|75794202|FG001|Overall Study|Adverse event, not fatal|2|||
41987040|NCT03971422|75794203|FG002|Overall Study|Adverse event, not fatal|5|||
41987041|NCT03971422|75794201|FG000|Overall Study|Worsening of MG Symptoms|1|||
41987042|NCT03971422|75794202|FG001|Overall Study|Worsening of MG Symptoms|4|||
41987043|NCT03971422|75794203|FG002|Overall Study|Worsening of MG Symptoms|2|||
42131772|NCT00414609|75942695|FG000|Core Study|Abnormal laboratory values|0|||
42231523|NCT00521599|76052222|FG000|Overall Study|Withdrawal by subject treatment related|3|||
42231524|NCT00521599|76052223|FG001|Overall Study|Withdrawal by subject treatment related|1|||
42231525|NCT00521599|76052224|FG002|Overall Study|Withdrawal by subject treatment related|2|||
42302540|NCT02416453|76137792|FG002|Overall Study|Physician Decision|0|||
42231526|NCT00521599|76052222|FG000|Overall Study|Protocol Violation|2|||
42302541|NCT02416453|76137793|FG003|Overall Study|Physician Decision|0|||
41987044|NCT03971422|75794201|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
42231527|NCT00521599|76052223|FG001|Overall Study|Protocol Violation|4|||
41987045|NCT03971422|75794202|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
41987046|NCT03971422|75794203|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
41987047|NCT03971422|75794201|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
42231528|NCT00521599|76052224|FG002|Overall Study|Protocol Violation|2|||
42231529|NCT00521599|76052222|FG000|Overall Study|Did not meet protocol eligibility|2|||
42302542|NCT02416453|76137794|FG004|Overall Study|Physician Decision|0|||
42231530|NCT00521599|76052223|FG001|Overall Study|Did not meet protocol eligibility|2|||
42231531|NCT00521599|76052224|FG002|Overall Study|Did not meet protocol eligibility|1|||
42231532|NCT00442897|76052235|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
42231533|NCT00442897|76052236|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
42231534|NCT00442897|76052235|FG000|Base Study (12 Week Follow-up)|Death|0|||
42231535|NCT00442897|76052236|FG001|Base Study (12 Week Follow-up)|Death|1|||
42231536|NCT00442897|76052235|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
42231537|NCT00442897|76052236|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
42231538|NCT00442897|76052235|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
42231539|NCT00442897|76052236|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
42231540|NCT00442897|76052235|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
42231541|NCT00442897|76052236|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
42231542|NCT00442897|76052235|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
42231543|NCT00442897|76052236|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
42231544|NCT00442897|76052235|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
42231545|NCT00442897|76052236|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
42231546|NCT00442897|76052235|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
42231547|NCT00442897|76052236|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
42231548|NCT02834390|76052244|FG000|Induction Phase|Progressive disease|0|||
42231549|NCT02834390|76052245|FG001|Induction Phase|Progressive disease|1|||
42231550|NCT02834390|76052244|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
42231551|NCT02834390|76052245|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
42231552|NCT02834390|76052244|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
42231553|NCT02834390|76052245|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
42231554|NCT02834390|76052244|FG000|Consolidation Phase|Physician Decision|1|||
42231555|NCT02834390|76052245|FG001|Consolidation Phase|Physician Decision|1|||
42231556|NCT03141151|76052253|FG000|Overall Study|Lost to Follow-up|3|||
42231557|NCT03141151|76052254|FG001|Overall Study|Lost to Follow-up|2|||
42231558|NCT03141151|76052253|FG000|Overall Study|Withdrawal by Subject|3|||
42231559|NCT03141151|76052254|FG001|Overall Study|Withdrawal by Subject|2|||
42231560|NCT01358708|76052262|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
42231561|NCT01358708|76052263|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
42231562|NCT01358708|76052262|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
42231563|NCT01358708|76052263|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
42231564|NCT01356602|76052276|FG000|Overall Study|Protocol Deviation|0|||
42231565|NCT01356602|76052277|FG001|Overall Study|Protocol Deviation|1|||
42231566|NCT01356602|76052278|FG002|Overall Study|Protocol Deviation|1|||
42231567|NCT01356602|76052276|FG000|Overall Study|Administrative Problems|1|||
42231568|NCT01356602|76052277|FG001|Overall Study|Administrative Problems|4|||
42231569|NCT01356602|76052278|FG002|Overall Study|Administrative Problems|5|||
42231570|NCT01356602|76052276|FG000|Overall Study|Lost to Follow-up|4|||
42231571|NCT01356602|76052277|FG001|Overall Study|Lost to Follow-up|5|||
42231572|NCT01356602|76052278|FG002|Overall Study|Lost to Follow-up|6|||
42231573|NCT01356602|76052276|FG000|Overall Study|Withdrawal by Subject|4|||
42231574|NCT01356602|76052277|FG001|Overall Study|Withdrawal by Subject|3|||
42231575|NCT01356602|76052278|FG002|Overall Study|Withdrawal by Subject|7|||
42231576|NCT01356602|76052276|FG000|Overall Study|Lack of Efficacy|0|||
42231577|NCT01356602|76052277|FG001|Overall Study|Lack of Efficacy|1|||
42231578|NCT01356602|76052278|FG002|Overall Study|Lack of Efficacy|4|||
42231579|NCT01356602|76052276|FG000|Overall Study|Adverse Event|0|||
42231580|NCT01356602|76052277|FG001|Overall Study|Adverse Event|1|||
42231581|NCT01356602|76052278|FG002|Overall Study|Adverse Event|1|||
42231582|NCT02830880|76052286|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
42231583|NCT02830880|76052286|FG000|Overall Study|Death|1|||
42231584|NCT02830880|76052286|FG000|Overall Study|Physician Decision|1|||
42231585|NCT03141307|76052292|FG000|In-Hospital|Withdrawal by Subject|0|||
42231586|NCT03141307|76052293|FG001|In-Hospital|Withdrawal by Subject|2|||
42231587|NCT03141307|76052292|FG000|In-Hospital|Protocol Violation|4|||
42231588|NCT03141307|76052293|FG001|In-Hospital|Protocol Violation|0|||
42231589|NCT03141307|76052292|FG000|Follow-Up|Lost to Follow-up|97|||
42231590|NCT03141307|76052293|FG001|Follow-Up|Lost to Follow-up|54|||
42231591|NCT02825420|76052301|FG000|Overall Study|Death|30|||
42231592|NCT02825420|76052302|FG001|Overall Study|Death|12|||
42231593|NCT02825420|76052301|FG000|Overall Study|Progressive disease|6|||
42231594|NCT02825420|76052302|FG001|Overall Study|Progressive disease|1|||
42231595|NCT02825420|76052301|FG000|Overall Study|Lost to Follow-up|2|||
42231596|NCT02825420|76052302|FG001|Overall Study|Lost to Follow-up|2|||
42231597|NCT02825420|76052301|FG000|Overall Study|Withdrawal by Subject|1|||
42231598|NCT02825420|76052302|FG001|Overall Study|Withdrawal by Subject|1|||
42231599|NCT02825420|76052301|FG000|Overall Study|Protocol amendment not signed|1|||
42231600|NCT02825420|76052302|FG001|Overall Study|Protocol amendment not signed|1|||
42231601|NCT02825420|76052301|FG000|Overall Study|Physician Decision|1|||
42231602|NCT02825420|76052302|FG001|Overall Study|Physician Decision|0|||
42231603|NCT02825420|76052301|FG000|Overall Study|Did not receive PLD|2|||
42231604|NCT02825420|76052302|FG001|Overall Study|Did not receive PLD|0|||
42231605|NCT02829944|76052315|FG000|Overall Study|Physician Decision|0|||
42231606|NCT02829944|76052316|FG001|Overall Study|Physician Decision|1|||
42231607|NCT02829944|76052315|FG000|Overall Study|Screen Failure|2|||
42231608|NCT02829944|76052316|FG001|Overall Study|Screen Failure|2|||
42231609|NCT02829944|76052315|FG000|Overall Study|Inadequate Neuraxial Block|1|||
42231610|NCT02829944|76052316|FG001|Overall Study|Inadequate Neuraxial Block|1|||
42231611|NCT02829944|76052315|FG000|Overall Study|Withdrawal by Subject|2|||
42231612|NCT02829944|76052316|FG001|Overall Study|Withdrawal by Subject|1|||
42231613|NCT02829944|76052315|FG000|Overall Study|Catheter Displacement|1|||
42231614|NCT02829944|76052316|FG001|Overall Study|Catheter Displacement|0|||
42231615|NCT02829944|76052315|FG000|Overall Study|Catheter broke|0|||
42231616|NCT02829944|76052316|FG001|Overall Study|Catheter broke|1|||
42231617|NCT02829944|76052315|FG000|Overall Study|Staff unavailable|0|||
42231618|NCT02829944|76052316|FG001|Overall Study|Staff unavailable|1|||
42231619|NCT02824562|76052324|FG000|Overall Study|Lost to Follow-up|3|||
42231620|NCT02824562|76052325|FG001|Overall Study|Lost to Follow-up|4|||
42231621|NCT02824562|76052324|FG000|Overall Study|Death|0|||
42231622|NCT02824562|76052325|FG001|Overall Study|Death|1|||
42231623|NCT02744066|76052333|FG000|Overall Study|Withdrawal by parent|0|||
42231624|NCT02744066|76052334|FG001|Overall Study|Withdrawal by parent|1|||
42231625|NCT02744066|76052333|FG000|Overall Study|Discharged from NICU prior to completion|0|||
42231626|NCT02744066|76052334|FG001|Overall Study|Discharged from NICU prior to completion|4|||
42231627|NCT01338818|76052342|FG000|Overall Study|Adverse Event|8|||
42231628|NCT01338818|76052342|FG000|Overall Study|Lack of Efficacy|5|||
42231629|NCT01338818|76052342|FG000|Overall Study|no longer require study drug|1|||
42231630|NCT01338818|76052342|FG000|Overall Study|Withdrawal by Subject|11|||
42231631|NCT01338818|76052342|FG000|Overall Study|Lost to Follow-up|4|||
42231632|NCT01338818|76052342|FG000|Overall Study|Administrative problems|3|||
42231633|NCT01338818|76052342|FG000|Overall Study|Protocol Deviation|4|||
42231634|NCT02823470|76052348|FG000|Overall Study|Adverse Event|1|||
42231635|NCT02823470|76052349|FG001|Overall Study|Adverse Event|0|||
42231636|NCT02823470|76052348|FG000|Overall Study|Study terminated by sponsor|8|||
42231637|NCT02823470|76052349|FG001|Overall Study|Study terminated by sponsor|15|||
42231638|NCT01371656|76052360|FG000|Overall Study|Death|7|||
42231639|NCT01371656|76052361|FG001|Overall Study|Death|4|||
42231640|NCT01371656|76052360|FG000|Overall Study|Physician Decision|46|||
42231641|NCT01371656|76052361|FG001|Overall Study|Physician Decision|7|||
42231642|NCT01371656|76052360|FG000|Overall Study|Withdrawal by Subject|7|||
42231643|NCT01371656|76052361|FG001|Overall Study|Withdrawal by Subject|0|||
42231644|NCT01371656|76052360|FG000|Overall Study|Ineligible|4|||
42231645|NCT01371656|76052361|FG001|Overall Study|Ineligible|3|||
42231646|NCT01354106|76052367|FG000|Overall Study|Withdrawal by Subject|2|||
42231647|NCT01354028|76052373|FG000|Overall Study|Physician Decision|0|||
42231648|NCT01354028|76052374|FG001|Overall Study|Physician Decision|2|||
42231649|NCT01354028|76052373|FG000|Overall Study|Discharged before study start|2|||
42231650|NCT01354028|76052374|FG001|Overall Study|Discharged before study start|2|||
42231651|NCT01354028|76052373|FG000|Overall Study|No quiet alert state|0|||
42231652|NCT01354028|76052374|FG001|Overall Study|No quiet alert state|1|||
42231653|NCT01354964|76052388|FG000|Overall Study|Lost to Follow-up|2|||
42231654|NCT01354964|76052389|FG001|Overall Study|Lost to Follow-up|0|||
42231655|NCT01354964|76052388|FG000|Overall Study|IV access issues|1|||
42231656|NCT01354964|76052389|FG001|Overall Study|IV access issues|1|||
42231657|NCT01354964|76052388|FG000|Overall Study|Physician Decision|1|||
42231658|NCT01354964|76052389|FG001|Overall Study|Physician Decision|0|||
42231659|NCT01354496|76052399|FG000|Period 1|Adverse Event|0|||
42231660|NCT01354496|76052400|FG001|Period 1|Adverse Event|0|||
42231661|NCT01354496|76052401|FG002|Period 1|Adverse Event|1|||
42231662|NCT01354496|76052402|FG003|Period 1|Adverse Event|0|||
41987048|NCT03971422|75794202|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
42231663|NCT01354496|76052403|FG004|Period 1|Adverse Event|0|||
41987049|NCT03971422|75794203|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
42231664|NCT01354496|76052404|FG005|Period 1|Adverse Event|0|||
42231665|NCT01354496|76052399|FG000|Period 1|Physician Decision|0|||
42231666|NCT01354496|76052400|FG001|Period 1|Physician Decision|0|||
42231667|NCT01354496|76052401|FG002|Period 1|Physician Decision|1|||
42231668|NCT01354496|76052402|FG003|Period 1|Physician Decision|0|||
42231669|NCT01354496|76052403|FG004|Period 1|Physician Decision|0|||
42231670|NCT01354496|76052404|FG005|Period 1|Physician Decision|0|||
42231671|NCT01354496|76052399|FG000|Period 2|Adverse Event|0|||
42231672|NCT01354496|76052400|FG001|Period 2|Adverse Event|0|||
42231673|NCT01354496|76052401|FG002|Period 2|Adverse Event|0|||
42231674|NCT01354496|76052402|FG003|Period 2|Adverse Event|1|||
42231675|NCT01354496|76052403|FG004|Period 2|Adverse Event|0|||
42231676|NCT01354496|76052404|FG005|Period 2|Adverse Event|0|||
42231677|NCT01354496|76052399|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
42231678|NCT01354496|76052400|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
42231679|NCT01354496|76052401|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
42231680|NCT01354496|76052402|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
42231681|NCT01354496|76052403|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
42231682|NCT01354496|76052404|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
42231683|NCT02822222|76052427|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
42231684|NCT02822222|76052428|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
42231685|NCT02821910|76052440|FG000|Overall Study|Withdrawal by Subject|0|||
42231686|NCT02821910|76052441|FG001|Overall Study|Withdrawal by Subject|0|||
42231687|NCT02821910|76052442|FG002|Overall Study|Withdrawal by Subject|1|||
42231688|NCT02821910|76052443|FG003|Overall Study|Withdrawal by Subject|0|||
42231689|NCT02821910|76052444|FG004|Overall Study|Withdrawal by Subject|0|||
42231690|NCT02821910|76052445|FG005|Overall Study|Withdrawal by Subject|1|||
42231691|NCT02821910|76052440|FG000|Overall Study|Other than specified|1|||
42231692|NCT02821910|76052441|FG001|Overall Study|Other than specified|0|||
42231693|NCT02821910|76052442|FG002|Overall Study|Other than specified|1|||
42231694|NCT02821910|76052443|FG003|Overall Study|Other than specified|0|||
42231695|NCT02821910|76052444|FG004|Overall Study|Other than specified|0|||
42231696|NCT02821910|76052445|FG005|Overall Study|Other than specified|0|||
42231697|NCT02817776|76052459|FG000|Overall Study|Excluded|33|||
41987050|NCT03971422|75794201|FG000|Overall Study|Due to COVID-19 pandemic|0|||
41987051|NCT03971422|75794202|FG001|Overall Study|Due to COVID-19 pandemic|1|||
41987052|NCT03971422|75794203|FG002|Overall Study|Due to COVID-19 pandemic|1|||
41987053|NCT03770260|75794218|FG000|Overall Study|Disease progression|0|||
42231698|NCT02817776|76052459|FG000|Overall Study|Lost to Follow-up|20|||
42231699|NCT02817776|76052459|FG000|Overall Study|Withdrawal by Subject|33|||
42231700|NCT02817776|76052459|FG000|Overall Study|Death|2|||
42231701|NCT03138655|76052471|FG000|Overall Study|Adverse Event|2|||
42231702|NCT03138655|76052472|FG001|Overall Study|Adverse Event|1|||
42231703|NCT03138655|76052473|FG002|Overall Study|Adverse Event|2|||
42231704|NCT03138655|76052474|FG003|Overall Study|Adverse Event|1|||
42231705|NCT03138655|76052475|FG004|Overall Study|Adverse Event|1|||
42231706|NCT03138655|76052476|FG005|Overall Study|Adverse Event|4|||
42231707|NCT03138655|76052477|FG006|Overall Study|Adverse Event|2|||
42231708|NCT03138655|76052478|FG007|Overall Study|Adverse Event|2|||
42231709|NCT03138655|76052471|FG000|Overall Study|Withdrawal by Subject|0|||
42231710|NCT03138655|76052472|FG001|Overall Study|Withdrawal by Subject|1|||
42231711|NCT03138655|76052473|FG002|Overall Study|Withdrawal by Subject|0|||
42231712|NCT03138655|76052474|FG003|Overall Study|Withdrawal by Subject|0|||
42231713|NCT03138655|76052475|FG004|Overall Study|Withdrawal by Subject|0|||
42231714|NCT03138655|76052476|FG005|Overall Study|Withdrawal by Subject|0|||
42231715|NCT03138655|76052477|FG006|Overall Study|Withdrawal by Subject|1|||
42231716|NCT03138655|76052478|FG007|Overall Study|Withdrawal by Subject|0|||
42231717|NCT03138655|76052471|FG000|Overall Study|Reason not Specified|1|||
42231718|NCT03138655|76052472|FG001|Overall Study|Reason not Specified|0|||
42231719|NCT03138655|76052473|FG002|Overall Study|Reason not Specified|0|||
42231720|NCT03138655|76052474|FG003|Overall Study|Reason not Specified|2|||
42231721|NCT03138655|76052475|FG004|Overall Study|Reason not Specified|1|||
42231722|NCT03138655|76052476|FG005|Overall Study|Reason not Specified|1|||
42231723|NCT03138655|76052477|FG006|Overall Study|Reason not Specified|0|||
42231724|NCT03138655|76052478|FG007|Overall Study|Reason not Specified|0|||
42231725|NCT02820038|76052504|FG000|Overall Study|Lost to Follow-up|7|||
42231726|NCT02820038|76052505|FG001|Overall Study|Lost to Follow-up|11|||
42231727|NCT02820038|76052506|FG002|Overall Study|Lost to Follow-up|2|||
42231728|NCT02820038|76052507|FG003|Overall Study|Lost to Follow-up|9|||
42231729|NCT02820038|76052504|FG000|Overall Study|Withdrawal by Subject|3|||
42231730|NCT02820038|76052505|FG001|Overall Study|Withdrawal by Subject|14|||
42231731|NCT02820038|76052506|FG002|Overall Study|Withdrawal by Subject|3|||
42231732|NCT02820038|76052507|FG003|Overall Study|Withdrawal by Subject|13|||
42231733|NCT02819804|76052518|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
42231734|NCT02819726|76052525|FG000|Part A (All Participants)|Lost to Follow-up|0|||
42231735|NCT02819726|76052526|FG001|Part A (All Participants)|Lost to Follow-up|1|||
42231736|NCT02819726|76052527|FG002|Part A (All Participants)|Lost to Follow-up|0|||
42231737|NCT02819726|76052528|FG003|Part A (All Participants)|Lost to Follow-up|0|||
42231738|NCT02819726|76052525|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
41987054|NCT03770260|75794219|FG001|Overall Study|Disease progression|1|||
42231739|NCT02819726|76052526|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
42231740|NCT02819726|76052527|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
42231741|NCT02819726|76052528|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
42231742|NCT02819726|76052525|FG000|Part A (All Participants)|Protocol non-compliance|3|||
42231743|NCT02819726|76052526|FG001|Part A (All Participants)|Protocol non-compliance|4|||
42231744|NCT02819726|76052527|FG002|Part A (All Participants)|Protocol non-compliance|5|||
42231745|NCT02819726|76052528|FG003|Part A (All Participants)|Protocol non-compliance|0|||
41987055|NCT03770260|75794220|FG002|Overall Study|Disease progression|0|||
41987056|NCT03770260|75794221|FG003|Overall Study|Disease progression|0|||
42231746|NCT02819726|76052525|FG000|Part B (All Participants)|Lost to Follow-up|1|||
42231747|NCT02819726|76052526|FG001|Part B (All Participants)|Lost to Follow-up|1|||
42231748|NCT02819726|76052527|FG002|Part B (All Participants)|Lost to Follow-up|2|||
42231749|NCT02819726|76052528|FG003|Part B (All Participants)|Lost to Follow-up|2|||
42231750|NCT02819726|76052525|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
42231751|NCT02819726|76052526|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
42231752|NCT02819726|76052527|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
42231753|NCT02819726|76052528|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
42231754|NCT02819726|76052525|FG000|Part B (All Participants)|Protocol non-compliance|0|||
42231755|NCT02819726|76052526|FG001|Part B (All Participants)|Protocol non-compliance|0|||
42231756|NCT02819726|76052527|FG002|Part B (All Participants)|Protocol non-compliance|1|||
42231757|NCT02819726|76052528|FG003|Part B (All Participants)|Protocol non-compliance|0|||
42231758|NCT02816138|76052536|FG000|Overall Study|Adverse Event|1|||
42231759|NCT02815670|76052540|FG000|Overall Study|Prematurely discontinued of the trial|1|||
42231760|NCT02809976|76052544|FG000|Overall Study|Lost to Follow-up|1|||
42231761|NCT02809976|76052544|FG000|Overall Study|Withdrawal by Subject|1|||
42231762|NCT02880865|76052550|FG000|Overall Study|Adverse Event|1|||
42231763|NCT02880865|76052551|FG001|Overall Study|Adverse Event|0|||
42231764|NCT02880865|76052550|FG000|Overall Study|Withdrawal by Subject|0|||
42231765|NCT02880865|76052551|FG001|Overall Study|Withdrawal by Subject|2|||
42231766|NCT02880865|76052550|FG000|Overall Study|Physician Decision|0|||
42231767|NCT02880865|76052551|FG001|Overall Study|Physician Decision|1|||
42231768|NCT01854385|76052578|FG000|Pre-Treatment|Withdrawal by Subject|4|||
42231769|NCT01854385|76052578|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
42231770|NCT01854385|76052578|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
42231771|NCT01854385|76052578|FG000|Pre-Treatment|Unable to come for study visits|1|||
42231772|NCT01854385|76052578|FG000|Treatment|Lost to Follow-up|1|||
42231773|NCT02809118|76052585|FG000|Overall Study|Withdrawal by Subject|0|||
42231774|NCT02809118|76052586|FG001|Overall Study|Withdrawal by Subject|1|||
42231775|NCT02809118|76052587|FG002|Overall Study|Withdrawal by Subject|1|||
42231776|NCT03604159|76052597|FG000|Overall Study|Lost to Follow-up|6|||
42231777|NCT03604159|76052598|FG001|Overall Study|Lost to Follow-up|7|||
42231778|NCT02808338|76052604|FG000|Screening|Screen Failure|10|||
42231779|NCT02808338|76052604|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
42231780|NCT02808338|76052604|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
42231781|NCT02807948|76052615|FG000|Overall Study|Physician Decision|1|||
42231782|NCT02807948|76052616|FG001|Overall Study|Physician Decision|0|||
42231783|NCT02879383|76052625|FG000|First 24 Weeks|Physician Decision|0|||
42231784|NCT02879383|76052626|FG001|First 24 Weeks|Physician Decision|1|||
42231785|NCT02879383|76052627|FG002|First 24 Weeks|Physician Decision|0|||
42231786|NCT02879383|76052628|FG003|First 24 Weeks|Physician Decision|0|||
42231787|NCT02049710|76052642|FG000|Overall Study|Lost to Follow-up|319|||
42231788|NCT02049710|76052643|FG001|Overall Study|Lost to Follow-up|324|||
42231789|NCT02806232|76052671|FG000|Overall Study|Lost to Follow-up|1|||
42302543|NCT02416453|76137795|FG005|Overall Study|Physician Decision|1|||
42302544|NCT02416453|76137796|FG006|Overall Study|Physician Decision|1|||
41987057|NCT03737110|75794232|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
41987058|NCT03737110|75794233|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
41987059|NCT03737110|75794234|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
41987060|NCT03737110|75794235|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
41987061|NCT03737110|75794236|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
41987062|NCT03737110|75794237|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
41987063|NCT03737110|75794232|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
41987064|NCT03737110|75794233|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
41987065|NCT03737110|75794234|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
41987066|NCT03737110|75794235|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
41987067|NCT03737110|75794236|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
41987068|NCT03737110|75794237|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
41987069|NCT03737110|75794232|FG000|Run-in (RI) Period|Adverse Event|4|||
41987070|NCT03737110|75794233|FG001|Run-in (RI) Period|Adverse Event|0|||
41987071|NCT03737110|75794234|FG002|Run-in (RI) Period|Adverse Event|0|||
41987072|NCT03737110|75794235|FG003|Run-in (RI) Period|Adverse Event|0|||
41987073|NCT03737110|75794236|FG004|Run-in (RI) Period|Adverse Event|0|||
41987074|NCT03737110|75794237|FG005|Run-in (RI) Period|Adverse Event|0|||
42231790|NCT02806232|76052672|FG001|Overall Study|Lost to Follow-up|2|||
42231791|NCT02806232|76052673|FG002|Overall Study|Lost to Follow-up|1|||
42231792|NCT02806232|76052674|FG003|Overall Study|Lost to Follow-up|0|||
42231793|NCT02806232|76052675|FG004|Overall Study|Lost to Follow-up|0|||
42231794|NCT02806232|76052676|FG005|Overall Study|Lost to Follow-up|1|||
42231795|NCT02806232|76052677|FG006|Overall Study|Lost to Follow-up|0|||
41987075|NCT03737110|75794232|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
42231796|NCT02806232|76052678|FG007|Overall Study|Lost to Follow-up|0|||
42231797|NCT02806232|76052679|FG008|Overall Study|Lost to Follow-up|0|||
42302545|NCT02416453|76137797|FG007|Overall Study|Physician Decision|1|||
41987076|NCT03737110|75794233|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
41987077|NCT03737110|75794234|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
41987078|NCT03737110|75794235|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
41987079|NCT03737110|75794236|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
41987080|NCT03737110|75794237|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
41987081|NCT03737110|75794232|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
41987082|NCT03737110|75794233|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
41987083|NCT03737110|75794234|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
41987084|NCT03737110|75794235|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
41987085|NCT03737110|75794236|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
41987086|NCT03737110|75794237|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
41987087|NCT03737110|75794232|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
41987088|NCT03737110|75794233|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
41987089|NCT03737110|75794234|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
41987090|NCT03737110|75794235|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
41987091|NCT03737110|75794236|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
41987092|NCT03737110|75794237|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
41987093|NCT03737110|75794232|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
41987094|NCT03737110|75794233|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
41987095|NCT03737110|75794234|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
41987096|NCT03737110|75794235|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
41987097|NCT03737110|75794236|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
41987098|NCT03737110|75794237|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
41987099|NCT03737110|75794232|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
41987100|NCT03737110|75794233|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
41987101|NCT03737110|75794234|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
41987102|NCT03737110|75794235|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
41987103|NCT03737110|75794236|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
41987104|NCT03737110|75794237|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
41987105|NCT03592771|75794272|FG000|Overall Study|Adverse Event|2|||
41987106|NCT03592771|75794273|FG001|Overall Study|Adverse Event|0|||
41987107|NCT03592771|75794274|FG002|Overall Study|Adverse Event|1|||
41987108|NCT03592771|75794272|FG000|Overall Study|Death|0|||
41987109|NCT03592771|75794273|FG001|Overall Study|Death|1|||
41987110|NCT03592771|75794274|FG002|Overall Study|Death|1|||
41987111|NCT03592771|75794272|FG000|Overall Study|Lost to Follow-up|5|||
41987112|NCT03592771|75794273|FG001|Overall Study|Lost to Follow-up|11|||
41987113|NCT03592771|75794274|FG002|Overall Study|Lost to Follow-up|15|||
41987114|NCT03592771|75794272|FG000|Overall Study|Withdrawal by Subject|0|||
41987115|NCT03592771|75794273|FG001|Overall Study|Withdrawal by Subject|2|||
41987116|NCT03592771|75794274|FG002|Overall Study|Withdrawal by Subject|0|||
41987117|NCT03495154|75794282|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
41987118|NCT03495154|75794282|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
41987119|NCT03495154|75794282|FG000|Overall Study|Screen Failures During Surgery|6|||
41987120|NCT03495154|75794282|FG000|Overall Study|Death|2|||
41987121|NCT03495154|75794282|FG000|Overall Study|Lost to Follow-up|16|||
41987122|NCT03495154|75794282|FG000|Overall Study|Withdrawal by Subject|2|||
41987123|NCT03495154|75794282|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
41987124|NCT03334253|75794322|FG000|Overall Study|Withdrawal by Subject|1|||
41987125|NCT03334253|75794323|FG001|Overall Study|Withdrawal by Subject|0|||
41987126|NCT03334253|75794322|FG000|Overall Study|Lost to Follow-up|4|||
41987127|NCT03334253|75794323|FG001|Overall Study|Lost to Follow-up|3|||
41987128|NCT03334253|75794322|FG000|Overall Study|Moved residence|2|||
41987129|NCT03334253|75794323|FG001|Overall Study|Moved residence|2|||
41987130|NCT03314857|75794329|FG000|Overall Study|Death|4|||
41987131|NCT03314857|75794329|FG000|Overall Study|Physician Decision|1|||
41987132|NCT03302156|75794335|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
41987133|NCT03302156|75794336|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
42231798|NCT02806232|76052671|FG000|Overall Study|Withdrawal by Subject|0|||
42231799|NCT02806232|76052672|FG001|Overall Study|Withdrawal by Subject|2|||
42231800|NCT02806232|76052673|FG002|Overall Study|Withdrawal by Subject|0|||
42231801|NCT02806232|76052674|FG003|Overall Study|Withdrawal by Subject|0|||
42231802|NCT02806232|76052675|FG004|Overall Study|Withdrawal by Subject|2|||
42231803|NCT02806232|76052676|FG005|Overall Study|Withdrawal by Subject|1|||
42231804|NCT02806232|76052677|FG006|Overall Study|Withdrawal by Subject|0|||
42231805|NCT02806232|76052678|FG007|Overall Study|Withdrawal by Subject|0|||
42231806|NCT02806232|76052679|FG008|Overall Study|Withdrawal by Subject|0|||
42231807|NCT02807402|76052699|FG000|Overall Study|Failure to Return|1|||
42302546|NCT02416453|76137798|FG008|Overall Study|Physician Decision|0|||
42231808|NCT02807402|76052699|FG000|Overall Study|Death|3|||
42231809|NCT02807402|76052699|FG000|Overall Study|Other|2|||
42231810|NCT02960490|76052713|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
42231811|NCT02960490|76052714|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
42231812|NCT02960490|76052715|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
42231813|NCT02960490|76052716|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
42231814|NCT02960490|76052717|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
42231815|NCT02960490|76052718|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
42231816|NCT02960490|76052719|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
42231817|NCT02960490|76052720|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
42231818|NCT02960490|76052721|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
42231819|NCT02960490|76052722|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
42231820|NCT02960490|76052713|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
42231821|NCT02960490|76052714|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
42231822|NCT02960490|76052715|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
42231823|NCT02960490|76052716|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
41987134|NCT03302156|75794337|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
41987135|NCT03235739|75794346|FG000|Overall Study|Withdrawal by Subject|2|||
41987136|NCT03235739|75794347|FG001|Overall Study|Withdrawal by Subject|2|||
41987137|NCT03235739|75794346|FG000|Overall Study|Physician Decision|0|||
41987138|NCT03235739|75794347|FG001|Overall Study|Physician Decision|1|||
41987139|NCT03176771|75794356|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
41987140|NCT03176771|75794357|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
41987141|NCT03176771|75794358|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
41987142|NCT03176771|75794359|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
41987143|NCT03176771|75794360|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
41987144|NCT03176771|75794356|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
41987145|NCT03176771|75794357|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
41987146|NCT03176771|75794358|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
41987147|NCT03176771|75794359|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
41987148|NCT03176771|75794360|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
41987149|NCT03176771|75794356|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
41987150|NCT03176771|75794357|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
41987151|NCT03176771|75794358|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
41987152|NCT03176771|75794359|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
41987153|NCT03176771|75794360|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
41987154|NCT03176771|75794356|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
41987155|NCT03176771|75794357|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
41987156|NCT03176771|75794358|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
41987157|NCT03176771|75794359|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
41987158|NCT03176771|75794360|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
41987159|NCT03176771|75794356|FG000|Double-Blind Extension Period|Adverse Event|0|||
41987160|NCT03176771|75794357|FG001|Double-Blind Extension Period|Adverse Event|0|||
41987161|NCT03176771|75794358|FG002|Double-Blind Extension Period|Adverse Event|0|||
41987162|NCT03176771|75794359|FG003|Double-Blind Extension Period|Adverse Event|15|||
41987163|NCT03176771|75794360|FG004|Double-Blind Extension Period|Adverse Event|18|||
41987164|NCT03176771|75794356|FG000|Double-Blind Extension Period|Death|0|||
41987165|NCT03176771|75794357|FG001|Double-Blind Extension Period|Death|0|||
41987166|NCT03176771|75794358|FG002|Double-Blind Extension Period|Death|0|||
41987167|NCT03176771|75794359|FG003|Double-Blind Extension Period|Death|3|||
41987168|NCT03176771|75794360|FG004|Double-Blind Extension Period|Death|4|||
41987169|NCT03176771|75794356|FG000|Double-Blind Extension Period|Physician Decision|0|||
41987170|NCT03176771|75794357|FG001|Double-Blind Extension Period|Physician Decision|0|||
41987171|NCT03176771|75794358|FG002|Double-Blind Extension Period|Physician Decision|0|||
41987172|NCT03176771|75794359|FG003|Double-Blind Extension Period|Physician Decision|3|||
41987173|NCT03176771|75794360|FG004|Double-Blind Extension Period|Physician Decision|1|||
41987174|NCT03176771|75794356|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
41987175|NCT03176771|75794357|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
41987176|NCT03176771|75794358|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
41987177|NCT03176771|75794359|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
41987178|NCT03176771|75794360|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
42231824|NCT02960490|76052717|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
42231825|NCT02960490|76052718|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
42231826|NCT02960490|76052719|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
42231827|NCT02960490|76052720|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
42231828|NCT02960490|76052721|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
42302547|NCT02416453|76137799|FG009|Overall Study|Physician Decision|0|||
41987179|NCT02829918|75794374|FG000|Overall Study|Death|2|||
42231829|NCT02960490|76052722|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
42231830|NCT02960490|76052713|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
42231831|NCT02960490|76052714|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
42231832|NCT02960490|76052715|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
42231833|NCT02960490|76052716|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
42231834|NCT02960490|76052717|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
42231835|NCT02960490|76052718|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
42231836|NCT02960490|76052719|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
42231837|NCT02960490|76052720|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
42231838|NCT02960490|76052721|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
42231839|NCT02960490|76052722|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
42231840|NCT02960490|76052713|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
42231841|NCT02960490|76052714|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
42231842|NCT02960490|76052715|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
42231843|NCT02960490|76052716|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
42231844|NCT02960490|76052717|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
42231845|NCT02960490|76052718|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
42231846|NCT02960490|76052719|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
42231847|NCT02960490|76052720|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
42231848|NCT02960490|76052721|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
42231849|NCT02960490|76052722|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
42231850|NCT02960490|76052713|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
42231851|NCT02960490|76052714|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
42231852|NCT02960490|76052715|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
42231853|NCT02960490|76052716|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
42231854|NCT02960490|76052717|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
42231855|NCT02960490|76052718|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
42231856|NCT02960490|76052719|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
42231857|NCT02960490|76052720|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
42231858|NCT02960490|76052721|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
42231859|NCT02960490|76052722|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
42231860|NCT02960490|76052713|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
42231861|NCT02960490|76052714|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
42231862|NCT02960490|76052715|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
42231863|NCT02960490|76052716|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
42231864|NCT02960490|76052717|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
42231865|NCT02960490|76052718|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
42231866|NCT02960490|76052719|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
42231867|NCT02960490|76052720|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
42231868|NCT02960490|76052721|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
42231869|NCT02960490|76052722|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
42231870|NCT02960490|76052713|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
42231871|NCT02960490|76052714|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
42231872|NCT02960490|76052715|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
42231873|NCT02960490|76052716|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
42231874|NCT02960490|76052717|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
42231875|NCT02960490|76052718|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
42231876|NCT02960490|76052719|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
42231877|NCT02960490|76052720|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
42231878|NCT02960490|76052721|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
42231879|NCT02960490|76052722|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
42231880|NCT02960490|76052713|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
42231881|NCT02960490|76052714|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
42231882|NCT02960490|76052715|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
42231883|NCT02960490|76052716|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
42231884|NCT02960490|76052717|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
42231885|NCT02960490|76052718|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
42231886|NCT02960490|76052719|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
42231887|NCT02960490|76052720|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
42231888|NCT02960490|76052721|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
42231889|NCT02960490|76052722|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
42231890|NCT02960490|76052713|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
42231891|NCT02960490|76052714|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
42231892|NCT02960490|76052715|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
41987180|NCT02829918|75794374|FG000|Overall Study|Withdrawal by Subject|4|||
42231893|NCT02960490|76052716|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
42231894|NCT02960490|76052717|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
42231895|NCT02960490|76052718|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
42231896|NCT02960490|76052719|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
42231897|NCT02960490|76052720|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
42231898|NCT02960490|76052721|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
42231899|NCT02960490|76052722|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
42231900|NCT02960490|76052713|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
42231901|NCT02960490|76052714|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
42231902|NCT02960490|76052715|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
42231903|NCT02960490|76052716|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
42231904|NCT02960490|76052717|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
42231905|NCT02960490|76052718|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
42231906|NCT02960490|76052719|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
42231907|NCT02960490|76052720|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
42231908|NCT02960490|76052721|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
42231909|NCT02960490|76052722|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
42231910|NCT02960490|76052713|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
42231911|NCT02960490|76052714|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
42231912|NCT02960490|76052715|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
42231913|NCT02960490|76052716|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
42231914|NCT02960490|76052717|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
42231915|NCT02960490|76052718|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
42231916|NCT02960490|76052719|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
42231917|NCT02960490|76052720|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
42231918|NCT02960490|76052721|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
42231919|NCT02960490|76052722|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
42231920|NCT02960490|76052713|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
42231921|NCT02960490|76052714|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
42231922|NCT02960490|76052715|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
42231923|NCT02960490|76052716|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
42231924|NCT02960490|76052717|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
42231925|NCT02960490|76052718|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
42231926|NCT02960490|76052719|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
42231927|NCT02960490|76052720|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
42231928|NCT02960490|76052721|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
42231929|NCT02960490|76052722|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
42231930|NCT02804750|76052746|FG000|Period 1|Adverse Event|0|||
41987181|NCT02829918|75794374|FG000|Overall Study|Adverse Event|1|||
41987182|NCT02829918|75794374|FG000|Overall Study|Progression|1|||
41987183|NCT02789020|75794380|FG000|Overall Study|Withdrawal by Subject|6|||
42231931|NCT02804750|76052747|FG001|Period 1|Adverse Event|2|||
42231932|NCT02804750|76052746|FG000|Period 1|Withdrawal by Subject|0|||
42231933|NCT02804750|76052747|FG001|Period 1|Withdrawal by Subject|1|||
42231934|NCT02804750|76052746|FG000|Period 2|Adverse Event|1|||
42231935|NCT02804750|76052747|FG001|Period 2|Adverse Event|0|||
42231936|NCT02804750|76052746|FG000|Period 3|Adverse Event|0|||
42231937|NCT02804750|76052747|FG001|Period 3|Adverse Event|2|||
42231938|NCT02804750|76052746|FG000|Period 4|Adverse Event|0|||
42231939|NCT02804750|76052747|FG001|Period 4|Adverse Event|5|||
42231940|NCT02959866|76052755|FG000|Overall Study|Withdrawal by Subject|1|||
42231941|NCT02748512|76052762|FG000|Overall Study|Lost to Follow-up|1|||
42231942|NCT02748512|76052763|FG001|Overall Study|Lost to Follow-up|1|||
42231943|NCT02748356|76052769|FG000|Overall Study|Withdrawal by Subject|1|||
42231944|NCT03439657|76052775|FG000|Overall Study|Adverse Event|2|||
42231945|NCT03439657|76052776|FG001|Overall Study|Adverse Event|3|||
42231946|NCT03439657|76052775|FG000|Overall Study|Lost to Follow-up|1|||
42231947|NCT03439657|76052776|FG001|Overall Study|Lost to Follow-up|0|||
42231948|NCT03439657|76052775|FG000|Overall Study|Protocol Violation|1|||
42231949|NCT03439657|76052776|FG001|Overall Study|Protocol Violation|1|||
42231950|NCT03439657|76052775|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
42231951|NCT03439657|76052776|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
41987184|NCT02789020|75794381|FG001|Overall Study|Withdrawal by Subject|5|||
41987185|NCT02427841|75794418|FG000|Overall Study|Lack of Efficacy|5|||
42231952|NCT02803580|76052784|FG000|Overall Study|Death|13|||
42231953|NCT02803580|76052784|FG000|Overall Study|Lost to Follow-up|19|||
42231954|NCT02803580|76052784|FG000|Overall Study|Withdrawal by Subject|3|||
42231955|NCT02803580|76052784|FG000|Overall Study|Inclusion in clinical trial|1|||
42231956|NCT02878213|76052788|FG000|Overall Study|Withdrawal by Subject|2|||
42231957|NCT02878213|76052788|FG000|Overall Study|Adverse Event|1|||
42231958|NCT02802878|76052795|FG000|Overall Study|Withdrawal by Subject|3|||
42231959|NCT02802878|76052796|FG001|Overall Study|Withdrawal by Subject|3|||
42231960|NCT02802878|76052795|FG000|Overall Study|Protocol Violation|1|||
42231961|NCT02802878|76052796|FG001|Overall Study|Protocol Violation|0|||
42231962|NCT02801396|76052802|FG000|Period 1|Withdrawal by Subject|0|||
42231963|NCT02801396|76052803|FG001|Period 1|Withdrawal by Subject|0|||
42231964|NCT02801396|76052804|FG002|Period 1|Withdrawal by Subject|0|||
42231965|NCT02801396|76052805|FG003|Period 1|Withdrawal by Subject|0|||
42231966|NCT02801396|76052806|FG004|Period 1|Withdrawal by Subject|1|||
42231967|NCT02801396|76052807|FG005|Period 1|Withdrawal by Subject|0|||
42231968|NCT02800928|76052815|FG000|Overall Study|Withdrawal by Subject|1|||
42231969|NCT02800928|76052816|FG001|Overall Study|Withdrawal by Subject|1|||
42231970|NCT02800928|76052815|FG000|Overall Study|Protocol Violation|1|||
42231971|NCT02800928|76052816|FG001|Overall Study|Protocol Violation|1|||
42231972|NCT03148691|76052825|FG000|Overall Study|Protocol Violation|1|||
42231973|NCT03148691|76052826|FG001|Overall Study|Protocol Violation|2|||
42231974|NCT03148691|76052827|FG002|Overall Study|Protocol Violation|7|||
42231975|NCT03148691|76052825|FG000|Overall Study|Lost to Follow-up|0|||
42231976|NCT03148691|76052826|FG001|Overall Study|Lost to Follow-up|0|||
42231977|NCT03148691|76052827|FG002|Overall Study|Lost to Follow-up|1|||
42231978|NCT03148691|76052825|FG000|Overall Study|Other|1|||
42231979|NCT03148691|76052826|FG001|Overall Study|Other|0|||
42231980|NCT03148691|76052827|FG002|Overall Study|Other|0|||
42231981|NCT03148691|76052825|FG000|Overall Study|Withdrawal by Subject|1|||
42231982|NCT03148691|76052826|FG001|Overall Study|Withdrawal by Subject|0|||
42231983|NCT03148691|76052827|FG002|Overall Study|Withdrawal by Subject|0|||
42231984|NCT03148067|76052835|FG000|Overall Study|Lost to Follow-up|3|||
42231985|NCT03148067|76052835|FG000|Overall Study|Death|1|||
42231986|NCT03146741|76052849|FG000|Overall Study|Txp with non-HCV+ heart|4|||
42231987|NCT03146741|76052849|FG000|Overall Study|Listeted for MOT|2|||
42231988|NCT03146741|76052849|FG000|Overall Study|Physician Decision|2|||
42231989|NCT03146741|76052849|FG000|Overall Study|Awaiting txp|2|||
42231990|NCT03150719|76052855|FG000|Overall Study|Adverse Event|0|||
42231991|NCT03150719|76052856|FG001|Overall Study|Adverse Event|1|||
42231992|NCT03150719|76052855|FG000|Overall Study|Death|0|||
42231993|NCT03150719|76052856|FG001|Overall Study|Death|1|||
42231994|NCT03150719|76052855|FG000|Overall Study|Other|1|||
42231995|NCT03150719|76052856|FG001|Overall Study|Other|0|||
42231996|NCT04039217|76052862|FG000|Overall Study|Lost to Follow-up|1|||
42231997|NCT00982111|76052872|FG000|Overall Study|Adverse Event|1|||
42231998|NCT00982111|76052873|FG001|Overall Study|Adverse Event|1|||
42231999|NCT00982111|76052872|FG000|Overall Study|Progressive Disease|46|||
42232000|NCT00982111|76052873|FG001|Overall Study|Progressive Disease|39|||
42232001|NCT00982111|76052872|FG000|Overall Study|Lost to Follow-up|9|||
42232002|NCT00982111|76052873|FG001|Overall Study|Lost to Follow-up|6|||
42232003|NCT00982111|76052872|FG000|Overall Study|New Anti-Cancer Therapy|5|||
42232004|NCT00982111|76052873|FG001|Overall Study|New Anti-Cancer Therapy|5|||
42232005|NCT00982111|76052872|FG000|Overall Study|Medical Decision|1|||
42232006|NCT00982111|76052873|FG001|Overall Study|Medical Decision|0|||
42232007|NCT00982111|76052872|FG000|Overall Study|Withdrawal by Subject|17|||
42232008|NCT00982111|76052873|FG001|Overall Study|Withdrawal by Subject|19|||
42232009|NCT00982111|76052872|FG000|Overall Study|Global Study End|0|||
42232010|NCT00982111|76052873|FG001|Overall Study|Global Study End|1|||
42232011|NCT00982111|76052872|FG000|Overall Study|Sponsor's Decision|0|||
42232012|NCT00982111|76052873|FG001|Overall Study|Sponsor's Decision|1|||
42232013|NCT02957682|76052882|FG000|Overall Study|Adverse Event|64|||
42232014|NCT02957682|76052883|FG001|Overall Study|Adverse Event|67|||
42232015|NCT02957682|76052882|FG000|Overall Study|Poor Compliance to Protocol|30|||
42232016|NCT02957682|76052883|FG001|Overall Study|Poor Compliance to Protocol|26|||
42232017|NCT02957682|76052882|FG000|Overall Study|Physician Decision|4|||
42232018|NCT02957682|76052883|FG001|Overall Study|Physician Decision|4|||
42232019|NCT02957682|76052882|FG000|Overall Study|Study Terminated by Sponsor|4|||
41987186|NCT02427841|75794418|FG000|Overall Study|Physician Decision|2|||
42232020|NCT02957682|76052883|FG001|Overall Study|Study Terminated by Sponsor|3|||
42232021|NCT02957682|76052882|FG000|Overall Study|Subject Moved|10|||
42302548|NCT02416453|76137800|FG010|Overall Study|Physician Decision|0|||
42302549|NCT02416453|76137790|FG000|Overall Study|Withdrawal by Subject|2|||
42232022|NCT02957682|76052883|FG001|Overall Study|Subject Moved|16|||
42232023|NCT02957682|76052882|FG000|Overall Study|Withdrawal by Subject|64|||
42232024|NCT02957682|76052883|FG001|Overall Study|Withdrawal by Subject|33|||
42232025|NCT02957682|76052882|FG000|Overall Study|Related to IMP Administration|3|||
42232026|NCT02957682|76052883|FG001|Overall Study|Related to IMP Administration|6|||
42232027|NCT02957682|76052882|FG000|Overall Study|Non-disclosed|16|||
42232028|NCT02957682|76052883|FG001|Overall Study|Non-disclosed|12|||
42232029|NCT02957682|76052882|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
42232030|NCT02957682|76052883|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
42232031|NCT03057951|76052891|FG000|Overall Study|Adverse Event|553|||
42232032|NCT03057951|76052892|FG001|Overall Study|Adverse Event|575|||
42232033|NCT03057951|76052891|FG000|Overall Study|Protocol Violation|30|||
42232034|NCT03057951|76052892|FG001|Overall Study|Protocol Violation|24|||
42232035|NCT03057951|76052891|FG000|Overall Study|Lost to Follow-up|6|||
42232036|NCT03057951|76052892|FG001|Overall Study|Lost to Follow-up|16|||
42232037|NCT03057951|76052891|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
42232038|NCT03057951|76052892|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
42232039|NCT03057951|76052891|FG000|Overall Study|Study drug stopped, reason missing|6|||
42232040|NCT03057951|76052892|FG001|Overall Study|Study drug stopped, reason missing|1|||
42232041|NCT03057951|76052891|FG000|Overall Study|Medical advice|6|||
42232042|NCT03057951|76052892|FG001|Overall Study|Medical advice|2|||
42232043|NCT03057951|76052891|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
42232044|NCT03057951|76052892|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
42232045|NCT03057951|76052891|FG000|Overall Study|Investigator decision|2|||
42232046|NCT03057951|76052892|FG001|Overall Study|Investigator decision|0|||
42232047|NCT03057951|76052891|FG000|Overall Study|Patient decision|5|||
42232048|NCT03057951|76052892|FG001|Overall Study|Patient decision|2|||
42232049|NCT03057951|76052891|FG000|Overall Study|Not attending study visits|3|||
42232050|NCT03057951|76052892|FG001|Overall Study|Not attending study visits|0|||
42232051|NCT03057951|76052891|FG000|Overall Study|Patient moved away|3|||
42232052|NCT03057951|76052892|FG001|Overall Study|Patient moved away|4|||
42232053|NCT03057951|76052891|FG000|Overall Study|Other reason than stated above|23|||
42232054|NCT03057951|76052892|FG001|Overall Study|Other reason than stated above|29|||
42232055|NCT03057951|76052891|FG000|Overall Study|Not treated|2|||
42232056|NCT03057951|76052892|FG001|Overall Study|Not treated|1|||
42232057|NCT03146663|76052900|FG000|Overall Study|Did not receive study treatment|1|||
42232058|NCT03146663|76052901|FG001|Overall Study|Did not receive study treatment|1|||
42232059|NCT02956278|76052911|FG000|Overall Study|Withdrawal by Subject|6|||
42232060|NCT02956278|76052912|FG001|Overall Study|Withdrawal by Subject|2|||
42232061|NCT02956278|76052913|FG002|Overall Study|Withdrawal by Subject|0|||
42232062|NCT02957136|76052923|FG000|Overall Study|Withdrawal by Subject|2|||
42232063|NCT02957136|76052924|FG001|Overall Study|Withdrawal by Subject|1|||
42232064|NCT03150485|76052930|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
42232065|NCT03150485|76052931|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
41987187|NCT02427841|75794418|FG000|Overall Study|Withdrawal by Subject|1|||
41987188|NCT02348216|75794430|FG000|Overall Study|Death|4|||
41987189|NCT02348216|75794431|FG001|Overall Study|Death|27|||
41987190|NCT02348216|75794432|FG002|Overall Study|Death|3|||
41987191|NCT02348216|75794433|FG003|Overall Study|Death|18|||
42232066|NCT03150485|76052932|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
42232067|NCT03150485|76052933|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
42232068|NCT03150485|76052934|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
42232069|NCT03150485|76052935|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
41987192|NCT02348216|75794434|FG004|Overall Study|Death|9|||
41987193|NCT02348216|75794435|FG005|Overall Study|Death|23|||
41987194|NCT02348216|75794436|FG006|Overall Study|Death|6|||
42232070|NCT03134911|76052942|FG000|Overall Study|Screen failure|31|||
42232071|NCT03134911|76052942|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
42232072|NCT03134599|76052961|FG000|Week 1|Lost to Follow-up|0|||
42232073|NCT03134599|76052962|FG001|Week 1|Lost to Follow-up|0|||
42232074|NCT03134599|76052963|FG002|Week 1|Lost to Follow-up|0|||
42232075|NCT03134599|76052964|FG003|Week 1|Lost to Follow-up|0|||
42232076|NCT03134599|76052965|FG004|Week 1|Lost to Follow-up|1|||
42232077|NCT03134599|76052966|FG005|Week 1|Lost to Follow-up|0|||
42232078|NCT03134599|76052961|FG000|Week 2|Lost to Follow-up|1|||
42232079|NCT03134599|76052962|FG001|Week 2|Lost to Follow-up|0|||
42232080|NCT03134599|76052963|FG002|Week 2|Lost to Follow-up|0|||
42232081|NCT03134599|76052964|FG003|Week 2|Lost to Follow-up|1|||
42232082|NCT03134599|76052965|FG004|Week 2|Lost to Follow-up|1|||
41987195|NCT02348216|75794430|FG000|Overall Study|Full consent withdrawal|0|||
41987196|NCT02348216|75794431|FG001|Overall Study|Full consent withdrawal|0|||
41987197|NCT02348216|75794432|FG002|Overall Study|Full consent withdrawal|0|||
42232083|NCT03134599|76052966|FG005|Week 2|Lost to Follow-up|0|||
42232084|NCT03134599|76052961|FG000|Week 3|Lost to Follow-up|0|||
41987198|NCT02348216|75794433|FG003|Overall Study|Full consent withdrawal|1|||
41987199|NCT02348216|75794434|FG004|Overall Study|Full consent withdrawal|0|||
42232085|NCT03134599|76052962|FG001|Week 3|Lost to Follow-up|0|||
42232086|NCT03134599|76052963|FG002|Week 3|Lost to Follow-up|0|||
42232087|NCT03134599|76052964|FG003|Week 3|Lost to Follow-up|1|||
42232088|NCT03134599|76052965|FG004|Week 3|Lost to Follow-up|0|||
42232089|NCT03134599|76052966|FG005|Week 3|Lost to Follow-up|1|||
42232090|NCT03153137|76052976|FG000|Overall Study|Lost to Follow-up|1|||
42232091|NCT03153137|76052977|FG001|Overall Study|Lost to Follow-up|0|||
42232092|NCT03153137|76052976|FG000|Overall Study|Withdrawal by Subject|2|||
42232093|NCT03153137|76052977|FG001|Overall Study|Withdrawal by Subject|1|||
41987200|NCT02348216|75794435|FG005|Overall Study|Full consent withdrawal|0|||
42232094|NCT03153137|76052976|FG000|Overall Study|Physician Decision|0|||
42232095|NCT03153137|76052977|FG001|Overall Study|Physician Decision|3|||
42232096|NCT03136861|76052990|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
42232097|NCT03136861|76052991|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
42232098|NCT03136861|76052992|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
42232099|NCT03136861|76052993|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
42232100|NCT03136861|76052994|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
42232101|NCT03136861|76052995|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
42232102|NCT03136861|76052996|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
42232103|NCT03136861|76052990|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
42232104|NCT03136861|76052991|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
42232105|NCT03136861|76052992|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
42232106|NCT03136861|76052993|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
42232107|NCT03136861|76052994|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
42232108|NCT03136861|76052995|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
42232109|NCT03136861|76052996|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
42232110|NCT03136861|76052990|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
42232111|NCT03136861|76052991|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
42232112|NCT03136861|76052992|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
42232113|NCT03136861|76052993|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
42232114|NCT03136861|76052994|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
42232115|NCT03136861|76052995|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
42232116|NCT03136861|76052996|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
42232117|NCT03136861|76052990|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
42232118|NCT03136861|76052991|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
42232119|NCT03136861|76052992|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
42232120|NCT03136861|76052993|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
42232121|NCT03136861|76052994|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
42232122|NCT03136861|76052995|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
42232123|NCT03136861|76052996|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
42232124|NCT03136861|76052990|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
42232125|NCT03136861|76052991|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
42232126|NCT03136861|76052992|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
42232127|NCT03136861|76052993|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
42232128|NCT03136861|76052994|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
42232129|NCT03136861|76052995|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
42232130|NCT03136861|76052996|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
42232131|NCT03136861|76052990|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
42232132|NCT03136861|76052991|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
42232133|NCT03136861|76052992|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
42232134|NCT03136861|76052993|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
42232135|NCT03136861|76052994|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
42232136|NCT03136861|76052995|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
42131773|NCT00414609|75942696|FG001|Core Study|Abnormal laboratory values|1|||
42131774|NCT00414609|75942697|FG002|Core Study|Abnormal laboratory values|0|||
42131775|NCT00414609|75942695|FG000|Core Study|Abnormal test procedure results|1|||
42131776|NCT00414609|75942696|FG001|Core Study|Abnormal test procedure results|1|||
42131777|NCT00414609|75942697|FG002|Core Study|Abnormal test procedure results|0|||
42131778|NCT00414609|75942695|FG000|Core Study|Protocol deviation|0|||
42131779|NCT00414609|75942696|FG001|Core Study|Protocol deviation|1|||
42131780|NCT00414609|75942697|FG002|Core Study|Protocol deviation|0|||
42131781|NCT00414609|75942695|FG000|Core Study|Patient withdrew consent|10|||
42131782|NCT00414609|75942696|FG001|Core Study|Patient withdrew consent|11|||
42131783|NCT00414609|75942697|FG002|Core Study|Patient withdrew consent|0|||
42131784|NCT00414609|75942695|FG000|Core Study|Lost to Follow-up|7|||
42131785|NCT00414609|75942696|FG001|Core Study|Lost to Follow-up|4|||
42131786|NCT00414609|75942697|FG002|Core Study|Lost to Follow-up|0|||
42131787|NCT00414609|75942695|FG000|Core Study|Administrative problems|0|||
42131788|NCT00414609|75942696|FG001|Core Study|Administrative problems|2|||
42131789|NCT00414609|75942697|FG002|Core Study|Administrative problems|0|||
42131790|NCT00414609|75942695|FG000|Core Study|Death|7|||
42131791|NCT00414609|75942696|FG001|Core Study|Death|14|||
42131792|NCT00414609|75942697|FG002|Core Study|Death|0|||
42131793|NCT00414609|75942695|FG000|Extension Study|Adverse Event|0|||
42131794|NCT00414609|75942696|FG001|Extension Study|Adverse Event|0|||
42131795|NCT00414609|75942697|FG002|Extension Study|Adverse Event|14|||
42131796|NCT00414609|75942695|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
42131797|NCT00414609|75942696|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
42232137|NCT03136861|76052996|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
42232138|NCT03136861|76052990|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
42232139|NCT03136861|76052991|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
42232140|NCT03136861|76052992|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
42232141|NCT03136861|76052993|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
42232142|NCT03136861|76052994|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
42232143|NCT03136861|76052995|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
42232144|NCT03136861|76052996|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
42232145|NCT03136861|76052990|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
42232146|NCT03136861|76052991|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
42232147|NCT03136861|76052992|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
42232148|NCT03136861|76052993|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
42232149|NCT03136861|76052994|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
42232150|NCT03136861|76052995|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
42232151|NCT03136861|76052996|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
42232152|NCT03316950|76053024|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
42232153|NCT03316950|76053025|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
42232154|NCT03316950|76053026|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
42232155|NCT03316950|76053027|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
42232156|NCT03316950|76053024|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
42232157|NCT03316950|76053025|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
42232158|NCT03316950|76053026|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
42232159|NCT03316950|76053027|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
42232160|NCT03316950|76053024|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
42232161|NCT03316950|76053025|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
42232162|NCT03316950|76053026|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
42232163|NCT03316950|76053027|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
42232164|NCT03139279|76053041|FG000|Overall Study|Physician Decision|2|||
42232165|NCT03139279|76053042|FG001|Overall Study|Physician Decision|0|||
42232166|NCT03139279|76053041|FG000|Overall Study|Protocol Violation|5|||
42232167|NCT03139279|76053042|FG001|Overall Study|Protocol Violation|4|||
42232168|NCT03139279|76053041|FG000|Overall Study|Withdrawal by Subject|0|||
42232169|NCT03139279|76053042|FG001|Overall Study|Withdrawal by Subject|2|||
42232170|NCT01370642|76053051|FG000|Overall Study|Adverse Event|2|||
42232171|NCT01370642|76053052|FG001|Overall Study|Adverse Event|1|||
42232172|NCT01370642|76053053|FG002|Overall Study|Adverse Event|1|||
42232173|NCT01370642|76053051|FG000|Overall Study|Detectable HCV RNA|0|||
42232174|NCT01370642|76053052|FG001|Overall Study|Detectable HCV RNA|0|||
42232175|NCT01370642|76053053|FG002|Overall Study|Detectable HCV RNA|22|||
42232176|NCT01370642|76053051|FG000|Overall Study|Lost to Follow-up|0|||
42232177|NCT01370642|76053052|FG001|Overall Study|Lost to Follow-up|0|||
42232178|NCT01370642|76053053|FG002|Overall Study|Lost to Follow-up|1|||
42232179|NCT01370642|76053051|FG000|Overall Study|Physician Decision|4|||
42232180|NCT01370642|76053052|FG001|Overall Study|Physician Decision|1|||
42232181|NCT01370642|76053053|FG002|Overall Study|Physician Decision|2|||
42232182|NCT01370642|76053051|FG000|Overall Study|Withdrawal by Subject|2|||
42232183|NCT01370642|76053052|FG001|Overall Study|Withdrawal by Subject|4|||
42232184|NCT01370642|76053053|FG002|Overall Study|Withdrawal by Subject|3|||
42232185|NCT02873208|76053061|FG000|Overall Study|Withdrawal by Subject|36|||
42232186|NCT02873208|76053061|FG000|Overall Study|Lost to Follow-up|22|||
42232187|NCT02873208|76053061|FG000|Overall Study|Adverse Event|15|||
42232188|NCT02873208|76053061|FG000|Overall Study|Non-compliance with study drug|12|||
42232189|NCT02873208|76053061|FG000|Overall Study|Protocol Violation|8|||
42232190|NCT02873208|76053061|FG000|Overall Study|Pregnancy|2|||
42232191|NCT02873208|76053061|FG000|Overall Study|Incarceration|1|||
42232192|NCT02873208|76053061|FG000|Overall Study|Lack of Efficacy|1|||
42232193|NCT02873208|76053061|FG000|Overall Study|Physician Decision|1|||
42232194|NCT03138967|76053067|FG000|Overall Study|Death|0|||
42232195|NCT03138967|76053068|FG001|Overall Study|Death|1|||
42232196|NCT03138967|76053067|FG000|Overall Study|Physician Decision|1|||
42232197|NCT03138967|76053068|FG001|Overall Study|Physician Decision|3|||
42232198|NCT01547117|76053078|FG000|Overall Study|Physician Decision|0|||
42232199|NCT01547117|76053079|FG001|Overall Study|Physician Decision|1|||
42232200|NCT01547117|76053080|FG002|Overall Study|Physician Decision|1|||
42232201|NCT01547117|76053081|FG003|Overall Study|Physician Decision|3|||
42232202|NCT01547117|76053078|FG000|Overall Study|Withdrawal by Subject|1|||
42232203|NCT01547117|76053079|FG001|Overall Study|Withdrawal by Subject|2|||
42232204|NCT01547117|76053080|FG002|Overall Study|Withdrawal by Subject|1|||
42232205|NCT01547117|76053081|FG003|Overall Study|Withdrawal by Subject|2|||
42232206|NCT03136159|76053109|FG000|Overall Study|chorioamnionitis|2|||
42232207|NCT03136159|76053110|FG001|Overall Study|chorioamnionitis|0|||
42232208|NCT03136159|76053109|FG000|Overall Study|vertical skin incision|1|||
42232209|NCT03136159|76053110|FG001|Overall Study|vertical skin incision|0|||
42232210|NCT03136159|76053109|FG000|Overall Study|additional dressing|1|||
42232211|NCT03136159|76053110|FG001|Overall Study|additional dressing|0|||
42232212|NCT03136159|76053109|FG000|Overall Study|never got dressing placed|1|||
42232213|NCT03136159|76053110|FG001|Overall Study|never got dressing placed|0|||
42232214|NCT01986933|76053121|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
42232215|NCT01986933|76053122|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
42232216|NCT01986933|76053123|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
42232217|NCT01986933|76053124|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
42232218|NCT01986933|76053125|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
42232219|NCT01986933|76053121|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
42232220|NCT01986933|76053122|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
42232221|NCT01986933|76053123|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
42232222|NCT01986933|76053124|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
42232223|NCT01986933|76053125|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
42232224|NCT01986933|76053121|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
42232225|NCT01986933|76053122|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
42232226|NCT01986933|76053123|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
42232227|NCT01986933|76053124|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
42232228|NCT01986933|76053125|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
42232229|NCT01986933|76053121|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
42232230|NCT01986933|76053122|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
42232231|NCT01986933|76053123|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
42232232|NCT01986933|76053124|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
42232233|NCT01986933|76053125|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
42232234|NCT01986933|76053121|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
42232235|NCT01986933|76053122|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
42232236|NCT01986933|76053123|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
42232237|NCT01986933|76053124|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
42232238|NCT01986933|76053125|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
42232239|NCT01986933|76053121|FG000|Active-to-active (Part B)|Adverse Event|0|||
42232240|NCT01986933|76053122|FG001|Active-to-active (Part B)|Adverse Event|2|||
42232241|NCT01986933|76053123|FG002|Active-to-active (Part B)|Adverse Event|0|||
42232242|NCT01986933|76053124|FG003|Active-to-active (Part B)|Adverse Event|1|||
42232243|NCT01986933|76053125|FG004|Active-to-active (Part B)|Adverse Event|3|||
42232244|NCT01986933|76053121|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
42232245|NCT01986933|76053122|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
42232246|NCT01986933|76053123|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
42232247|NCT01986933|76053124|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
42232248|NCT01986933|76053125|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
42232249|NCT01986933|76053121|FG000|Active-to-active (Part B)|Pregnancy|0|||
42232250|NCT01986933|76053122|FG001|Active-to-active (Part B)|Pregnancy|0|||
42232251|NCT01986933|76053123|FG002|Active-to-active (Part B)|Pregnancy|0|||
42232252|NCT01986933|76053124|FG003|Active-to-active (Part B)|Pregnancy|0|||
42232253|NCT01986933|76053125|FG004|Active-to-active (Part B)|Pregnancy|1|||
42232254|NCT01986933|76053121|FG000|Active-to-active (Part B)|Physician Decision|0|||
42232255|NCT01986933|76053122|FG001|Active-to-active (Part B)|Physician Decision|0|||
42232256|NCT01986933|76053123|FG002|Active-to-active (Part B)|Physician Decision|1|||
42232257|NCT01986933|76053124|FG003|Active-to-active (Part B)|Physician Decision|1|||
42232258|NCT01986933|76053125|FG004|Active-to-active (Part B)|Physician Decision|0|||
42232259|NCT01986933|76053121|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
42232260|NCT01986933|76053122|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
42232261|NCT01986933|76053123|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
42232262|NCT01986933|76053124|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
41987201|NCT02348216|75794436|FG006|Overall Study|Full consent withdrawal|1|||
42232263|NCT01986933|76053125|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
42232264|NCT01986933|76053121|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
42232265|NCT01986933|76053122|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
42232266|NCT01986933|76053123|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
42232267|NCT01986933|76053124|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
42232268|NCT01986933|76053125|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
42232269|NCT01986933|76053121|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
42232270|NCT01986933|76053122|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
42232271|NCT01986933|76053123|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
41987202|NCT02348216|75794430|FG000|Overall Study|Lost to Follow-up|0|||
42232272|NCT01986933|76053124|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
42232273|NCT01986933|76053125|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
42232274|NCT01986933|76053121|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
42232275|NCT01986933|76053122|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
42232276|NCT01986933|76053123|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
42232277|NCT01986933|76053124|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
42232278|NCT01986933|76053125|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
42232279|NCT01986933|76053121|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
42232280|NCT01986933|76053122|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
42232281|NCT01986933|76053123|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
42232282|NCT01986933|76053124|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
42232283|NCT01986933|76053125|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
42232284|NCT01986933|76053121|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
42232285|NCT01986933|76053122|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
42232286|NCT01986933|76053123|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
42232287|NCT01986933|76053124|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
42232288|NCT01986933|76053125|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
42232289|NCT01986933|76053121|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
42232290|NCT01986933|76053122|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
42232291|NCT01986933|76053123|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
42232292|NCT01986933|76053124|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
42232293|NCT01986933|76053125|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
42232294|NCT01986933|76053121|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
42232295|NCT01986933|76053122|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
42232296|NCT01986933|76053123|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
42232297|NCT01986933|76053124|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
42232298|NCT01986933|76053125|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
42232299|NCT00394355|76053169|FG000|Overall Study|Adverse Event|10|||
42232300|NCT00394355|76053170|FG001|Overall Study|Adverse Event|6|||
42232301|NCT00394355|76053171|FG002|Overall Study|Adverse Event|7|||
42232302|NCT00394355|76053172|FG003|Overall Study|Adverse Event|8|||
42232303|NCT00394355|76053169|FG000|Overall Study|Did not meet protocol eligibility|1|||
42232304|NCT00394355|76053170|FG001|Overall Study|Did not meet protocol eligibility|5|||
42232305|NCT00394355|76053171|FG002|Overall Study|Did not meet protocol eligibility|4|||
42232306|NCT00394355|76053172|FG003|Overall Study|Did not meet protocol eligibility|2|||
42232307|NCT00394355|76053169|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
42232308|NCT00394355|76053170|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
42232309|NCT00394355|76053171|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
42232310|NCT00394355|76053172|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
42232311|NCT00394355|76053169|FG000|Overall Study|Subject withdrawal - related to drug|1|||
42232312|NCT00394355|76053170|FG001|Overall Study|Subject withdrawal - related to drug|0|||
42232313|NCT00394355|76053171|FG002|Overall Study|Subject withdrawal - related to drug|0|||
42232314|NCT00394355|76053172|FG003|Overall Study|Subject withdrawal - related to drug|0|||
42232315|NCT00394355|76053169|FG000|Overall Study|Lost to Follow-up|7|||
42232316|NCT00394355|76053170|FG001|Overall Study|Lost to Follow-up|5|||
42232317|NCT00394355|76053171|FG002|Overall Study|Lost to Follow-up|4|||
42232318|NCT00394355|76053172|FG003|Overall Study|Lost to Follow-up|3|||
42232319|NCT00394355|76053169|FG000|Overall Study|Noncompliance with protocol|4|||
42232320|NCT00394355|76053170|FG001|Overall Study|Noncompliance with protocol|3|||
42232321|NCT00394355|76053171|FG002|Overall Study|Noncompliance with protocol|10|||
42232322|NCT00394355|76053172|FG003|Overall Study|Noncompliance with protocol|8|||
42232323|NCT00394355|76053169|FG000|Overall Study|Administrative|0|||
42232324|NCT00394355|76053170|FG001|Overall Study|Administrative|1|||
42232325|NCT00394355|76053171|FG002|Overall Study|Administrative|1|||
42232326|NCT00394355|76053172|FG003|Overall Study|Administrative|1|||
42232327|NCT00394355|76053169|FG000|Overall Study|Lack of Efficacy|0|||
42232328|NCT00394355|76053170|FG001|Overall Study|Lack of Efficacy|0|||
42232329|NCT00394355|76053171|FG002|Overall Study|Lack of Efficacy|2|||
42232330|NCT00394355|76053172|FG003|Overall Study|Lack of Efficacy|3|||
42302550|NCT02416453|76137791|FG001|Overall Study|Withdrawal by Subject|0|||
42232331|NCT02797808|76053184|FG000|Overall Study|Withdrawal by Subject|1|||
42232332|NCT02797808|76053185|FG001|Overall Study|Withdrawal by Subject|1|||
42232333|NCT02797808|76053184|FG000|Overall Study|Physician Decision|6|||
42232334|NCT02797808|76053185|FG001|Overall Study|Physician Decision|2|||
42232335|NCT02796560|76053193|FG000|Overall Study|Adverse Event|2|||
42232336|NCT02796560|76053194|FG001|Overall Study|Adverse Event|0|||
42232337|NCT02796560|76053193|FG000|Overall Study|Withdrawal by Subject|2|||
42232338|NCT02796560|76053194|FG001|Overall Study|Withdrawal by Subject|2|||
42232339|NCT00344487|76053200|FG000|Overall Study|immunologic failure|1|||
42232340|NCT02871492|76053209|FG000|Overall Study|Lost to Follow-up|6|||
42232341|NCT02871492|76053210|FG001|Overall Study|Lost to Follow-up|3|||
42302551|NCT02416453|76137792|FG002|Overall Study|Withdrawal by Subject|0|||
42131798|NCT00414609|75942697|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
42232342|NCT02871492|76053211|FG002|Overall Study|Lost to Follow-up|5|||
42232343|NCT02871492|76053209|FG000|Overall Study|Withdrawal by Subject|0|||
42232344|NCT02871492|76053210|FG001|Overall Study|Withdrawal by Subject|0|||
42232345|NCT02871492|76053211|FG002|Overall Study|Withdrawal by Subject|1|||
42232346|NCT03143855|76053221|FG000|Overall Study|Withdrawal by Subject|4|||
42232347|NCT03143855|76053222|FG001|Overall Study|Withdrawal by Subject|3|||
42232348|NCT03143855|76053221|FG000|Overall Study|Protocol Violation|1|||
42232349|NCT03143855|76053222|FG001|Overall Study|Protocol Violation|0|||
42232350|NCT03143855|76053221|FG000|Overall Study|Participant experienced withdrawal|0|||
42232351|NCT03143855|76053222|FG001|Overall Study|Participant experienced withdrawal|1|||
42232352|NCT02878603|76053230|FG000|Overall Study|Lost to Follow-up|4|||
42232353|NCT02878603|76053231|FG001|Overall Study|Lost to Follow-up|1|||
42232354|NCT02878603|76053230|FG000|Overall Study|Withdrawal by Subject|1|||
42232355|NCT02878603|76053231|FG001|Overall Study|Withdrawal by Subject|1|||
42232356|NCT02878603|76053230|FG000|Overall Study|Death|1|||
42232357|NCT02878603|76053231|FG001|Overall Study|Death|0|||
42232358|NCT02878603|76053230|FG000|Overall Study|Physician Decision|0|||
42232359|NCT02878603|76053231|FG001|Overall Study|Physician Decision|3|||
42232360|NCT01370408|76053237|FG000|Overall Study|treatment failure|9|||
42232361|NCT03294109|76053243|FG000|Overall Study|Withdrawal by Subject|6|||
42232362|NCT03294109|76053244|FG001|Overall Study|Withdrawal by Subject|5|||
42232363|NCT03132805|76053263|FG000|Overall Study|Lost to Follow-up|142|||
42232364|NCT03132805|76053264|FG001|Overall Study|Lost to Follow-up|141|||
42232365|NCT03132805|76053265|FG002|Overall Study|Lost to Follow-up|113|||
42232366|NCT02793128|76053273|FG000|Overall Study|Death|4|||
42232367|NCT02793128|76053273|FG000|Overall Study|Withdrawal by Subject|2|||
42232368|NCT02793128|76053273|FG000|Overall Study|Physician Decision|1|||
42232369|NCT02793128|76053273|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
42232370|NCT02793128|76053273|FG000|Overall Study|Patient elected nephroureterectomy|1|||
42232371|NCT03142451|76053287|FG000|Overall Study|Adverse Event|5|||
42232372|NCT03142451|76053288|FG001|Overall Study|Adverse Event|2|||
42232373|NCT03142451|76053287|FG000|Overall Study|Lost to Follow-up|25|||
42232374|NCT03142451|76053288|FG001|Overall Study|Lost to Follow-up|8|||
42232375|NCT03142451|76053287|FG000|Overall Study|Participant request|24|||
42232376|NCT03142451|76053288|FG001|Overall Study|Participant request|12|||
42232377|NCT03142451|76053287|FG000|Overall Study|Protocol Violation|3|||
42232378|NCT03142451|76053288|FG001|Overall Study|Protocol Violation|1|||
42232379|NCT03142451|76053287|FG000|Overall Study|Other|1|||
42232380|NCT03142451|76053288|FG001|Overall Study|Other|1|||
42232381|NCT03141905|76053296|FG000|Overall Study|Death|3|||
42232382|NCT03141905|76053297|FG001|Overall Study|Death|2|||
41987203|NCT02348216|75794431|FG001|Overall Study|Lost to Follow-up|0|||
41987204|NCT02348216|75794432|FG002|Overall Study|Lost to Follow-up|0|||
41987205|NCT02348216|75794433|FG003|Overall Study|Lost to Follow-up|0|||
41987206|NCT02348216|75794434|FG004|Overall Study|Lost to Follow-up|0|||
41987207|NCT02348216|75794435|FG005|Overall Study|Lost to Follow-up|0|||
41987208|NCT02348216|75794436|FG006|Overall Study|Lost to Follow-up|1|||
41987209|NCT02348216|75794430|FG000|Overall Study|Still on study|3|||
42232383|NCT03141905|76053296|FG000|Overall Study|Withdrawal by Subject|1|||
42232384|NCT03141905|76053297|FG001|Overall Study|Withdrawal by Subject|0|||
42232385|NCT03141905|76053296|FG000|Overall Study|Lost to Follow-up|3|||
42232386|NCT03141905|76053297|FG001|Overall Study|Lost to Follow-up|7|||
42232387|NCT03141905|76053296|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
42232388|NCT03141905|76053297|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
42232389|NCT01370018|76053304|FG000|Overall Study|Did not meet criteria for analysis|1|||
42232390|NCT04034355|76053310|FG000|Overall Study|Study terminated by Sponsor|10|||
42232391|NCT04034355|76053311|FG001|Overall Study|Study terminated by Sponsor|17|||
42232392|NCT04034355|76053310|FG000|Overall Study|Withdrawal by Subject|12|||
42232393|NCT04034355|76053311|FG001|Overall Study|Withdrawal by Subject|11|||
42232394|NCT04034355|76053310|FG000|Overall Study|Site terminated by Sponsor|4|||
42232395|NCT04034355|76053311|FG001|Overall Study|Site terminated by Sponsor|5|||
42232396|NCT04034355|76053310|FG000|Overall Study|Adverse Event|2|||
42232397|NCT04034355|76053311|FG001|Overall Study|Adverse Event|0|||
42232398|NCT04034355|76053310|FG000|Overall Study|Death|1|||
42232399|NCT04034355|76053311|FG001|Overall Study|Death|1|||
42232400|NCT04034355|76053310|FG000|Overall Study|Not reported|2|||
42232401|NCT04034355|76053311|FG001|Overall Study|Not reported|0|||
42232402|NCT04034355|76053310|FG000|Overall Study|Lost to Follow-up|1|||
42232403|NCT04034355|76053311|FG001|Overall Study|Lost to Follow-up|0|||
42232404|NCT04034355|76053310|FG000|Overall Study|Physician Decision|1|||
42232405|NCT04034355|76053311|FG001|Overall Study|Physician Decision|0|||
42232406|NCT04034355|76053310|FG000|Overall Study|Protocol Violation|0|||
42232407|NCT04034355|76053311|FG001|Overall Study|Protocol Violation|1|||
42232408|NCT04034355|76053310|FG000|Overall Study|Progressive disease|1|||
42232409|NCT04034355|76053311|FG001|Overall Study|Progressive disease|0|||
42232410|NCT01336764|76053328|FG000|Overall Study|Withdrawal by Subject|5|||
42232411|NCT01336764|76053329|FG001|Overall Study|Withdrawal by Subject|5|||
42232412|NCT01336608|76053338|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
42232413|NCT01336608|76053339|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
42232414|NCT01336608|76053340|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
42232415|NCT01336608|76053341|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
42232416|NCT01336608|76053338|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
42232417|NCT01336608|76053339|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
42232418|NCT01336608|76053340|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
42232419|NCT01336608|76053341|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
42232420|NCT01336608|76053338|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
42232421|NCT01336608|76053339|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
42232422|NCT01336608|76053340|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
42232423|NCT01336608|76053341|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
42232424|NCT01336608|76053338|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
42232425|NCT01336608|76053339|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
42232426|NCT01336608|76053340|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
42232427|NCT01336608|76053341|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
42232428|NCT01336608|76053338|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
42232429|NCT01336608|76053339|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
42232430|NCT01336608|76053340|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
42232431|NCT01336608|76053341|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
42232432|NCT01336608|76053338|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
42232433|NCT01336608|76053339|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
42232434|NCT01336608|76053340|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
42232435|NCT01336608|76053341|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
42232436|NCT01336608|76053338|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
42232437|NCT01336608|76053339|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
42232438|NCT01336608|76053340|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
42232439|NCT01336608|76053341|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
42232440|NCT01336608|76053338|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
42232441|NCT01336608|76053339|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
42232442|NCT01336608|76053340|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
42232443|NCT01336608|76053341|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
42232444|NCT01336608|76053338|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
42232445|NCT01336608|76053339|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
42232446|NCT01336608|76053340|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
42232447|NCT01336608|76053341|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
42232448|NCT01336608|76053338|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
42232449|NCT01336608|76053339|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
42232450|NCT01336608|76053340|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
42232451|NCT01336608|76053341|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
41987210|NCT02348216|75794431|FG001|Overall Study|Still on study|50|||
42232452|NCT01336608|76053338|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
42232453|NCT01336608|76053339|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
41987211|NCT02348216|75794432|FG002|Overall Study|Still on study|21|||
42232454|NCT01336608|76053340|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
42232455|NCT01336608|76053341|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
42232456|NCT01336608|76053338|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
42232457|NCT01336608|76053339|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
42232458|NCT01336608|76053340|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
41987212|NCT02348216|75794433|FG003|Overall Study|Still on study|19|||
42232459|NCT01336608|76053341|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
42232460|NCT01336608|76053338|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
42232461|NCT01336608|76053339|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
42232462|NCT01336608|76053340|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
42232463|NCT01336608|76053341|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
42232464|NCT01346371|76053360|FG000|Overall Study|Lost to Follow-up|2|||
42232465|NCT01346371|76053361|FG001|Overall Study|Lost to Follow-up|0|||
42232466|NCT03644849|76053379|FG000|Overall Study|Lost to Follow-up|1|||
42232467|NCT03644849|76053380|FG001|Overall Study|Lost to Follow-up|3|||
42232468|NCT03131479|76053391|FG000|Overall Study|Adverse Event|0|||
42232469|NCT03131479|76053392|FG001|Overall Study|Adverse Event|0|||
42232470|NCT03131479|76053393|FG002|Overall Study|Adverse Event|1|||
42232471|NCT03131479|76053394|FG003|Overall Study|Adverse Event|1|||
42232472|NCT03131479|76053395|FG004|Overall Study|Adverse Event|0|||
42232473|NCT03131479|76053391|FG000|Overall Study|Subject/Guardian Decision|0|||
42232474|NCT03131479|76053392|FG001|Overall Study|Subject/Guardian Decision|0|||
42232475|NCT03131479|76053393|FG002|Overall Study|Subject/Guardian Decision|0|||
42232476|NCT03131479|76053394|FG003|Overall Study|Subject/Guardian Decision|1|||
42232477|NCT03131479|76053395|FG004|Overall Study|Subject/Guardian Decision|0|||
42232478|NCT03602885|76053409|FG000|Overall Study|Lost to Follow-up|3|||
42232479|NCT03602885|76053410|FG001|Overall Study|Lost to Follow-up|0|||
42232480|NCT02880761|76053418|FG000|Overall Study|Death|6|||
42232481|NCT02880761|76053419|FG001|Overall Study|Death|8|||
42232482|NCT02880761|76053418|FG000|Overall Study|Withdrawal by Subject|3|||
42232483|NCT02880761|76053419|FG001|Overall Study|Withdrawal by Subject|6|||
42232484|NCT02880761|76053418|FG000|Overall Study|Protocol Violation|4|||
42232485|NCT02880761|76053419|FG001|Overall Study|Protocol Violation|3|||
42232486|NCT02880761|76053418|FG000|Overall Study|Lost to Follow-up|3|||
42232487|NCT02880761|76053419|FG001|Overall Study|Lost to Follow-up|4|||
42232488|NCT02930941|76053427|FG000|Overall Study|Lost to Follow-up|1|||
42232489|NCT02930941|76053428|FG001|Overall Study|Lost to Follow-up|2|||
42232490|NCT03137537|76053440|FG000|Overall Study|Adverse Event|0|||
42232491|NCT03137537|76053441|FG001|Overall Study|Adverse Event|1|||
42232492|NCT03137459|76053449|FG000|2-month Assessment|Withdrawal by Subject|13|||
42232493|NCT03137459|76053450|FG001|2-month Assessment|Withdrawal by Subject|3|||
42232494|NCT03137459|76053449|FG000|2-month Assessment|Unable to reach|42|||
42232495|NCT03137459|76053450|FG001|2-month Assessment|Unable to reach|32|||
42232496|NCT03137459|76053449|FG000|2-month Assessment|Refused assessment|7|||
42232497|NCT03137459|76053450|FG001|2-month Assessment|Refused assessment|5|||
42232498|NCT03137459|76053449|FG000|2-month Assessment|Acutely ill|6|||
42232499|NCT03137459|76053450|FG001|2-month Assessment|Acutely ill|2|||
42232500|NCT03137459|76053449|FG000|4-month Assessment|Death|4|||
42232501|NCT03137459|76053450|FG001|4-month Assessment|Death|2|||
42232502|NCT03137459|76053449|FG000|4-month Assessment|Withdrawal by Subject|4|||
42232503|NCT03137459|76053450|FG001|4-month Assessment|Withdrawal by Subject|2|||
42232504|NCT03137459|76053449|FG000|4-month Assessment|Unable to reach|44|||
42232505|NCT03137459|76053450|FG001|4-month Assessment|Unable to reach|29|||
42232506|NCT03137459|76053449|FG000|4-month Assessment|Refused assessment|24|||
42232507|NCT03137459|76053450|FG001|4-month Assessment|Refused assessment|10|||
42232508|NCT03137459|76053449|FG000|4-month Assessment|Acutely ill|2|||
42232509|NCT03137459|76053450|FG001|4-month Assessment|Acutely ill|3|||
42232510|NCT03137459|76053449|FG000|6-months|Lost to Follow-up|14|||
42232511|NCT03137459|76053450|FG001|6-months|Lost to Follow-up|11|||
42232512|NCT03137459|76053449|FG000|6-months|Death|0|||
42232513|NCT03137459|76053450|FG001|6-months|Death|2|||
42232514|NCT03137459|76053449|FG000|6-months|Refused assessment|6|||
42232515|NCT03137459|76053450|FG001|6-months|Refused assessment|3|||
42232516|NCT03137459|76053449|FG000|6-months|Acutely ill|1|||
42232517|NCT03137459|76053450|FG001|6-months|Acutely ill|1|||
41987213|NCT02348216|75794434|FG004|Overall Study|Still on study|32|||
42232518|NCT03131713|76053459|FG000|Overall Study|Lost to Follow-up|5|||
42232519|NCT03131713|76053460|FG001|Overall Study|Lost to Follow-up|0|||
42232520|NCT02930005|76053468|FG000|Overall Study|Lost to Follow-up|1|||
42232521|NCT02930005|76053469|FG001|Overall Study|Lost to Follow-up|5|||
42232522|NCT03637491|76053479|FG000|Overall Study|Death|9|||
42232523|NCT03637491|76053480|FG001|Overall Study|Death|9|||
42232524|NCT03637491|76053481|FG002|Overall Study|Death|5|||
42232525|NCT03637491|76053482|FG003|Overall Study|Death|3|||
41987214|NCT02348216|75794435|FG005|Overall Study|Still on study|27|||
42232526|NCT03637491|76053479|FG000|Overall Study|Lost to Follow-up|0|||
42232527|NCT03637491|76053480|FG001|Overall Study|Lost to Follow-up|1|||
42232528|NCT03637491|76053481|FG002|Overall Study|Lost to Follow-up|0|||
42232529|NCT03637491|76053482|FG003|Overall Study|Lost to Follow-up|1|||
42232530|NCT03637491|76053479|FG000|Overall Study|Study Terminated By Sponsor|0|||
42232531|NCT03637491|76053480|FG001|Overall Study|Study Terminated By Sponsor|2|||
42232532|NCT03637491|76053481|FG002|Overall Study|Study Terminated By Sponsor|1|||
41987215|NCT02348216|75794436|FG006|Overall Study|Still on study|32|||
42232533|NCT03637491|76053482|FG003|Overall Study|Study Terminated By Sponsor|0|||
42232534|NCT03637491|76053479|FG000|Overall Study|Withdrawal by Subject|1|||
42232535|NCT03637491|76053480|FG001|Overall Study|Withdrawal by Subject|0|||
42232536|NCT03637491|76053481|FG002|Overall Study|Withdrawal by Subject|1|||
42232537|NCT03637491|76053482|FG003|Overall Study|Withdrawal by Subject|2|||
42232538|NCT03334539|76053516|FG000|Overall Study|Adverse Event|3|||
42232539|NCT03334539|76053517|FG001|Overall Study|Adverse Event|5|||
42232540|NCT03334539|76053518|FG002|Overall Study|Adverse Event|0|||
42232541|NCT03334539|76053516|FG000|Overall Study|Withdrawal by Subject|0|||
42232542|NCT03334539|76053517|FG001|Overall Study|Withdrawal by Subject|1|||
42232543|NCT03334539|76053518|FG002|Overall Study|Withdrawal by Subject|1|||
42232544|NCT03334539|76053516|FG000|Overall Study|Administrative Reasons|1|||
42232545|NCT03334539|76053517|FG001|Overall Study|Administrative Reasons|0|||
42232546|NCT03334539|76053518|FG002|Overall Study|Administrative Reasons|0|||
42232547|NCT03334539|76053516|FG000|Overall Study|Hypertension Not Controlled|0|||
42232548|NCT03334539|76053517|FG001|Overall Study|Hypertension Not Controlled|1|||
42232549|NCT03334539|76053518|FG002|Overall Study|Hypertension Not Controlled|0|||
42232550|NCT03137303|76053533|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
42232551|NCT03137303|76053534|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
42232552|NCT03137303|76053533|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
42232553|NCT03137303|76053534|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
42232554|NCT03137303|76053533|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
41987216|NCT02348216|75794430|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
41987217|NCT02348216|75794431|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
41987218|NCT02348216|75794432|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
41987219|NCT02348216|75794433|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
41987220|NCT02348216|75794434|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
41987221|NCT02348216|75794435|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
42232555|NCT03137303|76053534|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
42232556|NCT03137303|76053533|FG000|T3: 9-month Follow-up|Death|1|||
42232557|NCT03137303|76053534|FG001|T3: 9-month Follow-up|Death|0|||
41987222|NCT02348216|75794436|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
42232558|NCT03137303|76053533|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
42232559|NCT03137303|76053534|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
42232560|NCT03137303|76053533|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
42232561|NCT03137303|76053534|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
42232562|NCT03137303|76053533|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
42232563|NCT03137303|76053534|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
42232564|NCT03296553|76053542|FG000|Overall Study|Withdrawal by Subject|1|||
42232565|NCT03296553|76053543|FG001|Overall Study|Withdrawal by Subject|1|||
42232566|NCT03296553|76053542|FG000|Overall Study|Death|1|||
42232567|NCT03296553|76053543|FG001|Overall Study|Death|0|||
42232568|NCT03131167|76053562|FG000|Overall Study|Other (Unspecified)|0|||
42232569|NCT03131167|76053563|FG001|Overall Study|Other (Unspecified)|0|||
42232570|NCT03131167|76053564|FG002|Overall Study|Other (Unspecified)|0|||
42232571|NCT03131167|76053565|FG003|Overall Study|Other (Unspecified)|0|||
42232572|NCT03131167|76053566|FG004|Overall Study|Other (Unspecified)|0|||
42232573|NCT03131167|76053567|FG005|Overall Study|Other (Unspecified)|1|||
42232574|NCT03131167|76053568|FG006|Overall Study|Other (Unspecified)|0|||
42232575|NCT03131167|76053569|FG007|Overall Study|Other (Unspecified)|0|||
42232576|NCT03131167|76053570|FG008|Overall Study|Other (Unspecified)|0|||
42232577|NCT03131167|76053571|FG009|Overall Study|Other (Unspecified)|0|||
41987223|NCT02037529|75794476|FG000|Overall Study|Withdrawal by Subject|1|||
41987224|NCT02037529|75794477|FG001|Overall Study|Withdrawal by Subject|3|||
41987225|NCT02037529|75794476|FG000|Overall Study|Adverse Event|0|||
41987226|NCT02037529|75794477|FG001|Overall Study|Adverse Event|1|||
41987227|NCT02030028|75794484|FG000|Overall Study|Withdrawal by Subject|4|||
41987228|NCT02030028|75794484|FG000|Overall Study|lack of transportation|1|||
41987229|NCT01956123|75794490|FG000|COS Cycle 2|Protocol Violation|8|||
41987230|NCT01956123|75794491|FG001|COS Cycle 2|Protocol Violation|3|||
41987231|NCT01956123|75794492|FG002|COS Cycle 2|Protocol Violation|0|||
41987232|NCT01956123|75794493|FG003|COS Cycle 2|Protocol Violation|0|||
41987233|NCT01956123|75794490|FG000|COS Cycle 2|Adverse Event|3|||
41987234|NCT01956123|75794491|FG001|COS Cycle 2|Adverse Event|4|||
41987235|NCT01956123|75794492|FG002|COS Cycle 2|Adverse Event|0|||
41987236|NCT01956123|75794493|FG003|COS Cycle 2|Adverse Event|0|||
41987237|NCT01956123|75794490|FG000|COS Cycle 2|Personal Reasons|2|||
41987238|NCT01956123|75794491|FG001|COS Cycle 2|Personal Reasons|0|||
42232578|NCT03131167|76053572|FG010|Overall Study|Other (Unspecified)|0|||
42232579|NCT03131167|76053573|FG011|Overall Study|Other (Unspecified)|0|||
42232580|NCT03131167|76053574|FG012|Overall Study|Other (Unspecified)|0|||
42232581|NCT03060447|76053605|FG000|Overall Study|Withdrawal by Subject|2|||
42232582|NCT03060447|76053606|FG001|Overall Study|Withdrawal by Subject|0|||
42232583|NCT01712789|76053618|FG000|Overall Study|Lack of Efficacy|2|||
42232584|NCT01712789|76053618|FG000|Overall Study|Lost to Follow-up|1|||
42232585|NCT01712789|76053618|FG000|Overall Study|Progressive Disease|504|||
42232586|NCT01712789|76053618|FG000|Overall Study|Death|57|||
42232587|NCT01712789|76053618|FG000|Overall Study|Adverse Event|52|||
42232588|NCT01712789|76053618|FG000|Overall Study|Miscellaneous|31|||
42232589|NCT01712789|76053618|FG000|Overall Study|Withdrawal by Subject|21|||
42232590|NCT01712789|76053618|FG000|Overall Study|Transition to Commercial Treatment|8|||
42232591|NCT01712789|76053618|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
42232592|NCT03074318|76053626|FG000|Overall Study|Adverse Event|0|||
42232593|NCT03074318|76053627|FG001|Overall Study|Adverse Event|1|||
42232594|NCT03074318|76053628|FG002|Overall Study|Adverse Event|1|||
42232595|NCT03074318|76053629|FG003|Overall Study|Adverse Event|1|||
42232596|NCT03074318|76053626|FG000|Overall Study|Death|1|||
42232597|NCT03074318|76053627|FG001|Overall Study|Death|0|||
42232598|NCT03074318|76053628|FG002|Overall Study|Death|0|||
41987239|NCT01956123|75794492|FG002|COS Cycle 2|Personal Reasons|0|||
41987240|NCT01956123|75794493|FG003|COS Cycle 2|Personal Reasons|0|||
41987241|NCT01956123|75794490|FG000|COS Cycle 2|Withdrawal by Subject|1|||
41987242|NCT01956123|75794491|FG001|COS Cycle 2|Withdrawal by Subject|0|||
41987243|NCT01956123|75794492|FG002|COS Cycle 2|Withdrawal by Subject|0|||
41987244|NCT01956123|75794493|FG003|COS Cycle 2|Withdrawal by Subject|0|||
41987245|NCT01956123|75794490|FG000|COS Cycle 3|Protocol Violation|0|||
41987246|NCT01956123|75794491|FG001|COS Cycle 3|Protocol Violation|0|||
41987247|NCT01956123|75794492|FG002|COS Cycle 3|Protocol Violation|2|||
41987248|NCT01956123|75794493|FG003|COS Cycle 3|Protocol Violation|1|||
41987249|NCT01956123|75794490|FG000|COS Cycle 3|Adverse Event|0|||
41987250|NCT01956123|75794491|FG001|COS Cycle 3|Adverse Event|0|||
41987251|NCT01956123|75794492|FG002|COS Cycle 3|Adverse Event|3|||
41987252|NCT01956123|75794493|FG003|COS Cycle 3|Adverse Event|0|||
41987253|NCT01956123|75794490|FG000|COS Cycle 3|Personal Reasons|0|||
41987254|NCT01956123|75794491|FG001|COS Cycle 3|Personal Reasons|0|||
41987255|NCT01956123|75794492|FG002|COS Cycle 3|Personal Reasons|1|||
41987256|NCT01956123|75794493|FG003|COS Cycle 3|Personal Reasons|0|||
41987257|NCT01956123|75794490|FG000|COS Cycle 3|Withdrawal by Subject|0|||
41987258|NCT01956123|75794491|FG001|COS Cycle 3|Withdrawal by Subject|0|||
41987259|NCT01956123|75794492|FG002|COS Cycle 3|Withdrawal by Subject|0|||
41987260|NCT01956123|75794493|FG003|COS Cycle 3|Withdrawal by Subject|1|||
41987261|NCT01191697|75794513|FG000|Overall Study|Death|1|||
41987262|NCT01191697|75794513|FG000|Overall Study|Physician Decision|2|||
42232599|NCT03074318|76053629|FG003|Overall Study|Death|0|||
42232600|NCT03074318|76053626|FG000|Overall Study|Withdrawal by Subject|1|||
42232601|NCT03074318|76053627|FG001|Overall Study|Withdrawal by Subject|2|||
42232602|NCT03074318|76053628|FG002|Overall Study|Withdrawal by Subject|2|||
42232603|NCT03074318|76053629|FG003|Overall Study|Withdrawal by Subject|4|||
42232604|NCT03074318|76053626|FG000|Overall Study|Trial Closure|2|||
42232605|NCT03074318|76053627|FG001|Overall Study|Trial Closure|2|||
42232606|NCT03074318|76053628|FG002|Overall Study|Trial Closure|3|||
41987263|NCT01191697|75794513|FG000|Overall Study|Pursue chemoradiation|2|||
41987264|NCT01191697|75794513|FG000|Overall Study|Break from chemotherapy|2|||
41987265|NCT01191697|75794513|FG000|Overall Study|Withdrawal by Subject|1|||
41987266|NCT01191697|75794513|FG000|Overall Study|Surveillance|1|||
41987267|NCT01191697|75794513|FG000|Overall Study|Adverse Event|2|||
41987268|NCT01191697|75794513|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
41987269|NCT01191697|75794513|FG000|Overall Study|Not completed but analyzed|25|||
41987270|NCT01044745|75794517|FG000|Overall Study|Ineiligible|2|||
41987271|NCT01295827|75794534|FG000|Overall Study|Adverse Event|1|||
41987272|NCT01295827|75794535|FG001|Overall Study|Adverse Event|2|||
42232607|NCT03074318|76053629|FG003|Overall Study|Trial Closure|11|||
42232608|NCT03135119|76053650|FG000|Overall Study|Lost to Follow-up|2|||
42232609|NCT03135119|76053651|FG001|Overall Study|Lost to Follow-up|0|||
42232610|NCT03135119|76053650|FG000|Overall Study|Physician Decision|1|||
42232611|NCT03135119|76053651|FG001|Overall Study|Physician Decision|1|||
42232612|NCT03135119|76053650|FG000|Overall Study|COVID-19 Shutdown|2|||
42232613|NCT03135119|76053651|FG001|Overall Study|COVID-19 Shutdown|2|||
42232614|NCT01369784|76053657|FG000|Overall Study|Protocol Violation|12|||
42232615|NCT03353675|76053661|FG000|Overall Study|Adverse Event|4|||
42232616|NCT03137069|76053671|FG000|Overall Study|Withdrawal by Subject|1|||
42232617|NCT03137069|76053672|FG001|Overall Study|Withdrawal by Subject|2|||
42232618|NCT03137069|76053673|FG002|Overall Study|Withdrawal by Subject|2|||
42232619|NCT03137069|76053674|FG003|Overall Study|Withdrawal by Subject|2|||
42232620|NCT03137069|76053675|FG004|Overall Study|Withdrawal by Subject|0|||
42232621|NCT03137069|76053676|FG005|Overall Study|Withdrawal by Subject|0|||
42232622|NCT03137069|76053671|FG000|Overall Study|Adverse Event|0|||
42232623|NCT03137069|76053672|FG001|Overall Study|Adverse Event|3|||
42232624|NCT03137069|76053673|FG002|Overall Study|Adverse Event|1|||
42232625|NCT03137069|76053674|FG003|Overall Study|Adverse Event|1|||
42232626|NCT03137069|76053675|FG004|Overall Study|Adverse Event|0|||
42232627|NCT03137069|76053676|FG005|Overall Study|Adverse Event|1|||
42232628|NCT03137069|76053671|FG000|Overall Study|Protocol Violation|0|||
42232629|NCT03137069|76053672|FG001|Overall Study|Protocol Violation|1|||
42232630|NCT03137069|76053673|FG002|Overall Study|Protocol Violation|0|||
42232631|NCT03137069|76053674|FG003|Overall Study|Protocol Violation|1|||
42232632|NCT03137069|76053675|FG004|Overall Study|Protocol Violation|1|||
42232633|NCT03137069|76053676|FG005|Overall Study|Protocol Violation|1|||
42232634|NCT03137069|76053671|FG000|Overall Study|Physician Decision|0|||
42232635|NCT03137069|76053672|FG001|Overall Study|Physician Decision|0|||
42232636|NCT03137069|76053673|FG002|Overall Study|Physician Decision|0|||
42232637|NCT03137069|76053674|FG003|Overall Study|Physician Decision|1|||
42232638|NCT03137069|76053675|FG004|Overall Study|Physician Decision|0|||
42232639|NCT03137069|76053676|FG005|Overall Study|Physician Decision|0|||
42232640|NCT03137069|76053671|FG000|Overall Study|Study Terminated by Sponsor|0|||
42232641|NCT03137069|76053672|FG001|Overall Study|Study Terminated by Sponsor|0|||
41987273|NCT01295827|75794536|FG002|Overall Study|Adverse Event|2|||
41987274|NCT01295827|75794537|FG003|Overall Study|Adverse Event|1|||
41987275|NCT01295827|75794538|FG004|Overall Study|Adverse Event|1|||
41987276|NCT01295827|75794539|FG005|Overall Study|Adverse Event|4|||
41987277|NCT01295827|75794540|FG006|Overall Study|Adverse Event|15|||
41987278|NCT01295827|75794541|FG007|Overall Study|Adverse Event|49|||
42232642|NCT03137069|76053673|FG002|Overall Study|Study Terminated by Sponsor|0|||
42232643|NCT03137069|76053674|FG003|Overall Study|Study Terminated by Sponsor|0|||
42232644|NCT03137069|76053675|FG004|Overall Study|Study Terminated by Sponsor|1|||
42232645|NCT03137069|76053676|FG005|Overall Study|Study Terminated by Sponsor|0|||
42232646|NCT03137069|76053671|FG000|Overall Study|Data Entry Error|0|||
42232647|NCT03137069|76053672|FG001|Overall Study|Data Entry Error|0|||
42232648|NCT03137069|76053673|FG002|Overall Study|Data Entry Error|0|||
42232649|NCT03137069|76053674|FG003|Overall Study|Data Entry Error|1|||
42232650|NCT03137069|76053675|FG004|Overall Study|Data Entry Error|0|||
42232651|NCT03137069|76053676|FG005|Overall Study|Data Entry Error|0|||
42232652|NCT02792504|76053694|FG000|Overall Study|Lost to Follow-up|24|||
42232653|NCT02792504|76053694|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
42232654|NCT03124459|76053704|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
42232655|NCT03124459|76053705|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
42232656|NCT03124459|76053706|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
42232657|NCT03124459|76053707|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
42232658|NCT03124459|76053708|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
42232659|NCT03124459|76053709|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
42232660|NCT03124459|76053704|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
42232661|NCT03124459|76053705|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
41987279|NCT01295827|75794542|FG008|Overall Study|Adverse Event|22|||
41987280|NCT01295827|75794543|FG009|Overall Study|Adverse Event|7|||
42232662|NCT03124459|76053706|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
42232663|NCT03124459|76053707|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
42232664|NCT03124459|76053708|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
42232665|NCT03124459|76053709|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
42232666|NCT03124459|76053704|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
42232667|NCT03124459|76053705|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
42232668|NCT03124459|76053706|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
42232669|NCT03124459|76053707|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
42232670|NCT03124459|76053708|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
42232671|NCT03124459|76053709|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
42232672|NCT03124459|76053704|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
41987281|NCT01295827|75794544|FG010|Overall Study|Adverse Event|50|||
41987282|NCT01295827|75794545|FG011|Overall Study|Adverse Event|21|||
42232673|NCT03124459|76053705|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
42232674|NCT03124459|76053706|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
42232675|NCT03124459|76053707|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
42232676|NCT03124459|76053708|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
42232677|NCT03124459|76053709|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
42232678|NCT03124459|76053704|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
42232679|NCT03124459|76053705|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
42232680|NCT03124459|76053706|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
42232681|NCT03124459|76053707|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
42232682|NCT03124459|76053708|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
42232683|NCT03124459|76053709|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
42232684|NCT03124459|76053704|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
42232685|NCT03124459|76053705|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
42232686|NCT03124459|76053706|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
42232687|NCT03124459|76053707|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
42232688|NCT03124459|76053708|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
42232689|NCT03124459|76053709|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
42232690|NCT03134183|76053724|FG000|Overall Study|Withdrawal by Subject|1|||
42232691|NCT03134183|76053725|FG001|Overall Study|Withdrawal by Subject|1|||
42232692|NCT03136367|76053734|FG000|T1 Consultation|discontinued mistakenly included|2|||
42232693|NCT03136367|76053735|FG001|T1 Consultation|discontinued mistakenly included|6|||
42232694|NCT03136367|76053736|FG002|T1 Consultation|discontinued mistakenly included|1|||
42232695|NCT03136367|76053734|FG000|T1 Consultation|Discontinued other|0|||
42232696|NCT03136367|76053735|FG001|T1 Consultation|Discontinued other|1|||
42232697|NCT03136367|76053736|FG002|T1 Consultation|Discontinued other|0|||
42232698|NCT03136367|76053734|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
42232699|NCT03136367|76053735|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
42232700|NCT03136367|76053736|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
42232701|NCT03136367|76053734|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
42232702|NCT03136367|76053735|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
42232703|NCT03136367|76053736|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
42232704|NCT03136367|76053734|FG000|T2 Post-consultation|Discontinued other|0|||
42232705|NCT03136367|76053735|FG001|T2 Post-consultation|Discontinued other|2|||
42232706|NCT03136367|76053736|FG002|T2 Post-consultation|Discontinued other|6|||
42232707|NCT03136367|76053734|FG000|T2 Post-consultation|Discontinued transferred care|0|||
42232708|NCT03136367|76053735|FG001|T2 Post-consultation|Discontinued transferred care|0|||
42232709|NCT03136367|76053736|FG002|T2 Post-consultation|Discontinued transferred care|3|||
42232710|NCT03136367|76053734|FG000|T2 Post-consultation|Discontinued lost contact|0|||
42232711|NCT03136367|76053735|FG001|T2 Post-consultation|Discontinued lost contact|1|||
42232712|NCT03136367|76053736|FG002|T2 Post-consultation|Discontinued lost contact|0|||
42232713|NCT03136367|76053734|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
42232714|NCT03136367|76053735|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
42232715|NCT03136367|76053736|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
42232716|NCT03136367|76053734|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
42232717|NCT03136367|76053735|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
42232718|NCT03136367|76053736|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
42232719|NCT03136367|76053734|FG000|T3 1 Week After Surgery|other discontinued|2|||
42232720|NCT03136367|76053735|FG001|T3 1 Week After Surgery|other discontinued|4|||
42232721|NCT03136367|76053736|FG002|T3 1 Week After Surgery|other discontinued|3|||
42232722|NCT03136367|76053734|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
42232723|NCT03136367|76053735|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
42232724|NCT03136367|76053736|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
42232725|NCT03136367|76053734|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
42232726|NCT03136367|76053735|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
42232727|NCT03136367|76053736|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
42232728|NCT03136367|76053734|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
42232729|NCT03136367|76053735|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
42232730|NCT03136367|76053736|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
42232731|NCT03136367|76053734|FG000|T4 12 Weeks After Surgery|Death|0|||
42232732|NCT03136367|76053735|FG001|T4 12 Weeks After Surgery|Death|1|||
41987283|NCT01295827|75794546|FG012|Overall Study|Adverse Event|0|||
42232733|NCT03136367|76053736|FG002|T4 12 Weeks After Surgery|Death|3|||
42232734|NCT03136367|76053734|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
41987284|NCT01295827|75794547|FG013|Overall Study|Adverse Event|0|||
42232735|NCT03136367|76053735|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
42232736|NCT03136367|76053736|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
42232737|NCT03136367|76053734|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
42232738|NCT03136367|76053735|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
42232739|NCT03136367|76053736|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
42232740|NCT03136367|76053734|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
42232741|NCT03136367|76053735|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
42232742|NCT03136367|76053736|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
42232743|NCT03136367|76053734|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
42232744|NCT03136367|76053735|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
42232745|NCT03136367|76053736|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
42232746|NCT03136367|76053734|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
42232747|NCT03136367|76053735|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
42232748|NCT03136367|76053736|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
42232749|NCT03136367|76053734|FG000|T5 1 Year After Surgery|Death|0|||
42232750|NCT03136367|76053735|FG001|T5 1 Year After Surgery|Death|0|||
42232751|NCT03136367|76053736|FG002|T5 1 Year After Surgery|Death|1|||
42232752|NCT03136367|76053734|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
42232753|NCT03136367|76053735|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
42232754|NCT03136367|76053736|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
42232755|NCT03136367|76053734|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
42232756|NCT03136367|76053735|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
42232757|NCT03136367|76053736|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
42232758|NCT03136367|76053734|FG000|T5 1 Year After Surgery|study ended before due|31|||
41987285|NCT01295827|75794548|FG014|Overall Study|Adverse Event|0|||
41987286|NCT01295827|75794534|FG000|Overall Study|Lost to Follow-up|0|||
41987287|NCT01295827|75794535|FG001|Overall Study|Lost to Follow-up|0|||
41987288|NCT01295827|75794536|FG002|Overall Study|Lost to Follow-up|3|||
41987289|NCT01295827|75794537|FG003|Overall Study|Lost to Follow-up|0|||
41987290|NCT01295827|75794538|FG004|Overall Study|Lost to Follow-up|1|||
41987291|NCT01295827|75794539|FG005|Overall Study|Lost to Follow-up|0|||
41987292|NCT01295827|75794540|FG006|Overall Study|Lost to Follow-up|4|||
41987293|NCT01295827|75794541|FG007|Overall Study|Lost to Follow-up|8|||
41987294|NCT01295827|75794542|FG008|Overall Study|Lost to Follow-up|7|||
41987295|NCT01295827|75794543|FG009|Overall Study|Lost to Follow-up|4|||
42131799|NCT00414609|75942695|FG000|Extension Study|Withdrawal by Subject|0|||
42232759|NCT03136367|76053735|FG001|T5 1 Year After Surgery|study ended before due|103|||
42232760|NCT03136367|76053736|FG002|T5 1 Year After Surgery|study ended before due|110|||
42232761|NCT03136367|76053734|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
42232762|NCT03136367|76053735|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
42232763|NCT03136367|76053736|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
42232764|NCT03124381|76053749|FG000|Overall Study|Lost to Follow-up|1|||
42232765|NCT03124381|76053750|FG001|Overall Study|Lost to Follow-up|1|||
42232766|NCT03124381|76053749|FG000|Overall Study|Withdrawal by Subject|6|||
42232767|NCT03124381|76053750|FG001|Overall Study|Withdrawal by Subject|3|||
42232768|NCT03124381|76053749|FG000|Overall Study|Protocol Violation|0|||
42232769|NCT03124381|76053750|FG001|Overall Study|Protocol Violation|1|||
42232770|NCT03124381|76053749|FG000|Overall Study|Adverse Event|1|||
42232771|NCT03124381|76053750|FG001|Overall Study|Adverse Event|1|||
42232772|NCT03124381|76053749|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
42232773|NCT03124381|76053750|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
42232774|NCT03133793|76053760|FG000|Overall Study|Withdrawal by Subject|0|||
42232775|NCT03133793|76053761|FG001|Overall Study|Withdrawal by Subject|4|||
42232776|NCT03133793|76053762|FG002|Overall Study|Withdrawal by Subject|2|||
42232777|NCT03133793|76053763|FG003|Overall Study|Withdrawal by Subject|4|||
42232778|NCT03133793|76053760|FG000|Overall Study|Lost to Follow-up|1|||
42232779|NCT03133793|76053761|FG001|Overall Study|Lost to Follow-up|0|||
42232780|NCT03133793|76053762|FG002|Overall Study|Lost to Follow-up|2|||
42232781|NCT03133793|76053763|FG003|Overall Study|Lost to Follow-up|0|||
42131800|NCT00414609|75942696|FG001|Extension Study|Withdrawal by Subject|0|||
42131801|NCT00414609|75942697|FG002|Extension Study|Withdrawal by Subject|13|||
42232782|NCT03133793|76053760|FG000|Overall Study|Death|0|||
42232783|NCT03133793|76053761|FG001|Overall Study|Death|0|||
42232784|NCT03133793|76053762|FG002|Overall Study|Death|0|||
42232785|NCT03133793|76053763|FG003|Overall Study|Death|1|||
42232786|NCT02747238|76053779|FG000|Overall Study|Lack of Efficacy|0|||
42232787|NCT02747238|76053780|FG001|Overall Study|Lack of Efficacy|1|||
42232788|NCT02747238|76053779|FG000|Overall Study|Data lost|3|||
42232789|NCT02747238|76053780|FG001|Overall Study|Data lost|5|||
42232790|NCT03133481|76053788|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
42232791|NCT03133481|76053789|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
42131802|NCT00414609|75942695|FG000|Extension Study|Lost to Follow-up|0|||
41987296|NCT01295827|75794544|FG010|Overall Study|Lost to Follow-up|7|||
41987297|NCT01295827|75794545|FG011|Overall Study|Lost to Follow-up|3|||
42232792|NCT02864316|76053797|FG000|Overall Study|Progressive Disease|2|||
42232793|NCT02864316|76053798|FG001|Overall Study|Progressive Disease|1|||
42232794|NCT02864316|76053797|FG000|Overall Study|Adverse Event|0|||
42232795|NCT02864316|76053798|FG001|Overall Study|Adverse Event|1|||
42232796|NCT02862600|76053804|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
42232797|NCT02862600|76053804|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
42232798|NCT02862600|76053804|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
42232799|NCT02862600|76053804|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
42232800|NCT02864082|76053812|FG000|Overall Study|Adverse Event|1|||
42232801|NCT02864082|76053813|FG001|Overall Study|Adverse Event|1|||
42232802|NCT02864082|76053812|FG000|Overall Study|Lost to Follow-up|0|||
42232803|NCT02864082|76053813|FG001|Overall Study|Lost to Follow-up|1|||
42232804|NCT02864082|76053812|FG000|Overall Study|Withdrawal by Subject|2|||
42232805|NCT02864082|76053813|FG001|Overall Study|Withdrawal by Subject|2|||
42232806|NCT02792192|76053837|FG000|Overall Study|Death|1|||
42232807|NCT02792192|76053838|FG001|Overall Study|Death|0|||
42232808|NCT02792192|76053839|FG002|Overall Study|Death|0|||
42232809|NCT02792192|76053840|FG003|Overall Study|Death|0|||
42232810|NCT02792192|76053837|FG000|Overall Study|Informed Consent Withdrawn|4|||
42232811|NCT02792192|76053838|FG001|Overall Study|Informed Consent Withdrawn|0|||
42232812|NCT02792192|76053839|FG002|Overall Study|Informed Consent Withdrawn|0|||
42232813|NCT02792192|76053840|FG003|Overall Study|Informed Consent Withdrawn|0|||
42232814|NCT02792192|76053837|FG000|Overall Study|Physician Decision|1|||
42232815|NCT02792192|76053838|FG001|Overall Study|Physician Decision|0|||
42232816|NCT02792192|76053839|FG002|Overall Study|Physician Decision|0|||
42232817|NCT02792192|76053840|FG003|Overall Study|Physician Decision|0|||
42232818|NCT02792192|76053837|FG000|Overall Study|Progressive Disease|0|||
42232819|NCT02792192|76053838|FG001|Overall Study|Progressive Disease|1|||
42232820|NCT02792192|76053839|FG002|Overall Study|Progressive Disease|0|||
42232821|NCT02792192|76053840|FG003|Overall Study|Progressive Disease|0|||
42232822|NCT02792192|76053837|FG000|Overall Study|Study Terminated By Sponsor|6|||
42232823|NCT02792192|76053838|FG001|Overall Study|Study Terminated By Sponsor|10|||
42232824|NCT02792192|76053839|FG002|Overall Study|Study Terminated By Sponsor|0|||
42232825|NCT02792192|76053840|FG003|Overall Study|Study Terminated By Sponsor|0|||
42232826|NCT02964507|76053859|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
42232827|NCT02964507|76053860|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
42232828|NCT02964507|76053861|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
42232829|NCT02964507|76053862|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
42232830|NCT02964507|76053863|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
42232831|NCT02964507|76053864|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
42232832|NCT02964507|76053865|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
42232833|NCT02964507|76053866|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
42232834|NCT02964507|76053859|FG000|Overall Study|Study terminated by Sponsor|9|||
42232835|NCT02964507|76053860|FG001|Overall Study|Study terminated by Sponsor|1|||
42232836|NCT02964507|76053861|FG002|Overall Study|Study terminated by Sponsor|9|||
42232837|NCT02964507|76053862|FG003|Overall Study|Study terminated by Sponsor|3|||
42232838|NCT02964507|76053863|FG004|Overall Study|Study terminated by Sponsor|3|||
42232839|NCT02964507|76053864|FG005|Overall Study|Study terminated by Sponsor|2|||
42232840|NCT02964507|76053865|FG006|Overall Study|Study terminated by Sponsor|0|||
42232841|NCT02964507|76053866|FG007|Overall Study|Study terminated by Sponsor|0|||
42232842|NCT02964507|76053859|FG000|Overall Study|Other|3|||
42232843|NCT02964507|76053860|FG001|Overall Study|Other|0|||
42232844|NCT02964507|76053861|FG002|Overall Study|Other|0|||
42232845|NCT02964507|76053862|FG003|Overall Study|Other|0|||
42232846|NCT02964507|76053863|FG004|Overall Study|Other|1|||
42232847|NCT02964507|76053864|FG005|Overall Study|Other|0|||
42232848|NCT02964507|76053865|FG006|Overall Study|Other|0|||
42232849|NCT02964507|76053866|FG007|Overall Study|Other|0|||
42232850|NCT02964507|76053859|FG000|Overall Study|Death|11|||
42232851|NCT02964507|76053860|FG001|Overall Study|Death|9|||
42232852|NCT02964507|76053861|FG002|Overall Study|Death|12|||
42232853|NCT02964507|76053862|FG003|Overall Study|Death|2|||
42232854|NCT02964507|76053863|FG004|Overall Study|Death|10|||
42232855|NCT02964507|76053864|FG005|Overall Study|Death|5|||
42232856|NCT02964507|76053865|FG006|Overall Study|Death|0|||
42232857|NCT02964507|76053866|FG007|Overall Study|Death|0|||
42232858|NCT02964507|76053859|FG000|Overall Study|Withdrawal by Subject|1|||
42232859|NCT02964507|76053860|FG001|Overall Study|Withdrawal by Subject|0|||
42232860|NCT02964507|76053861|FG002|Overall Study|Withdrawal by Subject|1|||
42232861|NCT02964507|76053862|FG003|Overall Study|Withdrawal by Subject|1|||
42232862|NCT02964507|76053863|FG004|Overall Study|Withdrawal by Subject|0|||
42232863|NCT02964507|76053864|FG005|Overall Study|Withdrawal by Subject|1|||
42232864|NCT02964507|76053865|FG006|Overall Study|Withdrawal by Subject|0|||
42232865|NCT02964507|76053866|FG007|Overall Study|Withdrawal by Subject|0|||
42232866|NCT02964507|76053859|FG000|Overall Study|Physician Decision|2|||
42232867|NCT02964507|76053860|FG001|Overall Study|Physician Decision|0|||
42232868|NCT02964507|76053861|FG002|Overall Study|Physician Decision|3|||
42232869|NCT02964507|76053862|FG003|Overall Study|Physician Decision|0|||
42232870|NCT02964507|76053863|FG004|Overall Study|Physician Decision|1|||
42232871|NCT02964507|76053864|FG005|Overall Study|Physician Decision|0|||
42232872|NCT02964507|76053865|FG006|Overall Study|Physician Decision|0|||
42232873|NCT02964507|76053866|FG007|Overall Study|Physician Decision|0|||
42232874|NCT03170869|76053885|FG000|Overall Study|Protocol Violation|5|||
42232875|NCT03170869|76053885|FG000|Overall Study|Early study termination|3|||
42232876|NCT02440464|76053892|FG000|Overall Study|Withdrawal by Subject|3|||
42232877|NCT02440464|76053893|FG001|Overall Study|Withdrawal by Subject|2|||
42232878|NCT03103321|76053904|FG000|Overall Study|Protocol Violation|1|||
42232879|NCT03103321|76053905|FG001|Overall Study|Protocol Violation|1|||
42232880|NCT03103321|76053906|FG002|Overall Study|Protocol Violation|1|||
42232881|NCT03103321|76053907|FG003|Overall Study|Protocol Violation|0|||
42232882|NCT03131453|76053920|FG000|Overall Study|Study terminated by Sponsor|424|||
42232883|NCT03131453|76053921|FG001|Overall Study|Study terminated by Sponsor|222|||
42232884|NCT03131453|76053922|FG002|Overall Study|Study terminated by Sponsor|438|||
42232885|NCT03131453|76053920|FG000|Overall Study|Withdrawal by Subject|18|||
42232886|NCT03131453|76053921|FG001|Overall Study|Withdrawal by Subject|7|||
42232887|NCT03131453|76053922|FG002|Overall Study|Withdrawal by Subject|13|||
42232888|NCT03131453|76053920|FG000|Overall Study|Adverse Event|10|||
42232889|NCT03131453|76053921|FG001|Overall Study|Adverse Event|3|||
42232890|NCT03131453|76053922|FG002|Overall Study|Adverse Event|3|||
42232891|NCT03131453|76053920|FG000|Overall Study|Lost to Follow-up|1|||
42232892|NCT03131453|76053921|FG001|Overall Study|Lost to Follow-up|0|||
42232893|NCT03131453|76053922|FG002|Overall Study|Lost to Follow-up|1|||
42232894|NCT03131453|76053920|FG000|Overall Study|Physician Decision|1|||
42232895|NCT03131453|76053921|FG001|Overall Study|Physician Decision|0|||
42232896|NCT03131453|76053922|FG002|Overall Study|Physician Decision|1|||
42232897|NCT03131453|76053920|FG000|Overall Study|Non-compliance with study treatment|1|||
42232898|NCT03131453|76053921|FG001|Overall Study|Non-compliance with study treatment|0|||
42232899|NCT03131453|76053922|FG002|Overall Study|Non-compliance with study treatment|0|||
42232900|NCT03131453|76053920|FG000|Overall Study|Technical problems|1|||
42232901|NCT03131453|76053921|FG001|Overall Study|Technical problems|0|||
42232902|NCT03131453|76053922|FG002|Overall Study|Technical problems|0|||
42232903|NCT03131453|76053920|FG000|Overall Study|Protocol deviation|0|||
42232904|NCT03131453|76053921|FG001|Overall Study|Protocol deviation|1|||
42232905|NCT03131453|76053922|FG002|Overall Study|Protocol deviation|0|||
42232906|NCT02942277|76053950|FG000|Year 1|Withdrawal by Subject|0|||
42232907|NCT02942277|76053951|FG001|Year 1|Withdrawal by Subject|0|||
42232908|NCT02942277|76053952|FG002|Year 1|Withdrawal by Subject|0|||
42232909|NCT02942277|76053953|FG003|Year 1|Withdrawal by Subject|0|||
42232910|NCT02942277|76053954|FG004|Year 1|Withdrawal by Subject|1|||
42232911|NCT02942277|76053955|FG005|Year 1|Withdrawal by Subject|3|||
42232912|NCT02942277|76053956|FG006|Year 1|Withdrawal by Subject|0|||
42232913|NCT02942277|76053957|FG007|Year 1|Withdrawal by Subject|1|||
42232914|NCT02942277|76053958|FG008|Year 1|Withdrawal by Subject|0|||
42232915|NCT02942277|76053959|FG009|Year 1|Withdrawal by Subject|0|||
42232916|NCT02942277|76053960|FG010|Year 1|Withdrawal by Subject|3|||
42232917|NCT02942277|76053950|FG000|Year 1|Travel|0|||
42232918|NCT02942277|76053951|FG001|Year 1|Travel|1|||
42232919|NCT02942277|76053952|FG002|Year 1|Travel|0|||
42232920|NCT02942277|76053953|FG003|Year 1|Travel|0|||
42232921|NCT02942277|76053954|FG004|Year 1|Travel|4|||
42232922|NCT02942277|76053955|FG005|Year 1|Travel|5|||
42232923|NCT02942277|76053956|FG006|Year 1|Travel|0|||
42232924|NCT02942277|76053957|FG007|Year 1|Travel|0|||
42232925|NCT02942277|76053958|FG008|Year 1|Travel|0|||
42232926|NCT02942277|76053959|FG009|Year 1|Travel|0|||
42232927|NCT02942277|76053960|FG010|Year 1|Travel|8|||
42232928|NCT02942277|76053950|FG000|Year 1|Joined Army|0|||
42232929|NCT02942277|76053951|FG001|Year 1|Joined Army|1|||
42232930|NCT02942277|76053952|FG002|Year 1|Joined Army|0|||
42232931|NCT02942277|76053953|FG003|Year 1|Joined Army|0|||
42032569|NCT01139021|75840785|FG001|Overall Study|Withdrawal by Subject|0|||
42232932|NCT02942277|76053954|FG004|Year 1|Joined Army|0|||
42232933|NCT02942277|76053955|FG005|Year 1|Joined Army|0|||
42232934|NCT02942277|76053956|FG006|Year 1|Joined Army|0|||
42232935|NCT02942277|76053957|FG007|Year 1|Joined Army|0|||
42232936|NCT02942277|76053958|FG008|Year 1|Joined Army|0|||
42232937|NCT02942277|76053959|FG009|Year 1|Joined Army|0|||
42232938|NCT02942277|76053960|FG010|Year 1|Joined Army|0|||
42232939|NCT02942277|76053950|FG000|Year 1|Subject met withdrawal criteria|0|||
42232940|NCT02942277|76053951|FG001|Year 1|Subject met withdrawal criteria|0|||
42232941|NCT02942277|76053952|FG002|Year 1|Subject met withdrawal criteria|0|||
42232942|NCT02942277|76053953|FG003|Year 1|Subject met withdrawal criteria|1|||
42232943|NCT02942277|76053954|FG004|Year 1|Subject met withdrawal criteria|0|||
42232944|NCT02942277|76053955|FG005|Year 1|Subject met withdrawal criteria|0|||
42232945|NCT02942277|76053956|FG006|Year 1|Subject met withdrawal criteria|0|||
42232946|NCT02942277|76053957|FG007|Year 1|Subject met withdrawal criteria|0|||
42232947|NCT02942277|76053958|FG008|Year 1|Subject met withdrawal criteria|0|||
42232948|NCT02942277|76053959|FG009|Year 1|Subject met withdrawal criteria|0|||
42232949|NCT02942277|76053960|FG010|Year 1|Subject met withdrawal criteria|0|||
42232950|NCT02942277|76053950|FG000|Year 1|Lost to Follow-up|0|||
42232951|NCT02942277|76053951|FG001|Year 1|Lost to Follow-up|0|||
42232952|NCT02942277|76053952|FG002|Year 1|Lost to Follow-up|0|||
42232953|NCT02942277|76053953|FG003|Year 1|Lost to Follow-up|0|||
42232954|NCT02942277|76053954|FG004|Year 1|Lost to Follow-up|1|||
42232955|NCT02942277|76053955|FG005|Year 1|Lost to Follow-up|0|||
42232956|NCT02942277|76053956|FG006|Year 1|Lost to Follow-up|0|||
42232957|NCT02942277|76053957|FG007|Year 1|Lost to Follow-up|0|||
42232958|NCT02942277|76053958|FG008|Year 1|Lost to Follow-up|0|||
42232959|NCT02942277|76053959|FG009|Year 1|Lost to Follow-up|0|||
42232960|NCT02942277|76053960|FG010|Year 1|Lost to Follow-up|2|||
42232961|NCT02942277|76053950|FG000|Year 1|Protocol Violation|0|||
42232962|NCT02942277|76053951|FG001|Year 1|Protocol Violation|0|||
42232963|NCT02942277|76053952|FG002|Year 1|Protocol Violation|0|||
42232964|NCT02942277|76053953|FG003|Year 1|Protocol Violation|0|||
42232965|NCT02942277|76053954|FG004|Year 1|Protocol Violation|1|||
42232966|NCT02942277|76053955|FG005|Year 1|Protocol Violation|1|||
42232967|NCT02942277|76053956|FG006|Year 1|Protocol Violation|0|||
42232968|NCT02942277|76053957|FG007|Year 1|Protocol Violation|0|||
42232969|NCT02942277|76053958|FG008|Year 1|Protocol Violation|0|||
42232970|NCT02942277|76053959|FG009|Year 1|Protocol Violation|0|||
42232971|NCT02942277|76053960|FG010|Year 1|Protocol Violation|2|||
42232972|NCT02942277|76053950|FG000|Year 1|Pregnancy|0|||
42232973|NCT02942277|76053951|FG001|Year 1|Pregnancy|0|||
42232974|NCT02942277|76053952|FG002|Year 1|Pregnancy|0|||
42232975|NCT02942277|76053953|FG003|Year 1|Pregnancy|0|||
42232976|NCT02942277|76053954|FG004|Year 1|Pregnancy|0|||
42232977|NCT02942277|76053955|FG005|Year 1|Pregnancy|1|||
42232978|NCT02942277|76053956|FG006|Year 1|Pregnancy|0|||
42232979|NCT02942277|76053957|FG007|Year 1|Pregnancy|0|||
42232980|NCT02942277|76053958|FG008|Year 1|Pregnancy|0|||
42232981|NCT02942277|76053959|FG009|Year 1|Pregnancy|0|||
42232982|NCT02942277|76053960|FG010|Year 1|Pregnancy|0|||
42232983|NCT02942277|76053950|FG000|Year 2|Lost to Follow-up|0|||
42232984|NCT02942277|76053951|FG001|Year 2|Lost to Follow-up|0|||
42232985|NCT02942277|76053952|FG002|Year 2|Lost to Follow-up|0|||
42232986|NCT02942277|76053953|FG003|Year 2|Lost to Follow-up|0|||
42232987|NCT02942277|76053954|FG004|Year 2|Lost to Follow-up|2|||
42232988|NCT02942277|76053955|FG005|Year 2|Lost to Follow-up|1|||
42232989|NCT02942277|76053956|FG006|Year 2|Lost to Follow-up|0|||
42232990|NCT02942277|76053957|FG007|Year 2|Lost to Follow-up|0|||
42232991|NCT02942277|76053958|FG008|Year 2|Lost to Follow-up|0|||
42232992|NCT02942277|76053959|FG009|Year 2|Lost to Follow-up|0|||
42232993|NCT02942277|76053960|FG010|Year 2|Lost to Follow-up|0|||
42232994|NCT02942277|76053950|FG000|Year 2|Did not rescreen|0|||
42232995|NCT02942277|76053951|FG001|Year 2|Did not rescreen|0|||
42232996|NCT02942277|76053952|FG002|Year 2|Did not rescreen|1|||
42232997|NCT02942277|76053953|FG003|Year 2|Did not rescreen|1|||
42232998|NCT02942277|76053954|FG004|Year 2|Did not rescreen|9|||
42232999|NCT02942277|76053955|FG005|Year 2|Did not rescreen|6|||
42233000|NCT02942277|76053956|FG006|Year 2|Did not rescreen|0|||
42233001|NCT02942277|76053957|FG007|Year 2|Did not rescreen|1|||
42233002|NCT02942277|76053958|FG008|Year 2|Did not rescreen|0|||
42233003|NCT02942277|76053959|FG009|Year 2|Did not rescreen|0|||
42233004|NCT02942277|76053960|FG010|Year 2|Did not rescreen|21|||
42233005|NCT02942277|76053950|FG000|Year 2|Met withdrawal criteria|0|||
42233006|NCT02942277|76053951|FG001|Year 2|Met withdrawal criteria|0|||
42233007|NCT02942277|76053952|FG002|Year 2|Met withdrawal criteria|0|||
42233008|NCT02942277|76053953|FG003|Year 2|Met withdrawal criteria|0|||
42233009|NCT02942277|76053954|FG004|Year 2|Met withdrawal criteria|1|||
42233010|NCT02942277|76053955|FG005|Year 2|Met withdrawal criteria|2|||
42233011|NCT02942277|76053956|FG006|Year 2|Met withdrawal criteria|0|||
42233012|NCT02942277|76053957|FG007|Year 2|Met withdrawal criteria|0|||
42233013|NCT02942277|76053958|FG008|Year 2|Met withdrawal criteria|0|||
42233014|NCT02942277|76053959|FG009|Year 2|Met withdrawal criteria|0|||
42233015|NCT02942277|76053960|FG010|Year 2|Met withdrawal criteria|1|||
42233016|NCT02942277|76053950|FG000|Year 2|Travel|0|||
42233017|NCT02942277|76053951|FG001|Year 2|Travel|1|||
42233018|NCT02942277|76053952|FG002|Year 2|Travel|0|||
42233019|NCT02942277|76053953|FG003|Year 2|Travel|0|||
42233020|NCT02942277|76053954|FG004|Year 2|Travel|0|||
42302552|NCT02416453|76137793|FG003|Overall Study|Withdrawal by Subject|5|||
42233021|NCT02942277|76053955|FG005|Year 2|Travel|1|||
42233022|NCT02942277|76053956|FG006|Year 2|Travel|0|||
42233023|NCT02942277|76053957|FG007|Year 2|Travel|0|||
42233024|NCT02942277|76053958|FG008|Year 2|Travel|0|||
42233025|NCT02942277|76053959|FG009|Year 2|Travel|1|||
42233026|NCT02942277|76053960|FG010|Year 2|Travel|3|||
42233027|NCT02942277|76053950|FG000|Year 2|Non-compliant|0|||
42233028|NCT02942277|76053951|FG001|Year 2|Non-compliant|0|||
42233029|NCT02942277|76053952|FG002|Year 2|Non-compliant|0|||
42233030|NCT02942277|76053953|FG003|Year 2|Non-compliant|0|||
42233031|NCT02942277|76053954|FG004|Year 2|Non-compliant|1|||
42233032|NCT02942277|76053955|FG005|Year 2|Non-compliant|1|||
42233033|NCT02942277|76053956|FG006|Year 2|Non-compliant|0|||
42233034|NCT02942277|76053957|FG007|Year 2|Non-compliant|0|||
42233035|NCT02942277|76053958|FG008|Year 2|Non-compliant|0|||
42233036|NCT02942277|76053959|FG009|Year 2|Non-compliant|0|||
42233037|NCT02942277|76053960|FG010|Year 2|Non-compliant|0|||
42233038|NCT02942277|76053950|FG000|Year 2|Withdrawal by Subject|0|||
42233039|NCT02942277|76053951|FG001|Year 2|Withdrawal by Subject|0|||
42233040|NCT02942277|76053952|FG002|Year 2|Withdrawal by Subject|0|||
42233041|NCT02942277|76053953|FG003|Year 2|Withdrawal by Subject|0|||
42233042|NCT02942277|76053954|FG004|Year 2|Withdrawal by Subject|0|||
42233043|NCT02942277|76053955|FG005|Year 2|Withdrawal by Subject|0|||
42233044|NCT02942277|76053956|FG006|Year 2|Withdrawal by Subject|1|||
42233045|NCT02942277|76053957|FG007|Year 2|Withdrawal by Subject|0|||
42233046|NCT02942277|76053958|FG008|Year 2|Withdrawal by Subject|0|||
42233047|NCT02942277|76053959|FG009|Year 2|Withdrawal by Subject|0|||
42233048|NCT02942277|76053960|FG010|Year 2|Withdrawal by Subject|0|||
42233049|NCT02859324|76054011|FG000|Overall Study|Death|4|||
42233050|NCT02859324|76054012|FG001|Overall Study|Death|6|||
42233051|NCT02859324|76054013|FG002|Overall Study|Death|5|||
42233052|NCT02859324|76054011|FG000|Overall Study|Other reasons|3|||
42233053|NCT02859324|76054012|FG001|Overall Study|Other reasons|3|||
42233054|NCT02859324|76054013|FG002|Overall Study|Other reasons|0|||
42233055|NCT02143063|76054024|FG000|Overall Study|Lost to Follow-up|16|||
42233056|NCT02143063|76054025|FG001|Overall Study|Lost to Follow-up|28|||
42233057|NCT02143063|76054026|FG002|Overall Study|Lost to Follow-up|29|||
42233058|NCT02143063|76054024|FG000|Overall Study|Withdrawal by Subject|0|||
42233059|NCT02143063|76054025|FG001|Overall Study|Withdrawal by Subject|1|||
42233060|NCT02143063|76054026|FG002|Overall Study|Withdrawal by Subject|0|||
42233061|NCT02143063|76054024|FG000|Overall Study|Death|0|||
42233062|NCT02143063|76054025|FG001|Overall Study|Death|1|||
42233063|NCT02143063|76054026|FG002|Overall Study|Death|1|||
42233064|NCT02859246|76054034|FG000|Overall Study|Screen fails|3|||
42233065|NCT02859246|76054034|FG000|Overall Study|Adverse Event|1|||
42233066|NCT02859246|76054034|FG000|Overall Study|Withdrawal by Subject|1|||
42233067|NCT01083433|76054057|FG000|Overall Study|Lost to Follow-up|2|||
42233068|NCT01083433|76054058|FG001|Overall Study|Lost to Follow-up|1|||
42233069|NCT01083433|76054059|FG002|Overall Study|Lost to Follow-up|1|||
42233070|NCT01083433|76054057|FG000|Overall Study|Withdrawal by Subject|0|||
42233071|NCT01083433|76054058|FG001|Overall Study|Withdrawal by Subject|5|||
42233072|NCT01083433|76054059|FG002|Overall Study|Withdrawal by Subject|3|||
42233073|NCT01083433|76054057|FG000|Overall Study|Pregnancy|0|||
42233074|NCT01083433|76054058|FG001|Overall Study|Pregnancy|0|||
42233075|NCT01083433|76054059|FG002|Overall Study|Pregnancy|1|||
42233076|NCT02791490|76054073|FG000|Overall Study|Lost to Follow-up|1|||
42233077|NCT02791490|76054074|FG001|Overall Study|Lost to Follow-up|2|||
42233078|NCT02791490|76054073|FG000|Overall Study|Withdrawal by Subject|2|||
42233079|NCT02791490|76054074|FG001|Overall Study|Withdrawal by Subject|6|||
42233080|NCT02507973|76054089|FG000|Overall Study|Adverse Event|1|||
42233081|NCT02425644|76054097|FG000|Overall Study|Lost to Follow-up|2|||
42233082|NCT02425644|76054098|FG001|Overall Study|Lost to Follow-up|3|||
42233083|NCT02425644|76054097|FG000|Overall Study|Withdrawal by Subject|41|||
42233084|NCT02425644|76054098|FG001|Overall Study|Withdrawal by Subject|36|||
42233085|NCT02425644|76054097|FG000|Overall Study|Lack of Efficacy|3|||
42233086|NCT02425644|76054098|FG001|Overall Study|Lack of Efficacy|10|||
42233087|NCT02425644|76054097|FG000|Overall Study|Adverse Event|13|||
42233088|NCT02425644|76054098|FG001|Overall Study|Adverse Event|3|||
41987298|NCT01295827|75794546|FG012|Overall Study|Lost to Follow-up|0|||
41987299|NCT01295827|75794547|FG013|Overall Study|Lost to Follow-up|0|||
42032570|NCT01139021|75840786|FG002|Overall Study|Withdrawal by Subject|0|||
42032571|NCT01139021|75840787|FG003|Overall Study|Withdrawal by Subject|1|||
42032572|NCT01139021|75840788|FG004|Overall Study|Withdrawal by Subject|4|||
42032573|NCT01139021|75840789|FG005|Overall Study|Withdrawal by Subject|0|||
42032574|NCT01193660|75840807|FG000|Overall Study|Withdrawal by Subject|2|||
42032575|NCT01193660|75840808|FG001|Overall Study|Withdrawal by Subject|3|||
42032576|NCT01193660|75840809|FG002|Overall Study|Withdrawal by Subject|1|||
41987300|NCT01295827|75794548|FG014|Overall Study|Lost to Follow-up|0|||
41987301|NCT01295827|75794534|FG000|Overall Study|Not Reported|0|||
41987302|NCT01295827|75794535|FG001|Overall Study|Not Reported|0|||
41987303|NCT01295827|75794536|FG002|Overall Study|Not Reported|0|||
41987304|NCT01295827|75794537|FG003|Overall Study|Not Reported|1|||
42032577|NCT01193660|75840807|FG000|Overall Study|Death|1|||
42233089|NCT02425644|76054097|FG000|Overall Study|Death|0|||
41987305|NCT01295827|75794538|FG004|Overall Study|Not Reported|0|||
42032578|NCT01193660|75840808|FG001|Overall Study|Death|0|||
42032579|NCT01193660|75840809|FG002|Overall Study|Death|0|||
42233090|NCT02425644|76054098|FG001|Overall Study|Death|2|||
42233091|NCT02425644|76054097|FG000|Overall Study|Other|18|||
42302553|NCT02416453|76137794|FG004|Overall Study|Withdrawal by Subject|1|||
41987306|NCT01295827|75794539|FG005|Overall Study|Not Reported|0|||
41987307|NCT01295827|75794540|FG006|Overall Study|Not Reported|24|||
42233092|NCT02425644|76054098|FG001|Overall Study|Other|17|||
42233093|NCT02861664|76054110|FG000|Overall Study|Withdrawal of Consent|0|||
42233094|NCT02861664|76054111|FG001|Overall Study|Withdrawal of Consent|1|||
42233095|NCT01307787|76054119|FG000|Overall Study|Withdrawal by Subject|2|||
42233096|NCT01307787|76054120|FG001|Overall Study|Withdrawal by Subject|0|||
42233097|NCT03284853|76054133|FG000|Overall Study|Adverse Event|40|||
42302554|NCT02416453|76137795|FG005|Overall Study|Withdrawal by Subject|8|||
42233098|NCT03284853|76054134|FG001|Overall Study|Adverse Event|4|||
42233099|NCT03284853|76054133|FG000|Overall Study|Withdrawal by Subject|5|||
42233100|NCT03284853|76054134|FG001|Overall Study|Withdrawal by Subject|1|||
42233101|NCT03284853|76054133|FG000|Overall Study|Lost to Follow-up|1|||
42233102|NCT03284853|76054134|FG001|Overall Study|Lost to Follow-up|0|||
42233103|NCT03284853|76054133|FG000|Overall Study|Lack of Efficacy|1|||
42233104|NCT03284853|76054134|FG001|Overall Study|Lack of Efficacy|0|||
42233105|NCT03284853|76054133|FG000|Overall Study|Disallowed Concurrent Medication|1|||
42233106|NCT03284853|76054134|FG001|Overall Study|Disallowed Concurrent Medication|1|||
42233107|NCT03284853|76054133|FG000|Overall Study|Protocol Violation|3|||
42233108|NCT03284853|76054134|FG001|Overall Study|Protocol Violation|3|||
42233109|NCT03284853|76054133|FG000|Overall Study|Death|0|||
42233110|NCT03284853|76054134|FG001|Overall Study|Death|1|||
42233111|NCT03284853|76054133|FG000|Overall Study|Other - Reason not reported in CSR|4|||
42233112|NCT03284853|76054134|FG001|Overall Study|Other - Reason not reported in CSR|3|||
42233113|NCT04497415|76054162|FG000|Overall Study|Lost to Follow-up|43|||
42233114|NCT04497415|76054163|FG001|Overall Study|Lost to Follow-up|27|||
42233115|NCT03125941|76054171|FG000|Overall Study|did not receive intervention|1|||
42233116|NCT03125941|76054172|FG001|Overall Study|did not receive intervention|2|||
42233117|NCT02774889|76054180|FG000|Overall Study|Lost to Follow-up|2|||
42233118|NCT02774889|76054181|FG001|Overall Study|Lost to Follow-up|1|||
42233119|NCT03125629|76054189|FG000|Overall Study|Withdrawal by Subject|2|||
42233120|NCT03125629|76054189|FG000|Overall Study|Equipment malfunction|1|||
42233121|NCT03125395|76054201|FG000|Overall Study|Adverse Event|2|||
42233122|NCT03125395|76054201|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
42233123|NCT03125395|76054201|FG000|Overall Study|Physician Decision|2|||
42233124|NCT03125395|76054201|FG000|Overall Study|Commercial drug is available|5|||
42233125|NCT00261807|76054215|FG000|Overall Study|Lost to Follow-up|2|||
42233126|NCT00261807|76054215|FG000|Overall Study|Adverse Event|2|||
42233127|NCT00261807|76054215|FG000|Overall Study|Death|1|||
42233128|NCT00261807|76054215|FG000|Overall Study|Protocol Violation|2|||
42233129|NCT02820753|76054222|FG000|2 Month|Withdrawal by Subject|3|||
42233130|NCT02820753|76054223|FG001|2 Month|Withdrawal by Subject|3|||
42233131|NCT02820753|76054222|FG000|2 Month|Lost to Follow-up|24|||
42233132|NCT02820753|76054223|FG001|2 Month|Lost to Follow-up|26|||
42233133|NCT02820753|76054222|FG000|2 Month|Stopped per NIH Hold|51|||
42233134|NCT02820753|76054223|FG001|2 Month|Stopped per NIH Hold|13|||
42233135|NCT02820753|76054222|FG000|6 Month|Withdrawal by Subject|2|||
42233136|NCT02820753|76054223|FG001|6 Month|Withdrawal by Subject|2|||
42233137|NCT02820753|76054222|FG000|6 Month|Lost to Follow-up|20|||
42233138|NCT02820753|76054223|FG001|6 Month|Lost to Follow-up|27|||
42233139|NCT02820753|76054222|FG000|6 Month|Stopped per NIH Hold|81|||
42233140|NCT02820753|76054223|FG001|6 Month|Stopped per NIH Hold|81|||
42233141|NCT02820753|76054222|FG000|6 Month|Death|0|||
42233142|NCT02820753|76054223|FG001|6 Month|Death|1|||
42233143|NCT02861586|76054237|FG000|Overall Study|Withdrawal by Subject|1|||
42233144|NCT02861586|76054238|FG001|Overall Study|Withdrawal by Subject|2|||
42233145|NCT02861586|76054239|FG002|Overall Study|Withdrawal by Subject|0|||
42233146|NCT02861586|76054240|FG003|Overall Study|Withdrawal by Subject|0|||
42233147|NCT02861586|76054241|FG004|Overall Study|Withdrawal by Subject|0|||
42233148|NCT02861586|76054242|FG005|Overall Study|Withdrawal by Subject|1|||
42233149|NCT02861586|76054243|FG006|Overall Study|Withdrawal by Subject|1|||
42233150|NCT02861586|76054244|FG007|Overall Study|Withdrawal by Subject|0|||
42233151|NCT02861586|76054237|FG000|Overall Study|Lost to Follow-up|3|||
42233152|NCT02861586|76054238|FG001|Overall Study|Lost to Follow-up|1|||
42233153|NCT02861586|76054239|FG002|Overall Study|Lost to Follow-up|1|||
42233154|NCT02861586|76054240|FG003|Overall Study|Lost to Follow-up|0|||
42233155|NCT02861586|76054241|FG004|Overall Study|Lost to Follow-up|0|||
42233156|NCT02861586|76054242|FG005|Overall Study|Lost to Follow-up|3|||
42233157|NCT02861586|76054243|FG006|Overall Study|Lost to Follow-up|0|||
42233158|NCT02861586|76054244|FG007|Overall Study|Lost to Follow-up|0|||
42233159|NCT02861586|76054237|FG000|Overall Study|Adverse Event|0|||
42233160|NCT02861586|76054238|FG001|Overall Study|Adverse Event|0|||
41987308|NCT01295827|75794541|FG007|Overall Study|Not Reported|58|||
41987309|NCT01295827|75794542|FG008|Overall Study|Not Reported|41|||
41987310|NCT01295827|75794543|FG009|Overall Study|Not Reported|2|||
42233161|NCT02861586|76054239|FG002|Overall Study|Adverse Event|0|||
42233162|NCT02861586|76054240|FG003|Overall Study|Adverse Event|0|||
42233163|NCT02861586|76054241|FG004|Overall Study|Adverse Event|0|||
42233164|NCT02861586|76054242|FG005|Overall Study|Adverse Event|1|||
42233165|NCT02861586|76054243|FG006|Overall Study|Adverse Event|0|||
42233166|NCT02861586|76054244|FG007|Overall Study|Adverse Event|0|||
42233167|NCT03124537|76054287|FG000|Overall Study|Lost to Follow-up|3|||
42233168|NCT03124537|76054288|FG001|Overall Study|Lost to Follow-up|5|||
41987311|NCT01295827|75794544|FG010|Overall Study|Not Reported|23|||
42233169|NCT03124537|76054287|FG000|Overall Study|App Crash, Incomplete Data|7|||
42233170|NCT03124537|76054288|FG001|Overall Study|App Crash, Incomplete Data|8|||
42233171|NCT03118297|76054296|FG000|Overall Study|Lost to Follow-up|0|||
42233172|NCT03118297|76054297|FG001|Overall Study|Lost to Follow-up|2|||
42233173|NCT03117361|76054303|FG000|Overall Study|Progressive disease|5|||
42233174|NCT03117361|76054303|FG000|Overall Study|Death|1|||
42233175|NCT03117361|76054303|FG000|Overall Study|Physician Decision|2|||
42233176|NCT03117361|76054303|FG000|Overall Study|On study treatment at the end of study|1|||
42233177|NCT03117361|76054303|FG000|Overall Study|Treatment-related adverse event|1|||
42233178|NCT01368614|76054307|FG000|Screening Period|Screen Failure|58|||
41987312|NCT01295827|75794545|FG011|Overall Study|Not Reported|13|||
41987313|NCT01295827|75794546|FG012|Overall Study|Not Reported|0|||
41987314|NCT01295827|75794547|FG013|Overall Study|Not Reported|0|||
41987315|NCT01295827|75794548|FG014|Overall Study|Not Reported|0|||
41987316|NCT01295827|75794534|FG000|Overall Study|Progressive Disease|2|||
41987317|NCT01295827|75794535|FG001|Overall Study|Progressive Disease|1|||
41987318|NCT01295827|75794536|FG002|Overall Study|Progressive Disease|5|||
41987319|NCT01295827|75794537|FG003|Overall Study|Progressive Disease|2|||
41987320|NCT01295827|75794538|FG004|Overall Study|Progressive Disease|0|||
41987321|NCT01295827|75794539|FG005|Overall Study|Progressive Disease|1|||
42131803|NCT00414609|75942696|FG001|Extension Study|Lost to Follow-up|0|||
42233179|NCT01368614|76054308|FG001|Screening Period|Screen Failure|0|||
42233180|NCT01368614|76054309|FG002|Screening Period|Screen Failure|0|||
42233181|NCT01368614|76054310|FG003|Screening Period|Screen Failure|0|||
42233182|NCT01368614|76054307|FG000|Study Period|Withdrawal by Subject|0|||
42233183|NCT01368614|76054308|FG001|Study Period|Withdrawal by Subject|1|||
42233184|NCT01368614|76054309|FG002|Study Period|Withdrawal by Subject|1|||
42233185|NCT01368614|76054310|FG003|Study Period|Withdrawal by Subject|3|||
42233186|NCT01368614|76054307|FG000|Study Period|Lost to Follow-up|0|||
42233187|NCT01368614|76054308|FG001|Study Period|Lost to Follow-up|0|||
42233188|NCT01368614|76054309|FG002|Study Period|Lost to Follow-up|1|||
42233189|NCT01368614|76054310|FG003|Study Period|Lost to Follow-up|0|||
42233190|NCT03053427|76054320|FG000|Overall Study|Adverse Event|4|||
42233191|NCT03053427|76054321|FG001|Overall Study|Adverse Event|4|||
42233192|NCT03053427|76054320|FG000|Overall Study|Lack of Efficacy|1|||
42233193|NCT03053427|76054321|FG001|Overall Study|Lack of Efficacy|3|||
42233194|NCT03053427|76054320|FG000|Overall Study|Lost to Follow-up|2|||
42233195|NCT03053427|76054321|FG001|Overall Study|Lost to Follow-up|2|||
42233196|NCT03053427|76054320|FG000|Overall Study|Worsening of the target disease|0|||
42233197|NCT03053427|76054321|FG001|Overall Study|Worsening of the target disease|1|||
42233198|NCT03053427|76054320|FG000|Overall Study|Protocol Deviation|3|||
42233199|NCT03053427|76054321|FG001|Overall Study|Protocol Deviation|3|||
42233200|NCT03053427|76054320|FG000|Overall Study|Withdrawal by Subject|3|||
42233201|NCT03053427|76054321|FG001|Overall Study|Withdrawal by Subject|2|||
42233202|NCT03053427|76054320|FG000|Overall Study|Miscellaneous|0|||
42233203|NCT03053427|76054321|FG001|Overall Study|Miscellaneous|1|||
42233204|NCT03052959|76054338|FG000|Overall Study|Lost to Follow-up|4|||
42233205|NCT03052959|76054339|FG001|Overall Study|Lost to Follow-up|5|||
42233206|NCT03120013|76054346|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
42233207|NCT03120013|76054347|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
42233208|NCT01845649|76054355|FG000|Overall Study|Adverse Event|7|||
42233209|NCT01845649|76054356|FG001|Overall Study|Adverse Event|10|||
42233210|NCT01845649|76054355|FG000|Overall Study|Lack of Efficacy|1|||
42233211|NCT01845649|76054356|FG001|Overall Study|Lack of Efficacy|1|||
42233212|NCT01845649|76054355|FG000|Overall Study|Lost to Follow-up|2|||
42233213|NCT01845649|76054356|FG001|Overall Study|Lost to Follow-up|2|||
42233214|NCT01845649|76054355|FG000|Overall Study|Withdrew Consent|12|||
42233215|NCT01845649|76054356|FG001|Overall Study|Withdrew Consent|4|||
42233216|NCT01845649|76054355|FG000|Overall Study|Protocol Deviation|7|||
42233217|NCT01845649|76054356|FG001|Overall Study|Protocol Deviation|4|||
42233218|NCT01845649|76054355|FG000|Overall Study|Reason not Specified|2|||
42233219|NCT01845649|76054356|FG001|Overall Study|Reason not Specified|1|||
42233220|NCT01345929|76054364|FG000|Overall Study|Withdrawal by Subject|9|||
42233221|NCT01345929|76054365|FG001|Overall Study|Withdrawal by Subject|8|||
42233222|NCT01345929|76054364|FG000|Overall Study|Lost to Follow-up|9|||
42233223|NCT01345929|76054365|FG001|Overall Study|Lost to Follow-up|9|||
41987322|NCT01295827|75794540|FG006|Overall Study|Progressive Disease|87|||
41987323|NCT01295827|75794541|FG007|Overall Study|Progressive Disease|144|||
42233224|NCT01345929|76054364|FG000|Overall Study|Adverse Event|0|||
42233225|NCT01345929|76054365|FG001|Overall Study|Adverse Event|1|||
42233226|NCT01345929|76054364|FG000|Overall Study|Didn't meet eligibility criteria|2|||
42233227|NCT01345929|76054365|FG001|Overall Study|Didn't meet eligibility criteria|0|||
42233228|NCT01345929|76054364|FG000|Overall Study|40,000 CFU/ML|1|||
42233229|NCT01345929|76054365|FG001|Overall Study|40,000 CFU/ML|0|||
42233230|NCT01345929|76054364|FG000|Overall Study|Patient withdrawal|0|||
42233231|NCT01345929|76054365|FG001|Overall Study|Patient withdrawal|1|||
41987324|NCT01295827|75794542|FG008|Overall Study|Progressive Disease|85|||
41987325|NCT01295827|75794543|FG009|Overall Study|Progressive Disease|40|||
41987326|NCT01295827|75794544|FG010|Overall Study|Progressive Disease|175|||
41987327|NCT01295827|75794545|FG011|Overall Study|Progressive Disease|136|||
41987328|NCT01295827|75794546|FG012|Overall Study|Progressive Disease|0|||
41987329|NCT01295827|75794547|FG013|Overall Study|Progressive Disease|0|||
41987330|NCT01295827|75794548|FG014|Overall Study|Progressive Disease|0|||
41987331|NCT01295827|75794534|FG000|Overall Study|Screen Failure|0|||
41987332|NCT01295827|75794535|FG001|Overall Study|Screen Failure|0|||
41987333|NCT01295827|75794536|FG002|Overall Study|Screen Failure|0|||
41987334|NCT01295827|75794537|FG003|Overall Study|Screen Failure|0|||
42233232|NCT01343901|76054371|FG000|Overall Study|Death|85|||
42233233|NCT01343901|76054371|FG000|Overall Study|Physician Decision|4|||
42233234|NCT01343901|76054371|FG000|Overall Study|Lost to Follow-up|12|||
41987335|NCT01295827|75794538|FG004|Overall Study|Screen Failure|0|||
41987336|NCT01295827|75794539|FG005|Overall Study|Screen Failure|0|||
41987337|NCT01295827|75794540|FG006|Overall Study|Screen Failure|2|||
41987338|NCT01295827|75794541|FG007|Overall Study|Screen Failure|2|||
41987339|NCT01295827|75794542|FG008|Overall Study|Screen Failure|2|||
41987340|NCT01295827|75794543|FG009|Overall Study|Screen Failure|0|||
41987341|NCT01295827|75794544|FG010|Overall Study|Screen Failure|1|||
41987342|NCT01295827|75794545|FG011|Overall Study|Screen Failure|0|||
41987343|NCT01295827|75794546|FG012|Overall Study|Screen Failure|0|||
41987344|NCT01295827|75794547|FG013|Overall Study|Screen Failure|0|||
41987345|NCT01295827|75794548|FG014|Overall Study|Screen Failure|0|||
41987346|NCT01295827|75794534|FG000|Overall Study|Withdrawal by Subject|1|||
41987347|NCT01295827|75794535|FG001|Overall Study|Withdrawal by Subject|0|||
41987348|NCT01295827|75794536|FG002|Overall Study|Withdrawal by Subject|2|||
42233235|NCT01343901|76054371|FG000|Overall Study|Management by another medical team|11|||
42233236|NCT01343901|76054371|FG000|Overall Study|Participant decision|1|||
42233237|NCT03053271|76054375|FG000|Overall Study|Did not meet randomization criteria|3|||
42233238|NCT03053271|76054375|FG000|Overall Study|Withdrawal by Subject|1|||
42233239|NCT01343823|76054383|FG000|Overall Study|Study Terminated|1|||
42032580|NCT01193660|75840807|FG000|Overall Study|Physician Decision|1|||
42032581|NCT01193660|75840808|FG001|Overall Study|Physician Decision|0|||
42032582|NCT01193660|75840809|FG002|Overall Study|Physician Decision|1|||
42233240|NCT01343823|76054384|FG001|Overall Study|Study Terminated|0|||
41987349|NCT01295827|75794537|FG003|Overall Study|Withdrawal by Subject|0|||
42233241|NCT01343823|76054385|FG002|Overall Study|Study Terminated|0|||
42233242|NCT01343823|76054386|FG003|Overall Study|Study Terminated|1|||
42233243|NCT01343823|76054383|FG000|Overall Study|Withdrawal by Subject|1|||
42233244|NCT01343823|76054384|FG001|Overall Study|Withdrawal by Subject|0|||
42233245|NCT01343823|76054385|FG002|Overall Study|Withdrawal by Subject|0|||
42233246|NCT01343823|76054386|FG003|Overall Study|Withdrawal by Subject|0|||
42233247|NCT01318083|76054399|FG000|Overall Study|Adverse Event|4|||
42233248|NCT01318083|76054400|FG001|Overall Study|Adverse Event|1|||
42233249|NCT01318083|76054401|FG002|Overall Study|Adverse Event|2|||
42233250|NCT01318083|76054399|FG000|Overall Study|Withdrawal by Subject|1|||
42233251|NCT01318083|76054400|FG001|Overall Study|Withdrawal by Subject|0|||
42233252|NCT01318083|76054401|FG002|Overall Study|Withdrawal by Subject|2|||
42233253|NCT01318083|76054399|FG000|Overall Study|Lack of Efficacy|0|||
42233254|NCT01318083|76054400|FG001|Overall Study|Lack of Efficacy|0|||
42233255|NCT01318083|76054401|FG002|Overall Study|Lack of Efficacy|1|||
42233256|NCT01318083|76054399|FG000|Overall Study|Treatment Complications|1|||
42233257|NCT01318083|76054400|FG001|Overall Study|Treatment Complications|0|||
42233258|NCT01318083|76054401|FG002|Overall Study|Treatment Complications|0|||
42233259|NCT01318083|76054399|FG000|Overall Study|Lack of Study Medication Compliance|0|||
42233260|NCT01318083|76054400|FG001|Overall Study|Lack of Study Medication Compliance|1|||
41987350|NCT01295827|75794538|FG004|Overall Study|Withdrawal by Subject|0|||
42032583|NCT01076166|75840817|FG000|Overall Study|Adverse Event|3|||
42032584|NCT01076166|75840817|FG000|Overall Study|Symptoms improved/resolved|6|||
42131804|NCT00414609|75942697|FG002|Extension Study|Lost to Follow-up|10|||
42131805|NCT00414609|75942695|FG000|Extension Study|Administrative problems|0|||
42032585|NCT01193582|75840828|FG000|Vaccination Series|Withdrawal by Subject|11|||
42233261|NCT01318083|76054401|FG002|Overall Study|Lack of Study Medication Compliance|0|||
42233262|NCT01376323|76054414|FG000|Overall Study|Adverse Event|1|||
41987351|NCT01295827|75794539|FG005|Overall Study|Withdrawal by Subject|1|||
41987352|NCT01295827|75794540|FG006|Overall Study|Withdrawal by Subject|13|||
41987353|NCT01295827|75794541|FG007|Overall Study|Withdrawal by Subject|35|||
42032586|NCT01193582|75840829|FG001|Vaccination Series|Withdrawal by Subject|13|||
42233263|NCT01376323|76054415|FG001|Overall Study|Adverse Event|0|||
42233264|NCT01376323|76054416|FG002|Overall Study|Adverse Event|0|||
42233265|NCT01376323|76054417|FG003|Overall Study|Adverse Event|2|||
42233266|NCT01376323|76054418|FG004|Overall Study|Adverse Event|0|||
42233267|NCT01376323|76054414|FG000|Overall Study|Lost to Follow-up|0|||
42233268|NCT01376323|76054415|FG001|Overall Study|Lost to Follow-up|0|||
42233269|NCT01376323|76054416|FG002|Overall Study|Lost to Follow-up|0|||
42233270|NCT01376323|76054417|FG003|Overall Study|Lost to Follow-up|2|||
42233271|NCT01376323|76054418|FG004|Overall Study|Lost to Follow-up|0|||
42233272|NCT01376323|76054414|FG000|Overall Study|Physician Decision|1|||
42233273|NCT01376323|76054415|FG001|Overall Study|Physician Decision|0|||
42233274|NCT01376323|76054416|FG002|Overall Study|Physician Decision|2|||
42233275|NCT01376323|76054417|FG003|Overall Study|Physician Decision|1|||
42233276|NCT01376323|76054418|FG004|Overall Study|Physician Decision|1|||
42233277|NCT01376323|76054414|FG000|Overall Study|Withdrawal by Subject|0|||
42233278|NCT01376323|76054415|FG001|Overall Study|Withdrawal by Subject|1|||
42233279|NCT01376323|76054416|FG002|Overall Study|Withdrawal by Subject|1|||
42233280|NCT01376323|76054417|FG003|Overall Study|Withdrawal by Subject|0|||
42233281|NCT01376323|76054418|FG004|Overall Study|Withdrawal by Subject|0|||
42233282|NCT03725293|76054455|FG000|Overall Study|Physician Decision|9|||
42233283|NCT03725293|76054456|FG001|Overall Study|Physician Decision|6|||
42233284|NCT03725293|76054455|FG000|Overall Study|alternative vascular access needs|1|||
42233285|NCT03725293|76054456|FG001|Overall Study|alternative vascular access needs|2|||
42233286|NCT03725293|76054455|FG000|Overall Study|venous anatomy screen failures|2|||
42233287|NCT03725293|76054456|FG001|Overall Study|venous anatomy screen failures|1|||
42233288|NCT01368536|76054465|FG000|Overall Study|Adverse Event|5|||
42233289|NCT01368536|76054466|FG001|Overall Study|Adverse Event|6|||
42233290|NCT01368536|76054467|FG002|Overall Study|Adverse Event|8|||
42233291|NCT01368536|76054465|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42233292|NCT01368536|76054466|FG001|Overall Study|Abnormal laboratory value(s)|1|||
42233293|NCT01368536|76054467|FG002|Overall Study|Abnormal laboratory value(s)|2|||
42233294|NCT01368536|76054465|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42233295|NCT01368536|76054466|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42233296|NCT01368536|76054467|FG002|Overall Study|Abnormal test procedure result(s)|1|||
42233297|NCT01368536|76054465|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
42233298|NCT01368536|76054466|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42233299|NCT01368536|76054467|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
42233300|NCT01368536|76054465|FG000|Overall Study|No longer required study medication|0|||
42233301|NCT01368536|76054466|FG001|Overall Study|No longer required study medication|0|||
42233302|NCT01368536|76054467|FG002|Overall Study|No longer required study medication|1|||
42233303|NCT01368536|76054465|FG000|Overall Study|Withdrawal by Subject|2|||
42233304|NCT01368536|76054466|FG001|Overall Study|Withdrawal by Subject|5|||
42233305|NCT01368536|76054467|FG002|Overall Study|Withdrawal by Subject|4|||
42233306|NCT01368536|76054465|FG000|Overall Study|Lost to Follow-up|3|||
42233307|NCT01368536|76054466|FG001|Overall Study|Lost to Follow-up|3|||
42233308|NCT01368536|76054467|FG002|Overall Study|Lost to Follow-up|5|||
42233309|NCT01368536|76054465|FG000|Overall Study|Administrative problems|34|||
42233310|NCT01368536|76054466|FG001|Overall Study|Administrative problems|39|||
42233311|NCT01368536|76054467|FG002|Overall Study|Administrative problems|35|||
42233312|NCT01368536|76054465|FG000|Overall Study|Protocol deviation|0|||
42233313|NCT01368536|76054466|FG001|Overall Study|Protocol deviation|3|||
42233314|NCT01368536|76054467|FG002|Overall Study|Protocol deviation|1|||
42233315|NCT03051165|76054476|FG000|Overall Study|Withdrawal by Subject|1|||
42233316|NCT03051165|76054476|FG000|Overall Study|Early termination of study|12|||
42233317|NCT01319929|76054482|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
42233318|NCT01319929|76054483|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
42233319|NCT01319929|76054482|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
42233320|NCT01319929|76054483|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
42233321|NCT01319929|76054482|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
42233322|NCT01319929|76054483|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
42233323|NCT01319929|76054482|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
42233324|NCT01319929|76054483|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
42233325|NCT01319929|76054482|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
42233326|NCT01319929|76054483|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
42233327|NCT03110185|76054492|FG000|Overall Study|Death|0|||
42233328|NCT03110185|76054493|FG001|Overall Study|Death|1|||
42233329|NCT03110185|76054492|FG000|Overall Study|Withdrawal by Subject|2|||
42233330|NCT03110185|76054493|FG001|Overall Study|Withdrawal by Subject|7|||
42233331|NCT03110185|76054492|FG000|Overall Study|Time Constraints|0|||
42233332|NCT03110185|76054493|FG001|Overall Study|Time Constraints|6|||
42233333|NCT03110185|76054492|FG000|Overall Study|Conflict with care|5|||
42233334|NCT03110185|76054493|FG001|Overall Study|Conflict with care|12|||
42233335|NCT03110185|76054492|FG000|Overall Study|Protocol Violation|1|||
42233336|NCT03110185|76054493|FG001|Overall Study|Protocol Violation|4|||
42233337|NCT03110185|76054492|FG000|Overall Study|MRI Incompatible|2|||
42233338|NCT03110185|76054493|FG001|Overall Study|MRI Incompatible|0|||
42233339|NCT03110185|76054492|FG000|Overall Study|Patient Refusal|0|||
42233340|NCT03110185|76054493|FG001|Overall Study|Patient Refusal|1|||
42233341|NCT02858076|76054504|FG000|Overall Study|Death|6|||
42233342|NCT02858076|76054505|FG001|Overall Study|Death|3|||
42233343|NCT02858076|76054504|FG000|Overall Study|Withdrawal by Subject|1|||
42233344|NCT02858076|76054505|FG001|Overall Study|Withdrawal by Subject|5|||
42233345|NCT02858076|76054504|FG000|Overall Study|Lost to Follow-up|2|||
42233346|NCT02858076|76054505|FG001|Overall Study|Lost to Follow-up|7|||
42233347|NCT02858076|76054504|FG000|Overall Study|Completed Out of Window|1|||
42233348|NCT02858076|76054505|FG001|Overall Study|Completed Out of Window|3|||
42233349|NCT04594759|76054513|FG000|Overall Study|Lost to Follow-up|3|||
42233350|NCT02856282|76054517|FG000|Overall Study|Withdrawal by Subject|1|||
42233351|NCT03833817|76054523|FG000|Overall Study|Withdrawal by Subject|3|||
42233352|NCT03833817|76054524|FG001|Overall Study|Withdrawal by Subject|3|||
42233353|NCT03833817|76054523|FG000|Overall Study|Lost to Follow-up|3|||
42233354|NCT03833817|76054524|FG001|Overall Study|Lost to Follow-up|3|||
42233355|NCT03119701|76054532|FG000|6-day Dosing|Death|4|||
42233356|NCT03119701|76054533|FG001|6-day Dosing|Death|1|||
42233357|NCT03119701|76054532|FG000|6-day Dosing|Adverse Event|3|||
42233358|NCT03119701|76054533|FG001|6-day Dosing|Adverse Event|0|||
42233359|NCT03119701|76054532|FG000|6-day Dosing|Physician Decision|0|||
42233360|NCT03119701|76054533|FG001|6-day Dosing|Physician Decision|1|||
42233361|NCT03119701|76054532|FG000|6-day Dosing|Withdrawal by Subject|0|||
42233362|NCT03119701|76054533|FG001|6-day Dosing|Withdrawal by Subject|1|||
42233363|NCT03119701|76054532|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
42233364|NCT03119701|76054533|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
42233365|NCT02679781|76054547|FG000|Overall Study|Lost to Follow-up|1|||
42233366|NCT02679781|76054548|FG001|Overall Study|Lost to Follow-up|2|||
42233367|NCT02679781|76054547|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
42233368|NCT02679781|76054548|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
42233369|NCT02624869|76054557|FG000|Overall Study|Lost to Follow-up|0|||
42233370|NCT02624869|76054558|FG001|Overall Study|Lost to Follow-up|0|||
42233371|NCT02624869|76054559|FG002|Overall Study|Lost to Follow-up|1|||
42233372|NCT02624869|76054557|FG000|Overall Study|Withdrawal by Subject|1|||
42233373|NCT02624869|76054558|FG001|Overall Study|Withdrawal by Subject|3|||
42233374|NCT02624869|76054559|FG002|Overall Study|Withdrawal by Subject|1|||
42233375|NCT03110029|76054579|FG000|Overall Study|Withdrawal by Subject|1|||
42233376|NCT03110029|76054580|FG001|Overall Study|Withdrawal by Subject|1|||
42233377|NCT04207749|76054588|FG000|Overall Study|Lost to Follow-up|0|||
42233378|NCT04207749|76054589|FG001|Overall Study|Lost to Follow-up|2|||
42233379|NCT04207749|76054588|FG000|Overall Study|Protocol Violation|0|||
42233380|NCT04207749|76054589|FG001|Overall Study|Protocol Violation|1|||
42233381|NCT04207749|76054588|FG000|Overall Study|Withdrawal by Subject|3|||
42233382|NCT04207749|76054589|FG001|Overall Study|Withdrawal by Subject|0|||
42233383|NCT04207749|76054588|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
42233384|NCT04207749|76054589|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
42233385|NCT03043365|76054600|FG000|Weeks 0 to Week 8|Adverse Event|1|||
42233386|NCT03043365|76054601|FG001|Weeks 0 to Week 8|Adverse Event|3|||
42233387|NCT03043365|76054600|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
42233388|NCT03043365|76054601|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
42233389|NCT03043365|76054600|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
42233390|NCT03043365|76054601|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
42233391|NCT03108157|76054611|FG000|Overall Study|Protocol Violation|15|||
42233392|NCT03108157|76054612|FG001|Overall Study|Protocol Violation|4|||
42233393|NCT04421131|76054619|FG000|Overall Study|Lost to Follow-up|1|||
42233394|NCT04421131|76054619|FG000|Overall Study|Protocol Violation|2|||
42233395|NCT04421131|76054619|FG000|Overall Study|App crashed|5|||
42233396|NCT04167345|76054628|FG000|Overall Study|Other|1|||
42233397|NCT04167345|76054629|FG001|Overall Study|Other|1|||
42233398|NCT04167345|76054630|FG002|Overall Study|Other|0|||
42233399|NCT04167345|76054631|FG003|Overall Study|Other|0|||
42233400|NCT04167345|76054632|FG004|Overall Study|Other|0|||
42233401|NCT02854800|76054651|FG000|Overall Study|Protocol Violation|16|||
42233402|NCT02854800|76054652|FG001|Overall Study|Protocol Violation|11|||
42233403|NCT02854800|76054653|FG002|Overall Study|Protocol Violation|3|||
42233404|NCT02854800|76054651|FG000|Overall Study|Withdrawal by Subject|4|||
42233405|NCT02854800|76054652|FG001|Overall Study|Withdrawal by Subject|2|||
42233406|NCT02854800|76054653|FG002|Overall Study|Withdrawal by Subject|3|||
42233407|NCT02931539|76054666|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
42233408|NCT02931539|76054667|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
42233409|NCT02931539|76054668|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
42233410|NCT02931539|76054666|FG000|Period 1: Treatment Phase|Adverse Event|5|||
42233411|NCT02931539|76054667|FG001|Period 1: Treatment Phase|Adverse Event|1|||
42233412|NCT02931539|76054668|FG002|Period 1: Treatment Phase|Adverse Event|0|||
42233413|NCT02931539|76054666|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
42233414|NCT02931539|76054667|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
42233415|NCT02931539|76054668|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
42233416|NCT02931539|76054666|FG000|Period 1: Treatment Phase|Death|8|||
42233417|NCT02931539|76054667|FG001|Period 1: Treatment Phase|Death|24|||
42233418|NCT02931539|76054668|FG002|Period 1: Treatment Phase|Death|0|||
42233419|NCT02931539|76054666|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
42010523|NCT00996307|75817650|FG003|Overall Study|Adverse Event|0|||
42233420|NCT02931539|76054667|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
42233421|NCT02931539|76054668|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
42233422|NCT02931539|76054666|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
42233423|NCT02931539|76054667|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
42233424|NCT02931539|76054668|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
42233425|NCT02931539|76054666|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
42233426|NCT02931539|76054667|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
42233427|NCT02931539|76054668|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
42233428|NCT02931539|76054666|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
42233429|NCT02931539|76054667|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
42233430|NCT02931539|76054668|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
42233431|NCT04042077|76054685|FG000|Overall Study|Adverse Event|0|||
42233432|NCT04042077|76054686|FG001|Overall Study|Adverse Event|1|||
42233433|NCT04042077|76054685|FG000|Overall Study|Death|2|||
42233434|NCT04042077|76054686|FG001|Overall Study|Death|1|||
42233435|NCT04042077|76054685|FG000|Overall Study|Physician Decision|2|||
42233436|NCT04042077|76054686|FG001|Overall Study|Physician Decision|0|||
42233437|NCT04042077|76054685|FG000|Overall Study|Withdrawal by Subject|3|||
42233438|NCT04042077|76054686|FG001|Overall Study|Withdrawal by Subject|2|||
42233439|NCT04042077|76054685|FG000|Overall Study|Lack of Efficacy|0|||
42233440|NCT04042077|76054686|FG001|Overall Study|Lack of Efficacy|1|||
42233441|NCT02853318|76054707|FG000|Overall Study|Withdrawal by Subject|1|||
42233442|NCT03113071|76054717|FG000|Overall Study|Withdrawal by Subject|1|||
42233443|NCT03113071|76054718|FG001|Overall Study|Withdrawal by Subject|0|||
42233444|NCT03050307|76054726|FG000|Overall Study|Adverse Event|4|||
42233445|NCT03050307|76054727|FG001|Overall Study|Adverse Event|2|||
42233446|NCT03050307|76054726|FG000|Overall Study|Significant Protocol Deviation|0|||
42233447|NCT03050307|76054727|FG001|Overall Study|Significant Protocol Deviation|1|||
42233448|NCT03050307|76054726|FG000|Overall Study|Lost to Follow-up|0|||
42233449|NCT03050307|76054727|FG001|Overall Study|Lost to Follow-up|1|||
42233450|NCT03050307|76054726|FG000|Overall Study|Voluntary Withdrawal|3|||
42233451|NCT03050307|76054727|FG001|Overall Study|Voluntary Withdrawal|4|||
42233452|NCT03050307|76054726|FG000|Overall Study|Reason not Specified|1|||
42233453|NCT03050307|76054727|FG001|Overall Study|Reason not Specified|1|||
42233454|NCT03118765|76054753|FG000|Overall Study|Withdrawal by Subject|0|||
42233455|NCT03118765|76054754|FG001|Overall Study|Withdrawal by Subject|0|||
42233456|NCT03118765|76054755|FG002|Overall Study|Withdrawal by Subject|1|||
42233457|NCT03118765|76054756|FG003|Overall Study|Withdrawal by Subject|0|||
42233458|NCT03118765|76054757|FG004|Overall Study|Withdrawal by Subject|0|||
42131806|NCT00414609|75942696|FG001|Extension Study|Administrative problems|0|||
42131807|NCT00414609|75942697|FG002|Extension Study|Administrative problems|1|||
42131808|NCT00414609|75942695|FG000|Extension Study|Death|0|||
42131809|NCT00414609|75942696|FG001|Extension Study|Death|0|||
42131810|NCT00414609|75942697|FG002|Extension Study|Death|17|||
42131811|NCT00393705|75942708|FG000|Overall Study|Adverse Event|0|||
42131812|NCT00393705|75942709|FG001|Overall Study|Adverse Event|2|||
42131813|NCT00393705|75942708|FG000|Overall Study|Death|0|||
42131814|NCT00393705|75942709|FG001|Overall Study|Death|1|||
42131815|NCT00393705|75942708|FG000|Overall Study|Lost to Follow-up|2|||
42131816|NCT00393705|75942709|FG001|Overall Study|Lost to Follow-up|2|||
42131817|NCT00393705|75942708|FG000|Overall Study|Entry Criteria Not Met|10|||
42131818|NCT00393705|75942709|FG001|Overall Study|Entry Criteria Not Met|10|||
42131819|NCT00393705|75942708|FG000|Overall Study|Protocol Violation|4|||
42131820|NCT00393705|75942709|FG001|Overall Study|Protocol Violation|3|||
42131821|NCT00393705|75942708|FG000|Overall Study|Withdrawal by Subject|5|||
42131822|NCT00393705|75942709|FG001|Overall Study|Withdrawal by Subject|3|||
42131823|NCT00393705|75942708|FG000|Overall Study|Physician Decision|2|||
42131824|NCT00393705|75942709|FG001|Overall Study|Physician Decision|2|||
42131825|NCT00303628|75942717|FG000|Overall Study|Disease progression|0|||
42131826|NCT00303628|75942718|FG001|Overall Study|Disease progression|1|||
42131827|NCT00303628|75942717|FG000|Overall Study|Adverse Event|26|||
42131828|NCT00303628|75942718|FG001|Overall Study|Adverse Event|36|||
42131829|NCT00303628|75942717|FG000|Overall Study|Death|0|||
42131830|NCT00303628|75942718|FG001|Overall Study|Death|1|||
42131831|NCT00303628|75942717|FG000|Overall Study|Withdrawal by Subject|11|||
42131832|NCT00303628|75942718|FG001|Overall Study|Withdrawal by Subject|20|||
42131833|NCT00303628|75942717|FG000|Overall Study|Alternative therapy|2|||
42131834|NCT00303628|75942718|FG001|Overall Study|Alternative therapy|0|||
42131835|NCT00303628|75942717|FG000|Overall Study|Other complicating disease|0|||
42233459|NCT03118765|76054753|FG000|Overall Study|Adverse Event|1|||
42233460|NCT03118765|76054754|FG001|Overall Study|Adverse Event|1|||
42233461|NCT03118765|76054755|FG002|Overall Study|Adverse Event|1|||
42233462|NCT03118765|76054756|FG003|Overall Study|Adverse Event|1|||
42233463|NCT03118765|76054757|FG004|Overall Study|Adverse Event|1|||
42233464|NCT03118765|76054753|FG000|Overall Study|Non compliance with Study Procedures|0|||
42233465|NCT03118765|76054754|FG001|Overall Study|Non compliance with Study Procedures|0|||
42233466|NCT03118765|76054755|FG002|Overall Study|Non compliance with Study Procedures|0|||
42233467|NCT03118765|76054756|FG003|Overall Study|Non compliance with Study Procedures|1|||
42233468|NCT03118765|76054757|FG004|Overall Study|Non compliance with Study Procedures|0|||
42233469|NCT03118765|76054753|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
42233470|NCT03118765|76054754|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
42233471|NCT03118765|76054755|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
42233472|NCT03118765|76054756|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
42233473|NCT03118765|76054757|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
42233474|NCT03118765|76054753|FG000|Overall Study|COPD Exacerbation|1|||
42233475|NCT03118765|76054754|FG001|Overall Study|COPD Exacerbation|0|||
42233476|NCT03118765|76054755|FG002|Overall Study|COPD Exacerbation|0|||
42233477|NCT03118765|76054756|FG003|Overall Study|COPD Exacerbation|1|||
42233478|NCT03118765|76054757|FG004|Overall Study|COPD Exacerbation|0|||
42233479|NCT03118765|76054753|FG000|Overall Study|Lost to Follow-up|1|||
42233480|NCT03118765|76054754|FG001|Overall Study|Lost to Follow-up|0|||
42233481|NCT03118765|76054755|FG002|Overall Study|Lost to Follow-up|1|||
42233482|NCT03118765|76054756|FG003|Overall Study|Lost to Follow-up|0|||
42233483|NCT03118765|76054757|FG004|Overall Study|Lost to Follow-up|0|||
42233484|NCT03118765|76054753|FG000|Overall Study|Sponsor Decision|1|||
42233485|NCT03118765|76054754|FG001|Overall Study|Sponsor Decision|0|||
42233486|NCT03118765|76054755|FG002|Overall Study|Sponsor Decision|1|||
42233487|NCT03118765|76054756|FG003|Overall Study|Sponsor Decision|0|||
42233488|NCT03118765|76054757|FG004|Overall Study|Sponsor Decision|1|||
42233489|NCT05222880|76054772|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
42233490|NCT05222880|76054772|FG000|Overall Study|Withdrew Consent during Study|1|||
42233491|NCT05222880|76054772|FG000|Overall Study|COVID-19 Related|1|||
42233492|NCT04810962|76054789|FG000|Overall Study|Adverse Event|0|||
42233493|NCT04810962|76054790|FG001|Overall Study|Adverse Event|1|||
42233494|NCT04810962|76054789|FG000|Overall Study|Lost to Follow-up|2|||
42233495|NCT04810962|76054790|FG001|Overall Study|Lost to Follow-up|1|||
42233496|NCT04810962|76054789|FG000|Overall Study|Physician Decision|1|||
42233497|NCT04810962|76054790|FG001|Overall Study|Physician Decision|0|||
42233498|NCT04810962|76054789|FG000|Overall Study|Withdrawal by Subject|1|||
42233499|NCT04810962|76054790|FG001|Overall Study|Withdrawal by Subject|3|||
42233500|NCT04810962|76054789|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
42233501|NCT04810962|76054790|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
42233502|NCT04606134|76054823|FG000|Overall Study|Adverse Event|0|||
42233503|NCT04606134|76054824|FG001|Overall Study|Adverse Event|1|||
42233504|NCT04426825|76054830|FG000|Overall Study|Continuing on study|6|||
42233505|NCT04426825|76054830|FG000|Overall Study|Death|17|||
42233506|NCT04399538|76054839|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
42233507|NCT04399538|76054840|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
42233508|NCT04399538|76054841|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
42233509|NCT04399538|76054842|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
42233510|NCT04399538|76054843|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
42233511|NCT04399538|76054839|FG000|Double-Blind Treatment|Adverse Event|0|||
42233512|NCT04399538|76054840|FG001|Double-Blind Treatment|Adverse Event|0|||
42233513|NCT04399538|76054841|FG002|Double-Blind Treatment|Adverse Event|0|||
42233514|NCT04399538|76054842|FG003|Double-Blind Treatment|Adverse Event|0|||
42233515|NCT04399538|76054843|FG004|Double-Blind Treatment|Adverse Event|1|||
42233516|NCT04399538|76054839|FG000|Follow-Up|Adverse Event|0|||
42233517|NCT04399538|76054840|FG001|Follow-Up|Adverse Event|0|||
42233518|NCT04399538|76054841|FG002|Follow-Up|Adverse Event|0|||
42233519|NCT04399538|76054842|FG003|Follow-Up|Adverse Event|0|||
42233520|NCT04399538|76054843|FG004|Follow-Up|Adverse Event|1|||
42233521|NCT04399538|76054839|FG000|Follow-Up|Withdrawal by Subject|0|||
42233522|NCT04399538|76054840|FG001|Follow-Up|Withdrawal by Subject|0|||
42233523|NCT04399538|76054841|FG002|Follow-Up|Withdrawal by Subject|0|||
42233524|NCT04399538|76054842|FG003|Follow-Up|Withdrawal by Subject|2|||
42233525|NCT04399538|76054843|FG004|Follow-Up|Withdrawal by Subject|0|||
42233526|NCT03094832|76054902|FG000|Overall Study|Lost to Follow-up|0|||
42233527|NCT03094832|76054903|FG001|Overall Study|Lost to Follow-up|0|||
42233528|NCT03094832|76054904|FG002|Overall Study|Lost to Follow-up|0|||
42233529|NCT03094832|76054905|FG003|Overall Study|Lost to Follow-up|1|||
42233530|NCT03094832|76054906|FG004|Overall Study|Lost to Follow-up|1|||
42233531|NCT03094832|76054902|FG000|Overall Study|Death|1|||
42233532|NCT03094832|76054903|FG001|Overall Study|Death|0|||
42233533|NCT03094832|76054904|FG002|Overall Study|Death|0|||
42233534|NCT03094832|76054905|FG003|Overall Study|Death|0|||
42233535|NCT03094832|76054906|FG004|Overall Study|Death|0|||
42233536|NCT03094832|76054902|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
42233537|NCT03094832|76054903|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
42233538|NCT03094832|76054904|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
42233539|NCT03094832|76054905|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
42233540|NCT03094832|76054906|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
42233541|NCT03094832|76054902|FG000|Overall Study|Other|13|||
42233542|NCT03094832|76054903|FG001|Overall Study|Other|20|||
42233543|NCT03094832|76054904|FG002|Overall Study|Other|1|||
42233544|NCT03094832|76054905|FG003|Overall Study|Other|7|||
42233545|NCT03094832|76054906|FG004|Overall Study|Other|1|||
42233546|NCT03036579|76054920|FG000|2 Years|Lost to Follow-up|1|||
42233547|NCT03036579|76054921|FG001|2 Years|Lost to Follow-up|0|||
42233548|NCT03036579|76054920|FG000|3 Years|Lost to Follow-up|0|||
42233549|NCT03036579|76054921|FG001|3 Years|Lost to Follow-up|1|||
42233550|NCT02867761|76054929|FG000|Overall Study|Participant withdrawn by investigator|0|||
42233551|NCT02867761|76054930|FG001|Overall Study|Participant withdrawn by investigator|1|||
42233552|NCT02867761|76054929|FG000|Overall Study|Lost to Follow-up|25|||
42233553|NCT02867761|76054930|FG001|Overall Study|Lost to Follow-up|18|||
42233554|NCT02867761|76054929|FG000|Overall Study|Unable to complete protocol|3|||
42233555|NCT02867761|76054930|FG001|Overall Study|Unable to complete protocol|7|||
42233556|NCT02719990|76054945|FG000|Overall Study|Physician Decision|2|||
42233557|NCT02719990|76054945|FG000|Overall Study|Withdrawal by Subject|2|||
42233558|NCT02719990|76054945|FG000|Overall Study|Study Terminated By Sponsor|32|||
42233559|NCT02494583|76054952|FG000|Overall Study|Death|224|||
42233560|NCT02494583|76054953|FG001|Overall Study|Death|214|||
42233561|NCT02494583|76054954|FG002|Overall Study|Death|225|||
42233562|NCT02494583|76054952|FG000|Overall Study|Lost to Follow-up|1|||
42233563|NCT02494583|76054953|FG001|Overall Study|Lost to Follow-up|0|||
42233564|NCT02494583|76054954|FG002|Overall Study|Lost to Follow-up|0|||
42233565|NCT02494583|76054952|FG000|Overall Study|Protocol Violation|1|||
42233566|NCT02494583|76054953|FG001|Overall Study|Protocol Violation|2|||
42233567|NCT02494583|76054954|FG002|Overall Study|Protocol Violation|0|||
42233568|NCT02494583|76054952|FG000|Overall Study|Screen Failure|0|||
42233569|NCT02494583|76054953|FG001|Overall Study|Screen Failure|1|||
42233570|NCT02494583|76054954|FG002|Overall Study|Screen Failure|0|||
42233571|NCT02494583|76054952|FG000|Overall Study|Transferred to Extension Study|15|||
42233572|NCT02494583|76054953|FG001|Overall Study|Transferred to Extension Study|15|||
42233573|NCT02494583|76054954|FG002|Overall Study|Transferred to Extension Study|6|||
42233574|NCT02494583|76054952|FG000|Overall Study|Did Not Continue on Extension Study|8|||
42233575|NCT02494583|76054953|FG001|Overall Study|Did Not Continue on Extension Study|10|||
42233576|NCT02494583|76054954|FG002|Overall Study|Did Not Continue on Extension Study|4|||
42233577|NCT02494583|76054952|FG000|Overall Study|Withdrawal by Subject|7|||
42233578|NCT02494583|76054953|FG001|Overall Study|Withdrawal by Subject|15|||
42233579|NCT02494583|76054954|FG002|Overall Study|Withdrawal by Subject|15|||
42233580|NCT02322814|76054969|FG000|Overall Study|Death|7|||
42233581|NCT02322814|76054970|FG001|Overall Study|Death|29|||
42233582|NCT02322814|76054971|FG002|Overall Study|Death|32|||
42233583|NCT02322814|76054972|FG003|Overall Study|Death|23|||
42233584|NCT02322814|76054973|FG004|Overall Study|Death|14|||
42233585|NCT02322814|76054969|FG000|Overall Study|Lost to Follow-up|1|||
42233586|NCT02322814|76054970|FG001|Overall Study|Lost to Follow-up|3|||
42233587|NCT02322814|76054971|FG002|Overall Study|Lost to Follow-up|3|||
42233588|NCT02322814|76054972|FG003|Overall Study|Lost to Follow-up|1|||
42233589|NCT02322814|76054973|FG004|Overall Study|Lost to Follow-up|0|||
42233590|NCT02322814|76054969|FG000|Overall Study|Various Reasons|2|||
42233591|NCT02322814|76054970|FG001|Overall Study|Various Reasons|0|||
42233592|NCT02322814|76054971|FG002|Overall Study|Various Reasons|1|||
42233593|NCT02322814|76054972|FG003|Overall Study|Various Reasons|1|||
42131836|NCT00303628|75942718|FG001|Overall Study|Other complicating disease|1|||
42131837|NCT00303628|75942717|FG000|Overall Study|Not start protocol therapy|3|||
42131838|NCT00303628|75942718|FG001|Overall Study|Not start protocol therapy|5|||
42131839|NCT00303628|75942717|FG000|Overall Study|Other|8|||
42131840|NCT00303628|75942718|FG001|Overall Study|Other|9|||
42131841|NCT00414453|75942724|FG000|Overall Study|Abnormal lab work|16|||
42131842|NCT00332488|75942737|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
42131843|NCT00332488|75942738|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
42131844|NCT00332488|75942739|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
42131845|NCT00332488|75942737|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
42233594|NCT02322814|76054973|FG004|Overall Study|Various Reasons|0|||
42233595|NCT02322814|76054969|FG000|Overall Study|Progressive Disease|0|||
42233596|NCT02322814|76054970|FG001|Overall Study|Progressive Disease|0|||
42233597|NCT02322814|76054971|FG002|Overall Study|Progressive Disease|0|||
42233598|NCT02322814|76054972|FG003|Overall Study|Progressive Disease|1|||
42233599|NCT02322814|76054973|FG004|Overall Study|Progressive Disease|1|||
42233600|NCT02322814|76054969|FG000|Overall Study|Protocol Violation|1|||
42233601|NCT02322814|76054970|FG001|Overall Study|Protocol Violation|0|||
42302555|NCT02416453|76137796|FG006|Overall Study|Withdrawal by Subject|0|||
42302556|NCT02416453|76137797|FG007|Overall Study|Withdrawal by Subject|8|||
42302557|NCT02416453|76137798|FG008|Overall Study|Withdrawal by Subject|4|||
42131846|NCT00332488|75942738|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
42131847|NCT00332488|75942739|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
42233602|NCT02322814|76054971|FG002|Overall Study|Protocol Violation|0|||
42233603|NCT02322814|76054972|FG003|Overall Study|Protocol Violation|0|||
42233604|NCT02322814|76054973|FG004|Overall Study|Protocol Violation|0|||
42233605|NCT02322814|76054969|FG000|Overall Study|Study Terminated by Sponsor|0|||
42233606|NCT02322814|76054970|FG001|Overall Study|Study Terminated by Sponsor|7|||
42233607|NCT02322814|76054971|FG002|Overall Study|Study Terminated by Sponsor|9|||
42233608|NCT02322814|76054972|FG003|Overall Study|Study Terminated by Sponsor|5|||
42233609|NCT02322814|76054973|FG004|Overall Study|Study Terminated by Sponsor|13|||
42233610|NCT02322814|76054969|FG000|Overall Study|Withdrawal by Subject|5|||
42233611|NCT02322814|76054970|FG001|Overall Study|Withdrawal by Subject|4|||
42233612|NCT02322814|76054971|FG002|Overall Study|Withdrawal by Subject|2|||
42233613|NCT02322814|76054972|FG003|Overall Study|Withdrawal by Subject|1|||
42233614|NCT02322814|76054973|FG004|Overall Study|Withdrawal by Subject|3|||
42233615|NCT01333033|76054995|FG000|Overall Study|Ineligible|0|||
42233616|NCT01333033|76054996|FG001|Overall Study|Ineligible|0|||
42233617|NCT01333033|76054997|FG002|Overall Study|Ineligible|0|||
42233618|NCT01333033|76054998|FG003|Overall Study|Ineligible|0|||
42233619|NCT01333033|76054999|FG004|Overall Study|Ineligible|6|||
42233620|NCT01333033|76055000|FG005|Overall Study|Ineligible|8|||
42233621|NCT01333033|76054995|FG000|Overall Study|Withdrawal by Subject|0|||
42233622|NCT01333033|76054996|FG001|Overall Study|Withdrawal by Subject|0|||
42233623|NCT01333033|76054997|FG002|Overall Study|Withdrawal by Subject|0|||
42233624|NCT01333033|76054998|FG003|Overall Study|Withdrawal by Subject|0|||
42233625|NCT01333033|76054999|FG004|Overall Study|Withdrawal by Subject|4|||
42233626|NCT01333033|76055000|FG005|Overall Study|Withdrawal by Subject|2|||
42233627|NCT01333033|76054995|FG000|Overall Study|PET inevaluable|0|||
42233628|NCT01333033|76054996|FG001|Overall Study|PET inevaluable|0|||
42233629|NCT01333033|76054997|FG002|Overall Study|PET inevaluable|0|||
42233630|NCT01333033|76054998|FG003|Overall Study|PET inevaluable|0|||
42233631|NCT01333033|76054999|FG004|Overall Study|PET inevaluable|2|||
42233632|NCT01333033|76055000|FG005|Overall Study|PET inevaluable|4|||
42233633|NCT01333033|76054995|FG000|Overall Study|Adverse Event|0|||
42233634|NCT01333033|76054996|FG001|Overall Study|Adverse Event|0|||
42233635|NCT01333033|76054997|FG002|Overall Study|Adverse Event|0|||
42233636|NCT01333033|76054998|FG003|Overall Study|Adverse Event|0|||
42233637|NCT01333033|76054999|FG004|Overall Study|Adverse Event|2|||
42233638|NCT01333033|76055000|FG005|Overall Study|Adverse Event|1|||
42233639|NCT01333033|76054995|FG000|Overall Study|Progression|0|||
42233640|NCT01333033|76054996|FG001|Overall Study|Progression|0|||
42131848|NCT00332488|75942737|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
42131849|NCT00332488|75942738|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
42233641|NCT01333033|76054997|FG002|Overall Study|Progression|0|||
42233642|NCT01333033|76054998|FG003|Overall Study|Progression|0|||
42233643|NCT01333033|76054999|FG004|Overall Study|Progression|0|||
42233644|NCT01333033|76055000|FG005|Overall Study|Progression|1|||
42233645|NCT01333033|76054995|FG000|Overall Study|MD Decision|0|||
42233646|NCT01333033|76054996|FG001|Overall Study|MD Decision|0|||
42233647|NCT01333033|76054997|FG002|Overall Study|MD Decision|0|||
42233648|NCT01333033|76054998|FG003|Overall Study|MD Decision|0|||
42233649|NCT01333033|76054999|FG004|Overall Study|MD Decision|0|||
42233650|NCT01333033|76055000|FG005|Overall Study|MD Decision|2|||
42233651|NCT01192776|76055022|FG000|Overall Study|Death|8|||
42233652|NCT01192776|76055023|FG001|Overall Study|Death|15|||
42233653|NCT01192776|76055024|FG002|Overall Study|Death|18|||
42233654|NCT01192776|76055025|FG003|Overall Study|Death|15|||
42233655|NCT01192776|76055022|FG000|Overall Study|Lost to Follow-up|3|||
42233656|NCT01192776|76055023|FG001|Overall Study|Lost to Follow-up|6|||
42233657|NCT01192776|76055024|FG002|Overall Study|Lost to Follow-up|3|||
42233658|NCT01192776|76055025|FG003|Overall Study|Lost to Follow-up|5|||
42233659|NCT01367834|76055058|FG000|Overall Study|Withdrawal by Subject|2|||
42233660|NCT01367834|76055059|FG001|Overall Study|Withdrawal by Subject|2|||
42233661|NCT01367834|76055058|FG000|Overall Study|Study was ended.|0|||
42233662|NCT01367834|76055059|FG001|Overall Study|Study was ended.|1|||
42233663|NCT03106753|76055067|FG000|Overall Study|Withdrawal by Subject|0|||
42233664|NCT03106753|76055068|FG001|Overall Study|Withdrawal by Subject|1|||
42233665|NCT03045081|76055078|FG000|Overall Study|Withdrawal by Subject|6|||
42233666|NCT03045081|76055079|FG001|Overall Study|Withdrawal by Subject|11|||
42233667|NCT03107377|76055087|FG000|Overall Study|Adverse Event|3|||
42233668|NCT03107377|76055088|FG001|Overall Study|Adverse Event|3|||
42233669|NCT03107377|76055087|FG000|Overall Study|Protocol Violation|9|||
42302558|NCT02416453|76137799|FG009|Overall Study|Withdrawal by Subject|0|||
42233670|NCT03107377|76055088|FG001|Overall Study|Protocol Violation|12|||
42233671|NCT03107377|76055087|FG000|Overall Study|Physician Decision|3|||
42233672|NCT03107377|76055088|FG001|Overall Study|Physician Decision|6|||
42302559|NCT02416453|76137800|FG010|Overall Study|Withdrawal by Subject|0|||
42233673|NCT03107377|76055087|FG000|Overall Study|Pregnancy|7|||
42233674|NCT03107377|76055088|FG001|Overall Study|Pregnancy|7|||
42233675|NCT03107377|76055087|FG000|Overall Study|Withdrawal by Subject|16|||
42233676|NCT03107377|76055088|FG001|Overall Study|Withdrawal by Subject|22|||
42233677|NCT03107377|76055087|FG000|Overall Study|Lost to Follow-up|37|||
42233678|NCT03107377|76055088|FG001|Overall Study|Lost to Follow-up|34|||
42233679|NCT03107377|76055087|FG000|Overall Study|Other reason not specified|16|||
42233680|NCT03107377|76055088|FG001|Overall Study|Other reason not specified|15|||
42233681|NCT02545283|76055096|FG000|Overall Study|Lost to Follow-up|2|||
42233682|NCT02545283|76055097|FG001|Overall Study|Lost to Follow-up|4|||
42233683|NCT02545283|76055096|FG000|Overall Study|Withdrawal by Subject|5|||
42233684|NCT02545283|76055097|FG001|Overall Study|Withdrawal by Subject|9|||
42233685|NCT02545283|76055096|FG000|Overall Study|Death|109|||
42233686|NCT02545283|76055097|FG001|Overall Study|Death|211|||
42233687|NCT02545283|76055096|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
42233688|NCT02545283|76055097|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
42233689|NCT02545283|76055096|FG000|Overall Study|Study Terminated By Sponsor|33|||
42233690|NCT02545283|76055097|FG001|Overall Study|Study Terminated By Sponsor|71|||
42233691|NCT03282565|76055108|FG000|Overall Study|COVID-19 Research Shutdown|0|||
42233692|NCT03282565|76055109|FG001|Overall Study|COVID-19 Research Shutdown|2|||
42233693|NCT03282565|76055110|FG002|Overall Study|COVID-19 Research Shutdown|2|||
42233694|NCT02875613|76055118|FG000|Overall Study|Withdrawal by Subject|1|||
42233695|NCT02815267|76055128|FG000|Double-Blind Phase|Adverse Event|0|||
42233696|NCT02815267|76055129|FG001|Double-Blind Phase|Adverse Event|3|||
42233697|NCT02815267|76055128|FG000|Double-Blind Phase|Lost to Follow-up|17|||
42233698|NCT02815267|76055129|FG001|Double-Blind Phase|Lost to Follow-up|9|||
42233699|NCT02815267|76055128|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
42233700|NCT02815267|76055129|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
42233701|NCT02815267|76055128|FG000|Double-Blind Phase|Protocol Violation|3|||
42233702|NCT02815267|76055129|FG001|Double-Blind Phase|Protocol Violation|2|||
42233703|NCT02815267|76055128|FG000|Double-Blind Phase|Site withdrawal|1|||
42233704|NCT02815267|76055129|FG001|Double-Blind Phase|Site withdrawal|6|||
42233705|NCT02815267|76055128|FG000|Double-Blind Phase|Received a disallowed medication|1|||
42233706|NCT02815267|76055129|FG001|Double-Blind Phase|Received a disallowed medication|1|||
42233707|NCT02815267|76055128|FG000|Open-Label Phase|Adverse Event|1|||
42233708|NCT02815267|76055129|FG001|Open-Label Phase|Adverse Event|1|||
42233709|NCT02815267|76055128|FG000|Open-Label Phase|Lost to Follow-up|23|||
42233710|NCT02815267|76055129|FG001|Open-Label Phase|Lost to Follow-up|9|||
42233711|NCT02815267|76055128|FG000|Open-Label Phase|Withdrawal by Subject|24|||
42233712|NCT02815267|76055129|FG001|Open-Label Phase|Withdrawal by Subject|13|||
42233713|NCT02815267|76055128|FG000|Open-Label Phase|Protocol Violation|0|||
42233714|NCT02815267|76055129|FG001|Open-Label Phase|Protocol Violation|1|||
42233715|NCT02815267|76055128|FG000|Open-Label Phase|Administrative|21|||
42233716|NCT02815267|76055129|FG001|Open-Label Phase|Administrative|12|||
42233717|NCT02815267|76055128|FG000|Open-Label Phase|Other|2|||
42233718|NCT02815267|76055129|FG001|Open-Label Phase|Other|5|||
42233719|NCT02930837|76055139|FG000|Overall Study|Adverse Event|6|||
42233720|NCT02930837|76055139|FG000|Overall Study|Lost to Follow-up|5|||
42233721|NCT02930837|76055139|FG000|Overall Study|Withdrawal by Subject|1|||
42233722|NCT01343277|76055145|FG000|Overall Study|Other|3|||
42233723|NCT01343277|76055146|FG001|Overall Study|Other|3|||
42233724|NCT01343277|76055145|FG000|Overall Study|Withdrawal by Subject|18|||
42233725|NCT01343277|76055146|FG001|Overall Study|Withdrawal by Subject|13|||
42233726|NCT01343277|76055145|FG000|Overall Study|Physician Decision|1|||
42233727|NCT01343277|76055146|FG001|Overall Study|Physician Decision|2|||
42233728|NCT01343277|76055145|FG000|Overall Study|Death|10|||
42233729|NCT01343277|76055146|FG001|Overall Study|Death|1|||
42233730|NCT01343277|76055145|FG000|Overall Study|Adverse Event|67|||
42233731|NCT01343277|76055146|FG001|Overall Study|Adverse Event|13|||
42233732|NCT01343277|76055145|FG000|Overall Study|Disease progression|270|||
42233733|NCT01343277|76055146|FG001|Overall Study|Disease progression|138|||
42233734|NCT01343277|76055145|FG000|Overall Study|Randomized not treated|6|||
42233735|NCT01343277|76055146|FG001|Overall Study|Randomized not treated|21|||
42233736|NCT01343277|76055145|FG000|Overall Study|Treatment ongoing|8|||
42233737|NCT01343277|76055146|FG001|Overall Study|Treatment ongoing|2|||
42233738|NCT01343277|76055145|FG000|Overall Study|Subsequent anticancer therapy|1|||
42233739|NCT01343277|76055146|FG001|Overall Study|Subsequent anticancer therapy|0|||
42233740|NCT03135899|76055160|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
42233741|NCT03135899|76055161|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
42233742|NCT03135899|76055162|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
42233743|NCT03135899|76055163|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
42233744|NCT03135899|76055164|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
42233745|NCT03135899|76055165|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
42233746|NCT03135899|76055166|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
42233747|NCT03135899|76055167|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
42233748|NCT03135899|76055160|FG000|Overall Study|Withdrawal by Subject|0|||
42233749|NCT03135899|76055161|FG001|Overall Study|Withdrawal by Subject|0|||
42233750|NCT03135899|76055162|FG002|Overall Study|Withdrawal by Subject|0|||
42233751|NCT03135899|76055163|FG003|Overall Study|Withdrawal by Subject|0|||
42233752|NCT03135899|76055164|FG004|Overall Study|Withdrawal by Subject|0|||
42233753|NCT03135899|76055165|FG005|Overall Study|Withdrawal by Subject|2|||
42233754|NCT03135899|76055166|FG006|Overall Study|Withdrawal by Subject|0|||
42233755|NCT03135899|76055167|FG007|Overall Study|Withdrawal by Subject|0|||
42233756|NCT02487979|76055181|FG000|Overall Study|Physician Decision|2|||
42233757|NCT02487979|76055181|FG000|Overall Study|Withdrawal by Subject|2|||
42233758|NCT02487979|76055181|FG000|Overall Study|Progressive Disease|17|||
42233759|NCT03103087|76055192|FG000|Overall Study|Did not receive any study drug|1|||
42233760|NCT03103087|76055193|FG001|Overall Study|Did not receive any study drug|0|||
42233761|NCT03103087|76055194|FG002|Overall Study|Did not receive any study drug|0|||
42233762|NCT03103087|76055192|FG000|Overall Study|Protocol Violation|1|||
42233763|NCT03103087|76055193|FG001|Overall Study|Protocol Violation|2|||
42233764|NCT03103087|76055194|FG002|Overall Study|Protocol Violation|1|||
42233765|NCT03103087|76055192|FG000|Overall Study|Lack of Efficacy|2|||
42233766|NCT03103087|76055193|FG001|Overall Study|Lack of Efficacy|1|||
42233767|NCT03103087|76055194|FG002|Overall Study|Lack of Efficacy|1|||
42233768|NCT03103087|76055192|FG000|Overall Study|Pregnancy|0|||
42233769|NCT03103087|76055193|FG001|Overall Study|Pregnancy|0|||
42233770|NCT03103087|76055194|FG002|Overall Study|Pregnancy|1|||
42233771|NCT03103087|76055192|FG000|Overall Study|Adverse Event|2|||
42233772|NCT03103087|76055193|FG001|Overall Study|Adverse Event|15|||
42233773|NCT03103087|76055194|FG002|Overall Study|Adverse Event|6|||
42233774|NCT03103087|76055192|FG000|Overall Study|Withdrawal by Subject|13|||
42233775|NCT03103087|76055193|FG001|Overall Study|Withdrawal by Subject|6|||
42233776|NCT03103087|76055194|FG002|Overall Study|Withdrawal by Subject|6|||
42233777|NCT03103087|76055192|FG000|Overall Study|Lost to Follow-up|4|||
42233778|NCT03103087|76055193|FG001|Overall Study|Lost to Follow-up|2|||
42233779|NCT03103087|76055194|FG002|Overall Study|Lost to Follow-up|7|||
42233780|NCT03103087|76055192|FG000|Overall Study|Other reason not reported|1|||
42233781|NCT03103087|76055193|FG001|Overall Study|Other reason not reported|3|||
42233782|NCT03103087|76055194|FG002|Overall Study|Other reason not reported|5|||
42233783|NCT03131999|76055206|FG000|Overall Study|Withdrawal by Subject|0|||
41987354|NCT01295827|75794542|FG008|Overall Study|Withdrawal by Subject|11|||
41987355|NCT01295827|75794543|FG009|Overall Study|Withdrawal by Subject|2|||
41987356|NCT01295827|75794544|FG010|Overall Study|Withdrawal by Subject|18|||
41987357|NCT01295827|75794545|FG011|Overall Study|Withdrawal by Subject|13|||
41987358|NCT01295827|75794546|FG012|Overall Study|Withdrawal by Subject|0|||
42233784|NCT03131999|76055207|FG001|Overall Study|Withdrawal by Subject|1|||
42233785|NCT02263885|76055222|FG000|Overall Study|Withdrawal by Subject|7|||
42233786|NCT02263885|76055222|FG000|Overall Study|Alternative Treatment|3|||
42233787|NCT02000219|76055227|FG000|14-Week Study Period|Physician Decision|1|||
42233788|NCT02000219|76055227|FG000|14-Week Study Period|Adverse Event|1|||
42233789|NCT02000219|76055227|FG000|14-Week Study Period|Underwent transplantation|1|||
42233790|NCT02000219|76055227|FG000|Continuation Period|Withdrawal by Subject|1|||
42233791|NCT02000219|76055227|FG000|Continuation Period|Had liver transplant|2|||
42233792|NCT02000219|76055227|FG000|Continuation Period|Non-compliance with study drug|2|||
42233793|NCT03101371|76055233|FG000|Overall Study|Physician Decision|0|||
42233794|NCT03101371|76055234|FG001|Overall Study|Physician Decision|1|||
42233795|NCT03101371|76055233|FG000|Overall Study|Lost to Follow-up|1|||
42233796|NCT03101371|76055234|FG001|Overall Study|Lost to Follow-up|4|||
42233797|NCT03101371|76055233|FG000|Overall Study|Did not meet eligibility criteria|2|||
42233798|NCT03101371|76055234|FG001|Overall Study|Did not meet eligibility criteria|1|||
42233799|NCT02850276|76055240|FG000|Overall Study|screen failure|43|||
42233800|NCT02850276|76055240|FG000|Overall Study|Withdrawal by Subject|14|||
42233801|NCT02850276|76055240|FG000|Overall Study|Physician Decision|2|||
42233802|NCT02850276|76055240|FG000|Overall Study|Lost to Follow-up|2|||
42233803|NCT02783768|76055245|FG000|Overall Study|Lost to Follow-up|1|||
42233804|NCT02783768|76055246|FG001|Overall Study|Lost to Follow-up|0|||
42233805|NCT03131687|76055258|FG000|Overall Study|Adverse Event|0|||
42233806|NCT03131687|76055259|FG001|Overall Study|Adverse Event|1|||
41987359|NCT01295827|75794547|FG013|Overall Study|Withdrawal by Subject|0|||
41987360|NCT01295827|75794548|FG014|Overall Study|Withdrawal by Subject|0|||
41987361|NCT01295827|75794534|FG000|Overall Study|Other|0|||
41987362|NCT01295827|75794535|FG001|Overall Study|Other|0|||
41987363|NCT01295827|75794536|FG002|Overall Study|Other|0|||
41987364|NCT01295827|75794537|FG003|Overall Study|Other|0|||
41987365|NCT01295827|75794538|FG004|Overall Study|Other|0|||
41987366|NCT01295827|75794539|FG005|Overall Study|Other|0|||
41987367|NCT01295827|75794540|FG006|Overall Study|Other|1|||
42233807|NCT03131687|76055260|FG002|Overall Study|Adverse Event|0|||
42233808|NCT03131687|76055261|FG003|Overall Study|Adverse Event|1|||
42233809|NCT03131687|76055262|FG004|Overall Study|Adverse Event|2|||
42233810|NCT03131687|76055263|FG005|Overall Study|Adverse Event|2|||
42233811|NCT03131687|76055258|FG000|Overall Study|Death|1|||
42233812|NCT03131687|76055259|FG001|Overall Study|Death|0|||
42233813|NCT03131687|76055260|FG002|Overall Study|Death|0|||
42233814|NCT03131687|76055261|FG003|Overall Study|Death|0|||
42233815|NCT03131687|76055262|FG004|Overall Study|Death|0|||
42302560|NCT02416453|76137790|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
41987368|NCT01295827|75794541|FG007|Overall Study|Other|1|||
42233816|NCT03131687|76055263|FG005|Overall Study|Death|0|||
42233817|NCT03131687|76055258|FG000|Overall Study|Withdrawal by Subject|3|||
42233818|NCT03131687|76055259|FG001|Overall Study|Withdrawal by Subject|3|||
42233819|NCT03131687|76055260|FG002|Overall Study|Withdrawal by Subject|3|||
42233820|NCT03131687|76055261|FG003|Overall Study|Withdrawal by Subject|1|||
42233821|NCT03131687|76055262|FG004|Overall Study|Withdrawal by Subject|2|||
42233822|NCT03131687|76055263|FG005|Overall Study|Withdrawal by Subject|1|||
42233823|NCT03131687|76055258|FG000|Overall Study|Lost to Follow-up|1|||
42233824|NCT03131687|76055259|FG001|Overall Study|Lost to Follow-up|4|||
42233825|NCT03131687|76055260|FG002|Overall Study|Lost to Follow-up|0|||
42233826|NCT03131687|76055261|FG003|Overall Study|Lost to Follow-up|1|||
42233827|NCT03131687|76055262|FG004|Overall Study|Lost to Follow-up|4|||
42233828|NCT03131687|76055263|FG005|Overall Study|Lost to Follow-up|2|||
42233829|NCT03131687|76055258|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
42233830|NCT03131687|76055259|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
42233831|NCT03131687|76055260|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
42233832|NCT03131687|76055261|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
42233833|NCT03131687|76055262|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
42233834|NCT03131687|76055263|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
42233835|NCT03131687|76055258|FG000|Overall Study|Principle Investigator Decision|0|||
42233836|NCT03131687|76055259|FG001|Overall Study|Principle Investigator Decision|1|||
42233837|NCT03131687|76055260|FG002|Overall Study|Principle Investigator Decision|0|||
42233838|NCT03131687|76055261|FG003|Overall Study|Principle Investigator Decision|0|||
42233839|NCT03131687|76055262|FG004|Overall Study|Principle Investigator Decision|0|||
42233840|NCT03131687|76055263|FG005|Overall Study|Principle Investigator Decision|0|||
42233841|NCT03131687|76055258|FG000|Overall Study|Inadvertent Enrollment|0|||
42233842|NCT03131687|76055259|FG001|Overall Study|Inadvertent Enrollment|0|||
42233843|NCT03131687|76055260|FG002|Overall Study|Inadvertent Enrollment|0|||
42233844|NCT03131687|76055261|FG003|Overall Study|Inadvertent Enrollment|1|||
42233845|NCT03131687|76055262|FG004|Overall Study|Inadvertent Enrollment|0|||
42233846|NCT03131687|76055263|FG005|Overall Study|Inadvertent Enrollment|0|||
42233847|NCT03101293|76055292|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
42233848|NCT03101293|76055293|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
42233849|NCT02850978|76055299|FG000|Overall Study|Uncollectable CRF|27|||
42233850|NCT02850978|76055299|FG000|Overall Study|No visit since the first visit|35|||
42233851|NCT02850978|76055299|FG000|Overall Study|Adverse Event|81|||
42233852|NCT02850978|76055299|FG000|Overall Study|Lack of Efficacy|40|||
42233853|NCT02850978|76055299|FG000|Overall Study|Improvement in condition|34|||
42233854|NCT02850978|76055299|FG000|Overall Study|Lost to Follow-up|121|||
42233855|NCT02850978|76055299|FG000|Overall Study|Reason not listed|88|||
42233856|NCT03135431|76055305|FG000|Overall Study|Study Surgeon not available|2|||
42233857|NCT03135431|76055306|FG001|Overall Study|Study Surgeon not available|0|||
42233858|NCT04534517|76055328|FG000|Overall Study|Adverse Event|1|||
42233859|NCT04534517|76055328|FG000|Overall Study|Withdrawal by Subject|1|||
42233860|NCT04534517|76055328|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
42233861|NCT04534517|76055328|FG000|Overall Study|COVID-19 Related|1|||
42233862|NCT02831257|76055332|FG000|Overall Study|Lack of Efficacy|3|||
42233863|NCT02831257|76055332|FG000|Overall Study|Adverse Event|2|||
42233864|NCT02831257|76055332|FG000|Overall Study|Physician Decision|1|||
42233865|NCT02831257|76055332|FG000|Overall Study|Withdrawal by Subject|6|||
42233866|NCT03100825|76055336|FG000|Overall Study|Participant/Guardian Decision|7|||
42233867|NCT03100825|76055336|FG000|Overall Study|Physician Decision|1|||
42233868|NCT02250534|76055343|FG000|Overall Study|Lost to Follow-up|18|||
42233869|NCT02250534|76055344|FG001|Overall Study|Lost to Follow-up|28|||
42233870|NCT02250534|76055345|FG002|Overall Study|Lost to Follow-up|33|||
41987369|NCT01295827|75794542|FG008|Overall Study|Other|1|||
41987370|NCT01295827|75794543|FG009|Overall Study|Other|0|||
41987371|NCT01295827|75794544|FG010|Overall Study|Other|2|||
41987372|NCT01295827|75794545|FG011|Overall Study|Other|0|||
41987373|NCT01295827|75794546|FG012|Overall Study|Other|0|||
42233871|NCT02250534|76055343|FG000|Overall Study|Personal reasons|7|||
42233872|NCT02250534|76055344|FG001|Overall Study|Personal reasons|8|||
42233873|NCT02250534|76055345|FG002|Overall Study|Personal reasons|14|||
42233874|NCT02250534|76055343|FG000|Overall Study|Adverse Event|6|||
42233875|NCT02250534|76055344|FG001|Overall Study|Adverse Event|3|||
42233876|NCT02250534|76055345|FG002|Overall Study|Adverse Event|8|||
42233877|NCT02250534|76055343|FG000|Overall Study|incarcerated|2|||
42233878|NCT02250534|76055344|FG001|Overall Study|incarcerated|1|||
42233879|NCT02250534|76055345|FG002|Overall Study|incarcerated|2|||
42233880|NCT02250534|76055343|FG000|Overall Study|Withdrawal by Subject|0|||
42233881|NCT02250534|76055344|FG001|Overall Study|Withdrawal by Subject|1|||
42233882|NCT02250534|76055345|FG002|Overall Study|Withdrawal by Subject|2|||
42233883|NCT02250534|76055343|FG000|Overall Study|Death|0|||
42233884|NCT02250534|76055344|FG001|Overall Study|Death|1|||
42233885|NCT02250534|76055345|FG002|Overall Study|Death|1|||
42233886|NCT02250534|76055343|FG000|Overall Study|Physician Decision|1|||
42233887|NCT02250534|76055344|FG001|Overall Study|Physician Decision|3|||
42233888|NCT02250534|76055345|FG002|Overall Study|Physician Decision|1|||
41987374|NCT01295827|75794547|FG013|Overall Study|Other|0|||
42233889|NCT02250534|76055343|FG000|Overall Study|Protocol Violation|1|||
42233890|NCT02250534|76055344|FG001|Overall Study|Protocol Violation|0|||
42233891|NCT02250534|76055345|FG002|Overall Study|Protocol Violation|1|||
42233892|NCT02250534|76055343|FG000|Overall Study|Reason unknown|1|||
42233893|NCT02250534|76055344|FG001|Overall Study|Reason unknown|0|||
42233894|NCT02250534|76055345|FG002|Overall Study|Reason unknown|0|||
42233895|NCT02848326|76055359|FG000|Treatment Period|Adverse Event|5|||
42233896|NCT02848326|76055360|FG001|Treatment Period|Adverse Event|4|||
42233897|NCT02848326|76055361|FG002|Treatment Period|Adverse Event|11|||
42233898|NCT02848326|76055362|FG003|Treatment Period|Adverse Event|6|||
42233899|NCT02848326|76055363|FG004|Treatment Period|Adverse Event|5|||
42233900|NCT02848326|76055364|FG005|Treatment Period|Adverse Event|7|||
41987375|NCT01295827|75794548|FG014|Overall Study|Other|0|||
41987376|NCT01295671|75794604|FG000|Overall Study|Lost to Follow-up|4|||
41987377|NCT01295671|75794605|FG001|Overall Study|Lost to Follow-up|6|||
41987378|NCT01295671|75794606|FG002|Overall Study|Lost to Follow-up|3|||
41987379|NCT01295671|75794604|FG000|Overall Study|Withdrawal by Subject|3|||
41987380|NCT01295671|75794605|FG001|Overall Study|Withdrawal by Subject|1|||
41987381|NCT01295671|75794606|FG002|Overall Study|Withdrawal by Subject|0|||
41987382|NCT01295320|75794614|FG000|Overall Study|Adverse Event|2|||
41987383|NCT01295320|75794614|FG000|Overall Study|Lost to Follow-up|4|||
41987384|NCT01295320|75794614|FG000|Overall Study|Withdrawal by Subject|2|||
41987385|NCT01295320|75794614|FG000|Overall Study|Subject was bedridden|1|||
41987386|NCT01295320|75794614|FG000|Overall Study|Unable to travel|1|||
42233901|NCT02848326|76055359|FG000|Treatment Period|Withdrawal of Consent|20|||
42233902|NCT02848326|76055360|FG001|Treatment Period|Withdrawal of Consent|6|||
42233903|NCT02848326|76055361|FG002|Treatment Period|Withdrawal of Consent|9|||
42233904|NCT02848326|76055362|FG003|Treatment Period|Withdrawal of Consent|6|||
42233905|NCT02848326|76055363|FG004|Treatment Period|Withdrawal of Consent|9|||
42233906|NCT02848326|76055364|FG005|Treatment Period|Withdrawal of Consent|6|||
42233907|NCT02848326|76055359|FG000|Treatment Period|Lost to Follow-up|5|||
42233908|NCT02848326|76055360|FG001|Treatment Period|Lost to Follow-up|1|||
42233909|NCT02848326|76055361|FG002|Treatment Period|Lost to Follow-up|11|||
42233910|NCT02848326|76055362|FG003|Treatment Period|Lost to Follow-up|7|||
42233911|NCT02848326|76055363|FG004|Treatment Period|Lost to Follow-up|2|||
42233912|NCT02848326|76055364|FG005|Treatment Period|Lost to Follow-up|3|||
42233913|NCT02848326|76055359|FG000|Treatment Period|Pregnancy|0|||
42233914|NCT02848326|76055360|FG001|Treatment Period|Pregnancy|0|||
42233915|NCT02848326|76055361|FG002|Treatment Period|Pregnancy|1|||
42233916|NCT02848326|76055362|FG003|Treatment Period|Pregnancy|1|||
42233917|NCT02848326|76055363|FG004|Treatment Period|Pregnancy|0|||
42233918|NCT02848326|76055364|FG005|Treatment Period|Pregnancy|1|||
41987387|NCT01295281|75794620|FG000|First Intervention (7 Days)|Death|0|||
42233919|NCT02848326|76055359|FG000|Treatment Period|Protocol Violation|4|||
42233920|NCT02848326|76055360|FG001|Treatment Period|Protocol Violation|3|||
42233921|NCT02848326|76055361|FG002|Treatment Period|Protocol Violation|4|||
42233922|NCT02848326|76055362|FG003|Treatment Period|Protocol Violation|2|||
42233923|NCT02848326|76055363|FG004|Treatment Period|Protocol Violation|3|||
42233924|NCT02848326|76055364|FG005|Treatment Period|Protocol Violation|3|||
42233925|NCT02848326|76055359|FG000|Treatment Period|Non-compliance with Study Drug|4|||
42233926|NCT02848326|76055360|FG001|Treatment Period|Non-compliance with Study Drug|0|||
42233927|NCT02848326|76055361|FG002|Treatment Period|Non-compliance with Study Drug|0|||
42233928|NCT02848326|76055362|FG003|Treatment Period|Non-compliance with Study Drug|1|||
42233929|NCT02848326|76055363|FG004|Treatment Period|Non-compliance with Study Drug|0|||
42233930|NCT02848326|76055364|FG005|Treatment Period|Non-compliance with Study Drug|0|||
42233931|NCT02848326|76055359|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
42233932|NCT02848326|76055360|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
42233933|NCT02848326|76055361|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
42233934|NCT02848326|76055362|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
42233935|NCT02848326|76055363|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
42233936|NCT02848326|76055364|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
41987388|NCT01295281|75794621|FG001|First Intervention (7 Days)|Death|1|||
41987389|NCT01294696|75794629|FG000|Overall Study|Screening failures|7|||
41987390|NCT01294696|75794629|FG000|Overall Study|Protocol Violation|8|||
41987391|NCT01294696|75794629|FG000|Overall Study|Missing BPI Response|7|||
42233937|NCT02848326|76055359|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
42233938|NCT02848326|76055360|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
42233939|NCT02848326|76055361|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
42233940|NCT02848326|76055362|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
41987392|NCT01294696|75794629|FG000|Overall Study|Site closure|52|||
42233941|NCT02848326|76055363|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
42233942|NCT02848326|76055364|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
41987393|NCT01294579|75794634|FG000|Overall Study|Disease progression|12|||
42233943|NCT03128723|76055378|FG000|Overall Study|Withdrawal by Subject|2|||
41987394|NCT01294579|75794634|FG000|Overall Study|Adverse Event|11|||
41987395|NCT01294579|75794634|FG000|Overall Study|Study closed/terminated|3|||
41987396|NCT01294579|75794634|FG000|Overall Study|Lost to Follow-up|1|||
42233944|NCT03128411|76055382|FG000|Treatment Phase|Adverse Event|21|||
42233945|NCT03128411|76055382|FG000|Treatment Phase|Physician Decision|1|||
42233946|NCT03128411|76055382|FG000|Treatment Phase|Other|2|||
42233947|NCT03128411|76055382|FG000|Long Term Follow-up Phase|Death|2|||
42233948|NCT02847858|76055388|FG000|Overall Study|Lost to Follow-up|401|||
42233949|NCT02847858|76055389|FG001|Overall Study|Lost to Follow-up|269|||
42233950|NCT03124199|76055400|FG000|Overall Study|Lost to Follow-up|4|||
42233951|NCT04465916|76055406|FG000|Overall Study|Withdrawal by Subject|0|||
42233952|NCT04465916|76055407|FG001|Overall Study|Withdrawal by Subject|1|||
42233953|NCT05090852|76055413|FG000|Overall Study|Physician Decision|5|||
42233954|NCT00075816|76055428|FG000|Overall Study|Did not undergo transplantation|14|||
42233955|NCT00075816|76055429|FG001|Overall Study|Did not undergo transplantation|11|||
42233956|NCT00109772|76055443|FG000|Double-blind Treatment|Adverse Event|14|||
42233957|NCT00109772|76055444|FG001|Double-blind Treatment|Adverse Event|5|||
42233958|NCT00109772|76055443|FG000|Double-blind Treatment|Lack of Efficacy|1|||
42233959|NCT00109772|76055444|FG001|Double-blind Treatment|Lack of Efficacy|0|||
42233960|NCT00109772|76055443|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
42233961|NCT00109772|76055444|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
42233962|NCT00109772|76055443|FG000|Double-blind Treatment|Lost to Follow-up|2|||
42233963|NCT00109772|76055444|FG001|Double-blind Treatment|Lost to Follow-up|3|||
42233964|NCT00109772|76055443|FG000|Double-blind Treatment|Protocol Violation|0|||
42233965|NCT00109772|76055444|FG001|Double-blind Treatment|Protocol Violation|1|||
42233966|NCT00109772|76055443|FG000|Double-blind Treatment|Other|0|||
42233967|NCT00109772|76055444|FG001|Double-blind Treatment|Other|4|||
42233968|NCT00109772|76055443|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
42233969|NCT00109772|76055444|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
42233970|NCT00109772|76055443|FG000|Open-label Extension|Adverse Event|10|||
42233971|NCT00109772|76055444|FG001|Open-label Extension|Adverse Event|19|||
42233972|NCT00109772|76055443|FG000|Open-label Extension|Lack of Efficacy|19|||
42233973|NCT00109772|76055444|FG001|Open-label Extension|Lack of Efficacy|11|||
42233974|NCT00109772|76055443|FG000|Open-label Extension|Withdrawal by Subject|9|||
42233975|NCT00109772|76055444|FG001|Open-label Extension|Withdrawal by Subject|6|||
42233976|NCT00109772|76055443|FG000|Open-label Extension|Lost to Follow-up|1|||
42233977|NCT00109772|76055444|FG001|Open-label Extension|Lost to Follow-up|0|||
42233978|NCT00109772|76055443|FG000|Open-label Extension|Death|0|||
42233979|NCT00109772|76055444|FG001|Open-label Extension|Death|1|||
42233980|NCT00109772|76055443|FG000|Open-label Extension|Protocol Violation|2|||
42233981|NCT00109772|76055444|FG001|Open-label Extension|Protocol Violation|2|||
42233982|NCT00109772|76055443|FG000|Open-label Extension|Other|4|||
42233983|NCT00109772|76055444|FG001|Open-label Extension|Other|10|||
42233984|NCT02783066|76055450|FG000|Overall Study|Withdrawal by Subject|13|||
42233985|NCT01371305|76055461|FG000|Overall Study|Adverse Event|0|||
42233986|NCT01371305|76055462|FG001|Overall Study|Adverse Event|0|||
42233987|NCT01371305|76055463|FG002|Overall Study|Adverse Event|0|||
42233988|NCT01371305|76055464|FG003|Overall Study|Adverse Event|2|||
42233989|NCT01371305|76055465|FG004|Overall Study|Adverse Event|1|||
42233990|NCT01371305|76055466|FG005|Overall Study|Adverse Event|0|||
42233991|NCT01371305|76055461|FG000|Overall Study|Study terminated by sponsor|0|||
42233992|NCT01371305|76055462|FG001|Overall Study|Study terminated by sponsor|0|||
42233993|NCT01371305|76055463|FG002|Overall Study|Study terminated by sponsor|0|||
42233994|NCT01371305|76055464|FG003|Overall Study|Study terminated by sponsor|0|||
42233995|NCT01371305|76055465|FG004|Overall Study|Study terminated by sponsor|3|||
42233996|NCT01371305|76055466|FG005|Overall Study|Study terminated by sponsor|1|||
42233997|NCT01371305|76055461|FG000|Overall Study|Subject request|0|||
42233998|NCT01371305|76055462|FG001|Overall Study|Subject request|0|||
42233999|NCT01371305|76055463|FG002|Overall Study|Subject request|0|||
42234000|NCT01371305|76055464|FG003|Overall Study|Subject request|0|||
42234001|NCT01371305|76055465|FG004|Overall Study|Subject request|0|||
42234002|NCT01371305|76055466|FG005|Overall Study|Subject request|1|||
42234003|NCT00109928|76055481|FG000|Overall Study|Adverse Event|2|||
42234004|NCT00109928|76055481|FG000|Overall Study|Progression|6|||
42234005|NCT00109928|76055481|FG000|Overall Study|Death|2|||
41987397|NCT01294579|75794634|FG000|Overall Study|Physician Decision|3|||
42234006|NCT00109928|76055481|FG000|Overall Study|not protocol specified|2|||
42234007|NCT00109928|76055481|FG000|Overall Study|not eligible|1|||
42234008|NCT00109850|76055486|FG000|Overall Study|Adverse Event|1|||
42234009|NCT00109850|76055486|FG000|Overall Study|Death|2|||
42234010|NCT00109850|76055486|FG000|Overall Study|Ineligible|1|||
42234011|NCT01342926|76055494|FG000|Overall Study|Adverse Event|5|||
42234012|NCT01342926|76055495|FG001|Overall Study|Adverse Event|8|||
42234013|NCT01342926|76055496|FG002|Overall Study|Adverse Event|10|||
42234014|NCT01342926|76055497|FG003|Overall Study|Adverse Event|7|||
42234015|NCT01342926|76055494|FG000|Overall Study|Lost to Follow-up|0|||
42234016|NCT01342926|76055495|FG001|Overall Study|Lost to Follow-up|1|||
42234017|NCT01342926|76055496|FG002|Overall Study|Lost to Follow-up|1|||
42234018|NCT01342926|76055497|FG003|Overall Study|Lost to Follow-up|0|||
41987398|NCT01294579|75794634|FG000|Overall Study|Withdrawal by Subject|5|||
41987399|NCT01294462|75794640|FG000|Overall Study|Lost to Follow-up|1|||
42234019|NCT01342926|76055494|FG000|Overall Study|Investigator Discretion|2|||
42234020|NCT01342926|76055495|FG001|Overall Study|Investigator Discretion|2|||
42234021|NCT01342926|76055496|FG002|Overall Study|Investigator Discretion|0|||
42234022|NCT01342926|76055497|FG003|Overall Study|Investigator Discretion|0|||
42234023|NCT01342926|76055494|FG000|Overall Study|Withdrawal by Subject|2|||
42234024|NCT01342926|76055495|FG001|Overall Study|Withdrawal by Subject|4|||
42234025|NCT01342926|76055496|FG002|Overall Study|Withdrawal by Subject|3|||
42234026|NCT01342926|76055497|FG003|Overall Study|Withdrawal by Subject|5|||
42234027|NCT01810016|76055510|FG000|Overall Study|Progressive disease|1|||
42234028|NCT01810016|76055511|FG001|Overall Study|Progressive disease|1|||
42234029|NCT01810016|76055512|FG002|Overall Study|Progressive disease|0|||
42234030|NCT01810016|76055510|FG000|Overall Study|Death|0|||
42234031|NCT01810016|76055511|FG001|Overall Study|Death|0|||
42234032|NCT01810016|76055512|FG002|Overall Study|Death|1|||
42234033|NCT02843178|76055524|FG000|Overall Study|Lost to Follow-up|8|||
42234034|NCT02843178|76055525|FG001|Overall Study|Lost to Follow-up|8|||
42234035|NCT02843178|76055526|FG002|Overall Study|Lost to Follow-up|6|||
42234036|NCT02843178|76055527|FG003|Overall Study|Lost to Follow-up|3|||
42234037|NCT02843178|76055524|FG000|Overall Study|Withdrawal by Subject|0|||
42234038|NCT02843178|76055525|FG001|Overall Study|Withdrawal by Subject|0|||
42234039|NCT02843178|76055526|FG002|Overall Study|Withdrawal by Subject|1|||
42234040|NCT02843178|76055527|FG003|Overall Study|Withdrawal by Subject|1|||
42234041|NCT03123185|76055551|FG000|Overall Study|Withdrawal by Subject|0|||
42234042|NCT03123185|76055552|FG001|Overall Study|Withdrawal by Subject|0|||
42234043|NCT03123185|76055553|FG002|Overall Study|Withdrawal by Subject|0|||
42234044|NCT03123185|76055554|FG003|Overall Study|Withdrawal by Subject|0|||
42234045|NCT03123185|76055555|FG004|Overall Study|Withdrawal by Subject|0|||
42234046|NCT03123185|76055556|FG005|Overall Study|Withdrawal by Subject|0|||
42234047|NCT03123185|76055557|FG006|Overall Study|Withdrawal by Subject|0|||
42234048|NCT03123185|76055558|FG007|Overall Study|Withdrawal by Subject|0|||
42234049|NCT03123185|76055559|FG008|Overall Study|Withdrawal by Subject|0|||
42234050|NCT03123185|76055560|FG009|Overall Study|Withdrawal by Subject|0|||
42234051|NCT03123185|76055561|FG010|Overall Study|Withdrawal by Subject|0|||
42234052|NCT03123185|76055562|FG011|Overall Study|Withdrawal by Subject|0|||
42234053|NCT03123185|76055563|FG012|Overall Study|Withdrawal by Subject|1|||
42234054|NCT03123185|76055564|FG013|Overall Study|Withdrawal by Subject|0|||
42234055|NCT02842866|76055623|FG000|Overall Study|Serious Adverse Event|0|||
42234056|NCT02842866|76055624|FG001|Overall Study|Serious Adverse Event|1|||
42234057|NCT02842866|76055623|FG000|Overall Study|Protocol Violation|4|||
42234058|NCT02842866|76055624|FG001|Overall Study|Protocol Violation|2|||
42234059|NCT02842866|76055623|FG000|Overall Study|Lost to Follow-up|2|||
42234060|NCT02842866|76055624|FG001|Overall Study|Lost to Follow-up|0|||
42234061|NCT02842866|76055623|FG000|Overall Study|Withdrawal by Subject|1|||
42234062|NCT02842866|76055624|FG001|Overall Study|Withdrawal by Subject|0|||
42234063|NCT01316913|76055634|FG000|Overall Study|Adverse Event|17|||
42234064|NCT01316913|76055635|FG001|Overall Study|Adverse Event|20|||
42234065|NCT01316913|76055636|FG002|Overall Study|Adverse Event|15|||
42234066|NCT01316913|76055637|FG003|Overall Study|Adverse Event|11|||
42234067|NCT01316913|76055634|FG000|Overall Study|Lack of Efficacy|22|||
42234068|NCT01316913|76055635|FG001|Overall Study|Lack of Efficacy|12|||
42234069|NCT01316913|76055636|FG002|Overall Study|Lack of Efficacy|9|||
42234070|NCT01316913|76055637|FG003|Overall Study|Lack of Efficacy|13|||
42234071|NCT01316913|76055634|FG000|Overall Study|Protocol Violation|1|||
42234072|NCT01316913|76055635|FG001|Overall Study|Protocol Violation|4|||
42234073|NCT01316913|76055636|FG002|Overall Study|Protocol Violation|4|||
42234074|NCT01316913|76055637|FG003|Overall Study|Protocol Violation|1|||
42234075|NCT01316913|76055634|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
42234076|NCT01316913|76055635|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
42234077|NCT01316913|76055636|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
42234078|NCT01316913|76055637|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
42234079|NCT01316913|76055634|FG000|Overall Study|Lost to Follow-up|0|||
42234080|NCT01316913|76055635|FG001|Overall Study|Lost to Follow-up|1|||
42234081|NCT01316913|76055636|FG002|Overall Study|Lost to Follow-up|0|||
42234082|NCT01316913|76055637|FG003|Overall Study|Lost to Follow-up|2|||
42234083|NCT01316913|76055634|FG000|Overall Study|Withdrawal by Subject|10|||
42234084|NCT01316913|76055635|FG001|Overall Study|Withdrawal by Subject|9|||
42234085|NCT01316913|76055636|FG002|Overall Study|Withdrawal by Subject|10|||
42234086|NCT01316913|76055637|FG003|Overall Study|Withdrawal by Subject|6|||
42234087|NCT02875067|76055648|FG000|Overall Study|Withdrawal by Subject|1|||
42234088|NCT02875067|76055648|FG000|Overall Study|Withdrawal by Termination of Study|5|||
42234089|NCT02781506|76055652|FG000|Overall Study|Adverse Event|5|||
42234090|NCT03132753|76055658|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
42234091|NCT03132753|76055659|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
42234092|NCT03132753|76055658|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
42234093|NCT03132753|76055659|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
42234094|NCT01468454|76055665|FG000|Overall Study|Did not have surgery after PET|9|||
42234095|NCT03067077|76055670|FG000|Overall Study|Did not receive surgery|4|||
42234096|NCT03067077|76055671|FG001|Overall Study|Did not receive surgery|5|||
42234097|NCT03067077|76055670|FG000|Overall Study|Lost to Follow-up|3|||
42234098|NCT03067077|76055671|FG001|Overall Study|Lost to Follow-up|2|||
42234099|NCT03096847|76055680|FG000|Overall Study|Other|2|||
42234100|NCT03096847|76055681|FG001|Overall Study|Other|1|||
42234101|NCT03096847|76055682|FG002|Overall Study|Other|2|||
42234102|NCT03096847|76055680|FG000|Overall Study|Lost to Follow-up|1|||
42234103|NCT03096847|76055681|FG001|Overall Study|Lost to Follow-up|0|||
42234104|NCT03096847|76055682|FG002|Overall Study|Lost to Follow-up|1|||
42234105|NCT03096847|76055680|FG000|Overall Study|Death|6|||
42234106|NCT03096847|76055681|FG001|Overall Study|Death|0|||
42234107|NCT03096847|76055682|FG002|Overall Study|Death|2|||
42234108|NCT03096847|76055680|FG000|Overall Study|Protocol Violation|3|||
42234109|NCT03096847|76055681|FG001|Overall Study|Protocol Violation|0|||
42234110|NCT03096847|76055682|FG002|Overall Study|Protocol Violation|6|||
42234111|NCT03096847|76055680|FG000|Overall Study|Physician Decision|12|||
42234112|NCT03096847|76055681|FG001|Overall Study|Physician Decision|2|||
42234113|NCT03096847|76055682|FG002|Overall Study|Physician Decision|8|||
42234114|NCT03096847|76055680|FG000|Overall Study|Withdrawal by Subject|24|||
42234115|NCT03096847|76055681|FG001|Overall Study|Withdrawal by Subject|1|||
42234116|NCT03096847|76055682|FG002|Overall Study|Withdrawal by Subject|12|||
42234117|NCT03096847|76055680|FG000|Overall Study|Adverse Event|72|||
42234118|NCT03096847|76055681|FG001|Overall Study|Adverse Event|6|||
42234119|NCT03096847|76055682|FG002|Overall Study|Adverse Event|28|||
42234120|NCT03096847|76055680|FG000|Overall Study|Progressive disease|97|||
42234121|NCT03096847|76055681|FG001|Overall Study|Progressive disease|10|||
42234122|NCT03096847|76055682|FG002|Overall Study|Progressive disease|78|||
42234123|NCT03096847|76055680|FG000|Overall Study|Non-compliance with study medication|1|||
42234124|NCT03096847|76055681|FG001|Overall Study|Non-compliance with study medication|0|||
42234125|NCT03096847|76055682|FG002|Overall Study|Non-compliance with study medication|0|||
41987400|NCT01294462|75794641|FG001|Overall Study|Lost to Follow-up|0|||
42234126|NCT03096847|76055680|FG000|Overall Study|New therapy for study indication|1|||
42234127|NCT03096847|76055681|FG001|Overall Study|New therapy for study indication|0|||
42234128|NCT03096847|76055682|FG002|Overall Study|New therapy for study indication|1|||
42234129|NCT01365182|76055701|FG000|Overall Study|Withdrawal by Subject|10|||
42234130|NCT01365182|76055702|FG001|Overall Study|Withdrawal by Subject|13|||
42234131|NCT01365182|76055703|FG002|Overall Study|Withdrawal by Subject|12|||
42234132|NCT03128099|76055721|FG000|Overall Study|High dose task was too long|0|||
42234133|NCT03128099|76055722|FG001|Overall Study|High dose task was too long|4|||
42234134|NCT03128099|76055723|FG002|Overall Study|High dose task was too long|0|||
42234135|NCT03128099|76055721|FG000|Overall Study|Participant got a full time job.|1|||
42234136|NCT03128099|76055722|FG001|Overall Study|Participant got a full time job.|0|||
42234137|NCT03128099|76055723|FG002|Overall Study|Participant got a full time job.|0|||
42234138|NCT03128099|76055721|FG000|Overall Study|Became homeless and lost contact|1|||
42234139|NCT03128099|76055722|FG001|Overall Study|Became homeless and lost contact|0|||
42234140|NCT03128099|76055723|FG002|Overall Study|Became homeless and lost contact|0|||
42234141|NCT03128099|76055721|FG000|Overall Study|Did not complete all the assessments|0|||
42234142|NCT03128099|76055722|FG001|Overall Study|Did not complete all the assessments|0|||
42234143|NCT03128099|76055723|FG002|Overall Study|Did not complete all the assessments|1|||
42234144|NCT02886494|76055731|FG000|Overall Study|Adverse Event|1|||
42234145|NCT02886494|76055732|FG001|Overall Study|Adverse Event|0|||
42234146|NCT02886494|76055731|FG000|Overall Study|Withdrawal by Subject|12|||
41987401|NCT01294462|75794640|FG000|Overall Study|Withdrawal by Subject|65|||
41987402|NCT01294462|75794641|FG001|Overall Study|Withdrawal by Subject|63|||
41987403|NCT01294423|75794650|FG000|Overall Study|Adverse Event|1|||
42234147|NCT02886494|76055732|FG001|Overall Study|Withdrawal by Subject|3|||
42234148|NCT02886494|76055731|FG000|Overall Study|Protocol Violation|4|||
42234149|NCT02886494|76055732|FG001|Overall Study|Protocol Violation|1|||
42234150|NCT00204477|76055743|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
42234151|NCT00204477|76055744|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
42234152|NCT00204477|76055743|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
42234153|NCT00204477|76055744|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
42234154|NCT02846532|76055753|FG000|Overall Study|Lost to Follow-up|0|||
42234155|NCT02846532|76055754|FG001|Overall Study|Lost to Follow-up|1|||
42234156|NCT02846532|76055755|FG002|Overall Study|Lost to Follow-up|1|||
42234157|NCT02846532|76055753|FG000|Overall Study|Withdrawal by Subject|1|||
42234158|NCT02846532|76055754|FG001|Overall Study|Withdrawal by Subject|2|||
42234159|NCT02846532|76055755|FG002|Overall Study|Withdrawal by Subject|0|||
42234160|NCT00842348|76055774|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
42234161|NCT00842348|76055775|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
42234162|NCT00842348|76055774|FG000|Study 729|Disease progression/death|19|||
42234163|NCT00842348|76055775|FG001|Study 729|Disease progression/death|30|||
41987404|NCT01294423|75794651|FG001|Overall Study|Adverse Event|2|||
41987405|NCT01294423|75794652|FG002|Overall Study|Adverse Event|3|||
42234164|NCT00842348|76055774|FG000|Study 729|Adverse Event|1|||
42234165|NCT00842348|76055775|FG001|Study 729|Adverse Event|1|||
42234166|NCT00842348|76055774|FG000|Study 729|Protocol Violation|1|||
42234167|NCT00842348|76055775|FG001|Study 729|Protocol Violation|1|||
42234168|NCT00842348|76055774|FG000|Study 729|Withdrawal by Subject|2|||
42234169|NCT00842348|76055775|FG001|Study 729|Withdrawal by Subject|4|||
42234170|NCT00842348|76055774|FG000|Study 729|Due to Sponsor stopping the study|1|||
42234171|NCT00842348|76055775|FG001|Study 729|Due to Sponsor stopping the study|1|||
42234172|NCT00842348|76055774|FG000|Study 729|Due to non-availability of IP|0|||
42234173|NCT00842348|76055775|FG001|Study 729|Due to non-availability of IP|1|||
42234174|NCT00842348|76055774|FG000|Study 729|Sponsor's decision|1|||
42234175|NCT00842348|76055775|FG001|Study 729|Sponsor's decision|0|||
42234176|NCT00842348|76055774|FG000|Study 729|Surgical resection|1|||
42234177|NCT00842348|76055775|FG001|Study 729|Surgical resection|0|||
42234178|NCT03095599|76055787|FG000|Overall Study|Withdrawal by Subject|1|||
42234179|NCT03095599|76055788|FG001|Overall Study|Withdrawal by Subject|0|||
42234180|NCT03095599|76055787|FG000|Overall Study|Lost to Follow-up|1|||
42234181|NCT03095599|76055788|FG001|Overall Study|Lost to Follow-up|0|||
42234182|NCT03095599|76055787|FG000|Overall Study|Withdrawal prior to vaccination|1|||
42234183|NCT03095599|76055788|FG001|Overall Study|Withdrawal prior to vaccination|0|||
42234184|NCT03095521|76055798|FG000|Overall Study|Withdrawal by Subject|0|||
42234185|NCT03095521|76055799|FG001|Overall Study|Withdrawal by Subject|1|||
42234186|NCT03095521|76055798|FG000|Overall Study|Lost to Follow-up|0|||
42234187|NCT03095521|76055799|FG001|Overall Study|Lost to Follow-up|1|||
42234188|NCT03033875|76055808|FG000|Overall Study|Withdrawal by Subject|5|||
42234189|NCT03033875|76055809|FG001|Overall Study|Withdrawal by Subject|9|||
42234190|NCT03033875|76055810|FG002|Overall Study|Withdrawal by Subject|4|||
42234191|NCT03033875|76055808|FG000|Overall Study|Other|14|||
42234192|NCT03033875|76055809|FG001|Overall Study|Other|15|||
42234193|NCT03033875|76055810|FG002|Overall Study|Other|8|||
42234194|NCT01968785|76055824|FG000|Overall Study|Withdrawal by Subject|1|||
42234195|NCT01968785|76055825|FG001|Overall Study|Withdrawal by Subject|0|||
42234196|NCT03095287|76055831|FG000|Overall Study|Treatment Failure|1|||
42234197|NCT03095287|76055831|FG000|Overall Study|Adverse Event|1|||
42234198|NCT02839746|76055849|FG000|Overall Study|Not met selection criteria|12|||
42234199|NCT00033293|76055855|FG000|Overall Study|Death|0|||
42234200|NCT00033293|76055856|FG001|Overall Study|Death|1|||
42234201|NCT00033293|76055855|FG000|Overall Study|Lack of Efficacy|5|||
42234202|NCT00033293|76055856|FG001|Overall Study|Lack of Efficacy|8|||
42234203|NCT00033293|76055855|FG000|Overall Study|Lost to Follow-up|0|||
42234204|NCT00033293|76055856|FG001|Overall Study|Lost to Follow-up|1|||
42234205|NCT00033293|76055855|FG000|Overall Study|Physician Decision|3|||
42234206|NCT00033293|76055856|FG001|Overall Study|Physician Decision|1|||
42234207|NCT00033293|76055855|FG000|Overall Study|Withdrawal by Subject|1|||
42234208|NCT00033293|76055856|FG001|Overall Study|Withdrawal by Subject|0|||
42234209|NCT00033293|76055855|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
42234210|NCT00033293|76055856|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
42234211|NCT00033293|76055855|FG000|Overall Study|Treatment refused|0|||
42234212|NCT00033293|76055856|FG001|Overall Study|Treatment refused|6|||
42234213|NCT02039674|76055878|FG000|Overall Study|Adverse Event|0|||
42234214|NCT02039674|76055879|FG001|Overall Study|Adverse Event|0|||
42234215|NCT02039674|76055880|FG002|Overall Study|Adverse Event|0|||
42234216|NCT02039674|76055881|FG003|Overall Study|Adverse Event|1|||
42234217|NCT02039674|76055882|FG004|Overall Study|Adverse Event|0|||
42234218|NCT02039674|76055883|FG005|Overall Study|Adverse Event|0|||
42234219|NCT02039674|76055884|FG006|Overall Study|Adverse Event|0|||
42234220|NCT02039674|76055885|FG007|Overall Study|Adverse Event|0|||
42234221|NCT02039674|76055886|FG008|Overall Study|Adverse Event|2|||
42234222|NCT02039674|76055887|FG009|Overall Study|Adverse Event|1|||
42234223|NCT02039674|76055888|FG010|Overall Study|Adverse Event|0|||
42234224|NCT02039674|76055889|FG011|Overall Study|Adverse Event|2|||
42234225|NCT02039674|76055890|FG012|Overall Study|Adverse Event|3|||
42234226|NCT02039674|76055891|FG013|Overall Study|Adverse Event|1|||
42131850|NCT00332488|75942739|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
42234227|NCT02039674|76055878|FG000|Overall Study|Death|2|||
42131851|NCT00332488|75942737|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
42234228|NCT02039674|76055879|FG001|Overall Study|Death|0|||
42234229|NCT02039674|76055880|FG002|Overall Study|Death|2|||
42234230|NCT02039674|76055881|FG003|Overall Study|Death|3|||
42234231|NCT02039674|76055882|FG004|Overall Study|Death|0|||
42131852|NCT00332488|75942738|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
42131853|NCT00332488|75942739|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
42234232|NCT02039674|76055883|FG005|Overall Study|Death|0|||
42234233|NCT02039674|76055884|FG006|Overall Study|Death|1|||
42131854|NCT00332488|75942737|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
42234234|NCT02039674|76055885|FG007|Overall Study|Death|0|||
42234235|NCT02039674|76055886|FG008|Overall Study|Death|2|||
42234236|NCT02039674|76055887|FG009|Overall Study|Death|0|||
42234237|NCT02039674|76055888|FG010|Overall Study|Death|1|||
42234238|NCT02039674|76055889|FG011|Overall Study|Death|3|||
42234239|NCT02039674|76055890|FG012|Overall Study|Death|2|||
42234240|NCT02039674|76055891|FG013|Overall Study|Death|8|||
42234241|NCT02039674|76055878|FG000|Overall Study|Excluded Medication|1|||
42234242|NCT02039674|76055879|FG001|Overall Study|Excluded Medication|1|||
42234243|NCT02039674|76055880|FG002|Overall Study|Excluded Medication|0|||
42234244|NCT02039674|76055881|FG003|Overall Study|Excluded Medication|1|||
42234245|NCT02039674|76055882|FG004|Overall Study|Excluded Medication|0|||
42234246|NCT02039674|76055883|FG005|Overall Study|Excluded Medication|1|||
42234247|NCT02039674|76055884|FG006|Overall Study|Excluded Medication|0|||
42234248|NCT02039674|76055885|FG007|Overall Study|Excluded Medication|0|||
42234249|NCT02039674|76055886|FG008|Overall Study|Excluded Medication|2|||
42234250|NCT02039674|76055887|FG009|Overall Study|Excluded Medication|3|||
42234251|NCT02039674|76055888|FG010|Overall Study|Excluded Medication|5|||
42234252|NCT02039674|76055889|FG011|Overall Study|Excluded Medication|6|||
42234253|NCT02039674|76055890|FG012|Overall Study|Excluded Medication|8|||
42234254|NCT02039674|76055891|FG013|Overall Study|Excluded Medication|3|||
42234255|NCT02039674|76055878|FG000|Overall Study|Lost to Follow-up|0|||
42234256|NCT02039674|76055879|FG001|Overall Study|Lost to Follow-up|0|||
42234257|NCT02039674|76055880|FG002|Overall Study|Lost to Follow-up|0|||
42234258|NCT02039674|76055881|FG003|Overall Study|Lost to Follow-up|0|||
42234259|NCT02039674|76055882|FG004|Overall Study|Lost to Follow-up|1|||
42234260|NCT02039674|76055883|FG005|Overall Study|Lost to Follow-up|1|||
42234261|NCT02039674|76055884|FG006|Overall Study|Lost to Follow-up|0|||
42234262|NCT02039674|76055885|FG007|Overall Study|Lost to Follow-up|0|||
42234263|NCT02039674|76055886|FG008|Overall Study|Lost to Follow-up|0|||
42234264|NCT02039674|76055887|FG009|Overall Study|Lost to Follow-up|0|||
42234265|NCT02039674|76055888|FG010|Overall Study|Lost to Follow-up|0|||
42234266|NCT02039674|76055889|FG011|Overall Study|Lost to Follow-up|2|||
42234267|NCT02039674|76055890|FG012|Overall Study|Lost to Follow-up|2|||
42234268|NCT02039674|76055891|FG013|Overall Study|Lost to Follow-up|1|||
42234269|NCT02039674|76055878|FG000|Overall Study|Physician Decision|0|||
42234270|NCT02039674|76055879|FG001|Overall Study|Physician Decision|0|||
42234271|NCT02039674|76055880|FG002|Overall Study|Physician Decision|0|||
42234272|NCT02039674|76055881|FG003|Overall Study|Physician Decision|0|||
42234273|NCT02039674|76055882|FG004|Overall Study|Physician Decision|0|||
42234274|NCT02039674|76055883|FG005|Overall Study|Physician Decision|0|||
42234275|NCT02039674|76055884|FG006|Overall Study|Physician Decision|0|||
42234276|NCT02039674|76055885|FG007|Overall Study|Physician Decision|0|||
42234277|NCT02039674|76055886|FG008|Overall Study|Physician Decision|0|||
42234278|NCT02039674|76055887|FG009|Overall Study|Physician Decision|0|||
42234279|NCT02039674|76055888|FG010|Overall Study|Physician Decision|0|||
42234280|NCT02039674|76055889|FG011|Overall Study|Physician Decision|1|||
42234281|NCT02039674|76055890|FG012|Overall Study|Physician Decision|1|||
42234282|NCT02039674|76055891|FG013|Overall Study|Physician Decision|0|||
42234283|NCT02039674|76055878|FG000|Overall Study|Progressive Disease|8|||
42234284|NCT02039674|76055879|FG001|Overall Study|Progressive Disease|8|||
42234285|NCT02039674|76055880|FG002|Overall Study|Progressive Disease|6|||
42234286|NCT02039674|76055881|FG003|Overall Study|Progressive Disease|7|||
42234287|NCT02039674|76055882|FG004|Overall Study|Progressive Disease|9|||
42234288|NCT02039674|76055883|FG005|Overall Study|Progressive Disease|10|||
42234289|NCT02039674|76055884|FG006|Overall Study|Progressive Disease|1|||
42234290|NCT02039674|76055885|FG007|Overall Study|Progressive Disease|3|||
42234291|NCT02039674|76055886|FG008|Overall Study|Progressive Disease|6|||
42234292|NCT02039674|76055887|FG009|Overall Study|Progressive Disease|4|||
42234293|NCT02039674|76055888|FG010|Overall Study|Progressive Disease|0|||
42234294|NCT02039674|76055889|FG011|Overall Study|Progressive Disease|34|||
42234295|NCT02039674|76055890|FG012|Overall Study|Progressive Disease|34|||
42234296|NCT02039674|76055891|FG013|Overall Study|Progressive Disease|18|||
42234297|NCT02039674|76055878|FG000|Overall Study|Withdrawal by Subject|1|||
41987406|NCT01294423|75794650|FG000|Overall Study|Withdrawal by Subject|1|||
41987407|NCT01294423|75794651|FG001|Overall Study|Withdrawal by Subject|2|||
42234298|NCT02039674|76055879|FG001|Overall Study|Withdrawal by Subject|2|||
42234299|NCT02039674|76055880|FG002|Overall Study|Withdrawal by Subject|3|||
42234300|NCT02039674|76055881|FG003|Overall Study|Withdrawal by Subject|0|||
42234301|NCT02039674|76055882|FG004|Overall Study|Withdrawal by Subject|1|||
42234302|NCT02039674|76055883|FG005|Overall Study|Withdrawal by Subject|0|||
42234303|NCT02039674|76055884|FG006|Overall Study|Withdrawal by Subject|0|||
42234304|NCT02039674|76055885|FG007|Overall Study|Withdrawal by Subject|0|||
42234305|NCT02039674|76055886|FG008|Overall Study|Withdrawal by Subject|0|||
42234306|NCT02039674|76055887|FG009|Overall Study|Withdrawal by Subject|1|||
42234307|NCT02039674|76055888|FG010|Overall Study|Withdrawal by Subject|1|||
42234308|NCT02039674|76055889|FG011|Overall Study|Withdrawal by Subject|4|||
42234309|NCT02039674|76055890|FG012|Overall Study|Withdrawal by Subject|6|||
42234310|NCT02039674|76055891|FG013|Overall Study|Withdrawal by Subject|2|||
42234311|NCT02039674|76055878|FG000|Overall Study|Clinical Progression|0|||
42234312|NCT02039674|76055879|FG001|Overall Study|Clinical Progression|0|||
42234313|NCT02039674|76055880|FG002|Overall Study|Clinical Progression|0|||
42234314|NCT02039674|76055881|FG003|Overall Study|Clinical Progression|0|||
42234315|NCT02039674|76055882|FG004|Overall Study|Clinical Progression|0|||
42234316|NCT02039674|76055883|FG005|Overall Study|Clinical Progression|0|||
42234317|NCT02039674|76055884|FG006|Overall Study|Clinical Progression|1|||
42234318|NCT02039674|76055885|FG007|Overall Study|Clinical Progression|0|||
42234319|NCT02039674|76055886|FG008|Overall Study|Clinical Progression|0|||
42234320|NCT02039674|76055887|FG009|Overall Study|Clinical Progression|0|||
42234321|NCT02039674|76055888|FG010|Overall Study|Clinical Progression|0|||
42234322|NCT02039674|76055889|FG011|Overall Study|Clinical Progression|0|||
42234323|NCT02039674|76055890|FG012|Overall Study|Clinical Progression|1|||
42234324|NCT02039674|76055891|FG013|Overall Study|Clinical Progression|0|||
42234325|NCT02039674|76055878|FG000|Overall Study|Sponsor Decision|1|||
42234326|NCT02039674|76055879|FG001|Overall Study|Sponsor Decision|1|||
42234327|NCT02039674|76055880|FG002|Overall Study|Sponsor Decision|1|||
42234328|NCT02039674|76055881|FG003|Overall Study|Sponsor Decision|1|||
42234329|NCT02039674|76055882|FG004|Overall Study|Sponsor Decision|1|||
42234330|NCT02039674|76055883|FG005|Overall Study|Sponsor Decision|0|||
42234331|NCT02039674|76055884|FG006|Overall Study|Sponsor Decision|0|||
42234332|NCT02039674|76055885|FG007|Overall Study|Sponsor Decision|0|||
42234333|NCT02039674|76055886|FG008|Overall Study|Sponsor Decision|0|||
42234334|NCT02039674|76055887|FG009|Overall Study|Sponsor Decision|3|||
42234335|NCT02039674|76055888|FG010|Overall Study|Sponsor Decision|0|||
42234336|NCT02039674|76055889|FG011|Overall Study|Sponsor Decision|8|||
42234337|NCT02039674|76055890|FG012|Overall Study|Sponsor Decision|5|||
42234338|NCT02039674|76055891|FG013|Overall Study|Sponsor Decision|0|||
42234339|NCT02039674|76055878|FG000|Overall Study|Other|0|||
42234340|NCT02039674|76055879|FG001|Overall Study|Other|0|||
42234341|NCT02039674|76055880|FG002|Overall Study|Other|0|||
42234342|NCT02039674|76055881|FG003|Overall Study|Other|0|||
42234343|NCT02039674|76055882|FG004|Overall Study|Other|0|||
42234344|NCT02039674|76055883|FG005|Overall Study|Other|0|||
42234345|NCT02039674|76055884|FG006|Overall Study|Other|0|||
42234346|NCT02039674|76055885|FG007|Overall Study|Other|0|||
42234347|NCT02039674|76055886|FG008|Overall Study|Other|0|||
42234348|NCT02039674|76055887|FG009|Overall Study|Other|0|||
42234349|NCT02039674|76055888|FG010|Overall Study|Other|0|||
42234350|NCT02039674|76055889|FG011|Overall Study|Other|0|||
42234351|NCT02039674|76055890|FG012|Overall Study|Other|1|||
42234352|NCT02039674|76055891|FG013|Overall Study|Other|0|||
42234353|NCT03126227|76055931|FG000|Overall Study|Adverse Event|43|||
42234354|NCT03126227|76055932|FG001|Overall Study|Adverse Event|4|||
42234355|NCT03126227|76055931|FG000|Overall Study|Death|0|||
42234356|NCT03126227|76055932|FG001|Overall Study|Death|1|||
42234357|NCT03126227|76055931|FG000|Overall Study|Lost to Follow-up|0|||
42234358|NCT03126227|76055932|FG001|Overall Study|Lost to Follow-up|1|||
42234359|NCT03126227|76055931|FG000|Overall Study|Physician Decision|2|||
42234360|NCT03126227|76055932|FG001|Overall Study|Physician Decision|0|||
42234361|NCT03126227|76055931|FG000|Overall Study|Protocol Violation|1|||
42234362|NCT03126227|76055932|FG001|Overall Study|Protocol Violation|0|||
42234363|NCT03126227|76055931|FG000|Overall Study|Withdrawal by Subject|19|||
42234364|NCT03126227|76055932|FG001|Overall Study|Withdrawal by Subject|3|||
42234365|NCT03126227|76055931|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
42234366|NCT03126227|76055932|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
42234367|NCT03126227|76055931|FG000|Overall Study|Lack of dosing compliance|2|||
42234368|NCT03126227|76055932|FG001|Overall Study|Lack of dosing compliance|0|||
42234369|NCT03126227|76055931|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
42234370|NCT03126227|76055932|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
42234371|NCT03126227|76055931|FG000|Overall Study|Scheduling conflict|1|||
42234372|NCT03126227|76055932|FG001|Overall Study|Scheduling conflict|0|||
42234373|NCT03099187|76055940|FG000|Double-blind Treatment|Adverse Event|19|||
42234374|NCT03099187|76055941|FG001|Double-blind Treatment|Adverse Event|1|||
42234375|NCT03099187|76055942|FG002|Double-blind Treatment|Adverse Event|0|||
42234376|NCT03099187|76055943|FG003|Double-blind Treatment|Adverse Event|0|||
42234377|NCT03099187|76055940|FG000|Double-blind Treatment|Death|1|||
42234378|NCT03099187|76055941|FG001|Double-blind Treatment|Death|3|||
42234379|NCT03099187|76055942|FG002|Double-blind Treatment|Death|0|||
42234380|NCT03099187|76055943|FG003|Double-blind Treatment|Death|0|||
42234381|NCT03099187|76055940|FG000|Double-blind Treatment|Lack of Efficacy|1|||
42234382|NCT03099187|76055941|FG001|Double-blind Treatment|Lack of Efficacy|0|||
42234383|NCT03099187|76055942|FG002|Double-blind Treatment|Lack of Efficacy|0|||
42234384|NCT03099187|76055943|FG003|Double-blind Treatment|Lack of Efficacy|0|||
42234385|NCT03099187|76055940|FG000|Double-blind Treatment|Physician Decision|2|||
42234386|NCT03099187|76055941|FG001|Double-blind Treatment|Physician Decision|1|||
42234387|NCT03099187|76055942|FG002|Double-blind Treatment|Physician Decision|0|||
42234388|NCT03099187|76055943|FG003|Double-blind Treatment|Physician Decision|0|||
42234389|NCT03099187|76055940|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
42234390|NCT03099187|76055941|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
42234391|NCT03099187|76055942|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
42234392|NCT03099187|76055943|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
42234393|NCT03099187|76055940|FG000|Double-blind Treatment|Lung transplantation|0|||
42234394|NCT03099187|76055941|FG001|Double-blind Treatment|Lung transplantation|1|||
42234395|NCT03099187|76055942|FG002|Double-blind Treatment|Lung transplantation|0|||
42234396|NCT03099187|76055943|FG003|Double-blind Treatment|Lung transplantation|0|||
42234397|NCT03099187|76055940|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
42234398|NCT03099187|76055941|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
42234399|NCT03099187|76055942|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
42234400|NCT03099187|76055943|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
42234401|NCT03099187|76055940|FG000|Double-blind Treatment|Disease progression|0|||
42234402|NCT03099187|76055941|FG001|Double-blind Treatment|Disease progression|1|||
42234403|NCT03099187|76055942|FG002|Double-blind Treatment|Disease progression|0|||
42234404|NCT03099187|76055943|FG003|Double-blind Treatment|Disease progression|0|||
42234405|NCT03099187|76055940|FG000|Double-blind Treatment|Randomization error|0|||
42234406|NCT03099187|76055941|FG001|Double-blind Treatment|Randomization error|2|||
42234407|NCT03099187|76055942|FG002|Double-blind Treatment|Randomization error|0|||
42234408|NCT03099187|76055943|FG003|Double-blind Treatment|Randomization error|0|||
42234409|NCT03099187|76055940|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
42234410|NCT03099187|76055941|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
42234411|NCT03099187|76055942|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
42234412|NCT03099187|76055943|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
42234413|NCT03099187|76055940|FG000|12-month Safety Follow-up|Adverse Event|0|||
42234414|NCT03099187|76055941|FG001|12-month Safety Follow-up|Adverse Event|0|||
42234415|NCT03099187|76055942|FG002|12-month Safety Follow-up|Adverse Event|5|||
42234416|NCT03099187|76055943|FG003|12-month Safety Follow-up|Adverse Event|12|||
42234417|NCT03099187|76055940|FG000|12-month Safety Follow-up|Death|0|||
42234418|NCT03099187|76055941|FG001|12-month Safety Follow-up|Death|0|||
42234419|NCT03099187|76055942|FG002|12-month Safety Follow-up|Death|7|||
42234420|NCT03099187|76055943|FG003|12-month Safety Follow-up|Death|9|||
42234421|NCT03099187|76055940|FG000|12-month Safety Follow-up|Lung transplantation|0|||
42234422|NCT03099187|76055941|FG001|12-month Safety Follow-up|Lung transplantation|0|||
42234423|NCT03099187|76055942|FG002|12-month Safety Follow-up|Lung transplantation|2|||
42234424|NCT03099187|76055943|FG003|12-month Safety Follow-up|Lung transplantation|1|||
42234425|NCT03099187|76055940|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
42234426|NCT03099187|76055941|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
42234427|NCT03099187|76055942|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
42234428|NCT03099187|76055943|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
42234429|NCT03099187|76055940|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
42234430|NCT03099187|76055941|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
42234431|NCT03099187|76055942|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
42234432|NCT03099187|76055943|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
42234433|NCT03099187|76055940|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
42234434|NCT03099187|76055941|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
42234435|NCT03099187|76055942|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
42234436|NCT03099187|76055943|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
42234437|NCT03099187|76055940|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
42234438|NCT03099187|76055941|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
42234439|NCT03099187|76055942|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
42234440|NCT03099187|76055943|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
42234441|NCT04535453|76055965|FG000|Overall Study|Death|0|||
42234442|NCT04535453|76055966|FG001|Overall Study|Death|1|||
42234443|NCT04535453|76055967|FG002|Overall Study|Death|0|||
42234444|NCT04535453|76055968|FG003|Overall Study|Death|0|||
42234445|NCT04535453|76055969|FG004|Overall Study|Death|0|||
42234446|NCT04535453|76055970|FG005|Overall Study|Death|0|||
42234447|NCT04535453|76055971|FG006|Overall Study|Death|0|||
42234448|NCT04535453|76055972|FG007|Overall Study|Death|0|||
42234449|NCT04535453|76055973|FG008|Overall Study|Death|0|||
42234450|NCT04535453|76055974|FG009|Overall Study|Death|0|||
42234451|NCT04535453|76055975|FG010|Overall Study|Death|0|||
42234452|NCT04535453|76055976|FG011|Overall Study|Death|0|||
42234453|NCT04535453|76055965|FG000|Overall Study|Lost to Follow-up|1|||
42234454|NCT04535453|76055966|FG001|Overall Study|Lost to Follow-up|1|||
42234455|NCT04535453|76055967|FG002|Overall Study|Lost to Follow-up|1|||
42234456|NCT04535453|76055968|FG003|Overall Study|Lost to Follow-up|0|||
42234457|NCT04535453|76055969|FG004|Overall Study|Lost to Follow-up|3|||
42234458|NCT04535453|76055970|FG005|Overall Study|Lost to Follow-up|1|||
42234459|NCT04535453|76055971|FG006|Overall Study|Lost to Follow-up|0|||
42234460|NCT04535453|76055972|FG007|Overall Study|Lost to Follow-up|0|||
42234461|NCT04535453|76055973|FG008|Overall Study|Lost to Follow-up|1|||
42234462|NCT04535453|76055974|FG009|Overall Study|Lost to Follow-up|1|||
42234463|NCT04535453|76055975|FG010|Overall Study|Lost to Follow-up|0|||
42234464|NCT04535453|76055976|FG011|Overall Study|Lost to Follow-up|0|||
42234465|NCT04535453|76055965|FG000|Overall Study|Physician Decision|0|||
42234466|NCT04535453|76055966|FG001|Overall Study|Physician Decision|0|||
42234467|NCT04535453|76055967|FG002|Overall Study|Physician Decision|0|||
42234468|NCT04535453|76055968|FG003|Overall Study|Physician Decision|1|||
42234469|NCT04535453|76055969|FG004|Overall Study|Physician Decision|0|||
42234470|NCT04535453|76055970|FG005|Overall Study|Physician Decision|0|||
42234471|NCT04535453|76055971|FG006|Overall Study|Physician Decision|0|||
42234472|NCT04535453|76055972|FG007|Overall Study|Physician Decision|0|||
42234473|NCT04535453|76055973|FG008|Overall Study|Physician Decision|0|||
42234474|NCT04535453|76055974|FG009|Overall Study|Physician Decision|0|||
42234475|NCT04535453|76055975|FG010|Overall Study|Physician Decision|0|||
42234476|NCT04535453|76055976|FG011|Overall Study|Physician Decision|0|||
42234477|NCT04535453|76055965|FG000|Overall Study|Withdrawal by Subject|3|||
42234478|NCT04535453|76055966|FG001|Overall Study|Withdrawal by Subject|6|||
42234479|NCT04535453|76055967|FG002|Overall Study|Withdrawal by Subject|3|||
42234480|NCT04535453|76055968|FG003|Overall Study|Withdrawal by Subject|3|||
41987408|NCT01294423|75794652|FG002|Overall Study|Withdrawal by Subject|2|||
41987409|NCT01294423|75794650|FG000|Overall Study|subject no longer meets study criteria|2|||
41987410|NCT01294423|75794651|FG001|Overall Study|subject no longer meets study criteria|5|||
42234481|NCT04535453|76055969|FG004|Overall Study|Withdrawal by Subject|2|||
42234482|NCT04535453|76055970|FG005|Overall Study|Withdrawal by Subject|1|||
42234483|NCT04535453|76055971|FG006|Overall Study|Withdrawal by Subject|1|||
42234484|NCT04535453|76055972|FG007|Overall Study|Withdrawal by Subject|1|||
42234485|NCT04535453|76055973|FG008|Overall Study|Withdrawal by Subject|1|||
42234486|NCT04535453|76055974|FG009|Overall Study|Withdrawal by Subject|1|||
42234487|NCT04535453|76055975|FG010|Overall Study|Withdrawal by Subject|0|||
42234488|NCT04535453|76055976|FG011|Overall Study|Withdrawal by Subject|1|||
42234489|NCT04535453|76055965|FG000|Overall Study|Other|0|||
42234490|NCT04535453|76055966|FG001|Overall Study|Other|0|||
42234491|NCT04535453|76055967|FG002|Overall Study|Other|1|||
42234492|NCT04535453|76055968|FG003|Overall Study|Other|0|||
42234493|NCT04535453|76055969|FG004|Overall Study|Other|1|||
42234494|NCT04535453|76055970|FG005|Overall Study|Other|0|||
42234495|NCT04535453|76055971|FG006|Overall Study|Other|1|||
42234496|NCT04535453|76055972|FG007|Overall Study|Other|1|||
42234497|NCT04535453|76055973|FG008|Overall Study|Other|1|||
42234498|NCT04535453|76055974|FG009|Overall Study|Other|0|||
42234499|NCT04535453|76055975|FG010|Overall Study|Other|0|||
42234500|NCT04535453|76055976|FG011|Overall Study|Other|0|||
42234501|NCT04463069|76056019|FG000|Overall Study|Withdrawal by Subject|2|||
42234502|NCT04463069|76056020|FG001|Overall Study|Withdrawal by Subject|10|||
42234503|NCT04463069|76056019|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
42234504|NCT04463069|76056020|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
42234505|NCT03521687|76056026|FG000|Overall Study|Adverse Event|4|||
42234506|NCT03521687|76056026|FG000|Overall Study|Physician Decision|1|||
42234507|NCT03125915|76056034|FG000|1 Month Follow up|Lost to Follow-up|3|||
42234508|NCT03125915|76056035|FG001|1 Month Follow up|Lost to Follow-up|3|||
42234509|NCT03125915|76056036|FG002|1 Month Follow up|Lost to Follow-up|2|||
42234510|NCT03125915|76056037|FG003|1 Month Follow up|Lost to Follow-up|3|||
42234511|NCT03125915|76056034|FG000|3 Month Follow-up|Lost to Follow-up|6|||
42234512|NCT03125915|76056035|FG001|3 Month Follow-up|Lost to Follow-up|4|||
42234513|NCT03125915|76056036|FG002|3 Month Follow-up|Lost to Follow-up|4|||
42234514|NCT03125915|76056037|FG003|3 Month Follow-up|Lost to Follow-up|2|||
42234515|NCT03125915|76056034|FG000|6 Month Follow-up|Lost to Follow-up|7|||
42234516|NCT03125915|76056035|FG001|6 Month Follow-up|Lost to Follow-up|3|||
42234517|NCT03125915|76056036|FG002|6 Month Follow-up|Lost to Follow-up|6|||
42234518|NCT03125915|76056037|FG003|6 Month Follow-up|Lost to Follow-up|3|||
42234519|NCT03122171|76056047|FG000|Overall Study|Withdrawal by Subject|1|||
42234520|NCT01427725|76056051|FG000|Overall Study|Lost to Follow-up|17|||
42234521|NCT01427725|76056051|FG000|Overall Study|Protocol Violation|1|||
42234522|NCT01427725|76056051|FG000|Overall Study|Drug not administered|1|||
42234523|NCT01427725|76056051|FG000|Overall Study|Failure to visit|7|||
42234524|NCT01427725|76056051|FG000|Overall Study|Adverse Event|46|||
42234525|NCT01427725|76056051|FG000|Overall Study|Failure to visit after administration|40|||
42234526|NCT01427725|76056051|FG000|Overall Study|Patient's rejection|27|||
42234527|NCT01427725|76056051|FG000|Overall Study|Transfer to a different hospital|17|||
42234528|NCT01427725|76056051|FG000|Overall Study|Lack of Efficacy|8|||
42234529|NCT01427725|76056051|FG000|Overall Study|Death|7|||
42234530|NCT01427725|76056051|FG000|Overall Study|Symptom improvement|6|||
42234531|NCT01427725|76056051|FG000|Overall Study|AE and Patient's rejection|5|||
42234532|NCT01427725|76056051|FG000|Overall Study|Physician Decision|5|||
42234533|NCT01427725|76056051|FG000|Overall Study|Exacerbation of underlying disease|5|||
42234534|NCT01427725|76056051|FG000|Overall Study|Oral feeding difficulty|5|||
42234535|NCT01427725|76056051|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
42234536|NCT01427725|76056051|FG000|Overall Study|Forgetting prescription|1|||
42234537|NCT01427725|76056051|FG000|Overall Study|Other|2|||
42234538|NCT02839200|76056062|FG000|Overall Study|Withdrawal by Subject|2|||
42234539|NCT02839200|76056063|FG001|Overall Study|Withdrawal by Subject|0|||
42234540|NCT02839200|76056064|FG002|Overall Study|Withdrawal by Subject|1|||
42234541|NCT02839200|76056065|FG003|Overall Study|Withdrawal by Subject|0|||
42234542|NCT02839200|76056066|FG004|Overall Study|Withdrawal by Subject|0|||
42234543|NCT02839200|76056067|FG005|Overall Study|Withdrawal by Subject|1|||
42234544|NCT02839200|76056062|FG000|Overall Study|Lost to Follow-up|2|||
42234545|NCT02839200|76056063|FG001|Overall Study|Lost to Follow-up|0|||
42234546|NCT02839200|76056064|FG002|Overall Study|Lost to Follow-up|0|||
42234547|NCT02839200|76056065|FG003|Overall Study|Lost to Follow-up|0|||
42234548|NCT02839200|76056066|FG004|Overall Study|Lost to Follow-up|1|||
42234549|NCT02839200|76056067|FG005|Overall Study|Lost to Follow-up|0|||
42234550|NCT02839200|76056062|FG000|Overall Study|Adverse Event|0|||
42234551|NCT02839200|76056063|FG001|Overall Study|Adverse Event|0|||
42234552|NCT02839200|76056064|FG002|Overall Study|Adverse Event|0|||
42234553|NCT02839200|76056065|FG003|Overall Study|Adverse Event|0|||
42234554|NCT02839200|76056066|FG004|Overall Study|Adverse Event|1|||
42234555|NCT02839200|76056067|FG005|Overall Study|Adverse Event|0|||
42234556|NCT02839200|76056062|FG000|Overall Study|Randomized in error|0|||
42234557|NCT02839200|76056063|FG001|Overall Study|Randomized in error|1|||
42234558|NCT02839200|76056064|FG002|Overall Study|Randomized in error|0|||
42234559|NCT02839200|76056065|FG003|Overall Study|Randomized in error|0|||
42234560|NCT02839200|76056066|FG004|Overall Study|Randomized in error|0|||
42234561|NCT02839200|76056067|FG005|Overall Study|Randomized in error|0|||
42234562|NCT03118739|76056083|FG000|Overall Study|Physician Decision|0|||
42234563|NCT03118739|76056084|FG001|Overall Study|Physician Decision|1|||
42234564|NCT03118739|76056083|FG000|Overall Study|Withdrawal by Subject|5|||
42234565|NCT03118739|76056084|FG001|Overall Study|Withdrawal by Subject|3|||
42234566|NCT03118739|76056083|FG000|Overall Study|Lost to Follow-up|2|||
42234567|NCT03118739|76056084|FG001|Overall Study|Lost to Follow-up|0|||
42234568|NCT03094195|76056093|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
42234569|NCT03094195|76056094|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
42234570|NCT03094195|76056095|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
42234571|NCT03094195|76056096|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
42234572|NCT03094195|76056097|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
42234573|NCT03094195|76056098|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
42234574|NCT03094195|76056099|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
42234575|NCT03094195|76056100|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
42234576|NCT03094195|76056093|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
42234577|NCT03094195|76056094|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
42234578|NCT03094195|76056095|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
42234579|NCT03094195|76056096|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
42234580|NCT03094195|76056097|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
42234581|NCT03094195|76056098|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
42234582|NCT03094195|76056099|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
42234583|NCT03094195|76056100|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
42234584|NCT03094195|76056093|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
42234585|NCT03094195|76056094|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
42234586|NCT03094195|76056095|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
42234587|NCT03094195|76056096|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
42234588|NCT03094195|76056097|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
42234589|NCT03094195|76056098|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
42234590|NCT03094195|76056099|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
42234591|NCT03094195|76056100|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
42234592|NCT03094195|76056093|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
42234593|NCT03094195|76056094|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
42131855|NCT00332488|75942738|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
42234594|NCT03094195|76056095|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
42234595|NCT03094195|76056096|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
42234596|NCT03094195|76056097|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
42234597|NCT03094195|76056098|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
42234598|NCT03094195|76056099|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
42234599|NCT03094195|76056100|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
42234600|NCT02835690|76056121|FG000|Overall Study|Death|12|||
42234601|NCT02835690|76056122|FG001|Overall Study|Death|11|||
42234602|NCT02835690|76056123|FG002|Overall Study|Death|13|||
42234603|NCT02835690|76056121|FG000|Overall Study|Transferred to Extension Study|2|||
42234604|NCT02835690|76056122|FG001|Overall Study|Transferred to Extension Study|2|||
42234605|NCT02835690|76056123|FG002|Overall Study|Transferred to Extension Study|1|||
42234606|NCT02835690|76056121|FG000|Overall Study|Did Not Continue on Extension Study|0|||
42234607|NCT02835690|76056122|FG001|Overall Study|Did Not Continue on Extension Study|0|||
42234608|NCT02835690|76056123|FG002|Overall Study|Did Not Continue on Extension Study|1|||
42234609|NCT02835690|76056121|FG000|Overall Study|Not Treated|0|||
42234610|NCT02835690|76056122|FG001|Overall Study|Not Treated|2|||
42234611|NCT02835690|76056123|FG002|Overall Study|Not Treated|0|||
42234612|NCT02837952|76056134|FG000|Overall Study|Adverse Event|0|||
42234613|NCT02837952|76056135|FG001|Overall Study|Adverse Event|1|||
42234614|NCT02837952|76056134|FG000|Overall Study|Withdrawal by Subject|4|||
42234615|NCT02837952|76056135|FG001|Overall Study|Withdrawal by Subject|5|||
42234616|NCT02837952|76056134|FG000|Overall Study|Medication Error|1|||
42234617|NCT02837952|76056135|FG001|Overall Study|Medication Error|0|||
42234618|NCT02832167|76056141|FG000|Treatment Period 1|Disease progression|90|||
42234619|NCT02832167|76056141|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
42234620|NCT02832167|76056141|FG000|Treatment Period 1|Death|2|||
42234621|NCT02832167|76056141|FG000|Treatment Period 1|Study Drug Toxicity|6|||
42234622|NCT02832167|76056141|FG000|Treatment Period 1|Participant request to discontinue|9|||
42234623|NCT02832167|76056141|FG000|Treatment Period 1|No longer meet study criteria|1|||
42234624|NCT02832167|76056141|FG000|Treatment Period 1|Participant withdrew consent|3|||
42234625|NCT02832167|76056141|FG000|Treatment Period 1|Other reasons|6|||
42234626|NCT02832167|76056141|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
42234627|NCT02832167|76056141|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
42234628|NCT02832167|76056141|FG000|Transition From Period 1 to Period 2|Death|2|||
42234629|NCT02832167|76056141|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
42234630|NCT02832167|76056141|FG000|Treatment Period 2|Disease progression|69|||
42234631|NCT02832167|76056141|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
42234632|NCT02832167|76056141|FG000|Treatment Period 2|Maximum clinical benefit|1|||
42234633|NCT02832167|76056141|FG000|Treatment Period 2|Study Drug Toxicity|5|||
42234634|NCT02832167|76056141|FG000|Treatment Period 2|Participant request to discontinue|2|||
42234635|NCT02832167|76056141|FG000|Treatment Period 2|Participant withdrew consent|3|||
42234636|NCT02832167|76056141|FG000|Treatment Period 2|Other reasons|3|||
42234637|NCT02674529|76056147|FG000|Overall Study|Lost to Follow-up|1|||
42234638|NCT02674529|76056148|FG001|Overall Study|Lost to Follow-up|2|||
42234639|NCT02674529|76056147|FG000|Overall Study|Withdrawal by Subject|2|||
42234640|NCT02674529|76056148|FG001|Overall Study|Withdrawal by Subject|1|||
42234641|NCT02674529|76056147|FG000|Overall Study|Physician Decision|0|||
42234642|NCT02674529|76056148|FG001|Overall Study|Physician Decision|1|||
42234643|NCT02674529|76056147|FG000|Overall Study|Protocol Violation|0|||
42234644|NCT02674529|76056148|FG001|Overall Study|Protocol Violation|1|||
42234645|NCT02626949|76056159|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
42234646|NCT02626949|76056160|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
42234647|NCT02626949|76056159|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
42234648|NCT02626949|76056160|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
42234649|NCT02626949|76056159|FG000|Enrolled|Lost to Follow-up|7|||
42234650|NCT02626949|76056160|FG001|Enrolled|Lost to Follow-up|6|||
42234651|NCT02626949|76056159|FG000|Enrolled|Withdrawal by Subject|3|||
42234652|NCT02626949|76056160|FG001|Enrolled|Withdrawal by Subject|2|||
42234653|NCT03116399|76056168|FG000|Overall Study|Death|8|||
42234654|NCT03116399|76056169|FG001|Overall Study|Death|3|||
42234655|NCT03116399|76056168|FG000|Overall Study|Lost to Follow-up|7|||
42234656|NCT03116399|76056169|FG001|Overall Study|Lost to Follow-up|11|||
42234657|NCT03116399|76056168|FG000|Overall Study|Investigator Decision|1|||
42234658|NCT03116399|76056169|FG001|Overall Study|Investigator Decision|1|||
42234659|NCT03116399|76056168|FG000|Overall Study|Withdrawal by Subject|24|||
42234660|NCT03116399|76056169|FG001|Overall Study|Withdrawal by Subject|9|||
42234661|NCT03097861|76056178|FG000|Overall Study|Adverse Event|3|||
42234662|NCT03097861|76056179|FG001|Overall Study|Adverse Event|8|||
42234663|NCT03097861|76056180|FG002|Overall Study|Adverse Event|4|||
42234664|NCT03097861|76056178|FG000|Overall Study|Investigator Decision|0|||
42234665|NCT03097861|76056179|FG001|Overall Study|Investigator Decision|1|||
42234666|NCT03097861|76056180|FG002|Overall Study|Investigator Decision|0|||
42234667|NCT03097861|76056178|FG000|Overall Study|Lost to Follow-up|0|||
42234668|NCT03097861|76056179|FG001|Overall Study|Lost to Follow-up|7|||
42234669|NCT03097861|76056180|FG002|Overall Study|Lost to Follow-up|1|||
42234670|NCT03097861|76056178|FG000|Overall Study|Withdrawal by Subject|1|||
42234671|NCT03097861|76056179|FG001|Overall Study|Withdrawal by Subject|5|||
42234672|NCT03097861|76056180|FG002|Overall Study|Withdrawal by Subject|3|||
42234673|NCT03097861|76056178|FG000|Overall Study|Reason not provided|3|||
42234674|NCT03097861|76056179|FG001|Overall Study|Reason not provided|1|||
42234675|NCT03097861|76056180|FG002|Overall Study|Reason not provided|1|||
42234676|NCT01816139|76056196|FG000|Overall Study|Adverse Event|6|||
42234677|NCT01816139|76056197|FG001|Overall Study|Adverse Event|8|||
42234678|NCT01816139|76056196|FG000|Overall Study|Lack of Efficacy|1|||
42234679|NCT01816139|76056197|FG001|Overall Study|Lack of Efficacy|2|||
42234680|NCT01816139|76056196|FG000|Overall Study|Lost to Follow-up|5|||
42234681|NCT01816139|76056197|FG001|Overall Study|Lost to Follow-up|3|||
42234682|NCT01816139|76056196|FG000|Overall Study|Withdrew Consent|6|||
42234683|NCT01816139|76056197|FG001|Overall Study|Withdrew Consent|4|||
42234684|NCT01816139|76056196|FG000|Overall Study|Protocol Violation|6|||
42234685|NCT01816139|76056197|FG001|Overall Study|Protocol Violation|3|||
42234686|NCT01816139|76056196|FG000|Overall Study|Reason not Specified|4|||
42234687|NCT01816139|76056197|FG001|Overall Study|Reason not Specified|2|||
42234688|NCT02833350|76056240|FG000|Overall Study|Adverse Event|0|||
42234689|NCT02833350|76056241|FG001|Overall Study|Adverse Event|3|||
42234690|NCT02833350|76056242|FG002|Overall Study|Adverse Event|4|||
42234691|NCT02833350|76056243|FG003|Overall Study|Adverse Event|4|||
42234692|NCT02833350|76056244|FG004|Overall Study|Adverse Event|1|||
42234693|NCT02833350|76056245|FG005|Overall Study|Adverse Event|0|||
42234694|NCT02833350|76056246|FG006|Overall Study|Adverse Event|1|||
42234695|NCT02833350|76056240|FG000|Overall Study|Death|0|||
42234696|NCT02833350|76056241|FG001|Overall Study|Death|0|||
42234697|NCT02833350|76056242|FG002|Overall Study|Death|1|||
42234698|NCT02833350|76056243|FG003|Overall Study|Death|0|||
42234699|NCT02833350|76056244|FG004|Overall Study|Death|0|||
42234700|NCT02833350|76056245|FG005|Overall Study|Death|0|||
42234701|NCT02833350|76056246|FG006|Overall Study|Death|0|||
42234702|NCT02833350|76056240|FG000|Overall Study|Lack of Efficacy|0|||
42234703|NCT02833350|76056241|FG001|Overall Study|Lack of Efficacy|2|||
42234704|NCT02833350|76056242|FG002|Overall Study|Lack of Efficacy|1|||
42234705|NCT02833350|76056243|FG003|Overall Study|Lack of Efficacy|4|||
42234706|NCT02833350|76056244|FG004|Overall Study|Lack of Efficacy|0|||
42234707|NCT02833350|76056245|FG005|Overall Study|Lack of Efficacy|1|||
42234708|NCT02833350|76056246|FG006|Overall Study|Lack of Efficacy|1|||
42234709|NCT02833350|76056240|FG000|Overall Study|Lost to Follow-up|0|||
42234710|NCT02833350|76056241|FG001|Overall Study|Lost to Follow-up|1|||
42234711|NCT02833350|76056242|FG002|Overall Study|Lost to Follow-up|0|||
42234712|NCT02833350|76056243|FG003|Overall Study|Lost to Follow-up|0|||
42234713|NCT02833350|76056244|FG004|Overall Study|Lost to Follow-up|0|||
42234714|NCT02833350|76056245|FG005|Overall Study|Lost to Follow-up|0|||
42234715|NCT02833350|76056246|FG006|Overall Study|Lost to Follow-up|1|||
42234716|NCT02833350|76056240|FG000|Overall Study|Withdrawal by Subject|3|||
42234717|NCT02833350|76056241|FG001|Overall Study|Withdrawal by Subject|3|||
42234718|NCT02833350|76056242|FG002|Overall Study|Withdrawal by Subject|2|||
42234719|NCT02833350|76056243|FG003|Overall Study|Withdrawal by Subject|0|||
42234720|NCT02833350|76056244|FG004|Overall Study|Withdrawal by Subject|2|||
42234721|NCT02833350|76056245|FG005|Overall Study|Withdrawal by Subject|0|||
42234722|NCT02833350|76056246|FG006|Overall Study|Withdrawal by Subject|2|||
42234723|NCT01343043|76056269|FG000|Overall Study|Disease progression before treatment|1|||
42234724|NCT01343043|76056270|FG001|Overall Study|Disease progression before treatment|0|||
42234725|NCT01343043|76056271|FG002|Overall Study|Disease progression before treatment|0|||
42234726|NCT01343043|76056272|FG003|Overall Study|Disease progression before treatment|0|||
42234727|NCT01343043|76056269|FG000|Overall Study|Withdrawal by Subject|1|||
42234728|NCT01343043|76056270|FG001|Overall Study|Withdrawal by Subject|0|||
42234729|NCT01343043|76056271|FG002|Overall Study|Withdrawal by Subject|0|||
42234730|NCT01343043|76056272|FG003|Overall Study|Withdrawal by Subject|0|||
42234731|NCT01343043|76056269|FG000|Overall Study|Death|1|||
42234732|NCT01343043|76056270|FG001|Overall Study|Death|1|||
42234733|NCT01343043|76056271|FG002|Overall Study|Death|0|||
42234734|NCT01343043|76056272|FG003|Overall Study|Death|1|||
42234735|NCT03548987|76056287|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
42234736|NCT03548987|76056288|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
42234737|NCT03548987|76056287|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
42234738|NCT03548987|76056288|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
42234739|NCT03548987|76056287|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
42234740|NCT03548987|76056288|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
42234741|NCT03548987|76056287|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
42234742|NCT03548987|76056288|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
42234743|NCT03548987|76056287|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
42234744|NCT03548987|76056288|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
42234745|NCT03548987|76056287|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
42234746|NCT03548987|76056288|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
42234747|NCT03548987|76056287|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
42234748|NCT03548987|76056288|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
42234749|NCT03548987|76056287|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
42234750|NCT03548987|76056288|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
42302561|NCT02416453|76137791|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
42234751|NCT03548987|76056287|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
42234752|NCT03548987|76056288|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
42234753|NCT03548987|76056287|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
42234754|NCT03548987|76056288|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
42234755|NCT03548987|76056287|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
42234756|NCT03548987|76056288|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
42234757|NCT03548987|76056287|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
42234758|NCT03548987|76056288|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
42234759|NCT03548987|76056287|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
42234760|NCT03548987|76056288|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
42234761|NCT03548987|76056287|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
42234762|NCT03548987|76056288|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
42234763|NCT01358760|76056298|FG000|Overall Study|Adverse Event|3|||
42234764|NCT01358760|76056299|FG001|Overall Study|Adverse Event|4|||
42234765|NCT01358760|76056300|FG002|Overall Study|Adverse Event|3|||
42234766|NCT01358760|76056298|FG000|Overall Study|Lost to Follow-up|1|||
42234767|NCT01358760|76056299|FG001|Overall Study|Lost to Follow-up|1|||
42234768|NCT01358760|76056300|FG002|Overall Study|Lost to Follow-up|3|||
42234769|NCT01358760|76056298|FG000|Overall Study|Withdrawal by Subject|5|||
42234770|NCT01358760|76056299|FG001|Overall Study|Withdrawal by Subject|3|||
42234771|NCT01358760|76056300|FG002|Overall Study|Withdrawal by Subject|2|||
42234772|NCT01358760|76056298|FG000|Overall Study|Physician Decision|1|||
42234773|NCT01358760|76056299|FG001|Overall Study|Physician Decision|0|||
42234774|NCT01358760|76056300|FG002|Overall Study|Physician Decision|1|||
42234775|NCT01358760|76056298|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
42234776|NCT01358760|76056299|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
42234777|NCT01358760|76056300|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
42234778|NCT01341990|76056310|FG000|Overall Study|Adverse Event|0|||
42234779|NCT01341990|76056311|FG001|Overall Study|Adverse Event|1|||
42234780|NCT01341990|76056310|FG000|Overall Study|Torn Study Lens|1|||
42234781|NCT01341990|76056311|FG001|Overall Study|Torn Study Lens|0|||
42234782|NCT01341990|76056310|FG000|Overall Study|Withdrawal by Subject|2|||
42234783|NCT01341990|76056311|FG001|Overall Study|Withdrawal by Subject|0|||
42234784|NCT03048747|76056317|FG000|Overall Study|Adverse Event|2|||
42234785|NCT03048747|76056317|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
42234786|NCT03048747|76056317|FG000|Overall Study|Physician Decision|1|||
42234787|NCT01991067|76056379|FG000|Overall Study|Lost to Follow-up|6|||
42234788|NCT01991067|76056380|FG001|Overall Study|Lost to Follow-up|5|||
42234789|NCT01709331|76056386|FG000|Overall Study|Adverse Event|1|||
42234790|NCT03255083|76056394|FG000|Overall Study|Clinical progression|1|||
42234791|NCT03255083|76056395|FG001|Overall Study|Clinical progression|0|||
42234792|NCT03255083|76056396|FG002|Overall Study|Clinical progression|0|||
42234793|NCT03255083|76056397|FG003|Overall Study|Clinical progression|0|||
42234794|NCT03255083|76056394|FG000|Overall Study|Adverse Event|0|||
42234795|NCT03255083|76056395|FG001|Overall Study|Adverse Event|1|||
42234796|NCT03255083|76056396|FG002|Overall Study|Adverse Event|0|||
42234797|NCT03255083|76056397|FG003|Overall Study|Adverse Event|0|||
42234798|NCT03255083|76056394|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
42234799|NCT03255083|76056395|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
42234800|NCT03255083|76056396|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
42234801|NCT03255083|76056397|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
42234802|NCT03255083|76056394|FG000|Overall Study|Withdrawal by Subject|1|||
42234803|NCT03255083|76056395|FG001|Overall Study|Withdrawal by Subject|1|||
42234804|NCT03255083|76056396|FG002|Overall Study|Withdrawal by Subject|1|||
42234805|NCT03255083|76056397|FG003|Overall Study|Withdrawal by Subject|0|||
42234806|NCT04552587|76056413|FG000|Overall Study|Lost to Follow-up|4|||
42234807|NCT01316055|76056429|FG000|Overall Study|Lost to Follow-up|1|||
42234808|NCT01316055|76056430|FG001|Overall Study|Lost to Follow-up|0|||
42234809|NCT01316055|76056431|FG002|Overall Study|Lost to Follow-up|0|||
42234810|NCT01340976|76056448|FG000|Overall Study|Physician Decision|2|||
42234811|NCT01340976|76056449|FG001|Overall Study|Physician Decision|0|||
42234812|NCT01340976|76056450|FG002|Overall Study|Physician Decision|1|||
42234813|NCT01340976|76056451|FG003|Overall Study|Physician Decision|1|||
42234814|NCT01340976|76056452|FG004|Overall Study|Physician Decision|1|||
42234815|NCT01340976|76056453|FG005|Overall Study|Physician Decision|0|||
42234816|NCT01340976|76056448|FG000|Overall Study|Death|0|||
42234817|NCT01340976|76056449|FG001|Overall Study|Death|1|||
42234818|NCT01340976|76056450|FG002|Overall Study|Death|0|||
42234819|NCT01340976|76056451|FG003|Overall Study|Death|0|||
42234820|NCT01340976|76056452|FG004|Overall Study|Death|0|||
42234821|NCT01340976|76056453|FG005|Overall Study|Death|0|||
42234822|NCT01340976|76056448|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
42234823|NCT01340976|76056449|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
42234824|NCT01340976|76056450|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
42234825|NCT01340976|76056451|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
42234826|NCT01340976|76056452|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
42234827|NCT01340976|76056453|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
42234828|NCT01340976|76056448|FG000|Overall Study|Withdrawal by Subject|0|||
42234829|NCT01340976|76056449|FG001|Overall Study|Withdrawal by Subject|0|||
42234830|NCT01340976|76056450|FG002|Overall Study|Withdrawal by Subject|0|||
42234831|NCT01340976|76056451|FG003|Overall Study|Withdrawal by Subject|1|||
42234832|NCT01340976|76056452|FG004|Overall Study|Withdrawal by Subject|1|||
42234833|NCT01340976|76056453|FG005|Overall Study|Withdrawal by Subject|0|||
42234834|NCT01340976|76056448|FG000|Overall Study|Other anemia treatment|1|||
42234835|NCT01340976|76056449|FG001|Overall Study|Other anemia treatment|0|||
42234836|NCT01340976|76056450|FG002|Overall Study|Other anemia treatment|2|||
42234837|NCT01340976|76056451|FG003|Overall Study|Other anemia treatment|1|||
41987411|NCT01294423|75794652|FG002|Overall Study|subject no longer meets study criteria|2|||
41987412|NCT01294423|75794650|FG000|Overall Study|poor/non-compliance|1|||
42234838|NCT01340976|76056452|FG004|Overall Study|Other anemia treatment|0|||
42234839|NCT01340976|76056453|FG005|Overall Study|Other anemia treatment|1|||
42234840|NCT01340976|76056448|FG000|Overall Study|Adverse Event|0|||
42234841|NCT01340976|76056449|FG001|Overall Study|Adverse Event|1|||
42234842|NCT01340976|76056450|FG002|Overall Study|Adverse Event|0|||
42234843|NCT01340976|76056451|FG003|Overall Study|Adverse Event|0|||
42234844|NCT01340976|76056452|FG004|Overall Study|Adverse Event|0|||
42234845|NCT01340976|76056453|FG005|Overall Study|Adverse Event|0|||
42234846|NCT01680016|76056475|FG000|Overall Study|Adverse Event|0|||
42234847|NCT01680016|76056476|FG001|Overall Study|Adverse Event|0|||
42234848|NCT01680016|76056477|FG002|Overall Study|Adverse Event|1|||
42234849|NCT01680016|76056478|FG003|Overall Study|Adverse Event|4|||
42234850|NCT01680016|76056475|FG000|Overall Study|The Subject went out of The Trial|1|||
42234851|NCT01680016|76056476|FG001|Overall Study|The Subject went out of The Trial|0|||
42234852|NCT01680016|76056477|FG002|Overall Study|The Subject went out of The Trial|3|||
42234853|NCT01680016|76056478|FG003|Overall Study|The Subject went out of The Trial|0|||
42234854|NCT01680016|76056475|FG000|Overall Study|Protocol Violation|0|||
42234855|NCT01680016|76056476|FG001|Overall Study|Protocol Violation|1|||
42234856|NCT01680016|76056477|FG002|Overall Study|Protocol Violation|0|||
42234857|NCT01680016|76056478|FG003|Overall Study|Protocol Violation|0|||
42234858|NCT01680016|76056475|FG000|Overall Study|Withdrawal by Subject|5|||
42234859|NCT01680016|76056476|FG001|Overall Study|Withdrawal by Subject|7|||
42234860|NCT01680016|76056477|FG002|Overall Study|Withdrawal by Subject|1|||
42234861|NCT01680016|76056478|FG003|Overall Study|Withdrawal by Subject|1|||
42234862|NCT01340898|76056503|FG000|Primary Phase|Serious Adverse Events|0|||
42234863|NCT01340898|76056504|FG001|Primary Phase|Serious Adverse Events|0|||
42234864|NCT01340898|76056505|FG002|Primary Phase|Serious Adverse Events|1|||
42234865|NCT01340898|76056503|FG000|Primary Phase|Withdrawal by Subject|8|||
42234866|NCT01340898|76056504|FG001|Primary Phase|Withdrawal by Subject|7|||
42234867|NCT01340898|76056505|FG002|Primary Phase|Withdrawal by Subject|5|||
42234868|NCT01340898|76056503|FG000|Primary Phase|Migrated/moved from study area|4|||
42234869|NCT01340898|76056504|FG001|Primary Phase|Migrated/moved from study area|1|||
42234870|NCT01340898|76056505|FG002|Primary Phase|Migrated/moved from study area|0|||
41987413|NCT01294423|75794651|FG001|Overall Study|poor/non-compliance|0|||
41987414|NCT01294423|75794652|FG002|Overall Study|poor/non-compliance|1|||
41987415|NCT01294150|75794662|FG000|Overall Study|Physician Decision|2|||
41987416|NCT01294150|75794663|FG001|Overall Study|Physician Decision|2|||
41987417|NCT01292473|75794675|FG000|Overall Study|Adverse Event|1|||
41987418|NCT01292473|75794676|FG001|Overall Study|Adverse Event|0|||
41987419|NCT01292473|75794677|FG002|Overall Study|Adverse Event|1|||
41987420|NCT01292473|75794678|FG003|Overall Study|Adverse Event|1|||
42234871|NCT01340898|76056503|FG000|Primary Phase|Lost to Follow-up|4|||
42234872|NCT01340898|76056504|FG001|Primary Phase|Lost to Follow-up|1|||
42234873|NCT01340898|76056505|FG002|Primary Phase|Lost to Follow-up|0|||
42234874|NCT01340898|76056503|FG000|Booster Phase|Withdrawal by Subject|3|||
42234875|NCT01340898|76056504|FG001|Booster Phase|Withdrawal by Subject|0|||
42234876|NCT01340898|76056505|FG002|Booster Phase|Withdrawal by Subject|4|||
41987421|NCT01292473|75794675|FG000|Overall Study|Lost to Follow-up|1|||
41987422|NCT01292473|75794676|FG001|Overall Study|Lost to Follow-up|1|||
42234877|NCT01340898|76056503|FG000|Booster Phase|Migrated/moved from study area|3|||
42234878|NCT01340898|76056504|FG001|Booster Phase|Migrated/moved from study area|0|||
42234879|NCT01340898|76056505|FG002|Booster Phase|Migrated/moved from study area|0|||
42234880|NCT01340898|76056503|FG000|Booster Phase|Lost to Follow-up|4|||
42234881|NCT01340898|76056504|FG001|Booster Phase|Lost to Follow-up|2|||
42234882|NCT01340898|76056505|FG002|Booster Phase|Lost to Follow-up|3|||
42302562|NCT02416453|76137792|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
41987423|NCT01292473|75794677|FG002|Overall Study|Lost to Follow-up|2|||
41987424|NCT01292473|75794678|FG003|Overall Study|Lost to Follow-up|2|||
41987425|NCT01292473|75794675|FG000|Overall Study|Withdrawal by Subject|3|||
42234883|NCT03097315|76056526|FG000|Overall Study|Withdrawal by Subject|1|||
42234884|NCT03039699|76056532|FG000|Overall Study|Incorrect inclusion|5|||
42234885|NCT03039699|76056533|FG001|Overall Study|Incorrect inclusion|4|||
42234886|NCT03039699|76056532|FG000|Overall Study|Lack of data to assess study endpoint|5|||
42234887|NCT03039699|76056533|FG001|Overall Study|Lack of data to assess study endpoint|3|||
42234888|NCT03039699|76056532|FG000|Overall Study|Bacterial infection|12|||
42234889|NCT03039699|76056533|FG001|Overall Study|Bacterial infection|28|||
42234890|NCT02833974|76056541|FG000|Overall Study|Lost to Follow-up|1|||
42234891|NCT02833974|76056542|FG001|Overall Study|Lost to Follow-up|0|||
42234892|NCT02833974|76056541|FG000|Overall Study|Adverse Event|0|||
42234893|NCT02833974|76056542|FG001|Overall Study|Adverse Event|3|||
42234894|NCT03093415|76056551|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
42234895|NCT03093415|76056552|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
42234896|NCT03093415|76056553|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
42234897|NCT03093415|76056551|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
42234898|NCT03093415|76056552|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
42234899|NCT03093415|76056553|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
42234900|NCT03093415|76056551|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
42234901|NCT03093415|76056552|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
42234902|NCT03093415|76056553|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
42234903|NCT03093415|76056551|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
41987426|NCT01292473|75794676|FG001|Overall Study|Withdrawal by Subject|4|||
41987427|NCT01292473|75794677|FG002|Overall Study|Withdrawal by Subject|3|||
41987428|NCT01292473|75794678|FG003|Overall Study|Withdrawal by Subject|3|||
42234904|NCT03093415|76056552|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
42234905|NCT03093415|76056553|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
42234906|NCT03093415|76056551|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
42234907|NCT03093415|76056552|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
42234908|NCT03093415|76056553|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
42234909|NCT03093415|76056551|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
42234910|NCT03093415|76056552|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
42234911|NCT03093415|76056553|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
42234912|NCT03093415|76056551|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
42234913|NCT03093415|76056552|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
42234914|NCT03093415|76056553|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
42234915|NCT03093415|76056551|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
42234916|NCT03093415|76056552|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
42234917|NCT03093415|76056553|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
42234918|NCT03093415|76056551|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
42234919|NCT03093415|76056552|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
42234920|NCT03093415|76056553|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
42234921|NCT03093415|76056551|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
42234922|NCT03093415|76056552|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
42234923|NCT03093415|76056553|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
42234924|NCT03093415|76056551|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
41987429|NCT01292473|75794675|FG000|Overall Study|Physician Decision|0|||
41987430|NCT01292473|75794676|FG001|Overall Study|Physician Decision|1|||
41987431|NCT01292473|75794677|FG002|Overall Study|Physician Decision|0|||
41987432|NCT01292473|75794678|FG003|Overall Study|Physician Decision|0|||
41987433|NCT01292473|75794675|FG000|Overall Study|Disease Progression|0|||
41987434|NCT01292473|75794676|FG001|Overall Study|Disease Progression|1|||
41987435|NCT01292473|75794677|FG002|Overall Study|Disease Progression|3|||
41987436|NCT01292473|75794678|FG003|Overall Study|Disease Progression|6|||
41987437|NCT01292239|75794694|FG000|Overall Study|Other|1|||
41987438|NCT01292239|75794695|FG001|Overall Study|Other|1|||
41987439|NCT01292239|75794694|FG000|Overall Study|Withdrawal by Subject|3|||
42234925|NCT03093415|76056552|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
42234926|NCT03093415|76056553|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
42234927|NCT01358526|76056563|FG000|Open-label Titration Period|Adverse Event|95|||
42302563|NCT02416453|76137793|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
42302564|NCT02416453|76137794|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
42302565|NCT02416453|76137795|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
41987440|NCT01292239|75794695|FG001|Overall Study|Withdrawal by Subject|6|||
41987441|NCT01291225|75794703|FG000|Overall Study|Lost to Follow-up|85|||
41987442|NCT01291225|75794704|FG001|Overall Study|Lost to Follow-up|39|||
41987443|NCT01290796|75794714|FG000|Overall Study|Lost to Follow-up|21|||
42234928|NCT01358526|76056564|FG001|Open-label Titration Period|Adverse Event|0|||
42234929|NCT01358526|76056565|FG002|Open-label Titration Period|Adverse Event|0|||
42234930|NCT01358526|76056563|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
42234931|NCT01358526|76056564|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
42234932|NCT01358526|76056565|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
42234933|NCT01358526|76056563|FG000|Open-label Titration Period|Lost to Follow-up|25|||
42234934|NCT01358526|76056564|FG001|Open-label Titration Period|Lost to Follow-up|0|||
42234935|NCT01358526|76056565|FG002|Open-label Titration Period|Lost to Follow-up|0|||
42234936|NCT01358526|76056563|FG000|Open-label Titration Period|Lack of Efficacy|107|||
42234937|NCT01358526|76056564|FG001|Open-label Titration Period|Lack of Efficacy|0|||
42234938|NCT01358526|76056565|FG002|Open-label Titration Period|Lack of Efficacy|0|||
42234939|NCT01358526|76056563|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
42234940|NCT01358526|76056564|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
42234941|NCT01358526|76056565|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
42234942|NCT01358526|76056563|FG000|Open-label Titration Period|Administrative|8|||
42234943|NCT01358526|76056564|FG001|Open-label Titration Period|Administrative|0|||
42234944|NCT01358526|76056565|FG002|Open-label Titration Period|Administrative|0|||
42234945|NCT01358526|76056563|FG000|Open-label Titration Period|Did not qualify|178|||
42234946|NCT01358526|76056564|FG001|Open-label Titration Period|Did not qualify|0|||
42234947|NCT01358526|76056565|FG002|Open-label Titration Period|Did not qualify|0|||
42234948|NCT01358526|76056563|FG000|Double-blind Phase|Adverse Event|0|||
42234949|NCT01358526|76056564|FG001|Double-blind Phase|Adverse Event|24|||
42234950|NCT01358526|76056565|FG002|Double-blind Phase|Adverse Event|23|||
42234951|NCT01358526|76056563|FG000|Double-blind Phase|Withdrawal by Subject|0|||
42234952|NCT01358526|76056564|FG001|Double-blind Phase|Withdrawal by Subject|10|||
42234953|NCT01358526|76056565|FG002|Double-blind Phase|Withdrawal by Subject|8|||
42234954|NCT01358526|76056563|FG000|Double-blind Phase|Lost to Follow-up|0|||
42234955|NCT01358526|76056564|FG001|Double-blind Phase|Lost to Follow-up|4|||
42234956|NCT01358526|76056565|FG002|Double-blind Phase|Lost to Follow-up|1|||
42234957|NCT01358526|76056563|FG000|Double-blind Phase|Lack of Efficacy|0|||
42234958|NCT01358526|76056564|FG001|Double-blind Phase|Lack of Efficacy|31|||
42234959|NCT01358526|76056565|FG002|Double-blind Phase|Lack of Efficacy|73|||
42234960|NCT01358526|76056563|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
42234961|NCT01358526|76056564|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
42234962|NCT01358526|76056565|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
42234963|NCT01358526|76056563|FG000|Double-blind Phase|Administrative|0|||
42234964|NCT01358526|76056564|FG001|Double-blind Phase|Administrative|6|||
42234965|NCT01358526|76056565|FG002|Double-blind Phase|Administrative|10|||
42234966|NCT02830776|76056572|FG000|Overall Study|Lost to Follow-up|1|||
42234967|NCT03039621|76056579|FG000|Overall Study|Violation of inclusion criteria|3|||
42234968|NCT03039621|76056580|FG001|Overall Study|Violation of inclusion criteria|2|||
42234969|NCT03039621|76056579|FG000|Overall Study|Non-compliance with protocol requirement|4|||
42234970|NCT03039621|76056580|FG001|Overall Study|Non-compliance with protocol requirement|5|||
42234971|NCT03039621|76056579|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
42234972|NCT03039621|76056580|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
42234973|NCT03039621|76056579|FG000|Overall Study|Violation of non-inclusion criteria|1|||
42234974|NCT03039621|76056580|FG001|Overall Study|Violation of non-inclusion criteria|2|||
42234975|NCT03041181|76056588|FG000|Overall Study|Disease Progression|1|||
42234976|NCT03041181|76056589|FG001|Overall Study|Disease Progression|2|||
42234977|NCT02828436|76056595|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
42234978|NCT02828436|76056596|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
42234979|NCT02828436|76056595|FG000|Period 1|Lost to Follow-up|0|||
42234980|NCT02828436|76056596|FG001|Period 1|Lost to Follow-up|1|||
42234981|NCT02828436|76056595|FG000|Period 2|Withdrawal by Subject|4|||
42234982|NCT02828436|76056596|FG001|Period 2|Withdrawal by Subject|0|||
42234983|NCT02828436|76056595|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
42234984|NCT02828436|76056596|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
42234985|NCT02828436|76056595|FG000|Period 2|Lost to Follow-up|1|||
42302566|NCT02416453|76137796|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
42234986|NCT02828436|76056596|FG001|Period 2|Lost to Follow-up|0|||
42234987|NCT02828124|76056610|FG000|Overall Study|Disease Progression|1|||
42234988|NCT02828124|76056611|FG001|Overall Study|Disease Progression|2|||
42234989|NCT02828124|76056612|FG002|Overall Study|Disease Progression|1|||
42234990|NCT02828124|76056613|FG003|Overall Study|Disease Progression|4|||
42234991|NCT02828124|76056610|FG000|Overall Study|AE Unrelated to Study Drug|0|||
42234992|NCT02828124|76056611|FG001|Overall Study|AE Unrelated to Study Drug|0|||
42234993|NCT02828124|76056612|FG002|Overall Study|AE Unrelated to Study Drug|0|||
42234994|NCT02828124|76056613|FG003|Overall Study|AE Unrelated to Study Drug|1|||
42234995|NCT02828124|76056610|FG000|Overall Study|Subject Withdrew Consent|0|||
42234996|NCT02828124|76056611|FG001|Overall Study|Subject Withdrew Consent|0|||
42234997|NCT02828124|76056612|FG002|Overall Study|Subject Withdrew Consent|0|||
42234998|NCT02828124|76056613|FG003|Overall Study|Subject Withdrew Consent|1|||
42234999|NCT02829996|76056628|FG000|Overall Study|Withdrawal by Subject|1|||
42235000|NCT02829996|76056629|FG001|Overall Study|Withdrawal by Subject|0|||
42235001|NCT02829996|76056630|FG002|Overall Study|Withdrawal by Subject|0|||
42235002|NCT02829996|76056631|FG003|Overall Study|Withdrawal by Subject|0|||
42235003|NCT02829996|76056632|FG004|Overall Study|Withdrawal by Subject|0|||
42235004|NCT02827500|76056646|FG000|Overall Study|Death|7|||
42235005|NCT02827500|76056647|FG001|Overall Study|Death|3|||
42235006|NCT02827500|76056646|FG000|Overall Study|Lost to Follow-up|1|||
42235007|NCT02827500|76056647|FG001|Overall Study|Lost to Follow-up|1|||
42235008|NCT02827500|76056646|FG000|Overall Study|Withdrawal by Subject|3|||
42235009|NCT02827500|76056647|FG001|Overall Study|Withdrawal by Subject|1|||
42235010|NCT02827500|76056646|FG000|Overall Study|Missing primary endpoint data|3|||
42235011|NCT02827500|76056647|FG001|Overall Study|Missing primary endpoint data|1|||
42235012|NCT02827500|76056646|FG000|Overall Study|Other|5|||
42235013|NCT02827500|76056647|FG001|Overall Study|Other|1|||
42235014|NCT02826798|76056658|FG000|Overall Study|Withdrawal by Subject|0|||
42235015|NCT02826798|76056659|FG001|Overall Study|Withdrawal by Subject|1|||
42235016|NCT02826798|76056660|FG002|Overall Study|Withdrawal by Subject|0|||
42235017|NCT02826798|76056661|FG003|Overall Study|Withdrawal by Subject|1|||
42235018|NCT02826798|76056662|FG004|Overall Study|Withdrawal by Subject|0|||
42235019|NCT02829138|76056676|FG000|Overall Study|Withdrawal by Subject|1|||
42235020|NCT02829138|76056677|FG001|Overall Study|Withdrawal by Subject|0|||
42235021|NCT02825550|76056683|FG000|Overall Study|Physician Decision|1|||
42235022|NCT02744040|76056692|FG000|Overall Study|Withdrawal by Subject|3|||
42235023|NCT02744040|76056693|FG001|Overall Study|Withdrawal by Subject|2|||
42235024|NCT02744040|76056694|FG002|Overall Study|Withdrawal by Subject|2|||
42235025|NCT02744040|76056692|FG000|Overall Study|Physician Decision|0|||
42235026|NCT02744040|76056693|FG001|Overall Study|Physician Decision|8|||
42235027|NCT02744040|76056694|FG002|Overall Study|Physician Decision|13|||
42235028|NCT02744040|76056692|FG000|Overall Study|Lost to Follow-up|3|||
42235029|NCT02744040|76056693|FG001|Overall Study|Lost to Follow-up|1|||
42235030|NCT02744040|76056694|FG002|Overall Study|Lost to Follow-up|7|||
42235031|NCT02743962|76056704|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
42235032|NCT02743962|76056705|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
42235033|NCT03094416|76056714|FG000|Run-in|Screening failure|8|||
42235034|NCT03094416|76056714|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
42235035|NCT03094416|76056714|FG000|Run-in|Withdrawal by Subject|3|||
42235036|NCT03094416|76056714|FG000|Treatment Period|Withdrawal by Subject|2|||
42235037|NCT03041025|76056722|FG000|Overall Study|Adverse Event|0|||
42235038|NCT03041025|76056723|FG001|Overall Study|Adverse Event|0|||
42235039|NCT03041025|76056724|FG002|Overall Study|Adverse Event|1|||
42235040|NCT03041025|76056722|FG000|Overall Study|Lost to Follow-up|1|||
42235041|NCT03041025|76056723|FG001|Overall Study|Lost to Follow-up|0|||
42235042|NCT03041025|76056724|FG002|Overall Study|Lost to Follow-up|0|||
42235043|NCT03041025|76056722|FG000|Overall Study|Withdrawal by Subject|0|||
42235044|NCT03041025|76056723|FG001|Overall Study|Withdrawal by Subject|0|||
42235045|NCT03041025|76056724|FG002|Overall Study|Withdrawal by Subject|1|||
42235046|NCT01338870|76056741|FG000|Overall Study|Lost to Follow-up|0|||
42235047|NCT01338870|76056742|FG001|Overall Study|Lost to Follow-up|0|||
42235048|NCT01338870|76056743|FG002|Overall Study|Lost to Follow-up|1|||
42235049|NCT01338870|76056744|FG003|Overall Study|Lost to Follow-up|0|||
42235050|NCT01338870|76056745|FG004|Overall Study|Lost to Follow-up|1|||
42235051|NCT01338870|76056746|FG005|Overall Study|Lost to Follow-up|0|||
42235052|NCT01338870|76056741|FG000|Overall Study|Withdrawal by Subject|2|||
42032587|NCT01193582|75840830|FG002|Vaccination Series|Withdrawal by Subject|8|||
42235053|NCT01338870|76056742|FG001|Overall Study|Withdrawal by Subject|3|||
42235054|NCT01338870|76056743|FG002|Overall Study|Withdrawal by Subject|4|||
42235055|NCT01338870|76056744|FG003|Overall Study|Withdrawal by Subject|0|||
42235056|NCT01338870|76056745|FG004|Overall Study|Withdrawal by Subject|0|||
42235057|NCT01338870|76056746|FG005|Overall Study|Withdrawal by Subject|2|||
42235058|NCT01338870|76056741|FG000|Overall Study|Other|3|||
42235059|NCT01338870|76056742|FG001|Overall Study|Other|3|||
42235060|NCT01338870|76056743|FG002|Overall Study|Other|3|||
42235061|NCT01338870|76056744|FG003|Overall Study|Other|2|||
42235062|NCT01338870|76056745|FG004|Overall Study|Other|0|||
42235063|NCT01338870|76056746|FG005|Overall Study|Other|2|||
42235064|NCT01338870|76056741|FG000|Overall Study|Protocol Violation|0|||
42235065|NCT01338870|76056742|FG001|Overall Study|Protocol Violation|2|||
42235066|NCT01338870|76056743|FG002|Overall Study|Protocol Violation|2|||
42235067|NCT01338870|76056744|FG003|Overall Study|Protocol Violation|2|||
42235068|NCT01338870|76056745|FG004|Overall Study|Protocol Violation|1|||
42235069|NCT01338870|76056746|FG005|Overall Study|Protocol Violation|1|||
42235070|NCT01338870|76056741|FG000|Overall Study|Adverse Event|4|||
42235071|NCT01338870|76056742|FG001|Overall Study|Adverse Event|4|||
42235072|NCT01338870|76056743|FG002|Overall Study|Adverse Event|1|||
42235073|NCT01338870|76056744|FG003|Overall Study|Adverse Event|5|||
42235074|NCT01338870|76056745|FG004|Overall Study|Adverse Event|4|||
42235075|NCT01338870|76056746|FG005|Overall Study|Adverse Event|1|||
42235076|NCT02824224|76056762|FG000|Overall Study|Discontinued, IUS expulsion|0|||
42235077|NCT02824224|76056763|FG001|Overall Study|Discontinued, IUS expulsion|1|||
42235078|NCT02824224|76056762|FG000|Overall Study|Did not show up for allocation visit|2|||
42235079|NCT02824224|76056763|FG001|Overall Study|Did not show up for allocation visit|0|||
42235080|NCT01338792|76056769|FG000|Overall Study|Adverse Event|2|||
42235081|NCT01338792|76056769|FG000|Overall Study|Death|1|||
42235082|NCT01338792|76056769|FG000|Overall Study|Withdrawal by Subject|1|||
42235083|NCT01314105|76056775|FG000|Overall Study|Progressive Disease|6|||
42235084|NCT01314105|76056776|FG001|Overall Study|Progressive Disease|10|||
42235085|NCT01314105|76056775|FG000|Overall Study|Refused to continue taking medication|0|||
42235086|NCT01314105|76056776|FG001|Overall Study|Refused to continue taking medication|1|||
42235087|NCT01314105|76056775|FG000|Overall Study|Other Adverse Event|1|||
42235088|NCT01314105|76056776|FG001|Overall Study|Other Adverse Event|1|||
42235089|NCT03040713|76056784|FG000|Overall Study|Positive amyloid scan|3|||
42235090|NCT01966471|76056790|FG000|Overall Study|Death|44|||
42235091|NCT01966471|76056791|FG001|Overall Study|Death|56|||
42235092|NCT01966471|76056790|FG000|Overall Study|Lost to Follow-up|46|||
42235093|NCT01966471|76056791|FG001|Overall Study|Lost to Follow-up|39|||
42235094|NCT01966471|76056790|FG000|Overall Study|Various reasons|4|||
42235095|NCT01966471|76056791|FG001|Overall Study|Various reasons|4|||
42235096|NCT01966471|76056790|FG000|Overall Study|Physician Decision|7|||
42235097|NCT01966471|76056791|FG001|Overall Study|Physician Decision|5|||
42235098|NCT01966471|76056790|FG000|Overall Study|Study Terminated By Sponsor|758|||
42235099|NCT01966471|76056791|FG001|Overall Study|Study Terminated By Sponsor|773|||
42235100|NCT01966471|76056790|FG000|Overall Study|Withdrawal by Subject|59|||
42235101|NCT01966471|76056791|FG001|Overall Study|Withdrawal by Subject|51|||
42235102|NCT03227471|76056820|FG000|Overall Study|Withdrawal by Subject|0|||
42235103|NCT03227471|76056821|FG001|Overall Study|Withdrawal by Subject|0|||
42235104|NCT03227471|76056822|FG002|Overall Study|Withdrawal by Subject|0|||
42235105|NCT03227471|76056823|FG003|Overall Study|Withdrawal by Subject|0|||
42235106|NCT03227471|76056824|FG004|Overall Study|Withdrawal by Subject|1|||
42235107|NCT03227471|76056825|FG005|Overall Study|Withdrawal by Subject|0|||
42235108|NCT03227471|76056826|FG006|Overall Study|Withdrawal by Subject|0|||
42235109|NCT03227471|76056827|FG007|Overall Study|Withdrawal by Subject|0|||
42235110|NCT03227471|76056828|FG008|Overall Study|Withdrawal by Subject|0|||
42235111|NCT03227471|76056829|FG009|Overall Study|Withdrawal by Subject|0|||
42235112|NCT03227471|76056830|FG010|Overall Study|Withdrawal by Subject|0|||
42235113|NCT03227471|76056831|FG011|Overall Study|Withdrawal by Subject|0|||
42235114|NCT03227471|76056832|FG012|Overall Study|Withdrawal by Subject|1|||
42235115|NCT03227471|76056833|FG013|Overall Study|Withdrawal by Subject|0|||
42235116|NCT03227471|76056834|FG014|Overall Study|Withdrawal by Subject|0|||
42235117|NCT03227471|76056820|FG000|Overall Study|Randomized, Never Dosed|0|||
42235118|NCT03227471|76056821|FG001|Overall Study|Randomized, Never Dosed|0|||
42235119|NCT03227471|76056822|FG002|Overall Study|Randomized, Never Dosed|0|||
42235120|NCT03227471|76056823|FG003|Overall Study|Randomized, Never Dosed|0|||
42235121|NCT03227471|76056824|FG004|Overall Study|Randomized, Never Dosed|0|||
42235122|NCT03227471|76056825|FG005|Overall Study|Randomized, Never Dosed|0|||
42235123|NCT03227471|76056826|FG006|Overall Study|Randomized, Never Dosed|0|||
42235124|NCT03227471|76056827|FG007|Overall Study|Randomized, Never Dosed|0|||
42235125|NCT03227471|76056828|FG008|Overall Study|Randomized, Never Dosed|0|||
42235126|NCT03227471|76056829|FG009|Overall Study|Randomized, Never Dosed|0|||
42235127|NCT03227471|76056830|FG010|Overall Study|Randomized, Never Dosed|0|||
42235128|NCT03227471|76056831|FG011|Overall Study|Randomized, Never Dosed|0|||
42235129|NCT03227471|76056832|FG012|Overall Study|Randomized, Never Dosed|0|||
42235130|NCT03227471|76056833|FG013|Overall Study|Randomized, Never Dosed|0|||
42235131|NCT03227471|76056834|FG014|Overall Study|Randomized, Never Dosed|1|||
42235132|NCT01354314|76056899|FG000|Overall Study|Lost to Follow-up|1|||
42235133|NCT01354314|76056900|FG001|Overall Study|Lost to Follow-up|0|||
42235134|NCT01354314|76056901|FG002|Overall Study|Lost to Follow-up|1|||
42235135|NCT01354314|76056902|FG003|Overall Study|Lost to Follow-up|1|||
42235136|NCT01354314|76056899|FG000|Overall Study|Withdrawal by Subject|0|||
42235137|NCT01354314|76056900|FG001|Overall Study|Withdrawal by Subject|0|||
42235138|NCT01354314|76056901|FG002|Overall Study|Withdrawal by Subject|1|||
42235139|NCT01354314|76056902|FG003|Overall Study|Withdrawal by Subject|0|||
42235140|NCT01354314|76056899|FG000|Overall Study|Adverse Event|0|||
42235141|NCT01354314|76056900|FG001|Overall Study|Adverse Event|0|||
42235142|NCT01354314|76056901|FG002|Overall Study|Adverse Event|0|||
42235143|NCT01354314|76056902|FG003|Overall Study|Adverse Event|1|||
42235144|NCT01354314|76056899|FG000|Overall Study|Protocol Violation|1|||
42235145|NCT01354314|76056900|FG001|Overall Study|Protocol Violation|1|||
42235146|NCT01354314|76056901|FG002|Overall Study|Protocol Violation|0|||
42235147|NCT01354314|76056902|FG003|Overall Study|Protocol Violation|0|||
42235148|NCT01354314|76056899|FG000|Overall Study|Less than 90% Adherence|4|||
42235149|NCT01354314|76056900|FG001|Overall Study|Less than 90% Adherence|2|||
42235150|NCT01354314|76056901|FG002|Overall Study|Less than 90% Adherence|6|||
42235151|NCT01354314|76056902|FG003|Overall Study|Less than 90% Adherence|4|||
42235152|NCT03194321|76056914|FG000|Overall Study|Withdrawal by Subject|1|||
42235153|NCT03194321|76056914|FG000|Overall Study|Lost to Follow-up|1|||
42235154|NCT03194321|76056914|FG000|Overall Study|Travel for Follow-up|1|||
42235155|NCT01354938|76056918|FG000|Overall Study|Lost to Follow-up|1|||
42235156|NCT03092791|76056941|FG000|Overall Study|Lost to Follow-up|0|||
42235157|NCT03092791|76056942|FG001|Overall Study|Lost to Follow-up|0|||
42235158|NCT03092791|76056943|FG002|Overall Study|Lost to Follow-up|0|||
42235159|NCT03092791|76056944|FG003|Overall Study|Lost to Follow-up|0|||
42235160|NCT03092791|76056945|FG004|Overall Study|Lost to Follow-up|0|||
42235161|NCT03092791|76056946|FG005|Overall Study|Lost to Follow-up|0|||
42235162|NCT03092791|76056947|FG006|Overall Study|Lost to Follow-up|1|||
42235163|NCT03092791|76056948|FG007|Overall Study|Lost to Follow-up|0|||
42235164|NCT03092791|76056941|FG000|Overall Study|Withdrawal of Consent|0|||
42235165|NCT03092791|76056942|FG001|Overall Study|Withdrawal of Consent|0|||
42235166|NCT03092791|76056943|FG002|Overall Study|Withdrawal of Consent|0|||
42235167|NCT03092791|76056944|FG003|Overall Study|Withdrawal of Consent|0|||
42235168|NCT03092791|76056945|FG004|Overall Study|Withdrawal of Consent|4|||
42235169|NCT03092791|76056946|FG005|Overall Study|Withdrawal of Consent|12|||
42235170|NCT03092791|76056947|FG006|Overall Study|Withdrawal of Consent|6|||
42235171|NCT03092791|76056948|FG007|Overall Study|Withdrawal of Consent|4|||
42235172|NCT03092791|76056941|FG000|Overall Study|Study Termination|0|||
42235173|NCT03092791|76056942|FG001|Overall Study|Study Termination|0|||
42235174|NCT03092791|76056943|FG002|Overall Study|Study Termination|0|||
42235175|NCT03092791|76056944|FG003|Overall Study|Study Termination|0|||
42235176|NCT03092791|76056945|FG004|Overall Study|Study Termination|55|||
42235177|NCT03092791|76056946|FG005|Overall Study|Study Termination|46|||
42235178|NCT03092791|76056947|FG006|Overall Study|Study Termination|53|||
42235179|NCT03092791|76056948|FG007|Overall Study|Study Termination|55|||
42235180|NCT03092791|76056941|FG000|Overall Study|Death|0|||
42235181|NCT03092791|76056942|FG001|Overall Study|Death|0|||
42235182|NCT03092791|76056943|FG002|Overall Study|Death|0|||
42235183|NCT03092791|76056944|FG003|Overall Study|Death|0|||
42235184|NCT03092791|76056945|FG004|Overall Study|Death|0|||
42235185|NCT03092791|76056946|FG005|Overall Study|Death|1|||
42235186|NCT03092791|76056947|FG006|Overall Study|Death|0|||
42032588|NCT01193582|75840831|FG003|Vaccination Series|Withdrawal by Subject|3|||
42032589|NCT01193582|75840828|FG000|12 Month Follow-up|Death|0|||
42032590|NCT01193582|75840829|FG001|12 Month Follow-up|Death|0|||
42032591|NCT01193582|75840830|FG002|12 Month Follow-up|Death|1|||
42032592|NCT01193582|75840831|FG003|12 Month Follow-up|Death|0|||
42032593|NCT01193582|75840828|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
42032594|NCT01193582|75840829|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
42032595|NCT01193582|75840830|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
42032596|NCT01193582|75840831|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
42032597|NCT00945477|75840843|FG000|Overall Study|Adverse Event|3|||
42032598|NCT00945477|75840843|FG000|Overall Study|Lack of Efficacy|2|||
42032599|NCT00945477|75840843|FG000|Overall Study|Withdrawal by Subject|1|||
42032600|NCT01076088|75840854|FG000|Overall Study|Adverse Event|1|||
42032601|NCT01076088|75840855|FG001|Overall Study|Adverse Event|6|||
42032602|NCT01076088|75840856|FG002|Overall Study|Adverse Event|3|||
42032603|NCT01076088|75840857|FG003|Overall Study|Adverse Event|2|||
42032604|NCT01076088|75840858|FG004|Overall Study|Adverse Event|3|||
42032605|NCT01076088|75840859|FG005|Overall Study|Adverse Event|3|||
42235187|NCT03092791|76056948|FG007|Overall Study|Death|1|||
42235188|NCT03092791|76056941|FG000|Overall Study|Reason Not Specified|0|||
42235189|NCT03092791|76056942|FG001|Overall Study|Reason Not Specified|0|||
42235190|NCT03092791|76056943|FG002|Overall Study|Reason Not Specified|0|||
42235191|NCT03092791|76056944|FG003|Overall Study|Reason Not Specified|0|||
42235192|NCT03092791|76056945|FG004|Overall Study|Reason Not Specified|1|||
42235193|NCT03092791|76056946|FG005|Overall Study|Reason Not Specified|1|||
42235194|NCT03092791|76056947|FG006|Overall Study|Reason Not Specified|0|||
42235195|NCT03092791|76056948|FG007|Overall Study|Reason Not Specified|0|||
42235196|NCT02505425|76056975|FG000|Overall Study|Lost to Follow-up|41|||
42235197|NCT02505425|76056976|FG001|Overall Study|Lost to Follow-up|61|||
42032606|NCT01076088|75840854|FG000|Overall Study|Lost to Follow-up|1|||
42032607|NCT01076088|75840855|FG001|Overall Study|Lost to Follow-up|1|||
42032608|NCT01076088|75840856|FG002|Overall Study|Lost to Follow-up|0|||
42032609|NCT01076088|75840857|FG003|Overall Study|Lost to Follow-up|1|||
42032610|NCT01076088|75840858|FG004|Overall Study|Lost to Follow-up|1|||
42235198|NCT02505425|76056977|FG002|Overall Study|Lost to Follow-up|31|||
42235199|NCT02505425|76056978|FG003|Overall Study|Lost to Follow-up|19|||
42235200|NCT02505425|76056975|FG000|Overall Study|Withdrawal by Subject|39|||
42032611|NCT01076088|75840859|FG005|Overall Study|Lost to Follow-up|2|||
42032612|NCT01076088|75840854|FG000|Overall Study|Non-compliance with study drug|0|||
42032613|NCT01076088|75840855|FG001|Overall Study|Non-compliance with study drug|0|||
42032614|NCT01076088|75840856|FG002|Overall Study|Non-compliance with study drug|0|||
42032615|NCT01076088|75840857|FG003|Overall Study|Non-compliance with study drug|1|||
42032616|NCT01076088|75840858|FG004|Overall Study|Non-compliance with study drug|0|||
42032617|NCT01076088|75840859|FG005|Overall Study|Non-compliance with study drug|0|||
42032618|NCT01076088|75840854|FG000|Overall Study|Physician Decision|1|||
42032619|NCT01076088|75840855|FG001|Overall Study|Physician Decision|3|||
42032620|NCT01076088|75840856|FG002|Overall Study|Physician Decision|0|||
42032621|NCT01076088|75840857|FG003|Overall Study|Physician Decision|1|||
42032622|NCT01076088|75840858|FG004|Overall Study|Physician Decision|1|||
42032623|NCT01076088|75840859|FG005|Overall Study|Physician Decision|0|||
42032624|NCT01076088|75840854|FG000|Overall Study|Withdrawal by Subject|8|||
42032625|NCT01076088|75840855|FG001|Overall Study|Withdrawal by Subject|8|||
42032626|NCT01076088|75840856|FG002|Overall Study|Withdrawal by Subject|14|||
42032627|NCT01076088|75840857|FG003|Overall Study|Withdrawal by Subject|10|||
42032628|NCT01076088|75840858|FG004|Overall Study|Withdrawal by Subject|11|||
42032629|NCT01076088|75840859|FG005|Overall Study|Withdrawal by Subject|17|||
42032630|NCT01076088|75840854|FG000|Overall Study|Other protocol specified criteria|0|||
42032631|NCT01076088|75840855|FG001|Overall Study|Other protocol specified criteria|0|||
42032632|NCT01076088|75840856|FG002|Overall Study|Other protocol specified criteria|0|||
42032633|NCT01076088|75840857|FG003|Overall Study|Other protocol specified criteria|0|||
42032634|NCT01076088|75840858|FG004|Overall Study|Other protocol specified criteria|0|||
42032635|NCT01076088|75840859|FG005|Overall Study|Other protocol specified criteria|1|||
42032636|NCT01193348|75840874|FG000|Screening Period|Screen Failure|5|||
42032637|NCT01193348|75840874|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
42032638|NCT01193348|75840874|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
42032639|NCT01193348|75840874|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
42032640|NCT01193348|75840874|FG000|Extension Treatment Period|Physician Decision|1|||
42032641|NCT01193348|75840874|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
42032642|NCT00945321|75840883|FG000|Period 1|Adverse Event|0|||
42032643|NCT00945321|75840884|FG001|Period 1|Adverse Event|0|||
42032644|NCT00945321|75840885|FG002|Period 1|Adverse Event|0|||
42032645|NCT00945321|75840886|FG003|Period 1|Adverse Event|0|||
42032646|NCT00945321|75840887|FG004|Period 1|Adverse Event|1|||
42032647|NCT00945321|75840888|FG005|Period 1|Adverse Event|0|||
42032648|NCT00945321|75840883|FG000|Period 4|Lost to Follow-up|0|||
42032649|NCT00945321|75840884|FG001|Period 4|Lost to Follow-up|0|||
42032650|NCT00945321|75840885|FG002|Period 4|Lost to Follow-up|0|||
42032651|NCT00945321|75840886|FG003|Period 4|Lost to Follow-up|0|||
42032652|NCT00945321|75840887|FG004|Period 4|Lost to Follow-up|0|||
42032653|NCT00945321|75840888|FG005|Period 4|Lost to Follow-up|1|||
42032654|NCT00945243|75840906|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
42032655|NCT01192412|75840912|FG000|Overall Study|Lost to Follow-up|2|||
42032656|NCT01192412|75840913|FG001|Overall Study|Lost to Follow-up|1|||
42032657|NCT01192412|75840912|FG000|Overall Study|Withdrawal by Subject|2|||
42032658|NCT01192412|75840913|FG001|Overall Study|Withdrawal by Subject|1|||
42032659|NCT01192178|75840921|FG000|Overall Study|Withdrawal by Subject|6|||
42032660|NCT01192178|75840922|FG001|Overall Study|Withdrawal by Subject|10|||
42032661|NCT01192178|75840921|FG000|Overall Study|Protocol Violation|10|||
42032662|NCT01192178|75840922|FG001|Overall Study|Protocol Violation|3|||
42032663|NCT01192178|75840921|FG000|Overall Study|Physician Decision|2|||
42235201|NCT02505425|76056976|FG001|Overall Study|Withdrawal by Subject|9|||
42235202|NCT02505425|76056977|FG002|Overall Study|Withdrawal by Subject|19|||
42235203|NCT02505425|76056978|FG003|Overall Study|Withdrawal by Subject|7|||
42235204|NCT02505425|76056975|FG000|Overall Study|Death|8|||
42235205|NCT02505425|76056976|FG001|Overall Study|Death|12|||
42235206|NCT02505425|76056977|FG002|Overall Study|Death|0|||
42235207|NCT02505425|76056978|FG003|Overall Study|Death|0|||
42235208|NCT03089047|76056990|FG000|Overall Study|Lost to Follow-up|1|||
42235209|NCT03089047|76056991|FG001|Overall Study|Lost to Follow-up|0|||
42032664|NCT01192178|75840922|FG001|Overall Study|Physician Decision|4|||
42235210|NCT01371006|76056999|FG000|Overall Study|Adverse Event|1|||
42032665|NCT01192178|75840921|FG000|Overall Study|Lost to Follow-up|3|||
42032666|NCT01192178|75840922|FG001|Overall Study|Lost to Follow-up|3|||
42235211|NCT01371006|76057000|FG001|Overall Study|Adverse Event|0|||
42235212|NCT01371552|76057035|FG000|Part 1, First 3 Days|Inconvenience|0|||
42235213|NCT01371552|76057036|FG001|Part 1, First 3 Days|Inconvenience|0|||
42235214|NCT01371552|76057037|FG002|Part 1, First 3 Days|Inconvenience|1|||
42032667|NCT01192178|75840921|FG000|Overall Study|Adverse Event|2|||
42032668|NCT01192178|75840922|FG001|Overall Study|Adverse Event|1|||
42032669|NCT01192178|75840921|FG000|Overall Study|Lack of Efficacy|1|||
42235215|NCT01371552|76057038|FG003|Part 1, First 3 Days|Inconvenience|0|||
42032670|NCT01192178|75840922|FG001|Overall Study|Lack of Efficacy|2|||
42032671|NCT01192100|75840930|FG000|Overall Study|Withdrawal by Subject|0|||
42235216|NCT01371552|76057039|FG004|Part 1, First 3 Days|Inconvenience|0|||
42131856|NCT00332488|75942739|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
42131857|NCT00332488|75942737|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
42235217|NCT01371552|76057040|FG005|Part 1, First 3 Days|Inconvenience|0|||
42235218|NCT02819310|76057049|FG000|Overall Study|Withdrawal by Subject|37|||
42235219|NCT02819310|76057049|FG000|Overall Study|Lost to Follow-up|16|||
42235220|NCT02819310|76057049|FG000|Overall Study|Adverse Event|13|||
42235221|NCT02819310|76057049|FG000|Overall Study|Lack of Efficacy|5|||
41987444|NCT01290796|75794714|FG000|Overall Study|Withdrawal by Subject|4|||
41987445|NCT01290796|75794714|FG000|Overall Study|Physician Decision|2|||
41987446|NCT01290796|75794714|FG000|Overall Study|Secondary Surgical Intervention|2|||
41987447|NCT01290796|75794714|FG000|Overall Study|Withdrawal by Sponsor|1|||
41987448|NCT01290757|75794720|FG000|Overall Study|Adverse Event|1|||
41987449|NCT01290757|75794721|FG001|Overall Study|Adverse Event|0|||
41987450|NCT01290757|75794720|FG000|Overall Study|Protocol Violation|1|||
41987451|NCT01290757|75794721|FG001|Overall Study|Protocol Violation|1|||
41987452|NCT01290757|75794720|FG000|Overall Study|Other|0|||
41987453|NCT01290757|75794721|FG001|Overall Study|Other|1|||
41987454|NCT01290718|75794727|FG000|Overall Study|Early termination of the study|4|||
41987455|NCT01290679|75794733|FG000|Overall Study|Adverse Event|2|||
41987456|NCT01290679|75794734|FG001|Overall Study|Adverse Event|0|||
41987457|NCT01290679|75794733|FG000|Overall Study|Lost to Follow-up|8|||
41987458|NCT01290679|75794734|FG001|Overall Study|Lost to Follow-up|10|||
41987459|NCT01290679|75794733|FG000|Overall Study|Protocol Violation|0|||
41987460|NCT01290679|75794734|FG001|Overall Study|Protocol Violation|1|||
41987461|NCT01290679|75794733|FG000|Overall Study|Withdrawal by Subject|6|||
41987462|NCT01290679|75794734|FG001|Overall Study|Withdrawal by Subject|5|||
41987463|NCT01290679|75794733|FG000|Overall Study|Subject Entered Another Trial|0|||
41987464|NCT01290679|75794734|FG001|Overall Study|Subject Entered Another Trial|5|||
41987465|NCT01290601|75794742|FG000|Overall Study|Adverse Event|0|||
41987466|NCT01290601|75794743|FG001|Overall Study|Adverse Event|2|||
41987467|NCT01290601|75794744|FG002|Overall Study|Adverse Event|0|||
41987468|NCT01290601|75794745|FG003|Overall Study|Adverse Event|0|||
41987469|NCT01290601|75794742|FG000|Overall Study|Lack of Efficacy|2|||
42131858|NCT00332488|75942738|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
42131859|NCT00332488|75942739|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
42131860|NCT00332488|75942737|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
42235222|NCT02819310|76057049|FG000|Overall Study|Physician Decision|8|||
42235223|NCT02819310|76057049|FG000|Overall Study|Protocol Violation|30|||
42235224|NCT03087643|76057055|FG000|Overall Study|Withdrawal by Subject|2|||
42235225|NCT03087643|76057056|FG001|Overall Study|Withdrawal by Subject|4|||
42235226|NCT03087643|76057055|FG000|Overall Study|Death|2|||
42235227|NCT03087643|76057056|FG001|Overall Study|Death|2|||
42235228|NCT02821962|76057064|FG000|Overall Study|Lost to Follow-up|2|||
42235229|NCT02821962|76057065|FG001|Overall Study|Lost to Follow-up|0|||
42235230|NCT03092479|76057073|FG000|Overall Study|Lost to Follow-up|3|||
42235231|NCT03092479|76057074|FG001|Overall Study|Lost to Follow-up|2|||
42235232|NCT03092479|76057073|FG000|Overall Study|Withdrawal by Subject|4|||
42235233|NCT03092479|76057074|FG001|Overall Study|Withdrawal by Subject|0|||
42235234|NCT03086551|76057082|FG000|First Intervention|Failure to meet inclusion criterion|1|||
42235235|NCT03086551|76057083|FG001|First Intervention|Failure to meet inclusion criterion|0|||
42235236|NCT03086551|76057082|FG000|First Intervention|Lost to Follow-up|0|||
42235237|NCT03086551|76057083|FG001|First Intervention|Lost to Follow-up|1|||
42235238|NCT03086551|76057082|FG000|Washout|Lost to Follow-up|1|||
42235239|NCT03086551|76057083|FG001|Washout|Lost to Follow-up|2|||
42235240|NCT03086551|76057082|FG000|Washout|Withdrawal by Subject|2|||
42235241|NCT03086551|76057083|FG001|Washout|Withdrawal by Subject|1|||
42235242|NCT03265249|76057091|FG000|Overall Study|Withdrawal by Subject|0|||
42235243|NCT03265249|76057092|FG001|Overall Study|Withdrawal by Subject|1|||
42235244|NCT02951767|76057098|FG000|Overall Study|Ongoing at data cutoff 04 July 2016|54|||
41987470|NCT01290601|75794743|FG001|Overall Study|Lack of Efficacy|1|||
41987471|NCT01290601|75794744|FG002|Overall Study|Lack of Efficacy|0|||
41987472|NCT01290601|75794745|FG003|Overall Study|Lack of Efficacy|0|||
41987473|NCT01290601|75794742|FG000|Overall Study|Lost to Follow-up|7|||
41987474|NCT01290601|75794743|FG001|Overall Study|Lost to Follow-up|2|||
41987475|NCT01290601|75794744|FG002|Overall Study|Lost to Follow-up|0|||
41987476|NCT01290601|75794745|FG003|Overall Study|Lost to Follow-up|0|||
42235245|NCT02951767|76057098|FG000|Overall Study|Withdrawal by Subject|5|||
42235246|NCT02951767|76057098|FG000|Overall Study|Death|59|||
42235247|NCT02951767|76057098|FG000|Overall Study|Lost to Follow-up|1|||
42235248|NCT03093181|76057105|FG000|Overall Study|Withdrawal by Subject|2|||
42235249|NCT03093181|76057106|FG001|Overall Study|Withdrawal by Subject|1|||
42235250|NCT03093181|76057107|FG002|Overall Study|Withdrawal by Subject|2|||
42235251|NCT03093181|76057105|FG000|Overall Study|Other (Not specified)|1|||
42235252|NCT03093181|76057106|FG001|Overall Study|Other (Not specified)|0|||
42235253|NCT03093181|76057107|FG002|Overall Study|Other (Not specified)|0|||
42235254|NCT03093181|76057105|FG000|Overall Study|Adverse Event|0|||
42235255|NCT03093181|76057106|FG001|Overall Study|Adverse Event|1|||
42235256|NCT03093181|76057107|FG002|Overall Study|Adverse Event|0|||
42235257|NCT03093181|76057105|FG000|Overall Study|Other (Protocol violation)|0|||
42235258|NCT03093181|76057106|FG001|Overall Study|Other (Protocol violation)|0|||
42235259|NCT03093181|76057107|FG002|Overall Study|Other (Protocol violation)|1|||
42235260|NCT03091777|76057118|FG000|Overall Study|Pregnancy|2|||
42235261|NCT03091777|76057119|FG001|Overall Study|Pregnancy|1|||
42235262|NCT03091777|76057120|FG002|Overall Study|Pregnancy|0|||
42235263|NCT03091777|76057118|FG000|Overall Study|Adverse Event|2|||
42235264|NCT03091777|76057119|FG001|Overall Study|Adverse Event|1|||
42235265|NCT03091777|76057120|FG002|Overall Study|Adverse Event|4|||
42235266|NCT03091777|76057118|FG000|Overall Study|Withdrawal by Subject|4|||
42235267|NCT03091777|76057119|FG001|Overall Study|Withdrawal by Subject|2|||
42235268|NCT03091777|76057120|FG002|Overall Study|Withdrawal by Subject|6|||
42235269|NCT03091777|76057118|FG000|Overall Study|Protocol Violation|2|||
42235270|NCT03091777|76057119|FG001|Overall Study|Protocol Violation|1|||
42235271|NCT03091777|76057120|FG002|Overall Study|Protocol Violation|1|||
42235272|NCT03091777|76057118|FG000|Overall Study|Lost to Follow-up|12|||
42235273|NCT03091777|76057119|FG001|Overall Study|Lost to Follow-up|14|||
42235274|NCT03091777|76057120|FG002|Overall Study|Lost to Follow-up|7|||
42235275|NCT03091777|76057118|FG000|Overall Study|Lack of Efficacy|0|||
42235276|NCT03091777|76057119|FG001|Overall Study|Lack of Efficacy|0|||
41987477|NCT01290601|75794742|FG000|Overall Study|Other|1|||
42235277|NCT03091777|76057120|FG002|Overall Study|Lack of Efficacy|5|||
42235278|NCT03091777|76057118|FG000|Overall Study|Noncompliance with study drug|2|||
42235279|NCT03091777|76057119|FG001|Overall Study|Noncompliance with study drug|3|||
42235280|NCT03091777|76057120|FG002|Overall Study|Noncompliance with study drug|1|||
42235281|NCT03091777|76057118|FG000|Overall Study|Physician Decision|1|||
42235282|NCT03091777|76057119|FG001|Overall Study|Physician Decision|0|||
42235283|NCT03091777|76057120|FG002|Overall Study|Physician Decision|1|||
42235284|NCT03091777|76057118|FG000|Overall Study|Abnormal Laboratory Value|7|||
42235285|NCT03091777|76057119|FG001|Overall Study|Abnormal Laboratory Value|11|||
42235286|NCT03091777|76057120|FG002|Overall Study|Abnormal Laboratory Value|12|||
42235287|NCT02818998|76057131|FG000|Overall Study|Adverse Event|3|||
42235288|NCT02818998|76057132|FG001|Overall Study|Adverse Event|2|||
42235289|NCT02818998|76057133|FG002|Overall Study|Adverse Event|1|||
42235290|NCT02818998|76057131|FG000|Overall Study|Lost to Follow-up|4|||
42235291|NCT02818998|76057132|FG001|Overall Study|Lost to Follow-up|1|||
42235292|NCT02818998|76057133|FG002|Overall Study|Lost to Follow-up|2|||
42235293|NCT02818998|76057131|FG000|Overall Study|Withdrawal by sponsor|0|||
42235294|NCT02818998|76057132|FG001|Overall Study|Withdrawal by sponsor|1|||
42235295|NCT02818998|76057133|FG002|Overall Study|Withdrawal by sponsor|1|||
42235296|NCT02818998|76057131|FG000|Overall Study|Death|3|||
42235297|NCT02818998|76057132|FG001|Overall Study|Death|6|||
42235298|NCT02818998|76057133|FG002|Overall Study|Death|8|||
42235299|NCT02818998|76057131|FG000|Overall Study|Withdrawal by Subject|7|||
42235300|NCT02818998|76057132|FG001|Overall Study|Withdrawal by Subject|6|||
42235301|NCT02818998|76057133|FG002|Overall Study|Withdrawal by Subject|6|||
42235302|NCT02818998|76057131|FG000|Overall Study|Physician Decision|1|||
42235303|NCT02818998|76057132|FG001|Overall Study|Physician Decision|0|||
42235304|NCT02818998|76057133|FG002|Overall Study|Physician Decision|0|||
41987478|NCT01290601|75794743|FG001|Overall Study|Other|0|||
41987479|NCT01290601|75794744|FG002|Overall Study|Other|0|||
41987480|NCT01290601|75794745|FG003|Overall Study|Other|0|||
41987481|NCT01290601|75794742|FG000|Overall Study|Protocol Violation|1|||
42235305|NCT02821416|76057143|FG000|Overall Study|Adverse Event|0|||
42235306|NCT02821416|76057144|FG001|Overall Study|Adverse Event|1|||
42235307|NCT02821416|76057143|FG000|Overall Study|Withdrawal by Subject|2|||
42235308|NCT02821416|76057144|FG001|Overall Study|Withdrawal by Subject|0|||
42235309|NCT02821416|76057143|FG000|Overall Study|Lost to Follow-up|1|||
42235310|NCT02821416|76057144|FG001|Overall Study|Lost to Follow-up|0|||
41987482|NCT01290601|75794743|FG001|Overall Study|Protocol Violation|0|||
41987483|NCT01290601|75794744|FG002|Overall Study|Protocol Violation|0|||
42235311|NCT03108521|76057153|FG000|Overall Study|Lost to Follow-up|3|||
42235312|NCT03108521|76057154|FG001|Overall Study|Lost to Follow-up|0|||
42235313|NCT03108521|76057153|FG000|Overall Study|Lack of Efficacy|2|||
42235314|NCT03108521|76057154|FG001|Overall Study|Lack of Efficacy|0|||
42235315|NCT03108521|76057153|FG000|Overall Study|Physician Decision|4|||
41987484|NCT01290601|75794745|FG003|Overall Study|Protocol Violation|0|||
41987485|NCT01290523|75794751|FG000|Overall Study|Death|3|||
42235316|NCT03108521|76057154|FG001|Overall Study|Physician Decision|0|||
42235317|NCT03108521|76057153|FG000|Overall Study|Adverse Event|3|||
42235318|NCT03108521|76057154|FG001|Overall Study|Adverse Event|0|||
42235319|NCT02817828|76057177|FG000|Overall Study|Lost to Follow-up|41|||
42235320|NCT02817828|76057177|FG000|Overall Study|Adverse event not related to bleeding|104|||
42235321|NCT02817828|76057177|FG000|Overall Study|Adverse event related to bleeding|53|||
42235322|NCT02817828|76057177|FG000|Overall Study|Protocol Violation|11|||
42235323|NCT02817828|76057177|FG000|Overall Study|Pregnancy|7|||
42235324|NCT02817828|76057177|FG000|Overall Study|Pregnancy wish|15|||
42235325|NCT02817828|76057177|FG000|Overall Study|Withdrawal by Subject|78|||
42235326|NCT02817828|76057177|FG000|Overall Study|Other|26|||
42235327|NCT02817906|76057188|FG000|Overall Study|Adverse Event|3|||
42235328|NCT02817906|76057189|FG001|Overall Study|Adverse Event|0|||
42235329|NCT02817906|76057188|FG000|Overall Study|Lack of Efficacy|1|||
42235330|NCT02817906|76057189|FG001|Overall Study|Lack of Efficacy|0|||
42235331|NCT02817906|76057188|FG000|Overall Study|Protocol Violation|1|||
42235332|NCT02817906|76057189|FG001|Overall Study|Protocol Violation|1|||
42235333|NCT02817906|76057188|FG000|Overall Study|Study Terminated by Sponsor|2|||
42235334|NCT02817906|76057189|FG001|Overall Study|Study Terminated by Sponsor|2|||
42235335|NCT02817906|76057188|FG000|Overall Study|Withdrawal by Subject|7|||
42235336|NCT02817906|76057189|FG001|Overall Study|Withdrawal by Subject|0|||
42235337|NCT02817906|76057188|FG000|Overall Study|Other|2|||
42235338|NCT02817906|76057189|FG001|Overall Study|Other|2|||
42235339|NCT02817594|76057200|FG000|Overall Study|Withdrawal by Subject|1|||
42235340|NCT02817594|76057200|FG000|Overall Study|Other|1|||
42235341|NCT02817594|76057200|FG000|Overall Study|Did Not Receive Treatment|1|||
42235342|NCT02813694|76057210|FG000|Overall Study|Physician Decision|0|||
42235343|NCT02813694|76057211|FG001|Overall Study|Physician Decision|1|||
42235344|NCT02813694|76057210|FG000|Overall Study|Withdrawal by Subject|10|||
42235345|NCT02813694|76057211|FG001|Overall Study|Withdrawal by Subject|9|||
42235346|NCT02813694|76057210|FG000|Overall Study|Lost to Follow-up|1|||
42235347|NCT02813694|76057211|FG001|Overall Study|Lost to Follow-up|1|||
42235348|NCT02813694|76057210|FG000|Overall Study|Death|3|||
42235349|NCT02813694|76057211|FG001|Overall Study|Death|3|||
42235350|NCT02813694|76057210|FG000|Overall Study|Randomized- did not receive study drug|2|||
42235351|NCT02813694|76057211|FG001|Overall Study|Randomized- did not receive study drug|0|||
42235352|NCT02813694|76057210|FG000|Overall Study|Patient hospitalized|1|||
42235353|NCT02813694|76057211|FG001|Overall Study|Patient hospitalized|0|||
42235354|NCT03103919|76057219|FG000|Overall Study|Adverse Event|2|||
42235355|NCT03103919|76057220|FG001|Overall Study|Adverse Event|2|||
42235356|NCT02810964|76057230|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
42235357|NCT02810964|76057231|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
42235358|NCT02810964|76057230|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
42235359|NCT02810964|76057231|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
42235360|NCT02810964|76057230|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
42235361|NCT02810964|76057231|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
42235362|NCT02810964|76057230|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
42235363|NCT02810964|76057231|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
42235364|NCT03103763|76057240|FG000|Overall Study|Death|15|||
42235365|NCT03103763|76057241|FG001|Overall Study|Death|5|||
42235366|NCT03103763|76057242|FG002|Overall Study|Death|5|||
42235367|NCT03103763|76057240|FG000|Overall Study|Withdrawal by Subject|0|||
42235368|NCT03103763|76057241|FG001|Overall Study|Withdrawal by Subject|3|||
42235369|NCT03103763|76057242|FG002|Overall Study|Withdrawal by Subject|2|||
42235370|NCT03101267|76057266|FG000|Primary Study Period|Withdrawal by Subject|1|||
42235371|NCT03101267|76057267|FG001|Primary Study Period|Withdrawal by Subject|2|||
42235372|NCT03101267|76057268|FG002|Primary Study Period|Withdrawal by Subject|3|||
42235373|NCT03101267|76057266|FG000|Primary Study Period|Miscellaneous|2|||
41987486|NCT01290094|75794755|FG000|Overall Study|Withdrawal by Subject|1|||
41987487|NCT01290094|75794755|FG000|Overall Study|Lost to Follow-up|5|||
41987488|NCT01289821|75794768|FG000|Treatment Period|Withdrawal by Subject|1|||
41987489|NCT01289821|75794768|FG000|Treatment Period|Physician Decision|3|||
41987490|NCT01289821|75794768|FG000|Treatment Period|Adverse Event|4|||
41987491|NCT01289821|75794768|FG000|Treatment Period|Radiological Progression|43|||
41987492|NCT01289821|75794768|FG000|Treatment Period|Clinical Progression|2|||
42032672|NCT01192100|75840931|FG001|Overall Study|Withdrawal by Subject|0|||
42235374|NCT03101267|76057267|FG001|Primary Study Period|Miscellaneous|0|||
42235375|NCT03101267|76057268|FG002|Primary Study Period|Miscellaneous|0|||
42235376|NCT02810418|76057283|FG000|Arm A Dose Escalation|Adverse Event|2|||
42235377|NCT02810418|76057284|FG001|Arm A Dose Escalation|Adverse Event|1|||
42235378|NCT02810418|76057285|FG002|Arm A Dose Escalation|Adverse Event|0|||
42235379|NCT02810418|76057286|FG003|Arm A Dose Escalation|Adverse Event|0|||
42235380|NCT02810418|76057287|FG004|Arm A Dose Escalation|Adverse Event|0|||
42235381|NCT02810418|76057288|FG005|Arm A Dose Escalation|Adverse Event|0|||
41987493|NCT01289821|75794768|FG000|Treatment Period|Therapeutic procedure required|1|||
42235382|NCT02810418|76057289|FG006|Arm A Dose Escalation|Adverse Event|0|||
42235383|NCT02810418|76057283|FG000|Dose Expansion|Adverse Event|0|||
42235384|NCT02810418|76057284|FG001|Dose Expansion|Adverse Event|1|||
42235385|NCT02810418|76057285|FG002|Dose Expansion|Adverse Event|1|||
42235386|NCT02810418|76057286|FG003|Dose Expansion|Adverse Event|0|||
42235387|NCT02810418|76057287|FG004|Dose Expansion|Adverse Event|0|||
42235388|NCT02810418|76057288|FG005|Dose Expansion|Adverse Event|0|||
42235389|NCT02810418|76057289|FG006|Dose Expansion|Adverse Event|0|||
42235390|NCT02810418|76057283|FG000|Dose Expansion|Physician Decision|0|||
42235391|NCT02810418|76057284|FG001|Dose Expansion|Physician Decision|0|||
42235392|NCT02810418|76057285|FG002|Dose Expansion|Physician Decision|2|||
42235393|NCT02810418|76057286|FG003|Dose Expansion|Physician Decision|0|||
42235394|NCT02810418|76057287|FG004|Dose Expansion|Physician Decision|0|||
42235395|NCT02810418|76057288|FG005|Dose Expansion|Physician Decision|0|||
42235396|NCT02810418|76057289|FG006|Dose Expansion|Physician Decision|0|||
42235397|NCT02810418|76057283|FG000|Arm B Dose Escalation|Adverse Event|0|||
42235398|NCT02810418|76057284|FG001|Arm B Dose Escalation|Adverse Event|0|||
42235399|NCT02810418|76057285|FG002|Arm B Dose Escalation|Adverse Event|0|||
42235400|NCT02810418|76057286|FG003|Arm B Dose Escalation|Adverse Event|0|||
42235401|NCT02810418|76057287|FG004|Arm B Dose Escalation|Adverse Event|1|||
42235402|NCT02810418|76057288|FG005|Arm B Dose Escalation|Adverse Event|2|||
42235403|NCT02810418|76057289|FG006|Arm B Dose Escalation|Adverse Event|0|||
42235404|NCT02810340|76057355|FG000|Overall Study|Withdrawal by Subject|1|||
42235405|NCT02810340|76057356|FG001|Overall Study|Withdrawal by Subject|0|||
42235406|NCT02810340|76057357|FG002|Overall Study|Withdrawal by Subject|0|||
42235407|NCT02810340|76057355|FG000|Overall Study|Incarceration|0|||
42235408|NCT02810340|76057356|FG001|Overall Study|Incarceration|1|||
42235409|NCT02810340|76057357|FG002|Overall Study|Incarceration|0|||
42235410|NCT02810340|76057355|FG000|Overall Study|Lost to Follow-up|0|||
42235411|NCT02810340|76057356|FG001|Overall Study|Lost to Follow-up|0|||
42235412|NCT02810340|76057357|FG002|Overall Study|Lost to Follow-up|1|||
42235413|NCT02817516|76057369|FG000|Overall Study|Other|0|||
42235414|NCT02817516|76057370|FG001|Overall Study|Other|0|||
42235415|NCT02817516|76057371|FG002|Overall Study|Other|1|||
42235416|NCT02817516|76057372|FG003|Overall Study|Other|0|||
42235417|NCT02928029|76057387|FG000|Overall Study|Withdrawal by Subject|0|||
42235418|NCT02928029|76057388|FG001|Overall Study|Withdrawal by Subject|1|||
42235419|NCT02928029|76057387|FG000|Overall Study|Radiological progression|1|||
42235420|NCT02928029|76057388|FG001|Overall Study|Radiological progression|0|||
42235421|NCT02928029|76057387|FG000|Overall Study|Clinical progression|1|||
42235422|NCT02928029|76057388|FG001|Overall Study|Clinical progression|2|||
42235423|NCT02928029|76057387|FG000|Overall Study|AE not related to clinical progression|1|||
42235424|NCT02928029|76057388|FG001|Overall Study|AE not related to clinical progression|1|||
42235425|NCT02806986|76057394|FG000|Treatment Stage 1|Adverse Event|1|||
42235426|NCT02806986|76057394|FG000|Treatment Stage 2|Adverse Event|3|||
42235427|NCT02806986|76057394|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
42235428|NCT03095651|76057410|FG000|Overall Study|Lost to Follow-up|1|||
42235429|NCT03095651|76057411|FG001|Overall Study|Lost to Follow-up|1|||
42235430|NCT03095651|76057412|FG002|Overall Study|Lost to Follow-up|0|||
42235431|NCT03095651|76057413|FG003|Overall Study|Lost to Follow-up|1|||
42235432|NCT03095651|76057414|FG004|Overall Study|Lost to Follow-up|0|||
42235433|NCT03095651|76057415|FG005|Overall Study|Lost to Follow-up|0|||
42235434|NCT03095651|76057416|FG006|Overall Study|Lost to Follow-up|0|||
42235435|NCT03095651|76057417|FG007|Overall Study|Lost to Follow-up|0|||
42235436|NCT03095651|76057410|FG000|Overall Study|Withdrawal by Subject|0|||
42235437|NCT03095651|76057411|FG001|Overall Study|Withdrawal by Subject|0|||
42235438|NCT03095651|76057412|FG002|Overall Study|Withdrawal by Subject|0|||
42235439|NCT03095651|76057413|FG003|Overall Study|Withdrawal by Subject|0|||
42235440|NCT03095651|76057414|FG004|Overall Study|Withdrawal by Subject|0|||
42235441|NCT03095651|76057415|FG005|Overall Study|Withdrawal by Subject|1|||
42235442|NCT03095651|76057416|FG006|Overall Study|Withdrawal by Subject|0|||
42235443|NCT03095651|76057417|FG007|Overall Study|Withdrawal by Subject|0|||
42235444|NCT02808312|76057440|FG000|Overall Study|Enrolled but Never Treated|0|||
42235445|NCT02808312|76057441|FG001|Overall Study|Enrolled but Never Treated|0|||
42235446|NCT02808312|76057442|FG002|Overall Study|Enrolled but Never Treated|1|||
42235447|NCT02808312|76057443|FG003|Overall Study|Enrolled but Never Treated|0|||
42235448|NCT02808312|76057444|FG004|Overall Study|Enrolled but Never Treated|0|||
42235449|NCT03099161|76057464|FG000|Overall Study|Adverse Event|0|||
42235450|NCT03099161|76057465|FG001|Overall Study|Adverse Event|0|||
42235451|NCT03099161|76057466|FG002|Overall Study|Adverse Event|2|||
42235452|NCT03099161|76057464|FG000|Overall Study|Physician Decision|2|||
42235453|NCT03099161|76057465|FG001|Overall Study|Physician Decision|0|||
42235454|NCT03099161|76057466|FG002|Overall Study|Physician Decision|0|||
42235455|NCT03099161|76057464|FG000|Overall Study|Progressive Disease|1|||
42235456|NCT03099161|76057465|FG001|Overall Study|Progressive Disease|4|||
42235457|NCT03099161|76057466|FG002|Overall Study|Progressive Disease|1|||
42235458|NCT03095027|76057474|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
42235459|NCT03095027|76057475|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
42235460|NCT04227197|76057483|FG000|Randomization|Protocol Violation|1|||
42235461|NCT04227197|76057484|FG001|Randomization|Protocol Violation|0|||
42235462|NCT04227197|76057483|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
42235463|NCT04227197|76057484|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
42235464|NCT04227197|76057483|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
42235465|NCT04227197|76057484|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
41987494|NCT01289821|75794768|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
42235466|NCT04227197|76057483|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
42235467|NCT04227197|76057484|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
42235468|NCT04227197|76057483|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
42235469|NCT04227197|76057484|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
42235470|NCT04227197|76057483|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
42235471|NCT04227197|76057484|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
41987495|NCT01289821|75794768|FG000|Safety Follow-up Period|Protocol Violation|3|||
41987496|NCT01289821|75794768|FG000|Safety Follow-up Period|Unspecified reason|1|||
41987497|NCT01289821|75794768|FG000|Survival Follow-up Period|Protocol Violation|1|||
41987498|NCT01289821|75794768|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
42235472|NCT04227197|76057483|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
42235473|NCT04227197|76057484|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
42235474|NCT03080935|76057495|FG000|Overall Study|Death|34|||
42235475|NCT03080935|76057496|FG001|Overall Study|Death|50|||
42235476|NCT03080935|76057495|FG000|Overall Study|Lost to Follow-up|5|||
42235477|NCT03080935|76057496|FG001|Overall Study|Lost to Follow-up|4|||
42235478|NCT03080935|76057495|FG000|Overall Study|Withdrawal by Subject|11|||
42235479|NCT03080935|76057496|FG001|Overall Study|Withdrawal by Subject|15|||
42235480|NCT02921789|76057508|FG000|Overall Study|Adverse Event|0|||
42235481|NCT02921789|76057509|FG001|Overall Study|Adverse Event|1|||
42235482|NCT02921789|76057508|FG000|Overall Study|Lost to Follow-up|1|||
42235483|NCT02921789|76057509|FG001|Overall Study|Lost to Follow-up|0|||
42235484|NCT02921789|76057508|FG000|Overall Study|Protocol Deviation|2|||
42235485|NCT02921789|76057509|FG001|Overall Study|Protocol Deviation|0|||
42235486|NCT02921789|76057508|FG000|Overall Study|Withdrawal by Subject|2|||
42235487|NCT02921789|76057509|FG001|Overall Study|Withdrawal by Subject|1|||
42235488|NCT02921789|76057508|FG000|Overall Study|Miscellaneous|3|||
42235489|NCT02921789|76057509|FG001|Overall Study|Miscellaneous|2|||
42235490|NCT03097289|76057524|FG000|Overall Study|Adverse Event|1|||
42235491|NCT03097289|76057524|FG000|Overall Study|Equipment failure|2|||
42235492|NCT03097289|76057524|FG000|Overall Study|Collected platelet product unusable|3|||
42235493|NCT02419742|76057531|FG000|Overall Study|Adverse Event|2|||
42235494|NCT02419742|76057532|FG001|Overall Study|Adverse Event|0|||
42235495|NCT02419742|76057531|FG000|Overall Study|Disease Progression|0|||
42235496|NCT02419742|76057532|FG001|Overall Study|Disease Progression|1|||
42235497|NCT02419742|76057531|FG000|Overall Study|Withdrew Consent|2|||
42235498|NCT02419742|76057532|FG001|Overall Study|Withdrew Consent|1|||
42235499|NCT02419742|76057531|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
42235500|NCT02419742|76057532|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
42235501|NCT02409290|76057542|FG000|Overall Study|Protocol Violation|3|||
42235502|NCT02409290|76057543|FG001|Overall Study|Protocol Violation|6|||
42235503|NCT02409290|76057544|FG002|Overall Study|Protocol Violation|9|||
42235504|NCT02409290|76057545|FG003|Overall Study|Protocol Violation|4|||
42235505|NCT02409290|76057542|FG000|Overall Study|No positive culture/no baseline sample|3|||
42235506|NCT02409290|76057543|FG001|Overall Study|No positive culture/no baseline sample|9|||
42235507|NCT02409290|76057544|FG002|Overall Study|No positive culture/no baseline sample|6|||
42235508|NCT02409290|76057545|FG003|Overall Study|No positive culture/no baseline sample|5|||
42235509|NCT02409290|76057542|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
42235510|NCT02409290|76057543|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
42302567|NCT02416453|76137797|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
42302568|NCT02416453|76137798|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
42302569|NCT02416453|76137799|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
42302570|NCT02416453|76137800|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
41987499|NCT01289821|75794768|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
41987500|NCT01289782|75794774|FG000|Overall Study|Lost to Follow-up|14|||
42032673|NCT01192100|75840932|FG002|Overall Study|Withdrawal by Subject|0|||
42032674|NCT01192100|75840933|FG003|Overall Study|Withdrawal by Subject|0|||
42032675|NCT01192100|75840934|FG004|Overall Study|Withdrawal by Subject|1|||
42032676|NCT01192100|75840935|FG005|Overall Study|Withdrawal by Subject|0|||
42235511|NCT02409290|76057544|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
42235512|NCT02409290|76057545|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
42235513|NCT02898077|76057557|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
42235514|NCT02898077|76057558|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
42235515|NCT02898077|76057557|FG000|Overall Study|Lost to Follow-up|4|||
42235516|NCT02898077|76057558|FG001|Overall Study|Lost to Follow-up|3|||
42235517|NCT02898077|76057557|FG000|Overall Study|Physician Decision|0|||
42235518|NCT02898077|76057558|FG001|Overall Study|Physician Decision|2|||
42235519|NCT02898077|76057557|FG000|Overall Study|Sponsor Decision|32|||
42235520|NCT02898077|76057558|FG001|Overall Study|Sponsor Decision|13|||
42235521|NCT02898077|76057557|FG000|Overall Study|Withdrawal by Subject|6|||
42235522|NCT02898077|76057558|FG001|Overall Study|Withdrawal by Subject|3|||
42235523|NCT02898077|76057557|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
42235524|NCT02898077|76057558|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
42235525|NCT02898077|76057557|FG000|Overall Study|Ended extension period|3|||
42235526|NCT02898077|76057558|FG001|Overall Study|Ended extension period|0|||
42235527|NCT03097133|76057566|FG000|Overall Study|Lost to Follow-up|3|||
42235528|NCT03097133|76057567|FG001|Overall Study|Lost to Follow-up|2|||
42235529|NCT03097133|76057566|FG000|Overall Study|Withdrawal by Subject|2|||
42235530|NCT03097133|76057567|FG001|Overall Study|Withdrawal by Subject|5|||
42235531|NCT03097133|76057566|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
42235532|NCT03097133|76057567|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
42235533|NCT03097133|76057566|FG000|Overall Study|Other|3|||
42235534|NCT03097133|76057567|FG001|Overall Study|Other|2|||
42235535|NCT03097133|76057566|FG000|Overall Study|Adverse Event|1|||
42235536|NCT03097133|76057567|FG001|Overall Study|Adverse Event|0|||
42235537|NCT03889639|76057581|FG000|Overall Study|Withdrawal by Subject|0|||
42235538|NCT03889639|76057582|FG001|Overall Study|Withdrawal by Subject|0|||
42235539|NCT03889639|76057583|FG002|Overall Study|Withdrawal by Subject|0|||
42235540|NCT03889639|76057584|FG003|Overall Study|Withdrawal by Subject|0|||
42235541|NCT03889639|76057585|FG004|Overall Study|Withdrawal by Subject|0|||
42235542|NCT03889639|76057586|FG005|Overall Study|Withdrawal by Subject|0|||
42235543|NCT03889639|76057587|FG006|Overall Study|Withdrawal by Subject|0|||
42235544|NCT03889639|76057588|FG007|Overall Study|Withdrawal by Subject|1|||
42235545|NCT03265145|76057611|FG000|Overall Study|Protocol Violation|2|||
42235546|NCT03265145|76057612|FG001|Overall Study|Protocol Violation|0|||
42235547|NCT03265145|76057611|FG000|Overall Study|Adverse Event|1|||
42235548|NCT03265145|76057612|FG001|Overall Study|Adverse Event|0|||
42235549|NCT03265145|76057611|FG000|Overall Study|Withdrawal by Subject|23|||
42235550|NCT03265145|76057612|FG001|Overall Study|Withdrawal by Subject|19|||
42302571|NCT02416453|76137790|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
42302572|NCT02416453|76137791|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
42302573|NCT02416453|76137792|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
42302574|NCT02416453|76137793|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
42302575|NCT02416453|76137794|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
42302576|NCT02416453|76137795|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
42302577|NCT02416453|76137796|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
42302578|NCT02416453|76137797|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
42302579|NCT02416453|76137798|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
42302580|NCT02416453|76137799|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
41987501|NCT01289782|75794775|FG001|Overall Study|Lost to Follow-up|7|||
41987502|NCT01289782|75794774|FG000|Overall Study|Protocol Violation|1|||
41987503|NCT01289782|75794775|FG001|Overall Study|Protocol Violation|1|||
41987504|NCT01289782|75794774|FG000|Overall Study|Withdrawal by Subject|8|||
41987505|NCT01289782|75794775|FG001|Overall Study|Withdrawal by Subject|2|||
41987506|NCT01289782|75794774|FG000|Overall Study|Sponsor's Decision|1|||
41987507|NCT01289782|75794775|FG001|Overall Study|Sponsor's Decision|0|||
41987508|NCT01289782|75794774|FG000|Overall Study|Reason not specified|1|||
41987509|NCT01289782|75794775|FG001|Overall Study|Reason not specified|2|||
42032677|NCT01192100|75840930|FG000|Overall Study|Protocol Violation|0|||
42235551|NCT03265145|76057611|FG000|Overall Study|Death|12|||
42235552|NCT03265145|76057612|FG001|Overall Study|Death|12|||
42235553|NCT03265145|76057611|FG000|Overall Study|Lost to Follow-up|13|||
42235554|NCT03265145|76057612|FG001|Overall Study|Lost to Follow-up|9|||
42235555|NCT03265145|76057611|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
42302581|NCT02416453|76137800|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
41987510|NCT01289353|75794781|FG000|Overall Study|Lost to Follow-up|2|||
41987511|NCT01289119|75794791|FG000|Overall Study|Adverse Event|2|||
42235556|NCT03265145|76057612|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
42235557|NCT03265145|76057611|FG000|Overall Study|Switched back to previous medication|1|||
42235558|NCT03265145|76057612|FG001|Overall Study|Switched back to previous medication|0|||
42235559|NCT03265145|76057611|FG000|Overall Study|Did not want to take medication|1|||
42235560|NCT03265145|76057612|FG001|Overall Study|Did not want to take medication|0|||
42235561|NCT03265145|76057611|FG000|Overall Study|Subject could not afford medication|0|||
41987512|NCT01289119|75794792|FG001|Overall Study|Adverse Event|1|||
41987513|NCT01289119|75794793|FG002|Overall Study|Adverse Event|0|||
41987514|NCT01289119|75794794|FG003|Overall Study|Adverse Event|2|||
41987515|NCT01289119|75794795|FG004|Overall Study|Adverse Event|1|||
41987516|NCT01289119|75794796|FG005|Overall Study|Adverse Event|0|||
41987517|NCT01289119|75794791|FG000|Overall Study|Major Protocol Deviation|2|||
41987518|NCT01289119|75794792|FG001|Overall Study|Major Protocol Deviation|1|||
41987519|NCT01289119|75794793|FG002|Overall Study|Major Protocol Deviation|3|||
41987520|NCT01289119|75794794|FG003|Overall Study|Major Protocol Deviation|0|||
41987521|NCT01289119|75794795|FG004|Overall Study|Major Protocol Deviation|2|||
41987522|NCT01289119|75794796|FG005|Overall Study|Major Protocol Deviation|1|||
41987523|NCT01289119|75794791|FG000|Overall Study|Lost to Follow-up|0|||
41987524|NCT01289119|75794792|FG001|Overall Study|Lost to Follow-up|3|||
41987525|NCT01289119|75794793|FG002|Overall Study|Lost to Follow-up|0|||
41987526|NCT01289119|75794794|FG003|Overall Study|Lost to Follow-up|0|||
41987527|NCT01289119|75794795|FG004|Overall Study|Lost to Follow-up|0|||
41987528|NCT01289119|75794796|FG005|Overall Study|Lost to Follow-up|1|||
41987529|NCT01289119|75794791|FG000|Overall Study|Withdrawal by Subject|4|||
41987530|NCT01289119|75794792|FG001|Overall Study|Withdrawal by Subject|2|||
41987531|NCT01289119|75794793|FG002|Overall Study|Withdrawal by Subject|4|||
41987532|NCT01289119|75794794|FG003|Overall Study|Withdrawal by Subject|3|||
41987533|NCT01289119|75794795|FG004|Overall Study|Withdrawal by Subject|1|||
41987534|NCT01289119|75794796|FG005|Overall Study|Withdrawal by Subject|1|||
41987535|NCT01289119|75794791|FG000|Overall Study|Pregnancy|0|||
41987536|NCT01289119|75794792|FG001|Overall Study|Pregnancy|1|||
41987537|NCT01289119|75794793|FG002|Overall Study|Pregnancy|0|||
41987538|NCT01289119|75794794|FG003|Overall Study|Pregnancy|0|||
41987539|NCT01289119|75794795|FG004|Overall Study|Pregnancy|0|||
41987540|NCT01289119|75794796|FG005|Overall Study|Pregnancy|0|||
42131861|NCT00332488|75942738|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
42131862|NCT00332488|75942739|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
41987541|NCT01289119|75794791|FG000|Overall Study|Lack of Efficacy|0|||
41987542|NCT01289119|75794792|FG001|Overall Study|Lack of Efficacy|1|||
41987543|NCT01289119|75794793|FG002|Overall Study|Lack of Efficacy|1|||
42131863|NCT00332488|75942737|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
42131864|NCT00332488|75942738|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
42131865|NCT00332488|75942739|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
42131866|NCT00332488|75942737|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
42235562|NCT03265145|76057612|FG001|Overall Study|Subject could not afford medication|1|||
42235563|NCT03265145|76057611|FG000|Overall Study|Site closed|2|||
42235564|NCT03265145|76057612|FG001|Overall Study|Site closed|3|||
42235565|NCT03265145|76057611|FG000|Overall Study|Incorrectly randomized|16|||
42235566|NCT03265145|76057612|FG001|Overall Study|Incorrectly randomized|6|||
42235567|NCT03265145|76057611|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
42235568|NCT03265145|76057612|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
42235569|NCT03265145|76057611|FG000|Overall Study|Physician Decision|0|||
42235570|NCT03265145|76057612|FG001|Overall Study|Physician Decision|3|||
42235571|NCT03265145|76057611|FG000|Overall Study|Subject transferred to another facility|0|||
42235572|NCT03265145|76057612|FG001|Overall Study|Subject transferred to another facility|1|||
42235573|NCT05674344|76057623|FG000|Overall Study|Screen Fail|21|||
42235574|NCT05674344|76057623|FG000|Overall Study|Incomplete study procedures|3|||
42235575|NCT04424641|76057689|FG000|Overall Study|Death|1|||
42235576|NCT04424641|76057690|FG001|Overall Study|Death|2|||
42235577|NCT04424641|76057691|FG002|Overall Study|Death|3|||
42235578|NCT04424641|76057692|FG003|Overall Study|Death|0|||
42235579|NCT04424641|76057693|FG004|Overall Study|Death|3|||
42235580|NCT04424641|76057694|FG005|Overall Study|Death|0|||
42235581|NCT04424641|76057695|FG006|Overall Study|Death|1|||
42235582|NCT04424641|76057696|FG007|Overall Study|Death|2|||
42235583|NCT04424641|76057689|FG000|Overall Study|Sponsor decision|0|||
42235584|NCT04424641|76057690|FG001|Overall Study|Sponsor decision|2|||
41987544|NCT01289119|75794794|FG003|Overall Study|Lack of Efficacy|1|||
41987545|NCT01289119|75794795|FG004|Overall Study|Lack of Efficacy|1|||
41987546|NCT01289119|75794796|FG005|Overall Study|Lack of Efficacy|1|||
41987547|NCT01289119|75794791|FG000|Overall Study|Other|1|||
41987548|NCT01289119|75794792|FG001|Overall Study|Other|0|||
41987549|NCT01289119|75794793|FG002|Overall Study|Other|1|||
41987550|NCT01289119|75794794|FG003|Overall Study|Other|0|||
41987551|NCT01289119|75794795|FG004|Overall Study|Other|0|||
41987552|NCT01289119|75794796|FG005|Overall Study|Other|0|||
42235585|NCT04424641|76057691|FG002|Overall Study|Sponsor decision|3|||
42235586|NCT04424641|76057692|FG003|Overall Study|Sponsor decision|7|||
42235587|NCT04424641|76057693|FG004|Overall Study|Sponsor decision|2|||
42235588|NCT04424641|76057694|FG005|Overall Study|Sponsor decision|2|||
42235589|NCT04424641|76057695|FG006|Overall Study|Sponsor decision|3|||
42235590|NCT04424641|76057696|FG007|Overall Study|Sponsor decision|4|||
42235591|NCT04424641|76057689|FG000|Overall Study|Withdrawal by Subject|0|||
42235592|NCT04424641|76057690|FG001|Overall Study|Withdrawal by Subject|0|||
42235593|NCT04424641|76057691|FG002|Overall Study|Withdrawal by Subject|0|||
42235594|NCT04424641|76057692|FG003|Overall Study|Withdrawal by Subject|0|||
42235595|NCT04424641|76057693|FG004|Overall Study|Withdrawal by Subject|1|||
42235596|NCT04424641|76057694|FG005|Overall Study|Withdrawal by Subject|0|||
42235597|NCT04424641|76057695|FG006|Overall Study|Withdrawal by Subject|0|||
42235598|NCT04424641|76057696|FG007|Overall Study|Withdrawal by Subject|0|||
42235599|NCT04424641|76057689|FG000|Overall Study|Other|0|||
42235600|NCT04424641|76057690|FG001|Overall Study|Other|0|||
42235601|NCT04424641|76057691|FG002|Overall Study|Other|1|||
42235602|NCT04424641|76057692|FG003|Overall Study|Other|0|||
42235603|NCT04424641|76057693|FG004|Overall Study|Other|0|||
42235604|NCT04424641|76057694|FG005|Overall Study|Other|0|||
42235605|NCT04424641|76057695|FG006|Overall Study|Other|0|||
42235606|NCT04424641|76057696|FG007|Overall Study|Other|0|||
42235607|NCT04276090|76057725|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
42235608|NCT04276090|76057726|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
42235609|NCT04105842|76057736|FG000|Overall Study|Withdrawal by Subject|2|||
42235610|NCT04088734|76057743|FG000|Overall Study|Other, Not Specified|5|||
42235611|NCT03868787|76057766|FG000|Overall Study|Withdrawal by Subject|2|||
42235612|NCT03868787|76057767|FG001|Overall Study|Withdrawal by Subject|1|||
42235613|NCT03457701|76057798|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
42235614|NCT03457701|76057799|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
42235615|NCT03457701|76057798|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
42235616|NCT03457701|76057799|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
42235617|NCT02694978|76057892|FG000|Overall Study|Adverse Event|10|||
42235618|NCT02694978|76057893|FG001|Overall Study|Adverse Event|9|||
42235619|NCT02694978|76057892|FG000|Overall Study|Withdrawal by Subject|22|||
42235620|NCT02694978|76057893|FG001|Overall Study|Withdrawal by Subject|19|||
42235621|NCT02694978|76057892|FG000|Overall Study|Lost to Follow-up|14|||
42235622|NCT02694978|76057893|FG001|Overall Study|Lost to Follow-up|17|||
42235623|NCT02694978|76057892|FG000|Overall Study|Death|4|||
42235624|NCT02694978|76057893|FG001|Overall Study|Death|1|||
42235625|NCT02694978|76057892|FG000|Overall Study|Other-Decision of Participant|6|||
42235626|NCT02694978|76057893|FG001|Overall Study|Other-Decision of Participant|1|||
42235627|NCT02694978|76057892|FG000|Overall Study|Other-Investigator's decision|1|||
42235628|NCT02694978|76057893|FG001|Overall Study|Other-Investigator's decision|0|||
42235629|NCT02694978|76057892|FG000|Overall Study|Other-Unable to be reached|0|||
42235630|NCT02694978|76057893|FG001|Overall Study|Other-Unable to be reached|1|||
42235631|NCT02694978|76057892|FG000|Overall Study|Other-Protocol noncompliant|2|||
42235632|NCT02694978|76057893|FG001|Overall Study|Other-Protocol noncompliant|1|||
42235633|NCT02694978|76057892|FG000|Overall Study|Other-Personal reasons|3|||
42235634|NCT02694978|76057893|FG001|Overall Study|Other-Personal reasons|3|||
42235635|NCT02694978|76057892|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
42235636|NCT02694978|76057893|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
42235637|NCT02563002|76057901|FG000|Overall Study|Death|62|||
42235638|NCT02563002|76057902|FG001|Overall Study|Death|75|||
42235639|NCT02563002|76057901|FG000|Overall Study|Lost to Follow-up|1|||
42235640|NCT02563002|76057902|FG001|Overall Study|Lost to Follow-up|0|||
42235641|NCT02563002|76057901|FG000|Overall Study|Withdrawal by Subject|0|||
42235642|NCT02563002|76057902|FG001|Overall Study|Withdrawal by Subject|9|||
42235643|NCT02563002|76057901|FG000|Overall Study|Ongoing|90|||
42235644|NCT02563002|76057902|FG001|Overall Study|Ongoing|70|||
42235645|NCT02454933|76057913|FG000|Overall Study|Progressive disease|7|||
42235646|NCT02454933|76057914|FG001|Overall Study|Progressive disease|5|||
42235647|NCT02454933|76057913|FG000|Overall Study|Adverse Event|1|||
42235648|NCT02454933|76057914|FG001|Overall Study|Adverse Event|1|||
42235649|NCT02454933|76057913|FG000|Overall Study|Withdrawal by Subject|0|||
41987553|NCT01289041|75794810|FG000|Overall Study|Adverse Event|24|||
42235650|NCT02454933|76057914|FG001|Overall Study|Withdrawal by Subject|2|||
42235651|NCT02430480|76057919|FG000|Overall Study|Death|1|||
42235652|NCT02430480|76057919|FG000|Overall Study|Anesthesia concerns|1|||
42235653|NCT02430480|76057919|FG000|Overall Study|Progressed on treatment|1|||
42235654|NCT01796197|76057931|FG000|Overall Study|Lost to Follow-up|1|||
42235655|NCT01796197|76057931|FG000|Overall Study|Lack of Efficacy|1|||
42235656|NCT01205048|76057937|FG000|Overall Study|Withdrawal by Subject|14|||
42235657|NCT01205048|76057937|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
42235658|NCT01205048|76057937|FG000|Overall Study|Lost to Follow-up|4|||
42235659|NCT01205048|76057937|FG000|Overall Study|Other|2|||
42235660|NCT01052779|76057945|FG000|Overall Study|Adverse Event|1|||
42235661|NCT01052779|76057946|FG001|Overall Study|Adverse Event|4|||
42235662|NCT01052779|76057945|FG000|Overall Study|Withdrawal by Subject|1|||
42235663|NCT01052779|76057946|FG001|Overall Study|Withdrawal by Subject|2|||
42235664|NCT01052779|76057945|FG000|Overall Study|Other-Protocol Violation|1|||
42235665|NCT01052779|76057946|FG001|Overall Study|Other-Protocol Violation|1|||
42235666|NCT01052779|76057945|FG000|Overall Study|Other-Surgery|0|||
42235667|NCT01052779|76057946|FG001|Overall Study|Other-Surgery|2|||
42235668|NCT01052779|76057945|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
42235669|NCT01052779|76057946|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
42235670|NCT00591370|76057956|FG000|Overall Study|Not Treated|2|||
42235671|NCT03064763|76057960|FG000|Overall Study|Lost to Follow-up|1|||
42235672|NCT03064763|76057960|FG000|Overall Study|Death|8|||
42235673|NCT02782676|76057964|FG000|Overall Study|Lost to Follow-up|0|||
42235674|NCT02782676|76057965|FG001|Overall Study|Lost to Follow-up|1|||
42235675|NCT02471339|76057973|FG000|Overall Study|Did not provide follow-up data|2|||
42235676|NCT02471339|76057974|FG001|Overall Study|Did not provide follow-up data|0|||
42235677|NCT00107978|76057982|FG000|Overall Study|Adverse Event|1|||
42235678|NCT00107978|76057983|FG001|Overall Study|Adverse Event|5|||
42235679|NCT00107978|76057982|FG000|Overall Study|Death|3|||
42235680|NCT00107978|76057983|FG001|Overall Study|Death|3|||
42235681|NCT00107978|76057982|FG000|Overall Study|Lost to Follow-up|20|||
42235682|NCT00107978|76057983|FG001|Overall Study|Lost to Follow-up|28|||
42235683|NCT00107978|76057982|FG000|Overall Study|Withdrawal by Subject|4|||
42235684|NCT00107978|76057983|FG001|Overall Study|Withdrawal by Subject|9|||
42235685|NCT00107978|76057982|FG000|Overall Study|Protocol Violation|0|||
42235686|NCT00107978|76057983|FG001|Overall Study|Protocol Violation|1|||
42235687|NCT00107978|76057982|FG000|Overall Study|Other|5|||
42235688|NCT00107978|76057983|FG001|Overall Study|Other|4|||
42032678|NCT01192100|75840931|FG001|Overall Study|Protocol Violation|0|||
42032679|NCT01192100|75840932|FG002|Overall Study|Protocol Violation|0|||
42032680|NCT01192100|75840933|FG003|Overall Study|Protocol Violation|1|||
42032681|NCT01192100|75840934|FG004|Overall Study|Protocol Violation|0|||
42032682|NCT01192100|75840935|FG005|Overall Study|Protocol Violation|0|||
42032683|NCT00869401|75840948|FG000|Overall Study|Withdrawal by Subject|0|||
42032684|NCT00869401|75840949|FG001|Overall Study|Withdrawal by Subject|0|||
42032685|NCT00869401|75840950|FG002|Overall Study|Withdrawal by Subject|0|||
42032686|NCT00869401|75840951|FG003|Overall Study|Withdrawal by Subject|5|||
42032687|NCT00869401|75840952|FG004|Overall Study|Withdrawal by Subject|3|||
42032688|NCT01076010|75840967|FG000|Overall Study|Death|15|||
42032689|NCT01076010|75840968|FG001|Overall Study|Death|1|||
42032690|NCT01076010|75840969|FG002|Overall Study|Death|0|||
42032691|NCT01076010|75840967|FG000|Overall Study|Adverse Event|7|||
42032692|NCT01076010|75840968|FG001|Overall Study|Adverse Event|2|||
42032693|NCT01076010|75840969|FG002|Overall Study|Adverse Event|0|||
42032694|NCT01076010|75840967|FG000|Overall Study|Progressive disease|90|||
42032695|NCT01076010|75840968|FG001|Overall Study|Progressive disease|30|||
42032696|NCT01076010|75840969|FG002|Overall Study|Progressive disease|1|||
42032697|NCT01076010|75840967|FG000|Overall Study|Lack of Efficacy|4|||
42032698|NCT01076010|75840968|FG001|Overall Study|Lack of Efficacy|0|||
42131867|NCT00332488|75942738|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
42235689|NCT02781818|76057992|FG000|Overall Study|Lost to Follow-up|4|||
42235690|NCT02781818|76057993|FG001|Overall Study|Lost to Follow-up|2|||
42235691|NCT02781818|76057994|FG002|Overall Study|Lost to Follow-up|1|||
42235692|NCT02927873|76058008|FG000|Overall Study|Lost to Follow-up|0|||
42235693|NCT02927873|76058009|FG001|Overall Study|Lost to Follow-up|1|||
42235694|NCT02927873|76058010|FG002|Overall Study|Lost to Follow-up|0|||
42235695|NCT02927873|76058011|FG003|Overall Study|Lost to Follow-up|0|||
42235696|NCT02927873|76058012|FG004|Overall Study|Lost to Follow-up|0|||
42235697|NCT02927873|76058013|FG005|Overall Study|Lost to Follow-up|0|||
42235698|NCT02927873|76058008|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
42032699|NCT01076010|75840969|FG002|Overall Study|Lack of Efficacy|0|||
42235699|NCT02927873|76058009|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
42235700|NCT02927873|76058010|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
42235701|NCT02927873|76058011|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
42235702|NCT02927873|76058012|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
42235703|NCT02927873|76058013|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
42235704|NCT02927873|76058008|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42235705|NCT02927873|76058009|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42235706|NCT02927873|76058010|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42235707|NCT02927873|76058011|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42235708|NCT02927873|76058012|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42235709|NCT02927873|76058013|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
42235710|NCT02927873|76058008|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
42235711|NCT02927873|76058009|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
42235712|NCT02927873|76058010|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
42235713|NCT02927873|76058011|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
42235714|NCT02927873|76058012|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
42235715|NCT02927873|76058013|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
42235716|NCT02927873|76058008|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
42235717|NCT02927873|76058009|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
42235718|NCT02927873|76058010|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
41987554|NCT01289041|75794810|FG000|Overall Study|Physician Decision|1|||
42235719|NCT02927873|76058011|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
42235720|NCT02927873|76058012|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
42235721|NCT02927873|76058013|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
42235722|NCT02927873|76058008|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
42235723|NCT02927873|76058009|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
42235724|NCT02927873|76058010|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
42235725|NCT02927873|76058011|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
42235726|NCT02927873|76058012|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
42235727|NCT02927873|76058013|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
42235728|NCT01220999|76058032|FG000|Overall Study|Progressive disease|0|||
42235729|NCT01220999|76058033|FG001|Overall Study|Progressive disease|0|||
42235730|NCT01220999|76058034|FG002|Overall Study|Progressive disease|1|||
42235731|NCT01220999|76058035|FG003|Overall Study|Progressive disease|0|||
42235732|NCT01220999|76058036|FG004|Overall Study|Progressive disease|0|||
42235733|NCT00142415|76058054|FG000|Overall Study|Physician Decision|0|||
42235734|NCT00142415|76058055|FG001|Overall Study|Physician Decision|0|||
41987555|NCT01289041|75794810|FG000|Overall Study|Progressive Disease|41|||
41987556|NCT01289041|75794810|FG000|Overall Study|Withdrawal by Subject|3|||
41987557|NCT01289041|75794810|FG000|Overall Study|Death|1|||
41987558|NCT01288729|75794818|FG000|Overall Study|Withdrawal by Subject|1|||
41987559|NCT01288729|75794819|FG001|Overall Study|Withdrawal by Subject|0|||
41987560|NCT01288612|75794828|FG000|Overall Study|Unable to contact|11|||
41987561|NCT01288612|75794829|FG001|Overall Study|Unable to contact|16|||
41987562|NCT01288612|75794830|FG002|Overall Study|Unable to contact|20|||
41987563|NCT01288612|75794828|FG000|Overall Study|Declined|78|||
41987564|NCT01288612|75794829|FG001|Overall Study|Declined|63|||
41987565|NCT01288612|75794830|FG002|Overall Study|Declined|62|||
41987566|NCT01288612|75794828|FG000|Overall Study|Unable to intubate|0|||
41987567|NCT01288612|75794829|FG001|Overall Study|Unable to intubate|3|||
41987568|NCT01288612|75794830|FG002|Overall Study|Unable to intubate|0|||
42235735|NCT00142415|76058056|FG002|Overall Study|Physician Decision|0|||
41987569|NCT01287832|75794840|FG000|Overall Study|Adverse Event|1|||
41987570|NCT01287832|75794841|FG001|Overall Study|Adverse Event|0|||
41987571|NCT01287832|75794840|FG000|Overall Study|Death|0|||
41987572|NCT01287832|75794841|FG001|Overall Study|Death|1|||
41987573|NCT01287754|75794849|FG000|Overall Study|Death|2|||
41987574|NCT01287754|75794850|FG001|Overall Study|Death|12|||
41987575|NCT01287754|75794849|FG000|Overall Study|Lost to Follow-up|1|||
41987576|NCT01287754|75794850|FG001|Overall Study|Lost to Follow-up|6|||
42235736|NCT00142415|76058057|FG003|Overall Study|Physician Decision|0|||
42235737|NCT00142415|76058058|FG004|Overall Study|Physician Decision|1|||
42235738|NCT00142415|76058059|FG005|Overall Study|Physician Decision|2|||
42235739|NCT02781584|76058101|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
42235740|NCT02781584|76058102|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
42235741|NCT02781584|76058103|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
42235742|NCT02781584|76058104|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
42235743|NCT02781584|76058105|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
42235744|NCT02781584|76058106|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
42235745|NCT02781584|76058107|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
42235746|NCT02781584|76058108|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
42235747|NCT02781584|76058109|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
42235748|NCT02781584|76058110|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
42235749|NCT02781584|76058111|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
42235750|NCT02781584|76058112|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
42235751|NCT02781584|76058113|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
42235752|NCT02781584|76058101|FG000|Pre-treatment Phase|Adverse Event|0|||
42235753|NCT02781584|76058102|FG001|Pre-treatment Phase|Adverse Event|0|||
42235754|NCT02781584|76058103|FG002|Pre-treatment Phase|Adverse Event|0|||
42235755|NCT02781584|76058104|FG003|Pre-treatment Phase|Adverse Event|0|||
42235756|NCT02781584|76058105|FG004|Pre-treatment Phase|Adverse Event|0|||
42235757|NCT02781584|76058106|FG005|Pre-treatment Phase|Adverse Event|0|||
42235758|NCT02781584|76058107|FG006|Pre-treatment Phase|Adverse Event|0|||
42235759|NCT02781584|76058108|FG007|Pre-treatment Phase|Adverse Event|0|||
42235760|NCT02781584|76058109|FG008|Pre-treatment Phase|Adverse Event|0|||
42235761|NCT02781584|76058110|FG009|Pre-treatment Phase|Adverse Event|0|||
42235762|NCT02781584|76058111|FG010|Pre-treatment Phase|Adverse Event|0|||
42235763|NCT02781584|76058112|FG011|Pre-treatment Phase|Adverse Event|1|||
42235764|NCT02781584|76058113|FG012|Pre-treatment Phase|Adverse Event|0|||
42235765|NCT02781584|76058101|FG000|Treatment Phase|Withdrew Consent|0|||
42235766|NCT02781584|76058102|FG001|Treatment Phase|Withdrew Consent|0|||
42235767|NCT02781584|76058103|FG002|Treatment Phase|Withdrew Consent|0|||
41987577|NCT01287754|75794849|FG000|Overall Study|Protocol Violation|0|||
42235768|NCT02781584|76058104|FG003|Treatment Phase|Withdrew Consent|0|||
42235769|NCT02781584|76058105|FG004|Treatment Phase|Withdrew Consent|0|||
42235770|NCT02781584|76058106|FG005|Treatment Phase|Withdrew Consent|1|||
42235771|NCT02781584|76058107|FG006|Treatment Phase|Withdrew Consent|0|||
42235772|NCT02781584|76058108|FG007|Treatment Phase|Withdrew Consent|0|||
42235773|NCT02781584|76058109|FG008|Treatment Phase|Withdrew Consent|0|||
42235774|NCT02781584|76058110|FG009|Treatment Phase|Withdrew Consent|0|||
42235775|NCT02781584|76058111|FG010|Treatment Phase|Withdrew Consent|1|||
42235776|NCT02781584|76058112|FG011|Treatment Phase|Withdrew Consent|2|||
42235777|NCT02781584|76058113|FG012|Treatment Phase|Withdrew Consent|0|||
42235778|NCT02781584|76058101|FG000|Treatment Phase|Adverse Event|0|||
42235779|NCT02781584|76058102|FG001|Treatment Phase|Adverse Event|0|||
42235780|NCT02781584|76058103|FG002|Treatment Phase|Adverse Event|0|||
42235781|NCT02781584|76058104|FG003|Treatment Phase|Adverse Event|0|||
42235782|NCT02781584|76058105|FG004|Treatment Phase|Adverse Event|0|||
42235783|NCT02781584|76058106|FG005|Treatment Phase|Adverse Event|0|||
42235784|NCT02781584|76058107|FG006|Treatment Phase|Adverse Event|0|||
42235785|NCT02781584|76058108|FG007|Treatment Phase|Adverse Event|1|||
41987578|NCT01287754|75794850|FG001|Overall Study|Protocol Violation|3|||
41987579|NCT01287520|75794865|FG000|Overall Study|Adverse Event|2|||
41987580|NCT01287520|75794866|FG001|Overall Study|Adverse Event|2|||
41987581|NCT01287520|75794867|FG002|Overall Study|Adverse Event|2|||
41987582|NCT01287520|75794868|FG003|Overall Study|Adverse Event|1|||
41987583|NCT01287520|75794869|FG004|Overall Study|Adverse Event|1|||
42235786|NCT02781584|76058109|FG008|Treatment Phase|Adverse Event|0|||
42235787|NCT02781584|76058110|FG009|Treatment Phase|Adverse Event|0|||
42235788|NCT02781584|76058111|FG010|Treatment Phase|Adverse Event|0|||
42235789|NCT02781584|76058112|FG011|Treatment Phase|Adverse Event|0|||
42235790|NCT02781584|76058113|FG012|Treatment Phase|Adverse Event|0|||
42235791|NCT02776670|76058143|FG000|Overall Study|Adverse Event|0|||
42235792|NCT02776670|76058144|FG001|Overall Study|Adverse Event|2|||
42235793|NCT02776670|76058143|FG000|Overall Study|Protocol Violation|0|||
42235794|NCT02776670|76058144|FG001|Overall Study|Protocol Violation|2|||
42235795|NCT02776670|76058143|FG000|Overall Study|Withdrawal by Subject|0|||
42235796|NCT02776670|76058144|FG001|Overall Study|Withdrawal by Subject|1|||
41987584|NCT01287520|75794870|FG005|Overall Study|Adverse Event|2|||
41987585|NCT01287520|75794871|FG006|Overall Study|Adverse Event|0|||
41987586|NCT01287520|75794872|FG007|Overall Study|Adverse Event|2|||
42235797|NCT02776670|76058143|FG000|Overall Study|Other - Reason not given|0|||
42235798|NCT02776670|76058144|FG001|Overall Study|Other - Reason not given|1|||
42235799|NCT01307423|76058153|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
42235800|NCT01307423|76058154|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
42235801|NCT01307423|76058155|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
42235802|NCT01307423|76058156|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42235803|NCT01307423|76058157|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
41987587|NCT01287520|75794873|FG008|Overall Study|Adverse Event|0|||
41987588|NCT01287520|75794865|FG000|Overall Study|Physician Decision|1|||
41987589|NCT01287520|75794866|FG001|Overall Study|Physician Decision|1|||
41987590|NCT01287520|75794867|FG002|Overall Study|Physician Decision|2|||
41987591|NCT01287520|75794868|FG003|Overall Study|Physician Decision|0|||
41987592|NCT01287520|75794869|FG004|Overall Study|Physician Decision|1|||
42235804|NCT01307423|76058158|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42235805|NCT01307423|76058159|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42235806|NCT01307423|76058160|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42235807|NCT01307423|76058161|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42235808|NCT01307423|76058153|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
42235809|NCT01307423|76058154|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
42235810|NCT01307423|76058155|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
42235811|NCT01307423|76058156|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
41987593|NCT01287520|75794870|FG005|Overall Study|Physician Decision|1|||
41987594|NCT01287520|75794871|FG006|Overall Study|Physician Decision|0|||
41987595|NCT01287520|75794872|FG007|Overall Study|Physician Decision|1|||
41987596|NCT01287520|75794873|FG008|Overall Study|Physician Decision|0|||
41987597|NCT01287520|75794865|FG000|Overall Study|Progressive disease|0|||
41987598|NCT01287520|75794866|FG001|Overall Study|Progressive disease|4|||
42235812|NCT01307423|76058157|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42235813|NCT01307423|76058158|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42235814|NCT01307423|76058159|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42235815|NCT01307423|76058160|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42235816|NCT01307423|76058161|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42235817|NCT01307423|76058153|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
42235818|NCT01307423|76058154|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
42235819|NCT01307423|76058155|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
42235820|NCT01307423|76058156|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42235821|NCT01307423|76058157|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42235822|NCT01307423|76058158|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42235823|NCT01307423|76058159|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42235824|NCT01307423|76058160|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42235825|NCT01307423|76058161|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42235826|NCT01307423|76058153|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
42235827|NCT01307423|76058154|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
42235828|NCT01307423|76058155|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
42235829|NCT01307423|76058156|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
42235830|NCT01307423|76058157|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
41987599|NCT01287520|75794867|FG002|Overall Study|Progressive disease|1|||
41987600|NCT01287520|75794868|FG003|Overall Study|Progressive disease|6|||
41987601|NCT01287520|75794869|FG004|Overall Study|Progressive disease|1|||
41987602|NCT01287520|75794870|FG005|Overall Study|Progressive disease|0|||
41987603|NCT01287520|75794871|FG006|Overall Study|Progressive disease|2|||
41987604|NCT01287520|75794872|FG007|Overall Study|Progressive disease|2|||
41987605|NCT01287520|75794873|FG008|Overall Study|Progressive disease|4|||
42032700|NCT01076010|75840967|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
42032701|NCT01076010|75840968|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
42032702|NCT01076010|75840969|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
42235831|NCT01307423|76058158|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
42235832|NCT01307423|76058159|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
42302582|NCT02469961|76137832|FG000|Overall Study|Physician Decision|4|||
42302583|NCT02469961|76137833|FG001|Overall Study|Physician Decision|1|||
42302584|NCT02415595|76137848|FG000|Overall Study|Administrative reason by sponsor|39|||
42302585|NCT02415595|76137849|FG001|Overall Study|Administrative reason by sponsor|40|||
42302586|NCT02415595|76137850|FG002|Overall Study|Administrative reason by sponsor|41|||
42302587|NCT02415595|76137851|FG003|Overall Study|Administrative reason by sponsor|39|||
42302588|NCT02415595|76137848|FG000|Overall Study|Adverse Event|1|||
42302589|NCT02415595|76137849|FG001|Overall Study|Adverse Event|3|||
42235833|NCT01307423|76058160|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
42235834|NCT01307423|76058161|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
42235835|NCT01307423|76058153|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
42235836|NCT01307423|76058154|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
42302590|NCT02415595|76137850|FG002|Overall Study|Adverse Event|5|||
42302591|NCT02415595|76137851|FG003|Overall Study|Adverse Event|10|||
41987606|NCT01287520|75794865|FG000|Overall Study|Withdrawal by Subject|0|||
41987607|NCT01287520|75794866|FG001|Overall Study|Withdrawal by Subject|0|||
41987608|NCT01287520|75794867|FG002|Overall Study|Withdrawal by Subject|0|||
41987609|NCT01287520|75794868|FG003|Overall Study|Withdrawal by Subject|0|||
41987610|NCT01287520|75794869|FG004|Overall Study|Withdrawal by Subject|0|||
41987611|NCT01287520|75794870|FG005|Overall Study|Withdrawal by Subject|1|||
41987612|NCT01287520|75794871|FG006|Overall Study|Withdrawal by Subject|0|||
41987613|NCT01287520|75794872|FG007|Overall Study|Withdrawal by Subject|0|||
41987614|NCT01287520|75794873|FG008|Overall Study|Withdrawal by Subject|1|||
41987615|NCT01287403|75794922|FG000|1st Intervention (1 Day)|Adverse Event|1|||
41987616|NCT01287364|75794938|FG000|Overall Study|Adverse Event|0|||
42235837|NCT01307423|76058155|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
42235838|NCT01307423|76058156|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42235839|NCT01307423|76058157|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42235840|NCT01307423|76058158|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42235841|NCT01307423|76058159|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42235842|NCT01307423|76058160|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42235843|NCT01307423|76058161|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42235844|NCT01307423|76058153|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
42235845|NCT01307423|76058154|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42235846|NCT01307423|76058155|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42235847|NCT01307423|76058156|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42235848|NCT01307423|76058157|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42235849|NCT01307423|76058158|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42235850|NCT01307423|76058159|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
41987617|NCT01287364|75794939|FG001|Overall Study|Adverse Event|3|||
42235851|NCT01307423|76058160|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42235852|NCT01307423|76058161|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42235853|NCT01307423|76058153|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
42302592|NCT02415595|76137848|FG000|Overall Study|Lack of Efficacy|4|||
42302593|NCT02415595|76137849|FG001|Overall Study|Lack of Efficacy|4|||
42302594|NCT02415595|76137850|FG002|Overall Study|Lack of Efficacy|0|||
42302595|NCT02415595|76137851|FG003|Overall Study|Lack of Efficacy|0|||
42302596|NCT02415595|76137848|FG000|Overall Study|Lost to Follow-up|1|||
42302597|NCT02415595|76137849|FG001|Overall Study|Lost to Follow-up|3|||
42302598|NCT02415595|76137850|FG002|Overall Study|Lost to Follow-up|1|||
42302599|NCT02415595|76137851|FG003|Overall Study|Lost to Follow-up|1|||
42302600|NCT02415595|76137848|FG000|Overall Study|Poor/Non-compliance|1|||
42302601|NCT02415595|76137849|FG001|Overall Study|Poor/Non-compliance|0|||
42302602|NCT02415595|76137850|FG002|Overall Study|Poor/Non-compliance|1|||
42302603|NCT02415595|76137851|FG003|Overall Study|Poor/Non-compliance|0|||
42302604|NCT02415595|76137848|FG000|Overall Study|Reached stopping criteria|0|||
42302605|NCT02415595|76137849|FG001|Overall Study|Reached stopping criteria|1|||
42235854|NCT01307423|76058154|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
42235855|NCT01307423|76058155|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
42235856|NCT01307423|76058156|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
42235857|NCT01307423|76058157|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
42235858|NCT01307423|76058158|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
42235859|NCT01307423|76058159|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
42235860|NCT01307423|76058160|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
42235861|NCT01307423|76058161|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
42235862|NCT01307423|76058153|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
42235863|NCT01307423|76058154|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
42235864|NCT01307423|76058155|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
42235865|NCT01307423|76058156|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
41987618|NCT01287364|75794938|FG000|Overall Study|Protocol Violation|5|||
41987619|NCT01287364|75794939|FG001|Overall Study|Protocol Violation|5|||
41987620|NCT01287364|75794938|FG000|Overall Study|Other Reason|4|||
41987621|NCT01287364|75794939|FG001|Overall Study|Other Reason|2|||
41987622|NCT02889835|75794958|FG000|Overall Study|Lost to Follow-up|13|||
41987623|NCT02889835|75794959|FG001|Overall Study|Lost to Follow-up|13|||
41987624|NCT02889835|75794960|FG002|Overall Study|Lost to Follow-up|13|||
42302606|NCT02415595|76137850|FG002|Overall Study|Reached stopping criteria|1|||
42235866|NCT01307423|76058157|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
42235867|NCT01307423|76058158|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
42302607|NCT02415595|76137851|FG003|Overall Study|Reached stopping criteria|0|||
42302608|NCT02415595|76137848|FG000|Overall Study|Withdrawal by Subject|4|||
42302609|NCT02415595|76137849|FG001|Overall Study|Withdrawal by Subject|0|||
41987625|NCT02889835|75794958|FG000|Overall Study|Withdrawal by Subject|2|||
41987626|NCT02889835|75794959|FG001|Overall Study|Withdrawal by Subject|2|||
41987627|NCT02889835|75794960|FG002|Overall Study|Withdrawal by Subject|2|||
41987628|NCT02889835|75794958|FG000|Overall Study|Protocol Violation|1|||
42302610|NCT02415595|76137850|FG002|Overall Study|Withdrawal by Subject|1|||
41987629|NCT02889835|75794959|FG001|Overall Study|Protocol Violation|1|||
41987630|NCT02889835|75794960|FG002|Overall Study|Protocol Violation|1|||
41987631|NCT02889835|75794958|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
41987632|NCT02889835|75794959|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
42235868|NCT01307423|76058159|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
42235869|NCT01307423|76058160|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
42235870|NCT01307423|76058161|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
42235871|NCT01307423|76058153|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
42235872|NCT01307423|76058154|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
42235873|NCT01307423|76058155|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
42235874|NCT01307423|76058156|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
42235875|NCT01307423|76058157|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
42235876|NCT01307423|76058158|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
42235877|NCT01307423|76058159|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
42235878|NCT01307423|76058160|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
42235879|NCT01307423|76058161|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
42235880|NCT01307423|76058153|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
42235881|NCT01307423|76058154|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
42235882|NCT01307423|76058155|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
42235883|NCT01307423|76058156|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
42235884|NCT01307423|76058157|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
42235885|NCT01307423|76058158|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
42235886|NCT01307423|76058159|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
42235887|NCT01307423|76058160|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
42235888|NCT01307423|76058161|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
42235889|NCT01307423|76058153|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
42235890|NCT01307423|76058154|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
42235891|NCT01307423|76058155|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
42235892|NCT01307423|76058156|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
42235893|NCT01307423|76058157|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
42235894|NCT01307423|76058158|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
42235895|NCT01307423|76058159|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
42235896|NCT01307423|76058160|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
42235897|NCT01307423|76058161|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
42235898|NCT01307423|76058153|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
42235899|NCT01307423|76058154|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
42235900|NCT01307423|76058155|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
42235901|NCT01307423|76058156|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
42235902|NCT01307423|76058157|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
42235903|NCT01307423|76058158|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
42235904|NCT01307423|76058159|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
42235905|NCT01307423|76058160|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
42235906|NCT01307423|76058161|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
42235907|NCT01307423|76058153|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
42235908|NCT01307423|76058154|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
42235909|NCT01307423|76058155|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
42235910|NCT01307423|76058156|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
42235911|NCT01307423|76058157|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
42235912|NCT01307423|76058158|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
42235913|NCT01307423|76058159|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
42235914|NCT01307423|76058160|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
42235915|NCT01307423|76058161|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
42235916|NCT01307423|76058153|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
42235917|NCT01307423|76058154|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
42235918|NCT01307423|76058155|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
42235919|NCT01307423|76058156|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
42235920|NCT01307423|76058157|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
42235921|NCT01307423|76058158|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
42235922|NCT01307423|76058159|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
42235923|NCT01307423|76058160|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
42235924|NCT01307423|76058161|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
42235925|NCT01307423|76058153|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
42235926|NCT01307423|76058154|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
41987633|NCT02889835|75794960|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
41987634|NCT02889835|75794958|FG000|Overall Study|Death|1|||
41987635|NCT02889835|75794959|FG001|Overall Study|Death|1|||
41987636|NCT02889835|75794960|FG002|Overall Study|Death|1|||
41987637|NCT01287013|75794971|FG000|Overall Study|Non-evaluable|3|||
41987638|NCT01287013|75794972|FG001|Overall Study|Non-evaluable|5|||
41987639|NCT01287013|75794973|FG002|Overall Study|Non-evaluable|21|||
41987640|NCT01286779|75794981|FG000|Overall Study|Withdrawal by Subject|9|||
42235927|NCT01307423|76058155|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
42235928|NCT01307423|76058156|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
42235929|NCT01307423|76058157|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
42235930|NCT01307423|76058158|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
42235931|NCT01307423|76058159|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
42235932|NCT01307423|76058160|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
42235933|NCT01307423|76058161|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
42235934|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
42235935|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
42235936|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
42235937|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
42235938|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
42235939|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
42235940|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
42235941|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
42235942|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
42235943|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
42235944|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
42235945|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
42235946|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
42235947|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
42235948|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
42235949|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
42235950|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
42235951|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
42235952|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
42235953|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
42235954|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
42235955|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
42235956|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
42235957|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
42235958|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
42235959|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
42235960|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
42235961|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
42235962|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
42235963|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
42235964|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
42235965|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
42235966|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
42235967|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
42235968|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
42235969|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
42235970|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42235971|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
42235972|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42235973|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42235974|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42235975|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42235976|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
42235977|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
42235978|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
42235979|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
42235980|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
42235981|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
42235982|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
42235983|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
42235984|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
42235985|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
42235986|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
42235987|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
42235988|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
42235989|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
42235990|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
42235991|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
42235992|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
42235993|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
42235994|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
42235995|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
42235996|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
42235997|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
42235998|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
42235999|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
42236000|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
42236001|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
42236002|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
42236003|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
42236004|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
42236005|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
42236006|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
42236007|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
42236008|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
42236009|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
42236010|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
42236011|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
42236012|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
42236013|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
42236014|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
42236015|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42236016|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
42236017|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
42236018|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42236019|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42236020|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42236021|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
42236022|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
42236023|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
42236024|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
42236025|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
42236026|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
42236027|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
42236028|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
42236029|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
42236030|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
42236031|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
42236032|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
42236033|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42236034|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
42236035|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42236036|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42236037|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42236038|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42236039|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42236040|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42236041|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
42236042|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42236043|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
42236044|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42236045|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42236046|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42236047|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42236048|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42236049|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
42236050|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
42236051|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42236052|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
42236053|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
42236054|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42236055|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42236056|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42236057|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
42236058|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
42236059|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
42236060|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42236061|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42236062|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
42236063|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42236064|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42236065|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42236066|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42236067|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42236068|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
42236069|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42236070|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42236071|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42236072|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42236073|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42236074|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42236075|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
41987641|NCT01286779|75794981|FG000|Overall Study|Protocol Violation|5|||
41987642|NCT01286779|75794981|FG000|Overall Study|Physician Decision|2|||
42236076|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
42236077|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
42236078|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42236079|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
42236080|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
42236081|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42236082|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42236083|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42236084|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42236085|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
42236086|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
42236087|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42236088|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
42236089|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
42236090|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42236091|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42236092|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42236093|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42236094|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42236095|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
42236096|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42236097|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
42236098|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
42236099|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42236100|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42236101|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42236102|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42236103|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
42236104|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
42236105|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
42236106|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
42236107|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
42236108|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
42236109|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
42236110|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
42236111|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
41987643|NCT01286779|75794981|FG000|Overall Study|Participant had scheduled surgery|1|||
41987644|NCT01286779|75794981|FG000|Overall Study|Participant moved to another country|1|||
41987645|NCT01286779|75794981|FG000|Overall Study|Discontinued by sponsor|1|||
41987646|NCT01286740|75794995|FG000|Overall Study|Enrolled but not treated|1|||
41987647|NCT01286740|75794995|FG000|Overall Study|Protocol Violation|1|||
41987648|NCT01286311|75795001|FG000|Overall Study|Physician did not want outreach sent|14|||
41987649|NCT01286311|75795002|FG001|Overall Study|Physician did not want outreach sent|0|||
42236112|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
42236113|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
42236114|NCT01307423|76058153|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42236115|NCT01307423|76058154|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42236116|NCT01307423|76058155|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
42236117|NCT01307423|76058156|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
41987650|NCT01286077|75795010|FG000|Overall Study|Adverse Event|2|||
41987651|NCT01286077|75795011|FG001|Overall Study|Adverse Event|0|||
42236118|NCT01307423|76058157|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42236119|NCT01307423|76058158|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42236120|NCT01307423|76058159|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
42236121|NCT01307423|76058160|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
42236122|NCT01307423|76058161|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
42236123|NCT02778074|76058195|FG000|Overall Study|Lost to Follow-up|7|||
42236124|NCT02778074|76058196|FG001|Overall Study|Lost to Follow-up|10|||
42236125|NCT02775344|76058213|FG000|Overall Study|No ovarian cyst identified|3|||
42236126|NCT02775344|76058214|FG001|Overall Study|No ovarian cyst identified|2|||
42236127|NCT02777918|76058222|FG000|Overall Study|Medical reasons|1|||
42236128|NCT02777918|76058223|FG001|Overall Study|Medical reasons|2|||
42236129|NCT02777918|76058222|FG000|Overall Study|Too busy / stressed|1|||
42236130|NCT02777918|76058223|FG001|Overall Study|Too busy / stressed|1|||
42236131|NCT02777918|76058222|FG000|Overall Study|Withdrawal by Subject|1|||
42236132|NCT02777918|76058223|FG001|Overall Study|Withdrawal by Subject|1|||
42236133|NCT02927795|76058229|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
42236134|NCT02927795|76058229|FG000|Overall Study|Not Treated|4|||
42236135|NCT02767856|76058235|FG000|Overall Study|Lost to Follow-up|9|||
42236136|NCT02767856|76058236|FG001|Overall Study|Lost to Follow-up|1|||
42236137|NCT02767856|76058235|FG000|Overall Study|Withdrawal by Subject|2|||
42236138|NCT02767856|76058236|FG001|Overall Study|Withdrawal by Subject|1|||
42236139|NCT03087851|76058245|FG000|Overall Study|Withdraw on medical grounds|0|||
42236140|NCT03087851|76058246|FG001|Overall Study|Withdraw on medical grounds|1|||
42236141|NCT03087851|76058247|FG002|Overall Study|Withdraw on medical grounds|2|||
42236142|NCT03092375|76058259|FG000|Overall Study|Lack of Efficacy|0|||
42236143|NCT03092375|76058260|FG001|Overall Study|Lack of Efficacy|1|||
42236144|NCT03092375|76058261|FG002|Overall Study|Lack of Efficacy|1|||
42236145|NCT03092375|76058262|FG003|Overall Study|Lack of Efficacy|0|||
42236146|NCT01995513|76058279|FG000|Period 1: First Open Label Treatment|Other|34|||
42236147|NCT01995513|76058280|FG001|Period 1: First Open Label Treatment|Other|0|||
42236148|NCT01995513|76058281|FG002|Period 1: First Open Label Treatment|Other|0|||
42236149|NCT01995513|76058282|FG003|Period 1: First Open Label Treatment|Other|0|||
42236150|NCT01995513|76058279|FG000|Period 1: First Open Label Treatment|Death|14|||
42236151|NCT01995513|76058280|FG001|Period 1: First Open Label Treatment|Death|0|||
42236152|NCT01995513|76058281|FG002|Period 1: First Open Label Treatment|Death|0|||
42236153|NCT01995513|76058282|FG003|Period 1: First Open Label Treatment|Death|0|||
42236154|NCT01995513|76058279|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
42236155|NCT01995513|76058280|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
42236156|NCT01995513|76058281|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
42236157|NCT01995513|76058282|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
42236158|NCT01995513|76058279|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
42236159|NCT01995513|76058280|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
42236160|NCT01995513|76058281|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
42236161|NCT01995513|76058282|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
42236162|NCT01995513|76058279|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
42236163|NCT01995513|76058280|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
42236164|NCT01995513|76058281|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
42236165|NCT01995513|76058282|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
42236166|NCT01995513|76058279|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
42236167|NCT01995513|76058280|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
42236168|NCT01995513|76058281|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
42236169|NCT01995513|76058282|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
42236170|NCT01995513|76058279|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
42236171|NCT01995513|76058280|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
42236172|NCT01995513|76058281|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
41987652|NCT01286077|75795010|FG000|Overall Study|Death|1|||
41987653|NCT01286077|75795011|FG001|Overall Study|Death|0|||
41987654|NCT01286077|75795010|FG000|Overall Study|Protocol Violation|1|||
41987655|NCT01286077|75795011|FG001|Overall Study|Protocol Violation|1|||
41987656|NCT01286077|75795010|FG000|Overall Study|Withdrawal by Subject|0|||
41987657|NCT01286077|75795011|FG001|Overall Study|Withdrawal by Subject|2|||
42236173|NCT01995513|76058282|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
41987658|NCT01286077|75795010|FG000|Overall Study|Intercurrent illness|1|||
41987659|NCT01286077|75795011|FG001|Overall Study|Intercurrent illness|0|||
41987660|NCT01286077|75795010|FG000|Overall Study|Non-compliance|1|||
41987661|NCT01286077|75795011|FG001|Overall Study|Non-compliance|0|||
41987662|NCT01286077|75795010|FG000|Overall Study|The subject starts with alternative MMY|0|||
41987663|NCT01286077|75795011|FG001|Overall Study|The subject starts with alternative MMY|3|||
41987664|NCT01286077|75795010|FG000|Overall Study|Patient's decision to stop treatment|3|||
42236174|NCT01995513|76058279|FG000|Period 1: Second Open Label Treatment|Other|0|||
42236175|NCT01995513|76058280|FG001|Period 1: Second Open Label Treatment|Other|2|||
42236176|NCT01995513|76058281|FG002|Period 1: Second Open Label Treatment|Other|0|||
42236177|NCT01995513|76058282|FG003|Period 1: Second Open Label Treatment|Other|0|||
42236178|NCT01995513|76058279|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
42236179|NCT01995513|76058280|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
42236180|NCT01995513|76058281|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
42236181|NCT01995513|76058282|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
42236182|NCT01995513|76058279|FG000|Period 2: Double Blind Treatment|Death|0|||
42236183|NCT01995513|76058280|FG001|Period 2: Double Blind Treatment|Death|0|||
42236184|NCT01995513|76058281|FG002|Period 2: Double Blind Treatment|Death|0|||
42236185|NCT01995513|76058282|FG003|Period 2: Double Blind Treatment|Death|1|||
42236186|NCT01995513|76058279|FG000|Period 2: Double Blind Treatment|Other|0|||
42236187|NCT01995513|76058280|FG001|Period 2: Double Blind Treatment|Other|0|||
42236188|NCT01995513|76058281|FG002|Period 2: Double Blind Treatment|Other|3|||
42236189|NCT01995513|76058282|FG003|Period 2: Double Blind Treatment|Other|3|||
42236190|NCT01995513|76058279|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
42236191|NCT01995513|76058280|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
42236192|NCT01995513|76058281|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
42236193|NCT01995513|76058282|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
42236194|NCT01995513|76058279|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
42236195|NCT01995513|76058280|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
42236196|NCT01995513|76058281|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
42236197|NCT01995513|76058282|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
42236198|NCT01995513|76058279|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
42236199|NCT01995513|76058280|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
42236200|NCT01995513|76058281|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
42236201|NCT01995513|76058282|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
42236202|NCT01995513|76058279|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
42236203|NCT01995513|76058280|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
42236204|NCT01995513|76058281|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
42236205|NCT01995513|76058282|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
42236206|NCT02927171|76058298|FG000|Overall Study|Lost to Follow-up|0|||
42236207|NCT02927171|76058299|FG001|Overall Study|Lost to Follow-up|1|||
42236208|NCT03087617|76058309|FG000|Overall Study|Lost to Follow-up|32|||
42236209|NCT03087617|76058310|FG001|Overall Study|Lost to Follow-up|30|||
42236210|NCT03087617|76058311|FG002|Overall Study|Lost to Follow-up|30|||
42236211|NCT03087617|76058312|FG003|Overall Study|Lost to Follow-up|39|||
42236212|NCT00103610|76058324|FG000|Overall Study|Entered Rescue Procedure|10|||
42236213|NCT00103610|76058325|FG001|Overall Study|Entered Rescue Procedure|52|||
42236214|NCT00103610|76058324|FG000|Overall Study|Death|16|||
42236215|NCT00103610|76058325|FG001|Overall Study|Death|12|||
42236216|NCT00103610|76058324|FG000|Overall Study|Elective Withdrawal|4|||
42236217|NCT00103610|76058325|FG001|Overall Study|Elective Withdrawal|0|||
42236218|NCT00103610|76058324|FG000|Overall Study|Lost to Follow-up|3|||
42236219|NCT00103610|76058325|FG001|Overall Study|Lost to Follow-up|1|||
42236220|NCT00103610|76058324|FG000|Overall Study|Adverse Event|2|||
42236221|NCT00103610|76058325|FG001|Overall Study|Adverse Event|2|||
42236222|NCT00103610|76058324|FG000|Overall Study|Other|2|||
42236223|NCT00103610|76058325|FG001|Overall Study|Other|7|||
42236224|NCT00103610|76058324|FG000|Overall Study|Failed mobilization|1|||
42236225|NCT00103610|76058325|FG001|Overall Study|Failed mobilization|5|||
42236226|NCT00103610|76058324|FG000|Overall Study|Noncompliance|0|||
42236227|NCT00103610|76058325|FG001|Overall Study|Noncompliance|1|||
42236228|NCT03091439|76058334|FG000|Overall Study|Study Terminated by the Sponsor|1|||
42236229|NCT03091439|76058335|FG001|Overall Study|Study Terminated by the Sponsor|0|||
42236230|NCT03086447|76058343|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
42236231|NCT03086447|76058344|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
42236232|NCT03086447|76058343|FG000|Overall Study|Lost Lens|2|||
42236233|NCT03086447|76058344|FG001|Overall Study|Lost Lens|5|||
42236234|NCT03086447|76058343|FG000|Overall Study|Product quality complaint|0|||
42236235|NCT03086447|76058344|FG001|Overall Study|Product quality complaint|1|||
42236236|NCT03086447|76058343|FG000|Overall Study|Lens Damage|1|||
42236237|NCT03086447|76058344|FG001|Overall Study|Lens Damage|6|||
42236238|NCT03086447|76058343|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
42236239|NCT03086447|76058344|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
42236240|NCT03086447|76058343|FG000|Overall Study|Test Article No Longer Available|1|||
42131868|NCT00332488|75942739|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
42131869|NCT00332488|75942737|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
42236241|NCT03086447|76058344|FG001|Overall Study|Test Article No Longer Available|0|||
42236242|NCT03086447|76058343|FG000|Overall Study|Protocol Violation|2|||
42131870|NCT00332488|75942738|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
42236243|NCT03086447|76058344|FG001|Overall Study|Protocol Violation|4|||
42236244|NCT03086447|76058343|FG000|Overall Study|Lost to Follow-up|0|||
42236245|NCT03086447|76058344|FG001|Overall Study|Lost to Follow-up|1|||
42236246|NCT03086447|76058343|FG000|Overall Study|Adverse Event|3|||
42236247|NCT03086447|76058344|FG001|Overall Study|Adverse Event|0|||
42236248|NCT03086447|76058343|FG000|Overall Study|Lens Discomfort|2|||
42236249|NCT03086447|76058344|FG001|Overall Study|Lens Discomfort|1|||
42236250|NCT03083639|76058375|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
42236251|NCT03083639|76058376|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
42236252|NCT03083639|76058375|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
42236253|NCT03083639|76058376|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
42236254|NCT02927431|76058385|FG000|Overall Study|Withdrawal by Subject|0|||
42236255|NCT02927431|76058386|FG001|Overall Study|Withdrawal by Subject|0|||
42236256|NCT02927431|76058387|FG002|Overall Study|Withdrawal by Subject|1|||
42236257|NCT03083483|76058400|FG000|Overall Study|Adverse Event|1|||
42236258|NCT03083483|76058401|FG001|Overall Study|Adverse Event|1|||
42236259|NCT03083483|76058402|FG002|Overall Study|Adverse Event|1|||
42236260|NCT03083483|76058400|FG000|Overall Study|Lost to Follow-up|2|||
42236261|NCT03083483|76058401|FG001|Overall Study|Lost to Follow-up|1|||
42236262|NCT03083483|76058402|FG002|Overall Study|Lost to Follow-up|1|||
42236263|NCT03083483|76058400|FG000|Overall Study|technological issues|1|||
42236264|NCT03083483|76058401|FG001|Overall Study|technological issues|0|||
42236265|NCT03083483|76058402|FG002|Overall Study|technological issues|1|||
42236266|NCT03085927|76058414|FG000|Overall Study|Withdrawal by Subject|1|||
42236267|NCT03085927|76058415|FG001|Overall Study|Withdrawal by Subject|4|||
42236268|NCT03085927|76058414|FG000|Overall Study|Lost to Follow-up|3|||
42236269|NCT03085927|76058415|FG001|Overall Study|Lost to Follow-up|1|||
42131871|NCT00332488|75942739|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
42131872|NCT00332488|75942737|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
42131873|NCT00332488|75942738|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
42131874|NCT00332488|75942739|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
42236270|NCT03085927|76058414|FG000|Overall Study|Death|1|||
42236271|NCT03085927|76058415|FG001|Overall Study|Death|0|||
42236272|NCT03085927|76058414|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
42236273|NCT03085927|76058415|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
42236274|NCT03085927|76058414|FG000|Overall Study|Dyad Became Ineligible|0|||
42236275|NCT03085927|76058415|FG001|Overall Study|Dyad Became Ineligible|1|||
42236276|NCT04392583|76058423|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
42236277|NCT04497987|76058429|FG000|Overall Study|Adverse Event|1|||
42236278|NCT04497987|76058430|FG001|Overall Study|Adverse Event|0|||
42236279|NCT04497987|76058429|FG000|Overall Study|Death|21|||
42236280|NCT04497987|76058430|FG001|Overall Study|Death|13|||
42236281|NCT04497987|76058429|FG000|Overall Study|Lost to Follow-up|19|||
42236282|NCT04497987|76058430|FG001|Overall Study|Lost to Follow-up|17|||
42236283|NCT04497987|76058429|FG000|Overall Study|Other - as reported by the investigator|22|||
42236284|NCT04497987|76058430|FG001|Overall Study|Other - as reported by the investigator|16|||
42236285|NCT04497987|76058429|FG000|Overall Study|Physician Decision|1|||
42236286|NCT04497987|76058430|FG001|Overall Study|Physician Decision|0|||
42236287|NCT04497987|76058429|FG000|Overall Study|Withdrawal by Subject|35|||
42236288|NCT04497987|76058430|FG001|Overall Study|Withdrawal by Subject|21|||
42236289|NCT00974571|76058440|FG000|Overall Study|Adverse Event|31|||
42236290|NCT00974571|76058441|FG001|Overall Study|Adverse Event|4|||
42236291|NCT00974571|76058442|FG002|Overall Study|Adverse Event|27|||
42236292|NCT00974571|76058440|FG000|Overall Study|Lack of Efficacy|3|||
42236293|NCT00974571|76058441|FG001|Overall Study|Lack of Efficacy|2|||
42236294|NCT00974571|76058442|FG002|Overall Study|Lack of Efficacy|9|||
42236295|NCT00974571|76058440|FG000|Overall Study|Lost to Follow-up|2|||
42236296|NCT00974571|76058441|FG001|Overall Study|Lost to Follow-up|1|||
42236297|NCT00974571|76058442|FG002|Overall Study|Lost to Follow-up|2|||
42236298|NCT00974571|76058440|FG000|Overall Study|Protocol Violation|13|||
42236299|NCT00974571|76058441|FG001|Overall Study|Protocol Violation|4|||
42236300|NCT00974571|76058442|FG002|Overall Study|Protocol Violation|18|||
42236301|NCT00974571|76058440|FG000|Overall Study|Withdrawal by Subject|14|||
42236302|NCT00974571|76058441|FG001|Overall Study|Withdrawal by Subject|5|||
42236303|NCT00974571|76058442|FG002|Overall Study|Withdrawal by Subject|16|||
42236304|NCT00974571|76058440|FG000|Overall Study|Patient Moved|1|||
42236305|NCT00974571|76058441|FG001|Overall Study|Patient Moved|0|||
42236306|NCT00974571|76058442|FG002|Overall Study|Patient Moved|1|||
42236307|NCT00974571|76058440|FG000|Overall Study|Other|4|||
42236308|NCT00974571|76058441|FG001|Overall Study|Other|0|||
42236309|NCT00974571|76058442|FG002|Overall Study|Other|10|||
42236310|NCT02766608|76058455|FG000|Overall Study|Adverse Event|27|||
42236311|NCT02766608|76058456|FG001|Overall Study|Adverse Event|22|||
42236312|NCT02766608|76058457|FG002|Overall Study|Adverse Event|17|||
42236313|NCT02766608|76058458|FG003|Overall Study|Adverse Event|13|||
42236314|NCT02766608|76058459|FG004|Overall Study|Adverse Event|12|||
42236315|NCT02766608|76058455|FG000|Overall Study|Withdrawal by Subject|21|||
42236316|NCT02766608|76058456|FG001|Overall Study|Withdrawal by Subject|20|||
42236317|NCT02766608|76058457|FG002|Overall Study|Withdrawal by Subject|24|||
42236318|NCT02766608|76058458|FG003|Overall Study|Withdrawal by Subject|13|||
42236319|NCT02766608|76058459|FG004|Overall Study|Withdrawal by Subject|10|||
42236320|NCT02766608|76058455|FG000|Overall Study|Lack of Efficacy|16|||
42236321|NCT02766608|76058456|FG001|Overall Study|Lack of Efficacy|15|||
42236322|NCT02766608|76058457|FG002|Overall Study|Lack of Efficacy|32|||
42236323|NCT02766608|76058458|FG003|Overall Study|Lack of Efficacy|8|||
42236324|NCT02766608|76058459|FG004|Overall Study|Lack of Efficacy|2|||
42236325|NCT02766608|76058455|FG000|Overall Study|Lost to Follow-up|6|||
42236326|NCT02766608|76058456|FG001|Overall Study|Lost to Follow-up|3|||
42236327|NCT02766608|76058457|FG002|Overall Study|Lost to Follow-up|5|||
42236328|NCT02766608|76058458|FG003|Overall Study|Lost to Follow-up|2|||
42236329|NCT02766608|76058459|FG004|Overall Study|Lost to Follow-up|2|||
42236330|NCT02766608|76058455|FG000|Overall Study|Physician Decision|3|||
42236331|NCT02766608|76058456|FG001|Overall Study|Physician Decision|2|||
42236332|NCT02766608|76058457|FG002|Overall Study|Physician Decision|3|||
42236333|NCT02766608|76058458|FG003|Overall Study|Physician Decision|1|||
42236334|NCT02766608|76058459|FG004|Overall Study|Physician Decision|2|||
42236335|NCT02766608|76058455|FG000|Overall Study|Protocol disc criteria|3|||
42236336|NCT02766608|76058456|FG001|Overall Study|Protocol disc criteria|3|||
42236337|NCT02766608|76058457|FG002|Overall Study|Protocol disc criteria|4|||
42236338|NCT02766608|76058458|FG003|Overall Study|Protocol disc criteria|0|||
42236339|NCT02766608|76058459|FG004|Overall Study|Protocol disc criteria|0|||
42236340|NCT02766608|76058455|FG000|Overall Study|Protocol Violation|0|||
42236341|NCT02766608|76058456|FG001|Overall Study|Protocol Violation|4|||
42236342|NCT02766608|76058457|FG002|Overall Study|Protocol Violation|4|||
42236343|NCT02766608|76058458|FG003|Overall Study|Protocol Violation|0|||
42236344|NCT02766608|76058459|FG004|Overall Study|Protocol Violation|1|||
42236345|NCT02766608|76058455|FG000|Overall Study|Administrative Reasons|3|||
42236346|NCT02766608|76058456|FG001|Overall Study|Administrative Reasons|1|||
42236347|NCT02766608|76058457|FG002|Overall Study|Administrative Reasons|1|||
42236348|NCT02766608|76058458|FG003|Overall Study|Administrative Reasons|0|||
42236349|NCT02766608|76058459|FG004|Overall Study|Administrative Reasons|0|||
42236350|NCT00960141|76058477|FG000|Overall Study|Adverse Event|4|||
42236351|NCT00960141|76058478|FG001|Overall Study|Adverse Event|8|||
42236352|NCT00960141|76058479|FG002|Overall Study|Adverse Event|2|||
42236353|NCT00960141|76058477|FG000|Overall Study|Lack of Efficacy|3|||
42236354|NCT00960141|76058478|FG001|Overall Study|Lack of Efficacy|4|||
42236355|NCT00960141|76058479|FG002|Overall Study|Lack of Efficacy|2|||
42236356|NCT00960141|76058477|FG000|Overall Study|Lost to Follow-up|1|||
42236357|NCT00960141|76058478|FG001|Overall Study|Lost to Follow-up|0|||
42236358|NCT00960141|76058479|FG002|Overall Study|Lost to Follow-up|0|||
42236359|NCT00960141|76058477|FG000|Overall Study|Protocol Violation|1|||
42236360|NCT00960141|76058478|FG001|Overall Study|Protocol Violation|3|||
42236361|NCT00960141|76058479|FG002|Overall Study|Protocol Violation|2|||
42236362|NCT00960141|76058477|FG000|Overall Study|Withdrawal by Subject|1|||
42236363|NCT00960141|76058478|FG001|Overall Study|Withdrawal by Subject|2|||
42236364|NCT00960141|76058479|FG002|Overall Study|Withdrawal by Subject|1|||
42236365|NCT02771522|76058487|FG000|Overall Study|Lost to Follow-up|3|||
42236366|NCT02771522|76058487|FG000|Overall Study|Withdrawal by Subject|2|||
42236367|NCT02771522|76058487|FG000|Overall Study|No white spot lesions|3|||
42236368|NCT00759655|76058496|FG000|Overall Study|Termination of the study by sponsor|1|||
42236369|NCT02771366|76058502|FG000|Period 1|Withdrawal by Subject|0|||
42236370|NCT02771366|76058503|FG001|Period 1|Withdrawal by Subject|2|||
42236371|NCT02771366|76058502|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
42236372|NCT02771366|76058503|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
42236373|NCT03396471|76058510|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
42236374|NCT03396471|76058510|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
42236375|NCT03396471|76058510|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
42236376|NCT03396471|76058510|FG000|Study Treatment - Up to 22 Months|Death|2|||
42236377|NCT03396471|76058510|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
42236378|NCT03396471|76058510|FG000|Follow up - Up to 2 Years|Death|9|||
42236379|NCT03396471|76058510|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
42236380|NCT03396471|76058510|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
42236381|NCT03396471|76058510|FG000|Follow up - Up to 2 Years|study terminated|1|||
42236382|NCT03396471|76058510|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
42236383|NCT03396471|76058510|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
42236384|NCT00103142|76058516|FG000|Overall Study|Adverse Event|1|||
42236385|NCT00103142|76058517|FG001|Overall Study|Adverse Event|0|||
42236386|NCT00103142|76058516|FG000|Overall Study|Progression of disease|2|||
42236387|NCT00103142|76058517|FG001|Overall Study|Progression of disease|1|||
42236388|NCT00943683|76058527|FG000|Overall Study|Adverse Event|3|||
42236389|NCT00943683|76058528|FG001|Overall Study|Adverse Event|3|||
42236390|NCT00943683|76058527|FG000|Overall Study|Lost to Follow-up|1|||
42236391|NCT00943683|76058528|FG001|Overall Study|Lost to Follow-up|1|||
42236392|NCT00943683|76058527|FG000|Overall Study|Protocol Violation|1|||
42236393|NCT00943683|76058528|FG001|Overall Study|Protocol Violation|2|||
42236394|NCT00943683|76058527|FG000|Overall Study|Withdrawal by Subject|1|||
42236395|NCT00943683|76058528|FG001|Overall Study|Withdrawal by Subject|0|||
42236396|NCT00943683|76058527|FG000|Overall Study|Patient Moved|1|||
42236397|NCT00943683|76058528|FG001|Overall Study|Patient Moved|0|||
42236398|NCT00911547|76058538|FG000|Overall Study|Adverse Event|8|||
42236399|NCT00911547|76058539|FG001|Overall Study|Adverse Event|27|||
42236400|NCT00911547|76058540|FG002|Overall Study|Adverse Event|11|||
42236401|NCT00911547|76058541|FG003|Overall Study|Adverse Event|6|||
41987665|NCT01286077|75795011|FG001|Overall Study|Patient's decision to stop treatment|0|||
42236402|NCT00911547|76058538|FG000|Overall Study|Lost to Follow-up|0|||
42236403|NCT00911547|76058539|FG001|Overall Study|Lost to Follow-up|0|||
42236404|NCT00911547|76058540|FG002|Overall Study|Lost to Follow-up|2|||
42236405|NCT00911547|76058541|FG003|Overall Study|Lost to Follow-up|1|||
42236406|NCT00911547|76058538|FG000|Overall Study|Protocol Violation|0|||
42236407|NCT00911547|76058539|FG001|Overall Study|Protocol Violation|5|||
42236408|NCT00911547|76058540|FG002|Overall Study|Protocol Violation|5|||
42302611|NCT02415595|76137851|FG003|Overall Study|Withdrawal by Subject|3|||
42302612|NCT02415595|76137848|FG000|Overall Study|Other|0|||
42302613|NCT02415595|76137849|FG001|Overall Study|Other|1|||
42302614|NCT02415595|76137850|FG002|Overall Study|Other|1|||
42302615|NCT02415595|76137851|FG003|Overall Study|Other|0|||
42302616|NCT02446717|76137867|FG000|Overall Study|Adverse Event|0|||
42302617|NCT02446717|76137868|FG001|Overall Study|Adverse Event|0|||
42302618|NCT02446717|76137869|FG002|Overall Study|Adverse Event|1|||
42302619|NCT02446717|76137870|FG003|Overall Study|Adverse Event|0|||
42302620|NCT02446717|76137871|FG004|Overall Study|Adverse Event|0|||
42302621|NCT02446717|76137867|FG000|Overall Study|Lost to Follow-up|0|||
42302622|NCT02446717|76137868|FG001|Overall Study|Lost to Follow-up|1|||
42302623|NCT02446717|76137869|FG002|Overall Study|Lost to Follow-up|1|||
42302624|NCT02446717|76137870|FG003|Overall Study|Lost to Follow-up|0|||
42302625|NCT02446717|76137871|FG004|Overall Study|Lost to Follow-up|1|||
42302626|NCT02446717|76137867|FG000|Overall Study|Withdrew consent|0|||
42302627|NCT02446717|76137868|FG001|Overall Study|Withdrew consent|0|||
42302628|NCT02446717|76137869|FG002|Overall Study|Withdrew consent|0|||
42302629|NCT02446717|76137870|FG003|Overall Study|Withdrew consent|1|||
41987666|NCT01286077|75795010|FG000|Overall Study|Progression of disease|0|||
41987667|NCT01286077|75795011|FG001|Overall Study|Progression of disease|1|||
41987668|NCT01286077|75795010|FG000|Overall Study|refill medication not received in time|1|||
41987669|NCT01286077|75795011|FG001|Overall Study|refill medication not received in time|0|||
41987670|NCT01285960|75795017|FG000|Overall Study|Withdrawal by Subject|2|||
41987671|NCT01285960|75795017|FG000|Overall Study|Lost to Follow-up|2|||
41987672|NCT01285960|75795017|FG000|Overall Study|2 subjects received less 10 sonications|2|||
41987673|NCT01285609|75795028|FG000|Randomized|Progressive Disease|41|||
41987674|NCT01285609|75795029|FG001|Randomized|Progressive Disease|61|||
42236409|NCT00911547|76058541|FG003|Overall Study|Protocol Violation|1|||
42236410|NCT00911547|76058538|FG000|Overall Study|Withdrawal by Subject|3|||
42236411|NCT00911547|76058539|FG001|Overall Study|Withdrawal by Subject|10|||
42236412|NCT00911547|76058540|FG002|Overall Study|Withdrawal by Subject|4|||
42236413|NCT00911547|76058541|FG003|Overall Study|Withdrawal by Subject|8|||
42236414|NCT00899379|76058556|FG000|Overall Study|Adverse Event|2|||
42236415|NCT00899379|76058557|FG001|Overall Study|Adverse Event|2|||
42236416|NCT00899379|76058558|FG002|Overall Study|Adverse Event|1|||
42302630|NCT02446717|76137871|FG004|Overall Study|Withdrew consent|0|||
42302631|NCT02469415|76137883|FG000|Overall Study|Withdrawal by Subject|1|||
41987675|NCT01285609|75795028|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
41987676|NCT01285609|75795029|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
41987677|NCT01285609|75795028|FG000|Randomized|Study Drug Toxicity|13|||
41987678|NCT01285609|75795029|FG001|Randomized|Study Drug Toxicity|14|||
41987679|NCT01285609|75795028|FG000|Randomized|Death|5|||
41987680|NCT01285609|75795029|FG001|Randomized|Death|7|||
41987681|NCT01285609|75795028|FG000|Randomized|Withdrawal by Subject|8|||
41987682|NCT01285609|75795029|FG001|Randomized|Withdrawal by Subject|11|||
41987683|NCT01285609|75795028|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
42236417|NCT00899379|76058559|FG003|Overall Study|Adverse Event|1|||
42236418|NCT00899379|76058560|FG004|Overall Study|Adverse Event|2|||
42236419|NCT00899379|76058556|FG000|Overall Study|Lack of Efficacy|0|||
42236420|NCT00899379|76058557|FG001|Overall Study|Lack of Efficacy|4|||
42302632|NCT02469415|76137883|FG000|Overall Study|Investigational agent placed on hold|2|||
42236421|NCT00899379|76058558|FG002|Overall Study|Lack of Efficacy|3|||
42302633|NCT02446171|76137891|FG000|Overall Study|Withdrawal by Subject|0|||
42302634|NCT02446171|76137892|FG001|Overall Study|Withdrawal by Subject|0|||
42236422|NCT00899379|76058559|FG003|Overall Study|Lack of Efficacy|0|||
42236423|NCT00899379|76058560|FG004|Overall Study|Lack of Efficacy|1|||
42302635|NCT02446171|76137893|FG002|Overall Study|Withdrawal by Subject|2|||
42302636|NCT02446171|76137894|FG003|Overall Study|Withdrawal by Subject|0|||
42236424|NCT00899379|76058556|FG000|Overall Study|Lost to Follow-up|9|||
42236425|NCT00899379|76058557|FG001|Overall Study|Lost to Follow-up|3|||
42236426|NCT00899379|76058558|FG002|Overall Study|Lost to Follow-up|0|||
42302637|NCT02446015|76137908|FG000|Overall Study|Adverse Event|0|||
42236427|NCT00899379|76058559|FG003|Overall Study|Lost to Follow-up|6|||
42236428|NCT00899379|76058560|FG004|Overall Study|Lost to Follow-up|2|||
42236429|NCT00899379|76058556|FG000|Overall Study|Protocol Violation|0|||
42236430|NCT00899379|76058557|FG001|Overall Study|Protocol Violation|0|||
42302638|NCT02446015|76137909|FG001|Overall Study|Adverse Event|1|||
42302639|NCT02446015|76137908|FG000|Overall Study|Withdrawal by Subject|1|||
42302640|NCT02446015|76137909|FG001|Overall Study|Withdrawal by Subject|0|||
42302641|NCT02415127|76137918|FG000|Overall Study|Adverse Event|1|||
42302642|NCT02415127|76137919|FG001|Overall Study|Adverse Event|0|||
42302643|NCT02468557|76137925|FG000|Overall Study|Adverse Event|1|||
42302644|NCT02468557|76137925|FG000|Overall Study|Death|1|||
42302645|NCT02468557|76137925|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
42302646|NCT02468557|76137925|FG000|Overall Study|All Enrolled but Never Dosed|4|||
42302647|NCT02413489|76137936|FG000|Overall Study|Death|11|||
42302648|NCT02413489|76137937|FG001|Overall Study|Death|3|||
42302649|NCT02413489|76137938|FG002|Overall Study|Death|4|||
42302650|NCT02413489|76137936|FG000|Overall Study|Withdrawal by Subject|2|||
41987684|NCT01285609|75795029|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
41987685|NCT01285609|75795028|FG000|Randomized|Undisclosed Reasons|1|||
41987686|NCT01285609|75795029|FG001|Randomized|Undisclosed Reasons|0|||
41987687|NCT01285609|75795028|FG000|Randomized|Randomized but not Treated|4|||
41987688|NCT01285609|75795029|FG001|Randomized|Randomized but not Treated|4|||
41987689|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
41987690|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
41987691|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
41987692|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
41987693|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
41987694|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
41987695|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
41987696|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
41987697|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Death|11|||
41987698|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Death|3|||
41987699|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
41987700|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
41987701|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Not Reported|0|||
41987702|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Not Reported|2|||
41987703|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
41987704|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
41987705|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
41987706|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
41987707|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
41987708|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
41987709|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
41987710|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
41987711|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
41987712|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
41987713|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
41987714|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
41987715|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
41987716|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
41987717|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
41987718|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
41987719|NCT01285609|75795028|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
41987720|NCT01285609|75795029|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
41987721|NCT01285609|75795028|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
41987722|NCT01285609|75795029|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
42131875|NCT00332488|75942737|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
42131876|NCT00332488|75942738|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
42236431|NCT00899379|76058558|FG002|Overall Study|Protocol Violation|1|||
41987723|NCT01285492|75795039|FG000|Overall Study|Adverse Event|11|||
41987724|NCT01285492|75795040|FG001|Overall Study|Adverse Event|0|||
42236432|NCT00899379|76058559|FG003|Overall Study|Protocol Violation|1|||
42236433|NCT00899379|76058560|FG004|Overall Study|Protocol Violation|0|||
42236434|NCT00899379|76058556|FG000|Overall Study|Withdrawal by Subject|2|||
42302651|NCT02413489|76137937|FG001|Overall Study|Withdrawal by Subject|0|||
42302652|NCT02413489|76137938|FG002|Overall Study|Withdrawal by Subject|0|||
42236435|NCT00899379|76058557|FG001|Overall Study|Withdrawal by Subject|4|||
42236436|NCT00899379|76058558|FG002|Overall Study|Withdrawal by Subject|2|||
42236437|NCT00899379|76058559|FG003|Overall Study|Withdrawal by Subject|3|||
42236438|NCT00899379|76058560|FG004|Overall Study|Withdrawal by Subject|6|||
42236439|NCT00899379|76058556|FG000|Overall Study|Pregnancy|0|||
42236440|NCT00899379|76058557|FG001|Overall Study|Pregnancy|0|||
42236441|NCT00899379|76058558|FG002|Overall Study|Pregnancy|1|||
42236442|NCT00899379|76058559|FG003|Overall Study|Pregnancy|0|||
42236443|NCT00899379|76058560|FG004|Overall Study|Pregnancy|1|||
42236444|NCT00899379|76058556|FG000|Overall Study|Patient Uncooperative|0|||
41987725|NCT01285492|75795039|FG000|Overall Study|Protocol Violation|3|||
41987726|NCT01285492|75795040|FG001|Overall Study|Protocol Violation|0|||
42131877|NCT00332488|75942739|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
42131878|NCT00332332|75942749|FG000|Overall Study|Adverse Event|13|||
42236445|NCT00899379|76058557|FG001|Overall Study|Patient Uncooperative|1|||
42236446|NCT00899379|76058558|FG002|Overall Study|Patient Uncooperative|0|||
42236447|NCT00899379|76058559|FG003|Overall Study|Patient Uncooperative|1|||
42236448|NCT00899379|76058560|FG004|Overall Study|Patient Uncooperative|2|||
42236449|NCT00899379|76058556|FG000|Overall Study|Abnormal Baseline ECG|0|||
42236450|NCT00899379|76058557|FG001|Overall Study|Abnormal Baseline ECG|0|||
42236451|NCT00899379|76058558|FG002|Overall Study|Abnormal Baseline ECG|0|||
42236452|NCT00899379|76058559|FG003|Overall Study|Abnormal Baseline ECG|1|||
42236453|NCT00899379|76058560|FG004|Overall Study|Abnormal Baseline ECG|0|||
42236454|NCT00899379|76058556|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
42236455|NCT00899379|76058557|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
42236456|NCT00899379|76058558|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
42236457|NCT00899379|76058559|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
42236458|NCT00899379|76058560|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
42236459|NCT00899379|76058556|FG000|Overall Study|Not Completed/Entered Extn|5|||
42236460|NCT00899379|76058557|FG001|Overall Study|Not Completed/Entered Extn|1|||
42236461|NCT00899379|76058558|FG002|Overall Study|Not Completed/Entered Extn|6|||
42236462|NCT00899379|76058559|FG003|Overall Study|Not Completed/Entered Extn|4|||
42236463|NCT00899379|76058560|FG004|Overall Study|Not Completed/Entered Extn|3|||
42236464|NCT00899379|76058556|FG000|Overall Study|Study Terminated|3|||
42236465|NCT00899379|76058557|FG001|Overall Study|Study Terminated|0|||
42236466|NCT00899379|76058558|FG002|Overall Study|Study Terminated|3|||
42236467|NCT00899379|76058559|FG003|Overall Study|Study Terminated|3|||
42236468|NCT00899379|76058560|FG004|Overall Study|Study Terminated|1|||
42236469|NCT00899379|76058556|FG000|Overall Study|Lost to Follow-up|3|||
42236470|NCT00899379|76058557|FG001|Overall Study|Lost to Follow-up|1|||
42236471|NCT00899379|76058558|FG002|Overall Study|Lost to Follow-up|0|||
42236472|NCT00899379|76058559|FG003|Overall Study|Lost to Follow-up|2|||
42236473|NCT00899379|76058560|FG004|Overall Study|Lost to Follow-up|5|||
42236474|NCT00899379|76058556|FG000|Overall Study|Withdrawal by Subject|4|||
42236475|NCT00899379|76058557|FG001|Overall Study|Withdrawal by Subject|7|||
42236476|NCT00899379|76058558|FG002|Overall Study|Withdrawal by Subject|4|||
42236477|NCT00899379|76058559|FG003|Overall Study|Withdrawal by Subject|7|||
42236478|NCT00899379|76058560|FG004|Overall Study|Withdrawal by Subject|2|||
42236479|NCT00899379|76058556|FG000|Overall Study|Pregnancy|1|||
42236480|NCT00899379|76058557|FG001|Overall Study|Pregnancy|0|||
42131879|NCT00332332|75942749|FG000|Overall Study|Death|1|||
42131880|NCT00332332|75942749|FG000|Overall Study|Withdrawal by Subject|8|||
42131881|NCT00332332|75942749|FG000|Overall Study|Physician Decision|1|||
42131882|NCT00332332|75942749|FG000|Overall Study|Lost to Follow-up|3|||
42131883|NCT00332332|75942749|FG000|Overall Study|Protocol deviation|4|||
42131884|NCT00332332|75942749|FG000|Overall Study|Noncompliance|2|||
42131885|NCT00332332|75942749|FG000|Overall Study|Disease progression|2|||
42131886|NCT00332332|75942749|FG000|Overall Study|Other|18|||
42131887|NCT00332332|75942749|FG000|Overall Study|Did not receive study treatment|16|||
42131888|NCT00392925|75942757|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
42131889|NCT00392925|75942758|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
42131890|NCT00392925|75942759|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
42131891|NCT00392925|75942760|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
42131892|NCT00392925|75942757|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
42131893|NCT00392925|75942758|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
42236481|NCT00899379|76058558|FG002|Overall Study|Pregnancy|0|||
42236482|NCT00899379|76058559|FG003|Overall Study|Pregnancy|0|||
42236483|NCT00899379|76058560|FG004|Overall Study|Pregnancy|0|||
42236484|NCT00899379|76058556|FG000|Overall Study|Patient Uncooperative|0|||
42236485|NCT00899379|76058557|FG001|Overall Study|Patient Uncooperative|0|||
42236486|NCT00899379|76058558|FG002|Overall Study|Patient Uncooperative|0|||
42236487|NCT00899379|76058559|FG003|Overall Study|Patient Uncooperative|1|||
42236488|NCT00899379|76058560|FG004|Overall Study|Patient Uncooperative|0|||
42236489|NCT00899379|76058556|FG000|Overall Study|Abnormal Prestudy Labs|0|||
42236490|NCT00899379|76058557|FG001|Overall Study|Abnormal Prestudy Labs|0|||
42236491|NCT00899379|76058558|FG002|Overall Study|Abnormal Prestudy Labs|0|||
42236492|NCT00899379|76058559|FG003|Overall Study|Abnormal Prestudy Labs|0|||
42236493|NCT00899379|76058560|FG004|Overall Study|Abnormal Prestudy Labs|2|||
42236494|NCT00899379|76058556|FG000|Overall Study|Abnormal Baseline ECG|0|||
42236495|NCT00899379|76058557|FG001|Overall Study|Abnormal Baseline ECG|0|||
42236496|NCT00899379|76058558|FG002|Overall Study|Abnormal Baseline ECG|1|||
42236497|NCT00899379|76058559|FG003|Overall Study|Abnormal Baseline ECG|1|||
42236498|NCT00899379|76058560|FG004|Overall Study|Abnormal Baseline ECG|0|||
42236499|NCT00899379|76058556|FG000|Overall Study|No Attack Pretreatment|3|||
42236500|NCT00899379|76058557|FG001|Overall Study|No Attack Pretreatment|5|||
42236501|NCT00899379|76058558|FG002|Overall Study|No Attack Pretreatment|5|||
42236502|NCT00899379|76058559|FG003|Overall Study|No Attack Pretreatment|6|||
42236503|NCT00899379|76058560|FG004|Overall Study|No Attack Pretreatment|4|||
42236504|NCT00899379|76058556|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
42236505|NCT00899379|76058557|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
42236506|NCT00899379|76058558|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
42236507|NCT00899379|76058559|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
42236508|NCT00899379|76058560|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
42236509|NCT00899379|76058556|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
42236510|NCT00899379|76058557|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
42236511|NCT00899379|76058558|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
42236512|NCT00899379|76058559|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
42236513|NCT00899379|76058560|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
42236514|NCT04326439|76058568|FG000|Overall Study|Withdrawal by Subject|1|||
42236515|NCT04326439|76058569|FG001|Overall Study|Withdrawal by Subject|0|||
42236516|NCT04326439|76058568|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
42236517|NCT04326439|76058569|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
42236518|NCT04326439|76058568|FG000|Overall Study|Relapse after Induction 2|0|||
42236519|NCT04326439|76058569|FG001|Overall Study|Relapse after Induction 2|1|||
42236520|NCT04326439|76058568|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
42236521|NCT04326439|76058569|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
42236522|NCT00145795|76058583|FG000|Overall Study|Adverse Event|1|||
42236523|NCT00145795|76058584|FG001|Overall Study|Adverse Event|0|||
42236524|NCT02771210|76058592|FG000|Period 1|Adverse Event|5|||
42236525|NCT02771210|76058593|FG001|Period 1|Adverse Event|3|||
42236526|NCT02771210|76058592|FG000|Period 1|Lack of Efficacy|3|||
42236527|NCT02771210|76058593|FG001|Period 1|Lack of Efficacy|6|||
42236528|NCT02771210|76058592|FG000|Period 1|Lost to Follow-up|2|||
42236529|NCT02771210|76058593|FG001|Period 1|Lost to Follow-up|0|||
42236530|NCT02771210|76058592|FG000|Period 1|Physician Decision|0|||
42236531|NCT02771210|76058593|FG001|Period 1|Physician Decision|1|||
42236532|NCT02771210|76058592|FG000|Period 1|Withdrawal by Subject|0|||
42236533|NCT02771210|76058593|FG001|Period 1|Withdrawal by Subject|3|||
42236534|NCT02771210|76058592|FG000|Period 1|Withdrawal of informed consent|1|||
42236535|NCT02771210|76058593|FG001|Period 1|Withdrawal of informed consent|5|||
42236536|NCT02771210|76058592|FG000|Period 2|Adverse Event|1|||
42236537|NCT02771210|76058593|FG001|Period 2|Adverse Event|0|||
42236538|NCT02771210|76058592|FG000|Period 2|Lack of Efficacy|0|||
42236539|NCT02771210|76058593|FG001|Period 2|Lack of Efficacy|1|||
42236540|NCT02771210|76058592|FG000|Period 2|Withdrawal by Subject|1|||
42236541|NCT02771210|76058593|FG001|Period 2|Withdrawal by Subject|0|||
42236542|NCT02771210|76058592|FG000|Period 2|Withdrawal of informed consent|0|||
42236543|NCT02771210|76058593|FG001|Period 2|Withdrawal of informed consent|2|||
42236544|NCT00898677|76058603|FG000|Overall Study|Adverse Event|0|||
42236545|NCT00898677|76058604|FG001|Overall Study|Adverse Event|0|||
42236546|NCT00898677|76058605|FG002|Overall Study|Adverse Event|1|||
42236547|NCT00898677|76058606|FG003|Overall Study|Adverse Event|0|||
42236548|NCT00898677|76058603|FG000|Overall Study|Lost to Follow-up|0|||
42236549|NCT00898677|76058604|FG001|Overall Study|Lost to Follow-up|0|||
42236550|NCT00898677|76058605|FG002|Overall Study|Lost to Follow-up|2|||
42236551|NCT00898677|76058606|FG003|Overall Study|Lost to Follow-up|0|||
42236552|NCT00898677|76058603|FG000|Overall Study|Protocol Violation|1|||
42236553|NCT00898677|76058604|FG001|Overall Study|Protocol Violation|1|||
42236554|NCT00898677|76058605|FG002|Overall Study|Protocol Violation|2|||
42236555|NCT00898677|76058606|FG003|Overall Study|Protocol Violation|0|||
42236556|NCT00898677|76058603|FG000|Overall Study|Withdrawal by Subject|0|||
42236557|NCT00898677|76058604|FG001|Overall Study|Withdrawal by Subject|0|||
42236558|NCT00898677|76058605|FG002|Overall Study|Withdrawal by Subject|0|||
42236559|NCT00898677|76058606|FG003|Overall Study|Withdrawal by Subject|1|||
42236560|NCT00898677|76058603|FG000|Overall Study|Not Treated: Adverse Event|0|||
42236561|NCT00898677|76058604|FG001|Overall Study|Not Treated: Adverse Event|2|||
42236562|NCT00898677|76058605|FG002|Overall Study|Not Treated: Adverse Event|1|||
42236563|NCT00898677|76058606|FG003|Overall Study|Not Treated: Adverse Event|0|||
42236564|NCT00898677|76058603|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
42236565|NCT00898677|76058604|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
42236566|NCT00898677|76058605|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
42236567|NCT00898677|76058606|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
42236568|NCT00898677|76058603|FG000|Overall Study|Not Treated: Pregnancy|0|||
42236569|NCT00898677|76058604|FG001|Overall Study|Not Treated: Pregnancy|0|||
42236570|NCT00898677|76058605|FG002|Overall Study|Not Treated: Pregnancy|1|||
42236571|NCT00898677|76058606|FG003|Overall Study|Not Treated: Pregnancy|0|||
42236572|NCT00898677|76058603|FG000|Overall Study|Not Treated: Protocol Violation|2|||
42236573|NCT00898677|76058604|FG001|Overall Study|Not Treated: Protocol Violation|0|||
42236574|NCT00898677|76058605|FG002|Overall Study|Not Treated: Protocol Violation|2|||
42236575|NCT00898677|76058606|FG003|Overall Study|Not Treated: Protocol Violation|0|||
42236576|NCT00898677|76058603|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
42236577|NCT00898677|76058604|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
42236578|NCT00898677|76058605|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
42236579|NCT00898677|76058606|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
42236580|NCT00898677|76058603|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
42236581|NCT00898677|76058604|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
42236582|NCT00898677|76058605|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
42236583|NCT00898677|76058606|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
42236584|NCT00898677|76058603|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
42236585|NCT00898677|76058604|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
42236586|NCT00898677|76058605|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
42236587|NCT00898677|76058606|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
42236588|NCT00898677|76058603|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
42236589|NCT00898677|76058604|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
42236590|NCT00898677|76058605|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
42236591|NCT00898677|76058606|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
42236592|NCT00898677|76058603|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
42236593|NCT00898677|76058604|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
42236594|NCT00898677|76058605|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
42236595|NCT00898677|76058606|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
42236596|NCT00898677|76058603|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
42236597|NCT00898677|76058604|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
42236598|NCT00898677|76058605|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
42236599|NCT00898677|76058606|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
42236600|NCT00898677|76058603|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
42236601|NCT00898677|76058604|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
42236602|NCT00898677|76058605|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
42236603|NCT00898677|76058606|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
42236604|NCT02770820|76058616|FG000|Overall Study|Death|1|||
42236605|NCT02770820|76058616|FG000|Overall Study|Physician Decision|2|||
42236606|NCT03082729|76058620|FG000|Overall Study|Lost to Follow-up|7|||
42236607|NCT03082729|76058620|FG000|Overall Study|Physician Decision|2|||
42236608|NCT03082729|76058620|FG000|Overall Study|Withdrawal by Subject|1|||
42236609|NCT03082729|76058620|FG000|Overall Study|Lack of Efficacy|9|||
42236610|NCT03082729|76058620|FG000|Overall Study|Adverse Event|4|||
42236611|NCT03082729|76058620|FG000|Overall Study|Protocol Violation|6|||
42236612|NCT03082729|76058620|FG000|Overall Study|Fear of study procedure|1|||
42236613|NCT03082729|76058620|FG000|Overall Study|Scheduling conflict|1|||
42236614|NCT02764190|76058632|FG000|Overall Study|Lost to Follow-up|17|||
42236615|NCT02764190|76058633|FG001|Overall Study|Lost to Follow-up|13|||
42236616|NCT03077659|76058642|FG000|Overall Study|Withdrawal by Subject|0|||
42236617|NCT03077659|76058643|FG001|Overall Study|Withdrawal by Subject|0|||
42236618|NCT03077659|76058644|FG002|Overall Study|Withdrawal by Subject|1|||
42236619|NCT02807883|76058655|FG000|Overall Study|Withdrawal by Subject|2|||
42236620|NCT03082261|76058659|FG000|Overall Study|Death|4|||
42236621|NCT03082261|76058659|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
42236622|NCT03082261|76058659|FG000|Overall Study|Insurance denial|1|||
42236623|NCT03082261|76058659|FG000|Overall Study|Peripheral lead added|1|||
42236624|NCT03082261|76058659|FG000|Overall Study|Withdrawal by Subject|40|||
42236625|NCT03082261|76058659|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
42236626|NCT03082261|76058659|FG000|Overall Study|Subject implanted with device other than study device|1|||
42236627|NCT03082261|76058659|FG000|Overall Study|Lost to Follow-up|14|||
42236628|NCT03082261|76058659|FG000|Overall Study|Subject moved to a different state|1|||
42236629|NCT03082261|76058659|FG000|Overall Study|Subject non-compliance|2|||
42236630|NCT03082261|76058659|FG000|Overall Study|Subject participation terminated by investigator|9|||
42236631|NCT03082261|76058659|FG000|Overall Study|Subject participation terminated by sponsor|4|||
42236632|NCT03082261|76058659|FG000|Overall Study|System explant|19|||
42236633|NCT03082261|76058659|FG000|Overall Study|Unable to place lead(s)|2|||
42236634|NCT03082261|76058659|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
42236635|NCT00102440|76058666|FG000|Overall Study|Lost to Follow-up|25|||
42236636|NCT00102440|76058667|FG001|Overall Study|Lost to Follow-up|18|||
42236637|NCT00102440|76058668|FG002|Overall Study|Lost to Follow-up|21|||
42236638|NCT00102440|76058666|FG000|Overall Study|Adverse Event|16|||
42236639|NCT00102440|76058667|FG001|Overall Study|Adverse Event|23|||
42236640|NCT00102440|76058668|FG002|Overall Study|Adverse Event|8|||
42236641|NCT00102440|76058666|FG000|Overall Study|Gout Flare|10|||
42236642|NCT00102440|76058667|FG001|Overall Study|Gout Flare|28|||
42236643|NCT00102440|76058668|FG002|Overall Study|Gout Flare|9|||
42236644|NCT00102440|76058666|FG000|Overall Study|Personal Reason(s)|19|||
42236645|NCT00102440|76058667|FG001|Overall Study|Personal Reason(s)|13|||
42236646|NCT00102440|76058668|FG002|Overall Study|Personal Reason(s)|13|||
42236647|NCT00102440|76058666|FG000|Overall Study|Other|11|||
42236648|NCT00102440|76058667|FG001|Overall Study|Other|14|||
42236649|NCT00102440|76058668|FG002|Overall Study|Other|14|||
42236650|NCT00102440|76058666|FG000|Overall Study|Protocol Violation|7|||
42236651|NCT00102440|76058667|FG001|Overall Study|Protocol Violation|2|||
42236652|NCT00102440|76058668|FG002|Overall Study|Protocol Violation|1|||
42236653|NCT02762084|76058692|FG000|Overall Study|Withdrawal by Subject|1|||
42236654|NCT02762084|76058693|FG001|Overall Study|Withdrawal by Subject|0|||
42236655|NCT02762084|76058694|FG002|Overall Study|Withdrawal by Subject|0|||
42236656|NCT02762084|76058692|FG000|Overall Study|Adverse Event|0|||
42236657|NCT02762084|76058693|FG001|Overall Study|Adverse Event|0|||
42236658|NCT02762084|76058694|FG002|Overall Study|Adverse Event|1|||
42236659|NCT02763644|76058706|FG000|Overall Study|Patient/guardian decision|1|||
42236660|NCT02763644|76058707|FG001|Overall Study|Patient/guardian decision|0|||
42236661|NCT02763644|76058706|FG000|Overall Study|Death|1|||
42236662|NCT02763644|76058707|FG001|Overall Study|Death|1|||
42236663|NCT02763644|76058706|FG000|Overall Study|Adverse Event|1|||
42236664|NCT02763644|76058707|FG001|Overall Study|Adverse Event|1|||
42236665|NCT02807844|76058725|FG000|Overall Study|Physician Decision|0|||
42236666|NCT02807844|76058726|FG001|Overall Study|Physician Decision|0|||
42236667|NCT02807844|76058727|FG002|Overall Study|Physician Decision|0|||
42236668|NCT02807844|76058728|FG003|Overall Study|Physician Decision|0|||
42236669|NCT02807844|76058729|FG004|Overall Study|Physician Decision|0|||
42236670|NCT02807844|76058730|FG005|Overall Study|Physician Decision|0|||
42236671|NCT02807844|76058731|FG006|Overall Study|Physician Decision|3|||
42236672|NCT02807844|76058732|FG007|Overall Study|Physician Decision|0|||
42236673|NCT02807844|76058733|FG008|Overall Study|Physician Decision|1|||
42236674|NCT02807844|76058734|FG009|Overall Study|Physician Decision|2|||
42236675|NCT02807844|76058725|FG000|Overall Study|Death|0|||
42236676|NCT02807844|76058726|FG001|Overall Study|Death|0|||
42236677|NCT02807844|76058727|FG002|Overall Study|Death|2|||
42236678|NCT02807844|76058728|FG003|Overall Study|Death|4|||
42236679|NCT02807844|76058729|FG004|Overall Study|Death|1|||
42236680|NCT02807844|76058730|FG005|Overall Study|Death|2|||
42236681|NCT02807844|76058731|FG006|Overall Study|Death|1|||
42236682|NCT02807844|76058732|FG007|Overall Study|Death|2|||
42236683|NCT02807844|76058733|FG008|Overall Study|Death|0|||
42236684|NCT02807844|76058734|FG009|Overall Study|Death|1|||
42236685|NCT02807844|76058725|FG000|Overall Study|Withdrawal by Subject|0|||
42236686|NCT02807844|76058726|FG001|Overall Study|Withdrawal by Subject|0|||
42236687|NCT02807844|76058727|FG002|Overall Study|Withdrawal by Subject|2|||
42236688|NCT02807844|76058728|FG003|Overall Study|Withdrawal by Subject|1|||
42236689|NCT02807844|76058729|FG004|Overall Study|Withdrawal by Subject|1|||
42236690|NCT02807844|76058730|FG005|Overall Study|Withdrawal by Subject|0|||
42236691|NCT02807844|76058731|FG006|Overall Study|Withdrawal by Subject|1|||
42236692|NCT02807844|76058732|FG007|Overall Study|Withdrawal by Subject|0|||
42236693|NCT02807844|76058733|FG008|Overall Study|Withdrawal by Subject|0|||
42236694|NCT02807844|76058734|FG009|Overall Study|Withdrawal by Subject|0|||
42236695|NCT02807844|76058725|FG000|Overall Study|Progressive disease|5|||
41987727|NCT01285492|75795039|FG000|Overall Study|Withdrawal by Subject|2|||
41987728|NCT01285492|75795040|FG001|Overall Study|Withdrawal by Subject|1|||
41987729|NCT01285492|75795039|FG000|Overall Study|Death|1|||
41987730|NCT01285492|75795040|FG001|Overall Study|Death|0|||
41987731|NCT01284634|75795050|FG000|Overall Study|Adverse Event|1|||
42236696|NCT02807844|76058726|FG001|Overall Study|Progressive disease|12|||
42236697|NCT02807844|76058727|FG002|Overall Study|Progressive disease|8|||
42236698|NCT02807844|76058728|FG003|Overall Study|Progressive disease|8|||
42236699|NCT02807844|76058729|FG004|Overall Study|Progressive disease|3|||
42236700|NCT02807844|76058730|FG005|Overall Study|Progressive disease|8|||
42236701|NCT02807844|76058731|FG006|Overall Study|Progressive disease|14|||
42236702|NCT02807844|76058732|FG007|Overall Study|Progressive disease|17|||
42236703|NCT02807844|76058733|FG008|Overall Study|Progressive disease|19|||
42236704|NCT02807844|76058734|FG009|Overall Study|Progressive disease|15|||
42236705|NCT02807844|76058725|FG000|Overall Study|Adverse Event|1|||
42236706|NCT02807844|76058726|FG001|Overall Study|Adverse Event|0|||
41987732|NCT01284634|75795051|FG001|Overall Study|Adverse Event|0|||
42236707|NCT02807844|76058727|FG002|Overall Study|Adverse Event|0|||
42236708|NCT02807844|76058728|FG003|Overall Study|Adverse Event|0|||
42236709|NCT02807844|76058729|FG004|Overall Study|Adverse Event|1|||
42236710|NCT02807844|76058730|FG005|Overall Study|Adverse Event|1|||
42236711|NCT02807844|76058731|FG006|Overall Study|Adverse Event|1|||
42236712|NCT02807844|76058732|FG007|Overall Study|Adverse Event|1|||
42236713|NCT02807844|76058733|FG008|Overall Study|Adverse Event|1|||
42236714|NCT02807844|76058734|FG009|Overall Study|Adverse Event|2|||
42236715|NCT02763254|76058760|FG000|Overall Study|Adverse Event|1|||
42236716|NCT02805972|76058766|FG000|Washout Period|Lost to Follow-up|3|||
42236717|NCT02805972|76058767|FG001|Washout Period|Lost to Follow-up|0|||
42236718|NCT03032523|76058785|FG000|Overall Study|Withdrawal by Subject|2|||
42236719|NCT03032523|76058786|FG001|Overall Study|Withdrawal by Subject|2|||
42236720|NCT03032523|76058785|FG000|Overall Study|Physician Decision|1|||
42236721|NCT03032523|76058786|FG001|Overall Study|Physician Decision|0|||
42236722|NCT03031899|76058793|FG000|Overall Study|Protocol Violation|1|||
42236723|NCT03031899|76058793|FG000|Overall Study|lesion disappeared after stopping habit|1|||
42236724|NCT03086369|76058806|FG000|Overall Study|Lost to Follow-up|1|||
42236725|NCT03086369|76058807|FG001|Overall Study|Lost to Follow-up|0|||
42236726|NCT03086369|76058808|FG002|Overall Study|Lost to Follow-up|0|||
42236727|NCT03086369|76058809|FG003|Overall Study|Lost to Follow-up|2|||
42236728|NCT03086369|76058810|FG004|Overall Study|Lost to Follow-up|1|||
42236729|NCT03086369|76058806|FG000|Overall Study|Physician Decision|0|||
42236730|NCT03086369|76058807|FG001|Overall Study|Physician Decision|0|||
42236731|NCT03086369|76058808|FG002|Overall Study|Physician Decision|0|||
42236732|NCT03086369|76058809|FG003|Overall Study|Physician Decision|1|||
42236733|NCT03086369|76058810|FG004|Overall Study|Physician Decision|2|||
42236734|NCT03086369|76058806|FG000|Overall Study|Withdrawal by Subject|0|||
42236735|NCT03086369|76058807|FG001|Overall Study|Withdrawal by Subject|0|||
42236736|NCT03086369|76058808|FG002|Overall Study|Withdrawal by Subject|0|||
42236737|NCT03086369|76058809|FG003|Overall Study|Withdrawal by Subject|5|||
42236738|NCT03086369|76058810|FG004|Overall Study|Withdrawal by Subject|3|||
42236739|NCT03086369|76058806|FG000|Overall Study|Progressive Disease|0|||
42236740|NCT03086369|76058807|FG001|Overall Study|Progressive Disease|0|||
42236741|NCT03086369|76058808|FG002|Overall Study|Progressive Disease|0|||
42236742|NCT03086369|76058809|FG003|Overall Study|Progressive Disease|1|||
42236743|NCT03086369|76058810|FG004|Overall Study|Progressive Disease|1|||
42236744|NCT00101582|76058826|FG000|Overall Study|Ineligibility determined|0|||
42236745|NCT00101582|76058827|FG001|Overall Study|Ineligibility determined|1|||
42236746|NCT00101582|76058826|FG000|Overall Study|Adverse Event|1|||
42236747|NCT00101582|76058827|FG001|Overall Study|Adverse Event|4|||
42236748|NCT00101582|76058826|FG000|Overall Study|Withdrawal by Subject|6|||
42236749|NCT00101582|76058827|FG001|Overall Study|Withdrawal by Subject|4|||
42236750|NCT00101582|76058826|FG000|Overall Study|Physician Decision|1|||
42236751|NCT00101582|76058827|FG001|Overall Study|Physician Decision|0|||
42236752|NCT00101582|76058826|FG000|Overall Study|Death|3|||
42236753|NCT00101582|76058827|FG001|Overall Study|Death|5|||
42236754|NCT00101582|76058826|FG000|Overall Study|Other|0|||
42236755|NCT00101582|76058827|FG001|Overall Study|Other|1|||
42236756|NCT03086135|76058858|FG000|Overall Study|Adverse Event|1|||
42236757|NCT03086135|76058858|FG000|Overall Study|Lost to Follow-up|2|||
42236758|NCT02762708|76058875|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
42236759|NCT02762708|76058876|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
42236760|NCT02762708|76058877|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
42236761|NCT02762708|76058878|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
42236762|NCT02760602|76058890|FG000|Overall Study|Withdrawal by Subject|1|||
42236763|NCT02760602|76058891|FG001|Overall Study|Withdrawal by Subject|0|||
42236764|NCT02760602|76058890|FG000|Overall Study|Terminated by sponsor|12|||
42236765|NCT02760602|76058891|FG001|Overall Study|Terminated by sponsor|13|||
42236766|NCT00210249|76058897|FG000|Overall Study|Lost to Follow-up|5|||
42236767|NCT00210249|76058897|FG000|Overall Study|Protocol Violation|11|||
42236768|NCT03086057|76058905|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
42236769|NCT03086057|76058906|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
42236770|NCT03086057|76058907|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
42236771|NCT03086057|76058908|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
42236772|NCT03086057|76058905|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
42236773|NCT03086057|76058906|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
42236774|NCT03086057|76058907|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
42236775|NCT03086057|76058908|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
42236776|NCT03086057|76058905|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
42236777|NCT03086057|76058906|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
42236778|NCT03086057|76058907|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
42236779|NCT03086057|76058908|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
42236780|NCT03086057|76058905|FG000|Stage 1: PrEP Uptake|Death|1|||
42236781|NCT03086057|76058906|FG001|Stage 1: PrEP Uptake|Death|0|||
42236782|NCT03086057|76058907|FG002|Stage 1: PrEP Uptake|Death|0|||
42236783|NCT03086057|76058908|FG003|Stage 1: PrEP Uptake|Death|0|||
42236784|NCT03086057|76058905|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
42236785|NCT03086057|76058906|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
42236786|NCT03086057|76058907|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
42236787|NCT03086057|76058908|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
42236788|NCT03086057|76058905|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
42236789|NCT03086057|76058906|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
42236790|NCT03086057|76058907|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
42236791|NCT03086057|76058908|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
42236792|NCT03086057|76058905|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
42236793|NCT03086057|76058906|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
42236794|NCT03086057|76058907|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
42236795|NCT03086057|76058908|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
42236796|NCT02759120|76058920|FG000|Overall Study|Death|34|||
42236797|NCT02759120|76058921|FG001|Overall Study|Death|36|||
42236798|NCT02759120|76058920|FG000|Overall Study|Lost to Follow-up|4|||
42236799|NCT02759120|76058921|FG001|Overall Study|Lost to Follow-up|7|||
42236800|NCT02759120|76058920|FG000|Overall Study|Physician Decision|3|||
42236801|NCT02759120|76058921|FG001|Overall Study|Physician Decision|0|||
42236802|NCT02759120|76058920|FG000|Overall Study|Withdrawal by Subject|28|||
42236803|NCT02759120|76058921|FG001|Overall Study|Withdrawal by Subject|15|||
42236804|NCT02759120|76058920|FG000|Overall Study|Moved out of area|3|||
42236805|NCT02759120|76058921|FG001|Overall Study|Moved out of area|4|||
42236806|NCT02759120|76058920|FG000|Overall Study|Lung transplant|3|||
42236807|NCT02759120|76058921|FG001|Overall Study|Lung transplant|5|||
42236808|NCT02759120|76058920|FG000|Overall Study|Other reason not completed|10|||
42236809|NCT02759120|76058921|FG001|Overall Study|Other reason not completed|12|||
42236810|NCT00101192|76058940|FG000|Overall Study|Ineligible|6|||
42236811|NCT00101192|76058940|FG000|Overall Study|Inevaluable|1|||
42236812|NCT03031431|76058944|FG000|Overall Study|Infant removed by maternal request|1|||
42236813|NCT03029247|76058950|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
42236814|NCT03029247|76058951|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
42236815|NCT03029247|76058950|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
42236816|NCT03029247|76058951|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
42236817|NCT03029247|76058950|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
42236818|NCT03029247|76058951|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
42236819|NCT03029247|76058950|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
42236820|NCT03029247|76058951|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
42236821|NCT04313283|76058957|FG000|Overall Study|did not complete intervention|4|||
42236822|NCT02754440|76058965|FG000|Overall Study|Protocol Violation|3|||
42236823|NCT02754440|76058966|FG001|Overall Study|Protocol Violation|2|||
42236824|NCT02754440|76058967|FG002|Overall Study|Protocol Violation|2|||
42236825|NCT02754440|76058968|FG003|Overall Study|Protocol Violation|6|||
42236826|NCT02754440|76058965|FG000|Overall Study|Adverse Event|3|||
42236827|NCT02754440|76058966|FG001|Overall Study|Adverse Event|1|||
42236828|NCT02754440|76058967|FG002|Overall Study|Adverse Event|0|||
42236829|NCT02754440|76058968|FG003|Overall Study|Adverse Event|9|||
42236830|NCT02754440|76058965|FG000|Overall Study|Withdrawal by Subject|0|||
42236831|NCT02754440|76058966|FG001|Overall Study|Withdrawal by Subject|0|||
42236832|NCT02754440|76058967|FG002|Overall Study|Withdrawal by Subject|0|||
42236833|NCT02754440|76058968|FG003|Overall Study|Withdrawal by Subject|1|||
42236834|NCT02754440|76058965|FG000|Overall Study|Equipment failure|0|||
42236835|NCT02754440|76058966|FG001|Overall Study|Equipment failure|5|||
42236836|NCT02754440|76058967|FG002|Overall Study|Equipment failure|5|||
42236837|NCT02754440|76058968|FG003|Overall Study|Equipment failure|7|||
42236838|NCT02754440|76058965|FG000|Overall Study|Subject issues not resulting in AE|0|||
42236839|NCT02754440|76058966|FG001|Overall Study|Subject issues not resulting in AE|0|||
42236840|NCT02754440|76058967|FG002|Overall Study|Subject issues not resulting in AE|0|||
42236841|NCT02754440|76058968|FG003|Overall Study|Subject issues not resulting in AE|12|||
42236842|NCT02753816|76058980|FG000|Overall Study|Protocol Violation|0|||
42236843|NCT02753816|76058981|FG001|Overall Study|Protocol Violation|1|||
42236844|NCT02753816|76058982|FG002|Overall Study|Protocol Violation|0|||
42236845|NCT02752802|76058990|FG000|Overall Study|Contrast Volume Not Collected|1|||
42236846|NCT02752802|76058991|FG001|Overall Study|Contrast Volume Not Collected|0|||
42236847|NCT02756078|76059008|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
42236848|NCT02756078|76059009|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
42236849|NCT02756078|76059008|FG000|Period 1|Lost to Follow-up|0|||
42236850|NCT02756078|76059009|FG001|Period 1|Lost to Follow-up|2|||
42236851|NCT02756078|76059008|FG000|Period 1|Protocol Violation|0|||
42236852|NCT02756078|76059009|FG001|Period 1|Protocol Violation|1|||
42236853|NCT02756078|76059008|FG000|Period 1|Adverse Event|1|||
42236854|NCT02756078|76059009|FG001|Period 1|Adverse Event|10|||
42236855|NCT02756078|76059008|FG000|Period 1|Withdrawal by Subject|6|||
42236856|NCT02756078|76059009|FG001|Period 1|Withdrawal by Subject|6|||
42236857|NCT02756078|76059008|FG000|Period 1|Lens Discomfort|2|||
42236858|NCT02756078|76059009|FG001|Period 1|Lens Discomfort|2|||
42236859|NCT02756078|76059008|FG000|Period 2|Adverse Event|3|||
42236860|NCT02756078|76059009|FG001|Period 2|Adverse Event|5|||
42236861|NCT02756078|76059008|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
42236862|NCT02756078|76059009|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
42236863|NCT02756078|76059008|FG000|Period 2|Withdrawal by Subject|3|||
42236864|NCT02756078|76059009|FG001|Period 2|Withdrawal by Subject|1|||
42236865|NCT02752958|76059015|FG000|Overall Study|Adverse Event|3|||
42236866|NCT02752958|76059015|FG000|Overall Study|Lost to Follow-up|1|||
42236867|NCT02752958|76059015|FG000|Overall Study|Protocol Violation|1|||
42236868|NCT02752958|76059015|FG000|Overall Study|Withdrawal by Subject|2|||
42236869|NCT02752958|76059015|FG000|Overall Study|Other (Reason not specified)|2|||
42236870|NCT02805660|76059028|FG000|Overall Study|Death|5|||
42236871|NCT02805660|76059029|FG001|Overall Study|Death|2|||
42236872|NCT02805660|76059030|FG002|Overall Study|Death|9|||
42236873|NCT02805660|76059031|FG003|Overall Study|Death|5|||
42236874|NCT02805660|76059032|FG004|Overall Study|Death|0|||
42236875|NCT02805660|76059033|FG005|Overall Study|Death|14|||
42236876|NCT02805660|76059034|FG006|Overall Study|Death|12|||
42236877|NCT02805660|76059028|FG000|Overall Study|Lost to Follow-up|0|||
42236878|NCT02805660|76059029|FG001|Overall Study|Lost to Follow-up|1|||
42236879|NCT02805660|76059030|FG002|Overall Study|Lost to Follow-up|1|||
42236880|NCT02805660|76059031|FG003|Overall Study|Lost to Follow-up|2|||
42236881|NCT02805660|76059032|FG004|Overall Study|Lost to Follow-up|0|||
42236882|NCT02805660|76059033|FG005|Overall Study|Lost to Follow-up|0|||
42236883|NCT02805660|76059034|FG006|Overall Study|Lost to Follow-up|0|||
42236884|NCT02805660|76059028|FG000|Overall Study|Withdrawal by Subject|0|||
42236885|NCT02805660|76059029|FG001|Overall Study|Withdrawal by Subject|0|||
42236886|NCT02805660|76059030|FG002|Overall Study|Withdrawal by Subject|0|||
42236887|NCT02805660|76059031|FG003|Overall Study|Withdrawal by Subject|3|||
42236888|NCT02805660|76059032|FG004|Overall Study|Withdrawal by Subject|1|||
42236889|NCT02805660|76059033|FG005|Overall Study|Withdrawal by Subject|0|||
42236890|NCT02805660|76059034|FG006|Overall Study|Withdrawal by Subject|2|||
42236891|NCT02805660|76059028|FG000|Overall Study|Study terminated by Sponsor|0|||
42236892|NCT02805660|76059029|FG001|Overall Study|Study terminated by Sponsor|0|||
42236893|NCT02805660|76059030|FG002|Overall Study|Study terminated by Sponsor|1|||
42236894|NCT02805660|76059031|FG003|Overall Study|Study terminated by Sponsor|4|||
42236895|NCT02805660|76059032|FG004|Overall Study|Study terminated by Sponsor|2|||
42236896|NCT02805660|76059033|FG005|Overall Study|Study terminated by Sponsor|3|||
42236897|NCT02805660|76059034|FG006|Overall Study|Study terminated by Sponsor|1|||
42236898|NCT02805660|76059028|FG000|Overall Study|Miscellaneous|0|||
42236899|NCT02805660|76059029|FG001|Overall Study|Miscellaneous|1|||
42236900|NCT02805660|76059030|FG002|Overall Study|Miscellaneous|0|||
42236901|NCT02805660|76059031|FG003|Overall Study|Miscellaneous|4|||
42236902|NCT02805660|76059032|FG004|Overall Study|Miscellaneous|0|||
42236903|NCT02805660|76059033|FG005|Overall Study|Miscellaneous|6|||
42236904|NCT02805660|76059034|FG006|Overall Study|Miscellaneous|4|||
42236905|NCT02807376|76059065|FG000|Overall Study|Intra-operative exclusion criteria|3|||
42236906|NCT02807376|76059066|FG001|Overall Study|Intra-operative exclusion criteria|0|||
42236907|NCT02807376|76059065|FG000|Overall Study|Lost to Follow-up|0|||
42236908|NCT02807376|76059066|FG001|Overall Study|Lost to Follow-up|1|||
42236909|NCT02804178|76059072|FG000|Overall Study|Adverse Event|1|||
42236910|NCT02917941|76059076|FG000|Treatment Period|Adverse Event|11|||
42236911|NCT02917941|76059076|FG000|Treatment Period|Progressive Disease|11|||
42236912|NCT02917941|76059076|FG000|Treatment Period|Reason not Specified|2|||
42236913|NCT02917941|76059076|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
42236914|NCT02917941|76059076|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
42236915|NCT01333956|76059084|FG000|Overall Study|Lost to Follow-up|1|||
42236916|NCT01333956|76059085|FG001|Overall Study|Lost to Follow-up|2|||
42236917|NCT01333956|76059086|FG002|Overall Study|Lost to Follow-up|0|||
42236918|NCT01333956|76059087|FG003|Overall Study|Lost to Follow-up|1|||
42236919|NCT01333956|76059084|FG000|Overall Study|Unable to complete study procedure|1|||
42236920|NCT01333956|76059085|FG001|Overall Study|Unable to complete study procedure|0|||
42236921|NCT01333956|76059086|FG002|Overall Study|Unable to complete study procedure|0|||
42236922|NCT01333956|76059087|FG003|Overall Study|Unable to complete study procedure|1|||
42236923|NCT01333956|76059084|FG000|Overall Study|Withdrawal by Subject|0|||
42236924|NCT01333956|76059085|FG001|Overall Study|Withdrawal by Subject|2|||
42236925|NCT01333956|76059086|FG002|Overall Study|Withdrawal by Subject|1|||
42236926|NCT01333956|76059087|FG003|Overall Study|Withdrawal by Subject|0|||
42236927|NCT01333722|76059100|FG000|Overall Study|Lack of Efficacy|0|||
42236928|NCT01333722|76059101|FG001|Overall Study|Lack of Efficacy|2|||
42236929|NCT01333722|76059100|FG000|Overall Study|Withdrawal by Subject|0|||
42236930|NCT01333722|76059101|FG001|Overall Study|Withdrawal by Subject|1|||
42236931|NCT01370694|76059109|FG000|Overall Study|Switched to rituximab|4|||
42236932|NCT01370694|76059109|FG000|Overall Study|Progressive disease|2|||
42236933|NCT03315143|76059115|FG000|Overall Study|Death|240|||
42236934|NCT03315143|76059116|FG001|Overall Study|Death|246|||
42236935|NCT03315143|76059115|FG000|Overall Study|Withdrawal by Subject|57|||
42236936|NCT03315143|76059116|FG001|Overall Study|Withdrawal by Subject|68|||
42236937|NCT03315143|76059115|FG000|Overall Study|Site Terminated by Sponsor|256|||
42302653|NCT02413489|76137936|FG000|Overall Study|Study Terminated By Sponsor|2|||
42302654|NCT02413489|76137937|FG001|Overall Study|Study Terminated By Sponsor|13|||
41987733|NCT01284634|75795052|FG002|Overall Study|Adverse Event|2|||
42236938|NCT03315143|76059116|FG001|Overall Study|Site Terminated by Sponsor|282|||
42236939|NCT03315143|76059115|FG000|Overall Study|Study Terminated by Sponsor|4723|||
42236940|NCT03315143|76059116|FG001|Overall Study|Study Terminated by Sponsor|4664|||
42236941|NCT03315143|76059115|FG000|Overall Study|Reason not Specified|16|||
41987734|NCT01284634|75795053|FG003|Overall Study|Adverse Event|1|||
42236942|NCT03315143|76059116|FG001|Overall Study|Reason not Specified|32|||
42236943|NCT02797080|76059122|FG000|Overall Study|Lost to Follow-up|1|||
42236944|NCT02797080|76059122|FG000|Overall Study|Withdrawal by Subject|1|||
42236945|NCT02915835|76059128|FG000|Overall Study|Physician Decision|1|||
42236946|NCT02915835|76059129|FG001|Overall Study|Physician Decision|0|||
42236947|NCT02915835|76059128|FG000|Overall Study|Withdrawal by Subject|0|||
42236948|NCT02915835|76059129|FG001|Overall Study|Withdrawal by Subject|1|||
42236949|NCT01370616|76059137|FG000|Overall Study|Adverse Event|11|||
42236950|NCT01370616|76059138|FG001|Overall Study|Adverse Event|16|||
42236951|NCT01370616|76059137|FG000|Overall Study|Death|1|||
42236952|NCT01370616|76059138|FG001|Overall Study|Death|0|||
42236953|NCT01370616|76059137|FG000|Overall Study|Lack of Efficacy|6|||
42236954|NCT01370616|76059138|FG001|Overall Study|Lack of Efficacy|2|||
42236955|NCT01370616|76059137|FG000|Overall Study|Lost to Follow-up|0|||
42236956|NCT01370616|76059138|FG001|Overall Study|Lost to Follow-up|3|||
42236957|NCT01370616|76059137|FG000|Overall Study|Physician Decision|6|||
42236958|NCT01370616|76059138|FG001|Overall Study|Physician Decision|6|||
42236959|NCT01370616|76059137|FG000|Overall Study|Progressive Disease|0|||
42236960|NCT01370616|76059138|FG001|Overall Study|Progressive Disease|1|||
42236961|NCT01370616|76059137|FG000|Overall Study|Recovery|1|||
42236962|NCT01370616|76059138|FG001|Overall Study|Recovery|0|||
42236963|NCT01370616|76059137|FG000|Overall Study|Technical Problems|3|||
42236964|NCT01370616|76059138|FG001|Overall Study|Technical Problems|5|||
42236965|NCT01370616|76059137|FG000|Overall Study|Withdrawal by Subject|34|||
42236966|NCT01370616|76059138|FG001|Overall Study|Withdrawal by Subject|34|||
42236967|NCT02916927|76059151|FG000|Overall Study|Discharged prior to study drug receipt|0|||
42236968|NCT02916927|76059152|FG001|Overall Study|Discharged prior to study drug receipt|2|||
42236969|NCT02916927|76059151|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
42236970|NCT02916927|76059152|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
42236971|NCT02916927|76059151|FG000|Overall Study|Withdrawal before first time point|1|||
42236972|NCT02916927|76059152|FG001|Overall Study|Withdrawal before first time point|0|||
42236973|NCT02916693|76059158|FG000|Overall Study|Lost to Follow-up|7|||
42236974|NCT02574455|76059168|FG000|Overall Study|Death|197|||
42236975|NCT02574455|76059169|FG001|Overall Study|Death|210|||
42236976|NCT02574455|76059168|FG000|Overall Study|Withdrawal of Consent|11|||
42236977|NCT02574455|76059169|FG001|Overall Study|Withdrawal of Consent|28|||
42236978|NCT02574455|76059168|FG000|Overall Study|Lost to Follow-up|4|||
42236979|NCT02574455|76059169|FG001|Overall Study|Lost to Follow-up|4|||
42236980|NCT02574455|76059168|FG000|Overall Study|Sponsor's Decision|55|||
42236981|NCT02574455|76059169|FG001|Overall Study|Sponsor's Decision|20|||
42236982|NCT02795832|76059181|FG000|Overall Study|Adverse Event|0|||
42236983|NCT02795832|76059182|FG001|Overall Study|Adverse Event|0|||
42236984|NCT02795832|76059183|FG002|Overall Study|Adverse Event|0|||
42236985|NCT02795832|76059184|FG003|Overall Study|Adverse Event|0|||
42236986|NCT02795832|76059185|FG004|Overall Study|Adverse Event|0|||
42236987|NCT02795832|76059186|FG005|Overall Study|Adverse Event|3|||
42236988|NCT02794974|76059210|FG000|Overall Study|Physician Decision|0|||
42236989|NCT02794974|76059211|FG001|Overall Study|Physician Decision|1|||
42236990|NCT02419417|76059228|FG000|Overall Study|Disease progression|5|||
42236991|NCT02419417|76059229|FG001|Overall Study|Disease progression|4|||
42236992|NCT02419417|76059230|FG002|Overall Study|Disease progression|13|||
42236993|NCT02419417|76059231|FG003|Overall Study|Disease progression|10|||
42236994|NCT02419417|76059232|FG004|Overall Study|Disease progression|10|||
42236995|NCT02419417|76059233|FG005|Overall Study|Disease progression|3|||
42236996|NCT02419417|76059234|FG006|Overall Study|Disease progression|4|||
42236997|NCT02419417|76059235|FG007|Overall Study|Disease progression|5|||
42236998|NCT02419417|76059236|FG008|Overall Study|Disease progression|13|||
42236999|NCT02419417|76059237|FG009|Overall Study|Disease progression|9|||
42237000|NCT02419417|76059238|FG010|Overall Study|Disease progression|0|||
42237001|NCT02419417|76059228|FG000|Overall Study|Study drug toxicity|0|||
42237002|NCT02419417|76059229|FG001|Overall Study|Study drug toxicity|0|||
42237003|NCT02419417|76059230|FG002|Overall Study|Study drug toxicity|0|||
42237004|NCT02419417|76059231|FG003|Overall Study|Study drug toxicity|0|||
42237005|NCT02419417|76059232|FG004|Overall Study|Study drug toxicity|1|||
42237006|NCT02419417|76059233|FG005|Overall Study|Study drug toxicity|0|||
42237007|NCT02419417|76059234|FG006|Overall Study|Study drug toxicity|0|||
42237008|NCT02419417|76059235|FG007|Overall Study|Study drug toxicity|0|||
42237009|NCT02419417|76059236|FG008|Overall Study|Study drug toxicity|0|||
42237010|NCT02419417|76059237|FG009|Overall Study|Study drug toxicity|0|||
42237011|NCT02419417|76059238|FG010|Overall Study|Study drug toxicity|0|||
42237012|NCT02419417|76059228|FG000|Overall Study|Adverse event unrelated to study drug|0|||
42237013|NCT02419417|76059229|FG001|Overall Study|Adverse event unrelated to study drug|0|||
42237014|NCT02419417|76059230|FG002|Overall Study|Adverse event unrelated to study drug|0|||
42237015|NCT02419417|76059231|FG003|Overall Study|Adverse event unrelated to study drug|0|||
42237016|NCT02419417|76059232|FG004|Overall Study|Adverse event unrelated to study drug|2|||
42237017|NCT02419417|76059233|FG005|Overall Study|Adverse event unrelated to study drug|1|||
42237018|NCT02419417|76059234|FG006|Overall Study|Adverse event unrelated to study drug|0|||
42237019|NCT02419417|76059235|FG007|Overall Study|Adverse event unrelated to study drug|1|||
42237020|NCT02419417|76059236|FG008|Overall Study|Adverse event unrelated to study drug|0|||
42237021|NCT02419417|76059237|FG009|Overall Study|Adverse event unrelated to study drug|0|||
42237022|NCT02419417|76059238|FG010|Overall Study|Adverse event unrelated to study drug|0|||
42237023|NCT02419417|76059228|FG000|Overall Study|Participant request to discontinue|0|||
42237024|NCT02419417|76059229|FG001|Overall Study|Participant request to discontinue|0|||
42237025|NCT02419417|76059230|FG002|Overall Study|Participant request to discontinue|0|||
42237026|NCT02419417|76059231|FG003|Overall Study|Participant request to discontinue|0|||
42237027|NCT02419417|76059232|FG004|Overall Study|Participant request to discontinue|0|||
42237028|NCT02419417|76059233|FG005|Overall Study|Participant request to discontinue|0|||
42237029|NCT02419417|76059234|FG006|Overall Study|Participant request to discontinue|0|||
42237030|NCT02419417|76059235|FG007|Overall Study|Participant request to discontinue|0|||
42237031|NCT02419417|76059236|FG008|Overall Study|Participant request to discontinue|0|||
42237032|NCT02419417|76059237|FG009|Overall Study|Participant request to discontinue|1|||
42237033|NCT02419417|76059238|FG010|Overall Study|Participant request to discontinue|0|||
42237034|NCT02419417|76059228|FG000|Overall Study|Withdrawal by Subject|0|||
42237035|NCT02419417|76059229|FG001|Overall Study|Withdrawal by Subject|0|||
42237036|NCT02419417|76059230|FG002|Overall Study|Withdrawal by Subject|0|||
42237037|NCT02419417|76059231|FG003|Overall Study|Withdrawal by Subject|0|||
42237038|NCT02419417|76059232|FG004|Overall Study|Withdrawal by Subject|0|||
42237039|NCT02419417|76059233|FG005|Overall Study|Withdrawal by Subject|0|||
42237040|NCT02419417|76059234|FG006|Overall Study|Withdrawal by Subject|0|||
42237041|NCT02419417|76059235|FG007|Overall Study|Withdrawal by Subject|0|||
42237042|NCT02419417|76059236|FG008|Overall Study|Withdrawal by Subject|0|||
42237043|NCT02419417|76059237|FG009|Overall Study|Withdrawal by Subject|0|||
42237044|NCT02419417|76059238|FG010|Overall Study|Withdrawal by Subject|1|||
42237045|NCT00777491|76059279|FG000|Overall Study|Protocol Violation|0|||
42237046|NCT00777491|76059280|FG001|Overall Study|Protocol Violation|2|||
42237047|NCT00777491|76059279|FG000|Overall Study|Did not receive any protocol treatment|2|||
42237048|NCT00777491|76059280|FG001|Overall Study|Did not receive any protocol treatment|0|||
42237049|NCT02066532|76059290|FG000|Phase II|Withdrawal by Subject|1|||
42237050|NCT02066532|76059291|FG001|Phase II|Withdrawal by Subject|0|||
42237051|NCT02066532|76059292|FG002|Phase II|Withdrawal by Subject|0|||
42237052|NCT02066532|76059293|FG003|Phase II|Withdrawal by Subject|0|||
42237053|NCT03077711|76059300|FG000|Overall Study|Lost to Follow-up|2|||
42237054|NCT03077711|76059301|FG001|Overall Study|Lost to Follow-up|2|||
42237055|NCT03077711|76059300|FG000|Overall Study|noncompliant taking medication|2|||
42237056|NCT03077711|76059301|FG001|Overall Study|noncompliant taking medication|0|||
42237057|NCT04311463|76059328|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
42237058|NCT04311463|76059329|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
42237059|NCT04311463|76059328|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
42237060|NCT04311463|76059329|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
42237061|NCT04311463|76059328|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
42237062|NCT04311463|76059329|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
42237063|NCT01370538|76059342|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
42237064|NCT01370538|76059343|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
42237065|NCT01370538|76059342|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42237066|NCT01370538|76059343|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
42237067|NCT01370538|76059342|FG000|Overall Study|Adverse Event|1|||
42237068|NCT01370538|76059343|FG001|Overall Study|Adverse Event|0|||
42237069|NCT01370538|76059342|FG000|Overall Study|Protocol Violation|8|||
42237070|NCT01370538|76059343|FG001|Overall Study|Protocol Violation|5|||
42237071|NCT01370538|76059342|FG000|Overall Study|Development of study specific withdrawal|1|||
42237072|NCT01370538|76059343|FG001|Overall Study|Development of study specific withdrawal|1|||
42237073|NCT01370538|76059342|FG000|Overall Study|Lost to follow up|6|||
42237074|NCT01370538|76059343|FG001|Overall Study|Lost to follow up|10|||
42237075|NCT03402841|76059362|FG000|Overall Study|Withdrawal by Subject|3|||
42237076|NCT03402841|76059362|FG000|Overall Study|Lost to Follow-up|2|||
42237077|NCT03402841|76059362|FG000|Overall Study|Death|146|||
42237078|NCT02881957|76059377|FG000|Overall Study|Comfort care|0|||
42237079|NCT02881957|76059378|FG001|Overall Study|Comfort care|1|||
42237080|NCT02881957|76059377|FG000|Overall Study|Concurrent trial enrollment|0|||
42237081|NCT02881957|76059378|FG001|Overall Study|Concurrent trial enrollment|1|||
42237082|NCT02881957|76059377|FG000|Overall Study|Discharged within 48 hours|0|||
42237083|NCT02881957|76059378|FG001|Overall Study|Discharged within 48 hours|1|||
42237084|NCT02881957|76059377|FG000|Overall Study|Withdrawal by Subject|2|||
42237085|NCT02881957|76059378|FG001|Overall Study|Withdrawal by Subject|1|||
42237086|NCT02881957|76059377|FG000|Overall Study|Protocol Violation|1|||
42237087|NCT02881957|76059378|FG001|Overall Study|Protocol Violation|0|||
42237088|NCT03022461|76059384|FG000|Overall Study|Death|3|||
42237089|NCT02750930|76059389|FG000|Overall Study|Study closed/terminated|8|||
42237090|NCT03078907|76059395|FG000|Overall Study|Adverse Event|2|||
42237091|NCT03078907|76059396|FG001|Overall Study|Adverse Event|0|||
42237092|NCT03078907|76059395|FG000|Overall Study|Other|1|||
42237093|NCT03078907|76059396|FG001|Overall Study|Other|0|||
42237094|NCT03078907|76059395|FG000|Overall Study|Protocol Violation|0|||
42237095|NCT03078907|76059396|FG001|Overall Study|Protocol Violation|1|||
42237096|NCT03249714|76059404|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
42237097|NCT03249714|76059405|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
41987735|NCT01284361|75795063|FG000|Overall Study|Withdrawal by Subject|1|||
41987736|NCT01284361|75795063|FG000|Overall Study|Protocol Violation|5|||
41987737|NCT01284361|75795063|FG000|Overall Study|Adverse Event|1|||
41987738|NCT01284361|75795063|FG000|Overall Study|Lost to Follow-up|2|||
41987739|NCT01284127|75795070|FG000|Overall Study|Adverse Event|2|||
41987740|NCT01284127|75795070|FG000|Overall Study|Withdrawal by Subject|4|||
42237098|NCT03249714|76059404|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
42237099|NCT03249714|76059405|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
42237100|NCT03249714|76059404|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
42237101|NCT03249714|76059405|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
42237102|NCT03249714|76059404|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
42237103|NCT03249714|76059405|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
42237104|NCT02925117|76059431|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
42237105|NCT02925117|76059432|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
42237106|NCT02925117|76059433|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
42237107|NCT02925117|76059434|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
42237108|NCT02925117|76059435|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
42237109|NCT02925117|76059436|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
42237110|NCT02925117|76059437|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
42237111|NCT02925117|76059438|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
42237112|NCT02925117|76059439|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
42237113|NCT02925117|76059440|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
42237114|NCT02925117|76059441|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
42237115|NCT02925117|76059442|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
42237116|NCT02925117|76059431|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
42237117|NCT02925117|76059432|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
42237118|NCT02925117|76059433|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
42237119|NCT02925117|76059434|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
42237120|NCT02925117|76059435|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
42237121|NCT02925117|76059436|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
42237122|NCT02925117|76059437|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
42237123|NCT02925117|76059438|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
42237124|NCT02925117|76059439|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
42237125|NCT02925117|76059440|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
42237126|NCT02925117|76059441|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
42237127|NCT02925117|76059442|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
42237128|NCT02925117|76059431|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
42237129|NCT02925117|76059432|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
42237130|NCT02925117|76059433|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
42237131|NCT02925117|76059434|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
42237132|NCT02925117|76059435|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
42237133|NCT02925117|76059436|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
42237134|NCT02925117|76059437|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
42237135|NCT02925117|76059438|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
42237136|NCT02925117|76059439|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
42237137|NCT02925117|76059440|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
42237138|NCT02925117|76059441|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
42237139|NCT02925117|76059442|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
42237140|NCT02925117|76059431|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
42237141|NCT02925117|76059432|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
42237142|NCT02925117|76059433|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
41987741|NCT01284127|75795070|FG000|Overall Study|Physician Decision|1|||
41987742|NCT01283971|75795076|FG000|Overall Study|Adverse Event|3|||
41987743|NCT01283971|75795077|FG001|Overall Study|Adverse Event|5|||
41987744|NCT01283971|75795076|FG000|Overall Study|Insufficient therapeutic responses|3|||
41987745|NCT01283971|75795077|FG001|Overall Study|Insufficient therapeutic responses|3|||
41987746|NCT01283971|75795076|FG000|Overall Study|Protocol Violation|5|||
41987747|NCT01283971|75795077|FG001|Overall Study|Protocol Violation|1|||
41987748|NCT01283971|75795076|FG000|Overall Study|Refused treatment|3|||
41987749|NCT01283971|75795077|FG001|Overall Study|Refused treatment|1|||
41987750|NCT01283971|75795076|FG000|Overall Study|Failure to return|0|||
41987751|NCT01283971|75795077|FG001|Overall Study|Failure to return|1|||
42237143|NCT02925117|76059434|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
42237144|NCT02925117|76059435|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
42237145|NCT02925117|76059436|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
42237146|NCT02925117|76059437|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
42237147|NCT02925117|76059438|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
42237148|NCT02925117|76059439|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
41987752|NCT01283971|75795076|FG000|Overall Study|Administrative reasons|1|||
41987753|NCT01283971|75795077|FG001|Overall Study|Administrative reasons|1|||
42237149|NCT02925117|76059440|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
42237150|NCT02925117|76059441|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
41987754|NCT01283581|75795086|FG000|Overall Study|Lost to Follow-up|8|||
41987755|NCT01283581|75795087|FG001|Overall Study|Lost to Follow-up|6|||
41987756|NCT01283581|75795088|FG002|Overall Study|Lost to Follow-up|8|||
41987757|NCT01283581|75795086|FG000|Overall Study|Withdrawal by Subject|2|||
41987758|NCT01283581|75795087|FG001|Overall Study|Withdrawal by Subject|5|||
41987759|NCT01283581|75795088|FG002|Overall Study|Withdrawal by Subject|2|||
41987760|NCT01283581|75795086|FG000|Overall Study|Adverse Event|1|||
41987761|NCT01283581|75795087|FG001|Overall Study|Adverse Event|1|||
41987762|NCT01283581|75795088|FG002|Overall Study|Adverse Event|4|||
41987763|NCT01283581|75795086|FG000|Overall Study|Physician Decision|0|||
41987764|NCT01283581|75795087|FG001|Overall Study|Physician Decision|1|||
41987765|NCT01283581|75795088|FG002|Overall Study|Physician Decision|2|||
41987766|NCT01283581|75795086|FG000|Overall Study|Protocol Violation|0|||
42237151|NCT02925117|76059442|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
42237152|NCT02925117|76059431|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
42237153|NCT02925117|76059432|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
42237154|NCT02925117|76059433|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
42237155|NCT02925117|76059434|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
42237156|NCT02925117|76059435|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
42237157|NCT02925117|76059436|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
42237158|NCT02925117|76059437|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
42237159|NCT02925117|76059438|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
42237160|NCT02925117|76059439|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
42237161|NCT02925117|76059440|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
42237162|NCT02925117|76059441|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
42237163|NCT02925117|76059442|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
42237164|NCT02925117|76059431|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
42237165|NCT02925117|76059432|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
42237166|NCT02925117|76059433|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
42237167|NCT02925117|76059434|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
42237168|NCT02925117|76059435|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
42237169|NCT02925117|76059436|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
42237170|NCT02925117|76059437|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
42237171|NCT02925117|76059438|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
42237172|NCT02925117|76059439|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
42237173|NCT02925117|76059440|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
42237174|NCT02925117|76059441|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
42237175|NCT02925117|76059442|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
42237176|NCT02925117|76059431|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
42237177|NCT02925117|76059432|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
42237178|NCT02925117|76059433|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
42237179|NCT02925117|76059434|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
41987767|NCT01283581|75795087|FG001|Overall Study|Protocol Violation|1|||
41987768|NCT01283581|75795088|FG002|Overall Study|Protocol Violation|2|||
41987769|NCT01283581|75795086|FG000|Overall Study|Noncompliance|1|||
41987770|NCT01283581|75795087|FG001|Overall Study|Noncompliance|0|||
41987771|NCT01283581|75795088|FG002|Overall Study|Noncompliance|0|||
41987772|NCT01283581|75795086|FG000|Overall Study|Investigator unblinded|0|||
41987773|NCT01283581|75795087|FG001|Overall Study|Investigator unblinded|0|||
41987774|NCT01283581|75795088|FG002|Overall Study|Investigator unblinded|1|||
41987775|NCT01283581|75795086|FG000|Overall Study|"Early termination"|0|||
41987776|NCT01283581|75795087|FG001|Overall Study|"Early termination"|0|||
41987777|NCT01283581|75795088|FG002|Overall Study|"Early termination"|1|||
41987778|NCT01283542|75795099|FG000|Main Phase|Acute or progressive vision loss|1|||
41987779|NCT01283542|75795099|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
41987780|NCT01283542|75795099|FG000|Main Phase|abnormal laboratory values|5|||
41987781|NCT01283542|75795099|FG000|Extension Phase|Physician Decision|1|||
41987782|NCT01283542|75795099|FG000|Extension Phase|Adverse Event|1|||
41987783|NCT01283542|75795099|FG000|Extension Phase|Administrative problems|1|||
41987784|NCT01283386|75795123|FG000|Overall Study|Death|2|||
41987785|NCT01283386|75795124|FG001|Overall Study|Death|0|||
41987786|NCT01283386|75795123|FG000|Overall Study|Withdrawal by Subject|2|||
41987787|NCT01283386|75795124|FG001|Overall Study|Withdrawal by Subject|1|||
41987788|NCT01283386|75795123|FG000|Overall Study|Relapse of underlying disease|1|||
41987789|NCT01283386|75795124|FG001|Overall Study|Relapse of underlying disease|3|||
42237180|NCT02925117|76059435|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
42237181|NCT02925117|76059436|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
42237182|NCT02925117|76059437|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
42237183|NCT02925117|76059438|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
42237184|NCT02925117|76059439|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
41987790|NCT01283386|75795123|FG000|Overall Study|Progression of underlying disease|2|||
41987791|NCT01283386|75795124|FG001|Overall Study|Progression of underlying disease|7|||
41987792|NCT01283386|75795123|FG000|Overall Study|Reason not specified|1|||
41987793|NCT01283386|75795124|FG001|Overall Study|Reason not specified|0|||
41987794|NCT01283386|75795123|FG000|Overall Study|Protocol Violation|0|||
41987795|NCT01283386|75795124|FG001|Overall Study|Protocol Violation|1|||
41987796|NCT01283152|75795132|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
41987797|NCT01283152|75795133|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
41987798|NCT01283152|75795132|FG000|Overall Study|Refused HESA|1|||
41987799|NCT01283152|75795133|FG001|Overall Study|Refused HESA|0|||
41987800|NCT01283035|75795139|FG000|Overall Study|Subject later found ineligible|1|||
41987801|NCT01283464|75795145|FG000|Overall Study|Lost to Follow-up|0|||
41987802|NCT01283464|75795146|FG001|Overall Study|Lost to Follow-up|1|||
41987803|NCT01283464|75795145|FG000|Overall Study|Withdrawal by Subject|1|||
41987804|NCT01283464|75795146|FG001|Overall Study|Withdrawal by Subject|0|||
41987805|NCT01283464|75795145|FG000|Overall Study|Physician Decision|1|||
41987806|NCT01283464|75795146|FG001|Overall Study|Physician Decision|0|||
41987807|NCT01282801|75795154|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
41987808|NCT01282801|75795155|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
41987809|NCT01282372|75795161|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
41987810|NCT01282372|75795161|FG000|Overall Study|Lost to Follow-up|23|||
42131894|NCT00392925|75942759|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
42131895|NCT00392925|75942760|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
42131896|NCT00392925|75942757|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
42131897|NCT00392925|75942758|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
42131898|NCT00392925|75942759|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
42131899|NCT00392925|75942760|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
41987811|NCT01282372|75795161|FG000|Overall Study|Withdrawal by Subject|11|||
41987812|NCT01282372|75795161|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
42131900|NCT00392925|75942757|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
42131901|NCT00392925|75942758|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
42131902|NCT00392925|75942759|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
42131903|NCT00392925|75942760|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
42131904|NCT00392925|75942757|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
42131905|NCT00392925|75942758|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
42131906|NCT00392925|75942759|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
42131907|NCT00392925|75942760|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
42131908|NCT00392925|75942757|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
42131909|NCT00392925|75942758|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
42131910|NCT00392925|75942759|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
42131911|NCT00392925|75942760|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
42131912|NCT00392925|75942757|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
42131913|NCT00392925|75942758|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
42131914|NCT00392925|75942759|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
42131915|NCT00392925|75942760|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
42131916|NCT00392925|75942757|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
42131917|NCT00392925|75942758|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
42131918|NCT00392925|75942759|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
42131919|NCT00392925|75942760|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
42131920|NCT00392925|75942757|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
42131921|NCT00392925|75942758|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
42131922|NCT00392925|75942759|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
42131923|NCT00392925|75942760|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
42131924|NCT00474786|75942778|FG000|Overall Study|Not Meeting Study Criteria|0|||
41987813|NCT01282372|75795161|FG000|Overall Study|Death|1|||
41987814|NCT01282372|75795161|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
42131925|NCT00474786|75942779|FG001|Overall Study|Not Meeting Study Criteria|1|||
42237185|NCT02925117|76059440|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
42237186|NCT02925117|76059441|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
41987815|NCT01282372|75795161|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
41987816|NCT01282372|75795161|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
41987817|NCT01282372|75795161|FG000|Overall Study|Adverse Event|12|||
41987818|NCT01282294|75795172|FG000|Overall Study|Lost to Follow-up|14|||
41987819|NCT01282294|75795172|FG000|Overall Study|Screening failure|1|||
42237187|NCT02925117|76059442|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
42237188|NCT02925117|76059431|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
42237189|NCT02925117|76059432|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
41987820|NCT01282294|75795172|FG000|Overall Study|Adverse Event|1|||
41987821|NCT01282294|75795172|FG000|Overall Study|Patient non-compliance|2|||
41987822|NCT01282294|75795172|FG000|Overall Study|Physician Decision|1|||
41987823|NCT01282216|75795178|FG000|Overall Study|Graft failure|0|||
41987824|NCT01282216|75795179|FG001|Overall Study|Graft failure|0|||
42237190|NCT02925117|76059433|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
42237191|NCT02925117|76059434|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
42237192|NCT02925117|76059435|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
42237193|NCT02925117|76059436|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
42237194|NCT02925117|76059437|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
42237195|NCT02925117|76059438|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
42237196|NCT02925117|76059439|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
42237197|NCT02925117|76059440|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
42237198|NCT02925117|76059441|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
42237199|NCT02925117|76059442|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
42237200|NCT03075163|76059466|FG000|Overall Study|not eligible for treatment limb|138|||
42237201|NCT03075163|76059467|FG001|Overall Study|not eligible for treatment limb|138|||
42237202|NCT03078751|76059475|FG000|Overall Study|Adverse Event|4|||
42237203|NCT03078751|76059476|FG001|Overall Study|Adverse Event|0|||
42237204|NCT03078751|76059475|FG000|Overall Study|Physician Decision|1|||
42237205|NCT03078751|76059476|FG001|Overall Study|Physician Decision|0|||
42237206|NCT03078751|76059475|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
42237207|NCT03078751|76059476|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
42237208|NCT03078751|76059475|FG000|Overall Study|Subject/guardian decision|8|||
42237209|NCT03078751|76059476|FG001|Overall Study|Subject/guardian decision|1|||
42237210|NCT03078751|76059475|FG000|Overall Study|Untreated|0|||
42237211|NCT03078751|76059476|FG001|Overall Study|Untreated|4|||
42237212|NCT02924883|76059501|FG000|Overall Study|Death|39|||
41987825|NCT01282216|75795180|FG002|Overall Study|Graft failure|3|||
41987826|NCT01282216|75795181|FG003|Overall Study|Graft failure|2|||
41987827|NCT01282216|75795178|FG000|Overall Study|Physician Decision|0|||
41987828|NCT01282216|75795179|FG001|Overall Study|Physician Decision|0|||
41987829|NCT01282216|75795180|FG002|Overall Study|Physician Decision|11|||
41987830|NCT01282216|75795181|FG003|Overall Study|Physician Decision|0|||
41987831|NCT01282216|75795178|FG000|Overall Study|Relapse|0|||
41987832|NCT01282216|75795179|FG001|Overall Study|Relapse|0|||
41987833|NCT01282216|75795180|FG002|Overall Study|Relapse|17|||
41987834|NCT01282216|75795181|FG003|Overall Study|Relapse|6|||
41987835|NCT01282216|75795178|FG000|Overall Study|Death|0|||
41987836|NCT01282216|75795179|FG001|Overall Study|Death|0|||
41987837|NCT01282216|75795180|FG002|Overall Study|Death|2|||
41987838|NCT01282216|75795181|FG003|Overall Study|Death|0|||
41987839|NCT01281865|75795189|FG000|Overall Study|Adverse Event|1|||
41987840|NCT01281865|75795190|FG001|Overall Study|Adverse Event|1|||
41987841|NCT01281865|75795189|FG000|Overall Study|Withdrawal by Subject|1|||
41987842|NCT01281865|75795190|FG001|Overall Study|Withdrawal by Subject|0|||
41987843|NCT01281865|75795189|FG000|Overall Study|Lack of Efficacy|1|||
41987844|NCT01281865|75795190|FG001|Overall Study|Lack of Efficacy|0|||
42131926|NCT00474786|75942778|FG000|Overall Study|Investigator Request|2|||
42131927|NCT00474786|75942779|FG001|Overall Study|Investigator Request|1|||
42131928|NCT00474786|75942778|FG000|Overall Study|Death|189|||
42131929|NCT00474786|75942779|FG001|Overall Study|Death|170|||
42131930|NCT00474786|75942778|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
42131931|NCT00474786|75942779|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
42131932|NCT00474786|75942778|FG000|Overall Study|Lost to Follow-up|4|||
42131933|NCT00474786|75942779|FG001|Overall Study|Lost to Follow-up|7|||
42131934|NCT00474786|75942778|FG000|Overall Study|Protocol Violation|2|||
42131935|NCT00474786|75942779|FG001|Overall Study|Protocol Violation|0|||
41987845|NCT01281202|75795198|FG000|Overall Study|Adverse Event|2|||
41987846|NCT01281202|75795199|FG001|Overall Study|Adverse Event|0|||
41987847|NCT01281202|75795198|FG000|Overall Study|Withdrawal by Subject|2|||
41987848|NCT01281202|75795199|FG001|Overall Study|Withdrawal by Subject|2|||
41987849|NCT01281202|75795198|FG000|Overall Study|Protocol Violation|11|||
41987850|NCT01281202|75795199|FG001|Overall Study|Protocol Violation|10|||
42131936|NCT00474786|75942778|FG000|Overall Study|Withdrawal by Subject|15|||
42131937|NCT00474786|75942779|FG001|Overall Study|Withdrawal by Subject|15|||
42237213|NCT02924883|76059502|FG001|Overall Study|Death|20|||
42237214|NCT02924883|76059501|FG000|Overall Study|Lost to Follow-up|1|||
42237215|NCT02924883|76059502|FG001|Overall Study|Lost to Follow-up|0|||
42237216|NCT02924883|76059501|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
41987851|NCT01281202|75795198|FG000|Overall Study|Administrative|2|||
41987852|NCT01281202|75795199|FG001|Overall Study|Administrative|8|||
41987853|NCT01281202|75795198|FG000|Overall Study|Lost to Follow-up|11|||
41987854|NCT01281202|75795199|FG001|Overall Study|Lost to Follow-up|13|||
41987855|NCT01281202|75795198|FG000|Overall Study|Incarceration|0|||
42131938|NCT00474786|75942778|FG000|Overall Study|Other|5|||
42237217|NCT02924883|76059502|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
42237218|NCT02924883|76059501|FG000|Overall Study|Protocol Violation|1|||
42237219|NCT02924883|76059502|FG001|Overall Study|Protocol Violation|0|||
42237220|NCT02924883|76059501|FG000|Overall Study|Withdrawal by Subject|22|||
42237221|NCT02924883|76059502|FG001|Overall Study|Withdrawal by Subject|16|||
42237222|NCT02924883|76059501|FG000|Overall Study|Progressive Disease|1|||
42237223|NCT02924883|76059502|FG001|Overall Study|Progressive Disease|0|||
42237224|NCT02924883|76059501|FG000|Overall Study|Study Terminated by Sponsor|69|||
42237225|NCT02924883|76059502|FG001|Overall Study|Study Terminated by Sponsor|32|||
42237226|NCT01369680|76059525|FG000|Overall Study|Lost to Follow-up|0|||
42237227|NCT01369680|76059526|FG001|Overall Study|Lost to Follow-up|0|||
42237228|NCT01369680|76059527|FG002|Overall Study|Lost to Follow-up|1|||
42237229|NCT01369680|76059528|FG003|Overall Study|Lost to Follow-up|2|||
42237230|NCT03074149|76059560|FG000|Overall Study|Reason unknown|22|||
42237231|NCT03074149|76059561|FG001|Overall Study|Reason unknown|35|||
42237232|NCT03074149|76059560|FG000|Overall Study|Death|10|||
42237233|NCT03074149|76059561|FG001|Overall Study|Death|45|||
42237234|NCT02751320|76059569|FG000|Overall Study|Adverse Event|2|||
42237235|NCT02751320|76059569|FG000|Overall Study|Withdrawal by Subject|1|||
42237236|NCT02206035|76059597|FG000|Overall Study|Physician Decision|10|||
42237237|NCT02206035|76059598|FG001|Overall Study|Physician Decision|0|||
42237238|NCT02206035|76059599|FG002|Overall Study|Physician Decision|175|||
42237239|NCT02746471|76059606|FG000|Overall Study|Death|43|||
42237240|NCT02746471|76059606|FG000|Overall Study|Exited before 36 months|1119|||
42237241|NCT02591953|76059613|FG000|Overall Study|Lost to Follow-up|6|||
42237242|NCT02591953|76059614|FG001|Overall Study|Lost to Follow-up|6|||
42237243|NCT03073213|76059622|FG000|Multiple Dose Period|Protocol Violation|0|||
42237244|NCT03073213|76059623|FG001|Multiple Dose Period|Protocol Violation|0|||
42237245|NCT03073213|76059624|FG002|Multiple Dose Period|Protocol Violation|1|||
42237246|NCT03070483|76059633|FG000|Overall Study|Lost to Follow-up|2|||
42237247|NCT02231762|76059638|FG000|Combination Phase|Adverse Event|10|||
42237248|NCT02231762|76059639|FG001|Combination Phase|Adverse Event|0|||
42237249|NCT02231762|76059640|FG002|Combination Phase|Adverse Event|0|||
42237250|NCT02231762|76059641|FG003|Combination Phase|Adverse Event|0|||
42237251|NCT02231762|76059638|FG000|Combination Phase|Withdrawal by Subject|2|||
42237252|NCT02231762|76059639|FG001|Combination Phase|Withdrawal by Subject|0|||
42237253|NCT02231762|76059640|FG002|Combination Phase|Withdrawal by Subject|0|||
42237254|NCT02231762|76059641|FG003|Combination Phase|Withdrawal by Subject|0|||
42237255|NCT02231762|76059638|FG000|Combination Phase|Disease Progression|6|||
42237256|NCT02231762|76059639|FG001|Combination Phase|Disease Progression|0|||
42237257|NCT02231762|76059640|FG002|Combination Phase|Disease Progression|0|||
42237258|NCT02231762|76059641|FG003|Combination Phase|Disease Progression|0|||
42237259|NCT02231762|76059638|FG000|Combination Phase|Did not meet inclusion criteria|1|||
42237260|NCT02231762|76059639|FG001|Combination Phase|Did not meet inclusion criteria|0|||
42237261|NCT02231762|76059640|FG002|Combination Phase|Did not meet inclusion criteria|0|||
42237262|NCT02231762|76059641|FG003|Combination Phase|Did not meet inclusion criteria|0|||
42237263|NCT02231762|76059638|FG000|Combination Phase|Protocol Violation|1|||
42237264|NCT02231762|76059639|FG001|Combination Phase|Protocol Violation|0|||
42237265|NCT02231762|76059640|FG002|Combination Phase|Protocol Violation|0|||
42237266|NCT02231762|76059641|FG003|Combination Phase|Protocol Violation|0|||
42237267|NCT02231762|76059638|FG000|Maintenance Phase|Disease progression|0|||
42237268|NCT02231762|76059639|FG001|Maintenance Phase|Disease progression|3|||
42237269|NCT02231762|76059640|FG002|Maintenance Phase|Disease progression|4|||
42237270|NCT02231762|76059641|FG003|Maintenance Phase|Disease progression|3|||
42237271|NCT02231762|76059638|FG000|Maintenance Phase|Adverse Event|0|||
42237272|NCT02231762|76059639|FG001|Maintenance Phase|Adverse Event|0|||
42237273|NCT02231762|76059640|FG002|Maintenance Phase|Adverse Event|1|||
42237274|NCT02231762|76059641|FG003|Maintenance Phase|Adverse Event|2|||
42237275|NCT03023397|76059658|FG000|Run-In|Failed screening allergen challenge|1|||
42237276|NCT03023397|76059659|FG001|Run-In|Failed screening allergen challenge|0|||
42237277|NCT03023397|76059660|FG002|Run-In|Failed screening allergen challenge|0|||
42237278|NCT03023397|76059658|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
42237279|NCT03023397|76059659|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
42237280|NCT03023397|76059660|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
42237281|NCT04325906|76059671|FG000|Overall Study|Withdrawal by Subject|2|||
42237282|NCT04325906|76059672|FG001|Overall Study|Withdrawal by Subject|0|||
42237283|NCT03068455|76059680|FG000|Pre-treatment Period|Disease progression|0|||
42237284|NCT03068455|76059681|FG001|Pre-treatment Period|Disease progression|1|||
42237285|NCT03068455|76059680|FG000|Pre-treatment Period|Participant withdrew consent|1|||
42237286|NCT03068455|76059681|FG001|Pre-treatment Period|Participant withdrew consent|1|||
42237287|NCT03068455|76059680|FG000|Pre-treatment Period|Poor/non-compliance|0|||
42237288|NCT03068455|76059681|FG001|Pre-treatment Period|Poor/non-compliance|1|||
42237289|NCT03068455|76059680|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
42237290|NCT03068455|76059681|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
42237291|NCT03068455|76059680|FG000|Pre-treatment Period|Not reported|2|||
42237292|NCT03068455|76059681|FG001|Pre-treatment Period|Not reported|1|||
42237293|NCT03068455|76059680|FG000|Treatment Period|Disease progression|166|||
42237294|NCT03068455|76059681|FG001|Treatment Period|Disease progression|208|||
41987856|NCT01281202|75795199|FG001|Overall Study|Incarceration|3|||
41987857|NCT01281124|75795207|FG000|Overall Study|Death|1|||
41987858|NCT01280968|75795215|FG000|Overall Study|Lost to Follow-up|8|||
41987859|NCT01280968|75795216|FG001|Overall Study|Lost to Follow-up|2|||
41987860|NCT01280968|75795215|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
41987861|NCT01280968|75795216|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
41987862|NCT01280968|75795215|FG000|Overall Study|Commuting Problems|2|||
41987863|NCT01280968|75795216|FG001|Overall Study|Commuting Problems|0|||
41987864|NCT01280968|75795215|FG000|Overall Study|Anxiety|2|||
41987865|NCT01280968|75795216|FG001|Overall Study|Anxiety|0|||
41987866|NCT01280968|75795215|FG000|Overall Study|Adverse Event|1|||
41987867|NCT01280968|75795216|FG001|Overall Study|Adverse Event|0|||
41987868|NCT01280968|75795215|FG000|Overall Study|Scheduling Conflicts|1|||
41987869|NCT01280968|75795216|FG001|Overall Study|Scheduling Conflicts|1|||
41987870|NCT01280968|75795215|FG000|Overall Study|Pre-existing Neurological Condition|1|||
41987871|NCT01280968|75795216|FG001|Overall Study|Pre-existing Neurological Condition|0|||
41987872|NCT01280968|75795215|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
41987873|NCT01280968|75795216|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
41987874|NCT01280812|75795226|FG000|Overall Study|Withdrawal by Subject|2|||
41987875|NCT01280812|75795227|FG001|Overall Study|Withdrawal by Subject|1|||
41987876|NCT01280812|75795228|FG002|Overall Study|Withdrawal by Subject|0|||
41987877|NCT01280812|75795226|FG000|Overall Study|Lost to Follow-up|1|||
41987878|NCT01280812|75795227|FG001|Overall Study|Lost to Follow-up|1|||
41987879|NCT01280812|75795228|FG002|Overall Study|Lost to Follow-up|1|||
41987880|NCT01280656|75795240|FG000|Overall Study|Adverse Event|1|||
41987881|NCT01280656|75795241|FG001|Overall Study|Adverse Event|14|||
41987882|NCT01280656|75795242|FG002|Overall Study|Adverse Event|13|||
41987883|NCT01280656|75795240|FG000|Overall Study|Lack of Efficacy|1|||
41987884|NCT01280656|75795241|FG001|Overall Study|Lack of Efficacy|22|||
41987885|NCT01280656|75795242|FG002|Overall Study|Lack of Efficacy|38|||
41987886|NCT01280656|75795240|FG000|Overall Study|Treatment shortening (RGT)|0|||
41987887|NCT01280656|75795241|FG001|Overall Study|Treatment shortening (RGT)|4|||
41987888|NCT01280656|75795242|FG002|Overall Study|Treatment shortening (RGT)|5|||
41987889|NCT01280656|75795240|FG000|Overall Study|Other|1|||
41987890|NCT01280656|75795241|FG001|Overall Study|Other|7|||
41987891|NCT01280656|75795242|FG002|Overall Study|Other|7|||
41987892|NCT01280617|75795252|FG000|Overall Study|Adverse Event|0|||
41987893|NCT01280617|75795253|FG001|Overall Study|Adverse Event|1|||
41987894|NCT01280266|75795261|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
41987895|NCT01280266|75795262|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
41987896|NCT01280266|75795261|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
41987897|NCT01280266|75795262|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
41987898|NCT01279447|75795274|FG000|Overall Study|Lost to Follow-up|3|||
41987899|NCT01279447|75795275|FG001|Overall Study|Lost to Follow-up|1|||
41987900|NCT01276639|75795297|FG000|Week 0 to 16|Death|1|||
41987901|NCT01276639|75795298|FG001|Week 0 to 16|Death|0|||
41987902|NCT01276639|75795299|FG002|Week 0 to 16|Death|0|||
41987903|NCT01276639|75795300|FG003|Week 0 to 16|Death|0|||
41987904|NCT01276639|75795301|FG004|Week 0 to 16|Death|0|||
41987905|NCT01276639|75795297|FG000|Week 0 to 16|Adverse Event|11|||
41987906|NCT01276639|75795298|FG001|Week 0 to 16|Adverse Event|8|||
41987907|NCT01276639|75795299|FG002|Week 0 to 16|Adverse Event|11|||
41987908|NCT01276639|75795300|FG003|Week 0 to 16|Adverse Event|0|||
41987909|NCT01276639|75795301|FG004|Week 0 to 16|Adverse Event|0|||
41987910|NCT01276639|75795297|FG000|Week 0 to 16|Lack of Efficacy|20|||
42237295|NCT03068455|76059680|FG000|Treatment Period|Study drug toxicity|317|||
42237296|NCT03068455|76059681|FG001|Treatment Period|Study drug toxicity|104|||
42237297|NCT03068455|76059680|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
41987911|NCT01276639|75795298|FG001|Week 0 to 16|Lack of Efficacy|15|||
41987912|NCT01276639|75795299|FG002|Week 0 to 16|Lack of Efficacy|25|||
41987913|NCT01276639|75795300|FG003|Week 0 to 16|Lack of Efficacy|0|||
41987914|NCT01276639|75795301|FG004|Week 0 to 16|Lack of Efficacy|0|||
41987915|NCT01276639|75795297|FG000|Week 0 to 16|Lost to Follow-up|3|||
41987916|NCT01276639|75795298|FG001|Week 0 to 16|Lost to Follow-up|5|||
41987917|NCT01276639|75795299|FG002|Week 0 to 16|Lost to Follow-up|3|||
41987918|NCT01276639|75795300|FG003|Week 0 to 16|Lost to Follow-up|0|||
41987919|NCT01276639|75795301|FG004|Week 0 to 16|Lost to Follow-up|0|||
41987920|NCT01276639|75795297|FG000|Week 0 to 16|Withdrawal by Subject|8|||
41987921|NCT01276639|75795298|FG001|Week 0 to 16|Withdrawal by Subject|5|||
41987922|NCT01276639|75795299|FG002|Week 0 to 16|Withdrawal by Subject|4|||
41987923|NCT01276639|75795300|FG003|Week 0 to 16|Withdrawal by Subject|0|||
41987924|NCT01276639|75795301|FG004|Week 0 to 16|Withdrawal by Subject|0|||
41987925|NCT01276639|75795297|FG000|Week 0 to 16|Other|7|||
41987926|NCT01276639|75795298|FG001|Week 0 to 16|Other|7|||
41987927|NCT01276639|75795299|FG002|Week 0 to 16|Other|2|||
41987928|NCT01276639|75795300|FG003|Week 0 to 16|Other|0|||
41987929|NCT01276639|75795301|FG004|Week 0 to 16|Other|0|||
41987930|NCT01276639|75795297|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
41987931|NCT01276639|75795298|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
41987932|NCT01276639|75795299|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
42237298|NCT03068455|76059681|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
42237299|NCT03068455|76059680|FG000|Treatment Period|Participant request to stop therapy|33|||
42237300|NCT03068455|76059681|FG001|Treatment Period|Participant request to stop therapy|20|||
42237301|NCT03068455|76059680|FG000|Treatment Period|Participant withdrew consent|5|||
42237302|NCT03068455|76059681|FG001|Treatment Period|Participant withdrew consent|10|||
42237303|NCT03068455|76059680|FG000|Treatment Period|Poor/non-compliance|3|||
41987933|NCT01276639|75795300|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
41987934|NCT01276639|75795301|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
41987935|NCT01276639|75795297|FG000|Week 16 to 52|Death|1|||
41987936|NCT01276639|75795298|FG001|Week 16 to 52|Death|0|||
41987937|NCT01276639|75795299|FG002|Week 16 to 52|Death|0|||
41987938|NCT01276639|75795300|FG003|Week 16 to 52|Death|0|||
41987939|NCT01276639|75795301|FG004|Week 16 to 52|Death|0|||
41987940|NCT01276639|75795297|FG000|Week 16 to 52|Adverse Event|10|||
41987941|NCT01276639|75795298|FG001|Week 16 to 52|Adverse Event|13|||
41987942|NCT01276639|75795299|FG002|Week 16 to 52|Adverse Event|0|||
41987943|NCT01276639|75795300|FG003|Week 16 to 52|Adverse Event|1|||
41987944|NCT01276639|75795301|FG004|Week 16 to 52|Adverse Event|3|||
41987945|NCT01276639|75795297|FG000|Week 16 to 52|Lack of Efficacy|99|||
41987946|NCT01276639|75795298|FG001|Week 16 to 52|Lack of Efficacy|71|||
41987947|NCT01276639|75795299|FG002|Week 16 to 52|Lack of Efficacy|0|||
41987948|NCT01276639|75795300|FG003|Week 16 to 52|Lack of Efficacy|14|||
41987949|NCT01276639|75795301|FG004|Week 16 to 52|Lack of Efficacy|13|||
41987950|NCT01276639|75795297|FG000|Week 16 to 52|Lost to Follow-up|3|||
41987951|NCT01276639|75795298|FG001|Week 16 to 52|Lost to Follow-up|1|||
41987952|NCT01276639|75795299|FG002|Week 16 to 52|Lost to Follow-up|0|||
41987953|NCT01276639|75795300|FG003|Week 16 to 52|Lost to Follow-up|0|||
41987954|NCT01276639|75795301|FG004|Week 16 to 52|Lost to Follow-up|1|||
41987955|NCT01276639|75795297|FG000|Week 16 to 52|Withdrawal by Subject|4|||
41987956|NCT01276639|75795298|FG001|Week 16 to 52|Withdrawal by Subject|4|||
41987957|NCT01276639|75795299|FG002|Week 16 to 52|Withdrawal by Subject|0|||
41987958|NCT01276639|75795300|FG003|Week 16 to 52|Withdrawal by Subject|0|||
41987959|NCT01276639|75795301|FG004|Week 16 to 52|Withdrawal by Subject|1|||
41987960|NCT01276639|75795297|FG000|Week 16 to 52|Other|10|||
41987961|NCT01276639|75795298|FG001|Week 16 to 52|Other|12|||
41987962|NCT01276639|75795299|FG002|Week 16 to 52|Other|0|||
41987963|NCT01276639|75795300|FG003|Week 16 to 52|Other|1|||
41987964|NCT01276639|75795301|FG004|Week 16 to 52|Other|3|||
41987965|NCT01275625|75795316|FG000|Overall Study|Death|1|||
41987966|NCT01275625|75795316|FG000|Overall Study|Lack of Efficacy|2|||
41987967|NCT01275625|75795316|FG000|Overall Study|Lost to Follow-up|1|||
41987968|NCT01275625|75795316|FG000|Overall Study|Withdrawal by Subject|3|||
41987969|NCT01275625|75795316|FG000|Overall Study|Protocol Violation|1|||
41987970|NCT01275625|75795316|FG000|Overall Study|Adverse Event|4|||
41987971|NCT01275625|75795316|FG000|Overall Study|Other|1|||
41987972|NCT01272193|75795322|FG000|Overall Study|Adverse Event|1|||
41987973|NCT01272193|75795323|FG001|Overall Study|Adverse Event|1|||
41987974|NCT01272193|75795322|FG000|Overall Study|Lack of Efficacy|0|||
41987975|NCT01272193|75795323|FG001|Overall Study|Lack of Efficacy|3|||
41987976|NCT01272193|75795322|FG000|Overall Study|Withdrawal Criteria|1|||
41987977|NCT01272193|75795323|FG001|Overall Study|Withdrawal Criteria|1|||
41987978|NCT01272193|75795322|FG000|Overall Study|Unclassified|8|||
42237304|NCT03068455|76059681|FG001|Treatment Period|Poor/non-compliance|0|||
42237305|NCT03068455|76059680|FG000|Treatment Period|Participant no longer meets study criteria|1|||
42237306|NCT03068455|76059681|FG001|Treatment Period|Participant no longer meets study criteria|3|||
42237307|NCT03068455|76059680|FG000|Treatment Period|Other reasons|12|||
42237308|NCT03068455|76059681|FG001|Treatment Period|Other reasons|4|||
41987979|NCT01272193|75795323|FG001|Overall Study|Unclassified|7|||
41987980|NCT01270828|75795335|FG000|Pregabalin CR SB|Reason Unspecified|0|||
41987981|NCT01270828|75795336|FG001|Pregabalin CR SB|Reason Unspecified|0|||
41987982|NCT01270828|75795337|FG002|Pregabalin CR SB|Reason Unspecified|8|||
41987983|NCT01270828|75795335|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
41987984|NCT01270828|75795336|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
41987985|NCT01270828|75795337|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
41987986|NCT01270828|75795335|FG000|Pregabalin CR SB|Related adverse event|0|||
41987987|NCT01270828|75795336|FG001|Pregabalin CR SB|Related adverse event|0|||
41987988|NCT01270828|75795337|FG002|Pregabalin CR SB|Related adverse event|46|||
41987989|NCT01270828|75795335|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
41987990|NCT01270828|75795336|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
41987991|NCT01270828|75795337|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
41987992|NCT01270828|75795335|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
41987993|NCT01270828|75795336|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
42237309|NCT03067987|76059689|FG000|Overall Study|Lost to Follow-up|7|||
42237310|NCT03067987|76059690|FG001|Overall Study|Lost to Follow-up|10|||
42237311|NCT03067987|76059689|FG000|Overall Study|Protocol Violation|1|||
42237312|NCT03067987|76059690|FG001|Overall Study|Protocol Violation|2|||
42237313|NCT03067987|76059689|FG000|Overall Study|Withdrawal by Subject|2|||
42237314|NCT03067987|76059690|FG001|Overall Study|Withdrawal by Subject|1|||
42237315|NCT04035200|76059699|FG000|Overall Study|Lost to Follow-up|0|||
42237316|NCT04035200|76059700|FG001|Overall Study|Lost to Follow-up|1|||
42237317|NCT04035200|76059701|FG002|Overall Study|Lost to Follow-up|0|||
42237318|NCT04035200|76059699|FG000|Overall Study|Withdrawal by Subject|1|||
42237319|NCT04035200|76059700|FG001|Overall Study|Withdrawal by Subject|4|||
42237320|NCT04035200|76059701|FG002|Overall Study|Withdrawal by Subject|4|||
42237321|NCT04035200|76059699|FG000|Overall Study|COVID-19|1|||
42237322|NCT04035200|76059700|FG001|Overall Study|COVID-19|0|||
42237323|NCT04035200|76059701|FG002|Overall Study|COVID-19|0|||
42237324|NCT04035200|76059699|FG000|Overall Study|Early Termination|0|||
42237325|NCT04035200|76059700|FG001|Overall Study|Early Termination|1|||
42237326|NCT04035200|76059701|FG002|Overall Study|Early Termination|0|||
42237327|NCT04035200|76059699|FG000|Overall Study|Non-compliance|0|||
42237328|NCT04035200|76059700|FG001|Overall Study|Non-compliance|1|||
42237329|NCT04035200|76059701|FG002|Overall Study|Non-compliance|0|||
42237330|NCT03197870|76059712|FG000|Overall Study|Adverse Event|9|||
42237331|NCT03197870|76059713|FG001|Overall Study|Adverse Event|4|||
42237332|NCT03197870|76059714|FG002|Overall Study|Adverse Event|6|||
42237333|NCT03197870|76059712|FG000|Overall Study|Withdrawal by Subject|2|||
42237334|NCT03197870|76059713|FG001|Overall Study|Withdrawal by Subject|3|||
42237335|NCT03197870|76059714|FG002|Overall Study|Withdrawal by Subject|0|||
42237336|NCT03197870|76059712|FG000|Overall Study|Lost to Follow-up|2|||
42237337|NCT03197870|76059713|FG001|Overall Study|Lost to Follow-up|2|||
42237338|NCT03197870|76059714|FG002|Overall Study|Lost to Follow-up|0|||
42237339|NCT03197870|76059712|FG000|Overall Study|data not available|1|||
42237340|NCT03197870|76059713|FG001|Overall Study|data not available|1|||
42237341|NCT03197870|76059714|FG002|Overall Study|data not available|0|||
42237342|NCT04889222|76059725|FG000|Overall Study|Did not meet eligibility criteria|8|||
42237343|NCT04889222|76059725|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
42237344|NCT04889222|76059725|FG000|Overall Study|Did not proceed due to time constraints|5|||
42237345|NCT03067441|76059757|FG000|Overall Study|Withdrawal by Subject|16|||
42237346|NCT03067441|76059758|FG001|Overall Study|Withdrawal by Subject|34|||
42237347|NCT03067441|76059757|FG000|Overall Study|Lost to Follow-up|7|||
42237348|NCT03067441|76059758|FG001|Overall Study|Lost to Follow-up|5|||
42237349|NCT03067441|76059757|FG000|Overall Study|Adverse Event|7|||
42237350|NCT03067441|76059758|FG001|Overall Study|Adverse Event|14|||
42237351|NCT03067441|76059757|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
42237352|NCT03067441|76059758|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
42237353|NCT03067441|76059757|FG000|Overall Study|Physician Decision|1|||
42237354|NCT03067441|76059758|FG001|Overall Study|Physician Decision|3|||
42237355|NCT03067441|76059757|FG000|Overall Study|Other|1|||
42237356|NCT03067441|76059758|FG001|Overall Study|Other|1|||
42237357|NCT02600923|76059767|FG000|Overall Study|Death|10|||
41987994|NCT01270828|75795337|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
41987995|NCT01270828|75795335|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
41987996|NCT01270828|75795336|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
41987997|NCT01270828|75795337|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
41987998|NCT01270828|75795335|FG000|Pregabalin CR SB|Unrelated AE|0|||
41987999|NCT01270828|75795336|FG001|Pregabalin CR SB|Unrelated AE|0|||
41988000|NCT01270828|75795337|FG002|Pregabalin CR SB|Unrelated AE|8|||
41988001|NCT01270828|75795335|FG000|Pregabalin CR SB|Protocol Violation|0|||
41988002|NCT01270828|75795336|FG001|Pregabalin CR SB|Protocol Violation|0|||
41988003|NCT01270828|75795337|FG002|Pregabalin CR SB|Protocol Violation|8|||
41988004|NCT01270828|75795335|FG000|Double Blind Phase|Death|0|||
41988005|NCT01270828|75795336|FG001|Double Blind Phase|Death|1|||
41988006|NCT01270828|75795337|FG002|Double Blind Phase|Death|0|||
42237358|NCT02600923|76059767|FG000|Overall Study|Adverse Event|3|||
42237359|NCT02600923|76059767|FG000|Overall Study|Global deterioration of health status|2|||
42237360|NCT02600923|76059767|FG000|Overall Study|Insufficient clinical response|6|||
42237361|NCT02600923|76059767|FG000|Overall Study|Lost to Follow-up|1|||
42237362|NCT02600923|76059767|FG000|Overall Study|Withdrawal by Subject|5|||
42237363|NCT02600923|76059767|FG000|Overall Study|Objective progression or relapse|50|||
42237364|NCT02600923|76059767|FG000|Overall Study|Study terminated by Sponsor|53|||
41988007|NCT01270828|75795335|FG000|Double Blind Phase|Protocol Violation|0|||
41988008|NCT01270828|75795336|FG001|Double Blind Phase|Protocol Violation|1|||
42237365|NCT02600923|76059767|FG000|Overall Study|Not treated|1|||
42237366|NCT03070171|76059773|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
42237367|NCT03070171|76059774|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
42237368|NCT03070171|76059773|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
42237369|NCT03070171|76059774|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
42237370|NCT03644017|76059780|FG000|Overall Study|Access Abandonment|5|||
42237371|NCT03644017|76059780|FG000|Overall Study|Kidney Transplant|2|||
42237372|NCT00158054|76059786|FG000|Overall Study|Refused to continue|3|||
42237373|NCT00158054|76059787|FG001|Overall Study|Refused to continue|0|||
42237374|NCT00158054|76059786|FG000|Overall Study|Unavailable for follow up|7|||
42237375|NCT00158054|76059787|FG001|Overall Study|Unavailable for follow up|3|||
42237376|NCT01337960|76059796|FG000|Overall Study|Lost to Follow-up|1|||
42237377|NCT01337960|76059797|FG001|Overall Study|Lost to Follow-up|0|||
42237378|NCT01337960|76059798|FG002|Overall Study|Lost to Follow-up|0|||
42237379|NCT01337960|76059796|FG000|Overall Study|Withdrawal by Subject|1|||
42237380|NCT01337960|76059797|FG001|Overall Study|Withdrawal by Subject|0|||
42237381|NCT01337960|76059798|FG002|Overall Study|Withdrawal by Subject|0|||
42237382|NCT02750306|76059817|FG000|Overall Study|Withdrawal by Subject|5|||
42237383|NCT02750306|76059818|FG001|Overall Study|Withdrawal by Subject|2|||
42237384|NCT02750306|76059817|FG000|Overall Study|Protocol Violation|1|||
42237385|NCT02750306|76059818|FG001|Overall Study|Protocol Violation|0|||
42237386|NCT01816165|76059826|FG000|Overall Study|Adverse Event|1|||
42237387|NCT01816165|76059827|FG001|Overall Study|Adverse Event|0|||
42237388|NCT01816165|76059828|FG002|Overall Study|Adverse Event|0|||
42237389|NCT01816165|76059829|FG003|Overall Study|Adverse Event|0|||
42237390|NCT01677988|76059858|FG000|Overall Study|Lack of Efficacy|2|||
42237391|NCT02926573|76059865|FG000|Overall Study|Nausea|1|||
42237392|NCT02926573|76059866|FG001|Overall Study|Nausea|0|||
42237393|NCT02926573|76059865|FG000|Overall Study|Remain intubated|2|||
42237394|NCT02926573|76059866|FG001|Overall Study|Remain intubated|2|||
42237395|NCT02926573|76059865|FG000|Overall Study|Change in surgery plan|3|||
42237396|NCT02926573|76059866|FG001|Overall Study|Change in surgery plan|1|||
42237397|NCT02926573|76059865|FG000|Overall Study|Change to outpatient status|5|||
42237398|NCT02926573|76059866|FG001|Overall Study|Change to outpatient status|1|||
42237399|NCT02926573|76059865|FG000|Overall Study|Withdrawal by Subject|0|||
42237400|NCT02926573|76059866|FG001|Overall Study|Withdrawal by Subject|2|||
42237401|NCT02926573|76059865|FG000|Overall Study|Return to operating room|0|||
42237402|NCT02926573|76059866|FG001|Overall Study|Return to operating room|2|||
42237403|NCT02926573|76059865|FG000|Overall Study|Delirium|0|||
42237404|NCT02926573|76059866|FG001|Overall Study|Delirium|1|||
42237405|NCT00158860|76059874|FG000|Overall Study|Adverse Event|3|||
42237406|NCT00158860|76059875|FG001|Overall Study|Adverse Event|6|||
42237407|NCT00158860|76059874|FG000|Overall Study|Lost to Follow-up|11|||
42237408|NCT00158860|76059875|FG001|Overall Study|Lost to Follow-up|17|||
42237409|NCT00158860|76059874|FG000|Overall Study|Protocol Violation|8|||
42237410|NCT00158860|76059875|FG001|Overall Study|Protocol Violation|23|||
42237411|NCT00158860|76059874|FG000|Overall Study|Withdrawal by Subject|7|||
42237412|NCT00158860|76059875|FG001|Overall Study|Withdrawal by Subject|17|||
42237413|NCT00158860|76059874|FG000|Overall Study|MOVING OUT OF STATE|1|||
42237414|NCT00158860|76059875|FG001|Overall Study|MOVING OUT OF STATE|0|||
42237415|NCT00158860|76059874|FG000|Overall Study|Pregnancy|3|||
42237416|NCT00158860|76059875|FG001|Overall Study|Pregnancy|3|||
42237417|NCT00158860|76059874|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
42237418|NCT00158860|76059875|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
42237419|NCT00158860|76059874|FG000|Overall Study|SPONSOR REQUEST|0|||
42237420|NCT00158860|76059875|FG001|Overall Study|SPONSOR REQUEST|1|||
42237421|NCT00158860|76059874|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
42237422|NCT00158860|76059875|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
42237423|NCT00158860|76059874|FG000|Overall Study|Closed per sponsor|0|||
42131939|NCT00474786|75942779|FG001|Overall Study|Other|0|||
42237424|NCT00158860|76059875|FG001|Overall Study|Closed per sponsor|1|||
42237425|NCT03067129|76059886|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
42237426|NCT03067129|76059887|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
42237427|NCT03067129|76059888|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
42237428|NCT03067129|76059889|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
42237429|NCT03067129|76059886|FG000|Overall Study|Withdrawal by Subject|0|||
42237430|NCT03067129|76059887|FG001|Overall Study|Withdrawal by Subject|0|||
42237431|NCT03067129|76059888|FG002|Overall Study|Withdrawal by Subject|1|||
42237432|NCT03067129|76059889|FG003|Overall Study|Withdrawal by Subject|2|||
42237433|NCT03067129|76059886|FG000|Overall Study|Lost to Follow-up|5|||
42237434|NCT03067129|76059887|FG001|Overall Study|Lost to Follow-up|5|||
42131940|NCT00392769|75942785|FG000|Overall Study|Clinical Deterioration|9|||
42237435|NCT03067129|76059888|FG002|Overall Study|Lost to Follow-up|4|||
42237436|NCT03067129|76059889|FG003|Overall Study|Lost to Follow-up|3|||
42237437|NCT01679236|76059911|FG000|Overall Study|Lost to Follow-up|15|||
42237438|NCT01679236|76059912|FG001|Overall Study|Lost to Follow-up|15|||
42237439|NCT01679002|76059921|FG000|Overall Study|Adverse Event|1|||
42237440|NCT01679002|76059922|FG001|Overall Study|Adverse Event|1|||
42237441|NCT01679002|76059923|FG002|Overall Study|Adverse Event|0|||
42237442|NCT04409509|76059933|FG000|Overall Study|Failure to meet randomization requirement|1|||
42237443|NCT04409509|76059934|FG001|Overall Study|Failure to meet randomization requirement|0|||
42237444|NCT04409509|76059933|FG000|Overall Study|Adverse Event|0|||
42237445|NCT04409509|76059934|FG001|Overall Study|Adverse Event|1|||
42237446|NCT04409509|76059933|FG000|Overall Study|Death|11|||
42237447|NCT04409509|76059934|FG001|Overall Study|Death|10|||
42237448|NCT04409509|76059933|FG000|Overall Study|Non-compliance with study drug|0|||
42237449|NCT04409509|76059934|FG001|Overall Study|Non-compliance with study drug|1|||
42237450|NCT04409509|76059933|FG000|Overall Study|Lost to Follow-up|0|||
42237451|NCT04409509|76059934|FG001|Overall Study|Lost to Follow-up|3|||
42237452|NCT04409509|76059933|FG000|Overall Study|Withdrawal by Subject|0|||
42237453|NCT04409509|76059934|FG001|Overall Study|Withdrawal by Subject|3|||
42237454|NCT04409509|76059933|FG000|Overall Study|Randomized by mistake|0|||
42237455|NCT04409509|76059934|FG001|Overall Study|Randomized by mistake|1|||
42237456|NCT04409509|76059933|FG000|Overall Study|Other|1|||
42237457|NCT04409509|76059934|FG001|Overall Study|Other|1|||
42237458|NCT01678924|76059945|FG000|Overall Study|Adverse Event|1|||
42237459|NCT01678924|76059946|FG001|Overall Study|Adverse Event|1|||
42237460|NCT01678924|76059947|FG002|Overall Study|Adverse Event|0|||
42237461|NCT01678924|76059948|FG003|Overall Study|Adverse Event|1|||
42237462|NCT01678924|76059945|FG000|Overall Study|Lack of Efficacy|7|||
42237463|NCT01678924|76059946|FG001|Overall Study|Lack of Efficacy|2|||
42237464|NCT01678924|76059947|FG002|Overall Study|Lack of Efficacy|0|||
42237465|NCT01678924|76059948|FG003|Overall Study|Lack of Efficacy|5|||
42237466|NCT01678924|76059945|FG000|Overall Study|Lost to Follow-up|0|||
42237467|NCT01678924|76059946|FG001|Overall Study|Lost to Follow-up|4|||
42237468|NCT01678924|76059947|FG002|Overall Study|Lost to Follow-up|0|||
42237469|NCT01678924|76059948|FG003|Overall Study|Lost to Follow-up|2|||
42237470|NCT01678924|76059945|FG000|Overall Study|Personal Reasons|2|||
42237471|NCT01678924|76059946|FG001|Overall Study|Personal Reasons|2|||
42237472|NCT01678924|76059947|FG002|Overall Study|Personal Reasons|2|||
42237473|NCT01678924|76059948|FG003|Overall Study|Personal Reasons|7|||
42237474|NCT01678924|76059945|FG000|Overall Study|Withdrawal by Subject|0|||
42237475|NCT01678924|76059946|FG001|Overall Study|Withdrawal by Subject|3|||
42237476|NCT01678924|76059947|FG002|Overall Study|Withdrawal by Subject|0|||
42237477|NCT01678924|76059948|FG003|Overall Study|Withdrawal by Subject|2|||
42237478|NCT01678924|76059945|FG000|Overall Study|Unable to attend scheduled visits|0|||
42237479|NCT01678924|76059946|FG001|Overall Study|Unable to attend scheduled visits|0|||
42237480|NCT01678924|76059947|FG002|Overall Study|Unable to attend scheduled visits|0|||
42237481|NCT01678924|76059948|FG003|Overall Study|Unable to attend scheduled visits|1|||
42237482|NCT02925793|76059962|FG000|Overall Study|Adverse Event|3|||
42237483|NCT02925793|76059963|FG001|Overall Study|Adverse Event|3|||
42237484|NCT02925793|76059964|FG002|Overall Study|Adverse Event|6|||
42237485|NCT02925793|76059962|FG000|Overall Study|Withdrawal by Subject|16|||
42237486|NCT02925793|76059963|FG001|Overall Study|Withdrawal by Subject|15|||
41988009|NCT01270828|75795337|FG002|Double Blind Phase|Protocol Violation|0|||
41988010|NCT01270828|75795335|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
41988011|NCT01270828|75795336|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
41988012|NCT01270828|75795337|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
41988013|NCT01270828|75795335|FG000|Double Blind Phase|Reason Unspecified|7|||
41988014|NCT01270828|75795336|FG001|Double Blind Phase|Reason Unspecified|4|||
41988015|NCT01270828|75795337|FG002|Double Blind Phase|Reason Unspecified|0|||
41988016|NCT01270828|75795335|FG000|Double Blind Phase|Withdrawal by Subject|6|||
41988017|NCT01270828|75795336|FG001|Double Blind Phase|Withdrawal by Subject|15|||
41988018|NCT01270828|75795337|FG002|Double Blind Phase|Withdrawal by Subject|0|||
41988019|NCT01270828|75795335|FG000|Double Blind Phase|Lost to Follow-up|1|||
41988020|NCT01270828|75795336|FG001|Double Blind Phase|Lost to Follow-up|2|||
41988021|NCT01270828|75795337|FG002|Double Blind Phase|Lost to Follow-up|0|||
41988022|NCT01270828|75795335|FG000|Double Blind Phase|Lack of Efficacy|2|||
41988023|NCT01270828|75795336|FG001|Double Blind Phase|Lack of Efficacy|11|||
42237487|NCT02925793|76059964|FG002|Overall Study|Withdrawal by Subject|13|||
42237488|NCT02925793|76059962|FG000|Overall Study|Investigator Discretion|0|||
42237489|NCT02925793|76059963|FG001|Overall Study|Investigator Discretion|1|||
42237490|NCT02925793|76059964|FG002|Overall Study|Investigator Discretion|1|||
42237491|NCT02925793|76059962|FG000|Overall Study|Lost to Follow-up|2|||
42237492|NCT02925793|76059963|FG001|Overall Study|Lost to Follow-up|3|||
42237493|NCT02925793|76059964|FG002|Overall Study|Lost to Follow-up|1|||
42237494|NCT02925793|76059962|FG000|Overall Study|Lack of Efficacy|2|||
42237495|NCT02925793|76059963|FG001|Overall Study|Lack of Efficacy|6|||
42237496|NCT02925793|76059964|FG002|Overall Study|Lack of Efficacy|4|||
42237497|NCT02925793|76059962|FG000|Overall Study|Other:|2|||
42237498|NCT02925793|76059963|FG001|Overall Study|Other:|1|||
41988024|NCT01270828|75795337|FG002|Double Blind Phase|Lack of Efficacy|0|||
42237499|NCT02925793|76059964|FG002|Overall Study|Other:|3|||
42237500|NCT03071263|76059974|FG000|Overall Study|Adverse Event|1|||
42237501|NCT03071263|76059975|FG001|Overall Study|Adverse Event|3|||
42237502|NCT03071263|76059974|FG000|Overall Study|Withdrawal by Subject|1|||
42237503|NCT03071263|76059975|FG001|Overall Study|Withdrawal by Subject|3|||
42237504|NCT03071263|76059974|FG000|Overall Study|Physician Decision|1|||
42237505|NCT03071263|76059975|FG001|Overall Study|Physician Decision|0|||
42237506|NCT03071263|76059974|FG000|Overall Study|Participant moved to another city|0|||
42237507|NCT03071263|76059975|FG001|Overall Study|Participant moved to another city|1|||
42237508|NCT00157196|76059987|FG000|Overall Study|Ongoing at data cut-off|9|||
42237509|NCT03066193|76059991|FG000|Overall Study|Withdrawal by Subject|1|||
42237510|NCT03922321|76059995|FG000|Overall Study|Participant Moved|1|||
42237511|NCT03922321|76059995|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
42237512|NCT01677910|76060002|FG000|Double-Blind Treatment Period|Adverse Event|6|||
42237513|NCT01677910|76060003|FG001|Double-Blind Treatment Period|Adverse Event|2|||
42237514|NCT01677910|76060004|FG002|Double-Blind Treatment Period|Adverse Event|3|||
42237515|NCT01677910|76060005|FG003|Double-Blind Treatment Period|Adverse Event|0|||
42237516|NCT01677910|76060002|FG000|Double-Blind Treatment Period|Physician Decision|0|||
42237517|NCT01677910|76060003|FG001|Double-Blind Treatment Period|Physician Decision|0|||
42237518|NCT01677910|76060004|FG002|Double-Blind Treatment Period|Physician Decision|1|||
42237519|NCT01677910|76060005|FG003|Double-Blind Treatment Period|Physician Decision|0|||
42237520|NCT01677910|76060002|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
42237521|NCT01677910|76060003|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
42237522|NCT01677910|76060004|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
42237523|NCT01677910|76060005|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
42237524|NCT01677910|76060002|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
42237525|NCT01677910|76060003|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
42237526|NCT01677910|76060004|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
42237527|NCT01677910|76060005|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
42237528|NCT01677910|76060002|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
42237529|NCT01677910|76060003|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
42237530|NCT01677910|76060004|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
42237531|NCT01677910|76060005|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
42237532|NCT01677910|76060002|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
42237533|NCT01677910|76060003|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
42237534|NCT01677910|76060004|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
42237535|NCT01677910|76060005|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
42237536|NCT01677910|76060002|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
42237537|NCT01677910|76060003|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
42237538|NCT01677910|76060004|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
42237539|NCT01677910|76060005|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
42237540|NCT01677910|76060002|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
42237541|NCT01677910|76060003|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
42237542|NCT01677910|76060004|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
42237543|NCT01677910|76060005|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
42237544|NCT01677910|76060002|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
42237545|NCT01677910|76060003|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
42237546|NCT01677910|76060004|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
42237547|NCT01677910|76060005|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
42237548|NCT01677910|76060002|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
42237549|NCT01677910|76060003|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
42237550|NCT01677910|76060004|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
42237551|NCT01677910|76060005|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
42237552|NCT03911713|76060020|FG000|Overall Study|Lost to Follow-up|0|||
42237553|NCT03911713|76060021|FG001|Overall Study|Lost to Follow-up|2|||
42237554|NCT03911713|76060022|FG002|Overall Study|Lost to Follow-up|0|||
42237555|NCT03911713|76060023|FG003|Overall Study|Lost to Follow-up|0|||
42237556|NCT03911713|76060024|FG004|Overall Study|Lost to Follow-up|0|||
42237557|NCT03911713|76060020|FG000|Overall Study|Other|0|||
42237558|NCT03911713|76060021|FG001|Overall Study|Other|0|||
42237559|NCT03911713|76060022|FG002|Overall Study|Other|0|||
42237560|NCT03911713|76060023|FG003|Overall Study|Other|1|||
42237561|NCT03911713|76060024|FG004|Overall Study|Other|0|||
42237562|NCT03911713|76060020|FG000|Overall Study|Randomized, Never Dosed|1|||
42237563|NCT03911713|76060021|FG001|Overall Study|Randomized, Never Dosed|0|||
42237564|NCT03911713|76060022|FG002|Overall Study|Randomized, Never Dosed|0|||
42237565|NCT03911713|76060023|FG003|Overall Study|Randomized, Never Dosed|1|||
42237566|NCT03911713|76060024|FG004|Overall Study|Randomized, Never Dosed|0|||
42237567|NCT03065023|76060042|FG000|Overall Study|Progressive Disease|0|||
42237568|NCT03065023|76060043|FG001|Overall Study|Progressive Disease|1|||
42237569|NCT03065023|76060044|FG002|Overall Study|Progressive Disease|0|||
42237570|NCT03065023|76060045|FG003|Overall Study|Progressive Disease|0|||
42237571|NCT03065023|76060046|FG004|Overall Study|Progressive Disease|0|||
42237572|NCT03065023|76060042|FG000|Overall Study|Death|2|||
42237573|NCT03065023|76060043|FG001|Overall Study|Death|0|||
42237574|NCT03065023|76060044|FG002|Overall Study|Death|1|||
42237575|NCT03065023|76060045|FG003|Overall Study|Death|1|||
42237576|NCT03065023|76060046|FG004|Overall Study|Death|0|||
42237577|NCT03065023|76060042|FG000|Overall Study|Lost to Follow-up|0|||
42237578|NCT03065023|76060043|FG001|Overall Study|Lost to Follow-up|1|||
42237579|NCT03065023|76060044|FG002|Overall Study|Lost to Follow-up|0|||
42237580|NCT03065023|76060045|FG003|Overall Study|Lost to Follow-up|0|||
42237581|NCT03065023|76060046|FG004|Overall Study|Lost to Follow-up|0|||
42237582|NCT03065023|76060042|FG000|Overall Study|Participant Decision|0|||
42237583|NCT03065023|76060043|FG001|Overall Study|Participant Decision|0|||
42237584|NCT03065023|76060044|FG002|Overall Study|Participant Decision|0|||
42237585|NCT03065023|76060045|FG003|Overall Study|Participant Decision|1|||
42237586|NCT03065023|76060046|FG004|Overall Study|Participant Decision|0|||
42237587|NCT03065023|76060042|FG000|Overall Study|Withdrawal by Subject|0|||
42237588|NCT03065023|76060043|FG001|Overall Study|Withdrawal by Subject|0|||
42237589|NCT03065023|76060044|FG002|Overall Study|Withdrawal by Subject|0|||
42237590|NCT03065023|76060045|FG003|Overall Study|Withdrawal by Subject|1|||
42237591|NCT03065023|76060046|FG004|Overall Study|Withdrawal by Subject|0|||
42237592|NCT03614923|76060059|FG000|Overall Study|Withdrawal by Subject|2|||
42237593|NCT03614923|76060060|FG001|Overall Study|Withdrawal by Subject|1|||
42237594|NCT03614923|76060061|FG002|Overall Study|Withdrawal by Subject|1|||
42237595|NCT03614923|76060059|FG000|Overall Study|Adverse Event|0|||
42237596|NCT03614923|76060060|FG001|Overall Study|Adverse Event|2|||
42237597|NCT03614923|76060061|FG002|Overall Study|Adverse Event|1|||
42237598|NCT03614923|76060059|FG000|Overall Study|Lost to Follow-up|1|||
42237599|NCT03614923|76060060|FG001|Overall Study|Lost to Follow-up|0|||
42237600|NCT03614923|76060061|FG002|Overall Study|Lost to Follow-up|1|||
42237601|NCT03614923|76060059|FG000|Overall Study|Lack of Efficacy|2|||
42237602|NCT03614923|76060060|FG001|Overall Study|Lack of Efficacy|0|||
42237603|NCT03614923|76060061|FG002|Overall Study|Lack of Efficacy|1|||
42237604|NCT03614923|76060059|FG000|Overall Study|Non-compliance|0|||
42237605|NCT03614923|76060060|FG001|Overall Study|Non-compliance|1|||
42237606|NCT03614923|76060061|FG002|Overall Study|Non-compliance|0|||
42237607|NCT03614923|76060059|FG000|Overall Study|Other|0|||
42237608|NCT03614923|76060060|FG001|Overall Study|Other|1|||
42237609|NCT03614923|76060061|FG002|Overall Study|Other|1|||
42237610|NCT05098509|76060083|FG000|Overall Study|Withdrawal by Subject|0|||
42237611|NCT05098509|76060084|FG001|Overall Study|Withdrawal by Subject|0|||
42237612|NCT05098509|76060085|FG002|Overall Study|Withdrawal by Subject|1|||
42237613|NCT05098509|76060086|FG003|Overall Study|Withdrawal by Subject|0|||
42237614|NCT05098509|76060083|FG000|Overall Study|Early study termination|1|||
42237615|NCT05098509|76060084|FG001|Overall Study|Early study termination|1|||
42237616|NCT05098509|76060085|FG002|Overall Study|Early study termination|1|||
42237617|NCT05098509|76060086|FG003|Overall Study|Early study termination|0|||
42237618|NCT04962698|76060096|FG000|Motor Imagery|Technical difficulty|1|||
42237619|NCT04962698|76060097|FG001|Motor Imagery|Technical difficulty|0|||
42237620|NCT04962698|76060096|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
42237621|NCT04962698|76060097|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
42237622|NCT04962698|76060096|FG000|Kinesthetic MI|Technical difficulty|1|||
42237623|NCT04962698|76060097|FG001|Kinesthetic MI|Technical difficulty|0|||
42237624|NCT04962698|76060096|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
42237625|NCT04962698|76060097|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
42237626|NCT04962698|76060096|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
42237627|NCT04962698|76060097|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
42237628|NCT04962698|76060096|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
42237629|NCT04962698|76060097|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
42237630|NCT04962698|76060096|FG000|Virtual-hand Interaction|Technical difficulty|1|||
42131941|NCT00392769|75942785|FG000|Overall Study|Adverse Event|1|||
42237631|NCT04962698|76060097|FG001|Virtual-hand Interaction|Technical difficulty|0|||
42237632|NCT04962698|76060096|FG000|Robotic Action Observation|Technical difficulty|1|||
42237633|NCT04962698|76060097|FG001|Robotic Action Observation|Technical difficulty|0|||
42237634|NCT04962698|76060096|FG000|Rest|Technical difficulty|1|||
42237635|NCT04962698|76060097|FG001|Rest|Technical difficulty|0|||
42237636|NCT04962698|76060096|FG000|Rest|Exclusion criteria met after enrollment|0|||
42237637|NCT04962698|76060097|FG001|Rest|Exclusion criteria met after enrollment|2|||
42237638|NCT04609514|76060106|FG000|Overall Study|Lost to Follow-up|5|||
42237639|NCT04609514|76060107|FG001|Overall Study|Lost to Follow-up|4|||
42237640|NCT04609514|76060106|FG000|Overall Study|Withdrawal by PI|0|||
42237641|NCT04609514|76060107|FG001|Overall Study|Withdrawal by PI|2|||
42237642|NCT04467840|76060116|FG000|Overall Study|Death|35|||
42237643|NCT04467840|76060117|FG001|Overall Study|Death|39|||
42237644|NCT04467840|76060116|FG000|Overall Study|Withdrawal by Subject|8|||
42237645|NCT04467840|76060117|FG001|Overall Study|Withdrawal by Subject|4|||
42237646|NCT04467840|76060116|FG000|Overall Study|Adverse Event|2|||
42237647|NCT04467840|76060117|FG001|Overall Study|Adverse Event|0|||
42237648|NCT04467840|76060116|FG000|Overall Study|Lost to Follow-up|1|||
42237649|NCT04467840|76060117|FG001|Overall Study|Lost to Follow-up|3|||
42237650|NCT04467840|76060116|FG000|Overall Study|Physician Decision|1|||
42237651|NCT04467840|76060117|FG001|Overall Study|Physician Decision|0|||
42237652|NCT04467840|76060116|FG000|Overall Study|Other|1|||
42237653|NCT04467840|76060117|FG001|Overall Study|Other|5|||
42237654|NCT04467840|76060116|FG000|Overall Study|Missing study completion status|3|||
42237655|NCT04467840|76060117|FG001|Overall Study|Missing study completion status|1|||
42237656|NCT04295499|76060127|FG000|Overall Study|moving out of state|1|||
42237657|NCT04295499|76060128|FG001|Overall Study|moving out of state|0|||
42237658|NCT04295499|76060127|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
42237659|NCT04295499|76060128|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
42237660|NCT04021290|76060136|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
42237661|NCT04021290|76060137|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
42237662|NCT04021290|76060138|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
42237663|NCT04021290|76060136|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
42237664|NCT04021290|76060137|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
42237665|NCT04021290|76060138|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
42237666|NCT04021290|76060136|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
42237667|NCT04021290|76060137|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
42237668|NCT04021290|76060138|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
42237669|NCT04021290|76060136|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
42237670|NCT04021290|76060137|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
42237671|NCT04021290|76060138|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
42237672|NCT04021290|76060136|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
42237673|NCT04021290|76060137|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
42237674|NCT04021290|76060138|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
42237675|NCT04021290|76060136|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
42237676|NCT04021290|76060137|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
42237677|NCT04021290|76060138|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
42237678|NCT04021290|76060136|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
42237679|NCT04021290|76060137|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
42237680|NCT04021290|76060138|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
42237681|NCT04021290|76060136|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
42237682|NCT04021290|76060137|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
42237683|NCT04021290|76060138|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
42237684|NCT04021290|76060136|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
42237685|NCT04021290|76060137|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
42237686|NCT04021290|76060138|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
42237687|NCT04021290|76060136|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
42237688|NCT04021290|76060137|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
42237689|NCT04021290|76060138|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
42237690|NCT04021290|76060136|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
42237691|NCT04021290|76060137|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
42237692|NCT04021290|76060138|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
42237693|NCT04021290|76060136|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
42237694|NCT04021290|76060137|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
42237695|NCT04021290|76060138|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
42237696|NCT03630705|76060150|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
42237697|NCT03630705|76060151|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
42237698|NCT03630705|76060152|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
42237699|NCT03630705|76060153|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
42302655|NCT02413489|76137938|FG002|Overall Study|Study Terminated By Sponsor|1|||
42237700|NCT03630705|76060150|FG000|Overall Study|Lost to Follow-up|1|||
42237701|NCT03630705|76060151|FG001|Overall Study|Lost to Follow-up|2|||
42237702|NCT03630705|76060152|FG002|Overall Study|Lost to Follow-up|0|||
42237703|NCT03630705|76060153|FG003|Overall Study|Lost to Follow-up|0|||
42302656|NCT02413333|76137950|FG000|Period 1|Adverse Event|1|||
42302657|NCT02413333|76137951|FG001|Period 1|Adverse Event|0|||
41988025|NCT01270828|75795335|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
41988026|NCT01270828|75795336|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
41988027|NCT01270828|75795337|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
41988028|NCT01270828|75795335|FG000|Double Blind Phase|Adverse event related to study drug|5|||
41988029|NCT01270828|75795336|FG001|Double Blind Phase|Adverse event related to study drug|7|||
41988030|NCT01270828|75795337|FG002|Double Blind Phase|Adverse event related to study drug|0|||
41988031|NCT01269385|75795345|FG000|Overall Study|Adverse Event|1|||
41988032|NCT01269385|75795346|FG001|Overall Study|Adverse Event|1|||
42237704|NCT03539458|76060170|FG000|Overall Study|Death|1|||
42237705|NCT03534180|76060174|FG000|Overall Study|Withdrawal by Subject|1|||
42237706|NCT03494166|76060184|FG000|Overall Study|Death|0|||
42237707|NCT03494166|76060185|FG001|Overall Study|Death|0|||
42237708|NCT03494166|76060186|FG002|Overall Study|Death|0|||
42237709|NCT03494166|76060187|FG003|Overall Study|Death|1|||
42237710|NCT03494166|76060188|FG004|Overall Study|Death|3|||
42237711|NCT03494166|76060189|FG005|Overall Study|Death|0|||
42237712|NCT03494166|76060184|FG000|Overall Study|Lost to Follow-up|2|||
42237713|NCT03494166|76060185|FG001|Overall Study|Lost to Follow-up|2|||
42237714|NCT03494166|76060186|FG002|Overall Study|Lost to Follow-up|2|||
42237715|NCT03494166|76060187|FG003|Overall Study|Lost to Follow-up|2|||
42237716|NCT03494166|76060188|FG004|Overall Study|Lost to Follow-up|14|||
42237717|NCT03494166|76060189|FG005|Overall Study|Lost to Follow-up|0|||
42237718|NCT03494166|76060184|FG000|Overall Study|Withdrawal by Subject|10|||
42237719|NCT03494166|76060185|FG001|Overall Study|Withdrawal by Subject|7|||
42237720|NCT03494166|76060186|FG002|Overall Study|Withdrawal by Subject|0|||
42237721|NCT03494166|76060187|FG003|Overall Study|Withdrawal by Subject|5|||
42237722|NCT03494166|76060188|FG004|Overall Study|Withdrawal by Subject|3|||
42237723|NCT03494166|76060189|FG005|Overall Study|Withdrawal by Subject|17|||
42237724|NCT03494166|76060184|FG000|Overall Study|Screen failure|1|||
42237725|NCT03494166|76060185|FG001|Overall Study|Screen failure|0|||
42237726|NCT03494166|76060186|FG002|Overall Study|Screen failure|0|||
42237727|NCT03494166|76060187|FG003|Overall Study|Screen failure|0|||
42237728|NCT03494166|76060188|FG004|Overall Study|Screen failure|1|||
42237729|NCT03494166|76060189|FG005|Overall Study|Screen failure|0|||
42237730|NCT03367156|76060211|FG000|Overall Study|Lack of interest|3|||
42237731|NCT03367156|76060212|FG001|Overall Study|Lack of interest|1|||
42237732|NCT03367156|76060211|FG000|Overall Study|Death|2|||
42237733|NCT03367156|76060212|FG001|Overall Study|Death|0|||
42237734|NCT03367156|76060211|FG000|Overall Study|Lost to Follow-up|2|||
42237735|NCT03367156|76060212|FG001|Overall Study|Lost to Follow-up|1|||
42237736|NCT03367156|76060211|FG000|Overall Study|Became ineligible|1|||
42237737|NCT03367156|76060212|FG001|Overall Study|Became ineligible|2|||
42237738|NCT03367156|76060211|FG000|Overall Study|Hospitalization|1|||
42237739|NCT03367156|76060212|FG001|Overall Study|Hospitalization|0|||
42237740|NCT03367156|76060211|FG000|Overall Study|Concerned about Treatment|11|||
42237741|NCT03367156|76060212|FG001|Overall Study|Concerned about Treatment|3|||
42237742|NCT03367156|76060211|FG000|Overall Study|Started new treatment|4|||
42237743|NCT03367156|76060212|FG001|Overall Study|Started new treatment|1|||
42237744|NCT03302299|76060220|FG000|Overall Study|Protocol Violation|1|||
42237745|NCT03262935|76060227|FG000|Overall Study|Withdrawal by Subject|6|||
42237746|NCT03262935|76060228|FG001|Overall Study|Withdrawal by Subject|7|||
42237747|NCT03262935|76060227|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
42237748|NCT03262935|76060228|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
42237749|NCT03262935|76060227|FG000|Overall Study|Death|181|||
42237750|NCT03262935|76060228|FG001|Overall Study|Death|94|||
42237751|NCT03262935|76060227|FG000|Overall Study|Lost to Follow-up|9|||
42237752|NCT03262935|76060228|FG001|Overall Study|Lost to Follow-up|4|||
42237753|NCT03262935|76060227|FG000|Overall Study|Other reason|5|||
42237754|NCT03262935|76060228|FG001|Overall Study|Other reason|0|||
42237755|NCT02603562|76060277|FG000|Overall Study|Lost to Follow-up|1|||
42237756|NCT02586727|76060283|FG000|Overall Study|Lost to Follow-up|1|||
42237757|NCT02586727|76060284|FG001|Overall Study|Lost to Follow-up|0|||
42237758|NCT02339909|76060311|FG000|Overall Study|Became ineligible after randomisation|89|||
42237759|NCT02339909|76060312|FG001|Overall Study|Became ineligible after randomisation|63|||
42237760|NCT02339909|76060313|FG002|Overall Study|Became ineligible after randomisation|71|||
42237761|NCT02076113|76060323|FG000|Overall Study|Lost to Follow-up|4|||
42237762|NCT02076113|76060324|FG001|Overall Study|Lost to Follow-up|1|||
42237763|NCT02076113|76060323|FG000|Overall Study|Withdrawal by Subject|2|||
42237764|NCT02076113|76060324|FG001|Overall Study|Withdrawal by Subject|3|||
42237765|NCT02076113|76060323|FG000|Overall Study|Death|1|||
42237766|NCT02076113|76060324|FG001|Overall Study|Death|3|||
42237767|NCT01701674|76060333|FG000|Overall Study|Unable to safely complete treatment|1|||
42237768|NCT01586910|76060339|FG000|Overall Study|Death|4|||
42237769|NCT01586910|76060340|FG001|Overall Study|Death|4|||
42237770|NCT01586910|76060339|FG000|Overall Study|Withdrawal by Subject|6|||
42237771|NCT01586910|76060340|FG001|Overall Study|Withdrawal by Subject|43|||
42237772|NCT01586910|76060339|FG000|Overall Study|Physician withdrew Subject|5|||
42237773|NCT01586910|76060340|FG001|Overall Study|Physician withdrew Subject|24|||
42237774|NCT01496976|76060348|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
42237775|NCT02915016|76060371|FG000|Overall Study|Lost to Follow-up|4|||
42237776|NCT02915016|76060372|FG001|Overall Study|Lost to Follow-up|2|||
42237777|NCT02915016|76060373|FG002|Overall Study|Lost to Follow-up|5|||
42237778|NCT02915016|76060374|FG003|Overall Study|Lost to Follow-up|3|||
42237779|NCT02915016|76060375|FG004|Overall Study|Lost to Follow-up|5|||
42237780|NCT02915016|76060376|FG005|Overall Study|Lost to Follow-up|2|||
42237781|NCT02915016|76060377|FG006|Overall Study|Lost to Follow-up|8|||
42237782|NCT02915016|76060378|FG007|Overall Study|Lost to Follow-up|2|||
42237783|NCT02915016|76060371|FG000|Overall Study|Physician Decision|0|||
42237784|NCT02915016|76060372|FG001|Overall Study|Physician Decision|0|||
42237785|NCT02915016|76060373|FG002|Overall Study|Physician Decision|1|||
42237786|NCT02915016|76060374|FG003|Overall Study|Physician Decision|0|||
42237787|NCT02915016|76060375|FG004|Overall Study|Physician Decision|0|||
42237788|NCT02915016|76060376|FG005|Overall Study|Physician Decision|1|||
42237789|NCT02915016|76060377|FG006|Overall Study|Physician Decision|2|||
42237790|NCT02915016|76060378|FG007|Overall Study|Physician Decision|0|||
42237791|NCT02915016|76060371|FG000|Overall Study|Withdrawal by Subject|2|||
42237792|NCT02915016|76060372|FG001|Overall Study|Withdrawal by Subject|0|||
42237793|NCT02915016|76060373|FG002|Overall Study|Withdrawal by Subject|1|||
42237794|NCT02915016|76060374|FG003|Overall Study|Withdrawal by Subject|0|||
42237795|NCT02915016|76060375|FG004|Overall Study|Withdrawal by Subject|1|||
42237796|NCT02915016|76060376|FG005|Overall Study|Withdrawal by Subject|3|||
42237797|NCT02915016|76060377|FG006|Overall Study|Withdrawal by Subject|1|||
42237798|NCT02915016|76060378|FG007|Overall Study|Withdrawal by Subject|1|||
42237799|NCT02915016|76060371|FG000|Overall Study|Elected not to continue|0|||
42237800|NCT02915016|76060372|FG001|Overall Study|Elected not to continue|0|||
42237801|NCT02915016|76060373|FG002|Overall Study|Elected not to continue|0|||
42237802|NCT02915016|76060374|FG003|Overall Study|Elected not to continue|1|||
42237803|NCT02915016|76060375|FG004|Overall Study|Elected not to continue|0|||
42237804|NCT02915016|76060376|FG005|Overall Study|Elected not to continue|0|||
42237805|NCT02915016|76060377|FG006|Overall Study|Elected not to continue|1|||
42237806|NCT02915016|76060378|FG007|Overall Study|Elected not to continue|0|||
42237807|NCT02915016|76060371|FG000|Overall Study|HIV infection|1|||
42237808|NCT02915016|76060372|FG001|Overall Study|HIV infection|1|||
42237809|NCT02915016|76060373|FG002|Overall Study|HIV infection|1|||
42237810|NCT02915016|76060374|FG003|Overall Study|HIV infection|0|||
42237811|NCT02915016|76060375|FG004|Overall Study|HIV infection|1|||
42237812|NCT02915016|76060376|FG005|Overall Study|HIV infection|0|||
42237813|NCT02915016|76060377|FG006|Overall Study|HIV infection|0|||
42237814|NCT02915016|76060378|FG007|Overall Study|HIV infection|0|||
42237815|NCT02915016|76060371|FG000|Overall Study|Participant unable to adhere|0|||
42237816|NCT02915016|76060372|FG001|Overall Study|Participant unable to adhere|0|||
42237817|NCT02915016|76060373|FG002|Overall Study|Participant unable to adhere|0|||
42237818|NCT02915016|76060374|FG003|Overall Study|Participant unable to adhere|0|||
42237819|NCT02915016|76060375|FG004|Overall Study|Participant unable to adhere|0|||
42237820|NCT02915016|76060376|FG005|Overall Study|Participant unable to adhere|0|||
42237821|NCT02915016|76060377|FG006|Overall Study|Participant unable to adhere|0|||
42237822|NCT02915016|76060378|FG007|Overall Study|Participant unable to adhere|1|||
42237823|NCT03323749|76060398|FG000|Double-blind Period|Lost to Follow-up|4|||
42237824|NCT03323749|76060399|FG001|Double-blind Period|Lost to Follow-up|5|||
42237825|NCT03323749|76060398|FG000|Double-blind Period|Adverse Event|3|||
42237826|NCT03323749|76060399|FG001|Double-blind Period|Adverse Event|1|||
42237827|NCT03323749|76060398|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
42237828|NCT03323749|76060399|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
42237829|NCT03323749|76060398|FG000|Open-Label Period|Adverse Event|3|||
42237830|NCT03323749|76060399|FG001|Open-Label Period|Adverse Event|10|||
42237831|NCT03323749|76060398|FG000|Open-Label Period|Withdrawal by Subject|7|||
42237832|NCT03323749|76060399|FG001|Open-Label Period|Withdrawal by Subject|5|||
42237833|NCT02208024|76060418|FG000|Overall Study|Withdrawal by Subject|1|||
42237834|NCT02660086|76060424|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
42237835|NCT02660086|76060425|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
42237836|NCT02660086|76060424|FG000|Overall Study- 12-month|Left full-time employment|12|||
42237837|NCT02660086|76060425|FG001|Overall Study- 12-month|Left full-time employment|20|||
42237838|NCT02660086|76060424|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
42237839|NCT02660086|76060425|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
42237840|NCT02660086|76060424|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
42237841|NCT02660086|76060425|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
42237842|NCT02660086|76060424|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
42237843|NCT02660086|76060425|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
42237844|NCT02660086|76060424|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
42237845|NCT02660086|76060425|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
42237846|NCT01678144|76060431|FG000|Stage 1: MAR Classic|Adverse Event|1|||
42237847|NCT00153920|76060435|FG000|Overall Study|Adverse Event|9|||
42237848|NCT00153920|76060435|FG000|Overall Study|Progressive Disease|9|||
42237849|NCT00153920|76060435|FG000|Overall Study|Physician Decision|3|||
42237850|NCT00153920|76060435|FG000|Overall Study|Lack of Response|3|||
42237851|NCT00153920|76060435|FG000|Overall Study|Death|2|||
42237852|NCT00153920|76060435|FG000|Overall Study|Withdrawal by Subject|1|||
42237853|NCT00153920|76060435|FG000|Overall Study|Non-Protocol Therapy|1|||
42237854|NCT00153920|76060435|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
42237855|NCT00153920|76060435|FG000|Overall Study|Progressive Disease before Trt|1|||
42237856|NCT02660242|76060439|FG000|Glucose Tabs|Lost to Follow-up|1|||
42237857|NCT02660242|76060439|FG000|Glucagon Injection|Lost to Follow-up|1|||
42237858|NCT03072043|76060455|FG000|Overall Study|Death|0|||
42237859|NCT03072043|76060456|FG001|Overall Study|Death|0|||
42237860|NCT03072043|76060457|FG002|Overall Study|Death|3|||
42237861|NCT03072043|76060455|FG000|Overall Study|Adverse Event|0|||
42237862|NCT03072043|76060456|FG001|Overall Study|Adverse Event|0|||
42237863|NCT03072043|76060457|FG002|Overall Study|Adverse Event|2|||
42237864|NCT03072043|76060455|FG000|Overall Study|Withdrawal by Subject|0|||
42237865|NCT03072043|76060456|FG001|Overall Study|Withdrawal by Subject|0|||
42237866|NCT03072043|76060457|FG002|Overall Study|Withdrawal by Subject|4|||
42237867|NCT03069313|76060469|FG000|Overall Study|Adverse Event|5|||
42237868|NCT03068767|76060475|FG000|Overall Study|Lost to Follow-up|7|||
42237869|NCT03068767|76060476|FG001|Overall Study|Lost to Follow-up|3|||
42237870|NCT03068767|76060475|FG000|Overall Study|Protocol Violation|3|||
42237871|NCT03068767|76060476|FG001|Overall Study|Protocol Violation|0|||
42237872|NCT03020745|76060490|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
42237873|NCT03020745|76060491|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
42237874|NCT03020745|76060492|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
42237875|NCT03020745|76060493|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
42237876|NCT03020745|76060494|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
42237877|NCT03020745|76060495|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
42237878|NCT03020745|76060496|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
42237879|NCT03020745|76060497|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
42237880|NCT03020745|76060498|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
42237881|NCT03020745|76060499|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
42237882|NCT03020745|76060490|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
42237883|NCT03020745|76060491|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
42237884|NCT03020745|76060492|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
42237885|NCT03020745|76060493|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
42237886|NCT03020745|76060494|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
42237887|NCT03020745|76060495|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
42237888|NCT03020745|76060496|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
42237889|NCT03020745|76060497|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
42237890|NCT03020745|76060498|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
42237891|NCT03020745|76060499|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
42237892|NCT03020745|76060490|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
42237893|NCT03020745|76060491|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
42237894|NCT03020745|76060492|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
42237895|NCT03020745|76060493|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
42237896|NCT03020745|76060494|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
42237897|NCT03020745|76060495|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
42237898|NCT03020745|76060496|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
42237899|NCT03020745|76060497|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
42237900|NCT03020745|76060498|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
42237901|NCT03020745|76060499|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
42237902|NCT03020745|76060490|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
42237903|NCT03020745|76060491|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
42237904|NCT03020745|76060492|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
42237905|NCT03020745|76060493|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
42237906|NCT03020745|76060494|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
42237907|NCT03020745|76060495|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
42237908|NCT03020745|76060496|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
42237909|NCT03020745|76060497|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
42237910|NCT03020745|76060498|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
42237911|NCT03020745|76060499|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
42237912|NCT03019965|76060534|FG000|Overall Study|Withdrawal by Subject|1|||
42237913|NCT03019965|76060535|FG001|Overall Study|Withdrawal by Subject|0|||
42237914|NCT03019965|76060534|FG000|Overall Study|Protocol Violation|1|||
42237915|NCT03019965|76060535|FG001|Overall Study|Protocol Violation|3|||
42237916|NCT03019965|76060534|FG000|Overall Study|viral or fungal infection|3|||
42237917|NCT03019965|76060535|FG001|Overall Study|viral or fungal infection|4|||
42237918|NCT03019965|76060534|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
42237919|NCT03019965|76060535|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
42237920|NCT03019965|76060534|FG000|Overall Study|Physician Decision|1|||
42237921|NCT03019965|76060535|FG001|Overall Study|Physician Decision|1|||
42237922|NCT01675882|76060554|FG000|Overall Study|Adverse Event|0|||
42237923|NCT01675882|76060555|FG001|Overall Study|Adverse Event|2|||
42237924|NCT01675882|76060556|FG002|Overall Study|Adverse Event|1|||
42237925|NCT01675882|76060557|FG003|Overall Study|Adverse Event|0|||
42237926|NCT01675882|76060554|FG000|Overall Study|Participant unwilling to continue|2|||
42237927|NCT01675882|76060555|FG001|Overall Study|Participant unwilling to continue|4|||
42237928|NCT01675882|76060556|FG002|Overall Study|Participant unwilling to continue|2|||
42237929|NCT01675882|76060557|FG003|Overall Study|Participant unwilling to continue|1|||
42237930|NCT01675882|76060554|FG000|Overall Study|Lost to Follow-up|0|||
42237931|NCT01675882|76060555|FG001|Overall Study|Lost to Follow-up|1|||
42237932|NCT01675882|76060556|FG002|Overall Study|Lost to Follow-up|0|||
42237933|NCT01675882|76060557|FG003|Overall Study|Lost to Follow-up|0|||
42237934|NCT01675882|76060554|FG000|Overall Study|Non-compliance|0|||
42237935|NCT01675882|76060555|FG001|Overall Study|Non-compliance|0|||
42237936|NCT01675882|76060556|FG002|Overall Study|Non-compliance|0|||
42237937|NCT01675882|76060557|FG003|Overall Study|Non-compliance|1|||
42237938|NCT03018249|76060569|FG000|Overall Study|Withdrawal by Subject|2|||
42237939|NCT03018249|76060570|FG001|Overall Study|Withdrawal by Subject|2|||
42237940|NCT02923245|76060588|FG000|Overall Study|ultrasound order was cancelled|2|||
42237941|NCT02923245|76060589|FG001|Overall Study|ultrasound order was cancelled|1|||
42237942|NCT00905606|76060605|FG000|Period 1|Adverse Event|0|||
42237943|NCT00905606|76060606|FG001|Period 1|Adverse Event|1|||
42237944|NCT00905606|76060605|FG000|Washout|Withdrawal by Subject|1|||
42237945|NCT00905606|76060606|FG001|Washout|Withdrawal by Subject|0|||
42237946|NCT01676896|76060613|FG000|Overall Study|Withdrawal by Subject|12|||
42237947|NCT01676896|76060614|FG001|Overall Study|Withdrawal by Subject|7|||
42237948|NCT01676896|76060615|FG002|Overall Study|Withdrawal by Subject|19|||
42237949|NCT03017235|76060625|FG000|Overall Study|Withdrawal by Subject|4|||
42237950|NCT03017235|76060626|FG001|Overall Study|Withdrawal by Subject|3|||
42237951|NCT03017235|76060625|FG000|Overall Study|Lost to Follow-up|2|||
42237952|NCT03017235|76060626|FG001|Overall Study|Lost to Follow-up|7|||
42237953|NCT03017235|76060625|FG000|Overall Study|Adverse Event|0|||
42237954|NCT03017235|76060626|FG001|Overall Study|Adverse Event|1|||
42237955|NCT03017235|76060625|FG000|Overall Study|Protocol Violation|2|||
42237956|NCT03017235|76060626|FG001|Overall Study|Protocol Violation|1|||
42237957|NCT03017235|76060625|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
42237958|NCT03017235|76060626|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
42237959|NCT03017079|76060634|FG000|Overall Study|Physician Decision|1|||
42237960|NCT03017079|76060635|FG001|Overall Study|Physician Decision|1|||
42237961|NCT03017079|76060634|FG000|Overall Study|Death|3|||
42237962|NCT03017079|76060635|FG001|Overall Study|Death|2|||
42237963|NCT03017079|76060634|FG000|Overall Study|Lack of Efficacy|2|||
42237964|NCT03017079|76060635|FG001|Overall Study|Lack of Efficacy|2|||
42237965|NCT03017079|76060634|FG000|Overall Study|Protocol Violation|0|||
42237966|NCT03017079|76060635|FG001|Overall Study|Protocol Violation|1|||
42237967|NCT03015363|76060648|FG000|Overall Study|Physician Decision|14|||
42237968|NCT03015363|76060648|FG000|Overall Study|Withdrawal by Subject|3|||
42237969|NCT02880371|76060660|FG000|Phase 1b|Lost to Follow-up|1|||
42237970|NCT02880371|76060661|FG001|Phase 1b|Lost to Follow-up|0|||
42237971|NCT02880371|76060662|FG002|Phase 1b|Lost to Follow-up|0|||
42237972|NCT02880371|76060663|FG003|Phase 1b|Lost to Follow-up|0|||
42237973|NCT02880371|76060664|FG004|Phase 1b|Lost to Follow-up|0|||
42237974|NCT02880371|76060665|FG005|Phase 1b|Lost to Follow-up|0|||
42237975|NCT02880371|76060666|FG006|Phase 1b|Lost to Follow-up|0|||
42237976|NCT02880371|76060667|FG007|Phase 1b|Lost to Follow-up|0|||
42237977|NCT02880371|76060660|FG000|Phase 1b|Participants terminated by Sponsor|1|||
42131942|NCT00319696|75942789|FG000|Overall Study|Adverse Event|36|||
42131943|NCT00319696|75942789|FG000|Overall Study|withdrawal of consent|14|||
42237978|NCT02880371|76060661|FG001|Phase 1b|Participants terminated by Sponsor|0|||
42237979|NCT02880371|76060662|FG002|Phase 1b|Participants terminated by Sponsor|0|||
42237980|NCT02880371|76060663|FG003|Phase 1b|Participants terminated by Sponsor|0|||
42237981|NCT02880371|76060664|FG004|Phase 1b|Participants terminated by Sponsor|0|||
42237982|NCT02880371|76060665|FG005|Phase 1b|Participants terminated by Sponsor|0|||
42237983|NCT02880371|76060666|FG006|Phase 1b|Participants terminated by Sponsor|0|||
42237984|NCT02880371|76060667|FG007|Phase 1b|Participants terminated by Sponsor|0|||
42237985|NCT02880371|76060660|FG000|Phase 1b|Withdrawal by Subject|0|||
42237986|NCT02880371|76060661|FG001|Phase 1b|Withdrawal by Subject|0|||
42237987|NCT02880371|76060662|FG002|Phase 1b|Withdrawal by Subject|1|||
42237988|NCT02880371|76060663|FG003|Phase 1b|Withdrawal by Subject|0|||
42237989|NCT02880371|76060664|FG004|Phase 1b|Withdrawal by Subject|0|||
42237990|NCT02880371|76060665|FG005|Phase 1b|Withdrawal by Subject|0|||
42237991|NCT02880371|76060666|FG006|Phase 1b|Withdrawal by Subject|0|||
42237992|NCT02880371|76060667|FG007|Phase 1b|Withdrawal by Subject|0|||
42237993|NCT02880371|76060660|FG000|Phase 1b|Death|4|||
42237994|NCT02880371|76060661|FG001|Phase 1b|Death|6|||
42237995|NCT02880371|76060662|FG002|Phase 1b|Death|5|||
42237996|NCT02880371|76060663|FG003|Phase 1b|Death|1|||
42237997|NCT02880371|76060664|FG004|Phase 1b|Death|0|||
42237998|NCT02880371|76060665|FG005|Phase 1b|Death|0|||
42237999|NCT02880371|76060666|FG006|Phase 1b|Death|0|||
42238000|NCT02880371|76060667|FG007|Phase 1b|Death|0|||
42238001|NCT02880371|76060660|FG000|Phase 1b|Enrolled but not Treated|0|||
42238002|NCT02880371|76060661|FG001|Phase 1b|Enrolled but not Treated|1|||
42238003|NCT02880371|76060662|FG002|Phase 1b|Enrolled but not Treated|0|||
42238004|NCT02880371|76060663|FG003|Phase 1b|Enrolled but not Treated|0|||
42238005|NCT02880371|76060664|FG004|Phase 1b|Enrolled but not Treated|0|||
42238006|NCT02880371|76060665|FG005|Phase 1b|Enrolled but not Treated|0|||
42238007|NCT02880371|76060666|FG006|Phase 1b|Enrolled but not Treated|0|||
42238008|NCT02880371|76060667|FG007|Phase 1b|Enrolled but not Treated|0|||
42238009|NCT02880371|76060660|FG000|Phase 2|Enrolled but not Treated|0|||
42238010|NCT02880371|76060661|FG001|Phase 2|Enrolled but not Treated|0|||
42238011|NCT02880371|76060662|FG002|Phase 2|Enrolled but not Treated|0|||
42238012|NCT02880371|76060663|FG003|Phase 2|Enrolled but not Treated|0|||
42238013|NCT02880371|76060664|FG004|Phase 2|Enrolled but not Treated|0|||
42238014|NCT02880371|76060665|FG005|Phase 2|Enrolled but not Treated|1|||
42238015|NCT02880371|76060666|FG006|Phase 2|Enrolled but not Treated|1|||
42238016|NCT02880371|76060667|FG007|Phase 2|Enrolled but not Treated|0|||
42238017|NCT02880371|76060660|FG000|Phase 2|Other|0|||
42238018|NCT02880371|76060661|FG001|Phase 2|Other|0|||
42238019|NCT02880371|76060662|FG002|Phase 2|Other|0|||
42238020|NCT02880371|76060663|FG003|Phase 2|Other|0|||
42238021|NCT02880371|76060664|FG004|Phase 2|Other|0|||
42238022|NCT02880371|76060665|FG005|Phase 2|Other|1|||
42238023|NCT02880371|76060666|FG006|Phase 2|Other|2|||
42238024|NCT02880371|76060667|FG007|Phase 2|Other|1|||
42238025|NCT02880371|76060660|FG000|Phase 2|Participants terminated by Sponsor|0|||
42238026|NCT02880371|76060661|FG001|Phase 2|Participants terminated by Sponsor|0|||
42238027|NCT02880371|76060662|FG002|Phase 2|Participants terminated by Sponsor|0|||
42238028|NCT02880371|76060663|FG003|Phase 2|Participants terminated by Sponsor|0|||
42238029|NCT02880371|76060664|FG004|Phase 2|Participants terminated by Sponsor|1|||
42238030|NCT02880371|76060665|FG005|Phase 2|Participants terminated by Sponsor|6|||
42238031|NCT02880371|76060666|FG006|Phase 2|Participants terminated by Sponsor|1|||
42238032|NCT02880371|76060667|FG007|Phase 2|Participants terminated by Sponsor|5|||
42238033|NCT02880371|76060660|FG000|Phase 2|Death|0|||
42238034|NCT02880371|76060661|FG001|Phase 2|Death|0|||
42238035|NCT02880371|76060662|FG002|Phase 2|Death|0|||
42238036|NCT02880371|76060663|FG003|Phase 2|Death|0|||
42238037|NCT02880371|76060664|FG004|Phase 2|Death|1|||
42238038|NCT02880371|76060665|FG005|Phase 2|Death|10|||
42238039|NCT02880371|76060666|FG006|Phase 2|Death|20|||
42238040|NCT02880371|76060667|FG007|Phase 2|Death|5|||
42238041|NCT02880371|76060660|FG000|Phase 2|Lost to Follow-up|0|||
42238042|NCT02880371|76060661|FG001|Phase 2|Lost to Follow-up|0|||
42238043|NCT02880371|76060662|FG002|Phase 2|Lost to Follow-up|0|||
42238044|NCT02880371|76060663|FG003|Phase 2|Lost to Follow-up|0|||
42238045|NCT02880371|76060664|FG004|Phase 2|Lost to Follow-up|0|||
42238046|NCT02880371|76060665|FG005|Phase 2|Lost to Follow-up|0|||
42238047|NCT02880371|76060666|FG006|Phase 2|Lost to Follow-up|3|||
42238048|NCT02880371|76060667|FG007|Phase 2|Lost to Follow-up|0|||
42238049|NCT02880371|76060660|FG000|Phase 2|Withdrawal by Subject|0|||
42238050|NCT02880371|76060661|FG001|Phase 2|Withdrawal by Subject|0|||
42238051|NCT02880371|76060662|FG002|Phase 2|Withdrawal by Subject|0|||
42238052|NCT02880371|76060663|FG003|Phase 2|Withdrawal by Subject|0|||
42238053|NCT02880371|76060664|FG004|Phase 2|Withdrawal by Subject|0|||
42238054|NCT02880371|76060665|FG005|Phase 2|Withdrawal by Subject|1|||
42238055|NCT02880371|76060666|FG006|Phase 2|Withdrawal by Subject|1|||
42238056|NCT02880371|76060667|FG007|Phase 2|Withdrawal by Subject|0|||
42238057|NCT02880371|76060660|FG000|Phase 2|End of Study page not completed by error|0|||
42238058|NCT02880371|76060661|FG001|Phase 2|End of Study page not completed by error|0|||
42238059|NCT02880371|76060662|FG002|Phase 2|End of Study page not completed by error|0|||
42238060|NCT02880371|76060663|FG003|Phase 2|End of Study page not completed by error|0|||
42238061|NCT02880371|76060664|FG004|Phase 2|End of Study page not completed by error|0|||
42238062|NCT02880371|76060665|FG005|Phase 2|End of Study page not completed by error|1|||
42238063|NCT02880371|76060666|FG006|Phase 2|End of Study page not completed by error|0|||
42238064|NCT02880371|76060667|FG007|Phase 2|End of Study page not completed by error|0|||
42238065|NCT02837029|76060690|FG000|Screening|Failed to meet screening requirements.|7|||
42238066|NCT02837029|76060691|FG001|Screening|Failed to meet screening requirements.|3|||
42302658|NCT02413333|76137950|FG000|Period 1|Reason Not Specified|0|||
42238067|NCT02837029|76060692|FG002|Screening|Failed to meet screening requirements.|0|||
42238068|NCT02837029|76060690|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
42238069|NCT02837029|76060691|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
42238070|NCT02837029|76060692|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
42238071|NCT02837029|76060690|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
42238072|NCT02837029|76060691|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
42238073|NCT02837029|76060692|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
42238074|NCT02837029|76060690|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
42238075|NCT02837029|76060691|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
42238076|NCT02837029|76060692|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
42238077|NCT02837029|76060690|FG000|Cycle 2 and Beyond|Adverse Event|1|||
42238078|NCT02837029|76060691|FG001|Cycle 2 and Beyond|Adverse Event|0|||
42238079|NCT02837029|76060692|FG002|Cycle 2 and Beyond|Adverse Event|0|||
42238080|NCT02837029|76060690|FG000|2 Year Follow-up|Death|6|||
42238081|NCT02837029|76060691|FG001|2 Year Follow-up|Death|7|||
42238082|NCT02837029|76060692|FG002|2 Year Follow-up|Death|0|||
42238083|NCT03010527|76060704|FG000|Overall Study|Death|0|||
42238084|NCT03010527|76060705|FG001|Overall Study|Death|0|||
42238085|NCT03010527|76060706|FG002|Overall Study|Death|1|||
42238086|NCT03010527|76060704|FG000|Overall Study|Adverse Event|0|||
42238087|NCT03010527|76060705|FG001|Overall Study|Adverse Event|4|||
42238088|NCT03010527|76060706|FG002|Overall Study|Adverse Event|2|||
42238089|NCT03010527|76060704|FG000|Overall Study|Protocol Violation|0|||
42238090|NCT03010527|76060705|FG001|Overall Study|Protocol Violation|1|||
42238091|NCT03010527|76060706|FG002|Overall Study|Protocol Violation|0|||
42238092|NCT03010527|76060704|FG000|Overall Study|Lost to Follow-up|0|||
42238093|NCT03010527|76060705|FG001|Overall Study|Lost to Follow-up|2|||
42238094|NCT03010527|76060706|FG002|Overall Study|Lost to Follow-up|1|||
42238095|NCT03010527|76060704|FG000|Overall Study|Withdrawal by Subject|0|||
42238096|NCT03010527|76060705|FG001|Overall Study|Withdrawal by Subject|3|||
42238097|NCT03010527|76060706|FG002|Overall Study|Withdrawal by Subject|4|||
42238098|NCT03010527|76060704|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
42238099|NCT03010527|76060705|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
42238100|NCT03010527|76060706|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
42238101|NCT03010527|76060704|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
42238102|NCT03010527|76060705|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
42238103|NCT03010527|76060706|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
42238104|NCT03010527|76060704|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
42238105|NCT03010527|76060705|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
42238106|NCT03010527|76060706|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
42238107|NCT00794924|76060739|FG000|Overall Study|Lost to Follow-up|6|||
42238108|NCT00794924|76060740|FG001|Overall Study|Lost to Follow-up|8|||
42238109|NCT00794924|76060739|FG000|Overall Study|Withdrawal by Subject|48|||
42238110|NCT00794924|76060740|FG001|Overall Study|Withdrawal by Subject|60|||
42238111|NCT00794924|76060739|FG000|Overall Study|Adverse Event|6|||
42238112|NCT00794924|76060740|FG001|Overall Study|Adverse Event|2|||
42238113|NCT02914275|76060746|FG000|Overall Study|Lost to Follow-up|84|||
42238114|NCT02914275|76060747|FG001|Overall Study|Lost to Follow-up|29|||
42238115|NCT02914275|76060746|FG000|Overall Study|Withdrawal by Subject|26|||
42238116|NCT02914275|76060747|FG001|Overall Study|Withdrawal by Subject|10|||
42238117|NCT02914275|76060746|FG000|Overall Study|Protocol Violation|1|||
42238118|NCT02914275|76060747|FG001|Overall Study|Protocol Violation|1|||
42238119|NCT02914275|76060746|FG000|Overall Study|Physician Decision|3|||
42238120|NCT02914275|76060747|FG001|Overall Study|Physician Decision|1|||
42238121|NCT02914275|76060746|FG000|Overall Study|Other|4|||
42238122|NCT02914275|76060747|FG001|Overall Study|Other|1|||
42238123|NCT02914275|76060746|FG000|Overall Study|Excluded due to invalid informed consent|3|||
42238124|NCT02914275|76060747|FG001|Overall Study|Excluded due to invalid informed consent|0|||
42238125|NCT00792116|76060759|FG000|Overall Study|Lost to Follow-up|0|||
42238126|NCT00792116|76060760|FG001|Overall Study|Lost to Follow-up|1|||
42238127|NCT00792116|76060759|FG000|Overall Study|Discontnued intervention|1|||
42238128|NCT00792116|76060760|FG001|Overall Study|Discontnued intervention|0|||
42238129|NCT00489827|76060775|FG000|Overall Study|Intraoperative exclusion criteria|1|||
41988033|NCT01269385|75795347|FG002|Overall Study|Adverse Event|0|||
41988034|NCT01269385|75795348|FG003|Overall Study|Adverse Event|0|||
41988035|NCT01268683|75795358|FG000|Overall Study|Lost to Follow-up|1|||
41988036|NCT01268683|75795358|FG000|Overall Study|Death|1|||
41988037|NCT01268566|75795362|FG000|Overall Study|Lost to Follow-up|1|||
41988038|NCT01268566|75795362|FG000|Overall Study|Withdrawal by Subject|12|||
41988039|NCT01268566|75795362|FG000|Overall Study|Death|30|||
41988040|NCT01268488|75795366|FG000|Overall Study|Adverse Event|3|||
41988041|NCT01268488|75795366|FG000|Overall Study|Physician Decision|2|||
42131944|NCT00319696|75942789|FG000|Overall Study|administrative|7|||
42238130|NCT00489827|76060776|FG001|Overall Study|Intraoperative exclusion criteria|1|||
42238131|NCT00489827|76060775|FG000|Overall Study|Intraoperative exclusion criteria|1|||
41988042|NCT01268098|75795373|FG000|Overall Study|Adverse Event|1|||
42238132|NCT00489827|76060776|FG001|Overall Study|Intraoperative exclusion criteria|1|||
42238133|NCT02604433|76060784|FG000|Overall Study|Withdrawal by Subject|37|||
42238134|NCT02604433|76060785|FG001|Overall Study|Withdrawal by Subject|16|||
42238135|NCT02604433|76060784|FG000|Overall Study|Adverse Event|4|||
42238136|NCT02604433|76060785|FG001|Overall Study|Adverse Event|0|||
41988043|NCT01268098|75795374|FG001|Overall Study|Adverse Event|0|||
42238137|NCT02604433|76060784|FG000|Overall Study|Other reasons|3|||
42238138|NCT02604433|76060785|FG001|Overall Study|Other reasons|5|||
42238139|NCT02604433|76060784|FG000|Overall Study|Death|4|||
42238140|NCT02604433|76060785|FG001|Overall Study|Death|1|||
42131945|NCT00319696|75942789|FG000|Overall Study|Lost to Follow-up|3|||
42238141|NCT02604433|76060784|FG000|Overall Study|Transition to Rollover Protocol|169|||
42238142|NCT02604433|76060785|FG001|Overall Study|Transition to Rollover Protocol|82|||
42238143|NCT02604433|76060784|FG000|Overall Study|Physician Decision|1|||
42238144|NCT02604433|76060785|FG001|Overall Study|Physician Decision|1|||
42238145|NCT02604433|76060784|FG000|Overall Study|Lack of Efficacy|0|||
42238146|NCT02604433|76060785|FG001|Overall Study|Lack of Efficacy|1|||
42238147|NCT02659150|76060791|FG000|Subject Enrollment|Physician Decision|3|||
42238148|NCT02659150|76060791|FG000|Subject Enrollment|Withdrawal by Subject|2|||
42238149|NCT02659150|76060791|FG000|Baseline Imaging|Withdrawal by Subject|1|||
42238150|NCT02659150|76060791|FG000|Baseline Imaging|Physician Decision|1|||
42238151|NCT02659150|76060791|FG000|Study Drug Dosing|Adverse Event|1|||
42238152|NCT03006393|76060798|FG000|Overall Study|Withdrawal by Subject|1|||
42238153|NCT03006393|76060799|FG001|Overall Study|Withdrawal by Subject|1|||
42238154|NCT03006393|76060798|FG000|Overall Study|Pregnancy|0|||
42238155|NCT03006393|76060799|FG001|Overall Study|Pregnancy|1|||
42238156|NCT03006393|76060798|FG000|Overall Study|Lost to Follow-up|0|||
42238157|NCT03006393|76060799|FG001|Overall Study|Lost to Follow-up|1|||
42238158|NCT00882440|76060816|FG000|Overall Study|Adverse Event|2|||
42238159|NCT00882440|76060817|FG001|Overall Study|Adverse Event|2|||
42238160|NCT00882440|76060818|FG002|Overall Study|Adverse Event|2|||
42238161|NCT00882440|76060819|FG003|Overall Study|Adverse Event|1|||
42238162|NCT00882440|76060820|FG004|Overall Study|Adverse Event|1|||
42238163|NCT00882440|76060821|FG005|Overall Study|Adverse Event|4|||
42238164|NCT00882440|76060822|FG006|Overall Study|Adverse Event|2|||
42238165|NCT00882440|76060816|FG000|Overall Study|Lack of Efficacy|3|||
42238166|NCT00882440|76060817|FG001|Overall Study|Lack of Efficacy|5|||
42238167|NCT00882440|76060818|FG002|Overall Study|Lack of Efficacy|2|||
42238168|NCT00882440|76060819|FG003|Overall Study|Lack of Efficacy|0|||
42238169|NCT00882440|76060820|FG004|Overall Study|Lack of Efficacy|0|||
42238170|NCT00882440|76060821|FG005|Overall Study|Lack of Efficacy|3|||
42238171|NCT00882440|76060822|FG006|Overall Study|Lack of Efficacy|0|||
41988044|NCT01268059|75795384|FG000|Overall Study|Lost to Follow-up|0|||
41988045|NCT01268059|75795385|FG001|Overall Study|Lost to Follow-up|1|||
41988046|NCT01268059|75795386|FG002|Overall Study|Lost to Follow-up|0|||
41988047|NCT01268059|75795387|FG003|Overall Study|Lost to Follow-up|0|||
41988048|NCT01268059|75795384|FG000|Overall Study|Withdrawal by Subject|7|||
41988049|NCT01268059|75795385|FG001|Overall Study|Withdrawal by Subject|4|||
41988050|NCT01268059|75795386|FG002|Overall Study|Withdrawal by Subject|0|||
41988051|NCT01268059|75795387|FG003|Overall Study|Withdrawal by Subject|0|||
41988052|NCT01268059|75795384|FG000|Overall Study|Death|20|||
41988053|NCT01268059|75795385|FG001|Overall Study|Death|30|||
41988054|NCT01268059|75795386|FG002|Overall Study|Death|3|||
41988055|NCT01268059|75795387|FG003|Overall Study|Death|5|||
41988056|NCT01268059|75795384|FG000|Overall Study|Progression of disease|1|||
41988057|NCT01268059|75795385|FG001|Overall Study|Progression of disease|0|||
41988058|NCT01268059|75795386|FG002|Overall Study|Progression of disease|0|||
41988059|NCT01268059|75795387|FG003|Overall Study|Progression of disease|0|||
41988060|NCT01267825|75795402|FG000|Overall Study|study terminated. no data collected.|1|||
41988061|NCT01267825|75795403|FG001|Overall Study|study terminated. no data collected.|0|||
41988062|NCT01260181|75795409|FG000|Overall Study|Decision of Investigator|1|||
41988063|NCT01260142|75795419|FG000|Treatment Period 1|Study on hold|1|||
41988064|NCT01260142|75795420|FG001|Treatment Period 1|Study on hold|1|||
41988065|NCT01260142|75795421|FG002|Treatment Period 1|Study on hold|0|||
41988066|NCT01260142|75795422|FG003|Treatment Period 1|Study on hold|0|||
41988067|NCT01260142|75795423|FG004|Treatment Period 1|Study on hold|1|||
41988068|NCT01260142|75795424|FG005|Treatment Period 1|Study on hold|2|||
41988069|NCT01260142|75795419|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
41988070|NCT01260142|75795420|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
41988071|NCT01260142|75795421|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
41988072|NCT01260142|75795422|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
41988073|NCT01260142|75795423|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
41988074|NCT01260142|75795424|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
41988075|NCT01260142|75795419|FG000|Treatment Period 1|Withdrawal by Subject|0|||
41988076|NCT01260142|75795420|FG001|Treatment Period 1|Withdrawal by Subject|0|||
41988077|NCT01260142|75795421|FG002|Treatment Period 1|Withdrawal by Subject|0|||
41988078|NCT01260142|75795422|FG003|Treatment Period 1|Withdrawal by Subject|0|||
41988079|NCT01260142|75795423|FG004|Treatment Period 1|Withdrawal by Subject|0|||
41988080|NCT01260142|75795424|FG005|Treatment Period 1|Withdrawal by Subject|1|||
41988081|NCT01259869|75795444|FG000|Overall Study|Duplicated registration|1|||
42238172|NCT00882440|76060816|FG000|Overall Study|Lost to Follow-up|2|||
42238173|NCT00882440|76060817|FG001|Overall Study|Lost to Follow-up|0|||
42238174|NCT00882440|76060818|FG002|Overall Study|Lost to Follow-up|1|||
42238175|NCT00882440|76060819|FG003|Overall Study|Lost to Follow-up|1|||
42238176|NCT00882440|76060820|FG004|Overall Study|Lost to Follow-up|1|||
42238177|NCT00882440|76060821|FG005|Overall Study|Lost to Follow-up|0|||
42238178|NCT00882440|76060822|FG006|Overall Study|Lost to Follow-up|1|||
41988082|NCT01259713|75795450|FG000|Overall Study|Adverse Event|54|||
41988083|NCT01259713|75795451|FG001|Overall Study|Adverse Event|23|||
41988084|NCT01259713|75795450|FG000|Overall Study|Death Not Related to IFI|8|||
41988085|NCT01259713|75795451|FG001|Overall Study|Death Not Related to IFI|1|||
41988086|NCT01259713|75795450|FG000|Overall Study|Investigators Discretion|14|||
41988087|NCT01259713|75795451|FG001|Overall Study|Investigators Discretion|6|||
41988088|NCT01259713|75795450|FG000|Overall Study|Lack of Efficacy|2|||
41988089|NCT01259713|75795451|FG001|Overall Study|Lack of Efficacy|0|||
42238179|NCT00882440|76060816|FG000|Overall Study|Protocol Violation|0|||
42238180|NCT00882440|76060817|FG001|Overall Study|Protocol Violation|0|||
42238181|NCT00882440|76060818|FG002|Overall Study|Protocol Violation|1|||
42238182|NCT00882440|76060819|FG003|Overall Study|Protocol Violation|1|||
42238183|NCT00882440|76060820|FG004|Overall Study|Protocol Violation|1|||
42238184|NCT00882440|76060821|FG005|Overall Study|Protocol Violation|0|||
42238185|NCT00882440|76060822|FG006|Overall Study|Protocol Violation|0|||
42238186|NCT00882440|76060816|FG000|Overall Study|Withdrawal by Subject|2|||
42238187|NCT00882440|76060817|FG001|Overall Study|Withdrawal by Subject|1|||
42238188|NCT00882440|76060818|FG002|Overall Study|Withdrawal by Subject|1|||
42238189|NCT00882440|76060819|FG003|Overall Study|Withdrawal by Subject|0|||
42238190|NCT00882440|76060820|FG004|Overall Study|Withdrawal by Subject|6|||
42238191|NCT00882440|76060821|FG005|Overall Study|Withdrawal by Subject|0|||
42238192|NCT00882440|76060822|FG006|Overall Study|Withdrawal by Subject|1|||
42238193|NCT00882440|76060816|FG000|Overall Study|Patient Uncooperative|2|||
42238194|NCT00882440|76060817|FG001|Overall Study|Patient Uncooperative|0|||
42238195|NCT00882440|76060818|FG002|Overall Study|Patient Uncooperative|0|||
42238196|NCT00882440|76060819|FG003|Overall Study|Patient Uncooperative|0|||
42238197|NCT00882440|76060820|FG004|Overall Study|Patient Uncooperative|1|||
42238198|NCT00882440|76060821|FG005|Overall Study|Patient Uncooperative|0|||
42238199|NCT00882440|76060822|FG006|Overall Study|Patient Uncooperative|0|||
42238200|NCT03005067|76060833|FG000|Overall Study|Withdrawal by Subject|3|||
42238201|NCT03005067|76060834|FG001|Overall Study|Withdrawal by Subject|2|||
42238202|NCT03005067|76060833|FG000|Overall Study|Adverse Event|4|||
42238203|NCT03005067|76060834|FG001|Overall Study|Adverse Event|3|||
42238204|NCT03005067|76060833|FG000|Overall Study|Other (reason not specified)|3|||
42238205|NCT03005067|76060834|FG001|Overall Study|Other (reason not specified)|1|||
42238206|NCT03005067|76060833|FG000|Overall Study|Protocol Violation|0|||
42238207|NCT03005067|76060834|FG001|Overall Study|Protocol Violation|1|||
42238208|NCT02658448|76060840|FG000|Overall Study|Lost to Follow-up|1|||
42238209|NCT00870818|76060849|FG000|Overall Study|Lost to Follow-up|3|||
42238210|NCT00870818|76060850|FG001|Overall Study|Lost to Follow-up|2|||
42238211|NCT00870818|76060851|FG002|Overall Study|Lost to Follow-up|1|||
42238212|NCT00870818|76060852|FG003|Overall Study|Lost to Follow-up|0|||
42238213|NCT00870818|76060853|FG004|Overall Study|Lost to Follow-up|0|||
42238214|NCT00870818|76060849|FG000|Overall Study|Withdrawal by Subject|0|||
42238215|NCT00870818|76060850|FG001|Overall Study|Withdrawal by Subject|0|||
42238216|NCT00870818|76060851|FG002|Overall Study|Withdrawal by Subject|1|||
42238217|NCT00870818|76060852|FG003|Overall Study|Withdrawal by Subject|2|||
42238218|NCT00870818|76060853|FG004|Overall Study|Withdrawal by Subject|0|||
42238219|NCT00870818|76060849|FG000|Overall Study|Terminated by sponsor|29|||
42238220|NCT00870818|76060850|FG001|Overall Study|Terminated by sponsor|70|||
42238221|NCT00870818|76060851|FG002|Overall Study|Terminated by sponsor|36|||
42238222|NCT00870818|76060852|FG003|Overall Study|Terminated by sponsor|36|||
42238223|NCT00870818|76060853|FG004|Overall Study|Terminated by sponsor|38|||
42238224|NCT00870818|76060849|FG000|Overall Study|Other|0|||
42238225|NCT00870818|76060850|FG001|Overall Study|Other|1|||
42238226|NCT00870818|76060851|FG002|Overall Study|Other|0|||
42238227|NCT00870818|76060852|FG003|Overall Study|Other|0|||
42238228|NCT00870818|76060853|FG004|Overall Study|Other|0|||
42238229|NCT03075761|76060867|FG000|Overall Study|Lost to Follow-up|1|||
42238230|NCT03075761|76060868|FG001|Overall Study|Lost to Follow-up|6|||
42238231|NCT03000075|76060882|FG000|Part A|Adverse Event|4|||
42238232|NCT03000075|76060883|FG001|Part A|Adverse Event|0|||
41988090|NCT01259713|75795450|FG000|Overall Study|Protocol Violation|5|||
41988091|NCT01259713|75795451|FG001|Overall Study|Protocol Violation|4|||
42238233|NCT03000075|76060884|FG002|Part A|Adverse Event|0|||
42238234|NCT03000075|76060885|FG003|Part A|Adverse Event|0|||
42238235|NCT03000075|76060886|FG004|Part A|Adverse Event|0|||
42238236|NCT03000075|76060887|FG005|Part A|Adverse Event|0|||
42238237|NCT03000075|76060888|FG006|Part A|Adverse Event|0|||
42238238|NCT03000075|76060882|FG000|Part B|Not dosed due to AE|0|||
41988092|NCT01259713|75795450|FG000|Overall Study|Subject Withdrew Consent|12|||
42238239|NCT03000075|76060883|FG001|Part B|Not dosed due to AE|0|||
42238240|NCT03000075|76060884|FG002|Part B|Not dosed due to AE|0|||
42238241|NCT03000075|76060885|FG003|Part B|Not dosed due to AE|0|||
42238242|NCT03000075|76060886|FG004|Part B|Not dosed due to AE|0|||
42238243|NCT03000075|76060887|FG005|Part B|Not dosed due to AE|2|||
42131946|NCT00474630|75942801|FG000|Overall Study|Adverse Event|98|||
42238244|NCT03000075|76060888|FG006|Part B|Not dosed due to AE|1|||
42238245|NCT03000075|76060882|FG000|Part B|Adverse Event|0|||
42238246|NCT03000075|76060883|FG001|Part B|Adverse Event|0|||
42238247|NCT03000075|76060884|FG002|Part B|Adverse Event|0|||
42238248|NCT03000075|76060885|FG003|Part B|Adverse Event|0|||
42238249|NCT03000075|76060886|FG004|Part B|Adverse Event|1|||
42238250|NCT03000075|76060887|FG005|Part B|Adverse Event|0|||
42238251|NCT03000075|76060888|FG006|Part B|Adverse Event|0|||
42238252|NCT03073109|76060906|FG000|Overall Study|Adverse Event|0|||
42238253|NCT03073109|76060907|FG001|Overall Study|Adverse Event|1|||
42238254|NCT03073109|76060906|FG000|Overall Study|Other|2|||
42238255|NCT03073109|76060907|FG001|Overall Study|Other|0|||
42238256|NCT03073109|76060906|FG000|Overall Study|Lost to Follow-up|8|||
42238257|NCT03073109|76060907|FG001|Overall Study|Lost to Follow-up|1|||
42238258|NCT02371889|76060929|FG000|Overall Study|Adverse medication effect|11|||
42238259|NCT02371889|76060930|FG001|Overall Study|Adverse medication effect|2|||
42238260|NCT02371889|76060929|FG000|Overall Study|Lost to Follow-up|6|||
42238261|NCT02371889|76060930|FG001|Overall Study|Lost to Follow-up|5|||
42238262|NCT02371889|76060929|FG000|Overall Study|Personal time constraints|2|||
42238263|NCT02371889|76060930|FG001|Overall Study|Personal time constraints|4|||
42238264|NCT02371889|76060929|FG000|Overall Study|Lack of Efficacy|0|||
42238265|NCT02371889|76060930|FG001|Overall Study|Lack of Efficacy|2|||
42238266|NCT02371889|76060929|FG000|Overall Study|Relapse|0|||
42238267|NCT02371889|76060930|FG001|Overall Study|Relapse|1|||
42238268|NCT03072875|76060940|FG000|Overall Study|Lost to Follow-up|1|||
42238269|NCT04250077|76060948|FG000|Overall Study|Withdrawal by Subject|0|||
42238270|NCT04250077|76060949|FG001|Overall Study|Withdrawal by Subject|1|||
42238271|NCT04250077|76060950|FG002|Overall Study|Withdrawal by Subject|0|||
42238272|NCT04250077|76060948|FG000|Overall Study|Lost to Follow-up|2|||
42238273|NCT04250077|76060949|FG001|Overall Study|Lost to Follow-up|3|||
42238274|NCT04250077|76060950|FG002|Overall Study|Lost to Follow-up|0|||
42238275|NCT00859430|76060962|FG000|First Intervention|Withdrawal by Subject|0|||
42238276|NCT00859430|76060963|FG001|First Intervention|Withdrawal by Subject|1|||
42238277|NCT02913105|76060980|FG000|Overall Study|Adverse Event|11|||
42238278|NCT02913105|76060981|FG001|Overall Study|Adverse Event|0|||
42238279|NCT02913105|76060982|FG002|Overall Study|Adverse Event|4|||
42238280|NCT02913105|76060980|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42238281|NCT02913105|76060981|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42238282|NCT02913105|76060982|FG002|Overall Study|Non-Compliance With Study Drug|1|||
42238283|NCT02913105|76060980|FG000|Overall Study|Reason Not Specified|3|||
42238284|NCT02913105|76060981|FG001|Overall Study|Reason Not Specified|1|||
42238285|NCT02913105|76060982|FG002|Overall Study|Reason Not Specified|1|||
42238286|NCT02913105|76060980|FG000|Overall Study|Physician Decision|1|||
42238287|NCT02913105|76060981|FG001|Overall Study|Physician Decision|1|||
42238288|NCT02913105|76060982|FG002|Overall Study|Physician Decision|0|||
42238289|NCT02913105|76060980|FG000|Overall Study|Withdrawal by Subject|0|||
42238290|NCT02913105|76060981|FG001|Overall Study|Withdrawal by Subject|3|||
42238291|NCT02913105|76060982|FG002|Overall Study|Withdrawal by Subject|1|||
42238292|NCT00840632|76061000|FG000|First Intervention|Withdrawal by Subject|0|||
41988093|NCT01259713|75795451|FG001|Overall Study|Subject Withdrew Consent|7|||
41988094|NCT01259401|75795459|FG000|4-month Follow-up|Death|0|||
41988095|NCT01259401|75795460|FG001|4-month Follow-up|Death|1|||
41988096|NCT01259401|75795459|FG000|4-month Follow-up|Lost to Follow-up|0|||
41988097|NCT01259401|75795460|FG001|4-month Follow-up|Lost to Follow-up|1|||
41988098|NCT01313923|75795475|FG000|Overall Study|Physician Decision|3|||
41988099|NCT01313884|75795479|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
41988100|NCT01135459|75795485|FG000|Overall Study|Adverse Event|8|||
41988101|NCT01135459|75795486|FG001|Overall Study|Adverse Event|10|||
42131947|NCT00474630|75942802|FG001|Overall Study|Adverse Event|26|||
42131948|NCT00474630|75942801|FG000|Overall Study|Lost to Follow-up|22|||
42302659|NCT02413333|76137951|FG001|Period 1|Reason Not Specified|1|||
42302660|NCT02413333|76137950|FG000|Period 2|Protocol Deviation|1|||
42238293|NCT00840632|76061001|FG001|First Intervention|Withdrawal by Subject|1|||
42238294|NCT00840632|76061000|FG000|Washout|Withdrawal by Subject|1|||
42238295|NCT00840632|76061001|FG001|Washout|Withdrawal by Subject|1|||
42238296|NCT01602562|76061018|FG000|Overall Study|Adverse Event|3|||
42238297|NCT01602562|76061019|FG001|Overall Study|Adverse Event|1|||
42238298|NCT01602562|76061018|FG000|Overall Study|Physician Decision|1|||
42238299|NCT01602562|76061019|FG001|Overall Study|Physician Decision|1|||
42238300|NCT01602562|76061018|FG000|Overall Study|Withdrawal by Subject|1|||
42238301|NCT01602562|76061019|FG001|Overall Study|Withdrawal by Subject|1|||
42238302|NCT01945775|76061028|FG000|Overall Study|Death|214|||
42238303|NCT01945775|76061029|FG001|Overall Study|Death|98|||
42238304|NCT01945775|76061028|FG000|Overall Study|Lost to Follow-up|12|||
42302661|NCT02413333|76137951|FG001|Period 2|Protocol Deviation|0|||
42302662|NCT02413255|76137974|FG000|Overall Study|Voluntary Withdrawal|0|||
41988102|NCT01135459|75795485|FG000|Overall Study|Lack of Efficacy|3|||
41988103|NCT01135459|75795486|FG001|Overall Study|Lack of Efficacy|1|||
41988104|NCT01135459|75795485|FG000|Overall Study|Withdrawal by Subject|2|||
42131949|NCT00474630|75942802|FG001|Overall Study|Lost to Follow-up|15|||
41988105|NCT01135459|75795486|FG001|Overall Study|Withdrawal by Subject|3|||
41988106|NCT01135459|75795485|FG000|Overall Study|Protocol Violation|5|||
41988107|NCT01135459|75795486|FG001|Overall Study|Protocol Violation|3|||
41988108|NCT01135459|75795485|FG000|Overall Study|Lost to Follow-up|2|||
41988109|NCT01135459|75795486|FG001|Overall Study|Lost to Follow-up|1|||
41988110|NCT01135459|75795485|FG000|Overall Study|Non-compliance to study procedures|0|||
41988111|NCT01135459|75795486|FG001|Overall Study|Non-compliance to study procedures|1|||
41988112|NCT01135459|75795485|FG000|Overall Study|Other than specified|1|||
41988113|NCT01135459|75795486|FG001|Overall Study|Other than specified|1|||
42238305|NCT01945775|76061029|FG001|Overall Study|Lost to Follow-up|7|||
42238306|NCT01945775|76061028|FG000|Overall Study|Withdrawal by Subject|11|||
42238307|NCT01945775|76061029|FG001|Overall Study|Withdrawal by Subject|21|||
42238308|NCT01945775|76061028|FG000|Overall Study|Other|50|||
42238309|NCT01945775|76061029|FG001|Overall Study|Other|18|||
42238310|NCT03072719|76061057|FG000|Overall Study|Adverse Event|1|||
42238311|NCT03072719|76061058|FG001|Overall Study|Adverse Event|1|||
42238312|NCT00835796|76061066|FG000|First Intervention|Withdrawal by Subject|0|||
42238313|NCT00835796|76061067|FG001|First Intervention|Withdrawal by Subject|1|||
42238314|NCT00835640|76061073|FG000|Second Intervention|Protocol Violation|1|||
42238315|NCT00835640|76061074|FG001|Second Intervention|Protocol Violation|0|||
42238316|NCT02942017|76061080|FG000|Overall Study|Adverse Event|0|||
42238317|NCT02942017|76061081|FG001|Overall Study|Adverse Event|1|||
42238318|NCT02942017|76061080|FG000|Overall Study|Withdrawal by Subject|0|||
42238319|NCT02942017|76061081|FG001|Overall Study|Withdrawal by Subject|1|||
42238320|NCT02942017|76061080|FG000|Overall Study|Lost to Follow-up|1|||
42238321|NCT02942017|76061081|FG001|Overall Study|Lost to Follow-up|1|||
42238322|NCT02942017|76061080|FG000|Overall Study|Randomized but not dosed|1|||
42238323|NCT02942017|76061081|FG001|Overall Study|Randomized but not dosed|3|||
42238324|NCT00835406|76061096|FG000|Period: First Intervention|Adverse Event|0|||
41988114|NCT01259284|75795495|FG000|Overall Study|Study Termination|2|||
41988115|NCT01259284|75795496|FG001|Overall Study|Study Termination|0|||
41988116|NCT01259284|75795497|FG002|Overall Study|Study Termination|0|||
41988117|NCT01259245|75795507|FG000|Overall Study|Withdrawal by Subject|27|||
41988118|NCT01259245|75795508|FG001|Overall Study|Withdrawal by Subject|24|||
41988119|NCT01259245|75795507|FG000|Overall Study|Death|1|||
41988120|NCT01259245|75795508|FG001|Overall Study|Death|2|||
41988121|NCT01259089|75795516|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
41988122|NCT01259089|75795517|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
41988123|NCT01259089|75795518|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
41988124|NCT01259089|75795519|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
41988125|NCT01259089|75795520|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
41988126|NCT01259089|75795521|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
42238325|NCT00835406|76061097|FG001|Period: First Intervention|Adverse Event|1|||
42238326|NCT00835406|76061096|FG000|Period: First Intervention|Withdrawal by Subject|2|||
42238327|NCT00835406|76061097|FG001|Period: First Intervention|Withdrawal by Subject|0|||
42238328|NCT00835406|76061096|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
42238329|NCT00835406|76061097|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
41988127|NCT01259089|75795516|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
41988128|NCT01259089|75795517|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
41988129|NCT01259089|75795518|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
41988130|NCT01259089|75795519|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
41988131|NCT01259089|75795520|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
41988132|NCT01259089|75795521|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
41988133|NCT01259089|75795516|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
41988134|NCT01259089|75795517|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
41988135|NCT01259089|75795518|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
41988136|NCT01259089|75795519|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
41988137|NCT01259089|75795520|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
41988138|NCT01259089|75795521|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
42238330|NCT00835172|76061103|FG000|Washout|Protocol Violation|0|||
41988139|NCT01259089|75795516|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
41988140|NCT01259089|75795517|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
42131950|NCT00474630|75942801|FG000|Overall Study|Withdrawal by Subject|21|||
42131951|NCT00474630|75942802|FG001|Overall Study|Withdrawal by Subject|15|||
41988141|NCT01259089|75795518|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
41988142|NCT01259089|75795519|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
41988143|NCT01259089|75795520|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
42131952|NCT00474630|75942801|FG000|Overall Study|Protocol Violation|3|||
42238331|NCT00835172|76061104|FG001|Washout|Protocol Violation|1|||
42238332|NCT01676116|76061110|FG000|Overall Study|Withdrawal criteria|2|||
42238333|NCT01676116|76061111|FG001|Overall Study|Withdrawal criteria|14|||
42238334|NCT01676116|76061110|FG000|Overall Study|Adverse Event|1|||
41988144|NCT01259089|75795521|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
42131953|NCT00474630|75942802|FG001|Overall Study|Protocol Violation|4|||
42131954|NCT00474630|75942801|FG000|Overall Study|Lack of Efficacy|5|||
42131955|NCT00474630|75942802|FG001|Overall Study|Lack of Efficacy|6|||
42131956|NCT00474630|75942801|FG000|Overall Study|Drug noncompliance, other|11|||
42131957|NCT00474630|75942802|FG001|Overall Study|Drug noncompliance, other|4|||
42131958|NCT00392379|75942811|FG000|Overall Study|Withdrawal by Subject|17|||
42131959|NCT00392379|75942812|FG001|Overall Study|Withdrawal by Subject|28|||
42131960|NCT00392379|75942811|FG000|Overall Study|Lost to Follow-up|4|||
42131961|NCT00392379|75942812|FG001|Overall Study|Lost to Follow-up|9|||
42131962|NCT00392379|75942811|FG000|Overall Study|Adverse Event|1|||
42131963|NCT00392379|75942812|FG001|Overall Study|Adverse Event|1|||
42238335|NCT01676116|76061111|FG001|Overall Study|Adverse Event|2|||
42238336|NCT01676116|76061110|FG000|Overall Study|Unclassified|4|||
42238337|NCT01676116|76061111|FG001|Overall Study|Unclassified|10|||
42238338|NCT01676116|76061110|FG000|Overall Study|Protocol Violation|9|||
42238339|NCT01676116|76061111|FG001|Overall Study|Protocol Violation|3|||
42238340|NCT00740480|76061117|FG000|Overall Study|Adverse Event|1|||
42238341|NCT00740480|76061117|FG000|Overall Study|Physician Decision|1|||
42238342|NCT02743520|76061120|FG000|Overall Study|Withdrawal by Subject|1|||
42238343|NCT03001557|76061139|FG000|Core Phase|Randomized but not treated|0|||
42238344|NCT03001557|76061140|FG001|Core Phase|Randomized but not treated|0|||
42238345|NCT03001557|76061141|FG002|Core Phase|Randomized but not treated|1|||
42238346|NCT03001557|76061142|FG003|Core Phase|Randomized but not treated|0|||
41988145|NCT01259089|75795516|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
41988146|NCT01259089|75795517|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
41988147|NCT01259089|75795518|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
42238347|NCT03001557|76061143|FG004|Core Phase|Randomized but not treated|0|||
42238348|NCT03001557|76061144|FG005|Core Phase|Randomized but not treated|0|||
42238349|NCT03001557|76061145|FG006|Core Phase|Randomized but not treated|0|||
42238350|NCT03001557|76061146|FG007|Core Phase|Randomized but not treated|0|||
42238351|NCT03001557|76061139|FG000|Extension Phase|Adverse Event|0|||
42238352|NCT03001557|76061140|FG001|Extension Phase|Adverse Event|0|||
42238353|NCT03001557|76061141|FG002|Extension Phase|Adverse Event|0|||
42238354|NCT03001557|76061142|FG003|Extension Phase|Adverse Event|0|||
42238355|NCT03001557|76061143|FG004|Extension Phase|Adverse Event|0|||
42238356|NCT03001557|76061144|FG005|Extension Phase|Adverse Event|2|||
42238357|NCT03001557|76061145|FG006|Extension Phase|Adverse Event|0|||
42238358|NCT03001557|76061146|FG007|Extension Phase|Adverse Event|0|||
42238359|NCT03001557|76061139|FG000|Extension Phase|Withdrawal by Subject|0|||
42238360|NCT03001557|76061140|FG001|Extension Phase|Withdrawal by Subject|0|||
42238361|NCT03001557|76061141|FG002|Extension Phase|Withdrawal by Subject|0|||
42238362|NCT03001557|76061142|FG003|Extension Phase|Withdrawal by Subject|0|||
42238363|NCT03001557|76061143|FG004|Extension Phase|Withdrawal by Subject|0|||
42238364|NCT03001557|76061144|FG005|Extension Phase|Withdrawal by Subject|1|||
42238365|NCT03001557|76061145|FG006|Extension Phase|Withdrawal by Subject|5|||
42238366|NCT03001557|76061146|FG007|Extension Phase|Withdrawal by Subject|2|||
42238367|NCT03001557|76061139|FG000|Extension Phase|Lost to Follow-up|0|||
42238368|NCT03001557|76061140|FG001|Extension Phase|Lost to Follow-up|0|||
42238369|NCT03001557|76061141|FG002|Extension Phase|Lost to Follow-up|0|||
42238370|NCT03001557|76061142|FG003|Extension Phase|Lost to Follow-up|0|||
42238371|NCT03001557|76061143|FG004|Extension Phase|Lost to Follow-up|0|||
42238372|NCT03001557|76061144|FG005|Extension Phase|Lost to Follow-up|0|||
42238373|NCT03001557|76061145|FG006|Extension Phase|Lost to Follow-up|2|||
42238374|NCT03001557|76061146|FG007|Extension Phase|Lost to Follow-up|1|||
42238375|NCT03001557|76061139|FG000|Extension Phase|Administrative Reason|0|||
42238376|NCT03001557|76061140|FG001|Extension Phase|Administrative Reason|0|||
42238377|NCT03001557|76061141|FG002|Extension Phase|Administrative Reason|0|||
42238378|NCT03001557|76061142|FG003|Extension Phase|Administrative Reason|0|||
41988148|NCT01259089|75795519|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
41988149|NCT01259089|75795520|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
41988150|NCT01259089|75795521|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
42238379|NCT03001557|76061143|FG004|Extension Phase|Administrative Reason|0|||
42238380|NCT03001557|76061144|FG005|Extension Phase|Administrative Reason|1|||
42238381|NCT03001557|76061145|FG006|Extension Phase|Administrative Reason|3|||
42238382|NCT03001557|76061146|FG007|Extension Phase|Administrative Reason|3|||
42238383|NCT03001557|76061139|FG000|Extension Phase|Loss of caregiver|0|||
42238384|NCT03001557|76061140|FG001|Extension Phase|Loss of caregiver|0|||
42238385|NCT03001557|76061141|FG002|Extension Phase|Loss of caregiver|0|||
42238386|NCT03001557|76061142|FG003|Extension Phase|Loss of caregiver|0|||
42238387|NCT03001557|76061143|FG004|Extension Phase|Loss of caregiver|0|||
42238388|NCT03001557|76061144|FG005|Extension Phase|Loss of caregiver|0|||
42238389|NCT03001557|76061145|FG006|Extension Phase|Loss of caregiver|1|||
42238390|NCT03001557|76061146|FG007|Extension Phase|Loss of caregiver|0|||
42238391|NCT03001557|76061139|FG000|Extension Phase|Others|0|||
42238392|NCT03001557|76061140|FG001|Extension Phase|Others|0|||
42238393|NCT03001557|76061141|FG002|Extension Phase|Others|0|||
42238394|NCT03001557|76061142|FG003|Extension Phase|Others|0|||
42238395|NCT03001557|76061143|FG004|Extension Phase|Others|0|||
42238396|NCT03001557|76061144|FG005|Extension Phase|Others|1|||
42238397|NCT03001557|76061145|FG006|Extension Phase|Others|3|||
42238398|NCT03001557|76061146|FG007|Extension Phase|Others|0|||
42238399|NCT00830336|76061183|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
42238400|NCT00830336|76061184|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
42238401|NCT00830258|76061190|FG000|First Intervention|Adverse Event|1|||
42238402|NCT00830258|76061191|FG001|First Intervention|Adverse Event|0|||
42238403|NCT00830258|76061190|FG000|Washout: 7 Days|Protocol Violation|1|||
42238404|NCT00830258|76061191|FG001|Washout: 7 Days|Protocol Violation|0|||
42238405|NCT03349775|76061197|FG000|Overall Study|Side Effects|1|||
42238406|NCT03349775|76061198|FG001|Overall Study|Side Effects|2|||
42238407|NCT03349775|76061197|FG000|Overall Study|Withdrawal by Subject|1|||
42238408|NCT03349775|76061198|FG001|Overall Study|Withdrawal by Subject|1|||
42238409|NCT03349775|76061197|FG000|Overall Study|No primary outcome measurements|0|||
42238410|NCT03349775|76061198|FG001|Overall Study|No primary outcome measurements|1|||
42238411|NCT00830024|76061206|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
42238412|NCT00830024|76061207|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
42238413|NCT00829868|76061213|FG000|Washout|Physician Decision|1|||
42238414|NCT00829868|76061214|FG001|Washout|Physician Decision|0|||
42238415|NCT00829790|76061220|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
42238416|NCT00829790|76061221|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
42238417|NCT03207815|76061227|FG000|Overall Study|Protocol Violation|3|||
42238418|NCT03207815|76061228|FG001|Overall Study|Protocol Violation|1|||
42238419|NCT03207815|76061227|FG000|Overall Study|Adverse Event|1|||
42238420|NCT03207815|76061228|FG001|Overall Study|Adverse Event|2|||
42238421|NCT03207815|76061227|FG000|Overall Study|Lost to Follow-up|1|||
42238422|NCT03207815|76061228|FG001|Overall Study|Lost to Follow-up|2|||
42238423|NCT03207815|76061227|FG000|Overall Study|Investigator's Discretion|1|||
42238424|NCT03207815|76061228|FG001|Overall Study|Investigator's Discretion|1|||
42238425|NCT03207815|76061227|FG000|Overall Study|Lack of Efficacy|0|||
42238426|NCT03207815|76061228|FG001|Overall Study|Lack of Efficacy|1|||
42238427|NCT03207815|76061227|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
42238428|NCT03207815|76061228|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
42238429|NCT03207815|76061227|FG000|Overall Study|Withdrew Consent|1|||
42238430|NCT03207815|76061228|FG001|Overall Study|Withdrew Consent|0|||
42238431|NCT02911935|76061236|FG000|Overall Study|Lost to Follow-up|5|||
42238432|NCT02911935|76061237|FG001|Overall Study|Lost to Follow-up|7|||
42238433|NCT00829712|76061245|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
42238434|NCT00829712|76061246|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
42238435|NCT03069989|76061261|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
42238436|NCT03069989|76061262|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
42238437|NCT02698163|76061289|FG000|Overall Study|Lost to Follow-up|0|||
42238438|NCT02698163|76061290|FG001|Overall Study|Lost to Follow-up|1|||
42238439|NCT03817190|76061298|FG000|Overall Study|Early Termination|13|||
42238440|NCT03817190|76061299|FG001|Overall Study|Early Termination|20|||
42238441|NCT03817190|76061298|FG000|Overall Study|Adverse Event|10|||
42238442|NCT03817190|76061299|FG001|Overall Study|Adverse Event|17|||
42238443|NCT03817190|76061298|FG000|Overall Study|Withdrawal by Subject|12|||
42238444|NCT03817190|76061299|FG001|Overall Study|Withdrawal by Subject|8|||
42238445|NCT03817190|76061298|FG000|Overall Study|Lost to Follow-up|11|||
42238446|NCT03817190|76061299|FG001|Overall Study|Lost to Follow-up|7|||
42238447|NCT03817190|76061298|FG000|Overall Study|Lack of Efficacy|7|||
42238448|NCT03817190|76061299|FG001|Overall Study|Lack of Efficacy|5|||
42238449|NCT03817190|76061298|FG000|Overall Study|Investigator Decision|5|||
42238450|NCT03817190|76061299|FG001|Overall Study|Investigator Decision|1|||
42238451|NCT03817190|76061298|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
42238452|NCT03817190|76061299|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
42238453|NCT03817190|76061298|FG000|Overall Study|Lack of Contact|1|||
42238454|NCT03817190|76061299|FG001|Overall Study|Lack of Contact|0|||
42302663|NCT02413255|76137975|FG001|Overall Study|Voluntary Withdrawal|0|||
42131964|NCT00497874|75942820|FG000|Overall Study|Withdrawal by Subject|48|||
42238455|NCT03817190|76061298|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
42238456|NCT03817190|76061299|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
42238457|NCT03797222|76061318|FG000|Overall Study|Withdrawal by Subject|1|||
42238458|NCT02742818|76061328|FG000|Overall Study|Adverse Event|0|||
42238459|NCT02742818|76061329|FG001|Overall Study|Adverse Event|1|||
42238460|NCT02742818|76061328|FG000|Overall Study|Protocol Violation|0|||
42238461|NCT02742818|76061329|FG001|Overall Study|Protocol Violation|1|||
42238462|NCT03069365|76061337|FG000|Overall Study|Adverse Event|1|||
42238463|NCT03065933|76061341|FG000|Overall Study|study terminated|5|||
42238464|NCT04256629|76061351|FG000|Overall Study|Adverse Event|0|||
42238465|NCT04256629|76061352|FG001|Overall Study|Adverse Event|0|||
42238466|NCT04256629|76061353|FG002|Overall Study|Adverse Event|0|||
42238467|NCT04256629|76061354|FG003|Overall Study|Adverse Event|0|||
42238468|NCT04256629|76061355|FG004|Overall Study|Adverse Event|0|||
42238469|NCT04256629|76061356|FG005|Overall Study|Adverse Event|1|||
42238470|NCT04256629|76061351|FG000|Overall Study|Protocol Violation|0|||
42238471|NCT04256629|76061352|FG001|Overall Study|Protocol Violation|1|||
42238472|NCT04256629|76061353|FG002|Overall Study|Protocol Violation|0|||
42238473|NCT04256629|76061354|FG003|Overall Study|Protocol Violation|0|||
42238474|NCT04256629|76061355|FG004|Overall Study|Protocol Violation|0|||
42238475|NCT04256629|76061356|FG005|Overall Study|Protocol Violation|0|||
42238476|NCT01346293|76061366|FG000|Overall Study|Protocol Violation|30|||
42238477|NCT01346293|76061367|FG001|Overall Study|Protocol Violation|9|||
42238478|NCT01346293|76061366|FG000|Overall Study|Lost to Follow-up|21|||
42238479|NCT01346293|76061367|FG001|Overall Study|Lost to Follow-up|8|||
42238480|NCT01346293|76061366|FG000|Overall Study|Withdrawal by Subject|15|||
42238481|NCT01346293|76061367|FG001|Overall Study|Withdrawal by Subject|4|||
42238482|NCT01346293|76061366|FG000|Overall Study|Other|1|||
42238483|NCT01346293|76061367|FG001|Overall Study|Other|0|||
42238484|NCT03502187|76061387|FG000|Overall Study|Withdrawal by Subject|4|||
42238485|NCT03502187|76061388|FG001|Overall Study|Withdrawal by Subject|3|||
42238486|NCT03502187|76061389|FG002|Overall Study|Withdrawal by Subject|3|||
42238487|NCT03502187|76061387|FG000|Overall Study|Lost to Follow-up|5|||
42238488|NCT03502187|76061388|FG001|Overall Study|Lost to Follow-up|4|||
42238489|NCT03502187|76061389|FG002|Overall Study|Lost to Follow-up|5|||
42238490|NCT03058705|76061397|FG000|Overall Study|Withdrawal by Subject|2|||
42238491|NCT03058705|76061397|FG000|Overall Study|Physician Decision|2|||
42238492|NCT02998671|76061406|FG000|Period 1|Study Terminated By Sponsor|2|||
42238493|NCT02998671|76061407|FG001|Period 1|Study Terminated By Sponsor|1|||
42238494|NCT02998671|76061408|FG002|Period 1|Study Terminated By Sponsor|0|||
42238495|NCT02998671|76061409|FG003|Period 1|Study Terminated By Sponsor|0|||
42238496|NCT02998671|76061410|FG004|Period 1|Study Terminated By Sponsor|1|||
42238497|NCT02998671|76061406|FG000|Period 1|Withdrawal by Subject|1|||
42238498|NCT02998671|76061407|FG001|Period 1|Withdrawal by Subject|2|||
42238499|NCT02998671|76061408|FG002|Period 1|Withdrawal by Subject|0|||
42238500|NCT02998671|76061409|FG003|Period 1|Withdrawal by Subject|0|||
42238501|NCT02998671|76061410|FG004|Period 1|Withdrawal by Subject|2|||
42238502|NCT02998671|76061406|FG000|Period 1|Pregnancy|1|||
42238503|NCT02998671|76061407|FG001|Period 1|Pregnancy|0|||
42238504|NCT02998671|76061408|FG002|Period 1|Pregnancy|0|||
42238505|NCT02998671|76061409|FG003|Period 1|Pregnancy|0|||
42238506|NCT02998671|76061410|FG004|Period 1|Pregnancy|0|||
42238507|NCT02998671|76061406|FG000|Period 1|Adverse Event|0|||
42238508|NCT02998671|76061407|FG001|Period 1|Adverse Event|0|||
42238509|NCT02998671|76061408|FG002|Period 1|Adverse Event|0|||
42238510|NCT02998671|76061409|FG003|Period 1|Adverse Event|0|||
42238511|NCT02998671|76061410|FG004|Period 1|Adverse Event|1|||
42238512|NCT02998671|76061406|FG000|Period 2|Adverse Event|0|||
42238513|NCT02998671|76061407|FG001|Period 2|Adverse Event|1|||
42238514|NCT02998671|76061408|FG002|Period 2|Adverse Event|0|||
42238515|NCT02998671|76061409|FG003|Period 2|Adverse Event|0|||
42238516|NCT02998671|76061410|FG004|Period 2|Adverse Event|0|||
42238517|NCT02998671|76061406|FG000|Period 2|Study Terminated By Sponsor|3|||
42238518|NCT02998671|76061407|FG001|Period 2|Study Terminated By Sponsor|5|||
42238519|NCT02998671|76061408|FG002|Period 2|Study Terminated By Sponsor|1|||
42238520|NCT02998671|76061409|FG003|Period 2|Study Terminated By Sponsor|3|||
42238521|NCT02998671|76061410|FG004|Period 2|Study Terminated By Sponsor|0|||
41988151|NCT01259089|75795516|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
41988152|NCT01259089|75795517|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
41988153|NCT01259089|75795518|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
41988154|NCT01259089|75795519|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
41988155|NCT01259089|75795520|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
42302664|NCT02413255|76137976|FG002|Overall Study|Voluntary Withdrawal|0|||
42302665|NCT02413255|76137977|FG003|Overall Study|Voluntary Withdrawal|0|||
42238522|NCT02998671|76061406|FG000|Period 2|Withdrawal by Subject|0|||
42238523|NCT02998671|76061407|FG001|Period 2|Withdrawal by Subject|1|||
42238524|NCT02998671|76061408|FG002|Period 2|Withdrawal by Subject|0|||
42238525|NCT02998671|76061409|FG003|Period 2|Withdrawal by Subject|0|||
42238526|NCT02998671|76061410|FG004|Period 2|Withdrawal by Subject|0|||
42238527|NCT02998671|76061406|FG000|Period 2|Lost to Follow-up|0|||
42238528|NCT02998671|76061407|FG001|Period 2|Lost to Follow-up|0|||
42238529|NCT02998671|76061408|FG002|Period 2|Lost to Follow-up|0|||
42238530|NCT02998671|76061409|FG003|Period 2|Lost to Follow-up|1|||
42238531|NCT02998671|76061410|FG004|Period 2|Lost to Follow-up|0|||
42238532|NCT02660827|76061430|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
42238533|NCT02660827|76061430|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
42238534|NCT02660827|76061430|FG000|From Study to End of Continued Access|Adverse Event|3|||
42302666|NCT02413255|76137978|FG004|Overall Study|Voluntary Withdrawal|0|||
42238535|NCT02660827|76061430|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
42238536|NCT02660827|76061430|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
42238537|NCT02660827|76061430|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
42238538|NCT02660827|76061430|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
42238539|NCT02660827|76061430|FG000|Period 2: Continued Access Period|Adverse Event|3|||
42238540|NCT01069419|76061451|FG000|Overall Study|Adverse Event|233|||
42238541|NCT01069419|76061451|FG000|Overall Study|Lack of Efficacy|332|||
42238542|NCT01069419|76061451|FG000|Overall Study|Lost to Follow-up|49|||
42238543|NCT01069419|76061451|FG000|Overall Study|Remission of disease|11|||
42238544|NCT01069419|76061451|FG000|Overall Study|Withdrawal by Subject|34|||
42238545|NCT01069419|76061451|FG000|Overall Study|Other Reason|43|||
42238546|NCT01069419|76061451|FG000|Overall Study|Missing termination information|13|||
42238547|NCT01069341|76061455|FG000|Overall Study|Lost to Follow-up|1|||
42238548|NCT02996097|76061459|FG000|Overall Study|Lost to Follow-up|11|||
42238549|NCT02996097|76061460|FG001|Overall Study|Lost to Follow-up|11|||
42238550|NCT02992899|76061476|FG000|Overall Study|Withdrawal by Subject|1|||
42238551|NCT02992899|76061477|FG001|Overall Study|Withdrawal by Subject|0|||
42238552|NCT02992899|76061476|FG000|Overall Study|Lost to Follow-up|1|||
42238553|NCT02992899|76061477|FG001|Overall Study|Lost to Follow-up|3|||
42238554|NCT01602484|76061485|FG000|Overall Study|Airway issues unrelated to study|0|||
42238555|NCT01602484|76061486|FG001|Overall Study|Airway issues unrelated to study|1|||
42238556|NCT02989389|76061506|FG000|Period 1|Lost to Follow-up|0|||
42238557|NCT02989389|76061507|FG001|Period 1|Lost to Follow-up|1|||
42238558|NCT02989389|76061508|FG002|Period 1|Lost to Follow-up|0|||
42238559|NCT02989389|76061509|FG003|Period 1|Lost to Follow-up|0|||
42238560|NCT02989389|76061510|FG004|Period 1|Lost to Follow-up|0|||
42238561|NCT02989389|76061511|FG005|Period 1|Lost to Follow-up|0|||
42238562|NCT02989389|76061512|FG006|Period 1|Lost to Follow-up|0|||
42238563|NCT02989389|76061513|FG007|Period 1|Lost to Follow-up|0|||
42238564|NCT02989389|76061514|FG008|Period 1|Lost to Follow-up|0|||
42238565|NCT02989389|76061515|FG009|Period 1|Lost to Follow-up|0|||
42238566|NCT02989389|76061506|FG000|Period 1|Physician Decision|0|||
42238567|NCT02989389|76061507|FG001|Period 1|Physician Decision|0|||
42238568|NCT02989389|76061508|FG002|Period 1|Physician Decision|0|||
42238569|NCT02989389|76061509|FG003|Period 1|Physician Decision|0|||
42238570|NCT02989389|76061510|FG004|Period 1|Physician Decision|0|||
42238571|NCT02989389|76061511|FG005|Period 1|Physician Decision|0|||
42238572|NCT02989389|76061512|FG006|Period 1|Physician Decision|0|||
42238573|NCT02989389|76061513|FG007|Period 1|Physician Decision|0|||
41988156|NCT01259089|75795521|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
42302667|NCT02413255|76137979|FG005|Overall Study|Voluntary Withdrawal|0|||
42302668|NCT02413255|76137980|FG006|Overall Study|Voluntary Withdrawal|0|||
42302669|NCT02413255|76137981|FG007|Overall Study|Voluntary Withdrawal|0|||
42302670|NCT02413255|76137982|FG008|Overall Study|Voluntary Withdrawal|0|||
42302671|NCT02413255|76137983|FG009|Overall Study|Voluntary Withdrawal|0|||
42302672|NCT02413255|76137984|FG010|Overall Study|Voluntary Withdrawal|0|||
41988157|NCT01259089|75795516|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
41988158|NCT01259089|75795517|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
41988159|NCT01259089|75795518|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
41988160|NCT01259089|75795519|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
42302673|NCT02413255|76137985|FG011|Overall Study|Voluntary Withdrawal|0|||
42302674|NCT02413255|76137986|FG012|Overall Study|Voluntary Withdrawal|0|||
42302675|NCT02413255|76137987|FG013|Overall Study|Voluntary Withdrawal|0|||
42302676|NCT02413255|76137988|FG014|Overall Study|Voluntary Withdrawal|1|||
41988161|NCT01259089|75795520|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
41988162|NCT01259089|75795521|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
41988163|NCT01259089|75795516|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
41988164|NCT01259089|75795517|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
41988165|NCT01259089|75795518|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
41988166|NCT01259089|75795519|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
41988167|NCT01259089|75795520|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
42032703|NCT01076010|75840967|FG000|Overall Study|Significant Surgical Procedure|0|||
42032704|NCT01076010|75840968|FG001|Overall Study|Significant Surgical Procedure|1|||
42032705|NCT01076010|75840969|FG002|Overall Study|Significant Surgical Procedure|0|||
42238574|NCT02989389|76061514|FG008|Period 1|Physician Decision|1|||
42238575|NCT02989389|76061515|FG009|Period 1|Physician Decision|0|||
42238576|NCT02653300|76061555|FG000|Overall Study|Withdrawal by Subject|2|||
42238577|NCT00430508|76061563|FG000|Overall Study|Adverse Event|2|||
42238578|NCT00430508|76061564|FG001|Overall Study|Adverse Event|3|||
42238579|NCT00430508|76061565|FG002|Overall Study|Adverse Event|5|||
42238580|NCT00430508|76061566|FG003|Overall Study|Adverse Event|3|||
42302677|NCT02413255|76137989|FG015|Overall Study|Voluntary Withdrawal|0|||
41988168|NCT01259089|75795521|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
42238581|NCT00430508|76061563|FG000|Overall Study|Withdrawal by Subject|0|||
42238582|NCT00430508|76061564|FG001|Overall Study|Withdrawal by Subject|1|||
42238583|NCT00430508|76061565|FG002|Overall Study|Withdrawal by Subject|1|||
42238584|NCT00430508|76061566|FG003|Overall Study|Withdrawal by Subject|1|||
42238585|NCT00430508|76061563|FG000|Overall Study|responder at visit 4|0|||
42238586|NCT00430508|76061564|FG001|Overall Study|responder at visit 4|0|||
42238587|NCT00430508|76061565|FG002|Overall Study|responder at visit 4|2|||
42238588|NCT00430508|76061566|FG003|Overall Study|responder at visit 4|0|||
42238589|NCT00430508|76061563|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
42238590|NCT00430508|76061564|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
42238591|NCT00430508|76061565|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
42238592|NCT00430508|76061566|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
42238593|NCT00430508|76061563|FG000|Overall Study|Other|1|||
42238594|NCT00430508|76061564|FG001|Overall Study|Other|1|||
42238595|NCT00430508|76061565|FG002|Overall Study|Other|3|||
42238596|NCT00430508|76061566|FG003|Overall Study|Other|0|||
42238597|NCT02988219|76061574|FG000|Overall Study|Lack of Efficacy|1|||
42238598|NCT02988219|76061575|FG001|Overall Study|Lack of Efficacy|1|||
42238599|NCT02988219|76061574|FG000|Overall Study|Withdrawal by Subject|0|||
42238600|NCT02988219|76061575|FG001|Overall Study|Withdrawal by Subject|2|||
42238601|NCT01346059|76061583|FG000|Overall Study|Withdrawal by Subject|1|||
42238602|NCT01346059|76061584|FG001|Overall Study|Withdrawal by Subject|0|||
42238603|NCT01318915|76061590|FG000|Overall Study|Lost to Follow-up|1|||
42238604|NCT02987205|76061596|FG000|Overall Study|Adverse Event|1|||
42238605|NCT02987205|76061596|FG000|Overall Study|Withdrawal by Subject|3|||
42238606|NCT02926937|76061618|FG000|Overall Study|Adverse Event|0|||
42238607|NCT02926937|76061619|FG001|Overall Study|Adverse Event|1|||
42238608|NCT02926937|76061620|FG002|Overall Study|Adverse Event|1|||
42238609|NCT02926937|76061618|FG000|Overall Study|Poor Compliance to Protocol|1|||
42238610|NCT02926937|76061619|FG001|Overall Study|Poor Compliance to Protocol|0|||
42238611|NCT02926937|76061620|FG002|Overall Study|Poor Compliance to Protocol|0|||
42238612|NCT02926937|76061618|FG000|Overall Study|Lost to Follow-up|4|||
42238613|NCT02926937|76061619|FG001|Overall Study|Lost to Follow-up|5|||
42238614|NCT02926937|76061620|FG002|Overall Study|Lost to Follow-up|0|||
41988169|NCT01259089|75795516|FG000|Survival Follow up for Two Years|Death|3|||
42238615|NCT02926937|76061618|FG000|Overall Study|At the Participant's own Request|11|||
42238616|NCT02926937|76061619|FG001|Overall Study|At the Participant's own Request|5|||
42238617|NCT02926937|76061620|FG002|Overall Study|At the Participant's own Request|8|||
42238618|NCT02926937|76061618|FG000|Overall Study|Reason not Specified|3|||
42238619|NCT02926937|76061619|FG001|Overall Study|Reason not Specified|4|||
42238620|NCT02926937|76061620|FG002|Overall Study|Reason not Specified|2|||
42238621|NCT00151892|76061631|FG000|Overall Study|Lack of Efficacy|50|||
42238622|NCT00151892|76061632|FG001|Overall Study|Lack of Efficacy|57|||
42238623|NCT00151892|76061631|FG000|Overall Study|Patient request|10|||
42238624|NCT00151892|76061632|FG001|Overall Study|Patient request|7|||
42238625|NCT00151892|76061631|FG000|Overall Study|Lost to Follow-up|5|||
42238626|NCT00151892|76061632|FG001|Overall Study|Lost to Follow-up|10|||
42238627|NCT00151892|76061631|FG000|Overall Study|Adverse Event|6|||
42238628|NCT00151892|76061632|FG001|Overall Study|Adverse Event|3|||
42238629|NCT00151892|76061631|FG000|Overall Study|Protocol Violation|3|||
41988170|NCT01259089|75795517|FG001|Survival Follow up for Two Years|Death|2|||
41988171|NCT01259089|75795518|FG002|Survival Follow up for Two Years|Death|2|||
41988172|NCT01259089|75795519|FG003|Survival Follow up for Two Years|Death|3|||
41988173|NCT01259089|75795520|FG004|Survival Follow up for Two Years|Death|6|||
41988174|NCT01259089|75795521|FG005|Survival Follow up for Two Years|Death|13|||
41988175|NCT01259089|75795516|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
41988176|NCT01259089|75795517|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
41988177|NCT01259089|75795518|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
41988178|NCT01259089|75795519|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
41988179|NCT01259089|75795520|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
41988180|NCT01259089|75795521|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
41988181|NCT01259089|75795516|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
41988182|NCT01259089|75795517|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
41988183|NCT01259089|75795518|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
41988184|NCT01259089|75795519|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
41988185|NCT01259089|75795520|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
41988186|NCT01259089|75795521|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
42238630|NCT00151892|76061632|FG001|Overall Study|Protocol Violation|3|||
42238631|NCT00151892|76061631|FG000|Overall Study|Non-compliance|0|||
42238632|NCT00151892|76061632|FG001|Overall Study|Non-compliance|1|||
42238633|NCT00151892|76061631|FG000|Overall Study|Pregnancy|0|||
42238634|NCT00151892|76061632|FG001|Overall Study|Pregnancy|1|||
42238635|NCT00151892|76061631|FG000|Overall Study|Did not return for a visit|1|||
42238636|NCT00151892|76061632|FG001|Overall Study|Did not return for a visit|0|||
42238637|NCT00151892|76061631|FG000|Overall Study|Used prohibited corticosteroids|1|||
42238638|NCT00151892|76061632|FG001|Overall Study|Used prohibited corticosteroids|0|||
42238639|NCT00151892|76061631|FG000|Overall Study|Lack of study medication at center|0|||
42238640|NCT00151892|76061632|FG001|Overall Study|Lack of study medication at center|1|||
42238641|NCT03055195|76061656|FG000|Overall Study|Lack of Efficacy|1|||
42238642|NCT03055195|76061657|FG001|Overall Study|Lack of Efficacy|0|||
42238643|NCT03055195|76061656|FG000|Overall Study|Withdrawal by Subject|6|||
42238644|NCT03055195|76061657|FG001|Overall Study|Withdrawal by Subject|7|||
42238645|NCT03055195|76061656|FG000|Overall Study|Study Terminated by Sponsor|2|||
42238646|NCT03055195|76061657|FG001|Overall Study|Study Terminated by Sponsor|6|||
42238647|NCT03055195|76061656|FG000|Overall Study|Protocol Violation|2|||
42238648|NCT03055195|76061657|FG001|Overall Study|Protocol Violation|1|||
42238649|NCT03055195|76061656|FG000|Overall Study|Physician Decision|1|||
42238650|NCT03055195|76061657|FG001|Overall Study|Physician Decision|0|||
42238651|NCT02921919|76061665|FG000|Overall Study|Other|5|||
42238652|NCT02921919|76061666|FG001|Overall Study|Other|6|||
42238653|NCT02921919|76061665|FG000|Overall Study|Lost to Follow-up|0|||
42238654|NCT02921919|76061666|FG001|Overall Study|Lost to Follow-up|1|||
42238655|NCT02921919|76061665|FG000|Overall Study|Withdrawal by Subject|5|||
42238656|NCT02921919|76061666|FG001|Overall Study|Withdrawal by Subject|1|||
42238657|NCT02921919|76061665|FG000|Overall Study|Disease Progression|47|||
42238658|NCT02921919|76061666|FG001|Overall Study|Disease Progression|38|||
42238659|NCT02921919|76061665|FG000|Overall Study|Physician Decision|3|||
42238660|NCT02921919|76061666|FG001|Overall Study|Physician Decision|2|||
42238661|NCT02921919|76061665|FG000|Overall Study|Adverse Event|6|||
42238662|NCT02921919|76061666|FG001|Overall Study|Adverse Event|4|||
42238663|NCT02910219|76061688|FG000|Overall Study|Withdrawal by Subject|1|||
42238664|NCT02910219|76061689|FG001|Overall Study|Withdrawal by Subject|1|||
42238665|NCT01068717|76061695|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
42238666|NCT01068717|76061696|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
42238667|NCT01068717|76061697|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
42238668|NCT01068717|76061698|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
42238669|NCT02921763|76061712|FG000|Overall Study|Adverse Event|4|||
42238670|NCT02921763|76061712|FG000|Overall Study|Lost to Follow-up|4|||
42238671|NCT02921763|76061712|FG000|Overall Study|Lack of Efficacy|3|||
42238672|NCT02921763|76061712|FG000|Overall Study|Protocol Violation|2|||
42238673|NCT02921763|76061712|FG000|Overall Study|Withdrawal by Subject|2|||
42238674|NCT02921763|76061712|FG000|Overall Study|Physician Decision|1|||
42238675|NCT02921763|76061712|FG000|Overall Study|No data obtained|2|||
42238676|NCT01318135|76061734|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
42238677|NCT01318135|76061735|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
42238678|NCT01318135|76061736|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
42238679|NCT01318135|76061737|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
42238680|NCT01318135|76061738|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
42238681|NCT01318135|76061739|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
42238682|NCT01318135|76061740|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
42238683|NCT01318135|76061741|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
42238684|NCT01318135|76061734|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
42238685|NCT01318135|76061735|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
42238686|NCT01318135|76061736|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
42238687|NCT01318135|76061737|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
42238688|NCT01318135|76061738|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
42238689|NCT01318135|76061739|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
42238690|NCT01318135|76061740|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
42238691|NCT01318135|76061741|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
42238692|NCT01318135|76061734|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
42238693|NCT01318135|76061735|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
42238694|NCT01318135|76061736|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
42238695|NCT01318135|76061737|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
42238696|NCT01318135|76061738|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
42238697|NCT01318135|76061739|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
42238698|NCT01318135|76061740|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
42238699|NCT01318135|76061741|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
42238700|NCT01318135|76061734|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
42238701|NCT01318135|76061735|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
42238702|NCT01318135|76061736|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
42238703|NCT01318135|76061737|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
42238704|NCT01318135|76061738|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
42238705|NCT01318135|76061739|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
42238706|NCT01318135|76061740|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
42238707|NCT01318135|76061741|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
42238708|NCT01318135|76061734|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
42238709|NCT01318135|76061735|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
42238710|NCT01318135|76061736|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
42238711|NCT01318135|76061737|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
42238712|NCT01318135|76061738|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
42238713|NCT01318135|76061739|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
42032706|NCT01076010|75840967|FG000|Overall Study|Protocol Violation|0|||
42032707|NCT01076010|75840968|FG001|Overall Study|Protocol Violation|1|||
42032708|NCT01076010|75840969|FG002|Overall Study|Protocol Violation|0|||
42032709|NCT01076010|75840967|FG000|Overall Study|Noncompliance|1|||
42032710|NCT01076010|75840968|FG001|Overall Study|Noncompliance|1|||
42032711|NCT01076010|75840969|FG002|Overall Study|Noncompliance|0|||
42032712|NCT01076010|75840967|FG000|Overall Study|Withdrawal by Subject|3|||
42032713|NCT01076010|75840968|FG001|Overall Study|Withdrawal by Subject|0|||
42032714|NCT01076010|75840969|FG002|Overall Study|Withdrawal by Subject|1|||
42032715|NCT01076010|75840967|FG000|Overall Study|Other|5|||
42131965|NCT00497874|75942821|FG001|Overall Study|Withdrawal by Subject|17|||
42238714|NCT01318135|76061740|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
42238715|NCT01318135|76061741|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
42238716|NCT01318135|76061734|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
42238717|NCT01318135|76061735|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
42238718|NCT01318135|76061736|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
42238719|NCT01318135|76061737|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
42238720|NCT01318135|76061738|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
42238721|NCT01318135|76061739|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
42238722|NCT01318135|76061740|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
42238723|NCT01318135|76061741|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
42238724|NCT01318135|76061734|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
42238725|NCT01318135|76061735|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
42238726|NCT01318135|76061736|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
42238727|NCT01318135|76061737|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
42238728|NCT01318135|76061738|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
42238729|NCT01318135|76061739|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
42238730|NCT01318135|76061740|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
42238731|NCT01318135|76061741|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
42238732|NCT02922153|76061753|FG000|Overall Study|Death|8|||
42238733|NCT02922153|76061754|FG001|Overall Study|Death|1|||
42032716|NCT01076010|75840968|FG001|Overall Study|Other|2|||
42032717|NCT01076010|75840969|FG002|Overall Study|Other|0|||
42238734|NCT02922153|76061753|FG000|Overall Study|Lost to Follow-up|1|||
42238735|NCT02922153|76061754|FG001|Overall Study|Lost to Follow-up|0|||
42238736|NCT02922153|76061753|FG000|Overall Study|Physician Decision|1|||
42238737|NCT02922153|76061754|FG001|Overall Study|Physician Decision|1|||
42238738|NCT02920983|76061760|FG000|Dispense 1|Unacceptable Lens Fit|0|||
42238739|NCT02920983|76061761|FG001|Dispense 1|Unacceptable Lens Fit|0|||
42238740|NCT02920983|76061762|FG002|Dispense 1|Unacceptable Lens Fit|0|||
42238741|NCT02920983|76061763|FG003|Dispense 1|Unacceptable Lens Fit|0|||
42238742|NCT02920983|76061764|FG004|Dispense 1|Unacceptable Lens Fit|1|||
42238743|NCT02920983|76061765|FG005|Dispense 1|Unacceptable Lens Fit|0|||
42238744|NCT02920983|76061760|FG000|Dispense 2|Unscceptable lens fit|1|||
42238745|NCT02920983|76061761|FG001|Dispense 2|Unscceptable lens fit|0|||
42238746|NCT02920983|76061762|FG002|Dispense 2|Unscceptable lens fit|0|||
42238747|NCT02920983|76061763|FG003|Dispense 2|Unscceptable lens fit|0|||
42238748|NCT02920983|76061764|FG004|Dispense 2|Unscceptable lens fit|1|||
42238749|NCT02920983|76061765|FG005|Dispense 2|Unscceptable lens fit|0|||
42238750|NCT02920983|76061760|FG000|Dispense 3|Unacceptable Lens Fit|1|||
42238751|NCT02920983|76061761|FG001|Dispense 3|Unacceptable Lens Fit|1|||
42238752|NCT02920983|76061762|FG002|Dispense 3|Unacceptable Lens Fit|0|||
42238753|NCT02920983|76061763|FG003|Dispense 3|Unacceptable Lens Fit|0|||
42238754|NCT02920983|76061764|FG004|Dispense 3|Unacceptable Lens Fit|1|||
42238755|NCT02920983|76061765|FG005|Dispense 3|Unacceptable Lens Fit|0|||
42238756|NCT02654002|76061782|FG000|Overall Study|Adverse Event|0|||
42238757|NCT02654002|76061783|FG001|Overall Study|Adverse Event|0|||
42238758|NCT02654002|76061784|FG002|Overall Study|Adverse Event|0|||
42238759|NCT02654002|76061785|FG003|Overall Study|Adverse Event|0|||
42238760|NCT02654002|76061786|FG004|Overall Study|Adverse Event|0|||
42238761|NCT02654002|76061787|FG005|Overall Study|Adverse Event|0|||
42238762|NCT02654002|76061788|FG006|Overall Study|Adverse Event|1|||
42238763|NCT02654002|76061789|FG007|Overall Study|Adverse Event|0|||
42238764|NCT02654002|76061790|FG008|Overall Study|Adverse Event|0|||
42238765|NCT02654002|76061782|FG000|Overall Study|Withdrew Consent|0|||
42238766|NCT02654002|76061783|FG001|Overall Study|Withdrew Consent|0|||
42238767|NCT02654002|76061784|FG002|Overall Study|Withdrew Consent|0|||
42238768|NCT02654002|76061785|FG003|Overall Study|Withdrew Consent|0|||
42238769|NCT02654002|76061786|FG004|Overall Study|Withdrew Consent|0|||
42238770|NCT02654002|76061787|FG005|Overall Study|Withdrew Consent|1|||
42238771|NCT02654002|76061788|FG006|Overall Study|Withdrew Consent|0|||
42238772|NCT02654002|76061789|FG007|Overall Study|Withdrew Consent|1|||
42238773|NCT02654002|76061790|FG008|Overall Study|Withdrew Consent|0|||
42238774|NCT01675492|76061825|FG000|Overall Study|study completed early - product approval|42|||
42238775|NCT03924622|76061836|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
42238776|NCT03924622|76061837|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
42238777|NCT03924622|76061838|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
42238778|NCT03924622|76061839|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
42238779|NCT03924622|76061840|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
42238780|NCT03924622|76061841|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
42238781|NCT04044664|76061858|FG000|Stage 1|Adverse Event|3|||
42238782|NCT04044664|76061859|FG001|Stage 1|Adverse Event|3|||
42238783|NCT04044664|76061860|FG002|Stage 1|Adverse Event|1|||
42238784|NCT04044664|76061858|FG000|Stage 1|Lost to Follow-up|3|||
42238785|NCT04044664|76061859|FG001|Stage 1|Lost to Follow-up|2|||
42238786|NCT04044664|76061860|FG002|Stage 1|Lost to Follow-up|2|||
42238787|NCT04044664|76061858|FG000|Stage 1|Withdrawal by Subject|9|||
42238788|NCT04044664|76061859|FG001|Stage 1|Withdrawal by Subject|1|||
42238789|NCT04044664|76061860|FG002|Stage 1|Withdrawal by Subject|0|||
41988187|NCT01258738|75795537|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
42238790|NCT04044664|76061858|FG000|Stage 1|noncompliance, personal reason|2|||
42238791|NCT04044664|76061859|FG001|Stage 1|noncompliance, personal reason|0|||
42238792|NCT04044664|76061860|FG002|Stage 1|noncompliance, personal reason|0|||
42238793|NCT04044664|76061858|FG000|Stage 1|randomization error|0|||
42238794|NCT04044664|76061859|FG001|Stage 1|randomization error|1|||
42238795|NCT04044664|76061860|FG002|Stage 1|randomization error|0|||
42238796|NCT04044664|76061858|FG000|Stage 2|Adverse Event|2|||
42238797|NCT04044664|76061859|FG001|Stage 2|Adverse Event|0|||
42238798|NCT04044664|76061860|FG002|Stage 2|Adverse Event|0|||
42238799|NCT04044664|76061858|FG000|Stage 2|Lost to Follow-up|3|||
41988188|NCT01258738|75795538|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
41988189|NCT01258738|75795537|FG000|Double-blind Period|Withdrawal by Subject|2|||
42238800|NCT04044664|76061859|FG001|Stage 2|Lost to Follow-up|2|||
42238801|NCT04044664|76061860|FG002|Stage 2|Lost to Follow-up|1|||
42238802|NCT04044664|76061858|FG000|Stage 2|Withdrawal by Subject|3|||
42238803|NCT04044664|76061859|FG001|Stage 2|Withdrawal by Subject|0|||
42238804|NCT04044664|76061860|FG002|Stage 2|Withdrawal by Subject|0|||
42238805|NCT04044664|76061858|FG000|Stage 2|protocol deviation|1|||
42238806|NCT04044664|76061859|FG001|Stage 2|protocol deviation|0|||
42238807|NCT04044664|76061860|FG002|Stage 2|protocol deviation|0|||
42238808|NCT00150176|76061870|FG000|Overall Study|Adverse Event|16|||
42238809|NCT00150176|76061871|FG001|Overall Study|Adverse Event|53|||
42238810|NCT00150176|76061870|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
42238811|NCT00150176|76061871|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
42238812|NCT00150176|76061870|FG000|Overall Study|Withdrawal by Subject|19|||
42238813|NCT00150176|76061871|FG001|Overall Study|Withdrawal by Subject|12|||
42238814|NCT00150176|76061870|FG000|Overall Study|Lost to Follow-up|3|||
42238815|NCT00150176|76061871|FG001|Overall Study|Lost to Follow-up|3|||
42238816|NCT00150176|76061870|FG000|Overall Study|OTHER|11|||
42238817|NCT00150176|76061871|FG001|Overall Study|OTHER|13|||
42238818|NCT02985879|76061881|FG000|Overall Study|Adverse Event|7|||
42238819|NCT02985879|76061882|FG001|Overall Study|Adverse Event|9|||
42238820|NCT02985879|76061883|FG002|Overall Study|Adverse Event|7|||
42238821|NCT02985879|76061881|FG000|Overall Study|Withdrew consent|6|||
42238822|NCT02985879|76061882|FG001|Overall Study|Withdrew consent|8|||
42238823|NCT02985879|76061883|FG002|Overall Study|Withdrew consent|10|||
42238824|NCT02985879|76061881|FG000|Overall Study|Lost to Follow-up|1|||
42238825|NCT02985879|76061882|FG001|Overall Study|Lost to Follow-up|0|||
42238826|NCT02985879|76061883|FG002|Overall Study|Lost to Follow-up|2|||
42238827|NCT02985879|76061881|FG000|Overall Study|Other, not specified|62|||
42238828|NCT02985879|76061882|FG001|Overall Study|Other, not specified|58|||
42238829|NCT02985879|76061883|FG002|Overall Study|Other, not specified|58|||
42238830|NCT01067469|76061899|FG000|Overall Study|Withdrawal by Subject|0|||
42238831|NCT01067469|76061900|FG001|Overall Study|Withdrawal by Subject|1|||
42238832|NCT01067469|76061899|FG000|Overall Study|Disease Progression|0|||
42238833|NCT01067469|76061900|FG001|Overall Study|Disease Progression|1|||
42238834|NCT02985021|76061906|FG000|Overall Study|Inability to comply with study procedures|1|||
42238835|NCT01066923|76061914|FG000|Overall Study|Withdrawal by Subject|3|||
42238836|NCT01066923|76061915|FG001|Overall Study|Withdrawal by Subject|3|||
42238837|NCT01066923|76061916|FG002|Overall Study|Withdrawal by Subject|8|||
42238838|NCT01066923|76061917|FG003|Overall Study|Withdrawal by Subject|8|||
42238839|NCT02919267|76061942|FG000|Overall Study|Protocol Violation|0|||
42238840|NCT02919267|76061943|FG001|Overall Study|Protocol Violation|3|||
42238841|NCT02919267|76061944|FG002|Overall Study|Protocol Violation|3|||
42238842|NCT02919267|76061945|FG003|Overall Study|Protocol Violation|4|||
42238843|NCT01368900|76061955|FG000|Overall Study|Lost to Follow-up|7|||
42238844|NCT02910063|76061961|FG000|Phase 2|Withdrawal by Subject|3|||
42238845|NCT02910063|76061962|FG001|Phase 2|Withdrawal by Subject|0|||
42238846|NCT02910063|76061963|FG002|Phase 2|Withdrawal by Subject|0|||
42238847|NCT02910063|76061961|FG000|Phase 2|Lost to Follow-up|1|||
42238848|NCT02910063|76061962|FG001|Phase 2|Lost to Follow-up|0|||
42238849|NCT02910063|76061963|FG002|Phase 2|Lost to Follow-up|0|||
42238850|NCT02910063|76061961|FG000|Phase 2|Death|24|||
42238851|NCT02910063|76061962|FG001|Phase 2|Death|0|||
42238852|NCT02910063|76061963|FG002|Phase 2|Death|0|||
42238853|NCT02909907|76061974|FG000|Overall Study|Withdrawal by Subject|0|||
42238854|NCT02909907|76061975|FG001|Overall Study|Withdrawal by Subject|1|||
42238855|NCT02651194|76061981|FG000|Overall Study|Lost to Follow-up|3|||
42238856|NCT02651194|76061981|FG000|Overall Study|Other|2|||
41988190|NCT01258738|75795538|FG001|Double-blind Period|Withdrawal by Subject|2|||
41988191|NCT01258738|75795537|FG000|Double-blind Period|Protocol Violation|1|||
42238857|NCT02907177|76061987|FG000|Overall Study|Death|0|||
42238858|NCT02907177|76061988|FG001|Overall Study|Death|1|||
42238859|NCT02907177|76061987|FG000|Overall Study|Physician Decision|3|||
41988192|NCT01258738|75795538|FG001|Double-blind Period|Protocol Violation|1|||
42238860|NCT02907177|76061988|FG001|Overall Study|Physician Decision|3|||
42238861|NCT02907177|76061987|FG000|Overall Study|Withdrawal by Subject|15|||
42238862|NCT02907177|76061988|FG001|Overall Study|Withdrawal by Subject|7|||
42238863|NCT02907177|76061987|FG000|Overall Study|Sponsor's Decision|50|||
42238864|NCT02907177|76061988|FG001|Overall Study|Sponsor's Decision|57|||
42238865|NCT02652442|76061994|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
42238866|NCT02906709|76062008|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
42238867|NCT02906709|76062009|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
42238868|NCT02906709|76062008|FG000|Phase A (Week 0 to Week 16)|Death|0|||
42238869|NCT02906709|76062009|FG001|Phase A (Week 0 to Week 16)|Death|1|||
42238870|NCT02906709|76062008|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
42238871|NCT02906709|76062009|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
42238872|NCT02906709|76062008|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
42238873|NCT02906709|76062009|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
42238874|NCT00318656|76062023|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
42238875|NCT00318656|76062024|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
42238876|NCT00318656|76062023|FG000|Overall Study|Did not receive any treatment|0|||
42238877|NCT00318656|76062024|FG001|Overall Study|Did not receive any treatment|1|||
42238878|NCT02908347|76062030|FG000|Overall Study|Adverse Event|0|||
42238879|NCT02908347|76062031|FG001|Overall Study|Adverse Event|1|||
42238880|NCT02908347|76062030|FG000|Overall Study|Lost to Follow-up|1|||
42238881|NCT02908347|76062031|FG001|Overall Study|Lost to Follow-up|0|||
42238882|NCT02983305|76062053|FG000|Overall Study|incomplete data|2|||
42238883|NCT02983305|76062054|FG001|Overall Study|incomplete data|0|||
42238884|NCT03663166|76062060|FG000|Overall Study|Withdrawal by Subject|1|||
42238885|NCT02983227|76062067|FG000|Overall Study|Adverse Event|21|||
42238886|NCT02983227|76062068|FG001|Overall Study|Adverse Event|3|||
42238887|NCT02983227|76062067|FG000|Overall Study|Death|3|||
42238888|NCT02983227|76062068|FG001|Overall Study|Death|0|||
42238889|NCT02983227|76062067|FG000|Overall Study|Lack of Efficacy|8|||
42238890|NCT02983227|76062068|FG001|Overall Study|Lack of Efficacy|1|||
42238891|NCT02983227|76062067|FG000|Overall Study|Lost to Follow-up|3|||
42238892|NCT02983227|76062068|FG001|Overall Study|Lost to Follow-up|0|||
42238893|NCT02983227|76062067|FG000|Overall Study|Multiple Reasons|2|||
42238894|NCT02983227|76062068|FG001|Overall Study|Multiple Reasons|1|||
42238895|NCT02983227|76062067|FG000|Overall Study|Physician Decision|3|||
42238896|NCT02983227|76062068|FG001|Overall Study|Physician Decision|1|||
42238897|NCT02983227|76062067|FG000|Overall Study|Withdrawal by Subject|19|||
42238898|NCT02983227|76062068|FG001|Overall Study|Withdrawal by Subject|8|||
42238899|NCT00301262|76062076|FG000|Double Blind Phase (DB)|Adverse Event|1|||
42238900|NCT00301262|76062077|FG001|Double Blind Phase (DB)|Adverse Event|0|||
42238901|NCT00301262|76062076|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
42238902|NCT00301262|76062077|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
42238903|NCT00301262|76062076|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
42238904|NCT00301262|76062077|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
42238905|NCT00301262|76062076|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
42238906|NCT00301262|76062077|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
42238907|NCT00301262|76062076|FG000|Double Blind Phase (DB)|Other|1|||
42238908|NCT00301262|76062077|FG001|Double Blind Phase (DB)|Other|4|||
42238909|NCT00301262|76062076|FG000|Open Label Phase (OL)|Adverse Event|1|||
42238910|NCT00301262|76062077|FG001|Open Label Phase (OL)|Adverse Event|0|||
42238911|NCT00301262|76062076|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
42238912|NCT00301262|76062077|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
42238913|NCT00301262|76062076|FG000|Open Label Phase (OL)|Other|2|||
42238914|NCT00301262|76062077|FG001|Open Label Phase (OL)|Other|0|||
42238915|NCT02905149|76062104|FG000|Overall Study|Lost to Follow-up|2|||
42238916|NCT02905149|76062105|FG001|Overall Study|Lost to Follow-up|0|||
42238917|NCT02790606|76062111|FG000|Overall Study|Death|27|||
42238918|NCT02790606|76062111|FG000|Overall Study|Lost to Follow-up|4|||
42238919|NCT02790606|76062111|FG000|Overall Study|Physician Decision|3|||
42238920|NCT02790606|76062111|FG000|Overall Study|Withdrawal by Subject|1|||
42238921|NCT03077620|76062119|FG000|Overall Study|Unable to place lumbar catheter|1|||
42238922|NCT03077620|76062120|FG001|Overall Study|Unable to place lumbar catheter|0|||
42238923|NCT03077620|76062121|FG002|Overall Study|Unable to place lumbar catheter|1|||
42238924|NCT03077620|76062122|FG003|Overall Study|Unable to place lumbar catheter|0|||
42238925|NCT03077620|76062119|FG000|Overall Study|Withdrawal by Subject|0|||
42238926|NCT03077620|76062120|FG001|Overall Study|Withdrawal by Subject|1|||
42238927|NCT03077620|76062121|FG002|Overall Study|Withdrawal by Subject|0|||
42238928|NCT03077620|76062122|FG003|Overall Study|Withdrawal by Subject|0|||
42238929|NCT03077620|76062119|FG000|Overall Study|Physician Decision|0|||
42238930|NCT03077620|76062120|FG001|Overall Study|Physician Decision|0|||
41988193|NCT01258738|75795537|FG000|Double-blind Period|Adverse Event|3|||
42238931|NCT03077620|76062121|FG002|Overall Study|Physician Decision|1|||
41988194|NCT01258738|75795538|FG001|Double-blind Period|Adverse Event|1|||
41988195|NCT01258738|75795537|FG000|Open-label Period|Did not meet inclusion criteria|0|||
41988196|NCT01258738|75795538|FG001|Open-label Period|Did not meet inclusion criteria|1|||
41988197|NCT01258738|75795537|FG000|Open-label Period|Insufficient clinical response|5|||
41988198|NCT01258738|75795538|FG001|Open-label Period|Insufficient clinical response|3|||
42238932|NCT03077620|76062122|FG003|Overall Study|Physician Decision|0|||
42238933|NCT02982213|76062143|FG000|Overall Study|Did not complete follow up questionnaire|5|||
42238934|NCT02982213|76062144|FG001|Overall Study|Did not complete follow up questionnaire|1|||
42238935|NCT02649634|76062152|FG000|Overall Study|Withdrawal by Subject|3|||
42238936|NCT02649634|76062153|FG001|Overall Study|Withdrawal by Subject|5|||
42238937|NCT02649634|76062152|FG000|Overall Study|Lost to Follow-up|0|||
42238938|NCT02649634|76062153|FG001|Overall Study|Lost to Follow-up|1|||
42238939|NCT01066143|76062159|FG000|Overall Study|ineligible for the study|8|||
42238940|NCT02980107|76062165|FG000|Overall Study|Withdrawal by Subject|51|||
42238941|NCT02980107|76062166|FG001|Overall Study|Withdrawal by Subject|62|||
41988199|NCT01258738|75795537|FG000|Open-label Period|Lost to Follow-up|0|||
42238942|NCT02652130|76062172|FG000|Overall Study|Death|1|||
42238943|NCT02979639|76062176|FG000|Overall Study|Withdrawal based on medical judgement|1|||
42238944|NCT02979639|76062176|FG000|Overall Study|Lost to Follow-up|8|||
42238945|NCT02979639|76062176|FG000|Overall Study|Withdrawal by Subject|3|||
42238946|NCT02979639|76062176|FG000|Overall Study|Adverse Event|2|||
42238947|NCT01674634|76062180|FG000|Overall Study|Withdrawal by Subject|3|||
42238948|NCT01674634|76062180|FG000|Overall Study|Lost to Follow-up|3|||
42238949|NCT02979249|76062188|FG000|Overall Study|Lost to Follow-up|2|||
42032718|NCT01075152|75840979|FG000|Overall Study|Withdrawal by Subject|1|||
42032719|NCT01075152|75840980|FG001|Overall Study|Withdrawal by Subject|0|||
41988200|NCT01258738|75795538|FG001|Open-label Period|Lost to Follow-up|2|||
41988201|NCT01258738|75795537|FG000|Open-label Period|Withdrawal by Subject|5|||
41988202|NCT01258738|75795538|FG001|Open-label Period|Withdrawal by Subject|6|||
41988203|NCT01258738|75795537|FG000|Open-label Period|Protocol Violation|2|||
41988204|NCT01258738|75795538|FG001|Open-label Period|Protocol Violation|2|||
41988205|NCT01258738|75795537|FG000|Open-label Period|Adverse Event|4|||
41988206|NCT01258738|75795538|FG001|Open-label Period|Adverse Event|5|||
41988207|NCT01258738|75795537|FG000|Open-label Period|Other Reasons|0|||
41988208|NCT01258738|75795538|FG001|Open-label Period|Other Reasons|1|||
42032720|NCT01078116|75840988|FG000|Overall Study|Lost to Follow-up|17|||
42032721|NCT01078116|75840988|FG000|Overall Study|Adverse Event|5|||
41988209|NCT01258738|75795537|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
41988210|NCT01258738|75795538|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
42238950|NCT02979249|76062188|FG000|Overall Study|Withdrawal by Subject|4|||
42238951|NCT02112552|76062192|FG000|Overall Study|Withdrawal by Subject|1|||
42238952|NCT02112552|76062192|FG000|Overall Study|Adverse Event|1|||
42238953|NCT02976519|76062203|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
42238954|NCT02976519|76062204|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
42238955|NCT02976519|76062205|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
42238956|NCT02976519|76062206|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
42238957|NCT02976519|76062207|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
42238958|NCT02976519|76062208|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
42238959|NCT02976519|76062209|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
42238960|NCT02976519|76062203|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
42238961|NCT02976519|76062204|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
42238962|NCT02976519|76062205|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
41988211|NCT01258660|75795546|FG000|Overall Study|Adverse Event|2|||
41988212|NCT01258660|75795547|FG001|Overall Study|Adverse Event|4|||
41988213|NCT01258660|75795546|FG000|Overall Study|Withdrawal by Subject|3|||
41988214|NCT01258660|75795547|FG001|Overall Study|Withdrawal by Subject|0|||
42032722|NCT01078116|75840988|FG000|Overall Study|Withdrawal by Subject|8|||
42032723|NCT01078116|75840988|FG000|Overall Study|Lack of effectiveness|15|||
42032724|NCT01078116|75840988|FG000|Overall Study|Case report form not completed|3|||
42032725|NCT00950859|75840994|FG000|Overall Study|Adverse Event|3|||
42238963|NCT02976519|76062206|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
42238964|NCT02976519|76062207|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
42238965|NCT02976519|76062208|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
42238966|NCT02976519|76062209|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
42238967|NCT02976519|76062203|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
42238968|NCT02976519|76062204|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
42238969|NCT02976519|76062205|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
42238970|NCT02976519|76062206|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
42238971|NCT02976519|76062207|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
42238972|NCT02976519|76062208|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
42238973|NCT02976519|76062209|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
41988215|NCT01258660|75795546|FG000|Overall Study|due to relocation|2|||
41988216|NCT01258660|75795547|FG001|Overall Study|due to relocation|0|||
42032726|NCT00950859|75840995|FG001|Overall Study|Adverse Event|3|||
42032727|NCT00950859|75840994|FG000|Overall Study|Insufficient Viral Load Response|12|||
42131966|NCT00497874|75942820|FG000|Overall Study|Illness|8|||
42238974|NCT02976519|76062203|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
41988217|NCT01258660|75795546|FG000|Overall Study|Protocol Violation|0|||
42032728|NCT00950859|75840995|FG001|Overall Study|Insufficient Viral Load Response|3|||
42238975|NCT02976519|76062204|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
42032729|NCT00950859|75840994|FG000|Overall Study|Protocol Violation|1|||
42238976|NCT02976519|76062205|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
42032730|NCT00950859|75840995|FG001|Overall Study|Protocol Violation|1|||
42032731|NCT00950859|75840994|FG000|Overall Study|Lost to Follow-up|0|||
42032732|NCT00950859|75840995|FG001|Overall Study|Lost to Follow-up|3|||
42131967|NCT00497874|75942821|FG001|Overall Study|Illness|4|||
42238977|NCT02976519|76062206|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
41988218|NCT01258660|75795547|FG001|Overall Study|Protocol Violation|1|||
42238978|NCT02976519|76062207|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
42238979|NCT02976519|76062208|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
42238980|NCT02976519|76062209|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
42238981|NCT02976519|76062203|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
42238982|NCT02976519|76062204|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
42238983|NCT02976519|76062205|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
42238984|NCT02976519|76062206|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
42238985|NCT02976519|76062207|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
42238986|NCT02976519|76062208|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
42238987|NCT02976519|76062209|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
42238988|NCT02975973|76062314|FG000|Overall Study|Adverse Event|1|||
42238989|NCT02975973|76062315|FG001|Overall Study|Adverse Event|1|||
42238990|NCT02975973|76062316|FG002|Overall Study|Adverse Event|1|||
42238991|NCT02975973|76062317|FG003|Overall Study|Adverse Event|0|||
42238992|NCT01362322|76062329|FG000|Overall Study|Withdrawal by Subject|3|||
42238993|NCT01362322|76062330|FG001|Overall Study|Withdrawal by Subject|1|||
42238994|NCT01362322|76062329|FG000|Overall Study|Lost to Follow-up|2|||
42238995|NCT01362322|76062330|FG001|Overall Study|Lost to Follow-up|6|||
42238996|NCT02918877|76062338|FG000|Overall Study|Withdrawal by Subject|2|||
42238997|NCT02918877|76062339|FG001|Overall Study|Withdrawal by Subject|2|||
42238998|NCT02918877|76062338|FG000|Overall Study|Surgery cancelled|1|||
42238999|NCT02918877|76062339|FG001|Overall Study|Surgery cancelled|0|||
42239000|NCT02918877|76062338|FG000|Overall Study|Physician Decision|1|||
42239001|NCT02918877|76062339|FG001|Overall Study|Physician Decision|0|||
42239002|NCT02918877|76062338|FG000|Overall Study|Received intraoperative steroids|1|||
42239003|NCT02918877|76062339|FG001|Overall Study|Received intraoperative steroids|0|||
42239004|NCT02918877|76062338|FG000|Overall Study|Unable to obtain lab samples|1|||
42239005|NCT02918877|76062339|FG001|Overall Study|Unable to obtain lab samples|0|||
42239006|NCT02918877|76062338|FG000|Overall Study|Unsafe to perform BAL|0|||
42239007|NCT02918877|76062339|FG001|Overall Study|Unsafe to perform BAL|1|||
42239008|NCT01674712|76062350|FG000|Overall Study|Adverse Event|5|||
42239009|NCT01674712|76062351|FG001|Overall Study|Adverse Event|6|||
42239010|NCT01674712|76062352|FG002|Overall Study|Adverse Event|3|||
42239011|NCT01674712|76062353|FG003|Overall Study|Adverse Event|4|||
42239012|NCT01674712|76062354|FG004|Overall Study|Adverse Event|6|||
42239013|NCT01674712|76062350|FG000|Overall Study|Lost to Follow-up|1|||
42239014|NCT01674712|76062351|FG001|Overall Study|Lost to Follow-up|0|||
42239015|NCT01674712|76062352|FG002|Overall Study|Lost to Follow-up|0|||
42239016|NCT01674712|76062353|FG003|Overall Study|Lost to Follow-up|0|||
42239017|NCT01674712|76062354|FG004|Overall Study|Lost to Follow-up|0|||
42239018|NCT01674712|76062350|FG000|Overall Study|Protocol Violation|2|||
42239019|NCT01674712|76062351|FG001|Overall Study|Protocol Violation|0|||
42239020|NCT01674712|76062352|FG002|Overall Study|Protocol Violation|0|||
42239021|NCT01674712|76062353|FG003|Overall Study|Protocol Violation|0|||
42239022|NCT01674712|76062354|FG004|Overall Study|Protocol Violation|0|||
42239023|NCT01674712|76062350|FG000|Overall Study|Withdrawal by Subject|2|||
42239024|NCT01674712|76062351|FG001|Overall Study|Withdrawal by Subject|2|||
42239025|NCT01674712|76062352|FG002|Overall Study|Withdrawal by Subject|5|||
42239026|NCT01674712|76062353|FG003|Overall Study|Withdrawal by Subject|4|||
42239027|NCT01674712|76062354|FG004|Overall Study|Withdrawal by Subject|3|||
42239028|NCT01674712|76062350|FG000|Overall Study|Administrative|0|||
42239029|NCT01674712|76062351|FG001|Overall Study|Administrative|1|||
42239030|NCT01674712|76062352|FG002|Overall Study|Administrative|0|||
42239031|NCT01674712|76062353|FG003|Overall Study|Administrative|0|||
42239032|NCT01674712|76062354|FG004|Overall Study|Administrative|1|||
42239033|NCT01674712|76062350|FG000|Overall Study|Lack of Efficacy|0|||
42239034|NCT01674712|76062351|FG001|Overall Study|Lack of Efficacy|0|||
42239035|NCT01674712|76062352|FG002|Overall Study|Lack of Efficacy|1|||
42239036|NCT01674712|76062353|FG003|Overall Study|Lack of Efficacy|0|||
42239037|NCT01674712|76062354|FG004|Overall Study|Lack of Efficacy|1|||
42239038|NCT01368432|76062368|FG000|Overall Study|Lost to Follow-up|0|||
42239039|NCT01368432|76062369|FG001|Overall Study|Lost to Follow-up|1|||
42239040|NCT01063881|76062392|FG000|Overall Study|Adverse Event|12|||
42239041|NCT01063881|76062393|FG001|Overall Study|Adverse Event|2|||
42239042|NCT01063881|76062394|FG002|Overall Study|Adverse Event|0|||
42239043|NCT01063881|76062392|FG000|Overall Study|Lost to Follow-up|13|||
42239044|NCT01063881|76062393|FG001|Overall Study|Lost to Follow-up|7|||
42239045|NCT01063881|76062394|FG002|Overall Study|Lost to Follow-up|1|||
42239046|NCT01063881|76062392|FG000|Overall Study|Withdrawal by Subject|25|||
42239047|NCT01063881|76062393|FG001|Overall Study|Withdrawal by Subject|1|||
42239048|NCT01063881|76062394|FG002|Overall Study|Withdrawal by Subject|0|||
42239049|NCT01063881|76062392|FG000|Overall Study|Reason for not completed not specified|5|||
42239050|NCT01063881|76062393|FG001|Overall Study|Reason for not completed not specified|1|||
42239051|NCT01063881|76062394|FG002|Overall Study|Reason for not completed not specified|0|||
42239052|NCT01062555|76062411|FG000|Phase 1|Death|10|||
42239053|NCT01062555|76062412|FG001|Phase 1|Death|17|||
42239054|NCT01062555|76062413|FG002|Phase 1|Death|0|||
42239055|NCT01062555|76062414|FG003|Phase 1|Death|0|||
42239056|NCT01062555|76062411|FG000|Phase 1|Graft Failure|12|||
42239057|NCT01062555|76062412|FG001|Phase 1|Graft Failure|8|||
42239058|NCT01062555|76062413|FG002|Phase 1|Graft Failure|0|||
42239059|NCT01062555|76062414|FG003|Phase 1|Graft Failure|0|||
42239060|NCT01062555|76062411|FG000|Phase 1|Withdrawal by Subject|1|||
42239061|NCT01062555|76062412|FG001|Phase 1|Withdrawal by Subject|1|||
42239062|NCT01062555|76062413|FG002|Phase 1|Withdrawal by Subject|0|||
42239063|NCT01062555|76062414|FG003|Phase 1|Withdrawal by Subject|0|||
42239064|NCT01062555|76062411|FG000|Phase 2|Death|0|||
42239065|NCT01062555|76062412|FG001|Phase 2|Death|0|||
42239066|NCT01062555|76062413|FG002|Phase 2|Death|8|||
42239067|NCT01062555|76062414|FG003|Phase 2|Death|3|||
42239068|NCT01062555|76062411|FG000|Phase 2|Graft failure|0|||
42239069|NCT01062555|76062412|FG001|Phase 2|Graft failure|0|||
42239070|NCT01062555|76062413|FG002|Phase 2|Graft failure|7|||
42239071|NCT01062555|76062414|FG003|Phase 2|Graft failure|4|||
42239072|NCT01062555|76062411|FG000|Phase 2|Withdrawal by Subject|0|||
42239073|NCT01062555|76062412|FG001|Phase 2|Withdrawal by Subject|0|||
42239074|NCT01062555|76062413|FG002|Phase 2|Withdrawal by Subject|0|||
42239075|NCT01062555|76062414|FG003|Phase 2|Withdrawal by Subject|7|||
42239076|NCT01062555|76062411|FG000|Phase 2|Protocol Violation|0|||
42239077|NCT01062555|76062412|FG001|Phase 2|Protocol Violation|0|||
42239078|NCT01062555|76062413|FG002|Phase 2|Protocol Violation|0|||
42239079|NCT01062555|76062414|FG003|Phase 2|Protocol Violation|3|||
42239080|NCT01062555|76062411|FG000|Phase 2|Physician Decision|0|||
42239081|NCT01062555|76062412|FG001|Phase 2|Physician Decision|0|||
42239082|NCT01062555|76062413|FG002|Phase 2|Physician Decision|0|||
42239083|NCT01062555|76062414|FG003|Phase 2|Physician Decision|17|||
42239084|NCT01064817|76062426|FG000|Study Completion|Physician Decision|1|||
42239085|NCT01064817|76062427|FG001|Study Completion|Physician Decision|0|||
42239086|NCT01064817|76062426|FG000|Study Completion|Withdrawal by Subject|1|||
42239087|NCT01064817|76062427|FG001|Study Completion|Withdrawal by Subject|0|||
42239088|NCT01368276|76062435|FG000|Overall Study|Death|1|||
42239089|NCT01368276|76062436|FG001|Overall Study|Death|10|||
42239090|NCT01064739|76062442|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
42239091|NCT01061775|76062452|FG000|Overall Study|Physician Decision|2|||
42239092|NCT01061775|76062452|FG000|Overall Study|Lost to Follow-up|1|||
42239093|NCT02651116|76062459|FG000|Overall Study|Adverse Event|0|||
41988219|NCT01258660|75795546|FG000|Overall Study|Invalid for primary analysis data set|4|||
41988220|NCT01258660|75795547|FG001|Overall Study|Invalid for primary analysis data set|6|||
41988221|NCT01258348|75795554|FG000|Overall Study|Adverse Event|1|||
41988222|NCT01258348|75795555|FG001|Overall Study|Adverse Event|1|||
41988223|NCT01258348|75795556|FG002|Overall Study|Adverse Event|3|||
41988224|NCT01258348|75795557|FG003|Overall Study|Adverse Event|2|||
41988225|NCT01258348|75795558|FG004|Overall Study|Adverse Event|4|||
41988226|NCT01258348|75795554|FG000|Overall Study|Progressive Disease|0|||
41988227|NCT01258348|75795555|FG001|Overall Study|Progressive Disease|3|||
41988228|NCT01258348|75795556|FG002|Overall Study|Progressive Disease|0|||
41988229|NCT01258348|75795557|FG003|Overall Study|Progressive Disease|2|||
41988230|NCT01258348|75795558|FG004|Overall Study|Progressive Disease|2|||
41988231|NCT01258348|75795554|FG000|Overall Study|Physician Decision|0|||
41988232|NCT01258348|75795555|FG001|Overall Study|Physician Decision|0|||
41988233|NCT01258348|75795556|FG002|Overall Study|Physician Decision|0|||
41988234|NCT01258348|75795557|FG003|Overall Study|Physician Decision|2|||
41988235|NCT01258348|75795558|FG004|Overall Study|Physician Decision|0|||
41988236|NCT01258348|75795554|FG000|Overall Study|Withdrawal by Subject|0|||
42131968|NCT00497874|75942820|FG000|Overall Study|Death|2|||
42239094|NCT02651116|76062460|FG001|Overall Study|Adverse Event|1|||
42239095|NCT02651116|76062459|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
42239096|NCT02651116|76062460|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
42239097|NCT01061385|76062468|FG000|Overall Study|Lost to Follow-up|1|||
42239098|NCT01061385|76062469|FG001|Overall Study|Lost to Follow-up|0|||
42239099|NCT01061385|76062468|FG000|Overall Study|subject decision not related to AE|0|||
42239100|NCT01061385|76062469|FG001|Overall Study|subject decision not related to AE|1|||
42239101|NCT02973477|76062478|FG000|First Intervention|Lost to Follow-up|0|||
42239102|NCT02973477|76062479|FG001|First Intervention|Lost to Follow-up|2|||
42239103|NCT02973477|76062478|FG000|Washout|Withdrawal by Subject|1|||
42239104|NCT02973477|76062479|FG001|Washout|Withdrawal by Subject|0|||
42239105|NCT02973477|76062478|FG000|Second Intervention|Lost to Follow-up|1|||
41988237|NCT01258348|75795555|FG001|Overall Study|Withdrawal by Subject|1|||
41988238|NCT01258348|75795556|FG002|Overall Study|Withdrawal by Subject|0|||
42239106|NCT02973477|76062479|FG001|Second Intervention|Lost to Follow-up|0|||
41988239|NCT01258348|75795557|FG003|Overall Study|Withdrawal by Subject|0|||
41988240|NCT01258348|75795558|FG004|Overall Study|Withdrawal by Subject|0|||
41988241|NCT01258075|75795574|FG000|Overall Study|Adverse Event|8|||
41988242|NCT01258075|75795575|FG001|Overall Study|Adverse Event|3|||
41988243|NCT01258075|75795574|FG000|Overall Study|Lost to Follow-up|11|||
41988244|NCT01258075|75795575|FG001|Overall Study|Lost to Follow-up|6|||
41988245|NCT01258075|75795574|FG000|Overall Study|Withdrawal by Subject|10|||
41988246|NCT01258075|75795575|FG001|Overall Study|Withdrawal by Subject|7|||
41988247|NCT01258075|75795574|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
41988248|NCT01258075|75795575|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
41988249|NCT01258075|75795574|FG000|Overall Study|Other|12|||
41988250|NCT01258075|75795575|FG001|Overall Study|Other|5|||
41988251|NCT01257568|75795581|FG000|Overall Study|Lost to Follow-up|2|||
42131969|NCT00497874|75942821|FG001|Overall Study|Death|4|||
42239107|NCT02788656|76062493|FG000|Overall Study|Withdrawal by Subject|1|||
42239108|NCT02788656|76062494|FG001|Overall Study|Withdrawal by Subject|0|||
42239109|NCT00283868|76062502|FG000|Overall Study|Lost to Follow-up|7|||
42239110|NCT00283868|76062503|FG001|Overall Study|Lost to Follow-up|8|||
42239111|NCT02973087|76062509|FG000|Overall Study|Withdrawal by Subject|2|||
42239112|NCT02973087|76062510|FG001|Overall Study|Withdrawal by Subject|1|||
42239113|NCT02973087|76062509|FG000|Overall Study|Adverse Event|1|||
42239114|NCT02973087|76062510|FG001|Overall Study|Adverse Event|0|||
42239115|NCT02973087|76062509|FG000|Overall Study|other|1|||
42239116|NCT02973087|76062510|FG001|Overall Study|other|1|||
42239117|NCT00271544|76062530|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
42239118|NCT00271544|76062530|FG000|Overall Study|Model 4196 lead not attempted|9|||
42239119|NCT00271544|76062530|FG000|Overall Study|Implant not attempted|4|||
42239120|NCT05342532|76062548|FG000|Overall Study|Adverse Event|5|||
42239121|NCT05342532|76062549|FG001|Overall Study|Adverse Event|20|||
42239122|NCT05342532|76062548|FG000|Overall Study|Lost to Follow-up|10|||
42239123|NCT05342532|76062549|FG001|Overall Study|Lost to Follow-up|15|||
42239124|NCT02984943|76062555|FG000|Overall Study|Withdrawal by Subject|3|||
42239125|NCT02984943|76062555|FG000|Overall Study|Physician Decision|1|||
42239126|NCT02787408|76062559|FG000|Overall Study|Death|16|||
42239127|NCT02787408|76062559|FG000|Overall Study|Withdrawal by Subject|1|||
42239128|NCT02787408|76062559|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
42239129|NCT02971605|76062563|FG000|Overall Study|Withdrawal by Subject|1|||
42239130|NCT03054337|76062575|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
42239131|NCT03054337|76062576|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
42239132|NCT03054337|76062577|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
42239133|NCT03054337|76062578|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
42239134|NCT03054337|76062579|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
42239135|NCT03054337|76062580|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
42239136|NCT01060059|76062613|FG000|Overall Study|Adverse Event|1|||
42239137|NCT01060059|76062614|FG001|Overall Study|Adverse Event|1|||
42239138|NCT01060059|76062613|FG000|Overall Study|Death|2|||
42239139|NCT01060059|76062614|FG001|Overall Study|Death|3|||
42239140|NCT01060059|76062613|FG000|Overall Study|Lost to Follow-up|18|||
42239141|NCT01060059|76062614|FG001|Overall Study|Lost to Follow-up|34|||
42239142|NCT01060059|76062613|FG000|Overall Study|entry criteria not met|4|||
42239143|NCT01060059|76062614|FG001|Overall Study|entry criteria not met|3|||
42239144|NCT01060059|76062613|FG000|Overall Study|Withdrawal by Subject|35|||
42239145|NCT01060059|76062614|FG001|Overall Study|Withdrawal by Subject|23|||
42239146|NCT01060059|76062613|FG000|Overall Study|lack of glycemic control|2|||
42239147|NCT01060059|76062614|FG001|Overall Study|lack of glycemic control|1|||
42239148|NCT01060059|76062613|FG000|Overall Study|lack of compliance|5|||
42239149|NCT01060059|76062614|FG001|Overall Study|lack of compliance|2|||
42239150|NCT02648932|76062628|FG000|Overall Study|No transplant|3|||
42239151|NCT02648932|76062629|FG001|Overall Study|No transplant|1|||
42239152|NCT02122458|76062642|FG000|Overall Study|Withdrawal by Subject|0|||
42239153|NCT02122458|76062643|FG001|Overall Study|Withdrawal by Subject|0|||
41988252|NCT01257568|75795581|FG000|Overall Study|Withdrawal by Subject|6|||
41988253|NCT01257568|75795581|FG000|Overall Study|Terminated|1|||
41988254|NCT01257568|75795581|FG000|Overall Study|Component Revision|24|||
42239154|NCT02122458|76062644|FG002|Overall Study|Withdrawal by Subject|0|||
42239155|NCT02122458|76062645|FG003|Overall Study|Withdrawal by Subject|4|||
42239156|NCT02122458|76062646|FG004|Overall Study|Withdrawal by Subject|4|||
42239157|NCT02122458|76062647|FG005|Overall Study|Withdrawal by Subject|4|||
42239158|NCT02122458|76062648|FG006|Overall Study|Withdrawal by Subject|0|||
42239159|NCT02122458|76062642|FG000|Overall Study|Lost to Follow-up|1|||
42239160|NCT02122458|76062643|FG001|Overall Study|Lost to Follow-up|3|||
41988255|NCT01256788|75795590|FG000|Overall Study|Lost to Follow-up|5|||
41988256|NCT01256788|75795591|FG001|Overall Study|Lost to Follow-up|8|||
41988257|NCT01256788|75795592|FG002|Overall Study|Lost to Follow-up|3|||
42239161|NCT02122458|76062644|FG002|Overall Study|Lost to Follow-up|0|||
42239162|NCT02122458|76062645|FG003|Overall Study|Lost to Follow-up|7|||
42239163|NCT02122458|76062646|FG004|Overall Study|Lost to Follow-up|5|||
42239164|NCT02122458|76062647|FG005|Overall Study|Lost to Follow-up|15|||
42239165|NCT02122458|76062648|FG006|Overall Study|Lost to Follow-up|1|||
42239166|NCT02122458|76062642|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
42239167|NCT02122458|76062643|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
42239168|NCT02122458|76062644|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
42239169|NCT02122458|76062645|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
42239170|NCT02122458|76062646|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
42239171|NCT02122458|76062647|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
42239172|NCT02122458|76062648|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
42239173|NCT02122458|76062642|FG000|Overall Study|Adverse Event|1|||
42239174|NCT02122458|76062643|FG001|Overall Study|Adverse Event|0|||
42239175|NCT02122458|76062644|FG002|Overall Study|Adverse Event|0|||
42239176|NCT02122458|76062645|FG003|Overall Study|Adverse Event|0|||
42239177|NCT02122458|76062646|FG004|Overall Study|Adverse Event|0|||
42239178|NCT02122458|76062647|FG005|Overall Study|Adverse Event|0|||
42239179|NCT02122458|76062648|FG006|Overall Study|Adverse Event|0|||
42239180|NCT02122458|76062642|FG000|Overall Study|Experimental Error|0|||
42239181|NCT02122458|76062643|FG001|Overall Study|Experimental Error|0|||
42239182|NCT02122458|76062644|FG002|Overall Study|Experimental Error|0|||
42239183|NCT02122458|76062645|FG003|Overall Study|Experimental Error|0|||
42239184|NCT02122458|76062646|FG004|Overall Study|Experimental Error|3|||
42239185|NCT02122458|76062647|FG005|Overall Study|Experimental Error|0|||
42239186|NCT02122458|76062648|FG006|Overall Study|Experimental Error|0|||
42239187|NCT02122458|76062642|FG000|Overall Study|Deployed or Moved|0|||
42239188|NCT02122458|76062643|FG001|Overall Study|Deployed or Moved|0|||
42239189|NCT02122458|76062644|FG002|Overall Study|Deployed or Moved|0|||
42239190|NCT02122458|76062645|FG003|Overall Study|Deployed or Moved|0|||
42239191|NCT02122458|76062646|FG004|Overall Study|Deployed or Moved|1|||
42239192|NCT02122458|76062647|FG005|Overall Study|Deployed or Moved|0|||
42239193|NCT02122458|76062648|FG006|Overall Study|Deployed or Moved|0|||
42239194|NCT02122458|76062642|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
42239195|NCT02122458|76062643|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
42239196|NCT02122458|76062644|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
42239197|NCT02122458|76062645|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
42239198|NCT02122458|76062646|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
42239199|NCT02122458|76062647|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
42239200|NCT02122458|76062648|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
42239201|NCT02122458|76062642|FG000|Overall Study|Noncompliance|0|||
42239202|NCT02122458|76062643|FG001|Overall Study|Noncompliance|1|||
42239203|NCT02122458|76062644|FG002|Overall Study|Noncompliance|0|||
42239204|NCT02122458|76062645|FG003|Overall Study|Noncompliance|0|||
42239205|NCT02122458|76062646|FG004|Overall Study|Noncompliance|0|||
42239206|NCT02122458|76062647|FG005|Overall Study|Noncompliance|0|||
42239207|NCT02122458|76062648|FG006|Overall Study|Noncompliance|0|||
42239208|NCT02903511|76062664|FG000|Overall Study|Withdrawal by Subject|1|||
42239209|NCT02903511|76062665|FG001|Overall Study|Withdrawal by Subject|0|||
42239210|NCT02903511|76062664|FG000|Overall Study|Lost to Follow-up|3|||
42239211|NCT02903511|76062665|FG001|Overall Study|Lost to Follow-up|2|||
42239212|NCT01368042|76062682|FG000|Overall Study|Death|14|||
42239213|NCT01368042|76062682|FG000|Overall Study|Protocol Violation|11|||
41988258|NCT01256671|75795600|FG000|Overall Study|Adverse Event|29|||
41988259|NCT01256671|75795600|FG000|Overall Study|Lost to Follow-up|16|||
41988260|NCT01256671|75795600|FG000|Overall Study|Withdrawal by Subject|31|||
41988261|NCT01256671|75795600|FG000|Overall Study|Physician Decision|3|||
41988262|NCT01256671|75795600|FG000|Overall Study|Lack of Efficacy|4|||
41988263|NCT01256671|75795600|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
41988264|NCT01256476|75795606|FG000|Overall Study|Adverse Event|2|||
41988265|NCT01256476|75795607|FG001|Overall Study|Adverse Event|1|||
41988266|NCT01256476|75795606|FG000|Overall Study|Withdrawal by Subject|2|||
41988267|NCT01256476|75795607|FG001|Overall Study|Withdrawal by Subject|1|||
41988268|NCT01256476|75795606|FG000|Overall Study|Lost to Follow-up|1|||
41988269|NCT01256476|75795607|FG001|Overall Study|Lost to Follow-up|2|||
41988270|NCT01256476|75795606|FG000|Overall Study|Persistent ALT or AST elevation|1|||
41988271|NCT01256476|75795607|FG001|Overall Study|Persistent ALT or AST elevation|0|||
41988272|NCT01256476|75795606|FG000|Overall Study|Physician Decision|0|||
42239214|NCT01368042|76062682|FG000|Overall Study|Lost to Follow-up|4|||
42239215|NCT01368042|76062682|FG000|Overall Study|Transplanted|1|||
42239216|NCT00126776|76062688|FG000|Overall Study|follow up complete on all patients|0|||
42239217|NCT00126776|76062689|FG001|Overall Study|follow up complete on all patients|0|||
42239218|NCT01674010|76062693|FG000|Open Treatment Phase 1|Adverse Event|10|||
42239219|NCT01674010|76062694|FG001|Open Treatment Phase 1|Adverse Event|0|||
42239220|NCT01674010|76062695|FG002|Open Treatment Phase 1|Adverse Event|0|||
42239221|NCT01674010|76062693|FG000|Open Treatment Phase 1|Death|1|||
41988273|NCT01256476|75795607|FG001|Overall Study|Physician Decision|1|||
42239222|NCT01674010|76062694|FG001|Open Treatment Phase 1|Death|0|||
42239223|NCT01674010|76062695|FG002|Open Treatment Phase 1|Death|0|||
42239224|NCT01674010|76062693|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
42239225|NCT01674010|76062694|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
42239226|NCT01674010|76062695|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
42239227|NCT01674010|76062693|FG000|Open Treatment Phase 1|Physician Decision|9|||
42239228|NCT01674010|76062694|FG001|Open Treatment Phase 1|Physician Decision|0|||
42239229|NCT01674010|76062695|FG002|Open Treatment Phase 1|Physician Decision|0|||
42239230|NCT01674010|76062693|FG000|Open Treatment Phase 1|Protocol Violation|7|||
42239231|NCT01674010|76062694|FG001|Open Treatment Phase 1|Protocol Violation|0|||
42239232|NCT01674010|76062695|FG002|Open Treatment Phase 1|Protocol Violation|0|||
42239233|NCT01674010|76062693|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
42239234|NCT01674010|76062694|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
42239235|NCT01674010|76062695|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
42131970|NCT00497874|75942820|FG000|Overall Study|Unable to contact|52|||
42131971|NCT00497874|75942821|FG001|Overall Study|Unable to contact|67|||
42131972|NCT00497874|75942820|FG000|Overall Study|Unable to schedule|37|||
42131973|NCT00497874|75942821|FG001|Overall Study|Unable to schedule|24|||
42131974|NCT00403455|75942829|FG000|Overall Study|Withdrawal by Subject|1|||
42131975|NCT00318370|75942833|FG000|Period 1|Lack of Efficacy|5|||
42131976|NCT00318370|75942834|FG001|Period 1|Lack of Efficacy|0|||
42131977|NCT00318370|75942835|FG002|Period 1|Lack of Efficacy|0|||
42131978|NCT00318370|75942833|FG000|Period 1|Physician Decision|1|||
42131979|NCT00318370|75942834|FG001|Period 1|Physician Decision|0|||
42131980|NCT00318370|75942835|FG002|Period 1|Physician Decision|0|||
42131981|NCT00318370|75942833|FG000|Period 1|Withdrawal by Subject|1|||
42131982|NCT00318370|75942834|FG001|Period 1|Withdrawal by Subject|0|||
42131983|NCT00318370|75942835|FG002|Period 1|Withdrawal by Subject|0|||
42239236|NCT01674010|76062693|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
42239237|NCT01674010|76062694|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
41988274|NCT01256476|75795606|FG000|Overall Study|Subject non-compliance|0|||
41988275|NCT01256476|75795607|FG001|Overall Study|Subject non-compliance|1|||
41988276|NCT01256476|75795606|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
41988277|NCT01256476|75795607|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
41988278|NCT01256008|75795616|FG000|Overall Study|Lost to Follow-up|6|||
41988279|NCT01256008|75795617|FG001|Overall Study|Lost to Follow-up|4|||
41988280|NCT01256008|75795618|FG002|Overall Study|Lost to Follow-up|11|||
41988281|NCT01256008|75795616|FG000|Overall Study|Withdrawal by Subject|2|||
41988282|NCT01256008|75795617|FG001|Overall Study|Withdrawal by Subject|3|||
41988283|NCT01256008|75795618|FG002|Overall Study|Withdrawal by Subject|10|||
41988284|NCT01255423|75795630|FG000|Overall Study|Abnormal Laboratory value|3|||
41988285|NCT01255423|75795631|FG001|Overall Study|Abnormal Laboratory value|2|||
41988286|NCT01255423|75795630|FG000|Overall Study|Use of prohibited medications|0|||
41988287|NCT01255423|75795631|FG001|Overall Study|Use of prohibited medications|1|||
41988288|NCT01255306|75795639|FG000|Overall Study|Physician Decision|1|||
41988289|NCT01255306|75795640|FG001|Overall Study|Physician Decision|1|||
41988290|NCT01254721|75795651|FG000|Overall Study|Lost to Follow-up|0|||
41988291|NCT01254721|75795652|FG001|Overall Study|Lost to Follow-up|4|||
41988292|NCT01254721|75795651|FG000|Overall Study|Lack of Efficacy|4|||
41988293|NCT01254721|75795652|FG001|Overall Study|Lack of Efficacy|2|||
41988294|NCT01254721|75795651|FG000|Overall Study|Death|0|||
41988295|NCT01254721|75795652|FG001|Overall Study|Death|1|||
41988296|NCT01254721|75795651|FG000|Overall Study|technical problum|1|||
41988297|NCT01254721|75795652|FG001|Overall Study|technical problum|0|||
41988298|NCT01254721|75795651|FG000|Overall Study|Adverse Event|2|||
41988299|NCT01254721|75795652|FG001|Overall Study|Adverse Event|3|||
41988300|NCT01254721|75795651|FG000|Overall Study|Withdrawal by Subject|8|||
41988301|NCT01254721|75795652|FG001|Overall Study|Withdrawal by Subject|11|||
41988302|NCT01254721|75795651|FG000|Overall Study|Wrongly randomization|0|||
41988303|NCT01254721|75795652|FG001|Overall Study|Wrongly randomization|1|||
41988304|NCT01254643|75795658|FG000|Overall Study|Withdrawal by Subject|1|||
41988305|NCT01254604|75795664|FG000|Overall Study|Lost to Follow-up|1|||
41988306|NCT01254604|75795665|FG001|Overall Study|Lost to Follow-up|1|||
41988307|NCT01254604|75795664|FG000|Overall Study|Protocol Violation|2|||
41988308|NCT01254604|75795665|FG001|Overall Study|Protocol Violation|2|||
41988309|NCT01254604|75795664|FG000|Overall Study|Withdrawal by Subject|2|||
41988310|NCT01254604|75795665|FG001|Overall Study|Withdrawal by Subject|4|||
41988311|NCT01254604|75795664|FG000|Overall Study|Adverse Event|3|||
41988312|NCT01254604|75795665|FG001|Overall Study|Adverse Event|2|||
41988313|NCT01254565|75795677|FG000|Overall Study|Non-compliance to Study Procedures|0|||
41988314|NCT01254565|75795678|FG001|Overall Study|Non-compliance to Study Procedures|0|||
41988315|NCT01254565|75795679|FG002|Overall Study|Non-compliance to Study Procedures|0|||
42131984|NCT00318370|75942833|FG000|Period 2|Adverse Event|0|||
42131985|NCT00318370|75942834|FG001|Period 2|Adverse Event|3|||
42131986|NCT00318370|75942835|FG002|Period 2|Adverse Event|0|||
42131987|NCT00318370|75942833|FG000|Period 2|Lack of Efficacy|0|||
42131988|NCT00318370|75942834|FG001|Period 2|Lack of Efficacy|5|||
42239238|NCT01674010|76062695|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
42239239|NCT01674010|76062693|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
42239240|NCT01674010|76062694|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
42239241|NCT01674010|76062695|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
42239242|NCT01674010|76062693|FG000|Randomization Phase 2|Adverse Event|0|||
42239243|NCT01674010|76062694|FG001|Randomization Phase 2|Adverse Event|1|||
42239244|NCT01674010|76062695|FG002|Randomization Phase 2|Adverse Event|1|||
42239245|NCT01674010|76062693|FG000|Randomization Phase 2|Lost to Follow-up|0|||
42239246|NCT01674010|76062694|FG001|Randomization Phase 2|Lost to Follow-up|1|||
42239247|NCT01674010|76062695|FG002|Randomization Phase 2|Lost to Follow-up|2|||
42239248|NCT01674010|76062693|FG000|Randomization Phase 2|Mood episode recurrence|0|||
42239249|NCT01674010|76062694|FG001|Randomization Phase 2|Mood episode recurrence|8|||
42239250|NCT01674010|76062695|FG002|Randomization Phase 2|Mood episode recurrence|2|||
42239251|NCT01674010|76062693|FG000|Randomization Phase 2|Physician Decision|0|||
42239252|NCT01674010|76062694|FG001|Randomization Phase 2|Physician Decision|0|||
42239253|NCT01674010|76062695|FG002|Randomization Phase 2|Physician Decision|2|||
42239254|NCT01674010|76062693|FG000|Randomization Phase 2|Pregnancy|0|||
42239255|NCT01674010|76062694|FG001|Randomization Phase 2|Pregnancy|1|||
42239256|NCT01674010|76062695|FG002|Randomization Phase 2|Pregnancy|1|||
42239257|NCT01674010|76062693|FG000|Randomization Phase 2|Protocol Violation|0|||
42239258|NCT01674010|76062694|FG001|Randomization Phase 2|Protocol Violation|1|||
42239259|NCT01674010|76062695|FG002|Randomization Phase 2|Protocol Violation|1|||
42239260|NCT01674010|76062693|FG000|Randomization Phase 2|Sponsor Decision|0|||
42239261|NCT01674010|76062694|FG001|Randomization Phase 2|Sponsor Decision|42|||
42239262|NCT01674010|76062695|FG002|Randomization Phase 2|Sponsor Decision|45|||
42239263|NCT01674010|76062693|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
42239264|NCT01674010|76062694|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
42239265|NCT01674010|76062695|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
42239266|NCT01345669|76062705|FG000|Overall Study|Primary tumour recurrence|53|||
42239267|NCT01345669|76062706|FG001|Overall Study|Primary tumour recurrence|32|||
42239268|NCT01345669|76062705|FG000|Overall Study|Second primary tumour|4|||
42239269|NCT01345669|76062706|FG001|Overall Study|Second primary tumour|3|||
42239270|NCT01345669|76062705|FG000|Overall Study|Adverse Event|63|||
42239271|NCT01345669|76062706|FG001|Overall Study|Adverse Event|9|||
42239272|NCT01345669|76062705|FG000|Overall Study|Protocol Violation|3|||
42239273|NCT01345669|76062706|FG001|Overall Study|Protocol Violation|1|||
42239274|NCT01345669|76062705|FG000|Overall Study|Lost to Follow-up|1|||
42239275|NCT01345669|76062706|FG001|Overall Study|Lost to Follow-up|1|||
42239276|NCT01345669|76062705|FG000|Overall Study|Withdrawal by Subject|52|||
42239277|NCT01345669|76062706|FG001|Overall Study|Withdrawal by Subject|13|||
42239278|NCT01345669|76062705|FG000|Overall Study|Other Reasons|111|||
42239279|NCT01345669|76062706|FG001|Overall Study|Other Reasons|60|||
42239280|NCT05334212|76062712|FG000|Overall Study|Study terminated prematurely|7|||
42239281|NCT01673854|76062716|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
42239282|NCT01673854|76062716|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
42239283|NCT01673854|76062716|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
42239284|NCT01673854|76062716|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
42239285|NCT01673854|76062716|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
42239286|NCT01673854|76062716|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
42239287|NCT01673854|76062716|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
42239288|NCT01673854|76062716|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
42239289|NCT01673854|76062716|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
42239290|NCT01673854|76062716|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
42239291|NCT01673854|76062716|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
42239292|NCT01673854|76062716|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
42239293|NCT01343407|76062720|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
42239294|NCT01343407|76062721|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
42239295|NCT01343407|76062722|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
42239296|NCT01343407|76062723|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
42239297|NCT01343407|76062724|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
42239298|NCT01343407|76062725|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
42239299|NCT01343407|76062720|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
42131989|NCT00318370|75942835|FG002|Period 2|Lack of Efficacy|0|||
42239300|NCT01343407|76062721|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
42239301|NCT01343407|76062722|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
42239302|NCT01343407|76062723|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
42239303|NCT01343407|76062724|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
42239304|NCT01343407|76062725|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
42239305|NCT01367886|76062733|FG000|Overall Study|Lost to Follow-up|4|||
42239306|NCT01367886|76062733|FG000|Overall Study|Lack of Efficacy|2|||
42239307|NCT01367886|76062733|FG000|Overall Study|Death|1|||
42239308|NCT01673698|76062740|FG000|Overall Study|Lost to Follow-up|51|||
42239309|NCT01673698|76062741|FG001|Overall Study|Lost to Follow-up|13|||
42239310|NCT02786004|76062750|FG000|Overall Study|Withdrawal by Subject|0|||
42239311|NCT02786004|76062751|FG001|Overall Study|Withdrawal by Subject|1|||
42239312|NCT03051607|76062759|FG000|Overall Study|Adverse Event|66|||
42239313|NCT01062399|76062768|FG000|Overall Study|Protocol Violation|0|||
42239314|NCT01062399|76062769|FG001|Overall Study|Protocol Violation|1|||
42239315|NCT01062399|76062770|FG002|Overall Study|Protocol Violation|0|||
42239316|NCT01062399|76062771|FG003|Overall Study|Protocol Violation|6|||
42239317|NCT01062399|76062772|FG004|Overall Study|Protocol Violation|4|||
42239318|NCT01317277|76062786|FG000|Overall Study|Lost to Follow-up|3|||
42239319|NCT01317277|76062787|FG001|Overall Study|Lost to Follow-up|1|||
42239320|NCT01317277|76062786|FG000|Overall Study|Lost MEMS|1|||
42239321|NCT01317277|76062787|FG001|Overall Study|Lost MEMS|1|||
42239322|NCT01317277|76062786|FG000|Overall Study|Unable to comply with intervention|1|||
42239323|NCT01317277|76062787|FG001|Overall Study|Unable to comply with intervention|0|||
42239324|NCT01317277|76062786|FG000|Overall Study|Withdrawal by Subject|1|||
42239325|NCT01317277|76062787|FG001|Overall Study|Withdrawal by Subject|0|||
42239326|NCT01317277|76062786|FG000|Overall Study|Adverse Event|1|||
42239327|NCT01317277|76062787|FG001|Overall Study|Adverse Event|0|||
42239328|NCT04820686|76062796|FG000|Overall Study|Withdrawal by Subject|5|||
42239329|NCT04820686|76062797|FG001|Overall Study|Withdrawal by Subject|2|||
42239330|NCT04820686|76062798|FG002|Overall Study|Withdrawal by Subject|3|||
42239331|NCT04820686|76062796|FG000|Overall Study|Study Termination|25|||
42239332|NCT04820686|76062797|FG001|Overall Study|Study Termination|13|||
42239333|NCT04820686|76062798|FG002|Overall Study|Study Termination|14|||
42239334|NCT04820686|76062796|FG000|Overall Study|Adverse Event|0|||
42239335|NCT04820686|76062797|FG001|Overall Study|Adverse Event|1|||
42239336|NCT04820686|76062798|FG002|Overall Study|Adverse Event|0|||
42239337|NCT02740478|76062813|FG000|Overall Study|Withdrawal by Subject|1|||
42239338|NCT02969655|76062819|FG000|Overall Study|Withdrawal by Subject|3|||
42239339|NCT02969655|76062820|FG001|Overall Study|Withdrawal by Subject|2|||
42239340|NCT02969655|76062819|FG000|Overall Study|Physician Decision|4|||
42239341|NCT02969655|76062820|FG001|Overall Study|Physician Decision|3|||
42239342|NCT02969655|76062819|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
42239343|NCT02969655|76062820|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
42239344|NCT02969655|76062819|FG000|Overall Study|Adverse Event|10|||
42239345|NCT02969655|76062820|FG001|Overall Study|Adverse Event|8|||
42239346|NCT01317199|76062831|FG000|Dose-escalation Phase 1|Physician Decision|5|||
42239347|NCT01317199|76062832|FG001|Dose-escalation Phase 1|Physician Decision|0|||
42239348|NCT01317199|76062833|FG002|Dose-escalation Phase 1|Physician Decision|0|||
42239349|NCT01317199|76062834|FG003|Dose-escalation Phase 1|Physician Decision|0|||
42239350|NCT01317199|76062831|FG000|Dose-escalation Phase 1|Disease progression|1|||
42239351|NCT01317199|76062832|FG001|Dose-escalation Phase 1|Disease progression|0|||
42239352|NCT01317199|76062833|FG002|Dose-escalation Phase 1|Disease progression|0|||
42239353|NCT01317199|76062834|FG003|Dose-escalation Phase 1|Disease progression|0|||
42239354|NCT01317199|76062831|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
42239355|NCT01317199|76062832|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
42239356|NCT01317199|76062833|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
42239357|NCT01317199|76062834|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
42239358|NCT01317199|76062831|FG000|Randomized Phase 2|Disease progression|0|||
42239359|NCT01317199|76062832|FG001|Randomized Phase 2|Disease progression|3|||
42239360|NCT01317199|76062833|FG002|Randomized Phase 2|Disease progression|7|||
42239361|NCT01317199|76062834|FG003|Randomized Phase 2|Disease progression|5|||
42239362|NCT01317199|76062831|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
42239363|NCT01317199|76062832|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
42239364|NCT01317199|76062833|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
42239365|NCT01317199|76062834|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
42239366|NCT01317199|76062831|FG000|Randomized Phase 2|Adverse Event|0|||
42239367|NCT01317199|76062832|FG001|Randomized Phase 2|Adverse Event|0|||
42239368|NCT01317199|76062833|FG002|Randomized Phase 2|Adverse Event|0|||
42239369|NCT01317199|76062834|FG003|Randomized Phase 2|Adverse Event|1|||
42239370|NCT01317199|76062831|FG000|Randomized Phase 2|Comorbidities|0|||
42239371|NCT01317199|76062832|FG001|Randomized Phase 2|Comorbidities|2|||
42032733|NCT00862849|75841001|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
42239372|NCT01317199|76062833|FG002|Randomized Phase 2|Comorbidities|2|||
42239373|NCT01317199|76062834|FG003|Randomized Phase 2|Comorbidities|2|||
42239374|NCT01317199|76062831|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
42239375|NCT01317199|76062832|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
42239376|NCT01317199|76062833|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
42239377|NCT01317199|76062834|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
42239378|NCT01317199|76062831|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
42239379|NCT01317199|76062832|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
42239380|NCT01317199|76062833|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
42239381|NCT01317199|76062834|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
42239382|NCT01317199|76062831|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
42239383|NCT01317199|76062832|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
42239384|NCT01317199|76062833|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
42239385|NCT01317199|76062834|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
42239386|NCT01317199|76062831|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
42239387|NCT01317199|76062832|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
42239388|NCT01317199|76062833|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
42239389|NCT01317199|76062834|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
42239390|NCT02648698|76062853|FG000|Overall Study|Protocol Violation|1|||
42239391|NCT02648698|76062854|FG001|Overall Study|Protocol Violation|5|||
42239392|NCT02970669|76062862|FG000|Double-blind Period|Adverse Event|4|||
42239393|NCT02970669|76062863|FG001|Double-blind Period|Adverse Event|0|||
42239394|NCT02970669|76062862|FG000|Double-blind Period|Death|1|||
42239395|NCT02970669|76062863|FG001|Double-blind Period|Death|0|||
42239396|NCT02970669|76062862|FG000|Double-blind Period|Study terminated by sponsor|1|||
42239397|NCT02970669|76062863|FG001|Double-blind Period|Study terminated by sponsor|2|||
42239398|NCT02970669|76062862|FG000|Double-blind Period|Physician Decision|0|||
42239399|NCT02970669|76062863|FG001|Double-blind Period|Physician Decision|2|||
42239400|NCT02970669|76062862|FG000|Double-blind Period|Withdrawal by Subject|2|||
42239401|NCT02970669|76062863|FG001|Double-blind Period|Withdrawal by Subject|2|||
42239402|NCT02970669|76062862|FG000|Open-label Period|Withdrawal by Subject|2|||
42239403|NCT02970669|76062863|FG001|Open-label Period|Withdrawal by Subject|2|||
42239404|NCT02970669|76062862|FG000|Open-label Period|Adverse Event|1|||
42239405|NCT02970669|76062863|FG001|Open-label Period|Adverse Event|0|||
42239406|NCT02970669|76062862|FG000|Open-label Period|Physician Decision|1|||
42239407|NCT02970669|76062863|FG001|Open-label Period|Physician Decision|0|||
42239408|NCT02902965|76062871|FG000|Overall Study|Withdrawal by Subject|10|||
42239409|NCT02902809|76062876|FG000|Overall Study|Discontinuation of asthma program|28|||
42239410|NCT01362244|76062882|FG000|Overall Study|Adverse Event|3|||
42239411|NCT01362244|76062883|FG001|Overall Study|Adverse Event|5|||
42239412|NCT01362244|76062882|FG000|Overall Study|Lack of Efficacy|5|||
42239413|NCT01362244|76062883|FG001|Overall Study|Lack of Efficacy|11|||
42239414|NCT01362244|76062882|FG000|Overall Study|Lost to Follow-up|0|||
42239415|NCT01362244|76062883|FG001|Overall Study|Lost to Follow-up|2|||
42239416|NCT01362244|76062882|FG000|Overall Study|Protocol Violation|5|||
42239417|NCT01362244|76062883|FG001|Overall Study|Protocol Violation|1|||
42239418|NCT01362244|76062882|FG000|Overall Study|Withdrawal by Subject|2|||
42239419|NCT01362244|76062883|FG001|Overall Study|Withdrawal by Subject|1|||
42239420|NCT01362244|76062882|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
42239421|NCT01362244|76062883|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
42239422|NCT01362244|76062882|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
42239423|NCT01362244|76062883|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
42239424|NCT02969187|76062891|FG000|Overall Study|Physician Decision|12|||
42239425|NCT02969187|76062892|FG001|Overall Study|Physician Decision|13|||
42239426|NCT03050359|76062902|FG000|Overall Study|Randomized But Not Treated|2|||
42239427|NCT03050359|76062903|FG001|Overall Study|Randomized But Not Treated|0|||
42239428|NCT03050359|76062902|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
42239429|NCT03050359|76062903|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
42239430|NCT03050359|76062902|FG000|Overall Study|Significant Protocol Deviation|2|||
42239431|NCT03050359|76062903|FG001|Overall Study|Significant Protocol Deviation|3|||
42239432|NCT03050359|76062902|FG000|Overall Study|Lost to Follow-up|2|||
42239433|NCT03050359|76062903|FG001|Overall Study|Lost to Follow-up|1|||
42239434|NCT03050359|76062902|FG000|Overall Study|Voluntary Withdrawal|4|||
42239435|NCT03050359|76062903|FG001|Overall Study|Voluntary Withdrawal|6|||
42239436|NCT03050359|76062902|FG000|Overall Study|Pregnancy|1|||
42239437|NCT03050359|76062903|FG001|Overall Study|Pregnancy|0|||
42239438|NCT03050359|76062902|FG000|Overall Study|Reason Not Specified|1|||
42239439|NCT03050359|76062903|FG001|Overall Study|Reason Not Specified|0|||
42239440|NCT02785770|76062911|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
42239441|NCT02785770|76062912|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
42239442|NCT02785770|76062913|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
42239443|NCT02785770|76062914|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
42239444|NCT02785770|76062911|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
42239445|NCT02785770|76062912|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
42239446|NCT02785770|76062913|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
42239447|NCT02785770|76062914|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
42239448|NCT02785770|76062911|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
42239449|NCT02785770|76062912|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
42239450|NCT02785770|76062913|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
42239451|NCT02785770|76062914|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
42239452|NCT02965833|76062927|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
42239453|NCT02965833|76062928|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
42239454|NCT02965833|76062927|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
42239455|NCT02965833|76062928|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
42239456|NCT02965833|76062927|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
42239457|NCT02965833|76062928|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
42239458|NCT02965833|76062927|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
42239459|NCT02965833|76062928|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
42239460|NCT02965833|76062927|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
42239461|NCT02965833|76062928|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
42239462|NCT02968173|76062934|FG000|Overall Study|Withdrawal by Subject|1|||
42239463|NCT02785458|76062941|FG000|1 Month|Withdrawal by Subject|2|||
42239464|NCT02785458|76062942|FG001|1 Month|Withdrawal by Subject|1|||
42239465|NCT02785458|76062941|FG000|1 Month|Lost to Follow-up|38|||
42239466|NCT02785458|76062942|FG001|1 Month|Lost to Follow-up|31|||
42239467|NCT02785458|76062941|FG000|1 Month|Deemed Ineligible|1|||
42239468|NCT02785458|76062942|FG001|1 Month|Deemed Ineligible|0|||
42239469|NCT02785458|76062941|FG000|1 Month|Completed Evaluation by Baseline|42|||
42239470|NCT02785458|76062942|FG001|1 Month|Completed Evaluation by Baseline|39|||
42239471|NCT02785458|76062941|FG000|1 Month|Partial Interview|0|||
42239472|NCT02785458|76062942|FG001|1 Month|Partial Interview|4|||
42239473|NCT02785458|76062941|FG000|3 Months|Withdrawal by Subject|3|||
42239474|NCT02785458|76062942|FG001|3 Months|Withdrawal by Subject|1|||
42239475|NCT02785458|76062941|FG000|3 Months|Lost to Follow-up|25|||
42239476|NCT02785458|76062942|FG001|3 Months|Lost to Follow-up|21|||
42239477|NCT02785458|76062941|FG000|3 Months|Completed Evaluation at 1 Month|100|||
42239478|NCT02785458|76062942|FG001|3 Months|Completed Evaluation at 1 Month|89|||
42239479|NCT02784834|76062948|FG000|Overall Study|Lack of Efficacy|1|||
42239480|NCT02966223|76062952|FG000|Overall Study|Physician Decision|3|||
42239481|NCT02966223|76062952|FG000|Overall Study|Withdrawal by Subject|11|||
42239482|NCT02966223|76062952|FG000|Overall Study|Lost to Follow-up|1|||
42239483|NCT03049735|76062959|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
42239484|NCT03049735|76062960|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
42239485|NCT03049735|76062961|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
42239486|NCT03049735|76062959|FG000|Overall Study|Other|5|||
42239487|NCT03049735|76062960|FG001|Overall Study|Other|3|||
42239488|NCT03049735|76062961|FG002|Overall Study|Other|1|||
42239489|NCT03049735|76062959|FG000|Overall Study|Lack of Efficacy|4|||
42239490|NCT03049735|76062960|FG001|Overall Study|Lack of Efficacy|0|||
42239491|NCT03049735|76062961|FG002|Overall Study|Lack of Efficacy|3|||
42239492|NCT03049735|76062959|FG000|Overall Study|Protocol deviation|1|||
42239493|NCT03049735|76062960|FG001|Overall Study|Protocol deviation|0|||
42239494|NCT03049735|76062961|FG002|Overall Study|Protocol deviation|0|||
42239495|NCT03049735|76062959|FG000|Overall Study|Pregnancy|0|||
42239496|NCT03049735|76062960|FG001|Overall Study|Pregnancy|0|||
42239497|NCT03049735|76062961|FG002|Overall Study|Pregnancy|1|||
42239498|NCT03049735|76062959|FG000|Overall Study|Adverse Event|7|||
42239499|NCT03049735|76062960|FG001|Overall Study|Adverse Event|18|||
42239500|NCT03049735|76062961|FG002|Overall Study|Adverse Event|5|||
42239501|NCT03049735|76062959|FG000|Overall Study|Withdrawal by Subject|10|||
42239502|NCT03049735|76062960|FG001|Overall Study|Withdrawal by Subject|3|||
42239503|NCT03049735|76062961|FG002|Overall Study|Withdrawal by Subject|7|||
41988316|NCT01254565|75795680|FG003|Overall Study|Non-compliance to Study Procedures|0|||
41988317|NCT01254565|75795681|FG004|Overall Study|Non-compliance to Study Procedures|1|||
41988318|NCT01254565|75795682|FG005|Overall Study|Non-compliance to Study Procedures|0|||
41988319|NCT01254565|75795677|FG000|Overall Study|Did not Receive Treatment|1|||
41988320|NCT01254565|75795678|FG001|Overall Study|Did not Receive Treatment|1|||
41988321|NCT01254565|75795679|FG002|Overall Study|Did not Receive Treatment|0|||
41988322|NCT01254565|75795680|FG003|Overall Study|Did not Receive Treatment|0|||
41988323|NCT01254565|75795681|FG004|Overall Study|Did not Receive Treatment|3|||
41988324|NCT01254565|75795682|FG005|Overall Study|Did not Receive Treatment|4|||
41988325|NCT01254565|75795677|FG000|Overall Study|Other|0|||
41988326|NCT01254565|75795678|FG001|Overall Study|Other|0|||
41988327|NCT01254565|75795679|FG002|Overall Study|Other|0|||
42239504|NCT03049735|76062959|FG000|Overall Study|Lost to Follow-up|1|||
42239505|NCT03049735|76062960|FG001|Overall Study|Lost to Follow-up|5|||
42239506|NCT03049735|76062961|FG002|Overall Study|Lost to Follow-up|5|||
42239507|NCT01295944|76062969|FG000|Overall Study|Switched to alternative treatment|1|||
42239508|NCT01295944|76062969|FG000|Overall Study|Ineligible|9|||
42239509|NCT01295944|76062969|FG000|Overall Study|Withdrawal by Subject|4|||
42239510|NCT01295944|76062969|FG000|Overall Study|Participant chose to be treated in Peru|1|||
42239511|NCT01295944|76062969|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
42239512|NCT01295944|76062969|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
41988328|NCT01254565|75795680|FG003|Overall Study|Other|1|||
41988329|NCT01254565|75795681|FG004|Overall Study|Other|0|||
41988330|NCT01254565|75795682|FG005|Overall Study|Other|0|||
42239513|NCT01295944|76062969|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
42239514|NCT02965599|76062975|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
42239515|NCT02965599|76062976|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
42239516|NCT02898597|76062985|FG000|Overall Study|Protocol Violation|4|||
42239517|NCT02898597|76062986|FG001|Overall Study|Protocol Violation|2|||
42239518|NCT02898597|76062985|FG000|Overall Study|Lost to Follow-up|0|||
42239519|NCT02898597|76062986|FG001|Overall Study|Lost to Follow-up|9|||
42239520|NCT02898597|76062985|FG000|Overall Study|Death|0|||
42239521|NCT02898597|76062986|FG001|Overall Study|Death|1|||
42239522|NCT02899377|76062994|FG000|Overall Study|Adverse Event|1|||
42239523|NCT02899377|76062995|FG001|Overall Study|Adverse Event|0|||
42239524|NCT01316887|76063006|FG000|Overall Study|Adverse Event|13|||
42239525|NCT01316887|76063007|FG001|Overall Study|Adverse Event|21|||
42239526|NCT01316887|76063008|FG002|Overall Study|Adverse Event|17|||
42239527|NCT01316887|76063006|FG000|Overall Study|Lack of Efficacy|9|||
42239528|NCT01316887|76063007|FG001|Overall Study|Lack of Efficacy|3|||
42239529|NCT01316887|76063008|FG002|Overall Study|Lack of Efficacy|1|||
42239530|NCT01316887|76063006|FG000|Overall Study|Protocol Violation|2|||
42239531|NCT01316887|76063007|FG001|Overall Study|Protocol Violation|6|||
42239532|NCT01316887|76063008|FG002|Overall Study|Protocol Violation|6|||
42239533|NCT01316887|76063006|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
42239534|NCT01316887|76063007|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
42239535|NCT01316887|76063008|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
42239536|NCT01316887|76063006|FG000|Overall Study|Study Closed/Terminated|2|||
42239537|NCT01316887|76063007|FG001|Overall Study|Study Closed/Terminated|4|||
42239538|NCT01316887|76063008|FG002|Overall Study|Study Closed/Terminated|3|||
42239539|NCT01316887|76063006|FG000|Overall Study|Lost to Follow-up|1|||
42239540|NCT01316887|76063007|FG001|Overall Study|Lost to Follow-up|7|||
42239541|NCT01316887|76063008|FG002|Overall Study|Lost to Follow-up|5|||
42239542|NCT01316887|76063006|FG000|Overall Study|Withdrawal by Subject|8|||
42239543|NCT01316887|76063007|FG001|Overall Study|Withdrawal by Subject|16|||
42239544|NCT01316887|76063008|FG002|Overall Study|Withdrawal by Subject|15|||
42239545|NCT02897349|76063019|FG000|Overall Study|Lost to Follow-up|2|||
42239546|NCT02897349|76063020|FG001|Overall Study|Lost to Follow-up|2|||
42239547|NCT02897349|76063019|FG000|Overall Study|Adverse Event|3|||
42239548|NCT02897349|76063020|FG001|Overall Study|Adverse Event|3|||
42239549|NCT02897349|76063019|FG000|Overall Study|Other than listed above|0|||
42239550|NCT02897349|76063020|FG001|Overall Study|Other than listed above|1|||
42239551|NCT03047551|76063037|FG000|Overall Study|Did not receive TAS|1|||
42239552|NCT03047551|76063038|FG001|Overall Study|Did not receive TAS|0|||
42239553|NCT03047551|76063037|FG000|Overall Study|Physician Decision|1|||
42239554|NCT03047551|76063038|FG001|Overall Study|Physician Decision|0|||
42239555|NCT03047551|76063037|FG000|Overall Study|Withdrawal by Subject|0|||
42239556|NCT03047551|76063038|FG001|Overall Study|Withdrawal by Subject|1|||
42239557|NCT03047551|76063037|FG000|Overall Study|Probe malfunction|0|||
42239558|NCT03047551|76063038|FG001|Overall Study|Probe malfunction|1|||
42239559|NCT03047551|76063037|FG000|Overall Study|Ineligible|0|||
42239560|NCT03047551|76063038|FG001|Overall Study|Ineligible|1|||
42239561|NCT02964741|76063047|FG000|Overall Study|Protocol Violation|1|||
42239562|NCT02964741|76063048|FG001|Overall Study|Protocol Violation|0|||
42239563|NCT02964741|76063049|FG002|Overall Study|Protocol Violation|0|||
42239564|NCT02964741|76063047|FG000|Overall Study|Withdrawal by Subject|0|||
42239565|NCT02964741|76063048|FG001|Overall Study|Withdrawal by Subject|1|||
42239566|NCT02964741|76063049|FG002|Overall Study|Withdrawal by Subject|0|||
42239567|NCT02964741|76063047|FG000|Overall Study|claustrophobia|1|||
42239568|NCT02964741|76063048|FG001|Overall Study|claustrophobia|0|||
42239569|NCT02964741|76063049|FG002|Overall Study|claustrophobia|0|||
42239570|NCT01316419|76063055|FG000|Overall Study|Not treated|103|||
42239571|NCT01316419|76063055|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
42239572|NCT01316419|76063055|FG000|Overall Study|Lost to Follow-up|19|||
42239573|NCT02964039|76063062|FG000|Overall Study|Medical reason unrelated to study participation|1|||
42239574|NCT02964039|76063063|FG001|Overall Study|Medical reason unrelated to study participation|0|||
42239575|NCT02964039|76063064|FG002|Overall Study|Medical reason unrelated to study participation|3|||
42302678|NCT02413255|76137990|FG016|Overall Study|Voluntary Withdrawal|0|||
42239576|NCT02964039|76063062|FG000|Overall Study|Research shutdown due to pandemic|2|||
42239577|NCT02964039|76063063|FG001|Overall Study|Research shutdown due to pandemic|0|||
42239578|NCT02964039|76063064|FG002|Overall Study|Research shutdown due to pandemic|1|||
42239579|NCT02964039|76063062|FG000|Overall Study|Withdrawal by Subject|0|||
42239580|NCT02964039|76063063|FG001|Overall Study|Withdrawal by Subject|1|||
42239581|NCT02964039|76063064|FG002|Overall Study|Withdrawal by Subject|0|||
42302679|NCT02444533|76138043|FG000|Overall Study|Not able to complete forms|0|||
42239582|NCT02964039|76063062|FG000|Overall Study|Lost to Follow-up|1|||
42239583|NCT02964039|76063063|FG001|Overall Study|Lost to Follow-up|0|||
42239584|NCT02964039|76063064|FG002|Overall Study|Lost to Follow-up|1|||
42239585|NCT02897115|76063074|FG000|Overall Study|Early termination of study by sponsor|11|||
41988331|NCT01254409|75795700|FG000|Overall Study|Adverse Event|0|||
41988332|NCT01254409|75795701|FG001|Overall Study|Adverse Event|1|||
42239586|NCT02897115|76063075|FG001|Overall Study|Early termination of study by sponsor|8|||
42239587|NCT02896569|76063083|FG000|Overall Study|Lost to Follow-up|2|||
42239588|NCT02896569|76063084|FG001|Overall Study|Lost to Follow-up|1|||
42239589|NCT02896569|76063083|FG000|Overall Study|Physician Decision|1|||
42239590|NCT02896569|76063084|FG001|Overall Study|Physician Decision|3|||
42239591|NCT02896569|76063083|FG000|Overall Study|Adverse Event|0|||
42239592|NCT02896569|76063084|FG001|Overall Study|Adverse Event|1|||
42239593|NCT02896569|76063083|FG000|Overall Study|Withdrawal by Subject|1|||
42239594|NCT02896569|76063084|FG001|Overall Study|Withdrawal by Subject|0|||
42239595|NCT04030195|76063093|FG000|Overall Study|Withdrawal by Subject|2|||
42239596|NCT04030195|76063094|FG001|Overall Study|Withdrawal by Subject|0|||
42239597|NCT04030195|76063095|FG002|Overall Study|Withdrawal by Subject|0|||
42239598|NCT01673620|76063106|FG000|Overall Study|Adverse Event|1|||
42239599|NCT01673620|76063107|FG001|Overall Study|Adverse Event|0|||
42239600|NCT03044197|76063121|FG000|Overall Study|Withdrawal by Subject|3|||
42239601|NCT03044197|76063122|FG001|Overall Study|Withdrawal by Subject|1|||
42239602|NCT03043651|76063150|FG000|Overall Study|Death|1|||
42239603|NCT03043651|76063150|FG000|Overall Study|Progressive Disease|2|||
42239604|NCT03043651|76063150|FG000|Overall Study|Adverse Event|2|||
42239605|NCT03043651|76063150|FG000|Overall Study|Withdrawal by Subject|4|||
42239606|NCT03043651|76063150|FG000|Overall Study|Study Terminated by Sponsor|39|||
42239607|NCT03536143|76063154|FG000|Overall Study|Early termination, Sponsor decision|1|||
42239608|NCT01344759|76063164|FG000|Overall Study|Patients failed to reach sedation level|0|||
42239609|NCT01344759|76063165|FG001|Overall Study|Patients failed to reach sedation level|2|||
42239610|NCT05027451|76063188|FG000|Overall Study|Lost to Follow-up|1|||
42239611|NCT05027451|76063189|FG001|Overall Study|Lost to Follow-up|1|||
42302680|NCT02444533|76138044|FG001|Overall Study|Not able to complete forms|2|||
42302681|NCT02444533|76138043|FG000|Overall Study|Only gave post-procedure complications|2|||
42239614|NCT04549454|76063227|FG000|T1 to T2|Lost to Follow-up|22|||
42239615|NCT04549454|76063228|FG001|T1 to T2|Lost to Follow-up|26|||
42239616|NCT04549454|76063227|FG000|T1 to T3|Lost to Follow-up|31|||
42239617|NCT04549454|76063228|FG001|T1 to T3|Lost to Follow-up|36|||
42239618|NCT03519256|76063275|FG000|Overall Study|Disease recurrence|4|||
42239619|NCT03519256|76063276|FG001|Overall Study|Disease recurrence|4|||
42239620|NCT03519256|76063277|FG002|Overall Study|Disease recurrence|5|||
42239621|NCT03519256|76063278|FG003|Overall Study|Disease recurrence|2|||
42239622|NCT03519256|76063275|FG000|Overall Study|Study drug toxicity|0|||
42239623|NCT03519256|76063276|FG001|Overall Study|Study drug toxicity|2|||
42239624|NCT03519256|76063277|FG002|Overall Study|Study drug toxicity|5|||
42239625|NCT03519256|76063278|FG003|Overall Study|Study drug toxicity|2|||
42239626|NCT03519256|76063275|FG000|Overall Study|Adverse event unrelated to study drug|0|||
42239627|NCT03519256|76063276|FG001|Overall Study|Adverse event unrelated to study drug|1|||
42239628|NCT03519256|76063277|FG002|Overall Study|Adverse event unrelated to study drug|1|||
42239629|NCT03519256|76063278|FG003|Overall Study|Adverse event unrelated to study drug|0|||
42239630|NCT03519256|76063275|FG000|Overall Study|Participant request to discontinue study treatment|0|||
42239631|NCT03519256|76063276|FG001|Overall Study|Participant request to discontinue study treatment|0|||
42239632|NCT03519256|76063277|FG002|Overall Study|Participant request to discontinue study treatment|0|||
42239633|NCT03519256|76063278|FG003|Overall Study|Participant request to discontinue study treatment|2|||
42239634|NCT03519256|76063275|FG000|Overall Study|Other reasons|0|||
42239635|NCT03519256|76063276|FG001|Overall Study|Other reasons|0|||
42239636|NCT03519256|76063277|FG002|Overall Study|Other reasons|2|||
42239637|NCT03519256|76063278|FG003|Overall Study|Other reasons|0|||
42239638|NCT03519256|76063275|FG000|Overall Study|Disease progression|6|||
42239639|NCT03519256|76063276|FG001|Overall Study|Disease progression|3|||
42239640|NCT03519256|76063277|FG002|Overall Study|Disease progression|2|||
42239641|NCT03519256|76063278|FG003|Overall Study|Disease progression|1|||
42239642|NCT03519256|76063275|FG000|Overall Study|Lost to Follow-up|0|||
42239643|NCT03519256|76063276|FG001|Overall Study|Lost to Follow-up|1|||
42239644|NCT03519256|76063277|FG002|Overall Study|Lost to Follow-up|0|||
42239645|NCT03519256|76063278|FG003|Overall Study|Lost to Follow-up|0|||
42239646|NCT02799602|76063314|FG000|Overall Study|Protocol Violation|1|||
42239647|NCT02799602|76063315|FG001|Overall Study|Protocol Violation|0|||
42239648|NCT02799602|76063314|FG000|Overall Study|Physician Decision|3|||
42239649|NCT02799602|76063315|FG001|Overall Study|Physician Decision|7|||
42239650|NCT02799602|76063314|FG000|Overall Study|COVID-19 pandemic related other reason|0|||
42239651|NCT02799602|76063315|FG001|Overall Study|COVID-19 pandemic related other reason|1|||
42239652|NCT02799602|76063314|FG000|Overall Study|Lost to Follow-up|4|||
42239653|NCT02799602|76063315|FG001|Overall Study|Lost to Follow-up|1|||
42239654|NCT02799602|76063314|FG000|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|11|||
42239655|NCT02799602|76063315|FG001|Overall Study|ADDITIONAL PRIMARY MALIGNANCY|6|||
42239656|NCT02799602|76063314|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|14|||
42239657|NCT02799602|76063315|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|12|||
42239658|NCT02799602|76063314|FG000|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|24|||
42239659|NCT02799602|76063315|FG001|Overall Study|ADVERSE EVENT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|26|||
42239660|NCT02799602|76063314|FG000|Overall Study|Withdrawal by Subject|25|||
42239661|NCT02799602|76063315|FG001|Overall Study|Withdrawal by Subject|37|||
42239662|NCT02799602|76063314|FG000|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|48|||
42239663|NCT02799602|76063315|FG001|Overall Study|ADVERSE EVENT NOT ASSOCIATED WITH CLINICAL DISEASE PROGRESSION|27|||
42239664|NCT02799602|76063314|FG000|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|84|||
42239665|NCT02799602|76063315|FG001|Overall Study|PROGRESSIVE DISEASE - RADIOLOGICAL PROGRESSION|132|||
42239666|NCT02799602|76063314|FG000|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|127|||
42239667|NCT02799602|76063315|FG001|Overall Study|PROGRESSIVE DISEASE - CLINICAL PROGRESSION|272|||
42239668|NCT02799602|76063314|FG000|Overall Study|Death|8|||
42239669|NCT02799602|76063315|FG001|Overall Study|Death|5|||
42239670|NCT02799602|76063314|FG000|Overall Study|Other|3|||
42239671|NCT02799602|76063315|FG001|Overall Study|Other|3|||
42239672|NCT02799602|76063314|FG000|Overall Study|GCP violation|1|||
42239673|NCT02799602|76063315|FG001|Overall Study|GCP violation|0|||
42239674|NCT02243709|76063332|FG000|Phase 1|Lost to Follow-up|0|||
42239675|NCT02243709|76063333|FG001|Phase 1|Lost to Follow-up|1|||
42239676|NCT02243709|76063332|FG000|Phase 1|Withdrawal by Subject|1|||
42239677|NCT02243709|76063333|FG001|Phase 1|Withdrawal by Subject|0|||
42239678|NCT02243709|76063332|FG000|Phase 1|Protocol Violation|0|||
42239679|NCT02243709|76063333|FG001|Phase 1|Protocol Violation|1|||
42239680|NCT02243709|76063332|FG000|Phase 1|Adverse Event|0|||
42239681|NCT02243709|76063333|FG001|Phase 1|Adverse Event|1|||
42239682|NCT01891396|76063345|FG000|Overall Study|Withdrawal by Subject|4|||
42239683|NCT01891396|76063346|FG001|Overall Study|Withdrawal by Subject|4|||
42239684|NCT01891396|76063347|FG002|Overall Study|Withdrawal by Subject|3|||
42239685|NCT01891396|76063345|FG000|Overall Study|Lost to Follow-up|0|||
42239686|NCT01891396|76063346|FG001|Overall Study|Lost to Follow-up|1|||
42239687|NCT01891396|76063347|FG002|Overall Study|Lost to Follow-up|0|||
42239688|NCT01746225|76063362|FG000|Overall Study|Death|1|||
42239689|NCT01746225|76063363|FG001|Overall Study|Death|0|||
42239690|NCT01746225|76063364|FG002|Overall Study|Death|1|||
42239691|NCT01746225|76063362|FG000|Overall Study|Withdrawal by Subject|5|||
42239692|NCT01746225|76063363|FG001|Overall Study|Withdrawal by Subject|15|||
42239693|NCT01746225|76063364|FG002|Overall Study|Withdrawal by Subject|19|||
42239694|NCT01746225|76063362|FG000|Overall Study|Physician Decision|14|||
42239695|NCT01746225|76063363|FG001|Overall Study|Physician Decision|11|||
42239696|NCT01746225|76063364|FG002|Overall Study|Physician Decision|3|||
42239697|NCT01746225|76063362|FG000|Overall Study|Adverse Event|15|||
42239698|NCT01746225|76063363|FG001|Overall Study|Adverse Event|12|||
42239699|NCT01746225|76063364|FG002|Overall Study|Adverse Event|17|||
42239700|NCT01746225|76063362|FG000|Overall Study|Continuing Treatment|5|||
42239701|NCT01746225|76063363|FG001|Overall Study|Continuing Treatment|8|||
42239702|NCT01746225|76063364|FG002|Overall Study|Continuing Treatment|3|||
42239703|NCT01471522|76063385|FG000|Overall Study|Withdrawal by Subject|28|||
42239704|NCT01471522|76063386|FG001|Overall Study|Withdrawal by Subject|22|||
42239705|NCT01471522|76063385|FG000|Overall Study|Lost to Follow-up|36|||
42239706|NCT01471522|76063386|FG001|Overall Study|Lost to Follow-up|26|||
42239707|NCT01191008|76063393|FG000|Overall Study|Protocol Violation|7|||
42239708|NCT01191008|76063393|FG000|Overall Study|Lost to Follow-up|8|||
42239709|NCT00821587|76063399|FG000|Overall Study|Physician Decision|0|||
42239710|NCT00821587|76063400|FG001|Overall Study|Physician Decision|1|||
42239711|NCT00645801|76063408|FG000|Overall Study|unclear if patient took all the medication.|1|||
42239712|NCT00645801|76063409|FG001|Overall Study|unclear if patient took all the medication.|0|||
42239713|NCT00645801|76063408|FG000|Overall Study|Lost to Follow-up|19|||
41988333|NCT01254409|75795702|FG002|Overall Study|Adverse Event|0|||
41988334|NCT01254409|75795703|FG003|Overall Study|Adverse Event|0|||
41988335|NCT01254331|75795716|FG000|Initial Phase|Adverse Event|3|||
41988336|NCT01254331|75795716|FG000|Initial Phase|Withdrawal by Subject|1|||
41988337|NCT01254331|75795716|FG000|Initial Phase|Pregnancy|1|||
41988338|NCT01254331|75795716|FG000|Extension Phase|Lack of Efficacy|1|||
41988339|NCT01254331|75795716|FG000|Extension Phase|Lost to Follow-up|3|||
41988340|NCT01254292|75795731|FG000|Comparative Phase|Adverse Event|25|||
42032734|NCT00862849|75841002|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
42239714|NCT00645801|76063409|FG001|Overall Study|Lost to Follow-up|15|||
42239715|NCT00424099|76063423|FG000|Overall Study|Adverse Event|0|||
42239716|NCT00424099|76063424|FG001|Overall Study|Adverse Event|1|||
42239717|NCT00424099|76063425|FG002|Overall Study|Adverse Event|1|||
42239718|NCT00424099|76063426|FG003|Overall Study|Adverse Event|0|||
42239719|NCT00424099|76063423|FG000|Overall Study|Death|0|||
42239720|NCT00424099|76063424|FG001|Overall Study|Death|1|||
42239721|NCT00424099|76063425|FG002|Overall Study|Death|0|||
42239722|NCT00424099|76063426|FG003|Overall Study|Death|0|||
42239723|NCT00424099|76063423|FG000|Overall Study|Illness|2|||
42239724|NCT00424099|76063424|FG001|Overall Study|Illness|0|||
42239725|NCT00424099|76063425|FG002|Overall Study|Illness|1|||
42239726|NCT00424099|76063426|FG003|Overall Study|Illness|4|||
42239727|NCT00424099|76063423|FG000|Overall Study|Lost to Follow-up|0|||
42239728|NCT00424099|76063424|FG001|Overall Study|Lost to Follow-up|0|||
42239729|NCT00424099|76063425|FG002|Overall Study|Lost to Follow-up|3|||
42239730|NCT00424099|76063426|FG003|Overall Study|Lost to Follow-up|0|||
42239731|NCT00424099|76063423|FG000|Overall Study|Hospitalized|1|||
42239732|NCT00424099|76063424|FG001|Overall Study|Hospitalized|2|||
42239733|NCT00424099|76063425|FG002|Overall Study|Hospitalized|1|||
42239734|NCT00424099|76063426|FG003|Overall Study|Hospitalized|3|||
42239735|NCT00424099|76063423|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
42239736|NCT00424099|76063424|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
42239737|NCT00424099|76063425|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
42239738|NCT00424099|76063426|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
42239739|NCT00424099|76063423|FG000|Overall Study|Withdrawal by Subject|1|||
42239740|NCT00424099|76063424|FG001|Overall Study|Withdrawal by Subject|9|||
42239741|NCT00424099|76063425|FG002|Overall Study|Withdrawal by Subject|4|||
42239742|NCT00424099|76063426|FG003|Overall Study|Withdrawal by Subject|6|||
42239743|NCT00424099|76063423|FG000|Overall Study|Physician Decision|0|||
42239744|NCT00424099|76063424|FG001|Overall Study|Physician Decision|0|||
42239745|NCT00424099|76063425|FG002|Overall Study|Physician Decision|1|||
42239746|NCT00424099|76063426|FG003|Overall Study|Physician Decision|0|||
42239747|NCT00424099|76063423|FG000|Overall Study|Missing|0|||
42239748|NCT00424099|76063424|FG001|Overall Study|Missing|0|||
42239749|NCT00424099|76063425|FG002|Overall Study|Missing|1|||
42239750|NCT00424099|76063426|FG003|Overall Study|Missing|0|||
42239751|NCT02988661|76063453|FG000|Overall Study|Death|2|||
42239752|NCT02988661|76063454|FG001|Overall Study|Death|18|||
42239753|NCT02988661|76063453|FG000|Overall Study|Lost to Follow-up|0|||
42239754|NCT02988661|76063454|FG001|Overall Study|Lost to Follow-up|33|||
42239755|NCT02988661|76063453|FG000|Overall Study|Withdrawal by Subject|0|||
42239756|NCT02988661|76063454|FG001|Overall Study|Withdrawal by Subject|6|||
42239757|NCT02988661|76063453|FG000|Overall Study|Unable to complete the 18-month survey|1|||
42239758|NCT02988661|76063454|FG001|Overall Study|Unable to complete the 18-month survey|27|||
42239759|NCT03738397|76063462|FG000|Overall Study|Adverse Event|3|||
42239760|NCT03738397|76063463|FG001|Overall Study|Adverse Event|7|||
42239761|NCT03738397|76063462|FG000|Overall Study|Withdrawal by Subject|8|||
42239762|NCT03738397|76063463|FG001|Overall Study|Withdrawal by Subject|11|||
42239763|NCT03738397|76063462|FG000|Overall Study|Lost to Follow-up|8|||
42239764|NCT03738397|76063463|FG001|Overall Study|Lost to Follow-up|5|||
42239765|NCT03738397|76063462|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
42239766|NCT03738397|76063463|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
42239767|NCT03738397|76063462|FG000|Overall Study|Other|4|||
42239768|NCT03738397|76063463|FG001|Overall Study|Other|6|||
42239769|NCT02960217|76063471|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
42239770|NCT02960217|76063472|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
42239771|NCT02960217|76063471|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
42239772|NCT02960217|76063472|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
42239773|NCT02960217|76063471|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
42239774|NCT02960217|76063472|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
42239775|NCT02960217|76063471|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
42239776|NCT02960217|76063472|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
42239777|NCT02960217|76063471|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
42239778|NCT02960217|76063472|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
42239779|NCT02960217|76063471|FG000|Open-Label Extension Phase|Adverse Event|1|||
42239780|NCT02960217|76063472|FG001|Open-Label Extension Phase|Adverse Event|0|||
42239781|NCT02960217|76063471|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
42239782|NCT02960217|76063472|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
42239783|NCT02960217|76063471|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
42239784|NCT02960217|76063472|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
42239785|NCT02960217|76063471|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
42239786|NCT02960217|76063472|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
42239787|NCT02959983|76063484|FG000|Overall Study|Protocol Violation|0|||
42239788|NCT02959983|76063485|FG001|Overall Study|Protocol Violation|1|||
42239789|NCT02959983|76063484|FG000|Overall Study|Lack of Efficacy|0|||
42239790|NCT02959983|76063485|FG001|Overall Study|Lack of Efficacy|1|||
42239791|NCT02959983|76063484|FG000|Overall Study|Lost to Follow-up|12|||
42239792|NCT02959983|76063485|FG001|Overall Study|Lost to Follow-up|9|||
42239793|NCT02959983|76063484|FG000|Overall Study|Other|1|||
42239794|NCT02959983|76063485|FG001|Overall Study|Other|1|||
42239795|NCT02959983|76063484|FG000|Overall Study|Physician Decision|1|||
42239796|NCT02959983|76063485|FG001|Overall Study|Physician Decision|0|||
42239797|NCT02959983|76063484|FG000|Overall Study|Adverse Event|5|||
42239798|NCT02959983|76063485|FG001|Overall Study|Adverse Event|1|||
41988341|NCT01254292|75795732|FG001|Comparative Phase|Adverse Event|25|||
42239799|NCT02959983|76063484|FG000|Overall Study|Withdrawal by Subject|7|||
42239800|NCT02959983|76063485|FG001|Overall Study|Withdrawal by Subject|12|||
42239801|NCT01344447|76063491|FG000|Overall Study|Adverse Event|1|||
42239802|NCT01344447|76063491|FG000|Overall Study|Protocol Violation|1|||
42239803|NCT01344447|76063491|FG000|Overall Study|Withdrawal by Subject|1|||
42239804|NCT01344447|76063491|FG000|Overall Study|The contrast was not seen|1|||
42239805|NCT01344447|76063491|FG000|Overall Study|Physician Decision|1|||
42239806|NCT01344447|76063491|FG000|Overall Study|MRA unsuccessful|1|||
42239807|NCT01344447|76063491|FG000|Overall Study|Bolus tracking failed|1|||
42239808|NCT01344447|76063491|FG000|Overall Study|Error of power injector|1|||
42239809|NCT03513068|76063501|FG000|Overall Study|Death|1|||
42239810|NCT03513068|76063502|FG001|Overall Study|Death|0|||
42239811|NCT03513068|76063501|FG000|Overall Study|Withdrawal by Subject|4|||
42239812|NCT03513068|76063502|FG001|Overall Study|Withdrawal by Subject|6|||
42239813|NCT01348425|76063510|FG000|Overall Study|Imaging was not taken.|1|||
42239814|NCT01348425|76063511|FG001|Overall Study|Imaging was not taken.|1|||
42239815|NCT03041701|76063519|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
42239816|NCT03041701|76063520|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
42239817|NCT03041701|76063521|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
42239818|NCT03041701|76063519|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
42239819|NCT03041701|76063520|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
42239820|NCT03041701|76063521|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
42239821|NCT02956629|76063538|FG000|Overall Study|Adverse Event|0|||
42239822|NCT02956629|76063539|FG001|Overall Study|Adverse Event|0|||
42239823|NCT02956629|76063540|FG002|Overall Study|Adverse Event|1|||
42239824|NCT02956629|76063541|FG003|Overall Study|Adverse Event|0|||
42239825|NCT02956629|76063542|FG004|Overall Study|Adverse Event|0|||
42239826|NCT02956629|76063543|FG005|Overall Study|Adverse Event|0|||
42131990|NCT00318370|75942833|FG000|Period 2|Physician Decision|0|||
42131991|NCT00318370|75942834|FG001|Period 2|Physician Decision|1|||
42131992|NCT00318370|75942835|FG002|Period 2|Physician Decision|0|||
42131993|NCT00318370|75942833|FG000|Period 2|Withdrawal by Subject|0|||
42239827|NCT02956629|76063538|FG000|Overall Study|Lost to Follow-up|2|||
42239828|NCT02956629|76063539|FG001|Overall Study|Lost to Follow-up|5|||
42239829|NCT02956629|76063540|FG002|Overall Study|Lost to Follow-up|3|||
42239830|NCT02956629|76063541|FG003|Overall Study|Lost to Follow-up|1|||
42239831|NCT02956629|76063542|FG004|Overall Study|Lost to Follow-up|0|||
42239832|NCT02956629|76063543|FG005|Overall Study|Lost to Follow-up|1|||
42239833|NCT02956629|76063538|FG000|Overall Study|Withdrawal by Subject|3|||
42239834|NCT02956629|76063539|FG001|Overall Study|Withdrawal by Subject|1|||
42239835|NCT02956629|76063540|FG002|Overall Study|Withdrawal by Subject|0|||
42239836|NCT02956629|76063541|FG003|Overall Study|Withdrawal by Subject|0|||
42239837|NCT02956629|76063542|FG004|Overall Study|Withdrawal by Subject|0|||
42239838|NCT02956629|76063543|FG005|Overall Study|Withdrawal by Subject|0|||
42239839|NCT01348347|76063560|FG000|Overall Study|Withdrawal by Subject|1|||
42239840|NCT01348347|76063561|FG001|Overall Study|Withdrawal by Subject|1|||
42239841|NCT01348347|76063562|FG002|Overall Study|Withdrawal by Subject|1|||
42239842|NCT01348347|76063560|FG000|Overall Study|Progressive disease|2|||
42239843|NCT01348347|76063561|FG001|Overall Study|Progressive disease|5|||
42239844|NCT01348347|76063562|FG002|Overall Study|Progressive disease|5|||
42239845|NCT02959671|76063571|FG000|Overall Study|Adverse Event|2|||
42239846|NCT02959671|76063571|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
42239847|NCT01597258|76063575|FG000|Overall Study|No Drug Administration|1|||
42239848|NCT02958267|76063581|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
42239849|NCT02958267|76063582|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
42239850|NCT02958267|76063581|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
42239851|NCT02958267|76063582|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
42239852|NCT02958267|76063581|FG000|Follow-up Visits|Additional treatment pursued|2|||
42239853|NCT02958267|76063582|FG001|Follow-up Visits|Additional treatment pursued|1|||
42239854|NCT01952574|76063592|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
42239855|NCT01952574|76063593|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
42239856|NCT01952574|76063594|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
42239857|NCT01952574|76063595|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
41988342|NCT01254292|75795731|FG000|Comparative Phase|Lost to Follow-up|3|||
41988343|NCT01254292|75795732|FG001|Comparative Phase|Lost to Follow-up|21|||
42239858|NCT01952574|76063596|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
42239859|NCT01952574|76063597|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
41988344|NCT01254292|75795731|FG000|Comparative Phase|Pregnancy|2|||
41988345|NCT01254292|75795732|FG001|Comparative Phase|Pregnancy|6|||
41988346|NCT01254292|75795731|FG000|Comparative Phase|Withdrawal by Subject|20|||
42131994|NCT00318370|75942834|FG001|Period 2|Withdrawal by Subject|1|||
42239860|NCT01952574|76063598|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
41988347|NCT01254292|75795732|FG001|Comparative Phase|Withdrawal by Subject|21|||
42239861|NCT01952574|76063592|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
42239862|NCT01952574|76063593|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
42239863|NCT01952574|76063594|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
42239864|NCT01952574|76063595|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
42239865|NCT01952574|76063596|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
42239866|NCT01952574|76063597|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
42239867|NCT01952574|76063598|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
42239868|NCT01952574|76063592|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
42239869|NCT01952574|76063593|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
42239870|NCT01952574|76063594|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
42239871|NCT01952574|76063595|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
42239872|NCT01952574|76063596|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
42239873|NCT01952574|76063597|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
42239874|NCT01952574|76063598|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
42239875|NCT01952574|76063592|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
42239876|NCT01952574|76063593|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
42239877|NCT01952574|76063594|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
42239878|NCT01952574|76063595|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
42239879|NCT01952574|76063596|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
42239880|NCT01952574|76063597|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
42239881|NCT01952574|76063598|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
42239882|NCT01952574|76063592|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
42239883|NCT01952574|76063593|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
42239884|NCT01952574|76063594|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
42239885|NCT01952574|76063595|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
42239886|NCT01952574|76063596|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
42239887|NCT01952574|76063597|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
42239888|NCT01952574|76063598|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
42239889|NCT01952574|76063592|FG000|Open-label Treatment Phase|Missing|0|||
42239890|NCT01952574|76063593|FG001|Open-label Treatment Phase|Missing|0|||
42239891|NCT01952574|76063594|FG002|Open-label Treatment Phase|Missing|0|||
42239892|NCT01952574|76063595|FG003|Open-label Treatment Phase|Missing|0|||
42239893|NCT01952574|76063596|FG004|Open-label Treatment Phase|Missing|4|||
42239894|NCT01952574|76063597|FG005|Open-label Treatment Phase|Missing|0|||
42239895|NCT01952574|76063598|FG006|Open-label Treatment Phase|Missing|0|||
42239896|NCT01952574|76063592|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
42239897|NCT01952574|76063593|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
42239898|NCT01952574|76063594|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
42239899|NCT01952574|76063595|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
42239900|NCT01952574|76063596|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
42239901|NCT01952574|76063597|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
42239902|NCT01952574|76063598|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
42239903|NCT01952574|76063592|FG000|Open-label Treatment Phase|Death|0|||
42239904|NCT01952574|76063593|FG001|Open-label Treatment Phase|Death|0|||
42239905|NCT01952574|76063594|FG002|Open-label Treatment Phase|Death|0|||
42239906|NCT01952574|76063595|FG003|Open-label Treatment Phase|Death|0|||
42239907|NCT01952574|76063596|FG004|Open-label Treatment Phase|Death|1|||
42239908|NCT01952574|76063597|FG005|Open-label Treatment Phase|Death|0|||
42239909|NCT01952574|76063598|FG006|Open-label Treatment Phase|Death|0|||
42239910|NCT01952574|76063592|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
42239911|NCT01952574|76063593|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
42239912|NCT01952574|76063594|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
42239913|NCT01952574|76063595|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
42239914|NCT01952574|76063596|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
42239915|NCT01952574|76063597|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
42239916|NCT01952574|76063598|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
42239917|NCT01952574|76063592|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
42239918|NCT01952574|76063593|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
42239919|NCT01952574|76063594|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
42239920|NCT01952574|76063595|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
42239921|NCT01952574|76063596|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
42239922|NCT01952574|76063597|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
42239923|NCT01952574|76063598|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
42239924|NCT02959437|76063627|FG000|Overall Study|Death|33|||
42239925|NCT02959437|76063628|FG001|Overall Study|Death|3|||
42239926|NCT02959437|76063629|FG002|Overall Study|Death|0|||
42239927|NCT02959437|76063630|FG003|Overall Study|Death|0|||
42239928|NCT02959437|76063627|FG000|Overall Study|Lost to Follow-up|3|||
42239929|NCT02959437|76063628|FG001|Overall Study|Lost to Follow-up|1|||
42239930|NCT02959437|76063629|FG002|Overall Study|Lost to Follow-up|0|||
42239931|NCT02959437|76063630|FG003|Overall Study|Lost to Follow-up|0|||
42239932|NCT02959437|76063627|FG000|Overall Study|Withdrawal by Subject|11|||
42239933|NCT02959437|76063628|FG001|Overall Study|Withdrawal by Subject|3|||
42239934|NCT02959437|76063629|FG002|Overall Study|Withdrawal by Subject|0|||
42239935|NCT02959437|76063630|FG003|Overall Study|Withdrawal by Subject|0|||
42239936|NCT02959437|76063627|FG000|Overall Study|Progressive Disease|9|||
42239937|NCT02959437|76063628|FG001|Overall Study|Progressive Disease|1|||
42239938|NCT02959437|76063629|FG002|Overall Study|Progressive Disease|0|||
42239939|NCT02959437|76063630|FG003|Overall Study|Progressive Disease|0|||
42239940|NCT02959437|76063627|FG000|Overall Study|Study Terminated by Sponsor|4|||
42239941|NCT02959437|76063628|FG001|Overall Study|Study Terminated by Sponsor|0|||
42239942|NCT02959437|76063629|FG002|Overall Study|Study Terminated by Sponsor|0|||
42239943|NCT02959437|76063630|FG003|Overall Study|Study Terminated by Sponsor|0|||
42239944|NCT02959437|76063627|FG000|Overall Study|Other Unspecified|2|||
42239945|NCT02959437|76063628|FG001|Overall Study|Other Unspecified|0|||
42239946|NCT02959437|76063629|FG002|Overall Study|Other Unspecified|0|||
42239947|NCT02959437|76063630|FG003|Overall Study|Other Unspecified|0|||
42239948|NCT02957331|76063643|FG000|Overall Study|Protocol Violation|1|||
42239949|NCT02957331|76063644|FG001|Overall Study|Protocol Violation|0|||
42239950|NCT05212883|76063650|FG000|Overall Study|Invalid test result|125|||
42239951|NCT04995055|76063658|FG000|Period 1|COVID-19 Related|1|||
42239952|NCT04995055|76063659|FG001|Period 1|COVID-19 Related|0|||
42239953|NCT04995055|76063658|FG000|Period 1|Withdrawal by Subject|0|||
42239954|NCT04995055|76063659|FG001|Period 1|Withdrawal by Subject|1|||
42239955|NCT04995055|76063658|FG000|Period 1|Subject discontinued due to timing|4|||
42239956|NCT04995055|76063659|FG001|Period 1|Subject discontinued due to timing|4|||
42239957|NCT04785144|76063675|FG000|Overall Study|Withdrawal by Subject|4|||
42239958|NCT04785144|76063676|FG001|Overall Study|Withdrawal by Subject|1|||
42239959|NCT04785144|76063677|FG002|Overall Study|Withdrawal by Subject|0|||
42239960|NCT04785144|76063678|FG003|Overall Study|Withdrawal by Subject|0|||
42239961|NCT04785144|76063679|FG004|Overall Study|Withdrawal by Subject|0|||
42239962|NCT04785144|76063680|FG005|Overall Study|Withdrawal by Subject|2|||
42239963|NCT04785144|76063681|FG006|Overall Study|Withdrawal by Subject|2|||
42239964|NCT04785144|76063682|FG007|Overall Study|Withdrawal by Subject|0|||
42239965|NCT04785144|76063683|FG008|Overall Study|Withdrawal by Subject|1|||
42239966|NCT04785144|76063684|FG009|Overall Study|Withdrawal by Subject|0|||
42239967|NCT04785144|76063675|FG000|Overall Study|Lost to Follow-up|1|||
42239968|NCT04785144|76063676|FG001|Overall Study|Lost to Follow-up|0|||
42239969|NCT04785144|76063677|FG002|Overall Study|Lost to Follow-up|0|||
42239970|NCT04785144|76063678|FG003|Overall Study|Lost to Follow-up|0|||
42239971|NCT04785144|76063679|FG004|Overall Study|Lost to Follow-up|1|||
42239972|NCT04785144|76063680|FG005|Overall Study|Lost to Follow-up|2|||
42239973|NCT04785144|76063681|FG006|Overall Study|Lost to Follow-up|1|||
41988348|NCT01254292|75795731|FG000|Comparative Phase|Protocol Violation|1|||
41988349|NCT01254292|75795732|FG001|Comparative Phase|Protocol Violation|2|||
41988350|NCT01254292|75795731|FG000|Comparative Phase|Wish for pregnancy|4|||
41988351|NCT01254292|75795732|FG001|Comparative Phase|Wish for pregnancy|6|||
41988352|NCT01254292|75795731|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
41988353|NCT01254292|75795732|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
41988354|NCT01254292|75795731|FG000|LCS12 Extension Phase|Adverse Event|9|||
41988355|NCT01254292|75795732|FG001|LCS12 Extension Phase|Adverse Event|0|||
41988356|NCT01254292|75795731|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
41988357|NCT01254292|75795732|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
41988358|NCT01254292|75795731|FG000|LCS12 Extension Phase|Other unknown|4|||
41988359|NCT01254292|75795732|FG001|LCS12 Extension Phase|Other unknown|0|||
41988360|NCT01254292|75795731|FG000|LCS12 Extension Phase|Pregnancy|2|||
41988361|NCT01254292|75795732|FG001|LCS12 Extension Phase|Pregnancy|0|||
42239974|NCT04785144|76063682|FG007|Overall Study|Lost to Follow-up|2|||
42239975|NCT04785144|76063683|FG008|Overall Study|Lost to Follow-up|4|||
42239976|NCT04785144|76063684|FG009|Overall Study|Lost to Follow-up|1|||
42239977|NCT04785144|76063675|FG000|Overall Study|Protocol Violation|0|||
41988362|NCT01254292|75795731|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
41988363|NCT01254292|75795732|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
41988364|NCT01254019|75795741|FG000|Overall Study|Adverse Event|0|||
41988365|NCT01254019|75795742|FG001|Overall Study|Adverse Event|2|||
41988366|NCT01254019|75795741|FG000|Overall Study|Protocol Violation|1|||
42239978|NCT04785144|76063676|FG001|Overall Study|Protocol Violation|0|||
41988367|NCT01254019|75795742|FG001|Overall Study|Protocol Violation|0|||
41988368|NCT01254019|75795741|FG000|Overall Study|Withdrawal by Subject|0|||
41988369|NCT01254019|75795742|FG001|Overall Study|Withdrawal by Subject|2|||
41988370|NCT01253317|75795751|FG000|Overall Study|Adverse Event|2|||
42239979|NCT04785144|76063677|FG002|Overall Study|Protocol Violation|0|||
42239980|NCT04785144|76063678|FG003|Overall Study|Protocol Violation|0|||
42239981|NCT04785144|76063679|FG004|Overall Study|Protocol Violation|0|||
42239982|NCT04785144|76063680|FG005|Overall Study|Protocol Violation|0|||
42239983|NCT04785144|76063681|FG006|Overall Study|Protocol Violation|1|||
41988371|NCT01253200|75795764|FG000|Overall Study|Death|1|||
41988372|NCT01253200|75795765|FG001|Overall Study|Death|0|||
41988373|NCT01253200|75795766|FG002|Overall Study|Death|0|||
41988374|NCT01253200|75795767|FG003|Overall Study|Death|0|||
41988375|NCT01253200|75795768|FG004|Overall Study|Death|0|||
41988376|NCT01253200|75795764|FG000|Overall Study|Lost to Follow-up|1|||
41988377|NCT01253200|75795765|FG001|Overall Study|Lost to Follow-up|1|||
42239984|NCT04785144|76063682|FG007|Overall Study|Protocol Violation|0|||
42239985|NCT04785144|76063683|FG008|Overall Study|Protocol Violation|0|||
42239986|NCT04785144|76063684|FG009|Overall Study|Protocol Violation|0|||
42239987|NCT04785144|76063675|FG000|Overall Study|Physician Decision|0|||
42239988|NCT04785144|76063676|FG001|Overall Study|Physician Decision|0|||
42239989|NCT04785144|76063677|FG002|Overall Study|Physician Decision|0|||
42239990|NCT04785144|76063678|FG003|Overall Study|Physician Decision|0|||
42239991|NCT04785144|76063679|FG004|Overall Study|Physician Decision|0|||
42239992|NCT04785144|76063680|FG005|Overall Study|Physician Decision|0|||
42239993|NCT04785144|76063681|FG006|Overall Study|Physician Decision|0|||
42239994|NCT04785144|76063682|FG007|Overall Study|Physician Decision|0|||
42239995|NCT04785144|76063683|FG008|Overall Study|Physician Decision|0|||
42239996|NCT04785144|76063684|FG009|Overall Study|Physician Decision|1|||
42239997|NCT04785144|76063675|FG000|Overall Study|Unable to continue due to work schedule|0|||
42239998|NCT04785144|76063676|FG001|Overall Study|Unable to continue due to work schedule|0|||
42239999|NCT04785144|76063677|FG002|Overall Study|Unable to continue due to work schedule|0|||
42240000|NCT04785144|76063678|FG003|Overall Study|Unable to continue due to work schedule|0|||
42240001|NCT04785144|76063679|FG004|Overall Study|Unable to continue due to work schedule|0|||
42240002|NCT04785144|76063680|FG005|Overall Study|Unable to continue due to work schedule|0|||
42240003|NCT04785144|76063681|FG006|Overall Study|Unable to continue due to work schedule|0|||
42240004|NCT04785144|76063682|FG007|Overall Study|Unable to continue due to work schedule|0|||
42240005|NCT04785144|76063683|FG008|Overall Study|Unable to continue due to work schedule|0|||
42240006|NCT04785144|76063684|FG009|Overall Study|Unable to continue due to work schedule|1|||
42240007|NCT04743635|76063727|FG000|Overall Study|Lost to Follow-up|2|||
42240008|NCT04743635|76063728|FG001|Overall Study|Lost to Follow-up|0|||
42240009|NCT04712110|76063735|FG000|Overall Study|Lost to Follow-up|0|||
42240010|NCT04712110|76063736|FG001|Overall Study|Lost to Follow-up|1|||
42240011|NCT04712110|76063735|FG000|Overall Study|Withdrawal by Subject|0|||
42240012|NCT04712110|76063736|FG001|Overall Study|Withdrawal by Subject|4|||
42240013|NCT04712110|76063735|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
42240014|NCT04712110|76063736|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
42240015|NCT03877510|76063746|FG000|Overall Study|Death|6|||
42240016|NCT03877510|76063746|FG000|Overall Study|Lost to Follow-up|2|||
42240017|NCT03877510|76063746|FG000|Overall Study|Non-compliance with study drug|2|||
42240018|NCT03877510|76063746|FG000|Overall Study|Lack of Efficacy|14|||
42240019|NCT03877510|76063746|FG000|Overall Study|Adverse Event|20|||
42240020|NCT03877510|76063746|FG000|Overall Study|Withdrawal by Subject|22|||
42240021|NCT03877510|76063746|FG000|Overall Study|Miscellaneous|1|||
42240022|NCT03846427|76063750|FG000|Overall Study|Death|13|||
42240023|NCT03846427|76063750|FG000|Overall Study|Withdrawal by Subject|3|||
42240024|NCT03846427|76063750|FG000|Overall Study|Physician Decision|1|||
42240025|NCT03706079|76063779|FG000|Predecessor Study|Death|0|||
42240026|NCT03706079|76063780|FG001|Predecessor Study|Death|2|||
42240027|NCT03706079|76063781|FG002|Predecessor Study|Death|0|||
42240028|NCT03706079|76063782|FG003|Predecessor Study|Death|1|||
42240029|NCT03706079|76063783|FG004|Predecessor Study|Death|0|||
42240030|NCT03706079|76063784|FG005|Predecessor Study|Death|0|||
42240031|NCT03706079|76063779|FG000|Predecessor Study|Lost to Follow-up|5|||
42240032|NCT03706079|76063780|FG001|Predecessor Study|Lost to Follow-up|2|||
42240033|NCT03706079|76063781|FG002|Predecessor Study|Lost to Follow-up|0|||
42240034|NCT03706079|76063782|FG003|Predecessor Study|Lost to Follow-up|0|||
42240035|NCT03706079|76063783|FG004|Predecessor Study|Lost to Follow-up|1|||
42240036|NCT03706079|76063784|FG005|Predecessor Study|Lost to Follow-up|0|||
42240037|NCT03706079|76063779|FG000|Predecessor Study|Withdrawal by Subject|8|||
42240038|NCT03706079|76063780|FG001|Predecessor Study|Withdrawal by Subject|15|||
42240039|NCT03706079|76063781|FG002|Predecessor Study|Withdrawal by Subject|0|||
42240040|NCT03706079|76063782|FG003|Predecessor Study|Withdrawal by Subject|5|||
42240041|NCT03706079|76063783|FG004|Predecessor Study|Withdrawal by Subject|2|||
42240042|NCT03706079|76063784|FG005|Predecessor Study|Withdrawal by Subject|0|||
42302682|NCT02444533|76138044|FG001|Overall Study|Only gave post-procedure complications|2|||
41988378|NCT01253200|75795766|FG002|Overall Study|Lost to Follow-up|0|||
42302683|NCT01651039|76138050|FG000|Overall Study|Non-evaluables|5|||
41988379|NCT01253200|75795767|FG003|Overall Study|Lost to Follow-up|0|||
42240043|NCT03706079|76063779|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
42240044|NCT03706079|76063780|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
42240045|NCT03706079|76063781|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
42272660|NCT01657760|76102927|FG001|Overall Study|Withdrawal by Subject|0|||
41988380|NCT01253200|75795768|FG004|Overall Study|Lost to Follow-up|0|||
42240046|NCT03706079|76063782|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
42240047|NCT03706079|76063783|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
42240048|NCT03706079|76063784|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
42240049|NCT03706079|76063779|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
42240050|NCT03706079|76063780|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
42240051|NCT03706079|76063781|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
42240052|NCT03706079|76063782|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
42240053|NCT03706079|76063783|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
42240054|NCT03706079|76063784|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
42240055|NCT03706079|76063779|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
42240056|NCT03706079|76063780|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
42240057|NCT03706079|76063781|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
42240058|NCT03706079|76063782|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
42240059|NCT03706079|76063783|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
42240060|NCT03706079|76063784|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
42240061|NCT03706079|76063779|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
42240062|NCT03706079|76063780|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
42240063|NCT03706079|76063781|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
42240064|NCT03706079|76063782|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
42240065|NCT03706079|76063783|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
42240066|NCT03706079|76063784|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
42240067|NCT03706079|76063779|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
42240068|NCT03706079|76063780|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
42240069|NCT03706079|76063781|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
41988381|NCT01253200|75795764|FG000|Overall Study|Withdrawal by Subject|2|||
41988382|NCT01253200|75795765|FG001|Overall Study|Withdrawal by Subject|0|||
41988383|NCT01253200|75795766|FG002|Overall Study|Withdrawal by Subject|0|||
41988384|NCT01253200|75795767|FG003|Overall Study|Withdrawal by Subject|0|||
41988385|NCT01253200|75795768|FG004|Overall Study|Withdrawal by Subject|0|||
41988386|NCT01253200|75795764|FG000|Overall Study|Protocol Violation|1|||
41988387|NCT01253200|75795765|FG001|Overall Study|Protocol Violation|4|||
41988388|NCT01253200|75795766|FG002|Overall Study|Protocol Violation|0|||
41988389|NCT01253200|75795767|FG003|Overall Study|Protocol Violation|0|||
41988390|NCT01253200|75795768|FG004|Overall Study|Protocol Violation|5|||
41988391|NCT01253200|75795764|FG000|Overall Study|intents|10|||
41988392|NCT01253200|75795765|FG001|Overall Study|intents|10|||
41988393|NCT01253200|75795766|FG002|Overall Study|intents|1|||
41988394|NCT01253200|75795767|FG003|Overall Study|intents|3|||
41988395|NCT01253200|75795768|FG004|Overall Study|intents|0|||
41988396|NCT01253200|75795764|FG000|Overall Study|Attempts|6|||
41988397|NCT01253200|75795765|FG001|Overall Study|Attempts|4|||
41988398|NCT01253200|75795766|FG002|Overall Study|Attempts|1|||
41988399|NCT01253200|75795767|FG003|Overall Study|Attempts|2|||
41988400|NCT01253200|75795768|FG004|Overall Study|Attempts|0|||
41988401|NCT01253044|75795779|FG000|Overall Study|Lost to Follow-up|38|||
41988402|NCT01253044|75795780|FG001|Overall Study|Lost to Follow-up|29|||
41988403|NCT01252966|75795788|FG000|Overall Study|Lost to Follow-up|16|||
41988404|NCT01252966|75795789|FG001|Overall Study|Lost to Follow-up|10|||
41988405|NCT01252966|75795788|FG000|Overall Study|Withdrawal by Subject|7|||
41988406|NCT01252966|75795789|FG001|Overall Study|Withdrawal by Subject|3|||
41988407|NCT01252810|75795799|FG000|Overall Study|Withdrawal by Subject|4|||
41988408|NCT01252810|75795800|FG001|Overall Study|Withdrawal by Subject|1|||
41988409|NCT01252810|75795799|FG000|Overall Study|Lost to Follow-up|0|||
41988410|NCT01252810|75795800|FG001|Overall Study|Lost to Follow-up|1|||
41988411|NCT01252810|75795799|FG000|Overall Study|Physician Decision|2|||
41988412|NCT01252810|75795800|FG001|Overall Study|Physician Decision|1|||
41988413|NCT01252810|75795799|FG000|Overall Study|Various reasons|8|||
41988414|NCT01252810|75795800|FG001|Overall Study|Various reasons|0|||
41988415|NCT01252186|75795809|FG000|Overall Study|Adverse Event|9|||
41988416|NCT01252186|75795810|FG001|Overall Study|Adverse Event|6|||
41988417|NCT01252186|75795811|FG002|Overall Study|Adverse Event|8|||
41988418|NCT01252186|75795809|FG000|Overall Study|Withdrawal by Subject|2|||
42032735|NCT00862849|75841003|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
42240070|NCT03706079|76063782|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
42240071|NCT03706079|76063783|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
41988419|NCT01252186|75795810|FG001|Overall Study|Withdrawal by Subject|5|||
41988420|NCT01252186|75795811|FG002|Overall Study|Withdrawal by Subject|2|||
41988421|NCT01252186|75795809|FG000|Overall Study|Physician Decision|0|||
41988422|NCT01252186|75795810|FG001|Overall Study|Physician Decision|0|||
41988423|NCT01252186|75795811|FG002|Overall Study|Physician Decision|1|||
42240072|NCT03706079|76063784|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
42240073|NCT03706079|76063779|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
42240074|NCT03706079|76063780|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
42240075|NCT03706079|76063781|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
42240076|NCT03706079|76063782|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
42240077|NCT03706079|76063783|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
42240078|NCT03706079|76063784|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
42240079|NCT03706079|76063779|FG000|Long Term Extension (DESTINATION)|Death|8|||
42240080|NCT03706079|76063780|FG001|Long Term Extension (DESTINATION)|Death|2|||
42240081|NCT03706079|76063781|FG002|Long Term Extension (DESTINATION)|Death|2|||
42240082|NCT03706079|76063782|FG003|Long Term Extension (DESTINATION)|Death|1|||
42240083|NCT03706079|76063783|FG004|Long Term Extension (DESTINATION)|Death|0|||
42240084|NCT03706079|76063784|FG005|Long Term Extension (DESTINATION)|Death|0|||
42240085|NCT03657160|76063798|FG000|Overall Study|Adverse Event|5|||
42240086|NCT03657160|76063799|FG001|Overall Study|Adverse Event|6|||
42240087|NCT03657160|76063798|FG000|Overall Study|Protocol Deviation|3|||
42240088|NCT03657160|76063799|FG001|Overall Study|Protocol Deviation|0|||
42240089|NCT03657160|76063798|FG000|Overall Study|Withdrawal by Subject|18|||
42240090|NCT03657160|76063799|FG001|Overall Study|Withdrawal by Subject|16|||
42240091|NCT03657160|76063798|FG000|Overall Study|Site Termination|1|||
42240092|NCT03657160|76063799|FG001|Overall Study|Site Termination|0|||
42240093|NCT03657160|76063798|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
42240094|NCT03657160|76063799|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
42240095|NCT03657160|76063798|FG000|Overall Study|Death|33|||
42240096|NCT03657160|76063799|FG001|Overall Study|Death|26|||
42240097|NCT03657160|76063798|FG000|Overall Study|Death (COVID-19-Related)|1|||
42240098|NCT03657160|76063799|FG001|Overall Study|Death (COVID-19-Related)|0|||
42240099|NCT03657160|76063798|FG000|Overall Study|Reason Not Specified|5|||
42240100|NCT03657160|76063799|FG001|Overall Study|Reason Not Specified|5|||
42240101|NCT03657160|76063798|FG000|Overall Study|Other (COVID-19-Related)|0|||
42240102|NCT03657160|76063799|FG001|Overall Study|Other (COVID-19-Related)|1|||
42240103|NCT03635320|76063809|FG000|Overall Study|not implanted the device|1|||
42240104|NCT03635320|76063810|FG001|Overall Study|not implanted the device|2|||
42240105|NCT03635320|76063809|FG000|Overall Study|Withdrawal by Subject|11|||
42240106|NCT03635320|76063810|FG001|Overall Study|Withdrawal by Subject|6|||
42240107|NCT03508726|76063827|FG000|Overall Study|Withdrawal by Subject|0|||
42240108|NCT03508726|76063828|FG001|Overall Study|Withdrawal by Subject|1|||
41988424|NCT01252186|75795809|FG000|Overall Study|Non-compliance|0|||
41988425|NCT01252186|75795810|FG001|Overall Study|Non-compliance|3|||
41988426|NCT01252186|75795811|FG002|Overall Study|Non-compliance|4|||
41988427|NCT01252186|75795809|FG000|Overall Study|Protocol Violation|0|||
41988428|NCT01252186|75795810|FG001|Overall Study|Protocol Violation|0|||
41988429|NCT01252186|75795811|FG002|Overall Study|Protocol Violation|1|||
41988430|NCT01252186|75795809|FG000|Overall Study|Pregnancy|2|||
41988431|NCT01252186|75795810|FG001|Overall Study|Pregnancy|2|||
41988432|NCT01252186|75795811|FG002|Overall Study|Pregnancy|0|||
41988433|NCT01252186|75795809|FG000|Overall Study|Sponsor Request|2|||
41988434|NCT01252186|75795810|FG001|Overall Study|Sponsor Request|1|||
42240109|NCT03499964|76063837|FG000|Overall Study|Lack of Efficacy|6|||
42240110|NCT03499964|76063838|FG001|Overall Study|Lack of Efficacy|26|||
42240111|NCT03499964|76063837|FG000|Overall Study|Adverse Event|1|||
42240112|NCT03499964|76063838|FG001|Overall Study|Adverse Event|0|||
42240113|NCT03499964|76063837|FG000|Overall Study|Death|1|||
42240114|NCT03499964|76063838|FG001|Overall Study|Death|0|||
42240115|NCT03499964|76063837|FG000|Overall Study|Withdrawal by Subject|2|||
42240116|NCT03499964|76063838|FG001|Overall Study|Withdrawal by Subject|1|||
42240117|NCT03499964|76063837|FG000|Overall Study|Lost to Follow-up|1|||
42240118|NCT03499964|76063838|FG001|Overall Study|Lost to Follow-up|0|||
42240119|NCT03279692|76063844|FG000|Overall Study|Withdrawal by Subject|1|||
42240120|NCT03001882|76063861|FG000|Overall Study|Death|1|||
42240121|NCT03001882|76063862|FG001|Overall Study|Death|0|||
42240122|NCT03001882|76063863|FG002|Overall Study|Death|0|||
41988435|NCT01252186|75795811|FG002|Overall Study|Sponsor Request|0|||
41988436|NCT01252186|75795809|FG000|Overall Study|Lost to Follow-up|10|||
41988437|NCT01252186|75795810|FG001|Overall Study|Lost to Follow-up|10|||
42240123|NCT03001882|76063864|FG003|Overall Study|Death|3|||
42240124|NCT03001882|76063861|FG000|Overall Study|Participant withdrew consent|0|||
42240125|NCT03001882|76063862|FG001|Overall Study|Participant withdrew consent|1|||
41988438|NCT01252186|75795811|FG002|Overall Study|Lost to Follow-up|11|||
41988439|NCT01252186|75795809|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
41988440|NCT01252186|75795810|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
41988441|NCT01252186|75795811|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
42240126|NCT03001882|76063863|FG002|Overall Study|Participant withdrew consent|0|||
42240127|NCT03001882|76063864|FG003|Overall Study|Participant withdrew consent|5|||
42240128|NCT03001882|76063861|FG000|Overall Study|Other reasons|1|||
42240129|NCT03001882|76063862|FG001|Overall Study|Other reasons|2|||
42240130|NCT03001882|76063863|FG002|Overall Study|Other reasons|0|||
42240131|NCT03001882|76063864|FG003|Overall Study|Other reasons|5|||
42240132|NCT03001882|76063861|FG000|Overall Study|Administrative reason by sponsor|0|||
42240133|NCT03001882|76063862|FG001|Overall Study|Administrative reason by sponsor|0|||
42240134|NCT03001882|76063863|FG002|Overall Study|Administrative reason by sponsor|0|||
42240135|NCT03001882|76063864|FG003|Overall Study|Administrative reason by sponsor|1|||
42240136|NCT03001882|76063861|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
42240137|NCT03001882|76063862|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
42240138|NCT03001882|76063863|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
42240139|NCT03001882|76063864|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
42240140|NCT03001882|76063861|FG000|Overall Study|Not reported|0|||
42240141|NCT03001882|76063862|FG001|Overall Study|Not reported|0|||
42240142|NCT03001882|76063863|FG002|Overall Study|Not reported|0|||
42240143|NCT03001882|76063864|FG003|Overall Study|Not reported|6|||
42240144|NCT03001882|76063861|FG000|Overall Study|Maximum clinical benefit|1|||
42240145|NCT03001882|76063862|FG001|Overall Study|Maximum clinical benefit|2|||
42240146|NCT03001882|76063863|FG002|Overall Study|Maximum clinical benefit|0|||
42240147|NCT03001882|76063864|FG003|Overall Study|Maximum clinical benefit|10|||
42240148|NCT03001882|76063861|FG000|Overall Study|AE unrelated to study drug|3|||
42240149|NCT03001882|76063862|FG001|Overall Study|AE unrelated to study drug|3|||
42240150|NCT03001882|76063863|FG002|Overall Study|AE unrelated to study drug|0|||
42240151|NCT03001882|76063864|FG003|Overall Study|AE unrelated to study drug|11|||
42240152|NCT03001882|76063861|FG000|Overall Study|Study Drug Toxicity|8|||
42240153|NCT03001882|76063862|FG001|Overall Study|Study Drug Toxicity|5|||
42240154|NCT03001882|76063863|FG002|Overall Study|Study Drug Toxicity|0|||
42240155|NCT03001882|76063864|FG003|Overall Study|Study Drug Toxicity|37|||
42240156|NCT03001882|76063861|FG000|Overall Study|Disease progression|15|||
42240157|NCT03001882|76063862|FG001|Overall Study|Disease progression|14|||
42240158|NCT03001882|76063863|FG002|Overall Study|Disease progression|2|||
42240159|NCT03001882|76063864|FG003|Overall Study|Disease progression|90|||
42240160|NCT02985151|76063881|FG000|Original Randomization|Withdrawal by Subject|0|||
42240161|NCT02985151|76063882|FG001|Original Randomization|Withdrawal by Subject|1|||
42240162|NCT02603432|76063954|FG000|Overall Study|Ongoing|184|||
42240163|NCT02603432|76063955|FG001|Overall Study|Ongoing|144|||
42240164|NCT02603432|76063954|FG000|Overall Study|Adverse Event|1|||
42240165|NCT02603432|76063955|FG001|Overall Study|Adverse Event|0|||
42240166|NCT02603432|76063954|FG000|Overall Study|Death|144|||
42240167|NCT02603432|76063955|FG001|Overall Study|Death|177|||
42240168|NCT02603432|76063954|FG000|Overall Study|Lost to Follow-up|4|||
42240169|NCT02603432|76063955|FG001|Overall Study|Lost to Follow-up|6|||
42240170|NCT02603432|76063954|FG000|Overall Study|Progressive Disease|5|||
42240171|NCT02603432|76063955|FG001|Overall Study|Progressive Disease|5|||
42240172|NCT02603432|76063954|FG000|Overall Study|Withdrawal by Subject|9|||
42240173|NCT02603432|76063955|FG001|Overall Study|Withdrawal by Subject|17|||
42240174|NCT02603432|76063954|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
42240175|NCT02603432|76063955|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
42240176|NCT02603432|76063954|FG000|Overall Study|Other|0|||
42240177|NCT02603432|76063955|FG001|Overall Study|Other|1|||
42240178|NCT02582866|76063961|FG000|Overall Study|Death|1|||
42240179|NCT02582866|76063961|FG000|Overall Study|Lack of Efficacy|2|||
42240180|NCT02582866|76063961|FG000|Overall Study|Lost to Follow-up|2|||
42240181|NCT02582866|76063961|FG000|Overall Study|Withdrawal by Subject|7|||
42240182|NCT02582866|76063961|FG000|Overall Study|Investigator decision|5|||
42240183|NCT02582866|76063961|FG000|Overall Study|Participant wants to get pregnant|1|||
42240184|NCT02582866|76063961|FG000|Overall Study|Pregnancy|2|||
42240185|NCT02582866|76063961|FG000|Overall Study|Sponsor decision|1|||
42240186|NCT02582866|76063961|FG000|Overall Study|Withdrawal due to personal reasons|1|||
42240187|NCT01734928|76063971|FG000|Randomization|Physician Decision|0|||
42240188|NCT01734928|76063972|FG001|Randomization|Physician Decision|1|||
42240189|NCT01734928|76063971|FG000|Randomization|clinical progression|0|||
42240190|NCT01734928|76063972|FG001|Randomization|clinical progression|1|||
42240191|NCT01734928|76063971|FG000|Randomization|progressive disease|0|||
42240192|NCT01734928|76063972|FG001|Randomization|progressive disease|2|||
42131995|NCT00318370|75942835|FG002|Period 2|Withdrawal by Subject|0|||
42131996|NCT00318370|75942833|FG000|Period 2|Other|0|||
42131997|NCT00318370|75942834|FG001|Period 2|Other|1|||
42240193|NCT01734928|76063971|FG000|Randomization|Withdrew informed consent|0|||
42240194|NCT01734928|76063972|FG001|Randomization|Withdrew informed consent|4|||
42240195|NCT01734928|76063971|FG000|Randomization|Death|1|||
42131998|NCT00318370|75942835|FG002|Period 2|Other|0|||
42131999|NCT00318370|75942833|FG000|Period 3|Adverse Event|0|||
42240196|NCT01734928|76063972|FG001|Randomization|Death|0|||
42240197|NCT01734928|76063971|FG000|Randomization|Randomization error|1|||
42240198|NCT01734928|76063972|FG001|Randomization|Randomization error|0|||
42240199|NCT01734928|76063971|FG000|Randomization|Lost to Follow-up|1|||
42240200|NCT01734928|76063972|FG001|Randomization|Lost to Follow-up|0|||
42240201|NCT01734928|76063971|FG000|Treatment Period|Lost to Follow-up|0|||
42132000|NCT00318370|75942834|FG001|Period 3|Adverse Event|0|||
42132001|NCT00318370|75942835|FG002|Period 3|Adverse Event|1|||
42240202|NCT01734928|76063972|FG001|Treatment Period|Lost to Follow-up|2|||
42240203|NCT01734928|76063971|FG000|Treatment Period|Progressive Disease|167|||
42240204|NCT01734928|76063972|FG001|Treatment Period|Progressive Disease|165|||
42240205|NCT01734928|76063971|FG000|Treatment Period|Adverse Event|39|||
42240206|NCT01734928|76063972|FG001|Treatment Period|Adverse Event|52|||
42240207|NCT01734928|76063971|FG000|Treatment Period|Withdrawal of Consent|25|||
42240208|NCT01734928|76063972|FG001|Treatment Period|Withdrawal of Consent|22|||
42240209|NCT01734928|76063971|FG000|Treatment Period|Death|20|||
42240210|NCT01734928|76063972|FG001|Treatment Period|Death|9|||
42240211|NCT01734928|76063971|FG000|Treatment Period|Other Reasons|27|||
42240212|NCT01734928|76063972|FG001|Treatment Period|Other Reasons|19|||
42240213|NCT01734928|76063971|FG000|Treatment Period|Pregnancy|0|||
42240214|NCT01734928|76063972|FG001|Treatment Period|Pregnancy|1|||
42240215|NCT00667459|76063980|FG000|Overall Study|Death|0|||
42240216|NCT00667459|76063981|FG001|Overall Study|Death|2|||
42240217|NCT00667459|76063980|FG000|Overall Study|Lost to Follow-up|8|||
42240218|NCT00667459|76063981|FG001|Overall Study|Lost to Follow-up|43|||
42240219|NCT00453544|76063995|FG000|Overall Study|Withdrawal by Subject|1|||
42240220|NCT00453544|76063996|FG001|Overall Study|Withdrawal by Subject|0|||
42240221|NCT00453544|76063997|FG002|Overall Study|Withdrawal by Subject|0|||
42240222|NCT00453544|76063998|FG003|Overall Study|Withdrawal by Subject|0|||
42240223|NCT00453544|76063995|FG000|Overall Study|Primary outcome measure not completed|1|||
42240224|NCT00453544|76063996|FG001|Overall Study|Primary outcome measure not completed|1|||
42240225|NCT00453544|76063997|FG002|Overall Study|Primary outcome measure not completed|0|||
42240226|NCT00453544|76063998|FG003|Overall Study|Primary outcome measure not completed|1|||
42240227|NCT02646124|76064022|FG000|Overall Study|Lost to Follow-up|0|||
42240228|NCT02646124|76064023|FG001|Overall Study|Lost to Follow-up|2|||
42240229|NCT01597492|76064031|FG000|Overall Study|Withdrawal by Subject|1|||
42240230|NCT01597492|76064032|FG001|Overall Study|Withdrawal by Subject|2|||
42240231|NCT01597492|76064031|FG000|Overall Study|Adverse Event|3|||
42240232|NCT01597492|76064032|FG001|Overall Study|Adverse Event|0|||
42240233|NCT01597492|76064031|FG000|Overall Study|Lost to Follow-up|0|||
42240234|NCT01597492|76064032|FG001|Overall Study|Lost to Follow-up|2|||
42240235|NCT01597492|76064031|FG000|Overall Study|Other Reason|2|||
42240236|NCT01597492|76064032|FG001|Overall Study|Other Reason|0|||
42240237|NCT03423602|76064038|FG000|Overall Study|Death|1|||
42240238|NCT03423602|76064038|FG000|Overall Study|Lost to Follow-up|6|||
42240239|NCT03423602|76064038|FG000|Overall Study|Protocol Violation|1|||
42240240|NCT03423602|76064038|FG000|Overall Study|Withdrawal by Subject|4|||
42240241|NCT00109590|76064045|FG000|Overall Study|Lost to Follow-up|1|||
42240242|NCT00109590|76064046|FG001|Overall Study|Lost to Follow-up|0|||
42240243|NCT00109590|76064047|FG002|Overall Study|Lost to Follow-up|1|||
42240244|NCT00109590|76064045|FG000|Overall Study|Never Started Treatment|1|||
42240245|NCT00109590|76064046|FG001|Overall Study|Never Started Treatment|2|||
42240246|NCT00109590|76064047|FG002|Overall Study|Never Started Treatment|3|||
42240247|NCT02781558|76064071|FG000|Overall Study|Lost to Follow-up|2|||
42240248|NCT02781558|76064072|FG001|Overall Study|Lost to Follow-up|2|||
42240249|NCT02781558|76064071|FG000|Overall Study|Adverse Event|1|||
41988442|NCT01251952|75795846|FG000|Overall Study|Adverse Event|1|||
42240250|NCT02781558|76064072|FG001|Overall Study|Adverse Event|0|||
42240251|NCT03041311|76064081|FG000|Overall Study|Death|39|||
42240252|NCT03041311|76064082|FG001|Overall Study|Death|42|||
42240253|NCT03041311|76064081|FG000|Overall Study|Lost to Follow-up|0|||
42240254|NCT03041311|76064082|FG001|Overall Study|Lost to Follow-up|1|||
42240255|NCT03041311|76064081|FG000|Overall Study|Withdrawal by Subject|8|||
42240256|NCT03041311|76064082|FG001|Overall Study|Withdrawal by Subject|5|||
42240257|NCT03041311|76064081|FG000|Overall Study|Sponsor Terminated Study|2|||
42240258|NCT03041311|76064082|FG001|Overall Study|Sponsor Terminated Study|4|||
42240259|NCT03041311|76064081|FG000|Overall Study|Disease Progression|3|||
42240260|NCT03041311|76064082|FG001|Overall Study|Disease Progression|1|||
41988443|NCT01251367|75795850|FG000|Overall Study|Protocol Violation|1|||
42240261|NCT03041311|76064081|FG000|Overall Study|Randomized in error, did not receive drug|2|||
42240262|NCT03041311|76064082|FG001|Overall Study|Randomized in error, did not receive drug|0|||
42240263|NCT02644096|76064098|FG000|Overall Study|Withdrawal by Subject|28|||
42240264|NCT02644096|76064099|FG001|Overall Study|Withdrawal by Subject|25|||
42240265|NCT02643628|76064107|FG000|Overall Study|Lost to Follow-up|1|||
42240266|NCT02643628|76064108|FG001|Overall Study|Lost to Follow-up|4|||
42240267|NCT02643628|76064107|FG000|Overall Study|Withdrawal by Subject|0|||
42240268|NCT02643628|76064108|FG001|Overall Study|Withdrawal by Subject|1|||
42240269|NCT02643628|76064107|FG000|Overall Study|Relocated out of state|0|||
42240270|NCT02643628|76064108|FG001|Overall Study|Relocated out of state|1|||
42240271|NCT02643472|76064118|FG000|Overall Study|Death|2|||
42240272|NCT02643472|76064119|FG001|Overall Study|Death|5|||
42240273|NCT02643472|76064118|FG000|Overall Study|Withdrawal by Subject|3|||
42240274|NCT02643472|76064119|FG001|Overall Study|Withdrawal by Subject|2|||
42240275|NCT02643472|76064118|FG000|Overall Study|Protocol Violation|0|||
42240276|NCT02643472|76064119|FG001|Overall Study|Protocol Violation|1|||
42240277|NCT02643472|76064118|FG000|Overall Study|Lost to Follow-up|22|||
42240278|NCT02643472|76064119|FG001|Overall Study|Lost to Follow-up|26|||
42240279|NCT02738840|76064127|FG000|Overall Study|MRI Scan not Performed|5|||
42240280|NCT02738840|76064127|FG000|Overall Study|Lost to Follow-up|1|||
42240281|NCT02738840|76064127|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
42240282|NCT02738840|76064127|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
42240283|NCT02643394|76064133|FG000|Overall Study|Protocol Violation|4|||
42240284|NCT02643394|76064134|FG001|Overall Study|Protocol Violation|5|||
42240285|NCT03538158|76064142|FG000|Overall Study|Lost to Follow-up|13|||
42240286|NCT03538158|76064143|FG001|Overall Study|Lost to Follow-up|7|||
42240287|NCT03538158|76064142|FG000|Overall Study|Withdrawal by Subject|2|||
42240288|NCT03538158|76064143|FG001|Overall Study|Withdrawal by Subject|1|||
42240289|NCT02643082|76064149|FG000|Period 1|Adverse Event|1|||
42240290|NCT02643082|76064150|FG001|Period 1|Adverse Event|0|||
42240291|NCT00353496|76064159|FG000|Overall Study|Adverse Event|1|||
42240292|NCT00353496|76064160|FG001|Overall Study|Adverse Event|0|||
42240293|NCT00353496|76064159|FG000|Overall Study|Protocol Violation|2|||
42240294|NCT00353496|76064160|FG001|Overall Study|Protocol Violation|2|||
42240295|NCT00353496|76064159|FG000|Overall Study|Withdrawal by Subject|3|||
42240296|NCT00353496|76064160|FG001|Overall Study|Withdrawal by Subject|4|||
42240297|NCT00353496|76064159|FG000|Overall Study|Physician Decision|6|||
42240298|NCT00353496|76064160|FG001|Overall Study|Physician Decision|9|||
42240299|NCT00353496|76064159|FG000|Overall Study|Not otherwise specified|4|||
42240300|NCT00353496|76064160|FG001|Overall Study|Not otherwise specified|2|||
42240301|NCT01361464|76064176|FG000|Overall Study|Death|1|||
42240302|NCT01361464|76064176|FG000|Overall Study|Withdrawal by Subject|2|||
42240303|NCT03486912|76064184|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
42240304|NCT03486912|76064185|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
42240305|NCT03486912|76064186|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
42240306|NCT03486912|76064187|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
42240307|NCT03486912|76064184|FG000|Treatment Period|Withdrawal by Subject|3|||
42240308|NCT03486912|76064185|FG001|Treatment Period|Withdrawal by Subject|3|||
42240309|NCT03486912|76064186|FG002|Treatment Period|Withdrawal by Subject|3|||
42240310|NCT03486912|76064187|FG003|Treatment Period|Withdrawal by Subject|2|||
42240311|NCT03486912|76064184|FG000|Treatment Period|Other Reasons|0|||
42240312|NCT03486912|76064185|FG001|Treatment Period|Other Reasons|2|||
42240313|NCT03486912|76064186|FG002|Treatment Period|Other Reasons|1|||
42240314|NCT03486912|76064187|FG003|Treatment Period|Other Reasons|1|||
42240315|NCT03486912|76064184|FG000|Treatment Period|Adverse Event|0|||
42240316|NCT03486912|76064185|FG001|Treatment Period|Adverse Event|1|||
42240317|NCT03486912|76064186|FG002|Treatment Period|Adverse Event|1|||
42240318|NCT03486912|76064187|FG003|Treatment Period|Adverse Event|0|||
42240319|NCT03486912|76064184|FG000|Treatment Period|Lost to Follow-up|1|||
42240320|NCT03486912|76064185|FG001|Treatment Period|Lost to Follow-up|0|||
42240321|NCT03486912|76064186|FG002|Treatment Period|Lost to Follow-up|0|||
42240322|NCT03486912|76064187|FG003|Treatment Period|Lost to Follow-up|2|||
42240323|NCT02642614|76064201|FG000|Overall Study|Adverse Event|1|||
42240324|NCT02642614|76064202|FG001|Overall Study|Adverse Event|1|||
42240325|NCT02642614|76064203|FG002|Overall Study|Adverse Event|2|||
42240326|NCT02642614|76064204|FG003|Overall Study|Adverse Event|2|||
42240327|NCT02642614|76064201|FG000|Overall Study|Lost to Follow-up|1|||
42240328|NCT02642614|76064202|FG001|Overall Study|Lost to Follow-up|0|||
42240329|NCT02642614|76064203|FG002|Overall Study|Lost to Follow-up|0|||
42240330|NCT02642614|76064204|FG003|Overall Study|Lost to Follow-up|0|||
42240331|NCT02642614|76064201|FG000|Overall Study|Withdrawal by Subject|1|||
42240332|NCT02642614|76064202|FG001|Overall Study|Withdrawal by Subject|1|||
42240333|NCT02642614|76064203|FG002|Overall Study|Withdrawal by Subject|0|||
42240334|NCT02642614|76064204|FG003|Overall Study|Withdrawal by Subject|0|||
42240335|NCT02781324|76064219|FG000|Overall Study|Withdrawal by Subject|1|||
42240336|NCT02781324|76064220|FG001|Overall Study|Withdrawal by Subject|0|||
42240337|NCT02781324|76064219|FG000|Overall Study|Physician Decision|1|||
42240338|NCT02781324|76064220|FG001|Overall Study|Physician Decision|2|||
42240339|NCT03292146|76064230|FG000|Baseline to 12 Months|Relocation|1|||
42240340|NCT03292146|76064231|FG001|Baseline to 12 Months|Relocation|0|||
42240341|NCT03292146|76064230|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
42240342|NCT03292146|76064231|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
42240343|NCT03292146|76064230|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
42240344|NCT03292146|76064231|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
42240345|NCT03292146|76064230|FG000|12 Months to 24 Months|Planning pregnancy|2|||
42240346|NCT03292146|76064231|FG001|12 Months to 24 Months|Planning pregnancy|2|||
42240347|NCT03292146|76064230|FG000|12 Months to 24 Months|Personal reasons|1|||
42240348|NCT03292146|76064231|FG001|12 Months to 24 Months|Personal reasons|0|||
42240349|NCT03292146|76064230|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
42240350|NCT03292146|76064231|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
42240351|NCT01360996|76064240|FG000|Overall Study|Withdrawal by Subject|4|||
42240352|NCT01360996|76064241|FG001|Overall Study|Withdrawal by Subject|3|||
42240353|NCT01360996|76064242|FG002|Overall Study|Withdrawal by Subject|2|||
42240354|NCT01360996|76064240|FG000|Overall Study|Noncompliant|2|||
42240355|NCT01360996|76064241|FG001|Overall Study|Noncompliant|0|||
42240356|NCT01360996|76064242|FG002|Overall Study|Noncompliant|0|||
42240357|NCT02639338|76064251|FG000|Overall Study|Lost to Follow-up|2|||
42240358|NCT02639338|76064252|FG001|Overall Study|Lost to Follow-up|2|||
42240359|NCT02639338|76064251|FG000|Overall Study|Withdrew Consent|1|||
42240360|NCT02639338|76064252|FG001|Overall Study|Withdrew Consent|2|||
42240361|NCT02639338|76064251|FG000|Overall Study|Death|1|||
42240362|NCT02639338|76064252|FG001|Overall Study|Death|0|||
42240363|NCT02639338|76064251|FG000|Overall Study|Randomized but Not Treated|0|||
42240364|NCT02639338|76064252|FG001|Overall Study|Randomized but Not Treated|1|||
42240365|NCT01754857|76064258|FG000|Overall Study|Adverse Event|7|||
42240366|NCT01754857|76064258|FG000|Overall Study|Disease progression|3|||
42240367|NCT01754857|76064258|FG000|Overall Study|Physician Decision|2|||
42240368|NCT01754857|76064258|FG000|Overall Study|Withdrawal by Subject|3|||
42240369|NCT01754857|76064258|FG000|Overall Study|other complicating disease|1|||
42240370|NCT01754857|76064258|FG000|Overall Study|ineligible to continue onto maintenance|1|||
42240371|NCT01754857|76064258|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
42240372|NCT01754857|76064258|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
42240373|NCT02900352|76064264|FG000|Overall Study|Lost to Follow-up|28|||
42240374|NCT02900352|76064265|FG001|Overall Study|Lost to Follow-up|17|||
42240375|NCT03040687|76064274|FG000|Overall Study|Withdrawal by Subject|1|||
42240376|NCT03040687|76064275|FG001|Overall Study|Withdrawal by Subject|0|||
42240377|NCT03040687|76064276|FG002|Overall Study|Withdrawal by Subject|0|||
42240378|NCT03042559|76064286|FG000|Overall Study|drop out|1|||
42240379|NCT03042559|76064287|FG001|Overall Study|drop out|1|||
42240380|NCT02780856|76064293|FG000|Overall Study|Lost to Follow-up|1|||
42240381|NCT02321540|76064306|FG000|Overall Study|Death|0|||
42240382|NCT02321540|76064307|FG001|Overall Study|Death|1|||
42240383|NCT02321540|76064306|FG000|Overall Study|Progression|3|||
42240384|NCT02321540|76064307|FG001|Overall Study|Progression|9|||
42240385|NCT00108732|76064337|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
42240386|NCT00108732|76064337|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
42240387|NCT00108732|76064337|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
42240388|NCT00108732|76064337|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
42240389|NCT00108732|76064337|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
42240390|NCT00108732|76064337|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
42240391|NCT00108732|76064337|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
42240392|NCT00107952|76064343|FG000|Overall Study|Death|75|||
42240393|NCT00107952|76064344|FG001|Overall Study|Death|61|||
42240394|NCT00107952|76064343|FG000|Overall Study|Lost to Follow-up|0|||
42240395|NCT00107952|76064344|FG001|Overall Study|Lost to Follow-up|3|||
42240396|NCT00107952|76064343|FG000|Overall Study|Withdrawal by Subject|9|||
42240397|NCT00107952|76064344|FG001|Overall Study|Withdrawal by Subject|6|||
42240398|NCT00107952|76064343|FG000|Overall Study|Other|2|||
42240399|NCT00107952|76064344|FG001|Overall Study|Other|5|||
42240400|NCT00107952|76064343|FG000|Overall Study|Never received study treatment|9|||
42240401|NCT00107952|76064344|FG001|Overall Study|Never received study treatment|6|||
42240402|NCT01366638|76064362|FG000|Overall Study|Withdrawal by Subject|0|||
42240403|NCT01366638|76064363|FG001|Overall Study|Withdrawal by Subject|0|||
42240404|NCT01366638|76064364|FG002|Overall Study|Withdrawal by Subject|6|||
42240405|NCT01366638|76064362|FG000|Overall Study|Other|1|||
42240406|NCT01366638|76064363|FG001|Overall Study|Other|0|||
42240407|NCT01366638|76064364|FG002|Overall Study|Other|0|||
42240408|NCT02780700|76064372|FG000|Overall Study|Progressive disease|1|||
42240409|NCT04230122|76064410|FG000|Overall Study|Lost to Follow-up|1|||
42240410|NCT04230122|76064411|FG001|Overall Study|Lost to Follow-up|0|||
42240411|NCT02780388|76064422|FG000|Overall Study|Lost to Follow-up|0|||
42240412|NCT02780388|76064423|FG001|Overall Study|Lost to Follow-up|1|||
42240413|NCT02780388|76064424|FG002|Overall Study|Lost to Follow-up|0|||
42240414|NCT02780388|76064425|FG003|Overall Study|Lost to Follow-up|0|||
42240415|NCT02780388|76064426|FG004|Overall Study|Lost to Follow-up|0|||
42240416|NCT02780388|76064422|FG000|Overall Study|Withdrawal by Subject|1|||
42240417|NCT02780388|76064423|FG001|Overall Study|Withdrawal by Subject|1|||
42240418|NCT02780388|76064424|FG002|Overall Study|Withdrawal by Subject|0|||
42240419|NCT02780388|76064425|FG003|Overall Study|Withdrawal by Subject|0|||
42240420|NCT02780388|76064426|FG004|Overall Study|Withdrawal by Subject|0|||
42240421|NCT03491462|76064444|FG000|Overall Study|Lost to Follow-up|2|||
42240422|NCT03491462|76064445|FG001|Overall Study|Lost to Follow-up|0|||
42240423|NCT03491462|76064444|FG000|Overall Study|Adverse Event|11|||
42240424|NCT03491462|76064445|FG001|Overall Study|Adverse Event|1|||
42240425|NCT03491462|76064444|FG000|Overall Study|Physician Decision|3|||
42240426|NCT03491462|76064445|FG001|Overall Study|Physician Decision|0|||
42240427|NCT03491462|76064444|FG000|Overall Study|Withdrawal by Subject|22|||
42240428|NCT03491462|76064445|FG001|Overall Study|Withdrawal by Subject|15|||
42240429|NCT02224573|76064453|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
42240430|NCT02224573|76064454|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
42240431|NCT02224573|76064453|FG000|Treatment Phase|Started on Other IMP|1|||
42240432|NCT02224573|76064454|FG001|Treatment Phase|Started on Other IMP|0|||
42240433|NCT02224573|76064453|FG000|Treatment Phase|Participant Discontinued IMP|0|||
42240434|NCT02224573|76064454|FG001|Treatment Phase|Participant Discontinued IMP|1|||
42240435|NCT02224573|76064453|FG000|Treatment Phase|Lack of Efficacy|15|||
42240436|NCT02224573|76064454|FG001|Treatment Phase|Lack of Efficacy|8|||
42240437|NCT02224573|76064453|FG000|Treatment Phase|Began Commercial Product|1|||
42240438|NCT02224573|76064454|FG001|Treatment Phase|Began Commercial Product|0|||
42240439|NCT02224573|76064453|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
42240440|NCT02224573|76064454|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
42240441|NCT02224573|76064453|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
42240442|NCT02224573|76064454|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
42240443|NCT02224573|76064453|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
42240444|NCT02224573|76064454|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
42240445|NCT02224573|76064453|FG000|Treatment Phase|Continued Compassionate Use|1|||
42240446|NCT02224573|76064454|FG001|Treatment Phase|Continued Compassionate Use|0|||
42240447|NCT02224573|76064453|FG000|Treatment Phase|Lack of Efficiency|2|||
42240448|NCT02224573|76064454|FG001|Treatment Phase|Lack of Efficiency|1|||
42240449|NCT02224573|76064453|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
42240450|NCT02224573|76064454|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
42240451|NCT02224573|76064453|FG000|Treatment Phase|Participant Moved|2|||
42240452|NCT02224573|76064454|FG001|Treatment Phase|Participant Moved|0|||
42240453|NCT02224573|76064453|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
42240454|NCT02224573|76064454|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
42240455|NCT02224573|76064453|FG000|Treatment Phase|Refused Medication|1|||
42240456|NCT02224573|76064454|FG001|Treatment Phase|Refused Medication|1|||
42240457|NCT02224573|76064453|FG000|Treatment Phase|Adverse Event|26|||
42240458|NCT02224573|76064454|FG001|Treatment Phase|Adverse Event|38|||
42240459|NCT02224573|76064453|FG000|Treatment Phase|Placed in Group Home|0|||
42240460|NCT02224573|76064454|FG001|Treatment Phase|Placed in Group Home|1|||
42240461|NCT02224573|76064453|FG000|Treatment Phase|Pursued Other Trials|1|||
42240462|NCT02224573|76064454|FG001|Treatment Phase|Pursued Other Trials|0|||
42240463|NCT02224573|76064453|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
42240464|NCT02224573|76064454|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
42240465|NCT02224573|76064453|FG000|Treatment Phase|Lost to Follow-up|2|||
42240466|NCT02224573|76064454|FG001|Treatment Phase|Lost to Follow-up|1|||
42240467|NCT02224573|76064453|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
42240468|NCT02224573|76064454|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
42240469|NCT02224573|76064453|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
42240470|NCT02224573|76064454|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
42240471|NCT02224573|76064453|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
42240472|NCT02224573|76064454|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
42240473|NCT02224573|76064453|FG000|Taper Phase|Adverse Event|1|||
42240474|NCT02224573|76064454|FG001|Taper Phase|Adverse Event|1|||
42240475|NCT01360840|76064464|FG000|Overall Study|Ongoing at data cut-off|10|||
42240476|NCT01360840|76064465|FG001|Overall Study|Ongoing at data cut-off|10|||
42240477|NCT01360840|76064466|FG002|Overall Study|Ongoing at data cut-off|9|||
42240478|NCT03350984|76064478|FG000|Overall Study|Death|1|||
42240479|NCT03350984|76064479|FG001|Overall Study|Death|0|||
42240480|NCT03350984|76064478|FG000|Overall Study|Lost to Follow-up|5|||
42240481|NCT03350984|76064479|FG001|Overall Study|Lost to Follow-up|6|||
42240482|NCT03350984|76064478|FG000|Overall Study|Protocol Violation|1|||
42240483|NCT03350984|76064479|FG001|Overall Study|Protocol Violation|2|||
42240484|NCT03350984|76064478|FG000|Overall Study|Physician Decision|1|||
42240485|NCT03350984|76064479|FG001|Overall Study|Physician Decision|0|||
42240486|NCT05176717|76064497|FG000|Overall Study|Sponsor Decision|1|||
42240487|NCT05176717|76064498|FG001|Overall Study|Sponsor Decision|2|||
42240488|NCT05176717|76064499|FG002|Overall Study|Sponsor Decision|2|||
42240489|NCT02770248|76064509|FG000|Overall Study|Adverse Event|0|||
42240490|NCT02770248|76064510|FG001|Overall Study|Adverse Event|1|||
42240491|NCT02770248|76064509|FG000|Overall Study|Randomized in error, prior to treatment|0|||
42240492|NCT02770248|76064510|FG001|Overall Study|Randomized in error, prior to treatment|1|||
42240493|NCT01344369|76064518|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
42240494|NCT01344369|76064519|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
42240495|NCT01344369|76064518|FG000|Washout of 28 Days|Physician Decision|0|||
42240496|NCT01344369|76064519|FG001|Washout of 28 Days|Physician Decision|1|||
42240497|NCT01344369|76064518|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
42240498|NCT01344369|76064519|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
42240499|NCT03179462|76064528|FG000|Overall Study|screening failure|1|||
42240500|NCT03179462|76064529|FG001|Overall Study|screening failure|2|||
42240501|NCT03179462|76064530|FG002|Overall Study|screening failure|0|||
42240502|NCT01314703|76064538|FG000|Overall Study|screen failure and closed enrollment|8|||
42240503|NCT01360762|76064543|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
42240504|NCT01360762|76064543|FG000|Main Study Period (12-month Treatment)|Death|5|||
42240505|NCT01360762|76064543|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
42240506|NCT01360762|76064543|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
42240507|NCT01360762|76064543|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
42240508|NCT01360762|76064543|FG000|Whole Study Period|Lost to Follow-up|10|||
42240509|NCT01360762|76064543|FG000|Whole Study Period|Death|7|||
42240510|NCT01360762|76064543|FG000|Whole Study Period|Patient relapsed|18|||
42240511|NCT01360762|76064543|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
42240512|NCT04382924|76064550|FG000|Overall Study|Death|2|||
42240513|NCT04382924|76064551|FG001|Overall Study|Death|5|||
42240514|NCT04382924|76064552|FG002|Overall Study|Death|4|||
42240515|NCT04382924|76064550|FG000|Overall Study|Protocol Violation|0|||
42240516|NCT04382924|76064551|FG001|Overall Study|Protocol Violation|1|||
42240517|NCT04382924|76064552|FG002|Overall Study|Protocol Violation|1|||
42240518|NCT04382924|76064550|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
42240519|NCT04382924|76064551|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
42240520|NCT04382924|76064552|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
42240521|NCT04382924|76064550|FG000|Overall Study|Withdrawal by Subject|6|||
42240522|NCT04382924|76064551|FG001|Overall Study|Withdrawal by Subject|3|||
42240523|NCT04382924|76064552|FG002|Overall Study|Withdrawal by Subject|6|||
42240524|NCT03044431|76064566|FG000|Overall Study|Lost to Follow-up|59|||
42240525|NCT02770170|76064574|FG000|Overall Study|Withdrawal by Subject|0|||
42240526|NCT02770170|76064575|FG001|Overall Study|Withdrawal by Subject|0|||
42240527|NCT02770170|76064576|FG002|Overall Study|Withdrawal by Subject|0|||
42240528|NCT02770170|76064577|FG003|Overall Study|Withdrawal by Subject|2|||
42240529|NCT02770170|76064574|FG000|Overall Study|due to pregnancy|1|||
42240530|NCT02770170|76064575|FG001|Overall Study|due to pregnancy|0|||
42240531|NCT02770170|76064576|FG002|Overall Study|due to pregnancy|0|||
42240532|NCT02770170|76064577|FG003|Overall Study|due to pregnancy|0|||
42240533|NCT02770170|76064574|FG000|Overall Study|Lack of Efficacy|2|||
42240534|NCT02770170|76064575|FG001|Overall Study|Lack of Efficacy|0|||
42240535|NCT02770170|76064576|FG002|Overall Study|Lack of Efficacy|0|||
42240536|NCT02770170|76064577|FG003|Overall Study|Lack of Efficacy|1|||
42240537|NCT02770170|76064574|FG000|Overall Study|Adverse Event|4|||
42240538|NCT02770170|76064575|FG001|Overall Study|Adverse Event|3|||
42240539|NCT02770170|76064576|FG002|Overall Study|Adverse Event|5|||
42240540|NCT02770170|76064577|FG003|Overall Study|Adverse Event|3|||
42240541|NCT02770170|76064574|FG000|Overall Study|due to disease worsening|0|||
42240542|NCT02770170|76064575|FG001|Overall Study|due to disease worsening|0|||
42240543|NCT02770170|76064576|FG002|Overall Study|due to disease worsening|0|||
42240544|NCT02770170|76064577|FG003|Overall Study|due to disease worsening|1|||
42240545|NCT02769858|76064587|FG000|Overall Study|Withdrawal by Subject|2|||
42240546|NCT02769624|76064591|FG000|Overall Study|Lost to Follow-up|0|||
42240547|NCT02769624|76064592|FG001|Overall Study|Lost to Follow-up|1|||
42240548|NCT03446768|76064600|FG000|Overall Study|Withdrawal by Subject|0|||
42240549|NCT03446768|76064601|FG001|Overall Study|Withdrawal by Subject|1|||
42240550|NCT02676284|76064607|FG000|Overall Study|Withdrawal by Subject|1|||
42240551|NCT02769312|76064613|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
42240552|NCT02769312|76064614|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
42240553|NCT02769312|76064613|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
42240554|NCT02769312|76064614|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
42240555|NCT02769312|76064613|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
42240556|NCT02769312|76064614|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
42240557|NCT02769312|76064613|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
42240558|NCT02769312|76064614|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
42240559|NCT02769312|76064613|FG000|Follow-up|Lost to Follow-up|1|||
42240560|NCT02769312|76064614|FG001|Follow-up|Lost to Follow-up|1|||
42240561|NCT01673386|76064621|FG000|Overall Study|Study terminated by sponsor|16|||
42240562|NCT01673386|76064622|FG001|Overall Study|Study terminated by sponsor|22|||
42240563|NCT01673386|76064621|FG000|Overall Study|Adverse Event|5|||
42240564|NCT01673386|76064622|FG001|Overall Study|Adverse Event|2|||
42240565|NCT01673386|76064621|FG000|Overall Study|Progressive disease|4|||
42240566|NCT01673386|76064622|FG001|Overall Study|Progressive disease|1|||
42240567|NCT01673386|76064621|FG000|Overall Study|Withdrawal by Subject|0|||
42240568|NCT01673386|76064622|FG001|Overall Study|Withdrawal by Subject|2|||
42240569|NCT00103740|76064630|FG000|Period 1 - Core|Adverse Event|1|||
42240570|NCT00103740|76064631|FG001|Period 1 - Core|Adverse Event|0|||
42240571|NCT00103740|76064630|FG000|Period 1 - Core|Protocol Violation|3|||
42240572|NCT00103740|76064631|FG001|Period 1 - Core|Protocol Violation|2|||
42240573|NCT00103740|76064630|FG000|Period 1 - Core|Patient withdrew consent|3|||
42240574|NCT00103740|76064631|FG001|Period 1 - Core|Patient withdrew consent|2|||
42240575|NCT00103740|76064630|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
42240576|NCT00103740|76064631|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
42240577|NCT00103740|76064630|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
42240578|NCT00103740|76064631|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
42240579|NCT00103740|76064630|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
42240580|NCT00103740|76064631|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
42240581|NCT00103740|76064630|FG000|Period 2 - Extended Observation Period|Death|6|||
42240582|NCT00103740|76064631|FG001|Period 2 - Extended Observation Period|Death|2|||
42240583|NCT00103740|76064630|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
42240584|NCT00103740|76064631|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
42240585|NCT01281644|76064637|FG000|Overall Study|Lost to Follow-up|3|||
42240586|NCT01281644|76064637|FG000|Overall Study|Withdrawal by Subject|2|||
42240587|NCT02869893|76064643|FG000|Overall Study|participant aversion to IV|5|||
42240588|NCT02869893|76064643|FG000|Overall Study|participant fear of MRI scanner|2|||
42240589|NCT02872311|76064667|FG000|Overall Study|Death|2|||
42240590|NCT02872311|76064668|FG001|Overall Study|Death|0|||
42240591|NCT02872311|76064669|FG002|Overall Study|Death|0|||
42240592|NCT02872311|76064670|FG003|Overall Study|Death|0|||
42240593|NCT02872311|76064671|FG004|Overall Study|Death|0|||
42240594|NCT02872311|76064667|FG000|Overall Study|Lost to Follow-up|2|||
42240595|NCT02872311|76064668|FG001|Overall Study|Lost to Follow-up|0|||
42240596|NCT02872311|76064669|FG002|Overall Study|Lost to Follow-up|0|||
42240597|NCT02872311|76064670|FG003|Overall Study|Lost to Follow-up|0|||
42240598|NCT02872311|76064671|FG004|Overall Study|Lost to Follow-up|0|||
42240599|NCT02872311|76064667|FG000|Overall Study|Protocol Violation|0|||
42240600|NCT02872311|76064668|FG001|Overall Study|Protocol Violation|2|||
42240601|NCT02872311|76064669|FG002|Overall Study|Protocol Violation|1|||
42240602|NCT02872311|76064670|FG003|Overall Study|Protocol Violation|0|||
42240603|NCT02872311|76064671|FG004|Overall Study|Protocol Violation|0|||
42240604|NCT02871375|76064699|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
42240605|NCT02871375|76064700|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
42240606|NCT02867709|76064711|FG000|Treatment Period|Adverse Event|1|||
42240607|NCT02867709|76064712|FG001|Treatment Period|Adverse Event|1|||
42240608|NCT02867709|76064713|FG002|Treatment Period|Adverse Event|2|||
42240609|NCT02867709|76064711|FG000|Treatment Period|Withdrawal of Consent|7|||
42240610|NCT02867709|76064712|FG001|Treatment Period|Withdrawal of Consent|9|||
42240611|NCT02867709|76064713|FG002|Treatment Period|Withdrawal of Consent|8|||
42240612|NCT02867709|76064711|FG000|Treatment Period|Lost to Follow-up|17|||
42240613|NCT02867709|76064712|FG001|Treatment Period|Lost to Follow-up|20|||
42240614|NCT02867709|76064713|FG002|Treatment Period|Lost to Follow-up|20|||
42240615|NCT02867709|76064711|FG000|Treatment Period|Lack of Qualifying Event|42|||
42240616|NCT02867709|76064712|FG001|Treatment Period|Lack of Qualifying Event|55|||
42240617|NCT02867709|76064713|FG002|Treatment Period|Lack of Qualifying Event|42|||
42240618|NCT02867709|76064711|FG000|Treatment Period|Protocol Violation|3|||
42240619|NCT02867709|76064712|FG001|Treatment Period|Protocol Violation|2|||
42240620|NCT02867709|76064713|FG002|Treatment Period|Protocol Violation|3|||
42240621|NCT02867709|76064711|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
42240622|NCT02867709|76064712|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
42240623|NCT02867709|76064713|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
42240624|NCT02867709|76064711|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
42240625|NCT02867709|76064712|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
42240626|NCT02867709|76064713|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
42240627|NCT02867709|76064711|FG000|Safety Follow-up Period|Pregnancy|0|||
42240628|NCT02867709|76064712|FG001|Safety Follow-up Period|Pregnancy|1|||
42132002|NCT00318370|75942833|FG000|Period 3|Lack of Efficacy|0|||
42132003|NCT00318370|75942834|FG001|Period 3|Lack of Efficacy|0|||
42132004|NCT00318370|75942835|FG002|Period 3|Lack of Efficacy|24|||
42132005|NCT00318370|75942833|FG000|Period 3|Death|0|||
42240629|NCT02867709|76064713|FG002|Safety Follow-up Period|Pregnancy|0|||
42240630|NCT02867709|76064711|FG000|Safety Follow-up Period|Protocol Violation|0|||
42240631|NCT02867709|76064712|FG001|Safety Follow-up Period|Protocol Violation|1|||
42240632|NCT02867709|76064713|FG002|Safety Follow-up Period|Protocol Violation|1|||
42132006|NCT00318370|75942834|FG001|Period 3|Death|0|||
42240633|NCT03044353|76064724|FG000|Overall Study|Adverse Event|0|||
42240634|NCT03044353|76064725|FG001|Overall Study|Adverse Event|1|||
42240635|NCT03044353|76064726|FG002|Overall Study|Adverse Event|0|||
42240636|NCT01361308|76064735|FG000|Overall Study|Withdrawal by Subject|9|||
42240637|NCT01361308|76064736|FG001|Overall Study|Withdrawal by Subject|13|||
42240638|NCT01361308|76064735|FG000|Overall Study|Physician Decision|3|||
42240639|NCT01361308|76064736|FG001|Overall Study|Physician Decision|3|||
42240640|NCT01361308|76064735|FG000|Overall Study|Lack of Efficacy|2|||
42240641|NCT01361308|76064736|FG001|Overall Study|Lack of Efficacy|0|||
42240642|NCT01361308|76064735|FG000|Overall Study|Protocol Violation|1|||
42240643|NCT01361308|76064736|FG001|Overall Study|Protocol Violation|0|||
42240644|NCT01361308|76064735|FG000|Overall Study|Lost to Follow-up|5|||
42240645|NCT01361308|76064736|FG001|Overall Study|Lost to Follow-up|4|||
42240646|NCT01361308|76064735|FG000|Overall Study|Adverse Event|8|||
42240647|NCT01361308|76064736|FG001|Overall Study|Adverse Event|4|||
42240648|NCT01361308|76064735|FG000|Overall Study|Eligibility Criteria Not Met|2|||
42240649|NCT01361308|76064736|FG001|Overall Study|Eligibility Criteria Not Met|3|||
42240650|NCT01361308|76064735|FG000|Overall Study|Failed C-SSRS|5|||
42240651|NCT01361308|76064736|FG001|Overall Study|Failed C-SSRS|2|||
42240652|NCT01361308|76064735|FG000|Overall Study|Other|0|||
42240653|NCT01361308|76064736|FG001|Overall Study|Other|1|||
42240654|NCT02872935|76064748|FG000|Overall Study|Other|0|||
42240655|NCT02872935|76064749|FG001|Overall Study|Other|1|||
42240656|NCT00103662|76064757|FG000|Overall Study|Entered Rescue Procedure|0|||
42240657|NCT00103662|76064758|FG001|Overall Study|Entered Rescue Procedure|7|||
42240658|NCT00103662|76064757|FG000|Overall Study|Death|7|||
42240659|NCT00103662|76064758|FG001|Overall Study|Death|7|||
42240660|NCT00103662|76064757|FG000|Overall Study|Elective Withdrawal|5|||
42240661|NCT00103662|76064758|FG001|Overall Study|Elective Withdrawal|5|||
42240662|NCT00103662|76064757|FG000|Overall Study|Lost to Follow-up|0|||
42240663|NCT00103662|76064758|FG001|Overall Study|Lost to Follow-up|1|||
42240664|NCT00103662|76064757|FG000|Overall Study|Other|6|||
42240665|NCT00103662|76064758|FG001|Overall Study|Other|9|||
42240666|NCT00103662|76064757|FG000|Overall Study|Failed mobilization|0|||
42240667|NCT00103662|76064758|FG001|Overall Study|Failed mobilization|4|||
42240668|NCT00103662|76064757|FG000|Overall Study|Intercurrent illness|1|||
42240669|NCT00103662|76064758|FG001|Overall Study|Intercurrent illness|0|||
42240670|NCT02865915|76064766|FG000|Overall Study|Pregnancy|1|||
42240671|NCT02865915|76064767|FG001|Overall Study|Pregnancy|0|||
42240672|NCT02865915|76064766|FG000|Overall Study|Withdrawal by Subject|1|||
42240673|NCT02865915|76064767|FG001|Overall Study|Withdrawal by Subject|1|||
42240674|NCT02865915|76064766|FG000|Overall Study|Adverse Event|0|||
42240675|NCT02865915|76064767|FG001|Overall Study|Adverse Event|4|||
42240676|NCT02865915|76064766|FG000|Overall Study|Lost to Follow-up|0|||
42240677|NCT02865915|76064767|FG001|Overall Study|Lost to Follow-up|1|||
42240678|NCT02865915|76064766|FG000|Overall Study|Protocol Violation|0|||
41988444|NCT01251367|75795850|FG000|Overall Study|Lack of Efficacy|2|||
42302684|NCT01651039|76138050|FG000|Overall Study|Physician Decision|2|||
41988445|NCT01251367|75795850|FG000|Overall Study|Adverse Event|19|||
42240679|NCT02865915|76064767|FG001|Overall Study|Protocol Violation|1|||
42132007|NCT00318370|75942835|FG002|Period 3|Death|1|||
42240680|NCT02865915|76064766|FG000|Overall Study|Study terminated by sponsor|23|||
42240681|NCT02865915|76064767|FG001|Overall Study|Study terminated by sponsor|18|||
42240682|NCT02865915|76064766|FG000|Overall Study|Dosing group discontinued|0|||
42240683|NCT02865915|76064767|FG001|Overall Study|Dosing group discontinued|5|||
42240684|NCT00104676|76064775|FG000|Overall Study|Death|3|||
42132008|NCT00318370|75942833|FG000|Period 3|Physician Decision|0|||
42240685|NCT00104676|76064776|FG001|Overall Study|Death|2|||
42240686|NCT00104676|76064775|FG000|Overall Study|Withdrawal by Subject|0|||
42240687|NCT00104676|76064776|FG001|Overall Study|Withdrawal by Subject|2|||
42240688|NCT00104676|76064775|FG000|Overall Study|treatment interruption|4|||
42240689|NCT00104676|76064776|FG001|Overall Study|treatment interruption|10|||
42240690|NCT00354835|76064784|FG000|Overall Study|Death|1|||
42240691|NCT00354835|76064785|FG001|Overall Study|Death|1|||
42240692|NCT00354835|76064784|FG000|Overall Study|Physician Decision|8|||
42240693|NCT00354835|76064785|FG001|Overall Study|Physician Decision|13|||
42240694|NCT00354835|76064784|FG000|Overall Study|Withdrawal by Subject|2|||
42240695|NCT00354835|76064785|FG001|Overall Study|Withdrawal by Subject|1|||
42240696|NCT00354835|76064784|FG000|Overall Study|Ineligible|17|||
42240697|NCT00354835|76064785|FG001|Overall Study|Ineligible|16|||
42240698|NCT00354835|76064784|FG000|Overall Study|Disease progression or relapse|15|||
42240699|NCT00354835|76064785|FG001|Overall Study|Disease progression or relapse|22|||
42240700|NCT00354835|76064784|FG000|Overall Study|Adverse Event|6|||
42240701|NCT00354835|76064785|FG001|Overall Study|Adverse Event|0|||
42240702|NCT00354835|76064784|FG000|Overall Study|Refusal of further therapy|3|||
42240703|NCT00354835|76064785|FG001|Overall Study|Refusal of further therapy|8|||
42240704|NCT02768298|76064808|FG000|Overall Study|Adverse Event|1|||
42240705|NCT02768298|76064809|FG001|Overall Study|Adverse Event|4|||
42240706|NCT02768298|76064808|FG000|Overall Study|Death|2|||
42240707|NCT02768298|76064809|FG001|Overall Study|Death|1|||
42240708|NCT02768298|76064808|FG000|Overall Study|Non-compliance with study treatment|0|||
42240709|NCT02768298|76064809|FG001|Overall Study|Non-compliance with study treatment|1|||
42240710|NCT02768298|76064808|FG000|Overall Study|Subject/guardian decision|1|||
42240711|NCT02768298|76064809|FG001|Overall Study|Subject/guardian decision|0|||
42240712|NCT02768298|76064808|FG000|Overall Study|Withdrawal of informed consent|0|||
42240713|NCT02768298|76064809|FG001|Overall Study|Withdrawal of informed consent|1|||
42240714|NCT02775864|76064819|FG000|Overall Study|Data ended end of 2010|1764|||
42240715|NCT02775864|76064820|FG001|Overall Study|Data ended end of 2010|2880|||
42240716|NCT02775864|76064821|FG002|Overall Study|Data ended end of 2010|1140|||
42240717|NCT02775864|76064822|FG003|Overall Study|Data ended end of 2010|1194|||
42240718|NCT02775864|76064819|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
42240719|NCT02775864|76064820|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
42240720|NCT02775864|76064821|FG002|Overall Study|Medicaid eligibility discontinued|720|||
42240721|NCT02775864|76064822|FG003|Overall Study|Medicaid eligibility discontinued|890|||
42240722|NCT02964273|76064835|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
42240723|NCT02964273|76064836|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
42240724|NCT02964273|76064837|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
42240725|NCT02964273|76064838|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
42032736|NCT00862849|75841004|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
42032737|NCT00862849|75841005|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
42032738|NCT00862849|75841006|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
42032739|NCT00862849|75841001|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
42032740|NCT00862849|75841002|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
42240726|NCT02964273|76064835|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
42240727|NCT02964273|76064836|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
42240728|NCT02964273|76064837|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
42240729|NCT02964273|76064838|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
42240730|NCT02964273|76064835|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
42240731|NCT02964273|76064836|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
41988446|NCT01251367|75795850|FG000|Overall Study|Withdrawal by Subject|36|||
41988447|NCT01251367|75795850|FG000|Overall Study|Lost to Follow-up|5|||
41988448|NCT01251367|75795850|FG000|Overall Study|Subject Required Alternative Treatment|7|||
41988449|NCT01251367|75795850|FG000|Overall Study|No Study Drug Available|1|||
41988450|NCT01251367|75795850|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
41988451|NCT01251367|75795850|FG000|Overall Study|End of Study Visit Performed in Error|1|||
41988452|NCT01250509|75795856|FG000|Overall Study|Lost to Follow-up|5|||
42240732|NCT02964273|76064837|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
42240733|NCT02964273|76064838|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
42240734|NCT02964273|76064835|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
41988453|NCT01250509|75795857|FG001|Overall Study|Lost to Follow-up|2|||
42240735|NCT02964273|76064836|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
42240736|NCT02964273|76064837|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
42240737|NCT02964273|76064838|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
42240738|NCT02964273|76064835|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
42240739|NCT02964273|76064836|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
42240740|NCT02964273|76064837|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
41988454|NCT01250119|75795865|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
41988455|NCT01250119|75795866|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
41988456|NCT01250119|75795865|FG000|Diagnostic Phase|Participants Not Tested|44|||
41988457|NCT01250119|75795866|FG001|Diagnostic Phase|Participants Not Tested|0|||
41988458|NCT01250119|75795865|FG000|Treatment Phase|Progressive Disease|0|||
41988459|NCT01250119|75795866|FG001|Treatment Phase|Progressive Disease|32|||
41988460|NCT01250119|75795865|FG000|Treatment Phase|Death|0|||
41988461|NCT01250119|75795866|FG001|Treatment Phase|Death|2|||
41988462|NCT01250119|75795865|FG000|Treatment Phase|Withdrawal by Subject|0|||
41988463|NCT01250119|75795866|FG001|Treatment Phase|Withdrawal by Subject|1|||
41988464|NCT01250119|75795865|FG000|Treatment Phase|Adverse Event|0|||
41988465|NCT01250119|75795866|FG001|Treatment Phase|Adverse Event|2|||
41988466|NCT01250119|75795865|FG000|Treatment Phase|Unknown reason|0|||
41988467|NCT01250119|75795866|FG001|Treatment Phase|Unknown reason|4|||
41988468|NCT01250002|75795875|FG000|Overall Study|Change to open surgical procedure|4|||
41988469|NCT01250002|75795876|FG001|Overall Study|Change to open surgical procedure|3|||
41988470|NCT01246960|75795884|FG000|Overall Study|Lost to Follow-up|3|||
41988471|NCT01246960|75795885|FG001|Overall Study|Lost to Follow-up|1|||
41988472|NCT01246960|75795884|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
41988473|NCT01246960|75795885|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
41988474|NCT01244620|75795891|FG000|Overall Study|Study terminated|4|||
41988475|NCT01244620|75795892|FG001|Overall Study|Study terminated|4|||
41988476|NCT01244620|75795893|FG002|Overall Study|Study terminated|4|||
41988477|NCT01244620|75795894|FG003|Overall Study|Study terminated|4|||
41988478|NCT01267201|75795904|FG000|First Intervention Period|Withdrawal by Subject|1|||
41988479|NCT01267201|75795905|FG001|First Intervention Period|Withdrawal by Subject|0|||
41988480|NCT01267201|75795906|FG002|First Intervention Period|Withdrawal by Subject|0|||
41988481|NCT01267201|75795907|FG003|First Intervention Period|Withdrawal by Subject|0|||
41988482|NCT01267201|75795908|FG004|First Intervention Period|Withdrawal by Subject|0|||
41988483|NCT01267201|75795909|FG005|First Intervention Period|Withdrawal by Subject|0|||
41988484|NCT01267201|75795904|FG000|Second Intervention Period|Withdrawal by Subject|0|||
41988485|NCT01267201|75795905|FG001|Second Intervention Period|Withdrawal by Subject|1|||
41988486|NCT01267201|75795906|FG002|Second Intervention Period|Withdrawal by Subject|0|||
41988487|NCT01267201|75795907|FG003|Second Intervention Period|Withdrawal by Subject|0|||
41988488|NCT01267201|75795908|FG004|Second Intervention Period|Withdrawal by Subject|0|||
41988489|NCT01267201|75795909|FG005|Second Intervention Period|Withdrawal by Subject|0|||
41988490|NCT01266967|75795919|FG000|Overall Study|Death|69|||
41988491|NCT01266967|75795920|FG001|Overall Study|Death|61|||
41988492|NCT01266967|75795919|FG000|Overall Study|Study Closed/Terminated|15|||
41988493|NCT01266967|75795920|FG001|Overall Study|Study Closed/Terminated|17|||
41988494|NCT01266967|75795919|FG000|Overall Study|Lost to Follow-up|2|||
41988495|NCT01266967|75795920|FG001|Overall Study|Lost to Follow-up|1|||
41988496|NCT01266967|75795919|FG000|Overall Study|Physician Decision|0|||
41988497|NCT01266967|75795920|FG001|Overall Study|Physician Decision|1|||
42032741|NCT00862849|75841003|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
42032742|NCT00862849|75841004|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
41988498|NCT01266967|75795919|FG000|Overall Study|Withdrawal by Subject|3|||
42032743|NCT00862849|75841005|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
42032744|NCT00862849|75841006|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
41988499|NCT01266967|75795920|FG001|Overall Study|Withdrawal by Subject|3|||
41988500|NCT01266850|75795934|FG000|Overall Study|Lost to Follow-up|19|||
41988501|NCT01266850|75795935|FG001|Overall Study|Lost to Follow-up|19|||
41988502|NCT01266850|75795936|FG002|Overall Study|Lost to Follow-up|13|||
41988503|NCT01266850|75795937|FG003|Overall Study|Lost to Follow-up|13|||
41988504|NCT01266850|75795938|FG004|Overall Study|Lost to Follow-up|12|||
41988505|NCT01266850|75795934|FG000|Overall Study|Withdrawal by Subject|8|||
42240741|NCT02964273|76064838|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
42240742|NCT02964273|76064835|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
42240743|NCT02964273|76064836|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
42240744|NCT02964273|76064837|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
42240745|NCT02964273|76064838|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
42240746|NCT02773446|76064857|FG000|First Admission|Withdrawal by Subject|0|||
42240747|NCT02773446|76064858|FG001|First Admission|Withdrawal by Subject|0|||
42240748|NCT02773446|76064859|FG002|First Admission|Withdrawal by Subject|0|||
42240749|NCT02773446|76064860|FG003|First Admission|Withdrawal by Subject|1|||
42240750|NCT02773446|76064861|FG004|First Admission|Withdrawal by Subject|0|||
42240751|NCT02773446|76064862|FG005|First Admission|Withdrawal by Subject|0|||
42240752|NCT02773446|76064857|FG000|First Admission|Lost to Follow-up|1|||
42240753|NCT02773446|76064858|FG001|First Admission|Lost to Follow-up|0|||
42240754|NCT02773446|76064859|FG002|First Admission|Lost to Follow-up|0|||
42240755|NCT02773446|76064860|FG003|First Admission|Lost to Follow-up|0|||
42240756|NCT02773446|76064861|FG004|First Admission|Lost to Follow-up|0|||
42240757|NCT02773446|76064862|FG005|First Admission|Lost to Follow-up|0|||
42240758|NCT02773368|76064881|FG000|Overall Study|Lost to Follow-up|4|||
42240759|NCT02773368|76064882|FG001|Overall Study|Lost to Follow-up|1|||
42240760|NCT02773368|76064881|FG000|Overall Study|Withdrawal by Subject|5|||
42240761|NCT02773368|76064882|FG001|Overall Study|Withdrawal by Subject|1|||
42240762|NCT02773368|76064881|FG000|Overall Study|Unclassified|1|||
42240763|NCT02773368|76064882|FG001|Overall Study|Unclassified|1|||
42240764|NCT02773368|76064881|FG000|Overall Study|Missing|0|||
42240765|NCT02773368|76064882|FG001|Overall Study|Missing|1|||
42240766|NCT01336647|76064891|FG000|Overall Study|Lost to Follow-up|4|||
42240767|NCT01336647|76064892|FG001|Overall Study|Lost to Follow-up|1|||
42240768|NCT01336647|76064893|FG002|Overall Study|Lost to Follow-up|3|||
42240769|NCT01336569|76064903|FG000|Overall Study|Lost to Follow-up|4|||
42240770|NCT02772978|76064907|FG000|Overall Study|Withdrawal by Subject|1|||
42240771|NCT02772978|76064908|FG001|Overall Study|Withdrawal by Subject|1|||
42240772|NCT00104052|76064913|FG000|Overall Study|Adverse Event|1|||
42240773|NCT00104052|76064913|FG000|Overall Study|Lack of Efficacy|26|||
42240774|NCT00104052|76064913|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
42240775|NCT02777970|76064920|FG000|Overall Study|Lost to Follow-up|0|||
42240776|NCT02777970|76064921|FG001|Overall Study|Lost to Follow-up|1|||
42240777|NCT02777970|76064922|FG002|Overall Study|Lost to Follow-up|0|||
42240778|NCT02777970|76064920|FG000|Overall Study|Protocol Violation|1|||
42240779|NCT02777970|76064921|FG001|Overall Study|Protocol Violation|0|||
42240780|NCT02777970|76064922|FG002|Overall Study|Protocol Violation|0|||
42240781|NCT03037489|76064934|FG000|Overall Study|Adverse Event|4|||
42240782|NCT03037489|76064935|FG001|Overall Study|Adverse Event|0|||
42240783|NCT03037489|76064934|FG000|Overall Study|Withdrawal by Subject|3|||
42240784|NCT03037489|76064935|FG001|Overall Study|Withdrawal by Subject|0|||
42240785|NCT01336023|76064944|FG000|Week 0 to Week 26|Adverse Event|8|||
42240786|NCT01336023|76064945|FG001|Week 0 to Week 26|Adverse Event|10|||
42240787|NCT01336023|76064946|FG002|Week 0 to Week 26|Adverse Event|24|||
42240788|NCT01336023|76064944|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
42240789|NCT01336023|76064945|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
42240790|NCT01336023|76064946|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
42240791|NCT01336023|76064944|FG000|Week 0 to Week 26|Protocol Violation|1|||
41988506|NCT01266850|75795935|FG001|Overall Study|Withdrawal by Subject|9|||
42032745|NCT01090050|75841016|FG000|Overall Study|Lost to Follow-up|0|||
42032746|NCT01090050|75841017|FG001|Overall Study|Lost to Follow-up|1|||
41988507|NCT01266850|75795936|FG002|Overall Study|Withdrawal by Subject|6|||
41988508|NCT01266850|75795937|FG003|Overall Study|Withdrawal by Subject|9|||
41988509|NCT01266850|75795938|FG004|Overall Study|Withdrawal by Subject|12|||
41988510|NCT01266850|75795934|FG000|Overall Study|Physician Decision|3|||
41988511|NCT01266850|75795935|FG001|Overall Study|Physician Decision|6|||
41988512|NCT01266850|75795936|FG002|Overall Study|Physician Decision|4|||
41988513|NCT01266850|75795937|FG003|Overall Study|Physician Decision|4|||
41988514|NCT01266850|75795938|FG004|Overall Study|Physician Decision|3|||
41988515|NCT01266850|75795934|FG000|Overall Study|Protocol Violation|0|||
41988516|NCT01266850|75795935|FG001|Overall Study|Protocol Violation|1|||
41988517|NCT01266850|75795936|FG002|Overall Study|Protocol Violation|0|||
41988518|NCT01266850|75795937|FG003|Overall Study|Protocol Violation|1|||
41988519|NCT01266850|75795938|FG004|Overall Study|Protocol Violation|2|||
42240792|NCT01336023|76064945|FG001|Week 0 to Week 26|Protocol Violation|2|||
42240793|NCT01336023|76064946|FG002|Week 0 to Week 26|Protocol Violation|0|||
42240794|NCT01336023|76064944|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
42240795|NCT01336023|76064945|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
42240796|NCT01336023|76064946|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
42240797|NCT01336023|76064944|FG000|Week 0 to Week 26|Unclassified|5|||
42240798|NCT01336023|76064945|FG001|Week 0 to Week 26|Unclassified|16|||
42240799|NCT01336023|76064946|FG002|Week 0 to Week 26|Unclassified|9|||
42240800|NCT01336023|76064944|FG000|Week 27 to 52|Adverse Event|1|||
42240801|NCT01336023|76064945|FG001|Week 27 to 52|Adverse Event|5|||
42240802|NCT01336023|76064946|FG002|Week 27 to 52|Adverse Event|2|||
42240803|NCT01336023|76064944|FG000|Week 27 to 52|Protocol Violation|0|||
42240804|NCT01336023|76064945|FG001|Week 27 to 52|Protocol Violation|2|||
42240805|NCT01336023|76064946|FG002|Week 27 to 52|Protocol Violation|1|||
42240806|NCT01336023|76064944|FG000|Week 27 to 52|Withdrawal Criteria|14|||
42240807|NCT01336023|76064945|FG001|Week 27 to 52|Withdrawal Criteria|19|||
42240808|NCT01336023|76064946|FG002|Week 27 to 52|Withdrawal Criteria|16|||
42240809|NCT01336023|76064944|FG000|Week 27 to 52|Unclassified|13|||
42240810|NCT01336023|76064945|FG001|Week 27 to 52|Unclassified|18|||
42240811|NCT01336023|76064946|FG002|Week 27 to 52|Unclassified|9|||
42240812|NCT03039283|76064954|FG000|Overall Study|Protocol Violation|2|||
42240813|NCT02863575|76064976|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
42240814|NCT02863575|76064977|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
42240815|NCT02863575|76064978|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
42240816|NCT02863575|76064976|FG000|Overall Study|Withdrawal by Subject|0|||
42240817|NCT02863575|76064977|FG001|Overall Study|Withdrawal by Subject|1|||
42240818|NCT02863575|76064978|FG002|Overall Study|Withdrawal by Subject|1|||
42240819|NCT02863575|76064976|FG000|Overall Study|Adverse Event|0|||
42240820|NCT02863575|76064977|FG001|Overall Study|Adverse Event|1|||
42240821|NCT02863575|76064978|FG002|Overall Study|Adverse Event|0|||
42240822|NCT01227187|76064990|FG000|Overall Study|Physician Decision|0|||
42240823|NCT01227187|76064991|FG001|Overall Study|Physician Decision|0|||
42240824|NCT01227187|76064992|FG002|Overall Study|Physician Decision|0|||
42240825|NCT01227187|76064993|FG003|Overall Study|Physician Decision|1|||
42240826|NCT02638012|76065014|FG000|Overall Study|Lost to Follow-up|1|||
42240827|NCT00103506|76065020|FG000|Overall Study|Study closed by sponsor|34|||
42240828|NCT00103506|76065021|FG001|Overall Study|Study closed by sponsor|37|||
42240829|NCT00103506|76065020|FG000|Overall Study|Death|257|||
42240830|NCT00103506|76065021|FG001|Overall Study|Death|253|||
42240831|NCT00103506|76065020|FG000|Overall Study|Lost to Follow-up|13|||
42240832|NCT00103506|76065021|FG001|Overall Study|Lost to Follow-up|13|||
42240833|NCT00103506|76065020|FG000|Overall Study|Withdrawal by Subject|18|||
42240834|NCT00103506|76065021|FG001|Overall Study|Withdrawal by Subject|21|||
42240835|NCT02765490|76065029|FG000|Overall Study|Lost to Follow-up|1|||
42240836|NCT02765490|76065030|FG001|Overall Study|Lost to Follow-up|1|||
42240837|NCT02765490|76065029|FG000|Overall Study|Other|0|||
42240838|NCT02765490|76065030|FG001|Overall Study|Other|1|||
42240839|NCT02765490|76065029|FG000|Overall Study|Death|0|||
42240840|NCT02765490|76065030|FG001|Overall Study|Death|1|||
42240841|NCT02639182|76065038|FG000|Overall Study|Disease Progression|50|||
42240842|NCT02639182|76065039|FG001|Overall Study|Disease Progression|49|||
42240843|NCT02639182|76065038|FG000|Overall Study|Adverse Event|7|||
42240844|NCT02639182|76065039|FG001|Overall Study|Adverse Event|5|||
42240845|NCT02639182|76065038|FG000|Overall Study|Physician Decision|3|||
42240846|NCT02639182|76065039|FG001|Overall Study|Physician Decision|3|||
42240847|NCT02639182|76065038|FG000|Overall Study|Withdrew Consent|5|||
42240848|NCT02639182|76065039|FG001|Overall Study|Withdrew Consent|4|||
42240849|NCT02639182|76065038|FG000|Overall Study|Lost to Follow-up|0|||
42240850|NCT02639182|76065039|FG001|Overall Study|Lost to Follow-up|1|||
42240851|NCT02639182|76065038|FG000|Overall Study|Study Closure|1|||
42240852|NCT02639182|76065039|FG001|Overall Study|Study Closure|2|||
42240853|NCT02639182|76065038|FG000|Overall Study|Sponsor Ended Study|0|||
42240854|NCT02639182|76065039|FG001|Overall Study|Sponsor Ended Study|1|||
42240855|NCT02639182|76065038|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
42240856|NCT02639182|76065039|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
42240857|NCT02863419|76065048|FG000|Overall Study|Lost to Follow-up|0|||
42240858|NCT02863419|76065049|FG001|Overall Study|Lost to Follow-up|1|||
42240859|NCT02863419|76065050|FG002|Overall Study|Lost to Follow-up|4|||
42240860|NCT02863419|76065048|FG000|Overall Study|Withdrawal by Subject|5|||
42240861|NCT02863419|76065049|FG001|Overall Study|Withdrawal by Subject|5|||
42240862|NCT02863419|76065050|FG002|Overall Study|Withdrawal by Subject|3|||
42240863|NCT02863419|76065048|FG000|Overall Study|Died|3|||
42240864|NCT02863419|76065049|FG001|Overall Study|Died|4|||
42240865|NCT02863419|76065050|FG002|Overall Study|Died|1|||
42240866|NCT02765100|76065060|FG000|Overall Study|subject found ineligible after baseline|1|||
42240867|NCT02765100|76065061|FG001|Overall Study|subject found ineligible after baseline|1|||
42240868|NCT02765100|76065060|FG000|Overall Study|Lost to Follow-up|0|||
42240869|NCT02765100|76065061|FG001|Overall Study|Lost to Follow-up|1|||
42240870|NCT02761980|76065071|FG000|Overall Study|Adverse Event|4|||
42240871|NCT02761980|76065072|FG001|Overall Study|Adverse Event|6|||
42240872|NCT02761980|76065073|FG002|Overall Study|Adverse Event|5|||
42240873|NCT02761980|76065074|FG003|Overall Study|Adverse Event|6|||
42240874|NCT02761980|76065071|FG000|Overall Study|Withdrawal by Subject|0|||
42240875|NCT02761980|76065072|FG001|Overall Study|Withdrawal by Subject|1|||
42240876|NCT02761980|76065073|FG002|Overall Study|Withdrawal by Subject|0|||
42240877|NCT02761980|76065074|FG003|Overall Study|Withdrawal by Subject|0|||
42240878|NCT02761980|76065071|FG000|Overall Study|Other|0|||
42240879|NCT02761980|76065072|FG001|Overall Study|Other|0|||
42240880|NCT02761980|76065073|FG002|Overall Study|Other|1|||
42240881|NCT02761980|76065074|FG003|Overall Study|Other|0|||
42240882|NCT02862171|76065093|FG000|Overall Study|Death|1|||
42240883|NCT02862171|76065093|FG000|Overall Study|Lost to Follow-up|13|||
42240884|NCT02862171|76065093|FG000|Overall Study|Withdrawal by Subject|57|||
42240885|NCT02862171|76065093|FG000|Overall Study|Non-compliance|4|||
42240886|NCT02862171|76065093|FG000|Overall Study|HIV-1 seroconversion|18|||
42240887|NCT02638948|76065101|FG000|Overall Study|Withdrawal by Subject|4|||
42240888|NCT02638948|76065102|FG001|Overall Study|Withdrawal by Subject|5|||
42240889|NCT02638948|76065103|FG002|Overall Study|Withdrawal by Subject|3|||
42240890|NCT02638948|76065104|FG003|Overall Study|Withdrawal by Subject|1|||
42240891|NCT02638948|76065101|FG000|Overall Study|Administrative Reason by Sponsor|0|||
42240892|NCT02638948|76065102|FG001|Overall Study|Administrative Reason by Sponsor|1|||
42240893|NCT02638948|76065103|FG002|Overall Study|Administrative Reason by Sponsor|0|||
42240894|NCT02638948|76065104|FG003|Overall Study|Administrative Reason by Sponsor|4|||
42240895|NCT02638948|76065101|FG000|Overall Study|Adverse Event|0|||
42240896|NCT02638948|76065102|FG001|Overall Study|Adverse Event|0|||
42240897|NCT02638948|76065103|FG002|Overall Study|Adverse Event|1|||
42240898|NCT02638948|76065104|FG003|Overall Study|Adverse Event|1|||
42240899|NCT02638948|76065101|FG000|Overall Study|Lack of Efficacy|1|||
42240900|NCT02638948|76065102|FG001|Overall Study|Lack of Efficacy|1|||
42240901|NCT02638948|76065103|FG002|Overall Study|Lack of Efficacy|0|||
42240902|NCT02638948|76065104|FG003|Overall Study|Lack of Efficacy|0|||
42240903|NCT02638948|76065101|FG000|Overall Study|Lost to Follow-up|0|||
42240904|NCT02638948|76065102|FG001|Overall Study|Lost to Follow-up|0|||
42240905|NCT02638948|76065103|FG002|Overall Study|Lost to Follow-up|1|||
42240906|NCT02638948|76065104|FG003|Overall Study|Lost to Follow-up|1|||
42240907|NCT02638948|76065101|FG000|Overall Study|Poor/Non-Compliance|0|||
42240908|NCT02638948|76065102|FG001|Overall Study|Poor/Non-Compliance|2|||
42240909|NCT02638948|76065103|FG002|Overall Study|Poor/Non-Compliance|1|||
42240910|NCT02638948|76065104|FG003|Overall Study|Poor/Non-Compliance|0|||
42240911|NCT02638948|76065101|FG000|Overall Study|Participant no longer met study criteria|0|||
42240912|NCT02638948|76065102|FG001|Overall Study|Participant no longer met study criteria|1|||
42240913|NCT02638948|76065103|FG002|Overall Study|Participant no longer met study criteria|0|||
42240914|NCT02638948|76065104|FG003|Overall Study|Participant no longer met study criteria|0|||
42240915|NCT02638948|76065101|FG000|Overall Study|Other than specified above|4|||
42240916|NCT02638948|76065102|FG001|Overall Study|Other than specified above|1|||
42240917|NCT02638948|76065103|FG002|Overall Study|Other than specified above|1|||
42240918|NCT02638948|76065104|FG003|Overall Study|Other than specified above|1|||
42240919|NCT00102960|76065120|FG000|Overall Study|Death|23|||
42240920|NCT00102960|76065121|FG001|Overall Study|Death|11|||
42240921|NCT00102960|76065122|FG002|Overall Study|Death|11|||
42240922|NCT00102960|76065120|FG000|Overall Study|Lost to Follow-up|6|||
42240923|NCT00102960|76065121|FG001|Overall Study|Lost to Follow-up|12|||
42240924|NCT00102960|76065122|FG002|Overall Study|Lost to Follow-up|16|||
42240925|NCT00102960|76065120|FG000|Overall Study|Withdrawal by Subject|1|||
42240926|NCT00102960|76065121|FG001|Overall Study|Withdrawal by Subject|0|||
42240927|NCT00102960|76065122|FG002|Overall Study|Withdrawal by Subject|1|||
42240928|NCT02858895|76065134|FG000|Overall Study|Disease progression|31|||
42240929|NCT02858895|76065134|FG000|Overall Study|Death|2|||
42240930|NCT02858895|76065134|FG000|Overall Study|Adverse Event|1|||
42240931|NCT02858895|76065134|FG000|Overall Study|Withdrawal by Subject|3|||
42240932|NCT02858895|76065134|FG000|Overall Study|hospice,|1|||
42240933|NCT02858895|76065134|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
42240934|NCT02637856|76065145|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
42240935|NCT02637856|76065146|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
42240936|NCT02637856|76065145|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
42240937|NCT02637856|76065146|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
42240938|NCT02637856|76065145|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
42240939|NCT02637856|76065146|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
42240940|NCT02637856|76065145|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
42240941|NCT02637856|76065146|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
42240942|NCT02637856|76065145|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
42240943|NCT02637856|76065146|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
42302685|NCT01651039|76138050|FG000|Overall Study|Withdrawal by Subject|1|||
42302686|NCT01651039|76138050|FG000|Overall Study|Progressive Disease|22|||
42302687|NCT02349633|76138068|FG000|Overall Study|Death|0|||
42302688|NCT02349633|76138069|FG001|Overall Study|Death|1|||
42240944|NCT02637856|76065145|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
42240945|NCT02637856|76065146|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
42240946|NCT02637856|76065145|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
42240947|NCT02637856|76065146|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
42240948|NCT02637856|76065145|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
42240949|NCT02637856|76065146|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
42240950|NCT02637856|76065145|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
42302689|NCT02349633|76138070|FG002|Overall Study|Death|0|||
42302690|NCT02349633|76138071|FG003|Overall Study|Death|0|||
42302691|NCT02349633|76138072|FG004|Overall Study|Death|0|||
42240951|NCT02637856|76065146|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
42240952|NCT02637856|76065145|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
42240953|NCT02637856|76065146|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
42240954|NCT02637856|76065145|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
42240955|NCT02637856|76065146|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
42240956|NCT02637856|76065145|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
42240957|NCT02637856|76065146|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
42240958|NCT02637856|76065145|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
42240959|NCT02637856|76065146|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
42240960|NCT02858037|76065152|FG000|Overall Study|Death|1|||
42240961|NCT02858037|76065152|FG000|Overall Study|Withdrawal by Subject|18|||
42240962|NCT02858037|76065152|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
42240963|NCT02858037|76065152|FG000|Overall Study|Lost to Follow-up|3|||
42240964|NCT02858037|76065152|FG000|Overall Study|Other|4|||
42240965|NCT02856555|76065159|FG000|Overall Study|Adverse Event|1|||
42240966|NCT02856555|76065160|FG001|Overall Study|Adverse Event|0|||
42240967|NCT02856555|76065161|FG002|Overall Study|Adverse Event|0|||
42240968|NCT02856555|76065159|FG000|Overall Study|Lost to Follow-up|1|||
42240969|NCT02856555|76065160|FG001|Overall Study|Lost to Follow-up|3|||
42240970|NCT02856555|76065161|FG002|Overall Study|Lost to Follow-up|0|||
42240971|NCT02856555|76065159|FG000|Overall Study|Withdrawal by Subject|3|||
42240972|NCT02856555|76065160|FG001|Overall Study|Withdrawal by Subject|0|||
42240973|NCT02856555|76065161|FG002|Overall Study|Withdrawal by Subject|0|||
42240974|NCT02856555|76065159|FG000|Overall Study|Randomized but Never Treated|0|||
42240975|NCT02856555|76065160|FG001|Overall Study|Randomized but Never Treated|1|||
42240976|NCT02856555|76065161|FG002|Overall Study|Randomized but Never Treated|0|||
42240977|NCT02637232|76065199|FG000|Overall Study|Lost to Follow-up|42|||
42240978|NCT02637232|76065199|FG000|Overall Study|Adverse Event|11|||
42240979|NCT02637232|76065199|FG000|Overall Study|patient 's decision|2|||
42240980|NCT02855541|76065203|FG000|Overall Study|Change in health status|2|||
42240981|NCT02855541|76065203|FG000|Overall Study|Withdrawal by Subject|2|||
42240982|NCT02635984|76065209|FG000|Overall Study|Lost to Follow-up|2|||
42240983|NCT02635984|76065210|FG001|Overall Study|Lost to Follow-up|4|||
42240984|NCT02635984|76065209|FG000|Overall Study|Study Arm Closed|1|||
42240985|NCT02635984|76065210|FG001|Overall Study|Study Arm Closed|0|||
42240986|NCT01147653|76065218|FG000|Year 2|Withdrawal by Subject|2|||
42240987|NCT01147653|76065219|FG001|Year 2|Withdrawal by Subject|3|||
42240988|NCT02747043|76065240|FG000|Overall Study|Other|1|||
42240989|NCT02747043|76065241|FG001|Overall Study|Other|1|||
42240990|NCT02747043|76065240|FG000|Overall Study|Adverse Event|3|||
42240991|NCT02747043|76065241|FG001|Overall Study|Adverse Event|1|||
42240992|NCT02747043|76065240|FG000|Overall Study|Withdrawal by Subject|1|||
42240993|NCT02747043|76065241|FG001|Overall Study|Withdrawal by Subject|1|||
42240994|NCT02747043|76065240|FG000|Overall Study|Physician Decision|1|||
42240995|NCT02747043|76065241|FG001|Overall Study|Physician Decision|1|||
42240996|NCT02747043|76065240|FG000|Overall Study|Protocol Violation|0|||
42240997|NCT02747043|76065241|FG001|Overall Study|Protocol Violation|1|||
42240998|NCT02747043|76065240|FG000|Overall Study|Disease progression|4|||
42240999|NCT02747043|76065241|FG001|Overall Study|Disease progression|0|||
42241000|NCT02637076|76065249|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
42241001|NCT02637076|76065250|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
42241002|NCT02637076|76065249|FG000|Overall Study|Withdrawal by Subject|0|||
42241003|NCT02637076|76065250|FG001|Overall Study|Withdrawal by Subject|4|||
42241004|NCT02854605|76065259|FG000|Overall Study|Adverse Event|1|||
42241005|NCT02854605|76065260|FG001|Overall Study|Adverse Event|5|||
42241006|NCT02854605|76065261|FG002|Overall Study|Adverse Event|2|||
42241007|NCT02854605|76065259|FG000|Overall Study|Lost to Follow-up|0|||
42241008|NCT02854605|76065260|FG001|Overall Study|Lost to Follow-up|2|||
42241009|NCT02854605|76065261|FG002|Overall Study|Lost to Follow-up|0|||
42241010|NCT02854605|76065259|FG000|Overall Study|Withdrew Consent|1|||
41988520|NCT01266850|75795934|FG000|Overall Study|Adverse Event|0|||
41988521|NCT01266850|75795935|FG001|Overall Study|Adverse Event|0|||
42241011|NCT02854605|76065260|FG001|Overall Study|Withdrew Consent|0|||
42241012|NCT02854605|76065261|FG002|Overall Study|Withdrew Consent|1|||
42241013|NCT02854605|76065259|FG000|Overall Study|Investigator's Discretion|1|||
42241014|NCT02854605|76065260|FG001|Overall Study|Investigator's Discretion|0|||
42241015|NCT02854605|76065261|FG002|Overall Study|Investigator's Discretion|0|||
42241016|NCT02854605|76065259|FG000|Overall Study|Protocol Violation|0|||
42241017|NCT02854605|76065260|FG001|Overall Study|Protocol Violation|0|||
41988522|NCT01266850|75795936|FG002|Overall Study|Adverse Event|0|||
42132009|NCT00318370|75942834|FG001|Period 3|Physician Decision|0|||
42241018|NCT02854605|76065261|FG002|Overall Study|Protocol Violation|1|||
42241019|NCT05059977|76065279|FG000|Overall Study|Withdrawal by Subject|0|||
42241020|NCT05059977|76065280|FG001|Overall Study|Withdrawal by Subject|0|||
41988523|NCT01266850|75795937|FG003|Overall Study|Adverse Event|0|||
41988524|NCT01266850|75795938|FG004|Overall Study|Adverse Event|1|||
42241021|NCT05059977|76065281|FG002|Overall Study|Withdrawal by Subject|1|||
42241022|NCT04803305|76065295|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
42241023|NCT04803305|76065296|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
42241024|NCT04803305|76065295|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
42241025|NCT04803305|76065296|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
42241026|NCT04803305|76065295|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
42241027|NCT04803305|76065296|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
42241028|NCT04803305|76065295|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
42241029|NCT04803305|76065296|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
42241030|NCT04803305|76065295|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
42241031|NCT04803305|76065296|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
42241032|NCT04803305|76065295|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
42241033|NCT04803305|76065296|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
42241034|NCT04803305|76065295|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
42241035|NCT04803305|76065296|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
42241036|NCT04803305|76065295|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
42241037|NCT04803305|76065296|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
42241038|NCT04607135|76065314|FG000|Overall Study|Physician Decision|1|||
42241039|NCT04607135|76065314|FG000|Overall Study|Withdrawal by Subject|1|||
42241040|NCT04607135|76065314|FG000|Overall Study|Equipment not working|3|||
42241041|NCT04525885|76065329|FG000|Overall Study|Screen Failure|1|||
42241042|NCT04525885|76065330|FG001|Overall Study|Screen Failure|0|||
42241043|NCT04525885|76065331|FG002|Overall Study|Screen Failure|0|||
42241044|NCT04525885|76065329|FG000|Overall Study|Withdrawal by Subject|14|||
42241045|NCT04525885|76065330|FG001|Overall Study|Withdrawal by Subject|6|||
42241046|NCT04525885|76065331|FG002|Overall Study|Withdrawal by Subject|20|||
42241047|NCT04525885|76065329|FG000|Overall Study|Physician Decision|1|||
42241048|NCT04525885|76065330|FG001|Overall Study|Physician Decision|0|||
42241049|NCT04525885|76065331|FG002|Overall Study|Physician Decision|1|||
42241050|NCT04426006|76065344|FG000|Inclusion|Protocol Violation|1|||
42241051|NCT04426006|76065344|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
42241052|NCT04426006|76065344|FG000|Inclusion|Blood sample at inclusion not done|1|||
42241053|NCT04426006|76065344|FG000|3 Months|Lost to Follow-up|17|||
42241054|NCT04426006|76065344|FG000|12 Months|Lost to Follow-up|38|||
42241055|NCT03959241|76065351|FG000|Overall Study|Withdrawal by Subject|7|||
42241056|NCT03959241|76065352|FG001|Overall Study|Withdrawal by Subject|8|||
42241057|NCT03959241|76065351|FG000|Overall Study|Lost to Follow-up|1|||
42241058|NCT03959241|76065352|FG001|Overall Study|Lost to Follow-up|0|||
42241059|NCT03959241|76065351|FG000|Overall Study|Move to Hospice Care|1|||
42241060|NCT03959241|76065352|FG001|Overall Study|Move to Hospice Care|0|||
42241061|NCT03959241|76065351|FG000|Overall Study|Screen Failure|1|||
42241062|NCT03959241|76065352|FG001|Overall Study|Screen Failure|0|||
42241063|NCT03959241|76065351|FG000|Overall Study|Disease Relapse|0|||
42241064|NCT03959241|76065352|FG001|Overall Study|Disease Relapse|1|||
42241065|NCT03959241|76065351|FG000|Overall Study|Off Study|1|||
42241066|NCT03959241|76065352|FG001|Overall Study|Off Study|0|||
42241067|NCT03705169|76065372|FG000|Overall Study|Lost to Follow-up|0|||
42241068|NCT03705169|76065373|FG001|Overall Study|Lost to Follow-up|0|||
42241069|NCT03705169|76065374|FG002|Overall Study|Lost to Follow-up|0|||
42241070|NCT03705169|76065375|FG003|Overall Study|Lost to Follow-up|2|||
42241071|NCT03705169|76065376|FG004|Overall Study|Lost to Follow-up|0|||
42241072|NCT03705169|76065377|FG005|Overall Study|Lost to Follow-up|2|||
42241073|NCT03705169|76065378|FG006|Overall Study|Lost to Follow-up|1|||
42241074|NCT03705169|76065379|FG007|Overall Study|Lost to Follow-up|0|||
42241075|NCT03705169|76065380|FG008|Overall Study|Lost to Follow-up|0|||
42241076|NCT03705169|76065381|FG009|Overall Study|Lost to Follow-up|1|||
42241077|NCT03705169|76065372|FG000|Overall Study|Adverse Event|0|||
42241078|NCT03705169|76065373|FG001|Overall Study|Adverse Event|0|||
42241079|NCT03705169|76065374|FG002|Overall Study|Adverse Event|0|||
42241080|NCT03705169|76065375|FG003|Overall Study|Adverse Event|1|||
42241081|NCT03705169|76065376|FG004|Overall Study|Adverse Event|0|||
42241082|NCT03705169|76065377|FG005|Overall Study|Adverse Event|0|||
42241083|NCT03705169|76065378|FG006|Overall Study|Adverse Event|0|||
42241084|NCT03705169|76065379|FG007|Overall Study|Adverse Event|0|||
42241085|NCT03705169|76065380|FG008|Overall Study|Adverse Event|0|||
42241086|NCT03705169|76065381|FG009|Overall Study|Adverse Event|0|||
42241087|NCT03705169|76065372|FG000|Overall Study|Site Closure|0|||
42241088|NCT03705169|76065373|FG001|Overall Study|Site Closure|0|||
42241089|NCT03705169|76065374|FG002|Overall Study|Site Closure|0|||
42241090|NCT03705169|76065375|FG003|Overall Study|Site Closure|1|||
42241091|NCT03705169|76065376|FG004|Overall Study|Site Closure|0|||
42241092|NCT03705169|76065377|FG005|Overall Study|Site Closure|0|||
42241093|NCT03705169|76065378|FG006|Overall Study|Site Closure|0|||
42241094|NCT03705169|76065379|FG007|Overall Study|Site Closure|0|||
42241095|NCT03705169|76065380|FG008|Overall Study|Site Closure|0|||
42241096|NCT03705169|76065381|FG009|Overall Study|Site Closure|0|||
42241097|NCT03705169|76065372|FG000|Overall Study|Did not receive study treatment|0|||
42241098|NCT03705169|76065373|FG001|Overall Study|Did not receive study treatment|0|||
42241099|NCT03705169|76065374|FG002|Overall Study|Did not receive study treatment|0|||
42241100|NCT03705169|76065375|FG003|Overall Study|Did not receive study treatment|1|||
42241101|NCT03705169|76065376|FG004|Overall Study|Did not receive study treatment|0|||
42241102|NCT03705169|76065377|FG005|Overall Study|Did not receive study treatment|0|||
42241103|NCT03705169|76065378|FG006|Overall Study|Did not receive study treatment|0|||
42241104|NCT03705169|76065379|FG007|Overall Study|Did not receive study treatment|0|||
42241105|NCT03705169|76065380|FG008|Overall Study|Did not receive study treatment|0|||
42241106|NCT03705169|76065381|FG009|Overall Study|Did not receive study treatment|0|||
42241107|NCT03705169|76065372|FG000|Overall Study|Concerns about study visit compliance|0|||
42241108|NCT03705169|76065373|FG001|Overall Study|Concerns about study visit compliance|0|||
42241109|NCT03705169|76065374|FG002|Overall Study|Concerns about study visit compliance|0|||
42241110|NCT03705169|76065375|FG003|Overall Study|Concerns about study visit compliance|1|||
42241111|NCT03705169|76065376|FG004|Overall Study|Concerns about study visit compliance|0|||
42241112|NCT03705169|76065377|FG005|Overall Study|Concerns about study visit compliance|0|||
42241113|NCT03705169|76065378|FG006|Overall Study|Concerns about study visit compliance|0|||
42241114|NCT03705169|76065379|FG007|Overall Study|Concerns about study visit compliance|0|||
42241115|NCT03705169|76065380|FG008|Overall Study|Concerns about study visit compliance|0|||
42241116|NCT03705169|76065381|FG009|Overall Study|Concerns about study visit compliance|0|||
42241117|NCT03414684|76065418|FG000|First-course Treatment|Complete response|0|||
42241118|NCT03414684|76065419|FG001|First-course Treatment|Complete response|1|||
42241119|NCT03414684|76065418|FG000|First-course Treatment|Intercurrent illness|1|||
41988525|NCT01266850|75795934|FG000|Overall Study|Site Closure|0|||
41988526|NCT01266850|75795935|FG001|Overall Study|Site Closure|1|||
41988527|NCT01266850|75795936|FG002|Overall Study|Site Closure|1|||
41988528|NCT01266850|75795937|FG003|Overall Study|Site Closure|1|||
41988529|NCT01266850|75795938|FG004|Overall Study|Site Closure|0|||
41988530|NCT01266460|75795950|FG000|Overall Study|Adverse Event|3|||
41988531|NCT01266460|75795950|FG000|Overall Study|Withdrawal by Subject|5|||
41988532|NCT01266460|75795950|FG000|Overall Study|Disease Progression|18|||
41988533|NCT01266460|75795950|FG000|Overall Study|Not otherwise specified|8|||
41988534|NCT01266265|75795956|FG000|Overall Study|Death|95|||
41988535|NCT01266265|75795957|FG001|Overall Study|Death|73|||
41988536|NCT01266265|75795956|FG000|Overall Study|Lost to Follow-up|23|||
41988537|NCT01266265|75795957|FG001|Overall Study|Lost to Follow-up|28|||
41988538|NCT01266265|75795956|FG000|Overall Study|Withdrawal by Subject|13|||
42241120|NCT03414684|76065419|FG001|First-course Treatment|Intercurrent illness|0|||
42241121|NCT03414684|76065418|FG000|First-course Treatment|Progressive Disease|31|||
42241122|NCT03414684|76065419|FG001|First-course Treatment|Progressive Disease|32|||
42241123|NCT03414684|76065418|FG000|First-course Treatment|Adverse Event|1|||
42241124|NCT03414684|76065419|FG001|First-course Treatment|Adverse Event|2|||
42241125|NCT03414684|76065418|FG000|First-course Treatment|Physician Decision|0|||
42241126|NCT03414684|76065419|FG001|First-course Treatment|Physician Decision|1|||
42241127|NCT03414684|76065418|FG000|First-course Treatment|Withdrawal by Subject|0|||
42241128|NCT03414684|76065419|FG001|First-course Treatment|Withdrawal by Subject|1|||
42241129|NCT03414684|76065418|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
42241130|NCT03414684|76065419|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
42241131|NCT03414684|76065418|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
42241132|NCT03414684|76065419|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
42241133|NCT03414684|76065418|FG000|First-course Treatment|Still on treatment|3|||
42241134|NCT03414684|76065419|FG001|First-course Treatment|Still on treatment|0|||
42241135|NCT03414684|76065418|FG000|First-course Treatment|Never started protocol therapy|2|||
42241136|NCT03414684|76065419|FG001|First-course Treatment|Never started protocol therapy|1|||
42241137|NCT03414684|76065418|FG000|Crossover Treatment|Progressive disease|0|||
42241138|NCT03414684|76065419|FG001|Crossover Treatment|Progressive disease|12|||
42241139|NCT03414684|76065418|FG000|Crossover Treatment|Adverse Event|0|||
42241140|NCT03414684|76065419|FG001|Crossover Treatment|Adverse Event|3|||
42241141|NCT03414684|76065418|FG000|Crossover Treatment|Physician Decision|0|||
42241142|NCT03414684|76065419|FG001|Crossover Treatment|Physician Decision|1|||
42241143|NCT03414684|76065418|FG000|Crossover Treatment|Still on treatment|0|||
42241144|NCT03414684|76065419|FG001|Crossover Treatment|Still on treatment|2|||
42241145|NCT03298451|76065440|FG000|Overall Study|Death|275|||
42241146|NCT03298451|76065441|FG001|Overall Study|Death|260|||
41988539|NCT01266265|75795957|FG001|Overall Study|Withdrawal by Subject|11|||
41988540|NCT01266265|75795956|FG000|Overall Study|Respiratory-related adverse event|2|||
41988541|NCT01266265|75795957|FG001|Overall Study|Respiratory-related adverse event|1|||
41988542|NCT01266265|75795956|FG000|Overall Study|Transferred care to another provider|22|||
41988543|NCT01266265|75795957|FG001|Overall Study|Transferred care to another provider|28|||
42241147|NCT03298451|76065442|FG002|Overall Study|Death|122|||
42241148|NCT03298451|76065443|FG003|Overall Study|Death|280|||
42241149|NCT03298451|76065440|FG000|Overall Study|Lost to Follow-up|1|||
41988544|NCT01266265|75795956|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
42241150|NCT03298451|76065441|FG001|Overall Study|Lost to Follow-up|1|||
42241151|NCT03298451|76065442|FG002|Overall Study|Lost to Follow-up|0|||
42241152|NCT03298451|76065443|FG003|Overall Study|Lost to Follow-up|7|||
42241153|NCT03298451|76065440|FG000|Overall Study|Withdrawal by Subject|9|||
42241154|NCT03298451|76065441|FG001|Overall Study|Withdrawal by Subject|7|||
42241155|NCT03298451|76065442|FG002|Overall Study|Withdrawal by Subject|1|||
42241156|NCT03298451|76065443|FG003|Overall Study|Withdrawal by Subject|20|||
42241157|NCT02288247|76065480|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
42241158|NCT02288247|76065481|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
42241159|NCT02288247|76065480|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
42241160|NCT02288247|76065481|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
42241161|NCT02288247|76065480|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
42241162|NCT02288247|76065481|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
42241163|NCT02288247|76065480|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
42241164|NCT02288247|76065481|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
42241165|NCT02288247|76065480|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
42241166|NCT02288247|76065481|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
42241167|NCT02288247|76065480|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
42241168|NCT02288247|76065481|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
42241169|NCT02288247|76065480|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
42241170|NCT02288247|76065481|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
42241171|NCT02288247|76065480|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
42241172|NCT02288247|76065481|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
42241173|NCT02288247|76065480|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
42241174|NCT02288247|76065481|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
42241175|NCT02288247|76065480|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
42241176|NCT02288247|76065481|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
42241177|NCT02288247|76065480|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
42241178|NCT02288247|76065481|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
42241179|NCT02288247|76065480|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
42241180|NCT02288247|76065481|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
42241181|NCT02288247|76065480|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
42241182|NCT02288247|76065481|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
42241183|NCT02288247|76065480|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
42241184|NCT02288247|76065481|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
42241185|NCT02288247|76065480|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
42241186|NCT02288247|76065481|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
42241187|NCT02244463|76065495|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
42241188|NCT02244463|76065496|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
42241189|NCT02244463|76065497|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
42241190|NCT02244463|76065498|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
42241191|NCT02244463|76065499|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
42241192|NCT02244463|76065500|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
42241193|NCT02244463|76065495|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
42241194|NCT02244463|76065496|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
42241195|NCT02244463|76065497|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
42241196|NCT02244463|76065498|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
42241197|NCT02244463|76065499|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
42241198|NCT02244463|76065500|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
42241199|NCT02244463|76065495|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
42241200|NCT02244463|76065496|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
42241201|NCT02244463|76065497|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
42241202|NCT02244463|76065498|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
42241203|NCT02244463|76065499|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
42241204|NCT02244463|76065500|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
42241205|NCT02244463|76065495|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
42241206|NCT02244463|76065496|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
42241207|NCT02244463|76065497|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
42032747|NCT01090050|75841016|FG000|Overall Study|Lack of Efficacy|1|||
42132010|NCT00318370|75942835|FG002|Period 3|Physician Decision|1|||
42132011|NCT00318370|75942833|FG000|Period 3|Withdrawal by Subject|0|||
42132012|NCT00318370|75942834|FG001|Period 3|Withdrawal by Subject|0|||
42132013|NCT00318370|75942835|FG002|Period 3|Withdrawal by Subject|3|||
42241208|NCT02244463|76065498|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
42241209|NCT02244463|76065499|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
42241210|NCT02244463|76065500|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
42241211|NCT02244463|76065495|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
42132014|NCT00318370|75942833|FG000|Period 3|Other|0|||
42241212|NCT02244463|76065496|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
42241213|NCT02244463|76065497|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
42241214|NCT02244463|76065498|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
42241215|NCT02244463|76065499|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
42241216|NCT02244463|76065500|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
42241217|NCT02244463|76065495|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
42241218|NCT02244463|76065496|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
42241219|NCT02244463|76065497|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
42241220|NCT02244463|76065498|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
42241221|NCT02244463|76065499|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
42241222|NCT02244463|76065500|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
42241223|NCT02244463|76065495|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
42241224|NCT02244463|76065496|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
42241225|NCT02244463|76065497|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
42241226|NCT02244463|76065498|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
42241227|NCT02244463|76065499|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
42241228|NCT02244463|76065500|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
42241229|NCT02244463|76065495|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
42241230|NCT02244463|76065496|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
42241231|NCT02244463|76065497|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
42241232|NCT02244463|76065498|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
42241233|NCT02244463|76065499|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
42241234|NCT02244463|76065500|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
42241235|NCT02244463|76065495|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
42241236|NCT02244463|76065496|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
42241237|NCT02244463|76065497|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
42241238|NCT02244463|76065498|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
42241239|NCT02244463|76065499|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
42241240|NCT02244463|76065500|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
41988545|NCT01266265|75795957|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
41988546|NCT01266265|75795956|FG000|Overall Study|Enrolled in another clinical study|15|||
41988547|NCT01266265|75795957|FG001|Overall Study|Enrolled in another clinical study|26|||
41988548|NCT01266265|75795956|FG000|Overall Study|Non-compliance|8|||
41988549|NCT01266265|75795957|FG001|Overall Study|Non-compliance|5|||
41988550|NCT01266265|75795956|FG000|Overall Study|Lung transplant|6|||
41988551|NCT01266265|75795957|FG001|Overall Study|Lung transplant|5|||
42241241|NCT02244463|76065495|FG000|Period 5: Phase II|Disease Progression|0|||
42241242|NCT02244463|76065496|FG001|Period 5: Phase II|Disease Progression|0|||
42241243|NCT02244463|76065497|FG002|Period 5: Phase II|Disease Progression|0|||
41988552|NCT01266265|75795956|FG000|Overall Study|Site closed early|4|||
41988553|NCT01266265|75795957|FG001|Overall Study|Site closed early|3|||
41988554|NCT01266265|75795956|FG000|Overall Study|Clinical worsening|1|||
42241244|NCT02244463|76065498|FG003|Period 5: Phase II|Disease Progression|0|||
42132015|NCT00318370|75942834|FG001|Period 3|Other|0|||
42241245|NCT02244463|76065499|FG004|Period 5: Phase II|Disease Progression|10|||
42241246|NCT02244463|76065500|FG005|Period 5: Phase II|Disease Progression|11|||
42241247|NCT02244463|76065495|FG000|Period 5: Phase II|Physician Decision|0|||
42241248|NCT02244463|76065496|FG001|Period 5: Phase II|Physician Decision|0|||
42241249|NCT02244463|76065497|FG002|Period 5: Phase II|Physician Decision|0|||
42241250|NCT02244463|76065498|FG003|Period 5: Phase II|Physician Decision|0|||
42241251|NCT02244463|76065499|FG004|Period 5: Phase II|Physician Decision|3|||
42241252|NCT02244463|76065500|FG005|Period 5: Phase II|Physician Decision|2|||
42241253|NCT02244463|76065495|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
42241254|NCT02244463|76065496|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
42241255|NCT02244463|76065497|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
42241256|NCT02244463|76065498|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
42241257|NCT02244463|76065499|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
42241258|NCT02244463|76065500|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
42241259|NCT02244463|76065495|FG000|Period 5: Phase II|Intercurrent Illness|0|||
42241260|NCT02244463|76065496|FG001|Period 5: Phase II|Intercurrent Illness|0|||
42241261|NCT02244463|76065497|FG002|Period 5: Phase II|Intercurrent Illness|0|||
42241262|NCT02244463|76065498|FG003|Period 5: Phase II|Intercurrent Illness|0|||
42241263|NCT02244463|76065499|FG004|Period 5: Phase II|Intercurrent Illness|2|||
41988555|NCT01266265|75795957|FG001|Overall Study|Clinical worsening|1|||
41988556|NCT01266148|75795982|FG000|Overall Study|Adverse Event|2|||
42132016|NCT00318370|75942835|FG002|Period 3|Other|3|||
42241264|NCT02244463|76065500|FG005|Period 5: Phase II|Intercurrent Illness|0|||
42241265|NCT02244463|76065495|FG000|Period 5: Phase II|Adverse Event|0|||
42241266|NCT02244463|76065496|FG001|Period 5: Phase II|Adverse Event|0|||
42241267|NCT02244463|76065497|FG002|Period 5: Phase II|Adverse Event|0|||
41988557|NCT01266148|75795983|FG001|Overall Study|Adverse Event|0|||
41988558|NCT01266148|75795982|FG000|Overall Study|Ongoing rejection|1|||
42241268|NCT02244463|76065498|FG003|Period 5: Phase II|Adverse Event|0|||
42241269|NCT02244463|76065499|FG004|Period 5: Phase II|Adverse Event|0|||
42241270|NCT02244463|76065500|FG005|Period 5: Phase II|Adverse Event|2|||
42241271|NCT02244463|76065495|FG000|Period 5: Phase II|Still On treatment|0|||
42241272|NCT02244463|76065496|FG001|Period 5: Phase II|Still On treatment|0|||
42241273|NCT02244463|76065497|FG002|Period 5: Phase II|Still On treatment|0|||
42241274|NCT02244463|76065498|FG003|Period 5: Phase II|Still On treatment|0|||
42241275|NCT02244463|76065499|FG004|Period 5: Phase II|Still On treatment|0|||
42241276|NCT02244463|76065500|FG005|Period 5: Phase II|Still On treatment|3|||
42241277|NCT02038777|76065537|FG000|Overall Study|Death|0|||
42241278|NCT02038777|76065538|FG001|Overall Study|Death|2|||
42241279|NCT02038777|76065539|FG002|Overall Study|Death|0|||
42241280|NCT02038777|76065540|FG003|Overall Study|Death|1|||
41988559|NCT01266148|75795983|FG001|Overall Study|Ongoing rejection|0|||
41988560|NCT01266148|75795982|FG000|Overall Study|2 2R rejections|1|||
41988561|NCT01266148|75795983|FG001|Overall Study|2 2R rejections|0|||
41988562|NCT01266148|75795982|FG000|Overall Study|Death|2|||
41988563|NCT01266148|75795983|FG001|Overall Study|Death|3|||
41988564|NCT01266148|75795982|FG000|Overall Study|missing mGFR value + AE|1|||
41988565|NCT01266148|75795983|FG001|Overall Study|missing mGFR value + AE|0|||
41988566|NCT01266070|75795989|FG000|Overall Study|Adverse Event|3|||
41988567|NCT01266070|75795989|FG000|Overall Study|Protocol Violation|1|||
41988568|NCT01265992|75795993|FG000|Overall Study|Lost to Follow-up|1|||
41988569|NCT01265992|75795993|FG000|Overall Study|Withdrawal by Subject|1|||
41988570|NCT01265992|75795993|FG000|Overall Study|Adverse Event|1|||
41988571|NCT01265992|75795993|FG000|Overall Study|Administrative reasons|2|||
41988572|NCT01265992|75795993|FG000|Overall Study|Stopped treatment|3|||
41988573|NCT01265992|75795993|FG000|Overall Study|Did not receive treatment|1|||
41988574|NCT01265953|75795999|FG000|Overall Study|Non compliance|5|||
41988575|NCT01265953|75796000|FG001|Overall Study|Non compliance|3|||
42241281|NCT02038777|76065541|FG004|Overall Study|Death|2|||
42241282|NCT02038777|76065542|FG005|Overall Study|Death|4|||
42241283|NCT02038777|76065543|FG006|Overall Study|Death|0|||
42241284|NCT02038777|76065544|FG007|Overall Study|Death|10|||
42241285|NCT02038777|76065537|FG000|Overall Study|Lost to Follow-up|0|||
42241286|NCT02038777|76065538|FG001|Overall Study|Lost to Follow-up|0|||
42241287|NCT02038777|76065539|FG002|Overall Study|Lost to Follow-up|0|||
42241288|NCT02038777|76065540|FG003|Overall Study|Lost to Follow-up|1|||
42241289|NCT02038777|76065541|FG004|Overall Study|Lost to Follow-up|0|||
42241290|NCT02038777|76065542|FG005|Overall Study|Lost to Follow-up|0|||
42241291|NCT02038777|76065543|FG006|Overall Study|Lost to Follow-up|0|||
42241292|NCT02038777|76065544|FG007|Overall Study|Lost to Follow-up|0|||
42241293|NCT02038777|76065537|FG000|Overall Study|Other|0|||
42241294|NCT02038777|76065538|FG001|Overall Study|Other|1|||
42241295|NCT02038777|76065539|FG002|Overall Study|Other|0|||
42241296|NCT02038777|76065540|FG003|Overall Study|Other|2|||
42241297|NCT02038777|76065541|FG004|Overall Study|Other|1|||
41988576|NCT01265875|75796006|FG000|Overall Study|Uncooperative/unreliable|1|||
42241298|NCT02038777|76065542|FG005|Overall Study|Other|0|||
42241299|NCT02038777|76065543|FG006|Overall Study|Other|0|||
42241300|NCT02038777|76065544|FG007|Overall Study|Other|0|||
42241301|NCT02038777|76065537|FG000|Overall Study|Randomized but not treated|0|||
42241302|NCT02038777|76065538|FG001|Overall Study|Randomized but not treated|1|||
42241303|NCT02038777|76065539|FG002|Overall Study|Randomized but not treated|0|||
42241304|NCT02038777|76065540|FG003|Overall Study|Randomized but not treated|0|||
42241305|NCT02038777|76065541|FG004|Overall Study|Randomized but not treated|0|||
42241306|NCT02038777|76065542|FG005|Overall Study|Randomized but not treated|0|||
42241307|NCT02038777|76065543|FG006|Overall Study|Randomized but not treated|0|||
41988577|NCT01265797|75796013|FG000|Run-in Month|Withdrawal by Subject|0|||
41988578|NCT01265797|75796014|FG001|Run-in Month|Withdrawal by Subject|4|||
41988579|NCT01265797|75796013|FG000|Run-in Month|1st seizure during run-in month|0|||
41988580|NCT01265797|75796014|FG001|Run-in Month|1st seizure during run-in month|1|||
41988581|NCT01265797|75796013|FG000|Blinded Month|Lack of Efficacy|5|||
41988582|NCT01265797|75796014|FG001|Blinded Month|Lack of Efficacy|0|||
41988583|NCT01265797|75796013|FG000|Blinded Month|Lost to Follow-up|1|||
41988584|NCT01265797|75796014|FG001|Blinded Month|Lost to Follow-up|0|||
42032748|NCT01090050|75841017|FG001|Overall Study|Lack of Efficacy|5|||
42241308|NCT02038777|76065544|FG007|Overall Study|Randomized but not treated|0|||
42241309|NCT02038777|76065537|FG000|Overall Study|Started Chemotherapy|1|||
42241310|NCT02038777|76065538|FG001|Overall Study|Started Chemotherapy|0|||
42241311|NCT02038777|76065539|FG002|Overall Study|Started Chemotherapy|3|||
42241312|NCT02038777|76065540|FG003|Overall Study|Started Chemotherapy|0|||
42241313|NCT02038777|76065541|FG004|Overall Study|Started Chemotherapy|0|||
42302692|NCT02349633|76138073|FG005|Overall Study|Death|1|||
42241314|NCT02038777|76065542|FG005|Overall Study|Started Chemotherapy|0|||
42241315|NCT02038777|76065543|FG006|Overall Study|Started Chemotherapy|0|||
41988585|NCT01265797|75796013|FG000|Blinded Month|Protocol Violation|2|||
41988586|NCT01265797|75796014|FG001|Blinded Month|Protocol Violation|1|||
41988587|NCT01265797|75796013|FG000|Blinded Month|Adverse Event|2|||
41988588|NCT01265797|75796014|FG001|Blinded Month|Adverse Event|0|||
41988589|NCT01265797|75796013|FG000|Blinded Month|Diary data incomplete|0|||
41988590|NCT01265797|75796014|FG001|Blinded Month|Diary data incomplete|1|||
41988591|NCT01265797|75796013|FG000|Open Label Month|Lost to Follow-up|0|||
41988592|NCT01265797|75796014|FG001|Open Label Month|Lost to Follow-up|1|||
41988593|NCT01265719|75796024|FG000|Overall Study|Does not meet entrance criteria|0|||
41988594|NCT01265719|75796025|FG001|Overall Study|Does not meet entrance criteria|3|||
41988595|NCT01265719|75796024|FG000|Overall Study|Other reasons|2|||
41988596|NCT01265719|75796025|FG001|Overall Study|Other reasons|0|||
41988597|NCT01265719|75796024|FG000|Overall Study|Withdrawal by Subject|8|||
41988598|NCT01265719|75796025|FG001|Overall Study|Withdrawal by Subject|3|||
41988599|NCT01265719|75796024|FG000|Overall Study|Lost to Follow-up|2|||
41988600|NCT01265719|75796025|FG001|Overall Study|Lost to Follow-up|7|||
41988601|NCT01265719|75796024|FG000|Overall Study|Adverse Event|2|||
41988602|NCT01265719|75796025|FG001|Overall Study|Adverse Event|0|||
41988603|NCT01265563|75796057|FG000|Overall Study|Withdrawal by Subject|0|||
41988604|NCT01265563|75796058|FG001|Overall Study|Withdrawal by Subject|1|||
41988605|NCT01265563|75796059|FG002|Overall Study|Withdrawal by Subject|1|||
41988606|NCT01265563|75796060|FG003|Overall Study|Withdrawal by Subject|0|||
41988607|NCT01265563|75796061|FG004|Overall Study|Withdrawal by Subject|2|||
41988608|NCT01265056|75796080|FG000|Initial Study Period|Withdrawal by Subject|1|||
41988609|NCT01265056|75796081|FG001|Initial Study Period|Withdrawal by Subject|1|||
41988610|NCT01265056|75796080|FG000|Initial Study Period|Withdrawal by Subject|1|||
41988611|NCT01265056|75796081|FG001|Initial Study Period|Withdrawal by Subject|1|||
41988612|NCT01265056|75796080|FG000|Follow up|Lost to Follow-up|7|||
41988613|NCT01265056|75796081|FG001|Follow up|Lost to Follow-up|3|||
41988614|NCT01264939|75796089|FG000|Overall Study|Adverse Event|1|||
41988615|NCT01264939|75796090|FG001|Overall Study|Adverse Event|3|||
41988616|NCT01264939|75796089|FG000|Overall Study|Lost to Follow-up|0|||
41988617|NCT01264939|75796090|FG001|Overall Study|Lost to Follow-up|3|||
41988618|NCT01264939|75796089|FG000|Overall Study|Physician Decision|1|||
41988619|NCT01264939|75796090|FG001|Overall Study|Physician Decision|1|||
41988620|NCT01264939|75796089|FG000|Overall Study|Patient/Guardian Decision|8|||
41988621|NCT01264939|75796090|FG001|Overall Study|Patient/Guardian Decision|10|||
41988622|NCT01264939|75796089|FG000|Overall Study|Disease Progression|8|||
41988623|NCT01264939|75796090|FG001|Overall Study|Disease Progression|11|||
41988624|NCT01264081|75796096|FG000|Participants Screened|Screening failures|30|||
42032749|NCT01090050|75841016|FG000|Overall Study|Physician Decision|0|||
42032750|NCT01090050|75841017|FG001|Overall Study|Physician Decision|1|||
42032751|NCT00944229|75841027|FG000|Overall Study|Withdrawal by Subject|11|||
42241316|NCT02038777|76065544|FG007|Overall Study|Started Chemotherapy|0|||
42272661|NCT01657760|76102928|FG002|Overall Study|Withdrawal by Subject|0|||
42272662|NCT01657760|76102929|FG003|Overall Study|Withdrawal by Subject|1|||
42272663|NCT01657760|76102926|FG000|Overall Study|Physician Decision|1|||
42272664|NCT01657760|76102927|FG001|Overall Study|Physician Decision|1|||
42272665|NCT01657760|76102928|FG002|Overall Study|Physician Decision|1|||
42272666|NCT01657760|76102929|FG003|Overall Study|Physician Decision|2|||
42272667|NCT02280304|76102956|FG000|Overall Study|Lost to Follow-up|7|||
42272668|NCT02280304|76102957|FG001|Overall Study|Lost to Follow-up|8|||
42272669|NCT02283658|76102977|FG000|Overall Study|Withdrawal by Subject|1|||
42272670|NCT02279524|76103004|FG000|Overall Study|Withdrawal by Subject|3|||
42272671|NCT02279524|76103005|FG001|Overall Study|Withdrawal by Subject|6|||
42272672|NCT02279524|76103006|FG002|Overall Study|Withdrawal by Subject|3|||
42272673|NCT02279524|76103004|FG000|Overall Study|Adverse Event|4|||
42272674|NCT02279524|76103005|FG001|Overall Study|Adverse Event|3|||
42272675|NCT02279524|76103006|FG002|Overall Study|Adverse Event|2|||
42272676|NCT02279524|76103004|FG000|Overall Study|Lost to Follow-up|1|||
42272677|NCT02279524|76103005|FG001|Overall Study|Lost to Follow-up|1|||
42272678|NCT02279524|76103006|FG002|Overall Study|Lost to Follow-up|0|||
42272679|NCT02279524|76103004|FG000|Overall Study|Disallowed medication|1|||
42272680|NCT02279524|76103005|FG001|Overall Study|Disallowed medication|1|||
41988625|NCT01264081|75796096|FG000|Started Treatment|Withdrawal by Subject|1|||
41988626|NCT01264081|75796096|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
41988627|NCT01263925|75796102|FG000|Overall Study|Protocol Violation|1|||
41988628|NCT01263925|75796103|FG001|Overall Study|Protocol Violation|0|||
41988629|NCT01263925|75796102|FG000|Overall Study|Lack of Efficacy|0|||
41988630|NCT01263925|75796103|FG001|Overall Study|Lack of Efficacy|1|||
41988631|NCT01263925|75796102|FG000|Overall Study|Adverse Event|23|||
41988632|NCT01263925|75796103|FG001|Overall Study|Adverse Event|22|||
41988633|NCT01263925|75796102|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
41988634|NCT01263925|75796103|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
41988635|NCT01263925|75796102|FG000|Overall Study|Withdrawal by Subject|6|||
41988636|NCT01263925|75796103|FG001|Overall Study|Withdrawal by Subject|8|||
41988637|NCT01263925|75796102|FG000|Overall Study|Other|4|||
42032752|NCT00944229|75841027|FG000|Overall Study|Physician Decision|14|||
42272681|NCT02279524|76103006|FG002|Overall Study|Disallowed medication|2|||
42272682|NCT02279524|76103004|FG000|Overall Study|Bariatric surgery|1|||
42272683|NCT02279524|76103005|FG001|Overall Study|Bariatric surgery|0|||
42241317|NCT02853435|76065581|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
42241318|NCT02853435|76065582|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
42241319|NCT02853435|76065583|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
42241320|NCT02853435|76065584|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
42241321|NCT02853435|76065585|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
42241322|NCT02853435|76065586|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
42241323|NCT02635204|76065618|FG000|Overall Study|Adverse Event|1|||
42241324|NCT02635204|76065619|FG001|Overall Study|Adverse Event|0|||
42241325|NCT02635204|76065618|FG000|Overall Study|Lost to Follow-up|1|||
42241326|NCT02635204|76065619|FG001|Overall Study|Lost to Follow-up|1|||
42241327|NCT00102804|76065627|FG000|Overall Study|Progressive Disease (PD)|307|||
42241328|NCT00102804|76065628|FG001|Overall Study|Progressive Disease (PD)|196|||
42241329|NCT00102804|76065627|FG000|Overall Study|Withdrawal by Subject|46|||
42241330|NCT00102804|76065628|FG001|Overall Study|Withdrawal by Subject|7|||
42241331|NCT00102804|76065627|FG000|Overall Study|Adverse Event|37|||
42241332|NCT00102804|76065628|FG001|Overall Study|Adverse Event|3|||
42241333|NCT00102804|76065627|FG000|Overall Study|Physician Decision|24|||
42241334|NCT00102804|76065628|FG001|Overall Study|Physician Decision|6|||
42241335|NCT00102804|76065627|FG000|Overall Study|Death|5|||
42241336|NCT00102804|76065628|FG001|Overall Study|Death|6|||
42241337|NCT00102804|76065627|FG000|Overall Study|Enrollment Criteria Not Met|6|||
42241338|NCT00102804|76065628|FG001|Overall Study|Enrollment Criteria Not Met|0|||
42241339|NCT00102804|76065627|FG000|Overall Study|Lost to Follow-up|4|||
42241340|NCT00102804|76065628|FG001|Overall Study|Lost to Follow-up|1|||
42241341|NCT00102804|76065627|FG000|Overall Study|Protocol Violation|2|||
42241342|NCT00102804|76065628|FG001|Overall Study|Protocol Violation|1|||
42241343|NCT00102804|76065627|FG000|Overall Study|Satisfactory Response|2|||
42241344|NCT00102804|76065628|FG001|Overall Study|Satisfactory Response|0|||
42241345|NCT00102804|76065627|FG000|Overall Study|Sponsor Decision|1|||
42241346|NCT00102804|76065628|FG001|Overall Study|Sponsor Decision|0|||
42241347|NCT00102804|76065627|FG000|Overall Study|Alive, Receiving Treatment|7|||
42241348|NCT00102804|76065628|FG001|Overall Study|Alive, Receiving Treatment|2|||
42241349|NCT01814072|76065666|FG000|Overall Study|Lost to Follow-up|2|||
42241350|NCT01814072|76065667|FG001|Overall Study|Lost to Follow-up|2|||
42241351|NCT01814072|76065668|FG002|Overall Study|Lost to Follow-up|2|||
42241352|NCT01814072|76065669|FG003|Overall Study|Lost to Follow-up|0|||
42241353|NCT01814072|76065670|FG004|Overall Study|Lost to Follow-up|2|||
42241354|NCT01814072|76065671|FG005|Overall Study|Lost to Follow-up|3|||
42241355|NCT01814072|76065672|FG006|Overall Study|Lost to Follow-up|3|||
42241356|NCT01814072|76065673|FG007|Overall Study|Lost to Follow-up|1|||
42241357|NCT01814072|76065674|FG008|Overall Study|Lost to Follow-up|2|||
42241358|NCT01814072|76065675|FG009|Overall Study|Lost to Follow-up|3|||
42241359|NCT01814072|76065676|FG010|Overall Study|Lost to Follow-up|1|||
42241360|NCT01814072|76065677|FG011|Overall Study|Lost to Follow-up|2|||
42241361|NCT01814072|76065678|FG012|Overall Study|Lost to Follow-up|2|||
42241362|NCT01814072|76065679|FG013|Overall Study|Lost to Follow-up|1|||
42241363|NCT01814072|76065680|FG014|Overall Study|Lost to Follow-up|2|||
42241364|NCT01814072|76065681|FG015|Overall Study|Lost to Follow-up|1|||
42241365|NCT01814072|76065682|FG016|Overall Study|Lost to Follow-up|3|||
42241366|NCT01814072|76065683|FG017|Overall Study|Lost to Follow-up|1|||
42241367|NCT01814072|76065684|FG018|Overall Study|Lost to Follow-up|3|||
42241368|NCT01814072|76065685|FG019|Overall Study|Lost to Follow-up|3|||
41988638|NCT01263925|75796103|FG001|Overall Study|Other|4|||
41988639|NCT01263925|75796102|FG000|Overall Study|Lost to Follow-up|3|||
41988640|NCT01263925|75796103|FG001|Overall Study|Lost to Follow-up|1|||
41988641|NCT01263925|75796102|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
42241369|NCT01814072|76065686|FG020|Overall Study|Lost to Follow-up|2|||
42241370|NCT01814072|76065687|FG021|Overall Study|Lost to Follow-up|1|||
42241371|NCT01814072|76065688|FG022|Overall Study|Lost to Follow-up|3|||
42241372|NCT01814072|76065689|FG023|Overall Study|Lost to Follow-up|1|||
42241373|NCT01814072|76065690|FG024|Overall Study|Lost to Follow-up|4|||
42241374|NCT01814072|76065691|FG025|Overall Study|Lost to Follow-up|1|||
42241375|NCT01814072|76065692|FG026|Overall Study|Lost to Follow-up|1|||
42241376|NCT01814072|76065693|FG027|Overall Study|Lost to Follow-up|2|||
42241377|NCT01814072|76065694|FG028|Overall Study|Lost to Follow-up|3|||
42241378|NCT01814072|76065695|FG029|Overall Study|Lost to Follow-up|3|||
42241379|NCT01814072|76065696|FG030|Overall Study|Lost to Follow-up|2|||
42241380|NCT01814072|76065697|FG031|Overall Study|Lost to Follow-up|0|||
42241381|NCT01814072|76065666|FG000|Overall Study|Withdrawal by Subject|2|||
42241382|NCT01814072|76065667|FG001|Overall Study|Withdrawal by Subject|0|||
42241383|NCT01814072|76065668|FG002|Overall Study|Withdrawal by Subject|1|||
41988642|NCT01263925|75796103|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
41988643|NCT01263925|75796102|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
42241384|NCT01814072|76065669|FG003|Overall Study|Withdrawal by Subject|0|||
42241385|NCT01814072|76065670|FG004|Overall Study|Withdrawal by Subject|2|||
42241386|NCT01814072|76065671|FG005|Overall Study|Withdrawal by Subject|3|||
42241387|NCT01814072|76065672|FG006|Overall Study|Withdrawal by Subject|1|||
42241388|NCT01814072|76065673|FG007|Overall Study|Withdrawal by Subject|0|||
42241389|NCT01814072|76065674|FG008|Overall Study|Withdrawal by Subject|1|||
42241390|NCT01814072|76065675|FG009|Overall Study|Withdrawal by Subject|2|||
42241391|NCT01814072|76065676|FG010|Overall Study|Withdrawal by Subject|0|||
42241392|NCT01814072|76065677|FG011|Overall Study|Withdrawal by Subject|0|||
42241393|NCT01814072|76065678|FG012|Overall Study|Withdrawal by Subject|1|||
42241394|NCT01814072|76065679|FG013|Overall Study|Withdrawal by Subject|1|||
42241395|NCT01814072|76065680|FG014|Overall Study|Withdrawal by Subject|1|||
42241396|NCT01814072|76065681|FG015|Overall Study|Withdrawal by Subject|1|||
42241397|NCT01814072|76065682|FG016|Overall Study|Withdrawal by Subject|0|||
42241398|NCT01814072|76065683|FG017|Overall Study|Withdrawal by Subject|0|||
42241399|NCT01814072|76065684|FG018|Overall Study|Withdrawal by Subject|0|||
42241400|NCT01814072|76065685|FG019|Overall Study|Withdrawal by Subject|2|||
42241401|NCT01814072|76065686|FG020|Overall Study|Withdrawal by Subject|0|||
42241402|NCT01814072|76065687|FG021|Overall Study|Withdrawal by Subject|0|||
42241403|NCT01814072|76065688|FG022|Overall Study|Withdrawal by Subject|1|||
42241404|NCT01814072|76065689|FG023|Overall Study|Withdrawal by Subject|0|||
42241405|NCT01814072|76065690|FG024|Overall Study|Withdrawal by Subject|2|||
42241406|NCT01814072|76065691|FG025|Overall Study|Withdrawal by Subject|1|||
42241407|NCT01814072|76065692|FG026|Overall Study|Withdrawal by Subject|1|||
42241408|NCT01814072|76065693|FG027|Overall Study|Withdrawal by Subject|2|||
42241409|NCT01814072|76065694|FG028|Overall Study|Withdrawal by Subject|1|||
42241410|NCT01814072|76065695|FG029|Overall Study|Withdrawal by Subject|0|||
42241411|NCT01814072|76065696|FG030|Overall Study|Withdrawal by Subject|0|||
42241412|NCT01814072|76065697|FG031|Overall Study|Withdrawal by Subject|0|||
42241413|NCT03038113|76065752|FG000|Overall Study|Withdrawal by Subject|0|||
42241414|NCT03038113|76065753|FG001|Overall Study|Withdrawal by Subject|0|||
42241415|NCT03038113|76065754|FG002|Overall Study|Withdrawal by Subject|1|||
42241416|NCT03038113|76065755|FG003|Overall Study|Withdrawal by Subject|0|||
42241417|NCT03038113|76065756|FG004|Overall Study|Withdrawal by Subject|0|||
42241418|NCT03038113|76065757|FG005|Overall Study|Withdrawal by Subject|0|||
42241419|NCT03038113|76065758|FG006|Overall Study|Withdrawal by Subject|0|||
42241420|NCT03038113|76065759|FG007|Overall Study|Withdrawal by Subject|0|||
42241421|NCT03038113|76065760|FG008|Overall Study|Withdrawal by Subject|0|||
42241422|NCT03038113|76065761|FG009|Overall Study|Withdrawal by Subject|0|||
42241423|NCT03038113|76065762|FG010|Overall Study|Withdrawal by Subject|0|||
42241424|NCT03038113|76065763|FG011|Overall Study|Withdrawal by Subject|0|||
42241425|NCT03038113|76065764|FG012|Overall Study|Withdrawal by Subject|0|||
42241426|NCT03038113|76065765|FG013|Overall Study|Withdrawal by Subject|1|||
42241427|NCT03038113|76065752|FG000|Overall Study|Lost to Follow-up|0|||
42241428|NCT03038113|76065753|FG001|Overall Study|Lost to Follow-up|0|||
42241429|NCT03038113|76065754|FG002|Overall Study|Lost to Follow-up|0|||
42241430|NCT03038113|76065755|FG003|Overall Study|Lost to Follow-up|0|||
42241431|NCT03038113|76065756|FG004|Overall Study|Lost to Follow-up|0|||
42241432|NCT03038113|76065757|FG005|Overall Study|Lost to Follow-up|0|||
42241433|NCT03038113|76065758|FG006|Overall Study|Lost to Follow-up|1|||
42241434|NCT03038113|76065759|FG007|Overall Study|Lost to Follow-up|0|||
42241435|NCT03038113|76065760|FG008|Overall Study|Lost to Follow-up|0|||
42241436|NCT03038113|76065761|FG009|Overall Study|Lost to Follow-up|0|||
42241437|NCT03038113|76065762|FG010|Overall Study|Lost to Follow-up|0|||
42241438|NCT03038113|76065763|FG011|Overall Study|Lost to Follow-up|0|||
42241439|NCT03038113|76065764|FG012|Overall Study|Lost to Follow-up|0|||
41988644|NCT01263925|75796103|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
41988645|NCT01263925|75796102|FG000|Overall Study|AE/ Withdrawal|1|||
41988646|NCT01263925|75796103|FG001|Overall Study|AE/ Withdrawal|4|||
41988647|NCT01263925|75796102|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
41988648|NCT01263925|75796103|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
41988649|NCT01263925|75796102|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
41988650|NCT01263925|75796103|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
41988651|NCT01263925|75796102|FG000|Overall Study|Withdrawal/ Not specified|0|||
41988652|NCT01263925|75796103|FG001|Overall Study|Withdrawal/ Not specified|1|||
41988653|NCT01263691|75796115|FG000|Overall Study|Lost to Follow-up|1|||
41988654|NCT01263691|75796116|FG001|Overall Study|Lost to Follow-up|0|||
41988655|NCT01263691|75796117|FG002|Overall Study|Lost to Follow-up|1|||
41988656|NCT01263691|75796118|FG003|Overall Study|Lost to Follow-up|1|||
41988657|NCT01263691|75796119|FG004|Overall Study|Lost to Follow-up|0|||
42241440|NCT03038113|76065765|FG013|Overall Study|Lost to Follow-up|0|||
42241441|NCT00968149|76065814|FG000|Overall Study|Adverse Event|5|||
42241442|NCT00968149|76065815|FG001|Overall Study|Adverse Event|1|||
42241443|NCT00968149|76065814|FG000|Overall Study|Lack of Efficacy|0|||
42241444|NCT00968149|76065815|FG001|Overall Study|Lack of Efficacy|4|||
42241445|NCT00968149|76065814|FG000|Overall Study|Lost to Follow-up|0|||
42241446|NCT00968149|76065815|FG001|Overall Study|Lost to Follow-up|1|||
42241447|NCT00968149|76065814|FG000|Overall Study|Protocol Violation|4|||
42241448|NCT00968149|76065815|FG001|Overall Study|Protocol Violation|0|||
42241449|NCT00968149|76065814|FG000|Overall Study|Withdrawal by Subject|2|||
41988658|NCT01263691|75796120|FG005|Overall Study|Lost to Follow-up|0|||
41988659|NCT01263691|75796115|FG000|Overall Study|Withdrawal by Subject|1|||
42241450|NCT00968149|76065815|FG001|Overall Study|Withdrawal by Subject|0|||
42241451|NCT00963469|76065824|FG000|Overall Study|Adverse Event|15|||
42241452|NCT00963469|76065825|FG001|Overall Study|Adverse Event|11|||
42241453|NCT00963469|76065826|FG002|Overall Study|Adverse Event|1|||
42241454|NCT00963469|76065824|FG000|Overall Study|Lack of Efficacy|10|||
42241455|NCT00963469|76065825|FG001|Overall Study|Lack of Efficacy|7|||
42241456|NCT00963469|76065826|FG002|Overall Study|Lack of Efficacy|2|||
42241457|NCT00963469|76065824|FG000|Overall Study|Lost to Follow-up|1|||
42241458|NCT00963469|76065825|FG001|Overall Study|Lost to Follow-up|1|||
42241459|NCT00963469|76065826|FG002|Overall Study|Lost to Follow-up|0|||
42241460|NCT00963469|76065824|FG000|Overall Study|Protocol Violation|5|||
42241461|NCT00963469|76065825|FG001|Overall Study|Protocol Violation|5|||
42241462|NCT00963469|76065826|FG002|Overall Study|Protocol Violation|3|||
42241463|NCT00963469|76065824|FG000|Overall Study|Withdrawal by Subject|4|||
42241464|NCT00963469|76065825|FG001|Overall Study|Withdrawal by Subject|1|||
42241465|NCT00963469|76065826|FG002|Overall Study|Withdrawal by Subject|1|||
42241466|NCT00963469|76065824|FG000|Overall Study|Pre-randomization Adverse Event|1|||
42241467|NCT00963469|76065825|FG001|Overall Study|Pre-randomization Adverse Event|2|||
42241468|NCT00963469|76065826|FG002|Overall Study|Pre-randomization Adverse Event|0|||
42241469|NCT00963469|76065824|FG000|Overall Study|Moved|1|||
42241470|NCT00963469|76065825|FG001|Overall Study|Moved|0|||
42241471|NCT00963469|76065826|FG002|Overall Study|Moved|0|||
42241472|NCT00963469|76065824|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
42241473|NCT00963469|76065825|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
42241474|NCT00963469|76065826|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
42241475|NCT00897949|76065837|FG000|Overall Study|Adverse Event|1|||
42241476|NCT00897949|76065838|FG001|Overall Study|Adverse Event|1|||
42241477|NCT00897949|76065839|FG002|Overall Study|Adverse Event|0|||
42241478|NCT00897949|76065837|FG000|Overall Study|Lost to Follow-up|0|||
42241479|NCT00897949|76065838|FG001|Overall Study|Lost to Follow-up|2|||
42241480|NCT00897949|76065839|FG002|Overall Study|Lost to Follow-up|1|||
42241481|NCT00897949|76065837|FG000|Overall Study|Protocol Violation|6|||
42241482|NCT00897949|76065838|FG001|Overall Study|Protocol Violation|3|||
42241483|NCT00897949|76065839|FG002|Overall Study|Protocol Violation|1|||
42241484|NCT00897949|76065837|FG000|Overall Study|Withdrawal by Subject|1|||
42241485|NCT00897949|76065838|FG001|Overall Study|Withdrawal by Subject|2|||
42241486|NCT00897949|76065839|FG002|Overall Study|Withdrawal by Subject|0|||
42241487|NCT00897949|76065837|FG000|Overall Study|Patient Uncoorperative|0|||
42241488|NCT00897949|76065838|FG001|Overall Study|Patient Uncoorperative|2|||
42241489|NCT00897949|76065839|FG002|Overall Study|Patient Uncoorperative|1|||
42241490|NCT00897949|76065837|FG000|Overall Study|Lost to Follow-up|30|||
42241491|NCT00897949|76065838|FG001|Overall Study|Lost to Follow-up|23|||
42241492|NCT00897949|76065839|FG002|Overall Study|Lost to Follow-up|17|||
42241493|NCT00897949|76065837|FG000|Overall Study|Withdrawal by Subject|24|||
42241494|NCT00897949|76065838|FG001|Overall Study|Withdrawal by Subject|31|||
42241495|NCT00897949|76065839|FG002|Overall Study|Withdrawal by Subject|17|||
42241496|NCT00897949|76065837|FG000|Overall Study|Abnormal Prestudy Labs|2|||
42241497|NCT00897949|76065838|FG001|Overall Study|Abnormal Prestudy Labs|3|||
42241498|NCT00897949|76065839|FG002|Overall Study|Abnormal Prestudy Labs|4|||
42241499|NCT00897949|76065837|FG000|Overall Study|Abnormal Baseline ECG|2|||
42241500|NCT00897949|76065838|FG001|Overall Study|Abnormal Baseline ECG|2|||
42241501|NCT00897949|76065839|FG002|Overall Study|Abnormal Baseline ECG|4|||
42241502|NCT00897949|76065837|FG000|Overall Study|Need for Concom. Med.|0|||
42241503|NCT00897949|76065838|FG001|Overall Study|Need for Concom. Med.|1|||
42241504|NCT00897949|76065839|FG002|Overall Study|Need for Concom. Med.|1|||
42241505|NCT00897949|76065837|FG000|Overall Study|Lack of Migraine Attack|29|||
42241506|NCT00897949|76065838|FG001|Overall Study|Lack of Migraine Attack|30|||
42241507|NCT00897949|76065839|FG002|Overall Study|Lack of Migraine Attack|19|||
42241508|NCT00897949|76065837|FG000|Overall Study|Did not take study drug|9|||
42241509|NCT00897949|76065838|FG001|Overall Study|Did not take study drug|3|||
42241510|NCT00897949|76065839|FG002|Overall Study|Did not take study drug|4|||
42241511|NCT02760810|76065853|FG000|Overall Study|Protocol Violation|1|||
42241512|NCT02760654|76065859|FG000|Overall Study|Lost to Follow-up|3|||
42241513|NCT02760654|76065860|FG001|Overall Study|Lost to Follow-up|3|||
42241514|NCT02760654|76065859|FG000|Overall Study|Withdrawal by Subject|4|||
42241515|NCT02760654|76065860|FG001|Overall Study|Withdrawal by Subject|3|||
42241516|NCT00725491|76065868|FG000|Overall Study|Adverse Event|3|||
42241517|NCT00725491|76065869|FG001|Overall Study|Adverse Event|2|||
42241518|NCT00725491|76065868|FG000|Overall Study|Pregnancy|0|||
42241519|NCT00725491|76065869|FG001|Overall Study|Pregnancy|3|||
42241520|NCT00725491|76065868|FG000|Overall Study|Risk for hyperstimulation|2|||
42241521|NCT00725491|76065869|FG001|Overall Study|Risk for hyperstimulation|9|||
42241522|NCT00725491|76065868|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
42241523|NCT00725491|76065869|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
42241524|NCT00725491|76065868|FG000|Overall Study|Fertilization failure|0|||
42241525|NCT00725491|76065869|FG001|Overall Study|Fertilization failure|1|||
42241526|NCT00725491|76065868|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
42241527|NCT00725491|76065869|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
42241528|NCT02634580|76065879|FG000|Double-blind Treatment Period|Subject Request|1|||
42241529|NCT02634580|76065880|FG001|Double-blind Treatment Period|Subject Request|0|||
42241530|NCT02634580|76065881|FG002|Double-blind Treatment Period|Subject Request|1|||
42241531|NCT02634580|76065882|FG003|Double-blind Treatment Period|Subject Request|1|||
42241532|NCT02634580|76065879|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
42241533|NCT02634580|76065880|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
42241534|NCT02634580|76065881|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
42241535|NCT02634580|76065882|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
42241536|NCT02225366|76065893|FG000|Overall Study|Lack of Efficacy|1|||
42241537|NCT02225366|76065894|FG001|Overall Study|Lack of Efficacy|0|||
42241538|NCT00697255|76065902|FG000|Stage 1a|Insufficient ovarian response|1|||
42241539|NCT00697255|76065903|FG001|Stage 1a|Insufficient ovarian response|0|||
42241540|NCT00697255|76065902|FG000|Stage 1a|Multifollicular growth|1|||
42241541|NCT00697255|76065903|FG001|Stage 1a|Multifollicular growth|0|||
42241542|NCT00697255|76065902|FG000|Stage 1a|Not growing of dominant follicle|1|||
42241543|NCT00697255|76065903|FG001|Stage 1a|Not growing of dominant follicle|0|||
42241544|NCT00697255|76065902|FG000|Stage 1b|Not growing of dominant follicle|0|||
42241545|NCT00697255|76065903|FG001|Stage 1b|Not growing of dominant follicle|1|||
42241546|NCT00697255|76065902|FG000|Stage 1b|Insufficient ovarian response|0|||
42241547|NCT00697255|76065903|FG001|Stage 1b|Insufficient ovarian response|1|||
42241548|NCT05350423|76065911|FG000|Overall Study|Lost to Follow-up|3|||
42241549|NCT05350423|76065912|FG001|Overall Study|Lost to Follow-up|3|||
42241550|NCT05350423|76065911|FG000|Overall Study|screen failure|5|||
42241551|NCT05350423|76065912|FG001|Overall Study|screen failure|6|||
42241552|NCT04896385|76065920|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
42241553|NCT04896385|76065921|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
42241554|NCT04896385|76065922|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
42241555|NCT04896385|76065923|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
42241556|NCT04896385|76065920|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
42241557|NCT04896385|76065921|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
42241558|NCT04896385|76065922|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
42241559|NCT04896385|76065923|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
42241560|NCT04896385|76065920|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
42241561|NCT04896385|76065921|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
42241562|NCT04896385|76065922|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
42241563|NCT04896385|76065923|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
42241564|NCT04896385|76065920|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
42241565|NCT04896385|76065921|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
42241566|NCT04896385|76065922|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
42241567|NCT04896385|76065923|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
42241568|NCT04896385|76065920|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
42241569|NCT04896385|76065921|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
42241570|NCT04896385|76065922|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
42241571|NCT04896385|76065923|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
42241572|NCT04896385|76065920|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
42241573|NCT04896385|76065921|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
42241574|NCT04896385|76065922|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
42241575|NCT04896385|76065923|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
42241576|NCT04359823|76065944|FG000|Overall Study|Lost to Follow-up|0|||
42241577|NCT04359823|76065945|FG001|Overall Study|Lost to Follow-up|1|||
42241578|NCT04359823|76065944|FG000|Overall Study|Withdrawal by Subject|0|||
42241579|NCT04359823|76065945|FG001|Overall Study|Withdrawal by Subject|1|||
42241580|NCT04229446|76065964|FG000|Overall Study|Death|12|||
42241581|NCT04229446|76065965|FG001|Overall Study|Death|10|||
42241582|NCT04229446|76065964|FG000|Overall Study|Lost to Follow-up|5|||
41988660|NCT01263691|75796116|FG001|Overall Study|Withdrawal by Subject|0|||
42241583|NCT04229446|76065965|FG001|Overall Study|Lost to Follow-up|8|||
42241584|NCT03701763|76066000|FG000|Placebo-controlled Phase|Adverse Event|1|||
42241585|NCT03701763|76066001|FG001|Placebo-controlled Phase|Adverse Event|5|||
42241586|NCT03701763|76066002|FG002|Placebo-controlled Phase|Adverse Event|0|||
41988661|NCT01263691|75796117|FG002|Overall Study|Withdrawal by Subject|0|||
42241587|NCT03701763|76066003|FG003|Placebo-controlled Phase|Adverse Event|0|||
42241588|NCT03701763|76066000|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
42241589|NCT03701763|76066001|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
42241590|NCT03701763|76066002|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
42241591|NCT03701763|76066003|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
42241592|NCT03701763|76066000|FG000|Placebo-controlled Phase|Miscellaneous|2|||
42241593|NCT03701763|76066001|FG001|Placebo-controlled Phase|Miscellaneous|0|||
42241594|NCT03701763|76066002|FG002|Placebo-controlled Phase|Miscellaneous|0|||
42241595|NCT03701763|76066003|FG003|Placebo-controlled Phase|Miscellaneous|0|||
42241596|NCT03701763|76066000|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
42241597|NCT03701763|76066001|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
42241598|NCT03701763|76066002|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
42241599|NCT03701763|76066003|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
42241600|NCT03701763|76066000|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
42241601|NCT03701763|76066001|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
42241602|NCT03701763|76066002|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
42241603|NCT03701763|76066003|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
42241604|NCT03701763|76066000|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
42241605|NCT03701763|76066001|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
42241606|NCT03701763|76066002|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
42241607|NCT03701763|76066003|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
42241608|NCT03701763|76066000|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
42241609|NCT03701763|76066001|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
42241610|NCT03701763|76066002|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
42241611|NCT03701763|76066003|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
42241612|NCT03701763|76066000|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
42241613|NCT03701763|76066001|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
42241614|NCT03701763|76066002|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
41988662|NCT01263691|75796118|FG003|Overall Study|Withdrawal by Subject|0|||
41988663|NCT01263691|75796119|FG004|Overall Study|Withdrawal by Subject|0|||
41988664|NCT01263691|75796120|FG005|Overall Study|Withdrawal by Subject|0|||
41988665|NCT01263691|75796115|FG000|Overall Study|Adverse Event|1|||
41988666|NCT01263691|75796116|FG001|Overall Study|Adverse Event|0|||
41988667|NCT01263691|75796117|FG002|Overall Study|Adverse Event|0|||
41988668|NCT01263691|75796118|FG003|Overall Study|Adverse Event|0|||
41988669|NCT01263691|75796119|FG004|Overall Study|Adverse Event|0|||
41988670|NCT01263691|75796120|FG005|Overall Study|Adverse Event|0|||
41988671|NCT01263496|75796197|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
41988672|NCT01263496|75796198|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
41988673|NCT01263496|75796199|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
41988674|NCT01263496|75796200|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
41988675|NCT01263496|75796201|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
42241615|NCT03701763|76066003|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
41988676|NCT01263496|75796202|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
41988677|NCT01263496|75796203|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
41988678|NCT01263496|75796204|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
42032753|NCT01077960|75841031|FG000|Overall Study|Adverse Event|6|||
42241616|NCT03701763|76066000|FG000|Apremilast Extension Phase|Adverse Event|0|||
42241617|NCT03701763|76066001|FG001|Apremilast Extension Phase|Adverse Event|0|||
42241618|NCT03701763|76066002|FG002|Apremilast Extension Phase|Adverse Event|3|||
42241619|NCT03701763|76066003|FG003|Apremilast Extension Phase|Adverse Event|1|||
42241620|NCT03701763|76066000|FG000|Apremilast Extension Phase|Miscellaneous|0|||
42241621|NCT03701763|76066001|FG001|Apremilast Extension Phase|Miscellaneous|0|||
42241622|NCT03701763|76066002|FG002|Apremilast Extension Phase|Miscellaneous|2|||
42241623|NCT03701763|76066003|FG003|Apremilast Extension Phase|Miscellaneous|1|||
42241624|NCT03701763|76066000|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
42241625|NCT03701763|76066001|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
42241626|NCT03701763|76066002|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
42241627|NCT03701763|76066003|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
42241628|NCT03701763|76066000|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
42032754|NCT01077960|75841031|FG000|Overall Study|Protocol Violation|3|||
42241629|NCT03701763|76066001|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
42302693|NCT02349633|76138074|FG006|Overall Study|Death|1|||
42241630|NCT03701763|76066002|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
42302694|NCT02349633|76138075|FG007|Overall Study|Death|1|||
42302695|NCT02349633|76138076|FG008|Overall Study|Death|0|||
42302696|NCT02349633|76138077|FG009|Overall Study|Death|1|||
42302697|NCT02349633|76138078|FG010|Overall Study|Death|0|||
41988679|NCT01263496|75796205|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
42032755|NCT01077960|75841031|FG000|Overall Study|Lost to Follow-up|5|||
41988680|NCT01263496|75796197|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
41988681|NCT01263496|75796198|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
42241631|NCT03701763|76066003|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
42241632|NCT03701763|76066000|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
42241633|NCT03701763|76066001|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
42241634|NCT03701763|76066002|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
42241635|NCT03701763|76066003|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
42241636|NCT03701763|76066000|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
42241637|NCT03701763|76066001|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
42241638|NCT03701763|76066002|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
42241639|NCT03701763|76066003|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
42241640|NCT03701763|76066000|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
42241641|NCT03701763|76066001|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
42241642|NCT03701763|76066002|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
42241643|NCT03701763|76066003|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
42241644|NCT03701763|76066000|FG000|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
42241645|NCT03701763|76066001|FG001|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
42241646|NCT03701763|76066002|FG002|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|1|||
42241647|NCT03701763|76066003|FG003|14-Week Observational Follow-up Phase|Study Terminated by Sponsor|0|||
42241648|NCT03701763|76066000|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
42241649|NCT03701763|76066001|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
42241650|NCT03701763|76066002|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
42241651|NCT03701763|76066003|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
42241652|NCT03701763|76066000|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
42241653|NCT03701763|76066001|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
42241654|NCT03701763|76066002|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
42241655|NCT03701763|76066003|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
42241656|NCT03575897|76066042|FG000|Overall Study|Lost to Follow-up|12|||
42241657|NCT03575897|76066043|FG001|Overall Study|Lost to Follow-up|13|||
42241658|NCT03439748|76066051|FG000|Overall Study|Withdrawal by Subject|11|||
42241659|NCT03439748|76066052|FG001|Overall Study|Withdrawal by Subject|17|||
42241660|NCT03433001|76066058|FG000|Overall Study|Lack of Efficacy|109|||
42241661|NCT03433001|76066058|FG000|Overall Study|Adverse Event|69|||
42241662|NCT03433001|76066058|FG000|Overall Study|Withdrawal by Subject|10|||
42241663|NCT03433001|76066058|FG000|Overall Study|Death|12|||
42241664|NCT03433001|76066058|FG000|Overall Study|Lost to Follow-up|4|||
42241665|NCT03433001|76066058|FG000|Overall Study|Other|25|||
42241666|NCT03412565|76066066|FG000|Overall Study|Lost to Follow-up|0|||
42241667|NCT03412565|76066067|FG001|Overall Study|Lost to Follow-up|0|||
42241668|NCT03412565|76066068|FG002|Overall Study|Lost to Follow-up|1|||
42241669|NCT03412565|76066069|FG003|Overall Study|Lost to Follow-up|0|||
42241670|NCT03412565|76066066|FG000|Overall Study|Physician Decision|0|||
42241671|NCT03412565|76066067|FG001|Overall Study|Physician Decision|0|||
41988682|NCT01263496|75796199|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
41988683|NCT01263496|75796200|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
41988684|NCT01263496|75796201|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
42241672|NCT03412565|76066068|FG002|Overall Study|Physician Decision|0|||
42241673|NCT03412565|76066069|FG003|Overall Study|Physician Decision|1|||
42241674|NCT03412565|76066066|FG000|Overall Study|Withdrawal by Subject|0|||
42241675|NCT03412565|76066067|FG001|Overall Study|Withdrawal by Subject|4|||
42241676|NCT03412565|76066068|FG002|Overall Study|Withdrawal by Subject|5|||
42241677|NCT03412565|76066069|FG003|Overall Study|Withdrawal by Subject|5|||
42241678|NCT03412565|76066066|FG000|Overall Study|Death|1|||
42241679|NCT03412565|76066067|FG001|Overall Study|Death|3|||
41988685|NCT01263496|75796202|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
41988686|NCT01263496|75796203|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
41988687|NCT01263496|75796204|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
41988688|NCT01263496|75796205|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
41988689|NCT01263496|75796197|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
41988690|NCT01263496|75796198|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
41988691|NCT01263496|75796199|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
42132017|NCT00510068|75942843|FG000|Double-blind Period|Disease progression|98|||
42132018|NCT00510068|75942844|FG001|Double-blind Period|Disease progression|169|||
42132019|NCT00510068|75942843|FG000|Double-blind Period|Final primary analysis|52|||
42132020|NCT00510068|75942844|FG001|Double-blind Period|Final primary analysis|18|||
42241680|NCT03412565|76066068|FG002|Overall Study|Death|4|||
42241681|NCT03412565|76066069|FG003|Overall Study|Death|5|||
42241682|NCT03412565|76066066|FG000|Overall Study|Data collection ended|0|||
42241683|NCT03412565|76066067|FG001|Overall Study|Data collection ended|41|||
42241684|NCT03412565|76066068|FG002|Overall Study|Data collection ended|41|||
42241685|NCT03412565|76066069|FG003|Overall Study|Data collection ended|40|||
42241686|NCT03330847|76066085|FG000|Overall Study|Patients ongoing study|62|||
42241687|NCT03330847|76066086|FG001|Overall Study|Patients ongoing study|65|||
41988692|NCT01263496|75796200|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
41988693|NCT01263496|75796201|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
41988694|NCT01263496|75796202|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
41988695|NCT01263496|75796203|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
41988696|NCT01263496|75796204|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
41988697|NCT01263496|75796205|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
41988698|NCT01263496|75796197|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
41988699|NCT01263496|75796198|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
41988700|NCT01263496|75796199|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
41988701|NCT01263496|75796200|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
41988702|NCT01263496|75796201|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
41988703|NCT01263496|75796202|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
41988704|NCT01263496|75796203|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
41988705|NCT01263496|75796204|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
41988706|NCT01263496|75796205|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
41988707|NCT01263496|75796197|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
41988708|NCT01263496|75796198|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
41988709|NCT01263496|75796199|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
41988710|NCT01263496|75796200|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
41988711|NCT01263496|75796201|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
41988712|NCT01263496|75796202|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
41988713|NCT01263496|75796203|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
41988714|NCT01263496|75796204|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
41988715|NCT01263496|75796205|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
42241688|NCT03330847|76066087|FG002|Overall Study|Patients ongoing study|15|||
42241689|NCT03314935|76066112|FG000|Phase 1|Death|4|||
42241690|NCT03314935|76066113|FG001|Phase 1|Death|2|||
42241691|NCT03314935|76066114|FG002|Phase 1|Death|5|||
42241692|NCT03314935|76066115|FG003|Phase 1|Death|4|||
41988716|NCT01263496|75796197|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
41988717|NCT01263496|75796198|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
41988718|NCT01263496|75796199|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
41988719|NCT01263496|75796200|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
41988720|NCT01263496|75796201|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
41988721|NCT01263496|75796202|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
42132021|NCT00510068|75942843|FG000|Double-blind Period|Adverse Event|37|||
42132022|NCT00510068|75942844|FG001|Double-blind Period|Adverse Event|7|||
42241693|NCT03314935|76066116|FG004|Phase 1|Death|3|||
42241694|NCT03314935|76066117|FG005|Phase 1|Death|4|||
42241695|NCT03314935|76066118|FG006|Phase 1|Death|5|||
42241696|NCT03314935|76066119|FG007|Phase 1|Death|4|||
42241697|NCT03314935|76066120|FG008|Phase 1|Death|3|||
42241698|NCT03314935|76066121|FG009|Phase 1|Death|0|||
42241699|NCT03314935|76066122|FG010|Phase 1|Death|0|||
42241700|NCT03314935|76066123|FG011|Phase 1|Death|0|||
42241701|NCT03314935|76066124|FG012|Phase 1|Death|0|||
42241702|NCT03314935|76066125|FG013|Phase 1|Death|0|||
42241703|NCT03314935|76066126|FG014|Phase 1|Death|0|||
42241704|NCT03314935|76066112|FG000|Phase 1|Withdrawal by Subject|2|||
42241705|NCT03314935|76066113|FG001|Phase 1|Withdrawal by Subject|1|||
42241706|NCT03314935|76066114|FG002|Phase 1|Withdrawal by Subject|1|||
42241707|NCT03314935|76066115|FG003|Phase 1|Withdrawal by Subject|2|||
42241708|NCT03314935|76066116|FG004|Phase 1|Withdrawal by Subject|1|||
42241709|NCT03314935|76066117|FG005|Phase 1|Withdrawal by Subject|0|||
42241710|NCT03314935|76066118|FG006|Phase 1|Withdrawal by Subject|1|||
42241711|NCT03314935|76066119|FG007|Phase 1|Withdrawal by Subject|0|||
42241712|NCT03314935|76066120|FG008|Phase 1|Withdrawal by Subject|1|||
42241713|NCT03314935|76066121|FG009|Phase 1|Withdrawal by Subject|0|||
42241714|NCT03314935|76066122|FG010|Phase 1|Withdrawal by Subject|0|||
42241715|NCT03314935|76066123|FG011|Phase 1|Withdrawal by Subject|0|||
42241716|NCT03314935|76066124|FG012|Phase 1|Withdrawal by Subject|0|||
42241717|NCT03314935|76066125|FG013|Phase 1|Withdrawal by Subject|0|||
42241718|NCT03314935|76066126|FG014|Phase 1|Withdrawal by Subject|0|||
41988722|NCT01263496|75796203|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
42241719|NCT03314935|76066112|FG000|Phase 1|Progressive Disease|2|||
41988723|NCT01263496|75796204|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
42132023|NCT00510068|75942843|FG000|Double-blind Period|Withdrawal by Subject|8|||
42241720|NCT03314935|76066113|FG001|Phase 1|Progressive Disease|0|||
42241721|NCT03314935|76066114|FG002|Phase 1|Progressive Disease|0|||
42132024|NCT00510068|75942844|FG001|Double-blind Period|Withdrawal by Subject|6|||
42241722|NCT03314935|76066115|FG003|Phase 1|Progressive Disease|1|||
42241723|NCT03314935|76066116|FG004|Phase 1|Progressive Disease|0|||
42241724|NCT03314935|76066117|FG005|Phase 1|Progressive Disease|0|||
42241725|NCT03314935|76066118|FG006|Phase 1|Progressive Disease|0|||
42241726|NCT03314935|76066119|FG007|Phase 1|Progressive Disease|0|||
42241727|NCT03314935|76066120|FG008|Phase 1|Progressive Disease|0|||
42241728|NCT03314935|76066121|FG009|Phase 1|Progressive Disease|0|||
42241729|NCT03314935|76066122|FG010|Phase 1|Progressive Disease|0|||
42241730|NCT03314935|76066123|FG011|Phase 1|Progressive Disease|0|||
42241731|NCT03314935|76066124|FG012|Phase 1|Progressive Disease|0|||
42241732|NCT03314935|76066125|FG013|Phase 1|Progressive Disease|0|||
42241733|NCT03314935|76066126|FG014|Phase 1|Progressive Disease|0|||
42241734|NCT03314935|76066112|FG000|Phase 1|Study Terminated by Sponsor|0|||
42241735|NCT03314935|76066113|FG001|Phase 1|Study Terminated by Sponsor|1|||
42241736|NCT03314935|76066114|FG002|Phase 1|Study Terminated by Sponsor|0|||
42241737|NCT03314935|76066115|FG003|Phase 1|Study Terminated by Sponsor|0|||
42241738|NCT03314935|76066116|FG004|Phase 1|Study Terminated by Sponsor|0|||
42241739|NCT03314935|76066117|FG005|Phase 1|Study Terminated by Sponsor|0|||
42241740|NCT03314935|76066118|FG006|Phase 1|Study Terminated by Sponsor|0|||
42241741|NCT03314935|76066119|FG007|Phase 1|Study Terminated by Sponsor|0|||
42241742|NCT03314935|76066120|FG008|Phase 1|Study Terminated by Sponsor|1|||
42241743|NCT03314935|76066121|FG009|Phase 1|Study Terminated by Sponsor|0|||
42241744|NCT03314935|76066122|FG010|Phase 1|Study Terminated by Sponsor|0|||
42241745|NCT03314935|76066123|FG011|Phase 1|Study Terminated by Sponsor|0|||
42241746|NCT03314935|76066124|FG012|Phase 1|Study Terminated by Sponsor|0|||
42241747|NCT03314935|76066125|FG013|Phase 1|Study Terminated by Sponsor|0|||
42241748|NCT03314935|76066126|FG014|Phase 1|Study Terminated by Sponsor|0|||
42241749|NCT03314935|76066112|FG000|Phase 1|"Captured as Other in Database"|0|||
42241750|NCT03314935|76066113|FG001|Phase 1|"Captured as Other in Database"|2|||
42241751|NCT03314935|76066114|FG002|Phase 1|"Captured as Other in Database"|0|||
42241752|NCT03314935|76066115|FG003|Phase 1|"Captured as Other in Database"|0|||
42241753|NCT03314935|76066116|FG004|Phase 1|"Captured as Other in Database"|0|||
42241754|NCT03314935|76066117|FG005|Phase 1|"Captured as Other in Database"|0|||
42241755|NCT03314935|76066118|FG006|Phase 1|"Captured as Other in Database"|1|||
42241756|NCT03314935|76066119|FG007|Phase 1|"Captured as Other in Database"|1|||
42241757|NCT03314935|76066120|FG008|Phase 1|"Captured as Other in Database"|1|||
42241758|NCT03314935|76066121|FG009|Phase 1|"Captured as Other in Database"|0|||
42241759|NCT03314935|76066122|FG010|Phase 1|"Captured as Other in Database"|0|||
42241760|NCT03314935|76066123|FG011|Phase 1|"Captured as Other in Database"|0|||
41988724|NCT01263496|75796205|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
41988725|NCT01263496|75796197|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
41988726|NCT01263496|75796198|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
41988727|NCT01263496|75796199|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
41988728|NCT01263496|75796200|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
41988729|NCT01263496|75796201|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
41988730|NCT01263496|75796202|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
41988731|NCT01263496|75796203|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
41988732|NCT01263496|75796204|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
41988733|NCT01263496|75796205|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
41988734|NCT01263223|75796217|FG000|Period 2|Withdrawal by Subject|0|||
41988735|NCT01263223|75796218|FG001|Period 2|Withdrawal by Subject|1|||
41988736|NCT01263223|75796217|FG000|7-day Follow-up|Withdrawal by Subject|0|||
41988737|NCT01263223|75796218|FG001|7-day Follow-up|Withdrawal by Subject|1|||
41988738|NCT01263223|75796217|FG000|7-day Follow-up|Lost to Follow-up|1|||
41988739|NCT01263223|75796218|FG001|7-day Follow-up|Lost to Follow-up|0|||
41988740|NCT01263106|75796227|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
41988741|NCT01263106|75796228|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
41988742|NCT01263028|75796237|FG000|Overall Study|Withdrawal by Subject|1|||
41988743|NCT01263028|75796237|FG000|Overall Study|Adverse Event|1|||
41988744|NCT01263028|75796237|FG000|Overall Study|Study terminated due to low enrollment.|4|||
41988745|NCT01262989|75796241|FG000|Period 1|Lost to Follow-up|1|||
41988746|NCT01262989|75796242|FG001|Period 1|Lost to Follow-up|1|||
41988747|NCT01262989|75796241|FG000|Period 1|Intercurrent disease|0|||
41988748|NCT01262989|75796242|FG001|Period 1|Intercurrent disease|1|||
41988749|NCT01262989|75796241|FG000|Period 1|Positive answer for exclusion criteria|0|||
42132025|NCT00510068|75942843|FG000|Double-blind Period|Death|4|||
42132026|NCT00510068|75942844|FG001|Double-blind Period|Death|3|||
42132027|NCT00510068|75942843|FG000|Double-blind Period|Abnormal test result (s)|1|||
42241761|NCT03314935|76066124|FG012|Phase 1|"Captured as Other in Database"|0|||
42241762|NCT03314935|76066125|FG013|Phase 1|"Captured as Other in Database"|0|||
42241763|NCT03314935|76066126|FG014|Phase 1|"Captured as Other in Database"|0|||
42241764|NCT03314935|76066112|FG000|Phase 1|Lost to Follow-up|0|||
41988750|NCT01262989|75796242|FG001|Period 1|Positive answer for exclusion criteria|1|||
41988751|NCT01262989|75796241|FG000|Period 2|Intercurrent disease|0|||
41988752|NCT01262989|75796242|FG001|Period 2|Intercurrent disease|1|||
42241765|NCT03314935|76066113|FG001|Phase 1|Lost to Follow-up|0|||
42241766|NCT03314935|76066114|FG002|Phase 1|Lost to Follow-up|0|||
42241767|NCT03314935|76066115|FG003|Phase 1|Lost to Follow-up|0|||
42241768|NCT03314935|76066116|FG004|Phase 1|Lost to Follow-up|0|||
41988753|NCT01262872|75796256|FG000|Step 2|Death|0|||
41988754|NCT01262872|75796257|FG001|Step 2|Death|0|||
41988755|NCT01262872|75796258|FG002|Step 2|Death|0|||
41988756|NCT01262872|75796259|FG003|Step 2|Death|1|||
41988757|NCT01262872|75796260|FG004|Step 2|Death|0|||
41988758|NCT01262872|75796261|FG005|Step 2|Death|2|||
41988759|NCT01262872|75796262|FG006|Step 2|Death|2|||
41988760|NCT01262872|75796263|FG007|Step 2|Death|1|||
42241769|NCT03314935|76066117|FG005|Phase 1|Lost to Follow-up|0|||
42241770|NCT03314935|76066118|FG006|Phase 1|Lost to Follow-up|0|||
42241771|NCT03314935|76066119|FG007|Phase 1|Lost to Follow-up|0|||
42241772|NCT03314935|76066120|FG008|Phase 1|Lost to Follow-up|1|||
42241773|NCT03314935|76066121|FG009|Phase 1|Lost to Follow-up|0|||
42241774|NCT03314935|76066122|FG010|Phase 1|Lost to Follow-up|0|||
42241775|NCT03314935|76066123|FG011|Phase 1|Lost to Follow-up|0|||
42241776|NCT03314935|76066124|FG012|Phase 1|Lost to Follow-up|0|||
42241777|NCT03314935|76066125|FG013|Phase 1|Lost to Follow-up|0|||
42241778|NCT03314935|76066126|FG014|Phase 1|Lost to Follow-up|0|||
42241779|NCT03314935|76066112|FG000|Phase 2|Death|0|||
42241780|NCT03314935|76066113|FG001|Phase 2|Death|0|||
42241781|NCT03314935|76066114|FG002|Phase 2|Death|0|||
42241782|NCT03314935|76066115|FG003|Phase 2|Death|0|||
42241783|NCT03314935|76066116|FG004|Phase 2|Death|0|||
42241784|NCT03314935|76066117|FG005|Phase 2|Death|0|||
42241785|NCT03314935|76066118|FG006|Phase 2|Death|0|||
42241786|NCT03314935|76066119|FG007|Phase 2|Death|0|||
42241787|NCT03314935|76066120|FG008|Phase 2|Death|0|||
42241788|NCT03314935|76066121|FG009|Phase 2|Death|5|||
42241789|NCT03314935|76066122|FG010|Phase 2|Death|20|||
42241790|NCT03314935|76066123|FG011|Phase 2|Death|6|||
42241791|NCT03314935|76066124|FG012|Phase 2|Death|7|||
42241792|NCT03314935|76066125|FG013|Phase 2|Death|6|||
42241793|NCT03314935|76066126|FG014|Phase 2|Death|17|||
42241794|NCT03314935|76066112|FG000|Phase 2|Withdrawal by Subject|0|||
42241795|NCT03314935|76066113|FG001|Phase 2|Withdrawal by Subject|0|||
42241796|NCT03314935|76066114|FG002|Phase 2|Withdrawal by Subject|0|||
42241797|NCT03314935|76066115|FG003|Phase 2|Withdrawal by Subject|0|||
42241798|NCT03314935|76066116|FG004|Phase 2|Withdrawal by Subject|0|||
42241799|NCT03314935|76066117|FG005|Phase 2|Withdrawal by Subject|0|||
42241800|NCT03314935|76066118|FG006|Phase 2|Withdrawal by Subject|0|||
42241801|NCT03314935|76066119|FG007|Phase 2|Withdrawal by Subject|0|||
42241802|NCT03314935|76066120|FG008|Phase 2|Withdrawal by Subject|0|||
42241803|NCT03314935|76066121|FG009|Phase 2|Withdrawal by Subject|1|||
42241804|NCT03314935|76066122|FG010|Phase 2|Withdrawal by Subject|4|||
42241805|NCT03314935|76066123|FG011|Phase 2|Withdrawal by Subject|0|||
42241806|NCT03314935|76066124|FG012|Phase 2|Withdrawal by Subject|1|||
42241807|NCT03314935|76066125|FG013|Phase 2|Withdrawal by Subject|0|||
42241808|NCT03314935|76066126|FG014|Phase 2|Withdrawal by Subject|1|||
42241809|NCT03314935|76066112|FG000|Phase 2|Progressive Disease|0|||
42241810|NCT03314935|76066113|FG001|Phase 2|Progressive Disease|0|||
42241811|NCT03314935|76066114|FG002|Phase 2|Progressive Disease|0|||
42241812|NCT03314935|76066115|FG003|Phase 2|Progressive Disease|0|||
42241813|NCT03314935|76066116|FG004|Phase 2|Progressive Disease|0|||
42241814|NCT03314935|76066117|FG005|Phase 2|Progressive Disease|0|||
42241815|NCT03314935|76066118|FG006|Phase 2|Progressive Disease|0|||
42241816|NCT03314935|76066119|FG007|Phase 2|Progressive Disease|0|||
42241817|NCT03314935|76066120|FG008|Phase 2|Progressive Disease|0|||
42241818|NCT03314935|76066121|FG009|Phase 2|Progressive Disease|1|||
42241819|NCT03314935|76066122|FG010|Phase 2|Progressive Disease|1|||
42241820|NCT03314935|76066123|FG011|Phase 2|Progressive Disease|1|||
42241821|NCT03314935|76066124|FG012|Phase 2|Progressive Disease|2|||
42241822|NCT03314935|76066125|FG013|Phase 2|Progressive Disease|0|||
42241823|NCT03314935|76066126|FG014|Phase 2|Progressive Disease|1|||
42241824|NCT03314935|76066112|FG000|Phase 2|Study Terminated by Sponsor|0|||
42241825|NCT03314935|76066113|FG001|Phase 2|Study Terminated by Sponsor|0|||
42241826|NCT03314935|76066114|FG002|Phase 2|Study Terminated by Sponsor|0|||
42241827|NCT03314935|76066115|FG003|Phase 2|Study Terminated by Sponsor|0|||
42241828|NCT03314935|76066116|FG004|Phase 2|Study Terminated by Sponsor|0|||
41988761|NCT01262872|75796256|FG000|Step 2|Protocol Violation|0|||
41988762|NCT01262872|75796257|FG001|Step 2|Protocol Violation|0|||
41988763|NCT01262872|75796258|FG002|Step 2|Protocol Violation|1|||
42241829|NCT03314935|76066117|FG005|Phase 2|Study Terminated by Sponsor|0|||
42241830|NCT03314935|76066118|FG006|Phase 2|Study Terminated by Sponsor|0|||
42241831|NCT03314935|76066119|FG007|Phase 2|Study Terminated by Sponsor|0|||
42241832|NCT03314935|76066120|FG008|Phase 2|Study Terminated by Sponsor|0|||
42241833|NCT03314935|76066121|FG009|Phase 2|Study Terminated by Sponsor|0|||
42241834|NCT03314935|76066122|FG010|Phase 2|Study Terminated by Sponsor|7|||
42241835|NCT03314935|76066123|FG011|Phase 2|Study Terminated by Sponsor|2|||
42241836|NCT03314935|76066124|FG012|Phase 2|Study Terminated by Sponsor|1|||
42241837|NCT03314935|76066125|FG013|Phase 2|Study Terminated by Sponsor|4|||
42241838|NCT03314935|76066126|FG014|Phase 2|Study Terminated by Sponsor|4|||
42241839|NCT03314935|76066112|FG000|Phase 2|Lost to Follow-up|0|||
42241840|NCT03314935|76066113|FG001|Phase 2|Lost to Follow-up|0|||
42241841|NCT03314935|76066114|FG002|Phase 2|Lost to Follow-up|0|||
42241842|NCT03314935|76066115|FG003|Phase 2|Lost to Follow-up|0|||
42241843|NCT03314935|76066116|FG004|Phase 2|Lost to Follow-up|0|||
42241844|NCT03314935|76066117|FG005|Phase 2|Lost to Follow-up|0|||
42241845|NCT03314935|76066118|FG006|Phase 2|Lost to Follow-up|0|||
42241846|NCT03314935|76066119|FG007|Phase 2|Lost to Follow-up|0|||
42241847|NCT03314935|76066120|FG008|Phase 2|Lost to Follow-up|0|||
42241848|NCT03314935|76066121|FG009|Phase 2|Lost to Follow-up|1|||
42241849|NCT03314935|76066122|FG010|Phase 2|Lost to Follow-up|0|||
42241850|NCT03314935|76066123|FG011|Phase 2|Lost to Follow-up|0|||
42241851|NCT03314935|76066124|FG012|Phase 2|Lost to Follow-up|0|||
42241852|NCT03314935|76066125|FG013|Phase 2|Lost to Follow-up|0|||
42241853|NCT03314935|76066126|FG014|Phase 2|Lost to Follow-up|1|||
42241854|NCT03314935|76066112|FG000|Phase 2|Physician Decision|0|||
42241855|NCT03314935|76066113|FG001|Phase 2|Physician Decision|0|||
42241856|NCT03314935|76066114|FG002|Phase 2|Physician Decision|0|||
42241857|NCT03314935|76066115|FG003|Phase 2|Physician Decision|0|||
42241858|NCT03314935|76066116|FG004|Phase 2|Physician Decision|0|||
42241859|NCT03314935|76066117|FG005|Phase 2|Physician Decision|0|||
42241860|NCT03314935|76066118|FG006|Phase 2|Physician Decision|0|||
42241861|NCT03314935|76066119|FG007|Phase 2|Physician Decision|0|||
42241862|NCT03314935|76066120|FG008|Phase 2|Physician Decision|0|||
42241863|NCT03314935|76066121|FG009|Phase 2|Physician Decision|0|||
42241864|NCT03314935|76066122|FG010|Phase 2|Physician Decision|1|||
42241865|NCT03314935|76066123|FG011|Phase 2|Physician Decision|0|||
42241866|NCT03314935|76066124|FG012|Phase 2|Physician Decision|0|||
42241867|NCT03314935|76066125|FG013|Phase 2|Physician Decision|0|||
42241868|NCT03314935|76066126|FG014|Phase 2|Physician Decision|0|||
42241869|NCT03169361|76066169|FG000|Overall Study|Protocol Violation|32|||
41988764|NCT01262872|75796259|FG003|Step 2|Protocol Violation|0|||
41988765|NCT01262872|75796260|FG004|Step 2|Protocol Violation|0|||
41988766|NCT01262872|75796261|FG005|Step 2|Protocol Violation|0|||
41988767|NCT01262872|75796262|FG006|Step 2|Protocol Violation|3|||
41988768|NCT01262872|75796263|FG007|Step 2|Protocol Violation|1|||
41988769|NCT01262872|75796256|FG000|Step 2|Withdrawal by Subject|0|||
42132028|NCT00510068|75942844|FG001|Double-blind Period|Abnormal test result (s)|0|||
42241870|NCT03031847|76066186|FG000|Overall Study|Death|1|||
42241871|NCT03031847|76066187|FG001|Overall Study|Death|1|||
42241872|NCT03031847|76066188|FG002|Overall Study|Death|2|||
42241873|NCT03031847|76066189|FG003|Overall Study|Death|3|||
42241874|NCT03031847|76066186|FG000|Overall Study|Lost to Follow-up|1|||
42241875|NCT03031847|76066187|FG001|Overall Study|Lost to Follow-up|1|||
42241876|NCT03031847|76066188|FG002|Overall Study|Lost to Follow-up|2|||
42241877|NCT03031847|76066189|FG003|Overall Study|Lost to Follow-up|3|||
42241878|NCT02831764|76066201|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
42241879|NCT02831764|76066202|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
42241880|NCT02831764|76066203|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
42241881|NCT02831764|76066204|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
42241882|NCT02831764|76066205|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
42241883|NCT02831764|76066201|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
42241884|NCT02831764|76066202|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
42241885|NCT02831764|76066203|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
42241886|NCT02831764|76066204|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
42241887|NCT02831764|76066205|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
42241888|NCT02831764|76066201|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
42241889|NCT02831764|76066202|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
42241890|NCT02831764|76066203|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
42241891|NCT02831764|76066204|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
42241892|NCT02831764|76066205|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
42241893|NCT02831764|76066201|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
42241894|NCT02831764|76066202|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
42132029|NCT00510068|75942843|FG000|Double-blind Period|Lost to Follow-up|1|||
41988770|NCT01262872|75796257|FG001|Step 2|Withdrawal by Subject|0|||
42241895|NCT02831764|76066203|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
42241896|NCT02831764|76066204|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
42241897|NCT02831764|76066205|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
42241898|NCT02831764|76066201|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
41988771|NCT01262872|75796258|FG002|Step 2|Withdrawal by Subject|4|||
42241899|NCT02831764|76066202|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
41988772|NCT01262872|75796259|FG003|Step 2|Withdrawal by Subject|6|||
41988773|NCT01262872|75796260|FG004|Step 2|Withdrawal by Subject|3|||
42241900|NCT02831764|76066203|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
42241901|NCT02831764|76066204|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
42241902|NCT02831764|76066205|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
42241903|NCT02831764|76066201|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
42241904|NCT02831764|76066202|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
42241905|NCT02831764|76066203|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
42241906|NCT02831764|76066204|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
42241907|NCT02831764|76066205|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
42241908|NCT02831764|76066201|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
42241909|NCT02831764|76066202|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
42241910|NCT02831764|76066203|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
42241911|NCT02831764|76066204|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
42241912|NCT02831764|76066205|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
42241913|NCT02831764|76066201|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
42241914|NCT02831764|76066202|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
42241915|NCT02831764|76066203|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
42241916|NCT02831764|76066204|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
42241917|NCT02831764|76066205|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
42241918|NCT02831764|76066201|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
42241919|NCT02831764|76066202|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
42241920|NCT02831764|76066203|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
42241921|NCT02831764|76066204|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
42241922|NCT02831764|76066205|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
42241923|NCT02831764|76066201|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
42241924|NCT02831764|76066202|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
42241925|NCT02831764|76066203|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
42241926|NCT02831764|76066204|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
42241927|NCT02831764|76066205|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
42241928|NCT02831764|76066201|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
42241929|NCT02831764|76066202|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
42241930|NCT02831764|76066203|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
42241931|NCT02831764|76066204|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
42241932|NCT02831764|76066205|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
42241933|NCT02831764|76066201|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
42241934|NCT02831764|76066202|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
42241935|NCT02831764|76066203|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
42241936|NCT02831764|76066204|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
42241937|NCT02831764|76066205|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
42241938|NCT02831764|76066201|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
42241939|NCT02831764|76066202|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
42241940|NCT02831764|76066203|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
42241941|NCT02831764|76066204|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
42241942|NCT02831764|76066205|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
42241943|NCT02831764|76066201|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
42241944|NCT02831764|76066202|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
42241945|NCT02831764|76066203|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
42241946|NCT02831764|76066204|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
42241947|NCT02831764|76066205|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
42241948|NCT02831764|76066201|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
42241949|NCT02831764|76066202|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
42241950|NCT02831764|76066203|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
42241951|NCT02831764|76066204|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
42241952|NCT02831764|76066205|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
42241953|NCT02831764|76066201|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
42241954|NCT02831764|76066202|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
42241955|NCT02831764|76066203|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
42241956|NCT02831764|76066204|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
42241957|NCT02831764|76066205|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
42241958|NCT02831764|76066201|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
42241959|NCT02831764|76066202|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
42241960|NCT02831764|76066203|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
42241961|NCT02831764|76066204|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
42272684|NCT02279524|76103006|FG002|Overall Study|Bariatric surgery|0|||
42241962|NCT02831764|76066205|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
42241963|NCT02831764|76066201|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
42241964|NCT02831764|76066202|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
42241965|NCT02831764|76066203|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
42241966|NCT02831764|76066204|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
42241967|NCT02831764|76066205|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
42241968|NCT02831764|76066201|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
42241969|NCT02831764|76066202|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
42241970|NCT02831764|76066203|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
42241971|NCT02831764|76066204|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
42241972|NCT02831764|76066205|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
42241973|NCT02396199|76066214|FG000|Overall Study|Lost to Follow-up|1|||
42241974|NCT02396199|76066214|FG000|Overall Study|Death|4|||
42241975|NCT01665144|76066229|FG000|Overall Study|New therapy for study indication|2|||
42241976|NCT01665144|76066230|FG001|Overall Study|New therapy for study indication|1|||
42241977|NCT01665144|76066229|FG000|Overall Study|Technical problems|2|||
42241978|NCT01665144|76066230|FG001|Overall Study|Technical problems|0|||
42241979|NCT01665144|76066229|FG000|Overall Study|Death|3|||
42241980|NCT01665144|76066230|FG001|Overall Study|Death|1|||
42241981|NCT01665144|76066229|FG000|Overall Study|Protocol deviation|3|||
42241982|NCT01665144|76066230|FG001|Overall Study|Protocol deviation|1|||
42241983|NCT01665144|76066229|FG000|Overall Study|Non-compliance w/study treatment|5|||
42241984|NCT01665144|76066230|FG001|Overall Study|Non-compliance w/study treatment|0|||
42241985|NCT01665144|76066229|FG000|Overall Study|Progressive disease|8|||
42241986|NCT01665144|76066230|FG001|Overall Study|Progressive disease|4|||
42241987|NCT01665144|76066229|FG000|Overall Study|Lost to Follow-up|9|||
42241988|NCT01665144|76066230|FG001|Overall Study|Lost to Follow-up|8|||
42241989|NCT01665144|76066229|FG000|Overall Study|Physician Decision|13|||
42241990|NCT01665144|76066230|FG001|Overall Study|Physician Decision|1|||
42241991|NCT01665144|76066229|FG000|Overall Study|Lack of Efficacy|16|||
42241992|NCT01665144|76066230|FG001|Overall Study|Lack of Efficacy|11|||
42241993|NCT01665144|76066229|FG000|Overall Study|Adverse Event|45|||
42241994|NCT01665144|76066230|FG001|Overall Study|Adverse Event|18|||
42241995|NCT01665144|76066229|FG000|Overall Study|Withdrawal by Subject|96|||
42241996|NCT01665144|76066230|FG001|Overall Study|Withdrawal by Subject|77|||
42241997|NCT01661881|76066236|FG000|Overall Study|Disease Progression|1|||
42241998|NCT01353313|76066242|FG000|Overall Study|Lost to Follow-up|22|||
42241999|NCT01353313|76066243|FG001|Overall Study|Lost to Follow-up|23|||
42242000|NCT01353313|76066242|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
42242001|NCT01353313|76066243|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
42242002|NCT02764320|76066251|FG000|Overall Study|Withdrawal by Subject|35|||
42242003|NCT02764320|76066252|FG001|Overall Study|Withdrawal by Subject|38|||
41988774|NCT01262872|75796261|FG005|Step 2|Withdrawal by Subject|1|||
42242004|NCT02764320|76066251|FG000|Overall Study|Protocol Violation|11|||
41988775|NCT01262872|75796262|FG006|Step 2|Withdrawal by Subject|2|||
41988776|NCT01262872|75796263|FG007|Step 2|Withdrawal by Subject|1|||
41988777|NCT01262872|75796256|FG000|Step 2|Migrated/moved from study area|0|||
41988778|NCT01262872|75796257|FG001|Step 2|Migrated/moved from study area|0|||
41988779|NCT01262872|75796258|FG002|Step 2|Migrated/moved from study area|4|||
41988780|NCT01262872|75796259|FG003|Step 2|Migrated/moved from study area|3|||
41988781|NCT01262872|75796260|FG004|Step 2|Migrated/moved from study area|2|||
41988782|NCT01262872|75796261|FG005|Step 2|Migrated/moved from study area|6|||
41988783|NCT01262872|75796262|FG006|Step 2|Migrated/moved from study area|2|||
41988784|NCT01262872|75796263|FG007|Step 2|Migrated/moved from study area|3|||
41988785|NCT01262677|75796300|FG000|Overall Study|Does not meet entrance criteria|0|||
41988786|NCT01262677|75796301|FG001|Overall Study|Does not meet entrance criteria|2|||
41988787|NCT01262677|75796302|FG002|Overall Study|Does not meet entrance criteria|0|||
41988788|NCT01262677|75796300|FG000|Overall Study|Insufficient clinical response|0|||
41988789|NCT01262677|75796301|FG001|Overall Study|Insufficient clinical response|0|||
41988790|NCT01262677|75796302|FG002|Overall Study|Insufficient clinical response|1|||
41988791|NCT01262677|75796300|FG000|Overall Study|Lost to Follow-up|1|||
41988792|NCT01262677|75796301|FG001|Overall Study|Lost to Follow-up|0|||
41988793|NCT01262677|75796302|FG002|Overall Study|Lost to Follow-up|2|||
41988794|NCT01262677|75796300|FG000|Overall Study|No longer willing to participate|3|||
41988795|NCT01262677|75796301|FG001|Overall Study|No longer willing to participate|3|||
42242005|NCT02764320|76066252|FG001|Overall Study|Protocol Violation|6|||
41988796|NCT01262677|75796302|FG002|Overall Study|No longer willing to participate|2|||
42242006|NCT02764320|76066251|FG000|Overall Study|Adverse Event|2|||
42242007|NCT02764320|76066252|FG001|Overall Study|Adverse Event|0|||
42242008|NCT02764320|76066251|FG000|Overall Study|Health Issues unable to continue|2|||
42242009|NCT02764320|76066252|FG001|Overall Study|Health Issues unable to continue|0|||
41988797|NCT01262677|75796300|FG000|Overall Study|Reason not provided|2|||
41988798|NCT01262677|75796301|FG001|Overall Study|Reason not provided|1|||
41988799|NCT01262677|75796302|FG002|Overall Study|Reason not provided|3|||
42242010|NCT02764320|76066251|FG000|Overall Study|Did not meet inclusion criteria|1|||
42242011|NCT02764320|76066252|FG001|Overall Study|Did not meet inclusion criteria|0|||
42242012|NCT02764320|76066251|FG000|Overall Study|Subject moved|0|||
42242013|NCT02764320|76066252|FG001|Overall Study|Subject moved|2|||
42242014|NCT02764320|76066251|FG000|Overall Study|Overused medication unavailable|0|||
42242015|NCT02764320|76066252|FG001|Overall Study|Overused medication unavailable|1|||
42242016|NCT02764320|76066251|FG000|Overall Study|Seeking care outside site|0|||
42242017|NCT02764320|76066252|FG001|Overall Study|Seeking care outside site|1|||
42242018|NCT02764320|76066251|FG000|Overall Study|Technology barriers|0|||
42242019|NCT02764320|76066252|FG001|Overall Study|Technology barriers|1|||
42242020|NCT02851407|76066260|FG000|Overall Study|Withdrawal by parent/guardian|2|||
42242021|NCT02851407|76066261|FG001|Overall Study|Withdrawal by parent/guardian|7|||
42242022|NCT02851407|76066260|FG000|Overall Study|Protocol deviation|0|||
42242023|NCT02851407|76066261|FG001|Overall Study|Protocol deviation|1|||
42242024|NCT02851407|76066260|FG000|Overall Study|Transferred to another hospital to continue|1|||
42242025|NCT02851407|76066261|FG001|Overall Study|Transferred to another hospital to continue|0|||
42242026|NCT02851407|76066260|FG000|Overall Study|Other Death|30|||
42242027|NCT02851407|76066261|FG001|Overall Study|Other Death|20|||
42242028|NCT02851407|76066260|FG000|Overall Study|Adverse event, serious fatal|6|||
42242029|NCT02851407|76066261|FG001|Overall Study|Adverse event, serious fatal|8|||
42242030|NCT02851407|76066260|FG000|Overall Study|Consent withdrawn by participant|5|||
42242031|NCT02851407|76066261|FG001|Overall Study|Consent withdrawn by participant|3|||
42242032|NCT02851407|76066260|FG000|Overall Study|Screen failure|2|||
42242033|NCT02851407|76066261|FG001|Overall Study|Screen failure|1|||
42242034|NCT02851407|76066260|FG000|Overall Study|Disease relapse|9|||
42242035|NCT02851407|76066261|FG001|Overall Study|Disease relapse|6|||
42242036|NCT02851407|76066260|FG000|Overall Study|Physician Decision|7|||
42242037|NCT02851407|76066261|FG001|Overall Study|Physician Decision|6|||
42242038|NCT02851407|76066260|FG000|Overall Study|Transferred to hospital closer to home|0|||
42242039|NCT02851407|76066261|FG001|Overall Study|Transferred to hospital closer to home|1|||
42242040|NCT02851407|76066260|FG000|Overall Study|Enrolled in an investigational study|0|||
42242041|NCT02851407|76066261|FG001|Overall Study|Enrolled in an investigational study|1|||
42242042|NCT02851407|76066260|FG000|Overall Study|Early recovery|1|||
42242043|NCT02851407|76066261|FG001|Overall Study|Early recovery|0|||
42242044|NCT02851407|76066260|FG000|Overall Study|Adverse event, non-fatal|7|||
42242045|NCT02851407|76066261|FG001|Overall Study|Adverse event, non-fatal|5|||
42242046|NCT02851407|76066260|FG000|Overall Study|Lost to Follow-up|0|||
42242047|NCT02851407|76066261|FG001|Overall Study|Lost to Follow-up|2|||
42242048|NCT02636608|76066267|FG000|Overall Study|Failure to Return|4|||
42242049|NCT02636608|76066267|FG000|Overall Study|Insufficient Virological Response|1|||
42242050|NCT02636608|76066267|FG000|Overall Study|Death|3|||
42242051|NCT02636608|76066267|FG000|Overall Study|Other|2|||
42242052|NCT02636608|76066267|FG000|Overall Study|Did Not Receive Treatment|1|||
42242053|NCT02759562|76066276|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
42242054|NCT02759562|76066277|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
42242055|NCT02759562|76066276|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
42242056|NCT02759562|76066277|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
42242057|NCT02746575|76066284|FG000|Overall Study|Surgery cancelled or time chaned|13|||
42242058|NCT02746575|76066284|FG000|Overall Study|Received epidural|10|||
42242059|NCT02746575|76066284|FG000|Overall Study|Withdrawal by Subject|3|||
42242060|NCT02746575|76066284|FG000|Overall Study|Bradycardia/hypotension|9|||
42242061|NCT02746575|76066284|FG000|Overall Study|Study paused|8|||
42242062|NCT02746575|76066284|FG000|Overall Study|put on beta-blocker|3|||
42242063|NCT02746575|76066284|FG000|Overall Study|type of surgery|1|||
42242064|NCT02746575|76066284|FG000|Overall Study|typ of surgery|1|||
42242065|NCT02746575|76066284|FG000|Overall Study|PI unavailable|1|||
42242066|NCT02746575|76066284|FG000|Overall Study|Unknown history of CVA|1|||
42242067|NCT03625466|76066290|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
42242068|NCT03625466|76066291|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
42032756|NCT01077960|75841031|FG000|Overall Study|Subject decision|1|||
42032757|NCT01077960|75841031|FG000|Overall Study|Reason unspecified|1|||
42242069|NCT03625466|76066292|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
42242070|NCT03625466|76066290|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
42242071|NCT03625466|76066291|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
42242072|NCT03625466|76066292|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
42242073|NCT03625466|76066290|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
42242074|NCT03625466|76066291|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
41988800|NCT01262677|75796300|FG000|Overall Study|Protocol Violation|0|||
41988801|NCT01262677|75796301|FG001|Overall Study|Protocol Violation|1|||
41988802|NCT01262677|75796302|FG002|Overall Study|Protocol Violation|1|||
41988803|NCT01262677|75796300|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
41988804|NCT01262677|75796301|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
42242075|NCT03625466|76066292|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
42242076|NCT02853123|76066299|FG000|Treatment Period 1|Adverse Event|0|||
42242077|NCT02853123|76066300|FG001|Treatment Period 1|Adverse Event|3|||
42242078|NCT02853123|76066299|FG000|Washout Period|Worsening of COPD|0|||
42242079|NCT02853123|76066300|FG001|Washout Period|Worsening of COPD|3|||
42242080|NCT02853123|76066299|FG000|Washout Period|Adverse Event|1|||
42242081|NCT02853123|76066300|FG001|Washout Period|Adverse Event|0|||
42242082|NCT02634346|76066310|FG000|Overall Study|Withdrawal by Subject|8|||
42242083|NCT02634346|76066311|FG001|Overall Study|Withdrawal by Subject|9|||
42242084|NCT02634346|76066312|FG002|Overall Study|Withdrawal by Subject|8|||
42242085|NCT02634346|76066310|FG000|Overall Study|Adverse Event|2|||
42242086|NCT02634346|76066311|FG001|Overall Study|Adverse Event|2|||
42242087|NCT02634346|76066312|FG002|Overall Study|Adverse Event|7|||
42242088|NCT02634346|76066310|FG000|Overall Study|Lack of Efficacy|1|||
42242089|NCT02634346|76066311|FG001|Overall Study|Lack of Efficacy|2|||
42242090|NCT02634346|76066312|FG002|Overall Study|Lack of Efficacy|8|||
42242091|NCT02634346|76066310|FG000|Overall Study|Lost to Follow-up|1|||
42242092|NCT02634346|76066311|FG001|Overall Study|Lost to Follow-up|0|||
42242093|NCT02634346|76066312|FG002|Overall Study|Lost to Follow-up|0|||
42242094|NCT02634346|76066310|FG000|Overall Study|Protocol Violation|0|||
42242095|NCT02634346|76066311|FG001|Overall Study|Protocol Violation|1|||
42242096|NCT02634346|76066312|FG002|Overall Study|Protocol Violation|0|||
42242097|NCT00849147|76066320|FG000|Overall Study|Withdrawal by Subject|1|||
42242098|NCT00849147|76066320|FG000|Overall Study|Protocol Violation|2|||
42242099|NCT00849147|76066320|FG000|Overall Study|Disease Relapse/Progression|2|||
42242100|NCT00101166|76066324|FG000|Overall Study|progressive disease|10|||
42242101|NCT02759016|76066330|FG000|Overall Study|Not treated with BI 836826|1|||
42242102|NCT02759016|76066331|FG001|Overall Study|Not treated with BI 836826|0|||
42242103|NCT02759016|76066330|FG000|Overall Study|Progressive disease|1|||
42242104|NCT02759016|76066331|FG001|Overall Study|Progressive disease|0|||
42242105|NCT02759016|76066330|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
42242106|NCT02759016|76066331|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
42242107|NCT02759016|76066330|FG000|Overall Study|Other not defined above|2|||
42242108|NCT02759016|76066331|FG001|Overall Study|Other not defined above|1|||
42242109|NCT02852967|76066343|FG000|Overall Study|Adverse Event|3|||
42242110|NCT02852967|76066344|FG001|Overall Study|Adverse Event|1|||
42242111|NCT02852967|76066345|FG002|Overall Study|Adverse Event|0|||
42242112|NCT02852967|76066346|FG003|Overall Study|Adverse Event|1|||
42242113|NCT02852967|76066347|FG004|Overall Study|Adverse Event|0|||
42242114|NCT02852967|76066343|FG000|Overall Study|Death|1|||
42242115|NCT02852967|76066344|FG001|Overall Study|Death|0|||
42242116|NCT02852967|76066345|FG002|Overall Study|Death|0|||
41988805|NCT01262677|75796302|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
41988806|NCT01262638|75796314|FG000|Overall Study|Adverse Event|3|||
41988807|NCT01262638|75796315|FG001|Overall Study|Adverse Event|4|||
41988808|NCT01262638|75796316|FG002|Overall Study|Adverse Event|3|||
41988809|NCT01262638|75796317|FG003|Overall Study|Adverse Event|4|||
41988810|NCT01262638|75796314|FG000|Overall Study|Protocol Violation|1|||
41988811|NCT01262638|75796315|FG001|Overall Study|Protocol Violation|0|||
41988812|NCT01262638|75796316|FG002|Overall Study|Protocol Violation|0|||
42242117|NCT02852967|76066346|FG003|Overall Study|Death|0|||
42242118|NCT02852967|76066347|FG004|Overall Study|Death|0|||
42242119|NCT02852967|76066343|FG000|Overall Study|Lost to Follow-up|1|||
42242120|NCT02852967|76066344|FG001|Overall Study|Lost to Follow-up|2|||
42242121|NCT02852967|76066345|FG002|Overall Study|Lost to Follow-up|3|||
42242122|NCT02852967|76066346|FG003|Overall Study|Lost to Follow-up|4|||
42242123|NCT02852967|76066347|FG004|Overall Study|Lost to Follow-up|4|||
42242124|NCT02852967|76066343|FG000|Overall Study|Withdrawal by Subject|6|||
41988813|NCT01262638|75796317|FG003|Overall Study|Protocol Violation|1|||
41988814|NCT01262638|75796314|FG000|Overall Study|Withdrawal by Subject|2|||
42242125|NCT02852967|76066344|FG001|Overall Study|Withdrawal by Subject|12|||
42242126|NCT02852967|76066345|FG002|Overall Study|Withdrawal by Subject|7|||
42242127|NCT02852967|76066346|FG003|Overall Study|Withdrawal by Subject|10|||
42242128|NCT02852967|76066347|FG004|Overall Study|Withdrawal by Subject|10|||
42242129|NCT02852967|76066343|FG000|Overall Study|SAE|0|||
41988815|NCT01262638|75796315|FG001|Overall Study|Withdrawal by Subject|1|||
42242130|NCT02852967|76066344|FG001|Overall Study|SAE|0|||
41988816|NCT01262638|75796316|FG002|Overall Study|Withdrawal by Subject|0|||
41988817|NCT01262638|75796317|FG003|Overall Study|Withdrawal by Subject|1|||
41988818|NCT01262638|75796314|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
41988819|NCT01262638|75796315|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
41988820|NCT01262638|75796316|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
41988821|NCT01262638|75796317|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
41988822|NCT01262638|75796314|FG000|Overall Study|Lost to Follow-up|1|||
41988823|NCT01262638|75796315|FG001|Overall Study|Lost to Follow-up|1|||
41988824|NCT01262638|75796316|FG002|Overall Study|Lost to Follow-up|1|||
41988825|NCT01262638|75796317|FG003|Overall Study|Lost to Follow-up|1|||
41988826|NCT01262638|75796314|FG000|Overall Study|Participant Went Out of Town|0|||
41988827|NCT01262638|75796315|FG001|Overall Study|Participant Went Out of Town|0|||
41988828|NCT01262638|75796316|FG002|Overall Study|Participant Went Out of Town|1|||
41988829|NCT01262638|75796317|FG003|Overall Study|Participant Went Out of Town|0|||
41988830|NCT01262560|75796333|FG000|Overall Study|Protocol Violation|0|||
41988831|NCT01262560|75796334|FG001|Overall Study|Protocol Violation|1|||
41988832|NCT01262560|75796335|FG002|Overall Study|Protocol Violation|2|||
42242131|NCT02852967|76066345|FG002|Overall Study|SAE|0|||
42242132|NCT02852967|76066346|FG003|Overall Study|SAE|3|||
42242133|NCT02852967|76066347|FG004|Overall Study|SAE|0|||
42242134|NCT02852967|76066343|FG000|Overall Study|Elevated Liver Enzymes|2|||
42242135|NCT02852967|76066344|FG001|Overall Study|Elevated Liver Enzymes|0|||
42242136|NCT02852967|76066345|FG002|Overall Study|Elevated Liver Enzymes|0|||
42242137|NCT02852967|76066346|FG003|Overall Study|Elevated Liver Enzymes|2|||
42242138|NCT02852967|76066347|FG004|Overall Study|Elevated Liver Enzymes|2|||
42242139|NCT02852967|76066343|FG000|Overall Study|Physician Decision|0|||
42242140|NCT02852967|76066344|FG001|Overall Study|Physician Decision|0|||
42242141|NCT02852967|76066345|FG002|Overall Study|Physician Decision|0|||
42242142|NCT02852967|76066346|FG003|Overall Study|Physician Decision|1|||
42242143|NCT02852967|76066347|FG004|Overall Study|Physician Decision|0|||
42242144|NCT02852967|76066343|FG000|Overall Study|Lack of Efficacy|0|||
42242145|NCT02852967|76066344|FG001|Overall Study|Lack of Efficacy|1|||
42242146|NCT02852967|76066345|FG002|Overall Study|Lack of Efficacy|0|||
42242147|NCT02852967|76066346|FG003|Overall Study|Lack of Efficacy|0|||
42242148|NCT02852967|76066347|FG004|Overall Study|Lack of Efficacy|0|||
42242149|NCT02852967|76066343|FG000|Overall Study|Non-compliance|0|||
42242150|NCT02852967|76066344|FG001|Overall Study|Non-compliance|0|||
42242151|NCT02852967|76066345|FG002|Overall Study|Non-compliance|1|||
42242152|NCT02852967|76066346|FG003|Overall Study|Non-compliance|1|||
42242153|NCT02852967|76066347|FG004|Overall Study|Non-compliance|0|||
42242154|NCT02852967|76066343|FG000|Overall Study|Dispensing Drug Violation|0|||
42242155|NCT02852967|76066344|FG001|Overall Study|Dispensing Drug Violation|0|||
42242156|NCT02852967|76066345|FG002|Overall Study|Dispensing Drug Violation|1|||
42242157|NCT02852967|76066346|FG003|Overall Study|Dispensing Drug Violation|0|||
42242158|NCT02852967|76066347|FG004|Overall Study|Dispensing Drug Violation|0|||
42242159|NCT02852967|76066343|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
42242160|NCT02852967|76066344|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
42242161|NCT02852967|76066345|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
42242162|NCT02852967|76066346|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
42242163|NCT02852967|76066347|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
42242164|NCT02762994|76066375|FG000|Overall Study|Withdrawal by Subject|0|||
42242165|NCT02762994|76066376|FG001|Overall Study|Withdrawal by Subject|1|||
42242166|NCT02762994|76066377|FG002|Overall Study|Withdrawal by Subject|2|||
42242167|NCT02762994|76066378|FG003|Overall Study|Withdrawal by Subject|0|||
42242168|NCT02762994|76066375|FG000|Overall Study|Protocol Violation|1|||
42242169|NCT02762994|76066376|FG001|Overall Study|Protocol Violation|0|||
42242170|NCT02762994|76066377|FG002|Overall Study|Protocol Violation|0|||
42242171|NCT02762994|76066378|FG003|Overall Study|Protocol Violation|2|||
42242172|NCT02852265|76066394|FG000|3-month Follow-up|Lost to Follow-up|1|||
42242173|NCT02852265|76066395|FG001|3-month Follow-up|Lost to Follow-up|1|||
42242174|NCT02633800|76066407|FG000|Overall Study|Death|3|||
42242175|NCT02633800|76066408|FG001|Overall Study|Death|3|||
42242176|NCT02633800|76066407|FG000|Overall Study|Reason not provided|1|||
42242177|NCT02633800|76066408|FG001|Overall Study|Reason not provided|0|||
42242178|NCT02633800|76066407|FG000|Overall Study|Radiologic(al) progression|23|||
41988833|NCT01262365|75796346|FG000|Overall Study|Lack of Efficacy|35|||
41988834|NCT01262365|75796347|FG001|Overall Study|Lack of Efficacy|30|||
42242179|NCT02633800|76066408|FG001|Overall Study|Radiologic(al) progression|23|||
42242180|NCT02633800|76066407|FG000|Overall Study|Clinical progression|3|||
42242181|NCT02633800|76066408|FG001|Overall Study|Clinical progression|6|||
42242182|NCT02633800|76066407|FG000|Overall Study|Study terminated by sponsor|6|||
42242183|NCT02633800|76066408|FG001|Overall Study|Study terminated by sponsor|5|||
42242184|NCT02633800|76066407|FG000|Overall Study|Adverse event, non-fatal|7|||
42242185|NCT02633800|76066408|FG001|Overall Study|Adverse event, non-fatal|2|||
41988835|NCT01262365|75796348|FG002|Overall Study|Lack of Efficacy|47|||
41988836|NCT01262365|75796346|FG000|Overall Study|Protocol Violation|3|||
42302698|NCT02349633|76138079|FG011|Overall Study|Death|0|||
42242186|NCT02633800|76066407|FG000|Overall Study|Withdrawal by Subject|0|||
42242187|NCT02633800|76066408|FG001|Overall Study|Withdrawal by Subject|3|||
42242188|NCT02633800|76066407|FG000|Overall Study|Patient Request|1|||
42242189|NCT02633800|76066408|FG001|Overall Study|Patient Request|1|||
42242190|NCT03829657|76066417|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
42242191|NCT03829657|76066418|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
42242192|NCT03829657|76066419|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
42242193|NCT03829657|76066420|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
42242194|NCT03829657|76066421|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
42242195|NCT03829657|76066417|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
42242196|NCT03829657|76066418|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
42242197|NCT03829657|76066419|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
42242198|NCT03829657|76066420|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
42242199|NCT03829657|76066421|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
42242200|NCT03829657|76066417|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
42242201|NCT03829657|76066418|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
42242202|NCT03829657|76066419|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
42242203|NCT03829657|76066420|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
42242204|NCT03829657|76066421|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
42242205|NCT03829657|76066417|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
42242206|NCT03829657|76066418|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
42242207|NCT03829657|76066419|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
42242208|NCT03829657|76066420|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
42242209|NCT03829657|76066421|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
42242210|NCT03829657|76066417|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
42242211|NCT03829657|76066418|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
42242212|NCT03829657|76066419|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
42242213|NCT03829657|76066420|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
42242214|NCT03829657|76066421|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
42242215|NCT03829657|76066417|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
42242216|NCT03829657|76066418|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
42242217|NCT03829657|76066419|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
42242218|NCT03829657|76066420|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
42242219|NCT03829657|76066421|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
42242220|NCT03829657|76066417|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
42242221|NCT03829657|76066418|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
42242222|NCT03829657|76066419|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
42242223|NCT03829657|76066420|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
42242224|NCT03829657|76066421|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
42242225|NCT03829657|76066417|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
42242226|NCT03829657|76066418|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
42242227|NCT03829657|76066419|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
42242228|NCT03829657|76066420|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
42242229|NCT03829657|76066421|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
42242230|NCT03829657|76066417|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
42242231|NCT03829657|76066418|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
42242232|NCT03829657|76066419|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
42242233|NCT03829657|76066420|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
42242234|NCT03829657|76066421|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
42242235|NCT03829657|76066417|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
42242236|NCT03829657|76066418|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
42242237|NCT03829657|76066419|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
42242238|NCT03829657|76066420|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
42242239|NCT03829657|76066421|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
42242240|NCT03035227|76066432|FG000|Overall Study|study stopped due to PI leaving institut|1|||
42242241|NCT03035227|76066433|FG001|Overall Study|study stopped due to PI leaving institut|1|||
42242242|NCT00100932|76066443|FG000|Overall Study|Adverse Event|11|||
42242243|NCT00100932|76066444|FG001|Overall Study|Adverse Event|2|||
42242244|NCT00100932|76066443|FG000|Overall Study|Withdrawal by Subject|6|||
42242245|NCT00100932|76066444|FG001|Overall Study|Withdrawal by Subject|0|||
42032758|NCT00944697|75841037|FG000|Overall Study|Withdrawal by Subject|1|||
42032759|NCT00944697|75841038|FG001|Overall Study|Withdrawal by Subject|1|||
42032760|NCT00944697|75841037|FG000|Overall Study|Adverse Event|0|||
42242246|NCT00100932|76066443|FG000|Overall Study|Progressive Disease|44|||
42242247|NCT00100932|76066444|FG001|Overall Study|Progressive Disease|18|||
42242248|NCT00100932|76066443|FG000|Overall Study|Physician Decision|7|||
42242249|NCT00100932|76066444|FG001|Overall Study|Physician Decision|5|||
42242250|NCT00100932|76066443|FG000|Overall Study|Other|5|||
42242251|NCT00100932|76066444|FG001|Overall Study|Other|2|||
42242252|NCT03180307|76066452|FG000|Overall Study|Lost to Follow-up|2|||
42242253|NCT03180307|76066453|FG001|Overall Study|Lost to Follow-up|0|||
42242254|NCT03180307|76066452|FG000|Overall Study|Death|1|||
42242255|NCT03180307|76066453|FG001|Overall Study|Death|0|||
42242256|NCT03180307|76066452|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
42242257|NCT03180307|76066453|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
42242258|NCT02848833|76066457|FG000|Overall Study|subject who are duplicated|1|||
42242259|NCT02848833|76066457|FG000|Overall Study|have not taken the study drug|11|||
42242260|NCT02848833|76066457|FG000|Overall Study|follow-up failure|6|||
42242261|NCT02848833|76066457|FG000|Overall Study|Protocol Violation|119|||
42242262|NCT03361189|76066463|FG000|Overall Study|Received heart transplant|1|||
42242263|NCT03361189|76066464|FG001|Overall Study|Received heart transplant|0|||
42242264|NCT03361189|76066463|FG000|Overall Study|Pacemake replacement|0|||
42242265|NCT03361189|76066464|FG001|Overall Study|Pacemake replacement|1|||
41988837|NCT01262365|75796347|FG001|Overall Study|Protocol Violation|1|||
41988838|NCT01262365|75796348|FG002|Overall Study|Protocol Violation|1|||
41988839|NCT01262365|75796346|FG000|Overall Study|Lost to Follow-up|3|||
41988840|NCT01262365|75796347|FG001|Overall Study|Lost to Follow-up|7|||
41988841|NCT01262365|75796348|FG002|Overall Study|Lost to Follow-up|6|||
41988842|NCT01262365|75796346|FG000|Overall Study|Withdrawal by Subject|17|||
41988843|NCT01262365|75796347|FG001|Overall Study|Withdrawal by Subject|22|||
41988844|NCT01262365|75796348|FG002|Overall Study|Withdrawal by Subject|22|||
41988845|NCT01262365|75796346|FG000|Overall Study|Death|1|||
41988846|NCT01262365|75796347|FG001|Overall Study|Death|2|||
41988847|NCT01262365|75796348|FG002|Overall Study|Death|1|||
41988848|NCT01262365|75796346|FG000|Overall Study|Adverse Event|26|||
41988849|NCT01262365|75796347|FG001|Overall Study|Adverse Event|16|||
41988850|NCT01262365|75796348|FG002|Overall Study|Adverse Event|11|||
41988851|NCT01262365|75796346|FG000|Overall Study|sponsor decision|1|||
41988852|NCT01262365|75796347|FG001|Overall Study|sponsor decision|1|||
41988853|NCT01262365|75796348|FG002|Overall Study|sponsor decision|0|||
41988854|NCT01262365|75796346|FG000|Overall Study|Randomization error|1|||
41988855|NCT01262365|75796347|FG001|Overall Study|Randomization error|0|||
41988856|NCT01262365|75796348|FG002|Overall Study|Randomization error|2|||
41988857|NCT01262365|75796346|FG000|Overall Study|Non-compliance|1|||
41988858|NCT01262365|75796347|FG001|Overall Study|Non-compliance|0|||
41988859|NCT01262365|75796348|FG002|Overall Study|Non-compliance|2|||
41988860|NCT01262365|75796346|FG000|Overall Study|Suspected pregnancy|1|||
41988861|NCT01262365|75796347|FG001|Overall Study|Suspected pregnancy|0|||
41988862|NCT01262365|75796348|FG002|Overall Study|Suspected pregnancy|0|||
41988863|NCT01262365|75796346|FG000|Overall Study|Patient pregnant|1|||
41988864|NCT01262365|75796347|FG001|Overall Study|Patient pregnant|0|||
41988865|NCT01262365|75796348|FG002|Overall Study|Patient pregnant|1|||
41988866|NCT01262365|75796346|FG000|Overall Study|Toxicity related to study drug|0|||
41988867|NCT01262365|75796347|FG001|Overall Study|Toxicity related to study drug|1|||
41988868|NCT01262365|75796348|FG002|Overall Study|Toxicity related to study drug|0|||
41988869|NCT01262365|75796346|FG000|Overall Study|Cannot tolerate the protocol|0|||
41988870|NCT01262365|75796347|FG001|Overall Study|Cannot tolerate the protocol|1|||
41988871|NCT01262365|75796348|FG002|Overall Study|Cannot tolerate the protocol|0|||
41988872|NCT01262365|75796346|FG000|Overall Study|Patient unavailable|0|||
41988873|NCT01262365|75796347|FG001|Overall Study|Patient unavailable|0|||
41988874|NCT01262365|75796348|FG002|Overall Study|Patient unavailable|1|||
41988875|NCT03932812|75796358|FG000|Overall Study|Lost to Follow-up|12|||
42032761|NCT00944697|75841038|FG001|Overall Study|Adverse Event|3|||
42242266|NCT00092131|76066472|FG000|Treatment Period I|Adverse Event|1|||
42242267|NCT00092131|76066473|FG001|Treatment Period I|Adverse Event|0|||
42242268|NCT00092131|76066472|FG000|Treatment Period II|Adverse Event|0|||
42242269|NCT00092131|76066473|FG001|Treatment Period II|Adverse Event|1|||
42242270|NCT02668783|76066481|FG000|Overall Study|Pregnancy|0|||
41988876|NCT03932812|75796359|FG001|Overall Study|Lost to Follow-up|14|||
42242271|NCT02668783|76066482|FG001|Overall Study|Pregnancy|1|||
42242272|NCT02668783|76066481|FG000|Overall Study|Protocol Violation|2|||
42242273|NCT02668783|76066482|FG001|Overall Study|Protocol Violation|1|||
41988877|NCT03932812|75796358|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
41988878|NCT03932812|75796359|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
41988879|NCT01262287|75796368|FG000|Overall Study|Lost to Follow-up|2|||
41988880|NCT01262287|75796369|FG001|Overall Study|Lost to Follow-up|1|||
41988881|NCT01262092|75796381|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
41988882|NCT01262092|75796382|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
41988883|NCT01262092|75796381|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
41988884|NCT01262092|75796382|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
41988885|NCT01262092|75796381|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
41988886|NCT01262092|75796382|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
41988887|NCT01262092|75796381|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
41988888|NCT01262092|75796382|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
41988889|NCT01261975|75796388|FG000|Overall Study|Surgical complication|1|||
41988890|NCT01261780|75796397|FG000|Overall Study|Withdrawal by Subject|1|||
41988891|NCT01261780|75796398|FG001|Overall Study|Withdrawal by Subject|0|||
41988892|NCT01261780|75796397|FG000|Overall Study|Event not related to subject|1|||
41988893|NCT01261780|75796398|FG001|Overall Study|Event not related to subject|2|||
41988894|NCT01261624|75796406|FG000|Week 0 to Week 12|Disease Progression|1|||
41988895|NCT01261624|75796407|FG001|Week 0 to Week 12|Disease Progression|1|||
41988896|NCT01261624|75796406|FG000|Week 0 to Week 12|Insufficient Response|0|||
41988897|NCT01261624|75796407|FG001|Week 0 to Week 12|Insufficient Response|2|||
41988898|NCT01261624|75796406|FG000|Week 13 to Week 24|Insufficient Response|0|||
41988899|NCT01261624|75796407|FG001|Week 13 to Week 24|Insufficient Response|1|||
41988900|NCT03694522|75796421|FG000|Overall Study|Withdrawal by Subject|8|||
41988901|NCT03694522|75796422|FG001|Overall Study|Withdrawal by Subject|10|||
41988902|NCT03694522|75796421|FG000|Overall Study|Physician Decision|53|||
41988903|NCT03694522|75796422|FG001|Overall Study|Physician Decision|54|||
41988904|NCT03694522|75796421|FG000|Overall Study|Other|1|||
41988905|NCT03694522|75796422|FG001|Overall Study|Other|1|||
41988906|NCT03694522|75796421|FG000|Overall Study|Lost to Follow-up|0|||
41988907|NCT03694522|75796422|FG001|Overall Study|Lost to Follow-up|1|||
41988908|NCT01261390|75796432|FG000|Overall Study|Significant Concurrent Illness|1|||
41988909|NCT01261390|75796433|FG001|Overall Study|Significant Concurrent Illness|0|||
41988910|NCT01261390|75796434|FG002|Overall Study|Significant Concurrent Illness|1|||
41988911|NCT01261390|75796435|FG003|Overall Study|Significant Concurrent Illness|0|||
41988912|NCT01261390|75796432|FG000|Overall Study|Dissatisfaction with Treatment|2|||
41988913|NCT01261390|75796433|FG001|Overall Study|Dissatisfaction with Treatment|1|||
41988914|NCT01261390|75796434|FG002|Overall Study|Dissatisfaction with Treatment|1|||
41988915|NCT01261390|75796435|FG003|Overall Study|Dissatisfaction with Treatment|2|||
41988916|NCT01261390|75796432|FG000|Overall Study|Relocation|0|||
42242274|NCT02668783|76066481|FG000|Overall Study|Study terminated by sponsor|9|||
42242275|NCT02668783|76066482|FG001|Overall Study|Study terminated by sponsor|10|||
42242276|NCT02668783|76066481|FG000|Overall Study|Subject moved|1|||
42242277|NCT02668783|76066482|FG001|Overall Study|Subject moved|0|||
42242278|NCT02668783|76066481|FG000|Overall Study|Withdrawal by Subject|1|||
42242279|NCT02668783|76066482|FG001|Overall Study|Withdrawal by Subject|0|||
42242280|NCT00101010|76066488|FG000|Overall Study|Physician Decision|1|||
42242281|NCT02848599|76066494|FG000|Overall Study|Protocol Violation|7|||
42242282|NCT02848599|76066495|FG001|Overall Study|Protocol Violation|9|||
42242283|NCT00778999|76066526|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
42242284|NCT00778999|76066527|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
42242285|NCT00778999|76066526|FG000|Overall Study|Did not receive recFSH|14|||
42242286|NCT00778999|76066527|FG001|Overall Study|Did not receive recFSH|20|||
42242287|NCT02631850|76066537|FG000|Treatment Period|Lost to Follow-up|0|||
42242288|NCT02631850|76066538|FG001|Treatment Period|Lost to Follow-up|1|||
42242289|NCT02631850|76066539|FG002|Treatment Period|Lost to Follow-up|0|||
42242290|NCT02631850|76066540|FG003|Treatment Period|Lost to Follow-up|0|||
42242291|NCT02631850|76066537|FG000|Treatment Period|Protocol Violation|1|||
42242292|NCT02631850|76066538|FG001|Treatment Period|Protocol Violation|0|||
42242293|NCT02631850|76066539|FG002|Treatment Period|Protocol Violation|0|||
42242294|NCT02631850|76066540|FG003|Treatment Period|Protocol Violation|0|||
42242295|NCT02631850|76066537|FG000|Treatment Period|Withdrawal by Subject|0|||
42242296|NCT02631850|76066538|FG001|Treatment Period|Withdrawal by Subject|5|||
42242297|NCT02631850|76066539|FG002|Treatment Period|Withdrawal by Subject|2|||
42242298|NCT02631850|76066540|FG003|Treatment Period|Withdrawal by Subject|2|||
42242299|NCT02631850|76066537|FG000|Treatment Period|Adverse Event|1|||
42242300|NCT02631850|76066538|FG001|Treatment Period|Adverse Event|0|||
42242301|NCT02631850|76066539|FG002|Treatment Period|Adverse Event|2|||
42242302|NCT02631850|76066540|FG003|Treatment Period|Adverse Event|3|||
41988917|NCT01261390|75796433|FG001|Overall Study|Relocation|1|||
41988918|NCT01261390|75796434|FG002|Overall Study|Relocation|0|||
41988919|NCT01261390|75796435|FG003|Overall Study|Relocation|0|||
42032762|NCT00944697|75841037|FG000|Overall Study|Administrative|1|||
42242303|NCT02631850|76066537|FG000|Treatment Period|Family medical issue|1|||
42242304|NCT02631850|76066538|FG001|Treatment Period|Family medical issue|0|||
42242305|NCT02631850|76066539|FG002|Treatment Period|Family medical issue|0|||
42242306|NCT02631850|76066540|FG003|Treatment Period|Family medical issue|0|||
42242307|NCT02631850|76066537|FG000|6 Month Follow up|Lost to Follow-up|5|||
42242308|NCT02631850|76066538|FG001|6 Month Follow up|Lost to Follow-up|8|||
41988920|NCT01261390|75796432|FG000|Overall Study|Loss of Interest in the Study|3|||
41988921|NCT01261390|75796433|FG001|Overall Study|Loss of Interest in the Study|1|||
41988922|NCT01261390|75796434|FG002|Overall Study|Loss of Interest in the Study|0|||
41988923|NCT01261390|75796435|FG003|Overall Study|Loss of Interest in the Study|0|||
42242309|NCT02631850|76066539|FG002|6 Month Follow up|Lost to Follow-up|3|||
42242310|NCT02631850|76066540|FG003|6 Month Follow up|Lost to Follow-up|5|||
42242311|NCT02631850|76066537|FG000|6 Month Follow up|Withdrawal by Subject|1|||
42242312|NCT02631850|76066538|FG001|6 Month Follow up|Withdrawal by Subject|0|||
42242313|NCT02631850|76066539|FG002|6 Month Follow up|Withdrawal by Subject|0|||
42242314|NCT02631850|76066540|FG003|6 Month Follow up|Withdrawal by Subject|2|||
42242315|NCT02631850|76066537|FG000|6 Month Follow up|Adverse Event|1|||
42242316|NCT02631850|76066538|FG001|6 Month Follow up|Adverse Event|4|||
42242317|NCT02631850|76066539|FG002|6 Month Follow up|Adverse Event|1|||
42242318|NCT02631850|76066540|FG003|6 Month Follow up|Adverse Event|3|||
42242319|NCT02631850|76066537|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
42242320|NCT02631850|76066538|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
41988924|NCT01261390|75796432|FG000|Overall Study|Lost to Follow-up|1|||
41988925|NCT01261390|75796433|FG001|Overall Study|Lost to Follow-up|6|||
41988926|NCT01261390|75796434|FG002|Overall Study|Lost to Follow-up|5|||
41988927|NCT01261390|75796435|FG003|Overall Study|Lost to Follow-up|6|||
41988928|NCT03391882|75796456|FG000|Study Overall|Adverse Event|3|||
41988929|NCT03391882|75796457|FG001|Study Overall|Adverse Event|6|||
41988930|NCT03391882|75796458|FG002|Study Overall|Adverse Event|1|||
41988931|NCT03391882|75796459|FG003|Study Overall|Adverse Event|1|||
41988932|NCT03391882|75796460|FG004|Study Overall|Adverse Event|3|||
41988933|NCT03391882|75796461|FG005|Study Overall|Adverse Event|1|||
41988934|NCT03391882|75796456|FG000|Study Overall|Lack of Efficacy|13|||
41988935|NCT03391882|75796457|FG001|Study Overall|Lack of Efficacy|9|||
42242321|NCT02631850|76066539|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
42242322|NCT02631850|76066540|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
42242323|NCT00103038|76066551|FG000|Overall Study|Withdrawal by Subject|8|||
42242324|NCT00103038|76066551|FG000|Overall Study|Screen failure|3|||
42242325|NCT00103038|76066551|FG000|Overall Study|Death|1|||
42242326|NCT00103038|76066551|FG000|Overall Study|Physician Decision|1|||
42242327|NCT00620035|76066558|FG000|Overall Study|Adverse Event|106|||
42242328|NCT00620035|76066558|FG000|Overall Study|Withdrawal of Informed Consent|1|||
42242329|NCT00620035|76066558|FG000|Overall Study|Other Reason|38|||
42242330|NCT03034057|76066562|FG000|Overall Study|Withdrawal by Subject|10|||
42242331|NCT03034057|76066562|FG000|Overall Study|Protocol Violation|1|||
42242332|NCT03034057|76066562|FG000|Overall Study|Not defined|2|||
42242333|NCT03034057|76066562|FG000|Overall Study|Lost to Follow-up|19|||
42242334|NCT03034057|76066562|FG000|Overall Study|Adverse Event|22|||
42242335|NCT03034057|76066562|FG000|Overall Study|Medication error without associated AE|1|||
42242336|NCT02757768|76066568|FG000|Overall Study|Randomized Never Received Study Drug|3|||
42242337|NCT02757768|76066569|FG001|Overall Study|Randomized Never Received Study Drug|4|||
42242338|NCT02757768|76066568|FG000|Overall Study|Adverse Event|5|||
42242339|NCT02757768|76066569|FG001|Overall Study|Adverse Event|3|||
42242340|NCT02757768|76066568|FG000|Overall Study|Lack of Efficacy|2|||
42242341|NCT02757768|76066569|FG001|Overall Study|Lack of Efficacy|1|||
42242342|NCT02757768|76066568|FG000|Overall Study|Lost to Follow-up|1|||
42242343|NCT02757768|76066569|FG001|Overall Study|Lost to Follow-up|0|||
42242344|NCT02757768|76066568|FG000|Overall Study|Protocol Deviation|2|||
42242345|NCT02757768|76066569|FG001|Overall Study|Protocol Deviation|9|||
42242346|NCT02757768|76066568|FG000|Overall Study|Withdrawal by Subject|16|||
42242347|NCT02757768|76066569|FG001|Overall Study|Withdrawal by Subject|9|||
42242348|NCT02757768|76066568|FG000|Overall Study|Miscellaneous|4|||
42242349|NCT02757768|76066569|FG001|Overall Study|Miscellaneous|2|||
42242350|NCT05225389|76066577|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
42242351|NCT02753946|76066583|FG000|Overall Study|Adverse Event|7|||
41988936|NCT03391882|75796458|FG002|Study Overall|Lack of Efficacy|0|||
41988937|NCT03391882|75796459|FG003|Study Overall|Lack of Efficacy|0|||
41988938|NCT03391882|75796460|FG004|Study Overall|Lack of Efficacy|0|||
41988939|NCT03391882|75796461|FG005|Study Overall|Lack of Efficacy|0|||
41988940|NCT03391882|75796456|FG000|Study Overall|Withdrawal by Subject|3|||
41988941|NCT03391882|75796457|FG001|Study Overall|Withdrawal by Subject|3|||
41988942|NCT03391882|75796458|FG002|Study Overall|Withdrawal by Subject|2|||
41988943|NCT03391882|75796459|FG003|Study Overall|Withdrawal by Subject|2|||
41988944|NCT03391882|75796460|FG004|Study Overall|Withdrawal by Subject|1|||
41988945|NCT03391882|75796461|FG005|Study Overall|Withdrawal by Subject|3|||
41988946|NCT03391882|75796456|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
41988947|NCT03391882|75796457|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
41988948|NCT03391882|75796458|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
41988949|NCT03391882|75796459|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
41988950|NCT03391882|75796460|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
41988951|NCT03391882|75796461|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
41988952|NCT03391882|75796456|FG000|Study Overall|Protocol Violation|1|||
41988953|NCT03391882|75796457|FG001|Study Overall|Protocol Violation|0|||
41988954|NCT03391882|75796458|FG002|Study Overall|Protocol Violation|0|||
41988955|NCT03391882|75796459|FG003|Study Overall|Protocol Violation|0|||
41988956|NCT03391882|75796460|FG004|Study Overall|Protocol Violation|0|||
41988957|NCT03391882|75796461|FG005|Study Overall|Protocol Violation|0|||
41988958|NCT03391882|75796456|FG000|Part A - Titration Phase|Adverse Event|3|||
41988959|NCT03391882|75796457|FG001|Part A - Titration Phase|Adverse Event|6|||
41988960|NCT03391882|75796458|FG002|Part A - Titration Phase|Adverse Event|0|||
41988961|NCT03391882|75796459|FG003|Part A - Titration Phase|Adverse Event|0|||
41988962|NCT03391882|75796460|FG004|Part A - Titration Phase|Adverse Event|0|||
41988963|NCT03391882|75796461|FG005|Part A - Titration Phase|Adverse Event|0|||
41988964|NCT03391882|75796456|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
41988965|NCT03391882|75796457|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
41988966|NCT03391882|75796458|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
41988967|NCT03391882|75796459|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
41988968|NCT03391882|75796460|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
42242352|NCT02753946|76066584|FG001|Overall Study|Adverse Event|6|||
42242353|NCT02753946|76066583|FG000|Overall Study|Withdrawal by Subject|6|||
42242354|NCT02753946|76066584|FG001|Overall Study|Withdrawal by Subject|1|||
42242355|NCT02753946|76066583|FG000|Overall Study|Lack of Efficacy|1|||
42242356|NCT02753946|76066584|FG001|Overall Study|Lack of Efficacy|0|||
42242357|NCT02753946|76066583|FG000|Overall Study|Physician Decision|0|||
42242358|NCT02753946|76066584|FG001|Overall Study|Physician Decision|2|||
42242359|NCT02756832|76066590|FG000|Overall Study|Lost for Observation after Baseline|6|||
42242360|NCT02756832|76066590|FG000|Overall Study|Lost for Observation|13|||
42242361|NCT02756832|76066590|FG000|Overall Study|Patient's Unwillingness|12|||
42242362|NCT02756832|76066590|FG000|Overall Study|Insufficient Efficacy|2|||
42242363|NCT02756832|76066590|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
42242364|NCT02756832|76066590|FG000|Overall Study|Reason not Specified|9|||
42242365|NCT02756832|76066590|FG000|Overall Study|Protocol Deviation|10|||
42242366|NCT00106080|76066596|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
42242367|NCT00106080|76066597|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
42242368|NCT02633020|76066605|FG000|Overall Study|Adverse Event|1|||
42242369|NCT02633020|76066606|FG001|Overall Study|Adverse Event|0|||
42242370|NCT00106626|76066616|FG000|Overall Study|Adverse Event|5|||
42242371|NCT00106626|76066617|FG001|Overall Study|Adverse Event|4|||
42242372|NCT00106626|76066618|FG002|Overall Study|Adverse Event|3|||
42242373|NCT00106626|76066619|FG003|Overall Study|Adverse Event|3|||
42242374|NCT00106626|76066616|FG000|Overall Study|Progressive Disease|4|||
42242375|NCT00106626|76066617|FG001|Overall Study|Progressive Disease|1|||
42242376|NCT00106626|76066618|FG002|Overall Study|Progressive Disease|9|||
42242377|NCT00106626|76066619|FG003|Overall Study|Progressive Disease|10|||
42242378|NCT00106626|76066616|FG000|Overall Study|Received radiation on new therapy|1|||
42242379|NCT00106626|76066617|FG001|Overall Study|Received radiation on new therapy|0|||
42242380|NCT00106626|76066618|FG002|Overall Study|Received radiation on new therapy|0|||
42242381|NCT00106626|76066619|FG003|Overall Study|Received radiation on new therapy|0|||
42242382|NCT00106626|76066616|FG000|Overall Study|> 14 day delay in therapy start|0|||
41988969|NCT03391882|75796461|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
41988970|NCT03391882|75796456|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
41988971|NCT03391882|75796457|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
41988972|NCT03391882|75796458|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
41988973|NCT03391882|75796459|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
42242383|NCT00106626|76066617|FG001|Overall Study|> 14 day delay in therapy start|1|||
42242384|NCT00106626|76066618|FG002|Overall Study|> 14 day delay in therapy start|0|||
42242385|NCT00106626|76066619|FG003|Overall Study|> 14 day delay in therapy start|0|||
42242386|NCT02632786|76066636|FG000|Overall Study|Adverse Event|2|||
42302699|NCT02349633|76138080|FG012|Overall Study|Death|0|||
41988974|NCT03391882|75796460|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
41988975|NCT03391882|75796461|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
41988976|NCT03391882|75796456|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
42032763|NCT00944697|75841038|FG001|Overall Study|Administrative|1|||
42242387|NCT02632786|76066637|FG001|Overall Study|Adverse Event|1|||
42242388|NCT02632786|76066636|FG000|Overall Study|Death|3|||
42242389|NCT02632786|76066637|FG001|Overall Study|Death|2|||
42242390|NCT02632786|76066636|FG000|Overall Study|Physician Decision|5|||
42242391|NCT02632786|76066637|FG001|Overall Study|Physician Decision|4|||
42242392|NCT02632786|76066636|FG000|Overall Study|Withdrawal by Subject|1|||
42242393|NCT02632786|76066637|FG001|Overall Study|Withdrawal by Subject|0|||
42242394|NCT02755818|76066648|FG000|Overall Study|Withdrawal by Subject|0|||
42242395|NCT02755818|76066649|FG001|Overall Study|Withdrawal by Subject|0|||
42242396|NCT02755818|76066650|FG002|Overall Study|Withdrawal by Subject|0|||
42242397|NCT02755818|76066651|FG003|Overall Study|Withdrawal by Subject|2|||
42242398|NCT02755818|76066648|FG000|Overall Study|withdrawal by PI|0|||
42242399|NCT02755818|76066649|FG001|Overall Study|withdrawal by PI|0|||
42242400|NCT02755818|76066650|FG002|Overall Study|withdrawal by PI|1|||
42242401|NCT02755818|76066651|FG003|Overall Study|withdrawal by PI|1|||
42242402|NCT03033745|76066666|FG000|Overall Study|Protocol Violation|0|||
42242403|NCT03033745|76066667|FG001|Overall Study|Protocol Violation|0|||
42242404|NCT03033745|76066668|FG002|Overall Study|Protocol Violation|1|||
42242405|NCT03033745|76066666|FG000|Overall Study|Adverse Event|1|||
42242406|NCT03033745|76066667|FG001|Overall Study|Adverse Event|0|||
42242407|NCT03033745|76066668|FG002|Overall Study|Adverse Event|1|||
42242408|NCT03033745|76066666|FG000|Overall Study|Withdrawal by Subject|0|||
42242409|NCT03033745|76066667|FG001|Overall Study|Withdrawal by Subject|1|||
42242410|NCT03033745|76066668|FG002|Overall Study|Withdrawal by Subject|0|||
42242411|NCT01672294|76066687|FG000|Overall Study|Withdrawal by Subject|4|||
42242412|NCT01672294|76066688|FG001|Overall Study|Withdrawal by Subject|4|||
42242413|NCT01672294|76066689|FG002|Overall Study|Withdrawal by Subject|4|||
42242414|NCT01672294|76066690|FG003|Overall Study|Withdrawal by Subject|4|||
42242415|NCT01672294|76066687|FG000|Overall Study|Excluded by study|1|||
42242416|NCT01672294|76066688|FG001|Overall Study|Excluded by study|1|||
42242417|NCT01672294|76066689|FG002|Overall Study|Excluded by study|0|||
41988977|NCT03391882|75796457|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
41988978|NCT03391882|75796458|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
41988979|NCT03391882|75796459|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
41988980|NCT03391882|75796460|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
41988981|NCT03391882|75796461|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
41988982|NCT03391882|75796456|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
41988983|NCT03391882|75796457|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
41988984|NCT03391882|75796458|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
41988985|NCT03391882|75796459|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
41988986|NCT03391882|75796460|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
41988987|NCT03391882|75796461|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
41988988|NCT03391882|75796456|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
41988989|NCT03391882|75796457|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
41988990|NCT03391882|75796458|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
41988991|NCT03391882|75796459|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
41988992|NCT03391882|75796460|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
41988993|NCT03391882|75796461|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
41988994|NCT03391882|75796456|FG000|Part B - Treatment Phase|Adverse Event|0|||
41988995|NCT03391882|75796457|FG001|Part B - Treatment Phase|Adverse Event|0|||
41988996|NCT03391882|75796458|FG002|Part B - Treatment Phase|Adverse Event|1|||
41988997|NCT03391882|75796459|FG003|Part B - Treatment Phase|Adverse Event|1|||
41988998|NCT03391882|75796460|FG004|Part B - Treatment Phase|Adverse Event|3|||
41988999|NCT03391882|75796461|FG005|Part B - Treatment Phase|Adverse Event|1|||
41989000|NCT03391882|75796456|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
41989001|NCT03391882|75796457|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
41989002|NCT03391882|75796458|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
41989003|NCT03391882|75796459|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
41989004|NCT03391882|75796460|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
41989005|NCT03391882|75796461|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
41989006|NCT01261000|75796471|FG000|Overall Study|Screen failure|1|||
41989007|NCT01234402|75796504|FG000|Overall Study|Lost to Follow-up|0|||
42242418|NCT01672294|76066690|FG003|Overall Study|Excluded by study|0|||
41989008|NCT01234402|75796505|FG001|Overall Study|Lost to Follow-up|1|||
42242419|NCT01672294|76066687|FG000|Overall Study|Lost to Follow-up|1|||
42242420|NCT01672294|76066688|FG001|Overall Study|Lost to Follow-up|16|||
42242421|NCT01672294|76066689|FG002|Overall Study|Lost to Follow-up|7|||
42242422|NCT01672294|76066690|FG003|Overall Study|Lost to Follow-up|9|||
42242423|NCT02755116|76066702|FG000|Overall Study|surgery converted to open, pt admitted|3|||
41989009|NCT01234402|75796506|FG002|Overall Study|Lost to Follow-up|3|||
41989010|NCT01234402|75796504|FG000|Overall Study|Withdrawal by Subject|1|||
41989011|NCT01234402|75796505|FG001|Overall Study|Withdrawal by Subject|3|||
41989012|NCT01234402|75796506|FG002|Overall Study|Withdrawal by Subject|4|||
41989013|NCT01234402|75796504|FG000|Overall Study|Never treated: Death|0|||
41989014|NCT01234402|75796505|FG001|Overall Study|Never treated: Death|0|||
42302700|NCT02349633|76138081|FG013|Overall Study|Death|0|||
41989015|NCT01234402|75796506|FG002|Overall Study|Never treated: Death|1|||
41989016|NCT01234402|75796504|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
41989017|NCT01234402|75796505|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
41989018|NCT01234402|75796506|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
42242424|NCT02755116|76066703|FG001|Overall Study|surgery converted to open, pt admitted|1|||
42242425|NCT02754492|76066713|FG000|Overall Study|Protocol Violation|2|||
42242426|NCT02754492|76066714|FG001|Overall Study|Protocol Violation|2|||
42242427|NCT02754492|76066715|FG002|Overall Study|Protocol Violation|0|||
42242428|NCT02754492|76066716|FG003|Overall Study|Protocol Violation|1|||
42242429|NCT02754492|76066713|FG000|Overall Study|Withdrawal by Subject|2|||
42242430|NCT02754492|76066714|FG001|Overall Study|Withdrawal by Subject|0|||
42242431|NCT02754492|76066715|FG002|Overall Study|Withdrawal by Subject|0|||
42242432|NCT02754492|76066716|FG003|Overall Study|Withdrawal by Subject|0|||
42242433|NCT02754492|76066713|FG000|Overall Study|Equipment malfuntion|0|||
42242434|NCT02754492|76066714|FG001|Overall Study|Equipment malfuntion|0|||
42242435|NCT02754492|76066715|FG002|Overall Study|Equipment malfuntion|2|||
42242436|NCT02754492|76066716|FG003|Overall Study|Equipment malfuntion|5|||
42242437|NCT02754492|76066713|FG000|Overall Study|Adverse Event|0|||
42242438|NCT02754492|76066714|FG001|Overall Study|Adverse Event|0|||
42242439|NCT02754492|76066715|FG002|Overall Study|Adverse Event|0|||
42242440|NCT02754492|76066716|FG003|Overall Study|Adverse Event|13|||
42242441|NCT02754492|76066713|FG000|Overall Study|Venous access issues not resulting in AE|0|||
42242442|NCT02754492|76066714|FG001|Overall Study|Venous access issues not resulting in AE|0|||
42242443|NCT02754492|76066715|FG002|Overall Study|Venous access issues not resulting in AE|0|||
42242444|NCT02754492|76066716|FG003|Overall Study|Venous access issues not resulting in AE|4|||
42242445|NCT04068688|76066735|FG000|Overall Study|Lost to Follow-up|1|||
42242446|NCT04068688|76066736|FG001|Overall Study|Lost to Follow-up|1|||
42242447|NCT04068688|76066737|FG002|Overall Study|Lost to Follow-up|0|||
42242448|NCT04068688|76066738|FG003|Overall Study|Lost to Follow-up|0|||
42242449|NCT04068688|76066739|FG004|Overall Study|Lost to Follow-up|5|||
42242450|NCT04068688|76066740|FG005|Overall Study|Lost to Follow-up|5|||
42242451|NCT04068688|76066741|FG006|Overall Study|Lost to Follow-up|0|||
42242452|NCT04068688|76066742|FG007|Overall Study|Lost to Follow-up|0|||
42242453|NCT04068688|76066743|FG008|Overall Study|Lost to Follow-up|1|||
42242454|NCT04068688|76066744|FG009|Overall Study|Lost to Follow-up|0|||
42242455|NCT04068688|76066735|FG000|Overall Study|Withdrawal by Subject|1|||
42242456|NCT04068688|76066736|FG001|Overall Study|Withdrawal by Subject|1|||
42242457|NCT04068688|76066737|FG002|Overall Study|Withdrawal by Subject|0|||
42242458|NCT04068688|76066738|FG003|Overall Study|Withdrawal by Subject|0|||
42242459|NCT04068688|76066739|FG004|Overall Study|Withdrawal by Subject|0|||
42242460|NCT04068688|76066740|FG005|Overall Study|Withdrawal by Subject|0|||
42242461|NCT04068688|76066741|FG006|Overall Study|Withdrawal by Subject|0|||
42242462|NCT04068688|76066742|FG007|Overall Study|Withdrawal by Subject|0|||
42242463|NCT04068688|76066743|FG008|Overall Study|Withdrawal by Subject|0|||
42242464|NCT04068688|76066744|FG009|Overall Study|Withdrawal by Subject|0|||
42242465|NCT04068688|76066735|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
42242466|NCT04068688|76066736|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
42242467|NCT04068688|76066737|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
42242468|NCT04068688|76066738|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
42242469|NCT04068688|76066739|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
42242470|NCT04068688|76066740|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
42242471|NCT04068688|76066741|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
42242472|NCT04068688|76066742|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
42242473|NCT04068688|76066743|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
42242474|NCT04068688|76066744|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
42242475|NCT01671748|76066772|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
42242476|NCT01671748|76066773|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
42242477|NCT01671748|76066772|FG000|4 Week run-in Phase|Adverse Event|1|||
42302701|NCT02349633|76138068|FG000|Overall Study|Withdrawal by Subject|0|||
42302702|NCT02349633|76138069|FG001|Overall Study|Withdrawal by Subject|0|||
42302703|NCT02349633|76138070|FG002|Overall Study|Withdrawal by Subject|0|||
41989019|NCT01234402|75796504|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
42242478|NCT01671748|76066773|FG001|4 Week run-in Phase|Adverse Event|0|||
42242479|NCT01671748|76066772|FG000|4 Week run-in Phase|Not eligible|9|||
42242480|NCT01671748|76066773|FG001|4 Week run-in Phase|Not eligible|0|||
42242481|NCT02657889|76066783|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
42242482|NCT02657889|76066784|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
42242483|NCT02657889|76066785|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
42242484|NCT02657889|76066786|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
42242485|NCT02657889|76066783|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
42242486|NCT02657889|76066784|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
42242487|NCT02657889|76066785|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
42242488|NCT02657889|76066786|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
42242489|NCT02657889|76066783|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
42242490|NCT02657889|76066784|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
42242491|NCT02657889|76066785|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
42242492|NCT02657889|76066786|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
42242493|NCT02657889|76066783|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
42242494|NCT02657889|76066784|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
42242495|NCT02657889|76066785|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
42242496|NCT02657889|76066786|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
42242497|NCT02657889|76066783|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
42242498|NCT02657889|76066784|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
42242499|NCT02657889|76066785|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
42242500|NCT02657889|76066786|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
42242501|NCT02657889|76066783|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
42242502|NCT02657889|76066784|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
42242503|NCT02657889|76066785|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
42242504|NCT02657889|76066786|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
42242505|NCT02657889|76066783|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
42242506|NCT02657889|76066784|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
42242507|NCT02657889|76066785|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
42242508|NCT02657889|76066786|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
42242509|NCT02657889|76066783|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
42242510|NCT02657889|76066784|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
42242511|NCT02657889|76066785|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
42242512|NCT02657889|76066786|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
42242513|NCT02657889|76066783|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
42242514|NCT02657889|76066784|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
42242515|NCT02657889|76066785|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
42242516|NCT02657889|76066786|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
42242517|NCT02657889|76066783|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
42242518|NCT02657889|76066784|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
42242519|NCT02657889|76066785|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
42242520|NCT02657889|76066786|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
42242521|NCT02657889|76066783|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
42242522|NCT02657889|76066784|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
42242523|NCT02657889|76066785|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
42242524|NCT02657889|76066786|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
41989020|NCT01234402|75796505|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
42242525|NCT02657889|76066783|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
42242526|NCT02657889|76066784|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
42242527|NCT02657889|76066785|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
42242528|NCT02657889|76066786|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
42242529|NCT03034915|76066801|FG000|Overall Study|Adverse Event|29|||
42242530|NCT03034915|76066802|FG001|Overall Study|Adverse Event|32|||
42242531|NCT03034915|76066803|FG002|Overall Study|Adverse Event|22|||
42242532|NCT03034915|76066801|FG000|Overall Study|Lost to Follow-up|5|||
42242533|NCT03034915|76066802|FG001|Overall Study|Lost to Follow-up|13|||
42242534|NCT03034915|76066803|FG002|Overall Study|Lost to Follow-up|3|||
42242535|NCT03034915|76066801|FG000|Overall Study|Withdrawal by Subject|29|||
42242536|NCT03034915|76066802|FG001|Overall Study|Withdrawal by Subject|46|||
42242537|NCT03034915|76066803|FG002|Overall Study|Withdrawal by Subject|41|||
42242538|NCT03034915|76066801|FG000|Overall Study|Protocol Deviation|2|||
42242539|NCT03034915|76066802|FG001|Overall Study|Protocol Deviation|14|||
42242540|NCT03034915|76066803|FG002|Overall Study|Protocol Deviation|7|||
42242541|NCT03034915|76066801|FG000|Overall Study|Lack of Efficacy|8|||
42242542|NCT03034915|76066802|FG001|Overall Study|Lack of Efficacy|16|||
42242543|NCT03034915|76066803|FG002|Overall Study|Lack of Efficacy|18|||
42242544|NCT03034915|76066801|FG000|Overall Study|Site closed|2|||
42242545|NCT03034915|76066802|FG001|Overall Study|Site closed|2|||
42242546|NCT03034915|76066803|FG002|Overall Study|Site closed|4|||
42242547|NCT03034915|76066801|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
41989021|NCT01234402|75796506|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
41989022|NCT01260922|75796518|FG000|First Intervention|Withdrawal by Subject|0|||
41989023|NCT01260922|75796519|FG001|First Intervention|Withdrawal by Subject|1|||
41989024|NCT01260922|75796518|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
42242548|NCT03034915|76066802|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
42242549|NCT03034915|76066803|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
42242550|NCT03034915|76066801|FG000|Overall Study|Physician Decision|1|||
42242551|NCT03034915|76066802|FG001|Overall Study|Physician Decision|5|||
42242552|NCT03034915|76066803|FG002|Overall Study|Physician Decision|2|||
42242553|NCT02631538|76066815|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
42242554|NCT02631538|76066816|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
42242555|NCT02631538|76066817|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
42242556|NCT02631538|76066818|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
42242557|NCT02631538|76066815|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
42242558|NCT02631538|76066816|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
42242559|NCT02631538|76066817|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
42242560|NCT02631538|76066818|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
42242561|NCT02631538|76066815|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
42242562|NCT02631538|76066816|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
42242563|NCT02631538|76066817|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
42242564|NCT02631538|76066818|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
42242565|NCT02631538|76066815|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
42242566|NCT02631538|76066816|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
42242567|NCT02631538|76066817|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
42242568|NCT02631538|76066818|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
42242569|NCT02631538|76066815|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
42242570|NCT02631538|76066816|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
42242571|NCT02631538|76066817|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
42242572|NCT02631538|76066818|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
42242573|NCT02631538|76066815|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
42242574|NCT02631538|76066816|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
42242575|NCT02631538|76066817|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
42242576|NCT02631538|76066818|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
42242577|NCT04587271|76066843|FG000|Overall Study|Lost to Follow-up|2|||
42242578|NCT04587271|76066844|FG001|Overall Study|Lost to Follow-up|2|||
42242579|NCT04587271|76066845|FG002|Overall Study|Lost to Follow-up|0|||
42242580|NCT04587271|76066846|FG003|Overall Study|Lost to Follow-up|2|||
42242581|NCT04587271|76066847|FG004|Overall Study|Lost to Follow-up|2|||
42242582|NCT04587271|76066848|FG005|Overall Study|Lost to Follow-up|0|||
42242583|NCT04587271|76066843|FG000|Overall Study|Caregiver brought child to visits|0|||
42242584|NCT04587271|76066844|FG001|Overall Study|Caregiver brought child to visits|0|||
42242585|NCT04587271|76066845|FG002|Overall Study|Caregiver brought child to visits|0|||
42242586|NCT04587271|76066846|FG003|Overall Study|Caregiver brought child to visits|1|||
42242587|NCT04587271|76066847|FG004|Overall Study|Caregiver brought child to visits|0|||
42242588|NCT04587271|76066848|FG005|Overall Study|Caregiver brought child to visits|0|||
42242589|NCT02631148|76066863|FG000|Overall Study|8 were ineligible|8|||
42242590|NCT02631148|76066864|FG001|Overall Study|8 were ineligible|0|||
42242591|NCT02631148|76066863|FG000|Overall Study|Withdrawal by Subject|1|||
42242592|NCT02631148|76066864|FG001|Overall Study|Withdrawal by Subject|0|||
42242593|NCT02631148|76066863|FG000|Overall Study|PAH not available to study participant|1|||
42242594|NCT02631148|76066864|FG001|Overall Study|PAH not available to study participant|0|||
42242595|NCT02753400|76066872|FG000|Overall Study|Adverse Event|3|||
42242596|NCT02753400|76066873|FG001|Overall Study|Adverse Event|0|||
42242597|NCT02753400|76066872|FG000|Overall Study|Withdrawal by Subject|2|||
42242598|NCT02753400|76066873|FG001|Overall Study|Withdrawal by Subject|1|||
42242599|NCT03943147|76066890|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
42242600|NCT03943147|76066891|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
42242601|NCT03943147|76066890|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
42242602|NCT03943147|76066891|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
42242603|NCT03943147|76066890|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
42242604|NCT03943147|76066891|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
42242605|NCT03943147|76066890|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
42242606|NCT03943147|76066891|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
42242607|NCT03943147|76066890|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
42242608|NCT03943147|76066891|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
42242609|NCT03943147|76066890|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
42242610|NCT03943147|76066891|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
42242611|NCT03730987|76066909|FG000|Overall Study|Lost to Follow-up|2|||
42242612|NCT03730987|76066910|FG001|Overall Study|Lost to Follow-up|0|||
42242613|NCT03730987|76066911|FG002|Overall Study|Lost to Follow-up|2|||
42242614|NCT03730987|76066912|FG003|Overall Study|Lost to Follow-up|0|||
42242615|NCT02844543|76066923|FG000|Overall Study|Withdrawal by Subject|4|||
42242616|NCT02844543|76066923|FG000|Overall Study|Did not meet eligibility criteria|1|||
42242617|NCT03034135|76066927|FG000|Overall Study|Withdrawal by Subject|2|||
42242618|NCT01671280|76066931|FG000|Overall Study|Withdrawal by Subject|2|||
42242619|NCT01405963|76066937|FG000|Overall Study|Moved Away|2|||
42242620|NCT01405963|76066938|FG001|Overall Study|Moved Away|0|||
42242621|NCT01405963|76066937|FG000|Overall Study|Adverse Event|0|||
42242622|NCT01405963|76066938|FG001|Overall Study|Adverse Event|1|||
42242623|NCT01405963|76066937|FG000|Overall Study|Lost to Follow-up|0|||
42242624|NCT01405963|76066938|FG001|Overall Study|Lost to Follow-up|1|||
42242625|NCT02628418|76066958|FG000|Overall Study|Lost to Follow-up|1|||
42242626|NCT02628418|76066959|FG001|Overall Study|Lost to Follow-up|2|||
42242627|NCT02752776|76066987|FG000|Overall Study|Adverse Event|15|||
42242628|NCT02752776|76066988|FG001|Overall Study|Adverse Event|23|||
42242629|NCT02752776|76066989|FG002|Overall Study|Adverse Event|11|||
42242630|NCT02752776|76066987|FG000|Overall Study|Lack of Efficacy|2|||
42242631|NCT02752776|76066988|FG001|Overall Study|Lack of Efficacy|6|||
42242632|NCT02752776|76066989|FG002|Overall Study|Lack of Efficacy|14|||
42242633|NCT02752776|76066987|FG000|Overall Study|Lost to Follow-up|11|||
42242634|NCT02752776|76066988|FG001|Overall Study|Lost to Follow-up|12|||
42242635|NCT02752776|76066989|FG002|Overall Study|Lost to Follow-up|4|||
42242636|NCT02752776|76066987|FG000|Overall Study|Non-compliance with study treatment|0|||
42242637|NCT02752776|76066988|FG001|Overall Study|Non-compliance with study treatment|0|||
42242638|NCT02752776|76066989|FG002|Overall Study|Non-compliance with study treatment|1|||
42242639|NCT02752776|76066987|FG000|Overall Study|Physician Decision|2|||
42242640|NCT02752776|76066988|FG001|Overall Study|Physician Decision|6|||
42242641|NCT02752776|76066989|FG002|Overall Study|Physician Decision|2|||
42242642|NCT02752776|76066987|FG000|Overall Study|Pregnancy|1|||
42242643|NCT02752776|76066988|FG001|Overall Study|Pregnancy|6|||
42242644|NCT02752776|76066989|FG002|Overall Study|Pregnancy|3|||
42242645|NCT02752776|76066987|FG000|Overall Study|Protocol Violation|10|||
42242646|NCT02752776|76066988|FG001|Overall Study|Protocol Violation|13|||
42242647|NCT02752776|76066989|FG002|Overall Study|Protocol Violation|6|||
42242648|NCT02752776|76066987|FG000|Overall Study|Subject/guardian decision|8|||
42242649|NCT02752776|76066988|FG001|Overall Study|Subject/guardian decision|6|||
42242650|NCT02752776|76066989|FG002|Overall Study|Subject/guardian decision|4|||
42242651|NCT02752776|76066987|FG000|Overall Study|Death|0|||
42242652|NCT02752776|76066988|FG001|Overall Study|Death|0|||
42242653|NCT02752776|76066989|FG002|Overall Study|Death|1|||
42242654|NCT02752776|76066987|FG000|Overall Study|Withdrawal by Subject|3|||
42242655|NCT02752776|76066988|FG001|Overall Study|Withdrawal by Subject|4|||
42242656|NCT02752776|76066989|FG002|Overall Study|Withdrawal by Subject|2|||
42242657|NCT01342965|76067001|FG000|Overall Study|Death|58|||
42242658|NCT01342965|76067002|FG001|Overall Study|Death|57|||
42242659|NCT01342965|76067001|FG000|Overall Study|Lost to Follow-up|5|||
42242660|NCT01342965|76067002|FG001|Overall Study|Lost to Follow-up|3|||
42242661|NCT01342965|76067001|FG000|Overall Study|Other Reasons- Unspecified|44|||
42242662|NCT01342965|76067002|FG001|Overall Study|Other Reasons- Unspecified|38|||
42242663|NCT01342965|76067001|FG000|Overall Study|Withdrawal by Subject|2|||
42242664|NCT01342965|76067002|FG001|Overall Study|Withdrawal by Subject|9|||
42242665|NCT02629822|76067008|FG000|Base Study|Lost to Follow-up|2|||
42242666|NCT02629822|76067008|FG000|Base Study|Non-Compliance With Study Drug|1|||
42242667|NCT02629822|76067008|FG000|Extension Study|Adverse Event|1|||
42242668|NCT02629822|76067008|FG000|Extension Study|Lost to Follow-up|1|||
42242669|NCT03462706|76067017|FG000|Overall Study|Polyp was pedunculated|1|||
42242670|NCT03462706|76067018|FG001|Overall Study|Polyp was pedunculated|0|||
42302704|NCT02349633|76138071|FG003|Overall Study|Withdrawal by Subject|1|||
42302705|NCT02349633|76138072|FG004|Overall Study|Withdrawal by Subject|0|||
42302706|NCT02349633|76138073|FG005|Overall Study|Withdrawal by Subject|0|||
42302707|NCT02349633|76138074|FG006|Overall Study|Withdrawal by Subject|0|||
42242671|NCT03462706|76067019|FG002|Overall Study|Polyp was pedunculated|1|||
42242672|NCT03462706|76067020|FG003|Overall Study|Polyp was pedunculated|0|||
42242673|NCT03462706|76067017|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
42242674|NCT03462706|76067018|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
42242675|NCT03462706|76067019|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
42242676|NCT03462706|76067020|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
42242677|NCT02840253|76067030|FG000|Overall Study|Unsuccessful block|4|||
42242678|NCT02752074|76067036|FG000|Overall Study|Lost to Follow-up|1|||
42242679|NCT02752074|76067037|FG001|Overall Study|Lost to Follow-up|4|||
42242680|NCT02752074|76067036|FG000|Overall Study|Death|146|||
42242681|NCT02752074|76067037|FG001|Overall Study|Death|129|||
42242682|NCT02752074|76067036|FG000|Overall Study|Withdrawal by Subject|9|||
42242683|NCT02752074|76067037|FG001|Overall Study|Withdrawal by Subject|10|||
42242684|NCT02835495|76067045|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
42242685|NCT02835495|76067046|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
42242686|NCT02835495|76067045|FG000|Overall Study|Declined in-person follow-up visit|4|||
42242687|NCT02835495|76067046|FG001|Overall Study|Declined in-person follow-up visit|2|||
42242688|NCT02835339|76067056|FG000|Overall Study|Did not receive allocated intervention|13|||
42242689|NCT02835339|76067057|FG001|Overall Study|Did not receive allocated intervention|16|||
42242690|NCT02832063|76067065|FG000|Overall Study|Adverse Event|2|||
42242691|NCT02832063|76067066|FG001|Overall Study|Adverse Event|1|||
42242692|NCT02832063|76067065|FG000|Overall Study|Physician Decision|5|||
42242693|NCT02832063|76067066|FG001|Overall Study|Physician Decision|7|||
42242694|NCT02832063|76067065|FG000|Overall Study|Lost to Follow-up|15|||
42242695|NCT02832063|76067066|FG001|Overall Study|Lost to Follow-up|8|||
42242696|NCT02832063|76067065|FG000|Overall Study|Withdrawal by Subject|10|||
42242697|NCT02832063|76067066|FG001|Overall Study|Withdrawal by Subject|21|||
42242698|NCT02832063|76067065|FG000|Overall Study|Other|2|||
42242699|NCT02832063|76067066|FG001|Overall Study|Other|1|||
42242700|NCT04412707|76067085|FG000|Cycle 1|Death|0|||
42242701|NCT04412707|76067086|FG001|Cycle 1|Death|3|||
42242702|NCT04412707|76067085|FG000|Cycle 1|Disease progression|1|||
42242703|NCT04412707|76067086|FG001|Cycle 1|Disease progression|2|||
42242704|NCT04412707|76067085|FG000|Cycle 2|Death|0|||
42242705|NCT04412707|76067086|FG001|Cycle 2|Death|1|||
42242706|NCT04412707|76067085|FG000|Cycle 2|Disease progression|3|||
42242707|NCT04412707|76067086|FG001|Cycle 2|Disease progression|0|||
42242708|NCT04412707|76067085|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
42242709|NCT04412707|76067086|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
42242710|NCT04412707|76067085|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
42242711|NCT04412707|76067086|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
42242712|NCT04412707|76067085|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
42242713|NCT04412707|76067086|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
42242714|NCT04412707|76067085|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
42242715|NCT04412707|76067086|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
42242716|NCT01358721|76067105|FG000|Overall Study|Withdrawal by Subject|0|||
42242717|NCT01358721|76067106|FG001|Overall Study|Withdrawal by Subject|0|||
42242718|NCT01358721|76067107|FG002|Overall Study|Withdrawal by Subject|0|||
42242719|NCT01358721|76067108|FG003|Overall Study|Withdrawal by Subject|1|||
42242720|NCT01358721|76067105|FG000|Overall Study|Death|0|||
42242721|NCT01358721|76067106|FG001|Overall Study|Death|2|||
42242722|NCT01358721|76067107|FG002|Overall Study|Death|0|||
42242723|NCT01358721|76067108|FG003|Overall Study|Death|0|||
42242724|NCT01358721|76067105|FG000|Overall Study|Study Drug Toxicity|1|||
42242725|NCT01358721|76067106|FG001|Overall Study|Study Drug Toxicity|3|||
42242726|NCT01358721|76067107|FG002|Overall Study|Study Drug Toxicity|4|||
42242727|NCT01358721|76067108|FG003|Overall Study|Study Drug Toxicity|5|||
42242728|NCT01358721|76067105|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
42242729|NCT01358721|76067106|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
42242730|NCT01358721|76067107|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
42242731|NCT01358721|76067108|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
42242732|NCT01358721|76067105|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
42242733|NCT01358721|76067106|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
42242734|NCT01358721|76067107|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
42242735|NCT01358721|76067108|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
42242736|NCT01358721|76067105|FG000|Overall Study|Adverse Event related to study drug|1|||
42242737|NCT01358721|76067106|FG001|Overall Study|Adverse Event related to study drug|0|||
42242738|NCT01358721|76067107|FG002|Overall Study|Adverse Event related to study drug|0|||
42242739|NCT01358721|76067108|FG003|Overall Study|Adverse Event related to study drug|1|||
42242740|NCT01358721|76067105|FG000|Overall Study|Disease Progression|19|||
42242741|NCT01358721|76067106|FG001|Overall Study|Disease Progression|15|||
42242742|NCT01358721|76067107|FG002|Overall Study|Disease Progression|17|||
42242743|NCT01358721|76067108|FG003|Overall Study|Disease Progression|15|||
42242744|NCT01358721|76067105|FG000|Overall Study|Out of State/Unmet Criteria|0|||
42242745|NCT01358721|76067106|FG001|Overall Study|Out of State/Unmet Criteria|0|||
42242746|NCT01358721|76067107|FG002|Overall Study|Out of State/Unmet Criteria|1|||
42242747|NCT01358721|76067108|FG003|Overall Study|Out of State/Unmet Criteria|0|||
42242748|NCT01341639|76067120|FG000|Infant Series|Protocol Violation|1|||
42242749|NCT01341639|76067121|FG001|Infant Series|Protocol Violation|0|||
42242750|NCT01341639|76067120|FG000|Infant Series|Not Vaccinated|0|||
42242751|NCT01341639|76067121|FG001|Infant Series|Not Vaccinated|1|||
42242752|NCT01341639|76067120|FG000|Infant Series|Adverse Event|0|||
42242753|NCT01341639|76067121|FG001|Infant Series|Adverse Event|5|||
42242754|NCT01341639|76067120|FG000|Infant Series|Withdrawal by Subject|11|||
42242755|NCT01341639|76067121|FG001|Infant Series|Withdrawal by Subject|8|||
42242756|NCT01341639|76067120|FG000|Infant Series|Lost to Follow-up|0|||
42242757|NCT01341639|76067121|FG001|Infant Series|Lost to Follow-up|2|||
42242758|NCT01341639|76067120|FG000|Infant Series|Site 0048 Participants|17|||
42242759|NCT01341639|76067121|FG001|Infant Series|Site 0048 Participants|16|||
41989025|NCT01260922|75796519|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
41989026|NCT01260922|75796518|FG000|Second Intervention|Emesis|0|||
42242760|NCT01341639|76067120|FG000|Interim Period|Withdrawal by Subject|6|||
42242761|NCT01341639|76067121|FG001|Interim Period|Withdrawal by Subject|7|||
42242762|NCT01341639|76067120|FG000|Interim Period|Lost to Follow-up|2|||
42242763|NCT01341639|76067121|FG001|Interim Period|Lost to Follow-up|0|||
42242764|NCT01341639|76067120|FG000|Interim Period|Physician Decision|0|||
42242765|NCT01341639|76067121|FG001|Interim Period|Physician Decision|1|||
42242766|NCT01341639|76067120|FG000|Interim Period|Protocol Violation|0|||
42242767|NCT01341639|76067121|FG001|Interim Period|Protocol Violation|1|||
42242768|NCT01341639|76067120|FG000|Post-Treatment|Withdrawal by Subject|0|||
42242769|NCT01341639|76067121|FG001|Post-Treatment|Withdrawal by Subject|1|||
42242770|NCT01341639|76067120|FG000|Post-Treatment|Adverse Event|0|||
42242771|NCT01341639|76067121|FG001|Post-Treatment|Adverse Event|2|||
42242772|NCT02628028|76067135|FG000|Dosing Period|Withdrawal by Subject|0|||
42242773|NCT02628028|76067136|FG001|Dosing Period|Withdrawal by Subject|0|||
42242774|NCT02628028|76067137|FG002|Dosing Period|Withdrawal by Subject|1|||
42242775|NCT02628028|76067138|FG003|Dosing Period|Withdrawal by Subject|0|||
42242776|NCT02628028|76067139|FG004|Dosing Period|Withdrawal by Subject|2|||
42242777|NCT02628028|76067140|FG005|Dosing Period|Withdrawal by Subject|4|||
42242778|NCT02628028|76067141|FG006|Dosing Period|Withdrawal by Subject|1|||
42242779|NCT02628028|76067142|FG007|Dosing Period|Withdrawal by Subject|1|||
42242780|NCT02628028|76067135|FG000|Dosing Period|Adverse Event|0|||
42242781|NCT02628028|76067136|FG001|Dosing Period|Adverse Event|0|||
42242782|NCT02628028|76067137|FG002|Dosing Period|Adverse Event|0|||
42242783|NCT02628028|76067138|FG003|Dosing Period|Adverse Event|0|||
42242784|NCT02628028|76067139|FG004|Dosing Period|Adverse Event|2|||
42242785|NCT02628028|76067140|FG005|Dosing Period|Adverse Event|1|||
42242786|NCT02628028|76067141|FG006|Dosing Period|Adverse Event|3|||
42242787|NCT02628028|76067142|FG007|Dosing Period|Adverse Event|2|||
42242788|NCT02628028|76067135|FG000|Dosing Period|Death|0|||
42242789|NCT02628028|76067136|FG001|Dosing Period|Death|0|||
42242790|NCT02628028|76067137|FG002|Dosing Period|Death|0|||
42242791|NCT02628028|76067138|FG003|Dosing Period|Death|0|||
42242792|NCT02628028|76067139|FG004|Dosing Period|Death|0|||
42242793|NCT02628028|76067140|FG005|Dosing Period|Death|0|||
42242794|NCT02628028|76067141|FG006|Dosing Period|Death|0|||
42242795|NCT02628028|76067142|FG007|Dosing Period|Death|1|||
42242796|NCT02628028|76067135|FG000|Dosing Period|Lack of Efficacy|0|||
42302708|NCT02349633|76138075|FG007|Overall Study|Withdrawal by Subject|2|||
42302709|NCT02349633|76138076|FG008|Overall Study|Withdrawal by Subject|2|||
41989027|NCT01260922|75796519|FG001|Second Intervention|Emesis|2|||
42242797|NCT02628028|76067136|FG001|Dosing Period|Lack of Efficacy|0|||
42242798|NCT02628028|76067137|FG002|Dosing Period|Lack of Efficacy|0|||
42242799|NCT02628028|76067138|FG003|Dosing Period|Lack of Efficacy|0|||
42242800|NCT02628028|76067139|FG004|Dosing Period|Lack of Efficacy|3|||
42242801|NCT02628028|76067140|FG005|Dosing Period|Lack of Efficacy|0|||
42242802|NCT02628028|76067141|FG006|Dosing Period|Lack of Efficacy|1|||
42242803|NCT02628028|76067142|FG007|Dosing Period|Lack of Efficacy|0|||
42242804|NCT02628028|76067135|FG000|Dosing Period|Study Terminated by Sponsor|0|||
42302710|NCT02349633|76138077|FG009|Overall Study|Withdrawal by Subject|1|||
42242805|NCT02628028|76067136|FG001|Dosing Period|Study Terminated by Sponsor|0|||
42242806|NCT02628028|76067137|FG002|Dosing Period|Study Terminated by Sponsor|0|||
42242807|NCT02628028|76067138|FG003|Dosing Period|Study Terminated by Sponsor|0|||
42242808|NCT02628028|76067139|FG004|Dosing Period|Study Terminated by Sponsor|7|||
42242809|NCT02628028|76067140|FG005|Dosing Period|Study Terminated by Sponsor|6|||
42242810|NCT02628028|76067141|FG006|Dosing Period|Study Terminated by Sponsor|7|||
42242811|NCT02628028|76067142|FG007|Dosing Period|Study Terminated by Sponsor|7|||
42242812|NCT02628028|76067135|FG000|Dosing Period|Physician Decision|0|||
42242813|NCT02628028|76067136|FG001|Dosing Period|Physician Decision|0|||
42242814|NCT02628028|76067137|FG002|Dosing Period|Physician Decision|0|||
42242815|NCT02628028|76067138|FG003|Dosing Period|Physician Decision|0|||
42242816|NCT02628028|76067139|FG004|Dosing Period|Physician Decision|0|||
42242817|NCT02628028|76067140|FG005|Dosing Period|Physician Decision|1|||
42242818|NCT02628028|76067141|FG006|Dosing Period|Physician Decision|0|||
42242819|NCT02628028|76067142|FG007|Dosing Period|Physician Decision|0|||
42242820|NCT02628028|76067135|FG000|Dosing Period|Site Terminated by Sponsor|0|||
42242821|NCT02628028|76067136|FG001|Dosing Period|Site Terminated by Sponsor|0|||
42242822|NCT02628028|76067137|FG002|Dosing Period|Site Terminated by Sponsor|0|||
42242823|NCT02628028|76067138|FG003|Dosing Period|Site Terminated by Sponsor|0|||
42242824|NCT02628028|76067139|FG004|Dosing Period|Site Terminated by Sponsor|0|||
42242825|NCT02628028|76067140|FG005|Dosing Period|Site Terminated by Sponsor|1|||
42242826|NCT02628028|76067141|FG006|Dosing Period|Site Terminated by Sponsor|1|||
42242827|NCT02628028|76067142|FG007|Dosing Period|Site Terminated by Sponsor|0|||
42242828|NCT02628028|76067135|FG000|Dosing Period|Lost to Follow-up|0|||
42242829|NCT02628028|76067136|FG001|Dosing Period|Lost to Follow-up|0|||
42242830|NCT02628028|76067137|FG002|Dosing Period|Lost to Follow-up|0|||
42242831|NCT02628028|76067138|FG003|Dosing Period|Lost to Follow-up|0|||
42242832|NCT02628028|76067139|FG004|Dosing Period|Lost to Follow-up|0|||
42242833|NCT02628028|76067140|FG005|Dosing Period|Lost to Follow-up|0|||
42242834|NCT02628028|76067141|FG006|Dosing Period|Lost to Follow-up|1|||
42242835|NCT02628028|76067142|FG007|Dosing Period|Lost to Follow-up|0|||
42242836|NCT02628028|76067135|FG000|Dosing Period|Other|0|||
42242837|NCT02628028|76067136|FG001|Dosing Period|Other|0|||
42242838|NCT02628028|76067137|FG002|Dosing Period|Other|0|||
42242839|NCT02628028|76067138|FG003|Dosing Period|Other|0|||
42242840|NCT02628028|76067139|FG004|Dosing Period|Other|2|||
42242841|NCT02628028|76067140|FG005|Dosing Period|Other|1|||
42242842|NCT02628028|76067141|FG006|Dosing Period|Other|2|||
42242843|NCT02628028|76067142|FG007|Dosing Period|Other|4|||
42242844|NCT02628028|76067135|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
42242845|NCT02628028|76067136|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
42242846|NCT02628028|76067137|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
42242847|NCT02628028|76067138|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
42242848|NCT02628028|76067139|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
42242849|NCT02628028|76067140|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
42242850|NCT02628028|76067141|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
42242851|NCT02628028|76067142|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
42242852|NCT02628028|76067135|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
42242853|NCT02628028|76067136|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
42242854|NCT02628028|76067137|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
41989028|NCT01233817|75796525|FG000|Overall Study|Lost to Follow-up|1|||
41989029|NCT01233817|75796525|FG000|Overall Study|Withdrawal by Subject|2|||
41989030|NCT01233232|75796532|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
41989031|NCT01233232|75796533|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
41989032|NCT01233232|75796534|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
41989033|NCT01233076|75796544|FG000|Period 2, One Week|Lost to Follow-up|1|||
41989034|NCT01233076|75796545|FG001|Period 2, One Week|Lost to Follow-up|0|||
42242855|NCT02628028|76067138|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
42242856|NCT02628028|76067139|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
42242857|NCT02628028|76067140|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
42242858|NCT02628028|76067141|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
42242859|NCT02628028|76067142|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
42242860|NCT02628028|76067135|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
42242861|NCT02628028|76067136|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
42242862|NCT02628028|76067137|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
42242863|NCT02628028|76067138|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
42242864|NCT02628028|76067139|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
42242865|NCT02628028|76067140|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
42242866|NCT02628028|76067141|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
42242867|NCT02628028|76067142|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
42242868|NCT02628028|76067135|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
42242869|NCT02628028|76067136|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
42242870|NCT02628028|76067137|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
42242871|NCT02628028|76067138|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
42242872|NCT02628028|76067139|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
42242873|NCT02628028|76067140|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
42242874|NCT02628028|76067141|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
42242875|NCT02628028|76067142|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
42242876|NCT02628028|76067135|FG000|Long-term Extension (LTE) Period|Other|0|||
42242877|NCT02628028|76067136|FG001|Long-term Extension (LTE) Period|Other|0|||
42242878|NCT02628028|76067137|FG002|Long-term Extension (LTE) Period|Other|0|||
42242879|NCT02628028|76067138|FG003|Long-term Extension (LTE) Period|Other|0|||
42242880|NCT02628028|76067139|FG004|Long-term Extension (LTE) Period|Other|0|||
42242881|NCT02628028|76067140|FG005|Long-term Extension (LTE) Period|Other|3|||
42242882|NCT02628028|76067141|FG006|Long-term Extension (LTE) Period|Other|4|||
42242883|NCT02628028|76067142|FG007|Long-term Extension (LTE) Period|Other|3|||
42242884|NCT03977701|76067174|FG000|Overall Study|COVID-19 pandemic|0|||
42242885|NCT03977701|76067175|FG001|Overall Study|COVID-19 pandemic|0|||
42242886|NCT03977701|76067176|FG002|Overall Study|COVID-19 pandemic|0|||
42242887|NCT03977701|76067177|FG003|Overall Study|COVID-19 pandemic|0|||
42242888|NCT03977701|76067178|FG004|Overall Study|COVID-19 pandemic|0|||
42242889|NCT03977701|76067179|FG005|Overall Study|COVID-19 pandemic|1|||
42242890|NCT03977701|76067180|FG006|Overall Study|COVID-19 pandemic|0|||
42242891|NCT03977701|76067181|FG007|Overall Study|COVID-19 pandemic|1|||
42242892|NCT03977701|76067182|FG008|Overall Study|COVID-19 pandemic|0|||
42242893|NCT03977701|76067183|FG009|Overall Study|COVID-19 pandemic|0|||
42242894|NCT02814526|76067222|FG000|Overall Study|Adverse Event|4|||
42242895|NCT02814526|76067223|FG001|Overall Study|Adverse Event|3|||
42242896|NCT02814526|76067222|FG000|Overall Study|Death|1|||
42242897|NCT02814526|76067223|FG001|Overall Study|Death|1|||
42242898|NCT02814526|76067222|FG000|Overall Study|Lost to Follow-up|3|||
42242899|NCT02814526|76067223|FG001|Overall Study|Lost to Follow-up|4|||
42242900|NCT02814526|76067222|FG000|Overall Study|non site physician decision|1|||
42242901|NCT02814526|76067223|FG001|Overall Study|non site physician decision|0|||
42242902|NCT02814526|76067222|FG000|Overall Study|participant noncompliance|1|||
42242903|NCT02814526|76067223|FG001|Overall Study|participant noncompliance|1|||
42242904|NCT02814526|76067222|FG000|Overall Study|Withdrawal by Subject|20|||
42242905|NCT02814526|76067223|FG001|Overall Study|Withdrawal by Subject|14|||
42242906|NCT02814526|76067222|FG000|Overall Study|safety risk|2|||
42242907|NCT02814526|76067223|FG001|Overall Study|safety risk|1|||
42242908|NCT02814526|76067222|FG000|Overall Study|early termination-study terminated|1|||
42242909|NCT02814526|76067223|FG001|Overall Study|early termination-study terminated|2|||
42242910|NCT02814526|76067222|FG000|Overall Study|Other|0|||
42242911|NCT02814526|76067223|FG001|Overall Study|Other|4|||
42242912|NCT02329834|76067231|FG000|Overall Study|Physician Decision|1|||
42242913|NCT02329834|76067232|FG001|Overall Study|Physician Decision|0|||
42242914|NCT01340937|76067243|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
42242915|NCT01340937|76067244|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
42242916|NCT01340937|76067245|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
42242917|NCT01340937|76067246|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
42242918|NCT01340937|76067243|FG000|Period 1: Infant Series|Adverse Event|0|||
42242919|NCT01340937|76067244|FG001|Period 1: Infant Series|Adverse Event|1|||
42242920|NCT01340937|76067245|FG002|Period 1: Infant Series|Adverse Event|4|||
41989035|NCT01212094|75796554|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
41989036|NCT01212094|75796555|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
41989037|NCT01212094|75796556|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
41989038|NCT01212094|75796554|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
41989039|NCT01212094|75796555|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
41989040|NCT01212094|75796556|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
41989041|NCT01212094|75796554|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
41989042|NCT01212094|75796555|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
41989043|NCT01212094|75796556|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
41989044|NCT01212094|75796554|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
41989045|NCT01212094|75796555|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
41989046|NCT01212094|75796556|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
41989047|NCT01212094|75796554|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
41989048|NCT01212094|75796555|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
41989049|NCT01212094|75796556|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
41989050|NCT01212094|75796554|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
41989051|NCT01212094|75796555|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
41989052|NCT01212094|75796556|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
41989053|NCT01232569|75796565|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
41989054|NCT01232569|75796566|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
41989055|NCT01232569|75796567|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
41989056|NCT01232569|75796568|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
41989057|NCT01232569|75796565|FG000|Double-blind Treatment Period|Escape|2|||
41989058|NCT01232569|75796566|FG001|Double-blind Treatment Period|Escape|2|||
41989059|NCT01232569|75796567|FG002|Double-blind Treatment Period|Escape|0|||
41989060|NCT01232569|75796568|FG003|Double-blind Treatment Period|Escape|0|||
41989061|NCT01232569|75796565|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
41989062|NCT01232569|75796566|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
41989063|NCT01232569|75796567|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
41989064|NCT01232569|75796568|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
41989065|NCT01232569|75796565|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
41989066|NCT01232569|75796566|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
41989067|NCT01232569|75796567|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
41989068|NCT01232569|75796568|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
41989069|NCT01232569|75796565|FG000|Double-blind Treatment Period|Physician Decision|1|||
41989070|NCT01232569|75796566|FG001|Double-blind Treatment Period|Physician Decision|0|||
41989071|NCT01232569|75796567|FG002|Double-blind Treatment Period|Physician Decision|0|||
41989072|NCT01232569|75796568|FG003|Double-blind Treatment Period|Physician Decision|0|||
42242921|NCT01340937|76067246|FG003|Period 1: Infant Series|Adverse Event|0|||
42242922|NCT01340937|76067243|FG000|Period 1: Infant Series|Death|2|||
42242923|NCT01340937|76067244|FG001|Period 1: Infant Series|Death|0|||
42242924|NCT01340937|76067245|FG002|Period 1: Infant Series|Death|2|||
42242925|NCT01340937|76067246|FG003|Period 1: Infant Series|Death|0|||
42242926|NCT01340937|76067243|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
42242927|NCT01340937|76067244|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
42242928|NCT01340937|76067245|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
42242929|NCT01340937|76067246|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
42242930|NCT01340937|76067243|FG000|Period 1: Infant Series|Physician Decision|2|||
42242931|NCT01340937|76067244|FG001|Period 1: Infant Series|Physician Decision|3|||
42242932|NCT01340937|76067245|FG002|Period 1: Infant Series|Physician Decision|1|||
42242933|NCT01340937|76067246|FG003|Period 1: Infant Series|Physician Decision|0|||
42242934|NCT01340937|76067243|FG000|Period 1: Infant Series|Protocol Violation|1|||
42242935|NCT01340937|76067244|FG001|Period 1: Infant Series|Protocol Violation|4|||
42242936|NCT01340937|76067245|FG002|Period 1: Infant Series|Protocol Violation|4|||
42242937|NCT01340937|76067246|FG003|Period 1: Infant Series|Protocol Violation|3|||
42242938|NCT01340937|76067243|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
42242939|NCT01340937|76067244|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
42242940|NCT01340937|76067245|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
42242941|NCT01340937|76067246|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
42242942|NCT01340937|76067243|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
42242943|NCT01340937|76067244|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
41989073|NCT01232569|75796565|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
41989074|NCT01232569|75796566|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
41989075|NCT01232569|75796567|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
41989076|NCT01232569|75796568|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
41989077|NCT01232569|75796565|FG000|Double-blind Treatment Period|Death|2|||
41989078|NCT01232569|75796566|FG001|Double-blind Treatment Period|Death|0|||
42242944|NCT01340937|76067245|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
42242945|NCT01340937|76067246|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
42242946|NCT01340937|76067243|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
42242947|NCT01340937|76067244|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
42242948|NCT01340937|76067245|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
42242949|NCT01340937|76067246|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
42242950|NCT01340937|76067243|FG000|Period 2: Interim Period|Adverse Event|1|||
42242951|NCT01340937|76067244|FG001|Period 2: Interim Period|Adverse Event|0|||
42242952|NCT01340937|76067245|FG002|Period 2: Interim Period|Adverse Event|1|||
42242953|NCT01340937|76067246|FG003|Period 2: Interim Period|Adverse Event|0|||
42242954|NCT01340937|76067243|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
42242955|NCT01340937|76067244|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
42242956|NCT01340937|76067245|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
42242957|NCT01340937|76067246|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
42242958|NCT01340937|76067243|FG000|Period 2: Interim Period|Physician Decision|0|||
42242959|NCT01340937|76067244|FG001|Period 2: Interim Period|Physician Decision|1|||
42242960|NCT01340937|76067245|FG002|Period 2: Interim Period|Physician Decision|1|||
42242961|NCT01340937|76067246|FG003|Period 2: Interim Period|Physician Decision|0|||
42242962|NCT01340937|76067243|FG000|Period 2: Interim Period|Protocol Violation|5|||
41989079|NCT01232569|75796567|FG002|Double-blind Treatment Period|Death|0|||
41989080|NCT01232569|75796568|FG003|Double-blind Treatment Period|Death|0|||
41989081|NCT01211665|75796579|FG000|Overall Study|Withdrawal by Subject|1|||
41989082|NCT01211665|75796580|FG001|Overall Study|Withdrawal by Subject|0|||
41989083|NCT01211665|75796579|FG000|Overall Study|Death|1|||
41989084|NCT01211665|75796580|FG001|Overall Study|Death|0|||
41989085|NCT01232491|75796588|FG000|Overall Study|Adverse Event|13|||
41989086|NCT01232491|75796589|FG001|Overall Study|Adverse Event|8|||
41989087|NCT01232491|75796588|FG000|Overall Study|Lack of Efficacy|1|||
42242963|NCT01340937|76067244|FG001|Period 2: Interim Period|Protocol Violation|3|||
42242964|NCT01340937|76067245|FG002|Period 2: Interim Period|Protocol Violation|6|||
42242965|NCT01340937|76067246|FG003|Period 2: Interim Period|Protocol Violation|3|||
41989088|NCT01232491|75796589|FG001|Overall Study|Lack of Efficacy|5|||
41989089|NCT01232491|75796588|FG000|Overall Study|Protocol Violation|13|||
41989090|NCT01232491|75796589|FG001|Overall Study|Protocol Violation|11|||
41989091|NCT01232491|75796588|FG000|Overall Study|Withdrawal Criteria|12|||
42242966|NCT01340937|76067243|FG000|Period 2: Interim Period|Technical problems|4|||
42242967|NCT01340937|76067244|FG001|Period 2: Interim Period|Technical problems|4|||
42242968|NCT01340937|76067245|FG002|Period 2: Interim Period|Technical problems|6|||
42242969|NCT01340937|76067246|FG003|Period 2: Interim Period|Technical problems|3|||
42242970|NCT01340937|76067243|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
42242971|NCT01340937|76067244|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
42242972|NCT01340937|76067245|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
42242973|NCT01340937|76067246|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
42242974|NCT01340937|76067243|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
42242975|NCT01340937|76067244|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
42242976|NCT01340937|76067245|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
42242977|NCT01340937|76067246|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
42242978|NCT01340937|76067243|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
42242979|NCT01340937|76067244|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
42242980|NCT01340937|76067245|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
42242981|NCT01340937|76067246|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
42242982|NCT01340937|76067243|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
42302711|NCT02349633|76138078|FG010|Overall Study|Withdrawal by Subject|0|||
42302712|NCT02349633|76138079|FG011|Overall Study|Withdrawal by Subject|0|||
41989092|NCT01232491|75796589|FG001|Overall Study|Withdrawal Criteria|21|||
41989093|NCT01232491|75796588|FG000|Overall Study|Other|21|||
41989094|NCT01232491|75796589|FG001|Overall Study|Other|18|||
41989095|NCT01232452|75796597|FG000|Overall Study|Adverse Event|17|||
41989096|NCT01232452|75796598|FG001|Overall Study|Adverse Event|15|||
41989097|NCT01232452|75796597|FG000|Overall Study|Withdrawal by Subject|11|||
41989098|NCT01232452|75796598|FG001|Overall Study|Withdrawal by Subject|8|||
41989099|NCT01232452|75796597|FG000|Overall Study|Physician Decision|8|||
41989100|NCT01232452|75796598|FG001|Overall Study|Physician Decision|12|||
41989101|NCT01232452|75796597|FG000|Overall Study|Protocol entry criterion not met|0|||
41989102|NCT01232452|75796598|FG001|Overall Study|Protocol entry criterion not met|2|||
41989103|NCT01232452|75796597|FG000|Overall Study|Sponsor Decision|3|||
41989104|NCT01232452|75796598|FG001|Overall Study|Sponsor Decision|1|||
42242983|NCT01340937|76067244|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
42242984|NCT01340937|76067245|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
42242985|NCT01340937|76067246|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
41989105|NCT01232452|75796597|FG000|Overall Study|Protocol Violation|0|||
41989106|NCT01232452|75796598|FG001|Overall Study|Protocol Violation|1|||
41989107|NCT01211197|75796604|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
41989108|NCT01211197|75796605|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
41989109|NCT01211197|75796606|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
41989110|NCT01211197|75796607|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42242986|NCT03028129|76067264|FG000|Overall Study|Adverse Event|13|||
42242987|NCT03028129|76067265|FG001|Overall Study|Adverse Event|2|||
42242988|NCT03028129|76067264|FG000|Overall Study|Lost to Follow-up|50|||
42242989|NCT03028129|76067265|FG001|Overall Study|Lost to Follow-up|38|||
42242990|NCT03028129|76067264|FG000|Overall Study|Physician Decision|0|||
42242991|NCT03028129|76067265|FG001|Overall Study|Physician Decision|1|||
42242992|NCT03028129|76067264|FG000|Overall Study|Protocol Violation|1|||
42242993|NCT03028129|76067265|FG001|Overall Study|Protocol Violation|1|||
42242994|NCT03028129|76067264|FG000|Overall Study|Withdrawal by Subject|62|||
42242995|NCT03028129|76067265|FG001|Overall Study|Withdrawal by Subject|45|||
42242996|NCT03026257|76067277|FG000|Overall Study|Adverse Event|3|||
42242997|NCT03026257|76067278|FG001|Overall Study|Adverse Event|0|||
42242998|NCT03026257|76067279|FG002|Overall Study|Adverse Event|0|||
42242999|NCT03026257|76067280|FG003|Overall Study|Adverse Event|0|||
42243000|NCT03026257|76067281|FG004|Overall Study|Adverse Event|0|||
42243001|NCT03026257|76067282|FG005|Overall Study|Adverse Event|0|||
42243002|NCT03026257|76067277|FG000|Overall Study|Lost to Follow-up|1|||
42243003|NCT03026257|76067278|FG001|Overall Study|Lost to Follow-up|0|||
42243004|NCT03026257|76067279|FG002|Overall Study|Lost to Follow-up|0|||
42132030|NCT00510068|75942844|FG001|Double-blind Period|Lost to Follow-up|0|||
42243005|NCT03026257|76067280|FG003|Overall Study|Lost to Follow-up|0|||
42243006|NCT03026257|76067281|FG004|Overall Study|Lost to Follow-up|0|||
42243007|NCT03026257|76067282|FG005|Overall Study|Lost to Follow-up|0|||
42243008|NCT03026257|76067277|FG000|Overall Study|Protocol Violation|1|||
42243009|NCT03026257|76067278|FG001|Overall Study|Protocol Violation|0|||
42243010|NCT03026257|76067279|FG002|Overall Study|Protocol Violation|0|||
42243011|NCT03026257|76067280|FG003|Overall Study|Protocol Violation|1|||
42243012|NCT03026257|76067281|FG004|Overall Study|Protocol Violation|1|||
42243013|NCT03026257|76067282|FG005|Overall Study|Protocol Violation|0|||
41989111|NCT01211197|75796608|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42243014|NCT03026257|76067277|FG000|Overall Study|Withdrawal by Subject|1|||
42243015|NCT03026257|76067278|FG001|Overall Study|Withdrawal by Subject|1|||
41989112|NCT01211197|75796609|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
41989113|NCT01211197|75796604|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
41989114|NCT01211197|75796605|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
41989115|NCT01211197|75796606|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
41989116|NCT01211197|75796607|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
41989117|NCT01211197|75796608|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
41989118|NCT01211197|75796609|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
41989119|NCT01232296|75796619|FG000|Overall Study|Adverse Event|24|||
41989120|NCT01232296|75796620|FG001|Overall Study|Adverse Event|12|||
41989121|NCT01232296|75796619|FG000|Overall Study|Physician Decision|1|||
41989122|NCT01232296|75796620|FG001|Overall Study|Physician Decision|1|||
41989123|NCT01232296|75796619|FG000|Overall Study|Progressive disease|43|||
41989124|NCT01232296|75796620|FG001|Overall Study|Progressive disease|61|||
41989125|NCT01232296|75796619|FG000|Overall Study|Study terminated by sponsor|0|||
41989126|NCT01232296|75796620|FG001|Overall Study|Study terminated by sponsor|1|||
41989127|NCT01232296|75796619|FG000|Overall Study|Technical problems|3|||
41989128|NCT01232296|75796620|FG001|Overall Study|Technical problems|0|||
41989129|NCT01232296|75796619|FG000|Overall Study|Subject/guardian decision|10|||
41989130|NCT01232296|75796620|FG001|Overall Study|Subject/guardian decision|2|||
41989131|NCT01232296|75796619|FG000|Overall Study|Death|1|||
42132031|NCT00510068|75942843|FG000|Double-blind Period|Protocol Violation|6|||
42132032|NCT00510068|75942844|FG001|Double-blind Period|Protocol Violation|0|||
42243016|NCT03026257|76067279|FG002|Overall Study|Withdrawal by Subject|0|||
42243017|NCT03026257|76067280|FG003|Overall Study|Withdrawal by Subject|0|||
42243018|NCT03026257|76067281|FG004|Overall Study|Withdrawal by Subject|0|||
42243019|NCT03026257|76067282|FG005|Overall Study|Withdrawal by Subject|0|||
42243020|NCT01670188|76067298|FG000|Overall Study|Death|0|||
42243021|NCT01670188|76067299|FG001|Overall Study|Death|1|||
42243022|NCT01933048|76067307|FG000|Overall Study|Lost to Follow-up|15|||
42243023|NCT01933048|76067308|FG001|Overall Study|Lost to Follow-up|18|||
42243024|NCT01933048|76067307|FG000|Overall Study|personal reasons|1|||
42243025|NCT01933048|76067308|FG001|Overall Study|personal reasons|1|||
42243026|NCT01933048|76067307|FG000|Overall Study|Protocol Violation|7|||
42243027|NCT01933048|76067308|FG001|Overall Study|Protocol Violation|8|||
42243028|NCT01933048|76067307|FG000|Overall Study|Physician Decision|1|||
42243029|NCT01933048|76067308|FG001|Overall Study|Physician Decision|0|||
42243030|NCT01933048|76067307|FG000|Overall Study|unknown reasons|1|||
42243031|NCT01933048|76067308|FG001|Overall Study|unknown reasons|1|||
42243032|NCT02751450|76067319|FG000|Overall Study|Adverse Event|1|||
42243033|NCT02751450|76067320|FG001|Overall Study|Adverse Event|0|||
42243034|NCT01358175|76067331|FG000|Overall Study|Death|1|||
42243035|NCT01358175|76067332|FG001|Overall Study|Death|0|||
42243036|NCT01358175|76067333|FG002|Overall Study|Death|1|||
42243037|NCT01358175|76067331|FG000|Overall Study|Withdrawal by Subject|9|||
42243038|NCT01358175|76067332|FG001|Overall Study|Withdrawal by Subject|5|||
42243039|NCT01358175|76067333|FG002|Overall Study|Withdrawal by Subject|10|||
41989132|NCT01232296|75796620|FG001|Overall Study|Death|6|||
41989133|NCT01231984|75796628|FG000|Study Period 1|Withdrawal by Subject|0|||
41989134|NCT01231984|75796629|FG001|Study Period 1|Withdrawal by Subject|0|||
42243040|NCT01358175|76067331|FG000|Overall Study|Technical issues|0|||
42243041|NCT01358175|76067332|FG001|Overall Study|Technical issues|1|||
41989135|NCT01231984|75796630|FG002|Study Period 1|Withdrawal by Subject|0|||
41989136|NCT01231984|75796631|FG003|Study Period 1|Withdrawal by Subject|1|||
42243042|NCT01358175|76067333|FG002|Overall Study|Technical issues|0|||
42243043|NCT01358175|76067331|FG000|Overall Study|Pregnancy|0|||
42243044|NCT01358175|76067332|FG001|Overall Study|Pregnancy|1|||
42243045|NCT01358175|76067333|FG002|Overall Study|Pregnancy|0|||
42243046|NCT01358175|76067331|FG000|Overall Study|Physician Decision|1|||
42243047|NCT01358175|76067332|FG001|Overall Study|Physician Decision|0|||
42243048|NCT01358175|76067333|FG002|Overall Study|Physician Decision|0|||
42243049|NCT01358175|76067331|FG000|Overall Study|Non Compliance with Study Treatment|0|||
42243050|NCT01358175|76067332|FG001|Overall Study|Non Compliance with Study Treatment|1|||
42243051|NCT01358175|76067333|FG002|Overall Study|Non Compliance with Study Treatment|1|||
42243052|NCT01358175|76067331|FG000|Overall Study|Lost to Follow-up|1|||
42243053|NCT01358175|76067332|FG001|Overall Study|Lost to Follow-up|1|||
42243054|NCT01358175|76067333|FG002|Overall Study|Lost to Follow-up|3|||
42243055|NCT01358175|76067331|FG000|Overall Study|Lack of Efficacy|3|||
42243056|NCT01358175|76067332|FG001|Overall Study|Lack of Efficacy|8|||
42243057|NCT01358175|76067333|FG002|Overall Study|Lack of Efficacy|6|||
42243058|NCT01358175|76067331|FG000|Overall Study|Adverse Event|6|||
42243059|NCT01358175|76067332|FG001|Overall Study|Adverse Event|11|||
42243060|NCT01358175|76067333|FG002|Overall Study|Adverse Event|11|||
42243061|NCT04116229|76067347|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
42243062|NCT04116229|76067348|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
42243063|NCT04116229|76067347|FG000|Overall Study|Scheduling not possible.|0|||
42243064|NCT04116229|76067348|FG001|Overall Study|Scheduling not possible.|1|||
42243065|NCT02210832|76067357|FG000|Overall Study|Pregnancy termination .|3|||
42243066|NCT02210832|76067358|FG001|Overall Study|Pregnancy termination .|4|||
42243067|NCT02210832|76067359|FG002|Overall Study|Pregnancy termination .|1|||
41989137|NCT01231984|75796628|FG000|Study Period 1|Lost to Follow-up|1|||
41989138|NCT01231984|75796629|FG001|Study Period 1|Lost to Follow-up|1|||
41989139|NCT01231984|75796630|FG002|Study Period 1|Lost to Follow-up|1|||
41989140|NCT01231984|75796631|FG003|Study Period 1|Lost to Follow-up|0|||
41989141|NCT01231984|75796628|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
41989142|NCT01231984|75796629|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
41989143|NCT01231984|75796630|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
42243068|NCT02210832|76067357|FG000|Overall Study|Lost to Follow-up|26|||
42243069|NCT02210832|76067358|FG001|Overall Study|Lost to Follow-up|32|||
42243070|NCT02210832|76067359|FG002|Overall Study|Lost to Follow-up|17|||
42243071|NCT02833077|76067372|FG000|Overall Study|Adverse Event|1|||
42243072|NCT02833077|76067373|FG001|Overall Study|Adverse Event|2|||
42243073|NCT02833077|76067372|FG000|Overall Study|Lost to Follow-up|10|||
42243074|NCT02833077|76067373|FG001|Overall Study|Lost to Follow-up|1|||
42243075|NCT02833077|76067372|FG000|Overall Study|Personal Reasons|6|||
42243076|NCT02833077|76067373|FG001|Overall Study|Personal Reasons|4|||
42243077|NCT02833077|76067372|FG000|Overall Study|Protocol Deviation|0|||
42243078|NCT02833077|76067373|FG001|Overall Study|Protocol Deviation|1|||
42243079|NCT01355679|76067380|FG000|Overall Study|benign tumor types found at biopsy|2|||
42243080|NCT02832375|76067387|FG000|Overall Study|Lost to Follow-up|1|||
42243081|NCT02832375|76067388|FG001|Overall Study|Lost to Follow-up|0|||
42243082|NCT02832375|76067387|FG000|Overall Study|Withdrawal of Consent|1|||
42243083|NCT02832375|76067388|FG001|Overall Study|Withdrawal of Consent|0|||
42243084|NCT02925403|76067397|FG000|Overall Study|Lost to Follow-up|0|||
42243085|NCT02925403|76067398|FG001|Overall Study|Lost to Follow-up|1|||
42243086|NCT02626780|76067404|FG000|Overall Study|Withdrawal by Subject|3|||
42243087|NCT02831673|76067419|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
42243088|NCT02831673|76067420|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
42243089|NCT02831673|76067421|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
42243090|NCT02831673|76067422|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
42243091|NCT02831673|76067423|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
42243092|NCT02831673|76067419|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
41989144|NCT01231984|75796631|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
41989145|NCT01231984|75796628|FG000|Study Period 1|Screen Failure|0|||
41989146|NCT01231984|75796629|FG001|Study Period 1|Screen Failure|0|||
42032764|NCT01077804|75841044|FG000|Overall Study|Unreachable|102|||
41989147|NCT01231984|75796630|FG002|Study Period 1|Screen Failure|0|||
41989148|NCT01231984|75796631|FG003|Study Period 1|Screen Failure|1|||
42032765|NCT01077804|75841044|FG000|Overall Study|Refused to continue|79|||
42032766|NCT01077804|75841044|FG000|Overall Study|Other|18|||
42032767|NCT01075074|75841068|FG000|Overall Study|Surgeon changed to open incisional case|1|||
42032768|NCT01075074|75841069|FG001|Overall Study|Surgeon changed to open incisional case|2|||
42243093|NCT02831673|76067420|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
42243094|NCT02831673|76067421|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
42243095|NCT02831673|76067422|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
42243096|NCT02831673|76067423|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
42032769|NCT01075074|75841070|FG002|Overall Study|Surgeon changed to open incisional case|2|||
42032770|NCT00866281|75841084|FG000|Overall Study|Adverse Event|1|||
41989149|NCT01231984|75796628|FG000|Study Period 1|Non-compliance with study requirements|5|||
41989150|NCT01231984|75796629|FG001|Study Period 1|Non-compliance with study requirements|0|||
41989151|NCT01231984|75796630|FG002|Study Period 1|Non-compliance with study requirements|2|||
41989152|NCT01231984|75796631|FG003|Study Period 1|Non-compliance with study requirements|1|||
41989153|NCT01231984|75796628|FG000|Study Period 1|Protocol Violation|3|||
41989154|NCT01231984|75796629|FG001|Study Period 1|Protocol Violation|4|||
41989155|NCT01231984|75796630|FG002|Study Period 1|Protocol Violation|2|||
41989156|NCT01231984|75796631|FG003|Study Period 1|Protocol Violation|3|||
41989157|NCT01231984|75796628|FG000|Study Period 1|Adverse Event|1|||
41989158|NCT01231984|75796629|FG001|Study Period 1|Adverse Event|0|||
41989159|NCT01231984|75796630|FG002|Study Period 1|Adverse Event|0|||
41989160|NCT01231984|75796631|FG003|Study Period 1|Adverse Event|0|||
41989161|NCT01231984|75796628|FG000|Study Period 1|Other|0|||
41989162|NCT01231984|75796629|FG001|Study Period 1|Other|0|||
41989163|NCT01231984|75796630|FG002|Study Period 1|Other|0|||
41989164|NCT01231984|75796631|FG003|Study Period 1|Other|1|||
41989165|NCT01231984|75796628|FG000|Study Period 2|Withdrawal by Subject|1|||
41989166|NCT01231984|75796629|FG001|Study Period 2|Withdrawal by Subject|1|||
41989167|NCT01231984|75796630|FG002|Study Period 2|Withdrawal by Subject|0|||
41989168|NCT01231984|75796631|FG003|Study Period 2|Withdrawal by Subject|0|||
41989169|NCT01231984|75796628|FG000|Study Period 2|Lost to Follow-up|1|||
41989170|NCT01231984|75796629|FG001|Study Period 2|Lost to Follow-up|0|||
41989171|NCT01231984|75796630|FG002|Study Period 2|Lost to Follow-up|0|||
41989172|NCT01231984|75796631|FG003|Study Period 2|Lost to Follow-up|3|||
41989173|NCT01231984|75796628|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
41989174|NCT01231984|75796629|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
41989175|NCT01231984|75796630|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
41989176|NCT01231984|75796631|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
41989177|NCT01210807|75796651|FG000|Overall Study|Lost to Follow-up|1|||
41989178|NCT01210807|75796652|FG001|Overall Study|Lost to Follow-up|2|||
41989179|NCT01210807|75796651|FG000|Overall Study|Not implanted bilaterally|2|||
41989180|NCT01210807|75796652|FG001|Overall Study|Not implanted bilaterally|1|||
41989181|NCT01231555|75796661|FG000|Overall Study|Study terminated|8|||
41989182|NCT01231555|75796662|FG001|Overall Study|Study terminated|5|||
41989183|NCT01231555|75796663|FG002|Overall Study|Study terminated|8|||
41989184|NCT01231555|75796661|FG000|Overall Study|Withdrawal by Subject|0|||
41989185|NCT01231555|75796662|FG001|Overall Study|Withdrawal by Subject|2|||
41989186|NCT01231555|75796663|FG002|Overall Study|Withdrawal by Subject|0|||
41989187|NCT01210690|75796671|FG000|Overall Study|Adverse Event|7|||
41989188|NCT01210690|75796671|FG000|Overall Study|Lack of Efficacy|12|||
41989189|NCT01210690|75796671|FG000|Overall Study|Lost to Follow-up|3|||
41989190|NCT01210690|75796671|FG000|Overall Study|Disease Remission|1|||
41989191|NCT01210690|75796671|FG000|Overall Study|Withdrawal by Subject|1|||
41989192|NCT01210690|75796671|FG000|Overall Study|Patient refused to swallow|1|||
41989193|NCT01210690|75796671|FG000|Overall Study|Patient could not take glucose|1|||
41989194|NCT01210651|75796678|FG000|Overall Study|Lost to Follow-up|1|||
41989195|NCT01210651|75796679|FG001|Overall Study|Lost to Follow-up|1|||
41989196|NCT01210651|75796678|FG000|Overall Study|schedule conflicts|1|||
41989197|NCT01210651|75796679|FG001|Overall Study|schedule conflicts|5|||
41989198|NCT01210651|75796678|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
41989199|NCT01210651|75796679|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
41989200|NCT01210651|75796678|FG000|Overall Study|Withdrawal by Subject|1|||
41989201|NCT01210651|75796679|FG001|Overall Study|Withdrawal by Subject|1|||
41989202|NCT01210651|75796678|FG000|Overall Study|Injury outside study|2|||
41989203|NCT01210651|75796679|FG001|Overall Study|Injury outside study|0|||
41989204|NCT01210495|75796758|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
41989205|NCT01210495|75796759|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
41989206|NCT01210495|75796760|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
41989207|NCT01210495|75796761|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
41989208|NCT01210495|75796758|FG000|Overall Study|Death|14|||
41989209|NCT01210495|75796759|FG001|Overall Study|Death|7|||
41989210|NCT01210495|75796760|FG002|Overall Study|Death|112|||
41989211|NCT01210495|75796761|FG003|Overall Study|Death|54|||
41989212|NCT01210495|75796758|FG000|Overall Study|Study Terminated by Sponsor|0|||
41989213|NCT01210495|75796759|FG001|Overall Study|Study Terminated by Sponsor|0|||
41989214|NCT01210495|75796760|FG002|Overall Study|Study Terminated by Sponsor|4|||
41989215|NCT01210495|75796761|FG003|Overall Study|Study Terminated by Sponsor|11|||
41989216|NCT01210495|75796758|FG000|Overall Study|Lost to Follow-up|0|||
41989217|NCT01210495|75796759|FG001|Overall Study|Lost to Follow-up|0|||
41989218|NCT01210495|75796760|FG002|Overall Study|Lost to Follow-up|1|||
41989219|NCT01210495|75796761|FG003|Overall Study|Lost to Follow-up|1|||
41989220|NCT01210495|75796758|FG000|Overall Study|Other unspecified|0|||
41989221|NCT01210495|75796759|FG001|Overall Study|Other unspecified|0|||
41989222|NCT01210495|75796760|FG002|Overall Study|Other unspecified|6|||
41989223|NCT01210495|75796761|FG003|Overall Study|Other unspecified|0|||
42032771|NCT00866281|75841085|FG001|Overall Study|Adverse Event|0|||
42032772|NCT00866281|75841084|FG000|Overall Study|Withdrawal by participants|3|||
42032773|NCT00866281|75841085|FG001|Overall Study|Withdrawal by participants|0|||
42032774|NCT00866281|75841084|FG000|Overall Study|Disease progression|3|||
42032775|NCT00866281|75841085|FG001|Overall Study|Disease progression|11|||
42032776|NCT00866281|75841084|FG000|Overall Study|New cancer therapy|0|||
42032777|NCT00866281|75841085|FG001|Overall Study|New cancer therapy|4|||
42032778|NCT01077258|75841094|FG000|Overall Study|Lost to Follow-up|1390|||
42032779|NCT01077258|75841094|FG000|Overall Study|Adverse drug reaction|218|||
42032780|NCT01077258|75841094|FG000|Overall Study|Lack of Efficacy|663|||
42032781|NCT01077258|75841094|FG000|Overall Study|Clinical remission|37|||
42032782|NCT01077258|75841094|FG000|Overall Study|Other reasons|260|||
42032783|NCT00943917|75841122|FG000|Stage I|Adverse Event|1|||
42032784|NCT00943917|75841123|FG001|Stage I|Adverse Event|2|||
42032785|NCT00943917|75841124|FG002|Stage I|Adverse Event|2|||
42032786|NCT00943917|75841125|FG003|Stage I|Adverse Event|0|||
42032787|NCT00943917|75841126|FG004|Stage I|Adverse Event|0|||
42032788|NCT00943917|75841127|FG005|Stage I|Adverse Event|0|||
42032789|NCT00943917|75841128|FG006|Stage I|Adverse Event|0|||
42032790|NCT00943917|75841129|FG007|Stage I|Adverse Event|0|||
42032791|NCT00943917|75841130|FG008|Stage I|Adverse Event|0|||
42032792|NCT00943917|75841131|FG009|Stage I|Adverse Event|0|||
42032793|NCT00943917|75841132|FG010|Stage I|Adverse Event|0|||
42032794|NCT00943917|75841133|FG011|Stage I|Adverse Event|0|||
42032795|NCT00943917|75841134|FG012|Stage I|Adverse Event|0|||
42032796|NCT00943917|75841135|FG013|Stage I|Adverse Event|0|||
42032797|NCT00943917|75841136|FG014|Stage I|Adverse Event|0|||
42032798|NCT00943917|75841122|FG000|Stage I|Lost to Follow-up|0|||
42032799|NCT00943917|75841123|FG001|Stage I|Lost to Follow-up|0|||
42032800|NCT00943917|75841124|FG002|Stage I|Lost to Follow-up|1|||
42032801|NCT00943917|75841125|FG003|Stage I|Lost to Follow-up|0|||
42032802|NCT00943917|75841126|FG004|Stage I|Lost to Follow-up|0|||
42032803|NCT00943917|75841127|FG005|Stage I|Lost to Follow-up|0|||
42032804|NCT00943917|75841128|FG006|Stage I|Lost to Follow-up|0|||
42032805|NCT00943917|75841129|FG007|Stage I|Lost to Follow-up|0|||
42243097|NCT02831673|76067419|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
42243098|NCT02831673|76067420|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
42243099|NCT02831673|76067421|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
42243100|NCT02831673|76067422|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
42243101|NCT02831673|76067423|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
42243102|NCT02831673|76067419|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
42243103|NCT02831673|76067420|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
42243104|NCT02831673|76067421|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
42243105|NCT02831673|76067422|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
42243106|NCT02831673|76067423|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
42243107|NCT02831673|76067419|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
42243108|NCT02831673|76067420|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
42243109|NCT02831673|76067421|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
42243110|NCT02831673|76067422|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
42243111|NCT02831673|76067423|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
42243112|NCT02831673|76067419|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
42243113|NCT02831673|76067420|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
42243114|NCT02831673|76067421|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
42243115|NCT02831673|76067422|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
42243116|NCT02831673|76067423|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
42243117|NCT02831673|76067419|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
42243118|NCT02831673|76067420|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
42243119|NCT02831673|76067421|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
42243120|NCT02831673|76067422|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
42243121|NCT02831673|76067423|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
42243122|NCT02831673|76067419|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
42243123|NCT02831673|76067420|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
42243124|NCT02831673|76067421|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
42243125|NCT02831673|76067422|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
42243126|NCT02831673|76067423|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
42243127|NCT02831673|76067419|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
42032806|NCT00943917|75841130|FG008|Stage I|Lost to Follow-up|0|||
42032807|NCT00943917|75841131|FG009|Stage I|Lost to Follow-up|0|||
42032808|NCT00943917|75841132|FG010|Stage I|Lost to Follow-up|0|||
42032809|NCT00943917|75841133|FG011|Stage I|Lost to Follow-up|0|||
42032810|NCT00943917|75841134|FG012|Stage I|Lost to Follow-up|0|||
42032811|NCT00943917|75841135|FG013|Stage I|Lost to Follow-up|0|||
42032812|NCT00943917|75841136|FG014|Stage I|Lost to Follow-up|0|||
42032813|NCT00943917|75841122|FG000|Stage I|hyperglycemia|0|||
42032814|NCT00943917|75841123|FG001|Stage I|hyperglycemia|0|||
42032815|NCT00943917|75841124|FG002|Stage I|hyperglycemia|1|||
42243128|NCT02831673|76067420|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
42243129|NCT02831673|76067421|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
42243130|NCT02831673|76067422|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
42243131|NCT02831673|76067423|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
42243132|NCT02831673|76067419|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
42243133|NCT02831673|76067420|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
42243134|NCT02831673|76067421|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
42243135|NCT02831673|76067422|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
42243136|NCT02831673|76067423|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
42243137|NCT02831673|76067419|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
42243138|NCT02831673|76067420|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
42243139|NCT02831673|76067421|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
42243140|NCT02831673|76067422|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
42243141|NCT02831673|76067423|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
42243142|NCT02831673|76067419|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
42243143|NCT02831673|76067420|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
42243144|NCT02831673|76067421|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
42243145|NCT02831673|76067422|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
42243146|NCT02831673|76067423|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
42243147|NCT02831673|76067419|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
42243148|NCT02831673|76067420|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
42243149|NCT02831673|76067421|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
42243150|NCT02831673|76067422|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
42243151|NCT02831673|76067423|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
42243152|NCT02831673|76067419|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
42243153|NCT02831673|76067420|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
42243154|NCT02831673|76067421|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
42243155|NCT02831673|76067422|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
42243156|NCT02831673|76067423|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
42243157|NCT02831673|76067419|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
42243158|NCT02831673|76067420|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
42243159|NCT02831673|76067421|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
42243160|NCT02831673|76067422|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
42243161|NCT02831673|76067423|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
42243162|NCT02831673|76067419|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
42243163|NCT02831673|76067420|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
42243164|NCT02831673|76067421|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
42243165|NCT02831673|76067422|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
42243166|NCT02831673|76067423|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
42243167|NCT02831673|76067419|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
42243168|NCT02831673|76067420|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
42243169|NCT02831673|76067421|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
42243170|NCT02831673|76067422|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
42243171|NCT02831673|76067423|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
42243172|NCT02831673|76067419|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
42243173|NCT02831673|76067420|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
42243174|NCT02831673|76067421|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
42243175|NCT02831673|76067422|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
42243176|NCT02831673|76067423|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
42243177|NCT02831673|76067419|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
42243178|NCT02831673|76067420|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
42032816|NCT00943917|75841125|FG003|Stage I|hyperglycemia|0|||
42243179|NCT02831673|76067421|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
42243180|NCT02831673|76067422|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
42243181|NCT02831673|76067423|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
42243182|NCT02831673|76067419|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
42243183|NCT02831673|76067420|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
42243184|NCT02831673|76067421|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
42243185|NCT02831673|76067422|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
42243186|NCT02831673|76067423|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
42243187|NCT02830893|76067441|FG000|Overall Study|Relocation to out of the country|1|||
42243188|NCT02830893|76067442|FG001|Overall Study|Relocation to out of the country|0|||
42243189|NCT02830893|76067441|FG000|Overall Study|Lost to Follow-up|0|||
42243190|NCT02830893|76067442|FG001|Overall Study|Lost to Follow-up|2|||
42243191|NCT02830893|76067441|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
42243192|NCT02830893|76067442|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
42243193|NCT02625922|76067450|FG000|Overall Study|Non-availability of IMP|1|||
42243194|NCT02625922|76067451|FG001|Overall Study|Non-availability of IMP|1|||
42243195|NCT02625922|76067450|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
42243196|NCT02625922|76067451|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
42243197|NCT03350035|76067463|FG000|Overall Study|Lack of Efficacy|2|||
42243198|NCT03350035|76067464|FG001|Overall Study|Lack of Efficacy|0|||
42243199|NCT03350035|76067465|FG002|Overall Study|Lack of Efficacy|0|||
42243200|NCT03350035|76067463|FG000|Overall Study|Subject discharged to hospice|0|||
42243201|NCT03350035|76067464|FG001|Overall Study|Subject discharged to hospice|0|||
42243202|NCT03350035|76067465|FG002|Overall Study|Subject discharged to hospice|1|||
42243203|NCT01358331|76067499|FG000|Overall Study|Lost to Follow-up|0|||
42243204|NCT01358331|76067500|FG001|Overall Study|Lost to Follow-up|0|||
42243205|NCT01358331|76067501|FG002|Overall Study|Lost to Follow-up|0|||
42243206|NCT01358331|76067502|FG003|Overall Study|Lost to Follow-up|1|||
42243207|NCT01358331|76067503|FG004|Overall Study|Lost to Follow-up|0|||
42243208|NCT01358331|76067504|FG005|Overall Study|Lost to Follow-up|0|||
42243209|NCT01358331|76067499|FG000|Overall Study|Withdrawal by Subject|0|||
42243210|NCT01358331|76067500|FG001|Overall Study|Withdrawal by Subject|0|||
42243211|NCT01358331|76067501|FG002|Overall Study|Withdrawal by Subject|0|||
42243212|NCT01358331|76067502|FG003|Overall Study|Withdrawal by Subject|1|||
42243213|NCT01358331|76067503|FG004|Overall Study|Withdrawal by Subject|1|||
42243214|NCT01358331|76067504|FG005|Overall Study|Withdrawal by Subject|1|||
42243215|NCT01358331|76067499|FG000|Overall Study|Adverse Events|1|||
42243216|NCT01358331|76067500|FG001|Overall Study|Adverse Events|1|||
42243217|NCT01358331|76067501|FG002|Overall Study|Adverse Events|1|||
42243218|NCT01358331|76067502|FG003|Overall Study|Adverse Events|0|||
42243219|NCT01358331|76067503|FG004|Overall Study|Adverse Events|1|||
42243220|NCT01358331|76067504|FG005|Overall Study|Adverse Events|5|||
42243221|NCT01358331|76067499|FG000|Overall Study|Symptomatic Deterioration|0|||
42243222|NCT01358331|76067500|FG001|Overall Study|Symptomatic Deterioration|0|||
42243223|NCT01358331|76067501|FG002|Overall Study|Symptomatic Deterioration|0|||
42243224|NCT01358331|76067502|FG003|Overall Study|Symptomatic Deterioration|0|||
42243225|NCT01358331|76067503|FG004|Overall Study|Symptomatic Deterioration|1|||
42243226|NCT01358331|76067504|FG005|Overall Study|Symptomatic Deterioration|0|||
42243227|NCT01358331|76067499|FG000|Overall Study|Participants did not wish to continue|0|||
42243228|NCT01358331|76067500|FG001|Overall Study|Participants did not wish to continue|0|||
42243229|NCT01358331|76067501|FG002|Overall Study|Participants did not wish to continue|0|||
42243230|NCT01358331|76067502|FG003|Overall Study|Participants did not wish to continue|0|||
42243231|NCT01358331|76067503|FG004|Overall Study|Participants did not wish to continue|1|||
42243232|NCT01358331|76067504|FG005|Overall Study|Participants did not wish to continue|0|||
42243233|NCT01358331|76067499|FG000|Overall Study|Progress of disease under investigation|1|||
42243234|NCT01358331|76067500|FG001|Overall Study|Progress of disease under investigation|2|||
42243235|NCT01358331|76067501|FG002|Overall Study|Progress of disease under investigation|3|||
42243236|NCT01358331|76067502|FG003|Overall Study|Progress of disease under investigation|1|||
42243237|NCT01358331|76067503|FG004|Overall Study|Progress of disease under investigation|3|||
42243238|NCT01358331|76067504|FG005|Overall Study|Progress of disease under investigation|0|||
42243239|NCT02828241|76067520|FG000|Overall Study|Adverse Event|7|||
42243240|NCT02828241|76067521|FG001|Overall Study|Adverse Event|2|||
42243241|NCT02828241|76067520|FG000|Overall Study|Protocol Violation|1|||
42243242|NCT02828241|76067521|FG001|Overall Study|Protocol Violation|0|||
42243243|NCT01355523|76067530|FG000|Overall Study|Withdrawal by Subject|1|||
42243244|NCT01355523|76067531|FG001|Overall Study|Withdrawal by Subject|4|||
42243245|NCT01355523|76067530|FG000|Overall Study|Lost to Follow-up|0|||
42243246|NCT01355523|76067531|FG001|Overall Study|Lost to Follow-up|2|||
42243247|NCT01355523|76067530|FG000|Overall Study|Protocol Violation|0|||
42243248|NCT01355523|76067531|FG001|Overall Study|Protocol Violation|2|||
42243249|NCT01355523|76067530|FG000|Overall Study|Adverse Event|0|||
42243250|NCT01355523|76067531|FG001|Overall Study|Adverse Event|2|||
42302713|NCT02349633|76138080|FG012|Overall Study|Withdrawal by Subject|0|||
42243251|NCT02625220|76067537|FG000|Overall Study|Adverse Event|2|||
42243252|NCT02625220|76067537|FG000|Overall Study|Lost to Follow-up|2|||
42243253|NCT02625220|76067537|FG000|Overall Study|Protocol Violation|1|||
42243254|NCT02625220|76067537|FG000|Overall Study|Study discontinued at site|2|||
42243255|NCT02826603|76067543|FG000|Overall Study|Adverse Event|17|||
42243256|NCT02826603|76067544|FG001|Overall Study|Adverse Event|9|||
42243257|NCT02826603|76067543|FG000|Overall Study|Lack of Efficacy|4|||
42243258|NCT02826603|76067544|FG001|Overall Study|Lack of Efficacy|9|||
42243259|NCT02826603|76067543|FG000|Overall Study|Lost to Follow-up|13|||
42243260|NCT02826603|76067544|FG001|Overall Study|Lost to Follow-up|12|||
42243261|NCT02826603|76067543|FG000|Overall Study|Noncompliance with treatment|0|||
42243262|NCT02826603|76067544|FG001|Overall Study|Noncompliance with treatment|2|||
42243263|NCT02826603|76067543|FG000|Overall Study|Physician Decision|1|||
42243264|NCT02826603|76067544|FG001|Overall Study|Physician Decision|7|||
42243265|NCT02826603|76067543|FG000|Overall Study|Pregnancy|1|||
42243266|NCT02826603|76067544|FG001|Overall Study|Pregnancy|2|||
42243267|NCT02826603|76067543|FG000|Overall Study|Protocol Violation|3|||
42243268|NCT02826603|76067544|FG001|Overall Study|Protocol Violation|3|||
42243269|NCT02826603|76067543|FG000|Overall Study|Withdrawal by Subject|20|||
42243270|NCT02826603|76067544|FG001|Overall Study|Withdrawal by Subject|19|||
42243271|NCT02826603|76067543|FG000|Overall Study|Death|2|||
42243272|NCT02826603|76067544|FG001|Overall Study|Death|0|||
42243273|NCT02826603|76067543|FG000|Overall Study|New therapy for study indication|0|||
42243274|NCT02826603|76067544|FG001|Overall Study|New therapy for study indication|1|||
42243275|NCT05270460|76067560|FG000|Overall Study|Adverse Event|0|||
42243276|NCT05270460|76067561|FG001|Overall Study|Adverse Event|1|||
42243277|NCT05270460|76067562|FG002|Overall Study|Adverse Event|0|||
42243278|NCT05270460|76067560|FG000|Overall Study|Early Termination|0|||
42243279|NCT05270460|76067561|FG001|Overall Study|Early Termination|1|||
42243280|NCT05270460|76067562|FG002|Overall Study|Early Termination|0|||
42243281|NCT04622592|76067587|FG000|Overall Study|Death|0|||
42243282|NCT04622592|76067588|FG001|Overall Study|Death|0|||
42243283|NCT04622592|76067589|FG002|Overall Study|Death|1|||
42243284|NCT04622592|76067590|FG003|Overall Study|Death|0|||
42243285|NCT04622592|76067591|FG004|Overall Study|Death|0|||
42243286|NCT04622592|76067592|FG005|Overall Study|Death|0|||
42243287|NCT04622592|76067593|FG006|Overall Study|Death|0|||
42243288|NCT04622592|76067594|FG007|Overall Study|Death|1|||
42243289|NCT04622592|76067587|FG000|Overall Study|Lost to Follow-up|0|||
42243290|NCT04622592|76067588|FG001|Overall Study|Lost to Follow-up|0|||
42243291|NCT04622592|76067589|FG002|Overall Study|Lost to Follow-up|0|||
42243292|NCT04622592|76067590|FG003|Overall Study|Lost to Follow-up|3|||
42243293|NCT04622592|76067591|FG004|Overall Study|Lost to Follow-up|1|||
42243294|NCT04622592|76067592|FG005|Overall Study|Lost to Follow-up|0|||
42243295|NCT04622592|76067593|FG006|Overall Study|Lost to Follow-up|2|||
42243296|NCT04622592|76067594|FG007|Overall Study|Lost to Follow-up|2|||
42243297|NCT04622592|76067587|FG000|Overall Study|Physician Decision|0|||
42243298|NCT04622592|76067588|FG001|Overall Study|Physician Decision|0|||
42243299|NCT04622592|76067589|FG002|Overall Study|Physician Decision|0|||
42243300|NCT04622592|76067590|FG003|Overall Study|Physician Decision|0|||
42243301|NCT04622592|76067591|FG004|Overall Study|Physician Decision|1|||
42243302|NCT04622592|76067592|FG005|Overall Study|Physician Decision|0|||
42243303|NCT04622592|76067593|FG006|Overall Study|Physician Decision|0|||
42243304|NCT04622592|76067594|FG007|Overall Study|Physician Decision|0|||
42243305|NCT04622592|76067587|FG000|Overall Study|Withdrawal by Subject|1|||
41989224|NCT01231516|75796773|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
42243306|NCT04622592|76067588|FG001|Overall Study|Withdrawal by Subject|0|||
42243307|NCT04622592|76067589|FG002|Overall Study|Withdrawal by Subject|2|||
42243308|NCT04622592|76067590|FG003|Overall Study|Withdrawal by Subject|0|||
42243309|NCT04622592|76067591|FG004|Overall Study|Withdrawal by Subject|0|||
42243310|NCT04622592|76067592|FG005|Overall Study|Withdrawal by Subject|0|||
42243311|NCT04622592|76067593|FG006|Overall Study|Withdrawal by Subject|1|||
42243312|NCT04622592|76067594|FG007|Overall Study|Withdrawal by Subject|4|||
42243313|NCT04622592|76067587|FG000|Overall Study|Other than specified above|0|||
42243314|NCT04622592|76067588|FG001|Overall Study|Other than specified above|0|||
42243315|NCT04622592|76067589|FG002|Overall Study|Other than specified above|1|||
42243316|NCT04622592|76067590|FG003|Overall Study|Other than specified above|0|||
41989225|NCT01231516|75796774|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
42243317|NCT04622592|76067591|FG004|Overall Study|Other than specified above|0|||
42243318|NCT04622592|76067592|FG005|Overall Study|Other than specified above|0|||
42243319|NCT04622592|76067593|FG006|Overall Study|Other than specified above|0|||
42243320|NCT04622592|76067594|FG007|Overall Study|Other than specified above|0|||
42243321|NCT04523220|76067615|FG000|Main Treatment Period|Physician Decision|1|||
42243322|NCT04523220|76067616|FG001|Main Treatment Period|Physician Decision|1|||
42243323|NCT04523220|76067617|FG002|Main Treatment Period|Physician Decision|0|||
42243324|NCT04523220|76067615|FG000|Main Treatment Period|Other|5|||
42243325|NCT04523220|76067616|FG001|Main Treatment Period|Other|2|||
42243326|NCT04523220|76067617|FG002|Main Treatment Period|Other|4|||
42243327|NCT04523220|76067615|FG000|Main Treatment Period|Subject Decision|5|||
42243328|NCT04523220|76067616|FG001|Main Treatment Period|Subject Decision|7|||
42243329|NCT04523220|76067617|FG002|Main Treatment Period|Subject Decision|3|||
42243330|NCT04523220|76067615|FG000|Main Treatment Period|Death|5|||
42243331|NCT04523220|76067616|FG001|Main Treatment Period|Death|11|||
42243332|NCT04523220|76067617|FG002|Main Treatment Period|Death|4|||
42243333|NCT04523220|76067615|FG000|Main Treatment Period|Adverse Event|11|||
42243334|NCT04523220|76067616|FG001|Main Treatment Period|Adverse Event|9|||
42243335|NCT04523220|76067617|FG002|Main Treatment Period|Adverse Event|9|||
42243336|NCT04523220|76067615|FG000|Main Treatment Period|Withdrawal by Subject|3|||
42243337|NCT04523220|76067616|FG001|Main Treatment Period|Withdrawal by Subject|3|||
42243338|NCT04523220|76067617|FG002|Main Treatment Period|Withdrawal by Subject|4|||
42243339|NCT04523220|76067615|FG000|Main Treatment Period|Study drug never adminstered|10|||
42243340|NCT04523220|76067616|FG001|Main Treatment Period|Study drug never adminstered|3|||
42243341|NCT04523220|76067617|FG002|Main Treatment Period|Study drug never adminstered|5|||
42243342|NCT04523220|76067615|FG000|Extension Treatment Period|Physician Decision|1|||
42243343|NCT04523220|76067616|FG001|Extension Treatment Period|Physician Decision|0|||
42243344|NCT04523220|76067617|FG002|Extension Treatment Period|Physician Decision|3|||
42243345|NCT04523220|76067615|FG000|Extension Treatment Period|Other|2|||
42243346|NCT04523220|76067616|FG001|Extension Treatment Period|Other|6|||
42243347|NCT04523220|76067617|FG002|Extension Treatment Period|Other|6|||
42243348|NCT04523220|76067615|FG000|Extension Treatment Period|Subject Decision|5|||
42243349|NCT04523220|76067616|FG001|Extension Treatment Period|Subject Decision|2|||
42243350|NCT04523220|76067617|FG002|Extension Treatment Period|Subject Decision|4|||
41989226|NCT01231516|75796773|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
41989227|NCT01231516|75796774|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
41989228|NCT01231516|75796773|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
41989229|NCT01231516|75796774|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
41989230|NCT01231516|75796773|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
41989231|NCT01231516|75796774|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
41989232|NCT01231516|75796773|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
42032817|NCT00943917|75841126|FG004|Stage I|hyperglycemia|0|||
42243351|NCT04523220|76067615|FG000|Extension Treatment Period|Death|6|||
42243352|NCT04523220|76067616|FG001|Extension Treatment Period|Death|4|||
42243353|NCT04523220|76067617|FG002|Extension Treatment Period|Death|7|||
42243354|NCT04523220|76067615|FG000|Extension Treatment Period|Adverse Event|6|||
42243355|NCT04523220|76067616|FG001|Extension Treatment Period|Adverse Event|7|||
42243356|NCT04523220|76067617|FG002|Extension Treatment Period|Adverse Event|9|||
42243357|NCT04523220|76067615|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
42243358|NCT04523220|76067616|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
42243359|NCT04523220|76067617|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
42243360|NCT04523220|76067615|FG000|Extension Treatment Period|Study drug never administered|0|||
42243361|NCT04523220|76067616|FG001|Extension Treatment Period|Study drug never administered|1|||
42243362|NCT04523220|76067617|FG002|Extension Treatment Period|Study drug never administered|0|||
42243363|NCT04222088|76067648|FG000|Overall Study|Lost to Follow-up|5|||
42243364|NCT04222088|76067649|FG001|Overall Study|Lost to Follow-up|1|||
42243365|NCT04222088|76067648|FG000|Overall Study|Withdrawal by Subject|4|||
42243366|NCT04222088|76067649|FG001|Overall Study|Withdrawal by Subject|0|||
42243367|NCT03978520|76067660|FG000|Overall Study|Adverse Event|2|||
42243368|NCT03978520|76067661|FG001|Overall Study|Adverse Event|5|||
42243369|NCT03978520|76067662|FG002|Overall Study|Adverse Event|3|||
42243370|NCT03978520|76067663|FG003|Overall Study|Adverse Event|5|||
42243371|NCT03978520|76067664|FG004|Overall Study|Adverse Event|6|||
42243372|NCT03978520|76067660|FG000|Overall Study|Withdrawal by Subject|10|||
42243373|NCT03978520|76067661|FG001|Overall Study|Withdrawal by Subject|4|||
42243374|NCT03978520|76067662|FG002|Overall Study|Withdrawal by Subject|5|||
42243375|NCT03978520|76067663|FG003|Overall Study|Withdrawal by Subject|6|||
42243376|NCT03978520|76067664|FG004|Overall Study|Withdrawal by Subject|5|||
42243377|NCT03978520|76067660|FG000|Overall Study|Lost to Follow-up|2|||
42243378|NCT03978520|76067661|FG001|Overall Study|Lost to Follow-up|2|||
42243379|NCT03978520|76067662|FG002|Overall Study|Lost to Follow-up|2|||
42243380|NCT03978520|76067663|FG003|Overall Study|Lost to Follow-up|0|||
42243381|NCT03978520|76067664|FG004|Overall Study|Lost to Follow-up|1|||
42243382|NCT03978520|76067660|FG000|Overall Study|COVID-19 infection|0|||
42243383|NCT03978520|76067661|FG001|Overall Study|COVID-19 infection|1|||
42243384|NCT03978520|76067662|FG002|Overall Study|COVID-19 infection|0|||
42243385|NCT03978520|76067663|FG003|Overall Study|COVID-19 infection|0|||
42243386|NCT03978520|76067664|FG004|Overall Study|COVID-19 infection|0|||
42243387|NCT03978520|76067660|FG000|Overall Study|Other, not specified|9|||
42243388|NCT03978520|76067661|FG001|Overall Study|Other, not specified|4|||
42243389|NCT03978520|76067662|FG002|Overall Study|Other, not specified|1|||
42243390|NCT03978520|76067663|FG003|Overall Study|Other, not specified|1|||
42243391|NCT03978520|76067664|FG004|Overall Study|Other, not specified|2|||
42243392|NCT03978520|76067660|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
42243393|NCT03978520|76067661|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
42243394|NCT03978520|76067662|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
42243395|NCT03978520|76067663|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
42243396|NCT03978520|76067664|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
42243397|NCT03929393|76067676|FG000|Overall Study|Death|1|||
42243398|NCT03929393|76067677|FG001|Overall Study|Death|0|||
42243399|NCT03929393|76067676|FG000|Overall Study|Time Commitment|2|||
42243400|NCT03929393|76067677|FG001|Overall Study|Time Commitment|5|||
42243401|NCT03929393|76067676|FG000|Overall Study|Motor Vehicle Accident|0|||
42243402|NCT03929393|76067677|FG001|Overall Study|Motor Vehicle Accident|1|||
42243403|NCT03929393|76067676|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
42243404|NCT03929393|76067677|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
42243405|NCT03929393|76067676|FG000|Overall Study|Other|1|||
42243406|NCT03929393|76067677|FG001|Overall Study|Other|3|||
42243407|NCT03874715|76067685|FG000|Overall Study|Adverse Event|2|||
42243408|NCT03874715|76067686|FG001|Overall Study|Adverse Event|0|||
42243409|NCT03874715|76067685|FG000|Overall Study|Poor compliance to protocol|5|||
42243410|NCT03874715|76067686|FG001|Overall Study|Poor compliance to protocol|1|||
42243411|NCT03874715|76067685|FG000|Overall Study|Withdrawal by Subject|1|||
42243412|NCT03874715|76067686|FG001|Overall Study|Withdrawal by Subject|0|||
42243413|NCT03874715|76067685|FG000|Overall Study|Other-unspecified|1|||
42243414|NCT03874715|76067686|FG001|Overall Study|Other-unspecified|0|||
42243415|NCT03502200|76067698|FG000|Overall Study|Adverse Event|1|||
42243416|NCT03502200|76067699|FG001|Overall Study|Adverse Event|0|||
42243417|NCT03502200|76067698|FG000|Overall Study|Lost to Follow-up|36|||
42243418|NCT03502200|76067699|FG001|Overall Study|Lost to Follow-up|38|||
42243419|NCT03502200|76067698|FG000|Overall Study|Study Team Decision|1|||
42243420|NCT03502200|76067699|FG001|Overall Study|Study Team Decision|1|||
42243421|NCT03502200|76067698|FG000|Overall Study|Withdrawal by Subject|5|||
42243422|NCT03502200|76067699|FG001|Overall Study|Withdrawal by Subject|7|||
42243423|NCT03502200|76067698|FG000|Overall Study|Death|0|||
42243424|NCT03502200|76067699|FG001|Overall Study|Death|2|||
42243425|NCT03336242|76067707|FG000|Overall Study|Adverse Event|0|||
42243426|NCT03336242|76067708|FG001|Overall Study|Adverse Event|1|||
42243427|NCT03334435|76067719|FG000|Overall Study|Ongoing as of Week 52|70|||
42243428|NCT03334435|76067720|FG001|Overall Study|Ongoing as of Week 52|32|||
42243429|NCT03334435|76067721|FG002|Overall Study|Ongoing as of Week 52|379|||
42243430|NCT03334435|76067722|FG003|Overall Study|Ongoing as of Week 52|519|||
42243431|NCT03334435|76067723|FG004|Overall Study|Ongoing as of Week 52|146|||
42243432|NCT03334435|76067719|FG000|Overall Study|Lack of Efficacy|3|||
42243433|NCT03334435|76067720|FG001|Overall Study|Lack of Efficacy|5|||
42243434|NCT03334435|76067721|FG002|Overall Study|Lack of Efficacy|76|||
42243435|NCT03334435|76067722|FG003|Overall Study|Lack of Efficacy|140|||
42243436|NCT03334435|76067723|FG004|Overall Study|Lack of Efficacy|61|||
42243437|NCT03334435|76067719|FG000|Overall Study|Adverse Event|2|||
42243438|NCT03334435|76067720|FG001|Overall Study|Adverse Event|1|||
42243439|NCT03334435|76067721|FG002|Overall Study|Adverse Event|9|||
42243440|NCT03334435|76067722|FG003|Overall Study|Adverse Event|23|||
42243441|NCT03334435|76067723|FG004|Overall Study|Adverse Event|13|||
42243442|NCT03334435|76067719|FG000|Overall Study|Withdrawal by Subject|11|||
42243443|NCT03334435|76067720|FG001|Overall Study|Withdrawal by Subject|4|||
42243444|NCT03334435|76067721|FG002|Overall Study|Withdrawal by Subject|38|||
42243445|NCT03334435|76067722|FG003|Overall Study|Withdrawal by Subject|42|||
42243446|NCT03334435|76067723|FG004|Overall Study|Withdrawal by Subject|20|||
42243447|NCT03334435|76067719|FG000|Overall Study|Lost to Follow-up|3|||
42243448|NCT03334435|76067720|FG001|Overall Study|Lost to Follow-up|0|||
42243449|NCT03334435|76067721|FG002|Overall Study|Lost to Follow-up|2|||
42243450|NCT03334435|76067722|FG003|Overall Study|Lost to Follow-up|1|||
42243451|NCT03334435|76067723|FG004|Overall Study|Lost to Follow-up|1|||
42243452|NCT03334435|76067719|FG000|Overall Study|Death|0|||
42243453|NCT03334435|76067720|FG001|Overall Study|Death|0|||
42243454|NCT03334435|76067721|FG002|Overall Study|Death|0|||
42243455|NCT03334435|76067722|FG003|Overall Study|Death|1|||
42243456|NCT03334435|76067723|FG004|Overall Study|Death|0|||
42243457|NCT03334435|76067719|FG000|Overall Study|Other|0|||
42243458|NCT03334435|76067720|FG001|Overall Study|Other|1|||
42243459|NCT03334435|76067721|FG002|Overall Study|Other|3|||
42243460|NCT03334435|76067722|FG003|Overall Study|Other|2|||
42243461|NCT03334435|76067723|FG004|Overall Study|Other|1|||
42243462|NCT02919449|76067796|FG000|Overall Study|Withdrawal by Subject|1|||
42243463|NCT02919449|76067796|FG000|Overall Study|Investigator decision|1|||
42243464|NCT02769832|76067800|FG000|Overall Study|Death|30|||
42243465|NCT02530970|76067805|FG000|Overall Study|Adverse Event|8|||
42243466|NCT02530970|76067805|FG000|Overall Study|Lost to Follow-up|88|||
42243467|NCT02530970|76067805|FG000|Overall Study|Physician Decision|5|||
42243468|NCT02530970|76067805|FG000|Overall Study|Withdrawal by Subject|14|||
42243469|NCT02530970|76067805|FG000|Overall Study|Death|6|||
42243470|NCT02530970|76067805|FG000|Overall Study|Hospitalization|1|||
42243471|NCT02530970|76067805|FG000|Overall Study|Insurance|2|||
42243472|NCT02530970|76067805|FG000|Overall Study|Explant|2|||
42243473|NCT02530970|76067805|FG000|Overall Study|Change in Provider|5|||
42243474|NCT02530970|76067805|FG000|Overall Study|Relocation|3|||
42243475|NCT02418156|76067809|FG000|Overall Study|Lost to Follow-up|12|||
42243476|NCT02418156|76067809|FG000|Overall Study|Death|2|||
42243477|NCT02418156|76067809|FG000|Overall Study|Physician Decision|1|||
42243478|NCT02418156|76067809|FG000|Overall Study|Withdrawal by Subject|1|||
42243479|NCT02418156|76067809|FG000|Overall Study|Subject refused to return|1|||
42243480|NCT01850524|76067849|FG000|Overall Study|Lost to Follow-up|5|||
42243481|NCT01850524|76067850|FG001|Overall Study|Lost to Follow-up|10|||
42243482|NCT01850524|76067849|FG000|Overall Study|Withdrawal by Subject|24|||
42243483|NCT01850524|76067850|FG001|Overall Study|Withdrawal by Subject|22|||
42243484|NCT01850524|76067849|FG000|Overall Study|Reason not Specified|142|||
42243485|NCT01850524|76067850|FG001|Overall Study|Reason not Specified|141|||
42243486|NCT01609842|76067867|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
42243487|NCT01609842|76067868|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
42243488|NCT01569594|76067878|FG000|Overall Study|Physician Decision|4|||
42243489|NCT01569594|76067878|FG000|Overall Study|Death|13|||
42243490|NCT01569594|76067878|FG000|Overall Study|Lost to Follow-up|22|||
42243491|NCT01569594|76067878|FG000|Overall Study|Adverse Event|2|||
42243492|NCT01569594|76067878|FG000|Overall Study|Withdrawal by Subject|13|||
42243493|NCT01569594|76067878|FG000|Overall Study|Other|4|||
42243494|NCT01569594|76067878|FG000|Overall Study|No ECM used|9|||
42243495|NCT00593840|76067882|FG000|Overall Study|Withdrawal by Subject|1|||
42243496|NCT01329900|76067915|FG000|Overall Study|Elevated creatinine/renal function|1|||
42243497|NCT02825043|76067919|FG000|Overall Study|Lost to Follow-up|4|||
42243498|NCT02750592|76067934|FG000|Overall Study|Adverse Event|3|||
42243499|NCT02750592|76067934|FG000|Overall Study|Lack of Efficacy|2|||
42243500|NCT02624986|76067946|FG000|Overall Study|Death|0|||
41989233|NCT01231516|75796774|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
41989234|NCT01231516|75796773|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
41989235|NCT01231516|75796774|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
41989236|NCT01231516|75796773|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
41989237|NCT01231516|75796774|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
41989238|NCT01231516|75796773|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
41989239|NCT01231516|75796774|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
41989240|NCT01231516|75796773|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
42032818|NCT00943917|75841127|FG005|Stage I|hyperglycemia|0|||
42032819|NCT00943917|75841128|FG006|Stage I|hyperglycemia|0|||
42032820|NCT00943917|75841129|FG007|Stage I|hyperglycemia|0|||
42032821|NCT00943917|75841130|FG008|Stage I|hyperglycemia|0|||
42032822|NCT00943917|75841131|FG009|Stage I|hyperglycemia|0|||
42243501|NCT02624986|76067947|FG001|Overall Study|Death|1|||
42243502|NCT02624986|76067948|FG002|Overall Study|Death|2|||
42243503|NCT02624986|76067949|FG003|Overall Study|Death|2|||
42243504|NCT02624986|76067950|FG004|Overall Study|Death|2|||
42243505|NCT02624986|76067951|FG005|Overall Study|Death|0|||
42243506|NCT02624986|76067952|FG006|Overall Study|Death|0|||
42243507|NCT02624986|76067953|FG007|Overall Study|Death|1|||
42243508|NCT02624986|76067946|FG000|Overall Study|Study Terminated by Sponsor|1|||
42243509|NCT02624986|76067947|FG001|Overall Study|Study Terminated by Sponsor|1|||
42243510|NCT02624986|76067948|FG002|Overall Study|Study Terminated by Sponsor|0|||
42243511|NCT02624986|76067949|FG003|Overall Study|Study Terminated by Sponsor|1|||
42243512|NCT02624986|76067950|FG004|Overall Study|Study Terminated by Sponsor|2|||
42243513|NCT02624986|76067951|FG005|Overall Study|Study Terminated by Sponsor|2|||
42243514|NCT02624986|76067952|FG006|Overall Study|Study Terminated by Sponsor|4|||
42243515|NCT02624986|76067953|FG007|Overall Study|Study Terminated by Sponsor|3|||
42243516|NCT02624986|76067946|FG000|Overall Study|Progressive Disease|0|||
42243517|NCT02624986|76067947|FG001|Overall Study|Progressive Disease|1|||
42243518|NCT02624986|76067948|FG002|Overall Study|Progressive Disease|0|||
41989241|NCT01231516|75796774|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
41989242|NCT01231516|75796773|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
41989243|NCT01231516|75796774|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
41989244|NCT01231516|75796773|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
42243519|NCT02624986|76067949|FG003|Overall Study|Progressive Disease|0|||
42243520|NCT02624986|76067950|FG004|Overall Study|Progressive Disease|0|||
42243521|NCT02624986|76067951|FG005|Overall Study|Progressive Disease|0|||
42243522|NCT02624986|76067952|FG006|Overall Study|Progressive Disease|0|||
42243523|NCT02624986|76067953|FG007|Overall Study|Progressive Disease|0|||
42243524|NCT02624986|76067946|FG000|Overall Study|Protocol Violation|1|||
42243525|NCT02624986|76067947|FG001|Overall Study|Protocol Violation|0|||
42243526|NCT02624986|76067948|FG002|Overall Study|Protocol Violation|0|||
42243527|NCT02624986|76067949|FG003|Overall Study|Protocol Violation|0|||
42243528|NCT02624986|76067950|FG004|Overall Study|Protocol Violation|0|||
42243529|NCT02624986|76067951|FG005|Overall Study|Protocol Violation|0|||
42243530|NCT02624986|76067952|FG006|Overall Study|Protocol Violation|0|||
42243531|NCT02624986|76067953|FG007|Overall Study|Protocol Violation|0|||
42243532|NCT02624986|76067946|FG000|Overall Study|Withdrawal by Subject|0|||
42243533|NCT02624986|76067947|FG001|Overall Study|Withdrawal by Subject|0|||
42243534|NCT02624986|76067948|FG002|Overall Study|Withdrawal by Subject|0|||
42243535|NCT02624986|76067949|FG003|Overall Study|Withdrawal by Subject|0|||
42243536|NCT02624986|76067950|FG004|Overall Study|Withdrawal by Subject|0|||
42243537|NCT02624986|76067951|FG005|Overall Study|Withdrawal by Subject|0|||
42243538|NCT02624986|76067952|FG006|Overall Study|Withdrawal by Subject|0|||
42243539|NCT02624986|76067953|FG007|Overall Study|Withdrawal by Subject|1|||
42243540|NCT02587598|76067986|FG000|Overall Study|Death|4|||
42243541|NCT02587598|76067987|FG001|Overall Study|Death|8|||
42243542|NCT02587598|76067988|FG002|Overall Study|Death|4|||
42243543|NCT02587598|76067989|FG003|Overall Study|Death|16|||
42243544|NCT02587598|76067990|FG004|Overall Study|Death|9|||
42243545|NCT02587598|76067991|FG005|Overall Study|Death|4|||
42243546|NCT02587598|76067992|FG006|Overall Study|Death|6|||
42243547|NCT02587598|76067993|FG007|Overall Study|Death|7|||
42243548|NCT02587598|76067994|FG008|Overall Study|Death|9|||
42243549|NCT02587598|76067995|FG009|Overall Study|Death|1|||
41989245|NCT01231516|75796774|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
42243550|NCT02587598|76067996|FG010|Overall Study|Death|3|||
42243551|NCT02587598|76067986|FG000|Overall Study|Study Terminated by the Sponsor|0|||
42243552|NCT02587598|76067987|FG001|Overall Study|Study Terminated by the Sponsor|1|||
42243553|NCT02587598|76067988|FG002|Overall Study|Study Terminated by the Sponsor|0|||
42243554|NCT02587598|76067989|FG003|Overall Study|Study Terminated by the Sponsor|3|||
42243555|NCT02587598|76067990|FG004|Overall Study|Study Terminated by the Sponsor|0|||
42243556|NCT02587598|76067991|FG005|Overall Study|Study Terminated by the Sponsor|1|||
42243557|NCT02587598|76067992|FG006|Overall Study|Study Terminated by the Sponsor|0|||
42243558|NCT02587598|76067993|FG007|Overall Study|Study Terminated by the Sponsor|0|||
42243559|NCT02587598|76067994|FG008|Overall Study|Study Terminated by the Sponsor|0|||
42243560|NCT02587598|76067995|FG009|Overall Study|Study Terminated by the Sponsor|1|||
42243561|NCT02587598|76067996|FG010|Overall Study|Study Terminated by the Sponsor|6|||
42243562|NCT02587598|76067986|FG000|Overall Study|Reason for study withdrawal not specified|0|||
42243563|NCT02587598|76067987|FG001|Overall Study|Reason for study withdrawal not specified|1|||
42243564|NCT02587598|76067988|FG002|Overall Study|Reason for study withdrawal not specified|0|||
42243565|NCT02587598|76067989|FG003|Overall Study|Reason for study withdrawal not specified|0|||
42243566|NCT02587598|76067990|FG004|Overall Study|Reason for study withdrawal not specified|0|||
42243567|NCT02587598|76067991|FG005|Overall Study|Reason for study withdrawal not specified|0|||
42243568|NCT02587598|76067992|FG006|Overall Study|Reason for study withdrawal not specified|0|||
42243569|NCT02587598|76067993|FG007|Overall Study|Reason for study withdrawal not specified|0|||
42243570|NCT02587598|76067994|FG008|Overall Study|Reason for study withdrawal not specified|0|||
42243571|NCT02587598|76067995|FG009|Overall Study|Reason for study withdrawal not specified|0|||
42243572|NCT02587598|76067996|FG010|Overall Study|Reason for study withdrawal not specified|0|||
42243573|NCT02587598|76067986|FG000|Overall Study|Withdrawal by Subject|0|||
42243574|NCT02587598|76067987|FG001|Overall Study|Withdrawal by Subject|1|||
42243575|NCT02587598|76067988|FG002|Overall Study|Withdrawal by Subject|0|||
42243576|NCT02587598|76067989|FG003|Overall Study|Withdrawal by Subject|2|||
42243577|NCT02587598|76067990|FG004|Overall Study|Withdrawal by Subject|3|||
42243578|NCT02587598|76067991|FG005|Overall Study|Withdrawal by Subject|1|||
42243579|NCT02587598|76067992|FG006|Overall Study|Withdrawal by Subject|0|||
42243580|NCT02587598|76067993|FG007|Overall Study|Withdrawal by Subject|0|||
42243581|NCT02587598|76067994|FG008|Overall Study|Withdrawal by Subject|0|||
42243582|NCT02587598|76067995|FG009|Overall Study|Withdrawal by Subject|1|||
42243583|NCT02587598|76067996|FG010|Overall Study|Withdrawal by Subject|2|||
42243584|NCT02587598|76067986|FG000|Overall Study|Physician Decision|0|||
42243585|NCT02587598|76067987|FG001|Overall Study|Physician Decision|0|||
42243586|NCT02587598|76067988|FG002|Overall Study|Physician Decision|0|||
42243587|NCT02587598|76067989|FG003|Overall Study|Physician Decision|0|||
42243588|NCT02587598|76067990|FG004|Overall Study|Physician Decision|0|||
42243589|NCT02587598|76067991|FG005|Overall Study|Physician Decision|0|||
42243590|NCT02587598|76067992|FG006|Overall Study|Physician Decision|0|||
42243591|NCT02587598|76067993|FG007|Overall Study|Physician Decision|0|||
42243592|NCT02587598|76067994|FG008|Overall Study|Physician Decision|0|||
42243593|NCT02587598|76067995|FG009|Overall Study|Physician Decision|0|||
42243594|NCT02587598|76067996|FG010|Overall Study|Physician Decision|3|||
42243595|NCT02485574|76068032|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
42243596|NCT02624284|76068044|FG000|Overall Study|Withdrawal by Subject|3|||
42243597|NCT02624284|76068045|FG001|Overall Study|Withdrawal by Subject|6|||
42243598|NCT02624284|76068046|FG002|Overall Study|Withdrawal by Subject|3|||
42243599|NCT02624284|76068044|FG000|Overall Study|Protocol Violation|9|||
42243600|NCT02624284|76068045|FG001|Overall Study|Protocol Violation|10|||
42243601|NCT02624284|76068046|FG002|Overall Study|Protocol Violation|7|||
42243602|NCT02624284|76068044|FG000|Overall Study|Revealed exclusionary condition|2|||
42243603|NCT02624284|76068045|FG001|Overall Study|Revealed exclusionary condition|2|||
42243604|NCT02624284|76068046|FG002|Overall Study|Revealed exclusionary condition|0|||
42243605|NCT02624284|76068044|FG000|Overall Study|Adverse Event|0|||
42243606|NCT02624284|76068045|FG001|Overall Study|Adverse Event|0|||
42243607|NCT02624284|76068046|FG002|Overall Study|Adverse Event|1|||
42243608|NCT02738450|76068058|FG000|Overall Study|Withdrawal by Subject|0|||
42243609|NCT02738450|76068059|FG001|Overall Study|Withdrawal by Subject|2|||
42243610|NCT02738450|76068060|FG002|Overall Study|Withdrawal by Subject|0|||
42243611|NCT02624050|76068071|FG000|Overall Study|Physician Decision|4|||
42243612|NCT02624050|76068072|FG001|Overall Study|Physician Decision|0|||
42243613|NCT02624050|76068071|FG000|Overall Study|Protocol Violation|2|||
42243614|NCT02624050|76068072|FG001|Overall Study|Protocol Violation|0|||
42243615|NCT01338987|76068088|FG000|Overall Study|enrolled on new protocol|0|||
42243616|NCT01338987|76068089|FG001|Overall Study|enrolled on new protocol|0|||
42243617|NCT01338987|76068090|FG002|Overall Study|enrolled on new protocol|1|||
42032823|NCT00943917|75841132|FG010|Stage I|hyperglycemia|0|||
42243618|NCT01338987|76068091|FG003|Overall Study|enrolled on new protocol|0|||
42243619|NCT01338987|76068092|FG004|Overall Study|enrolled on new protocol|0|||
42243620|NCT01338987|76068088|FG000|Overall Study|Disease progression on study|2|||
42243621|NCT01338987|76068089|FG001|Overall Study|Disease progression on study|1|||
42243622|NCT01338987|76068090|FG002|Overall Study|Disease progression on study|1|||
42243623|NCT01338987|76068091|FG003|Overall Study|Disease progression on study|0|||
42243624|NCT01338987|76068092|FG004|Overall Study|Disease progression on study|0|||
42243625|NCT03706430|76068106|FG000|Overall Study|No A-Line placed|5|||
42243626|NCT03706430|76068106|FG000|Overall Study|Subject had gel nail polish|1|||
42243627|NCT03706430|76068106|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
42243628|NCT03706430|76068106|FG000|Overall Study|Cancelled Case|6|||
42243629|NCT03706430|76068106|FG000|Overall Study|Physician Decision|2|||
42243630|NCT02738138|76068128|FG000|Overall Study|Adverse Event|0|||
42243631|NCT02738138|76068129|FG001|Overall Study|Adverse Event|1|||
42243632|NCT02738138|76068128|FG000|Overall Study|Lost to Follow-up|2|||
42243633|NCT02738138|76068129|FG001|Overall Study|Lost to Follow-up|0|||
42243634|NCT02738138|76068128|FG000|Overall Study|Other - not further specified|1|||
42243635|NCT02738138|76068129|FG001|Overall Study|Other - not further specified|0|||
42243636|NCT01355289|76068138|FG000|Core Study|Adverse Event, Non-Fatal|1|||
42243637|NCT01355289|76068139|FG001|Core Study|Adverse Event, Non-Fatal|0|||
42243638|NCT01355289|76068140|FG002|Core Study|Adverse Event, Non-Fatal|0|||
42243639|NCT01355289|76068141|FG003|Core Study|Adverse Event, Non-Fatal|0|||
42243640|NCT01355289|76068142|FG004|Core Study|Adverse Event, Non-Fatal|0|||
42243641|NCT01355289|76068138|FG000|Core Study|Inadequate Therapeutic Effect|0|||
42243642|NCT01355289|76068139|FG001|Core Study|Inadequate Therapeutic Effect|0|||
42243643|NCT01355289|76068140|FG002|Core Study|Inadequate Therapeutic Effect|0|||
42243644|NCT01355289|76068141|FG003|Core Study|Inadequate Therapeutic Effect|1|||
42243645|NCT01355289|76068142|FG004|Core Study|Inadequate Therapeutic Effect|0|||
42243646|NCT01355289|76068138|FG000|Core Study|Other|0|||
42243647|NCT01355289|76068139|FG001|Core Study|Other|0|||
42243648|NCT01355289|76068140|FG002|Core Study|Other|0|||
42243649|NCT01355289|76068141|FG003|Core Study|Other|1|||
42243650|NCT01355289|76068142|FG004|Core Study|Other|0|||
42243651|NCT01355289|76068138|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
42243652|NCT01355289|76068139|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
42243653|NCT01355289|76068140|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
42243654|NCT01355289|76068141|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
42243655|NCT01355289|76068142|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
42243656|NCT01355289|76068138|FG000|Open Label Extension|Lost to Follow-up|0|||
42243657|NCT01355289|76068139|FG001|Open Label Extension|Lost to Follow-up|0|||
42243658|NCT01355289|76068140|FG002|Open Label Extension|Lost to Follow-up|0|||
42243659|NCT01355289|76068141|FG003|Open Label Extension|Lost to Follow-up|0|||
42243660|NCT01355289|76068142|FG004|Open Label Extension|Lost to Follow-up|1|||
42243661|NCT01355289|76068138|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
42243662|NCT01355289|76068139|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
42243663|NCT01355289|76068140|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
42243664|NCT01355289|76068141|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
42243665|NCT01355289|76068142|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
42243666|NCT01355289|76068138|FG000|Open Label Extension|Other|0|||
42243667|NCT01355289|76068139|FG001|Open Label Extension|Other|0|||
42243668|NCT01355289|76068140|FG002|Open Label Extension|Other|0|||
42243669|NCT01355289|76068141|FG003|Open Label Extension|Other|0|||
42243670|NCT01355289|76068142|FG004|Open Label Extension|Other|3|||
42243671|NCT02737592|76068155|FG000|Overall Study|Withdrawal by Subject|1|||
42243672|NCT02737358|76068182|FG000|Overall Study|Withdrawal by Subject|7|||
42243673|NCT02737358|76068183|FG001|Overall Study|Withdrawal by Subject|12|||
42243674|NCT02737358|76068182|FG000|Overall Study|Lost to Follow-up|2|||
42132033|NCT00510068|75942843|FG000|Open-label Period|Disease Progression|124|||
42243675|NCT02737358|76068183|FG001|Overall Study|Lost to Follow-up|3|||
42243676|NCT01354431|76068192|FG000|Pre-Treatment Period|Not reported|1|||
42243677|NCT01354431|76068193|FG001|Pre-Treatment Period|Not reported|0|||
42243678|NCT01354431|76068194|FG002|Pre-Treatment Period|Not reported|0|||
42243679|NCT01354431|76068192|FG000|Treatment Period|Disease Progression|50|||
42243680|NCT01354431|76068193|FG001|Treatment Period|Disease Progression|40|||
42243681|NCT01354431|76068194|FG002|Treatment Period|Disease Progression|44|||
42243682|NCT01354431|76068192|FG000|Treatment Period|Study Drug Toxicity|5|||
42243683|NCT01354431|76068193|FG001|Treatment Period|Study Drug Toxicity|8|||
42243684|NCT01354431|76068194|FG002|Treatment Period|Study Drug Toxicity|4|||
42243685|NCT01354431|76068192|FG000|Treatment Period|Death|0|||
42243686|NCT01354431|76068193|FG001|Treatment Period|Death|1|||
42243687|NCT01354431|76068194|FG002|Treatment Period|Death|0|||
42243688|NCT01354431|76068192|FG000|Treatment Period|AE unrelated to study drug|1|||
42243689|NCT01354431|76068193|FG001|Treatment Period|AE unrelated to study drug|2|||
42243690|NCT01354431|76068194|FG002|Treatment Period|AE unrelated to study drug|5|||
42243691|NCT01354431|76068192|FG000|Treatment Period|Participant request to discontinue|2|||
42243692|NCT01354431|76068193|FG001|Treatment Period|Participant request to discontinue|2|||
42243693|NCT01354431|76068194|FG002|Treatment Period|Participant request to discontinue|1|||
42243694|NCT01354431|76068192|FG000|Treatment Period|Participant withdrew consent|0|||
42243695|NCT01354431|76068193|FG001|Treatment Period|Participant withdrew consent|1|||
42243696|NCT01354431|76068194|FG002|Treatment Period|Participant withdrew consent|0|||
42243697|NCT01354431|76068192|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
42243698|NCT01354431|76068193|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
42243699|NCT01354431|76068194|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
42243700|NCT02736578|76068204|FG000|Overall Study|Adverse Event|1|||
42243701|NCT02736578|76068205|FG001|Overall Study|Adverse Event|0|||
42243702|NCT02622724|76068217|FG000|Overall Study|Death|51|||
42243703|NCT02622724|76068218|FG001|Overall Study|Death|53|||
42243704|NCT02622724|76068217|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
42243705|NCT02622724|76068218|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
42243706|NCT02622724|76068217|FG000|Overall Study|Early termination of study|38|||
42243707|NCT02622724|76068218|FG001|Overall Study|Early termination of study|43|||
42243708|NCT01354353|76068236|FG000|Overall Study|Adverse Event|1|||
42243709|NCT01354353|76068237|FG001|Overall Study|Adverse Event|0|||
42243710|NCT01354353|76068238|FG002|Overall Study|Adverse Event|0|||
42243711|NCT01354353|76068239|FG003|Overall Study|Adverse Event|4|||
42243712|NCT01354353|76068240|FG004|Overall Study|Adverse Event|0|||
42243713|NCT01354353|76068241|FG005|Overall Study|Adverse Event|5|||
42243714|NCT01354353|76068236|FG000|Overall Study|Entry Criteria Not Met|0|||
42243715|NCT01354353|76068237|FG001|Overall Study|Entry Criteria Not Met|0|||
42243716|NCT01354353|76068238|FG002|Overall Study|Entry Criteria Not Met|0|||
42243717|NCT01354353|76068239|FG003|Overall Study|Entry Criteria Not Met|1|||
42243718|NCT01354353|76068240|FG004|Overall Study|Entry Criteria Not Met|1|||
42243719|NCT01354353|76068241|FG005|Overall Study|Entry Criteria Not Met|0|||
42243720|NCT01354353|76068236|FG000|Overall Study|Physician Decision|0|||
42243721|NCT01354353|76068237|FG001|Overall Study|Physician Decision|1|||
42243722|NCT01354353|76068238|FG002|Overall Study|Physician Decision|1|||
42243723|NCT01354353|76068239|FG003|Overall Study|Physician Decision|0|||
42243724|NCT01354353|76068240|FG004|Overall Study|Physician Decision|0|||
42243725|NCT01354353|76068241|FG005|Overall Study|Physician Decision|0|||
42243726|NCT01354353|76068236|FG000|Overall Study|Withdrawal by Subject|2|||
42243727|NCT01354353|76068237|FG001|Overall Study|Withdrawal by Subject|0|||
42243728|NCT01354353|76068238|FG002|Overall Study|Withdrawal by Subject|1|||
42243729|NCT01354353|76068239|FG003|Overall Study|Withdrawal by Subject|0|||
42243730|NCT01354353|76068240|FG004|Overall Study|Withdrawal by Subject|0|||
42243731|NCT01354353|76068241|FG005|Overall Study|Withdrawal by Subject|1|||
42243732|NCT02622568|76068264|FG000|Overall Study|Lost to Follow-up|5|||
42243733|NCT02622568|76068265|FG001|Overall Study|Lost to Follow-up|5|||
42243734|NCT01354899|76068271|FG000|Overall Study|discharge from the hospital|2|||
42243735|NCT01354899|76068271|FG000|Overall Study|Protocol Violation|1|||
42243736|NCT01353963|76068275|FG000|Overall Study|Adverse Event|2|||
42243737|NCT02820597|76068284|FG000|Overall Study|Lost to Follow-up|12|||
42243738|NCT02822235|76068290|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
42243739|NCT02822235|76068291|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
42243740|NCT02822235|76068290|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
42243741|NCT02822235|76068291|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
42243742|NCT02822235|76068290|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
42243743|NCT02822235|76068291|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
42243744|NCT02822235|76068290|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
42243745|NCT02822235|76068291|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
42243746|NCT02822235|76068290|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
42243747|NCT02822235|76068291|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
42243748|NCT02822235|76068290|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
42243749|NCT02822235|76068291|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
42243750|NCT02817555|76068306|FG000|Overall Study|Death|1|||
42243751|NCT02817555|76068307|FG001|Overall Study|Death|3|||
42243752|NCT02817555|76068306|FG000|Overall Study|moved away|1|||
42243753|NCT02817555|76068307|FG001|Overall Study|moved away|0|||
42243754|NCT02817555|76068306|FG000|Overall Study|transplant|1|||
42243755|NCT02817555|76068307|FG001|Overall Study|transplant|1|||
42243756|NCT02817555|76068306|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
42243757|NCT02817555|76068307|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
42243758|NCT02817087|76068315|FG000|Overall Study|Withdrawal by Subject|2|||
42243759|NCT02817087|76068316|FG001|Overall Study|Withdrawal by Subject|0|||
42243760|NCT02813577|76068322|FG000|Overall Study|Study terminated|4|||
42243761|NCT02815293|76068329|FG000|Overall Study|Study termination by sponsor|10|||
42243762|NCT02815293|76068330|FG001|Overall Study|Study termination by sponsor|7|||
42243763|NCT02815293|76068331|FG002|Overall Study|Study termination by sponsor|0|||
42243764|NCT02815293|76068329|FG000|Overall Study|Participants not randomized|0|||
42243765|NCT02815293|76068330|FG001|Overall Study|Participants not randomized|0|||
42243766|NCT02815293|76068331|FG002|Overall Study|Participants not randomized|18|||
42243767|NCT02815293|76068329|FG000|Overall Study|Adverse Event|0|||
42243768|NCT02815293|76068330|FG001|Overall Study|Adverse Event|1|||
42243769|NCT02815293|76068331|FG002|Overall Study|Adverse Event|0|||
42243770|NCT02813421|76068339|FG000|Overall Study|Withdrawal by Subject|1|||
42243771|NCT02813421|76068340|FG001|Overall Study|Withdrawal by Subject|2|||
42243772|NCT02813421|76068339|FG000|Overall Study|Lost to Follow-up|1|||
42243773|NCT02813421|76068340|FG001|Overall Study|Lost to Follow-up|1|||
42243774|NCT03672188|76068361|FG000|Overall Study|Withdrawal by Subject|0|||
42243775|NCT03672188|76068362|FG001|Overall Study|Withdrawal by Subject|0|||
42243776|NCT03672188|76068363|FG002|Overall Study|Withdrawal by Subject|0|||
42243777|NCT03672188|76068364|FG003|Overall Study|Withdrawal by Subject|3|||
42243778|NCT03672188|76068365|FG004|Overall Study|Withdrawal by Subject|0|||
42243779|NCT03672188|76068366|FG005|Overall Study|Withdrawal by Subject|0|||
42243780|NCT03672188|76068367|FG006|Overall Study|Withdrawal by Subject|0|||
42243781|NCT03672188|76068368|FG007|Overall Study|Withdrawal by Subject|0|||
42243782|NCT03672188|76068369|FG008|Overall Study|Withdrawal by Subject|0|||
42243783|NCT03672188|76068370|FG009|Overall Study|Withdrawal by Subject|0|||
42243784|NCT03672188|76068371|FG010|Overall Study|Withdrawal by Subject|0|||
42243785|NCT03672188|76068372|FG011|Overall Study|Withdrawal by Subject|0|||
42243786|NCT03672188|76068373|FG012|Overall Study|Withdrawal by Subject|0|||
42243787|NCT03672188|76068374|FG013|Overall Study|Withdrawal by Subject|0|||
41989246|NCT01231516|75796773|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
41989247|NCT01231516|75796774|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
41989248|NCT01231516|75796773|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
41989249|NCT01231516|75796774|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
41989250|NCT01231516|75796773|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
41989251|NCT01231516|75796774|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
41989252|NCT01231516|75796773|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
41989253|NCT01231516|75796774|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
41989254|NCT01231516|75796773|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
41989255|NCT01231516|75796774|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
41989256|NCT01231321|75796780|FG000|Overall Study|Adverse Event|3|||
41989257|NCT01231321|75796780|FG000|Overall Study|Lack of Efficacy|2|||
41989258|NCT01210222|75796790|FG000|Overall Study|Ineligible|2|||
42032824|NCT00943917|75841133|FG011|Stage I|hyperglycemia|0|||
42243788|NCT03672188|76068375|FG014|Overall Study|Withdrawal by Subject|0|||
42243789|NCT03672188|76068361|FG000|Overall Study|Death|0|||
41989259|NCT01210222|75796790|FG000|Overall Study|Never treated|1|||
42032825|NCT00943917|75841134|FG012|Stage I|hyperglycemia|0|||
42243790|NCT03672188|76068362|FG001|Overall Study|Death|0|||
42243791|NCT03672188|76068363|FG002|Overall Study|Death|0|||
42243792|NCT03672188|76068364|FG003|Overall Study|Death|0|||
42243793|NCT03672188|76068365|FG004|Overall Study|Death|0|||
42243794|NCT03672188|76068366|FG005|Overall Study|Death|0|||
42243795|NCT03672188|76068367|FG006|Overall Study|Death|0|||
42243796|NCT03672188|76068368|FG007|Overall Study|Death|0|||
41989260|NCT01210144|75796802|FG000|Overall Study|Lack of ovarian response|1|||
41989261|NCT01210144|75796803|FG001|Overall Study|Lack of ovarian response|0|||
41989262|NCT01210144|75796802|FG000|Overall Study|No fertilization|1|||
42243797|NCT03672188|76068369|FG008|Overall Study|Death|0|||
42243798|NCT03672188|76068370|FG009|Overall Study|Death|0|||
42243799|NCT03672188|76068371|FG010|Overall Study|Death|0|||
42243800|NCT03672188|76068372|FG011|Overall Study|Death|0|||
42243801|NCT03672188|76068373|FG012|Overall Study|Death|1|||
42243802|NCT03672188|76068374|FG013|Overall Study|Death|0|||
42243803|NCT03672188|76068375|FG014|Overall Study|Death|0|||
42243804|NCT03672188|76068361|FG000|Overall Study|Lost to Follow-up|0|||
42243805|NCT03672188|76068362|FG001|Overall Study|Lost to Follow-up|0|||
42243806|NCT03672188|76068363|FG002|Overall Study|Lost to Follow-up|1|||
42243807|NCT03672188|76068364|FG003|Overall Study|Lost to Follow-up|0|||
42243808|NCT03672188|76068365|FG004|Overall Study|Lost to Follow-up|0|||
42243809|NCT03672188|76068366|FG005|Overall Study|Lost to Follow-up|0|||
42243810|NCT03672188|76068367|FG006|Overall Study|Lost to Follow-up|0|||
42243811|NCT03672188|76068368|FG007|Overall Study|Lost to Follow-up|0|||
42243812|NCT03672188|76068369|FG008|Overall Study|Lost to Follow-up|0|||
42243813|NCT03672188|76068370|FG009|Overall Study|Lost to Follow-up|0|||
42243814|NCT03672188|76068371|FG010|Overall Study|Lost to Follow-up|0|||
42243815|NCT03672188|76068372|FG011|Overall Study|Lost to Follow-up|0|||
42243816|NCT03672188|76068373|FG012|Overall Study|Lost to Follow-up|0|||
42243817|NCT03672188|76068374|FG013|Overall Study|Lost to Follow-up|0|||
42243818|NCT03672188|76068375|FG014|Overall Study|Lost to Follow-up|0|||
42243819|NCT02620384|76068443|FG000|Overall Study|Adverse Event|2|||
42243820|NCT02620384|76068444|FG001|Overall Study|Adverse Event|1|||
42243821|NCT02620384|76068443|FG000|Overall Study|Discharged prior to 2nd dose|2|||
42243822|NCT02620384|76068444|FG001|Overall Study|Discharged prior to 2nd dose|5|||
42243823|NCT02620384|76068443|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
42243824|NCT02620384|76068444|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
42243825|NCT03915860|76068450|FG000|Overall Study|Adverse Event|3|||
42243826|NCT03915860|76068450|FG000|Overall Study|Withdrawal by Subject|6|||
42243827|NCT03915860|76068450|FG000|Overall Study|Lost to Follow-up|2|||
42243828|NCT03915860|76068450|FG000|Overall Study|Other than specified|3|||
42243829|NCT05047211|76068465|FG000|Overall Study|Lost to Follow-up|8|||
42243830|NCT05047211|76068466|FG001|Overall Study|Lost to Follow-up|5|||
42243831|NCT04958642|76068475|FG000|Overall Study|Transferred to OLEX program|3|||
42243832|NCT04958642|76068476|FG001|Overall Study|Transferred to OLEX program|0|||
42243833|NCT04958642|76068477|FG002|Overall Study|Transferred to OLEX program|5|||
42243834|NCT04958642|76068475|FG000|Overall Study|Death|0|||
42243835|NCT04958642|76068476|FG001|Overall Study|Death|0|||
42243836|NCT04958642|76068477|FG002|Overall Study|Death|1|||
42243837|NCT04958642|76068475|FG000|Overall Study|Withdrawal by Subject|4|||
42243838|NCT04958642|76068476|FG001|Overall Study|Withdrawal by Subject|9|||
42243839|NCT04958642|76068477|FG002|Overall Study|Withdrawal by Subject|13|||
42243840|NCT04958642|76068475|FG000|Overall Study|Investigator's Decision|0|||
42243841|NCT04958642|76068476|FG001|Overall Study|Investigator's Decision|0|||
42243842|NCT04958642|76068477|FG002|Overall Study|Investigator's Decision|1|||
42243843|NCT04958642|76068475|FG000|Overall Study|Adverse Event|1|||
42243844|NCT04958642|76068476|FG001|Overall Study|Adverse Event|0|||
42243845|NCT04958642|76068477|FG002|Overall Study|Adverse Event|1|||
42243846|NCT04958642|76068475|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
42243847|NCT04958642|76068476|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
42243848|NCT04958642|76068477|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
42243849|NCT04958642|76068475|FG000|Overall Study|Lost to Follow-up|1|||
42243850|NCT04958642|76068476|FG001|Overall Study|Lost to Follow-up|0|||
42243851|NCT04958642|76068477|FG002|Overall Study|Lost to Follow-up|0|||
42243852|NCT04958642|76068475|FG000|Overall Study|Transferred to EAP following study termination|0|||
42243853|NCT04958642|76068476|FG001|Overall Study|Transferred to EAP following study termination|0|||
42243854|NCT04958642|76068477|FG002|Overall Study|Transferred to EAP following study termination|1|||
42243855|NCT04958642|76068475|FG000|Overall Study|Transferred to Expanded Access Program|1|||
42243856|NCT04958642|76068476|FG001|Overall Study|Transferred to Expanded Access Program|0|||
42243857|NCT04958642|76068477|FG002|Overall Study|Transferred to Expanded Access Program|0|||
42243858|NCT04439357|76068485|FG000|Overall Study|Disease Progression|4|||
42243859|NCT04321343|76068493|FG000|Overall Study|Adverse Event|0|||
42243860|NCT04321343|76068494|FG001|Overall Study|Adverse Event|0|||
42243861|NCT04321343|76068495|FG002|Overall Study|Adverse Event|1|||
42243862|NCT04321343|76068496|FG003|Overall Study|Adverse Event|0|||
42243863|NCT04321343|76068493|FG000|Overall Study|Death|0|||
42243864|NCT04321343|76068494|FG001|Overall Study|Death|0|||
42243865|NCT04321343|76068495|FG002|Overall Study|Death|0|||
41989263|NCT01210144|75796803|FG001|Overall Study|No fertilization|0|||
42243866|NCT04321343|76068496|FG003|Overall Study|Death|1|||
42243867|NCT04321343|76068493|FG000|Overall Study|Pregnancy|1|||
42243868|NCT04321343|76068494|FG001|Overall Study|Pregnancy|0|||
42243869|NCT04321343|76068495|FG002|Overall Study|Pregnancy|0|||
42243870|NCT04321343|76068496|FG003|Overall Study|Pregnancy|0|||
42243871|NCT04321343|76068493|FG000|Overall Study|Protocol Violation|1|||
42243872|NCT04321343|76068494|FG001|Overall Study|Protocol Violation|1|||
42132034|NCT00510068|75942844|FG001|Open-label Period|Disease Progression|0|||
42132035|NCT00510068|75942843|FG000|Open-label Period|Adverse Event|46|||
42243873|NCT04321343|76068495|FG002|Overall Study|Protocol Violation|1|||
42243874|NCT04321343|76068496|FG003|Overall Study|Protocol Violation|1|||
42243875|NCT04321343|76068493|FG000|Overall Study|Withdrawal by Subject|0|||
42243876|NCT04321343|76068494|FG001|Overall Study|Withdrawal by Subject|6|||
42243877|NCT04321343|76068495|FG002|Overall Study|Withdrawal by Subject|0|||
42243878|NCT04321343|76068496|FG003|Overall Study|Withdrawal by Subject|2|||
42243879|NCT04321343|76068493|FG000|Overall Study|Lost to Follow-up|2|||
42243880|NCT04321343|76068494|FG001|Overall Study|Lost to Follow-up|2|||
42243881|NCT04321343|76068495|FG002|Overall Study|Lost to Follow-up|1|||
42243882|NCT04321343|76068496|FG003|Overall Study|Lost to Follow-up|3|||
42243883|NCT04238754|76068510|FG000|Washout - 1 Week|Lost to Follow-up|1|||
42243884|NCT04238754|76068511|FG001|Washout - 1 Week|Lost to Follow-up|0|||
42243885|NCT04150068|76068533|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
42243886|NCT04150068|76068534|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
42243887|NCT04150068|76068535|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
42243888|NCT04150068|76068533|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
42243889|NCT04150068|76068534|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
42243890|NCT04150068|76068535|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
42243891|NCT03920293|76068544|FG000|Overall Study|Withdrawal by Subject|2|||
42243892|NCT03920293|76068545|FG001|Overall Study|Withdrawal by Subject|1|||
42243893|NCT03920293|76068544|FG000|Overall Study|Physician Decision|1|||
42243894|NCT03920293|76068545|FG001|Overall Study|Physician Decision|2|||
42243895|NCT03920293|76068544|FG000|Overall Study|Adverse Event|0|||
42243896|NCT03920293|76068545|FG001|Overall Study|Adverse Event|2|||
42243897|NCT03920293|76068544|FG000|Overall Study|Sponsor Decision|0|||
42243898|NCT03920293|76068545|FG001|Overall Study|Sponsor Decision|1|||
42243899|NCT03920293|76068544|FG000|Overall Study|Death|2|||
42243900|NCT03920293|76068545|FG001|Overall Study|Death|0|||
42243901|NCT03920293|76068544|FG000|Overall Study|Protocol Violation|1|||
42243902|NCT03920293|76068545|FG001|Overall Study|Protocol Violation|0|||
42243903|NCT03920293|76068544|FG000|Overall Study|Noncompliance|1|||
42243904|NCT03920293|76068545|FG001|Overall Study|Noncompliance|0|||
42243905|NCT03317496|76068568|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
42243906|NCT03317496|76068569|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
42243907|NCT03317496|76068570|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
41989264|NCT01210144|75796802|FG000|Overall Study|No transfer|1|||
42243908|NCT03317496|76068571|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
42243909|NCT03317496|76068572|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
42243910|NCT03317496|76068568|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
42243911|NCT03317496|76068569|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
42132036|NCT00510068|75942844|FG001|Open-label Period|Adverse Event|0|||
42243912|NCT03317496|76068570|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
42243913|NCT03317496|76068571|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
42243914|NCT03317496|76068572|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
42243915|NCT03317496|76068568|FG000|Phase 1b Lead-in: Treatment|Death|0|||
42243916|NCT03317496|76068569|FG001|Phase 1b Lead-in: Treatment|Death|0|||
42243917|NCT03317496|76068570|FG002|Phase 1b Lead-in: Treatment|Death|1|||
42243918|NCT03317496|76068571|FG003|Phase 1b Lead-in: Treatment|Death|0|||
42243919|NCT03317496|76068572|FG004|Phase 1b Lead-in: Treatment|Death|0|||
42243920|NCT03317496|76068568|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
42243921|NCT03317496|76068569|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
42243922|NCT03317496|76068570|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
42243923|NCT03317496|76068571|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
42243924|NCT03317496|76068572|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
42243925|NCT03317496|76068568|FG000|Phase 1b Lead-in: Treatment|Other|2|||
42243926|NCT03317496|76068569|FG001|Phase 1b Lead-in: Treatment|Other|1|||
42243927|NCT03317496|76068570|FG002|Phase 1b Lead-in: Treatment|Other|0|||
42243928|NCT03317496|76068571|FG003|Phase 1b Lead-in: Treatment|Other|0|||
42243929|NCT03317496|76068572|FG004|Phase 1b Lead-in: Treatment|Other|0|||
42243930|NCT03317496|76068568|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
42243931|NCT03317496|76068569|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
42243932|NCT03317496|76068570|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
42243933|NCT03317496|76068571|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
42132037|NCT00510068|75942843|FG000|Open-label Period|Withdrawal by Subject|21|||
42243934|NCT03317496|76068572|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
42243935|NCT03317496|76068568|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
42243936|NCT03317496|76068569|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
41989265|NCT01210144|75796803|FG001|Overall Study|No transfer|0|||
42243937|NCT03317496|76068570|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
42243938|NCT03317496|76068571|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
42243939|NCT03317496|76068572|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
42243940|NCT03317496|76068568|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
42243941|NCT03317496|76068569|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
42243942|NCT03317496|76068570|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
42243943|NCT03317496|76068571|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
42243944|NCT03317496|76068572|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
42243945|NCT03317496|76068568|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
42243946|NCT03317496|76068569|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
42243947|NCT03317496|76068570|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
42243948|NCT03317496|76068571|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
41989266|NCT01209949|75796810|FG000|Overall Study|Lost to Follow-up|3|||
41989267|NCT01209832|75796814|FG000|Period 1|Sponsor Decision and was not dosed|1|||
41989268|NCT01209832|75796814|FG000|Period 2|Sponsor Decision|1|||
41989269|NCT01230892|75796827|FG000|Overall Study|Withdrawal by Subject|1|||
41989270|NCT01230892|75796828|FG001|Overall Study|Withdrawal by Subject|1|||
41989271|NCT01230892|75796827|FG000|Overall Study|Lost to Follow-up|2|||
41989272|NCT01230892|75796828|FG001|Overall Study|Lost to Follow-up|0|||
41989273|NCT01230814|75796836|FG000|Overall Study|Lost to Follow-up|11|||
42243949|NCT03317496|76068572|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
42243950|NCT03317496|76068568|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
42243951|NCT03317496|76068569|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
42243952|NCT03317496|76068570|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
42243953|NCT03317496|76068571|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
42243954|NCT03317496|76068572|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
42243955|NCT03317496|76068568|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
42243956|NCT03317496|76068569|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
42243957|NCT03317496|76068570|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
42243958|NCT03317496|76068571|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
42243959|NCT03317496|76068572|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
42243960|NCT03317496|76068568|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
42243961|NCT03317496|76068569|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
42243962|NCT03317496|76068570|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
42243963|NCT03317496|76068571|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
42243964|NCT03317496|76068572|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
42243965|NCT03317496|76068568|FG000|Phase 2: Treatment|Adverse Event|0|||
42243966|NCT03317496|76068569|FG001|Phase 2: Treatment|Adverse Event|0|||
42243967|NCT03317496|76068570|FG002|Phase 2: Treatment|Adverse Event|0|||
42243968|NCT03317496|76068571|FG003|Phase 2: Treatment|Adverse Event|0|||
42243969|NCT03317496|76068572|FG004|Phase 2: Treatment|Adverse Event|6|||
42243970|NCT03317496|76068568|FG000|Phase 2: Treatment|Progressive disease|0|||
42243971|NCT03317496|76068569|FG001|Phase 2: Treatment|Progressive disease|0|||
42243972|NCT03317496|76068570|FG002|Phase 2: Treatment|Progressive disease|0|||
42243973|NCT03317496|76068571|FG003|Phase 2: Treatment|Progressive disease|0|||
42243974|NCT03317496|76068572|FG004|Phase 2: Treatment|Progressive disease|22|||
42243975|NCT03317496|76068568|FG000|Phase 2: Treatment|Other|0|||
42243976|NCT03317496|76068569|FG001|Phase 2: Treatment|Other|0|||
42243977|NCT03317496|76068570|FG002|Phase 2: Treatment|Other|0|||
42243978|NCT03317496|76068571|FG003|Phase 2: Treatment|Other|0|||
42243979|NCT03317496|76068572|FG004|Phase 2: Treatment|Other|4|||
42243980|NCT03317496|76068568|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
42243981|NCT03317496|76068569|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
42243982|NCT03317496|76068570|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
42243983|NCT03317496|76068571|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
42243984|NCT03317496|76068572|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
42243985|NCT03317496|76068568|FG000|Phase 2: Treatment|Physician Decision|0|||
42243986|NCT03317496|76068569|FG001|Phase 2: Treatment|Physician Decision|0|||
42243987|NCT03317496|76068570|FG002|Phase 2: Treatment|Physician Decision|0|||
42243988|NCT03317496|76068571|FG003|Phase 2: Treatment|Physician Decision|0|||
41989274|NCT01230814|75796837|FG001|Overall Study|Lost to Follow-up|3|||
41989275|NCT01230814|75796836|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
42032826|NCT00943917|75841135|FG013|Stage I|hyperglycemia|0|||
42243989|NCT03317496|76068572|FG004|Phase 2: Treatment|Physician Decision|1|||
42032827|NCT00943917|75841136|FG014|Stage I|hyperglycemia|0|||
42032828|NCT00943917|75841122|FG000|Stage I|A1C elevation|1|||
42032829|NCT00943917|75841123|FG001|Stage I|A1C elevation|0|||
42243990|NCT03317496|76068568|FG000|Phase 2: Treatment|Death|0|||
42243991|NCT03317496|76068569|FG001|Phase 2: Treatment|Death|0|||
42243992|NCT03317496|76068570|FG002|Phase 2: Treatment|Death|0|||
42243993|NCT03317496|76068571|FG003|Phase 2: Treatment|Death|0|||
42243994|NCT03317496|76068572|FG004|Phase 2: Treatment|Death|1|||
42243995|NCT03317496|76068568|FG000|Phase 2: Follow-up|Death|0|||
42243996|NCT03317496|76068569|FG001|Phase 2: Follow-up|Death|0|||
42243997|NCT03317496|76068570|FG002|Phase 2: Follow-up|Death|0|||
42243998|NCT03317496|76068571|FG003|Phase 2: Follow-up|Death|0|||
42243999|NCT03317496|76068572|FG004|Phase 2: Follow-up|Death|24|||
42244000|NCT03317496|76068568|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
42244001|NCT03317496|76068569|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
42244002|NCT03317496|76068570|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
42244003|NCT03317496|76068571|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
42244004|NCT03317496|76068572|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
42244005|NCT03317496|76068568|FG000|Phase 2: Follow-up|Other|0|||
42244006|NCT03317496|76068569|FG001|Phase 2: Follow-up|Other|0|||
42244007|NCT03317496|76068570|FG002|Phase 2: Follow-up|Other|0|||
42244008|NCT03317496|76068571|FG003|Phase 2: Follow-up|Other|0|||
42244009|NCT03317496|76068572|FG004|Phase 2: Follow-up|Other|1|||
42244010|NCT03317496|76068568|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
42244011|NCT03317496|76068569|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
42244012|NCT03317496|76068570|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
42244013|NCT03317496|76068571|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
42244014|NCT03317496|76068572|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
42244015|NCT02836249|76068594|FG000|Overall Study|Randomized but Never Treated|0|||
42244016|NCT02836249|76068595|FG001|Overall Study|Randomized but Never Treated|1|||
42244017|NCT02836249|76068594|FG000|Overall Study|Pregnancy|2|||
42244018|NCT02836249|76068595|FG001|Overall Study|Pregnancy|0|||
42244019|NCT02836249|76068594|FG000|Overall Study|Withdrew Consent|0|||
42244020|NCT02836249|76068595|FG001|Overall Study|Withdrew Consent|1|||
42244021|NCT02836249|76068594|FG000|Overall Study|Lost to Follow-up|0|||
42244022|NCT02836249|76068595|FG001|Overall Study|Lost to Follow-up|1|||
42244023|NCT02836249|76068594|FG000|Overall Study|Still on Study|121|||
42244024|NCT02836249|76068595|FG001|Overall Study|Still on Study|55|||
42244025|NCT01849562|76068608|FG000|Overall Study|Lost to Follow-up|1|||
42244026|NCT01849562|76068609|FG001|Overall Study|Lost to Follow-up|0|||
42244027|NCT01849562|76068610|FG002|Overall Study|Lost to Follow-up|0|||
42244028|NCT01849562|76068608|FG000|Overall Study|Non-compliance with Study Drug|1|||
42244029|NCT01849562|76068609|FG001|Overall Study|Non-compliance with Study Drug|0|||
42244030|NCT01849562|76068610|FG002|Overall Study|Non-compliance with Study Drug|0|||
42244031|NCT01700179|76068619|FG000|Overall Study|Physician Decision|2|||
42244032|NCT00665223|76068635|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
42244033|NCT00665223|76068636|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
42244034|NCT00665223|76068637|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
42244035|NCT00665223|76068635|FG000|Randomized Phase (26 Weeks)|Death|0|||
42244036|NCT00665223|76068636|FG001|Randomized Phase (26 Weeks)|Death|0|||
42244037|NCT00665223|76068637|FG002|Randomized Phase (26 Weeks)|Death|1|||
41989276|NCT01230814|75796837|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
41989277|NCT01230307|75796845|FG000|Overall Study|LVAD Placement|0|||
42244038|NCT00665223|76068635|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
41989278|NCT01230307|75796846|FG001|Overall Study|LVAD Placement|2|||
42244039|NCT00665223|76068636|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
42244040|NCT00665223|76068637|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
42244041|NCT00665223|76068635|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
42244042|NCT00665223|76068636|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
42244043|NCT00665223|76068637|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
42244044|NCT00665223|76068635|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
42244045|NCT00665223|76068636|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
42032830|NCT00943917|75841124|FG002|Stage I|A1C elevation|0|||
42244046|NCT00665223|76068637|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
42244047|NCT00665223|76068635|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
42244048|NCT00665223|76068636|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
42244049|NCT00665223|76068637|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
42244050|NCT00665223|76068635|FG000|Open-Label Period (26 Weeks)|Death|0|||
42244051|NCT00665223|76068636|FG001|Open-Label Period (26 Weeks)|Death|1|||
42244052|NCT00665223|76068637|FG002|Open-Label Period (26 Weeks)|Death|0|||
42244053|NCT00665223|76068635|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
42244054|NCT00665223|76068636|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
42244055|NCT00665223|76068637|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
42244056|NCT00665223|76068635|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
42244057|NCT00665223|76068636|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
42244058|NCT00665223|76068637|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
42244059|NCT00665223|76068635|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
42244060|NCT00665223|76068636|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
42244061|NCT00665223|76068637|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
42244062|NCT00665223|76068635|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
42244063|NCT00665223|76068636|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
42244064|NCT00665223|76068637|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
42244065|NCT03786380|76068658|FG000|Overall Study|Adverse Event|1|||
41989279|NCT01209598|75796854|FG000|Overall Study|Withdrawal by Subject|1|||
41989280|NCT01209598|75796855|FG001|Overall Study|Withdrawal by Subject|0|||
41989281|NCT01209520|75796862|FG000|Overall Study|Withdrawal by Subject|3|||
41989282|NCT01209325|75796866|FG000|Overall Study|Lost to Follow-up|24|||
42244066|NCT03786380|76068659|FG001|Overall Study|Adverse Event|0|||
42244067|NCT03786380|76068660|FG002|Overall Study|Adverse Event|0|||
42244068|NCT03786380|76068661|FG003|Overall Study|Adverse Event|3|||
42244069|NCT03786380|76068662|FG004|Overall Study|Adverse Event|1|||
42244070|NCT03786380|76068658|FG000|Overall Study|Lack of Efficacy|0|||
42244071|NCT03786380|76068659|FG001|Overall Study|Lack of Efficacy|0|||
42244072|NCT03786380|76068660|FG002|Overall Study|Lack of Efficacy|0|||
42244073|NCT03786380|76068661|FG003|Overall Study|Lack of Efficacy|0|||
42244074|NCT03786380|76068662|FG004|Overall Study|Lack of Efficacy|1|||
42244075|NCT03786380|76068658|FG000|Overall Study|Withdrawal by Subject|1|||
42244076|NCT03786380|76068659|FG001|Overall Study|Withdrawal by Subject|2|||
42244077|NCT03786380|76068660|FG002|Overall Study|Withdrawal by Subject|2|||
42244078|NCT03786380|76068661|FG003|Overall Study|Withdrawal by Subject|1|||
42244079|NCT03786380|76068662|FG004|Overall Study|Withdrawal by Subject|2|||
42244080|NCT03786380|76068658|FG000|Overall Study|Lost to Follow-up|3|||
42244081|NCT03786380|76068659|FG001|Overall Study|Lost to Follow-up|0|||
42244082|NCT03786380|76068660|FG002|Overall Study|Lost to Follow-up|1|||
42244083|NCT03786380|76068661|FG003|Overall Study|Lost to Follow-up|2|||
42244084|NCT03786380|76068662|FG004|Overall Study|Lost to Follow-up|0|||
42244085|NCT03786380|76068658|FG000|Overall Study|Physician Decision|0|||
42244086|NCT03786380|76068659|FG001|Overall Study|Physician Decision|0|||
42244087|NCT03786380|76068660|FG002|Overall Study|Physician Decision|1|||
42244088|NCT03786380|76068661|FG003|Overall Study|Physician Decision|0|||
42244089|NCT03786380|76068662|FG004|Overall Study|Physician Decision|0|||
42244090|NCT03786380|76068658|FG000|Overall Study|Study Terminated by the Sponsor|30|||
42244091|NCT03786380|76068659|FG001|Overall Study|Study Terminated by the Sponsor|20|||
42244092|NCT03786380|76068660|FG002|Overall Study|Study Terminated by the Sponsor|50|||
42244093|NCT03786380|76068661|FG003|Overall Study|Study Terminated by the Sponsor|57|||
42244094|NCT03786380|76068662|FG004|Overall Study|Study Terminated by the Sponsor|23|||
42244095|NCT03786380|76068658|FG000|Overall Study|Reason Not Specified|0|||
42244096|NCT03786380|76068659|FG001|Overall Study|Reason Not Specified|0|||
42244097|NCT03786380|76068660|FG002|Overall Study|Reason Not Specified|0|||
42244098|NCT03786380|76068661|FG003|Overall Study|Reason Not Specified|0|||
42244099|NCT03786380|76068662|FG004|Overall Study|Reason Not Specified|1|||
42244100|NCT02626000|76068674|FG000|Overall Study|Decision by Sponsor|1|||
42244101|NCT02626000|76068674|FG000|Overall Study|Death|29|||
42244102|NCT02736890|76068690|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
42244103|NCT02736890|76068691|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
42244104|NCT02736890|76068690|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
42244105|NCT02736890|76068691|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
42244106|NCT02779556|76068699|FG000|Baseline|Partial baseline interview completed|1|||
42244107|NCT02779556|76068700|FG001|Baseline|Partial baseline interview completed|0|||
42244108|NCT02779556|76068699|FG000|3 Months|Lost to Follow-up|40|||
42244109|NCT02779556|76068700|FG001|3 Months|Lost to Follow-up|29|||
42244110|NCT02779556|76068699|FG000|3 Months|Missed 3 month clinic visit|27|||
42244111|NCT02779556|76068700|FG001|3 Months|Missed 3 month clinic visit|19|||
42244112|NCT02779556|76068699|FG000|6 Month|Lost to Follow-up|33|||
42244113|NCT02779556|76068700|FG001|6 Month|Lost to Follow-up|39|||
42244114|NCT02779556|76068699|FG000|6 Month HbA1c|No value collected during window|69|||
42244115|NCT02779556|76068700|FG001|6 Month HbA1c|No value collected during window|50|||
42244116|NCT02779556|76068699|FG000|12 Month HbA1c|No value collected during window|138|||
42244117|NCT02779556|76068700|FG001|12 Month HbA1c|No value collected during window|102|||
42244118|NCT01669798|76068706|FG000|Overall Study|Physician Decision|5|||
42244119|NCT02334722|76068712|FG000|Overall Study|Lost to Follow-up|4|||
42244120|NCT02334722|76068713|FG001|Overall Study|Lost to Follow-up|0|||
42244121|NCT02334722|76068712|FG000|Overall Study|6 week questionnaire not completed|2|||
42244122|NCT02334722|76068713|FG001|Overall Study|6 week questionnaire not completed|0|||
42244123|NCT02334722|76068712|FG000|Overall Study|Unable to obtain medication|1|||
42244124|NCT02334722|76068713|FG001|Overall Study|Unable to obtain medication|1|||
42244125|NCT02334722|76068712|FG000|Overall Study|Withdrawal by Subject|0|||
42244126|NCT02334722|76068713|FG001|Overall Study|Withdrawal by Subject|3|||
42244127|NCT02334722|76068712|FG000|Overall Study|Adverse Event|0|||
42244128|NCT02334722|76068713|FG001|Overall Study|Adverse Event|2|||
42244129|NCT02334722|76068712|FG000|Overall Study|Physician Decision|0|||
42244130|NCT02334722|76068713|FG001|Overall Study|Physician Decision|1|||
42244131|NCT00812708|76068728|FG000|Overall Study|Device could not be implanted|2|||
42244132|NCT00812708|76068728|FG000|Overall Study|Lack of medical insurance|1|||
42244133|NCT00812708|76068728|FG000|Overall Study|Switched to another study|1|||
42244134|NCT00812708|76068728|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
42244135|NCT00812708|76068728|FG000|Overall Study|Signed consent but later withdrew|3|||
42244136|NCT03761810|76068744|FG000|Overall Study|Adverse Event|12|||
42244137|NCT03761810|76068745|FG001|Overall Study|Adverse Event|0|||
42244138|NCT03761810|76068744|FG000|Overall Study|Lost to Follow-up|15|||
42244139|NCT03761810|76068745|FG001|Overall Study|Lost to Follow-up|7|||
42244140|NCT03761810|76068744|FG000|Overall Study|Pregnancy|1|||
42244141|NCT03761810|76068745|FG001|Overall Study|Pregnancy|0|||
42244142|NCT03761810|76068744|FG000|Overall Study|Withdrawal by Subject|14|||
42244143|NCT03761810|76068745|FG001|Overall Study|Withdrawal by Subject|5|||
42244144|NCT03761810|76068744|FG000|Overall Study|Physician Decision|1|||
42244145|NCT03761810|76068745|FG001|Overall Study|Physician Decision|0|||
42244146|NCT03761810|76068744|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
42244147|NCT03761810|76068745|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
42244148|NCT03761810|76068744|FG000|Overall Study|Other Than Specified|1|||
42244149|NCT03761810|76068745|FG001|Overall Study|Other Than Specified|0|||
41989283|NCT01209325|75796866|FG000|Overall Study|Adverse Event|1|||
41989284|NCT01209325|75796866|FG000|Overall Study|Relocated|3|||
41989285|NCT01209325|75796866|FG000|Overall Study|Refusal after starting therapy|8|||
41989286|NCT01209325|75796866|FG000|Overall Study|Protocol Violation|4|||
41989287|NCT01209325|75796866|FG000|Overall Study|Refusal prior to therapy|1|||
41989288|NCT01209325|75796866|FG000|Overall Study|Incarceration|2|||
41989289|NCT01209286|75796904|FG000|Overall Study|Adverse Event|4|||
41989290|NCT01209286|75796905|FG001|Overall Study|Adverse Event|3|||
41989291|NCT01209286|75796906|FG002|Overall Study|Adverse Event|1|||
41989292|NCT01209286|75796904|FG000|Overall Study|Hematological Relapse After Remission|0|||
41989293|NCT01209286|75796905|FG001|Overall Study|Hematological Relapse After Remission|1|||
41989294|NCT01209286|75796906|FG002|Overall Study|Hematological Relapse After Remission|1|||
41989295|NCT01209286|75796904|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
41989296|NCT01209286|75796905|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
41989297|NCT01209286|75796906|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
41989298|NCT01209286|75796904|FG000|Overall Study|Physician Decision|0|||
42244150|NCT02811159|76068756|FG000|Treatment Course 1|Lost to Follow-up|1|||
42244151|NCT01889186|76068762|FG000|Overall Study|Adverse event- not related to progression|18|||
42244152|NCT01889186|76068763|FG001|Overall Study|Adverse event- not related to progression|5|||
42244153|NCT01889186|76068762|FG000|Overall Study|Adverse event- related to progression|7|||
42244154|NCT01889186|76068763|FG001|Overall Study|Adverse event- related to progression|2|||
42244155|NCT01889186|76068762|FG000|Overall Study|COVID-19 logistical restrictions|1|||
42244156|NCT01889186|76068763|FG001|Overall Study|COVID-19 logistical restrictions|0|||
42244157|NCT01889186|76068762|FG000|Overall Study|Investigator request|1|||
42244158|NCT01889186|76068763|FG001|Overall Study|Investigator request|1|||
42244159|NCT01889186|76068762|FG000|Overall Study|Progressive disease- Richter's|12|||
42244160|NCT01889186|76068763|FG001|Overall Study|Progressive disease- Richter's|7|||
42244161|NCT01889186|76068762|FG000|Overall Study|Progressive disease per protocol|46|||
42244162|NCT01889186|76068763|FG001|Overall Study|Progressive disease per protocol|17|||
42244163|NCT01889186|76068762|FG000|Overall Study|Stem cell transplant|2|||
42244164|NCT01889186|76068763|FG001|Overall Study|Stem cell transplant|1|||
42244165|NCT01889186|76068762|FG000|Overall Study|Withdrew consent|2|||
42244166|NCT01889186|76068763|FG001|Overall Study|Withdrew consent|3|||
42244167|NCT01889186|76068762|FG000|Overall Study|Other, not specified|18|||
42244168|NCT01889186|76068763|FG001|Overall Study|Other, not specified|15|||
42244169|NCT01510184|76068773|FG000|Overall Study|Sponsor discretion|28|||
42244170|NCT01510184|76068774|FG001|Overall Study|Sponsor discretion|28|||
42244171|NCT01510184|76068773|FG000|Overall Study|Death|1|||
42244172|NCT01510184|76068774|FG001|Overall Study|Death|2|||
42244173|NCT01510184|76068773|FG000|Overall Study|Withdrawal by Subject|1|||
42244174|NCT01510184|76068774|FG001|Overall Study|Withdrawal by Subject|4|||
42244175|NCT01510184|76068773|FG000|Overall Study|Other|0|||
42244176|NCT01510184|76068774|FG001|Overall Study|Other|1|||
42244177|NCT02809833|76068799|FG000|Overall Study|Death|3|||
42244178|NCT02809833|76068799|FG000|Overall Study|Intolerance|54|||
42244179|NCT02809833|76068799|FG000|Overall Study|Lack of Efficacy|89|||
42244180|NCT02809833|76068799|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
42244181|NCT02809833|76068799|FG000|Overall Study|Noncompliance|1|||
42244182|NCT02809833|76068799|FG000|Overall Study|Withdrawal by Subject|34|||
42244183|NCT02809833|76068799|FG000|Overall Study|Lost to Follow-up|35|||
42244184|NCT02809833|76068799|FG000|Overall Study|Adverse Event (AE)|24|||
42244185|NCT02809833|76068799|FG000|Overall Study|Other|5|||
42244186|NCT02809833|76068799|FG000|Overall Study|Missing Information|52|||
42244187|NCT02797262|76068805|FG000|Overall Study|Withdrawal by Subject|5|||
42244188|NCT02797262|76068806|FG001|Overall Study|Withdrawal by Subject|1|||
41989299|NCT01209286|75796905|FG001|Overall Study|Physician Decision|2|||
41989300|NCT01209286|75796906|FG002|Overall Study|Physician Decision|0|||
41989301|NCT01209286|75796904|FG000|Overall Study|Other|0|||
41989302|NCT01209286|75796905|FG001|Overall Study|Other|1|||
41989303|NCT01209286|75796906|FG002|Overall Study|Other|0|||
41989304|NCT05048719|75796939|FG000|Overall Study|Withdrawal by Subject|2|||
41989305|NCT05048719|75796940|FG001|Overall Study|Withdrawal by Subject|1|||
41989306|NCT05048719|75796941|FG002|Overall Study|Withdrawal by Subject|3|||
42244189|NCT02797262|76068805|FG000|Overall Study|Lost to Follow-up|10|||
42244190|NCT02797262|76068806|FG001|Overall Study|Lost to Follow-up|7|||
42244191|NCT02797262|76068805|FG000|Overall Study|Death|1|||
42244192|NCT02797262|76068806|FG001|Overall Study|Death|2|||
42244193|NCT02797262|76068805|FG000|Overall Study|Adverse Event|1|||
42244194|NCT02797262|76068806|FG001|Overall Study|Adverse Event|0|||
42244195|NCT02797262|76068805|FG000|Overall Study|COVID-19|2|||
42244196|NCT02797262|76068806|FG001|Overall Study|COVID-19|1|||
42244197|NCT02797262|76068805|FG000|Overall Study|Out-of-country|1|||
42244198|NCT02797262|76068806|FG001|Overall Study|Out-of-country|0|||
42244199|NCT02809053|76068814|FG000|Overall Study|Death|0|||
42244200|NCT02809053|76068815|FG001|Overall Study|Death|1|||
42244201|NCT02809053|76068814|FG000|Overall Study|Lost to Follow-up|3|||
42244202|NCT02809053|76068815|FG001|Overall Study|Lost to Follow-up|1|||
42244203|NCT02809053|76068814|FG000|Overall Study|Withdrawal by Subject|2|||
42244204|NCT02809053|76068815|FG001|Overall Study|Withdrawal by Subject|3|||
42244205|NCT02809053|76068814|FG000|Overall Study|Disease Progression|2|||
42244206|NCT02809053|76068815|FG001|Overall Study|Disease Progression|1|||
42244207|NCT02808975|76068823|FG000|Overall Study|Adverse Event|3|||
42244208|NCT02808975|76068824|FG001|Overall Study|Adverse Event|4|||
42244209|NCT02808975|76068823|FG000|Overall Study|Withdrew consent|9|||
42244210|NCT02808975|76068824|FG001|Overall Study|Withdrew consent|8|||
42244211|NCT02808975|76068823|FG000|Overall Study|Lost to Follow-up|4|||
42244212|NCT02808975|76068824|FG001|Overall Study|Lost to Follow-up|6|||
42244213|NCT02808975|76068823|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
42244214|NCT02808975|76068824|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
42244215|NCT02808975|76068823|FG000|Overall Study|Other, not specified|5|||
42244216|NCT02808975|76068824|FG001|Overall Study|Other, not specified|1|||
42244217|NCT02976038|76068830|FG000|Overall Study|Physician Decision|22|||
42244218|NCT02976038|76068830|FG000|Overall Study|Withdrawal by Subject|3|||
42244219|NCT02976038|76068830|FG000|Overall Study|Lost to Follow-up|2|||
42244220|NCT02976038|76068830|FG000|Overall Study|Adverse Event|1|||
42244221|NCT02808819|76068855|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
42244222|NCT02808819|76068856|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
42244223|NCT02808819|76068855|FG000|Overall Study|Withdrawal by Subject|10|||
42244224|NCT02808819|76068856|FG001|Overall Study|Withdrawal by Subject|13|||
42244225|NCT02808819|76068855|FG000|Overall Study|Site terminated by sponsor|2|||
42244226|NCT02808819|76068856|FG001|Overall Study|Site terminated by sponsor|0|||
42244227|NCT02808819|76068855|FG000|Overall Study|Pregnancy|1|||
42244228|NCT02808819|76068856|FG001|Overall Study|Pregnancy|0|||
42244229|NCT02808819|76068855|FG000|Overall Study|Lost to Follow-up|1|||
42244230|NCT02808819|76068856|FG001|Overall Study|Lost to Follow-up|6|||
42244231|NCT02808819|76068855|FG000|Overall Study|Protocol Violation|0|||
42244232|NCT02808819|76068856|FG001|Overall Study|Protocol Violation|1|||
42244233|NCT02808819|76068855|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
42244234|NCT02808819|76068856|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
42244235|NCT02808819|76068855|FG000|Overall Study|Death|1|||
42244236|NCT02808819|76068856|FG001|Overall Study|Death|0|||
42244237|NCT02808819|76068855|FG000|Overall Study|Adverse Event|3|||
42244238|NCT02808819|76068856|FG001|Overall Study|Adverse Event|4|||
42244239|NCT02808429|76068866|FG000|Overall Study|Lost to Follow-up|1|||
42244240|NCT02808429|76068867|FG001|Overall Study|Lost to Follow-up|0|||
42244241|NCT02808429|76068868|FG002|Overall Study|Lost to Follow-up|0|||
42244242|NCT02808429|76068866|FG000|Overall Study|Protocol Violation|0|||
42244243|NCT02808429|76068867|FG001|Overall Study|Protocol Violation|1|||
42244244|NCT02808429|76068868|FG002|Overall Study|Protocol Violation|0|||
42244245|NCT02808429|76068866|FG000|Overall Study|Premature study termination by sponsor|2|||
42244246|NCT02808429|76068867|FG001|Overall Study|Premature study termination by sponsor|0|||
42244247|NCT02808429|76068868|FG002|Overall Study|Premature study termination by sponsor|1|||
42244248|NCT02808429|76068866|FG000|Overall Study|Relocation|0|||
42244249|NCT02808429|76068867|FG001|Overall Study|Relocation|0|||
42244250|NCT02808429|76068868|FG002|Overall Study|Relocation|1|||
42244251|NCT01594762|76068878|FG000|Overall Study|Withdrawal by Subject|1|||
42244252|NCT01594762|76068879|FG001|Overall Study|Withdrawal by Subject|0|||
42244253|NCT01594762|76068878|FG000|Overall Study|Lost to Follow-up|10|||
42244254|NCT01594762|76068879|FG001|Overall Study|Lost to Follow-up|10|||
42244255|NCT02615470|76068887|FG000|Overall Study|Lost to Follow-up|21|||
42244256|NCT02615470|76068888|FG001|Overall Study|Lost to Follow-up|32|||
42244257|NCT02806947|76068896|FG000|Overall Study|Withdrawal by Subject|5|||
42244258|NCT02806947|76068897|FG001|Overall Study|Withdrawal by Subject|1|||
42244259|NCT02806713|76068905|FG000|Overall Study|Urethral injury during procedure|1|||
41989307|NCT05048719|75796942|FG003|Overall Study|Withdrawal by Subject|1|||
42244260|NCT02806713|76068906|FG001|Overall Study|Urethral injury during procedure|0|||
42244261|NCT02806713|76068905|FG000|Overall Study|cancelled surgery|1|||
42244262|NCT02806713|76068906|FG001|Overall Study|cancelled surgery|2|||
42244263|NCT02807493|76068914|FG000|Overall Study|Adverse Event|5|||
42244264|NCT02807493|76068915|FG001|Overall Study|Adverse Event|2|||
42244265|NCT02807493|76068914|FG000|Overall Study|Lost to Follow-up|6|||
42244266|NCT02807493|76068915|FG001|Overall Study|Lost to Follow-up|0|||
42244267|NCT02807493|76068914|FG000|Overall Study|Physician Decision|4|||
42244268|NCT02807493|76068915|FG001|Overall Study|Physician Decision|1|||
42244269|NCT02807493|76068914|FG000|Overall Study|Protocol Violation|7|||
42244270|NCT02807493|76068915|FG001|Overall Study|Protocol Violation|0|||
42244271|NCT02807493|76068914|FG000|Overall Study|Withdrawal by Subject|17|||
42244272|NCT02807493|76068915|FG001|Overall Study|Withdrawal by Subject|10|||
42244273|NCT02807493|76068914|FG000|Overall Study|Other withdrawal|17|||
41989308|NCT05048719|75796943|FG004|Overall Study|Withdrawal by Subject|0|||
41989309|NCT05048719|75796944|FG005|Overall Study|Withdrawal by Subject|2|||
41989310|NCT05048719|75796945|FG006|Overall Study|Withdrawal by Subject|1|||
42244274|NCT02807493|76068915|FG001|Overall Study|Other withdrawal|0|||
42244275|NCT02807493|76068914|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
42244276|NCT02807493|76068915|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
42244277|NCT02807259|76068923|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
42244278|NCT02807259|76068924|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
42244279|NCT02807259|76068923|FG000|Midline (3 Months)|migration, refusal, not available|30|||
42244280|NCT02807259|76068924|FG001|Midline (3 Months)|migration, refusal, not available|34|||
42244281|NCT02807259|76068923|FG000|Endline (3 Months)|migration, refusal, not available|35|||
42244282|NCT02807259|76068924|FG001|Endline (3 Months)|migration, refusal, not available|87|||
42244283|NCT02802345|76068934|FG000|Overall Study|Not Treated|0|||
42244284|NCT02802345|76068935|FG001|Overall Study|Not Treated|1|||
42244285|NCT02802345|76068934|FG000|Overall Study|Adverse Event|28|||
42244286|NCT02802345|76068935|FG001|Overall Study|Adverse Event|20|||
42244287|NCT02802345|76068934|FG000|Overall Study|Withdrawal by Subject|3|||
42244288|NCT02802345|76068935|FG001|Overall Study|Withdrawal by Subject|3|||
41989311|NCT05048719|75796946|FG007|Overall Study|Withdrawal by Subject|1|||
42244289|NCT02802345|76068934|FG000|Overall Study|Protocol Violation|0|||
42244290|NCT02802345|76068935|FG001|Overall Study|Protocol Violation|1|||
42244291|NCT02802345|76068934|FG000|Overall Study|Other than listed|1|||
42244292|NCT02802345|76068935|FG001|Overall Study|Other than listed|5|||
42244293|NCT02801877|76068945|FG000|Overall Study|Lost to Follow-up|1|||
42244294|NCT02801877|76068946|FG001|Overall Study|Lost to Follow-up|1|||
42244295|NCT02801877|76068947|FG002|Overall Study|Lost to Follow-up|2|||
42244296|NCT02801877|76068948|FG003|Overall Study|Lost to Follow-up|0|||
42244297|NCT02801877|76068945|FG000|Overall Study|Never Started Treatment|2|||
42244298|NCT02801877|76068946|FG001|Overall Study|Never Started Treatment|0|||
42244299|NCT02801877|76068947|FG002|Overall Study|Never Started Treatment|4|||
42244300|NCT02801877|76068948|FG003|Overall Study|Never Started Treatment|0|||
42244301|NCT02805309|76068961|FG000|Overall Study|Lost to Follow-up|2|||
42244302|NCT02805309|76068962|FG001|Overall Study|Lost to Follow-up|2|||
42244303|NCT02805309|76068963|FG002|Overall Study|Lost to Follow-up|2|||
42244304|NCT02805309|76068961|FG000|Overall Study|Post-Randomization Exclusion|0|||
42244305|NCT02805309|76068962|FG001|Overall Study|Post-Randomization Exclusion|2|||
42244306|NCT02805309|76068963|FG002|Overall Study|Post-Randomization Exclusion|1|||
42244307|NCT02804763|76068975|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
42244308|NCT02804763|76068976|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
42244309|NCT02804763|76068977|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
42244310|NCT02804763|76068978|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
42244311|NCT02804763|76068975|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
42244312|NCT02804763|76068976|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
42244313|NCT02804763|76068977|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
42244314|NCT02804763|76068978|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
42244315|NCT02804763|76068975|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
42244316|NCT02804763|76068976|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
42244317|NCT02804763|76068977|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
42244318|NCT02804763|76068978|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
42244319|NCT02804763|76068975|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
42244320|NCT02804763|76068976|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
42244321|NCT02804763|76068977|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
42244322|NCT02804763|76068978|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
42244323|NCT02804763|76068975|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
42244324|NCT02804763|76068976|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
42244325|NCT02804763|76068977|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
42244326|NCT02804763|76068978|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
42244327|NCT02804763|76068975|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
42244328|NCT02804763|76068976|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
42244329|NCT02804763|76068977|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
42244330|NCT02804763|76068978|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
42244331|NCT02748057|76068994|FG000|Overall Study|Adverse Event|1|||
42244332|NCT02748057|76068995|FG001|Overall Study|Adverse Event|0|||
42244333|NCT02748057|76068994|FG000|Overall Study|Physician Decision|0|||
42244334|NCT02748057|76068995|FG001|Overall Study|Physician Decision|1|||
42244335|NCT02748057|76068994|FG000|Overall Study|Protocol Violation|2|||
41989312|NCT05048719|75796947|FG008|Overall Study|Withdrawal by Subject|0|||
41989313|NCT05048719|75796939|FG000|Overall Study|Death|1|||
42244336|NCT02748057|76068995|FG001|Overall Study|Protocol Violation|1|||
42244337|NCT02748057|76068994|FG000|Overall Study|Participant Moved|1|||
42244338|NCT02748057|76068995|FG001|Overall Study|Participant Moved|0|||
42244339|NCT02748057|76068994|FG000|Overall Study|Withdrawal by Subject|1|||
42244340|NCT02748057|76068995|FG001|Overall Study|Withdrawal by Subject|0|||
41989314|NCT05048719|75796940|FG001|Overall Study|Death|0|||
42244341|NCT02748213|76069003|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
42244342|NCT02748213|76069004|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
42244343|NCT02748213|76069003|FG000|Overall Study|Abnormal Laboratory Test|1|||
42244344|NCT02748213|76069004|FG001|Overall Study|Abnormal Laboratory Test|0|||
42244345|NCT02748213|76069003|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
42244346|NCT02748213|76069004|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
42244347|NCT02748213|76069003|FG000|Overall Study|Death|5|||
42244348|NCT02748213|76069004|FG001|Overall Study|Death|3|||
42244349|NCT02748213|76069003|FG000|Overall Study|Insufficient Therapeutic Response|56|||
42244350|NCT02748213|76069004|FG001|Overall Study|Insufficient Therapeutic Response|57|||
42244351|NCT02748213|76069003|FG000|Overall Study|Violation of Selection Criteria|2|||
42244352|NCT02748213|76069004|FG001|Overall Study|Violation of Selection Criteria|0|||
42244353|NCT02748213|76069003|FG000|Overall Study|Protocol Violation|6|||
42244354|NCT02748213|76069004|FG001|Overall Study|Protocol Violation|4|||
42244355|NCT02748213|76069003|FG000|Overall Study|Refused Treatment*|6|||
42244356|NCT02748213|76069004|FG001|Overall Study|Refused Treatment*|6|||
42244357|NCT02748213|76069003|FG000|Overall Study|Failure to Return|1|||
42244358|NCT02748213|76069004|FG001|Overall Study|Failure to Return|0|||
42244359|NCT02748213|76069003|FG000|Overall Study|Other|30|||
42244360|NCT02748213|76069004|FG001|Overall Study|Other|29|||
42244361|NCT02613910|76069010|FG000|Overall Study|Termination of study|1|||
42244362|NCT02802735|76069017|FG000|Overall Study|Withdrawal by Subject|0|||
42244363|NCT02802735|76069018|FG001|Overall Study|Withdrawal by Subject|1|||
42244364|NCT02802735|76069019|FG002|Overall Study|Withdrawal by Subject|0|||
42244365|NCT02802735|76069020|FG003|Overall Study|Withdrawal by Subject|0|||
42244366|NCT02802735|76069021|FG004|Overall Study|Withdrawal by Subject|0|||
42244367|NCT02799381|76069051|FG000|Overall Study|Withdrew consent|3|||
42244368|NCT02799381|76069052|FG001|Overall Study|Withdrew consent|2|||
42244369|NCT02799381|76069051|FG000|Overall Study|Adverse Event|0|||
42244370|NCT02799381|76069052|FG001|Overall Study|Adverse Event|1|||
42244371|NCT02799381|76069051|FG000|Overall Study|Participant did not take any study drug|1|||
42244372|NCT02799381|76069052|FG001|Overall Study|Participant did not take any study drug|0|||
42244373|NCT01333059|76069060|FG000|Overall Study|Physician Decision|3|||
42244374|NCT01333059|76069061|FG001|Overall Study|Physician Decision|3|||
42244375|NCT01333059|76069060|FG000|Overall Study|Protocol Violation|3|||
42244376|NCT01333059|76069061|FG001|Overall Study|Protocol Violation|0|||
42244377|NCT01370733|76069071|FG000|Overall Study|Withdrawal by Subject|8|||
42244378|NCT01370733|76069072|FG001|Overall Study|Withdrawal by Subject|8|||
42244379|NCT01370733|76069071|FG000|Overall Study|Lost to Follow-up|3|||
42244380|NCT01370733|76069072|FG001|Overall Study|Lost to Follow-up|0|||
42244381|NCT01370733|76069071|FG000|Overall Study|Adverse Event|2|||
42244382|NCT01370733|76069072|FG001|Overall Study|Adverse Event|4|||
42244383|NCT01370733|76069071|FG000|Overall Study|Lack of Efficacy|3|||
42244384|NCT01370733|76069072|FG001|Overall Study|Lack of Efficacy|5|||
42244385|NCT01370733|76069071|FG000|Overall Study|Physician Decision|0|||
42244386|NCT01370733|76069072|FG001|Overall Study|Physician Decision|2|||
42244387|NCT01370733|76069071|FG000|Overall Study|Protocol Violation|1|||
42244388|NCT01370733|76069072|FG001|Overall Study|Protocol Violation|3|||
42244389|NCT02613364|76069081|FG000|Overall Study|Other|19|||
42244390|NCT02613364|76069082|FG001|Overall Study|Other|29|||
42244391|NCT02613364|76069083|FG002|Overall Study|Other|17|||
42244392|NCT02613364|76069081|FG000|Overall Study|Too time consuming|21|||
42244393|NCT02613364|76069082|FG001|Overall Study|Too time consuming|26|||
42244394|NCT02613364|76069083|FG002|Overall Study|Too time consuming|26|||
42244395|NCT02613364|76069081|FG000|Overall Study|Withdrawal by Subject|13|||
42244396|NCT02613364|76069082|FG001|Overall Study|Withdrawal by Subject|18|||
41989315|NCT05048719|75796941|FG002|Overall Study|Death|0|||
42244397|NCT02613364|76069083|FG002|Overall Study|Withdrawal by Subject|17|||
42244398|NCT02613364|76069081|FG000|Overall Study|Medical|12|||
42244399|NCT02613364|76069082|FG001|Overall Study|Medical|13|||
41989316|NCT05048719|75796942|FG003|Overall Study|Death|0|||
42244400|NCT02613364|76069083|FG002|Overall Study|Medical|9|||
42244401|NCT02613364|76069081|FG000|Overall Study|Disliked Study Procedure|1|||
41989317|NCT05048719|75796943|FG004|Overall Study|Death|0|||
42244402|NCT02613364|76069082|FG001|Overall Study|Disliked Study Procedure|1|||
42244403|NCT02613364|76069083|FG002|Overall Study|Disliked Study Procedure|4|||
42244404|NCT02613364|76069081|FG000|Overall Study|Disliked Intervention|0|||
42244405|NCT02613364|76069082|FG001|Overall Study|Disliked Intervention|3|||
42244406|NCT02613364|76069083|FG002|Overall Study|Disliked Intervention|3|||
42244407|NCT01370655|76069103|FG000|Period 1|Adverse Event|2|||
42244408|NCT01370655|76069104|FG001|Period 1|Adverse Event|0|||
42244409|NCT01370655|76069105|FG002|Period 1|Adverse Event|0|||
42244410|NCT01370655|76069106|FG003|Period 1|Adverse Event|0|||
42244411|NCT01370655|76069107|FG004|Period 1|Adverse Event|0|||
42244412|NCT01370655|76069108|FG005|Period 1|Adverse Event|0|||
42244413|NCT01370655|76069109|FG006|Period 1|Adverse Event|1|||
42244414|NCT01370655|76069110|FG007|Period 1|Adverse Event|0|||
42244415|NCT01370655|76069111|FG008|Period 1|Adverse Event|0|||
42244416|NCT01370655|76069112|FG009|Period 1|Adverse Event|0|||
42244417|NCT01370655|76069113|FG010|Period 1|Adverse Event|0|||
42244418|NCT01370655|76069114|FG011|Period 1|Adverse Event|0|||
42244419|NCT01370655|76069103|FG000|Period 2|Adverse Event|0|||
42244420|NCT01370655|76069104|FG001|Period 2|Adverse Event|0|||
42244421|NCT01370655|76069105|FG002|Period 2|Adverse Event|1|||
42244422|NCT01370655|76069106|FG003|Period 2|Adverse Event|0|||
42244423|NCT01370655|76069107|FG004|Period 2|Adverse Event|1|||
42244424|NCT01370655|76069108|FG005|Period 2|Adverse Event|0|||
42244425|NCT01370655|76069109|FG006|Period 2|Adverse Event|0|||
42244426|NCT01370655|76069110|FG007|Period 2|Adverse Event|1|||
42244427|NCT01370655|76069111|FG008|Period 2|Adverse Event|0|||
42244428|NCT01370655|76069112|FG009|Period 2|Adverse Event|0|||
42244429|NCT01370655|76069113|FG010|Period 2|Adverse Event|0|||
42244430|NCT01370655|76069114|FG011|Period 2|Adverse Event|0|||
42244431|NCT01370655|76069103|FG000|Period 2|met protocol specified stopping criteria|0|||
42244432|NCT01370655|76069104|FG001|Period 2|met protocol specified stopping criteria|0|||
42244433|NCT01370655|76069105|FG002|Period 2|met protocol specified stopping criteria|1|||
42244434|NCT01370655|76069106|FG003|Period 2|met protocol specified stopping criteria|0|||
42244435|NCT01370655|76069107|FG004|Period 2|met protocol specified stopping criteria|0|||
42244436|NCT01370655|76069108|FG005|Period 2|met protocol specified stopping criteria|0|||
42244437|NCT01370655|76069109|FG006|Period 2|met protocol specified stopping criteria|1|||
42244438|NCT01370655|76069110|FG007|Period 2|met protocol specified stopping criteria|0|||
42244439|NCT01370655|76069111|FG008|Period 2|met protocol specified stopping criteria|1|||
42244440|NCT01370655|76069112|FG009|Period 2|met protocol specified stopping criteria|0|||
42244441|NCT01370655|76069113|FG010|Period 2|met protocol specified stopping criteria|1|||
42244442|NCT01370655|76069114|FG011|Period 2|met protocol specified stopping criteria|0|||
42244443|NCT01370655|76069103|FG000|Period 2|Withdrawal by Subject|0|||
42244444|NCT01370655|76069104|FG001|Period 2|Withdrawal by Subject|0|||
42244445|NCT01370655|76069105|FG002|Period 2|Withdrawal by Subject|0|||
42244446|NCT01370655|76069106|FG003|Period 2|Withdrawal by Subject|0|||
42244447|NCT01370655|76069107|FG004|Period 2|Withdrawal by Subject|0|||
42244448|NCT01370655|76069108|FG005|Period 2|Withdrawal by Subject|0|||
42244449|NCT01370655|76069109|FG006|Period 2|Withdrawal by Subject|0|||
42244450|NCT01370655|76069110|FG007|Period 2|Withdrawal by Subject|0|||
42244451|NCT01370655|76069111|FG008|Period 2|Withdrawal by Subject|1|||
42244452|NCT01370655|76069112|FG009|Period 2|Withdrawal by Subject|0|||
42244453|NCT01370655|76069113|FG010|Period 2|Withdrawal by Subject|0|||
42244454|NCT01370655|76069114|FG011|Period 2|Withdrawal by Subject|0|||
42244455|NCT02612194|76069127|FG000|Overall Study|Death|5|||
42244456|NCT02612194|76069128|FG001|Overall Study|Death|0|||
42244457|NCT02612194|76069129|FG002|Overall Study|Death|2|||
42244458|NCT02612194|76069127|FG000|Overall Study|Early Study Termination|1|||
42244459|NCT02612194|76069128|FG001|Overall Study|Early Study Termination|0|||
42244460|NCT02612194|76069129|FG002|Overall Study|Early Study Termination|0|||
42244461|NCT02798211|76069139|FG000|Period 1|Adverse Event|1|||
42244462|NCT02798211|76069140|FG001|Period 1|Adverse Event|1|||
42244463|NCT02798211|76069141|FG002|Period 1|Adverse Event|0|||
41989318|NCT05048719|75796944|FG005|Overall Study|Death|0|||
41989319|NCT05048719|75796945|FG006|Overall Study|Death|0|||
41989320|NCT05048719|75796946|FG007|Overall Study|Death|0|||
41989321|NCT05048719|75796947|FG008|Overall Study|Death|0|||
41989322|NCT05048719|75796939|FG000|Overall Study|Adverse Event|0|||
41989323|NCT05048719|75796940|FG001|Overall Study|Adverse Event|1|||
41989324|NCT05048719|75796941|FG002|Overall Study|Adverse Event|2|||
41989325|NCT05048719|75796942|FG003|Overall Study|Adverse Event|0|||
42244464|NCT02798211|76069142|FG003|Period 1|Adverse Event|0|||
42244465|NCT02798211|76069143|FG004|Period 1|Adverse Event|0|||
42244466|NCT02798211|76069144|FG005|Period 1|Adverse Event|0|||
42244467|NCT02798211|76069139|FG000|Period 1|Lost to Follow-up|2|||
42244468|NCT02798211|76069140|FG001|Period 1|Lost to Follow-up|1|||
42244469|NCT02798211|76069141|FG002|Period 1|Lost to Follow-up|0|||
42032831|NCT00943917|75841125|FG003|Stage I|A1C elevation|0|||
42244470|NCT02798211|76069142|FG003|Period 1|Lost to Follow-up|0|||
42244471|NCT02798211|76069143|FG004|Period 1|Lost to Follow-up|0|||
42244472|NCT02798211|76069144|FG005|Period 1|Lost to Follow-up|0|||
42244473|NCT02798211|76069139|FG000|Period 1|Protocol Violation|0|||
42244474|NCT02798211|76069140|FG001|Period 1|Protocol Violation|0|||
42244475|NCT02798211|76069141|FG002|Period 1|Protocol Violation|2|||
42244476|NCT02798211|76069142|FG003|Period 1|Protocol Violation|0|||
42244477|NCT02798211|76069143|FG004|Period 1|Protocol Violation|0|||
42244478|NCT02798211|76069144|FG005|Period 1|Protocol Violation|0|||
42244479|NCT02798211|76069139|FG000|Period 1|Withdrawal by Subject|1|||
42244480|NCT02798211|76069140|FG001|Period 1|Withdrawal by Subject|1|||
42244481|NCT02798211|76069141|FG002|Period 1|Withdrawal by Subject|0|||
42244482|NCT02798211|76069142|FG003|Period 1|Withdrawal by Subject|0|||
42244483|NCT02798211|76069143|FG004|Period 1|Withdrawal by Subject|0|||
42244484|NCT02798211|76069144|FG005|Period 1|Withdrawal by Subject|0|||
42244485|NCT02798211|76069139|FG000|Period 1|Death|0|||
42244486|NCT02798211|76069140|FG001|Period 1|Death|0|||
42244487|NCT02798211|76069141|FG002|Period 1|Death|1|||
42244488|NCT02798211|76069142|FG003|Period 1|Death|0|||
42244489|NCT02798211|76069143|FG004|Period 1|Death|0|||
42244490|NCT02798211|76069144|FG005|Period 1|Death|0|||
42244491|NCT02798211|76069139|FG000|Period 1|Withdrawal of Informed Consent|2|||
42244492|NCT02798211|76069140|FG001|Period 1|Withdrawal of Informed Consent|7|||
42244493|NCT02798211|76069141|FG002|Period 1|Withdrawal of Informed Consent|3|||
42244494|NCT02798211|76069142|FG003|Period 1|Withdrawal of Informed Consent|0|||
42244495|NCT02798211|76069143|FG004|Period 1|Withdrawal of Informed Consent|0|||
42244496|NCT02798211|76069144|FG005|Period 1|Withdrawal of Informed Consent|0|||
42244497|NCT02798211|76069139|FG000|Period 2|Withdrawal by Subject|2|||
42244498|NCT02798211|76069140|FG001|Period 2|Withdrawal by Subject|0|||
42244499|NCT02798211|76069141|FG002|Period 2|Withdrawal by Subject|0|||
42244500|NCT02798211|76069142|FG003|Period 2|Withdrawal by Subject|0|||
42244501|NCT02798211|76069143|FG004|Period 2|Withdrawal by Subject|2|||
42244502|NCT02798211|76069144|FG005|Period 2|Withdrawal by Subject|2|||
42244503|NCT02798211|76069139|FG000|Period 2|Adverse Event|5|||
42244504|NCT02798211|76069140|FG001|Period 2|Adverse Event|0|||
42244505|NCT02798211|76069141|FG002|Period 2|Adverse Event|0|||
42244506|NCT02798211|76069142|FG003|Period 2|Adverse Event|0|||
42244507|NCT02798211|76069143|FG004|Period 2|Adverse Event|1|||
42244508|NCT02798211|76069144|FG005|Period 2|Adverse Event|0|||
42244509|NCT02798211|76069139|FG000|Period 2|Lack of Efficacy|1|||
42244510|NCT02798211|76069140|FG001|Period 2|Lack of Efficacy|0|||
42244511|NCT02798211|76069141|FG002|Period 2|Lack of Efficacy|0|||
42244512|NCT02798211|76069142|FG003|Period 2|Lack of Efficacy|1|||
42244513|NCT02798211|76069143|FG004|Period 2|Lack of Efficacy|0|||
41989326|NCT05048719|75796943|FG004|Overall Study|Adverse Event|1|||
41989327|NCT05048719|75796944|FG005|Overall Study|Adverse Event|0|||
41989328|NCT05048719|75796945|FG006|Overall Study|Adverse Event|0|||
42032832|NCT00943917|75841126|FG004|Stage I|A1C elevation|0|||
42032833|NCT00943917|75841127|FG005|Stage I|A1C elevation|0|||
42244514|NCT02798211|76069144|FG005|Period 2|Lack of Efficacy|1|||
42244515|NCT02798211|76069139|FG000|Period 2|Lost to Follow-up|3|||
42244516|NCT02798211|76069140|FG001|Period 2|Lost to Follow-up|0|||
42244517|NCT02798211|76069141|FG002|Period 2|Lost to Follow-up|0|||
41989329|NCT05048719|75796946|FG007|Overall Study|Adverse Event|0|||
42032834|NCT00943917|75841128|FG006|Stage I|A1C elevation|0|||
42244518|NCT02798211|76069142|FG003|Period 2|Lost to Follow-up|0|||
42244519|NCT02798211|76069143|FG004|Period 2|Lost to Follow-up|2|||
42244520|NCT02798211|76069144|FG005|Period 2|Lost to Follow-up|0|||
42244521|NCT02798211|76069139|FG000|Period 2|Physician Decision|1|||
42244522|NCT02798211|76069140|FG001|Period 2|Physician Decision|0|||
41989330|NCT05048719|75796947|FG008|Overall Study|Adverse Event|0|||
42244523|NCT02798211|76069141|FG002|Period 2|Physician Decision|0|||
42244524|NCT02798211|76069142|FG003|Period 2|Physician Decision|1|||
41989331|NCT05048719|75796939|FG000|Overall Study|Lost to Follow-up|0|||
42032835|NCT00943917|75841129|FG007|Stage I|A1C elevation|0|||
42244525|NCT02798211|76069143|FG004|Period 2|Physician Decision|1|||
42244526|NCT02798211|76069144|FG005|Period 2|Physician Decision|0|||
42244527|NCT02798211|76069139|FG000|Period 2|Pregnancy|0|||
42244528|NCT02798211|76069140|FG001|Period 2|Pregnancy|0|||
42244529|NCT02798211|76069141|FG002|Period 2|Pregnancy|0|||
42244530|NCT02798211|76069142|FG003|Period 2|Pregnancy|2|||
42244531|NCT02798211|76069143|FG004|Period 2|Pregnancy|0|||
42244532|NCT02798211|76069144|FG005|Period 2|Pregnancy|0|||
42244533|NCT02798211|76069139|FG000|Period 2|Technical problems|1|||
42244534|NCT02798211|76069140|FG001|Period 2|Technical problems|0|||
42244535|NCT02798211|76069141|FG002|Period 2|Technical problems|0|||
42244536|NCT02798211|76069142|FG003|Period 2|Technical problems|1|||
42244537|NCT02798211|76069143|FG004|Period 2|Technical problems|0|||
42244538|NCT02798211|76069144|FG005|Period 2|Technical problems|0|||
42244539|NCT02798211|76069139|FG000|Period 2|Withdrawal of Informed Consent|1|||
42244540|NCT02798211|76069140|FG001|Period 2|Withdrawal of Informed Consent|0|||
42244541|NCT02798211|76069141|FG002|Period 2|Withdrawal of Informed Consent|0|||
42244542|NCT02798211|76069142|FG003|Period 2|Withdrawal of Informed Consent|2|||
42244543|NCT02798211|76069143|FG004|Period 2|Withdrawal of Informed Consent|2|||
42244544|NCT02798211|76069144|FG005|Period 2|Withdrawal of Informed Consent|3|||
42244545|NCT02799069|76069159|FG000|Overall Study|Adverse Event|0|||
42244546|NCT02799069|76069160|FG001|Overall Study|Adverse Event|2|||
42244547|NCT02799069|76069161|FG002|Overall Study|Adverse Event|2|||
42244548|NCT02799069|76069159|FG000|Overall Study|Lack of Efficacy|2|||
42244549|NCT02799069|76069160|FG001|Overall Study|Lack of Efficacy|0|||
42244550|NCT02799069|76069161|FG002|Overall Study|Lack of Efficacy|0|||
42244551|NCT02799069|76069159|FG000|Overall Study|Lost to Follow-up|1|||
42244552|NCT02799069|76069160|FG001|Overall Study|Lost to Follow-up|1|||
42244553|NCT02799069|76069161|FG002|Overall Study|Lost to Follow-up|0|||
42244554|NCT02799069|76069159|FG000|Overall Study|Withdrawal by Subject|4|||
42244555|NCT02799069|76069160|FG001|Overall Study|Withdrawal by Subject|4|||
42244556|NCT02799069|76069161|FG002|Overall Study|Withdrawal by Subject|3|||
42244557|NCT02799069|76069159|FG000|Overall Study|Protocol Violation|1|||
42244558|NCT02799069|76069160|FG001|Overall Study|Protocol Violation|0|||
42244559|NCT02799069|76069161|FG002|Overall Study|Protocol Violation|2|||
42244560|NCT01669174|76069171|FG000|Overall Study|Subject withdrew consent|2|||
42244561|NCT01669174|76069172|FG001|Overall Study|Subject withdrew consent|2|||
42244562|NCT01669174|76069171|FG000|Overall Study|Lost to Follow-up|1|||
42244563|NCT01669174|76069172|FG001|Overall Study|Lost to Follow-up|0|||
42244564|NCT01669174|76069171|FG000|Overall Study|Adverse Event|2|||
42244565|NCT01669174|76069172|FG001|Overall Study|Adverse Event|2|||
42244566|NCT01669174|76069171|FG000|Overall Study|Administrative problems|1|||
42244567|NCT01669174|76069172|FG001|Overall Study|Administrative problems|2|||
42244568|NCT02798835|76069181|FG000|Overall Study|Protocol Violation|0|||
42244569|NCT02798835|76069182|FG001|Overall Study|Protocol Violation|0|||
42244570|NCT02798835|76069183|FG002|Overall Study|Protocol Violation|3|||
42244571|NCT02611882|76069194|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
42244572|NCT02611882|76069195|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
42244573|NCT02611882|76069196|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
42244574|NCT02796963|76069207|FG000|Overall Study|Lost to Follow-up|89|||
42244575|NCT02796963|76069208|FG001|Overall Study|Lost to Follow-up|76|||
42244576|NCT02796963|76069209|FG002|Overall Study|Lost to Follow-up|69|||
42244577|NCT02796963|76069210|FG003|Overall Study|Lost to Follow-up|72|||
42244578|NCT02796651|76069220|FG000|Overall Study|Adverse Event|6|||
42244579|NCT02796651|76069220|FG000|Overall Study|Lost to Follow-up|1|||
42244580|NCT02796651|76069220|FG000|Overall Study|Withdrawal by Subject|4|||
41989332|NCT05048719|75796940|FG001|Overall Study|Lost to Follow-up|0|||
42244581|NCT02796651|76069220|FG000|Overall Study|Protocol Violation|4|||
42244582|NCT02796651|76069220|FG000|Overall Study|Lack of Efficacy|1|||
42244583|NCT02796651|76069220|FG000|Overall Study|Other|10|||
42244584|NCT02613208|76069235|FG000|Overall Study|Withdrawal by Subject|1|||
42244585|NCT02613208|76069235|FG000|Overall Study|Change of address|2|||
42244586|NCT02613208|76069235|FG000|Overall Study|Physician Decision|2|||
42244587|NCT02613208|76069235|FG000|Overall Study|Lost to Follow-up|5|||
42244588|NCT02613208|76069235|FG000|Overall Study|Death|37|||
41989333|NCT05048719|75796941|FG002|Overall Study|Lost to Follow-up|1|||
42244589|NCT01668784|76069241|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
42244590|NCT01668784|76069242|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
42244591|NCT01668784|76069241|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
42244592|NCT01668784|76069242|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
42244593|NCT01668784|76069241|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
42244594|NCT01668784|76069242|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
42244595|NCT01668784|76069241|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
42244596|NCT01668784|76069242|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
42244597|NCT01668784|76069241|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
42244598|NCT01668784|76069242|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
41989334|NCT05048719|75796942|FG003|Overall Study|Lost to Follow-up|3|||
42244599|NCT01668784|76069241|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
42244600|NCT01668784|76069242|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
42244601|NCT01668784|76069241|FG000|Treatment Period|Disease Progression|316|||
42244602|NCT01668784|76069242|FG001|Treatment Period|Disease Progression|293|||
42244603|NCT01668784|76069241|FG000|Treatment Period|Study Drug Toxicity|46|||
42244604|NCT01668784|76069242|FG001|Treatment Period|Study Drug Toxicity|53|||
42244605|NCT01668784|76069241|FG000|Treatment Period|Death|1|||
42244606|NCT01668784|76069242|FG001|Treatment Period|Death|1|||
41989335|NCT05048719|75796943|FG004|Overall Study|Lost to Follow-up|1|||
41989336|NCT05048719|75796944|FG005|Overall Study|Lost to Follow-up|1|||
42244607|NCT01668784|76069241|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
42244608|NCT01668784|76069242|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
42244609|NCT01668784|76069241|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
42244610|NCT01668784|76069242|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
42244611|NCT01668784|76069241|FG000|Treatment Period|Withdrawal by Subject|5|||
42244612|NCT01668784|76069242|FG001|Treatment Period|Withdrawal by Subject|3|||
42244613|NCT01668784|76069241|FG000|Treatment Period|Maximal Clinical Benefit|3|||
42244614|NCT01668784|76069242|FG001|Treatment Period|Maximal Clinical Benefit|3|||
42244615|NCT01668784|76069241|FG000|Treatment Period|Other|2|||
42244616|NCT01668784|76069242|FG001|Treatment Period|Other|8|||
42244617|NCT01668784|76069241|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
42244618|NCT01668784|76069242|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
42244619|NCT02750514|76069253|FG000|Track 1|Disease progression|20|||
42244620|NCT02750514|76069254|FG001|Track 1|Disease progression|1|||
42244621|NCT02750514|76069255|FG002|Track 1|Disease progression|0|||
42244622|NCT02750514|76069256|FG003|Track 1|Disease progression|1|||
42244623|NCT02750514|76069257|FG004|Track 1|Disease progression|0|||
42244624|NCT02750514|76069253|FG000|Track 1|Adverse event unrelated to study drug|1|||
42244625|NCT02750514|76069254|FG001|Track 1|Adverse event unrelated to study drug|0|||
42244626|NCT02750514|76069255|FG002|Track 1|Adverse event unrelated to study drug|0|||
42244627|NCT02750514|76069256|FG003|Track 1|Adverse event unrelated to study drug|0|||
42244628|NCT02750514|76069257|FG004|Track 1|Adverse event unrelated to study drug|0|||
42244629|NCT02750514|76069253|FG000|Track 1|Study drug toxicity|4|||
42244630|NCT02750514|76069254|FG001|Track 1|Study drug toxicity|1|||
42244631|NCT02750514|76069255|FG002|Track 1|Study drug toxicity|0|||
42244632|NCT02750514|76069256|FG003|Track 1|Study drug toxicity|1|||
42244633|NCT02750514|76069257|FG004|Track 1|Study drug toxicity|0|||
42244634|NCT02750514|76069253|FG000|Track 1|Participant request to discontinue|1|||
42244635|NCT02750514|76069254|FG001|Track 1|Participant request to discontinue|0|||
42244636|NCT02750514|76069255|FG002|Track 1|Participant request to discontinue|0|||
42244637|NCT02750514|76069256|FG003|Track 1|Participant request to discontinue|0|||
42244638|NCT02750514|76069257|FG004|Track 1|Participant request to discontinue|0|||
42244639|NCT02750514|76069253|FG000|Track 1|Other reasons|1|||
42244640|NCT02750514|76069254|FG001|Track 1|Other reasons|0|||
42244641|NCT02750514|76069255|FG002|Track 1|Other reasons|0|||
42244642|NCT02750514|76069256|FG003|Track 1|Other reasons|0|||
42244643|NCT02750514|76069257|FG004|Track 1|Other reasons|0|||
42244644|NCT02750514|76069253|FG000|Track 2|Disease progression|4|||
42244645|NCT02750514|76069254|FG001|Track 2|Disease progression|5|||
42244646|NCT02750514|76069255|FG002|Track 2|Disease progression|2|||
42244647|NCT02750514|76069256|FG003|Track 2|Disease progression|5|||
42244648|NCT02750514|76069257|FG004|Track 2|Disease progression|0|||
42244649|NCT02750514|76069253|FG000|Track 2|Adverse event unrelated to study drug|1|||
42244650|NCT02750514|76069254|FG001|Track 2|Adverse event unrelated to study drug|0|||
42244651|NCT02750514|76069255|FG002|Track 2|Adverse event unrelated to study drug|0|||
42244652|NCT02750514|76069256|FG003|Track 2|Adverse event unrelated to study drug|0|||
42244653|NCT02750514|76069257|FG004|Track 2|Adverse event unrelated to study drug|0|||
42244654|NCT02750514|76069253|FG000|Track 2|Study drug toxicity|1|||
41989337|NCT05048719|75796945|FG006|Overall Study|Lost to Follow-up|1|||
41989338|NCT05048719|75796946|FG007|Overall Study|Lost to Follow-up|1|||
41989339|NCT05048719|75796947|FG008|Overall Study|Lost to Follow-up|0|||
41989340|NCT05048719|75796939|FG000|Overall Study|Physician Decision|0|||
41989341|NCT05048719|75796940|FG001|Overall Study|Physician Decision|0|||
42244655|NCT02750514|76069254|FG001|Track 2|Study drug toxicity|2|||
42244656|NCT02750514|76069255|FG002|Track 2|Study drug toxicity|0|||
42244657|NCT02750514|76069256|FG003|Track 2|Study drug toxicity|2|||
42244658|NCT02750514|76069257|FG004|Track 2|Study drug toxicity|0|||
42244659|NCT02750514|76069253|FG000|Track 2|Participant withdrew consent|0|||
42244660|NCT02750514|76069254|FG001|Track 2|Participant withdrew consent|1|||
42244661|NCT02750514|76069255|FG002|Track 2|Participant withdrew consent|0|||
42244662|NCT02750514|76069256|FG003|Track 2|Participant withdrew consent|0|||
42244663|NCT02750514|76069257|FG004|Track 2|Participant withdrew consent|0|||
42244664|NCT02750514|76069253|FG000|Track 3|Disease progression|0|||
42244665|NCT02750514|76069254|FG001|Track 3|Disease progression|24|||
42244666|NCT02750514|76069255|FG002|Track 3|Disease progression|13|||
41989342|NCT05048719|75796941|FG002|Overall Study|Physician Decision|0|||
41989343|NCT05048719|75796942|FG003|Overall Study|Physician Decision|0|||
41989344|NCT05048719|75796943|FG004|Overall Study|Physician Decision|0|||
41989345|NCT05048719|75796944|FG005|Overall Study|Physician Decision|0|||
41989346|NCT05048719|75796945|FG006|Overall Study|Physician Decision|0|||
42244667|NCT02750514|76069256|FG003|Track 3|Disease progression|14|||
42244668|NCT02750514|76069257|FG004|Track 3|Disease progression|0|||
42244669|NCT02750514|76069253|FG000|Track 3|Adverse event unrelated to study drug|0|||
42244670|NCT02750514|76069254|FG001|Track 3|Adverse event unrelated to study drug|1|||
42244671|NCT02750514|76069255|FG002|Track 3|Adverse event unrelated to study drug|1|||
42244672|NCT02750514|76069256|FG003|Track 3|Adverse event unrelated to study drug|1|||
42244673|NCT02750514|76069257|FG004|Track 3|Adverse event unrelated to study drug|0|||
42244674|NCT02750514|76069253|FG000|Track 3|Study drug toxicity|0|||
42244675|NCT02750514|76069254|FG001|Track 3|Study drug toxicity|3|||
41989347|NCT05048719|75796946|FG007|Overall Study|Physician Decision|1|||
41989348|NCT05048719|75796947|FG008|Overall Study|Physician Decision|1|||
41989349|NCT05048719|75796939|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
41989350|NCT05048719|75796940|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
41989351|NCT05048719|75796941|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
41989352|NCT05048719|75796942|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
42302714|NCT02349633|76138081|FG013|Overall Study|Withdrawal by Subject|0|||
42302715|NCT02349633|76138068|FG000|Overall Study|Withdrawal of informed consent|0|||
42302716|NCT02349633|76138069|FG001|Overall Study|Withdrawal of informed consent|0|||
42302717|NCT02349633|76138070|FG002|Overall Study|Withdrawal of informed consent|0|||
42302718|NCT02349633|76138071|FG003|Overall Study|Withdrawal of informed consent|1|||
42302719|NCT02349633|76138072|FG004|Overall Study|Withdrawal of informed consent|1|||
42302720|NCT02349633|76138073|FG005|Overall Study|Withdrawal of informed consent|0|||
42302721|NCT02349633|76138074|FG006|Overall Study|Withdrawal of informed consent|0|||
42302722|NCT02349633|76138075|FG007|Overall Study|Withdrawal of informed consent|3|||
42302723|NCT02349633|76138076|FG008|Overall Study|Withdrawal of informed consent|0|||
41989353|NCT05048719|75796943|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
41989354|NCT05048719|75796944|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
41989355|NCT05048719|75796945|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
42244676|NCT02750514|76069255|FG002|Track 3|Study drug toxicity|0|||
42244677|NCT02750514|76069256|FG003|Track 3|Study drug toxicity|1|||
42244678|NCT02750514|76069257|FG004|Track 3|Study drug toxicity|0|||
42244679|NCT02750514|76069253|FG000|Track 3|Participant request to discontinue|0|||
42244680|NCT02750514|76069254|FG001|Track 3|Participant request to discontinue|2|||
42244681|NCT02750514|76069255|FG002|Track 3|Participant request to discontinue|0|||
42244682|NCT02750514|76069256|FG003|Track 3|Participant request to discontinue|0|||
42244683|NCT02750514|76069257|FG004|Track 3|Participant request to discontinue|0|||
42244684|NCT02750514|76069253|FG000|Track 3|Participant withdrew consent|0|||
42244685|NCT02750514|76069254|FG001|Track 3|Participant withdrew consent|3|||
42244686|NCT02750514|76069255|FG002|Track 3|Participant withdrew consent|1|||
42244687|NCT02750514|76069256|FG003|Track 3|Participant withdrew consent|0|||
42244688|NCT02750514|76069257|FG004|Track 3|Participant withdrew consent|0|||
42244689|NCT02750514|76069253|FG000|Track 3|Other reasons|0|||
42244690|NCT02750514|76069254|FG001|Track 3|Other reasons|3|||
42244691|NCT02750514|76069255|FG002|Track 3|Other reasons|0|||
42244692|NCT02750514|76069256|FG003|Track 3|Other reasons|0|||
41989356|NCT05048719|75796946|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
42032836|NCT00943917|75841130|FG008|Stage I|A1C elevation|0|||
42032837|NCT00943917|75841131|FG009|Stage I|A1C elevation|0|||
42244693|NCT02750514|76069257|FG004|Track 3|Other reasons|0|||
42244694|NCT02750514|76069253|FG000|Track 4|Study drug toxicity|0|||
42244695|NCT02750514|76069254|FG001|Track 4|Study drug toxicity|6|||
42244696|NCT02750514|76069255|FG002|Track 4|Study drug toxicity|0|||
42302724|NCT02349633|76138077|FG009|Overall Study|Withdrawal of informed consent|0|||
42244697|NCT02750514|76069256|FG003|Track 4|Study drug toxicity|5|||
42244698|NCT02750514|76069257|FG004|Track 4|Study drug toxicity|0|||
42244699|NCT02750514|76069253|FG000|Track 4|Participant request to discontinue|0|||
42244700|NCT02750514|76069254|FG001|Track 4|Participant request to discontinue|1|||
42244701|NCT02750514|76069255|FG002|Track 4|Participant request to discontinue|0|||
42244702|NCT02750514|76069256|FG003|Track 4|Participant request to discontinue|1|||
42244703|NCT02750514|76069257|FG004|Track 4|Participant request to discontinue|0|||
42244704|NCT02750514|76069253|FG000|Track 4|Participant withdrew consent|0|||
42244705|NCT02750514|76069254|FG001|Track 4|Participant withdrew consent|1|||
42244706|NCT02750514|76069255|FG002|Track 4|Participant withdrew consent|0|||
42244707|NCT02750514|76069256|FG003|Track 4|Participant withdrew consent|0|||
42244708|NCT02750514|76069257|FG004|Track 4|Participant withdrew consent|0|||
42244709|NCT02750514|76069253|FG000|Track 4|Other reasons|0|||
42244710|NCT02750514|76069254|FG001|Track 4|Other reasons|5|||
42244711|NCT02750514|76069255|FG002|Track 4|Other reasons|0|||
42244712|NCT02750514|76069256|FG003|Track 4|Other reasons|3|||
42244713|NCT02750514|76069257|FG004|Track 4|Other reasons|0|||
42244714|NCT02750514|76069253|FG000|Track 4|Disease progression|0|||
42244715|NCT02750514|76069254|FG001|Track 4|Disease progression|33|||
42244716|NCT02750514|76069255|FG002|Track 4|Disease progression|0|||
42244717|NCT02750514|76069256|FG003|Track 4|Disease progression|32|||
42244718|NCT02750514|76069257|FG004|Track 4|Disease progression|0|||
42244719|NCT02750514|76069253|FG000|Track 4|Adverse event unrelated to study drug|0|||
42244720|NCT02750514|76069254|FG001|Track 4|Adverse event unrelated to study drug|5|||
42244721|NCT02750514|76069255|FG002|Track 4|Adverse event unrelated to study drug|0|||
42244722|NCT02750514|76069256|FG003|Track 4|Adverse event unrelated to study drug|0|||
42244723|NCT02750514|76069257|FG004|Track 4|Adverse event unrelated to study drug|0|||
42244724|NCT02750514|76069253|FG000|Track 4|Death|0|||
42244725|NCT02750514|76069254|FG001|Track 4|Death|0|||
42244726|NCT02750514|76069255|FG002|Track 4|Death|0|||
42244727|NCT02750514|76069256|FG003|Track 4|Death|1|||
42244728|NCT02750514|76069257|FG004|Track 4|Death|0|||
42244729|NCT02750514|76069253|FG000|Track 5|Disease progression|0|||
42244730|NCT02750514|76069254|FG001|Track 5|Disease progression|0|||
42244731|NCT02750514|76069255|FG002|Track 5|Disease progression|0|||
42244732|NCT02750514|76069256|FG003|Track 5|Disease progression|0|||
42244733|NCT02750514|76069257|FG004|Track 5|Disease progression|34|||
42244734|NCT02750514|76069253|FG000|Track 5|Adverse event unrelated to study drug|0|||
42244735|NCT02750514|76069254|FG001|Track 5|Adverse event unrelated to study drug|0|||
42244736|NCT02750514|76069255|FG002|Track 5|Adverse event unrelated to study drug|0|||
42244737|NCT02750514|76069256|FG003|Track 5|Adverse event unrelated to study drug|0|||
42244738|NCT02750514|76069257|FG004|Track 5|Adverse event unrelated to study drug|2|||
42244739|NCT02750514|76069253|FG000|Track 5|Study drug toxicity|0|||
42244740|NCT02750514|76069254|FG001|Track 5|Study drug toxicity|0|||
42244741|NCT02750514|76069255|FG002|Track 5|Study drug toxicity|0|||
42244742|NCT02750514|76069256|FG003|Track 5|Study drug toxicity|0|||
42244743|NCT02750514|76069257|FG004|Track 5|Study drug toxicity|2|||
42244744|NCT02750514|76069253|FG000|Track 5|Participant request to discontinue|0|||
42244745|NCT02750514|76069254|FG001|Track 5|Participant request to discontinue|0|||
42244746|NCT02750514|76069255|FG002|Track 5|Participant request to discontinue|0|||
42244747|NCT02750514|76069256|FG003|Track 5|Participant request to discontinue|0|||
42244748|NCT02750514|76069257|FG004|Track 5|Participant request to discontinue|3|||
42244749|NCT02750514|76069253|FG000|Track 5|Other reasons|0|||
42244750|NCT02750514|76069254|FG001|Track 5|Other reasons|0|||
42244751|NCT02750514|76069255|FG002|Track 5|Other reasons|0|||
42244752|NCT02750514|76069256|FG003|Track 5|Other reasons|0|||
42244753|NCT02750514|76069257|FG004|Track 5|Other reasons|2|||
42244754|NCT03340974|76069281|FG000|Completion of Study -Long Term Follow up|Death|8|||
42244755|NCT03340974|76069282|FG001|Completion of Study -Long Term Follow up|Death|5|||
42244756|NCT03340974|76069283|FG002|Completion of Study -Long Term Follow up|Death|5|||
42032838|NCT00943917|75841132|FG010|Stage I|A1C elevation|0|||
42032839|NCT00943917|75841133|FG011|Stage I|A1C elevation|0|||
42244757|NCT03340974|76069284|FG003|Completion of Study -Long Term Follow up|Death|7|||
42244758|NCT03340974|76069281|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
42244759|NCT03340974|76069282|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
42244760|NCT03340974|76069283|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
42244761|NCT03340974|76069284|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
42244762|NCT03340974|76069281|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
42244763|NCT03340974|76069282|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
42244764|NCT03340974|76069283|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
42244765|NCT03340974|76069284|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
42244766|NCT03340974|76069281|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
42244767|NCT03340974|76069282|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
42244768|NCT03340974|76069283|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
42244769|NCT03340974|76069284|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
42244770|NCT02612428|76069300|FG000|VTL-308|Death|14|||
42244771|NCT02612428|76069301|FG001|VTL-308|Death|16|||
42244772|NCT02612428|76069300|FG000|VTL-308|Withdrawal by Subject|0|||
42244773|NCT02612428|76069301|FG001|VTL-308|Withdrawal by Subject|1|||
42244774|NCT02612428|76069300|FG000|VTL-308E|Death|9|||
42244775|NCT02612428|76069301|FG001|VTL-308E|Death|7|||
42244776|NCT02612428|76069300|FG000|VTL-308E|Lost to Follow-up|2|||
42244777|NCT02612428|76069301|FG001|VTL-308E|Lost to Follow-up|0|||
42244778|NCT03679884|76069312|FG000|Overall Study|Other|12|||
42244779|NCT03679884|76069313|FG001|Overall Study|Other|12|||
42244780|NCT03679884|76069314|FG002|Overall Study|Other|12|||
42244781|NCT03679884|76069315|FG003|Overall Study|Other|7|||
42244782|NCT03679884|76069316|FG004|Overall Study|Other|8|||
42244783|NCT03679884|76069312|FG000|Overall Study|Lack of Efficacy|15|||
42244784|NCT03679884|76069313|FG001|Overall Study|Lack of Efficacy|29|||
42244785|NCT03679884|76069314|FG002|Overall Study|Lack of Efficacy|13|||
42244786|NCT03679884|76069315|FG003|Overall Study|Lack of Efficacy|29|||
42244787|NCT03679884|76069316|FG004|Overall Study|Lack of Efficacy|10|||
42244788|NCT03679884|76069312|FG000|Overall Study|Death|1|||
42244789|NCT03679884|76069313|FG001|Overall Study|Death|0|||
42244790|NCT03679884|76069314|FG002|Overall Study|Death|0|||
42244791|NCT03679884|76069315|FG003|Overall Study|Death|0|||
42244792|NCT03679884|76069316|FG004|Overall Study|Death|0|||
42244793|NCT03679884|76069312|FG000|Overall Study|Adverse Event|2|||
42244794|NCT03679884|76069313|FG001|Overall Study|Adverse Event|10|||
42244795|NCT03679884|76069314|FG002|Overall Study|Adverse Event|9|||
42244796|NCT03679884|76069315|FG003|Overall Study|Adverse Event|6|||
42244797|NCT03679884|76069316|FG004|Overall Study|Adverse Event|6|||
42244798|NCT03679884|76069312|FG000|Overall Study|Withdrawal by Subject|12|||
42244799|NCT03679884|76069313|FG001|Overall Study|Withdrawal by Subject|23|||
42244800|NCT03679884|76069314|FG002|Overall Study|Withdrawal by Subject|8|||
42244801|NCT03679884|76069315|FG003|Overall Study|Withdrawal by Subject|8|||
42244802|NCT03679884|76069316|FG004|Overall Study|Withdrawal by Subject|9|||
42244803|NCT03679884|76069312|FG000|Overall Study|Lost to Follow-up|1|||
42244804|NCT03679884|76069313|FG001|Overall Study|Lost to Follow-up|4|||
42244805|NCT03679884|76069314|FG002|Overall Study|Lost to Follow-up|2|||
42244806|NCT03679884|76069315|FG003|Overall Study|Lost to Follow-up|0|||
42244807|NCT03679884|76069316|FG004|Overall Study|Lost to Follow-up|3|||
42244808|NCT01329978|76069331|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
42244809|NCT01329978|76069332|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
42244810|NCT01329978|76069333|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
42244811|NCT01329978|76069334|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
42244812|NCT01329978|76069335|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
42244813|NCT01329978|76069331|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
42244814|NCT01329978|76069332|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
42244815|NCT01329978|76069333|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
42244816|NCT01329978|76069334|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
42244817|NCT01329978|76069335|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
42244818|NCT01329978|76069331|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
42244819|NCT01329978|76069332|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
42244820|NCT01329978|76069333|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
42244821|NCT01329978|76069334|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
42132038|NCT00510068|75942844|FG001|Open-label Period|Withdrawal by Subject|0|||
42244822|NCT01329978|76069335|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
42244823|NCT01329978|76069331|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
42244824|NCT01329978|76069332|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
42244825|NCT01329978|76069333|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
42244826|NCT01329978|76069334|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
42132039|NCT00510068|75942843|FG000|Open-label Period|Administrative problems|17|||
42244827|NCT01329978|76069335|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
42244828|NCT01329978|76069331|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
42132040|NCT00510068|75942844|FG001|Open-label Period|Administrative problems|0|||
42244829|NCT01329978|76069332|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
42244830|NCT01329978|76069333|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
42244831|NCT01329978|76069334|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
42244832|NCT01329978|76069335|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
42132041|NCT00510068|75942843|FG000|Open-label Period|Death|7|||
42244833|NCT01329978|76069331|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
42244834|NCT01329978|76069332|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
42244835|NCT01329978|76069333|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
42244836|NCT01329978|76069334|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
42244837|NCT01329978|76069335|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
42244838|NCT01329978|76069331|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
42244839|NCT01329978|76069332|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
42244840|NCT01329978|76069333|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
42244841|NCT01329978|76069334|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
42244842|NCT01329978|76069335|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
42244843|NCT01338012|76069347|FG000|Overall Study|Death|4|||
42244844|NCT01338012|76069347|FG000|Overall Study|Study terminated|4|||
42244845|NCT04905498|76069353|FG000|Overall Study|Lost to Follow-up|0|||
42244846|NCT04905498|76069354|FG001|Overall Study|Lost to Follow-up|2|||
42244847|NCT04905498|76069353|FG000|Overall Study|COVID lockdown|1|||
42244848|NCT04905498|76069354|FG001|Overall Study|COVID lockdown|0|||
42244849|NCT02607280|76069362|FG000|Overall Study|Adverse Event|4|||
42244850|NCT02607280|76069363|FG001|Overall Study|Adverse Event|0|||
42244851|NCT02607280|76069362|FG000|Overall Study|Decrease in CrCl <15|0|||
42244852|NCT02607280|76069363|FG001|Overall Study|Decrease in CrCl <15|1|||
42244853|NCT02202434|76069373|FG000|Overall Study|Death|70|||
42244854|NCT02202434|76069374|FG001|Overall Study|Death|39|||
42244855|NCT02202434|76069375|FG002|Overall Study|Death|13|||
42244856|NCT02202434|76069376|FG003|Overall Study|Death|27|||
42244857|NCT02202434|76069373|FG000|Overall Study|Lost to Follow-up|1|||
42244858|NCT02202434|76069374|FG001|Overall Study|Lost to Follow-up|1|||
42244859|NCT02202434|76069375|FG002|Overall Study|Lost to Follow-up|1|||
42244860|NCT02202434|76069376|FG003|Overall Study|Lost to Follow-up|0|||
42244861|NCT02202434|76069373|FG000|Overall Study|Physician Decision|2|||
42244862|NCT02202434|76069374|FG001|Overall Study|Physician Decision|3|||
42244863|NCT02202434|76069375|FG002|Overall Study|Physician Decision|0|||
42244864|NCT02202434|76069376|FG003|Overall Study|Physician Decision|0|||
42244865|NCT02202434|76069373|FG000|Overall Study|Withdrawal by Subject|13|||
42244866|NCT02202434|76069374|FG001|Overall Study|Withdrawal by Subject|14|||
42244867|NCT02202434|76069375|FG002|Overall Study|Withdrawal by Subject|1|||
42244868|NCT02202434|76069376|FG003|Overall Study|Withdrawal by Subject|4|||
42244869|NCT02202434|76069373|FG000|Overall Study|Completed Study|1|||
42244870|NCT02202434|76069374|FG001|Overall Study|Completed Study|0|||
42244871|NCT02202434|76069375|FG002|Overall Study|Completed Study|0|||
42244872|NCT02202434|76069376|FG003|Overall Study|Completed Study|0|||
42244873|NCT02202434|76069373|FG000|Overall Study|Visit Missed|21|||
42244874|NCT02202434|76069374|FG001|Overall Study|Visit Missed|12|||
42244875|NCT02202434|76069375|FG002|Overall Study|Visit Missed|0|||
42244876|NCT02202434|76069376|FG003|Overall Study|Visit Missed|5|||
42244877|NCT02202434|76069373|FG000|Overall Study|Other|1|||
42244878|NCT02202434|76069374|FG001|Overall Study|Other|0|||
42244879|NCT02202434|76069375|FG002|Overall Study|Other|0|||
42244880|NCT02202434|76069376|FG003|Overall Study|Other|1|||
42244881|NCT02784288|76069386|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
42244882|NCT01230242|76069391|FG000|Overall Study|Physician Decision|2|||
42244883|NCT01230242|76069391|FG000|Overall Study|Withdrawal by Subject|1|||
42244884|NCT02608450|76069397|FG000|Overall Study|Lost to Follow-up|39|||
42244885|NCT02608450|76069398|FG001|Overall Study|Lost to Follow-up|32|||
42244886|NCT02608450|76069397|FG000|Overall Study|Withdrawal by Subject|21|||
42244887|NCT02608450|76069398|FG001|Overall Study|Withdrawal by Subject|15|||
42244888|NCT02608450|76069397|FG000|Overall Study|Adverse Event|3|||
42244889|NCT02608450|76069398|FG001|Overall Study|Adverse Event|6|||
42244890|NCT02608450|76069397|FG000|Overall Study|Withdrawal by parent|2|||
42302725|NCT02349633|76138078|FG010|Overall Study|Withdrawal of informed consent|0|||
42302726|NCT02349633|76138079|FG011|Overall Study|Withdrawal of informed consent|0|||
42302727|NCT02349633|76138080|FG012|Overall Study|Withdrawal of informed consent|0|||
42132042|NCT00510068|75942844|FG001|Open-label Period|Death|0|||
42302728|NCT02349633|76138081|FG013|Overall Study|Withdrawal of informed consent|0|||
42302729|NCT02349633|76138068|FG000|Overall Study|Transition to compassionate use|0|||
42302730|NCT02349633|76138069|FG001|Overall Study|Transition to compassionate use|0|||
42302731|NCT02349633|76138070|FG002|Overall Study|Transition to compassionate use|0|||
42302732|NCT02349633|76138071|FG003|Overall Study|Transition to compassionate use|0|||
42302733|NCT02349633|76138072|FG004|Overall Study|Transition to compassionate use|1|||
42302734|NCT02349633|76138073|FG005|Overall Study|Transition to compassionate use|0|||
42302735|NCT02349633|76138074|FG006|Overall Study|Transition to compassionate use|0|||
42302736|NCT02349633|76138075|FG007|Overall Study|Transition to compassionate use|3|||
42302737|NCT02349633|76138076|FG008|Overall Study|Transition to compassionate use|0|||
42244891|NCT02608450|76069398|FG001|Overall Study|Withdrawal by parent|3|||
42244892|NCT02608450|76069397|FG000|Overall Study|Lack of Efficacy|0|||
42244893|NCT02608450|76069398|FG001|Overall Study|Lack of Efficacy|3|||
42244894|NCT02608450|76069397|FG000|Overall Study|Noncompliance with study drug|0|||
42244895|NCT02608450|76069398|FG001|Overall Study|Noncompliance with study drug|2|||
42244896|NCT02608450|76069397|FG000|Overall Study|Physician Decision|0|||
42244897|NCT02608450|76069398|FG001|Overall Study|Physician Decision|1|||
42244898|NCT02608450|76069397|FG000|Overall Study|Pregnancy|0|||
42244899|NCT02608450|76069398|FG001|Overall Study|Pregnancy|1|||
42244900|NCT02608450|76069397|FG000|Overall Study|Progressive disease|1|||
42244901|NCT02608450|76069398|FG001|Overall Study|Progressive disease|0|||
42132043|NCT00510068|75942843|FG000|Open-label Period|New cancer therapy|7|||
42132044|NCT00510068|75942844|FG001|Open-label Period|New cancer therapy|0|||
42244902|NCT02608450|76069397|FG000|Overall Study|Multiple reasons|0|||
42244903|NCT02608450|76069398|FG001|Overall Study|Multiple reasons|2|||
42244904|NCT04918784|76069406|FG000|Overall Study|Amputation - no longer eligible|1|||
42244905|NCT04918784|76069407|FG001|Overall Study|Amputation - no longer eligible|2|||
42244906|NCT04918784|76069406|FG000|Overall Study|Death|1|||
42244907|NCT04918784|76069407|FG001|Overall Study|Death|0|||
42244908|NCT04918784|76069406|FG000|Overall Study|patient non-compliance|3|||
42244909|NCT04918784|76069407|FG001|Overall Study|patient non-compliance|1|||
42244910|NCT04918784|76069406|FG000|Overall Study|Adverse Event|1|||
42244911|NCT04918784|76069407|FG001|Overall Study|Adverse Event|0|||
42244912|NCT04786444|76069440|FG000|Overall Study|Withdrawal by Subject|4|||
42244913|NCT04786444|76069441|FG001|Overall Study|Withdrawal by Subject|7|||
42244914|NCT04786444|76069442|FG002|Overall Study|Withdrawal by Subject|2|||
42244915|NCT04786444|76069440|FG000|Overall Study|Lost to Follow-up|11|||
42244916|NCT04786444|76069441|FG001|Overall Study|Lost to Follow-up|9|||
42244917|NCT04786444|76069442|FG002|Overall Study|Lost to Follow-up|10|||
42244918|NCT04786444|76069440|FG000|Overall Study|Subject would like to become pregnant|0|||
42244919|NCT04786444|76069441|FG001|Overall Study|Subject would like to become pregnant|1|||
42244920|NCT04786444|76069442|FG002|Overall Study|Subject would like to become pregnant|0|||
42244921|NCT04692155|76069459|FG000|Overall Study|Death|1|||
42244922|NCT04499963|76069465|FG000|Overall Study|Adverse Event|3|||
42244923|NCT04499963|76069466|FG001|Overall Study|Adverse Event|0|||
42244924|NCT04499963|76069465|FG000|Overall Study|Death|3|||
42244925|NCT04499963|76069466|FG001|Overall Study|Death|0|||
42244926|NCT04499963|76069465|FG000|Overall Study|Lack of Efficacy|7|||
42244927|NCT04499963|76069466|FG001|Overall Study|Lack of Efficacy|0|||
42244928|NCT04499963|76069465|FG000|Overall Study|Lost to Follow-up|2|||
42244929|NCT04499963|76069466|FG001|Overall Study|Lost to Follow-up|0|||
42244930|NCT04330482|76069483|FG000|Overall Study|Lost to Follow-up|2|||
42244931|NCT04330482|76069484|FG001|Overall Study|Lost to Follow-up|1|||
42244932|NCT04330482|76069483|FG000|Overall Study|Withdrawal by Subject|0|||
42244933|NCT04330482|76069484|FG001|Overall Study|Withdrawal by Subject|3|||
42244934|NCT04325503|76069490|FG000|Overall Study|Withdrawal by Subject|1|||
42244935|NCT04325503|76069490|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
42244936|NCT04109222|76069501|FG000|Overall Study|Adverse Event|1|||
42244937|NCT04109222|76069502|FG001|Overall Study|Adverse Event|0|||
42244938|NCT04109222|76069503|FG002|Overall Study|Adverse Event|0|||
42244939|NCT03573297|76069542|FG000|Open Label Treatment Period|Adverse Event|67|||
42244940|NCT03573297|76069543|FG001|Open Label Treatment Period|Adverse Event|0|||
42244941|NCT03573297|76069544|FG002|Open Label Treatment Period|Adverse Event|0|||
42244942|NCT03573297|76069545|FG003|Open Label Treatment Period|Adverse Event|0|||
42244943|NCT03573297|76069542|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
42244944|NCT03573297|76069543|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
42244945|NCT03573297|76069544|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
42244946|NCT03573297|76069545|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
42244947|NCT03573297|76069542|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
42244948|NCT03573297|76069543|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
42244949|NCT03573297|76069544|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
42244950|NCT03573297|76069545|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
42244951|NCT03573297|76069542|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
41989357|NCT05048719|75796947|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
42244952|NCT03573297|76069543|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
42032840|NCT00943917|75841134|FG012|Stage I|A1C elevation|0|||
42244953|NCT03573297|76069544|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
42244954|NCT03573297|76069545|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
42244955|NCT03573297|76069542|FG000|Open Label Treatment Period|Pregnancy|1|||
42244956|NCT03573297|76069543|FG001|Open Label Treatment Period|Pregnancy|0|||
42244957|NCT03573297|76069544|FG002|Open Label Treatment Period|Pregnancy|0|||
42244958|NCT03573297|76069545|FG003|Open Label Treatment Period|Pregnancy|0|||
42244959|NCT03573297|76069542|FG000|Open Label Treatment Period|Protocol Violation|17|||
42244960|NCT03573297|76069543|FG001|Open Label Treatment Period|Protocol Violation|0|||
42244961|NCT03573297|76069544|FG002|Open Label Treatment Period|Protocol Violation|0|||
42244962|NCT03573297|76069545|FG003|Open Label Treatment Period|Protocol Violation|0|||
42244963|NCT03573297|76069542|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
42244964|NCT03573297|76069543|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
42244965|NCT03573297|76069544|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
42244966|NCT03573297|76069545|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
42244967|NCT03573297|76069542|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
42244968|NCT03573297|76069543|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
42244969|NCT03573297|76069544|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
42244970|NCT03573297|76069545|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
42244971|NCT03573297|76069542|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
42244972|NCT03573297|76069543|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
42244973|NCT03573297|76069544|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
42244974|NCT03573297|76069545|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
42244975|NCT03573297|76069542|FG000|Open Label Treatment Period|Other, Not Specified|7|||
42244976|NCT03573297|76069543|FG001|Open Label Treatment Period|Other, Not Specified|0|||
42244977|NCT03573297|76069544|FG002|Open Label Treatment Period|Other, Not Specified|0|||
42244978|NCT03573297|76069545|FG003|Open Label Treatment Period|Other, Not Specified|0|||
42244979|NCT03573297|76069542|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
42244980|NCT03573297|76069543|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
42244981|NCT03573297|76069544|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
42244982|NCT03573297|76069545|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
42244983|NCT03573297|76069542|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42244984|NCT03573297|76069543|FG001|Double-Blind Treatment Period|Adverse Event|1|||
42244985|NCT03573297|76069544|FG002|Double-Blind Treatment Period|Adverse Event|5|||
42244986|NCT03573297|76069545|FG003|Double-Blind Treatment Period|Adverse Event|1|||
42244987|NCT03573297|76069542|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
42244988|NCT03573297|76069543|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
42244989|NCT03573297|76069544|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
42244990|NCT03573297|76069545|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
42244991|NCT03573297|76069542|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42244992|NCT03573297|76069543|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
42244993|NCT03573297|76069544|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
42244994|NCT03573297|76069545|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
42244995|NCT03573297|76069542|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
42244996|NCT03573297|76069543|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
42244997|NCT03573297|76069544|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
42244998|NCT03573297|76069545|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
42244999|NCT03573297|76069542|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
42245000|NCT03573297|76069543|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
42245001|NCT03573297|76069544|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
42245002|NCT03573297|76069545|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
42245003|NCT03573297|76069542|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
42245004|NCT03573297|76069543|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
42245005|NCT03573297|76069544|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
42245006|NCT03573297|76069545|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
42245007|NCT03573297|76069542|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
42245008|NCT03573297|76069543|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
42245009|NCT03573297|76069544|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
42245010|NCT03573297|76069545|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
42245011|NCT03536884|76069556|FG000|Initial Treatment Period Week 0-16|Adverse Event|8|||
42245012|NCT03536884|76069557|FG001|Initial Treatment Period Week 0-16|Adverse Event|6|||
41989358|NCT05048719|75796939|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
41989359|NCT05048719|75796940|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
41989360|NCT05048719|75796941|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
42245013|NCT03536884|76069558|FG002|Initial Treatment Period Week 0-16|Adverse Event|0|||
42245014|NCT03536884|76069559|FG003|Initial Treatment Period Week 0-16|Adverse Event|0|||
42245015|NCT03536884|76069560|FG004|Initial Treatment Period Week 0-16|Adverse Event|0|||
42245016|NCT03536884|76069556|FG000|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
42245017|NCT03536884|76069557|FG001|Initial Treatment Period Week 0-16|Lost to Follow-up|3|||
42245018|NCT03536884|76069558|FG002|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
42245019|NCT03536884|76069559|FG003|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
41989361|NCT05048719|75796942|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
42010524|NCT00996307|75817647|FG000|Overall Study|Withdrawal by Subject|3|||
41989362|NCT05048719|75796943|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
42245020|NCT03536884|76069560|FG004|Initial Treatment Period Week 0-16|Lost to Follow-up|0|||
42245021|NCT03536884|76069556|FG000|Initial Treatment Period Week 0-16|Withdrawal by Subject|3|||
42245022|NCT03536884|76069557|FG001|Initial Treatment Period Week 0-16|Withdrawal by Subject|4|||
42245023|NCT03536884|76069558|FG002|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
42245024|NCT03536884|76069559|FG003|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
42245025|NCT03536884|76069560|FG004|Initial Treatment Period Week 0-16|Withdrawal by Subject|0|||
42245026|NCT03536884|76069556|FG000|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
42245027|NCT03536884|76069557|FG001|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|1|||
42245028|NCT03536884|76069558|FG002|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
42245029|NCT03536884|76069559|FG003|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
42245030|NCT03536884|76069560|FG004|Initial Treatment Period Week 0-16|Unblinding was reason for dropout|0|||
42245031|NCT03536884|76069556|FG000|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
42245032|NCT03536884|76069557|FG001|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|1|||
42245033|NCT03536884|76069558|FG002|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
42245034|NCT03536884|76069559|FG003|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
42245035|NCT03536884|76069560|FG004|Initial Treatment Period Week 0-16|Withdrawn by Investigator for abnormal lab values|0|||
42245036|NCT03536884|76069556|FG000|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
42245037|NCT03536884|76069557|FG001|Initial Treatment Period Week 0-16|Unable to attend visits|1|||
42245038|NCT03536884|76069558|FG002|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
42245039|NCT03536884|76069559|FG003|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
42245040|NCT03536884|76069560|FG004|Initial Treatment Period Week 0-16|Unable to attend visits|0|||
42245041|NCT03536884|76069556|FG000|Maintenance Treatment Period Week 16-48|Death|0|||
42245042|NCT03536884|76069557|FG001|Maintenance Treatment Period Week 16-48|Death|0|||
42245043|NCT03536884|76069558|FG002|Maintenance Treatment Period Week 16-48|Death|1|||
42245044|NCT03536884|76069559|FG003|Maintenance Treatment Period Week 16-48|Death|0|||
42245045|NCT03536884|76069560|FG004|Maintenance Treatment Period Week 16-48|Death|1|||
42245046|NCT03536884|76069556|FG000|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
42245047|NCT03536884|76069557|FG001|Maintenance Treatment Period Week 16-48|Adverse Event|0|||
42245048|NCT03536884|76069558|FG002|Maintenance Treatment Period Week 16-48|Adverse Event|1|||
42245049|NCT03536884|76069559|FG003|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
42245050|NCT03536884|76069560|FG004|Maintenance Treatment Period Week 16-48|Adverse Event|3|||
42032841|NCT00943917|75841135|FG013|Stage I|A1C elevation|0|||
42245051|NCT03536884|76069556|FG000|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
42245052|NCT03536884|76069557|FG001|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
42245053|NCT03536884|76069558|FG002|Maintenance Treatment Period Week 16-48|Lack of Efficacy|0|||
42245054|NCT03536884|76069559|FG003|Maintenance Treatment Period Week 16-48|Lack of Efficacy|1|||
42245055|NCT03536884|76069560|FG004|Maintenance Treatment Period Week 16-48|Lack of Efficacy|4|||
42245056|NCT03536884|76069556|FG000|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
42245057|NCT03536884|76069557|FG001|Maintenance Treatment Period Week 16-48|Lost to Follow-up|0|||
42245058|NCT03536884|76069558|FG002|Maintenance Treatment Period Week 16-48|Lost to Follow-up|1|||
42245059|NCT03536884|76069559|FG003|Maintenance Treatment Period Week 16-48|Lost to Follow-up|2|||
42245060|NCT03536884|76069560|FG004|Maintenance Treatment Period Week 16-48|Lost to Follow-up|8|||
42245061|NCT03536884|76069556|FG000|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
42245062|NCT03536884|76069557|FG001|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|0|||
42245063|NCT03536884|76069558|FG002|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|7|||
42245064|NCT03536884|76069559|FG003|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|3|||
42245065|NCT03536884|76069560|FG004|Maintenance Treatment Period Week 16-48|Withdrawal by Subject|12|||
42245066|NCT03536884|76069556|FG000|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
42245067|NCT03536884|76069557|FG001|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
42245068|NCT03536884|76069558|FG002|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
42245069|NCT03536884|76069559|FG003|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|0|||
42245070|NCT03536884|76069560|FG004|Maintenance Treatment Period Week 16-48|Unable to come back for study visits|1|||
42245071|NCT03225287|76069596|FG000|Overall Study|Adverse Event|0|||
42245072|NCT03225287|76069597|FG001|Overall Study|Adverse Event|0|||
42132045|NCT00510068|75942843|FG000|Open-label Period|Protocol Violation|2|||
42132046|NCT00510068|75942844|FG001|Open-label Period|Protocol Violation|0|||
42132047|NCT00510068|75942843|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
42245073|NCT03225287|76069598|FG002|Overall Study|Adverse Event|1|||
42245074|NCT03225287|76069596|FG000|Overall Study|Protocol non-compliance|0|||
42245075|NCT03225287|76069597|FG001|Overall Study|Protocol non-compliance|0|||
42245076|NCT03225287|76069598|FG002|Overall Study|Protocol non-compliance|1|||
42245077|NCT03225287|76069596|FG000|Overall Study|Subject withdraws consent|3|||
42245078|NCT03225287|76069597|FG001|Overall Study|Subject withdraws consent|0|||
42245079|NCT03225287|76069598|FG002|Overall Study|Subject withdraws consent|0|||
42245080|NCT03225287|76069596|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
42245081|NCT03225287|76069597|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
42245082|NCT03225287|76069598|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
42245083|NCT03225287|76069596|FG000|Overall Study|Trial drug not effective|0|||
42245084|NCT03225287|76069597|FG001|Overall Study|Trial drug not effective|1|||
42245085|NCT03225287|76069598|FG002|Overall Study|Trial drug not effective|0|||
42245086|NCT03225287|76069596|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
42245087|NCT03225287|76069597|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
42245088|NCT03225287|76069598|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
42245089|NCT03225287|76069596|FG000|Overall Study|Stem cell transplantation|0|||
42245090|NCT03225287|76069597|FG001|Overall Study|Stem cell transplantation|1|||
42245091|NCT03225287|76069598|FG002|Overall Study|Stem cell transplantation|0|||
41989363|NCT05048719|75796944|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
42245092|NCT03140670|76069606|FG000|Overall Study|Withdrawal by Subject|2|||
42245093|NCT03140670|76069606|FG000|Overall Study|Lost to Follow-up|1|||
42245094|NCT03140670|76069606|FG000|Overall Study|Physician Decision|1|||
42245095|NCT02779855|76069613|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
42245096|NCT02779855|76069614|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
42245097|NCT02779855|76069615|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
42245098|NCT02682927|76069630|FG000|Overall Study|Adverse Event|0|||
41989364|NCT05048719|75796945|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
42032842|NCT00943917|75841136|FG014|Stage I|A1C elevation|0|||
42032843|NCT00943917|75841122|FG000|Stage I|Withdrawal by Subject|2|||
41989365|NCT05048719|75796946|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
41989366|NCT05048719|75796947|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
41989367|NCT05048719|75796939|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
41989368|NCT05048719|75796940|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
41989369|NCT05048719|75796941|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
41989370|NCT05048719|75796942|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
41989371|NCT05048719|75796943|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
41989372|NCT05048719|75796944|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
41989373|NCT05048719|75796945|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
41989374|NCT05048719|75796946|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
41989375|NCT05048719|75796947|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
41989376|NCT05048719|75796939|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
41989377|NCT05048719|75796940|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
41989378|NCT05048719|75796941|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
41989379|NCT05048719|75796942|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
41989380|NCT05048719|75796943|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
41989381|NCT05048719|75796944|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
41989382|NCT05048719|75796945|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
41989383|NCT05048719|75796946|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
41989384|NCT05048719|75796947|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
41989385|NCT05048719|75796939|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
41989386|NCT05048719|75796940|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
41989387|NCT05048719|75796941|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
41989388|NCT05048719|75796942|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
41989389|NCT05048719|75796943|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
41989390|NCT05048719|75796944|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
41989391|NCT05048719|75796945|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
41989392|NCT05048719|75796946|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
41989393|NCT05048719|75796947|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
41989394|NCT04949802|75796972|FG000|Overall Study|Lost to Follow-up|3|||
42032844|NCT00943917|75841123|FG001|Stage I|Withdrawal by Subject|1|||
42245099|NCT02682927|76069631|FG001|Overall Study|Adverse Event|0|||
42245100|NCT02682927|76069632|FG002|Overall Study|Adverse Event|5|||
42245101|NCT02682927|76069633|FG003|Overall Study|Adverse Event|1|||
42245102|NCT02682927|76069634|FG004|Overall Study|Adverse Event|0|||
42245103|NCT02682927|76069635|FG005|Overall Study|Adverse Event|2|||
42245104|NCT02682927|76069630|FG000|Overall Study|Death|0|||
41989395|NCT04626297|75796988|FG000|Overall Study|Adverse Event|5|||
41989396|NCT04626297|75796989|FG001|Overall Study|Adverse Event|3|||
41989397|NCT04626297|75796988|FG000|Overall Study|Lost to Follow-up|7|||
41989398|NCT04626297|75796989|FG001|Overall Study|Lost to Follow-up|3|||
41989399|NCT04626297|75796988|FG000|Overall Study|Protocol Violation|5|||
41989400|NCT04626297|75796989|FG001|Overall Study|Protocol Violation|1|||
41989401|NCT04626297|75796988|FG000|Overall Study|Withdrawal by Subject|20|||
42245105|NCT02682927|76069631|FG001|Overall Study|Death|0|||
42245106|NCT02682927|76069632|FG002|Overall Study|Death|0|||
42245107|NCT02682927|76069633|FG003|Overall Study|Death|1|||
42245108|NCT02682927|76069634|FG004|Overall Study|Death|0|||
42245109|NCT02682927|76069635|FG005|Overall Study|Death|0|||
42245110|NCT02682927|76069630|FG000|Overall Study|Lack of Efficacy|1|||
42245111|NCT02682927|76069631|FG001|Overall Study|Lack of Efficacy|0|||
42245112|NCT02682927|76069632|FG002|Overall Study|Lack of Efficacy|0|||
42245113|NCT02682927|76069633|FG003|Overall Study|Lack of Efficacy|1|||
42245114|NCT02682927|76069634|FG004|Overall Study|Lack of Efficacy|0|||
42245115|NCT02682927|76069635|FG005|Overall Study|Lack of Efficacy|0|||
42245116|NCT02682927|76069630|FG000|Overall Study|Other|0|||
42245117|NCT02682927|76069631|FG001|Overall Study|Other|0|||
42245118|NCT02682927|76069632|FG002|Overall Study|Other|0|||
42245119|NCT02682927|76069633|FG003|Overall Study|Other|2|||
42245120|NCT02682927|76069634|FG004|Overall Study|Other|0|||
42245121|NCT02682927|76069635|FG005|Overall Study|Other|0|||
42245122|NCT02682927|76069630|FG000|Overall Study|Withdrawal by Subject|2|||
42245123|NCT02682927|76069631|FG001|Overall Study|Withdrawal by Subject|0|||
42245124|NCT02682927|76069632|FG002|Overall Study|Withdrawal by Subject|1|||
42245125|NCT02682927|76069633|FG003|Overall Study|Withdrawal by Subject|0|||
42245126|NCT02682927|76069634|FG004|Overall Study|Withdrawal by Subject|1|||
42245127|NCT02682927|76069635|FG005|Overall Study|Withdrawal by Subject|1|||
42245128|NCT02566850|76069690|FG000|Overall Study|Protocol Violation|1|||
42245129|NCT02408120|76069709|FG000|Overall Study|Withdrawal by Subject|0|||
42245130|NCT02408120|76069710|FG001|Overall Study|Withdrawal by Subject|1|||
42245131|NCT02408120|76069709|FG000|Overall Study|Treatment Refusal|1|||
42245132|NCT02408120|76069710|FG001|Overall Study|Treatment Refusal|0|||
42245133|NCT02408120|76069709|FG000|Overall Study|Received Steroids|1|||
42245134|NCT02408120|76069710|FG001|Overall Study|Received Steroids|1|||
42245135|NCT02408120|76069709|FG000|Overall Study|Discharged same day|1|||
42245136|NCT02408120|76069710|FG001|Overall Study|Discharged same day|1|||
42245137|NCT02408120|76069709|FG000|Overall Study|Did not receive insulin|1|||
42245138|NCT02408120|76069710|FG001|Overall Study|Did not receive insulin|2|||
41989402|NCT04626297|75796989|FG001|Overall Study|Withdrawal by Subject|6|||
41989403|NCT04626297|75796988|FG000|Overall Study|Sponsor decision|2|||
41989404|NCT04626297|75796989|FG001|Overall Study|Sponsor decision|1|||
41989405|NCT04154189|75797001|FG000|Overall Study|Death|16|||
41989406|NCT04154189|75797002|FG001|Overall Study|Death|15|||
41989407|NCT04154189|75797001|FG000|Overall Study|Withdrawal by Subject|4|||
41989408|NCT04154189|75797002|FG001|Overall Study|Withdrawal by Subject|6|||
42245139|NCT02391545|76069718|FG000|Overall Study|Death|0|||
41989409|NCT04154189|75797001|FG000|Overall Study|Ongoing|20|||
41989410|NCT04154189|75797002|FG001|Overall Study|Ongoing|20|||
42032845|NCT00943917|75841124|FG002|Stage I|Withdrawal by Subject|2|||
42245140|NCT02391545|76069719|FG001|Overall Study|Death|2|||
42245141|NCT02391545|76069718|FG000|Overall Study|Lost to Follow-up|0|||
42245142|NCT02391545|76069719|FG001|Overall Study|Lost to Follow-up|1|||
42245143|NCT02391545|76069718|FG000|Overall Study|Termination of study by sponsor|20|||
42245144|NCT02391545|76069719|FG001|Overall Study|Termination of study by sponsor|20|||
42245145|NCT02391545|76069718|FG000|Overall Study|Withdrawal by Subject|0|||
42245146|NCT02391545|76069719|FG001|Overall Study|Withdrawal by Subject|1|||
42245147|NCT02391545|76069718|FG000|Overall Study|Other Reasons|6|||
42245148|NCT02391545|76069719|FG001|Overall Study|Other Reasons|4|||
42245149|NCT01920932|76069726|FG000|Overall Study|Death|1|||
42245150|NCT01920932|76069726|FG000|Overall Study|Withdrawal of consent|1|||
42245151|NCT01774253|76069747|FG000|Overall Study|Lack of Efficacy|4|||
42245152|NCT01774253|76069747|FG000|Overall Study|Physician Decision|2|||
42245153|NCT01774253|76069747|FG000|Overall Study|Withdrawal by Subject|2|||
41989411|NCT03905512|75797025|FG000|Overall Study|Withdrawal by Subject|9|||
41989412|NCT03905512|75797026|FG001|Overall Study|Withdrawal by Subject|8|||
42245154|NCT01774253|76069747|FG000|Overall Study|Death|1|||
42245155|NCT01505608|76069753|FG000|Phase I|Lack of Efficacy|0|||
42245156|NCT01505608|76069754|FG001|Phase I|Lack of Efficacy|4|||
42245157|NCT01505608|76069753|FG000|Phase I|Adverse Event|0|||
41989413|NCT03905512|75797025|FG000|Overall Study|Adverse Event|1|||
42032846|NCT00943917|75841125|FG003|Stage I|Withdrawal by Subject|0|||
42245158|NCT01505608|76069754|FG001|Phase I|Adverse Event|1|||
42245159|NCT01505608|76069753|FG000|Phase I|Withdrawal by Subject|0|||
42245160|NCT01505608|76069754|FG001|Phase I|Withdrawal by Subject|1|||
42245161|NCT01505608|76069753|FG000|Phase II|Lack of Efficacy|2|||
42245162|NCT01505608|76069754|FG001|Phase II|Lack of Efficacy|1|||
42245163|NCT01505608|76069753|FG000|Phase II|Protocol Violation|0|||
42245164|NCT01505608|76069754|FG001|Phase II|Protocol Violation|1|||
42245165|NCT01483820|76069788|FG000|Overall Study|Lack of Efficacy|6|||
42245166|NCT01483820|76069788|FG000|Overall Study|Adverse Event|1|||
42245167|NCT01483820|76069788|FG000|Overall Study|Death|1|||
42245168|NCT01106898|76069803|FG000|Overall Study|Adverse Event|6|||
42245169|NCT01059071|76069807|FG000|Overall Study|Lack of Efficacy|1|||
42245170|NCT01059071|76069808|FG001|Overall Study|Lack of Efficacy|4|||
42245171|NCT01059071|76069809|FG002|Overall Study|Lack of Efficacy|2|||
42245172|NCT01059071|76069810|FG003|Overall Study|Lack of Efficacy|3|||
42245173|NCT01059071|76069807|FG000|Overall Study|Withdrawal by Subject|1|||
42245174|NCT01059071|76069808|FG001|Overall Study|Withdrawal by Subject|0|||
42245175|NCT01059071|76069809|FG002|Overall Study|Withdrawal by Subject|0|||
42245176|NCT01059071|76069810|FG003|Overall Study|Withdrawal by Subject|2|||
42245177|NCT01059071|76069807|FG000|Overall Study|Physician Decision|0|||
42245178|NCT01059071|76069808|FG001|Overall Study|Physician Decision|0|||
42245179|NCT01059071|76069809|FG002|Overall Study|Physician Decision|0|||
42245180|NCT01059071|76069810|FG003|Overall Study|Physician Decision|1|||
42245181|NCT00923702|76069823|FG000|Overall Study|Ongoing enrollment|0|||
42245182|NCT00923702|76069824|FG001|Overall Study|Ongoing enrollment|0|||
42245183|NCT00923702|76069825|FG002|Overall Study|Ongoing enrollment|0|||
42245184|NCT00923702|76069826|FG003|Overall Study|Ongoing enrollment|0|||
42245185|NCT00923702|76069827|FG004|Overall Study|Ongoing enrollment|354|||
42245186|NCT00867568|76069839|FG000|Overall Study|Lack of Efficacy|10|||
42245187|NCT00867568|76069839|FG000|Overall Study|Adverse Event|4|||
42245188|NCT00867568|76069839|FG000|Overall Study|Withdrawal by Subject|1|||
42245189|NCT00737698|76069846|FG000|Overall Study|Withdrawal by Subject|6|||
42245190|NCT00737698|76069847|FG001|Overall Study|Withdrawal by Subject|5|||
42245191|NCT00737698|76069848|FG002|Overall Study|Withdrawal by Subject|3|||
42245192|NCT00737698|76069846|FG000|Overall Study|Death|0|||
42245193|NCT00737698|76069847|FG001|Overall Study|Death|0|||
42245194|NCT00737698|76069848|FG002|Overall Study|Death|1|||
42245195|NCT01668004|76069883|FG000|Overall Study|Adverse Event|7|||
42245196|NCT01668004|76069883|FG000|Overall Study|Withdrawal by Subject|2|||
42245197|NCT01668004|76069883|FG000|Overall Study|Lost to Follow-up|5|||
42245198|NCT01668004|76069883|FG000|Overall Study|Lack of Efficacy|9|||
42245199|NCT01668004|76069883|FG000|Overall Study|Non-compliance with treatment|2|||
42245200|NCT01667926|76069891|FG000|Overall Study|Withdrawal by Subject|1|||
42245201|NCT01667926|76069892|FG001|Overall Study|Withdrawal by Subject|2|||
42245202|NCT01667926|76069893|FG002|Overall Study|Withdrawal by Subject|2|||
42245203|NCT01667926|76069891|FG000|Overall Study|Physician Decision|0|||
42245204|NCT01667926|76069892|FG001|Overall Study|Physician Decision|0|||
42245205|NCT01667926|76069893|FG002|Overall Study|Physician Decision|1|||
42245206|NCT01667926|76069891|FG000|Overall Study|Time committment|0|||
42245207|NCT01667926|76069892|FG001|Overall Study|Time committment|0|||
41989414|NCT03905512|75797026|FG001|Overall Study|Adverse Event|2|||
41989415|NCT03905512|75797025|FG000|Overall Study|Lost to Follow-up|4|||
42132048|NCT00510068|75942844|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
42132049|NCT00509600|75942852|FG000|Overall Study|Adverse Event|1|||
42132050|NCT00402987|75942860|FG000|Overall Study|Lack of Efficacy|0|||
42132051|NCT00402987|75942861|FG001|Overall Study|Lack of Efficacy|0|||
42132052|NCT00402987|75942862|FG002|Overall Study|Lack of Efficacy|1|||
42132053|NCT00402987|75942863|FG003|Overall Study|Lack of Efficacy|0|||
42132054|NCT00501644|75942887|FG000|Overall Study|Adverse Event|4|||
42132055|NCT00501644|75942887|FG000|Overall Study|Withdrawal by Subject|1|||
42132056|NCT00497796|75942893|FG000|Overall Study|Adverse event (not related)|9|||
42132057|NCT00497796|75942894|FG001|Overall Study|Adverse event (not related)|9|||
42132058|NCT00497796|75942893|FG000|Overall Study|Adverse event (related)|5|||
42132059|NCT00497796|75942894|FG001|Overall Study|Adverse event (related)|4|||
42132060|NCT00497796|75942893|FG000|Overall Study|CMV infection or disease treatment|30|||
42132061|NCT00497796|75942894|FG001|Overall Study|CMV infection or disease treatment|4|||
42132062|NCT00497796|75942893|FG000|Overall Study|Consent withdrawn|10|||
41989416|NCT03905512|75797026|FG001|Overall Study|Lost to Follow-up|3|||
41989417|NCT03905512|75797025|FG000|Overall Study|Other than Specified|7|||
42132063|NCT00497796|75942894|FG001|Overall Study|Consent withdrawn|3|||
42245208|NCT01667926|76069893|FG002|Overall Study|Time committment|2|||
42245209|NCT01667926|76069891|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
42245210|NCT01667926|76069892|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
42245211|NCT01667926|76069893|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
41989418|NCT03905512|75797026|FG001|Overall Study|Other than Specified|4|||
42132064|NCT00497796|75942893|FG000|Overall Study|Investigator/sponsor discretion|31|||
42245212|NCT01667926|76069891|FG000|Overall Study|Lost to Follow-up|1|||
42245213|NCT01667926|76069892|FG001|Overall Study|Lost to Follow-up|2|||
42245214|NCT01667926|76069893|FG002|Overall Study|Lost to Follow-up|1|||
41989419|NCT03891875|75797035|FG000|Overall Study|Withdrawal by Subject|20|||
42132065|NCT00497796|75942894|FG001|Overall Study|Investigator/sponsor discretion|34|||
42245215|NCT01667926|76069891|FG000|Overall Study|Side effects|3|||
41989420|NCT03891875|75797036|FG001|Overall Study|Withdrawal by Subject|3|||
42132066|NCT00497796|75942893|FG000|Overall Study|Lost to Follow-up|0|||
42132067|NCT00497796|75942894|FG001|Overall Study|Lost to Follow-up|1|||
42132068|NCT00497796|75942893|FG000|Overall Study|Not applicable (randomized not treated)|0|||
42132069|NCT00497796|75942894|FG001|Overall Study|Not applicable (randomized not treated)|4|||
42132070|NCT00496782|75942902|FG000|Overall Study|Protocol Violation|1|||
42132071|NCT00496782|75942903|FG001|Overall Study|Protocol Violation|2|||
42132072|NCT00402831|75942911|FG000|Overall Study|Lost to Follow-up|1|||
42132073|NCT00402831|75942912|FG001|Overall Study|Lost to Follow-up|2|||
42132074|NCT00402831|75942911|FG000|Overall Study|Non-compliance with protocol|0|||
42132075|NCT00402831|75942912|FG001|Overall Study|Non-compliance with protocol|1|||
42132076|NCT00496626|75942922|FG000|Overall Study|Lost to Follow-up|0|||
42245216|NCT01667926|76069892|FG001|Overall Study|Side effects|0|||
42245217|NCT01667926|76069893|FG002|Overall Study|Side effects|0|||
42245218|NCT02604160|76069901|FG000|Overall Study|Protocol Violation|0|||
42245219|NCT02604160|76069902|FG001|Overall Study|Protocol Violation|1|||
42245220|NCT02604160|76069901|FG000|Overall Study|Physician Decision|0|||
42132077|NCT00496626|75942923|FG001|Overall Study|Lost to Follow-up|1|||
42132078|NCT00496626|75942922|FG000|Overall Study|Protocol Violation|1|||
42132079|NCT00496626|75942923|FG001|Overall Study|Protocol Violation|0|||
42132080|NCT00496626|75942922|FG000|Overall Study|Withdrawal by Subject|5|||
42132081|NCT00496626|75942923|FG001|Overall Study|Withdrawal by Subject|4|||
42132082|NCT00496626|75942922|FG000|Overall Study|Relocated|0|||
42132083|NCT00496626|75942923|FG001|Overall Study|Relocated|1|||
42132084|NCT00471822|75942933|FG000|Overall Study|Protocol Violation|2|||
42132085|NCT00471276|75942937|FG000|Overall Study|Death|2|||
42132086|NCT00471276|75942937|FG000|Overall Study|Adverse Event|16|||
42132087|NCT00471276|75942937|FG000|Overall Study|Protocol Violation|1|||
42132088|NCT00471276|75942937|FG000|Overall Study|Objective progression or relapse|54|||
42132089|NCT00471276|75942937|FG000|Overall Study|Global deterioration of health status|1|||
42245221|NCT02604160|76069902|FG001|Overall Study|Physician Decision|1|||
42245222|NCT01359904|76069912|FG000|Overall Study|Withdrawal by Subject|1|||
42245223|NCT01359904|76069913|FG001|Overall Study|Withdrawal by Subject|0|||
42245224|NCT05044234|76069990|FG000|Overall Study|Lost to Follow-up|2|||
42245225|NCT05044234|76069991|FG001|Overall Study|Lost to Follow-up|1|||
42245226|NCT05044234|76069992|FG002|Overall Study|Lost to Follow-up|1|||
42132090|NCT00471276|75942937|FG000|Overall Study|Other|3|||
42132091|NCT00471276|75942937|FG000|Overall Study|Refused treatment|6|||
42132092|NCT00470262|75942943|FG000|Overall Study|Withdrawal by Subject|2|||
42132093|NCT00470262|75942944|FG001|Overall Study|Withdrawal by Subject|0|||
42132094|NCT00496470|75942953|FG000|Overall Study|Adverse Event|8|||
42132095|NCT00496470|75942954|FG001|Overall Study|Adverse Event|10|||
42132096|NCT00496470|75942953|FG000|Overall Study|Withdrawal by Subject|5|||
42245227|NCT05044234|76069993|FG003|Overall Study|Lost to Follow-up|2|||
42245228|NCT05044234|76069990|FG000|Overall Study|Withdrawal by Subject|6|||
42245229|NCT05044234|76069991|FG001|Overall Study|Withdrawal by Subject|4|||
42245230|NCT05044234|76069992|FG002|Overall Study|Withdrawal by Subject|5|||
41989421|NCT03891875|75797035|FG000|Overall Study|Adverse Event|10|||
42245231|NCT05044234|76069993|FG003|Overall Study|Withdrawal by Subject|8|||
42245232|NCT05044234|76069990|FG000|Overall Study|Study terminated by Sponsor|21|||
42245233|NCT05044234|76069991|FG001|Overall Study|Study terminated by Sponsor|21|||
42245234|NCT05044234|76069992|FG002|Overall Study|Study terminated by Sponsor|20|||
41989422|NCT03891875|75797036|FG001|Overall Study|Adverse Event|4|||
41989423|NCT03891875|75797035|FG000|Overall Study|Physician Decision|1|||
42132097|NCT00496470|75942954|FG001|Overall Study|Withdrawal by Subject|12|||
42245235|NCT05044234|76069993|FG003|Overall Study|Study terminated by Sponsor|14|||
42245236|NCT05044234|76069990|FG000|Overall Study|Other, not specified|0|||
41989424|NCT03891875|75797036|FG001|Overall Study|Physician Decision|1|||
42132098|NCT00496470|75942953|FG000|Overall Study|Incorrectly enrolled|13|||
42132099|NCT00496470|75942954|FG001|Overall Study|Incorrectly enrolled|5|||
42132100|NCT00496470|75942953|FG000|Overall Study|Other reason|0|||
42245237|NCT05044234|76069991|FG001|Overall Study|Other, not specified|0|||
42245238|NCT05044234|76069992|FG002|Overall Study|Other, not specified|1|||
42245239|NCT05044234|76069993|FG003|Overall Study|Other, not specified|2|||
42132101|NCT00496470|75942954|FG001|Overall Study|Other reason|2|||
42132102|NCT00496080|75942960|FG000|Overall Study|Lost to Follow-up|9|||
42245240|NCT05044234|76069990|FG000|Overall Study|Delayed data entry|0|||
42245241|NCT05044234|76069991|FG001|Overall Study|Delayed data entry|0|||
42245242|NCT05044234|76069992|FG002|Overall Study|Delayed data entry|0|||
42245243|NCT05044234|76069993|FG003|Overall Study|Delayed data entry|1|||
42245244|NCT04725812|76070011|FG000|Overall Study|Withdrawal by Subject|1|||
42245245|NCT04147247|76070042|FG000|Overall Study|Progressive disease|3|||
42245246|NCT04147247|76070043|FG001|Overall Study|Progressive disease|3|||
42245247|NCT04147247|76070044|FG002|Overall Study|Progressive disease|4|||
42245248|NCT04147247|76070045|FG003|Overall Study|Progressive disease|4|||
42245249|NCT04147247|76070046|FG004|Overall Study|Progressive disease|3|||
42245250|NCT04147247|76070042|FG000|Overall Study|Physician Decision|0|||
42245251|NCT04147247|76070043|FG001|Overall Study|Physician Decision|1|||
42245252|NCT04147247|76070044|FG002|Overall Study|Physician Decision|0|||
42245253|NCT04147247|76070045|FG003|Overall Study|Physician Decision|0|||
42245254|NCT04147247|76070046|FG004|Overall Study|Physician Decision|0|||
42245255|NCT04147247|76070042|FG000|Overall Study|Clinical Disease Progression|0|||
42245256|NCT04147247|76070043|FG001|Overall Study|Clinical Disease Progression|0|||
42245257|NCT04147247|76070044|FG002|Overall Study|Clinical Disease Progression|0|||
42245258|NCT04147247|76070045|FG003|Overall Study|Clinical Disease Progression|0|||
42245259|NCT04147247|76070046|FG004|Overall Study|Clinical Disease Progression|1|||
42245260|NCT04147247|76070042|FG000|Overall Study|Adverse Event|0|||
42245261|NCT04147247|76070043|FG001|Overall Study|Adverse Event|0|||
42245262|NCT04147247|76070044|FG002|Overall Study|Adverse Event|1|||
42245263|NCT04147247|76070045|FG003|Overall Study|Adverse Event|0|||
42245264|NCT04147247|76070046|FG004|Overall Study|Adverse Event|1|||
42245265|NCT04080167|76070061|FG000|Overall Study|Lost to Follow-up-Patients|7|||
42245266|NCT04080167|76070062|FG001|Overall Study|Lost to Follow-up-Patients|14|||
42245267|NCT04080167|76070063|FG002|Overall Study|Lost to Follow-up-Patients|0|||
42245268|NCT04080167|76070061|FG000|Overall Study|Lost to Follow-up-Providers|2|||
42245269|NCT04080167|76070062|FG001|Overall Study|Lost to Follow-up-Providers|2|||
42245270|NCT04080167|76070063|FG002|Overall Study|Lost to Follow-up-Providers|0|||
42245271|NCT04080167|76070061|FG000|Overall Study|Withdrawal by Subject|1|||
42245272|NCT04080167|76070062|FG001|Overall Study|Withdrawal by Subject|2|||
42245273|NCT04080167|76070063|FG002|Overall Study|Withdrawal by Subject|0|||
42245274|NCT04080167|76070061|FG000|Overall Study|Withdrawal by Provider|0|||
42245275|NCT04080167|76070062|FG001|Overall Study|Withdrawal by Provider|0|||
42245276|NCT04080167|76070063|FG002|Overall Study|Withdrawal by Provider|4|||
42245277|NCT04080167|76070061|FG000|Overall Study|Death-Patient|2|||
42245278|NCT04080167|76070062|FG001|Overall Study|Death-Patient|1|||
42245279|NCT04080167|76070063|FG002|Overall Study|Death-Patient|0|||
42245280|NCT04080167|76070061|FG000|Overall Study|Hydroxyurea New Starts|0|||
42245281|NCT04080167|76070062|FG001|Overall Study|Hydroxyurea New Starts|0|||
42245282|NCT04080167|76070063|FG002|Overall Study|Hydroxyurea New Starts|1|||
42245283|NCT04080167|76070061|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
42245284|NCT04080167|76070062|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
42245285|NCT04080167|76070063|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
42245286|NCT04070378|76070070|FG000|Overall Study|Withdrawal by Subject|2|||
42245287|NCT04070378|76070070|FG000|Overall Study|Screen Failure|6|||
42245288|NCT04070378|76070070|FG000|Overall Study|Physician Decision|1|||
42245289|NCT04070378|76070070|FG000|Overall Study|Adverse Event|1|||
42245290|NCT04007367|76070074|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
42245291|NCT04007367|76070075|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
42245292|NCT04007367|76070076|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
42245293|NCT04007367|76070074|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
42245294|NCT04007367|76070075|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
42245295|NCT04007367|76070076|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
42245296|NCT04007367|76070074|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
42245297|NCT04007367|76070075|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
42245298|NCT04007367|76070076|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
42245299|NCT04007367|76070074|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
42245300|NCT04007367|76070075|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
42245301|NCT04007367|76070076|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
42245302|NCT04007367|76070074|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
42245303|NCT04007367|76070075|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
42245304|NCT04007367|76070076|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
42245305|NCT03900650|76070103|FG000|Overall Study|Withdrawal by Subject|1|||
42245306|NCT03900650|76070104|FG001|Overall Study|Withdrawal by Subject|1|||
42245307|NCT03900650|76070105|FG002|Overall Study|Withdrawal by Subject|0|||
42245308|NCT03900650|76070106|FG003|Overall Study|Withdrawal by Subject|0|||
42245309|NCT03900650|76070103|FG000|Overall Study|Withdrawn by staff|1|||
42245310|NCT03900650|76070104|FG001|Overall Study|Withdrawn by staff|0|||
42245311|NCT03900650|76070105|FG002|Overall Study|Withdrawn by staff|0|||
42245312|NCT03900650|76070106|FG003|Overall Study|Withdrawn by staff|0|||
42245313|NCT03890120|76070118|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
42245314|NCT03890120|76070119|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
42245315|NCT03890120|76070120|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
42245316|NCT03890120|76070121|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
42245317|NCT03890120|76070118|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
42245318|NCT03890120|76070119|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
42245319|NCT03890120|76070120|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
42245320|NCT03890120|76070121|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
42245321|NCT03890120|76070118|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
42245322|NCT03890120|76070119|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
41989425|NCT03891875|75797035|FG000|Overall Study|Protocol Violation|1|||
41989426|NCT03891875|75797036|FG001|Overall Study|Protocol Violation|0|||
42245323|NCT03890120|76070120|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
42245324|NCT03890120|76070121|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
42245325|NCT03890120|76070118|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
42245326|NCT03890120|76070119|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
42245327|NCT03890120|76070120|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
42245328|NCT03890120|76070121|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
42245329|NCT03890120|76070118|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
42245330|NCT03890120|76070119|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
42245331|NCT03890120|76070120|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
42245332|NCT03890120|76070121|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
42245333|NCT03890120|76070118|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
42245334|NCT03890120|76070119|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
42245335|NCT03890120|76070120|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
42245336|NCT03890120|76070121|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
42245337|NCT03890120|76070118|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
42245338|NCT03890120|76070119|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
42245339|NCT03890120|76070120|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
42245340|NCT03890120|76070121|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
42245341|NCT03890120|76070118|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
42245342|NCT03890120|76070119|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
42245343|NCT03890120|76070120|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
42245344|NCT03890120|76070121|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
42245345|NCT03890120|76070118|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
42245346|NCT03890120|76070119|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
42245347|NCT03890120|76070120|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
41989427|NCT03891875|75797035|FG000|Overall Study|Lost to Follow-up|1|||
41989428|NCT03891875|75797036|FG001|Overall Study|Lost to Follow-up|0|||
41989429|NCT03891875|75797035|FG000|Overall Study|COVID-19 infection|1|||
41989430|NCT03891875|75797036|FG001|Overall Study|COVID-19 infection|0|||
41989431|NCT03830164|75797045|FG000|Overall Study|Adverse Event|0|||
42245348|NCT03890120|76070121|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
42245349|NCT03890120|76070118|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
42245350|NCT03890120|76070119|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
41989432|NCT03830164|75797046|FG001|Overall Study|Adverse Event|2|||
41989433|NCT03830164|75797047|FG002|Overall Study|Adverse Event|0|||
42245351|NCT03890120|76070120|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
42245352|NCT03890120|76070121|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
42245353|NCT03890120|76070118|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
42245354|NCT03890120|76070119|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
42245355|NCT03890120|76070120|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
42245356|NCT03890120|76070121|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
42245357|NCT03890120|76070118|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
42245358|NCT03890120|76070119|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
42245359|NCT03890120|76070120|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
42245360|NCT03890120|76070121|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
42245361|NCT03890120|76070118|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
42245362|NCT03890120|76070119|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
42245363|NCT03890120|76070120|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
42245364|NCT03890120|76070121|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
42245365|NCT03875235|76070133|FG000|Overall Study|Ongoing study treatment|63|||
42245366|NCT03875235|76070134|FG001|Overall Study|Ongoing study treatment|20|||
42245367|NCT03875235|76070133|FG000|Overall Study|Off treatment|77|||
42245368|NCT03875235|76070134|FG001|Overall Study|Off treatment|91|||
42245369|NCT03875235|76070133|FG000|Overall Study|Withdrawal by Subject|3|||
42245370|NCT03875235|76070134|FG001|Overall Study|Withdrawal by Subject|10|||
42245371|NCT03875235|76070133|FG000|Overall Study|Death|198|||
42245372|NCT03875235|76070134|FG001|Overall Study|Death|223|||
42245373|NCT03783689|76070148|FG000|Overall Study|Adverse Event|2|||
42245374|NCT03783689|76070149|FG001|Overall Study|Adverse Event|0|||
42245375|NCT03783689|76070148|FG000|Overall Study|Lost to Follow-up|2|||
42245376|NCT03783689|76070149|FG001|Overall Study|Lost to Follow-up|1|||
42245377|NCT03783689|76070148|FG000|Overall Study|Physician Decision|2|||
42245378|NCT03783689|76070149|FG001|Overall Study|Physician Decision|1|||
42245379|NCT03783689|76070148|FG000|Overall Study|Withdrawal by Subject|3|||
42245380|NCT03783689|76070149|FG001|Overall Study|Withdrawal by Subject|3|||
42245381|NCT03771664|76070158|FG000|Overall Study|Adverse Event|1|||
42245382|NCT03771664|76070159|FG001|Overall Study|Adverse Event|0|||
42245383|NCT03771664|76070158|FG000|Overall Study|Lost to Follow-up|1|||
42245384|NCT03771664|76070159|FG001|Overall Study|Lost to Follow-up|0|||
42245385|NCT03771664|76070158|FG000|Overall Study|Withdrawal by Participant|1|||
42245386|NCT03771664|76070159|FG001|Overall Study|Withdrawal by Participant|4|||
42245387|NCT03771664|76070158|FG000|Overall Study|Randomized but not Treated|0|||
42245388|NCT03771664|76070159|FG001|Overall Study|Randomized but not Treated|1|||
42245389|NCT03743415|76070175|FG000|Overall Study|Death|5|||
42245390|NCT03743415|76070176|FG001|Overall Study|Death|3|||
42245391|NCT03743415|76070177|FG002|Overall Study|Death|1|||
42245392|NCT03743415|76070178|FG003|Overall Study|Death|4|||
42245393|NCT03743415|76070179|FG004|Overall Study|Death|0|||
42245394|NCT03743415|76070180|FG005|Overall Study|Death|0|||
41989434|NCT03830164|75797045|FG000|Overall Study|Lack of Efficacy|1|||
41989435|NCT03830164|75797046|FG001|Overall Study|Lack of Efficacy|5|||
41989436|NCT03830164|75797047|FG002|Overall Study|Lack of Efficacy|0|||
41989437|NCT03830164|75797045|FG000|Overall Study|Lost to Follow-up|0|||
41989438|NCT03830164|75797046|FG001|Overall Study|Lost to Follow-up|1|||
41989439|NCT03830164|75797047|FG002|Overall Study|Lost to Follow-up|0|||
41989440|NCT03830164|75797045|FG000|Overall Study|Withdrawal by Subject|1|||
41989441|NCT03830164|75797046|FG001|Overall Study|Withdrawal by Subject|0|||
41989442|NCT03830164|75797047|FG002|Overall Study|Withdrawal by Subject|0|||
41989443|NCT03769181|75797059|FG000|Overall Study|Adverse Event|1|||
41989444|NCT03769181|75797060|FG001|Overall Study|Adverse Event|0|||
41989445|NCT03769181|75797061|FG002|Overall Study|Adverse Event|2|||
42302738|NCT02349633|76138077|FG009|Overall Study|Transition to compassionate use|1|||
41989446|NCT03769181|75797062|FG003|Overall Study|Adverse Event|4|||
41989447|NCT03769181|75797059|FG000|Overall Study|Withdrawal by Subject|1|||
41989448|NCT03769181|75797060|FG001|Overall Study|Withdrawal by Subject|0|||
41989449|NCT03769181|75797061|FG002|Overall Study|Withdrawal by Subject|2|||
41989450|NCT03769181|75797062|FG003|Overall Study|Withdrawal by Subject|1|||
42245395|NCT03743415|76070181|FG006|Overall Study|Death|0|||
42245396|NCT03743415|76070182|FG007|Overall Study|Death|0|||
42302739|NCT02349633|76138078|FG010|Overall Study|Transition to compassionate use|0|||
41989451|NCT03769181|75797059|FG000|Overall Study|Progressive disease|9|||
41989452|NCT03769181|75797060|FG001|Overall Study|Progressive disease|7|||
41989453|NCT03769181|75797061|FG002|Overall Study|Progressive disease|13|||
41989454|NCT03769181|75797062|FG003|Overall Study|Progressive disease|6|||
42032847|NCT00943917|75841126|FG004|Stage I|Withdrawal by Subject|0|||
42302740|NCT02349633|76138079|FG011|Overall Study|Transition to compassionate use|0|||
42302741|NCT02349633|76138080|FG012|Overall Study|Transition to compassionate use|0|||
41989455|NCT03769181|75797059|FG000|Overall Study|Other - Unspecified|2|||
42032848|NCT00943917|75841127|FG005|Stage I|Withdrawal by Subject|0|||
41989456|NCT03769181|75797060|FG001|Overall Study|Other - Unspecified|1|||
41989457|NCT03769181|75797061|FG002|Overall Study|Other - Unspecified|0|||
41989458|NCT03769181|75797062|FG003|Overall Study|Other - Unspecified|0|||
41989459|NCT03621696|75797105|FG000|Overall Study|Not eligible|0|||
42245397|NCT03743415|76070183|FG008|Overall Study|Death|1|||
42245398|NCT03743415|76070184|FG009|Overall Study|Death|0|||
42245399|NCT03743415|76070175|FG000|Overall Study|Withdrawal by Subject|1|||
42245400|NCT03743415|76070176|FG001|Overall Study|Withdrawal by Subject|0|||
41989460|NCT03621696|75797106|FG001|Overall Study|Not eligible|0|||
41989461|NCT03621696|75797107|FG002|Overall Study|Not eligible|0|||
41989462|NCT03621696|75797108|FG003|Overall Study|Not eligible|5|||
41989463|NCT03621696|75797105|FG000|Overall Study|Withdrawal by Subject|1|||
41989464|NCT03621696|75797106|FG001|Overall Study|Withdrawal by Subject|1|||
41989465|NCT03621696|75797107|FG002|Overall Study|Withdrawal by Subject|1|||
41989466|NCT03621696|75797108|FG003|Overall Study|Withdrawal by Subject|0|||
41989467|NCT03621696|75797105|FG000|Overall Study|Physician Decision|0|||
41989468|NCT03621696|75797106|FG001|Overall Study|Physician Decision|0|||
41989469|NCT03621696|75797107|FG002|Overall Study|Physician Decision|1|||
41989470|NCT03621696|75797108|FG003|Overall Study|Physician Decision|0|||
41989471|NCT03594747|75797119|FG000|Overall Study|Remain on study at the time of data cut off|69|||
41989472|NCT03594747|75797120|FG001|Overall Study|Remain on study at the time of data cut off|67|||
41989473|NCT03594747|75797121|FG002|Overall Study|Remain on study at the time of data cut off|53|||
41989474|NCT03594747|75797119|FG000|Overall Study|Death|48|||
41989475|NCT03594747|75797120|FG001|Overall Study|Death|47|||
41989476|NCT03594747|75797121|FG002|Overall Study|Death|52|||
41989477|NCT03594747|75797119|FG000|Overall Study|Withdrawal by Subject|3|||
41989478|NCT03594747|75797120|FG001|Overall Study|Withdrawal by Subject|4|||
41989479|NCT03594747|75797121|FG002|Overall Study|Withdrawal by Subject|14|||
41989480|NCT03594747|75797119|FG000|Overall Study|Lost to Follow-up|0|||
41989481|NCT03594747|75797120|FG001|Overall Study|Lost to Follow-up|0|||
41989482|NCT03594747|75797121|FG002|Overall Study|Lost to Follow-up|1|||
41989483|NCT03594747|75797119|FG000|Overall Study|Physician Decision|0|||
41989484|NCT03594747|75797120|FG001|Overall Study|Physician Decision|1|||
41989485|NCT03594747|75797121|FG002|Overall Study|Physician Decision|0|||
41989486|NCT03594747|75797119|FG000|Overall Study|Did not meet inclusion criteria|0|||
41989487|NCT03594747|75797120|FG001|Overall Study|Did not meet inclusion criteria|0|||
41989488|NCT03594747|75797121|FG002|Overall Study|Did not meet inclusion criteria|1|||
41989489|NCT03592641|75797129|FG000|Overall Study|Withdrawal by Subject|1|||
41989490|NCT03468985|75797137|FG000|Overall Study|Adverse Event|0|||
41989491|NCT03468985|75797138|FG001|Overall Study|Adverse Event|2|||
41989492|NCT03468985|75797139|FG002|Overall Study|Adverse Event|0|||
41989493|NCT03468985|75797140|FG003|Overall Study|Adverse Event|0|||
41989494|NCT03468985|75797137|FG000|Overall Study|Withdrawal by Subject|0|||
41989495|NCT03468985|75797138|FG001|Overall Study|Withdrawal by Subject|0|||
41989496|NCT03468985|75797139|FG002|Overall Study|Withdrawal by Subject|0|||
41989497|NCT03468985|75797140|FG003|Overall Study|Withdrawal by Subject|1|||
41989498|NCT03434418|75797159|FG000|Overall Study|Disease Progression|11|||
41989499|NCT03434418|75797159|FG000|Overall Study|Adverse Event|2|||
41989500|NCT03434418|75797159|FG000|Overall Study|Physician Decision|1|||
41989501|NCT03434418|75797159|FG000|Overall Study|Decline in Performance Status (PS)|1|||
41989502|NCT03366103|75797174|FG000|Overall Study|Disease Progression|3|||
41989503|NCT03366103|75797175|FG001|Overall Study|Disease Progression|1|||
41989504|NCT03366103|75797176|FG002|Overall Study|Disease Progression|0|||
41989505|NCT03366103|75797174|FG000|Overall Study|Adverse Event|0|||
41989506|NCT03366103|75797175|FG001|Overall Study|Adverse Event|1|||
41989507|NCT03366103|75797176|FG002|Overall Study|Adverse Event|0|||
41989508|NCT03253679|75797187|FG000|Overall Study|Screen Failure|1|||
41989509|NCT03099148|75797208|FG000|Wash-out|scheduling conflict|0|||
41989510|NCT03099148|75797209|FG001|Wash-out|scheduling conflict|1|||
41989511|NCT03099148|75797210|FG002|Wash-out|scheduling conflict|0|||
41989512|NCT03099148|75797211|FG003|Wash-out|scheduling conflict|0|||
41989513|NCT03099148|75797208|FG000|Wash-out|Adverse Event|0|||
41989514|NCT03099148|75797209|FG001|Wash-out|Adverse Event|1|||
41989515|NCT03099148|75797210|FG002|Wash-out|Adverse Event|0|||
41989516|NCT03099148|75797211|FG003|Wash-out|Adverse Event|0|||
41989517|NCT03088813|75797226|FG000|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
41989518|NCT03088813|75797227|FG001|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|1|||
41989519|NCT03088813|75797228|FG002|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
41989520|NCT03088813|75797229|FG003|Part 1: Dose Evaluation (Up to Week 172)|Lost to Follow-up|0|||
41989521|NCT03088813|75797226|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
41989522|NCT03088813|75797227|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
41989523|NCT03088813|75797228|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
41989524|NCT03088813|75797229|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
41989525|NCT03088813|75797226|FG000|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|1|||
41989526|NCT03088813|75797227|FG001|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|1|||
41989527|NCT03088813|75797228|FG002|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|0|||
41989528|NCT03088813|75797229|FG003|Part 1: Dose Evaluation (Up to Week 172)|Ongoing|0|||
41989529|NCT03088813|75797226|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
41989530|NCT03088813|75797227|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
41989531|NCT03088813|75797228|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
41989532|NCT03088813|75797229|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
42245401|NCT03743415|76070177|FG002|Overall Study|Withdrawal by Subject|4|||
41989533|NCT03088813|75797226|FG000|Part 2: Randomized Study (Upto Week 197)|Physician Decision|0|||
41989534|NCT03088813|75797227|FG001|Part 2: Randomized Study (Upto Week 197)|Physician Decision|0|||
41989535|NCT03088813|75797228|FG002|Part 2: Randomized Study (Upto Week 197)|Physician Decision|2|||
41989536|NCT03088813|75797229|FG003|Part 2: Randomized Study (Upto Week 197)|Physician Decision|2|||
41989537|NCT03088813|75797226|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
41989538|NCT03088813|75797227|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
42302742|NCT02349633|76138081|FG013|Overall Study|Transition to compassionate use|0|||
42302743|NCT02349633|76138068|FG000|Overall Study|Early termination of survival follow-up|0|||
42302744|NCT02349633|76138069|FG001|Overall Study|Early termination of survival follow-up|0|||
42302745|NCT02349633|76138070|FG002|Overall Study|Early termination of survival follow-up|0|||
42302746|NCT02349633|76138071|FG003|Overall Study|Early termination of survival follow-up|0|||
42302747|NCT02349633|76138072|FG004|Overall Study|Early termination of survival follow-up|0|||
42302748|NCT02349633|76138073|FG005|Overall Study|Early termination of survival follow-up|0|||
42302749|NCT02349633|76138074|FG006|Overall Study|Early termination of survival follow-up|0|||
42302750|NCT02349633|76138075|FG007|Overall Study|Early termination of survival follow-up|4|||
42302751|NCT02349633|76138076|FG008|Overall Study|Early termination of survival follow-up|0|||
42302752|NCT02349633|76138077|FG009|Overall Study|Early termination of survival follow-up|0|||
42302753|NCT02349633|76138078|FG010|Overall Study|Early termination of survival follow-up|0|||
42302754|NCT02349633|76138079|FG011|Overall Study|Early termination of survival follow-up|0|||
42302755|NCT02349633|76138080|FG012|Overall Study|Early termination of survival follow-up|0|||
42302756|NCT02349633|76138081|FG013|Overall Study|Early termination of survival follow-up|0|||
42302757|NCT02349633|76138068|FG000|Overall Study|Termination by sponsor|0|||
42302758|NCT02349633|76138069|FG001|Overall Study|Termination by sponsor|0|||
42302759|NCT02349633|76138070|FG002|Overall Study|Termination by sponsor|0|||
42302760|NCT02349633|76138071|FG003|Overall Study|Termination by sponsor|0|||
42302761|NCT02349633|76138072|FG004|Overall Study|Termination by sponsor|0|||
42302762|NCT02349633|76138073|FG005|Overall Study|Termination by sponsor|0|||
42302763|NCT02349633|76138074|FG006|Overall Study|Termination by sponsor|0|||
42302764|NCT02349633|76138075|FG007|Overall Study|Termination by sponsor|1|||
42302765|NCT02349633|76138076|FG008|Overall Study|Termination by sponsor|0|||
42302766|NCT02349633|76138077|FG009|Overall Study|Termination by sponsor|2|||
42302767|NCT02349633|76138078|FG010|Overall Study|Termination by sponsor|0|||
42302768|NCT02349633|76138079|FG011|Overall Study|Termination by sponsor|0|||
42302769|NCT02349633|76138080|FG012|Overall Study|Termination by sponsor|0|||
42302770|NCT02349633|76138081|FG013|Overall Study|Termination by sponsor|0|||
42302771|NCT02349633|76138068|FG000|Overall Study|Other|0|||
42302772|NCT02349633|76138069|FG001|Overall Study|Other|0|||
42302773|NCT02349633|76138070|FG002|Overall Study|Other|0|||
42302774|NCT02349633|76138071|FG003|Overall Study|Other|0|||
42302775|NCT02349633|76138072|FG004|Overall Study|Other|0|||
42302776|NCT02349633|76138073|FG005|Overall Study|Other|0|||
42302777|NCT02349633|76138074|FG006|Overall Study|Other|0|||
42302778|NCT02349633|76138075|FG007|Overall Study|Other|2|||
42302779|NCT02349633|76138076|FG008|Overall Study|Other|0|||
42302780|NCT02349633|76138077|FG009|Overall Study|Other|0|||
42302781|NCT02349633|76138078|FG010|Overall Study|Other|0|||
42302782|NCT02349633|76138079|FG011|Overall Study|Other|0|||
42302783|NCT02349633|76138080|FG012|Overall Study|Other|0|||
42302784|NCT02349633|76138081|FG013|Overall Study|Other|0|||
42302785|NCT02275611|76138146|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
41989539|NCT03088813|75797228|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|2|||
42302786|NCT02275611|76138147|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
42302787|NCT02275611|76138148|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
42302788|NCT02275611|76138149|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
42302789|NCT02275065|76138166|FG000|Overall Study|Randomized but not treated|1|||
42302790|NCT02275065|76138167|FG001|Overall Study|Randomized but not treated|0|||
42302791|NCT02275065|76138168|FG002|Overall Study|Randomized but not treated|1|||
42302792|NCT02275065|76138169|FG003|Overall Study|Randomized but not treated|1|||
42302793|NCT02275065|76138170|FG004|Overall Study|Randomized but not treated|0|||
42245402|NCT03743415|76070178|FG003|Overall Study|Withdrawal by Subject|5|||
42245403|NCT03743415|76070179|FG004|Overall Study|Withdrawal by Subject|5|||
42245404|NCT03743415|76070180|FG005|Overall Study|Withdrawal by Subject|2|||
42245405|NCT03743415|76070181|FG006|Overall Study|Withdrawal by Subject|2|||
42245406|NCT03743415|76070182|FG007|Overall Study|Withdrawal by Subject|5|||
42245407|NCT03743415|76070183|FG008|Overall Study|Withdrawal by Subject|9|||
42245408|NCT03743415|76070184|FG009|Overall Study|Withdrawal by Subject|10|||
42245409|NCT03743415|76070175|FG000|Overall Study|Lost to Follow-up|2|||
42302794|NCT02273973|76138184|FG000|Overall Study|Adverse Event|4|||
42302795|NCT02273973|76138185|FG001|Overall Study|Adverse Event|0|||
42302796|NCT02273973|76138184|FG000|Overall Study|Withdrawal by Subject|2|||
42302797|NCT02273973|76138185|FG001|Overall Study|Withdrawal by Subject|3|||
41989540|NCT03088813|75797229|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
41989541|NCT03088813|75797226|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
41989542|NCT03088813|75797227|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
42245410|NCT03743415|76070176|FG001|Overall Study|Lost to Follow-up|0|||
42245411|NCT03743415|76070177|FG002|Overall Study|Lost to Follow-up|2|||
42245412|NCT03743415|76070178|FG003|Overall Study|Lost to Follow-up|1|||
42245413|NCT03743415|76070179|FG004|Overall Study|Lost to Follow-up|1|||
42245414|NCT03743415|76070180|FG005|Overall Study|Lost to Follow-up|0|||
42245415|NCT03743415|76070181|FG006|Overall Study|Lost to Follow-up|1|||
42245416|NCT03743415|76070182|FG007|Overall Study|Lost to Follow-up|4|||
42245417|NCT03743415|76070183|FG008|Overall Study|Lost to Follow-up|13|||
42245418|NCT03743415|76070184|FG009|Overall Study|Lost to Follow-up|13|||
42245419|NCT03672175|76070203|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
42245420|NCT03672175|76070204|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
42245421|NCT03672175|76070205|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
42245422|NCT03672175|76070203|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
42245423|NCT03672175|76070204|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
42245424|NCT03672175|76070205|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
42245425|NCT03672175|76070203|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
42245426|NCT03672175|76070204|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
42245427|NCT03672175|76070205|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
42245428|NCT03672175|76070203|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
42245429|NCT03672175|76070204|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
42245430|NCT03672175|76070205|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
42245431|NCT03672175|76070203|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
42245432|NCT03672175|76070204|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
42245433|NCT03672175|76070205|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
42245434|NCT03672175|76070203|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
42245435|NCT03672175|76070204|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
42245436|NCT03672175|76070205|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
42245437|NCT03672175|76070203|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
41989543|NCT03088813|75797228|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
41989544|NCT03088813|75797229|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|12|||
41989545|NCT03088813|75797226|FG000|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|0|||
41989546|NCT03088813|75797227|FG001|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|0|||
41989547|NCT03088813|75797228|FG002|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|20|||
41989548|NCT03088813|75797229|FG003|Part 2: Randomized Study (Upto Week 197)|Ongoing in follow-up|37|||
41989549|NCT03088813|75797226|FG000|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|0|||
41989550|NCT03088813|75797227|FG001|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|0|||
41989551|NCT03088813|75797228|FG002|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|7|||
41989552|NCT03088813|75797229|FG003|Part 2: Randomized Study (Upto Week 197)|Ongoing on treatment|3|||
41989553|NCT03088813|75797226|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
41989554|NCT03088813|75797227|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
41989555|NCT03088813|75797228|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
41989556|NCT03088813|75797229|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
42245438|NCT03672175|76070204|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
42245439|NCT03672175|76070205|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
42245440|NCT03672175|76070203|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
42245441|NCT03672175|76070204|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
42245442|NCT03672175|76070205|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
42245443|NCT03672175|76070203|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
42245444|NCT03672175|76070204|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
41989557|NCT03061474|75797242|FG000|Overall Study|Adverse Event|2|||
41989558|NCT03061474|75797243|FG001|Overall Study|Adverse Event|0|||
42245445|NCT03672175|76070205|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
42245446|NCT03672175|76070203|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
41989559|NCT03061474|75797242|FG000|Overall Study|Safety Risk|0|||
41989560|NCT03061474|75797243|FG001|Overall Study|Safety Risk|1|||
42032849|NCT00943917|75841128|FG006|Stage I|Withdrawal by Subject|0|||
42245447|NCT03672175|76070204|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
41989561|NCT03061474|75797242|FG000|Overall Study|Participant unwilling or unable to participate|0|||
41989562|NCT03061474|75797243|FG001|Overall Study|Participant unwilling or unable to participate|2|||
41989563|NCT03061474|75797242|FG000|Overall Study|Lost to Follow-up|0|||
41989564|NCT03061474|75797243|FG001|Overall Study|Lost to Follow-up|1|||
41989565|NCT03040726|75797251|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
41989566|NCT03040726|75797252|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
41989567|NCT03040726|75797251|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
41989568|NCT03040726|75797252|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
41989569|NCT03040726|75797251|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
41989570|NCT03040726|75797252|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
41989571|NCT03040726|75797251|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
41989572|NCT03040726|75797252|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
41989573|NCT03040726|75797251|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
41989574|NCT03040726|75797252|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
42032850|NCT00943917|75841129|FG007|Stage I|Withdrawal by Subject|0|||
42302798|NCT02273973|76138184|FG000|Overall Study|Death|1|||
42302799|NCT02273973|76138185|FG001|Overall Study|Death|0|||
42302800|NCT02273973|76138184|FG000|Overall Study|Non-compliance|1|||
42302801|NCT02273973|76138185|FG001|Overall Study|Non-compliance|0|||
42302802|NCT02273973|76138184|FG000|Overall Study|Protocol Violation|1|||
42302803|NCT02273973|76138185|FG001|Overall Study|Protocol Violation|0|||
42302804|NCT02273973|76138184|FG000|Overall Study|Progression of disease|0|||
42302805|NCT02273973|76138185|FG001|Overall Study|Progression of disease|2|||
42302806|NCT02273973|76138184|FG000|Overall Study|Lost to Follow-up|0|||
42302807|NCT02273973|76138185|FG001|Overall Study|Lost to Follow-up|1|||
42302808|NCT02273973|76138184|FG000|Overall Study|Physician Decision|0|||
42302809|NCT02273973|76138185|FG001|Overall Study|Physician Decision|1|||
42302810|NCT02273973|76138184|FG000|Overall Study|Reason not specified|0|||
42302811|NCT02273973|76138185|FG001|Overall Study|Reason not specified|1|||
42302812|NCT02273739|76138195|FG000|Overall Study|Progression of Disease|3|||
42302813|NCT02273739|76138196|FG001|Overall Study|Progression of Disease|4|||
42302814|NCT02273739|76138197|FG002|Overall Study|Progression of Disease|5|||
42302815|NCT02273739|76138198|FG003|Overall Study|Progression of Disease|2|||
42302816|NCT02273739|76138195|FG000|Overall Study|Death|0|||
42302817|NCT02273739|76138196|FG001|Overall Study|Death|0|||
42302818|NCT02273739|76138197|FG002|Overall Study|Death|0|||
42302819|NCT02273739|76138198|FG003|Overall Study|Death|2|||
42302820|NCT02273739|76138195|FG000|Overall Study|Adverse Event|0|||
42302821|NCT02273739|76138196|FG001|Overall Study|Adverse Event|0|||
42302822|NCT02273739|76138197|FG002|Overall Study|Adverse Event|0|||
42302823|NCT02273739|76138198|FG003|Overall Study|Adverse Event|1|||
42302824|NCT02273739|76138195|FG000|Overall Study|Withdrawal by Subject|0|||
42302825|NCT02273739|76138196|FG001|Overall Study|Withdrawal by Subject|0|||
42302826|NCT02273739|76138197|FG002|Overall Study|Withdrawal by Subject|2|||
42302827|NCT02273739|76138198|FG003|Overall Study|Withdrawal by Subject|1|||
42302828|NCT02273739|76138195|FG000|Overall Study|Physician Decision|0|||
42302829|NCT02273739|76138196|FG001|Overall Study|Physician Decision|0|||
42302830|NCT02273739|76138197|FG002|Overall Study|Physician Decision|0|||
42302831|NCT02273739|76138198|FG003|Overall Study|Physician Decision|1|||
42302832|NCT02273037|76138215|FG000|Overall Study|Lost to Follow-up|1|||
42032851|NCT00943917|75841130|FG008|Stage I|Withdrawal by Subject|0|||
42245448|NCT03672175|76070205|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
42245449|NCT03672175|76070203|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
42245450|NCT03672175|76070204|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
42245451|NCT03672175|76070205|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
42245452|NCT03672175|76070203|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
42245453|NCT03672175|76070204|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
42245454|NCT03672175|76070205|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
42245455|NCT03524118|76070246|FG000|Overall Study|Lost to Follow-up|0|||
42245456|NCT03524118|76070247|FG001|Overall Study|Lost to Follow-up|0|||
42245457|NCT03524118|76070248|FG002|Overall Study|Lost to Follow-up|0|||
42302833|NCT02273037|76138216|FG001|Overall Study|Lost to Follow-up|0|||
42132103|NCT00496080|75942960|FG000|Overall Study|Surgical re-intervention|7|||
42245458|NCT03524118|76070249|FG003|Overall Study|Lost to Follow-up|0|||
42302834|NCT02273037|76138215|FG000|Overall Study|Delivered before monitoring initiated|1|||
42302835|NCT02273037|76138216|FG001|Overall Study|Delivered before monitoring initiated|3|||
42302836|NCT02273037|76138215|FG000|Overall Study|Breech delivery|2|||
42245459|NCT03524118|76070250|FG004|Overall Study|Lost to Follow-up|1|||
42245460|NCT03524118|76070251|FG005|Overall Study|Lost to Follow-up|0|||
42302837|NCT02273037|76138216|FG001|Overall Study|Breech delivery|3|||
42302838|NCT02273037|76138215|FG000|Overall Study|Multiple delivery|2|||
42302839|NCT02273037|76138216|FG001|Overall Study|Multiple delivery|2|||
42302840|NCT02273037|76138215|FG000|Overall Study|Other complication|2|||
42302841|NCT02273037|76138216|FG001|Overall Study|Other complication|0|||
42302842|NCT02465515|76138226|FG000|Overall Study|Investigator site closed|4|||
41989575|NCT02899728|75797261|FG000|Overall Study|Withdrawal by Subject|1|||
41989576|NCT02899728|75797262|FG001|Overall Study|Withdrawal by Subject|1|||
41989577|NCT02899065|75797270|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
41989578|NCT02899065|75797271|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
41989579|NCT02899065|75797270|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
41989580|NCT02899065|75797271|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
41989581|NCT02899065|75797270|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
41989582|NCT02899065|75797271|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
41989583|NCT02893930|75797277|FG000|Overall Study|Adverse Event|3|||
41989584|NCT02893930|75797277|FG000|Overall Study|Death|1|||
41989585|NCT02893930|75797277|FG000|Overall Study|Disease progression|5|||
41989586|NCT02893930|75797277|FG000|Overall Study|Withdrawal by Subject|2|||
41989587|NCT02893930|75797277|FG000|Overall Study|Physician Decision|1|||
41989588|NCT02893930|75797277|FG000|Overall Study|Ineligible|1|||
41989589|NCT02780804|75797284|FG000|Overall Study|Death|1|||
41989590|NCT02780804|75797285|FG001|Overall Study|Death|0|||
41989591|NCT02780804|75797286|FG002|Overall Study|Death|0|||
41989592|NCT02780804|75797284|FG000|Overall Study|Lack of Efficacy|5|||
41989593|NCT02780804|75797285|FG001|Overall Study|Lack of Efficacy|8|||
41989594|NCT02780804|75797286|FG002|Overall Study|Lack of Efficacy|4|||
41989595|NCT02780804|75797284|FG000|Overall Study|Physician Decision|0|||
41989596|NCT02780804|75797285|FG001|Overall Study|Physician Decision|0|||
41989597|NCT02780804|75797286|FG002|Overall Study|Physician Decision|2|||
41989598|NCT02780804|75797284|FG000|Overall Study|Withdrawal by Subject|0|||
41989599|NCT02780804|75797285|FG001|Overall Study|Withdrawal by Subject|1|||
41989600|NCT02780804|75797286|FG002|Overall Study|Withdrawal by Subject|0|||
41989601|NCT02629393|75797295|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
41989602|NCT02629393|75797295|FG000|Overall Study|Physician Decision|1|||
41989603|NCT02500797|75797342|FG000|Overall Study|Cancel (rapid disease progression)|0|||
41989604|NCT02500797|75797343|FG001|Overall Study|Cancel (rapid disease progression)|0|||
42302843|NCT02465515|76138227|FG001|Overall Study|Investigator site closed|5|||
42302844|NCT02465515|76138226|FG000|Overall Study|Withdrawal by Subject|74|||
42302845|NCT02465515|76138227|FG001|Overall Study|Withdrawal by Subject|43|||
42302846|NCT02465515|76138226|FG000|Overall Study|Physician Decision|8|||
42302847|NCT02465515|76138227|FG001|Overall Study|Physician Decision|12|||
42302848|NCT02465515|76138226|FG000|Overall Study|Lost to Follow-up|68|||
42302849|NCT02465515|76138227|FG001|Overall Study|Lost to Follow-up|51|||
42302850|NCT02412631|76138235|FG000|Overall Study|Adverse Event|1|||
41989605|NCT02500797|75797344|FG002|Overall Study|Cancel (rapid disease progression)|0|||
42302851|NCT02412631|76138236|FG001|Overall Study|Adverse Event|2|||
42302852|NCT02412631|76138235|FG000|Overall Study|Lost to Follow-up|5|||
42302853|NCT02412631|76138236|FG001|Overall Study|Lost to Follow-up|9|||
42302854|NCT02412631|76138235|FG000|Overall Study|Withdrawal by Subject|9|||
42302855|NCT02412631|76138236|FG001|Overall Study|Withdrawal by Subject|3|||
42302856|NCT02412631|76138235|FG000|Overall Study|Early stop by FDA|5|||
42302857|NCT02412631|76138236|FG001|Overall Study|Early stop by FDA|2|||
42302858|NCT02412631|76138235|FG000|Overall Study|Unspecified reason|6|||
42302859|NCT02412631|76138236|FG001|Overall Study|Unspecified reason|8|||
42302860|NCT02272803|76138244|FG000|Overall Study|Disease progression|16|||
42302861|NCT02272803|76138245|FG001|Overall Study|Disease progression|8|||
42302862|NCT02272803|76138244|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
42302863|NCT02272803|76138245|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
42302864|NCT02272803|76138244|FG000|Overall Study|Study drug toxicity|4|||
42302865|NCT02272803|76138245|FG001|Overall Study|Study drug toxicity|9|||
42302866|NCT02272803|76138244|FG000|Overall Study|Participant request to discontinue study treatment|3|||
42302867|NCT02272803|76138245|FG001|Overall Study|Participant request to discontinue study treatment|7|||
42302868|NCT02272803|76138244|FG000|Overall Study|Maximum clinical benefit|4|||
42302869|NCT02272803|76138245|FG001|Overall Study|Maximum clinical benefit|2|||
42302870|NCT02272803|76138244|FG000|Overall Study|Poor/non-compliance|2|||
42302871|NCT02272803|76138245|FG001|Overall Study|Poor/non-compliance|2|||
42302872|NCT02272803|76138244|FG000|Overall Study|Withdrawal by Subject|2|||
42302873|NCT02272803|76138245|FG001|Overall Study|Withdrawal by Subject|1|||
42302874|NCT02272803|76138244|FG000|Overall Study|Death|0|||
42302875|NCT02272803|76138245|FG001|Overall Study|Death|1|||
42302876|NCT02272803|76138244|FG000|Overall Study|Other reasons|1|||
42302877|NCT02272803|76138245|FG001|Overall Study|Other reasons|3|||
42302878|NCT02272803|76138244|FG000|Overall Study|Administrative reason by sponsor|5|||
42302879|NCT02272803|76138245|FG001|Overall Study|Administrative reason by sponsor|4|||
41989606|NCT02500797|75797345|FG003|Overall Study|Cancel (rapid disease progression)|0|||
41989607|NCT02500797|75797346|FG004|Overall Study|Cancel (rapid disease progression)|1|||
42032852|NCT00943917|75841131|FG009|Stage I|Withdrawal by Subject|0|||
42302880|NCT02272725|76138253|FG000|Overall Study|equipment malfunction|2|||
42302881|NCT02272725|76138254|FG001|Overall Study|equipment malfunction|0|||
42302882|NCT01650805|76138262|FG000|Overall Study|Withdrawal by Subject|1|||
42302883|NCT01650805|76138263|FG001|Overall Study|Withdrawal by Subject|0|||
42302884|NCT02442349|76138269|FG000|Overall Study|Death|14|||
42302885|NCT02442349|76138269|FG000|Overall Study|Withdrawal by Subject|8|||
42302886|NCT02442349|76138269|FG000|Overall Study|On-going Study at Data Cut-off|149|||
42302887|NCT02411539|76138275|FG000|Overall Study|Lost to Follow-up|2|||
42302888|NCT02411539|76138276|FG001|Overall Study|Lost to Follow-up|0|||
42302889|NCT02411539|76138275|FG000|Overall Study|Confounding medical condition|0|||
42302890|NCT02411539|76138276|FG001|Overall Study|Confounding medical condition|1|||
42302891|NCT02465437|76138289|FG000|Overall Study|Physician Decision|0|||
42302892|NCT02465437|76138290|FG001|Overall Study|Physician Decision|0|||
42032853|NCT00943917|75841132|FG010|Stage I|Withdrawal by Subject|0|||
42032854|NCT00943917|75841133|FG011|Stage I|Withdrawal by Subject|0|||
42032855|NCT00943917|75841134|FG012|Stage I|Withdrawal by Subject|0|||
42032856|NCT00943917|75841135|FG013|Stage I|Withdrawal by Subject|0|||
42032857|NCT00943917|75841136|FG014|Stage I|Withdrawal by Subject|0|||
42032858|NCT00943917|75841122|FG000|Stage II|Adverse Event|0|||
42032859|NCT00943917|75841123|FG001|Stage II|Adverse Event|0|||
42032860|NCT00943917|75841124|FG002|Stage II|Adverse Event|0|||
42032861|NCT00943917|75841125|FG003|Stage II|Adverse Event|0|||
42032862|NCT00943917|75841126|FG004|Stage II|Adverse Event|0|||
42032863|NCT00943917|75841127|FG005|Stage II|Adverse Event|1|||
42032864|NCT00943917|75841128|FG006|Stage II|Adverse Event|3|||
42032865|NCT00943917|75841129|FG007|Stage II|Adverse Event|0|||
42032866|NCT00943917|75841130|FG008|Stage II|Adverse Event|1|||
42245461|NCT03524118|76070246|FG000|Overall Study|Other|0|||
42245462|NCT03524118|76070247|FG001|Overall Study|Other|1|||
42245463|NCT03524118|76070248|FG002|Overall Study|Other|0|||
42245464|NCT03524118|76070249|FG003|Overall Study|Other|0|||
42245465|NCT03524118|76070250|FG004|Overall Study|Other|1|||
42245466|NCT03524118|76070251|FG005|Overall Study|Other|1|||
42245467|NCT03524118|76070246|FG000|Overall Study|Physician Decision|0|||
42245468|NCT03524118|76070247|FG001|Overall Study|Physician Decision|0|||
42245469|NCT03524118|76070248|FG002|Overall Study|Physician Decision|0|||
42245470|NCT03524118|76070249|FG003|Overall Study|Physician Decision|0|||
42245471|NCT03524118|76070250|FG004|Overall Study|Physician Decision|1|||
42245472|NCT03524118|76070251|FG005|Overall Study|Physician Decision|0|||
42245473|NCT03524118|76070246|FG000|Overall Study|Protocol Violation|0|||
42245474|NCT03524118|76070247|FG001|Overall Study|Protocol Violation|0|||
42245475|NCT03524118|76070248|FG002|Overall Study|Protocol Violation|1|||
42245476|NCT03524118|76070249|FG003|Overall Study|Protocol Violation|0|||
42245477|NCT03524118|76070250|FG004|Overall Study|Protocol Violation|1|||
42245478|NCT03524118|76070251|FG005|Overall Study|Protocol Violation|0|||
42245479|NCT03524118|76070246|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42245480|NCT03524118|76070247|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
42245481|NCT03524118|76070248|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
42032867|NCT00943917|75841131|FG009|Stage II|Adverse Event|0|||
42245482|NCT03524118|76070249|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
42245483|NCT03524118|76070250|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
42245484|NCT03524118|76070251|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
42245485|NCT03472586|76070265|FG000|Overall Study|Physician Decision|6|||
42245486|NCT03472586|76070265|FG000|Overall Study|Death|6|||
42245487|NCT03472586|76070265|FG000|Overall Study|Adverse Event|1|||
42245488|NCT03437265|76070269|FG000|Overall Study|Protocol Violation|6|||
42245489|NCT03414424|76070275|FG000|Overall Study|Screened out after consent|0|||
42032868|NCT00943917|75841132|FG010|Stage II|Adverse Event|0|||
42032869|NCT00943917|75841133|FG011|Stage II|Adverse Event|0|||
42302893|NCT02465437|76138291|FG002|Overall Study|Physician Decision|1|||
42032870|NCT00943917|75841134|FG012|Stage II|Adverse Event|0|||
42032871|NCT00943917|75841135|FG013|Stage II|Adverse Event|0|||
42032872|NCT00943917|75841136|FG014|Stage II|Adverse Event|0|||
42245490|NCT03414424|76070276|FG001|Overall Study|Screened out after consent|2|||
42302894|NCT02465437|76138292|FG003|Overall Study|Physician Decision|0|||
42302895|NCT02465437|76138289|FG000|Overall Study|Withdrawal by Subject|1|||
42302896|NCT02465437|76138290|FG001|Overall Study|Withdrawal by Subject|0|||
42032873|NCT00943917|75841122|FG000|Stage II|Withdrawal by Subject|0|||
42245491|NCT03414424|76070275|FG000|Overall Study|Lost to Follow-up|0|||
42245492|NCT03414424|76070276|FG001|Overall Study|Lost to Follow-up|1|||
42245493|NCT03349476|76070282|FG000|Overall Study|Physician Decision|3|||
42032874|NCT00943917|75841123|FG001|Stage II|Withdrawal by Subject|0|||
42245494|NCT03312634|76070288|FG000|Overall Study|Adverse Event|11|||
42245495|NCT03312634|76070289|FG001|Overall Study|Adverse Event|0|||
42245496|NCT03312634|76070288|FG000|Overall Study|Sponsor request|2|||
42245497|NCT03312634|76070289|FG001|Overall Study|Sponsor request|0|||
42245498|NCT03312634|76070288|FG000|Overall Study|Withdrawal by Subject|31|||
42245499|NCT03312634|76070289|FG001|Overall Study|Withdrawal by Subject|9|||
42032875|NCT00943917|75841124|FG002|Stage II|Withdrawal by Subject|0|||
42032876|NCT00943917|75841125|FG003|Stage II|Withdrawal by Subject|0|||
42032877|NCT00943917|75841126|FG004|Stage II|Withdrawal by Subject|0|||
42032878|NCT00943917|75841127|FG005|Stage II|Withdrawal by Subject|1|||
42032879|NCT00943917|75841128|FG006|Stage II|Withdrawal by Subject|0|||
42032880|NCT00943917|75841129|FG007|Stage II|Withdrawal by Subject|0|||
42032881|NCT00943917|75841130|FG008|Stage II|Withdrawal by Subject|0|||
42032882|NCT00943917|75841131|FG009|Stage II|Withdrawal by Subject|0|||
42032883|NCT00943917|75841132|FG010|Stage II|Withdrawal by Subject|0|||
42032884|NCT00943917|75841133|FG011|Stage II|Withdrawal by Subject|0|||
42032885|NCT00943917|75841134|FG012|Stage II|Withdrawal by Subject|0|||
42032886|NCT00943917|75841135|FG013|Stage II|Withdrawal by Subject|0|||
42032887|NCT00943917|75841136|FG014|Stage II|Withdrawal by Subject|0|||
42032888|NCT00943917|75841122|FG000|Stage II|Pregnancy|0|||
42032889|NCT00943917|75841123|FG001|Stage II|Pregnancy|0|||
42032890|NCT00943917|75841124|FG002|Stage II|Pregnancy|0|||
42032891|NCT00943917|75841125|FG003|Stage II|Pregnancy|0|||
42032892|NCT00943917|75841126|FG004|Stage II|Pregnancy|0|||
42032893|NCT00943917|75841127|FG005|Stage II|Pregnancy|1|||
42032894|NCT00943917|75841128|FG006|Stage II|Pregnancy|0|||
42032895|NCT00943917|75841129|FG007|Stage II|Pregnancy|0|||
42032896|NCT00943917|75841130|FG008|Stage II|Pregnancy|0|||
42032897|NCT00943917|75841131|FG009|Stage II|Pregnancy|0|||
42032898|NCT00943917|75841132|FG010|Stage II|Pregnancy|0|||
42032899|NCT00943917|75841133|FG011|Stage II|Pregnancy|0|||
42032900|NCT00943917|75841134|FG012|Stage II|Pregnancy|0|||
42032901|NCT00943917|75841135|FG013|Stage II|Pregnancy|0|||
42032902|NCT00943917|75841136|FG014|Stage II|Pregnancy|0|||
42302897|NCT02465437|76138291|FG002|Overall Study|Withdrawal by Subject|0|||
42302898|NCT02465437|76138292|FG003|Overall Study|Withdrawal by Subject|1|||
42302899|NCT02465437|76138289|FG000|Overall Study|Adverse Event|0|||
42302900|NCT02465437|76138290|FG001|Overall Study|Adverse Event|1|||
42302901|NCT02465437|76138291|FG002|Overall Study|Adverse Event|0|||
42302902|NCT02465437|76138292|FG003|Overall Study|Adverse Event|0|||
42302903|NCT02442271|76138300|FG000|Overall Study|Adverse Event|1|||
42302904|NCT02442271|76138300|FG000|Overall Study|Withdrew Consent|1|||
42302905|NCT02442271|76138300|FG000|Overall Study|Lost to Follow-up|1|||
42302906|NCT02442271|76138300|FG000|Overall Study|Other|1|||
42302907|NCT02465203|76138321|FG000|Overall Study|Protocol Violation|1|||
42302908|NCT02465203|76138322|FG001|Overall Study|Protocol Violation|1|||
41989608|NCT02500797|75797347|FG005|Overall Study|Cancel (rapid disease progression)|1|||
41989609|NCT02500797|75797348|FG006|Overall Study|Cancel (rapid disease progression)|0|||
41989610|NCT02500797|75797349|FG007|Overall Study|Cancel (rapid disease progression)|0|||
41989611|NCT02500797|75797342|FG000|Overall Study|Withdrawal by Subject|1|||
41989612|NCT02500797|75797343|FG001|Overall Study|Withdrawal by Subject|0|||
41989613|NCT02500797|75797344|FG002|Overall Study|Withdrawal by Subject|0|||
41989614|NCT02500797|75797345|FG003|Overall Study|Withdrawal by Subject|0|||
41989615|NCT02500797|75797346|FG004|Overall Study|Withdrawal by Subject|0|||
41989616|NCT02500797|75797347|FG005|Overall Study|Withdrawal by Subject|0|||
41989617|NCT02500797|75797348|FG006|Overall Study|Withdrawal by Subject|0|||
41989618|NCT02500797|75797349|FG007|Overall Study|Withdrawal by Subject|0|||
41989619|NCT02017704|75797382|FG000|Overall Study|Withdrawal by Subject|2|||
41989620|NCT02017704|75797383|FG001|Overall Study|Withdrawal by Subject|0|||
41989621|NCT02005471|75797393|FG000|Main Study|Adverse Event|0|||
41989622|NCT02005471|75797394|FG001|Main Study|Adverse Event|1|||
41989623|NCT02005471|75797395|FG002|Main Study|Adverse Event|0|||
41989624|NCT02005471|75797396|FG003|Main Study|Adverse Event|0|||
41989625|NCT02005471|75797393|FG000|Main Study|Death|83|||
41989626|NCT02005471|75797394|FG001|Main Study|Death|52|||
41989627|NCT02005471|75797395|FG002|Main Study|Death|0|||
41989628|NCT02005471|75797396|FG003|Main Study|Death|0|||
42302909|NCT02465203|76138323|FG002|Overall Study|Protocol Violation|1|||
42302910|NCT02465203|76138321|FG000|Overall Study|Study terminated by sponsor|50|||
42302911|NCT02465203|76138322|FG001|Overall Study|Study terminated by sponsor|34|||
42302912|NCT02465203|76138323|FG002|Overall Study|Study terminated by sponsor|11|||
42302913|NCT02465203|76138321|FG000|Overall Study|New therapy for study indication|4|||
42032903|NCT00943917|75841122|FG000|Stage II Continuation|Adverse Event|0|||
41989629|NCT02005471|75797393|FG000|Main Study|Lost to Follow-up|4|||
42302914|NCT02465203|76138322|FG001|Overall Study|New therapy for study indication|0|||
42302915|NCT02465203|76138323|FG002|Overall Study|New therapy for study indication|0|||
42302916|NCT02465203|76138321|FG000|Overall Study|Patient/guardian decision|1|||
41989630|NCT02005471|75797394|FG001|Main Study|Lost to Follow-up|5|||
41989631|NCT02005471|75797395|FG002|Main Study|Lost to Follow-up|0|||
42032904|NCT00943917|75841123|FG001|Stage II Continuation|Adverse Event|0|||
42032905|NCT00943917|75841124|FG002|Stage II Continuation|Adverse Event|0|||
42032906|NCT00943917|75841125|FG003|Stage II Continuation|Adverse Event|0|||
42032907|NCT00943917|75841126|FG004|Stage II Continuation|Adverse Event|0|||
42032908|NCT00943917|75841127|FG005|Stage II Continuation|Adverse Event|0|||
42302917|NCT02465203|76138322|FG001|Overall Study|Patient/guardian decision|1|||
42302918|NCT02465203|76138323|FG002|Overall Study|Patient/guardian decision|1|||
42302919|NCT02463409|76138330|FG000|Overall Study|Withdrawal by Subject|1|||
42302920|NCT02463409|76138330|FG000|Overall Study|Screen failure|1|||
42302921|NCT02528357|76138353|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302922|NCT02528357|76138354|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
42302923|NCT02528357|76138355|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302924|NCT02528357|76138356|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302925|NCT02528357|76138357|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302926|NCT02528357|76138358|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302927|NCT02528357|76138359|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302928|NCT02528357|76138360|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302929|NCT02528357|76138361|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302930|NCT02528357|76138362|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302931|NCT02528357|76138363|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302932|NCT02528357|76138364|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302933|NCT02528357|76138365|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302934|NCT02528357|76138366|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302935|NCT02528357|76138367|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302936|NCT02528357|76138368|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302937|NCT02528357|76138369|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302938|NCT02528357|76138370|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302939|NCT02528357|76138371|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
42302940|NCT02528357|76138353|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302941|NCT02528357|76138354|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302942|NCT02528357|76138355|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302943|NCT02528357|76138356|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
42302944|NCT02528357|76138357|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302945|NCT02528357|76138358|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
42302946|NCT02528357|76138359|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302947|NCT02528357|76138360|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
42302948|NCT02528357|76138361|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302949|NCT02528357|76138362|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302950|NCT02528357|76138363|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302951|NCT02528357|76138364|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302952|NCT02528357|76138365|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302953|NCT02528357|76138366|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302954|NCT02528357|76138367|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302955|NCT02528357|76138368|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302956|NCT02528357|76138369|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302957|NCT02528357|76138370|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302958|NCT02528357|76138371|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
42302959|NCT02528357|76138353|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302960|NCT02528357|76138354|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302961|NCT02528357|76138355|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
42302962|NCT02528357|76138356|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302963|NCT02528357|76138357|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
42302964|NCT02528357|76138358|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302965|NCT02528357|76138359|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
42302966|NCT02528357|76138360|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
42302967|NCT02528357|76138361|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302968|NCT02528357|76138362|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302969|NCT02528357|76138363|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302970|NCT02528357|76138364|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302971|NCT02528357|76138365|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302972|NCT02528357|76138366|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302973|NCT02528357|76138367|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42245500|NCT03312634|76070288|FG000|Overall Study|Enrolled in an interventional study|0|||
42245501|NCT03312634|76070289|FG001|Overall Study|Enrolled in an interventional study|52|||
42245502|NCT03312634|76070288|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
42245503|NCT03312634|76070289|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
42245504|NCT03312634|76070288|FG000|Overall Study|Death|0|||
42245505|NCT03312634|76070289|FG001|Overall Study|Death|1|||
42245506|NCT03312634|76070288|FG000|Overall Study|Non-compliance|0|||
42245507|NCT03312634|76070289|FG001|Overall Study|Non-compliance|2|||
41989632|NCT02005471|75797396|FG003|Main Study|Lost to Follow-up|0|||
41989633|NCT02005471|75797393|FG000|Main Study|Physician Decision|3|||
41989634|NCT02005471|75797394|FG001|Main Study|Physician Decision|1|||
42245508|NCT03312634|76070288|FG000|Overall Study|Lost to Follow-up|0|||
42245509|NCT03312634|76070289|FG001|Overall Study|Lost to Follow-up|1|||
42245510|NCT03312634|76070288|FG000|Overall Study|Enrolled into non-interventional study|0|||
42245511|NCT03312634|76070289|FG001|Overall Study|Enrolled into non-interventional study|5|||
42245512|NCT03312634|76070288|FG000|Overall Study|Worsening clinical condition|0|||
42245513|NCT03312634|76070289|FG001|Overall Study|Worsening clinical condition|1|||
42245514|NCT03312634|76070288|FG000|Overall Study|Participant did not want to travel|0|||
42245515|NCT03312634|76070289|FG001|Overall Study|Participant did not want to travel|1|||
42245516|NCT03312634|76070288|FG000|Overall Study|Physician Decision|1|||
42245517|NCT03312634|76070289|FG001|Overall Study|Physician Decision|0|||
42245518|NCT03312634|76070288|FG000|Overall Study|Other|13|||
42245519|NCT03312634|76070289|FG001|Overall Study|Other|0|||
42245520|NCT03000569|76070298|FG000|Overall Study|Withdrawal by Subject|1|||
42245521|NCT03000569|76070299|FG001|Overall Study|Withdrawal by Subject|0|||
42245522|NCT02205359|76070337|FG000|Overall Study|Death|293|||
42245523|NCT02205359|76070338|FG001|Overall Study|Death|327|||
42245524|NCT02205359|76070337|FG000|Overall Study|Lost to Follow-up|182|||
42245525|NCT02205359|76070338|FG001|Overall Study|Lost to Follow-up|162|||
42245526|NCT02205359|76070337|FG000|Overall Study|Physician Decision|51|||
42245527|NCT02205359|76070338|FG001|Overall Study|Physician Decision|53|||
42245528|NCT02205359|76070337|FG000|Overall Study|Withdrawal by Subject|167|||
42245529|NCT02205359|76070338|FG001|Overall Study|Withdrawal by Subject|169|||
42245530|NCT02101775|76070348|FG000|Overall Study|Adverse Event|4|||
42245531|NCT02101775|76070349|FG001|Overall Study|Adverse Event|0|||
42245532|NCT02101775|76070350|FG002|Overall Study|Adverse Event|0|||
42245533|NCT02101775|76070348|FG000|Overall Study|Admission to Hospital|0|||
42245534|NCT02101775|76070349|FG001|Overall Study|Admission to Hospital|1|||
42245535|NCT02101775|76070350|FG002|Overall Study|Admission to Hospital|0|||
42245536|NCT01979536|76070366|FG000|Overall Study|Physician Decision|2|||
42245537|NCT01979536|76070367|FG001|Overall Study|Physician Decision|3|||
42245538|NCT01979536|76070366|FG000|Overall Study|Withdrawal by Subject|0|||
42245539|NCT01979536|76070367|FG001|Overall Study|Withdrawal by Subject|1|||
42245540|NCT01979536|76070366|FG000|Overall Study|Refusal|0|||
42245541|NCT01979536|76070367|FG001|Overall Study|Refusal|1|||
42245542|NCT01979536|76070366|FG000|Overall Study|Relapse|0|||
42245543|NCT01979536|76070367|FG001|Overall Study|Relapse|1|||
42245544|NCT01979536|76070366|FG000|Overall Study|Study terminated by Sponsor|0|||
42245545|NCT01979536|76070367|FG001|Overall Study|Study terminated by Sponsor|1|||
42245546|NCT01979536|76070366|FG000|Overall Study|Did not start treatment|0|||
42245547|NCT01979536|76070367|FG001|Overall Study|Did not start treatment|1|||
42245548|NCT01798992|76070390|FG000|Overall Study|Administrative withdrawal|0|||
42245549|NCT01798992|76070391|FG001|Overall Study|Administrative withdrawal|1|||
42302974|NCT02528357|76138368|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
41989635|NCT02005471|75797395|FG002|Main Study|Physician Decision|0|||
42302975|NCT02528357|76138369|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302976|NCT02528357|76138370|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42302977|NCT02528357|76138371|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
42245550|NCT01798992|76070392|FG002|Overall Study|Administrative withdrawal|0|||
42245551|NCT01798992|76070393|FG003|Overall Study|Administrative withdrawal|1|||
42245552|NCT01798992|76070390|FG000|Overall Study|Lost to Follow-up|0|||
42245553|NCT01798992|76070391|FG001|Overall Study|Lost to Follow-up|1|||
42245554|NCT01798992|76070392|FG002|Overall Study|Lost to Follow-up|1|||
42245555|NCT01798992|76070393|FG003|Overall Study|Lost to Follow-up|0|||
42245556|NCT01798992|76070390|FG000|Overall Study|Insufficient biopsy tissue|0|||
42245557|NCT01798992|76070391|FG001|Overall Study|Insufficient biopsy tissue|0|||
42245558|NCT01798992|76070392|FG002|Overall Study|Insufficient biopsy tissue|1|||
42245559|NCT01798992|76070393|FG003|Overall Study|Insufficient biopsy tissue|0|||
42245560|NCT01570868|76070404|FG000|Overall Study|Adverse Event|8|||
42245561|NCT01570868|76070405|FG001|Overall Study|Adverse Event|1|||
42245562|NCT01570868|76070404|FG000|Overall Study|FDA Recommendation|23|||
42245563|NCT01570868|76070405|FG001|Overall Study|FDA Recommendation|3|||
42245564|NCT01570868|76070404|FG000|Overall Study|Physician Decision|10|||
42245565|NCT01570868|76070405|FG001|Overall Study|Physician Decision|4|||
42245566|NCT01570868|76070404|FG000|Overall Study|Lost to Follow-up|1|||
42245567|NCT01570868|76070405|FG001|Overall Study|Lost to Follow-up|0|||
42245568|NCT01570868|76070404|FG000|Overall Study|Withdrawal by Subject|1|||
42245569|NCT01570868|76070405|FG001|Overall Study|Withdrawal by Subject|0|||
42245570|NCT01251965|76070418|FG000|Overall Study|Participant/physician decision|1|||
42302978|NCT02528357|76138353|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302979|NCT02528357|76138354|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302980|NCT02528357|76138355|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302981|NCT02528357|76138356|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302982|NCT02528357|76138357|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
42302983|NCT02528357|76138358|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302984|NCT02528357|76138359|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
41989636|NCT02005471|75797396|FG003|Main Study|Physician Decision|0|||
41989637|NCT02005471|75797393|FG000|Main Study|Withdrawal by Subject|26|||
41989638|NCT02005471|75797394|FG001|Main Study|Withdrawal by Subject|11|||
42245571|NCT01251965|76070419|FG001|Overall Study|Participant/physician decision|2|||
42245572|NCT01251965|76070420|FG002|Overall Study|Participant/physician decision|0|||
42245573|NCT01251965|76070418|FG000|Overall Study|Death|0|||
42245574|NCT01251965|76070419|FG001|Overall Study|Death|0|||
42245575|NCT01251965|76070420|FG002|Overall Study|Death|11|||
42245576|NCT01190644|76070429|FG000|Overall Study|Death|2|||
42245577|NCT01190644|76070429|FG000|Overall Study|Disease progression|1|||
42245578|NCT00849290|76070434|FG000|Overall Study|Adverse Event|3|||
42245579|NCT00849290|76070434|FG000|Overall Study|Death|14|||
42245580|NCT00849290|76070434|FG000|Overall Study|Withdrawal by Subject|11|||
42245581|NCT00849290|76070434|FG000|Overall Study|Lost to Follow-up|2|||
42245582|NCT00849290|76070434|FG000|Overall Study|Protocol Violation|5|||
42245583|NCT00849290|76070434|FG000|Overall Study|Disease Progression|20|||
41989639|NCT02005471|75797395|FG002|Main Study|Withdrawal by Subject|0|||
41989640|NCT02005471|75797396|FG003|Main Study|Withdrawal by Subject|0|||
41989641|NCT02005471|75797393|FG000|Main Study|Reason not Specified|0|||
41989642|NCT02005471|75797394|FG001|Main Study|Reason not Specified|6|||
41989643|NCT02005471|75797395|FG002|Main Study|Reason not Specified|0|||
42245584|NCT00542451|76070442|FG000|Overall Study|Adverse Event|31|||
42245585|NCT00542451|76070442|FG000|Overall Study|Withdrawal by Subject|30|||
42245586|NCT00542451|76070442|FG000|Overall Study|Physician Decision|4|||
42245587|NCT00542451|76070442|FG000|Overall Study|Recurrent disease|1|||
41989644|NCT02005471|75797396|FG003|Main Study|Reason not Specified|0|||
42245588|NCT00542451|76070442|FG000|Overall Study|unknown reason|1|||
42245589|NCT00542451|76070442|FG000|Overall Study|Death|2|||
42245590|NCT00542451|76070442|FG000|Overall Study|Lost to Follow-up|10|||
42245591|NCT00506493|76070449|FG000|Overall Study|Death|6|||
42245592|NCT00506493|76070449|FG000|Overall Study|Withdrawal by Subject|5|||
42245593|NCT00157248|76070463|FG000|Overall Study|Adverse Event|36|||
42245594|NCT00157248|76070464|FG001|Overall Study|Adverse Event|25|||
42245595|NCT00157248|76070465|FG002|Overall Study|Adverse Event|13|||
42245596|NCT00157248|76070466|FG003|Overall Study|Adverse Event|33|||
42245597|NCT00157248|76070463|FG000|Overall Study|Protocol Violation|4|||
42302985|NCT02528357|76138360|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302986|NCT02528357|76138361|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
41989645|NCT02005471|75797393|FG000|Main Study|Randomized but not Dosed|8|||
41989646|NCT02005471|75797394|FG001|Main Study|Randomized but not Dosed|0|||
42302987|NCT02528357|76138362|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302988|NCT02528357|76138363|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302989|NCT02528357|76138364|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302990|NCT02528357|76138365|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302991|NCT02528357|76138366|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302992|NCT02528357|76138367|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302993|NCT02528357|76138368|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302994|NCT02528357|76138369|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302995|NCT02528357|76138370|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302996|NCT02528357|76138371|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42302997|NCT02528357|76138353|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42302998|NCT02528357|76138354|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42302999|NCT02528357|76138355|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303000|NCT02528357|76138356|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303001|NCT02528357|76138357|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303002|NCT02528357|76138358|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303003|NCT02528357|76138359|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303004|NCT02528357|76138360|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303005|NCT02528357|76138361|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303006|NCT02528357|76138362|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303007|NCT02528357|76138363|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303008|NCT02528357|76138364|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303009|NCT02528357|76138365|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303010|NCT02528357|76138366|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
42303011|NCT02528357|76138367|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
42303012|NCT02528357|76138368|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303013|NCT02528357|76138369|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303014|NCT02528357|76138370|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303015|NCT02528357|76138371|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
42303016|NCT02528357|76138353|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303017|NCT02528357|76138354|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303018|NCT02528357|76138355|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303019|NCT02528357|76138356|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303020|NCT02528357|76138357|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303021|NCT02528357|76138358|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303022|NCT02528357|76138359|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303023|NCT02528357|76138360|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303024|NCT02528357|76138361|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303025|NCT02528357|76138362|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303026|NCT02528357|76138363|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42245598|NCT00157248|76070464|FG001|Overall Study|Protocol Violation|0|||
42245599|NCT00157248|76070465|FG002|Overall Study|Protocol Violation|2|||
42245600|NCT00157248|76070466|FG003|Overall Study|Protocol Violation|2|||
42245601|NCT00157248|76070463|FG000|Overall Study|Lost to Follow-up|0|||
42245602|NCT00157248|76070464|FG001|Overall Study|Lost to Follow-up|1|||
42245603|NCT00157248|76070465|FG002|Overall Study|Lost to Follow-up|0|||
42245604|NCT00157248|76070466|FG003|Overall Study|Lost to Follow-up|0|||
42245605|NCT00157248|76070463|FG000|Overall Study|Withdrawal by Subject|1|||
42245606|NCT00157248|76070464|FG001|Overall Study|Withdrawal by Subject|4|||
42245607|NCT00157248|76070465|FG002|Overall Study|Withdrawal by Subject|3|||
41989647|NCT02005471|75797395|FG002|Main Study|Randomized but not Dosed|0|||
41989648|NCT02005471|75797396|FG003|Main Study|Randomized but not Dosed|0|||
41989649|NCT02005471|75797393|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
42245608|NCT00157248|76070466|FG003|Overall Study|Withdrawal by Subject|3|||
42245609|NCT00157248|76070463|FG000|Overall Study|site closures, subject moving|7|||
42245610|NCT00157248|76070464|FG001|Overall Study|site closures, subject moving|7|||
42245611|NCT00157248|76070465|FG002|Overall Study|site closures, subject moving|3|||
42245612|NCT00157248|76070466|FG003|Overall Study|site closures, subject moving|9|||
42245613|NCT02504580|76070488|FG000|Overall Study|Other|1|||
42245614|NCT02504580|76070489|FG001|Overall Study|Other|0|||
41989650|NCT02005471|75797394|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
41989651|NCT02005471|75797395|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
41989652|NCT02005471|75797396|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
41989653|NCT02005471|75797393|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
41989654|NCT02005471|75797394|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
41989655|NCT02005471|75797395|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
41989656|NCT02005471|75797396|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
42245615|NCT02504580|76070490|FG002|Overall Study|Other|0|||
42245616|NCT02504580|76070491|FG003|Overall Study|Other|2|||
42245617|NCT02504580|76070492|FG004|Overall Study|Other|1|||
42245618|NCT02504580|76070493|FG005|Overall Study|Other|1|||
42245619|NCT02504580|76070494|FG006|Overall Study|Other|1|||
42245620|NCT02504580|76070495|FG007|Overall Study|Other|2|||
42245621|NCT02504580|76070496|FG008|Overall Study|Other|0|||
42245622|NCT02504580|76070497|FG009|Overall Study|Other|0|||
42245623|NCT02504580|76070498|FG010|Overall Study|Other|0|||
42245624|NCT02504580|76070499|FG011|Overall Study|Other|2|||
42245625|NCT02504580|76070488|FG000|Overall Study|Subject refusal to continue|0|||
42245626|NCT02504580|76070489|FG001|Overall Study|Subject refusal to continue|1|||
42245627|NCT02504580|76070490|FG002|Overall Study|Subject refusal to continue|0|||
42245628|NCT02504580|76070491|FG003|Overall Study|Subject refusal to continue|0|||
42245629|NCT02504580|76070492|FG004|Overall Study|Subject refusal to continue|0|||
42245630|NCT02504580|76070493|FG005|Overall Study|Subject refusal to continue|0|||
42245631|NCT02504580|76070494|FG006|Overall Study|Subject refusal to continue|0|||
42245632|NCT02504580|76070495|FG007|Overall Study|Subject refusal to continue|0|||
42245633|NCT02504580|76070496|FG008|Overall Study|Subject refusal to continue|0|||
42245634|NCT02504580|76070497|FG009|Overall Study|Subject refusal to continue|0|||
42245635|NCT02504580|76070498|FG010|Overall Study|Subject refusal to continue|0|||
42245636|NCT02504580|76070499|FG011|Overall Study|Subject refusal to continue|0|||
42245637|NCT01328756|76070521|FG000|Overall Study|Protocol Violation|4|||
42245638|NCT01328756|76070521|FG000|Overall Study|Adverse Event|39|||
42245639|NCT01328756|76070521|FG000|Overall Study|Lack of Efficacy|5|||
42245640|NCT01328756|76070521|FG000|Overall Study|Withdrawal by Subject|41|||
42245641|NCT01328756|76070521|FG000|Overall Study|Lost to Follow-up|5|||
42245642|NCT01328756|76070521|FG000|Overall Study|Other|29|||
42245643|NCT03922308|76070528|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
42245644|NCT03922308|76070529|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
42245645|NCT03922308|76070530|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
42245646|NCT03922308|76070528|FG000|Overall Study|Lost to Follow-up|1|||
42245647|NCT03922308|76070529|FG001|Overall Study|Lost to Follow-up|0|||
42245648|NCT03922308|76070530|FG002|Overall Study|Lost to Follow-up|0|||
42245649|NCT03922308|76070528|FG000|Overall Study|Reason not Specified|0|||
42245650|NCT03922308|76070529|FG001|Overall Study|Reason not Specified|2|||
42245651|NCT03922308|76070530|FG002|Overall Study|Reason not Specified|1|||
42245652|NCT02607930|76070543|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
42245653|NCT02607930|76070544|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
42245654|NCT02607930|76070545|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
42245655|NCT02607930|76070546|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
42245656|NCT02607930|76070543|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
42245657|NCT02607930|76070544|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
42245658|NCT02607930|76070545|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
42245659|NCT02607930|76070546|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
42245660|NCT02607930|76070543|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
42245661|NCT02607930|76070544|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
42245662|NCT02607930|76070545|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
42245663|NCT02607930|76070546|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
41989657|NCT02005471|75797393|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
42032909|NCT00943917|75841128|FG006|Stage II Continuation|Adverse Event|0|||
42032910|NCT00943917|75841129|FG007|Stage II Continuation|Adverse Event|0|||
42245664|NCT02607930|76070543|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
42245665|NCT02607930|76070544|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
42245666|NCT02607930|76070545|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
42303027|NCT02528357|76138364|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42032911|NCT00943917|75841130|FG008|Stage II Continuation|Adverse Event|0|||
42245667|NCT02607930|76070546|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
42245668|NCT02607930|76070543|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
42245669|NCT02607930|76070544|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
42245670|NCT02607930|76070545|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
42303028|NCT02528357|76138365|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42032912|NCT00943917|75841131|FG009|Stage II Continuation|Adverse Event|0|||
41989658|NCT02005471|75797394|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
41989659|NCT02005471|75797395|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
41989660|NCT02005471|75797396|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
41989661|NCT01977651|75797407|FG000|4 Month Treatment Period|Adverse Event|34|||
41989662|NCT01977651|75797407|FG000|4 Month Treatment Period|Death|3|||
41989663|NCT01977651|75797407|FG000|4 Month Treatment Period|Progressive Disease|43|||
41989664|NCT01977651|75797407|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
41989665|NCT01977651|75797407|FG000|4 Month Treatment Period|Physician Decision|4|||
41989666|NCT01977651|75797407|FG000|1 Year Extension Period|Adverse Event|14|||
41989667|NCT01977651|75797407|FG000|1 Year Extension Period|Death|10|||
41989668|NCT01977651|75797407|FG000|1 Year Extension Period|Lost to Follow-up|2|||
41989669|NCT01977651|75797407|FG000|1 Year Extension Period|Progressive Disease|86|||
41989670|NCT01977651|75797407|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
41989671|NCT01977651|75797407|FG000|1 Year Extension Period|Physician Decision|6|||
41989672|NCT01977651|75797407|FG000|1 Year Extension Period|Miscellaneous|1|||
41989673|NCT01977651|75797407|FG000|Post 1 Year Extension Period|Adverse Event|5|||
41989674|NCT01977651|75797407|FG000|Post 1 Year Extension Period|Death|13|||
41989675|NCT01977651|75797407|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
41989676|NCT01977651|75797407|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
41989677|NCT01977651|75797407|FG000|Post 1 Year Extension Period|Physician Decision|4|||
42245671|NCT02607930|76070546|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
42245672|NCT02607930|76070543|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
42245673|NCT02607930|76070544|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
42245674|NCT02607930|76070545|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
42245675|NCT02607930|76070546|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
42245676|NCT02607930|76070543|FG000|Double-Blinded Treatment Phase|Death|2|||
42245677|NCT02607930|76070544|FG001|Double-Blinded Treatment Phase|Death|1|||
42245678|NCT02607930|76070545|FG002|Double-Blinded Treatment Phase|Death|0|||
42245679|NCT02607930|76070546|FG003|Double-Blinded Treatment Phase|Death|0|||
42245680|NCT02607930|76070543|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
42245681|NCT02607930|76070544|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
42245682|NCT02607930|76070545|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
42245683|NCT02607930|76070546|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
42245684|NCT02607930|76070543|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
42245685|NCT02607930|76070544|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
42245686|NCT02607930|76070545|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
42245687|NCT02607930|76070546|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
42245688|NCT02607930|76070543|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
42245689|NCT02607930|76070544|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
42245690|NCT02607930|76070545|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
42245691|NCT02607930|76070546|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
42245692|NCT02607930|76070543|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
42245693|NCT02607930|76070544|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
42245694|NCT02607930|76070545|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
42245695|NCT02607930|76070546|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
42245696|NCT02607930|76070543|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
42245697|NCT02607930|76070544|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
42245698|NCT02607930|76070545|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
42245699|NCT02607930|76070546|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
42245700|NCT02607930|76070543|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
41989678|NCT01977651|75797407|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
41989679|NCT01949311|75797411|FG000|Overall Study|Lost to Follow-up|73|||
41989680|NCT01949311|75797411|FG000|Overall Study|Terminated by Sponsor|708|||
41989681|NCT01949311|75797411|FG000|Overall Study|Withdrawal by Subject|375|||
42245701|NCT02607930|76070544|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
42245702|NCT02607930|76070545|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
42245703|NCT02607930|76070546|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
41989682|NCT01949311|75797411|FG000|Overall Study|Lack of Efficacy|50|||
41989683|NCT01949311|75797411|FG000|Overall Study|Protocol Deviation|34|||
41989684|NCT01949311|75797411|FG000|Overall Study|Pregnancy|20|||
41989685|NCT01949311|75797411|FG000|Overall Study|Physician Decision|9|||
41989686|NCT01949311|75797411|FG000|Overall Study|Other|4|||
41989687|NCT01949311|75797411|FG000|Overall Study|Adverse Event|107|||
41989688|NCT01933932|75797418|FG000|Overall Study|Death|173|||
41989689|NCT01933932|75797419|FG001|Overall Study|Death|163|||
41989690|NCT01933932|75797418|FG000|Overall Study|Withdrawal by Subject|11|||
41989691|NCT01933932|75797419|FG001|Overall Study|Withdrawal by Subject|14|||
41989692|NCT01933932|75797418|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
41989693|NCT01933932|75797419|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
41989694|NCT01892722|75797427|FG000|Overall Study|Protocol deviation|0|||
41989695|NCT01892722|75797428|FG001|Overall Study|Protocol deviation|1|||
41989696|NCT01892722|75797427|FG000|Overall Study|Administrative problems|0|||
41989697|NCT01892722|75797428|FG001|Overall Study|Administrative problems|1|||
41989698|NCT01892722|75797427|FG000|Overall Study|Patient/guardian decision|0|||
41989699|NCT01892722|75797428|FG001|Overall Study|Patient/guardian decision|2|||
41989700|NCT01892722|75797427|FG000|Overall Study|Physician Decision|1|||
41989701|NCT01892722|75797428|FG001|Overall Study|Physician Decision|2|||
41989702|NCT01892722|75797427|FG000|Overall Study|Adverse Event|3|||
41989703|NCT01892722|75797428|FG001|Overall Study|Adverse Event|2|||
41989704|NCT01892722|75797427|FG000|Overall Study|Lack of Efficacy|0|||
41989705|NCT01892722|75797428|FG001|Overall Study|Lack of Efficacy|7|||
41989706|NCT01892722|75797427|FG000|Overall Study|Withdrawal by Subject|3|||
41989707|NCT01892722|75797428|FG001|Overall Study|Withdrawal by Subject|5|||
41989708|NCT01698008|75797446|FG000|Overall Study|Withdrawal by Subject|1|||
41989709|NCT01698008|75797447|FG001|Overall Study|Withdrawal by Subject|2|||
42245704|NCT02607930|76070543|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
42245705|NCT02607930|76070544|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
42245706|NCT02607930|76070545|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
42245707|NCT02607930|76070546|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
42245708|NCT02607930|76070543|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
42245709|NCT02607930|76070544|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
42245710|NCT02607930|76070545|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
42245711|NCT02607930|76070546|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
42245712|NCT02607930|76070543|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
42245713|NCT02607930|76070544|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
42245714|NCT02607930|76070545|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
42245715|NCT02607930|76070546|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
42245716|NCT02736188|76070577|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
42245717|NCT02736188|76070577|FG000|Overall Study|Adverse Event|1|||
42245718|NCT02736188|76070577|FG000|Overall Study|Withdrawal by Subject|1|||
42245719|NCT02736188|76070577|FG000|Overall Study|Other|6|||
42245720|NCT00154284|76070585|FG000|Overall Study|Adverse Event|6|||
42245721|NCT00154284|76070586|FG001|Overall Study|Adverse Event|9|||
42245722|NCT00154284|76070585|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42245723|NCT00154284|76070586|FG001|Overall Study|Abnormal laboratory value(s)|1|||
42245724|NCT00154284|76070585|FG000|Overall Study|Lack of Efficacy|1|||
42245725|NCT00154284|76070586|FG001|Overall Study|Lack of Efficacy|2|||
42245726|NCT00154284|76070585|FG000|Overall Study|Protocol Violation|0|||
42245727|NCT00154284|76070586|FG001|Overall Study|Protocol Violation|1|||
42245728|NCT02735096|76070594|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
42245729|NCT00905346|76070607|FG000|Period 1|Withdrawal by Subject|1|||
42245730|NCT00905346|76070608|FG001|Period 1|Withdrawal by Subject|0|||
42245731|NCT01328444|76070621|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
42245732|NCT01328444|76070622|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
41989710|NCT01622868|75797455|FG000|Overall Study|Protocol Violation|7|||
41989711|NCT01622868|75797456|FG001|Overall Study|Protocol Violation|0|||
41989712|NCT01208233|75797485|FG000|Overall Study|Adverse Event|0|||
42032913|NCT00943917|75841132|FG010|Stage II Continuation|Adverse Event|0|||
42032914|NCT00943917|75841133|FG011|Stage II Continuation|Adverse Event|1|||
42245733|NCT01328444|76070623|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
42245734|NCT01328444|76070624|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
42245735|NCT01328444|76070625|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
42245736|NCT01328444|76070626|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
41989713|NCT01208233|75797486|FG001|Overall Study|Adverse Event|1|||
41989714|NCT01208233|75797487|FG002|Overall Study|Adverse Event|2|||
42032915|NCT00943917|75841134|FG012|Stage II Continuation|Adverse Event|2|||
42032916|NCT00943917|75841135|FG013|Stage II Continuation|Adverse Event|1|||
42245737|NCT01328444|76070621|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
41989715|NCT01208233|75797488|FG003|Overall Study|Adverse Event|0|||
41989716|NCT01208233|75797489|FG004|Overall Study|Adverse Event|3|||
41989717|NCT01208233|75797490|FG005|Overall Study|Adverse Event|5|||
41989718|NCT01208233|75797485|FG000|Overall Study|Death|0|||
41989719|NCT01208233|75797486|FG001|Overall Study|Death|0|||
41989720|NCT01208233|75797487|FG002|Overall Study|Death|0|||
41989721|NCT01208233|75797488|FG003|Overall Study|Death|0|||
41989722|NCT01208233|75797489|FG004|Overall Study|Death|3|||
41989723|NCT01208233|75797490|FG005|Overall Study|Death|5|||
41989724|NCT01208233|75797485|FG000|Overall Study|Did not meet entrance criteria|2|||
41989725|NCT01208233|75797486|FG001|Overall Study|Did not meet entrance criteria|1|||
41989726|NCT01208233|75797487|FG002|Overall Study|Did not meet entrance criteria|1|||
41989727|NCT01208233|75797488|FG003|Overall Study|Did not meet entrance criteria|0|||
41989728|NCT01208233|75797489|FG004|Overall Study|Did not meet entrance criteria|1|||
41989729|NCT01208233|75797490|FG005|Overall Study|Did not meet entrance criteria|0|||
41989730|NCT01208233|75797485|FG000|Overall Study|Medication error without adverse event|0|||
42245738|NCT01328444|76070622|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
42245739|NCT01328444|76070623|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
42245740|NCT01328444|76070624|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
42245741|NCT01328444|76070625|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
42245742|NCT01328444|76070626|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
42245743|NCT01328444|76070621|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
42245744|NCT01328444|76070622|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
42245745|NCT01328444|76070623|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
42245746|NCT01328444|76070624|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
42245747|NCT01328444|76070625|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
41989731|NCT01208233|75797486|FG001|Overall Study|Medication error without adverse event|0|||
41989732|NCT01208233|75797487|FG002|Overall Study|Medication error without adverse event|0|||
41989733|NCT01208233|75797488|FG003|Overall Study|Medication error without adverse event|0|||
41989734|NCT01208233|75797489|FG004|Overall Study|Medication error without adverse event|0|||
41989735|NCT01208233|75797490|FG005|Overall Study|Medication error without adverse event|1|||
41989736|NCT01208233|75797485|FG000|Overall Study|Study terminated by sponsor|0|||
41989737|NCT01208233|75797486|FG001|Overall Study|Study terminated by sponsor|0|||
41989738|NCT01208233|75797487|FG002|Overall Study|Study terminated by sponsor|0|||
41989739|NCT01208233|75797488|FG003|Overall Study|Study terminated by sponsor|0|||
41989740|NCT01208233|75797489|FG004|Overall Study|Study terminated by sponsor|10|||
41989741|NCT01208233|75797490|FG005|Overall Study|Study terminated by sponsor|7|||
41989742|NCT01208233|75797485|FG000|Overall Study|Protocol Violation|0|||
41989743|NCT01208233|75797486|FG001|Overall Study|Protocol Violation|0|||
41989744|NCT01208233|75797487|FG002|Overall Study|Protocol Violation|0|||
41989745|NCT01208233|75797488|FG003|Overall Study|Protocol Violation|0|||
41989746|NCT01208233|75797489|FG004|Overall Study|Protocol Violation|3|||
41989747|NCT01208233|75797490|FG005|Overall Study|Protocol Violation|0|||
41989748|NCT01208233|75797485|FG000|Overall Study|Other|2|||
42245748|NCT01328444|76070626|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
41989749|NCT01208233|75797486|FG001|Overall Study|Other|1|||
41989750|NCT01208233|75797487|FG002|Overall Study|Other|0|||
41989751|NCT01208233|75797488|FG003|Overall Study|Other|0|||
41989752|NCT01208233|75797489|FG004|Overall Study|Other|0|||
41989753|NCT01208233|75797490|FG005|Overall Study|Other|1|||
41989754|NCT01208233|75797485|FG000|Overall Study|Withdrawal by Subject|1|||
41989755|NCT01208233|75797486|FG001|Overall Study|Withdrawal by Subject|0|||
41989756|NCT01208233|75797487|FG002|Overall Study|Withdrawal by Subject|1|||
41989757|NCT01208233|75797488|FG003|Overall Study|Withdrawal by Subject|1|||
41989758|NCT01208233|75797489|FG004|Overall Study|Withdrawal by Subject|4|||
41989759|NCT01208233|75797490|FG005|Overall Study|Withdrawal by Subject|2|||
42303029|NCT02528357|76138366|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
42303030|NCT02528357|76138367|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303031|NCT02528357|76138368|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303032|NCT02528357|76138369|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303033|NCT02528357|76138370|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
41989760|NCT01208038|75797510|FG000|Overall Study|Withdrawal by Subject|1|||
41989761|NCT01207687|75797514|FG000|Overall Study|Adverse Event|1|||
41989762|NCT01207687|75797514|FG000|Overall Study|Withdrawal by Subject|1|||
42303034|NCT02528357|76138371|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
42303035|NCT02528357|76138353|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303036|NCT02528357|76138354|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303037|NCT02528357|76138355|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303038|NCT02528357|76138356|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
41989763|NCT01207453|75797526|FG000|First Intervention|Adverse Event|2|||
42245749|NCT01328444|76070621|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
42245750|NCT01328444|76070622|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
42245751|NCT01328444|76070623|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
42245752|NCT01328444|76070624|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
42245753|NCT01328444|76070625|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
42245754|NCT01328444|76070626|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
42245755|NCT01328444|76070621|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
42245756|NCT01328444|76070622|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42245757|NCT01328444|76070623|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42245758|NCT01328444|76070624|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
42245759|NCT01328444|76070625|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42245760|NCT01328444|76070626|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
42245761|NCT01328444|76070621|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
42245762|NCT01328444|76070622|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
42245763|NCT01328444|76070623|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
42245764|NCT01328444|76070624|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
42245765|NCT01328444|76070625|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
42245766|NCT01328444|76070626|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
42245767|NCT01328444|76070621|FG000|Washout Period (14 Days)|Adverse Event|1|||
42245768|NCT01328444|76070622|FG001|Washout Period (14 Days)|Adverse Event|1|||
42245769|NCT01328444|76070623|FG002|Washout Period (14 Days)|Adverse Event|0|||
42245770|NCT01328444|76070624|FG003|Washout Period (14 Days)|Adverse Event|1|||
42245771|NCT01328444|76070625|FG004|Washout Period (14 Days)|Adverse Event|1|||
42245772|NCT01328444|76070626|FG005|Washout Period (14 Days)|Adverse Event|2|||
42245773|NCT01328444|76070621|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
42245774|NCT01328444|76070622|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
42245775|NCT01328444|76070623|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
42245776|NCT01328444|76070624|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
42303039|NCT02528357|76138357|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303040|NCT02528357|76138358|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303041|NCT02528357|76138359|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303042|NCT02528357|76138360|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42245777|NCT01328444|76070625|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
42245778|NCT01328444|76070626|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
42245779|NCT01328444|76070621|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
42245780|NCT01328444|76070622|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
42245781|NCT01328444|76070623|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
42245782|NCT01328444|76070624|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
42245783|NCT01328444|76070625|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
42245784|NCT01328444|76070626|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
42245785|NCT01328444|76070621|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
42245786|NCT01328444|76070622|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
41989764|NCT01207453|75797527|FG001|First Intervention|Adverse Event|1|||
41989765|NCT01207453|75797526|FG000|Washout|Adverse Event|1|||
41989766|NCT01207453|75797527|FG001|Washout|Adverse Event|0|||
41989767|NCT01207453|75797526|FG000|Washout|Lost to Follow-up|1|||
42245787|NCT01328444|76070623|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
42245788|NCT01328444|76070624|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
42245789|NCT01328444|76070625|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
42245790|NCT01328444|76070626|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
42245791|NCT01328444|76070621|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
42245792|NCT01328444|76070622|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
42245793|NCT01328444|76070623|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
41989768|NCT01207453|75797527|FG001|Washout|Lost to Follow-up|0|||
41989769|NCT01207453|75797526|FG000|2nd Intervention|Adverse Event|1|||
41989770|NCT01207453|75797527|FG001|2nd Intervention|Adverse Event|2|||
42245794|NCT01328444|76070624|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
42245795|NCT01328444|76070625|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
42245796|NCT01328444|76070626|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
42245797|NCT01328444|76070621|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
42245798|NCT01328444|76070622|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
42245799|NCT01328444|76070623|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
42245800|NCT01328444|76070624|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
42245801|NCT01328444|76070625|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
42245802|NCT01328444|76070626|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
42245803|NCT01328444|76070621|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
42245804|NCT01328444|76070622|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
42245805|NCT01328444|76070623|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
42245806|NCT01328444|76070624|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
42245807|NCT01328444|76070625|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
42245808|NCT01328444|76070626|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
42245809|NCT01328444|76070621|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
42245810|NCT01328444|76070622|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
42245811|NCT01328444|76070623|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
42245812|NCT01328444|76070624|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
42245813|NCT01328444|76070625|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
42245814|NCT01328444|76070626|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
42245815|NCT01328444|76070621|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42245816|NCT01328444|76070622|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42245817|NCT01328444|76070623|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42245818|NCT01328444|76070624|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42245819|NCT01328444|76070625|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
41989771|NCT01207453|75797526|FG000|2nd Intervention|Lost to Follow-up|1|||
41989772|NCT01207453|75797527|FG001|2nd Intervention|Lost to Follow-up|0|||
41989773|NCT01207414|75797538|FG000|Overall Study|Adverse Event|25|||
41989774|NCT01207414|75797539|FG001|Overall Study|Adverse Event|39|||
41989775|NCT01207414|75797538|FG000|Overall Study|Abnormal test procedure results|0|||
41989776|NCT01207414|75797539|FG001|Overall Study|Abnormal test procedure results|1|||
41989777|NCT01207414|75797538|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
41989778|NCT01207414|75797539|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
41989779|NCT01207414|75797538|FG000|Overall Study|Patient withdrew consent|14|||
41989780|NCT01207414|75797539|FG001|Overall Study|Patient withdrew consent|11|||
41989781|NCT01207414|75797538|FG000|Overall Study|Lost to Follow-up|15|||
41989782|NCT01207414|75797539|FG001|Overall Study|Lost to Follow-up|17|||
41989783|NCT01207414|75797538|FG000|Overall Study|Administrative problems|1|||
41989784|NCT01207414|75797539|FG001|Overall Study|Administrative problems|1|||
41989785|NCT01207414|75797538|FG000|Overall Study|Protocol deviation|12|||
41989786|NCT01207414|75797539|FG001|Overall Study|Protocol deviation|9|||
42245820|NCT01328444|76070626|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
42245821|NCT00887250|76070643|FG000|Overall Study|Adverse Event|3|||
42245822|NCT00887250|76070644|FG001|Overall Study|Adverse Event|0|||
42245823|NCT00887250|76070645|FG002|Overall Study|Adverse Event|7|||
42245824|NCT00887250|76070643|FG000|Overall Study|Lack of Efficacy|9|||
42245825|NCT00887250|76070644|FG001|Overall Study|Lack of Efficacy|6|||
42245826|NCT00887250|76070645|FG002|Overall Study|Lack of Efficacy|1|||
42245827|NCT00887250|76070643|FG000|Overall Study|Lost to Follow-up|2|||
42245828|NCT00887250|76070644|FG001|Overall Study|Lost to Follow-up|3|||
41989787|NCT01207414|75797538|FG000|Overall Study|Randomized in error|1|||
41989788|NCT01207414|75797539|FG001|Overall Study|Randomized in error|0|||
41989789|NCT01207219|75797548|FG000|Overall Study|changed diagnosis during study period|5|||
41989790|NCT01207219|75797549|FG001|Overall Study|changed diagnosis during study period|3|||
41989791|NCT01207219|75797550|FG002|Overall Study|changed diagnosis during study period|1|||
42032917|NCT00943917|75841136|FG014|Stage II Continuation|Adverse Event|1|||
42245829|NCT00887250|76070645|FG002|Overall Study|Lost to Follow-up|1|||
41989792|NCT01207219|75797548|FG000|Overall Study|Lost to Follow-up|6|||
41989793|NCT01207219|75797549|FG001|Overall Study|Lost to Follow-up|8|||
41989794|NCT01207219|75797550|FG002|Overall Study|Lost to Follow-up|6|||
42032918|NCT00943917|75841122|FG000|Stage II Continuation|Withdrawal by Subject|0|||
42245830|NCT00887250|76070643|FG000|Overall Study|Protocol Violation|2|||
42245831|NCT00887250|76070644|FG001|Overall Study|Protocol Violation|2|||
42245832|NCT00887250|76070645|FG002|Overall Study|Protocol Violation|1|||
42245833|NCT00887250|76070643|FG000|Overall Study|Withdrawal by Subject|2|||
42245834|NCT00887250|76070644|FG001|Overall Study|Withdrawal by Subject|1|||
42245835|NCT00887250|76070645|FG002|Overall Study|Withdrawal by Subject|2|||
42245836|NCT00887250|76070643|FG000|Overall Study|Patient uncooperative|0|||
42245837|NCT00887250|76070644|FG001|Overall Study|Patient uncooperative|0|||
42245838|NCT00887250|76070645|FG002|Overall Study|Patient uncooperative|1|||
42245839|NCT02599402|76070650|FG000|Overall Study|Disease progression|153|||
42245840|NCT02599402|76070650|FG000|Overall Study|Study drug toxicity|201|||
42245841|NCT02599402|76070650|FG000|Overall Study|Death|26|||
42245842|NCT02599402|76070650|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
42245843|NCT02599402|76070650|FG000|Overall Study|Participant request to discontinue study treatment|13|||
42245844|NCT02599402|76070650|FG000|Overall Study|Participant withdrew consent|5|||
42245845|NCT02599402|76070650|FG000|Overall Study|Lost to Follow-up|1|||
42245846|NCT02599402|76070650|FG000|Overall Study|Maximum Clinical Benefit|7|||
42245847|NCT02599402|76070650|FG000|Overall Study|Poor/non-compliance|1|||
42245848|NCT02599402|76070650|FG000|Overall Study|Pregnancy|1|||
42245849|NCT02599402|76070650|FG000|Overall Study|Participant no longer met study criteria|7|||
42245850|NCT02599402|76070650|FG000|Overall Study|Other Reasons|95|||
42245851|NCT02734862|76070690|FG000|Part A|Death|3|||
42245852|NCT02734862|76070691|FG001|Part A|Death|4|||
42245853|NCT02734862|76070692|FG002|Part A|Death|6|||
42245854|NCT02734862|76070690|FG000|Part A|Lost to Follow-up|2|||
42245855|NCT02734862|76070691|FG001|Part A|Lost to Follow-up|1|||
42245856|NCT02734862|76070692|FG002|Part A|Lost to Follow-up|1|||
42245857|NCT02734862|76070690|FG000|Part A|Withdrawal by Subject|1|||
42245858|NCT02734862|76070691|FG001|Part A|Withdrawal by Subject|1|||
42245859|NCT02734862|76070692|FG002|Part A|Withdrawal by Subject|2|||
42245860|NCT02734862|76070690|FG000|Part A|Physician Decision|2|||
42245861|NCT02734862|76070691|FG001|Part A|Physician Decision|0|||
42245862|NCT02734862|76070692|FG002|Part A|Physician Decision|1|||
42245863|NCT02734862|76070690|FG000|Part A|Adverse Event|2|||
42245864|NCT02734862|76070691|FG001|Part A|Adverse Event|0|||
42245865|NCT02734862|76070692|FG002|Part A|Adverse Event|1|||
42245866|NCT02734862|76070690|FG000|Part A|Noncompliance|1|||
42245867|NCT02734862|76070691|FG001|Part A|Noncompliance|1|||
42245868|NCT02734862|76070692|FG002|Part A|Noncompliance|0|||
42245869|NCT02734862|76070690|FG000|Part A|Other|1|||
42245870|NCT02734862|76070691|FG001|Part A|Other|1|||
42245871|NCT02734862|76070692|FG002|Part A|Other|3|||
42245872|NCT02734862|76070690|FG000|Part B|Death|8|||
42245873|NCT02734862|76070691|FG001|Part B|Death|3|||
42245874|NCT02734862|76070692|FG002|Part B|Death|5|||
42245875|NCT02734862|76070690|FG000|Part B|Lost to Follow-up|2|||
42245876|NCT02734862|76070691|FG001|Part B|Lost to Follow-up|2|||
42245877|NCT02734862|76070692|FG002|Part B|Lost to Follow-up|0|||
42245878|NCT02734862|76070690|FG000|Part B|Withdrawal by Subject|3|||
42245879|NCT02734862|76070691|FG001|Part B|Withdrawal by Subject|1|||
41989795|NCT01206517|75797564|FG000|Overall Study|Withdrawal by Subject|0|||
41989796|NCT01206517|75797565|FG001|Overall Study|Withdrawal by Subject|0|||
42245880|NCT02734862|76070692|FG002|Part B|Withdrawal by Subject|0|||
42245881|NCT02734862|76070690|FG000|Part B|Other|0|||
42245882|NCT02734862|76070691|FG001|Part B|Other|1|||
42245883|NCT02734862|76070692|FG002|Part B|Other|0|||
42245884|NCT00858702|76070703|FG000|Overall Study|Lack of Efficacy|1|||
42245885|NCT00858702|76070704|FG001|Overall Study|Lack of Efficacy|0|||
42245886|NCT00858702|76070703|FG000|Overall Study|Protocol Violation|1|||
42245887|NCT00858702|76070704|FG001|Overall Study|Protocol Violation|1|||
42245888|NCT00858702|76070703|FG000|Overall Study|Other|2|||
42245889|NCT00858702|76070704|FG001|Overall Study|Other|1|||
42245890|NCT00858702|76070703|FG000|Overall Study|Withdrawal by Subject|1|||
41989797|NCT01206517|75797566|FG002|Overall Study|Withdrawal by Subject|2|||
41989798|NCT01206517|75797567|FG003|Overall Study|Withdrawal by Subject|0|||
41989799|NCT01206517|75797568|FG004|Overall Study|Withdrawal by Subject|1|||
41989800|NCT01206517|75797569|FG005|Overall Study|Withdrawal by Subject|0|||
41989801|NCT01206439|75797580|FG000|Overall Study|subject did not meet inclusion criteria|1|||
41989802|NCT01206322|75797586|FG000|Overall Study|Adverse Event|0|||
41989803|NCT01206322|75797587|FG001|Overall Study|Adverse Event|0|||
41989804|NCT01206322|75797588|FG002|Overall Study|Adverse Event|0|||
41989805|NCT01206322|75797589|FG003|Overall Study|Adverse Event|1|||
41989806|NCT01206166|75797601|FG000|Overall Study|No evaluable data|2|||
41989807|NCT01206166|75797602|FG001|Overall Study|No evaluable data|3|||
41989808|NCT01207102|75797611|FG000|Overall Study|Withdrawal by Subject|5|||
42245891|NCT00858702|76070704|FG001|Overall Study|Withdrawal by Subject|0|||
42245892|NCT02598934|76070712|FG000|Overall Study|Adverse Event|11|||
42245893|NCT02598934|76070713|FG001|Overall Study|Adverse Event|13|||
42245894|NCT02598934|76070712|FG000|Overall Study|Failure to Return|3|||
42245895|NCT02598934|76070713|FG001|Overall Study|Failure to Return|3|||
42245896|NCT02598934|76070712|FG000|Overall Study|Withdrawal by Subject|2|||
42245897|NCT02598934|76070713|FG001|Overall Study|Withdrawal by Subject|3|||
42245898|NCT02598934|76070712|FG000|Overall Study|Administrative|2|||
42245899|NCT02598934|76070713|FG001|Overall Study|Administrative|1|||
42245900|NCT02598934|76070712|FG000|Overall Study|Protocol Violation|1|||
42245901|NCT02598934|76070713|FG001|Overall Study|Protocol Violation|2|||
42245902|NCT02598622|76070721|FG000|Overall Study|Withdrawal by Subject|3|||
42245903|NCT02598622|76070722|FG001|Overall Study|Withdrawal by Subject|0|||
42245904|NCT02598622|76070721|FG000|Overall Study|Physician Decision|3|||
42245905|NCT02598622|76070722|FG001|Overall Study|Physician Decision|0|||
42245906|NCT00841698|76070730|FG000|First Intervention|Withdrawal by Subject|1|||
42245907|NCT00841698|76070731|FG001|First Intervention|Withdrawal by Subject|0|||
42245908|NCT00841542|76070737|FG000|Period 1|Adverse Event|1|||
42245909|NCT00841542|76070738|FG001|Period 1|Adverse Event|0|||
42245910|NCT00840216|76070760|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
42245911|NCT00840216|76070761|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
42245912|NCT00836706|76070771|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
42245913|NCT00836706|76070772|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
42245914|NCT00836472|76070778|FG000|Washout|Adverse Event|1|||
42245915|NCT00836472|76070779|FG001|Washout|Adverse Event|2|||
42245916|NCT00836472|76070778|FG000|Washout|Withdrawal by Subject|1|||
42245917|NCT00836472|76070779|FG001|Washout|Withdrawal by Subject|1|||
42245918|NCT02598388|76070795|FG000|Overall Study|Lost to Follow-up|1|||
42245919|NCT02598388|76070796|FG001|Overall Study|Lost to Follow-up|0|||
42245920|NCT02598388|76070797|FG002|Overall Study|Lost to Follow-up|1|||
42245921|NCT02598388|76070798|FG003|Overall Study|Lost to Follow-up|0|||
41989809|NCT01207102|75797611|FG000|Overall Study|Adverse Event|2|||
41989810|NCT01207102|75797611|FG000|Overall Study|progression|2|||
41989811|NCT01207102|75797611|FG000|Overall Study|Withdrawal by Treating Physician|1|||
41989812|NCT01205776|75797627|FG000|Overall Study|Lost to Follow-up|53|||
41989813|NCT01205776|75797628|FG001|Overall Study|Lost to Follow-up|61|||
42032919|NCT00943917|75841123|FG001|Stage II Continuation|Withdrawal by Subject|0|||
42245922|NCT02598388|76070799|FG004|Overall Study|Lost to Follow-up|5|||
42245923|NCT02598388|76070800|FG005|Overall Study|Lost to Follow-up|1|||
42245924|NCT02598388|76070801|FG006|Overall Study|Lost to Follow-up|2|||
42245925|NCT02598388|76070802|FG007|Overall Study|Lost to Follow-up|1|||
42245926|NCT02598388|76070803|FG008|Overall Study|Lost to Follow-up|0|||
42245927|NCT02598388|76070804|FG009|Overall Study|Lost to Follow-up|0|||
42245928|NCT02598388|76070805|FG010|Overall Study|Lost to Follow-up|1|||
42245929|NCT02598388|76070806|FG011|Overall Study|Lost to Follow-up|0|||
42245930|NCT02598388|76070795|FG000|Overall Study|Withdrawal by Subject|0|||
42245931|NCT02598388|76070796|FG001|Overall Study|Withdrawal by Subject|0|||
42245932|NCT02598388|76070797|FG002|Overall Study|Withdrawal by Subject|0|||
42245933|NCT02598388|76070798|FG003|Overall Study|Withdrawal by Subject|0|||
42245934|NCT02598388|76070799|FG004|Overall Study|Withdrawal by Subject|2|||
42245935|NCT02598388|76070800|FG005|Overall Study|Withdrawal by Subject|0|||
42245936|NCT02598388|76070801|FG006|Overall Study|Withdrawal by Subject|2|||
42245937|NCT02598388|76070802|FG007|Overall Study|Withdrawal by Subject|0|||
42245938|NCT02598388|76070803|FG008|Overall Study|Withdrawal by Subject|0|||
41989814|NCT01205776|75797627|FG000|Overall Study|Withdrawal by Subject|11|||
41989815|NCT01205776|75797628|FG001|Overall Study|Withdrawal by Subject|34|||
41989816|NCT01205581|75797640|FG000|Overall Study|Withdrawal by Subject|1|||
41989817|NCT01205581|75797641|FG001|Overall Study|Withdrawal by Subject|0|||
42245939|NCT02598388|76070804|FG009|Overall Study|Withdrawal by Subject|1|||
42245940|NCT02598388|76070805|FG010|Overall Study|Withdrawal by Subject|0|||
42245941|NCT02598388|76070806|FG011|Overall Study|Withdrawal by Subject|0|||
42245942|NCT02598388|76070795|FG000|Overall Study|Other|0|||
42245943|NCT02598388|76070796|FG001|Overall Study|Other|0|||
41989818|NCT01205581|75797642|FG002|Overall Study|Withdrawal by Subject|0|||
41989819|NCT01205581|75797643|FG003|Overall Study|Withdrawal by Subject|0|||
41989820|NCT01205581|75797644|FG004|Overall Study|Withdrawal by Subject|0|||
41989821|NCT01205581|75797645|FG005|Overall Study|Withdrawal by Subject|0|||
41989822|NCT01205269|75797676|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
41989823|NCT01205269|75797677|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
41989824|NCT01205269|75797678|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
41989825|NCT01205269|75797679|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
41989826|NCT01205269|75797680|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
41989827|NCT01205269|75797681|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
41989828|NCT01240915|75797706|FG000|Overall Study|Adverse Event|0|||
41989829|NCT01240915|75797707|FG001|Overall Study|Adverse Event|0|||
41989830|NCT01240915|75797708|FG002|Overall Study|Adverse Event|0|||
41989831|NCT01240915|75797709|FG003|Overall Study|Adverse Event|1|||
41989832|NCT01240915|75797710|FG004|Overall Study|Adverse Event|0|||
41989833|NCT01240915|75797711|FG005|Overall Study|Adverse Event|2|||
41989834|NCT01240915|75797712|FG006|Overall Study|Adverse Event|0|||
41989835|NCT01240915|75797713|FG007|Overall Study|Adverse Event|0|||
41989836|NCT01240915|75797714|FG008|Overall Study|Adverse Event|1|||
41989837|NCT01240915|75797706|FG000|Overall Study|Lost to Follow-up|0|||
41989838|NCT01240915|75797707|FG001|Overall Study|Lost to Follow-up|0|||
41989839|NCT01240915|75797708|FG002|Overall Study|Lost to Follow-up|0|||
41989840|NCT01240915|75797709|FG003|Overall Study|Lost to Follow-up|0|||
41989841|NCT01240915|75797710|FG004|Overall Study|Lost to Follow-up|1|||
41989842|NCT01240915|75797711|FG005|Overall Study|Lost to Follow-up|1|||
41989843|NCT01240915|75797712|FG006|Overall Study|Lost to Follow-up|0|||
41989844|NCT01240915|75797713|FG007|Overall Study|Lost to Follow-up|1|||
41989845|NCT01240915|75797714|FG008|Overall Study|Lost to Follow-up|1|||
41989846|NCT01240915|75797706|FG000|Overall Study|Withdrawal by Subject|2|||
41989847|NCT01240915|75797707|FG001|Overall Study|Withdrawal by Subject|1|||
41989848|NCT01240915|75797708|FG002|Overall Study|Withdrawal by Subject|0|||
41989849|NCT01240915|75797709|FG003|Overall Study|Withdrawal by Subject|2|||
41989850|NCT01240915|75797710|FG004|Overall Study|Withdrawal by Subject|0|||
41989851|NCT01240915|75797711|FG005|Overall Study|Withdrawal by Subject|4|||
41989852|NCT01240915|75797712|FG006|Overall Study|Withdrawal by Subject|2|||
41989853|NCT01240915|75797713|FG007|Overall Study|Withdrawal by Subject|3|||
41989854|NCT01240915|75797714|FG008|Overall Study|Withdrawal by Subject|3|||
41989855|NCT01240915|75797706|FG000|Overall Study|Other|0|||
41989856|NCT01240915|75797707|FG001|Overall Study|Other|0|||
41989857|NCT01240915|75797708|FG002|Overall Study|Other|0|||
41989858|NCT01240915|75797709|FG003|Overall Study|Other|0|||
42245944|NCT02598388|76070797|FG002|Overall Study|Other|1|||
42245945|NCT02598388|76070798|FG003|Overall Study|Other|0|||
42245946|NCT02598388|76070799|FG004|Overall Study|Other|3|||
42245947|NCT02598388|76070800|FG005|Overall Study|Other|0|||
42245948|NCT02598388|76070801|FG006|Overall Study|Other|1|||
42245949|NCT02598388|76070802|FG007|Overall Study|Other|0|||
42245950|NCT02598388|76070803|FG008|Overall Study|Other|0|||
42245951|NCT02598388|76070804|FG009|Overall Study|Other|0|||
41989859|NCT01240915|75797710|FG004|Overall Study|Other|2|||
42245952|NCT02598388|76070805|FG010|Overall Study|Other|0|||
42245953|NCT02598388|76070806|FG011|Overall Study|Other|0|||
42245954|NCT00835692|76070846|FG000|First Intervention|Withdrawal by Subject|1|||
41989860|NCT01240915|75797711|FG005|Overall Study|Other|0|||
41989861|NCT01240915|75797712|FG006|Overall Study|Other|0|||
41989862|NCT01240915|75797713|FG007|Overall Study|Other|0|||
41989863|NCT01240915|75797714|FG008|Overall Study|Other|0|||
41989864|NCT01240915|75797706|FG000|Overall Study|Insufficient Clinical Response|0|||
41989865|NCT01240915|75797707|FG001|Overall Study|Insufficient Clinical Response|0|||
41989866|NCT01240915|75797708|FG002|Overall Study|Insufficient Clinical Response|0|||
41989867|NCT01240915|75797709|FG003|Overall Study|Insufficient Clinical Response|0|||
42245955|NCT00835692|76070847|FG001|First Intervention|Withdrawal by Subject|0|||
42245956|NCT00835536|76070860|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
42245957|NCT00835536|76070861|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
42245958|NCT03865316|76070865|FG000|Overall Study|Procedure Cancelled|4|||
42245959|NCT03865316|76070865|FG000|Overall Study|Equipment failure|4|||
42245960|NCT02598076|76070871|FG000|Overall Study|Lost to Follow-up|2|||
42245961|NCT02598076|76070872|FG001|Overall Study|Lost to Follow-up|3|||
42245962|NCT02602288|76070880|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
42245963|NCT02602288|76070881|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
42245964|NCT02602288|76070880|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
42245965|NCT02602288|76070881|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
42245966|NCT02602288|76070880|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
42245967|NCT02602288|76070881|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
42245968|NCT02602288|76070880|FG000|12 Month Follow-up|Lost to Follow-up|0|||
42245969|NCT02602288|76070881|FG001|12 Month Follow-up|Lost to Follow-up|4|||
42245970|NCT02602288|76070880|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
42245971|NCT02602288|76070881|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
42245972|NCT02601820|76070887|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
42245973|NCT02601820|76070887|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
42245974|NCT02601820|76070887|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
42245975|NCT02601820|76070887|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
42245976|NCT02807454|76070906|FG000|Overall Study|Adverse Event|1|||
42245977|NCT02807454|76070907|FG001|Overall Study|Adverse Event|0|||
42245978|NCT02807454|76070906|FG000|Overall Study|Withdrawal by Subject|0|||
41989868|NCT01240915|75797710|FG004|Overall Study|Insufficient Clinical Response|1|||
41989869|NCT01240915|75797711|FG005|Overall Study|Insufficient Clinical Response|3|||
41989870|NCT01240915|75797712|FG006|Overall Study|Insufficient Clinical Response|6|||
41989871|NCT01240915|75797713|FG007|Overall Study|Insufficient Clinical Response|0|||
41989872|NCT01240915|75797714|FG008|Overall Study|Insufficient Clinical Response|3|||
41989873|NCT01239745|75797736|FG000|Overall Study|Study terminated by sponsor|45|||
41989874|NCT01239745|75797736|FG000|Overall Study|Adverse Event|1|||
41989875|NCT01239472|75797742|FG000|Overall Study|Withdrawal by Subject|5|||
41989876|NCT01239472|75797743|FG001|Overall Study|Withdrawal by Subject|1|||
41989877|NCT01239472|75797742|FG000|Overall Study|Adverse Event|0|||
42032920|NCT00943917|75841124|FG002|Stage II Continuation|Withdrawal by Subject|0|||
42032921|NCT00943917|75841125|FG003|Stage II Continuation|Withdrawal by Subject|0|||
42032922|NCT00943917|75841126|FG004|Stage II Continuation|Withdrawal by Subject|0|||
42245979|NCT02807454|76070907|FG001|Overall Study|Withdrawal by Subject|1|||
42245980|NCT02807454|76070906|FG000|Overall Study|Progressive Disease|30|||
42245981|NCT02807454|76070907|FG001|Overall Study|Progressive Disease|3|||
41989878|NCT01239472|75797743|FG001|Overall Study|Adverse Event|1|||
41989879|NCT01239472|75797742|FG000|Overall Study|Lack of Efficacy|0|||
41989880|NCT01239472|75797743|FG001|Overall Study|Lack of Efficacy|1|||
41989881|NCT01229449|75797756|FG000|Overall Study|Withdrawal by Subject|0|||
41989882|NCT01229449|75797757|FG001|Overall Study|Withdrawal by Subject|3|||
41989883|NCT01229449|75797758|FG002|Overall Study|Withdrawal by Subject|0|||
41989884|NCT01229449|75797759|FG003|Overall Study|Withdrawal by Subject|1|||
41989885|NCT01229449|75797760|FG004|Overall Study|Withdrawal by Subject|1|||
41989886|NCT01229449|75797756|FG000|Overall Study|Lost to Follow-up|1|||
41989887|NCT01229449|75797757|FG001|Overall Study|Lost to Follow-up|1|||
41989888|NCT01229449|75797758|FG002|Overall Study|Lost to Follow-up|1|||
41989889|NCT01229449|75797759|FG003|Overall Study|Lost to Follow-up|0|||
41989890|NCT01229449|75797760|FG004|Overall Study|Lost to Follow-up|0|||
41989891|NCT01229449|75797756|FG000|Overall Study|Physician Decision|0|||
41989892|NCT01229449|75797757|FG001|Overall Study|Physician Decision|0|||
41989893|NCT01229449|75797758|FG002|Overall Study|Physician Decision|1|||
41989894|NCT01229449|75797759|FG003|Overall Study|Physician Decision|0|||
41989895|NCT01229449|75797760|FG004|Overall Study|Physician Decision|0|||
41989896|NCT01239316|75797772|FG000|Overall Study|Progression/Relapse|11|||
41989897|NCT01239316|75797772|FG000|Overall Study|Adverse Event|1|||
42303043|NCT02528357|76138361|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303044|NCT02528357|76138362|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42032923|NCT00943917|75841127|FG005|Stage II Continuation|Withdrawal by Subject|0|||
42032924|NCT00943917|75841128|FG006|Stage II Continuation|Withdrawal by Subject|0|||
42032925|NCT00943917|75841129|FG007|Stage II Continuation|Withdrawal by Subject|0|||
42032926|NCT00943917|75841130|FG008|Stage II Continuation|Withdrawal by Subject|0|||
42245982|NCT02807454|76070906|FG000|Overall Study|Other Reasons|1|||
42245983|NCT02807454|76070907|FG001|Overall Study|Other Reasons|1|||
42245984|NCT02597920|76070922|FG000|Overall Study|Worsening of other pre-existing disease|0|||
41989898|NCT01239160|75797778|FG000|Overall Study|Lost to Follow-up|3|||
41989899|NCT01239160|75797779|FG001|Overall Study|Lost to Follow-up|5|||
41989900|NCT01239160|75797780|FG002|Overall Study|Lost to Follow-up|0|||
41989901|NCT01239160|75797778|FG000|Overall Study|Withdrawal by Subject|17|||
42032927|NCT00943917|75841131|FG009|Stage II Continuation|Withdrawal by Subject|0|||
42245985|NCT02597920|76070923|FG001|Overall Study|Worsening of other pre-existing disease|1|||
42245986|NCT02597920|76070924|FG002|Overall Study|Worsening of other pre-existing disease|0|||
42303045|NCT02528357|76138363|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
42303046|NCT02528357|76138364|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303047|NCT02528357|76138365|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
42303048|NCT02528357|76138366|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
42303049|NCT02528357|76138367|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
42303050|NCT02528357|76138368|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303051|NCT02528357|76138369|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303052|NCT02528357|76138370|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303053|NCT02528357|76138371|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
42303054|NCT02528357|76138353|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303055|NCT02528357|76138354|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303056|NCT02528357|76138355|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303057|NCT02528357|76138356|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303058|NCT02528357|76138357|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303059|NCT02528357|76138358|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303060|NCT02528357|76138359|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303061|NCT02528357|76138360|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303062|NCT02528357|76138361|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
42303063|NCT02528357|76138362|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
42303064|NCT02528357|76138363|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303065|NCT02528357|76138364|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
41989902|NCT01239160|75797779|FG001|Overall Study|Withdrawal by Subject|6|||
42303066|NCT02528357|76138365|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
42303067|NCT02528357|76138366|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
42303068|NCT02528357|76138367|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
42303069|NCT02528357|76138368|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303070|NCT02528357|76138369|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303071|NCT02528357|76138370|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303072|NCT02528357|76138371|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303073|NCT02528357|76138353|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
41989903|NCT01239160|75797780|FG002|Overall Study|Withdrawal by Subject|2|||
41989904|NCT01239160|75797778|FG000|Overall Study|Physician Decision|5|||
41989905|NCT01239160|75797779|FG001|Overall Study|Physician Decision|7|||
41989906|NCT01239160|75797780|FG002|Overall Study|Physician Decision|2|||
42303074|NCT02528357|76138354|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303075|NCT02528357|76138355|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303076|NCT02528357|76138356|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303077|NCT02528357|76138357|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303078|NCT02528357|76138358|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303079|NCT02528357|76138359|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303080|NCT02528357|76138360|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303081|NCT02528357|76138361|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42245987|NCT02597920|76070922|FG000|Overall Study|Other adverse event|20|||
42245988|NCT02597920|76070923|FG001|Overall Study|Other adverse event|30|||
42245989|NCT02597920|76070924|FG002|Overall Study|Other adverse event|0|||
42245990|NCT02597920|76070922|FG000|Overall Study|Lost to Follow-up|7|||
42245991|NCT02597920|76070923|FG001|Overall Study|Lost to Follow-up|9|||
42245992|NCT02597920|76070924|FG002|Overall Study|Lost to Follow-up|0|||
42245993|NCT02597920|76070922|FG000|Overall Study|Refuse to continue in the study|3|||
42245994|NCT02597920|76070923|FG001|Overall Study|Refuse to continue in the study|13|||
42245995|NCT02597920|76070924|FG002|Overall Study|Refuse to continue in the study|1|||
41989907|NCT01239160|75797778|FG000|Overall Study|Early Termination Due to Study Closure|0|||
42245996|NCT02597920|76070922|FG000|Overall Study|Other than specified|10|||
42303082|NCT02528357|76138362|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303083|NCT02528357|76138363|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303084|NCT02528357|76138364|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303085|NCT02528357|76138365|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303086|NCT02528357|76138366|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303087|NCT02528357|76138367|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303088|NCT02528357|76138368|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303089|NCT02528357|76138369|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
42303090|NCT02528357|76138370|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303091|NCT02528357|76138371|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
42303092|NCT02528357|76138353|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303093|NCT02528357|76138354|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303094|NCT02528357|76138355|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303095|NCT02528357|76138356|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303096|NCT02528357|76138357|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303097|NCT02528357|76138358|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303098|NCT02528357|76138359|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303099|NCT02528357|76138360|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
41989908|NCT01239160|75797779|FG001|Overall Study|Early Termination Due to Study Closure|1|||
42303100|NCT02528357|76138361|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303101|NCT02528357|76138362|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303102|NCT02528357|76138363|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303103|NCT02528357|76138364|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303104|NCT02528357|76138365|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303105|NCT02528357|76138366|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303106|NCT02528357|76138367|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303107|NCT02528357|76138368|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
42303108|NCT02528357|76138369|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
42303109|NCT02528357|76138370|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
42303110|NCT02528357|76138371|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
42303111|NCT02463331|76138413|FG000|Overall Study|Adverse Event|4|||
42303112|NCT02463331|76138414|FG001|Overall Study|Adverse Event|2|||
42303113|NCT02463331|76138413|FG000|Overall Study|Lost to Follow-up|1|||
42303114|NCT02463331|76138414|FG001|Overall Study|Lost to Follow-up|1|||
42303115|NCT02463331|76138413|FG000|Overall Study|Pregnancy|2|||
42303116|NCT02463331|76138414|FG001|Overall Study|Pregnancy|3|||
41989909|NCT01239160|75797780|FG002|Overall Study|Early Termination Due to Study Closure|6|||
41989910|NCT01239121|75797789|FG000|Overall Study|Withdrawal by Subject|2|||
41989911|NCT01239121|75797790|FG001|Overall Study|Withdrawal by Subject|4|||
41989912|NCT01239121|75797791|FG002|Overall Study|Withdrawal by Subject|0|||
41989913|NCT01239043|75797801|FG000|Overall Study|Protocol Violation|2|||
41989914|NCT01239043|75797802|FG001|Overall Study|Protocol Violation|1|||
41989915|NCT01238848|75797810|FG000|Overall Study|Physician Decision|13|||
42245997|NCT02597920|76070923|FG001|Overall Study|Other than specified|31|||
42245998|NCT02597920|76070924|FG002|Overall Study|Other than specified|5|||
42245999|NCT02597920|76070922|FG000|Overall Study|Other|1|||
42246000|NCT02597920|76070923|FG001|Overall Study|Other|0|||
42246001|NCT02597920|76070924|FG002|Overall Study|Other|0|||
42246002|NCT01235234|76070944|FG000|Overall Study|Adverse Event|2|||
42246003|NCT01235234|76070945|FG001|Overall Study|Adverse Event|2|||
42246004|NCT01235234|76070946|FG002|Overall Study|Adverse Event|1|||
41989916|NCT01238848|75797811|FG001|Overall Study|Physician Decision|5|||
41989917|NCT01238575|75797819|FG000|Overall Study|Lack of Efficacy|2|||
41989918|NCT01238575|75797820|FG001|Overall Study|Lack of Efficacy|4|||
41989919|NCT01238575|75797819|FG000|Overall Study|Adverse Event|2|||
41989920|NCT01238575|75797820|FG001|Overall Study|Adverse Event|0|||
41989921|NCT05376215|75797832|FG000|Overall Study|Withdrawal by Subject|2|||
42246005|NCT02597452|76070961|FG000|Overall Study|testing incomplete|30|||
41989922|NCT05376215|75797833|FG001|Overall Study|Withdrawal by Subject|1|||
41989923|NCT05376215|75797832|FG000|Overall Study|Lost to Follow-up|0|||
41989924|NCT05376215|75797833|FG001|Overall Study|Lost to Follow-up|1|||
42246006|NCT00834756|76070967|FG000|First Intervention|Adverse Event|1|||
42246007|NCT00834756|76070968|FG001|First Intervention|Adverse Event|0|||
41989925|NCT04447794|75797862|FG000|Overall Study|Lost to Follow-up|2|||
42246008|NCT00834756|76070967|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
42246009|NCT00834756|76070968|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
42246010|NCT00828854|76070972|FG000|Overall Study|Disease Progression|17|||
42246011|NCT00828854|76070972|FG000|Overall Study|Adverse Event|9|||
42246012|NCT00828854|76070972|FG000|Overall Study|Reason not Specified|1|||
42246013|NCT00834522|76070978|FG000|Washout|Adverse Event|1|||
42246014|NCT00834522|76070979|FG001|Washout|Adverse Event|0|||
42246015|NCT00834522|76070978|FG000|Washout|Withdrawal by Subject|2|||
42246016|NCT00834522|76070979|FG001|Washout|Withdrawal by Subject|1|||
42246017|NCT00834444|76070985|FG000|First Intervention|Adverse Event|1|||
42303117|NCT02463331|76138413|FG000|Overall Study|Lack of Efficacy|6|||
42303118|NCT02463331|76138414|FG001|Overall Study|Lack of Efficacy|0|||
42246018|NCT00834444|76070986|FG001|First Intervention|Adverse Event|0|||
42246019|NCT00834444|76070985|FG000|First Intervention|Intolerance to Venopuncture|0|||
42246020|NCT00834444|76070986|FG001|First Intervention|Intolerance to Venopuncture|1|||
42246021|NCT00834444|76070985|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
42303119|NCT02463331|76138413|FG000|Overall Study|Physician Decision|3|||
42303120|NCT02463331|76138414|FG001|Overall Study|Physician Decision|0|||
42246022|NCT00834444|76070986|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
42246023|NCT00834444|76070985|FG000|Second Intervention|Adverse Event|1|||
42303121|NCT02410837|76138420|FG000|Overall Study|Death|387|||
42303122|NCT02410837|76138420|FG000|Overall Study|Lost to Follow-up|50|||
42246024|NCT00834444|76070986|FG001|Second Intervention|Adverse Event|0|||
42246025|NCT02605954|76071006|FG000|Overall Study|Adverse Event|5|||
42246026|NCT02605954|76071007|FG001|Overall Study|Adverse Event|1|||
42246027|NCT02605954|76071006|FG000|Overall Study|Investigator's Discretion|1|||
42246028|NCT02605954|76071007|FG001|Overall Study|Investigator's Discretion|0|||
42303123|NCT02410837|76138420|FG000|Overall Study|Withdrawal by Subject|44|||
42132104|NCT00496080|75942960|FG000|Overall Study|Withdrawal by Subject|5|||
42246029|NCT02605954|76071006|FG000|Overall Study|Non-Compliance with Study Drug|1|||
42246030|NCT02605954|76071007|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42246031|NCT02605954|76071006|FG000|Overall Study|Withdrew Consent|2|||
42246032|NCT02605954|76071007|FG001|Overall Study|Withdrew Consent|2|||
42246033|NCT02605954|76071006|FG000|Overall Study|Lost to Follow-up|3|||
42246034|NCT02605954|76071007|FG001|Overall Study|Lost to Follow-up|0|||
42246035|NCT02605954|76071006|FG000|Overall Study|Randomized but not treated|0|||
42246036|NCT02605954|76071007|FG001|Overall Study|Randomized but not treated|1|||
42246037|NCT00724698|76071016|FG000|Overall Study|Adverse Event|9|||
42246038|NCT00724698|76071016|FG000|Overall Study|Failure of Therapy|4|||
42246039|NCT00724698|76071016|FG000|Overall Study|Poor Compliance|16|||
42246040|NCT00724698|76071016|FG000|Overall Study|Lost to Follow-up|36|||
42246041|NCT00724698|76071016|FG000|Overall Study|No Info|25|||
42246042|NCT00829998|76071021|FG000|Washout|Adverse Event|0|||
42246043|NCT00829998|76071022|FG001|Washout|Adverse Event|1|||
42246044|NCT00829764|76071033|FG000|First Intervention|Adverse Event|1|||
42246045|NCT00829764|76071034|FG001|First Intervention|Adverse Event|0|||
42246046|NCT00829764|76071033|FG000|First Intervention|Withdrawal by Subject|1|||
42246047|NCT00829764|76071034|FG001|First Intervention|Withdrawal by Subject|1|||
42246048|NCT00829530|76071056|FG000|First Intervention|Adverse Event|0|||
42246049|NCT00829530|76071057|FG001|First Intervention|Adverse Event|1|||
42246050|NCT00829530|76071056|FG000|First Intervention|Intolerance to Venopuncture|0|||
42246051|NCT00829530|76071057|FG001|First Intervention|Intolerance to Venopuncture|1|||
42246052|NCT00829530|76071056|FG000|Second Intervention|Intolerance to Venopuncture|1|||
42246053|NCT00829530|76071057|FG001|Second Intervention|Intolerance to Venopuncture|0|||
42246054|NCT01377194|76071064|FG000|Overall Study|Adverse Event|3|||
42246055|NCT01377194|76071065|FG001|Overall Study|Adverse Event|12|||
42246056|NCT01377194|76071066|FG002|Overall Study|Adverse Event|19|||
42246057|NCT01377194|76071064|FG000|Overall Study|Lack of Efficacy|3|||
42303124|NCT02410837|76138420|FG000|Overall Study|Physician Decision|6|||
42303125|NCT02410837|76138420|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
42246058|NCT01377194|76071065|FG001|Overall Study|Lack of Efficacy|3|||
42246059|NCT01377194|76071066|FG002|Overall Study|Lack of Efficacy|3|||
42246060|NCT01377194|76071064|FG000|Overall Study|Protocol Violation|4|||
42246061|NCT01377194|76071065|FG001|Overall Study|Protocol Violation|10|||
42132105|NCT00496080|75942960|FG000|Overall Study|Physician Decision|6|||
42246062|NCT01377194|76071066|FG002|Overall Study|Protocol Violation|6|||
42246063|NCT01377194|76071064|FG000|Overall Study|Withdrawal by Subject|8|||
42246064|NCT01377194|76071065|FG001|Overall Study|Withdrawal by Subject|10|||
42246065|NCT01377194|76071066|FG002|Overall Study|Withdrawal by Subject|7|||
42246066|NCT01377194|76071064|FG000|Overall Study|Lost to Follow-up|14|||
42303126|NCT02314247|76138426|FG000|Overall Study|Adverse Event|2|||
42246067|NCT01377194|76071065|FG001|Overall Study|Lost to Follow-up|8|||
42246068|NCT01377194|76071066|FG002|Overall Study|Lost to Follow-up|11|||
42303127|NCT02314247|76138427|FG001|Overall Study|Adverse Event|1|||
42246069|NCT00829452|76071079|FG000|First Intervention|Withdrawal by Subject|0|||
42246070|NCT00829452|76071080|FG001|First Intervention|Withdrawal by Subject|1|||
42246071|NCT00829452|76071079|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
42246072|NCT00829452|76071080|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
42246073|NCT00829452|76071079|FG000|Second Intervention|Physician Decision|0|||
42246074|NCT00829452|76071080|FG001|Second Intervention|Physician Decision|1|||
42246075|NCT04600076|76071084|FG000|Overall Study|Lost to Follow-up|3|||
42303128|NCT02314247|76138428|FG002|Overall Study|Adverse Event|0|||
42246076|NCT02064387|76071100|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
42246077|NCT02064387|76071101|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
42246078|NCT02064387|76071102|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
42246079|NCT02064387|76071103|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
42246080|NCT02064387|76071104|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
42246081|NCT02064387|76071105|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
42246082|NCT02064387|76071106|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
42246083|NCT02064387|76071107|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
42246084|NCT02064387|76071108|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
42246085|NCT02064387|76071109|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
42246086|NCT02064387|76071110|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
42246087|NCT02064387|76071111|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
42246088|NCT02064387|76071100|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
42303129|NCT02314247|76138426|FG000|Overall Study|Withdrawal by Subject|1|||
42303130|NCT02314247|76138427|FG001|Overall Study|Withdrawal by Subject|3|||
42303131|NCT02314247|76138428|FG002|Overall Study|Withdrawal by Subject|1|||
42303132|NCT02314247|76138426|FG000|Overall Study|Progression of Disease|6|||
42303133|NCT02314247|76138427|FG001|Overall Study|Progression of Disease|2|||
42303134|NCT02314247|76138428|FG002|Overall Study|Progression of Disease|0|||
42303135|NCT02463097|76138438|FG000|Overall Study|Withdrawal by Subject|1|||
42303136|NCT02441179|76138444|FG000|Overall Study|Withdrawal by Subject|1|||
42303137|NCT02441179|76138445|FG001|Overall Study|Withdrawal by Subject|1|||
42303138|NCT02462473|76138452|FG000|Overall Study|Death|1|||
42303139|NCT02462473|76138452|FG000|Overall Study|Other|3|||
42303140|NCT02440789|76138465|FG000|Overall Study|Withdrawal by Subject|3|||
42303141|NCT02440789|76138465|FG000|Overall Study|Not willing to adhere to reqs|1|||
42303142|NCT02462083|76138469|FG000|Overall Study|Sponsor request|39|||
42303143|NCT02462083|76138469|FG000|Overall Study|Withdrawal by Subject|87|||
42303144|NCT02462083|76138469|FG000|Overall Study|Lost to Follow-up|41|||
42303145|NCT02462083|76138469|FG000|Overall Study|Lack of Efficacy|151|||
42303146|NCT02462083|76138469|FG000|Overall Study|Pregnancy|1|||
42303147|NCT02462083|76138469|FG000|Overall Study|Protocol Violation|6|||
42303148|NCT02462083|76138469|FG000|Overall Study|Adverse Event|33|||
42303149|NCT02462083|76138469|FG000|Overall Study|Worsening condition|16|||
42303150|NCT02462083|76138469|FG000|Overall Study|Other than specified|45|||
42303151|NCT02538341|76138475|FG000|Overall Study|Lost to Follow-up|51|||
42303152|NCT02538341|76138476|FG001|Overall Study|Lost to Follow-up|46|||
42303153|NCT02538341|76138475|FG000|Overall Study|Withdrawal by Subject|3|||
42303154|NCT02538341|76138476|FG001|Overall Study|Withdrawal by Subject|1|||
42303155|NCT02538341|76138475|FG000|Overall Study|Death|2|||
42303156|NCT02538341|76138476|FG001|Overall Study|Death|0|||
42303157|NCT02538107|76138482|FG000|Overall Study|Did not receive any Mircera dose|11|||
42303158|NCT02538107|76138482|FG000|Overall Study|Missing|5|||
42303159|NCT02538107|76138482|FG000|Overall Study|Necessity of dialysis|20|||
42303160|NCT02538107|76138482|FG000|Overall Study|Administration of other ESA|11|||
42303161|NCT02538107|76138482|FG000|Overall Study|No further treatment necessary|18|||
42303162|NCT02538107|76138482|FG000|Overall Study|Withdrawal by Subject|17|||
42303163|NCT02538107|76138482|FG000|Overall Study|Death|4|||
42303164|NCT02538107|76138482|FG000|Overall Study|Administrative reason|5|||
42303165|NCT02538107|76138482|FG000|Overall Study|Adverse Event|4|||
42303166|NCT02538107|76138482|FG000|Overall Study|Surgery|1|||
42303167|NCT02538107|76138482|FG000|Overall Study|Other|7|||
42303168|NCT02538107|76138482|FG000|Overall Study|Not recorded|7|||
42303169|NCT02538029|76138499|FG000|Overall Study|unable to complete cognitive assessments|1|||
42246089|NCT02064387|76071101|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
42246090|NCT02064387|76071102|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
42246091|NCT02064387|76071103|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
42246092|NCT02064387|76071104|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
42303170|NCT02538029|76138500|FG001|Overall Study|unable to complete cognitive assessments|0|||
42303171|NCT02538029|76138501|FG002|Overall Study|unable to complete cognitive assessments|1|||
42303172|NCT02272413|76138513|FG000|Randomized Through Treatment Start|Not treated|3|||
42303173|NCT02272413|76138514|FG001|Randomized Through Treatment Start|Not treated|5|||
42303174|NCT02272413|76138513|FG000|Pre-switch Period|Adverse Event|38|||
42303175|NCT02272413|76138514|FG001|Pre-switch Period|Adverse Event|37|||
42303176|NCT02272413|76138513|FG000|Pre-switch Period|Death|26|||
42303177|NCT02272413|76138514|FG001|Pre-switch Period|Death|26|||
42303178|NCT02272413|76138513|FG000|Pre-switch Period|Withdrawal by Subject|27|||
42246093|NCT02064387|76071105|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
42246094|NCT02064387|76071106|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
42246095|NCT02064387|76071107|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
42246096|NCT02064387|76071108|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
42246097|NCT02064387|76071109|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
42246098|NCT02064387|76071110|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
42246099|NCT02064387|76071111|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
42246100|NCT02064387|76071100|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
42246101|NCT02064387|76071101|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
42246102|NCT02064387|76071102|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
42246103|NCT02064387|76071103|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
42246104|NCT02064387|76071104|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
42246105|NCT02064387|76071105|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
42246106|NCT02064387|76071106|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
42246107|NCT02064387|76071107|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
42246108|NCT02064387|76071108|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
42246109|NCT02064387|76071109|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
42246110|NCT02064387|76071110|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
42246111|NCT02064387|76071111|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
42246112|NCT02064387|76071100|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
42246113|NCT02064387|76071101|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
42246114|NCT02064387|76071102|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
42032928|NCT00943917|75841132|FG010|Stage II Continuation|Withdrawal by Subject|0|||
42032929|NCT00943917|75841133|FG011|Stage II Continuation|Withdrawal by Subject|0|||
42032930|NCT00943917|75841134|FG012|Stage II Continuation|Withdrawal by Subject|0|||
42032931|NCT00943917|75841135|FG013|Stage II Continuation|Withdrawal by Subject|1|||
42032932|NCT00943917|75841136|FG014|Stage II Continuation|Withdrawal by Subject|3|||
42032933|NCT00943917|75841122|FG000|Stage II Continuation|Protocol Violation|0|||
42032934|NCT00943917|75841123|FG001|Stage II Continuation|Protocol Violation|0|||
42246115|NCT02064387|76071103|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
42246116|NCT02064387|76071104|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
42246117|NCT02064387|76071105|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
42246118|NCT02064387|76071106|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
42246119|NCT02064387|76071107|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
42246120|NCT02064387|76071108|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
42246121|NCT02064387|76071109|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
42246122|NCT02064387|76071110|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
42246123|NCT02064387|76071111|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
42246124|NCT02064387|76071100|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
42246125|NCT02064387|76071101|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
42246126|NCT02064387|76071102|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
42246127|NCT02064387|76071103|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
42246128|NCT02064387|76071104|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
42246129|NCT02064387|76071105|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
42246130|NCT02064387|76071106|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
42246131|NCT02064387|76071107|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
42246132|NCT02064387|76071108|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
42246133|NCT02064387|76071109|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
42246134|NCT02064387|76071110|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
42246135|NCT02064387|76071111|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
42246136|NCT01328366|76071150|FG000|Overall Study|Death|1|||
42246137|NCT01328366|76071150|FG000|Overall Study|Withdrawal by Subject|2|||
42246138|NCT01328366|76071150|FG000|Overall Study|Lost to Follow-up|7|||
42246139|NCT03256344|76071156|FG000|Overall Study|Death|6|||
42246140|NCT03256344|76071157|FG001|Overall Study|Death|22|||
42246141|NCT03256344|76071156|FG000|Overall Study|Withdrawal by Subject|3|||
42246142|NCT03256344|76071157|FG001|Overall Study|Withdrawal by Subject|3|||
42246143|NCT03256344|76071156|FG000|Overall Study|Sponsor Decision|1|||
42246144|NCT03256344|76071157|FG001|Overall Study|Sponsor Decision|0|||
42032935|NCT00943917|75841124|FG002|Stage II Continuation|Protocol Violation|0|||
42032936|NCT00943917|75841125|FG003|Stage II Continuation|Protocol Violation|0|||
42032937|NCT00943917|75841126|FG004|Stage II Continuation|Protocol Violation|0|||
42032938|NCT00943917|75841127|FG005|Stage II Continuation|Protocol Violation|0|||
42246145|NCT01370499|76071165|FG000|Overall Study|Adverse Event|38|||
42246146|NCT01370499|76071166|FG001|Overall Study|Adverse Event|12|||
42246147|NCT01370499|76071165|FG000|Overall Study|Lack of Efficacy|4|||
42246148|NCT01370499|76071166|FG001|Overall Study|Lack of Efficacy|2|||
42246149|NCT01370499|76071165|FG000|Overall Study|Lost to Follow-up|2|||
42246150|NCT01370499|76071166|FG001|Overall Study|Lost to Follow-up|1|||
42246151|NCT01370499|76071165|FG000|Overall Study|Physician Decision|3|||
42246152|NCT01370499|76071166|FG001|Overall Study|Physician Decision|3|||
42246153|NCT01370499|76071165|FG000|Overall Study|Protocol Violation|5|||
42246154|NCT01370499|76071166|FG001|Overall Study|Protocol Violation|4|||
42246155|NCT01370499|76071165|FG000|Overall Study|Withdrawal by Subject|18|||
42246156|NCT01370499|76071166|FG001|Overall Study|Withdrawal by Subject|7|||
42303179|NCT02272413|76138514|FG001|Pre-switch Period|Withdrawal by Subject|15|||
42246157|NCT01370499|76071165|FG000|Overall Study|Sponsor Decision|41|||
42246158|NCT01370499|76071166|FG001|Overall Study|Sponsor Decision|15|||
42246159|NCT01370265|76071174|FG000|First Intervention|Adverse Event|1|||
42246160|NCT01370265|76071175|FG001|First Intervention|Adverse Event|1|||
42246161|NCT02792829|76071213|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
42303180|NCT02272413|76138513|FG000|Pre-switch Period|Physician Decision|6|||
42303181|NCT02272413|76138514|FG001|Pre-switch Period|Physician Decision|18|||
42303182|NCT02272413|76138513|FG000|Pre-switch Period|Progressive disease|185|||
42303183|NCT02272413|76138514|FG001|Pre-switch Period|Progressive disease|173|||
42303184|NCT02272413|76138513|FG000|Pre-switch Period|Lost to Follow-up|0|||
42303185|NCT02272413|76138514|FG001|Pre-switch Period|Lost to Follow-up|2|||
42303186|NCT02272413|76138513|FG000|Pre-switch Period|Protocol Violation|1|||
42303187|NCT02272413|76138514|FG001|Pre-switch Period|Protocol Violation|0|||
42303188|NCT02272413|76138513|FG000|Pre-switch Period|Other than listed|10|||
42303189|NCT02272413|76138514|FG001|Pre-switch Period|Other than listed|11|||
42303190|NCT02272413|76138513|FG000|Post-switch Period|Adverse Event|4|||
42303191|NCT02272413|76138514|FG001|Post-switch Period|Adverse Event|4|||
42303192|NCT02272413|76138513|FG000|Post-switch Period|Death|3|||
42303193|NCT02272413|76138514|FG001|Post-switch Period|Death|2|||
42303194|NCT02272413|76138513|FG000|Post-switch Period|Withdrawal by Subject|1|||
42303195|NCT02272413|76138514|FG001|Post-switch Period|Withdrawal by Subject|2|||
42303196|NCT02272413|76138513|FG000|Post-switch Period|Physician Decision|1|||
42303197|NCT02272413|76138514|FG001|Post-switch Period|Physician Decision|1|||
42303198|NCT02272413|76138513|FG000|Post-switch Period|Progressive disease|21|||
42303199|NCT02272413|76138514|FG001|Post-switch Period|Progressive disease|21|||
42303200|NCT02272413|76138513|FG000|Post-switch Period|Study terminated by sponsor|8|||
42303201|NCT02272413|76138514|FG001|Post-switch Period|Study terminated by sponsor|11|||
42303202|NCT02272413|76138513|FG000|Post-switch Period|Other than listed|4|||
42132106|NCT00487578|75942967|FG000|Overall Study|Adverse Event|1|||
42246162|NCT02792829|76071214|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
42246163|NCT02792829|76071215|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
42246164|NCT02792829|76071216|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
42246165|NCT02792829|76071217|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
42246166|NCT02792829|76071218|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
42246167|NCT02792829|76071219|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
42246168|NCT02792829|76071220|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
42246169|NCT02792829|76071213|FG000|Treatment Period 2|Adverse Event|0|||
42246170|NCT02792829|76071214|FG001|Treatment Period 2|Adverse Event|0|||
42246171|NCT02792829|76071215|FG002|Treatment Period 2|Adverse Event|0|||
42246172|NCT02792829|76071216|FG003|Treatment Period 2|Adverse Event|0|||
42246173|NCT02792829|76071217|FG004|Treatment Period 2|Adverse Event|1|||
42246174|NCT02792829|76071218|FG005|Treatment Period 2|Adverse Event|0|||
42246175|NCT02792829|76071219|FG006|Treatment Period 2|Adverse Event|1|||
42246176|NCT02792829|76071220|FG007|Treatment Period 2|Adverse Event|1|||
42246177|NCT02792829|76071213|FG000|Treatment Period 2|Use of proscribed medications|0|||
42246178|NCT02792829|76071214|FG001|Treatment Period 2|Use of proscribed medications|0|||
42246179|NCT02792829|76071215|FG002|Treatment Period 2|Use of proscribed medications|0|||
42246180|NCT02792829|76071216|FG003|Treatment Period 2|Use of proscribed medications|0|||
42246181|NCT02792829|76071217|FG004|Treatment Period 2|Use of proscribed medications|0|||
42246182|NCT02792829|76071218|FG005|Treatment Period 2|Use of proscribed medications|0|||
42246183|NCT02792829|76071219|FG006|Treatment Period 2|Use of proscribed medications|0|||
42246184|NCT02792829|76071220|FG007|Treatment Period 2|Use of proscribed medications|1|||
42246185|NCT02867592|76071252|FG000|Overall Study|Adverse Event|3|||
42246186|NCT02867592|76071253|FG001|Overall Study|Adverse Event|0|||
42246187|NCT02867592|76071254|FG002|Overall Study|Adverse Event|2|||
42246188|NCT02867592|76071255|FG003|Overall Study|Adverse Event|1|||
42246189|NCT02867592|76071256|FG004|Overall Study|Adverse Event|1|||
42246190|NCT02867592|76071257|FG005|Overall Study|Adverse Event|5|||
42246191|NCT02867592|76071252|FG000|Overall Study|Death|0|||
42246192|NCT02867592|76071253|FG001|Overall Study|Death|0|||
42246193|NCT02867592|76071254|FG002|Overall Study|Death|0|||
42246194|NCT02867592|76071255|FG003|Overall Study|Death|1|||
42246195|NCT02867592|76071256|FG004|Overall Study|Death|0|||
42246196|NCT02867592|76071257|FG005|Overall Study|Death|1|||
42246197|NCT02867592|76071252|FG000|Overall Study|Lack of Efficacy|8|||
42246198|NCT02867592|76071253|FG001|Overall Study|Lack of Efficacy|10|||
42246199|NCT02867592|76071254|FG002|Overall Study|Lack of Efficacy|8|||
42246200|NCT02867592|76071255|FG003|Overall Study|Lack of Efficacy|8|||
42246201|NCT02867592|76071256|FG004|Overall Study|Lack of Efficacy|12|||
42246202|NCT02867592|76071257|FG005|Overall Study|Lack of Efficacy|17|||
42246203|NCT02867592|76071252|FG000|Overall Study|Physician Decision|1|||
42246204|NCT02867592|76071253|FG001|Overall Study|Physician Decision|2|||
42246205|NCT02867592|76071254|FG002|Overall Study|Physician Decision|2|||
42246206|NCT02867592|76071255|FG003|Overall Study|Physician Decision|0|||
42246207|NCT02867592|76071256|FG004|Overall Study|Physician Decision|5|||
42246208|NCT02867592|76071257|FG005|Overall Study|Physician Decision|1|||
42246209|NCT02867592|76071252|FG000|Overall Study|Protocol Violation|0|||
42246210|NCT02867592|76071253|FG001|Overall Study|Protocol Violation|0|||
42246211|NCT02867592|76071254|FG002|Overall Study|Protocol Violation|0|||
42246212|NCT02867592|76071255|FG003|Overall Study|Protocol Violation|0|||
42246213|NCT02867592|76071256|FG004|Overall Study|Protocol Violation|1|||
42246214|NCT02867592|76071257|FG005|Overall Study|Protocol Violation|1|||
42246215|NCT02867592|76071252|FG000|Overall Study|Withdrawal by Subject|0|||
42246216|NCT02867592|76071253|FG001|Overall Study|Withdrawal by Subject|1|||
42246217|NCT02867592|76071254|FG002|Overall Study|Withdrawal by Subject|0|||
42246218|NCT02867592|76071255|FG003|Overall Study|Withdrawal by Subject|1|||
42246219|NCT02867592|76071256|FG004|Overall Study|Withdrawal by Subject|3|||
42246220|NCT02867592|76071257|FG005|Overall Study|Withdrawal by Subject|3|||
42246221|NCT02867592|76071252|FG000|Overall Study|Ineligible|1|||
42246222|NCT02867592|76071253|FG001|Overall Study|Ineligible|1|||
42246223|NCT02867592|76071254|FG002|Overall Study|Ineligible|0|||
42246224|NCT02867592|76071255|FG003|Overall Study|Ineligible|0|||
42246225|NCT02867592|76071256|FG004|Overall Study|Ineligible|2|||
42246226|NCT02867592|76071257|FG005|Overall Study|Ineligible|0|||
42246227|NCT02867592|76071252|FG000|Overall Study|No Treatment|1|||
42246228|NCT02867592|76071253|FG001|Overall Study|No Treatment|0|||
42246229|NCT02867592|76071254|FG002|Overall Study|No Treatment|0|||
42246230|NCT02867592|76071255|FG003|Overall Study|No Treatment|0|||
42246231|NCT02867592|76071256|FG004|Overall Study|No Treatment|0|||
42246232|NCT02867592|76071257|FG005|Overall Study|No Treatment|0|||
42246233|NCT02867592|76071252|FG000|Overall Study|Still on Therapy|0|||
42246234|NCT02867592|76071253|FG001|Overall Study|Still on Therapy|0|||
42246235|NCT02867592|76071254|FG002|Overall Study|Still on Therapy|0|||
42246236|NCT02867592|76071255|FG003|Overall Study|Still on Therapy|0|||
42246237|NCT02867592|76071256|FG004|Overall Study|Still on Therapy|1|||
42246238|NCT02867592|76071257|FG005|Overall Study|Still on Therapy|0|||
42246239|NCT02867592|76071252|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
42246240|NCT02867592|76071253|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
42246241|NCT02867592|76071254|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
42246242|NCT02867592|76071255|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
42272685|NCT02283268|76103014|FG000|Overall Study|Withdrawal by Subject|1|||
42246243|NCT02867592|76071256|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
42246244|NCT02867592|76071257|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
42246245|NCT02867592|76071252|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
42246246|NCT02867592|76071253|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
42246247|NCT02867592|76071254|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
42246248|NCT02867592|76071255|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
42246249|NCT02867592|76071256|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
42246250|NCT02867592|76071257|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
42246251|NCT00676494|76071273|FG000|Overall Study|Missed Visit|8|||
42246252|NCT00676494|76071273|FG000|Overall Study|Withdrawal by Subject|6|||
42246253|NCT02605642|76071278|FG000|Overall Study|Other|11|||
42246254|NCT02605642|76071279|FG001|Overall Study|Other|1|||
42246255|NCT02605642|76071278|FG000|Overall Study|Participant non-compliance|2|||
42246256|NCT02605642|76071279|FG001|Overall Study|Participant non-compliance|4|||
42246257|NCT02605642|76071278|FG000|Overall Study|Physician Decision|10|||
42246258|NCT02605642|76071279|FG001|Overall Study|Physician Decision|0|||
42246259|NCT02605642|76071278|FG000|Overall Study|Lost to Follow-up|12|||
42246260|NCT02605642|76071279|FG001|Overall Study|Lost to Follow-up|1|||
42246261|NCT02605642|76071278|FG000|Overall Study|Adverse Event|14|||
42246262|NCT02605642|76071279|FG001|Overall Study|Adverse Event|2|||
42246263|NCT02605642|76071278|FG000|Overall Study|Withdrawal by Subject|23|||
42246264|NCT02605642|76071279|FG001|Overall Study|Withdrawal by Subject|2|||
42246265|NCT02605642|76071278|FG000|Overall Study|Lack of response|24|||
42246266|NCT02605642|76071279|FG001|Overall Study|Lack of response|11|||
42246267|NCT02253810|76071287|FG000|Overall Study|Withdrawal by Subject|2|||
42246268|NCT02253810|76071288|FG001|Overall Study|Withdrawal by Subject|1|||
42246269|NCT02253810|76071287|FG000|Overall Study|Unknown concomitant procedure|3|||
42246270|NCT02253810|76071288|FG001|Overall Study|Unknown concomitant procedure|2|||
42246271|NCT02732912|76071312|FG000|Overall Study|Discharged before night|2|||
42246272|NCT02732912|76071313|FG001|Overall Study|Discharged before night|6|||
42246273|NCT02732912|76071312|FG000|Overall Study|Incomplete completion of questionnaire|2|||
41989926|NCT04447794|75797863|FG001|Overall Study|Lost to Follow-up|3|||
42246274|NCT02732912|76071313|FG001|Overall Study|Incomplete completion of questionnaire|3|||
42246275|NCT02732912|76071312|FG000|Overall Study|No outcome; discharged or refused|6|||
42246276|NCT02732912|76071313|FG001|Overall Study|No outcome; discharged or refused|9|||
42246277|NCT02792517|76071319|FG000|Overall Study|Withdrawal by Subject|10|||
42246278|NCT02792517|76071319|FG000|Overall Study|Decision by Sponsor|7|||
42246279|NCT02792517|76071319|FG000|Overall Study|Lost to Follow-up|3|||
42246280|NCT01369485|76071354|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
42246281|NCT01369485|76071355|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
42246282|NCT01369485|76071354|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
42246283|NCT01369485|76071355|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
42246284|NCT01369485|76071354|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
42246285|NCT01369485|76071355|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
42246286|NCT01369485|76071354|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
42246287|NCT01369485|76071355|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
42246288|NCT01369485|76071354|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
42246289|NCT01369485|76071355|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
42246290|NCT01369485|76071354|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
42246291|NCT01369485|76071355|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
42246292|NCT01369485|76071354|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
42246293|NCT01369485|76071355|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
42246294|NCT01369485|76071354|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
42246295|NCT01369485|76071355|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
42246296|NCT01369485|76071354|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
42246297|NCT01369485|76071355|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
42246298|NCT01369485|76071354|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
42246299|NCT01369485|76071355|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
42246300|NCT02886572|76071382|FG000|Overall Study|Death|8|||
42246301|NCT02741700|76071395|FG000|Overall Study|Lost to Follow-up|17|||
42246302|NCT02741700|76071396|FG001|Overall Study|Lost to Follow-up|8|||
42246303|NCT02741700|76071395|FG000|Overall Study|Withdrawal by Subject|2|||
42246304|NCT02741700|76071396|FG001|Overall Study|Withdrawal by Subject|5|||
42246305|NCT02741700|76071395|FG000|Overall Study|Physician Decision|3|||
42246306|NCT02741700|76071396|FG001|Overall Study|Physician Decision|0|||
42246307|NCT02741700|76071395|FG000|Overall Study|Moved out of State|0|||
42246308|NCT02741700|76071396|FG001|Overall Study|Moved out of State|1|||
42246309|NCT02741700|76071395|FG000|Overall Study|Death|4|||
42246310|NCT02741700|76071396|FG001|Overall Study|Death|5|||
42246311|NCT00430950|76071404|FG000|Overall Study|Adverse Event|7|||
42246312|NCT00430950|76071405|FG001|Overall Study|Adverse Event|6|||
42246313|NCT00430950|76071404|FG000|Overall Study|Withdrawal by Subject|1|||
42246314|NCT00430950|76071405|FG001|Overall Study|Withdrawal by Subject|0|||
42246315|NCT00430950|76071404|FG000|Overall Study|concomitant medication,etc.|5|||
42246316|NCT00430950|76071405|FG001|Overall Study|concomitant medication,etc.|7|||
42132107|NCT00487578|75942968|FG001|Overall Study|Adverse Event|2|||
42132108|NCT00487578|75942967|FG000|Overall Study|Lack of Efficacy|0|||
42246317|NCT02081391|76071413|FG000|12-hour Treatment|Withdrawal by Subject|3|||
42246318|NCT02081391|76071414|FG001|12-hour Treatment|Withdrawal by Subject|2|||
42246319|NCT02081391|76071415|FG002|12-hour Treatment|Withdrawal by Subject|0|||
42246320|NCT02081391|76071416|FG003|12-hour Treatment|Withdrawal by Subject|0|||
42246321|NCT02081391|76071413|FG000|12-hour Treatment|Physician Decision|4|||
42246322|NCT02081391|76071414|FG001|12-hour Treatment|Physician Decision|1|||
42303203|NCT02272413|76138514|FG001|Post-switch Period|Other than listed|5|||
42303204|NCT02396381|76138526|FG000|Overall Study|Adverse Event|3|||
42303205|NCT02396381|76138527|FG001|Overall Study|Adverse Event|2|||
42303206|NCT02396381|76138526|FG000|Overall Study|Withdrawal by Subject|33|||
42303207|NCT02396381|76138527|FG001|Overall Study|Withdrawal by Subject|24|||
42303208|NCT02396381|76138526|FG000|Overall Study|Lost to Follow-up|49|||
42303209|NCT02396381|76138527|FG001|Overall Study|Lost to Follow-up|31|||
42303210|NCT02396381|76138526|FG000|Overall Study|Protocol Violation|1|||
42303211|NCT02396381|76138527|FG001|Overall Study|Protocol Violation|0|||
42303212|NCT02396381|76138526|FG000|Overall Study|Site terminated by sponsor|7|||
42303213|NCT02396381|76138527|FG001|Overall Study|Site terminated by sponsor|8|||
42303214|NCT02396381|76138526|FG000|Overall Study|Physician Decision|5|||
42303215|NCT02396381|76138527|FG001|Overall Study|Physician Decision|5|||
42303216|NCT02396381|76138526|FG000|Overall Study|Pregnancy|2|||
42303217|NCT02396381|76138527|FG001|Overall Study|Pregnancy|0|||
42303218|NCT02396381|76138526|FG000|Overall Study|Non-compliance with study procedures|1|||
42303219|NCT02396381|76138527|FG001|Overall Study|Non-compliance with study procedures|0|||
41989927|NCT04447794|75797864|FG002|Overall Study|Lost to Follow-up|8|||
41989928|NCT04447794|75797862|FG000|Overall Study|Withdrawal by Subject|1|||
42303220|NCT02396381|76138526|FG000|Overall Study|Moved out of town/state|1|||
42303221|NCT02396381|76138527|FG001|Overall Study|Moved out of town/state|3|||
42303222|NCT02396381|76138526|FG000|Overall Study|Could not complete visit|1|||
42303223|NCT02396381|76138527|FG001|Overall Study|Could not complete visit|0|||
42303224|NCT02396381|76138526|FG000|Overall Study|Possible conflict of interest|1|||
42303225|NCT02396381|76138527|FG001|Overall Study|Possible conflict of interest|0|||
42303226|NCT02396381|76138526|FG000|Overall Study|Randomization/Screening Error|3|||
42303227|NCT02396381|76138527|FG001|Overall Study|Randomization/Screening Error|1|||
42303228|NCT02532647|76138539|FG000|Overall Study|Did not receive trial medication|1|||
41989929|NCT04447794|75797863|FG001|Overall Study|Withdrawal by Subject|1|||
41989930|NCT04447794|75797864|FG002|Overall Study|Withdrawal by Subject|0|||
41989931|NCT04138576|75797877|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
41989932|NCT04009291|75797891|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
41989933|NCT04009291|75797892|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
42246323|NCT02081391|76071415|FG002|12-hour Treatment|Physician Decision|0|||
42246324|NCT02081391|76071416|FG003|12-hour Treatment|Physician Decision|0|||
42246325|NCT02081391|76071413|FG000|12-hour Treatment|Lack of Efficacy|3|||
42246326|NCT02081391|76071414|FG001|12-hour Treatment|Lack of Efficacy|0|||
41989934|NCT04009291|75797893|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
41989935|NCT04009291|75797894|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
41989936|NCT04009291|75797895|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
41989937|NCT04009291|75797891|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
41989938|NCT04009291|75797892|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
41989939|NCT04009291|75797893|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
41989940|NCT04009291|75797894|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
41989941|NCT04009291|75797895|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
41989942|NCT03811340|75797906|FG000|Overall Study|subjects did not complete the survey.|90|||
41989943|NCT03668119|75797921|FG000|Pre-treatment|Disease Progression|1|||
41989944|NCT03668119|75797922|FG001|Pre-treatment|Disease Progression|0|||
42246327|NCT02081391|76071415|FG002|12-hour Treatment|Lack of Efficacy|0|||
42246328|NCT02081391|76071416|FG003|12-hour Treatment|Lack of Efficacy|0|||
42246329|NCT02081391|76071413|FG000|12-hour Treatment|Adverse Event|4|||
42246330|NCT02081391|76071414|FG001|12-hour Treatment|Adverse Event|2|||
42246331|NCT02081391|76071415|FG002|12-hour Treatment|Adverse Event|0|||
42246332|NCT02081391|76071416|FG003|12-hour Treatment|Adverse Event|0|||
42246333|NCT02081391|76071413|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
42303229|NCT02532647|76138540|FG001|Overall Study|Did not receive trial medication|0|||
42303230|NCT02532647|76138541|FG002|Overall Study|Did not receive trial medication|1|||
42303231|NCT02537015|76138549|FG000|Overall Study|Adverse Event|3|||
42303232|NCT02537015|76138549|FG000|Overall Study|Withdrawal by Subject|2|||
42303233|NCT02537015|76138549|FG000|Overall Study|Other Miscellaneous Reasons|1|||
42303234|NCT02271945|76138555|FG000|Overall Study|Death|3|||
41989945|NCT03668119|75797921|FG000|Treatment|Disease Progression|75|||
42303235|NCT02271945|76138556|FG001|Overall Study|Death|3|||
42303236|NCT02271945|76138555|FG000|Overall Study|Withdrawal by Subject|1|||
42303237|NCT02271945|76138556|FG001|Overall Study|Withdrawal by Subject|1|||
42303238|NCT02271945|76138555|FG000|Overall Study|Other|1|||
42303239|NCT02271945|76138556|FG001|Overall Study|Other|1|||
42303240|NCT01660763|76138564|FG000|Overall Study|Lack of Efficacy|45|||
42303241|NCT01660763|76138565|FG001|Overall Study|Lack of Efficacy|50|||
42303242|NCT01660763|76138564|FG000|Overall Study|Adverse Event|22|||
42303243|NCT01660763|76138565|FG001|Overall Study|Adverse Event|7|||
42303244|NCT01660763|76138564|FG000|Overall Study|Protocol Violation|1|||
42303245|NCT01660763|76138565|FG001|Overall Study|Protocol Violation|0|||
42303246|NCT01660763|76138564|FG000|Overall Study|Withdrawal by Subject|4|||
42303247|NCT01660763|76138565|FG001|Overall Study|Withdrawal by Subject|0|||
42303248|NCT01660763|76138564|FG000|Overall Study|Patient ready for early discharge|28|||
42303249|NCT01660763|76138565|FG001|Overall Study|Patient ready for early discharge|4|||
42303250|NCT01937117|76138571|FG000|Overall Study|Disease Progression|7|||
42303251|NCT01937117|76138571|FG000|Overall Study|Physician Decision|4|||
42303252|NCT01937117|76138571|FG000|Overall Study|Adverse Event|2|||
42303253|NCT02268045|76138577|FG000|Overall Study|Death|4|||
42303254|NCT02268045|76138578|FG001|Overall Study|Death|4|||
42303255|NCT02268045|76138577|FG000|Overall Study|Disease Progression|2|||
42303256|NCT02268045|76138578|FG001|Overall Study|Disease Progression|1|||
42303257|NCT02268045|76138577|FG000|Overall Study|Adverse Event|7|||
42303258|NCT02268045|76138578|FG001|Overall Study|Adverse Event|7|||
42303259|NCT02268045|76138577|FG000|Overall Study|Withdrawal by Subject|2|||
42303260|NCT02268045|76138578|FG001|Overall Study|Withdrawal by Subject|6|||
42303261|NCT02268045|76138577|FG000|Overall Study|Physician Decision|0|||
42303262|NCT02268045|76138578|FG001|Overall Study|Physician Decision|1|||
42303263|NCT02268045|76138577|FG000|Overall Study|Protocol Violation|1|||
42303264|NCT02268045|76138578|FG001|Overall Study|Protocol Violation|1|||
42303265|NCT02536781|76138588|FG000|Overall Study|Lost to Follow-up|2|||
42303266|NCT02536781|76138589|FG001|Overall Study|Lost to Follow-up|0|||
42303267|NCT02267187|76138595|FG000|Overall Study|Physician Decision|2|||
42303268|NCT02267187|76138595|FG000|Overall Study|Screen fail|3|||
42303269|NCT02532179|76138599|FG000|Overall Study|Lost to Follow-up|1|||
42303270|NCT02532179|76138599|FG000|Overall Study|Pregnancy|1|||
42303271|NCT02532179|76138599|FG000|Overall Study|Subject received depot steroid injection|1|||
42303272|NCT02409667|76138603|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
42246334|NCT02081391|76071414|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
42246335|NCT02081391|76071415|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
42246336|NCT02081391|76071416|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
42246337|NCT02081391|76071413|FG000|12-hour Treatment|Further reasons|2|||
42246338|NCT02081391|76071414|FG001|12-hour Treatment|Further reasons|1|||
42246339|NCT02081391|76071415|FG002|12-hour Treatment|Further reasons|0|||
42246340|NCT02081391|76071416|FG003|12-hour Treatment|Further reasons|0|||
42246341|NCT02081391|76071413|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
42246342|NCT02081391|76071414|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
42246343|NCT02081391|76071415|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
42246344|NCT02081391|76071416|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
42246345|NCT02081391|76071413|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
42246346|NCT02081391|76071414|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
42246347|NCT02081391|76071415|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
42246348|NCT02081391|76071416|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
42246349|NCT02081391|76071413|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
42246350|NCT02081391|76071414|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
42246351|NCT02081391|76071415|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
42246352|NCT02081391|76071416|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
42303273|NCT02409667|76138604|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
42303274|NCT02409667|76138605|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
42303275|NCT02409667|76138606|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
42303276|NCT02409667|76138607|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
42303277|NCT02409667|76138603|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
42246353|NCT02081391|76071413|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
42246354|NCT02081391|76071414|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
42246355|NCT02081391|76071415|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
42246356|NCT02081391|76071416|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
42246357|NCT02081391|76071413|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
42246358|NCT02081391|76071414|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
42246359|NCT02081391|76071415|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
42246360|NCT02081391|76071416|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
42246361|NCT02081391|76071413|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
42246362|NCT02081391|76071414|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
42246363|NCT02081391|76071415|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
42246364|NCT02081391|76071416|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
42246365|NCT00430092|76071439|FG000|Overall Study|Adverse Event|0|||
42246366|NCT00430092|76071440|FG001|Overall Study|Adverse Event|0|||
42246367|NCT00430092|76071441|FG002|Overall Study|Adverse Event|1|||
42246368|NCT00430092|76071439|FG000|Overall Study|Lack of Efficacy|5|||
42246369|NCT00430092|76071440|FG001|Overall Study|Lack of Efficacy|2|||
42246370|NCT00430092|76071441|FG002|Overall Study|Lack of Efficacy|54|||
42246371|NCT00430092|76071439|FG000|Overall Study|Lost to Follow-up|1|||
42246372|NCT00430092|76071440|FG001|Overall Study|Lost to Follow-up|0|||
42246373|NCT00430092|76071441|FG002|Overall Study|Lost to Follow-up|0|||
42246374|NCT00430092|76071439|FG000|Overall Study|Protocol Violation|0|||
42246375|NCT00430092|76071440|FG001|Overall Study|Protocol Violation|1|||
42246376|NCT00430092|76071441|FG002|Overall Study|Protocol Violation|1|||
42246377|NCT00430092|76071439|FG000|Overall Study|Withdrawal by Subject|0|||
42246378|NCT00430092|76071440|FG001|Overall Study|Withdrawal by Subject|1|||
42246379|NCT00430092|76071441|FG002|Overall Study|Withdrawal by Subject|1|||
42246380|NCT00425100|76071446|FG000|Overall Study|Adverse Event|36|||
42246381|NCT00425100|76071446|FG000|Overall Study|Lack of Efficacy|4|||
42246382|NCT00425100|76071446|FG000|Overall Study|Lost to Follow-up|2|||
42246383|NCT00425100|76071446|FG000|Overall Study|Protocol Violation|4|||
42246384|NCT00425100|76071446|FG000|Overall Study|Withdrawal by Subject|7|||
42246385|NCT00412932|76071451|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
42246386|NCT00412932|76071451|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
42246387|NCT00412932|76071451|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
42246388|NCT00412932|76071451|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
42246389|NCT00412932|76071451|FG000|Olmesartan (Olm) 20 mg|Other|1|||
42246390|NCT00412932|76071451|FG000|Olmesartan 40 mg|Adverse Event|4|||
42246391|NCT00412932|76071451|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
42246392|NCT00412932|76071451|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
42246393|NCT00412932|76071451|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
42246394|NCT00412932|76071451|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
42246395|NCT00412932|76071451|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
42246396|NCT00412932|76071451|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
42246397|NCT02696031|76071457|FG000|Up to Week 24|Adverse Event|2|||
42246398|NCT02696031|76071458|FG001|Up to Week 24|Adverse Event|4|||
42246399|NCT02696031|76071459|FG002|Up to Week 24|Adverse Event|2|||
42246400|NCT02696031|76071460|FG003|Up to Week 24|Adverse Event|0|||
42246401|NCT02696031|76071461|FG004|Up to Week 24|Adverse Event|0|||
42246402|NCT02696031|76071462|FG005|Up to Week 24|Adverse Event|0|||
42246403|NCT02696031|76071457|FG000|Up to Week 24|Lack of Efficacy|2|||
42246404|NCT02696031|76071458|FG001|Up to Week 24|Lack of Efficacy|1|||
42246405|NCT02696031|76071459|FG002|Up to Week 24|Lack of Efficacy|2|||
42246406|NCT02696031|76071460|FG003|Up to Week 24|Lack of Efficacy|0|||
42246407|NCT02696031|76071461|FG004|Up to Week 24|Lack of Efficacy|0|||
42246408|NCT02696031|76071462|FG005|Up to Week 24|Lack of Efficacy|0|||
42246409|NCT02696031|76071457|FG000|Up to Week 24|Lost to Follow-up|0|||
42246410|NCT02696031|76071458|FG001|Up to Week 24|Lost to Follow-up|1|||
42246411|NCT02696031|76071459|FG002|Up to Week 24|Lost to Follow-up|1|||
42246412|NCT02696031|76071460|FG003|Up to Week 24|Lost to Follow-up|0|||
42246413|NCT02696031|76071461|FG004|Up to Week 24|Lost to Follow-up|0|||
42246414|NCT02696031|76071462|FG005|Up to Week 24|Lost to Follow-up|0|||
42246415|NCT02696031|76071457|FG000|Up to Week 24|Physician Decision|1|||
42246416|NCT02696031|76071458|FG001|Up to Week 24|Physician Decision|0|||
42246417|NCT02696031|76071459|FG002|Up to Week 24|Physician Decision|1|||
42246418|NCT02696031|76071460|FG003|Up to Week 24|Physician Decision|0|||
42246419|NCT02696031|76071461|FG004|Up to Week 24|Physician Decision|0|||
42246420|NCT02696031|76071462|FG005|Up to Week 24|Physician Decision|0|||
42246421|NCT02696031|76071457|FG000|Up to Week 24|Protocol Violation|1|||
42246422|NCT02696031|76071458|FG001|Up to Week 24|Protocol Violation|0|||
42246423|NCT02696031|76071459|FG002|Up to Week 24|Protocol Violation|0|||
42246424|NCT02696031|76071460|FG003|Up to Week 24|Protocol Violation|0|||
42246425|NCT02696031|76071461|FG004|Up to Week 24|Protocol Violation|0|||
42246426|NCT02696031|76071462|FG005|Up to Week 24|Protocol Violation|0|||
42246427|NCT02696031|76071457|FG000|Up to Week 24|Withdrawal by Subject|4|||
42246428|NCT02696031|76071458|FG001|Up to Week 24|Withdrawal by Subject|1|||
42246429|NCT02696031|76071459|FG002|Up to Week 24|Withdrawal by Subject|5|||
42246430|NCT02696031|76071460|FG003|Up to Week 24|Withdrawal by Subject|0|||
42246431|NCT02696031|76071461|FG004|Up to Week 24|Withdrawal by Subject|0|||
42246432|NCT02696031|76071462|FG005|Up to Week 24|Withdrawal by Subject|0|||
42246433|NCT02696031|76071457|FG000|Up to Week 52|Adverse Event|4|||
42246434|NCT02696031|76071458|FG001|Up to Week 52|Adverse Event|5|||
42246435|NCT02696031|76071459|FG002|Up to Week 52|Adverse Event|3|||
42246436|NCT02696031|76071460|FG003|Up to Week 52|Adverse Event|0|||
42246437|NCT02696031|76071461|FG004|Up to Week 52|Adverse Event|0|||
42246438|NCT02696031|76071462|FG005|Up to Week 52|Adverse Event|0|||
42246439|NCT02696031|76071457|FG000|Up to Week 52|Lack of Efficacy|10|||
42246440|NCT02696031|76071458|FG001|Up to Week 52|Lack of Efficacy|7|||
42246441|NCT02696031|76071459|FG002|Up to Week 52|Lack of Efficacy|11|||
42246442|NCT02696031|76071460|FG003|Up to Week 52|Lack of Efficacy|0|||
42246443|NCT02696031|76071461|FG004|Up to Week 52|Lack of Efficacy|0|||
42246444|NCT02696031|76071462|FG005|Up to Week 52|Lack of Efficacy|0|||
42246445|NCT02696031|76071457|FG000|Up to Week 52|Lost to Follow-up|1|||
42246446|NCT02696031|76071458|FG001|Up to Week 52|Lost to Follow-up|1|||
42246447|NCT02696031|76071459|FG002|Up to Week 52|Lost to Follow-up|1|||
42246448|NCT02696031|76071460|FG003|Up to Week 52|Lost to Follow-up|0|||
42246449|NCT02696031|76071461|FG004|Up to Week 52|Lost to Follow-up|0|||
42246450|NCT02696031|76071462|FG005|Up to Week 52|Lost to Follow-up|0|||
42246451|NCT02696031|76071457|FG000|Up to Week 52|Physician Decision|1|||
42246452|NCT02696031|76071458|FG001|Up to Week 52|Physician Decision|1|||
42246453|NCT02696031|76071459|FG002|Up to Week 52|Physician Decision|2|||
42246454|NCT02696031|76071460|FG003|Up to Week 52|Physician Decision|0|||
42246455|NCT02696031|76071461|FG004|Up to Week 52|Physician Decision|0|||
42246456|NCT02696031|76071462|FG005|Up to Week 52|Physician Decision|0|||
42246457|NCT02696031|76071457|FG000|Up to Week 52|Pregnancy|0|||
42246458|NCT02696031|76071458|FG001|Up to Week 52|Pregnancy|2|||
42246459|NCT02696031|76071459|FG002|Up to Week 52|Pregnancy|0|||
42246460|NCT02696031|76071460|FG003|Up to Week 52|Pregnancy|0|||
42246461|NCT02696031|76071461|FG004|Up to Week 52|Pregnancy|0|||
42246462|NCT02696031|76071462|FG005|Up to Week 52|Pregnancy|0|||
42246463|NCT02696031|76071457|FG000|Up to Week 52|Protocol Violation|1|||
42246464|NCT02696031|76071458|FG001|Up to Week 52|Protocol Violation|0|||
42246465|NCT02696031|76071459|FG002|Up to Week 52|Protocol Violation|0|||
42246466|NCT02696031|76071460|FG003|Up to Week 52|Protocol Violation|0|||
42246467|NCT02696031|76071461|FG004|Up to Week 52|Protocol Violation|0|||
42246468|NCT02696031|76071462|FG005|Up to Week 52|Protocol Violation|0|||
42246469|NCT02696031|76071457|FG000|Up to Week 52|Withdrawal by Subject|12|||
42246470|NCT02696031|76071458|FG001|Up to Week 52|Withdrawal by Subject|3|||
42246471|NCT02696031|76071459|FG002|Up to Week 52|Withdrawal by Subject|9|||
42246472|NCT02696031|76071460|FG003|Up to Week 52|Withdrawal by Subject|0|||
42246473|NCT02696031|76071461|FG004|Up to Week 52|Withdrawal by Subject|0|||
42246474|NCT02696031|76071462|FG005|Up to Week 52|Withdrawal by Subject|0|||
42246475|NCT02696031|76071457|FG000|Up to Week 104|Pregnancy|0|||
42246476|NCT02696031|76071458|FG001|Up to Week 104|Pregnancy|2|||
42246477|NCT02696031|76071459|FG002|Up to Week 104|Pregnancy|1|||
42246478|NCT02696031|76071460|FG003|Up to Week 104|Pregnancy|0|||
42246479|NCT02696031|76071461|FG004|Up to Week 104|Pregnancy|0|||
42246480|NCT02696031|76071462|FG005|Up to Week 104|Pregnancy|0|||
42303278|NCT02409667|76138604|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
42246481|NCT02696031|76071457|FG000|Up to Week 104|Withdrawal by Subject|15|||
42303279|NCT02409667|76138605|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
41989946|NCT03668119|75797922|FG001|Treatment|Disease Progression|55|||
42246482|NCT02696031|76071458|FG001|Up to Week 104|Withdrawal by Subject|10|||
42246483|NCT02696031|76071459|FG002|Up to Week 104|Withdrawal by Subject|16|||
42246484|NCT02696031|76071460|FG003|Up to Week 104|Withdrawal by Subject|0|||
42246485|NCT02696031|76071461|FG004|Up to Week 104|Withdrawal by Subject|0|||
42246486|NCT02696031|76071462|FG005|Up to Week 104|Withdrawal by Subject|0|||
42246487|NCT02696031|76071457|FG000|Up to Week 104|Protocol Violation|1|||
42246488|NCT02696031|76071458|FG001|Up to Week 104|Protocol Violation|0|||
42246489|NCT02696031|76071459|FG002|Up to Week 104|Protocol Violation|0|||
42246490|NCT02696031|76071460|FG003|Up to Week 104|Protocol Violation|0|||
42246491|NCT02696031|76071461|FG004|Up to Week 104|Protocol Violation|0|||
42246492|NCT02696031|76071462|FG005|Up to Week 104|Protocol Violation|0|||
42246493|NCT02696031|76071457|FG000|Up to Week 104|Physician Decision|1|||
42246494|NCT02696031|76071458|FG001|Up to Week 104|Physician Decision|2|||
42246495|NCT02696031|76071459|FG002|Up to Week 104|Physician Decision|3|||
42246496|NCT02696031|76071460|FG003|Up to Week 104|Physician Decision|0|||
42246497|NCT02696031|76071461|FG004|Up to Week 104|Physician Decision|0|||
42246498|NCT02696031|76071462|FG005|Up to Week 104|Physician Decision|0|||
42246499|NCT02696031|76071457|FG000|Up to Week 104|Lost to Follow-up|2|||
42246500|NCT02696031|76071458|FG001|Up to Week 104|Lost to Follow-up|3|||
42246501|NCT02696031|76071459|FG002|Up to Week 104|Lost to Follow-up|1|||
42246502|NCT02696031|76071460|FG003|Up to Week 104|Lost to Follow-up|0|||
42246503|NCT02696031|76071461|FG004|Up to Week 104|Lost to Follow-up|0|||
42246504|NCT02696031|76071462|FG005|Up to Week 104|Lost to Follow-up|0|||
42246505|NCT02696031|76071457|FG000|Up to Week 104|Lack of Efficacy|13|||
42246506|NCT02696031|76071458|FG001|Up to Week 104|Lack of Efficacy|12|||
42246507|NCT02696031|76071459|FG002|Up to Week 104|Lack of Efficacy|11|||
42246508|NCT02696031|76071460|FG003|Up to Week 104|Lack of Efficacy|0|||
42246509|NCT02696031|76071461|FG004|Up to Week 104|Lack of Efficacy|0|||
42246510|NCT02696031|76071462|FG005|Up to Week 104|Lack of Efficacy|0|||
42246511|NCT02696031|76071457|FG000|Up to Week 104|Adverse Event|7|||
42246512|NCT02696031|76071458|FG001|Up to Week 104|Adverse Event|11|||
42246513|NCT02696031|76071459|FG002|Up to Week 104|Adverse Event|5|||
42246514|NCT02696031|76071460|FG003|Up to Week 104|Adverse Event|0|||
42246515|NCT02696031|76071461|FG004|Up to Week 104|Adverse Event|0|||
42246516|NCT02696031|76071462|FG005|Up to Week 104|Adverse Event|0|||
42246517|NCT02696031|76071457|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
42246518|NCT02696031|76071458|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
42246519|NCT02696031|76071459|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
42246520|NCT02696031|76071460|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
42246521|NCT02696031|76071461|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
42246522|NCT02696031|76071462|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
42246523|NCT02696031|76071457|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
42246524|NCT02696031|76071458|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
41989947|NCT03668119|75797921|FG000|Treatment|Study drug toxicity|19|||
41989948|NCT03668119|75797922|FG001|Treatment|Study drug toxicity|1|||
41989949|NCT03668119|75797921|FG000|Treatment|Death|3|||
41989950|NCT03668119|75797922|FG001|Treatment|Death|0|||
42132109|NCT00487578|75942968|FG001|Overall Study|Lack of Efficacy|1|||
42132110|NCT00487578|75942967|FG000|Overall Study|Lost to Follow-up|0|||
42246525|NCT02696031|76071459|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
42246526|NCT02696031|76071460|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
42132111|NCT00487578|75942968|FG001|Overall Study|Lost to Follow-up|1|||
42132112|NCT00495612|75942976|FG000|Overall Study|Lost to Follow-up|1|||
42132113|NCT00495612|75942977|FG001|Overall Study|Lost to Follow-up|0|||
42132114|NCT00495612|75942976|FG000|Overall Study|Subject's Decision to Withdraw|3|||
42132115|NCT00495612|75942977|FG001|Overall Study|Subject's Decision to Withdraw|0|||
42132116|NCT00487188|75942985|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
42132117|NCT00487188|75942986|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
42132118|NCT00487188|75942987|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
42132119|NCT00487188|75942985|FG000|Induction Phase|Adverse Event|5|||
42132120|NCT00487188|75942986|FG001|Induction Phase|Adverse Event|0|||
42132121|NCT00487188|75942987|FG002|Induction Phase|Adverse Event|0|||
42132122|NCT00487188|75942985|FG000|Induction Phase|Lack of Efficacy|0|||
42132123|NCT00487188|75942986|FG001|Induction Phase|Lack of Efficacy|1|||
42132124|NCT00487188|75942987|FG002|Induction Phase|Lack of Efficacy|0|||
42132125|NCT00487188|75942985|FG000|Induction Phase|Protocol Violation|1|||
42132126|NCT00487188|75942986|FG001|Induction Phase|Protocol Violation|0|||
42132127|NCT00487188|75942987|FG002|Induction Phase|Protocol Violation|0|||
42132128|NCT00487188|75942985|FG000|Induction Phase|Refused Treatment|1|||
42132129|NCT00487188|75942986|FG001|Induction Phase|Refused Treatment|2|||
42132130|NCT00487188|75942987|FG002|Induction Phase|Refused Treatment|0|||
42132131|NCT00487188|75942985|FG000|Induction Phase|Lost to Follow-up|2|||
42132132|NCT00487188|75942986|FG001|Induction Phase|Lost to Follow-up|2|||
42132133|NCT00487188|75942987|FG002|Induction Phase|Lost to Follow-up|0|||
42132134|NCT00487188|75942985|FG000|Induction Phase|Administrative|0|||
42246527|NCT02696031|76071461|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
42246528|NCT02696031|76071462|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
42246529|NCT02696031|76071457|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
42246530|NCT02696031|76071458|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
42246531|NCT02696031|76071459|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
42246532|NCT02696031|76071460|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
42246533|NCT02696031|76071461|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
42246534|NCT02696031|76071462|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
42246535|NCT02696031|76071457|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
42246536|NCT02696031|76071458|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
42246537|NCT02696031|76071459|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
42246538|NCT02696031|76071460|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
42246539|NCT02696031|76071461|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
42246540|NCT02696031|76071462|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
42132135|NCT00487188|75942986|FG001|Induction Phase|Administrative|1|||
42132136|NCT00487188|75942987|FG002|Induction Phase|Administrative|0|||
42132137|NCT00487188|75942985|FG000|Maintenance Phase|Adverse Event|1|||
42132138|NCT00487188|75942986|FG001|Maintenance Phase|Adverse Event|0|||
42132139|NCT00487188|75942987|FG002|Maintenance Phase|Adverse Event|0|||
42132140|NCT00487188|75942985|FG000|Maintenance Phase|Death|1|||
42132141|NCT00487188|75942986|FG001|Maintenance Phase|Death|0|||
42246541|NCT02696031|76071457|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
42246542|NCT02696031|76071458|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
42246543|NCT02696031|76071459|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
42246544|NCT02696031|76071460|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
42246545|NCT02696031|76071461|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
42246546|NCT02696031|76071462|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
42246547|NCT02696031|76071457|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
42246548|NCT02696031|76071458|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
42246549|NCT02696031|76071459|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
42246550|NCT02696031|76071460|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
42246551|NCT02696031|76071461|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
42246552|NCT02696031|76071462|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
42246553|NCT02696031|76071457|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
42246554|NCT02696031|76071458|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
42246555|NCT02696031|76071459|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
42246556|NCT02696031|76071460|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
42246557|NCT02696031|76071461|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
42246558|NCT02696031|76071462|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
42246559|NCT00397254|76071471|FG000|Overall Study|Lost to Follow-up|2|||
42246560|NCT00397254|76071472|FG001|Overall Study|Lost to Follow-up|2|||
42246561|NCT01369641|76071476|FG000|Overall Study|Withdrawal by Subject|1|||
42246562|NCT00529152|76071480|FG000|Overall Study|Adverse Event|2|||
42246563|NCT00529152|76071480|FG000|Overall Study|Withdrawal by Subject|2|||
42246564|NCT00529152|76071480|FG000|Overall Study|Lost to Follow-up|1|||
42246565|NCT02605174|76071487|FG000|Overall Study|Adverse Event|0|||
42246566|NCT02605174|76071488|FG001|Overall Study|Adverse Event|0|||
42246567|NCT02605174|76071489|FG002|Overall Study|Adverse Event|1|||
42246568|NCT02605174|76071490|FG003|Overall Study|Adverse Event|0|||
42246569|NCT02605174|76071491|FG004|Overall Study|Adverse Event|4|||
42246570|NCT02605174|76071492|FG005|Overall Study|Adverse Event|0|||
42246571|NCT02605174|76071493|FG006|Overall Study|Adverse Event|0|||
42246572|NCT02605174|76071487|FG000|Overall Study|Lost to Follow-up|20|||
42246573|NCT02605174|76071488|FG001|Overall Study|Lost to Follow-up|7|||
42246574|NCT02605174|76071489|FG002|Overall Study|Lost to Follow-up|27|||
42246575|NCT02605174|76071490|FG003|Overall Study|Lost to Follow-up|10|||
42246576|NCT02605174|76071491|FG004|Overall Study|Lost to Follow-up|20|||
42246577|NCT02605174|76071492|FG005|Overall Study|Lost to Follow-up|10|||
42246578|NCT02605174|76071493|FG006|Overall Study|Lost to Follow-up|29|||
42246579|NCT02605174|76071487|FG000|Overall Study|Protocol Violation|10|||
42246580|NCT02605174|76071488|FG001|Overall Study|Protocol Violation|4|||
42246581|NCT02605174|76071489|FG002|Overall Study|Protocol Violation|14|||
42246582|NCT02605174|76071490|FG003|Overall Study|Protocol Violation|6|||
42246583|NCT02605174|76071491|FG004|Overall Study|Protocol Violation|7|||
42246584|NCT02605174|76071492|FG005|Overall Study|Protocol Violation|7|||
42246585|NCT02605174|76071493|FG006|Overall Study|Protocol Violation|12|||
42246586|NCT02605174|76071487|FG000|Overall Study|Pregnancy|1|||
42246587|NCT02605174|76071488|FG001|Overall Study|Pregnancy|0|||
42246588|NCT02605174|76071489|FG002|Overall Study|Pregnancy|0|||
42246589|NCT02605174|76071490|FG003|Overall Study|Pregnancy|2|||
42132142|NCT00487188|75942987|FG002|Maintenance Phase|Death|0|||
42246590|NCT02605174|76071491|FG004|Overall Study|Pregnancy|0|||
42246591|NCT02605174|76071492|FG005|Overall Study|Pregnancy|0|||
42246592|NCT02605174|76071493|FG006|Overall Study|Pregnancy|0|||
42246593|NCT02605174|76071487|FG000|Overall Study|Withdrawal by Subject|9|||
42246594|NCT02605174|76071488|FG001|Overall Study|Withdrawal by Subject|6|||
42246595|NCT02605174|76071489|FG002|Overall Study|Withdrawal by Subject|14|||
42246596|NCT02605174|76071490|FG003|Overall Study|Withdrawal by Subject|11|||
42246597|NCT02605174|76071491|FG004|Overall Study|Withdrawal by Subject|6|||
42246598|NCT02605174|76071492|FG005|Overall Study|Withdrawal by Subject|4|||
42246599|NCT02605174|76071493|FG006|Overall Study|Withdrawal by Subject|15|||
42246600|NCT02605174|76071487|FG000|Overall Study|Physician Decision|2|||
42246601|NCT02605174|76071488|FG001|Overall Study|Physician Decision|0|||
42246602|NCT02605174|76071489|FG002|Overall Study|Physician Decision|0|||
42246603|NCT02605174|76071490|FG003|Overall Study|Physician Decision|0|||
42246604|NCT02605174|76071491|FG004|Overall Study|Physician Decision|0|||
42246605|NCT02605174|76071492|FG005|Overall Study|Physician Decision|0|||
42246606|NCT02605174|76071493|FG006|Overall Study|Physician Decision|3|||
42246607|NCT02605174|76071487|FG000|Overall Study|Randomization Failure|22|||
42246608|NCT02605174|76071488|FG001|Overall Study|Randomization Failure|6|||
42246609|NCT02605174|76071489|FG002|Overall Study|Randomization Failure|20|||
42246610|NCT02605174|76071490|FG003|Overall Study|Randomization Failure|7|||
42246611|NCT02605174|76071491|FG004|Overall Study|Randomization Failure|16|||
42246612|NCT02605174|76071492|FG005|Overall Study|Randomization Failure|11|||
42246613|NCT02605174|76071493|FG006|Overall Study|Randomization Failure|30|||
42246614|NCT02604550|76071521|FG000|Overall Study|Lost to Follow-up|7|||
42246615|NCT02604550|76071522|FG001|Overall Study|Lost to Follow-up|6|||
42246616|NCT02604550|76071521|FG000|Overall Study|Withdrawal by Subject|0|||
42246617|NCT02604550|76071522|FG001|Overall Study|Withdrawal by Subject|1|||
42246618|NCT02604550|76071521|FG000|Overall Study|Incomplete data using paper journal|18|||
42246619|NCT02604550|76071522|FG001|Overall Study|Incomplete data using paper journal|19|||
42246620|NCT02591290|76071528|FG000|Overall Study|Withdrawal by Subject|2|||
42246621|NCT02791893|76071534|FG000|Blinded Phase|Lost to Follow-up|2|||
42246622|NCT02791893|76071535|FG001|Blinded Phase|Lost to Follow-up|2|||
42246623|NCT02791893|76071534|FG000|Blinded Phase|Withdrawal by Subject|1|||
42246624|NCT02791893|76071535|FG001|Blinded Phase|Withdrawal by Subject|2|||
42246625|NCT02791893|76071534|FG000|Open Label Phase|Lost to Follow-up|3|||
42246626|NCT02791893|76071535|FG001|Open Label Phase|Lost to Follow-up|0|||
42246627|NCT02791893|76071534|FG000|Open Label Phase|Withdrawal by Subject|0|||
42246628|NCT02791893|76071535|FG001|Open Label Phase|Withdrawal by Subject|2|||
42246629|NCT00120042|76071544|FG000|Overall Study|all completed protocl|0|||
42246630|NCT00120042|76071545|FG001|Overall Study|all completed protocl|0|||
42246631|NCT00120042|76071546|FG002|Overall Study|all completed protocl|0|||
42246632|NCT02476851|76071553|FG000|Overall Study|Protocol Violation|1|||
42246633|NCT02476851|76071554|FG001|Overall Study|Protocol Violation|1|||
42246634|NCT02595970|76071560|FG000|Overall Study|Withdrawal by Subject|2|||
42246635|NCT02595970|76071560|FG000|Overall Study|Physician Decision|2|||
42246636|NCT02595970|76071560|FG000|Overall Study|Protocol Violation|4|||
42246637|NCT02595970|76071560|FG000|Overall Study|Adverse Event|5|||
42246638|NCT02595970|76071560|FG000|Overall Study|Lack of Efficacy|7|||
42246639|NCT01866111|76071568|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
42246640|NCT01866111|76071569|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
42246641|NCT01866111|76071570|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
42246642|NCT01866111|76071571|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
42246643|NCT01866111|76071568|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
42246644|NCT01866111|76071569|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
42246645|NCT01866111|76071570|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
42246646|NCT01866111|76071571|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
42246647|NCT02595502|76071581|FG000|Period 1|Adverse Event|0|||
42246648|NCT02595502|76071582|FG001|Period 1|Adverse Event|1|||
42246649|NCT02595502|76071581|FG000|Period 1|Withdrawal by Subject|1|||
42246650|NCT02595502|76071582|FG001|Period 1|Withdrawal by Subject|0|||
42246651|NCT02595502|76071581|FG000|Period 1|Lost to Follow-up|0|||
42246652|NCT02595502|76071582|FG001|Period 1|Lost to Follow-up|1|||
42246653|NCT02595502|76071581|FG000|Period 2|Adverse Event|1|||
42246654|NCT02595502|76071582|FG001|Period 2|Adverse Event|1|||
42246655|NCT02595502|76071581|FG000|Period 2|Received incorrect lens at Period 1|0|||
41989951|NCT03668119|75797921|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
42246656|NCT02595502|76071582|FG001|Period 2|Received incorrect lens at Period 1|1|||
42246657|NCT02595502|76071581|FG000|Period 3|Protocol Violation|0|||
42246658|NCT02595502|76071582|FG001|Period 3|Protocol Violation|1|||
42132143|NCT00487188|75942985|FG000|Maintenance Phase|Lost to Follow-up|1|||
42132144|NCT00487188|75942986|FG001|Maintenance Phase|Lost to Follow-up|0|||
42132145|NCT00487188|75942987|FG002|Maintenance Phase|Lost to Follow-up|0|||
42246659|NCT02595502|76071581|FG000|Period 3|Lost to Follow-up|1|||
42246660|NCT02595502|76071582|FG001|Period 3|Lost to Follow-up|0|||
42246661|NCT02595502|76071581|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
42246662|NCT02595502|76071582|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
42246663|NCT01369329|76071591|FG000|Overall Study|Withdrawal by Subject|8|||
42246664|NCT01369329|76071592|FG001|Overall Study|Withdrawal by Subject|6|||
42246665|NCT01369329|76071593|FG002|Overall Study|Withdrawal by Subject|10|||
42246666|NCT01369329|76071591|FG000|Overall Study|Lost to Follow-up|2|||
42246667|NCT01369329|76071592|FG001|Overall Study|Lost to Follow-up|2|||
42246668|NCT01369329|76071593|FG002|Overall Study|Lost to Follow-up|2|||
42246669|NCT01369329|76071591|FG000|Overall Study|Other|2|||
42246670|NCT01369329|76071592|FG001|Overall Study|Other|3|||
42132146|NCT00487188|75942985|FG000|Maintenance Phase|Administrative|0|||
42132147|NCT00487188|75942986|FG001|Maintenance Phase|Administrative|0|||
42132148|NCT00487188|75942987|FG002|Maintenance Phase|Administrative|1|||
42132149|NCT00509366|75943008|FG000|Overall Study|Not Treated (Screen Failure)|1|||
42246671|NCT01369329|76071593|FG002|Overall Study|Other|2|||
42246672|NCT02791659|76071603|FG000|Overall Study|Protocol Violation|0|||
42246673|NCT02791659|76071604|FG001|Overall Study|Protocol Violation|1|||
42246674|NCT02594098|76071612|FG000|Overall Study|Lack of Efficacy|17|||
42246675|NCT02594098|76071613|FG001|Overall Study|Lack of Efficacy|6|||
42246676|NCT02594098|76071612|FG000|Overall Study|Withdrawal by Subject|1|||
42246677|NCT02594098|76071613|FG001|Overall Study|Withdrawal by Subject|3|||
42246678|NCT02594098|76071612|FG000|Overall Study|Terminated participation|6|||
42246679|NCT02594098|76071613|FG001|Overall Study|Terminated participation|2|||
42246680|NCT02594098|76071612|FG000|Overall Study|Seek alternative treatment|2|||
42246681|NCT02594098|76071613|FG001|Overall Study|Seek alternative treatment|1|||
42246682|NCT02594098|76071612|FG000|Overall Study|Other|0|||
42246683|NCT02594098|76071613|FG001|Overall Study|Other|1|||
42246684|NCT02593864|76071621|FG000|Overall Study|Withdrawal by Subject|3|||
42246685|NCT02593864|76071621|FG000|Overall Study|Lost to Follow-up|3|||
42246686|NCT02590588|76071625|FG000|Overall Study|Adverse Event|1|||
42246687|NCT01434602|76071634|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
42246688|NCT01434602|76071635|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
42246689|NCT01434602|76071636|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
42246690|NCT01434602|76071637|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
42246691|NCT01434602|76071638|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
42246692|NCT01434602|76071634|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
42246693|NCT01434602|76071635|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
42246694|NCT01434602|76071636|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
42246695|NCT01434602|76071637|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
42246696|NCT01434602|76071638|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
42246697|NCT01434602|76071634|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
42246698|NCT01434602|76071635|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
42246699|NCT01434602|76071636|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
42246700|NCT01434602|76071637|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
42246701|NCT01434602|76071638|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
42246702|NCT01434602|76071634|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
42246703|NCT01434602|76071635|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
42246704|NCT01434602|76071636|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
42246705|NCT01434602|76071637|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
42246706|NCT01434602|76071638|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
42132150|NCT00509366|75943009|FG001|Overall Study|Not Treated (Screen Failure)|1|||
42132151|NCT00509366|75943010|FG002|Overall Study|Not Treated (Screen Failure)|1|||
42132152|NCT00509366|75943011|FG003|Overall Study|Not Treated (Screen Failure)|0|||
42132153|NCT00509366|75943012|FG004|Overall Study|Not Treated (Screen Failure)|0|||
42246707|NCT01434602|76071634|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
42246708|NCT01434602|76071635|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
42246709|NCT01434602|76071636|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
42246710|NCT01434602|76071637|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
42246711|NCT01434602|76071638|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
42246712|NCT01434602|76071634|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
42246713|NCT01434602|76071635|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
42246714|NCT01434602|76071636|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
42246715|NCT01434602|76071637|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
42246716|NCT01434602|76071638|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
42246717|NCT01434602|76071634|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
42246718|NCT01434602|76071635|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
42246719|NCT01434602|76071636|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
42246720|NCT01434602|76071637|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
42246721|NCT01434602|76071638|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
42246722|NCT01434602|76071634|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
42246723|NCT01434602|76071635|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
42246724|NCT01434602|76071636|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
42246725|NCT01434602|76071637|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
42246726|NCT01434602|76071638|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
42246727|NCT01434602|76071634|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
42246728|NCT01434602|76071635|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
42246729|NCT01434602|76071636|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
42246730|NCT01434602|76071637|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
42246731|NCT01434602|76071638|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
42246732|NCT01434602|76071634|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
42246733|NCT01434602|76071635|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
42246734|NCT01434602|76071636|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
42246735|NCT01434602|76071637|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
42246736|NCT01434602|76071638|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
42246737|NCT01767129|76071660|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
42246738|NCT01767129|76071661|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
42246739|NCT02791269|76071670|FG000|Overall Study|Lost to Follow-up|0|||
42246740|NCT02791269|76071671|FG001|Overall Study|Lost to Follow-up|1|||
42246741|NCT02696564|76071681|FG000|Overall Study|Death|1|||
42246742|NCT02696564|76071682|FG001|Overall Study|Death|2|||
42246743|NCT02696564|76071681|FG000|Overall Study|Withdrawal by Subject|3|||
42246744|NCT02696564|76071682|FG001|Overall Study|Withdrawal by Subject|2|||
42246745|NCT02696564|76071681|FG000|Overall Study|Lost to Follow-up|3|||
42246746|NCT02696564|76071682|FG001|Overall Study|Lost to Follow-up|3|||
42246747|NCT02696564|76071681|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
42246748|NCT02696564|76071682|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
42246749|NCT02696564|76071681|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
42246750|NCT02696564|76071682|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
42246751|NCT02696564|76071681|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
42246752|NCT02696564|76071682|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
42246753|NCT02696564|76071681|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
42246754|NCT02696564|76071682|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
42246755|NCT02696564|76071681|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
42246756|NCT02696564|76071682|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
42246757|NCT02640950|76071688|FG000|Overall Study|Adverse Event|1|||
42246758|NCT02640950|76071688|FG000|Overall Study|Withdrawal by Subject|1|||
42246759|NCT02593786|76071696|FG000|Overall Study|Disease progression|12|||
42246760|NCT02593786|76071697|FG001|Overall Study|Disease progression|16|||
42246761|NCT02593786|76071698|FG002|Overall Study|Disease progression|10|||
42246762|NCT02593786|76071699|FG003|Overall Study|Disease progression|7|||
42246763|NCT02593786|76071696|FG000|Overall Study|Study drug toxicity|1|||
42246764|NCT02593786|76071697|FG001|Overall Study|Study drug toxicity|0|||
42246765|NCT02593786|76071698|FG002|Overall Study|Study drug toxicity|0|||
42246766|NCT02593786|76071699|FG003|Overall Study|Study drug toxicity|0|||
42246767|NCT02593786|76071696|FG000|Overall Study|Adverse event unrelated to study drug|1|||
42246768|NCT02593786|76071697|FG001|Overall Study|Adverse event unrelated to study drug|1|||
42246769|NCT02593786|76071698|FG002|Overall Study|Adverse event unrelated to study drug|1|||
42246770|NCT02593786|76071699|FG003|Overall Study|Adverse event unrelated to study drug|0|||
42246771|NCT02593786|76071696|FG000|Overall Study|Participant request to discontinue study therapy|0|||
42246772|NCT02593786|76071697|FG001|Overall Study|Participant request to discontinue study therapy|2|||
42246773|NCT02593786|76071698|FG002|Overall Study|Participant request to discontinue study therapy|0|||
42246774|NCT02593786|76071699|FG003|Overall Study|Participant request to discontinue study therapy|0|||
42246775|NCT02593786|76071696|FG000|Overall Study|Other reasons|1|||
42246776|NCT02593786|76071697|FG001|Overall Study|Other reasons|1|||
42246777|NCT02593786|76071698|FG002|Overall Study|Other reasons|0|||
42246778|NCT02593786|76071699|FG003|Overall Study|Other reasons|5|||
42246779|NCT04829331|76071721|FG000|Overall Study|Lost to Follow-up|1|||
42246780|NCT04829331|76071722|FG001|Overall Study|Lost to Follow-up|0|||
42246781|NCT04602546|76071737|FG000|Overall Study|Training|2|||
42246782|NCT04602546|76071738|FG001|Overall Study|Training|2|||
42246783|NCT04602546|76071739|FG002|Overall Study|Training|1|||
42246784|NCT04602546|76071740|FG003|Overall Study|Training|2|||
42246785|NCT04602546|76071741|FG004|Overall Study|Training|0|||
42246786|NCT04602546|76071737|FG000|Overall Study|Randomized with disqualified data|2|||
42246787|NCT04602546|76071738|FG001|Overall Study|Randomized with disqualified data|0|||
42246788|NCT04602546|76071739|FG002|Overall Study|Randomized with disqualified data|2|||
42246789|NCT04602546|76071740|FG003|Overall Study|Randomized with disqualified data|5|||
42246790|NCT04602546|76071741|FG004|Overall Study|Randomized with disqualified data|3|||
42246791|NCT04004988|76071801|FG000|Period 1|Physician Decision|2|||
42246792|NCT04004988|76071802|FG001|Period 1|Physician Decision|0|||
42246793|NCT04004988|76071801|FG000|Period 1|Withdrawal by Subject|0|||
42246794|NCT04004988|76071802|FG001|Period 1|Withdrawal by Subject|1|||
42246795|NCT04004988|76071801|FG000|Period 1|Adverse Event|1|||
42246796|NCT04004988|76071802|FG001|Period 1|Adverse Event|2|||
42246797|NCT03898700|76071809|FG000|Overall Study|Withdrawal by Subject|2|||
42246798|NCT03586973|76071824|FG000|Overall Study|Death|15|||
42246799|NCT03586973|76071825|FG001|Overall Study|Death|8|||
42246800|NCT03586973|76071824|FG000|Overall Study|Site Terminated by Sponsor|3|||
42246801|NCT03586973|76071825|FG001|Overall Study|Site Terminated by Sponsor|6|||
42246802|NCT03586973|76071824|FG000|Overall Study|Withdrawal by Subject|1|||
42246803|NCT03586973|76071825|FG001|Overall Study|Withdrawal by Subject|0|||
42246804|NCT03586973|76071824|FG000|Overall Study|Lost to Follow-up|1|||
42246805|NCT03586973|76071825|FG001|Overall Study|Lost to Follow-up|0|||
42246806|NCT02669212|76071833|FG000|Overall Study|Lost to Follow-up|1|||
42246807|NCT02669212|76071834|FG001|Overall Study|Lost to Follow-up|0|||
42246808|NCT02669212|76071833|FG000|Overall Study|Medical Condition|3|||
42246809|NCT02669212|76071834|FG001|Overall Study|Medical Condition|4|||
42246810|NCT02669212|76071833|FG000|Overall Study|Withdrawal by Subject|0|||
42246811|NCT02669212|76071834|FG001|Overall Study|Withdrawal by Subject|2|||
42246812|NCT02669212|76071833|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
42246813|NCT02669212|76071834|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
42246814|NCT02536664|76071856|FG000|Overall Study|Inadequate completion of documentation|2|||
42246815|NCT02536664|76071857|FG001|Overall Study|Inadequate completion of documentation|4|||
42246816|NCT02536664|76071856|FG000|Overall Study|Progression|13|||
42246817|NCT02536664|76071857|FG001|Overall Study|Progression|18|||
42246818|NCT02536664|76071856|FG000|Overall Study|Death due to lymphoma|2|||
42246819|NCT02536664|76071857|FG001|Overall Study|Death due to lymphoma|1|||
42246820|NCT02536664|76071856|FG000|Overall Study|Death due to other reason|3|||
42246821|NCT02536664|76071857|FG001|Overall Study|Death due to other reason|2|||
42246822|NCT02536664|76071856|FG000|Overall Study|Intolerability|8|||
42246823|NCT02536664|76071857|FG001|Overall Study|Intolerability|6|||
42246824|NCT02536664|76071856|FG000|Overall Study|Withdrawal by Subject|8|||
42246825|NCT02536664|76071857|FG001|Overall Study|Withdrawal by Subject|5|||
42246826|NCT02536664|76071856|FG000|Overall Study|Other|18|||
42246827|NCT02536664|76071857|FG001|Overall Study|Other|24|||
42246828|NCT02536664|76071856|FG000|Overall Study|Missing|53|||
42303280|NCT02409667|76138606|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
42246829|NCT02536664|76071857|FG001|Overall Study|Missing|20|||
42246830|NCT02426892|76071863|FG000|Overall Study|Adverse Event|2|||
42246831|NCT02426892|76071863|FG000|Overall Study|Lack of Efficacy|17|||
42246832|NCT02426892|76071863|FG000|Overall Study|Withdrawal by Subject|1|||
42246833|NCT02312687|76071867|FG000|Overall Study|Other, Not Specified|1|||
42246834|NCT02304367|76071871|FG000|Overall Study|Lack of Response to Bruosumab|1|||
42246835|NCT02304367|76071871|FG000|Overall Study|Sponsor Decision|3|||
42246836|NCT02304367|76071871|FG000|Overall Study|Death|2|||
42246837|NCT02304367|76071871|FG000|Overall Study|Physician Decision|1|||
42246838|NCT02304367|76071871|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
42246839|NCT02054520|76071888|FG000|Overall Study|Adverse Event|1|||
42246840|NCT02054520|76071889|FG001|Overall Study|Adverse Event|4|||
42246841|NCT02054520|76071890|FG002|Overall Study|Adverse Event|2|||
42246842|NCT02054520|76071891|FG003|Overall Study|Adverse Event|1|||
42246843|NCT02054520|76071892|FG004|Overall Study|Adverse Event|1|||
42246844|NCT02054520|76071893|FG005|Overall Study|Adverse Event|0|||
42246845|NCT02054520|76071888|FG000|Overall Study|Lack of Efficacy|7|||
42246846|NCT02054520|76071889|FG001|Overall Study|Lack of Efficacy|0|||
42246847|NCT02054520|76071890|FG002|Overall Study|Lack of Efficacy|2|||
42246848|NCT02054520|76071891|FG003|Overall Study|Lack of Efficacy|1|||
42246849|NCT02054520|76071892|FG004|Overall Study|Lack of Efficacy|3|||
42246850|NCT02054520|76071893|FG005|Overall Study|Lack of Efficacy|2|||
42246851|NCT02054520|76071888|FG000|Overall Study|Withdrawal by Subject|1|||
42246852|NCT02054520|76071889|FG001|Overall Study|Withdrawal by Subject|0|||
42246853|NCT02054520|76071890|FG002|Overall Study|Withdrawal by Subject|0|||
42246854|NCT02054520|76071891|FG003|Overall Study|Withdrawal by Subject|2|||
42246855|NCT02054520|76071892|FG004|Overall Study|Withdrawal by Subject|1|||
42246856|NCT02054520|76071893|FG005|Overall Study|Withdrawal by Subject|0|||
42246857|NCT02054520|76071888|FG000|Overall Study|Physician Decision|0|||
42246858|NCT02054520|76071889|FG001|Overall Study|Physician Decision|1|||
42246859|NCT02054520|76071890|FG002|Overall Study|Physician Decision|0|||
42246860|NCT02054520|76071891|FG003|Overall Study|Physician Decision|1|||
42246861|NCT02054520|76071892|FG004|Overall Study|Physician Decision|0|||
42246862|NCT02054520|76071893|FG005|Overall Study|Physician Decision|1|||
42246863|NCT02054520|76071888|FG000|Overall Study|Study terminated by Sponsor|0|||
42246864|NCT02054520|76071889|FG001|Overall Study|Study terminated by Sponsor|0|||
42246865|NCT02054520|76071890|FG002|Overall Study|Study terminated by Sponsor|2|||
42246866|NCT02054520|76071891|FG003|Overall Study|Study terminated by Sponsor|1|||
42246867|NCT02054520|76071892|FG004|Overall Study|Study terminated by Sponsor|0|||
42246868|NCT02054520|76071893|FG005|Overall Study|Study terminated by Sponsor|0|||
42246869|NCT01546987|76071922|FG000|Overall Study|Protocol Violation|3|||
42246870|NCT01546987|76071923|FG001|Overall Study|Protocol Violation|4|||
42246871|NCT00261443|76071931|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
42246872|NCT00261443|76071932|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
42246873|NCT00261443|76071933|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
42246874|NCT00261443|76071931|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
42246875|NCT00261443|76071932|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
42246876|NCT00261443|76071933|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
42246877|NCT00261443|76071931|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
42246878|NCT00261443|76071932|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
42246879|NCT00261443|76071933|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
42246880|NCT00261443|76071931|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
42246881|NCT00261443|76071932|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
42246882|NCT00261443|76071933|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
42246883|NCT00261443|76071931|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
42246884|NCT00261443|76071932|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
42246885|NCT00261443|76071933|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
42246886|NCT00261443|76071931|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
42246887|NCT00261443|76071932|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
42246888|NCT00261443|76071933|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
42246889|NCT00261443|76071931|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
42246890|NCT00261443|76071932|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
42246891|NCT00261443|76071933|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
42246892|NCT00261443|76071931|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
42246893|NCT00261443|76071932|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
42246894|NCT00261443|76071933|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
42246895|NCT00261443|76071931|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
42246896|NCT00261443|76071932|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
42246897|NCT00261443|76071933|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
42246898|NCT00261443|76071931|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
42132154|NCT00500318|75943024|FG000|Overall Study|Adverse Event|3|||
42246899|NCT00261443|76071932|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
42246900|NCT00261443|76071933|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
42246901|NCT00261443|76071931|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
42246902|NCT00261443|76071932|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
42246903|NCT00261443|76071933|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
42246904|NCT00261443|76071931|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
42246905|NCT00261443|76071932|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
42246906|NCT00261443|76071933|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
42246907|NCT00261443|76071931|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
42246908|NCT00261443|76071932|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
42246909|NCT00261443|76071933|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
42246910|NCT00261443|76071931|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
42246911|NCT00261443|76071932|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
42246912|NCT00261443|76071933|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
42246913|NCT00261443|76071931|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
42246914|NCT00261443|76071932|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
42246915|NCT00261443|76071933|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
42246916|NCT00261443|76071931|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
42246917|NCT00261443|76071932|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
42246918|NCT00261443|76071933|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
42246919|NCT00261443|76071931|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
42246920|NCT00261443|76071932|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
42246921|NCT00261443|76071933|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
42246922|NCT00261443|76071931|FG000|3: Assessment of Relapse|Adverse Event|0|||
42246923|NCT00261443|76071932|FG001|3: Assessment of Relapse|Adverse Event|15|||
42246924|NCT00261443|76071933|FG002|3: Assessment of Relapse|Adverse Event|19|||
42246925|NCT00261443|76071931|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
42246926|NCT00261443|76071932|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
42246927|NCT00261443|76071933|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
42246928|NCT00261443|76071931|FG000|3: Assessment of Relapse|Death|0|||
42246929|NCT00261443|76071932|FG001|3: Assessment of Relapse|Death|0|||
42246930|NCT00261443|76071933|FG002|3: Assessment of Relapse|Death|1|||
42246931|NCT00261443|76071931|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
42246932|NCT00261443|76071932|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
42246933|NCT00261443|76071933|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
42246934|NCT00261443|76071931|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
42246935|NCT00261443|76071932|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
42246936|NCT00261443|76071933|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
42246937|NCT00261443|76071931|FG000|3: Assessment of Relapse|Pregnancy|0|||
42246938|NCT00261443|76071932|FG001|3: Assessment of Relapse|Pregnancy|2|||
42246939|NCT00261443|76071933|FG002|3: Assessment of Relapse|Pregnancy|1|||
42246940|NCT00261443|76071931|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
42246941|NCT00261443|76071932|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
42246942|NCT00261443|76071933|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
42246943|NCT00261443|76071931|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
42246944|NCT00261443|76071932|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
42246945|NCT00261443|76071933|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
42246946|NCT00261443|76071931|FG000|3: Assessment of Relapse|Other Reasons|0|||
42246947|NCT00261443|76071932|FG001|3: Assessment of Relapse|Other Reasons|4|||
42246948|NCT00261443|76071933|FG002|3: Assessment of Relapse|Other Reasons|3|||
42246949|NCT00261443|76071931|FG000|4: Extension Phase|Adverse Event|0|||
42246950|NCT00261443|76071932|FG001|4: Extension Phase|Adverse Event|1|||
42246951|NCT00261443|76071933|FG002|4: Extension Phase|Adverse Event|0|||
42246952|NCT00261443|76071931|FG000|4: Extension Phase|Withdrawal by Subject|0|||
42246953|NCT00261443|76071932|FG001|4: Extension Phase|Withdrawal by Subject|1|||
42246954|NCT00261443|76071933|FG002|4: Extension Phase|Withdrawal by Subject|2|||
42246955|NCT00261443|76071931|FG000|4: Extension Phase|Lost to Follow-up|0|||
42246956|NCT00261443|76071932|FG001|4: Extension Phase|Lost to Follow-up|1|||
42246957|NCT00261443|76071933|FG002|4: Extension Phase|Lost to Follow-up|0|||
42246958|NCT02593318|76071950|FG000|Overall Study|Withdrawal by Subject|1|||
42246959|NCT02593318|76071951|FG001|Overall Study|Withdrawal by Subject|1|||
42246960|NCT02343302|76071965|FG000|Overall Study|Physician Decision|1|||
42246961|NCT02343302|76071966|FG001|Overall Study|Physician Decision|1|||
42246962|NCT02590432|76071974|FG000|Open-label Treatment Period|Adverse Event|97|||
42246963|NCT02590432|76071975|FG001|Open-label Treatment Period|Adverse Event|79|||
42246964|NCT02590432|76071976|FG002|Open-label Treatment Period|Adverse Event|0|||
42246965|NCT02590432|76071977|FG003|Open-label Treatment Period|Adverse Event|0|||
42246966|NCT02590432|76071978|FG004|Open-label Treatment Period|Adverse Event|0|||
42246967|NCT02590432|76071979|FG005|Open-label Treatment Period|Adverse Event|0|||
42246968|NCT02590432|76071980|FG006|Open-label Treatment Period|Adverse Event|0|||
42246969|NCT02590432|76071981|FG007|Open-label Treatment Period|Adverse Event|0|||
42246970|NCT02590432|76071982|FG008|Open-label Treatment Period|Adverse Event|0|||
42246971|NCT02590432|76071974|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
42246972|NCT02590432|76071975|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
42246973|NCT02590432|76071976|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
42246974|NCT02590432|76071977|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
42246975|NCT02590432|76071978|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
42246976|NCT02590432|76071979|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
42246977|NCT02590432|76071980|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
42246978|NCT02590432|76071981|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
42246979|NCT02590432|76071982|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
42246980|NCT02590432|76071974|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
42246981|NCT02590432|76071975|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
42246982|NCT02590432|76071976|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
42246983|NCT02590432|76071977|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
42246984|NCT02590432|76071978|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
42246985|NCT02590432|76071979|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
42246986|NCT02590432|76071980|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
42246987|NCT02590432|76071981|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
42246988|NCT02590432|76071982|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
42246989|NCT02590432|76071974|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
42246990|NCT02590432|76071975|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
42246991|NCT02590432|76071976|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
42246992|NCT02590432|76071977|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
42246993|NCT02590432|76071978|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
42246994|NCT02590432|76071979|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
42246995|NCT02590432|76071980|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
42246996|NCT02590432|76071981|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
42246997|NCT02590432|76071982|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
42246998|NCT02590432|76071974|FG000|Open-label Treatment Period|Protocol Violation|10|||
42246999|NCT02590432|76071975|FG001|Open-label Treatment Period|Protocol Violation|4|||
42247000|NCT02590432|76071976|FG002|Open-label Treatment Period|Protocol Violation|0|||
42247001|NCT02590432|76071977|FG003|Open-label Treatment Period|Protocol Violation|0|||
42247002|NCT02590432|76071978|FG004|Open-label Treatment Period|Protocol Violation|0|||
42247003|NCT02590432|76071979|FG005|Open-label Treatment Period|Protocol Violation|0|||
42132155|NCT00500318|75943025|FG001|Overall Study|Adverse Event|8|||
42247004|NCT02590432|76071980|FG006|Open-label Treatment Period|Protocol Violation|0|||
42247005|NCT02590432|76071981|FG007|Open-label Treatment Period|Protocol Violation|0|||
42247006|NCT02590432|76071982|FG008|Open-label Treatment Period|Protocol Violation|0|||
42247007|NCT02590432|76071974|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
42247008|NCT02590432|76071975|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
42247009|NCT02590432|76071976|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
42247010|NCT02590432|76071977|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
42247011|NCT02590432|76071978|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
42247012|NCT02590432|76071979|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
42247013|NCT02590432|76071980|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
42247014|NCT02590432|76071981|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
42247015|NCT02590432|76071982|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
42247016|NCT02590432|76071974|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
42247017|NCT02590432|76071975|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
42247018|NCT02590432|76071976|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
42247019|NCT02590432|76071977|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
42247020|NCT02590432|76071978|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
42247021|NCT02590432|76071979|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
42247022|NCT02590432|76071980|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
42247023|NCT02590432|76071981|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
42247024|NCT02590432|76071982|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
42247025|NCT02590432|76071974|FG000|Double-blind Treatment Period|Adverse Event|0|||
42247026|NCT02590432|76071975|FG001|Double-blind Treatment Period|Adverse Event|0|||
42247027|NCT02590432|76071976|FG002|Double-blind Treatment Period|Adverse Event|14|||
42247028|NCT02590432|76071977|FG003|Double-blind Treatment Period|Adverse Event|12|||
42247029|NCT02590432|76071978|FG004|Double-blind Treatment Period|Adverse Event|6|||
42247030|NCT02590432|76071979|FG005|Double-blind Treatment Period|Adverse Event|22|||
42247031|NCT02590432|76071980|FG006|Double-blind Treatment Period|Adverse Event|20|||
42247032|NCT02590432|76071981|FG007|Double-blind Treatment Period|Adverse Event|0|||
42247033|NCT02590432|76071982|FG008|Double-blind Treatment Period|Adverse Event|0|||
42247034|NCT02590432|76071974|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
42247035|NCT02590432|76071975|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
42247036|NCT02590432|76071976|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
42247037|NCT02590432|76071977|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
42247038|NCT02590432|76071978|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
42247039|NCT02590432|76071979|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
42247040|NCT02590432|76071980|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
42247041|NCT02590432|76071981|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
42247042|NCT02590432|76071982|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
42247043|NCT02590432|76071974|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
42247044|NCT02590432|76071975|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
42247045|NCT02590432|76071976|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
42247046|NCT02590432|76071977|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
42247047|NCT02590432|76071978|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
42247048|NCT02590432|76071979|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
42247049|NCT02590432|76071980|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
42247050|NCT02590432|76071981|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
42247051|NCT02590432|76071982|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
42247052|NCT02590432|76071974|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
42247053|NCT02590432|76071975|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
42247054|NCT02590432|76071976|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
42247055|NCT02590432|76071977|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
42247056|NCT02590432|76071978|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
42247057|NCT02590432|76071979|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
42247058|NCT02590432|76071980|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
42247059|NCT02590432|76071981|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
42247060|NCT02590432|76071982|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
42247061|NCT02590432|76071974|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
42247062|NCT02590432|76071975|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
42247063|NCT02590432|76071976|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
42247064|NCT02590432|76071977|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
42247065|NCT02590432|76071978|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
42247066|NCT02590432|76071979|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
42247067|NCT02590432|76071980|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
42247068|NCT02590432|76071981|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
42247069|NCT02590432|76071982|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
42247070|NCT02590432|76071974|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
42247071|NCT02590432|76071975|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
42247072|NCT02590432|76071976|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
42247073|NCT02590432|76071977|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
42247074|NCT02590432|76071978|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
42247075|NCT02590432|76071979|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
42247076|NCT02590432|76071980|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
42247077|NCT02590432|76071981|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
42247078|NCT02590432|76071982|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
42247079|NCT02590432|76071974|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
42247080|NCT02590432|76071975|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
42247081|NCT02590432|76071976|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
42247082|NCT02590432|76071977|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
42247083|NCT02590432|76071978|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
42247084|NCT02590432|76071979|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
42247085|NCT02590432|76071980|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
42247086|NCT02590432|76071981|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
42247087|NCT02590432|76071982|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
42247088|NCT02590432|76071974|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
42247089|NCT02590432|76071975|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
42247090|NCT02590432|76071976|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
42247091|NCT02590432|76071977|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
42247092|NCT02590432|76071978|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
42247093|NCT02590432|76071979|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
42247094|NCT02590432|76071980|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
42247095|NCT02590432|76071981|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
42247096|NCT02590432|76071982|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
42247097|NCT02590432|76071974|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
42247098|NCT02590432|76071975|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
42132156|NCT00500318|75943024|FG000|Overall Study|Protocol Violation|1|||
42132157|NCT00500318|75943025|FG001|Overall Study|Protocol Violation|3|||
42247099|NCT02590432|76071976|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
42247100|NCT02590432|76071977|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
42247101|NCT02590432|76071978|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
42247102|NCT02590432|76071979|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
42247103|NCT02590432|76071980|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
42247104|NCT02590432|76071981|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
42247105|NCT02590432|76071982|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
42247106|NCT02590432|76071974|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
42247107|NCT02590432|76071975|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
42247108|NCT02590432|76071976|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
42247109|NCT02590432|76071977|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
42247110|NCT02590432|76071978|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
42247111|NCT02590432|76071979|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
42247112|NCT02590432|76071980|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
42247113|NCT02590432|76071981|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
42247114|NCT02590432|76071982|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
42247115|NCT02590432|76071974|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
42247116|NCT02590432|76071975|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
42247117|NCT02590432|76071976|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
42247118|NCT02590432|76071977|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
42247119|NCT02590432|76071978|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
42247120|NCT02590432|76071979|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
42247121|NCT02590432|76071980|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
42247122|NCT02590432|76071981|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
42247123|NCT02590432|76071982|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
42247124|NCT02590432|76071974|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
42247125|NCT02590432|76071975|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
42247126|NCT02590432|76071976|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
42247127|NCT02590432|76071977|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
42247128|NCT02590432|76071978|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
42247129|NCT02590432|76071979|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
42247130|NCT02590432|76071980|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
42247131|NCT02590432|76071981|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
42247132|NCT02590432|76071982|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
42247133|NCT02590354|76071994|FG000|Phase 1|Active hepatitis B or C infection|1|||
42247134|NCT02590354|76071994|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
42247135|NCT02590354|76071994|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
42247136|NCT02590354|76071994|FG000|Phase 1|Subject does not want to participate|20|||
42247137|NCT02590354|76071994|FG000|Phase 1|Lost to Follow-up|1|||
42247138|NCT02590354|76071994|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
42247139|NCT01667224|76072001|FG000|Overall Study|Withdrawal by Subject|3|||
42247140|NCT01667224|76072002|FG001|Overall Study|Withdrawal by Subject|1|||
42247141|NCT01667224|76072001|FG000|Overall Study|Protocol Violation|1|||
42247142|NCT01667224|76072002|FG001|Overall Study|Protocol Violation|1|||
42247143|NCT03923738|76072010|FG000|Period 1|Adverse Event|1|||
42247144|NCT03923738|76072010|FG000|Period 1|Withdrawal by Subject|1|||
42247145|NCT02588248|76072018|FG000|Overall Study|Physician Decision|4|||
42247146|NCT02588248|76072019|FG001|Overall Study|Physician Decision|3|||
42247147|NCT01328054|76072030|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
42247148|NCT01328054|76072031|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
42247149|NCT01328054|76072030|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
42247150|NCT01328054|76072031|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
42247151|NCT01328054|76072030|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
42272686|NCT00857285|76103028|FG000|Overall Study|Adverse Event|4|||
42303281|NCT02409667|76138607|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
42303282|NCT02409667|76138603|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
42303283|NCT02409667|76138604|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
42132158|NCT00500318|75943024|FG000|Overall Study|Withdrawal by Subject|1|||
42132159|NCT00500318|75943025|FG001|Overall Study|Withdrawal by Subject|2|||
42132160|NCT00500318|75943024|FG000|Overall Study|Lack of Efficacy|0|||
42132161|NCT00500318|75943025|FG001|Overall Study|Lack of Efficacy|3|||
42132162|NCT00500318|75943024|FG000|Overall Study|Other Reason|0|||
42132163|NCT00500318|75943025|FG001|Overall Study|Other Reason|1|||
42132164|NCT00508820|75943033|FG000|Overall Study|Adverse Event|6|||
42132165|NCT00508820|75943034|FG001|Overall Study|Adverse Event|10|||
42132166|NCT00508820|75943033|FG000|Overall Study|Death|6|||
42132167|NCT00508820|75943034|FG001|Overall Study|Death|8|||
42132168|NCT00508820|75943033|FG000|Overall Study|Lost to Follow-up|1|||
42132169|NCT00508820|75943034|FG001|Overall Study|Lost to Follow-up|1|||
42132170|NCT00508820|75943033|FG000|Overall Study|Physician Decision|8|||
42132171|NCT00508820|75943034|FG001|Overall Study|Physician Decision|2|||
42132172|NCT00508820|75943033|FG000|Overall Study|Pregnancy|0|||
42132173|NCT00508820|75943034|FG001|Overall Study|Pregnancy|2|||
42132174|NCT00508820|75943033|FG000|Overall Study|Protocol Violation|2|||
42132175|NCT00508820|75943034|FG001|Overall Study|Protocol Violation|0|||
42132176|NCT00508820|75943033|FG000|Overall Study|Withdrawal by Subject|10|||
42132177|NCT00508820|75943034|FG001|Overall Study|Withdrawal by Subject|12|||
42132178|NCT00508820|75943033|FG000|Overall Study|Other|11|||
42247152|NCT01328054|76072031|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
42247153|NCT01849250|76072054|FG000|Overall Study|Withdrawal by Subject|1|||
42247154|NCT01849250|76072055|FG001|Overall Study|Withdrawal by Subject|0|||
42247155|NCT01849250|76072054|FG000|Overall Study|Not Evaluable|5|||
42247156|NCT01849250|76072055|FG001|Overall Study|Not Evaluable|3|||
42247157|NCT01849250|76072054|FG000|Overall Study|Screen Failure|1|||
42247158|NCT01849250|76072055|FG001|Overall Study|Screen Failure|0|||
42247159|NCT02791191|76072065|FG000|Overall Study|Adverse Event|2|||
42247160|NCT02791191|76072066|FG001|Overall Study|Adverse Event|4|||
42247161|NCT02791191|76072067|FG002|Overall Study|Adverse Event|5|||
42247162|NCT02791191|76072065|FG000|Overall Study|Lack of Efficacy|0|||
42247163|NCT02791191|76072066|FG001|Overall Study|Lack of Efficacy|1|||
42247164|NCT02791191|76072067|FG002|Overall Study|Lack of Efficacy|0|||
42247165|NCT02791191|76072065|FG000|Overall Study|Study Drug Non-Compliance|0|||
42247166|NCT02791191|76072066|FG001|Overall Study|Study Drug Non-Compliance|2|||
42247167|NCT02791191|76072067|FG002|Overall Study|Study Drug Non-Compliance|0|||
42247168|NCT02791191|76072065|FG000|Overall Study|Site Closed by Sponsor|1|||
42247169|NCT02791191|76072066|FG001|Overall Study|Site Closed by Sponsor|1|||
42247170|NCT02791191|76072067|FG002|Overall Study|Site Closed by Sponsor|3|||
42247171|NCT02791191|76072065|FG000|Overall Study|Progressive Disease|1|||
42247172|NCT02791191|76072066|FG001|Overall Study|Progressive Disease|0|||
42247173|NCT02791191|76072067|FG002|Overall Study|Progressive Disease|0|||
42247174|NCT02791191|76072065|FG000|Overall Study|Study Terminated by Sponsor|29|||
42247175|NCT02791191|76072066|FG001|Overall Study|Study Terminated by Sponsor|101|||
42247176|NCT02791191|76072067|FG002|Overall Study|Study Terminated by Sponsor|109|||
42247177|NCT02791191|76072065|FG000|Overall Study|Withdrawal by Subject|3|||
42247178|NCT02791191|76072066|FG001|Overall Study|Withdrawal by Subject|1|||
42247179|NCT02791191|76072067|FG002|Overall Study|Withdrawal by Subject|3|||
42247180|NCT02791191|76072065|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
42247181|NCT02791191|76072066|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
42247182|NCT02791191|76072067|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
42247183|NCT02114697|76072090|FG000|Overall Study|Study terminated|5|||
42247184|NCT02114697|76072091|FG001|Overall Study|Study terminated|4|||
42247185|NCT01330017|76072102|FG000|Overall Study|Adverse Event|0|||
42247186|NCT01330017|76072103|FG001|Overall Study|Adverse Event|1|||
42247187|NCT01330017|76072104|FG002|Overall Study|Adverse Event|1|||
42247188|NCT01330017|76072105|FG003|Overall Study|Adverse Event|4|||
42247189|NCT01330017|76072106|FG004|Overall Study|Adverse Event|0|||
42247190|NCT01330017|76072102|FG000|Overall Study|Withdrawal by Subject|0|||
42247191|NCT01330017|76072103|FG001|Overall Study|Withdrawal by Subject|0|||
42247192|NCT01330017|76072104|FG002|Overall Study|Withdrawal by Subject|1|||
42247193|NCT01330017|76072105|FG003|Overall Study|Withdrawal by Subject|0|||
42247194|NCT01330017|76072106|FG004|Overall Study|Withdrawal by Subject|1|||
42247195|NCT01330017|76072102|FG000|Overall Study|Lost to Follow-up|0|||
42247196|NCT01330017|76072103|FG001|Overall Study|Lost to Follow-up|0|||
42247197|NCT01330017|76072104|FG002|Overall Study|Lost to Follow-up|1|||
42247198|NCT01330017|76072105|FG003|Overall Study|Lost to Follow-up|0|||
42247199|NCT01330017|76072106|FG004|Overall Study|Lost to Follow-up|0|||
42247200|NCT01330017|76072102|FG000|Overall Study|Protocol Violation|0|||
42247201|NCT01330017|76072103|FG001|Overall Study|Protocol Violation|0|||
42247202|NCT01330017|76072104|FG002|Overall Study|Protocol Violation|0|||
42247203|NCT01330017|76072105|FG003|Overall Study|Protocol Violation|1|||
42247204|NCT01330017|76072106|FG004|Overall Study|Protocol Violation|0|||
42247205|NCT01330017|76072102|FG000|Overall Study|Unknown Reason|5|||
42247206|NCT01330017|76072103|FG001|Overall Study|Unknown Reason|3|||
42247207|NCT01330017|76072104|FG002|Overall Study|Unknown Reason|5|||
42247208|NCT01330017|76072105|FG003|Overall Study|Unknown Reason|7|||
42247209|NCT01330017|76072106|FG004|Overall Study|Unknown Reason|2|||
42247210|NCT00150462|76072129|FG000|Overall Study|Disease Progression or Relapse|3|||
42247211|NCT00150462|76072130|FG001|Overall Study|Disease Progression or Relapse|1|||
42247212|NCT00150462|76072131|FG002|Overall Study|Disease Progression or Relapse|2|||
42247213|NCT00150462|76072132|FG003|Overall Study|Disease Progression or Relapse|1|||
42247214|NCT00150462|76072133|FG004|Overall Study|Disease Progression or Relapse|2|||
42247215|NCT00150462|76072134|FG005|Overall Study|Disease Progression or Relapse|2|||
42247216|NCT00150462|76072135|FG006|Overall Study|Disease Progression or Relapse|3|||
42247217|NCT00150462|76072136|FG007|Overall Study|Disease Progression or Relapse|5|||
42247218|NCT00150462|76072137|FG008|Overall Study|Disease Progression or Relapse|5|||
42247219|NCT00150462|76072138|FG009|Overall Study|Disease Progression or Relapse|3|||
42247220|NCT00150462|76072139|FG010|Overall Study|Disease Progression or Relapse|2|||
42247221|NCT00150462|76072129|FG000|Overall Study|Withdrawal by Subject|0|||
42247222|NCT00150462|76072130|FG001|Overall Study|Withdrawal by Subject|1|||
41989952|NCT03668119|75797922|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
42247223|NCT00150462|76072131|FG002|Overall Study|Withdrawal by Subject|1|||
42247224|NCT00150462|76072132|FG003|Overall Study|Withdrawal by Subject|0|||
42247225|NCT00150462|76072133|FG004|Overall Study|Withdrawal by Subject|1|||
42247226|NCT00150462|76072134|FG005|Overall Study|Withdrawal by Subject|2|||
42247227|NCT00150462|76072135|FG006|Overall Study|Withdrawal by Subject|0|||
42247228|NCT00150462|76072136|FG007|Overall Study|Withdrawal by Subject|1|||
42247229|NCT00150462|76072137|FG008|Overall Study|Withdrawal by Subject|0|||
42247230|NCT00150462|76072138|FG009|Overall Study|Withdrawal by Subject|1|||
42247231|NCT00150462|76072139|FG010|Overall Study|Withdrawal by Subject|0|||
42247232|NCT00150462|76072129|FG000|Overall Study|Death|0|||
42247233|NCT00150462|76072130|FG001|Overall Study|Death|1|||
42247234|NCT00150462|76072131|FG002|Overall Study|Death|0|||
42247235|NCT00150462|76072132|FG003|Overall Study|Death|0|||
42247236|NCT00150462|76072133|FG004|Overall Study|Death|0|||
42247237|NCT00150462|76072134|FG005|Overall Study|Death|0|||
42247238|NCT00150462|76072135|FG006|Overall Study|Death|0|||
42247239|NCT00150462|76072136|FG007|Overall Study|Death|0|||
42247240|NCT00150462|76072137|FG008|Overall Study|Death|1|||
42247241|NCT00150462|76072138|FG009|Overall Study|Death|0|||
42247242|NCT00150462|76072139|FG010|Overall Study|Death|0|||
42247243|NCT00150462|76072129|FG000|Overall Study|Adverse Event|0|||
42247244|NCT00150462|76072130|FG001|Overall Study|Adverse Event|0|||
42247245|NCT00150462|76072131|FG002|Overall Study|Adverse Event|0|||
42247246|NCT00150462|76072132|FG003|Overall Study|Adverse Event|1|||
42247247|NCT00150462|76072133|FG004|Overall Study|Adverse Event|0|||
42247248|NCT00150462|76072134|FG005|Overall Study|Adverse Event|0|||
42247249|NCT00150462|76072135|FG006|Overall Study|Adverse Event|0|||
42247250|NCT00150462|76072136|FG007|Overall Study|Adverse Event|2|||
42247251|NCT00150462|76072137|FG008|Overall Study|Adverse Event|0|||
42247252|NCT00150462|76072138|FG009|Overall Study|Adverse Event|1|||
42247253|NCT00150462|76072139|FG010|Overall Study|Adverse Event|0|||
42247254|NCT00150462|76072129|FG000|Overall Study|Physician Decision|0|||
42247255|NCT00150462|76072130|FG001|Overall Study|Physician Decision|0|||
42247256|NCT00150462|76072131|FG002|Overall Study|Physician Decision|1|||
42247257|NCT00150462|76072132|FG003|Overall Study|Physician Decision|1|||
42247258|NCT00150462|76072133|FG004|Overall Study|Physician Decision|0|||
42247259|NCT00150462|76072134|FG005|Overall Study|Physician Decision|0|||
42247260|NCT00150462|76072135|FG006|Overall Study|Physician Decision|0|||
42247261|NCT00150462|76072136|FG007|Overall Study|Physician Decision|0|||
42247262|NCT00150462|76072137|FG008|Overall Study|Physician Decision|0|||
42247263|NCT00150462|76072138|FG009|Overall Study|Physician Decision|0|||
42247264|NCT00150462|76072139|FG010|Overall Study|Physician Decision|0|||
42247265|NCT00150462|76072129|FG000|Overall Study|Other|0|||
42247266|NCT00150462|76072130|FG001|Overall Study|Other|0|||
42247267|NCT00150462|76072131|FG002|Overall Study|Other|0|||
42247268|NCT00150462|76072132|FG003|Overall Study|Other|0|||
42247269|NCT00150462|76072133|FG004|Overall Study|Other|0|||
42247270|NCT00150462|76072134|FG005|Overall Study|Other|0|||
42247271|NCT00150462|76072135|FG006|Overall Study|Other|0|||
42247272|NCT00150462|76072136|FG007|Overall Study|Other|0|||
42247273|NCT00150462|76072137|FG008|Overall Study|Other|0|||
42247274|NCT00150462|76072138|FG009|Overall Study|Other|1|||
42247275|NCT00150462|76072139|FG010|Overall Study|Other|1|||
42247276|NCT01368081|76072179|FG000|Overall Study|Adverse Event|4|||
42247277|NCT01368081|76072180|FG001|Overall Study|Adverse Event|4|||
42247278|NCT01368081|76072181|FG002|Overall Study|Adverse Event|3|||
42247279|NCT01368081|76072182|FG003|Overall Study|Adverse Event|2|||
42247280|NCT01368081|76072183|FG004|Overall Study|Adverse Event|2|||
42247281|NCT01368081|76072184|FG005|Overall Study|Adverse Event|5|||
42247282|NCT01368081|76072185|FG006|Overall Study|Adverse Event|6|||
42247283|NCT01368081|76072186|FG007|Overall Study|Adverse Event|2|||
42247284|NCT01368081|76072187|FG008|Overall Study|Adverse Event|3|||
42247285|NCT01368081|76072188|FG009|Overall Study|Adverse Event|5|||
42247286|NCT01368081|76072189|FG010|Overall Study|Adverse Event|6|||
42247287|NCT01368081|76072190|FG011|Overall Study|Adverse Event|1|||
42247288|NCT01368081|76072191|FG012|Overall Study|Adverse Event|3|||
42247289|NCT01368081|76072179|FG000|Overall Study|Lack of Efficacy|0|||
42247290|NCT01368081|76072180|FG001|Overall Study|Lack of Efficacy|1|||
42247291|NCT01368081|76072181|FG002|Overall Study|Lack of Efficacy|0|||
42247292|NCT01368081|76072182|FG003|Overall Study|Lack of Efficacy|1|||
42303284|NCT02409667|76138605|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
42247293|NCT01368081|76072183|FG004|Overall Study|Lack of Efficacy|0|||
42247294|NCT01368081|76072184|FG005|Overall Study|Lack of Efficacy|0|||
42247295|NCT01368081|76072185|FG006|Overall Study|Lack of Efficacy|0|||
42247296|NCT01368081|76072186|FG007|Overall Study|Lack of Efficacy|2|||
42247297|NCT01368081|76072187|FG008|Overall Study|Lack of Efficacy|0|||
42247298|NCT01368081|76072188|FG009|Overall Study|Lack of Efficacy|0|||
42247299|NCT01368081|76072189|FG010|Overall Study|Lack of Efficacy|0|||
42247300|NCT01368081|76072190|FG011|Overall Study|Lack of Efficacy|0|||
42247301|NCT01368081|76072191|FG012|Overall Study|Lack of Efficacy|0|||
42247302|NCT01368081|76072179|FG000|Overall Study|Protocol Violation|0|||
42247303|NCT01368081|76072180|FG001|Overall Study|Protocol Violation|0|||
42247304|NCT01368081|76072181|FG002|Overall Study|Protocol Violation|0|||
42247305|NCT01368081|76072182|FG003|Overall Study|Protocol Violation|0|||
42247306|NCT01368081|76072183|FG004|Overall Study|Protocol Violation|0|||
42247307|NCT01368081|76072184|FG005|Overall Study|Protocol Violation|1|||
42247308|NCT01368081|76072185|FG006|Overall Study|Protocol Violation|0|||
42247309|NCT01368081|76072186|FG007|Overall Study|Protocol Violation|1|||
42247310|NCT01368081|76072187|FG008|Overall Study|Protocol Violation|0|||
42247311|NCT01368081|76072188|FG009|Overall Study|Protocol Violation|0|||
42247312|NCT01368081|76072189|FG010|Overall Study|Protocol Violation|0|||
42247313|NCT01368081|76072190|FG011|Overall Study|Protocol Violation|0|||
42247314|NCT01368081|76072191|FG012|Overall Study|Protocol Violation|0|||
42247315|NCT01368081|76072179|FG000|Overall Study|Lost to Follow-up|0|||
42247316|NCT01368081|76072180|FG001|Overall Study|Lost to Follow-up|0|||
42247317|NCT01368081|76072181|FG002|Overall Study|Lost to Follow-up|0|||
42247318|NCT01368081|76072182|FG003|Overall Study|Lost to Follow-up|0|||
42247319|NCT01368081|76072183|FG004|Overall Study|Lost to Follow-up|0|||
42247320|NCT01368081|76072184|FG005|Overall Study|Lost to Follow-up|0|||
42247321|NCT01368081|76072185|FG006|Overall Study|Lost to Follow-up|0|||
42247322|NCT01368081|76072186|FG007|Overall Study|Lost to Follow-up|0|||
42247323|NCT01368081|76072187|FG008|Overall Study|Lost to Follow-up|0|||
42247324|NCT01368081|76072188|FG009|Overall Study|Lost to Follow-up|0|||
42247325|NCT01368081|76072189|FG010|Overall Study|Lost to Follow-up|0|||
42132179|NCT00508820|75943034|FG001|Overall Study|Other|2|||
42132180|NCT00508820|75943033|FG000|Overall Study|Noncompliance|1|||
42132181|NCT00508820|75943034|FG001|Overall Study|Noncompliance|0|||
42247326|NCT01368081|76072190|FG011|Overall Study|Lost to Follow-up|0|||
42247327|NCT01368081|76072191|FG012|Overall Study|Lost to Follow-up|1|||
42247328|NCT01368081|76072179|FG000|Overall Study|Withdrawal by Subject|4|||
42247329|NCT01368081|76072180|FG001|Overall Study|Withdrawal by Subject|4|||
42247330|NCT01368081|76072181|FG002|Overall Study|Withdrawal by Subject|1|||
42247331|NCT01368081|76072182|FG003|Overall Study|Withdrawal by Subject|1|||
42247332|NCT01368081|76072183|FG004|Overall Study|Withdrawal by Subject|0|||
42247333|NCT01368081|76072184|FG005|Overall Study|Withdrawal by Subject|3|||
42247334|NCT01368081|76072185|FG006|Overall Study|Withdrawal by Subject|4|||
42247335|NCT01368081|76072186|FG007|Overall Study|Withdrawal by Subject|2|||
42247336|NCT01368081|76072187|FG008|Overall Study|Withdrawal by Subject|5|||
42247337|NCT01368081|76072188|FG009|Overall Study|Withdrawal by Subject|4|||
42247338|NCT01368081|76072189|FG010|Overall Study|Withdrawal by Subject|3|||
42247339|NCT01368081|76072190|FG011|Overall Study|Withdrawal by Subject|2|||
42247340|NCT01368081|76072191|FG012|Overall Study|Withdrawal by Subject|0|||
42247341|NCT01368081|76072179|FG000|Overall Study|Other reason not defined above|2|||
42247342|NCT01368081|76072180|FG001|Overall Study|Other reason not defined above|0|||
42247343|NCT01368081|76072181|FG002|Overall Study|Other reason not defined above|0|||
42247344|NCT01368081|76072182|FG003|Overall Study|Other reason not defined above|1|||
42247345|NCT01368081|76072183|FG004|Overall Study|Other reason not defined above|0|||
42247346|NCT01368081|76072184|FG005|Overall Study|Other reason not defined above|1|||
42247347|NCT01368081|76072185|FG006|Overall Study|Other reason not defined above|2|||
42247348|NCT01368081|76072186|FG007|Overall Study|Other reason not defined above|0|||
42247349|NCT01368081|76072187|FG008|Overall Study|Other reason not defined above|0|||
42247350|NCT01368081|76072188|FG009|Overall Study|Other reason not defined above|1|||
42247351|NCT01368081|76072189|FG010|Overall Study|Other reason not defined above|0|||
42247352|NCT01368081|76072190|FG011|Overall Study|Other reason not defined above|0|||
42247353|NCT01368081|76072191|FG012|Overall Study|Other reason not defined above|3|||
42247354|NCT00303498|76072221|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
42247355|NCT00303498|76072222|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
42247356|NCT00303498|76072221|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
42247357|NCT00303498|76072222|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
42247358|NCT00303498|76072221|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
42247359|NCT00303498|76072222|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
42247360|NCT00303498|76072221|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
42247361|NCT00303498|76072222|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
42247362|NCT00303498|76072221|FG000|Run-In-Phase (10 Weeks)|Other|4|||
42247363|NCT00303498|76072222|FG001|Run-In-Phase (10 Weeks)|Other|1|||
42247364|NCT00303498|76072221|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
42247365|NCT00303498|76072222|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
42247366|NCT00303498|76072221|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
42272687|NCT00857285|76103029|FG001|Overall Study|Adverse Event|2|||
42247367|NCT00303498|76072222|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
42247368|NCT00303498|76072221|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
42247369|NCT00303498|76072222|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
42247370|NCT00303498|76072221|FG000|Maintenance Phase (24 Weeks)|Death|1|||
42247371|NCT00303498|76072222|FG001|Maintenance Phase (24 Weeks)|Death|0|||
42247372|NCT00303498|76072221|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
42247373|NCT00303498|76072222|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
42247374|NCT00303498|76072221|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
42247375|NCT00303498|76072222|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
42247376|NCT00303498|76072221|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
42247377|NCT00303498|76072222|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
42247378|NCT00303498|76072221|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
42247379|NCT00303498|76072222|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
42247380|NCT00303498|76072221|FG000|Maintenance Phase (24 Weeks)|Other|1|||
42247381|NCT00303498|76072222|FG001|Maintenance Phase (24 Weeks)|Other|0|||
42247382|NCT00303498|76072221|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
42247383|NCT00303498|76072222|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
42247384|NCT00303498|76072221|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
42247385|NCT00303498|76072222|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
42247386|NCT02588092|76072238|FG000|Overall Study|Death|4|||
42247387|NCT02588092|76072239|FG001|Overall Study|Death|3|||
42247388|NCT02588092|76072240|FG002|Overall Study|Death|3|||
42247389|NCT02588092|76072241|FG003|Overall Study|Death|3|||
42247390|NCT02588092|76072242|FG004|Overall Study|Death|2|||
42247391|NCT02588092|76072243|FG005|Overall Study|Death|2|||
42247392|NCT02588092|76072244|FG006|Overall Study|Death|2|||
42247393|NCT02588092|76072245|FG007|Overall Study|Death|1|||
42247394|NCT02588092|76072246|FG008|Overall Study|Death|5|||
42247395|NCT02588092|76072247|FG009|Overall Study|Death|2|||
42247396|NCT02588092|76072238|FG000|Overall Study|Withdrawal by Subject|0|||
42247397|NCT02588092|76072239|FG001|Overall Study|Withdrawal by Subject|0|||
42247398|NCT02588092|76072240|FG002|Overall Study|Withdrawal by Subject|0|||
42247399|NCT02588092|76072241|FG003|Overall Study|Withdrawal by Subject|0|||
42247400|NCT02588092|76072242|FG004|Overall Study|Withdrawal by Subject|0|||
42247401|NCT02588092|76072243|FG005|Overall Study|Withdrawal by Subject|1|||
42247402|NCT02588092|76072244|FG006|Overall Study|Withdrawal by Subject|1|||
42247403|NCT02588092|76072245|FG007|Overall Study|Withdrawal by Subject|2|||
42247404|NCT02588092|76072246|FG008|Overall Study|Withdrawal by Subject|0|||
42247405|NCT02588092|76072247|FG009|Overall Study|Withdrawal by Subject|0|||
42247406|NCT02588092|76072238|FG000|Overall Study|Started Another Treatment|0|||
42247407|NCT02588092|76072239|FG001|Overall Study|Started Another Treatment|0|||
42247408|NCT02588092|76072240|FG002|Overall Study|Started Another Treatment|0|||
42247409|NCT02588092|76072241|FG003|Overall Study|Started Another Treatment|0|||
42247410|NCT02588092|76072242|FG004|Overall Study|Started Another Treatment|1|||
42247411|NCT02588092|76072243|FG005|Overall Study|Started Another Treatment|0|||
42247412|NCT02588092|76072244|FG006|Overall Study|Started Another Treatment|0|||
42247413|NCT02588092|76072245|FG007|Overall Study|Started Another Treatment|1|||
42247414|NCT02588092|76072246|FG008|Overall Study|Started Another Treatment|0|||
42247415|NCT02588092|76072247|FG009|Overall Study|Started Another Treatment|0|||
42247416|NCT02588092|76072238|FG000|Overall Study|Sponsor Decision|0|||
42247417|NCT02588092|76072239|FG001|Overall Study|Sponsor Decision|0|||
42247418|NCT02588092|76072240|FG002|Overall Study|Sponsor Decision|0|||
42247419|NCT02588092|76072241|FG003|Overall Study|Sponsor Decision|0|||
42247420|NCT02588092|76072242|FG004|Overall Study|Sponsor Decision|0|||
42247421|NCT02588092|76072243|FG005|Overall Study|Sponsor Decision|0|||
42247422|NCT02588092|76072244|FG006|Overall Study|Sponsor Decision|0|||
42247423|NCT02588092|76072245|FG007|Overall Study|Sponsor Decision|0|||
42247424|NCT02588092|76072246|FG008|Overall Study|Sponsor Decision|1|||
42247425|NCT02588092|76072247|FG009|Overall Study|Sponsor Decision|1|||
42247426|NCT01367847|76072275|FG000|Overall Study|Withdrawal by Subject|2|||
42247427|NCT01367847|76072276|FG001|Overall Study|Withdrawal by Subject|2|||
42247428|NCT00150618|76072288|FG000|Overall Study|Adverse Event|2|||
42247429|NCT00150618|76072289|FG001|Overall Study|Adverse Event|2|||
42247430|NCT00150618|76072290|FG002|Overall Study|Adverse Event|6|||
42247431|NCT00150618|76072291|FG003|Overall Study|Adverse Event|9|||
42247432|NCT00150618|76072292|FG004|Overall Study|Adverse Event|5|||
42247433|NCT00150618|76072288|FG000|Overall Study|Withdrawal by Subject|6|||
42247434|NCT00150618|76072289|FG001|Overall Study|Withdrawal by Subject|8|||
42247435|NCT00150618|76072290|FG002|Overall Study|Withdrawal by Subject|8|||
42272688|NCT00857285|76103028|FG000|Overall Study|Lack of Efficacy|0|||
42247436|NCT00150618|76072291|FG003|Overall Study|Withdrawal by Subject|4|||
42247437|NCT00150618|76072292|FG004|Overall Study|Withdrawal by Subject|5|||
42247438|NCT00150618|76072288|FG000|Overall Study|Lost to Follow-up|4|||
42247439|NCT00150618|76072289|FG001|Overall Study|Lost to Follow-up|1|||
42247440|NCT00150618|76072290|FG002|Overall Study|Lost to Follow-up|5|||
42247441|NCT00150618|76072291|FG003|Overall Study|Lost to Follow-up|8|||
42247442|NCT00150618|76072292|FG004|Overall Study|Lost to Follow-up|4|||
42247443|NCT00150618|76072288|FG000|Overall Study|Protocol Violation|1|||
42247444|NCT00150618|76072289|FG001|Overall Study|Protocol Violation|0|||
42247445|NCT00150618|76072290|FG002|Overall Study|Protocol Violation|0|||
42247446|NCT00150618|76072291|FG003|Overall Study|Protocol Violation|0|||
42247447|NCT00150618|76072292|FG004|Overall Study|Protocol Violation|1|||
42247448|NCT00150618|76072288|FG000|Overall Study|Lack of Efficacy|1|||
42247449|NCT00150618|76072289|FG001|Overall Study|Lack of Efficacy|4|||
42247450|NCT00150618|76072290|FG002|Overall Study|Lack of Efficacy|7|||
42247451|NCT00150618|76072291|FG003|Overall Study|Lack of Efficacy|4|||
42247452|NCT00150618|76072292|FG004|Overall Study|Lack of Efficacy|6|||
42247453|NCT00150618|76072288|FG000|Overall Study|No study meds|0|||
42247454|NCT00150618|76072289|FG001|Overall Study|No study meds|0|||
42247455|NCT00150618|76072290|FG002|Overall Study|No study meds|0|||
42247456|NCT00150618|76072291|FG003|Overall Study|No study meds|0|||
42247457|NCT00150618|76072292|FG004|Overall Study|No study meds|2|||
42247458|NCT00150618|76072288|FG000|Overall Study|Physician Decision|0|||
42247459|NCT00150618|76072289|FG001|Overall Study|Physician Decision|2|||
42247460|NCT00150618|76072290|FG002|Overall Study|Physician Decision|0|||
42247461|NCT00150618|76072291|FG003|Overall Study|Physician Decision|0|||
42247462|NCT00150618|76072292|FG004|Overall Study|Physician Decision|1|||
42247463|NCT00150618|76072288|FG000|Overall Study|Lack of compliance|2|||
42247464|NCT00150618|76072289|FG001|Overall Study|Lack of compliance|1|||
42247465|NCT00150618|76072290|FG002|Overall Study|Lack of compliance|1|||
42247466|NCT00150618|76072291|FG003|Overall Study|Lack of compliance|0|||
42247467|NCT00150618|76072292|FG004|Overall Study|Lack of compliance|1|||
42247468|NCT00150618|76072288|FG000|Overall Study|Abnormal ECG|1|||
42247469|NCT00150618|76072289|FG001|Overall Study|Abnormal ECG|0|||
42247470|NCT00150618|76072290|FG002|Overall Study|Abnormal ECG|0|||
42247471|NCT00150618|76072291|FG003|Overall Study|Abnormal ECG|0|||
42247472|NCT00150618|76072292|FG004|Overall Study|Abnormal ECG|0|||
42247473|NCT00150618|76072288|FG000|Overall Study|Sponsor's decision|0|||
42247474|NCT00150618|76072289|FG001|Overall Study|Sponsor's decision|0|||
42247475|NCT00150618|76072290|FG002|Overall Study|Sponsor's decision|0|||
42247476|NCT00150618|76072291|FG003|Overall Study|Sponsor's decision|1|||
42247477|NCT00150618|76072292|FG004|Overall Study|Sponsor's decision|0|||
42247478|NCT01359046|76072306|FG000|Overall Study|Did not receive allocated intervention|6|||
42247479|NCT01359046|76072307|FG001|Overall Study|Did not receive allocated intervention|6|||
42247480|NCT01359046|76072306|FG000|Overall Study|Physician Decision|1|||
42247481|NCT01359046|76072307|FG001|Overall Study|Physician Decision|11|||
42247482|NCT02741310|76072315|FG000|Overall Study|Sponsor Decision|2|||
42247483|NCT02741310|76072316|FG001|Overall Study|Sponsor Decision|2|||
42247484|NCT01367457|76072333|FG000|Overall Study|Death|2|||
42247485|NCT01367457|76072334|FG001|Overall Study|Death|0|||
42247486|NCT01367457|76072335|FG002|Overall Study|Death|0|||
42247487|NCT01367457|76072333|FG000|Overall Study|Investigator's decision|2|||
42247488|NCT01367457|76072334|FG001|Overall Study|Investigator's decision|0|||
42247489|NCT01367457|76072335|FG002|Overall Study|Investigator's decision|0|||
42247490|NCT01367457|76072333|FG000|Overall Study|Clinical decline (CD)|2|||
42247491|NCT01367457|76072334|FG001|Overall Study|Clinical decline (CD)|0|||
42247492|NCT01367457|76072335|FG002|Overall Study|Clinical decline (CD)|0|||
42247493|NCT01367457|76072333|FG000|Overall Study|Progression and death|8|||
42247494|NCT01367457|76072334|FG001|Overall Study|Progression and death|0|||
42247495|NCT01367457|76072335|FG002|Overall Study|Progression and death|0|||
42247496|NCT01367457|76072333|FG000|Overall Study|Toxicity|16|||
42247497|NCT01367457|76072334|FG001|Overall Study|Toxicity|0|||
42247498|NCT01367457|76072335|FG002|Overall Study|Toxicity|0|||
42247499|NCT01367457|76072333|FG000|Overall Study|Progression|137|||
42247500|NCT01367457|76072334|FG001|Overall Study|Progression|0|||
42247501|NCT01367457|76072335|FG002|Overall Study|Progression|0|||
42247502|NCT01367457|76072333|FG000|Overall Study|Patient asks for rest + slow progression|1|||
42247503|NCT01367457|76072334|FG001|Overall Study|Patient asks for rest + slow progression|0|||
42032939|NCT00943917|75841128|FG006|Stage II Continuation|Protocol Violation|0|||
42032940|NCT00943917|75841129|FG007|Stage II Continuation|Protocol Violation|0|||
42032941|NCT00943917|75841130|FG008|Stage II Continuation|Protocol Violation|0|||
42032942|NCT00943917|75841131|FG009|Stage II Continuation|Protocol Violation|1|||
42032943|NCT00943917|75841132|FG010|Stage II Continuation|Protocol Violation|0|||
42032944|NCT00943917|75841133|FG011|Stage II Continuation|Protocol Violation|1|||
42247504|NCT01367457|76072335|FG002|Overall Study|Patient asks for rest + slow progression|0|||
42247505|NCT01367457|76072333|FG000|Overall Study|Investigator's opinion, stable disease|1|||
42247506|NCT01367457|76072334|FG001|Overall Study|Investigator's opinion, stable disease|0|||
42247507|NCT01367457|76072335|FG002|Overall Study|Investigator's opinion, stable disease|0|||
42247508|NCT01367457|76072333|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
41989953|NCT03668119|75797921|FG000|Treatment|Withdrawal by Subject|2|||
41989954|NCT03668119|75797922|FG001|Treatment|Withdrawal by Subject|1|||
41989955|NCT03668119|75797921|FG000|Treatment|Participant request to discontinue study treatment|3|||
41989956|NCT03668119|75797922|FG001|Treatment|Participant request to discontinue study treatment|1|||
41989957|NCT03668119|75797921|FG000|Treatment|Maximum Clinical Benefit|0|||
41989958|NCT03668119|75797922|FG001|Treatment|Maximum Clinical Benefit|1|||
41989959|NCT03668119|75797921|FG000|Treatment|Participants completed treatment|20|||
41989960|NCT03668119|75797922|FG001|Treatment|Participants completed treatment|8|||
41989961|NCT03668119|75797921|FG000|Treatment|Other reasons|1|||
41989962|NCT03668119|75797922|FG001|Treatment|Other reasons|2|||
41989963|NCT03224819|75797948|FG000|Overall Study|Withdrawal by Subject|0|||
41989964|NCT03224819|75797949|FG001|Overall Study|Withdrawal by Subject|0|||
42247509|NCT01367457|76072334|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
42247510|NCT01367457|76072335|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
42247511|NCT01367457|76072333|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
42247512|NCT01367457|76072334|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
42247513|NCT01367457|76072335|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
42247514|NCT01367457|76072333|FG000|Overall Study|low grade toxicities + stable disease|1|||
42247515|NCT01367457|76072334|FG001|Overall Study|low grade toxicities + stable disease|0|||
42247516|NCT01367457|76072335|FG002|Overall Study|low grade toxicities + stable disease|0|||
42247517|NCT01367457|76072333|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
42247518|NCT01367457|76072334|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
42247519|NCT01367457|76072335|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
42247520|NCT01367457|76072333|FG000|Overall Study|Withdrawal by Subject|1|||
42247521|NCT01367457|76072334|FG001|Overall Study|Withdrawal by Subject|0|||
42247522|NCT01367457|76072335|FG002|Overall Study|Withdrawal by Subject|0|||
42247523|NCT01367457|76072333|FG000|Overall Study|CD, associated leukaemia|1|||
42247524|NCT01367457|76072334|FG001|Overall Study|CD, associated leukaemia|0|||
42247525|NCT01367457|76072335|FG002|Overall Study|CD, associated leukaemia|0|||
42247526|NCT01367457|76072333|FG000|Overall Study|Uncontrolled pain|1|||
42247527|NCT01367457|76072334|FG001|Overall Study|Uncontrolled pain|0|||
42247528|NCT01367457|76072335|FG002|Overall Study|Uncontrolled pain|0|||
42247529|NCT01367457|76072333|FG000|Overall Study|Overall status worsens to grade 4|1|||
42247530|NCT01367457|76072334|FG001|Overall Study|Overall status worsens to grade 4|0|||
42247531|NCT01367457|76072335|FG002|Overall Study|Overall status worsens to grade 4|0|||
42247532|NCT01367457|76072333|FG000|Overall Study|Stabilisation + frequent infections|1|||
42247533|NCT01367457|76072334|FG001|Overall Study|Stabilisation + frequent infections|0|||
42247534|NCT01367457|76072335|FG002|Overall Study|Stabilisation + frequent infections|0|||
42247535|NCT01367457|76072333|FG000|Overall Study|No clinical benefit|1|||
42247536|NCT01367457|76072334|FG001|Overall Study|No clinical benefit|0|||
42247537|NCT01367457|76072335|FG002|Overall Study|No clinical benefit|0|||
42247538|NCT01367457|76072333|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
42247539|NCT01367457|76072334|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
42247540|NCT01367457|76072335|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
42247541|NCT01367457|76072333|FG000|Overall Study|Overall decline|1|||
42247542|NCT01367457|76072334|FG001|Overall Study|Overall decline|0|||
42247543|NCT01367457|76072335|FG002|Overall Study|Overall decline|0|||
42247544|NCT01367457|76072333|FG000|Overall Study|Rejection of treatment|1|||
42303285|NCT02409667|76138606|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
42303286|NCT02409667|76138607|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
42032945|NCT00943917|75841134|FG012|Stage II Continuation|Protocol Violation|0|||
42247545|NCT01367457|76072334|FG001|Overall Study|Rejection of treatment|0|||
42247546|NCT01367457|76072335|FG002|Overall Study|Rejection of treatment|0|||
42247547|NCT01367457|76072333|FG000|Overall Study|Lost to Follow-up|1|||
42247548|NCT01367457|76072334|FG001|Overall Study|Lost to Follow-up|0|||
42247549|NCT01367457|76072335|FG002|Overall Study|Lost to Follow-up|0|||
42247550|NCT01367457|76072333|FG000|Overall Study|Death from septic shock|1|||
42247551|NCT01367457|76072334|FG001|Overall Study|Death from septic shock|0|||
42247552|NCT01367457|76072335|FG002|Overall Study|Death from septic shock|0|||
42247553|NCT01367457|76072333|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
42247554|NCT01367457|76072334|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
42247555|NCT01367457|76072335|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
42247556|NCT01367457|76072333|FG000|Overall Study|Patient's Wish|1|||
42247557|NCT01367457|76072334|FG001|Overall Study|Patient's Wish|0|||
42247558|NCT01367457|76072335|FG002|Overall Study|Patient's Wish|0|||
42247559|NCT01367457|76072333|FG000|Overall Study|Palliative. Overall decline|1|||
42247560|NCT01367457|76072334|FG001|Overall Study|Palliative. Overall decline|0|||
42247561|NCT01367457|76072335|FG002|Overall Study|Palliative. Overall decline|0|||
42247562|NCT01367457|76072333|FG000|Overall Study|Suspected DP/suspected active infection|1|||
42247563|NCT01367457|76072334|FG001|Overall Study|Suspected DP/suspected active infection|0|||
42247564|NCT01367457|76072335|FG002|Overall Study|Suspected DP/suspected active infection|0|||
42247565|NCT00235326|76072345|FG000|Overall Study|Lost to Follow-up|746|||
42247566|NCT00235326|76072346|FG001|Overall Study|Lost to Follow-up|1400|||
42247567|NCT00162942|76072356|FG000|Overall Study|Adverse Event|10|||
42132182|NCT00508820|75943033|FG000|Overall Study|Requirement for alternative therapy|7|||
42132183|NCT00508820|75943034|FG001|Overall Study|Requirement for alternative therapy|15|||
42132184|NCT00508820|75943033|FG000|Overall Study|Protocol-specified Criteria|3|||
42132185|NCT00508820|75943034|FG001|Overall Study|Protocol-specified Criteria|12|||
42132186|NCT00499694|75943040|FG000|Overall Study|Patient never received treatment.|1|||
42132187|NCT00486954|75943049|FG000|Pilot Part|Adverse Event|4|||
42132188|NCT00486954|75943050|FG001|Pilot Part|Adverse Event|0|||
42247568|NCT00162942|76072357|FG001|Overall Study|Adverse Event|6|||
42247569|NCT00162942|76072356|FG000|Overall Study|Death|1|||
42132189|NCT00486954|75943051|FG002|Pilot Part|Adverse Event|5|||
42132190|NCT00486954|75943052|FG003|Pilot Part|Adverse Event|0|||
42132191|NCT00486954|75943053|FG004|Pilot Part|Adverse Event|0|||
42132192|NCT00486954|75943049|FG000|Pilot Part|Disease Progression|2|||
42132193|NCT00486954|75943050|FG001|Pilot Part|Disease Progression|0|||
42132194|NCT00486954|75943051|FG002|Pilot Part|Disease Progression|1|||
42132195|NCT00486954|75943052|FG003|Pilot Part|Disease Progression|0|||
42247570|NCT00162942|76072357|FG001|Overall Study|Death|0|||
42247571|NCT00162942|76072356|FG000|Overall Study|Withdrawal by Subject|3|||
42247572|NCT00162942|76072357|FG001|Overall Study|Withdrawal by Subject|6|||
42247573|NCT00162942|76072356|FG000|Overall Study|Physician Decision|1|||
42247574|NCT00162942|76072357|FG001|Overall Study|Physician Decision|0|||
42247575|NCT00162942|76072356|FG000|Overall Study|Enter Open-Label Study|76|||
42132196|NCT00486954|75943053|FG004|Pilot Part|Disease Progression|0|||
42132197|NCT00486954|75943049|FG000|Randomized Part|Lost to Follow-up|0|||
42247576|NCT00162942|76072357|FG001|Overall Study|Enter Open-Label Study|35|||
42247577|NCT00162942|76072356|FG000|Overall Study|Alternate Therapy|6|||
42247578|NCT00162942|76072357|FG001|Overall Study|Alternate Therapy|2|||
42247579|NCT00162942|76072356|FG000|Overall Study|Lack of Efficacy|1|||
42247580|NCT00162942|76072357|FG001|Overall Study|Lack of Efficacy|0|||
42247581|NCT00162942|76072356|FG000|Overall Study|Flare During Active Treatment|7|||
42247582|NCT00162942|76072357|FG001|Overall Study|Flare During Active Treatment|3|||
42247583|NCT00162942|76072356|FG000|Overall Study|2 or more consecutive treatments missed|1|||
42247584|NCT00162942|76072357|FG001|Overall Study|2 or more consecutive treatments missed|0|||
42247585|NCT02786901|76072387|FG000|Overall Study|Adverse Event|1|||
42247586|NCT02786901|76072388|FG001|Overall Study|Adverse Event|1|||
42247587|NCT02786901|76072389|FG002|Overall Study|Adverse Event|2|||
42132198|NCT00486954|75943050|FG001|Randomized Part|Lost to Follow-up|0|||
42132199|NCT00486954|75943051|FG002|Randomized Part|Lost to Follow-up|0|||
42132200|NCT00486954|75943052|FG003|Randomized Part|Lost to Follow-up|0|||
42132201|NCT00486954|75943053|FG004|Randomized Part|Lost to Follow-up|1|||
42132202|NCT00486954|75943049|FG000|Randomized Part|Withdrawal by Subject|0|||
42132203|NCT00486954|75943050|FG001|Randomized Part|Withdrawal by Subject|0|||
42132204|NCT00486954|75943051|FG002|Randomized Part|Withdrawal by Subject|0|||
42132205|NCT00486954|75943052|FG003|Randomized Part|Withdrawal by Subject|1|||
42247588|NCT02786901|76072387|FG000|Overall Study|Physician Decision|1|||
42247589|NCT02786901|76072388|FG001|Overall Study|Physician Decision|0|||
42247590|NCT02786901|76072389|FG002|Overall Study|Physician Decision|0|||
42247591|NCT02786901|76072387|FG000|Overall Study|Rescue Therapy Use|71|||
42247592|NCT02786901|76072388|FG001|Overall Study|Rescue Therapy Use|49|||
42247593|NCT02786901|76072389|FG002|Overall Study|Rescue Therapy Use|33|||
42247594|NCT02786901|76072387|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
42247595|NCT02786901|76072388|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
42247596|NCT02786901|76072389|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
42247597|NCT02786901|76072387|FG000|Overall Study|Disallowed medication|1|||
42247598|NCT02786901|76072388|FG001|Overall Study|Disallowed medication|1|||
42247599|NCT02786901|76072389|FG002|Overall Study|Disallowed medication|0|||
42247600|NCT02786901|76072387|FG000|Overall Study|Randomized in error|2|||
42247601|NCT02786901|76072388|FG001|Overall Study|Randomized in error|0|||
42247602|NCT02786901|76072389|FG002|Overall Study|Randomized in error|1|||
42247603|NCT02137239|76072399|FG000|Overall Study|Discontinued Study Treatment|0|||
42247604|NCT02137239|76072400|FG001|Overall Study|Discontinued Study Treatment|3|||
42247605|NCT02137239|76072399|FG000|Overall Study|Withdrew Consent|1|||
42247606|NCT02137239|76072400|FG001|Overall Study|Withdrew Consent|1|||
42247607|NCT02137239|76072399|FG000|Overall Study|Adverse Event|2|||
42247608|NCT02137239|76072400|FG001|Overall Study|Adverse Event|2|||
42247609|NCT02741076|76072419|FG000|Overall Study|Adverse Event|0|||
42247610|NCT02741076|76072420|FG001|Overall Study|Adverse Event|1|||
42247611|NCT02741076|76072421|FG002|Overall Study|Adverse Event|1|||
42247612|NCT02741076|76072422|FG003|Overall Study|Adverse Event|0|||
42247613|NCT02741076|76072419|FG000|Overall Study|Lack of Efficacy|1|||
42247614|NCT02741076|76072420|FG001|Overall Study|Lack of Efficacy|0|||
42247615|NCT02741076|76072421|FG002|Overall Study|Lack of Efficacy|0|||
42247616|NCT02741076|76072422|FG003|Overall Study|Lack of Efficacy|0|||
42247617|NCT02741076|76072419|FG000|Overall Study|Withdrawal by Subject|0|||
42247618|NCT02741076|76072420|FG001|Overall Study|Withdrawal by Subject|1|||
42247619|NCT02741076|76072421|FG002|Overall Study|Withdrawal by Subject|0|||
42247620|NCT02741076|76072422|FG003|Overall Study|Withdrawal by Subject|0|||
42132206|NCT00486954|75943053|FG004|Randomized Part|Withdrawal by Subject|0|||
42247621|NCT02741076|76072419|FG000|Overall Study|Sponsor Request|2|||
42247622|NCT02741076|76072420|FG001|Overall Study|Sponsor Request|3|||
42247623|NCT02741076|76072421|FG002|Overall Study|Sponsor Request|0|||
42132207|NCT00486954|75943049|FG000|Randomized Part|Sponsor Terminated Study|0|||
42132208|NCT00486954|75943050|FG001|Randomized Part|Sponsor Terminated Study|0|||
42247624|NCT02741076|76072422|FG003|Overall Study|Sponsor Request|1|||
42247625|NCT02741076|76072419|FG000|Overall Study|No additional information available|0|||
42247626|NCT02741076|76072420|FG001|Overall Study|No additional information available|0|||
42247627|NCT02741076|76072421|FG002|Overall Study|No additional information available|1|||
42247628|NCT02741076|76072422|FG003|Overall Study|No additional information available|1|||
42247629|NCT01666444|76072435|FG000|Overall Study|Did not initiate treatment|2|||
42247630|NCT01666444|76072436|FG001|Overall Study|Did not initiate treatment|1|||
42247631|NCT05159622|76072444|FG000|Overall Study|Lost to Follow-up|4|||
42247632|NCT05159622|76072445|FG001|Overall Study|Lost to Follow-up|5|||
42247633|NCT01665430|76072457|FG000|Overall Study|Adverse Event|1|||
42247634|NCT01665430|76072457|FG000|Overall Study|Withdrawal by Subject|6|||
42247635|NCT01665430|76072457|FG000|Overall Study|Other Unspecified|2|||
42247636|NCT02739594|76072463|FG000|Overall Study|Undesired Event|3|||
42247637|NCT02739594|76072464|FG001|Overall Study|Undesired Event|4|||
42247638|NCT02739594|76072463|FG000|Overall Study|Violation of Eligibility Criteria|1|||
42247639|NCT02739594|76072464|FG001|Overall Study|Violation of Eligibility Criteria|2|||
42247640|NCT02739594|76072463|FG000|Overall Study|Protocol Violation|5|||
42247641|NCT02739594|76072464|FG001|Overall Study|Protocol Violation|6|||
42247642|NCT02739594|76072463|FG000|Overall Study|Death|4|||
42247643|NCT02739594|76072464|FG001|Overall Study|Death|2|||
42247644|NCT02739594|76072463|FG000|Overall Study|Renal Insufficiency|4|||
42247645|NCT02739594|76072464|FG001|Overall Study|Renal Insufficiency|6|||
42247646|NCT02739594|76072463|FG000|Overall Study|Administrative Reasons|1|||
42247647|NCT02739594|76072464|FG001|Overall Study|Administrative Reasons|3|||
42247648|NCT02739594|76072463|FG000|Overall Study|Withdrawal by Subject|1|||
42247649|NCT02739594|76072464|FG001|Overall Study|Withdrawal by Subject|1|||
42247650|NCT02739594|76072463|FG000|Overall Study|Lost to Follow-up|0|||
42247651|NCT02739594|76072464|FG001|Overall Study|Lost to Follow-up|1|||
42247652|NCT02739594|76072463|FG000|Overall Study|Elevated Serum Creatinine|0|||
42247653|NCT02739594|76072464|FG001|Overall Study|Elevated Serum Creatinine|1|||
42247654|NCT02739594|76072463|FG000|Overall Study|Other|6|||
42247655|NCT02739594|76072464|FG001|Overall Study|Other|2|||
42247656|NCT03989232|76072473|FG000|Overall Study|Lost to Follow-up|3|||
42247657|NCT03989232|76072474|FG001|Overall Study|Lost to Follow-up|10|||
42247658|NCT03989232|76072473|FG000|Overall Study|Withdrawal by Subject|6|||
42247659|NCT03989232|76072474|FG001|Overall Study|Withdrawal by Subject|6|||
42032946|NCT00943917|75841135|FG013|Stage II Continuation|Protocol Violation|0|||
42032947|NCT00943917|75841136|FG014|Stage II Continuation|Protocol Violation|0|||
42247660|NCT03989232|76072473|FG000|Overall Study|Death|1|||
42247661|NCT03989232|76072474|FG001|Overall Study|Death|2|||
42247662|NCT02585830|76072480|FG000|Overall Study|Withdrawal by Subject|3|||
42247663|NCT02584504|76072487|FG000|Double-blind Treatment|Participant withdrew consent|0|||
42247664|NCT02584504|76072488|FG001|Double-blind Treatment|Participant withdrew consent|0|||
42247665|NCT02584504|76072489|FG002|Double-blind Treatment|Participant withdrew consent|1|||
42032948|NCT00943917|75841122|FG000|Stage II Continuation|hypoglycemia|0|||
42032949|NCT00943917|75841123|FG001|Stage II Continuation|hypoglycemia|0|||
42247666|NCT02584504|76072487|FG000|Double-blind Treatment|Adverse Event|0|||
42247667|NCT02584504|76072488|FG001|Double-blind Treatment|Adverse Event|1|||
42247668|NCT02584504|76072489|FG002|Double-blind Treatment|Adverse Event|0|||
42247669|NCT02584504|76072487|FG000|Double-blind Treatment|Family Matter|0|||
42247670|NCT02584504|76072488|FG001|Double-blind Treatment|Family Matter|1|||
42247671|NCT02584504|76072489|FG002|Double-blind Treatment|Family Matter|0|||
42247672|NCT02584504|76072487|FG000|Open-label Treatment|Participant withdrew consent|0|||
42247673|NCT02584504|76072488|FG001|Open-label Treatment|Participant withdrew consent|0|||
42247674|NCT02584504|76072489|FG002|Open-label Treatment|Participant withdrew consent|4|||
42247675|NCT02584504|76072487|FG000|Open-label Treatment|Adverse Event|2|||
42247676|NCT02584504|76072488|FG001|Open-label Treatment|Adverse Event|2|||
42247677|NCT02584504|76072489|FG002|Open-label Treatment|Adverse Event|3|||
42247678|NCT02584504|76072487|FG000|Open-label Treatment|Physician Decision|0|||
42247679|NCT02584504|76072488|FG001|Open-label Treatment|Physician Decision|1|||
42247680|NCT02584504|76072489|FG002|Open-label Treatment|Physician Decision|0|||
42247681|NCT02584504|76072487|FG000|Open-label Treatment|Entered but not treated|0|||
42247682|NCT02584504|76072488|FG001|Open-label Treatment|Entered but not treated|1|||
42247683|NCT02584504|76072489|FG002|Open-label Treatment|Entered but not treated|1|||
42247684|NCT04354155|76072514|FG000|Overall Study|Withdrawal by Subject|1|||
42247685|NCT04354155|76072514|FG000|Overall Study|Did not meet criteria for study intervention|1|||
41989965|NCT03224819|75797950|FG002|Overall Study|Withdrawal by Subject|0|||
41989966|NCT03224819|75797951|FG003|Overall Study|Withdrawal by Subject|0|||
42247686|NCT02586064|76072520|FG000|Overall Study|Other Obligations|6|||
42247687|NCT02586064|76072521|FG001|Overall Study|Other Obligations|6|||
42247688|NCT02586064|76072520|FG000|Overall Study|Other|3|||
42247689|NCT02586064|76072521|FG001|Overall Study|Other|7|||
42247690|NCT02586064|76072520|FG000|Overall Study|Never Started|3|||
42247691|NCT02586064|76072521|FG001|Overall Study|Never Started|3|||
42247692|NCT02586064|76072520|FG000|Overall Study|Lost Interest|1|||
42247693|NCT02586064|76072521|FG001|Overall Study|Lost Interest|4|||
42247694|NCT02586064|76072520|FG000|Overall Study|Miscellaneous Life Issues|0|||
42247695|NCT02586064|76072521|FG001|Overall Study|Miscellaneous Life Issues|5|||
42247696|NCT02586064|76072520|FG000|Overall Study|Infrequent Attendance|2|||
42247697|NCT02586064|76072521|FG001|Overall Study|Infrequent Attendance|1|||
42247698|NCT02586064|76072520|FG000|Overall Study|Timed Out|2|||
42247699|NCT02586064|76072521|FG001|Overall Study|Timed Out|0|||
42247700|NCT02586064|76072520|FG000|Overall Study|AUD relapse|0|||
42247701|NCT02586064|76072521|FG001|Overall Study|AUD relapse|2|||
42247702|NCT02586064|76072520|FG000|Overall Study|Legal Issue|1|||
42247703|NCT02586064|76072521|FG001|Overall Study|Legal Issue|0|||
42247704|NCT03810495|76072530|FG000|Overall Study|Lost to Follow-up|2|||
42247705|NCT03810495|76072530|FG000|Overall Study|Withdrawal by Subject|1|||
42247706|NCT02782923|76072534|FG000|Overall Study|Lost to Follow-up|15|||
42247707|NCT03760458|76072543|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
42247708|NCT03760458|76072544|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
42247709|NCT03760458|76072545|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
42247710|NCT03760458|76072546|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
42247711|NCT03760458|76072547|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
42247712|NCT02066415|76072562|FG000|Overall Study|Decision by Sponsor|5|||
42247713|NCT02066415|76072563|FG001|Overall Study|Decision by Sponsor|4|||
42247714|NCT02066415|76072564|FG002|Overall Study|Decision by Sponsor|2|||
42247715|NCT02066415|76072562|FG000|Overall Study|Withdrawal by Subject|9|||
42247716|NCT02066415|76072563|FG001|Overall Study|Withdrawal by Subject|1|||
42247717|NCT02066415|76072564|FG002|Overall Study|Withdrawal by Subject|4|||
42247718|NCT02066415|76072562|FG000|Overall Study|Lost to Follow-up|7|||
42247719|NCT02066415|76072563|FG001|Overall Study|Lost to Follow-up|2|||
42247720|NCT02066415|76072564|FG002|Overall Study|Lost to Follow-up|2|||
42247721|NCT02583256|76072576|FG000|Overall Study|Withdrawal by Subject|0|||
42247722|NCT02583256|76072577|FG001|Overall Study|Withdrawal by Subject|1|||
42247723|NCT02583256|76072578|FG002|Overall Study|Withdrawal by Subject|1|||
42247724|NCT02583256|76072579|FG003|Overall Study|Withdrawal by Subject|0|||
42247725|NCT02583256|76072576|FG000|Overall Study|Lost to Follow-up|1|||
42247726|NCT02583256|76072577|FG001|Overall Study|Lost to Follow-up|1|||
42247727|NCT02583256|76072578|FG002|Overall Study|Lost to Follow-up|0|||
42247728|NCT02583256|76072579|FG003|Overall Study|Lost to Follow-up|1|||
42247729|NCT02583256|76072576|FG000|Overall Study|Administrative/Other|2|||
42247730|NCT02583256|76072577|FG001|Overall Study|Administrative/Other|0|||
42247731|NCT02583256|76072578|FG002|Overall Study|Administrative/Other|1|||
42247732|NCT02583256|76072579|FG003|Overall Study|Administrative/Other|2|||
42247733|NCT02584660|76072602|FG000|Overall Study|Adverse Event|4|||
42247734|NCT02584660|76072603|FG001|Overall Study|Adverse Event|0|||
42303287|NCT02409667|76138603|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
42247735|NCT02584660|76072602|FG000|Overall Study|Lost to Follow-up|3|||
42247736|NCT02584660|76072603|FG001|Overall Study|Lost to Follow-up|4|||
42247737|NCT02584660|76072602|FG000|Overall Study|Protocol Violation|0|||
42247738|NCT02584660|76072603|FG001|Overall Study|Protocol Violation|1|||
42247739|NCT02584660|76072602|FG000|Overall Study|Withdrawal by Subject|0|||
42032950|NCT00943917|75841124|FG002|Stage II Continuation|hypoglycemia|0|||
42247740|NCT02584660|76072603|FG001|Overall Study|Withdrawal by Subject|2|||
42247741|NCT02584660|76072602|FG000|Overall Study|Other|0|||
42247742|NCT02584660|76072603|FG001|Overall Study|Other|1|||
42247743|NCT02582632|76072625|FG000|Overall Study|Other|1|||
42247744|NCT02178722|76072634|FG000|Overall Study|Withdrawal by Subject|0|||
42247745|NCT02178722|76072635|FG001|Overall Study|Withdrawal by Subject|0|||
42247746|NCT02178722|76072636|FG002|Overall Study|Withdrawal by Subject|0|||
42247747|NCT02178722|76072637|FG003|Overall Study|Withdrawal by Subject|2|||
42247748|NCT02178722|76072638|FG004|Overall Study|Withdrawal by Subject|33|||
42247749|NCT02178722|76072634|FG000|Overall Study|Death|2|||
42303288|NCT02409667|76138604|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
42303289|NCT02409667|76138605|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
42303290|NCT02409667|76138606|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
42303291|NCT02409667|76138607|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
42303292|NCT02409667|76138603|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
42303293|NCT02409667|76138604|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
42303294|NCT02409667|76138605|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
42247750|NCT02178722|76072635|FG001|Overall Study|Death|13|||
42247751|NCT02178722|76072636|FG002|Overall Study|Death|12|||
42247752|NCT02178722|76072637|FG003|Overall Study|Death|12|||
42247753|NCT02178722|76072638|FG004|Overall Study|Death|205|||
42247754|NCT02178722|76072634|FG000|Overall Study|Lost to Follow-up|0|||
42247755|NCT02178722|76072635|FG001|Overall Study|Lost to Follow-up|0|||
42247756|NCT02178722|76072636|FG002|Overall Study|Lost to Follow-up|0|||
42247757|NCT02178722|76072637|FG003|Overall Study|Lost to Follow-up|2|||
42247758|NCT02178722|76072638|FG004|Overall Study|Lost to Follow-up|11|||
42247759|NCT02178722|76072634|FG000|Overall Study|Study terminated by Sponsor|2|||
42247760|NCT02178722|76072635|FG001|Overall Study|Study terminated by Sponsor|7|||
42247761|NCT02178722|76072636|FG002|Overall Study|Study terminated by Sponsor|6|||
42247762|NCT02178722|76072637|FG003|Overall Study|Study terminated by Sponsor|4|||
42247763|NCT02178722|76072638|FG004|Overall Study|Study terminated by Sponsor|128|||
42247764|NCT02178722|76072634|FG000|Overall Study|Physician Decision|0|||
42247765|NCT02178722|76072635|FG001|Overall Study|Physician Decision|0|||
42247766|NCT02178722|76072636|FG002|Overall Study|Physician Decision|0|||
42247767|NCT02178722|76072637|FG003|Overall Study|Physician Decision|0|||
42247768|NCT02178722|76072638|FG004|Overall Study|Physician Decision|3|||
42247769|NCT02178722|76072634|FG000|Overall Study|Other|0|||
42247770|NCT02178722|76072635|FG001|Overall Study|Other|0|||
42303295|NCT02409667|76138606|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
42247771|NCT02178722|76072636|FG002|Overall Study|Other|0|||
42247772|NCT02178722|76072637|FG003|Overall Study|Other|0|||
42247773|NCT02178722|76072638|FG004|Overall Study|Other|2|||
42247774|NCT00972309|76072655|FG000|Overall Study|Switched to alternative treatment|0|||
42247775|NCT00972309|76072656|FG001|Overall Study|Switched to alternative treatment|2|||
42247776|NCT00972309|76072655|FG000|Overall Study|Refused further treatment|0|||
42247777|NCT00972309|76072656|FG001|Overall Study|Refused further treatment|1|||
42247778|NCT00972309|76072655|FG000|Overall Study|Late determination of ineligibility|0|||
42247779|NCT00972309|76072656|FG001|Overall Study|Late determination of ineligibility|1|||
42247780|NCT00972309|76072655|FG000|Overall Study|Second malignancy|1|||
42247781|NCT00972309|76072656|FG001|Overall Study|Second malignancy|1|||
42247782|NCT00972309|76072655|FG000|Overall Study|Visa issues|0|||
42247783|NCT00972309|76072656|FG001|Overall Study|Visa issues|1|||
42247784|NCT00972309|76072655|FG000|Overall Study|Secondary cancer (SCC)|0|||
42247785|NCT00972309|76072656|FG001|Overall Study|Secondary cancer (SCC)|1|||
42247786|NCT00972309|76072655|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
42247787|NCT00972309|76072656|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
42247788|NCT00972309|76072655|FG000|Overall Study|Lost to Follow-up|1|||
42247789|NCT00972309|76072656|FG001|Overall Study|Lost to Follow-up|1|||
42247790|NCT00972309|76072655|FG000|Overall Study|Disease progression on study|10|||
42247791|NCT00972309|76072656|FG001|Overall Study|Disease progression on study|4|||
42247792|NCT02582242|76072675|FG000|Overall Study|Adverse Event|4|||
42247793|NCT02582242|76072676|FG001|Overall Study|Adverse Event|3|||
42247794|NCT02582242|76072675|FG000|Overall Study|Protocol Violation|3|||
42247795|NCT02582242|76072676|FG001|Overall Study|Protocol Violation|1|||
42247796|NCT02582242|76072675|FG000|Overall Study|Lost to Follow-up|0|||
42247797|NCT02582242|76072676|FG001|Overall Study|Lost to Follow-up|1|||
42247798|NCT02582242|76072675|FG000|Overall Study|Withdrawal by Subject|11|||
42247799|NCT02582242|76072676|FG001|Overall Study|Withdrawal by Subject|11|||
42247800|NCT02582242|76072675|FG000|Overall Study|Unclassified|2|||
42247801|NCT02582242|76072676|FG001|Overall Study|Unclassified|1|||
42247802|NCT00663351|76072684|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
42247803|NCT00663351|76072685|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
42247804|NCT00663351|76072684|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
42247805|NCT00663351|76072685|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
42247806|NCT00663351|76072684|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
42247807|NCT00663351|76072685|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
42247808|NCT00663351|76072684|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
42247809|NCT00663351|76072685|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
42247810|NCT00663351|76072684|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
42247811|NCT00663351|76072685|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
42247812|NCT00663351|76072684|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
42247813|NCT00663351|76072685|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
42247814|NCT00616941|76072694|FG000|Overall Study|Progressive Disease|1|||
42247815|NCT00616941|76072695|FG001|Overall Study|Progressive Disease|2|||
42247816|NCT00616941|76072696|FG002|Overall Study|Progressive Disease|1|||
42247817|NCT00616941|76072694|FG000|Overall Study|Adverse Event|0|||
42247818|NCT00616941|76072695|FG001|Overall Study|Adverse Event|1|||
42247819|NCT00616941|76072696|FG002|Overall Study|Adverse Event|1|||
42247820|NCT00616941|76072694|FG000|Overall Study|Subject Non-compliance|0|||
42247821|NCT00616941|76072695|FG001|Overall Study|Subject Non-compliance|0|||
42247822|NCT00616941|76072696|FG002|Overall Study|Subject Non-compliance|1|||
42247823|NCT00616941|76072694|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
42247824|NCT00616941|76072695|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
42247825|NCT00616941|76072696|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
42247826|NCT00616941|76072694|FG000|Overall Study|Vaccination Suspended|0|||
42247827|NCT00616941|76072695|FG001|Overall Study|Vaccination Suspended|0|||
42247828|NCT00616941|76072696|FG002|Overall Study|Vaccination Suspended|3|||
42247829|NCT00105560|76072704|FG000|Overall Study|Lost to Follow-up|1|||
42247830|NCT02577718|76072717|FG000|Overall Study|Death|6|||
42247831|NCT02577718|76072717|FG000|Overall Study|Withdrawal by Subject|2|||
42247832|NCT00520533|76072723|FG000|Overall Study|Death|1|||
42247833|NCT00520533|76072723|FG000|Overall Study|Suspension of the study for safety reasons|1|||
42247834|NCT00520533|76072723|FG000|Overall Study|Withdrawal by Subject|1|||
42247835|NCT00520533|76072723|FG000|Overall Study|Physician Decision|1|||
42247836|NCT01664104|76072732|FG000|Overall Study|Adverse Event|6|||
42247837|NCT01664104|76072732|FG000|Overall Study|Lack of Efficacy|2|||
42247838|NCT01664104|76072732|FG000|Overall Study|Withdrawal by Subject|1|||
42247839|NCT01664104|76072732|FG000|Overall Study|Lost to Follow-up|4|||
42247840|NCT01664104|76072732|FG000|Overall Study|Other|1|||
42247841|NCT01664104|76072732|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
42247842|NCT02739984|76072740|FG000|Overall Study|Sponsor Decision|1|||
42247843|NCT02739984|76072741|FG001|Overall Study|Sponsor Decision|0|||
42247844|NCT02739984|76072740|FG000|Overall Study|Withdrawal by Subject|1|||
42247845|NCT02739984|76072741|FG001|Overall Study|Withdrawal by Subject|1|||
42247846|NCT02739984|76072740|FG000|Overall Study|Death|0|||
42247847|NCT02739984|76072741|FG001|Overall Study|Death|1|||
42247848|NCT02739984|76072740|FG000|Overall Study|Lost to Follow-up|3|||
42247849|NCT02739984|76072741|FG001|Overall Study|Lost to Follow-up|0|||
42247850|NCT00496730|76072749|FG000|Overall Study|Lost to Follow-up|4|||
42247851|NCT00496730|76072750|FG001|Overall Study|Lost to Follow-up|3|||
42247852|NCT00496730|76072749|FG000|Overall Study|Withdrawal by Subject|2|||
42247853|NCT00496730|76072750|FG001|Overall Study|Withdrawal by Subject|2|||
42247854|NCT02739828|76072756|FG000|Overall Study|Adverse Event|1|||
42247855|NCT02739828|76072756|FG000|Overall Study|Lost to Follow-up|4|||
42247856|NCT04435808|76072771|FG000|Overall Study|Study stopped by DSMB|0|||
42247857|NCT04435808|76072772|FG001|Overall Study|Study stopped by DSMB|1|||
42247858|NCT01664494|76072795|FG000|Overall Study|Withdrawal by Subject|27|||
42247859|NCT01664494|76072795|FG000|Overall Study|Death|18|||
42247860|NCT01664494|76072795|FG000|Overall Study|Other|49|||
42247861|NCT01664494|76072795|FG000|Overall Study|Lost to Follow-up|99|||
42247862|NCT02577016|76072801|FG000|Overall Study|Adverse Event|2|||
42247863|NCT02577016|76072802|FG001|Overall Study|Adverse Event|1|||
42247864|NCT02577016|76072801|FG000|Overall Study|Physician Decision|0|||
42247865|NCT02577016|76072802|FG001|Overall Study|Physician Decision|1|||
42247866|NCT05101252|76072810|FG000|Overall Study|Unsatisfactory Test Article|1|||
42247867|NCT05101252|76072811|FG001|Overall Study|Unsatisfactory Test Article|0|||
42247868|NCT05101252|76072810|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
42247869|NCT05101252|76072811|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
42247870|NCT05101252|76072810|FG000|Overall Study|Withdrew Consent during study|0|||
42247871|NCT05101252|76072811|FG001|Overall Study|Withdrew Consent during study|1|||
42247872|NCT05101252|76072810|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
42247873|NCT05101252|76072811|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
42247874|NCT03316586|76072817|FG000|Overall Study|Adverse Event|2|||
42247875|NCT03316586|76072817|FG000|Overall Study|Physician Decision|3|||
42247876|NCT03316586|76072817|FG000|Overall Study|Lack of Efficacy|10|||
42247877|NCT03316586|76072817|FG000|Overall Study|still on treatment|1|||
42247878|NCT03316586|76072817|FG000|Overall Study|Patient needed radiation therapy|1|||
42247879|NCT03316586|76072817|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
42247880|NCT00107991|76072821|FG000|Eligibility Assessment|Disease not severe enough|7|||
42247881|NCT00107991|76072821|FG000|Eligibility Assessment|Unwilling to participate|7|||
42247882|NCT00107991|76072821|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
42247883|NCT00107991|76072821|FG000|Eligibility Assessment|Abnormal labs|2|||
42247884|NCT00107991|76072821|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
42247885|NCT00107991|76072821|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
42247886|NCT00107991|76072821|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
42247887|NCT00107991|76072821|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
42247888|NCT00107991|76072821|FG000|12 Week Treatment Period|Adverse Event|1|||
42247889|NCT00107991|76072821|FG000|12 Week Treatment Period|Protocol Violation|1|||
42247890|NCT00107991|76072821|FG000|12 Week Treatment Period|Incarcerated|1|||
42247891|NCT00107991|76072821|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
42247892|NCT00492856|76072825|FG000|Induction|Adverse Event|2|||
42247893|NCT00492856|76072826|FG001|Induction|Adverse Event|0|||
42247894|NCT00492856|76072827|FG002|Induction|Adverse Event|0|||
42247895|NCT00492856|76072828|FG003|Induction|Adverse Event|0|||
42247896|NCT00492856|76072825|FG000|Induction|Withdrawal by Subject|1|||
42247897|NCT00492856|76072826|FG001|Induction|Withdrawal by Subject|0|||
42247898|NCT00492856|76072827|FG002|Induction|Withdrawal by Subject|0|||
42247899|NCT00492856|76072828|FG003|Induction|Withdrawal by Subject|0|||
42247900|NCT00492856|76072825|FG000|Induction|Death|3|||
42247901|NCT00492856|76072826|FG001|Induction|Death|0|||
42247902|NCT00492856|76072827|FG002|Induction|Death|0|||
42247903|NCT00492856|76072828|FG003|Induction|Death|0|||
42247904|NCT00492856|76072825|FG000|Consolidation|Adverse Event|6|||
42247905|NCT00492856|76072826|FG001|Consolidation|Adverse Event|0|||
42247906|NCT00492856|76072827|FG002|Consolidation|Adverse Event|0|||
42247907|NCT00492856|76072828|FG003|Consolidation|Adverse Event|0|||
42247908|NCT00492856|76072825|FG000|Consolidation|Not protocol specified|2|||
42247909|NCT00492856|76072826|FG001|Consolidation|Not protocol specified|0|||
42247910|NCT00492856|76072827|FG002|Consolidation|Not protocol specified|0|||
42247911|NCT00492856|76072828|FG003|Consolidation|Not protocol specified|0|||
42247912|NCT00492856|76072825|FG000|Consolidation|Lost to Follow-up|1|||
42247913|NCT00492856|76072826|FG001|Consolidation|Lost to Follow-up|0|||
42247914|NCT00492856|76072827|FG002|Consolidation|Lost to Follow-up|0|||
42247915|NCT00492856|76072828|FG003|Consolidation|Lost to Follow-up|0|||
42247916|NCT00492856|76072825|FG000|Post-consolidation|Adverse Event|0|||
42247917|NCT00492856|76072826|FG001|Post-consolidation|Adverse Event|4|||
42247918|NCT00492856|76072827|FG002|Post-consolidation|Adverse Event|0|||
42247919|NCT00492856|76072828|FG003|Post-consolidation|Adverse Event|1|||
42247920|NCT00492856|76072825|FG000|Post-consolidation|Withdrawal by Subject|0|||
42247921|NCT00492856|76072826|FG001|Post-consolidation|Withdrawal by Subject|4|||
42247922|NCT00492856|76072827|FG002|Post-consolidation|Withdrawal by Subject|0|||
42247923|NCT00492856|76072828|FG003|Post-consolidation|Withdrawal by Subject|0|||
42247924|NCT00492856|76072825|FG000|Post-consolidation|Death|0|||
42247925|NCT00492856|76072826|FG001|Post-consolidation|Death|1|||
42247926|NCT00492856|76072827|FG002|Post-consolidation|Death|0|||
42247927|NCT00492856|76072828|FG003|Post-consolidation|Death|0|||
42247928|NCT00492856|76072825|FG000|Post-consolidation|Not protocol specified|0|||
42247929|NCT00492856|76072826|FG001|Post-consolidation|Not protocol specified|1|||
42247930|NCT00492856|76072827|FG002|Post-consolidation|Not protocol specified|0|||
42247931|NCT00492856|76072828|FG003|Post-consolidation|Not protocol specified|0|||
42247932|NCT00492856|76072825|FG000|Post-consolidation|Lost to Follow-up|0|||
42247933|NCT00492856|76072826|FG001|Post-consolidation|Lost to Follow-up|2|||
42247934|NCT00492856|76072827|FG002|Post-consolidation|Lost to Follow-up|0|||
42247935|NCT00492856|76072828|FG003|Post-consolidation|Lost to Follow-up|0|||
42247936|NCT00492856|76072825|FG000|Post-consolidation|Observation Arm|0|||
42247937|NCT00492856|76072826|FG001|Post-consolidation|Observation Arm|0|||
42247938|NCT00492856|76072827|FG002|Post-consolidation|Observation Arm|27|||
42247939|NCT00492856|76072828|FG003|Post-consolidation|Observation Arm|0|||
42247940|NCT02782377|76072840|FG000|Overall Study|Physician Decision|5|||
42247941|NCT02410629|76072847|FG000|Overall Study|Family cannot commit to the study|2|||
42032951|NCT00943917|75841125|FG003|Stage II Continuation|hypoglycemia|0|||
42032952|NCT00943917|75841126|FG004|Stage II Continuation|hypoglycemia|0|||
42032953|NCT00943917|75841127|FG005|Stage II Continuation|hypoglycemia|0|||
42247942|NCT02410629|76072848|FG001|Overall Study|Family cannot commit to the study|1|||
42032954|NCT00943917|75841128|FG006|Stage II Continuation|hypoglycemia|0|||
42247943|NCT02410629|76072847|FG000|Overall Study|Subject returned to work|1|||
42247944|NCT02410629|76072848|FG001|Overall Study|Subject returned to work|0|||
42247945|NCT02410629|76072847|FG000|Overall Study|Subject moved back to home country|0|||
42247946|NCT02410629|76072848|FG001|Overall Study|Subject moved back to home country|1|||
42247947|NCT02410629|76072847|FG000|Overall Study|Subject underwent heart surgery|0|||
42247948|NCT02410629|76072848|FG001|Overall Study|Subject underwent heart surgery|1|||
42247949|NCT02252211|76072856|FG000|Overall Study|Adverse Event|0|||
42247950|NCT02252211|76072857|FG001|Overall Study|Adverse Event|1|||
42247951|NCT02252211|76072858|FG002|Overall Study|Adverse Event|0|||
42247952|NCT02252211|76072856|FG000|Overall Study|Progressive disease|3|||
42247953|NCT02252211|76072857|FG001|Overall Study|Progressive disease|2|||
42247954|NCT02252211|76072858|FG002|Overall Study|Progressive disease|0|||
42247955|NCT02252211|76072856|FG000|Overall Study|Withdrawal by Subject|1|||
42247956|NCT02252211|76072857|FG001|Overall Study|Withdrawal by Subject|0|||
42247957|NCT02252211|76072858|FG002|Overall Study|Withdrawal by Subject|0|||
42247958|NCT02252211|76072856|FG000|Overall Study|Serious Adverse Event During Screening|1|||
42247959|NCT02252211|76072857|FG001|Overall Study|Serious Adverse Event During Screening|0|||
42247960|NCT02252211|76072858|FG002|Overall Study|Serious Adverse Event During Screening|1|||
42247961|NCT02776683|76072865|FG000|Pre-switch Period|Protocol Violation|1|||
42247962|NCT02776683|76072866|FG001|Pre-switch Period|Protocol Violation|0|||
42247963|NCT02776683|76072865|FG000|Pre-switch Period|Adverse Event|21|||
42247964|NCT02776683|76072866|FG001|Pre-switch Period|Adverse Event|0|||
42247965|NCT02776683|76072865|FG000|Pre-switch Period|Withdrawal by Subject|9|||
42247966|NCT02776683|76072866|FG001|Pre-switch Period|Withdrawal by Subject|0|||
42247967|NCT02776683|76072865|FG000|Pre-switch Period|Physician Decision|7|||
42247968|NCT02776683|76072866|FG001|Pre-switch Period|Physician Decision|0|||
42247969|NCT02776683|76072865|FG000|Pre-switch Period|Progressive disease|39|||
42247970|NCT02776683|76072866|FG001|Pre-switch Period|Progressive disease|0|||
42247971|NCT02776683|76072865|FG000|Pre-switch Period|Other than listed|3|||
42247972|NCT02776683|76072866|FG001|Pre-switch Period|Other than listed|0|||
42247973|NCT02776683|76072865|FG000|Post-switch Period|Adverse Event|0|||
42247974|NCT02776683|76072866|FG001|Post-switch Period|Adverse Event|3|||
42247975|NCT02776683|76072865|FG000|Post-switch Period|Withdrawal by Subject|0|||
42247976|NCT02776683|76072866|FG001|Post-switch Period|Withdrawal by Subject|2|||
42247977|NCT02776683|76072865|FG000|Post-switch Period|Physician Decision|0|||
42247978|NCT02776683|76072866|FG001|Post-switch Period|Physician Decision|3|||
42247979|NCT02776683|76072865|FG000|Post-switch Period|Progressive disease|0|||
42247980|NCT02776683|76072866|FG001|Post-switch Period|Progressive disease|20|||
42247981|NCT02776683|76072865|FG000|Post-switch Period|Other than listed|0|||
42247982|NCT02776683|76072866|FG001|Post-switch Period|Other than listed|15|||
42247983|NCT02731742|76072874|FG000|Overall Study|Death|1|||
42247984|NCT02731742|76072875|FG001|Overall Study|Death|2|||
42247985|NCT02731742|76072876|FG002|Overall Study|Death|5|||
42247986|NCT02731742|76072877|FG003|Overall Study|Death|0|||
42247987|NCT02731742|76072874|FG000|Overall Study|Physician Decision|0|||
42247988|NCT02731742|76072875|FG001|Overall Study|Physician Decision|0|||
42247989|NCT02731742|76072876|FG002|Overall Study|Physician Decision|0|||
42247990|NCT02731742|76072877|FG003|Overall Study|Physician Decision|1|||
42247991|NCT02731742|76072874|FG000|Overall Study|Study Terminated by Sponsor|2|||
42247992|NCT02731742|76072875|FG001|Overall Study|Study Terminated by Sponsor|1|||
42247993|NCT02731742|76072876|FG002|Overall Study|Study Terminated by Sponsor|1|||
42247994|NCT02731742|76072877|FG003|Overall Study|Study Terminated by Sponsor|1|||
42247995|NCT00104871|76072900|FG000|Overall Study|Not evaluable|1|||
42247996|NCT03487796|76072908|FG000|Overall Study|Lost to Follow-up|18|||
42247997|NCT03487796|76072909|FG001|Overall Study|Lost to Follow-up|6|||
42247998|NCT02148705|76072924|FG000|Overall Study|Death|2|||
42247999|NCT02148705|76072925|FG001|Overall Study|Death|0|||
42248000|NCT02148705|76072926|FG002|Overall Study|Death|0|||
42248001|NCT02148705|76072924|FG000|Overall Study|Lost to Follow-up|13|||
42248002|NCT02148705|76072925|FG001|Overall Study|Lost to Follow-up|4|||
42248003|NCT02148705|76072926|FG002|Overall Study|Lost to Follow-up|10|||
42248004|NCT02148705|76072924|FG000|Overall Study|Withdrawal by Subject|3|||
42248005|NCT02148705|76072925|FG001|Overall Study|Withdrawal by Subject|0|||
42248006|NCT02148705|76072926|FG002|Overall Study|Withdrawal by Subject|2|||
42248007|NCT02148705|76072924|FG000|Overall Study|Not Treated|0|||
42248008|NCT02148705|76072925|FG001|Overall Study|Not Treated|1|||
42248009|NCT02148705|76072926|FG002|Overall Study|Not Treated|5|||
42248010|NCT03446612|76072936|FG000|Overall Study|Protocol defined stopping criteria|0|||
42248011|NCT03446612|76072937|FG001|Overall Study|Protocol defined stopping criteria|1|||
42248012|NCT02730728|76072948|FG000|Overall Study|Withdrawal by Subject|0|||
42248013|NCT02730728|76072949|FG001|Overall Study|Withdrawal by Subject|1|||
42248014|NCT02730728|76072950|FG002|Overall Study|Withdrawal by Subject|0|||
42248015|NCT02730728|76072948|FG000|Overall Study|Lack of Efficacy|0|||
42248016|NCT02730728|76072949|FG001|Overall Study|Lack of Efficacy|1|||
42248017|NCT02730728|76072950|FG002|Overall Study|Lack of Efficacy|1|||
42248018|NCT00104637|76072958|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
42248019|NCT00104637|76072959|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
42248020|NCT02768103|76072968|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
42248021|NCT02767323|76072977|FG000|Overall Study|Withdrawal by Subject|17|||
42248022|NCT02767323|76072978|FG001|Overall Study|Withdrawal by Subject|5|||
42248023|NCT02767323|76072979|FG002|Overall Study|Withdrawal by Subject|13|||
42248024|NCT02767323|76072980|FG003|Overall Study|Withdrawal by Subject|0|||
42248025|NCT02767323|76072977|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
42248026|NCT02767323|76072978|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
42248027|NCT02767323|76072979|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
42248028|NCT02767323|76072980|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
42248029|NCT04304950|76072995|FG000|Overall Study|Lost to Follow-up|1|||
42248030|NCT04304950|76072996|FG001|Overall Study|Lost to Follow-up|1|||
42248031|NCT02780115|76073010|FG000|Overall Study|Withdrawal by Subject|0|||
42248032|NCT02780115|76073011|FG001|Overall Study|Withdrawal by Subject|1|||
42248033|NCT02780115|76073012|FG002|Overall Study|Withdrawal by Subject|1|||
42248034|NCT02780115|76073013|FG003|Overall Study|Withdrawal by Subject|0|||
42248035|NCT02780115|76073014|FG004|Overall Study|Withdrawal by Subject|0|||
42248036|NCT02780115|76073010|FG000|Overall Study|Adverse Event|0|||
42248037|NCT02780115|76073011|FG001|Overall Study|Adverse Event|0|||
42248038|NCT02780115|76073012|FG002|Overall Study|Adverse Event|0|||
42248039|NCT02780115|76073013|FG003|Overall Study|Adverse Event|1|||
42248040|NCT02780115|76073014|FG004|Overall Study|Adverse Event|1|||
42248041|NCT02766777|76073026|FG000|Overall Study|Adverse Event|12|||
42248042|NCT02766777|76073026|FG000|Overall Study|Lost to Follow-up|16|||
42248043|NCT02766777|76073026|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42248044|NCT02766777|76073026|FG000|Overall Study|Protocol Violation|1|||
42248045|NCT02766777|76073026|FG000|Overall Study|Withdrawal by Subject|4|||
42248046|NCT00157014|76073034|FG000|Overall Study|Death|4|||
42248047|NCT00157014|76073035|FG001|Overall Study|Death|2|||
42248048|NCT00157014|76073036|FG002|Overall Study|Death|1|||
42248049|NCT00157014|76073037|FG003|Overall Study|Death|1|||
42248050|NCT00157014|76073034|FG000|Overall Study|Physician Decision|0|||
42248051|NCT00157014|76073035|FG001|Overall Study|Physician Decision|1|||
42248052|NCT00157014|76073036|FG002|Overall Study|Physician Decision|0|||
42248053|NCT00157014|76073037|FG003|Overall Study|Physician Decision|0|||
42248054|NCT00157014|76073034|FG000|Overall Study|Medications withdrawn on family request|0|||
42248055|NCT00157014|76073035|FG001|Overall Study|Medications withdrawn on family request|1|||
42248056|NCT00157014|76073036|FG002|Overall Study|Medications withdrawn on family request|0|||
42248057|NCT00157014|76073037|FG003|Overall Study|Medications withdrawn on family request|0|||
42248058|NCT00157014|76073034|FG000|Overall Study|Patient withdrawn by investigator|1|||
42248059|NCT00157014|76073035|FG001|Overall Study|Patient withdrawn by investigator|0|||
42248060|NCT00157014|76073036|FG002|Overall Study|Patient withdrawn by investigator|0|||
42248061|NCT00157014|76073037|FG003|Overall Study|Patient withdrawn by investigator|0|||
42248062|NCT00157014|76073034|FG000|Overall Study|Patient unable to return in nursing home|1|||
42248063|NCT00157014|76073035|FG001|Overall Study|Patient unable to return in nursing home|0|||
42248064|NCT00157014|76073036|FG002|Overall Study|Patient unable to return in nursing home|0|||
42248065|NCT00157014|76073037|FG003|Overall Study|Patient unable to return in nursing home|0|||
42248066|NCT00157014|76073034|FG000|Overall Study|Patient would not receive transplant|0|||
42248067|NCT00157014|76073035|FG001|Overall Study|Patient would not receive transplant|1|||
42248068|NCT00157014|76073036|FG002|Overall Study|Patient would not receive transplant|0|||
42248069|NCT00157014|76073037|FG003|Overall Study|Patient would not receive transplant|0|||
42248070|NCT00157014|76073034|FG000|Overall Study|Withdrawal by Subject|1|||
42248071|NCT00157014|76073035|FG001|Overall Study|Withdrawal by Subject|0|||
42248072|NCT00157014|76073036|FG002|Overall Study|Withdrawal by Subject|0|||
42248073|NCT00157014|76073037|FG003|Overall Study|Withdrawal by Subject|0|||
42248074|NCT02778867|76073049|FG000|Phase 1|Withdrawal by Subject|2|||
42248075|NCT02778867|76073050|FG001|Phase 1|Withdrawal by Subject|3|||
42248076|NCT02778867|76073051|FG002|Phase 1|Withdrawal by Subject|0|||
42248077|NCT02778867|76073052|FG003|Phase 1|Withdrawal by Subject|0|||
42248078|NCT02778867|76073049|FG000|Phase 2|Withdrawal by Subject|0|||
42248079|NCT02778867|76073050|FG001|Phase 2|Withdrawal by Subject|0|||
42248080|NCT02778867|76073051|FG002|Phase 2|Withdrawal by Subject|1|||
42248081|NCT02778867|76073052|FG003|Phase 2|Withdrawal by Subject|0|||
42248082|NCT02778867|76073049|FG000|Phase 2|Physician Decision|0|||
42248083|NCT02778867|76073050|FG001|Phase 2|Physician Decision|0|||
42248084|NCT02778867|76073051|FG002|Phase 2|Physician Decision|0|||
42248085|NCT02778867|76073052|FG003|Phase 2|Physician Decision|1|||
42248086|NCT02778867|76073049|FG000|Phase 2|Adverse Event|0|||
42248087|NCT02778867|76073050|FG001|Phase 2|Adverse Event|0|||
42248088|NCT02778867|76073051|FG002|Phase 2|Adverse Event|0|||
42248089|NCT02778867|76073052|FG003|Phase 2|Adverse Event|1|||
42248090|NCT02778555|76073065|FG000|Overall Study|Withdrawal by Subject|55|||
42248091|NCT02778555|76073066|FG001|Overall Study|Withdrawal by Subject|32|||
42248092|NCT02778555|76073067|FG002|Overall Study|Withdrawal by Subject|107|||
42248093|NCT02778399|76073081|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
42248094|NCT02778399|76073082|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
42248095|NCT02778399|76073083|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
42248096|NCT02778399|76073084|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
42248097|NCT02778399|76073085|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
42248098|NCT02778399|76073086|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
42248099|NCT02778399|76073081|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
42248100|NCT02778399|76073082|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
42248101|NCT02778399|76073083|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
42248102|NCT02778399|76073084|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
42248103|NCT02778399|76073085|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
42248104|NCT02778399|76073086|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
42248105|NCT02778399|76073081|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
42248106|NCT02778399|76073082|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
42248107|NCT02778399|76073083|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
42248108|NCT02778399|76073084|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
42248109|NCT02778399|76073085|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
42248110|NCT02778399|76073086|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
42248111|NCT02778399|76073081|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
42248112|NCT02778399|76073082|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
42248113|NCT02778399|76073083|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
42248114|NCT02778399|76073084|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
42248115|NCT02778399|76073085|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
42248116|NCT02778399|76073086|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
42248117|NCT02778399|76073081|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
42248118|NCT02778399|76073082|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
42248119|NCT02778399|76073083|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
42248120|NCT02778399|76073084|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
42248121|NCT02778399|76073085|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
42248122|NCT02778399|76073086|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
42248123|NCT02778399|76073081|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
42248124|NCT02778399|76073082|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
42248125|NCT02778399|76073083|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
42248126|NCT02778399|76073084|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
42248127|NCT02778399|76073085|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
42248128|NCT02778399|76073086|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
42248129|NCT02778399|76073081|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
42248130|NCT02778399|76073082|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
42248131|NCT02778399|76073083|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
42248132|NCT02778399|76073084|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
42248133|NCT02778399|76073085|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
42248134|NCT02778399|76073086|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
42248135|NCT02778399|76073081|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
42248136|NCT02778399|76073082|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
42248137|NCT02778399|76073083|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
42248138|NCT02778399|76073084|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
42248139|NCT02778399|76073085|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
42248140|NCT02778399|76073086|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
42248141|NCT02778399|76073081|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
42248142|NCT02778399|76073082|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
42248143|NCT02778399|76073083|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
42248144|NCT02778399|76073084|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
42248145|NCT02778399|76073085|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
42248146|NCT02778399|76073086|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
42248147|NCT02778399|76073081|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
42248148|NCT02778399|76073082|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
42248149|NCT02778399|76073083|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
42248150|NCT02778399|76073084|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
42248151|NCT02778399|76073085|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
42248152|NCT02778399|76073086|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
41989967|NCT03224819|75797952|FG004|Overall Study|Withdrawal by Subject|0|||
41989968|NCT03224819|75797953|FG005|Overall Study|Withdrawal by Subject|0|||
42248153|NCT02778399|76073081|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
42248154|NCT02778399|76073082|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
42248155|NCT02778399|76073083|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
42248156|NCT02778399|76073084|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
42248157|NCT02778399|76073085|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
42248158|NCT02778399|76073086|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
42248159|NCT03656744|76073135|FG000|Overall Study|Adverse Event|1|||
42248160|NCT03656744|76073136|FG001|Overall Study|Adverse Event|4|||
42248161|NCT03656744|76073137|FG002|Overall Study|Adverse Event|1|||
42248162|NCT03656744|76073135|FG000|Overall Study|Protocol Violation|1|||
42248163|NCT03656744|76073136|FG001|Overall Study|Protocol Violation|0|||
42248164|NCT03656744|76073137|FG002|Overall Study|Protocol Violation|0|||
42248165|NCT03656744|76073135|FG000|Overall Study|Lost to Follow-up|2|||
42248166|NCT03656744|76073136|FG001|Overall Study|Lost to Follow-up|2|||
42248167|NCT03656744|76073137|FG002|Overall Study|Lost to Follow-up|0|||
42248168|NCT03656744|76073135|FG000|Overall Study|Withdrawal by Subject|0|||
42248169|NCT03656744|76073136|FG001|Overall Study|Withdrawal by Subject|1|||
42248170|NCT03656744|76073137|FG002|Overall Study|Withdrawal by Subject|0|||
42248171|NCT03656744|76073135|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
42248172|NCT03656744|76073136|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
42248173|NCT03656744|76073137|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
42248174|NCT02739360|76073145|FG000|Overall Study|Adverse Event|1|||
42248175|NCT02739360|76073145|FG000|Overall Study|Study terminated by Sponsor|2|||
42248176|NCT01822522|76073155|FG000|Overall Study|Adverse Event|1|||
42248177|NCT01822522|76073156|FG001|Overall Study|Adverse Event|1|||
42248178|NCT01822522|76073157|FG002|Overall Study|Adverse Event|1|||
42248179|NCT01822522|76073158|FG003|Overall Study|Adverse Event|0|||
42248180|NCT01822522|76073159|FG004|Overall Study|Adverse Event|0|||
42248181|NCT01822522|76073160|FG005|Overall Study|Adverse Event|1|||
42248182|NCT01822522|76073155|FG000|Overall Study|Death|3|||
42248183|NCT01822522|76073156|FG001|Overall Study|Death|0|||
42248184|NCT01822522|76073157|FG002|Overall Study|Death|2|||
42248185|NCT01822522|76073158|FG003|Overall Study|Death|0|||
42248186|NCT01822522|76073159|FG004|Overall Study|Death|0|||
42248187|NCT01822522|76073160|FG005|Overall Study|Death|0|||
42248188|NCT01822522|76073155|FG000|Overall Study|Lost to Follow-up|0|||
42248189|NCT01822522|76073156|FG001|Overall Study|Lost to Follow-up|0|||
42248190|NCT01822522|76073157|FG002|Overall Study|Lost to Follow-up|1|||
42248191|NCT01822522|76073158|FG003|Overall Study|Lost to Follow-up|1|||
42248192|NCT01822522|76073159|FG004|Overall Study|Lost to Follow-up|0|||
42248193|NCT01822522|76073160|FG005|Overall Study|Lost to Follow-up|1|||
42248194|NCT01822522|76073155|FG000|Overall Study|Withdrawal by Subject|0|||
42248195|NCT01822522|76073156|FG001|Overall Study|Withdrawal by Subject|0|||
42248196|NCT01822522|76073157|FG002|Overall Study|Withdrawal by Subject|0|||
42248197|NCT01822522|76073158|FG003|Overall Study|Withdrawal by Subject|1|||
42248198|NCT01822522|76073159|FG004|Overall Study|Withdrawal by Subject|0|||
42248199|NCT01822522|76073160|FG005|Overall Study|Withdrawal by Subject|0|||
42248200|NCT01822522|76073155|FG000|Overall Study|Lack of Efficacy|0|||
42248201|NCT01822522|76073156|FG001|Overall Study|Lack of Efficacy|0|||
42248202|NCT01822522|76073157|FG002|Overall Study|Lack of Efficacy|0|||
42248203|NCT01822522|76073158|FG003|Overall Study|Lack of Efficacy|0|||
42248204|NCT01822522|76073159|FG004|Overall Study|Lack of Efficacy|0|||
42248205|NCT01822522|76073160|FG005|Overall Study|Lack of Efficacy|2|||
42248206|NCT00102687|76073204|FG000|Initial Period|Withdrawal by Subject|6|||
42248207|NCT00102687|76073205|FG001|Initial Period|Withdrawal by Subject|3|||
42248208|NCT00102687|76073206|FG002|Initial Period|Withdrawal by Subject|5|||
42248209|NCT00102687|76073207|FG003|Initial Period|Withdrawal by Subject|0|||
42248210|NCT00102687|76073208|FG004|Initial Period|Withdrawal by Subject|0|||
42248211|NCT00102687|76073204|FG000|Initial Period|Adverse Event|4|||
42248212|NCT00102687|76073205|FG001|Initial Period|Adverse Event|7|||
42248213|NCT00102687|76073206|FG002|Initial Period|Adverse Event|9|||
42248214|NCT00102687|76073207|FG003|Initial Period|Adverse Event|0|||
42248215|NCT00102687|76073208|FG004|Initial Period|Adverse Event|0|||
42248216|NCT00102687|76073204|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
42248217|NCT00102687|76073205|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
42248218|NCT00102687|76073206|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
42248219|NCT00102687|76073207|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
42248220|NCT00102687|76073208|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
42248221|NCT00102687|76073204|FG000|Initial Period|Protocol Violation|0|||
42248222|NCT00102687|76073205|FG001|Initial Period|Protocol Violation|0|||
42248223|NCT00102687|76073206|FG002|Initial Period|Protocol Violation|2|||
42248224|NCT00102687|76073207|FG003|Initial Period|Protocol Violation|0|||
42248225|NCT00102687|76073208|FG004|Initial Period|Protocol Violation|0|||
42248226|NCT00102687|76073204|FG000|Initial Period|Physician Decision|2|||
42248227|NCT00102687|76073205|FG001|Initial Period|Physician Decision|9|||
42248228|NCT00102687|76073206|FG002|Initial Period|Physician Decision|6|||
42248229|NCT00102687|76073207|FG003|Initial Period|Physician Decision|0|||
42248230|NCT00102687|76073208|FG004|Initial Period|Physician Decision|0|||
42248231|NCT00102687|76073204|FG000|Initial Period|Sponsor's decision|0|||
42248232|NCT00102687|76073205|FG001|Initial Period|Sponsor's decision|1|||
42248233|NCT00102687|76073206|FG002|Initial Period|Sponsor's decision|1|||
42248234|NCT00102687|76073207|FG003|Initial Period|Sponsor's decision|0|||
42248235|NCT00102687|76073208|FG004|Initial Period|Sponsor's decision|0|||
42248236|NCT00102687|76073204|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
42248237|NCT00102687|76073205|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
42248238|NCT00102687|76073206|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
42248239|NCT00102687|76073207|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
42248240|NCT00102687|76073208|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
42248241|NCT00102687|76073204|FG000|Initial Period|Death|1|||
42248242|NCT00102687|76073205|FG001|Initial Period|Death|1|||
42248243|NCT00102687|76073206|FG002|Initial Period|Death|1|||
42248244|NCT00102687|76073207|FG003|Initial Period|Death|0|||
42248245|NCT00102687|76073208|FG004|Initial Period|Death|0|||
42248246|NCT00102687|76073204|FG000|Maintenance Period|Withdrawal by Subject|4|||
42248247|NCT00102687|76073205|FG001|Maintenance Period|Withdrawal by Subject|0|||
42248248|NCT00102687|76073206|FG002|Maintenance Period|Withdrawal by Subject|2|||
42248249|NCT00102687|76073207|FG003|Maintenance Period|Withdrawal by Subject|3|||
42248250|NCT00102687|76073208|FG004|Maintenance Period|Withdrawal by Subject|1|||
42248251|NCT00102687|76073204|FG000|Maintenance Period|Adverse Event|1|||
42248252|NCT00102687|76073205|FG001|Maintenance Period|Adverse Event|0|||
42248253|NCT00102687|76073206|FG002|Maintenance Period|Adverse Event|0|||
42248254|NCT00102687|76073207|FG003|Maintenance Period|Adverse Event|1|||
42248255|NCT00102687|76073208|FG004|Maintenance Period|Adverse Event|3|||
42248256|NCT00102687|76073204|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
42248257|NCT00102687|76073205|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
42248258|NCT00102687|76073206|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
42248259|NCT00102687|76073207|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
42248260|NCT00102687|76073208|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
42248261|NCT00102687|76073204|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
42248262|NCT00102687|76073205|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
42248263|NCT00102687|76073206|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
42248264|NCT00102687|76073207|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
42248265|NCT00102687|76073208|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
42132209|NCT00486954|75943051|FG002|Randomized Part|Sponsor Terminated Study|0|||
42248266|NCT00102687|76073204|FG000|Maintenance Period|Death|0|||
42248267|NCT00102687|76073205|FG001|Maintenance Period|Death|0|||
42248268|NCT00102687|76073206|FG002|Maintenance Period|Death|0|||
42248269|NCT00102687|76073207|FG003|Maintenance Period|Death|1|||
42248270|NCT00102687|76073208|FG004|Maintenance Period|Death|1|||
42248271|NCT00102687|76073204|FG000|Maintenance Period|Physician Decision|1|||
42248272|NCT00102687|76073205|FG001|Maintenance Period|Physician Decision|2|||
42248273|NCT00102687|76073206|FG002|Maintenance Period|Physician Decision|3|||
42248274|NCT00102687|76073207|FG003|Maintenance Period|Physician Decision|0|||
42248275|NCT00102687|76073208|FG004|Maintenance Period|Physician Decision|4|||
42248276|NCT00102531|76073226|FG000|Overall Study|Adverse Event|0|||
42248277|NCT00102531|76073227|FG001|Overall Study|Adverse Event|1|||
42248278|NCT00102531|76073226|FG000|Overall Study|Disease Progression|5|||
42248279|NCT00102531|76073227|FG001|Overall Study|Disease Progression|9|||
42248280|NCT00102531|76073226|FG000|Overall Study|Physician Decision|0|||
42248281|NCT00102531|76073227|FG001|Overall Study|Physician Decision|1|||
42248282|NCT02771145|76073233|FG000|Overall Study|Adverse Event|3|||
42248283|NCT02771145|76073233|FG000|Overall Study|Lost to Follow-up|1|||
42248284|NCT02578186|76073253|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
42248285|NCT02578186|76073254|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
42248286|NCT02578186|76073253|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
42248287|NCT02578186|76073254|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
42248288|NCT00103311|76073262|FG000|Overall Study|Lost to Follow-up|1|||
42248289|NCT00103311|76073263|FG001|Overall Study|Lost to Follow-up|0|||
42248290|NCT00103311|76073262|FG000|Overall Study|Withdrawal by Subject|2|||
42248291|NCT00103311|76073263|FG001|Overall Study|Withdrawal by Subject|1|||
42248292|NCT00103311|76073262|FG000|Overall Study|Adverse Event|1|||
42248293|NCT00103311|76073263|FG001|Overall Study|Adverse Event|0|||
42248294|NCT02576938|76073276|FG000|Overall Study|Adverse Event|5|||
42248295|NCT02576938|76073277|FG001|Overall Study|Adverse Event|3|||
42248296|NCT02576938|76073278|FG002|Overall Study|Adverse Event|6|||
42248297|NCT02576938|76073276|FG000|Overall Study|Protocol Violation|1|||
42248298|NCT02576938|76073277|FG001|Overall Study|Protocol Violation|1|||
42248299|NCT02576938|76073278|FG002|Overall Study|Protocol Violation|1|||
42248300|NCT02576938|76073276|FG000|Overall Study|Withdrawal by Subject|3|||
42248301|NCT02576938|76073277|FG001|Overall Study|Withdrawal by Subject|2|||
42248302|NCT02576938|76073278|FG002|Overall Study|Withdrawal by Subject|4|||
42248303|NCT02576938|76073276|FG000|Overall Study|Lack of Efficacy|9|||
42248304|NCT02576938|76073277|FG001|Overall Study|Lack of Efficacy|4|||
42248305|NCT02576938|76073278|FG002|Overall Study|Lack of Efficacy|0|||
42248306|NCT02576938|76073276|FG000|Overall Study|Lost to Follow-up|2|||
42248307|NCT02576938|76073277|FG001|Overall Study|Lost to Follow-up|0|||
42248308|NCT02576938|76073278|FG002|Overall Study|Lost to Follow-up|1|||
42248309|NCT02576938|76073276|FG000|Overall Study|Physician Decision|0|||
42248310|NCT02576938|76073277|FG001|Overall Study|Physician Decision|1|||
42248311|NCT02576938|76073278|FG002|Overall Study|Physician Decision|0|||
42248312|NCT02576938|76073276|FG000|Overall Study|Met Exclusion Criteria|0|||
42248313|NCT02576938|76073277|FG001|Overall Study|Met Exclusion Criteria|1|||
42248314|NCT02576938|76073278|FG002|Overall Study|Met Exclusion Criteria|0|||
42248315|NCT02576860|76073290|FG000|Overall Study|Adverse Event|6|||
42248316|NCT02576860|76073291|FG001|Overall Study|Adverse Event|6|||
42248317|NCT02576860|76073290|FG000|Overall Study|Lost to Follow-up|5|||
42248318|NCT02576860|76073291|FG001|Overall Study|Lost to Follow-up|7|||
42248319|NCT02576860|76073290|FG000|Overall Study|Physician Decision|0|||
42248320|NCT02576860|76073291|FG001|Overall Study|Physician Decision|1|||
42248321|NCT02576860|76073290|FG000|Overall Study|Protocol Violation|0|||
42248322|NCT02576860|76073291|FG001|Overall Study|Protocol Violation|2|||
42248323|NCT02576860|76073290|FG000|Overall Study|Withdrawal by Subject|13|||
42248324|NCT02576860|76073291|FG001|Overall Study|Withdrawal by Subject|8|||
42248325|NCT02576860|76073290|FG000|Overall Study|Disallowed medication|1|||
42248326|NCT02576860|76073291|FG001|Overall Study|Disallowed medication|0|||
42248327|NCT02572570|76073298|FG000|Overall Study|Study Terminated|27|||
42248328|NCT00709202|76073307|FG000|Overall Study|Withdrawal by Subject|6|||
42248329|NCT00709202|76073308|FG001|Overall Study|Withdrawal by Subject|6|||
42248330|NCT00709124|76073317|FG000|Overall Study|Death|3|||
42248331|NCT00709124|76073318|FG001|Overall Study|Death|1|||
42248332|NCT00709124|76073317|FG000|Overall Study|encephalopathy; can't do assessment|1|||
42248333|NCT00709124|76073318|FG001|Overall Study|encephalopathy; can't do assessment|0|||
42248334|NCT02738580|76073330|FG000|Overall Study|Adverse Event|1|||
42248335|NCT02738580|76073331|FG001|Overall Study|Adverse Event|0|||
42248336|NCT02738580|76073330|FG000|Overall Study|Lack of Efficacy|3|||
42248337|NCT02738580|76073331|FG001|Overall Study|Lack of Efficacy|2|||
42248338|NCT02738580|76073330|FG000|Overall Study|Withdrawal by Subject|0|||
42248339|NCT02738580|76073331|FG001|Overall Study|Withdrawal by Subject|1|||
42248340|NCT02738580|76073330|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
42248341|NCT02738580|76073331|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
42248342|NCT02571244|76073339|FG000|Overall Study|Lost to Follow-up|0|||
42248343|NCT02571244|76073340|FG001|Overall Study|Lost to Follow-up|1|||
42248344|NCT02571244|76073339|FG000|Overall Study|Unable to reach out post discharge|3|||
42248345|NCT02571244|76073340|FG001|Overall Study|Unable to reach out post discharge|0|||
42248346|NCT02573350|76073351|FG000|Overall Study|Lost to Follow-up|2|||
42132210|NCT00486954|75943052|FG003|Randomized Part|Sponsor Terminated Study|19|||
42248347|NCT02573350|76073352|FG001|Overall Study|Lost to Follow-up|1|||
42248348|NCT02573350|76073351|FG000|Overall Study|Adverse Event|3|||
42248349|NCT02573350|76073352|FG001|Overall Study|Adverse Event|4|||
42248350|NCT02573350|76073351|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
42248351|NCT02573350|76073352|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
42272689|NCT00857285|76103029|FG001|Overall Study|Lack of Efficacy|2|||
42248352|NCT02573350|76073351|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
42248353|NCT02573350|76073352|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
42248354|NCT02573350|76073351|FG000|Overall Study|Subject withdrew consent to participate|6|||
42248355|NCT02573350|76073352|FG001|Overall Study|Subject withdrew consent to participate|1|||
42248356|NCT02573350|76073351|FG000|Overall Study|Protocol Deviation|1|||
42248357|NCT02573350|76073352|FG001|Overall Study|Protocol Deviation|1|||
42248358|NCT01376804|76073361|FG000|Treatment Period|Withdrawal by Subject|1|||
42248359|NCT01376804|76073361|FG000|Treatment Period|Adverse Event|6|||
42248360|NCT01376804|76073361|FG000|Treatment Period|Patient did not receive study drug|1|||
42248361|NCT02574520|76073369|FG000|Overall Study|Not dosed|2|||
42248362|NCT02574520|76073370|FG001|Overall Study|Not dosed|0|||
42248363|NCT02574520|76073371|FG002|Overall Study|Not dosed|5|||
42248364|NCT02574520|76073372|FG003|Overall Study|Not dosed|4|||
42248365|NCT02574520|76073369|FG000|Overall Study|Adverse Event|0|||
42248366|NCT02574520|76073370|FG001|Overall Study|Adverse Event|0|||
42248367|NCT02574520|76073371|FG002|Overall Study|Adverse Event|0|||
42248368|NCT02574520|76073372|FG003|Overall Study|Adverse Event|1|||
42248369|NCT02574520|76073369|FG000|Overall Study|Withdrawal by Subject|0|||
42248370|NCT02574520|76073370|FG001|Overall Study|Withdrawal by Subject|0|||
42248371|NCT02574520|76073371|FG002|Overall Study|Withdrawal by Subject|0|||
42248372|NCT02574520|76073372|FG003|Overall Study|Withdrawal by Subject|1|||
42248373|NCT02574520|76073369|FG000|Overall Study|Other|0|||
42248374|NCT02574520|76073370|FG001|Overall Study|Other|0|||
42248375|NCT02574520|76073371|FG002|Overall Study|Other|0|||
42248376|NCT02574520|76073372|FG003|Overall Study|Other|2|||
42248377|NCT00709592|76073384|FG000|Overall Study|Unable to proceed to transplant|0|||
42248378|NCT00709592|76073385|FG001|Overall Study|Unable to proceed to transplant|1|||
42248379|NCT02570152|76073391|FG000|Overall Study|Protocol Violation|2|||
42248380|NCT02570152|76073391|FG000|Overall Study|Migrated/moved from study area|13|||
42248381|NCT02570074|76073397|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
42248382|NCT02570074|76073398|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
42248383|NCT02569996|76073416|FG000|Overall Study|Adverse Event|6|||
42248384|NCT02569996|76073416|FG000|Overall Study|Physician Decision|3|||
42248385|NCT02569996|76073416|FG000|Overall Study|Progression of the disease|18|||
42248386|NCT02569996|76073416|FG000|Overall Study|New anti-lymphoma treatment|1|||
42248387|NCT02569996|76073416|FG000|Overall Study|Non-compliance|9|||
42248388|NCT02569996|76073416|FG000|Overall Study|Withdrawal by Subject|5|||
42248389|NCT02569996|76073416|FG000|Overall Study|Lost to Follow-up|5|||
42248390|NCT02569996|76073416|FG000|Overall Study|Complete remission|7|||
42248391|NCT02569996|76073416|FG000|Overall Study|Unknown reason|1|||
42248392|NCT02572882|76073420|FG000|Overall Study|Withdrawal by Subject|1|||
42248393|NCT02572882|76073420|FG000|Overall Study|Participant received kidney transplant|1|||
42248394|NCT00708500|76073450|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
42248395|NCT00708500|76073451|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
42248396|NCT00708500|76073452|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
42248397|NCT00708500|76073450|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
42248398|NCT00708500|76073451|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
42248399|NCT00708500|76073452|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
42248400|NCT00708500|76073450|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
42248401|NCT00708500|76073451|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
42248402|NCT00708500|76073452|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
42248403|NCT00708500|76073450|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
42248404|NCT00708500|76073451|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
42248405|NCT00708500|76073452|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
42248406|NCT00708500|76073450|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
42248407|NCT00708500|76073451|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
42248408|NCT00708500|76073452|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
42248409|NCT00708500|76073450|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
42248410|NCT00708500|76073451|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
42248411|NCT00708500|76073452|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
42248412|NCT00708500|76073450|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
42248413|NCT00708500|76073451|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
42248414|NCT00708500|76073452|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
42248415|NCT00708500|76073450|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
42248416|NCT00708500|76073451|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
42248417|NCT00708500|76073452|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
42248418|NCT00708500|76073450|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
42248419|NCT00708500|76073451|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
42248420|NCT00708500|76073452|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
42248421|NCT00708500|76073450|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
42248422|NCT00708500|76073451|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
42248423|NCT00708500|76073452|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
42248424|NCT00708500|76073450|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
42248425|NCT00708500|76073451|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
42248426|NCT00708500|76073452|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
42248427|NCT00708500|76073450|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
42248428|NCT00708500|76073451|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
42248429|NCT00708500|76073452|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
42248430|NCT00708500|76073450|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
42248431|NCT00708500|76073451|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
42248432|NCT00708500|76073452|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
42248433|NCT00708500|76073450|FG000|FOLLOWUP|Adverse Event|0|||
42248434|NCT00708500|76073451|FG001|FOLLOWUP|Adverse Event|1|||
42248435|NCT00708500|76073452|FG002|FOLLOWUP|Adverse Event|0|||
42248436|NCT00708500|76073450|FG000|FOLLOWUP|Lost to Follow-up|1|||
42248437|NCT00708500|76073451|FG001|FOLLOWUP|Lost to Follow-up|6|||
42248438|NCT00708500|76073452|FG002|FOLLOWUP|Lost to Follow-up|4|||
42248439|NCT00708500|76073450|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
42248440|NCT00708500|76073451|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
42248441|NCT00708500|76073452|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
42248442|NCT00708500|76073450|FG000|FOLLOWUP|Subject withdrew consent|31|||
42248443|NCT00708500|76073451|FG001|FOLLOWUP|Subject withdrew consent|4|||
42248444|NCT00708500|76073452|FG002|FOLLOWUP|Subject withdrew consent|5|||
42248445|NCT00708500|76073450|FG000|FOLLOWUP|Non-compliance with protocol|5|||
42248446|NCT00708500|76073451|FG001|FOLLOWUP|Non-compliance with protocol|0|||
42248447|NCT00708500|76073452|FG002|FOLLOWUP|Non-compliance with protocol|1|||
42248448|NCT00708734|76073469|FG000|Overall Study|scheduling conflict|2|||
42248449|NCT00708734|76073469|FG000|Overall Study|moved|1|||
42248450|NCT00708734|76073469|FG000|Overall Study|leg injury|1|||
42248451|NCT00708734|76073469|FG000|Overall Study|knee replacement|1|||
42248452|NCT00708734|76073469|FG000|Overall Study|vertigo|1|||
42248453|NCT00708734|76073469|FG000|Overall Study|leg fracture|1|||
42248454|NCT04834362|76073475|FG000|Overall Study|Death|1|||
42248455|NCT04834362|76073476|FG001|Overall Study|Death|2|||
42248456|NCT00101907|76073488|FG000|Overall Study|Adverse Event|1|||
42248457|NCT00101907|76073489|FG001|Overall Study|Adverse Event|0|||
42248458|NCT00101907|76073490|FG002|Overall Study|Adverse Event|0|||
42248459|NCT00101907|76073491|FG003|Overall Study|Adverse Event|0|||
42248460|NCT00101907|76073492|FG004|Overall Study|Adverse Event|0|||
42248461|NCT00101907|76073493|FG005|Overall Study|Adverse Event|0|||
42248462|NCT00101907|76073488|FG000|Overall Study|Death|0|||
42248463|NCT00101907|76073489|FG001|Overall Study|Death|1|||
42248464|NCT00101907|76073490|FG002|Overall Study|Death|0|||
42248465|NCT00101907|76073491|FG003|Overall Study|Death|0|||
42248466|NCT00101907|76073492|FG004|Overall Study|Death|3|||
42248467|NCT00101907|76073493|FG005|Overall Study|Death|0|||
42248468|NCT00101907|76073488|FG000|Overall Study|Physician Decision|0|||
42248469|NCT00101907|76073489|FG001|Overall Study|Physician Decision|0|||
42248470|NCT00101907|76073490|FG002|Overall Study|Physician Decision|0|||
42248471|NCT00101907|76073491|FG003|Overall Study|Physician Decision|1|||
42248472|NCT00101907|76073492|FG004|Overall Study|Physician Decision|1|||
42248473|NCT00101907|76073493|FG005|Overall Study|Physician Decision|0|||
42248474|NCT00101907|76073488|FG000|Overall Study|Withdrawal by Subject|1|||
42248475|NCT00101907|76073489|FG001|Overall Study|Withdrawal by Subject|0|||
42248476|NCT00101907|76073490|FG002|Overall Study|Withdrawal by Subject|1|||
42248477|NCT00101907|76073491|FG003|Overall Study|Withdrawal by Subject|0|||
42248478|NCT00101907|76073492|FG004|Overall Study|Withdrawal by Subject|1|||
42248479|NCT00101907|76073493|FG005|Overall Study|Withdrawal by Subject|0|||
42248480|NCT02565784|76073514|FG000|First Treatment|Adverse Event|1|||
42248481|NCT02565784|76073514|FG000|First Treatment|Withdrawal by Subject|1|||
42248482|NCT02565784|76073514|FG000|Second Treatment|Withdrawal by Subject|2|||
42248483|NCT04650204|76073561|FG000|Overall Study|Study was Terminated|2|||
42248484|NCT04650204|76073562|FG001|Overall Study|Study was Terminated|1|||
42248485|NCT02761629|76073570|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
42248486|NCT02761629|76073571|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
42248487|NCT02761629|76073570|FG000|Overall Study|Insufficient Therapeutic Response|2|||
42248488|NCT02761629|76073571|FG001|Overall Study|Insufficient Therapeutic Response|7|||
42248489|NCT02761629|76073570|FG000|Overall Study|Failure to Return|2|||
42248490|NCT02761629|76073571|FG001|Overall Study|Failure to Return|4|||
42248491|NCT02761629|76073570|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
42248492|NCT02761629|76073571|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
42248493|NCT02761629|76073570|FG000|Overall Study|Protocol Violation|2|||
42248494|NCT02761629|76073571|FG001|Overall Study|Protocol Violation|2|||
42248495|NCT02761629|76073570|FG000|Overall Study|Withdrawal by Subject|0|||
42248496|NCT02761629|76073571|FG001|Overall Study|Withdrawal by Subject|3|||
42248497|NCT02761629|76073570|FG000|Overall Study|Other|0|||
42248498|NCT02761629|76073571|FG001|Overall Study|Other|2|||
42248499|NCT02761629|76073570|FG000|Overall Study|Lost to Follow-up|4|||
42248500|NCT02761629|76073571|FG001|Overall Study|Lost to Follow-up|1|||
42248501|NCT02761629|76073570|FG000|Overall Study|Randomized But Not Treated|8|||
42248502|NCT02761629|76073571|FG001|Overall Study|Randomized But Not Treated|4|||
42248503|NCT02760927|76073577|FG000|Overall Study|Tube Slippage from Device|1|||
42248504|NCT00101439|76073583|FG000|Period 2|Withdrawal by Subject|0|||
42248505|NCT00101439|76073584|FG001|Period 2|Withdrawal by Subject|2|||
42248506|NCT04033068|76073594|FG000|Overall Study|Withdrawal by Subject|0|||
42248507|NCT04033068|76073595|FG001|Overall Study|Withdrawal by Subject|0|||
42248508|NCT04033068|76073596|FG002|Overall Study|Withdrawal by Subject|1|||
42248509|NCT04033068|76073597|FG003|Overall Study|Withdrawal by Subject|0|||
42248510|NCT04033068|76073594|FG000|Overall Study|Lost to Follow-up|0|||
42248511|NCT04033068|76073595|FG001|Overall Study|Lost to Follow-up|1|||
42248512|NCT04033068|76073596|FG002|Overall Study|Lost to Follow-up|0|||
42248513|NCT04033068|76073597|FG003|Overall Study|Lost to Follow-up|0|||
42248514|NCT04033068|76073594|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
42248515|NCT04033068|76073595|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
42248516|NCT04033068|76073596|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
42248517|NCT04033068|76073597|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
42248518|NCT02762565|76073607|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
42248519|NCT02757963|76073620|FG000|Overall Study|Adverse Event|3|||
42248520|NCT02757963|76073620|FG000|Overall Study|Reached Stopping Criteria|1054|||
42248521|NCT02757963|76073620|FG000|Overall Study|Lost to Follow-up|5|||
42248522|NCT02757963|76073620|FG000|Overall Study|Physician Decision|1|||
42248523|NCT02757963|76073620|FG000|Overall Study|Withdrawal by Subject|34|||
42248524|NCT03111732|76073635|FG000|Overall Study|Enrolled in different study|1|||
42248525|NCT03111732|76073635|FG000|Overall Study|Progressive disease|3|||
42248526|NCT03111732|76073635|FG000|Overall Study|Withdrawal by Subject|1|||
42248527|NCT01663714|76073644|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
42248528|NCT01663714|76073644|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
42248529|NCT01663714|76073644|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
42248530|NCT01663714|76073644|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
42248531|NCT01663714|76073644|FG000|Long-Term Follow-Up|Death|4|||
42248532|NCT01663714|76073644|FG000|Long-Term Follow-Up|Non-compliance|1|||
42248533|NCT01663636|76073666|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
42248534|NCT01663636|76073667|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
42248535|NCT03065244|76073675|FG000|Overall Study|Lost to Follow-up|1|||
42248536|NCT03065244|76073676|FG001|Overall Study|Lost to Follow-up|1|||
42248537|NCT03065244|76073675|FG000|Overall Study|Diagnosed with a different disease|1|||
42248538|NCT03065244|76073676|FG001|Overall Study|Diagnosed with a different disease|1|||
42248539|NCT03065244|76073675|FG000|Overall Study|Protocol Violation|0|||
42248540|NCT03065244|76073676|FG001|Overall Study|Protocol Violation|1|||
42248541|NCT03065244|76073675|FG000|Overall Study|Withdrawal by Subject|1|||
42248542|NCT03065244|76073676|FG001|Overall Study|Withdrawal by Subject|1|||
42248543|NCT00100815|76073682|FG000|Overall Study|Progression|24|||
42248544|NCT00100815|76073682|FG000|Overall Study|Adverse Event|18|||
42248545|NCT00100815|76073682|FG000|Overall Study|Death|4|||
42248546|NCT00100815|76073682|FG000|Overall Study|Other|3|||
42248547|NCT00708422|76073688|FG000|Overall Study|Adverse Event|3|||
42248548|NCT00708422|76073689|FG001|Overall Study|Adverse Event|1|||
42248549|NCT00708422|76073688|FG000|Overall Study|Withdrawal by Subject|1|||
42248550|NCT00708422|76073689|FG001|Overall Study|Withdrawal by Subject|0|||
42248551|NCT02760069|76073698|FG000|Overall Study|Withdrawal by Subject|0|||
41989969|NCT03224819|75797954|FG006|Overall Study|Withdrawal by Subject|0|||
42132211|NCT00486954|75943053|FG004|Randomized Part|Sponsor Terminated Study|13|||
42132212|NCT00494676|75943063|FG000|Allocation|Withdrawal by Subject|2|||
42132213|NCT00494676|75943064|FG001|Allocation|Withdrawal by Subject|4|||
42132214|NCT00494676|75943063|FG000|First Intervention|Withdrawal by Subject|1|||
42132215|NCT00494676|75943064|FG001|First Intervention|Withdrawal by Subject|3|||
42132216|NCT00494676|75943063|FG000|Second Intervention|Withdrawal by Subject|1|||
42132217|NCT00494676|75943064|FG001|Second Intervention|Withdrawal by Subject|1|||
41989970|NCT03224819|75797955|FG007|Overall Study|Withdrawal by Subject|0|||
41989971|NCT03224819|75797956|FG008|Overall Study|Withdrawal by Subject|0|||
41989972|NCT03224819|75797957|FG009|Overall Study|Withdrawal by Subject|0|||
41989973|NCT03224819|75797958|FG010|Overall Study|Withdrawal by Subject|0|||
41989974|NCT03224819|75797959|FG011|Overall Study|Withdrawal by Subject|0|||
41989975|NCT03224819|75797960|FG012|Overall Study|Withdrawal by Subject|1|||
41989976|NCT03224819|75797961|FG013|Overall Study|Withdrawal by Subject|0|||
41989977|NCT03224819|75797948|FG000|Overall Study|Sponsor Decision|0|||
41989978|NCT03224819|75797949|FG001|Overall Study|Sponsor Decision|0|||
41989979|NCT03224819|75797950|FG002|Overall Study|Sponsor Decision|0|||
41989980|NCT03224819|75797951|FG003|Overall Study|Sponsor Decision|1|||
41989981|NCT03224819|75797952|FG004|Overall Study|Sponsor Decision|1|||
41989982|NCT03224819|75797953|FG005|Overall Study|Sponsor Decision|2|||
41989983|NCT03224819|75797954|FG006|Overall Study|Sponsor Decision|1|||
41989984|NCT03224819|75797955|FG007|Overall Study|Sponsor Decision|1|||
41989985|NCT03224819|75797956|FG008|Overall Study|Sponsor Decision|1|||
41989986|NCT03224819|75797957|FG009|Overall Study|Sponsor Decision|2|||
41989987|NCT03224819|75797958|FG010|Overall Study|Sponsor Decision|1|||
41989988|NCT03224819|75797959|FG011|Overall Study|Sponsor Decision|1|||
41989989|NCT03224819|75797960|FG012|Overall Study|Sponsor Decision|1|||
41989990|NCT03224819|75797961|FG013|Overall Study|Sponsor Decision|0|||
41989991|NCT03224819|75797948|FG000|Overall Study|Lost to Follow-up|0|||
41989992|NCT03224819|75797949|FG001|Overall Study|Lost to Follow-up|0|||
41989993|NCT03224819|75797950|FG002|Overall Study|Lost to Follow-up|0|||
42132218|NCT00486720|75943072|FG000|Overall Study|Adverse Event|1|||
42132219|NCT00486720|75943073|FG001|Overall Study|Adverse Event|2|||
42132220|NCT00486720|75943072|FG000|Overall Study|Lack of Efficacy|4|||
42132221|NCT00486720|75943073|FG001|Overall Study|Lack of Efficacy|6|||
42132222|NCT00486720|75943072|FG000|Overall Study|Physician Decision|1|||
42132223|NCT00486720|75943073|FG001|Overall Study|Physician Decision|2|||
42248552|NCT02760069|76073699|FG001|Overall Study|Withdrawal by Subject|1|||
41989994|NCT03224819|75797951|FG003|Overall Study|Lost to Follow-up|0|||
41989995|NCT03224819|75797952|FG004|Overall Study|Lost to Follow-up|0|||
41989996|NCT03224819|75797953|FG005|Overall Study|Lost to Follow-up|0|||
41989997|NCT03224819|75797954|FG006|Overall Study|Lost to Follow-up|0|||
41989998|NCT03224819|75797955|FG007|Overall Study|Lost to Follow-up|0|||
42132224|NCT00486720|75943072|FG000|Overall Study|Protocol Violation|1|||
42132225|NCT00486720|75943073|FG001|Overall Study|Protocol Violation|0|||
42248553|NCT02760069|76073700|FG002|Overall Study|Withdrawal by Subject|1|||
42248554|NCT00707486|76073708|FG000|Overall Study|Withdrawal by Subject|1|||
41989999|NCT03224819|75797956|FG008|Overall Study|Lost to Follow-up|1|||
41990000|NCT03224819|75797957|FG009|Overall Study|Lost to Follow-up|0|||
41990001|NCT03224819|75797958|FG010|Overall Study|Lost to Follow-up|0|||
41990002|NCT03224819|75797959|FG011|Overall Study|Lost to Follow-up|0|||
41990003|NCT03224819|75797960|FG012|Overall Study|Lost to Follow-up|0|||
41990004|NCT03224819|75797961|FG013|Overall Study|Lost to Follow-up|0|||
41990005|NCT03224819|75797948|FG000|Overall Study|Death|0|||
41990006|NCT03224819|75797949|FG001|Overall Study|Death|1|||
41990007|NCT03224819|75797950|FG002|Overall Study|Death|0|||
41990008|NCT03224819|75797951|FG003|Overall Study|Death|0|||
41990009|NCT03224819|75797952|FG004|Overall Study|Death|0|||
41990010|NCT03224819|75797953|FG005|Overall Study|Death|0|||
41990011|NCT03224819|75797954|FG006|Overall Study|Death|0|||
41990012|NCT03224819|75797955|FG007|Overall Study|Death|1|||
41990013|NCT03224819|75797956|FG008|Overall Study|Death|0|||
41990014|NCT03224819|75797957|FG009|Overall Study|Death|0|||
41990015|NCT03224819|75797958|FG010|Overall Study|Death|0|||
41990016|NCT03224819|75797959|FG011|Overall Study|Death|1|||
41990017|NCT03224819|75797960|FG012|Overall Study|Death|0|||
42248555|NCT02759055|76073716|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
42248556|NCT02759055|76073717|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
42248557|NCT00708032|76073725|FG000|Overall Study|Adverse Event|0|||
42248558|NCT00708032|76073726|FG001|Overall Study|Adverse Event|2|||
42248559|NCT00708032|76073725|FG000|Overall Study|Lost to Follow-up|1|||
42248560|NCT00708032|76073726|FG001|Overall Study|Lost to Follow-up|2|||
42248561|NCT00708032|76073725|FG000|Overall Study|Pregnancy|0|||
42248562|NCT00708032|76073726|FG001|Overall Study|Pregnancy|1|||
42248563|NCT00708032|76073725|FG000|Overall Study|Poor vision|0|||
42248564|NCT00708032|76073726|FG001|Overall Study|Poor vision|6|||
42248565|NCT00708032|76073725|FG000|Overall Study|Visit out of range at month 12|4|||
42248566|NCT00708032|76073726|FG001|Overall Study|Visit out of range at month 12|1|||
42248567|NCT00708032|76073725|FG000|Overall Study|Did not meet protocol criteria|1|||
42248568|NCT00708032|76073726|FG001|Overall Study|Did not meet protocol criteria|2|||
42248569|NCT00708032|76073725|FG000|Overall Study|Protocol Violation|4|||
42248570|NCT00708032|76073726|FG001|Overall Study|Protocol Violation|1|||
42248571|NCT00708032|76073725|FG000|Overall Study|Withdrawal by Subject|0|||
42248572|NCT00708032|76073726|FG001|Overall Study|Withdrawal by Subject|1|||
42248573|NCT00707174|76073734|FG000|Overall Study|Adverse Event|1|||
42248574|NCT00707174|76073735|FG001|Overall Study|Adverse Event|6|||
42248575|NCT00707174|76073734|FG000|Overall Study|Withdrawal by Subject|4|||
42248576|NCT00707174|76073735|FG001|Overall Study|Withdrawal by Subject|1|||
42248577|NCT02756403|76073745|FG000|Overall Study|Unable to swallow medication|0|||
42248578|NCT02756403|76073746|FG001|Overall Study|Unable to swallow medication|1|||
42248579|NCT02756403|76073747|FG002|Overall Study|Unable to swallow medication|1|||
42248580|NCT02756403|76073748|FG003|Overall Study|Unable to swallow medication|1|||
42248581|NCT02756403|76073745|FG000|Overall Study|Did not complete Procedure|0|||
42248582|NCT02756403|76073746|FG001|Overall Study|Did not complete Procedure|1|||
42248583|NCT02756403|76073747|FG002|Overall Study|Did not complete Procedure|0|||
42248584|NCT02756403|76073748|FG003|Overall Study|Did not complete Procedure|0|||
42248585|NCT02756403|76073745|FG000|Overall Study|Changed Mind About Procedure|0|||
42248586|NCT02756403|76073746|FG001|Overall Study|Changed Mind About Procedure|0|||
42248587|NCT02756403|76073747|FG002|Overall Study|Changed Mind About Procedure|1|||
42248588|NCT02756403|76073748|FG003|Overall Study|Changed Mind About Procedure|0|||
42248589|NCT02756403|76073745|FG000|Overall Study|Protocol Violation|0|||
42248590|NCT02756403|76073746|FG001|Overall Study|Protocol Violation|1|||
42248591|NCT02756403|76073747|FG002|Overall Study|Protocol Violation|0|||
42248592|NCT02756403|76073748|FG003|Overall Study|Protocol Violation|1|||
42248593|NCT02753595|76073760|FG000|Overall Study|Sponsor termination|2|||
42248594|NCT02753595|76073761|FG001|Overall Study|Sponsor termination|2|||
42248595|NCT00707954|76073771|FG000|Overall Study|Physician Decision|0|||
42248596|NCT00707954|76073772|FG001|Overall Study|Physician Decision|0|||
41990018|NCT03224819|75797961|FG013|Overall Study|Death|0|||
41990019|NCT02549573|75798004|FG000|Overall Study|Withdrawal by Subject|0|||
41990020|NCT02549573|75798005|FG001|Overall Study|Withdrawal by Subject|2|||
42032955|NCT00943917|75841129|FG007|Stage II Continuation|hypoglycemia|0|||
42248597|NCT00707954|76073773|FG002|Overall Study|Physician Decision|0|||
42248598|NCT00707954|76073774|FG003|Overall Study|Physician Decision|0|||
42248599|NCT00707954|76073775|FG004|Overall Study|Physician Decision|1|||
42248600|NCT02561962|76073796|FG000|Overall Study|Ongoing in study|1|||
42248601|NCT02561962|76073797|FG001|Overall Study|Ongoing in study|0|||
42248602|NCT02561962|76073798|FG002|Overall Study|Ongoing in study|0|||
41990021|NCT02549573|75798004|FG000|Overall Study|Protocol Violation|0|||
41990022|NCT02549573|75798005|FG001|Overall Study|Protocol Violation|1|||
41990023|NCT02378181|75798013|FG000|Overall Study|Lost to Follow-up|2|||
41990024|NCT02378181|75798014|FG001|Overall Study|Lost to Follow-up|5|||
42032956|NCT00943917|75841130|FG008|Stage II Continuation|hypoglycemia|0|||
42248603|NCT02561962|76073799|FG003|Overall Study|Ongoing in study|1|||
42248604|NCT02561962|76073800|FG004|Overall Study|Ongoing in study|0|||
42248605|NCT02561962|76073801|FG005|Overall Study|Ongoing in study|1|||
42248606|NCT02561962|76073802|FG006|Overall Study|Ongoing in study|0|||
42248607|NCT02561962|76073803|FG007|Overall Study|Ongoing in study|4|||
42248608|NCT02561962|76073804|FG008|Overall Study|Ongoing in study|1|||
42248609|NCT02561962|76073796|FG000|Overall Study|Withdrawal by Subject|1|||
42248610|NCT02561962|76073797|FG001|Overall Study|Withdrawal by Subject|0|||
42248611|NCT02561962|76073798|FG002|Overall Study|Withdrawal by Subject|0|||
42248612|NCT02561962|76073799|FG003|Overall Study|Withdrawal by Subject|0|||
42248613|NCT02561962|76073800|FG004|Overall Study|Withdrawal by Subject|1|||
42248614|NCT02561962|76073801|FG005|Overall Study|Withdrawal by Subject|1|||
42248615|NCT02561962|76073802|FG006|Overall Study|Withdrawal by Subject|2|||
42248616|NCT02561962|76073803|FG007|Overall Study|Withdrawal by Subject|1|||
42248617|NCT02561962|76073804|FG008|Overall Study|Withdrawal by Subject|0|||
42248618|NCT02561962|76073796|FG000|Overall Study|Decision by sponsor|0|||
42248619|NCT02561962|76073797|FG001|Overall Study|Decision by sponsor|0|||
42248620|NCT02561962|76073798|FG002|Overall Study|Decision by sponsor|0|||
42248621|NCT02561962|76073799|FG003|Overall Study|Decision by sponsor|0|||
42248622|NCT02561962|76073800|FG004|Overall Study|Decision by sponsor|1|||
42248623|NCT02561962|76073801|FG005|Overall Study|Decision by sponsor|1|||
42248624|NCT02561962|76073802|FG006|Overall Study|Decision by sponsor|0|||
42248625|NCT02561962|76073803|FG007|Overall Study|Decision by sponsor|3|||
42248626|NCT02561962|76073804|FG008|Overall Study|Decision by sponsor|0|||
42248627|NCT02561962|76073796|FG000|Overall Study|Lost to Follow-up|0|||
42248628|NCT02561962|76073797|FG001|Overall Study|Lost to Follow-up|0|||
42248629|NCT02561962|76073798|FG002|Overall Study|Lost to Follow-up|0|||
42248630|NCT02561962|76073799|FG003|Overall Study|Lost to Follow-up|0|||
42248631|NCT02561962|76073800|FG004|Overall Study|Lost to Follow-up|0|||
42248632|NCT02561962|76073801|FG005|Overall Study|Lost to Follow-up|1|||
42248633|NCT02561962|76073802|FG006|Overall Study|Lost to Follow-up|0|||
42248634|NCT02561962|76073803|FG007|Overall Study|Lost to Follow-up|0|||
42248635|NCT02561962|76073804|FG008|Overall Study|Lost to Follow-up|0|||
42248636|NCT02565706|76073828|FG000|Overall Study|Withdrawal by Subject|5|||
42248637|NCT02565706|76073829|FG001|Overall Study|Withdrawal by Subject|7|||
42248638|NCT02565706|76073830|FG002|Overall Study|Withdrawal by Subject|7|||
42248639|NCT02565706|76073831|FG003|Overall Study|Withdrawal by Subject|11|||
42248640|NCT02565706|76073828|FG000|Overall Study|Lost to Follow-up|72|||
42248641|NCT02565706|76073829|FG001|Overall Study|Lost to Follow-up|75|||
42248642|NCT02565706|76073830|FG002|Overall Study|Lost to Follow-up|82|||
42248643|NCT02565706|76073831|FG003|Overall Study|Lost to Follow-up|74|||
42248644|NCT00706628|76073850|FG000|Overall Study|Other Adverse Event|16|||
42248645|NCT00706628|76073851|FG001|Overall Study|Other Adverse Event|5|||
42248646|NCT00706628|76073852|FG002|Overall Study|Other Adverse Event|5|||
42248647|NCT00706628|76073853|FG003|Overall Study|Other Adverse Event|2|||
42248648|NCT00706628|76073850|FG000|Overall Study|Non compliant with protocol|0|||
42248649|NCT00706628|76073851|FG001|Overall Study|Non compliant with protocol|1|||
42248650|NCT00706628|76073852|FG002|Overall Study|Non compliant with protocol|0|||
42248651|NCT00706628|76073853|FG003|Overall Study|Non compliant with protocol|0|||
42248652|NCT00706628|76073850|FG000|Overall Study|Consent withdrawn|6|||
42248653|NCT00706628|76073851|FG001|Overall Study|Consent withdrawn|1|||
42248654|NCT00706628|76073852|FG002|Overall Study|Consent withdrawn|3|||
42248655|NCT00706628|76073853|FG003|Overall Study|Consent withdrawn|0|||
42248656|NCT00706628|76073850|FG000|Overall Study|Progressive disease|20|||
42248657|NCT00706628|76073851|FG001|Overall Study|Progressive disease|13|||
42248658|NCT00706628|76073852|FG002|Overall Study|Progressive disease|8|||
42248659|NCT00706628|76073853|FG003|Overall Study|Progressive disease|1|||
42248660|NCT00706628|76073850|FG000|Overall Study|Other than those stated above|4|||
42248661|NCT00706628|76073851|FG001|Overall Study|Other than those stated above|0|||
41990025|NCT02378181|75798013|FG000|Overall Study|Withdrawal by Subject|1|||
41990026|NCT02378181|75798014|FG001|Overall Study|Withdrawal by Subject|1|||
41990027|NCT02378181|75798013|FG000|Overall Study|Incarcerated|0|||
41990028|NCT02378181|75798014|FG001|Overall Study|Incarcerated|1|||
41990029|NCT02201108|75798022|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
41990030|NCT02201108|75798023|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
42248662|NCT00706628|76073852|FG002|Overall Study|Other than those stated above|0|||
41990031|NCT02201108|75798022|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
41990032|NCT02201108|75798023|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
42248663|NCT00706628|76073853|FG003|Overall Study|Other than those stated above|0|||
42248664|NCT00706628|76073850|FG000|Overall Study|Not treated|1|||
42248665|NCT00706628|76073851|FG001|Overall Study|Not treated|1|||
42248666|NCT00706628|76073852|FG002|Overall Study|Not treated|0|||
42248667|NCT00706628|76073853|FG003|Overall Study|Not treated|0|||
42248668|NCT02561806|76073868|FG000|Induction Period|Adverse Event|0|||
42248669|NCT02561806|76073869|FG001|Induction Period|Adverse Event|2|||
42248670|NCT02561806|76073868|FG000|Induction Period|Lack of Efficacy|1|||
42248671|NCT02561806|76073869|FG001|Induction Period|Lack of Efficacy|0|||
42248672|NCT02561806|76073868|FG000|Induction Period|Withdrawal by Subject|0|||
42248673|NCT02561806|76073869|FG001|Induction Period|Withdrawal by Subject|2|||
42248674|NCT02561806|76073868|FG000|Induction Period|Site staff became unblinded|1|||
42248675|NCT02561806|76073869|FG001|Induction Period|Site staff became unblinded|0|||
42248676|NCT02561806|76073868|FG000|Induction Period|Randomized but not treated|0|||
42248677|NCT02561806|76073869|FG001|Induction Period|Randomized but not treated|1|||
42248678|NCT02561806|76073868|FG000|Maintenance Period|Adverse Event|2|||
42248679|NCT02561806|76073869|FG001|Maintenance Period|Adverse Event|1|||
42248680|NCT02561806|76073868|FG000|Maintenance Period|Lack of Efficacy|3|||
42248681|NCT02561806|76073869|FG001|Maintenance Period|Lack of Efficacy|1|||
42248682|NCT02561806|76073868|FG000|Maintenance Period|Lost to Follow-up|2|||
42248683|NCT02561806|76073869|FG001|Maintenance Period|Lost to Follow-up|2|||
42248684|NCT02561806|76073868|FG000|Maintenance Period|Protocol Violation|1|||
42248685|NCT02561806|76073869|FG001|Maintenance Period|Protocol Violation|0|||
42248686|NCT02561806|76073868|FG000|Maintenance Period|Withdrawal by Subject|5|||
42248687|NCT02561806|76073869|FG001|Maintenance Period|Withdrawal by Subject|3|||
42248688|NCT02561806|76073868|FG000|Maintenance Period|Site staff became unblinded|0|||
42248689|NCT02561806|76073869|FG001|Maintenance Period|Site staff became unblinded|1|||
42248690|NCT02561806|76073868|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
42248691|NCT02561806|76073869|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
42248692|NCT02561806|76073868|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
42248693|NCT02561806|76073869|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
42248694|NCT02561572|76073892|FG000|Overall Study|Inadequate time before surgery|2|||
42248695|NCT02561572|76073893|FG001|Overall Study|Inadequate time before surgery|1|||
42248696|NCT02561572|76073892|FG000|Overall Study|Protocol Violation|0|||
42248697|NCT02561572|76073893|FG001|Overall Study|Protocol Violation|1|||
42248698|NCT02180217|76073902|FG000|Overall Study|Adverse Event|3|||
42248699|NCT02180217|76073903|FG001|Overall Study|Adverse Event|2|||
42248700|NCT02180217|76073904|FG002|Overall Study|Adverse Event|22|||
42248701|NCT02180217|76073902|FG000|Overall Study|Death|1|||
42248702|NCT02180217|76073903|FG001|Overall Study|Death|1|||
42248703|NCT02180217|76073904|FG002|Overall Study|Death|0|||
42248704|NCT02180217|76073902|FG000|Overall Study|Withdrawal by Subject|1|||
42248705|NCT02180217|76073903|FG001|Overall Study|Withdrawal by Subject|1|||
42248706|NCT02180217|76073904|FG002|Overall Study|Withdrawal by Subject|4|||
42248707|NCT02180217|76073902|FG000|Overall Study|Subject/Guardian decision|5|||
42248708|NCT02180217|76073903|FG001|Overall Study|Subject/Guardian decision|3|||
42248709|NCT02180217|76073904|FG002|Overall Study|Subject/Guardian decision|6|||
42248710|NCT02180217|76073902|FG000|Overall Study|Physician Decision|1|||
42248711|NCT02180217|76073903|FG001|Overall Study|Physician Decision|1|||
42248712|NCT02180217|76073904|FG002|Overall Study|Physician Decision|6|||
42248713|NCT02180217|76073902|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42248714|NCT02180217|76073903|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42248715|NCT02180217|76073904|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
42248716|NCT02560558|76073921|FG000|Overall Study|Adverse Event|1|||
42248717|NCT02560558|76073922|FG001|Overall Study|Adverse Event|0|||
42248718|NCT02560558|76073921|FG000|Overall Study|Death|0|||
42248719|NCT02560558|76073922|FG001|Overall Study|Death|2|||
42248720|NCT02560558|76073921|FG000|Overall Study|Lost to Follow-up|0|||
42248721|NCT02560558|76073922|FG001|Overall Study|Lost to Follow-up|4|||
42248722|NCT02560558|76073921|FG000|Overall Study|Protocol Violation|3|||
42248723|NCT02560558|76073922|FG001|Overall Study|Protocol Violation|0|||
42248724|NCT02560558|76073921|FG000|Overall Study|Withdrawal by Subject|3|||
42248725|NCT02560558|76073922|FG001|Overall Study|Withdrawal by Subject|0|||
42248726|NCT02568046|76073930|FG000|Overall Study|Adverse Event|0|||
42248727|NCT02568046|76073931|FG001|Overall Study|Adverse Event|1|||
42248728|NCT02568046|76073930|FG000|Overall Study|Death|2|||
42248729|NCT02568046|76073931|FG001|Overall Study|Death|0|||
42248730|NCT02568046|76073930|FG000|Overall Study|Progressive Disease|1|||
42248731|NCT02568046|76073931|FG001|Overall Study|Progressive Disease|0|||
42248732|NCT02568046|76073930|FG000|Overall Study|Withdrawal by Subject|2|||
42248733|NCT02568046|76073931|FG001|Overall Study|Withdrawal by Subject|1|||
42248734|NCT02568046|76073930|FG000|Overall Study|Other Events|0|||
42248735|NCT02568046|76073931|FG001|Overall Study|Other Events|1|||
42248736|NCT02567656|76073943|FG000|Overall Study|Premature discontinuation due to PD|1|||
42248737|NCT02567656|76073944|FG001|Overall Study|Premature discontinuation due to PD|1|||
42248738|NCT02567656|76073945|FG002|Overall Study|Premature discontinuation due to PD|2|||
42248739|NCT02567656|76073946|FG003|Overall Study|Premature discontinuation due to PD|0|||
42248740|NCT02567656|76073947|FG004|Overall Study|Premature discontinuation due to PD|0|||
42132226|NCT00486720|75943072|FG000|Overall Study|Withdrawal by Subject|3|||
42132227|NCT00486720|75943073|FG001|Overall Study|Withdrawal by Subject|1|||
42248741|NCT02567656|76073948|FG005|Overall Study|Premature discontinuation due to PD|0|||
42248742|NCT02560012|76073962|FG000|Overall Study|Study Terminated|2|||
42248743|NCT02567266|76073969|FG000|Overall Study|Withdrawal by Subject|10|||
42132228|NCT00486720|75943072|FG000|Overall Study|Progressive Disease|0|||
42248744|NCT02567266|76073970|FG001|Overall Study|Withdrawal by Subject|7|||
42248745|NCT02567266|76073971|FG002|Overall Study|Withdrawal by Subject|6|||
42248746|NCT02567266|76073969|FG000|Overall Study|Lost to Follow-up|13|||
42248747|NCT02567266|76073970|FG001|Overall Study|Lost to Follow-up|8|||
42248748|NCT02567266|76073971|FG002|Overall Study|Lost to Follow-up|10|||
42132229|NCT00486720|75943073|FG001|Overall Study|Progressive Disease|1|||
42132230|NCT00486330|75943079|FG000|Overall Study|Adverse Event|2|||
42132231|NCT00486252|75943083|FG000|Overall Study|Adverse Event|7|||
42132232|NCT00486252|75943083|FG000|Overall Study|Lack of Efficacy|9|||
42132233|NCT00486252|75943083|FG000|Overall Study|Lost to Follow-up|24|||
42132234|NCT00486252|75943083|FG000|Overall Study|Other|18|||
42132235|NCT00494442|75943091|FG000|Overall Study|Death|1|||
42132236|NCT00494442|75943092|FG001|Overall Study|Death|1|||
42132237|NCT00494442|75943091|FG000|Overall Study|Lack of Efficacy|16|||
42132238|NCT00494442|75943092|FG001|Overall Study|Lack of Efficacy|10|||
42132239|NCT00494442|75943091|FG000|Overall Study|Adverse Event|0|||
42132240|NCT00494442|75943092|FG001|Overall Study|Adverse Event|2|||
42132241|NCT00494442|75943091|FG000|Overall Study|Physician Decision|0|||
42132242|NCT00494442|75943092|FG001|Overall Study|Physician Decision|1|||
42132243|NCT00494442|75943091|FG000|Overall Study|Non-compliance|0|||
42132244|NCT00494442|75943092|FG001|Overall Study|Non-compliance|1|||
42132245|NCT00494442|75943091|FG000|Overall Study|Intercurrent illness|0|||
42132246|NCT00494442|75943092|FG001|Overall Study|Intercurrent illness|1|||
41990033|NCT02201108|75798022|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
42032957|NCT00943917|75841131|FG009|Stage II Continuation|hypoglycemia|0|||
42032958|NCT00943917|75841132|FG010|Stage II Continuation|hypoglycemia|0|||
42032959|NCT00943917|75841133|FG011|Stage II Continuation|hypoglycemia|0|||
42032960|NCT00943917|75841134|FG012|Stage II Continuation|hypoglycemia|1|||
42032961|NCT00943917|75841135|FG013|Stage II Continuation|hypoglycemia|0|||
42132247|NCT03851016|75943100|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
42132248|NCT03851016|75943101|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
41990034|NCT02201108|75798023|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
41990035|NCT02201108|75798022|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
41990036|NCT02201108|75798023|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
41990037|NCT02201108|75798022|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
41990038|NCT02201108|75798023|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
41990039|NCT02201108|75798022|FG000|Open Label Period (up to Week 192)|Other reason|4|||
41990040|NCT02201108|75798023|FG001|Open Label Period (up to Week 192)|Other reason|7|||
41990041|NCT02201108|75798022|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
41990042|NCT02201108|75798023|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
41990043|NCT02180243|75798044|FG000|Overall Study|Withdrawal by Subject|12|||
41990044|NCT02180243|75798045|FG001|Overall Study|Withdrawal by Subject|12|||
41990045|NCT02180243|75798044|FG000|Overall Study|Lost to Follow-up|12|||
41990046|NCT02180243|75798045|FG001|Overall Study|Lost to Follow-up|2|||
41990047|NCT01772563|75798052|FG000|Cycle 1|Dose limiting toxicity|2|||
41990048|NCT01772563|75798052|FG000|Cycle 1|Progressive disease|2|||
41990049|NCT01772563|75798052|FG000|Cycle 2 and Beyond|Progressive disease|17|||
41990050|NCT01772563|75798052|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
41990051|NCT01772563|75798052|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
41990052|NCT01445171|75798058|FG000|Overall Study|Lost to Follow-up|11|||
41990053|NCT01445171|75798058|FG000|Overall Study|Withdrawal by Subject|16|||
41990054|NCT01445171|75798058|FG000|Overall Study|Death|51|||
41990055|NCT01445171|75798058|FG000|Overall Study|Subjects declined to return for followup|9|||
41990056|NCT01445171|75798058|FG000|Overall Study|Consented but did not receive device|8|||
41990057|NCT00492050|75798064|FG000|Overall Study|Adverse Event|1|||
41990058|NCT00492050|75798064|FG000|Overall Study|Lack of Efficacy|1|||
41990059|NCT00492050|75798064|FG000|Overall Study|Withdrawal by Subject|3|||
41990060|NCT00492050|75798064|FG000|Overall Study|Unable to collect SCT|2|||
41990061|NCT00492050|75798064|FG000|Overall Study|Progressive Disease|2|||
41990062|NCT01237951|75798068|FG000|Overall Study|Death|1|||
41990063|NCT01239394|75798072|FG000|Overall Study|Adverse Event|1|||
41990064|NCT01237678|75798079|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
41990065|NCT01237678|75798080|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
41990066|NCT01237678|75798081|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
41990067|NCT01237678|75798079|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
41990068|NCT01237678|75798080|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
42132249|NCT00493974|75943109|FG000|Overall Study|Death|1|||
42132250|NCT00493974|75943110|FG001|Overall Study|Death|2|||
42132251|NCT00493974|75943109|FG000|Overall Study|Withdrawal by Subject|8|||
42132252|NCT00493974|75943110|FG001|Overall Study|Withdrawal by Subject|6|||
42132253|NCT00493974|75943109|FG000|Overall Study|Lost to Follow-up|4|||
42132254|NCT00493974|75943110|FG001|Overall Study|Lost to Follow-up|6|||
41990069|NCT01237678|75798081|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
42132255|NCT00469092|75943118|FG000|Overall Study|Adverse Event|5|||
42132256|NCT00469092|75943119|FG001|Overall Study|Adverse Event|4|||
42132257|NCT00469092|75943118|FG000|Overall Study|Lack of Efficacy|1|||
42132258|NCT00469092|75943119|FG001|Overall Study|Lack of Efficacy|0|||
42132259|NCT00469092|75943118|FG000|Overall Study|Lost to Follow-up|1|||
42132260|NCT00469092|75943119|FG001|Overall Study|Lost to Follow-up|2|||
42132261|NCT00469092|75943118|FG000|Overall Study|Protocol Violation|3|||
42132262|NCT00469092|75943119|FG001|Overall Study|Protocol Violation|3|||
42132263|NCT00469092|75943118|FG000|Overall Study|Withdrawal by Subject|4|||
42132264|NCT00469092|75943119|FG001|Overall Study|Withdrawal by Subject|4|||
42132265|NCT00469092|75943118|FG000|Overall Study|Withdrawal Criteria|3|||
42132266|NCT00469092|75943119|FG001|Overall Study|Withdrawal Criteria|4|||
42132267|NCT00469092|75943118|FG000|Overall Study|Incorrectly Randomised|4|||
42132268|NCT00469092|75943119|FG001|Overall Study|Incorrectly Randomised|3|||
42132269|NCT00469092|75943118|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
42132270|NCT00469092|75943119|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
42132271|NCT00469092|75943118|FG000|Overall Study|Use of lipid lowering drug|1|||
42132272|NCT00469092|75943119|FG001|Overall Study|Use of lipid lowering drug|0|||
42132273|NCT00469092|75943118|FG000|Overall Study|Hypoglycaemic Episodes|1|||
42132274|NCT00469092|75943119|FG001|Overall Study|Hypoglycaemic Episodes|1|||
42132275|NCT00469092|75943118|FG000|Overall Study|Abnormal lab value|1|||
41990070|NCT01237678|75798079|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
41990071|NCT01237678|75798080|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
41990072|NCT01237678|75798081|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
41990073|NCT01237678|75798079|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
41990074|NCT01237678|75798080|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
41990075|NCT01237678|75798081|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
41990076|NCT01237678|75798079|FG000|Phase II|Adverse Event|0|||
41990077|NCT01237678|75798080|FG001|Phase II|Adverse Event|39|||
41990078|NCT01237678|75798081|FG002|Phase II|Adverse Event|9|||
41990079|NCT01237678|75798079|FG000|Phase II|Death|0|||
41990080|NCT01237678|75798080|FG001|Phase II|Death|0|||
41990081|NCT01237678|75798081|FG002|Phase II|Death|2|||
41990082|NCT01237678|75798079|FG000|Phase II|Lack of Efficacy|0|||
41990083|NCT01237678|75798080|FG001|Phase II|Lack of Efficacy|25|||
41990084|NCT01237678|75798081|FG002|Phase II|Lack of Efficacy|3|||
41990085|NCT01237678|75798079|FG000|Phase II|Withdrawal by Subject|0|||
41990086|NCT01237678|75798080|FG001|Phase II|Withdrawal by Subject|1|||
42132276|NCT00469092|75943119|FG001|Overall Study|Abnormal lab value|0|||
42132277|NCT00469092|75943118|FG000|Overall Study|Use of Corticosteroid|1|||
42132278|NCT00469092|75943119|FG001|Overall Study|Use of Corticosteroid|0|||
42132279|NCT00499616|75943129|FG000|Overall Study|Death|1|||
42132280|NCT00499616|75943130|FG001|Overall Study|Death|5|||
41990087|NCT01237678|75798081|FG002|Phase II|Withdrawal by Subject|5|||
41990088|NCT01237678|75798079|FG000|Phase II|Completed Cycles 4-6|0|||
41990089|NCT01237678|75798080|FG001|Phase II|Completed Cycles 4-6|11|||
41990090|NCT01237678|75798081|FG002|Phase II|Completed Cycles 4-6|21|||
41990091|NCT01237678|75798079|FG000|Phase II|Sponsor Decision/Study Closed|0|||
41990092|NCT01237678|75798080|FG001|Phase II|Sponsor Decision/Study Closed|18|||
41990093|NCT01237678|75798081|FG002|Phase II|Sponsor Decision/Study Closed|7|||
41990094|NCT01237678|75798079|FG000|Phase II|Randomized but were not treated|0|||
41990095|NCT01237678|75798080|FG001|Phase II|Randomized but were not treated|4|||
41990096|NCT01237678|75798081|FG002|Phase II|Randomized but were not treated|3|||
41990097|NCT01229371|75798104|FG000|Overall Study|Withdrawal by Subject|0|||
41990098|NCT01229371|75798105|FG001|Overall Study|Withdrawal by Subject|1|||
42132281|NCT00499616|75943131|FG002|Overall Study|Death|3|||
42132282|NCT00499616|75943132|FG003|Overall Study|Death|1|||
42132283|NCT00499616|75943129|FG000|Overall Study|Lack of Efficacy|5|||
42132284|NCT00499616|75943130|FG001|Overall Study|Lack of Efficacy|0|||
42132285|NCT00499616|75943131|FG002|Overall Study|Lack of Efficacy|19|||
42132286|NCT00499616|75943132|FG003|Overall Study|Lack of Efficacy|0|||
42132287|NCT00499616|75943129|FG000|Overall Study|Lost to Follow-up|0|||
42132288|NCT00499616|75943130|FG001|Overall Study|Lost to Follow-up|0|||
42132289|NCT00499616|75943131|FG002|Overall Study|Lost to Follow-up|1|||
42132290|NCT00499616|75943132|FG003|Overall Study|Lost to Follow-up|0|||
42303296|NCT02409667|76138607|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
41990099|NCT01229371|75798106|FG002|Overall Study|Withdrawal by Subject|0|||
41990100|NCT01229371|75798107|FG003|Overall Study|Withdrawal by Subject|0|||
41990101|NCT01237327|75798119|FG000|Overall Study|Protocol Violation: Core Study|1|||
41990102|NCT01237327|75798120|FG001|Overall Study|Protocol Violation: Core Study|0|||
42132291|NCT00499616|75943129|FG000|Overall Study|Physician Decision|6|||
42132292|NCT00499616|75943130|FG001|Overall Study|Physician Decision|16|||
42132293|NCT00499616|75943131|FG002|Overall Study|Physician Decision|9|||
42132294|NCT00499616|75943132|FG003|Overall Study|Physician Decision|0|||
42132295|NCT00499616|75943129|FG000|Overall Study|Withdrawal by Subject|1|||
42132296|NCT00499616|75943130|FG001|Overall Study|Withdrawal by Subject|0|||
42132297|NCT00499616|75943131|FG002|Overall Study|Withdrawal by Subject|1|||
41990103|NCT01237327|75798119|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
41990104|NCT01237327|75798120|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
41990105|NCT01237327|75798119|FG000|Overall Study|Progression of Disease: Core Study|18|||
41990106|NCT01237327|75798120|FG001|Overall Study|Progression of Disease: Core Study|22|||
41990107|NCT01237327|75798119|FG000|Overall Study|Progression of Disease: Extension Study|15|||
41990108|NCT01237327|75798120|FG001|Overall Study|Progression of Disease: Extension Study|13|||
42248749|NCT02567188|76073979|FG000|Overall Study|Death|10|||
42248750|NCT02567188|76073979|FG000|Overall Study|Terminated Mircera Treatment|9|||
42248751|NCT02567188|76073979|FG000|Overall Study|Lost to Follow-up|5|||
42248752|NCT02567188|76073979|FG000|Overall Study|Adverse Event|1|||
42248753|NCT02567188|76073979|FG000|Overall Study|Withdrawal by Subject|1|||
42248754|NCT02567188|76073979|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
42248755|NCT02567188|76073979|FG000|Overall Study|Moved and Changed Clinic|1|||
42132298|NCT00499616|75943132|FG003|Overall Study|Withdrawal by Subject|0|||
42132299|NCT00499616|75943129|FG000|Overall Study|Ineligible|1|||
42132300|NCT00499616|75943130|FG001|Overall Study|Ineligible|2|||
42132301|NCT00499616|75943131|FG002|Overall Study|Ineligible|0|||
42132302|NCT00499616|75943132|FG003|Overall Study|Ineligible|15|||
42132303|NCT00499616|75943129|FG000|Overall Study|Not evaluable|0|||
42132304|NCT00499616|75943130|FG001|Overall Study|Not evaluable|0|||
42132305|NCT00499616|75943131|FG002|Overall Study|Not evaluable|0|||
41990109|NCT01237327|75798119|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
41990110|NCT01237327|75798120|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
41990111|NCT01237327|75798119|FG000|Overall Study|Withdrawal by Subject|1|||
42132306|NCT00499616|75943132|FG003|Overall Study|Not evaluable|41|||
42132307|NCT00499616|75943129|FG000|Overall Study|Patient/Parent Refusal|1|||
42132308|NCT00499616|75943130|FG001|Overall Study|Patient/Parent Refusal|5|||
42132309|NCT00499616|75943131|FG002|Overall Study|Patient/Parent Refusal|3|||
42132310|NCT00499616|75943132|FG003|Overall Study|Patient/Parent Refusal|0|||
42132311|NCT00402597|75943150|FG000|Overall Study|Death|15|||
42132312|NCT00402597|75943151|FG001|Overall Study|Death|7|||
42132313|NCT00402597|75943152|FG002|Overall Study|Death|6|||
42132314|NCT00402597|75943153|FG003|Overall Study|Death|4|||
42132315|NCT00402597|75943154|FG004|Overall Study|Death|6|||
42132316|NCT00402597|75943150|FG000|Overall Study|Adverse Event|81|||
42132317|NCT00402597|75943151|FG001|Overall Study|Adverse Event|18|||
42132318|NCT00402597|75943152|FG002|Overall Study|Adverse Event|106|||
42132319|NCT00402597|75943153|FG003|Overall Study|Adverse Event|39|||
42132320|NCT00402597|75943154|FG004|Overall Study|Adverse Event|71|||
42248756|NCT02567188|76073979|FG000|Overall Study|Started Hemodialysis|2|||
42248757|NCT02567188|76073979|FG000|Overall Study|Protocol Violation|5|||
42248758|NCT00706238|76073984|FG000|Overall Study|Disease progression|4|||
42248759|NCT00706238|76073984|FG000|Overall Study|Other|1|||
42248760|NCT03321968|76073991|FG000|Overall Study|Withdrawal by Subject|1|||
42248761|NCT03321968|76073992|FG001|Overall Study|Withdrawal by Subject|2|||
42248762|NCT03321968|76073993|FG002|Overall Study|Withdrawal by Subject|1|||
42248763|NCT03321968|76073991|FG000|Overall Study|Lost to Follow-up|2|||
42248764|NCT03321968|76073992|FG001|Overall Study|Lost to Follow-up|0|||
42248765|NCT03321968|76073993|FG002|Overall Study|Lost to Follow-up|1|||
42248766|NCT03321968|76073991|FG000|Overall Study|Other than specified|0|||
42248767|NCT03321968|76073992|FG001|Overall Study|Other than specified|0|||
42248768|NCT03321968|76073993|FG002|Overall Study|Other than specified|1|||
42248769|NCT05338333|76074007|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
42248770|NCT05338333|76074008|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
42248771|NCT05051579|76074024|FG000|Overall Study|Withdrawal by Subject|3|||
42248772|NCT05051579|76074025|FG001|Overall Study|Withdrawal by Subject|5|||
42248773|NCT05051579|76074026|FG002|Overall Study|Withdrawal by Subject|2|||
42248774|NCT05051579|76074027|FG003|Overall Study|Withdrawal by Subject|1|||
42248775|NCT05051579|76074028|FG004|Overall Study|Withdrawal by Subject|4|||
42248776|NCT05051579|76074029|FG005|Overall Study|Withdrawal by Subject|0|||
42248777|NCT05051579|76074030|FG006|Overall Study|Withdrawal by Subject|4|||
42248778|NCT05051579|76074024|FG000|Overall Study|Lost to Follow-up|1|||
42248779|NCT05051579|76074025|FG001|Overall Study|Lost to Follow-up|0|||
42248780|NCT05051579|76074026|FG002|Overall Study|Lost to Follow-up|0|||
42248781|NCT05051579|76074027|FG003|Overall Study|Lost to Follow-up|0|||
42248782|NCT05051579|76074028|FG004|Overall Study|Lost to Follow-up|1|||
42132321|NCT00402597|75943150|FG000|Overall Study|Lost to Follow-up|8|||
42248783|NCT05051579|76074029|FG005|Overall Study|Lost to Follow-up|0|||
42248784|NCT05051579|76074030|FG006|Overall Study|Lost to Follow-up|1|||
42248785|NCT05051579|76074024|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
42132322|NCT00402597|75943151|FG001|Overall Study|Lost to Follow-up|1|||
42132323|NCT00402597|75943152|FG002|Overall Study|Lost to Follow-up|8|||
42248786|NCT05051579|76074025|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
41990112|NCT01237327|75798120|FG001|Overall Study|Withdrawal by Subject|3|||
42132324|NCT00402597|75943153|FG003|Overall Study|Lost to Follow-up|2|||
42132325|NCT00402597|75943154|FG004|Overall Study|Lost to Follow-up|3|||
42248787|NCT05051579|76074026|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
42248788|NCT05051579|76074027|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
42248789|NCT05051579|76074028|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
42248790|NCT05051579|76074029|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
42272690|NCT00857285|76103028|FG000|Overall Study|Protocol Violation|3|||
42132326|NCT00402597|75943150|FG000|Overall Study|Withdrawal by Subject|57|||
42132327|NCT00402597|75943151|FG001|Overall Study|Withdrawal by Subject|16|||
42248791|NCT05051579|76074030|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
42248792|NCT05051579|76074024|FG000|Overall Study|Adverse Event|2|||
42248793|NCT05051579|76074025|FG001|Overall Study|Adverse Event|1|||
42248794|NCT05051579|76074026|FG002|Overall Study|Adverse Event|0|||
42248795|NCT05051579|76074027|FG003|Overall Study|Adverse Event|4|||
42248796|NCT05051579|76074028|FG004|Overall Study|Adverse Event|1|||
42248797|NCT05051579|76074029|FG005|Overall Study|Adverse Event|2|||
42248798|NCT05051579|76074030|FG006|Overall Study|Adverse Event|0|||
42248799|NCT05051579|76074024|FG000|Overall Study|Inadvertent Enrollment|0|||
42248800|NCT05051579|76074025|FG001|Overall Study|Inadvertent Enrollment|0|||
42248801|NCT05051579|76074026|FG002|Overall Study|Inadvertent Enrollment|0|||
42248802|NCT05051579|76074027|FG003|Overall Study|Inadvertent Enrollment|0|||
42248803|NCT05051579|76074028|FG004|Overall Study|Inadvertent Enrollment|0|||
42248804|NCT05051579|76074029|FG005|Overall Study|Inadvertent Enrollment|0|||
42248805|NCT05051579|76074030|FG006|Overall Study|Inadvertent Enrollment|1|||
42248806|NCT05051579|76074024|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
42248807|NCT05051579|76074025|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
42248808|NCT05051579|76074026|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
42248809|NCT05051579|76074027|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
42248810|NCT05051579|76074028|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
42248811|NCT05051579|76074029|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
42248812|NCT05051579|76074030|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
42248813|NCT05051579|76074024|FG000|Overall Study|Sponsor Decision|0|||
42248814|NCT05051579|76074025|FG001|Overall Study|Sponsor Decision|0|||
42248815|NCT05051579|76074026|FG002|Overall Study|Sponsor Decision|0|||
42248816|NCT05051579|76074027|FG003|Overall Study|Sponsor Decision|0|||
42248817|NCT05051579|76074028|FG004|Overall Study|Sponsor Decision|1|||
42248818|NCT05051579|76074029|FG005|Overall Study|Sponsor Decision|0|||
42248819|NCT05051579|76074030|FG006|Overall Study|Sponsor Decision|0|||
42248820|NCT05051579|76074024|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
42248821|NCT05051579|76074025|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
42248822|NCT05051579|76074026|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
42248823|NCT05051579|76074027|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
42248824|NCT05051579|76074028|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
42248825|NCT05051579|76074029|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
42248826|NCT05051579|76074030|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
42248827|NCT04964128|76074054|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
42248828|NCT04964128|76074054|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
42248829|NCT04881760|76074069|FG000|Overall Study|Adverse Event|0|||
42248830|NCT04881760|76074070|FG001|Overall Study|Adverse Event|1|||
42248831|NCT04881760|76074071|FG002|Overall Study|Adverse Event|1|||
42248832|NCT04881760|76074072|FG003|Overall Study|Adverse Event|0|||
42248833|NCT04881760|76074073|FG004|Overall Study|Adverse Event|1|||
42248834|NCT04881760|76074074|FG005|Overall Study|Adverse Event|1|||
42248835|NCT04881760|76074075|FG006|Overall Study|Adverse Event|2|||
42248836|NCT04881760|76074069|FG000|Overall Study|Death|0|||
42248837|NCT04881760|76074070|FG001|Overall Study|Death|0|||
42248838|NCT04881760|76074071|FG002|Overall Study|Death|0|||
42248839|NCT04881760|76074072|FG003|Overall Study|Death|1|||
42248840|NCT04881760|76074073|FG004|Overall Study|Death|0|||
42248841|NCT04881760|76074074|FG005|Overall Study|Death|0|||
42248842|NCT04881760|76074075|FG006|Overall Study|Death|0|||
42248843|NCT04881760|76074069|FG000|Overall Study|Lost to Follow-up|5|||
41990113|NCT01237327|75798119|FG000|Overall Study|Lost to Follow-up|3|||
42132328|NCT00402597|75943152|FG002|Overall Study|Withdrawal by Subject|65|||
41990114|NCT01237327|75798120|FG001|Overall Study|Lost to Follow-up|0|||
42248844|NCT04881760|76074070|FG001|Overall Study|Lost to Follow-up|7|||
42248845|NCT04881760|76074071|FG002|Overall Study|Lost to Follow-up|5|||
42248846|NCT04881760|76074072|FG003|Overall Study|Lost to Follow-up|1|||
42248847|NCT04881760|76074073|FG004|Overall Study|Lost to Follow-up|2|||
42248848|NCT04881760|76074074|FG005|Overall Study|Lost to Follow-up|4|||
41990115|NCT01237054|75798126|FG000|Overall Study|imaging 10C0096|1|||
41990116|NCT01236352|75798163|FG000|Overall Study|Death|0|||
41990117|NCT01236352|75798164|FG001|Overall Study|Death|0|||
41990118|NCT01236352|75798165|FG002|Overall Study|Death|0|||
41990119|NCT01236352|75798166|FG003|Overall Study|Death|0|||
41990120|NCT01236352|75798167|FG004|Overall Study|Death|0|||
41990121|NCT01236352|75798168|FG005|Overall Study|Death|0|||
41990122|NCT01236352|75798169|FG006|Overall Study|Death|0|||
41990123|NCT01236352|75798170|FG007|Overall Study|Death|1|||
42248849|NCT04881760|76074075|FG006|Overall Study|Lost to Follow-up|4|||
42248850|NCT04881760|76074069|FG000|Overall Study|Withdrawal by Subject|13|||
42248851|NCT04881760|76074070|FG001|Overall Study|Withdrawal by Subject|1|||
42248852|NCT04881760|76074071|FG002|Overall Study|Withdrawal by Subject|1|||
42248853|NCT04881760|76074072|FG003|Overall Study|Withdrawal by Subject|4|||
42248854|NCT04881760|76074073|FG004|Overall Study|Withdrawal by Subject|2|||
42248855|NCT04881760|76074074|FG005|Overall Study|Withdrawal by Subject|1|||
42248856|NCT04881760|76074075|FG006|Overall Study|Withdrawal by Subject|2|||
42248857|NCT04881760|76074069|FG000|Overall Study|Randomized but Never Treated|0|||
42248858|NCT04881760|76074070|FG001|Overall Study|Randomized but Never Treated|0|||
42248859|NCT04881760|76074071|FG002|Overall Study|Randomized but Never Treated|0|||
42248860|NCT04881760|76074072|FG003|Overall Study|Randomized but Never Treated|1|||
42248861|NCT04881760|76074073|FG004|Overall Study|Randomized but Never Treated|0|||
42248862|NCT04881760|76074074|FG005|Overall Study|Randomized but Never Treated|0|||
42248863|NCT04881760|76074075|FG006|Overall Study|Randomized but Never Treated|0|||
42248864|NCT04881760|76074069|FG000|Overall Study|Inadvertent Enrollment|2|||
42248865|NCT04881760|76074070|FG001|Overall Study|Inadvertent Enrollment|0|||
42248866|NCT04881760|76074071|FG002|Overall Study|Inadvertent Enrollment|0|||
42248867|NCT04881760|76074072|FG003|Overall Study|Inadvertent Enrollment|0|||
42248868|NCT04881760|76074073|FG004|Overall Study|Inadvertent Enrollment|0|||
42248869|NCT04881760|76074074|FG005|Overall Study|Inadvertent Enrollment|0|||
42248870|NCT04881760|76074075|FG006|Overall Study|Inadvertent Enrollment|0|||
42248871|NCT04881760|76074069|FG000|Overall Study|Site Closure|0|||
42248872|NCT04881760|76074070|FG001|Overall Study|Site Closure|0|||
42248873|NCT04881760|76074071|FG002|Overall Study|Site Closure|0|||
42248874|NCT04881760|76074072|FG003|Overall Study|Site Closure|1|||
42248875|NCT04881760|76074073|FG004|Overall Study|Site Closure|0|||
42248876|NCT04881760|76074074|FG005|Overall Study|Site Closure|0|||
42248877|NCT04881760|76074075|FG006|Overall Study|Site Closure|0|||
42248878|NCT04749797|76074094|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
42248879|NCT04749797|76074095|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
42248880|NCT04749797|76074096|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
42248881|NCT04747275|76074106|FG000|Overall Study|Study terminated|0|||
42248882|NCT04747275|76074107|FG001|Overall Study|Study terminated|1|||
42248883|NCT04556552|76074115|FG000|Overall Study|Lost to Follow-up|1|||
42248884|NCT04556552|76074116|FG001|Overall Study|Lost to Follow-up|0|||
42248885|NCT04556552|76074115|FG000|Overall Study|Claustrophobia|0|||
42248886|NCT04556552|76074116|FG001|Overall Study|Claustrophobia|1|||
42248887|NCT04556552|76074115|FG000|Overall Study|Inability to continue|0|||
42248888|NCT04556552|76074116|FG001|Overall Study|Inability to continue|1|||
42248889|NCT04496167|76074124|FG000|Overall Study|Adverse Event|6|||
42248890|NCT04496167|76074125|FG001|Overall Study|Adverse Event|2|||
42248891|NCT04496167|76074124|FG000|Overall Study|Withdrawal by Subject|7|||
41990124|NCT01236352|75798171|FG008|Overall Study|Death|0|||
42248892|NCT04496167|76074125|FG001|Overall Study|Withdrawal by Subject|6|||
42248893|NCT04496167|76074124|FG000|Overall Study|Lost to Follow-up|3|||
41990125|NCT01236352|75798172|FG009|Overall Study|Death|0|||
41990126|NCT01236352|75798173|FG010|Overall Study|Death|0|||
41990127|NCT01236352|75798163|FG000|Overall Study|Withdrawal by Subject|0|||
41990128|NCT01236352|75798164|FG001|Overall Study|Withdrawal by Subject|0|||
42248894|NCT04496167|76074125|FG001|Overall Study|Lost to Follow-up|5|||
42248895|NCT04496167|76074124|FG000|Overall Study|Not Treated|1|||
42248896|NCT04496167|76074125|FG001|Overall Study|Not Treated|2|||
42248897|NCT04496167|76074124|FG000|Overall Study|Other Than Specified|1|||
42248898|NCT04496167|76074125|FG001|Overall Study|Other Than Specified|1|||
42248899|NCT04238481|76074168|FG000|Overall Study|Miscellaneous|0|||
42248900|NCT04238481|76074169|FG001|Overall Study|Miscellaneous|1|||
42248901|NCT04238481|76074170|FG002|Overall Study|Miscellaneous|0|||
41990129|NCT01236352|75798165|FG002|Overall Study|Withdrawal by Subject|0|||
41990130|NCT01236352|75798166|FG003|Overall Study|Withdrawal by Subject|0|||
41990131|NCT01236352|75798167|FG004|Overall Study|Withdrawal by Subject|0|||
41990132|NCT01236352|75798168|FG005|Overall Study|Withdrawal by Subject|0|||
41990133|NCT01236352|75798169|FG006|Overall Study|Withdrawal by Subject|0|||
41990134|NCT01236352|75798170|FG007|Overall Study|Withdrawal by Subject|0|||
42248902|NCT04238481|76074171|FG003|Overall Study|Miscellaneous|0|||
42248903|NCT04145700|76074183|FG000|Overall Study|Withdrawal by Subject|8|||
42248904|NCT04145700|76074184|FG001|Overall Study|Withdrawal by Subject|3|||
42248905|NCT04079738|76074190|FG000|Study Treatment|Death|1|||
42248906|NCT04079738|76074191|FG001|Study Treatment|Death|0|||
42248907|NCT04079738|76074192|FG002|Study Treatment|Death|0|||
42248908|NCT04079738|76074193|FG003|Study Treatment|Death|0|||
42248909|NCT04079738|76074190|FG000|Study Treatment|Adverse Event|2|||
42248910|NCT04079738|76074191|FG001|Study Treatment|Adverse Event|0|||
42248911|NCT04079738|76074192|FG002|Study Treatment|Adverse Event|0|||
42248912|NCT04079738|76074193|FG003|Study Treatment|Adverse Event|0|||
42248913|NCT04079738|76074190|FG000|Study Treatment|withdrawal before treatment|1|||
42248914|NCT04079738|76074191|FG001|Study Treatment|withdrawal before treatment|0|||
42248915|NCT04079738|76074192|FG002|Study Treatment|withdrawal before treatment|0|||
42248916|NCT04079738|76074193|FG003|Study Treatment|withdrawal before treatment|0|||
42248917|NCT04079738|76074190|FG000|Study Treatment|symptomatic deterioration|2|||
42248918|NCT04079738|76074191|FG001|Study Treatment|symptomatic deterioration|0|||
42248919|NCT04079738|76074192|FG002|Study Treatment|symptomatic deterioration|0|||
42248920|NCT04079738|76074193|FG003|Study Treatment|symptomatic deterioration|0|||
42248921|NCT04079738|76074190|FG000|Study Treatment|Disease Progression|1|||
42248922|NCT04079738|76074191|FG001|Study Treatment|Disease Progression|0|||
42248923|NCT04079738|76074192|FG002|Study Treatment|Disease Progression|0|||
42248924|NCT04079738|76074193|FG003|Study Treatment|Disease Progression|0|||
42248925|NCT04079738|76074190|FG000|Study Treatment|withdrawal after treatment|1|||
42248926|NCT04079738|76074191|FG001|Study Treatment|withdrawal after treatment|0|||
42248927|NCT04079738|76074192|FG002|Study Treatment|withdrawal after treatment|0|||
42248928|NCT04079738|76074193|FG003|Study Treatment|withdrawal after treatment|0|||
42248929|NCT04079738|76074190|FG000|Follow up|Withdrawal by Subject|3|||
42248930|NCT04079738|76074191|FG001|Follow up|Withdrawal by Subject|0|||
42248931|NCT04079738|76074192|FG002|Follow up|Withdrawal by Subject|0|||
42248932|NCT04079738|76074193|FG003|Follow up|Withdrawal by Subject|0|||
42248933|NCT04079738|76074190|FG000|Follow up|Death|5|||
42248934|NCT04079738|76074191|FG001|Follow up|Death|0|||
42248935|NCT04079738|76074192|FG002|Follow up|Death|0|||
42248936|NCT04079738|76074193|FG003|Follow up|Death|0|||
42248937|NCT04054635|76074202|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
42248938|NCT04054635|76074203|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
42248939|NCT04054635|76074204|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
42248940|NCT04054635|76074202|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
42248941|NCT04054635|76074203|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
42248942|NCT04054635|76074204|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
42248943|NCT03820726|76074212|FG000|Overall Study|Other than listed|23|||
42248944|NCT03820726|76074212|FG000|Overall Study|Withdrawal by Subject|37|||
42248945|NCT03820726|76074212|FG000|Overall Study|Lost to Follow-up|3|||
42248946|NCT03820726|76074212|FG000|Overall Study|Protocol deviation|1|||
42248947|NCT03820726|76074212|FG000|Overall Study|Adverse Event|146|||
42248948|NCT03820726|76074212|FG000|Overall Study|Not treated|1|||
42248949|NCT03744312|76074218|FG000|Overall Study|Withdrawal by Subject|0|||
42248950|NCT03744312|76074219|FG001|Overall Study|Withdrawal by Subject|1|||
42248951|NCT03744312|76074218|FG000|Overall Study|Screen fail|0|||
42248952|NCT03744312|76074219|FG001|Overall Study|Screen fail|1|||
42248953|NCT03737123|76074227|FG000|Study Treatment|Adverse Event|2|||
42248954|NCT03737123|76074228|FG001|Study Treatment|Adverse Event|0|||
42248955|NCT03737123|76074227|FG000|Study Treatment|Disease Progression|2|||
42248956|NCT03737123|76074228|FG001|Study Treatment|Disease Progression|0|||
42303297|NCT02409667|76138603|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
42303298|NCT02409667|76138604|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
42303299|NCT02409667|76138605|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
42303300|NCT02409667|76138606|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
42303301|NCT02409667|76138607|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
42248957|NCT03737123|76074227|FG000|Study Treatment|Withdrawal by Subject|2|||
42248958|NCT03737123|76074228|FG001|Study Treatment|Withdrawal by Subject|0|||
42248959|NCT03737123|76074227|FG000|Follow up|Death|1|||
41990135|NCT01236352|75798171|FG008|Overall Study|Withdrawal by Subject|0|||
42248960|NCT03737123|76074228|FG001|Follow up|Death|0|||
42248961|NCT03737123|76074227|FG000|Follow up|Withdrawal by Subject|1|||
42248962|NCT03737123|76074228|FG001|Follow up|Withdrawal by Subject|0|||
42248963|NCT03737123|76074227|FG000|Follow up|Termination of study|4|||
42248964|NCT03737123|76074228|FG001|Follow up|Termination of study|0|||
42248965|NCT03502707|76074251|FG000|Overall Study|Adverse Event|0|||
42248966|NCT03502707|76074252|FG001|Overall Study|Adverse Event|0|||
42248967|NCT03502707|76074253|FG002|Overall Study|Adverse Event|0|||
42248968|NCT03502707|76074254|FG003|Overall Study|Adverse Event|0|||
42248969|NCT03502707|76074255|FG004|Overall Study|Adverse Event|0|||
42248970|NCT03502707|76074256|FG005|Overall Study|Adverse Event|0|||
42248971|NCT03502707|76074257|FG006|Overall Study|Adverse Event|0|||
42248972|NCT03502707|76074258|FG007|Overall Study|Adverse Event|0|||
42248973|NCT03502707|76074259|FG008|Overall Study|Adverse Event|0|||
42248974|NCT03502707|76074260|FG009|Overall Study|Adverse Event|0|||
42248975|NCT03502707|76074261|FG010|Overall Study|Adverse Event|0|||
42248976|NCT03502707|76074262|FG011|Overall Study|Adverse Event|0|||
42248977|NCT03502707|76074263|FG012|Overall Study|Adverse Event|0|||
42248978|NCT03502707|76074264|FG013|Overall Study|Adverse Event|0|||
42248979|NCT03502707|76074265|FG014|Overall Study|Adverse Event|0|||
42248980|NCT03502707|76074266|FG015|Overall Study|Adverse Event|1|||
42248981|NCT03502707|76074267|FG016|Overall Study|Adverse Event|5|||
42248982|NCT03502707|76074268|FG017|Overall Study|Adverse Event|0|||
42248983|NCT03502707|76074251|FG000|Overall Study|Death|0|||
42248984|NCT03502707|76074252|FG001|Overall Study|Death|0|||
42248985|NCT03502707|76074253|FG002|Overall Study|Death|0|||
42248986|NCT03502707|76074254|FG003|Overall Study|Death|1|||
42248987|NCT03502707|76074255|FG004|Overall Study|Death|0|||
42248988|NCT03502707|76074256|FG005|Overall Study|Death|0|||
42248989|NCT03502707|76074257|FG006|Overall Study|Death|0|||
42248990|NCT03502707|76074258|FG007|Overall Study|Death|0|||
42248991|NCT03502707|76074259|FG008|Overall Study|Death|1|||
42248992|NCT03502707|76074260|FG009|Overall Study|Death|1|||
42248993|NCT03502707|76074261|FG010|Overall Study|Death|0|||
42248994|NCT03502707|76074262|FG011|Overall Study|Death|0|||
42248995|NCT03502707|76074263|FG012|Overall Study|Death|1|||
41990136|NCT01236352|75798172|FG009|Overall Study|Withdrawal by Subject|2|||
41990137|NCT01236352|75798173|FG010|Overall Study|Withdrawal by Subject|1|||
42248996|NCT03502707|76074264|FG013|Overall Study|Death|0|||
41990138|NCT01236352|75798163|FG000|Overall Study|Adverse Event|0|||
42248997|NCT03502707|76074265|FG014|Overall Study|Death|0|||
42248998|NCT03502707|76074266|FG015|Overall Study|Death|1|||
42248999|NCT03502707|76074267|FG016|Overall Study|Death|0|||
42249000|NCT03502707|76074268|FG017|Overall Study|Death|0|||
42249001|NCT03502707|76074251|FG000|Overall Study|Lost to Follow-up|0|||
42249002|NCT03502707|76074252|FG001|Overall Study|Lost to Follow-up|0|||
41990139|NCT01236352|75798164|FG001|Overall Study|Adverse Event|0|||
41990140|NCT01236352|75798165|FG002|Overall Study|Adverse Event|0|||
41990141|NCT01236352|75798166|FG003|Overall Study|Adverse Event|0|||
41990142|NCT01236352|75798167|FG004|Overall Study|Adverse Event|0|||
41990143|NCT01236352|75798168|FG005|Overall Study|Adverse Event|0|||
41990144|NCT01236352|75798169|FG006|Overall Study|Adverse Event|2|||
41990145|NCT01236352|75798170|FG007|Overall Study|Adverse Event|0|||
41990146|NCT01236352|75798171|FG008|Overall Study|Adverse Event|0|||
41990147|NCT01236352|75798172|FG009|Overall Study|Adverse Event|4|||
41990148|NCT01236352|75798173|FG010|Overall Study|Adverse Event|1|||
41990149|NCT01236352|75798163|FG000|Overall Study|Study drug toxicity|0|||
41990150|NCT01236352|75798164|FG001|Overall Study|Study drug toxicity|0|||
41990151|NCT01236352|75798165|FG002|Overall Study|Study drug toxicity|0|||
41990152|NCT01236352|75798166|FG003|Overall Study|Study drug toxicity|0|||
41990153|NCT01236352|75798167|FG004|Overall Study|Study drug toxicity|0|||
42249003|NCT03502707|76074253|FG002|Overall Study|Lost to Follow-up|0|||
42249004|NCT03502707|76074254|FG003|Overall Study|Lost to Follow-up|0|||
42249005|NCT03502707|76074255|FG004|Overall Study|Lost to Follow-up|0|||
42249006|NCT03502707|76074256|FG005|Overall Study|Lost to Follow-up|0|||
42249007|NCT03502707|76074257|FG006|Overall Study|Lost to Follow-up|0|||
42249008|NCT03502707|76074258|FG007|Overall Study|Lost to Follow-up|5|||
42249009|NCT03502707|76074259|FG008|Overall Study|Lost to Follow-up|0|||
42249010|NCT03502707|76074260|FG009|Overall Study|Lost to Follow-up|2|||
42249011|NCT03502707|76074261|FG010|Overall Study|Lost to Follow-up|1|||
42249012|NCT03502707|76074262|FG011|Overall Study|Lost to Follow-up|2|||
42249013|NCT03502707|76074263|FG012|Overall Study|Lost to Follow-up|1|||
42249014|NCT03502707|76074264|FG013|Overall Study|Lost to Follow-up|1|||
42249015|NCT03502707|76074265|FG014|Overall Study|Lost to Follow-up|0|||
42249016|NCT03502707|76074266|FG015|Overall Study|Lost to Follow-up|4|||
41990154|NCT01236352|75798168|FG005|Overall Study|Study drug toxicity|1|||
41990155|NCT01236352|75798169|FG006|Overall Study|Study drug toxicity|1|||
41990156|NCT01236352|75798170|FG007|Overall Study|Study drug toxicity|0|||
41990157|NCT01236352|75798171|FG008|Overall Study|Study drug toxicity|0|||
42249017|NCT03502707|76074267|FG016|Overall Study|Lost to Follow-up|9|||
42249018|NCT03502707|76074268|FG017|Overall Study|Lost to Follow-up|2|||
42249019|NCT03502707|76074251|FG000|Overall Study|Physician Decision|0|||
42249020|NCT03502707|76074252|FG001|Overall Study|Physician Decision|0|||
41990158|NCT01236352|75798172|FG009|Overall Study|Study drug toxicity|2|||
41990159|NCT01236352|75798173|FG010|Overall Study|Study drug toxicity|2|||
41990160|NCT01236352|75798163|FG000|Overall Study|Disease progression|1|||
41990161|NCT01236352|75798164|FG001|Overall Study|Disease progression|2|||
41990162|NCT01236352|75798165|FG002|Overall Study|Disease progression|1|||
41990163|NCT01236352|75798166|FG003|Overall Study|Disease progression|2|||
41990164|NCT01236352|75798167|FG004|Overall Study|Disease progression|2|||
41990165|NCT01236352|75798168|FG005|Overall Study|Disease progression|2|||
41990166|NCT01236352|75798169|FG006|Overall Study|Disease progression|1|||
41990167|NCT01236352|75798170|FG007|Overall Study|Disease progression|3|||
41990168|NCT01236352|75798171|FG008|Overall Study|Disease progression|2|||
42249021|NCT03502707|76074253|FG002|Overall Study|Physician Decision|0|||
41990169|NCT01236352|75798172|FG009|Overall Study|Disease progression|2|||
41990170|NCT01236352|75798173|FG010|Overall Study|Disease progression|2|||
42249022|NCT03502707|76074254|FG003|Overall Study|Physician Decision|0|||
42249023|NCT03502707|76074255|FG004|Overall Study|Physician Decision|0|||
42249024|NCT03502707|76074256|FG005|Overall Study|Physician Decision|0|||
42249025|NCT03502707|76074257|FG006|Overall Study|Physician Decision|0|||
42249026|NCT03502707|76074258|FG007|Overall Study|Physician Decision|0|||
42249027|NCT03502707|76074259|FG008|Overall Study|Physician Decision|2|||
42249028|NCT03502707|76074260|FG009|Overall Study|Physician Decision|1|||
42249029|NCT03502707|76074261|FG010|Overall Study|Physician Decision|0|||
42249030|NCT03502707|76074262|FG011|Overall Study|Physician Decision|0|||
42249031|NCT03502707|76074263|FG012|Overall Study|Physician Decision|0|||
42249032|NCT03502707|76074264|FG013|Overall Study|Physician Decision|0|||
42249033|NCT03502707|76074265|FG014|Overall Study|Physician Decision|1|||
42249034|NCT03502707|76074266|FG015|Overall Study|Physician Decision|3|||
42249035|NCT03502707|76074267|FG016|Overall Study|Physician Decision|0|||
42249036|NCT03502707|76074268|FG017|Overall Study|Physician Decision|0|||
42249037|NCT03502707|76074251|FG000|Overall Study|Protocol Violation|0|||
42249038|NCT03502707|76074252|FG001|Overall Study|Protocol Violation|0|||
42249039|NCT03502707|76074253|FG002|Overall Study|Protocol Violation|0|||
42249040|NCT03502707|76074254|FG003|Overall Study|Protocol Violation|0|||
42249041|NCT03502707|76074255|FG004|Overall Study|Protocol Violation|0|||
42249042|NCT03502707|76074256|FG005|Overall Study|Protocol Violation|0|||
42249043|NCT03502707|76074257|FG006|Overall Study|Protocol Violation|0|||
42249044|NCT03502707|76074258|FG007|Overall Study|Protocol Violation|0|||
41990171|NCT01236352|75798163|FG000|Overall Study|Poor/Non-compliance|1|||
41990172|NCT01236352|75798164|FG001|Overall Study|Poor/Non-compliance|0|||
41990173|NCT01236352|75798165|FG002|Overall Study|Poor/Non-compliance|0|||
42249045|NCT03502707|76074259|FG008|Overall Study|Protocol Violation|0|||
42249046|NCT03502707|76074260|FG009|Overall Study|Protocol Violation|0|||
42249047|NCT03502707|76074261|FG010|Overall Study|Protocol Violation|0|||
42249048|NCT03502707|76074262|FG011|Overall Study|Protocol Violation|0|||
42249049|NCT03502707|76074263|FG012|Overall Study|Protocol Violation|0|||
41990174|NCT01236352|75798166|FG003|Overall Study|Poor/Non-compliance|0|||
41990175|NCT01236352|75798167|FG004|Overall Study|Poor/Non-compliance|0|||
42249050|NCT03502707|76074264|FG013|Overall Study|Protocol Violation|0|||
42249051|NCT03502707|76074265|FG014|Overall Study|Protocol Violation|0|||
42249052|NCT03502707|76074266|FG015|Overall Study|Protocol Violation|1|||
42249053|NCT03502707|76074267|FG016|Overall Study|Protocol Violation|0|||
42249054|NCT03502707|76074268|FG017|Overall Study|Protocol Violation|0|||
41990176|NCT01236352|75798168|FG005|Overall Study|Poor/Non-compliance|0|||
41990177|NCT01236352|75798169|FG006|Overall Study|Poor/Non-compliance|0|||
42249055|NCT03502707|76074251|FG000|Overall Study|Withdrawal by Subject|1|||
42249056|NCT03502707|76074252|FG001|Overall Study|Withdrawal by Subject|1|||
41990178|NCT01236352|75798170|FG007|Overall Study|Poor/Non-compliance|0|||
41990179|NCT01236352|75798171|FG008|Overall Study|Poor/Non-compliance|0|||
42249057|NCT03502707|76074253|FG002|Overall Study|Withdrawal by Subject|0|||
42249058|NCT03502707|76074254|FG003|Overall Study|Withdrawal by Subject|0|||
42249059|NCT03502707|76074255|FG004|Overall Study|Withdrawal by Subject|0|||
42249060|NCT03502707|76074256|FG005|Overall Study|Withdrawal by Subject|2|||
42249061|NCT03502707|76074257|FG006|Overall Study|Withdrawal by Subject|0|||
42249062|NCT03502707|76074258|FG007|Overall Study|Withdrawal by Subject|3|||
42249063|NCT03502707|76074259|FG008|Overall Study|Withdrawal by Subject|1|||
42249064|NCT03502707|76074260|FG009|Overall Study|Withdrawal by Subject|2|||
42249065|NCT03502707|76074261|FG010|Overall Study|Withdrawal by Subject|12|||
42249066|NCT03502707|76074262|FG011|Overall Study|Withdrawal by Subject|23|||
42249067|NCT03502707|76074263|FG012|Overall Study|Withdrawal by Subject|5|||
42249068|NCT03502707|76074264|FG013|Overall Study|Withdrawal by Subject|3|||
42249069|NCT03502707|76074265|FG014|Overall Study|Withdrawal by Subject|3|||
42249070|NCT03502707|76074266|FG015|Overall Study|Withdrawal by Subject|43|||
42249071|NCT03502707|76074267|FG016|Overall Study|Withdrawal by Subject|44|||
42249072|NCT03502707|76074268|FG017|Overall Study|Withdrawal by Subject|18|||
42249073|NCT03502707|76074251|FG000|Overall Study|Sponsor's Decision|1|||
42249074|NCT03502707|76074252|FG001|Overall Study|Sponsor's Decision|0|||
42249075|NCT03502707|76074253|FG002|Overall Study|Sponsor's Decision|0|||
42249076|NCT03502707|76074254|FG003|Overall Study|Sponsor's Decision|0|||
42249077|NCT03502707|76074255|FG004|Overall Study|Sponsor's Decision|0|||
42249078|NCT03502707|76074256|FG005|Overall Study|Sponsor's Decision|0|||
42249079|NCT03502707|76074257|FG006|Overall Study|Sponsor's Decision|0|||
42249080|NCT03502707|76074258|FG007|Overall Study|Sponsor's Decision|0|||
42249081|NCT03502707|76074259|FG008|Overall Study|Sponsor's Decision|0|||
42249082|NCT03502707|76074260|FG009|Overall Study|Sponsor's Decision|1|||
42249083|NCT03502707|76074261|FG010|Overall Study|Sponsor's Decision|0|||
42249084|NCT03502707|76074262|FG011|Overall Study|Sponsor's Decision|0|||
42249085|NCT03502707|76074263|FG012|Overall Study|Sponsor's Decision|0|||
42249086|NCT03502707|76074264|FG013|Overall Study|Sponsor's Decision|0|||
42249087|NCT03502707|76074265|FG014|Overall Study|Sponsor's Decision|0|||
42249088|NCT03502707|76074266|FG015|Overall Study|Sponsor's Decision|2|||
42249089|NCT03502707|76074267|FG016|Overall Study|Sponsor's Decision|1|||
42249090|NCT03502707|76074268|FG017|Overall Study|Sponsor's Decision|0|||
42249091|NCT03502707|76074251|FG000|Overall Study|Initiated Prohibited Medication|0|||
42249092|NCT03502707|76074252|FG001|Overall Study|Initiated Prohibited Medication|0|||
42249093|NCT03502707|76074253|FG002|Overall Study|Initiated Prohibited Medication|0|||
42249094|NCT03502707|76074254|FG003|Overall Study|Initiated Prohibited Medication|0|||
42249095|NCT03502707|76074255|FG004|Overall Study|Initiated Prohibited Medication|0|||
42249096|NCT03502707|76074256|FG005|Overall Study|Initiated Prohibited Medication|0|||
42249097|NCT03502707|76074257|FG006|Overall Study|Initiated Prohibited Medication|0|||
42249098|NCT03502707|76074258|FG007|Overall Study|Initiated Prohibited Medication|0|||
42249099|NCT03502707|76074259|FG008|Overall Study|Initiated Prohibited Medication|0|||
42249100|NCT03502707|76074260|FG009|Overall Study|Initiated Prohibited Medication|0|||
42303302|NCT02409667|76138603|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
42303303|NCT02409667|76138604|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
42249101|NCT03502707|76074261|FG010|Overall Study|Initiated Prohibited Medication|0|||
42249102|NCT03502707|76074262|FG011|Overall Study|Initiated Prohibited Medication|0|||
42249103|NCT03502707|76074263|FG012|Overall Study|Initiated Prohibited Medication|0|||
42249104|NCT03502707|76074264|FG013|Overall Study|Initiated Prohibited Medication|0|||
42249105|NCT03502707|76074265|FG014|Overall Study|Initiated Prohibited Medication|0|||
42303304|NCT02409667|76138605|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
42303305|NCT02409667|76138606|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
42303306|NCT02409667|76138607|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
42303307|NCT02409667|76138603|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
42303308|NCT02409667|76138604|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
42303309|NCT02409667|76138605|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
42303310|NCT02409667|76138606|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
42249106|NCT03502707|76074266|FG015|Overall Study|Initiated Prohibited Medication|0|||
42249107|NCT03502707|76074267|FG016|Overall Study|Initiated Prohibited Medication|1|||
42249108|NCT03502707|76074268|FG017|Overall Study|Initiated Prohibited Medication|0|||
42249109|NCT03502707|76074251|FG000|Overall Study|Other|0|||
42249110|NCT03502707|76074252|FG001|Overall Study|Other|0|||
42249111|NCT03502707|76074253|FG002|Overall Study|Other|0|||
42249112|NCT03502707|76074254|FG003|Overall Study|Other|0|||
42249113|NCT03502707|76074255|FG004|Overall Study|Other|0|||
42249114|NCT03502707|76074256|FG005|Overall Study|Other|0|||
42249115|NCT03502707|76074257|FG006|Overall Study|Other|0|||
42249116|NCT03502707|76074258|FG007|Overall Study|Other|0|||
42249117|NCT03502707|76074259|FG008|Overall Study|Other|1|||
42249118|NCT03502707|76074260|FG009|Overall Study|Other|1|||
42249119|NCT03502707|76074261|FG010|Overall Study|Other|2|||
42249120|NCT03502707|76074262|FG011|Overall Study|Other|0|||
42249121|NCT03502707|76074263|FG012|Overall Study|Other|0|||
42249122|NCT03502707|76074264|FG013|Overall Study|Other|0|||
42249123|NCT03502707|76074265|FG014|Overall Study|Other|0|||
42249124|NCT03502707|76074266|FG015|Overall Study|Other|4|||
42249125|NCT03502707|76074267|FG016|Overall Study|Other|1|||
42249126|NCT03502707|76074268|FG017|Overall Study|Other|0|||
42249127|NCT03502707|76074251|FG000|Overall Study|Randomized but not vaccinated|0|||
42249128|NCT03502707|76074252|FG001|Overall Study|Randomized but not vaccinated|0|||
42249129|NCT03502707|76074253|FG002|Overall Study|Randomized but not vaccinated|0|||
42249130|NCT03502707|76074254|FG003|Overall Study|Randomized but not vaccinated|0|||
42249131|NCT03502707|76074255|FG004|Overall Study|Randomized but not vaccinated|0|||
42249132|NCT03502707|76074256|FG005|Overall Study|Randomized but not vaccinated|0|||
42249133|NCT03502707|76074257|FG006|Overall Study|Randomized but not vaccinated|0|||
42249134|NCT03502707|76074258|FG007|Overall Study|Randomized but not vaccinated|0|||
42249135|NCT03502707|76074259|FG008|Overall Study|Randomized but not vaccinated|0|||
42249136|NCT03502707|76074260|FG009|Overall Study|Randomized but not vaccinated|0|||
42249137|NCT03502707|76074261|FG010|Overall Study|Randomized but not vaccinated|0|||
42249138|NCT03502707|76074262|FG011|Overall Study|Randomized but not vaccinated|1|||
42249139|NCT03502707|76074263|FG012|Overall Study|Randomized but not vaccinated|0|||
42249140|NCT03502707|76074264|FG013|Overall Study|Randomized but not vaccinated|0|||
42249141|NCT03502707|76074265|FG014|Overall Study|Randomized but not vaccinated|0|||
42249142|NCT03502707|76074266|FG015|Overall Study|Randomized but not vaccinated|0|||
42249143|NCT03502707|76074267|FG016|Overall Study|Randomized but not vaccinated|0|||
42249144|NCT03502707|76074268|FG017|Overall Study|Randomized but not vaccinated|1|||
42249145|NCT03425006|76074318|FG000|Overall Study|Withdrawal by Subject|1|||
42249146|NCT03425006|76074318|FG000|Overall Study|Physician Decision|1|||
42249147|NCT03425006|76074318|FG000|Overall Study|Death|1|||
42249148|NCT03401073|76074324|FG000|Overall Study|Lost to Follow-up|1|||
42249149|NCT03401073|76074325|FG001|Overall Study|Lost to Follow-up|2|||
42249150|NCT03173560|76074337|FG000|Overall Study|Ongoing on Treatment|38|||
42249151|NCT03173560|76074338|FG001|Overall Study|Ongoing on Treatment|50|||
42249152|NCT03173560|76074337|FG000|Overall Study|Ongoing Survival Follow-up|56|||
42249153|NCT03173560|76074338|FG001|Overall Study|Ongoing Survival Follow-up|57|||
42249154|NCT03173560|76074337|FG000|Overall Study|Lost to Follow-up|1|||
42249155|NCT03173560|76074338|FG001|Overall Study|Lost to Follow-up|4|||
42249156|NCT03173560|76074337|FG000|Overall Study|Withdrawal by Subject|10|||
42249157|NCT03173560|76074338|FG001|Overall Study|Withdrawal by Subject|5|||
42249158|NCT03173560|76074337|FG000|Overall Study|Other|0|||
42249159|NCT03173560|76074338|FG001|Overall Study|Other|1|||
42249160|NCT02915263|76074359|FG000|Overall Study|Covid|3|||
42249161|NCT02915263|76074360|FG001|Overall Study|Covid|2|||
42249162|NCT02343952|76074366|FG000|Study Treatment|Disease Progression|23|||
42249163|NCT02343952|76074366|FG000|Study Treatment|Death|3|||
42249164|NCT02343952|76074366|FG000|Study Treatment|Adverse Event|19|||
42249165|NCT02343952|76074366|FG000|Study Treatment|Withdrawal by Subject|7|||
42249166|NCT02343952|76074366|FG000|Study Treatment|other complicating Diseases|1|||
42249167|NCT02343952|76074366|FG000|Follow up|Withdrawal by Subject|3|||
42249168|NCT02343952|76074366|FG000|Follow up|Death|33|||
42132329|NCT00402597|75943153|FG003|Overall Study|Withdrawal by Subject|15|||
42132330|NCT00402597|75943154|FG004|Overall Study|Withdrawal by Subject|24|||
42249169|NCT02343952|76074366|FG000|Follow up|Patient does not meet eligibility for study.|1|||
42249170|NCT02343952|76074366|FG000|Follow up|Research department closed by the practice.|5|||
42249171|NCT02343952|76074366|FG000|Follow up|Patient went home to Russia|1|||
42249172|NCT02343952|76074366|FG000|Follow up|Disease Progression|1|||
42249173|NCT02343952|76074366|FG000|Follow up|study terminated|1|||
42249174|NCT01592370|76074377|FG000|Overall Study|Disease Progression|62|||
42249175|NCT01592370|76074378|FG001|Overall Study|Disease Progression|16|||
42249176|NCT01592370|76074379|FG002|Overall Study|Disease Progression|52|||
42249177|NCT01592370|76074380|FG003|Overall Study|Disease Progression|3|||
42249178|NCT01592370|76074381|FG004|Overall Study|Disease Progression|3|||
42249179|NCT01592370|76074382|FG005|Overall Study|Disease Progression|31|||
42249180|NCT01592370|76074383|FG006|Overall Study|Disease Progression|14|||
42249181|NCT01592370|76074377|FG000|Overall Study|Study Drug Toxicity|14|||
42249182|NCT01592370|76074378|FG001|Overall Study|Study Drug Toxicity|3|||
42249183|NCT01592370|76074379|FG002|Overall Study|Study Drug Toxicity|0|||
42249184|NCT01592370|76074380|FG003|Overall Study|Study Drug Toxicity|0|||
42249185|NCT01592370|76074381|FG004|Overall Study|Study Drug Toxicity|0|||
42249186|NCT01592370|76074382|FG005|Overall Study|Study Drug Toxicity|0|||
42249187|NCT01592370|76074383|FG006|Overall Study|Study Drug Toxicity|1|||
42249188|NCT01592370|76074377|FG000|Overall Study|AE unrelated to study drug|4|||
42249189|NCT01592370|76074378|FG001|Overall Study|AE unrelated to study drug|3|||
42249190|NCT01592370|76074379|FG002|Overall Study|AE unrelated to study drug|0|||
42249191|NCT01592370|76074380|FG003|Overall Study|AE unrelated to study drug|0|||
42249192|NCT01592370|76074381|FG004|Overall Study|AE unrelated to study drug|0|||
42249193|NCT01592370|76074382|FG005|Overall Study|AE unrelated to study drug|0|||
42249194|NCT01592370|76074383|FG006|Overall Study|AE unrelated to study drug|1|||
42249195|NCT01592370|76074377|FG000|Overall Study|Request to discontinue study treatment|5|||
42249196|NCT01592370|76074378|FG001|Overall Study|Request to discontinue study treatment|0|||
42249197|NCT01592370|76074379|FG002|Overall Study|Request to discontinue study treatment|2|||
42249198|NCT01592370|76074380|FG003|Overall Study|Request to discontinue study treatment|0|||
42249199|NCT01592370|76074381|FG004|Overall Study|Request to discontinue study treatment|1|||
42249200|NCT01592370|76074382|FG005|Overall Study|Request to discontinue study treatment|2|||
42249201|NCT01592370|76074383|FG006|Overall Study|Request to discontinue study treatment|0|||
42249202|NCT01592370|76074377|FG000|Overall Study|Withdrew consent|1|||
42249203|NCT01592370|76074378|FG001|Overall Study|Withdrew consent|2|||
42132331|NCT00402597|75943150|FG000|Overall Study|reason not specified|30|||
42132332|NCT00402597|75943151|FG001|Overall Study|reason not specified|4|||
42249204|NCT01592370|76074379|FG002|Overall Study|Withdrew consent|1|||
42249205|NCT01592370|76074380|FG003|Overall Study|Withdrew consent|1|||
42249206|NCT01592370|76074381|FG004|Overall Study|Withdrew consent|0|||
42249207|NCT01592370|76074382|FG005|Overall Study|Withdrew consent|0|||
42249208|NCT01592370|76074383|FG006|Overall Study|Withdrew consent|0|||
42249209|NCT01592370|76074377|FG000|Overall Study|Maximum clinical benefit|11|||
42249210|NCT01592370|76074378|FG001|Overall Study|Maximum clinical benefit|1|||
42249211|NCT01592370|76074379|FG002|Overall Study|Maximum clinical benefit|7|||
42249212|NCT01592370|76074380|FG003|Overall Study|Maximum clinical benefit|1|||
42249213|NCT01592370|76074381|FG004|Overall Study|Maximum clinical benefit|0|||
42249214|NCT01592370|76074382|FG005|Overall Study|Maximum clinical benefit|0|||
42249215|NCT01592370|76074383|FG006|Overall Study|Maximum clinical benefit|0|||
42249216|NCT01592370|76074377|FG000|Overall Study|No longer meets study criteria|1|||
42249217|NCT01592370|76074378|FG001|Overall Study|No longer meets study criteria|0|||
42249218|NCT01592370|76074379|FG002|Overall Study|No longer meets study criteria|0|||
42249219|NCT01592370|76074380|FG003|Overall Study|No longer meets study criteria|0|||
42249220|NCT01592370|76074381|FG004|Overall Study|No longer meets study criteria|0|||
42249221|NCT01592370|76074382|FG005|Overall Study|No longer meets study criteria|0|||
42249222|NCT01592370|76074383|FG006|Overall Study|No longer meets study criteria|0|||
42249223|NCT01592370|76074377|FG000|Overall Study|Other Reasons|6|||
42249224|NCT01592370|76074378|FG001|Overall Study|Other Reasons|0|||
42249225|NCT01592370|76074379|FG002|Overall Study|Other Reasons|10|||
42249226|NCT01592370|76074380|FG003|Overall Study|Other Reasons|0|||
42249227|NCT01592370|76074381|FG004|Overall Study|Other Reasons|0|||
42249228|NCT01592370|76074382|FG005|Overall Study|Other Reasons|1|||
42249229|NCT01592370|76074383|FG006|Overall Study|Other Reasons|0|||
41990180|NCT01236352|75798172|FG009|Overall Study|Poor/Non-compliance|0|||
41990181|NCT01236352|75798173|FG010|Overall Study|Poor/Non-compliance|0|||
42249230|NCT00777036|76074411|FG000|On Treatment|Reason Not Specified|4|||
42249231|NCT00777036|76074412|FG001|On Treatment|Reason Not Specified|7|||
42249232|NCT00777036|76074413|FG002|On Treatment|Reason Not Specified|12|||
42249233|NCT00777036|76074411|FG000|On Treatment|Failure to Meet Study Criteria|0|||
42249234|NCT00777036|76074412|FG001|On Treatment|Failure to Meet Study Criteria|1|||
42249235|NCT00777036|76074413|FG002|On Treatment|Failure to Meet Study Criteria|0|||
42249236|NCT00777036|76074411|FG000|On Treatment|Non-compliance with Study Drug|1|||
42249237|NCT00777036|76074412|FG001|On Treatment|Non-compliance with Study Drug|0|||
42249238|NCT00777036|76074413|FG002|On Treatment|Non-compliance with Study Drug|0|||
42249239|NCT00777036|76074411|FG000|On Treatment|Maximum Clinical Benefit|2|||
42249240|NCT00777036|76074412|FG001|On Treatment|Maximum Clinical Benefit|0|||
42249241|NCT00777036|76074413|FG002|On Treatment|Maximum Clinical Benefit|1|||
42249242|NCT00777036|76074411|FG000|On Treatment|Withdrawal by Subject|3|||
42249243|NCT00777036|76074412|FG001|On Treatment|Withdrawal by Subject|2|||
42249244|NCT00777036|76074413|FG002|On Treatment|Withdrawal by Subject|3|||
42249245|NCT00777036|76074411|FG000|On Treatment|Death|0|||
42249246|NCT00777036|76074412|FG001|On Treatment|Death|2|||
42249247|NCT00777036|76074413|FG002|On Treatment|Death|0|||
42249248|NCT00777036|76074411|FG000|On Treatment|Study Drug Toxicity|0|||
42249249|NCT00777036|76074412|FG001|On Treatment|Study Drug Toxicity|0|||
42249250|NCT00777036|76074413|FG002|On Treatment|Study Drug Toxicity|1|||
42249251|NCT00777036|76074411|FG000|On Treatment|Progressive Disease|5|||
42249252|NCT00777036|76074412|FG001|On Treatment|Progressive Disease|4|||
42249253|NCT00777036|76074413|FG002|On Treatment|Progressive Disease|6|||
42249254|NCT00777036|76074411|FG000|Follow-Up|Lost to Follow-up|1|||
42249255|NCT00777036|76074412|FG001|Follow-Up|Lost to Follow-up|0|||
42249256|NCT00777036|76074413|FG002|Follow-Up|Lost to Follow-up|0|||
42249257|NCT00777036|76074411|FG000|Follow-Up|Reason Not Specified|2|||
42249258|NCT00777036|76074412|FG001|Follow-Up|Reason Not Specified|0|||
42249259|NCT00777036|76074413|FG002|Follow-Up|Reason Not Specified|0|||
42249260|NCT00777036|76074411|FG000|Follow-Up|Withdrawal by Subject|1|||
42249261|NCT00777036|76074412|FG001|Follow-Up|Withdrawal by Subject|0|||
42249262|NCT00777036|76074413|FG002|Follow-Up|Withdrawal by Subject|4|||
42249263|NCT00777036|76074411|FG000|Follow-Up|Death|1|||
42249264|NCT00777036|76074412|FG001|Follow-Up|Death|8|||
42249265|NCT00777036|76074413|FG002|Follow-Up|Death|0|||
42249266|NCT00176644|76074428|FG000|Overall Study|Withdrawal by Subject|1|||
42249267|NCT04649164|76074446|FG000|Overall Study|Withdrawal by Subject|1|||
42249268|NCT04649164|76074447|FG001|Overall Study|Withdrawal by Subject|1|||
42249269|NCT04649164|76074448|FG002|Overall Study|Withdrawal by Subject|2|||
42249270|NCT04649164|76074446|FG000|Overall Study|Participant's care recipient expired|0|||
42249271|NCT04649164|76074447|FG001|Overall Study|Participant's care recipient expired|0|||
42249272|NCT04649164|76074448|FG002|Overall Study|Participant's care recipient expired|2|||
42249273|NCT00706004|76074489|FG000|Overall Study|Did not meet eligibility criteria|2|||
42249274|NCT02724644|76074496|FG000|Overall Study|Adverse Event|7|||
42249275|NCT02724644|76074497|FG001|Overall Study|Adverse Event|1|||
42249276|NCT02724644|76074496|FG000|Overall Study|Lost to Follow-up|6|||
42249277|NCT02724644|76074497|FG001|Overall Study|Lost to Follow-up|2|||
42249278|NCT02724644|76074496|FG000|Overall Study|Withdrawal by Subject|7|||
42249279|NCT02724644|76074497|FG001|Overall Study|Withdrawal by Subject|1|||
42249280|NCT02724644|76074496|FG000|Overall Study|Administrative|1|||
42249281|NCT02724644|76074497|FG001|Overall Study|Administrative|0|||
42249282|NCT02725268|76074507|FG000|Overall Study|Death|58|||
42249283|NCT02725268|76074508|FG001|Overall Study|Death|59|||
41990182|NCT01236352|75798163|FG000|Overall Study|Maximum clinical benefit|1|||
41990183|NCT01236352|75798164|FG001|Overall Study|Maximum clinical benefit|1|||
41990184|NCT01236352|75798165|FG002|Overall Study|Maximum clinical benefit|1|||
41990185|NCT01236352|75798166|FG003|Overall Study|Maximum clinical benefit|0|||
41990186|NCT01236352|75798167|FG004|Overall Study|Maximum clinical benefit|2|||
41990187|NCT01236352|75798168|FG005|Overall Study|Maximum clinical benefit|0|||
41990188|NCT01236352|75798169|FG006|Overall Study|Maximum clinical benefit|3|||
42249284|NCT02725268|76074509|FG002|Overall Study|Death|30|||
42249285|NCT02725268|76074510|FG003|Overall Study|Death|16|||
42249286|NCT02725268|76074507|FG000|Overall Study|Lost to Follow-up|4|||
42249287|NCT02725268|76074508|FG001|Overall Study|Lost to Follow-up|3|||
42249288|NCT02725268|76074509|FG002|Overall Study|Lost to Follow-up|0|||
42249289|NCT02725268|76074510|FG003|Overall Study|Lost to Follow-up|1|||
42249290|NCT02725268|76074507|FG000|Overall Study|Site Terminated by Sponsor|0|||
42249291|NCT02725268|76074508|FG001|Overall Study|Site Terminated by Sponsor|1|||
42249292|NCT02725268|76074509|FG002|Overall Study|Site Terminated by Sponsor|0|||
42249293|NCT02725268|76074510|FG003|Overall Study|Site Terminated by Sponsor|0|||
41990189|NCT01236352|75798170|FG007|Overall Study|Maximum clinical benefit|1|||
41990190|NCT01236352|75798171|FG008|Overall Study|Maximum clinical benefit|1|||
41990191|NCT01236352|75798172|FG009|Overall Study|Maximum clinical benefit|4|||
41990192|NCT01236352|75798173|FG010|Overall Study|Maximum clinical benefit|2|||
41990193|NCT01236352|75798163|FG000|Overall Study|Subject request to discontinue treatment|0|||
41990194|NCT01236352|75798164|FG001|Overall Study|Subject request to discontinue treatment|0|||
42249294|NCT02725268|76074507|FG000|Overall Study|Withdrawal by Subject|8|||
42249295|NCT02725268|76074508|FG001|Overall Study|Withdrawal by Subject|6|||
42249296|NCT02725268|76074509|FG002|Overall Study|Withdrawal by Subject|8|||
42249297|NCT02725268|76074510|FG003|Overall Study|Withdrawal by Subject|1|||
42249298|NCT02725268|76074507|FG000|Overall Study|Reason not Specified|2|||
42249299|NCT02725268|76074508|FG001|Overall Study|Reason not Specified|1|||
42249300|NCT02725268|76074509|FG002|Overall Study|Reason not Specified|0|||
42249301|NCT02725268|76074510|FG003|Overall Study|Reason not Specified|0|||
42249302|NCT02724956|76074522|FG000|Overall Study|Physician Decision|1|||
42249303|NCT02724956|76074523|FG001|Overall Study|Physician Decision|0|||
42249304|NCT02724956|76074522|FG000|Overall Study|Lack of Efficacy|0|||
42249305|NCT02724956|76074523|FG001|Overall Study|Lack of Efficacy|1|||
42249306|NCT02724956|76074522|FG000|Overall Study|Withdrawal by Subject|0|||
42249307|NCT02724956|76074523|FG001|Overall Study|Withdrawal by Subject|1|||
42249308|NCT00705536|76074531|FG000|Start Period 1|Withdrawal by Subject|0|||
42249309|NCT00705536|76074532|FG001|Start Period 1|Withdrawal by Subject|0|||
42249310|NCT00705536|76074533|FG002|Start Period 1|Withdrawal by Subject|0|||
42249311|NCT00705536|76074534|FG003|Start Period 1|Withdrawal by Subject|1|||
42249312|NCT02724020|76074556|FG000|Overall Study|Death|16|||
42249313|NCT02724020|76074557|FG001|Overall Study|Death|18|||
42249314|NCT02724020|76074558|FG002|Overall Study|Death|19|||
42249315|NCT02724020|76074556|FG000|Overall Study|Lost to Follow-up|0|||
42249316|NCT02724020|76074557|FG001|Overall Study|Lost to Follow-up|3|||
42249317|NCT02724020|76074558|FG002|Overall Study|Lost to Follow-up|0|||
42249318|NCT02724020|76074556|FG000|Overall Study|Site Terminated by Sponsor|15|||
42249319|NCT02724020|76074557|FG001|Overall Study|Site Terminated by Sponsor|8|||
42249320|NCT02724020|76074558|FG002|Overall Study|Site Terminated by Sponsor|8|||
42249321|NCT02724020|76074556|FG000|Overall Study|Withdrawal by Subject|1|||
42249322|NCT02724020|76074557|FG001|Overall Study|Withdrawal by Subject|3|||
42249323|NCT02724020|76074558|FG002|Overall Study|Withdrawal by Subject|5|||
42249324|NCT02660034|76074580|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
42249325|NCT02660034|76074581|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
42249326|NCT02660034|76074582|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
42249327|NCT02660034|76074583|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
42249328|NCT02660034|76074584|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
42249329|NCT02660034|76074585|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
42249330|NCT02660034|76074586|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
42249331|NCT02660034|76074587|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
42249332|NCT02660034|76074588|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
42249333|NCT02660034|76074589|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
42249334|NCT02660034|76074590|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
42249335|NCT02660034|76074591|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
42303311|NCT02409667|76138607|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
42303312|NCT02409667|76138603|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
42303313|NCT02409667|76138604|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
42303314|NCT02409667|76138605|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
42303315|NCT02409667|76138606|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
42303316|NCT02409667|76138607|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
42303317|NCT02409667|76138603|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
42249336|NCT02660034|76074592|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
42249337|NCT02660034|76074593|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
42249338|NCT02660034|76074580|FG000|Overall Study|Progressive Disease (Clinical)|7|||
42249339|NCT02660034|76074581|FG001|Overall Study|Progressive Disease (Clinical)|8|||
42249340|NCT02660034|76074582|FG002|Overall Study|Progressive Disease (Clinical)|3|||
42249341|NCT02660034|76074583|FG003|Overall Study|Progressive Disease (Clinical)|9|||
42249342|NCT02660034|76074584|FG004|Overall Study|Progressive Disease (Clinical)|3|||
42249343|NCT02660034|76074585|FG005|Overall Study|Progressive Disease (Clinical)|0|||
42272691|NCT00857285|76103029|FG001|Overall Study|Protocol Violation|1|||
42249344|NCT02660034|76074586|FG006|Overall Study|Progressive Disease (Clinical)|0|||
42249345|NCT02660034|76074587|FG007|Overall Study|Progressive Disease (Clinical)|0|||
42249346|NCT02660034|76074588|FG008|Overall Study|Progressive Disease (Clinical)|0|||
42249347|NCT02660034|76074589|FG009|Overall Study|Progressive Disease (Clinical)|0|||
42249348|NCT02660034|76074590|FG010|Overall Study|Progressive Disease (Clinical)|0|||
42249349|NCT02660034|76074591|FG011|Overall Study|Progressive Disease (Clinical)|0|||
42249350|NCT02660034|76074592|FG012|Overall Study|Progressive Disease (Clinical)|0|||
42303318|NCT02409667|76138604|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
42303319|NCT02409667|76138605|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
42249351|NCT02660034|76074593|FG013|Overall Study|Progressive Disease (Clinical)|0|||
42249352|NCT02660034|76074580|FG000|Overall Study|Lost to Follow-up|0|||
42249353|NCT02660034|76074581|FG001|Overall Study|Lost to Follow-up|0|||
42249354|NCT02660034|76074582|FG002|Overall Study|Lost to Follow-up|1|||
42249355|NCT02660034|76074583|FG003|Overall Study|Lost to Follow-up|1|||
42249356|NCT02660034|76074584|FG004|Overall Study|Lost to Follow-up|0|||
42249357|NCT02660034|76074585|FG005|Overall Study|Lost to Follow-up|0|||
42249358|NCT02660034|76074586|FG006|Overall Study|Lost to Follow-up|0|||
42249359|NCT02660034|76074587|FG007|Overall Study|Lost to Follow-up|0|||
42249360|NCT02660034|76074588|FG008|Overall Study|Lost to Follow-up|0|||
42249361|NCT02660034|76074589|FG009|Overall Study|Lost to Follow-up|1|||
42249362|NCT02660034|76074590|FG010|Overall Study|Lost to Follow-up|1|||
42249363|NCT02660034|76074591|FG011|Overall Study|Lost to Follow-up|1|||
42249364|NCT02660034|76074592|FG012|Overall Study|Lost to Follow-up|0|||
42249365|NCT02660034|76074593|FG013|Overall Study|Lost to Follow-up|0|||
42249366|NCT02660034|76074580|FG000|Overall Study|Participant moved into special access scheme|1|||
42249367|NCT02660034|76074581|FG001|Overall Study|Participant moved into special access scheme|2|||
42249368|NCT02660034|76074582|FG002|Overall Study|Participant moved into special access scheme|0|||
42249369|NCT02660034|76074583|FG003|Overall Study|Participant moved into special access scheme|0|||
42249370|NCT02660034|76074584|FG004|Overall Study|Participant moved into special access scheme|0|||
42249371|NCT02660034|76074585|FG005|Overall Study|Participant moved into special access scheme|0|||
42249372|NCT02660034|76074586|FG006|Overall Study|Participant moved into special access scheme|0|||
42249373|NCT02660034|76074587|FG007|Overall Study|Participant moved into special access scheme|0|||
42249374|NCT02660034|76074588|FG008|Overall Study|Participant moved into special access scheme|0|||
42249375|NCT02660034|76074589|FG009|Overall Study|Participant moved into special access scheme|0|||
42249376|NCT02660034|76074590|FG010|Overall Study|Participant moved into special access scheme|0|||
42249377|NCT02660034|76074591|FG011|Overall Study|Participant moved into special access scheme|0|||
42249378|NCT02660034|76074592|FG012|Overall Study|Participant moved into special access scheme|0|||
42249379|NCT02660034|76074593|FG013|Overall Study|Participant moved into special access scheme|0|||
42249380|NCT02660034|76074580|FG000|Overall Study|Adverse Event|1|||
42249381|NCT02660034|76074581|FG001|Overall Study|Adverse Event|0|||
42249382|NCT02660034|76074582|FG002|Overall Study|Adverse Event|0|||
42249383|NCT02660034|76074583|FG003|Overall Study|Adverse Event|0|||
42249384|NCT02660034|76074584|FG004|Overall Study|Adverse Event|0|||
42249385|NCT02660034|76074585|FG005|Overall Study|Adverse Event|0|||
42249386|NCT02660034|76074586|FG006|Overall Study|Adverse Event|0|||
42249387|NCT02660034|76074587|FG007|Overall Study|Adverse Event|0|||
42249388|NCT02660034|76074588|FG008|Overall Study|Adverse Event|0|||
42249389|NCT02660034|76074589|FG009|Overall Study|Adverse Event|0|||
42303320|NCT02409667|76138606|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
42303321|NCT02409667|76138607|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
42303322|NCT02409667|76138603|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
41990195|NCT01236352|75798165|FG002|Overall Study|Subject request to discontinue treatment|1|||
42303323|NCT02409667|76138604|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
42303324|NCT02409667|76138605|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
42132333|NCT00402597|75943152|FG002|Overall Study|reason not specified|27|||
42132334|NCT00402597|75943153|FG003|Overall Study|reason not specified|14|||
42132335|NCT00402597|75943154|FG004|Overall Study|reason not specified|20|||
42132336|NCT00402363|75943170|FG000|Overall Study|Adverse Event|9|||
42303325|NCT02409667|76138606|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
42303326|NCT02409667|76138607|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
41990196|NCT01236352|75798166|FG003|Overall Study|Subject request to discontinue treatment|1|||
42132337|NCT00402363|75943171|FG001|Overall Study|Adverse Event|14|||
42249390|NCT02660034|76074590|FG010|Overall Study|Adverse Event|0|||
42249391|NCT02660034|76074591|FG011|Overall Study|Adverse Event|0|||
42249392|NCT02660034|76074592|FG012|Overall Study|Adverse Event|0|||
42249393|NCT02660034|76074593|FG013|Overall Study|Adverse Event|0|||
42249394|NCT02660034|76074580|FG000|Overall Study|Sponsor Decision|0|||
42249395|NCT02660034|76074581|FG001|Overall Study|Sponsor Decision|1|||
42249396|NCT02660034|76074582|FG002|Overall Study|Sponsor Decision|2|||
42249397|NCT02660034|76074583|FG003|Overall Study|Sponsor Decision|2|||
42249398|NCT02660034|76074584|FG004|Overall Study|Sponsor Decision|3|||
42249399|NCT02660034|76074585|FG005|Overall Study|Sponsor Decision|0|||
42249400|NCT02660034|76074586|FG006|Overall Study|Sponsor Decision|0|||
42249401|NCT02660034|76074587|FG007|Overall Study|Sponsor Decision|0|||
42249402|NCT02660034|76074588|FG008|Overall Study|Sponsor Decision|0|||
42249403|NCT02660034|76074589|FG009|Overall Study|Sponsor Decision|0|||
42249404|NCT02660034|76074590|FG010|Overall Study|Sponsor Decision|0|||
42249405|NCT02660034|76074591|FG011|Overall Study|Sponsor Decision|0|||
42249406|NCT02660034|76074592|FG012|Overall Study|Sponsor Decision|0|||
42249407|NCT02660034|76074593|FG013|Overall Study|Sponsor Decision|1|||
42249408|NCT02660034|76074580|FG000|Overall Study|Withdrawal by Subject|0|||
42249409|NCT02660034|76074581|FG001|Overall Study|Withdrawal by Subject|0|||
42249410|NCT02660034|76074582|FG002|Overall Study|Withdrawal by Subject|0|||
42249411|NCT02660034|76074583|FG003|Overall Study|Withdrawal by Subject|0|||
42249412|NCT02660034|76074584|FG004|Overall Study|Withdrawal by Subject|0|||
42249413|NCT02660034|76074585|FG005|Overall Study|Withdrawal by Subject|0|||
42249414|NCT02660034|76074586|FG006|Overall Study|Withdrawal by Subject|1|||
42249415|NCT02660034|76074587|FG007|Overall Study|Withdrawal by Subject|1|||
42249416|NCT02660034|76074588|FG008|Overall Study|Withdrawal by Subject|1|||
42249417|NCT02660034|76074589|FG009|Overall Study|Withdrawal by Subject|0|||
42249418|NCT02660034|76074590|FG010|Overall Study|Withdrawal by Subject|0|||
42249419|NCT02660034|76074591|FG011|Overall Study|Withdrawal by Subject|1|||
42249420|NCT02660034|76074592|FG012|Overall Study|Withdrawal by Subject|2|||
42249421|NCT02660034|76074593|FG013|Overall Study|Withdrawal by Subject|0|||
42249422|NCT02660034|76074580|FG000|Overall Study|Death|0|||
42249423|NCT02660034|76074581|FG001|Overall Study|Death|0|||
42249424|NCT02660034|76074582|FG002|Overall Study|Death|0|||
42249425|NCT02660034|76074583|FG003|Overall Study|Death|0|||
42249426|NCT02660034|76074584|FG004|Overall Study|Death|0|||
42249427|NCT02660034|76074585|FG005|Overall Study|Death|13|||
41990197|NCT01236352|75798167|FG004|Overall Study|Subject request to discontinue treatment|0|||
41990198|NCT01236352|75798168|FG005|Overall Study|Subject request to discontinue treatment|1|||
41990199|NCT01236352|75798169|FG006|Overall Study|Subject request to discontinue treatment|0|||
42249428|NCT02660034|76074586|FG006|Overall Study|Death|14|||
42249429|NCT02660034|76074587|FG007|Overall Study|Death|10|||
42132338|NCT00402363|75943172|FG002|Overall Study|Adverse Event|2|||
42249430|NCT02660034|76074588|FG008|Overall Study|Death|9|||
42249431|NCT02660034|76074589|FG009|Overall Study|Death|21|||
42249432|NCT02660034|76074590|FG010|Overall Study|Death|17|||
42249433|NCT02660034|76074591|FG011|Overall Study|Death|15|||
42249434|NCT02660034|76074592|FG012|Overall Study|Death|18|||
42249435|NCT02660034|76074593|FG013|Overall Study|Death|7|||
42249436|NCT02660034|76074580|FG000|Overall Study|Physician Decision|0|||
42249437|NCT02660034|76074581|FG001|Overall Study|Physician Decision|0|||
42249438|NCT02660034|76074582|FG002|Overall Study|Physician Decision|0|||
42249439|NCT02660034|76074583|FG003|Overall Study|Physician Decision|0|||
42249440|NCT02660034|76074584|FG004|Overall Study|Physician Decision|0|||
42249441|NCT02660034|76074585|FG005|Overall Study|Physician Decision|0|||
42249442|NCT02660034|76074586|FG006|Overall Study|Physician Decision|0|||
42249443|NCT02660034|76074587|FG007|Overall Study|Physician Decision|0|||
42249444|NCT02660034|76074588|FG008|Overall Study|Physician Decision|0|||
42249445|NCT02660034|76074589|FG009|Overall Study|Physician Decision|0|||
42249446|NCT02660034|76074590|FG010|Overall Study|Physician Decision|0|||
42249447|NCT02660034|76074591|FG011|Overall Study|Physician Decision|0|||
42249448|NCT02660034|76074592|FG012|Overall Study|Physician Decision|0|||
42249449|NCT02660034|76074593|FG013|Overall Study|Physician Decision|1|||
42249450|NCT02660034|76074580|FG000|Overall Study|Participants transferred to LTE|0|||
42249451|NCT02660034|76074581|FG001|Overall Study|Participants transferred to LTE|0|||
42249452|NCT02660034|76074582|FG002|Overall Study|Participants transferred to LTE|0|||
42249453|NCT02660034|76074583|FG003|Overall Study|Participants transferred to LTE|0|||
42249454|NCT02660034|76074584|FG004|Overall Study|Participants transferred to LTE|0|||
42249455|NCT02660034|76074585|FG005|Overall Study|Participants transferred to LTE|10|||
42249456|NCT02660034|76074586|FG006|Overall Study|Participants transferred to LTE|8|||
42249457|NCT02660034|76074587|FG007|Overall Study|Participants transferred to LTE|8|||
42249458|NCT02660034|76074588|FG008|Overall Study|Participants transferred to LTE|10|||
42249459|NCT02660034|76074589|FG009|Overall Study|Participants transferred to LTE|1|||
42249460|NCT02660034|76074590|FG010|Overall Study|Participants transferred to LTE|2|||
42249461|NCT02660034|76074591|FG011|Overall Study|Participants transferred to LTE|4|||
42249462|NCT02660034|76074592|FG012|Overall Study|Participants transferred to LTE|1|||
42249463|NCT02660034|76074593|FG013|Overall Study|Participants transferred to LTE|1|||
42249464|NCT02193867|76074636|FG000|Overall Study|Death|2|||
42249465|NCT02193867|76074636|FG000|Overall Study|Sponsor Study Termination|2|||
42249466|NCT02200770|76074664|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
42249467|NCT02200770|76074665|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
42249468|NCT02200770|76074664|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
42249469|NCT02200770|76074665|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
42249470|NCT02200770|76074664|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
42249471|NCT02200770|76074665|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
42249472|NCT02200770|76074664|FG000|Randomized-controlled Period (RCP)|Other|1|||
42249473|NCT02200770|76074665|FG001|Randomized-controlled Period (RCP)|Other|2|||
42249474|NCT02200770|76074664|FG000|Open-label Period (OLP)|Adverse Event|1|||
42249475|NCT02200770|76074665|FG001|Open-label Period (OLP)|Adverse Event|2|||
42249476|NCT02200770|76074664|FG000|Open-label Period (OLP)|Death|1|||
42249477|NCT02200770|76074665|FG001|Open-label Period (OLP)|Death|2|||
42249478|NCT02200770|76074664|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
42249479|NCT02200770|76074665|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
42249480|NCT02200770|76074664|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
42249481|NCT02200770|76074665|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
42249482|NCT02200770|76074664|FG000|Open-label Period (OLP)|Other|6|||
42249483|NCT02200770|76074665|FG001|Open-label Period (OLP)|Other|15|||
42249484|NCT01186848|76074687|FG000|Overall Study|Lost to Follow-up|4|||
42249485|NCT01186848|76074687|FG000|Overall Study|Withdrawal by Subject|2|||
42249486|NCT01186848|76074687|FG000|Overall Study|Adverse Event|2|||
42249487|NCT01024608|76074695|FG000|Overall Study|Adverse Event|1|||
42249488|NCT01024608|76074696|FG001|Overall Study|Adverse Event|0|||
42249489|NCT01024608|76074695|FG000|Overall Study|Withdrawal by Subject|1|||
42249490|NCT01024608|76074696|FG001|Overall Study|Withdrawal by Subject|0|||
41990200|NCT01236352|75798170|FG007|Overall Study|Subject request to discontinue treatment|0|||
41990201|NCT01236352|75798171|FG008|Overall Study|Subject request to discontinue treatment|0|||
41990202|NCT01236352|75798172|FG009|Overall Study|Subject request to discontinue treatment|1|||
41990203|NCT01236352|75798173|FG010|Overall Study|Subject request to discontinue treatment|4|||
42249491|NCT01024608|76074695|FG000|Overall Study|Lost to Follow-up|0|||
42249492|NCT01024608|76074696|FG001|Overall Study|Lost to Follow-up|1|||
42249493|NCT01024608|76074695|FG000|Overall Study|Protocol Violation|0|||
42249494|NCT01024608|76074696|FG001|Overall Study|Protocol Violation|3|||
42249495|NCT01024608|76074695|FG000|Overall Study|Never received study treatment|2|||
42249496|NCT01024608|76074696|FG001|Overall Study|Never received study treatment|0|||
42249497|NCT00910650|76074702|FG000|Overall Study|Death|2|||
42249498|NCT03996876|76074737|FG000|Overall Study|Incomplete Data|2|||
42249499|NCT03996876|76074738|FG001|Overall Study|Incomplete Data|4|||
42249500|NCT01460160|76074745|FG000|Treatment Phase|Lack of Efficacy|3|||
42249501|NCT01460160|76074745|FG000|Treatment Phase|Study Drug Toxicity|2|||
42249502|NCT01460160|76074745|FG000|Treatment Phase|Adverse Event|8|||
42249503|NCT01460160|76074745|FG000|Treatment Phase|Withdrawal by Subject|4|||
42249504|NCT01460160|76074745|FG000|Treatment Phase|Death|2|||
42249505|NCT01460160|76074745|FG000|Treatment Phase|Other reasons|9|||
42249506|NCT01460160|76074745|FG000|Follow-up Phase|Withdrawal by Subject|4|||
42249507|NCT01460160|76074745|FG000|Follow-up Phase|Death|14|||
42249508|NCT01460160|76074745|FG000|Follow-up Phase|Lost to Follow-up|7|||
42249509|NCT01460160|76074745|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
42249510|NCT01460160|76074745|FG000|Follow-up Phase|Other and not reported reasons|5|||
42249511|NCT01170702|76074753|FG000|Overall Study|Exclusion criteria met after consent|1|||
42249512|NCT01170702|76074754|FG001|Overall Study|Exclusion criteria met after consent|2|||
42249513|NCT01170702|76074755|FG002|Overall Study|Exclusion criteria met after consent|0|||
42249514|NCT01170702|76074756|FG003|Overall Study|Exclusion criteria met after consent|2|||
42249515|NCT02723864|76074795|FG000|Overall Study|Refused further treatment|1|||
42249516|NCT02723864|76074796|FG001|Overall Study|Refused further treatment|0|||
42249517|NCT02723864|76074797|FG002|Overall Study|Refused further treatment|0|||
42249518|NCT02723864|76074798|FG003|Overall Study|Refused further treatment|0|||
42249519|NCT02723864|76074799|FG004|Overall Study|Refused further treatment|1|||
42249520|NCT02723864|76074800|FG005|Overall Study|Refused further treatment|2|||
42249521|NCT02723864|76074801|FG006|Overall Study|Refused further treatment|0|||
42249522|NCT02723864|76074795|FG000|Overall Study|Exceed treatment hold time|0|||
42249523|NCT02723864|76074796|FG001|Overall Study|Exceed treatment hold time|1|||
42249524|NCT02723864|76074797|FG002|Overall Study|Exceed treatment hold time|0|||
42249525|NCT02723864|76074798|FG003|Overall Study|Exceed treatment hold time|0|||
42249526|NCT02723864|76074799|FG004|Overall Study|Exceed treatment hold time|0|||
42249527|NCT02723864|76074800|FG005|Overall Study|Exceed treatment hold time|0|||
42249528|NCT02723864|76074801|FG006|Overall Study|Exceed treatment hold time|0|||
42249529|NCT02723864|76074795|FG000|Overall Study|Clinical progression|0|||
42249530|NCT02723864|76074796|FG001|Overall Study|Clinical progression|0|||
42249531|NCT02723864|76074797|FG002|Overall Study|Clinical progression|1|||
42249532|NCT02723864|76074798|FG003|Overall Study|Clinical progression|0|||
42249533|NCT02723864|76074799|FG004|Overall Study|Clinical progression|0|||
42249534|NCT02723864|76074800|FG005|Overall Study|Clinical progression|3|||
42249535|NCT02723864|76074801|FG006|Overall Study|Clinical progression|1|||
42249536|NCT02723864|76074795|FG000|Overall Study|Physician Decision|0|||
42249537|NCT02723864|76074796|FG001|Overall Study|Physician Decision|0|||
42249538|NCT02723864|76074797|FG002|Overall Study|Physician Decision|0|||
42249539|NCT02723864|76074798|FG003|Overall Study|Physician Decision|0|||
42249540|NCT02723864|76074799|FG004|Overall Study|Physician Decision|0|||
42249541|NCT02723864|76074800|FG005|Overall Study|Physician Decision|0|||
42249542|NCT02723864|76074801|FG006|Overall Study|Physician Decision|1|||
42249543|NCT02723864|76074795|FG000|Overall Study|Changes in patient condition|0|||
42249544|NCT02723864|76074796|FG001|Overall Study|Changes in patient condition|0|||
42249545|NCT02723864|76074797|FG002|Overall Study|Changes in patient condition|0|||
42249546|NCT02723864|76074798|FG003|Overall Study|Changes in patient condition|0|||
42249547|NCT02723864|76074799|FG004|Overall Study|Changes in patient condition|0|||
42249548|NCT02723864|76074800|FG005|Overall Study|Changes in patient condition|1|||
42249549|NCT02723864|76074801|FG006|Overall Study|Changes in patient condition|0|||
42249550|NCT02723864|76074795|FG000|Overall Study|Patient choice|0|||
42249551|NCT02723864|76074796|FG001|Overall Study|Patient choice|0|||
42249552|NCT02723864|76074797|FG002|Overall Study|Patient choice|0|||
42249553|NCT02723864|76074798|FG003|Overall Study|Patient choice|0|||
42249554|NCT02723864|76074799|FG004|Overall Study|Patient choice|0|||
42249555|NCT02723864|76074800|FG005|Overall Study|Patient choice|1|||
42249556|NCT02723864|76074801|FG006|Overall Study|Patient choice|0|||
42249557|NCT02723864|76074795|FG000|Overall Study|Adverse Event|0|||
41990204|NCT01236352|75798163|FG000|Overall Study|Subject to receive drug via EAP|1|||
41990205|NCT01236352|75798164|FG001|Overall Study|Subject to receive drug via EAP|1|||
41990206|NCT01236352|75798165|FG002|Overall Study|Subject to receive drug via EAP|1|||
42132339|NCT00402363|75943173|FG003|Overall Study|Adverse Event|2|||
42132340|NCT00402363|75943170|FG000|Overall Study|Withdrew Consent|10|||
42132341|NCT00402363|75943171|FG001|Overall Study|Withdrew Consent|5|||
41990207|NCT01236352|75798166|FG003|Overall Study|Subject to receive drug via EAP|0|||
42249558|NCT02723864|76074796|FG001|Overall Study|Adverse Event|0|||
42249559|NCT02723864|76074797|FG002|Overall Study|Adverse Event|0|||
42249560|NCT02723864|76074798|FG003|Overall Study|Adverse Event|0|||
42249561|NCT02723864|76074799|FG004|Overall Study|Adverse Event|0|||
42249562|NCT02723864|76074800|FG005|Overall Study|Adverse Event|1|||
42249563|NCT02723864|76074801|FG006|Overall Study|Adverse Event|0|||
42249564|NCT02723864|76074795|FG000|Overall Study|Started new treatment|0|||
42249565|NCT02723864|76074796|FG001|Overall Study|Started new treatment|0|||
42249566|NCT02723864|76074797|FG002|Overall Study|Started new treatment|0|||
42249567|NCT02723864|76074798|FG003|Overall Study|Started new treatment|0|||
42249568|NCT02723864|76074799|FG004|Overall Study|Started new treatment|0|||
42249569|NCT02723864|76074800|FG005|Overall Study|Started new treatment|1|||
42249570|NCT02723864|76074801|FG006|Overall Study|Started new treatment|0|||
42249571|NCT02723864|76074795|FG000|Overall Study|Switched to alternative treatment|0|||
42249572|NCT02723864|76074796|FG001|Overall Study|Switched to alternative treatment|0|||
42249573|NCT02723864|76074797|FG002|Overall Study|Switched to alternative treatment|0|||
42249574|NCT02723864|76074798|FG003|Overall Study|Switched to alternative treatment|0|||
42249575|NCT02723864|76074799|FG004|Overall Study|Switched to alternative treatment|0|||
42249576|NCT02723864|76074800|FG005|Overall Study|Switched to alternative treatment|1|||
42249577|NCT02723864|76074801|FG006|Overall Study|Switched to alternative treatment|0|||
42249578|NCT02723864|76074795|FG000|Overall Study|Late determination of ineligibility|0|||
42249579|NCT02723864|76074796|FG001|Overall Study|Late determination of ineligibility|0|||
42249580|NCT02723864|76074797|FG002|Overall Study|Late determination of ineligibility|0|||
42249581|NCT02723864|76074798|FG003|Overall Study|Late determination of ineligibility|0|||
42249582|NCT02723864|76074799|FG004|Overall Study|Late determination of ineligibility|0|||
42249583|NCT02723864|76074800|FG005|Overall Study|Late determination of ineligibility|1|||
42249584|NCT02723864|76074801|FG006|Overall Study|Late determination of ineligibility|0|||
42249585|NCT00705146|76074840|FG000|Overall Study|Lost to Follow-up|1|||
42249586|NCT00705146|76074841|FG001|Overall Study|Lost to Follow-up|1|||
42249587|NCT03203642|76074849|FG000|Overall Study|Adverse Event|3|||
42249588|NCT03203642|76074850|FG001|Overall Study|Adverse Event|1|||
42249589|NCT03203642|76074849|FG000|Overall Study|Withdrawal by Subject|6|||
42249590|NCT03203642|76074850|FG001|Overall Study|Withdrawal by Subject|6|||
42249591|NCT03203642|76074849|FG000|Overall Study|Lost to Follow-up|2|||
42249592|NCT03203642|76074850|FG001|Overall Study|Lost to Follow-up|1|||
42249593|NCT03203642|76074849|FG000|Overall Study|Termination of the study by sponsor|1|||
42249594|NCT03203642|76074850|FG001|Overall Study|Termination of the study by sponsor|1|||
42249595|NCT03203642|76074849|FG000|Overall Study|Participant moved|0|||
42249596|NCT03203642|76074850|FG001|Overall Study|Participant moved|1|||
42249597|NCT03203642|76074849|FG000|Overall Study|Investigator's decision|3|||
42249598|NCT03203642|76074850|FG001|Overall Study|Investigator's decision|0|||
42249599|NCT03203642|76074849|FG000|Overall Study|Other than above specified|0|||
42249600|NCT03203642|76074850|FG001|Overall Study|Other than above specified|1|||
42249601|NCT02737722|76074860|FG000|Overall Study|Physician Decision|0|||
42249602|NCT02737722|76074861|FG001|Overall Study|Physician Decision|0|||
42249603|NCT02737722|76074862|FG002|Overall Study|Physician Decision|1|||
42249604|NCT02737722|76074863|FG003|Overall Study|Physician Decision|0|||
42249605|NCT03792750|76074873|FG000|Overall Study|Death|3|||
42249606|NCT02750709|76074878|FG000|Treatment Period 1|Adverse Event|0|||
42249607|NCT02750709|76074879|FG001|Treatment Period 1|Adverse Event|0|||
42249608|NCT02750709|76074880|FG002|Treatment Period 1|Adverse Event|0|||
42249609|NCT02750709|76074881|FG003|Treatment Period 1|Adverse Event|0|||
42249610|NCT02750709|76074882|FG004|Treatment Period 1|Adverse Event|0|||
42249611|NCT02750709|76074883|FG005|Treatment Period 1|Adverse Event|1|||
42249612|NCT02723786|76074891|FG000|Overall Study|Lost to Follow-up|1|||
42249613|NCT02723084|76074910|FG000|Overall Study|Withdrawal by Subject|1|||
42249614|NCT02723084|76074911|FG001|Overall Study|Withdrawal by Subject|1|||
42249615|NCT02723084|76074910|FG000|Overall Study|Lost to Follow-up|3|||
42249616|NCT02723084|76074911|FG001|Overall Study|Lost to Follow-up|0|||
42249617|NCT02750943|76074919|FG000|Overall Study|Lost to Follow-up|1|||
42249618|NCT02750943|76074920|FG001|Overall Study|Lost to Follow-up|2|||
42249619|NCT02750943|76074919|FG000|Overall Study|Withdrawal by Subject|5|||
42249620|NCT02750943|76074920|FG001|Overall Study|Withdrawal by Subject|7|||
42249621|NCT05177094|76074945|FG000|Overall Study|Adverse Event|5|||
42249622|NCT05177094|76074946|FG001|Overall Study|Adverse Event|5|||
42249623|NCT05177094|76074945|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
42249624|NCT05177094|76074946|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
42249625|NCT05177094|76074945|FG000|Overall Study|Protocol Deviation|3|||
42249626|NCT05177094|76074946|FG001|Overall Study|Protocol Deviation|0|||
42249627|NCT05177094|76074945|FG000|Overall Study|Withdrawal by Subject|6|||
42249628|NCT05177094|76074946|FG001|Overall Study|Withdrawal by Subject|3|||
42249629|NCT05177094|76074945|FG000|Overall Study|Participant could not tolerate long study visits|1|||
42249630|NCT05177094|76074946|FG001|Overall Study|Participant could not tolerate long study visits|0|||
42249631|NCT05104749|76074956|FG000|Overall Study|Lost to Follow-up|2|||
42249632|NCT05104749|76074957|FG001|Overall Study|Lost to Follow-up|3|||
42249633|NCT05098041|76074963|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
42249634|NCT04648241|76074984|FG000|Overall Study|Lost to Follow-up|1|||
42249635|NCT04648241|76074985|FG001|Overall Study|Lost to Follow-up|0|||
42249636|NCT04124952|76075020|FG000|Overall Study|Lost to Follow-up|1|||
42249637|NCT03677596|76075061|FG000|Overall Study|Adverse Event|0|||
42249638|NCT03677596|76075062|FG001|Overall Study|Adverse Event|1|||
42249639|NCT03677596|76075061|FG000|Overall Study|Death|10|||
42249640|NCT03677596|76075062|FG001|Overall Study|Death|6|||
42249641|NCT03677596|76075061|FG000|Overall Study|Lost to Follow-up|0|||
42249642|NCT03677596|76075062|FG001|Overall Study|Lost to Follow-up|1|||
42249643|NCT03677596|76075061|FG000|Overall Study|Progressive Disease|8|||
42249644|NCT03677596|76075062|FG001|Overall Study|Progressive Disease|8|||
42249645|NCT03677596|76075061|FG000|Overall Study|Withdrawal by Subject|3|||
42249646|NCT03677596|76075062|FG001|Overall Study|Withdrawal by Subject|0|||
42249647|NCT03677596|76075061|FG000|Overall Study|Disease Relapse|2|||
42249648|NCT03677596|76075062|FG001|Overall Study|Disease Relapse|2|||
42249649|NCT03677596|76075061|FG000|Overall Study|Other|0|||
42249650|NCT03677596|76075062|FG001|Overall Study|Other|1|||
42249651|NCT03422627|76075082|FG000|Overall Study|Protocol-specified Criteria|1|||
42249652|NCT03422627|76075083|FG001|Overall Study|Protocol-specified Criteria|1|||
42249653|NCT03422627|76075084|FG002|Overall Study|Protocol-specified Criteria|0|||
42249654|NCT03422627|76075085|FG003|Overall Study|Protocol-specified Criteria|0|||
42249655|NCT03422627|76075086|FG004|Overall Study|Protocol-specified Criteria|2|||
42249656|NCT03422627|76075082|FG000|Overall Study|Requirement for Alternative Therapy|1|||
42249657|NCT03422627|76075083|FG001|Overall Study|Requirement for Alternative Therapy|1|||
42249658|NCT03422627|76075084|FG002|Overall Study|Requirement for Alternative Therapy|2|||
41990208|NCT01236352|75798167|FG004|Overall Study|Subject to receive drug via EAP|0|||
41990209|NCT01236352|75798168|FG005|Overall Study|Subject to receive drug via EAP|0|||
41990210|NCT01236352|75798169|FG006|Overall Study|Subject to receive drug via EAP|0|||
41990211|NCT01236352|75798170|FG007|Overall Study|Subject to receive drug via EAP|2|||
42132342|NCT00402363|75943172|FG002|Overall Study|Withdrew Consent|2|||
42132343|NCT00402363|75943173|FG003|Overall Study|Withdrew Consent|1|||
42132344|NCT00402363|75943170|FG000|Overall Study|Protocol Violation|3|||
42132345|NCT00402363|75943171|FG001|Overall Study|Protocol Violation|5|||
42132346|NCT00402363|75943172|FG002|Overall Study|Protocol Violation|0|||
42132347|NCT00402363|75943173|FG003|Overall Study|Protocol Violation|3|||
42132348|NCT00402363|75943170|FG000|Overall Study|Lost to Follow-up|5|||
42132349|NCT00402363|75943171|FG001|Overall Study|Lost to Follow-up|4|||
42132350|NCT00402363|75943172|FG002|Overall Study|Lost to Follow-up|0|||
42132351|NCT00402363|75943173|FG003|Overall Study|Lost to Follow-up|2|||
42132352|NCT00402363|75943170|FG000|Overall Study|"Captured as Other"|6|||
42132353|NCT00402363|75943171|FG001|Overall Study|"Captured as Other"|2|||
42132354|NCT00402363|75943172|FG002|Overall Study|"Captured as Other"|2|||
42132355|NCT00402363|75943173|FG003|Overall Study|"Captured as Other"|2|||
42132356|NCT00469014|75943193|FG000|Initial Phase Randomization|Disease Progression|0|||
42132357|NCT00469014|75943194|FG001|Initial Phase Randomization|Disease Progression|1|||
42132358|NCT00469014|75943195|FG002|Initial Phase Randomization|Disease Progression|1|||
42132359|NCT00469014|75943196|FG003|Initial Phase Randomization|Disease Progression|0|||
42132360|NCT00469014|75943193|FG000|Initial Phase Randomization|No Response|1|||
42132361|NCT00469014|75943194|FG001|Initial Phase Randomization|No Response|0|||
42132362|NCT00469014|75943195|FG002|Initial Phase Randomization|No Response|0|||
42132363|NCT00469014|75943196|FG003|Initial Phase Randomization|No Response|1|||
42132364|NCT00469014|75943193|FG000|Adaptive Randomization|Not Evaluable|1|||
42132365|NCT00469014|75943194|FG001|Adaptive Randomization|Not Evaluable|0|||
42249659|NCT03422627|76075085|FG003|Overall Study|Requirement for Alternative Therapy|0|||
42249660|NCT03422627|76075086|FG004|Overall Study|Requirement for Alternative Therapy|0|||
42132366|NCT00469014|75943195|FG002|Adaptive Randomization|Not Evaluable|0|||
42132367|NCT00469014|75943196|FG003|Adaptive Randomization|Not Evaluable|1|||
42132368|NCT00469014|75943193|FG000|Adaptive Randomization|No Response|0|||
42132369|NCT00469014|75943194|FG001|Adaptive Randomization|No Response|1|||
42249661|NCT03422627|76075082|FG000|Overall Study|Disease Progression|1|||
41990212|NCT01236352|75798171|FG008|Overall Study|Subject to receive drug via EAP|0|||
41990213|NCT01236352|75798172|FG009|Overall Study|Subject to receive drug via EAP|4|||
42132370|NCT00469014|75943195|FG002|Adaptive Randomization|No Response|0|||
42132371|NCT00469014|75943196|FG003|Adaptive Randomization|No Response|0|||
42132372|NCT00469014|75943193|FG000|Adaptive Randomization|Death|0|||
42249662|NCT03422627|76075083|FG001|Overall Study|Disease Progression|0|||
42249663|NCT03422627|76075084|FG002|Overall Study|Disease Progression|1|||
42249664|NCT03422627|76075085|FG003|Overall Study|Disease Progression|2|||
42249665|NCT03422627|76075086|FG004|Overall Study|Disease Progression|0|||
42132373|NCT00469014|75943194|FG001|Adaptive Randomization|Death|0|||
42132374|NCT00469014|75943195|FG002|Adaptive Randomization|Death|1|||
42132375|NCT00469014|75943196|FG003|Adaptive Randomization|Death|0|||
42132376|NCT00493038|75943208|FG000|Treatment|Adverse Event|8|||
42132377|NCT00493038|75943209|FG001|Treatment|Adverse Event|4|||
42132378|NCT00493038|75943208|FG000|Treatment|Lost to Follow-up|5|||
42132379|NCT00493038|75943209|FG001|Treatment|Lost to Follow-up|3|||
42249666|NCT03422627|76075082|FG000|Overall Study|Adverse Event|2|||
42249667|NCT03422627|76075083|FG001|Overall Study|Adverse Event|1|||
42249668|NCT03422627|76075084|FG002|Overall Study|Adverse Event|0|||
42249669|NCT03422627|76075085|FG003|Overall Study|Adverse Event|0|||
42249670|NCT03422627|76075086|FG004|Overall Study|Adverse Event|2|||
42249671|NCT03422627|76075082|FG000|Overall Study|Ineligibility Determined|0|||
42249672|NCT03422627|76075083|FG001|Overall Study|Ineligibility Determined|1|||
42249673|NCT03422627|76075084|FG002|Overall Study|Ineligibility Determined|0|||
42249674|NCT03422627|76075085|FG003|Overall Study|Ineligibility Determined|0|||
42249675|NCT03422627|76075086|FG004|Overall Study|Ineligibility Determined|0|||
42249676|NCT03422627|76075082|FG000|Overall Study|Death|0|||
42249677|NCT03422627|76075083|FG001|Overall Study|Death|1|||
42249678|NCT03422627|76075084|FG002|Overall Study|Death|1|||
42249679|NCT03422627|76075085|FG003|Overall Study|Death|0|||
42249680|NCT03422627|76075086|FG004|Overall Study|Death|0|||
42249681|NCT03422627|76075082|FG000|Overall Study|Withdrawal by Subject|0|||
42249682|NCT03422627|76075083|FG001|Overall Study|Withdrawal by Subject|0|||
42249683|NCT03422627|76075084|FG002|Overall Study|Withdrawal by Subject|0|||
42249684|NCT03422627|76075085|FG003|Overall Study|Withdrawal by Subject|1|||
42249685|NCT03422627|76075086|FG004|Overall Study|Withdrawal by Subject|0|||
42249686|NCT03403621|76075098|FG000|Overall Study|Withdrawal by Subject|2|||
42249687|NCT03403621|76075099|FG001|Overall Study|Withdrawal by Subject|2|||
42249688|NCT03225105|76075109|FG000|Overall Study|Withdrawal by Subject|1|||
42249689|NCT03225105|76075110|FG001|Overall Study|Withdrawal by Subject|0|||
42249690|NCT03225105|76075111|FG002|Overall Study|Withdrawal by Subject|0|||
42249691|NCT03225105|76075112|FG003|Overall Study|Withdrawal by Subject|0|||
42249692|NCT03225105|76075109|FG000|Overall Study|Death|0|||
42249693|NCT03225105|76075110|FG001|Overall Study|Death|4|||
42249694|NCT03225105|76075111|FG002|Overall Study|Death|2|||
42249695|NCT03225105|76075112|FG003|Overall Study|Death|0|||
42249696|NCT03225105|76075109|FG000|Overall Study|Study termination per Sponsor Decision|2|||
42249697|NCT03225105|76075110|FG001|Overall Study|Study termination per Sponsor Decision|0|||
42249698|NCT03225105|76075111|FG002|Overall Study|Study termination per Sponsor Decision|3|||
42249699|NCT03225105|76075112|FG003|Overall Study|Study termination per Sponsor Decision|3|||
42249700|NCT02900976|76075143|FG000|Overall Study|Adverse Event|0|||
42249701|NCT02900976|76075144|FG001|Overall Study|Adverse Event|1|||
42249702|NCT02900976|76075143|FG000|Overall Study|Physician Decision|0|||
42249703|NCT02900976|76075144|FG001|Overall Study|Physician Decision|2|||
42249704|NCT02900976|76075143|FG000|Overall Study|Progressive disease|0|||
42249705|NCT02900976|76075144|FG001|Overall Study|Progressive disease|6|||
42249706|NCT02654015|76075151|FG000|Overall Study|Death|12|||
42249707|NCT02654015|76075151|FG000|Overall Study|Lost to Follow-up|3|||
42132380|NCT00493038|75943208|FG000|Treatment|Withdrawal by Subject|11|||
42132381|NCT00493038|75943209|FG001|Treatment|Withdrawal by Subject|12|||
42249708|NCT02542696|76075155|FG000|Overall Study|Adverse Event|167|||
42249709|NCT02542696|76075155|FG000|Overall Study|Lack of Efficacy|26|||
42249710|NCT02542696|76075155|FG000|Overall Study|Lost to Follow-up|6|||
42249711|NCT02542696|76075155|FG000|Overall Study|Withdrawal by Subject|104|||
42249712|NCT02542696|76075155|FG000|Overall Study|Protocol Violation|5|||
42249713|NCT02542696|76075155|FG000|Overall Study|Death|8|||
42132382|NCT00493038|75943208|FG000|Treatment|Other|0|||
42132383|NCT00493038|75943209|FG001|Treatment|Other|1|||
42249714|NCT02542696|76075155|FG000|Overall Study|DECREASED OFF TIME|1|||
42249715|NCT02542696|76075155|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
42249716|NCT02542696|76075155|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
42249717|NCT02542696|76075155|FG000|Overall Study|MEDICAL HISTORY|1|||
42249718|NCT02542696|76075155|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
42249719|NCT02542696|76075155|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
42249720|NCT02542696|76075155|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
42132384|NCT00493038|75943208|FG000|Follow-up|Lost to Follow-up|1|||
42249721|NCT02542696|76075155|FG000|Overall Study|SPONSOR DECISION|3|||
42249722|NCT02542696|76075155|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
42249723|NCT02542696|76075155|FG000|Overall Study|SUBJECT DECISION|2|||
42249724|NCT02339740|76075162|FG000|Overall Study|Death|1|||
42249725|NCT02339740|76075163|FG001|Overall Study|Death|0|||
42249726|NCT02339740|76075162|FG000|Overall Study|Physician Decision|0|||
42249727|NCT02339740|76075163|FG001|Overall Study|Physician Decision|2|||
42249728|NCT02339740|76075162|FG000|Overall Study|Withdrawal by Subject|5|||
42249729|NCT02339740|76075163|FG001|Overall Study|Withdrawal by Subject|1|||
42249730|NCT02339740|76075162|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
42249731|NCT02339740|76075163|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
42249732|NCT02163395|76075169|FG000|Overall Study|Withdrawal by Subject|1|||
42249733|NCT02163395|76075169|FG000|Overall Study|Lost to Follow-up|3|||
42249734|NCT02163395|76075169|FG000|Overall Study|Adverse Event|1|||
42249735|NCT01397552|76075184|FG000|Overall Study|Adverse Event|1|||
42249736|NCT01397552|76075185|FG001|Overall Study|Adverse Event|0|||
42249737|NCT01397552|76075184|FG000|Overall Study|Withdrawal by Subject|2|||
42249738|NCT01397552|76075185|FG001|Overall Study|Withdrawal by Subject|1|||
42249739|NCT01256710|76075191|FG000|Overall Study|Death|449|||
42249740|NCT01256710|76075191|FG000|Overall Study|System Explant|67|||
42249741|NCT01256710|76075191|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
42249742|NCT01256710|76075191|FG000|Overall Study|Lost to Follow-up|67|||
42249743|NCT01256710|76075191|FG000|Overall Study|Withdrawal by Subject|29|||
42249744|NCT01256710|76075191|FG000|Overall Study|Physician Decision|9|||
42249745|NCT01256710|76075191|FG000|Overall Study|Subject Noncompliance|2|||
42249746|NCT01256710|76075191|FG000|Overall Study|Study Terminated by Sponsor|273|||
42249747|NCT01096368|76075202|FG000|Overall Study|Death|0|||
42249748|NCT01096368|76075203|FG001|Overall Study|Death|1|||
42249749|NCT01096368|76075204|FG002|Overall Study|Death|0|||
42249750|NCT01096368|76075205|FG003|Overall Study|Death|0|||
42249751|NCT01096368|76075206|FG004|Overall Study|Death|0|||
42249752|NCT01096368|76075202|FG000|Overall Study|Physician Decision|0|||
42249753|NCT01096368|76075203|FG001|Overall Study|Physician Decision|13|||
42249754|NCT01096368|76075204|FG002|Overall Study|Physician Decision|2|||
42249755|NCT01096368|76075205|FG003|Overall Study|Physician Decision|4|||
42249756|NCT01096368|76075206|FG004|Overall Study|Physician Decision|6|||
42249757|NCT01096368|76075202|FG000|Overall Study|Withdrawal by Subject|0|||
42249758|NCT01096368|76075203|FG001|Overall Study|Withdrawal by Subject|52|||
42249759|NCT01096368|76075204|FG002|Overall Study|Withdrawal by Subject|0|||
42249760|NCT01096368|76075205|FG003|Overall Study|Withdrawal by Subject|10|||
42249761|NCT01096368|76075206|FG004|Overall Study|Withdrawal by Subject|14|||
42249762|NCT01096368|76075202|FG000|Overall Study|Ineligible|0|||
42249763|NCT01096368|76075203|FG001|Overall Study|Ineligible|3|||
42249764|NCT01096368|76075204|FG002|Overall Study|Ineligible|2|||
41990214|NCT01236352|75798173|FG010|Overall Study|Subject to receive drug via EAP|0|||
41990215|NCT01236352|75798163|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
41990216|NCT01236352|75798164|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
41990217|NCT01236352|75798165|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
41990218|NCT01236352|75798166|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
41990219|NCT01236352|75798167|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
41990220|NCT01236352|75798168|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
41990221|NCT01236352|75798169|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
41990222|NCT01236352|75798170|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
41990223|NCT01236352|75798171|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
41990224|NCT01236352|75798172|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
41990225|NCT01236352|75798173|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
41990226|NCT01236352|75798163|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
41990227|NCT01236352|75798164|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
41990228|NCT01236352|75798165|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
42249765|NCT01096368|76075205|FG003|Overall Study|Ineligible|0|||
42249766|NCT01096368|76075206|FG004|Overall Study|Ineligible|25|||
42249767|NCT01096368|76075202|FG000|Overall Study|Did not start treatment|0|||
42249768|NCT01096368|76075203|FG001|Overall Study|Did not start treatment|4|||
42249769|NCT01096368|76075204|FG002|Overall Study|Did not start treatment|4|||
42249770|NCT01096368|76075205|FG003|Overall Study|Did not start treatment|0|||
42249771|NCT01096368|76075206|FG004|Overall Study|Did not start treatment|0|||
42249772|NCT01096368|76075202|FG000|Overall Study|Progressive disease|0|||
42249773|NCT01096368|76075203|FG001|Overall Study|Progressive disease|6|||
42249774|NCT01096368|76075204|FG002|Overall Study|Progressive disease|0|||
41990229|NCT01236352|75798166|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
42132385|NCT00493038|75943209|FG001|Follow-up|Lost to Follow-up|0|||
42249775|NCT01096368|76075205|FG003|Overall Study|Progressive disease|10|||
42249776|NCT01096368|76075206|FG004|Overall Study|Progressive disease|3|||
42249777|NCT01096368|76075202|FG000|Overall Study|Other|0|||
42249778|NCT01096368|76075203|FG001|Overall Study|Other|0|||
42249779|NCT01096368|76075204|FG002|Overall Study|Other|1|||
42249780|NCT01096368|76075205|FG003|Overall Study|Other|0|||
41990230|NCT01236352|75798167|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
42249781|NCT01096368|76075206|FG004|Overall Study|Other|0|||
42249782|NCT01096368|76075202|FG000|Overall Study|Treated with institutional review|0|||
42249783|NCT01096368|76075203|FG001|Overall Study|Treated with institutional review|0|||
42249784|NCT01096368|76075204|FG002|Overall Study|Treated with institutional review|0|||
42249785|NCT01096368|76075205|FG003|Overall Study|Treated with institutional review|0|||
42249786|NCT01096368|76075206|FG004|Overall Study|Treated with institutional review|1|||
42249787|NCT00938587|76075234|FG000|Overall Study|Adverse Event|2|||
42249788|NCT00938587|76075235|FG001|Overall Study|Adverse Event|0|||
42249789|NCT00938587|76075236|FG002|Overall Study|Adverse Event|0|||
42249790|NCT00938587|76075237|FG003|Overall Study|Adverse Event|2|||
42249791|NCT00938587|76075234|FG000|Overall Study|Did not meet entrance criteria|0|||
42249792|NCT00938587|76075235|FG001|Overall Study|Did not meet entrance criteria|0|||
41990231|NCT01236352|75798168|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
42249793|NCT00938587|76075236|FG002|Overall Study|Did not meet entrance criteria|1|||
42249794|NCT00938587|76075237|FG003|Overall Study|Did not meet entrance criteria|0|||
42249795|NCT00938587|76075234|FG000|Overall Study|Withdrawal by Subject|1|||
42249796|NCT00938587|76075235|FG001|Overall Study|Withdrawal by Subject|1|||
42249797|NCT00938587|76075236|FG002|Overall Study|Withdrawal by Subject|0|||
42249798|NCT00938587|76075237|FG003|Overall Study|Withdrawal by Subject|0|||
42249799|NCT00937937|76075247|FG000|Overall Study|Adverse Event|6|||
42249800|NCT00937937|76075247|FG000|Overall Study|Withdrawal by Subject|2|||
42249801|NCT00937937|76075247|FG000|Overall Study|Progression/relapse|61|||
42249802|NCT00937937|76075247|FG000|Overall Study|Death|1|||
42249803|NCT00937937|76075247|FG000|Overall Study|Other|2|||
42249804|NCT00810693|76075255|FG000|Treatment Period|Adverse Event|8|||
42249805|NCT00810693|76075256|FG001|Treatment Period|Adverse Event|1|||
42249806|NCT00810693|76075257|FG002|Treatment Period|Adverse Event|7|||
42249807|NCT00810693|76075255|FG000|Treatment Period|Death|0|||
42249808|NCT00810693|76075256|FG001|Treatment Period|Death|1|||
42249809|NCT00810693|76075257|FG002|Treatment Period|Death|2|||
42249810|NCT00810693|76075255|FG000|Treatment Period|Lack of Efficacy|0|||
41990232|NCT01236352|75798169|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
41990233|NCT01236352|75798170|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
41990234|NCT01236352|75798171|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
41990235|NCT01236352|75798172|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
42132386|NCT00392223|75943217|FG000|Overall Study|Adverse Event|5|||
42249811|NCT00810693|76075256|FG001|Treatment Period|Lack of Efficacy|0|||
42249812|NCT00810693|76075257|FG002|Treatment Period|Lack of Efficacy|1|||
42249813|NCT00810693|76075255|FG000|Treatment Period|Lost to Follow-up|1|||
42249814|NCT00810693|76075256|FG001|Treatment Period|Lost to Follow-up|0|||
42249815|NCT00810693|76075257|FG002|Treatment Period|Lost to Follow-up|0|||
42249816|NCT00810693|76075255|FG000|Treatment Period|Non-compliance|1|||
42249817|NCT00810693|76075256|FG001|Treatment Period|Non-compliance|0|||
42249818|NCT00810693|76075257|FG002|Treatment Period|Non-compliance|0|||
42249819|NCT00810693|76075255|FG000|Treatment Period|Protocol Violation|1|||
42249820|NCT00810693|76075256|FG001|Treatment Period|Protocol Violation|2|||
42249821|NCT00810693|76075257|FG002|Treatment Period|Protocol Violation|2|||
42249822|NCT00810693|76075255|FG000|Treatment Period|Withdrawal by Subject|6|||
42249823|NCT00810693|76075256|FG001|Treatment Period|Withdrawal by Subject|2|||
42249824|NCT00810693|76075257|FG002|Treatment Period|Withdrawal by Subject|3|||
42249825|NCT00810693|76075255|FG000|Treatment Period|Not treated|0|||
42249826|NCT00810693|76075256|FG001|Treatment Period|Not treated|1|||
42249827|NCT00810693|76075257|FG002|Treatment Period|Not treated|1|||
42249828|NCT00810693|76075255|FG000|Follow-up Period (FUP)|Adverse Event|3|||
42249829|NCT00810693|76075256|FG001|Follow-up Period (FUP)|Adverse Event|1|||
42249830|NCT00810693|76075257|FG002|Follow-up Period (FUP)|Adverse Event|1|||
42249831|NCT00810693|76075255|FG000|Follow-up Period (FUP)|Death|2|||
42249832|NCT00810693|76075256|FG001|Follow-up Period (FUP)|Death|0|||
42249833|NCT00810693|76075257|FG002|Follow-up Period (FUP)|Death|1|||
42249834|NCT00810693|76075255|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
42249835|NCT00810693|76075256|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
42249836|NCT00810693|76075257|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
42249837|NCT00810693|76075255|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
42249838|NCT00810693|76075256|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
42249839|NCT00810693|76075257|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
42249840|NCT00810693|76075255|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
42249841|NCT00810693|76075256|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
42249842|NCT00810693|76075257|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
42249843|NCT00381641|76075267|FG000|Overall Study|Withdrawal by Subject|0|||
42249844|NCT00381641|76075268|FG001|Overall Study|Withdrawal by Subject|2|||
42249845|NCT00334815|76075276|FG000|Overall Study|Adverse Event|3|||
42249846|NCT00334815|76075277|FG001|Overall Study|Adverse Event|2|||
42249847|NCT00334815|76075276|FG000|Overall Study|Death|0|||
42249848|NCT00334815|76075277|FG001|Overall Study|Death|2|||
42249849|NCT00334815|76075276|FG000|Overall Study|Progression|1|||
42249850|NCT00334815|76075277|FG001|Overall Study|Progression|0|||
42249851|NCT00334815|76075276|FG000|Overall Study|ineligible|1|||
42249852|NCT00334815|76075277|FG001|Overall Study|ineligible|1|||
42249853|NCT00334815|76075276|FG000|Overall Study|patient refused treatment|0|||
42249854|NCT00334815|76075277|FG001|Overall Study|patient refused treatment|1|||
42249855|NCT00334815|76075276|FG000|Overall Study|Physician Decision|2|||
42249856|NCT00334815|76075277|FG001|Overall Study|Physician Decision|4|||
42249857|NCT04730349|76075296|FG000|Overall Study|Participant withdrew consent|1|||
41990236|NCT01236352|75798173|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
41990237|NCT01236352|75798163|FG000|Overall Study|Lack of response to drug|0|||
41990238|NCT01236352|75798164|FG001|Overall Study|Lack of response to drug|0|||
41990239|NCT01236352|75798165|FG002|Overall Study|Lack of response to drug|0|||
41990240|NCT01236352|75798166|FG003|Overall Study|Lack of response to drug|0|||
41990241|NCT01236352|75798167|FG004|Overall Study|Lack of response to drug|0|||
41990242|NCT01236352|75798168|FG005|Overall Study|Lack of response to drug|0|||
41990243|NCT01236352|75798169|FG006|Overall Study|Lack of response to drug|0|||
41990244|NCT01236352|75798170|FG007|Overall Study|Lack of response to drug|0|||
41990245|NCT01236352|75798171|FG008|Overall Study|Lack of response to drug|0|||
41990246|NCT01236352|75798172|FG009|Overall Study|Lack of response to drug|1|||
41990247|NCT01236352|75798173|FG010|Overall Study|Lack of response to drug|1|||
41990248|NCT01236352|75798163|FG000|Overall Study|Patient transferred to IST|0|||
41990249|NCT01236352|75798164|FG001|Overall Study|Patient transferred to IST|0|||
41990250|NCT01236352|75798165|FG002|Overall Study|Patient transferred to IST|0|||
41990251|NCT01236352|75798166|FG003|Overall Study|Patient transferred to IST|0|||
41990252|NCT01236352|75798167|FG004|Overall Study|Patient transferred to IST|0|||
41990253|NCT01236352|75798168|FG005|Overall Study|Patient transferred to IST|0|||
41990254|NCT01236352|75798169|FG006|Overall Study|Patient transferred to IST|0|||
41990255|NCT01236352|75798170|FG007|Overall Study|Patient transferred to IST|0|||
41990256|NCT01236352|75798171|FG008|Overall Study|Patient transferred to IST|0|||
41990257|NCT01236352|75798172|FG009|Overall Study|Patient transferred to IST|2|||
41990258|NCT01236352|75798173|FG010|Overall Study|Patient transferred to IST|6|||
41990259|NCT01236118|75798200|FG000|Overall Study|Adverse Event|2|||
41990260|NCT01236118|75798201|FG001|Overall Study|Adverse Event|0|||
41990261|NCT01236118|75798202|FG002|Overall Study|Adverse Event|2|||
41990262|NCT01236118|75798200|FG000|Overall Study|Physician Decision|0|||
41990263|NCT01236118|75798201|FG001|Overall Study|Physician Decision|1|||
41990264|NCT01236118|75798202|FG002|Overall Study|Physician Decision|0|||
41990265|NCT01236118|75798200|FG000|Overall Study|Withdrawal by Subject|0|||
41990266|NCT01236118|75798201|FG001|Overall Study|Withdrawal by Subject|0|||
41990267|NCT01236118|75798202|FG002|Overall Study|Withdrawal by Subject|1|||
41990268|NCT01236001|75798212|FG000|Overall Study|Adverse Event|5|||
41990269|NCT01236001|75798213|FG001|Overall Study|Adverse Event|14|||
41990270|NCT01236001|75798212|FG000|Overall Study|Lack of Efficacy|6|||
41990271|NCT01236001|75798213|FG001|Overall Study|Lack of Efficacy|6|||
41990272|NCT01236001|75798212|FG000|Overall Study|Lost to Follow-up|6|||
41990273|NCT01236001|75798213|FG001|Overall Study|Lost to Follow-up|1|||
41990274|NCT01236001|75798212|FG000|Overall Study|Incompliance|1|||
41990275|NCT01236001|75798213|FG001|Overall Study|Incompliance|0|||
42249858|NCT04730349|76075297|FG001|Overall Study|Participant withdrew consent|0|||
42249859|NCT04730349|76075296|FG000|Overall Study|Disease progression|6|||
42249860|NCT04730349|76075297|FG001|Overall Study|Disease progression|4|||
42249861|NCT04730349|76075296|FG000|Overall Study|Study drug toxicity|0|||
42249862|NCT04730349|76075297|FG001|Overall Study|Study drug toxicity|1|||
42249863|NCT04307394|76075316|FG000|Overall Study|Lost to Follow-up|3|||
42249864|NCT04307394|76075316|FG000|Overall Study|Withdrawal by Subject|2|||
42249865|NCT03940742|76075342|FG000|Overall Study|Lost to Follow-up|0|||
42303327|NCT02409667|76138603|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
42303328|NCT02409667|76138604|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
42303329|NCT02409667|76138605|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
42303330|NCT02409667|76138606|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
42303331|NCT02409667|76138607|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
42303332|NCT02409667|76138603|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
42303333|NCT02409667|76138604|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
42303334|NCT02409667|76138605|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
42303335|NCT02409667|76138606|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
42303336|NCT02409667|76138607|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
41990276|NCT01236001|75798212|FG000|Overall Study|Planned Visit After End of Study|0|||
42249866|NCT03940742|76075343|FG001|Overall Study|Lost to Follow-up|0|||
41990277|NCT01236001|75798213|FG001|Overall Study|Planned Visit After End of Study|1|||
41990278|NCT01229254|75798223|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
41990279|NCT01229254|75798224|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
42132387|NCT00392223|75943218|FG001|Overall Study|Adverse Event|4|||
42132388|NCT00392223|75943217|FG000|Overall Study|Lost to Follow-up|1|||
42132389|NCT00392223|75943218|FG001|Overall Study|Lost to Follow-up|4|||
42132390|NCT00392223|75943217|FG000|Overall Study|Protocol Violation|0|||
42132391|NCT00392223|75943218|FG001|Overall Study|Protocol Violation|3|||
42132392|NCT00392223|75943217|FG000|Overall Study|Withdrawal by Subject|3|||
42132393|NCT00392223|75943218|FG001|Overall Study|Withdrawal by Subject|2|||
42132394|NCT00402285|75943227|FG000|Overall Study|insufficient RNA quality|7|||
42132395|NCT00402285|75943228|FG001|Overall Study|insufficient RNA quality|6|||
42132396|NCT00402285|75943229|FG002|Overall Study|insufficient RNA quality|2|||
42132397|NCT00413283|75943239|FG000|Overall Study|Withdrawal by Subject|1|||
42132398|NCT00413283|75943240|FG001|Overall Study|Withdrawal by Subject|0|||
42132399|NCT00413283|75943241|FG002|Overall Study|Withdrawal by Subject|0|||
42132400|NCT00413283|75943242|FG003|Overall Study|Withdrawal by Subject|1|||
42132401|NCT00413283|75943239|FG000|Overall Study|Death|0|||
42132402|NCT00413283|75943240|FG001|Overall Study|Death|0|||
42132403|NCT00413283|75943241|FG002|Overall Study|Death|1|||
42132404|NCT00413283|75943242|FG003|Overall Study|Death|1|||
42132405|NCT00413283|75943239|FG000|Overall Study|Adverse Event|0|||
42132406|NCT00413283|75943240|FG001|Overall Study|Adverse Event|0|||
42132407|NCT00413283|75943241|FG002|Overall Study|Adverse Event|0|||
42132408|NCT00413283|75943242|FG003|Overall Study|Adverse Event|1|||
42132409|NCT00413283|75943239|FG000|Overall Study|Ineligibility determined|0|||
42132410|NCT00413283|75943240|FG001|Overall Study|Ineligibility determined|0|||
42132411|NCT00413283|75943241|FG002|Overall Study|Ineligibility determined|0|||
42132412|NCT00413283|75943242|FG003|Overall Study|Ineligibility determined|1|||
42132413|NCT00413283|75943239|FG000|Overall Study|Protocol deviation|0|||
42132414|NCT00413283|75943240|FG001|Overall Study|Protocol deviation|1|||
42132415|NCT00413283|75943241|FG002|Overall Study|Protocol deviation|0|||
42132416|NCT00413283|75943242|FG003|Overall Study|Protocol deviation|0|||
42132417|NCT00413283|75943239|FG000|Overall Study|Requirement for alternative therapy|0|||
42132418|NCT00413283|75943240|FG001|Overall Study|Requirement for alternative therapy|2|||
42132419|NCT00413283|75943241|FG002|Overall Study|Requirement for alternative therapy|0|||
42132420|NCT00413283|75943242|FG003|Overall Study|Requirement for alternative therapy|0|||
42132421|NCT00413283|75943239|FG000|Overall Study|Other|0|||
42132422|NCT00413283|75943240|FG001|Overall Study|Other|0|||
42132423|NCT00413283|75943241|FG002|Overall Study|Other|1|||
42132424|NCT00413283|75943242|FG003|Overall Study|Other|0|||
42132425|NCT00402051|75943254|FG000|Overall Study|Progressive Disease|13|||
42132426|NCT00402051|75943255|FG001|Overall Study|Progressive Disease|20|||
42132427|NCT00402051|75943254|FG000|Overall Study|Adverse Event|11|||
42132428|NCT00402051|75943255|FG001|Overall Study|Adverse Event|4|||
42132429|NCT00402051|75943254|FG000|Overall Study|Physician Decision|7|||
42132430|NCT00402051|75943255|FG001|Overall Study|Physician Decision|3|||
42132431|NCT00402051|75943254|FG000|Overall Study|Withdrawal by Subject|3|||
42132432|NCT00402051|75943255|FG001|Overall Study|Withdrawal by Subject|3|||
42132433|NCT00402051|75943254|FG000|Overall Study|Death - Related to Study Drug|1|||
42132434|NCT00402051|75943255|FG001|Overall Study|Death - Related to Study Drug|2|||
42132435|NCT00402051|75943254|FG000|Overall Study|Death Due to Study Disease|2|||
42132436|NCT00402051|75943255|FG001|Overall Study|Death Due to Study Disease|1|||
42132437|NCT00402051|75943254|FG000|Overall Study|Death Due to Adverse Event|0|||
42132438|NCT00402051|75943255|FG001|Overall Study|Death Due to Adverse Event|2|||
42132439|NCT00402051|75943254|FG000|Overall Study|Lost to Follow-up|1|||
42132440|NCT00402051|75943255|FG001|Overall Study|Lost to Follow-up|0|||
42132441|NCT00468858|75943264|FG000|Overall Study|Adverse Event|0|||
42132442|NCT00468858|75943265|FG001|Overall Study|Adverse Event|1|||
42132443|NCT00468858|75943266|FG002|Overall Study|Adverse Event|0|||
42132444|NCT00468858|75943264|FG000|Overall Study|Withdrawal by Subject|7|||
42132445|NCT00468858|75943265|FG001|Overall Study|Withdrawal by Subject|4|||
42132446|NCT00468858|75943266|FG002|Overall Study|Withdrawal by Subject|5|||
42132447|NCT00468858|75943264|FG000|Overall Study|Relocation|1|||
42132448|NCT00468858|75943265|FG001|Overall Study|Relocation|3|||
42249867|NCT03940742|76075344|FG002|Overall Study|Lost to Follow-up|0|||
42249868|NCT03940742|76075345|FG003|Overall Study|Lost to Follow-up|1|||
42249869|NCT03917654|76075367|FG000|Year 1|Withdrawal by Subject|1|||
42249870|NCT03917654|76075368|FG001|Year 1|Withdrawal by Subject|0|||
42249871|NCT03917654|76075369|FG002|Year 1|Withdrawal by Subject|0|||
42249872|NCT03917654|76075370|FG003|Year 1|Withdrawal by Subject|0|||
42249873|NCT03917654|76075371|FG004|Year 1|Withdrawal by Subject|0|||
42249874|NCT03917654|76075372|FG005|Year 1|Withdrawal by Subject|1|||
42249875|NCT03917654|76075373|FG006|Year 1|Withdrawal by Subject|6|||
42249876|NCT03917654|76075374|FG007|Year 1|Withdrawal by Subject|2|||
42249877|NCT03917654|76075375|FG008|Year 1|Withdrawal by Subject|5|||
42249878|NCT03917654|76075376|FG009|Year 1|Withdrawal by Subject|3|||
42249879|NCT03917654|76075377|FG010|Year 1|Withdrawal by Subject|1|||
42249880|NCT03917654|76075378|FG011|Year 1|Withdrawal by Subject|0|||
42249881|NCT03917654|76075367|FG000|Year 1|Travel|0|||
42249882|NCT03917654|76075368|FG001|Year 1|Travel|1|||
42249883|NCT03917654|76075369|FG002|Year 1|Travel|1|||
42249884|NCT03917654|76075370|FG003|Year 1|Travel|0|||
42249885|NCT03917654|76075371|FG004|Year 1|Travel|4|||
42249886|NCT03917654|76075372|FG005|Year 1|Travel|4|||
42249887|NCT03917654|76075373|FG006|Year 1|Travel|10|||
42249888|NCT03917654|76075374|FG007|Year 1|Travel|8|||
42249889|NCT03917654|76075375|FG008|Year 1|Travel|2|||
42249890|NCT03917654|76075376|FG009|Year 1|Travel|5|||
42249891|NCT03917654|76075377|FG010|Year 1|Travel|3|||
42249892|NCT03917654|76075378|FG011|Year 1|Travel|3|||
42249893|NCT03917654|76075367|FG000|Year 1|Subject moved away from site|0|||
42249894|NCT03917654|76075368|FG001|Year 1|Subject moved away from site|1|||
42249895|NCT03917654|76075369|FG002|Year 1|Subject moved away from site|0|||
42249896|NCT03917654|76075370|FG003|Year 1|Subject moved away from site|0|||
42249897|NCT03917654|76075371|FG004|Year 1|Subject moved away from site|0|||
42249898|NCT03917654|76075372|FG005|Year 1|Subject moved away from site|0|||
42249899|NCT03917654|76075373|FG006|Year 1|Subject moved away from site|1|||
42249900|NCT03917654|76075374|FG007|Year 1|Subject moved away from site|2|||
42249901|NCT03917654|76075375|FG008|Year 1|Subject moved away from site|1|||
42249902|NCT03917654|76075376|FG009|Year 1|Subject moved away from site|0|||
42249903|NCT03917654|76075377|FG010|Year 1|Subject moved away from site|0|||
42249904|NCT03917654|76075378|FG011|Year 1|Subject moved away from site|3|||
42249905|NCT03917654|76075367|FG000|Year 1|Spouse/Family member request|0|||
42249906|NCT03917654|76075368|FG001|Year 1|Spouse/Family member request|0|||
42249907|NCT03917654|76075369|FG002|Year 1|Spouse/Family member request|1|||
42249908|NCT03917654|76075370|FG003|Year 1|Spouse/Family member request|0|||
42249909|NCT03917654|76075371|FG004|Year 1|Spouse/Family member request|1|||
42303337|NCT02409667|76138603|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
42303338|NCT02409667|76138604|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
42132449|NCT00468858|75943266|FG002|Overall Study|Relocation|3|||
42132450|NCT00468858|75943264|FG000|Overall Study|Lost to Follow-up|1|||
42132451|NCT00468858|75943265|FG001|Overall Study|Lost to Follow-up|2|||
42132452|NCT00468858|75943266|FG002|Overall Study|Lost to Follow-up|5|||
42132453|NCT00468858|75943264|FG000|Overall Study|Other|0|||
42249910|NCT03917654|76075372|FG005|Year 1|Spouse/Family member request|0|||
42132454|NCT00468858|75943265|FG001|Overall Study|Other|0|||
42132455|NCT00468858|75943266|FG002|Overall Study|Other|1|||
42249911|NCT03917654|76075373|FG006|Year 1|Spouse/Family member request|0|||
42249912|NCT03917654|76075374|FG007|Year 1|Spouse/Family member request|2|||
42249913|NCT03917654|76075375|FG008|Year 1|Spouse/Family member request|0|||
42249914|NCT03917654|76075376|FG009|Year 1|Spouse/Family member request|0|||
42249915|NCT03917654|76075377|FG010|Year 1|Spouse/Family member request|0|||
42249916|NCT03917654|76075378|FG011|Year 1|Spouse/Family member request|1|||
42249917|NCT03917654|76075367|FG000|Year 1|Death|0|||
42249918|NCT03917654|76075368|FG001|Year 1|Death|0|||
42249919|NCT03917654|76075369|FG002|Year 1|Death|0|||
42249920|NCT03917654|76075370|FG003|Year 1|Death|0|||
42249921|NCT03917654|76075371|FG004|Year 1|Death|0|||
42249922|NCT03917654|76075372|FG005|Year 1|Death|0|||
42249923|NCT03917654|76075373|FG006|Year 1|Death|0|||
42249924|NCT03917654|76075374|FG007|Year 1|Death|0|||
42249925|NCT03917654|76075375|FG008|Year 1|Death|1|||
42249926|NCT03917654|76075376|FG009|Year 1|Death|1|||
42249927|NCT03917654|76075377|FG010|Year 1|Death|0|||
42249928|NCT03917654|76075378|FG011|Year 1|Death|0|||
42249929|NCT03917654|76075367|FG000|Year 1|Lost to Follow-up|0|||
42249930|NCT03917654|76075368|FG001|Year 1|Lost to Follow-up|0|||
42249931|NCT03917654|76075369|FG002|Year 1|Lost to Follow-up|0|||
42249932|NCT03917654|76075370|FG003|Year 1|Lost to Follow-up|0|||
42249933|NCT03917654|76075371|FG004|Year 1|Lost to Follow-up|0|||
42249934|NCT03917654|76075372|FG005|Year 1|Lost to Follow-up|0|||
42249935|NCT03917654|76075373|FG006|Year 1|Lost to Follow-up|2|||
42249936|NCT03917654|76075374|FG007|Year 1|Lost to Follow-up|0|||
42249937|NCT03917654|76075375|FG008|Year 1|Lost to Follow-up|0|||
42249938|NCT03917654|76075376|FG009|Year 1|Lost to Follow-up|0|||
42249939|NCT03917654|76075377|FG010|Year 1|Lost to Follow-up|0|||
42249940|NCT03917654|76075378|FG011|Year 1|Lost to Follow-up|0|||
42249941|NCT03917654|76075367|FG000|Year 1|Missed visits|0|||
42249942|NCT03917654|76075368|FG001|Year 1|Missed visits|0|||
42249943|NCT03917654|76075369|FG002|Year 1|Missed visits|0|||
42249944|NCT03917654|76075370|FG003|Year 1|Missed visits|0|||
42249945|NCT03917654|76075371|FG004|Year 1|Missed visits|0|||
42249946|NCT03917654|76075372|FG005|Year 1|Missed visits|0|||
42249947|NCT03917654|76075373|FG006|Year 1|Missed visits|0|||
42249948|NCT03917654|76075374|FG007|Year 1|Missed visits|0|||
42249949|NCT03917654|76075375|FG008|Year 1|Missed visits|0|||
42249950|NCT03917654|76075376|FG009|Year 1|Missed visits|0|||
42249951|NCT03917654|76075377|FG010|Year 1|Missed visits|1|||
42249952|NCT03917654|76075378|FG011|Year 1|Missed visits|1|||
42249953|NCT03917654|76075367|FG000|Year 1|Pregnancy|0|||
42249954|NCT03917654|76075368|FG001|Year 1|Pregnancy|0|||
42249955|NCT03917654|76075369|FG002|Year 1|Pregnancy|0|||
42249956|NCT03917654|76075370|FG003|Year 1|Pregnancy|0|||
42249957|NCT03917654|76075371|FG004|Year 1|Pregnancy|0|||
42249958|NCT03917654|76075372|FG005|Year 1|Pregnancy|0|||
42249959|NCT03917654|76075373|FG006|Year 1|Pregnancy|0|||
42249960|NCT03917654|76075374|FG007|Year 1|Pregnancy|1|||
42249961|NCT03917654|76075375|FG008|Year 1|Pregnancy|0|||
42249962|NCT03917654|76075376|FG009|Year 1|Pregnancy|1|||
42249963|NCT03917654|76075377|FG010|Year 1|Pregnancy|0|||
42249964|NCT03917654|76075378|FG011|Year 1|Pregnancy|0|||
42249965|NCT03917654|76075367|FG000|Year 2|Travel|1|||
42249966|NCT03917654|76075368|FG001|Year 2|Travel|0|||
42249967|NCT03917654|76075369|FG002|Year 2|Travel|0|||
42249968|NCT03917654|76075370|FG003|Year 2|Travel|0|||
42249969|NCT03917654|76075371|FG004|Year 2|Travel|1|||
42249970|NCT03917654|76075372|FG005|Year 2|Travel|1|||
42249971|NCT03917654|76075373|FG006|Year 2|Travel|2|||
42249972|NCT03917654|76075374|FG007|Year 2|Travel|1|||
42249973|NCT03917654|76075375|FG008|Year 2|Travel|0|||
42132456|NCT00401973|75943331|FG000|Overall Study|Adverse Event|2|||
42132457|NCT00401973|75943332|FG001|Overall Study|Adverse Event|8|||
42249974|NCT03917654|76075376|FG009|Year 2|Travel|1|||
42249975|NCT03917654|76075377|FG010|Year 2|Travel|0|||
42249976|NCT03917654|76075378|FG011|Year 2|Travel|1|||
42249977|NCT03917654|76075367|FG000|Year 2|Married|1|||
42132458|NCT00401973|75943333|FG002|Overall Study|Adverse Event|4|||
42132459|NCT00401973|75943331|FG000|Overall Study|Clinical Relapse|0|||
42249978|NCT03917654|76075368|FG001|Year 2|Married|0|||
42249979|NCT03917654|76075369|FG002|Year 2|Married|0|||
42132460|NCT00401973|75943332|FG001|Overall Study|Clinical Relapse|1|||
42132461|NCT00401973|75943333|FG002|Overall Study|Clinical Relapse|1|||
42249980|NCT03917654|76075370|FG003|Year 2|Married|0|||
42249981|NCT03917654|76075371|FG004|Year 2|Married|0|||
42249982|NCT03917654|76075372|FG005|Year 2|Married|0|||
42249983|NCT03917654|76075373|FG006|Year 2|Married|1|||
42249984|NCT03917654|76075374|FG007|Year 2|Married|1|||
42249985|NCT03917654|76075375|FG008|Year 2|Married|0|||
42249986|NCT03917654|76075376|FG009|Year 2|Married|0|||
42249987|NCT03917654|76075377|FG010|Year 2|Married|0|||
42249988|NCT03917654|76075378|FG011|Year 2|Married|0|||
42249989|NCT03917654|76075367|FG000|Year 2|Subject moved away from site|1|||
42249990|NCT03917654|76075368|FG001|Year 2|Subject moved away from site|0|||
42249991|NCT03917654|76075369|FG002|Year 2|Subject moved away from site|0|||
42249992|NCT03917654|76075370|FG003|Year 2|Subject moved away from site|0|||
42249993|NCT03917654|76075371|FG004|Year 2|Subject moved away from site|1|||
42249994|NCT03917654|76075372|FG005|Year 2|Subject moved away from site|0|||
42249995|NCT03917654|76075373|FG006|Year 2|Subject moved away from site|2|||
42249996|NCT03917654|76075374|FG007|Year 2|Subject moved away from site|3|||
42249997|NCT03917654|76075375|FG008|Year 2|Subject moved away from site|0|||
41990280|NCT01229254|75798225|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
41990281|NCT01229254|75798223|FG000|Overall Study|Adverse Event|4|||
41990282|NCT01229254|75798224|FG001|Overall Study|Adverse Event|5|||
42249998|NCT03917654|76075376|FG009|Year 2|Subject moved away from site|2|||
42132462|NCT00401973|75943331|FG000|Overall Study|Lack of Efficacy|0|||
42132463|NCT00401973|75943332|FG001|Overall Study|Lack of Efficacy|0|||
42132464|NCT00401973|75943333|FG002|Overall Study|Lack of Efficacy|3|||
42132465|NCT00401973|75943331|FG000|Overall Study|Lost to Follow-up|2|||
42249999|NCT03917654|76075377|FG010|Year 2|Subject moved away from site|0|||
42250000|NCT03917654|76075378|FG011|Year 2|Subject moved away from site|1|||
42250001|NCT03917654|76075367|FG000|Year 2|Year 2 Screening failure|0|||
42250002|NCT03917654|76075368|FG001|Year 2|Year 2 Screening failure|1|||
42250003|NCT03917654|76075369|FG002|Year 2|Year 2 Screening failure|0|||
42250004|NCT03917654|76075370|FG003|Year 2|Year 2 Screening failure|0|||
42250005|NCT03917654|76075371|FG004|Year 2|Year 2 Screening failure|2|||
42250006|NCT03917654|76075372|FG005|Year 2|Year 2 Screening failure|0|||
42250007|NCT03917654|76075373|FG006|Year 2|Year 2 Screening failure|4|||
42250008|NCT03917654|76075374|FG007|Year 2|Year 2 Screening failure|3|||
42250009|NCT03917654|76075375|FG008|Year 2|Year 2 Screening failure|10|||
42250010|NCT03917654|76075376|FG009|Year 2|Year 2 Screening failure|2|||
42250011|NCT03917654|76075377|FG010|Year 2|Year 2 Screening failure|1|||
42250012|NCT03917654|76075378|FG011|Year 2|Year 2 Screening failure|1|||
42250013|NCT03917654|76075367|FG000|Year 2|Death|0|||
42250014|NCT03917654|76075368|FG001|Year 2|Death|0|||
42250015|NCT03917654|76075369|FG002|Year 2|Death|0|||
42250016|NCT03917654|76075370|FG003|Year 2|Death|0|||
42250017|NCT03917654|76075371|FG004|Year 2|Death|0|||
42250018|NCT03917654|76075372|FG005|Year 2|Death|1|||
42250019|NCT03917654|76075373|FG006|Year 2|Death|0|||
42250020|NCT03917654|76075374|FG007|Year 2|Death|0|||
42250021|NCT03917654|76075375|FG008|Year 2|Death|1|||
42250022|NCT03917654|76075376|FG009|Year 2|Death|1|||
42250023|NCT03917654|76075377|FG010|Year 2|Death|0|||
42250024|NCT03917654|76075378|FG011|Year 2|Death|0|||
42250025|NCT03917654|76075367|FG000|Year 2|Withdrawal by Subject|0|||
42250026|NCT03917654|76075368|FG001|Year 2|Withdrawal by Subject|0|||
42250027|NCT03917654|76075369|FG002|Year 2|Withdrawal by Subject|0|||
42250028|NCT03917654|76075370|FG003|Year 2|Withdrawal by Subject|0|||
42250029|NCT03917654|76075371|FG004|Year 2|Withdrawal by Subject|0|||
42250030|NCT03917654|76075372|FG005|Year 2|Withdrawal by Subject|0|||
42250031|NCT03917654|76075373|FG006|Year 2|Withdrawal by Subject|3|||
42250032|NCT03917654|76075374|FG007|Year 2|Withdrawal by Subject|0|||
42250033|NCT03917654|76075375|FG008|Year 2|Withdrawal by Subject|2|||
42250034|NCT03917654|76075376|FG009|Year 2|Withdrawal by Subject|5|||
42250035|NCT03917654|76075377|FG010|Year 2|Withdrawal by Subject|0|||
42250036|NCT03917654|76075378|FG011|Year 2|Withdrawal by Subject|0|||
41990283|NCT01229254|75798225|FG002|Overall Study|Adverse Event|3|||
41990284|NCT01229254|75798223|FG000|Overall Study|Lost to Follow-up|3|||
41990285|NCT01229254|75798224|FG001|Overall Study|Lost to Follow-up|0|||
41990286|NCT01229254|75798225|FG002|Overall Study|Lost to Follow-up|1|||
41990287|NCT01229254|75798223|FG000|Overall Study|Physician Decision|0|||
41990288|NCT01229254|75798224|FG001|Overall Study|Physician Decision|3|||
41990289|NCT01229254|75798225|FG002|Overall Study|Physician Decision|0|||
41990290|NCT01229254|75798223|FG000|Overall Study|Protocol Violation|4|||
41990291|NCT01229254|75798224|FG001|Overall Study|Protocol Violation|6|||
41990292|NCT01229254|75798225|FG002|Overall Study|Protocol Violation|5|||
41990293|NCT01229254|75798223|FG000|Overall Study|Withdrawal by Subject|1|||
41990294|NCT01229254|75798224|FG001|Overall Study|Withdrawal by Subject|0|||
41990295|NCT01229254|75798225|FG002|Overall Study|Withdrawal by Subject|1|||
41990296|NCT01229254|75798223|FG000|Overall Study|Non-compliance with Study Drug|0|||
41990297|NCT01229254|75798224|FG001|Overall Study|Non-compliance with Study Drug|1|||
41990298|NCT01229254|75798225|FG002|Overall Study|Non-compliance with Study Drug|1|||
41990299|NCT01235728|75798234|FG000|Overall Study|Protocol Violation|0|||
41990300|NCT01235728|75798235|FG001|Overall Study|Protocol Violation|0|||
41990301|NCT01235728|75798236|FG002|Overall Study|Protocol Violation|0|||
41990302|NCT01235728|75798237|FG003|Overall Study|Protocol Violation|1|||
41990303|NCT01235728|75798238|FG004|Overall Study|Protocol Violation|0|||
41990304|NCT01235728|75798239|FG005|Overall Study|Protocol Violation|0|||
41990305|NCT01235728|75798240|FG006|Overall Study|Protocol Violation|0|||
41990306|NCT01235728|75798241|FG007|Overall Study|Protocol Violation|0|||
41990307|NCT01235689|75798251|FG000|Overall Study|Adverse Event|12|||
41990308|NCT01235689|75798252|FG001|Overall Study|Adverse Event|16|||
41990309|NCT01235689|75798251|FG000|Overall Study|Lack of Efficacy|12|||
41990310|NCT01235689|75798252|FG001|Overall Study|Lack of Efficacy|5|||
42132466|NCT00401973|75943332|FG001|Overall Study|Lost to Follow-up|2|||
42250037|NCT03917654|76075367|FG000|Year 2|Spouse/family member request|0|||
42132467|NCT00401973|75943333|FG002|Overall Study|Lost to Follow-up|2|||
42250038|NCT03917654|76075368|FG001|Year 2|Spouse/family member request|0|||
42250039|NCT03917654|76075369|FG002|Year 2|Spouse/family member request|0|||
42250040|NCT03917654|76075370|FG003|Year 2|Spouse/family member request|0|||
42250041|NCT03917654|76075371|FG004|Year 2|Spouse/family member request|0|||
42250042|NCT03917654|76075372|FG005|Year 2|Spouse/family member request|0|||
42250043|NCT03917654|76075373|FG006|Year 2|Spouse/family member request|1|||
42250044|NCT03917654|76075374|FG007|Year 2|Spouse/family member request|0|||
42250045|NCT03917654|76075375|FG008|Year 2|Spouse/family member request|0|||
42250046|NCT03917654|76075376|FG009|Year 2|Spouse/family member request|0|||
42250047|NCT03917654|76075377|FG010|Year 2|Spouse/family member request|0|||
42250048|NCT03917654|76075378|FG011|Year 2|Spouse/family member request|0|||
42250049|NCT03917654|76075367|FG000|Year 2|Lost to Follow-up|0|||
42250050|NCT03917654|76075368|FG001|Year 2|Lost to Follow-up|0|||
42250051|NCT03917654|76075369|FG002|Year 2|Lost to Follow-up|0|||
42250052|NCT03917654|76075370|FG003|Year 2|Lost to Follow-up|0|||
42250053|NCT03917654|76075371|FG004|Year 2|Lost to Follow-up|0|||
42250054|NCT03917654|76075372|FG005|Year 2|Lost to Follow-up|0|||
42250055|NCT03917654|76075373|FG006|Year 2|Lost to Follow-up|1|||
42250056|NCT03917654|76075374|FG007|Year 2|Lost to Follow-up|0|||
42250057|NCT03917654|76075375|FG008|Year 2|Lost to Follow-up|1|||
42250058|NCT03917654|76075376|FG009|Year 2|Lost to Follow-up|0|||
42250059|NCT03917654|76075377|FG010|Year 2|Lost to Follow-up|0|||
42250060|NCT03917654|76075378|FG011|Year 2|Lost to Follow-up|1|||
42250061|NCT03917654|76075367|FG000|Year 2|Adverse Event|0|||
42250062|NCT03917654|76075368|FG001|Year 2|Adverse Event|0|||
42250063|NCT03917654|76075369|FG002|Year 2|Adverse Event|0|||
42250064|NCT03917654|76075370|FG003|Year 2|Adverse Event|0|||
42250065|NCT03917654|76075371|FG004|Year 2|Adverse Event|0|||
42250066|NCT03917654|76075372|FG005|Year 2|Adverse Event|0|||
42250067|NCT03917654|76075373|FG006|Year 2|Adverse Event|0|||
42250068|NCT03917654|76075374|FG007|Year 2|Adverse Event|0|||
42250069|NCT03917654|76075375|FG008|Year 2|Adverse Event|0|||
42250070|NCT03917654|76075376|FG009|Year 2|Adverse Event|1|||
42250071|NCT03917654|76075377|FG010|Year 2|Adverse Event|0|||
42250072|NCT03917654|76075378|FG011|Year 2|Adverse Event|0|||
42250073|NCT03060577|76075415|FG000|Overall Study|Withdrawal by Subject|25|||
42250074|NCT03060577|76075416|FG001|Overall Study|Withdrawal by Subject|5|||
42250075|NCT03060577|76075415|FG000|Overall Study|Physician Decision|4|||
42250076|NCT03060577|76075416|FG001|Overall Study|Physician Decision|3|||
42250077|NCT03060577|76075415|FG000|Overall Study|Lost to Follow-up|3|||
42250078|NCT03060577|76075416|FG001|Overall Study|Lost to Follow-up|0|||
42250079|NCT03060577|76075415|FG000|Overall Study|Death|7|||
42250080|NCT03060577|76075416|FG001|Overall Study|Death|1|||
42250081|NCT03060577|76075415|FG000|Overall Study|Adverse Event|9|||
42250082|NCT03060577|76075416|FG001|Overall Study|Adverse Event|1|||
42250083|NCT03060577|76075415|FG000|Overall Study|Inclusion/Exclusion|1|||
42250084|NCT03060577|76075416|FG001|Overall Study|Inclusion/Exclusion|0|||
42250085|NCT03060577|76075415|FG000|Overall Study|Other|8|||
42250086|NCT03060577|76075416|FG001|Overall Study|Other|2|||
42250087|NCT02872714|76075427|FG000|Overall Study|Progressive Disease|1|||
42250088|NCT02872714|76075428|FG001|Overall Study|Progressive Disease|2|||
42250089|NCT02872714|76075429|FG002|Overall Study|Progressive Disease|0|||
42250090|NCT02872714|76075430|FG003|Overall Study|Progressive Disease|0|||
42250091|NCT02872714|76075431|FG004|Overall Study|Progressive Disease|0|||
42250092|NCT02872714|76075427|FG000|Overall Study|Death|87|||
42250093|NCT02872714|76075428|FG001|Overall Study|Death|36|||
42250094|NCT02872714|76075429|FG002|Overall Study|Death|8|||
42250095|NCT02872714|76075430|FG003|Overall Study|Death|81|||
42250096|NCT02872714|76075431|FG004|Overall Study|Death|2|||
42250097|NCT02872714|76075427|FG000|Overall Study|Lost to Follow-up|2|||
42250098|NCT02872714|76075428|FG001|Overall Study|Lost to Follow-up|1|||
42250099|NCT02872714|76075429|FG002|Overall Study|Lost to Follow-up|0|||
42250100|NCT02872714|76075430|FG003|Overall Study|Lost to Follow-up|3|||
42032962|NCT00943917|75841136|FG014|Stage II Continuation|hypoglycemia|0|||
42032963|NCT00943917|75841122|FG000|Stage II Continuation|A1C elevation|0|||
42032964|NCT00943917|75841123|FG001|Stage II Continuation|A1C elevation|0|||
42250101|NCT02872714|76075431|FG004|Overall Study|Lost to Follow-up|0|||
42250102|NCT02872714|76075427|FG000|Overall Study|Physician Decision|0|||
42250103|NCT02872714|76075428|FG001|Overall Study|Physician Decision|0|||
42250104|NCT02872714|76075429|FG002|Overall Study|Physician Decision|0|||
42250105|NCT02872714|76075430|FG003|Overall Study|Physician Decision|1|||
42250106|NCT02872714|76075431|FG004|Overall Study|Physician Decision|0|||
42250107|NCT02872714|76075427|FG000|Overall Study|Withdrawal by Subject|1|||
42250108|NCT02872714|76075428|FG001|Overall Study|Withdrawal by Subject|3|||
42250109|NCT02872714|76075429|FG002|Overall Study|Withdrawal by Subject|0|||
42250110|NCT02872714|76075430|FG003|Overall Study|Withdrawal by Subject|2|||
42250111|NCT02872714|76075431|FG004|Overall Study|Withdrawal by Subject|0|||
42250112|NCT02872714|76075427|FG000|Overall Study|Captured as Other|2|||
42250113|NCT02872714|76075428|FG001|Overall Study|Captured as Other|0|||
42032965|NCT00943917|75841124|FG002|Stage II Continuation|A1C elevation|0|||
42250114|NCT02872714|76075429|FG002|Overall Study|Captured as Other|0|||
42250115|NCT02872714|76075430|FG003|Overall Study|Captured as Other|1|||
42250116|NCT02872714|76075431|FG004|Overall Study|Captured as Other|0|||
42250117|NCT02787005|76075451|FG000|Overall Study|Adverse Event|24|||
42250118|NCT02787005|76075452|FG001|Overall Study|Adverse Event|9|||
42250119|NCT02787005|76075453|FG002|Overall Study|Adverse Event|9|||
42250120|NCT02787005|76075454|FG003|Overall Study|Adverse Event|7|||
42250121|NCT02787005|76075455|FG004|Overall Study|Adverse Event|2|||
42250122|NCT02787005|76075451|FG000|Overall Study|Death|100|||
42250123|NCT02787005|76075452|FG001|Overall Study|Death|53|||
42250124|NCT02787005|76075453|FG002|Overall Study|Death|48|||
42250125|NCT02787005|76075454|FG003|Overall Study|Death|69|||
42250126|NCT02787005|76075455|FG004|Overall Study|Death|38|||
42250127|NCT02787005|76075451|FG000|Overall Study|Sponsor Decision|7|||
42250128|NCT02787005|76075452|FG001|Overall Study|Sponsor Decision|4|||
42250129|NCT02787005|76075453|FG002|Overall Study|Sponsor Decision|0|||
42250130|NCT02787005|76075454|FG003|Overall Study|Sponsor Decision|4|||
42250131|NCT02787005|76075455|FG004|Overall Study|Sponsor Decision|5|||
42250132|NCT02787005|76075451|FG000|Overall Study|Withdrawal by Subject|2|||
42250133|NCT02787005|76075452|FG001|Overall Study|Withdrawal by Subject|1|||
42250134|NCT02787005|76075453|FG002|Overall Study|Withdrawal by Subject|1|||
42250135|NCT02787005|76075454|FG003|Overall Study|Withdrawal by Subject|0|||
42250136|NCT02787005|76075455|FG004|Overall Study|Withdrawal by Subject|1|||
42250137|NCT02787005|76075451|FG000|Overall Study|Screen Failure|0|||
42250138|NCT02787005|76075452|FG001|Overall Study|Screen Failure|2|||
42250139|NCT02787005|76075453|FG002|Overall Study|Screen Failure|0|||
42250140|NCT02787005|76075454|FG003|Overall Study|Screen Failure|0|||
42250141|NCT02787005|76075455|FG004|Overall Study|Screen Failure|1|||
42250142|NCT02787005|76075451|FG000|Overall Study|Lost to Follow-up|0|||
42250143|NCT02787005|76075452|FG001|Overall Study|Lost to Follow-up|0|||
42250144|NCT02787005|76075453|FG002|Overall Study|Lost to Follow-up|0|||
42250145|NCT02787005|76075454|FG003|Overall Study|Lost to Follow-up|1|||
42250146|NCT02787005|76075455|FG004|Overall Study|Lost to Follow-up|0|||
42250147|NCT02514083|76075486|FG000|Overall Study|Adverse Event|1|||
42250148|NCT02395848|76075490|FG000|Overall Study|Lost to Follow-up|2|||
42250149|NCT02061761|76075507|FG000|Overall Study|Disease progression|2|||
42132468|NCT00401973|75943331|FG000|Overall Study|Physician Decision|2|||
42250150|NCT02061761|76075508|FG001|Overall Study|Disease progression|8|||
42250151|NCT02061761|76075509|FG002|Overall Study|Disease progression|4|||
42250152|NCT02061761|76075510|FG003|Overall Study|Disease progression|5|||
42250153|NCT02061761|76075511|FG004|Overall Study|Disease progression|9|||
42132469|NCT00401973|75943332|FG001|Overall Study|Physician Decision|0|||
42132470|NCT00401973|75943333|FG002|Overall Study|Physician Decision|1|||
42132471|NCT00401973|75943331|FG000|Overall Study|Protocol Violation|1|||
42132472|NCT00401973|75943332|FG001|Overall Study|Protocol Violation|2|||
42132473|NCT00401973|75943333|FG002|Overall Study|Protocol Violation|3|||
42132474|NCT00401973|75943331|FG000|Overall Study|Sponsor Decision|0|||
42132475|NCT00401973|75943332|FG001|Overall Study|Sponsor Decision|1|||
42132476|NCT00401973|75943333|FG002|Overall Study|Sponsor Decision|0|||
42132477|NCT00401973|75943331|FG000|Overall Study|Withdrawal by Subject|4|||
42132478|NCT00401973|75943332|FG001|Overall Study|Withdrawal by Subject|12|||
42132479|NCT00401973|75943333|FG002|Overall Study|Withdrawal by Subject|9|||
42132480|NCT00401193|75943346|FG000|Overall Study|Adverse Event|1|||
42132481|NCT00401193|75943347|FG001|Overall Study|Adverse Event|3|||
42132482|NCT00401193|75943348|FG002|Overall Study|Adverse Event|1|||
42132483|NCT00401193|75943346|FG000|Overall Study|Protocol Violation|3|||
42132484|NCT00401193|75943347|FG001|Overall Study|Protocol Violation|1|||
42132485|NCT00401193|75943348|FG002|Overall Study|Protocol Violation|1|||
42132486|NCT00401193|75943346|FG000|Overall Study|Lost to Follow-up|6|||
42132487|NCT00401193|75943347|FG001|Overall Study|Lost to Follow-up|5|||
42132488|NCT00401193|75943348|FG002|Overall Study|Lost to Follow-up|1|||
42132489|NCT00401193|75943346|FG000|Overall Study|Withdrawal by Subject|2|||
42132490|NCT00401193|75943347|FG001|Overall Study|Withdrawal by Subject|0|||
42132491|NCT00401193|75943348|FG002|Overall Study|Withdrawal by Subject|1|||
42132492|NCT00401193|75943346|FG000|Overall Study|Other Event|3|||
42132493|NCT00401193|75943347|FG001|Overall Study|Other Event|2|||
42132494|NCT00401193|75943348|FG002|Overall Study|Other Event|2|||
42132495|NCT00400569|75943357|FG000|Overall Study|Death|1|||
42250154|NCT02061761|76075512|FG005|Overall Study|Disease progression|3|||
42250155|NCT02061761|76075513|FG006|Overall Study|Disease progression|1|||
42250156|NCT02061761|76075514|FG007|Overall Study|Disease progression|2|||
42250157|NCT02061761|76075515|FG008|Overall Study|Disease progression|28|||
42250158|NCT02061761|76075507|FG000|Overall Study|Study Drug toxicity|0|||
42303339|NCT02409667|76138605|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
42132496|NCT00413049|75943366|FG000|Overall Study|Adverse Event|10|||
42132497|NCT00413049|75943367|FG001|Overall Study|Adverse Event|8|||
42132498|NCT00413049|75943366|FG000|Overall Study|Withdrawal by Subject|7|||
42132499|NCT00413049|75943367|FG001|Overall Study|Withdrawal by Subject|5|||
42132500|NCT00413049|75943366|FG000|Overall Study|Lost to Follow-up|2|||
42132501|NCT00413049|75943367|FG001|Overall Study|Lost to Follow-up|3|||
42132502|NCT00413049|75943366|FG000|Overall Study|Protocol Violation|3|||
42250159|NCT02061761|76075508|FG001|Overall Study|Study Drug toxicity|0|||
42250160|NCT02061761|76075509|FG002|Overall Study|Study Drug toxicity|0|||
42250161|NCT02061761|76075510|FG003|Overall Study|Study Drug toxicity|0|||
42250162|NCT02061761|76075511|FG004|Overall Study|Study Drug toxicity|0|||
42250163|NCT02061761|76075512|FG005|Overall Study|Study Drug toxicity|1|||
42250164|NCT02061761|76075513|FG006|Overall Study|Study Drug toxicity|0|||
42132503|NCT00413049|75943367|FG001|Overall Study|Protocol Violation|1|||
42132504|NCT00413049|75943366|FG000|Overall Study|Subject no longer requires study drug|0|||
42132505|NCT00413049|75943367|FG001|Overall Study|Subject no longer requires study drug|1|||
42132506|NCT00413049|75943366|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42132507|NCT00413049|75943367|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42132508|NCT00413049|75943366|FG000|Overall Study|Lack of Efficacy|1|||
42132509|NCT00413049|75943367|FG001|Overall Study|Lack of Efficacy|0|||
42132510|NCT00454194|75943375|FG000|Overall Study|Adverse Event|7|||
42132511|NCT00454194|75943376|FG001|Overall Study|Adverse Event|2|||
42132512|NCT00454194|75943375|FG000|Overall Study|Withdrawal by Subject|12|||
42132513|NCT00454194|75943376|FG001|Overall Study|Withdrawal by Subject|8|||
42132514|NCT00454194|75943375|FG000|Overall Study|Other Medical Problems|1|||
42132515|NCT00454194|75943376|FG001|Overall Study|Other Medical Problems|2|||
42132516|NCT00454194|75943375|FG000|Overall Study|Other Unspecified Reason|2|||
42132517|NCT00454194|75943376|FG001|Overall Study|Other Unspecified Reason|2|||
42132518|NCT00412971|75943384|FG000|Overall Study|Lost to Follow-up|17|||
42132519|NCT00412971|75943385|FG001|Overall Study|Lost to Follow-up|9|||
42250165|NCT02061761|76075514|FG007|Overall Study|Study Drug toxicity|2|||
42250166|NCT02061761|76075515|FG008|Overall Study|Study Drug toxicity|6|||
42132520|NCT00412971|75943384|FG000|Overall Study|Protocol Violation|13|||
42132521|NCT00412971|75943385|FG001|Overall Study|Protocol Violation|1|||
42132522|NCT00303472|75943398|FG000|Treatment Period|Adverse Event|0|||
42132523|NCT00303472|75943399|FG001|Treatment Period|Adverse Event|0|||
42132524|NCT00303472|75943400|FG002|Treatment Period|Adverse Event|0|||
42132525|NCT00303472|75943401|FG003|Treatment Period|Adverse Event|0|||
42132526|NCT00303472|75943402|FG004|Treatment Period|Adverse Event|1|||
42132527|NCT00303472|75943403|FG005|Treatment Period|Adverse Event|0|||
42132528|NCT00303472|75943404|FG006|Treatment Period|Adverse Event|0|||
42132529|NCT00303472|75943398|FG000|Treatment Period|Death|0|||
42250167|NCT02061761|76075507|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
42250168|NCT02061761|76075508|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
42250169|NCT02061761|76075509|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
42250170|NCT02061761|76075510|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
42250171|NCT02061761|76075511|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
42250172|NCT02061761|76075512|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
42250173|NCT02061761|76075513|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
42250174|NCT02061761|76075514|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
42250175|NCT02061761|76075515|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
42250176|NCT02061761|76075507|FG000|Overall Study|Participant request to discontinue study treatment|0|||
42250177|NCT02061761|76075508|FG001|Overall Study|Participant request to discontinue study treatment|0|||
42250178|NCT02061761|76075509|FG002|Overall Study|Participant request to discontinue study treatment|2|||
42250179|NCT02061761|76075510|FG003|Overall Study|Participant request to discontinue study treatment|2|||
42250180|NCT02061761|76075511|FG004|Overall Study|Participant request to discontinue study treatment|0|||
42250181|NCT02061761|76075512|FG005|Overall Study|Participant request to discontinue study treatment|1|||
42250182|NCT02061761|76075513|FG006|Overall Study|Participant request to discontinue study treatment|0|||
42250183|NCT02061761|76075514|FG007|Overall Study|Participant request to discontinue study treatment|0|||
42250184|NCT02061761|76075515|FG008|Overall Study|Participant request to discontinue study treatment|2|||
42250185|NCT02061761|76075507|FG000|Overall Study|Withdrawal by Subject|0|||
42250186|NCT02061761|76075508|FG001|Overall Study|Withdrawal by Subject|0|||
42250187|NCT02061761|76075509|FG002|Overall Study|Withdrawal by Subject|0|||
42250188|NCT02061761|76075510|FG003|Overall Study|Withdrawal by Subject|0|||
42250189|NCT02061761|76075511|FG004|Overall Study|Withdrawal by Subject|0|||
42250190|NCT02061761|76075512|FG005|Overall Study|Withdrawal by Subject|0|||
42250191|NCT02061761|76075513|FG006|Overall Study|Withdrawal by Subject|0|||
42250192|NCT02061761|76075514|FG007|Overall Study|Withdrawal by Subject|0|||
42250193|NCT02061761|76075515|FG008|Overall Study|Withdrawal by Subject|2|||
42250194|NCT02061761|76075507|FG000|Overall Study|Maximum clinical benefit|0|||
42250195|NCT02061761|76075508|FG001|Overall Study|Maximum clinical benefit|0|||
42250196|NCT02061761|76075509|FG002|Overall Study|Maximum clinical benefit|0|||
42250197|NCT02061761|76075510|FG003|Overall Study|Maximum clinical benefit|1|||
42132530|NCT00303472|75943399|FG001|Treatment Period|Death|0|||
42132531|NCT00303472|75943400|FG002|Treatment Period|Death|0|||
42132532|NCT00303472|75943401|FG003|Treatment Period|Death|1|||
42132533|NCT00303472|75943402|FG004|Treatment Period|Death|0|||
42132534|NCT00303472|75943403|FG005|Treatment Period|Death|0|||
42132535|NCT00303472|75943404|FG006|Treatment Period|Death|1|||
42132536|NCT00303472|75943398|FG000|Treatment Period|Withdrawal by Subject|0|||
42132537|NCT00303472|75943399|FG001|Treatment Period|Withdrawal by Subject|0|||
42132538|NCT00303472|75943400|FG002|Treatment Period|Withdrawal by Subject|0|||
42132539|NCT00303472|75943401|FG003|Treatment Period|Withdrawal by Subject|1|||
42132540|NCT00303472|75943402|FG004|Treatment Period|Withdrawal by Subject|0|||
42250198|NCT02061761|76075511|FG004|Overall Study|Maximum clinical benefit|0|||
42250199|NCT02061761|76075512|FG005|Overall Study|Maximum clinical benefit|0|||
42250200|NCT02061761|76075513|FG006|Overall Study|Maximum clinical benefit|0|||
42250201|NCT02061761|76075514|FG007|Overall Study|Maximum clinical benefit|0|||
42250202|NCT02061761|76075515|FG008|Overall Study|Maximum clinical benefit|6|||
42250203|NCT02061761|76075507|FG000|Overall Study|Participant no longer meets study criteria|0|||
42250204|NCT02061761|76075508|FG001|Overall Study|Participant no longer meets study criteria|0|||
42250205|NCT02061761|76075509|FG002|Overall Study|Participant no longer meets study criteria|0|||
42250206|NCT02061761|76075510|FG003|Overall Study|Participant no longer meets study criteria|0|||
42250207|NCT02061761|76075511|FG004|Overall Study|Participant no longer meets study criteria|0|||
42250208|NCT02061761|76075512|FG005|Overall Study|Participant no longer meets study criteria|0|||
42250209|NCT02061761|76075513|FG006|Overall Study|Participant no longer meets study criteria|0|||
42250210|NCT02061761|76075514|FG007|Overall Study|Participant no longer meets study criteria|0|||
42250211|NCT02061761|76075515|FG008|Overall Study|Participant no longer meets study criteria|1|||
42250212|NCT02061761|76075507|FG000|Overall Study|Other reasons|0|||
42250213|NCT02061761|76075508|FG001|Overall Study|Other reasons|0|||
42250214|NCT02061761|76075509|FG002|Overall Study|Other reasons|0|||
42250215|NCT02061761|76075510|FG003|Overall Study|Other reasons|0|||
42250216|NCT02061761|76075511|FG004|Overall Study|Other reasons|2|||
42250217|NCT02061761|76075512|FG005|Overall Study|Other reasons|0|||
42250218|NCT02061761|76075513|FG006|Overall Study|Other reasons|0|||
42250219|NCT02061761|76075514|FG007|Overall Study|Other reasons|0|||
42250220|NCT02061761|76075515|FG008|Overall Study|Other reasons|6|||
42250221|NCT01927068|76075543|FG000|Overall Study|Death|37|||
42250222|NCT01927068|76075544|FG001|Overall Study|Death|3|||
42250223|NCT01927068|76075543|FG000|Overall Study|Withdrawal by Subject|50|||
42250224|NCT01927068|76075544|FG001|Overall Study|Withdrawal by Subject|3|||
42250225|NCT01927068|76075543|FG000|Overall Study|Lost to Follow-up|10|||
42250226|NCT01927068|76075544|FG001|Overall Study|Lost to Follow-up|2|||
42250227|NCT01927068|76075543|FG000|Overall Study|Physician Decision|9|||
42250228|NCT01927068|76075544|FG001|Overall Study|Physician Decision|0|||
42250229|NCT01927068|76075543|FG000|Overall Study|Missed last follow-up visit|2|||
42250230|NCT01927068|76075544|FG001|Overall Study|Missed last follow-up visit|0|||
42250231|NCT01309230|76075553|FG000|Overall Study|Withdrawal by Subject|0|||
42250232|NCT01309230|76075554|FG001|Overall Study|Withdrawal by Subject|2|||
42250233|NCT01309230|76075553|FG000|Overall Study|Observation arm closed|0|||
42250234|NCT01309230|76075554|FG001|Overall Study|Observation arm closed|2|||
42250235|NCT00819832|76075566|FG000|Overall Study|Sponsor Termination of Study|3|||
42250236|NCT00819832|76075567|FG001|Overall Study|Sponsor Termination of Study|0|||
42250237|NCT00819832|76075568|FG002|Overall Study|Sponsor Termination of Study|0|||
42250238|NCT00819832|76075569|FG003|Overall Study|Sponsor Termination of Study|0|||
42250239|NCT00819832|76075570|FG004|Overall Study|Sponsor Termination of Study|0|||
42250240|NCT00819832|76075571|FG005|Overall Study|Sponsor Termination of Study|0|||
42250241|NCT00704522|76075587|FG000|Overall Study|Lack of Efficacy|65|||
42250242|NCT00704522|76075588|FG001|Overall Study|Lack of Efficacy|17|||
42250243|NCT00704522|76075587|FG000|Overall Study|Failure to appear again at hospital|56|||
42250244|NCT00704522|76075588|FG001|Overall Study|Failure to appear again at hospital|10|||
42250245|NCT00704522|76075587|FG000|Overall Study|Withdrawal by Subject|17|||
42250246|NCT00704522|76075588|FG001|Overall Study|Withdrawal by Subject|8|||
42250247|NCT00704522|76075587|FG000|Overall Study|Adverse Event|9|||
42250248|NCT00704522|76075588|FG001|Overall Study|Adverse Event|1|||
42250249|NCT00704522|76075587|FG000|Overall Study|Undefined causes|9|||
42250250|NCT00704522|76075588|FG001|Overall Study|Undefined causes|7|||
42250251|NCT00704522|76075587|FG000|Overall Study|No information on therapy end|27|||
42250252|NCT00704522|76075588|FG001|Overall Study|No information on therapy end|2|||
42250253|NCT02723630|76075603|FG000|Intervention Period 1|Adverse Event|1|||
42250254|NCT02723630|76075604|FG001|Intervention Period 1|Adverse Event|0|||
42250255|NCT02723630|76075605|FG002|Intervention Period 1|Adverse Event|0|||
42250256|NCT02723630|76075606|FG003|Intervention Period 1|Adverse Event|0|||
42250257|NCT02723630|76075607|FG004|Intervention Period 1|Adverse Event|0|||
42250258|NCT02723630|76075608|FG005|Intervention Period 1|Adverse Event|0|||
42250259|NCT02723630|76075603|FG000|Intervention Period 3|consumption of restricted item|0|||
42250260|NCT02723630|76075604|FG001|Intervention Period 3|consumption of restricted item|1|||
42250261|NCT02723630|76075605|FG002|Intervention Period 3|consumption of restricted item|0|||
42250262|NCT02723630|76075606|FG003|Intervention Period 3|consumption of restricted item|0|||
42250263|NCT02723630|76075607|FG004|Intervention Period 3|consumption of restricted item|0|||
42250264|NCT02723630|76075608|FG005|Intervention Period 3|consumption of restricted item|0|||
42250265|NCT04089735|76075651|FG000|Overall Study|Adverse Event|1|||
42250266|NCT04089735|76075652|FG001|Overall Study|Adverse Event|0|||
42250267|NCT04089735|76075653|FG002|Overall Study|Adverse Event|1|||
42250268|NCT04089735|76075654|FG003|Overall Study|Adverse Event|1|||
42250269|NCT04089735|76075655|FG004|Overall Study|Adverse Event|0|||
42250270|NCT04089735|76075656|FG005|Overall Study|Adverse Event|0|||
42250271|NCT04089735|76075651|FG000|Overall Study|Physician Decision|0|||
42250272|NCT04089735|76075652|FG001|Overall Study|Physician Decision|3|||
42250273|NCT04089735|76075653|FG002|Overall Study|Physician Decision|0|||
42250274|NCT04089735|76075654|FG003|Overall Study|Physician Decision|0|||
42250275|NCT04089735|76075655|FG004|Overall Study|Physician Decision|0|||
42250276|NCT04089735|76075656|FG005|Overall Study|Physician Decision|0|||
42250277|NCT04089735|76075651|FG000|Overall Study|Withdrawal by Subject|0|||
42250278|NCT04089735|76075652|FG001|Overall Study|Withdrawal by Subject|0|||
42250279|NCT04089735|76075653|FG002|Overall Study|Withdrawal by Subject|1|||
42250280|NCT04089735|76075654|FG003|Overall Study|Withdrawal by Subject|0|||
42250281|NCT04089735|76075655|FG004|Overall Study|Withdrawal by Subject|0|||
42250282|NCT04089735|76075656|FG005|Overall Study|Withdrawal by Subject|0|||
42250283|NCT04089735|76075651|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
42250284|NCT04089735|76075652|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
42250285|NCT04089735|76075653|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
42250286|NCT04089735|76075654|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
42250287|NCT04089735|76075655|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
42250288|NCT04089735|76075656|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
42250289|NCT01876784|76075672|FG000|Overall Study|Withdrawal by Subject|17|||
42250290|NCT01876784|76075673|FG001|Overall Study|Withdrawal by Subject|2|||
42250291|NCT01876784|76075672|FG000|Overall Study|Adverse Event|15|||
42250292|NCT01876784|76075673|FG001|Overall Study|Adverse Event|2|||
42250293|NCT01876784|76075672|FG000|Overall Study|Protocol Violation|1|||
42250294|NCT01876784|76075673|FG001|Overall Study|Protocol Violation|0|||
42250295|NCT01876784|76075672|FG000|Overall Study|Disease progression|37|||
42250296|NCT01876784|76075673|FG001|Overall Study|Disease progression|67|||
42250297|NCT01876784|76075672|FG000|Overall Study|Lost to Follow-up|0|||
42250298|NCT01876784|76075673|FG001|Overall Study|Lost to Follow-up|1|||
42250299|NCT01876784|76075672|FG000|Overall Study|Death|1|||
42250300|NCT01876784|76075673|FG001|Overall Study|Death|0|||
42250301|NCT01876784|76075672|FG000|Overall Study|Randomized but not treated|2|||
42250302|NCT01876784|76075673|FG001|Overall Study|Randomized but not treated|1|||
42250303|NCT01876784|76075672|FG000|Overall Study|Other than specified above|5|||
42250304|NCT01876784|76075673|FG001|Overall Study|Other than specified above|6|||
42250305|NCT01876784|76075672|FG000|Overall Study|Ongoing|41|||
42250306|NCT01876784|76075673|FG001|Overall Study|Ongoing|40|||
42250307|NCT04205162|76075681|FG000|Overall Study|Lost to Follow-up|1|||
42250308|NCT04205162|76075682|FG001|Overall Study|Lost to Follow-up|0|||
42250309|NCT04205162|76075681|FG000|Overall Study|Withdrawal by Subject|2|||
42250310|NCT04205162|76075682|FG001|Overall Study|Withdrawal by Subject|0|||
42250311|NCT04205162|76075681|FG000|Overall Study|University closure due to COVID-19|1|||
42250312|NCT04205162|76075682|FG001|Overall Study|University closure due to COVID-19|0|||
42250313|NCT01329939|76075707|FG000|Overall Study|Lost to Follow-up|3|||
42250314|NCT01329939|76075708|FG001|Overall Study|Lost to Follow-up|0|||
42132541|NCT00303472|75943403|FG005|Treatment Period|Withdrawal by Subject|1|||
42132542|NCT00303472|75943404|FG006|Treatment Period|Withdrawal by Subject|0|||
42132543|NCT00303472|75943398|FG000|Treatment Period|Other|0|||
42132544|NCT00303472|75943399|FG001|Treatment Period|Other|0|||
42250315|NCT01329939|76075709|FG002|Overall Study|Lost to Follow-up|1|||
42250316|NCT01329939|76075710|FG003|Overall Study|Lost to Follow-up|2|||
42250317|NCT01329939|76075707|FG000|Overall Study|Withdrawal by Subject|0|||
42250318|NCT01329939|76075708|FG001|Overall Study|Withdrawal by Subject|1|||
42250319|NCT01329939|76075709|FG002|Overall Study|Withdrawal by Subject|0|||
42250320|NCT01329939|76075710|FG003|Overall Study|Withdrawal by Subject|0|||
42250321|NCT01329939|76075707|FG000|Overall Study|Adverse Event|0|||
42250322|NCT01329939|76075708|FG001|Overall Study|Adverse Event|0|||
42250323|NCT01329939|76075709|FG002|Overall Study|Adverse Event|0|||
42250324|NCT01329939|76075710|FG003|Overall Study|Adverse Event|3|||
42250325|NCT02499900|76075722|FG000|Core Study Period|Other|1|||
42132545|NCT00303472|75943400|FG002|Treatment Period|Other|0|||
42250326|NCT02499900|76075723|FG001|Core Study Period|Other|4|||
42250327|NCT02499900|76075722|FG000|Core Study Period|Lost to Follow-up|1|||
42250328|NCT02499900|76075723|FG001|Core Study Period|Lost to Follow-up|2|||
42250329|NCT02499900|76075722|FG000|Core Study Period|Per sponsor request|0|||
42250330|NCT02499900|76075723|FG001|Core Study Period|Per sponsor request|1|||
42250331|NCT02499900|76075722|FG000|Core Study Period|Pregnancy|1|||
42250332|NCT02499900|76075723|FG001|Core Study Period|Pregnancy|0|||
42250333|NCT02499900|76075722|FG000|Core Study Period|Protocol Violation|3|||
42250334|NCT02499900|76075723|FG001|Core Study Period|Protocol Violation|0|||
42250335|NCT02499900|76075722|FG000|Core Study Period|Withdrawal by Subject|11|||
42250336|NCT02499900|76075723|FG001|Core Study Period|Withdrawal by Subject|10|||
42250337|NCT02499900|76075722|FG000|Core Study Period|Adverse Event|18|||
42250338|NCT02499900|76075723|FG001|Core Study Period|Adverse Event|14|||
42250339|NCT02499900|76075722|FG000|Core Study Period|Death|0|||
42250340|NCT02499900|76075723|FG001|Core Study Period|Death|1|||
42250341|NCT02499900|76075722|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
42250342|NCT02499900|76075723|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
42250343|NCT02499900|76075722|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
42250344|NCT02499900|76075723|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
42250345|NCT02499900|76075722|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
42250346|NCT02499900|76075723|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
42250347|NCT02499900|76075722|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
42250348|NCT02499900|76075723|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
42250349|NCT02499900|76075722|FG000|Extension Study Period|Adverse Event|2|||
42250350|NCT02499900|76075723|FG001|Extension Study Period|Adverse Event|4|||
42250351|NCT02499900|76075722|FG000|Extension Study Period|Withdrawal by Subject|5|||
42250352|NCT02499900|76075723|FG001|Extension Study Period|Withdrawal by Subject|2|||
42250353|NCT02499900|76075722|FG000|Extension Study Period|Physician Decision|2|||
42250354|NCT02499900|76075723|FG001|Extension Study Period|Physician Decision|5|||
42250355|NCT02499900|76075722|FG000|Extension Study Period|Pregnancy|1|||
42250356|NCT02499900|76075723|FG001|Extension Study Period|Pregnancy|2|||
42250357|NCT02499900|76075722|FG000|Extension Study Period|Lost to Follow-up|2|||
42250358|NCT02499900|76075723|FG001|Extension Study Period|Lost to Follow-up|5|||
42250359|NCT02499900|76075722|FG000|Extension Study Period|Other|0|||
42250360|NCT02499900|76075723|FG001|Extension Study Period|Other|2|||
42250361|NCT03505749|76075737|FG000|Overall Study|Lost to Follow-up|7|||
42250362|NCT03505749|76075738|FG001|Overall Study|Lost to Follow-up|11|||
42250363|NCT03505749|76075737|FG000|Overall Study|Withdrawal by Subject|6|||
42250364|NCT03505749|76075738|FG001|Overall Study|Withdrawal by Subject|0|||
42250365|NCT03505749|76075737|FG000|Overall Study|Discharged from treatment|3|||
42250366|NCT03505749|76075738|FG001|Overall Study|Discharged from treatment|6|||
42250367|NCT03436797|76075760|FG000|Overall Study|Withdrawal by Subject|2|||
42250368|NCT03436797|76075760|FG000|Overall Study|Adverse Event|4|||
42250369|NCT03436797|76075760|FG000|Overall Study|Lost to Follow-up|1|||
42250370|NCT03436797|76075760|FG000|Overall Study|Death|1|||
42250371|NCT03436797|76075760|FG000|Overall Study|Non-Specific|2|||
42250372|NCT03710642|76075769|FG000|Overall Study|Adverse Event|5|||
42250373|NCT03710642|76075770|FG001|Overall Study|Adverse Event|1|||
42250374|NCT03710642|76075769|FG000|Overall Study|non-site physician recommendation|1|||
42250375|NCT03710642|76075770|FG001|Overall Study|non-site physician recommendation|0|||
42250376|NCT03710642|76075769|FG000|Overall Study|Participant unwilling or unable to participate|1|||
42132546|NCT00303472|75943401|FG003|Treatment Period|Other|0|||
42132547|NCT00303472|75943402|FG004|Treatment Period|Other|1|||
42132548|NCT00303472|75943403|FG005|Treatment Period|Other|0|||
42132549|NCT00303472|75943404|FG006|Treatment Period|Other|1|||
42132550|NCT00303472|75943398|FG000|Treatment Period|Disease Progression (to AML)|0|||
42132551|NCT00303472|75943399|FG001|Treatment Period|Disease Progression (to AML)|0|||
42132552|NCT00303472|75943400|FG002|Treatment Period|Disease Progression (to AML)|0|||
42132553|NCT00303472|75943401|FG003|Treatment Period|Disease Progression (to AML)|0|||
42132554|NCT00303472|75943402|FG004|Treatment Period|Disease Progression (to AML)|1|||
42132555|NCT00303472|75943403|FG005|Treatment Period|Disease Progression (to AML)|0|||
42250377|NCT03710642|76075770|FG001|Overall Study|Participant unwilling or unable to participate|1|||
42250378|NCT03710642|76075769|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
42250379|NCT03710642|76075770|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
42250380|NCT03710642|76075769|FG000|Overall Study|NA-no code provided|1|||
42250381|NCT03710642|76075770|FG001|Overall Study|NA-no code provided|0|||
42250382|NCT03710642|76075769|FG000|Overall Study|Withdrawal by Subject|1|||
42250383|NCT03710642|76075770|FG001|Overall Study|Withdrawal by Subject|0|||
42250384|NCT00705224|76075776|FG000|Overall Study|Adverse Event|1|||
42250385|NCT00705224|76075776|FG000|Overall Study|Lack of Efficacy|2|||
42250386|NCT00705224|76075776|FG000|Overall Study|Withdrawal by Subject|3|||
42250387|NCT00705224|76075776|FG000|Overall Study|Lost to Follow-up|5|||
42250388|NCT02722148|76075783|FG000|Overall Study|Lost to Follow-up|2|||
42250389|NCT02722148|76075783|FG000|Overall Study|Non compliant with treatment regimen|3|||
42250390|NCT00704132|76075789|FG000|Overall Study|Clinical Adverse Experience|1|||
42250391|NCT00704132|76075790|FG001|Overall Study|Clinical Adverse Experience|0|||
42250392|NCT00704132|76075789|FG000|Overall Study|Lack of Efficacy|0|||
42250393|NCT00704132|76075790|FG001|Overall Study|Lack of Efficacy|1|||
42250394|NCT00704132|76075789|FG000|Overall Study|Withdrawal by Subject|0|||
42250395|NCT00704132|76075790|FG001|Overall Study|Withdrawal by Subject|1|||
42250396|NCT01329549|76075805|FG000|Overall Study|Withdrawal by Subject|1|||
42250397|NCT01329549|76075805|FG000|Overall Study|Adverse Event|1|||
42132556|NCT00303472|75943404|FG006|Treatment Period|Disease Progression (to AML)|0|||
42132557|NCT00303472|75943398|FG000|Treatment Extension (Optional)|Adverse Event|1|||
42132558|NCT00303472|75943399|FG001|Treatment Extension (Optional)|Adverse Event|0|||
42132559|NCT00303472|75943400|FG002|Treatment Extension (Optional)|Adverse Event|1|||
42132560|NCT00303472|75943401|FG003|Treatment Extension (Optional)|Adverse Event|0|||
42132561|NCT00303472|75943402|FG004|Treatment Extension (Optional)|Adverse Event|0|||
42132562|NCT00303472|75943403|FG005|Treatment Extension (Optional)|Adverse Event|0|||
42132563|NCT00303472|75943404|FG006|Treatment Extension (Optional)|Adverse Event|0|||
42132564|NCT00303472|75943398|FG000|Treatment Extension (Optional)|Death|2|||
42132565|NCT00303472|75943399|FG001|Treatment Extension (Optional)|Death|0|||
42132566|NCT00303472|75943400|FG002|Treatment Extension (Optional)|Death|1|||
42132567|NCT00303472|75943401|FG003|Treatment Extension (Optional)|Death|0|||
42132568|NCT00303472|75943402|FG004|Treatment Extension (Optional)|Death|0|||
42132569|NCT00303472|75943403|FG005|Treatment Extension (Optional)|Death|0|||
42132570|NCT00303472|75943404|FG006|Treatment Extension (Optional)|Death|0|||
42132571|NCT00303472|75943398|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
42132572|NCT00303472|75943399|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
42132573|NCT00303472|75943400|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
42250398|NCT02736474|76075811|FG000|Overall Study|Lost to Follow-up|0|||
42250399|NCT02736474|76075812|FG001|Overall Study|Lost to Follow-up|1|||
42250400|NCT00702650|76075834|FG000|Overall Study|Withdrawal by Subject|9|||
42250401|NCT00702650|76075834|FG000|Overall Study|Non-Compliance of Study Drug|3|||
42250402|NCT00702650|76075834|FG000|Overall Study|Lost to Follow-up|2|||
42250403|NCT00702650|76075834|FG000|Overall Study|Non-Compliance with Site Directives|1|||
42250404|NCT00702650|76075834|FG000|Overall Study|Sponsor Request|1|||
42132574|NCT00303472|75943401|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
42132575|NCT00303472|75943402|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
42250405|NCT00702650|76075834|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
42250406|NCT00702650|76075834|FG000|Overall Study|Adverse Event|3|||
42250407|NCT03230916|76075849|FG000|Overall Study|Withdrawal by Subject|0|||
42132576|NCT00303472|75943403|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
42132577|NCT00303472|75943404|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
42132578|NCT00303472|75943398|FG000|Treatment Extension (Optional)|Physician Decision|0|||
42250408|NCT03230916|76075850|FG001|Overall Study|Withdrawal by Subject|0|||
42250409|NCT03230916|76075851|FG002|Overall Study|Withdrawal by Subject|0|||
42250410|NCT03230916|76075852|FG003|Overall Study|Withdrawal by Subject|0|||
42250411|NCT03230916|76075853|FG004|Overall Study|Withdrawal by Subject|0|||
42250412|NCT03230916|76075854|FG005|Overall Study|Withdrawal by Subject|1|||
42250413|NCT03230916|76075855|FG006|Overall Study|Withdrawal by Subject|0|||
42250414|NCT03230916|76075856|FG007|Overall Study|Withdrawal by Subject|0|||
42250415|NCT03230916|76075857|FG008|Overall Study|Withdrawal by Subject|0|||
42250416|NCT03230916|76075858|FG009|Overall Study|Withdrawal by Subject|0|||
42250417|NCT03230916|76075859|FG010|Overall Study|Withdrawal by Subject|0|||
42250418|NCT01337115|76075902|FG000|Overall Study|Protocol Violation|2|||
42250419|NCT01337115|76075903|FG001|Overall Study|Protocol Violation|0|||
42250420|NCT03761784|76075913|FG000|Overall Study|Adverse Event|4|||
42250421|NCT03761784|76075914|FG001|Overall Study|Adverse Event|0|||
42250422|NCT03761784|76075913|FG000|Overall Study|Lost to Follow-up|10|||
42250423|NCT03761784|76075914|FG001|Overall Study|Lost to Follow-up|7|||
42250424|NCT03761784|76075913|FG000|Overall Study|Pregnancy|1|||
42250425|NCT03761784|76075914|FG001|Overall Study|Pregnancy|0|||
42250426|NCT03761784|76075913|FG000|Overall Study|Protocol Violation|2|||
42250427|NCT03761784|76075914|FG001|Overall Study|Protocol Violation|0|||
42250428|NCT03761784|76075913|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
42250429|NCT03761784|76075914|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
42250430|NCT03761784|76075913|FG000|Overall Study|Withdrawal by Subject|9|||
42250431|NCT03761784|76075914|FG001|Overall Study|Withdrawal by Subject|4|||
42250432|NCT03761784|76075913|FG000|Overall Study|Physician Decision|1|||
42250433|NCT03761784|76075914|FG001|Overall Study|Physician Decision|0|||
42250434|NCT03761784|76075913|FG000|Overall Study|Other Than Specified|1|||
42250435|NCT03761784|76075914|FG001|Overall Study|Other Than Specified|0|||
42250436|NCT03195894|76075922|FG000|Overall Study|"An example is Started other treatment."|4|||
42250437|NCT03195894|76075923|FG001|Overall Study|"An example is Started other treatment."|5|||
42250438|NCT03195894|76075922|FG000|Overall Study|Withdrawal by Subject|15|||
42250439|NCT03195894|76075923|FG001|Overall Study|Withdrawal by Subject|4|||
42250440|NCT03195894|76075922|FG000|Overall Study|Lost to Follow-up|14|||
42250441|NCT03195894|76075923|FG001|Overall Study|Lost to Follow-up|19|||
42250442|NCT01337973|76075935|FG000|Overall Study|Lost to Follow-up|2|||
42250443|NCT01337973|76075936|FG001|Overall Study|Lost to Follow-up|4|||
42250444|NCT01337973|76075937|FG002|Overall Study|Lost to Follow-up|3|||
42250445|NCT01337973|76075935|FG000|Overall Study|Death|1|||
42250446|NCT01337973|76075936|FG001|Overall Study|Death|2|||
42250447|NCT01337973|76075937|FG002|Overall Study|Death|1|||
42250448|NCT01337973|76075935|FG000|Overall Study|Withdrawal by Subject|10|||
42250449|NCT01337973|76075936|FG001|Overall Study|Withdrawal by Subject|8|||
42250450|NCT01337973|76075937|FG002|Overall Study|Withdrawal by Subject|4|||
42250451|NCT01337973|76075935|FG000|Overall Study|missing data on primary outcome|3|||
42250452|NCT01337973|76075936|FG001|Overall Study|missing data on primary outcome|1|||
42250453|NCT01337973|76075937|FG002|Overall Study|missing data on primary outcome|3|||
42250454|NCT02929056|76075947|FG000|Overall Study|Lost to Follow-up|0|||
42250455|NCT02929056|76075948|FG001|Overall Study|Lost to Follow-up|1|||
42250456|NCT00157755|76075967|FG000|Overall Study|Death|2|||
42250457|NCT00157755|76075968|FG001|Overall Study|Death|3|||
42250458|NCT00157755|76075969|FG002|Overall Study|Death|3|||
42250459|NCT00157755|76075970|FG003|Overall Study|Death|2|||
42250460|NCT00157755|76075971|FG004|Overall Study|Death|0|||
42250461|NCT00157755|76075972|FG005|Overall Study|Death|0|||
42250462|NCT00157755|76075967|FG000|Overall Study|Lost to Follow-up|0|||
42250463|NCT00157755|76075968|FG001|Overall Study|Lost to Follow-up|0|||
42250464|NCT00157755|76075969|FG002|Overall Study|Lost to Follow-up|1|||
42250465|NCT00157755|76075970|FG003|Overall Study|Lost to Follow-up|0|||
42250466|NCT00157755|76075971|FG004|Overall Study|Lost to Follow-up|0|||
42250467|NCT00157755|76075972|FG005|Overall Study|Lost to Follow-up|0|||
42250468|NCT00157755|76075967|FG000|Overall Study|Withdrawal by Subject|0|||
42250469|NCT00157755|76075968|FG001|Overall Study|Withdrawal by Subject|0|||
42250470|NCT00157755|76075969|FG002|Overall Study|Withdrawal by Subject|1|||
42250471|NCT00157755|76075970|FG003|Overall Study|Withdrawal by Subject|1|||
42250472|NCT00157755|76075971|FG004|Overall Study|Withdrawal by Subject|1|||
42250473|NCT00157755|76075972|FG005|Overall Study|Withdrawal by Subject|2|||
42250474|NCT00157755|76075967|FG000|Overall Study|Explant due to infection|0|||
42250475|NCT00157755|76075968|FG001|Overall Study|Explant due to infection|0|||
42250476|NCT00157755|76075969|FG002|Overall Study|Explant due to infection|1|||
42250477|NCT00157755|76075970|FG003|Overall Study|Explant due to infection|0|||
42250478|NCT00157755|76075971|FG004|Overall Study|Explant due to infection|0|||
42250479|NCT00157755|76075972|FG005|Overall Study|Explant due to infection|0|||
42250480|NCT00157755|76075967|FG000|Overall Study|Medical reason|0|||
42250481|NCT00157755|76075968|FG001|Overall Study|Medical reason|0|||
42250482|NCT00157755|76075969|FG002|Overall Study|Medical reason|1|||
42250483|NCT00157755|76075970|FG003|Overall Study|Medical reason|1|||
42250484|NCT00157755|76075971|FG004|Overall Study|Medical reason|0|||
42250485|NCT00157755|76075972|FG005|Overall Study|Medical reason|0|||
42250486|NCT00157755|76075967|FG000|Overall Study|Study site closure|0|||
42250487|NCT00157755|76075968|FG001|Overall Study|Study site closure|1|||
42250488|NCT00157755|76075969|FG002|Overall Study|Study site closure|0|||
42250489|NCT00157755|76075970|FG003|Overall Study|Study site closure|0|||
42250490|NCT00157755|76075971|FG004|Overall Study|Study site closure|0|||
42250491|NCT00157755|76075972|FG005|Overall Study|Study site closure|0|||
42250492|NCT00157755|76075967|FG000|Overall Study|Subject non-compliance|0|||
42250493|NCT00157755|76075968|FG001|Overall Study|Subject non-compliance|0|||
42250494|NCT00157755|76075969|FG002|Overall Study|Subject non-compliance|0|||
42250495|NCT00157755|76075970|FG003|Overall Study|Subject non-compliance|0|||
42250496|NCT00157755|76075971|FG004|Overall Study|Subject non-compliance|0|||
42250497|NCT00157755|76075972|FG005|Overall Study|Subject non-compliance|1|||
42250498|NCT00157755|76075967|FG000|Overall Study|Study completion|0|||
42250499|NCT00157755|76075968|FG001|Overall Study|Study completion|0|||
42250500|NCT00157755|76075969|FG002|Overall Study|Study completion|0|||
42250501|NCT00157755|76075970|FG003|Overall Study|Study completion|0|||
42250502|NCT00157755|76075971|FG004|Overall Study|Study completion|1|||
42250503|NCT00157755|76075972|FG005|Overall Study|Study completion|2|||
42250504|NCT02723006|76075981|FG000|Overall Study|Withdrawal by Subject|0|||
42250505|NCT02723006|76075982|FG001|Overall Study|Withdrawal by Subject|1|||
42250506|NCT02723006|76075983|FG002|Overall Study|Withdrawal by Subject|1|||
42250507|NCT02723006|76075981|FG000|Overall Study|Study Terminated by Sponsor|1|||
42250508|NCT02723006|76075982|FG001|Overall Study|Study Terminated by Sponsor|6|||
42250509|NCT02723006|76075983|FG002|Overall Study|Study Terminated by Sponsor|6|||
42250510|NCT00702962|76075993|FG000|Overall Study|Progressive disease|0|||
42250511|NCT00702962|76075994|FG001|Overall Study|Progressive disease|1|||
42132579|NCT00303472|75943399|FG001|Treatment Extension (Optional)|Physician Decision|4|||
42250512|NCT00702962|76075993|FG000|Overall Study|Hospitalized for other health disorder|1|||
42250513|NCT00702962|76075994|FG001|Overall Study|Hospitalized for other health disorder|0|||
42250514|NCT01379508|76076006|FG000|Treatment to Week 104|Adverse Event|2|||
42250515|NCT01379508|76076007|FG001|Treatment to Week 104|Adverse Event|0|||
42250516|NCT01379508|76076008|FG002|Treatment to Week 104|Adverse Event|5|||
42250517|NCT01379508|76076009|FG003|Treatment to Week 104|Adverse Event|0|||
42250518|NCT01379508|76076006|FG000|Treatment to Week 104|Abnormal lab value|1|||
42250519|NCT01379508|76076007|FG001|Treatment to Week 104|Abnormal lab value|0|||
42250520|NCT01379508|76076008|FG002|Treatment to Week 104|Abnormal lab value|0|||
42250521|NCT01379508|76076009|FG003|Treatment to Week 104|Abnormal lab value|0|||
42250522|NCT01379508|76076006|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
42250523|NCT01379508|76076007|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
42132580|NCT00303472|75943400|FG002|Treatment Extension (Optional)|Physician Decision|2|||
42132581|NCT00303472|75943401|FG003|Treatment Extension (Optional)|Physician Decision|3|||
42132582|NCT00303472|75943402|FG004|Treatment Extension (Optional)|Physician Decision|2|||
42132583|NCT00303472|75943403|FG005|Treatment Extension (Optional)|Physician Decision|0|||
42132584|NCT00303472|75943404|FG006|Treatment Extension (Optional)|Physician Decision|0|||
42132585|NCT00303472|75943398|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
42132586|NCT00303472|75943399|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
42132587|NCT00303472|75943400|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
42132588|NCT00303472|75943401|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
42132589|NCT00303472|75943402|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
42132590|NCT00303472|75943403|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
42132591|NCT00303472|75943404|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
42132592|NCT00303472|75943398|FG000|Treatment Extension (Optional)|Other|0|||
42132593|NCT00303472|75943399|FG001|Treatment Extension (Optional)|Other|2|||
42132594|NCT00303472|75943400|FG002|Treatment Extension (Optional)|Other|4|||
42132595|NCT00303472|75943401|FG003|Treatment Extension (Optional)|Other|2|||
42132596|NCT00303472|75943402|FG004|Treatment Extension (Optional)|Other|1|||
42132597|NCT00303472|75943403|FG005|Treatment Extension (Optional)|Other|0|||
42132598|NCT00303472|75943404|FG006|Treatment Extension (Optional)|Other|0|||
42132599|NCT00303472|75943398|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
42132600|NCT00303472|75943399|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
42132601|NCT00303472|75943400|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
42132602|NCT00303472|75943401|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
42132603|NCT00303472|75943402|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
42132604|NCT00303472|75943403|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
42132605|NCT00303472|75943404|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
42132606|NCT00468546|75943422|FG000|Week 24 Analysis|Lack of Efficacy|83|||
42132607|NCT00468546|75943423|FG001|Week 24 Analysis|Lack of Efficacy|37|||
42250524|NCT01379508|76076008|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
42250525|NCT01379508|76076009|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
42250526|NCT01379508|76076006|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
42303340|NCT02409667|76138606|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
42132608|NCT00468546|75943422|FG000|Week 24 Analysis|Refused treatment|5|||
42132609|NCT00468546|75943423|FG001|Week 24 Analysis|Refused treatment|5|||
42132610|NCT00468546|75943422|FG000|Week 24 Analysis|Adverse Event|1|||
42132611|NCT00468546|75943423|FG001|Week 24 Analysis|Adverse Event|8|||
42132612|NCT00468546|75943422|FG000|Week 24 Analysis|Failure to return|3|||
42132613|NCT00468546|75943423|FG001|Week 24 Analysis|Failure to return|4|||
42132614|NCT00468546|75943422|FG000|Week 24 Analysis|Rescue therapy|2|||
42132615|NCT00468546|75943423|FG001|Week 24 Analysis|Rescue therapy|0|||
42132616|NCT00468546|75943422|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
42132617|NCT00468546|75943423|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
42132618|NCT00468546|75943422|FG000|Week 24 Analysis|Due to clinical hold|1|||
42132619|NCT00468546|75943423|FG001|Week 24 Analysis|Due to clinical hold|0|||
42132620|NCT00468546|75943422|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
42132621|NCT00468546|75943423|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
42132622|NCT00468546|75943422|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
42132623|NCT00468546|75943423|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
42132624|NCT00468546|75943422|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
42132625|NCT00468546|75943423|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
42132626|NCT00468546|75943422|FG000|Week 24 to Week 104 Analysis|Death|1|||
42132627|NCT00468546|75943423|FG001|Week 24 to Week 104 Analysis|Death|0|||
42132628|NCT00468546|75943422|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
42132629|NCT00468546|75943423|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
42132630|NCT00468546|75943422|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
42132631|NCT00468546|75943423|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
42132632|NCT00468546|75943422|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
42132633|NCT00468546|75943423|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
42132634|NCT00468546|75943422|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
42132635|NCT00468546|75943423|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
42132636|NCT00468546|75943422|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
42132637|NCT00468546|75943423|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
42132638|NCT00468546|75943422|FG000|Week 24 to Week 104 Analysis|Other|17|||
42132639|NCT00468546|75943423|FG001|Week 24 to Week 104 Analysis|Other|14|||
42132640|NCT00303316|75943431|FG000|Overall Study|Protocol Violation|1|||
42132641|NCT00303316|75943432|FG001|Overall Study|Protocol Violation|0|||
42132642|NCT00303316|75943431|FG000|Overall Study|Lost to Follow-up|0|||
42132643|NCT00303316|75943432|FG001|Overall Study|Lost to Follow-up|1|||
42132644|NCT00303316|75943431|FG000|Overall Study|Withdrawal by Subject|1|||
42132645|NCT00303316|75943432|FG001|Overall Study|Withdrawal by Subject|2|||
42132646|NCT00468312|75943440|FG000|Overall Study|Adverse Event|2|||
42132647|NCT00468312|75943441|FG001|Overall Study|Adverse Event|1|||
42132648|NCT00468312|75943440|FG000|Overall Study|Lack of Efficacy|0|||
42132649|NCT00468312|75943441|FG001|Overall Study|Lack of Efficacy|1|||
42132650|NCT00468312|75943440|FG000|Overall Study|Withdrawal by Subject|0|||
42132651|NCT00468312|75943441|FG001|Overall Study|Withdrawal by Subject|1|||
42132652|NCT00468312|75943440|FG000|Overall Study|Protocol Violation|2|||
42132653|NCT00468312|75943441|FG001|Overall Study|Protocol Violation|1|||
42132654|NCT00468312|75943440|FG000|Overall Study|Did not meet protocol eligibility|0|||
42132655|NCT00468312|75943441|FG001|Overall Study|Did not meet protocol eligibility|1|||
42132656|NCT00331864|75943449|FG000|Overall Study|Adverse Event|30|||
42132657|NCT00331864|75943450|FG001|Overall Study|Adverse Event|1|||
42132658|NCT00331864|75943449|FG000|Overall Study|Lack of Efficacy|4|||
42132659|NCT00331864|75943450|FG001|Overall Study|Lack of Efficacy|0|||
42132660|NCT00331864|75943449|FG000|Overall Study|Protocol Violation|3|||
42132661|NCT00331864|75943450|FG001|Overall Study|Protocol Violation|0|||
42132662|NCT00331864|75943449|FG000|Overall Study|Withdrawal by Subject|10|||
42132663|NCT00331864|75943450|FG001|Overall Study|Withdrawal by Subject|0|||
42132664|NCT00331864|75943449|FG000|Overall Study|Lost to Follow-up|4|||
42132665|NCT00331864|75943450|FG001|Overall Study|Lost to Follow-up|3|||
42132666|NCT00331864|75943449|FG000|Overall Study|Administrative Problems|1|||
42132667|NCT00331864|75943450|FG001|Overall Study|Administrative Problems|0|||
42132668|NCT00331864|75943449|FG000|Overall Study|Death|6|||
42132669|NCT00331864|75943450|FG001|Overall Study|Death|0|||
42132670|NCT00331630|75943456|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
42250527|NCT01379508|76076007|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
42250528|NCT01379508|76076008|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
42250529|NCT01379508|76076009|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
42250530|NCT01379508|76076006|FG000|Treatment to Week 104|Lost to Follow-up|5|||
42250531|NCT01379508|76076007|FG001|Treatment to Week 104|Lost to Follow-up|0|||
42132671|NCT00331630|75943456|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
42250532|NCT01379508|76076008|FG002|Treatment to Week 104|Lost to Follow-up|3|||
42132672|NCT00331630|75943456|FG000|Follow up for 5 Years|Death|5|||
42132673|NCT00331630|75943456|FG000|Follow up for 5 Years|Data collection was stopped|24|||
42132674|NCT00331552|75943462|FG000|Period 3: Phase II|Neurological Symptoms|1|||
42132675|NCT00331552|75943463|FG001|Period 3: Phase II|Neurological Symptoms|0|||
42132676|NCT00331552|75943462|FG000|Period 3: Phase II|Severe Nausea|1|||
42132677|NCT00331552|75943463|FG001|Period 3: Phase II|Severe Nausea|0|||
42132678|NCT00317356|75943478|FG000|Overall Study|Adverse Event|0|||
42132679|NCT00317356|75943479|FG001|Overall Study|Adverse Event|0|||
42132680|NCT00317356|75943480|FG002|Overall Study|Adverse Event|1|||
42132681|NCT00317356|75943481|FG003|Overall Study|Adverse Event|0|||
42132682|NCT00317356|75943478|FG000|Overall Study|Lack of Efficacy|1|||
42132683|NCT00317356|75943479|FG001|Overall Study|Lack of Efficacy|1|||
42250533|NCT01379508|76076009|FG003|Treatment to Week 104|Lost to Follow-up|0|||
42250534|NCT01379508|76076006|FG000|Treatment to Week 104|Administrative problems|3|||
42250535|NCT01379508|76076007|FG001|Treatment to Week 104|Administrative problems|1|||
42250536|NCT01379508|76076008|FG002|Treatment to Week 104|Administrative problems|0|||
42250537|NCT01379508|76076009|FG003|Treatment to Week 104|Administrative problems|0|||
42250538|NCT01379508|76076006|FG000|Treatment to Week 104|Protocol Violation|1|||
42250539|NCT01379508|76076007|FG001|Treatment to Week 104|Protocol Violation|1|||
42132684|NCT00317356|75943480|FG002|Overall Study|Lack of Efficacy|0|||
42250540|NCT01379508|76076008|FG002|Treatment to Week 104|Protocol Violation|1|||
42250541|NCT01379508|76076009|FG003|Treatment to Week 104|Protocol Violation|0|||
42250542|NCT01379508|76076006|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
42250543|NCT01379508|76076007|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
42250544|NCT01379508|76076008|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
42250545|NCT01379508|76076009|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
42250546|NCT01379508|76076006|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
42250547|NCT01379508|76076007|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
42250548|NCT01379508|76076008|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
42250549|NCT01379508|76076009|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
42250550|NCT01379508|76076006|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
42250551|NCT01379508|76076007|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
42250552|NCT01379508|76076008|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
42250553|NCT01379508|76076009|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
42250554|NCT01379508|76076006|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
42250555|NCT01379508|76076007|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
42250556|NCT01379508|76076008|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
42250557|NCT01379508|76076009|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
42250558|NCT02722928|76076025|FG000|Overall Study|Standard CT was not as required per prot|5|||
42250559|NCT02722928|76076026|FG001|Overall Study|Standard CT was not as required per prot|13|||
42250560|NCT02722928|76076025|FG000|Overall Study|Required Intraoperative MRI|5|||
42250561|NCT02722928|76076026|FG001|Overall Study|Required Intraoperative MRI|7|||
42250562|NCT02722304|76076057|FG000|Overall Study|Study Terminated by Sponsor|1|||
42250563|NCT02722304|76076058|FG001|Overall Study|Study Terminated by Sponsor|0|||
42250564|NCT02722304|76076059|FG002|Overall Study|Study Terminated by Sponsor|2|||
42250565|NCT02722304|76076060|FG003|Overall Study|Study Terminated by Sponsor|1|||
42250566|NCT02722304|76076061|FG004|Overall Study|Study Terminated by Sponsor|1|||
42250567|NCT02722304|76076057|FG000|Overall Study|Other|0|||
42250568|NCT02722304|76076058|FG001|Overall Study|Other|0|||
42250569|NCT02722304|76076059|FG002|Overall Study|Other|0|||
42250570|NCT02722304|76076060|FG003|Overall Study|Other|1|||
42250571|NCT02722304|76076061|FG004|Overall Study|Other|1|||
42250572|NCT00709956|76076077|FG000|Overall Study|Withdrawal by Subject|1|||
42250573|NCT00709956|76076078|FG001|Overall Study|Withdrawal by Subject|1|||
42250574|NCT00709956|76076077|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
42250575|NCT00709956|76076078|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
42250576|NCT02719028|76076108|FG000|Overall Study|Adverse Event|2|||
42250577|NCT02719028|76076109|FG001|Overall Study|Adverse Event|1|||
42250578|NCT02719028|76076110|FG002|Overall Study|Adverse Event|4|||
42250579|NCT02719028|76076111|FG003|Overall Study|Adverse Event|8|||
42250580|NCT02719028|76076108|FG000|Overall Study|Physician Decision|0|||
42250581|NCT02719028|76076109|FG001|Overall Study|Physician Decision|1|||
42250582|NCT02719028|76076110|FG002|Overall Study|Physician Decision|1|||
42250583|NCT02719028|76076111|FG003|Overall Study|Physician Decision|1|||
42250584|NCT02719028|76076108|FG000|Overall Study|Use of prohibited medication|0|||
42250585|NCT02719028|76076109|FG001|Overall Study|Use of prohibited medication|0|||
42250586|NCT02719028|76076110|FG002|Overall Study|Use of prohibited medication|1|||
42250587|NCT02719028|76076111|FG003|Overall Study|Use of prohibited medication|0|||
42250588|NCT02719028|76076108|FG000|Overall Study|Protocol Violation|0|||
42132685|NCT00317356|75943481|FG003|Overall Study|Lack of Efficacy|3|||
42132686|NCT00317356|75943478|FG000|Overall Study|Physician Decision|0|||
42250589|NCT02719028|76076109|FG001|Overall Study|Protocol Violation|0|||
42250590|NCT02719028|76076110|FG002|Overall Study|Protocol Violation|0|||
42250591|NCT02719028|76076111|FG003|Overall Study|Protocol Violation|1|||
42250592|NCT02720510|76076123|FG000|Overall Study|Study Terminated by the sponsor|2|||
41990311|NCT01235689|75798251|FG000|Overall Study|Withdrawal by Subject|3|||
41990312|NCT01235689|75798252|FG001|Overall Study|Withdrawal by Subject|4|||
42250593|NCT02720510|76076124|FG001|Overall Study|Study Terminated by the sponsor|0|||
42250594|NCT02720510|76076123|FG000|Overall Study|Adverse Event|0|||
42250595|NCT02720510|76076124|FG001|Overall Study|Adverse Event|1|||
42250596|NCT02720510|76076123|FG000|Overall Study|Physician Decision|1|||
42132687|NCT00317356|75943479|FG001|Overall Study|Physician Decision|1|||
42132688|NCT00317356|75943480|FG002|Overall Study|Physician Decision|0|||
42250597|NCT02720510|76076124|FG001|Overall Study|Physician Decision|2|||
42250598|NCT02720198|76076132|FG000|Overall Study|Withdrawal by Subject|0|||
42250599|NCT02720198|76076133|FG001|Overall Study|Withdrawal by Subject|1|||
42250600|NCT00703118|76076155|FG000|Overall Study|Adverse Event|1|||
42250601|NCT00703118|76076156|FG001|Overall Study|Adverse Event|2|||
42250602|NCT00703118|76076157|FG002|Overall Study|Adverse Event|2|||
42250603|NCT00703118|76076155|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
42250604|NCT00703118|76076156|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
42250605|NCT00703118|76076157|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
42250606|NCT00703118|76076155|FG000|Overall Study|Lost to Follow-up|6|||
42250607|NCT00703118|76076156|FG001|Overall Study|Lost to Follow-up|4|||
42250608|NCT00703118|76076157|FG002|Overall Study|Lost to Follow-up|4|||
42250609|NCT00703118|76076155|FG000|Overall Study|Withdrawal by Subject|8|||
42250610|NCT00703118|76076156|FG001|Overall Study|Withdrawal by Subject|7|||
42250611|NCT00703118|76076157|FG002|Overall Study|Withdrawal by Subject|13|||
42250612|NCT00703118|76076155|FG000|Overall Study|Other|0|||
42250613|NCT00703118|76076156|FG001|Overall Study|Other|0|||
42250614|NCT00703118|76076157|FG002|Overall Study|Other|1|||
42250615|NCT00909753|76076179|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
42250616|NCT00909753|76076180|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
42250617|NCT00909753|76076179|FG000|Period: Second Intervention|Protocol Violation|1|||
42250618|NCT00909753|76076180|FG001|Period: Second Intervention|Protocol Violation|0|||
42250619|NCT03715764|76076186|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
42250620|NCT03715764|76076187|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
42250621|NCT03715764|76076186|FG000|3 Month Follow-up|Lost to Follow-up|2|||
42250622|NCT03715764|76076187|FG001|3 Month Follow-up|Lost to Follow-up|2|||
42250623|NCT03715764|76076186|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
42132689|NCT00317356|75943481|FG003|Overall Study|Physician Decision|0|||
42132690|NCT00331006|75943491|FG000|Screening Phase|Withdrawal by Subject|1|||
42132691|NCT00331006|75943491|FG000|Screening Phase|enrollment halted|1|||
42132692|NCT00331006|75943491|FG000|Screening Phase|Lost to Follow-up|1|||
42132693|NCT00331006|75943491|FG000|Screening Phase|Ineligible for treatment phase|4|||
42250624|NCT03715764|76076187|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
42250625|NCT03715764|76076186|FG000|6 Month Follow-up|Lost to Follow-up|3|||
42250626|NCT03715764|76076187|FG001|6 Month Follow-up|Lost to Follow-up|0|||
42250627|NCT03715764|76076186|FG000|12 Month Follow-up|Lost to Follow-up|2|||
42250628|NCT03715764|76076187|FG001|12 Month Follow-up|Lost to Follow-up|3|||
42250629|NCT03715764|76076186|FG000|12 Month Follow-up|Pregnancy|0|||
42250630|NCT03715764|76076187|FG001|12 Month Follow-up|Pregnancy|1|||
42250631|NCT03715764|76076186|FG000|12 Month Follow-up|Surgery|2|||
42250632|NCT03715764|76076187|FG001|12 Month Follow-up|Surgery|0|||
42250633|NCT03715764|76076186|FG000|12 Month Follow-up|Wrong address|1|||
42250634|NCT03715764|76076187|FG001|12 Month Follow-up|Wrong address|0|||
42250635|NCT03715764|76076186|FG000|12 Month Follow-up|No symptoms|1|||
42250636|NCT03715764|76076187|FG001|12 Month Follow-up|No symptoms|0|||
42250637|NCT03715764|76076186|FG000|12 Month Follow-up|Changed primary care centre|0|||
42250638|NCT03715764|76076187|FG001|12 Month Follow-up|Changed primary care centre|1|||
42303341|NCT02409667|76138607|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
42303342|NCT02409667|76138603|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
42303343|NCT02409667|76138604|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
42303344|NCT02409667|76138605|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
42303345|NCT02409667|76138606|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
42303346|NCT02409667|76138607|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
42303347|NCT02409667|76138603|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
42303348|NCT02409667|76138604|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
42303349|NCT02409667|76138605|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
42303350|NCT02409667|76138606|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
42303351|NCT02409667|76138607|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
42132694|NCT00331006|75943491|FG000|Treatment Phase|Withdrawal by Subject|1|||
42132695|NCT00331006|75943491|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
42132696|NCT00331006|75943491|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
42132697|NCT00302458|75943495|FG000|Overall Study|Lost to Follow-up|1|||
42132698|NCT00302458|75943495|FG000|Overall Study|Ineligible after screening|1|||
42132699|NCT00302458|75943495|FG000|Overall Study|Withdrawal by Subject|1|||
42250639|NCT02718326|76076196|FG000|Overall Study|Adverse Event|4|||
42250640|NCT02718326|76076197|FG001|Overall Study|Adverse Event|9|||
42250641|NCT02718326|76076198|FG002|Overall Study|Adverse Event|0|||
42250642|NCT02718326|76076196|FG000|Overall Study|Death|8|||
42250643|NCT02718326|76076197|FG001|Overall Study|Death|1|||
42132700|NCT00391053|75943507|FG000|Overall Study|Serious Adverse Events|1|||
42250644|NCT02718326|76076198|FG002|Overall Study|Death|2|||
42250645|NCT02718326|76076196|FG000|Overall Study|Withdrawal by Subject|4|||
42250646|NCT02718326|76076197|FG001|Overall Study|Withdrawal by Subject|9|||
42250647|NCT02718326|76076198|FG002|Overall Study|Withdrawal by Subject|6|||
42303352|NCT01641939|76138621|FG000|Overall Study|Death|90|||
42303353|NCT01641939|76138622|FG001|Overall Study|Death|187|||
42303354|NCT01641939|76138623|FG002|Overall Study|Death|61|||
42303355|NCT01641939|76138621|FG000|Overall Study|Lost to Follow-up|3|||
42303356|NCT01641939|76138622|FG001|Overall Study|Lost to Follow-up|2|||
42303357|NCT01641939|76138623|FG002|Overall Study|Lost to Follow-up|1|||
42303358|NCT01641939|76138621|FG000|Overall Study|Withdrawal by Subject|14|||
42303359|NCT01641939|76138622|FG001|Overall Study|Withdrawal by Subject|11|||
42303360|NCT01641939|76138623|FG002|Overall Study|Withdrawal by Subject|5|||
42303361|NCT01641939|76138621|FG000|Overall Study|Study Terminated by Sponsor|10|||
42303362|NCT01641939|76138622|FG001|Overall Study|Study Terminated by Sponsor|28|||
42303363|NCT01641939|76138623|FG002|Overall Study|Study Terminated by Sponsor|3|||
42303364|NCT01641861|76138635|FG000|Overall Study|Lost to Follow-up|21|||
42303365|NCT01641861|76138636|FG001|Overall Study|Lost to Follow-up|16|||
42303366|NCT01641861|76138635|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
42303367|NCT01641861|76138636|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
42303368|NCT01641861|76138635|FG000|Overall Study|Died due to drowning|0|||
42303369|NCT01641861|76138636|FG001|Overall Study|Died due to drowning|1|||
42303370|NCT02409355|76138644|FG000|Overall Study|Withdrawal by Subject|1|||
42303371|NCT02409355|76138645|FG001|Overall Study|Withdrawal by Subject|0|||
42303372|NCT02409355|76138644|FG000|Overall Study|Death|1|||
42303373|NCT02409355|76138645|FG001|Overall Study|Death|1|||
42303374|NCT02409355|76138644|FG000|Overall Study|Study terminated by Sponsor|2|||
42303375|NCT02409355|76138645|FG001|Overall Study|Study terminated by Sponsor|3|||
42303376|NCT02408887|76138653|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
42303377|NCT02408887|76138654|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
42303378|NCT02408887|76138653|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
42303379|NCT02408887|76138654|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
42303380|NCT02266875|76138662|FG000|Overall Study|Withdrawal by Subject|9|||
42303381|NCT02266875|76138663|FG001|Overall Study|Withdrawal by Subject|0|||
42303382|NCT02266875|76138662|FG000|Overall Study|Lost to Follow-up|2|||
42303383|NCT02266875|76138663|FG001|Overall Study|Lost to Follow-up|0|||
42303384|NCT02438371|76138671|FG000|Overall Study|Lost to Follow-up|3|||
42303385|NCT02438371|76138672|FG001|Overall Study|Lost to Follow-up|2|||
42303386|NCT02438371|76138671|FG000|Overall Study|Withdrawal by Subject|1|||
42303387|NCT02438371|76138672|FG001|Overall Study|Withdrawal by Subject|1|||
42303388|NCT02438137|76138680|FG000|Overall Study|Lost to Follow-up|3|||
42303389|NCT02438137|76138681|FG001|Overall Study|Lost to Follow-up|2|||
42303390|NCT02438137|76138680|FG000|Overall Study|Adverse Event|1|||
42303391|NCT02438137|76138681|FG001|Overall Study|Adverse Event|0|||
42303392|NCT02438137|76138680|FG000|Overall Study|Withdrawal by Subject|4|||
42303393|NCT02438137|76138681|FG001|Overall Study|Withdrawal by Subject|3|||
42303394|NCT02438137|76138680|FG000|Overall Study|Physician Decision|0|||
42303395|NCT02438137|76138681|FG001|Overall Study|Physician Decision|1|||
42303396|NCT02437903|76138689|FG000|Overall Study|Adverse Event|1|||
42303397|NCT02437903|76138689|FG000|Overall Study|Withdrawal by Subject|1|||
42303398|NCT02437903|76138689|FG000|Overall Study|Lost to Follow-up|3|||
42250648|NCT02718326|76076196|FG000|Overall Study|Lost to Follow-up|18|||
42250649|NCT02718326|76076197|FG001|Overall Study|Lost to Follow-up|5|||
42250650|NCT02718326|76076198|FG002|Overall Study|Lost to Follow-up|14|||
42250651|NCT02718326|76076196|FG000|Overall Study|Protocol Deviation|1|||
42250652|NCT02718326|76076197|FG001|Overall Study|Protocol Deviation|0|||
42250653|NCT02718326|76076198|FG002|Overall Study|Protocol Deviation|0|||
42250654|NCT02718326|76076196|FG000|Overall Study|Pregnancy|1|||
42250655|NCT02718326|76076197|FG001|Overall Study|Pregnancy|0|||
42250656|NCT02718326|76076198|FG002|Overall Study|Pregnancy|0|||
42250657|NCT03600714|76076208|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
42250658|NCT02720042|76076247|FG000|Overall Study|Death|3|||
42250659|NCT02720042|76076247|FG000|Overall Study|Lost to Follow-up|4|||
42250660|NCT02720042|76076247|FG000|Overall Study|Withdrawal by Subject|1|||
42250661|NCT02720042|76076247|FG000|Overall Study|Physician Decision|3|||
42250662|NCT02720042|76076247|FG000|Overall Study|Phasix Mesh explanted|1|||
42250663|NCT02720042|76076247|FG000|Overall Study|unable due to non-study-related illness|3|||
42250664|NCT01352793|76076253|FG000|Overall Study|Lost to Follow-up|289|||
42250665|NCT01352793|76076254|FG001|Overall Study|Lost to Follow-up|125|||
42303399|NCT02437513|76138694|FG000|Overall Study|Withdrawal by Subject|2|||
42303400|NCT02460991|76138700|FG000|Overall Study|Withdrawal by Subject|0|||
42303401|NCT02460991|76138701|FG001|Overall Study|Withdrawal by Subject|2|||
42303402|NCT02407249|76138712|FG000|Overall Study|Did not complete 12-month follow-up|13|||
42250666|NCT01352793|76076253|FG000|Overall Study|Withdrawal by Subject|120|||
42250667|NCT01352793|76076254|FG001|Overall Study|Withdrawal by Subject|55|||
42303403|NCT02407249|76138712|FG000|Overall Study|Not treated|13|||
42303404|NCT02460679|76138716|FG000|Overall Study|Investigator Decision|1|||
42303405|NCT02460679|76138716|FG000|Overall Study|Withdrawal by Subject|4|||
42250668|NCT01352793|76076253|FG000|Overall Study|Protocol Violation|44|||
42250669|NCT01352793|76076254|FG001|Overall Study|Protocol Violation|23|||
42250670|NCT01352793|76076253|FG000|Overall Study|Adverse Event|44|||
42250671|NCT01352793|76076254|FG001|Overall Study|Adverse Event|10|||
42303406|NCT02459899|76138724|FG000|Overall Study|Adverse Event|1|||
42303407|NCT02459899|76138725|FG001|Overall Study|Adverse Event|1|||
42303408|NCT02459899|76138726|FG002|Overall Study|Adverse Event|0|||
42303409|NCT02459899|76138727|FG003|Overall Study|Adverse Event|0|||
42303410|NCT02459899|76138724|FG000|Overall Study|Lost to Follow-up|1|||
42303411|NCT02459899|76138725|FG001|Overall Study|Lost to Follow-up|2|||
42303412|NCT02459899|76138726|FG002|Overall Study|Lost to Follow-up|0|||
42303413|NCT02459899|76138727|FG003|Overall Study|Lost to Follow-up|1|||
42303414|NCT02459899|76138724|FG000|Overall Study|Non-compliance with the treatment|0|||
42303415|NCT02459899|76138725|FG001|Overall Study|Non-compliance with the treatment|0|||
42303416|NCT02459899|76138726|FG002|Overall Study|Non-compliance with the treatment|0|||
42303417|NCT02459899|76138727|FG003|Overall Study|Non-compliance with the treatment|1|||
42303418|NCT02459899|76138724|FG000|Overall Study|Withdrawal by Subject|1|||
42303419|NCT02459899|76138725|FG001|Overall Study|Withdrawal by Subject|3|||
42303420|NCT02459899|76138726|FG002|Overall Study|Withdrawal by Subject|0|||
42303421|NCT02459899|76138727|FG003|Overall Study|Withdrawal by Subject|0|||
42303422|NCT02436889|76138739|FG000|Overall Study|No improvement in symptoms|1|||
42303423|NCT02436889|76138740|FG001|Overall Study|No improvement in symptoms|0|||
42303424|NCT02436889|76138739|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
42303425|NCT02436889|76138740|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
42303426|NCT02436811|76138749|FG000|Overall Study|Lost to Follow-up|2|||
42303427|NCT02436811|76138750|FG001|Overall Study|Lost to Follow-up|9|||
42303428|NCT02436811|76138751|FG002|Overall Study|Lost to Follow-up|7|||
42303429|NCT02436577|76138765|FG000|Overall Study|Protocol Deviation|0|||
42303430|NCT02436577|76138766|FG001|Overall Study|Protocol Deviation|1|||
42303431|NCT02436577|76138767|FG002|Overall Study|Protocol Deviation|0|||
42303432|NCT02436577|76138768|FG003|Overall Study|Protocol Deviation|0|||
42303433|NCT02436577|76138769|FG004|Overall Study|Protocol Deviation|0|||
42303434|NCT02436577|76138770|FG005|Overall Study|Protocol Deviation|0|||
42303435|NCT02265705|76138780|FG000|Treatment Period Week 0-24|Adverse Event|3|||
42303436|NCT02265705|76138781|FG001|Treatment Period Week 0-24|Adverse Event|2|||
42303437|NCT02265705|76138782|FG002|Treatment Period Week 0-24|Adverse Event|0|||
42303438|NCT02265705|76138783|FG003|Treatment Period Week 0-24|Adverse Event|0|||
41990313|NCT01235689|75798251|FG000|Overall Study|Lost to Follow-up|1|||
41990314|NCT01235689|75798252|FG001|Overall Study|Lost to Follow-up|2|||
41990315|NCT01235689|75798251|FG000|Overall Study|Miscellaneous|1|||
41990316|NCT01235689|75798252|FG001|Overall Study|Miscellaneous|5|||
42250672|NCT01352793|76076253|FG000|Overall Study|Physician Decision|1|||
41990317|NCT01229176|75798266|FG000|Overall Study|Withdrawal by Subject|0|||
41990318|NCT01229176|75798267|FG001|Overall Study|Withdrawal by Subject|0|||
41990319|NCT01229176|75798268|FG002|Overall Study|Withdrawal by Subject|0|||
41990320|NCT01229176|75798269|FG003|Overall Study|Withdrawal by Subject|1|||
41990321|NCT01229176|75798270|FG004|Overall Study|Withdrawal by Subject|1|||
41990322|NCT01229176|75798271|FG005|Overall Study|Withdrawal by Subject|1|||
41990323|NCT01229176|75798272|FG006|Overall Study|Withdrawal by Subject|0|||
41990324|NCT01229176|75798273|FG007|Overall Study|Withdrawal by Subject|1|||
41990325|NCT01229176|75798266|FG000|Overall Study|Lost to Follow-up|0|||
41990326|NCT01229176|75798267|FG001|Overall Study|Lost to Follow-up|3|||
41990327|NCT01229176|75798268|FG002|Overall Study|Lost to Follow-up|0|||
41990328|NCT01229176|75798269|FG003|Overall Study|Lost to Follow-up|0|||
41990329|NCT01229176|75798270|FG004|Overall Study|Lost to Follow-up|1|||
41990330|NCT01229176|75798271|FG005|Overall Study|Lost to Follow-up|1|||
41990331|NCT01229176|75798272|FG006|Overall Study|Lost to Follow-up|0|||
41990332|NCT01229176|75798273|FG007|Overall Study|Lost to Follow-up|2|||
41990333|NCT01228747|75798293|FG000|Overall Study|Adverse Event|8|||
41990334|NCT01228747|75798294|FG001|Overall Study|Adverse Event|4|||
41990335|NCT01228747|75798293|FG000|Overall Study|Lack of Efficacy|40|||
41990336|NCT01228747|75798294|FG001|Overall Study|Lack of Efficacy|27|||
41990337|NCT01228747|75798293|FG000|Overall Study|Protocol Violation|6|||
41990338|NCT01228747|75798294|FG001|Overall Study|Protocol Violation|5|||
42250673|NCT01352793|76076254|FG001|Overall Study|Physician Decision|0|||
42250674|NCT01352793|76076253|FG000|Overall Study|Pregnancy|26|||
42250675|NCT01352793|76076254|FG001|Overall Study|Pregnancy|8|||
42250676|NCT01352793|76076253|FG000|Overall Study|Other|25|||
42250677|NCT01352793|76076254|FG001|Overall Study|Other|7|||
42250678|NCT01352793|76076253|FG000|Overall Study|Medication error|2|||
42250679|NCT01352793|76076254|FG001|Overall Study|Medication error|2|||
42303439|NCT02265705|76138784|FG004|Treatment Period Week 0-24|Adverse Event|0|||
41990339|NCT01228747|75798293|FG000|Overall Study|Lost to Follow-up|4|||
41990340|NCT01228747|75798294|FG001|Overall Study|Lost to Follow-up|3|||
41990341|NCT01228747|75798293|FG000|Overall Study|Withdrawal by Subject|5|||
41990342|NCT01228747|75798294|FG001|Overall Study|Withdrawal by Subject|1|||
41990343|NCT01228747|75798293|FG000|Overall Study|Other Reason|2|||
42032966|NCT00943917|75841125|FG003|Stage II Continuation|A1C elevation|0|||
42250680|NCT01352793|76076253|FG000|Overall Study|Death|1|||
42250681|NCT01352793|76076254|FG001|Overall Study|Death|0|||
42303440|NCT02265705|76138785|FG005|Treatment Period Week 0-24|Adverse Event|0|||
42303441|NCT02265705|76138786|FG006|Treatment Period Week 0-24|Adverse Event|0|||
41990344|NCT01228747|75798294|FG001|Overall Study|Other Reason|5|||
41990345|NCT01228591|75798300|FG000|Baseline|Lack of Efficacy|1|||
41990346|NCT01228591|75798301|FG001|Baseline|Lack of Efficacy|2|||
41990347|NCT01235338|75798313|FG000|Overall Study|Adverse Event|3|||
41990348|NCT01235338|75798314|FG001|Overall Study|Adverse Event|2|||
42303442|NCT02265705|76138780|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
42303443|NCT02265705|76138781|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
42303444|NCT02265705|76138782|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
42303445|NCT02265705|76138783|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
42303446|NCT02265705|76138784|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
42303447|NCT02265705|76138785|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
42303448|NCT02265705|76138786|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
42303449|NCT02265705|76138780|FG000|Treatment Period Week 0-24|Physician Decision|1|||
42303450|NCT02265705|76138781|FG001|Treatment Period Week 0-24|Physician Decision|0|||
42303451|NCT02265705|76138782|FG002|Treatment Period Week 0-24|Physician Decision|0|||
42303452|NCT02265705|76138783|FG003|Treatment Period Week 0-24|Physician Decision|0|||
42303453|NCT02265705|76138784|FG004|Treatment Period Week 0-24|Physician Decision|0|||
42303454|NCT02265705|76138785|FG005|Treatment Period Week 0-24|Physician Decision|0|||
42303455|NCT02265705|76138786|FG006|Treatment Period Week 0-24|Physician Decision|0|||
42303456|NCT02265705|76138780|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
42303457|NCT02265705|76138781|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
42303458|NCT02265705|76138782|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
42303459|NCT02265705|76138783|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
42303460|NCT02265705|76138784|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
42303461|NCT02265705|76138785|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
42303462|NCT02265705|76138786|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
42303463|NCT02265705|76138780|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
42303464|NCT02265705|76138781|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
42303465|NCT02265705|76138782|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
42303466|NCT02265705|76138783|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
42303467|NCT02265705|76138784|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
42303468|NCT02265705|76138785|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
42303469|NCT02265705|76138786|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
42303470|NCT02265705|76138780|FG000|Rescue Period|Withdrawal by Subject|0|||
42303471|NCT02265705|76138781|FG001|Rescue Period|Withdrawal by Subject|0|||
42303472|NCT02265705|76138782|FG002|Rescue Period|Withdrawal by Subject|1|||
42303473|NCT02265705|76138783|FG003|Rescue Period|Withdrawal by Subject|0|||
42303474|NCT02265705|76138784|FG004|Rescue Period|Withdrawal by Subject|0|||
42303475|NCT02265705|76138785|FG005|Rescue Period|Withdrawal by Subject|0|||
42303476|NCT02265705|76138786|FG006|Rescue Period|Withdrawal by Subject|0|||
42303477|NCT02265705|76138780|FG000|Rescue Period|Death|0|||
42303478|NCT02265705|76138781|FG001|Rescue Period|Death|0|||
42303479|NCT02265705|76138782|FG002|Rescue Period|Death|1|||
42303480|NCT02265705|76138783|FG003|Rescue Period|Death|0|||
42303481|NCT02265705|76138784|FG004|Rescue Period|Death|0|||
42303482|NCT02265705|76138785|FG005|Rescue Period|Death|0|||
42303483|NCT02265705|76138786|FG006|Rescue Period|Death|0|||
42303484|NCT02265705|76138780|FG000|Rescue Period|Lack of Efficacy|0|||
42303485|NCT02265705|76138781|FG001|Rescue Period|Lack of Efficacy|0|||
42303486|NCT02265705|76138782|FG002|Rescue Period|Lack of Efficacy|1|||
42303487|NCT02265705|76138783|FG003|Rescue Period|Lack of Efficacy|0|||
42303488|NCT02265705|76138784|FG004|Rescue Period|Lack of Efficacy|0|||
42303489|NCT02265705|76138785|FG005|Rescue Period|Lack of Efficacy|0|||
42303490|NCT02265705|76138786|FG006|Rescue Period|Lack of Efficacy|0|||
42303491|NCT02265705|76138780|FG000|Open Label Period|Adverse Event|0|||
42303492|NCT02265705|76138781|FG001|Open Label Period|Adverse Event|0|||
42303493|NCT02265705|76138782|FG002|Open Label Period|Adverse Event|0|||
42303494|NCT02265705|76138783|FG003|Open Label Period|Adverse Event|2|||
42303495|NCT02265705|76138784|FG004|Open Label Period|Adverse Event|2|||
42303496|NCT02265705|76138785|FG005|Open Label Period|Adverse Event|0|||
42303497|NCT02265705|76138786|FG006|Open Label Period|Adverse Event|0|||
42303498|NCT02265705|76138780|FG000|Open Label Period|Physician Decision|0|||
42303499|NCT02265705|76138781|FG001|Open Label Period|Physician Decision|0|||
42303500|NCT02265705|76138782|FG002|Open Label Period|Physician Decision|0|||
42303501|NCT02265705|76138783|FG003|Open Label Period|Physician Decision|0|||
42303502|NCT02265705|76138784|FG004|Open Label Period|Physician Decision|1|||
42303503|NCT02265705|76138785|FG005|Open Label Period|Physician Decision|0|||
42303504|NCT02265705|76138786|FG006|Open Label Period|Physician Decision|0|||
42303505|NCT02265705|76138780|FG000|Open Label Period|Withdrawal by Subject|0|||
42303506|NCT02265705|76138781|FG001|Open Label Period|Withdrawal by Subject|0|||
42303507|NCT02265705|76138782|FG002|Open Label Period|Withdrawal by Subject|0|||
42303508|NCT02265705|76138783|FG003|Open Label Period|Withdrawal by Subject|0|||
42303509|NCT02265705|76138784|FG004|Open Label Period|Withdrawal by Subject|2|||
42303510|NCT02265705|76138785|FG005|Open Label Period|Withdrawal by Subject|0|||
42303511|NCT02265705|76138786|FG006|Open Label Period|Withdrawal by Subject|0|||
41990349|NCT01235338|75798313|FG000|Overall Study|Protocol Violation|1|||
42303512|NCT02265705|76138780|FG000|Follow-up Period|Sponsor Decision|0|||
42303513|NCT02265705|76138781|FG001|Follow-up Period|Sponsor Decision|0|||
42303514|NCT02265705|76138782|FG002|Follow-up Period|Sponsor Decision|0|||
42303515|NCT02265705|76138783|FG003|Follow-up Period|Sponsor Decision|0|||
42303516|NCT02265705|76138784|FG004|Follow-up Period|Sponsor Decision|0|||
42303517|NCT02265705|76138785|FG005|Follow-up Period|Sponsor Decision|1|||
42303518|NCT02265705|76138786|FG006|Follow-up Period|Sponsor Decision|6|||
42303519|NCT02265705|76138780|FG000|Follow-up Period|Adverse Event|0|||
42303520|NCT02265705|76138781|FG001|Follow-up Period|Adverse Event|0|||
42303521|NCT02265705|76138782|FG002|Follow-up Period|Adverse Event|0|||
42303522|NCT02265705|76138783|FG003|Follow-up Period|Adverse Event|0|||
42303523|NCT02265705|76138784|FG004|Follow-up Period|Adverse Event|0|||
42303524|NCT02265705|76138785|FG005|Follow-up Period|Adverse Event|0|||
42303525|NCT02265705|76138786|FG006|Follow-up Period|Adverse Event|3|||
42303526|NCT02265705|76138780|FG000|Follow-up Period|Physician Decision|0|||
42303527|NCT02265705|76138781|FG001|Follow-up Period|Physician Decision|0|||
42303528|NCT02265705|76138782|FG002|Follow-up Period|Physician Decision|0|||
42303529|NCT02265705|76138783|FG003|Follow-up Period|Physician Decision|0|||
42303530|NCT02265705|76138784|FG004|Follow-up Period|Physician Decision|0|||
42303531|NCT02265705|76138785|FG005|Follow-up Period|Physician Decision|0|||
42303532|NCT02265705|76138786|FG006|Follow-up Period|Physician Decision|1|||
42303533|NCT02265705|76138780|FG000|Follow-up Period|Withdrawal by Subject|0|||
42303534|NCT02265705|76138781|FG001|Follow-up Period|Withdrawal by Subject|0|||
42303535|NCT02265705|76138782|FG002|Follow-up Period|Withdrawal by Subject|0|||
42303536|NCT02265705|76138783|FG003|Follow-up Period|Withdrawal by Subject|0|||
42303537|NCT02265705|76138784|FG004|Follow-up Period|Withdrawal by Subject|0|||
42303538|NCT02265705|76138785|FG005|Follow-up Period|Withdrawal by Subject|0|||
42303539|NCT02265705|76138786|FG006|Follow-up Period|Withdrawal by Subject|1|||
42303540|NCT02459665|76138801|FG000|Overall Study|Withdrawal by Subject|0|||
42303541|NCT02459665|76138802|FG001|Overall Study|Withdrawal by Subject|1|||
42303542|NCT02459665|76138803|FG002|Overall Study|Withdrawal by Subject|1|||
42303543|NCT02459665|76138804|FG003|Overall Study|Withdrawal by Subject|2|||
42303544|NCT02265237|76138825|FG000|As Treated (Overall Study)|Adverse Event|1|||
42303545|NCT02265237|76138826|FG001|As Treated (Overall Study)|Adverse Event|1|||
42303546|NCT02265237|76138827|FG002|As Treated (Overall Study)|Adverse Event|0|||
42303547|NCT02265237|76138828|FG003|As Treated (Overall Study)|Adverse Event|0|||
42303548|NCT02265237|76138825|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
42303549|NCT02265237|76138826|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
42303550|NCT02265237|76138827|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
42303551|NCT02265237|76138828|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
42303552|NCT02265237|76138825|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
41990350|NCT01235338|75798314|FG001|Overall Study|Protocol Violation|1|||
41990351|NCT01235338|75798313|FG000|Overall Study|Withdrawal by Subject|5|||
41990352|NCT01235338|75798314|FG001|Overall Study|Withdrawal by Subject|0|||
41990353|NCT01235338|75798313|FG000|Overall Study|Exclusion criteria violations|1|||
41990354|NCT01235338|75798314|FG001|Overall Study|Exclusion criteria violations|1|||
41990355|NCT01235338|75798313|FG000|Overall Study|Positive drug screen|0|||
41990356|NCT01235338|75798314|FG001|Overall Study|Positive drug screen|1|||
41990357|NCT01235338|75798313|FG000|Overall Study|Prohibited meds|1|||
41990358|NCT01235338|75798314|FG001|Overall Study|Prohibited meds|0|||
42032967|NCT00943917|75841126|FG004|Stage II Continuation|A1C elevation|0|||
42132701|NCT00391053|75943508|FG001|Overall Study|Serious Adverse Events|0|||
42250682|NCT01352793|76076253|FG000|Overall Study|Randomized but not vaccinated|8|||
42250683|NCT01352793|76076254|FG001|Overall Study|Randomized but not vaccinated|0|||
42250684|NCT01352793|76076253|FG000|Overall Study|No longer meets eligibility criteria|25|||
42250685|NCT01352793|76076254|FG001|Overall Study|No longer meets eligibility criteria|15|||
42250686|NCT02717546|76076260|FG000|Overall Study|Lost to Follow-up|12|||
42250687|NCT01378962|76076264|FG000|Overall Study|Death|14|||
42250688|NCT01378962|76076264|FG000|Overall Study|Lost to Follow-up|1|||
42250689|NCT01378962|76076264|FG000|Overall Study|Other|2|||
42250690|NCT00890409|76076270|FG000|Overall Study|Lost to Follow-up|20|||
42250691|NCT00890409|76076271|FG001|Overall Study|Lost to Follow-up|21|||
42250692|NCT04495478|76076282|FG000|Overall Study|Withdrawal by Subject|0|||
42250693|NCT04495478|76076283|FG001|Overall Study|Withdrawal by Subject|0|||
42250694|NCT04495478|76076284|FG002|Overall Study|Withdrawal by Subject|0|||
42132702|NCT00391053|75943509|FG002|Overall Study|Serious Adverse Events|1|||
42250695|NCT04495478|76076285|FG003|Overall Study|Withdrawal by Subject|1|||
42303553|NCT02265237|76138826|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
42303554|NCT02265237|76138827|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
42303555|NCT02265237|76138828|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
42303556|NCT02265237|76138825|FG000|As Treated (Overall Study)|Other|2|||
42303557|NCT02265237|76138826|FG001|As Treated (Overall Study)|Other|0|||
42303558|NCT02265237|76138827|FG002|As Treated (Overall Study)|Other|3|||
42303559|NCT02265237|76138828|FG003|As Treated (Overall Study)|Other|1|||
42303560|NCT02263365|76138841|FG000|Overall Study|Physician Decision|22|||
42303561|NCT02263365|76138842|FG001|Overall Study|Physician Decision|18|||
42303562|NCT02261493|76138852|FG000|Overall Study|Noncompliance|0|||
42303563|NCT02261493|76138853|FG001|Overall Study|Noncompliance|0|||
42303564|NCT02261493|76138854|FG002|Overall Study|Noncompliance|2|||
42303565|NCT02261493|76138852|FG000|Overall Study|Physician Decision|0|||
42303566|NCT02261493|76138853|FG001|Overall Study|Physician Decision|1|||
42303567|NCT02261493|76138854|FG002|Overall Study|Physician Decision|0|||
42303568|NCT02261493|76138852|FG000|Overall Study|Undisclosed alcohol abuse|0|||
42303569|NCT02261493|76138853|FG001|Overall Study|Undisclosed alcohol abuse|1|||
42303570|NCT02261493|76138854|FG002|Overall Study|Undisclosed alcohol abuse|0|||
42303571|NCT02261493|76138852|FG000|Overall Study|Protocol Violation|1|||
42303572|NCT02261493|76138853|FG001|Overall Study|Protocol Violation|0|||
42303573|NCT02261493|76138854|FG002|Overall Study|Protocol Violation|0|||
42303574|NCT02261493|76138852|FG000|Overall Study|Personal Reasons|14|||
42303575|NCT02261493|76138853|FG001|Overall Study|Personal Reasons|14|||
42303576|NCT02261493|76138854|FG002|Overall Study|Personal Reasons|16|||
42303577|NCT02261493|76138852|FG000|Overall Study|Lost to Follow-up|14|||
42250696|NCT04495478|76076286|FG004|Overall Study|Withdrawal by Subject|0|||
42250697|NCT04495478|76076287|FG005|Overall Study|Withdrawal by Subject|0|||
42250698|NCT04495478|76076288|FG006|Overall Study|Withdrawal by Subject|0|||
42250699|NCT04495478|76076282|FG000|Overall Study|Physician Decision|0|||
42250700|NCT04495478|76076283|FG001|Overall Study|Physician Decision|1|||
42250701|NCT04495478|76076284|FG002|Overall Study|Physician Decision|0|||
42250702|NCT04495478|76076285|FG003|Overall Study|Physician Decision|0|||
42303578|NCT02261493|76138853|FG001|Overall Study|Lost to Follow-up|27|||
42303579|NCT02261493|76138854|FG002|Overall Study|Lost to Follow-up|8|||
42303580|NCT02261493|76138852|FG000|Overall Study|Pregnancy|1|||
41990359|NCT01234675|75798322|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
41990360|NCT01234675|75798323|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
42250703|NCT04495478|76076286|FG004|Overall Study|Physician Decision|1|||
42250704|NCT04495478|76076287|FG005|Overall Study|Physician Decision|0|||
42250705|NCT04495478|76076288|FG006|Overall Study|Physician Decision|0|||
42250706|NCT00152763|76076314|FG000|Overall Study|Death|4|||
42250707|NCT00152763|76076315|FG001|Overall Study|Death|1|||
42250708|NCT00152763|76076316|FG002|Overall Study|Death|2|||
42250709|NCT00152763|76076317|FG003|Overall Study|Death|1|||
42250710|NCT00152763|76076314|FG000|Overall Study|Lost to Follow-up|6|||
42250711|NCT00152763|76076315|FG001|Overall Study|Lost to Follow-up|4|||
42250712|NCT00152763|76076316|FG002|Overall Study|Lost to Follow-up|2|||
42250713|NCT00152763|76076317|FG003|Overall Study|Lost to Follow-up|13|||
42250714|NCT03181542|76076331|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
42250715|NCT03181542|76076332|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
42250716|NCT00806403|76076340|FG000|Overall Study|Death|4|||
42250717|NCT00806403|76076341|FG001|Overall Study|Death|3|||
42250718|NCT00701558|76076358|FG000|Overall Study|Death|7|||
42250719|NCT00701558|76076358|FG000|Overall Study|Lost to Follow-up|8|||
42250720|NCT01663402|76076381|FG000|Overall Study|Randomized but not treated|19|||
42250721|NCT01663402|76076382|FG001|Overall Study|Randomized but not treated|11|||
42250722|NCT01663402|76076381|FG000|Overall Study|Adverse Event|347|||
42250723|NCT01663402|76076382|FG001|Overall Study|Adverse Event|362|||
42250724|NCT01663402|76076381|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
42250725|NCT01663402|76076382|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
42250726|NCT01663402|76076381|FG000|Overall Study|Poor compliance to protocol|529|||
42250727|NCT01663402|76076382|FG001|Overall Study|Poor compliance to protocol|454|||
42250728|NCT01663402|76076381|FG000|Overall Study|Physician Decision|77|||
42250729|NCT01663402|76076382|FG001|Overall Study|Physician Decision|62|||
42250730|NCT01663402|76076381|FG000|Overall Study|Site terminated by sponsor|1|||
42250731|NCT01663402|76076382|FG001|Overall Study|Site terminated by sponsor|3|||
42250732|NCT01663402|76076381|FG000|Overall Study|Participant moved|139|||
42250733|NCT01663402|76076382|FG001|Overall Study|Participant moved|104|||
42250734|NCT01663402|76076381|FG000|Overall Study|Withdrawal by Subject|118|||
42250735|NCT01663402|76076382|FG001|Overall Study|Withdrawal by Subject|91|||
42250736|NCT01663402|76076381|FG000|Overall Study|Related to study drug administration|96|||
42250737|NCT01663402|76076382|FG001|Overall Study|Related to study drug administration|105|||
42250738|NCT01663402|76076381|FG000|Overall Study|Lost to Follow-up|17|||
42303581|NCT02261493|76138853|FG001|Overall Study|Pregnancy|2|||
42250739|NCT01663402|76076382|FG001|Overall Study|Lost to Follow-up|15|||
42250740|NCT01663402|76076381|FG000|Overall Study|Other than specified above|172|||
42250741|NCT01663402|76076382|FG001|Overall Study|Other than specified above|147|||
42250742|NCT00859521|76076399|FG000|Washout|Withdrawal by Subject|0|||
42250743|NCT00859521|76076400|FG001|Washout|Withdrawal by Subject|1|||
42250744|NCT00841815|76076415|FG000|Washout|Withdrawal by Subject|0|||
42250745|NCT00841815|76076416|FG001|Washout|Withdrawal by Subject|1|||
42250746|NCT00841659|76076423|FG000|Washout: 2 Weeks|Protocol Violation|1|||
42303582|NCT02261493|76138854|FG002|Overall Study|Pregnancy|0|||
42303583|NCT02261493|76138852|FG000|Overall Study|Lack of Efficacy|0|||
42303584|NCT02261493|76138853|FG001|Overall Study|Lack of Efficacy|1|||
42250747|NCT00841659|76076424|FG001|Washout: 2 Weeks|Protocol Violation|0|||
42303585|NCT02261493|76138854|FG002|Overall Study|Lack of Efficacy|0|||
42303586|NCT02261493|76138852|FG000|Overall Study|Adverse Event|0|||
42303587|NCT02261493|76138853|FG001|Overall Study|Adverse Event|1|||
42303588|NCT02261493|76138854|FG002|Overall Study|Adverse Event|0|||
42303589|NCT02260791|76138864|FG000|Overall Study|Lost to Follow-up|4|||
42303590|NCT02260791|76138865|FG001|Overall Study|Lost to Follow-up|4|||
42303591|NCT02260791|76138864|FG000|Overall Study|Lack of Efficacy|2|||
42303592|NCT02260791|76138865|FG001|Overall Study|Lack of Efficacy|1|||
42303593|NCT02260791|76138864|FG000|Overall Study|Adverse Event|13|||
42303594|NCT02260791|76138865|FG001|Overall Study|Adverse Event|9|||
42303595|NCT02260791|76138864|FG000|Overall Study|Death|1|||
42303596|NCT02260791|76138865|FG001|Overall Study|Death|0|||
42303597|NCT02260791|76138864|FG000|Overall Study|Withdrawal by Subject|11|||
42303598|NCT02260791|76138865|FG001|Overall Study|Withdrawal by Subject|16|||
42250748|NCT02716298|76076428|FG000|First Intervention (1 Month)|Lens discomfort|1|||
42250749|NCT02716298|76076429|FG001|First Intervention (1 Month)|Lens discomfort|1|||
42250750|NCT00840879|76076442|FG000|Second Intervention|Withdrawal by Subject|1|||
42250751|NCT00840879|76076443|FG001|Second Intervention|Withdrawal by Subject|0|||
42250752|NCT00840411|76076458|FG000|First Intervention|Adverse Event|1|||
42250753|NCT00840411|76076459|FG001|First Intervention|Adverse Event|0|||
42250754|NCT00840411|76076458|FG000|Washout|Withdrawal by Subject|1|||
42250755|NCT00840411|76076459|FG001|Washout|Withdrawal by Subject|0|||
42250756|NCT00836901|76076472|FG000|First Intervention|Withdrawal by Subject|1|||
42250757|NCT00836901|76076473|FG001|First Intervention|Withdrawal by Subject|0|||
42250758|NCT04466384|76076477|FG000|First Phase|Protocol Violation|1|||
42250759|NCT04466384|76076478|FG001|First Phase|Protocol Violation|0|||
42132703|NCT00391053|75943510|FG003|Overall Study|Serious Adverse Events|4|||
42132704|NCT00391053|75943507|FG000|Overall Study|Protocol Violation|2|||
42132705|NCT00391053|75943508|FG001|Overall Study|Protocol Violation|0|||
42132706|NCT00391053|75943509|FG002|Overall Study|Protocol Violation|0|||
42132707|NCT00391053|75943510|FG003|Overall Study|Protocol Violation|0|||
42132708|NCT00391053|75943507|FG000|Overall Study|Lost to Follow-up|1|||
42132709|NCT00391053|75943508|FG001|Overall Study|Lost to Follow-up|0|||
42132710|NCT00391053|75943509|FG002|Overall Study|Lost to Follow-up|0|||
42132711|NCT00391053|75943510|FG003|Overall Study|Lost to Follow-up|5|||
42132712|NCT00391053|75943507|FG000|Overall Study|Withdrawal by Subject|5|||
42132713|NCT00391053|75943508|FG001|Overall Study|Withdrawal by Subject|1|||
42132714|NCT00391053|75943509|FG002|Overall Study|Withdrawal by Subject|1|||
42132715|NCT00391053|75943510|FG003|Overall Study|Withdrawal by Subject|1|||
42132716|NCT00317044|75943523|FG000|Overall Study|Protocol Violation|28|||
42132717|NCT00317044|75943524|FG001|Overall Study|Protocol Violation|22|||
42250760|NCT04466384|76076477|FG000|First Phase|Missing data|1|||
42250761|NCT04466384|76076478|FG001|First Phase|Missing data|0|||
42303599|NCT02260791|76138864|FG000|Overall Study|Screen failure|0|||
42303600|NCT02260791|76138865|FG001|Overall Study|Screen failure|1|||
42303601|NCT02260791|76138864|FG000|Overall Study|Protocol deviation|2|||
42303602|NCT02260791|76138865|FG001|Overall Study|Protocol deviation|3|||
42303603|NCT02260635|76138873|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
42303604|NCT02260635|76138874|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
42303605|NCT02260635|76138873|FG000|Open-Label Extension|Study Termination|25|||
42303606|NCT02260635|76138874|FG001|Open-Label Extension|Study Termination|25|||
42303607|NCT02260635|76138873|FG000|Open-Label Extension|Withdrawal by Subject|1|||
42303608|NCT02260635|76138874|FG001|Open-Label Extension|Withdrawal by Subject|0|||
42032968|NCT00943917|75841127|FG005|Stage II Continuation|A1C elevation|0|||
42032969|NCT00943917|75841128|FG006|Stage II Continuation|A1C elevation|0|||
42303609|NCT02259231|76138889|FG000|Overall Study|Adverse Event|1|||
42032970|NCT00943917|75841129|FG007|Stage II Continuation|A1C elevation|0|||
42250762|NCT04466384|76076477|FG000|Cross Over Phase|Physician Decision|1|||
42250763|NCT04466384|76076478|FG001|Cross Over Phase|Physician Decision|0|||
42250764|NCT04466384|76076477|FG000|Cross Over Phase|Withdrawal by Subject|0|||
42250765|NCT04466384|76076478|FG001|Cross Over Phase|Withdrawal by Subject|1|||
42250766|NCT03050814|76076489|FG000|Overall Study|Screen failures|0|||
42250767|NCT03050814|76076490|FG001|Overall Study|Screen failures|0|||
42132718|NCT00317044|75943525|FG002|Overall Study|Protocol Violation|20|||
42132719|NCT00317044|75943523|FG000|Overall Study|Adverse Event|4|||
42303610|NCT02259231|76138890|FG001|Overall Study|Adverse Event|1|||
42303611|NCT02259231|76138891|FG002|Overall Study|Adverse Event|2|||
42303612|NCT02259231|76138892|FG003|Overall Study|Adverse Event|0|||
42303613|NCT02259231|76138893|FG004|Overall Study|Adverse Event|0|||
42303614|NCT02259231|76138894|FG005|Overall Study|Adverse Event|0|||
42303615|NCT02259231|76138895|FG006|Overall Study|Adverse Event|0|||
42303616|NCT02259231|76138889|FG000|Overall Study|Progressive Disease|4|||
42303617|NCT02259231|76138890|FG001|Overall Study|Progressive Disease|5|||
42303618|NCT02259231|76138891|FG002|Overall Study|Progressive Disease|4|||
42303619|NCT02259231|76138892|FG003|Overall Study|Progressive Disease|5|||
42303620|NCT02259231|76138893|FG004|Overall Study|Progressive Disease|4|||
42303621|NCT02259231|76138894|FG005|Overall Study|Progressive Disease|5|||
42303622|NCT02259231|76138895|FG006|Overall Study|Progressive Disease|4|||
42303623|NCT02259231|76138889|FG000|Overall Study|Sponsor termination of study|1|||
42303624|NCT02259231|76138890|FG001|Overall Study|Sponsor termination of study|0|||
42303625|NCT02259231|76138891|FG002|Overall Study|Sponsor termination of study|0|||
42303626|NCT02259231|76138892|FG003|Overall Study|Sponsor termination of study|1|||
42303627|NCT02259231|76138893|FG004|Overall Study|Sponsor termination of study|2|||
42303628|NCT02259231|76138894|FG005|Overall Study|Sponsor termination of study|1|||
42303629|NCT02259231|76138895|FG006|Overall Study|Sponsor termination of study|1|||
42303630|NCT02258529|76138911|FG000|Overall Study|Study Terminated by Sponsor|9|||
42303631|NCT02258529|76138911|FG000|Overall Study|Adverse Event|1|||
41990361|NCT01234675|75798322|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
42303632|NCT02256969|76138918|FG000|Overall Study|Screenfailed or withdrew|2|||
42303633|NCT02256969|76138919|FG001|Overall Study|Screenfailed or withdrew|1|||
42303634|NCT02256969|76138920|FG002|Overall Study|Screenfailed or withdrew|1|||
42303635|NCT02256891|76138930|FG000|Overall Study|Death|0|||
42303636|NCT02256891|76138931|FG001|Overall Study|Death|2|||
42303637|NCT02256891|76138930|FG000|Overall Study|Lost to Follow-up|0|||
42303638|NCT02256891|76138931|FG001|Overall Study|Lost to Follow-up|3|||
42303639|NCT02256891|76138930|FG000|Overall Study|Physician Decision|7|||
42303640|NCT02256891|76138931|FG001|Overall Study|Physician Decision|3|||
42303641|NCT02256891|76138930|FG000|Overall Study|Screen Fail|5|||
42303642|NCT02256891|76138931|FG001|Overall Study|Screen Fail|4|||
42303643|NCT02256891|76138930|FG000|Overall Study|Equipment Malfunction|0|||
41990362|NCT01234675|75798323|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
41990363|NCT01228318|75798331|FG000|Overall Study|Clinic no show to receive intervention|1|||
41990364|NCT01228318|75798332|FG001|Overall Study|Clinic no show to receive intervention|0|||
41990365|NCT01228318|75798331|FG000|Overall Study|Unable to contact|2|||
41990366|NCT01228318|75798332|FG001|Overall Study|Unable to contact|5|||
41990367|NCT01228318|75798331|FG000|Overall Study|Moved|0|||
42303644|NCT02256891|76138931|FG001|Overall Study|Equipment Malfunction|1|||
42303645|NCT02256267|76138939|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
42303646|NCT02256267|76138939|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
42303647|NCT01641471|76138948|FG000|Overall Study|Withdrawal by Subject|19|||
42303648|NCT01641471|76138949|FG001|Overall Study|Withdrawal by Subject|19|||
42303649|NCT01641471|76138948|FG000|Overall Study|Lost to Follow-up|2|||
42303650|NCT01641471|76138949|FG001|Overall Study|Lost to Follow-up|4|||
41990368|NCT01228318|75798332|FG001|Overall Study|Moved|2|||
41990369|NCT01228318|75798331|FG000|Overall Study|Incarcerated|1|||
42303651|NCT01641471|76138948|FG000|Overall Study|Protocol Violation|2|||
42303652|NCT01641471|76138949|FG001|Overall Study|Protocol Violation|4|||
42303653|NCT02255565|76138958|FG000|Overall Study|Withdrawal by Subject|0|||
42303654|NCT02255565|76138959|FG001|Overall Study|Withdrawal by Subject|1|||
42303655|NCT02255565|76138960|FG002|Overall Study|Withdrawal by Subject|0|||
42303656|NCT01640301|76139003|FG000|Overall Study|Death|0|||
42303657|NCT01640301|76139004|FG001|Overall Study|Death|8|||
42250768|NCT03050814|76076491|FG002|Overall Study|Screen failures|4|||
42250769|NCT00835575|76076499|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
42250770|NCT00835575|76076500|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
42250771|NCT04601194|76076504|FG000|Overall Study|Lost to Follow-up|7|||
42250772|NCT00835263|76076517|FG000|Second Intervention|Adverse Event|1|||
42250773|NCT00835263|76076518|FG001|Second Intervention|Adverse Event|0|||
42250774|NCT01963208|76076556|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
42250775|NCT01963208|76076557|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
42250776|NCT01963208|76076558|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
42250777|NCT01963208|76076559|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
42250778|NCT01963208|76076560|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
42250779|NCT01963208|76076561|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
42250780|NCT01963208|76076556|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
42250781|NCT01963208|76076557|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
42250782|NCT01963208|76076558|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
42250783|NCT01963208|76076559|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
42250784|NCT01963208|76076560|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
42250785|NCT01963208|76076561|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
42250786|NCT01963208|76076556|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
42250787|NCT01963208|76076557|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
42250788|NCT01963208|76076558|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
42250789|NCT01963208|76076559|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
42250790|NCT01963208|76076560|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
42250791|NCT01963208|76076561|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
42250792|NCT01963208|76076556|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
42250793|NCT01963208|76076557|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
42250794|NCT01963208|76076558|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
42250795|NCT01963208|76076559|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
42250796|NCT01963208|76076560|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
42250797|NCT01963208|76076561|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
42250798|NCT01963208|76076556|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
42250799|NCT01963208|76076557|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
42250800|NCT01963208|76076558|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
42250801|NCT01963208|76076559|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
42303658|NCT01642407|76139012|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
42303659|NCT01642407|76139012|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
42303660|NCT01642407|76139012|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
42303661|NCT02255097|76139016|FG000|Overall Study|Death|151|||
42303662|NCT02255097|76139016|FG000|Overall Study|Lost to Follow-up|5|||
42303663|NCT02255097|76139016|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
42303664|NCT02255097|76139016|FG000|Overall Study|Withdrawal by Subject|7|||
42303665|NCT02255097|76139016|FG000|Overall Study|Allocated but not treated|1|||
42303666|NCT02254551|76139021|FG000|Dose Escalation|Physician Decision|1|||
42303667|NCT02254551|76139021|FG000|Dose Escalation|Dose-limiting toxicity|2|||
42250802|NCT01963208|76076560|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
42250803|NCT01963208|76076561|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
42303668|NCT01641237|76139028|FG000|Period II|Withdrawal by Subject|1|||
42303669|NCT01641237|76139029|FG001|Period II|Withdrawal by Subject|0|||
42303670|NCT01641237|76139030|FG002|Period II|Withdrawal by Subject|0|||
42303671|NCT01641237|76139031|FG003|Period II|Withdrawal by Subject|0|||
42250804|NCT01963208|76076556|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
42250805|NCT01963208|76076557|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
42250806|NCT01963208|76076558|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
42303672|NCT01641237|76139028|FG000|Period III|Lost to Follow-up|1|||
42303673|NCT01641237|76139029|FG001|Period III|Lost to Follow-up|0|||
42303674|NCT01641237|76139030|FG002|Period III|Lost to Follow-up|0|||
42303675|NCT01641237|76139031|FG003|Period III|Lost to Follow-up|0|||
42250807|NCT01963208|76076559|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
42250808|NCT01963208|76076560|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
42250809|NCT01963208|76076561|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
42303676|NCT01639833|76139043|FG000|Overall Study|Death|4|||
42303677|NCT01639833|76139044|FG001|Overall Study|Death|2|||
42303678|NCT01639833|76139043|FG000|Overall Study|Withdrawal by Subject|2|||
42303679|NCT01639833|76139044|FG001|Overall Study|Withdrawal by Subject|2|||
42303680|NCT01639131|76139050|FG000|Overall Study|Disease Progression|6|||
42303681|NCT01641159|76139056|FG000|Overall Study|Lost to Follow-up|2|||
42303682|NCT01641159|76139057|FG001|Overall Study|Lost to Follow-up|1|||
42303683|NCT01641159|76139056|FG000|Overall Study|Withdrawal by Subject|0|||
42303684|NCT01641159|76139057|FG001|Overall Study|Withdrawal by Subject|1|||
42303685|NCT01641081|76139063|FG000|Period 1|Sponsor request (potential unblinding)|0|||
42303686|NCT01641081|76139064|FG001|Period 1|Sponsor request (potential unblinding)|0|||
42303687|NCT01641081|76139065|FG002|Period 1|Sponsor request (potential unblinding)|0|||
42303688|NCT01641081|76139066|FG003|Period 1|Sponsor request (potential unblinding)|0|||
42303689|NCT01641081|76139067|FG004|Period 1|Sponsor request (potential unblinding)|0|||
42303690|NCT01641081|76139068|FG005|Period 1|Sponsor request (potential unblinding)|0|||
41990370|NCT01228318|75798332|FG001|Overall Study|Incarcerated|0|||
41990371|NCT01227967|75798340|FG000|Overall Study|Protocol Violation|3|||
41990372|NCT01227967|75798341|FG001|Overall Study|Protocol Violation|1|||
41990373|NCT01227967|75798340|FG000|Overall Study|Death|0|||
42303691|NCT01641081|76139069|FG006|Period 1|Sponsor request (potential unblinding)|1|||
42303692|NCT01641081|76139070|FG007|Period 1|Sponsor request (potential unblinding)|0|||
42303693|NCT01641081|76139071|FG008|Period 1|Sponsor request (potential unblinding)|0|||
42303694|NCT01641081|76139072|FG009|Period 1|Sponsor request (potential unblinding)|0|||
42303695|NCT01641081|76139063|FG000|Period 1|Protocol Violation|0|||
42303696|NCT01641081|76139064|FG001|Period 1|Protocol Violation|0|||
42303697|NCT01641081|76139065|FG002|Period 1|Protocol Violation|0|||
42303698|NCT01641081|76139066|FG003|Period 1|Protocol Violation|0|||
42303699|NCT01641081|76139067|FG004|Period 1|Protocol Violation|1|||
42303700|NCT01641081|76139068|FG005|Period 1|Protocol Violation|0|||
42303701|NCT01641081|76139069|FG006|Period 1|Protocol Violation|0|||
42303702|NCT01641081|76139070|FG007|Period 1|Protocol Violation|1|||
42303703|NCT01641081|76139071|FG008|Period 1|Protocol Violation|0|||
42303704|NCT01641081|76139072|FG009|Period 1|Protocol Violation|0|||
42303705|NCT01641081|76139063|FG000|Period 1|Adverse Event|1|||
42303706|NCT01641081|76139064|FG001|Period 1|Adverse Event|0|||
42303707|NCT01641081|76139065|FG002|Period 1|Adverse Event|0|||
41990374|NCT01227967|75798341|FG001|Overall Study|Death|1|||
42250810|NCT01963208|76076556|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
42303708|NCT01641081|76139066|FG003|Period 1|Adverse Event|0|||
42250811|NCT01963208|76076557|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
42250812|NCT01963208|76076558|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
42250813|NCT01963208|76076559|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
42250814|NCT01963208|76076560|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
42250815|NCT01963208|76076561|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
42250816|NCT01963208|76076556|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
42250817|NCT01963208|76076557|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
42250818|NCT01963208|76076558|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
42250819|NCT01963208|76076559|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
42250820|NCT01963208|76076560|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
42250821|NCT01963208|76076561|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
42250822|NCT01963208|76076556|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
42250823|NCT01963208|76076557|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
42250824|NCT01963208|76076558|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
42250825|NCT01963208|76076559|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
42250826|NCT01963208|76076560|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
42250827|NCT01963208|76076561|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
42303709|NCT01641081|76139067|FG004|Period 1|Adverse Event|0|||
42303710|NCT01641081|76139068|FG005|Period 1|Adverse Event|0|||
42303711|NCT01641081|76139069|FG006|Period 1|Adverse Event|0|||
42303712|NCT01641081|76139070|FG007|Period 1|Adverse Event|2|||
42303713|NCT01641081|76139071|FG008|Period 1|Adverse Event|0|||
42303714|NCT01641081|76139072|FG009|Period 1|Adverse Event|0|||
42303715|NCT01641081|76139063|FG000|Period 2|Adverse Event|0|||
42303716|NCT01641081|76139064|FG001|Period 2|Adverse Event|0|||
42303717|NCT01641081|76139065|FG002|Period 2|Adverse Event|0|||
42303718|NCT01641081|76139066|FG003|Period 2|Adverse Event|0|||
42303719|NCT01641081|76139067|FG004|Period 2|Adverse Event|0|||
41990375|NCT01227967|75798340|FG000|Overall Study|Lost to Follow-up|8|||
41990376|NCT01227967|75798341|FG001|Overall Study|Lost to Follow-up|3|||
41990377|NCT01227967|75798340|FG000|Overall Study|Withdrawal by Subject|4|||
42250828|NCT01963208|76076556|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
42303720|NCT01641081|76139068|FG005|Period 2|Adverse Event|1|||
42303721|NCT01641081|76139069|FG006|Period 2|Adverse Event|0|||
42303722|NCT01641081|76139070|FG007|Period 2|Adverse Event|0|||
42303723|NCT01641081|76139071|FG008|Period 2|Adverse Event|0|||
42303724|NCT01641081|76139072|FG009|Period 2|Adverse Event|0|||
42303725|NCT01641081|76139063|FG000|Period 2|Withdrawal by Subject|0|||
42303726|NCT01641081|76139064|FG001|Period 2|Withdrawal by Subject|0|||
42303727|NCT01641081|76139065|FG002|Period 2|Withdrawal by Subject|0|||
42303728|NCT01641081|76139066|FG003|Period 2|Withdrawal by Subject|1|||
42303729|NCT01641081|76139067|FG004|Period 2|Withdrawal by Subject|0|||
42303730|NCT01641081|76139068|FG005|Period 2|Withdrawal by Subject|0|||
42303731|NCT01641081|76139069|FG006|Period 2|Withdrawal by Subject|2|||
42303732|NCT01641081|76139070|FG007|Period 2|Withdrawal by Subject|0|||
42303733|NCT01641081|76139071|FG008|Period 2|Withdrawal by Subject|0|||
42303734|NCT01641081|76139072|FG009|Period 2|Withdrawal by Subject|0|||
42303735|NCT01641081|76139063|FG000|Period 2|Protocol Violation|1|||
42303736|NCT01641081|76139064|FG001|Period 2|Protocol Violation|0|||
42303737|NCT01641081|76139065|FG002|Period 2|Protocol Violation|0|||
42303738|NCT01641081|76139066|FG003|Period 2|Protocol Violation|0|||
42303739|NCT01641081|76139067|FG004|Period 2|Protocol Violation|0|||
42303740|NCT01641081|76139068|FG005|Period 2|Protocol Violation|0|||
42303741|NCT01641081|76139069|FG006|Period 2|Protocol Violation|0|||
42303742|NCT01641081|76139070|FG007|Period 2|Protocol Violation|0|||
42303743|NCT01641081|76139071|FG008|Period 2|Protocol Violation|0|||
42303744|NCT01641081|76139072|FG009|Period 2|Protocol Violation|0|||
42303745|NCT01641081|76139063|FG000|Period 3|Adverse Event|0|||
42303746|NCT01641081|76139064|FG001|Period 3|Adverse Event|0|||
42303747|NCT01641081|76139065|FG002|Period 3|Adverse Event|1|||
42303748|NCT01641081|76139066|FG003|Period 3|Adverse Event|0|||
42303749|NCT01641081|76139067|FG004|Period 3|Adverse Event|0|||
42303750|NCT01641081|76139068|FG005|Period 3|Adverse Event|0|||
42303751|NCT01641081|76139069|FG006|Period 3|Adverse Event|0|||
42303752|NCT01641081|76139070|FG007|Period 3|Adverse Event|0|||
42303753|NCT01641081|76139071|FG008|Period 3|Adverse Event|0|||
42303754|NCT01641081|76139072|FG009|Period 3|Adverse Event|0|||
42303755|NCT01641081|76139063|FG000|Period 3|Withdrawal by Subject|0|||
42303756|NCT01641081|76139064|FG001|Period 3|Withdrawal by Subject|0|||
42303757|NCT01641081|76139065|FG002|Period 3|Withdrawal by Subject|0|||
42303758|NCT01641081|76139066|FG003|Period 3|Withdrawal by Subject|0|||
42303759|NCT01641081|76139067|FG004|Period 3|Withdrawal by Subject|0|||
42303760|NCT01641081|76139068|FG005|Period 3|Withdrawal by Subject|0|||
42303761|NCT01641081|76139069|FG006|Period 3|Withdrawal by Subject|0|||
42303762|NCT01641081|76139070|FG007|Period 3|Withdrawal by Subject|0|||
42303763|NCT01641081|76139071|FG008|Period 3|Withdrawal by Subject|1|||
42303764|NCT01641081|76139072|FG009|Period 3|Withdrawal by Subject|0|||
42303765|NCT01641081|76139063|FG000|Period 4|Adverse Event|0|||
42303766|NCT01641081|76139064|FG001|Period 4|Adverse Event|1|||
42303767|NCT01641081|76139065|FG002|Period 4|Adverse Event|0|||
42303768|NCT01641081|76139066|FG003|Period 4|Adverse Event|1|||
42303769|NCT01641081|76139067|FG004|Period 4|Adverse Event|0|||
42303770|NCT01641081|76139068|FG005|Period 4|Adverse Event|0|||
42303771|NCT01641081|76139069|FG006|Period 4|Adverse Event|0|||
42303772|NCT01641081|76139070|FG007|Period 4|Adverse Event|0|||
42303773|NCT01641081|76139071|FG008|Period 4|Adverse Event|0|||
42303774|NCT01641081|76139072|FG009|Period 4|Adverse Event|0|||
42303775|NCT01641081|76139063|FG000|Period 5|Adverse Event|0|||
42303776|NCT01641081|76139064|FG001|Period 5|Adverse Event|0|||
41990378|NCT01227967|75798341|FG001|Overall Study|Withdrawal by Subject|3|||
41990379|NCT01227967|75798340|FG000|Overall Study|Physician Decision|0|||
42250829|NCT01963208|76076557|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
42250830|NCT01963208|76076558|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
42250831|NCT01963208|76076559|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
42250832|NCT01963208|76076560|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
42250833|NCT01963208|76076561|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
42250834|NCT01963208|76076556|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
42250835|NCT01963208|76076557|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
42250836|NCT01963208|76076558|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
42250837|NCT01963208|76076559|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
42250838|NCT01963208|76076560|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
42250839|NCT01963208|76076561|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
41990380|NCT01227967|75798341|FG001|Overall Study|Physician Decision|1|||
41990381|NCT01227967|75798340|FG000|Overall Study|Never Started Treatment|0|||
41990382|NCT01227967|75798341|FG001|Overall Study|Never Started Treatment|4|||
42250840|NCT01963208|76076556|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
42303777|NCT01641081|76139065|FG002|Period 5|Adverse Event|2|||
42303778|NCT01641081|76139066|FG003|Period 5|Adverse Event|0|||
42303779|NCT01641081|76139067|FG004|Period 5|Adverse Event|0|||
41990383|NCT01227967|75798340|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
42303780|NCT01641081|76139068|FG005|Period 5|Adverse Event|0|||
41990384|NCT01227967|75798341|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
42250841|NCT01963208|76076557|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
42303781|NCT01641081|76139069|FG006|Period 5|Adverse Event|0|||
42303782|NCT01641081|76139070|FG007|Period 5|Adverse Event|0|||
42303783|NCT01641081|76139071|FG008|Period 5|Adverse Event|0|||
42303784|NCT01641081|76139072|FG009|Period 5|Adverse Event|0|||
42303785|NCT01640925|76139086|FG000|Overall Study|Withdrawal by Subject|1|||
42303786|NCT01640925|76139087|FG001|Overall Study|Withdrawal by Subject|0|||
42303787|NCT01640925|76139086|FG000|Overall Study|Previously enrolled in this trial|13|||
42250842|NCT01963208|76076558|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
42250843|NCT01963208|76076559|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
42250844|NCT01963208|76076560|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
42250845|NCT01963208|76076561|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
42250846|NCT01963208|76076556|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
42250847|NCT01963208|76076557|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
42250848|NCT01963208|76076558|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
42250849|NCT01963208|76076559|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
42250850|NCT01963208|76076560|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
42250851|NCT01963208|76076561|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
42250852|NCT01963208|76076556|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
42250853|NCT01963208|76076557|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
42250854|NCT01963208|76076558|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
42250855|NCT01963208|76076559|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
42250856|NCT01963208|76076560|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
42250857|NCT01963208|76076561|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
42250858|NCT00834873|76076573|FG000|First Intervention|Adverse Event|0|||
42250859|NCT00834873|76076574|FG001|First Intervention|Adverse Event|1|||
42250860|NCT01377480|76076582|FG000|Overall Study|Protocol Violation|0|||
42250861|NCT01377480|76076583|FG001|Overall Study|Protocol Violation|0|||
42250862|NCT01377480|76076584|FG002|Overall Study|Protocol Violation|0|||
42250863|NCT01377480|76076585|FG003|Overall Study|Protocol Violation|4|||
42250864|NCT01377480|76076582|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
42250865|NCT01377480|76076583|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
42250866|NCT01377480|76076584|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
42250867|NCT01377480|76076585|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
42250868|NCT01377480|76076582|FG000|Overall Study|Withdrawal by Subject|0|||
42250869|NCT01377480|76076583|FG001|Overall Study|Withdrawal by Subject|0|||
42250870|NCT01377480|76076584|FG002|Overall Study|Withdrawal by Subject|1|||
42250871|NCT01377480|76076585|FG003|Overall Study|Withdrawal by Subject|0|||
42250872|NCT01377480|76076582|FG000|Overall Study|Serious adverse event|0|||
42250873|NCT01377480|76076583|FG001|Overall Study|Serious adverse event|0|||
42250874|NCT01377480|76076584|FG002|Overall Study|Serious adverse event|1|||
42250875|NCT01377480|76076585|FG003|Overall Study|Serious adverse event|1|||
42250876|NCT01377480|76076582|FG000|Overall Study|Other|0|||
42250877|NCT01377480|76076583|FG001|Overall Study|Other|0|||
42250878|NCT01377480|76076584|FG002|Overall Study|Other|7|||
42250879|NCT01377480|76076585|FG003|Overall Study|Other|6|||
42250880|NCT00834795|76076597|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
42250881|NCT00834795|76076598|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
42250882|NCT00834795|76076597|FG000|Second Intervention|Adverse Event|1|||
42250883|NCT00834795|76076598|FG001|Second Intervention|Adverse Event|0|||
42250884|NCT00834717|76076604|FG000|First Intervention|Adverse Event|1|||
42250885|NCT00834717|76076605|FG001|First Intervention|Adverse Event|0|||
42250886|NCT00834717|76076604|FG000|First Intervention|Withdrawal by Subject|0|||
42250887|NCT00834717|76076605|FG001|First Intervention|Withdrawal by Subject|1|||
42250888|NCT00834639|76076611|FG000|Second Intervention|Physician Decision|0|||
42250889|NCT00834639|76076612|FG001|Second Intervention|Physician Decision|2|||
42250890|NCT00834249|76076632|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
42250891|NCT00834249|76076633|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
42250892|NCT00834249|76076632|FG000|Second Intervention|Adverse Event|1|||
42250893|NCT00834249|76076633|FG001|Second Intervention|Adverse Event|0|||
42250894|NCT00833937|76076639|FG000|Washout|Withdrawal by Subject|1|||
42250895|NCT00833937|76076640|FG001|Washout|Withdrawal by Subject|0|||
42250896|NCT00924170|76076646|FG000|Overall Study|Refused further treatment|0|||
42250897|NCT00924170|76076647|FG001|Overall Study|Refused further treatment|1|||
42250898|NCT00924170|76076646|FG000|Overall Study|Physician Decision|0|||
42250899|NCT00924170|76076647|FG001|Overall Study|Physician Decision|1|||
42250900|NCT00924170|76076646|FG000|Overall Study|Progressive disease|3|||
42303788|NCT01640925|76139087|FG001|Overall Study|Previously enrolled in this trial|11|||
42303789|NCT01638429|76139093|FG000|Overall Study|Withdrawal by Subject|1|||
41990385|NCT01227928|75798349|FG000|Overall Study|Lost to Follow-up|4|||
42250901|NCT00924170|76076647|FG001|Overall Study|Progressive disease|6|||
42303790|NCT01639755|76139101|FG000|Overall Study|Study Ongoing|15|||
42250902|NCT00924170|76076646|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
42250903|NCT00924170|76076647|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
42250904|NCT00924170|76076646|FG000|Overall Study|Death|1|||
42250905|NCT00924170|76076647|FG001|Overall Study|Death|0|||
42250906|NCT00828321|76076661|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
42250907|NCT00828321|76076662|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
42250908|NCT00828321|76076661|FG000|Second Intervention|Protocol Violation|0|||
42250909|NCT00828321|76076662|FG001|Second Intervention|Protocol Violation|1|||
42250910|NCT01352715|76076668|FG000|Overall Study|Death|3|||
42250911|NCT01352715|76076669|FG001|Overall Study|Death|3|||
42032971|NCT00943917|75841130|FG008|Stage II Continuation|A1C elevation|0|||
42032972|NCT00943917|75841131|FG009|Stage II Continuation|A1C elevation|0|||
42032973|NCT00943917|75841132|FG010|Stage II Continuation|A1C elevation|0|||
42032974|NCT00943917|75841133|FG011|Stage II Continuation|A1C elevation|0|||
42032975|NCT00943917|75841134|FG012|Stage II Continuation|A1C elevation|0|||
42032976|NCT00943917|75841135|FG013|Stage II Continuation|A1C elevation|1|||
42032977|NCT00943917|75841136|FG014|Stage II Continuation|A1C elevation|0|||
42032978|NCT01077024|75841171|FG000|Overall Study|Lost to Follow-up|20|||
42032979|NCT01077024|75841172|FG001|Overall Study|Lost to Follow-up|14|||
42032980|NCT01077024|75841171|FG000|Overall Study|Withdrawal by Subject|0|||
42250912|NCT01352715|76076668|FG000|Overall Study|Lost to Follow-up|5|||
42250913|NCT01352715|76076669|FG001|Overall Study|Lost to Follow-up|7|||
42250914|NCT01352715|76076668|FG000|Overall Study|Withdrawal by Subject|4|||
42303791|NCT01639755|76139101|FG000|Overall Study|Patient had device explantation|4|||
42303792|NCT01601535|76139111|FG000|Phase 1|Adverse Event|1|||
42303793|NCT01601535|76139112|FG001|Phase 1|Adverse Event|0|||
42303794|NCT01601535|76139113|FG002|Phase 1|Adverse Event|2|||
42303795|NCT01601535|76139114|FG003|Phase 1|Adverse Event|1|||
42303796|NCT01601535|76139115|FG004|Phase 1|Adverse Event|0|||
42032981|NCT01077024|75841172|FG001|Overall Study|Withdrawal by Subject|2|||
42032982|NCT01077024|75841171|FG000|Overall Study|Incarcerated|7|||
42032983|NCT01077024|75841172|FG001|Overall Study|Incarcerated|8|||
42250915|NCT01352715|76076669|FG001|Overall Study|Withdrawal by Subject|8|||
42250916|NCT01352715|76076668|FG000|Overall Study|site closure|16|||
42250917|NCT01352715|76076669|FG001|Overall Study|site closure|15|||
42250918|NCT01352715|76076668|FG000|Overall Study|no final visit in closeout period|15|||
42250919|NCT01352715|76076669|FG001|Overall Study|no final visit in closeout period|12|||
42250920|NCT01352715|76076668|FG000|Overall Study|major ineligibility|2|||
42250921|NCT01352715|76076669|FG001|Overall Study|major ineligibility|1|||
42250922|NCT00919893|76076680|FG000|Overall Study|Protocol Violation|19|||
42250923|NCT00919893|76076681|FG001|Overall Study|Protocol Violation|9|||
42250924|NCT02559622|76076689|FG000|Overall Study|Progressive disease|0|||
42250925|NCT02559622|76076690|FG001|Overall Study|Progressive disease|1|||
42250926|NCT02559622|76076691|FG002|Overall Study|Progressive disease|0|||
42250927|NCT02559622|76076692|FG003|Overall Study|Progressive disease|0|||
42250928|NCT02559622|76076689|FG000|Overall Study|Adverse Event|0|||
42250929|NCT02559622|76076690|FG001|Overall Study|Adverse Event|2|||
42250930|NCT02559622|76076691|FG002|Overall Study|Adverse Event|2|||
42250931|NCT02559622|76076692|FG003|Overall Study|Adverse Event|2|||
42250932|NCT02559622|76076689|FG000|Overall Study|Patient/guardian decision|1|||
42250933|NCT02559622|76076690|FG001|Overall Study|Patient/guardian decision|2|||
42250934|NCT02559622|76076691|FG002|Overall Study|Patient/guardian decision|0|||
42250935|NCT02559622|76076692|FG003|Overall Study|Patient/guardian decision|1|||
42250936|NCT02559310|76076708|FG000|Overall Study|Death|4|||
42250937|NCT02559310|76076709|FG001|Overall Study|Death|3|||
42250938|NCT02559310|76076708|FG000|Overall Study|Lost to Follow-up|5|||
42032984|NCT01077024|75841171|FG000|Overall Study|Other|4|||
42032985|NCT01077024|75841172|FG001|Overall Study|Other|4|||
42250939|NCT02559310|76076709|FG001|Overall Study|Lost to Follow-up|3|||
42250940|NCT02559310|76076708|FG000|Overall Study|Physician Decision|2|||
42250941|NCT02559310|76076709|FG001|Overall Study|Physician Decision|1|||
42250942|NCT02559310|76076708|FG000|Overall Study|Withdrawal by Subject|13|||
42250943|NCT02559310|76076709|FG001|Overall Study|Withdrawal by Subject|9|||
42032986|NCT01089582|75841178|FG000|Overall Study|Death|2|||
42250944|NCT02559310|76076708|FG000|Overall Study|Sponsor Decision|0|||
42250945|NCT02559310|76076709|FG001|Overall Study|Sponsor Decision|1|||
42250946|NCT02559310|76076708|FG000|Overall Study|Randomized but not treated|3|||
42250947|NCT02559310|76076709|FG001|Overall Study|Randomized but not treated|2|||
42303797|NCT01601535|76139116|FG005|Phase 1|Adverse Event|0|||
42250948|NCT02555878|76076717|FG000|Overall Study|Lost to Follow-up|2|||
42250949|NCT02555878|76076718|FG001|Overall Study|Lost to Follow-up|3|||
42250950|NCT02555878|76076717|FG000|Overall Study|Withdrawal by Subject|48|||
42303798|NCT01601535|76139111|FG000|Phase 1|Withdrawal by Subject|2|||
42303799|NCT01601535|76139112|FG001|Phase 1|Withdrawal by Subject|1|||
42303800|NCT01601535|76139113|FG002|Phase 1|Withdrawal by Subject|1|||
42303801|NCT01601535|76139114|FG003|Phase 1|Withdrawal by Subject|2|||
42303802|NCT01601535|76139115|FG004|Phase 1|Withdrawal by Subject|0|||
42303803|NCT01601535|76139116|FG005|Phase 1|Withdrawal by Subject|0|||
42303804|NCT01601535|76139111|FG000|Phase 1|Progressive Disease|2|||
42303805|NCT01601535|76139112|FG001|Phase 1|Progressive Disease|3|||
42303806|NCT01601535|76139113|FG002|Phase 1|Progressive Disease|2|||
42303807|NCT01601535|76139114|FG003|Phase 1|Progressive Disease|1|||
42303808|NCT01601535|76139115|FG004|Phase 1|Progressive Disease|0|||
42303809|NCT01601535|76139116|FG005|Phase 1|Progressive Disease|0|||
42303810|NCT01601535|76139111|FG000|Phase 1|Started Another Treatment|1|||
42303811|NCT01601535|76139112|FG001|Phase 1|Started Another Treatment|2|||
42303812|NCT01601535|76139113|FG002|Phase 1|Started Another Treatment|0|||
42303813|NCT01601535|76139114|FG003|Phase 1|Started Another Treatment|0|||
42303814|NCT01601535|76139115|FG004|Phase 1|Started Another Treatment|0|||
42303815|NCT01601535|76139116|FG005|Phase 1|Started Another Treatment|0|||
42303816|NCT01601535|76139111|FG000|Phase 2|Adverse Event|0|||
42303817|NCT01601535|76139112|FG001|Phase 2|Adverse Event|0|||
42303818|NCT01601535|76139113|FG002|Phase 2|Adverse Event|0|||
42303819|NCT01601535|76139114|FG003|Phase 2|Adverse Event|0|||
42303820|NCT01601535|76139115|FG004|Phase 2|Adverse Event|5|||
42303821|NCT01601535|76139116|FG005|Phase 2|Adverse Event|1|||
42303822|NCT01601535|76139111|FG000|Phase 2|Withdrawal by Subject|0|||
42250951|NCT02555878|76076718|FG001|Overall Study|Withdrawal by Subject|48|||
42250952|NCT02555878|76076717|FG000|Overall Study|Adverse Event|12|||
42250953|NCT02555878|76076718|FG001|Overall Study|Adverse Event|8|||
42250954|NCT02555878|76076717|FG000|Overall Study|Death|74|||
42250955|NCT02555878|76076718|FG001|Overall Study|Death|59|||
42250956|NCT02555878|76076717|FG000|Overall Study|Protocol Violation|1|||
42250957|NCT02555878|76076718|FG001|Overall Study|Protocol Violation|2|||
42250958|NCT02555878|76076717|FG000|Overall Study|Physician Decision|12|||
42250959|NCT02555878|76076718|FG001|Overall Study|Physician Decision|13|||
42250960|NCT02555878|76076717|FG000|Overall Study|Other|17|||
42250961|NCT02555878|76076718|FG001|Overall Study|Other|17|||
42250962|NCT02555722|76076726|FG000|Week 2|Adverse Event|0|||
42250963|NCT02555722|76076727|FG001|Week 2|Adverse Event|1|||
42250964|NCT02555722|76076726|FG000|Week 2|Withdrawal by Subject|1|||
42250965|NCT02555722|76076727|FG001|Week 2|Withdrawal by Subject|0|||
42250966|NCT02555722|76076726|FG000|Month 1|Lens Discomfort|1|||
42250967|NCT02555722|76076727|FG001|Month 1|Lens Discomfort|0|||
42250968|NCT02555722|76076726|FG000|Month 2|Withdrawal by Subject|3|||
42250969|NCT02555722|76076727|FG001|Month 2|Withdrawal by Subject|0|||
42250970|NCT02555722|76076726|FG000|Month 2|Lost to Follow-up|1|||
42250971|NCT02555722|76076727|FG001|Month 2|Lost to Follow-up|0|||
42250972|NCT03287960|76076779|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
42250973|NCT03287960|76076779|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
42303823|NCT01601535|76139112|FG001|Phase 2|Withdrawal by Subject|0|||
42303824|NCT01601535|76139113|FG002|Phase 2|Withdrawal by Subject|0|||
42303825|NCT01601535|76139114|FG003|Phase 2|Withdrawal by Subject|0|||
42250974|NCT02558296|76076786|FG000|Completed the Study Through Week 24|Adverse Event|9|||
42250975|NCT02558296|76076787|FG001|Completed the Study Through Week 24|Adverse Event|3|||
42250976|NCT02558296|76076786|FG000|Completed the Study Through Week 24|Death|7|||
42303826|NCT01601535|76139115|FG004|Phase 2|Withdrawal by Subject|8|||
42303827|NCT01601535|76139116|FG005|Phase 2|Withdrawal by Subject|2|||
42303828|NCT01601535|76139111|FG000|Phase 2|Progressive Disease|0|||
42303829|NCT01601535|76139112|FG001|Phase 2|Progressive Disease|0|||
42303830|NCT01601535|76139113|FG002|Phase 2|Progressive Disease|0|||
42303831|NCT01601535|76139114|FG003|Phase 2|Progressive Disease|0|||
42250977|NCT02558296|76076787|FG001|Completed the Study Through Week 24|Death|7|||
42250978|NCT02558296|76076786|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
42250979|NCT02558296|76076787|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
42250980|NCT02558296|76076786|FG000|Completed the Study Through Week 24|Physician Decision|1|||
42303832|NCT01601535|76139115|FG004|Phase 2|Progressive Disease|5|||
42303833|NCT01601535|76139116|FG005|Phase 2|Progressive Disease|7|||
42303834|NCT01601535|76139111|FG000|Phase 2|Started Another Treatment|0|||
42250981|NCT02558296|76076787|FG001|Completed the Study Through Week 24|Physician Decision|0|||
42250982|NCT02558296|76076786|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
42250983|NCT02558296|76076787|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
42250984|NCT02558296|76076786|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
42250985|NCT02558296|76076787|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
42250986|NCT02558296|76076786|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
42250987|NCT02558296|76076787|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
42250988|NCT02558296|76076786|FG000|Completed the Study|Adverse Event|14|||
42250989|NCT02558296|76076787|FG001|Completed the Study|Adverse Event|5|||
42250990|NCT02558296|76076786|FG000|Completed the Study|Death|39|||
42303835|NCT01601535|76139112|FG001|Phase 2|Started Another Treatment|0|||
42303836|NCT01601535|76139113|FG002|Phase 2|Started Another Treatment|0|||
42303837|NCT01601535|76139114|FG003|Phase 2|Started Another Treatment|0|||
42303838|NCT01601535|76139115|FG004|Phase 2|Started Another Treatment|1|||
42303839|NCT01601535|76139116|FG005|Phase 2|Started Another Treatment|2|||
42303840|NCT01638819|76139141|FG000|Overall Study|Lost to Follow-up|1|||
42303841|NCT01638819|76139142|FG001|Overall Study|Lost to Follow-up|0|||
42303842|NCT01363713|76139147|FG000|Overall Study|Adverse Event|1|||
42303843|NCT01363713|76139147|FG000|Overall Study|Protocol Violation|3|||
42303844|NCT01363713|76139147|FG000|Overall Study|Withdrawal by Subject|2|||
42303845|NCT01637961|76139151|FG000|Overall Study|Ineligible: wrong primary|1|||
42303846|NCT01637961|76139151|FG000|Overall Study|Ineligible: inadequate pathology|1|||
42303847|NCT04183335|76139163|FG000|Overall Study|Adverse Event|1|||
42303848|NCT04183335|76139164|FG001|Overall Study|Adverse Event|0|||
42303849|NCT04183335|76139163|FG000|Overall Study|Withdrawal by Subject|12|||
42303850|NCT04183335|76139164|FG001|Overall Study|Withdrawal by Subject|3|||
42303851|NCT04199793|76139172|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
42303852|NCT04199793|76139173|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
42303853|NCT04199793|76139172|FG000|Overall Study|Withdrawal by Subject|1|||
42303854|NCT04199793|76139173|FG001|Overall Study|Withdrawal by Subject|1|||
42303855|NCT04114539|76139179|FG000|Overall Study|Adverse Event|14|||
42303856|NCT04114539|76139179|FG000|Overall Study|Lost to Follow-up|2|||
42303857|NCT04114539|76139179|FG000|Overall Study|Non-compliance with Protocol|2|||
42303858|NCT04114539|76139179|FG000|Overall Study|Non-compliance with Study Drug|1|||
42303859|NCT04114539|76139179|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
42303860|NCT04114539|76139179|FG000|Overall Study|Withdrew consent|10|||
42303861|NCT04114539|76139179|FG000|Overall Study|Others not specified|5|||
42303862|NCT04114539|76139179|FG000|Overall Study|Investigator Decision|2|||
42303863|NCT01636947|76139185|FG000|Overall Study|Not Treated|2|||
42303864|NCT01636947|76139186|FG001|Overall Study|Not Treated|2|||
42303865|NCT01636947|76139185|FG000|Overall Study|Lost to Follow-up|4|||
42303866|NCT01636947|76139186|FG001|Overall Study|Lost to Follow-up|0|||
42303867|NCT01636947|76139185|FG000|Overall Study|Protocol Violation|1|||
42303868|NCT01636947|76139186|FG001|Overall Study|Protocol Violation|1|||
42303869|NCT01636947|76139185|FG000|Overall Study|Withdrawal by Subject|3|||
42303870|NCT01636947|76139186|FG001|Overall Study|Withdrawal by Subject|3|||
42303871|NCT01636947|76139185|FG000|Overall Study|Adverse Event|1|||
42250991|NCT02558296|76076787|FG001|Completed the Study|Death|25|||
42250992|NCT02558296|76076786|FG000|Completed the Study|Lost to Follow-up|31|||
42250993|NCT02558296|76076787|FG001|Completed the Study|Lost to Follow-up|23|||
42250994|NCT02558296|76076786|FG000|Completed the Study|Physician Decision|6|||
42250995|NCT02558296|76076787|FG001|Completed the Study|Physician Decision|0|||
42250996|NCT02558296|76076786|FG000|Completed the Study|Protocol Violation|2|||
42303872|NCT01636947|76139186|FG001|Overall Study|Adverse Event|1|||
42303873|NCT01636947|76139185|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
42303874|NCT01636947|76139186|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
42303875|NCT01635933|76139194|FG000|Overall Study|Adverse Event|1|||
42303876|NCT01635933|76139195|FG001|Overall Study|Adverse Event|0|||
42303877|NCT01635933|76139194|FG000|Overall Study|Lost to Follow-up|0|||
42303878|NCT01635933|76139195|FG001|Overall Study|Lost to Follow-up|5|||
41990386|NCT01227928|75798350|FG001|Overall Study|Lost to Follow-up|2|||
41990387|NCT01227928|75798349|FG000|Overall Study|Withdrawal by Subject|4|||
41990388|NCT01227928|75798350|FG001|Overall Study|Withdrawal by Subject|3|||
42250997|NCT02558296|76076787|FG001|Completed the Study|Protocol Violation|1|||
42250998|NCT02558296|76076786|FG000|Completed the Study|Withdrawal by Subject|53|||
42250999|NCT02558296|76076787|FG001|Completed the Study|Withdrawal by Subject|31|||
42303879|NCT01635933|76139194|FG000|Overall Study|Subject decision|1|||
42303880|NCT01635933|76139195|FG001|Overall Study|Subject decision|1|||
42303881|NCT01635933|76139194|FG000|Overall Study|Noncompliance|0|||
42303882|NCT01635933|76139195|FG001|Overall Study|Noncompliance|1|||
42303883|NCT01635933|76139194|FG000|Overall Study|No longer had transportation|0|||
41990389|NCT01227928|75798349|FG000|Overall Study|Death|14|||
42303884|NCT01635933|76139195|FG001|Overall Study|No longer had transportation|1|||
42303885|NCT01635855|76139201|FG000|Overall Study|Withdrawal by Subject|4|||
42251000|NCT02558296|76076786|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
42251001|NCT02558296|76076787|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
42251002|NCT02737475|76076824|FG000|Overall Study|Other reasons|0|||
42251003|NCT02737475|76076825|FG001|Overall Study|Other reasons|0|||
42251004|NCT02737475|76076826|FG002|Overall Study|Other reasons|0|||
42251005|NCT02737475|76076827|FG003|Overall Study|Other reasons|0|||
42251006|NCT02737475|76076828|FG004|Overall Study|Other reasons|1|||
42251007|NCT02737475|76076829|FG005|Overall Study|Other reasons|1|||
42251008|NCT02737475|76076830|FG006|Overall Study|Other reasons|0|||
42251009|NCT02737475|76076831|FG007|Overall Study|Other reasons|0|||
42251010|NCT02737475|76076832|FG008|Overall Study|Other reasons|1|||
42251011|NCT02737475|76076833|FG009|Overall Study|Other reasons|0|||
42251012|NCT02737475|76076834|FG010|Overall Study|Other reasons|1|||
42251013|NCT02737475|76076835|FG011|Overall Study|Other reasons|0|||
42303886|NCT03052725|76139207|FG000|Overall Study|Adverse Event|2|||
42303887|NCT03052725|76139208|FG001|Overall Study|Adverse Event|0|||
42251014|NCT02737475|76076836|FG012|Overall Study|Other reasons|0|||
42303888|NCT03052725|76139207|FG000|Overall Study|Withdrawal by Subject|3|||
42303889|NCT03052725|76139208|FG001|Overall Study|Withdrawal by Subject|4|||
42303890|NCT03052725|76139207|FG000|Overall Study|Pregnancy|0|||
42303891|NCT03052725|76139208|FG001|Overall Study|Pregnancy|1|||
42303892|NCT03052725|76139207|FG000|Overall Study|Site closure|0|||
42303893|NCT03052725|76139208|FG001|Overall Study|Site closure|1|||
42303894|NCT03052725|76139207|FG000|Overall Study|Study terminated by sponsor|143|||
42303895|NCT03052725|76139208|FG001|Overall Study|Study terminated by sponsor|144|||
42303896|NCT01635153|76139232|FG000|Overall Study|Lost to Follow-up|40|||
42303897|NCT01635153|76139233|FG001|Overall Study|Lost to Follow-up|43|||
42303898|NCT01636713|76139242|FG000|Overall Study|Adverse Event|16|||
42303899|NCT01636713|76139243|FG001|Overall Study|Adverse Event|16|||
42303900|NCT01636713|76139244|FG002|Overall Study|Adverse Event|7|||
42303901|NCT01636713|76139242|FG000|Overall Study|Lack of Efficacy|6|||
42303902|NCT01636713|76139243|FG001|Overall Study|Lack of Efficacy|6|||
42303903|NCT01636713|76139244|FG002|Overall Study|Lack of Efficacy|2|||
42303904|NCT01636713|76139242|FG000|Overall Study|Protocol Violation|3|||
42303905|NCT01636713|76139243|FG001|Overall Study|Protocol Violation|0|||
42303906|NCT01636713|76139244|FG002|Overall Study|Protocol Violation|1|||
42303907|NCT01636713|76139242|FG000|Overall Study|Lost to Follow-up|0|||
42303908|NCT01636713|76139243|FG001|Overall Study|Lost to Follow-up|0|||
42303909|NCT01636713|76139244|FG002|Overall Study|Lost to Follow-up|1|||
42303910|NCT01636713|76139242|FG000|Overall Study|Withdrawal by Subject|5|||
42303911|NCT01636713|76139243|FG001|Overall Study|Withdrawal by Subject|4|||
42303912|NCT01636713|76139244|FG002|Overall Study|Withdrawal by Subject|8|||
42303913|NCT01636713|76139242|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
42303914|NCT01636713|76139243|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
42303915|NCT01636713|76139244|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
42303916|NCT01600053|76139252|FG000|Overall Study|Adverse Event|2|||
42303917|NCT01600053|76139252|FG000|Overall Study|trial will not meet the interim endpoint|9|||
42303918|NCT01068249|76139256|FG000|Overall Study|Death|1|||
42303919|NCT01068249|76139256|FG000|Overall Study|Withdrawal by Subject|3|||
42303920|NCT02246673|76139275|FG000|Overall Study|Sponsor Decision|1|||
42303921|NCT02246673|76139276|FG001|Overall Study|Sponsor Decision|0|||
42303922|NCT02246673|76139277|FG002|Overall Study|Sponsor Decision|0|||
42303923|NCT02246673|76139278|FG003|Overall Study|Sponsor Decision|0|||
41990390|NCT01227928|75798350|FG001|Overall Study|Death|12|||
42303924|NCT02246673|76139279|FG004|Overall Study|Sponsor Decision|0|||
42251015|NCT02737475|76076837|FG013|Overall Study|Other reasons|0|||
42303925|NCT02246673|76139275|FG000|Overall Study|Withdrawal by Subject|0|||
42303926|NCT02246673|76139276|FG001|Overall Study|Withdrawal by Subject|0|||
42303927|NCT02246673|76139277|FG002|Overall Study|Withdrawal by Subject|0|||
42303928|NCT02246673|76139278|FG003|Overall Study|Withdrawal by Subject|0|||
41990391|NCT01227889|75798358|FG000|Randomized Phase (RP)|Adverse Event|13|||
41990392|NCT01227889|75798359|FG001|Randomized Phase (RP)|Adverse Event|0|||
41990393|NCT01227889|75798358|FG000|Randomized Phase (RP)|Physician Decision|13|||
42251016|NCT02737475|76076838|FG014|Overall Study|Other reasons|0|||
42251017|NCT02737475|76076839|FG015|Overall Study|Other reasons|0|||
42303929|NCT02246673|76139279|FG004|Overall Study|Withdrawal by Subject|1|||
42303930|NCT02246673|76139275|FG000|Overall Study|Lost to Follow-up|0|||
42303931|NCT02246673|76139276|FG001|Overall Study|Lost to Follow-up|0|||
42303932|NCT02246673|76139277|FG002|Overall Study|Lost to Follow-up|0|||
42303933|NCT02246673|76139278|FG003|Overall Study|Lost to Follow-up|1|||
42251018|NCT02737475|76076840|FG016|Overall Study|Other reasons|0|||
42251019|NCT02737475|76076841|FG017|Overall Study|Other reasons|0|||
42303934|NCT02246673|76139279|FG004|Overall Study|Lost to Follow-up|0|||
42303935|NCT02246673|76139275|FG000|Overall Study|Protocol Violation|0|||
41990394|NCT01227889|75798359|FG001|Randomized Phase (RP)|Physician Decision|5|||
41990395|NCT01227889|75798358|FG000|Randomized Phase (RP)|Progressive Disease|135|||
42251020|NCT02737475|76076842|FG018|Overall Study|Other reasons|0|||
42303936|NCT02246673|76139276|FG001|Overall Study|Protocol Violation|0|||
42303937|NCT02246673|76139277|FG002|Overall Study|Protocol Violation|0|||
42303938|NCT02246673|76139278|FG003|Overall Study|Protocol Violation|1|||
42303939|NCT02246673|76139279|FG004|Overall Study|Protocol Violation|0|||
42303940|NCT02246439|76139341|FG000|Overall Study|Adverse Event|3|||
42303941|NCT02246439|76139342|FG001|Overall Study|Adverse Event|0|||
42303942|NCT02246439|76139341|FG000|Overall Study|Lost to Follow-up|7|||
42303943|NCT02246439|76139342|FG001|Overall Study|Lost to Follow-up|5|||
42303944|NCT02246439|76139341|FG000|Overall Study|Protocol Violation|0|||
42303945|NCT02246439|76139342|FG001|Overall Study|Protocol Violation|2|||
42303946|NCT02246439|76139341|FG000|Overall Study|Physician Decision|0|||
42303947|NCT02246439|76139342|FG001|Overall Study|Physician Decision|1|||
42303948|NCT02246439|76139341|FG000|Overall Study|Unkonwn|1|||
42303949|NCT02246439|76139342|FG001|Overall Study|Unkonwn|3|||
42303950|NCT02246439|76139341|FG000|Overall Study|Withdrawal by Subject|1|||
42303951|NCT02246439|76139342|FG001|Overall Study|Withdrawal by Subject|0|||
42303952|NCT02245737|76139351|FG000|Overall Study|Adverse Event|23|||
42303953|NCT02245737|76139352|FG001|Overall Study|Adverse Event|26|||
42303954|NCT02245737|76139353|FG002|Overall Study|Adverse Event|33|||
42303955|NCT02245737|76139351|FG000|Overall Study|Condition Worsened|9|||
42303956|NCT02245737|76139352|FG001|Overall Study|Condition Worsened|10|||
42303957|NCT02245737|76139353|FG002|Overall Study|Condition Worsened|9|||
42303958|NCT02245737|76139351|FG000|Overall Study|Death|2|||
42303959|NCT02245737|76139352|FG001|Overall Study|Death|4|||
42303960|NCT02245737|76139353|FG002|Overall Study|Death|4|||
42303961|NCT02245737|76139351|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
42303962|NCT02245737|76139352|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
42303963|NCT02245737|76139353|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
42303964|NCT02245737|76139351|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
42303965|NCT02245737|76139352|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
42303966|NCT02245737|76139353|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
42303967|NCT02245737|76139351|FG000|Overall Study|Lost to Follow-up|2|||
42303968|NCT02245737|76139352|FG001|Overall Study|Lost to Follow-up|5|||
42303969|NCT02245737|76139353|FG002|Overall Study|Lost to Follow-up|4|||
42303970|NCT02245737|76139351|FG000|Overall Study|Other-determined by Investigator|9|||
41990396|NCT01227889|75798359|FG001|Randomized Phase (RP)|Progressive Disease|52|||
41990397|NCT01227889|75798358|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
41990398|NCT01227889|75798359|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
41990399|NCT01227889|75798358|FG000|Randomized Phase (RP)|Missing|1|||
42132720|NCT00317044|75943524|FG001|Overall Study|Adverse Event|7|||
42251021|NCT02737475|76076843|FG019|Overall Study|Other reasons|0|||
42251022|NCT02737475|76076844|FG020|Overall Study|Other reasons|0|||
42251023|NCT02737475|76076845|FG021|Overall Study|Other reasons|1|||
42251024|NCT02737475|76076846|FG022|Overall Study|Other reasons|0|||
42251025|NCT02737475|76076847|FG023|Overall Study|Other reasons|1|||
42251026|NCT02737475|76076848|FG024|Overall Study|Other reasons|1|||
42251027|NCT02737475|76076849|FG025|Overall Study|Other reasons|1|||
42251028|NCT02737475|76076850|FG026|Overall Study|Other reasons|0|||
42251029|NCT02737475|76076824|FG000|Overall Study|Death|1|||
42251030|NCT02737475|76076825|FG001|Overall Study|Death|0|||
42251031|NCT02737475|76076826|FG002|Overall Study|Death|0|||
42251032|NCT02737475|76076827|FG003|Overall Study|Death|1|||
42251033|NCT02737475|76076828|FG004|Overall Study|Death|0|||
42251034|NCT02737475|76076829|FG005|Overall Study|Death|0|||
42251035|NCT02737475|76076830|FG006|Overall Study|Death|0|||
42251036|NCT02737475|76076831|FG007|Overall Study|Death|2|||
42303971|NCT02245737|76139352|FG001|Overall Study|Other-determined by Investigator|10|||
42303972|NCT02245737|76139353|FG002|Overall Study|Other-determined by Investigator|10|||
42303973|NCT02245737|76139351|FG000|Overall Study|Physician Decision|6|||
42251037|NCT02737475|76076832|FG008|Overall Study|Death|0|||
42251038|NCT02737475|76076833|FG009|Overall Study|Death|0|||
42251039|NCT02737475|76076834|FG010|Overall Study|Death|0|||
42251040|NCT02737475|76076835|FG011|Overall Study|Death|4|||
42251041|NCT02737475|76076836|FG012|Overall Study|Death|2|||
42303974|NCT02245737|76139352|FG001|Overall Study|Physician Decision|3|||
42303975|NCT02245737|76139353|FG002|Overall Study|Physician Decision|6|||
42303976|NCT02245737|76139351|FG000|Overall Study|Protocol Violation|3|||
42303977|NCT02245737|76139352|FG001|Overall Study|Protocol Violation|2|||
42303978|NCT02245737|76139353|FG002|Overall Study|Protocol Violation|3|||
42303979|NCT02245737|76139351|FG000|Overall Study|Withdrawal by Subject|40|||
42303980|NCT02245737|76139352|FG001|Overall Study|Withdrawal by Subject|41|||
42303981|NCT02245737|76139353|FG002|Overall Study|Withdrawal by Subject|44|||
42303982|NCT02245737|76139351|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
42303983|NCT02245737|76139352|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
42303984|NCT02245737|76139353|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
42303985|NCT02245737|76139351|FG000|Overall Study|Sponsor Decision|445|||
42303986|NCT02245737|76139352|FG001|Overall Study|Sponsor Decision|430|||
42303987|NCT02245737|76139353|FG002|Overall Study|Sponsor Decision|432|||
42303988|NCT02244957|76139365|FG000|Overall Study|Lack of Efficacy|1|||
42303989|NCT02244957|76139366|FG001|Overall Study|Lack of Efficacy|0|||
42303990|NCT02243865|76139376|FG000|Overall Study|Protocol Violation|1|||
42303991|NCT02243865|76139377|FG001|Overall Study|Protocol Violation|3|||
42303992|NCT02243865|76139376|FG000|Overall Study|Lost to Follow-up|1|||
42303993|NCT02243865|76139377|FG001|Overall Study|Lost to Follow-up|1|||
42303994|NCT02243865|76139376|FG000|Overall Study|Withdrawal by Subject|1|||
42303995|NCT02243865|76139377|FG001|Overall Study|Withdrawal by Subject|0|||
42303996|NCT02243865|76139376|FG000|Overall Study|Adverse Event|1|||
42303997|NCT02243865|76139377|FG001|Overall Study|Adverse Event|1|||
42303998|NCT02243631|76139387|FG000|Overall Study|no synovial fluid on second aspirate|0|||
42303999|NCT02243631|76139388|FG001|Overall Study|no synovial fluid on second aspirate|1|||
42304000|NCT02242305|76139396|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
42304001|NCT02242305|76139397|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
42304002|NCT02242305|76139396|FG000|Overall Study|Adverse Event|1|||
42304003|NCT02242305|76139397|FG001|Overall Study|Adverse Event|0|||
42304004|NCT02242305|76139396|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
42304005|NCT02242305|76139397|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
42304006|NCT02242305|76139396|FG000|Overall Study|Subject withdraws inform consent|0|||
42304007|NCT02242305|76139397|FG001|Overall Study|Subject withdraws inform consent|4|||
42304008|NCT02242305|76139396|FG000|Overall Study|Lost to Follow-up|2|||
42304009|NCT02242305|76139397|FG001|Overall Study|Lost to Follow-up|0|||
42304010|NCT02240121|76139405|FG000|Overall Study|Protocol Violation|1|||
42304011|NCT02240121|76139406|FG001|Overall Study|Protocol Violation|2|||
41990400|NCT01227889|75798359|FG001|Randomized Phase (RP)|Missing|3|||
41990401|NCT01227889|75798358|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
41990402|NCT01227889|75798359|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
41990403|NCT01227889|75798358|FG000|Crossover Phase|Adverse Event|0|||
41990404|NCT01227889|75798359|FG001|Crossover Phase|Adverse Event|1|||
41990405|NCT01227889|75798358|FG000|Crossover Phase|Physician Decision|0|||
41990406|NCT01227889|75798359|FG001|Crossover Phase|Physician Decision|3|||
41990407|NCT01227889|75798358|FG000|Crossover Phase|Progressive Disease|0|||
41990408|NCT01227889|75798359|FG001|Crossover Phase|Progressive Disease|31|||
42251042|NCT02737475|76076837|FG013|Overall Study|Death|2|||
42251043|NCT02737475|76076838|FG014|Overall Study|Death|0|||
42251044|NCT02737475|76076839|FG015|Overall Study|Death|2|||
42251045|NCT02737475|76076840|FG016|Overall Study|Death|2|||
42251046|NCT02737475|76076841|FG017|Overall Study|Death|2|||
42251047|NCT02737475|76076842|FG018|Overall Study|Death|1|||
42251048|NCT02737475|76076843|FG019|Overall Study|Death|0|||
42251049|NCT02737475|76076844|FG020|Overall Study|Death|0|||
42251050|NCT02737475|76076845|FG021|Overall Study|Death|0|||
42251051|NCT02737475|76076846|FG022|Overall Study|Death|0|||
42251052|NCT02737475|76076847|FG023|Overall Study|Death|0|||
42251053|NCT02737475|76076848|FG024|Overall Study|Death|0|||
42251054|NCT02737475|76076849|FG025|Overall Study|Death|0|||
42251055|NCT02737475|76076850|FG026|Overall Study|Death|0|||
42251056|NCT02737475|76076824|FG000|Overall Study|Participant withdrew consent|0|||
42251057|NCT02737475|76076825|FG001|Overall Study|Participant withdrew consent|0|||
42251058|NCT02737475|76076826|FG002|Overall Study|Participant withdrew consent|0|||
42251059|NCT02737475|76076827|FG003|Overall Study|Participant withdrew consent|0|||
42251060|NCT02737475|76076828|FG004|Overall Study|Participant withdrew consent|0|||
42251061|NCT02737475|76076829|FG005|Overall Study|Participant withdrew consent|2|||
42251062|NCT02737475|76076830|FG006|Overall Study|Participant withdrew consent|0|||
42251063|NCT02737475|76076831|FG007|Overall Study|Participant withdrew consent|0|||
42251064|NCT02737475|76076832|FG008|Overall Study|Participant withdrew consent|0|||
42304012|NCT02240121|76139405|FG000|Overall Study|Physician Decision|0|||
42304013|NCT02240121|76139406|FG001|Overall Study|Physician Decision|1|||
42304014|NCT02240121|76139405|FG000|Overall Study|Change in protocol interpretation|1|||
42304015|NCT02240121|76139406|FG001|Overall Study|Change in protocol interpretation|0|||
41990409|NCT01227889|75798358|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
41990410|NCT01227889|75798359|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
41990411|NCT01227889|75798358|FG000|Crossover Phase|Withdrawal by Subject|0|||
41990412|NCT01227889|75798359|FG001|Crossover Phase|Withdrawal by Subject|1|||
41990413|NCT01227577|75798373|FG000|Overall Study|Protocol deviation|3|||
41990414|NCT01227577|75798373|FG000|Overall Study|Death|3|||
41990415|NCT01227577|75798373|FG000|Overall Study|Administrative problems|2|||
41990416|NCT01227577|75798373|FG000|Overall Study|Lost to Follow-up|1|||
41990417|NCT01227577|75798373|FG000|Overall Study|Withdrawal by Subject|4|||
41990418|NCT01227577|75798373|FG000|Overall Study|Lack of Efficacy|5|||
41990419|NCT01227577|75798373|FG000|Overall Study|Adverse Event|17|||
41990420|NCT01227421|75798393|FG000|Overall Study|Lost to Follow-up|6|||
41990421|NCT01227421|75798394|FG001|Overall Study|Lost to Follow-up|7|||
41990422|NCT01227421|75798395|FG002|Overall Study|Lost to Follow-up|5|||
41990423|NCT01227421|75798393|FG000|Overall Study|Adverse Event|2|||
41990424|NCT01227421|75798394|FG001|Overall Study|Adverse Event|7|||
41990425|NCT01227421|75798395|FG002|Overall Study|Adverse Event|2|||
41990426|NCT01227421|75798393|FG000|Overall Study|Withdrawal by Subject|1|||
41990427|NCT01227421|75798394|FG001|Overall Study|Withdrawal by Subject|2|||
41990428|NCT01227421|75798395|FG002|Overall Study|Withdrawal by Subject|1|||
41990429|NCT01227421|75798393|FG000|Overall Study|Protocol Violation|1|||
41990430|NCT01227421|75798394|FG001|Overall Study|Protocol Violation|1|||
41990431|NCT01227421|75798395|FG002|Overall Study|Protocol Violation|2|||
41990432|NCT01227421|75798393|FG000|Overall Study|Randomized in error|1|||
41990433|NCT01227421|75798394|FG001|Overall Study|Randomized in error|1|||
41990434|NCT01227421|75798395|FG002|Overall Study|Randomized in error|0|||
41990435|NCT01227265|75798406|FG000|Overall Study|Did Not Receive Treatment|1|||
41990436|NCT01227265|75798407|FG001|Overall Study|Did Not Receive Treatment|2|||
41990437|NCT01227265|75798408|FG002|Overall Study|Did Not Receive Treatment|0|||
41990438|NCT01227265|75798406|FG000|Overall Study|Administrative|1|||
41990439|NCT01227265|75798407|FG001|Overall Study|Administrative|0|||
41990440|NCT01227265|75798408|FG002|Overall Study|Administrative|2|||
41990441|NCT01227265|75798406|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
41990442|NCT01227265|75798407|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
41990443|NCT01227265|75798408|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
41990444|NCT01227265|75798406|FG000|Overall Study|Protocol Violation|2|||
41990445|NCT01227265|75798407|FG001|Overall Study|Protocol Violation|1|||
41990446|NCT01227265|75798408|FG002|Overall Study|Protocol Violation|0|||
41990447|NCT01227265|75798406|FG000|Overall Study|Withdrawal by Subject|7|||
41990448|NCT01227265|75798407|FG001|Overall Study|Withdrawal by Subject|7|||
41990449|NCT01227265|75798408|FG002|Overall Study|Withdrawal by Subject|3|||
41990450|NCT01227265|75798406|FG000|Overall Study|Lost to Follow-up|2|||
41990451|NCT01227265|75798407|FG001|Overall Study|Lost to Follow-up|0|||
41990452|NCT01227265|75798408|FG002|Overall Study|Lost to Follow-up|3|||
41990453|NCT01227265|75798406|FG000|Overall Study|Adverse Event|6|||
41990454|NCT01227265|75798407|FG001|Overall Study|Adverse Event|10|||
41990455|NCT01227265|75798408|FG002|Overall Study|Adverse Event|5|||
41990456|NCT01226095|75798416|FG000|Overall Study|Poor compliance|1|||
42251065|NCT02737475|76076833|FG009|Overall Study|Participant withdrew consent|0|||
42251066|NCT02737475|76076834|FG010|Overall Study|Participant withdrew consent|0|||
42251067|NCT02737475|76076835|FG011|Overall Study|Participant withdrew consent|0|||
42251068|NCT02737475|76076836|FG012|Overall Study|Participant withdrew consent|0|||
42251069|NCT02737475|76076837|FG013|Overall Study|Participant withdrew consent|0|||
42251070|NCT02737475|76076838|FG014|Overall Study|Participant withdrew consent|1|||
42251071|NCT02737475|76076839|FG015|Overall Study|Participant withdrew consent|0|||
42251072|NCT02737475|76076840|FG016|Overall Study|Participant withdrew consent|0|||
42251073|NCT02737475|76076841|FG017|Overall Study|Participant withdrew consent|2|||
42304016|NCT02240121|76139405|FG000|Overall Study|Lack of Efficacy|2|||
41990457|NCT01225822|75798432|FG000|Overall Study|Adverse Event|13|||
41990458|NCT01225822|75798433|FG001|Overall Study|Adverse Event|31|||
41990459|NCT01225822|75798434|FG002|Overall Study|Adverse Event|18|||
41990460|NCT01225822|75798435|FG003|Overall Study|Adverse Event|23|||
41990461|NCT01225822|75798436|FG004|Overall Study|Adverse Event|14|||
41990462|NCT01225822|75798432|FG000|Overall Study|Protocol Violation|6|||
41990463|NCT01225822|75798433|FG001|Overall Study|Protocol Violation|8|||
41990464|NCT01225822|75798434|FG002|Overall Study|Protocol Violation|6|||
41990465|NCT01225822|75798435|FG003|Overall Study|Protocol Violation|7|||
41990466|NCT01225822|75798436|FG004|Overall Study|Protocol Violation|4|||
41990467|NCT01225822|75798432|FG000|Overall Study|Lost to Follow-up|0|||
41990468|NCT01225822|75798433|FG001|Overall Study|Lost to Follow-up|0|||
42251074|NCT02737475|76076842|FG018|Overall Study|Participant withdrew consent|1|||
41990469|NCT01225822|75798434|FG002|Overall Study|Lost to Follow-up|0|||
41990470|NCT01225822|75798435|FG003|Overall Study|Lost to Follow-up|1|||
41990471|NCT01225822|75798436|FG004|Overall Study|Lost to Follow-up|0|||
42304017|NCT02240121|76139406|FG001|Overall Study|Lack of Efficacy|3|||
42304018|NCT02240121|76139405|FG000|Overall Study|Site closed|1|||
42304019|NCT02240121|76139406|FG001|Overall Study|Site closed|1|||
42304020|NCT02240121|76139405|FG000|Overall Study|Pregnancy|1|||
42304021|NCT02240121|76139406|FG001|Overall Study|Pregnancy|0|||
42304022|NCT02240121|76139405|FG000|Overall Study|Adverse Event|2|||
42304023|NCT02240121|76139406|FG001|Overall Study|Adverse Event|4|||
42304024|NCT02240121|76139405|FG000|Overall Study|Withdrawal by Subject|6|||
42304025|NCT02240121|76139406|FG001|Overall Study|Withdrawal by Subject|2|||
42304026|NCT02240121|76139405|FG000|Overall Study|Lost to Follow-up|3|||
42304027|NCT02240121|76139406|FG001|Overall Study|Lost to Follow-up|4|||
42304028|NCT02240121|76139405|FG000|Overall Study|Other than specified|1|||
42304029|NCT02240121|76139406|FG001|Overall Study|Other than specified|3|||
42304030|NCT02239263|76139412|FG000|Overall Study|Protocol Violation|6|||
42304031|NCT02238483|76139420|FG000|Overall Study|Withdrawal by Subject|2|||
42304032|NCT02238483|76139421|FG001|Overall Study|Withdrawal by Subject|7|||
42304033|NCT02238483|76139420|FG000|Overall Study|Lost to Follow-up|1|||
42304034|NCT02238483|76139421|FG001|Overall Study|Lost to Follow-up|1|||
42304035|NCT02238483|76139420|FG000|Overall Study|Protocol Violation|1|||
42304036|NCT02238483|76139421|FG001|Overall Study|Protocol Violation|2|||
42304037|NCT02238483|76139420|FG000|Overall Study|Death|1|||
42304038|NCT02238483|76139421|FG001|Overall Study|Death|0|||
42304039|NCT02238483|76139420|FG000|Overall Study|Adverse Event|7|||
42304040|NCT02238483|76139421|FG001|Overall Study|Adverse Event|3|||
42304041|NCT02238483|76139420|FG000|Overall Study|Withdrawn due to physician decision|1|||
42304042|NCT02238483|76139421|FG001|Overall Study|Withdrawn due to physician decision|0|||
42304043|NCT02238483|76139420|FG000|Overall Study|Completion status not recorded|1|||
42304044|NCT02238483|76139421|FG001|Overall Study|Completion status not recorded|1|||
42304045|NCT02238483|76139420|FG000|Overall Study|Illness in family member|1|||
42304046|NCT02238483|76139421|FG001|Overall Study|Illness in family member|0|||
42304047|NCT01632891|76139429|FG000|Overall Study|Lost to Follow-up|0|||
42304048|NCT01632891|76139430|FG001|Overall Study|Lost to Follow-up|1|||
42304049|NCT01632891|76139429|FG000|Overall Study|Withdrawal by Subject|1|||
42304050|NCT01632891|76139430|FG001|Overall Study|Withdrawal by Subject|0|||
42304051|NCT02208999|76139442|FG000|Overall Study|Lost to Follow-up|1|||
42304052|NCT02208843|76139461|FG000|Overall Study|Clinical symptoms of progression|2|||
42304053|NCT02208843|76139461|FG000|Overall Study|Progression disease according to RECIST|24|||
42304054|NCT02208843|76139461|FG000|Overall Study|Adverse Event|12|||
42304055|NCT02208843|76139461|FG000|Overall Study|Protocol Violation|1|||
42304056|NCT02208843|76139461|FG000|Overall Study|Withdrawal by Subject|1|||
42304057|NCT02208843|76139461|FG000|Overall Study|Switched to commercial afatinib|20|||
42304058|NCT02208063|76139467|FG000|Overall Study|Death|3|||
42304059|NCT02208063|76139468|FG001|Overall Study|Death|5|||
42304060|NCT02208063|76139467|FG000|Overall Study|Not Specified in report|3|||
42304061|NCT02208063|76139468|FG001|Overall Study|Not Specified in report|4|||
42304062|NCT02208063|76139467|FG000|Overall Study|Withdrawal by Subject|5|||
42304063|NCT02208063|76139468|FG001|Overall Study|Withdrawal by Subject|2|||
42304064|NCT02208063|76139467|FG000|Overall Study|Lost to Follow-up|1|||
42304065|NCT02208063|76139468|FG001|Overall Study|Lost to Follow-up|0|||
42304066|NCT02207907|76139476|FG000|Overall Study|Lost to Follow-up|3|||
42304067|NCT02207907|76139477|FG001|Overall Study|Lost to Follow-up|1|||
42304068|NCT02207907|76139476|FG000|Overall Study|Withdrawal by Subject|5|||
42304069|NCT02207907|76139477|FG001|Overall Study|Withdrawal by Subject|6|||
42304070|NCT02207907|76139476|FG000|Overall Study|Did not meet study criteria|3|||
42304071|NCT02207907|76139477|FG001|Overall Study|Did not meet study criteria|0|||
42304072|NCT02207907|76139476|FG000|Overall Study|Pregnancy|0|||
42304073|NCT02207907|76139477|FG001|Overall Study|Pregnancy|1|||
42304074|NCT02207829|76139486|FG000|Overall Study|Adverse Event|10|||
42304075|NCT02207829|76139487|FG001|Overall Study|Adverse Event|9|||
42304076|NCT02207829|76139486|FG000|Overall Study|Lack of Efficacy|7|||
42304077|NCT02207829|76139487|FG001|Overall Study|Lack of Efficacy|5|||
42304078|NCT02207829|76139486|FG000|Overall Study|Lost to Follow-up|2|||
42304079|NCT02207829|76139487|FG001|Overall Study|Lost to Follow-up|2|||
42304080|NCT02207829|76139486|FG000|Overall Study|Protocol deviation|5|||
42304081|NCT02207829|76139487|FG001|Overall Study|Protocol deviation|4|||
42304082|NCT02207829|76139486|FG000|Overall Study|Withdrew consent|18|||
42304083|NCT02207829|76139487|FG001|Overall Study|Withdrew consent|14|||
42304084|NCT02237157|76139493|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
42304085|NCT02237157|76139494|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
42304086|NCT02237157|76139495|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
42304087|NCT02237157|76139496|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
42304088|NCT02237157|76139493|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
42304089|NCT02237157|76139494|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
42304090|NCT02237157|76139495|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
42304091|NCT02237157|76139496|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
42304092|NCT02237001|76139503|FG000|Overall Study|Lost to Follow-up|2|||
42304093|NCT02237001|76139503|FG000|Overall Study|Withdrawal by Subject|1|||
42304094|NCT02237001|76139503|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
42304095|NCT02237001|76139503|FG000|Overall Study|Re-operation|4|||
42304096|NCT02237001|76139503|FG000|Overall Study|Incarceration|1|||
42304097|NCT02236611|76139509|FG000|Overall Study|Adverse Event|10|||
42304098|NCT02236611|76139510|FG001|Overall Study|Adverse Event|16|||
42304099|NCT02236611|76139509|FG000|Overall Study|Lack of Efficacy|4|||
42304100|NCT02236611|76139510|FG001|Overall Study|Lack of Efficacy|7|||
42304101|NCT02236611|76139509|FG000|Overall Study|Lost to Follow-up|0|||
42304102|NCT02236611|76139510|FG001|Overall Study|Lost to Follow-up|2|||
42304103|NCT02236611|76139509|FG000|Overall Study|Protocol deviation|3|||
42304104|NCT02236611|76139510|FG001|Overall Study|Protocol deviation|5|||
42304105|NCT02236611|76139509|FG000|Overall Study|Withdrew consent|9|||
42304106|NCT02236611|76139510|FG001|Overall Study|Withdrew consent|4|||
42304107|NCT02234583|76139518|FG000|Overall Study|Adverse Event|172|||
42304108|NCT02234583|76139519|FG001|Overall Study|Adverse Event|156|||
42304109|NCT02234583|76139518|FG000|Overall Study|Withdrawal by Subject|109|||
42304110|NCT02234583|76139519|FG001|Overall Study|Withdrawal by Subject|157|||
42304111|NCT02234583|76139518|FG000|Overall Study|Lost to Follow-up|0|||
42304112|NCT02234583|76139519|FG001|Overall Study|Lost to Follow-up|1|||
42304113|NCT02234583|76139518|FG000|Overall Study|Lack of Efficacy|58|||
42304114|NCT02234583|76139519|FG001|Overall Study|Lack of Efficacy|103|||
42304115|NCT02234583|76139518|FG000|Overall Study|Protocol Violation|35|||
42304116|NCT02234583|76139519|FG001|Overall Study|Protocol Violation|42|||
42304117|NCT02234583|76139518|FG000|Overall Study|Other|39|||
41990472|NCT01225822|75798432|FG000|Overall Study|Withdrawal by Subject|6|||
41990473|NCT01225822|75798433|FG001|Overall Study|Withdrawal by Subject|7|||
41990474|NCT01225822|75798434|FG002|Overall Study|Withdrawal by Subject|7|||
41990475|NCT01225822|75798435|FG003|Overall Study|Withdrawal by Subject|11|||
42304118|NCT02234583|76139519|FG001|Overall Study|Other|97|||
42304119|NCT03686397|76139533|FG000|Overall Study|Lack of Efficacy|3|||
42304120|NCT03686397|76139534|FG001|Overall Study|Lack of Efficacy|5|||
42304121|NCT03686397|76139533|FG000|Overall Study|Adverse Event|0|||
42304122|NCT03686397|76139534|FG001|Overall Study|Adverse Event|1|||
42304123|NCT03686397|76139533|FG000|Overall Study|Protocol Violation|0|||
42304124|NCT03686397|76139534|FG001|Overall Study|Protocol Violation|1|||
42304125|NCT03686397|76139533|FG000|Overall Study|Withdrawal by Subject|0|||
42304126|NCT03686397|76139534|FG001|Overall Study|Withdrawal by Subject|1|||
42304127|NCT03686397|76139533|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
41990476|NCT01225822|75798436|FG004|Overall Study|Withdrawal by Subject|6|||
41990477|NCT01225822|75798432|FG000|Overall Study|Other|13|||
41990478|NCT01225822|75798433|FG001|Overall Study|Other|10|||
41990479|NCT01225822|75798434|FG002|Overall Study|Other|7|||
42304128|NCT03686397|76139534|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
42304129|NCT02233803|76139540|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
42304130|NCT02233803|76139541|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
42304131|NCT02233803|76139540|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
41990480|NCT01225822|75798435|FG003|Overall Study|Other|10|||
41990481|NCT01225822|75798436|FG004|Overall Study|Other|7|||
41990482|NCT01225549|75798451|FG000|Period 4 - Washout|Disallowed medication|0|||
41990483|NCT01225549|75798452|FG001|Period 4 - Washout|Disallowed medication|1|||
41990484|NCT01225549|75798453|FG002|Period 4 - Washout|Disallowed medication|0|||
41990485|NCT01225549|75798454|FG003|Period 4 - Washout|Disallowed medication|0|||
41990486|NCT01225549|75798455|FG004|Period 4 - Washout|Disallowed medication|0|||
41990487|NCT01225549|75798456|FG005|Period 4 - Washout|Disallowed medication|0|||
41990488|NCT01225549|75798457|FG006|Period 4 - Washout|Disallowed medication|0|||
42251075|NCT02737475|76076843|FG019|Overall Study|Participant withdrew consent|0|||
42251076|NCT02737475|76076844|FG020|Overall Study|Participant withdrew consent|2|||
42251077|NCT02737475|76076845|FG021|Overall Study|Participant withdrew consent|0|||
42251078|NCT02737475|76076846|FG022|Overall Study|Participant withdrew consent|0|||
42251079|NCT02737475|76076847|FG023|Overall Study|Participant withdrew consent|0|||
42251080|NCT02737475|76076848|FG024|Overall Study|Participant withdrew consent|0|||
42251081|NCT02737475|76076849|FG025|Overall Study|Participant withdrew consent|0|||
42251082|NCT02737475|76076850|FG026|Overall Study|Participant withdrew consent|0|||
42251083|NCT02737475|76076824|FG000|Overall Study|Lost to Follow-up|0|||
42251084|NCT02737475|76076825|FG001|Overall Study|Lost to Follow-up|0|||
42251085|NCT02737475|76076826|FG002|Overall Study|Lost to Follow-up|0|||
42251086|NCT02737475|76076827|FG003|Overall Study|Lost to Follow-up|0|||
42251087|NCT02737475|76076828|FG004|Overall Study|Lost to Follow-up|0|||
42251088|NCT02737475|76076829|FG005|Overall Study|Lost to Follow-up|0|||
42251089|NCT02737475|76076830|FG006|Overall Study|Lost to Follow-up|0|||
42251090|NCT02737475|76076831|FG007|Overall Study|Lost to Follow-up|0|||
42251091|NCT02737475|76076832|FG008|Overall Study|Lost to Follow-up|0|||
42251092|NCT02737475|76076833|FG009|Overall Study|Lost to Follow-up|0|||
42251093|NCT02737475|76076834|FG010|Overall Study|Lost to Follow-up|0|||
42251094|NCT02737475|76076835|FG011|Overall Study|Lost to Follow-up|0|||
42251095|NCT02737475|76076836|FG012|Overall Study|Lost to Follow-up|0|||
42251096|NCT02737475|76076837|FG013|Overall Study|Lost to Follow-up|0|||
42304132|NCT02233803|76139541|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
42304133|NCT02233803|76139540|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
42304134|NCT02233803|76139541|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
41990489|NCT01225549|75798458|FG007|Period 4 - Washout|Disallowed medication|0|||
41990490|NCT01225549|75798459|FG008|Period 4 - Washout|Disallowed medication|0|||
41990491|NCT01225549|75798460|FG009|Period 4 - Washout|Disallowed medication|0|||
41990492|NCT01225549|75798451|FG000|Period 6 - Washout|Disallowed medication|0|||
41990493|NCT01225549|75798452|FG001|Period 6 - Washout|Disallowed medication|0|||
41990494|NCT01225549|75798453|FG002|Period 6 - Washout|Disallowed medication|0|||
41990495|NCT01225549|75798454|FG003|Period 6 - Washout|Disallowed medication|1|||
41990496|NCT01225549|75798455|FG004|Period 6 - Washout|Disallowed medication|0|||
41990497|NCT01225549|75798456|FG005|Period 6 - Washout|Disallowed medication|0|||
41990498|NCT01225549|75798457|FG006|Period 6 - Washout|Disallowed medication|0|||
41990499|NCT01225549|75798458|FG007|Period 6 - Washout|Disallowed medication|0|||
41990500|NCT01225549|75798459|FG008|Period 6 - Washout|Disallowed medication|0|||
41990501|NCT01225549|75798460|FG009|Period 6 - Washout|Disallowed medication|0|||
41990502|NCT01225159|75798472|FG000|Overall Study|Change operation|1|||
41990503|NCT01225159|75798473|FG001|Overall Study|Change operation|0|||
41990504|NCT01224925|75798481|FG000|Overall Study|Lost to Follow-up|3|||
41990505|NCT01224925|75798482|FG001|Overall Study|Lost to Follow-up|2|||
41990506|NCT01223404|75798490|FG000|First Intervention (1 Day)|Adverse Event|0|||
41990507|NCT01223404|75798491|FG001|First Intervention (1 Day)|Adverse Event|0|||
41990508|NCT01223404|75798492|FG002|First Intervention (1 Day)|Adverse Event|0|||
41990509|NCT01223404|75798493|FG003|First Intervention (1 Day)|Adverse Event|1|||
42304135|NCT02233803|76139540|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
42304136|NCT02233803|76139541|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
42304137|NCT02233803|76139540|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
42304138|NCT02233803|76139541|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
42304139|NCT02233803|76139540|FG000|Washout Period (4-Wks)|Physician Decision|1|||
42304140|NCT02233803|76139541|FG001|Washout Period (4-Wks)|Physician Decision|0|||
42304141|NCT02233803|76139540|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
42304142|NCT02233803|76139541|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
42304143|NCT02233803|76139540|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
42304144|NCT02233803|76139541|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
42304145|NCT02233803|76139540|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
42304146|NCT02233803|76139541|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
42304147|NCT02233647|76139549|FG000|Overall Study|Adverse Event|1|||
42304148|NCT02233413|76139555|FG000|Overall Study|Lost to Follow-up|7|||
42304149|NCT02233413|76139556|FG001|Overall Study|Lost to Follow-up|9|||
42304150|NCT02233413|76139555|FG000|Overall Study|Withdrawal by Subject|4|||
42304151|NCT02233413|76139556|FG001|Overall Study|Withdrawal by Subject|5|||
42304152|NCT01632579|76139562|FG000|Washout Period|Adverse Event|1|||
41990510|NCT01223404|75798494|FG004|First Intervention (1 Day)|Adverse Event|0|||
41990511|NCT01223404|75798495|FG005|First Intervention (1 Day)|Adverse Event|0|||
41990512|NCT01223404|75798490|FG000|Second Intervention (1 Day)|Adverse Event|1|||
41990513|NCT01223404|75798491|FG001|Second Intervention (1 Day)|Adverse Event|0|||
41990514|NCT01223404|75798492|FG002|Second Intervention (1 Day)|Adverse Event|0|||
41990515|NCT01223404|75798493|FG003|Second Intervention (1 Day)|Adverse Event|0|||
41990516|NCT01223404|75798494|FG004|Second Intervention (1 Day)|Adverse Event|0|||
41990517|NCT01223404|75798495|FG005|Second Intervention (1 Day)|Adverse Event|0|||
41990518|NCT01223404|75798490|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
41990519|NCT01223404|75798491|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
41990520|NCT01223404|75798492|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
41990521|NCT01223404|75798493|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
41990522|NCT01223404|75798494|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
42304153|NCT01632579|76139563|FG001|Washout Period|Adverse Event|0|||
42304154|NCT01632579|76139564|FG002|Washout Period|Adverse Event|0|||
42304155|NCT01632579|76139565|FG003|Washout Period|Adverse Event|0|||
42304156|NCT01632579|76139566|FG004|Washout Period|Adverse Event|0|||
42304157|NCT01632579|76139567|FG005|Washout Period|Adverse Event|0|||
42304158|NCT01632579|76139568|FG006|Washout Period|Adverse Event|0|||
42304159|NCT01632579|76139569|FG007|Washout Period|Adverse Event|0|||
42304160|NCT01632579|76139570|FG008|Washout Period|Adverse Event|0|||
42304161|NCT01632579|76139562|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
42304162|NCT01632579|76139563|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
42304163|NCT01632579|76139564|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
42304164|NCT01632579|76139565|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
42304165|NCT01632579|76139566|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
42032987|NCT01089582|75841178|FG000|Overall Study|Adverse Event|15|||
42032988|NCT01089582|75841178|FG000|Overall Study|Lost to Follow-up|8|||
42032989|NCT01089582|75841178|FG000|Overall Study|Other|4|||
42032990|NCT01089582|75841178|FG000|Overall Study|Withdrawal by Subject|1|||
42032991|NCT00862459|75841185|FG000|Overall Study|Lost to Follow-up|1|||
42032992|NCT00862459|75841186|FG001|Overall Study|Lost to Follow-up|2|||
42251097|NCT02737475|76076838|FG014|Overall Study|Lost to Follow-up|0|||
42251098|NCT02737475|76076839|FG015|Overall Study|Lost to Follow-up|1|||
42304166|NCT01632579|76139567|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
42304167|NCT01632579|76139568|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
42304168|NCT01632579|76139569|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
42304169|NCT01632579|76139570|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
42304170|NCT01632345|76139599|FG000|Treatment: Part I|Adverse Event|1|||
42304171|NCT01632345|76139600|FG001|Treatment: Part I|Adverse Event|4|||
42304172|NCT01632345|76139601|FG002|Treatment: Part I|Adverse Event|2|||
42304173|NCT01632345|76139602|FG003|Treatment: Part I|Adverse Event|1|||
42304174|NCT01632345|76139603|FG004|Treatment: Part I|Adverse Event|3|||
42304175|NCT01632345|76139604|FG005|Treatment: Part I|Adverse Event|0|||
42304176|NCT01632345|76139605|FG006|Treatment: Part I|Adverse Event|0|||
42251099|NCT02737475|76076840|FG016|Overall Study|Lost to Follow-up|0|||
42251100|NCT02737475|76076841|FG017|Overall Study|Lost to Follow-up|0|||
42251101|NCT02737475|76076842|FG018|Overall Study|Lost to Follow-up|0|||
42251102|NCT02737475|76076843|FG019|Overall Study|Lost to Follow-up|0|||
42251103|NCT02737475|76076844|FG020|Overall Study|Lost to Follow-up|0|||
42251104|NCT02737475|76076845|FG021|Overall Study|Lost to Follow-up|0|||
42251105|NCT02737475|76076846|FG022|Overall Study|Lost to Follow-up|0|||
42251106|NCT02737475|76076847|FG023|Overall Study|Lost to Follow-up|0|||
42251107|NCT02737475|76076848|FG024|Overall Study|Lost to Follow-up|0|||
42251108|NCT02737475|76076849|FG025|Overall Study|Lost to Follow-up|0|||
42251109|NCT02737475|76076850|FG026|Overall Study|Lost to Follow-up|0|||
42251110|NCT02737475|76076824|FG000|Overall Study|Disease Progression|0|||
42251111|NCT02737475|76076825|FG001|Overall Study|Disease Progression|0|||
42251112|NCT02737475|76076826|FG002|Overall Study|Disease Progression|0|||
42251113|NCT02737475|76076827|FG003|Overall Study|Disease Progression|0|||
42251114|NCT02737475|76076828|FG004|Overall Study|Disease Progression|0|||
42304177|NCT01632345|76139599|FG000|Treatment: Part I|Lack of Efficacy|0|||
42032993|NCT00862459|75841187|FG002|Overall Study|Lost to Follow-up|2|||
42032994|NCT00862459|75841185|FG000|Overall Study|Protocol Violation|1|||
42032995|NCT00862459|75841186|FG001|Overall Study|Protocol Violation|0|||
42251115|NCT02737475|76076829|FG005|Overall Study|Disease Progression|0|||
42251116|NCT02737475|76076830|FG006|Overall Study|Disease Progression|0|||
42251117|NCT02737475|76076831|FG007|Overall Study|Disease Progression|0|||
42304178|NCT01632345|76139600|FG001|Treatment: Part I|Lack of Efficacy|1|||
42304179|NCT01632345|76139601|FG002|Treatment: Part I|Lack of Efficacy|0|||
42304180|NCT01632345|76139602|FG003|Treatment: Part I|Lack of Efficacy|1|||
42304181|NCT01632345|76139603|FG004|Treatment: Part I|Lack of Efficacy|1|||
42304182|NCT01632345|76139604|FG005|Treatment: Part I|Lack of Efficacy|0|||
42304183|NCT01632345|76139605|FG006|Treatment: Part I|Lack of Efficacy|0|||
42304184|NCT01632345|76139599|FG000|Treatment: Part I|Lost to Follow-up|3|||
42304185|NCT01632345|76139600|FG001|Treatment: Part I|Lost to Follow-up|2|||
42304186|NCT01632345|76139601|FG002|Treatment: Part I|Lost to Follow-up|1|||
42304187|NCT01632345|76139602|FG003|Treatment: Part I|Lost to Follow-up|3|||
42304188|NCT01632345|76139603|FG004|Treatment: Part I|Lost to Follow-up|4|||
42304189|NCT01632345|76139604|FG005|Treatment: Part I|Lost to Follow-up|0|||
42032996|NCT00862459|75841187|FG002|Overall Study|Protocol Violation|0|||
42032997|NCT00862459|75841185|FG000|Overall Study|Withdrawal by Subject|1|||
42032998|NCT00862459|75841186|FG001|Overall Study|Withdrawal by Subject|1|||
42032999|NCT00862459|75841187|FG002|Overall Study|Withdrawal by Subject|3|||
42033000|NCT00862459|75841185|FG000|Overall Study|Adverse Event|0|||
42033001|NCT00862459|75841186|FG001|Overall Study|Adverse Event|1|||
42304190|NCT01632345|76139605|FG006|Treatment: Part I|Lost to Follow-up|0|||
42304191|NCT01632345|76139599|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
42304192|NCT01632345|76139600|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
42304193|NCT01632345|76139601|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
42033002|NCT00862459|75841187|FG002|Overall Study|Adverse Event|0|||
42033003|NCT00862459|75841185|FG000|Overall Study|Personal reasons|1|||
42033004|NCT00862459|75841186|FG001|Overall Study|Personal reasons|0|||
42033005|NCT00862459|75841187|FG002|Overall Study|Personal reasons|0|||
42033006|NCT00862459|75841185|FG000|Overall Study|Operation|1|||
42033007|NCT00862459|75841186|FG001|Overall Study|Operation|1|||
42304194|NCT01632345|76139602|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
42304195|NCT01632345|76139603|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
42304196|NCT01632345|76139604|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
42304197|NCT01632345|76139605|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
42304198|NCT01632345|76139599|FG000|Treatment: Part I|Physician Decision|2|||
42304199|NCT01632345|76139600|FG001|Treatment: Part I|Physician Decision|1|||
42304200|NCT01632345|76139601|FG002|Treatment: Part I|Physician Decision|0|||
42304201|NCT01632345|76139602|FG003|Treatment: Part I|Physician Decision|0|||
42304202|NCT01632345|76139603|FG004|Treatment: Part I|Physician Decision|1|||
42304203|NCT01632345|76139604|FG005|Treatment: Part I|Physician Decision|0|||
42304204|NCT01632345|76139605|FG006|Treatment: Part I|Physician Decision|0|||
42304205|NCT01632345|76139599|FG000|Treatment: Part I|Pregnancy|0|||
42304206|NCT01632345|76139600|FG001|Treatment: Part I|Pregnancy|1|||
42304207|NCT01632345|76139601|FG002|Treatment: Part I|Pregnancy|0|||
41990523|NCT01223404|75798495|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
41990524|NCT01223365|75798543|FG000|Open-label Titration Period|Enrolled but not treated|1|||
41990525|NCT01223365|75798543|FG000|Open-label Titration Period|Adverse Event|23|||
42033008|NCT00862459|75841187|FG002|Overall Study|Operation|0|||
42033009|NCT00862459|75841185|FG000|Overall Study|Intravenous (IV) site problems|1|||
42033010|NCT00862459|75841186|FG001|Overall Study|Intravenous (IV) site problems|0|||
42033011|NCT00862459|75841187|FG002|Overall Study|Intravenous (IV) site problems|1|||
42033012|NCT00862459|75841185|FG000|Overall Study|Unable to hold still for imaging|0|||
42033013|NCT00862459|75841186|FG001|Overall Study|Unable to hold still for imaging|1|||
42033014|NCT00862459|75841187|FG002|Overall Study|Unable to hold still for imaging|0|||
42033015|NCT00862459|75841185|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
42033016|NCT00862459|75841186|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
42033017|NCT00862459|75841187|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
42033018|NCT00862459|75841185|FG000|Overall Study|Administrative problems|0|||
42033019|NCT00862459|75841186|FG001|Overall Study|Administrative problems|1|||
42033020|NCT00862459|75841187|FG002|Overall Study|Administrative problems|0|||
42304208|NCT01632345|76139602|FG003|Treatment: Part I|Pregnancy|0|||
41990526|NCT01223365|75798543|FG000|Open-label Titration Period|Lack of Efficacy|3|||
41990527|NCT01223365|75798543|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
41990528|NCT01223365|75798543|FG000|Open-label Titration Period|Protocol Violation|1|||
41990529|NCT01223365|75798543|FG000|Open-label Titration Period|Lost to Follow-up|2|||
41990530|NCT01223365|75798543|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
41990531|NCT01223365|75798543|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
41990532|NCT01223365|75798543|FG000|Open-label Titration Period|Starting physical therapy|1|||
41990533|NCT01223365|75798543|FG000|Open-label Treatment Period|Adverse Event|39|||
42304209|NCT01632345|76139603|FG004|Treatment: Part I|Pregnancy|0|||
41990534|NCT01223365|75798543|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
41990535|NCT01223365|75798543|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
41990536|NCT01223365|75798543|FG000|Open-label Treatment Period|Protocol Violation|15|||
42033021|NCT01074450|75841198|FG000|First Intervention|Emesis in Dosing Interval|0|||
42304210|NCT01632345|76139604|FG005|Treatment: Part I|Pregnancy|0|||
42304211|NCT01632345|76139605|FG006|Treatment: Part I|Pregnancy|0|||
42304212|NCT01632345|76139599|FG000|Treatment: Part I|Protocol Deviation|0|||
42304213|NCT01632345|76139600|FG001|Treatment: Part I|Protocol Deviation|0|||
42304214|NCT01632345|76139601|FG002|Treatment: Part I|Protocol Deviation|1|||
42304215|NCT01632345|76139602|FG003|Treatment: Part I|Protocol Deviation|1|||
42304216|NCT01632345|76139603|FG004|Treatment: Part I|Protocol Deviation|0|||
42304217|NCT01632345|76139604|FG005|Treatment: Part I|Protocol Deviation|0|||
42304218|NCT01632345|76139605|FG006|Treatment: Part I|Protocol Deviation|0|||
42304219|NCT01632345|76139599|FG000|Treatment: Part I|Withdrawal by Subject|3|||
42304220|NCT01632345|76139600|FG001|Treatment: Part I|Withdrawal by Subject|4|||
42304221|NCT01632345|76139601|FG002|Treatment: Part I|Withdrawal by Subject|4|||
42304222|NCT01632345|76139602|FG003|Treatment: Part I|Withdrawal by Subject|1|||
42304223|NCT01632345|76139603|FG004|Treatment: Part I|Withdrawal by Subject|4|||
42304224|NCT01632345|76139604|FG005|Treatment: Part I|Withdrawal by Subject|0|||
42304225|NCT01632345|76139605|FG006|Treatment: Part I|Withdrawal by Subject|0|||
42304226|NCT01632345|76139599|FG000|Treatment: Part II|Adverse Event|0|||
42304227|NCT01632345|76139600|FG001|Treatment: Part II|Adverse Event|0|||
42304228|NCT01632345|76139601|FG002|Treatment: Part II|Adverse Event|0|||
42304229|NCT01632345|76139602|FG003|Treatment: Part II|Adverse Event|0|||
42304230|NCT01632345|76139603|FG004|Treatment: Part II|Adverse Event|0|||
42304231|NCT01632345|76139604|FG005|Treatment: Part II|Adverse Event|3|||
42304232|NCT01632345|76139605|FG006|Treatment: Part II|Adverse Event|8|||
42304233|NCT01632345|76139599|FG000|Treatment: Part II|Lost to Follow-up|0|||
42304234|NCT01632345|76139600|FG001|Treatment: Part II|Lost to Follow-up|0|||
42304235|NCT01632345|76139601|FG002|Treatment: Part II|Lost to Follow-up|0|||
42304236|NCT01632345|76139602|FG003|Treatment: Part II|Lost to Follow-up|0|||
42304237|NCT01632345|76139603|FG004|Treatment: Part II|Lost to Follow-up|0|||
42304238|NCT01632345|76139604|FG005|Treatment: Part II|Lost to Follow-up|3|||
42304239|NCT01632345|76139605|FG006|Treatment: Part II|Lost to Follow-up|1|||
42304240|NCT01632345|76139599|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
42304241|NCT01632345|76139600|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
42304242|NCT01632345|76139601|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
42304243|NCT01632345|76139602|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
42304244|NCT01632345|76139603|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
42304245|NCT01632345|76139604|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
42304246|NCT01632345|76139605|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
42304247|NCT01632345|76139599|FG000|Treatment: Part II|Withdrawal by Subject|0|||
42304248|NCT01632345|76139600|FG001|Treatment: Part II|Withdrawal by Subject|0|||
42304249|NCT01632345|76139601|FG002|Treatment: Part II|Withdrawal by Subject|0|||
42304250|NCT01632345|76139602|FG003|Treatment: Part II|Withdrawal by Subject|0|||
42304251|NCT01632345|76139603|FG004|Treatment: Part II|Withdrawal by Subject|0|||
42304252|NCT01632345|76139604|FG005|Treatment: Part II|Withdrawal by Subject|2|||
42304253|NCT01632345|76139605|FG006|Treatment: Part II|Withdrawal by Subject|2|||
42304254|NCT02232243|76139623|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
42304255|NCT02232243|76139624|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
42304256|NCT02232243|76139625|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
42304257|NCT02205333|76139643|FG000|Overall Study|Death|5|||
42304258|NCT02205333|76139644|FG001|Overall Study|Death|6|||
42304259|NCT02205333|76139645|FG002|Overall Study|Death|2|||
42304260|NCT02205333|76139646|FG003|Overall Study|Death|6|||
42304261|NCT02205333|76139647|FG004|Overall Study|Death|5|||
42304262|NCT02205333|76139648|FG005|Overall Study|Death|3|||
41990537|NCT01223365|75798543|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
41990538|NCT01223365|75798543|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
41990539|NCT01223365|75798543|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
41990540|NCT01223365|75798543|FG000|Open-label Treatment Period|Moved out of area|2|||
41990541|NCT01223365|75798543|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
41990542|NCT01223365|75798543|FG000|Open-label Treatment Period|"Out of window"|1|||
41990543|NCT01223365|75798543|FG000|Open-label Treatment Period|Starting physical therapy|1|||
41990544|NCT01223365|75798543|FG000|Open-label Treatment Period|Physician Decision|2|||
41990545|NCT01222507|75798552|FG000|Overall Study|Physician Decision|1|||
41990546|NCT01222507|75798552|FG000|Overall Study|Withdrawal by Subject|1|||
41990547|NCT01222078|75798556|FG000|Overall Study|Early termination of the study|1|||
41990548|NCT01221727|75798563|FG000|Overall Study|Physician Decision|2|||
41990549|NCT01221727|75798564|FG001|Overall Study|Physician Decision|0|||
41990550|NCT01221727|75798563|FG000|Overall Study|Withdrawal by Subject|1|||
41990551|NCT01221727|75798564|FG001|Overall Study|Withdrawal by Subject|1|||
41990552|NCT01221181|75798576|FG000|Overall Study|Lost to Follow-up|1|||
41990553|NCT01220557|75798582|FG000|Overall Study|Lost to Follow-up|5|||
42304263|NCT02205333|76139649|FG006|Overall Study|Death|3|||
42304264|NCT02205333|76139650|FG007|Overall Study|Death|2|||
42304265|NCT02205333|76139651|FG008|Overall Study|Death|0|||
42304266|NCT02205333|76139643|FG000|Overall Study|Withdrawal by Subject|1|||
42304267|NCT02205333|76139644|FG001|Overall Study|Withdrawal by Subject|0|||
42304268|NCT02205333|76139645|FG002|Overall Study|Withdrawal by Subject|0|||
42304269|NCT02205333|76139646|FG003|Overall Study|Withdrawal by Subject|1|||
42304270|NCT02205333|76139647|FG004|Overall Study|Withdrawal by Subject|0|||
41990554|NCT01220557|75798583|FG001|Overall Study|Lost to Follow-up|3|||
41990555|NCT01220557|75798582|FG000|Overall Study|attended less than 6 lessons|1|||
41990556|NCT01220557|75798583|FG001|Overall Study|attended less than 6 lessons|2|||
41990557|NCT01220401|75798589|FG000|Overall Study|Withdrawal by Subject|2|||
41990558|NCT01220401|75798589|FG000|Overall Study|Protocol Violation|1|||
41990559|NCT01220167|75798596|FG000|Period 3|Urine positive for substance abuse|0|||
42033022|NCT01074450|75841199|FG001|First Intervention|Emesis in Dosing Interval|2|||
42033023|NCT01074450|75841198|FG000|Second Intervention|Protocol Violation|1|||
42033024|NCT01074450|75841199|FG001|Second Intervention|Protocol Violation|0|||
42033025|NCT01074450|75841198|FG000|Second Intervention|Physician Decision|0|||
42251118|NCT02737475|76076832|FG008|Overall Study|Disease Progression|0|||
42251119|NCT02737475|76076833|FG009|Overall Study|Disease Progression|0|||
42251120|NCT02737475|76076834|FG010|Overall Study|Disease Progression|0|||
42251121|NCT02737475|76076835|FG011|Overall Study|Disease Progression|0|||
42251122|NCT02737475|76076836|FG012|Overall Study|Disease Progression|0|||
42251123|NCT02737475|76076837|FG013|Overall Study|Disease Progression|0|||
42251124|NCT02737475|76076838|FG014|Overall Study|Disease Progression|0|||
42251125|NCT02737475|76076839|FG015|Overall Study|Disease Progression|0|||
42251126|NCT02737475|76076840|FG016|Overall Study|Disease Progression|0|||
42251127|NCT02737475|76076841|FG017|Overall Study|Disease Progression|0|||
42251128|NCT02737475|76076842|FG018|Overall Study|Disease Progression|0|||
42251129|NCT02737475|76076843|FG019|Overall Study|Disease Progression|0|||
42251130|NCT02737475|76076844|FG020|Overall Study|Disease Progression|0|||
42251131|NCT02737475|76076845|FG021|Overall Study|Disease Progression|0|||
42251132|NCT02737475|76076846|FG022|Overall Study|Disease Progression|0|||
42251133|NCT02737475|76076847|FG023|Overall Study|Disease Progression|0|||
42251134|NCT02737475|76076848|FG024|Overall Study|Disease Progression|0|||
41990560|NCT01220167|75798597|FG001|Period 3|Urine positive for substance abuse|1|||
41990561|NCT01220167|75798598|FG002|Period 3|Urine positive for substance abuse|0|||
41990562|NCT01220128|75798611|FG000|Overall Study|Progressive disease|0|||
41990563|NCT01220128|75798612|FG001|Overall Study|Progressive disease|0|||
41990564|NCT01220128|75798613|FG002|Overall Study|Progressive disease|2|||
41990565|NCT01220128|75798614|FG003|Overall Study|Progressive disease|0|||
41990566|NCT01220128|75798615|FG004|Overall Study|Progressive disease|0|||
41990567|NCT01220128|75798616|FG005|Overall Study|Progressive disease|0|||
41990568|NCT01220128|75798617|FG006|Overall Study|Progressive disease|0|||
41990569|NCT01220128|75798611|FG000|Overall Study|Sponsor study termination|0|||
42033026|NCT01074450|75841199|FG001|Second Intervention|Physician Decision|1|||
42033027|NCT00943761|75841207|FG000|Overall Study|Lost to Follow-up|2|||
42251135|NCT02737475|76076849|FG025|Overall Study|Disease Progression|0|||
42251136|NCT02737475|76076850|FG026|Overall Study|Disease Progression|1|||
41990570|NCT01220128|75798612|FG001|Overall Study|Sponsor study termination|1|||
42033028|NCT00943761|75841208|FG001|Overall Study|Lost to Follow-up|0|||
42251137|NCT02557672|76076940|FG000|Overall Study|Withdrawal by Subject|4|||
42304271|NCT02205333|76139648|FG005|Overall Study|Withdrawal by Subject|0|||
42304272|NCT02205333|76139649|FG006|Overall Study|Withdrawal by Subject|2|||
42304273|NCT02205333|76139650|FG007|Overall Study|Withdrawal by Subject|0|||
42304274|NCT02205333|76139651|FG008|Overall Study|Withdrawal by Subject|0|||
42304275|NCT02230683|76139671|FG000|Overall Study|Adverse Event|1|||
42304276|NCT02230527|76139683|FG000|Overall Study|Withdrawal by Subject|1|||
42304277|NCT02230527|76139684|FG001|Overall Study|Withdrawal by Subject|1|||
42304278|NCT02230527|76139683|FG000|Overall Study|Death|1|||
42304279|NCT02230527|76139684|FG001|Overall Study|Death|0|||
42304280|NCT02230527|76139683|FG000|Overall Study|Lost to Follow-up|2|||
42304281|NCT02230527|76139684|FG001|Overall Study|Lost to Follow-up|1|||
42304282|NCT02230527|76139683|FG000|Overall Study|Other|1|||
42304283|NCT02230527|76139684|FG001|Overall Study|Other|0|||
42304284|NCT02204319|76139690|FG000|Overall Study|Pregnancy|1|||
42304285|NCT02204319|76139690|FG000|Overall Study|Withdrawal by Subject|2|||
42304286|NCT02204007|76139697|FG000|Overall Study|Surgery Canceled|1|||
42304287|NCT02204007|76139698|FG001|Overall Study|Surgery Canceled|1|||
42304288|NCT02203851|76139704|FG000|Overall Study|Lost to Follow-up|4|||
42304289|NCT02203851|76139704|FG000|Overall Study|Withdrawal by Subject|6|||
42304290|NCT02203851|76139704|FG000|Overall Study|Other|1|||
42304291|NCT02228967|76139717|FG000|Overall Study|Lost to Follow-up|146|||
42304292|NCT02228967|76139718|FG001|Overall Study|Lost to Follow-up|142|||
42304293|NCT02228967|76139717|FG000|Overall Study|Withdrawal by Subject|13|||
42304294|NCT02228967|76139718|FG001|Overall Study|Withdrawal by Subject|18|||
42304295|NCT02227875|76139726|FG000|Overall Study|Protocol Violation|10|||
42304296|NCT02227875|76139727|FG001|Overall Study|Protocol Violation|7|||
42304297|NCT02227875|76139726|FG000|Overall Study|Other|1|||
42304298|NCT02227875|76139727|FG001|Overall Study|Other|3|||
42304299|NCT02227875|76139726|FG000|Overall Study|Physician Decision|1|||
42304300|NCT02227875|76139727|FG001|Overall Study|Physician Decision|0|||
42304301|NCT02227875|76139726|FG000|Overall Study|Adverse Event|3|||
42304302|NCT02227875|76139727|FG001|Overall Study|Adverse Event|0|||
42304303|NCT02227875|76139726|FG000|Overall Study|Withdrawal by Subject|12|||
42304304|NCT02227875|76139727|FG001|Overall Study|Withdrawal by Subject|13|||
42304305|NCT02227875|76139726|FG000|Overall Study|Lost to Follow-up|10|||
42304306|NCT02227875|76139727|FG001|Overall Study|Lost to Follow-up|10|||
42304307|NCT02203149|76139738|FG000|Part 1|Adverse Event|0|||
42304308|NCT02203149|76139739|FG001|Part 1|Adverse Event|1|||
42304309|NCT02203149|76139740|FG002|Part 1|Adverse Event|0|||
42304310|NCT02203149|76139741|FG003|Part 1|Adverse Event|0|||
42304311|NCT02203149|76139742|FG004|Part 1|Adverse Event|0|||
42304312|NCT02203149|76139738|FG000|Part 2|Death|0|||
42304313|NCT02203149|76139739|FG001|Part 2|Death|0|||
42304314|NCT02203149|76139740|FG002|Part 2|Death|1|||
41990571|NCT01220128|75798613|FG002|Overall Study|Sponsor study termination|0|||
41990572|NCT01220128|75798614|FG003|Overall Study|Sponsor study termination|0|||
41990573|NCT01220128|75798615|FG004|Overall Study|Sponsor study termination|0|||
41990574|NCT01220128|75798616|FG005|Overall Study|Sponsor study termination|0|||
41990575|NCT01220128|75798617|FG006|Overall Study|Sponsor study termination|1|||
41990576|NCT01220128|75798611|FG000|Overall Study|Adverse event, serious fatal|2|||
41990577|NCT01220128|75798612|FG001|Overall Study|Adverse event, serious fatal|0|||
41990578|NCT01220128|75798613|FG002|Overall Study|Adverse event, serious fatal|0|||
41990579|NCT01220128|75798614|FG003|Overall Study|Adverse event, serious fatal|0|||
41990580|NCT01220128|75798615|FG004|Overall Study|Adverse event, serious fatal|0|||
42304315|NCT02203149|76139741|FG003|Part 2|Death|1|||
42304316|NCT02203149|76139742|FG004|Part 2|Death|0|||
42304317|NCT02203149|76139738|FG000|Part 2|Withdrawal by Subject|0|||
42304318|NCT02203149|76139739|FG001|Part 2|Withdrawal by Subject|0|||
41990581|NCT01220128|75798616|FG005|Overall Study|Adverse event, serious fatal|0|||
42304319|NCT02203149|76139740|FG002|Part 2|Withdrawal by Subject|0|||
42304320|NCT02203149|76139741|FG003|Part 2|Withdrawal by Subject|1|||
42304321|NCT02203149|76139742|FG004|Part 2|Withdrawal by Subject|0|||
42304322|NCT02203149|76139738|FG000|Part 2|Adverse Event|0|||
42304323|NCT02203149|76139739|FG001|Part 2|Adverse Event|0|||
42304324|NCT02203149|76139740|FG002|Part 2|Adverse Event|0|||
42304325|NCT02203149|76139741|FG003|Part 2|Adverse Event|1|||
42304326|NCT02203149|76139742|FG004|Part 2|Adverse Event|1|||
42304327|NCT02203071|76139766|FG000|Overall Study|Lost to Follow-up|3|||
42304328|NCT02203071|76139767|FG001|Overall Study|Lost to Follow-up|1|||
42304329|NCT02202837|76139775|FG000|Overall Study|Enbrel treatment discontinued|36|||
42304330|NCT02202837|76139776|FG001|Overall Study|Enbrel treatment discontinued|4|||
42304331|NCT02202837|76139775|FG000|Overall Study|Other|10|||
41990582|NCT01220128|75798617|FG006|Overall Study|Adverse event, serious fatal|1|||
41990583|NCT01220128|75798611|FG000|Overall Study|Adverse event, non-fatal|1|||
41990584|NCT01220128|75798612|FG001|Overall Study|Adverse event, non-fatal|0|||
42251138|NCT02557672|76076941|FG001|Overall Study|Withdrawal by Subject|2|||
42251139|NCT02714426|76076953|FG000|Overall Study|Withdrawal by Subject|2|||
42251140|NCT02714426|76076954|FG001|Overall Study|Withdrawal by Subject|2|||
42251141|NCT02925923|76076967|FG000|Overall Study|blood samples hemolyzed|0|||
42251142|NCT02925923|76076968|FG001|Overall Study|blood samples hemolyzed|2|||
42251143|NCT02410343|76076976|FG000|Core Period (24 Weeks)|Adverse Event|1|||
41990585|NCT01220128|75798613|FG002|Overall Study|Adverse event, non-fatal|0|||
41990586|NCT01220128|75798614|FG003|Overall Study|Adverse event, non-fatal|0|||
41990587|NCT01220128|75798615|FG004|Overall Study|Adverse event, non-fatal|0|||
41990588|NCT01220128|75798616|FG005|Overall Study|Adverse event, non-fatal|0|||
41990589|NCT01220128|75798617|FG006|Overall Study|Adverse event, non-fatal|3|||
41990590|NCT01220128|75798611|FG000|Overall Study|Other|0|||
41990591|NCT01220128|75798612|FG001|Overall Study|Other|0|||
41990592|NCT01220128|75798613|FG002|Overall Study|Other|1|||
41990593|NCT01220128|75798614|FG003|Overall Study|Other|0|||
42251144|NCT02410343|76076977|FG001|Core Period (24 Weeks)|Adverse Event|0|||
42251145|NCT02410343|76076976|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
42251146|NCT02410343|76076977|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
42251147|NCT02410343|76076976|FG000|Extension Period (12 Months)|Adverse Event|1|||
42251148|NCT02410343|76076977|FG001|Extension Period (12 Months)|Adverse Event|0|||
42251149|NCT02410343|76076976|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
42251150|NCT02410343|76076977|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
42251151|NCT03064841|76076984|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
42251152|NCT03064841|76076984|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
42251153|NCT03064841|76076984|FG000|Overall Study|Screen failure|2|||
42251154|NCT02045303|76076990|FG000|Overall Study|Protocol Violation|2|||
42251155|NCT02045303|76076991|FG001|Overall Study|Protocol Violation|1|||
42251156|NCT02045303|76076992|FG002|Overall Study|Protocol Violation|0|||
42251157|NCT02045303|76076990|FG000|Overall Study|Withdrawal by Subject|0|||
42251158|NCT02045303|76076991|FG001|Overall Study|Withdrawal by Subject|2|||
42251159|NCT02045303|76076992|FG002|Overall Study|Withdrawal by Subject|0|||
42251160|NCT03064451|76077005|FG000|Overall Study|Lost to Follow-up|1|||
42251161|NCT03064451|76077005|FG000|Overall Study|Mapping Failure|4|||
42251162|NCT03064451|76077005|FG000|Overall Study|Exited prior to procedure|8|||
42251163|NCT03064451|76077005|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
42251164|NCT03058679|76077011|FG000|Baseline to Week 6|Lost to Follow-up|3|||
42251165|NCT03058679|76077012|FG001|Baseline to Week 6|Lost to Follow-up|2|||
42251166|NCT03058679|76077011|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
42251167|NCT03058679|76077012|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
42251168|NCT03058679|76077011|FG000|Baseline to Week 6|Adverse Event|6|||
42251169|NCT03058679|76077012|FG001|Baseline to Week 6|Adverse Event|6|||
42251170|NCT03058679|76077011|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
42251171|NCT03058679|76077012|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
42251172|NCT03058679|76077011|FG000|Baseline to Week 6|Difficulty following the diet|0|||
42251173|NCT03058679|76077012|FG001|Baseline to Week 6|Difficulty following the diet|2|||
42251174|NCT03058679|76077011|FG000|Baseline to Week 6|Physician Decision|1|||
42251175|NCT03058679|76077012|FG001|Baseline to Week 6|Physician Decision|0|||
42251176|NCT03058679|76077011|FG000|Week 6 to Week 12|Change in medication|5|||
42251177|NCT03058679|76077012|FG001|Week 6 to Week 12|Change in medication|7|||
42251178|NCT03058679|76077011|FG000|Week 6 to Week 12|Adverse Event|4|||
42251179|NCT03058679|76077012|FG001|Week 6 to Week 12|Adverse Event|3|||
42251180|NCT03058679|76077011|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
42251181|NCT03058679|76077012|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
42304332|NCT02202837|76139776|FG001|Overall Study|Other|0|||
42304333|NCT02202837|76139775|FG000|Overall Study|Lost to Follow-up|7|||
42304334|NCT02202837|76139776|FG001|Overall Study|Lost to Follow-up|1|||
42304335|NCT02202759|76139785|FG000|Overall Study|Study Terminated by Sponsor|3|||
42304336|NCT02202759|76139786|FG001|Overall Study|Study Terminated by Sponsor|3|||
42304337|NCT02202759|76139787|FG002|Overall Study|Study Terminated by Sponsor|3|||
42304338|NCT02202759|76139785|FG000|Overall Study|Withdrawal by Subject|2|||
42304339|NCT02202759|76139786|FG001|Overall Study|Withdrawal by Subject|1|||
42304340|NCT02202759|76139787|FG002|Overall Study|Withdrawal by Subject|1|||
42304341|NCT02202759|76139785|FG000|Overall Study|Reason not Specified|4|||
42304342|NCT02202759|76139786|FG001|Overall Study|Reason not Specified|11|||
42304343|NCT02202759|76139787|FG002|Overall Study|Reason not Specified|10|||
42304344|NCT02226549|76139796|FG000|Overall Study|Randomized but Never Treated|1|||
42304345|NCT02226549|76139797|FG001|Overall Study|Randomized but Never Treated|0|||
41990594|NCT01220128|75798615|FG004|Overall Study|Other|0|||
42304346|NCT02226549|76139796|FG000|Overall Study|Lost to Follow-up|0|||
42304347|NCT02226549|76139797|FG001|Overall Study|Lost to Follow-up|1|||
42304348|NCT02226003|76139806|FG000|Overall Study|Lost to Follow-up|2|||
42304349|NCT02226003|76139807|FG001|Overall Study|Lost to Follow-up|1|||
42304350|NCT02226003|76139808|FG002|Overall Study|Lost to Follow-up|3|||
41990595|NCT01220128|75798616|FG005|Overall Study|Other|0|||
41990596|NCT01220128|75798617|FG006|Overall Study|Other|0|||
41990597|NCT01220128|75798611|FG000|Overall Study|Consent withdrawn by subject|1|||
41990598|NCT01220128|75798612|FG001|Overall Study|Consent withdrawn by subject|0|||
41990599|NCT01220128|75798613|FG002|Overall Study|Consent withdrawn by subject|0|||
41990600|NCT01220128|75798614|FG003|Overall Study|Consent withdrawn by subject|0|||
41990601|NCT01220128|75798615|FG004|Overall Study|Consent withdrawn by subject|0|||
41990602|NCT01220128|75798616|FG005|Overall Study|Consent withdrawn by subject|0|||
41990603|NCT01220128|75798617|FG006|Overall Study|Consent withdrawn by subject|0|||
41990604|NCT01219933|75798634|FG000|Overall Study|Adverse Event|8|||
41990605|NCT01219933|75798634|FG000|Overall Study|No LDA reached|5|||
41990606|NCT01219933|75798634|FG000|Overall Study|No LDA maintained|7|||
41990607|NCT01219933|75798634|FG000|Overall Study|Lost to Follow-up|3|||
42033029|NCT00943761|75841207|FG000|Overall Study|Withdrawal by Subject|2|||
42033030|NCT00943761|75841208|FG001|Overall Study|Withdrawal by Subject|1|||
42033031|NCT00949533|75841216|FG000|Overall Study|Lost to Follow-up|0|||
42033032|NCT00949533|75841217|FG001|Overall Study|Lost to Follow-up|1|||
42033033|NCT00866047|75841223|FG000|Treatment Period|Progressive disease|13|||
42033034|NCT00866047|75841223|FG000|Treatment Period|Adverse Event|16|||
42033035|NCT00866047|75841223|FG000|Treatment Period|Physician Decision|14|||
42033036|NCT00866047|75841223|FG000|Treatment Period|Withdrawal by Subject|5|||
42033037|NCT00866047|75841223|FG000|Follow-up Period|Lost to Follow-up|5|||
42033038|NCT00869323|75841227|FG000|Maintenance Therapy|concurrent illness|1|||
42033039|NCT01192022|75841235|FG000|Overall Study|Withdrawal of Consent|3|||
42033040|NCT01192022|75841236|FG001|Overall Study|Withdrawal of Consent|1|||
42033041|NCT01192022|75841237|FG002|Overall Study|Withdrawal of Consent|0|||
42033042|NCT01192022|75841238|FG003|Overall Study|Withdrawal of Consent|0|||
42033043|NCT01192022|75841239|FG004|Overall Study|Withdrawal of Consent|0|||
42033044|NCT01192022|75841235|FG000|Overall Study|Lost to Follow-up|4|||
42033045|NCT01192022|75841236|FG001|Overall Study|Lost to Follow-up|2|||
42033046|NCT01192022|75841237|FG002|Overall Study|Lost to Follow-up|1|||
42033047|NCT01192022|75841238|FG003|Overall Study|Lost to Follow-up|1|||
42033048|NCT01192022|75841239|FG004|Overall Study|Lost to Follow-up|0|||
42033049|NCT01192022|75841235|FG000|Overall Study|Adverse Event|1|||
42033050|NCT01192022|75841236|FG001|Overall Study|Adverse Event|0|||
42033051|NCT01192022|75841237|FG002|Overall Study|Adverse Event|0|||
42033052|NCT01192022|75841238|FG003|Overall Study|Adverse Event|0|||
42033053|NCT01192022|75841239|FG004|Overall Study|Adverse Event|0|||
42033054|NCT01192022|75841235|FG000|Overall Study|Fatal Adverse Event|4|||
42033055|NCT01192022|75841236|FG001|Overall Study|Fatal Adverse Event|6|||
42033056|NCT01192022|75841237|FG002|Overall Study|Fatal Adverse Event|0|||
42251182|NCT03058679|76077011|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
42251183|NCT03058679|76077012|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
42251184|NCT03382821|76077020|FG000|Overall Study|Did not receive allocated intervention.|0|||
41990608|NCT01219933|75798634|FG000|Overall Study|GC free|1|||
41990609|NCT01219933|75798634|FG000|Overall Study|Withdrawal by Subject|5|||
41990610|NCT01219933|75798634|FG000|Overall Study|Protocol Violation|8|||
41990611|NCT01219933|75798634|FG000|Overall Study|Lack of Efficacy|1|||
42251185|NCT03382821|76077021|FG001|Overall Study|Did not receive allocated intervention.|3|||
42251186|NCT02557516|76077032|FG000|Overall Study|Adverse Event|1|||
42251187|NCT02557516|76077033|FG001|Overall Study|Adverse Event|0|||
42251188|NCT02557516|76077034|FG002|Overall Study|Adverse Event|2|||
42251189|NCT02557516|76077035|FG003|Overall Study|Adverse Event|1|||
42251190|NCT02557516|76077032|FG000|Overall Study|Disease progression|0|||
42251191|NCT02557516|76077033|FG001|Overall Study|Disease progression|2|||
42251192|NCT02557516|76077034|FG002|Overall Study|Disease progression|0|||
42251193|NCT02557516|76077035|FG003|Overall Study|Disease progression|0|||
42033057|NCT01192022|75841238|FG003|Overall Study|Fatal Adverse Event|0|||
42033058|NCT01192022|75841239|FG004|Overall Study|Fatal Adverse Event|1|||
42033059|NCT01192022|75841235|FG000|Overall Study|Physician withdrew-patient hardship|1|||
42251194|NCT02557516|76077032|FG000|Overall Study|Physician Decision|0|||
42304351|NCT02226003|76139806|FG000|Overall Study|Withdrawal by Subject|0|||
42304352|NCT02226003|76139807|FG001|Overall Study|Withdrawal by Subject|0|||
41990612|NCT01218802|75798641|FG000|Overall Study|Lost to Follow-up|5|||
41990613|NCT01218802|75798642|FG001|Overall Study|Lost to Follow-up|6|||
41990614|NCT01218802|75798641|FG000|Overall Study|Withdrawal by Subject|3|||
41990615|NCT01218802|75798642|FG001|Overall Study|Withdrawal by Subject|10|||
42033060|NCT01192022|75841236|FG001|Overall Study|Physician withdrew-patient hardship|0|||
42033061|NCT01192022|75841237|FG002|Overall Study|Physician withdrew-patient hardship|0|||
42033062|NCT01192022|75841238|FG003|Overall Study|Physician withdrew-patient hardship|0|||
42033063|NCT01192022|75841239|FG004|Overall Study|Physician withdrew-patient hardship|0|||
42033064|NCT01192022|75841235|FG000|Overall Study|Patient too sick from chemotherapy|0|||
42033065|NCT01192022|75841236|FG001|Overall Study|Patient too sick from chemotherapy|1|||
42033066|NCT01192022|75841237|FG002|Overall Study|Patient too sick from chemotherapy|0|||
42251195|NCT02557516|76077033|FG001|Overall Study|Physician Decision|2|||
42251196|NCT02557516|76077034|FG002|Overall Study|Physician Decision|0|||
42251197|NCT02557516|76077035|FG003|Overall Study|Physician Decision|0|||
42251198|NCT02557516|76077032|FG000|Overall Study|Sponsor decision|0|||
42251199|NCT02557516|76077033|FG001|Overall Study|Sponsor decision|1|||
42251200|NCT02557516|76077034|FG002|Overall Study|Sponsor decision|2|||
42251201|NCT02557516|76077035|FG003|Overall Study|Sponsor decision|8|||
42251202|NCT00711555|76077054|FG000|Overall Study|Adverse Event|3|||
42251203|NCT02713490|76077059|FG000|Overall Study|Withdrawal by Subject|2|||
42251204|NCT02713490|76077060|FG001|Overall Study|Withdrawal by Subject|1|||
42304353|NCT02226003|76139808|FG002|Overall Study|Withdrawal by Subject|3|||
42033067|NCT01192022|75841238|FG003|Overall Study|Patient too sick from chemotherapy|0|||
42033068|NCT01192022|75841239|FG004|Overall Study|Patient too sick from chemotherapy|0|||
42033069|NCT01192022|75841235|FG000|Overall Study|Patient needed surgery|0|||
42033070|NCT01192022|75841236|FG001|Overall Study|Patient needed surgery|1|||
42033071|NCT01192022|75841237|FG002|Overall Study|Patient needed surgery|0|||
42033072|NCT01192022|75841238|FG003|Overall Study|Patient needed surgery|0|||
42033073|NCT01192022|75841239|FG004|Overall Study|Patient needed surgery|0|||
42033074|NCT01192022|75841235|FG000|Overall Study|Parents did not allow all follow up|0|||
42033075|NCT01192022|75841236|FG001|Overall Study|Parents did not allow all follow up|0|||
42033076|NCT01192022|75841237|FG002|Overall Study|Parents did not allow all follow up|0|||
42033077|NCT01192022|75841238|FG003|Overall Study|Parents did not allow all follow up|1|||
42033078|NCT01192022|75841239|FG004|Overall Study|Parents did not allow all follow up|0|||
42033079|NCT01191944|75841252|FG000|Overall Study|Adverse Event|11|||
42033080|NCT01191944|75841253|FG001|Overall Study|Adverse Event|12|||
42033081|NCT01191944|75841252|FG000|Overall Study|Protocol Violation|1|||
42033082|NCT01191944|75841253|FG001|Overall Study|Protocol Violation|2|||
42033083|NCT01191944|75841252|FG000|Overall Study|Withdrawal by Subject|4|||
42033084|NCT01191944|75841253|FG001|Overall Study|Withdrawal by Subject|2|||
42033085|NCT01191944|75841252|FG000|Overall Study|Other|1|||
42033086|NCT01191944|75841253|FG001|Overall Study|Other|3|||
42033087|NCT01191788|75841261|FG000|Overall Study|Lost to Follow-up|21|||
42304354|NCT02225223|76139818|FG000|Overall Study|Death|10|||
42304355|NCT02225223|76139819|FG001|Overall Study|Death|1|||
42304356|NCT02225223|76139818|FG000|Overall Study|Lost to Follow-up|5|||
42304357|NCT02225223|76139819|FG001|Overall Study|Lost to Follow-up|0|||
42304358|NCT02225223|76139818|FG000|Overall Study|Other|1|||
42304359|NCT02225223|76139819|FG001|Overall Study|Other|2|||
42304360|NCT02225223|76139818|FG000|Overall Study|Physician Decision|1|||
41990616|NCT01218802|75798641|FG000|Overall Study|Adverse Event|0|||
41990617|NCT01218802|75798642|FG001|Overall Study|Adverse Event|2|||
41990618|NCT01218802|75798641|FG000|Overall Study|Incarcerated|2|||
41990619|NCT01218802|75798642|FG001|Overall Study|Incarcerated|0|||
41990620|NCT01218646|75798652|FG000|Overall Study|Adverse Event|0|||
41990621|NCT01218646|75798653|FG001|Overall Study|Adverse Event|0|||
41990622|NCT01218646|75798654|FG002|Overall Study|Adverse Event|1|||
41990623|NCT01218646|75798655|FG003|Overall Study|Adverse Event|0|||
41990624|NCT01218646|75798652|FG000|Overall Study|Lost to Follow-up|1|||
41990625|NCT01218646|75798653|FG001|Overall Study|Lost to Follow-up|0|||
41990626|NCT01218646|75798654|FG002|Overall Study|Lost to Follow-up|0|||
41990627|NCT01218646|75798655|FG003|Overall Study|Lost to Follow-up|0|||
41990628|NCT01218646|75798652|FG000|Overall Study|Protocol Violation|0|||
41990629|NCT01218646|75798653|FG001|Overall Study|Protocol Violation|0|||
41990630|NCT01218646|75798654|FG002|Overall Study|Protocol Violation|1|||
41990631|NCT01218646|75798655|FG003|Overall Study|Protocol Violation|1|||
42033088|NCT01191788|75841262|FG001|Overall Study|Lost to Follow-up|22|||
42033089|NCT00940875|75841271|FG000|Treatment Phase|Adverse Event|9|||
42033090|NCT00940875|75841272|FG001|Treatment Phase|Adverse Event|3|||
42251205|NCT02713490|76077059|FG000|Overall Study|Did not receive study drug|1|||
42251206|NCT02713490|76077060|FG001|Overall Study|Did not receive study drug|0|||
41990632|NCT01188772|75798669|FG000|Overall Study|Randomized but Not Treated|0|||
42251207|NCT02713490|76077059|FG000|Overall Study|Met exclusion criteria|0|||
42033091|NCT00940875|75841271|FG000|Treatment Phase|Death|3|||
42033092|NCT00940875|75841272|FG001|Treatment Phase|Death|5|||
42033093|NCT00940875|75841271|FG000|Treatment Phase|Lack of Efficacy|1|||
42033094|NCT00940875|75841272|FG001|Treatment Phase|Lack of Efficacy|0|||
42033095|NCT00940875|75841271|FG000|Treatment Phase|Withdrawal by Subject|3|||
42304361|NCT02225223|76139819|FG001|Overall Study|Physician Decision|0|||
41990633|NCT01188772|75798670|FG001|Overall Study|Randomized but Not Treated|1|||
41990634|NCT01188772|75798671|FG002|Overall Study|Randomized but Not Treated|0|||
42251208|NCT02713490|76077060|FG001|Overall Study|Met exclusion criteria|1|||
42251209|NCT03772574|76077069|FG000|Overall Study|Protocol Violation|2|||
42251210|NCT03772574|76077070|FG001|Overall Study|Protocol Violation|0|||
42251211|NCT03772574|76077071|FG002|Overall Study|Protocol Violation|0|||
42251212|NCT03772574|76077069|FG000|Overall Study|Discomfort|0|||
42251213|NCT03772574|76077070|FG001|Overall Study|Discomfort|5|||
42251214|NCT03772574|76077071|FG002|Overall Study|Discomfort|4|||
42304362|NCT02225223|76139818|FG000|Overall Study|Withdrawal by Subject|2|||
42304363|NCT02225223|76139819|FG001|Overall Study|Withdrawal by Subject|2|||
42304364|NCT01634139|76139828|FG000|Overall Study|Non compliant with protocol|1|||
42251215|NCT02743221|76077081|FG000|Overall Study|Progressive disease|29|||
42251216|NCT02743221|76077082|FG001|Overall Study|Progressive disease|38|||
42251217|NCT02743221|76077081|FG000|Overall Study|Adverse Event|17|||
42251218|NCT02743221|76077082|FG001|Overall Study|Adverse Event|14|||
42251219|NCT02743221|76077081|FG000|Overall Study|non medical reason|8|||
42251220|NCT02743221|76077082|FG001|Overall Study|non medical reason|2|||
42251221|NCT02743221|76077081|FG000|Overall Study|Physician Decision|2|||
42251222|NCT02743221|76077082|FG001|Overall Study|Physician Decision|5|||
42251223|NCT02743221|76077081|FG000|Overall Study|Patient not eligible, not treated|0|||
42251224|NCT02743221|76077082|FG001|Overall Study|Patient not eligible, not treated|1|||
42251225|NCT03836625|76077090|FG000|Overall Study|Lost to Follow-up|9|||
42251226|NCT03836625|76077091|FG001|Overall Study|Lost to Follow-up|9|||
42251227|NCT03836625|76077090|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
42251228|NCT03836625|76077091|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
42251229|NCT03836625|76077090|FG000|Overall Study|Death|0|||
42251230|NCT03836625|76077091|FG001|Overall Study|Death|1|||
42251231|NCT03836625|76077090|FG000|Overall Study|Refused follow-up|0|||
42251232|NCT03836625|76077091|FG001|Overall Study|Refused follow-up|1|||
42251233|NCT01358968|76077097|FG000|Period 2|Adverse Event|0|||
42304365|NCT01634139|76139829|FG001|Overall Study|Non compliant with protocol|0|||
42304366|NCT01634139|76139830|FG002|Overall Study|Non compliant with protocol|0|||
42304367|NCT01634139|76139828|FG000|Overall Study|Consent withdrawn not due to AE|4|||
42304368|NCT01634139|76139829|FG001|Overall Study|Consent withdrawn not due to AE|3|||
42304369|NCT01634139|76139830|FG002|Overall Study|Consent withdrawn not due to AE|2|||
42304370|NCT01634139|76139828|FG000|Overall Study|Other|4|||
42304371|NCT01634139|76139829|FG001|Overall Study|Other|0|||
42304372|NCT01634139|76139830|FG002|Overall Study|Other|3|||
42304373|NCT01634139|76139828|FG000|Overall Study|Lost to Follow-up|0|||
42304374|NCT01634139|76139829|FG001|Overall Study|Lost to Follow-up|2|||
42304375|NCT01634139|76139830|FG002|Overall Study|Lost to Follow-up|0|||
42304376|NCT01634139|76139828|FG000|Overall Study|Not treated|1|||
42251234|NCT01358968|76077098|FG001|Period 2|Adverse Event|1|||
42251235|NCT01358968|76077099|FG002|Period 2|Adverse Event|0|||
42251236|NCT01358968|76077100|FG003|Period 2|Adverse Event|0|||
42304377|NCT01634139|76139829|FG001|Overall Study|Not treated|1|||
42304378|NCT01634139|76139830|FG002|Overall Study|Not treated|0|||
42304379|NCT02224755|76139840|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
42251237|NCT01358968|76077097|FG000|Continued Access Phase|Progression of Disease|0|||
42251238|NCT01358968|76077098|FG001|Continued Access Phase|Progression of Disease|0|||
42251239|NCT01358968|76077099|FG002|Continued Access Phase|Progression of Disease|8|||
42251240|NCT01358968|76077100|FG003|Continued Access Phase|Progression of Disease|4|||
42251241|NCT01358968|76077097|FG000|Continued Access Phase|Protocol Violation|0|||
42304380|NCT02224755|76139841|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
42304381|NCT02224755|76139840|FG000|Two Year Follow up Post-implant|Death|103|||
42304382|NCT02224755|76139841|FG001|Two Year Follow up Post-implant|Death|98|||
42304383|NCT02224755|76139840|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
42304384|NCT02224755|76139841|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
42304385|NCT02224755|76139840|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
42304386|NCT02224755|76139841|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
42304387|NCT02224755|76139840|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
42304388|NCT02224755|76139841|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
42304389|NCT02404441|76139861|FG000|Phase 1 Part|Adverse Event|1|||
42304390|NCT02404441|76139862|FG001|Phase 1 Part|Adverse Event|0|||
42304391|NCT02404441|76139863|FG002|Phase 1 Part|Adverse Event|0|||
42304392|NCT02404441|76139864|FG003|Phase 1 Part|Adverse Event|0|||
42304393|NCT02404441|76139865|FG004|Phase 1 Part|Adverse Event|0|||
42304394|NCT02404441|76139866|FG005|Phase 1 Part|Adverse Event|0|||
42304395|NCT02404441|76139867|FG006|Phase 1 Part|Adverse Event|0|||
42304396|NCT02404441|76139868|FG007|Phase 1 Part|Adverse Event|0|||
42304397|NCT02404441|76139869|FG008|Phase 1 Part|Adverse Event|0|||
42304398|NCT02404441|76139870|FG009|Phase 1 Part|Adverse Event|0|||
42304399|NCT02404441|76139861|FG000|Phase 1 Part|Physician Decision|0|||
42304400|NCT02404441|76139862|FG001|Phase 1 Part|Physician Decision|1|||
42304401|NCT02404441|76139863|FG002|Phase 1 Part|Physician Decision|0|||
42304402|NCT02404441|76139864|FG003|Phase 1 Part|Physician Decision|0|||
42304403|NCT02404441|76139865|FG004|Phase 1 Part|Physician Decision|0|||
42304404|NCT02404441|76139866|FG005|Phase 1 Part|Physician Decision|0|||
42304405|NCT02404441|76139867|FG006|Phase 1 Part|Physician Decision|0|||
42304406|NCT02404441|76139868|FG007|Phase 1 Part|Physician Decision|0|||
42304407|NCT02404441|76139869|FG008|Phase 1 Part|Physician Decision|0|||
42304408|NCT02404441|76139870|FG009|Phase 1 Part|Physician Decision|0|||
42304409|NCT02404441|76139861|FG000|Phase 1 Part|Progressive Disease|14|||
42304410|NCT02404441|76139862|FG001|Phase 1 Part|Progressive Disease|11|||
42304411|NCT02404441|76139863|FG002|Phase 1 Part|Progressive Disease|7|||
42304412|NCT02404441|76139864|FG003|Phase 1 Part|Progressive Disease|6|||
42304413|NCT02404441|76139865|FG004|Phase 1 Part|Progressive Disease|9|||
42304414|NCT02404441|76139866|FG005|Phase 1 Part|Progressive Disease|0|||
42304415|NCT02404441|76139867|FG006|Phase 1 Part|Progressive Disease|0|||
42304416|NCT02404441|76139868|FG007|Phase 1 Part|Progressive Disease|0|||
42304417|NCT02404441|76139869|FG008|Phase 1 Part|Progressive Disease|0|||
42304418|NCT02404441|76139870|FG009|Phase 1 Part|Progressive Disease|0|||
42304419|NCT02404441|76139861|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
42304420|NCT02404441|76139862|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
42304421|NCT02404441|76139863|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
42304422|NCT02404441|76139864|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
42304423|NCT02404441|76139865|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
42304424|NCT02404441|76139866|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
42304425|NCT02404441|76139867|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
42304426|NCT02404441|76139868|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
42304427|NCT02404441|76139869|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
42304428|NCT02404441|76139870|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
42304429|NCT02404441|76139861|FG000|Phase 1 Part|Death|1|||
42304430|NCT02404441|76139862|FG001|Phase 1 Part|Death|1|||
42304431|NCT02404441|76139863|FG002|Phase 1 Part|Death|1|||
42304432|NCT02404441|76139864|FG003|Phase 1 Part|Death|0|||
42304433|NCT02404441|76139865|FG004|Phase 1 Part|Death|1|||
42304434|NCT02404441|76139866|FG005|Phase 1 Part|Death|0|||
42304435|NCT02404441|76139867|FG006|Phase 1 Part|Death|0|||
42304436|NCT02404441|76139868|FG007|Phase 1 Part|Death|0|||
42304437|NCT02404441|76139869|FG008|Phase 1 Part|Death|0|||
42304438|NCT02404441|76139870|FG009|Phase 1 Part|Death|0|||
42304439|NCT02404441|76139861|FG000|Phase 2 Part|Adverse Event|0|||
42304440|NCT02404441|76139862|FG001|Phase 2 Part|Adverse Event|0|||
42304441|NCT02404441|76139863|FG002|Phase 2 Part|Adverse Event|0|||
42304442|NCT02404441|76139864|FG003|Phase 2 Part|Adverse Event|0|||
42304443|NCT02404441|76139865|FG004|Phase 2 Part|Adverse Event|0|||
42304444|NCT02404441|76139866|FG005|Phase 2 Part|Adverse Event|2|||
42304445|NCT02404441|76139867|FG006|Phase 2 Part|Adverse Event|3|||
42304446|NCT02404441|76139868|FG007|Phase 2 Part|Adverse Event|3|||
42304447|NCT02404441|76139869|FG008|Phase 2 Part|Adverse Event|6|||
42304448|NCT02404441|76139870|FG009|Phase 2 Part|Adverse Event|1|||
42304449|NCT02404441|76139861|FG000|Phase 2 Part|Physician Decision|0|||
42304450|NCT02404441|76139862|FG001|Phase 2 Part|Physician Decision|0|||
42304451|NCT02404441|76139863|FG002|Phase 2 Part|Physician Decision|0|||
42251242|NCT01358968|76077098|FG001|Continued Access Phase|Protocol Violation|0|||
42251243|NCT01358968|76077099|FG002|Continued Access Phase|Protocol Violation|0|||
42251244|NCT01358968|76077100|FG003|Continued Access Phase|Protocol Violation|2|||
42251245|NCT01358968|76077097|FG000|Continued Access Phase|Withdrawal by Subject|0|||
42251246|NCT01358968|76077098|FG001|Continued Access Phase|Withdrawal by Subject|0|||
42251247|NCT01358968|76077099|FG002|Continued Access Phase|Withdrawal by Subject|3|||
42251248|NCT01358968|76077100|FG003|Continued Access Phase|Withdrawal by Subject|0|||
42251249|NCT01358968|76077097|FG000|Continued Access Phase|Death|0|||
42251250|NCT01358968|76077098|FG001|Continued Access Phase|Death|0|||
42251251|NCT01358968|76077099|FG002|Continued Access Phase|Death|1|||
42251252|NCT01358968|76077100|FG003|Continued Access Phase|Death|1|||
42251253|NCT00701090|76077112|FG000|Overall Study|Adverse Event|11|||
41990635|NCT01188772|75798672|FG003|Overall Study|Randomized but Not Treated|0|||
41990636|NCT01188772|75798669|FG000|Overall Study|Adverse Event|0|||
41990637|NCT01188772|75798670|FG001|Overall Study|Adverse Event|1|||
42033096|NCT00940875|75841272|FG001|Treatment Phase|Withdrawal by Subject|0|||
41990638|NCT01188772|75798671|FG002|Overall Study|Adverse Event|2|||
42251254|NCT00701090|76077113|FG001|Overall Study|Adverse Event|2|||
42251255|NCT00701090|76077112|FG000|Overall Study|Death|0|||
42251256|NCT00701090|76077113|FG001|Overall Study|Death|1|||
42251257|NCT00701090|76077112|FG000|Overall Study|Lack of Efficacy|5|||
42251258|NCT00701090|76077113|FG001|Overall Study|Lack of Efficacy|4|||
42251259|NCT00701090|76077112|FG000|Overall Study|Lost to Follow-up|9|||
42251260|NCT00701090|76077113|FG001|Overall Study|Lost to Follow-up|9|||
42251261|NCT00701090|76077112|FG000|Overall Study|Physician Decision|3|||
42251262|NCT00701090|76077113|FG001|Overall Study|Physician Decision|4|||
42251263|NCT00701090|76077112|FG000|Overall Study|Protocol Violation|2|||
42251264|NCT00701090|76077113|FG001|Overall Study|Protocol Violation|3|||
42251265|NCT00701090|76077112|FG000|Overall Study|Withdrawal by Subject|11|||
42251266|NCT00701090|76077113|FG001|Overall Study|Withdrawal by Subject|16|||
42251267|NCT00701090|76077112|FG000|Overall Study|Other|7|||
42251268|NCT00701090|76077113|FG001|Overall Study|Other|12|||
42251269|NCT03057977|76077121|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
42251270|NCT03057977|76077122|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
42251271|NCT03057977|76077121|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
42251272|NCT03057977|76077122|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
42251273|NCT03057977|76077121|FG000|Discontinuation From Treatment|Protocol Violation|6|||
41990639|NCT01188772|75798672|FG003|Overall Study|Adverse Event|0|||
41990640|NCT01188772|75798669|FG000|Overall Study|Lost to Follow-up|4|||
41990641|NCT01188772|75798670|FG001|Overall Study|Lost to Follow-up|1|||
41990642|NCT01188772|75798671|FG002|Overall Study|Lost to Follow-up|1|||
41990643|NCT01188772|75798672|FG003|Overall Study|Lost to Follow-up|1|||
42251274|NCT03057977|76077122|FG001|Discontinuation From Treatment|Protocol Violation|5|||
42251275|NCT03057977|76077121|FG000|Discontinuation From Treatment|Not treated|4|||
42251276|NCT03057977|76077122|FG001|Discontinuation From Treatment|Not treated|0|||
42251277|NCT03057977|76077121|FG000|Discontinuation From Treatment|Adverse Event|343|||
42251278|NCT03057977|76077122|FG001|Discontinuation From Treatment|Adverse Event|337|||
42251279|NCT03057977|76077121|FG000|Discontinuation From Treatment|Reason Unknown|0|||
42251280|NCT03057977|76077122|FG001|Discontinuation From Treatment|Reason Unknown|1|||
42251281|NCT03057977|76077121|FG000|Discontinuation From Treatment|Personal Reasons|1|||
42251282|NCT03057977|76077122|FG001|Discontinuation From Treatment|Personal Reasons|1|||
42251283|NCT03057977|76077121|FG000|Discontinuation From Treatment|Unblinded medication|1|||
42251284|NCT03057977|76077122|FG001|Discontinuation From Treatment|Unblinded medication|0|||
42033097|NCT00940875|75841271|FG000|Treatment Phase|Disease progression|9|||
42033098|NCT00940875|75841272|FG001|Treatment Phase|Disease progression|11|||
41990644|NCT01188772|75798669|FG000|Overall Study|Non-responder|0|||
41990645|NCT01188772|75798670|FG001|Overall Study|Non-responder|0|||
42033099|NCT00940875|75841271|FG000|Treatment Phase|Physician Decision|1|||
42251285|NCT03057977|76077121|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
42251286|NCT03057977|76077122|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
42251287|NCT03057977|76077121|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
42251288|NCT03057977|76077122|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
42251289|NCT03057977|76077121|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
42304452|NCT02404441|76139864|FG003|Phase 2 Part|Physician Decision|0|||
42304453|NCT02404441|76139865|FG004|Phase 2 Part|Physician Decision|0|||
42304454|NCT02404441|76139866|FG005|Phase 2 Part|Physician Decision|7|||
42251290|NCT03057977|76077122|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
42251291|NCT03057977|76077121|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
42251292|NCT03057977|76077122|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
42251293|NCT03057977|76077121|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
42251294|NCT03057977|76077122|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
42251295|NCT03057977|76077121|FG000|Discontinuation From Treatment|Not attending study visit|3|||
42251296|NCT03057977|76077122|FG001|Discontinuation From Treatment|Not attending study visit|10|||
42251297|NCT03057977|76077121|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
42251298|NCT03057977|76077122|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
42251299|NCT03057977|76077121|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
42251300|NCT03057977|76077122|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
42251301|NCT03057977|76077121|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
42251302|NCT03057977|76077122|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
42251303|NCT03057977|76077121|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
42251304|NCT03057977|76077122|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
42304455|NCT02404441|76139867|FG006|Phase 2 Part|Physician Decision|9|||
42304456|NCT02404441|76139868|FG007|Phase 2 Part|Physician Decision|2|||
42304457|NCT02404441|76139869|FG008|Phase 2 Part|Physician Decision|1|||
42304458|NCT02404441|76139870|FG009|Phase 2 Part|Physician Decision|3|||
42304459|NCT02404441|76139861|FG000|Phase 2 Part|Progressive disease|0|||
42304460|NCT02404441|76139862|FG001|Phase 2 Part|Progressive disease|0|||
42304461|NCT02404441|76139863|FG002|Phase 2 Part|Progressive disease|0|||
42304462|NCT02404441|76139864|FG003|Phase 2 Part|Progressive disease|0|||
42304463|NCT02404441|76139865|FG004|Phase 2 Part|Progressive disease|0|||
42304464|NCT02404441|76139866|FG005|Phase 2 Part|Progressive disease|43|||
42304465|NCT02404441|76139867|FG006|Phase 2 Part|Progressive disease|32|||
42304466|NCT02404441|76139868|FG007|Phase 2 Part|Progressive disease|31|||
42304467|NCT02404441|76139869|FG008|Phase 2 Part|Progressive disease|39|||
42304468|NCT02404441|76139870|FG009|Phase 2 Part|Progressive disease|27|||
42304469|NCT02404441|76139861|FG000|Phase 2 Part|Subject/guardian decision|0|||
42304470|NCT02404441|76139862|FG001|Phase 2 Part|Subject/guardian decision|0|||
42304471|NCT02404441|76139863|FG002|Phase 2 Part|Subject/guardian decision|0|||
42304472|NCT02404441|76139864|FG003|Phase 2 Part|Subject/guardian decision|0|||
42304473|NCT02404441|76139865|FG004|Phase 2 Part|Subject/guardian decision|0|||
42304474|NCT02404441|76139866|FG005|Phase 2 Part|Subject/guardian decision|3|||
42304475|NCT02404441|76139867|FG006|Phase 2 Part|Subject/guardian decision|9|||
42304476|NCT02404441|76139868|FG007|Phase 2 Part|Subject/guardian decision|0|||
42304477|NCT02404441|76139869|FG008|Phase 2 Part|Subject/guardian decision|3|||
42304478|NCT02404441|76139870|FG009|Phase 2 Part|Subject/guardian decision|2|||
42304479|NCT02404441|76139861|FG000|Phase 2 Part|Death|0|||
42304480|NCT02404441|76139862|FG001|Phase 2 Part|Death|0|||
42304481|NCT02404441|76139863|FG002|Phase 2 Part|Death|0|||
42304482|NCT02404441|76139864|FG003|Phase 2 Part|Death|0|||
42304483|NCT02404441|76139865|FG004|Phase 2 Part|Death|0|||
42304484|NCT02404441|76139866|FG005|Phase 2 Part|Death|4|||
42304485|NCT02404441|76139867|FG006|Phase 2 Part|Death|8|||
41990646|NCT01188772|75798671|FG002|Overall Study|Non-responder|3|||
41990647|NCT01188772|75798672|FG003|Overall Study|Non-responder|0|||
41990648|NCT01188772|75798669|FG000|Overall Study|Physician Decision|0|||
41990649|NCT01188772|75798670|FG001|Overall Study|Physician Decision|0|||
41990650|NCT01188772|75798671|FG002|Overall Study|Physician Decision|1|||
41990651|NCT01188772|75798672|FG003|Overall Study|Physician Decision|0|||
41990652|NCT01188772|75798669|FG000|Overall Study|Terminated by Sponsor|0|||
41990653|NCT01188772|75798670|FG001|Overall Study|Terminated by Sponsor|0|||
41990654|NCT01188772|75798671|FG002|Overall Study|Terminated by Sponsor|1|||
41990655|NCT01188772|75798672|FG003|Overall Study|Terminated by Sponsor|0|||
41990656|NCT01188772|75798669|FG000|Overall Study|Treatment Failure|0|||
42304486|NCT02404441|76139868|FG007|Phase 2 Part|Death|4|||
42304487|NCT02404441|76139869|FG008|Phase 2 Part|Death|10|||
42304488|NCT02404441|76139870|FG009|Phase 2 Part|Death|9|||
42304489|NCT02101281|76139916|FG000|Overall Study|Adverse Event|0|||
42304490|NCT02101281|76139917|FG001|Overall Study|Adverse Event|1|||
42304491|NCT02224599|76139929|FG000|Overall Study|Physician Decision|1|||
42304492|NCT02224599|76139929|FG000|Overall Study|Progression of Disease|1|||
42304493|NCT02201901|76139936|FG000|Overall Study|Randomized but never treated|0|||
42304494|NCT02201901|76139937|FG001|Overall Study|Randomized but never treated|1|||
42304495|NCT02201901|76139938|FG002|Overall Study|Randomized but never treated|0|||
42132721|NCT00317044|75943525|FG002|Overall Study|Adverse Event|4|||
42132722|NCT00317044|75943523|FG000|Overall Study|Withdrawal by Subject|10|||
42132723|NCT00317044|75943524|FG001|Overall Study|Withdrawal by Subject|7|||
42132724|NCT00317044|75943525|FG002|Overall Study|Withdrawal by Subject|12|||
42132725|NCT00317044|75943523|FG000|Overall Study|Lost to Follow-up|0|||
42132726|NCT00317044|75943524|FG001|Overall Study|Lost to Follow-up|2|||
42132727|NCT00317044|75943525|FG002|Overall Study|Lost to Follow-up|3|||
42132728|NCT00317044|75943523|FG000|Overall Study|Multiple Reasons|6|||
42132729|NCT00317044|75943524|FG001|Overall Study|Multiple Reasons|2|||
42132730|NCT00317044|75943525|FG002|Overall Study|Multiple Reasons|6|||
42132731|NCT00301834|75943533|FG000|Overall Study|Death|1|||
42132732|NCT00301366|75943540|FG000|Overall Study|Adverse Event|1|||
42132733|NCT00330928|75943544|FG000|Overall Study|Lost to Follow-up|6|||
42251305|NCT03057977|76077121|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
42251306|NCT03057977|76077122|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
42251307|NCT03062891|76077134|FG000|Overall Study|Withdrawal by Subject|2|||
42251308|NCT03062891|76077135|FG001|Overall Study|Withdrawal by Subject|0|||
42251309|NCT03062891|76077134|FG000|Overall Study|Lost to Follow-up|50|||
42251310|NCT03062891|76077135|FG001|Overall Study|Lost to Follow-up|38|||
41990657|NCT01188772|75798670|FG001|Overall Study|Treatment Failure|0|||
41990658|NCT01188772|75798671|FG002|Overall Study|Treatment Failure|1|||
42304496|NCT02201901|76139936|FG000|Overall Study|Lack of Efficacy|7|||
42304497|NCT02201901|76139937|FG001|Overall Study|Lack of Efficacy|1|||
42304498|NCT02201901|76139938|FG002|Overall Study|Lack of Efficacy|6|||
42304499|NCT02201901|76139936|FG000|Overall Study|Death|3|||
42304500|NCT02201901|76139937|FG001|Overall Study|Death|3|||
42304501|NCT02201901|76139938|FG002|Overall Study|Death|3|||
42251311|NCT02552212|76077144|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
42251312|NCT02552212|76077145|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
42304502|NCT02201901|76139936|FG000|Overall Study|Lost to Follow-up|2|||
42304503|NCT02201901|76139937|FG001|Overall Study|Lost to Follow-up|3|||
42304504|NCT02201901|76139938|FG002|Overall Study|Lost to Follow-up|2|||
42304505|NCT02201901|76139936|FG000|Overall Study|Withdrew Consent|2|||
42304506|NCT02201901|76139937|FG001|Overall Study|Withdrew Consent|0|||
42304507|NCT02201901|76139938|FG002|Overall Study|Withdrew Consent|2|||
42304508|NCT02201901|76139936|FG000|Overall Study|Adverse Event|1|||
42304509|NCT02201901|76139937|FG001|Overall Study|Adverse Event|1|||
42132734|NCT00330928|75943544|FG000|Overall Study|Physician Decision|9|||
42132735|NCT00330928|75943544|FG000|Overall Study|Death|1|||
42132736|NCT00330928|75943544|FG000|Overall Study|IVUS could not be performed.|1|||
42251313|NCT02552212|76077146|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
42251314|NCT02552212|76077144|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
42304510|NCT02201901|76139938|FG002|Overall Study|Adverse Event|0|||
42304511|NCT02201277|76139949|FG000|Overall Study|Death|3|||
42304512|NCT02201277|76139950|FG001|Overall Study|Death|4|||
42304513|NCT02201277|76139949|FG000|Overall Study|Lost to Follow-up|2|||
42132737|NCT00330616|75943548|FG000|Overall Study|Adverse Event|13|||
42132738|NCT00330616|75943548|FG000|Overall Study|Lack of Efficacy|1|||
42132739|NCT00330616|75943548|FG000|Overall Study|Lost to Follow-up|2|||
42304514|NCT02201277|76139950|FG001|Overall Study|Lost to Follow-up|1|||
42251315|NCT02552212|76077145|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
42251316|NCT02552212|76077146|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
42304515|NCT02201277|76139949|FG000|Overall Study|Failed retrieval|1|||
42304516|NCT02201277|76139950|FG001|Overall Study|Failed retrieval|0|||
42304517|NCT02201277|76139949|FG000|Overall Study|Physician Decision|1|||
42304518|NCT02201277|76139950|FG001|Overall Study|Physician Decision|0|||
42304519|NCT02224053|76139960|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
42304520|NCT02224053|76139960|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
42304521|NCT02224053|76139960|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
42304522|NCT02224053|76139960|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
41990659|NCT01188772|75798672|FG003|Overall Study|Treatment Failure|0|||
41990660|NCT01188772|75798669|FG000|Overall Study|Virologic Failure|1|||
41990661|NCT01188772|75798670|FG001|Overall Study|Virologic Failure|0|||
41990662|NCT01188772|75798671|FG002|Overall Study|Virologic Failure|0|||
42251317|NCT02552212|76077144|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
42251318|NCT02552212|76077145|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
41990663|NCT01188772|75798672|FG003|Overall Study|Virologic Failure|0|||
42251319|NCT02552212|76077146|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
42251320|NCT02552212|76077144|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
42251321|NCT02552212|76077145|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
42251322|NCT02552212|76077146|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
42251323|NCT02552212|76077144|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
42251324|NCT02552212|76077145|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
42251325|NCT02552212|76077146|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
42251326|NCT02552212|76077144|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
42251327|NCT02552212|76077145|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
42251328|NCT02552212|76077146|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
41990664|NCT01188772|75798669|FG000|Overall Study|Withdrawal by Subject|0|||
41990665|NCT01188772|75798670|FG001|Overall Study|Withdrawal by Subject|0|||
41990666|NCT01188772|75798671|FG002|Overall Study|Withdrawal by Subject|2|||
42251329|NCT02552212|76077144|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
41990667|NCT01188772|75798672|FG003|Overall Study|Withdrawal by Subject|0|||
42251330|NCT02552212|76077145|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
41990668|NCT01188655|75798685|FG000|Overall Study|Lack of Efficacy|1|||
41990669|NCT01188655|75798685|FG000|Overall Study|Lost to Follow-up|1|||
41990670|NCT01188655|75798685|FG000|Overall Study|Other|11|||
41990671|NCT01188538|75798691|FG000|Overall Study|Lost to Follow-up|0|||
41990672|NCT01188538|75798692|FG001|Overall Study|Lost to Follow-up|1|||
41990673|NCT01188343|75798703|FG000|Overall Study|Not vaccinated|0|||
41990674|NCT01188343|75798704|FG001|Overall Study|Not vaccinated|2|||
41990675|NCT01188343|75798705|FG002|Overall Study|Not vaccinated|1|||
41990676|NCT01188343|75798703|FG000|Overall Study|Withdrawal by Subject|1|||
41990677|NCT01188343|75798704|FG001|Overall Study|Withdrawal by Subject|24|||
41990678|NCT01188343|75798705|FG002|Overall Study|Withdrawal by Subject|0|||
41990679|NCT01188226|75798716|FG000|Overall Study|Withdrawal by Subject|4|||
41990680|NCT01218100|75798734|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
41990681|NCT01218100|75798735|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
41990682|NCT01218100|75798736|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
41990683|NCT01218100|75798737|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
41990684|NCT01218100|75798734|FG000|Overall Study|Adverse Event|4|||
41990685|NCT01218100|75798735|FG001|Overall Study|Adverse Event|6|||
41990686|NCT01218100|75798736|FG002|Overall Study|Adverse Event|6|||
41990687|NCT01218100|75798737|FG003|Overall Study|Adverse Event|7|||
41990688|NCT01218100|75798734|FG000|Overall Study|Lack of Efficacy|9|||
41990689|NCT01218100|75798735|FG001|Overall Study|Lack of Efficacy|6|||
41990690|NCT01218100|75798736|FG002|Overall Study|Lack of Efficacy|5|||
41990691|NCT01218100|75798737|FG003|Overall Study|Lack of Efficacy|12|||
41990692|NCT01218100|75798734|FG000|Overall Study|Protocol Violation|0|||
41990693|NCT01218100|75798735|FG001|Overall Study|Protocol Violation|0|||
41990694|NCT01218100|75798736|FG002|Overall Study|Protocol Violation|1|||
41990695|NCT01218100|75798737|FG003|Overall Study|Protocol Violation|1|||
41990696|NCT01218100|75798734|FG000|Overall Study|Withdrawal by Subject|5|||
41990697|NCT01218100|75798735|FG001|Overall Study|Withdrawal by Subject|2|||
41990698|NCT01218100|75798736|FG002|Overall Study|Withdrawal by Subject|6|||
41990699|NCT01218100|75798737|FG003|Overall Study|Withdrawal by Subject|7|||
41990700|NCT01218100|75798734|FG000|Overall Study|Lost to Follow-up|3|||
41990701|NCT01218100|75798735|FG001|Overall Study|Lost to Follow-up|8|||
41990702|NCT01218100|75798736|FG002|Overall Study|Lost to Follow-up|2|||
41990703|NCT01218100|75798737|FG003|Overall Study|Lost to Follow-up|1|||
41990704|NCT01218100|75798734|FG000|Overall Study|Other Reason|2|||
41990705|NCT01218100|75798735|FG001|Overall Study|Other Reason|2|||
41990706|NCT01218100|75798736|FG002|Overall Study|Other Reason|6|||
42251331|NCT02552212|76077146|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
42251332|NCT02552212|76077144|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
42251333|NCT02552212|76077145|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
42251334|NCT02552212|76077146|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
42251335|NCT02552212|76077144|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
42251336|NCT02552212|76077145|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
42251337|NCT02552212|76077146|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
42251338|NCT02552212|76077144|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
42251339|NCT02552212|76077145|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
42251340|NCT02552212|76077146|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
42251341|NCT02552212|76077144|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
42251342|NCT02552212|76077145|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
42251343|NCT02552212|76077146|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
42251344|NCT02552212|76077144|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
42251345|NCT02552212|76077145|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
42251346|NCT02552212|76077146|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
42251347|NCT02552212|76077144|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
42251348|NCT02552212|76077145|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
42251349|NCT02552212|76077146|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
42251350|NCT02552212|76077144|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
42251351|NCT02552212|76077145|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
42251352|NCT02552212|76077146|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
41990707|NCT01218100|75798737|FG003|Overall Study|Other Reason|4|||
41990708|NCT01187953|75798783|FG000|Overall Study|Death|11|||
41990709|NCT01187953|75798784|FG001|Overall Study|Death|13|||
41990710|NCT01187953|75798783|FG000|Overall Study|Adverse Event|1|||
41990711|NCT01187953|75798784|FG001|Overall Study|Adverse Event|2|||
41990712|NCT01187953|75798783|FG000|Overall Study|Lost to Follow-up|0|||
41990713|NCT01187953|75798784|FG001|Overall Study|Lost to Follow-up|3|||
41990714|NCT01187953|75798783|FG000|Overall Study|Withdrawal by Subject|3|||
42251353|NCT02552212|76077144|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
42251354|NCT02552212|76077145|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
42251355|NCT02552212|76077146|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
42251356|NCT02552212|76077144|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
41990715|NCT01187953|75798784|FG001|Overall Study|Withdrawal by Subject|3|||
41990716|NCT01217944|75798800|FG000|Overall Study|Protocol Violation|1|||
41990717|NCT01217944|75798801|FG001|Overall Study|Protocol Violation|1|||
41990718|NCT01217944|75798802|FG002|Overall Study|Protocol Violation|0|||
41990719|NCT01217944|75798800|FG000|Overall Study|Lost to Follow-up|3|||
41990720|NCT01217944|75798801|FG001|Overall Study|Lost to Follow-up|1|||
41990721|NCT01217944|75798802|FG002|Overall Study|Lost to Follow-up|0|||
41990722|NCT01217944|75798800|FG000|Overall Study|Withdrawal by Subject|1|||
41990723|NCT01217944|75798801|FG001|Overall Study|Withdrawal by Subject|2|||
42251357|NCT02552212|76077145|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
42251358|NCT02552212|76077146|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
42251359|NCT02552212|76077144|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
42251360|NCT02552212|76077145|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
42251361|NCT02552212|76077146|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
42251362|NCT02552212|76077144|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
42251363|NCT02552212|76077145|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
42251364|NCT02552212|76077146|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
42251365|NCT02552212|76077144|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
42251366|NCT02552212|76077145|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
42251367|NCT02552212|76077146|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
42251368|NCT02552212|76077144|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
42251369|NCT02552212|76077145|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
42251370|NCT02552212|76077146|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
42251371|NCT02552212|76077144|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
42251372|NCT02552212|76077145|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
41990724|NCT01217944|75798802|FG002|Overall Study|Withdrawal by Subject|0|||
41990725|NCT01217944|75798800|FG000|Overall Study|Lack of Efficacy|1|||
41990726|NCT01217944|75798801|FG001|Overall Study|Lack of Efficacy|0|||
41990727|NCT01217944|75798802|FG002|Overall Study|Lack of Efficacy|0|||
41990728|NCT01187446|75798814|FG000|Overall Study|Patient started non-protocol therapy|0|||
41990729|NCT01187446|75798815|FG001|Overall Study|Patient started non-protocol therapy|1|||
41990730|NCT01187407|75798825|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
41990731|NCT01187407|75798826|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
41990732|NCT01187407|75798827|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
41990733|NCT01187407|75798828|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
41990734|NCT01187407|75798829|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
41990735|NCT01187407|75798825|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
41990736|NCT01187407|75798826|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
41990737|NCT01187407|75798827|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
41990738|NCT01187407|75798828|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
41990739|NCT01187407|75798829|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
41990740|NCT01187407|75798825|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
41990741|NCT01187407|75798826|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
41990742|NCT01187407|75798827|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
42251373|NCT02552212|76077146|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
42251374|NCT00685919|76077166|FG000|Overall Study|Withdrawal by Subject|0|||
42251375|NCT00685919|76077167|FG001|Overall Study|Withdrawal by Subject|0|||
42251376|NCT00685919|76077168|FG002|Overall Study|Withdrawal by Subject|1|||
42251377|NCT00685919|76077169|FG003|Overall Study|Withdrawal by Subject|0|||
42251378|NCT00685919|76077166|FG000|Overall Study|Physician Decision|1|||
42251379|NCT00685919|76077167|FG001|Overall Study|Physician Decision|0|||
41990743|NCT01187407|75798828|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
41990744|NCT01187407|75798829|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
41990745|NCT01187407|75798825|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
41990746|NCT01187407|75798826|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
41990747|NCT01187407|75798827|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
41990748|NCT01187407|75798828|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
41990749|NCT01187407|75798829|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
41990750|NCT01187407|75798825|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
41990751|NCT01187407|75798826|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
41990752|NCT01187407|75798827|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
41990753|NCT01187407|75798828|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
41990754|NCT01187407|75798829|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
41990755|NCT01187407|75798825|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
41990756|NCT01187407|75798826|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
41990757|NCT01187407|75798827|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
41990758|NCT01187407|75798828|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
41990759|NCT01187407|75798829|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
41990760|NCT01187407|75798825|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
41990761|NCT01187407|75798826|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
41990762|NCT01187407|75798827|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
41990763|NCT01187407|75798828|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
41990764|NCT01187407|75798829|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
41990765|NCT01187407|75798825|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
41990766|NCT01187407|75798826|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
41990767|NCT01187407|75798827|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
41990768|NCT01187407|75798828|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
41990769|NCT01187407|75798829|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
41990770|NCT01187407|75798825|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
41990771|NCT01187407|75798826|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
41990772|NCT01187407|75798827|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
42251380|NCT00685919|76077168|FG002|Overall Study|Physician Decision|0|||
42251381|NCT00685919|76077169|FG003|Overall Study|Physician Decision|0|||
42251382|NCT03061331|76077181|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
42251383|NCT03061331|76077182|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
42251384|NCT00700778|76077188|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
41990773|NCT01187407|75798828|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
41990774|NCT01187407|75798829|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
41990775|NCT01187407|75798825|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
41990776|NCT01187407|75798826|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
41990777|NCT01187407|75798827|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
41990778|NCT01187407|75798828|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
41990779|NCT01187407|75798829|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
41990780|NCT01187407|75798825|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
41990781|NCT01187407|75798826|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
41990782|NCT01187407|75798827|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
41990783|NCT01187407|75798828|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
41990784|NCT01187407|75798829|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
41990785|NCT01187407|75798825|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
41990786|NCT01187407|75798826|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
41990787|NCT01187407|75798827|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
41990788|NCT01187407|75798828|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
41990789|NCT01187407|75798829|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
41990790|NCT01187407|75798825|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
41990791|NCT01187407|75798826|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
41990792|NCT01187407|75798827|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
41990793|NCT01187407|75798828|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
41990794|NCT01187407|75798829|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
41990795|NCT01187407|75798825|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
41990796|NCT01187407|75798826|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
41990797|NCT01187407|75798827|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
42251385|NCT02551666|76077194|FG000|Overall Study|Withdrawal by Subject|1|||
41990798|NCT01187407|75798828|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
41990799|NCT01187407|75798829|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
41990800|NCT01186978|75798846|FG000|Overall Study|Withdrawal by Subject|1|||
41990801|NCT01186939|75798850|FG000|Overall Study|Death|7|||
41990802|NCT01186939|75798850|FG000|Overall Study|Withdrawal by Subject|2|||
41990803|NCT01186939|75798850|FG000|Overall Study|No longer receiving clinical benefit|17|||
41990804|NCT01186939|75798850|FG000|Overall Study|Program closed|5|||
42033100|NCT00940875|75841272|FG001|Treatment Phase|Physician Decision|0|||
42033101|NCT00940875|75841271|FG000|Post-Study Treatment|Death|0|||
41990805|NCT01186939|75798850|FG000|Overall Study|Sponsor decision|4|||
41990806|NCT01186939|75798850|FG000|Overall Study|Started additional treatment|1|||
41990807|NCT01186939|75798850|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
42033102|NCT00940875|75841272|FG001|Post-Study Treatment|Death|1|||
42033103|NCT00940875|75841271|FG000|Post-Study Treatment|Disease Progression|0|||
42033104|NCT00940875|75841272|FG001|Post-Study Treatment|Disease Progression|2|||
42033105|NCT00940485|75841281|FG000|Overall Study|HBeAb positive at Baseline|3|||
42033106|NCT00940485|75841282|FG001|Overall Study|HBeAb positive at Baseline|2|||
42033107|NCT00940485|75841281|FG000|Overall Study|Lost to Follow-up|2|||
42033108|NCT00940485|75841282|FG001|Overall Study|Lost to Follow-up|3|||
42033109|NCT00940485|75841281|FG000|Overall Study|Adverse Event|8|||
42033110|NCT00940485|75841282|FG001|Overall Study|Adverse Event|0|||
41990808|NCT01186939|75798850|FG000|Overall Study|Myocardial infarction|1|||
41990809|NCT01186939|75798850|FG000|Overall Study|Bone marrow transplant|1|||
42033111|NCT00940485|75841281|FG000|Overall Study|Withdrawal by Subject|1|||
42033112|NCT00940485|75841282|FG001|Overall Study|Withdrawal by Subject|1|||
42033113|NCT00940485|75841281|FG000|Overall Study|Others|1|||
41990810|NCT01186939|75798850|FG000|Overall Study|Transformation to AML|1|||
42033114|NCT00940485|75841282|FG001|Overall Study|Others|1|||
42033115|NCT00943605|75841290|FG000|Overall Study|Study termination|30|||
42033116|NCT00943605|75841291|FG001|Overall Study|Study termination|30|||
41990811|NCT04938648|75798875|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
41990812|NCT04938648|75798876|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
41990813|NCT04938648|75798875|FG000|Overall Study|Patient too ill|0|||
41990814|NCT04938648|75798876|FG001|Overall Study|Patient too ill|1|||
41990815|NCT04938648|75798875|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
41990816|NCT04938648|75798876|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
41990817|NCT04938648|75798875|FG000|Overall Study|Patient did not have memory problems|1|||
41990818|NCT04938648|75798876|FG001|Overall Study|Patient did not have memory problems|1|||
41990819|NCT04938648|75798875|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
41990820|NCT04938648|75798876|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
42132740|NCT00330616|75943548|FG000|Overall Study|Withdrawal by Subject|4|||
42132741|NCT00330616|75943548|FG000|Overall Study|Other|1|||
42132742|NCT00466440|75943555|FG000|Overall Study|Adverse Event|0|||
42132743|NCT00466440|75943556|FG001|Overall Study|Adverse Event|3|||
42132744|NCT00466440|75943557|FG002|Overall Study|Adverse Event|1|||
42132745|NCT00466440|75943555|FG000|Overall Study|Death|1|||
42132746|NCT00466440|75943556|FG001|Overall Study|Death|1|||
42132747|NCT00466440|75943557|FG002|Overall Study|Death|0|||
42132748|NCT00466440|75943555|FG000|Overall Study|Progressive disease|13|||
42132749|NCT00466440|75943556|FG001|Overall Study|Progressive disease|5|||
42132750|NCT00466440|75943557|FG002|Overall Study|Progressive disease|4|||
42132751|NCT00466440|75943555|FG000|Overall Study|Lost to Follow-up|0|||
42132752|NCT00466440|75943556|FG001|Overall Study|Lost to Follow-up|1|||
42132753|NCT00466440|75943557|FG002|Overall Study|Lost to Follow-up|0|||
42132754|NCT00466440|75943555|FG000|Overall Study|Physician Decision|0|||
42132755|NCT00466440|75943556|FG001|Overall Study|Physician Decision|1|||
42132756|NCT00466440|75943557|FG002|Overall Study|Physician Decision|2|||
42132757|NCT00466440|75943555|FG000|Overall Study|Protocol entry criteria not met|0|||
42132758|NCT00466440|75943556|FG001|Overall Study|Protocol entry criteria not met|0|||
42132759|NCT00466440|75943557|FG002|Overall Study|Protocol entry criteria not met|4|||
42132760|NCT00466440|75943555|FG000|Overall Study|Withdrawal by Subject|0|||
42132761|NCT00466440|75943556|FG001|Overall Study|Withdrawal by Subject|1|||
42132762|NCT00466440|75943557|FG002|Overall Study|Withdrawal by Subject|0|||
42132763|NCT00466440|75943555|FG000|Overall Study|Sponsor decision|0|||
42132764|NCT00466440|75943556|FG001|Overall Study|Sponsor decision|0|||
42132765|NCT00466440|75943557|FG002|Overall Study|Sponsor decision|1|||
42132766|NCT00465972|75943576|FG000|Overall Study|Withdrawal by Subject|2|||
42132767|NCT00465972|75943577|FG001|Overall Study|Withdrawal by Subject|1|||
42251386|NCT02551666|76077195|FG001|Overall Study|Withdrawal by Subject|3|||
42033117|NCT01132313|75841309|FG000|Overall Study|Lack of Efficacy|1|||
42033118|NCT01132313|75841310|FG001|Overall Study|Lack of Efficacy|0|||
42033119|NCT01132313|75841311|FG002|Overall Study|Lack of Efficacy|0|||
42132768|NCT00465894|75943587|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
42132769|NCT00465894|75943588|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
42132770|NCT00465894|75943587|FG000|Treatment For 12 Weeks|Family Issues|1|||
42132771|NCT00465894|75943588|FG001|Treatment For 12 Weeks|Family Issues|1|||
42132772|NCT00465894|75943587|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
42132773|NCT00465894|75943588|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
42251387|NCT03061175|76077207|FG000|Baseline|Participant was deemed ineligible|1|||
42251388|NCT03061175|76077208|FG001|Baseline|Participant was deemed ineligible|0|||
42251389|NCT03061175|76077207|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
41990821|NCT04938648|75798875|FG000|Overall Study|Care partner could not be reached|0|||
41990822|NCT04938648|75798876|FG001|Overall Study|Care partner could not be reached|1|||
42251390|NCT03061175|76077208|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
42251391|NCT03061175|76077207|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
42251392|NCT03061175|76077208|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
42251393|NCT03061175|76077207|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
42251394|NCT03061175|76077208|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
41990823|NCT04938648|75798875|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
41990824|NCT04938648|75798876|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
41990825|NCT04938648|75798875|FG000|Overall Study|Withdrawal by Subject|2|||
41990826|NCT04938648|75798876|FG001|Overall Study|Withdrawal by Subject|1|||
41990827|NCT04564092|75798883|FG000|Overall Study|Withdrawal by Subject|1|||
41990828|NCT01658826|75798924|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
41990829|NCT01658826|75798925|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
41990830|NCT01658826|75798924|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
41990831|NCT01658826|75798925|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
41990832|NCT01658826|75798924|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
41990833|NCT01658826|75798925|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
41990834|NCT01658826|75798924|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
41990835|NCT01658826|75798925|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
41990836|NCT01658826|75798924|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
41990837|NCT01658826|75798925|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
41990838|NCT01658826|75798924|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
41990839|NCT01658826|75798925|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
41990840|NCT01658826|75798924|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
41990841|NCT01658826|75798925|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
41990842|NCT01658826|75798924|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
41990843|NCT01658826|75798925|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
41990844|NCT01658826|75798924|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
41990845|NCT01658826|75798925|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
41990846|NCT01186744|75798941|FG000|Overall Study|Lack of Efficacy|156|||
41990847|NCT01186744|75798942|FG001|Overall Study|Lack of Efficacy|99|||
41990848|NCT01186744|75798943|FG002|Overall Study|Lack of Efficacy|0|||
41990849|NCT01186744|75798944|FG003|Overall Study|Lack of Efficacy|2|||
41990850|NCT01186744|75798945|FG004|Overall Study|Lack of Efficacy|2|||
41990851|NCT01186744|75798946|FG005|Overall Study|Lack of Efficacy|5|||
41990852|NCT01186744|75798941|FG000|Overall Study|Protocol Violation|1|||
41990853|NCT01186744|75798942|FG001|Overall Study|Protocol Violation|2|||
41990854|NCT01186744|75798943|FG002|Overall Study|Protocol Violation|0|||
41990855|NCT01186744|75798944|FG003|Overall Study|Protocol Violation|1|||
41990856|NCT01186744|75798945|FG004|Overall Study|Protocol Violation|1|||
41990857|NCT01186744|75798946|FG005|Overall Study|Protocol Violation|2|||
41990858|NCT01186744|75798941|FG000|Overall Study|Lost to Follow-up|15|||
41990859|NCT01186744|75798942|FG001|Overall Study|Lost to Follow-up|16|||
41990860|NCT01186744|75798943|FG002|Overall Study|Lost to Follow-up|2|||
42251401|NCT03061097|76077234|FG000|Overall Study|Withdrawal by Subject|0|||
42251402|NCT03061097|76077235|FG001|Overall Study|Withdrawal by Subject|3|||
42251403|NCT02554318|76077243|FG000|Overall Study|Withdrawal by Subject|10|||
42251404|NCT02554318|76077244|FG001|Overall Study|Withdrawal by Subject|8|||
41990861|NCT01186744|75798944|FG003|Overall Study|Lost to Follow-up|1|||
41990862|NCT01186744|75798945|FG004|Overall Study|Lost to Follow-up|1|||
41990863|NCT01186744|75798946|FG005|Overall Study|Lost to Follow-up|4|||
41990864|NCT01186744|75798941|FG000|Overall Study|Screen failure|1|||
42251405|NCT02550106|76077250|FG000|Overall Study|Adverse Event|1|||
42251406|NCT02550106|76077250|FG000|Overall Study|Lack of Efficacy|3|||
42251407|NCT02550106|76077250|FG000|Overall Study|Protocol Violation|6|||
42251408|NCT02550106|76077250|FG000|Overall Study|Withdrawal by Subject|2|||
41990865|NCT01186744|75798942|FG001|Overall Study|Screen failure|1|||
41990866|NCT01186744|75798943|FG002|Overall Study|Screen failure|0|||
41990867|NCT01186744|75798944|FG003|Overall Study|Screen failure|1|||
41990868|NCT01186744|75798945|FG004|Overall Study|Screen failure|0|||
41990869|NCT01186744|75798946|FG005|Overall Study|Screen failure|0|||
41990870|NCT01186744|75798941|FG000|Overall Study|Withdrawal by Subject|14|||
42251409|NCT03060551|76077256|FG000|Overall Study|Withdrawal by Subject|1|||
42251410|NCT03060551|76077256|FG000|Overall Study|Adverse Event|1|||
42251411|NCT01662310|76077260|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
42251412|NCT01662310|76077261|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
42251413|NCT01662310|76077262|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
42251414|NCT01662310|76077263|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
42251415|NCT01662310|76077264|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
42251416|NCT01662310|76077260|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
42251417|NCT01662310|76077261|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
42251418|NCT01662310|76077262|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
42251419|NCT01662310|76077263|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
42251420|NCT01662310|76077264|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
42251421|NCT01662310|76077260|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
42251422|NCT01662310|76077261|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
42251423|NCT01662310|76077262|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
42251424|NCT01662310|76077263|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
42251425|NCT01662310|76077264|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
42251426|NCT01662310|76077260|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
42251427|NCT01662310|76077261|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
42251428|NCT01662310|76077262|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
42251429|NCT01662310|76077263|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
42251430|NCT01662310|76077264|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
42251431|NCT01662310|76077260|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
42251432|NCT01662310|76077261|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
42251433|NCT01662310|76077262|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
42251434|NCT01662310|76077263|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
42251435|NCT01662310|76077264|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
42251436|NCT01662310|76077260|FG000|Run-In or Stabilization Phase|Other|1|||
42251437|NCT01662310|76077261|FG001|Run-In or Stabilization Phase|Other|0|||
42251438|NCT01662310|76077262|FG002|Run-In or Stabilization Phase|Other|0|||
42251439|NCT01662310|76077263|FG003|Run-In or Stabilization Phase|Other|0|||
42251440|NCT01662310|76077264|FG004|Run-In or Stabilization Phase|Other|0|||
42251441|NCT01662310|76077260|FG000|Double-Blind Phase|Adverse Event|0|||
42251442|NCT01662310|76077261|FG001|Double-Blind Phase|Adverse Event|0|||
42251443|NCT01662310|76077262|FG002|Double-Blind Phase|Adverse Event|1|||
42251444|NCT01662310|76077263|FG003|Double-Blind Phase|Adverse Event|0|||
42251445|NCT01662310|76077264|FG004|Double-Blind Phase|Adverse Event|0|||
42251446|NCT01662310|76077260|FG000|Double-Blind Phase|Lost to Follow-up|0|||
42251447|NCT01662310|76077261|FG001|Double-Blind Phase|Lost to Follow-up|3|||
42251448|NCT01662310|76077262|FG002|Double-Blind Phase|Lost to Follow-up|0|||
42251449|NCT01662310|76077263|FG003|Double-Blind Phase|Lost to Follow-up|0|||
42251450|NCT01662310|76077264|FG004|Double-Blind Phase|Lost to Follow-up|0|||
42251451|NCT01662310|76077260|FG000|Double-Blind Phase|Pregnancy|0|||
42251452|NCT01662310|76077261|FG001|Double-Blind Phase|Pregnancy|2|||
42251453|NCT01662310|76077262|FG002|Double-Blind Phase|Pregnancy|0|||
42251454|NCT01662310|76077263|FG003|Double-Blind Phase|Pregnancy|0|||
42251455|NCT01662310|76077264|FG004|Double-Blind Phase|Pregnancy|0|||
42251456|NCT01662310|76077260|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
42251457|NCT01662310|76077261|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
42251458|NCT01662310|76077262|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
42251459|NCT01662310|76077263|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
42251460|NCT01662310|76077264|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
42033120|NCT01132313|75841312|FG003|Overall Study|Lack of Efficacy|0|||
42033121|NCT01132313|75841313|FG004|Overall Study|Lack of Efficacy|0|||
42251461|NCT01662310|76077260|FG000|Double-Blind Phase|Other|0|||
42251462|NCT01662310|76077261|FG001|Double-Blind Phase|Other|0|||
42251463|NCT01662310|76077262|FG002|Double-Blind Phase|Other|1|||
42251464|NCT01662310|76077263|FG003|Double-Blind Phase|Other|0|||
42251465|NCT01662310|76077264|FG004|Double-Blind Phase|Other|0|||
42033122|NCT01132313|75841314|FG005|Overall Study|Lack of Efficacy|0|||
42251466|NCT01662310|76077260|FG000|Double-Blind Phase|Randomized but not treated|0|||
41990871|NCT01186744|75798942|FG001|Overall Study|Withdrawal by Subject|10|||
41990872|NCT01186744|75798943|FG002|Overall Study|Withdrawal by Subject|2|||
41990873|NCT01186744|75798944|FG003|Overall Study|Withdrawal by Subject|5|||
41990874|NCT01186744|75798945|FG004|Overall Study|Withdrawal by Subject|0|||
41990875|NCT01186744|75798946|FG005|Overall Study|Withdrawal by Subject|6|||
41990876|NCT01186744|75798941|FG000|Overall Study|Study terminated by Sponsor|1|||
41990877|NCT01186744|75798942|FG001|Overall Study|Study terminated by Sponsor|0|||
41990878|NCT01186744|75798943|FG002|Overall Study|Study terminated by Sponsor|0|||
41990879|NCT01186744|75798944|FG003|Overall Study|Study terminated by Sponsor|0|||
41990880|NCT01186744|75798945|FG004|Overall Study|Study terminated by Sponsor|0|||
41990881|NCT01186744|75798946|FG005|Overall Study|Study terminated by Sponsor|0|||
41990882|NCT01186744|75798941|FG000|Overall Study|Other|9|||
41990883|NCT01186744|75798942|FG001|Overall Study|Other|10|||
41990884|NCT01186744|75798943|FG002|Overall Study|Other|1|||
41990885|NCT01186744|75798944|FG003|Overall Study|Other|2|||
41990886|NCT01186744|75798945|FG004|Overall Study|Other|1|||
41990887|NCT01186744|75798946|FG005|Overall Study|Other|5|||
41990888|NCT01186744|75798941|FG000|Overall Study|Adverse Event|10|||
42132774|NCT00330460|75943612|FG000|Overall Study|Physician Decision|1|||
42132775|NCT00330460|75943613|FG001|Overall Study|Physician Decision|0|||
42304523|NCT02224053|76139960|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
42304524|NCT02457793|76139972|FG000|Overall Study|Reason not specified|0|||
42304525|NCT02457793|76139973|FG001|Overall Study|Reason not specified|0|||
42304526|NCT02457793|76139974|FG002|Overall Study|Reason not specified|0|||
42304527|NCT02457793|76139975|FG003|Overall Study|Reason not specified|1|||
42304528|NCT02457793|76139976|FG004|Overall Study|Reason not specified|1|||
42304529|NCT02457793|76139977|FG005|Overall Study|Reason not specified|1|||
42304530|NCT02457793|76139972|FG000|Overall Study|Withdrawal by Subject|0|||
42304531|NCT02457793|76139973|FG001|Overall Study|Withdrawal by Subject|4|||
42304532|NCT02457793|76139974|FG002|Overall Study|Withdrawal by Subject|2|||
42304533|NCT02457793|76139975|FG003|Overall Study|Withdrawal by Subject|2|||
42304534|NCT02457793|76139976|FG004|Overall Study|Withdrawal by Subject|2|||
42304535|NCT02457793|76139977|FG005|Overall Study|Withdrawal by Subject|2|||
42304536|NCT02457793|76139972|FG000|Overall Study|Adverse Event|0|||
42304537|NCT02457793|76139973|FG001|Overall Study|Adverse Event|0|||
42304538|NCT02457793|76139974|FG002|Overall Study|Adverse Event|0|||
42304539|NCT02457793|76139975|FG003|Overall Study|Adverse Event|1|||
42304540|NCT02457793|76139976|FG004|Overall Study|Adverse Event|0|||
42132776|NCT00330460|75943612|FG000|Overall Study|Adverse Event|10|||
42132777|NCT00330460|75943613|FG001|Overall Study|Adverse Event|8|||
42132778|NCT00330460|75943612|FG000|Overall Study|Withdrawal by Subject|18|||
42132779|NCT00330460|75943613|FG001|Overall Study|Withdrawal by Subject|17|||
42132780|NCT00330460|75943612|FG000|Overall Study|Death|1|||
41990889|NCT01186744|75798942|FG001|Overall Study|Adverse Event|14|||
42132781|NCT00330460|75943613|FG001|Overall Study|Death|1|||
42132782|NCT00330460|75943612|FG000|Overall Study|Ineligibility determined|1|||
42132783|NCT00330460|75943613|FG001|Overall Study|Ineligibility determined|3|||
42251467|NCT01662310|76077261|FG001|Double-Blind Phase|Randomized but not treated|1|||
42251468|NCT01662310|76077262|FG002|Double-Blind Phase|Randomized but not treated|0|||
42251469|NCT01662310|76077263|FG003|Double-Blind Phase|Randomized but not treated|0|||
42251470|NCT01662310|76077264|FG004|Double-Blind Phase|Randomized but not treated|0|||
42251471|NCT01662310|76077260|FG000|Open-Label Extension Phase|Adverse Event|0|||
42251472|NCT01662310|76077261|FG001|Open-Label Extension Phase|Adverse Event|0|||
42251473|NCT01662310|76077262|FG002|Open-Label Extension Phase|Adverse Event|0|||
42251474|NCT01662310|76077263|FG003|Open-Label Extension Phase|Adverse Event|3|||
42304541|NCT02457793|76139977|FG005|Overall Study|Adverse Event|0|||
42304542|NCT02457793|76139972|FG000|Overall Study|Physician Decision|1|||
42132784|NCT00330460|75943612|FG000|Overall Study|Lost to Follow-up|8|||
42304543|NCT02457793|76139973|FG001|Overall Study|Physician Decision|0|||
42304544|NCT02457793|76139974|FG002|Overall Study|Physician Decision|1|||
42304545|NCT02457793|76139975|FG003|Overall Study|Physician Decision|1|||
42304546|NCT02457793|76139976|FG004|Overall Study|Physician Decision|1|||
41990890|NCT01186744|75798943|FG002|Overall Study|Adverse Event|1|||
41990891|NCT01186744|75798944|FG003|Overall Study|Adverse Event|0|||
42132785|NCT00330460|75943613|FG001|Overall Study|Lost to Follow-up|3|||
42132786|NCT00330460|75943612|FG000|Overall Study|Noncompliance|2|||
42132787|NCT00330460|75943613|FG001|Overall Study|Noncompliance|1|||
42132788|NCT00330460|75943612|FG000|Overall Study|Other|1|||
42304547|NCT02457793|76139977|FG005|Overall Study|Physician Decision|3|||
42304548|NCT01650259|76139994|FG000|Overall Study|Improvement|105|||
42304549|NCT01650259|76139995|FG001|Overall Study|Improvement|0|||
42304550|NCT01650259|76139994|FG000|Overall Study|Adverse Event|127|||
42304551|NCT01650259|76139995|FG001|Overall Study|Adverse Event|0|||
42251475|NCT01662310|76077264|FG004|Open-Label Extension Phase|Adverse Event|0|||
42251476|NCT01662310|76077260|FG000|Open-Label Extension Phase|Death|0|||
42251477|NCT01662310|76077261|FG001|Open-Label Extension Phase|Death|0|||
42251478|NCT01662310|76077262|FG002|Open-Label Extension Phase|Death|0|||
42251479|NCT01662310|76077263|FG003|Open-Label Extension Phase|Death|1|||
42251480|NCT01662310|76077264|FG004|Open-Label Extension Phase|Death|0|||
42251481|NCT01662310|76077260|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
41990892|NCT01186744|75798945|FG004|Overall Study|Adverse Event|1|||
41990893|NCT01186744|75798946|FG005|Overall Study|Adverse Event|4|||
41990894|NCT01186744|75798941|FG000|Overall Study|Death|1|||
42251482|NCT01662310|76077261|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
42251483|NCT01662310|76077262|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
42251484|NCT01662310|76077263|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
42251485|NCT01662310|76077264|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
42251486|NCT01662310|76077260|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
42251487|NCT01662310|76077261|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
42251488|NCT01662310|76077262|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
42251489|NCT01662310|76077263|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
42251490|NCT01662310|76077264|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
42251491|NCT01662310|76077260|FG000|Open-Label Extension Phase|Pregnancy|0|||
42251492|NCT01662310|76077261|FG001|Open-Label Extension Phase|Pregnancy|0|||
42251493|NCT01662310|76077262|FG002|Open-Label Extension Phase|Pregnancy|0|||
42251494|NCT01662310|76077263|FG003|Open-Label Extension Phase|Pregnancy|1|||
42251495|NCT01662310|76077264|FG004|Open-Label Extension Phase|Pregnancy|0|||
42251496|NCT01662310|76077260|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
42251497|NCT01662310|76077261|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
42251498|NCT01662310|76077262|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
42251499|NCT01662310|76077263|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
42251500|NCT01662310|76077264|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
42251501|NCT00700622|76077278|FG000|Overall Study|Adverse Event|4|||
42251502|NCT00700622|76077279|FG001|Overall Study|Adverse Event|0|||
42251503|NCT00700622|76077278|FG000|Overall Study|Lost to Follow-up|0|||
42251504|NCT00700622|76077279|FG001|Overall Study|Lost to Follow-up|1|||
42251505|NCT00700622|76077278|FG000|Overall Study|Physician Decision|2|||
42251506|NCT00700622|76077279|FG001|Overall Study|Physician Decision|1|||
42251507|NCT00700622|76077278|FG000|Overall Study|Protocol Violation|0|||
42251508|NCT00700622|76077279|FG001|Overall Study|Protocol Violation|1|||
42251509|NCT00700622|76077278|FG000|Overall Study|Withdrawal by Subject|4|||
42304552|NCT01650259|76139994|FG000|Overall Study|Lack of Efficacy|143|||
42304553|NCT01650259|76139995|FG001|Overall Study|Lack of Efficacy|0|||
42304554|NCT01650259|76139994|FG000|Overall Study|Lost to Follow-up|435|||
42304555|NCT01650259|76139995|FG001|Overall Study|Lost to Follow-up|0|||
42304556|NCT01650259|76139994|FG000|Overall Study|Patients had no visit after entry|70|||
42304557|NCT01650259|76139995|FG001|Overall Study|Patients had no visit after entry|0|||
42304558|NCT01650259|76139994|FG000|Overall Study|CRF not collected|98|||
42304559|NCT01650259|76139995|FG001|Overall Study|CRF not collected|82|||
42304560|NCT01650259|76139994|FG000|Overall Study|Not treated|1|||
42304561|NCT01650259|76139995|FG001|Overall Study|Not treated|7|||
42304562|NCT01650259|76139994|FG000|Overall Study|Other than listed|64|||
42304563|NCT01650259|76139995|FG001|Overall Study|Other than listed|146|||
42304564|NCT02434939|76140001|FG000|Overall Study|Lack of Efficacy|34|||
42304565|NCT02434939|76140002|FG001|Overall Study|Lack of Efficacy|48|||
42304566|NCT02434939|76140001|FG000|Overall Study|Withdrawal by Subject|3|||
42304567|NCT02434939|76140002|FG001|Overall Study|Withdrawal by Subject|0|||
42304568|NCT02434939|76140001|FG000|Overall Study|Adverse Event|0|||
42304569|NCT02434939|76140002|FG001|Overall Study|Adverse Event|1|||
42304570|NCT02434471|76140009|FG000|Overall Study|Physician Decision|9|||
42304571|NCT02457637|76140014|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
42304572|NCT02457325|76140021|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
42304573|NCT02457325|76140022|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
42304574|NCT02434081|76140028|FG000|Overall Study|Death (never started treatment)|2|||
42304575|NCT02434081|76140028|FG000|Overall Study|Death|2|||
42304576|NCT02434081|76140028|FG000|Overall Study|Progression|20|||
42304577|NCT02434081|76140028|FG000|Overall Study|Adverse Event|20|||
42304578|NCT02434081|76140028|FG000|Overall Study|Physician Decision|2|||
42304579|NCT02434081|76140028|FG000|Overall Study|Withdrawal by Subject|1|||
42304580|NCT02434081|76140028|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
42304581|NCT02222493|76140034|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
42304582|NCT02222493|76140035|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
42304583|NCT02222493|76140034|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
42304584|NCT02222493|76140035|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
42304585|NCT02222493|76140034|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
42304586|NCT02222493|76140035|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
42304587|NCT02222493|76140034|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
42304588|NCT02222493|76140035|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
42304589|NCT02222493|76140034|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
42304590|NCT02222493|76140035|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
42304591|NCT02222493|76140034|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
42304592|NCT02222493|76140035|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
42304593|NCT02222493|76140034|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
42304594|NCT02222493|76140035|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
42304595|NCT02222493|76140034|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
42304596|NCT02222493|76140035|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
42304597|NCT02222493|76140034|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
42304598|NCT02222493|76140035|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
42304599|NCT02222493|76140034|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
42304600|NCT02222493|76140035|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
42304601|NCT02222493|76140034|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
42304602|NCT02222493|76140035|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
42251510|NCT00700622|76077279|FG001|Overall Study|Withdrawal by Subject|1|||
42251511|NCT00700622|76077278|FG000|Overall Study|Other|3|||
42251512|NCT00700622|76077279|FG001|Overall Study|Other|1|||
42251513|NCT02553928|76077287|FG000|Overall Study|Adverse Event|2|||
42251514|NCT02553928|76077288|FG001|Overall Study|Adverse Event|1|||
42251515|NCT02553928|76077287|FG000|Overall Study|Lost to Follow-up|0|||
42251516|NCT02553928|76077288|FG001|Overall Study|Lost to Follow-up|1|||
42251517|NCT02553928|76077287|FG000|Overall Study|Administrative reason(s)|0|||
42251518|NCT02553928|76077288|FG001|Overall Study|Administrative reason(s)|1|||
42251519|NCT03076775|76077297|FG000|Overall Study|Lost to Follow-up|1|||
42251520|NCT03076775|76077298|FG001|Overall Study|Lost to Follow-up|0|||
42304603|NCT02222493|76140034|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
42304604|NCT02222493|76140035|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
42304605|NCT02222493|76140034|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
42304606|NCT02222493|76140035|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
42304607|NCT02222493|76140034|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
42251521|NCT03058991|76077315|FG000|Overall Study|Lost to Follow-up|17|||
42251522|NCT03058991|76077316|FG001|Overall Study|Lost to Follow-up|12|||
42251523|NCT03058991|76077317|FG002|Overall Study|Lost to Follow-up|12|||
42251524|NCT03058991|76077315|FG000|Overall Study|Withdrawal by Subject|1|||
42304608|NCT02222493|76140035|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
42304609|NCT02222493|76140034|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
42304610|NCT02222493|76140035|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
42304611|NCT02222493|76140034|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
42304612|NCT02222493|76140035|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
42304613|NCT02222493|76140034|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
42304614|NCT02222493|76140035|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
42304615|NCT02222493|76140034|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
42304616|NCT02222493|76140035|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
42304617|NCT02222493|76140034|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
42304618|NCT02222493|76140035|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
42304619|NCT02222493|76140034|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
42304620|NCT02222493|76140035|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
42304621|NCT02222493|76140034|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
42304622|NCT02222493|76140035|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
42304623|NCT02222493|76140034|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
42304624|NCT02222493|76140035|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
42304625|NCT02433379|76140054|FG000|Overall Study|Screen Failures|55|||
42304626|NCT02433379|76140054|FG000|Overall Study|Death|57|||
42304627|NCT02433379|76140054|FG000|Overall Study|Total Withdrawals|209|||
42304628|NCT02199795|76140062|FG000|Overall Study|no longer met inclusion criteria|1|||
42304629|NCT02199795|76140063|FG001|Overall Study|no longer met inclusion criteria|0|||
42304630|NCT02199795|76140062|FG000|Overall Study|withdrew due to shoulder pain|1|||
42304631|NCT02199795|76140063|FG001|Overall Study|withdrew due to shoulder pain|0|||
42304632|NCT02403817|76140071|FG000|Overall Study|Withdrawal by Subject|5|||
42304633|NCT02403817|76140072|FG001|Overall Study|Withdrawal by Subject|0|||
42304634|NCT02403271|76140078|FG000|Period 1|Other varied reasons|1|||
42304635|NCT02403271|76140079|FG001|Period 1|Other varied reasons|0|||
42304636|NCT02403271|76140078|FG000|Period 2|Withdrawal by Subject|0|||
42304637|NCT02403271|76140079|FG001|Period 2|Withdrawal by Subject|14|||
42304638|NCT02403271|76140078|FG000|Period 2|Death|0|||
42304639|NCT02403271|76140079|FG001|Period 2|Death|84|||
42304640|NCT02403271|76140078|FG000|Period 2|Lost to Follow-up|0|||
42304641|NCT02403271|76140079|FG001|Period 2|Lost to Follow-up|2|||
42304642|NCT02403271|76140078|FG000|Period 2|Study Terminated by Sponsor|0|||
42304643|NCT02403271|76140079|FG001|Period 2|Study Terminated by Sponsor|14|||
42304644|NCT02403271|76140078|FG000|Period 2|Other varied reasons|0|||
42304645|NCT02403271|76140079|FG001|Period 2|Other varied reasons|10|||
42304646|NCT02219685|76140087|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
42304647|NCT02219685|76140088|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
42304648|NCT02219685|76140087|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
42304649|NCT02219685|76140088|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
42304650|NCT02457247|76140100|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
42304651|NCT02457247|76140101|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
42304652|NCT02457247|76140102|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
42304653|NCT02457247|76140103|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
42304654|NCT02457247|76140100|FG000|Period 1|Significant Protocol Deviation|1|||
42251525|NCT03058991|76077316|FG001|Overall Study|Withdrawal by Subject|0|||
42251526|NCT03058991|76077317|FG002|Overall Study|Withdrawal by Subject|0|||
42251527|NCT00700310|76077329|FG000|Overall Study|Adverse Event|6|||
42251528|NCT00700310|76077330|FG001|Overall Study|Adverse Event|10|||
42251529|NCT00700310|76077331|FG002|Overall Study|Adverse Event|5|||
42251530|NCT00700310|76077332|FG003|Overall Study|Adverse Event|11|||
42251531|NCT00700310|76077329|FG000|Overall Study|Lost to Follow-up|4|||
42251532|NCT00700310|76077330|FG001|Overall Study|Lost to Follow-up|1|||
42251533|NCT00700310|76077331|FG002|Overall Study|Lost to Follow-up|0|||
42251534|NCT00700310|76077332|FG003|Overall Study|Lost to Follow-up|1|||
42251535|NCT00700310|76077329|FG000|Overall Study|Withdrawal by Subject|8|||
42251536|NCT00700310|76077330|FG001|Overall Study|Withdrawal by Subject|9|||
42251537|NCT00700310|76077331|FG002|Overall Study|Withdrawal by Subject|8|||
42251538|NCT00700310|76077332|FG003|Overall Study|Withdrawal by Subject|8|||
42251539|NCT00700310|76077329|FG000|Overall Study|Lack of Efficacy|0|||
42304655|NCT02457247|76140101|FG001|Period 1|Significant Protocol Deviation|1|||
42304656|NCT02457247|76140102|FG002|Period 1|Significant Protocol Deviation|0|||
42304657|NCT02457247|76140103|FG003|Period 1|Significant Protocol Deviation|0|||
42304658|NCT02457247|76140100|FG000|Period 1|Voluntary Withdrawal|1|||
42304659|NCT02457247|76140101|FG001|Period 1|Voluntary Withdrawal|0|||
42304660|NCT02457247|76140102|FG002|Period 1|Voluntary Withdrawal|0|||
42251540|NCT00700310|76077330|FG001|Overall Study|Lack of Efficacy|3|||
42251541|NCT00700310|76077331|FG002|Overall Study|Lack of Efficacy|0|||
42251542|NCT00700310|76077332|FG003|Overall Study|Lack of Efficacy|1|||
42251543|NCT00700310|76077329|FG000|Overall Study|Administrative/Other|1|||
41990895|NCT01186744|75798942|FG001|Overall Study|Death|0|||
42304661|NCT02457247|76140103|FG003|Period 1|Voluntary Withdrawal|0|||
42304662|NCT02457247|76140100|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
42304663|NCT02457247|76140101|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
42304664|NCT02457247|76140102|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
42304665|NCT02457247|76140103|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
42304666|NCT02457247|76140100|FG000|Period 2|Significant Protocol Deviation|1|||
42304667|NCT02457247|76140101|FG001|Period 2|Significant Protocol Deviation|0|||
42304668|NCT02457247|76140102|FG002|Period 2|Significant Protocol Deviation|0|||
42304669|NCT02457247|76140103|FG003|Period 2|Significant Protocol Deviation|0|||
42304670|NCT02457247|76140100|FG000|Period 2|Lost to Follow-up|0|||
42304671|NCT02457247|76140101|FG001|Period 2|Lost to Follow-up|1|||
42304672|NCT02457247|76140102|FG002|Period 2|Lost to Follow-up|0|||
42304673|NCT02457247|76140103|FG003|Period 2|Lost to Follow-up|0|||
42304674|NCT02457247|76140100|FG000|Period 2|Voluntary Withdrawal|1|||
42304675|NCT02457247|76140101|FG001|Period 2|Voluntary Withdrawal|1|||
42304676|NCT02457247|76140102|FG002|Period 2|Voluntary Withdrawal|0|||
42304677|NCT02457247|76140103|FG003|Period 2|Voluntary Withdrawal|0|||
42304678|NCT02401867|76140119|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
42304679|NCT02401867|76140119|FG000|Analysis|Cervical assay could not be conducted|9|||
42304680|NCT02198235|76140127|FG000|Overall Study|Lost to Follow-up|3|||
42304681|NCT02198235|76140128|FG001|Overall Study|Lost to Follow-up|2|||
42304682|NCT02198235|76140129|FG002|Overall Study|Lost to Follow-up|2|||
42304683|NCT02253147|76140137|FG000|Overall Study|Protocol Violation|30|||
42304684|NCT02253147|76140137|FG000|Overall Study|Did not consent to study extension|9|||
42304685|NCT02253147|76140137|FG000|Overall Study|Conditional re-treatment at W52|5|||
42304686|NCT02253147|76140137|FG000|Overall Study|Lost to Follow-up|2|||
42304687|NCT02253147|76140137|FG000|Overall Study|Withdrawal by Subject|1|||
42304688|NCT02217501|76140145|FG000|Overall Study|Death|3|||
42304689|NCT02217501|76140146|FG001|Overall Study|Death|4|||
42304690|NCT01649869|76140154|FG000|Overall Study|Family member illness|1|||
42304691|NCT01649869|76140155|FG001|Overall Study|Family member illness|0|||
42304692|NCT01649869|76140154|FG000|Overall Study|Required treatment outside protocol|1|||
42304693|NCT01649869|76140155|FG001|Overall Study|Required treatment outside protocol|0|||
42304694|NCT01649869|76140154|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
42304695|NCT01649869|76140155|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
42304696|NCT02197377|76140165|FG000|Overall Study|Insertion Failure|0|||
42304697|NCT02197377|76140166|FG001|Overall Study|Insertion Failure|3|||
42304698|NCT02400307|76140174|FG000|Overall Study|Enrolled and Never Dosed|1|||
42304699|NCT02400307|76140175|FG001|Overall Study|Enrolled and Never Dosed|0|||
42304700|NCT02196675|76140184|FG000|Overall Study|Withdrawal by Subject|1|||
42304701|NCT02196675|76140185|FG001|Overall Study|Withdrawal by Subject|0|||
42304702|NCT02196675|76140186|FG002|Overall Study|Withdrawal by Subject|0|||
42304703|NCT02196675|76140184|FG000|Overall Study|Intra-operative surgical exclusion|1|||
42304704|NCT02196675|76140185|FG001|Overall Study|Intra-operative surgical exclusion|1|||
42251544|NCT00700310|76077330|FG001|Overall Study|Administrative/Other|3|||
42251545|NCT00700310|76077331|FG002|Overall Study|Administrative/Other|1|||
42251546|NCT00700310|76077332|FG003|Overall Study|Administrative/Other|3|||
42251547|NCT00700310|76077329|FG000|Overall Study|Randomized, Not Treated|2|||
42251548|NCT00700310|76077330|FG001|Overall Study|Randomized, Not Treated|0|||
42251549|NCT00700310|76077331|FG002|Overall Study|Randomized, Not Treated|2|||
42251550|NCT00700310|76077332|FG003|Overall Study|Randomized, Not Treated|2|||
42251551|NCT01575548|76077353|FG000|Overall Study|Adverse Event|15|||
42251552|NCT01575548|76077354|FG001|Overall Study|Adverse Event|2|||
42251553|NCT01575548|76077353|FG000|Overall Study|Disease progression|12|||
42251554|NCT01575548|76077354|FG001|Overall Study|Disease progression|25|||
42251555|NCT01575548|76077353|FG000|Overall Study|Death|1|||
42251556|NCT01575548|76077354|FG001|Overall Study|Death|0|||
42251557|NCT01575548|76077353|FG000|Overall Study|Other complicating disease|1|||
42251558|NCT01575548|76077354|FG001|Overall Study|Other complicating disease|0|||
42251559|NCT01575548|76077353|FG000|Overall Study|Withdrawal by Subject|7|||
42251560|NCT01575548|76077354|FG001|Overall Study|Withdrawal by Subject|3|||
42251561|NCT01575548|76077353|FG000|Overall Study|Noncompliance|1|||
42251562|NCT01575548|76077354|FG001|Overall Study|Noncompliance|0|||
42304705|NCT02196675|76140186|FG002|Overall Study|Intra-operative surgical exclusion|0|||
42304706|NCT02196675|76140184|FG000|Overall Study|Protocol Violation|0|||
42304707|NCT02196675|76140185|FG001|Overall Study|Protocol Violation|1|||
42304708|NCT02196675|76140186|FG002|Overall Study|Protocol Violation|0|||
42304709|NCT02196675|76140184|FG000|Overall Study|Death|0|||
42304710|NCT02196675|76140185|FG001|Overall Study|Death|0|||
42304711|NCT02196675|76140186|FG002|Overall Study|Death|1|||
42304712|NCT02399449|76140196|FG000|Overall Study|Withdrawal by Subject|3|||
41990896|NCT01186744|75798943|FG002|Overall Study|Death|0|||
42304713|NCT02399449|76140197|FG001|Overall Study|Withdrawal by Subject|9|||
42304714|NCT02399449|76140196|FG000|Overall Study|Physician Decision|0|||
42304715|NCT02399449|76140197|FG001|Overall Study|Physician Decision|1|||
42304716|NCT02217345|76140205|FG000|Overall Study|Lost to Follow-up|2|||
42304717|NCT02217345|76140206|FG001|Overall Study|Lost to Follow-up|1|||
42304718|NCT02217345|76140205|FG000|Overall Study|Withdrawal by Subject|3|||
42304719|NCT02217345|76140206|FG001|Overall Study|Withdrawal by Subject|2|||
42304720|NCT02217345|76140205|FG000|Overall Study|Adverse Event|2|||
42304721|NCT02217345|76140206|FG001|Overall Study|Adverse Event|1|||
42304722|NCT02217345|76140205|FG000|Overall Study|Physician Decision|0|||
42304723|NCT02217345|76140206|FG001|Overall Study|Physician Decision|1|||
42304724|NCT01652287|76140214|FG000|Overall Study|Withdrawal by Subject|2|||
42304725|NCT01652287|76140215|FG001|Overall Study|Withdrawal by Subject|0|||
42304726|NCT02251743|76140223|FG000|Overall Study|Withdrawal by Subject|1|||
42304727|NCT02251743|76140224|FG001|Overall Study|Withdrawal by Subject|1|||
42304728|NCT02428855|76140230|FG000|Overall Study|Withdrawal by Subject|2|||
42304729|NCT02428699|76140234|FG000|Washout Period 1|Screen Failure|1|||
42304730|NCT02428699|76140235|FG001|Washout Period 1|Screen Failure|2|||
42304731|NCT02428231|76140248|FG000|Overall Study|Other|10|||
42304732|NCT02428231|76140249|FG001|Overall Study|Other|16|||
42304733|NCT02428231|76140248|FG000|Overall Study|Required Symptomatic Therapy|0|||
42304734|NCT02428231|76140249|FG001|Overall Study|Required Symptomatic Therapy|1|||
42304735|NCT02428231|76140248|FG000|Overall Study|Adverse Event|3|||
42304736|NCT02428231|76140249|FG001|Overall Study|Adverse Event|0|||
42304737|NCT02397889|76140257|FG000|Overall Study|Physician Decision|1|||
42304738|NCT02397889|76140258|FG001|Overall Study|Physician Decision|0|||
42304739|NCT02397655|76140264|FG000|Overall Study|data not completed|1301|||
42304740|NCT02396953|76140271|FG000|Overall Study|Withdrawal by Subject|0|||
42304741|NCT02396953|76140272|FG001|Overall Study|Withdrawal by Subject|0|||
42304742|NCT02396953|76140273|FG002|Overall Study|Withdrawal by Subject|1|||
42304743|NCT02396953|76140271|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
42304744|NCT02396953|76140272|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
42304745|NCT02396953|76140273|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
42304746|NCT02396953|76140271|FG000|Overall Study|Personal Reasons|1|||
42304747|NCT02396953|76140272|FG001|Overall Study|Personal Reasons|1|||
42304748|NCT02396953|76140273|FG002|Overall Study|Personal Reasons|0|||
42304749|NCT02387983|76140288|FG000|Overall Study|Adverse Event|4|||
42304750|NCT02387983|76140288|FG000|Overall Study|Protocol Violation|1|||
42304751|NCT02387983|76140288|FG000|Overall Study|Withdrawal by Subject|2|||
42304752|NCT02395627|76140295|FG000|Overall Study|Withdrawal by Subject|0|||
42304753|NCT02395627|76140296|FG001|Overall Study|Withdrawal by Subject|2|||
42304754|NCT02395627|76140297|FG002|Overall Study|Withdrawal by Subject|0|||
42304755|NCT02395627|76140295|FG000|Overall Study|Did not receive pembrolizumab|3|||
42304756|NCT02395627|76140296|FG001|Overall Study|Did not receive pembrolizumab|1|||
42304757|NCT02395627|76140297|FG002|Overall Study|Did not receive pembrolizumab|0|||
42304758|NCT02395471|76140309|FG000|Overall Study|Lost to Follow-up|2|||
42304759|NCT02395471|76140310|FG001|Overall Study|Lost to Follow-up|0|||
42304760|NCT02395471|76140309|FG000|Overall Study|Withdrawal by Subject|2|||
42304761|NCT02395471|76140310|FG001|Overall Study|Withdrawal by Subject|1|||
42304762|NCT02395471|76140309|FG000|Overall Study|Physician Decision|1|||
42304763|NCT02395471|76140310|FG001|Overall Study|Physician Decision|0|||
42304764|NCT02395471|76140309|FG000|Overall Study|Protocol Violation|0|||
42304765|NCT02395471|76140310|FG001|Overall Study|Protocol Violation|1|||
42304766|NCT02395471|76140309|FG000|Overall Study|Failure to swollow sponge twice|1|||
42304767|NCT02395471|76140310|FG001|Overall Study|Failure to swollow sponge twice|0|||
42304768|NCT02395471|76140309|FG000|Overall Study|Patient did not return for procedure|0|||
42304769|NCT02395471|76140310|FG001|Overall Study|Patient did not return for procedure|1|||
42304770|NCT02395471|76140309|FG000|Overall Study|Subject not eligible|1|||
42304771|NCT02395471|76140310|FG001|Overall Study|Subject not eligible|0|||
42304772|NCT02395081|76140328|FG000|Overall Study|Withdrawal by Subject|1|||
42304773|NCT02395081|76140329|FG001|Overall Study|Withdrawal by Subject|1|||
42304774|NCT02395081|76140330|FG002|Overall Study|Withdrawal by Subject|0|||
42304775|NCT02395081|76140328|FG000|Overall Study|Moved where blood couldn't be collected|4|||
42304776|NCT02395081|76140329|FG001|Overall Study|Moved where blood couldn't be collected|1|||
42304777|NCT02395081|76140330|FG002|Overall Study|Moved where blood couldn't be collected|3|||
42304778|NCT02395081|76140328|FG000|Overall Study|Fetal Loss|2|||
42304779|NCT02395081|76140329|FG001|Overall Study|Fetal Loss|3|||
42304780|NCT02395081|76140330|FG002|Overall Study|Fetal Loss|1|||
42304781|NCT02394925|76140341|FG000|Overall Study|Adverse Event|1|||
42304782|NCT02394925|76140341|FG000|Overall Study|Lens Discomfort|3|||
42304783|NCT02394925|76140341|FG000|Overall Study|Lens handling difficulities|5|||
42304784|NCT02394925|76140341|FG000|Overall Study|Lost to Follow-up|9|||
42304785|NCT02394925|76140341|FG000|Overall Study|Protocol Violation|5|||
42304786|NCT02394925|76140341|FG000|Overall Study|No longer meet eligibility criteria|1|||
42304787|NCT02394925|76140341|FG000|Overall Study|Unsatisfactory Visual Response|5|||
42304788|NCT02427607|76140345|FG000|Overall Study|Withdrawal by Subject|1|||
42304789|NCT02425111|76140349|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
42304790|NCT02425111|76140349|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
42304791|NCT02425111|76140349|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
42304792|NCT02425111|76140349|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
42304793|NCT02425111|76140349|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
42304794|NCT02425111|76140349|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
42304795|NCT02424565|76140354|FG000|Period 1 (D0)|Protocol Violation|0|||
42304796|NCT02424565|76140355|FG001|Period 1 (D0)|Protocol Violation|1|||
42304797|NCT02424253|76140363|FG000|Overall Study|Other, unspecified|1|||
42304798|NCT02424253|76140364|FG001|Overall Study|Other, unspecified|0|||
42304799|NCT02424253|76140363|FG000|Overall Study|Compliance problems|1|||
42304800|NCT02424253|76140364|FG001|Overall Study|Compliance problems|0|||
42304801|NCT02424253|76140363|FG000|Overall Study|Physician Decision|2|||
42304802|NCT02424253|76140364|FG001|Overall Study|Physician Decision|0|||
42304803|NCT02424253|76140363|FG000|Overall Study|Lack of Efficacy|0|||
42304804|NCT02424253|76140364|FG001|Overall Study|Lack of Efficacy|7|||
42304805|NCT02424253|76140363|FG000|Overall Study|Adverse Event|2|||
42304806|NCT02424253|76140364|FG001|Overall Study|Adverse Event|0|||
42304807|NCT02424253|76140363|FG000|Overall Study|Consent withdrawn by subject|4|||
42304808|NCT02424253|76140364|FG001|Overall Study|Consent withdrawn by subject|1|||
42304809|NCT02424253|76140363|FG000|Overall Study|Lost to Follow-up|1|||
42304810|NCT02424253|76140364|FG001|Overall Study|Lost to Follow-up|1|||
42304811|NCT02393755|76140372|FG000|Overall Study|Withdrawal by Subject|0|||
42304812|NCT02393755|76140373|FG001|Overall Study|Withdrawal by Subject|3|||
42304813|NCT02393755|76140372|FG000|Overall Study|Adverse Event|0|||
42304814|NCT02393755|76140373|FG001|Overall Study|Adverse Event|2|||
41990897|NCT01186744|75798944|FG003|Overall Study|Death|0|||
41990898|NCT01186744|75798945|FG004|Overall Study|Death|0|||
42132789|NCT00330460|75943613|FG001|Overall Study|Other|0|||
42132790|NCT00454116|75943622|FG000|Overall Study|Adverse Event|5|||
42132791|NCT00454116|75943623|FG001|Overall Study|Adverse Event|11|||
42132792|NCT00454116|75943624|FG002|Overall Study|Adverse Event|9|||
42132793|NCT00454116|75943622|FG000|Overall Study|Condition under investigation worsened|17|||
42251563|NCT01575548|76077353|FG000|Overall Study|Anticipated surgery|0|||
42251564|NCT01575548|76077354|FG001|Overall Study|Anticipated surgery|1|||
42251565|NCT01575548|76077353|FG000|Overall Study|Never started protocol therapy|3|||
42251566|NCT01575548|76077354|FG001|Overall Study|Never started protocol therapy|2|||
42251567|NCT02554786|76077382|FG000|Overall Study|Subject/guardian decision|29|||
42251568|NCT02554786|76077383|FG001|Overall Study|Subject/guardian decision|17|||
42251569|NCT02554786|76077384|FG002|Overall Study|Subject/guardian decision|18|||
42251570|NCT02554786|76077385|FG003|Overall Study|Subject/guardian decision|30|||
42251571|NCT02554786|76077386|FG004|Overall Study|Subject/guardian decision|20|||
42251572|NCT02554786|76077382|FG000|Overall Study|Lost to Follow-up|4|||
42251573|NCT02554786|76077383|FG001|Overall Study|Lost to Follow-up|3|||
42251574|NCT02554786|76077384|FG002|Overall Study|Lost to Follow-up|4|||
42251575|NCT02554786|76077385|FG003|Overall Study|Lost to Follow-up|2|||
42251576|NCT02554786|76077386|FG004|Overall Study|Lost to Follow-up|2|||
42251577|NCT02554786|76077382|FG000|Overall Study|Protocol deviation|1|||
42251578|NCT02554786|76077383|FG001|Overall Study|Protocol deviation|3|||
42251579|NCT02554786|76077384|FG002|Overall Study|Protocol deviation|3|||
42132794|NCT00454116|75943623|FG001|Overall Study|Condition under investigation worsened|13|||
42132795|NCT00454116|75943624|FG002|Overall Study|Condition under investigation worsened|18|||
42132796|NCT00454116|75943622|FG000|Overall Study|Withdrawal by Subject|3|||
42132797|NCT00454116|75943623|FG001|Overall Study|Withdrawal by Subject|3|||
42132798|NCT00454116|75943624|FG002|Overall Study|Withdrawal by Subject|1|||
42304815|NCT02393755|76140372|FG000|Overall Study|Physician Decision|0|||
42304816|NCT02393755|76140373|FG001|Overall Study|Physician Decision|2|||
42304817|NCT02393209|76140380|FG000|Overall Study|Study Terminated by Sponsor|1|||
42304818|NCT02393209|76140381|FG001|Overall Study|Study Terminated by Sponsor|1|||
42304819|NCT02393209|76140382|FG002|Overall Study|Study Terminated by Sponsor|0|||
42304820|NCT02393209|76140383|FG003|Overall Study|Study Terminated by Sponsor|0|||
42132799|NCT00454116|75943622|FG000|Overall Study|Other|2|||
42132800|NCT00454116|75943623|FG001|Overall Study|Other|2|||
42132801|NCT00454116|75943624|FG002|Overall Study|Other|0|||
42251580|NCT02554786|76077385|FG003|Overall Study|Protocol deviation|4|||
42251581|NCT02554786|76077386|FG004|Overall Study|Protocol deviation|2|||
42304821|NCT02393209|76140380|FG000|Overall Study|Withdrawal by Patient|1|||
42304822|NCT02393209|76140381|FG001|Overall Study|Withdrawal by Patient|0|||
42304823|NCT02393209|76140382|FG002|Overall Study|Withdrawal by Patient|0|||
42304824|NCT02393209|76140383|FG003|Overall Study|Withdrawal by Patient|0|||
42132802|NCT00465816|75943635|FG000|Overall Study|Lost to Follow-up|0|||
42132803|NCT00465816|75943636|FG001|Overall Study|Lost to Follow-up|0|||
42132804|NCT00465816|75943637|FG002|Overall Study|Lost to Follow-up|2|||
42132805|NCT00465738|75943648|FG000|Overall Study|Lost to Follow-up|2|||
42132806|NCT00465738|75943649|FG001|Overall Study|Lost to Follow-up|0|||
42132807|NCT00465738|75943648|FG000|Overall Study|Adverse Event|0|||
42132808|NCT00465738|75943649|FG001|Overall Study|Adverse Event|1|||
42132809|NCT00465738|75943648|FG000|Overall Study|Withdrawal by Subject|2|||
42132810|NCT00465738|75943649|FG001|Overall Study|Withdrawal by Subject|0|||
42132811|NCT00465738|75943648|FG000|Overall Study|Other|2|||
42132812|NCT00465738|75943649|FG001|Overall Study|Other|5|||
42251582|NCT02554786|76077382|FG000|Overall Study|Technical problems|1|||
42251583|NCT02554786|76077383|FG001|Overall Study|Technical problems|1|||
42251584|NCT02554786|76077384|FG002|Overall Study|Technical problems|0|||
42304825|NCT02393209|76140380|FG000|Overall Study|Death|2|||
42304826|NCT02393209|76140381|FG001|Overall Study|Death|2|||
42304827|NCT02393209|76140382|FG002|Overall Study|Death|0|||
42304828|NCT02393209|76140383|FG003|Overall Study|Death|0|||
42304829|NCT02393209|76140380|FG000|Overall Study|Death due to Disease Progression|2|||
42304830|NCT02393209|76140381|FG001|Overall Study|Death due to Disease Progression|2|||
42304831|NCT02393209|76140382|FG002|Overall Study|Death due to Disease Progression|0|||
42304832|NCT02393209|76140383|FG003|Overall Study|Death due to Disease Progression|0|||
42304833|NCT02393209|76140380|FG000|Overall Study|Death from Legionella Infection|0|||
42304834|NCT02393209|76140381|FG001|Overall Study|Death from Legionella Infection|1|||
42304835|NCT02393209|76140382|FG002|Overall Study|Death from Legionella Infection|0|||
42304836|NCT02393209|76140383|FG003|Overall Study|Death from Legionella Infection|0|||
42304837|NCT02393209|76140380|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
42304838|NCT02393209|76140381|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
42304839|NCT02393209|76140382|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
42132813|NCT00400179|75943657|FG000|Overall Study|Adverse Event|2|||
42132814|NCT00400179|75943658|FG001|Overall Study|Adverse Event|2|||
42132815|NCT00400179|75943657|FG000|Overall Study|Death|1|||
42251585|NCT02554786|76077385|FG003|Overall Study|Technical problems|2|||
42251586|NCT02554786|76077386|FG004|Overall Study|Technical problems|1|||
42251587|NCT02554786|76077382|FG000|Overall Study|Adverse Event|0|||
42251588|NCT02554786|76077383|FG001|Overall Study|Adverse Event|0|||
42251589|NCT02554786|76077384|FG002|Overall Study|Adverse Event|0|||
42251590|NCT02554786|76077385|FG003|Overall Study|Adverse Event|0|||
42251591|NCT02554786|76077386|FG004|Overall Study|Adverse Event|2|||
42251592|NCT02554786|76077382|FG000|Overall Study|Death|0|||
42251593|NCT02554786|76077383|FG001|Overall Study|Death|0|||
42251594|NCT02554786|76077384|FG002|Overall Study|Death|0|||
42251595|NCT02554786|76077385|FG003|Overall Study|Death|1|||
42251596|NCT02554786|76077386|FG004|Overall Study|Death|0|||
42251597|NCT02554786|76077382|FG000|Overall Study|Non-compliance with study treatment|0|||
42251598|NCT02554786|76077383|FG001|Overall Study|Non-compliance with study treatment|1|||
42251599|NCT02554786|76077384|FG002|Overall Study|Non-compliance with study treatment|1|||
42251600|NCT02554786|76077385|FG003|Overall Study|Non-compliance with study treatment|0|||
42251601|NCT02554786|76077386|FG004|Overall Study|Non-compliance with study treatment|1|||
42251602|NCT02554786|76077382|FG000|Overall Study|Physician Decision|0|||
42251603|NCT02554786|76077383|FG001|Overall Study|Physician Decision|1|||
42251604|NCT02554786|76077384|FG002|Overall Study|Physician Decision|4|||
42251605|NCT02554786|76077385|FG003|Overall Study|Physician Decision|1|||
42304840|NCT02393209|76140383|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
42304841|NCT02393209|76140380|FG000|Overall Study|Lost to Follow-up|0|||
42033123|NCT01132313|75841315|FG006|Overall Study|Lack of Efficacy|0|||
42132816|NCT00400179|75943658|FG001|Overall Study|Death|2|||
42132817|NCT00400179|75943657|FG000|Overall Study|Withdrew Consent|1|||
42132818|NCT00400179|75943658|FG001|Overall Study|Withdrew Consent|5|||
42132819|NCT00400179|75943657|FG000|Overall Study|Disease progression|1|||
42251606|NCT02554786|76077386|FG004|Overall Study|Physician Decision|1|||
42251607|NCT02554786|76077382|FG000|Overall Study|Pregnancy|0|||
42251608|NCT02554786|76077383|FG001|Overall Study|Pregnancy|0|||
42251609|NCT02554786|76077384|FG002|Overall Study|Pregnancy|0|||
42251610|NCT02554786|76077385|FG003|Overall Study|Pregnancy|1|||
42251611|NCT02554786|76077386|FG004|Overall Study|Pregnancy|1|||
42251612|NCT01347645|76077407|FG000|Overall Study|Death|1|||
42304842|NCT02393209|76140381|FG001|Overall Study|Lost to Follow-up|1|||
42304843|NCT02393209|76140382|FG002|Overall Study|Lost to Follow-up|0|||
42304844|NCT02393209|76140383|FG003|Overall Study|Lost to Follow-up|0|||
42304845|NCT02424097|76140394|FG000|Overall Study|Lost to Follow-up|1|||
42304846|NCT02424097|76140395|FG001|Overall Study|Lost to Follow-up|2|||
42304847|NCT02392507|76140401|FG000|Induction Regimen|Death|3|||
41990899|NCT01186744|75798946|FG005|Overall Study|Death|0|||
41990900|NCT01185964|75798984|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
41990901|NCT01185964|75798985|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
42304848|NCT02392507|76140401|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
42304849|NCT02392507|76140401|FG000|Induction Regimen|Physician Decision|1|||
42304850|NCT02392507|76140401|FG000|Induction Regimen|Withdrawal by Subject|2|||
42304851|NCT02392507|76140401|FG000|Maintenance Regimen|Death|1|||
42304852|NCT02392507|76140401|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
42304853|NCT02386345|76140410|FG000|Overall Study|Not treated|14|||
42304854|NCT02386345|76140410|FG000|Overall Study|Lost to Follow-up|1|||
42304855|NCT02386345|76140410|FG000|Overall Study|Adverse Event|5|||
42304856|NCT02386345|76140410|FG000|Overall Study|Repeat Procedure|10|||
42304857|NCT02386345|76140410|FG000|Overall Study|Did not complete 12-month follow-up|72|||
42304858|NCT01651117|76140418|FG000|Overall Study|Death|2|||
42304859|NCT01651117|76140419|FG001|Overall Study|Death|3|||
42304860|NCT01651117|76140420|FG002|Overall Study|Death|2|||
42304861|NCT01651117|76140421|FG003|Overall Study|Death|2|||
42304862|NCT02386189|76140436|FG000|Overall Study|Lost to Follow-up|2|||
42304863|NCT02386189|76140437|FG001|Overall Study|Lost to Follow-up|3|||
42304864|NCT02386189|76140436|FG000|Overall Study|Withdrawal by Subject|1|||
42304865|NCT02386189|76140437|FG001|Overall Study|Withdrawal by Subject|0|||
42304866|NCT02386189|76140436|FG000|Overall Study|Death|1|||
42304867|NCT02386189|76140437|FG001|Overall Study|Death|0|||
42304868|NCT02385799|76140445|FG000|Overall Study|Lost to Follow-up|1|||
42304869|NCT02385799|76140446|FG001|Overall Study|Lost to Follow-up|2|||
42304870|NCT02385799|76140445|FG000|Overall Study|Adverse Event|4|||
42304871|NCT02385799|76140446|FG001|Overall Study|Adverse Event|2|||
42304872|NCT02385799|76140445|FG000|Overall Study|Withdrawal by Subject|0|||
42304873|NCT02385799|76140446|FG001|Overall Study|Withdrawal by Subject|4|||
42304874|NCT02422303|76140454|FG000|Overall Study|Lost to Follow-up|1|||
42304875|NCT02422303|76140455|FG001|Overall Study|Lost to Follow-up|1|||
42304876|NCT02392195|76140461|FG000|Overall Study|Lost to Follow-up|4|||
42304877|NCT02392195|76140461|FG000|Overall Study|Withdrawal by Subject|4|||
42304878|NCT02391961|76140467|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
42304879|NCT02391961|76140468|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
42304880|NCT02391961|76140467|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
42304881|NCT02391961|76140468|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
42304882|NCT02391961|76140467|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
42304883|NCT02391961|76140468|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
42304884|NCT02384941|76140477|FG000|Overall Study|Adverse Event|11|||
42304885|NCT02384941|76140478|FG001|Overall Study|Adverse Event|13|||
42304886|NCT02384941|76140479|FG002|Overall Study|Adverse Event|17|||
42304887|NCT02384941|76140477|FG000|Overall Study|Lost to Follow-up|3|||
42304888|NCT02384941|76140478|FG001|Overall Study|Lost to Follow-up|2|||
42304889|NCT02384941|76140479|FG002|Overall Study|Lost to Follow-up|1|||
42304890|NCT02384941|76140477|FG000|Overall Study|Non-Compliance With Study Drug|2|||
42304891|NCT02384941|76140478|FG001|Overall Study|Non-Compliance With Study Drug|0|||
41990902|NCT01185964|75798986|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
41990903|NCT01185964|75798987|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
41990904|NCT01185964|75798984|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
42304892|NCT02384941|76140479|FG002|Overall Study|Non-Compliance With Study Drug|1|||
42304893|NCT02384941|76140477|FG000|Overall Study|Physician Decision|1|||
42304894|NCT02384941|76140478|FG001|Overall Study|Physician Decision|1|||
42304895|NCT02384941|76140479|FG002|Overall Study|Physician Decision|0|||
42304896|NCT02384941|76140477|FG000|Overall Study|Protocol Violation|3|||
42304897|NCT02384941|76140478|FG001|Overall Study|Protocol Violation|0|||
42304898|NCT02384941|76140479|FG002|Overall Study|Protocol Violation|0|||
42304899|NCT02384941|76140477|FG000|Overall Study|Withdrawal by Subject|26|||
42304900|NCT02384941|76140478|FG001|Overall Study|Withdrawal by Subject|19|||
42304901|NCT02384941|76140479|FG002|Overall Study|Withdrawal by Subject|20|||
42304902|NCT02384941|76140477|FG000|Overall Study|Pregnancy|0|||
42304903|NCT02384941|76140478|FG001|Overall Study|Pregnancy|0|||
42304904|NCT02384941|76140479|FG002|Overall Study|Pregnancy|1|||
42304905|NCT02384941|76140477|FG000|Overall Study|Other than specified above|4|||
42304906|NCT02384941|76140478|FG001|Overall Study|Other than specified above|0|||
42304907|NCT02384941|76140479|FG002|Overall Study|Other than specified above|1|||
42304908|NCT02384395|76140488|FG000|Overall Study|Physician Decision|4|||
42304909|NCT02384395|76140488|FG000|Overall Study|Withdrawal by Subject|3|||
42304910|NCT02384395|76140488|FG000|Overall Study|Lost to Follow-up|3|||
42304911|NCT02420353|76140494|FG000|Overall Study|Withdrawal by Subject|0|||
42304912|NCT02420353|76140495|FG001|Overall Study|Withdrawal by Subject|1|||
42304913|NCT02391337|76140503|FG000|6 Months Follow-up|Death|5|||
41990905|NCT01185964|75798985|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
41990906|NCT01185964|75798986|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
41990907|NCT01185964|75798987|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
41990908|NCT01185964|75798984|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
42304914|NCT02391337|76140504|FG001|6 Months Follow-up|Death|4|||
42304915|NCT02391337|76140503|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
41990909|NCT01185964|75798985|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
41990910|NCT01185964|75798986|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
41990911|NCT01185964|75798987|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
41990912|NCT01185964|75798984|FG000|Phase 1b and Phase 2|Adverse Event|1|||
41990913|NCT01185964|75798985|FG001|Phase 1b and Phase 2|Adverse Event|0|||
41990914|NCT01185964|75798986|FG002|Phase 1b and Phase 2|Adverse Event|2|||
41990915|NCT01185964|75798987|FG003|Phase 1b and Phase 2|Adverse Event|0|||
41990916|NCT01185964|75798984|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
41990917|NCT01185964|75798985|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
41990918|NCT01185964|75798986|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
41990919|NCT01185964|75798987|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
42251613|NCT01347645|76077408|FG001|Overall Study|Death|5|||
42251614|NCT01347645|76077409|FG002|Overall Study|Death|2|||
41990920|NCT01185964|75798984|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
41990921|NCT01185964|75798985|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
41990922|NCT01185964|75798986|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
41990923|NCT01185964|75798987|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
41990924|NCT01185964|75798984|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
41990925|NCT01185964|75798985|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
41990926|NCT01185964|75798986|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
41990927|NCT01185964|75798987|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
41990928|NCT01185964|75798984|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
41990929|NCT01185964|75798985|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
41990930|NCT01185964|75798986|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
41990931|NCT01185964|75798987|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
41990932|NCT01217476|75799005|FG000|Overall Study|Adverse Event|6|||
41990933|NCT01217476|75799006|FG001|Overall Study|Adverse Event|1|||
41990934|NCT01217476|75799005|FG000|Overall Study|Physician Decision|0|||
41990935|NCT01217476|75799006|FG001|Overall Study|Physician Decision|1|||
41990936|NCT01217476|75799005|FG000|Overall Study|Withdrawal by Subject|3|||
41990937|NCT01217476|75799006|FG001|Overall Study|Withdrawal by Subject|3|||
42251615|NCT01347645|76077410|FG003|Overall Study|Death|7|||
42251616|NCT01347645|76077411|FG004|Overall Study|Death|7|||
41990938|NCT01217476|75799005|FG000|Overall Study|Surgery on the Target Limb|0|||
41990939|NCT01217476|75799006|FG001|Overall Study|Surgery on the Target Limb|2|||
41990940|NCT01217476|75799005|FG000|Overall Study|Protocol Deviation|1|||
41990941|NCT01217476|75799006|FG001|Overall Study|Protocol Deviation|0|||
41990942|NCT01217476|75799005|FG000|Overall Study|Other|2|||
41990943|NCT01217476|75799006|FG001|Overall Study|Other|0|||
41990944|NCT01217437|75799027|FG000|Overall Study|Adverse Event|0|||
41990945|NCT01217437|75799028|FG001|Overall Study|Adverse Event|8|||
41990946|NCT01217437|75799027|FG000|Overall Study|Death|5|||
41990947|NCT01217437|75799028|FG001|Overall Study|Death|0|||
41990948|NCT01217437|75799027|FG000|Overall Study|Lack of Efficacy|29|||
41990949|NCT01217437|75799028|FG001|Overall Study|Lack of Efficacy|25|||
41990950|NCT01217437|75799027|FG000|Overall Study|Physician Decision|8|||
41990951|NCT01217437|75799028|FG001|Overall Study|Physician Decision|5|||
41990952|NCT01217437|75799027|FG000|Overall Study|Withdrawal by Subject|0|||
41990953|NCT01217437|75799028|FG001|Overall Study|Withdrawal by Subject|2|||
42251617|NCT01347645|76077407|FG000|Overall Study|Lost to Follow-up|1|||
42251618|NCT01347645|76077408|FG001|Overall Study|Lost to Follow-up|1|||
42304916|NCT02391337|76140504|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
42304917|NCT02391337|76140503|FG000|12 Months Follow-up|Death|2|||
41990954|NCT01217437|75799027|FG000|Overall Study|Ineligible|1|||
41990955|NCT01217437|75799028|FG001|Overall Study|Ineligible|1|||
42251619|NCT01347645|76077409|FG002|Overall Study|Lost to Follow-up|0|||
42251620|NCT01347645|76077410|FG003|Overall Study|Lost to Follow-up|1|||
42304918|NCT02391337|76140504|FG001|12 Months Follow-up|Death|0|||
42251621|NCT01347645|76077411|FG004|Overall Study|Lost to Follow-up|1|||
42304919|NCT02391337|76140503|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
42251622|NCT01347645|76077407|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
42251623|NCT01347645|76077408|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
42251624|NCT01347645|76077409|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
42251625|NCT01347645|76077410|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
42251626|NCT01347645|76077411|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
42251627|NCT01347645|76077407|FG000|Overall Study|Other|1|||
42251628|NCT01347645|76077408|FG001|Overall Study|Other|0|||
42304920|NCT02391337|76140504|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
42304921|NCT02391337|76140503|FG000|12 Months Follow-up|Lost to Follow-up|0|||
42304922|NCT02391337|76140504|FG001|12 Months Follow-up|Lost to Follow-up|2|||
42304923|NCT02382991|76140512|FG000|Overall Study|Adverse Event|1|||
42304924|NCT02382991|76140513|FG001|Overall Study|Adverse Event|2|||
42304925|NCT02382991|76140512|FG000|Overall Study|Lost to Follow-up|1|||
42304926|NCT02382991|76140513|FG001|Overall Study|Lost to Follow-up|0|||
42304927|NCT02382991|76140512|FG000|Overall Study|Withdrawal by Subject|0|||
42304928|NCT02382991|76140513|FG001|Overall Study|Withdrawal by Subject|1|||
42304929|NCT02390557|76140521|FG000|Wave 2|Survey non-respondent|72|||
42304930|NCT02390557|76140522|FG001|Wave 2|Survey non-respondent|41|||
42304931|NCT02390557|76140523|FG002|Wave 2|Survey non-respondent|23|||
42304932|NCT01649791|76140531|FG000|Overall Study|Disease Progression|2|||
42304933|NCT01649791|76140531|FG000|Overall Study|Adverse Event|1|||
42304934|NCT01649557|76140538|FG000|Overall Study|Lost to Follow-up|5|||
42304935|NCT01649557|76140539|FG001|Overall Study|Lost to Follow-up|0|||
42304936|NCT01649557|76140540|FG002|Overall Study|Lost to Follow-up|3|||
42304937|NCT01649557|76140538|FG000|Overall Study|Adverse Event|7|||
42304938|NCT01649557|76140539|FG001|Overall Study|Adverse Event|5|||
42304939|NCT01649557|76140540|FG002|Overall Study|Adverse Event|1|||
42304940|NCT01649557|76140538|FG000|Overall Study|Met withdrawal criteria|4|||
42304941|NCT01649557|76140539|FG001|Overall Study|Met withdrawal criteria|0|||
42304942|NCT01649557|76140540|FG002|Overall Study|Met withdrawal criteria|0|||
42304943|NCT01649557|76140538|FG000|Overall Study|Physician Decision|8|||
42304944|NCT01649557|76140539|FG001|Overall Study|Physician Decision|2|||
42304945|NCT01649557|76140540|FG002|Overall Study|Physician Decision|1|||
42304946|NCT01649557|76140538|FG000|Overall Study|Withdrawal by Subject|15|||
42304947|NCT01649557|76140539|FG001|Overall Study|Withdrawal by Subject|5|||
42304948|NCT01649557|76140540|FG002|Overall Study|Withdrawal by Subject|4|||
42304949|NCT01649557|76140538|FG000|Overall Study|Protocol deviation|0|||
42304950|NCT01649557|76140539|FG001|Overall Study|Protocol deviation|2|||
42304951|NCT01649557|76140540|FG002|Overall Study|Protocol deviation|0|||
42304952|NCT01649557|76140538|FG000|Overall Study|Lack of Efficacy|5|||
42304953|NCT01649557|76140539|FG001|Overall Study|Lack of Efficacy|0|||
42304954|NCT01649557|76140540|FG002|Overall Study|Lack of Efficacy|0|||
42304955|NCT02390245|76140548|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
42304956|NCT02390245|76140549|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
42304957|NCT02390245|76140550|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
42304958|NCT02390245|76140548|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
42304959|NCT02390245|76140549|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
42132820|NCT00400179|75943658|FG001|Overall Study|Disease progression|1|||
42132821|NCT00400179|75943657|FG000|Overall Study|Intercurrent illness|0|||
42132822|NCT00400179|75943658|FG001|Overall Study|Intercurrent illness|1|||
42304960|NCT02390245|76140550|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
42304961|NCT02390167|76140559|FG000|Overall Study|Lost to Follow-up|1|||
42304962|NCT02347657|76140569|FG000|Overall Study|Physician Decision|0|||
42304963|NCT02347657|76140570|FG001|Overall Study|Physician Decision|1|||
42304964|NCT02347657|76140569|FG000|Overall Study|Adverse Event|8|||
42132823|NCT00400179|75943657|FG000|Overall Study|Investigator judgment|0|||
42304965|NCT02347657|76140570|FG001|Overall Study|Adverse Event|4|||
42304966|NCT02347657|76140569|FG000|Overall Study|Withdrawal by Subject|6|||
42033124|NCT01132313|75841316|FG007|Overall Study|Lack of Efficacy|3|||
42033125|NCT01132313|75841317|FG008|Overall Study|Lack of Efficacy|14|||
42033126|NCT01132313|75841318|FG009|Overall Study|Lack of Efficacy|16|||
42033127|NCT01132313|75841319|FG010|Overall Study|Lack of Efficacy|0|||
42033128|NCT01132313|75841320|FG011|Overall Study|Lack of Efficacy|0|||
42251629|NCT01347645|76077409|FG002|Overall Study|Other|0|||
42251630|NCT01347645|76077410|FG003|Overall Study|Other|0|||
42251631|NCT01347645|76077411|FG004|Overall Study|Other|1|||
42251632|NCT01347645|76077407|FG000|Overall Study|Withdrawal by Subject|0|||
42251633|NCT01347645|76077408|FG001|Overall Study|Withdrawal by Subject|0|||
42251634|NCT01347645|76077409|FG002|Overall Study|Withdrawal by Subject|0|||
42251635|NCT01347645|76077410|FG003|Overall Study|Withdrawal by Subject|3|||
42251636|NCT01347645|76077411|FG004|Overall Study|Withdrawal by Subject|3|||
42251637|NCT01347645|76077407|FG000|Overall Study|Physician Decision|0|||
42251638|NCT01347645|76077408|FG001|Overall Study|Physician Decision|0|||
42251639|NCT01347645|76077409|FG002|Overall Study|Physician Decision|0|||
42251640|NCT01347645|76077410|FG003|Overall Study|Physician Decision|0|||
42251641|NCT01347645|76077411|FG004|Overall Study|Physician Decision|1|||
42251642|NCT01347645|76077407|FG000|Overall Study|Adverse Event|0|||
42251643|NCT01347645|76077408|FG001|Overall Study|Adverse Event|0|||
42251644|NCT01347645|76077409|FG002|Overall Study|Adverse Event|0|||
42251645|NCT01347645|76077410|FG003|Overall Study|Adverse Event|1|||
42251646|NCT01347645|76077411|FG004|Overall Study|Adverse Event|1|||
42251647|NCT00484419|76077449|FG000|Overall Study|Adverse Event|3|||
42251648|NCT00484419|76077450|FG001|Overall Study|Adverse Event|0|||
42251649|NCT00484419|76077451|FG002|Overall Study|Adverse Event|0|||
42251650|NCT00484419|76077449|FG000|Overall Study|Lost to Follow-up|1|||
42251651|NCT00484419|76077450|FG001|Overall Study|Lost to Follow-up|0|||
42251652|NCT00484419|76077451|FG002|Overall Study|Lost to Follow-up|2|||
42251653|NCT00484419|76077449|FG000|Overall Study|Withdrawal by Subject|3|||
42251654|NCT00484419|76077450|FG001|Overall Study|Withdrawal by Subject|1|||
42251655|NCT00484419|76077451|FG002|Overall Study|Withdrawal by Subject|1|||
42251656|NCT00484419|76077449|FG000|Overall Study|subject met discontinuation criteria|2|||
42251657|NCT00484419|76077450|FG001|Overall Study|subject met discontinuation criteria|2|||
42251658|NCT00484419|76077451|FG002|Overall Study|subject met discontinuation criteria|4|||
42251659|NCT00484419|76077449|FG000|Overall Study|required restricted medication|1|||
42251660|NCT00484419|76077450|FG001|Overall Study|required restricted medication|0|||
42251661|NCT00484419|76077451|FG002|Overall Study|required restricted medication|1|||
42251662|NCT00484419|76077449|FG000|Overall Study|Physician Decision|1|||
42251663|NCT00484419|76077450|FG001|Overall Study|Physician Decision|1|||
42251664|NCT00484419|76077451|FG002|Overall Study|Physician Decision|1|||
42251665|NCT00484419|76077449|FG000|Overall Study|subject unable to receive medication|1|||
42251666|NCT00484419|76077450|FG001|Overall Study|subject unable to receive medication|0|||
42251667|NCT00484419|76077451|FG002|Overall Study|subject unable to receive medication|0|||
42251668|NCT00484419|76077449|FG000|Overall Study|subject relocated|0|||
42251669|NCT00484419|76077450|FG001|Overall Study|subject relocated|1|||
42251670|NCT00484419|76077451|FG002|Overall Study|subject relocated|0|||
42251671|NCT00484419|76077449|FG000|Overall Study|sponsor decision, randomized in error|0|||
42251672|NCT00484419|76077450|FG001|Overall Study|sponsor decision, randomized in error|0|||
42251673|NCT00484419|76077451|FG002|Overall Study|sponsor decision, randomized in error|2|||
42251674|NCT03220724|76077460|FG000|Overall Study|Lost to Follow-up|2|||
42251675|NCT03220724|76077461|FG001|Overall Study|Lost to Follow-up|1|||
42251676|NCT03220724|76077462|FG002|Overall Study|Lost to Follow-up|0|||
42251677|NCT03220724|76077463|FG003|Overall Study|Lost to Follow-up|3|||
42251678|NCT03220724|76077460|FG000|Overall Study|Withdrawal by Subject|1|||
42251679|NCT03220724|76077461|FG001|Overall Study|Withdrawal by Subject|1|||
42251680|NCT03220724|76077462|FG002|Overall Study|Withdrawal by Subject|1|||
42251681|NCT03220724|76077463|FG003|Overall Study|Withdrawal by Subject|0|||
42251682|NCT03056573|76077475|FG000|Overall Study|Death|2|||
42251683|NCT03056573|76077476|FG001|Overall Study|Death|4|||
42251684|NCT03056573|76077475|FG000|Overall Study|Withdrawal by Subject|2|||
42251685|NCT03056573|76077476|FG001|Overall Study|Withdrawal by Subject|0|||
42251686|NCT03056573|76077475|FG000|Overall Study|Lost to Follow-up|1|||
42251687|NCT03056573|76077476|FG001|Overall Study|Lost to Follow-up|1|||
42251688|NCT02553772|76077484|FG000|Overall Study|Adverse Event|2|||
42033129|NCT01132313|75841309|FG000|Overall Study|Not treated|2|||
42251689|NCT02553772|76077485|FG001|Overall Study|Adverse Event|3|||
42251690|NCT02553772|76077484|FG000|Overall Study|Lost to Follow-up|2|||
42251691|NCT02553772|76077485|FG001|Overall Study|Lost to Follow-up|1|||
42251692|NCT02553772|76077484|FG000|Overall Study|Withdrawal of Consent|1|||
42251693|NCT02553772|76077485|FG001|Overall Study|Withdrawal of Consent|1|||
42251694|NCT02553772|76077484|FG000|Overall Study|Lack of Efficacy|1|||
42251695|NCT02553772|76077485|FG001|Overall Study|Lack of Efficacy|0|||
42304967|NCT02347657|76140570|FG001|Overall Study|Withdrawal by Subject|7|||
42304968|NCT02347657|76140569|FG000|Overall Study|Randomized but not treated|1|||
42304969|NCT02347657|76140570|FG001|Overall Study|Randomized but not treated|0|||
42304970|NCT02347657|76140569|FG000|Overall Study|Other|3|||
42304971|NCT02347657|76140570|FG001|Overall Study|Other|3|||
42304972|NCT02347189|76140577|FG000|Overall Study|No implant attempted of study device|9|||
42304973|NCT02347189|76140577|FG000|Overall Study|No primary outcome data available|2|||
42304974|NCT02382133|76140592|FG000|Overall Study|Death|22|||
42304975|NCT02382133|76140592|FG000|Overall Study|transfer out of ICU|4|||
42304976|NCT02382133|76140592|FG000|Overall Study|Physician Decision|2|||
42304977|NCT02382133|76140592|FG000|Overall Study|arterial catheter loss|4|||
42304978|NCT02382133|76140592|FG000|Overall Study|pressure injury both sites|1|||
42304979|NCT02346877|76140598|FG000|Overall Study|Adverse Event|1|||
42304980|NCT02346877|76140599|FG001|Overall Study|Adverse Event|0|||
42304981|NCT02346877|76140598|FG000|Overall Study|Administrative Decision|1|||
42304982|NCT02346877|76140599|FG001|Overall Study|Administrative Decision|0|||
42304983|NCT02346877|76140598|FG000|Overall Study|Sponsor Decision|12|||
42304984|NCT02346877|76140599|FG001|Overall Study|Sponsor Decision|0|||
42304985|NCT02346877|76140598|FG000|Overall Study|Missing|5|||
42304986|NCT02346877|76140599|FG001|Overall Study|Missing|0|||
42304987|NCT02346721|76140605|FG000|Overall Study|Withdrew Consent|3|||
42304988|NCT02346721|76140605|FG000|Overall Study|Lack of Efficacy|1|||
42304989|NCT02389621|76140613|FG000|Treatment Period|Withdrawal by Subject|1|||
42304990|NCT02389621|76140614|FG001|Treatment Period|Withdrawal by Subject|1|||
42304991|NCT02389621|76140613|FG000|Posttreatment Period|Adverse Event|3|||
42304992|NCT02389621|76140614|FG001|Posttreatment Period|Adverse Event|1|||
42304993|NCT02389621|76140613|FG000|Posttreatment Period|Withdrawal by Subject|3|||
42304994|NCT02389621|76140614|FG001|Posttreatment Period|Withdrawal by Subject|2|||
42304995|NCT02389621|76140613|FG000|Posttreatment Period|Lost to Follow-up|1|||
42304996|NCT02389621|76140614|FG001|Posttreatment Period|Lost to Follow-up|1|||
42251696|NCT02553772|76077484|FG000|Overall Study|Other Miscellaneous Reasons|0|||
42251697|NCT02553772|76077485|FG001|Overall Study|Other Miscellaneous Reasons|1|||
42251698|NCT02553538|76077493|FG000|Overall Study|Could Not Reach by Telephone|133|||
42251699|NCT02553538|76077494|FG001|Overall Study|Could Not Reach by Telephone|0|||
42251700|NCT02553538|76077493|FG000|Overall Study|Died or Left Network|54|||
42251701|NCT02553538|76077494|FG001|Overall Study|Died or Left Network|56|||
42251702|NCT02548156|76077500|FG000|Washout Period 1|Lost to Follow-up|0|||
42251703|NCT02548156|76077501|FG001|Washout Period 1|Lost to Follow-up|0|||
42304997|NCT02389621|76140613|FG000|Posttreatment Period|Other - Miscellaneous|2|||
42251704|NCT02548156|76077502|FG002|Washout Period 1|Lost to Follow-up|0|||
42304998|NCT02389621|76140614|FG001|Posttreatment Period|Other - Miscellaneous|0|||
42251705|NCT02548156|76077503|FG003|Washout Period 1|Lost to Follow-up|0|||
42251706|NCT02548156|76077504|FG004|Washout Period 1|Lost to Follow-up|1|||
42251707|NCT02548156|76077505|FG005|Washout Period 1|Lost to Follow-up|0|||
42251708|NCT01503515|76077515|FG000|Overall Study|Adverse Event|4|||
42251709|NCT01503515|76077516|FG001|Overall Study|Adverse Event|5|||
42251710|NCT01503515|76077515|FG000|Overall Study|Death|0|||
42251711|NCT01503515|76077516|FG001|Overall Study|Death|1|||
42251712|NCT01503515|76077515|FG000|Overall Study|Physician Decision|14|||
42251713|NCT01503515|76077516|FG001|Overall Study|Physician Decision|23|||
42251714|NCT01503515|76077515|FG000|Overall Study|Withdrawal by Subject|0|||
42304999|NCT02388997|76140626|FG000|Overall Study|Adverse Event|1|||
42305000|NCT02388997|76140627|FG001|Overall Study|Adverse Event|2|||
42305001|NCT02388997|76140626|FG000|Overall Study|Withdrawal by Subject|2|||
42251715|NCT01503515|76077516|FG001|Overall Study|Withdrawal by Subject|1|||
42251716|NCT01503515|76077515|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
42251717|NCT01503515|76077516|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
42251718|NCT01503515|76077515|FG000|Overall Study|Ineligible|1|||
42305002|NCT02388997|76140627|FG001|Overall Study|Withdrawal by Subject|1|||
42305003|NCT02388997|76140626|FG000|Overall Study|Lung function exclusion criteria|0|||
42305004|NCT02388997|76140627|FG001|Overall Study|Lung function exclusion criteria|2|||
42305005|NCT02388997|76140626|FG000|Overall Study|Tested positive for virus during run-in|0|||
42305006|NCT02388997|76140627|FG001|Overall Study|Tested positive for virus during run-in|1|||
42305007|NCT02388763|76140633|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
42251719|NCT01503515|76077516|FG001|Overall Study|Ineligible|1|||
42251720|NCT02742519|76077524|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
42305008|NCT02388763|76140634|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
42251721|NCT02742519|76077525|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
42251722|NCT02742519|76077526|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
42251723|NCT02742519|76077524|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
42251724|NCT02742519|76077525|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
42251725|NCT02742519|76077526|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
42251726|NCT02742519|76077524|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
42251727|NCT02742519|76077525|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
42251728|NCT02742519|76077526|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
42251729|NCT01375010|76077536|FG000|Overall Study|Lost to Follow-up|8|||
42251730|NCT01375010|76077537|FG001|Overall Study|Lost to Follow-up|2|||
42251731|NCT01375010|76077536|FG000|Overall Study|Withdrawal by Subject|4|||
42251732|NCT01375010|76077537|FG001|Overall Study|Withdrawal by Subject|2|||
42251733|NCT00659061|76077561|FG000|Overall Study|Migration due to political unrest|21|||
42251734|NCT00659061|76077562|FG001|Overall Study|Migration due to political unrest|15|||
42251735|NCT02548078|76077579|FG000|Overall Study|Serious adverse event/Adverse event|1|||
42251736|NCT02548078|76077580|FG001|Overall Study|Serious adverse event/Adverse event|0|||
42251737|NCT02548078|76077579|FG000|Overall Study|Moved from study area|3|||
42251738|NCT02548078|76077580|FG001|Overall Study|Moved from study area|3|||
42251739|NCT02548078|76077579|FG000|Overall Study|Lost to Follow-up|1|||
42251740|NCT02548078|76077580|FG001|Overall Study|Lost to Follow-up|3|||
42251741|NCT02916433|76077595|FG000|Overall Study|Withdrawal by Subject|1|||
42251742|NCT02916433|76077596|FG001|Overall Study|Withdrawal by Subject|0|||
42251743|NCT02916433|76077595|FG000|Overall Study|Physician Decision|1|||
42251744|NCT02916433|76077596|FG001|Overall Study|Physician Decision|0|||
42251745|NCT00526227|76077605|FG000|Overall Study|Device not implanted|1|||
42251746|NCT00526227|76077605|FG000|Overall Study|Death|1|||
42251747|NCT02547922|76077613|FG000|Overall Study|Withdrawal by Subject|9|||
42251748|NCT02547922|76077614|FG001|Overall Study|Withdrawal by Subject|6|||
42251749|NCT02547922|76077615|FG002|Overall Study|Withdrawal by Subject|10|||
42251750|NCT02547922|76077613|FG000|Overall Study|Adverse Event|3|||
42251751|NCT02547922|76077614|FG001|Overall Study|Adverse Event|1|||
42251752|NCT02547922|76077615|FG002|Overall Study|Adverse Event|2|||
42251753|NCT02547922|76077613|FG000|Overall Study|Lost to Follow-up|1|||
42251754|NCT02547922|76077614|FG001|Overall Study|Lost to Follow-up|0|||
42251755|NCT02547922|76077615|FG002|Overall Study|Lost to Follow-up|0|||
42251756|NCT02547922|76077613|FG000|Overall Study|Lack of Efficacy|5|||
42251757|NCT02547922|76077614|FG001|Overall Study|Lack of Efficacy|7|||
42251758|NCT02547922|76077615|FG002|Overall Study|Lack of Efficacy|4|||
42251759|NCT02547922|76077613|FG000|Overall Study|Death|1|||
42251760|NCT02547922|76077614|FG001|Overall Study|Death|0|||
42251761|NCT02547922|76077615|FG002|Overall Study|Death|0|||
42251762|NCT02547922|76077613|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
42251763|NCT02547922|76077614|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
42251764|NCT02547922|76077615|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
42251765|NCT02547922|76077613|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
42251766|NCT02547922|76077614|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
42251767|NCT02547922|76077615|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
42251768|NCT02547922|76077613|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
42251769|NCT02547922|76077614|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
42251770|NCT02547922|76077615|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
42251771|NCT02547922|76077613|FG000|Overall Study|Physician Decision|2|||
42251772|NCT02547922|76077614|FG001|Overall Study|Physician Decision|1|||
42251773|NCT02547922|76077615|FG002|Overall Study|Physician Decision|2|||
42251774|NCT02547922|76077613|FG000|Overall Study|Patients did not receive IP|1|||
42251775|NCT02547922|76077614|FG001|Overall Study|Patients did not receive IP|1|||
42251776|NCT02547922|76077615|FG002|Overall Study|Patients did not receive IP|0|||
42251777|NCT02547766|76077629|FG000|Overall Study|Withdrawal by Subject|1|||
42251778|NCT02742441|76077642|FG000|Overall Study|Lost to Follow-up|4|||
42251779|NCT02742441|76077643|FG001|Overall Study|Lost to Follow-up|4|||
42251780|NCT02742441|76077642|FG000|Overall Study|Withdrawal by Subject|2|||
42251781|NCT02742441|76077643|FG001|Overall Study|Withdrawal by Subject|2|||
42251782|NCT02742441|76077642|FG000|Overall Study|Adverse Event|0|||
42251783|NCT02742441|76077643|FG001|Overall Study|Adverse Event|2|||
42251784|NCT02547220|76077651|FG000|Overall Study|Withdrawal by Subject|1|||
42251785|NCT02547220|76077652|FG001|Overall Study|Withdrawal by Subject|0|||
42251786|NCT02547220|76077651|FG000|Overall Study|Study terminated by sponsor|18|||
42251787|NCT02547220|76077652|FG001|Overall Study|Study terminated by sponsor|20|||
42251788|NCT02542072|76077660|FG000|First Intervention (1 Month)|Adverse Event|1|||
42251789|NCT02542072|76077661|FG001|First Intervention (1 Month)|Adverse Event|1|||
42251790|NCT02542072|76077660|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
42251791|NCT02542072|76077661|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
42251792|NCT02542072|76077660|FG000|First Intervention (1 Month)|Lens discomfort|1|||
42251793|NCT02542072|76077661|FG001|First Intervention (1 Month)|Lens discomfort|2|||
42251794|NCT02542072|76077660|FG000|First Intervention (1 Month)|Protocol Violation|1|||
42251795|NCT02542072|76077661|FG001|First Intervention (1 Month)|Protocol Violation|0|||
42251796|NCT02542072|76077660|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
42251797|NCT02542072|76077661|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
42251798|NCT02542072|76077660|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
42251799|NCT02542072|76077661|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
42251800|NCT02547454|76077687|FG000|Overall Study|Due to hemodialysis|53|||
42251801|NCT02547454|76077687|FG000|Overall Study|Due to transplantation|1|||
42251802|NCT02547454|76077687|FG000|Overall Study|Due to no further need to treat|4|||
42251803|NCT02547454|76077687|FG000|Overall Study|Death|38|||
42251804|NCT02547454|76077687|FG000|Overall Study|Lost to Follow-up|26|||
42251805|NCT02547454|76077687|FG000|Overall Study|Other|39|||
42251806|NCT02547454|76077687|FG000|Overall Study|No data|11|||
42251807|NCT00415623|76077693|FG000|Overall Study|Adverse Event|3|||
42251808|NCT00415623|76077694|FG001|Overall Study|Adverse Event|4|||
42251809|NCT00415623|76077693|FG000|Overall Study|Death|1|||
42251810|NCT00415623|76077694|FG001|Overall Study|Death|0|||
42251811|NCT00415623|76077693|FG000|Overall Study|Withdrawal by Subject|1|||
42251812|NCT00415623|76077694|FG001|Overall Study|Withdrawal by Subject|1|||
42251813|NCT01969409|76077703|FG000|Overall Study|Death|2|||
42251814|NCT01969409|76077704|FG001|Overall Study|Death|2|||
42251815|NCT01969409|76077703|FG000|Overall Study|Transplant|1|||
42251816|NCT01969409|76077704|FG001|Overall Study|Transplant|1|||
42251817|NCT01969409|76077703|FG000|Overall Study|Withdrawal by Subject|0|||
42251818|NCT01969409|76077704|FG001|Overall Study|Withdrawal by Subject|1|||
42251819|NCT00150813|76077710|FG000|Overall Study|Adverse Event|1|||
42251820|NCT00150813|76077710|FG000|Overall Study|Lack of Efficacy|1|||
42251821|NCT00150813|76077710|FG000|Overall Study|Lost to Follow-up|5|||
42251822|NCT00150813|76077710|FG000|Overall Study|Withdrawal by Subject|5|||
42251823|NCT00150813|76077710|FG000|Overall Study|Remission|3|||
42251824|NCT00150813|76077710|FG000|Overall Study|Planned pregancy|1|||
42251825|NCT00150813|76077710|FG000|Overall Study|Switch to commercially available LEV|2|||
42251826|NCT02712788|76077716|FG000|Overall Study|Physician Decision|1|||
42251827|NCT02712788|76077717|FG001|Overall Study|Physician Decision|0|||
42251828|NCT02712788|76077716|FG000|Overall Study|Protocol Violation|1|||
42251829|NCT02712788|76077717|FG001|Overall Study|Protocol Violation|0|||
42251830|NCT02308111|76077725|FG000|Overall Study|Adverse Event|31|||
42251831|NCT02308111|76077726|FG001|Overall Study|Adverse Event|19|||
42251832|NCT02308111|76077725|FG000|Overall Study|Death|9|||
42251833|NCT02308111|76077726|FG001|Overall Study|Death|6|||
42251834|NCT02308111|76077725|FG000|Overall Study|Lost to Follow-up|2|||
42251835|NCT02308111|76077726|FG001|Overall Study|Lost to Follow-up|7|||
42251836|NCT02308111|76077725|FG000|Overall Study|Physician Decision|6|||
42251837|NCT02308111|76077726|FG001|Overall Study|Physician Decision|17|||
42251838|NCT02308111|76077725|FG000|Overall Study|Protocol Violation|0|||
42251839|NCT02308111|76077726|FG001|Overall Study|Protocol Violation|1|||
42251840|NCT02308111|76077725|FG000|Overall Study|Withdrawal by Subject|28|||
42251841|NCT02308111|76077726|FG001|Overall Study|Withdrawal by Subject|38|||
42305009|NCT02388763|76140633|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
42305010|NCT02388763|76140634|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
42305011|NCT02388295|76140646|FG000|Dose Escalation Week 1|Adverse Event|1|||
42305012|NCT02388295|76140647|FG001|Dose Escalation Week 1|Adverse Event|2|||
42305013|NCT02388295|76140648|FG002|Dose Escalation Week 1|Adverse Event|1|||
42305014|NCT02388295|76140646|FG000|Dose Escalation Week 1|Determined not eligible|1|||
42305015|NCT02388295|76140647|FG001|Dose Escalation Week 1|Determined not eligible|1|||
42305016|NCT02388295|76140648|FG002|Dose Escalation Week 1|Determined not eligible|1|||
42305017|NCT02388295|76140646|FG000|Dose Escalation Week 2|Protocol Violation|0|||
42305018|NCT02388295|76140647|FG001|Dose Escalation Week 2|Protocol Violation|1|||
42305019|NCT02388295|76140648|FG002|Dose Escalation Week 2|Protocol Violation|0|||
42305020|NCT02388295|76140646|FG000|Dose Escalation Week 2|Determined not eligible|1|||
42305021|NCT02388295|76140647|FG001|Dose Escalation Week 2|Determined not eligible|1|||
41990956|NCT04531904|75799052|FG000|Overall Study|Lost to Follow-up|1|||
42305022|NCT02388295|76140648|FG002|Dose Escalation Week 2|Determined not eligible|1|||
42305023|NCT02388295|76140646|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
42305024|NCT02388295|76140647|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
42305025|NCT02388295|76140648|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
42251842|NCT02308111|76077725|FG000|Overall Study|Study Terminated by Sponsor|72|||
42251843|NCT02308111|76077726|FG001|Overall Study|Study Terminated by Sponsor|61|||
42251844|NCT02308111|76077725|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
42251845|NCT02308111|76077726|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
42251846|NCT02308111|76077725|FG000|Overall Study|Site Closure|3|||
42251847|NCT02308111|76077726|FG001|Overall Study|Site Closure|3|||
42305026|NCT02345161|76140658|FG000|Overall Study|Withdrawal by Subject|25|||
42305027|NCT02345161|76140659|FG001|Overall Study|Withdrawal by Subject|33|||
42251848|NCT02308111|76077725|FG000|Overall Study|Non-compliance with Study Drug|3|||
42251849|NCT02308111|76077726|FG001|Overall Study|Non-compliance with Study Drug|1|||
42251850|NCT02308111|76077725|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
41990957|NCT04531904|75799052|FG000|Overall Study|Death|14|||
42305028|NCT02345161|76140658|FG000|Overall Study|Adverse Event|16|||
42305029|NCT02345161|76140659|FG001|Overall Study|Adverse Event|19|||
42305030|NCT02345161|76140658|FG000|Overall Study|Physician Decision|4|||
42305031|NCT02345161|76140659|FG001|Overall Study|Physician Decision|4|||
42305032|NCT02345161|76140658|FG000|Overall Study|Lost to Follow-up|0|||
42305033|NCT02345161|76140659|FG001|Overall Study|Lost to Follow-up|1|||
42305034|NCT02251275|76140675|FG000|Overall Study|Adverse Event|23|||
42305035|NCT02251275|76140676|FG001|Overall Study|Adverse Event|60|||
42305036|NCT02251275|76140677|FG002|Overall Study|Adverse Event|28|||
42305037|NCT02251275|76140678|FG003|Overall Study|Adverse Event|0|||
42305038|NCT02251275|76140679|FG004|Overall Study|Adverse Event|0|||
42251851|NCT02308111|76077726|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
42251852|NCT02308111|76077725|FG000|Overall Study|Liver Transplant|3|||
42251853|NCT02308111|76077726|FG001|Overall Study|Liver Transplant|3|||
42251854|NCT02308111|76077725|FG000|Overall Study|Liver Transplant Waitlist|2|||
42251855|NCT02308111|76077726|FG001|Overall Study|Liver Transplant Waitlist|2|||
42251856|NCT02308111|76077725|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
42251857|NCT02308111|76077726|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
42251858|NCT01346189|76077737|FG000|Overall Study|Withdrawal by Subject|7|||
42305039|NCT02251275|76140675|FG000|Overall Study|Lost to Follow-up|5|||
42305040|NCT02251275|76140676|FG001|Overall Study|Lost to Follow-up|6|||
42305041|NCT02251275|76140677|FG002|Overall Study|Lost to Follow-up|4|||
42305042|NCT02251275|76140678|FG003|Overall Study|Lost to Follow-up|0|||
42305043|NCT02251275|76140679|FG004|Overall Study|Lost to Follow-up|0|||
42305044|NCT02251275|76140675|FG000|Overall Study|Physician Decision|19|||
42305045|NCT02251275|76140676|FG001|Overall Study|Physician Decision|30|||
42305046|NCT02251275|76140677|FG002|Overall Study|Physician Decision|26|||
42305047|NCT02251275|76140678|FG003|Overall Study|Physician Decision|0|||
42305048|NCT02251275|76140679|FG004|Overall Study|Physician Decision|1|||
42305049|NCT02251275|76140675|FG000|Overall Study|Protocol Deviation|0|||
42305050|NCT02251275|76140676|FG001|Overall Study|Protocol Deviation|0|||
42305051|NCT02251275|76140677|FG002|Overall Study|Protocol Deviation|1|||
42305052|NCT02251275|76140678|FG003|Overall Study|Protocol Deviation|0|||
42305053|NCT02251275|76140679|FG004|Overall Study|Protocol Deviation|0|||
42305054|NCT02251275|76140675|FG000|Overall Study|Withdrawal by Subject|25|||
42305055|NCT02251275|76140676|FG001|Overall Study|Withdrawal by Subject|51|||
42305056|NCT02251275|76140677|FG002|Overall Study|Withdrawal by Subject|35|||
42305057|NCT02251275|76140678|FG003|Overall Study|Withdrawal by Subject|1|||
42305058|NCT02251275|76140679|FG004|Overall Study|Withdrawal by Subject|0|||
42305059|NCT02379637|76140693|FG000|Overall Study|Protocol Violation|0|||
42305060|NCT02379637|76140694|FG001|Overall Study|Protocol Violation|1|||
42305061|NCT02379637|76140693|FG000|Overall Study|Adverse Event|1|||
42305062|NCT02379637|76140694|FG001|Overall Study|Adverse Event|0|||
42305063|NCT02379637|76140693|FG000|Overall Study|Withdrawal by Subject|1|||
42305064|NCT02379637|76140694|FG001|Overall Study|Withdrawal by Subject|0|||
42305065|NCT02195583|76140700|FG000|Overall Study|Lost to Follow-up|1|||
42305066|NCT02195583|76140700|FG000|Overall Study|Withdrawal by Subject|4|||
42305067|NCT02195583|76140700|FG000|Overall Study|Adverse Event|2|||
42305068|NCT02195583|76140700|FG000|Overall Study|Other Reason|2|||
42305069|NCT02379091|76140719|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
42305070|NCT02379091|76140720|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
42305071|NCT02379091|76140721|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
42305072|NCT02379091|76140722|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
42305073|NCT02379091|76140719|FG000|Overall Study|Principal Investigator Discretion|0|||
42305074|NCT02379091|76140720|FG001|Overall Study|Principal Investigator Discretion|1|||
42305075|NCT02379091|76140721|FG002|Overall Study|Principal Investigator Discretion|0|||
42305076|NCT02379091|76140722|FG003|Overall Study|Principal Investigator Discretion|0|||
42305077|NCT02379091|76140719|FG000|Overall Study|Lost to Follow-up|0|||
42305078|NCT02379091|76140720|FG001|Overall Study|Lost to Follow-up|0|||
42305079|NCT02379091|76140721|FG002|Overall Study|Lost to Follow-up|0|||
42305080|NCT02379091|76140722|FG003|Overall Study|Lost to Follow-up|1|||
42305081|NCT02379091|76140719|FG000|Overall Study|Voluntary Withdrawal|2|||
42305082|NCT02379091|76140720|FG001|Overall Study|Voluntary Withdrawal|5|||
42305083|NCT02379091|76140721|FG002|Overall Study|Voluntary Withdrawal|2|||
41990958|NCT04137380|75799063|FG000|Overall Study|Physician Decision|0|||
41990959|NCT04137380|75799064|FG001|Overall Study|Physician Decision|0|||
42251859|NCT01346189|76077738|FG001|Overall Study|Withdrawal by Subject|5|||
42305084|NCT02379091|76140722|FG003|Overall Study|Voluntary Withdrawal|4|||
42305085|NCT02379091|76140719|FG000|Overall Study|Study Termination|7|||
42305086|NCT02379091|76140720|FG001|Overall Study|Study Termination|2|||
42305087|NCT02379091|76140721|FG002|Overall Study|Study Termination|5|||
42305088|NCT02379091|76140722|FG003|Overall Study|Study Termination|8|||
42305089|NCT02379091|76140719|FG000|Overall Study|Lack of Efficacy|3|||
42305090|NCT02379091|76140720|FG001|Overall Study|Lack of Efficacy|0|||
42305091|NCT02379091|76140721|FG002|Overall Study|Lack of Efficacy|0|||
42305092|NCT02379091|76140722|FG003|Overall Study|Lack of Efficacy|0|||
42305093|NCT02378935|76140741|FG000|Overall Study|Lack of Efficacy|10|||
42305094|NCT02378935|76140742|FG001|Overall Study|Lack of Efficacy|0|||
42305095|NCT02378935|76140743|FG002|Overall Study|Lack of Efficacy|2|||
42305096|NCT02378935|76140744|FG003|Overall Study|Lack of Efficacy|6|||
42305097|NCT02378935|76140745|FG004|Overall Study|Lack of Efficacy|0|||
42305098|NCT02378935|76140746|FG005|Overall Study|Lack of Efficacy|0|||
42305099|NCT02378935|76140747|FG006|Overall Study|Lack of Efficacy|0|||
42305100|NCT02378935|76140741|FG000|Overall Study|Death|0|||
42305101|NCT02378935|76140742|FG001|Overall Study|Death|0|||
42305102|NCT02378935|76140743|FG002|Overall Study|Death|1|||
42305103|NCT02378935|76140744|FG003|Overall Study|Death|0|||
42305104|NCT02378935|76140745|FG004|Overall Study|Death|0|||
42305105|NCT02378935|76140746|FG005|Overall Study|Death|0|||
42305106|NCT02378935|76140747|FG006|Overall Study|Death|0|||
42305107|NCT02250651|76140766|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
42305108|NCT02250651|76140767|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
42305109|NCT02250651|76140768|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
42305110|NCT02250651|76140766|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
42305111|NCT02250651|76140767|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
42305112|NCT02250651|76140768|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
42305113|NCT02250651|76140766|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
42305114|NCT02250651|76140767|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
42305115|NCT02250651|76140768|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
42305116|NCT02250651|76140766|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
42305117|NCT02250651|76140767|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
42305118|NCT02250651|76140768|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
42305119|NCT02250651|76140766|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
42305120|NCT02250651|76140767|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
42305121|NCT02250651|76140768|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
42305122|NCT02250651|76140766|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
41990960|NCT04137380|75799065|FG002|Overall Study|Physician Decision|0|||
41990961|NCT04137380|75799066|FG003|Overall Study|Physician Decision|1|||
41990962|NCT04137380|75799067|FG004|Overall Study|Physician Decision|0|||
41990963|NCT04137380|75799068|FG005|Overall Study|Physician Decision|0|||
41990964|NCT04137380|75799069|FG006|Overall Study|Physician Decision|0|||
41990965|NCT02927301|75799093|FG000|Overall Study|Adverse Event|7|||
41990966|NCT02927301|75799093|FG000|Overall Study|Withdrawal by Subject|1|||
41990967|NCT02927301|75799093|FG000|Overall Study|Physician Decision|2|||
41990968|NCT02653976|75799097|FG000|Overall Study|Withdrawal by Subject|5|||
41990969|NCT02653976|75799097|FG000|Overall Study|Death|4|||
41990970|NCT02611037|75799101|FG000|Overall Study|Withdrawal prior to treatment|2|||
41990971|NCT02611037|75799102|FG001|Overall Study|Withdrawal prior to treatment|0|||
41990972|NCT02446236|75799110|FG000|Overall Study|Screen Failure|1|||
41990973|NCT02446236|75799111|FG001|Overall Study|Screen Failure|0|||
41990974|NCT02446236|75799112|FG002|Overall Study|Screen Failure|1|||
41990975|NCT02446236|75799110|FG000|Overall Study|Actively Receiving Therapy|0|||
41990976|NCT02446236|75799111|FG001|Overall Study|Actively Receiving Therapy|0|||
41990977|NCT02446236|75799112|FG002|Overall Study|Actively Receiving Therapy|1|||
41990978|NCT01566695|75799120|FG000|Overall Study|Lack of Efficacy|18|||
41990979|NCT01566695|75799121|FG001|Overall Study|Lack of Efficacy|45|||
41990980|NCT01566695|75799120|FG000|Overall Study|Adverse Event|28|||
41990981|NCT01566695|75799121|FG001|Overall Study|Adverse Event|27|||
41990982|NCT01566695|75799120|FG000|Overall Study|Death|20|||
41990983|NCT01566695|75799121|FG001|Overall Study|Death|8|||
41990984|NCT01566695|75799120|FG000|Overall Study|Withdrawal by Subject|14|||
41990985|NCT01566695|75799121|FG001|Overall Study|Withdrawal by Subject|7|||
41990986|NCT01566695|75799120|FG000|Overall Study|Progressive Disease|11|||
41990987|NCT01566695|75799121|FG001|Overall Study|Progressive Disease|6|||
41990988|NCT01566695|75799120|FG000|Overall Study|Miscellaneous|4|||
41990989|NCT01566695|75799121|FG001|Overall Study|Miscellaneous|6|||
41990990|NCT01081951|75799129|FG000|Overall Study|Death|54|||
41990991|NCT01081951|75799130|FG001|Overall Study|Death|47|||
41990992|NCT01081951|75799129|FG000|Overall Study|Withdrawal by Subject|2|||
41990993|NCT01081951|75799130|FG001|Overall Study|Withdrawal by Subject|6|||
41990994|NCT01081951|75799129|FG000|Overall Study|Allocated treatment but did not take it|0|||
41990995|NCT01081951|75799130|FG001|Overall Study|Allocated treatment but did not take it|1|||
41990996|NCT01081951|75799129|FG000|Overall Study|Lost to Follow-up|0|||
42033130|NCT01132313|75841310|FG001|Overall Study|Not treated|0|||
41990997|NCT01081951|75799130|FG001|Overall Study|Lost to Follow-up|1|||
41990998|NCT00736385|75799138|FG000|Overall Study|Withdrawal by Subject|2|||
41990999|NCT00736385|75799139|FG001|Overall Study|Withdrawal by Subject|2|||
42305123|NCT02250651|76140767|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
42305124|NCT02250651|76140768|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
41991000|NCT00736385|75799138|FG000|Overall Study|Adverse Event|0|||
41991001|NCT00736385|75799139|FG001|Overall Study|Adverse Event|1|||
41991002|NCT00392327|75799153|FG000|Overall Study|Death|1|||
41991003|NCT00392327|75799154|FG001|Overall Study|Death|0|||
41991004|NCT00392327|75799155|FG002|Overall Study|Death|1|||
41991005|NCT00392327|75799156|FG003|Overall Study|Death|0|||
41991006|NCT00392327|75799157|FG004|Overall Study|Death|0|||
41991007|NCT00392327|75799158|FG005|Overall Study|Death|0|||
41991008|NCT00392327|75799159|FG006|Overall Study|Death|0|||
41991009|NCT00392327|75799160|FG007|Overall Study|Death|0|||
41991010|NCT00392327|75799153|FG000|Overall Study|Lack of Efficacy|8|||
41991011|NCT00392327|75799154|FG001|Overall Study|Lack of Efficacy|8|||
42132824|NCT00400179|75943658|FG001|Overall Study|Investigator judgment|1|||
42251860|NCT01346189|76077739|FG002|Overall Study|Withdrawal by Subject|3|||
42251861|NCT01346189|76077740|FG003|Overall Study|Withdrawal by Subject|5|||
42251862|NCT01346189|76077737|FG000|Overall Study|Physician Decision|4|||
42305125|NCT02250651|76140766|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
42305126|NCT02250651|76140767|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
42305127|NCT02250651|76140768|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
42305128|NCT02250651|76140766|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
42305129|NCT02250651|76140767|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
42305130|NCT02250651|76140768|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
42305131|NCT02250651|76140766|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
42305132|NCT02250651|76140767|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
42305133|NCT02250651|76140768|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
42305134|NCT02250651|76140766|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
42305135|NCT02250651|76140767|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
42305136|NCT02250651|76140768|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
42251863|NCT01346189|76077738|FG001|Overall Study|Physician Decision|0|||
42251864|NCT01346189|76077739|FG002|Overall Study|Physician Decision|0|||
42251865|NCT01346189|76077740|FG003|Overall Study|Physician Decision|0|||
42251866|NCT01346189|76077737|FG000|Overall Study|Moved|3|||
42251867|NCT01346189|76077738|FG001|Overall Study|Moved|0|||
42251868|NCT01346189|76077739|FG002|Overall Study|Moved|4|||
42251869|NCT01346189|76077740|FG003|Overall Study|Moved|0|||
42251870|NCT01346189|76077737|FG000|Overall Study|Other|2|||
42251871|NCT01346189|76077738|FG001|Overall Study|Other|4|||
42251872|NCT01346189|76077739|FG002|Overall Study|Other|7|||
42251873|NCT01346189|76077740|FG003|Overall Study|Other|3|||
42251874|NCT01346189|76077737|FG000|Overall Study|Death|0|||
42251875|NCT01346189|76077738|FG001|Overall Study|Death|3|||
42305137|NCT02250651|76140766|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
42305138|NCT02250651|76140767|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
41991012|NCT00392327|75799155|FG002|Overall Study|Lack of Efficacy|9|||
42033131|NCT01132313|75841311|FG002|Overall Study|Not treated|0|||
41991013|NCT00392327|75799156|FG003|Overall Study|Lack of Efficacy|6|||
41991014|NCT00392327|75799157|FG004|Overall Study|Lack of Efficacy|3|||
41991015|NCT00392327|75799158|FG005|Overall Study|Lack of Efficacy|3|||
42251876|NCT01346189|76077739|FG002|Overall Study|Death|0|||
42251877|NCT01346189|76077740|FG003|Overall Study|Death|0|||
42251878|NCT01346189|76077737|FG000|Overall Study|Non-health system primary care physician|0|||
42305139|NCT02250651|76140768|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
42305140|NCT02250651|76140766|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
42305141|NCT02250651|76140767|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
42305142|NCT02250651|76140768|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
42305143|NCT02250651|76140766|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
42305144|NCT02250651|76140767|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
42305145|NCT02250651|76140768|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
42305146|NCT02250651|76140766|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
42305147|NCT02250651|76140767|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
42305148|NCT02250651|76140768|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
42305149|NCT02250651|76140766|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
42305150|NCT02250651|76140767|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
42305151|NCT02250651|76140768|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
42305152|NCT02377921|76140778|FG000|Overall Study|Subject non-compliance|1|||
42305153|NCT02377921|76140779|FG001|Overall Study|Subject non-compliance|1|||
42305154|NCT02311153|76140787|FG000|Overall Study|Lost to Follow-up|5|||
42305155|NCT02311153|76140788|FG001|Overall Study|Lost to Follow-up|7|||
42305156|NCT02195427|76140796|FG000|Overall Study|Did not consent to study extension|13|||
42305157|NCT02195427|76140797|FG001|Overall Study|Did not consent to study extension|9|||
42305158|NCT02195427|76140796|FG000|Overall Study|Withdrawal by Subject|4|||
42305159|NCT02195427|76140797|FG001|Overall Study|Withdrawal by Subject|2|||
42305160|NCT02195427|76140796|FG000|Overall Study|Lost to Follow-up|0|||
42305161|NCT02195427|76140797|FG001|Overall Study|Lost to Follow-up|1|||
42305162|NCT02195427|76140796|FG000|Overall Study|Protocol Violation|7|||
42305163|NCT02195427|76140797|FG001|Overall Study|Protocol Violation|14|||
42305164|NCT02195427|76140796|FG000|Overall Study|Conditional re-treatment at W52|2|||
42305165|NCT02195427|76140797|FG001|Overall Study|Conditional re-treatment at W52|1|||
42305166|NCT02214225|76140810|FG000|Overall Study|Lost to Follow-up|46|||
42305167|NCT02214225|76140811|FG001|Overall Study|Lost to Follow-up|18|||
42305168|NCT02214225|76140812|FG002|Overall Study|Lost to Follow-up|18|||
42305169|NCT02214225|76140810|FG000|Overall Study|Withdrawal by Subject|2|||
42305170|NCT02214225|76140811|FG001|Overall Study|Withdrawal by Subject|0|||
42305171|NCT02214225|76140812|FG002|Overall Study|Withdrawal by Subject|2|||
42305172|NCT02214225|76140810|FG000|Overall Study|Death|5|||
42305173|NCT02214225|76140811|FG001|Overall Study|Death|0|||
42305174|NCT02214225|76140812|FG002|Overall Study|Death|1|||
42305175|NCT02214225|76140810|FG000|Overall Study|randomized in error, not vaccinated|2|||
42305176|NCT02214225|76140811|FG001|Overall Study|randomized in error, not vaccinated|1|||
42305177|NCT02214225|76140812|FG002|Overall Study|randomized in error, not vaccinated|1|||
42305178|NCT02250183|76140843|FG000|Overall Study|Withdrawal by Subject|2|||
42305179|NCT02250183|76140843|FG000|Overall Study|Adverse Event|5|||
42305180|NCT02250183|76140843|FG000|Overall Study|Lost to Follow-up|1|||
42305181|NCT02249949|76140850|FG000|Overall Study|Cancelled prior to treatment|2|||
42305182|NCT02249091|76140856|FG000|Overall Study|Lack of Efficacy|8|||
42305183|NCT02249091|76140857|FG001|Overall Study|Lack of Efficacy|3|||
42305184|NCT02249091|76140856|FG000|Overall Study|Physician Decision|4|||
42305185|NCT02249091|76140857|FG001|Overall Study|Physician Decision|1|||
42305186|NCT02249091|76140856|FG000|Overall Study|Withdrawal by Subject|2|||
42305187|NCT02249091|76140857|FG001|Overall Study|Withdrawal by Subject|2|||
42305188|NCT02249091|76140856|FG000|Overall Study|Death|3|||
42305189|NCT02249091|76140857|FG001|Overall Study|Death|4|||
42305190|NCT02249091|76140856|FG000|Overall Study|Adverse Event|1|||
42305191|NCT02249091|76140857|FG001|Overall Study|Adverse Event|0|||
42305192|NCT02249091|76140856|FG000|Overall Study|Stable disease with following SCT|0|||
42305193|NCT02249091|76140857|FG001|Overall Study|Stable disease with following SCT|1|||
42305194|NCT02249091|76140856|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
42305195|NCT02249091|76140857|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
42305196|NCT02249091|76140856|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
42305197|NCT02249091|76140857|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
42305198|NCT02249091|76140856|FG000|Overall Study|Refractory AML|1|||
42305199|NCT02249091|76140857|FG001|Overall Study|Refractory AML|1|||
42305200|NCT02248857|76140866|FG000|3 Month|Withdrawal by Subject|9|||
42305201|NCT02248857|76140867|FG001|3 Month|Withdrawal by Subject|3|||
42305202|NCT02248857|76140868|FG002|3 Month|Withdrawal by Subject|4|||
42305203|NCT02248857|76140866|FG000|3 Month|Unable to reach for 3 month|35|||
42305204|NCT02248857|76140867|FG001|3 Month|Unable to reach for 3 month|29|||
42305205|NCT02248857|76140868|FG002|3 Month|Unable to reach for 3 month|26|||
42305206|NCT02248857|76140866|FG000|3 Month|Partially completed, unable to finish|2|||
42305207|NCT02248857|76140867|FG001|3 Month|Partially completed, unable to finish|2|||
41991016|NCT00392327|75799159|FG006|Overall Study|Lack of Efficacy|3|||
41991017|NCT00392327|75799160|FG007|Overall Study|Lack of Efficacy|3|||
41991018|NCT00392327|75799153|FG000|Overall Study|Physician Decision|3|||
42251879|NCT01346189|76077738|FG001|Overall Study|Non-health system primary care physician|5|||
42251880|NCT01346189|76077739|FG002|Overall Study|Non-health system primary care physician|0|||
42251881|NCT01346189|76077740|FG003|Overall Study|Non-health system primary care physician|0|||
42251882|NCT01346189|76077737|FG000|Overall Study|Travel|0|||
42251883|NCT01346189|76077738|FG001|Overall Study|Travel|0|||
42251884|NCT01346189|76077739|FG002|Overall Study|Travel|0|||
42305208|NCT02248857|76140868|FG002|3 Month|Partially completed, unable to finish|1|||
42305209|NCT02248857|76140866|FG000|6 Month|Lost to Follow-up|27|||
42305210|NCT02248857|76140867|FG001|6 Month|Lost to Follow-up|26|||
42305211|NCT02248857|76140868|FG002|6 Month|Lost to Follow-up|15|||
42305212|NCT02248857|76140866|FG000|6 Month|Partially completed, unable to finish|0|||
42305213|NCT02248857|76140867|FG001|6 Month|Partially completed, unable to finish|1|||
42251885|NCT01346189|76077740|FG003|Overall Study|Travel|3|||
42251886|NCT00369317|76077750|FG000|Overall Study|Adverse Event|3|||
42251887|NCT00369317|76077750|FG000|Overall Study|Death|1|||
42251888|NCT00369317|76077750|FG000|Overall Study|Lack of Efficacy|5|||
42251889|NCT00369317|76077750|FG000|Overall Study|Physician Decision|2|||
42251890|NCT00369317|76077750|FG000|Overall Study|Withdrawal by Subject|8|||
42305214|NCT02248857|76140868|FG002|6 Month|Partially completed, unable to finish|0|||
42251891|NCT00369317|76077750|FG000|Overall Study|Ineligible|1|||
42251892|NCT03193021|76077757|FG000|Overall Study|Lost to Follow-up|1|||
42251893|NCT03193021|76077758|FG001|Overall Study|Lost to Follow-up|1|||
42251894|NCT03913091|76077766|FG000|Overall Study|Lost to Follow-up|18|||
41991019|NCT00392327|75799154|FG001|Overall Study|Physician Decision|5|||
41991020|NCT00392327|75799155|FG002|Overall Study|Physician Decision|2|||
42251895|NCT03913091|76077767|FG001|Overall Study|Lost to Follow-up|11|||
42251896|NCT03913091|76077766|FG000|Overall Study|Required additional meds/surgery|1|||
42251897|NCT03913091|76077767|FG001|Overall Study|Required additional meds/surgery|2|||
42251898|NCT03913091|76077766|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
42251899|NCT03913091|76077767|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
42251900|NCT01318499|76077791|FG000|Overall Study|Adverse Event|16|||
42251901|NCT01318499|76077792|FG001|Overall Study|Adverse Event|11|||
42251902|NCT01318499|76077793|FG002|Overall Study|Adverse Event|6|||
42251903|NCT01318499|76077791|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
42251904|NCT01318499|76077792|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
42251905|NCT01318499|76077793|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
42251906|NCT01318499|76077791|FG000|Overall Study|Noncompliance|2|||
42305215|NCT02248857|76140866|FG000|6 Month|Withdrawal by Subject|0|||
42305216|NCT02248857|76140867|FG001|6 Month|Withdrawal by Subject|2|||
42305217|NCT02248857|76140868|FG002|6 Month|Withdrawal by Subject|2|||
42305218|NCT02248857|76140866|FG000|6 Month|Death|1|||
42305219|NCT02248857|76140867|FG001|6 Month|Death|0|||
42251907|NCT01318499|76077792|FG001|Overall Study|Noncompliance|3|||
42251908|NCT01318499|76077793|FG002|Overall Study|Noncompliance|0|||
42251909|NCT01318499|76077791|FG000|Overall Study|Treatment Failure|19|||
42251910|NCT01318499|76077792|FG001|Overall Study|Treatment Failure|19|||
42251911|NCT01318499|76077793|FG002|Overall Study|Treatment Failure|101|||
42251912|NCT01318499|76077791|FG000|Overall Study|Protocol Violation|2|||
42251913|NCT01318499|76077792|FG001|Overall Study|Protocol Violation|4|||
42251914|NCT01318499|76077793|FG002|Overall Study|Protocol Violation|2|||
42251915|NCT01318499|76077791|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
42251916|NCT01318499|76077792|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
42251917|NCT01318499|76077793|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
42251918|NCT01318499|76077791|FG000|Overall Study|Other|7|||
42251919|NCT01318499|76077792|FG001|Overall Study|Other|10|||
42305220|NCT02248857|76140868|FG002|6 Month|Death|0|||
42305221|NCT02213055|76140878|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
42305222|NCT02213055|76140879|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
42305223|NCT02213055|76140878|FG000|Overall Study|Protocol was not Followed during Study|1|||
42305224|NCT02213055|76140879|FG001|Overall Study|Protocol was not Followed during Study|0|||
42305225|NCT02213055|76140878|FG000|Overall Study|Documentation Issue at Enrollment|1|||
42305226|NCT02213055|76140879|FG001|Overall Study|Documentation Issue at Enrollment|0|||
42305227|NCT02213055|76140878|FG000|Overall Study|Documentation Issue during Study|10|||
42305228|NCT02213055|76140879|FG001|Overall Study|Documentation Issue during Study|0|||
42305229|NCT02213055|76140878|FG000|Overall Study|Did not have Live Lice|8|||
42305230|NCT02213055|76140879|FG001|Overall Study|Did not have Live Lice|0|||
42305231|NCT02213055|76140878|FG000|Overall Study|Had another Treatment during the Study|3|||
42305232|NCT02213055|76140879|FG001|Overall Study|Had another Treatment during the Study|0|||
42305233|NCT02213055|76140878|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
42305234|NCT02213055|76140879|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
42305235|NCT02213055|76140878|FG000|Overall Study|Did not Return to School|5|||
42305236|NCT02213055|76140879|FG001|Overall Study|Did not Return to School|0|||
42305237|NCT02310763|76140888|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
42305238|NCT02310763|76140889|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
42305239|NCT02310763|76140890|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
42305240|NCT02310763|76140888|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
42305241|NCT02310763|76140889|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
42305242|NCT02310763|76140890|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
42305243|NCT02310763|76140888|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
42305244|NCT02310763|76140889|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
42305245|NCT02310763|76140890|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
42305246|NCT02310763|76140888|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
42305247|NCT02310763|76140889|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
41991021|NCT00392327|75799156|FG003|Overall Study|Physician Decision|2|||
41991022|NCT00392327|75799157|FG004|Overall Study|Physician Decision|0|||
41991023|NCT00392327|75799158|FG005|Overall Study|Physician Decision|1|||
41991024|NCT00392327|75799159|FG006|Overall Study|Physician Decision|5|||
41991025|NCT00392327|75799160|FG007|Overall Study|Physician Decision|3|||
41991026|NCT00392327|75799153|FG000|Overall Study|Protocol Violation|0|||
42251920|NCT01318499|76077793|FG002|Overall Study|Other|22|||
42305248|NCT02310763|76140890|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
42305249|NCT02310763|76140888|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
42305250|NCT02310763|76140889|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
42305251|NCT02310763|76140890|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
42305252|NCT02342743|76140916|FG000|Baseline Period|Withdrawal by Subject|3|||
42305253|NCT02342743|76140916|FG000|Baseline Period|Lost to Follow-up|2|||
42305254|NCT02342743|76140916|FG000|Baseline Period|Change in prophylactic medication|3|||
42305255|NCT02342743|76140916|FG000|Baseline Period|Screening failure regarding baseline|7|||
42305256|NCT02342743|76140916|FG000|Treatment Period|Withdrawal by Subject|2|||
41991027|NCT00392327|75799154|FG001|Overall Study|Protocol Violation|0|||
42033132|NCT01132313|75841312|FG003|Overall Study|Not treated|0|||
42132825|NCT00400179|75943657|FG000|Overall Study|Randomization error/patient ineligible|1|||
42251921|NCT02285595|76077827|FG000|Overall Study|Lost to Follow-up|14|||
42251922|NCT02285595|76077827|FG000|Overall Study|Withdrawal by Subject|1|||
42251923|NCT02712398|76077850|FG000|Overall Study|Withdrawal by Subject|6|||
42305257|NCT02342743|76140916|FG000|Treatment Period|Lost to Follow-up|8|||
42305258|NCT02342743|76140916|FG000|Treatment Period|Change in prophylactic medication|1|||
42305259|NCT02377063|76140920|FG000|Overall Study|Non-compliance|5|||
42305260|NCT02309515|76140926|FG000|Overall Study|Withdrawal by Subject|0|||
42305261|NCT02309515|76140927|FG001|Overall Study|Withdrawal by Subject|1|||
41991028|NCT00392327|75799155|FG002|Overall Study|Protocol Violation|1|||
42033133|NCT01132313|75841313|FG004|Overall Study|Not treated|2|||
42305262|NCT02309359|76140938|FG000|Overall Study|Adverse Event|4|||
42305263|NCT02309359|76140939|FG001|Overall Study|Adverse Event|5|||
42305264|NCT02309359|76140940|FG002|Overall Study|Adverse Event|5|||
42305265|NCT02309359|76140941|FG003|Overall Study|Adverse Event|4|||
42305266|NCT02309359|76140942|FG004|Overall Study|Adverse Event|4|||
42305267|NCT02309359|76140938|FG000|Overall Study|Death|1|||
42305268|NCT02309359|76140939|FG001|Overall Study|Death|0|||
42305269|NCT02309359|76140940|FG002|Overall Study|Death|0|||
42305270|NCT02309359|76140941|FG003|Overall Study|Death|0|||
42305271|NCT02309359|76140942|FG004|Overall Study|Death|0|||
42305272|NCT02309359|76140938|FG000|Overall Study|Withdrawal by Subject|2|||
42251924|NCT02712398|76077850|FG000|Overall Study|Lost to Follow-up|6|||
42251925|NCT02712398|76077850|FG000|Overall Study|Sponsor Decision|1|||
42251926|NCT02712398|76077850|FG000|Overall Study|Physician Decision|1|||
42251927|NCT02712398|76077850|FG000|Overall Study|Death|2|||
42251928|NCT02712398|76077850|FG000|Overall Study|Re-operation|21|||
42251929|NCT00282867|76077857|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
42305273|NCT02309359|76140939|FG001|Overall Study|Withdrawal by Subject|2|||
42305274|NCT02309359|76140940|FG002|Overall Study|Withdrawal by Subject|4|||
42305275|NCT02309359|76140941|FG003|Overall Study|Withdrawal by Subject|4|||
42305276|NCT02309359|76140942|FG004|Overall Study|Withdrawal by Subject|0|||
42305277|NCT02309359|76140938|FG000|Overall Study|Lack of Efficacy|3|||
42305278|NCT02309359|76140939|FG001|Overall Study|Lack of Efficacy|1|||
42305279|NCT02309359|76140940|FG002|Overall Study|Lack of Efficacy|0|||
42305280|NCT02309359|76140941|FG003|Overall Study|Lack of Efficacy|0|||
42305281|NCT02309359|76140942|FG004|Overall Study|Lack of Efficacy|3|||
42305282|NCT02309359|76140938|FG000|Overall Study|Lost to Follow-up|0|||
42305283|NCT02309359|76140939|FG001|Overall Study|Lost to Follow-up|0|||
42305284|NCT02309359|76140940|FG002|Overall Study|Lost to Follow-up|0|||
42305285|NCT02309359|76140941|FG003|Overall Study|Lost to Follow-up|1|||
42305286|NCT02309359|76140942|FG004|Overall Study|Lost to Follow-up|0|||
42305287|NCT02309359|76140938|FG000|Overall Study|Other|2|||
42305288|NCT02309359|76140939|FG001|Overall Study|Other|0|||
42305289|NCT02309359|76140940|FG002|Overall Study|Other|2|||
42305290|NCT02309359|76140941|FG003|Overall Study|Other|3|||
42305291|NCT02309359|76140942|FG004|Overall Study|Other|2|||
41991029|NCT00392327|75799156|FG003|Overall Study|Protocol Violation|0|||
42251930|NCT00282867|76077858|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
42251931|NCT00282867|76077859|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
42251932|NCT00151281|76077869|FG000|Overall Study|Not evaluable|3|||
42251933|NCT01318109|76077884|FG000|Overall Study|Adverse Event|0|||
42251934|NCT01318109|76077885|FG001|Overall Study|Adverse Event|2|||
42251935|NCT01318109|76077886|FG002|Overall Study|Adverse Event|0|||
42251936|NCT01318109|76077884|FG000|Overall Study|Withdrawal by Subject|1|||
42305292|NCT02247531|76140958|FG000|Overall Study|Adverse Event|3|||
42305293|NCT02247531|76140959|FG001|Overall Study|Adverse Event|4|||
42305294|NCT02247531|76140960|FG002|Overall Study|Adverse Event|9|||
42305295|NCT02247531|76140958|FG000|Overall Study|Death|8|||
42305296|NCT02247531|76140959|FG001|Overall Study|Death|9|||
41991030|NCT00392327|75799157|FG004|Overall Study|Protocol Violation|0|||
42305297|NCT02247531|76140960|FG002|Overall Study|Death|5|||
42305298|NCT02247531|76140958|FG000|Overall Study|Lost to Follow-up|1|||
42305299|NCT02247531|76140959|FG001|Overall Study|Lost to Follow-up|8|||
41991031|NCT00392327|75799158|FG005|Overall Study|Protocol Violation|0|||
42305300|NCT02247531|76140960|FG002|Overall Study|Lost to Follow-up|3|||
41991032|NCT00392327|75799159|FG006|Overall Study|Protocol Violation|0|||
42305301|NCT02247531|76140958|FG000|Overall Study|Non-compliance|2|||
42305302|NCT02247531|76140959|FG001|Overall Study|Non-compliance|2|||
42305303|NCT02247531|76140960|FG002|Overall Study|Non-compliance|0|||
41991033|NCT00392327|75799160|FG007|Overall Study|Protocol Violation|0|||
41991034|NCT00392327|75799153|FG000|Overall Study|Withdrawal by Subject|3|||
41991035|NCT00392327|75799154|FG001|Overall Study|Withdrawal by Subject|2|||
41991036|NCT00392327|75799155|FG002|Overall Study|Withdrawal by Subject|4|||
41991037|NCT00392327|75799156|FG003|Overall Study|Withdrawal by Subject|6|||
41991038|NCT00392327|75799157|FG004|Overall Study|Withdrawal by Subject|0|||
41991039|NCT00392327|75799158|FG005|Overall Study|Withdrawal by Subject|1|||
41991040|NCT00392327|75799159|FG006|Overall Study|Withdrawal by Subject|1|||
41991041|NCT00392327|75799160|FG007|Overall Study|Withdrawal by Subject|5|||
41991042|NCT00392327|75799153|FG000|Overall Study|Ineligible|0|||
41991043|NCT00392327|75799154|FG001|Overall Study|Ineligible|4|||
42305304|NCT02247531|76140958|FG000|Overall Study|Withdrawal by Subject|26|||
42305305|NCT02247531|76140959|FG001|Overall Study|Withdrawal by Subject|31|||
42305306|NCT02247531|76140960|FG002|Overall Study|Withdrawal by Subject|25|||
42305307|NCT02247531|76140958|FG000|Overall Study|Study Terminated by Sponsor|64|||
42305308|NCT02247531|76140959|FG001|Overall Study|Study Terminated by Sponsor|66|||
42305309|NCT02247531|76140960|FG002|Overall Study|Study Terminated by Sponsor|62|||
42305310|NCT02247531|76140958|FG000|Overall Study|Physician Decision|0|||
42305311|NCT02247531|76140959|FG001|Overall Study|Physician Decision|2|||
42305312|NCT02247531|76140960|FG002|Overall Study|Physician Decision|2|||
42305313|NCT02247531|76140958|FG000|Overall Study|Unspecified Reason|2|||
42305314|NCT02247531|76140959|FG001|Overall Study|Unspecified Reason|3|||
42305315|NCT02247531|76140960|FG002|Overall Study|Unspecified Reason|4|||
42305316|NCT02375971|76140971|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
42305317|NCT02375971|76140972|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
42305318|NCT02375971|76140973|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
42305319|NCT02375971|76140971|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
42305320|NCT02375971|76140972|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
42305321|NCT02375971|76140973|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
42305322|NCT02375971|76140971|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
42305323|NCT02375971|76140972|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
42305324|NCT02375971|76140973|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
42305325|NCT02375971|76140971|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
42305326|NCT02375971|76140972|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
42305327|NCT02375971|76140973|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
42305328|NCT02375971|76140971|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
42305329|NCT02375971|76140972|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
42305330|NCT02375971|76140973|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
42305331|NCT02375971|76140971|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
42305332|NCT02375971|76140972|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
42305333|NCT02375971|76140973|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
42305334|NCT02375971|76140971|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
42305335|NCT02375971|76140972|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
42305336|NCT02375971|76140973|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
42305337|NCT02375971|76140971|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
42305338|NCT02375971|76140972|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
42305339|NCT02375971|76140973|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
42305340|NCT02308735|76140985|FG000|Overall Study|Physician Decision|2|||
42305341|NCT02308735|76140986|FG001|Overall Study|Physician Decision|0|||
42305342|NCT02308735|76140987|FG002|Overall Study|Physician Decision|0|||
42305343|NCT02308735|76140988|FG003|Overall Study|Physician Decision|2|||
42305344|NCT02212197|76141001|FG000|Overall Study|Need for radiotherapy|1|||
42305345|NCT02212197|76141002|FG001|Overall Study|Need for radiotherapy|0|||
42305346|NCT02212197|76141003|FG002|Overall Study|Need for radiotherapy|0|||
42305347|NCT02193165|76141014|FG000|4 Week Product Use|Lost to Follow-up|1|||
42305348|NCT02193165|76141015|FG001|4 Week Product Use|Lost to Follow-up|1|||
41991044|NCT00392327|75799155|FG002|Overall Study|Ineligible|3|||
42305349|NCT02193165|76141016|FG002|4 Week Product Use|Lost to Follow-up|1|||
42305350|NCT02193165|76141014|FG000|6 Week Product Use|Lost to Follow-up|0|||
41991045|NCT00392327|75799156|FG003|Overall Study|Ineligible|2|||
41991046|NCT00392327|75799157|FG004|Overall Study|Ineligible|0|||
42132826|NCT00400179|75943658|FG001|Overall Study|Randomization error/patient ineligible|6|||
42251937|NCT01318109|76077885|FG001|Overall Study|Withdrawal by Subject|0|||
42251938|NCT01318109|76077886|FG002|Overall Study|Withdrawal by Subject|0|||
42251939|NCT01318109|76077884|FG000|Overall Study|Schedule Conflict|0|||
42251940|NCT01318109|76077885|FG001|Overall Study|Schedule Conflict|1|||
42251941|NCT01318109|76077886|FG002|Overall Study|Schedule Conflict|0|||
42251942|NCT02712554|76077896|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
42251943|NCT02712554|76077897|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
42251944|NCT02712554|76077896|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
42251945|NCT02712554|76077897|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
41991047|NCT00392327|75799158|FG005|Overall Study|Ineligible|0|||
41991048|NCT00392327|75799159|FG006|Overall Study|Ineligible|0|||
41991049|NCT00392327|75799160|FG007|Overall Study|Ineligible|0|||
41991050|NCT00352534|75799180|FG000|Initial Staging|Ineligible|8|||
42305351|NCT02193165|76141015|FG001|6 Week Product Use|Lost to Follow-up|1|||
42305352|NCT02193165|76141016|FG002|6 Week Product Use|Lost to Follow-up|0|||
42305353|NCT01617460|76141024|FG000|Overall Study|Adverse Event|10|||
41991051|NCT00352534|75799181|FG001|Initial Staging|Ineligible|9|||
41991052|NCT00352534|75799182|FG002|Initial Staging|Ineligible|0|||
42305354|NCT01617460|76141024|FG000|Overall Study|Physician Decision|16|||
42305355|NCT01617460|76141024|FG000|Overall Study|Protocol Violation|5|||
42305356|NCT01617460|76141024|FG000|Overall Study|Withdrawal by Subject|9|||
42305357|NCT01890148|76141028|FG000|Overall Study|Adverse Event|1|||
42305358|NCT01889602|76141035|FG000|First Intervention|Adverse Event|1|||
42305359|NCT01889602|76141036|FG001|First Intervention|Adverse Event|1|||
42305360|NCT01889602|76141037|FG002|First Intervention|Adverse Event|1|||
42305361|NCT01889602|76141035|FG000|First Intervention|Protocol Violation|0|||
42305362|NCT01889602|76141036|FG001|First Intervention|Protocol Violation|1|||
42305363|NCT01889602|76141037|FG002|First Intervention|Protocol Violation|1|||
42305364|NCT01889602|76141035|FG000|First Intervention|Study ending|0|||
42305365|NCT01889602|76141036|FG001|First Intervention|Study ending|1|||
42305366|NCT01889602|76141037|FG002|First Intervention|Study ending|0|||
42305367|NCT01889602|76141035|FG000|Second Intervention|Adverse Event|0|||
42305368|NCT01889602|76141036|FG001|Second Intervention|Adverse Event|0|||
42305369|NCT01889602|76141037|FG002|Second Intervention|Adverse Event|1|||
41991053|NCT00352534|75799183|FG003|Initial Staging|Ineligible|0|||
42305370|NCT01889602|76141035|FG000|Second Intervention|Study ending|1|||
42305371|NCT01889602|76141036|FG001|Second Intervention|Study ending|0|||
42305372|NCT01889602|76141037|FG002|Second Intervention|Study ending|0|||
42305373|NCT01889602|76141035|FG000|Second Intervention|Withdrawal by Subject|0|||
42305374|NCT01889602|76141036|FG001|Second Intervention|Withdrawal by Subject|0|||
42305375|NCT01889602|76141037|FG002|Second Intervention|Withdrawal by Subject|1|||
41991054|NCT00352534|75799184|FG004|Initial Staging|Ineligible|0|||
42305376|NCT01889602|76141035|FG000|Third Intervention|Protocol Violation|1|||
42251946|NCT02712554|76077896|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
42251947|NCT02712554|76077897|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
42251948|NCT02712554|76077896|FG000|Part B: Qualification Phase|Adverse Event|0|||
42251949|NCT02712554|76077897|FG001|Part B: Qualification Phase|Adverse Event|1|||
42305377|NCT01889602|76141036|FG001|Third Intervention|Protocol Violation|0|||
41991055|NCT00352534|75799185|FG005|Initial Staging|Ineligible|0|||
41991056|NCT00352534|75799186|FG006|Initial Staging|Ineligible|0|||
41991057|NCT00352534|75799180|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
42251950|NCT02712554|76077896|FG000|Part B: Treatment Phase|Adverse Event|0|||
42251951|NCT02712554|76077897|FG001|Part B: Treatment Phase|Adverse Event|1|||
42251952|NCT02712554|76077896|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
42251953|NCT02712554|76077897|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
42251954|NCT02712554|76077896|FG000|Part B: Treatment Phase|Other|0|||
42251955|NCT02712554|76077897|FG001|Part B: Treatment Phase|Other|1|||
42305378|NCT01889602|76141037|FG002|Third Intervention|Protocol Violation|0|||
41991058|NCT00352534|75799181|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
42251956|NCT02712320|76077920|FG000|Overall Study|Lost to Follow-up|1|||
42305379|NCT01889602|76141035|FG000|Third Intervention|Withdrawal by Subject|2|||
42251957|NCT02712320|76077920|FG000|Overall Study|Withdrawal by Subject|1|||
42251958|NCT02712320|76077920|FG000|Overall Study|Transferred to another facility|1|||
42251959|NCT02712320|76077920|FG000|Overall Study|Treating with the prohibited medications|2|||
42251960|NCT03052751|76077926|FG000|Dosing Period 1|Adverse Event|0|||
42251961|NCT03052751|76077927|FG001|Dosing Period 1|Adverse Event|1|||
42251962|NCT03052751|76077928|FG002|Dosing Period 1|Adverse Event|0|||
42251963|NCT03052751|76077929|FG003|Dosing Period 1|Adverse Event|0|||
42251964|NCT03052751|76077930|FG004|Dosing Period 1|Adverse Event|0|||
42251965|NCT03052751|76077931|FG005|Dosing Period 1|Adverse Event|0|||
42251966|NCT03052751|76077926|FG000|Dosing Period 2|Adverse Event|0|||
42251967|NCT03052751|76077927|FG001|Dosing Period 2|Adverse Event|0|||
42251968|NCT03052751|76077928|FG002|Dosing Period 2|Adverse Event|3|||
42251969|NCT03052751|76077929|FG003|Dosing Period 2|Adverse Event|0|||
42251970|NCT03052751|76077930|FG004|Dosing Period 2|Adverse Event|0|||
42251971|NCT03052751|76077931|FG005|Dosing Period 2|Adverse Event|0|||
42251972|NCT03052751|76077926|FG000|Observation Period|Adverse Event|0|||
42251973|NCT03052751|76077927|FG001|Observation Period|Adverse Event|0|||
42251974|NCT03052751|76077928|FG002|Observation Period|Adverse Event|0|||
42251975|NCT03052751|76077929|FG003|Observation Period|Adverse Event|0|||
42305380|NCT01889602|76141036|FG001|Third Intervention|Withdrawal by Subject|2|||
42305381|NCT01889602|76141037|FG002|Third Intervention|Withdrawal by Subject|0|||
42305382|NCT01935700|76141055|FG000|Overall Study|Withdrawal by Subject|1|||
42305383|NCT01935700|76141056|FG001|Overall Study|Withdrawal by Subject|0|||
42132827|NCT00465270|75943666|FG000|Overall Study|Death|7|||
42132828|NCT00465270|75943667|FG001|Overall Study|Death|11|||
42251976|NCT03052751|76077930|FG004|Observation Period|Adverse Event|1|||
42251977|NCT03052751|76077931|FG005|Observation Period|Adverse Event|0|||
42305384|NCT01935700|76141055|FG000|Overall Study|Physician Decision|4|||
42251978|NCT01317797|76077944|FG000|Overall Study|Other|0|||
42305385|NCT01935700|76141056|FG001|Overall Study|Physician Decision|0|||
42305386|NCT01618162|76141066|FG000|Overall Study|Protocol Violation|13|||
42305387|NCT01618162|76141067|FG001|Overall Study|Protocol Violation|10|||
42305388|NCT01618162|76141066|FG000|Overall Study|Adverse Event|9|||
42305389|NCT01618162|76141067|FG001|Overall Study|Adverse Event|2|||
42305390|NCT01618162|76141066|FG000|Overall Study|Withdrawal Criteria|2|||
42305391|NCT01618162|76141067|FG001|Overall Study|Withdrawal Criteria|10|||
42305392|NCT01618162|76141066|FG000|Overall Study|Unclassified|14|||
42305393|NCT01618162|76141067|FG001|Overall Study|Unclassified|13|||
42305394|NCT02193087|76141077|FG000|Overall Study|Adverse Event|2|||
42305395|NCT02193087|76141078|FG001|Overall Study|Adverse Event|0|||
42305396|NCT02193087|76141079|FG002|Overall Study|Adverse Event|0|||
42305397|NCT02193087|76141080|FG003|Overall Study|Adverse Event|11|||
42305398|NCT02193087|76141077|FG000|Overall Study|Lost to Follow-up|14|||
42305399|NCT02193087|76141078|FG001|Overall Study|Lost to Follow-up|6|||
42305400|NCT02193087|76141079|FG002|Overall Study|Lost to Follow-up|4|||
42305401|NCT02193087|76141080|FG003|Overall Study|Lost to Follow-up|37|||
42305402|NCT02193087|76141077|FG000|Overall Study|Protocol Violation|2|||
42305403|NCT02193087|76141078|FG001|Overall Study|Protocol Violation|0|||
42305404|NCT02193087|76141079|FG002|Overall Study|Protocol Violation|1|||
42305405|NCT02193087|76141080|FG003|Overall Study|Protocol Violation|2|||
42305406|NCT02193087|76141077|FG000|Overall Study|Withdrawal by Subject|10|||
42305407|NCT02193087|76141078|FG001|Overall Study|Withdrawal by Subject|3|||
42305408|NCT02193087|76141079|FG002|Overall Study|Withdrawal by Subject|1|||
42305409|NCT02193087|76141080|FG003|Overall Study|Withdrawal by Subject|19|||
42305410|NCT02193087|76141077|FG000|Overall Study|Other Reason Not Specified|7|||
42305411|NCT02193087|76141078|FG001|Overall Study|Other Reason Not Specified|2|||
42305412|NCT02193087|76141079|FG002|Overall Study|Other Reason Not Specified|1|||
42305413|NCT02193087|76141080|FG003|Overall Study|Other Reason Not Specified|9|||
42251979|NCT01317797|76077945|FG001|Overall Study|Other|1|||
42251980|NCT01317797|76077946|FG002|Overall Study|Other|0|||
42305414|NCT02193087|76141077|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
42305415|NCT02193087|76141078|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
42305416|NCT02193087|76141079|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
42305417|NCT02193087|76141080|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
42305418|NCT01617070|76141097|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
42305419|NCT02341417|76141110|FG000|Overall Study|Withdrawal by Subject|0|||
42033134|NCT01132313|75841314|FG005|Overall Study|Not treated|1|||
42132829|NCT00465270|75943666|FG000|Overall Study|Withdrawal by Subject|34|||
42251981|NCT01317797|76077944|FG000|Overall Study|Withdrawal of Patient|0|||
42251982|NCT01317797|76077945|FG001|Overall Study|Withdrawal of Patient|0|||
42251983|NCT01317797|76077946|FG002|Overall Study|Withdrawal of Patient|1|||
42251984|NCT01343693|76077954|FG000|Overall Study|Lost to Follow-up|9|||
42305420|NCT02341417|76141111|FG001|Overall Study|Withdrawal by Subject|2|||
42305421|NCT02341417|76141112|FG002|Overall Study|Withdrawal by Subject|0|||
42305422|NCT02341417|76141110|FG000|Overall Study|Decision by sponsor|2|||
42305423|NCT02341417|76141111|FG001|Overall Study|Decision by sponsor|0|||
42305424|NCT02341417|76141112|FG002|Overall Study|Decision by sponsor|0|||
42305425|NCT02341417|76141110|FG000|Overall Study|Death|0|||
42305426|NCT02341417|76141111|FG001|Overall Study|Death|0|||
42305427|NCT02341417|76141112|FG002|Overall Study|Death|1|||
42305428|NCT01888900|76141123|FG000|Overall Study|failed treatment|0|||
42305429|NCT01888900|76141124|FG001|Overall Study|failed treatment|2|||
42305430|NCT02340949|76141134|FG000|Overall Study|Adverse Event|4|||
42305431|NCT02340949|76141135|FG001|Overall Study|Adverse Event|2|||
42305432|NCT02340949|76141134|FG000|Overall Study|Withdrawal by Subject|2|||
42305433|NCT02340949|76141135|FG001|Overall Study|Withdrawal by Subject|0|||
42305434|NCT02340949|76141134|FG000|Overall Study|Progression disease|6|||
42305435|NCT02340949|76141135|FG001|Overall Study|Progression disease|2|||
42305436|NCT02340949|76141134|FG000|Overall Study|Death|3|||
42305437|NCT02340949|76141135|FG001|Overall Study|Death|0|||
42305438|NCT02340949|76141134|FG000|Overall Study|Physician Decision|1|||
42305439|NCT02340949|76141135|FG001|Overall Study|Physician Decision|0|||
42305440|NCT01646203|76141144|FG000|Overall Study|Adverse Event|2|||
42305441|NCT01646203|76141145|FG001|Overall Study|Adverse Event|0|||
42305442|NCT01646203|76141146|FG002|Overall Study|Adverse Event|1|||
42305443|NCT01646203|76141144|FG000|Overall Study|Withdrawal by Subject|0|||
42305444|NCT01646203|76141145|FG001|Overall Study|Withdrawal by Subject|1|||
42305445|NCT01646203|76141146|FG002|Overall Study|Withdrawal by Subject|0|||
42305446|NCT01646203|76141144|FG000|Overall Study|Physician's Decision|0|||
42305447|NCT01646203|76141145|FG001|Overall Study|Physician's Decision|1|||
42305448|NCT01646203|76141146|FG002|Overall Study|Physician's Decision|0|||
42305449|NCT02375347|76141159|FG000|Overall Study|Protocol Violation|1|||
42305450|NCT02374957|76141165|FG000|Overall Study|Patient did not complete forms correctly|1|||
41991059|NCT00352534|75799182|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
42251985|NCT02712008|76077961|FG000|Baseline (Day 1) up to Week 12|Death|3|||
42251986|NCT02712008|76077962|FG001|Baseline (Day 1) up to Week 12|Death|0|||
42251987|NCT02712008|76077963|FG002|Baseline (Day 1) up to Week 12|Death|0|||
42251988|NCT02712008|76077964|FG003|Baseline (Day 1) up to Week 12|Death|0|||
42251989|NCT02712008|76077965|FG004|Baseline (Day 1) up to Week 12|Death|0|||
42251990|NCT02712008|76077966|FG005|Baseline (Day 1) up to Week 12|Death|0|||
42251991|NCT02712008|76077967|FG006|Baseline (Day 1) up to Week 12|Death|0|||
42251992|NCT02712008|76077968|FG007|Baseline (Day 1) up to Week 12|Death|0|||
42251993|NCT02712008|76077961|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42251994|NCT02712008|76077962|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
42251995|NCT02712008|76077963|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
42251996|NCT02712008|76077964|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42251997|NCT02712008|76077965|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42251998|NCT02712008|76077966|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42251999|NCT02712008|76077967|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42252000|NCT02712008|76077968|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
42252001|NCT02712008|76077961|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
42252002|NCT02712008|76077962|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42252003|NCT02712008|76077963|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
42252004|NCT02712008|76077964|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42252005|NCT02712008|76077965|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42252006|NCT02712008|76077966|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42252007|NCT02712008|76077967|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42252008|NCT02712008|76077968|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
42252009|NCT02712008|76077961|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
42252010|NCT02712008|76077962|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
42252011|NCT02712008|76077963|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
42252012|NCT02712008|76077964|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
42305451|NCT02374957|76141166|FG001|Overall Study|Patient did not complete forms correctly|0|||
42305452|NCT02374255|76141176|FG000|Overall Study|Withdrawal by Subject|2|||
42305453|NCT02374255|76141177|FG001|Overall Study|Withdrawal by Subject|0|||
42305454|NCT02374255|76141178|FG002|Overall Study|Withdrawal by Subject|0|||
42305455|NCT02374255|76141179|FG003|Overall Study|Withdrawal by Subject|0|||
42305456|NCT02308033|76141197|FG000|Overall Study|Normal Gram stain at Baseline|13|||
42305457|NCT02308033|76141198|FG001|Overall Study|Normal Gram stain at Baseline|10|||
42305458|NCT02308033|76141197|FG000|Overall Study|Positive for STD at Baseline|7|||
41991060|NCT00352534|75799183|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
42305459|NCT02308033|76141198|FG001|Overall Study|Positive for STD at Baseline|4|||
42305460|NCT02308033|76141197|FG000|Overall Study|Lost to Follow-up|6|||
42305461|NCT02308033|76141198|FG001|Overall Study|Lost to Follow-up|5|||
42305462|NCT02339155|76141206|FG000|Overall Study|Adverse Event|0|||
42305463|NCT02339155|76141207|FG001|Overall Study|Adverse Event|6|||
42305464|NCT02339155|76141206|FG000|Overall Study|Death|1|||
42305465|NCT02339155|76141207|FG001|Overall Study|Death|1|||
42305466|NCT02339155|76141206|FG000|Overall Study|Lost to Follow-up|8|||
42305467|NCT02339155|76141207|FG001|Overall Study|Lost to Follow-up|9|||
42305468|NCT02339155|76141206|FG000|Overall Study|Physician Decision|2|||
42305469|NCT02339155|76141207|FG001|Overall Study|Physician Decision|1|||
42305470|NCT02339155|76141206|FG000|Overall Study|Withdrawal by Subject|4|||
42305471|NCT02339155|76141207|FG001|Overall Study|Withdrawal by Subject|4|||
41991061|NCT00352534|75799184|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
41991062|NCT00352534|75799185|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
41991063|NCT00352534|75799186|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
41991064|NCT00352534|75799180|FG000|Final Risk Group Assignment|Physician Decision|0|||
41991065|NCT00352534|75799181|FG001|Final Risk Group Assignment|Physician Decision|0|||
41991066|NCT00352534|75799182|FG002|Final Risk Group Assignment|Physician Decision|0|||
41991067|NCT00352534|75799183|FG003|Final Risk Group Assignment|Physician Decision|0|||
41991068|NCT00352534|75799184|FG004|Final Risk Group Assignment|Physician Decision|0|||
41991069|NCT00352534|75799185|FG005|Final Risk Group Assignment|Physician Decision|8|||
41991070|NCT00352534|75799186|FG006|Final Risk Group Assignment|Physician Decision|0|||
41991071|NCT00352534|75799180|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
41991072|NCT00352534|75799181|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
41991073|NCT00352534|75799182|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
41991074|NCT00352534|75799183|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
41991075|NCT00352534|75799184|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
41991076|NCT00352534|75799185|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
41991077|NCT00352534|75799186|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
41991078|NCT00352534|75799180|FG000|Final Risk Group Assignment|Ineligible|0|||
41991079|NCT00352534|75799181|FG001|Final Risk Group Assignment|Ineligible|0|||
41991080|NCT00352534|75799182|FG002|Final Risk Group Assignment|Ineligible|3|||
42033135|NCT01132313|75841315|FG006|Overall Study|Not treated|3|||
42252013|NCT02712008|76077965|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
42252014|NCT02712008|76077966|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
42252015|NCT02712008|76077967|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
42252016|NCT02712008|76077968|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
42252017|NCT02712008|76077961|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
42252018|NCT02712008|76077962|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
42252019|NCT02712008|76077963|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
42305472|NCT02211261|76141226|FG000|Overall Study|Withdrawal by Subject|0|||
42305473|NCT02211261|76141227|FG001|Overall Study|Withdrawal by Subject|0|||
42305474|NCT02211261|76141228|FG002|Overall Study|Withdrawal by Subject|1|||
42305475|NCT02211261|76141229|FG003|Overall Study|Withdrawal by Subject|0|||
42305476|NCT02211261|76141230|FG004|Overall Study|Withdrawal by Subject|2|||
42305477|NCT02211261|76141231|FG005|Overall Study|Withdrawal by Subject|0|||
42305478|NCT02211261|76141232|FG006|Overall Study|Withdrawal by Subject|0|||
41991081|NCT00352534|75799183|FG003|Final Risk Group Assignment|Ineligible|1|||
41991082|NCT00352534|75799184|FG004|Final Risk Group Assignment|Ineligible|0|||
42305479|NCT02211261|76141233|FG007|Overall Study|Withdrawal by Subject|0|||
42305480|NCT02211261|76141234|FG008|Overall Study|Withdrawal by Subject|0|||
42305481|NCT02211261|76141235|FG009|Overall Study|Withdrawal by Subject|0|||
42305482|NCT02211261|76141236|FG010|Overall Study|Withdrawal by Subject|0|||
42305483|NCT02211261|76141226|FG000|Overall Study|Other|0|||
42305484|NCT02211261|76141227|FG001|Overall Study|Other|0|||
42305485|NCT02211261|76141228|FG002|Overall Study|Other|0|||
42305486|NCT02211261|76141229|FG003|Overall Study|Other|0|||
42305487|NCT02211261|76141230|FG004|Overall Study|Other|0|||
42305488|NCT02211261|76141231|FG005|Overall Study|Other|1|||
42305489|NCT02211261|76141232|FG006|Overall Study|Other|0|||
42305490|NCT02211261|76141233|FG007|Overall Study|Other|0|||
42305491|NCT02211261|76141234|FG008|Overall Study|Other|0|||
42305492|NCT02211261|76141235|FG009|Overall Study|Other|2|||
42305493|NCT02211261|76141236|FG010|Overall Study|Other|0|||
42305494|NCT02211261|76141226|FG000|Overall Study|Lost to Follow-up|0|||
42305495|NCT02211261|76141227|FG001|Overall Study|Lost to Follow-up|0|||
42305496|NCT02211261|76141228|FG002|Overall Study|Lost to Follow-up|0|||
42305497|NCT02211261|76141229|FG003|Overall Study|Lost to Follow-up|0|||
42305498|NCT02211261|76141230|FG004|Overall Study|Lost to Follow-up|0|||
42305499|NCT02211261|76141231|FG005|Overall Study|Lost to Follow-up|0|||
42305500|NCT02211261|76141232|FG006|Overall Study|Lost to Follow-up|0|||
42305501|NCT02211261|76141233|FG007|Overall Study|Lost to Follow-up|1|||
42305502|NCT02211261|76141234|FG008|Overall Study|Lost to Follow-up|0|||
42305503|NCT02211261|76141235|FG009|Overall Study|Lost to Follow-up|0|||
42305504|NCT02211261|76141236|FG010|Overall Study|Lost to Follow-up|0|||
42305505|NCT02170077|76141272|FG000|Overall Study|Withdrawal by Subject|3|||
42305506|NCT02170077|76141273|FG001|Overall Study|Withdrawal by Subject|4|||
42305507|NCT02170077|76141274|FG002|Overall Study|Withdrawal by Subject|2|||
42305508|NCT02170077|76141272|FG000|Overall Study|Adverse Event|4|||
42305509|NCT02170077|76141273|FG001|Overall Study|Adverse Event|4|||
42305510|NCT02170077|76141274|FG002|Overall Study|Adverse Event|4|||
42305511|NCT02170077|76141272|FG000|Overall Study|Lost to Follow-up|0|||
42305512|NCT02170077|76141273|FG001|Overall Study|Lost to Follow-up|1|||
42305513|NCT02170077|76141274|FG002|Overall Study|Lost to Follow-up|0|||
42305514|NCT02170077|76141272|FG000|Overall Study|Exclusion criteria|2|||
42305515|NCT02170077|76141273|FG001|Overall Study|Exclusion criteria|2|||
42305516|NCT02170077|76141274|FG002|Overall Study|Exclusion criteria|5|||
42305517|NCT02170077|76141272|FG000|Overall Study|Exacerbation of seizures|0|||
42305518|NCT02170077|76141273|FG001|Overall Study|Exacerbation of seizures|2|||
42305519|NCT02170077|76141274|FG002|Overall Study|Exacerbation of seizures|1|||
42305520|NCT02210091|76141284|FG000|Overall Study|Physician Decision|0|||
42305521|NCT02210091|76141285|FG001|Overall Study|Physician Decision|1|||
42305522|NCT02210091|76141284|FG000|Overall Study|Withdrawal by Sponsor|0|||
42305523|NCT02210091|76141285|FG001|Overall Study|Withdrawal by Sponsor|1|||
42305524|NCT02338999|76141309|FG000|First Intervention|Withdrawal by Subject|3|||
42305525|NCT02338999|76141310|FG001|First Intervention|Withdrawal by Subject|1|||
42305526|NCT02338999|76141309|FG000|Washout Period|Withdrawal by Subject|0|||
42305527|NCT02338999|76141310|FG001|Washout Period|Withdrawal by Subject|2|||
42305528|NCT02338999|76141309|FG000|Second Intervention|Withdrawal by Subject|0|||
42305529|NCT02338999|76141310|FG001|Second Intervention|Withdrawal by Subject|2|||
42305530|NCT02169219|76141316|FG000|Overall Study|Lack of Efficacy|6|||
42305531|NCT02191605|76141330|FG000|Overall Study|Lost to Follow-up|9|||
42305532|NCT02191605|76141331|FG001|Overall Study|Lost to Follow-up|4|||
42305533|NCT02191605|76141332|FG002|Overall Study|Lost to Follow-up|7|||
42305534|NCT02191605|76141333|FG003|Overall Study|Lost to Follow-up|3|||
42305535|NCT02191605|76141334|FG004|Overall Study|Lost to Follow-up|4|||
42305536|NCT02191137|76141346|FG000|Treatment|Death|4|||
42305537|NCT02191137|76141346|FG000|Treatment|Withdrawal by Subject|3|||
42305538|NCT02191137|76141346|FG000|Treatment|Adverse Event|2|||
42305539|NCT02191137|76141346|FG000|Treatment|Other|1|||
42305540|NCT02191137|76141346|FG000|Follow-up|Lost to Follow-up|2|||
42305541|NCT02191137|76141346|FG000|Follow-up|Ongoing/unknown|2|||
42305542|NCT02191137|76141346|FG000|Follow-up|Adverse Event|1|||
42305543|NCT02168439|76141352|FG000|Overall Study|Protocol Violation|0|||
42305544|NCT02168439|76141353|FG001|Overall Study|Protocol Violation|2|||
42305545|NCT02190591|76141361|FG000|Overall Study|Withdrawal by Subject|1|||
42305546|NCT02190591|76141362|FG001|Overall Study|Withdrawal by Subject|8|||
42305547|NCT02190591|76141361|FG000|Overall Study|Protocol Violation|1|||
42305548|NCT02190591|76141362|FG001|Overall Study|Protocol Violation|0|||
42305549|NCT02190591|76141361|FG000|Overall Study|did not use peanut ball as instructed|0|||
42305550|NCT02190591|76141362|FG001|Overall Study|did not use peanut ball as instructed|2|||
42305551|NCT02190591|76141361|FG000|Overall Study|face presentation so she was ineligible|0|||
42305552|NCT02190591|76141362|FG001|Overall Study|face presentation so she was ineligible|1|||
42305553|NCT02190435|76141370|FG000|Overall Study|First 12 patients were lead-ins|12|||
42305554|NCT02190435|76141371|FG001|Overall Study|First 12 patients were lead-ins|0|||
42305555|NCT02190435|76141370|FG000|Overall Study|3 consented screen fails|3|||
42305556|NCT02190435|76141371|FG001|Overall Study|3 consented screen fails|0|||
42305557|NCT02338843|76141379|FG000|Overall Study|Adverse Event|2|||
42305558|NCT02338843|76141380|FG001|Overall Study|Adverse Event|1|||
42305559|NCT02338843|76141379|FG000|Overall Study|Death|40|||
42305560|NCT02338843|76141380|FG001|Overall Study|Death|53|||
42305561|NCT02338843|76141379|FG000|Overall Study|Physician Decision|1|||
42305562|NCT02338843|76141380|FG001|Overall Study|Physician Decision|0|||
42305563|NCT02338843|76141379|FG000|Overall Study|Withdrawal by Subject|0|||
42305564|NCT02338843|76141380|FG001|Overall Study|Withdrawal by Subject|2|||
42305565|NCT02338843|76141379|FG000|Overall Study|Subject Recovered|0|||
42305566|NCT02338843|76141380|FG001|Overall Study|Subject Recovered|2|||
42305567|NCT02338843|76141379|FG000|Overall Study|Discontinued prior to randomizat|1|||
42305568|NCT02338843|76141380|FG001|Overall Study|Discontinued prior to randomizat|0|||
42305569|NCT02190279|76141389|FG000|Overall Study|Withdrawal consent|1|||
42305570|NCT02190279|76141390|FG001|Overall Study|Withdrawal consent|0|||
42305571|NCT02190279|76141391|FG002|Overall Study|Withdrawal consent|1|||
42305572|NCT02190279|76141389|FG000|Overall Study|Lost to Follow-up|2|||
42305573|NCT02190279|76141390|FG001|Overall Study|Lost to Follow-up|0|||
42305574|NCT02190279|76141391|FG002|Overall Study|Lost to Follow-up|0|||
42305575|NCT02190279|76141389|FG000|Overall Study|Refused further treatment|0|||
42305576|NCT02190279|76141390|FG001|Overall Study|Refused further treatment|0|||
42305577|NCT02190279|76141391|FG002|Overall Study|Refused further treatment|1|||
42305578|NCT02190279|76141389|FG000|Overall Study|Screening failure|0|||
42305579|NCT02190279|76141390|FG001|Overall Study|Screening failure|0|||
42305580|NCT02190279|76141391|FG002|Overall Study|Screening failure|1|||
42305581|NCT02135445|76141403|FG000|Overall Study|Lost to Follow-up|1|||
42305582|NCT02135445|76141404|FG001|Overall Study|Lost to Follow-up|0|||
42305583|NCT02135445|76141403|FG000|Overall Study|Withdrawal by Subject|1|||
42305584|NCT02135445|76141404|FG001|Overall Study|Withdrawal by Subject|0|||
42305585|NCT02374099|76141412|FG000|Overall Study|Adverse Event|1|||
42305586|NCT02374099|76141413|FG001|Overall Study|Adverse Event|0|||
42252020|NCT02712008|76077964|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
42252021|NCT02712008|76077965|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
42252022|NCT02712008|76077966|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
42252023|NCT02712008|76077967|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
42252024|NCT02712008|76077968|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
42252025|NCT02712008|76077961|FG000|From Week 12 up to Week 36|Adverse Event|0|||
42252026|NCT02712008|76077962|FG001|From Week 12 up to Week 36|Adverse Event|0|||
42252027|NCT02712008|76077963|FG002|From Week 12 up to Week 36|Adverse Event|0|||
42252028|NCT02712008|76077964|FG003|From Week 12 up to Week 36|Adverse Event|0|||
42252029|NCT02712008|76077965|FG004|From Week 12 up to Week 36|Adverse Event|1|||
42252030|NCT02712008|76077966|FG005|From Week 12 up to Week 36|Adverse Event|0|||
42252031|NCT02712008|76077967|FG006|From Week 12 up to Week 36|Adverse Event|0|||
42252032|NCT02712008|76077968|FG007|From Week 12 up to Week 36|Adverse Event|2|||
42305587|NCT02374099|76141412|FG000|Overall Study|Progressive Disease|35|||
42305588|NCT02374099|76141413|FG001|Overall Study|Progressive Disease|40|||
42252033|NCT02712008|76077961|FG000|From Week 12 up to Week 36|Death|1|||
42252034|NCT02712008|76077962|FG001|From Week 12 up to Week 36|Death|0|||
42305589|NCT02374099|76141412|FG000|Overall Study|Withdrawal by Subject|5|||
42305590|NCT02374099|76141413|FG001|Overall Study|Withdrawal by Subject|1|||
42305591|NCT02374099|76141412|FG000|Overall Study|Miscellaneous|2|||
42305592|NCT02374099|76141413|FG001|Overall Study|Miscellaneous|3|||
42305593|NCT02374099|76141412|FG000|Overall Study|Randomized, but not treated|2|||
42305594|NCT02374099|76141413|FG001|Overall Study|Randomized, but not treated|1|||
42305595|NCT02374099|76141412|FG000|Overall Study|Study Terminated by Sponsor|3|||
42305596|NCT02374099|76141413|FG001|Overall Study|Study Terminated by Sponsor|4|||
42305597|NCT02134977|76141419|FG000|Overall Study|Protocol Deviation|102|||
42305598|NCT02374021|76141425|FG000|Overall Study|Adverse Event|1|||
42305599|NCT02374021|76141426|FG001|Overall Study|Adverse Event|0|||
42305600|NCT02374021|76141425|FG000|Overall Study|Lost to Follow-up|3|||
42305601|NCT02374021|76141426|FG001|Overall Study|Lost to Follow-up|2|||
42305602|NCT02374021|76141425|FG000|Overall Study|Physician Decision|0|||
42305603|NCT02374021|76141426|FG001|Overall Study|Physician Decision|3|||
42305604|NCT02374021|76141425|FG000|Overall Study|Withdrawal by Subject|6|||
42305605|NCT02374021|76141426|FG001|Overall Study|Withdrawal by Subject|5|||
42305606|NCT02374021|76141425|FG000|Overall Study|Poor Adherence|0|||
42305607|NCT02374021|76141426|FG001|Overall Study|Poor Adherence|1|||
42305608|NCT02374021|76141425|FG000|Overall Study|Scan protocol not followed|0|||
42305609|NCT02374021|76141426|FG001|Overall Study|Scan protocol not followed|1|||
42305610|NCT02374021|76141425|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
42305611|NCT02374021|76141426|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
42305612|NCT02372383|76141434|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
42305613|NCT02372383|76141435|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
42305614|NCT02372383|76141436|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
42305615|NCT01648699|76141446|FG000|Overall Study|Death|1|||
42305616|NCT01648699|76141446|FG000|Overall Study|Lost to Follow-up|2|||
42305617|NCT01648699|76141446|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
42305618|NCT02134353|76141461|FG000|Overall Study|Adverse Event|10|||
42305619|NCT02134353|76141462|FG001|Overall Study|Adverse Event|6|||
42305620|NCT02134353|76141461|FG000|Overall Study|Lost to Follow-up|1|||
42305621|NCT02134353|76141462|FG001|Overall Study|Lost to Follow-up|1|||
42305622|NCT02134353|76141461|FG000|Overall Study|Lack of Efficacy|2|||
42305623|NCT02134353|76141462|FG001|Overall Study|Lack of Efficacy|1|||
42305624|NCT02134353|76141461|FG000|Overall Study|Withdrawal by Subject|12|||
42305625|NCT02134353|76141462|FG001|Overall Study|Withdrawal by Subject|13|||
42305626|NCT02134353|76141461|FG000|Overall Study|Death|0|||
42305627|NCT02134353|76141462|FG001|Overall Study|Death|1|||
42305628|NCT02134353|76141461|FG000|Overall Study|Pregnancy|0|||
42305629|NCT02134353|76141462|FG001|Overall Study|Pregnancy|1|||
42305630|NCT02134353|76141461|FG000|Overall Study|Relocation|1|||
42305631|NCT02134353|76141462|FG001|Overall Study|Relocation|0|||
42305632|NCT02134353|76141461|FG000|Overall Study|Other - Patient's Choice|0|||
42305633|NCT02134353|76141462|FG001|Overall Study|Other - Patient's Choice|1|||
42252035|NCT02712008|76077963|FG002|From Week 12 up to Week 36|Death|0|||
42252036|NCT02712008|76077964|FG003|From Week 12 up to Week 36|Death|0|||
42252037|NCT02712008|76077965|FG004|From Week 12 up to Week 36|Death|0|||
42252038|NCT02712008|76077966|FG005|From Week 12 up to Week 36|Death|0|||
42252039|NCT02712008|76077967|FG006|From Week 12 up to Week 36|Death|1|||
42252040|NCT02712008|76077968|FG007|From Week 12 up to Week 36|Death|0|||
42252041|NCT02712008|76077961|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
42252042|NCT02712008|76077962|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
42252043|NCT02712008|76077963|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
42252044|NCT02712008|76077964|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
42252045|NCT02712008|76077965|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
42305634|NCT01646125|76141470|FG000|Overall Study|Untreated|2|||
42305635|NCT01646125|76141471|FG001|Overall Study|Untreated|5|||
42305636|NCT01646125|76141470|FG000|Overall Study|Adverse Event|2|||
42305637|NCT01646125|76141471|FG001|Overall Study|Adverse Event|1|||
42305638|NCT01646125|76141470|FG000|Overall Study|Death|1|||
42305639|NCT01646125|76141471|FG001|Overall Study|Death|1|||
42305640|NCT01646125|76141470|FG000|Overall Study|Physician Decision|1|||
42305641|NCT01646125|76141471|FG001|Overall Study|Physician Decision|3|||
42305642|NCT01646125|76141470|FG000|Overall Study|Progressive disease|22|||
42305643|NCT01646125|76141471|FG001|Overall Study|Progressive disease|16|||
42305644|NCT01646125|76141470|FG000|Overall Study|Study terminated by sponsor|2|||
42305645|NCT01646125|76141471|FG001|Overall Study|Study terminated by sponsor|1|||
42305646|NCT01646125|76141470|FG000|Overall Study|Subject/Guardian decision|1|||
42305647|NCT01646125|76141471|FG001|Overall Study|Subject/Guardian decision|1|||
42305648|NCT01362790|76141484|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
42252046|NCT02712008|76077966|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
42305649|NCT01362790|76141485|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
42305650|NCT01362790|76141486|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
42305651|NCT01362790|76141487|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
42305652|NCT01362790|76141488|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
42305653|NCT01362790|76141489|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
42305654|NCT01362790|76141490|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
42305655|NCT01362790|76141484|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
42305656|NCT01362790|76141485|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
42305657|NCT01362790|76141486|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
42305658|NCT01362790|76141487|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
42305659|NCT01362790|76141488|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
42305660|NCT01362790|76141489|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
42305661|NCT01362790|76141490|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
42305662|NCT01362790|76141484|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
42305663|NCT01362790|76141485|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
42305664|NCT01362790|76141486|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
42305665|NCT01362790|76141487|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
42305666|NCT01362790|76141488|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
42305667|NCT01362790|76141489|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
42305668|NCT01362790|76141490|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
42305669|NCT01362790|76141484|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
42305670|NCT01362790|76141485|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
42305671|NCT01362790|76141486|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
42305672|NCT01362790|76141487|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
42305673|NCT01362790|76141488|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
42305674|NCT01362790|76141489|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
42305675|NCT01362790|76141490|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
42305676|NCT01362790|76141484|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
42305677|NCT01362790|76141485|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
42305678|NCT01362790|76141486|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
42305679|NCT01362790|76141487|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
42305680|NCT01362790|76141488|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
42305681|NCT01362790|76141489|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
42305682|NCT01362790|76141490|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
42305683|NCT01362790|76141484|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
42305684|NCT01362790|76141485|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
42305685|NCT01362790|76141486|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
42305686|NCT01362790|76141487|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
42305687|NCT01362790|76141488|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
42305688|NCT01362790|76141489|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
42305689|NCT01362790|76141490|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
42305690|NCT01362790|76141484|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
42305691|NCT01362790|76141485|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
42305692|NCT01362790|76141486|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
42305693|NCT01362790|76141487|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
42305694|NCT01362790|76141488|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
42305695|NCT01362790|76141489|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
42305696|NCT01362790|76141490|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
42305697|NCT01362790|76141484|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
42305698|NCT01362790|76141485|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
42305699|NCT01362790|76141486|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
42305700|NCT01362790|76141487|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
42305701|NCT01362790|76141488|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
42305702|NCT01362790|76141489|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
42305703|NCT01362790|76141490|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
42305704|NCT01362790|76141484|FG000|Pilot Phase & Phase 2|Death on study|0|||
42305705|NCT01362790|76141485|FG001|Pilot Phase & Phase 2|Death on study|0|||
42305706|NCT01362790|76141486|FG002|Pilot Phase & Phase 2|Death on study|0|||
42305707|NCT01362790|76141487|FG003|Pilot Phase & Phase 2|Death on study|1|||
42305708|NCT01362790|76141488|FG004|Pilot Phase & Phase 2|Death on study|0|||
42305709|NCT01362790|76141489|FG005|Pilot Phase & Phase 2|Death on study|0|||
42305710|NCT01362790|76141490|FG006|Pilot Phase & Phase 2|Death on study|0|||
42305711|NCT01362790|76141484|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
42305712|NCT01362790|76141485|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
42305713|NCT01362790|76141486|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
42305714|NCT01362790|76141487|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
42305715|NCT01362790|76141488|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
42305716|NCT01362790|76141489|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
42305717|NCT01362790|76141490|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
42305718|NCT01362790|76141484|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
42305719|NCT01362790|76141485|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
42305720|NCT01362790|76141486|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
42305721|NCT01362790|76141487|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
42305722|NCT01362790|76141488|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
42305723|NCT01362790|76141489|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
42305724|NCT01362790|76141490|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
42305725|NCT01362790|76141484|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
42305726|NCT01362790|76141485|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
42305727|NCT01362790|76141486|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
42305728|NCT01362790|76141487|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
42305729|NCT01362790|76141488|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
42305730|NCT01362790|76141489|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
42305731|NCT01362790|76141490|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
42305732|NCT02167893|76141510|FG000|Overall Study|Investigator transferred|85|||
42305733|NCT02167893|76141510|FG000|Overall Study|Investigator health reasons|10|||
42305734|NCT02167893|76141510|FG000|Overall Study|Case report forms not collected|68|||
42305735|NCT02167035|76141516|FG000|Overall Study|Adverse Event|2|||
42305736|NCT02167035|76141517|FG001|Overall Study|Adverse Event|2|||
42305737|NCT02167035|76141516|FG000|Overall Study|Lost to Follow-up|3|||
42305738|NCT02167035|76141517|FG001|Overall Study|Lost to Follow-up|3|||
42305739|NCT02167035|76141516|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
42305740|NCT02167035|76141517|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
42305741|NCT01615198|76141527|FG000|Overall Study|Withdrawal by Subject|5|||
42305742|NCT01615198|76141528|FG001|Overall Study|Withdrawal by Subject|5|||
42305743|NCT01615198|76141527|FG000|Overall Study|Protocol deviation|1|||
42305744|NCT01615198|76141528|FG001|Overall Study|Protocol deviation|1|||
42305745|NCT01615198|76141527|FG000|Overall Study|Physician Decision|5|||
42305746|NCT01615198|76141528|FG001|Overall Study|Physician Decision|1|||
42305747|NCT01615198|76141527|FG000|Overall Study|Lost to Follow-up|1|||
42305748|NCT01615198|76141528|FG001|Overall Study|Lost to Follow-up|1|||
42305749|NCT01615198|76141527|FG000|Overall Study|Lack of Efficacy|1|||
42305750|NCT01615198|76141528|FG001|Overall Study|Lack of Efficacy|6|||
42305751|NCT01615198|76141527|FG000|Overall Study|Adverse Event|11|||
42305752|NCT01615198|76141528|FG001|Overall Study|Adverse Event|5|||
42305753|NCT02337907|76141540|FG000|Overall Study|Other than listed|1|||
42305754|NCT02337907|76141541|FG001|Overall Study|Other than listed|0|||
42305755|NCT02337907|76141542|FG002|Overall Study|Other than listed|0|||
42305756|NCT02337907|76141543|FG003|Overall Study|Other than listed|1|||
42305757|NCT02337907|76141544|FG004|Overall Study|Other than listed|1|||
42305758|NCT02337907|76141545|FG005|Overall Study|Other than listed|0|||
42305759|NCT02337907|76141540|FG000|Overall Study|Withdrawal by Subject|2|||
42305760|NCT02337907|76141541|FG001|Overall Study|Withdrawal by Subject|3|||
42305761|NCT02337907|76141542|FG002|Overall Study|Withdrawal by Subject|0|||
42305762|NCT02337907|76141543|FG003|Overall Study|Withdrawal by Subject|2|||
42305763|NCT02337907|76141544|FG004|Overall Study|Withdrawal by Subject|5|||
42305764|NCT02337907|76141545|FG005|Overall Study|Withdrawal by Subject|0|||
42305765|NCT02337907|76141540|FG000|Overall Study|Lost to Follow-up|0|||
42305766|NCT02337907|76141541|FG001|Overall Study|Lost to Follow-up|0|||
42305767|NCT02337907|76141542|FG002|Overall Study|Lost to Follow-up|0|||
42305768|NCT02337907|76141543|FG003|Overall Study|Lost to Follow-up|0|||
42305769|NCT02337907|76141544|FG004|Overall Study|Lost to Follow-up|0|||
42305770|NCT02337907|76141545|FG005|Overall Study|Lost to Follow-up|1|||
42305771|NCT02337907|76141540|FG000|Overall Study|Adverse Event|1|||
42305772|NCT02337907|76141541|FG001|Overall Study|Adverse Event|1|||
42305773|NCT02337907|76141542|FG002|Overall Study|Adverse Event|1|||
42305774|NCT02337907|76141543|FG003|Overall Study|Adverse Event|1|||
42305775|NCT02337907|76141544|FG004|Overall Study|Adverse Event|4|||
42305776|NCT02337907|76141545|FG005|Overall Study|Adverse Event|0|||
42305777|NCT01913470|76141562|FG000|Overall Study|Lost to Follow-up|0|||
42305778|NCT01913470|76141563|FG001|Overall Study|Lost to Follow-up|1|||
42305779|NCT01913470|76141562|FG000|Overall Study|Physician Decision|0|||
42305780|NCT01913470|76141563|FG001|Overall Study|Physician Decision|1|||
42305781|NCT01913470|76141562|FG000|Overall Study|Withdrawal by Subject|0|||
42305782|NCT01913470|76141563|FG001|Overall Study|Withdrawal by Subject|1|||
42305783|NCT02372071|76141570|FG000|Overall Study|Protocol Violation|18|||
42305784|NCT02337751|76141577|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
42305785|NCT02337751|76141578|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
42305786|NCT02337751|76141577|FG000|Overall Study|Voluntary Withdrawal|6|||
42305787|NCT02337751|76141578|FG001|Overall Study|Voluntary Withdrawal|8|||
42305788|NCT02337751|76141577|FG000|Overall Study|Lack of Efficacy|2|||
42305789|NCT02337751|76141578|FG001|Overall Study|Lack of Efficacy|5|||
42305790|NCT02337751|76141577|FG000|Overall Study|Investigator's Judgement|1|||
42305791|NCT02337751|76141578|FG001|Overall Study|Investigator's Judgement|0|||
42305792|NCT02166333|76141589|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
42305793|NCT02166333|76141590|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
41991083|NCT00352534|75799185|FG005|Final Risk Group Assignment|Ineligible|13|||
41991084|NCT00352534|75799186|FG006|Final Risk Group Assignment|Ineligible|0|||
42132830|NCT00465270|75943667|FG001|Overall Study|Withdrawal by Subject|78|||
42132831|NCT00465270|75943666|FG000|Overall Study|Lost to Follow-up|60|||
42132832|NCT00465270|75943667|FG001|Overall Study|Lost to Follow-up|67|||
42132833|NCT00465270|75943666|FG000|Overall Study|Investigator request|3|||
42252047|NCT02712008|76077967|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
42252048|NCT02712008|76077968|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
42252049|NCT02712008|76077961|FG000|From Week 12 up to Week 36|Physician Decision|0|||
42252050|NCT02712008|76077962|FG001|From Week 12 up to Week 36|Physician Decision|0|||
42252051|NCT02712008|76077963|FG002|From Week 12 up to Week 36|Physician Decision|0|||
42252052|NCT02712008|76077964|FG003|From Week 12 up to Week 36|Physician Decision|1|||
42252053|NCT02712008|76077965|FG004|From Week 12 up to Week 36|Physician Decision|1|||
42252054|NCT02712008|76077966|FG005|From Week 12 up to Week 36|Physician Decision|0|||
42252055|NCT02712008|76077967|FG006|From Week 12 up to Week 36|Physician Decision|0|||
42252056|NCT02712008|76077968|FG007|From Week 12 up to Week 36|Physician Decision|0|||
42252057|NCT02712008|76077961|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
42252058|NCT02712008|76077962|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
42252059|NCT02712008|76077963|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
42252060|NCT02712008|76077964|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
42252061|NCT02712008|76077965|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
42252062|NCT02712008|76077966|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
42252063|NCT02712008|76077967|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
42252064|NCT02712008|76077968|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
42252065|NCT02711306|76077988|FG000|Overall Study|Withdrawal by Subject|2|||
42252066|NCT02711306|76077989|FG001|Overall Study|Withdrawal by Subject|2|||
42252067|NCT02710292|76077995|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
42252068|NCT02710292|76077996|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
42252069|NCT02710292|76077995|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
42252070|NCT02710292|76077996|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
42252071|NCT02710214|76078005|FG000|Overall Study|Lost to Follow-up|1|||
42252072|NCT02710214|76078006|FG001|Overall Study|Lost to Follow-up|0|||
42252073|NCT02710214|76078005|FG000|Overall Study|Lack of Efficacy|0|||
42252074|NCT02710214|76078006|FG001|Overall Study|Lack of Efficacy|1|||
42252075|NCT02710214|76078005|FG000|Overall Study|Death|0|||
42252076|NCT02710214|76078006|FG001|Overall Study|Death|1|||
42252077|NCT03052517|76078015|FG000|Overall Study|Study Terminated By Sponsor|928|||
42252078|NCT03052517|76078016|FG001|Overall Study|Study Terminated By Sponsor|938|||
41991085|NCT00352534|75799180|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
42132834|NCT00465270|75943667|FG001|Overall Study|Investigator request|4|||
42132835|NCT00464568|75943673|FG000|Overall Study|Adverse Event|2|||
42252079|NCT03052517|76078017|FG002|Overall Study|Study Terminated By Sponsor|296|||
42252080|NCT03052517|76078015|FG000|Overall Study|Subject/Guardian Decision|50|||
42252081|NCT03052517|76078016|FG001|Overall Study|Subject/Guardian Decision|45|||
42252082|NCT03052517|76078017|FG002|Overall Study|Subject/Guardian Decision|22|||
42252083|NCT03052517|76078015|FG000|Overall Study|Lack of Efficacy|23|||
42252084|NCT03052517|76078016|FG001|Overall Study|Lack of Efficacy|14|||
42252085|NCT03052517|76078017|FG002|Overall Study|Lack of Efficacy|7|||
42252086|NCT03052517|76078015|FG000|Overall Study|Adverse Event|6|||
42252087|NCT03052517|76078016|FG001|Overall Study|Adverse Event|5|||
42252088|NCT03052517|76078017|FG002|Overall Study|Adverse Event|0|||
42252089|NCT03052517|76078015|FG000|Overall Study|Physician Decision|4|||
42252090|NCT03052517|76078016|FG001|Overall Study|Physician Decision|5|||
42252091|NCT03052517|76078017|FG002|Overall Study|Physician Decision|1|||
42252092|NCT03052517|76078015|FG000|Overall Study|Death|3|||
42252093|NCT03052517|76078016|FG001|Overall Study|Death|0|||
42252094|NCT03052517|76078017|FG002|Overall Study|Death|1|||
42252095|NCT03052517|76078015|FG000|Overall Study|Lost to Follow-up|2|||
42252096|NCT03052517|76078016|FG001|Overall Study|Lost to Follow-up|4|||
42252097|NCT03052517|76078017|FG002|Overall Study|Lost to Follow-up|0|||
42252098|NCT03052517|76078015|FG000|Overall Study|Pregnancy|1|||
42252099|NCT03052517|76078016|FG001|Overall Study|Pregnancy|0|||
42252100|NCT03052517|76078017|FG002|Overall Study|Pregnancy|1|||
42252101|NCT03052517|76078015|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
42252102|NCT03052517|76078016|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
42252103|NCT03052517|76078017|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
42252104|NCT03052517|76078015|FG000|Overall Study|Technical Problems|0|||
42252105|NCT03052517|76078016|FG001|Overall Study|Technical Problems|1|||
42252106|NCT03052517|76078017|FG002|Overall Study|Technical Problems|0|||
42252107|NCT02708498|76078033|FG000|Overall Study|Death|20|||
42252108|NCT02708498|76078034|FG001|Overall Study|Death|19|||
42252109|NCT02708498|76078035|FG002|Overall Study|Death|0|||
42252110|NCT02708498|76078036|FG003|Overall Study|Death|0|||
42252111|NCT02708498|76078037|FG004|Overall Study|Death|1|||
42252112|NCT02708498|76078038|FG005|Overall Study|Death|0|||
42252113|NCT02708498|76078039|FG006|Overall Study|Death|0|||
42252114|NCT02708498|76078040|FG007|Overall Study|Death|0|||
42252115|NCT02708498|76078033|FG000|Overall Study|Unknown reason, missing data|0|||
42252116|NCT02708498|76078034|FG001|Overall Study|Unknown reason, missing data|0|||
42252117|NCT02708498|76078035|FG002|Overall Study|Unknown reason, missing data|62|||
42252118|NCT02708498|76078036|FG003|Overall Study|Unknown reason, missing data|51|||
42252119|NCT02708498|76078037|FG004|Overall Study|Unknown reason, missing data|195|||
42252120|NCT02708498|76078038|FG005|Overall Study|Unknown reason, missing data|132|||
42252121|NCT02708498|76078039|FG006|Overall Study|Unknown reason, missing data|0|||
42252122|NCT02708498|76078040|FG007|Overall Study|Unknown reason, missing data|0|||
42252123|NCT02710136|76078058|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
42252124|NCT02710136|76078059|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
42252125|NCT03702231|76078069|FG000|Overall Study|Withdrawal by Subject|1|||
42252126|NCT03702231|76078070|FG001|Overall Study|Withdrawal by Subject|0|||
42252127|NCT03702231|76078071|FG002|Overall Study|Withdrawal by Subject|0|||
42252128|NCT03702231|76078069|FG000|Overall Study|Protocol Violation|0|||
42252129|NCT03702231|76078070|FG001|Overall Study|Protocol Violation|0|||
42252130|NCT03702231|76078071|FG002|Overall Study|Protocol Violation|1|||
42252131|NCT03702231|76078069|FG000|Overall Study|Change in CLL Treatment|0|||
42252132|NCT03702231|76078070|FG001|Overall Study|Change in CLL Treatment|0|||
42252133|NCT03702231|76078071|FG002|Overall Study|Change in CLL Treatment|1|||
42252134|NCT03702231|76078069|FG000|Overall Study|COVID Pandemic|1|||
42252135|NCT03702231|76078070|FG001|Overall Study|COVID Pandemic|4|||
42252136|NCT03702231|76078071|FG002|Overall Study|COVID Pandemic|1|||
42252137|NCT03702231|76078069|FG000|Overall Study|Non-compliance|0|||
42252138|NCT03702231|76078070|FG001|Overall Study|Non-compliance|0|||
42252139|NCT03702231|76078071|FG002|Overall Study|Non-compliance|1|||
42252140|NCT02741271|76078081|FG000|Overall Study|Lost to Follow-up|2|||
42252141|NCT02741271|76078082|FG001|Overall Study|Lost to Follow-up|0|||
42252142|NCT02741271|76078081|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42252143|NCT02741271|76078082|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
42252144|NCT02709746|76078095|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
42252145|NCT02709746|76078096|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
42252146|NCT02709746|76078097|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
42252147|NCT02709746|76078098|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
42305794|NCT02166333|76141591|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
42305795|NCT02166333|76141592|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
42305796|NCT02166333|76141593|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
41991086|NCT00352534|75799181|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
41991087|NCT00352534|75799182|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
41991088|NCT00352534|75799183|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
41991089|NCT00352534|75799184|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
41991090|NCT00352534|75799185|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
42132836|NCT00464490|75943692|FG000|Overall Study|Physician Decision|11|||
42252148|NCT02709746|76078099|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
42252149|NCT02709746|76078095|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
42252150|NCT02709746|76078096|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
42252151|NCT02709746|76078097|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
42252152|NCT02709746|76078098|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
42252153|NCT02709746|76078099|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
42252154|NCT02709746|76078095|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
42252155|NCT02709746|76078096|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
42252156|NCT02709746|76078097|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
42252157|NCT02709746|76078098|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
42252158|NCT02709746|76078099|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
42252159|NCT02709746|76078095|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
42252160|NCT02709746|76078096|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
42305797|NCT02166333|76141594|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
42305798|NCT02166333|76141589|FG000|Stage 1|Death|4|||
42305799|NCT02166333|76141590|FG001|Stage 1|Death|0|||
42305800|NCT02166333|76141591|FG002|Stage 1|Death|2|||
42305801|NCT02166333|76141592|FG003|Stage 1|Death|0|||
42305802|NCT02166333|76141593|FG004|Stage 1|Death|3|||
42305803|NCT02166333|76141594|FG005|Stage 1|Death|2|||
42305804|NCT02166333|76141589|FG000|Stage 1|Lost to Follow-up|12|||
42305805|NCT02166333|76141590|FG001|Stage 1|Lost to Follow-up|0|||
42305806|NCT02166333|76141591|FG002|Stage 1|Lost to Follow-up|6|||
42305807|NCT02166333|76141592|FG003|Stage 1|Lost to Follow-up|0|||
42305808|NCT02166333|76141593|FG004|Stage 1|Lost to Follow-up|3|||
42305809|NCT02166333|76141594|FG005|Stage 1|Lost to Follow-up|3|||
42305810|NCT02166333|76141589|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
42305811|NCT02166333|76141590|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
42305812|NCT02166333|76141591|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
42305813|NCT02166333|76141592|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
42305814|NCT02166333|76141593|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
42305815|NCT02166333|76141594|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
42305816|NCT02166333|76141589|FG000|Stage 2|Death|4|||
42305817|NCT02166333|76141590|FG001|Stage 2|Death|2|||
42252161|NCT02709746|76078097|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
42252162|NCT02709746|76078098|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
42252163|NCT02709746|76078099|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
42252164|NCT02709746|76078095|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
42252165|NCT02709746|76078096|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
42252166|NCT02709746|76078097|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
42252167|NCT02709746|76078098|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
42252168|NCT02709746|76078099|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
42252169|NCT02709746|76078095|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
42252170|NCT02709746|76078096|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
42252171|NCT02709746|76078097|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
42252172|NCT02709746|76078098|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
42252173|NCT02709746|76078099|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
42252174|NCT02709746|76078095|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
42252175|NCT02709746|76078096|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
42252176|NCT02709746|76078097|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
42252177|NCT02709746|76078098|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
42252178|NCT02709746|76078099|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
42252179|NCT02709746|76078095|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
42305818|NCT02166333|76141591|FG002|Stage 2|Death|1|||
42305819|NCT02166333|76141592|FG003|Stage 2|Death|0|||
42132837|NCT00464490|75943693|FG001|Overall Study|Physician Decision|11|||
42132838|NCT03849300|75943703|FG000|Overall Study|move out to different area|1|||
41991091|NCT00352534|75799186|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
41991092|NCT00352534|75799180|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
41991093|NCT00352534|75799181|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
41991094|NCT00352534|75799182|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
41991095|NCT00352534|75799183|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
41991096|NCT00352534|75799184|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
42305820|NCT02166333|76141593|FG004|Stage 2|Death|0|||
42132839|NCT03849300|75943704|FG001|Overall Study|move out to different area|3|||
42132840|NCT03849300|75943705|FG002|Overall Study|move out to different area|1|||
42132841|NCT03849300|75943706|FG003|Overall Study|move out to different area|4|||
42132842|NCT03849300|75943703|FG000|Overall Study|scheduling/transportation conflict|4|||
42132843|NCT03849300|75943704|FG001|Overall Study|scheduling/transportation conflict|4|||
42305821|NCT02166333|76141594|FG005|Stage 2|Death|1|||
42305822|NCT02166333|76141589|FG000|Stage 2|Lost to Follow-up|23|||
42305823|NCT02166333|76141590|FG001|Stage 2|Lost to Follow-up|4|||
42305824|NCT02166333|76141591|FG002|Stage 2|Lost to Follow-up|11|||
42305825|NCT02166333|76141592|FG003|Stage 2|Lost to Follow-up|9|||
42305826|NCT02166333|76141593|FG004|Stage 2|Lost to Follow-up|3|||
42305827|NCT02166333|76141594|FG005|Stage 2|Lost to Follow-up|6|||
42305828|NCT02132949|76141608|FG000|Overall Study|Death|7|||
42305829|NCT02132949|76141609|FG001|Overall Study|Death|13|||
41991097|NCT00352534|75799185|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
41991098|NCT00352534|75799186|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
41991099|NCT00352534|75799180|FG000|Final Risk Group Assignment|Death|0|||
41991100|NCT00352534|75799181|FG001|Final Risk Group Assignment|Death|0|||
41991101|NCT00352534|75799182|FG002|Final Risk Group Assignment|Death|0|||
41991102|NCT00352534|75799183|FG003|Final Risk Group Assignment|Death|0|||
41991103|NCT00352534|75799184|FG004|Final Risk Group Assignment|Death|0|||
41991104|NCT00352534|75799185|FG005|Final Risk Group Assignment|Death|2|||
41991105|NCT00352534|75799186|FG006|Final Risk Group Assignment|Death|0|||
42010525|NCT00996307|75817648|FG001|Overall Study|Withdrawal by Subject|2|||
42010526|NCT00996307|75817649|FG002|Overall Study|Withdrawal by Subject|5|||
42010527|NCT00996307|75817650|FG003|Overall Study|Withdrawal by Subject|5|||
42010528|NCT00996307|75817647|FG000|Overall Study|Lost to Follow-up|13|||
42010529|NCT00996307|75817648|FG001|Overall Study|Lost to Follow-up|13|||
42010530|NCT00996307|75817649|FG002|Overall Study|Lost to Follow-up|7|||
42010531|NCT00996307|75817650|FG003|Overall Study|Lost to Follow-up|15|||
42010532|NCT00996307|75817647|FG000|Overall Study|Administrative reason|0|||
42010533|NCT00996307|75817648|FG001|Overall Study|Administrative reason|1|||
42010534|NCT00996307|75817649|FG002|Overall Study|Administrative reason|0|||
42010535|NCT00996307|75817650|FG003|Overall Study|Administrative reason|0|||
42010536|NCT00996307|75817647|FG000|Overall Study|Unable to classify|4|||
42010537|NCT00996307|75817648|FG001|Overall Study|Unable to classify|0|||
42010538|NCT00996307|75817649|FG002|Overall Study|Unable to classify|2|||
42010539|NCT00996307|75817650|FG003|Overall Study|Unable to classify|1|||
42010540|NCT01219959|75817680|FG000|Overall Study|Adverse Event|6|||
42010541|NCT01219959|75817681|FG001|Overall Study|Adverse Event|14|||
42010542|NCT01219959|75817680|FG000|Overall Study|Physician Decision|0|||
42010543|NCT01219959|75817681|FG001|Overall Study|Physician Decision|4|||
42010544|NCT01219959|75817680|FG000|Overall Study|Withdrawal by Subject|0|||
42010545|NCT01219959|75817681|FG001|Overall Study|Withdrawal by Subject|2|||
42010546|NCT01219959|75817680|FG000|Overall Study|Renal Transplantation|0|||
42010547|NCT01219959|75817681|FG001|Overall Study|Renal Transplantation|3|||
42010548|NCT01219959|75817680|FG000|Overall Study|Other|1|||
42010549|NCT01219959|75817681|FG001|Overall Study|Other|0|||
42305830|NCT02132949|76141608|FG000|Overall Study|Lost to Follow-up|14|||
42305831|NCT02132949|76141609|FG001|Overall Study|Lost to Follow-up|4|||
42305832|NCT02132949|76141608|FG000|Overall Study|Withdrawal by Subject|6|||
41991106|NCT01217047|75799200|FG000|Overall Study|Lost to Follow-up|0|||
42305833|NCT02132949|76141609|FG001|Overall Study|Withdrawal by Subject|5|||
42305834|NCT02132949|76141608|FG000|Overall Study|Noncompliance|5|||
42305835|NCT02132949|76141609|FG001|Overall Study|Noncompliance|1|||
42305836|NCT02132949|76141608|FG000|Overall Study|Physician Decision|3|||
42305837|NCT02132949|76141609|FG001|Overall Study|Physician Decision|1|||
42305838|NCT02132949|76141608|FG000|Overall Study|Disease Progression|3|||
42305839|NCT02132949|76141609|FG001|Overall Study|Disease Progression|0|||
42305840|NCT02132949|76141608|FG000|Overall Study|Adverse Event|2|||
42305841|NCT02132949|76141609|FG001|Overall Study|Adverse Event|1|||
42305842|NCT02132949|76141608|FG000|Overall Study|Withdrew Prior to Treatment|1|||
41991107|NCT01217047|75799201|FG001|Overall Study|Lost to Follow-up|1|||
42305843|NCT02132949|76141609|FG001|Overall Study|Withdrew Prior to Treatment|2|||
42305844|NCT02132949|76141608|FG000|Overall Study|Reason Unspecified|0|||
42305845|NCT02132949|76141609|FG001|Overall Study|Reason Unspecified|1|||
42305846|NCT02165397|76141618|FG000|Overall Study|Death|7|||
42305847|NCT02165397|76141619|FG001|Overall Study|Death|10|||
42305848|NCT02165397|76141620|FG002|Overall Study|Death|8|||
42305849|NCT02165397|76141618|FG000|Overall Study|Lost to Follow-up|1|||
42305850|NCT02165397|76141619|FG001|Overall Study|Lost to Follow-up|3|||
42305851|NCT02165397|76141620|FG002|Overall Study|Lost to Follow-up|0|||
42305852|NCT02165397|76141618|FG000|Overall Study|Withdrawal by Subject|6|||
41991108|NCT01217047|75799202|FG002|Overall Study|Lost to Follow-up|0|||
41991109|NCT01185340|75799214|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
41991110|NCT01185340|75799215|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
41991111|NCT01185340|75799216|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
41991112|NCT01185340|75799217|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
41991113|NCT01185340|75799214|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
41991114|NCT01185340|75799215|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
41991115|NCT01185340|75799216|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
41991116|NCT01185340|75799217|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
41991117|NCT01185340|75799214|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
41991118|NCT01185340|75799215|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
41991119|NCT01185340|75799216|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
41991120|NCT01185340|75799217|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
41991121|NCT01185340|75799214|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
41991122|NCT01185340|75799215|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
41991123|NCT01185340|75799216|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
41991124|NCT01185340|75799217|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
41991125|NCT01185340|75799214|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
41991126|NCT01185340|75799215|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
41991127|NCT01185340|75799216|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
41991128|NCT01185340|75799217|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
41991129|NCT01185340|75799214|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
41991130|NCT01185340|75799215|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
41991131|NCT01185340|75799216|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
41991132|NCT01185340|75799217|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
41991133|NCT01185340|75799214|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
41991134|NCT01185340|75799215|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
41991135|NCT01185340|75799216|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
41991136|NCT01185340|75799217|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
41991137|NCT01185340|75799214|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
41991138|NCT01185340|75799215|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
42305853|NCT02165397|76141619|FG001|Overall Study|Withdrawal by Subject|6|||
41991139|NCT01185340|75799216|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
41991140|NCT01185340|75799217|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
41991141|NCT01185340|75799214|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
42305854|NCT02165397|76141620|FG002|Overall Study|Withdrawal by Subject|1|||
42305855|NCT02165397|76141618|FG000|Overall Study|Other, Not Specified|0|||
42305856|NCT02165397|76141619|FG001|Overall Study|Other, Not Specified|0|||
41991142|NCT01185340|75799215|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
42305857|NCT02165397|76141620|FG002|Overall Study|Other, Not Specified|1|||
42305858|NCT02132637|76141632|FG000|Study Period 1|Withdrawal by Subject|0|||
42305859|NCT02132637|76141633|FG001|Study Period 1|Withdrawal by Subject|4|||
42305860|NCT02132637|76141632|FG000|Study Period 1|Physician Decision|1|||
42305861|NCT02132637|76141633|FG001|Study Period 1|Physician Decision|0|||
42305862|NCT02132637|76141632|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
42305863|NCT02132637|76141633|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
42305864|NCT02132637|76141632|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
42305865|NCT02132637|76141633|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
42305866|NCT02164929|76141643|FG000|Overall Study|Converted to open procedure|1|||
42305867|NCT02164929|76141644|FG001|Overall Study|Converted to open procedure|0|||
42305868|NCT02164929|76141645|FG002|Overall Study|Converted to open procedure|0|||
42305869|NCT02164929|76141646|FG003|Overall Study|Converted to open procedure|2|||
42305870|NCT02164929|76141643|FG000|Overall Study|Failed regional block|0|||
42305871|NCT02164929|76141644|FG001|Overall Study|Failed regional block|0|||
42305872|NCT02164929|76141645|FG002|Overall Study|Failed regional block|1|||
42305873|NCT02164929|76141646|FG003|Overall Study|Failed regional block|0|||
42305874|NCT01888432|76141658|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
42305875|NCT01888432|76141659|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
42305876|NCT01888432|76141658|FG000|12-month Analysis (FAS)|Physician Decision|1|||
42305877|NCT01888432|76141659|FG001|12-month Analysis (FAS)|Physician Decision|1|||
42305878|NCT01888432|76141658|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
42305879|NCT01888432|76141659|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
42305880|NCT01888432|76141658|FG000|12-month Analysis (FAS)|Death|4|||
42305881|NCT01888432|76141659|FG001|12-month Analysis (FAS)|Death|3|||
42305882|NCT01888432|76141658|FG000|24-month Analysis (FAS)|Graft loss|0|||
42305883|NCT01888432|76141659|FG001|24-month Analysis (FAS)|Graft loss|1|||
42305884|NCT01888432|76141658|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
42305885|NCT01888432|76141659|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
42305886|NCT01888432|76141658|FG000|24-month Analysis (FAS)|Physician Decision|2|||
42305887|NCT01888432|76141659|FG001|24-month Analysis (FAS)|Physician Decision|4|||
42305888|NCT01888432|76141658|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
42305889|NCT01888432|76141659|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
42305890|NCT01888432|76141658|FG000|24-month Analysis (FAS)|Death|8|||
42305891|NCT01888432|76141659|FG001|24-month Analysis (FAS)|Death|4|||
42305892|NCT01888432|76141658|FG000|36-month Analysis (Extension)|Death|1|||
42305893|NCT01888432|76141659|FG001|36-month Analysis (Extension)|Death|0|||
42305894|NCT02188719|76141671|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
42252180|NCT02709746|76078096|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
42252181|NCT02709746|76078097|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
42252182|NCT02709746|76078098|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
42252183|NCT02709746|76078099|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
42252184|NCT02709746|76078095|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
42252185|NCT02709746|76078096|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
42252186|NCT02709746|76078097|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
42252187|NCT02709746|76078098|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
42252188|NCT02709746|76078099|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
42252189|NCT02709746|76078095|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
42252190|NCT02709746|76078096|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
42252191|NCT02709746|76078097|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
42252192|NCT02709746|76078098|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
42252193|NCT02709746|76078099|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
42252194|NCT02709746|76078095|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
42252195|NCT02709746|76078096|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
42252196|NCT02709746|76078097|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
42252197|NCT02709746|76078098|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
42252198|NCT02709746|76078099|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
42252199|NCT02709746|76078095|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
42252200|NCT02709746|76078096|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
42252201|NCT02709746|76078097|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
42252202|NCT02709746|76078098|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
42305895|NCT02188719|76141672|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
42305896|NCT02188719|76141673|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
42305897|NCT02188719|76141674|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
42305898|NCT01934140|76141684|FG000|Persistence Phase (Year 6-10)|Other|24|||
42305899|NCT01934140|76141685|FG001|Persistence Phase (Year 6-10)|Other|6|||
42305900|NCT01934140|76141684|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
42305901|NCT01934140|76141685|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
42305902|NCT01934140|76141684|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
42305903|NCT01934140|76141685|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
42305904|NCT01934140|76141684|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
42305905|NCT01934140|76141685|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
42305906|NCT01934140|76141684|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
42305907|NCT01934140|76141685|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
42305908|NCT01934140|76141684|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
42305909|NCT01934140|76141685|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
41991143|NCT01185340|75799216|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
41991144|NCT01185340|75799217|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
41991145|NCT01185340|75799214|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
42252203|NCT02709746|76078099|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
42252204|NCT02709746|76078095|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
42252205|NCT02709746|76078096|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
42305910|NCT01934140|76141684|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
42305911|NCT01934140|76141685|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
42305912|NCT01934140|76141684|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
42305913|NCT01934140|76141685|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
42305914|NCT01933672|76141693|FG000|Metformin Run-in Period|Adverse Event|1|||
42252206|NCT02709746|76078097|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
42252207|NCT02709746|76078098|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
42252208|NCT02709746|76078099|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
42305915|NCT01933672|76141694|FG001|Metformin Run-in Period|Adverse Event|0|||
42305916|NCT01933672|76141695|FG002|Metformin Run-in Period|Adverse Event|0|||
42305917|NCT01933672|76141696|FG003|Metformin Run-in Period|Adverse Event|0|||
42305918|NCT01933672|76141697|FG004|Metformin Run-in Period|Adverse Event|0|||
42305919|NCT01933672|76141698|FG005|Metformin Run-in Period|Adverse Event|0|||
42305920|NCT01933672|76141699|FG006|Metformin Run-in Period|Adverse Event|0|||
42305921|NCT01933672|76141693|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
42305922|NCT01933672|76141694|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
42305923|NCT01933672|76141695|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
42305924|NCT01933672|76141696|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
42305925|NCT01933672|76141697|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
42305926|NCT01933672|76141698|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
42305927|NCT01933672|76141699|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
42305928|NCT01933672|76141693|FG000|Metformin Run-in Period|Other|5|||
42305929|NCT01933672|76141694|FG001|Metformin Run-in Period|Other|0|||
42305930|NCT01933672|76141695|FG002|Metformin Run-in Period|Other|0|||
42305931|NCT01933672|76141696|FG003|Metformin Run-in Period|Other|0|||
42305932|NCT01933672|76141697|FG004|Metformin Run-in Period|Other|0|||
42305933|NCT01933672|76141698|FG005|Metformin Run-in Period|Other|0|||
42252209|NCT02709746|76078095|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
42252210|NCT02709746|76078096|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
42252211|NCT02709746|76078097|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
42252212|NCT02709746|76078098|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
42252213|NCT02709746|76078099|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
42252214|NCT02709746|76078095|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
42252215|NCT02709746|76078096|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
42252216|NCT02709746|76078097|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
42252217|NCT02709746|76078098|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
42252218|NCT02709746|76078099|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
42252219|NCT02709746|76078095|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
42305934|NCT01933672|76141699|FG006|Metformin Run-in Period|Other|0|||
42305935|NCT01933672|76141693|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
41991146|NCT01185340|75799215|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
42252220|NCT02709746|76078096|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
42252221|NCT02709746|76078097|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
42252222|NCT02709746|76078098|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
42252223|NCT02709746|76078099|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
42252224|NCT02709746|76078095|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
42252225|NCT02709746|76078096|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
42252226|NCT02709746|76078097|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
42252227|NCT02709746|76078098|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
42252228|NCT02709746|76078099|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
42252229|NCT01317641|76078120|FG000|Overall Study|Not treated|0|||
42252230|NCT01317641|76078121|FG001|Overall Study|Not treated|0|||
42252231|NCT01317641|76078122|FG002|Overall Study|Not treated|0|||
42252232|NCT01317641|76078123|FG003|Overall Study|Not treated|0|||
42252233|NCT01317641|76078124|FG004|Overall Study|Not treated|0|||
42252234|NCT01317641|76078125|FG005|Overall Study|Not treated|0|||
42252235|NCT01317641|76078126|FG006|Overall Study|Not treated|0|||
42252236|NCT01317641|76078127|FG007|Overall Study|Not treated|1|||
42252237|NCT01317641|76078128|FG008|Overall Study|Not treated|1|||
42252238|NCT01317641|76078120|FG000|Overall Study|Adverse Event|0|||
42252239|NCT01317641|76078121|FG001|Overall Study|Adverse Event|1|||
42252240|NCT01317641|76078122|FG002|Overall Study|Adverse Event|0|||
42252241|NCT01317641|76078123|FG003|Overall Study|Adverse Event|1|||
42252242|NCT01317641|76078124|FG004|Overall Study|Adverse Event|0|||
42252243|NCT01317641|76078125|FG005|Overall Study|Adverse Event|0|||
42252244|NCT01317641|76078126|FG006|Overall Study|Adverse Event|2|||
42252245|NCT01317641|76078127|FG007|Overall Study|Adverse Event|1|||
42252246|NCT01317641|76078128|FG008|Overall Study|Adverse Event|0|||
42252247|NCT01317641|76078120|FG000|Overall Study|Protocol Violation|1|||
42252248|NCT01317641|76078121|FG001|Overall Study|Protocol Violation|0|||
42252249|NCT01317641|76078122|FG002|Overall Study|Protocol Violation|0|||
42252250|NCT01317641|76078123|FG003|Overall Study|Protocol Violation|0|||
42252251|NCT01317641|76078124|FG004|Overall Study|Protocol Violation|0|||
42252252|NCT01317641|76078125|FG005|Overall Study|Protocol Violation|0|||
42252253|NCT01317641|76078126|FG006|Overall Study|Protocol Violation|0|||
42252254|NCT01317641|76078127|FG007|Overall Study|Protocol Violation|0|||
42252255|NCT01317641|76078128|FG008|Overall Study|Protocol Violation|0|||
42252256|NCT01317641|76078120|FG000|Overall Study|Disease progression|0|||
42252257|NCT01317641|76078121|FG001|Overall Study|Disease progression|0|||
42252258|NCT01317641|76078122|FG002|Overall Study|Disease progression|0|||
42252259|NCT01317641|76078123|FG003|Overall Study|Disease progression|0|||
42252260|NCT01317641|76078124|FG004|Overall Study|Disease progression|0|||
42252261|NCT01317641|76078125|FG005|Overall Study|Disease progression|0|||
42252262|NCT01317641|76078126|FG006|Overall Study|Disease progression|0|||
42252263|NCT01317641|76078127|FG007|Overall Study|Disease progression|3|||
42252264|NCT01317641|76078128|FG008|Overall Study|Disease progression|4|||
42252265|NCT01317641|76078120|FG000|Overall Study|Withdrawal by Subject|0|||
42305936|NCT01933672|76141694|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
42010550|NCT00993421|75817694|FG000|Overall Study|Adverse Event|2|||
42252266|NCT01317641|76078121|FG001|Overall Study|Withdrawal by Subject|0|||
42252267|NCT01317641|76078122|FG002|Overall Study|Withdrawal by Subject|0|||
42252268|NCT01317641|76078123|FG003|Overall Study|Withdrawal by Subject|0|||
42252269|NCT01317641|76078124|FG004|Overall Study|Withdrawal by Subject|0|||
42252270|NCT01317641|76078125|FG005|Overall Study|Withdrawal by Subject|0|||
42252271|NCT01317641|76078126|FG006|Overall Study|Withdrawal by Subject|1|||
42252272|NCT01317641|76078127|FG007|Overall Study|Withdrawal by Subject|0|||
42252273|NCT01317641|76078128|FG008|Overall Study|Withdrawal by Subject|0|||
42305937|NCT01933672|76141695|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
42305938|NCT01933672|76141696|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
42305939|NCT01933672|76141697|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
42305940|NCT01933672|76141698|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
42305941|NCT01933672|76141699|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
42305942|NCT01933672|76141693|FG000|First Intervention Period (12-16 Days)|Other|0|||
42305943|NCT01933672|76141694|FG001|First Intervention Period (12-16 Days)|Other|0|||
42305944|NCT01933672|76141695|FG002|First Intervention Period (12-16 Days)|Other|1|||
42305945|NCT01933672|76141696|FG003|First Intervention Period (12-16 Days)|Other|0|||
42305946|NCT01933672|76141697|FG004|First Intervention Period (12-16 Days)|Other|0|||
42305947|NCT01933672|76141698|FG005|First Intervention Period (12-16 Days)|Other|1|||
42305948|NCT01933672|76141699|FG006|First Intervention Period (12-16 Days)|Other|0|||
42305949|NCT01933672|76141693|FG000|Second Intervention Period (12-16 Days)|Other|0|||
42305950|NCT01933672|76141694|FG001|Second Intervention Period (12-16 Days)|Other|1|||
42305951|NCT01933672|76141695|FG002|Second Intervention Period (12-16 Days)|Other|1|||
42305952|NCT01933672|76141696|FG003|Second Intervention Period (12-16 Days)|Other|0|||
42305953|NCT01933672|76141697|FG004|Second Intervention Period (12-16 Days)|Other|0|||
42305954|NCT01933672|76141698|FG005|Second Intervention Period (12-16 Days)|Other|0|||
42305955|NCT01933672|76141699|FG006|Second Intervention Period (12-16 Days)|Other|0|||
42305956|NCT01933672|76141693|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
42305957|NCT01933672|76141694|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
42305958|NCT01933672|76141695|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
42305959|NCT01933672|76141696|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
42305960|NCT01933672|76141697|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
42305961|NCT01933672|76141698|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
42305962|NCT01933672|76141699|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
42305963|NCT01933672|76141693|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
42305964|NCT01933672|76141694|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
42305965|NCT01933672|76141695|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
42305966|NCT01933672|76141696|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
42305967|NCT01933672|76141697|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
42305968|NCT01933672|76141698|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
42305969|NCT01933672|76141699|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
42305970|NCT02164539|76141718|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
42305971|NCT02164539|76141719|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
42305972|NCT02164539|76141720|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
42305973|NCT02164539|76141721|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
42305974|NCT02164539|76141722|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
42305975|NCT02164539|76141723|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
42305976|NCT02164539|76141724|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
42305977|NCT02164539|76141718|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
42305978|NCT02164539|76141719|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
42305979|NCT02164539|76141720|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
41991147|NCT01185340|75799216|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
41991148|NCT01185340|75799217|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
41991149|NCT01185340|75799214|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
41991150|NCT01185340|75799215|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
41991151|NCT01185340|75799216|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
41991152|NCT01185340|75799217|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
41991153|NCT01185340|75799214|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
41991154|NCT01185340|75799215|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
41991155|NCT01185340|75799216|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
41991156|NCT01185340|75799217|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
41991157|NCT01185340|75799214|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
41991158|NCT01185340|75799215|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
41991159|NCT01185340|75799216|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
41991160|NCT01185340|75799217|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
41991161|NCT01185340|75799214|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
41991162|NCT01185340|75799215|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
41991163|NCT01185340|75799216|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
42305980|NCT02164539|76141721|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
42305981|NCT02164539|76141722|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
42305982|NCT02164539|76141723|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
42305983|NCT02164539|76141724|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
42305984|NCT02164539|76141718|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
42305985|NCT02164539|76141719|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
42305986|NCT02164539|76141720|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
42305987|NCT02164539|76141721|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
42305988|NCT02164539|76141722|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
42305989|NCT02164539|76141723|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
41991164|NCT01185340|75799217|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
41991165|NCT01216189|75799231|FG000|Overall Study|Lost to Follow-up|21|||
41991166|NCT01216189|75799232|FG001|Overall Study|Lost to Follow-up|3|||
42305990|NCT02164539|76141724|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
41991167|NCT01216189|75799231|FG000|Overall Study|Death|4|||
42305991|NCT02164539|76141718|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
42305992|NCT02164539|76141719|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
42305993|NCT02164539|76141720|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
42305994|NCT02164539|76141721|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
42305995|NCT02164539|76141722|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
42305996|NCT02164539|76141723|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
42305997|NCT02164539|76141724|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
42305998|NCT02164539|76141718|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
42305999|NCT02164539|76141719|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
42306000|NCT02164539|76141720|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
42306001|NCT02164539|76141721|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
42306002|NCT02164539|76141722|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
42306003|NCT02164539|76141723|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
42306004|NCT02164539|76141724|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
42306005|NCT02164539|76141718|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
42306006|NCT02164539|76141719|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
42306007|NCT02164539|76141720|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
42306008|NCT02164539|76141721|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
42306009|NCT02164539|76141722|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
42306010|NCT02164539|76141723|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
42306011|NCT02164539|76141724|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
42306012|NCT02188485|76141741|FG000|Overall Study|Withdrawal by Subject|2|||
42306013|NCT02188485|76141742|FG001|Overall Study|Withdrawal by Subject|1|||
42306014|NCT02188485|76141741|FG000|Overall Study|PI withdrew, lack of capacity|0|||
42306015|NCT02188485|76141742|FG001|Overall Study|PI withdrew, lack of capacity|2|||
42306016|NCT02132247|76141750|FG000|Overall Study|Protocol Violation|1|||
42306017|NCT02132247|76141751|FG001|Overall Study|Protocol Violation|0|||
42306018|NCT01629381|76141759|FG000|Overall Study|Withdrawal by Subject|2|||
42306019|NCT01629381|76141760|FG001|Overall Study|Withdrawal by Subject|5|||
42306020|NCT02131311|76141770|FG000|Overall Study|Adverse Event|2|||
42306021|NCT02131311|76141770|FG000|Overall Study|Protocol Violation|1|||
42306022|NCT02131311|76141770|FG000|Overall Study|Lost to Follow-up|1|||
42306023|NCT01628913|76141777|FG000|Overall Study|Adverse Event|12|||
42306024|NCT01628913|76141778|FG001|Overall Study|Adverse Event|5|||
42306025|NCT01628913|76141777|FG000|Overall Study|Disease Progression|11|||
42306026|NCT01628913|76141778|FG001|Overall Study|Disease Progression|14|||
42306027|NCT01628913|76141777|FG000|Overall Study|Protocol Violation|1|||
42306028|NCT01628913|76141778|FG001|Overall Study|Protocol Violation|0|||
42306029|NCT01628913|76141777|FG000|Overall Study|Death|1|||
42306030|NCT01628913|76141778|FG001|Overall Study|Death|0|||
42306031|NCT01628913|76141777|FG000|Overall Study|study terminated by Sponsor|4|||
42306032|NCT01628913|76141778|FG001|Overall Study|study terminated by Sponsor|9|||
42306033|NCT01628913|76141777|FG000|Overall Study|Withdrawal by Subject|1|||
42306034|NCT01628913|76141778|FG001|Overall Study|Withdrawal by Subject|0|||
41991168|NCT01216189|75799232|FG001|Overall Study|Death|2|||
42306035|NCT01628913|76141777|FG000|Overall Study|Physician Decision|1|||
42306036|NCT01628913|76141778|FG001|Overall Study|Physician Decision|3|||
42306037|NCT02164383|76141786|FG000|Overall Study|Lost to Follow-up|1|||
42306038|NCT02164383|76141787|FG001|Overall Study|Lost to Follow-up|0|||
42306039|NCT02131233|76141795|FG000|Overall Study|Not Treated|2|||
42306040|NCT02131233|76141796|FG001|Overall Study|Not Treated|3|||
42306041|NCT02131233|76141795|FG000|Overall Study|Adverse Event|7|||
42306042|NCT02131233|76141796|FG001|Overall Study|Adverse Event|6|||
42306043|NCT02131233|76141795|FG000|Overall Study|Death|0|||
42306044|NCT02131233|76141796|FG001|Overall Study|Death|1|||
42306045|NCT02131233|76141795|FG000|Overall Study|Lack of Efficacy|6|||
42252274|NCT03186794|76078164|FG000|Overall Study|Physician Decision|2|||
42252275|NCT03186794|76078164|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
42306046|NCT02131233|76141796|FG001|Overall Study|Lack of Efficacy|3|||
42306047|NCT02131233|76141795|FG000|Overall Study|Lost to Follow-up|14|||
42306048|NCT02131233|76141796|FG001|Overall Study|Lost to Follow-up|13|||
42306049|NCT02131233|76141795|FG000|Overall Study|Non-Compliance With Study Drug|8|||
42033136|NCT01132313|75841316|FG007|Overall Study|Not treated|0|||
42252276|NCT02290431|76078169|FG000|Overall Study|Adverse Event|20|||
42252277|NCT02290431|76078169|FG000|Overall Study|Progressive disease|4|||
42252278|NCT02290431|76078169|FG000|Overall Study|Study terminated by Sponsor|1|||
42252279|NCT02290431|76078169|FG000|Overall Study|Physician Decision|2|||
42252280|NCT02707952|76078177|FG000|Overall Study|Adverse Event|1|||
42252281|NCT02707952|76078178|FG001|Overall Study|Adverse Event|0|||
42252282|NCT02707952|76078179|FG002|Overall Study|Adverse Event|0|||
42033137|NCT01132313|75841317|FG008|Overall Study|Not treated|0|||
42033138|NCT01132313|75841318|FG009|Overall Study|Not treated|0|||
42033139|NCT01132313|75841319|FG010|Overall Study|Not treated|0|||
42033140|NCT01132313|75841320|FG011|Overall Study|Not treated|0|||
42033141|NCT01132313|75841309|FG000|Overall Study|Adverse Event|0|||
42033142|NCT01132313|75841310|FG001|Overall Study|Adverse Event|0|||
42033143|NCT01132313|75841311|FG002|Overall Study|Adverse Event|4|||
42033144|NCT01132313|75841312|FG003|Overall Study|Adverse Event|10|||
42033145|NCT01132313|75841313|FG004|Overall Study|Adverse Event|19|||
42033146|NCT01132313|75841314|FG005|Overall Study|Adverse Event|6|||
42033147|NCT01132313|75841315|FG006|Overall Study|Adverse Event|5|||
42033148|NCT01132313|75841316|FG007|Overall Study|Adverse Event|3|||
42033149|NCT01132313|75841317|FG008|Overall Study|Adverse Event|7|||
42033150|NCT01132313|75841318|FG009|Overall Study|Adverse Event|2|||
42033151|NCT01132313|75841319|FG010|Overall Study|Adverse Event|0|||
42033152|NCT01132313|75841320|FG011|Overall Study|Adverse Event|0|||
42033153|NCT01132313|75841309|FG000|Overall Study|Protocol Violation|0|||
42033154|NCT01132313|75841310|FG001|Overall Study|Protocol Violation|0|||
42033155|NCT01132313|75841311|FG002|Overall Study|Protocol Violation|0|||
42033156|NCT01132313|75841312|FG003|Overall Study|Protocol Violation|1|||
42252283|NCT02707952|76078180|FG003|Overall Study|Adverse Event|0|||
42252284|NCT02707952|76078177|FG000|Overall Study|Lost to Follow-up|1|||
42252285|NCT02707952|76078178|FG001|Overall Study|Lost to Follow-up|0|||
42252286|NCT02707952|76078179|FG002|Overall Study|Lost to Follow-up|0|||
42252287|NCT02707952|76078180|FG003|Overall Study|Lost to Follow-up|0|||
42252288|NCT02707952|76078177|FG000|Overall Study|Withdrawal by Subject|0|||
42252289|NCT02707952|76078178|FG001|Overall Study|Withdrawal by Subject|1|||
42252290|NCT02707952|76078179|FG002|Overall Study|Withdrawal by Subject|2|||
42252291|NCT02707952|76078180|FG003|Overall Study|Withdrawal by Subject|0|||
42252292|NCT03050801|76078198|FG000|Experiment 1|Lost to Follow-up|0|||
42252293|NCT03050801|76078199|FG001|Experiment 1|Lost to Follow-up|1|||
42252294|NCT03050801|76078200|FG002|Experiment 1|Lost to Follow-up|0|||
42252295|NCT03050801|76078201|FG003|Experiment 1|Lost to Follow-up|0|||
42252296|NCT03050801|76078202|FG004|Experiment 1|Lost to Follow-up|0|||
42252297|NCT03050801|76078203|FG005|Experiment 1|Lost to Follow-up|0|||
42252298|NCT03050801|76078198|FG000|Experiment 1|Physician Decision|0|||
42252299|NCT03050801|76078199|FG001|Experiment 1|Physician Decision|3|||
42252300|NCT03050801|76078200|FG002|Experiment 1|Physician Decision|0|||
42252301|NCT03050801|76078201|FG003|Experiment 1|Physician Decision|0|||
42306050|NCT02131233|76141796|FG001|Overall Study|Non-Compliance With Study Drug|5|||
42033157|NCT01132313|75841313|FG004|Overall Study|Protocol Violation|0|||
42033158|NCT01132313|75841314|FG005|Overall Study|Protocol Violation|0|||
42033159|NCT01132313|75841315|FG006|Overall Study|Protocol Violation|0|||
42033160|NCT01132313|75841316|FG007|Overall Study|Protocol Violation|0|||
42033161|NCT01132313|75841317|FG008|Overall Study|Protocol Violation|0|||
42033162|NCT01132313|75841318|FG009|Overall Study|Protocol Violation|0|||
42033163|NCT01132313|75841319|FG010|Overall Study|Protocol Violation|0|||
42252302|NCT03050801|76078202|FG004|Experiment 1|Physician Decision|0|||
42033164|NCT01132313|75841320|FG011|Overall Study|Protocol Violation|0|||
42033165|NCT01132313|75841309|FG000|Overall Study|Lost to Follow-up|0|||
42252303|NCT03050801|76078203|FG005|Experiment 1|Physician Decision|0|||
42306051|NCT02131233|76141795|FG000|Overall Study|Physician Decision|7|||
42033166|NCT01132313|75841310|FG001|Overall Study|Lost to Follow-up|0|||
42252304|NCT03050801|76078198|FG000|Experiment 1|Change of experimental design|0|||
42252305|NCT03050801|76078199|FG001|Experiment 1|Change of experimental design|3|||
42252306|NCT03050801|76078200|FG002|Experiment 1|Change of experimental design|0|||
42252307|NCT03050801|76078201|FG003|Experiment 1|Change of experimental design|0|||
42252308|NCT03050801|76078202|FG004|Experiment 1|Change of experimental design|0|||
42252309|NCT03050801|76078203|FG005|Experiment 1|Change of experimental design|0|||
42306052|NCT02131233|76141796|FG001|Overall Study|Physician Decision|0|||
42306053|NCT02131233|76141795|FG000|Overall Study|Pregnancy|4|||
42306054|NCT02131233|76141796|FG001|Overall Study|Pregnancy|0|||
42306055|NCT02131233|76141795|FG000|Overall Study|Withdrawal by Subject|18|||
42306056|NCT02131233|76141796|FG001|Overall Study|Withdrawal by Subject|11|||
42306057|NCT02131155|76141804|FG000|Overall Study|Adverse Event|1|||
41991169|NCT01185301|75799242|FG000|Overall Study|Adverse Event|3|||
42033167|NCT01132313|75841311|FG002|Overall Study|Lost to Follow-up|1|||
42033168|NCT01132313|75841312|FG003|Overall Study|Lost to Follow-up|0|||
42033169|NCT01132313|75841313|FG004|Overall Study|Lost to Follow-up|0|||
42033170|NCT01132313|75841314|FG005|Overall Study|Lost to Follow-up|0|||
42033171|NCT01132313|75841315|FG006|Overall Study|Lost to Follow-up|0|||
42033172|NCT01132313|75841316|FG007|Overall Study|Lost to Follow-up|1|||
42033173|NCT01132313|75841317|FG008|Overall Study|Lost to Follow-up|0|||
42033174|NCT01132313|75841318|FG009|Overall Study|Lost to Follow-up|0|||
42033175|NCT01132313|75841319|FG010|Overall Study|Lost to Follow-up|0|||
42033176|NCT01132313|75841320|FG011|Overall Study|Lost to Follow-up|0|||
42033177|NCT01132313|75841309|FG000|Overall Study|Withdrawal by Subject|0|||
42033178|NCT01132313|75841310|FG001|Overall Study|Withdrawal by Subject|0|||
42033179|NCT01132313|75841311|FG002|Overall Study|Withdrawal by Subject|3|||
42033180|NCT01132313|75841312|FG003|Overall Study|Withdrawal by Subject|3|||
42252310|NCT03050801|76078198|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
42252311|NCT03050801|76078199|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
42252312|NCT03050801|76078200|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
42252313|NCT03050801|76078201|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
42252314|NCT03050801|76078202|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
42252315|NCT03050801|76078203|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
42252316|NCT03050801|76078198|FG000|Experiment 2|Lost to Follow-up|0|||
42252317|NCT03050801|76078199|FG001|Experiment 2|Lost to Follow-up|0|||
42252318|NCT03050801|76078200|FG002|Experiment 2|Lost to Follow-up|0|||
42252319|NCT03050801|76078201|FG003|Experiment 2|Lost to Follow-up|1|||
42252320|NCT03050801|76078202|FG004|Experiment 2|Lost to Follow-up|1|||
42252321|NCT03050801|76078203|FG005|Experiment 2|Lost to Follow-up|0|||
42252322|NCT03050801|76078198|FG000|Experiment 2|Physician Decision|0|||
42252323|NCT03050801|76078199|FG001|Experiment 2|Physician Decision|0|||
42252324|NCT03050801|76078200|FG002|Experiment 2|Physician Decision|0|||
42252325|NCT03050801|76078201|FG003|Experiment 2|Physician Decision|0|||
42252326|NCT03050801|76078202|FG004|Experiment 2|Physician Decision|1|||
42252327|NCT03050801|76078203|FG005|Experiment 2|Physician Decision|0|||
42252328|NCT03050801|76078198|FG000|Experiment 2|Pregnancy|0|||
42252329|NCT03050801|76078199|FG001|Experiment 2|Pregnancy|0|||
42252330|NCT03050801|76078200|FG002|Experiment 2|Pregnancy|0|||
42252331|NCT03050801|76078201|FG003|Experiment 2|Pregnancy|0|||
42252332|NCT03050801|76078202|FG004|Experiment 2|Pregnancy|1|||
42252333|NCT03050801|76078203|FG005|Experiment 2|Pregnancy|0|||
42252334|NCT03050801|76078198|FG000|Experiment 2|Withdrawal by Subject|0|||
42252335|NCT03050801|76078199|FG001|Experiment 2|Withdrawal by Subject|0|||
42252336|NCT03050801|76078200|FG002|Experiment 2|Withdrawal by Subject|0|||
42252337|NCT03050801|76078201|FG003|Experiment 2|Withdrawal by Subject|1|||
41991170|NCT01185301|75799243|FG001|Overall Study|Adverse Event|0|||
41991171|NCT01185301|75799244|FG002|Overall Study|Adverse Event|2|||
41991172|NCT01185301|75799245|FG003|Overall Study|Adverse Event|3|||
41991173|NCT01185301|75799242|FG000|Overall Study|Withdrawal by Subject|7|||
41991174|NCT01185301|75799243|FG001|Overall Study|Withdrawal by Subject|5|||
41991175|NCT01185301|75799244|FG002|Overall Study|Withdrawal by Subject|2|||
41991176|NCT01185301|75799245|FG003|Overall Study|Withdrawal by Subject|3|||
41991177|NCT01185301|75799242|FG000|Overall Study|Lost to Follow-up|2|||
41991178|NCT01185301|75799243|FG001|Overall Study|Lost to Follow-up|0|||
41991179|NCT01185301|75799244|FG002|Overall Study|Lost to Follow-up|0|||
42033181|NCT01132313|75841313|FG004|Overall Study|Withdrawal by Subject|6|||
42033182|NCT01132313|75841314|FG005|Overall Study|Withdrawal by Subject|0|||
42252338|NCT03050801|76078202|FG004|Experiment 2|Withdrawal by Subject|0|||
42252339|NCT03050801|76078203|FG005|Experiment 2|Withdrawal by Subject|0|||
42252340|NCT03050801|76078198|FG000|Experiment 2|Poor data quality|0|||
41991180|NCT01185301|75799245|FG003|Overall Study|Lost to Follow-up|1|||
41991181|NCT01185301|75799242|FG000|Overall Study|Other Reason|3|||
41991182|NCT01185301|75799243|FG001|Overall Study|Other Reason|2|||
42252341|NCT03050801|76078199|FG001|Experiment 2|Poor data quality|0|||
42252342|NCT03050801|76078200|FG002|Experiment 2|Poor data quality|0|||
42252343|NCT03050801|76078201|FG003|Experiment 2|Poor data quality|4|||
42252344|NCT03050801|76078202|FG004|Experiment 2|Poor data quality|1|||
42252345|NCT03050801|76078203|FG005|Experiment 2|Poor data quality|0|||
42252346|NCT03050801|76078198|FG000|Experiment 2|Discomfort during stimulation|0|||
42306058|NCT02131155|76141805|FG001|Overall Study|Adverse Event|0|||
42033183|NCT01132313|75841315|FG006|Overall Study|Withdrawal by Subject|1|||
42033184|NCT01132313|75841316|FG007|Overall Study|Withdrawal by Subject|0|||
42033185|NCT01132313|75841317|FG008|Overall Study|Withdrawal by Subject|0|||
42033186|NCT01132313|75841318|FG009|Overall Study|Withdrawal by Subject|2|||
42033187|NCT01132313|75841319|FG010|Overall Study|Withdrawal by Subject|0|||
42033188|NCT01132313|75841320|FG011|Overall Study|Withdrawal by Subject|0|||
42252347|NCT03050801|76078199|FG001|Experiment 2|Discomfort during stimulation|0|||
42252348|NCT03050801|76078200|FG002|Experiment 2|Discomfort during stimulation|0|||
42252349|NCT03050801|76078201|FG003|Experiment 2|Discomfort during stimulation|0|||
42252350|NCT03050801|76078202|FG004|Experiment 2|Discomfort during stimulation|0|||
42252351|NCT03050801|76078203|FG005|Experiment 2|Discomfort during stimulation|2|||
42252352|NCT02707640|76078222|FG000|Overall Study|Adverse Event|4|||
42252353|NCT02707640|76078223|FG001|Overall Study|Adverse Event|2|||
42252354|NCT02707640|76078222|FG000|Overall Study|Death|1|||
42252355|NCT02707640|76078223|FG001|Overall Study|Death|2|||
42252356|NCT02707640|76078222|FG000|Overall Study|Physician Decision|2|||
42252357|NCT02707640|76078223|FG001|Overall Study|Physician Decision|0|||
42252358|NCT02707640|76078222|FG000|Overall Study|Withdrawal by Subject|0|||
42252359|NCT02707640|76078223|FG001|Overall Study|Withdrawal by Subject|1|||
42252360|NCT02707640|76078222|FG000|Overall Study|Participant's Personal Decision|1|||
42252361|NCT02707640|76078223|FG001|Overall Study|Participant's Personal Decision|2|||
42252362|NCT02707640|76078222|FG000|Overall Study|Sponsor Discretion|1|||
42252363|NCT02707640|76078223|FG001|Overall Study|Sponsor Discretion|0|||
42252364|NCT02708966|76078231|FG000|Overall Study|Lost to Follow-up|2|||
42252365|NCT02708966|76078232|FG001|Overall Study|Lost to Follow-up|2|||
42252366|NCT02706938|76078240|FG000|First Period, 6 Weeks|Adverse Event|8|||
41991183|NCT01185301|75799244|FG002|Overall Study|Other Reason|2|||
41991184|NCT01185301|75799245|FG003|Overall Study|Other Reason|2|||
41991185|NCT01216072|75799257|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
41991186|NCT01216072|75799258|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
41991187|NCT01216072|75799257|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
42252367|NCT02706938|76078241|FG001|First Period, 6 Weeks|Adverse Event|0|||
42252368|NCT02706938|76078240|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
42252369|NCT02706938|76078241|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
42252370|NCT02706938|76078240|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
42252371|NCT02706938|76078241|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
42252372|NCT02706938|76078240|FG000|Second Period, 6 Weeks|Adverse Event|0|||
42252373|NCT02706938|76078241|FG001|Second Period, 6 Weeks|Adverse Event|7|||
42252374|NCT02706938|76078240|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
42252375|NCT02706938|76078241|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
42252376|NCT03053063|76078251|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
42252377|NCT03053063|76078252|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
42252378|NCT03053063|76078253|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
42252379|NCT03053063|76078254|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
42252380|NCT03053063|76078251|FG000|Randomized Phase|Withdrew consent|8|||
41991188|NCT01216072|75799258|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
41991189|NCT01216072|75799257|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
41991190|NCT01216072|75799258|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
41991191|NCT01216072|75799257|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
41991192|NCT01216072|75799258|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
42010551|NCT00993421|75817695|FG001|Overall Study|Adverse Event|7|||
42252381|NCT03053063|76078252|FG001|Randomized Phase|Withdrew consent|11|||
42252382|NCT03053063|76078253|FG002|Randomized Phase|Withdrew consent|5|||
42252383|NCT03053063|76078254|FG003|Randomized Phase|Withdrew consent|0|||
42252384|NCT03053063|76078251|FG000|Randomized Phase|Investigator's Discretion|8|||
42252385|NCT03053063|76078252|FG001|Randomized Phase|Investigator's Discretion|6|||
42252386|NCT03053063|76078253|FG002|Randomized Phase|Investigator's Discretion|2|||
42252387|NCT03053063|76078254|FG003|Randomized Phase|Investigator's Discretion|0|||
42033189|NCT01132313|75841309|FG000|Overall Study|Lack of antiviral response|0|||
42033190|NCT01132313|75841310|FG001|Overall Study|Lack of antiviral response|0|||
42033191|NCT01132313|75841311|FG002|Overall Study|Lack of antiviral response|12|||
42252388|NCT03053063|76078251|FG000|Randomized Phase|Lost to Follow-up|3|||
42252389|NCT03053063|76078252|FG001|Randomized Phase|Lost to Follow-up|5|||
42252390|NCT03053063|76078253|FG002|Randomized Phase|Lost to Follow-up|1|||
42252391|NCT03053063|76078254|FG003|Randomized Phase|Lost to Follow-up|0|||
42252392|NCT03053063|76078251|FG000|Randomized Phase|Adverse Event|0|||
42252393|NCT03053063|76078252|FG001|Randomized Phase|Adverse Event|1|||
42252394|NCT03053063|76078253|FG002|Randomized Phase|Adverse Event|0|||
42252395|NCT03053063|76078254|FG003|Randomized Phase|Adverse Event|0|||
42306059|NCT02131155|76141804|FG000|Overall Study|Treatment completed|1|||
42306060|NCT02131155|76141805|FG001|Overall Study|Treatment completed|0|||
42033192|NCT01132313|75841312|FG003|Overall Study|Lack of antiviral response|18|||
42033193|NCT01132313|75841313|FG004|Overall Study|Lack of antiviral response|18|||
42033194|NCT01132313|75841314|FG005|Overall Study|Lack of antiviral response|18|||
42033195|NCT01132313|75841315|FG006|Overall Study|Lack of antiviral response|21|||
42033196|NCT01132313|75841316|FG007|Overall Study|Lack of antiviral response|0|||
42033197|NCT01132313|75841317|FG008|Overall Study|Lack of antiviral response|0|||
42033198|NCT01132313|75841318|FG009|Overall Study|Lack of antiviral response|0|||
42033199|NCT01132313|75841319|FG010|Overall Study|Lack of antiviral response|1|||
42306061|NCT02131155|76141804|FG000|Overall Study|Primary tumour recurrence|2|||
42033200|NCT01132313|75841320|FG011|Overall Study|Lack of antiviral response|0|||
42033201|NCT01132313|75841309|FG000|Overall Study|Other reason not defined above|0|||
42033202|NCT01132313|75841310|FG001|Overall Study|Other reason not defined above|0|||
42033203|NCT01132313|75841311|FG002|Overall Study|Other reason not defined above|0|||
42033204|NCT01132313|75841312|FG003|Overall Study|Other reason not defined above|0|||
42033205|NCT01132313|75841313|FG004|Overall Study|Other reason not defined above|0|||
42033206|NCT01132313|75841314|FG005|Overall Study|Other reason not defined above|0|||
42033207|NCT01132313|75841315|FG006|Overall Study|Other reason not defined above|0|||
42033208|NCT01132313|75841316|FG007|Overall Study|Other reason not defined above|1|||
42033209|NCT01132313|75841317|FG008|Overall Study|Other reason not defined above|0|||
42033210|NCT01132313|75841318|FG009|Overall Study|Other reason not defined above|0|||
42033211|NCT01132313|75841319|FG010|Overall Study|Other reason not defined above|0|||
42033212|NCT01132313|75841320|FG011|Overall Study|Other reason not defined above|0|||
42033213|NCT00861757|75841355|FG000|Overall Study|Adverse Event|1|||
42033214|NCT00861757|75841356|FG001|Overall Study|Adverse Event|5|||
42033215|NCT00861757|75841357|FG002|Overall Study|Adverse Event|7|||
42033216|NCT00861757|75841358|FG003|Overall Study|Adverse Event|2|||
42033217|NCT00861757|75841355|FG000|Overall Study|Entry Criteria Not Met|1|||
42252396|NCT03053063|76078251|FG000|Randomized Phase|Randomized but Never Treated|1|||
42306062|NCT02131155|76141805|FG001|Overall Study|Primary tumour recurrence|1|||
42306063|NCT02131155|76141804|FG000|Overall Study|Refused to continue study medication|1|||
42306064|NCT02131155|76141805|FG001|Overall Study|Refused to continue study medication|0|||
42306065|NCT02131155|76141804|FG000|Overall Study|Study early termination|20|||
42306066|NCT02131155|76141805|FG001|Overall Study|Study early termination|10|||
42306067|NCT01933594|76141817|FG000|Overall Study|Lost to Follow-up|1|||
42306068|NCT01933594|76141818|FG001|Overall Study|Lost to Follow-up|0|||
42306069|NCT01933594|76141819|FG002|Overall Study|Lost to Follow-up|0|||
42306070|NCT01933594|76141820|FG003|Overall Study|Lost to Follow-up|0|||
42306071|NCT01933594|76141821|FG004|Overall Study|Lost to Follow-up|1|||
42306072|NCT01933594|76141822|FG005|Overall Study|Lost to Follow-up|0|||
42306073|NCT01933594|76141817|FG000|Overall Study|Ineligible for subsequent study step|0|||
42306074|NCT01933594|76141818|FG001|Overall Study|Ineligible for subsequent study step|0|||
41991193|NCT01216072|75799257|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
41991194|NCT01216072|75799258|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
41991195|NCT01216072|75799257|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
41991196|NCT01216072|75799258|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
41991197|NCT01216072|75799257|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
41991198|NCT01216072|75799258|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
41991199|NCT01216072|75799257|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
41991200|NCT01216072|75799258|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
41991201|NCT01216072|75799257|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
42252397|NCT03053063|76078252|FG001|Randomized Phase|Randomized but Never Treated|3|||
42252398|NCT03053063|76078253|FG002|Randomized Phase|Randomized but Never Treated|2|||
42252399|NCT03053063|76078254|FG003|Randomized Phase|Randomized but Never Treated|0|||
42252400|NCT03053063|76078251|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
42252401|NCT03053063|76078252|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
42252402|NCT03053063|76078253|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
42252403|NCT03053063|76078254|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
42306075|NCT01933594|76141819|FG002|Overall Study|Ineligible for subsequent study step|0|||
42306076|NCT01933594|76141820|FG003|Overall Study|Ineligible for subsequent study step|0|||
42033218|NCT00861757|75841356|FG001|Overall Study|Entry Criteria Not Met|2|||
42033219|NCT00861757|75841357|FG002|Overall Study|Entry Criteria Not Met|1|||
42033220|NCT00861757|75841358|FG003|Overall Study|Entry Criteria Not Met|1|||
42252404|NCT03053063|76078251|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
42252405|NCT03053063|76078252|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
42306077|NCT01933594|76141821|FG004|Overall Study|Ineligible for subsequent study step|1|||
42306078|NCT01933594|76141822|FG005|Overall Study|Ineligible for subsequent study step|0|||
42306079|NCT01932970|76141840|FG000|Overall Study|Withdrawal by Subject|5|||
42306080|NCT01932970|76141840|FG000|Overall Study|Death|1|||
42306081|NCT01932970|76141840|FG000|Overall Study|Lost to Follow-up|2|||
42306082|NCT01932970|76141840|FG000|Overall Study|Protocol Specified Criteria|10|||
42306083|NCT01912768|76141846|FG000|Overall Study|Adverse Event|2|||
42252406|NCT03053063|76078253|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
42252407|NCT03053063|76078254|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
42252408|NCT03053063|76078251|FG000|Open-Label Phase|Death|0|||
42252409|NCT03053063|76078252|FG001|Open-Label Phase|Death|0|||
42252410|NCT03053063|76078253|FG002|Open-Label Phase|Death|0|||
42252411|NCT03053063|76078254|FG003|Open-Label Phase|Death|2|||
42252412|NCT03053063|76078251|FG000|Open-Label Phase|Investigator's discretion|0|||
42306084|NCT01912768|76141847|FG001|Overall Study|Adverse Event|0|||
42306085|NCT01912768|76141846|FG000|Overall Study|Lost to Follow-up|2|||
42306086|NCT01912768|76141847|FG001|Overall Study|Lost to Follow-up|1|||
42306087|NCT01912768|76141846|FG000|Overall Study|Withdrawal by Subject|5|||
42306088|NCT01912768|76141847|FG001|Overall Study|Withdrawal by Subject|3|||
42306089|NCT01912768|76141846|FG000|Overall Study|Randomized in error|1|||
42306090|NCT01912768|76141847|FG001|Overall Study|Randomized in error|0|||
42306091|NCT02305849|76141857|FG000|Overall Study|Adverse Event|10|||
42306092|NCT02305849|76141858|FG001|Overall Study|Adverse Event|12|||
42306093|NCT02305849|76141859|FG002|Overall Study|Adverse Event|7|||
42306094|NCT02305849|76141860|FG003|Overall Study|Adverse Event|3|||
42252413|NCT03053063|76078252|FG001|Open-Label Phase|Investigator's discretion|0|||
42252414|NCT03053063|76078253|FG002|Open-Label Phase|Investigator's discretion|0|||
42252415|NCT03053063|76078254|FG003|Open-Label Phase|Investigator's discretion|2|||
42252416|NCT01316939|76078276|FG000|Overall Study|Study closed/terminated|26|||
42252417|NCT01316939|76078277|FG001|Overall Study|Study closed/terminated|25|||
42306095|NCT02305849|76141857|FG000|Overall Study|Lack of Efficacy|10|||
42132844|NCT03849300|75943705|FG002|Overall Study|scheduling/transportation conflict|3|||
42252418|NCT01316939|76078278|FG002|Overall Study|Study closed/terminated|23|||
42306096|NCT02305849|76141858|FG001|Overall Study|Lack of Efficacy|6|||
42306097|NCT02305849|76141859|FG002|Overall Study|Lack of Efficacy|3|||
42306098|NCT02305849|76141860|FG003|Overall Study|Lack of Efficacy|9|||
42252419|NCT01316939|76078276|FG000|Overall Study|Lack of Efficacy|24|||
42306099|NCT02305849|76141857|FG000|Overall Study|Withdrawal by Subject|2|||
42306100|NCT02305849|76141858|FG001|Overall Study|Withdrawal by Subject|2|||
42306101|NCT02305849|76141859|FG002|Overall Study|Withdrawal by Subject|1|||
42306102|NCT02305849|76141860|FG003|Overall Study|Withdrawal by Subject|4|||
41991202|NCT01216072|75799258|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
42306103|NCT02305849|76141857|FG000|Overall Study|Lost to Follow-up|0|||
42306104|NCT02305849|76141858|FG001|Overall Study|Lost to Follow-up|2|||
42306105|NCT02305849|76141859|FG002|Overall Study|Lost to Follow-up|0|||
42306106|NCT02305849|76141860|FG003|Overall Study|Lost to Follow-up|0|||
42306107|NCT02305849|76141857|FG000|Overall Study|Protocol Violation|3|||
42306108|NCT02305849|76141858|FG001|Overall Study|Protocol Violation|2|||
42306109|NCT02305849|76141859|FG002|Overall Study|Protocol Violation|1|||
42306110|NCT02305849|76141860|FG003|Overall Study|Protocol Violation|1|||
42306111|NCT02305849|76141857|FG000|Overall Study|Lab data met discontinuation criteria|0|||
42306112|NCT02305849|76141858|FG001|Overall Study|Lab data met discontinuation criteria|1|||
42306113|NCT02305849|76141859|FG002|Overall Study|Lab data met discontinuation criteria|2|||
42306114|NCT02305849|76141860|FG003|Overall Study|Lab data met discontinuation criteria|1|||
42306115|NCT02305849|76141857|FG000|Overall Study|Miscellaneous|1|||
42306116|NCT02305849|76141858|FG001|Overall Study|Miscellaneous|2|||
42306117|NCT02305849|76141859|FG002|Overall Study|Miscellaneous|4|||
42306118|NCT02305849|76141860|FG003|Overall Study|Miscellaneous|1|||
42306119|NCT02305849|76141857|FG000|Overall Study|Not fulfill eligibility criteria|1|||
42306120|NCT02305849|76141858|FG001|Overall Study|Not fulfill eligibility criteria|1|||
42306121|NCT02305849|76141859|FG002|Overall Study|Not fulfill eligibility criteria|0|||
42306122|NCT02305849|76141860|FG003|Overall Study|Not fulfill eligibility criteria|0|||
42306123|NCT02371759|76141899|FG000|Overall Study|Protocol Violation|3|||
42306124|NCT02371759|76141900|FG001|Overall Study|Protocol Violation|1|||
42306125|NCT02371759|76141901|FG002|Overall Study|Protocol Violation|1|||
41991203|NCT01216072|75799257|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
41991204|NCT01216072|75799258|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
42252420|NCT01316939|76078277|FG001|Overall Study|Lack of Efficacy|25|||
42252421|NCT01316939|76078278|FG002|Overall Study|Lack of Efficacy|25|||
42252422|NCT01316939|76078276|FG000|Overall Study|Adverse Event|9|||
42306126|NCT02371759|76141902|FG003|Overall Study|Protocol Violation|0|||
42306127|NCT02371759|76141903|FG004|Overall Study|Protocol Violation|3|||
42306128|NCT02371759|76141904|FG005|Overall Study|Protocol Violation|1|||
42306129|NCT02371759|76141905|FG006|Overall Study|Protocol Violation|0|||
42306130|NCT02371759|76141906|FG007|Overall Study|Protocol Violation|3|||
42306131|NCT02371759|76141899|FG000|Overall Study|Withdrawal by Subject|0|||
42306132|NCT02371759|76141900|FG001|Overall Study|Withdrawal by Subject|0|||
42306133|NCT02371759|76141901|FG002|Overall Study|Withdrawal by Subject|0|||
41991205|NCT01184989|75799267|FG000|Overall Study|Adverse Event|11|||
42252423|NCT01316939|76078277|FG001|Overall Study|Adverse Event|12|||
41991206|NCT01184989|75799267|FG000|Overall Study|Withdrawal by Subject|1|||
42252424|NCT01316939|76078278|FG002|Overall Study|Adverse Event|11|||
42252425|NCT01316939|76078276|FG000|Overall Study|Withdrawal by Subject|1|||
42252426|NCT01316939|76078277|FG001|Overall Study|Withdrawal by Subject|3|||
42252427|NCT01316939|76078278|FG002|Overall Study|Withdrawal by Subject|6|||
42252428|NCT01316939|76078276|FG000|Overall Study|Physician Decision|2|||
42252429|NCT01316939|76078277|FG001|Overall Study|Physician Decision|2|||
42252430|NCT01316939|76078278|FG002|Overall Study|Physician Decision|1|||
42252431|NCT01316939|76078276|FG000|Overall Study|Lost to Follow-up|0|||
42306134|NCT02371759|76141902|FG003|Overall Study|Withdrawal by Subject|0|||
42306135|NCT02371759|76141903|FG004|Overall Study|Withdrawal by Subject|0|||
42306136|NCT02371759|76141904|FG005|Overall Study|Withdrawal by Subject|0|||
42306137|NCT02371759|76141905|FG006|Overall Study|Withdrawal by Subject|0|||
42306138|NCT02371759|76141906|FG007|Overall Study|Withdrawal by Subject|1|||
42306139|NCT02531633|76141929|FG000|Part A (52 Weeks)|Sponsor request|24|||
42306140|NCT02531633|76141930|FG001|Part A (52 Weeks)|Sponsor request|24|||
42306141|NCT02531633|76141931|FG002|Part A (52 Weeks)|Sponsor request|18|||
42306142|NCT02531633|76141932|FG003|Part A (52 Weeks)|Sponsor request|18|||
42306143|NCT02531633|76141933|FG004|Part A (52 Weeks)|Sponsor request|19|||
42306144|NCT02531633|76141934|FG005|Part A (52 Weeks)|Sponsor request|0|||
42306145|NCT02531633|76141935|FG006|Part A (52 Weeks)|Sponsor request|0|||
42306146|NCT02531633|76141936|FG007|Part A (52 Weeks)|Sponsor request|0|||
42306147|NCT02531633|76141937|FG008|Part A (52 Weeks)|Sponsor request|0|||
42306148|NCT02531633|76141938|FG009|Part A (52 Weeks)|Sponsor request|0|||
42306149|NCT02531633|76141929|FG000|Part A (52 Weeks)|Protocol Violation|1|||
42306150|NCT02531633|76141930|FG001|Part A (52 Weeks)|Protocol Violation|0|||
42306151|NCT02531633|76141931|FG002|Part A (52 Weeks)|Protocol Violation|0|||
42306152|NCT02531633|76141932|FG003|Part A (52 Weeks)|Protocol Violation|0|||
42306153|NCT02531633|76141933|FG004|Part A (52 Weeks)|Protocol Violation|0|||
42306154|NCT02531633|76141934|FG005|Part A (52 Weeks)|Protocol Violation|0|||
42306155|NCT02531633|76141935|FG006|Part A (52 Weeks)|Protocol Violation|0|||
42306156|NCT02531633|76141936|FG007|Part A (52 Weeks)|Protocol Violation|0|||
42306157|NCT02531633|76141937|FG008|Part A (52 Weeks)|Protocol Violation|0|||
42306158|NCT02531633|76141938|FG009|Part A (52 Weeks)|Protocol Violation|0|||
42306159|NCT02531633|76141929|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
42306160|NCT02531633|76141930|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
42306161|NCT02531633|76141931|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
42306162|NCT02531633|76141932|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
42306163|NCT02531633|76141933|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
42306164|NCT02531633|76141934|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
42306165|NCT02531633|76141935|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
42306166|NCT02531633|76141936|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
42306167|NCT02531633|76141937|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
42306168|NCT02531633|76141938|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
42306169|NCT02531633|76141929|FG000|Part A (52 Weeks)|Physician Decision|1|||
42306170|NCT02531633|76141930|FG001|Part A (52 Weeks)|Physician Decision|4|||
42306171|NCT02531633|76141931|FG002|Part A (52 Weeks)|Physician Decision|3|||
42306172|NCT02531633|76141932|FG003|Part A (52 Weeks)|Physician Decision|1|||
42306173|NCT02531633|76141933|FG004|Part A (52 Weeks)|Physician Decision|0|||
42306174|NCT02531633|76141934|FG005|Part A (52 Weeks)|Physician Decision|0|||
42306175|NCT02531633|76141935|FG006|Part A (52 Weeks)|Physician Decision|0|||
42306176|NCT02531633|76141936|FG007|Part A (52 Weeks)|Physician Decision|0|||
42306177|NCT02531633|76141937|FG008|Part A (52 Weeks)|Physician Decision|0|||
42306178|NCT02531633|76141938|FG009|Part A (52 Weeks)|Physician Decision|0|||
42306179|NCT02531633|76141929|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
42306180|NCT02531633|76141930|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
42306181|NCT02531633|76141931|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
42306182|NCT02531633|76141932|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
42306183|NCT02531633|76141933|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
42306184|NCT02531633|76141934|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
42306185|NCT02531633|76141935|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
42306186|NCT02531633|76141936|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
41991207|NCT01215955|75799275|FG000|Overall Study|Adverse Event|1|||
42252432|NCT01316939|76078277|FG001|Overall Study|Lost to Follow-up|0|||
42252433|NCT01316939|76078278|FG002|Overall Study|Lost to Follow-up|2|||
42252434|NCT01316939|76078276|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
42252435|NCT01316939|76078277|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
42252436|NCT01316939|76078278|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
42252437|NCT01316939|76078276|FG000|Overall Study|Protocol Violation|0|||
42252438|NCT01316939|76078277|FG001|Overall Study|Protocol Violation|1|||
42252439|NCT01316939|76078278|FG002|Overall Study|Protocol Violation|0|||
42252440|NCT03044249|76078288|FG000|Overall Study|Adverse Event|4|||
42252441|NCT03044249|76078289|FG001|Overall Study|Adverse Event|9|||
42306187|NCT02531633|76141937|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
42306188|NCT02531633|76141938|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
42252442|NCT03044249|76078288|FG000|Overall Study|Lost to Follow-up|1|||
42306189|NCT02531633|76141929|FG000|Part A (52 Weeks)|Other|2|||
42306190|NCT02531633|76141930|FG001|Part A (52 Weeks)|Other|0|||
42306191|NCT02531633|76141931|FG002|Part A (52 Weeks)|Other|0|||
42306192|NCT02531633|76141932|FG003|Part A (52 Weeks)|Other|0|||
41991208|NCT01215955|75799276|FG001|Overall Study|Adverse Event|4|||
42306193|NCT02531633|76141933|FG004|Part A (52 Weeks)|Other|0|||
42306194|NCT02531633|76141934|FG005|Part A (52 Weeks)|Other|0|||
42132845|NCT03849300|75943706|FG003|Overall Study|scheduling/transportation conflict|2|||
42252443|NCT03044249|76078289|FG001|Overall Study|Lost to Follow-up|0|||
42306195|NCT02531633|76141935|FG006|Part A (52 Weeks)|Other|0|||
42306196|NCT02531633|76141936|FG007|Part A (52 Weeks)|Other|0|||
42306197|NCT02531633|76141937|FG008|Part A (52 Weeks)|Other|0|||
42306198|NCT02531633|76141938|FG009|Part A (52 Weeks)|Other|0|||
42306199|NCT02531633|76141929|FG000|Part B (104 Weeks)|Sponsor request|0|||
42306200|NCT02531633|76141930|FG001|Part B (104 Weeks)|Sponsor request|0|||
42306201|NCT02531633|76141931|FG002|Part B (104 Weeks)|Sponsor request|0|||
42306202|NCT02531633|76141932|FG003|Part B (104 Weeks)|Sponsor request|0|||
42306203|NCT02531633|76141933|FG004|Part B (104 Weeks)|Sponsor request|0|||
42306204|NCT02531633|76141934|FG005|Part B (104 Weeks)|Sponsor request|8|||
42306205|NCT02531633|76141935|FG006|Part B (104 Weeks)|Sponsor request|5|||
42306206|NCT02531633|76141936|FG007|Part B (104 Weeks)|Sponsor request|3|||
42306207|NCT02531633|76141937|FG008|Part B (104 Weeks)|Sponsor request|5|||
42306208|NCT02531633|76141938|FG009|Part B (104 Weeks)|Sponsor request|4|||
42306209|NCT02531633|76141929|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
42306210|NCT02531633|76141930|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
42306211|NCT02531633|76141931|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
42306212|NCT02531633|76141932|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
42306213|NCT02531633|76141933|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
42306214|NCT02531633|76141934|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
42306215|NCT02531633|76141935|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
42306216|NCT02531633|76141936|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
42306217|NCT02531633|76141937|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
42306218|NCT02531633|76141938|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
42306219|NCT02536313|76141980|FG000|Overall Study|Lack of Efficacy|0|||
42306220|NCT02536313|76141981|FG001|Overall Study|Lack of Efficacy|1|||
42306221|NCT02187861|76141993|FG000|Overall Study|Adverse Event|2|||
42306222|NCT02187861|76141994|FG001|Overall Study|Adverse Event|1|||
42306223|NCT02187861|76141995|FG002|Overall Study|Adverse Event|2|||
42306224|NCT02187861|76141996|FG003|Overall Study|Adverse Event|1|||
42306225|NCT02187861|76141993|FG000|Overall Study|Death|0|||
42306226|NCT02187861|76141994|FG001|Overall Study|Death|3|||
42306227|NCT02187861|76141995|FG002|Overall Study|Death|1|||
42306228|NCT02187861|76141996|FG003|Overall Study|Death|2|||
42306229|NCT02187861|76141993|FG000|Overall Study|Physician Decision|0|||
42306230|NCT02187861|76141994|FG001|Overall Study|Physician Decision|1|||
42306231|NCT02187861|76141995|FG002|Overall Study|Physician Decision|0|||
42306232|NCT02187861|76141996|FG003|Overall Study|Physician Decision|3|||
42306233|NCT02187861|76141993|FG000|Overall Study|Progressive Disease|4|||
42306234|NCT02187861|76141994|FG001|Overall Study|Progressive Disease|42|||
42306235|NCT02187861|76141995|FG002|Overall Study|Progressive Disease|19|||
42306236|NCT02187861|76141996|FG003|Overall Study|Progressive Disease|22|||
42306237|NCT02187861|76141993|FG000|Overall Study|Withdrawal by Subject|0|||
42306238|NCT02187861|76141994|FG001|Overall Study|Withdrawal by Subject|0|||
42252444|NCT03044249|76078288|FG000|Overall Study|Non-compliance with Study Drug|1|||
42252445|NCT03044249|76078289|FG001|Overall Study|Non-compliance with Study Drug|0|||
42252446|NCT03044249|76078288|FG000|Overall Study|Study Terminated by Sponsor|2|||
42252447|NCT03044249|76078289|FG001|Overall Study|Study Terminated by Sponsor|0|||
42252448|NCT03044249|76078288|FG000|Overall Study|Withdrawal by Subject|2|||
42252449|NCT03044249|76078289|FG001|Overall Study|Withdrawal by Subject|5|||
42252450|NCT02704130|76078302|FG000|Overall Study|Physician Decision|5|||
42252451|NCT02704130|76078303|FG001|Overall Study|Physician Decision|3|||
42252452|NCT03740009|76078309|FG000|Overall Study|Physician Decision|9|||
42252453|NCT03740009|76078309|FG000|Overall Study|Lost to Follow-up|1|||
42252454|NCT03649217|76078313|FG000|Overall Study|subject had severe ataxia not initially found|1|||
42306239|NCT02187861|76141995|FG002|Overall Study|Withdrawal by Subject|3|||
42306240|NCT02187861|76141996|FG003|Overall Study|Withdrawal by Subject|3|||
42306241|NCT02187861|76141993|FG000|Overall Study|Other|0|||
42306242|NCT02187861|76141994|FG001|Overall Study|Other|1|||
42306243|NCT02187861|76141995|FG002|Overall Study|Other|7|||
42306244|NCT02187861|76141996|FG003|Overall Study|Other|1|||
42306245|NCT02163993|76142011|FG000|Treatment Period|Adverse Event|0|||
42306246|NCT02163993|76142012|FG001|Treatment Period|Adverse Event|1|||
42252455|NCT03649217|76078313|FG000|Overall Study|subject had cognitive issues not initially found|1|||
42132846|NCT00412893|75943720|FG000|Overall Study|Adverse Event|31|||
42252456|NCT03138889|76078342|FG000|Overall Study|Withdrawal by Subject|5|||
42306247|NCT02163993|76142013|FG002|Treatment Period|Adverse Event|0|||
42306248|NCT02163993|76142014|FG003|Treatment Period|Adverse Event|0|||
42306249|NCT02163993|76142015|FG004|Treatment Period|Adverse Event|1|||
42306250|NCT02163993|76142011|FG000|Treatment Period|Lost to Follow-up|2|||
42306251|NCT02163993|76142012|FG001|Treatment Period|Lost to Follow-up|3|||
42306252|NCT02163993|76142013|FG002|Treatment Period|Lost to Follow-up|1|||
42306253|NCT02163993|76142014|FG003|Treatment Period|Lost to Follow-up|3|||
42306254|NCT02163993|76142015|FG004|Treatment Period|Lost to Follow-up|1|||
42306255|NCT02163993|76142011|FG000|Treatment Period|Physician Decision|1|||
42306256|NCT02163993|76142012|FG001|Treatment Period|Physician Decision|0|||
42306257|NCT02163993|76142013|FG002|Treatment Period|Physician Decision|0|||
42306258|NCT02163993|76142014|FG003|Treatment Period|Physician Decision|0|||
42306259|NCT02163993|76142015|FG004|Treatment Period|Physician Decision|0|||
42306260|NCT02163993|76142011|FG000|Treatment Period|Protocol Violation|2|||
42306261|NCT02163993|76142012|FG001|Treatment Period|Protocol Violation|1|||
42306262|NCT02163993|76142013|FG002|Treatment Period|Protocol Violation|0|||
42306263|NCT02163993|76142014|FG003|Treatment Period|Protocol Violation|1|||
42306264|NCT02163993|76142015|FG004|Treatment Period|Protocol Violation|2|||
42306265|NCT02163993|76142011|FG000|Treatment Period|Withdrawal by Subject|6|||
42306266|NCT02163993|76142012|FG001|Treatment Period|Withdrawal by Subject|4|||
42306267|NCT02163993|76142013|FG002|Treatment Period|Withdrawal by Subject|1|||
42306268|NCT02163993|76142014|FG003|Treatment Period|Withdrawal by Subject|4|||
42306269|NCT02163993|76142015|FG004|Treatment Period|Withdrawal by Subject|1|||
42306270|NCT02163993|76142011|FG000|Treatment Period|Not treated|1|||
42306271|NCT02163993|76142012|FG001|Treatment Period|Not treated|0|||
42306272|NCT02163993|76142013|FG002|Treatment Period|Not treated|0|||
42306273|NCT02163993|76142014|FG003|Treatment Period|Not treated|1|||
42306274|NCT02163993|76142015|FG004|Treatment Period|Not treated|2|||
42306275|NCT02163993|76142011|FG000|Post-treatment Period|Adverse Event|0|||
42306276|NCT02163993|76142012|FG001|Post-treatment Period|Adverse Event|0|||
42306277|NCT02163993|76142013|FG002|Post-treatment Period|Adverse Event|1|||
42306278|NCT02163993|76142014|FG003|Post-treatment Period|Adverse Event|0|||
42306279|NCT02163993|76142015|FG004|Post-treatment Period|Adverse Event|0|||
42306280|NCT02163993|76142011|FG000|Post-treatment Period|Lost to Follow-up|2|||
42306281|NCT02163993|76142012|FG001|Post-treatment Period|Lost to Follow-up|2|||
42306282|NCT02163993|76142013|FG002|Post-treatment Period|Lost to Follow-up|3|||
42306283|NCT02163993|76142014|FG003|Post-treatment Period|Lost to Follow-up|1|||
42306284|NCT02163993|76142015|FG004|Post-treatment Period|Lost to Follow-up|0|||
42306285|NCT02163993|76142011|FG000|Post-treatment Period|Protocol Violation|0|||
42306286|NCT02163993|76142012|FG001|Post-treatment Period|Protocol Violation|0|||
42306287|NCT02163993|76142013|FG002|Post-treatment Period|Protocol Violation|0|||
42306288|NCT02163993|76142014|FG003|Post-treatment Period|Protocol Violation|0|||
42306289|NCT02163993|76142015|FG004|Post-treatment Period|Protocol Violation|1|||
42306290|NCT02163993|76142011|FG000|Post-treatment Period|Withdrawal by Subject|2|||
42306291|NCT02163993|76142012|FG001|Post-treatment Period|Withdrawal by Subject|4|||
42306292|NCT02163993|76142013|FG002|Post-treatment Period|Withdrawal by Subject|0|||
42306293|NCT02163993|76142014|FG003|Post-treatment Period|Withdrawal by Subject|1|||
42306294|NCT02163993|76142015|FG004|Post-treatment Period|Withdrawal by Subject|2|||
42306295|NCT02527421|76142038|FG000|Overall Study|Withdrawal by Subject|1|||
42306296|NCT02527421|76142039|FG001|Overall Study|Withdrawal by Subject|0|||
42306297|NCT02163915|76142050|FG000|Overall Study|Withdrawal by Subject|2|||
42306298|NCT02163915|76142051|FG001|Overall Study|Withdrawal by Subject|0|||
42306299|NCT02163915|76142052|FG002|Overall Study|Withdrawal by Subject|2|||
42306300|NCT02163915|76142053|FG003|Overall Study|Withdrawal by Subject|2|||
42306301|NCT02163915|76142054|FG004|Overall Study|Withdrawal by Subject|2|||
42252457|NCT03138889|76078343|FG001|Overall Study|Withdrawal by Subject|5|||
42252458|NCT03138889|76078344|FG002|Overall Study|Withdrawal by Subject|0|||
42252459|NCT03138889|76078345|FG003|Overall Study|Withdrawal by Subject|2|||
42252460|NCT03138889|76078346|FG004|Overall Study|Withdrawal by Subject|1|||
42252461|NCT03138889|76078347|FG005|Overall Study|Withdrawal by Subject|3|||
42252462|NCT03138889|76078348|FG006|Overall Study|Withdrawal by Subject|0|||
42252463|NCT03138889|76078349|FG007|Overall Study|Withdrawal by Subject|1|||
42252464|NCT02706392|76078401|FG000|Overall Study|Death|1|||
42252465|NCT02706392|76078402|FG001|Overall Study|Death|0|||
42252466|NCT02706392|76078403|FG002|Overall Study|Death|2|||
42252467|NCT02706392|76078404|FG003|Overall Study|Death|2|||
42252468|NCT02706392|76078405|FG004|Overall Study|Death|5|||
42252469|NCT02706392|76078406|FG005|Overall Study|Death|2|||
42252470|NCT03042767|76078422|FG000|Overall Study|Lost to Follow-up|1|||
42252471|NCT03042767|76078423|FG001|Overall Study|Lost to Follow-up|2|||
42252472|NCT00703820|76078431|FG000|Overall Study|Adverse Event|12|||
42306302|NCT02163915|76142050|FG000|Overall Study|Study termination|1|||
42306303|NCT02163915|76142051|FG001|Overall Study|Study termination|0|||
42306304|NCT02163915|76142052|FG002|Overall Study|Study termination|0|||
42306305|NCT02163915|76142053|FG003|Overall Study|Study termination|0|||
42306306|NCT02163915|76142054|FG004|Overall Study|Study termination|2|||
42306307|NCT02163915|76142050|FG000|Overall Study|Physician Decision|0|||
42306308|NCT02163915|76142051|FG001|Overall Study|Physician Decision|0|||
42252473|NCT00703820|76078432|FG001|Overall Study|Adverse Event|17|||
42252474|NCT00703820|76078431|FG000|Overall Study|Death|5|||
42252475|NCT00703820|76078432|FG001|Overall Study|Death|0|||
42252476|NCT00703820|76078431|FG000|Overall Study|Lack of Efficacy|11|||
42252477|NCT00703820|76078432|FG001|Overall Study|Lack of Efficacy|11|||
42306309|NCT02163915|76142052|FG002|Overall Study|Physician Decision|0|||
41991209|NCT01215955|75799277|FG002|Overall Study|Adverse Event|2|||
41991210|NCT01215955|75799278|FG003|Overall Study|Adverse Event|3|||
41991211|NCT01215955|75799275|FG000|Overall Study|Death|2|||
41991212|NCT01215955|75799276|FG001|Overall Study|Death|0|||
41991213|NCT01215955|75799277|FG002|Overall Study|Death|1|||
42306310|NCT02163915|76142053|FG003|Overall Study|Physician Decision|1|||
41991214|NCT01215955|75799278|FG003|Overall Study|Death|3|||
41991215|NCT01215955|75799275|FG000|Overall Study|Entry Criteria Not Met|1|||
41991216|NCT01215955|75799276|FG001|Overall Study|Entry Criteria Not Met|3|||
41991217|NCT01215955|75799277|FG002|Overall Study|Entry Criteria Not Met|4|||
41991218|NCT01215955|75799278|FG003|Overall Study|Entry Criteria Not Met|7|||
41991219|NCT01215955|75799275|FG000|Overall Study|Lack of Efficacy|1|||
41991220|NCT01215955|75799276|FG001|Overall Study|Lack of Efficacy|2|||
41991221|NCT01215955|75799277|FG002|Overall Study|Lack of Efficacy|1|||
41991222|NCT01215955|75799278|FG003|Overall Study|Lack of Efficacy|0|||
41991223|NCT01215955|75799275|FG000|Overall Study|Lost to Follow-up|4|||
41991224|NCT01215955|75799276|FG001|Overall Study|Lost to Follow-up|4|||
41991225|NCT01215955|75799277|FG002|Overall Study|Lost to Follow-up|8|||
41991226|NCT01215955|75799278|FG003|Overall Study|Lost to Follow-up|9|||
41991227|NCT01215955|75799275|FG000|Overall Study|Physician Decision|4|||
41991228|NCT01215955|75799276|FG001|Overall Study|Physician Decision|10|||
41991229|NCT01215955|75799277|FG002|Overall Study|Physician Decision|8|||
41991230|NCT01215955|75799278|FG003|Overall Study|Physician Decision|11|||
41991231|NCT01215955|75799275|FG000|Overall Study|Protocol Violation|17|||
41991232|NCT01215955|75799276|FG001|Overall Study|Protocol Violation|13|||
41991233|NCT01215955|75799277|FG002|Overall Study|Protocol Violation|8|||
41991234|NCT01215955|75799278|FG003|Overall Study|Protocol Violation|8|||
41991235|NCT01215955|75799275|FG000|Overall Study|Sponsor Decision|1|||
41991236|NCT01215955|75799276|FG001|Overall Study|Sponsor Decision|2|||
41991237|NCT01215955|75799277|FG002|Overall Study|Sponsor Decision|0|||
41991238|NCT01215955|75799278|FG003|Overall Study|Sponsor Decision|1|||
41991239|NCT01215955|75799275|FG000|Overall Study|Withdrawal by Subject|14|||
41991240|NCT01215955|75799276|FG001|Overall Study|Withdrawal by Subject|15|||
41991241|NCT01215955|75799277|FG002|Overall Study|Withdrawal by Subject|13|||
42132847|NCT00412893|75943721|FG001|Overall Study|Adverse Event|53|||
42252478|NCT00703820|76078431|FG000|Overall Study|Received non-protocol therapy|1|||
42252479|NCT00703820|76078432|FG001|Overall Study|Received non-protocol therapy|0|||
42252480|NCT00703820|76078431|FG000|Overall Study|Physician Decision|4|||
42252481|NCT00703820|76078432|FG001|Overall Study|Physician Decision|5|||
42252482|NCT00703820|76078431|FG000|Overall Study|Withdrawal by Subject|2|||
42252483|NCT00703820|76078432|FG001|Overall Study|Withdrawal by Subject|1|||
42252484|NCT03045887|76078450|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
42252485|NCT03045887|76078451|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
42252486|NCT03045887|76078452|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
42252487|NCT03045887|76078453|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
42252488|NCT03045887|76078454|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
42252489|NCT03045887|76078455|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
42252490|NCT03045887|76078456|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
42252491|NCT03045887|76078457|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
42252492|NCT03045887|76078458|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
42252493|NCT03045887|76078459|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
42252494|NCT03045887|76078450|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
42252495|NCT03045887|76078451|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
42252496|NCT03045887|76078452|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
42252497|NCT03045887|76078453|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
42252498|NCT03045887|76078454|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
42252499|NCT03045887|76078455|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
42252500|NCT03045887|76078456|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
42306311|NCT02163915|76142054|FG004|Overall Study|Physician Decision|0|||
42306312|NCT02163759|76142073|FG000|Overall Study|Withdrawal by Subject|1|||
41991242|NCT01215955|75799278|FG003|Overall Study|Withdrawal by Subject|9|||
41991243|NCT01215955|75799275|FG000|Overall Study|Quality Issues|0|||
41991244|NCT01215955|75799276|FG001|Overall Study|Quality Issues|0|||
41991245|NCT01215955|75799277|FG002|Overall Study|Quality Issues|3|||
42132848|NCT00412893|75943720|FG000|Overall Study|Death|17|||
41991246|NCT01215955|75799278|FG003|Overall Study|Quality Issues|2|||
41991247|NCT01215916|75799313|FG000|Overall Study|Progressive Disease|0|||
41991248|NCT01215916|75799314|FG001|Overall Study|Progressive Disease|2|||
41991249|NCT01215916|75799315|FG002|Overall Study|Progressive Disease|1|||
41991250|NCT01215916|75799316|FG003|Overall Study|Progressive Disease|2|||
42306313|NCT02163759|76142074|FG001|Overall Study|Withdrawal by Subject|5|||
41991251|NCT01215916|75799317|FG004|Overall Study|Progressive Disease|5|||
41991252|NCT01215916|75799318|FG005|Overall Study|Progressive Disease|4|||
41991253|NCT01215916|75799319|FG006|Overall Study|Progressive Disease|5|||
42252501|NCT03045887|76078457|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
42252502|NCT03045887|76078458|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
42306314|NCT02163759|76142075|FG002|Overall Study|Withdrawal by Subject|1|||
42306315|NCT02163759|76142073|FG000|Overall Study|Adverse Event|0|||
42306316|NCT02163759|76142074|FG001|Overall Study|Adverse Event|0|||
42306317|NCT02163759|76142075|FG002|Overall Study|Adverse Event|1|||
42306318|NCT02163759|76142073|FG000|Overall Study|Death|0|||
42306319|NCT02163759|76142074|FG001|Overall Study|Death|0|||
42306320|NCT02163759|76142075|FG002|Overall Study|Death|1|||
42306321|NCT02371369|76142088|FG000|Part 1|Physician Decision|0|||
42306322|NCT02371369|76142089|FG001|Part 1|Physician Decision|3|||
42306323|NCT02371369|76142088|FG000|Part 1|Adverse Event|8|||
42306324|NCT02371369|76142089|FG001|Part 1|Adverse Event|0|||
42306325|NCT02371369|76142088|FG000|Part 1|Withdrawal by Subject|1|||
42306326|NCT02371369|76142089|FG001|Part 1|Withdrawal by Subject|6|||
42306327|NCT02371369|76142088|FG000|Part 1|Disease progression|0|||
42306328|NCT02371369|76142089|FG001|Part 1|Disease progression|1|||
42306329|NCT02371369|76142088|FG000|Part 1|Protocol Violation|0|||
42306330|NCT02371369|76142089|FG001|Part 1|Protocol Violation|1|||
42306331|NCT02371369|76142088|FG000|Part 2|Adverse Event|6|||
42306332|NCT02371369|76142089|FG001|Part 2|Adverse Event|5|||
42252503|NCT03045887|76078459|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
42252504|NCT03045887|76078450|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
42252505|NCT03045887|76078451|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
42306333|NCT02371369|76142088|FG000|Part 2|Withdrawal by Subject|16|||
42306334|NCT02371369|76142089|FG001|Part 2|Withdrawal by Subject|6|||
42306335|NCT02371369|76142088|FG000|Part 2|Investigator decision|1|||
42306336|NCT02371369|76142089|FG001|Part 2|Investigator decision|2|||
42306337|NCT02371369|76142088|FG000|Part 2|Death|0|||
42306338|NCT02371369|76142089|FG001|Part 2|Death|1|||
42306339|NCT02371369|76142088|FG000|Part 2|Disease progression|1|||
42306340|NCT02371369|76142089|FG001|Part 2|Disease progression|0|||
42306341|NCT02371369|76142088|FG000|Part 2|Subject Noncompliance|1|||
42306342|NCT02371369|76142089|FG001|Part 2|Subject Noncompliance|0|||
42306343|NCT02371369|76142088|FG000|Part 2|Lost to Follow-up|1|||
42306344|NCT02371369|76142089|FG001|Part 2|Lost to Follow-up|1|||
42306345|NCT02371369|76142088|FG000|Part 2|Subject transitioned to commercial supply|6|||
42306346|NCT02371369|76142089|FG001|Part 2|Subject transitioned to commercial supply|4|||
42306347|NCT02371369|76142088|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
42306348|NCT02371369|76142089|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
42306349|NCT02371369|76142088|FG000|Part 2|Surgical resection of tumor|1|||
42306350|NCT02371369|76142089|FG001|Part 2|Surgical resection of tumor|1|||
42306351|NCT02371369|76142088|FG000|Part 2|Other|0|||
42306352|NCT02371369|76142089|FG001|Part 2|Other|1|||
42306353|NCT02187783|76142111|FG000|Overall Study|Adverse Event|8|||
42306354|NCT02187783|76142111|FG000|Overall Study|Death|3|||
42306355|NCT02187783|76142111|FG000|Overall Study|Progressive disease|80|||
42306356|NCT02187783|76142111|FG000|Overall Study|Protocol Violation|3|||
42306357|NCT02187783|76142111|FG000|Overall Study|Physician Decision|2|||
42306358|NCT02187783|76142111|FG000|Overall Study|Withdrawal by Subject|9|||
42306359|NCT02187783|76142111|FG000|Overall Study|Study terminated by sponsor|1|||
42306360|NCT02337361|76142117|FG000|3-month Follow-up|Lost to Follow-up|19|||
42306361|NCT02337361|76142118|FG001|3-month Follow-up|Lost to Follow-up|14|||
42306362|NCT02337361|76142117|FG000|6-month Follow-up|Lost to Follow-up|2|||
42252506|NCT03045887|76078452|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
42252507|NCT03045887|76078453|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
42306363|NCT02337361|76142118|FG001|6-month Follow-up|Lost to Follow-up|4|||
42306364|NCT02336737|76142125|FG000|Overall Study|Withdrawal by Subject|5|||
42306365|NCT02336737|76142125|FG000|Overall Study|Physician Decision|8|||
42306366|NCT02130765|76142134|FG000|Overall Study|Did not receive treatment|4|||
42306367|NCT02130765|76142135|FG001|Overall Study|Did not receive treatment|0|||
42306368|NCT02130765|76142136|FG002|Overall Study|Did not receive treatment|0|||
42306369|NCT02130765|76142137|FG003|Overall Study|Did not receive treatment|0|||
42306370|NCT02305381|76142152|FG000|Overall Study|Unclassified|5|||
42306371|NCT02305381|76142153|FG001|Overall Study|Unclassified|5|||
42306372|NCT02305381|76142154|FG002|Overall Study|Unclassified|7|||
42306373|NCT02336425|76142166|FG000|Overall Study|Study terminated.|2|||
42306374|NCT02336425|76142167|FG001|Overall Study|Study terminated.|2|||
42306375|NCT02336425|76142168|FG002|Overall Study|Study terminated.|3|||
42306376|NCT02336425|76142169|FG003|Overall Study|Study terminated.|3|||
41991254|NCT01215916|75799320|FG007|Overall Study|Progressive Disease|3|||
41991255|NCT01215916|75799321|FG008|Overall Study|Progressive Disease|1|||
42306377|NCT02163447|76142182|FG000|Overall Study|Withdrawal by Subject|2|||
42306378|NCT02163447|76142183|FG001|Overall Study|Withdrawal by Subject|0|||
42306379|NCT02163447|76142184|FG002|Overall Study|Withdrawal by Subject|1|||
42306380|NCT02163447|76142182|FG000|Overall Study|Lost to Follow-up|1|||
42306381|NCT02163447|76142183|FG001|Overall Study|Lost to Follow-up|3|||
42306382|NCT02163447|76142184|FG002|Overall Study|Lost to Follow-up|0|||
42306383|NCT02163447|76142182|FG000|Overall Study|Moved out of study area|2|||
42306384|NCT02163447|76142183|FG001|Overall Study|Moved out of study area|3|||
42306385|NCT02163447|76142184|FG002|Overall Study|Moved out of study area|2|||
42306386|NCT02163447|76142182|FG000|Overall Study|Became HIV infected at time of delivery|1|||
42306387|NCT02163447|76142183|FG001|Overall Study|Became HIV infected at time of delivery|0|||
42306388|NCT02163447|76142184|FG002|Overall Study|Became HIV infected at time of delivery|0|||
42306389|NCT02370667|76142205|FG000|Overall Study|Lost to Follow-up|0|||
42306390|NCT02370667|76142206|FG001|Overall Study|Lost to Follow-up|1|||
42306391|NCT02370667|76142207|FG002|Overall Study|Lost to Follow-up|0|||
42306392|NCT02130297|76142215|FG000|Overall Study|Lost to Follow-up|4|||
42306393|NCT01931956|76142223|FG000|Overall Study|Death|42|||
42306394|NCT01931956|76142224|FG001|Overall Study|Death|7|||
42306395|NCT01931956|76142225|FG002|Overall Study|Death|379|||
42306396|NCT01931956|76142226|FG003|Overall Study|Death|96|||
42306397|NCT01931956|76142223|FG000|Overall Study|Withdrawal by Subject|5|||
42306398|NCT01931956|76142224|FG001|Overall Study|Withdrawal by Subject|0|||
42306399|NCT01931956|76142225|FG002|Overall Study|Withdrawal by Subject|70|||
42306400|NCT01931956|76142226|FG003|Overall Study|Withdrawal by Subject|30|||
42306401|NCT01931956|76142223|FG000|Overall Study|Lost to Follow-up|2|||
42306402|NCT01931956|76142224|FG001|Overall Study|Lost to Follow-up|0|||
42306403|NCT01931956|76142225|FG002|Overall Study|Lost to Follow-up|11|||
42306404|NCT01931956|76142226|FG003|Overall Study|Lost to Follow-up|7|||
42306405|NCT01931956|76142223|FG000|Overall Study|Expected|2|||
42306406|NCT01931956|76142224|FG001|Overall Study|Expected|0|||
42306407|NCT01931956|76142225|FG002|Overall Study|Expected|6|||
42306408|NCT01931956|76142226|FG003|Overall Study|Expected|0|||
42306409|NCT01931956|76142223|FG000|Overall Study|Not due|0|||
42306410|NCT01931956|76142224|FG001|Overall Study|Not due|0|||
42306411|NCT01931956|76142225|FG002|Overall Study|Not due|21|||
42306412|NCT01931956|76142226|FG003|Overall Study|Not due|0|||
42306413|NCT01887418|76142252|FG000|Overall Study|Travelling difficulties|0|||
42306414|NCT01887418|76142253|FG001|Overall Study|Travelling difficulties|0|||
42306415|NCT01887418|76142254|FG002|Overall Study|Travelling difficulties|1|||
42306416|NCT01886716|76142266|FG000|Week 1|Lost to Follow-up|0|||
42306417|NCT01886716|76142267|FG001|Week 1|Lost to Follow-up|0|||
42306418|NCT01886716|76142268|FG002|Week 1|Lost to Follow-up|2|||
42306419|NCT01886716|76142269|FG003|Week 1|Lost to Follow-up|2|||
42306420|NCT01886716|76142266|FG000|Week 2|Lost to Follow-up|3|||
42306421|NCT01886716|76142267|FG001|Week 2|Lost to Follow-up|2|||
42306422|NCT01886716|76142268|FG002|Week 2|Lost to Follow-up|1|||
42306423|NCT01886716|76142269|FG003|Week 2|Lost to Follow-up|3|||
42306424|NCT01886716|76142266|FG000|Week 3|Lost to Follow-up|1|||
42306425|NCT01886716|76142267|FG001|Week 3|Lost to Follow-up|1|||
42306426|NCT01886716|76142268|FG002|Week 3|Lost to Follow-up|0|||
42306427|NCT01886716|76142269|FG003|Week 3|Lost to Follow-up|1|||
42306428|NCT01912612|76142281|FG000|Overall Study|Adverse Event|4|||
42306429|NCT01912612|76142282|FG001|Overall Study|Adverse Event|0|||
42306430|NCT01912612|76142283|FG002|Overall Study|Adverse Event|0|||
42306431|NCT01912612|76142281|FG000|Overall Study|Withdrew consent|1|||
42306432|NCT01912612|76142282|FG001|Overall Study|Withdrew consent|0|||
42306433|NCT01912612|76142283|FG002|Overall Study|Withdrew consent|0|||
42306434|NCT01912612|76142281|FG000|Overall Study|Study design change|0|||
42306435|NCT01912612|76142282|FG001|Overall Study|Study design change|0|||
42306436|NCT01912612|76142283|FG002|Overall Study|Study design change|3|||
42306437|NCT02370511|76142292|FG000|Overall Study|Death|10|||
42306438|NCT02370511|76142293|FG001|Overall Study|Death|7|||
42306439|NCT02370511|76142294|FG002|Overall Study|Death|1|||
42306440|NCT02370511|76142292|FG000|Overall Study|Withdrawal by Subject|2|||
41991256|NCT01215916|75799313|FG000|Overall Study|Adverse Event|1|||
41991257|NCT01215916|75799314|FG001|Overall Study|Adverse Event|1|||
41991258|NCT01215916|75799315|FG002|Overall Study|Adverse Event|0|||
41991259|NCT01215916|75799316|FG003|Overall Study|Adverse Event|1|||
41991260|NCT01215916|75799317|FG004|Overall Study|Adverse Event|0|||
42306441|NCT02370511|76142293|FG001|Overall Study|Withdrawal by Subject|0|||
42306442|NCT02370511|76142294|FG002|Overall Study|Withdrawal by Subject|0|||
42306443|NCT02370511|76142292|FG000|Overall Study|Lost to Follow-up|0|||
42306444|NCT02370511|76142293|FG001|Overall Study|Lost to Follow-up|4|||
42306445|NCT02370511|76142294|FG002|Overall Study|Lost to Follow-up|0|||
42306446|NCT02303041|76142304|FG000|Overall Study|Adverse Event|1|||
42132849|NCT00412893|75943721|FG001|Overall Study|Death|21|||
42132850|NCT00412893|75943720|FG000|Overall Study|Insufficient Therapeutic Response|39|||
42132851|NCT00412893|75943721|FG001|Overall Study|Insufficient Therapeutic Response|23|||
41991261|NCT01215916|75799318|FG005|Overall Study|Adverse Event|0|||
42306447|NCT02303041|76142305|FG001|Overall Study|Adverse Event|2|||
42306448|NCT02302807|76142313|FG000|Overall Study|Withdrawal by Subject|28|||
42306449|NCT02302807|76142314|FG001|Overall Study|Withdrawal by Subject|11|||
42306450|NCT02302807|76142313|FG000|Overall Study|Lost to Follow-up|4|||
42306451|NCT02302807|76142314|FG001|Overall Study|Lost to Follow-up|6|||
42306452|NCT02302807|76142313|FG000|Overall Study|Death|397|||
42306453|NCT02302807|76142314|FG001|Overall Study|Death|385|||
42306454|NCT02302807|76142313|FG000|Overall Study|Study Terminated By Sponsor|35|||
42306455|NCT02302807|76142314|FG001|Overall Study|Study Terminated By Sponsor|64|||
42306456|NCT02302807|76142313|FG000|Overall Study|Physician Decision|0|||
42306457|NCT02302807|76142314|FG001|Overall Study|Physician Decision|1|||
42306458|NCT02335489|76142333|FG000|Overall Study|Sponsor terminated study|4|||
42306459|NCT02335489|76142333|FG000|Overall Study|Lost to Follow-up|1|||
42306460|NCT02335489|76142333|FG000|Overall Study|Withdrawal by Subject|2|||
42306461|NCT02335489|76142333|FG000|Overall Study|Physician Decision|2|||
42306462|NCT02335489|76142333|FG000|Overall Study|Lack of Efficacy|1|||
42306463|NCT02527343|76142339|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
42306464|NCT02527343|76142340|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
42306465|NCT02527343|76142341|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
42306466|NCT02527343|76142342|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
42306467|NCT02527343|76142343|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
42306468|NCT02527343|76142344|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
42306469|NCT02527343|76142339|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
42306470|NCT02527343|76142340|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
42306471|NCT02527343|76142341|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
42306472|NCT02527343|76142342|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
42306473|NCT02527343|76142343|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
42306474|NCT02527343|76142344|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
42306475|NCT02527343|76142339|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
42306476|NCT02527343|76142340|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
42306477|NCT02527343|76142341|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
42306478|NCT02527343|76142342|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
42306479|NCT02527343|76142343|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
42306480|NCT02527343|76142344|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
42306481|NCT02527343|76142339|FG000|RT Period: Weeks 1 to 52|Other|4|||
42306482|NCT02527343|76142340|FG001|RT Period: Weeks 1 to 52|Other|3|||
42306483|NCT02527343|76142341|FG002|RT Period: Weeks 1 to 52|Other|0|||
42306484|NCT02527343|76142342|FG003|RT Period: Weeks 1 to 52|Other|0|||
42306485|NCT02527343|76142343|FG004|RT Period: Weeks 1 to 52|Other|0|||
42306486|NCT02527343|76142344|FG005|RT Period: Weeks 1 to 52|Other|0|||
42306487|NCT02527343|76142339|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
42306488|NCT02527343|76142340|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
42306489|NCT02527343|76142341|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
42306490|NCT02527343|76142342|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
42306491|NCT02527343|76142343|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
42306492|NCT02527343|76142344|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
42306493|NCT02527343|76142339|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
42306494|NCT02527343|76142340|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
42306495|NCT02527343|76142341|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
42306496|NCT02527343|76142342|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
42306497|NCT02527343|76142343|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
42306498|NCT02527343|76142344|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
42306499|NCT02527343|76142339|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
42306500|NCT02527343|76142340|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
42306501|NCT02527343|76142341|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
42306502|NCT02527343|76142342|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
42306503|NCT02527343|76142343|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
42306504|NCT02527343|76142344|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
42306505|NCT02527343|76142339|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
42306506|NCT02527343|76142340|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
42306507|NCT02527343|76142341|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
42306508|NCT02527343|76142342|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
42306509|NCT02527343|76142343|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
42306510|NCT02527343|76142344|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
42306511|NCT02527343|76142339|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
42306512|NCT02527343|76142340|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
42306513|NCT02527343|76142341|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
41991262|NCT01215916|75799319|FG006|Overall Study|Adverse Event|3|||
42306514|NCT02527343|76142342|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
42306515|NCT02527343|76142343|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
42306516|NCT02527343|76142344|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
42306517|NCT02527343|76142339|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
42306518|NCT02527343|76142340|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
42306519|NCT02527343|76142341|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
42306520|NCT02527343|76142342|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
42306521|NCT02527343|76142343|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
42306522|NCT02527343|76142344|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
42306523|NCT02527343|76142339|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
42306524|NCT02527343|76142340|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
42306525|NCT02527343|76142341|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
42306526|NCT02527343|76142342|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
42306527|NCT02527343|76142343|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
42306528|NCT02527343|76142344|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
42306529|NCT02527343|76142339|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
42306530|NCT02527343|76142340|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
42306531|NCT02527343|76142341|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
42306532|NCT02527343|76142342|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
42306533|NCT02527343|76142343|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
41991263|NCT01215916|75799320|FG007|Overall Study|Adverse Event|0|||
41991264|NCT01215916|75799321|FG008|Overall Study|Adverse Event|0|||
41991265|NCT01215916|75799313|FG000|Overall Study|Withdrawal by Subject|0|||
42132852|NCT00412893|75943720|FG000|Overall Study|Lost to Follow-up|2|||
42132853|NCT00412893|75943721|FG001|Overall Study|Lost to Follow-up|1|||
42132854|NCT00412893|75943720|FG000|Overall Study|Violation of Selection at Entry|17|||
42252508|NCT03045887|76078454|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
42252509|NCT03045887|76078455|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
42252510|NCT03045887|76078456|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
42252511|NCT03045887|76078457|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
42252512|NCT03045887|76078458|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
42252513|NCT03045887|76078459|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
42252514|NCT03045887|76078450|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
42252515|NCT03045887|76078451|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
41991266|NCT01215916|75799314|FG001|Overall Study|Withdrawal by Subject|1|||
42252516|NCT03045887|76078452|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
42252517|NCT03045887|76078453|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
42252518|NCT03045887|76078454|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
42306534|NCT02527343|76142344|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
42306535|NCT02527343|76142339|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
41991267|NCT01215916|75799315|FG002|Overall Study|Withdrawal by Subject|1|||
42252519|NCT03045887|76078455|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
42252520|NCT03045887|76078456|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
42252521|NCT03045887|76078457|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
42252522|NCT03045887|76078458|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
42252523|NCT03045887|76078459|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
42252524|NCT03045887|76078450|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42252525|NCT03045887|76078451|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42252526|NCT03045887|76078452|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42252527|NCT03045887|76078453|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
42252528|NCT03045887|76078454|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42252529|NCT03045887|76078455|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42252530|NCT03045887|76078456|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42252531|NCT03045887|76078457|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42306536|NCT02527343|76142340|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
42306537|NCT02527343|76142341|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
42306538|NCT02527343|76142342|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
42306539|NCT02527343|76142343|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
42306540|NCT02527343|76142344|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
42306541|NCT01931566|76142362|FG000|Overall Study|Randomized But Not Treated|6|||
42306542|NCT01931566|76142363|FG001|Overall Study|Randomized But Not Treated|9|||
42306543|NCT01931566|76142364|FG002|Overall Study|Randomized But Not Treated|14|||
42306544|NCT01931566|76142362|FG000|Overall Study|Adverse Event|37|||
42306545|NCT01931566|76142363|FG001|Overall Study|Adverse Event|167|||
42306546|NCT01931566|76142364|FG002|Overall Study|Adverse Event|132|||
42306547|NCT01931566|76142362|FG000|Overall Study|Major Protocol Deviation|5|||
42306548|NCT01931566|76142363|FG001|Overall Study|Major Protocol Deviation|14|||
42306549|NCT01931566|76142364|FG002|Overall Study|Major Protocol Deviation|21|||
42306550|NCT01931566|76142362|FG000|Overall Study|Lost to Follow-up|3|||
42306551|NCT01931566|76142363|FG001|Overall Study|Lost to Follow-up|26|||
42306552|NCT01931566|76142364|FG002|Overall Study|Lost to Follow-up|23|||
42306553|NCT01931566|76142362|FG000|Overall Study|Voluntary Withdrawal|78|||
42306554|NCT01931566|76142363|FG001|Overall Study|Voluntary Withdrawal|245|||
42306555|NCT01931566|76142364|FG002|Overall Study|Voluntary Withdrawal|225|||
42306556|NCT01931566|76142362|FG000|Overall Study|Study Termination|289|||
42306557|NCT01931566|76142363|FG001|Overall Study|Study Termination|968|||
42306558|NCT01931566|76142364|FG002|Overall Study|Study Termination|1037|||
42306559|NCT01931566|76142362|FG000|Overall Study|Reason Not Specified|11|||
42306560|NCT01931566|76142363|FG001|Overall Study|Reason Not Specified|47|||
42306561|NCT01931566|76142364|FG002|Overall Study|Reason Not Specified|53|||
42306562|NCT01931566|76142362|FG000|Overall Study|Missing|0|||
41991268|NCT01215916|75799316|FG003|Overall Study|Withdrawal by Subject|2|||
41991269|NCT01215916|75799317|FG004|Overall Study|Withdrawal by Subject|0|||
41991270|NCT01215916|75799318|FG005|Overall Study|Withdrawal by Subject|0|||
42306563|NCT01931566|76142363|FG001|Overall Study|Missing|0|||
42306564|NCT01931566|76142364|FG002|Overall Study|Missing|1|||
42306565|NCT01912456|76142375|FG000|Period 1|Physician Decision|0|||
42306566|NCT01912456|76142376|FG001|Period 1|Physician Decision|0|||
42306567|NCT01912456|76142377|FG002|Period 1|Physician Decision|1|||
42306568|NCT01912456|76142378|FG003|Period 1|Physician Decision|0|||
42306569|NCT01912456|76142375|FG000|Period 1|non-compliance|1|||
42306570|NCT01912456|76142376|FG001|Period 1|non-compliance|0|||
42306571|NCT01912456|76142377|FG002|Period 1|non-compliance|0|||
42306572|NCT01912456|76142378|FG003|Period 1|non-compliance|1|||
42306573|NCT01912456|76142375|FG000|Period 1|Adverse Event|1|||
42306574|NCT01912456|76142376|FG001|Period 1|Adverse Event|0|||
42306575|NCT01912456|76142377|FG002|Period 1|Adverse Event|0|||
42306576|NCT01912456|76142378|FG003|Period 1|Adverse Event|1|||
42306577|NCT01912456|76142375|FG000|Period 1|Withdrawal by Subject|0|||
42306578|NCT01912456|76142376|FG001|Period 1|Withdrawal by Subject|1|||
42306579|NCT01912456|76142377|FG002|Period 1|Withdrawal by Subject|1|||
42306580|NCT01912456|76142378|FG003|Period 1|Withdrawal by Subject|1|||
42306581|NCT01912456|76142375|FG000|Period 2|Lack of Efficacy|0|||
42306582|NCT01912456|76142376|FG001|Period 2|Lack of Efficacy|2|||
42306583|NCT01912456|76142377|FG002|Period 2|Lack of Efficacy|0|||
41991271|NCT01215916|75799319|FG006|Overall Study|Withdrawal by Subject|1|||
41991272|NCT01215916|75799320|FG007|Overall Study|Withdrawal by Subject|0|||
41991273|NCT01215916|75799321|FG008|Overall Study|Withdrawal by Subject|0|||
41991274|NCT01215916|75799313|FG000|Overall Study|Death|0|||
42306584|NCT01912456|76142378|FG003|Period 2|Lack of Efficacy|0|||
42306585|NCT01912456|76142375|FG000|Period 2|Adverse Event|0|||
42306586|NCT01912456|76142376|FG001|Period 2|Adverse Event|0|||
42306587|NCT01912456|76142377|FG002|Period 2|Adverse Event|0|||
42306588|NCT01912456|76142378|FG003|Period 2|Adverse Event|1|||
42306589|NCT01885936|76142390|FG000|Overall Study|Withdrawal by Subject|1|||
42306590|NCT01885936|76142391|FG001|Overall Study|Withdrawal by Subject|0|||
42306591|NCT01912222|76142400|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
42306592|NCT01912222|76142401|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
42306593|NCT01912222|76142402|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
42306594|NCT01912222|76142400|FG000|Part B: Treatment Period|Progressive disease|10|||
42306595|NCT01912222|76142401|FG001|Part B: Treatment Period|Progressive disease|12|||
42306596|NCT01912222|76142402|FG002|Part B: Treatment Period|Progressive disease|15|||
42306597|NCT01912222|76142400|FG000|Part B: Treatment Period|Adverse Event|1|||
42306598|NCT01912222|76142401|FG001|Part B: Treatment Period|Adverse Event|2|||
42306599|NCT01912222|76142402|FG002|Part B: Treatment Period|Adverse Event|3|||
42306600|NCT01912222|76142400|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
42306601|NCT01912222|76142401|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
42306602|NCT01912222|76142402|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
41991275|NCT01215916|75799314|FG001|Overall Study|Death|1|||
41991276|NCT01215916|75799315|FG002|Overall Study|Death|0|||
42306603|NCT02525861|76142413|FG000|Overall Study|Adverse Event|1|||
42306604|NCT02525861|76142414|FG001|Overall Study|Adverse Event|0|||
42306605|NCT02525861|76142413|FG000|Overall Study|Withdrawal by Subject|0|||
42306606|NCT02525861|76142414|FG001|Overall Study|Withdrawal by Subject|1|||
42306607|NCT02525861|76142413|FG000|Overall Study|Physician Decision|0|||
42306608|NCT02525861|76142414|FG001|Overall Study|Physician Decision|1|||
42306609|NCT02524847|76142422|FG000|Overall Study|Adverse Event|4|||
42306610|NCT02524847|76142422|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
42306611|NCT02524847|76142422|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
42306612|NCT02524847|76142422|FG000|Overall Study|Death|1|||
42306613|NCT02524847|76142422|FG000|Overall Study|Reason not Specified|1|||
42306614|NCT02525627|76142429|FG000|Overall Study|Revision|1|||
42306615|NCT02525627|76142430|FG001|Overall Study|Revision|1|||
42306616|NCT02525627|76142429|FG000|Overall Study|Withdrawal by Subject|1|||
42306617|NCT02525627|76142430|FG001|Overall Study|Withdrawal by Subject|2|||
42306618|NCT02525627|76142429|FG000|Overall Study|Death|1|||
42306619|NCT02525627|76142430|FG001|Overall Study|Death|0|||
42306620|NCT02525627|76142429|FG000|Overall Study|Site terminated|11|||
42306621|NCT02525627|76142430|FG001|Overall Study|Site terminated|10|||
42306622|NCT02129205|76142446|FG000|Overall Study|Withdrawal by Subject|0|||
42306623|NCT02129205|76142447|FG001|Overall Study|Withdrawal by Subject|0|||
42306624|NCT02129205|76142448|FG002|Overall Study|Withdrawal by Subject|0|||
42306625|NCT02129205|76142449|FG003|Overall Study|Withdrawal by Subject|0|||
42306626|NCT02129205|76142450|FG004|Overall Study|Withdrawal by Subject|1|||
42306627|NCT02129205|76142451|FG005|Overall Study|Withdrawal by Subject|1|||
42306628|NCT02129205|76142452|FG006|Overall Study|Withdrawal by Subject|1|||
42306629|NCT02129205|76142453|FG007|Overall Study|Withdrawal by Subject|0|||
42252532|NCT03045887|76078458|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42252533|NCT03045887|76078459|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
42306630|NCT02129205|76142454|FG008|Overall Study|Withdrawal by Subject|1|||
42306631|NCT02129205|76142455|FG009|Overall Study|Withdrawal by Subject|0|||
42306632|NCT02129205|76142446|FG000|Overall Study|Other|1|||
42306633|NCT02129205|76142447|FG001|Overall Study|Other|0|||
42306634|NCT02129205|76142448|FG002|Overall Study|Other|0|||
42306635|NCT02129205|76142449|FG003|Overall Study|Other|0|||
42306636|NCT02129205|76142450|FG004|Overall Study|Other|2|||
42306637|NCT02129205|76142451|FG005|Overall Study|Other|3|||
42306638|NCT02129205|76142452|FG006|Overall Study|Other|3|||
42306639|NCT02129205|76142453|FG007|Overall Study|Other|2|||
42306640|NCT02129205|76142454|FG008|Overall Study|Other|1|||
42306641|NCT02129205|76142455|FG009|Overall Study|Other|0|||
42306642|NCT02128269|76142479|FG000|Treatment Period|Adverse Event|1|||
42306643|NCT02128269|76142479|FG000|Treatment Period|Physician Decision|1|||
42252534|NCT01564537|76078488|FG000|Overall Study|Site Terminated by Sponsor|1|||
42252535|NCT01564537|76078489|FG001|Overall Study|Site Terminated by Sponsor|0|||
42252536|NCT01564537|76078488|FG000|Overall Study|Withdrawal by Subject|12|||
42306644|NCT01626885|76142483|FG000|Overall Study|Adverse Event|8|||
42306645|NCT01626885|76142483|FG000|Overall Study|Withdrawal by Subject|4|||
41991277|NCT01215916|75799316|FG003|Overall Study|Death|0|||
41991278|NCT01215916|75799317|FG004|Overall Study|Death|1|||
41991279|NCT01215916|75799318|FG005|Overall Study|Death|0|||
41991280|NCT01215916|75799319|FG006|Overall Study|Death|0|||
41991281|NCT01215916|75799320|FG007|Overall Study|Death|0|||
41991282|NCT01215916|75799321|FG008|Overall Study|Death|1|||
42252537|NCT01564537|76078489|FG001|Overall Study|Withdrawal by Subject|14|||
42252538|NCT01564537|76078488|FG000|Overall Study|Lost to Follow-up|7|||
42252539|NCT01564537|76078489|FG001|Overall Study|Lost to Follow-up|3|||
42252540|NCT01564537|76078488|FG000|Overall Study|Reason not specified|81|||
42252541|NCT01564537|76078489|FG001|Overall Study|Reason not specified|82|||
42252542|NCT03042611|76078500|FG000|Core Phase|Withdrawal by Subject|13|||
42252543|NCT03042611|76078501|FG001|Core Phase|Withdrawal by Subject|4|||
42252544|NCT03042611|76078502|FG002|Core Phase|Withdrawal by Subject|0|||
42252545|NCT03042611|76078503|FG003|Core Phase|Withdrawal by Subject|0|||
42252546|NCT03042611|76078500|FG000|Core Phase|Death|232|||
42252547|NCT03042611|76078501|FG001|Core Phase|Death|110|||
42306646|NCT02524379|76142487|FG000|Overall Study|Death|1|||
42306647|NCT02524145|76142494|FG000|Overall Study|Withdrawal by Subject|2|||
42306648|NCT02524145|76142495|FG001|Overall Study|Withdrawal by Subject|2|||
42306649|NCT02524145|76142496|FG002|Overall Study|Withdrawal by Subject|3|||
42306650|NCT01658813|76142504|FG000|Overall Study|Disease progression|3|||
42306651|NCT02187471|76142516|FG000|Overall Study|Protocol Violation|4|||
42306652|NCT02187471|76142517|FG001|Overall Study|Protocol Violation|5|||
42306653|NCT02187471|76142518|FG002|Overall Study|Protocol Violation|4|||
42306654|NCT02187471|76142519|FG003|Overall Study|Protocol Violation|4|||
42306655|NCT02187471|76142516|FG000|Overall Study|Missing|0|||
42306656|NCT02187471|76142517|FG001|Overall Study|Missing|0|||
42306657|NCT02187471|76142518|FG002|Overall Study|Missing|0|||
41991283|NCT01215916|75799313|FG000|Overall Study|Physician Decision|0|||
41991284|NCT01215916|75799314|FG001|Overall Study|Physician Decision|0|||
41991285|NCT01215916|75799315|FG002|Overall Study|Physician Decision|1|||
42306658|NCT02187471|76142519|FG003|Overall Study|Missing|1|||
42306659|NCT02187471|76142516|FG000|Overall Study|Lack of Efficacy|18|||
42306660|NCT02187471|76142517|FG001|Overall Study|Lack of Efficacy|9|||
42306661|NCT02187471|76142518|FG002|Overall Study|Lack of Efficacy|13|||
42306662|NCT02187471|76142519|FG003|Overall Study|Lack of Efficacy|11|||
42306663|NCT02187471|76142516|FG000|Overall Study|Adverse Event|24|||
42306664|NCT02187471|76142517|FG001|Overall Study|Adverse Event|34|||
42306665|NCT02187471|76142518|FG002|Overall Study|Adverse Event|44|||
42306666|NCT02187471|76142519|FG003|Overall Study|Adverse Event|36|||
42306667|NCT02187471|76142516|FG000|Overall Study|Withdrawal by Subject|23|||
42306668|NCT02187471|76142517|FG001|Overall Study|Withdrawal by Subject|29|||
42306669|NCT02187471|76142518|FG002|Overall Study|Withdrawal by Subject|22|||
42306670|NCT02187471|76142519|FG003|Overall Study|Withdrawal by Subject|24|||
42306671|NCT02187471|76142516|FG000|Overall Study|Other|7|||
42306672|NCT02187471|76142517|FG001|Overall Study|Other|5|||
42306673|NCT02187471|76142518|FG002|Overall Study|Other|3|||
42306674|NCT02187471|76142519|FG003|Overall Study|Other|4|||
42306675|NCT02525471|76142530|FG000|Overall Study|Screen Failure|6|||
42306676|NCT02525471|76142530|FG000|Overall Study|Withdrawal by Subject|4|||
42306677|NCT02525471|76142530|FG000|Overall Study|Death|1|||
42306678|NCT01658735|76142538|FG000|Overall Study|Lack of Efficacy|1|||
42306679|NCT01658735|76142539|FG001|Overall Study|Lack of Efficacy|0|||
42306680|NCT01658735|76142540|FG002|Overall Study|Lack of Efficacy|1|||
42306681|NCT01658735|76142538|FG000|Overall Study|Lost to Follow-up|1|||
42306682|NCT01658735|76142539|FG001|Overall Study|Lost to Follow-up|1|||
42306683|NCT01658735|76142540|FG002|Overall Study|Lost to Follow-up|0|||
42306684|NCT01658735|76142538|FG000|Overall Study|Protocol Violation|0|||
42306685|NCT01658735|76142539|FG001|Overall Study|Protocol Violation|1|||
42306686|NCT01658735|76142540|FG002|Overall Study|Protocol Violation|0|||
42306687|NCT01658735|76142538|FG000|Overall Study|Withdrawal by Subject|3|||
42306688|NCT01658735|76142539|FG001|Overall Study|Withdrawal by Subject|5|||
42306689|NCT01658735|76142540|FG002|Overall Study|Withdrawal by Subject|3|||
42306690|NCT02523599|76142550|FG000|Overall Study|Adverse Event|1|||
42306691|NCT02523599|76142551|FG001|Overall Study|Adverse Event|0|||
42306692|NCT02523599|76142550|FG000|Overall Study|Physician Decision|1|||
42306693|NCT02523599|76142551|FG001|Overall Study|Physician Decision|0|||
42306694|NCT02523599|76142550|FG000|Overall Study|Lost to Follow-up|4|||
42306695|NCT02523599|76142551|FG001|Overall Study|Lost to Follow-up|1|||
42306696|NCT02523599|76142550|FG000|Overall Study|Did not return for Day 30 visit|2|||
42306697|NCT02523599|76142551|FG001|Overall Study|Did not return for Day 30 visit|0|||
42306698|NCT02187159|76142561|FG000|Overall Study|Protocol Violation|4|||
42306699|NCT02187159|76142562|FG001|Overall Study|Protocol Violation|6|||
42306700|NCT02187159|76142563|FG002|Overall Study|Protocol Violation|3|||
42306701|NCT02187159|76142564|FG003|Overall Study|Protocol Violation|4|||
42306702|NCT02187159|76142561|FG000|Overall Study|Lack of Efficacy|10|||
42306703|NCT02187159|76142562|FG001|Overall Study|Lack of Efficacy|5|||
42306704|NCT02187159|76142563|FG002|Overall Study|Lack of Efficacy|4|||
42306705|NCT02187159|76142564|FG003|Overall Study|Lack of Efficacy|7|||
42306706|NCT02187159|76142561|FG000|Overall Study|Adverse Event|28|||
42306707|NCT02187159|76142562|FG001|Overall Study|Adverse Event|33|||
42306708|NCT02187159|76142563|FG002|Overall Study|Adverse Event|42|||
42306709|NCT02187159|76142564|FG003|Overall Study|Adverse Event|50|||
42306710|NCT02187159|76142561|FG000|Overall Study|Withdrawal by Subject|24|||
42306711|NCT02187159|76142562|FG001|Overall Study|Withdrawal by Subject|28|||
42033221|NCT00861757|75841355|FG000|Overall Study|Lack of Efficacy|3|||
42132855|NCT00412893|75943721|FG001|Overall Study|Violation of Selection at Entry|10|||
42252548|NCT03042611|76078502|FG002|Core Phase|Death|0|||
42252549|NCT03042611|76078503|FG003|Core Phase|Death|0|||
42252550|NCT03042611|76078500|FG000|Core Phase|Lost to Follow-up|4|||
42252551|NCT03042611|76078501|FG001|Core Phase|Lost to Follow-up|7|||
42252552|NCT03042611|76078502|FG002|Core Phase|Lost to Follow-up|0|||
42252553|NCT03042611|76078503|FG003|Core Phase|Lost to Follow-up|0|||
42252554|NCT03042611|76078500|FG000|Core Phase|Physician Decision|7|||
42252555|NCT03042611|76078501|FG001|Core Phase|Physician Decision|2|||
42252556|NCT03042611|76078502|FG002|Core Phase|Physician Decision|0|||
42252557|NCT03042611|76078503|FG003|Core Phase|Physician Decision|0|||
42252558|NCT03042611|76078500|FG000|Core Phase|Study Closed|0|||
42252559|NCT03042611|76078501|FG001|Core Phase|Study Closed|1|||
42252560|NCT03042611|76078502|FG002|Core Phase|Study Closed|0|||
42252561|NCT03042611|76078503|FG003|Core Phase|Study Closed|0|||
42252562|NCT03042611|76078500|FG000|Extension Phase|Death|0|||
42252563|NCT03042611|76078501|FG001|Extension Phase|Death|0|||
42252564|NCT03042611|76078502|FG002|Extension Phase|Death|34|||
42252565|NCT03042611|76078503|FG003|Extension Phase|Death|16|||
42252566|NCT03042611|76078500|FG000|Extension Phase|Lost to Follow-up|0|||
42252567|NCT03042611|76078501|FG001|Extension Phase|Lost to Follow-up|0|||
42252568|NCT03042611|76078502|FG002|Extension Phase|Lost to Follow-up|1|||
42306712|NCT02187159|76142563|FG002|Overall Study|Withdrawal by Subject|25|||
42252569|NCT03042611|76078503|FG003|Extension Phase|Lost to Follow-up|1|||
42252570|NCT03042611|76078500|FG000|Extension Phase|Study Closed|0|||
42252571|NCT03042611|76078501|FG001|Extension Phase|Study Closed|0|||
42306713|NCT02187159|76142564|FG003|Overall Study|Withdrawal by Subject|26|||
42306714|NCT02187159|76142561|FG000|Overall Study|Other|3|||
42306715|NCT02187159|76142562|FG001|Overall Study|Other|7|||
42306716|NCT02187159|76142563|FG002|Overall Study|Other|3|||
42306717|NCT02187159|76142564|FG003|Overall Study|Other|9|||
42306718|NCT02335411|76142577|FG000|Overall Study|Death|223|||
42306719|NCT02335411|76142578|FG001|Overall Study|Death|22|||
42306720|NCT02335411|76142579|FG002|Overall Study|Death|26|||
42306721|NCT02335411|76142577|FG000|Overall Study|Physician Decision|3|||
42306722|NCT02335411|76142578|FG001|Overall Study|Physician Decision|0|||
42306723|NCT02335411|76142579|FG002|Overall Study|Physician Decision|0|||
42306724|NCT02335411|76142577|FG000|Overall Study|Protocol Violation|1|||
42306725|NCT02335411|76142578|FG001|Overall Study|Protocol Violation|0|||
42306726|NCT02335411|76142579|FG002|Overall Study|Protocol Violation|0|||
42306727|NCT02335411|76142577|FG000|Overall Study|Withdrawal by Subject|11|||
42306728|NCT02335411|76142578|FG001|Overall Study|Withdrawal by Subject|0|||
42306729|NCT02335411|76142579|FG002|Overall Study|Withdrawal by Subject|3|||
42306730|NCT02335411|76142577|FG000|Overall Study|Sponsor Decision|12|||
42306731|NCT02335411|76142578|FG001|Overall Study|Sponsor Decision|3|||
42306732|NCT02335411|76142579|FG002|Overall Study|Sponsor Decision|2|||
42306733|NCT02335411|76142577|FG000|Overall Study|Adverse Event|9|||
42306734|NCT02335411|76142578|FG001|Overall Study|Adverse Event|0|||
42306735|NCT02335411|76142579|FG002|Overall Study|Adverse Event|0|||
42306736|NCT02186301|76142593|FG000|Overall Study|Progressive Disease|7|||
42306737|NCT02186301|76142594|FG001|Overall Study|Progressive Disease|22|||
42306738|NCT02186301|76142595|FG002|Overall Study|Progressive Disease|27|||
42306739|NCT02186301|76142593|FG000|Overall Study|Adverse Event|5|||
42306740|NCT02186301|76142594|FG001|Overall Study|Adverse Event|5|||
42306741|NCT02186301|76142595|FG002|Overall Study|Adverse Event|5|||
42306742|NCT02186301|76142593|FG000|Overall Study|Death|1|||
42306743|NCT02186301|76142594|FG001|Overall Study|Death|0|||
42306744|NCT02186301|76142595|FG002|Overall Study|Death|0|||
42306745|NCT02186301|76142593|FG000|Overall Study|Withdrawal by Subject|5|||
42306746|NCT02186301|76142594|FG001|Overall Study|Withdrawal by Subject|1|||
42306747|NCT02186301|76142595|FG002|Overall Study|Withdrawal by Subject|3|||
42306748|NCT02186301|76142593|FG000|Overall Study|Physician Decision|1|||
42306749|NCT02186301|76142594|FG001|Overall Study|Physician Decision|0|||
42306750|NCT02186301|76142595|FG002|Overall Study|Physician Decision|1|||
42306751|NCT02186301|76142593|FG000|Overall Study|Study Terminated by Sponsor|1|||
42306752|NCT02186301|76142594|FG001|Overall Study|Study Terminated by Sponsor|0|||
42306753|NCT02186301|76142595|FG002|Overall Study|Study Terminated by Sponsor|11|||
42306754|NCT02186301|76142593|FG000|Overall Study|Protocol Deviation|0|||
42306755|NCT02186301|76142594|FG001|Overall Study|Protocol Deviation|2|||
42306756|NCT02186301|76142595|FG002|Overall Study|Protocol Deviation|0|||
42306757|NCT02186301|76142593|FG000|Overall Study|Missing|0|||
42306758|NCT02186301|76142594|FG001|Overall Study|Missing|0|||
42306759|NCT02186301|76142595|FG002|Overall Study|Missing|2|||
42306760|NCT02186301|76142593|FG000|Overall Study|Other|0|||
42306761|NCT02186301|76142594|FG001|Overall Study|Other|0|||
42306762|NCT02186301|76142595|FG002|Overall Study|Other|1|||
42306763|NCT02186223|76142605|FG000|Overall Study|Not eligible for device placement|6|||
42252572|NCT03042611|76078502|FG002|Extension Phase|Study Closed|17|||
42252573|NCT03042611|76078503|FG003|Extension Phase|Study Closed|11|||
42252574|NCT02701634|76078511|FG000|Overall Study|Adverse Event|2|||
42252575|NCT02701634|76078512|FG001|Overall Study|Adverse Event|3|||
42252576|NCT02701634|76078511|FG000|Overall Study|Death|1|||
42252577|NCT02701634|76078512|FG001|Overall Study|Death|0|||
42252578|NCT02701634|76078511|FG000|Overall Study|Investigator's Discretion|7|||
42252579|NCT02701634|76078512|FG001|Overall Study|Investigator's Discretion|4|||
42252580|NCT02701634|76078511|FG000|Overall Study|Study terminated by Sponsor|15|||
42252581|NCT02701634|76078512|FG001|Overall Study|Study terminated by Sponsor|17|||
42252582|NCT02701634|76078511|FG000|Overall Study|Withdrew Consent|6|||
42252583|NCT02701634|76078512|FG001|Overall Study|Withdrew Consent|7|||
42252584|NCT02701634|76078511|FG000|Overall Study|Randomized but not treated|1|||
42252585|NCT02701634|76078512|FG001|Overall Study|Randomized but not treated|0|||
42252586|NCT02442765|76078522|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
42252587|NCT02442765|76078523|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
42252588|NCT02442765|76078524|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
42252589|NCT02442765|76078525|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
42252590|NCT02442765|76078526|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
42306764|NCT02186223|76142605|FG000|Overall Study|Unable to obtain femoral access|3|||
42306765|NCT02186223|76142605|FG000|Overall Study|Death|3|||
42306766|NCT02186223|76142605|FG000|Overall Study|Device in place less than 48 hours|9|||
42306767|NCT02163057|76142612|FG000|Overall Study|Participant Refusal to Continue|2|||
42306768|NCT02163057|76142613|FG001|Overall Study|Participant Refusal to Continue|2|||
42306769|NCT02163057|76142612|FG000|Overall Study|Participant Significant Noncompliance|0|||
42306770|NCT02163057|76142613|FG001|Overall Study|Participant Significant Noncompliance|1|||
42306771|NCT02163057|76142612|FG000|Overall Study|Progression of Disease|1|||
42306772|NCT02163057|76142613|FG001|Overall Study|Progression of Disease|2|||
42306773|NCT02185521|76142621|FG000|Overall Study|Withdrawal by Subject|1|||
42306774|NCT02185521|76142621|FG000|Overall Study|Protocol Violation|1|||
42252591|NCT02442765|76078527|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
42252592|NCT02442765|76078528|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
42252593|NCT02442765|76078529|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
42252594|NCT02442765|76078522|FG000|Stage 2- (Days 43 to 85)|Death|0|||
42252595|NCT02442765|76078523|FG001|Stage 2- (Days 43 to 85)|Death|0|||
42252596|NCT02442765|76078524|FG002|Stage 2- (Days 43 to 85)|Death|0|||
42252597|NCT02442765|76078525|FG003|Stage 2- (Days 43 to 85)|Death|1|||
42252598|NCT02442765|76078526|FG004|Stage 2- (Days 43 to 85)|Death|1|||
42252599|NCT02442765|76078527|FG005|Stage 2- (Days 43 to 85)|Death|0|||
42252600|NCT02442765|76078528|FG006|Stage 2- (Days 43 to 85)|Death|2|||
42252601|NCT02442765|76078529|FG007|Stage 2- (Days 43 to 85)|Death|0|||
42252602|NCT02442765|76078522|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
42252603|NCT02442765|76078523|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
42252604|NCT02442765|76078524|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
42252605|NCT02442765|76078525|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
42252606|NCT02442765|76078526|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
42252607|NCT02442765|76078527|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
42252608|NCT02442765|76078528|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
42252609|NCT02442765|76078529|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
42252610|NCT02442765|76078522|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
42252611|NCT02442765|76078523|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
42252612|NCT02442765|76078524|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
42252613|NCT02442765|76078525|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
42252614|NCT02442765|76078526|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
42252615|NCT02442765|76078527|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
42252616|NCT02442765|76078528|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
42252617|NCT02442765|76078529|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
42252618|NCT02442765|76078522|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
42252619|NCT02442765|76078523|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
42252620|NCT02442765|76078524|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
42252621|NCT02442765|76078525|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
42252622|NCT02442765|76078526|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
42252623|NCT02442765|76078527|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
42252624|NCT02442765|76078528|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
42252625|NCT02442765|76078529|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
41991286|NCT01215916|75799316|FG003|Overall Study|Physician Decision|1|||
41991287|NCT01215916|75799317|FG004|Overall Study|Physician Decision|0|||
41991288|NCT01215916|75799318|FG005|Overall Study|Physician Decision|0|||
41991289|NCT01215916|75799319|FG006|Overall Study|Physician Decision|0|||
41991290|NCT01215916|75799320|FG007|Overall Study|Physician Decision|0|||
41991291|NCT01215916|75799321|FG008|Overall Study|Physician Decision|0|||
41991292|NCT01184872|75799347|FG000|Overall Study|Adverse Event|3|||
41991293|NCT01184872|75799348|FG001|Overall Study|Adverse Event|4|||
41991294|NCT01184872|75799347|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
41991295|NCT01184872|75799348|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
41991296|NCT01184872|75799347|FG000|Overall Study|Withdrawal by Subject|2|||
41991297|NCT01184872|75799348|FG001|Overall Study|Withdrawal by Subject|0|||
41991298|NCT01184872|75799347|FG000|Overall Study|Lost to Follow-up|0|||
41991299|NCT01184872|75799348|FG001|Overall Study|Lost to Follow-up|1|||
41991300|NCT01184872|75799347|FG000|Overall Study|Administrative problems|1|||
41991301|NCT01184872|75799348|FG001|Overall Study|Administrative problems|1|||
41991302|NCT01184872|75799347|FG000|Overall Study|Protocol deviation|1|||
41991303|NCT01184872|75799348|FG001|Overall Study|Protocol deviation|0|||
41991304|NCT01215721|75799354|FG000|Overall Study|Adverse Event|2|||
41991305|NCT01184326|75799361|FG000|Overall Study|Adverse Event|1|||
41991306|NCT01184326|75799362|FG001|Overall Study|Adverse Event|2|||
42252626|NCT02442765|76078522|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
42252627|NCT02442765|76078523|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
42252628|NCT02442765|76078524|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
42252629|NCT02442765|76078525|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
42252630|NCT02442765|76078526|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
42252631|NCT02442765|76078527|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
42252632|NCT02442765|76078528|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
42252633|NCT02442765|76078529|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
42252634|NCT02442765|76078522|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
42252635|NCT02442765|76078523|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
42252636|NCT02442765|76078524|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
41991307|NCT01184326|75799363|FG002|Overall Study|Adverse Event|0|||
41991308|NCT01184326|75799361|FG000|Overall Study|Death|0|||
41991309|NCT01184326|75799362|FG001|Overall Study|Death|0|||
41991310|NCT01184326|75799363|FG002|Overall Study|Death|1|||
41991311|NCT01184326|75799361|FG000|Overall Study|Withdrawal by Subject|0|||
42033222|NCT00861757|75841356|FG001|Overall Study|Lack of Efficacy|1|||
42033223|NCT00861757|75841357|FG002|Overall Study|Lack of Efficacy|0|||
42033224|NCT00861757|75841358|FG003|Overall Study|Lack of Efficacy|1|||
42033225|NCT00861757|75841355|FG000|Overall Study|Lost to Follow-up|1|||
42033226|NCT00861757|75841356|FG001|Overall Study|Lost to Follow-up|0|||
42033227|NCT00861757|75841357|FG002|Overall Study|Lost to Follow-up|1|||
42033228|NCT00861757|75841358|FG003|Overall Study|Lost to Follow-up|1|||
42033229|NCT00861757|75841355|FG000|Overall Study|Physician Decision|0|||
42033230|NCT00861757|75841356|FG001|Overall Study|Physician Decision|0|||
42252637|NCT02442765|76078525|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
42252638|NCT02442765|76078526|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
42252639|NCT02442765|76078527|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
42252640|NCT02442765|76078528|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
42252641|NCT02442765|76078529|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
42252642|NCT02442765|76078522|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
42252643|NCT02442765|76078523|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
42252644|NCT02442765|76078524|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
42252645|NCT02442765|76078525|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
42252646|NCT02442765|76078526|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
42252647|NCT02442765|76078527|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
42252648|NCT02442765|76078528|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
42252649|NCT02442765|76078529|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
42252650|NCT02699684|76078560|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
42252651|NCT02699684|76078561|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
42252652|NCT02700698|76078570|FG000|Overall Study|Withdrawal by Subject|1|||
42252653|NCT02700698|76078571|FG001|Overall Study|Withdrawal by Subject|0|||
42252654|NCT01774721|76078579|FG000|Overall Study|Death|133|||
42252655|NCT01774721|76078580|FG001|Overall Study|Death|152|||
42252656|NCT01774721|76078579|FG000|Overall Study|Withdrawal by Subject|20|||
42252657|NCT01774721|76078580|FG001|Overall Study|Withdrawal by Subject|14|||
42252658|NCT01774721|76078579|FG000|Overall Study|Lost to Follow-up|6|||
42252659|NCT01774721|76078580|FG001|Overall Study|Lost to Follow-up|7|||
42252660|NCT01774721|76078579|FG000|Overall Study|Did not meet eligibility criteria|0|||
42252661|NCT01774721|76078580|FG001|Overall Study|Did not meet eligibility criteria|3|||
42252662|NCT01774721|76078579|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
42252663|NCT01774721|76078580|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
42252664|NCT01774721|76078579|FG000|Overall Study|Study terminated by sponsor|5|||
42252665|NCT01774721|76078580|FG001|Overall Study|Study terminated by sponsor|0|||
42252666|NCT01774721|76078579|FG000|Overall Study|Disease progression|5|||
42252667|NCT01774721|76078580|FG001|Overall Study|Disease progression|0|||
42252668|NCT02699450|76078592|FG000|Overall Study|Death|2|||
42252669|NCT02699450|76078593|FG001|Overall Study|Death|1|||
42252670|NCT02699450|76078594|FG002|Overall Study|Death|2|||
42252671|NCT02699450|76078592|FG000|Overall Study|Met Criteria for Study Exit|0|||
42252672|NCT02699450|76078593|FG001|Overall Study|Met Criteria for Study Exit|0|||
42252673|NCT02699450|76078594|FG002|Overall Study|Met Criteria for Study Exit|1|||
42252674|NCT02699450|76078592|FG000|Overall Study|Protocol Violation|4|||
42252675|NCT02699450|76078593|FG001|Overall Study|Protocol Violation|3|||
42252676|NCT02699450|76078594|FG002|Overall Study|Protocol Violation|5|||
42252677|NCT02699450|76078592|FG000|Overall Study|Lost to Follow-up|3|||
41991312|NCT01184326|75799362|FG001|Overall Study|Withdrawal by Subject|0|||
41991313|NCT01184326|75799363|FG002|Overall Study|Withdrawal by Subject|1|||
41991314|NCT01184326|75799361|FG000|Overall Study|Physician Decision|1|||
41991315|NCT01184326|75799362|FG001|Overall Study|Physician Decision|1|||
41991316|NCT01184326|75799363|FG002|Overall Study|Physician Decision|0|||
41991317|NCT01184326|75799361|FG000|Overall Study|Disease Progression|1|||
41991318|NCT01184326|75799362|FG001|Overall Study|Disease Progression|3|||
41991319|NCT01184326|75799363|FG002|Overall Study|Disease Progression|12|||
41991320|NCT01215253|75799376|FG000|Overall Study|Withdrawal by Subject|57|||
41991321|NCT01215253|75799377|FG001|Overall Study|Withdrawal by Subject|35|||
41991322|NCT01215253|75799376|FG000|Overall Study|Physician Decision|9|||
41991323|NCT01215253|75799377|FG001|Overall Study|Physician Decision|12|||
41991324|NCT01215253|75799376|FG000|Overall Study|Lost to Follow-up|6|||
41991325|NCT01215253|75799377|FG001|Overall Study|Lost to Follow-up|4|||
41991326|NCT01215253|75799376|FG000|Overall Study|Other|14|||
41991327|NCT01215253|75799377|FG001|Overall Study|Other|12|||
42252678|NCT02699450|76078593|FG001|Overall Study|Lost to Follow-up|0|||
42252679|NCT02699450|76078594|FG002|Overall Study|Lost to Follow-up|5|||
42252680|NCT02699450|76078592|FG000|Overall Study|Physician Decision|2|||
42252681|NCT02699450|76078593|FG001|Overall Study|Physician Decision|0|||
42033231|NCT00861757|75841357|FG002|Overall Study|Physician Decision|0|||
42033232|NCT00861757|75841358|FG003|Overall Study|Physician Decision|1|||
42033233|NCT00861757|75841355|FG000|Overall Study|Protocol Violation|2|||
42306775|NCT01599585|76142628|FG000|Overall Study|Withdrawal by Subject|16|||
42306776|NCT01599585|76142629|FG001|Overall Study|Withdrawal by Subject|9|||
42306777|NCT01599585|76142628|FG000|Overall Study|Lost to Follow-up|3|||
42306778|NCT01599585|76142629|FG001|Overall Study|Lost to Follow-up|5|||
42306779|NCT01599585|76142628|FG000|Overall Study|randomized did not start treatment|3|||
42306780|NCT01599585|76142629|FG001|Overall Study|randomized did not start treatment|3|||
42306781|NCT02185053|76142635|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
42306782|NCT02185053|76142636|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
42306783|NCT02185053|76142637|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
42306784|NCT02185053|76142635|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
42306785|NCT02185053|76142636|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
42306786|NCT02185053|76142637|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
42306787|NCT02185053|76142635|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
42306788|NCT02185053|76142636|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
42306789|NCT02185053|76142637|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
42306790|NCT02185053|76142635|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
42306791|NCT02185053|76142636|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
42306792|NCT02185053|76142637|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
42306793|NCT02185053|76142635|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
41991328|NCT01184053|75799384|FG000|Overall Study|progression while on treatment|3|||
41991329|NCT01183975|75799389|FG000|Overall Study|Lost to Follow-up|73|||
42033234|NCT00861757|75841356|FG001|Overall Study|Protocol Violation|2|||
42033235|NCT00861757|75841357|FG002|Overall Study|Protocol Violation|4|||
41991330|NCT01183858|75799395|FG000|Overall Study|Death not related to Progressive Disease|5|||
41991331|NCT01183858|75799396|FG001|Overall Study|Death not related to Progressive Disease|6|||
41991332|NCT01183858|75799395|FG000|Overall Study|Adverse Event|14|||
41991333|NCT01183858|75799396|FG001|Overall Study|Adverse Event|11|||
41991334|NCT01183858|75799395|FG000|Overall Study|Investigator's Decision|0|||
41991335|NCT01183858|75799396|FG001|Overall Study|Investigator's Decision|3|||
41991336|NCT01183858|75799395|FG000|Overall Study|Insufficient Therapeutic Response|2|||
41991337|NCT01183858|75799396|FG001|Overall Study|Insufficient Therapeutic Response|0|||
41991338|NCT01183858|75799395|FG000|Overall Study|Refused Treatment|1|||
42033236|NCT00861757|75841358|FG003|Overall Study|Protocol Violation|1|||
42033237|NCT00861757|75841355|FG000|Overall Study|Withdrawal by Subject|1|||
42033238|NCT00861757|75841356|FG001|Overall Study|Withdrawal by Subject|5|||
42132856|NCT00412893|75943720|FG000|Overall Study|Other Protocol Violation|10|||
41991339|NCT01183858|75799396|FG001|Overall Study|Refused Treatment|4|||
41991340|NCT01183858|75799395|FG000|Overall Study|Withdrew Consent|4|||
42033239|NCT00861757|75841357|FG002|Overall Study|Withdrawal by Subject|5|||
42132857|NCT00412893|75943721|FG001|Overall Study|Other Protocol Violation|6|||
42252682|NCT02699450|76078594|FG002|Overall Study|Physician Decision|0|||
42252683|NCT02699450|76078592|FG000|Overall Study|Withdrawal by Subject|3|||
42252684|NCT02699450|76078593|FG001|Overall Study|Withdrawal by Subject|1|||
42252685|NCT02699450|76078594|FG002|Overall Study|Withdrawal by Subject|2|||
42252686|NCT02699450|76078592|FG000|Overall Study|Adverse Event|1|||
42252687|NCT02699450|76078593|FG001|Overall Study|Adverse Event|0|||
42252688|NCT02699450|76078594|FG002|Overall Study|Adverse Event|0|||
42252689|NCT02699996|76078605|FG000|Overall Study|Withdrawal by Subject|5|||
42252690|NCT02699996|76078606|FG001|Overall Study|Withdrawal by Subject|2|||
42252691|NCT02739321|76078615|FG000|Overall Study|Lack of Efficacy|1|||
42252692|NCT02739321|76078616|FG001|Overall Study|Lack of Efficacy|1|||
42252693|NCT02739321|76078615|FG000|Overall Study|Lost to Follow-up|1|||
42252694|NCT02739321|76078616|FG001|Overall Study|Lost to Follow-up|1|||
42306794|NCT02185053|76142636|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
42306795|NCT02185053|76142637|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
42306796|NCT02185053|76142635|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
42306797|NCT02185053|76142636|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
42306798|NCT02185053|76142637|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
42306799|NCT02185053|76142635|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
42306800|NCT02185053|76142636|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
42306801|NCT02185053|76142637|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
42306802|NCT02185053|76142635|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
42306803|NCT02185053|76142636|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
42306804|NCT02185053|76142637|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
42306805|NCT02161731|76142646|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
42306806|NCT02161731|76142647|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
42306807|NCT02161731|76142646|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
42306808|NCT02161731|76142647|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
42306809|NCT02124759|76142657|FG000|Overall Study|Withdrawal by Subject|3|||
42306810|NCT02124759|76142658|FG001|Overall Study|Withdrawal by Subject|1|||
42306811|NCT02124759|76142659|FG002|Overall Study|Withdrawal by Subject|1|||
42306812|NCT02124759|76142657|FG000|Overall Study|Screen Fail|2|||
42306813|NCT02124759|76142658|FG001|Overall Study|Screen Fail|2|||
42306814|NCT02124759|76142659|FG002|Overall Study|Screen Fail|3|||
42306815|NCT02302339|76142676|FG000|Overall Study|Lost to Follow-up|1|||
42306816|NCT02302339|76142677|FG001|Overall Study|Lost to Follow-up|0|||
42306817|NCT02302339|76142678|FG002|Overall Study|Lost to Follow-up|0|||
42306818|NCT02302339|76142679|FG003|Overall Study|Lost to Follow-up|0|||
42306819|NCT02302339|76142676|FG000|Overall Study|Withdrawal by Subject|0|||
42306820|NCT02302339|76142677|FG001|Overall Study|Withdrawal by Subject|2|||
42306821|NCT02302339|76142678|FG002|Overall Study|Withdrawal by Subject|1|||
42306822|NCT02302339|76142679|FG003|Overall Study|Withdrawal by Subject|0|||
42306823|NCT02161575|76142690|FG000|Overall Study|Protocol Violation|8|||
42306824|NCT02161575|76142690|FG000|Overall Study|Lack of Efficacy|1|||
42306825|NCT02161575|76142690|FG000|Overall Study|Adverse Event|2|||
42306826|NCT02370121|76142696|FG000|Overall Study|Lost to Follow-up|1|||
42306827|NCT02370121|76142697|FG001|Overall Study|Lost to Follow-up|1|||
42306828|NCT02161185|76142703|FG000|Treatment Phase|Administrative/Other|7|||
42306829|NCT02159469|76142707|FG000|Overall Study|Missing Completion status|1|||
42306830|NCT02159469|76142707|FG000|Overall Study|Adverse Event|5|||
42306831|NCT02159469|76142707|FG000|Overall Study|Non-compliance|2|||
42306832|NCT02159469|76142707|FG000|Overall Study|Withdrawal by Subject|9|||
42306833|NCT02159469|76142707|FG000|Overall Study|Lost to Follow-up|1|||
42306834|NCT02159469|76142707|FG000|Overall Study|Sponsor's request|2|||
42306835|NCT02159469|76142707|FG000|Overall Study|Met Stopping Criteria|3|||
42306836|NCT02159469|76142707|FG000|Overall Study|Other|1|||
42306837|NCT02159469|76142707|FG000|Overall Study|Multiple|29|||
42306838|NCT02123511|76142714|FG000|Overall Study|Cancelled treatment|1|||
42306839|NCT02123511|76142715|FG001|Overall Study|Cancelled treatment|0|||
42306840|NCT02123511|76142714|FG000|Overall Study|Incomplete data|1|||
42306841|NCT02123511|76142715|FG001|Overall Study|Incomplete data|3|||
42306842|NCT02123511|76142714|FG000|Overall Study|Ineligible|0|||
42306843|NCT02123511|76142715|FG001|Overall Study|Ineligible|1|||
42306844|NCT02122887|76142723|FG000|Overall Study|Withdrawal by Subject|20|||
42306845|NCT02122887|76142724|FG001|Overall Study|Withdrawal by Subject|2|||
42306846|NCT02182947|76142730|FG000|Overall Study|Withdrawal by Subject|7|||
42306847|NCT02182947|76142730|FG000|Overall Study|Lost to Follow-up|3|||
42306848|NCT02182947|76142730|FG000|Overall Study|Failed screening activities|8|||
42306849|NCT02370043|76142734|FG000|Overall Study|Withdrawal by Subject|0|||
42306850|NCT02370043|76142735|FG001|Overall Study|Withdrawal by Subject|0|||
42306851|NCT02370043|76142736|FG002|Overall Study|Withdrawal by Subject|0|||
42306852|NCT02370043|76142737|FG003|Overall Study|Withdrawal by Subject|0|||
42306853|NCT02370043|76142738|FG004|Overall Study|Withdrawal by Subject|1|||
42306854|NCT02370043|76142739|FG005|Overall Study|Withdrawal by Subject|1|||
42306855|NCT02301403|76142769|FG000|Overall Study|Withdrawal by Subject|28|||
42306856|NCT02301403|76142770|FG001|Overall Study|Withdrawal by Subject|41|||
42306857|NCT02301169|76142778|FG000|Overall Study|Adverse Event|1|||
42306858|NCT02301169|76142779|FG001|Overall Study|Adverse Event|0|||
42306859|NCT02333383|76142785|FG000|Overall Study|Adalimumab discontinuation|21|||
42306860|NCT02333383|76142785|FG000|Overall Study|Lost to Follow-up|15|||
42306861|NCT02333383|76142785|FG000|Overall Study|Withdrawal by Subject|3|||
41991341|NCT01183858|75799396|FG001|Overall Study|Withdrew Consent|4|||
41991342|NCT01183858|75799395|FG000|Overall Study|Discontinued Smoking|3|||
42306862|NCT02333383|76142785|FG000|Overall Study|Transfer to another hospital|2|||
42306863|NCT02332915|76142791|FG000|Overall Study|Moved out of region|3|||
42306864|NCT02332915|76142792|FG001|Overall Study|Moved out of region|0|||
42306865|NCT02332915|76142791|FG000|Overall Study|Unrelated illness|1|||
42306866|NCT02332915|76142792|FG001|Overall Study|Unrelated illness|1|||
42306867|NCT02332915|76142791|FG000|Overall Study|Travel distance prohibitive|0|||
42306868|NCT02332915|76142792|FG001|Overall Study|Travel distance prohibitive|1|||
42306869|NCT02332915|76142791|FG000|Overall Study|did not meet inclusion criteria|2|||
42132858|NCT00412893|75943720|FG000|Overall Study|Did Not Cooperate|12|||
42132859|NCT00412893|75943721|FG001|Overall Study|Did Not Cooperate|9|||
42132860|NCT00412893|75943720|FG000|Overall Study|Administrative Reason|12|||
42252695|NCT02739321|76078615|FG000|Overall Study|Withdrawal by Subject|1|||
42306870|NCT02332915|76142792|FG001|Overall Study|did not meet inclusion criteria|4|||
42306871|NCT02369341|76142805|FG000|Overall Study|Migrated/moved from study area|1|||
42306872|NCT02369341|76142806|FG001|Overall Study|Migrated/moved from study area|0|||
42306873|NCT02121795|76142818|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
42306874|NCT02121795|76142819|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
42306875|NCT02121795|76142818|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
42306876|NCT02121795|76142819|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
42306877|NCT02121795|76142818|FG000|Double-Blind Phase|Lost to Follow-up|7|||
42306878|NCT02121795|76142819|FG001|Double-Blind Phase|Lost to Follow-up|4|||
42306879|NCT02121795|76142818|FG000|Double-Blind Phase|Physician Decision|2|||
42306880|NCT02121795|76142819|FG001|Double-Blind Phase|Physician Decision|5|||
42306881|NCT02121795|76142818|FG000|Double-Blind Phase|Adverse Event|5|||
42306882|NCT02121795|76142819|FG001|Double-Blind Phase|Adverse Event|0|||
42306883|NCT02121795|76142818|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
42306884|NCT02121795|76142819|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
42306885|NCT02121795|76142818|FG000|Double-Blind Phase|Protocol Violation|0|||
42306886|NCT02121795|76142819|FG001|Double-Blind Phase|Protocol Violation|3|||
42306887|NCT02121795|76142818|FG000|Double-Blind Phase|Death|1|||
42306888|NCT02121795|76142819|FG001|Double-Blind Phase|Death|1|||
42306889|NCT02121795|76142818|FG000|Open-Label Phase|Physician Decision|8|||
42306890|NCT02121795|76142819|FG001|Open-Label Phase|Physician Decision|8|||
42306891|NCT02121795|76142818|FG000|Open-Label Phase|Withdrawal by Subject|3|||
42306892|NCT02121795|76142819|FG001|Open-Label Phase|Withdrawal by Subject|2|||
42306893|NCT02121795|76142818|FG000|Open-Label Phase|Lost to Follow-up|1|||
41991343|NCT01183858|75799396|FG001|Overall Study|Discontinued Smoking|1|||
42306894|NCT02121795|76142819|FG001|Open-Label Phase|Lost to Follow-up|0|||
42306895|NCT02158533|76142830|FG000|Stage 1|Adverse Event|6|||
42306896|NCT02158533|76142831|FG001|Stage 1|Adverse Event|4|||
42306897|NCT02158533|76142832|FG002|Stage 1|Adverse Event|7|||
42306898|NCT02158533|76142833|FG003|Stage 1|Adverse Event|0|||
42306899|NCT02158533|76142834|FG004|Stage 1|Adverse Event|0|||
42306900|NCT02158533|76142835|FG005|Stage 1|Adverse Event|0|||
41991344|NCT01183858|75799395|FG000|Overall Study|Protocol Violation|1|||
41991345|NCT01183858|75799396|FG001|Overall Study|Protocol Violation|0|||
41991346|NCT01183858|75799395|FG000|Overall Study|Administrative/Other|6|||
41991347|NCT01183858|75799396|FG001|Overall Study|Administrative/Other|6|||
41991348|NCT01183858|75799395|FG000|Overall Study|Progressive Disease|112|||
41991349|NCT01183858|75799396|FG001|Overall Study|Progressive Disease|115|||
41991350|NCT01183858|75799395|FG000|Overall Study|Death related to Progressive Disease|4|||
41991351|NCT01183858|75799396|FG001|Overall Study|Death related to Progressive Disease|5|||
41991352|NCT01183858|75799395|FG000|Overall Study|Lost to Follow-up|1|||
41991353|NCT01183858|75799396|FG001|Overall Study|Lost to Follow-up|1|||
41991354|NCT01215175|75799407|FG000|Overall Study|Lost to Follow-up|0|||
42033240|NCT00861757|75841358|FG003|Overall Study|Withdrawal by Subject|2|||
42033241|NCT01131455|75841375|FG000|Overall Study|Death of PI|6|||
42033242|NCT01131455|75841376|FG001|Overall Study|Death of PI|4|||
42132861|NCT00412893|75943721|FG001|Overall Study|Administrative Reason|15|||
42252696|NCT02739321|76078616|FG001|Overall Study|Withdrawal by Subject|2|||
42252697|NCT02696798|76078634|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
42252698|NCT02696798|76078635|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
42252699|NCT02696798|76078636|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
42252700|NCT02696798|76078634|FG000|Blinded Treatment Dosing Period|Death|0|||
42252701|NCT02696798|76078635|FG001|Blinded Treatment Dosing Period|Death|0|||
42252702|NCT02696798|76078636|FG002|Blinded Treatment Dosing Period|Death|1|||
42252703|NCT02696798|76078634|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
42252704|NCT02696798|76078635|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
42252705|NCT02696798|76078636|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
42252706|NCT02696798|76078634|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
42306901|NCT02158533|76142830|FG000|Stage 1|Withdrawal by Subject|3|||
42306902|NCT02158533|76142831|FG001|Stage 1|Withdrawal by Subject|2|||
41991355|NCT01215175|75799408|FG001|Overall Study|Lost to Follow-up|1|||
42132862|NCT00412893|75943720|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
42252707|NCT02696798|76078635|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
42306903|NCT02158533|76142832|FG002|Stage 1|Withdrawal by Subject|1|||
42306904|NCT02158533|76142833|FG003|Stage 1|Withdrawal by Subject|0|||
42306905|NCT02158533|76142834|FG004|Stage 1|Withdrawal by Subject|0|||
42306906|NCT02158533|76142835|FG005|Stage 1|Withdrawal by Subject|0|||
42306907|NCT02158533|76142830|FG000|Stage 1|Lack of Efficacy|1|||
42306908|NCT02158533|76142831|FG001|Stage 1|Lack of Efficacy|0|||
42306909|NCT02158533|76142832|FG002|Stage 1|Lack of Efficacy|0|||
42306910|NCT02158533|76142833|FG003|Stage 1|Lack of Efficacy|0|||
42306911|NCT02158533|76142834|FG004|Stage 1|Lack of Efficacy|0|||
42306912|NCT02158533|76142835|FG005|Stage 1|Lack of Efficacy|0|||
42306913|NCT02158533|76142830|FG000|Stage 1|Lost to Follow-up|3|||
42306914|NCT02158533|76142831|FG001|Stage 1|Lost to Follow-up|1|||
42306915|NCT02158533|76142832|FG002|Stage 1|Lost to Follow-up|0|||
42306916|NCT02158533|76142833|FG003|Stage 1|Lost to Follow-up|0|||
42306917|NCT02158533|76142834|FG004|Stage 1|Lost to Follow-up|0|||
42306918|NCT02158533|76142835|FG005|Stage 1|Lost to Follow-up|0|||
42306919|NCT02158533|76142830|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
42306920|NCT02158533|76142831|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
42306921|NCT02158533|76142832|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
42306922|NCT02158533|76142833|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
42306923|NCT02158533|76142834|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
42306924|NCT02158533|76142835|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
42306925|NCT02158533|76142830|FG000|Stage 1|Non-compliance with study visits|1|||
42306926|NCT02158533|76142831|FG001|Stage 1|Non-compliance with study visits|0|||
42306927|NCT02158533|76142832|FG002|Stage 1|Non-compliance with study visits|0|||
42306928|NCT02158533|76142833|FG003|Stage 1|Non-compliance with study visits|0|||
42306929|NCT02158533|76142834|FG004|Stage 1|Non-compliance with study visits|0|||
42306930|NCT02158533|76142835|FG005|Stage 1|Non-compliance with study visits|0|||
42306931|NCT02158533|76142830|FG000|Stage 2|Adverse Event|0|||
42306932|NCT02158533|76142831|FG001|Stage 2|Adverse Event|0|||
42306933|NCT02158533|76142832|FG002|Stage 2|Adverse Event|0|||
42306934|NCT02158533|76142833|FG003|Stage 2|Adverse Event|0|||
42306935|NCT02158533|76142834|FG004|Stage 2|Adverse Event|0|||
42306936|NCT02158533|76142835|FG005|Stage 2|Adverse Event|1|||
42306937|NCT02158533|76142830|FG000|Stage 2|Lack of Efficacy|0|||
42306938|NCT02158533|76142831|FG001|Stage 2|Lack of Efficacy|0|||
42306939|NCT02158533|76142832|FG002|Stage 2|Lack of Efficacy|0|||
42306940|NCT02158533|76142833|FG003|Stage 2|Lack of Efficacy|0|||
42306941|NCT02158533|76142834|FG004|Stage 2|Lack of Efficacy|1|||
42306942|NCT02158533|76142835|FG005|Stage 2|Lack of Efficacy|0|||
42306943|NCT02158533|76142830|FG000|Stage 2|Lost to Follow-up|0|||
42306944|NCT02158533|76142831|FG001|Stage 2|Lost to Follow-up|0|||
42306945|NCT02158533|76142832|FG002|Stage 2|Lost to Follow-up|0|||
42306946|NCT02158533|76142833|FG003|Stage 2|Lost to Follow-up|1|||
42306947|NCT02158533|76142834|FG004|Stage 2|Lost to Follow-up|1|||
42306948|NCT02158533|76142835|FG005|Stage 2|Lost to Follow-up|2|||
42306949|NCT02158533|76142830|FG000|Stage 2|Withdrawal by Subject|0|||
42306950|NCT02158533|76142831|FG001|Stage 2|Withdrawal by Subject|0|||
41991356|NCT01215175|75799409|FG002|Overall Study|Lost to Follow-up|0|||
41991357|NCT01215175|75799410|FG003|Overall Study|Lost to Follow-up|1|||
42306951|NCT02158533|76142832|FG002|Stage 2|Withdrawal by Subject|0|||
42306952|NCT02158533|76142833|FG003|Stage 2|Withdrawal by Subject|0|||
42306953|NCT02158533|76142834|FG004|Stage 2|Withdrawal by Subject|1|||
41991358|NCT01215175|75799411|FG004|Overall Study|Lost to Follow-up|0|||
41991359|NCT01215097|75799425|FG000|Overall Study|Adverse Event|1|||
41991360|NCT01215097|75799426|FG001|Overall Study|Adverse Event|3|||
41991361|NCT01215097|75799425|FG000|Overall Study|Protocol Violation|0|||
42306954|NCT02158533|76142835|FG005|Stage 2|Withdrawal by Subject|2|||
42306955|NCT02158533|76142830|FG000|Stage 2|Physician Decision|0|||
42306956|NCT02158533|76142831|FG001|Stage 2|Physician Decision|0|||
42306957|NCT02158533|76142832|FG002|Stage 2|Physician Decision|0|||
42306958|NCT02158533|76142833|FG003|Stage 2|Physician Decision|0|||
42306959|NCT02158533|76142834|FG004|Stage 2|Physician Decision|1|||
42306960|NCT02158533|76142835|FG005|Stage 2|Physician Decision|0|||
42306961|NCT02158533|76142830|FG000|Stage 2|Pregnancy|0|||
42306962|NCT02158533|76142831|FG001|Stage 2|Pregnancy|0|||
42306963|NCT02158533|76142832|FG002|Stage 2|Pregnancy|0|||
42306964|NCT02158533|76142833|FG003|Stage 2|Pregnancy|1|||
42306965|NCT02158533|76142834|FG004|Stage 2|Pregnancy|0|||
42306966|NCT02158533|76142835|FG005|Stage 2|Pregnancy|0|||
41991362|NCT01215097|75799426|FG001|Overall Study|Protocol Violation|2|||
42306967|NCT02158533|76142830|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
42306968|NCT02158533|76142831|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
42306969|NCT02158533|76142832|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
42306970|NCT02158533|76142833|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
42306971|NCT02158533|76142834|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
42306972|NCT02158533|76142835|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
42306973|NCT02158533|76142830|FG000|Stage 2|Non-adherence with study visits|0|||
42306974|NCT02158533|76142831|FG001|Stage 2|Non-adherence with study visits|0|||
42306975|NCT02158533|76142832|FG002|Stage 2|Non-adherence with study visits|0|||
42306976|NCT02158533|76142833|FG003|Stage 2|Non-adherence with study visits|0|||
42306977|NCT02158533|76142834|FG004|Stage 2|Non-adherence with study visits|0|||
42306978|NCT02158533|76142835|FG005|Stage 2|Non-adherence with study visits|1|||
42306979|NCT02120781|76142851|FG000|Overall Study|Physician Decision|2|||
42306980|NCT02120781|76142852|FG001|Overall Study|Physician Decision|0|||
42306981|NCT02120781|76142851|FG000|Overall Study|Completion not documented|2|||
42306982|NCT02120781|76142852|FG001|Overall Study|Completion not documented|1|||
42306983|NCT02120625|76142858|FG000|Overall Study|Physician Decision|2|||
42306984|NCT02120469|76142865|FG000|Overall Study|HER-2/neu-amplified|1|||
42306985|NCT02120469|76142866|FG001|Overall Study|HER-2/neu-amplified|0|||
42306986|NCT02120469|76142867|FG002|Overall Study|HER-2/neu-amplified|1|||
42306987|NCT02157519|76142880|FG000|Overall Study|Death|3|||
42306988|NCT02157519|76142881|FG001|Overall Study|Death|1|||
42306989|NCT02157519|76142880|FG000|Overall Study|Withdrawal by Subject|7|||
42306990|NCT02157519|76142881|FG001|Overall Study|Withdrawal by Subject|0|||
42306991|NCT02157519|76142880|FG000|Overall Study|Lost to Follow-up|1|||
42306992|NCT02157519|76142881|FG001|Overall Study|Lost to Follow-up|0|||
42306993|NCT02180061|76142889|FG000|Overall Study|Adverse Event|4|||
42306994|NCT02180061|76142890|FG001|Overall Study|Adverse Event|2|||
42306995|NCT02180061|76142889|FG000|Overall Study|Clinical Progression|5|||
42306996|NCT02180061|76142890|FG001|Overall Study|Clinical Progression|1|||
42306997|NCT02180061|76142889|FG000|Overall Study|Progressive Disease|15|||
42306998|NCT02180061|76142890|FG001|Overall Study|Progressive Disease|5|||
42306999|NCT02180061|76142889|FG000|Overall Study|Physician Decision|1|||
42307000|NCT02180061|76142890|FG001|Overall Study|Physician Decision|0|||
42307001|NCT02179515|76142899|FG000|Overall Study|switched to alternative treatment|0|||
42307002|NCT02179515|76142900|FG001|Overall Study|switched to alternative treatment|1|||
42307003|NCT02179515|76142901|FG002|Overall Study|switched to alternative treatment|1|||
42307004|NCT02179515|76142899|FG000|Overall Study|Death|0|||
42307005|NCT02179515|76142900|FG001|Overall Study|Death|1|||
42307006|NCT02179515|76142901|FG002|Overall Study|Death|1|||
42307007|NCT02179515|76142899|FG000|Overall Study|refused further treatment|0|||
42307008|NCT02179515|76142900|FG001|Overall Study|refused further treatment|3|||
42307009|NCT02179515|76142901|FG002|Overall Study|refused further treatment|4|||
42307010|NCT02179515|76142899|FG000|Overall Study|Disease progression on study|2|||
42307011|NCT02179515|76142900|FG001|Overall Study|Disease progression on study|11|||
42307012|NCT02179515|76142901|FG002|Overall Study|Disease progression on study|8|||
42307013|NCT02120157|76142913|FG000|Overall Study|Death|8|||
42307014|NCT02119299|76142919|FG000|Overall Study|Withdrawal by Subject|7|||
42307015|NCT02119299|76142919|FG000|Overall Study|Lack of Efficacy|1|||
42307016|NCT02119299|76142919|FG000|Overall Study|Pregnancy|1|||
42307017|NCT02156271|76142925|FG000|Overall Study|Physician Decision|4|||
42307018|NCT02156271|76142926|FG001|Overall Study|Physician Decision|3|||
42307019|NCT01365455|76142935|FG000|Induction Period|Adverse Event|5|||
42307020|NCT01365455|76142936|FG001|Induction Period|Adverse Event|3|||
42307021|NCT01365455|76142937|FG002|Induction Period|Adverse Event|4|||
42307022|NCT01365455|76142938|FG003|Induction Period|Adverse Event|0|||
42307023|NCT01365455|76142939|FG004|Induction Period|Adverse Event|0|||
42307024|NCT01365455|76142935|FG000|Induction Period|Lack of Efficacy|1|||
42307025|NCT01365455|76142936|FG001|Induction Period|Lack of Efficacy|1|||
42307026|NCT01365455|76142937|FG002|Induction Period|Lack of Efficacy|0|||
42307027|NCT01365455|76142938|FG003|Induction Period|Lack of Efficacy|0|||
42307028|NCT01365455|76142939|FG004|Induction Period|Lack of Efficacy|0|||
42307029|NCT01365455|76142935|FG000|Induction Period|Pregnancy|0|||
42307030|NCT01365455|76142936|FG001|Induction Period|Pregnancy|1|||
42307031|NCT01365455|76142937|FG002|Induction Period|Pregnancy|0|||
42307032|NCT01365455|76142938|FG003|Induction Period|Pregnancy|0|||
42307033|NCT01365455|76142939|FG004|Induction Period|Pregnancy|0|||
42307034|NCT01365455|76142935|FG000|Induction Period|Protocol deviation|0|||
42307035|NCT01365455|76142936|FG001|Induction Period|Protocol deviation|1|||
42307036|NCT01365455|76142937|FG002|Induction Period|Protocol deviation|1|||
42307037|NCT01365455|76142938|FG003|Induction Period|Protocol deviation|0|||
42307038|NCT01365455|76142939|FG004|Induction Period|Protocol deviation|0|||
42307039|NCT01365455|76142935|FG000|Induction Period|Subject/guardian decision|9|||
42132863|NCT00412893|75943721|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
42307040|NCT01365455|76142936|FG001|Induction Period|Subject/guardian decision|1|||
42307041|NCT01365455|76142937|FG002|Induction Period|Subject/guardian decision|8|||
42307042|NCT01365455|76142938|FG003|Induction Period|Subject/guardian decision|0|||
42307043|NCT01365455|76142939|FG004|Induction Period|Subject/guardian decision|0|||
42307044|NCT01365455|76142935|FG000|Induction Period|Lost to Follow-up|0|||
42307045|NCT01365455|76142936|FG001|Induction Period|Lost to Follow-up|0|||
42307046|NCT01365455|76142937|FG002|Induction Period|Lost to Follow-up|3|||
42307047|NCT01365455|76142938|FG003|Induction Period|Lost to Follow-up|0|||
42307048|NCT01365455|76142939|FG004|Induction Period|Lost to Follow-up|0|||
42307049|NCT01365455|76142935|FG000|Maintenance Period|Adverse Event|12|||
42307050|NCT01365455|76142936|FG001|Maintenance Period|Adverse Event|5|||
42307051|NCT01365455|76142937|FG002|Maintenance Period|Adverse Event|1|||
42307052|NCT01365455|76142938|FG003|Maintenance Period|Adverse Event|2|||
42307053|NCT01365455|76142939|FG004|Maintenance Period|Adverse Event|4|||
42307054|NCT01365455|76142935|FG000|Maintenance Period|Lack of Efficacy|10|||
42307055|NCT01365455|76142936|FG001|Maintenance Period|Lack of Efficacy|2|||
42307056|NCT01365455|76142937|FG002|Maintenance Period|Lack of Efficacy|0|||
42307057|NCT01365455|76142938|FG003|Maintenance Period|Lack of Efficacy|2|||
42307058|NCT01365455|76142939|FG004|Maintenance Period|Lack of Efficacy|2|||
42307059|NCT01365455|76142935|FG000|Maintenance Period|Lost to Follow-up|2|||
42307060|NCT01365455|76142936|FG001|Maintenance Period|Lost to Follow-up|4|||
42307061|NCT01365455|76142937|FG002|Maintenance Period|Lost to Follow-up|0|||
42307062|NCT01365455|76142938|FG003|Maintenance Period|Lost to Follow-up|0|||
42307063|NCT01365455|76142939|FG004|Maintenance Period|Lost to Follow-up|3|||
42307064|NCT01365455|76142935|FG000|Maintenance Period|Non-compliance with study treatment|0|||
42307065|NCT01365455|76142936|FG001|Maintenance Period|Non-compliance with study treatment|0|||
42307066|NCT01365455|76142937|FG002|Maintenance Period|Non-compliance with study treatment|0|||
42307067|NCT01365455|76142938|FG003|Maintenance Period|Non-compliance with study treatment|1|||
42307068|NCT01365455|76142939|FG004|Maintenance Period|Non-compliance with study treatment|0|||
42307069|NCT01365455|76142935|FG000|Maintenance Period|Physician Decision|0|||
42307070|NCT01365455|76142936|FG001|Maintenance Period|Physician Decision|1|||
42307071|NCT01365455|76142937|FG002|Maintenance Period|Physician Decision|0|||
42307072|NCT01365455|76142938|FG003|Maintenance Period|Physician Decision|0|||
42307073|NCT01365455|76142939|FG004|Maintenance Period|Physician Decision|1|||
42307074|NCT01365455|76142935|FG000|Maintenance Period|Pregnancy|0|||
42307075|NCT01365455|76142936|FG001|Maintenance Period|Pregnancy|4|||
42307076|NCT01365455|76142937|FG002|Maintenance Period|Pregnancy|0|||
42307077|NCT01365455|76142938|FG003|Maintenance Period|Pregnancy|0|||
42307078|NCT01365455|76142939|FG004|Maintenance Period|Pregnancy|2|||
42307079|NCT01365455|76142935|FG000|Maintenance Period|Protocol deviation|1|||
42307080|NCT01365455|76142936|FG001|Maintenance Period|Protocol deviation|1|||
42307081|NCT01365455|76142937|FG002|Maintenance Period|Protocol deviation|0|||
42307082|NCT01365455|76142938|FG003|Maintenance Period|Protocol deviation|0|||
42307083|NCT01365455|76142939|FG004|Maintenance Period|Protocol deviation|0|||
42307084|NCT01365455|76142935|FG000|Maintenance Period|Subject/guardian decision|4|||
42307085|NCT01365455|76142936|FG001|Maintenance Period|Subject/guardian decision|6|||
42307086|NCT01365455|76142937|FG002|Maintenance Period|Subject/guardian decision|2|||
42307087|NCT01365455|76142938|FG003|Maintenance Period|Subject/guardian decision|4|||
42307088|NCT01365455|76142939|FG004|Maintenance Period|Subject/guardian decision|1|||
42307089|NCT02155881|76142959|FG000|Overall Study|Withdrawal by Subject|0|||
42307090|NCT02155881|76142960|FG001|Overall Study|Withdrawal by Subject|2|||
42307091|NCT02155881|76142959|FG000|Overall Study|Inappropriately randomized|2|||
42307092|NCT02155881|76142960|FG001|Overall Study|Inappropriately randomized|2|||
42307093|NCT01658579|76142970|FG000|Treatment Period A|Other|0|||
42307094|NCT01658579|76142971|FG001|Treatment Period A|Other|0|||
42307095|NCT01658579|76142972|FG002|Treatment Period A|Other|1|||
42307096|NCT01658579|76142973|FG003|Treatment Period A|Other|1|||
42307097|NCT01658579|76142970|FG000|Treatment Period A|Adverse Event|1|||
42307098|NCT01658579|76142971|FG001|Treatment Period A|Adverse Event|0|||
42307099|NCT01658579|76142972|FG002|Treatment Period A|Adverse Event|0|||
42307100|NCT01658579|76142973|FG003|Treatment Period A|Adverse Event|0|||
42307101|NCT01658579|76142970|FG000|Treatment Period B|Other|0|||
42307102|NCT01658579|76142971|FG001|Treatment Period B|Other|0|||
42307103|NCT01658579|76142972|FG002|Treatment Period B|Other|0|||
42307104|NCT01658579|76142973|FG003|Treatment Period B|Other|1|||
42307105|NCT02154087|76142979|FG000|Overall Study|Study Termination|1|||
42307106|NCT02118597|76142983|FG000|Overall Study|Sponsor terminated the study|14|||
42307107|NCT02118597|76142983|FG000|Overall Study|Serious Adverse Event|1|||
42307108|NCT02118597|76142983|FG000|Overall Study|Investigator's decision|1|||
42307109|NCT01659125|76142987|FG000|Overall Study|Withdrawal by Subject|2|||
42307110|NCT01659125|76142987|FG000|Overall Study|Lost to Follow-up|7|||
42307111|NCT01659125|76142987|FG000|Overall Study|Technical Problem|1|||
42307112|NCT01659125|76142987|FG000|Overall Study|Time Constraints|2|||
42307113|NCT01659125|76142987|FG000|Overall Study|Failed to Start Treatment|2|||
42307114|NCT01657253|76142993|FG000|Overall Study|Lost to Follow-up|6|||
42307115|NCT01657253|76142994|FG001|Overall Study|Lost to Follow-up|5|||
42307116|NCT01657253|76142993|FG000|Overall Study|Withdrawal by Subject|11|||
42307117|NCT01657253|76142994|FG001|Overall Study|Withdrawal by Subject|12|||
42307118|NCT01657253|76142993|FG000|Overall Study|Adverse Event|0|||
42307119|NCT01657253|76142994|FG001|Overall Study|Adverse Event|1|||
42307120|NCT02117427|76143003|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
42307121|NCT02117427|76143004|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
42307122|NCT02117427|76143005|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
42307123|NCT02117427|76143003|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
42307124|NCT02117427|76143004|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
42307125|NCT02117427|76143005|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
42307126|NCT02117427|76143003|FG000|Overall Study|Physician Decision|0|||
42307127|NCT02117427|76143004|FG001|Overall Study|Physician Decision|2|||
42307128|NCT02117427|76143005|FG002|Overall Study|Physician Decision|0|||
42307129|NCT02117427|76143003|FG000|Overall Study|No longer meets inclusion criteria|0|||
42307130|NCT02117427|76143004|FG001|Overall Study|No longer meets inclusion criteria|1|||
42307131|NCT02117427|76143005|FG002|Overall Study|No longer meets inclusion criteria|0|||
42307132|NCT02117427|76143003|FG000|Overall Study|Death|0|||
42307133|NCT02117427|76143004|FG001|Overall Study|Death|1|||
42307134|NCT02117427|76143005|FG002|Overall Study|Death|0|||
42307135|NCT02117349|76143013|FG000|Overall Study|Withdrawal by Subject|1|||
42307136|NCT02117349|76143014|FG001|Overall Study|Withdrawal by Subject|0|||
42307137|NCT02117349|76143013|FG000|Overall Study|Lost to Follow-up|1|||
42307138|NCT02117349|76143014|FG001|Overall Study|Lost to Follow-up|1|||
42307139|NCT02117349|76143013|FG000|Overall Study|Death|1|||
42307140|NCT02117349|76143014|FG001|Overall Study|Death|0|||
42307141|NCT01626495|76143020|FG000|Overall Study|Adverse Event|3|||
42307142|NCT01626495|76143020|FG000|Overall Study|Disease progression|27|||
42307143|NCT01626495|76143020|FG000|Overall Study|Withdrawal by Subject|1|||
42307144|NCT01626495|76143020|FG000|Overall Study|Administrative problem|1|||
42307145|NCT01626495|76143020|FG000|Overall Study|Death|2|||
42307146|NCT01626495|76143020|FG000|Overall Study|Physician Decision|1|||
42307147|NCT01626495|76143020|FG000|Overall Study|New cancer therapy|16|||
42307148|NCT01626495|76143020|FG000|Overall Study|Manufacturing failure|1|||
42307149|NCT02177175|76143026|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
42307150|NCT02177175|76143027|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
42307151|NCT02153073|76143033|FG000|Overall Study|Case Report Forms Uncollected|230|||
42307152|NCT02153073|76143033|FG000|Overall Study|Protocol Deviation|68|||
42307153|NCT01657877|76143037|FG000|Overall Study|Withdrawal by Subject|4|||
42307154|NCT01657877|76143037|FG000|Overall Study|Protocol Violation|6|||
42307155|NCT01657877|76143037|FG000|Overall Study|Adverse Event|2|||
42307156|NCT01657877|76143037|FG000|Overall Study|Other Reason|2|||
42307157|NCT02175771|76143062|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
42307158|NCT02175771|76143063|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42307159|NCT02175771|76143064|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42307160|NCT02175771|76143065|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42307161|NCT02175771|76143066|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42307162|NCT02175771|76143067|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42307163|NCT02175771|76143068|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42307164|NCT02175771|76143069|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42307165|NCT02175771|76143070|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42307166|NCT02175771|76143062|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
42307167|NCT02175771|76143063|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42307168|NCT02175771|76143064|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42307169|NCT02175771|76143065|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42307170|NCT02175771|76143066|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42307171|NCT02175771|76143067|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42307172|NCT02175771|76143068|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42307173|NCT02175771|76143069|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42307174|NCT02175771|76143070|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42307175|NCT02175771|76143062|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
42307176|NCT02175771|76143063|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42307177|NCT02175771|76143064|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42307178|NCT02175771|76143065|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42307179|NCT02175771|76143066|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42307180|NCT02175771|76143067|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42307181|NCT02175771|76143068|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42307182|NCT02175771|76143069|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42307183|NCT02175771|76143070|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42307184|NCT02175771|76143062|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
42307185|NCT02175771|76143063|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
42307186|NCT02175771|76143064|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
42307187|NCT02175771|76143065|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
42307188|NCT02175771|76143066|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
42307189|NCT02175771|76143067|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
42307190|NCT02175771|76143068|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
42307191|NCT02175771|76143069|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
42307192|NCT02175771|76143070|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
42307193|NCT02175771|76143062|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
42307194|NCT02175771|76143063|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42307195|NCT02175771|76143064|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42307196|NCT02175771|76143065|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42307197|NCT02175771|76143066|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42307198|NCT02175771|76143067|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42307199|NCT02175771|76143068|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42307200|NCT02175771|76143069|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42307201|NCT02175771|76143070|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42307202|NCT02175771|76143062|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
42307203|NCT02175771|76143063|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42307204|NCT02175771|76143064|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42307205|NCT02175771|76143065|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42307206|NCT02175771|76143066|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42307207|NCT02175771|76143067|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42307208|NCT02175771|76143068|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42307209|NCT02175771|76143069|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42307210|NCT02175771|76143070|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42307211|NCT02175771|76143062|FG000|Run-In Period (Pre-assignment)|Other|8|||
42307212|NCT02175771|76143063|FG001|Run-In Period (Pre-assignment)|Other|0|||
42307213|NCT02175771|76143064|FG002|Run-In Period (Pre-assignment)|Other|0|||
42307214|NCT02175771|76143065|FG003|Run-In Period (Pre-assignment)|Other|0|||
42307215|NCT02175771|76143066|FG004|Run-In Period (Pre-assignment)|Other|0|||
42307216|NCT02175771|76143067|FG005|Run-In Period (Pre-assignment)|Other|0|||
42307217|NCT02175771|76143068|FG006|Run-In Period (Pre-assignment)|Other|0|||
42307218|NCT02175771|76143069|FG007|Run-In Period (Pre-assignment)|Other|0|||
42307219|NCT02175771|76143070|FG008|Run-In Period (Pre-assignment)|Other|0|||
42307220|NCT02175771|76143062|FG000|Treatment Period|Adverse Event|0|||
42307221|NCT02175771|76143063|FG001|Treatment Period|Adverse Event|2|||
42307222|NCT02175771|76143064|FG002|Treatment Period|Adverse Event|1|||
42307223|NCT02175771|76143065|FG003|Treatment Period|Adverse Event|1|||
42307224|NCT02175771|76143066|FG004|Treatment Period|Adverse Event|1|||
42307225|NCT02175771|76143067|FG005|Treatment Period|Adverse Event|3|||
42307226|NCT02175771|76143068|FG006|Treatment Period|Adverse Event|2|||
42307227|NCT02175771|76143069|FG007|Treatment Period|Adverse Event|0|||
42307228|NCT02175771|76143070|FG008|Treatment Period|Adverse Event|1|||
42307229|NCT02175771|76143062|FG000|Treatment Period|Withdrawal by Subject|0|||
42307230|NCT02175771|76143063|FG001|Treatment Period|Withdrawal by Subject|9|||
42307231|NCT02175771|76143064|FG002|Treatment Period|Withdrawal by Subject|3|||
42307232|NCT02175771|76143065|FG003|Treatment Period|Withdrawal by Subject|6|||
42307233|NCT02175771|76143066|FG004|Treatment Period|Withdrawal by Subject|2|||
42307234|NCT02175771|76143067|FG005|Treatment Period|Withdrawal by Subject|4|||
42307235|NCT02175771|76143068|FG006|Treatment Period|Withdrawal by Subject|2|||
42307236|NCT02175771|76143069|FG007|Treatment Period|Withdrawal by Subject|9|||
42307237|NCT02175771|76143070|FG008|Treatment Period|Withdrawal by Subject|2|||
42307238|NCT02175771|76143062|FG000|Treatment Period|Noncompliance|0|||
42307239|NCT02175771|76143063|FG001|Treatment Period|Noncompliance|1|||
42307240|NCT02175771|76143064|FG002|Treatment Period|Noncompliance|2|||
42307241|NCT02175771|76143065|FG003|Treatment Period|Noncompliance|0|||
42307242|NCT02175771|76143066|FG004|Treatment Period|Noncompliance|0|||
42307243|NCT02175771|76143067|FG005|Treatment Period|Noncompliance|0|||
42307244|NCT02175771|76143068|FG006|Treatment Period|Noncompliance|0|||
42307245|NCT02175771|76143069|FG007|Treatment Period|Noncompliance|0|||
42307246|NCT02175771|76143070|FG008|Treatment Period|Noncompliance|1|||
42307247|NCT02175771|76143062|FG000|Treatment Period|Protocol Violation|0|||
42307248|NCT02175771|76143063|FG001|Treatment Period|Protocol Violation|0|||
42307249|NCT02175771|76143064|FG002|Treatment Period|Protocol Violation|0|||
42307250|NCT02175771|76143065|FG003|Treatment Period|Protocol Violation|0|||
42307251|NCT02175771|76143066|FG004|Treatment Period|Protocol Violation|0|||
42307252|NCT02175771|76143067|FG005|Treatment Period|Protocol Violation|0|||
42307253|NCT02175771|76143068|FG006|Treatment Period|Protocol Violation|0|||
42307254|NCT02175771|76143069|FG007|Treatment Period|Protocol Violation|1|||
42307255|NCT02175771|76143070|FG008|Treatment Period|Protocol Violation|0|||
42307256|NCT02175771|76143062|FG000|Treatment Period|Disease progression|0|||
42307257|NCT02175771|76143063|FG001|Treatment Period|Disease progression|0|||
42307258|NCT02175771|76143064|FG002|Treatment Period|Disease progression|0|||
42307259|NCT02175771|76143065|FG003|Treatment Period|Disease progression|0|||
42307260|NCT02175771|76143066|FG004|Treatment Period|Disease progression|0|||
42307261|NCT02175771|76143067|FG005|Treatment Period|Disease progression|0|||
42307262|NCT02175771|76143068|FG006|Treatment Period|Disease progression|0|||
42307263|NCT02175771|76143069|FG007|Treatment Period|Disease progression|2|||
42307264|NCT02175771|76143070|FG008|Treatment Period|Disease progression|0|||
42307265|NCT02175771|76143062|FG000|Treatment Period|Lost to Follow-up|0|||
42307266|NCT02175771|76143063|FG001|Treatment Period|Lost to Follow-up|3|||
42307267|NCT02175771|76143064|FG002|Treatment Period|Lost to Follow-up|1|||
42307268|NCT02175771|76143065|FG003|Treatment Period|Lost to Follow-up|3|||
42307269|NCT02175771|76143066|FG004|Treatment Period|Lost to Follow-up|1|||
42307270|NCT02175771|76143067|FG005|Treatment Period|Lost to Follow-up|2|||
42307271|NCT02175771|76143068|FG006|Treatment Period|Lost to Follow-up|1|||
42307272|NCT02175771|76143069|FG007|Treatment Period|Lost to Follow-up|2|||
42307273|NCT02175771|76143070|FG008|Treatment Period|Lost to Follow-up|2|||
42307274|NCT02175771|76143062|FG000|Treatment Period|Lack of Efficacy|0|||
42307275|NCT02175771|76143063|FG001|Treatment Period|Lack of Efficacy|0|||
42307276|NCT02175771|76143064|FG002|Treatment Period|Lack of Efficacy|0|||
42307277|NCT02175771|76143065|FG003|Treatment Period|Lack of Efficacy|0|||
42307278|NCT02175771|76143066|FG004|Treatment Period|Lack of Efficacy|0|||
42307279|NCT02175771|76143067|FG005|Treatment Period|Lack of Efficacy|1|||
42307280|NCT02175771|76143068|FG006|Treatment Period|Lack of Efficacy|0|||
42307281|NCT02175771|76143069|FG007|Treatment Period|Lack of Efficacy|1|||
42307282|NCT02175771|76143070|FG008|Treatment Period|Lack of Efficacy|0|||
42307283|NCT02175771|76143062|FG000|Treatment Period|Other|0|||
42307284|NCT02175771|76143063|FG001|Treatment Period|Other|1|||
42307285|NCT02175771|76143064|FG002|Treatment Period|Other|0|||
42307286|NCT02175771|76143065|FG003|Treatment Period|Other|3|||
42307287|NCT02175771|76143066|FG004|Treatment Period|Other|1|||
42307288|NCT02175771|76143067|FG005|Treatment Period|Other|0|||
42307289|NCT02175771|76143068|FG006|Treatment Period|Other|0|||
42307290|NCT02175771|76143069|FG007|Treatment Period|Other|2|||
42307291|NCT02175771|76143070|FG008|Treatment Period|Other|0|||
42307292|NCT01657799|76143091|FG000|Overall Study|Adverse Event Related to progression|6|||
42307293|NCT01657799|76143092|FG001|Overall Study|Adverse Event Related to progression|8|||
42307294|NCT01657799|76143093|FG002|Overall Study|Adverse Event Related to progression|12|||
42307295|NCT01657799|76143091|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
42307296|NCT01657799|76143092|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
42307297|NCT01657799|76143093|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
42307298|NCT01657799|76143091|FG000|Overall Study|Withdrawal by Subject|13|||
42307299|NCT01657799|76143092|FG001|Overall Study|Withdrawal by Subject|10|||
42307300|NCT01657799|76143093|FG002|Overall Study|Withdrawal by Subject|10|||
42307301|NCT01657799|76143091|FG000|Overall Study|Lost to Follow-up|1|||
42307302|NCT01657799|76143092|FG001|Overall Study|Lost to Follow-up|0|||
42307303|NCT01657799|76143093|FG002|Overall Study|Lost to Follow-up|1|||
42307304|NCT01657799|76143091|FG000|Overall Study|Disease Progression|2|||
42307305|NCT01657799|76143092|FG001|Overall Study|Disease Progression|4|||
42307306|NCT01657799|76143093|FG002|Overall Study|Disease Progression|4|||
42307307|NCT01657799|76143091|FG000|Overall Study|Progressive Disease Clinical|7|||
42307308|NCT01657799|76143092|FG001|Overall Study|Progressive Disease Clinical|4|||
42307309|NCT01657799|76143093|FG002|Overall Study|Progressive Disease Clinical|7|||
42307310|NCT01657799|76143091|FG000|Overall Study|Radiographic & Clinical Progression|16|||
42307311|NCT01657799|76143092|FG001|Overall Study|Radiographic & Clinical Progression|11|||
42307312|NCT01657799|76143093|FG002|Overall Study|Radiographic & Clinical Progression|15|||
42307313|NCT01657799|76143091|FG000|Overall Study|Other|52|||
42307314|NCT01657799|76143092|FG001|Overall Study|Other|62|||
42307315|NCT01657799|76143093|FG002|Overall Study|Other|49|||
42307316|NCT02116803|76143103|FG000|Overall Study|Adverse Event|2|||
42307317|NCT02116803|76143104|FG001|Overall Study|Adverse Event|1|||
42307318|NCT02116803|76143103|FG000|Overall Study|Physician Decision|1|||
42307319|NCT02116803|76143104|FG001|Overall Study|Physician Decision|0|||
42307320|NCT02116803|76143103|FG000|Overall Study|Progressive disease|4|||
42307321|NCT02116803|76143104|FG001|Overall Study|Progressive disease|0|||
42307322|NCT02116803|76143103|FG000|Overall Study|Study terminated by sponsor|2|||
42307323|NCT02116803|76143104|FG001|Overall Study|Study terminated by sponsor|1|||
42307324|NCT02116803|76143103|FG000|Overall Study|Death|1|||
42307325|NCT02116803|76143104|FG001|Overall Study|Death|0|||
42307326|NCT02115321|76143112|FG000|Overall Study|Death|1|||
41991363|NCT01215097|75799425|FG000|Overall Study|Lost to Follow-up|2|||
42132864|NCT00412737|75943729|FG000|Overall Study|Death|1|||
42307327|NCT02115321|76143113|FG001|Overall Study|Death|0|||
42307328|NCT02367781|76143121|FG000|Overall Study|Withdrawal by Subject|20|||
42307329|NCT02367781|76143122|FG001|Overall Study|Withdrawal by Subject|13|||
42307330|NCT02367781|76143121|FG000|Overall Study|Protocol Violation|0|||
42307331|NCT02367781|76143122|FG001|Overall Study|Protocol Violation|1|||
42307332|NCT02367781|76143121|FG000|Overall Study|Physician Decision|7|||
42307333|NCT02367781|76143122|FG001|Overall Study|Physician Decision|0|||
42307334|NCT02367781|76143121|FG000|Overall Study|Randomized in Error|5|||
42307335|NCT02367781|76143122|FG001|Overall Study|Randomized in Error|4|||
42307336|NCT02367781|76143121|FG000|Overall Study|Non-Compliance|1|||
42307337|NCT02367781|76143122|FG001|Overall Study|Non-Compliance|0|||
42307338|NCT02367781|76143121|FG000|Overall Study|Lost to Follow-up|1|||
42307339|NCT02367781|76143122|FG001|Overall Study|Lost to Follow-up|2|||
42307340|NCT02367781|76143121|FG000|Overall Study|Death|330|||
42307341|NCT02367781|76143122|FG001|Overall Study|Death|176|||
42307342|NCT02367781|76143121|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
42132865|NCT00412737|75943730|FG001|Overall Study|Death|0|||
42307343|NCT02367781|76143122|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
42307344|NCT02367781|76143121|FG000|Overall Study|Prolonged Hospitalization|1|||
42307345|NCT02367781|76143122|FG001|Overall Study|Prolonged Hospitalization|0|||
42307346|NCT02367781|76143121|FG000|Overall Study|Death Prior First Dose|1|||
42307347|NCT02367781|76143122|FG001|Overall Study|Death Prior First Dose|0|||
42307348|NCT02367781|76143121|FG000|Overall Study|Administrative-Change Facility|1|||
42307349|NCT02367781|76143122|FG001|Overall Study|Administrative-Change Facility|0|||
42307350|NCT02367781|76143121|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
42307351|NCT02367781|76143122|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
42307352|NCT02367781|76143121|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
42307353|NCT02367781|76143122|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
42307354|NCT02367781|76143121|FG000|Overall Study|Study Terminated by Sponsor|3|||
42307355|NCT02367781|76143122|FG001|Overall Study|Study Terminated by Sponsor|1|||
42307356|NCT02367781|76143121|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
42252708|NCT02696798|76078636|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
42252709|NCT02696798|76078634|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
42132866|NCT00412737|75943729|FG000|Overall Study|Adverse Event|3|||
42252710|NCT02696798|76078635|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
42307357|NCT02367781|76143122|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
42307358|NCT02367781|76143121|FG000|Overall Study|Sponsor Decision|2|||
42307359|NCT02367781|76143122|FG001|Overall Study|Sponsor Decision|0|||
42307360|NCT02367781|76143121|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
42307361|NCT02367781|76143122|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
42307362|NCT02152761|76143134|FG000|Epoch: Treatment Epoch|Technical problems|0|||
42307363|NCT02152761|76143135|FG001|Epoch: Treatment Epoch|Technical problems|0|||
42307364|NCT02152761|76143136|FG002|Epoch: Treatment Epoch|Technical problems|0|||
42307365|NCT02152761|76143137|FG003|Epoch: Treatment Epoch|Technical problems|1|||
42307366|NCT02152761|76143134|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
42307367|NCT02152761|76143135|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
42307368|NCT02152761|76143136|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
42307369|NCT02152761|76143137|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
42307370|NCT02152761|76143134|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
42307371|NCT02152761|76143135|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
42307372|NCT02152761|76143136|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
42307373|NCT02152761|76143137|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
42307374|NCT02152761|76143134|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
42307375|NCT02152761|76143135|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
42307376|NCT02152761|76143136|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
42132867|NCT00412737|75943730|FG001|Overall Study|Adverse Event|2|||
42252711|NCT02696798|76078636|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
42252712|NCT02696798|76078634|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
42252713|NCT02696798|76078635|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
42252714|NCT02696798|76078636|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
42252715|NCT02696798|76078634|FG000|Extended Treatment Period|Adverse Event|1|||
42252716|NCT02696798|76078635|FG001|Extended Treatment Period|Adverse Event|4|||
42252717|NCT02696798|76078636|FG002|Extended Treatment Period|Adverse Event|5|||
42252718|NCT02696798|76078634|FG000|Extended Treatment Period|Lack of Efficacy|7|||
42252719|NCT02696798|76078635|FG001|Extended Treatment Period|Lack of Efficacy|2|||
42252720|NCT02696798|76078636|FG002|Extended Treatment Period|Lack of Efficacy|2|||
42252721|NCT02696798|76078634|FG000|Extended Treatment Period|Lost to Follow-up|1|||
42252722|NCT02696798|76078635|FG001|Extended Treatment Period|Lost to Follow-up|0|||
42252723|NCT02696798|76078636|FG002|Extended Treatment Period|Lost to Follow-up|0|||
42252724|NCT02696798|76078634|FG000|Extended Treatment Period|Physician Decision|0|||
42252725|NCT02696798|76078635|FG001|Extended Treatment Period|Physician Decision|1|||
42252726|NCT02696798|76078636|FG002|Extended Treatment Period|Physician Decision|0|||
42252727|NCT02696798|76078634|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
42252728|NCT02696798|76078635|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
42307377|NCT02152761|76143137|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
42307378|NCT02152761|76143134|FG000|Epoch: Treatment Epoch|Death|0|||
42307379|NCT02152761|76143135|FG001|Epoch: Treatment Epoch|Death|3|||
42307380|NCT02152761|76143136|FG002|Epoch: Treatment Epoch|Death|1|||
42307381|NCT02152761|76143137|FG003|Epoch: Treatment Epoch|Death|0|||
42307382|NCT02152761|76143134|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
42307383|NCT02152761|76143135|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
42307384|NCT02152761|76143136|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
42132868|NCT00412737|75943729|FG000|Overall Study|Refused Treatment|6|||
42252729|NCT02696798|76078636|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
41991364|NCT01215097|75799426|FG001|Overall Study|Lost to Follow-up|0|||
41991365|NCT01215097|75799425|FG000|Overall Study|Withdrawal by Subject|6|||
41991366|NCT01215097|75799426|FG001|Overall Study|Withdrawal by Subject|3|||
41991367|NCT01215097|75799425|FG000|Overall Study|Lack of Efficacy|0|||
41991368|NCT01215097|75799426|FG001|Overall Study|Lack of Efficacy|3|||
41991369|NCT01215097|75799425|FG000|Overall Study|patient's refusal to come|2|||
41991370|NCT01215097|75799426|FG001|Overall Study|patient's refusal to come|2|||
41991371|NCT01215097|75799425|FG000|Overall Study|patient's private reason|1|||
41991372|NCT01215097|75799426|FG001|Overall Study|patient's private reason|1|||
41991373|NCT03303339|75799444|FG000|Overall Study|Death|2|||
41991374|NCT03303339|75799445|FG001|Overall Study|Death|2|||
41991375|NCT03303339|75799446|FG002|Overall Study|Death|2|||
41991376|NCT03303339|75799447|FG003|Overall Study|Death|1|||
41991377|NCT03303339|75799448|FG004|Overall Study|Death|4|||
41991378|NCT03303339|75799449|FG005|Overall Study|Death|2|||
41991379|NCT03303339|75799450|FG006|Overall Study|Death|2|||
41991380|NCT03303339|75799451|FG007|Overall Study|Death|2|||
41991381|NCT03303339|75799452|FG008|Overall Study|Death|3|||
41991382|NCT03303339|75799453|FG009|Overall Study|Death|3|||
41991383|NCT03303339|75799454|FG010|Overall Study|Death|4|||
41991384|NCT03303339|75799455|FG011|Overall Study|Death|24|||
41991385|NCT03303339|75799444|FG000|Overall Study|Study Terminated by Sponsor|0|||
41991386|NCT03303339|75799445|FG001|Overall Study|Study Terminated by Sponsor|0|||
41991387|NCT03303339|75799446|FG002|Overall Study|Study Terminated by Sponsor|0|||
41991388|NCT03303339|75799447|FG003|Overall Study|Study Terminated by Sponsor|0|||
41991389|NCT03303339|75799448|FG004|Overall Study|Study Terminated by Sponsor|0|||
41991390|NCT03303339|75799449|FG005|Overall Study|Study Terminated by Sponsor|0|||
41991391|NCT03303339|75799450|FG006|Overall Study|Study Terminated by Sponsor|0|||
41991392|NCT03303339|75799451|FG007|Overall Study|Study Terminated by Sponsor|0|||
41991393|NCT03303339|75799452|FG008|Overall Study|Study Terminated by Sponsor|1|||
41991394|NCT03303339|75799453|FG009|Overall Study|Study Terminated by Sponsor|0|||
41991395|NCT03303339|75799454|FG010|Overall Study|Study Terminated by Sponsor|1|||
41991396|NCT03303339|75799455|FG011|Overall Study|Study Terminated by Sponsor|1|||
41991397|NCT03303339|75799444|FG000|Overall Study|Withdrawal by Subject|1|||
41991398|NCT03303339|75799445|FG001|Overall Study|Withdrawal by Subject|0|||
41991399|NCT03303339|75799446|FG002|Overall Study|Withdrawal by Subject|0|||
41991400|NCT03303339|75799447|FG003|Overall Study|Withdrawal by Subject|0|||
41991401|NCT03303339|75799448|FG004|Overall Study|Withdrawal by Subject|0|||
41991402|NCT03303339|75799449|FG005|Overall Study|Withdrawal by Subject|1|||
41991403|NCT03303339|75799450|FG006|Overall Study|Withdrawal by Subject|1|||
41991404|NCT03303339|75799451|FG007|Overall Study|Withdrawal by Subject|0|||
42132869|NCT00412737|75943730|FG001|Overall Study|Refused Treatment|2|||
41991405|NCT03303339|75799452|FG008|Overall Study|Withdrawal by Subject|0|||
42307385|NCT02152761|76143137|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
42307386|NCT02152761|76143134|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
42307387|NCT02152761|76143135|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
42307388|NCT02152761|76143136|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
42307389|NCT02152761|76143137|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
42307390|NCT02152761|76143134|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
42307391|NCT02152761|76143135|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
42307392|NCT02152761|76143136|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
42307393|NCT02152761|76143137|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
42307394|NCT02152761|76143134|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
42307395|NCT02152761|76143135|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
42307396|NCT02152761|76143136|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
42307397|NCT02152761|76143137|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
42307398|NCT02152761|76143134|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
42307399|NCT02152761|76143135|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
42307400|NCT02152761|76143136|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
42307401|NCT02152761|76143137|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
42307402|NCT02152605|76143159|FG000|Overall Study|Adverse Event|6|||
42307403|NCT02152605|76143160|FG001|Overall Study|Adverse Event|8|||
42307404|NCT02152605|76143159|FG000|Overall Study|Lack of Efficacy|7|||
42307405|NCT02152605|76143160|FG001|Overall Study|Lack of Efficacy|4|||
42307406|NCT02152605|76143159|FG000|Overall Study|Protocol deviation|1|||
42307407|NCT02152605|76143160|FG001|Overall Study|Protocol deviation|4|||
42307408|NCT02152605|76143159|FG000|Overall Study|Lost to Follow-up|1|||
42307409|NCT02152605|76143160|FG001|Overall Study|Lost to Follow-up|0|||
42307410|NCT02152605|76143159|FG000|Overall Study|Withdrew consent|4|||
42307411|NCT02152605|76143160|FG001|Overall Study|Withdrew consent|2|||
42307412|NCT02152371|76143169|FG000|Overall Study|Adverse Event|6|||
42307413|NCT02152371|76143170|FG001|Overall Study|Adverse Event|2|||
42307414|NCT02152371|76143169|FG000|Overall Study|Withdrawal by Subject|3|||
42307415|NCT02152371|76143170|FG001|Overall Study|Withdrawal by Subject|7|||
42307416|NCT02152371|76143169|FG000|Overall Study|Protocol Violation|2|||
42307417|NCT02152371|76143170|FG001|Overall Study|Protocol Violation|3|||
42307418|NCT02152371|76143169|FG000|Overall Study|Lost to Follow-up|1|||
42307419|NCT02152371|76143170|FG001|Overall Study|Lost to Follow-up|0|||
42307420|NCT02152371|76143169|FG000|Overall Study|Lack of Efficacy|0|||
42307421|NCT02152371|76143170|FG001|Overall Study|Lack of Efficacy|1|||
42307422|NCT02152371|76143169|FG000|Overall Study|Physician Decision|0|||
42307423|NCT02152371|76143170|FG001|Overall Study|Physician Decision|2|||
42307424|NCT02152371|76143169|FG000|Overall Study|Reason Not Given|0|||
42307425|NCT02152371|76143170|FG001|Overall Study|Reason Not Given|1|||
42307426|NCT02332291|76143178|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
42307427|NCT02332291|76143179|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
42307428|NCT02332291|76143178|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
42307429|NCT02332291|76143179|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
42307430|NCT02332291|76143178|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
42307431|NCT02332291|76143179|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
42307432|NCT02332291|76143178|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
41991406|NCT03303339|75799453|FG009|Overall Study|Withdrawal by Subject|0|||
41991407|NCT03303339|75799454|FG010|Overall Study|Withdrawal by Subject|0|||
41991408|NCT03303339|75799455|FG011|Overall Study|Withdrawal by Subject|2|||
41991409|NCT03303339|75799444|FG000|Overall Study|Physician Decision|0|||
42132870|NCT00412737|75943729|FG000|Overall Study|Failure to Return|6|||
42307433|NCT02332291|76143179|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
42307434|NCT02332291|76143178|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
42307435|NCT02332291|76143179|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
42307436|NCT02332291|76143178|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
42307437|NCT02332291|76143179|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
42307438|NCT01656395|76143195|FG000|Overall Study|Adverse Event|1|||
42307439|NCT01656395|76143196|FG001|Overall Study|Adverse Event|14|||
42307440|NCT01656395|76143197|FG002|Overall Study|Adverse Event|5|||
42307441|NCT01656395|76143198|FG003|Overall Study|Adverse Event|4|||
42307442|NCT01656395|76143199|FG004|Overall Study|Adverse Event|5|||
42307443|NCT01656395|76143200|FG005|Overall Study|Adverse Event|7|||
42307444|NCT01656395|76143201|FG006|Overall Study|Adverse Event|0|||
42307445|NCT01656395|76143202|FG007|Overall Study|Adverse Event|0|||
41991410|NCT03303339|75799445|FG001|Overall Study|Physician Decision|0|||
41991411|NCT03303339|75799446|FG002|Overall Study|Physician Decision|0|||
41991412|NCT03303339|75799447|FG003|Overall Study|Physician Decision|0|||
41991413|NCT03303339|75799448|FG004|Overall Study|Physician Decision|1|||
41991414|NCT03303339|75799449|FG005|Overall Study|Physician Decision|0|||
41991415|NCT03303339|75799450|FG006|Overall Study|Physician Decision|0|||
42252730|NCT02696798|76078634|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
42252731|NCT02696798|76078635|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
42252732|NCT02696798|76078636|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
42252733|NCT02696798|76078634|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
42252734|NCT02696798|76078635|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
42252735|NCT02696798|76078636|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
42252736|NCT02696798|76078634|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
42252737|NCT02696798|76078635|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
42252738|NCT02696798|76078636|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
42252739|NCT02696798|76078634|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
42252740|NCT02696798|76078635|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
42252741|NCT02696798|76078636|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
42252742|NCT02696798|76078634|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
42252743|NCT02696798|76078635|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
42252744|NCT02696798|76078636|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
42252745|NCT02696798|76078634|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
42252746|NCT02696798|76078635|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
42252747|NCT02696798|76078636|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
42252748|NCT02698826|76078658|FG000|Overall Study|Death|13|||
42252749|NCT02698826|76078658|FG000|Overall Study|Adverse Event|1|||
42252750|NCT02541604|76078676|FG000|Overall Study|Death|6|||
42252751|NCT02541604|76078677|FG001|Overall Study|Death|5|||
42252752|NCT02541604|76078678|FG002|Overall Study|Death|7|||
42252753|NCT02541604|76078679|FG003|Overall Study|Death|2|||
42252754|NCT02541604|76078680|FG004|Overall Study|Death|9|||
42252755|NCT02541604|76078681|FG005|Overall Study|Death|8|||
42252756|NCT02541604|76078682|FG006|Overall Study|Death|9|||
42252757|NCT02541604|76078683|FG007|Overall Study|Death|9|||
42252758|NCT02541604|76078684|FG008|Overall Study|Death|3|||
42307446|NCT01656395|76143195|FG000|Overall Study|Lack of Efficacy|1|||
42307447|NCT01656395|76143196|FG001|Overall Study|Lack of Efficacy|8|||
41991416|NCT03303339|75799451|FG007|Overall Study|Physician Decision|0|||
41991417|NCT03303339|75799452|FG008|Overall Study|Physician Decision|0|||
41991418|NCT03303339|75799453|FG009|Overall Study|Physician Decision|0|||
42252759|NCT02541604|76078685|FG009|Overall Study|Death|4|||
42252760|NCT02541604|76078686|FG010|Overall Study|Death|2|||
42252761|NCT02541604|76078687|FG011|Overall Study|Death|3|||
42252762|NCT02541604|76078676|FG000|Overall Study|Lost to Follow-up|2|||
42307448|NCT01656395|76143197|FG002|Overall Study|Lack of Efficacy|6|||
42307449|NCT01656395|76143198|FG003|Overall Study|Lack of Efficacy|1|||
42307450|NCT01656395|76143199|FG004|Overall Study|Lack of Efficacy|1|||
42307451|NCT01656395|76143200|FG005|Overall Study|Lack of Efficacy|6|||
42307452|NCT01656395|76143201|FG006|Overall Study|Lack of Efficacy|0|||
42307453|NCT01656395|76143202|FG007|Overall Study|Lack of Efficacy|0|||
42307454|NCT01656395|76143195|FG000|Overall Study|Lost to Follow-up|1|||
42307455|NCT01656395|76143196|FG001|Overall Study|Lost to Follow-up|0|||
42307456|NCT01656395|76143197|FG002|Overall Study|Lost to Follow-up|0|||
42307457|NCT01656395|76143198|FG003|Overall Study|Lost to Follow-up|0|||
42307458|NCT01656395|76143199|FG004|Overall Study|Lost to Follow-up|0|||
42307459|NCT01656395|76143200|FG005|Overall Study|Lost to Follow-up|0|||
42307460|NCT01656395|76143201|FG006|Overall Study|Lost to Follow-up|0|||
42307461|NCT01656395|76143202|FG007|Overall Study|Lost to Follow-up|0|||
42307462|NCT01656395|76143195|FG000|Overall Study|Non-Compliance with Study Drug|1|||
42307463|NCT01656395|76143196|FG001|Overall Study|Non-Compliance with Study Drug|1|||
42307464|NCT01656395|76143197|FG002|Overall Study|Non-Compliance with Study Drug|0|||
42307465|NCT01656395|76143198|FG003|Overall Study|Non-Compliance with Study Drug|0|||
42307466|NCT01656395|76143199|FG004|Overall Study|Non-Compliance with Study Drug|1|||
42307467|NCT01656395|76143200|FG005|Overall Study|Non-Compliance with Study Drug|1|||
42307468|NCT01656395|76143201|FG006|Overall Study|Non-Compliance with Study Drug|0|||
42307469|NCT01656395|76143202|FG007|Overall Study|Non-Compliance with Study Drug|0|||
42307470|NCT01656395|76143195|FG000|Overall Study|Other|0|||
42307471|NCT01656395|76143196|FG001|Overall Study|Other|0|||
42307472|NCT01656395|76143197|FG002|Overall Study|Other|1|||
42307473|NCT01656395|76143198|FG003|Overall Study|Other|0|||
42307474|NCT01656395|76143199|FG004|Overall Study|Other|0|||
42307475|NCT01656395|76143200|FG005|Overall Study|Other|1|||
42307476|NCT01656395|76143201|FG006|Overall Study|Other|0|||
42307477|NCT01656395|76143202|FG007|Overall Study|Other|0|||
42307478|NCT01656395|76143195|FG000|Overall Study|Physician Decision|2|||
42307479|NCT01656395|76143196|FG001|Overall Study|Physician Decision|3|||
42307480|NCT01656395|76143197|FG002|Overall Study|Physician Decision|3|||
42307481|NCT01656395|76143198|FG003|Overall Study|Physician Decision|2|||
42252763|NCT02541604|76078677|FG001|Overall Study|Lost to Follow-up|0|||
42252764|NCT02541604|76078678|FG002|Overall Study|Lost to Follow-up|1|||
42252765|NCT02541604|76078679|FG003|Overall Study|Lost to Follow-up|0|||
42252766|NCT02541604|76078680|FG004|Overall Study|Lost to Follow-up|0|||
42252767|NCT02541604|76078681|FG005|Overall Study|Lost to Follow-up|1|||
42252768|NCT02541604|76078682|FG006|Overall Study|Lost to Follow-up|1|||
42252769|NCT02541604|76078683|FG007|Overall Study|Lost to Follow-up|0|||
42252770|NCT02541604|76078684|FG008|Overall Study|Lost to Follow-up|0|||
42307482|NCT01656395|76143199|FG004|Overall Study|Physician Decision|3|||
42307483|NCT01656395|76143200|FG005|Overall Study|Physician Decision|3|||
42307484|NCT01656395|76143201|FG006|Overall Study|Physician Decision|0|||
42307485|NCT01656395|76143202|FG007|Overall Study|Physician Decision|0|||
42307486|NCT01656395|76143195|FG000|Overall Study|Pregnancy|0|||
42307487|NCT01656395|76143196|FG001|Overall Study|Pregnancy|0|||
42307488|NCT01656395|76143197|FG002|Overall Study|Pregnancy|1|||
42307489|NCT01656395|76143198|FG003|Overall Study|Pregnancy|0|||
42307490|NCT01656395|76143199|FG004|Overall Study|Pregnancy|0|||
42307491|NCT01656395|76143200|FG005|Overall Study|Pregnancy|0|||
42307492|NCT01656395|76143201|FG006|Overall Study|Pregnancy|0|||
42307493|NCT01656395|76143202|FG007|Overall Study|Pregnancy|0|||
42307494|NCT01656395|76143195|FG000|Overall Study|Progressive Disease|0|||
42307495|NCT01656395|76143196|FG001|Overall Study|Progressive Disease|0|||
42307496|NCT01656395|76143197|FG002|Overall Study|Progressive Disease|0|||
42307497|NCT01656395|76143198|FG003|Overall Study|Progressive Disease|0|||
42307498|NCT01656395|76143199|FG004|Overall Study|Progressive Disease|0|||
42307499|NCT01656395|76143200|FG005|Overall Study|Progressive Disease|1|||
42307500|NCT01656395|76143201|FG006|Overall Study|Progressive Disease|0|||
42307501|NCT01656395|76143202|FG007|Overall Study|Progressive Disease|0|||
42307502|NCT01656395|76143195|FG000|Overall Study|Protocol Violation|6|||
42307503|NCT01656395|76143196|FG001|Overall Study|Protocol Violation|6|||
42307504|NCT01656395|76143197|FG002|Overall Study|Protocol Violation|9|||
42307505|NCT01656395|76143198|FG003|Overall Study|Protocol Violation|2|||
42307506|NCT01656395|76143199|FG004|Overall Study|Protocol Violation|4|||
42307507|NCT01656395|76143200|FG005|Overall Study|Protocol Violation|10|||
42307508|NCT01656395|76143201|FG006|Overall Study|Protocol Violation|0|||
42307509|NCT01656395|76143202|FG007|Overall Study|Protocol Violation|0|||
42307510|NCT01656395|76143195|FG000|Overall Study|Screen Failure|2|||
42307511|NCT01656395|76143196|FG001|Overall Study|Screen Failure|1|||
42307512|NCT01656395|76143197|FG002|Overall Study|Screen Failure|7|||
41991419|NCT03303339|75799454|FG010|Overall Study|Physician Decision|0|||
42252771|NCT02541604|76078685|FG009|Overall Study|Lost to Follow-up|0|||
42252772|NCT02541604|76078686|FG010|Overall Study|Lost to Follow-up|0|||
42252773|NCT02541604|76078687|FG011|Overall Study|Lost to Follow-up|0|||
42252774|NCT02541604|76078676|FG000|Overall Study|Withdrawal by Subject|2|||
42252775|NCT02541604|76078677|FG001|Overall Study|Withdrawal by Subject|0|||
42252776|NCT02541604|76078678|FG002|Overall Study|Withdrawal by Subject|1|||
42252777|NCT02541604|76078679|FG003|Overall Study|Withdrawal by Subject|0|||
42252778|NCT02541604|76078680|FG004|Overall Study|Withdrawal by Subject|1|||
42252779|NCT02541604|76078681|FG005|Overall Study|Withdrawal by Subject|1|||
42252780|NCT02541604|76078682|FG006|Overall Study|Withdrawal by Subject|0|||
42252781|NCT02541604|76078683|FG007|Overall Study|Withdrawal by Subject|0|||
42252782|NCT02541604|76078684|FG008|Overall Study|Withdrawal by Subject|1|||
42252783|NCT02541604|76078685|FG009|Overall Study|Withdrawal by Subject|0|||
42252784|NCT02541604|76078686|FG010|Overall Study|Withdrawal by Subject|0|||
42252785|NCT02541604|76078687|FG011|Overall Study|Withdrawal by Subject|0|||
42252786|NCT02541604|76078676|FG000|Overall Study|Study Terminated by Sponsor|1|||
42252787|NCT02541604|76078677|FG001|Overall Study|Study Terminated by Sponsor|4|||
42252788|NCT02541604|76078678|FG002|Overall Study|Study Terminated by Sponsor|2|||
42252789|NCT02541604|76078679|FG003|Overall Study|Study Terminated by Sponsor|1|||
42252790|NCT02541604|76078680|FG004|Overall Study|Study Terminated by Sponsor|0|||
42252791|NCT02541604|76078681|FG005|Overall Study|Study Terminated by Sponsor|0|||
42252792|NCT02541604|76078682|FG006|Overall Study|Study Terminated by Sponsor|0|||
42252793|NCT02541604|76078683|FG007|Overall Study|Study Terminated by Sponsor|0|||
42252794|NCT02541604|76078684|FG008|Overall Study|Study Terminated by Sponsor|0|||
42252795|NCT02541604|76078685|FG009|Overall Study|Study Terminated by Sponsor|0|||
42252796|NCT02541604|76078686|FG010|Overall Study|Study Terminated by Sponsor|0|||
42252797|NCT02541604|76078687|FG011|Overall Study|Study Terminated by Sponsor|0|||
42252798|NCT02541604|76078676|FG000|Overall Study|Medical condition may jeopardize safety|0|||
42252799|NCT02541604|76078677|FG001|Overall Study|Medical condition may jeopardize safety|0|||
42252800|NCT02541604|76078678|FG002|Overall Study|Medical condition may jeopardize safety|0|||
42252801|NCT02541604|76078679|FG003|Overall Study|Medical condition may jeopardize safety|0|||
42252802|NCT02541604|76078680|FG004|Overall Study|Medical condition may jeopardize safety|0|||
41991420|NCT03303339|75799455|FG011|Overall Study|Physician Decision|0|||
42307513|NCT01656395|76143198|FG003|Overall Study|Screen Failure|1|||
42307514|NCT01656395|76143199|FG004|Overall Study|Screen Failure|0|||
42307515|NCT01656395|76143200|FG005|Overall Study|Screen Failure|8|||
42307516|NCT01656395|76143201|FG006|Overall Study|Screen Failure|0|||
42307517|NCT01656395|76143202|FG007|Overall Study|Screen Failure|0|||
42307518|NCT01656395|76143195|FG000|Overall Study|Withdrawal by Subject|3|||
42307519|NCT01656395|76143196|FG001|Overall Study|Withdrawal by Subject|1|||
42252803|NCT02541604|76078681|FG005|Overall Study|Medical condition may jeopardize safety|0|||
42252804|NCT02541604|76078682|FG006|Overall Study|Medical condition may jeopardize safety|0|||
42252805|NCT02541604|76078683|FG007|Overall Study|Medical condition may jeopardize safety|1|||
42252806|NCT02541604|76078684|FG008|Overall Study|Medical condition may jeopardize safety|0|||
42252807|NCT02541604|76078685|FG009|Overall Study|Medical condition may jeopardize safety|0|||
42252808|NCT02541604|76078686|FG010|Overall Study|Medical condition may jeopardize safety|0|||
42252809|NCT02541604|76078687|FG011|Overall Study|Medical condition may jeopardize safety|0|||
42252810|NCT02546674|76078736|FG000|Overall Study|Adverse Event|19|||
42252811|NCT02546674|76078736|FG000|Overall Study|Death|1|||
42252812|NCT02546674|76078736|FG000|Overall Study|Lost to Follow-up|1|||
42252813|NCT02546674|76078736|FG000|Overall Study|Physician Decision|13|||
42252814|NCT02546674|76078736|FG000|Overall Study|Pregnancy|1|||
42252815|NCT02546674|76078736|FG000|Overall Study|Progressive Disease|2|||
42252816|NCT02546674|76078736|FG000|Overall Study|Protocol Deviation|2|||
42252817|NCT02546674|76078736|FG000|Overall Study|Subject/Guardian Decision|6|||
42252818|NCT02546674|76078736|FG000|Overall Study|Withdrawal of Informed Consent|3|||
42252819|NCT02546362|76078741|FG000|4-week Treatment Period|Lost to Follow-up|1|||
42307520|NCT01656395|76143197|FG002|Overall Study|Withdrawal by Subject|4|||
42307521|NCT01656395|76143198|FG003|Overall Study|Withdrawal by Subject|2|||
42307522|NCT01656395|76143199|FG004|Overall Study|Withdrawal by Subject|0|||
42307523|NCT01656395|76143200|FG005|Overall Study|Withdrawal by Subject|3|||
42307524|NCT01656395|76143201|FG006|Overall Study|Withdrawal by Subject|0|||
42307525|NCT01656395|76143202|FG007|Overall Study|Withdrawal by Subject|0|||
42307526|NCT02114931|76143218|FG000|Overall Study|Withdrawal by Subject|15|||
42307527|NCT02114931|76143219|FG001|Overall Study|Withdrawal by Subject|18|||
42307528|NCT02114931|76143218|FG000|Overall Study|Adverse Event|4|||
42307529|NCT02114931|76143219|FG001|Overall Study|Adverse Event|6|||
42307530|NCT02114931|76143218|FG000|Overall Study|Lost to Follow-up|3|||
42307531|NCT02114931|76143219|FG001|Overall Study|Lost to Follow-up|3|||
42307532|NCT02114931|76143218|FG000|Overall Study|Physician Decision|1|||
42307533|NCT02114931|76143219|FG001|Overall Study|Physician Decision|2|||
42307534|NCT02114931|76143218|FG000|Overall Study|Other|2|||
42307535|NCT02114931|76143219|FG001|Overall Study|Other|1|||
42307536|NCT01657019|76143225|FG000|Overall Study|Withdrawal by Subject|65|||
42307537|NCT01657019|76143225|FG000|Overall Study|Adverse Event|55|||
42307538|NCT01657019|76143225|FG000|Overall Study|Lost to Follow-up|48|||
42307539|NCT01657019|76143225|FG000|Overall Study|Protocol Violation|6|||
42307540|NCT01657019|76143225|FG000|Overall Study|Lack of Efficacy|3|||
42307541|NCT01657019|76143225|FG000|Overall Study|Other|58|||
42307542|NCT02329327|76143231|FG000|Overall Study|Death|78|||
42307543|NCT02329327|76143232|FG001|Overall Study|Death|0|||
42307544|NCT02329327|76143231|FG000|Overall Study|Withdrawal by Subject|3|||
42307545|NCT02329327|76143232|FG001|Overall Study|Withdrawal by Subject|0|||
42307546|NCT02329327|76143231|FG000|Overall Study|Lost to Follow-up|4|||
42307547|NCT02329327|76143232|FG001|Overall Study|Lost to Follow-up|0|||
42307548|NCT02328937|76143251|FG000|Period 1|Lost to Follow-up|0|||
42307549|NCT02328937|76143252|FG001|Period 1|Lost to Follow-up|0|||
42307550|NCT02328937|76143253|FG002|Period 1|Lost to Follow-up|0|||
42307551|NCT02328937|76143254|FG003|Period 1|Lost to Follow-up|1|||
42307552|NCT02328937|76143255|FG004|Period 1|Lost to Follow-up|0|||
42307553|NCT02328937|76143256|FG005|Period 1|Lost to Follow-up|0|||
42307554|NCT02328937|76143251|FG000|Period 2|Adverse Event|0|||
42307555|NCT02328937|76143252|FG001|Period 2|Adverse Event|0|||
42307556|NCT02328937|76143253|FG002|Period 2|Adverse Event|1|||
42307557|NCT02328937|76143254|FG003|Period 2|Adverse Event|0|||
42307558|NCT02328937|76143255|FG004|Period 2|Adverse Event|0|||
42307559|NCT02328937|76143256|FG005|Period 2|Adverse Event|0|||
42307560|NCT02328547|76143266|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
42307561|NCT02328547|76143267|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
42307562|NCT02328547|76143266|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
42307563|NCT02328547|76143267|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
42307564|NCT02300311|76143281|FG000|Overall Study|Other than the reason specified|1|||
42307565|NCT02300311|76143282|FG001|Overall Study|Other than the reason specified|0|||
42307566|NCT02300311|76143281|FG000|Overall Study|Refused to continue taking medication|18|||
42307567|NCT02300311|76143282|FG001|Overall Study|Refused to continue taking medication|0|||
42307568|NCT02300233|76143295|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
42307569|NCT02300233|76143296|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
42307570|NCT02300233|76143297|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
42307571|NCT02300233|76143295|FG000|Overall Study|Withdrawal by Subject|1|||
42307572|NCT02300233|76143296|FG001|Overall Study|Withdrawal by Subject|0|||
42307573|NCT02300233|76143297|FG002|Overall Study|Withdrawal by Subject|3|||
42307574|NCT02300233|76143295|FG000|Overall Study|Investigator Judgement|0|||
42307575|NCT02300233|76143296|FG001|Overall Study|Investigator Judgement|0|||
42307576|NCT02300233|76143297|FG002|Overall Study|Investigator Judgement|1|||
42307577|NCT02300233|76143295|FG000|Overall Study|Reason Not Specified|0|||
42307578|NCT02300233|76143296|FG001|Overall Study|Reason Not Specified|0|||
42010552|NCT00993421|75817696|FG002|Overall Study|Adverse Event|6|||
42307579|NCT02300233|76143297|FG002|Overall Study|Reason Not Specified|5|||
42307580|NCT02175225|76143308|FG000|Overall Study|Withdrawal by Subject|1|||
42307581|NCT02175225|76143309|FG001|Overall Study|Withdrawal by Subject|2|||
42307582|NCT02175225|76143308|FG000|Overall Study|Lost to Follow-up|6|||
42307583|NCT02175225|76143309|FG001|Overall Study|Lost to Follow-up|7|||
42307584|NCT02175225|76143308|FG000|Overall Study|Study drug not administered|1|||
42307585|NCT02175225|76143309|FG001|Overall Study|Study drug not administered|2|||
42307586|NCT02299375|76143317|FG000|Overall Study|Adverse Event, serious fatal|1|||
42307587|NCT02299375|76143318|FG001|Overall Study|Adverse Event, serious fatal|3|||
42307588|NCT02299375|76143317|FG000|Overall Study|Adverse Event, non-fatal|8|||
42307589|NCT02299375|76143318|FG001|Overall Study|Adverse Event, non-fatal|9|||
42307590|NCT02299375|76143317|FG000|Overall Study|Lack of Efficacy|1|||
42307591|NCT02299375|76143318|FG001|Overall Study|Lack of Efficacy|3|||
42307592|NCT02299375|76143317|FG000|Overall Study|Protocol Violation|1|||
42307593|NCT02299375|76143318|FG001|Overall Study|Protocol Violation|3|||
42307594|NCT02299375|76143317|FG000|Overall Study|Other: Met stopping criteria|1|||
42307595|NCT02299375|76143318|FG001|Overall Study|Other: Met stopping criteria|0|||
42307596|NCT02299375|76143317|FG000|Overall Study|Other: Study closed/terminated|66|||
42307597|NCT02299375|76143318|FG001|Overall Study|Other: Study closed/terminated|55|||
42307598|NCT02299375|76143317|FG000|Overall Study|Lost to Follow-up|0|||
42307599|NCT02299375|76143318|FG001|Overall Study|Lost to Follow-up|2|||
42307600|NCT02299375|76143317|FG000|Overall Study|Physician Decision|1|||
42307601|NCT02299375|76143318|FG001|Overall Study|Physician Decision|1|||
42307602|NCT02299375|76143317|FG000|Overall Study|Withdrawal by Subject|1|||
42307603|NCT02299375|76143318|FG001|Overall Study|Withdrawal by Subject|4|||
42307604|NCT02151903|76143327|FG000|Overall Study|Withdrawal by Subject|1|||
42307605|NCT02151903|76143328|FG001|Overall Study|Withdrawal by Subject|0|||
42307606|NCT02151903|76143327|FG000|Overall Study|Progressive disease|2|||
42307607|NCT02151903|76143328|FG001|Overall Study|Progressive disease|1|||
42307608|NCT02151591|76143336|FG000|Overall Study|Lost to Follow-up|6|||
42307609|NCT02151591|76143337|FG001|Overall Study|Lost to Follow-up|3|||
42307610|NCT02174523|76143345|FG000|Overall Study|Withdrawal by Subject|1|||
42307611|NCT02174523|76143346|FG001|Overall Study|Withdrawal by Subject|0|||
42307612|NCT02297815|76143353|FG000|Overall Study|Lost to Follow-up|236|||
42307613|NCT02297815|76143354|FG001|Overall Study|Lost to Follow-up|140|||
42307614|NCT02114385|76143364|FG000|Overall Study|Withdrawal by Subject|3|||
42307615|NCT02114385|76143365|FG001|Overall Study|Withdrawal by Subject|2|||
42307616|NCT02114385|76143364|FG000|Overall Study|Lost to Follow-up|0|||
42307617|NCT02114385|76143365|FG001|Overall Study|Lost to Follow-up|6|||
42307618|NCT02114151|76143371|FG000|Overall Study|Death|1|||
42307619|NCT02114151|76143371|FG000|Overall Study|Lost to Follow-up|1|||
42307620|NCT02114151|76143371|FG000|Overall Study|Withdrawal by Subject|5|||
42307621|NCT02297503|76143377|FG000|Overall Study|Withdrawal by Subject|1|||
42307622|NCT02297503|76143378|FG001|Overall Study|Withdrawal by Subject|1|||
42307623|NCT02297503|76143377|FG000|Overall Study|Protocol Violation|1|||
42307624|NCT02297503|76143378|FG001|Overall Study|Protocol Violation|0|||
42307625|NCT02297503|76143377|FG000|Overall Study|Pregnancy|0|||
42307626|NCT02297503|76143378|FG001|Overall Study|Pregnancy|1|||
42307627|NCT02297503|76143377|FG000|Overall Study|Lost to Follow-up|0|||
42307628|NCT02297503|76143378|FG001|Overall Study|Lost to Follow-up|1|||
42307629|NCT02297503|76143377|FG000|Overall Study|Medical reason|0|||
42307630|NCT02297503|76143378|FG001|Overall Study|Medical reason|1|||
42307631|NCT02113449|76143393|FG000|Overall Study|Adverse Event|4|||
42307632|NCT02366923|76143401|FG000|Overall Study|Withdrawal by Subject|1|||
42307633|NCT02366923|76143401|FG000|Overall Study|Positive Slit Lamp Findings|2|||
41991421|NCT03303339|75799444|FG000|Overall Study|Safety/Non-compliance|0|||
42252820|NCT02546362|76078741|FG000|4-week Treatment Period|Change in medication|2|||
42252821|NCT02546362|76078741|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
42252822|NCT02546362|76078741|FG000|12-week Treatment Period|Lost to Follow-up|2|||
42252823|NCT02546362|76078741|FG000|12-week Treatment Period|Change in medication|1|||
42252824|NCT02698436|76078747|FG000|Overall Study|Adverse Event|1|||
42252825|NCT02698436|76078748|FG001|Overall Study|Adverse Event|0|||
42252826|NCT02698436|76078747|FG000|Overall Study|Withdrawal by Subject|3|||
42252827|NCT02698436|76078748|FG001|Overall Study|Withdrawal by Subject|3|||
42252828|NCT02698436|76078747|FG000|Overall Study|Lost to Follow-up|2|||
42252829|NCT02698436|76078748|FG001|Overall Study|Lost to Follow-up|4|||
42252830|NCT02698436|76078747|FG000|Overall Study|Non-compliance with study regimen|1|||
42252831|NCT02698436|76078748|FG001|Overall Study|Non-compliance with study regimen|0|||
42252832|NCT02694536|76078754|FG000|Overall Study|Progressive Disease|40|||
42252833|NCT02694536|76078754|FG000|Overall Study|Lost to Follow-up|1|||
42252834|NCT02694536|76078754|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
42252835|NCT02694536|76078754|FG000|Overall Study|Withdrawal by Subject|8|||
42252836|NCT02694536|76078754|FG000|Overall Study|Death|8|||
42252837|NCT02694536|76078754|FG000|Overall Study|Other|22|||
42252838|NCT01661686|76078760|FG000|Overall Study|Lost to Follow-up|2|||
42252839|NCT01661686|76078761|FG001|Overall Study|Lost to Follow-up|1|||
42307634|NCT02366923|76143401|FG000|Overall Study|High Astigmatism|3|||
42307635|NCT02326597|76143408|FG000|Overall Study|Lost to Follow-up|42|||
42307636|NCT02326597|76143409|FG001|Overall Study|Lost to Follow-up|32|||
42307637|NCT02366767|76143419|FG000|Overall Study|left for home after 1 day at camp|1|||
42307638|NCT02366767|76143420|FG001|Overall Study|left for home after 1 day at camp|0|||
42307639|NCT02150343|76143430|FG000|Overall Study|Adverse Event|2|||
42307640|NCT02150343|76143431|FG001|Overall Study|Adverse Event|0|||
42307641|NCT02150343|76143432|FG002|Overall Study|Adverse Event|1|||
42307642|NCT02150343|76143433|FG003|Overall Study|Adverse Event|1|||
42307643|NCT02150343|76143430|FG000|Overall Study|Withdrawal by Subject|13|||
42307644|NCT02150343|76143431|FG001|Overall Study|Withdrawal by Subject|10|||
42307645|NCT02150343|76143432|FG002|Overall Study|Withdrawal by Subject|9|||
42307646|NCT02150343|76143433|FG003|Overall Study|Withdrawal by Subject|4|||
42307647|NCT02150343|76143430|FG000|Overall Study|Lost to Follow-up|4|||
42307648|NCT02150343|76143431|FG001|Overall Study|Lost to Follow-up|4|||
42307649|NCT02150343|76143432|FG002|Overall Study|Lost to Follow-up|2|||
42307650|NCT02150343|76143433|FG003|Overall Study|Lost to Follow-up|3|||
42307651|NCT02150343|76143430|FG000|Overall Study|Other|2|||
41991422|NCT03303339|75799445|FG001|Overall Study|Safety/Non-compliance|0|||
41991423|NCT03303339|75799446|FG002|Overall Study|Safety/Non-compliance|0|||
41991424|NCT03303339|75799447|FG003|Overall Study|Safety/Non-compliance|0|||
41991425|NCT03303339|75799448|FG004|Overall Study|Safety/Non-compliance|0|||
41991426|NCT03303339|75799449|FG005|Overall Study|Safety/Non-compliance|0|||
41991427|NCT03303339|75799450|FG006|Overall Study|Safety/Non-compliance|0|||
41991428|NCT03303339|75799451|FG007|Overall Study|Safety/Non-compliance|0|||
41991429|NCT03303339|75799452|FG008|Overall Study|Safety/Non-compliance|0|||
41991430|NCT03303339|75799453|FG009|Overall Study|Safety/Non-compliance|0|||
41991431|NCT03303339|75799454|FG010|Overall Study|Safety/Non-compliance|0|||
41991432|NCT03303339|75799455|FG011|Overall Study|Safety/Non-compliance|1|||
41991433|NCT01183780|75799500|FG000|Overall Study|Withdrawal by Subject|25|||
41991434|NCT01183780|75799501|FG001|Overall Study|Withdrawal by Subject|14|||
41991435|NCT01183780|75799500|FG000|Overall Study|Lost to Follow-up|6|||
41991436|NCT01183780|75799501|FG001|Overall Study|Lost to Follow-up|11|||
41991437|NCT01183468|75799511|FG000|Overall Study|Lost to Follow-up|2|||
41991438|NCT01183468|75799512|FG001|Overall Study|Lost to Follow-up|1|||
41991439|NCT01183468|75799513|FG002|Overall Study|Lost to Follow-up|0|||
41991440|NCT01183468|75799514|FG003|Overall Study|Lost to Follow-up|0|||
41991441|NCT01183468|75799511|FG000|Overall Study|Physician Decision|1|||
41991442|NCT01183468|75799512|FG001|Overall Study|Physician Decision|0|||
41991443|NCT01183468|75799513|FG002|Overall Study|Physician Decision|0|||
41991444|NCT01183468|75799514|FG003|Overall Study|Physician Decision|0|||
41991445|NCT01183468|75799511|FG000|Overall Study|Withdrawal by Subject|0|||
41991446|NCT01183468|75799512|FG001|Overall Study|Withdrawal by Subject|1|||
41991447|NCT01183468|75799513|FG002|Overall Study|Withdrawal by Subject|0|||
41991448|NCT01183468|75799514|FG003|Overall Study|Withdrawal by Subject|0|||
41991449|NCT01183390|75799524|FG000|First Intervention|Adverse Event|0|||
41991450|NCT01183390|75799525|FG001|First Intervention|Adverse Event|1|||
41991451|NCT01214668|75799537|FG000|Overall Study|Adverse Event|0|||
41991452|NCT01214668|75799538|FG001|Overall Study|Adverse Event|1|||
41991453|NCT01214668|75799539|FG002|Overall Study|Adverse Event|0|||
41991454|NCT01214668|75799540|FG003|Overall Study|Adverse Event|2|||
41991455|NCT01214668|75799541|FG004|Overall Study|Adverse Event|1|||
41991456|NCT01214668|75799542|FG005|Overall Study|Adverse Event|1|||
41991457|NCT01214668|75799537|FG000|Overall Study|Death|0|||
41991458|NCT01214668|75799538|FG001|Overall Study|Death|0|||
41991459|NCT01214668|75799539|FG002|Overall Study|Death|1|||
41991460|NCT01214668|75799540|FG003|Overall Study|Death|0|||
41991461|NCT01214668|75799541|FG004|Overall Study|Death|0|||
41991462|NCT01214668|75799542|FG005|Overall Study|Death|0|||
41991463|NCT01214668|75799537|FG000|Overall Study|Progressive Disease|4|||
41991464|NCT01214668|75799538|FG001|Overall Study|Progressive Disease|2|||
41991465|NCT01214668|75799539|FG002|Overall Study|Progressive Disease|5|||
41991466|NCT01214668|75799540|FG003|Overall Study|Progressive Disease|4|||
41991467|NCT01214668|75799541|FG004|Overall Study|Progressive Disease|4|||
41991468|NCT01214668|75799542|FG005|Overall Study|Progressive Disease|5|||
41991469|NCT01214668|75799537|FG000|Overall Study|Withdrawal by Subject|0|||
41991470|NCT01214668|75799538|FG001|Overall Study|Withdrawal by Subject|0|||
41991471|NCT01214668|75799539|FG002|Overall Study|Withdrawal by Subject|0|||
41991472|NCT01214668|75799540|FG003|Overall Study|Withdrawal by Subject|0|||
41991473|NCT01214668|75799541|FG004|Overall Study|Withdrawal by Subject|1|||
41991474|NCT01214668|75799542|FG005|Overall Study|Withdrawal by Subject|0|||
41991475|NCT01191268|75799560|FG000|Overall Study|Withdrawal by Subject|19|||
41991476|NCT01191268|75799561|FG001|Overall Study|Withdrawal by Subject|25|||
41991477|NCT01191268|75799562|FG002|Overall Study|Withdrawal by Subject|21|||
42307652|NCT02150343|76143431|FG001|Overall Study|Other|6|||
42307653|NCT02150343|76143432|FG002|Overall Study|Other|0|||
42307654|NCT02150343|76143433|FG003|Overall Study|Other|2|||
41991478|NCT01191268|75799560|FG000|Overall Study|Adverse Event|21|||
41991479|NCT01191268|75799561|FG001|Overall Study|Adverse Event|13|||
41991480|NCT01191268|75799562|FG002|Overall Study|Adverse Event|8|||
41991481|NCT01191268|75799560|FG000|Overall Study|Physician Decision|6|||
41991482|NCT01191268|75799561|FG001|Overall Study|Physician Decision|8|||
41991483|NCT01191268|75799562|FG002|Overall Study|Physician Decision|9|||
42307655|NCT02149875|76143446|FG000|Overall Study|Lost to Follow-up|3|||
42307656|NCT02149875|76143447|FG001|Overall Study|Lost to Follow-up|4|||
41991484|NCT01191268|75799560|FG000|Overall Study|Lost to Follow-up|8|||
41991485|NCT01191268|75799561|FG001|Overall Study|Lost to Follow-up|5|||
41991486|NCT01191268|75799562|FG002|Overall Study|Lost to Follow-up|9|||
42307657|NCT02149875|76143448|FG002|Overall Study|Lost to Follow-up|5|||
42307658|NCT02149875|76143446|FG000|Overall Study|Withdrawal by Subject|3|||
42307659|NCT02149875|76143447|FG001|Overall Study|Withdrawal by Subject|2|||
42307660|NCT02149875|76143448|FG002|Overall Study|Withdrawal by Subject|2|||
42307661|NCT02149875|76143446|FG000|Overall Study|Physician Decision|1|||
42307662|NCT02149875|76143447|FG001|Overall Study|Physician Decision|2|||
42307663|NCT02149875|76143448|FG002|Overall Study|Physician Decision|2|||
42252840|NCT01661686|76078760|FG000|Overall Study|did not receive allocated intervention|0|||
42252841|NCT01661686|76078761|FG001|Overall Study|did not receive allocated intervention|1|||
42252842|NCT02696096|76078767|FG000|Overall Study|ruled out at screening|1|||
42252843|NCT02696096|76078767|FG000|Overall Study|did not attend second fMRI|1|||
42252844|NCT02695628|76078775|FG000|Overall Study|Withdrawal by Subject|1|||
42252845|NCT02693834|76078779|FG000|Baseline Measurement|Withdrawal by Subject|1|||
42252846|NCT02693834|76078780|FG001|Baseline Measurement|Withdrawal by Subject|0|||
42252847|NCT02693834|76078779|FG000|Baseline Measurement|Adverse Event|1|||
42252848|NCT02693834|76078780|FG001|Baseline Measurement|Adverse Event|0|||
42252849|NCT02693834|76078779|FG000|Week 2 Practice|Adverse Event|0|||
42252850|NCT02693834|76078780|FG001|Week 2 Practice|Adverse Event|1|||
42252851|NCT02545504|76078788|FG000|Overall Study|Death|174|||
42252852|NCT02545504|76078789|FG001|Overall Study|Death|168|||
42252853|NCT02545504|76078788|FG000|Overall Study|Unknown reason|30|||
42252854|NCT02545504|76078789|FG001|Overall Study|Unknown reason|32|||
42252855|NCT02545504|76078788|FG000|Overall Study|Withdrew consent|9|||
42252856|NCT02545504|76078789|FG001|Overall Study|Withdrew consent|11|||
42252857|NCT02545504|76078788|FG000|Overall Study|Investigator's discretion|3|||
42252858|NCT02545504|76078789|FG001|Overall Study|Investigator's discretion|1|||
42252859|NCT02545504|76078788|FG000|Overall Study|Lost to Follow-up|2|||
42252860|NCT02545504|76078789|FG001|Overall Study|Lost to Follow-up|2|||
42252861|NCT02545270|76078802|FG000|Overall Study|technical difficulties|0|||
42252862|NCT02545270|76078803|FG001|Overall Study|technical difficulties|1|||
42252863|NCT02545270|76078804|FG002|Overall Study|technical difficulties|0|||
42252864|NCT02545270|76078802|FG000|Overall Study|Videos being too similar to other|0|||
42252865|NCT02545270|76078803|FG001|Overall Study|Videos being too similar to other|0|||
42252866|NCT02545270|76078804|FG002|Overall Study|Videos being too similar to other|2|||
42252867|NCT02540668|76078813|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
42252868|NCT02540668|76078814|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
42252869|NCT02535364|76078838|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
42252870|NCT02535364|76078838|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
42252871|NCT02535364|76078838|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
42252872|NCT02535364|76078838|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
42252873|NCT02535364|76078838|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
42252874|NCT02535364|76078838|FG000|Part B Screening|Death|2|||
42252875|NCT02535364|76078838|FG000|Part B Screening|Physician Decision|1|||
42252876|NCT02535364|76078838|FG000|Part B Screening|Withdrawal by Subject|1|||
42307664|NCT02112045|76143458|FG000|Overall Study|Withdrawal by Subject|1|||
42307665|NCT02112045|76143459|FG001|Overall Study|Withdrawal by Subject|0|||
42307666|NCT01629693|76143467|FG000|Overall Study|Lost to Follow-up|2|||
42307667|NCT01629693|76143468|FG001|Overall Study|Lost to Follow-up|4|||
42307668|NCT01629693|76143467|FG000|Overall Study|Withdrawal by Subject|2|||
42307669|NCT01629693|76143468|FG001|Overall Study|Withdrawal by Subject|2|||
42307670|NCT01629693|76143467|FG000|Overall Study|Adverse Event|1|||
42307671|NCT01629693|76143468|FG001|Overall Study|Adverse Event|0|||
42307672|NCT01629693|76143467|FG000|Overall Study|Investigator decision|0|||
42307673|NCT01629693|76143468|FG001|Overall Study|Investigator decision|1|||
42307674|NCT01629693|76143467|FG000|Overall Study|Poor comfort of study lenses|0|||
42307675|NCT01629693|76143468|FG001|Overall Study|Poor comfort of study lenses|2|||
42307676|NCT01629693|76143467|FG000|Overall Study|Subject decision unrelated to AE|0|||
42252877|NCT02535364|76078838|FG000|Part B Screening|Adverse Event|1|||
42252878|NCT02535364|76078838|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
42307677|NCT01629693|76143468|FG001|Overall Study|Subject decision unrelated to AE|1|||
42307678|NCT02147691|76143476|FG000|Overall Study|Withdrawal by Subject|2|||
42307679|NCT02147691|76143477|FG001|Overall Study|Withdrawal by Subject|0|||
42307680|NCT02147691|76143476|FG000|Overall Study|Adverse Event|2|||
42307681|NCT02147691|76143477|FG001|Overall Study|Adverse Event|0|||
42307682|NCT02147691|76143476|FG000|Overall Study|Lost to Follow-up|0|||
42307683|NCT02147691|76143477|FG001|Overall Study|Lost to Follow-up|1|||
42307684|NCT02111811|76143485|FG000|Treatment Phase|Lost to Follow-up|22|||
42307685|NCT02111811|76143486|FG001|Treatment Phase|Lost to Follow-up|18|||
42307686|NCT02111811|76143485|FG000|Treatment Phase|Death|2|||
42307687|NCT02111811|76143486|FG001|Treatment Phase|Death|0|||
42307688|NCT02111811|76143485|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
42132871|NCT00412737|75943730|FG001|Overall Study|Failure to Return|2|||
42132872|NCT00508742|75943738|FG000|Period 1: Infant Series|Adverse Event|5|||
42132873|NCT00508742|75943739|FG001|Period 1: Infant Series|Adverse Event|4|||
42132874|NCT00508742|75943738|FG000|Period 1: Infant Series|Protocol Violation|1|||
42132875|NCT00508742|75943739|FG001|Period 1: Infant Series|Protocol Violation|0|||
42132876|NCT00508742|75943738|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
42132877|NCT00508742|75943739|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
42132878|NCT00508742|75943738|FG000|Period 1: Infant Series|Physician Decision|1|||
42132879|NCT00508742|75943739|FG001|Period 1: Infant Series|Physician Decision|0|||
42132880|NCT00508742|75943738|FG000|Period 1: Infant Series|Other|4|||
42132881|NCT00508742|75943739|FG001|Period 1: Infant Series|Other|1|||
42252879|NCT02535364|76078838|FG000|Study Treatment|Death|1|||
42252880|NCT02535364|76078838|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
42252881|NCT02535364|76078838|FG000|12-Month Follow-up Period|Disease progression|22|||
42307689|NCT02111811|76143486|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
42307690|NCT02111811|76143485|FG000|Follow up Period (Aim 2)|Death|2|||
42307691|NCT02111811|76143486|FG001|Follow up Period (Aim 2)|Death|0|||
42307692|NCT01655693|76143495|FG000|Overall Study|Progression of Disease|92|||
42307693|NCT01655693|76143496|FG001|Overall Study|Progression of Disease|76|||
42307694|NCT01655693|76143497|FG002|Overall Study|Progression of Disease|58|||
42307695|NCT01655693|76143495|FG000|Overall Study|Death|8|||
42307696|NCT01655693|76143496|FG001|Overall Study|Death|9|||
42307697|NCT01655693|76143497|FG002|Overall Study|Death|12|||
42307698|NCT01655693|76143495|FG000|Overall Study|Serious Adverse Event|3|||
42307699|NCT01655693|76143496|FG001|Overall Study|Serious Adverse Event|15|||
42307700|NCT01655693|76143497|FG002|Overall Study|Serious Adverse Event|11|||
42307701|NCT01655693|76143495|FG000|Overall Study|Withdrawal by Subject|3|||
42307702|NCT01655693|76143496|FG001|Overall Study|Withdrawal by Subject|2|||
42307703|NCT01655693|76143497|FG002|Overall Study|Withdrawal by Subject|20|||
42307704|NCT01655693|76143495|FG000|Overall Study|Adverse Event|3|||
41991487|NCT01191268|75799560|FG000|Overall Study|Entry Criteria Not Met|3|||
41991488|NCT01191268|75799561|FG001|Overall Study|Entry Criteria Not Met|1|||
41991489|NCT01191268|75799562|FG002|Overall Study|Entry Criteria Not Met|1|||
42307705|NCT01655693|76143496|FG001|Overall Study|Adverse Event|11|||
42307706|NCT01655693|76143497|FG002|Overall Study|Adverse Event|3|||
42307707|NCT01655693|76143495|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
42307708|NCT01655693|76143496|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
42307709|NCT01655693|76143497|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
42307710|NCT01655693|76143495|FG000|Overall Study|Non-Compliance|0|||
42307711|NCT01655693|76143496|FG001|Overall Study|Non-Compliance|0|||
42307712|NCT01655693|76143497|FG002|Overall Study|Non-Compliance|7|||
42252882|NCT02535364|76078838|FG000|12-Month Follow-up Period|Death|5|||
42252883|NCT02535364|76078838|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
42252884|NCT02535364|76078838|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
42252885|NCT02535364|76078838|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
42252886|NCT02540356|76078844|FG000|Overall Study|Terminated due to disease progression|1|||
42252887|NCT02540356|76078845|FG001|Overall Study|Terminated due to disease progression|0|||
42252888|NCT02534896|76078853|FG000|Overall Study|Adverse Event|2|||
42252889|NCT02534896|76078854|FG001|Overall Study|Adverse Event|1|||
42252890|NCT02534896|76078855|FG002|Overall Study|Adverse Event|1|||
42252891|NCT02534896|76078853|FG000|Overall Study|Insufficient therapeutic response|2|||
42252892|NCT02534896|76078854|FG001|Overall Study|Insufficient therapeutic response|0|||
42132882|NCT00508742|75943738|FG000|Period 2: After Infant Series|Adverse Event|2|||
42307713|NCT01655693|76143495|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
42307714|NCT01655693|76143496|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
42307715|NCT01655693|76143497|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
42307716|NCT01655693|76143495|FG000|Overall Study|Protocol Violation|1|||
42307717|NCT01655693|76143496|FG001|Overall Study|Protocol Violation|0|||
42307718|NCT01655693|76143497|FG002|Overall Study|Protocol Violation|3|||
41991490|NCT01191268|75799560|FG000|Overall Study|Death|0|||
42252893|NCT02534896|76078855|FG002|Overall Study|Insufficient therapeutic response|0|||
42307719|NCT01655693|76143495|FG000|Overall Study|Lost to Follow-up|1|||
42307720|NCT01655693|76143496|FG001|Overall Study|Lost to Follow-up|0|||
42307721|NCT01655693|76143497|FG002|Overall Study|Lost to Follow-up|1|||
42307722|NCT01655693|76143495|FG000|Overall Study|Screening Failure|1|||
42307723|NCT01655693|76143496|FG001|Overall Study|Screening Failure|0|||
42307724|NCT01655693|76143497|FG002|Overall Study|Screening Failure|0|||
42307725|NCT01655693|76143495|FG000|Overall Study|Other|8|||
42307726|NCT01655693|76143496|FG001|Overall Study|Other|6|||
42307727|NCT01655693|76143497|FG002|Overall Study|Other|15|||
42307728|NCT01655381|76143515|FG000|Overall Study|Investigator Decision|1|||
42307729|NCT01655381|76143515|FG000|Overall Study|Moved to Another City|1|||
42307730|NCT01655381|76143515|FG000|Overall Study|Insufficient Treatment Response|1|||
42307731|NCT01656161|76143520|FG000|Overall Study|Death|3|||
42307732|NCT01656161|76143520|FG000|Overall Study|Adverse Event|2|||
42307733|NCT01656161|76143520|FG000|Overall Study|Protocol Violation|1|||
42307734|NCT01656161|76143520|FG000|Overall Study|Withdrawal by Subject|1|||
42307735|NCT02111577|76143529|FG000|Overall Study|Protocol Violation|2|||
42307736|NCT02111577|76143530|FG001|Overall Study|Protocol Violation|0|||
42307737|NCT02111577|76143529|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
42307738|NCT02111577|76143530|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
42307739|NCT02111577|76143529|FG000|Overall Study|Failure to produce study treatment|6|||
42307740|NCT02111577|76143530|FG001|Overall Study|Failure to produce study treatment|0|||
42307741|NCT02111577|76143529|FG000|Overall Study|Death|518|||
42307742|NCT02111577|76143530|FG001|Overall Study|Death|254|||
42307743|NCT02111577|76143529|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
42307744|NCT02111577|76143530|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
42307745|NCT02111577|76143529|FG000|Overall Study|Adverse Event|1|||
42307746|NCT02111577|76143530|FG001|Overall Study|Adverse Event|1|||
42307747|NCT02111577|76143529|FG000|Overall Study|Withdrawal by Subject|51|||
42307748|NCT02111577|76143530|FG001|Overall Study|Withdrawal by Subject|23|||
42307749|NCT02111577|76143529|FG000|Overall Study|Disease progression|0|||
42307750|NCT02111577|76143530|FG001|Overall Study|Disease progression|1|||
42307751|NCT02111577|76143529|FG000|Overall Study|Lost to Follow-up|19|||
42307752|NCT02111577|76143530|FG001|Overall Study|Lost to Follow-up|10|||
42307753|NCT02170779|76143540|FG000|Overall Study|Withdrawal by Subject|1|||
42307754|NCT02170779|76143541|FG001|Overall Study|Withdrawal by Subject|0|||
42307755|NCT02170779|76143540|FG000|Overall Study|Lost to Follow-up|0|||
42307756|NCT02170779|76143541|FG001|Overall Study|Lost to Follow-up|1|||
42307757|NCT02147067|76143549|FG000|Overall Study|Withdrawal by Subject|2|||
42307758|NCT02147067|76143550|FG001|Overall Study|Withdrawal by Subject|2|||
42307759|NCT02170389|76143556|FG000|Overall Study|Study terminated prior to start of treat|1|||
42307760|NCT02146599|76143560|FG000|Overall Study|Failed to meet inclusion criteria|5|||
42307761|NCT02146365|76143570|FG000|Overall Study|Lost to Follow-up|2|||
42307762|NCT02146365|76143571|FG001|Overall Study|Lost to Follow-up|1|||
42307763|NCT02146365|76143572|FG002|Overall Study|Lost to Follow-up|3|||
42307764|NCT02146365|76143573|FG003|Overall Study|Lost to Follow-up|3|||
42307765|NCT02146365|76143574|FG004|Overall Study|Lost to Follow-up|1|||
42307766|NCT02146365|76143575|FG005|Overall Study|Lost to Follow-up|1|||
42307767|NCT02146365|76143576|FG006|Overall Study|Lost to Follow-up|0|||
42307768|NCT02146365|76143577|FG007|Overall Study|Lost to Follow-up|1|||
42307769|NCT02146365|76143570|FG000|Overall Study|Withdrawal by Subject|1|||
42307770|NCT02146365|76143571|FG001|Overall Study|Withdrawal by Subject|2|||
42307771|NCT02146365|76143572|FG002|Overall Study|Withdrawal by Subject|1|||
42307772|NCT02146365|76143573|FG003|Overall Study|Withdrawal by Subject|5|||
42307773|NCT02146365|76143574|FG004|Overall Study|Withdrawal by Subject|1|||
42307774|NCT02146365|76143575|FG005|Overall Study|Withdrawal by Subject|0|||
41991491|NCT01191268|75799561|FG001|Overall Study|Death|1|||
41991492|NCT01191268|75799562|FG002|Overall Study|Death|3|||
42307775|NCT02146365|76143576|FG006|Overall Study|Withdrawal by Subject|0|||
42307776|NCT02146365|76143577|FG007|Overall Study|Withdrawal by Subject|0|||
42307777|NCT02146365|76143570|FG000|Overall Study|Unable to Comply with Protocol|0|||
42307778|NCT02146365|76143571|FG001|Overall Study|Unable to Comply with Protocol|1|||
42307779|NCT02146365|76143572|FG002|Overall Study|Unable to Comply with Protocol|1|||
42307780|NCT02146365|76143573|FG003|Overall Study|Unable to Comply with Protocol|0|||
42307781|NCT02146365|76143574|FG004|Overall Study|Unable to Comply with Protocol|0|||
42307782|NCT02146365|76143575|FG005|Overall Study|Unable to Comply with Protocol|0|||
42307783|NCT02146365|76143576|FG006|Overall Study|Unable to Comply with Protocol|0|||
42307784|NCT02146365|76143577|FG007|Overall Study|Unable to Comply with Protocol|0|||
42307785|NCT02146365|76143570|FG000|Overall Study|Other|1|||
42307786|NCT02146365|76143571|FG001|Overall Study|Other|0|||
42307787|NCT02146365|76143572|FG002|Overall Study|Other|2|||
42307788|NCT02146365|76143573|FG003|Overall Study|Other|1|||
42252894|NCT02697734|76078865|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
42252895|NCT02697734|76078866|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
42252896|NCT02697734|76078865|FG000|Core Phase - up to Week 48|Adverse Event|1|||
42307789|NCT02146365|76143574|FG004|Overall Study|Other|0|||
42307790|NCT02146365|76143575|FG005|Overall Study|Other|0|||
42307791|NCT02146365|76143576|FG006|Overall Study|Other|0|||
42307792|NCT02146365|76143577|FG007|Overall Study|Other|0|||
42252897|NCT02697734|76078866|FG001|Core Phase - up to Week 48|Adverse Event|2|||
42252898|NCT02697734|76078865|FG000|Core Phase - up to Week 48|Physician Decision|1|||
42252899|NCT02697734|76078866|FG001|Core Phase - up to Week 48|Physician Decision|0|||
42252900|NCT02697734|76078865|FG000|Optional Extension Phase|Adverse Event|5|||
42252901|NCT02697734|76078866|FG001|Optional Extension Phase|Adverse Event|1|||
42252902|NCT02697734|76078865|FG000|Optional Extension Phase|Physician Decision|0|||
42307793|NCT02146131|76143597|FG000|Overall Study|Physician Decision|61|||
42307794|NCT02146131|76143598|FG001|Overall Study|Physician Decision|56|||
42307795|NCT02107131|76143606|FG000|Overall Study|Lost to Follow-up|4|||
42307796|NCT02107131|76143607|FG001|Overall Study|Lost to Follow-up|4|||
42307797|NCT02107131|76143606|FG000|Overall Study|Physician Decision|1|||
42307798|NCT02107131|76143607|FG001|Overall Study|Physician Decision|0|||
42307799|NCT02107131|76143606|FG000|Overall Study|Withdrawal by Subject|2|||
42307800|NCT02107131|76143607|FG001|Overall Study|Withdrawal by Subject|0|||
42307801|NCT02107131|76143606|FG000|Overall Study|mental instability|1|||
42307802|NCT02107131|76143607|FG001|Overall Study|mental instability|0|||
42307803|NCT02107131|76143606|FG000|Overall Study|Death|0|||
42307804|NCT02107131|76143607|FG001|Overall Study|Death|1|||
42307805|NCT02107131|76143606|FG000|Overall Study|Protocol Violation|0|||
42307806|NCT02107131|76143607|FG001|Overall Study|Protocol Violation|4|||
42307807|NCT02106975|76143617|FG000|Overall Study|Death|25|||
42307808|NCT02106975|76143618|FG001|Overall Study|Death|39|||
42307809|NCT02145429|76143626|FG000|Overall Study|Death|4|||
42307810|NCT02145429|76143627|FG001|Overall Study|Death|5|||
42252903|NCT02697734|76078866|FG001|Optional Extension Phase|Physician Decision|1|||
42252904|NCT02692586|76078880|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
42252905|NCT02692586|76078880|FG000|Overall Study|Received adjunctive thrombolytics|2|||
42252906|NCT02534350|76078886|FG000|Overall Study|Randomized But Not Treated|1|||
42252907|NCT02534350|76078887|FG001|Overall Study|Randomized But Not Treated|0|||
42252908|NCT02534350|76078886|FG000|Overall Study|Protocol Violation|1|||
42252909|NCT02534350|76078887|FG001|Overall Study|Protocol Violation|0|||
42252910|NCT02534350|76078886|FG000|Overall Study|Withdrew Consent|2|||
42252911|NCT02534350|76078887|FG001|Overall Study|Withdrew Consent|0|||
42252912|NCT02688764|76078895|FG000|Overall Study|Adverse Event|3|||
42252913|NCT02688764|76078896|FG001|Overall Study|Adverse Event|3|||
42252914|NCT02688764|76078895|FG000|Overall Study|AE/Kidney transplant|1|||
42252915|NCT02688764|76078896|FG001|Overall Study|AE/Kidney transplant|0|||
42252916|NCT02688764|76078895|FG000|Overall Study|AE/Lack of efficacy|1|||
42252917|NCT02688764|76078896|FG001|Overall Study|AE/Lack of efficacy|0|||
42252918|NCT02688764|76078895|FG000|Overall Study|AE/Non-compl.|1|||
42252919|NCT02688764|76078896|FG001|Overall Study|AE/Non-compl.|0|||
42252920|NCT02688764|76078895|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
42252921|NCT02688764|76078896|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
42252922|NCT02688764|76078895|FG000|Overall Study|AE/Other|0|||
42307811|NCT02145429|76143626|FG000|Overall Study|Lost to Follow-up|4|||
42307812|NCT02145429|76143627|FG001|Overall Study|Lost to Follow-up|3|||
42307813|NCT02145429|76143626|FG000|Overall Study|Withdrawal by Subject|8|||
42252923|NCT02688764|76078896|FG001|Overall Study|AE/Other|1|||
42307814|NCT02145429|76143627|FG001|Overall Study|Withdrawal by Subject|3|||
42307815|NCT02144337|76143635|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
42307816|NCT02144337|76143636|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
42252924|NCT02688764|76078895|FG000|Overall Study|AE/Physician decision|1|||
42252925|NCT02688764|76078896|FG001|Overall Study|AE/Physician decision|0|||
42307817|NCT02144337|76143635|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
42307818|NCT02144337|76143636|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
42307819|NCT02144337|76143635|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
42307820|NCT02144337|76143636|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
42307821|NCT02144337|76143635|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
42307822|NCT02144337|76143636|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
42307823|NCT02144337|76143635|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
42252926|NCT02688764|76078895|FG000|Overall Study|AE/Withd. parent|3|||
42307824|NCT02144337|76143636|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
42307825|NCT02520011|76143646|FG000|Overall Study|Adverse Event|0|||
42307826|NCT02520011|76143647|FG001|Overall Study|Adverse Event|1|||
42307827|NCT02520011|76143648|FG002|Overall Study|Adverse Event|2|||
42307828|NCT02520011|76143646|FG000|Overall Study|Death|0|||
42307829|NCT02520011|76143647|FG001|Overall Study|Death|8|||
42307830|NCT02520011|76143648|FG002|Overall Study|Death|1|||
42307831|NCT02520011|76143646|FG000|Overall Study|Lack of Efficacy|4|||
42307832|NCT02520011|76143647|FG001|Overall Study|Lack of Efficacy|26|||
42307833|NCT02520011|76143648|FG002|Overall Study|Lack of Efficacy|4|||
42307834|NCT02520011|76143646|FG000|Overall Study|Physician Decision|0|||
42307835|NCT02520011|76143647|FG001|Overall Study|Physician Decision|2|||
42307836|NCT02520011|76143648|FG002|Overall Study|Physician Decision|0|||
42307837|NCT02520011|76143646|FG000|Overall Study|Withdrawal by Subject|1|||
42307838|NCT02520011|76143647|FG001|Overall Study|Withdrawal by Subject|3|||
42307839|NCT02520011|76143648|FG002|Overall Study|Withdrawal by Subject|0|||
42307840|NCT02520011|76143646|FG000|Overall Study|Protocol Deviation|0|||
42307841|NCT02520011|76143647|FG001|Overall Study|Protocol Deviation|1|||
42307842|NCT02520011|76143648|FG002|Overall Study|Protocol Deviation|0|||
42307843|NCT02520011|76143646|FG000|Overall Study|Patient went to hospice|0|||
42252927|NCT02688764|76078896|FG001|Overall Study|AE/Withd. parent|0|||
42252928|NCT02688764|76078895|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
42252929|NCT02688764|76078896|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
42252930|NCT02688764|76078895|FG000|Overall Study|AE/Withd. subject|1|||
42252931|NCT02688764|76078896|FG001|Overall Study|AE/Withd. subject|0|||
42252932|NCT02688764|76078895|FG000|Overall Study|Kidney transplant|10|||
42252933|NCT02688764|76078896|FG001|Overall Study|Kidney transplant|4|||
42252934|NCT02688764|76078895|FG000|Overall Study|Lack of Efficacy|3|||
42307844|NCT02520011|76143647|FG001|Overall Study|Patient went to hospice|1|||
42307845|NCT02520011|76143648|FG002|Overall Study|Patient went to hospice|0|||
42252935|NCT02688764|76078896|FG001|Overall Study|Lack of Efficacy|2|||
42252936|NCT02688764|76078895|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
42252937|NCT02688764|76078896|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
42307846|NCT02520011|76143646|FG000|Overall Study|Progressive disease following response|0|||
42307847|NCT02520011|76143647|FG001|Overall Study|Progressive disease following response|4|||
42307848|NCT02520011|76143648|FG002|Overall Study|Progressive disease following response|2|||
42307849|NCT02519231|76143663|FG000|Overall Study|Lost to Follow-up|2|||
42307850|NCT02519231|76143664|FG001|Overall Study|Lost to Follow-up|5|||
42307851|NCT02519231|76143663|FG000|Overall Study|Withdrawal by Subject|0|||
42307852|NCT02519231|76143664|FG001|Overall Study|Withdrawal by Subject|1|||
42307853|NCT02106351|76143675|FG000|Treatment Cycle 1|Adverse Event|2|||
42307854|NCT02106351|76143676|FG001|Treatment Cycle 1|Adverse Event|0|||
42307855|NCT02106351|76143677|FG002|Treatment Cycle 1|Adverse Event|0|||
42307856|NCT02106351|76143675|FG000|Treatment Cycle 1|Consent withdrawn|1|||
42307857|NCT02106351|76143676|FG001|Treatment Cycle 1|Consent withdrawn|0|||
42307858|NCT02106351|76143677|FG002|Treatment Cycle 1|Consent withdrawn|2|||
42307859|NCT02106351|76143675|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
42307860|NCT02106351|76143676|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
42307861|NCT02106351|76143677|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
42307862|NCT02106351|76143675|FG000|Treatment Cycle 1|Other|0|||
42307863|NCT02106351|76143676|FG001|Treatment Cycle 1|Other|3|||
42307864|NCT02106351|76143677|FG002|Treatment Cycle 1|Other|1|||
42307865|NCT02106351|76143675|FG000|Treatment Cycle 1|Randomised but not treated|1|||
42307866|NCT02106351|76143676|FG001|Treatment Cycle 1|Randomised but not treated|0|||
42307867|NCT02106351|76143677|FG002|Treatment Cycle 1|Randomised but not treated|1|||
42307868|NCT02106351|76143675|FG000|Treatment Cycle 2|Adverse Event|0|||
42307869|NCT02106351|76143676|FG001|Treatment Cycle 2|Adverse Event|2|||
42307870|NCT02106351|76143677|FG002|Treatment Cycle 2|Adverse Event|0|||
42307871|NCT02106351|76143675|FG000|Treatment Cycle 2|Consent withdrawn|0|||
42307872|NCT02106351|76143676|FG001|Treatment Cycle 2|Consent withdrawn|1|||
42307873|NCT02106351|76143677|FG002|Treatment Cycle 2|Consent withdrawn|1|||
42132883|NCT00508742|75943739|FG001|Period 2: After Infant Series|Adverse Event|6|||
42132884|NCT00508742|75943738|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
42132885|NCT00508742|75943739|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
42132886|NCT00508742|75943738|FG000|Period 2: After Infant Series|Protocol Violation|1|||
42132887|NCT00508742|75943739|FG001|Period 2: After Infant Series|Protocol Violation|0|||
42132888|NCT00508742|75943738|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
42132889|NCT00508742|75943739|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
42252938|NCT02688764|76078895|FG000|Overall Study|Non-compliance with study drug|4|||
42252939|NCT02688764|76078896|FG001|Overall Study|Non-compliance with study drug|0|||
42307874|NCT02106351|76143675|FG000|Treatment Cycle 2|Other|0|||
42307875|NCT02106351|76143676|FG001|Treatment Cycle 2|Other|2|||
42307876|NCT02106351|76143677|FG002|Treatment Cycle 2|Other|2|||
42307877|NCT02106351|76143675|FG000|Treatment Cycle 3|Adverse Event|0|||
42307878|NCT02106351|76143676|FG001|Treatment Cycle 3|Adverse Event|1|||
42307879|NCT02106351|76143677|FG002|Treatment Cycle 3|Adverse Event|0|||
42307880|NCT02106351|76143675|FG000|Treatment Cycle 3|Consent withdrawn|0|||
42132890|NCT00508742|75943738|FG000|Period 2: After Infant Series|Failed to Return|1|||
42132891|NCT00508742|75943739|FG001|Period 2: After Infant Series|Failed to Return|0|||
42132892|NCT00508742|75943738|FG000|Period 2: After Infant Series|Other|2|||
42252940|NCT02688764|76078895|FG000|Overall Study|Non-compl./Physician decision|2|||
42252941|NCT02688764|76078896|FG001|Overall Study|Non-compl./Physician decision|0|||
42252942|NCT02688764|76078895|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
42252943|NCT02688764|76078896|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
42252944|NCT02688764|76078895|FG000|Overall Study|Non-compl./Withd. subject|0|||
42252945|NCT02688764|76078896|FG001|Overall Study|Non-compl./Withd. subject|2|||
42252946|NCT02688764|76078895|FG000|Overall Study|Phosphorus level outside safe range|0|||
42252947|NCT02688764|76078896|FG001|Overall Study|Phosphorus level outside safe range|1|||
42252948|NCT02688764|76078895|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
42252949|NCT02688764|76078896|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
42252950|NCT02688764|76078895|FG000|Overall Study|Study drug taste/Withd. parent|1|||
42252951|NCT02688764|76078896|FG001|Overall Study|Study drug taste/Withd. parent|0|||
42252952|NCT02688764|76078895|FG000|Overall Study|Subject moving out|2|||
42252953|NCT02688764|76078896|FG001|Overall Study|Subject moving out|0|||
42252954|NCT02688764|76078895|FG000|Overall Study|Subject taken off dialysis|1|||
42307881|NCT02106351|76143676|FG001|Treatment Cycle 3|Consent withdrawn|0|||
42252955|NCT02688764|76078896|FG001|Overall Study|Subject taken off dialysis|0|||
42252956|NCT02688764|76078895|FG000|Overall Study|Withdrawal by parent|3|||
42252957|NCT02688764|76078896|FG001|Overall Study|Withdrawal by parent|0|||
42307882|NCT02106351|76143677|FG002|Treatment Cycle 3|Consent withdrawn|2|||
42307883|NCT02106351|76143675|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
42307884|NCT02106351|76143676|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
42307885|NCT02106351|76143677|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
42307886|NCT02106351|76143675|FG000|Treatment Cycle 3|Other|0|||
42307887|NCT02106351|76143676|FG001|Treatment Cycle 3|Other|2|||
42307888|NCT02106351|76143677|FG002|Treatment Cycle 3|Other|3|||
42307889|NCT02106351|76143675|FG000|Treatment Cycle 4|Consent withdrawn|0|||
42307890|NCT02106351|76143676|FG001|Treatment Cycle 4|Consent withdrawn|0|||
42307891|NCT02106351|76143677|FG002|Treatment Cycle 4|Consent withdrawn|2|||
42307892|NCT02106351|76143675|FG000|Treatment Cycle 4|Other|0|||
42307893|NCT02106351|76143676|FG001|Treatment Cycle 4|Other|1|||
42252958|NCT02688608|76078905|FG000|Overall Study|Lost to Follow-up|1|||
42252959|NCT02688530|76078913|FG000|Overall Study|Withdrawal by Subject|0|||
42252960|NCT02688530|76078914|FG001|Overall Study|Withdrawal by Subject|1|||
42252961|NCT02688530|76078915|FG002|Overall Study|Withdrawal by Subject|0|||
42307894|NCT02106351|76143677|FG002|Treatment Cycle 4|Other|0|||
42307895|NCT02143947|76143693|FG000|Overall Study|Lost to Follow-up|4|||
42307896|NCT02143947|76143694|FG001|Overall Study|Lost to Follow-up|2|||
41991493|NCT01191268|75799560|FG000|Overall Study|Protocol Violation|1|||
41991494|NCT01191268|75799561|FG001|Overall Study|Protocol Violation|0|||
41991495|NCT01191268|75799562|FG002|Overall Study|Protocol Violation|1|||
41991496|NCT01191268|75799560|FG000|Overall Study|Sponsor Decision|0|||
41991497|NCT01191268|75799561|FG001|Overall Study|Sponsor Decision|2|||
41991498|NCT01191268|75799562|FG002|Overall Study|Sponsor Decision|0|||
41991499|NCT01191190|75799571|FG000|Overall Study|Withdrawal by Subject|1|||
42252962|NCT02688530|76078916|FG003|Overall Study|Withdrawal by Subject|0|||
42252963|NCT02688530|76078913|FG000|Overall Study|Lost to Follow-up|0|||
42252964|NCT02688530|76078914|FG001|Overall Study|Lost to Follow-up|0|||
42252965|NCT02688530|76078915|FG002|Overall Study|Lost to Follow-up|2|||
42307897|NCT02075073|76143705|FG000|Overall Study|Withdrawal by Subject|0|||
42307898|NCT02075073|76143706|FG001|Overall Study|Withdrawal by Subject|1|||
42307899|NCT02075073|76143707|FG002|Overall Study|Withdrawal by Subject|0|||
42307900|NCT02074059|76143721|FG000|Overall Study|Death|0|||
42307901|NCT02074059|76143722|FG001|Overall Study|Death|0|||
42307902|NCT02074059|76143723|FG002|Overall Study|Death|0|||
42307903|NCT02074059|76143724|FG003|Overall Study|Death|0|||
42307904|NCT02074059|76143725|FG004|Overall Study|Death|1|||
42307905|NCT02074059|76143726|FG005|Overall Study|Death|1|||
42307906|NCT02143713|76143745|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
42307907|NCT02143713|76143746|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
42307908|NCT02143713|76143747|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
42307909|NCT02143713|76143748|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
42307910|NCT02143713|76143745|FG000|Treatment Period (6 Months)|Adverse Event|7|||
42307911|NCT02143713|76143746|FG001|Treatment Period (6 Months)|Adverse Event|8|||
42307912|NCT02143713|76143747|FG002|Treatment Period (6 Months)|Adverse Event|8|||
42307913|NCT02143713|76143748|FG003|Treatment Period (6 Months)|Adverse Event|9|||
42307914|NCT02143713|76143745|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
42307915|NCT02143713|76143746|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
42307916|NCT02143713|76143747|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
42307917|NCT02143713|76143748|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
42307918|NCT02143713|76143745|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
42307919|NCT02143713|76143746|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
42307920|NCT02143713|76143747|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
42307921|NCT02143713|76143748|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
42307922|NCT02143713|76143745|FG000|Treatment Period (6 Months)|Pregnancy|0|||
42307923|NCT02143713|76143746|FG001|Treatment Period (6 Months)|Pregnancy|2|||
42307924|NCT02143713|76143747|FG002|Treatment Period (6 Months)|Pregnancy|2|||
42307925|NCT02143713|76143748|FG003|Treatment Period (6 Months)|Pregnancy|0|||
42307926|NCT02143713|76143745|FG000|Treatment Period (6 Months)|Non-compliance|1|||
42307927|NCT02143713|76143746|FG001|Treatment Period (6 Months)|Non-compliance|0|||
42307928|NCT02143713|76143747|FG002|Treatment Period (6 Months)|Non-compliance|0|||
42252966|NCT02688530|76078916|FG003|Overall Study|Lost to Follow-up|0|||
42252967|NCT02467270|76078933|FG000|Overall Study|Participants Never Treated|0|||
42252968|NCT02467270|76078934|FG001|Overall Study|Participants Never Treated|1|||
42252969|NCT02467270|76078935|FG002|Overall Study|Participants Never Treated|0|||
42307929|NCT02143713|76143748|FG003|Treatment Period (6 Months)|Non-compliance|3|||
42307930|NCT02143713|76143745|FG000|Treatment Period (6 Months)|Other|3|||
41991500|NCT05751629|75799575|FG000|Overall Study|Withdrawal by Subject|6|||
41991501|NCT05751629|75799575|FG000|Overall Study|Death|25|||
42252970|NCT02467270|76078933|FG000|Overall Study|Ongoing|50|||
42252971|NCT02467270|76078934|FG001|Overall Study|Ongoing|41|||
42252972|NCT02467270|76078935|FG002|Overall Study|Ongoing|43|||
42252973|NCT02467270|76078933|FG000|Overall Study|Adverse Event|16|||
42307931|NCT02143713|76143746|FG001|Treatment Period (6 Months)|Other|0|||
42307932|NCT02143713|76143747|FG002|Treatment Period (6 Months)|Other|3|||
42307933|NCT02143713|76143748|FG003|Treatment Period (6 Months)|Other|2|||
42307934|NCT02143713|76143745|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
42252974|NCT02467270|76078934|FG001|Overall Study|Adverse Event|15|||
42307935|NCT02143713|76143746|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
42307936|NCT02143713|76143747|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
42307937|NCT02143713|76143748|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
42307938|NCT02143713|76143745|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
42307939|NCT02143713|76143746|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
42307940|NCT02143713|76143747|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
42307941|NCT02143713|76143748|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
42307942|NCT02143713|76143745|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
42307943|NCT02143713|76143746|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
42307944|NCT02143713|76143747|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
42307945|NCT02143713|76143748|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
42307946|NCT02143713|76143745|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
42307947|NCT02143713|76143746|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
42307948|NCT02143713|76143747|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
42307949|NCT02143713|76143748|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
42307950|NCT02143713|76143745|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
42307951|NCT02143713|76143746|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
42307952|NCT02143713|76143747|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
42307953|NCT02143713|76143748|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
42307954|NCT02143713|76143745|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
42307955|NCT02143713|76143746|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
42307956|NCT02143713|76143747|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
42307957|NCT02143713|76143748|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
42307958|NCT02143713|76143745|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
42307959|NCT02143713|76143746|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
42307960|NCT02143713|76143747|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
42307961|NCT02143713|76143748|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
42307962|NCT02143713|76143745|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
42307963|NCT02143713|76143746|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
42307964|NCT02143713|76143747|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
42307965|NCT02143713|76143748|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
42307966|NCT02143713|76143745|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
42307967|NCT02143713|76143746|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
42307968|NCT02143713|76143747|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
42307969|NCT02143713|76143748|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
42307970|NCT02519855|76143761|FG000|Overall Study|Adverse Event|0|||
42307971|NCT02519855|76143762|FG001|Overall Study|Adverse Event|1|||
42307972|NCT02519855|76143761|FG000|Overall Study|Lost to Follow-up|3|||
42252975|NCT02467270|76078935|FG002|Overall Study|Adverse Event|14|||
42252976|NCT02467270|76078933|FG000|Overall Study|Progressive Disease|7|||
42252977|NCT02467270|76078934|FG001|Overall Study|Progressive Disease|7|||
42252978|NCT02467270|76078935|FG002|Overall Study|Progressive Disease|4|||
42252979|NCT02467270|76078933|FG000|Overall Study|Death|2|||
42252980|NCT02467270|76078934|FG001|Overall Study|Death|0|||
42252981|NCT02467270|76078935|FG002|Overall Study|Death|2|||
42252982|NCT02467270|76078933|FG000|Overall Study|Lack of Efficacy|12|||
42252983|NCT02467270|76078934|FG001|Overall Study|Lack of Efficacy|18|||
42252984|NCT02467270|76078935|FG002|Overall Study|Lack of Efficacy|23|||
42252985|NCT02467270|76078933|FG000|Overall Study|Non-compliance With Study Drug|0|||
42252986|NCT02467270|76078934|FG001|Overall Study|Non-compliance With Study Drug|2|||
42252987|NCT02467270|76078935|FG002|Overall Study|Non-compliance With Study Drug|1|||
42252988|NCT02467270|76078933|FG000|Overall Study|Lost to Follow-up|2|||
42252989|NCT02467270|76078934|FG001|Overall Study|Lost to Follow-up|1|||
42252990|NCT02467270|76078935|FG002|Overall Study|Lost to Follow-up|0|||
42252991|NCT02467270|76078933|FG000|Overall Study|Pregnancy|0|||
42252992|NCT02467270|76078934|FG001|Overall Study|Pregnancy|1|||
42252993|NCT02467270|76078935|FG002|Overall Study|Pregnancy|0|||
42252994|NCT02467270|76078933|FG000|Overall Study|Physician Decision|0|||
42252995|NCT02467270|76078934|FG001|Overall Study|Physician Decision|4|||
42252996|NCT02467270|76078935|FG002|Overall Study|Physician Decision|1|||
42307973|NCT02519855|76143762|FG001|Overall Study|Lost to Follow-up|3|||
42307974|NCT02142387|76143770|FG000|Overall Study|<19 years old|49|||
42307975|NCT02142387|76143771|FG001|Overall Study|<19 years old|326|||
42307976|NCT02142387|76143770|FG000|Overall Study|non-cardiac etiology|504|||
42307977|NCT02142387|76143771|FG001|Overall Study|non-cardiac etiology|3431|||
42252997|NCT02467270|76078933|FG000|Overall Study|Withdrawal by Subject|4|||
42252998|NCT02467270|76078934|FG001|Overall Study|Withdrawal by Subject|3|||
42252999|NCT02467270|76078935|FG002|Overall Study|Withdrawal by Subject|5|||
42253000|NCT02467270|76078933|FG000|Overall Study|Reason not Specified|1|||
42253001|NCT02467270|76078934|FG001|Overall Study|Reason not Specified|2|||
42253002|NCT02467270|76078935|FG002|Overall Study|Reason not Specified|1|||
41991502|NCT05751629|75799575|FG000|Overall Study|Study Site Closed|9|||
41991503|NCT05751629|75799575|FG000|Overall Study|Physician Decision|1|||
41991504|NCT05306977|75799579|FG000|Overall Study|Withdrawal by Subject|1|||
41991505|NCT05086276|75799585|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
41991506|NCT05086276|75799586|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
41991507|NCT04870710|75799592|FG000|Overall Study|Lost to Follow-up|3|||
41991508|NCT04858802|75799598|FG000|Overall Study|Lost to Follow-up|1|||
41991509|NCT04858802|75799599|FG001|Overall Study|Lost to Follow-up|1|||
41991510|NCT04858802|75799598|FG000|Overall Study|Withdrawal by Subject|1|||
41991511|NCT04858802|75799599|FG001|Overall Study|Withdrawal by Subject|1|||
41991512|NCT04562090|75799617|FG000|Overall Study|Withdrawal by Subject|3|||
41991513|NCT04562090|75799618|FG001|Overall Study|Withdrawal by Subject|4|||
41991514|NCT04562090|75799617|FG000|Overall Study|Protocol Violation|2|||
41991515|NCT04562090|75799618|FG001|Overall Study|Protocol Violation|0|||
41991516|NCT04562090|75799617|FG000|Overall Study|Lack of Efficacy|0|||
41991517|NCT04562090|75799618|FG001|Overall Study|Lack of Efficacy|1|||
42253003|NCT05083559|76078945|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
42253004|NCT05083559|76078946|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
42253005|NCT05083559|76078945|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
42253006|NCT05083559|76078946|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
42253007|NCT05083559|76078945|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
42253008|NCT05083559|76078946|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
42253009|NCT03037307|76078952|FG000|Period 1|Did Not Meet Study Criteria|0|||
42253010|NCT03037307|76078953|FG001|Period 1|Did Not Meet Study Criteria|0|||
42253011|NCT03037307|76078954|FG002|Period 1|Did Not Meet Study Criteria|0|||
42253012|NCT03037307|76078955|FG003|Period 1|Did Not Meet Study Criteria|1|||
42253013|NCT03037307|76078956|FG004|Period 1|Did Not Meet Study Criteria|0|||
42253014|NCT03037307|76078957|FG005|Period 1|Did Not Meet Study Criteria|0|||
42253015|NCT02538094|76078966|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
42253016|NCT02538094|76078967|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
42253017|NCT02538094|76078966|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
42253018|NCT02538094|76078967|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
42253019|NCT02686034|76078975|FG000|Run-In Period 1|Eligibility|12|||
42253020|NCT02686034|76078976|FG001|Run-In Period 1|Eligibility|10|||
42253021|NCT02686034|76078975|FG000|Run-In Period 1|Withdrawal by Subject|4|||
42253022|NCT02686034|76078976|FG001|Run-In Period 1|Withdrawal by Subject|3|||
42253023|NCT02686034|76078975|FG000|Run-In Period 1|Lost to Follow-up|4|||
42253024|NCT02686034|76078976|FG001|Run-In Period 1|Lost to Follow-up|4|||
42253025|NCT02686034|76078975|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
41991518|NCT04562090|75799617|FG000|Overall Study|Adverse Event|1|||
42253026|NCT02686034|76078976|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
42253027|NCT02686034|76078975|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
41991519|NCT04562090|75799618|FG001|Overall Study|Adverse Event|4|||
41991520|NCT04562090|75799617|FG000|Overall Study|Miscellaneous|0|||
41991521|NCT04562090|75799618|FG001|Overall Study|Miscellaneous|3|||
41991522|NCT04557189|75799629|FG000|Overall Study|Adverse Event|0|||
41991523|NCT04557189|75799630|FG001|Overall Study|Adverse Event|1|||
41991524|NCT04557189|75799629|FG000|Overall Study|Lost to Follow-up|1|||
42307978|NCT02142387|76143770|FG000|Overall Study|CPR not performed|74|||
42307979|NCT02142387|76143771|FG001|Overall Study|CPR not performed|473|||
42307980|NCT02142387|76143770|FG000|Overall Study|witnessed by paramedic|139|||
42307981|NCT02142387|76143771|FG001|Overall Study|witnessed by paramedic|917|||
42307982|NCT02142387|76143770|FG000|Overall Study|incomplete data|1|||
42307983|NCT02142387|76143771|FG001|Overall Study|incomplete data|9|||
42307984|NCT02142387|76143770|FG000|Overall Study|occurred not at home|298|||
42307985|NCT02142387|76143771|FG001|Overall Study|occurred not at home|2474|||
42307986|NCT02518919|76143780|FG000|Overall Study|Protocol Violation|1|||
42307987|NCT02518919|76143781|FG001|Overall Study|Protocol Violation|1|||
42307988|NCT02518919|76143782|FG002|Overall Study|Protocol Violation|2|||
42307989|NCT02518685|76143792|FG000|Overall Study|Adverse Event|29|||
42307990|NCT02518685|76143793|FG001|Overall Study|Adverse Event|1|||
42307991|NCT02518685|76143792|FG000|Overall Study|Withdrawal by Subject|10|||
42307992|NCT02518685|76143793|FG001|Overall Study|Withdrawal by Subject|3|||
42307993|NCT02518685|76143792|FG000|Overall Study|relocation, study fatigue|7|||
42307994|NCT02518685|76143793|FG001|Overall Study|relocation, study fatigue|2|||
42307995|NCT02518685|76143792|FG000|Overall Study|Pregnancy|1|||
42307996|NCT02518685|76143793|FG001|Overall Study|Pregnancy|0|||
42307997|NCT02518685|76143792|FG000|Overall Study|Physician Decision|1|||
42307998|NCT02518685|76143793|FG001|Overall Study|Physician Decision|0|||
42307999|NCT02518685|76143792|FG000|Overall Study|Lost to Follow-up|1|||
42308000|NCT02518685|76143793|FG001|Overall Study|Lost to Follow-up|4|||
42308001|NCT02520089|76143802|FG000|Overall Study|Lost to Follow-up|3|||
42308002|NCT02520089|76143803|FG001|Overall Study|Lost to Follow-up|4|||
42308003|NCT02105961|76143812|FG000|Overall Study|Adverse Event|18|||
42308004|NCT02105961|76143813|FG001|Overall Study|Adverse Event|7|||
42308005|NCT02105961|76143814|FG002|Overall Study|Adverse Event|13|||
42308006|NCT02105961|76143812|FG000|Overall Study|Lack of Efficacy|3|||
42308007|NCT02105961|76143813|FG001|Overall Study|Lack of Efficacy|0|||
42308008|NCT02105961|76143814|FG002|Overall Study|Lack of Efficacy|3|||
42308009|NCT02105961|76143812|FG000|Overall Study|Lost to Follow-up|2|||
42308010|NCT02105961|76143813|FG001|Overall Study|Lost to Follow-up|0|||
42308011|NCT02105961|76143814|FG002|Overall Study|Lost to Follow-up|1|||
42308012|NCT02105961|76143812|FG000|Overall Study|Physician Decision|3|||
42308013|NCT02105961|76143813|FG001|Overall Study|Physician Decision|3|||
41991525|NCT04557189|75799630|FG001|Overall Study|Lost to Follow-up|1|||
42308014|NCT02105961|76143814|FG002|Overall Study|Physician Decision|2|||
42308015|NCT02105961|76143812|FG000|Overall Study|Withdrawal by Subject|15|||
42308016|NCT02105961|76143813|FG001|Overall Study|Withdrawal by Subject|7|||
42308017|NCT02105961|76143814|FG002|Overall Study|Withdrawal by Subject|11|||
42308018|NCT02141997|76143827|FG000|Overall Study|Adverse Event|0|||
42308019|NCT02141997|76143828|FG001|Overall Study|Adverse Event|2|||
42308020|NCT02141997|76143829|FG002|Overall Study|Adverse Event|0|||
42308021|NCT02141997|76143830|FG003|Overall Study|Adverse Event|1|||
42308022|NCT02141997|76143827|FG000|Overall Study|Participant noncompliance|1|||
41991526|NCT04557189|75799629|FG000|Overall Study|Withdrawal by Subject|2|||
41991527|NCT04557189|75799630|FG001|Overall Study|Withdrawal by Subject|1|||
41991528|NCT04557189|75799629|FG000|Overall Study|Reason not Specified|3|||
41991529|NCT04557189|75799630|FG001|Overall Study|Reason not Specified|6|||
42253028|NCT02686034|76078976|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
42253029|NCT02686034|76078975|FG000|Randomized Controlled Period 2|Adverse Event|0|||
42253030|NCT02686034|76078976|FG001|Randomized Controlled Period 2|Adverse Event|2|||
42253031|NCT02686034|76078975|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
42253032|NCT02686034|76078976|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
42253033|NCT02686034|76078975|FG000|Open Label Period 3|Lost to Follow-up|0|||
42253034|NCT02686034|76078976|FG001|Open Label Period 3|Lost to Follow-up|1|||
42308023|NCT02141997|76143828|FG001|Overall Study|Participant noncompliance|0|||
42308024|NCT02141997|76143829|FG002|Overall Study|Participant noncompliance|0|||
42308025|NCT02141997|76143830|FG003|Overall Study|Participant noncompliance|0|||
42308026|NCT02141997|76143827|FG000|Overall Study|Withdrew consent|1|||
41991530|NCT04530838|75799643|FG000|Overall Study|Other|2|||
42308027|NCT02141997|76143828|FG001|Overall Study|Withdrew consent|0|||
42308028|NCT02141997|76143829|FG002|Overall Study|Withdrew consent|3|||
42308029|NCT02141997|76143830|FG003|Overall Study|Withdrew consent|0|||
42308030|NCT02141997|76143827|FG000|Overall Study|Other|1|||
42308031|NCT02141997|76143828|FG001|Overall Study|Other|4|||
42308032|NCT02141997|76143829|FG002|Overall Study|Other|0|||
42308033|NCT02141997|76143830|FG003|Overall Study|Other|0|||
42308034|NCT01628367|76143842|FG000|Overall Study|Adverse Event|1|||
42308035|NCT01628367|76143843|FG001|Overall Study|Adverse Event|0|||
42308036|NCT01627899|76143849|FG000|Overall Study|Study terminated early by sponsor.|5|||
42308037|NCT02519777|76143856|FG000|Overall Study|Death|1|||
42308038|NCT02519777|76143857|FG001|Overall Study|Death|0|||
42308039|NCT02519777|76143858|FG002|Overall Study|Death|0|||
42308040|NCT02519777|76143856|FG000|Overall Study|Lost to Follow-up|0|||
42308041|NCT02519777|76143857|FG001|Overall Study|Lost to Follow-up|4|||
42308042|NCT02519777|76143858|FG002|Overall Study|Lost to Follow-up|2|||
42308043|NCT02519777|76143856|FG000|Overall Study|Withdrawal by Subject|3|||
42308044|NCT02519777|76143857|FG001|Overall Study|Withdrawal by Subject|1|||
42308045|NCT02519777|76143858|FG002|Overall Study|Withdrawal by Subject|0|||
42308046|NCT02519777|76143856|FG000|Overall Study|Severe Debilitation|1|||
42308047|NCT02519777|76143857|FG001|Overall Study|Severe Debilitation|1|||
42308048|NCT02519777|76143858|FG002|Overall Study|Severe Debilitation|1|||
42308049|NCT02519777|76143856|FG000|Overall Study|Not able to get to clinic|1|||
42308050|NCT02519777|76143857|FG001|Overall Study|Not able to get to clinic|2|||
42308051|NCT02519777|76143858|FG002|Overall Study|Not able to get to clinic|1|||
42308052|NCT02515331|76143869|FG000|Overall Study|Withdrawal by Subject|0|||
42308053|NCT02515331|76143870|FG001|Overall Study|Withdrawal by Subject|0|||
42308054|NCT02515331|76143871|FG002|Overall Study|Withdrawal by Subject|1|||
42308055|NCT02515331|76143869|FG000|Overall Study|Protocol deviation|0|||
42308056|NCT02515331|76143870|FG001|Overall Study|Protocol deviation|0|||
42308057|NCT02515331|76143871|FG002|Overall Study|Protocol deviation|3|||
42308058|NCT02515331|76143869|FG000|Overall Study|Adverse Event|2|||
42308059|NCT02515331|76143870|FG001|Overall Study|Adverse Event|0|||
42308060|NCT02515331|76143871|FG002|Overall Study|Adverse Event|0|||
42308061|NCT02515097|76143881|FG000|Overall Study|Lost to Follow-up|4|||
42308062|NCT02515097|76143882|FG001|Overall Study|Lost to Follow-up|2|||
42308063|NCT02515097|76143881|FG000|Overall Study|Withdrawal by Subject|1|||
42308064|NCT02515097|76143882|FG001|Overall Study|Withdrawal by Subject|3|||
42308065|NCT02515097|76143881|FG000|Overall Study|Adverse Event|2|||
42308066|NCT02515097|76143882|FG001|Overall Study|Adverse Event|1|||
42308067|NCT02141295|76143891|FG000|Overall Study|Adverse Event|1|||
42308068|NCT02141295|76143892|FG001|Overall Study|Adverse Event|18|||
42308069|NCT02141295|76143893|FG002|Overall Study|Adverse Event|11|||
42308070|NCT02141295|76143891|FG000|Overall Study|Physician Decision|2|||
42308071|NCT02141295|76143892|FG001|Overall Study|Physician Decision|19|||
42308072|NCT02141295|76143893|FG002|Overall Study|Physician Decision|14|||
42308073|NCT02141295|76143891|FG000|Overall Study|Study terminated by sponsor|0|||
42308074|NCT02141295|76143892|FG001|Overall Study|Study terminated by sponsor|6|||
42308075|NCT02141295|76143893|FG002|Overall Study|Study terminated by sponsor|6|||
42308076|NCT02141295|76143891|FG000|Overall Study|Non-compliance|0|||
42308077|NCT02141295|76143892|FG001|Overall Study|Non-compliance|1|||
42308078|NCT02141295|76143893|FG002|Overall Study|Non-compliance|0|||
42308079|NCT02141295|76143891|FG000|Overall Study|Progressive disease|3|||
42308080|NCT02141295|76143892|FG001|Overall Study|Progressive disease|32|||
42308081|NCT02141295|76143893|FG002|Overall Study|Progressive disease|50|||
42308082|NCT02141295|76143891|FG000|Overall Study|Reason not specified|0|||
42308083|NCT02141295|76143892|FG001|Overall Study|Reason not specified|9|||
42308084|NCT02141295|76143893|FG002|Overall Study|Reason not specified|10|||
42308085|NCT02141295|76143891|FG000|Overall Study|Withdrawal by Subject|0|||
42308086|NCT02141295|76143892|FG001|Overall Study|Withdrawal by Subject|9|||
42308087|NCT02141295|76143893|FG002|Overall Study|Withdrawal by Subject|4|||
42308088|NCT02514551|76143905|FG000|Overall Study|Lost to Follow-up|0|||
42308089|NCT02514551|76143906|FG001|Overall Study|Lost to Follow-up|1|||
42308090|NCT02514551|76143905|FG000|Overall Study|Participant Never Treated|0|||
42308091|NCT02514551|76143906|FG001|Overall Study|Participant Never Treated|2|||
42308092|NCT02141217|76143915|FG000|Overall Study|Adverse Event|1|||
42308093|NCT02141217|76143916|FG001|Overall Study|Adverse Event|2|||
42308094|NCT02141217|76143915|FG000|Overall Study|Protocol Violation|1|||
42308095|NCT02141217|76143916|FG001|Overall Study|Protocol Violation|4|||
42308096|NCT02141217|76143915|FG000|Overall Study|Withdrawal by Subject|6|||
42308097|NCT02141217|76143916|FG001|Overall Study|Withdrawal by Subject|0|||
42308098|NCT02141217|76143915|FG000|Overall Study|Lost to Follow-up|1|||
42308099|NCT02141217|76143916|FG001|Overall Study|Lost to Follow-up|1|||
42308100|NCT02141217|76143915|FG000|Overall Study|Physician Decision|1|||
42308101|NCT02141217|76143916|FG001|Overall Study|Physician Decision|0|||
42308102|NCT02141217|76143915|FG000|Overall Study|Surgical Intervention|1|||
42308103|NCT02141217|76143916|FG001|Overall Study|Surgical Intervention|1|||
41991531|NCT04530838|75799644|FG001|Overall Study|Other|1|||
42308104|NCT02138253|76143927|FG000|Overall Study|Adverse Event|3|||
42308105|NCT02138253|76143928|FG001|Overall Study|Adverse Event|3|||
42308106|NCT02138253|76143927|FG000|Overall Study|Lost to Follow-up|2|||
42308107|NCT02138253|76143928|FG001|Overall Study|Lost to Follow-up|1|||
42308108|NCT02138253|76143927|FG000|Overall Study|Physician Decision|2|||
42308109|NCT02138253|76143928|FG001|Overall Study|Physician Decision|0|||
42308110|NCT02138253|76143927|FG000|Overall Study|Non compliance|1|||
42308111|NCT02138253|76143928|FG001|Overall Study|Non compliance|0|||
42308112|NCT02138253|76143927|FG000|Overall Study|Withdrawal by Subject|1|||
42308113|NCT02138253|76143928|FG001|Overall Study|Withdrawal by Subject|0|||
42308114|NCT02514473|76143936|FG000|Overall Study|Adverse Event|0|||
42308115|NCT02514473|76143937|FG001|Overall Study|Adverse Event|2|||
42308116|NCT02514473|76143936|FG000|Overall Study|Withdrawal by Subject|2|||
42308117|NCT02514473|76143937|FG001|Overall Study|Withdrawal by Subject|1|||
42308118|NCT02514473|76143936|FG000|Overall Study|Lost to Follow-up|0|||
42308119|NCT02514473|76143937|FG001|Overall Study|Lost to Follow-up|1|||
42308120|NCT02514473|76143936|FG000|Overall Study|Other|1|||
42308121|NCT02514473|76143937|FG001|Overall Study|Other|1|||
42308122|NCT02513771|76143946|FG000|Overall Study|Lost to Follow-up|1|||
42308123|NCT02513771|76143947|FG001|Overall Study|Lost to Follow-up|1|||
42308124|NCT02513771|76143946|FG000|Overall Study|Not being able to get to clinic|1|||
41991532|NCT04530838|75799645|FG002|Overall Study|Other|0|||
41991533|NCT04530838|75799643|FG000|Overall Study|Physician Decision|0|||
42253035|NCT02685488|76078984|FG000|Overall Study|Withdrawal by Subject|0|||
42253036|NCT02685488|76078985|FG001|Overall Study|Withdrawal by Subject|1|||
42253037|NCT02533570|76078994|FG000|Overall Study|Adverse Event|0|||
42253038|NCT02533570|76078995|FG001|Overall Study|Adverse Event|1|||
42253039|NCT02533570|76078996|FG002|Overall Study|Adverse Event|1|||
42253040|NCT03036839|76079007|FG000|Overall Study|Adverse Event|0|||
42253041|NCT03036839|76079008|FG001|Overall Study|Adverse Event|0|||
42253042|NCT03036839|76079009|FG002|Overall Study|Adverse Event|1|||
42253043|NCT03036839|76079007|FG000|Overall Study|Death|3|||
42253044|NCT03036839|76079008|FG001|Overall Study|Death|0|||
42253045|NCT03036839|76079009|FG002|Overall Study|Death|3|||
42253046|NCT03036839|76079007|FG000|Overall Study|Withdrew Consent|0|||
42253047|NCT03036839|76079008|FG001|Overall Study|Withdrew Consent|0|||
42253048|NCT03036839|76079009|FG002|Overall Study|Withdrew Consent|1|||
42253049|NCT01286207|76079020|FG000|Overall Study|Adverse Event|27|||
42253050|NCT01286207|76079021|FG001|Overall Study|Adverse Event|41|||
42253051|NCT01286207|76079022|FG002|Overall Study|Adverse Event|8|||
42253052|NCT01286207|76079020|FG000|Overall Study|Lost to Follow-up|49|||
42253053|NCT01286207|76079021|FG001|Overall Study|Lost to Follow-up|43|||
42253054|NCT01286207|76079022|FG002|Overall Study|Lost to Follow-up|20|||
42253055|NCT01286207|76079020|FG000|Overall Study|Withdrawal by Subject|93|||
42253056|NCT01286207|76079021|FG001|Overall Study|Withdrawal by Subject|79|||
42253057|NCT01286207|76079022|FG002|Overall Study|Withdrawal by Subject|41|||
42253058|NCT01286207|76079020|FG000|Overall Study|Lack of Response|92|||
42308125|NCT02513771|76143947|FG001|Overall Study|Not being able to get to clinic|0|||
41991534|NCT04530838|75799644|FG001|Overall Study|Physician Decision|0|||
42253059|NCT01286207|76079021|FG001|Overall Study|Lack of Response|38|||
42253060|NCT01286207|76079022|FG002|Overall Study|Lack of Response|8|||
42308126|NCT02104947|76143955|FG000|Overall Study|Withdrawal by Subject|10|||
42308127|NCT02104947|76143956|FG001|Overall Study|Withdrawal by Subject|3|||
42308128|NCT02104947|76143955|FG000|Overall Study|Lost to Follow-up|4|||
42308129|NCT02104947|76143956|FG001|Overall Study|Lost to Follow-up|4|||
42253061|NCT01286207|76079020|FG000|Overall Study|Other|37|||
42308130|NCT02104947|76143955|FG000|Overall Study|Protocol Violation|6|||
42308131|NCT02104947|76143956|FG001|Overall Study|Protocol Violation|8|||
42308132|NCT02104947|76143955|FG000|Overall Study|Adverse Event|57|||
42308133|NCT02104947|76143956|FG001|Overall Study|Adverse Event|38|||
42308134|NCT02104947|76143955|FG000|Overall Study|Other than stated above|2|||
42308135|NCT02104947|76143956|FG001|Overall Study|Other than stated above|3|||
42308136|NCT02513459|76143966|FG000|Overall Study|Adverse Event|7|||
42308137|NCT02513459|76143966|FG000|Overall Study|Withdrew consent|5|||
42308138|NCT02513459|76143966|FG000|Overall Study|Loss of efficacy|2|||
42308139|NCT02513459|76143966|FG000|Overall Study|Pregnancy|2|||
42308140|NCT02513459|76143966|FG000|Overall Study|Subject decision|2|||
42308141|NCT02513459|76143966|FG000|Overall Study|Lack of response|1|||
42308142|NCT02513459|76143966|FG000|Overall Study|Reproductive plans|1|||
42308143|NCT02513459|76143966|FG000|Overall Study|Surgery planned-- not done|1|||
42308144|NCT02104557|76143975|FG000|Overall Study|Adverse Event|24|||
42308145|NCT02104557|76143975|FG000|Overall Study|Lost to Follow-up|34|||
42308146|NCT02104557|76143975|FG000|Overall Study|Violated the usage and dosage|14|||
42308147|NCT02104557|76143975|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
42308148|NCT02104557|76143975|FG000|Overall Study|Administered Sayana prior to the contract|1|||
42308149|NCT02104557|76143975|FG000|Overall Study|Other|17|||
42308150|NCT02104557|76143975|FG000|Overall Study|Change to other contraception methods|5|||
42308151|NCT02104557|76143975|FG000|Overall Study|Discontinuation due to no pain|1|||
42308152|NCT02104557|76143975|FG000|Overall Study|Withdrawal consent|2|||
42308153|NCT02104557|76143975|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
42308154|NCT02104557|76143975|FG000|Overall Study|Discontinuation of contraception|9|||
42308155|NCT02069379|76143981|FG000|Baseline Measurements|Lost to Follow-up|1|||
42308156|NCT02069379|76143982|FG001|Baseline Measurements|Lost to Follow-up|0|||
42308157|NCT02069379|76143983|FG002|Baseline Measurements|Lost to Follow-up|0|||
42308158|NCT02069379|76143984|FG003|Baseline Measurements|Lost to Follow-up|0|||
42308159|NCT02069379|76143981|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
42308160|NCT02069379|76143982|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
42308161|NCT02069379|76143983|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
42308162|NCT02069379|76143984|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
42308163|NCT02069379|76143981|FG000|First Treatment Arm|Lost to Follow-up|0|||
42308164|NCT02069379|76143982|FG001|First Treatment Arm|Lost to Follow-up|1|||
42308165|NCT02069379|76143983|FG002|First Treatment Arm|Lost to Follow-up|1|||
42308166|NCT02069379|76143984|FG003|First Treatment Arm|Lost to Follow-up|0|||
42308167|NCT02069379|76143981|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
42308168|NCT02069379|76143982|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
42308169|NCT02069379|76143983|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
42308170|NCT02069379|76143984|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
42308171|NCT02069379|76143981|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
42308172|NCT02069379|76143982|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
42308173|NCT02069379|76143983|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
42308174|NCT02069379|76143984|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
42308175|NCT02069379|76143981|FG000|Second Treatment Arm|Lost to Follow-up|0|||
42308176|NCT02069379|76143982|FG001|Second Treatment Arm|Lost to Follow-up|0|||
42308177|NCT02069379|76143983|FG002|Second Treatment Arm|Lost to Follow-up|1|||
42308178|NCT02069379|76143984|FG003|Second Treatment Arm|Lost to Follow-up|0|||
42308179|NCT02511431|76144000|FG000|Treatment|Lost to Follow-up|0|||
42308180|NCT02511431|76144001|FG001|Treatment|Lost to Follow-up|0|||
42308181|NCT02511431|76144002|FG002|Treatment|Lost to Follow-up|1|||
42308182|NCT02511431|76144003|FG003|Treatment|Lost to Follow-up|0|||
42308183|NCT02511431|76144004|FG004|Treatment|Lost to Follow-up|0|||
42308184|NCT02511431|76144005|FG005|Treatment|Lost to Follow-up|1|||
42253062|NCT01286207|76079021|FG001|Overall Study|Other|47|||
42253063|NCT01286207|76079022|FG002|Overall Study|Other|13|||
42253064|NCT00968201|76079059|FG000|Base Study - (Period II)|Adverse Event|8|||
42253065|NCT00968201|76079060|FG001|Base Study - (Period II)|Adverse Event|0|||
42253066|NCT00968201|76079061|FG002|Base Study - (Period II)|Adverse Event|16|||
42253067|NCT00968201|76079059|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
42253068|NCT00968201|76079060|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
42253069|NCT00968201|76079061|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
42253070|NCT00968201|76079059|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
42253071|NCT00968201|76079060|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
42308185|NCT02137785|76144022|FG000|Overall Study|Lost to Follow-up|1|||
42308186|NCT02137785|76144023|FG001|Overall Study|Lost to Follow-up|0|||
42308187|NCT02137785|76144022|FG000|Overall Study|Withdrawal by Subject|1|||
42308188|NCT02137785|76144023|FG001|Overall Study|Withdrawal by Subject|4|||
41991535|NCT04530838|75799645|FG002|Overall Study|Physician Decision|1|||
42308189|NCT02137785|76144022|FG000|Overall Study|subject moved out of state|1|||
42308190|NCT02137785|76144023|FG001|Overall Study|subject moved out of state|0|||
42308191|NCT01655069|76144033|FG000|Overall Study|Physician Decision|0|||
42308192|NCT01655069|76144034|FG001|Overall Study|Physician Decision|0|||
42308193|NCT01655069|76144035|FG002|Overall Study|Physician Decision|0|||
42308194|NCT01655069|76144036|FG003|Overall Study|Physician Decision|1|||
42308195|NCT01655069|76144033|FG000|Overall Study|Adverse Event|6|||
42308196|NCT01655069|76144034|FG001|Overall Study|Adverse Event|7|||
42308197|NCT01655069|76144035|FG002|Overall Study|Adverse Event|2|||
42308198|NCT01655069|76144036|FG003|Overall Study|Adverse Event|3|||
42308199|NCT01655069|76144033|FG000|Overall Study|Lack of Efficacy|0|||
42308200|NCT01655069|76144034|FG001|Overall Study|Lack of Efficacy|1|||
42308201|NCT01655069|76144035|FG002|Overall Study|Lack of Efficacy|0|||
42308202|NCT01655069|76144036|FG003|Overall Study|Lack of Efficacy|0|||
42308203|NCT01655069|76144033|FG000|Overall Study|No Treatment Needed|0|||
42308204|NCT01655069|76144034|FG001|Overall Study|No Treatment Needed|1|||
42308205|NCT01655069|76144035|FG002|Overall Study|No Treatment Needed|0|||
42308206|NCT01655069|76144036|FG003|Overall Study|No Treatment Needed|0|||
42308207|NCT01655069|76144033|FG000|Overall Study|Withdrawal by Subject|2|||
42308208|NCT01655069|76144034|FG001|Overall Study|Withdrawal by Subject|3|||
42308209|NCT01655069|76144035|FG002|Overall Study|Withdrawal by Subject|0|||
42308210|NCT01655069|76144036|FG003|Overall Study|Withdrawal by Subject|0|||
42308211|NCT02068599|76144047|FG000|Overall Study|Adverse Event|4|||
42308212|NCT02068599|76144048|FG001|Overall Study|Adverse Event|1|||
42308213|NCT02068599|76144049|FG002|Overall Study|Adverse Event|1|||
42308214|NCT02068599|76144047|FG000|Overall Study|Withdrawal by Subject|2|||
42308215|NCT02068599|76144048|FG001|Overall Study|Withdrawal by Subject|7|||
42308216|NCT02068599|76144049|FG002|Overall Study|Withdrawal by Subject|5|||
42308217|NCT02068599|76144047|FG000|Overall Study|Protocol Violation|4|||
42308218|NCT02068599|76144048|FG001|Overall Study|Protocol Violation|2|||
42308219|NCT02068599|76144049|FG002|Overall Study|Protocol Violation|3|||
42308220|NCT02068599|76144047|FG000|Overall Study|Lost to Follow-up|1|||
42308221|NCT02068599|76144048|FG001|Overall Study|Lost to Follow-up|0|||
42308222|NCT02068599|76144049|FG002|Overall Study|Lost to Follow-up|0|||
42308223|NCT02068599|76144047|FG000|Overall Study|Lack of Efficacy|0|||
42308224|NCT02068599|76144048|FG001|Overall Study|Lack of Efficacy|0|||
42308225|NCT02068599|76144049|FG002|Overall Study|Lack of Efficacy|3|||
42308226|NCT02068599|76144047|FG000|Overall Study|Noncompliance|0|||
42308227|NCT02068599|76144048|FG001|Overall Study|Noncompliance|0|||
41991536|NCT04530838|75799643|FG000|Overall Study|Death|0|||
41991537|NCT04530838|75799644|FG001|Overall Study|Death|0|||
41991538|NCT04530838|75799645|FG002|Overall Study|Death|1|||
41991539|NCT04530838|75799643|FG000|Overall Study|Adverse Event|0|||
41991540|NCT04530838|75799644|FG001|Overall Study|Adverse Event|1|||
42253072|NCT00968201|76079061|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
42253073|NCT00968201|76079059|FG000|Base Study - (Period II)|Protocol Violation|12|||
42253074|NCT00968201|76079060|FG001|Base Study - (Period II)|Protocol Violation|0|||
42253075|NCT00968201|76079061|FG002|Base Study - (Period II)|Protocol Violation|12|||
42253076|NCT00968201|76079059|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
42253077|NCT00968201|76079060|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
42253078|NCT00968201|76079061|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
42253079|NCT00968201|76079059|FG000|Base Study - (Period II)|Site Error|0|||
42253080|NCT00968201|76079060|FG001|Base Study - (Period II)|Site Error|0|||
42253081|NCT00968201|76079061|FG002|Base Study - (Period II)|Site Error|1|||
42253082|NCT00968201|76079059|FG000|Extension Study - (Period III)|Adverse Event|0|||
42253083|NCT00968201|76079060|FG001|Extension Study - (Period III)|Adverse Event|5|||
42253084|NCT00968201|76079061|FG002|Extension Study - (Period III)|Adverse Event|22|||
42253085|NCT00968201|76079059|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
42253086|NCT00968201|76079060|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
42253087|NCT00968201|76079061|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
42253088|NCT00968201|76079059|FG000|Extension Study - (Period III)|Protocol Violation|0|||
41991541|NCT04530838|75799645|FG002|Overall Study|Adverse Event|0|||
41991542|NCT04530838|75799643|FG000|Overall Study|No longer meets eligibility criteria|1|||
42253089|NCT00968201|76079060|FG001|Extension Study - (Period III)|Protocol Violation|17|||
41991543|NCT04530838|75799644|FG001|Overall Study|No longer meets eligibility criteria|0|||
42308228|NCT02068599|76144049|FG002|Overall Study|Noncompliance|1|||
42308229|NCT01654601|76144059|FG000|1st Administration|Withdrawal by Subject|2|||
42308230|NCT01654601|76144060|FG001|1st Administration|Withdrawal by Subject|0|||
42308231|NCT01654601|76144059|FG000|1st Administration|Protocol Violation|0|||
42308232|NCT01654601|76144060|FG001|1st Administration|Protocol Violation|2|||
42308233|NCT01654601|76144059|FG000|2nd Administration|Adverse Event|1|||
42308234|NCT01654601|76144060|FG001|2nd Administration|Adverse Event|0|||
42308235|NCT01654601|76144059|FG000|2nd Administration|Protocol Violation|0|||
42308236|NCT01654601|76144060|FG001|2nd Administration|Protocol Violation|1|||
42308237|NCT01654523|76144066|FG000|Overall Study|Withdrawal by Subject|1|||
42308238|NCT02508935|76144070|FG000|Overall Study|Withdrawal by Subject|1|||
42308239|NCT02508935|76144070|FG000|Overall Study|Withdrawal by Caregiver|8|||
42308240|NCT02508935|76144070|FG000|Overall Study|Pain Score <4|1|||
42308241|NCT02508935|76144070|FG000|Overall Study|Emesis|3|||
42308242|NCT02508935|76144070|FG000|Overall Study|Adverse Event|3|||
42308243|NCT02508935|76144070|FG000|Overall Study|Protocol Violation|1|||
42308244|NCT02508935|76144070|FG000|Overall Study|Physician Decision|1|||
42308245|NCT02508935|76144070|FG000|Overall Study|Trial terminated by sponsor|5|||
42033243|NCT01131455|75841377|FG002|Overall Study|Death of PI|0|||
42033244|NCT01138007|75841388|FG000|Overall Study|Adverse Event|4|||
42253090|NCT00968201|76079061|FG002|Extension Study - (Period III)|Protocol Violation|14|||
42253091|NCT00968201|76079059|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
42253092|NCT00968201|76079060|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
42253093|NCT00968201|76079061|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
42253094|NCT00968201|76079059|FG000|Extension Study - (Period III)|Patient Relocated|0|||
42253095|NCT00968201|76079060|FG001|Extension Study - (Period III)|Patient Relocated|1|||
42253096|NCT00968201|76079061|FG002|Extension Study - (Period III)|Patient Relocated|1|||
42253097|NCT00968201|76079059|FG000|Extension Study - (Period III)|Noncompliance|0|||
42253098|NCT00968201|76079060|FG001|Extension Study - (Period III)|Noncompliance|0|||
42308246|NCT02508701|76144080|FG000|Overall Study|Lost to Follow-up|9|||
42308247|NCT02508701|76144081|FG001|Overall Study|Lost to Follow-up|5|||
42308248|NCT02508701|76144082|FG002|Overall Study|Lost to Follow-up|5|||
42253099|NCT00968201|76079061|FG002|Extension Study - (Period III)|Noncompliance|3|||
42253100|NCT00968201|76079059|FG000|Extension Study - (Period III)|Other|0|||
42253101|NCT00968201|76079060|FG001|Extension Study - (Period III)|Other|0|||
42253102|NCT00968201|76079061|FG002|Extension Study - (Period III)|Other|2|||
42253103|NCT00968201|76079059|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
42253104|NCT00968201|76079060|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
42253105|NCT00968201|76079061|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
42253106|NCT00943397|76079072|FG000|Overall Study|Adverse Event|0|||
42253107|NCT00943397|76079073|FG001|Overall Study|Adverse Event|6|||
42253108|NCT00943397|76079072|FG000|Overall Study|Lost to Follow-up|0|||
42253109|NCT00943397|76079073|FG001|Overall Study|Lost to Follow-up|4|||
42253110|NCT00943397|76079072|FG000|Overall Study|Protocol Violation|2|||
42253111|NCT00943397|76079073|FG001|Overall Study|Protocol Violation|5|||
42253112|NCT00943397|76079072|FG000|Overall Study|Withdrawal by Subject|1|||
42253113|NCT00943397|76079073|FG001|Overall Study|Withdrawal by Subject|1|||
42253114|NCT00943397|76079072|FG000|Overall Study|Site terminated and other|12|||
42253115|NCT00943397|76079073|FG001|Overall Study|Site terminated and other|56|||
41991544|NCT04530838|75799645|FG002|Overall Study|No longer meets eligibility criteria|2|||
42253116|NCT00702845|76079081|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
42253117|NCT00702845|76079082|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
42253118|NCT00702845|76079081|FG000|Overall Study|Too high ovarian response|5|||
42253119|NCT00702845|76079082|FG001|Overall Study|Too high ovarian response|1|||
42308249|NCT02508701|76144083|FG003|Overall Study|Lost to Follow-up|3|||
41991545|NCT04530838|75799643|FG000|Overall Study|Withdrawal by parent/guardian|5|||
41991546|NCT04530838|75799644|FG001|Overall Study|Withdrawal by parent/guardian|2|||
41991547|NCT04530838|75799645|FG002|Overall Study|Withdrawal by parent/guardian|2|||
41991548|NCT04424901|75799659|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
42253120|NCT00702845|76079081|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
42253121|NCT00702845|76079082|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
42253122|NCT00702845|76079081|FG000|Overall Study|Insufficient ovarian response|1|||
42253123|NCT00702845|76079082|FG001|Overall Study|Insufficient ovarian response|0|||
42253124|NCT00702845|76079081|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
42253125|NCT00702845|76079082|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
42253126|NCT00702845|76079081|FG000|Overall Study|No or abnormal fertilization|4|||
42308250|NCT02507375|76144099|FG000|Overall Study|Progressive Disease|4|||
41991549|NCT04424901|75799660|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
41991550|NCT04410445|75799668|FG000|Overall Study|Lost to Follow-up|3|||
41991551|NCT04410445|75799669|FG001|Overall Study|Lost to Follow-up|9|||
41991552|NCT04410445|75799668|FG000|Overall Study|Withdrawal by Subject|27|||
41991553|NCT04410445|75799669|FG001|Overall Study|Withdrawal by Subject|15|||
41991554|NCT04062448|75799693|FG000|Overall Study|Lost to Follow-up|1|||
41991555|NCT04062448|75799693|FG000|Overall Study|Withdrawal by Subject|1|||
41991556|NCT04062448|75799693|FG000|Overall Study|Ongoing|14|||
41991557|NCT03970733|75799700|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
41991558|NCT03970733|75799701|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
41991559|NCT03970733|75799702|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
41991560|NCT03970733|75799703|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
41991561|NCT03970733|75799704|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
41991562|NCT03970733|75799700|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
41991563|NCT03970733|75799701|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
42253127|NCT00702845|76079082|FG001|Overall Study|No or abnormal fertilization|2|||
42253128|NCT00702845|76079081|FG000|Overall Study|Patient's decision|2|||
42253129|NCT00702845|76079082|FG001|Overall Study|Patient's decision|1|||
42253130|NCT00702845|76079081|FG000|Overall Study|Not randomized|0|||
42253131|NCT00702845|76079082|FG001|Overall Study|Not randomized|1|||
42253132|NCT01302847|76079096|FG000|Overall Study|Ongoing|0|||
42253133|NCT01302847|76079097|FG001|Overall Study|Ongoing|0|||
42253134|NCT01302847|76079098|FG002|Overall Study|Ongoing|0|||
42253135|NCT01302847|76079099|FG003|Overall Study|Ongoing|0|||
42253136|NCT01302847|76079100|FG004|Overall Study|Ongoing|0|||
42253137|NCT01302847|76079101|FG005|Overall Study|Ongoing|27|||
42253138|NCT01302847|76079102|FG006|Overall Study|Ongoing|22|||
42253139|NCT01302847|76079103|FG007|Overall Study|Ongoing|17|||
41991564|NCT03970733|75799702|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
41991565|NCT03970733|75799703|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
42308251|NCT02507375|76144100|FG001|Overall Study|Progressive Disease|5|||
42010553|NCT00993421|75817697|FG003|Overall Study|Adverse Event|9|||
42253140|NCT01302847|76079096|FG000|Overall Study|Death|0|||
42308252|NCT02507375|76144099|FG000|Overall Study|Death|0|||
41991566|NCT03970733|75799704|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
41991567|NCT03970733|75799700|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
41991568|NCT03970733|75799701|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
42253141|NCT01302847|76079097|FG001|Overall Study|Death|1|||
42253142|NCT01302847|76079098|FG002|Overall Study|Death|0|||
42253143|NCT01302847|76079099|FG003|Overall Study|Death|0|||
42253144|NCT01302847|76079100|FG004|Overall Study|Death|0|||
42253145|NCT01302847|76079101|FG005|Overall Study|Death|1|||
42253146|NCT01302847|76079102|FG006|Overall Study|Death|1|||
42253147|NCT01302847|76079103|FG007|Overall Study|Death|0|||
42253148|NCT01302847|76079096|FG000|Overall Study|Pregnancy|2|||
42253149|NCT01302847|76079097|FG001|Overall Study|Pregnancy|0|||
42253150|NCT01302847|76079098|FG002|Overall Study|Pregnancy|0|||
42253151|NCT01302847|76079099|FG003|Overall Study|Pregnancy|0|||
42253152|NCT01302847|76079100|FG004|Overall Study|Pregnancy|0|||
42253153|NCT01302847|76079101|FG005|Overall Study|Pregnancy|0|||
42253154|NCT01302847|76079102|FG006|Overall Study|Pregnancy|0|||
42253155|NCT01302847|76079103|FG007|Overall Study|Pregnancy|0|||
42253156|NCT01302847|76079096|FG000|Overall Study|Virologic failure|0|||
42253157|NCT01302847|76079097|FG001|Overall Study|Virologic failure|2|||
42253158|NCT01302847|76079098|FG002|Overall Study|Virologic failure|2|||
42253159|NCT01302847|76079099|FG003|Overall Study|Virologic failure|0|||
42253160|NCT01302847|76079100|FG004|Overall Study|Virologic failure|1|||
42253161|NCT01302847|76079101|FG005|Overall Study|Virologic failure|1|||
42253162|NCT01302847|76079102|FG006|Overall Study|Virologic failure|0|||
42253163|NCT01302847|76079103|FG007|Overall Study|Virologic failure|2|||
42253164|NCT01302847|76079096|FG000|Overall Study|Severe debilitation, unable to continue|0|||
42253165|NCT01302847|76079097|FG001|Overall Study|Severe debilitation, unable to continue|0|||
42253166|NCT01302847|76079098|FG002|Overall Study|Severe debilitation, unable to continue|0|||
42253167|NCT01302847|76079099|FG003|Overall Study|Severe debilitation, unable to continue|0|||
42253168|NCT01302847|76079100|FG004|Overall Study|Severe debilitation, unable to continue|0|||
42253169|NCT01302847|76079101|FG005|Overall Study|Severe debilitation, unable to continue|1|||
42253170|NCT01302847|76079102|FG006|Overall Study|Severe debilitation, unable to continue|1|||
42253171|NCT01302847|76079103|FG007|Overall Study|Severe debilitation, unable to continue|0|||
42308253|NCT02507375|76144100|FG001|Overall Study|Death|1|||
42308254|NCT02507375|76144099|FG000|Overall Study|Refused treatment|0|||
42308255|NCT02507375|76144100|FG001|Overall Study|Refused treatment|1|||
41991569|NCT03970733|75799702|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
42253172|NCT01302847|76079096|FG000|Overall Study|Not able to get to clinic|1|||
42253173|NCT01302847|76079097|FG001|Overall Study|Not able to get to clinic|1|||
42253174|NCT01302847|76079098|FG002|Overall Study|Not able to get to clinic|0|||
42253175|NCT01302847|76079099|FG003|Overall Study|Not able to get to clinic|0|||
42253176|NCT01302847|76079100|FG004|Overall Study|Not able to get to clinic|0|||
42253177|NCT01302847|76079101|FG005|Overall Study|Not able to get to clinic|0|||
42308256|NCT02507375|76144099|FG000|Overall Study|Adverse Event|0|||
42308257|NCT02507375|76144100|FG001|Overall Study|Adverse Event|1|||
42308258|NCT02507219|76144110|FG000|Overall Study|Physician Decision|1|||
42308259|NCT02507219|76144111|FG001|Overall Study|Physician Decision|0|||
42308260|NCT02507219|76144112|FG002|Overall Study|Physician Decision|0|||
42308261|NCT02507219|76144113|FG003|Overall Study|Physician Decision|0|||
42308262|NCT02507219|76144114|FG004|Overall Study|Physician Decision|0|||
42308263|NCT02507219|76144115|FG005|Overall Study|Physician Decision|0|||
42308264|NCT02507219|76144110|FG000|Overall Study|Withdrawal by Subject|0|||
42308265|NCT02507219|76144111|FG001|Overall Study|Withdrawal by Subject|0|||
42308266|NCT02507219|76144112|FG002|Overall Study|Withdrawal by Subject|0|||
42308267|NCT02507219|76144113|FG003|Overall Study|Withdrawal by Subject|0|||
42308268|NCT02507219|76144114|FG004|Overall Study|Withdrawal by Subject|1|||
42308269|NCT02507219|76144115|FG005|Overall Study|Withdrawal by Subject|0|||
42308270|NCT02483975|76144125|FG000|Overall Study|Adverse Event|0|||
42308271|NCT02483975|76144126|FG001|Overall Study|Adverse Event|1|||
42308272|NCT02483975|76144125|FG000|Overall Study|Lost to Follow-up|0|||
42308273|NCT02483975|76144126|FG001|Overall Study|Lost to Follow-up|1|||
42308274|NCT02483975|76144125|FG000|Overall Study|Physician Decision|2|||
42308275|NCT02483975|76144126|FG001|Overall Study|Physician Decision|0|||
42308276|NCT02047227|76144137|FG000|Overall Study|Adverse Event|2|||
42308277|NCT02047227|76144138|FG001|Overall Study|Adverse Event|4|||
42308278|NCT02047227|76144137|FG000|Overall Study|Lost to Follow-up|0|||
42308279|NCT02047227|76144138|FG001|Overall Study|Lost to Follow-up|3|||
42308280|NCT02047227|76144137|FG000|Overall Study|Protocol Violation|1|||
42308281|NCT02047227|76144138|FG001|Overall Study|Protocol Violation|0|||
42308282|NCT02047227|76144137|FG000|Overall Study|Spontaneous pregnancy|1|||
42308283|NCT02047227|76144138|FG001|Overall Study|Spontaneous pregnancy|0|||
42308284|NCT02047227|76144137|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
42308285|NCT02047227|76144138|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
42308286|NCT02047227|76144137|FG000|Overall Study|No oocytes retrieved|21|||
42308287|NCT02047227|76144138|FG001|Overall Study|No oocytes retrieved|20|||
42308288|NCT02047227|76144137|FG000|Overall Study|No fertilization|61|||
42308289|NCT02047227|76144138|FG001|Overall Study|No fertilization|51|||
42308290|NCT02047227|76144137|FG000|Overall Study|Intention to freeze all embryos|1|||
42308291|NCT02047227|76144138|FG001|Overall Study|Intention to freeze all embryos|0|||
42308292|NCT02047227|76144137|FG000|Overall Study|All embryos discarded|12|||
42308293|NCT02047227|76144138|FG001|Overall Study|All embryos discarded|11|||
42308294|NCT02047227|76144137|FG000|Overall Study|Other|10|||
42308295|NCT02047227|76144138|FG001|Overall Study|Other|9|||
42308296|NCT02483585|76144146|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
42308297|NCT02483585|76144147|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
42308298|NCT02483585|76144146|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
42308299|NCT02483585|76144147|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
42308300|NCT02483585|76144146|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
42308301|NCT02483585|76144147|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
42308302|NCT02483585|76144146|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
42308303|NCT02483585|76144147|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
42308304|NCT02483585|76144146|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
42308305|NCT02483585|76144147|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
42308306|NCT02483585|76144146|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
42308307|NCT02483585|76144147|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
42308308|NCT02483585|76144146|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
42308309|NCT02483585|76144147|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
42308310|NCT02046993|76144159|FG000|Overall Study|Withdrawal by Subject|2|||
42308311|NCT02046993|76144160|FG001|Overall Study|Withdrawal by Subject|10|||
42308312|NCT02046993|76144159|FG000|Overall Study|Lost to Follow-up|1|||
42308313|NCT02046993|76144160|FG001|Overall Study|Lost to Follow-up|1|||
42308314|NCT02101983|76144170|FG000|Overall Study|Physician Decision|1|||
42308315|NCT02101983|76144171|FG001|Overall Study|Physician Decision|0|||
42308316|NCT02482805|76144180|FG000|Overall Study|Lost to Follow-up|4|||
42308317|NCT02482805|76144181|FG001|Overall Study|Lost to Follow-up|4|||
42308318|NCT02482805|76144182|FG002|Overall Study|Lost to Follow-up|0|||
42308319|NCT02503865|76144193|FG000|Overall Study|Moved out of area|1|||
42308320|NCT02503865|76144194|FG001|Overall Study|Moved out of area|8|||
42308321|NCT02503865|76144195|FG002|Overall Study|Moved out of area|0|||
42308322|NCT02503865|76144193|FG000|Overall Study|Refused treatment|4|||
42308323|NCT02503865|76144194|FG001|Overall Study|Refused treatment|39|||
42308324|NCT02503865|76144195|FG002|Overall Study|Refused treatment|2|||
42308325|NCT01623531|76144206|FG000|Overall Study|Death|1|||
42308326|NCT01623531|76144207|FG001|Overall Study|Death|0|||
42308327|NCT01623531|76144206|FG000|Overall Study|Protocol Violation|2|||
42308328|NCT01623531|76144207|FG001|Overall Study|Protocol Violation|1|||
42308329|NCT01623531|76144206|FG000|Overall Study|Missing data at primary outcome time poi|1|||
42308330|NCT01623531|76144207|FG001|Overall Study|Missing data at primary outcome time poi|1|||
42308331|NCT02503787|76144216|FG000|Enrollment|Withdrawal by Subject|6|||
42308332|NCT02503787|76144216|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
42308333|NCT02503787|76144216|FG000|Enrollment|Physician Decision|2|||
42308334|NCT02503787|76144216|FG000|Enrollment|Insurance issue|2|||
42308335|NCT02503787|76144216|FG000|Enrollment|Lost to Follow-up|1|||
42308336|NCT02503787|76144216|FG000|Enrollment|Study closure|1|||
42308337|NCT02503787|76144216|FG000|Enrollment|Adverse Event|1|||
42308338|NCT02503787|76144216|FG000|Enrollment|Protocol Violation|1|||
42308339|NCT02503787|76144216|FG000|Enrollment|Inability to implant system|1|||
42308340|NCT02503787|76144216|FG000|Enrollment|Unable to be programmed|1|||
41991570|NCT03970733|75799703|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
41991571|NCT03970733|75799704|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
41991572|NCT03970733|75799700|FG000|Main Study Phase (18 Months)|Other|1|||
41991573|NCT03970733|75799701|FG001|Main Study Phase (18 Months)|Other|1|||
41991574|NCT03970733|75799702|FG002|Main Study Phase (18 Months)|Other|0|||
41991575|NCT03970733|75799703|FG003|Main Study Phase (18 Months)|Other|0|||
42308341|NCT02503787|76144216|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
42308342|NCT02503787|76144216|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
42308343|NCT02503787|76144216|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
42308344|NCT02503787|76144216|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
42308345|NCT02503787|76144216|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
42308346|NCT02503787|76144216|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
42308347|NCT02482571|76144220|FG000|Overall Study|Adverse Event|1|||
42308348|NCT02482571|76144220|FG000|Overall Study|Scanner or Respiract failure|3|||
42308349|NCT02482571|76144220|FG000|Overall Study|Withdrawal by Subject|4|||
42308350|NCT02481947|76144227|FG000|Overall Study|Withdrawal by Subject|24|||
42308351|NCT02481947|76144228|FG001|Overall Study|Withdrawal by Subject|10|||
42308352|NCT02481947|76144227|FG000|Overall Study|Lost to Follow-up|11|||
42308353|NCT02481947|76144228|FG001|Overall Study|Lost to Follow-up|5|||
42308354|NCT02481947|76144227|FG000|Overall Study|Adverse Event|6|||
42308355|NCT02481947|76144228|FG001|Overall Study|Adverse Event|11|||
42308356|NCT02481947|76144227|FG000|Overall Study|Physician Decision|4|||
42308357|NCT02481947|76144228|FG001|Overall Study|Physician Decision|5|||
42308358|NCT02481947|76144227|FG000|Overall Study|Protocol Violation|1|||
42308359|NCT02481947|76144228|FG001|Overall Study|Protocol Violation|5|||
42308360|NCT02503085|76144234|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
42308361|NCT02503085|76144235|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
42308362|NCT02503085|76144236|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
42308363|NCT02503085|76144237|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
42308364|NCT02481869|76144246|FG000|Overall Study|Lost to Follow-up|3|||
42308365|NCT02481869|76144247|FG001|Overall Study|Lost to Follow-up|4|||
42308366|NCT02481869|76144246|FG000|Overall Study|Withdrawal by Subject|2|||
42308367|NCT02481869|76144247|FG001|Overall Study|Withdrawal by Subject|0|||
42308368|NCT02502149|76144254|FG000|Intermediate|Discontinued prematurely|1|||
42308369|NCT02502149|76144255|FG001|Intermediate|Discontinued prematurely|0|||
42308370|NCT02502149|76144256|FG002|Intermediate|Discontinued prematurely|0|||
42308371|NCT02502149|76144257|FG003|Intermediate|Discontinued prematurely|0|||
42308372|NCT02502149|76144258|FG004|Intermediate|Discontinued prematurely|0|||
42308373|NCT02480621|76144277|FG000|Randomization|Withdrawal by Subject|1|||
42308374|NCT02480621|76144278|FG001|Randomization|Withdrawal by Subject|0|||
42308375|NCT02480621|76144277|FG000|Randomization|Surgeon did not give intervention|0|||
42308376|NCT02480621|76144278|FG001|Randomization|Surgeon did not give intervention|1|||
42308377|NCT02480621|76144277|FG000|Follow Up|Lost to Follow-up|4|||
42308378|NCT02480621|76144278|FG001|Follow Up|Lost to Follow-up|2|||
42308379|NCT02046603|76144286|FG000|Overall Study|Other|11|||
42308380|NCT02046603|76144287|FG001|Overall Study|Other|66|||
42308381|NCT02046603|76144286|FG000|Overall Study|Protocol Violation|0|||
42308382|NCT02046603|76144287|FG001|Overall Study|Protocol Violation|1|||
42308383|NCT02046603|76144286|FG000|Overall Study|Participant/legal guardian decision|1|||
42308384|NCT02046603|76144287|FG001|Overall Study|Participant/legal guardian decision|3|||
42308385|NCT02046603|76144286|FG000|Overall Study|Physician Decision|2|||
42308386|NCT02046603|76144287|FG001|Overall Study|Physician Decision|1|||
42308387|NCT02046603|76144286|FG000|Overall Study|Lost to Follow-up|1|||
42308388|NCT02046603|76144287|FG001|Overall Study|Lost to Follow-up|2|||
42308389|NCT02046603|76144286|FG000|Overall Study|Death|0|||
42308390|NCT02046603|76144287|FG001|Overall Study|Death|1|||
41991576|NCT03970733|75799704|FG004|Main Study Phase (18 Months)|Other|0|||
41991577|NCT03970733|75799700|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
41991578|NCT03970733|75799701|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
42308391|NCT02046603|76144286|FG000|Overall Study|Adverse Event|0|||
42308392|NCT02046603|76144287|FG001|Overall Study|Adverse Event|1|||
42308393|NCT01885078|76144302|FG000|Treatment Period|Adverse Event|52|||
42308394|NCT01885078|76144303|FG001|Treatment Period|Adverse Event|136|||
42308395|NCT01885078|76144304|FG002|Treatment Period|Adverse Event|30|||
42308396|NCT01885078|76144305|FG003|Treatment Period|Adverse Event|73|||
42308397|NCT01885078|76144306|FG004|Treatment Period|Adverse Event|17|||
42308398|NCT01885078|76144307|FG005|Treatment Period|Adverse Event|72|||
42308399|NCT01885078|76144308|FG006|Treatment Period|Adverse Event|24|||
42308400|NCT01885078|76144309|FG007|Treatment Period|Adverse Event|5|||
42253178|NCT01302847|76079102|FG006|Overall Study|Not able to get to clinic|0|||
42253179|NCT01302847|76079103|FG007|Overall Study|Not able to get to clinic|0|||
42308401|NCT01885078|76144310|FG008|Treatment Period|Adverse Event|0|||
42308402|NCT01885078|76144311|FG009|Treatment Period|Adverse Event|0|||
42308403|NCT01885078|76144302|FG000|Treatment Period|Death|13|||
42308404|NCT01885078|76144303|FG001|Treatment Period|Death|33|||
42308405|NCT01885078|76144304|FG002|Treatment Period|Death|5|||
42308406|NCT01885078|76144305|FG003|Treatment Period|Death|9|||
42308407|NCT01885078|76144306|FG004|Treatment Period|Death|2|||
42308408|NCT01885078|76144307|FG005|Treatment Period|Death|10|||
42308409|NCT01885078|76144308|FG006|Treatment Period|Death|3|||
42308410|NCT01885078|76144309|FG007|Treatment Period|Death|2|||
42308411|NCT01885078|76144310|FG008|Treatment Period|Death|0|||
42308412|NCT01885078|76144311|FG009|Treatment Period|Death|0|||
42308413|NCT01885078|76144302|FG000|Treatment Period|Lack of Efficacy|12|||
42308414|NCT01885078|76144303|FG001|Treatment Period|Lack of Efficacy|33|||
42308415|NCT01885078|76144304|FG002|Treatment Period|Lack of Efficacy|10|||
42308416|NCT01885078|76144305|FG003|Treatment Period|Lack of Efficacy|23|||
42308417|NCT01885078|76144306|FG004|Treatment Period|Lack of Efficacy|24|||
42308418|NCT01885078|76144307|FG005|Treatment Period|Lack of Efficacy|58|||
42308419|NCT01885078|76144308|FG006|Treatment Period|Lack of Efficacy|9|||
42253180|NCT01302847|76079096|FG000|Overall Study|Site closing|2|||
42253181|NCT01302847|76079097|FG001|Overall Study|Site closing|2|||
42253182|NCT01302847|76079098|FG002|Overall Study|Site closing|0|||
42253183|NCT01302847|76079099|FG003|Overall Study|Site closing|0|||
42253184|NCT01302847|76079100|FG004|Overall Study|Site closing|0|||
42253185|NCT01302847|76079101|FG005|Overall Study|Site closing|0|||
42253186|NCT01302847|76079102|FG006|Overall Study|Site closing|0|||
42253187|NCT01302847|76079103|FG007|Overall Study|Site closing|0|||
42253188|NCT01302847|76079096|FG000|Overall Study|Withdrawal by Subject|1|||
42253189|NCT01302847|76079097|FG001|Overall Study|Withdrawal by Subject|0|||
42253190|NCT01302847|76079098|FG002|Overall Study|Withdrawal by Subject|0|||
42253191|NCT01302847|76079099|FG003|Overall Study|Withdrawal by Subject|0|||
42308420|NCT01885078|76144309|FG007|Treatment Period|Lack of Efficacy|5|||
42308421|NCT01885078|76144310|FG008|Treatment Period|Lack of Efficacy|0|||
42308422|NCT01885078|76144311|FG009|Treatment Period|Lack of Efficacy|0|||
42308423|NCT01885078|76144302|FG000|Treatment Period|Lost to Follow-up|16|||
42033245|NCT01138007|75841389|FG001|Overall Study|Adverse Event|12|||
42033246|NCT01138007|75841390|FG002|Overall Study|Adverse Event|9|||
42253192|NCT01302847|76079100|FG004|Overall Study|Withdrawal by Subject|1|||
42253193|NCT01302847|76079101|FG005|Overall Study|Withdrawal by Subject|0|||
42253194|NCT01302847|76079102|FG006|Overall Study|Withdrawal by Subject|0|||
42308424|NCT01885078|76144303|FG001|Treatment Period|Lost to Follow-up|19|||
42308425|NCT01885078|76144304|FG002|Treatment Period|Lost to Follow-up|7|||
42308426|NCT01885078|76144305|FG003|Treatment Period|Lost to Follow-up|9|||
42308427|NCT01885078|76144306|FG004|Treatment Period|Lost to Follow-up|2|||
42308428|NCT01885078|76144307|FG005|Treatment Period|Lost to Follow-up|8|||
42308429|NCT01885078|76144308|FG006|Treatment Period|Lost to Follow-up|2|||
42308430|NCT01885078|76144309|FG007|Treatment Period|Lost to Follow-up|0|||
42308431|NCT01885078|76144310|FG008|Treatment Period|Lost to Follow-up|0|||
42308432|NCT01885078|76144311|FG009|Treatment Period|Lost to Follow-up|0|||
42308433|NCT01885078|76144302|FG000|Treatment Period|Physician Decision|19|||
42308434|NCT01885078|76144303|FG001|Treatment Period|Physician Decision|21|||
42308435|NCT01885078|76144304|FG002|Treatment Period|Physician Decision|5|||
42308436|NCT01885078|76144305|FG003|Treatment Period|Physician Decision|12|||
42308437|NCT01885078|76144306|FG004|Treatment Period|Physician Decision|9|||
42308438|NCT01885078|76144307|FG005|Treatment Period|Physician Decision|24|||
42308439|NCT01885078|76144308|FG006|Treatment Period|Physician Decision|4|||
42308440|NCT01885078|76144309|FG007|Treatment Period|Physician Decision|3|||
42308441|NCT01885078|76144310|FG008|Treatment Period|Physician Decision|0|||
42308442|NCT01885078|76144311|FG009|Treatment Period|Physician Decision|0|||
42308443|NCT01885078|76144302|FG000|Treatment Period|Protocol Violation|3|||
42308444|NCT01885078|76144303|FG001|Treatment Period|Protocol Violation|5|||
42308445|NCT01885078|76144304|FG002|Treatment Period|Protocol Violation|0|||
42308446|NCT01885078|76144305|FG003|Treatment Period|Protocol Violation|3|||
42308447|NCT01885078|76144306|FG004|Treatment Period|Protocol Violation|1|||
42308448|NCT01885078|76144307|FG005|Treatment Period|Protocol Violation|6|||
42308449|NCT01885078|76144308|FG006|Treatment Period|Protocol Violation|0|||
42308450|NCT01885078|76144309|FG007|Treatment Period|Protocol Violation|0|||
42308451|NCT01885078|76144310|FG008|Treatment Period|Protocol Violation|0|||
42308452|NCT01885078|76144311|FG009|Treatment Period|Protocol Violation|0|||
42308453|NCT01885078|76144302|FG000|Treatment Period|Sponsor Decision|245|||
42308454|NCT01885078|76144303|FG001|Treatment Period|Sponsor Decision|648|||
42308455|NCT01885078|76144304|FG002|Treatment Period|Sponsor Decision|49|||
42308456|NCT01885078|76144305|FG003|Treatment Period|Sponsor Decision|90|||
42308457|NCT01885078|76144306|FG004|Treatment Period|Sponsor Decision|20|||
42308458|NCT01885078|76144307|FG005|Treatment Period|Sponsor Decision|38|||
42308459|NCT01885078|76144308|FG006|Treatment Period|Sponsor Decision|162|||
42308460|NCT01885078|76144309|FG007|Treatment Period|Sponsor Decision|3|||
42308461|NCT01885078|76144310|FG008|Treatment Period|Sponsor Decision|0|||
42308462|NCT01885078|76144311|FG009|Treatment Period|Sponsor Decision|0|||
42308463|NCT01885078|76144302|FG000|Treatment Period|Withdrawal by Subject|72|||
42308464|NCT01885078|76144303|FG001|Treatment Period|Withdrawal by Subject|132|||
42308465|NCT01885078|76144304|FG002|Treatment Period|Withdrawal by Subject|25|||
42308466|NCT01885078|76144305|FG003|Treatment Period|Withdrawal by Subject|63|||
41991579|NCT03970733|75799702|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
41991580|NCT03970733|75799703|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
41991581|NCT03970733|75799704|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
41991582|NCT03921411|75799716|FG000|Overall Study|Withdrawal by Subject|1|||
41991583|NCT03921411|75799716|FG000|Overall Study|Protocol Deviation|2|||
41991584|NCT03921411|75799716|FG000|Overall Study|Enrolled, but never treated|2|||
41991585|NCT03728582|75799720|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
41991586|NCT03728582|75799721|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
41991587|NCT03728582|75799720|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
41991588|NCT03728582|75799721|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
41991589|NCT03416179|75799740|FG000|Overall Study|Death|90|||
41991590|NCT03416179|75799741|FG001|Overall Study|Death|87|||
41991591|NCT03416179|75799742|FG002|Overall Study|Death|117|||
41991592|NCT03416179|75799743|FG003|Overall Study|Death|113|||
41991593|NCT03416179|75799740|FG000|Overall Study|Withdrawal by Subject|15|||
41991594|NCT03416179|75799741|FG001|Overall Study|Withdrawal by Subject|20|||
41991595|NCT03416179|75799742|FG002|Overall Study|Withdrawal by Subject|6|||
41991596|NCT03416179|75799743|FG003|Overall Study|Withdrawal by Subject|9|||
41991597|NCT03416179|75799740|FG000|Overall Study|Lost to Follow-up|1|||
41991598|NCT03416179|75799741|FG001|Overall Study|Lost to Follow-up|1|||
42308467|NCT01885078|76144306|FG004|Treatment Period|Withdrawal by Subject|15|||
42308468|NCT01885078|76144307|FG005|Treatment Period|Withdrawal by Subject|34|||
42308469|NCT01885078|76144308|FG006|Treatment Period|Withdrawal by Subject|17|||
42308470|NCT01885078|76144309|FG007|Treatment Period|Withdrawal by Subject|10|||
42308471|NCT01885078|76144310|FG008|Treatment Period|Withdrawal by Subject|0|||
42308472|NCT01885078|76144311|FG009|Treatment Period|Withdrawal by Subject|0|||
42308473|NCT01885078|76144302|FG000|Treatment Period|Other|0|||
42308474|NCT01885078|76144303|FG001|Treatment Period|Other|0|||
42308475|NCT01885078|76144304|FG002|Treatment Period|Other|0|||
42308476|NCT01885078|76144305|FG003|Treatment Period|Other|1|||
42308477|NCT01885078|76144306|FG004|Treatment Period|Other|0|||
42308478|NCT01885078|76144307|FG005|Treatment Period|Other|0|||
42308479|NCT01885078|76144308|FG006|Treatment Period|Other|0|||
42308480|NCT01885078|76144309|FG007|Treatment Period|Other|0|||
42308481|NCT01885078|76144310|FG008|Treatment Period|Other|0|||
42308482|NCT01885078|76144311|FG009|Treatment Period|Other|0|||
42308483|NCT01885078|76144302|FG000|Step-down Period|Sponsor Decision|0|||
42308484|NCT01885078|76144303|FG001|Step-down Period|Sponsor Decision|0|||
42308485|NCT01885078|76144304|FG002|Step-down Period|Sponsor Decision|0|||
42308486|NCT01885078|76144305|FG003|Step-down Period|Sponsor Decision|0|||
42308487|NCT01885078|76144306|FG004|Step-down Period|Sponsor Decision|0|||
42308488|NCT01885078|76144307|FG005|Step-down Period|Sponsor Decision|0|||
42308489|NCT01885078|76144308|FG006|Step-down Period|Sponsor Decision|0|||
42308490|NCT01885078|76144309|FG007|Step-down Period|Sponsor Decision|0|||
42308491|NCT01885078|76144310|FG008|Step-down Period|Sponsor Decision|1|||
42308492|NCT01885078|76144311|FG009|Step-down Period|Sponsor Decision|1|||
42308493|NCT01885078|76144302|FG000|Step-down Period|Adverse Event|0|||
42308494|NCT01885078|76144303|FG001|Step-down Period|Adverse Event|0|||
42308495|NCT01885078|76144304|FG002|Step-down Period|Adverse Event|0|||
42308496|NCT01885078|76144305|FG003|Step-down Period|Adverse Event|0|||
42308497|NCT01885078|76144306|FG004|Step-down Period|Adverse Event|0|||
42308498|NCT01885078|76144307|FG005|Step-down Period|Adverse Event|0|||
42308499|NCT01885078|76144308|FG006|Step-down Period|Adverse Event|0|||
42308500|NCT01885078|76144309|FG007|Step-down Period|Adverse Event|0|||
42308501|NCT01885078|76144310|FG008|Step-down Period|Adverse Event|29|||
42308502|NCT01885078|76144311|FG009|Step-down Period|Adverse Event|38|||
42308503|NCT01885078|76144302|FG000|Step-down Period|Withdrawal by Subject|0|||
42308504|NCT01885078|76144303|FG001|Step-down Period|Withdrawal by Subject|0|||
42308505|NCT01885078|76144304|FG002|Step-down Period|Withdrawal by Subject|0|||
42308506|NCT01885078|76144305|FG003|Step-down Period|Withdrawal by Subject|0|||
42308507|NCT01885078|76144306|FG004|Step-down Period|Withdrawal by Subject|0|||
42308508|NCT01885078|76144307|FG005|Step-down Period|Withdrawal by Subject|0|||
42308509|NCT01885078|76144308|FG006|Step-down Period|Withdrawal by Subject|0|||
42308510|NCT01885078|76144309|FG007|Step-down Period|Withdrawal by Subject|0|||
42308511|NCT01885078|76144310|FG008|Step-down Period|Withdrawal by Subject|25|||
42308512|NCT01885078|76144311|FG009|Step-down Period|Withdrawal by Subject|15|||
42308513|NCT01885078|76144302|FG000|Step-down Period|Physician Decision|0|||
42308514|NCT01885078|76144303|FG001|Step-down Period|Physician Decision|0|||
42308515|NCT01885078|76144304|FG002|Step-down Period|Physician Decision|0|||
42308516|NCT01885078|76144305|FG003|Step-down Period|Physician Decision|0|||
42308517|NCT01885078|76144306|FG004|Step-down Period|Physician Decision|0|||
42308518|NCT01885078|76144307|FG005|Step-down Period|Physician Decision|0|||
42308519|NCT01885078|76144308|FG006|Step-down Period|Physician Decision|0|||
42308520|NCT01885078|76144309|FG007|Step-down Period|Physician Decision|0|||
42308521|NCT01885078|76144310|FG008|Step-down Period|Physician Decision|7|||
42308522|NCT01885078|76144311|FG009|Step-down Period|Physician Decision|2|||
42308523|NCT01885078|76144302|FG000|Step-down Period|Death|0|||
42308524|NCT01885078|76144303|FG001|Step-down Period|Death|0|||
42308525|NCT01885078|76144304|FG002|Step-down Period|Death|0|||
42308526|NCT01885078|76144305|FG003|Step-down Period|Death|0|||
42308527|NCT01885078|76144306|FG004|Step-down Period|Death|0|||
42308528|NCT01885078|76144307|FG005|Step-down Period|Death|0|||
42308529|NCT01885078|76144308|FG006|Step-down Period|Death|0|||
42308530|NCT01885078|76144309|FG007|Step-down Period|Death|0|||
42308531|NCT01885078|76144310|FG008|Step-down Period|Death|4|||
42308532|NCT01885078|76144311|FG009|Step-down Period|Death|3|||
42308533|NCT01885078|76144302|FG000|Step-down Period|Lost to Follow-up|0|||
42308534|NCT01885078|76144303|FG001|Step-down Period|Lost to Follow-up|0|||
42308535|NCT01885078|76144304|FG002|Step-down Period|Lost to Follow-up|0|||
42308536|NCT01885078|76144305|FG003|Step-down Period|Lost to Follow-up|0|||
42308537|NCT01885078|76144306|FG004|Step-down Period|Lost to Follow-up|0|||
42308538|NCT01885078|76144307|FG005|Step-down Period|Lost to Follow-up|0|||
42308539|NCT01885078|76144308|FG006|Step-down Period|Lost to Follow-up|0|||
42308540|NCT01885078|76144309|FG007|Step-down Period|Lost to Follow-up|0|||
42308541|NCT01885078|76144310|FG008|Step-down Period|Lost to Follow-up|1|||
42308542|NCT01885078|76144311|FG009|Step-down Period|Lost to Follow-up|1|||
42308543|NCT01885078|76144302|FG000|Step-down Period|Lack of Efficacy|0|||
42308544|NCT01885078|76144303|FG001|Step-down Period|Lack of Efficacy|0|||
42308545|NCT01885078|76144304|FG002|Step-down Period|Lack of Efficacy|0|||
42308546|NCT01885078|76144305|FG003|Step-down Period|Lack of Efficacy|0|||
42308547|NCT01885078|76144306|FG004|Step-down Period|Lack of Efficacy|0|||
42308548|NCT01885078|76144307|FG005|Step-down Period|Lack of Efficacy|0|||
42308549|NCT01885078|76144308|FG006|Step-down Period|Lack of Efficacy|0|||
42308550|NCT01885078|76144309|FG007|Step-down Period|Lack of Efficacy|0|||
42308551|NCT01885078|76144310|FG008|Step-down Period|Lack of Efficacy|1|||
42308552|NCT01885078|76144311|FG009|Step-down Period|Lack of Efficacy|0|||
42308553|NCT01885078|76144302|FG000|Step-down Period|Protocol Violation|0|||
42308554|NCT01885078|76144303|FG001|Step-down Period|Protocol Violation|0|||
42308555|NCT01885078|76144304|FG002|Step-down Period|Protocol Violation|0|||
42308556|NCT01885078|76144305|FG003|Step-down Period|Protocol Violation|0|||
42308557|NCT01885078|76144306|FG004|Step-down Period|Protocol Violation|0|||
42308558|NCT01885078|76144307|FG005|Step-down Period|Protocol Violation|0|||
42308559|NCT01885078|76144308|FG006|Step-down Period|Protocol Violation|0|||
42308560|NCT01885078|76144309|FG007|Step-down Period|Protocol Violation|0|||
42308561|NCT01885078|76144310|FG008|Step-down Period|Protocol Violation|1|||
42308562|NCT01885078|76144311|FG009|Step-down Period|Protocol Violation|1|||
42308563|NCT02046369|76144334|FG000|Overall Study|Adverse Event|3|||
42308564|NCT02046369|76144335|FG001|Overall Study|Adverse Event|3|||
42308565|NCT02046369|76144334|FG000|Overall Study|Lack of Efficacy|3|||
42308566|NCT02046369|76144335|FG001|Overall Study|Lack of Efficacy|3|||
42308567|NCT02046369|76144334|FG000|Overall Study|Lost to Follow-up|3|||
42308568|NCT02046369|76144335|FG001|Overall Study|Lost to Follow-up|3|||
42308569|NCT02046369|76144334|FG000|Overall Study|Protocol Violation|1|||
42308570|NCT02046369|76144335|FG001|Overall Study|Protocol Violation|2|||
42308571|NCT02046369|76144334|FG000|Overall Study|Withdrawal by Subject|3|||
42308572|NCT02046369|76144335|FG001|Overall Study|Withdrawal by Subject|6|||
42308573|NCT02046369|76144334|FG000|Overall Study|never received study drug|0|||
41991599|NCT03416179|75799742|FG002|Overall Study|Lost to Follow-up|0|||
41991600|NCT03416179|75799743|FG003|Overall Study|Lost to Follow-up|3|||
41991601|NCT03416179|75799740|FG000|Overall Study|Study participation terminated by Sponsor|93|||
41991602|NCT03416179|75799741|FG001|Overall Study|Study participation terminated by Sponsor|91|||
42132893|NCT00508742|75943739|FG001|Period 2: After Infant Series|Other|1|||
42308574|NCT02046369|76144335|FG001|Overall Study|never received study drug|1|||
42308575|NCT02046369|76144334|FG000|Overall Study|non compliance|1|||
42308576|NCT02046369|76144335|FG001|Overall Study|non compliance|0|||
42308577|NCT02101359|76144343|FG000|Overall Study|Not included|23|||
42308578|NCT02101359|76144344|FG001|Overall Study|Not included|13|||
42308579|NCT02101359|76144343|FG000|Overall Study|Withdrawal by Subject|5|||
42308580|NCT02101359|76144344|FG001|Overall Study|Withdrawal by Subject|4|||
42132894|NCT00508742|75943738|FG000|Period 3: Toddler Dose|Adverse Event|1|||
42132895|NCT00508742|75943739|FG001|Period 3: Toddler Dose|Adverse Event|0|||
42308581|NCT02101359|76144343|FG000|Overall Study|Lost to Follow-up|1|||
42308582|NCT02101359|76144344|FG001|Overall Study|Lost to Follow-up|0|||
42308583|NCT02101359|76144343|FG000|Overall Study|Protocol Violation|0|||
42308584|NCT02101359|76144344|FG001|Overall Study|Protocol Violation|2|||
42308585|NCT02100969|76144350|FG000|Overall Study|Did not pass screening phase|1|||
42308586|NCT01885000|76144357|FG000|Overall Study|Adverse Event|1|||
42308587|NCT01885000|76144358|FG001|Overall Study|Adverse Event|0|||
42308588|NCT01885000|76144357|FG000|Overall Study|Withdrawal by Subject|1|||
42308589|NCT01885000|76144358|FG001|Overall Study|Withdrawal by Subject|1|||
42308590|NCT01885000|76144357|FG000|Overall Study|Protocol Violation|0|||
42308591|NCT01885000|76144358|FG001|Overall Study|Protocol Violation|1|||
42308592|NCT01884688|76144364|FG000|Overall Study|Screen Failure|2|||
42308593|NCT01883362|76144370|FG000|Treatment|Adverse Event|1|||
42308594|NCT01883362|76144371|FG001|Treatment|Adverse Event|8|||
42308595|NCT01883362|76144370|FG000|Treatment|Withdrawal by Subject|6|||
42308596|NCT01883362|76144371|FG001|Treatment|Withdrawal by Subject|2|||
42308597|NCT01883362|76144370|FG000|Treatment|Administrative problems|4|||
42308598|NCT01883362|76144371|FG001|Treatment|Administrative problems|1|||
42308599|NCT01883362|76144370|FG000|Treatment|Relapse|4|||
42308600|NCT01883362|76144371|FG001|Treatment|Relapse|2|||
42308601|NCT01883362|76144370|FG000|Treatment|Randomized, not treated|1|||
42308602|NCT01883362|76144371|FG001|Treatment|Randomized, not treated|1|||
42308603|NCT01883362|76144370|FG000|Post Treatment Follow-up|Protocol Violation|0|||
42308604|NCT01883362|76144371|FG001|Post Treatment Follow-up|Protocol Violation|1|||
42308605|NCT01883362|76144370|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
42308606|NCT01883362|76144371|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
42308607|NCT01883362|76144370|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
42308608|NCT01883362|76144371|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
42308609|NCT01883362|76144370|FG000|Post Treatment Follow-up|Administrative problems|2|||
42308610|NCT01883362|76144371|FG001|Post Treatment Follow-up|Administrative problems|0|||
42308611|NCT01883362|76144370|FG000|Post Treatment Follow-up|Death|8|||
42308612|NCT01883362|76144371|FG001|Post Treatment Follow-up|Death|4|||
42308613|NCT01883362|76144370|FG000|Post Treatment Follow-up|Relapse|1|||
42308614|NCT01883362|76144371|FG001|Post Treatment Follow-up|Relapse|2|||
42308615|NCT02100813|76144389|FG000|Overall Study|Adverse Event|0|||
42308616|NCT02100813|76144390|FG001|Overall Study|Adverse Event|0|||
42308617|NCT02100813|76144391|FG002|Overall Study|Adverse Event|0|||
42308618|NCT02100813|76144392|FG003|Overall Study|Adverse Event|0|||
42308619|NCT02100813|76144393|FG004|Overall Study|Adverse Event|0|||
42308620|NCT02100813|76144394|FG005|Overall Study|Adverse Event|0|||
42308621|NCT02100813|76144395|FG006|Overall Study|Adverse Event|0|||
42308622|NCT02100813|76144396|FG007|Overall Study|Adverse Event|1|||
42308623|NCT01930162|76144418|FG000|Overall Study|Abnormal test procedure result(s)|4|||
42308624|NCT01930162|76144418|FG000|Overall Study|Death|1|||
42308625|NCT02045979|76144426|FG000|Overall Study|Informed Consent Withdrawn|2|||
42308626|NCT02045979|76144427|FG001|Overall Study|Informed Consent Withdrawn|0|||
42308627|NCT02045979|76144428|FG002|Overall Study|Informed Consent Withdrawn|1|||
42308628|NCT02045979|76144426|FG000|Overall Study|not specified above|0|||
42253195|NCT01302847|76079103|FG007|Overall Study|Withdrawal by Subject|1|||
42253196|NCT01302847|76079096|FG000|Overall Study|Not willing to adhere to requirements|5|||
42253197|NCT01302847|76079097|FG001|Overall Study|Not willing to adhere to requirements|0|||
42253198|NCT01302847|76079098|FG002|Overall Study|Not willing to adhere to requirements|0|||
42253199|NCT01302847|76079099|FG003|Overall Study|Not willing to adhere to requirements|1|||
42253200|NCT01302847|76079100|FG004|Overall Study|Not willing to adhere to requirements|0|||
42253201|NCT01302847|76079101|FG005|Overall Study|Not willing to adhere to requirements|0|||
42253202|NCT01302847|76079102|FG006|Overall Study|Not willing to adhere to requirements|0|||
42253203|NCT01302847|76079103|FG007|Overall Study|Not willing to adhere to requirements|2|||
42253204|NCT01302847|76079096|FG000|Overall Study|Site unable to contact participant|2|||
42253205|NCT01302847|76079097|FG001|Overall Study|Site unable to contact participant|1|||
42253206|NCT01302847|76079098|FG002|Overall Study|Site unable to contact participant|0|||
42253207|NCT01302847|76079099|FG003|Overall Study|Site unable to contact participant|0|||
42253208|NCT01302847|76079100|FG004|Overall Study|Site unable to contact participant|0|||
42253209|NCT01302847|76079101|FG005|Overall Study|Site unable to contact participant|0|||
42253210|NCT01302847|76079102|FG006|Overall Study|Site unable to contact participant|2|||
42253211|NCT01302847|76079103|FG007|Overall Study|Site unable to contact participant|0|||
42253212|NCT03039569|76079132|FG000|Overall Study|Lost to Follow-up|5|||
42253213|NCT03039569|76079133|FG001|Overall Study|Lost to Follow-up|4|||
42253214|NCT02738775|76079146|FG000|Overall Study|Withdrawal by Subject|0|||
42253215|NCT02738775|76079147|FG001|Overall Study|Withdrawal by Subject|1|||
42253216|NCT02738775|76079148|FG002|Overall Study|Withdrawal by Subject|0|||
42253217|NCT02738775|76079149|FG003|Overall Study|Withdrawal by Subject|0|||
42253218|NCT02738775|76079150|FG004|Overall Study|Withdrawal by Subject|0|||
42308629|NCT02045979|76144427|FG001|Overall Study|not specified above|1|||
42308630|NCT02045979|76144428|FG002|Overall Study|not specified above|0|||
42308631|NCT01929226|76144438|FG000|Overall Study|Lost to Follow-up|4|||
42308632|NCT01929226|76144439|FG001|Overall Study|Lost to Follow-up|0|||
42308633|NCT01929226|76144438|FG000|Overall Study|Withdrawal by Subject|1|||
42308634|NCT01929226|76144439|FG001|Overall Study|Withdrawal by Subject|1|||
42308635|NCT02045433|76144446|FG000|Overall Study|Withdrawal by Subject|1|||
42308636|NCT01911442|76144453|FG000|Overall Study|Adverse Event|2|||
42308637|NCT01911442|76144454|FG001|Overall Study|Adverse Event|2|||
42308638|NCT01911442|76144455|FG002|Overall Study|Adverse Event|4|||
42308639|NCT01911442|76144453|FG000|Overall Study|Lack of Efficacy|1|||
42308640|NCT01911442|76144454|FG001|Overall Study|Lack of Efficacy|1|||
42308641|NCT01911442|76144455|FG002|Overall Study|Lack of Efficacy|1|||
42308642|NCT01911442|76144453|FG000|Overall Study|Lost to Follow-up|2|||
42308643|NCT01911442|76144454|FG001|Overall Study|Lost to Follow-up|0|||
42308644|NCT01911442|76144455|FG002|Overall Study|Lost to Follow-up|1|||
42308645|NCT01911442|76144453|FG000|Overall Study|Withdrawal by Subject|1|||
42308646|NCT01911442|76144454|FG001|Overall Study|Withdrawal by Subject|0|||
42308647|NCT01911442|76144455|FG002|Overall Study|Withdrawal by Subject|6|||
42308648|NCT01911442|76144453|FG000|Overall Study|Mother's Work Schedule|0|||
42308649|NCT01911442|76144454|FG001|Overall Study|Mother's Work Schedule|1|||
42308650|NCT01911442|76144455|FG002|Overall Study|Mother's Work Schedule|0|||
42308651|NCT01928758|76144469|FG000|Overall Study|Lost to Follow-up|14|||
42308652|NCT01928758|76144470|FG001|Overall Study|Lost to Follow-up|9|||
42308653|NCT01928758|76144469|FG000|Overall Study|Withdrawal by Subject|5|||
42308654|NCT01928758|76144470|FG001|Overall Study|Withdrawal by Subject|2|||
42308655|NCT01928758|76144469|FG000|Overall Study|Adverse Event|3|||
42308656|NCT01928758|76144470|FG001|Overall Study|Adverse Event|5|||
42308657|NCT01928758|76144469|FG000|Overall Study|Protocol Violation|3|||
42308658|NCT01928758|76144470|FG001|Overall Study|Protocol Violation|4|||
42308659|NCT01910116|76144479|FG000|Overall Study|Adverse Event|0|||
42308660|NCT01910116|76144480|FG001|Overall Study|Adverse Event|3|||
42308661|NCT01910116|76144479|FG000|Overall Study|Lack of Efficacy|3|||
42308662|NCT01910116|76144480|FG001|Overall Study|Lack of Efficacy|4|||
42308663|NCT01910116|76144479|FG000|Overall Study|Lost to Follow-up|1|||
42308664|NCT01910116|76144480|FG001|Overall Study|Lost to Follow-up|0|||
42308665|NCT01910116|76144479|FG000|Overall Study|Protocol Violation|1|||
42308666|NCT01910116|76144480|FG001|Overall Study|Protocol Violation|2|||
42308667|NCT01910116|76144479|FG000|Overall Study|Withdrawal by Subject|8|||
42308668|NCT01910116|76144480|FG001|Overall Study|Withdrawal by Subject|3|||
42308669|NCT01910116|76144479|FG000|Overall Study|uncertain allocation|1|||
42308670|NCT01910116|76144480|FG001|Overall Study|uncertain allocation|3|||
42308671|NCT01910116|76144479|FG000|Overall Study|incomplete data|0|||
42308672|NCT01910116|76144480|FG001|Overall Study|incomplete data|1|||
42308673|NCT01614886|76144488|FG000|Overall Study|Adverse Event|15|||
42308674|NCT01614886|76144489|FG001|Overall Study|Adverse Event|20|||
42308675|NCT01614886|76144488|FG000|Overall Study|Withdrawal by Subject|4|||
41991603|NCT03416179|75799742|FG002|Overall Study|Study participation terminated by Sponsor|26|||
41991604|NCT03416179|75799743|FG003|Overall Study|Study participation terminated by Sponsor|31|||
41991605|NCT03416179|75799740|FG000|Overall Study|Other|2|||
41991606|NCT03416179|75799741|FG001|Overall Study|Other|3|||
41991607|NCT03416179|75799742|FG002|Overall Study|Other|1|||
41991608|NCT03416179|75799743|FG003|Overall Study|Other|0|||
41991609|NCT02932332|75799770|FG000|Overall Study|Withdrawal by Subject|1|||
41991610|NCT02932332|75799771|FG001|Overall Study|Withdrawal by Subject|1|||
41991611|NCT02932332|75799772|FG002|Overall Study|Withdrawal by Subject|0|||
41991612|NCT02932332|75799773|FG003|Overall Study|Withdrawal by Subject|1|||
41991613|NCT02932332|75799770|FG000|Overall Study|Chest pain|0|||
41991614|NCT02932332|75799771|FG001|Overall Study|Chest pain|0|||
41991615|NCT02932332|75799772|FG002|Overall Study|Chest pain|0|||
42253219|NCT02738775|76079151|FG005|Overall Study|Withdrawal by Subject|0|||
42253220|NCT02738775|76079146|FG000|Overall Study|Adverse Event|0|||
42253221|NCT02738775|76079147|FG001|Overall Study|Adverse Event|0|||
42253222|NCT02738775|76079148|FG002|Overall Study|Adverse Event|0|||
42253223|NCT02738775|76079149|FG003|Overall Study|Adverse Event|1|||
42253224|NCT02738775|76079150|FG004|Overall Study|Adverse Event|0|||
41991616|NCT02932332|75799773|FG003|Overall Study|Chest pain|1|||
41991617|NCT02932332|75799770|FG000|Overall Study|Not Dyspneic cough|1|||
41991618|NCT02932332|75799771|FG001|Overall Study|Not Dyspneic cough|2|||
41991619|NCT02932332|75799772|FG002|Overall Study|Not Dyspneic cough|1|||
41991620|NCT02932332|75799773|FG003|Overall Study|Not Dyspneic cough|0|||
42253225|NCT02738775|76079151|FG005|Overall Study|Adverse Event|0|||
42253226|NCT02738775|76079146|FG000|Overall Study|Pregnancy|0|||
42253227|NCT02738775|76079147|FG001|Overall Study|Pregnancy|1|||
42253228|NCT02738775|76079148|FG002|Overall Study|Pregnancy|0|||
42253229|NCT02738775|76079149|FG003|Overall Study|Pregnancy|0|||
42253230|NCT02738775|76079150|FG004|Overall Study|Pregnancy|0|||
42253231|NCT02738775|76079151|FG005|Overall Study|Pregnancy|0|||
42253232|NCT02738775|76079146|FG000|Overall Study|Missing|0|||
42253233|NCT02738775|76079147|FG001|Overall Study|Missing|0|||
42253234|NCT02738775|76079148|FG002|Overall Study|Missing|0|||
42253235|NCT02738775|76079149|FG003|Overall Study|Missing|0|||
42253236|NCT02738775|76079150|FG004|Overall Study|Missing|0|||
42253237|NCT02738775|76079151|FG005|Overall Study|Missing|1|||
42253238|NCT02314923|76079188|FG000|Overall Study|Death|0|||
42253239|NCT02314923|76079189|FG001|Overall Study|Death|0|||
42253240|NCT02314923|76079190|FG002|Overall Study|Death|0|||
42253241|NCT02314923|76079191|FG003|Overall Study|Death|1|||
42308676|NCT01614886|76144489|FG001|Overall Study|Withdrawal by Subject|4|||
42308677|NCT01614886|76144488|FG000|Overall Study|Death|1|||
42308678|NCT01614886|76144489|FG001|Overall Study|Death|0|||
42308679|NCT01614886|76144488|FG000|Overall Study|Protocol deviation|0|||
42308680|NCT01614886|76144489|FG001|Overall Study|Protocol deviation|2|||
42308681|NCT01880554|76144495|FG000|Overall Study|Protocol Violation|14|||
42308682|NCT01880554|76144495|FG000|Overall Study|Simon's design requirements|2|||
42308683|NCT02100657|76144503|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
42308684|NCT02100657|76144504|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
42308685|NCT02100657|76144505|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
41991621|NCT02820623|75799807|FG000|Overall Study|Withdrawal by Subject|1|||
41991622|NCT02820623|75799808|FG001|Overall Study|Withdrawal by Subject|3|||
41991623|NCT02820623|75799809|FG002|Overall Study|Withdrawal by Subject|3|||
41991624|NCT02820623|75799807|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
41991625|NCT02820623|75799808|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
41991626|NCT02820623|75799809|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
41991627|NCT02820623|75799807|FG000|Overall Study|Therapist unable to enroll clients|1|||
41991628|NCT02820623|75799808|FG001|Overall Study|Therapist unable to enroll clients|1|||
41991629|NCT02820623|75799809|FG002|Overall Study|Therapist unable to enroll clients|3|||
41991630|NCT02820623|75799807|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
41991631|NCT02820623|75799808|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
41991632|NCT02820623|75799809|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
41991633|NCT02774005|75799817|FG000|Overall Study|Adverse Event|8|||
41991634|NCT02774005|75799817|FG000|Overall Study|Withdrawal by Subject|23|||
41991635|NCT02774005|75799817|FG000|Overall Study|Lost to Follow-up|7|||
41991636|NCT02774005|75799817|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
41991637|NCT02774005|75799817|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
41991638|NCT02774005|75799817|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
41991639|NCT02774005|75799817|FG000|Overall Study|Death|1|||
41991640|NCT02774005|75799817|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
41991641|NCT02774005|75799817|FG000|Overall Study|Lack of compliance with study medication|4|||
42253242|NCT02314923|76079192|FG004|Overall Study|Death|0|||
42253243|NCT02314923|76079193|FG005|Overall Study|Death|0|||
42253244|NCT02314923|76079194|FG006|Overall Study|Death|0|||
42253245|NCT02314923|76079195|FG007|Overall Study|Death|0|||
42253246|NCT02314923|76079196|FG008|Overall Study|Death|0|||
42253247|NCT02314923|76079197|FG009|Overall Study|Death|0|||
42253248|NCT02314923|76079188|FG000|Overall Study|Lost to Follow-up|2|||
42253249|NCT02314923|76079189|FG001|Overall Study|Lost to Follow-up|3|||
42253250|NCT02314923|76079190|FG002|Overall Study|Lost to Follow-up|1|||
42253251|NCT02314923|76079191|FG003|Overall Study|Lost to Follow-up|0|||
42308686|NCT02100657|76144503|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
41991642|NCT02774005|75799817|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
41991643|NCT02774005|75799817|FG000|Overall Study|another study|1|||
41991644|NCT02774005|75799817|FG000|Overall Study|cardiologist imposed travel restriction|1|||
41991645|NCT01975428|75799847|FG000|Overall Study|Lost to Follow-up|17|||
41991646|NCT01975428|75799848|FG001|Overall Study|Lost to Follow-up|4|||
42253252|NCT02314923|76079192|FG004|Overall Study|Lost to Follow-up|0|||
42308687|NCT02100657|76144504|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
42253253|NCT02314923|76079193|FG005|Overall Study|Lost to Follow-up|0|||
41991647|NCT01975428|75799847|FG000|Overall Study|Withdrawal by Subject|3|||
42308688|NCT02100657|76144505|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
42308689|NCT02100657|76144503|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
42308690|NCT02100657|76144504|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
42308691|NCT02100657|76144505|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
42308692|NCT02100657|76144503|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
42308693|NCT02100657|76144504|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
42308694|NCT02100657|76144505|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
42308695|NCT02100657|76144503|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
42308696|NCT02100657|76144504|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
42308697|NCT02100657|76144505|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
42308698|NCT02100657|76144503|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
42308699|NCT02100657|76144504|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
42308700|NCT02100657|76144505|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
42308701|NCT02100657|76144503|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
42308702|NCT02100657|76144504|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
42308703|NCT02100657|76144505|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
42308704|NCT02100657|76144503|FG000|Cohort 3: Dose Level 3|Death|0|||
42308705|NCT02100657|76144504|FG001|Cohort 3: Dose Level 3|Death|0|||
42308706|NCT02100657|76144505|FG002|Cohort 3: Dose Level 3|Death|1|||
42308707|NCT02100657|76144503|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
42308708|NCT02100657|76144504|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
42308709|NCT02100657|76144505|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
42308710|NCT02100657|76144503|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
42308711|NCT02100657|76144504|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
42308712|NCT02100657|76144505|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
42308713|NCT02100657|76144503|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
42308714|NCT02100657|76144504|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
42308715|NCT02100657|76144505|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
42308716|NCT02100657|76144503|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
42308717|NCT02100657|76144504|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
42308718|NCT02100657|76144505|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
42308719|NCT02100657|76144503|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
42308720|NCT02100657|76144504|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
42308721|NCT02100657|76144505|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
42308722|NCT02067663|76144516|FG000|Overall Study|Lost to Follow-up|13|||
42308723|NCT02067663|76144517|FG001|Overall Study|Lost to Follow-up|14|||
42308724|NCT01909804|76144535|FG000|Overall Study|Randomized but Never Treated|0|||
42308725|NCT01909804|76144536|FG001|Overall Study|Randomized but Never Treated|0|||
42308726|NCT01909804|76144537|FG002|Overall Study|Randomized but Never Treated|0|||
42308727|NCT01909804|76144538|FG003|Overall Study|Randomized but Never Treated|0|||
42308728|NCT01909804|76144539|FG004|Overall Study|Randomized but Never Treated|0|||
42308729|NCT01909804|76144540|FG005|Overall Study|Randomized but Never Treated|0|||
42308730|NCT01909804|76144541|FG006|Overall Study|Randomized but Never Treated|1|||
42308731|NCT01909804|76144542|FG007|Overall Study|Randomized but Never Treated|0|||
42308732|NCT01909804|76144543|FG008|Overall Study|Randomized but Never Treated|0|||
42308733|NCT01909804|76144544|FG009|Overall Study|Randomized but Never Treated|0|||
42308734|NCT01909804|76144545|FG010|Overall Study|Randomized but Never Treated|0|||
42308735|NCT01909804|76144546|FG011|Overall Study|Randomized but Never Treated|1|||
42308736|NCT01909804|76144535|FG000|Overall Study|Death|0|||
41991648|NCT01975428|75799848|FG001|Overall Study|Withdrawal by Subject|10|||
41991649|NCT01047540|75799889|FG000|Overall Study|Protocol Violation|1|||
41991650|NCT01047540|75799890|FG001|Overall Study|Protocol Violation|0|||
41991651|NCT01047540|75799891|FG002|Overall Study|Protocol Violation|0|||
41991652|NCT01047540|75799892|FG003|Overall Study|Protocol Violation|0|||
41991653|NCT01047540|75799893|FG004|Overall Study|Protocol Violation|0|||
42253254|NCT02314923|76079194|FG006|Overall Study|Lost to Follow-up|3|||
42253255|NCT02314923|76079195|FG007|Overall Study|Lost to Follow-up|4|||
42253256|NCT02314923|76079196|FG008|Overall Study|Lost to Follow-up|2|||
42253257|NCT02314923|76079197|FG009|Overall Study|Lost to Follow-up|0|||
42253258|NCT02314923|76079188|FG000|Overall Study|Withdrawal by Subject|0|||
42253259|NCT02314923|76079189|FG001|Overall Study|Withdrawal by Subject|0|||
42253260|NCT02314923|76079190|FG002|Overall Study|Withdrawal by Subject|1|||
42253261|NCT02314923|76079191|FG003|Overall Study|Withdrawal by Subject|0|||
42253262|NCT02314923|76079192|FG004|Overall Study|Withdrawal by Subject|1|||
42253263|NCT02314923|76079193|FG005|Overall Study|Withdrawal by Subject|0|||
42253264|NCT02314923|76079194|FG006|Overall Study|Withdrawal by Subject|1|||
42253265|NCT02314923|76079195|FG007|Overall Study|Withdrawal by Subject|0|||
42253266|NCT02314923|76079196|FG008|Overall Study|Withdrawal by Subject|0|||
42253267|NCT02314923|76079197|FG009|Overall Study|Withdrawal by Subject|0|||
42253268|NCT02314923|76079188|FG000|Overall Study|Physician Decision|0|||
42253269|NCT02314923|76079189|FG001|Overall Study|Physician Decision|1|||
42253270|NCT02314923|76079190|FG002|Overall Study|Physician Decision|0|||
42308737|NCT01909804|76144536|FG001|Overall Study|Death|0|||
42308738|NCT01909804|76144537|FG002|Overall Study|Death|0|||
42308739|NCT01909804|76144538|FG003|Overall Study|Death|0|||
42308740|NCT01909804|76144539|FG004|Overall Study|Death|0|||
42308741|NCT01909804|76144540|FG005|Overall Study|Death|0|||
42308742|NCT01909804|76144541|FG006|Overall Study|Death|0|||
42308743|NCT01909804|76144542|FG007|Overall Study|Death|0|||
42308744|NCT01909804|76144543|FG008|Overall Study|Death|0|||
42308745|NCT01909804|76144544|FG009|Overall Study|Death|0|||
42308746|NCT01909804|76144545|FG010|Overall Study|Death|1|||
42308747|NCT01909804|76144546|FG011|Overall Study|Death|0|||
42308748|NCT01909804|76144535|FG000|Overall Study|Lack of Efficacy|4|||
42308749|NCT01909804|76144536|FG001|Overall Study|Lack of Efficacy|1|||
42308750|NCT01909804|76144537|FG002|Overall Study|Lack of Efficacy|0|||
42308751|NCT01909804|76144538|FG003|Overall Study|Lack of Efficacy|0|||
42308752|NCT01909804|76144539|FG004|Overall Study|Lack of Efficacy|7|||
42308753|NCT01909804|76144540|FG005|Overall Study|Lack of Efficacy|3|||
42308754|NCT01909804|76144541|FG006|Overall Study|Lack of Efficacy|1|||
42308755|NCT01909804|76144542|FG007|Overall Study|Lack of Efficacy|1|||
42308756|NCT01909804|76144543|FG008|Overall Study|Lack of Efficacy|0|||
42308757|NCT01909804|76144544|FG009|Overall Study|Lack of Efficacy|1|||
42308758|NCT01909804|76144545|FG010|Overall Study|Lack of Efficacy|0|||
42308759|NCT01909804|76144546|FG011|Overall Study|Lack of Efficacy|1|||
42308760|NCT01909804|76144535|FG000|Overall Study|Withdrew Consent|0|||
42308761|NCT01909804|76144536|FG001|Overall Study|Withdrew Consent|0|||
42308762|NCT01909804|76144537|FG002|Overall Study|Withdrew Consent|0|||
42308763|NCT01909804|76144538|FG003|Overall Study|Withdrew Consent|0|||
42308764|NCT01909804|76144539|FG004|Overall Study|Withdrew Consent|1|||
42308765|NCT01909804|76144540|FG005|Overall Study|Withdrew Consent|1|||
42308766|NCT01909804|76144541|FG006|Overall Study|Withdrew Consent|0|||
42308767|NCT01909804|76144542|FG007|Overall Study|Withdrew Consent|0|||
42308768|NCT01909804|76144543|FG008|Overall Study|Withdrew Consent|0|||
42308769|NCT01909804|76144544|FG009|Overall Study|Withdrew Consent|0|||
42308770|NCT01909804|76144545|FG010|Overall Study|Withdrew Consent|0|||
42308771|NCT01909804|76144546|FG011|Overall Study|Withdrew Consent|0|||
42308772|NCT01909804|76144535|FG000|Overall Study|Protocol Violation|0|||
42308773|NCT01909804|76144536|FG001|Overall Study|Protocol Violation|0|||
42308774|NCT01909804|76144537|FG002|Overall Study|Protocol Violation|0|||
42308775|NCT01909804|76144538|FG003|Overall Study|Protocol Violation|0|||
42308776|NCT01909804|76144539|FG004|Overall Study|Protocol Violation|0|||
42308777|NCT01909804|76144540|FG005|Overall Study|Protocol Violation|0|||
41991654|NCT01047540|75799889|FG000|Overall Study|Lost to Follow-up|1|||
41991655|NCT01047540|75799890|FG001|Overall Study|Lost to Follow-up|0|||
41991656|NCT01047540|75799891|FG002|Overall Study|Lost to Follow-up|0|||
41991657|NCT01047540|75799892|FG003|Overall Study|Lost to Follow-up|0|||
41991658|NCT01047540|75799893|FG004|Overall Study|Lost to Follow-up|0|||
41991659|NCT01047540|75799889|FG000|Overall Study|Withdrawal by Subject|1|||
41991660|NCT01047540|75799890|FG001|Overall Study|Withdrawal by Subject|0|||
41991661|NCT01047540|75799891|FG002|Overall Study|Withdrawal by Subject|3|||
41991662|NCT01047540|75799892|FG003|Overall Study|Withdrawal by Subject|0|||
41991663|NCT01047540|75799893|FG004|Overall Study|Withdrawal by Subject|1|||
42033247|NCT01138007|75841388|FG000|Overall Study|Lack of Efficacy|2|||
42033248|NCT01138007|75841389|FG001|Overall Study|Lack of Efficacy|0|||
42033249|NCT01138007|75841390|FG002|Overall Study|Lack of Efficacy|6|||
42033250|NCT01138007|75841388|FG000|Overall Study|Protocol Violation|2|||
42033251|NCT01138007|75841389|FG001|Overall Study|Protocol Violation|3|||
42033252|NCT01138007|75841390|FG002|Overall Study|Protocol Violation|2|||
41991664|NCT01047540|75799889|FG000|Overall Study|Pregnancy|1|||
42033253|NCT01138007|75841388|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
42253271|NCT02314923|76079191|FG003|Overall Study|Physician Decision|0|||
42253272|NCT02314923|76079192|FG004|Overall Study|Physician Decision|0|||
42253273|NCT02314923|76079193|FG005|Overall Study|Physician Decision|0|||
42253274|NCT02314923|76079194|FG006|Overall Study|Physician Decision|0|||
42253275|NCT02314923|76079195|FG007|Overall Study|Physician Decision|0|||
42253276|NCT02314923|76079196|FG008|Overall Study|Physician Decision|0|||
42253277|NCT02314923|76079197|FG009|Overall Study|Physician Decision|0|||
42253278|NCT02314923|76079188|FG000|Overall Study|Participant unavailable|0|||
42308778|NCT01909804|76144541|FG006|Overall Study|Protocol Violation|0|||
42308779|NCT01909804|76144542|FG007|Overall Study|Protocol Violation|0|||
42308780|NCT01909804|76144543|FG008|Overall Study|Protocol Violation|0|||
42308781|NCT01909804|76144544|FG009|Overall Study|Protocol Violation|0|||
42308782|NCT01909804|76144545|FG010|Overall Study|Protocol Violation|0|||
42308783|NCT01909804|76144546|FG011|Overall Study|Protocol Violation|1|||
42308784|NCT01880086|76144570|FG000|Overall Study|Lost to Follow-up|1|||
42308785|NCT01880086|76144571|FG001|Overall Study|Lost to Follow-up|1|||
42308786|NCT01879852|76144579|FG000|Overall Study|Withdrawal by Subject|2|||
42308787|NCT01879852|76144580|FG001|Overall Study|Withdrawal by Subject|0|||
42308788|NCT01879618|76144586|FG000|Overall Study|Does not meet entrance criteria|1|||
41991665|NCT01047540|75799890|FG001|Overall Study|Pregnancy|0|||
41991666|NCT01047540|75799891|FG002|Overall Study|Pregnancy|0|||
41991667|NCT01047540|75799892|FG003|Overall Study|Pregnancy|0|||
41991668|NCT01047540|75799893|FG004|Overall Study|Pregnancy|0|||
41991669|NCT01047540|75799889|FG000|Overall Study|Adverse Event|1|||
41991670|NCT01047540|75799890|FG001|Overall Study|Adverse Event|0|||
41991671|NCT01047540|75799891|FG002|Overall Study|Adverse Event|0|||
41991672|NCT01047540|75799892|FG003|Overall Study|Adverse Event|0|||
41991673|NCT01047540|75799893|FG004|Overall Study|Adverse Event|0|||
42308789|NCT01879618|76144586|FG000|Overall Study|Withdrawal by Subject|1|||
42308790|NCT01879618|76144586|FG000|Overall Study|Surgery;changed schedule; not available|8|||
42308791|NCT01879618|76144586|FG000|Overall Study|Protocol Violation|6|||
42308792|NCT01879618|76144586|FG000|Overall Study|Adverse Event|5|||
42308793|NCT01926886|76144590|FG000|Overall Study|Administrative/other|1|||
42308794|NCT01926886|76144591|FG001|Overall Study|Administrative/other|0|||
42308795|NCT01926886|76144590|FG000|Overall Study|Adverse event/intercurrent illness|4|||
42308796|NCT01926886|76144591|FG001|Overall Study|Adverse event/intercurrent illness|0|||
42308797|NCT01926886|76144590|FG000|Overall Study|Disease progression/recurrence|4|||
41991674|NCT00521222|75799909|FG000|Overall Study|Lost to Follow-up|0|||
41991675|NCT00521222|75799910|FG001|Overall Study|Lost to Follow-up|0|||
41991676|NCT00521222|75799911|FG002|Overall Study|Lost to Follow-up|1|||
41991677|NCT00521222|75799912|FG003|Overall Study|Lost to Follow-up|1|||
41991678|NCT00521222|75799909|FG000|Overall Study|Withdrawal by Subject|0|||
41991679|NCT00521222|75799910|FG001|Overall Study|Withdrawal by Subject|0|||
41991680|NCT00521222|75799911|FG002|Overall Study|Withdrawal by Subject|2|||
41991681|NCT00521222|75799912|FG003|Overall Study|Withdrawal by Subject|0|||
41991682|NCT00521222|75799909|FG000|Overall Study|Physician Decision|0|||
41991683|NCT00521222|75799910|FG001|Overall Study|Physician Decision|1|||
41991684|NCT00521222|75799911|FG002|Overall Study|Physician Decision|0|||
41991685|NCT00521222|75799912|FG003|Overall Study|Physician Decision|1|||
41991686|NCT01214629|75799946|FG000|Overall Study|Progressive Disease|1|||
41991687|NCT01214629|75799947|FG001|Overall Study|Progressive Disease|1|||
41991688|NCT01214629|75799948|FG002|Overall Study|Progressive Disease|0|||
41991689|NCT01214629|75799949|FG003|Overall Study|Progressive Disease|1|||
41991690|NCT01214629|75799950|FG004|Overall Study|Progressive Disease|2|||
41991691|NCT01214629|75799951|FG005|Overall Study|Progressive Disease|3|||
41991692|NCT01214629|75799952|FG006|Overall Study|Progressive Disease|1|||
41991693|NCT01214629|75799953|FG007|Overall Study|Progressive Disease|1|||
41991694|NCT01214629|75799954|FG008|Overall Study|Progressive Disease|1|||
41991695|NCT01214629|75799955|FG009|Overall Study|Progressive Disease|5|||
41991696|NCT01214629|75799956|FG010|Overall Study|Progressive Disease|1|||
41991697|NCT01214629|75799946|FG000|Overall Study|Adverse Event|0|||
41991698|NCT01214629|75799947|FG001|Overall Study|Adverse Event|0|||
41991699|NCT01214629|75799948|FG002|Overall Study|Adverse Event|0|||
41991700|NCT01214629|75799949|FG003|Overall Study|Adverse Event|1|||
41991701|NCT01214629|75799950|FG004|Overall Study|Adverse Event|0|||
41991702|NCT01214629|75799951|FG005|Overall Study|Adverse Event|1|||
41991703|NCT01214629|75799952|FG006|Overall Study|Adverse Event|0|||
41991704|NCT01214629|75799953|FG007|Overall Study|Adverse Event|0|||
41991705|NCT01214629|75799954|FG008|Overall Study|Adverse Event|0|||
41991706|NCT01214629|75799955|FG009|Overall Study|Adverse Event|1|||
41991707|NCT01214629|75799956|FG010|Overall Study|Adverse Event|0|||
41991708|NCT01214629|75799946|FG000|Overall Study|Physician Decision|0|||
41991709|NCT01214629|75799947|FG001|Overall Study|Physician Decision|0|||
41991710|NCT01214629|75799948|FG002|Overall Study|Physician Decision|0|||
41991711|NCT01214629|75799949|FG003|Overall Study|Physician Decision|0|||
41991712|NCT01214629|75799950|FG004|Overall Study|Physician Decision|0|||
41991713|NCT01214629|75799951|FG005|Overall Study|Physician Decision|0|||
42308798|NCT01926886|76144591|FG001|Overall Study|Disease progression/recurrence|0|||
42308799|NCT01926886|76144590|FG000|Overall Study|Withdrawal by Subject|15|||
42308800|NCT01926886|76144591|FG001|Overall Study|Withdrawal by Subject|0|||
42308801|NCT01926886|76144590|FG000|Overall Study|Failure to return|3|||
41991714|NCT01214629|75799952|FG006|Overall Study|Physician Decision|0|||
41991715|NCT01214629|75799953|FG007|Overall Study|Physician Decision|0|||
41991716|NCT01214629|75799954|FG008|Overall Study|Physician Decision|0|||
42308802|NCT01926886|76144591|FG001|Overall Study|Failure to return|0|||
42308803|NCT01926886|76144590|FG000|Overall Study|Recurrence of disease|1|||
42308804|NCT01926886|76144591|FG001|Overall Study|Recurrence of disease|0|||
42308805|NCT01926886|76144590|FG000|Overall Study|Progression of disease|2|||
42308806|NCT01926886|76144591|FG001|Overall Study|Progression of disease|0|||
42308807|NCT01926886|76144590|FG000|Overall Study|Death|1|||
42308808|NCT01926886|76144591|FG001|Overall Study|Death|0|||
42308809|NCT01926886|76144590|FG000|Overall Study|Did not cooperate|1|||
42308810|NCT01926886|76144591|FG001|Overall Study|Did not cooperate|0|||
42308811|NCT01909336|76144600|FG000|Overall Study|Lost to Follow-up|4|||
42308812|NCT01909336|76144601|FG001|Overall Study|Lost to Follow-up|2|||
42308813|NCT01909336|76144602|FG002|Overall Study|Lost to Follow-up|2|||
42308814|NCT01909336|76144600|FG000|Overall Study|Physician Decision|0|||
42308815|NCT01909336|76144601|FG001|Overall Study|Physician Decision|1|||
42308816|NCT01909336|76144602|FG002|Overall Study|Physician Decision|1|||
41991717|NCT01214629|75799955|FG009|Overall Study|Physician Decision|0|||
41991718|NCT01214629|75799956|FG010|Overall Study|Physician Decision|1|||
41991719|NCT01214629|75799946|FG000|Overall Study|Withdrawal by Subject|0|||
41991720|NCT01214629|75799947|FG001|Overall Study|Withdrawal by Subject|0|||
41991721|NCT01214629|75799948|FG002|Overall Study|Withdrawal by Subject|0|||
41991722|NCT01214629|75799949|FG003|Overall Study|Withdrawal by Subject|0|||
41991723|NCT01214629|75799950|FG004|Overall Study|Withdrawal by Subject|0|||
41991724|NCT01214629|75799951|FG005|Overall Study|Withdrawal by Subject|0|||
41991725|NCT01214629|75799952|FG006|Overall Study|Withdrawal by Subject|0|||
41991726|NCT01214629|75799953|FG007|Overall Study|Withdrawal by Subject|0|||
41991727|NCT01214629|75799954|FG008|Overall Study|Withdrawal by Subject|0|||
41991728|NCT01214629|75799955|FG009|Overall Study|Withdrawal by Subject|1|||
41991729|NCT01214629|75799956|FG010|Overall Study|Withdrawal by Subject|0|||
41991730|NCT01214434|75799996|FG000|Overall Study|Withdrawal by Subject|1|||
41991731|NCT01214434|75799997|FG001|Overall Study|Withdrawal by Subject|0|||
41991732|NCT01214434|75799996|FG000|Overall Study|Lost to Follow-up|2|||
41991733|NCT01214434|75799997|FG001|Overall Study|Lost to Follow-up|2|||
41991734|NCT01214434|75799996|FG000|Overall Study|Site error|1|||
41991735|NCT01214434|75799997|FG001|Overall Study|Site error|0|||
41991736|NCT01214395|75800003|FG000|Overall Study|All patients had infection|5|||
42033254|NCT01138007|75841389|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
42253279|NCT02314923|76079189|FG001|Overall Study|Participant unavailable|0|||
42253280|NCT02314923|76079190|FG002|Overall Study|Participant unavailable|0|||
42253281|NCT02314923|76079191|FG003|Overall Study|Participant unavailable|0|||
42253282|NCT02314923|76079192|FG004|Overall Study|Participant unavailable|0|||
42253283|NCT02314923|76079193|FG005|Overall Study|Participant unavailable|1|||
42253284|NCT02314923|76079194|FG006|Overall Study|Participant unavailable|0|||
42253285|NCT02314923|76079195|FG007|Overall Study|Participant unavailable|0|||
42253286|NCT02314923|76079196|FG008|Overall Study|Participant unavailable|0|||
42253287|NCT02314923|76079197|FG009|Overall Study|Participant unavailable|0|||
42253288|NCT02314923|76079188|FG000|Overall Study|Screen failure|0|||
42253289|NCT02314923|76079189|FG001|Overall Study|Screen failure|0|||
42308817|NCT01926028|76144613|FG000|Overall Study|Lost to Follow-up|7|||
42308818|NCT01926028|76144614|FG001|Overall Study|Lost to Follow-up|6|||
42308819|NCT01926028|76144615|FG002|Overall Study|Lost to Follow-up|0|||
42308820|NCT01926028|76144613|FG000|Overall Study|Physician Decision|1|||
41991737|NCT01214239|75800010|FG000|Overall Study|Adverse Event|3|||
41991738|NCT01214239|75800011|FG001|Overall Study|Adverse Event|4|||
42253290|NCT02314923|76079190|FG002|Overall Study|Screen failure|0|||
42308821|NCT01926028|76144614|FG001|Overall Study|Physician Decision|5|||
42253291|NCT02314923|76079191|FG003|Overall Study|Screen failure|0|||
42308822|NCT01926028|76144615|FG002|Overall Study|Physician Decision|0|||
42308823|NCT01926028|76144613|FG000|Overall Study|Withdrawal by Subject|9|||
42308824|NCT01926028|76144614|FG001|Overall Study|Withdrawal by Subject|9|||
42308825|NCT01926028|76144615|FG002|Overall Study|Withdrawal by Subject|2|||
42308826|NCT01926028|76144613|FG000|Overall Study|Non compliance or other reasons|4|||
42308827|NCT01926028|76144614|FG001|Overall Study|Non compliance or other reasons|2|||
42308828|NCT01926028|76144615|FG002|Overall Study|Non compliance or other reasons|0|||
42308829|NCT01925950|76144626|FG000|Part 2|Withdrawal by Subject|1|||
42308830|NCT01925950|76144627|FG001|Part 2|Withdrawal by Subject|0|||
42308831|NCT01878292|76144636|FG000|Randomized|Protocol Violation|1|||
42308832|NCT01878292|76144637|FG001|Randomized|Protocol Violation|0|||
42308833|NCT01878292|76144638|FG002|Randomized|Protocol Violation|0|||
42308834|NCT01878292|76144636|FG000|Randomized|Lost to Follow-up|1|||
42308835|NCT01878292|76144637|FG001|Randomized|Lost to Follow-up|0|||
42308836|NCT01878292|76144638|FG002|Randomized|Lost to Follow-up|0|||
42308837|NCT01878292|76144636|FG000|Randomized|Adverse Event|1|||
42308838|NCT01878292|76144637|FG001|Randomized|Adverse Event|0|||
42308839|NCT01878292|76144638|FG002|Randomized|Adverse Event|0|||
42308840|NCT01878292|76144636|FG000|Double-blind Treatment Period|Other Reasons|2|||
42308841|NCT01878292|76144637|FG001|Double-blind Treatment Period|Other Reasons|0|||
42308842|NCT01878292|76144638|FG002|Double-blind Treatment Period|Other Reasons|0|||
42308843|NCT01878292|76144636|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
42308844|NCT01878292|76144637|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
42308845|NCT01878292|76144638|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
42308846|NCT01878292|76144636|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
42308847|NCT01878292|76144637|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
42308848|NCT01878292|76144638|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
42308849|NCT01878292|76144636|FG000|Double-blind Treatment Period|Protocol Violation|3|||
42308850|NCT01878292|76144637|FG001|Double-blind Treatment Period|Protocol Violation|4|||
42308851|NCT01878292|76144638|FG002|Double-blind Treatment Period|Protocol Violation|2|||
42308852|NCT01878292|76144636|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
42308853|NCT01878292|76144637|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
42308854|NCT01878292|76144638|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
42308855|NCT01878292|76144636|FG000|Double-blind Treatment Period|Adverse Event|4|||
42308856|NCT01878292|76144637|FG001|Double-blind Treatment Period|Adverse Event|9|||
42308857|NCT01878292|76144638|FG002|Double-blind Treatment Period|Adverse Event|8|||
42308858|NCT01878292|76144636|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
42308859|NCT01878292|76144637|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
42308860|NCT01878292|76144638|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
42308861|NCT01908634|76144646|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
42308862|NCT01908634|76144646|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
42308863|NCT01878214|76144656|FG000|Overall Study|Withdrawal by Subject|18|||
42308864|NCT01878214|76144657|FG001|Overall Study|Withdrawal by Subject|7|||
42308865|NCT01878214|76144656|FG000|Overall Study|Death|0|||
42308866|NCT01878214|76144657|FG001|Overall Study|Death|1|||
42308867|NCT01878214|76144656|FG000|Overall Study|Lost to Follow-up|35|||
42308868|NCT01878214|76144657|FG001|Overall Study|Lost to Follow-up|36|||
42308869|NCT01907854|76144665|FG000|Overall Study|Protocol Violation|1|||
42308870|NCT01907854|76144666|FG001|Overall Study|Protocol Violation|1|||
42308871|NCT01907854|76144665|FG000|Overall Study|Withdrawal by Subject|9|||
42308872|NCT01907854|76144666|FG001|Overall Study|Withdrawal by Subject|7|||
42308873|NCT01907854|76144665|FG000|Overall Study|Lost to Follow-up|2|||
42308874|NCT01907854|76144666|FG001|Overall Study|Lost to Follow-up|2|||
42308875|NCT01907854|76144665|FG000|Overall Study|Unclassified|4|||
42308876|NCT01907854|76144666|FG001|Overall Study|Unclassified|3|||
42308877|NCT02480153|76144674|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
42308878|NCT02480153|76144675|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
42308879|NCT02480153|76144676|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
42308880|NCT02480153|76144674|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
42308881|NCT02480153|76144675|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
42308882|NCT02480153|76144676|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
42308883|NCT02480153|76144674|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
42308884|NCT02480153|76144675|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
42253292|NCT02314923|76079192|FG004|Overall Study|Screen failure|0|||
42253293|NCT02314923|76079193|FG005|Overall Study|Screen failure|0|||
42253294|NCT02314923|76079194|FG006|Overall Study|Screen failure|1|||
42253295|NCT02314923|76079195|FG007|Overall Study|Screen failure|0|||
42253296|NCT02314923|76079196|FG008|Overall Study|Screen failure|0|||
42253297|NCT02314923|76079197|FG009|Overall Study|Screen failure|0|||
42253298|NCT02314923|76079188|FG000|Overall Study|Participant relocation|1|||
42253299|NCT02314923|76079189|FG001|Overall Study|Participant relocation|0|||
42308885|NCT02480153|76144676|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
42308886|NCT02480153|76144674|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
42308887|NCT02480153|76144675|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
42308888|NCT02480153|76144676|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
42308889|NCT02480153|76144674|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
42308890|NCT02480153|76144675|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
42308891|NCT02480153|76144676|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
42308892|NCT02480153|76144674|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
42308893|NCT02480153|76144675|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
42308894|NCT02480153|76144676|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
42308895|NCT02480153|76144674|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
42308896|NCT02480153|76144675|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
42308897|NCT02480153|76144676|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
42308898|NCT02480153|76144674|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
42308899|NCT02480153|76144675|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
42308900|NCT02480153|76144676|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
42308901|NCT02480153|76144674|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
42308902|NCT02480153|76144675|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
42308903|NCT02480153|76144676|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
42308904|NCT02480153|76144674|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
42308905|NCT02480153|76144675|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
42308906|NCT02480153|76144676|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
42308907|NCT02480153|76144674|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
42308908|NCT02480153|76144675|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
42308909|NCT02480153|76144676|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
42308910|NCT02480153|76144674|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
42308911|NCT02480153|76144675|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
42308912|NCT02480153|76144676|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
42308913|NCT02480153|76144674|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
42308914|NCT02480153|76144675|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
42308915|NCT02480153|76144676|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
42253300|NCT02314923|76079190|FG002|Overall Study|Participant relocation|0|||
42253301|NCT02314923|76079191|FG003|Overall Study|Participant relocation|0|||
42253302|NCT02314923|76079192|FG004|Overall Study|Participant relocation|0|||
42253303|NCT02314923|76079193|FG005|Overall Study|Participant relocation|0|||
42253304|NCT02314923|76079194|FG006|Overall Study|Participant relocation|0|||
42253305|NCT02314923|76079195|FG007|Overall Study|Participant relocation|1|||
42253306|NCT02314923|76079196|FG008|Overall Study|Participant relocation|0|||
42253307|NCT02314923|76079197|FG009|Overall Study|Participant relocation|0|||
42253308|NCT03023137|76079222|FG000|Overall Study|Multiple pregnancy|2|||
42253309|NCT03023137|76079223|FG001|Overall Study|Multiple pregnancy|4|||
42253310|NCT03023137|76079222|FG000|Overall Study|Lost to Follow-up|1|||
42253311|NCT03023137|76079223|FG001|Overall Study|Lost to Follow-up|1|||
42253312|NCT03023137|76079222|FG000|Overall Study|Protocol Violation|0|||
42253313|NCT03023137|76079223|FG001|Overall Study|Protocol Violation|4|||
42253314|NCT03023137|76079222|FG000|Overall Study|Lost the baby in a car accident|1|||
42253315|NCT03023137|76079223|FG001|Overall Study|Lost the baby in a car accident|0|||
42253316|NCT03049813|76079234|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
42253317|NCT03049813|76079235|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
42253318|NCT03049813|76079236|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
42253319|NCT03049813|76079237|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
42253320|NCT03049813|76079234|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
42253321|NCT03049813|76079235|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
42253322|NCT03049813|76079236|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
42253323|NCT03049813|76079237|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
42253324|NCT03049813|76079234|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
42253325|NCT03049813|76079235|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
42253326|NCT03049813|76079236|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
42308916|NCT02480153|76144674|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
42308917|NCT02480153|76144675|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
42308918|NCT02480153|76144676|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
42308919|NCT02480153|76144674|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
42253327|NCT03049813|76079237|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
42253328|NCT03049813|76079234|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
42253329|NCT03049813|76079235|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
42308920|NCT02480153|76144675|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
42308921|NCT02480153|76144676|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
42308922|NCT02480153|76144674|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
42308923|NCT02480153|76144675|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
42308924|NCT02480153|76144676|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
42308925|NCT02480153|76144674|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
42308926|NCT02480153|76144675|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
42308927|NCT02480153|76144676|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
42308928|NCT02480153|76144674|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
42308929|NCT02480153|76144675|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
42308930|NCT02480153|76144676|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
42033255|NCT01138007|75841390|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
42033256|NCT01138007|75841388|FG000|Overall Study|Lost to Follow-up|3|||
42033257|NCT01138007|75841389|FG001|Overall Study|Lost to Follow-up|3|||
42033258|NCT01138007|75841390|FG002|Overall Study|Lost to Follow-up|5|||
42033259|NCT01138007|75841388|FG000|Overall Study|Physician Decision|0|||
42033260|NCT01138007|75841389|FG001|Overall Study|Physician Decision|5|||
42033261|NCT01138007|75841390|FG002|Overall Study|Physician Decision|3|||
42033262|NCT01138007|75841388|FG000|Overall Study|Withdrawal by Subject|5|||
42033263|NCT01138007|75841389|FG001|Overall Study|Withdrawal by Subject|6|||
42033264|NCT01138007|75841390|FG002|Overall Study|Withdrawal by Subject|15|||
42033265|NCT00865345|75841400|FG000|Overall Study|Withdrawal by Subject|2|||
42033266|NCT01131299|75841404|FG000|Overall Study|Withdrawal by Subject|4|||
42033267|NCT01131299|75841405|FG001|Overall Study|Withdrawal by Subject|7|||
42033268|NCT01130831|75841410|FG000|Overall Study|Withdrawal by Subject|7|||
42033269|NCT01130831|75841410|FG000|Overall Study|Death|4|||
42033270|NCT01130831|75841410|FG000|Overall Study|Information was missing|3|||
42033271|NCT01130597|75841426|FG000|Overall Study|Protocol-specified (High K+)|1|||
42033272|NCT01130597|75841426|FG000|Overall Study|Adverse Event|4|||
42033273|NCT01130597|75841426|FG000|Overall Study|Death|1|||
42033274|NCT01130597|75841426|FG000|Overall Study|Protocol Violation|1|||
42033275|NCT00939003|75841432|FG000|Double-blind Treatment Period|Adverse Event|1|||
42033276|NCT00939003|75841433|FG001|Double-blind Treatment Period|Adverse Event|1|||
42033277|NCT00939003|75841432|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
42033278|NCT00939003|75841433|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
42033279|NCT00939003|75841432|FG000|Double-blind Treatment Period|Pregnancy|0|||
42033280|NCT00939003|75841433|FG001|Double-blind Treatment Period|Pregnancy|1|||
42033281|NCT00939003|75841432|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
42132896|NCT00508742|75943738|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
42132897|NCT00508742|75943739|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
42132898|NCT00508742|75943738|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
42132899|NCT00508742|75943739|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
42253330|NCT03049813|76079236|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
42253331|NCT03049813|76079237|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
42253332|NCT03022981|76079248|FG000|Overall Study|Adverse Event|0|||
42253333|NCT03022981|76079249|FG001|Overall Study|Adverse Event|1|||
42253334|NCT03022981|76079250|FG002|Overall Study|Adverse Event|0|||
42253335|NCT03022981|76079248|FG000|Overall Study|Investigator's Discretion|0|||
42253336|NCT03022981|76079249|FG001|Overall Study|Investigator's Discretion|1|||
42253337|NCT03022981|76079250|FG002|Overall Study|Investigator's Discretion|2|||
42253338|NCT03022981|76079248|FG000|Overall Study|Lost to Follow-up|6|||
42033282|NCT00939003|75841433|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
42033283|NCT00939003|75841432|FG000|Open-label Treatment Period|Adverse Event|4|||
42033284|NCT00939003|75841433|FG001|Open-label Treatment Period|Adverse Event|8|||
42033285|NCT00939003|75841432|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
42033286|NCT00939003|75841433|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
42033287|NCT00939003|75841432|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
42033288|NCT00939003|75841433|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
42033289|NCT00939003|75841432|FG000|Open-label Treatment Period|Pregnancy|1|||
42033290|NCT00939003|75841433|FG001|Open-label Treatment Period|Pregnancy|1|||
42033291|NCT00939003|75841432|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
42033292|NCT00939003|75841433|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
42033293|NCT00939003|75841432|FG000|Open-label Treatment Period|Site Closure|3|||
42033294|NCT00939003|75841433|FG001|Open-label Treatment Period|Site Closure|4|||
42033295|NCT01188668|75841442|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
42033296|NCT01188668|75841442|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
42033297|NCT01188668|75841442|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
42033298|NCT01130051|75841449|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
42033299|NCT01130051|75841450|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
42132900|NCT00508742|75943738|FG000|Period 3: Toddler Dose|Other|5|||
42253339|NCT03022981|76079249|FG001|Overall Study|Lost to Follow-up|2|||
42253340|NCT03022981|76079250|FG002|Overall Study|Lost to Follow-up|1|||
42308931|NCT02500979|76144701|FG000|Period 1|Hyperglycemia|1|||
42308932|NCT02500979|76144702|FG001|Period 1|Hyperglycemia|0|||
41991739|NCT01214239|75800010|FG000|Overall Study|Protocol Violation|2|||
41991740|NCT01214239|75800011|FG001|Overall Study|Protocol Violation|1|||
41991741|NCT01214239|75800010|FG000|Overall Study|Lost to Follow-up|1|||
41991742|NCT01214239|75800011|FG001|Overall Study|Lost to Follow-up|1|||
41991743|NCT01214239|75800010|FG000|Overall Study|Withdrawal by Subject|4|||
41991744|NCT01214239|75800011|FG001|Overall Study|Withdrawal by Subject|9|||
41991745|NCT01214239|75800010|FG000|Overall Study|Lack of Efficacy|1|||
41991746|NCT01214239|75800011|FG001|Overall Study|Lack of Efficacy|2|||
41991747|NCT01214239|75800010|FG000|Overall Study|patient's private reason|1|||
41991748|NCT01214239|75800011|FG001|Overall Study|patient's private reason|1|||
41991749|NCT01214200|75800017|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
41991750|NCT01214200|75800017|FG000|Overall Study|Withdrawal by Subject|2|||
41991751|NCT01214044|75800023|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
41991752|NCT01214044|75800023|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
41991753|NCT01214044|75800023|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
41991754|NCT01214044|75800023|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
41991755|NCT01214044|75800023|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
41991756|NCT01214044|75800023|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
41991757|NCT01213966|75800035|FG000|Overall Study|Protocol Violation|1|||
41991758|NCT01213966|75800036|FG001|Overall Study|Protocol Violation|0|||
41991759|NCT01213966|75800037|FG002|Overall Study|Protocol Violation|3|||
41991760|NCT01213966|75800038|FG003|Overall Study|Protocol Violation|1|||
41991761|NCT01213264|75800051|FG000|Overall Study|Adverse Event|1|||
41991762|NCT01213264|75800052|FG001|Overall Study|Adverse Event|0|||
41991763|NCT01213264|75800053|FG002|Overall Study|Adverse Event|0|||
41991764|NCT01213264|75800051|FG000|Overall Study|Lost to Follow-up|1|||
41991765|NCT01213264|75800052|FG001|Overall Study|Lost to Follow-up|2|||
41991766|NCT01213264|75800053|FG002|Overall Study|Lost to Follow-up|6|||
41991767|NCT01212991|75800066|FG000|Double-blind|Lost to Follow-up|8|||
41991768|NCT01212991|75800067|FG001|Double-blind|Lost to Follow-up|4|||
41991769|NCT01212991|75800068|FG002|Double-blind|Lost to Follow-up|0|||
41991770|NCT01212991|75800066|FG000|Double-blind|Death|699|||
41991771|NCT01212991|75800067|FG001|Double-blind|Death|550|||
41991772|NCT01212991|75800068|FG002|Double-blind|Death|0|||
41991773|NCT01212991|75800066|FG000|Double-blind|Withdrawal by Subject|16|||
41991774|NCT01212991|75800067|FG001|Double-blind|Withdrawal by Subject|19|||
41991775|NCT01212991|75800068|FG002|Double-blind|Withdrawal by Subject|0|||
41991776|NCT01212991|75800066|FG000|Double-blind|Other|7|||
41991777|NCT01212991|75800067|FG001|Double-blind|Other|0|||
41991778|NCT01212991|75800068|FG002|Double-blind|Other|0|||
41991779|NCT01212991|75800066|FG000|Double-blind|Sponsor decision|142|||
41991780|NCT01212991|75800067|FG001|Double-blind|Sponsor decision|38|||
41991781|NCT01212991|75800068|FG002|Double-blind|Sponsor decision|0|||
41991782|NCT01212991|75800066|FG000|Open-label|Death|0|||
41991783|NCT01212991|75800067|FG001|Open-label|Death|0|||
42132901|NCT00508742|75943739|FG001|Period 3: Toddler Dose|Other|4|||
42132902|NCT00508274|75943760|FG000|Overall Study|Adverse Event|5|||
42132903|NCT00508274|75943760|FG000|Overall Study|Death|7|||
42132904|NCT00508274|75943760|FG000|Overall Study|Disease progression|32|||
42132905|NCT00508274|75943760|FG000|Overall Study|Withdrawal by Subject|1|||
42132906|NCT00508274|75943760|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
42132907|NCT00508274|75943760|FG000|Overall Study|Missing|3|||
42253341|NCT03022981|76079248|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42253342|NCT03022981|76079249|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42132908|NCT00499460|75943766|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
42033300|NCT01130051|75841449|FG000|Washout Period of 14 Days|Protocol Violation|1|||
42033301|NCT01130051|75841450|FG001|Washout Period of 14 Days|Protocol Violation|1|||
42033302|NCT00865189|75841458|FG000|Overall Study|Other|1|||
42033303|NCT00865189|75841459|FG001|Overall Study|Other|2|||
42132909|NCT00499460|75943767|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
42132910|NCT00499460|75943766|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
42132911|NCT00499460|75943767|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
42132912|NCT00499460|75943766|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
42253343|NCT03022981|76079250|FG002|Overall Study|Non-Compliance With Study Drug|2|||
42253344|NCT03022981|76079248|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
42253345|NCT03022981|76079249|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
42253346|NCT03022981|76079250|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
42033304|NCT00865189|75841458|FG000|Overall Study|Death|4|||
42132913|NCT00499460|75943767|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
42253347|NCT03377699|76079270|FG000|Overall Study|Withdrawal by Subject|2|||
42033305|NCT00865189|75841459|FG001|Overall Study|Death|11|||
42033306|NCT00865189|75841458|FG000|Overall Study|Lost to Follow-up|6|||
41991784|NCT01212991|75800068|FG002|Open-label|Death|166|||
41991785|NCT01212991|75800066|FG000|Open-label|Lost to Follow-up|0|||
41991786|NCT01212991|75800067|FG001|Open-label|Lost to Follow-up|0|||
41991787|NCT01212991|75800068|FG002|Open-label|Lost to Follow-up|5|||
41991788|NCT01212991|75800066|FG000|Open-label|Withdrawal by Subject|0|||
41991789|NCT01212991|75800067|FG001|Open-label|Withdrawal by Subject|0|||
41991790|NCT01212991|75800068|FG002|Open-label|Withdrawal by Subject|7|||
41991791|NCT01212991|75800066|FG000|Open-label|Sponsor decision|0|||
41991792|NCT01212991|75800067|FG001|Open-label|Sponsor decision|0|||
41991793|NCT01212991|75800068|FG002|Open-label|Sponsor decision|53|||
41991794|NCT01212991|75800066|FG000|Open-label|Other|0|||
41991795|NCT01212991|75800067|FG001|Open-label|Other|0|||
41991796|NCT01212991|75800068|FG002|Open-label|Other|3|||
41991797|NCT01212757|75800079|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
41991798|NCT01212757|75800080|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
41991799|NCT01212757|75800081|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
41991800|NCT01212757|75800082|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
41991801|NCT01212757|75800083|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42132914|NCT00412113|75943785|FG000|Overall Study|Adverse Event|11|||
42132915|NCT00412113|75943786|FG001|Overall Study|Adverse Event|15|||
42033307|NCT00865189|75841459|FG001|Overall Study|Lost to Follow-up|6|||
42033308|NCT00865189|75841458|FG000|Overall Study|Withdrawal by Subject|1|||
42033309|NCT00865189|75841459|FG001|Overall Study|Withdrawal by Subject|0|||
42033310|NCT01182194|75841467|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
42033311|NCT01182194|75841468|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
42033312|NCT01181726|75841476|FG000|First Intervention|Adverse Event|1|||
42033313|NCT01181726|75841477|FG001|First Intervention|Adverse Event|0|||
42033314|NCT01137071|75841483|FG000|Overall Study|Disease Progression|11|||
42308933|NCT02500979|76144701|FG000|Period 1|Severe non-compliance to protocol|0|||
41991802|NCT01212757|75800084|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
41991803|NCT01212757|75800085|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
42010554|NCT00993421|75817698|FG004|Overall Study|Adverse Event|5|||
42132916|NCT00412113|75943785|FG000|Overall Study|did not receive treatment|1|||
42253348|NCT03377699|76079271|FG001|Overall Study|Withdrawal by Subject|9|||
42253349|NCT03377699|76079270|FG000|Overall Study|Lost to Follow-up|1|||
42132917|NCT00412113|75943786|FG001|Overall Study|did not receive treatment|0|||
42253350|NCT03377699|76079271|FG001|Overall Study|Lost to Follow-up|1|||
42253351|NCT03377699|76079270|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
42253352|NCT03377699|76079271|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
42253353|NCT03377699|76079270|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
42132918|NCT00411645|75943794|FG000|Overall Study|Consent Withdrawn|13|||
42308934|NCT02500979|76144702|FG001|Period 1|Severe non-compliance to protocol|1|||
42308935|NCT02500979|76144701|FG000|Period 1|Adverse Event|1|||
42308936|NCT02500979|76144702|FG001|Period 1|Adverse Event|0|||
42308937|NCT02500979|76144701|FG000|Period 1|Subject decision|2|||
42308938|NCT02500979|76144702|FG001|Period 1|Subject decision|0|||
42308939|NCT02500979|76144701|FG000|Period 2|Change in risk|1|||
42308940|NCT02500979|76144702|FG001|Period 2|Change in risk|0|||
42308941|NCT02500901|76144708|FG000|Overall Study|Disease ProgressionDD|2|||
42308942|NCT02479139|76144718|FG000|Overall Study|Lost to Follow-up|2|||
42308943|NCT02479139|76144719|FG001|Overall Study|Lost to Follow-up|4|||
42308944|NCT02479139|76144720|FG002|Overall Study|Lost to Follow-up|4|||
42308945|NCT02479139|76144721|FG003|Overall Study|Lost to Follow-up|2|||
42308946|NCT02479139|76144722|FG004|Overall Study|Lost to Follow-up|3|||
42308947|NCT02479139|76144723|FG005|Overall Study|Lost to Follow-up|5|||
42308948|NCT02479139|76144718|FG000|Overall Study|Withdrew Consent|5|||
42308949|NCT02479139|76144719|FG001|Overall Study|Withdrew Consent|6|||
42308950|NCT02479139|76144720|FG002|Overall Study|Withdrew Consent|1|||
42308951|NCT02479139|76144721|FG003|Overall Study|Withdrew Consent|4|||
42308952|NCT02479139|76144722|FG004|Overall Study|Withdrew Consent|1|||
42308953|NCT02479139|76144723|FG005|Overall Study|Withdrew Consent|1|||
42308954|NCT02479139|76144718|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
42308955|NCT02479139|76144719|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
42308956|NCT02479139|76144720|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
42308957|NCT02479139|76144721|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
42308958|NCT02479139|76144722|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
42308959|NCT02479139|76144723|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
42308960|NCT02479139|76144718|FG000|Overall Study|Other Miscellaneous Reasons|1|||
42308961|NCT02479139|76144719|FG001|Overall Study|Other Miscellaneous Reasons|0|||
42308962|NCT02479139|76144720|FG002|Overall Study|Other Miscellaneous Reasons|1|||
42308963|NCT02479139|76144721|FG003|Overall Study|Other Miscellaneous Reasons|1|||
42308964|NCT02479139|76144722|FG004|Overall Study|Other Miscellaneous Reasons|1|||
42308965|NCT02479139|76144723|FG005|Overall Study|Other Miscellaneous Reasons|0|||
42308966|NCT02478359|76144739|FG000|Overall Study|Disenrolled from health plan|106|||
42308967|NCT02478359|76144740|FG001|Overall Study|Disenrolled from health plan|65|||
42308968|NCT01877668|76144753|FG000|Overall Study|Death|0|||
42308969|NCT01877668|76144754|FG001|Overall Study|Death|0|||
42308970|NCT01877668|76144755|FG002|Overall Study|Death|0|||
42308971|NCT01877668|76144756|FG003|Overall Study|Death|1|||
42308972|NCT01877668|76144757|FG004|Overall Study|Death|0|||
42308973|NCT01877668|76144753|FG000|Overall Study|No longer met study criteria|1|||
42308974|NCT01877668|76144754|FG001|Overall Study|No longer met study criteria|0|||
42308975|NCT01877668|76144755|FG002|Overall Study|No longer met study criteria|1|||
42308976|NCT01877668|76144756|FG003|Overall Study|No longer met study criteria|0|||
42308977|NCT01877668|76144757|FG004|Overall Study|No longer met study criteria|0|||
42308978|NCT01877668|76144753|FG000|Overall Study|Insufficient clinical response|0|||
42308979|NCT01877668|76144754|FG001|Overall Study|Insufficient clinical response|1|||
42308980|NCT01877668|76144755|FG002|Overall Study|Insufficient clinical response|2|||
42308981|NCT01877668|76144756|FG003|Overall Study|Insufficient clinical response|2|||
42308982|NCT01877668|76144757|FG004|Overall Study|Insufficient clinical response|0|||
42308983|NCT01877668|76144753|FG000|Overall Study|Lost to Follow-up|0|||
42308984|NCT01877668|76144754|FG001|Overall Study|Lost to Follow-up|2|||
42308985|NCT01877668|76144755|FG002|Overall Study|Lost to Follow-up|1|||
42308986|NCT01877668|76144756|FG003|Overall Study|Lost to Follow-up|0|||
42308987|NCT01877668|76144757|FG004|Overall Study|Lost to Follow-up|0|||
42308988|NCT01877668|76144753|FG000|Overall Study|Withdrawal by Subject|2|||
42308989|NCT01877668|76144754|FG001|Overall Study|Withdrawal by Subject|0|||
42308990|NCT01877668|76144755|FG002|Overall Study|Withdrawal by Subject|3|||
42308991|NCT01877668|76144756|FG003|Overall Study|Withdrawal by Subject|2|||
42308992|NCT01877668|76144757|FG004|Overall Study|Withdrawal by Subject|2|||
42308993|NCT01877668|76144753|FG000|Overall Study|Other|1|||
42308994|NCT01877668|76144754|FG001|Overall Study|Other|1|||
42308995|NCT01877668|76144755|FG002|Overall Study|Other|1|||
42308996|NCT01877668|76144756|FG003|Overall Study|Other|1|||
42308997|NCT01877668|76144757|FG004|Overall Study|Other|3|||
42308998|NCT01877668|76144753|FG000|Overall Study|Protocol Violation|1|||
42308999|NCT01877668|76144754|FG001|Overall Study|Protocol Violation|1|||
42309000|NCT01877668|76144755|FG002|Overall Study|Protocol Violation|0|||
42309001|NCT01877668|76144756|FG003|Overall Study|Protocol Violation|0|||
42309002|NCT01877668|76144757|FG004|Overall Study|Protocol Violation|3|||
42309003|NCT01877668|76144753|FG000|Overall Study|Adverse event related to study drug|2|||
42309004|NCT01877668|76144754|FG001|Overall Study|Adverse event related to study drug|2|||
42309005|NCT01877668|76144755|FG002|Overall Study|Adverse event related to study drug|2|||
42309006|NCT01877668|76144756|FG003|Overall Study|Adverse event related to study drug|2|||
42309007|NCT01877668|76144757|FG004|Overall Study|Adverse event related to study drug|1|||
42309008|NCT01877668|76144753|FG000|Overall Study|Adverse event unrelated to study drug|4|||
42309009|NCT01877668|76144754|FG001|Overall Study|Adverse event unrelated to study drug|1|||
42309010|NCT01877668|76144755|FG002|Overall Study|Adverse event unrelated to study drug|2|||
42309011|NCT01877668|76144756|FG003|Overall Study|Adverse event unrelated to study drug|0|||
42309012|NCT01877668|76144757|FG004|Overall Study|Adverse event unrelated to study drug|1|||
42309013|NCT01877278|76144775|FG000|Overall Study|Lost to Follow-up|3|||
42309014|NCT01877278|76144776|FG001|Overall Study|Lost to Follow-up|3|||
42309015|NCT01906372|76144782|FG000|Overall Study|Withdrawal by Subject|2|||
42309016|NCT01925170|76144787|FG000|Overall Study|Unverified cancer status|53|||
42309017|NCT01925014|76144795|FG000|Overall Study|Inappropriate enrollment|4|||
42309018|NCT01925014|76144796|FG001|Overall Study|Inappropriate enrollment|6|||
42309019|NCT01925014|76144795|FG000|Overall Study|Withdrawal by Subject|5|||
42309020|NCT01925014|76144796|FG001|Overall Study|Withdrawal by Subject|13|||
42309021|NCT01876810|76144802|FG000|Overall Study|Physician Decision|0|||
42309022|NCT01876810|76144803|FG001|Overall Study|Physician Decision|1|||
42309023|NCT01876732|76144812|FG000|Overall Study|MMA was not over 800mg/dL|75|||
42309024|NCT01905592|76144819|FG000|Overall Study|Disease Progression|51|||
42309025|NCT01905592|76144820|FG001|Overall Study|Disease Progression|110|||
42309026|NCT01905592|76144819|FG000|Overall Study|Toxicity|1|||
42309027|NCT01905592|76144820|FG001|Overall Study|Toxicity|16|||
42309028|NCT01905592|76144819|FG000|Overall Study|Physician Decision|0|||
42309029|NCT01905592|76144820|FG001|Overall Study|Physician Decision|2|||
42309030|NCT01905592|76144819|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
42309031|NCT01905592|76144820|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
42309032|NCT01905592|76144819|FG000|Overall Study|Protocol Violation|0|||
42309033|NCT01905592|76144820|FG001|Overall Study|Protocol Violation|1|||
42309034|NCT01905592|76144819|FG000|Overall Study|Sponsor's decision|1|||
42309035|NCT01905592|76144820|FG001|Overall Study|Sponsor's decision|1|||
42309036|NCT01905592|76144819|FG000|Overall Study|Not treated|7|||
42309037|NCT01905592|76144820|FG001|Overall Study|Not treated|3|||
42309038|NCT01905592|76144819|FG000|Overall Study|Withdrawal by Subject|10|||
42309039|NCT01905592|76144820|FG001|Overall Study|Withdrawal by Subject|2|||
42309040|NCT01876420|76144826|FG000|Overall Study|Missed 30 day visit|1|||
42309041|NCT01875874|76144830|FG000|Overall Study|Death|3|||
42309042|NCT02500121|76144837|FG000|Overall Study|Lost to Follow-up|0|||
42309043|NCT02500121|76144838|FG001|Overall Study|Lost to Follow-up|1|||
42309044|NCT02500121|76144837|FG000|Overall Study|Withdrawal by Subject|1|||
42309045|NCT02500121|76144838|FG001|Overall Study|Withdrawal by Subject|1|||
42309046|NCT02500121|76144837|FG000|Overall Study|Death|26|||
42309047|NCT02500121|76144838|FG001|Overall Study|Death|24|||
42309048|NCT01875250|76144848|FG000|Overall Study|Adverse Event|2|||
42309049|NCT01875250|76144849|FG001|Overall Study|Adverse Event|0|||
42309050|NCT01904032|76144859|FG000|Overall Study|Adverse Event|3|||
42309051|NCT01904032|76144860|FG001|Overall Study|Adverse Event|1|||
42309052|NCT01904032|76144859|FG000|Overall Study|Lost to Follow-up|4|||
42309053|NCT01904032|76144860|FG001|Overall Study|Lost to Follow-up|2|||
42309054|NCT01903876|76144868|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
42309055|NCT01903876|76144869|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
42309056|NCT01903876|76144868|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
42309057|NCT01903876|76144869|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
42309058|NCT01921348|76144877|FG000|Overall Study|Withdrawal by Subject|1|||
42309059|NCT01921348|76144878|FG001|Overall Study|Withdrawal by Subject|0|||
42309060|NCT01921348|76144877|FG000|Overall Study|Lost to Follow-up|0|||
42309061|NCT01921348|76144878|FG001|Overall Study|Lost to Follow-up|2|||
42309062|NCT01921270|76144884|FG000|Overall Study|Withdrawal by Subject|1|||
42309063|NCT02325739|76144899|FG000|Phase I Part|Adverse Event|1|||
42309064|NCT02325739|76144900|FG001|Phase I Part|Adverse Event|0|||
41991804|NCT01212757|75800086|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
41991805|NCT01212757|75800087|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
41991806|NCT01212757|75800079|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
42309065|NCT02325739|76144901|FG002|Phase I Part|Adverse Event|1|||
42309066|NCT02325739|76144902|FG003|Phase I Part|Adverse Event|2|||
42309067|NCT02325739|76144903|FG004|Phase I Part|Adverse Event|3|||
42309068|NCT02325739|76144904|FG005|Phase I Part|Adverse Event|1|||
42309069|NCT02325739|76144905|FG006|Phase I Part|Adverse Event|0|||
42309070|NCT02325739|76144906|FG007|Phase I Part|Adverse Event|2|||
42309071|NCT02325739|76144907|FG008|Phase I Part|Adverse Event|0|||
42309072|NCT02325739|76144908|FG009|Phase I Part|Adverse Event|0|||
42309073|NCT02325739|76144909|FG010|Phase I Part|Adverse Event|0|||
42309074|NCT02325739|76144899|FG000|Phase I Part|Progressive disease|9|||
42309075|NCT02325739|76144900|FG001|Phase I Part|Progressive disease|6|||
42309076|NCT02325739|76144901|FG002|Phase I Part|Progressive disease|3|||
42309077|NCT02325739|76144902|FG003|Phase I Part|Progressive disease|23|||
42309078|NCT02325739|76144903|FG004|Phase I Part|Progressive disease|14|||
42309079|NCT02325739|76144904|FG005|Phase I Part|Progressive disease|6|||
42309080|NCT02325739|76144905|FG006|Phase I Part|Progressive disease|6|||
42309081|NCT02325739|76144906|FG007|Phase I Part|Progressive disease|3|||
42309082|NCT02325739|76144907|FG008|Phase I Part|Progressive disease|0|||
42309083|NCT02325739|76144908|FG009|Phase I Part|Progressive disease|0|||
42309084|NCT02325739|76144909|FG010|Phase I Part|Progressive disease|0|||
42309085|NCT02325739|76144899|FG000|Phase I Part|Subject/guardian decision|1|||
42309086|NCT02325739|76144900|FG001|Phase I Part|Subject/guardian decision|0|||
42309087|NCT02325739|76144901|FG002|Phase I Part|Subject/guardian decision|1|||
41991807|NCT01212757|75800080|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
41991808|NCT01212757|75800081|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
41991809|NCT01212757|75800082|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
41991810|NCT01212757|75800083|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
42309088|NCT02325739|76144902|FG003|Phase I Part|Subject/guardian decision|1|||
42309089|NCT02325739|76144903|FG004|Phase I Part|Subject/guardian decision|0|||
42309090|NCT02325739|76144904|FG005|Phase I Part|Subject/guardian decision|0|||
42309091|NCT02325739|76144905|FG006|Phase I Part|Subject/guardian decision|0|||
42309092|NCT02325739|76144906|FG007|Phase I Part|Subject/guardian decision|1|||
42309093|NCT02325739|76144907|FG008|Phase I Part|Subject/guardian decision|0|||
42309094|NCT02325739|76144908|FG009|Phase I Part|Subject/guardian decision|0|||
42309095|NCT02325739|76144909|FG010|Phase I Part|Subject/guardian decision|0|||
42309096|NCT02325739|76144899|FG000|Phase I Part|Death|0|||
42309097|NCT02325739|76144900|FG001|Phase I Part|Death|0|||
42309098|NCT02325739|76144901|FG002|Phase I Part|Death|0|||
41991811|NCT01212757|75800084|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
41991812|NCT01212757|75800085|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
41991813|NCT01212757|75800086|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
41991814|NCT01212757|75800087|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
41991815|NCT01212757|75800079|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
41991816|NCT01212757|75800080|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
42010555|NCT00993421|75817699|FG005|Overall Study|Adverse Event|7|||
42253354|NCT03377699|76079271|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
42253355|NCT03377699|76079270|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
42253356|NCT03377699|76079271|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
42253357|NCT03377699|76079270|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
42253358|NCT03377699|76079271|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
42253359|NCT01314443|76079283|FG000|Overall Study|Withdrawal by Subject|2|||
42253360|NCT01314443|76079284|FG001|Overall Study|Withdrawal by Subject|1|||
42253361|NCT01314443|76079285|FG002|Overall Study|Withdrawal by Subject|1|||
42253362|NCT01314443|76079286|FG003|Overall Study|Withdrawal by Subject|1|||
42253363|NCT01314443|76079283|FG000|Overall Study|Protocol Violation|2|||
42253364|NCT01314443|76079284|FG001|Overall Study|Protocol Violation|2|||
42253365|NCT01314443|76079285|FG002|Overall Study|Protocol Violation|1|||
42253366|NCT01314443|76079286|FG003|Overall Study|Protocol Violation|1|||
42253367|NCT02923921|76079298|FG000|Overall Study|Sponsor Decision|39|||
42253368|NCT02923921|76079299|FG001|Overall Study|Sponsor Decision|38|||
42253369|NCT02923921|76079298|FG000|Overall Study|Lost to Follow-up|1|||
42253370|NCT02923921|76079299|FG001|Overall Study|Lost to Follow-up|0|||
42253371|NCT02923921|76079298|FG000|Overall Study|Withdrawal by Subject|6|||
42253372|NCT02923921|76079299|FG001|Overall Study|Withdrawal by Subject|13|||
42309099|NCT02325739|76144902|FG003|Phase I Part|Death|0|||
42309100|NCT02325739|76144903|FG004|Phase I Part|Death|2|||
42309101|NCT02325739|76144904|FG005|Phase I Part|Death|0|||
42309102|NCT02325739|76144905|FG006|Phase I Part|Death|0|||
42309103|NCT02325739|76144906|FG007|Phase I Part|Death|0|||
42309104|NCT02325739|76144907|FG008|Phase I Part|Death|0|||
42309105|NCT02325739|76144908|FG009|Phase I Part|Death|0|||
42309106|NCT02325739|76144909|FG010|Phase I Part|Death|0|||
42309107|NCT02325739|76144899|FG000|Phase II Part|Adverse Event|0|||
42309108|NCT02325739|76144900|FG001|Phase II Part|Adverse Event|0|||
42309109|NCT02325739|76144901|FG002|Phase II Part|Adverse Event|0|||
42309110|NCT02325739|76144902|FG003|Phase II Part|Adverse Event|0|||
42309111|NCT02325739|76144903|FG004|Phase II Part|Adverse Event|0|||
42309112|NCT02325739|76144904|FG005|Phase II Part|Adverse Event|0|||
42309113|NCT02325739|76144905|FG006|Phase II Part|Adverse Event|0|||
42309114|NCT02325739|76144906|FG007|Phase II Part|Adverse Event|0|||
42309115|NCT02325739|76144907|FG008|Phase II Part|Adverse Event|4|||
42309116|NCT02325739|76144908|FG009|Phase II Part|Adverse Event|5|||
42309117|NCT02325739|76144909|FG010|Phase II Part|Adverse Event|1|||
42309118|NCT02325739|76144899|FG000|Phase II Part|Physician Decision|0|||
42309119|NCT02325739|76144900|FG001|Phase II Part|Physician Decision|0|||
42309120|NCT02325739|76144901|FG002|Phase II Part|Physician Decision|0|||
42309121|NCT02325739|76144902|FG003|Phase II Part|Physician Decision|0|||
42309122|NCT02325739|76144903|FG004|Phase II Part|Physician Decision|0|||
42309123|NCT02325739|76144904|FG005|Phase II Part|Physician Decision|0|||
42309124|NCT02325739|76144905|FG006|Phase II Part|Physician Decision|0|||
42309125|NCT02325739|76144906|FG007|Phase II Part|Physician Decision|0|||
42309126|NCT02325739|76144907|FG008|Phase II Part|Physician Decision|0|||
42309127|NCT02325739|76144908|FG009|Phase II Part|Physician Decision|1|||
42309128|NCT02325739|76144909|FG010|Phase II Part|Physician Decision|0|||
42309129|NCT02325739|76144899|FG000|Phase II Part|Progressive disease|0|||
42309130|NCT02325739|76144900|FG001|Phase II Part|Progressive disease|0|||
42309131|NCT02325739|76144901|FG002|Phase II Part|Progressive disease|0|||
42309132|NCT02325739|76144902|FG003|Phase II Part|Progressive disease|0|||
42309133|NCT02325739|76144903|FG004|Phase II Part|Progressive disease|0|||
41991817|NCT01212757|75800081|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
42253373|NCT02923921|76079298|FG000|Overall Study|Unknown, Not Collected|7|||
42253374|NCT02923921|76079299|FG001|Overall Study|Unknown, Not Collected|6|||
42253375|NCT03039023|76079310|FG000|Overall Study|Withdrawal by Subject|1|||
42253376|NCT03039023|76079311|FG001|Overall Study|Withdrawal by Subject|0|||
42253377|NCT03039023|76079312|FG002|Overall Study|Withdrawal by Subject|1|||
42253378|NCT03039023|76079313|FG003|Overall Study|Withdrawal by Subject|1|||
42253379|NCT03039023|76079314|FG004|Overall Study|Withdrawal by Subject|0|||
42253380|NCT03039023|76079310|FG000|Overall Study|Physician Decision|0|||
42253381|NCT03039023|76079311|FG001|Overall Study|Physician Decision|0|||
42253382|NCT03039023|76079312|FG002|Overall Study|Physician Decision|0|||
42253383|NCT03039023|76079313|FG003|Overall Study|Physician Decision|1|||
42253384|NCT03039023|76079314|FG004|Overall Study|Physician Decision|0|||
42253385|NCT03022045|76079328|FG000|Overall Study|Adverse Event|0|||
42253386|NCT03022045|76079329|FG001|Overall Study|Adverse Event|1|||
42253387|NCT03022045|76079328|FG000|Overall Study|Withdrawal by Subject|1|||
42253388|NCT03022045|76079329|FG001|Overall Study|Withdrawal by Subject|1|||
42253389|NCT03037619|76079341|FG000|Overall Study|Lost to Follow-up|0|||
42253390|NCT03037619|76079342|FG001|Overall Study|Lost to Follow-up|1|||
42253391|NCT04771013|76079350|FG000|Overall Study|Withdrawal by Subject|2|||
42253392|NCT04771013|76079351|FG001|Overall Study|Withdrawal by Subject|0|||
42253393|NCT04771013|76079350|FG000|Overall Study|Death|0|||
42253394|NCT04771013|76079351|FG001|Overall Study|Death|5|||
42253395|NCT04771013|76079350|FG000|Overall Study|Referred to another hospital before day 20|0|||
42253396|NCT04771013|76079351|FG001|Overall Study|Referred to another hospital before day 20|1|||
42253397|NCT03021265|76079357|FG000|Overall Study|Adverse Event|29|||
42253398|NCT03021265|76079357|FG000|Overall Study|Lack of Efficacy|3|||
42253399|NCT03021265|76079357|FG000|Overall Study|Improved|17|||
42253400|NCT03021265|76079357|FG000|Overall Study|Lost to Follow-up|67|||
42253401|NCT03021265|76079357|FG000|Overall Study|No reason given|2|||
42253402|NCT03021265|76079357|FG000|Overall Study|No visit since the first visit|4|||
42253403|NCT04611789|76079364|FG000|Overall Study|Lost to Follow-up|1|||
42253404|NCT04611789|76079365|FG001|Overall Study|Lost to Follow-up|0|||
42253405|NCT04611789|76079366|FG002|Overall Study|Lost to Follow-up|0|||
42253406|NCT03561597|76079382|FG000|Overall Study|Lost to Follow-up|20|||
42253407|NCT03034967|76079405|FG000|Overall Study|Withdrawal by Subject|9|||
42309134|NCT02325739|76144904|FG005|Phase II Part|Progressive disease|0|||
42309135|NCT02325739|76144905|FG006|Phase II Part|Progressive disease|0|||
42309136|NCT02325739|76144906|FG007|Phase II Part|Progressive disease|0|||
42309137|NCT02325739|76144907|FG008|Phase II Part|Progressive disease|22|||
42309138|NCT02325739|76144908|FG009|Phase II Part|Progressive disease|29|||
42253408|NCT03034967|76079406|FG001|Overall Study|Withdrawal by Subject|2|||
42253409|NCT03034967|76079407|FG002|Overall Study|Withdrawal by Subject|6|||
42253410|NCT03034967|76079408|FG003|Overall Study|Withdrawal by Subject|6|||
42253411|NCT03034967|76079409|FG004|Overall Study|Withdrawal by Subject|9|||
42253412|NCT03034967|76079410|FG005|Overall Study|Withdrawal by Subject|2|||
42253413|NCT03034967|76079405|FG000|Overall Study|Physician Decision|1|||
42253414|NCT03034967|76079406|FG001|Overall Study|Physician Decision|0|||
42309139|NCT02325739|76144909|FG010|Phase II Part|Progressive disease|18|||
42309140|NCT02325739|76144899|FG000|Phase II Part|Subject/guardian decision|0|||
42309141|NCT02325739|76144900|FG001|Phase II Part|Subject/guardian decision|0|||
42309142|NCT02325739|76144901|FG002|Phase II Part|Subject/guardian decision|0|||
42309143|NCT02325739|76144902|FG003|Phase II Part|Subject/guardian decision|0|||
42309144|NCT02325739|76144903|FG004|Phase II Part|Subject/guardian decision|0|||
42309145|NCT02325739|76144904|FG005|Phase II Part|Subject/guardian decision|0|||
42309146|NCT02325739|76144905|FG006|Phase II Part|Subject/guardian decision|0|||
42309147|NCT02325739|76144906|FG007|Phase II Part|Subject/guardian decision|0|||
42309148|NCT02325739|76144907|FG008|Phase II Part|Subject/guardian decision|4|||
42309149|NCT02325739|76144908|FG009|Phase II Part|Subject/guardian decision|1|||
42309150|NCT02325739|76144909|FG010|Phase II Part|Subject/guardian decision|1|||
42309151|NCT01903720|76144954|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
42309152|NCT01903720|76144954|FG000|Overall Study|Adverse Event|1|||
41991818|NCT01212757|75800082|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
41991819|NCT01212757|75800083|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42010556|NCT00993421|75817700|FG006|Overall Study|Adverse Event|1|||
42309153|NCT01903720|76144954|FG000|Overall Study|Rescinding of informed consent|2|||
42309154|NCT01903720|76144954|FG000|Overall Study|Lost to Follow-up|2|||
42309155|NCT01903720|76144954|FG000|Overall Study|Treatment with alternative drug|1|||
42309156|NCT02366689|76144961|FG000|Overall Study|Withdrawal by Subject|1|||
42309157|NCT02366689|76144962|FG001|Overall Study|Withdrawal by Subject|0|||
42309158|NCT02366689|76144963|FG002|Overall Study|Withdrawal by Subject|1|||
42309159|NCT02366689|76144961|FG000|Overall Study|Lost to Follow-up|3|||
42309160|NCT02366689|76144962|FG001|Overall Study|Lost to Follow-up|2|||
42309161|NCT02366689|76144963|FG002|Overall Study|Lost to Follow-up|0|||
42309162|NCT02366689|76144961|FG000|Overall Study|Pregnancy|0|||
42309163|NCT02366689|76144962|FG001|Overall Study|Pregnancy|1|||
42309164|NCT02366689|76144963|FG002|Overall Study|Pregnancy|1|||
42309165|NCT01903252|76144973|FG000|Double-Blind Induction|Adverse Event|20|||
42309166|NCT01903252|76144974|FG001|Double-Blind Induction|Adverse Event|18|||
42309167|NCT01903252|76144975|FG002|Double-Blind Induction|Adverse Event|0|||
42309168|NCT01903252|76144976|FG003|Double-Blind Induction|Adverse Event|0|||
42309169|NCT01903252|76144977|FG004|Double-Blind Induction|Adverse Event|0|||
42309170|NCT01903252|76144978|FG005|Double-Blind Induction|Adverse Event|0|||
42309171|NCT01903252|76144973|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
42309172|NCT01903252|76144974|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
42309173|NCT01903252|76144975|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
42309174|NCT01903252|76144976|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
42309175|NCT01903252|76144977|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
42309176|NCT01903252|76144978|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
42309177|NCT01903252|76144973|FG000|Double-Blind Induction|Physician Decision|2|||
42309178|NCT01903252|76144974|FG001|Double-Blind Induction|Physician Decision|3|||
42309179|NCT01903252|76144975|FG002|Double-Blind Induction|Physician Decision|0|||
42309180|NCT01903252|76144976|FG003|Double-Blind Induction|Physician Decision|0|||
42309181|NCT01903252|76144977|FG004|Double-Blind Induction|Physician Decision|0|||
42309182|NCT01903252|76144978|FG005|Double-Blind Induction|Physician Decision|0|||
42309183|NCT01903252|76144973|FG000|Double-Blind Induction|non-compliance,|7|||
42309184|NCT01903252|76144974|FG001|Double-Blind Induction|non-compliance,|7|||
42309185|NCT01903252|76144975|FG002|Double-Blind Induction|non-compliance,|0|||
42309186|NCT01903252|76144976|FG003|Double-Blind Induction|non-compliance,|0|||
42309187|NCT01903252|76144977|FG004|Double-Blind Induction|non-compliance,|0|||
42309188|NCT01903252|76144978|FG005|Double-Blind Induction|non-compliance,|0|||
42309189|NCT01903252|76144973|FG000|Extended Induction, Open-Label|Adverse Event|0|||
42309190|NCT01903252|76144974|FG001|Extended Induction, Open-Label|Adverse Event|0|||
42309191|NCT01903252|76144975|FG002|Extended Induction, Open-Label|Adverse Event|17|||
42309192|NCT01903252|76144976|FG003|Extended Induction, Open-Label|Adverse Event|0|||
42309193|NCT01903252|76144977|FG004|Extended Induction, Open-Label|Adverse Event|0|||
42309194|NCT01903252|76144978|FG005|Extended Induction, Open-Label|Adverse Event|0|||
42309195|NCT01903252|76144973|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
42309196|NCT01903252|76144974|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
42309197|NCT01903252|76144975|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
42309198|NCT01903252|76144976|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
42309199|NCT01903252|76144977|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
42309200|NCT01903252|76144978|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
42309201|NCT01903252|76144973|FG000|Extended Induction, Open-Label|Physician Decision|0|||
42309202|NCT01903252|76144974|FG001|Extended Induction, Open-Label|Physician Decision|0|||
42309203|NCT01903252|76144975|FG002|Extended Induction, Open-Label|Physician Decision|1|||
42309204|NCT01903252|76144976|FG003|Extended Induction, Open-Label|Physician Decision|0|||
41991820|NCT01212757|75800084|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42309205|NCT01903252|76144977|FG004|Extended Induction, Open-Label|Physician Decision|0|||
42309206|NCT01903252|76144978|FG005|Extended Induction, Open-Label|Physician Decision|0|||
42309207|NCT01903252|76144973|FG000|Maintenance, Open-Label|Adverse Event|0|||
42309208|NCT01903252|76144974|FG001|Maintenance, Open-Label|Adverse Event|0|||
42309209|NCT01903252|76144975|FG002|Maintenance, Open-Label|Adverse Event|0|||
42309210|NCT01903252|76144976|FG003|Maintenance, Open-Label|Adverse Event|3|||
42309211|NCT01903252|76144977|FG004|Maintenance, Open-Label|Adverse Event|9|||
42309212|NCT01903252|76144978|FG005|Maintenance, Open-Label|Adverse Event|14|||
42309213|NCT01903252|76144973|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
42309214|NCT01903252|76144974|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
42309215|NCT01903252|76144975|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
42309216|NCT01903252|76144976|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
42309217|NCT01903252|76144977|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
42309218|NCT01903252|76144978|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
42309219|NCT01903252|76144973|FG000|Maintenance, Open-Label|Other|0|||
42309220|NCT01903252|76144974|FG001|Maintenance, Open-Label|Other|0|||
42309221|NCT01903252|76144975|FG002|Maintenance, Open-Label|Other|0|||
42309222|NCT01903252|76144976|FG003|Maintenance, Open-Label|Other|2|||
42309223|NCT01903252|76144977|FG004|Maintenance, Open-Label|Other|6|||
42309224|NCT01903252|76144978|FG005|Maintenance, Open-Label|Other|2|||
42309225|NCT01920958|76144996|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
42309226|NCT01613716|76145000|FG000|Overall Study|screen failures|3|||
42309227|NCT01613716|76145000|FG000|Overall Study|Lost to Follow-up|4|||
42309228|NCT01872910|76145010|FG000|Overall Study|Lost to Follow-up|2|||
42309229|NCT01872910|76145011|FG001|Overall Study|Lost to Follow-up|0|||
42309230|NCT01872910|76145012|FG002|Overall Study|Lost to Follow-up|2|||
42309231|NCT01872910|76145013|FG003|Overall Study|Lost to Follow-up|0|||
42309232|NCT01872910|76145014|FG004|Overall Study|Lost to Follow-up|0|||
42309233|NCT01872910|76145015|FG005|Overall Study|Lost to Follow-up|0|||
42309234|NCT01920568|76145030|FG000|Overall Study|Adverse Event|27|||
42309235|NCT01920568|76145031|FG001|Overall Study|Adverse Event|8|||
42309236|NCT01920568|76145030|FG000|Overall Study|Protocol Violation|5|||
42309237|NCT01920568|76145031|FG001|Overall Study|Protocol Violation|3|||
42309238|NCT01920568|76145030|FG000|Overall Study|Lost to Follow-up|2|||
42309239|NCT01920568|76145031|FG001|Overall Study|Lost to Follow-up|2|||
42309240|NCT01920568|76145030|FG000|Overall Study|Physician Decision|13|||
42309241|NCT01920568|76145031|FG001|Overall Study|Physician Decision|4|||
42309242|NCT01920568|76145030|FG000|Overall Study|Withdrawal by Subject|79|||
42309243|NCT01920568|76145031|FG001|Overall Study|Withdrawal by Subject|55|||
42309244|NCT01920568|76145030|FG000|Overall Study|Death due to disease progression|25|||
42309245|NCT01920568|76145031|FG001|Overall Study|Death due to disease progression|12|||
42309246|NCT01902628|76145038|FG000|Overall Study|Withdrawal of participant's consent|7|||
41991821|NCT01212757|75800085|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42309247|NCT01902628|76145038|FG000|Overall Study|Adverse Event|41|||
42309248|NCT01902628|76145038|FG000|Overall Study|Lost to Follow-up|35|||
42309249|NCT01920178|76145044|FG000|Overall Study|Lost to Follow-up|2|||
42309250|NCT01920178|76145045|FG001|Overall Study|Lost to Follow-up|1|||
42309251|NCT01901848|76145053|FG000|Randomized and Treated|Lost to Follow-up|3|||
42309252|NCT01901848|76145054|FG001|Randomized and Treated|Lost to Follow-up|6|||
42309253|NCT01901848|76145053|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
42309254|NCT01901848|76145054|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
42309255|NCT01901614|76145062|FG000|Overall Study|Adverse Event|0|||
42309256|NCT01901614|76145063|FG001|Overall Study|Adverse Event|1|||
42309257|NCT01901614|76145062|FG000|Overall Study|Lost to Follow-up|1|||
42309258|NCT01901614|76145063|FG001|Overall Study|Lost to Follow-up|0|||
42309259|NCT01901614|76145062|FG000|Overall Study|Screen Fail|1|||
42309260|NCT01901614|76145063|FG001|Overall Study|Screen Fail|0|||
42132919|NCT00411645|75943795|FG001|Overall Study|Consent Withdrawn|22|||
42132920|NCT00411645|75943794|FG000|Overall Study|Death|56|||
42132921|NCT00411645|75943795|FG001|Overall Study|Death|135|||
42132922|NCT00411645|75943794|FG000|Overall Study|Investigator/Sponsor Decision|10|||
42132923|NCT00411645|75943795|FG001|Overall Study|Investigator/Sponsor Decision|7|||
42132924|NCT00411645|75943794|FG000|Overall Study|Lost to Follow-up|2|||
42132925|NCT00411645|75943795|FG001|Overall Study|Lost to Follow-up|0|||
42132926|NCT00490724|75943805|FG000|Period I|Physician Decision|0|||
42309261|NCT01901302|76145071|FG000|Overall Study|Adverse Event|2|||
42309262|NCT01901302|76145072|FG001|Overall Study|Adverse Event|1|||
41991822|NCT01212757|75800086|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
41991823|NCT01212757|75800087|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
42309263|NCT01901302|76145071|FG000|Overall Study|Lack of Efficacy|0|||
42309264|NCT01901302|76145072|FG001|Overall Study|Lack of Efficacy|2|||
42309265|NCT01901302|76145071|FG000|Overall Study|Study Terminated by Sponsor|23|||
42309266|NCT01901302|76145072|FG001|Overall Study|Study Terminated by Sponsor|20|||
41991824|NCT01212757|75800079|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
41991825|NCT01212757|75800080|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
41991826|NCT01212757|75800081|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
41991827|NCT01212757|75800082|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
41991828|NCT01212757|75800083|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
41991829|NCT01212757|75800084|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
42309267|NCT01901302|76145071|FG000|Overall Study|Withdrawal by Subject|2|||
42309268|NCT01901302|76145072|FG001|Overall Study|Withdrawal by Subject|0|||
42309269|NCT01919398|76145081|FG000|Overall Study|Progressive Disease|0|||
42309270|NCT01919398|76145082|FG001|Overall Study|Progressive Disease|0|||
42309271|NCT01919398|76145083|FG002|Overall Study|Progressive Disease|4|||
42309272|NCT02500043|76145093|FG000|Overall Study|Randomized, but not Treated|2|||
42309273|NCT02500043|76145094|FG001|Overall Study|Randomized, but not Treated|2|||
42309274|NCT02500043|76145093|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
42309275|NCT02500043|76145094|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
42309276|NCT02500043|76145093|FG000|Overall Study|Adverse Event|33|||
42309277|NCT02500043|76145094|FG001|Overall Study|Adverse Event|11|||
42309278|NCT02500043|76145093|FG000|Overall Study|Clinical Progression|54|||
42309279|NCT02500043|76145094|FG001|Overall Study|Clinical Progression|35|||
42309280|NCT02500043|76145093|FG000|Overall Study|Radiological Progression|192|||
42309281|NCT02500043|76145094|FG001|Overall Study|Radiological Progression|110|||
41991830|NCT01212757|75800085|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
42033315|NCT01137071|75841483|FG000|Overall Study|Withdrawal by Subject|2|||
42132927|NCT00490724|75943806|FG001|Period I|Physician Decision|0|||
42132928|NCT00490724|75943807|FG002|Period I|Physician Decision|1|||
42309282|NCT02500043|76145093|FG000|Overall Study|Physician's Decision|11|||
42309283|NCT02500043|76145094|FG001|Overall Study|Physician's Decision|3|||
42309284|NCT02500043|76145093|FG000|Overall Study|Withdrawal by Subject|14|||
42309285|NCT02500043|76145094|FG001|Overall Study|Withdrawal by Subject|4|||
42309286|NCT02500043|76145093|FG000|Overall Study|Death|11|||
42309287|NCT02500043|76145094|FG001|Overall Study|Death|2|||
42309288|NCT02500043|76145093|FG000|Overall Study|Protocol Deviation|1|||
42309289|NCT02500043|76145094|FG001|Overall Study|Protocol Deviation|0|||
42309290|NCT02499575|76145102|FG000|Overall Study|Protocol Violation|0|||
42309291|NCT02499575|76145103|FG001|Overall Study|Protocol Violation|1|||
42309292|NCT02065791|76145111|FG000|Overall Study|Closed Site|1|||
42309293|NCT02065791|76145112|FG001|Overall Study|Closed Site|1|||
42309294|NCT02065791|76145111|FG000|Overall Study|Withdrawal by Subject|11|||
42309295|NCT02065791|76145112|FG001|Overall Study|Withdrawal by Subject|5|||
42309296|NCT02065791|76145111|FG000|Overall Study|Lost to Follow-up|13|||
42309297|NCT02065791|76145112|FG001|Overall Study|Lost to Follow-up|9|||
42309298|NCT02499263|76145118|FG000|Overall Study|Lost to Follow-up|9|||
42309299|NCT02499263|76145118|FG000|Overall Study|Participant's withdrawal of consent|4|||
42309300|NCT02499263|76145118|FG000|Overall Study|Lack of Efficacy|22|||
42309301|NCT02499263|76145118|FG000|Overall Study|investigator's judgment|12|||
42309302|NCT02499263|76145118|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
42309303|NCT02499263|76145118|FG000|Overall Study|Participant's decision|3|||
41991831|NCT01212757|75800086|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
41991832|NCT01212757|75800087|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
41991833|NCT01212757|75800079|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
42309304|NCT02499263|76145118|FG000|Overall Study|Pregnancy|1|||
42309305|NCT01654289|76145125|FG000|Overall Study|Withdrawal by Subject|10|||
42309306|NCT01654289|76145126|FG001|Overall Study|Withdrawal by Subject|8|||
42309307|NCT01654289|76145127|FG002|Overall Study|Withdrawal by Subject|5|||
42309308|NCT01654289|76145125|FG000|Overall Study|Withdrew from intervention only|17|||
42309309|NCT01654289|76145126|FG001|Overall Study|Withdrew from intervention only|20|||
42309310|NCT01654289|76145127|FG002|Overall Study|Withdrew from intervention only|0|||
42309311|NCT02499029|76145137|FG000|Overall Study|Lost to Follow-up|2|||
42309312|NCT02499029|76145138|FG001|Overall Study|Lost to Follow-up|2|||
42309313|NCT02499029|76145137|FG000|Overall Study|Physician Decision|2|||
42309314|NCT02499029|76145138|FG001|Overall Study|Physician Decision|1|||
42309315|NCT02499029|76145137|FG000|Overall Study|Death|1|||
42309316|NCT02499029|76145138|FG001|Overall Study|Death|0|||
42309317|NCT04968353|76145148|FG000|Overall Study|Non-compliance|1|||
42309318|NCT04968353|76145149|FG001|Overall Study|Non-compliance|0|||
41991834|NCT01212757|75800080|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
41991835|NCT01212757|75800081|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
41991836|NCT01212757|75800082|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
41991837|NCT01212757|75800083|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
41991838|NCT01212757|75800084|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
41991839|NCT01212757|75800085|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
41991840|NCT01212757|75800086|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
41991841|NCT01212757|75800087|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42033316|NCT01137071|75841483|FG000|Overall Study|Wrongly Included|1|||
42253415|NCT03034967|76079407|FG002|Overall Study|Physician Decision|1|||
42253416|NCT03034967|76079408|FG003|Overall Study|Physician Decision|1|||
42253417|NCT03034967|76079409|FG004|Overall Study|Physician Decision|1|||
42253418|NCT03034967|76079410|FG005|Overall Study|Physician Decision|0|||
42253419|NCT03034967|76079405|FG000|Overall Study|Lost to Follow-up|0|||
42253420|NCT03034967|76079406|FG001|Overall Study|Lost to Follow-up|0|||
42253421|NCT03034967|76079407|FG002|Overall Study|Lost to Follow-up|0|||
42253422|NCT03034967|76079408|FG003|Overall Study|Lost to Follow-up|1|||
42253423|NCT03034967|76079409|FG004|Overall Study|Lost to Follow-up|0|||
42253424|NCT03034967|76079410|FG005|Overall Study|Lost to Follow-up|2|||
42253425|NCT03034967|76079405|FG000|Overall Study|Liver function test abnormality|0|||
42253426|NCT03034967|76079406|FG001|Overall Study|Liver function test abnormality|0|||
42253427|NCT03034967|76079407|FG002|Overall Study|Liver function test abnormality|1|||
42253428|NCT03034967|76079408|FG003|Overall Study|Liver function test abnormality|0|||
42309319|NCT04968353|76145150|FG002|Overall Study|Non-compliance|2|||
42253429|NCT03034967|76079409|FG004|Overall Study|Liver function test abnormality|0|||
42309320|NCT04968353|76145151|FG003|Overall Study|Non-compliance|0|||
42309321|NCT02065713|76145163|FG000|Overall Study|Adverse Event|0|||
42253430|NCT03034967|76079410|FG005|Overall Study|Liver function test abnormality|0|||
42253431|NCT03034967|76079405|FG000|Overall Study|Protocol Violation|1|||
42309322|NCT02065713|76145164|FG001|Overall Study|Adverse Event|1|||
42309323|NCT02065713|76145163|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42309324|NCT02065713|76145164|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42309325|NCT02497781|76145172|FG000|Overall Study|Withdrawal by Subject|2|||
42309326|NCT02497781|76145173|FG001|Overall Study|Withdrawal by Subject|0|||
42309327|NCT02497781|76145172|FG000|Overall Study|Lack of Efficacy|0|||
42309328|NCT02497781|76145173|FG001|Overall Study|Lack of Efficacy|1|||
42309329|NCT02497781|76145172|FG000|Overall Study|Randomised but not treated|1|||
42309330|NCT02497781|76145173|FG001|Overall Study|Randomised but not treated|1|||
42309331|NCT02497781|76145172|FG000|Overall Study|Lost to Follow-up|1|||
42309332|NCT02497781|76145173|FG001|Overall Study|Lost to Follow-up|1|||
42309333|NCT02497469|76145181|FG000|Overall Study|Randomized but not Treated|0|||
42309334|NCT02497469|76145182|FG001|Overall Study|Randomized but not Treated|2|||
42309335|NCT02497469|76145181|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
42309336|NCT02497469|76145182|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
42309337|NCT02497469|76145181|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
42309338|NCT02497469|76145182|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
42309339|NCT02497469|76145181|FG000|Overall Study|Significant Protocol Deviation|4|||
42309340|NCT02497469|76145182|FG001|Overall Study|Significant Protocol Deviation|5|||
42309341|NCT02497469|76145181|FG000|Overall Study|Lost to Follow-up|14|||
42309342|NCT02497469|76145182|FG001|Overall Study|Lost to Follow-up|4|||
42309343|NCT02497469|76145181|FG000|Overall Study|Voluntary Withdrawal|39|||
42309344|NCT02497469|76145182|FG001|Overall Study|Voluntary Withdrawal|41|||
42309345|NCT02497469|76145181|FG000|Overall Study|Pregnancy|1|||
42309346|NCT02497469|76145182|FG001|Overall Study|Pregnancy|1|||
42309347|NCT02497469|76145181|FG000|Overall Study|Lack of Efficacy|86|||
42309348|NCT02497469|76145182|FG001|Overall Study|Lack of Efficacy|40|||
42309349|NCT02497469|76145181|FG000|Overall Study|Reason not Specified|6|||
42309350|NCT02497469|76145182|FG001|Overall Study|Reason not Specified|6|||
42309351|NCT02497391|76145188|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
42309352|NCT02497391|76145189|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
42253432|NCT03034967|76079406|FG001|Overall Study|Protocol Violation|0|||
42033317|NCT00860743|75841498|FG000|Overall Study|Withdrawal by Subject|3|||
42253433|NCT03034967|76079407|FG002|Overall Study|Protocol Violation|0|||
42253434|NCT03034967|76079408|FG003|Overall Study|Protocol Violation|0|||
42253435|NCT03034967|76079409|FG004|Overall Study|Protocol Violation|0|||
42253436|NCT03034967|76079410|FG005|Overall Study|Protocol Violation|2|||
42253437|NCT03034967|76079405|FG000|Overall Study|Lack of Efficacy|0|||
42253438|NCT03034967|76079406|FG001|Overall Study|Lack of Efficacy|1|||
42253439|NCT03034967|76079407|FG002|Overall Study|Lack of Efficacy|2|||
42253440|NCT03034967|76079408|FG003|Overall Study|Lack of Efficacy|1|||
42253441|NCT03034967|76079409|FG004|Overall Study|Lack of Efficacy|1|||
42253442|NCT03034967|76079410|FG005|Overall Study|Lack of Efficacy|0|||
42253443|NCT03034967|76079405|FG000|Overall Study|Adverse Event, non-fatal|3|||
42253444|NCT03034967|76079406|FG001|Overall Study|Adverse Event, non-fatal|1|||
42309353|NCT02497391|76145190|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
42309354|NCT02497391|76145191|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
42253445|NCT03034967|76079407|FG002|Overall Study|Adverse Event, non-fatal|2|||
42309355|NCT02497391|76145192|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
42309356|NCT02497391|76145193|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
42309357|NCT02497391|76145188|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
42309358|NCT02497391|76145189|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
42309359|NCT02497391|76145190|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
41991842|NCT01212757|75800079|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42132929|NCT00490724|75943805|FG000|Period II|Treatment Discontinuation|3|||
42132930|NCT00490724|75943806|FG001|Period II|Treatment Discontinuation|1|||
42132931|NCT00490724|75943807|FG002|Period II|Treatment Discontinuation|3|||
42132932|NCT03835221|75943815|FG000|Methafilcon A|Withdrawal by Subject|1|||
42132933|NCT00398073|75943823|FG000|Overall Study|Withdrawal by Subject|1|||
42132934|NCT00398073|75943824|FG001|Overall Study|Withdrawal by Subject|0|||
42132935|NCT00490646|75943832|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
42132936|NCT00490646|75943833|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
42132937|NCT00490646|75943832|FG000|Overall Study|Never Treated (had an adverse event)|1|||
42132938|NCT00490646|75943833|FG001|Overall Study|Never Treated (had an adverse event)|0|||
42132939|NCT00490646|75943832|FG000|Overall Study|Never Treated (withdrew consent)|0|||
41991843|NCT01212757|75800080|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
41991844|NCT01212757|75800081|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
41991845|NCT01212757|75800082|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
41991846|NCT01212757|75800083|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
41991847|NCT01212757|75800084|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
41991848|NCT01212757|75800085|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
42132940|NCT00490646|75943833|FG001|Overall Study|Never Treated (withdrew consent)|1|||
42132941|NCT00388947|75943839|FG000|Overall Study|Protocol Violation|47|||
42132942|NCT00490568|75943843|FG000|Overall Study|Adverse Event|116|||
42132943|NCT00490568|75943843|FG000|Overall Study|Lost to Follow-up|13|||
42253446|NCT03034967|76079408|FG003|Overall Study|Adverse Event, non-fatal|0|||
42253447|NCT03034967|76079409|FG004|Overall Study|Adverse Event, non-fatal|2|||
42253448|NCT03034967|76079410|FG005|Overall Study|Adverse Event, non-fatal|8|||
41991849|NCT01212757|75800086|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
41991850|NCT01212757|75800087|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
41991851|NCT01212757|75800079|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
41991852|NCT01212757|75800080|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
41991853|NCT01212757|75800081|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
42132944|NCT00490568|75943843|FG000|Overall Study|Protocol Violation|45|||
42253449|NCT03034967|76079405|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
42132945|NCT00490568|75943843|FG000|Overall Study|Withdrawal by Subject|135|||
42033318|NCT00860743|75841499|FG001|Overall Study|Withdrawal by Subject|0|||
42132946|NCT00490568|75943843|FG000|Overall Study|Still in the study at termination|974|||
42132947|NCT00490568|75943843|FG000|Overall Study|Other|1|||
42132948|NCT00490568|75943843|FG000|Overall Study|Exclusion criteria met|1|||
42309360|NCT02497391|76145191|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
42309361|NCT02497391|76145192|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
42309362|NCT02497391|76145193|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
42309363|NCT02497391|76145188|FG000|Period 3 (14 Days)|Adverse Event|0|||
42309364|NCT02497391|76145189|FG001|Period 3 (14 Days)|Adverse Event|1|||
42309365|NCT02497391|76145190|FG002|Period 3 (14 Days)|Adverse Event|0|||
42309366|NCT02497391|76145191|FG003|Period 3 (14 Days)|Adverse Event|0|||
42309367|NCT02497391|76145192|FG004|Period 3 (14 Days)|Adverse Event|0|||
42309368|NCT02497391|76145193|FG005|Period 3 (14 Days)|Adverse Event|0|||
42309369|NCT02497391|76145188|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
42309370|NCT02497391|76145189|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
42309371|NCT02497391|76145190|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
42309372|NCT02497391|76145191|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
42309373|NCT02497391|76145192|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
41991854|NCT01212757|75800082|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
41991855|NCT01212757|75800083|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
41991856|NCT01212757|75800084|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
41991857|NCT01212757|75800085|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
41991858|NCT01212757|75800086|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
41991859|NCT01212757|75800087|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
41991860|NCT01212757|75800079|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
41991861|NCT01212757|75800080|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
41991862|NCT01212757|75800081|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
41991863|NCT01212757|75800082|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
42253450|NCT03034967|76079406|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
42253451|NCT03034967|76079407|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
42253452|NCT03034967|76079408|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
42253453|NCT03034967|76079409|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
42253454|NCT03034967|76079410|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
42253455|NCT03021187|76079433|FG000|Overall Study|Death|0|||
42253456|NCT03021187|76079434|FG001|Overall Study|Death|0|||
42253457|NCT03021187|76079435|FG002|Overall Study|Death|3|||
42253458|NCT03021187|76079436|FG003|Overall Study|Death|0|||
42253459|NCT03021187|76079433|FG000|Overall Study|Withdrawal by Subject|0|||
42253460|NCT03021187|76079434|FG001|Overall Study|Withdrawal by Subject|6|||
42253461|NCT03021187|76079435|FG002|Overall Study|Withdrawal by Subject|2|||
42253462|NCT03021187|76079436|FG003|Overall Study|Withdrawal by Subject|5|||
42253463|NCT03021187|76079433|FG000|Overall Study|Lost to Follow-up|10|||
42253464|NCT03021187|76079434|FG001|Overall Study|Lost to Follow-up|3|||
42253465|NCT03021187|76079435|FG002|Overall Study|Lost to Follow-up|1|||
42253466|NCT03021187|76079436|FG003|Overall Study|Lost to Follow-up|4|||
42253467|NCT04766333|76079448|FG000|Overall Study|Lost to Follow-up|40|||
42253468|NCT04766333|76079449|FG001|Overall Study|Lost to Follow-up|826|||
42253469|NCT03020641|76079457|FG000|Overall Study|Lost to Follow-up|0|||
42253470|NCT03020641|76079458|FG001|Overall Study|Lost to Follow-up|1|||
42253471|NCT03020641|76079457|FG000|Overall Study|Converted to open surgery|2|||
42253472|NCT03020641|76079458|FG001|Overall Study|Converted to open surgery|1|||
42253473|NCT03020641|76079457|FG000|Overall Study|for surgery not performed|0|||
42253474|NCT03020641|76079458|FG001|Overall Study|for surgery not performed|1|||
42253475|NCT03020407|76079469|FG000|Overall Study|Withdrawal by Subject|2|||
42253476|NCT03020407|76079470|FG001|Overall Study|Withdrawal by Subject|1|||
42253477|NCT03020407|76079469|FG000|Overall Study|Lost to Follow-up|2|||
42253478|NCT03020407|76079470|FG001|Overall Study|Lost to Follow-up|3|||
42253479|NCT03020407|76079469|FG000|Overall Study|Protocol Violation|0|||
42253480|NCT03020407|76079470|FG001|Overall Study|Protocol Violation|1|||
42253481|NCT02536846|76079476|FG000|Overall Study|Withdrawal by Subject|1|||
42253482|NCT03014011|76079481|FG000|First Intervention|Withdrawal by Subject|1|||
42253483|NCT03014011|76079482|FG001|First Intervention|Withdrawal by Subject|0|||
42253484|NCT03014011|76079481|FG000|Washout|Withdrawal by Subject|1|||
42253485|NCT03014011|76079482|FG001|Washout|Withdrawal by Subject|0|||
42253486|NCT03012841|76079488|FG000|Overall Study|Protocol Violation|0|||
42253487|NCT03012841|76079489|FG001|Overall Study|Protocol Violation|10|||
42253488|NCT03012841|76079488|FG000|Overall Study|Lost to Follow-up|6|||
42253489|NCT03012841|76079489|FG001|Overall Study|Lost to Follow-up|1|||
42253490|NCT03012841|76079488|FG000|Overall Study|Withdrawal by Subject|6|||
42132949|NCT00490568|75943843|FG000|Overall Study|Caregiver related|20|||
42253491|NCT03012841|76079489|FG001|Overall Study|Withdrawal by Subject|0|||
42253492|NCT03012841|76079488|FG000|Overall Study|Unable to complete 12 month visit|6|||
42253493|NCT03012841|76079489|FG001|Overall Study|Unable to complete 12 month visit|0|||
42253494|NCT03012841|76079488|FG000|Overall Study|Subject relocation|1|||
42309374|NCT02497391|76145193|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
42309375|NCT02497391|76145188|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
42309376|NCT02497391|76145189|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
42309377|NCT02497391|76145190|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
41991864|NCT01212757|75800083|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
41991865|NCT01212757|75800084|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
41991866|NCT01212757|75800085|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
41991867|NCT01212757|75800086|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
41991868|NCT01212757|75800087|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
41991869|NCT01212757|75800079|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
42309378|NCT02497391|76145191|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
42309379|NCT02497391|76145192|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
42309380|NCT02497391|76145193|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
42309381|NCT02476175|76145201|FG000|Overall Study|Adverse Event|2|||
42309382|NCT02065557|76145208|FG000|Induction Period|Withdrawal by Subject|2|||
42309383|NCT02065557|76145209|FG001|Induction Period|Withdrawal by Subject|1|||
42309384|NCT02065557|76145210|FG002|Induction Period|Withdrawal by Subject|0|||
42309385|NCT02065557|76145211|FG003|Induction Period|Withdrawal by Subject|0|||
42309386|NCT02065557|76145212|FG004|Induction Period|Withdrawal by Subject|0|||
42309387|NCT02065557|76145213|FG005|Induction Period|Withdrawal by Subject|0|||
42309388|NCT02065557|76145208|FG000|Induction Period|Lack of Efficacy|2|||
42309389|NCT02065557|76145209|FG001|Induction Period|Lack of Efficacy|1|||
42309390|NCT02065557|76145210|FG002|Induction Period|Lack of Efficacy|1|||
42309391|NCT02065557|76145211|FG003|Induction Period|Lack of Efficacy|0|||
42309392|NCT02065557|76145212|FG004|Induction Period|Lack of Efficacy|0|||
42309393|NCT02065557|76145213|FG005|Induction Period|Lack of Efficacy|0|||
42309394|NCT02065557|76145208|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
42309395|NCT02065557|76145209|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
42309396|NCT02065557|76145210|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
42309397|NCT02065557|76145211|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
42309398|NCT02065557|76145212|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
42309399|NCT02065557|76145213|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
42309400|NCT02065557|76145208|FG000|Induction Period|Non-Responder at Week 8|4|||
42309401|NCT02065557|76145209|FG001|Induction Period|Non-Responder at Week 8|4|||
42309402|NCT02065557|76145210|FG002|Induction Period|Non-Responder at Week 8|0|||
42309403|NCT02065557|76145211|FG003|Induction Period|Non-Responder at Week 8|0|||
42309404|NCT02065557|76145212|FG004|Induction Period|Non-Responder at Week 8|0|||
42309405|NCT02065557|76145213|FG005|Induction Period|Non-Responder at Week 8|0|||
41991870|NCT01212757|75800080|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
41991871|NCT01212757|75800081|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
42309406|NCT02065557|76145208|FG000|Induction Period|Adverse Event|1|||
42309407|NCT02065557|76145209|FG001|Induction Period|Adverse Event|1|||
42309408|NCT02065557|76145210|FG002|Induction Period|Adverse Event|0|||
42309409|NCT02065557|76145211|FG003|Induction Period|Adverse Event|0|||
42309410|NCT02065557|76145212|FG004|Induction Period|Adverse Event|0|||
42309411|NCT02065557|76145213|FG005|Induction Period|Adverse Event|0|||
42309412|NCT02065557|76145208|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
42309413|NCT02065557|76145209|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
42309414|NCT02065557|76145210|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
42309415|NCT02065557|76145211|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
42309416|NCT02065557|76145212|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
42309417|NCT02065557|76145213|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
41991872|NCT01212757|75800082|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
41991873|NCT01212757|75800083|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
42309418|NCT02065557|76145208|FG000|Maintenance Period|Withdrawal by Subject|0|||
42309419|NCT02065557|76145209|FG001|Maintenance Period|Withdrawal by Subject|0|||
42309420|NCT02065557|76145210|FG002|Maintenance Period|Withdrawal by Subject|0|||
42309421|NCT02065557|76145211|FG003|Maintenance Period|Withdrawal by Subject|0|||
42309422|NCT02065557|76145212|FG004|Maintenance Period|Withdrawal by Subject|2|||
42309423|NCT02065557|76145213|FG005|Maintenance Period|Withdrawal by Subject|1|||
42309424|NCT02065557|76145208|FG000|Maintenance Period|Lack of Efficacy|0|||
42309425|NCT02065557|76145209|FG001|Maintenance Period|Lack of Efficacy|0|||
41991874|NCT01212757|75800084|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
41991875|NCT01212757|75800085|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
41991876|NCT01212757|75800086|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
42309426|NCT02065557|76145210|FG002|Maintenance Period|Lack of Efficacy|0|||
41991877|NCT01212757|75800087|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
42010557|NCT00993421|75817694|FG000|Overall Study|Sponsor Decision|36|||
42033319|NCT01186796|75841507|FG000|Overall Study|Adverse Event|3|||
42309427|NCT02065557|76145211|FG003|Maintenance Period|Lack of Efficacy|0|||
42309428|NCT02065557|76145212|FG004|Maintenance Period|Lack of Efficacy|5|||
42309429|NCT02065557|76145213|FG005|Maintenance Period|Lack of Efficacy|2|||
42309430|NCT02065557|76145208|FG000|Maintenance Period|Subject Non-Compliance|0|||
41991878|NCT01212757|75800079|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
41991879|NCT01212757|75800080|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
41991880|NCT01212757|75800081|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
41991881|NCT01212757|75800082|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
41991882|NCT01212757|75800083|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
41991883|NCT01212757|75800084|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
41991884|NCT01212757|75800085|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
41991885|NCT01212757|75800086|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
41991886|NCT01212757|75800087|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
41991887|NCT01212757|75800079|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
41991888|NCT01212757|75800080|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
42309431|NCT02065557|76145209|FG001|Maintenance Period|Subject Non-Compliance|0|||
42309432|NCT02065557|76145210|FG002|Maintenance Period|Subject Non-Compliance|0|||
42309433|NCT02065557|76145211|FG003|Maintenance Period|Subject Non-Compliance|0|||
41991889|NCT01212757|75800081|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
41991890|NCT01212757|75800082|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
41991891|NCT01212757|75800083|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
41991892|NCT01212757|75800084|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
41991893|NCT01212757|75800085|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
41991894|NCT01212757|75800086|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
41991895|NCT01212757|75800087|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
41991896|NCT01212757|75800079|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
41991897|NCT01212757|75800080|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
41991898|NCT01212757|75800081|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
41991899|NCT01212757|75800082|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
42253495|NCT03012841|76079489|FG001|Overall Study|Subject relocation|0|||
42253496|NCT03012841|76079488|FG000|Overall Study|Seasonal winter travel|1|||
42253497|NCT03012841|76079489|FG001|Overall Study|Seasonal winter travel|0|||
42309434|NCT02065557|76145212|FG004|Maintenance Period|Subject Non-Compliance|0|||
42309435|NCT02065557|76145213|FG005|Maintenance Period|Subject Non-Compliance|1|||
42309436|NCT02065245|76145245|FG000|Infusion 1|Lost to Follow-up|0|||
42309437|NCT02065245|76145246|FG001|Infusion 1|Lost to Follow-up|0|||
42309438|NCT02065245|76145247|FG002|Infusion 1|Lost to Follow-up|0|||
42309439|NCT02065245|76145248|FG003|Infusion 1|Lost to Follow-up|0|||
42309440|NCT02065245|76145249|FG004|Infusion 1|Lost to Follow-up|0|||
42309441|NCT02065245|76145250|FG005|Infusion 1|Lost to Follow-up|0|||
42253498|NCT03012841|76079488|FG000|Overall Study|Physician Decision|0|||
42253499|NCT03012841|76079489|FG001|Overall Study|Physician Decision|2|||
42253500|NCT03012841|76079488|FG000|Overall Study|No ablation performed|0|||
42309442|NCT02065245|76145251|FG006|Infusion 1|Lost to Follow-up|1|||
42309443|NCT02065245|76145245|FG000|Infusion 1|Death|0|||
42309444|NCT02065245|76145246|FG001|Infusion 1|Death|0|||
42309445|NCT02065245|76145247|FG002|Infusion 1|Death|1|||
42309446|NCT02065245|76145248|FG003|Infusion 1|Death|0|||
42309447|NCT02065245|76145249|FG004|Infusion 1|Death|1|||
42309448|NCT02065245|76145250|FG005|Infusion 1|Death|0|||
42309449|NCT02065245|76145251|FG006|Infusion 1|Death|0|||
42309450|NCT02065245|76145245|FG000|Infusion 2|Death|0|||
42309451|NCT02065245|76145246|FG001|Infusion 2|Death|0|||
42309452|NCT02065245|76145247|FG002|Infusion 2|Death|0|||
42309453|NCT02065245|76145248|FG003|Infusion 2|Death|0|||
42309454|NCT02065245|76145249|FG004|Infusion 2|Death|0|||
42253501|NCT03012841|76079489|FG001|Overall Study|No ablation performed|2|||
42253502|NCT03012841|76079488|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
42253503|NCT03012841|76079489|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
42253504|NCT03012841|76079488|FG000|Overall Study|Insurance change|0|||
42253505|NCT03012841|76079489|FG001|Overall Study|Insurance change|1|||
42309455|NCT02065245|76145250|FG005|Infusion 2|Death|0|||
42309456|NCT02065245|76145251|FG006|Infusion 2|Death|1|||
42309457|NCT02065245|76145245|FG000|Infusion 3|Lost to Follow-up|1|||
42309458|NCT02065245|76145246|FG001|Infusion 3|Lost to Follow-up|1|||
42309459|NCT02065245|76145247|FG002|Infusion 3|Lost to Follow-up|0|||
42309460|NCT02065245|76145248|FG003|Infusion 3|Lost to Follow-up|0|||
42309461|NCT02065245|76145249|FG004|Infusion 3|Lost to Follow-up|0|||
42309462|NCT02065245|76145250|FG005|Infusion 3|Lost to Follow-up|0|||
42309463|NCT02065245|76145251|FG006|Infusion 3|Lost to Follow-up|0|||
42309464|NCT02043015|76145267|FG000|Overall Study|Lost to Follow-up|4|||
42309465|NCT02043015|76145267|FG000|Overall Study|Withdrawal by Subject|4|||
42309466|NCT02043015|76145267|FG000|Overall Study|Removed once target enrollment reached|15|||
42309467|NCT02043015|76145267|FG000|Overall Study|Participant moved away from study city|4|||
42309468|NCT02043015|76145267|FG000|Overall Study|Incarceration|1|||
42309469|NCT02064231|76145273|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
42309470|NCT02064231|76145274|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
42309471|NCT02064231|76145275|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
42309472|NCT02064231|76145276|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
41991900|NCT01212757|75800083|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
42309473|NCT02064231|76145273|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
42309474|NCT02064231|76145274|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
42309475|NCT02064231|76145275|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
42309476|NCT02064231|76145276|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
42309477|NCT02064231|76145273|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
42309478|NCT02064231|76145274|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
41991901|NCT01212757|75800084|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
41991902|NCT01212757|75800085|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
42309479|NCT02064231|76145275|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
42309480|NCT02064231|76145276|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
42309481|NCT02064231|76145273|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
42309482|NCT02064231|76145274|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
42309483|NCT02064231|76145275|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
42309484|NCT02064231|76145276|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
42309485|NCT02063217|76145291|FG000|Overall Study|Withdrawal by Subject|1|||
42309486|NCT02063217|76145292|FG001|Overall Study|Withdrawal by Subject|0|||
42309487|NCT02063217|76145293|FG002|Overall Study|Withdrawal by Subject|0|||
42309488|NCT02497001|76145305|FG000|Overall Study|Lost to Follow-up|10|||
42309489|NCT02497001|76145306|FG001|Overall Study|Lost to Follow-up|2|||
42309490|NCT02497001|76145307|FG002|Overall Study|Lost to Follow-up|0|||
42309491|NCT02497001|76145308|FG003|Overall Study|Lost to Follow-up|2|||
42309492|NCT02497001|76145305|FG000|Overall Study|Adverse Event|28|||
42309493|NCT02497001|76145306|FG001|Overall Study|Adverse Event|30|||
42309494|NCT02497001|76145307|FG002|Overall Study|Adverse Event|11|||
42309495|NCT02497001|76145308|FG003|Overall Study|Adverse Event|11|||
42309496|NCT02497001|76145305|FG000|Overall Study|Withdrawal by Subject|14|||
42309497|NCT02497001|76145306|FG001|Overall Study|Withdrawal by Subject|37|||
41991903|NCT01212757|75800086|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
41991904|NCT01212757|75800087|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
41991905|NCT01212757|75800079|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
41991906|NCT01212757|75800080|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
41991907|NCT01212757|75800081|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
42309498|NCT02497001|76145307|FG002|Overall Study|Withdrawal by Subject|19|||
42309499|NCT02497001|76145308|FG003|Overall Study|Withdrawal by Subject|15|||
42309500|NCT02497001|76145305|FG000|Overall Study|Physician Decision|5|||
42309501|NCT02497001|76145306|FG001|Overall Study|Physician Decision|11|||
42309502|NCT02497001|76145307|FG002|Overall Study|Physician Decision|5|||
42309503|NCT02497001|76145308|FG003|Overall Study|Physician Decision|1|||
42309504|NCT02497001|76145305|FG000|Overall Study|subjects that were not treated|1|||
41991908|NCT01212757|75800082|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
41991909|NCT01212757|75800083|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
42309505|NCT02497001|76145306|FG001|Overall Study|subjects that were not treated|2|||
42309506|NCT02497001|76145307|FG002|Overall Study|subjects that were not treated|2|||
42309507|NCT02497001|76145308|FG003|Overall Study|subjects that were not treated|1|||
42309508|NCT02497001|76145305|FG000|Overall Study|Major Protocol Deviation|3|||
41991910|NCT01212757|75800084|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
41991911|NCT01212757|75800085|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
41991912|NCT01212757|75800086|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
41991913|NCT01212757|75800087|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
41991914|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
41991915|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
41991916|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
41991917|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
41991918|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
42253506|NCT02359864|76079496|FG000|Overall Study|Withdrawal by Subject|1|||
42253507|NCT02359864|76079497|FG001|Overall Study|Withdrawal by Subject|0|||
42253508|NCT02533258|76079503|FG000|Overall Study|Adverse Event|1|||
42253509|NCT02533258|76079503|FG000|Overall Study|Death|2|||
42253510|NCT02533258|76079503|FG000|Overall Study|Other|1|||
42253511|NCT02533258|76079503|FG000|Overall Study|Economic factor|1|||
42253512|NCT02533258|76079503|FG000|Overall Study|Progression of pleural effusion|1|||
42253513|NCT02533258|76079503|FG000|Overall Study|Lack of Efficacy|2|||
42309509|NCT02497001|76145306|FG001|Overall Study|Major Protocol Deviation|4|||
42309510|NCT02497001|76145307|FG002|Overall Study|Major Protocol Deviation|4|||
42309511|NCT02497001|76145308|FG003|Overall Study|Major Protocol Deviation|4|||
42253514|NCT03019627|76079522|FG000|Overall Study|Adverse Event|8|||
42309512|NCT02497001|76145305|FG000|Overall Study|Lack of Efficacy|10|||
42309513|NCT02497001|76145306|FG001|Overall Study|Lack of Efficacy|16|||
42309514|NCT02497001|76145307|FG002|Overall Study|Lack of Efficacy|6|||
42309515|NCT02497001|76145308|FG003|Overall Study|Lack of Efficacy|6|||
42309516|NCT02497001|76145305|FG000|Overall Study|Protocol Violation|3|||
42309517|NCT02497001|76145306|FG001|Overall Study|Protocol Violation|1|||
42309518|NCT02497001|76145307|FG002|Overall Study|Protocol Violation|3|||
42309519|NCT02497001|76145308|FG003|Overall Study|Protocol Violation|1|||
42309520|NCT02366143|76145324|FG000|Overall Study|Death|307|||
42309521|NCT02366143|76145325|FG001|Overall Study|Death|278|||
42309522|NCT02366143|76145326|FG002|Overall Study|Death|280|||
42309523|NCT02366143|76145324|FG000|Overall Study|Lost to Follow-up|2|||
42309524|NCT02366143|76145325|FG001|Overall Study|Lost to Follow-up|4|||
41991919|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
41991920|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
41991921|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
41991922|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
42309525|NCT02366143|76145326|FG002|Overall Study|Lost to Follow-up|2|||
42309526|NCT02366143|76145324|FG000|Overall Study|Physician Decision|1|||
42309527|NCT02366143|76145325|FG001|Overall Study|Physician Decision|2|||
42309528|NCT02366143|76145326|FG002|Overall Study|Physician Decision|1|||
42309529|NCT02366143|76145324|FG000|Overall Study|Protocol Violation|0|||
42309530|NCT02366143|76145325|FG001|Overall Study|Protocol Violation|0|||
42309531|NCT02366143|76145326|FG002|Overall Study|Protocol Violation|2|||
42309532|NCT02366143|76145324|FG000|Overall Study|Withdrawal by Subject|16|||
42309533|NCT02366143|76145325|FG001|Overall Study|Withdrawal by Subject|17|||
41991923|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
41991924|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
41991925|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
41991926|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
41991927|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
41991928|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
41991929|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
41991930|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
41991931|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
41991932|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
41991933|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
42033320|NCT01186796|75841508|FG001|Overall Study|Adverse Event|0|||
42033321|NCT01186796|75841507|FG000|Overall Study|Withdrawal by Subject|1|||
42033322|NCT01186796|75841508|FG001|Overall Study|Withdrawal by Subject|1|||
42253515|NCT03019627|76079523|FG001|Overall Study|Adverse Event|0|||
42253516|NCT03019627|76079522|FG000|Overall Study|Unrelated to adverse event|1|||
42253517|NCT03019627|76079523|FG001|Overall Study|Unrelated to adverse event|3|||
42253518|NCT03019627|76079522|FG000|Overall Study|Lost to Follow-up|2|||
42253519|NCT03019627|76079523|FG001|Overall Study|Lost to Follow-up|1|||
42253520|NCT03019627|76079522|FG000|Overall Study|not compliance|2|||
42253521|NCT03019627|76079523|FG001|Overall Study|not compliance|2|||
42253522|NCT03019627|76079522|FG000|Overall Study|Other|2|||
42253523|NCT03019627|76079523|FG001|Overall Study|Other|2|||
42253524|NCT01661140|76079529|FG000|Open-Label Period|Adverse Event|44|||
42253525|NCT01661140|76079530|FG001|Open-Label Period|Adverse Event|0|||
42253526|NCT01661140|76079531|FG002|Open-Label Period|Adverse Event|0|||
42253527|NCT01661140|76079529|FG000|Open-Label Period|Protocol Violation|3|||
42253528|NCT01661140|76079530|FG001|Open-Label Period|Protocol Violation|0|||
42253529|NCT01661140|76079531|FG002|Open-Label Period|Protocol Violation|0|||
42253530|NCT01661140|76079529|FG000|Open-Label Period|Withdrawal by Subject|5|||
42253531|NCT01661140|76079530|FG001|Open-Label Period|Withdrawal by Subject|0|||
42253532|NCT01661140|76079531|FG002|Open-Label Period|Withdrawal by Subject|0|||
42253533|NCT01661140|76079529|FG000|Open-Label Period|Investigator Decision|3|||
42253534|NCT01661140|76079530|FG001|Open-Label Period|Investigator Decision|0|||
42253535|NCT01661140|76079531|FG002|Open-Label Period|Investigator Decision|0|||
42253536|NCT01661140|76079529|FG000|Open-Label Period|Death|1|||
42253537|NCT01661140|76079530|FG001|Open-Label Period|Death|0|||
42253538|NCT01661140|76079531|FG002|Open-Label Period|Death|0|||
42253539|NCT01661140|76079529|FG000|Open-Label Period|Administrative/Other|1|||
42253540|NCT01661140|76079530|FG001|Open-Label Period|Administrative/Other|0|||
42309534|NCT02366143|76145326|FG002|Overall Study|Withdrawal by Subject|22|||
42309535|NCT02366143|76145324|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
42033323|NCT01186796|75841507|FG000|Overall Study|Protocol Violation|0|||
42253541|NCT01661140|76079531|FG002|Open-Label Period|Administrative/Other|0|||
42253542|NCT01661140|76079529|FG000|Open-Label Period|Sponsor termination|16|||
42033324|NCT01186796|75841508|FG001|Overall Study|Protocol Violation|1|||
42253543|NCT01661140|76079530|FG001|Open-Label Period|Sponsor termination|0|||
42309536|NCT02366143|76145325|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
42309537|NCT02366143|76145326|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
41991934|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
42253544|NCT01661140|76079531|FG002|Open-Label Period|Sponsor termination|0|||
42253545|NCT01661140|76079529|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
42253546|NCT01661140|76079530|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
42309538|NCT02366143|76145324|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
42309539|NCT02366143|76145325|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
42309540|NCT02366143|76145326|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
42309541|NCT02366143|76145324|FG000|Overall Study|Randomization Error|1|||
41991935|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
41991936|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
41991937|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
41991938|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
41991939|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
41991940|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
41991941|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
41991942|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
41991943|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
42309542|NCT02366143|76145325|FG001|Overall Study|Randomization Error|0|||
42309543|NCT02366143|76145326|FG002|Overall Study|Randomization Error|0|||
42309544|NCT02366143|76145324|FG000|Overall Study|PI Move and Site Closure|1|||
41991944|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
41991945|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
41991946|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
41991947|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
41991948|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
41991949|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
41991950|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
41991951|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
41991952|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
41991953|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
41991954|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
41991955|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
41991956|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
41991957|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
41991958|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
41991959|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
42253547|NCT01661140|76079531|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
42253548|NCT01661140|76079529|FG000|Open-Label Period|Lost to Follow-up|2|||
42253549|NCT01661140|76079530|FG001|Open-Label Period|Lost to Follow-up|0|||
41991960|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
41991961|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
41991962|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
41991963|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
41991964|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
41991965|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
41991966|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
41991967|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
41991968|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
42253550|NCT01661140|76079531|FG002|Open-Label Period|Lost to Follow-up|0|||
42253551|NCT01661140|76079529|FG000|Double-Blind Period|Refused Treatment|0|||
42253552|NCT01661140|76079530|FG001|Double-Blind Period|Refused Treatment|0|||
42253553|NCT01661140|76079531|FG002|Double-Blind Period|Refused Treatment|1|||
42253554|NCT01661140|76079529|FG000|Double-Blind Period|Adverse Event|0|||
42253555|NCT01661140|76079530|FG001|Double-Blind Period|Adverse Event|16|||
42253556|NCT01661140|76079531|FG002|Double-Blind Period|Adverse Event|18|||
42253557|NCT01661140|76079529|FG000|Double-Blind Period|Protocol Violation|0|||
42253558|NCT01661140|76079530|FG001|Double-Blind Period|Protocol Violation|2|||
42253559|NCT01661140|76079531|FG002|Double-Blind Period|Protocol Violation|3|||
42253560|NCT01661140|76079529|FG000|Double-Blind Period|Withdrawal by Subject|0|||
42253561|NCT01661140|76079530|FG001|Double-Blind Period|Withdrawal by Subject|1|||
42253562|NCT01661140|76079531|FG002|Double-Blind Period|Withdrawal by Subject|3|||
42253563|NCT01661140|76079529|FG000|Double-Blind Period|Investigator's Decision|0|||
42253564|NCT01661140|76079530|FG001|Double-Blind Period|Investigator's Decision|1|||
42253565|NCT01661140|76079531|FG002|Double-Blind Period|Investigator's Decision|2|||
42253566|NCT01661140|76079529|FG000|Double-Blind Period|Sponsor Termination|0|||
41991969|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
41991970|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
41991971|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
41991972|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
41991973|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
41991974|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
41991975|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
41991976|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
41991977|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
41991978|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
42309545|NCT02366143|76145325|FG001|Overall Study|PI Move and Site Closure|0|||
42309546|NCT02366143|76145326|FG002|Overall Study|PI Move and Site Closure|1|||
42309547|NCT02366143|76145324|FG000|Overall Study|Study Terminated By Sponsor|0|||
42309548|NCT02366143|76145325|FG001|Overall Study|Study Terminated By Sponsor|0|||
42309549|NCT02366143|76145326|FG002|Overall Study|Study Terminated By Sponsor|2|||
41991979|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
41991980|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
41991981|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
41991982|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
41991983|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
41991984|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
41991985|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
42033325|NCT01136915|75841516|FG000|Overall Study|Lost to Follow-up|2|||
42033326|NCT01136915|75841517|FG001|Overall Study|Lost to Follow-up|0|||
42033327|NCT01136915|75841516|FG000|Overall Study|Exclusion criterion met|0|||
42132950|NCT00490568|75943843|FG000|Overall Study|Abnormal ECG|25|||
42132951|NCT00490568|75943843|FG000|Overall Study|Participant refused follow-up|9|||
42253567|NCT01661140|76079530|FG001|Double-Blind Period|Sponsor Termination|14|||
42253568|NCT01661140|76079531|FG002|Double-Blind Period|Sponsor Termination|17|||
42253569|NCT01661140|76079529|FG000|Double-Blind Period|Administrative/Other|0|||
42253570|NCT01661140|76079530|FG001|Double-Blind Period|Administrative/Other|7|||
42253571|NCT01661140|76079531|FG002|Double-Blind Period|Administrative/Other|6|||
42253572|NCT03019549|76079539|FG000|Washout|DId not meet genotype criteria|11|||
42253573|NCT03019549|76079539|FG000|Period 2|Adverse Event|2|||
42253574|NCT03019549|76079539|FG000|Period 2|Physician Decision|2|||
42253575|NCT03019549|76079539|FG000|Period 2|Withdrawal by Subject|1|||
42253576|NCT01661062|76079548|FG000|Overall Study|Completed Treatment Off Study|3|||
42253577|NCT01661062|76079548|FG000|Overall Study|Withdrawal by Subject|2|||
42253578|NCT02536378|76079554|FG000|Overall Study|Physician Decision|0|||
42253579|NCT02536378|76079555|FG001|Overall Study|Physician Decision|2|||
42253580|NCT02536378|76079554|FG000|Overall Study|Withdrawal by Subject|0|||
42132952|NCT00490568|75943843|FG000|Overall Study|Legal representative withdrew consent|1|||
42132953|NCT00490568|75943843|FG000|Overall Study|Disease progression|4|||
42132954|NCT00490568|75943843|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
42132955|NCT00490568|75943843|FG000|Overall Study|Investigator decision|3|||
42132956|NCT00490568|75943843|FG000|Overall Study|Non-Compliance|7|||
42132957|NCT00490568|75943843|FG000|Overall Study|Efficacy related|3|||
42132958|NCT00490568|75943843|FG000|Overall Study|Participant died|1|||
42132959|NCT00490568|75943843|FG000|Overall Study|Participant withdrawal due to surgery|1|||
42132960|NCT00561353|75943858|FG000|Overall Study|Subject reached a virologic endpoint|2|||
42132961|NCT00561353|75943859|FG001|Overall Study|Subject reached a virologic endpoint|1|||
42132962|NCT00561353|75943860|FG002|Overall Study|Subject reached a virologic endpoint|1|||
42253581|NCT02536378|76079555|FG001|Overall Study|Withdrawal by Subject|1|||
42253582|NCT02536378|76079554|FG000|Overall Study|Death|1|||
42253583|NCT02536378|76079555|FG001|Overall Study|Death|2|||
42253584|NCT02536378|76079554|FG000|Overall Study|Patient refused further follow up|6|||
42253585|NCT02536378|76079555|FG001|Overall Study|Patient refused further follow up|2|||
42253586|NCT01373151|76079570|FG000|Period 1|Lack of Efficacy|3|||
42253587|NCT01373151|76079571|FG001|Period 1|Lack of Efficacy|0|||
42253588|NCT01373151|76079572|FG002|Period 1|Lack of Efficacy|0|||
42253589|NCT01373151|76079573|FG003|Period 1|Lack of Efficacy|0|||
42253590|NCT01373151|76079574|FG004|Period 1|Lack of Efficacy|1|||
42309550|NCT02366143|76145324|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
42309551|NCT02366143|76145325|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
42309552|NCT02366143|76145326|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
42253591|NCT01373151|76079575|FG005|Period 1|Lack of Efficacy|0|||
42253592|NCT01373151|76079576|FG006|Period 1|Lack of Efficacy|0|||
42132963|NCT00561353|75943861|FG003|Overall Study|Subject reached a virologic endpoint|4|||
42253593|NCT01373151|76079570|FG000|Period 1|Adverse Event|0|||
42132964|NCT00561353|75943862|FG004|Overall Study|Subject reached a virologic endpoint|1|||
42253594|NCT01373151|76079571|FG001|Period 1|Adverse Event|0|||
42253595|NCT01373151|76079572|FG002|Period 1|Adverse Event|1|||
41991986|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
41991987|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
41991988|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
41991989|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
41991990|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
41991991|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
41991992|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
41991993|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
41991994|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
41991995|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
41991996|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
41991997|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
41991998|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
41991999|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
41992000|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
41992001|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
41992002|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
41992003|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
41992004|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
41992005|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
41992006|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
41992007|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
41992008|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
41992009|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
41992010|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
41992011|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
41992012|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
41992013|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
41992014|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
41992015|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
41992016|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
41992017|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
41992018|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
41992019|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
41992020|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
41992021|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
41992022|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
41992023|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
41992024|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
41992025|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
41992026|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
41992027|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
41992028|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
41992029|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
41992030|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
41992031|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
41992032|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
41992033|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
41992034|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
41992035|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
42253596|NCT01373151|76079573|FG003|Period 1|Adverse Event|0|||
42253597|NCT01373151|76079574|FG004|Period 1|Adverse Event|4|||
42253598|NCT01373151|76079575|FG005|Period 1|Adverse Event|3|||
42253599|NCT01373151|76079576|FG006|Period 1|Adverse Event|0|||
42253600|NCT01373151|76079570|FG000|Period 1|Withdrawal by Subject|2|||
42253601|NCT01373151|76079571|FG001|Period 1|Withdrawal by Subject|0|||
42253602|NCT01373151|76079572|FG002|Period 1|Withdrawal by Subject|3|||
42253603|NCT01373151|76079573|FG003|Period 1|Withdrawal by Subject|1|||
42253604|NCT01373151|76079574|FG004|Period 1|Withdrawal by Subject|0|||
42253605|NCT01373151|76079575|FG005|Period 1|Withdrawal by Subject|1|||
42253606|NCT01373151|76079576|FG006|Period 1|Withdrawal by Subject|0|||
42253607|NCT01373151|76079570|FG000|Period 2|Lack of Efficacy|9|||
41992036|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
41992037|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
41992038|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
41992039|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
41992040|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
41992041|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
41992042|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
42253608|NCT01373151|76079571|FG001|Period 2|Lack of Efficacy|0|||
42253609|NCT01373151|76079572|FG002|Period 2|Lack of Efficacy|0|||
41992043|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
41992044|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
41992045|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
41992046|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
41992047|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
41992048|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
41992049|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
41992050|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
41992051|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
41992052|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
41992053|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
41992054|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
41992055|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
41992056|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
41992057|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
41992058|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
41992059|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
41992060|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
41992061|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
41992062|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
41992063|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
41992064|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
42033328|NCT01136915|75841517|FG001|Overall Study|Exclusion criterion met|1|||
42253610|NCT01373151|76079573|FG003|Period 2|Lack of Efficacy|1|||
42253611|NCT01373151|76079574|FG004|Period 2|Lack of Efficacy|2|||
42253612|NCT01373151|76079575|FG005|Period 2|Lack of Efficacy|0|||
42253613|NCT01373151|76079576|FG006|Period 2|Lack of Efficacy|3|||
42253614|NCT01373151|76079570|FG000|Period 2|Adverse Event|0|||
42253615|NCT01373151|76079571|FG001|Period 2|Adverse Event|0|||
42253616|NCT01373151|76079572|FG002|Period 2|Adverse Event|3|||
42253617|NCT01373151|76079573|FG003|Period 2|Adverse Event|3|||
42253618|NCT01373151|76079574|FG004|Period 2|Adverse Event|0|||
42253619|NCT01373151|76079575|FG005|Period 2|Adverse Event|0|||
42253620|NCT01373151|76079576|FG006|Period 2|Adverse Event|1|||
42253621|NCT01373151|76079570|FG000|Period 2|subject request to discontinue|0|||
42253622|NCT01373151|76079571|FG001|Period 2|subject request to discontinue|1|||
42033329|NCT00940017|75841525|FG000|Overall Study|did not meet entrance criteria|3|||
42253623|NCT01373151|76079572|FG002|Period 2|subject request to discontinue|0|||
42253624|NCT01373151|76079573|FG003|Period 2|subject request to discontinue|0|||
42253625|NCT01373151|76079574|FG004|Period 2|subject request to discontinue|0|||
42253626|NCT01373151|76079575|FG005|Period 2|subject request to discontinue|0|||
42253627|NCT01373151|76079576|FG006|Period 2|subject request to discontinue|0|||
42253628|NCT01373151|76079570|FG000|Period 2|Withdrawal by Subject|0|||
42253629|NCT01373151|76079571|FG001|Period 2|Withdrawal by Subject|0|||
42253630|NCT01373151|76079572|FG002|Period 2|Withdrawal by Subject|0|||
42309553|NCT02366143|76145324|FG000|Overall Study|Patient moved to roll-over study|1|||
41992065|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
41992066|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
41992067|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
41992068|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
42253631|NCT01373151|76079573|FG003|Period 2|Withdrawal by Subject|1|||
42309554|NCT02366143|76145325|FG001|Overall Study|Patient moved to roll-over study|19|||
42309555|NCT02366143|76145326|FG002|Overall Study|Patient moved to roll-over study|28|||
42309556|NCT02366143|76145324|FG000|Overall Study|Patient moved to commercial stock|0|||
42309557|NCT02366143|76145325|FG001|Overall Study|Patient moved to commercial stock|0|||
42309558|NCT02366143|76145326|FG002|Overall Study|Patient moved to commercial stock|1|||
42309559|NCT02366143|76145324|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
42309560|NCT02366143|76145325|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
42309561|NCT02366143|76145326|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
42309562|NCT02366143|76145324|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
42309563|NCT02366143|76145325|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
42309564|NCT02366143|76145326|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
42309565|NCT02366143|76145324|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
42309566|NCT02366143|76145325|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
42309567|NCT02366143|76145326|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
42309568|NCT02366143|76145324|FG000|Overall Study|Requester's instructions|1|||
42309569|NCT02366143|76145325|FG001|Overall Study|Requester's instructions|1|||
42309570|NCT02366143|76145326|FG002|Overall Study|Requester's instructions|1|||
42309571|NCT02366143|76145324|FG000|Overall Study|Uneligible|0|||
42309572|NCT02366143|76145325|FG001|Overall Study|Uneligible|1|||
42309573|NCT02366143|76145326|FG002|Overall Study|Uneligible|0|||
42309574|NCT02366143|76145324|FG000|Overall Study|Post Trial Migration|0|||
42309575|NCT02366143|76145325|FG001|Overall Study|Post Trial Migration|1|||
42309576|NCT02366143|76145326|FG002|Overall Study|Post Trial Migration|0|||
42309577|NCT02366143|76145324|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
42309578|NCT02366143|76145325|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
42309579|NCT02366143|76145326|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
42309580|NCT02366143|76145324|FG000|Overall Study|Patient switched to PTAP|0|||
42309581|NCT02366143|76145325|FG001|Overall Study|Patient switched to PTAP|1|||
42309582|NCT02366143|76145326|FG002|Overall Study|Patient switched to PTAP|0|||
42309583|NCT02366143|76145324|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
42309584|NCT02366143|76145325|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
42309585|NCT02366143|76145326|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
42309586|NCT02098395|76145342|FG000|Overall Study|Protocol Violation|2|||
42309587|NCT02098395|76145343|FG001|Overall Study|Protocol Violation|2|||
42309588|NCT02098395|76145344|FG002|Overall Study|Protocol Violation|0|||
42309589|NCT02098395|76145345|FG003|Overall Study|Protocol Violation|7|||
42309590|NCT02098395|76145342|FG000|Overall Study|Withdrawal by Subject|10|||
42309591|NCT02098395|76145343|FG001|Overall Study|Withdrawal by Subject|10|||
42309592|NCT02098395|76145344|FG002|Overall Study|Withdrawal by Subject|5|||
42309593|NCT02098395|76145345|FG003|Overall Study|Withdrawal by Subject|13|||
42132965|NCT00561353|75943863|FG005|Overall Study|Subject reached a virologic endpoint|3|||
42132966|NCT00561353|75943864|FG006|Overall Study|Subject reached a virologic endpoint|4|||
42132967|NCT00561353|75943865|FG007|Overall Study|Subject reached a virologic endpoint|4|||
42132968|NCT00561353|75943866|FG008|Overall Study|Subject reached a virologic endpoint|5|||
42132969|NCT00561353|75943867|FG009|Overall Study|Subject reached a virologic endpoint|0|||
42132970|NCT00561353|75943858|FG000|Overall Study|Subject ineligible to continue the trial|0|||
42132971|NCT00561353|75943859|FG001|Overall Study|Subject ineligible to continue the trial|0|||
42132972|NCT00561353|75943860|FG002|Overall Study|Subject ineligible to continue the trial|0|||
42253632|NCT01373151|76079574|FG004|Period 2|Withdrawal by Subject|0|||
42253633|NCT01373151|76079575|FG005|Period 2|Withdrawal by Subject|0|||
42253634|NCT01373151|76079576|FG006|Period 2|Withdrawal by Subject|0|||
42253635|NCT01373151|76079570|FG000|Period 2|Other|0|||
42253636|NCT01373151|76079571|FG001|Period 2|Other|0|||
42253637|NCT01373151|76079572|FG002|Period 2|Other|1|||
42253638|NCT01373151|76079573|FG003|Period 2|Other|0|||
42253639|NCT01373151|76079574|FG004|Period 2|Other|0|||
42253640|NCT01373151|76079575|FG005|Period 2|Other|0|||
42253641|NCT01373151|76079576|FG006|Period 2|Other|1|||
42253642|NCT01660906|76079592|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
42132973|NCT00561353|75943861|FG003|Overall Study|Subject ineligible to continue the trial|0|||
42253643|NCT03015181|76079612|FG000|Overall Study|Enrolled, but product never administered|1|||
42253644|NCT03015181|76079613|FG001|Overall Study|Enrolled, but product never administered|0|||
42309594|NCT02098395|76145342|FG000|Overall Study|Adverse Event|12|||
42309595|NCT02098395|76145343|FG001|Overall Study|Adverse Event|19|||
42309596|NCT02098395|76145344|FG002|Overall Study|Adverse Event|34|||
42132974|NCT00561353|75943862|FG004|Overall Study|Subject ineligible to continue the trial|0|||
42132975|NCT00561353|75943863|FG005|Overall Study|Subject ineligible to continue the trial|1|||
42132976|NCT00561353|75943864|FG006|Overall Study|Subject ineligible to continue the trial|1|||
42132977|NCT00561353|75943865|FG007|Overall Study|Subject ineligible to continue the trial|0|||
42132978|NCT00561353|75943866|FG008|Overall Study|Subject ineligible to continue the trial|2|||
42132979|NCT00561353|75943867|FG009|Overall Study|Subject ineligible to continue the trial|1|||
42132980|NCT00561353|75943858|FG000|Overall Study|Other|1|||
42132981|NCT00561353|75943859|FG001|Overall Study|Other|0|||
42132982|NCT00561353|75943860|FG002|Overall Study|Other|1|||
42132983|NCT00561353|75943861|FG003|Overall Study|Other|0|||
42132984|NCT00561353|75943862|FG004|Overall Study|Other|0|||
42132985|NCT00561353|75943863|FG005|Overall Study|Other|2|||
41992069|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
42132986|NCT00561353|75943864|FG006|Overall Study|Other|0|||
42132987|NCT00561353|75943865|FG007|Overall Study|Other|0|||
42253645|NCT03015181|76079614|FG002|Overall Study|Enrolled, but product never administered|0|||
42253646|NCT03015181|76079615|FG003|Overall Study|Enrolled, but product never administered|0|||
42253647|NCT03015181|76079616|FG004|Overall Study|Enrolled, but product never administered|0|||
42253648|NCT03015181|76079617|FG005|Overall Study|Enrolled, but product never administered|0|||
41992070|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
41992071|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
41992072|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
41992073|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
41992074|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
41992075|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
42033330|NCT00940017|75841525|FG000|Overall Study|Adverse Event|1|||
42253649|NCT03015181|76079618|FG006|Overall Study|Enrolled, but product never administered|0|||
42253650|NCT03015181|76079612|FG000|Overall Study|Withdrawal by Subject|0|||
42253651|NCT03015181|76079613|FG001|Overall Study|Withdrawal by Subject|0|||
42253652|NCT03015181|76079614|FG002|Overall Study|Withdrawal by Subject|0|||
42253653|NCT03015181|76079615|FG003|Overall Study|Withdrawal by Subject|0|||
42253654|NCT03015181|76079616|FG004|Overall Study|Withdrawal by Subject|0|||
41992076|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
41992077|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
41992078|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
42132988|NCT00561353|75943866|FG008|Overall Study|Other|0|||
42253655|NCT03015181|76079617|FG005|Overall Study|Withdrawal by Subject|1|||
42253656|NCT03015181|76079618|FG006|Overall Study|Withdrawal by Subject|0|||
42253657|NCT03015181|76079612|FG000|Overall Study|Physician Decision|0|||
42253658|NCT03015181|76079613|FG001|Overall Study|Physician Decision|0|||
42253659|NCT03015181|76079614|FG002|Overall Study|Physician Decision|0|||
42253660|NCT03015181|76079615|FG003|Overall Study|Physician Decision|0|||
42253661|NCT03015181|76079616|FG004|Overall Study|Physician Decision|0|||
42253662|NCT03015181|76079617|FG005|Overall Study|Physician Decision|0|||
42253663|NCT03015181|76079618|FG006|Overall Study|Physician Decision|1|||
42253664|NCT00960297|76079667|FG000|Overall Study|Physician Decision|1|||
42253665|NCT00960297|76079667|FG000|Overall Study|Venous port infection|1|||
42253666|NCT00960297|76079667|FG000|Overall Study|Disease progression|1|||
42253667|NCT03018691|76079674|FG000|Overall Study|Adverse Event|1|||
42253668|NCT03018691|76079675|FG001|Overall Study|Adverse Event|1|||
42253669|NCT03018691|76079676|FG002|Overall Study|Adverse Event|4|||
42253670|NCT03018691|76079674|FG000|Overall Study|Lack of Efficacy|0|||
42253671|NCT03018691|76079675|FG001|Overall Study|Lack of Efficacy|0|||
42253672|NCT03018691|76079676|FG002|Overall Study|Lack of Efficacy|1|||
42253673|NCT03018691|76079674|FG000|Overall Study|Withdrawal by Subject|0|||
42253674|NCT03018691|76079675|FG001|Overall Study|Withdrawal by Subject|0|||
42253675|NCT03018691|76079676|FG002|Overall Study|Withdrawal by Subject|1|||
42253676|NCT03018691|76079674|FG000|Overall Study|Withdrawal by parent/guardian|1|||
42253677|NCT03018691|76079675|FG001|Overall Study|Withdrawal by parent/guardian|0|||
42253678|NCT03018691|76079676|FG002|Overall Study|Withdrawal by parent/guardian|1|||
42253679|NCT03012061|76079689|FG000|Overall Study|Withdrawal by Subject|1|||
42253680|NCT03012061|76079690|FG001|Overall Study|Withdrawal by Subject|5|||
42253681|NCT03012061|76079691|FG002|Overall Study|Withdrawal by Subject|4|||
42132989|NCT00561353|75943867|FG009|Overall Study|Other|0|||
42253682|NCT03012061|76079689|FG000|Overall Study|Investigator Site Closed|1|||
42309597|NCT02098395|76145345|FG003|Overall Study|Adverse Event|2|||
42309598|NCT02098395|76145342|FG000|Overall Study|Lost to Follow-up|2|||
42309599|NCT02098395|76145343|FG001|Overall Study|Lost to Follow-up|1|||
42309600|NCT02098395|76145344|FG002|Overall Study|Lost to Follow-up|0|||
42309601|NCT02098395|76145345|FG003|Overall Study|Lost to Follow-up|3|||
42309602|NCT02098395|76145342|FG000|Overall Study|Unclassified|0|||
42309603|NCT02098395|76145343|FG001|Overall Study|Unclassified|0|||
42309604|NCT02098395|76145344|FG002|Overall Study|Unclassified|3|||
42309605|NCT02098395|76145345|FG003|Overall Study|Unclassified|2|||
42309606|NCT02041923|76145357|FG000|Overall Study|Lost to Follow-up|26|||
42309607|NCT02041923|76145358|FG001|Overall Study|Lost to Follow-up|30|||
42309608|NCT02062437|76145366|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
42309609|NCT02062437|76145366|FG000|Overall Study|Patient not available for the 2y visit|18|||
42309610|NCT02062437|76145366|FG000|Overall Study|Death|2|||
42309611|NCT02062437|76145366|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
42309612|NCT02365519|76145372|FG000|Randomized and Treated|Adverse Event|0|||
42309613|NCT02365519|76145373|FG001|Randomized and Treated|Adverse Event|1|||
42309614|NCT02365519|76145374|FG002|Randomized and Treated|Adverse Event|0|||
42309615|NCT02365519|76145372|FG000|Randomized and Treated|Withdrawal by Subject|0|||
42309616|NCT02365519|76145373|FG001|Randomized and Treated|Withdrawal by Subject|1|||
42309617|NCT02365519|76145374|FG002|Randomized and Treated|Withdrawal by Subject|1|||
42309618|NCT02061813|76145383|FG000|Overall Study|Withdrawal by Subject|1|||
42309619|NCT02061813|76145383|FG000|Overall Study|Protocol Violation|2|||
42309620|NCT02096835|76145393|FG000|Overall Study|Withdrawal by Subject|1|||
42253683|NCT03012061|76079690|FG001|Overall Study|Investigator Site Closed|2|||
42309621|NCT02096835|76145394|FG001|Overall Study|Withdrawal by Subject|0|||
42309622|NCT02096835|76145395|FG002|Overall Study|Withdrawal by Subject|0|||
42309623|NCT02096835|76145393|FG000|Overall Study|converted to open procedures|1|||
42309624|NCT02096835|76145394|FG001|Overall Study|converted to open procedures|0|||
42309625|NCT02096835|76145395|FG002|Overall Study|converted to open procedures|0|||
42309626|NCT02096835|76145393|FG000|Overall Study|Lost to Follow-up|1|||
42309627|NCT02096835|76145394|FG001|Overall Study|Lost to Follow-up|0|||
42309628|NCT02096835|76145395|FG002|Overall Study|Lost to Follow-up|1|||
42309629|NCT02294773|76145405|FG000|Overall Study|Withdrawal by Subject|0|||
42309630|NCT02294773|76145406|FG001|Overall Study|Withdrawal by Subject|2|||
42309631|NCT02365285|76145416|FG000|Overall Study|Physician Decision|0|||
42309632|NCT02365285|76145417|FG001|Overall Study|Physician Decision|1|||
42309633|NCT02365285|76145418|FG002|Overall Study|Physician Decision|1|||
42309634|NCT02365285|76145419|FG003|Overall Study|Physician Decision|0|||
42309635|NCT02365285|76145416|FG000|Overall Study|Adverse Event|0|||
42309636|NCT02365285|76145417|FG001|Overall Study|Adverse Event|0|||
42309637|NCT02365285|76145418|FG002|Overall Study|Adverse Event|0|||
42309638|NCT02365285|76145419|FG003|Overall Study|Adverse Event|2|||
42309639|NCT02041299|76145433|FG000|Overall Study|Adverse Event|9|||
42253684|NCT03012061|76079691|FG002|Overall Study|Investigator Site Closed|0|||
42253685|NCT03012061|76079689|FG000|Overall Study|Lost to Follow-up|2|||
42253686|NCT03012061|76079690|FG001|Overall Study|Lost to Follow-up|1|||
42253687|NCT03012061|76079691|FG002|Overall Study|Lost to Follow-up|0|||
42253688|NCT03012061|76079689|FG000|Overall Study|Study closed/ Terminated|0|||
42253689|NCT03012061|76079690|FG001|Overall Study|Study closed/ Terminated|0|||
42253690|NCT03012061|76079691|FG002|Overall Study|Study closed/ Terminated|1|||
42253691|NCT03012061|76079689|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
42253692|NCT03012061|76079690|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
42309640|NCT02041299|76145434|FG001|Overall Study|Adverse Event|3|||
42309641|NCT02041299|76145433|FG000|Overall Study|Lost to Follow-up|4|||
42309642|NCT02041299|76145434|FG001|Overall Study|Lost to Follow-up|1|||
42309643|NCT02041299|76145433|FG000|Overall Study|Physician Decision|1|||
42309644|NCT02041299|76145434|FG001|Overall Study|Physician Decision|1|||
42309645|NCT02041299|76145433|FG000|Overall Study|Withdrawal by Subject|13|||
42309646|NCT02041299|76145434|FG001|Overall Study|Withdrawal by Subject|7|||
42309647|NCT02041299|76145433|FG000|Overall Study|Protocol Violation|11|||
42309648|NCT02041299|76145434|FG001|Overall Study|Protocol Violation|4|||
42309649|NCT02041299|76145433|FG000|Overall Study|Termination of the study|7|||
42309650|NCT02041299|76145434|FG001|Overall Study|Termination of the study|3|||
42309651|NCT02041299|76145433|FG000|Overall Study|Required bone marrow transplant|0|||
42309652|NCT02041299|76145434|FG001|Overall Study|Required bone marrow transplant|1|||
42309653|NCT02041299|76145433|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
42309654|NCT02041299|76145434|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
42309655|NCT01645735|76145446|FG000|Overall Study|Physician Decision|2|||
42309656|NCT01645735|76145447|FG001|Overall Study|Physician Decision|0|||
42309657|NCT01645735|76145446|FG000|Overall Study|Withdrawal by Subject|1|||
42309658|NCT01645735|76145447|FG001|Overall Study|Withdrawal by Subject|0|||
42309659|NCT01645735|76145446|FG000|Overall Study|Protocol Violation|1|||
42309660|NCT01645735|76145447|FG001|Overall Study|Protocol Violation|0|||
42309661|NCT01645735|76145446|FG000|Overall Study|Adverse Event|0|||
42309662|NCT01645735|76145447|FG001|Overall Study|Adverse Event|1|||
42309663|NCT02365207|76145454|FG000|Overall Study|Withdrawal by Subject|1|||
42309664|NCT02365207|76145454|FG000|Overall Study|Physician Decision|1|||
42309665|NCT01645111|76145458|FG000|Overall Study|Did not require Clevidipine|15|||
42309666|NCT02364037|76145464|FG000|Overall Study|Withdrawal by Subject|7|||
42309667|NCT02364037|76145465|FG001|Overall Study|Withdrawal by Subject|4|||
42309668|NCT02364037|76145464|FG000|Overall Study|Lost to Follow-up|37|||
42309669|NCT02364037|76145465|FG001|Overall Study|Lost to Follow-up|49|||
42309670|NCT01919164|76145476|FG000|Overall Study|Adverse Event|6|||
42309671|NCT01919164|76145477|FG001|Overall Study|Adverse Event|4|||
42309672|NCT01919164|76145478|FG002|Overall Study|Adverse Event|9|||
42309673|NCT01919164|76145479|FG003|Overall Study|Adverse Event|3|||
42309674|NCT01919164|76145480|FG004|Overall Study|Adverse Event|2|||
42309675|NCT01919164|76145476|FG000|Overall Study|Lost to Follow-up|2|||
42309676|NCT01919164|76145477|FG001|Overall Study|Lost to Follow-up|2|||
42309677|NCT01919164|76145478|FG002|Overall Study|Lost to Follow-up|2|||
42309678|NCT01919164|76145479|FG003|Overall Study|Lost to Follow-up|0|||
42309679|NCT01919164|76145480|FG004|Overall Study|Lost to Follow-up|4|||
42309680|NCT01919164|76145476|FG000|Overall Study|Death|1|||
42309681|NCT01919164|76145477|FG001|Overall Study|Death|0|||
42309682|NCT01919164|76145478|FG002|Overall Study|Death|0|||
42309683|NCT01919164|76145479|FG003|Overall Study|Death|0|||
42309684|NCT01919164|76145480|FG004|Overall Study|Death|0|||
42309685|NCT01919164|76145476|FG000|Overall Study|Protocol Violation|6|||
42309686|NCT01919164|76145477|FG001|Overall Study|Protocol Violation|0|||
42309687|NCT01919164|76145478|FG002|Overall Study|Protocol Violation|3|||
42309688|NCT01919164|76145479|FG003|Overall Study|Protocol Violation|2|||
42309689|NCT01919164|76145480|FG004|Overall Study|Protocol Violation|2|||
42309690|NCT01919164|76145476|FG000|Overall Study|Disease progression|2|||
42309691|NCT01919164|76145477|FG001|Overall Study|Disease progression|2|||
42309692|NCT01919164|76145478|FG002|Overall Study|Disease progression|1|||
42309693|NCT01919164|76145479|FG003|Overall Study|Disease progression|2|||
42309694|NCT01919164|76145480|FG004|Overall Study|Disease progression|1|||
42309695|NCT01919164|76145476|FG000|Overall Study|Withdrew consent|13|||
42253693|NCT03012061|76079691|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
42253694|NCT03012061|76079689|FG000|Overall Study|Protocol Violation|0|||
42253695|NCT03012061|76079690|FG001|Overall Study|Protocol Violation|0|||
42253696|NCT03012061|76079691|FG002|Overall Study|Protocol Violation|2|||
42253697|NCT03012061|76079689|FG000|Overall Study|Lack of Efficacy|0|||
42253698|NCT03012061|76079690|FG001|Overall Study|Lack of Efficacy|1|||
42253699|NCT03012061|76079691|FG002|Overall Study|Lack of Efficacy|0|||
42253700|NCT03012061|76079689|FG000|Overall Study|Adverse Event|2|||
42253701|NCT03012061|76079690|FG001|Overall Study|Adverse Event|0|||
42253702|NCT03012061|76079691|FG002|Overall Study|Adverse Event|0|||
42253703|NCT03010501|76079699|FG000|Study Week 1|Withdrawal by Subject|2|||
42253704|NCT03010501|76079700|FG001|Study Week 1|Withdrawal by Subject|1|||
42253705|NCT03010501|76079701|FG002|Study Week 1|Withdrawal by Subject|0|||
42253706|NCT03010501|76079702|FG003|Study Week 1|Withdrawal by Subject|2|||
42253707|NCT03010501|76079703|FG004|Study Week 1|Withdrawal by Subject|0|||
42309696|NCT01919164|76145477|FG001|Overall Study|Withdrew consent|13|||
42309697|NCT01919164|76145478|FG002|Overall Study|Withdrew consent|14|||
42309698|NCT01919164|76145479|FG003|Overall Study|Withdrew consent|14|||
42033331|NCT01129583|75841531|FG000|Overall Study|Death|1|||
42309699|NCT01919164|76145480|FG004|Overall Study|Withdrew consent|9|||
42253708|NCT03010501|76079704|FG005|Study Week 1|Withdrawal by Subject|0|||
42253709|NCT03010501|76079699|FG000|Study Week 3|Withdrawal by Subject|0|||
42309700|NCT01919164|76145476|FG000|Overall Study|Other Un-specified|13|||
42309701|NCT01919164|76145477|FG001|Overall Study|Other Un-specified|9|||
42309702|NCT01919164|76145478|FG002|Overall Study|Other Un-specified|8|||
42253710|NCT03010501|76079700|FG001|Study Week 3|Withdrawal by Subject|0|||
42253711|NCT03010501|76079701|FG002|Study Week 3|Withdrawal by Subject|0|||
42309703|NCT01919164|76145479|FG003|Overall Study|Other Un-specified|7|||
42309704|NCT01919164|76145480|FG004|Overall Study|Other Un-specified|15|||
42033332|NCT01129583|75841532|FG001|Overall Study|Death|0|||
42309705|NCT01901224|76145492|FG000|Overall Study|study was not funded and terminated|2|||
42309706|NCT01901146|76145498|FG000|Neoadjuvant Phase|Death|1|||
42309707|NCT01901146|76145499|FG001|Neoadjuvant Phase|Death|2|||
42309708|NCT01901146|76145500|FG002|Neoadjuvant Phase|Death|0|||
42309709|NCT01901146|76145501|FG003|Neoadjuvant Phase|Death|0|||
42309710|NCT01901146|76145502|FG004|Neoadjuvant Phase|Death|0|||
42309711|NCT01901146|76145498|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
42309712|NCT01901146|76145499|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
42309713|NCT01901146|76145500|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
42309714|NCT01901146|76145501|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
42309715|NCT01901146|76145502|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
42309716|NCT01901146|76145498|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
42309717|NCT01901146|76145499|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
42309718|NCT01901146|76145500|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
42309719|NCT01901146|76145501|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
42309720|NCT01901146|76145502|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
42309721|NCT01901146|76145498|FG000|Neoadjuvant Phase|Physician Decision|1|||
42309722|NCT01901146|76145499|FG001|Neoadjuvant Phase|Physician Decision|2|||
42309723|NCT01901146|76145500|FG002|Neoadjuvant Phase|Physician Decision|0|||
42309724|NCT01901146|76145501|FG003|Neoadjuvant Phase|Physician Decision|0|||
42309725|NCT01901146|76145502|FG004|Neoadjuvant Phase|Physician Decision|0|||
42309726|NCT01901146|76145498|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
42309727|NCT01901146|76145499|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
42309728|NCT01901146|76145500|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
42309729|NCT01901146|76145501|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
42309730|NCT01901146|76145502|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
42309731|NCT01901146|76145498|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
42309732|NCT01901146|76145499|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
42309733|NCT01901146|76145500|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
42309734|NCT01901146|76145501|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
42309735|NCT01901146|76145502|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
42309736|NCT01901146|76145498|FG000|Adjuvant Phase|Other|0|||
42309737|NCT01901146|76145499|FG001|Adjuvant Phase|Other|0|||
42309738|NCT01901146|76145500|FG002|Adjuvant Phase|Other|1|||
42309739|NCT01901146|76145501|FG003|Adjuvant Phase|Other|0|||
42309740|NCT01901146|76145502|FG004|Adjuvant Phase|Other|0|||
42309741|NCT01901146|76145498|FG000|Adjuvant Phase|Death|0|||
42309742|NCT01901146|76145499|FG001|Adjuvant Phase|Death|0|||
42309743|NCT01901146|76145500|FG002|Adjuvant Phase|Death|0|||
42309744|NCT01901146|76145501|FG003|Adjuvant Phase|Death|0|||
42309745|NCT01901146|76145502|FG004|Adjuvant Phase|Death|3|||
42309746|NCT01901146|76145498|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
42309747|NCT01901146|76145499|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
42309748|NCT01901146|76145500|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
42309749|NCT01901146|76145501|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
42132990|NCT00561353|75943858|FG000|Overall Study|Adverse Event|0|||
42132991|NCT00561353|75943859|FG001|Overall Study|Adverse Event|0|||
42132992|NCT00561353|75943860|FG002|Overall Study|Adverse Event|0|||
42132993|NCT00561353|75943861|FG003|Overall Study|Adverse Event|2|||
42132994|NCT00561353|75943862|FG004|Overall Study|Adverse Event|0|||
42253712|NCT03010501|76079702|FG003|Study Week 3|Withdrawal by Subject|1|||
42253713|NCT03010501|76079703|FG004|Study Week 3|Withdrawal by Subject|0|||
42253714|NCT03010501|76079704|FG005|Study Week 3|Withdrawal by Subject|0|||
42253715|NCT03002623|76079714|FG000|Overall Study|Lost to Follow-up|1|||
42253716|NCT03002623|76079715|FG001|Overall Study|Lost to Follow-up|0|||
42253717|NCT03002623|76079714|FG000|Overall Study|Physician Decision|1|||
42253718|NCT03002623|76079715|FG001|Overall Study|Physician Decision|1|||
42253719|NCT03010423|76079723|FG000|Overall Study|Study termination|8|||
42253720|NCT03002311|76079729|FG000|Overall Study|Lost to Follow-up|13|||
42253721|NCT03002311|76079730|FG001|Overall Study|Lost to Follow-up|26|||
42253722|NCT03002311|76079729|FG000|Overall Study|Referral provider called to schedule app|3|||
42309750|NCT01901146|76145502|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
42309751|NCT01901146|76145498|FG000|Adjuvant Phase|Physician Decision|0|||
42309752|NCT01901146|76145499|FG001|Adjuvant Phase|Physician Decision|0|||
42309753|NCT01901146|76145500|FG002|Adjuvant Phase|Physician Decision|9|||
42309754|NCT01901146|76145501|FG003|Adjuvant Phase|Physician Decision|2|||
42309755|NCT01901146|76145502|FG004|Adjuvant Phase|Physician Decision|4|||
42132995|NCT00561353|75943863|FG005|Overall Study|Adverse Event|0|||
42132996|NCT00561353|75943864|FG006|Overall Study|Adverse Event|1|||
42309756|NCT01901146|76145498|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
42309757|NCT01901146|76145499|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
42309758|NCT01901146|76145500|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
42309759|NCT01901146|76145501|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
42132997|NCT00561353|75943865|FG007|Overall Study|Adverse Event|0|||
42253723|NCT03002311|76079730|FG001|Overall Study|Referral provider called to schedule app|3|||
42253724|NCT03002311|76079729|FG000|Overall Study|Physician Decision|3|||
42309760|NCT01901146|76145502|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
42309761|NCT01644643|76145515|FG000|Overall Study|Death|1|||
42309762|NCT01644643|76145516|FG001|Overall Study|Death|0|||
42309763|NCT01644643|76145517|FG002|Overall Study|Death|3|||
42309764|NCT01644643|76145518|FG003|Overall Study|Death|3|||
42309765|NCT01644643|76145515|FG000|Overall Study|Lost to Follow-up|0|||
42309766|NCT01644643|76145516|FG001|Overall Study|Lost to Follow-up|0|||
42309767|NCT01644643|76145517|FG002|Overall Study|Lost to Follow-up|0|||
42309768|NCT01644643|76145518|FG003|Overall Study|Lost to Follow-up|4|||
42309769|NCT01644643|76145515|FG000|Overall Study|Withdrawal by Subject|1|||
42309770|NCT01644643|76145516|FG001|Overall Study|Withdrawal by Subject|0|||
42309771|NCT01644643|76145517|FG002|Overall Study|Withdrawal by Subject|2|||
42309772|NCT01644643|76145518|FG003|Overall Study|Withdrawal by Subject|1|||
42309773|NCT01644643|76145515|FG000|Overall Study|Other Eligibility criteria|0|||
42309774|NCT01644643|76145516|FG001|Overall Study|Other Eligibility criteria|0|||
42309775|NCT01644643|76145517|FG002|Overall Study|Other Eligibility criteria|0|||
42309776|NCT01644643|76145518|FG003|Overall Study|Other Eligibility criteria|2|||
42309777|NCT01864564|76145536|FG000|Overall Study|Lost to Follow-up|17|||
42309778|NCT01864564|76145537|FG001|Overall Study|Lost to Follow-up|23|||
42309779|NCT01864564|76145536|FG000|Overall Study|Withdrawal by Subject|20|||
42309780|NCT01864564|76145537|FG001|Overall Study|Withdrawal by Subject|11|||
42309781|NCT01864564|76145536|FG000|Overall Study|Protocol Violation|0|||
42309782|NCT01864564|76145537|FG001|Overall Study|Protocol Violation|27|||
42309783|NCT01864564|76145536|FG000|Overall Study|not reported|0|||
42309784|NCT01864564|76145537|FG001|Overall Study|not reported|34|||
42309785|NCT01864174|76145545|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
42309786|NCT01864174|76145546|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
42309787|NCT01864174|76145545|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
42309788|NCT01864174|76145546|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
42309789|NCT01864174|76145545|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
42132998|NCT00561353|75943866|FG008|Overall Study|Adverse Event|0|||
42132999|NCT00561353|75943867|FG009|Overall Study|Adverse Event|1|||
42133000|NCT00561353|75943858|FG000|Overall Study|Lost to Follow-up|2|||
42253725|NCT03002311|76079730|FG001|Overall Study|Physician Decision|1|||
42253726|NCT03002077|76079736|FG000|Overall Study|Non-compliance with Study Drug|4|||
42253727|NCT03002077|76079736|FG000|Overall Study|Non-compliance w/Background ADT|1|||
42253728|NCT03002077|76079736|FG000|Overall Study|Study Terminated by Sponsor|257|||
42253729|NCT03002077|76079736|FG000|Overall Study|Site Terminated by Sponsor|5|||
42253730|NCT03002077|76079736|FG000|Overall Study|Miscellaneous Reasons|10|||
42253731|NCT03002077|76079736|FG000|Overall Study|Adverse Event|23|||
42253732|NCT03002077|76079736|FG000|Overall Study|Lack of Efficacy|20|||
42253733|NCT03002077|76079736|FG000|Overall Study|Withdrawal by Subject|72|||
42253734|NCT03002077|76079736|FG000|Overall Study|Lost to Follow-up|21|||
42309790|NCT01864174|76145546|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
42309791|NCT01864174|76145545|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
42253735|NCT03002077|76079736|FG000|Overall Study|Pregnancy|4|||
42133001|NCT00561353|75943859|FG001|Overall Study|Lost to Follow-up|0|||
42309792|NCT01864174|76145546|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
42309793|NCT01864174|76145545|FG000|Double Blind - Compliant Randomized|Death|1|||
42309794|NCT01864174|76145546|FG001|Double Blind - Compliant Randomized|Death|0|||
42309795|NCT01864174|76145545|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
42309796|NCT01864174|76145546|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
42309797|NCT01864174|76145545|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
42309798|NCT01864174|76145546|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
42309799|NCT01864174|76145545|FG000|Double Blind - Compliant Randomized|Other|6|||
42309800|NCT01864174|76145546|FG001|Double Blind - Compliant Randomized|Other|10|||
42309801|NCT01864174|76145545|FG000|Off Treatment Follow-Up|Other|2|||
42309802|NCT01864174|76145546|FG001|Off Treatment Follow-Up|Other|0|||
42309803|NCT01864174|76145545|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
42309804|NCT01864174|76145546|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
42309805|NCT01900444|76145552|FG000|Overall Study|Protocol Violation|2|||
42309806|NCT01900444|76145552|FG000|Overall Study|Lost to Follow-up|1|||
42309807|NCT02294227|76145559|FG000|Overall Study|Death|0|||
42309808|NCT02294227|76145560|FG001|Overall Study|Death|0|||
42309809|NCT02294227|76145561|FG002|Overall Study|Death|1|||
42309810|NCT02294227|76145559|FG000|Overall Study|Subject/Guardian Decision|6|||
42309811|NCT02294227|76145560|FG001|Overall Study|Subject/Guardian Decision|3|||
42309812|NCT02294227|76145561|FG002|Overall Study|Subject/Guardian Decision|7|||
42309813|NCT02294227|76145559|FG000|Overall Study|Physician Decision|1|||
42309814|NCT02294227|76145560|FG001|Overall Study|Physician Decision|2|||
42309815|NCT02294227|76145561|FG002|Overall Study|Physician Decision|1|||
42309816|NCT02294227|76145559|FG000|Overall Study|Lost to Follow-up|1|||
42309817|NCT02294227|76145560|FG001|Overall Study|Lost to Follow-up|0|||
42309818|NCT02294227|76145561|FG002|Overall Study|Lost to Follow-up|0|||
42309819|NCT02294227|76145559|FG000|Overall Study|Lack of Efficacy|11|||
42309820|NCT02294227|76145560|FG001|Overall Study|Lack of Efficacy|12|||
42309821|NCT02294227|76145561|FG002|Overall Study|Lack of Efficacy|8|||
42309822|NCT02294227|76145559|FG000|Overall Study|Adverse Event|6|||
42309823|NCT02294227|76145560|FG001|Overall Study|Adverse Event|8|||
42309824|NCT02294227|76145561|FG002|Overall Study|Adverse Event|2|||
42309825|NCT02496767|76145575|FG000|Open-label Lead-in Phase|Adverse Event|176|||
42309826|NCT02496767|76145576|FG001|Open-label Lead-in Phase|Adverse Event|0|||
42309827|NCT02496767|76145577|FG002|Open-label Lead-in Phase|Adverse Event|0|||
42309828|NCT02496767|76145578|FG003|Open-label Lead-in Phase|Adverse Event|0|||
42309829|NCT02496767|76145579|FG004|Open-label Lead-in Phase|Adverse Event|0|||
42309830|NCT02496767|76145580|FG005|Open-label Lead-in Phase|Adverse Event|0|||
42309831|NCT02496767|76145581|FG006|Open-label Lead-in Phase|Adverse Event|0|||
42309832|NCT02496767|76145582|FG007|Open-label Lead-in Phase|Adverse Event|0|||
42309833|NCT02496767|76145575|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
42309834|NCT02496767|76145576|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
42309835|NCT02496767|76145577|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
42309836|NCT02496767|76145578|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
42309837|NCT02496767|76145579|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
42309838|NCT02496767|76145580|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
42309839|NCT02496767|76145581|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
42309840|NCT02496767|76145582|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
42309841|NCT02496767|76145575|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
42309842|NCT02496767|76145576|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
42309843|NCT02496767|76145577|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
42309844|NCT02496767|76145578|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
42133002|NCT00561353|75943860|FG002|Overall Study|Lost to Follow-up|1|||
42309845|NCT02496767|76145579|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
42309846|NCT02496767|76145580|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
42309847|NCT02496767|76145581|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
42309848|NCT02496767|76145582|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
42309849|NCT02496767|76145575|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
42309850|NCT02496767|76145576|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
42309851|NCT02496767|76145577|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
42309852|NCT02496767|76145578|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
42309853|NCT02496767|76145579|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
42309854|NCT02496767|76145580|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
42309855|NCT02496767|76145581|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
42309856|NCT02496767|76145582|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
42309857|NCT02496767|76145575|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
42309858|NCT02496767|76145576|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
42309859|NCT02496767|76145577|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
42309860|NCT02496767|76145578|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
42309861|NCT02496767|76145579|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
42309862|NCT02496767|76145580|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
42309863|NCT02496767|76145581|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
42309864|NCT02496767|76145582|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
42309865|NCT02496767|76145575|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
42309866|NCT02496767|76145576|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
42309867|NCT02496767|76145577|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
42309868|NCT02496767|76145578|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
42309869|NCT02496767|76145579|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
42309870|NCT02496767|76145580|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
42309871|NCT02496767|76145581|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
42309872|NCT02496767|76145582|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
42309873|NCT02496767|76145575|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
42309874|NCT02496767|76145576|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
42309875|NCT02496767|76145577|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
42309876|NCT02496767|76145578|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
42309877|NCT02496767|76145579|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
42309878|NCT02496767|76145580|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
42309879|NCT02496767|76145581|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
42309880|NCT02496767|76145582|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
42309881|NCT02496767|76145575|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
42309882|NCT02496767|76145576|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
42309883|NCT02496767|76145577|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
42309884|NCT02496767|76145578|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
42309885|NCT02496767|76145579|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
42309886|NCT02496767|76145580|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
42309887|NCT02496767|76145581|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
42309888|NCT02496767|76145582|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
42309889|NCT02496767|76145575|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
42309890|NCT02496767|76145576|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
42309891|NCT02496767|76145577|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
42309892|NCT02496767|76145578|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
42309893|NCT02496767|76145579|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
42309894|NCT02496767|76145580|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
42309895|NCT02496767|76145581|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
42309896|NCT02496767|76145582|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
42309897|NCT02496767|76145575|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
42309898|NCT02496767|76145576|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
42309899|NCT02496767|76145577|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
42309900|NCT02496767|76145578|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
42309901|NCT02496767|76145579|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
42309902|NCT02496767|76145580|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
42309903|NCT02496767|76145581|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
42309904|NCT02496767|76145582|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
42309905|NCT02496767|76145575|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
42309906|NCT02496767|76145576|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
42309907|NCT02496767|76145577|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
42033333|NCT01129583|75841531|FG000|Overall Study|Lost to Follow-up|1|||
42033334|NCT01129583|75841532|FG001|Overall Study|Lost to Follow-up|1|||
42033335|NCT01129583|75841531|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
42033336|NCT01129583|75841532|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
42033337|NCT01186328|75841538|FG000|Overall Study|Death|1|||
42033338|NCT01186328|75841539|FG001|Overall Study|Death|0|||
42033339|NCT01186328|75841540|FG002|Overall Study|Death|0|||
42133003|NCT00561353|75943861|FG003|Overall Study|Lost to Follow-up|0|||
42253736|NCT03002077|76079736|FG000|Overall Study|Protocol Violation|21|||
42253737|NCT03008005|76079743|FG000|Overall Study|Physician Decision|1|||
42253738|NCT03008005|76079744|FG001|Overall Study|Physician Decision|0|||
42253739|NCT03008005|76079745|FG002|Overall Study|Physician Decision|0|||
42253740|NCT03008005|76079743|FG000|Overall Study|Withdrawal by Subject|1|||
42253741|NCT03008005|76079744|FG001|Overall Study|Withdrawal by Subject|0|||
42253742|NCT03008005|76079745|FG002|Overall Study|Withdrawal by Subject|0|||
42253743|NCT03008005|76079743|FG000|Overall Study|Ineligible|0|||
42253744|NCT03008005|76079744|FG001|Overall Study|Ineligible|1|||
42253745|NCT03008005|76079745|FG002|Overall Study|Ineligible|0|||
42253746|NCT02440425|76079762|FG000|Overall Study|Death likely due to disease progression|1|||
42253747|NCT02440425|76079762|FG000|Overall Study|Withdrawal by Subject|2|||
42033340|NCT00848497|75841547|FG000|Overall Study|Screen failure|2|||
42253748|NCT02440425|76079762|FG000|Overall Study|Adverse Event|1|||
42309908|NCT02496767|76145578|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
42309909|NCT02496767|76145579|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
42309910|NCT02496767|76145580|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
42309911|NCT02496767|76145581|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
42309912|NCT02496767|76145582|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
42309913|NCT02496767|76145575|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
42309914|NCT02496767|76145576|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
42309915|NCT02496767|76145577|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
42309916|NCT02496767|76145578|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
42309917|NCT02496767|76145579|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
42309918|NCT02496767|76145580|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
42309919|NCT02496767|76145581|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
42309920|NCT02496767|76145582|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
42309921|NCT02496767|76145575|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
42309922|NCT02496767|76145576|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
42309923|NCT02496767|76145577|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
42309924|NCT02496767|76145578|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
42309925|NCT02496767|76145579|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
42309926|NCT02496767|76145580|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
42309927|NCT02496767|76145581|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
42309928|NCT02496767|76145582|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
42309929|NCT02496767|76145575|FG000|Double-blind, Withdrawal Phase|Death|0|||
42309930|NCT02496767|76145576|FG001|Double-blind, Withdrawal Phase|Death|0|||
42309931|NCT02496767|76145577|FG002|Double-blind, Withdrawal Phase|Death|0|||
42309932|NCT02496767|76145578|FG003|Double-blind, Withdrawal Phase|Death|0|||
42309933|NCT02496767|76145579|FG004|Double-blind, Withdrawal Phase|Death|0|||
42309934|NCT02496767|76145580|FG005|Double-blind, Withdrawal Phase|Death|0|||
42309935|NCT02496767|76145581|FG006|Double-blind, Withdrawal Phase|Death|1|||
42309936|NCT02496767|76145582|FG007|Double-blind, Withdrawal Phase|Death|2|||
42309937|NCT02496767|76145575|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
42309938|NCT02496767|76145576|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
42309939|NCT02496767|76145577|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
42309940|NCT02496767|76145578|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
42309941|NCT02496767|76145579|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
42309942|NCT02496767|76145580|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
42309943|NCT02496767|76145581|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
42309944|NCT02496767|76145582|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
42309945|NCT02496533|76145598|FG000|Overall Study|Lack of data on outcome|3|||
42309946|NCT02496533|76145599|FG001|Overall Study|Lack of data on outcome|0|||
42309947|NCT02496533|76145598|FG000|Overall Study|Patient did not complete all measures|0|||
42309948|NCT02496533|76145599|FG001|Overall Study|Patient did not complete all measures|4|||
42309949|NCT02496533|76145598|FG000|Overall Study|Late for radiologic testing|0|||
42309950|NCT02496533|76145599|FG001|Overall Study|Late for radiologic testing|2|||
42309951|NCT02496221|76145605|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
42133004|NCT00561353|75943862|FG004|Overall Study|Lost to Follow-up|0|||
42309952|NCT02496221|76145606|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
42309953|NCT02496221|76145605|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
42309954|NCT02496221|76145606|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
42309955|NCT02496221|76145605|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
42309956|NCT02496221|76145606|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
42309957|NCT02475629|76145614|FG000|Overall Study|Adverse Event|1|||
42309958|NCT02475629|76145614|FG000|Overall Study|Death|4|||
42309959|NCT02475629|76145614|FG000|Overall Study|Physician Decision|1|||
42309960|NCT02475629|76145614|FG000|Overall Study|Withdrawal by Subject|1|||
42309961|NCT02475629|76145614|FG000|Overall Study|Lost to Follow-up|1|||
42309962|NCT02475629|76145614|FG000|Overall Study|Subject non-compliance|1|||
42309963|NCT02475395|76145620|FG000|Overall Study|Protocol Violation|30|||
42309964|NCT02475395|76145621|FG001|Overall Study|Protocol Violation|3|||
42309965|NCT01653743|76145629|FG000|Overall Study|Withdrawal by Subject|1|||
42309966|NCT01653743|76145630|FG001|Overall Study|Withdrawal by Subject|0|||
42309967|NCT01653743|76145629|FG000|Overall Study|Investigator discretion|3|||
42309968|NCT01653743|76145630|FG001|Overall Study|Investigator discretion|0|||
42133005|NCT00561353|75943863|FG005|Overall Study|Lost to Follow-up|0|||
42309969|NCT02293993|76145640|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
42309970|NCT02293993|76145641|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
42309971|NCT02293993|76145642|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
42309972|NCT02293993|76145643|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
42309973|NCT02293993|76145640|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
42309974|NCT02293993|76145641|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
42309975|NCT02293993|76145642|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
42309976|NCT02293993|76145643|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
42309977|NCT02293993|76145640|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
42309978|NCT02293993|76145641|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
42309979|NCT02293993|76145642|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
42309980|NCT02293993|76145643|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
42309981|NCT02293993|76145640|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
42309982|NCT02293993|76145641|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
42309983|NCT02293993|76145642|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
42309984|NCT02293993|76145643|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
42309985|NCT02293993|76145640|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
42309986|NCT02293993|76145641|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
42309987|NCT02293993|76145642|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
42309988|NCT02293993|76145643|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
42309989|NCT02322775|76145663|FG000|Overall Study|Adverse Event|1|||
42309990|NCT02322775|76145664|FG001|Overall Study|Adverse Event|0|||
42309991|NCT02322775|76145663|FG000|Overall Study|Lost to Follow-up|0|||
42309992|NCT02322775|76145664|FG001|Overall Study|Lost to Follow-up|1|||
41992079|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
41992080|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
41992081|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
41992082|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
41992083|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
41992084|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
41992085|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
41992086|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
41992087|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
41992088|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
41992089|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
41992090|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
41992091|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
41992092|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
41992093|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
41992094|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
41992095|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
41992096|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
41992097|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
41992098|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
41992099|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
41992100|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
42309993|NCT02322775|76145663|FG000|Overall Study|Protocol Violation|1|||
42309994|NCT02322775|76145664|FG001|Overall Study|Protocol Violation|0|||
41992101|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
41992102|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
41992103|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
41992104|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
41992105|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
41992106|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
41992107|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
41992108|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
41992109|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
42309995|NCT02322775|76145663|FG000|Overall Study|Withdrawal by Subject|3|||
42309996|NCT02322775|76145664|FG001|Overall Study|Withdrawal by Subject|4|||
42309997|NCT02322775|76145663|FG000|Overall Study|Not willing to perform all FU visits|0|||
42253749|NCT02440425|76079762|FG000|Overall Study|Adverse Event/Ineligible|1|||
42253750|NCT03001219|76079777|FG000|Proof of Concept|Study Termination by Sponsor|0|||
42253751|NCT03001219|76079778|FG001|Proof of Concept|Study Termination by Sponsor|1|||
42253752|NCT03001219|76079777|FG000|Proof of Concept|Withdrawal by Subject|0|||
42253753|NCT03001219|76079778|FG001|Proof of Concept|Withdrawal by Subject|4|||
42253754|NCT03001219|76079777|FG000|Proof of Concept|Protocol Deviation|0|||
42253755|NCT03001219|76079778|FG001|Proof of Concept|Protocol Deviation|1|||
42253756|NCT03001219|76079777|FG000|Proof of Concept|Adverse Event|1|||
42253757|NCT03001219|76079778|FG001|Proof of Concept|Adverse Event|1|||
42253758|NCT03001219|76079777|FG000|Proof of Concept|Physician Decision|1|||
42309998|NCT02322775|76145664|FG001|Overall Study|Not willing to perform all FU visits|1|||
42309999|NCT02322229|76145670|FG000|Overall Study|Physician Decision|2|||
42310000|NCT02362789|76145677|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
42310001|NCT02362789|76145678|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
42310002|NCT02362789|76145679|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
42310003|NCT02362789|76145677|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
42310004|NCT02362789|76145678|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
42310005|NCT02362789|76145679|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
42310006|NCT02362789|76145677|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
42310007|NCT02362789|76145678|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
42310008|NCT02362789|76145679|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
42310009|NCT02362789|76145677|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
42133006|NCT00561353|75943864|FG006|Overall Study|Lost to Follow-up|0|||
42133007|NCT00561353|75943865|FG007|Overall Study|Lost to Follow-up|0|||
42133008|NCT00561353|75943866|FG008|Overall Study|Lost to Follow-up|0|||
42133009|NCT00561353|75943867|FG009|Overall Study|Lost to Follow-up|0|||
42133010|NCT00561353|75943858|FG000|Overall Study|Withdrawal by Subject|0|||
41992110|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
41992111|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
42133011|NCT00561353|75943859|FG001|Overall Study|Withdrawal by Subject|2|||
42133012|NCT00561353|75943860|FG002|Overall Study|Withdrawal by Subject|0|||
42133013|NCT00561353|75943861|FG003|Overall Study|Withdrawal by Subject|0|||
42133014|NCT00561353|75943862|FG004|Overall Study|Withdrawal by Subject|0|||
42253759|NCT03001219|76079778|FG001|Proof of Concept|Physician Decision|0|||
42310010|NCT02362789|76145678|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
42310011|NCT02362789|76145679|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
42310012|NCT02362789|76145677|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
42310013|NCT02362789|76145678|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
42310014|NCT02362789|76145679|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
42310015|NCT01646827|76145688|FG000|Overall Study|Lost to Follow-up|0|||
42310016|NCT01646827|76145689|FG001|Overall Study|Lost to Follow-up|3|||
42310017|NCT01646827|76145688|FG000|Overall Study|Physician Decision|1|||
42310018|NCT01646827|76145689|FG001|Overall Study|Physician Decision|2|||
42310019|NCT01646827|76145688|FG000|Overall Study|Withdrawal by Subject|1|||
42310020|NCT01646827|76145689|FG001|Overall Study|Withdrawal by Subject|0|||
42310021|NCT02293837|76145699|FG000|Overall Study|Lost to Follow-up|0|||
42310022|NCT02293837|76145700|FG001|Overall Study|Lost to Follow-up|2|||
42310023|NCT02293837|76145701|FG002|Overall Study|Lost to Follow-up|1|||
42310024|NCT02293837|76145702|FG003|Overall Study|Lost to Follow-up|0|||
42310025|NCT02293837|76145699|FG000|Overall Study|Withdrawal by Subject|2|||
42310026|NCT02293837|76145700|FG001|Overall Study|Withdrawal by Subject|1|||
41992112|NCT01212757|75800079|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
41992113|NCT01212757|75800080|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
41992114|NCT01212757|75800081|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
41992115|NCT01212757|75800082|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
41992116|NCT01212757|75800083|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
42133015|NCT00561353|75943863|FG005|Overall Study|Withdrawal by Subject|0|||
42310027|NCT02293837|76145701|FG002|Overall Study|Withdrawal by Subject|2|||
42310028|NCT02293837|76145702|FG003|Overall Study|Withdrawal by Subject|1|||
42253760|NCT03001219|76079777|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
42310029|NCT02293837|76145699|FG000|Overall Study|COVID-19 Related|1|||
42310030|NCT02293837|76145700|FG001|Overall Study|COVID-19 Related|1|||
42310031|NCT02293837|76145701|FG002|Overall Study|COVID-19 Related|0|||
42310032|NCT02293837|76145702|FG003|Overall Study|COVID-19 Related|0|||
42310033|NCT02293837|76145699|FG000|Overall Study|Participant ill and could not be infused|0|||
42310034|NCT02293837|76145700|FG001|Overall Study|Participant ill and could not be infused|0|||
42310035|NCT02293837|76145701|FG002|Overall Study|Participant ill and could not be infused|1|||
42310036|NCT02293837|76145702|FG003|Overall Study|Participant ill and could not be infused|0|||
42310037|NCT02361307|76145718|FG000|Overall Study|Unstable medical condition.|0|||
41992117|NCT01212757|75800084|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
41992118|NCT01212757|75800085|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
41992119|NCT01212757|75800086|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
41992120|NCT01212757|75800087|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
41992121|NCT01190410|75800107|FG000|Overall Study|Adverse Event|0|||
41992122|NCT01190410|75800108|FG001|Overall Study|Adverse Event|3|||
41992123|NCT01190410|75800107|FG000|Overall Study|Lack of Efficacy|0|||
41992124|NCT01190410|75800108|FG001|Overall Study|Lack of Efficacy|2|||
41992125|NCT01190410|75800107|FG000|Overall Study|Withdrawal by Subject|0|||
41992126|NCT01190410|75800108|FG001|Overall Study|Withdrawal by Subject|2|||
41992127|NCT01190410|75800107|FG000|Overall Study|Administrative decision|1|||
41992128|NCT01190410|75800108|FG001|Overall Study|Administrative decision|0|||
42310038|NCT02361307|76145719|FG001|Overall Study|Unstable medical condition.|1|||
42310039|NCT02320903|76145728|FG000|Overall Study|Withdrawal by Subject|0|||
42310040|NCT02320903|76145729|FG001|Overall Study|Withdrawal by Subject|9|||
42310041|NCT02320903|76145730|FG002|Overall Study|Withdrawal by Subject|9|||
42310042|NCT02320903|76145728|FG000|Overall Study|Exited therapy; no longer eligible|8|||
42310043|NCT02320903|76145729|FG001|Overall Study|Exited therapy; no longer eligible|2|||
42310044|NCT02320903|76145730|FG002|Overall Study|Exited therapy; no longer eligible|2|||
42310045|NCT02320903|76145728|FG000|Overall Study|Lost to Follow-up|0|||
42310046|NCT02320903|76145729|FG001|Overall Study|Lost to Follow-up|5|||
42310047|NCT02320903|76145730|FG002|Overall Study|Lost to Follow-up|5|||
42310048|NCT02320123|76145741|FG000|Overall Study|Lost to Follow-up|4|||
42310049|NCT02320123|76145742|FG001|Overall Study|Lost to Follow-up|6|||
42310050|NCT02320123|76145741|FG000|Overall Study|Death|6|||
41992129|NCT01190410|75800107|FG000|Overall Study|PI discretion|0|||
41992130|NCT01190410|75800108|FG001|Overall Study|PI discretion|2|||
41992131|NCT01190254|75800123|FG000|Overall Study|Adverse Event|3|||
42310051|NCT02320123|76145742|FG001|Overall Study|Death|5|||
42310052|NCT02360995|76145755|FG000|Overall Study|Lost to Follow-up|2|||
42310053|NCT02360995|76145756|FG001|Overall Study|Lost to Follow-up|0|||
42310054|NCT02360995|76145757|FG002|Overall Study|Lost to Follow-up|2|||
42310055|NCT02360995|76145755|FG000|Overall Study|Withdrawal by Subject|0|||
42310056|NCT02360995|76145756|FG001|Overall Study|Withdrawal by Subject|1|||
42310057|NCT02360995|76145757|FG002|Overall Study|Withdrawal by Subject|0|||
41992132|NCT01190254|75800124|FG001|Overall Study|Adverse Event|6|||
41992133|NCT01190254|75800125|FG002|Overall Study|Adverse Event|8|||
41992134|NCT01190254|75800123|FG000|Overall Study|Lack of Efficacy|7|||
41992135|NCT01190254|75800124|FG001|Overall Study|Lack of Efficacy|4|||
41992136|NCT01190254|75800125|FG002|Overall Study|Lack of Efficacy|5|||
41992137|NCT01190254|75800123|FG000|Overall Study|Lost to Follow-up|4|||
41992138|NCT01190254|75800124|FG001|Overall Study|Lost to Follow-up|2|||
41992139|NCT01190254|75800125|FG002|Overall Study|Lost to Follow-up|0|||
41992140|NCT01190254|75800123|FG000|Overall Study|Withdrawal by Subject|4|||
41992141|NCT01190254|75800124|FG001|Overall Study|Withdrawal by Subject|5|||
42253761|NCT03001219|76079778|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
42253762|NCT03001219|76079777|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
42253763|NCT03001219|76079778|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
42253764|NCT03001219|76079777|FG000|Extension Period Analysis|Physician Decision|0|||
42253765|NCT03001219|76079778|FG001|Extension Period Analysis|Physician Decision|1|||
42253766|NCT03001219|76079777|FG000|Extension Period Analysis|Adverse Event|1|||
42253767|NCT03001219|76079778|FG001|Extension Period Analysis|Adverse Event|1|||
42253768|NCT03001219|76079777|FG000|Extension Period Analysis|Protocol Deviation|0|||
42253769|NCT03001219|76079778|FG001|Extension Period Analysis|Protocol Deviation|1|||
42253770|NCT03001219|76079777|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
42253771|NCT03001219|76079778|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
42253772|NCT03000673|76079793|FG000|Overall Study|Withdrawal by Subject|1|||
42253773|NCT03000673|76079794|FG001|Overall Study|Withdrawal by Subject|0|||
42253774|NCT03000673|76079795|FG002|Overall Study|Withdrawal by Subject|0|||
42253775|NCT03000673|76079796|FG003|Overall Study|Withdrawal by Subject|0|||
42310058|NCT02360605|76145767|FG000|Overall Study|Withdrawal by Subject|4|||
42310059|NCT02360605|76145768|FG001|Overall Study|Withdrawal by Subject|9|||
42310060|NCT02360605|76145767|FG000|Overall Study|Lost to Follow-up|7|||
42310061|NCT02360605|76145768|FG001|Overall Study|Lost to Follow-up|8|||
42310062|NCT02360605|76145767|FG000|Overall Study|Death|0|||
41992142|NCT01190254|75800125|FG002|Overall Study|Withdrawal by Subject|7|||
41992143|NCT01190254|75800123|FG000|Overall Study|Protocol Violation|2|||
41992144|NCT01190254|75800124|FG001|Overall Study|Protocol Violation|0|||
41992145|NCT01190254|75800125|FG002|Overall Study|Protocol Violation|2|||
41992146|NCT01190254|75800123|FG000|Overall Study|Did not meet protocol eligibility|1|||
42310063|NCT02360605|76145768|FG001|Overall Study|Death|1|||
42310064|NCT02360293|76145778|FG000|Overall Study|Lost to Follow-up|73|||
42310065|NCT02360293|76145779|FG001|Overall Study|Lost to Follow-up|95|||
42310066|NCT02360293|76145778|FG000|Overall Study|Withdrawal by Subject|2|||
42310067|NCT02360293|76145779|FG001|Overall Study|Withdrawal by Subject|1|||
41992147|NCT01190254|75800124|FG001|Overall Study|Did not meet protocol eligibility|0|||
41992148|NCT01190254|75800125|FG002|Overall Study|Did not meet protocol eligibility|0|||
41992149|NCT01190839|75800135|FG000|Overall Study|Adverse Event|32|||
42310068|NCT02360293|76145778|FG000|Overall Study|Excluded|1|||
42310069|NCT02360293|76145779|FG001|Overall Study|Excluded|0|||
42310070|NCT02359903|76145787|FG000|Overall Study|Adverse Event|0|||
42310071|NCT02359903|76145788|FG001|Overall Study|Adverse Event|2|||
42310072|NCT02291419|76145796|FG000|Overall Study|Early study termination|1|||
42310073|NCT02291419|76145797|FG001|Overall Study|Early study termination|5|||
42310074|NCT02319031|76145805|FG000|Treatment Period|Death|1|||
42310075|NCT02319031|76145806|FG001|Treatment Period|Death|0|||
42310076|NCT02318797|76145814|FG000|Overall Study|Death|3|||
42310077|NCT02318797|76145815|FG001|Overall Study|Death|6|||
42310078|NCT02318797|76145814|FG000|Overall Study|Lost to Follow-up|85|||
42310079|NCT02318797|76145815|FG001|Overall Study|Lost to Follow-up|96|||
42310080|NCT02359435|76145823|FG000|Overall Study|Lost to Follow-up|4|||
42310081|NCT02359435|76145824|FG001|Overall Study|Lost to Follow-up|4|||
42310082|NCT02318719|76145834|FG000|Double-blind Phase|Adverse Event|7|||
42310083|NCT02318719|76145835|FG001|Double-blind Phase|Adverse Event|6|||
42310084|NCT02318719|76145836|FG002|Double-blind Phase|Adverse Event|12|||
42310085|NCT02318719|76145837|FG003|Double-blind Phase|Adverse Event|4|||
42310086|NCT02318719|76145838|FG004|Double-blind Phase|Adverse Event|0|||
42310087|NCT02318719|76145834|FG000|Double-blind Phase|Lack of Efficacy|5|||
42310088|NCT02318719|76145835|FG001|Double-blind Phase|Lack of Efficacy|0|||
42310089|NCT02318719|76145836|FG002|Double-blind Phase|Lack of Efficacy|1|||
42310090|NCT02318719|76145837|FG003|Double-blind Phase|Lack of Efficacy|1|||
42310091|NCT02318719|76145838|FG004|Double-blind Phase|Lack of Efficacy|0|||
42310092|NCT02318719|76145834|FG000|Double-blind Phase|Protocol Violation|0|||
42310093|NCT02318719|76145835|FG001|Double-blind Phase|Protocol Violation|1|||
42310094|NCT02318719|76145836|FG002|Double-blind Phase|Protocol Violation|3|||
42310095|NCT02318719|76145837|FG003|Double-blind Phase|Protocol Violation|0|||
42310096|NCT02318719|76145838|FG004|Double-blind Phase|Protocol Violation|0|||
42310097|NCT02318719|76145834|FG000|Double-blind Phase|Withdrawal by Subject|25|||
42310098|NCT02318719|76145835|FG001|Double-blind Phase|Withdrawal by Subject|7|||
42310099|NCT02318719|76145836|FG002|Double-blind Phase|Withdrawal by Subject|9|||
42310100|NCT02318719|76145837|FG003|Double-blind Phase|Withdrawal by Subject|10|||
42310101|NCT02318719|76145838|FG004|Double-blind Phase|Withdrawal by Subject|0|||
42310102|NCT02318719|76145834|FG000|Double-blind Phase|Other|1|||
42310103|NCT02318719|76145835|FG001|Double-blind Phase|Other|2|||
42310104|NCT02318719|76145836|FG002|Double-blind Phase|Other|0|||
42310105|NCT02318719|76145837|FG003|Double-blind Phase|Other|0|||
42310106|NCT02318719|76145838|FG004|Double-blind Phase|Other|0|||
42310107|NCT02318719|76145834|FG000|Open-label Extension Phase|Adverse Event|0|||
42310108|NCT02318719|76145835|FG001|Open-label Extension Phase|Adverse Event|0|||
42310109|NCT02318719|76145836|FG002|Open-label Extension Phase|Adverse Event|0|||
42310110|NCT02318719|76145837|FG003|Open-label Extension Phase|Adverse Event|0|||
42310111|NCT02318719|76145838|FG004|Open-label Extension Phase|Adverse Event|15|||
42310112|NCT02318719|76145834|FG000|Open-label Extension Phase|Death|0|||
42310113|NCT02318719|76145835|FG001|Open-label Extension Phase|Death|0|||
42310114|NCT02318719|76145836|FG002|Open-label Extension Phase|Death|0|||
42310115|NCT02318719|76145837|FG003|Open-label Extension Phase|Death|0|||
42310116|NCT02318719|76145838|FG004|Open-label Extension Phase|Death|1|||
42310117|NCT02318719|76145834|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
42310118|NCT02318719|76145835|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
42310119|NCT02318719|76145836|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
42310120|NCT02318719|76145837|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
42310121|NCT02318719|76145838|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
42310122|NCT02318719|76145834|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
42310123|NCT02318719|76145835|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
42310124|NCT02318719|76145836|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
42310125|NCT02318719|76145837|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
42310126|NCT02318719|76145838|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
41992150|NCT01190839|75800136|FG001|Overall Study|Adverse Event|41|||
41992151|NCT01190839|75800135|FG000|Overall Study|Protocol Violation|2|||
42310127|NCT02318719|76145834|FG000|Open-label Extension Phase|Other|0|||
42310128|NCT02318719|76145835|FG001|Open-label Extension Phase|Other|0|||
42310129|NCT02318719|76145836|FG002|Open-label Extension Phase|Other|0|||
42310130|NCT02318719|76145837|FG003|Open-label Extension Phase|Other|0|||
42310131|NCT02318719|76145838|FG004|Open-label Extension Phase|Other|7|||
42310132|NCT01870726|76145857|FG000|Overall Study|Withdrawal of informed consent|0|||
41992152|NCT01190839|75800136|FG001|Overall Study|Protocol Violation|2|||
41992153|NCT01190839|75800135|FG000|Overall Study|Lost to Follow-up|7|||
42310133|NCT01870726|76145858|FG001|Overall Study|Withdrawal of informed consent|0|||
41992154|NCT01190839|75800136|FG001|Overall Study|Lost to Follow-up|1|||
41992155|NCT01190839|75800135|FG000|Overall Study|Death|1|||
41992156|NCT01190839|75800136|FG001|Overall Study|Death|0|||
41992157|NCT01190839|75800135|FG000|Overall Study|Trial stopped by Sponsor|71|||
41992158|NCT01190839|75800136|FG001|Overall Study|Trial stopped by Sponsor|68|||
41992159|NCT01190839|75800135|FG000|Overall Study|Undefined|35|||
41992160|NCT01190839|75800136|FG001|Overall Study|Undefined|31|||
41992161|NCT01190839|75800135|FG000|Overall Study|Randomized but not treated|2|||
42310134|NCT01870726|76145859|FG002|Overall Study|Withdrawal of informed consent|0|||
41992162|NCT01190839|75800136|FG001|Overall Study|Randomized but not treated|4|||
42310135|NCT01870726|76145860|FG003|Overall Study|Withdrawal of informed consent|1|||
42310136|NCT01870726|76145861|FG004|Overall Study|Withdrawal of informed consent|0|||
42310137|NCT01870726|76145862|FG005|Overall Study|Withdrawal of informed consent|0|||
42310138|NCT01870726|76145863|FG006|Overall Study|Withdrawal of informed consent|0|||
42310139|NCT01870726|76145857|FG000|Overall Study|Withdrawal by Subject|0|||
42310140|NCT01870726|76145858|FG001|Overall Study|Withdrawal by Subject|1|||
42310141|NCT01870726|76145859|FG002|Overall Study|Withdrawal by Subject|0|||
42310142|NCT01870726|76145860|FG003|Overall Study|Withdrawal by Subject|0|||
42310143|NCT01870726|76145861|FG004|Overall Study|Withdrawal by Subject|0|||
42310144|NCT01870726|76145862|FG005|Overall Study|Withdrawal by Subject|0|||
42310145|NCT01870726|76145863|FG006|Overall Study|Withdrawal by Subject|0|||
41992163|NCT01190215|75800146|FG000|Up to Month 6|Lost to Follow-up|2|||
41992164|NCT01190215|75800147|FG001|Up to Month 6|Lost to Follow-up|0|||
41992165|NCT01190449|75800155|FG000|Overall Study|Ineligible|0|||
41992166|NCT01190449|75800156|FG001|Overall Study|Ineligible|4|||
42033341|NCT00848497|75841548|FG001|Overall Study|Screen failure|0|||
42033342|NCT00848497|75841547|FG000|Overall Study|Withdrawal by Subject|0|||
42310146|NCT01870726|76145857|FG000|Overall Study|Adverse Event|0|||
42310147|NCT01870726|76145858|FG001|Overall Study|Adverse Event|0|||
42310148|NCT01870726|76145859|FG002|Overall Study|Adverse Event|0|||
42310149|NCT01870726|76145860|FG003|Overall Study|Adverse Event|0|||
42310150|NCT01870726|76145861|FG004|Overall Study|Adverse Event|1|||
42310151|NCT01870726|76145862|FG005|Overall Study|Adverse Event|1|||
42310152|NCT01870726|76145863|FG006|Overall Study|Adverse Event|0|||
42310153|NCT01870726|76145857|FG000|Overall Study|Progressive disease|5|||
42310154|NCT01870726|76145858|FG001|Overall Study|Progressive disease|5|||
42310155|NCT01870726|76145859|FG002|Overall Study|Progressive disease|4|||
42310156|NCT01870726|76145860|FG003|Overall Study|Progressive disease|5|||
42310157|NCT01870726|76145861|FG004|Overall Study|Progressive disease|6|||
42310158|NCT01870726|76145862|FG005|Overall Study|Progressive disease|4|||
42310159|NCT01870726|76145863|FG006|Overall Study|Progressive disease|10|||
42310160|NCT01900054|76145888|FG000|Overall Study|Physician Decision|1|||
42310161|NCT01900054|76145888|FG000|Overall Study|Withdrawal by Subject|1|||
42310162|NCT01612156|76145894|FG000|Overall Study|Protocol Violation|2|||
42310163|NCT01612156|76145895|FG001|Overall Study|Protocol Violation|0|||
42310164|NCT01899742|76145903|FG000|Overall Study|Adverse Event|5|||
42310165|NCT01899742|76145904|FG001|Overall Study|Adverse Event|4|||
42310166|NCT01899742|76145903|FG000|Overall Study|Lack of Efficacy|1|||
42310167|NCT01899742|76145904|FG001|Overall Study|Lack of Efficacy|5|||
42310168|NCT01899742|76145903|FG000|Overall Study|Protocol Violation|2|||
42310169|NCT01899742|76145904|FG001|Overall Study|Protocol Violation|2|||
42310170|NCT01899742|76145903|FG000|Overall Study|Withdrawal by Subject|9|||
42310171|NCT01899742|76145904|FG001|Overall Study|Withdrawal by Subject|5|||
42310172|NCT01615822|76145913|FG000|Period 1|Withdrawal by Subject|0|||
42310173|NCT01615822|76145914|FG001|Period 1|Withdrawal by Subject|1|||
42310174|NCT01615822|76145915|FG002|Period 1|Withdrawal by Subject|0|||
42310175|NCT01615822|76145913|FG000|Period 1|Adverse Event|1|||
42310176|NCT01615822|76145914|FG001|Period 1|Adverse Event|1|||
42310177|NCT01615822|76145915|FG002|Period 1|Adverse Event|0|||
42310178|NCT01615822|76145913|FG000|Period 2|Lost to Follow-up|0|||
42310179|NCT01615822|76145914|FG001|Period 2|Lost to Follow-up|1|||
42310180|NCT01615822|76145915|FG002|Period 2|Lost to Follow-up|2|||
42310181|NCT01898884|76145931|FG000|Multiple Dose Period|Adverse Event|0|||
42310182|NCT01898884|76145932|FG001|Multiple Dose Period|Adverse Event|0|||
42310183|NCT01898884|76145933|FG002|Multiple Dose Period|Adverse Event|0|||
42310184|NCT01898884|76145934|FG003|Multiple Dose Period|Adverse Event|0|||
42310185|NCT01898884|76145935|FG004|Multiple Dose Period|Adverse Event|0|||
42310186|NCT01898884|76145936|FG005|Multiple Dose Period|Adverse Event|0|||
42310187|NCT01898884|76145937|FG006|Multiple Dose Period|Adverse Event|1|||
42310188|NCT01898884|76145938|FG007|Multiple Dose Period|Adverse Event|0|||
42310189|NCT01898884|76145939|FG008|Multiple Dose Period|Adverse Event|0|||
42310190|NCT01898884|76145931|FG000|Multiple Dose Period|Randomized Not Treated|0|||
42310191|NCT01898884|76145932|FG001|Multiple Dose Period|Randomized Not Treated|0|||
42310192|NCT01898884|76145933|FG002|Multiple Dose Period|Randomized Not Treated|0|||
42310193|NCT01898884|76145934|FG003|Multiple Dose Period|Randomized Not Treated|0|||
42253776|NCT02912455|76079809|FG000|Overall Study|Withdrawal by Subject|0|||
42253777|NCT02912455|76079810|FG001|Overall Study|Withdrawal by Subject|1|||
42253778|NCT02912455|76079809|FG000|Overall Study|Lack of Efficacy|0|||
42253779|NCT02912455|76079810|FG001|Overall Study|Lack of Efficacy|1|||
42253780|NCT02912455|76079809|FG000|Overall Study|Lost to Follow-up|2|||
42253781|NCT02912455|76079810|FG001|Overall Study|Lost to Follow-up|1|||
42253782|NCT04524507|76079818|FG000|Overall Study|Lost to Follow-up|2|||
42253783|NCT04524507|76079819|FG001|Overall Study|Lost to Follow-up|4|||
42253784|NCT04524507|76079818|FG000|Overall Study|Withdrawal by Subject|2|||
42253785|NCT04524507|76079819|FG001|Overall Study|Withdrawal by Subject|9|||
42253786|NCT04524507|76079818|FG000|Overall Study|Death|2|||
42253787|NCT04524507|76079819|FG001|Overall Study|Death|10|||
42253788|NCT02999191|76079828|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
42253789|NCT02999191|76079829|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
42253790|NCT02999191|76079830|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
42253791|NCT02531698|76079840|FG000|Overall Study|Adverse Event|2|||
42310194|NCT01898884|76145935|FG004|Multiple Dose Period|Randomized Not Treated|0|||
42310195|NCT01898884|76145936|FG005|Multiple Dose Period|Randomized Not Treated|0|||
42310196|NCT01898884|76145937|FG006|Multiple Dose Period|Randomized Not Treated|0|||
42310197|NCT01898884|76145938|FG007|Multiple Dose Period|Randomized Not Treated|0|||
41992167|NCT01190176|75800162|FG000|Overall Study|Withdrawal by Subject|1|||
41992168|NCT01190176|75800162|FG000|Overall Study|Lost to Follow-up|1|||
42253792|NCT02531698|76079841|FG001|Overall Study|Adverse Event|1|||
42253793|NCT02531698|76079840|FG000|Overall Study|Withdrawal by Subject|6|||
42310198|NCT01898884|76145939|FG008|Multiple Dose Period|Randomized Not Treated|1|||
42310199|NCT01613326|76145977|FG000|Overall Study|Adverse Event|7|||
42310200|NCT01613326|76145978|FG001|Overall Study|Adverse Event|5|||
42253794|NCT02531698|76079841|FG001|Overall Study|Withdrawal by Subject|1|||
42253795|NCT02531698|76079840|FG000|Overall Study|Protocol Violation|2|||
42310201|NCT01613326|76145977|FG000|Overall Study|Withdrawal by Subject|3|||
42310202|NCT01613326|76145978|FG001|Overall Study|Withdrawal by Subject|4|||
42310203|NCT01613326|76145977|FG000|Overall Study|Abnormal test procedure result(s)|2|||
42310204|NCT01613326|76145978|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42310205|NCT01613326|76145977|FG000|Overall Study|inability to use device|1|||
42310206|NCT01613326|76145978|FG001|Overall Study|inability to use device|0|||
42310207|NCT01613326|76145977|FG000|Overall Study|Lack of Efficacy|0|||
42310208|NCT01613326|76145978|FG001|Overall Study|Lack of Efficacy|1|||
42310209|NCT01613326|76145977|FG000|Overall Study|Lost to Follow-up|0|||
42310210|NCT01613326|76145978|FG001|Overall Study|Lost to Follow-up|1|||
42310211|NCT01613326|76145977|FG000|Overall Study|Administrative|0|||
42310212|NCT01613326|76145978|FG001|Overall Study|Administrative|2|||
42310213|NCT01613326|76145977|FG000|Overall Study|Protocol Violation|0|||
42310214|NCT01613326|76145978|FG001|Overall Study|Protocol Violation|1|||
42310215|NCT01613248|76145990|FG000|Overall Study|Adverse Event|0|||
42310216|NCT01613248|76145991|FG001|Overall Study|Adverse Event|0|||
42310217|NCT01613248|76145992|FG002|Overall Study|Adverse Event|0|||
42310218|NCT01613248|76145993|FG003|Overall Study|Adverse Event|1|||
42310219|NCT01613248|76145994|FG004|Overall Study|Adverse Event|0|||
42310220|NCT01613248|76145995|FG005|Overall Study|Adverse Event|0|||
42310221|NCT01613248|76145990|FG000|Overall Study|Withdrawal by Subject|3|||
42310222|NCT01613248|76145991|FG001|Overall Study|Withdrawal by Subject|2|||
42310223|NCT01613248|76145992|FG002|Overall Study|Withdrawal by Subject|2|||
42310224|NCT01613248|76145993|FG003|Overall Study|Withdrawal by Subject|5|||
42310225|NCT01613248|76145994|FG004|Overall Study|Withdrawal by Subject|0|||
42310226|NCT01613248|76145995|FG005|Overall Study|Withdrawal by Subject|1|||
42310227|NCT01613248|76145990|FG000|Overall Study|Lost to Follow-up|5|||
42310228|NCT01613248|76145991|FG001|Overall Study|Lost to Follow-up|7|||
42310229|NCT01613248|76145992|FG002|Overall Study|Lost to Follow-up|4|||
42310230|NCT01613248|76145993|FG003|Overall Study|Lost to Follow-up|8|||
42310231|NCT01613248|76145994|FG004|Overall Study|Lost to Follow-up|4|||
42310232|NCT01613248|76145995|FG005|Overall Study|Lost to Follow-up|2|||
42310233|NCT01613248|76145990|FG000|Overall Study|Study Terminated by Sponsor|4|||
42310234|NCT01613248|76145991|FG001|Overall Study|Study Terminated by Sponsor|6|||
42310235|NCT01613248|76145992|FG002|Overall Study|Study Terminated by Sponsor|8|||
42310236|NCT01613248|76145993|FG003|Overall Study|Study Terminated by Sponsor|8|||
42310237|NCT01613248|76145994|FG004|Overall Study|Study Terminated by Sponsor|9|||
42310238|NCT01613248|76145995|FG005|Overall Study|Study Terminated by Sponsor|11|||
42310239|NCT01613248|76145990|FG000|Overall Study|Physician Decision|8|||
42310240|NCT01613248|76145991|FG001|Overall Study|Physician Decision|8|||
42310241|NCT01613248|76145992|FG002|Overall Study|Physician Decision|9|||
42310242|NCT01613248|76145993|FG003|Overall Study|Physician Decision|4|||
41992169|NCT01190098|75800168|FG000|Overall Study|Adverse Event|2|||
41992170|NCT01190098|75800169|FG001|Overall Study|Adverse Event|0|||
41992171|NCT01190098|75800168|FG000|Overall Study|Patient coomorbidity|0|||
41992172|NCT01190098|75800169|FG001|Overall Study|Patient coomorbidity|1|||
41992173|NCT01190098|75800168|FG000|Overall Study|Lack of transportation|1|||
41992174|NCT01190098|75800169|FG001|Overall Study|Lack of transportation|0|||
42310243|NCT01613248|76145994|FG004|Overall Study|Physician Decision|7|||
42310244|NCT01613248|76145995|FG005|Overall Study|Physician Decision|6|||
42310245|NCT01613248|76145990|FG000|Overall Study|Lack of Qualifying Event|9|||
42310246|NCT01613248|76145991|FG001|Overall Study|Lack of Qualifying Event|11|||
42310247|NCT01613248|76145992|FG002|Overall Study|Lack of Qualifying Event|10|||
42310248|NCT01613248|76145993|FG003|Overall Study|Lack of Qualifying Event|11|||
42310249|NCT01613248|76145994|FG004|Overall Study|Lack of Qualifying Event|15|||
42310250|NCT01613248|76145995|FG005|Overall Study|Lack of Qualifying Event|18|||
42310251|NCT01613248|76145990|FG000|Overall Study|Pregnancy|0|||
41992175|NCT01190098|75800168|FG000|Overall Study|Other|0|||
41992176|NCT01190098|75800169|FG001|Overall Study|Other|1|||
42310252|NCT01613248|76145991|FG001|Overall Study|Pregnancy|0|||
42310253|NCT01613248|76145992|FG002|Overall Study|Pregnancy|0|||
42310254|NCT01613248|76145993|FG003|Overall Study|Pregnancy|1|||
42310255|NCT01613248|76145994|FG004|Overall Study|Pregnancy|0|||
42310256|NCT01613248|76145995|FG005|Overall Study|Pregnancy|0|||
42310257|NCT01898806|76146009|FG000|Overall Study|Withdrawal by Subject|2|||
42310258|NCT01898806|76146009|FG000|Overall Study|Physician Decision|1|||
42310259|NCT02291029|76146019|FG000|Overall Study|Withdrawal by Subject|0|||
42310260|NCT02291029|76146020|FG001|Overall Study|Withdrawal by Subject|0|||
42310261|NCT02291029|76146021|FG002|Overall Study|Withdrawal by Subject|1|||
41992177|NCT01190020|75800177|FG000|Overall Study|Adverse Event|2|||
41992178|NCT01190020|75800178|FG001|Overall Study|Adverse Event|0|||
41992179|NCT01190020|75800177|FG000|Overall Study|Lost to Follow-up|2|||
41992180|NCT01190020|75800178|FG001|Overall Study|Lost to Follow-up|0|||
41992181|NCT01190020|75800177|FG000|Overall Study|Withdrawal by Subject|3|||
41992182|NCT01190020|75800178|FG001|Overall Study|Withdrawal by Subject|0|||
41992183|NCT01189435|75800184|FG000|Overall Study|Withdrawal by Subject|1|||
41992184|NCT01189435|75800184|FG000|Overall Study|Physician Decision|1|||
41992185|NCT01165996|75800188|FG000|Overall Study|Death|1|||
41992186|NCT01165996|75800188|FG000|Overall Study|Physician Decision|1|||
41992187|NCT01165684|75800195|FG000|Overall Study|Adverse Event|1|||
41992188|NCT01165684|75800196|FG001|Overall Study|Adverse Event|1|||
41992189|NCT01165684|75800195|FG000|Overall Study|Lack of Efficacy|2|||
41992190|NCT01165684|75800196|FG001|Overall Study|Lack of Efficacy|1|||
41992191|NCT01165684|75800195|FG000|Overall Study|Protocol Violation|7|||
41992192|NCT01165684|75800196|FG001|Overall Study|Protocol Violation|15|||
42253796|NCT02531698|76079841|FG001|Overall Study|Protocol Violation|0|||
42253797|NCT02531698|76079840|FG000|Overall Study|Lost to Follow-up|1|||
42253798|NCT02531698|76079841|FG001|Overall Study|Lost to Follow-up|0|||
42253799|NCT02998021|76079858|FG000|Overall Study|Withdrawal by Subject|3|||
42253800|NCT02998021|76079859|FG001|Overall Study|Withdrawal by Subject|1|||
42253801|NCT02998021|76079858|FG000|Overall Study|unsafe home|0|||
42253802|NCT02998021|76079859|FG001|Overall Study|unsafe home|1|||
42253803|NCT03034577|76079873|FG000|Overall Study|Withdrawal by Subject|6|||
42253804|NCT03034577|76079874|FG001|Overall Study|Withdrawal by Subject|9|||
42253805|NCT03034577|76079873|FG000|Overall Study|Lost to Follow-up|25|||
42253806|NCT03034577|76079874|FG001|Overall Study|Lost to Follow-up|26|||
42253807|NCT01659736|76079884|FG000|Treatment Period|Adverse Event|1|||
42253808|NCT01659736|76079885|FG001|Treatment Period|Adverse Event|1|||
42253809|NCT01659736|76079884|FG000|Treatment Period|Protocol Violation|3|||
42253810|NCT01659736|76079885|FG001|Treatment Period|Protocol Violation|1|||
42253811|NCT01659736|76079884|FG000|Treatment Period|Withdrawal by Subject|1|||
42253812|NCT01659736|76079885|FG001|Treatment Period|Withdrawal by Subject|0|||
42253813|NCT01659736|76079884|FG000|3-month Follow-up|Lost to Follow-up|0|||
42253814|NCT01659736|76079885|FG001|3-month Follow-up|Lost to Follow-up|1|||
42253815|NCT02997163|76079897|FG000|Overall Study|Adverse Event|1|||
42253816|NCT02997163|76079898|FG001|Overall Study|Adverse Event|0|||
42253817|NCT02997163|76079899|FG002|Overall Study|Adverse Event|0|||
42253818|NCT02997163|76079900|FG003|Overall Study|Adverse Event|1|||
42253819|NCT00458536|76079910|FG000|Overall Study|Disease progression prior to treatment|7|||
42253820|NCT00458536|76079910|FG000|Overall Study|Unable to make vaccine|3|||
42253821|NCT00458536|76079910|FG000|Overall Study|No measurable disease after surgery|2|||
42253822|NCT00458536|76079910|FG000|Overall Study|Did not have renal cell carcinoma|2|||
42253823|NCT00458536|76079910|FG000|Overall Study|Patient did not have surgery|1|||
42253824|NCT00458536|76079910|FG000|Overall Study|Ineligible due to toxicity|1|||
42253825|NCT00458536|76079910|FG000|Overall Study|Withdrawal by Subject|1|||
42253826|NCT00458536|76079910|FG000|Overall Study|Progressive disease during treatment|2|||
42253827|NCT02526550|76079914|FG000|Overall Study|Lost to Follow-up|1|||
42253828|NCT03030989|76079929|FG000|Overall Study|Fever|2|||
41992193|NCT01165684|75800195|FG000|Overall Study|Withdrawal Criteria|2|||
41992194|NCT01165684|75800196|FG001|Overall Study|Withdrawal Criteria|13|||
41992195|NCT01165684|75800195|FG000|Overall Study|Unclassified|16|||
41992196|NCT01165684|75800196|FG001|Overall Study|Unclassified|22|||
41992197|NCT01189201|75800202|FG000|Overall Study|Adverse Event|1|||
42253829|NCT03030989|76079930|FG001|Overall Study|Fever|2|||
42310262|NCT02291029|76146022|FG003|Overall Study|Withdrawal by Subject|0|||
42310263|NCT02291029|76146023|FG004|Overall Study|Withdrawal by Subject|0|||
42310264|NCT02291029|76146024|FG005|Overall Study|Withdrawal by Subject|0|||
42033343|NCT00848497|75841548|FG001|Overall Study|Withdrawal by Subject|1|||
42033344|NCT00857623|75841558|FG000|Overall Study|Adverse Event|5|||
42033345|NCT00857623|75841559|FG001|Overall Study|Adverse Event|2|||
42033346|NCT00857623|75841558|FG000|Overall Study|Study-specific discontinuation criteria|5|||
42033347|NCT00857623|75841559|FG001|Overall Study|Study-specific discontinuation criteria|3|||
42033348|NCT00857623|75841558|FG000|Overall Study|Withdrawal by Subject|2|||
42033349|NCT00857623|75841559|FG001|Overall Study|Withdrawal by Subject|1|||
42033350|NCT00857623|75841558|FG000|Overall Study|Lack of Efficacy|1|||
42033351|NCT00857623|75841559|FG001|Overall Study|Lack of Efficacy|1|||
42033352|NCT00857623|75841558|FG000|Overall Study|Severe non-compliance to protocol|1|||
42033353|NCT00857623|75841559|FG001|Overall Study|Severe non-compliance to protocol|1|||
42033354|NCT00857623|75841558|FG000|Overall Study|Intake of prohibited medication|0|||
42033355|NCT00857623|75841559|FG001|Overall Study|Intake of prohibited medication|1|||
42033356|NCT00857623|75841558|FG000|Overall Study|Positive for HEP C|0|||
42033357|NCT00857623|75841559|FG001|Overall Study|Positive for HEP C|1|||
42033358|NCT01185782|75841567|FG000|Overall Study|Adverse Event|0|||
42033359|NCT01185782|75841568|FG001|Overall Study|Adverse Event|1|||
42033360|NCT01185782|75841567|FG000|Overall Study|Protocol Violation|1|||
42033361|NCT01185782|75841568|FG001|Overall Study|Protocol Violation|0|||
42033362|NCT01185782|75841567|FG000|Overall Study|Poor Response to Treatment|3|||
42033363|NCT01185782|75841568|FG001|Overall Study|Poor Response to Treatment|1|||
42033364|NCT01185782|75841567|FG000|Overall Study|Other|2|||
42033365|NCT01185782|75841568|FG001|Overall Study|Other|5|||
42133016|NCT00561353|75943864|FG006|Overall Study|Withdrawal by Subject|0|||
42133017|NCT00561353|75943865|FG007|Overall Study|Withdrawal by Subject|0|||
42253830|NCT03030989|76079929|FG000|Overall Study|Rash|2|||
42310265|NCT02291029|76146019|FG000|Overall Study|Adverse Event|0|||
42310266|NCT02291029|76146020|FG001|Overall Study|Adverse Event|1|||
42310267|NCT02291029|76146021|FG002|Overall Study|Adverse Event|0|||
42310268|NCT02291029|76146022|FG003|Overall Study|Adverse Event|0|||
42310269|NCT02291029|76146023|FG004|Overall Study|Adverse Event|0|||
42310270|NCT02291029|76146024|FG005|Overall Study|Adverse Event|0|||
41992198|NCT01188967|75800219|FG000|Overall Study|Withdrawal by Subject|1|||
41992199|NCT01188967|75800220|FG001|Overall Study|Withdrawal by Subject|1|||
41992200|NCT01188967|75800219|FG000|Overall Study|Physician Decision|1|||
41992201|NCT01188967|75800220|FG001|Overall Study|Physician Decision|1|||
41992202|NCT01188967|75800219|FG000|Overall Study|Lost to Follow-up|3|||
41992203|NCT01188967|75800220|FG001|Overall Study|Lost to Follow-up|2|||
41992204|NCT01188811|75800230|FG000|Overall Study|Withdrawal by Subject|0|||
41992205|NCT01188811|75800231|FG001|Overall Study|Withdrawal by Subject|2|||
41992206|NCT01188811|75800230|FG000|Overall Study|Adverse Event|6|||
41992207|NCT01188811|75800231|FG001|Overall Study|Adverse Event|0|||
41992208|NCT01183234|75800239|FG000|First Intervention|Adverse Event|1|||
41992209|NCT01183234|75800240|FG001|First Intervention|Adverse Event|0|||
41992210|NCT01165216|75800248|FG000|Overall Study|Adverse Event|6|||
41992211|NCT01165216|75800249|FG001|Overall Study|Adverse Event|3|||
41992212|NCT01165216|75800248|FG000|Overall Study|Withdrawal by Subject|1|||
41992213|NCT01165216|75800249|FG001|Overall Study|Withdrawal by Subject|1|||
41992214|NCT01165216|75800248|FG000|Overall Study|Disease progression|1|||
42033366|NCT01185782|75841567|FG000|Overall Study|Randomized but not treated|0|||
42253831|NCT03030989|76079930|FG001|Overall Study|Rash|1|||
42253832|NCT03030989|76079929|FG000|Overall Study|Fatigue/Overwhelmed|1|||
42253833|NCT03030989|76079930|FG001|Overall Study|Fatigue/Overwhelmed|5|||
42253834|NCT03030989|76079929|FG000|Overall Study|Positive Blood Cultures|2|||
42253835|NCT03030989|76079930|FG001|Overall Study|Positive Blood Cultures|1|||
42253836|NCT03030989|76079929|FG000|Overall Study|Line Removed|0|||
42253837|NCT03030989|76079930|FG001|Overall Study|Line Removed|2|||
42253838|NCT03030989|76079929|FG000|Overall Study|No longer interested|5|||
42253839|NCT03030989|76079930|FG001|Overall Study|No longer interested|3|||
42253840|NCT03030599|76079936|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
42253841|NCT03030599|76079937|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
42253842|NCT03030599|76079938|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
42253843|NCT03030599|76079936|FG000|Open Label Treatment and Titration|Other|1|||
42310271|NCT02290873|76146041|FG000|Overall Study|Withdrawal by Subject|0|||
42310272|NCT02290873|76146042|FG001|Overall Study|Withdrawal by Subject|1|||
41992215|NCT01165216|75800249|FG001|Overall Study|Disease progression|3|||
42033367|NCT01185782|75841568|FG001|Overall Study|Randomized but not treated|4|||
42033368|NCT01129115|75841578|FG000|Overall Study|Adverse Event|1|||
42133018|NCT00561353|75943866|FG008|Overall Study|Withdrawal by Subject|0|||
41992216|NCT04545476|75800274|FG000|Overall Study|Lost to Follow-up|1|||
41992217|NCT04545476|75800275|FG001|Overall Study|Lost to Follow-up|1|||
42033369|NCT01129115|75841579|FG001|Overall Study|Adverse Event|2|||
42253844|NCT03030599|76079937|FG001|Open Label Treatment and Titration|Other|0|||
42253845|NCT03030599|76079938|FG002|Open Label Treatment and Titration|Other|0|||
42310273|NCT02290873|76146043|FG002|Overall Study|Withdrawal by Subject|1|||
42033370|NCT01129115|75841580|FG002|Overall Study|Adverse Event|3|||
42310274|NCT02290873|76146041|FG000|Overall Study|Nellcor device error|1|||
42310275|NCT02290873|76146042|FG001|Overall Study|Nellcor device error|0|||
42310276|NCT02290873|76146043|FG002|Overall Study|Nellcor device error|0|||
42310277|NCT02290873|76146041|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
42310278|NCT02290873|76146042|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
42310279|NCT02290873|76146043|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
42310280|NCT02290873|76146041|FG000|Overall Study|Protocol Violation|0|||
42310281|NCT02290873|76146042|FG001|Overall Study|Protocol Violation|0|||
42310282|NCT02290873|76146043|FG002|Overall Study|Protocol Violation|1|||
42310283|NCT02290405|76146054|FG000|Overall Study|Withdrawal by Subject|1|||
42310284|NCT02290405|76146055|FG001|Overall Study|Withdrawal by Subject|0|||
42310285|NCT02359045|76146063|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
42310286|NCT02359045|76146064|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
42310287|NCT02359045|76146063|FG000|Overall Study|Lost to Follow-up|1|||
42310288|NCT02359045|76146064|FG001|Overall Study|Lost to Follow-up|1|||
42310289|NCT02359045|76146063|FG000|Overall Study|Adverse Event|0|||
42310290|NCT02359045|76146064|FG001|Overall Study|Adverse Event|1|||
42310291|NCT02358343|76146085|FG000|Screening Intervention|Death|0|||
42310292|NCT02358343|76146086|FG001|Screening Intervention|Death|2|||
42310293|NCT02358343|76146087|FG002|Screening Intervention|Death|0|||
41992218|NCT04545476|75800276|FG002|Overall Study|Lost to Follow-up|0|||
41992219|NCT04545476|75800277|FG003|Overall Study|Lost to Follow-up|0|||
41992220|NCT01969838|75800292|FG000|Double-blind Phase|Adverse Event|10|||
41992221|NCT01969838|75800293|FG001|Double-blind Phase|Adverse Event|4|||
41992222|NCT01969838|75800294|FG002|Double-blind Phase|Adverse Event|0|||
41992223|NCT01969838|75800295|FG003|Double-blind Phase|Adverse Event|0|||
42253846|NCT03030599|76079936|FG000|Open Label Treatment and Titration|Physician Decision|3|||
42253847|NCT03030599|76079937|FG001|Open Label Treatment and Titration|Physician Decision|0|||
42253848|NCT03030599|76079938|FG002|Open Label Treatment and Titration|Physician Decision|0|||
41992224|NCT01969838|75800292|FG000|Double-blind Phase|Death|5|||
42253849|NCT03030599|76079936|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
42253850|NCT03030599|76079937|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
42253851|NCT03030599|76079938|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
42253852|NCT03030599|76079936|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
42253853|NCT03030599|76079937|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
42253854|NCT03030599|76079938|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
42253855|NCT03030599|76079936|FG000|Open Label Treatment and Titration|Adverse Event|18|||
42253856|NCT03030599|76079937|FG001|Open Label Treatment and Titration|Adverse Event|0|||
42253857|NCT03030599|76079938|FG002|Open Label Treatment and Titration|Adverse Event|0|||
42253858|NCT03030599|76079936|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
42253859|NCT03030599|76079937|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
42253860|NCT03030599|76079938|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
42253861|NCT03030599|76079936|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
42253862|NCT03030599|76079937|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
42253863|NCT03030599|76079938|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
42253864|NCT03030599|76079936|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
42310294|NCT02358343|76146088|FG003|Screening Intervention|Death|0|||
42310295|NCT02358343|76146089|FG004|Screening Intervention|Death|0|||
42310296|NCT02358343|76146085|FG000|Screening Intervention|Withdrawal by Subject|1|||
41992225|NCT01969838|75800293|FG001|Double-blind Phase|Death|2|||
41992226|NCT01969838|75800294|FG002|Double-blind Phase|Death|0|||
41992227|NCT01969838|75800295|FG003|Double-blind Phase|Death|0|||
42310297|NCT02358343|76146086|FG001|Screening Intervention|Withdrawal by Subject|0|||
42310298|NCT02358343|76146087|FG002|Screening Intervention|Withdrawal by Subject|0|||
42310299|NCT02358343|76146088|FG003|Screening Intervention|Withdrawal by Subject|0|||
42310300|NCT02358343|76146089|FG004|Screening Intervention|Withdrawal by Subject|0|||
42310301|NCT02358343|76146085|FG000|Screening Intervention|Determined Ineligible|5|||
42310302|NCT02358343|76146086|FG001|Screening Intervention|Determined Ineligible|6|||
42310303|NCT02358343|76146087|FG002|Screening Intervention|Determined Ineligible|0|||
42310304|NCT02358343|76146088|FG003|Screening Intervention|Determined Ineligible|0|||
41992228|NCT01969838|75800292|FG000|Double-blind Phase|Physician Decision|5|||
42310305|NCT02358343|76146089|FG004|Screening Intervention|Determined Ineligible|0|||
42310306|NCT02358343|76146085|FG000|Comparative Efficacy Trial / Observation|Death|0|||
42310307|NCT02358343|76146086|FG001|Comparative Efficacy Trial / Observation|Death|0|||
42310308|NCT02358343|76146087|FG002|Comparative Efficacy Trial / Observation|Death|2|||
42310309|NCT02358343|76146088|FG003|Comparative Efficacy Trial / Observation|Death|0|||
42310310|NCT02358343|76146089|FG004|Comparative Efficacy Trial / Observation|Death|0|||
42310311|NCT02358343|76146085|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
42310312|NCT02358343|76146086|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
41992229|NCT01969838|75800293|FG001|Double-blind Phase|Physician Decision|1|||
41992230|NCT01969838|75800294|FG002|Double-blind Phase|Physician Decision|0|||
41992231|NCT01969838|75800295|FG003|Double-blind Phase|Physician Decision|0|||
41992232|NCT01969838|75800292|FG000|Double-blind Phase|Subject Decision|4|||
41992233|NCT01969838|75800293|FG001|Double-blind Phase|Subject Decision|2|||
41992234|NCT01969838|75800294|FG002|Double-blind Phase|Subject Decision|0|||
42033371|NCT01129115|75841581|FG003|Overall Study|Adverse Event|3|||
42033372|NCT01129115|75841578|FG000|Overall Study|Withdrawal by Subject|1|||
42133019|NCT00561353|75943867|FG009|Overall Study|Withdrawal by Subject|0|||
42310313|NCT02358343|76146087|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
42310314|NCT02358343|76146088|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
42310315|NCT02358343|76146089|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
42310316|NCT02358343|76146085|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
42310317|NCT02358343|76146086|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
42310318|NCT02358343|76146087|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
42310319|NCT02358343|76146088|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
42310320|NCT02358343|76146089|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
42310321|NCT02356783|76146102|FG000|Overall Study|Lost to Follow-up|1|||
42310322|NCT02356783|76146103|FG001|Overall Study|Lost to Follow-up|3|||
42310323|NCT02289469|76146111|FG000|Overall Study|Unable to match a control|6|||
42310324|NCT02289469|76146112|FG001|Overall Study|Unable to match a control|0|||
42310325|NCT02318095|76146118|FG000|Overall Study|Adverse Event|1|||
42310326|NCT02317705|76146123|FG000|Overall Study|Withdrawal by Subject|3|||
42310327|NCT02317705|76146123|FG000|Overall Study|Physician Decision|1|||
42310328|NCT02317705|76146123|FG000|Overall Study|Drug not usable|1|||
42310329|NCT02474069|76146127|FG000|Selection Phase (SP)|Adverse Event|8|||
42310330|NCT02474069|76146128|FG001|Selection Phase (SP)|Adverse Event|0|||
42310331|NCT02474069|76146129|FG002|Selection Phase (SP)|Adverse Event|0|||
42310332|NCT02474069|76146127|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
42310333|NCT02474069|76146128|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
42310334|NCT02474069|76146129|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
42310335|NCT02474069|76146127|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
42310336|NCT02474069|76146128|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
42310337|NCT02474069|76146129|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
42310338|NCT02474069|76146127|FG000|Selection Phase (SP)|Physician Decision|1|||
42310339|NCT02474069|76146128|FG001|Selection Phase (SP)|Physician Decision|0|||
42310340|NCT02474069|76146129|FG002|Selection Phase (SP)|Physician Decision|0|||
42310341|NCT02474069|76146127|FG000|Selection Phase (SP)|Protocol Violation|1|||
42310342|NCT02474069|76146128|FG001|Selection Phase (SP)|Protocol Violation|0|||
42310343|NCT02474069|76146129|FG002|Selection Phase (SP)|Protocol Violation|0|||
42033373|NCT01129115|75841579|FG001|Overall Study|Withdrawal by Subject|3|||
42310344|NCT02474069|76146127|FG000|Selection Phase (SP)|No longer requires treatment|1|||
42310345|NCT02474069|76146128|FG001|Selection Phase (SP)|No longer requires treatment|0|||
42310346|NCT02474069|76146129|FG002|Selection Phase (SP)|No longer requires treatment|0|||
42310347|NCT02474069|76146127|FG000|Selection Phase (SP)|Technical Problem|1|||
41992235|NCT01969838|75800295|FG003|Double-blind Phase|Subject Decision|0|||
42310348|NCT02474069|76146128|FG001|Selection Phase (SP)|Technical Problem|0|||
42310349|NCT02474069|76146129|FG002|Selection Phase (SP)|Technical Problem|0|||
42310350|NCT02474069|76146127|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
42310351|NCT02474069|76146128|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
42310352|NCT02474069|76146129|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
42310353|NCT02474069|76146127|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
42310354|NCT02474069|76146128|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
42310355|NCT02474069|76146129|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
42310356|NCT02474069|76146127|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
42310357|NCT02474069|76146128|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
42310358|NCT02474069|76146129|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
42310359|NCT02474069|76146127|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
42310360|NCT02474069|76146128|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
42310361|NCT02474069|76146129|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
42310362|NCT02474069|76146127|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
42310363|NCT02474069|76146128|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
42310364|NCT02474069|76146129|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
42310365|NCT02474069|76146127|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
42310366|NCT02474069|76146128|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
42310367|NCT02474069|76146129|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
42310368|NCT02317627|76146142|FG000|Overall Study|Withdrawal by Subject|0|||
42310369|NCT02317627|76146143|FG001|Overall Study|Withdrawal by Subject|1|||
42310370|NCT02317627|76146144|FG002|Overall Study|Withdrawal by Subject|1|||
42310371|NCT02317627|76146142|FG000|Overall Study|Lost to Follow-up|2|||
42310372|NCT02317627|76146143|FG001|Overall Study|Lost to Follow-up|0|||
42310373|NCT02317627|76146144|FG002|Overall Study|Lost to Follow-up|0|||
42253865|NCT03030599|76079937|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
42253866|NCT03030599|76079938|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
42253867|NCT03030599|76079936|FG000|Stable Dose|Protocol deviation|3|||
42253868|NCT03030599|76079937|FG001|Stable Dose|Protocol deviation|0|||
42253869|NCT03030599|76079938|FG002|Stable Dose|Protocol deviation|0|||
42253870|NCT03030599|76079936|FG000|Stable Dose|Adverse Event|1|||
42253871|NCT03030599|76079937|FG001|Stable Dose|Adverse Event|0|||
42253872|NCT03030599|76079938|FG002|Stable Dose|Adverse Event|0|||
42253873|NCT03030599|76079936|FG000|Stable Dose|Lost to Follow-up|1|||
42253874|NCT03030599|76079937|FG001|Stable Dose|Lost to Follow-up|0|||
42310374|NCT02317627|76146142|FG000|Overall Study|Stopped by Investigator|0|||
42310375|NCT02317627|76146143|FG001|Overall Study|Stopped by Investigator|1|||
42310376|NCT02317627|76146144|FG002|Overall Study|Stopped by Investigator|0|||
42310377|NCT02317627|76146142|FG000|Overall Study|Adverse Event|0|||
42253875|NCT03030599|76079938|FG002|Stable Dose|Lost to Follow-up|0|||
42310378|NCT02317627|76146143|FG001|Overall Study|Adverse Event|2|||
42310379|NCT02317627|76146144|FG002|Overall Study|Adverse Event|3|||
42310380|NCT02317627|76146142|FG000|Overall Study|Non-compliance with study drug|0|||
42310381|NCT02317627|76146143|FG001|Overall Study|Non-compliance with study drug|1|||
42310382|NCT02317627|76146144|FG002|Overall Study|Non-compliance with study drug|0|||
42310383|NCT02517905|76146160|FG000|Overall Study|Lost to Follow-up|4|||
42310384|NCT02517905|76146161|FG001|Overall Study|Lost to Follow-up|0|||
42310385|NCT02517905|76146160|FG000|Overall Study|Withdrawal by Subject|4|||
42310386|NCT02517905|76146161|FG001|Overall Study|Withdrawal by Subject|0|||
42310387|NCT02517905|76146160|FG000|Overall Study|Screen failure|2|||
42310388|NCT02517905|76146161|FG001|Overall Study|Screen failure|2|||
42310389|NCT02473913|76146169|FG000|Overall Study|Lost to Follow-up|3|||
42310390|NCT02473913|76146170|FG001|Overall Study|Lost to Follow-up|3|||
42310391|NCT02316847|76146178|FG000|Overall Study|Adverse Event|0|||
42310392|NCT02316847|76146179|FG001|Overall Study|Adverse Event|3|||
42310393|NCT02316847|76146178|FG000|Overall Study|Lost to Follow-up|0|||
42310394|NCT02316847|76146179|FG001|Overall Study|Lost to Follow-up|2|||
42310395|NCT02316847|76146178|FG000|Overall Study|Physician Decision|0|||
42310396|NCT02316847|76146179|FG001|Overall Study|Physician Decision|1|||
42310397|NCT02316847|76146178|FG000|Overall Study|Pregnancy|0|||
42310398|NCT02316847|76146179|FG001|Overall Study|Pregnancy|1|||
42310399|NCT02316847|76146178|FG000|Overall Study|Withdrawal by Subject|2|||
42310400|NCT02316847|76146179|FG001|Overall Study|Withdrawal by Subject|9|||
42310401|NCT02316847|76146178|FG000|Overall Study|Noncompliance with study drug|0|||
42310402|NCT02316847|76146179|FG001|Overall Study|Noncompliance with study drug|3|||
42310403|NCT02316847|76146178|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
42310404|NCT02316847|76146179|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
42310405|NCT02473523|76146187|FG000|Overall Study|Death|1|||
42310406|NCT02473523|76146187|FG000|Overall Study|Lost to Follow-up|1|||
42310407|NCT02316769|76146193|FG000|Overall Study|Physician Decision|1|||
42310408|NCT02316769|76146194|FG001|Overall Study|Physician Decision|0|||
42310409|NCT02316769|76146193|FG000|Overall Study|Withdrawal by Subject|1|||
42310410|NCT02316769|76146194|FG001|Overall Study|Withdrawal by Subject|0|||
42310411|NCT02473445|76146200|FG000|Overall Study|Withdrawal by Subject|2|||
42310412|NCT02473445|76146200|FG000|Overall Study|Sponsor Decision|20|||
42310413|NCT02473367|76146204|FG000|Wait 1|Withdrawal by Subject|1|||
42310414|NCT02473367|76146204|FG000|Period 4|Lost to Follow-up|1|||
42310415|NCT02316613|76146214|FG000|Overall Study|Death|63|||
42310416|NCT02316613|76146214|FG000|Overall Study|Lost to Follow-up|9|||
42310417|NCT02316613|76146214|FG000|Overall Study|Lymphoma transformation|2|||
42310418|NCT02316613|76146214|FG000|Overall Study|Participant moved/changed medical team|11|||
42310419|NCT02316613|76146214|FG000|Overall Study|No data and duplicate cases|5|||
42310420|NCT02316613|76146214|FG000|Overall Study|Did not met selection criteria|14|||
42310421|NCT02492165|76146233|FG000|Overall Study|Withdrawal by Subject|0|||
41992236|NCT01969838|75800292|FG000|Double-blind Phase|Disease Progression|2|||
41992237|NCT01969838|75800293|FG001|Double-blind Phase|Disease Progression|0|||
41992238|NCT01969838|75800294|FG002|Double-blind Phase|Disease Progression|0|||
41992239|NCT01969838|75800295|FG003|Double-blind Phase|Disease Progression|0|||
41992240|NCT01969838|75800292|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
41992241|NCT01969838|75800293|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
41992242|NCT01969838|75800294|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
41992243|NCT01969838|75800295|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
41992244|NCT01969838|75800292|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
41992245|NCT01969838|75800293|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
41992246|NCT01969838|75800294|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
41992247|NCT01969838|75800295|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
42310422|NCT02492165|76146234|FG001|Overall Study|Withdrawal by Subject|1|||
42310423|NCT02492165|76146235|FG002|Overall Study|Withdrawal by Subject|0|||
42310424|NCT02492165|76146236|FG003|Overall Study|Withdrawal by Subject|0|||
42310425|NCT02355691|76146248|FG000|Overall Study|Loss of Research Personnel|7|||
42310426|NCT02355691|76146249|FG001|Overall Study|Loss of Research Personnel|9|||
41992248|NCT01969838|75800292|FG000|Open-label Phase|Adverse Event|0|||
42310427|NCT02473289|76146257|FG000|Overall Study|Adverse Event|2|||
42310428|NCT02473289|76146258|FG001|Overall Study|Adverse Event|3|||
41992249|NCT01969838|75800293|FG001|Open-label Phase|Adverse Event|0|||
41992250|NCT01969838|75800294|FG002|Open-label Phase|Adverse Event|37|||
41992251|NCT01969838|75800295|FG003|Open-label Phase|Adverse Event|49|||
41992252|NCT01969838|75800292|FG000|Open-label Phase|Disease Progression|0|||
41992253|NCT01969838|75800293|FG001|Open-label Phase|Disease Progression|0|||
41992254|NCT01969838|75800294|FG002|Open-label Phase|Disease Progression|26|||
41992255|NCT01969838|75800295|FG003|Open-label Phase|Disease Progression|27|||
41992256|NCT01969838|75800292|FG000|Open-label Phase|Lack of Efficacy|0|||
41992257|NCT01969838|75800293|FG001|Open-label Phase|Lack of Efficacy|0|||
41992258|NCT01969838|75800294|FG002|Open-label Phase|Lack of Efficacy|17|||
41992259|NCT01969838|75800295|FG003|Open-label Phase|Lack of Efficacy|19|||
41992260|NCT01969838|75800292|FG000|Open-label Phase|Subject Decision|0|||
41992261|NCT01969838|75800293|FG001|Open-label Phase|Subject Decision|0|||
41992262|NCT01969838|75800294|FG002|Open-label Phase|Subject Decision|14|||
41992263|NCT01969838|75800295|FG003|Open-label Phase|Subject Decision|15|||
41992264|NCT01969838|75800292|FG000|Open-label Phase|Death|0|||
41992265|NCT01969838|75800293|FG001|Open-label Phase|Death|0|||
41992266|NCT01969838|75800294|FG002|Open-label Phase|Death|13|||
41992267|NCT01969838|75800295|FG003|Open-label Phase|Death|11|||
41992268|NCT01969838|75800292|FG000|Open-label Phase|Physician Decision|0|||
41992269|NCT01969838|75800293|FG001|Open-label Phase|Physician Decision|0|||
41992270|NCT01969838|75800294|FG002|Open-label Phase|Physician Decision|9|||
42310429|NCT02473289|76146257|FG000|Overall Study|Lost to Follow-up|1|||
42310430|NCT02473289|76146258|FG001|Overall Study|Lost to Follow-up|1|||
42310431|NCT02473289|76146257|FG000|Overall Study|Protocol Violation|0|||
42310432|NCT02473289|76146258|FG001|Overall Study|Protocol Violation|1|||
42310433|NCT02473289|76146257|FG000|Overall Study|Withdrawal of consent|6|||
42310434|NCT02473289|76146258|FG001|Overall Study|Withdrawal of consent|7|||
42310435|NCT02473289|76146257|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
42310436|NCT02473289|76146258|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
42310437|NCT02473289|76146257|FG000|Overall Study|Other|2|||
42310438|NCT02473289|76146258|FG001|Overall Study|Other|0|||
42310439|NCT02354599|76146270|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
42310440|NCT02354599|76146271|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
42310441|NCT02354599|76146272|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
42310442|NCT02354599|76146273|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
42310443|NCT02354599|76146274|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
42310444|NCT02354599|76146275|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
42310445|NCT02354599|76146270|FG000|Overall Study|Withdrawal by Subject|1|||
42310446|NCT02354599|76146271|FG001|Overall Study|Withdrawal by Subject|1|||
42310447|NCT02354599|76146272|FG002|Overall Study|Withdrawal by Subject|0|||
42310448|NCT02354599|76146273|FG003|Overall Study|Withdrawal by Subject|0|||
42310449|NCT02354599|76146274|FG004|Overall Study|Withdrawal by Subject|0|||
42310450|NCT02354599|76146275|FG005|Overall Study|Withdrawal by Subject|0|||
42310451|NCT02316223|76146298|FG000|Overall Study|Lack of Efficacy|0|||
42310452|NCT02316223|76146299|FG001|Overall Study|Lack of Efficacy|1|||
42310453|NCT02316223|76146300|FG002|Overall Study|Lack of Efficacy|1|||
42310454|NCT02316223|76146298|FG000|Overall Study|Lost to Follow-up|27|||
42310455|NCT02316223|76146299|FG001|Overall Study|Lost to Follow-up|34|||
42310456|NCT02316223|76146300|FG002|Overall Study|Lost to Follow-up|36|||
42310457|NCT02316223|76146298|FG000|Overall Study|COPD Diagnosis|3|||
42310458|NCT02316223|76146299|FG001|Overall Study|COPD Diagnosis|2|||
42310459|NCT02316223|76146300|FG002|Overall Study|COPD Diagnosis|3|||
42310460|NCT02316223|76146298|FG000|Overall Study|Reside outside study area|1|||
42310461|NCT02316223|76146299|FG001|Overall Study|Reside outside study area|1|||
42310462|NCT02316223|76146300|FG002|Overall Study|Reside outside study area|1|||
42310463|NCT02316223|76146298|FG000|Overall Study|No asthma|2|||
42310464|NCT02316223|76146299|FG001|Overall Study|No asthma|0|||
42310465|NCT02316223|76146300|FG002|Overall Study|No asthma|0|||
42310466|NCT02316223|76146298|FG000|Overall Study|Discontinued by PI|11|||
41992271|NCT01969838|75800295|FG003|Open-label Phase|Physician Decision|14|||
42310467|NCT02316223|76146299|FG001|Overall Study|Discontinued by PI|19|||
41992272|NCT01969838|75800292|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
41992273|NCT01969838|75800293|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
41992274|NCT01969838|75800294|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
42310468|NCT02316223|76146300|FG002|Overall Study|Discontinued by PI|3|||
42310469|NCT02286895|76146310|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
41992275|NCT01969838|75800295|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
41992276|NCT01165177|75800306|FG000|Overall Study|Serious Adverse Event|227|||
42310470|NCT02286895|76146311|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
42310471|NCT02286895|76146310|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
42310472|NCT02286895|76146311|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
42310473|NCT02286895|76146310|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
42310474|NCT02286895|76146311|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
42310475|NCT02472977|76146320|FG000|Overall Study|Disease progression|4|||
42310476|NCT02472977|76146321|FG001|Overall Study|Disease progression|25|||
42310477|NCT02472977|76146322|FG002|Overall Study|Disease progression|6|||
42310478|NCT02472977|76146320|FG000|Overall Study|Withdrawal by Subject|0|||
42310479|NCT02472977|76146321|FG001|Overall Study|Withdrawal by Subject|1|||
42310480|NCT02472977|76146322|FG002|Overall Study|Withdrawal by Subject|0|||
42310481|NCT02472977|76146320|FG000|Overall Study|Study drug toxicity|2|||
42310482|NCT02472977|76146321|FG001|Overall Study|Study drug toxicity|0|||
42310483|NCT02472977|76146322|FG002|Overall Study|Study drug toxicity|2|||
42310484|NCT02472977|76146320|FG000|Overall Study|Subject request to discontinue treatment|0|||
42310485|NCT02472977|76146321|FG001|Overall Study|Subject request to discontinue treatment|1|||
42310486|NCT02472977|76146322|FG002|Overall Study|Subject request to discontinue treatment|0|||
42310487|NCT02060487|76146333|FG000|Overall Study|Other|1|||
42310488|NCT02060487|76146334|FG001|Overall Study|Other|2|||
42310489|NCT02060487|76146335|FG002|Overall Study|Other|1|||
42310490|NCT02060487|76146333|FG000|Overall Study|Lack of Efficacy|0|||
42310491|NCT02060487|76146334|FG001|Overall Study|Lack of Efficacy|1|||
42310492|NCT02060487|76146335|FG002|Overall Study|Lack of Efficacy|0|||
42310493|NCT02060487|76146333|FG000|Overall Study|Withdrawal by Subject|3|||
42310494|NCT02060487|76146334|FG001|Overall Study|Withdrawal by Subject|10|||
42310495|NCT02060487|76146335|FG002|Overall Study|Withdrawal by Subject|4|||
42310496|NCT02060487|76146333|FG000|Overall Study|Study Terminated By Sponsor|87|||
42310497|NCT02060487|76146334|FG001|Overall Study|Study Terminated By Sponsor|89|||
42310498|NCT02060487|76146335|FG002|Overall Study|Study Terminated By Sponsor|100|||
42310499|NCT02060487|76146333|FG000|Overall Study|Randomized in error|1|||
42310500|NCT02060487|76146334|FG001|Overall Study|Randomized in error|0|||
42310501|NCT02060487|76146335|FG002|Overall Study|Randomized in error|0|||
42310502|NCT02060487|76146333|FG000|Overall Study|Protocol Violation|0|||
41992277|NCT01165177|75800307|FG001|Overall Study|Serious Adverse Event|235|||
41992278|NCT01165177|75800306|FG000|Overall Study|Withdrawal by Subject|368|||
41992279|NCT01165177|75800307|FG001|Overall Study|Withdrawal by Subject|354|||
41992280|NCT01165177|75800306|FG000|Overall Study|Protocol Violation|19|||
42310503|NCT02060487|76146334|FG001|Overall Study|Protocol Violation|1|||
42310504|NCT02060487|76146335|FG002|Overall Study|Protocol Violation|1|||
42310505|NCT02060487|76146333|FG000|Overall Study|Lost to Follow-up|3|||
42310506|NCT02060487|76146334|FG001|Overall Study|Lost to Follow-up|0|||
41992281|NCT01165177|75800307|FG001|Overall Study|Protocol Violation|21|||
41992282|NCT01165177|75800306|FG000|Overall Study|Non-serious adverse event|30|||
41992283|NCT01165177|75800307|FG001|Overall Study|Non-serious adverse event|18|||
41992284|NCT01165177|75800306|FG000|Overall Study|Other unspecified reasons|47|||
42310507|NCT02060487|76146335|FG002|Overall Study|Lost to Follow-up|2|||
42310508|NCT02060487|76146333|FG000|Overall Study|Death|34|||
42310509|NCT02060487|76146334|FG001|Overall Study|Death|25|||
42310510|NCT02060487|76146335|FG002|Overall Study|Death|19|||
42310511|NCT02060487|76146333|FG000|Overall Study|Adverse Event|0|||
42310512|NCT02060487|76146334|FG001|Overall Study|Adverse Event|0|||
42310513|NCT02060487|76146335|FG002|Overall Study|Adverse Event|1|||
42310514|NCT02059395|76146345|FG000|Overall Study|Lost to Follow-up|2|||
42253876|NCT03030599|76079936|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
42253877|NCT03030599|76079937|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
42253878|NCT03030599|76079938|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
42253879|NCT03030599|76079936|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
42253880|NCT03030599|76079937|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
42253881|NCT03030599|76079938|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
42253882|NCT03030599|76079936|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
42253883|NCT03030599|76079937|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
42253884|NCT03030599|76079938|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
42253885|NCT03030599|76079936|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
42253886|NCT03030599|76079937|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
42253887|NCT03030599|76079938|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
42253888|NCT03030599|76079936|FG000|Open-label Extension|Adverse Event|3|||
42253889|NCT03030599|76079937|FG001|Open-label Extension|Adverse Event|0|||
42253890|NCT03030599|76079938|FG002|Open-label Extension|Adverse Event|0|||
42253891|NCT03030599|76079936|FG000|Open-label Extension|Lost to Follow-up|2|||
42253892|NCT03030599|76079937|FG001|Open-label Extension|Lost to Follow-up|0|||
42253893|NCT03030599|76079938|FG002|Open-label Extension|Lost to Follow-up|0|||
42253894|NCT03030599|76079936|FG000|Open-label Extension|Lack of Efficacy|1|||
42253895|NCT03030599|76079937|FG001|Open-label Extension|Lack of Efficacy|0|||
42253896|NCT03030599|76079938|FG002|Open-label Extension|Lack of Efficacy|0|||
42253897|NCT03030599|76079936|FG000|Open-label Extension|Other Reason|1|||
42253898|NCT03030599|76079937|FG001|Open-label Extension|Other Reason|0|||
42253899|NCT03030599|76079938|FG002|Open-label Extension|Other Reason|0|||
42253900|NCT03028415|76079946|FG000|Overall Study|Lost to Follow-up|6|||
42253901|NCT03028415|76079947|FG001|Overall Study|Lost to Follow-up|3|||
42253902|NCT03028415|76079946|FG000|Overall Study|Withdrawal by Subject|1|||
42253903|NCT03028415|76079947|FG001|Overall Study|Withdrawal by Subject|0|||
42253904|NCT03028415|76079946|FG000|Overall Study|Discontinued due to COVID-19|1|||
42253905|NCT03028415|76079947|FG001|Overall Study|Discontinued due to COVID-19|0|||
42253906|NCT02692040|76079971|FG000|Overall Study|Protocol Violation|0|||
42253907|NCT02692040|76079972|FG001|Overall Study|Protocol Violation|0|||
42253908|NCT02692040|76079973|FG002|Overall Study|Protocol Violation|0|||
42253909|NCT02692040|76079974|FG003|Overall Study|Protocol Violation|0|||
42253910|NCT02692040|76079975|FG004|Overall Study|Protocol Violation|0|||
42253911|NCT02692040|76079976|FG005|Overall Study|Protocol Violation|0|||
42253912|NCT02692040|76079977|FG006|Overall Study|Protocol Violation|0|||
42253913|NCT02692040|76079978|FG007|Overall Study|Protocol Violation|0|||
42253914|NCT02692040|76079979|FG008|Overall Study|Protocol Violation|0|||
42253915|NCT02692040|76079980|FG009|Overall Study|Protocol Violation|0|||
42253916|NCT02692040|76079981|FG010|Overall Study|Protocol Violation|0|||
42253917|NCT02692040|76079982|FG011|Overall Study|Protocol Violation|0|||
42253918|NCT02692040|76079983|FG012|Overall Study|Protocol Violation|1|||
42253919|NCT02692040|76079984|FG013|Overall Study|Protocol Violation|0|||
42253920|NCT02692040|76079985|FG014|Overall Study|Protocol Violation|0|||
42253921|NCT02692040|76079986|FG015|Overall Study|Protocol Violation|0|||
42253922|NCT02692040|76079987|FG016|Overall Study|Protocol Violation|0|||
42253923|NCT02692040|76079971|FG000|Overall Study|Adverse Event|0|||
42253924|NCT02692040|76079972|FG001|Overall Study|Adverse Event|0|||
42310515|NCT02059395|76146346|FG001|Overall Study|Lost to Follow-up|4|||
42310516|NCT02059239|76146354|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
42310517|NCT02059239|76146355|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
42310518|NCT02059239|76146354|FG000|Overall Study|Physician Decision|1|||
41992285|NCT01165177|75800307|FG001|Overall Study|Other unspecified reasons|35|||
41992286|NCT01165177|75800306|FG000|Overall Study|Suspected HZ episode|0|||
41992287|NCT01165177|75800307|FG001|Overall Study|Suspected HZ episode|2|||
42310519|NCT02059239|76146355|FG001|Overall Study|Physician Decision|0|||
42310520|NCT02059161|76146364|FG000|Overall Study|Pregnancy|0|||
42310521|NCT02059161|76146365|FG001|Overall Study|Pregnancy|2|||
42310522|NCT02059161|76146364|FG000|Overall Study|Adverse Event|2|||
42310523|NCT02059161|76146365|FG001|Overall Study|Adverse Event|6|||
42310524|NCT02059161|76146364|FG000|Overall Study|Lost to Follow-up|20|||
42310525|NCT02059161|76146365|FG001|Overall Study|Lost to Follow-up|12|||
42310526|NCT02059161|76146364|FG000|Overall Study|Physician Decision|4|||
42310527|NCT02059161|76146365|FG001|Overall Study|Physician Decision|4|||
42310528|NCT02059161|76146364|FG000|Overall Study|Protocol Violation|1|||
42310529|NCT02059161|76146365|FG001|Overall Study|Protocol Violation|1|||
42310530|NCT02059161|76146364|FG000|Overall Study|Withdrawal by Subject|16|||
42310531|NCT02059161|76146365|FG001|Overall Study|Withdrawal by Subject|13|||
42310532|NCT02059161|76146364|FG000|Overall Study|Randomized in error, no study drug|0|||
42310533|NCT02059161|76146365|FG001|Overall Study|Randomized in error, no study drug|1|||
42310534|NCT02059161|76146364|FG000|Overall Study|Non-compliance with study drug|6|||
42310535|NCT02059161|76146365|FG001|Overall Study|Non-compliance with study drug|2|||
42310536|NCT01897714|76146377|FG000|Phase I (Dose Escalation)|Disease progression|3|||
42310537|NCT01897714|76146378|FG001|Phase I (Dose Escalation)|Disease progression|5|||
42310538|NCT01897714|76146379|FG002|Phase I (Dose Escalation)|Disease progression|1|||
42310539|NCT01897714|76146380|FG003|Phase I (Dose Escalation)|Disease progression|3|||
42310540|NCT01897714|76146381|FG004|Phase I (Dose Escalation)|Disease progression|0|||
42310541|NCT01897714|76146382|FG005|Phase I (Dose Escalation)|Disease progression|0|||
42310542|NCT01897714|76146377|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
42310543|NCT01897714|76146378|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
42310544|NCT01897714|76146379|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
42310545|NCT01897714|76146380|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
42310546|NCT01897714|76146381|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
42310547|NCT01897714|76146382|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
42310548|NCT01897714|76146377|FG000|Phase I (Dose Escalation)|Other|0|||
42310549|NCT01897714|76146378|FG001|Phase I (Dose Escalation)|Other|1|||
42310550|NCT01897714|76146379|FG002|Phase I (Dose Escalation)|Other|0|||
42310551|NCT01897714|76146380|FG003|Phase I (Dose Escalation)|Other|0|||
42310552|NCT01897714|76146381|FG004|Phase I (Dose Escalation)|Other|0|||
42310553|NCT01897714|76146382|FG005|Phase I (Dose Escalation)|Other|0|||
42310554|NCT01897714|76146377|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
42310555|NCT01897714|76146378|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
42310556|NCT01897714|76146379|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
42310557|NCT01897714|76146380|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
41992288|NCT01165177|75800306|FG000|Overall Study|Lost to Follow-up|183|||
41992289|NCT01165177|75800307|FG001|Overall Study|Lost to Follow-up|194|||
42253925|NCT02692040|76079973|FG002|Overall Study|Adverse Event|0|||
42253926|NCT02692040|76079974|FG003|Overall Study|Adverse Event|0|||
42253927|NCT02692040|76079975|FG004|Overall Study|Adverse Event|0|||
42253928|NCT02692040|76079976|FG005|Overall Study|Adverse Event|0|||
42253929|NCT02692040|76079977|FG006|Overall Study|Adverse Event|0|||
42253930|NCT02692040|76079978|FG007|Overall Study|Adverse Event|0|||
42253931|NCT02692040|76079979|FG008|Overall Study|Adverse Event|0|||
42253932|NCT02692040|76079980|FG009|Overall Study|Adverse Event|0|||
42253933|NCT02692040|76079981|FG010|Overall Study|Adverse Event|0|||
42253934|NCT02692040|76079982|FG011|Overall Study|Adverse Event|0|||
42253935|NCT02692040|76079983|FG012|Overall Study|Adverse Event|0|||
42253936|NCT02692040|76079984|FG013|Overall Study|Adverse Event|3|||
42253937|NCT02692040|76079985|FG014|Overall Study|Adverse Event|1|||
42253938|NCT02692040|76079986|FG015|Overall Study|Adverse Event|1|||
42253939|NCT02692040|76079987|FG016|Overall Study|Adverse Event|0|||
42253940|NCT03029819|76080066|FG000|Overall Study|Lost to Follow-up|3|||
42310558|NCT01897714|76146381|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
42253941|NCT03029819|76080067|FG001|Overall Study|Lost to Follow-up|5|||
42310559|NCT01897714|76146382|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
42310560|NCT01897714|76146377|FG000|Phase II (MTD)|Lost to Follow-up|0|||
42310561|NCT01897714|76146378|FG001|Phase II (MTD)|Lost to Follow-up|0|||
42310562|NCT01897714|76146379|FG002|Phase II (MTD)|Lost to Follow-up|0|||
42310563|NCT01897714|76146380|FG003|Phase II (MTD)|Lost to Follow-up|0|||
42010558|NCT00993421|75817695|FG001|Overall Study|Sponsor Decision|31|||
42253942|NCT03029819|76080066|FG000|Overall Study|Removed due to disruptive behavior|0|||
42253943|NCT03029819|76080067|FG001|Overall Study|Removed due to disruptive behavior|1|||
42253944|NCT02678390|76080078|FG000|AE (1 Day)|Withdrawal by Subject|0|||
42253945|NCT02678390|76080079|FG001|AE (1 Day)|Withdrawal by Subject|1|||
42310564|NCT01897714|76146381|FG004|Phase II (MTD)|Lost to Follow-up|1|||
42310565|NCT01897714|76146382|FG005|Phase II (MTD)|Lost to Follow-up|0|||
42310566|NCT01897714|76146377|FG000|Phase II (MTD)|Death|0|||
42310567|NCT01897714|76146378|FG001|Phase II (MTD)|Death|0|||
42310568|NCT01897714|76146379|FG002|Phase II (MTD)|Death|0|||
42310569|NCT01897714|76146380|FG003|Phase II (MTD)|Death|0|||
42310570|NCT01897714|76146381|FG004|Phase II (MTD)|Death|25|||
42310571|NCT01897714|76146382|FG005|Phase II (MTD)|Death|10|||
42310572|NCT01897714|76146377|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
41992290|NCT01165177|75800306|FG000|Overall Study|Migrated/ moved from study area|48|||
41992291|NCT01165177|75800307|FG001|Overall Study|Migrated/ moved from study area|43|||
41992292|NCT01165138|75800324|FG000|Overall Study|Adverse Event|0|||
42133020|NCT00560885|75943934|FG000|Overall Study|Death|7|||
42310573|NCT01897714|76146378|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
42310574|NCT01897714|76146379|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
42310575|NCT01897714|76146380|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
42310576|NCT01897714|76146381|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
42310577|NCT01897714|76146382|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
42310578|NCT01897714|76146377|FG000|Phase II (MTD)|Other|0|||
42310579|NCT01897714|76146378|FG001|Phase II (MTD)|Other|0|||
42310580|NCT01897714|76146379|FG002|Phase II (MTD)|Other|0|||
42310581|NCT01897714|76146380|FG003|Phase II (MTD)|Other|0|||
42310582|NCT01897714|76146381|FG004|Phase II (MTD)|Other|3|||
42310583|NCT01897714|76146382|FG005|Phase II (MTD)|Other|0|||
42310584|NCT01861522|76146400|FG000|Overall Study|Adverse Event|1|||
42310585|NCT01861522|76146401|FG001|Overall Study|Adverse Event|0|||
42310586|NCT01861522|76146400|FG000|Overall Study|Withdrawal by Subject|2|||
42310587|NCT01861522|76146401|FG001|Overall Study|Withdrawal by Subject|0|||
42310588|NCT01860976|76146409|FG000|Blinded Treatment|Adverse Event|1|||
42310589|NCT01860976|76146410|FG001|Blinded Treatment|Adverse Event|3|||
42310590|NCT01860976|76146409|FG000|Blinded Treatment|Lack of Efficacy|5|||
42310591|NCT01860976|76146410|FG001|Blinded Treatment|Lack of Efficacy|12|||
42310592|NCT01860976|76146409|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
42310593|NCT01860976|76146410|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
42310594|NCT01860976|76146409|FG000|Blinded Treatment|Withdrawal by Subject|3|||
42310595|NCT01860976|76146410|FG001|Blinded Treatment|Withdrawal by Subject|5|||
42310596|NCT01860976|76146409|FG000|Blinded Treatment|Subject no longer met criteria|1|||
42310597|NCT01860976|76146410|FG001|Blinded Treatment|Subject no longer met criteria|0|||
42310598|NCT01860976|76146409|FG000|Blinded Treatment|Entered Open-Label in error|0|||
42310599|NCT01860976|76146410|FG001|Blinded Treatment|Entered Open-Label in error|1|||
42310600|NCT01860976|76146409|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
42310601|NCT01860976|76146410|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
42310602|NCT01860976|76146409|FG000|Open-Label|Adverse Event|2|||
42310603|NCT01860976|76146410|FG001|Open-Label|Adverse Event|4|||
42310604|NCT01860976|76146409|FG000|Open-Label|Lack of Efficacy|16|||
42310605|NCT01860976|76146410|FG001|Open-Label|Lack of Efficacy|8|||
42310606|NCT01860976|76146409|FG000|Open-Label|Lost to Follow-up|1|||
42310607|NCT01860976|76146410|FG001|Open-Label|Lost to Follow-up|2|||
42310608|NCT01860976|76146409|FG000|Open-Label|Subject request discontinue treatment|4|||
42310609|NCT01860976|76146410|FG001|Open-Label|Subject request discontinue treatment|3|||
42310610|NCT01860976|76146409|FG000|Open-Label|Withdrawal by Subject|4|||
42310611|NCT01860976|76146410|FG001|Open-Label|Withdrawal by Subject|1|||
42310612|NCT01860976|76146409|FG000|Open-Label|Other Reasons|1|||
42310613|NCT01860976|76146410|FG001|Open-Label|Other Reasons|1|||
42310614|NCT01860976|76146409|FG000|Long Term Extension|Adverse Event|4|||
42310615|NCT01860976|76146410|FG001|Long Term Extension|Adverse Event|0|||
42310616|NCT01860976|76146409|FG000|Long Term Extension|Lack of Efficacy|2|||
42310617|NCT01860976|76146410|FG001|Long Term Extension|Lack of Efficacy|0|||
42310618|NCT01860976|76146409|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
42310619|NCT01860976|76146410|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
42310620|NCT01860976|76146409|FG000|Long Term Extension|Lost to Follow-up|2|||
42310621|NCT01860976|76146410|FG001|Long Term Extension|Lost to Follow-up|0|||
42310622|NCT01860976|76146409|FG000|Long Term Extension|subject withdrew consent|7|||
42310623|NCT01860976|76146410|FG001|Long Term Extension|subject withdrew consent|0|||
42310624|NCT01860040|76146421|FG000|Overall Study|Withdrawal by Subject|1|||
42310625|NCT01860040|76146422|FG001|Overall Study|Withdrawal by Subject|0|||
42310626|NCT01896934|76146427|FG000|Overall Study|Adverse Event|1|||
42310627|NCT01896934|76146427|FG000|Overall Study|Withdrawal by Subject|1|||
42310628|NCT02039505|76146434|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
42310629|NCT02039505|76146435|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
42310630|NCT02039505|76146436|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
42310631|NCT02039505|76146437|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
42310632|NCT02039505|76146438|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
42310633|NCT02039505|76146439|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
42310634|NCT02039505|76146440|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
42310635|NCT02039505|76146434|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
42310636|NCT02039505|76146435|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
42310637|NCT02039505|76146436|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
42310638|NCT02039505|76146437|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
42310639|NCT02039505|76146438|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
42310640|NCT02039505|76146439|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
42310641|NCT02039505|76146440|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
42310642|NCT02039505|76146434|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
42310643|NCT02039505|76146435|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
42310644|NCT02039505|76146436|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
42310645|NCT02039505|76146437|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
42310646|NCT02039505|76146438|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
42310647|NCT02039505|76146439|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
42310648|NCT02039505|76146440|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
42310649|NCT02039505|76146434|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
42310650|NCT02039505|76146435|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
42310651|NCT02039505|76146436|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
42310652|NCT02039505|76146437|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
42310653|NCT02039505|76146438|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
42310654|NCT02039505|76146439|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
42310655|NCT02039505|76146440|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
42310656|NCT02039505|76146434|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
42310657|NCT02039505|76146435|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
42310658|NCT02039505|76146436|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
42310659|NCT02039505|76146437|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
42310660|NCT02039505|76146438|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
42310661|NCT02039505|76146439|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
42310662|NCT02039505|76146440|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
42310663|NCT02039505|76146434|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
42310664|NCT02039505|76146435|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
42310665|NCT02039505|76146436|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
42310666|NCT02039505|76146437|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
42310667|NCT02039505|76146438|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
42310668|NCT02039505|76146439|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
42310669|NCT02039505|76146440|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
42310670|NCT02039505|76146434|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
42310671|NCT02039505|76146435|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
42310672|NCT02039505|76146436|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
42310673|NCT02039505|76146437|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
42310674|NCT02039505|76146438|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
42310675|NCT02039505|76146439|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
42310676|NCT02039505|76146440|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
42310677|NCT02039505|76146434|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
42310678|NCT02039505|76146435|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
42310679|NCT02039505|76146436|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
42310680|NCT02039505|76146437|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
42310681|NCT02039505|76146438|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
42310682|NCT02039505|76146439|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
42310683|NCT02039505|76146440|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
42310684|NCT02039505|76146434|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
42310685|NCT02039505|76146435|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
42310686|NCT02039505|76146436|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
42310687|NCT02039505|76146437|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
42310688|NCT02039505|76146438|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
42310689|NCT02039505|76146439|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
42310690|NCT02039505|76146440|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
42310691|NCT02039505|76146434|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
42310692|NCT02039505|76146435|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
42310693|NCT02039505|76146436|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
42253946|NCT03027557|76080088|FG000|Overall Study|Adverse Event|1|||
42310694|NCT02039505|76146437|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
42310695|NCT02039505|76146438|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
42310696|NCT02039505|76146439|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
42310697|NCT02039505|76146440|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
42310698|NCT02039505|76146434|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
42310699|NCT02039505|76146435|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
42310700|NCT02039505|76146436|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
42310701|NCT02039505|76146437|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
42310702|NCT02039505|76146438|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
42310703|NCT02039505|76146439|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
42310704|NCT02039505|76146440|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
42310705|NCT02095197|76146462|FG000|Overall Study|Lost to Follow-up|0|||
42310706|NCT02095197|76146463|FG001|Overall Study|Lost to Follow-up|3|||
42310707|NCT02039427|76146473|FG000|Overall Study|Duration of surgery > 3h|1|||
42310708|NCT02039427|76146474|FG001|Overall Study|Duration of surgery > 3h|1|||
42310709|NCT02039427|76146475|FG002|Overall Study|Duration of surgery > 3h|0|||
42310710|NCT02039427|76146476|FG003|Overall Study|Duration of surgery > 3h|0|||
42310711|NCT02039427|76146473|FG000|Overall Study|Withdrawal on concent|0|||
42310712|NCT02039427|76146474|FG001|Overall Study|Withdrawal on concent|0|||
42310713|NCT02039427|76146475|FG002|Overall Study|Withdrawal on concent|0|||
42310714|NCT02039427|76146476|FG003|Overall Study|Withdrawal on concent|1|||
42310715|NCT02039427|76146473|FG000|Overall Study|Cancellation of surgery|0|||
42310716|NCT02039427|76146474|FG001|Overall Study|Cancellation of surgery|0|||
42310717|NCT02039427|76146475|FG002|Overall Study|Cancellation of surgery|1|||
42310718|NCT02039427|76146476|FG003|Overall Study|Cancellation of surgery|0|||
42310719|NCT02039427|76146473|FG000|Overall Study|Loss of follow - up|1|||
42310720|NCT02039427|76146474|FG001|Overall Study|Loss of follow - up|0|||
42310721|NCT02039427|76146475|FG002|Overall Study|Loss of follow - up|2|||
42310722|NCT02039427|76146476|FG003|Overall Study|Loss of follow - up|4|||
42310723|NCT02039427|76146473|FG000|Overall Study|Steroid Use|1|||
42310724|NCT02039427|76146474|FG001|Overall Study|Steroid Use|0|||
42310725|NCT02039427|76146475|FG002|Overall Study|Steroid Use|0|||
42310726|NCT02039427|76146476|FG003|Overall Study|Steroid Use|0|||
42310727|NCT02094885|76146492|FG000|Overall Study|Death|1|||
42310728|NCT02094885|76146493|FG001|Overall Study|Death|5|||
42310729|NCT02094885|76146492|FG000|Overall Study|Withdrawn due to age|1|||
42310730|NCT02094885|76146493|FG001|Overall Study|Withdrawn due to age|0|||
42310731|NCT01896856|76146505|FG000|Overall Study|Transportation issues / Non-compliance|0|||
42310732|NCT01896856|76146506|FG001|Overall Study|Transportation issues / Non-compliance|0|||
42310733|NCT01896856|76146507|FG002|Overall Study|Transportation issues / Non-compliance|1|||
42310734|NCT01896856|76146508|FG003|Overall Study|Transportation issues / Non-compliance|0|||
42310735|NCT01896856|76146509|FG004|Overall Study|Transportation issues / Non-compliance|0|||
42310736|NCT01896856|76146510|FG005|Overall Study|Transportation issues / Non-compliance|0|||
42310737|NCT02038959|76146527|FG000|Overall Study|Withdrawal by Subject|6|||
42310738|NCT02038959|76146528|FG001|Overall Study|Withdrawal by Subject|8|||
42310739|NCT01896700|76146536|FG000|Overall Study|Adverse Event|4|||
42310740|NCT01896700|76146537|FG001|Overall Study|Adverse Event|5|||
42310741|NCT01896700|76146536|FG000|Overall Study|Withdrawal by Subject|0|||
42310742|NCT01896700|76146537|FG001|Overall Study|Withdrawal by Subject|1|||
42310743|NCT02352493|76146561|FG000|Overall Study|Pregnancy|0|||
42310744|NCT02352493|76146562|FG001|Overall Study|Pregnancy|0|||
42310745|NCT02352493|76146563|FG002|Overall Study|Pregnancy|0|||
42310746|NCT02352493|76146564|FG003|Overall Study|Pregnancy|0|||
42310747|NCT02352493|76146565|FG004|Overall Study|Pregnancy|0|||
42310748|NCT02352493|76146566|FG005|Overall Study|Pregnancy|0|||
42310749|NCT02352493|76146567|FG006|Overall Study|Pregnancy|1|||
42310750|NCT02352493|76146568|FG007|Overall Study|Pregnancy|0|||
42310751|NCT02352493|76146569|FG008|Overall Study|Pregnancy|1|||
42310752|NCT02352493|76146570|FG009|Overall Study|Pregnancy|0|||
42253947|NCT03027557|76080089|FG001|Overall Study|Adverse Event|0|||
42253948|NCT03027557|76080090|FG002|Overall Study|Adverse Event|0|||
42253949|NCT03029585|76080100|FG000|Overall Study|Death|1|||
42253950|NCT03029585|76080101|FG001|Overall Study|Death|1|||
42253951|NCT03029585|76080100|FG000|Overall Study|Withdrawal by Subject|1|||
42253952|NCT03029585|76080101|FG001|Overall Study|Withdrawal by Subject|0|||
42253953|NCT02678000|76080112|FG000|PART 2|Adverse Event|0|||
42253954|NCT02678000|76080113|FG001|PART 2|Adverse Event|0|||
42253955|NCT02678000|76080114|FG002|PART 2|Adverse Event|2|||
42253956|NCT02678000|76080115|FG003|PART 2|Adverse Event|1|||
42310753|NCT02352493|76146571|FG010|Overall Study|Pregnancy|0|||
42310754|NCT02352493|76146572|FG011|Overall Study|Pregnancy|0|||
42310755|NCT02352493|76146573|FG012|Overall Study|Pregnancy|0|||
42310756|NCT02352493|76146574|FG013|Overall Study|Pregnancy|0|||
42310757|NCT02352493|76146575|FG014|Overall Study|Pregnancy|0|||
42310758|NCT02352493|76146576|FG015|Overall Study|Pregnancy|0|||
42310759|NCT02352493|76146577|FG016|Overall Study|Pregnancy|0|||
42310760|NCT02352493|76146578|FG017|Overall Study|Pregnancy|0|||
42310761|NCT02352493|76146561|FG000|Overall Study|Withdrawal by Subject|0|||
42310762|NCT02352493|76146562|FG001|Overall Study|Withdrawal by Subject|0|||
42310763|NCT02352493|76146563|FG002|Overall Study|Withdrawal by Subject|0|||
42310764|NCT02352493|76146564|FG003|Overall Study|Withdrawal by Subject|0|||
41992293|NCT01165138|75800325|FG001|Overall Study|Adverse Event|1|||
41992294|NCT01165138|75800326|FG002|Overall Study|Adverse Event|0|||
41992295|NCT01165138|75800327|FG003|Overall Study|Adverse Event|2|||
41992296|NCT01165138|75800324|FG000|Overall Study|Lack of Efficacy|0|||
41992297|NCT01165138|75800325|FG001|Overall Study|Lack of Efficacy|32|||
41992298|NCT01165138|75800326|FG002|Overall Study|Lack of Efficacy|6|||
41992299|NCT01165138|75800327|FG003|Overall Study|Lack of Efficacy|7|||
41992300|NCT01165138|75800324|FG000|Overall Study|Protocol Violation|0|||
41992301|NCT01165138|75800325|FG001|Overall Study|Protocol Violation|7|||
41992302|NCT01165138|75800326|FG002|Overall Study|Protocol Violation|0|||
41992303|NCT01165138|75800327|FG003|Overall Study|Protocol Violation|2|||
41992304|NCT01165138|75800324|FG000|Overall Study|Lost to Follow-up|0|||
41992305|NCT01165138|75800325|FG001|Overall Study|Lost to Follow-up|0|||
41992306|NCT01165138|75800326|FG002|Overall Study|Lost to Follow-up|1|||
41992307|NCT01165138|75800327|FG003|Overall Study|Lost to Follow-up|2|||
41992308|NCT01165138|75800324|FG000|Overall Study|Physician Decision|0|||
41992309|NCT01165138|75800325|FG001|Overall Study|Physician Decision|6|||
41992310|NCT01165138|75800326|FG002|Overall Study|Physician Decision|7|||
42253957|NCT02678000|76080116|FG004|PART 2|Adverse Event|0|||
42253958|NCT02678000|76080112|FG000|PART 2|Withdrawal by Subject|0|||
42253959|NCT02678000|76080113|FG001|PART 2|Withdrawal by Subject|0|||
42253960|NCT02678000|76080114|FG002|PART 2|Withdrawal by Subject|1|||
42253961|NCT02678000|76080115|FG003|PART 2|Withdrawal by Subject|0|||
42253962|NCT02678000|76080116|FG004|PART 2|Withdrawal by Subject|0|||
42253963|NCT02691572|76080143|FG000|Overall Study|Withdrawal by Subject|1|||
42253964|NCT02691572|76080144|FG001|Overall Study|Withdrawal by Subject|0|||
42253965|NCT02691572|76080143|FG000|Overall Study|Protocol Violation|0|||
42253966|NCT02691572|76080144|FG001|Overall Study|Protocol Violation|1|||
42253967|NCT02677844|76080152|FG000|Period 3|Withdrawal by Subject|0|||
42253968|NCT02677844|76080153|FG001|Period 3|Withdrawal by Subject|0|||
42253969|NCT02677844|76080154|FG002|Period 3|Withdrawal by Subject|0|||
42253970|NCT02677844|76080155|FG003|Period 3|Withdrawal by Subject|1|||
42253971|NCT02677844|76080156|FG004|Period 3|Withdrawal by Subject|0|||
42253972|NCT02677844|76080157|FG005|Period 3|Withdrawal by Subject|0|||
42253973|NCT02677844|76080158|FG006|Period 3|Withdrawal by Subject|0|||
42253974|NCT02691494|76080180|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
42253975|NCT02691494|76080181|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
42253976|NCT02691494|76080182|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
42253977|NCT02691494|76080180|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
42253978|NCT02691494|76080181|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
42253979|NCT02691494|76080182|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
42253980|NCT02691494|76080180|FG000|Post-Treatment Follow-Up Period|Other|2|||
42253981|NCT02691494|76080181|FG001|Post-Treatment Follow-Up Period|Other|1|||
42253982|NCT02691494|76080182|FG002|Post-Treatment Follow-Up Period|Other|1|||
42253983|NCT02691494|76080180|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
42253984|NCT02691494|76080181|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
42253985|NCT02691494|76080182|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
42310765|NCT02352493|76146565|FG004|Overall Study|Withdrawal by Subject|0|||
42310766|NCT02352493|76146566|FG005|Overall Study|Withdrawal by Subject|0|||
42310767|NCT02352493|76146567|FG006|Overall Study|Withdrawal by Subject|0|||
41992311|NCT01165138|75800327|FG003|Overall Study|Physician Decision|6|||
41992312|NCT01165138|75800324|FG000|Overall Study|Withdrawal by Subject|0|||
41992313|NCT01165138|75800325|FG001|Overall Study|Withdrawal by Subject|6|||
42033374|NCT01129115|75841580|FG002|Overall Study|Withdrawal by Subject|1|||
42033375|NCT01129115|75841581|FG003|Overall Study|Withdrawal by Subject|4|||
42310768|NCT02352493|76146568|FG007|Overall Study|Withdrawal by Subject|0|||
41992314|NCT01165138|75800326|FG002|Overall Study|Withdrawal by Subject|6|||
41992315|NCT01165138|75800327|FG003|Overall Study|Withdrawal by Subject|3|||
42253986|NCT02691494|76080180|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
42310769|NCT02352493|76146569|FG008|Overall Study|Withdrawal by Subject|1|||
42253987|NCT02691494|76080181|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
42310770|NCT02352493|76146570|FG009|Overall Study|Withdrawal by Subject|0|||
41992316|NCT01165021|75800335|FG000|Overall Study|Death|1|||
41992317|NCT01182844|75800341|FG000|Overall Study|Withdrawal by Subject|0|||
41992318|NCT01182844|75800342|FG001|Overall Study|Withdrawal by Subject|2|||
42310771|NCT02352493|76146571|FG010|Overall Study|Withdrawal by Subject|0|||
42310772|NCT02352493|76146572|FG011|Overall Study|Withdrawal by Subject|0|||
42310773|NCT02352493|76146573|FG012|Overall Study|Withdrawal by Subject|0|||
42310774|NCT02352493|76146574|FG013|Overall Study|Withdrawal by Subject|0|||
42310775|NCT02352493|76146575|FG014|Overall Study|Withdrawal by Subject|1|||
42310776|NCT02352493|76146576|FG015|Overall Study|Withdrawal by Subject|0|||
42310777|NCT02352493|76146577|FG016|Overall Study|Withdrawal by Subject|0|||
42310778|NCT02352493|76146578|FG017|Overall Study|Withdrawal by Subject|0|||
42310779|NCT02352493|76146561|FG000|Overall Study|Lost to Follow-up|0|||
42310780|NCT02352493|76146562|FG001|Overall Study|Lost to Follow-up|0|||
42310781|NCT02352493|76146563|FG002|Overall Study|Lost to Follow-up|0|||
42310782|NCT02352493|76146564|FG003|Overall Study|Lost to Follow-up|0|||
42310783|NCT02352493|76146565|FG004|Overall Study|Lost to Follow-up|0|||
42310784|NCT02352493|76146566|FG005|Overall Study|Lost to Follow-up|0|||
42310785|NCT02352493|76146567|FG006|Overall Study|Lost to Follow-up|0|||
42310786|NCT02352493|76146568|FG007|Overall Study|Lost to Follow-up|0|||
41992319|NCT01164865|75800350|FG000|Overall Study|Lost to Follow-up|2|||
41992320|NCT01164865|75800351|FG001|Overall Study|Lost to Follow-up|1|||
42310787|NCT02352493|76146569|FG008|Overall Study|Lost to Follow-up|0|||
42310788|NCT02352493|76146570|FG009|Overall Study|Lost to Follow-up|1|||
42310789|NCT02352493|76146571|FG010|Overall Study|Lost to Follow-up|0|||
42310790|NCT02352493|76146572|FG011|Overall Study|Lost to Follow-up|0|||
42310791|NCT02352493|76146573|FG012|Overall Study|Lost to Follow-up|1|||
42310792|NCT02352493|76146574|FG013|Overall Study|Lost to Follow-up|2|||
42310793|NCT02352493|76146575|FG014|Overall Study|Lost to Follow-up|0|||
42310794|NCT02352493|76146576|FG015|Overall Study|Lost to Follow-up|0|||
42310795|NCT02352493|76146577|FG016|Overall Study|Lost to Follow-up|0|||
42310796|NCT02352493|76146578|FG017|Overall Study|Lost to Follow-up|0|||
42310797|NCT02286193|76146633|FG000|Overall Study|Referred: CRS unable to make contact|62|||
42310798|NCT02286193|76146633|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
42310799|NCT02286193|76146633|FG000|Overall Study|Referred: Declined service|38|||
42310800|NCT01896232|76146640|FG000|Overall Study|Death|6|||
42310801|NCT01896232|76146641|FG001|Overall Study|Death|10|||
41992321|NCT01164475|75800359|FG000|Overall Study|Lack of Efficacy|1|||
41992322|NCT01164475|75800360|FG001|Overall Study|Lack of Efficacy|0|||
42253988|NCT02691494|76080182|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
42253989|NCT02677220|76080190|FG000|Overall Study|Adverse Event|1|||
42253990|NCT02682602|76080197|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
42253991|NCT02682602|76080198|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
42253992|NCT02682602|76080197|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
42310802|NCT01896232|76146640|FG000|Overall Study|Withdrawal by Subject|32|||
42310803|NCT01896232|76146641|FG001|Overall Study|Withdrawal by Subject|31|||
42310804|NCT01896232|76146640|FG000|Overall Study|Sponsor Decision|2|||
42310805|NCT01896232|76146641|FG001|Overall Study|Sponsor Decision|0|||
42310806|NCT01896232|76146640|FG000|Overall Study|Lost to Follow-up|9|||
42310807|NCT01896232|76146641|FG001|Overall Study|Lost to Follow-up|12|||
42310808|NCT02460224|76146676|FG000|Overall Study|Adverse Event|0|||
42310809|NCT02460224|76146677|FG001|Overall Study|Adverse Event|0|||
42310810|NCT02460224|76146678|FG002|Overall Study|Adverse Event|0|||
42310811|NCT02460224|76146679|FG003|Overall Study|Adverse Event|0|||
42310812|NCT02460224|76146680|FG004|Overall Study|Adverse Event|0|||
42253993|NCT02682602|76080198|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
42253994|NCT02681510|76080208|FG000|Overall Study|Withdrawal by Subject|1|||
42253995|NCT02681510|76080208|FG000|Overall Study|Lost to Follow-up|9|||
42253996|NCT02690714|76080212|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
42253997|NCT02690714|76080212|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
42253998|NCT01791543|76080220|FG000|Overall Study|Lost to Follow-up|1|||
42253999|NCT01791543|76080220|FG000|Overall Study|Adverse Event|1|||
42254000|NCT02925455|76080227|FG000|Overall Study|Withdrawal by Subject|2|||
42254001|NCT02925455|76080228|FG001|Overall Study|Withdrawal by Subject|0|||
42254002|NCT03033069|76080238|FG000|Overall Study|Adverse Event|6|||
42254003|NCT03033069|76080239|FG001|Overall Study|Adverse Event|7|||
42254004|NCT03033069|76080240|FG002|Overall Study|Adverse Event|4|||
42254005|NCT03033069|76080241|FG003|Overall Study|Adverse Event|6|||
42254006|NCT03033069|76080238|FG000|Overall Study|Lack of Efficacy|0|||
41992323|NCT01164475|75800359|FG000|Overall Study|Other|0|||
41992324|NCT01164475|75800360|FG001|Overall Study|Other|1|||
42310813|NCT02460224|76146681|FG005|Overall Study|Adverse Event|0|||
42310814|NCT02460224|76146682|FG006|Overall Study|Adverse Event|1|||
41992325|NCT01164475|75800359|FG000|Overall Study|Progressive disease|0|||
42254007|NCT03033069|76080239|FG001|Overall Study|Lack of Efficacy|0|||
42254008|NCT03033069|76080240|FG002|Overall Study|Lack of Efficacy|1|||
42310815|NCT02460224|76146683|FG007|Overall Study|Adverse Event|0|||
42310816|NCT02460224|76146684|FG008|Overall Study|Adverse Event|0|||
42310817|NCT02460224|76146685|FG009|Overall Study|Adverse Event|0|||
42310818|NCT02460224|76146686|FG010|Overall Study|Adverse Event|0|||
41992326|NCT01164475|75800360|FG001|Overall Study|Progressive disease|1|||
42310819|NCT02460224|76146687|FG011|Overall Study|Adverse Event|0|||
42254009|NCT03033069|76080241|FG003|Overall Study|Lack of Efficacy|0|||
42254010|NCT03033069|76080238|FG000|Overall Study|Lost to Follow-up|6|||
42254011|NCT03033069|76080239|FG001|Overall Study|Lost to Follow-up|5|||
42254012|NCT03033069|76080240|FG002|Overall Study|Lost to Follow-up|5|||
42254013|NCT03033069|76080241|FG003|Overall Study|Lost to Follow-up|6|||
42254014|NCT03033069|76080238|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42254015|NCT03033069|76080239|FG001|Overall Study|Non-Compliance With Study Drug|1|||
42254016|NCT03033069|76080240|FG002|Overall Study|Non-Compliance With Study Drug|1|||
42254017|NCT03033069|76080241|FG003|Overall Study|Non-Compliance With Study Drug|0|||
42254018|NCT03033069|76080238|FG000|Overall Study|Protocol Deviation|0|||
42254019|NCT03033069|76080239|FG001|Overall Study|Protocol Deviation|1|||
42254020|NCT03033069|76080240|FG002|Overall Study|Protocol Deviation|0|||
42254021|NCT03033069|76080241|FG003|Overall Study|Protocol Deviation|0|||
42254022|NCT03033069|76080238|FG000|Overall Study|Withdrawal by Subject|10|||
42254023|NCT03033069|76080239|FG001|Overall Study|Withdrawal by Subject|10|||
42254024|NCT03033069|76080240|FG002|Overall Study|Withdrawal by Subject|11|||
42254025|NCT03033069|76080241|FG003|Overall Study|Withdrawal by Subject|6|||
42254026|NCT03033069|76080238|FG000|Overall Study|Withdrawal By Caregiver|1|||
42254027|NCT03033069|76080239|FG001|Overall Study|Withdrawal By Caregiver|0|||
42254028|NCT03033069|76080240|FG002|Overall Study|Withdrawal By Caregiver|0|||
42310820|NCT02460224|76146688|FG012|Overall Study|Adverse Event|1|||
42310821|NCT02460224|76146689|FG013|Overall Study|Adverse Event|0|||
42310822|NCT02460224|76146690|FG014|Overall Study|Adverse Event|0|||
42310823|NCT02460224|76146691|FG015|Overall Study|Adverse Event|0|||
42310824|NCT02460224|76146692|FG016|Overall Study|Adverse Event|1|||
42133021|NCT00560885|75943934|FG000|Overall Study|Withdrawal by Subject|1|||
42133022|NCT00397215|75943942|FG000|Month 0 (Day 0)|Adverse Event|0|||
42310825|NCT02460224|76146693|FG017|Overall Study|Adverse Event|0|||
42310826|NCT02460224|76146694|FG018|Overall Study|Adverse Event|1|||
42310827|NCT02460224|76146695|FG019|Overall Study|Adverse Event|0|||
42310828|NCT02460224|76146696|FG020|Overall Study|Adverse Event|1|||
42310829|NCT02460224|76146697|FG021|Overall Study|Adverse Event|1|||
42310830|NCT02460224|76146698|FG022|Overall Study|Adverse Event|1|||
42310831|NCT02460224|76146699|FG023|Overall Study|Adverse Event|0|||
42310832|NCT02460224|76146700|FG024|Overall Study|Adverse Event|0|||
42310833|NCT02460224|76146701|FG025|Overall Study|Adverse Event|0|||
42310834|NCT02460224|76146702|FG026|Overall Study|Adverse Event|11|||
42310835|NCT02460224|76146703|FG027|Overall Study|Adverse Event|1|||
42310836|NCT02460224|76146704|FG028|Overall Study|Adverse Event|6|||
42310837|NCT02460224|76146676|FG000|Overall Study|Death|0|||
42310838|NCT02460224|76146677|FG001|Overall Study|Death|0|||
42310839|NCT02460224|76146678|FG002|Overall Study|Death|0|||
42310840|NCT02460224|76146679|FG003|Overall Study|Death|0|||
42310841|NCT02460224|76146680|FG004|Overall Study|Death|0|||
42310842|NCT02460224|76146681|FG005|Overall Study|Death|2|||
42310843|NCT02460224|76146682|FG006|Overall Study|Death|1|||
42310844|NCT02460224|76146683|FG007|Overall Study|Death|0|||
42310845|NCT02460224|76146684|FG008|Overall Study|Death|0|||
42310846|NCT02460224|76146685|FG009|Overall Study|Death|1|||
42310847|NCT02460224|76146686|FG010|Overall Study|Death|0|||
42310848|NCT02460224|76146687|FG011|Overall Study|Death|0|||
42310849|NCT02460224|76146688|FG012|Overall Study|Death|0|||
42254029|NCT03033069|76080241|FG003|Overall Study|Withdrawal By Caregiver|0|||
41992327|NCT01164475|75800359|FG000|Overall Study|Protocol Violation|1|||
42310850|NCT02460224|76146689|FG013|Overall Study|Death|1|||
42310851|NCT02460224|76146690|FG014|Overall Study|Death|0|||
42310852|NCT02460224|76146691|FG015|Overall Study|Death|0|||
42310853|NCT02460224|76146692|FG016|Overall Study|Death|2|||
42310854|NCT02460224|76146693|FG017|Overall Study|Death|1|||
42310855|NCT02460224|76146694|FG018|Overall Study|Death|0|||
42310856|NCT02460224|76146695|FG019|Overall Study|Death|2|||
42310857|NCT02460224|76146696|FG020|Overall Study|Death|0|||
42310858|NCT02460224|76146697|FG021|Overall Study|Death|0|||
41992328|NCT01164475|75800360|FG001|Overall Study|Protocol Violation|0|||
41992329|NCT01164007|75800366|FG000|Overall Study|Adverse Event|5|||
42254030|NCT03033069|76080238|FG000|Overall Study|Reason not Specified|0|||
42310859|NCT02460224|76146698|FG022|Overall Study|Death|0|||
42310860|NCT02460224|76146699|FG023|Overall Study|Death|0|||
42310861|NCT02460224|76146700|FG024|Overall Study|Death|1|||
42254031|NCT03033069|76080239|FG001|Overall Study|Reason not Specified|1|||
42254032|NCT03033069|76080240|FG002|Overall Study|Reason not Specified|0|||
42254033|NCT03033069|76080241|FG003|Overall Study|Reason not Specified|1|||
42310862|NCT02460224|76146701|FG025|Overall Study|Death|1|||
42310863|NCT02460224|76146702|FG026|Overall Study|Death|5|||
42310864|NCT02460224|76146703|FG027|Overall Study|Death|0|||
42310865|NCT02460224|76146704|FG028|Overall Study|Death|1|||
42310866|NCT02460224|76146676|FG000|Overall Study|Lost to Follow-up|0|||
41992330|NCT01164007|75800366|FG000|Overall Study|Progression of Disease|30|||
42310867|NCT02460224|76146677|FG001|Overall Study|Lost to Follow-up|0|||
42310868|NCT02460224|76146678|FG002|Overall Study|Lost to Follow-up|0|||
42310869|NCT02460224|76146679|FG003|Overall Study|Lost to Follow-up|0|||
42310870|NCT02460224|76146680|FG004|Overall Study|Lost to Follow-up|0|||
42310871|NCT02460224|76146681|FG005|Overall Study|Lost to Follow-up|0|||
42310872|NCT02460224|76146682|FG006|Overall Study|Lost to Follow-up|0|||
42310873|NCT02460224|76146683|FG007|Overall Study|Lost to Follow-up|0|||
42310874|NCT02460224|76146684|FG008|Overall Study|Lost to Follow-up|0|||
42310875|NCT02460224|76146685|FG009|Overall Study|Lost to Follow-up|0|||
42310876|NCT02460224|76146686|FG010|Overall Study|Lost to Follow-up|0|||
42310877|NCT02460224|76146687|FG011|Overall Study|Lost to Follow-up|0|||
42310878|NCT02460224|76146688|FG012|Overall Study|Lost to Follow-up|0|||
42310879|NCT02460224|76146689|FG013|Overall Study|Lost to Follow-up|0|||
42310880|NCT02460224|76146690|FG014|Overall Study|Lost to Follow-up|0|||
42310881|NCT02460224|76146691|FG015|Overall Study|Lost to Follow-up|0|||
42310882|NCT02460224|76146692|FG016|Overall Study|Lost to Follow-up|0|||
42310883|NCT02460224|76146693|FG017|Overall Study|Lost to Follow-up|0|||
42310884|NCT02460224|76146694|FG018|Overall Study|Lost to Follow-up|0|||
42310885|NCT02460224|76146695|FG019|Overall Study|Lost to Follow-up|0|||
42310886|NCT02460224|76146696|FG020|Overall Study|Lost to Follow-up|0|||
42310887|NCT02460224|76146697|FG021|Overall Study|Lost to Follow-up|0|||
42310888|NCT02460224|76146698|FG022|Overall Study|Lost to Follow-up|1|||
42310889|NCT02460224|76146699|FG023|Overall Study|Lost to Follow-up|0|||
42310890|NCT02460224|76146700|FG024|Overall Study|Lost to Follow-up|0|||
42310891|NCT02460224|76146701|FG025|Overall Study|Lost to Follow-up|0|||
42310892|NCT02460224|76146702|FG026|Overall Study|Lost to Follow-up|0|||
42310893|NCT02460224|76146703|FG027|Overall Study|Lost to Follow-up|0|||
42310894|NCT02460224|76146704|FG028|Overall Study|Lost to Follow-up|0|||
42310895|NCT02460224|76146676|FG000|Overall Study|Physician Decision|0|||
42310896|NCT02460224|76146677|FG001|Overall Study|Physician Decision|1|||
42310897|NCT02460224|76146678|FG002|Overall Study|Physician Decision|0|||
42310898|NCT02460224|76146679|FG003|Overall Study|Physician Decision|0|||
42310899|NCT02460224|76146680|FG004|Overall Study|Physician Decision|1|||
42310900|NCT02460224|76146681|FG005|Overall Study|Physician Decision|0|||
42310901|NCT02460224|76146682|FG006|Overall Study|Physician Decision|0|||
42310902|NCT02460224|76146683|FG007|Overall Study|Physician Decision|1|||
42310903|NCT02460224|76146684|FG008|Overall Study|Physician Decision|0|||
42254034|NCT02917265|76080253|FG000|Overall Study|Physician Decision|1|||
42254035|NCT02917265|76080254|FG001|Overall Study|Physician Decision|0|||
42254036|NCT02917265|76080253|FG000|Overall Study|Withdrawal by Subject|1|||
42254037|NCT02917265|76080254|FG001|Overall Study|Withdrawal by Subject|0|||
42254038|NCT02136069|76080264|FG000|Overall Study|UC flare-up|1|||
42254039|NCT02136069|76080265|FG001|Overall Study|UC flare-up|0|||
42254040|NCT02136069|76080264|FG000|Overall Study|Adverse Event|6|||
42254041|NCT02136069|76080265|FG001|Overall Study|Adverse Event|8|||
42254042|NCT02136069|76080264|FG000|Overall Study|Death|0|||
42254043|NCT02136069|76080265|FG001|Overall Study|Death|1|||
42254044|NCT02136069|76080264|FG000|Overall Study|Lack of Efficacy|10|||
42254045|NCT02136069|76080265|FG001|Overall Study|Lack of Efficacy|4|||
42254046|NCT02136069|76080264|FG000|Overall Study|Lost to Follow-up|1|||
42254047|NCT02136069|76080265|FG001|Overall Study|Lost to Follow-up|0|||
42254048|NCT02136069|76080264|FG000|Overall Study|Non-Compliance|1|||
42254049|NCT02136069|76080265|FG001|Overall Study|Non-Compliance|0|||
42254050|NCT02136069|76080264|FG000|Overall Study|Physician Decision|5|||
42254051|NCT02136069|76080265|FG001|Overall Study|Physician Decision|4|||
42254052|NCT02136069|76080264|FG000|Overall Study|Withdrawal by Subject|10|||
42254053|NCT02136069|76080265|FG001|Overall Study|Withdrawal by Subject|11|||
42310904|NCT02460224|76146685|FG009|Overall Study|Physician Decision|0|||
41992331|NCT01164007|75800366|FG000|Overall Study|Protocol Violation|1|||
41992332|NCT01164007|75800366|FG000|Overall Study|Withdrawal by Subject|1|||
41992333|NCT01164007|75800366|FG000|Overall Study|Medical Decision|3|||
42254054|NCT02917031|76080274|FG000|Overall Study|Reason not specified|7|||
42254055|NCT02917031|76080275|FG001|Overall Study|Reason not specified|5|||
42310905|NCT02460224|76146686|FG010|Overall Study|Physician Decision|0|||
42310906|NCT02460224|76146687|FG011|Overall Study|Physician Decision|1|||
42310907|NCT02460224|76146688|FG012|Overall Study|Physician Decision|0|||
42310908|NCT02460224|76146689|FG013|Overall Study|Physician Decision|1|||
42310909|NCT02460224|76146690|FG014|Overall Study|Physician Decision|0|||
42254056|NCT02917031|76080276|FG002|Overall Study|Reason not specified|6|||
42310910|NCT02460224|76146691|FG015|Overall Study|Physician Decision|0|||
42310911|NCT02460224|76146692|FG016|Overall Study|Physician Decision|2|||
41992334|NCT01163851|75800372|FG000|Overall Study|Site Closure|0|||
41992335|NCT01163851|75800373|FG001|Overall Study|Site Closure|1|||
41992336|NCT01163851|75800372|FG000|Overall Study|Enrolled but not treated|1|||
42310912|NCT02460224|76146693|FG017|Overall Study|Physician Decision|1|||
42310913|NCT02460224|76146694|FG018|Overall Study|Physician Decision|1|||
42310914|NCT02460224|76146695|FG019|Overall Study|Physician Decision|2|||
42310915|NCT02460224|76146696|FG020|Overall Study|Physician Decision|1|||
42310916|NCT02460224|76146697|FG021|Overall Study|Physician Decision|1|||
42310917|NCT02460224|76146698|FG022|Overall Study|Physician Decision|0|||
42310918|NCT02460224|76146699|FG023|Overall Study|Physician Decision|0|||
42310919|NCT02460224|76146700|FG024|Overall Study|Physician Decision|1|||
42310920|NCT02460224|76146701|FG025|Overall Study|Physician Decision|0|||
42310921|NCT02460224|76146702|FG026|Overall Study|Physician Decision|14|||
42254057|NCT02917031|76080274|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
42254058|NCT02917031|76080275|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
42254059|NCT02917031|76080276|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
42254060|NCT02917031|76080274|FG000|Overall Study|Withdrawal by Subject|3|||
42254061|NCT02917031|76080275|FG001|Overall Study|Withdrawal by Subject|3|||
42254062|NCT02917031|76080276|FG002|Overall Study|Withdrawal by Subject|0|||
42254063|NCT02917031|76080274|FG000|Overall Study|Physician Decision|1|||
42254064|NCT02917031|76080275|FG001|Overall Study|Physician Decision|0|||
42254065|NCT02917031|76080276|FG002|Overall Study|Physician Decision|0|||
42254066|NCT02917031|76080274|FG000|Overall Study|Adverse Event|4|||
42254067|NCT02917031|76080275|FG001|Overall Study|Adverse Event|1|||
42310922|NCT02460224|76146703|FG027|Overall Study|Physician Decision|1|||
42310923|NCT02460224|76146704|FG028|Overall Study|Physician Decision|6|||
42310924|NCT02460224|76146676|FG000|Overall Study|Progressive disease|15|||
42310925|NCT02460224|76146677|FG001|Overall Study|Progressive disease|11|||
42310926|NCT02460224|76146678|FG002|Overall Study|Progressive disease|5|||
42310927|NCT02460224|76146679|FG003|Overall Study|Progressive disease|6|||
42310928|NCT02460224|76146680|FG004|Overall Study|Progressive disease|3|||
42310929|NCT02460224|76146681|FG005|Overall Study|Progressive disease|26|||
42310930|NCT02460224|76146682|FG006|Overall Study|Progressive disease|28|||
42310931|NCT02460224|76146683|FG007|Overall Study|Progressive disease|4|||
42310932|NCT02460224|76146684|FG008|Overall Study|Progressive disease|5|||
42310933|NCT02460224|76146685|FG009|Overall Study|Progressive disease|9|||
42310934|NCT02460224|76146686|FG010|Overall Study|Progressive disease|5|||
42310935|NCT02460224|76146687|FG011|Overall Study|Progressive disease|4|||
42310936|NCT02460224|76146688|FG012|Overall Study|Progressive disease|5|||
42310937|NCT02460224|76146689|FG013|Overall Study|Progressive disease|4|||
42310938|NCT02460224|76146690|FG014|Overall Study|Progressive disease|5|||
42310939|NCT02460224|76146691|FG015|Overall Study|Progressive disease|5|||
42310940|NCT02460224|76146692|FG016|Overall Study|Progressive disease|15|||
42310941|NCT02460224|76146693|FG017|Overall Study|Progressive disease|3|||
42310942|NCT02460224|76146694|FG018|Overall Study|Progressive disease|8|||
42310943|NCT02460224|76146695|FG019|Overall Study|Progressive disease|3|||
42310944|NCT02460224|76146696|FG020|Overall Study|Progressive disease|4|||
42310945|NCT02460224|76146697|FG021|Overall Study|Progressive disease|9|||
42310946|NCT02460224|76146698|FG022|Overall Study|Progressive disease|4|||
42310947|NCT02460224|76146699|FG023|Overall Study|Progressive disease|11|||
42310948|NCT02460224|76146700|FG024|Overall Study|Progressive disease|4|||
42310949|NCT02460224|76146701|FG025|Overall Study|Progressive disease|5|||
42310950|NCT02460224|76146702|FG026|Overall Study|Progressive disease|85|||
42310951|NCT02460224|76146703|FG027|Overall Study|Progressive disease|17|||
42310952|NCT02460224|76146704|FG028|Overall Study|Progressive disease|77|||
42310953|NCT02460224|76146676|FG000|Overall Study|Subject/guardian decision|2|||
42310954|NCT02460224|76146677|FG001|Overall Study|Subject/guardian decision|0|||
42310955|NCT02460224|76146678|FG002|Overall Study|Subject/guardian decision|1|||
42310956|NCT02460224|76146679|FG003|Overall Study|Subject/guardian decision|0|||
42254068|NCT02917031|76080276|FG002|Overall Study|Adverse Event|5|||
42254069|NCT02917031|76080274|FG000|Overall Study|Death|2|||
42310957|NCT02460224|76146680|FG004|Overall Study|Subject/guardian decision|2|||
42310958|NCT02460224|76146681|FG005|Overall Study|Subject/guardian decision|2|||
42310959|NCT02460224|76146682|FG006|Overall Study|Subject/guardian decision|0|||
42310960|NCT02460224|76146683|FG007|Overall Study|Subject/guardian decision|0|||
42310961|NCT02460224|76146684|FG008|Overall Study|Subject/guardian decision|1|||
42310962|NCT02460224|76146685|FG009|Overall Study|Subject/guardian decision|1|||
42310963|NCT02460224|76146686|FG010|Overall Study|Subject/guardian decision|0|||
42310964|NCT02460224|76146687|FG011|Overall Study|Subject/guardian decision|1|||
42310965|NCT02460224|76146688|FG012|Overall Study|Subject/guardian decision|0|||
42133023|NCT00397215|75943943|FG001|Month 0 (Day 0)|Adverse Event|1|||
42254070|NCT02917031|76080275|FG001|Overall Study|Death|3|||
42254071|NCT02917031|76080276|FG002|Overall Study|Death|4|||
42254072|NCT01018563|76080285|FG000|Overall Study|Termination of the study by Sponsor|2|||
42254073|NCT01018563|76080286|FG001|Overall Study|Termination of the study by Sponsor|1|||
42254074|NCT02528188|76080299|FG000|Overall Study|Adverse Event|23|||
42254075|NCT02528188|76080300|FG001|Overall Study|Adverse Event|22|||
42254076|NCT02528188|76080301|FG002|Overall Study|Adverse Event|8|||
42254077|NCT02528188|76080299|FG000|Overall Study|Protocol Violation|4|||
42254078|NCT02528188|76080300|FG001|Overall Study|Protocol Violation|6|||
42254079|NCT02528188|76080301|FG002|Overall Study|Protocol Violation|4|||
42254080|NCT02528188|76080299|FG000|Overall Study|Lack of Efficacy|19|||
42254081|NCT02528188|76080300|FG001|Overall Study|Lack of Efficacy|21|||
42254082|NCT02528188|76080301|FG002|Overall Study|Lack of Efficacy|22|||
42254083|NCT02528188|76080299|FG000|Overall Study|Withdrawal by Subject|97|||
42254084|NCT02528188|76080300|FG001|Overall Study|Withdrawal by Subject|104|||
42254085|NCT02528188|76080301|FG002|Overall Study|Withdrawal by Subject|100|||
42254086|NCT02528188|76080299|FG000|Overall Study|Lost to Follow-up|25|||
42254087|NCT02528188|76080300|FG001|Overall Study|Lost to Follow-up|21|||
42254088|NCT02528188|76080301|FG002|Overall Study|Lost to Follow-up|31|||
42254089|NCT02528188|76080299|FG000|Overall Study|Death|4|||
42254090|NCT02528188|76080300|FG001|Overall Study|Death|4|||
42254091|NCT02528188|76080301|FG002|Overall Study|Death|0|||
42254092|NCT02528188|76080299|FG000|Overall Study|Other|89|||
42254093|NCT02528188|76080300|FG001|Overall Study|Other|91|||
42254094|NCT02528188|76080301|FG002|Overall Study|Other|74|||
42254095|NCT02528188|76080299|FG000|Overall Study|Randomized but not treated|6|||
42254096|NCT02528188|76080300|FG001|Overall Study|Randomized but not treated|7|||
42254097|NCT02528188|76080301|FG002|Overall Study|Randomized but not treated|12|||
42254098|NCT03896165|76080309|FG000|Overall Study|Withdrawal by Subject|2|||
42254099|NCT05361304|76080322|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
42254100|NCT05361304|76080323|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
42254101|NCT05361304|76080322|FG000|Overall Study|COVID-19 Related|1|||
42254102|NCT05361304|76080323|FG001|Overall Study|COVID-19 Related|2|||
42254103|NCT05361304|76080322|FG000|Overall Study|Withdrawal by Subject|1|||
42254104|NCT05361304|76080323|FG001|Overall Study|Withdrawal by Subject|0|||
42254105|NCT02269917|76080346|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
42254106|NCT02269917|76080347|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
42254107|NCT02269917|76080348|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
42254108|NCT02269917|76080346|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
42254109|NCT02269917|76080347|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
42254110|NCT02269917|76080348|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
42254111|NCT02269917|76080346|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
42254112|NCT02269917|76080347|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
42254113|NCT02269917|76080348|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
42254114|NCT02269917|76080346|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
42254115|NCT02269917|76080347|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
42254116|NCT02269917|76080348|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
42254117|NCT02269917|76080346|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
42254118|NCT02269917|76080347|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
42310966|NCT02460224|76146689|FG013|Overall Study|Subject/guardian decision|0|||
42310967|NCT02460224|76146690|FG014|Overall Study|Subject/guardian decision|0|||
42310968|NCT02460224|76146691|FG015|Overall Study|Subject/guardian decision|1|||
42310969|NCT02460224|76146692|FG016|Overall Study|Subject/guardian decision|0|||
42310970|NCT02460224|76146693|FG017|Overall Study|Subject/guardian decision|1|||
42133024|NCT00397215|75943944|FG002|Month 0 (Day 0)|Adverse Event|0|||
42133025|NCT00397215|75943945|FG003|Month 0 (Day 0)|Adverse Event|0|||
42133026|NCT00397215|75943942|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
42133027|NCT00397215|75943943|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
42133028|NCT00397215|75943944|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
42133029|NCT00397215|75943945|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
42133030|NCT00397215|75943942|FG000|Month 0 (Day 0)|Other|4|||
42133031|NCT00397215|75943943|FG001|Month 0 (Day 0)|Other|1|||
42133032|NCT00397215|75943944|FG002|Month 0 (Day 0)|Other|3|||
42133033|NCT00397215|75943945|FG003|Month 0 (Day 0)|Other|3|||
42254119|NCT02269917|76080348|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
41992337|NCT01163851|75800373|FG001|Overall Study|Enrolled but not treated|0|||
42254120|NCT02269917|76080346|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
42310971|NCT02460224|76146694|FG018|Overall Study|Subject/guardian decision|2|||
42133034|NCT00397215|75943942|FG000|Month 6 (Day 180)|Adverse Event|0|||
42133035|NCT00397215|75943943|FG001|Month 6 (Day 180)|Adverse Event|3|||
42133036|NCT00397215|75943944|FG002|Month 6 (Day 180)|Adverse Event|2|||
42310972|NCT02460224|76146695|FG019|Overall Study|Subject/guardian decision|0|||
42310973|NCT02460224|76146696|FG020|Overall Study|Subject/guardian decision|0|||
42310974|NCT02460224|76146697|FG021|Overall Study|Subject/guardian decision|1|||
42310975|NCT02460224|76146698|FG022|Overall Study|Subject/guardian decision|0|||
42310976|NCT02460224|76146699|FG023|Overall Study|Subject/guardian decision|0|||
42310977|NCT02460224|76146700|FG024|Overall Study|Subject/guardian decision|0|||
42310978|NCT02460224|76146701|FG025|Overall Study|Subject/guardian decision|0|||
42310979|NCT02460224|76146702|FG026|Overall Study|Subject/guardian decision|6|||
42310980|NCT02460224|76146703|FG027|Overall Study|Subject/guardian decision|2|||
42310981|NCT02460224|76146704|FG028|Overall Study|Subject/guardian decision|3|||
42310982|NCT02094573|76146778|FG000|Overall Study|Adverse Event|4|||
42310983|NCT02094573|76146779|FG001|Overall Study|Adverse Event|14|||
42310984|NCT02094573|76146778|FG000|Overall Study|Clinical Progressive Disease|9|||
42310985|NCT02094573|76146779|FG001|Overall Study|Clinical Progressive Disease|13|||
42310986|NCT02094573|76146778|FG000|Overall Study|Death|11|||
42310987|NCT02094573|76146779|FG001|Overall Study|Death|3|||
42310988|NCT02094573|76146778|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
42310989|NCT02094573|76146779|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
42310990|NCT02094573|76146778|FG000|Overall Study|Non-compliance with Study Drug|1|||
42310991|NCT02094573|76146779|FG001|Overall Study|Non-compliance with Study Drug|1|||
42310992|NCT02094573|76146778|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
42310993|NCT02094573|76146779|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
42310994|NCT02094573|76146778|FG000|Overall Study|Physician Decision|4|||
42310995|NCT02094573|76146779|FG001|Overall Study|Physician Decision|4|||
42310996|NCT02094573|76146778|FG000|Overall Study|Site Terminated by Sponsor|10|||
42133037|NCT00397215|75943945|FG003|Month 6 (Day 180)|Adverse Event|0|||
42133038|NCT00397215|75943942|FG000|Month 6 (Day 180)|Other|2|||
42133039|NCT00397215|75943943|FG001|Month 6 (Day 180)|Other|0|||
42133040|NCT00397215|75943944|FG002|Month 6 (Day 180)|Other|3|||
42133041|NCT00397215|75943945|FG003|Month 6 (Day 180)|Other|0|||
42133042|NCT00556439|75943962|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
42133043|NCT00556439|75943963|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
42133044|NCT00556439|75943964|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
42133045|NCT00556439|75943965|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
42254121|NCT02269917|76080347|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
42254122|NCT02269917|76080348|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
42254123|NCT02269917|76080346|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
42254124|NCT02269917|76080347|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
42254125|NCT02269917|76080348|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
42254126|NCT02269917|76080346|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
42254127|NCT02269917|76080347|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
42254128|NCT02269917|76080348|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
42254129|NCT02269917|76080346|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
42254130|NCT02269917|76080347|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
42254131|NCT02269917|76080348|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
42254132|NCT02269917|76080346|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
42254133|NCT02269917|76080347|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
42254134|NCT02269917|76080348|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
42254135|NCT02269917|76080346|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
42310997|NCT02094573|76146779|FG001|Overall Study|Site Terminated by Sponsor|17|||
42133046|NCT00556439|75943962|FG000|Study Entry to Week 12|Physician Decision|1|||
42254136|NCT02269917|76080347|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
42310998|NCT02094573|76146778|FG000|Overall Study|Withdrawal by Subject|6|||
42310999|NCT02094573|76146779|FG001|Overall Study|Withdrawal by Subject|8|||
42311000|NCT02094573|76146778|FG000|Overall Study|Randomized but not Treated|3|||
42254137|NCT02269917|76080348|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
42254138|NCT02269917|76080346|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
42254139|NCT02269917|76080347|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
42254140|NCT02269917|76080348|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
42254141|NCT02269917|76080346|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
42254142|NCT02269917|76080347|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
42311001|NCT02094573|76146779|FG001|Overall Study|Randomized but not Treated|0|||
42311002|NCT01859494|76146785|FG000|Overall Study|Adverse Event|1|||
42311003|NCT01858636|76146789|FG000|Overall Study|No Device Deployment Attempted|24|||
42311004|NCT01858636|76146789|FG000|Overall Study|Physician Decision|1|||
42254143|NCT02269917|76080348|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
42254144|NCT02269917|76080346|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
42254145|NCT02269917|76080347|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
42254146|NCT02269917|76080348|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
42254147|NCT02269917|76080346|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
42254148|NCT02269917|76080347|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
42254149|NCT02269917|76080348|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
42254150|NCT02269917|76080346|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
42254151|NCT02269917|76080347|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
42254152|NCT02269917|76080348|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
42311005|NCT01858636|76146789|FG000|Overall Study|Death|1|||
42311006|NCT01858636|76146789|FG000|Overall Study|Lost to Follow-up|1|||
42311007|NCT01858636|76146789|FG000|Overall Study|Withdrawal by Subject|1|||
42311008|NCT02058849|76146796|FG000|Overall Study|Hospitalization|1|||
42311009|NCT02058849|76146797|FG001|Overall Study|Hospitalization|1|||
42311010|NCT02058849|76146796|FG000|Overall Study|Death|1|||
42311011|NCT02058849|76146797|FG001|Overall Study|Death|0|||
42311012|NCT02058849|76146796|FG000|Overall Study|Lost to Follow-up|1|||
42311013|NCT02058849|76146797|FG001|Overall Study|Lost to Follow-up|0|||
42311014|NCT02058849|76146796|FG000|Overall Study|Withdrawal by Subject|4|||
42311015|NCT02058849|76146797|FG001|Overall Study|Withdrawal by Subject|0|||
42311016|NCT01858558|76146805|FG000|Overall Study|Death|1|||
42311017|NCT01858558|76146806|FG001|Overall Study|Death|1|||
42311018|NCT01858558|76146805|FG000|Overall Study|Lost to Follow-up|1|||
42311019|NCT01858558|76146806|FG001|Overall Study|Lost to Follow-up|0|||
42311020|NCT01858558|76146805|FG000|Overall Study|Disease progression|3|||
42311021|NCT01858558|76146806|FG001|Overall Study|Disease progression|1|||
42311022|NCT01858558|76146805|FG000|Overall Study|Product contamination|2|||
42311023|NCT01858558|76146806|FG001|Overall Study|Product contamination|0|||
41992338|NCT01163617|75800379|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
41992339|NCT01163617|75800380|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
41992340|NCT01163617|75800381|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
41992341|NCT01163617|75800382|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
41992342|NCT01163617|75800383|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
41992343|NCT01163617|75800384|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
41992344|NCT01163617|75800385|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
41992345|NCT01163617|75800386|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
41992346|NCT01163617|75800379|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
41992347|NCT01163617|75800380|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
41992348|NCT01163617|75800381|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
41992349|NCT01163617|75800382|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
41992350|NCT01163617|75800383|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
41992351|NCT01163617|75800384|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
41992352|NCT01163617|75800385|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
42010559|NCT00993421|75817696|FG002|Overall Study|Sponsor Decision|28|||
42033376|NCT01129115|75841578|FG000|Overall Study|Protocol Violation|0|||
42033377|NCT01129115|75841579|FG001|Overall Study|Protocol Violation|2|||
42033378|NCT01129115|75841580|FG002|Overall Study|Protocol Violation|2|||
42033379|NCT01129115|75841581|FG003|Overall Study|Protocol Violation|2|||
42033380|NCT01185704|75841593|FG000|Overall Study|Randomized but not treated|3|||
42033381|NCT01185704|75841594|FG001|Overall Study|Randomized but not treated|3|||
42033382|NCT01185704|75841593|FG000|Overall Study|Lack of ovarian response|5|||
42033383|NCT01185704|75841594|FG001|Overall Study|Lack of ovarian response|1|||
42033384|NCT01185704|75841593|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
42033385|NCT01185704|75841594|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
42254153|NCT02522494|76080359|FG000|Overall Study|Lost to Follow-up|6|||
42254154|NCT02522494|76080360|FG001|Overall Study|Lost to Follow-up|2|||
42254155|NCT02522494|76080359|FG000|Overall Study|Withdrawal by Subject|1|||
42254156|NCT02522494|76080360|FG001|Overall Study|Withdrawal by Subject|0|||
42311024|NCT01858558|76146805|FG000|Overall Study|Failed expansion of cell product|2|||
42311025|NCT01858558|76146806|FG001|Overall Study|Failed expansion of cell product|0|||
42311026|NCT02058537|76146812|FG000|Overall Study|Withdrawal by Subject|1|||
41992353|NCT01163617|75800386|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
41992354|NCT01163617|75800379|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
41992355|NCT01163617|75800380|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
41992356|NCT01163617|75800381|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
41992357|NCT01163617|75800382|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
41992358|NCT01163617|75800383|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
41992359|NCT01163617|75800384|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
41992360|NCT01163617|75800385|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
41992361|NCT01163617|75800386|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
41992362|NCT01182337|75800408|FG000|Overall Study|Withdrawal by Subject|3|||
41992363|NCT01182337|75800409|FG001|Overall Study|Withdrawal by Subject|1|||
41992364|NCT01182337|75800408|FG000|Overall Study|Lost to Follow-up|0|||
41992365|NCT01182337|75800409|FG001|Overall Study|Lost to Follow-up|1|||
41992366|NCT01182298|75800416|FG000|Overall Study|Lack of Efficacy|4|||
41992367|NCT01182298|75800416|FG000|Overall Study|Withdrawal by Subject|2|||
41992368|NCT01163266|75800423|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
42254157|NCT02522494|76080359|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
42311027|NCT01612000|76146820|FG000|Overall Study|Lost to Follow-up|6|||
42254158|NCT02522494|76080360|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
42254159|NCT02522494|76080359|FG000|Overall Study|Participant did not watch the video|1|||
42254160|NCT02522494|76080360|FG001|Overall Study|Participant did not watch the video|0|||
42254161|NCT02522494|76080359|FG000|Overall Study|Death|0|||
42254162|NCT02522494|76080360|FG001|Overall Study|Death|1|||
42311028|NCT01612000|76146821|FG001|Overall Study|Lost to Follow-up|4|||
42311029|NCT01612000|76146822|FG002|Overall Study|Lost to Follow-up|4|||
42311030|NCT01612000|76146823|FG003|Overall Study|Lost to Follow-up|8|||
42311031|NCT01612000|76146820|FG000|Overall Study|Physician Decision|0|||
42311032|NCT01612000|76146821|FG001|Overall Study|Physician Decision|0|||
42311033|NCT01612000|76146822|FG002|Overall Study|Physician Decision|1|||
42311034|NCT01612000|76146823|FG003|Overall Study|Physician Decision|0|||
42311035|NCT01612000|76146820|FG000|Overall Study|Withdrawal by Subject|3|||
42311036|NCT01612000|76146821|FG001|Overall Study|Withdrawal by Subject|1|||
42311037|NCT01612000|76146822|FG002|Overall Study|Withdrawal by Subject|2|||
42311038|NCT01612000|76146823|FG003|Overall Study|Withdrawal by Subject|2|||
42311039|NCT01895608|76146837|FG000|Overall Study|change in health status|0|||
42311040|NCT01895608|76146838|FG001|Overall Study|change in health status|1|||
42311041|NCT01895608|76146839|FG002|Overall Study|change in health status|1|||
42311042|NCT01895608|76146840|FG003|Overall Study|change in health status|0|||
42311043|NCT01895608|76146837|FG000|Overall Study|Withdrawal by Subject|0|||
42311044|NCT01895608|76146838|FG001|Overall Study|Withdrawal by Subject|0|||
42311045|NCT01895608|76146839|FG002|Overall Study|Withdrawal by Subject|2|||
42311046|NCT01895608|76146840|FG003|Overall Study|Withdrawal by Subject|0|||
42311047|NCT02409680|76146852|FG000|Overall Study|Lost to Follow-up|15|||
42311048|NCT02409680|76146853|FG001|Overall Study|Lost to Follow-up|30|||
42311049|NCT01895452|76146861|FG000|Overall Study|Adverse Event|1|||
42311050|NCT01895452|76146862|FG001|Overall Study|Adverse Event|4|||
42311051|NCT01895452|76146861|FG000|Overall Study|Lost to Follow-up|1|||
42311052|NCT01895452|76146862|FG001|Overall Study|Lost to Follow-up|5|||
42311053|NCT01895452|76146861|FG000|Overall Study|Pregnancy|0|||
42311054|NCT01895452|76146862|FG001|Overall Study|Pregnancy|1|||
42311055|NCT01895452|76146861|FG000|Overall Study|Withdrawal by Subject|2|||
42311056|NCT01895452|76146862|FG001|Overall Study|Withdrawal by Subject|14|||
42311057|NCT01895452|76146861|FG000|Overall Study|Underlying disease|0|||
42311058|NCT01895452|76146862|FG001|Overall Study|Underlying disease|3|||
42311059|NCT01895452|76146861|FG000|Overall Study|Noncompliance with study drug|0|||
42311060|NCT01895452|76146862|FG001|Overall Study|Noncompliance with study drug|1|||
42311061|NCT02094417|76146872|FG000|Overall Study|Adverse Event|0|||
41992369|NCT01163266|75800424|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
42254163|NCT01658020|76080368|FG000|Overall Study|Adverse Event|3|||
41992370|NCT01163266|75800425|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
42254164|NCT01658020|76080369|FG001|Overall Study|Adverse Event|3|||
42254165|NCT01658020|76080368|FG000|Overall Study|Lost to Follow-up|1|||
42254166|NCT01658020|76080369|FG001|Overall Study|Lost to Follow-up|0|||
42254167|NCT01658020|76080368|FG000|Overall Study|Withdrawal by Subject|4|||
42254168|NCT01658020|76080369|FG001|Overall Study|Withdrawal by Subject|5|||
42254169|NCT01658020|76080368|FG000|Overall Study|Protocol Violation|0|||
42254170|NCT01658020|76080369|FG001|Overall Study|Protocol Violation|1|||
42254171|NCT03389477|76080387|FG000|Step 1|Withdrawal by Subject|1|||
42254172|NCT03389477|76080388|FG001|Step 1|Withdrawal by Subject|0|||
42254173|NCT03389477|76080387|FG000|Step 2|Withdrawal by Subject|1|||
42254174|NCT03389477|76080388|FG001|Step 2|Withdrawal by Subject|2|||
42254175|NCT03389477|76080387|FG000|Step 2|Disease progression|1|||
42311062|NCT02094417|76146873|FG001|Overall Study|Adverse Event|0|||
42311063|NCT02094417|76146874|FG002|Overall Study|Adverse Event|0|||
42311064|NCT02094417|76146875|FG003|Overall Study|Adverse Event|1|||
42311065|NCT02094417|76146872|FG000|Overall Study|Eligibility criteria|0|||
42311066|NCT02094417|76146873|FG001|Overall Study|Eligibility criteria|1|||
42311067|NCT02094417|76146874|FG002|Overall Study|Eligibility criteria|0|||
42311068|NCT02094417|76146875|FG003|Overall Study|Eligibility criteria|0|||
42311069|NCT02094417|76146872|FG000|Overall Study|No responder|4|||
42311070|NCT02094417|76146873|FG001|Overall Study|No responder|4|||
42311071|NCT02094417|76146874|FG002|Overall Study|No responder|4|||
42311072|NCT02094417|76146875|FG003|Overall Study|No responder|3|||
42311073|NCT02094417|76146872|FG000|Overall Study|Unable to conduct observations or assess|0|||
42311074|NCT02094417|76146873|FG001|Overall Study|Unable to conduct observations or assess|1|||
42311075|NCT02094417|76146874|FG002|Overall Study|Unable to conduct observations or assess|0|||
42311076|NCT02094417|76146875|FG003|Overall Study|Unable to conduct observations or assess|0|||
42311077|NCT02094417|76146872|FG000|Overall Study|Withdrawal by Subject|1|||
42311078|NCT02094417|76146873|FG001|Overall Study|Withdrawal by Subject|2|||
42311079|NCT02094417|76146874|FG002|Overall Study|Withdrawal by Subject|1|||
42311080|NCT02094417|76146875|FG003|Overall Study|Withdrawal by Subject|3|||
42311081|NCT01894984|76146887|FG000|Overall Study|Other|314|||
42311082|NCT01894984|76146888|FG001|Overall Study|Other|175|||
42311083|NCT02375672|76146894|FG000|Overall Study|remain on follow up|20|||
42311084|NCT01894516|76146902|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
42311085|NCT01894516|76146903|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
42311086|NCT01894516|76146904|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
42311087|NCT01894516|76146905|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
42311088|NCT01894516|76146902|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
42311089|NCT01894516|76146903|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
42311090|NCT01894516|76146904|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
42311091|NCT01894516|76146905|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
42311092|NCT01894516|76146902|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
42311093|NCT01894516|76146903|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
42311094|NCT01894516|76146904|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
42311095|NCT01894516|76146905|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
42311096|NCT01894516|76146902|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
42311097|NCT01894516|76146903|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
42311098|NCT01894516|76146904|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
42311099|NCT01894516|76146905|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
42311100|NCT01894516|76146902|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
42311101|NCT01894516|76146903|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
42311102|NCT01894516|76146904|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
42311103|NCT01894516|76146905|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
42311104|NCT01894516|76146902|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
42311105|NCT01894516|76146903|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
42254176|NCT03389477|76080388|FG001|Step 2|Disease progression|0|||
42254177|NCT03389477|76080387|FG000|Step 2|Death|0|||
42254178|NCT03389477|76080388|FG001|Step 2|Death|1|||
42254179|NCT03389477|76080387|FG000|Step 2|Poor performance status and nutrition|0|||
42254180|NCT03389477|76080388|FG001|Step 2|Poor performance status and nutrition|1|||
42254181|NCT03389477|76080387|FG000|Step 3|Withdrawal after 3 cycles|0|||
42254182|NCT03389477|76080388|FG001|Step 3|Withdrawal after 3 cycles|1|||
42254183|NCT03389477|76080387|FG000|Step 3|Still receiving active treatment|4|||
42254184|NCT03389477|76080388|FG001|Step 3|Still receiving active treatment|0|||
42254185|NCT03389477|76080387|FG000|Step 3|Progressive disease after 2 cycles|1|||
42254186|NCT03389477|76080388|FG001|Step 3|Progressive disease after 2 cycles|0|||
42254187|NCT02680574|76080398|FG000|Overall Study|Death|137|||
42254188|NCT02680574|76080399|FG001|Overall Study|Death|137|||
42254189|NCT02680574|76080398|FG000|Overall Study|Withdrawal by Subject|17|||
42254190|NCT02680574|76080399|FG001|Overall Study|Withdrawal by Subject|9|||
42254191|NCT02680574|76080398|FG000|Overall Study|Lost to Follow-up|4|||
42254192|NCT02680574|76080399|FG001|Overall Study|Lost to Follow-up|6|||
42254193|NCT02522884|76080405|FG000|Overall Study|Withdrawal by Subject|6|||
42254194|NCT02522884|76080405|FG000|Overall Study|Death|3|||
42254195|NCT02522884|76080405|FG000|Overall Study|Missed 12-month Follow-up|9|||
42254196|NCT02674568|76080422|FG000|Overall Study|Withdrawal by Subject|5|||
42311106|NCT01894516|76146904|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
42311107|NCT01894516|76146905|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
42254197|NCT02674568|76080422|FG000|Overall Study|Death|303|||
42311108|NCT01894516|76146902|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
42311109|NCT01894516|76146903|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
42254198|NCT02674568|76080422|FG000|Overall Study|Physician Decision|2|||
42254199|NCT02674568|76080422|FG000|Overall Study|Lost to Follow-up|9|||
42254200|NCT02674568|76080422|FG000|Overall Study|Other, Not Specified|20|||
42254201|NCT03022799|76080451|FG000|Overall Study|Adverse Event|0|||
42311110|NCT01894516|76146904|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
42311111|NCT01894516|76146905|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
42311112|NCT01894516|76146902|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
42311113|NCT01894516|76146903|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
42311114|NCT01894516|76146904|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
42311115|NCT01894516|76146905|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
42311116|NCT02491463|76146923|FG000|Overall Study|Withdrawal by Subject|1|||
42311117|NCT02491463|76146924|FG001|Overall Study|Withdrawal by Subject|2|||
42311118|NCT02491463|76146925|FG002|Overall Study|Withdrawal by Subject|0|||
42311119|NCT02491463|76146926|FG003|Overall Study|Withdrawal by Subject|0|||
42311120|NCT02491463|76146923|FG000|Overall Study|Migrated/moved from study area|1|||
42311121|NCT02491463|76146924|FG001|Overall Study|Migrated/moved from study area|5|||
42311122|NCT02491463|76146925|FG002|Overall Study|Migrated/moved from study area|1|||
42311123|NCT02491463|76146926|FG003|Overall Study|Migrated/moved from study area|1|||
42311124|NCT02491463|76146923|FG000|Overall Study|Lost to Follow-up|0|||
42311125|NCT02491463|76146924|FG001|Overall Study|Lost to Follow-up|3|||
42311126|NCT02491463|76146925|FG002|Overall Study|Lost to Follow-up|3|||
42311127|NCT02491463|76146926|FG003|Overall Study|Lost to Follow-up|0|||
42311128|NCT02038881|76146939|FG000|Overall Study|Withdrawal by Subject|0|||
42311129|NCT02038881|76146940|FG001|Overall Study|Withdrawal by Subject|0|||
42311130|NCT02038881|76146941|FG002|Overall Study|Withdrawal by Subject|1|||
42311131|NCT02038881|76146939|FG000|Overall Study|Lost to Follow-up|2|||
42311132|NCT02038881|76146940|FG001|Overall Study|Lost to Follow-up|0|||
42311133|NCT02038881|76146941|FG002|Overall Study|Lost to Follow-up|0|||
42311134|NCT02038881|76146939|FG000|Overall Study|incarcerated|1|||
42311135|NCT02038881|76146940|FG001|Overall Study|incarcerated|0|||
42311136|NCT02038881|76146941|FG002|Overall Study|incarcerated|0|||
42311137|NCT01857622|76146954|FG000|Overall Study|Adverse Event|5|||
42311138|NCT01857622|76146955|FG001|Overall Study|Adverse Event|0|||
42311139|NCT01857622|76146956|FG002|Overall Study|Adverse Event|2|||
42311140|NCT01857622|76146954|FG000|Overall Study|Physician Decision|1|||
42311141|NCT01857622|76146955|FG001|Overall Study|Physician Decision|0|||
42311142|NCT01857622|76146956|FG002|Overall Study|Physician Decision|0|||
42311143|NCT01857622|76146954|FG000|Overall Study|Protocol Violation|4|||
42311144|NCT01857622|76146955|FG001|Overall Study|Protocol Violation|1|||
42311145|NCT01857622|76146956|FG002|Overall Study|Protocol Violation|0|||
42311146|NCT01857622|76146954|FG000|Overall Study|Withdrawal by Subject|1|||
42311147|NCT01857622|76146955|FG001|Overall Study|Withdrawal by Subject|0|||
42311148|NCT01857622|76146956|FG002|Overall Study|Withdrawal by Subject|0|||
42254202|NCT03022799|76080452|FG001|Overall Study|Adverse Event|0|||
42254203|NCT03022799|76080453|FG002|Overall Study|Adverse Event|0|||
42254204|NCT03022799|76080454|FG003|Overall Study|Adverse Event|0|||
42254205|NCT03022799|76080455|FG004|Overall Study|Adverse Event|0|||
42254206|NCT03022799|76080456|FG005|Overall Study|Adverse Event|0|||
42254207|NCT03022799|76080457|FG006|Overall Study|Adverse Event|0|||
42311149|NCT01857310|76146966|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
42311150|NCT01857310|76146967|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
42311151|NCT02472353|76146975|FG000|Overall Study|Lost to Follow-up|1|||
42311152|NCT02472353|76146976|FG001|Overall Study|Lost to Follow-up|1|||
42311153|NCT02472353|76146975|FG000|Overall Study|Withdrawal by Subject|2|||
42311154|NCT02472353|76146976|FG001|Overall Study|Withdrawal by Subject|1|||
41992371|NCT01163266|75800423|FG000|Overall Study|Lack of Efficacy|1|||
41992372|NCT01163266|75800424|FG001|Overall Study|Lack of Efficacy|3|||
41992373|NCT01163266|75800425|FG002|Overall Study|Lack of Efficacy|1|||
41992374|NCT01163266|75800423|FG000|Overall Study|Noncompliance with Study Drug|0|||
41992375|NCT01163266|75800424|FG001|Overall Study|Noncompliance with Study Drug|2|||
42254208|NCT03022799|76080458|FG007|Overall Study|Adverse Event|0|||
42254209|NCT03022799|76080459|FG008|Overall Study|Adverse Event|0|||
42254210|NCT03022799|76080460|FG009|Overall Study|Adverse Event|1|||
42254211|NCT03022799|76080461|FG010|Overall Study|Adverse Event|1|||
42254212|NCT03022799|76080462|FG011|Overall Study|Adverse Event|0|||
42311155|NCT02472353|76146975|FG000|Overall Study|Study Termination|1|||
42311156|NCT02472353|76146976|FG001|Overall Study|Study Termination|4|||
42311157|NCT02491073|76146984|FG000|Overall Study|screen failure|1|||
42311158|NCT02491073|76146985|FG001|Overall Study|screen failure|0|||
42311159|NCT02314117|76147009|FG000|Overall Study|Lost to Follow-up|9|||
42311160|NCT02314117|76147010|FG001|Overall Study|Lost to Follow-up|14|||
42311161|NCT02314117|76147009|FG000|Overall Study|Withdrawal by Subject|3|||
42311162|NCT02314117|76147010|FG001|Overall Study|Withdrawal by Subject|2|||
42311163|NCT01893346|76147021|FG000|Overall Study|Lost to Follow-up|0|||
42311164|NCT01893346|76147022|FG001|Overall Study|Lost to Follow-up|1|||
41992376|NCT01163266|75800425|FG002|Overall Study|Noncompliance with Study Drug|0|||
42254213|NCT03022799|76080463|FG012|Overall Study|Adverse Event|0|||
42311165|NCT01893346|76147023|FG002|Overall Study|Lost to Follow-up|0|||
42311166|NCT01893346|76147024|FG003|Overall Study|Lost to Follow-up|0|||
42311167|NCT01893346|76147021|FG000|Overall Study|Protocol Violation|1|||
42311168|NCT01893346|76147022|FG001|Overall Study|Protocol Violation|0|||
42311169|NCT01893346|76147023|FG002|Overall Study|Protocol Violation|0|||
42311170|NCT01893346|76147024|FG003|Overall Study|Protocol Violation|0|||
42311171|NCT01893346|76147021|FG000|Overall Study|Withdrawal by Subject|2|||
42311172|NCT01893346|76147022|FG001|Overall Study|Withdrawal by Subject|0|||
42311173|NCT01893346|76147023|FG002|Overall Study|Withdrawal by Subject|0|||
42311174|NCT01893346|76147024|FG003|Overall Study|Withdrawal by Subject|0|||
42311175|NCT02490371|76147036|FG000|Overall Study|Lost to Follow-up|1|||
42311176|NCT02490371|76147037|FG001|Overall Study|Lost to Follow-up|1|||
42254214|NCT02674334|76080510|FG000|Overall Study|Lost to Follow-up|5|||
42254215|NCT02674334|76080511|FG001|Overall Study|Lost to Follow-up|3|||
42254216|NCT02674334|76080510|FG000|Overall Study|participant difficulty breathing|1|||
42254217|NCT02674334|76080511|FG001|Overall Study|participant difficulty breathing|0|||
42254218|NCT02674334|76080510|FG000|Overall Study|NIRS not recording|1|||
42254219|NCT02674334|76080511|FG001|Overall Study|NIRS not recording|0|||
42254220|NCT03026075|76080517|FG000|Overall Study|Physician Decision|1|||
42254221|NCT01373918|76080523|FG000|Overall Study|Physician Decision|0|||
42254222|NCT01373918|76080524|FG001|Overall Study|Physician Decision|1|||
42254223|NCT02667626|76080532|FG000|Overall Study|Withdrawal by Subject|0|||
42254224|NCT02667626|76080533|FG001|Overall Study|Withdrawal by Subject|1|||
42254225|NCT02522728|76080544|FG000|Overall Study|Withdrawal by Subject|6|||
42311177|NCT02058147|76147046|FG000|Overall Study|Randomized but not treated|0|||
42311178|NCT02058147|76147047|FG001|Overall Study|Randomized but not treated|0|||
42311179|NCT02058147|76147048|FG002|Overall Study|Randomized but not treated|1|||
42311180|NCT02058147|76147046|FG000|Overall Study|Adverse Event|12|||
42311181|NCT02058147|76147047|FG001|Overall Study|Adverse Event|9|||
42311182|NCT02058147|76147048|FG002|Overall Study|Adverse Event|21|||
42311183|NCT02058147|76147046|FG000|Overall Study|Lack of Efficacy|1|||
42311184|NCT02058147|76147047|FG001|Overall Study|Lack of Efficacy|0|||
42311185|NCT02058147|76147048|FG002|Overall Study|Lack of Efficacy|3|||
42311186|NCT02058147|76147046|FG000|Overall Study|Poor compliance to protocol|8|||
42311187|NCT02058147|76147047|FG001|Overall Study|Poor compliance to protocol|9|||
42311188|NCT02058147|76147048|FG002|Overall Study|Poor compliance to protocol|4|||
42311189|NCT02058147|76147046|FG000|Overall Study|Other than specified|8|||
42311190|NCT02058147|76147047|FG001|Overall Study|Other than specified|9|||
42311191|NCT02058147|76147048|FG002|Overall Study|Other than specified|0|||
42311192|NCT02489981|76147056|FG000|Overall Study|Adverse Event|21|||
42311193|NCT02489981|76147056|FG000|Overall Study|Insufficient effectiveness|16|||
42311194|NCT02489981|76147056|FG000|Overall Study|Improved|31|||
42311195|NCT02489981|76147056|FG000|Overall Study|Lost to Follow-up|31|||
42311196|NCT02489981|76147056|FG000|Overall Study|Other than listed|28|||
42311197|NCT02471183|76147060|FG000|Main Treatment Period|Adverse Event|1|||
42311198|NCT02471183|76147060|FG000|Main Treatment Period|Withdrawal by Subject|1|||
42311199|NCT02471183|76147060|FG000|Extended Treatment Period|Lack of Efficacy|1|||
42311200|NCT01855828|76147064|FG000|Overall Study|Adverse Event|1|||
42311201|NCT01855828|76147064|FG000|Overall Study|Withdrawal by Subject|1|||
42311202|NCT02489279|76147075|FG000|Overall Study|Lost to Follow-up|12|||
42311203|NCT02489279|76147076|FG001|Overall Study|Lost to Follow-up|10|||
42311204|NCT02489045|76147082|FG000|Overall Study|unable to collect usable data|53|||
42311205|NCT02489045|76147082|FG000|Follow-up|Lost to Follow-up|10|||
42311206|NCT02488109|76147088|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
42311207|NCT02488109|76147089|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
42311208|NCT02488109|76147088|FG000|12-month Follow-Up|Lost to Follow-up|4|||
42311209|NCT02488109|76147089|FG001|12-month Follow-Up|Lost to Follow-up|7|||
42311210|NCT02351167|76147100|FG000|Overall Study|Withdrawal by Subject|19|||
42311211|NCT02351167|76147101|FG001|Overall Study|Withdrawal by Subject|18|||
42311212|NCT02351167|76147102|FG002|Overall Study|Withdrawal by Subject|21|||
42254226|NCT02522728|76080545|FG001|Overall Study|Withdrawal by Subject|6|||
42254227|NCT02522728|76080544|FG000|Overall Study|Death|4|||
42311213|NCT02350309|76147117|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
42311214|NCT02350309|76147118|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
42311215|NCT02350309|76147119|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
42311216|NCT02350309|76147120|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
42311217|NCT02350309|76147121|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
42311218|NCT02350309|76147122|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
42254228|NCT02522728|76080545|FG001|Overall Study|Death|3|||
42311219|NCT02350309|76147117|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
42311220|NCT02350309|76147118|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
42311221|NCT02350309|76147119|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
42311222|NCT02350309|76147120|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
42311223|NCT02350309|76147121|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
42311224|NCT02350309|76147122|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
42311225|NCT02038647|76147139|FG000|Overall Study|Progressive Disease|50|||
42311226|NCT02038647|76147140|FG001|Overall Study|Progressive Disease|59|||
42311227|NCT02038647|76147139|FG000|Overall Study|Adverse Event|18|||
42311228|NCT02038647|76147140|FG001|Overall Study|Adverse Event|10|||
42311229|NCT02038647|76147139|FG000|Overall Study|Symptomatic Deterioration|7|||
42311230|NCT02038647|76147140|FG001|Overall Study|Symptomatic Deterioration|7|||
42311231|NCT02038647|76147139|FG000|Overall Study|Withdrawal by Subject|5|||
42311232|NCT02038647|76147140|FG001|Overall Study|Withdrawal by Subject|2|||
42311233|NCT02038647|76147139|FG000|Overall Study|Not Reported|0|||
42311234|NCT02038647|76147140|FG001|Overall Study|Not Reported|1|||
42311235|NCT02038647|76147139|FG000|Overall Study|Ongoing at Datacut|9|||
42311236|NCT02038647|76147140|FG001|Overall Study|Ongoing at Datacut|10|||
42311237|NCT02058069|76147146|FG000|Overall Study|Exclusion due to implant size|5|||
42311238|NCT02058069|76147146|FG000|Overall Study|Withdrawal by Subject|6|||
41992377|NCT01163266|75800423|FG000|Overall Study|Protocol Deviations|2|||
41992378|NCT01163266|75800424|FG001|Overall Study|Protocol Deviations|2|||
41992379|NCT01163266|75800425|FG002|Overall Study|Protocol Deviations|5|||
41992380|NCT01163266|75800423|FG000|Overall Study|Withdrawal of Consent|5|||
41992381|NCT01163266|75800424|FG001|Overall Study|Withdrawal of Consent|7|||
41992382|NCT01163266|75800425|FG002|Overall Study|Withdrawal of Consent|3|||
41992383|NCT01163266|75800423|FG000|Overall Study|Lost to Follow-up|7|||
41992384|NCT01163266|75800424|FG001|Overall Study|Lost to Follow-up|7|||
41992385|NCT01163266|75800425|FG002|Overall Study|Lost to Follow-up|10|||
41992386|NCT01163266|75800423|FG000|Overall Study|Other|1|||
41992387|NCT01163266|75800424|FG001|Overall Study|Other|1|||
41992388|NCT01163266|75800425|FG002|Overall Study|Other|2|||
41992389|NCT01163149|75800483|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
42254229|NCT02522728|76080544|FG000|Overall Study|Adverse Event|2|||
42254230|NCT02522728|76080545|FG001|Overall Study|Adverse Event|1|||
42254231|NCT02522728|76080544|FG000|Overall Study|Did not receive randomized study device|0|||
42254232|NCT02522728|76080545|FG001|Overall Study|Did not receive randomized study device|1|||
42254233|NCT03025217|76080560|FG000|Overall Study|Pregnancy|1|||
42254234|NCT03025217|76080560|FG000|Overall Study|Lost to Follow-up|1|||
42254235|NCT03025217|76080560|FG000|Overall Study|Not eligible, poor English|2|||
42254236|NCT03023813|76080567|FG000|Overall Study|Lost to Follow-up|1|||
42254237|NCT03023813|76080568|FG001|Overall Study|Lost to Follow-up|2|||
42254238|NCT03023813|76080569|FG002|Overall Study|Lost to Follow-up|0|||
42311239|NCT02057835|76147160|FG000|Overall Study|Withdrawal by Subject|0|||
42311240|NCT02057835|76147161|FG001|Overall Study|Withdrawal by Subject|2|||
41992390|NCT01163149|75800484|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
41992391|NCT01163149|75800485|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
41992392|NCT01163149|75800483|FG000|Extension Treatment Period|Adverse Event|0|||
41992393|NCT01163149|75800484|FG001|Extension Treatment Period|Adverse Event|1|||
42254239|NCT01365130|76080578|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
42311241|NCT02057835|76147162|FG002|Overall Study|Withdrawal by Subject|0|||
42311242|NCT02057835|76147163|FG003|Overall Study|Withdrawal by Subject|0|||
42254240|NCT01657162|76080584|FG000|Overall Study|Adverse Event|26|||
42254241|NCT01657162|76080585|FG001|Overall Study|Adverse Event|36|||
42311243|NCT02057835|76147164|FG004|Overall Study|Withdrawal by Subject|0|||
42311244|NCT02057835|76147165|FG005|Overall Study|Withdrawal by Subject|0|||
42311245|NCT02057835|76147166|FG006|Overall Study|Withdrawal by Subject|0|||
42311246|NCT02057835|76147167|FG007|Overall Study|Withdrawal by Subject|0|||
42311247|NCT02057835|76147168|FG008|Overall Study|Withdrawal by Subject|0|||
42311248|NCT02057835|76147169|FG009|Overall Study|Withdrawal by Subject|0|||
42311249|NCT02057757|76147200|FG000|Overall Study|Withdrawal by Subject|3|||
42311250|NCT02057757|76147201|FG001|Overall Study|Withdrawal by Subject|5|||
42311251|NCT02057757|76147200|FG000|Overall Study|Death|2|||
41992394|NCT01163149|75800485|FG002|Extension Treatment Period|Adverse Event|0|||
41992395|NCT01163149|75800483|FG000|Extension Treatment Period|Noncompliance|0|||
42311252|NCT02057757|76147201|FG001|Overall Study|Death|0|||
41992396|NCT01163149|75800484|FG001|Extension Treatment Period|Noncompliance|0|||
41992397|NCT01163149|75800485|FG002|Extension Treatment Period|Noncompliance|1|||
42254242|NCT01657162|76080584|FG000|Overall Study|Withdrawal by Subject|13|||
42254243|NCT01657162|76080585|FG001|Overall Study|Withdrawal by Subject|13|||
42311253|NCT02057757|76147200|FG000|Overall Study|Lost to Follow-up|8|||
42311254|NCT02057757|76147201|FG001|Overall Study|Lost to Follow-up|3|||
42311255|NCT02057757|76147200|FG000|Overall Study|Non-compliance|1|||
42311256|NCT02057757|76147201|FG001|Overall Study|Non-compliance|0|||
42311257|NCT02037477|76147215|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
42311258|NCT02037477|76147216|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
42311259|NCT02037477|76147217|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
42311260|NCT02037477|76147218|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
42311261|NCT02057523|76147228|FG000|Overall Study|Withdrawal by Subject|1|||
42311262|NCT02057523|76147228|FG000|Overall Study|Lack of Efficacy|1|||
42254244|NCT01657162|76080584|FG000|Overall Study|Continuing Significant Deterioration|9|||
42311263|NCT02037165|76147237|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
42311264|NCT02037165|76147238|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
42311265|NCT02037165|76147239|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
42311266|NCT02037165|76147240|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
42311267|NCT02037165|76147241|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
42346919|NCT01707693|76185933|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
42346920|NCT01707693|76185934|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
42346921|NCT01707693|76185933|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
42346922|NCT01707693|76185934|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
42346923|NCT01722669|76185947|FG000|Overall Study|Withdrawal by Subject|0|||
42346924|NCT01722669|76185948|FG001|Overall Study|Withdrawal by Subject|0|||
42346925|NCT01722669|76185949|FG002|Overall Study|Withdrawal by Subject|0|||
42346926|NCT01722669|76185950|FG003|Overall Study|Withdrawal by Subject|0|||
42254245|NCT01657162|76080585|FG001|Overall Study|Continuing Significant Deterioration|3|||
42254246|NCT01657162|76080584|FG000|Overall Study|Refusal of Treatment|4|||
42254247|NCT01657162|76080585|FG001|Overall Study|Refusal of Treatment|6|||
42254248|NCT01657162|76080584|FG000|Overall Study|Lost to Follow-up|3|||
42254249|NCT01657162|76080585|FG001|Overall Study|Lost to Follow-up|4|||
42254250|NCT01657162|76080584|FG000|Overall Study|Death|2|||
42254251|NCT01657162|76080585|FG001|Overall Study|Death|3|||
42254252|NCT01657162|76080584|FG000|Overall Study|Inability to Complete Study Procedures|1|||
42254253|NCT01657162|76080585|FG001|Overall Study|Inability to Complete Study Procedures|7|||
42254254|NCT01657162|76080584|FG000|Overall Study|Protocol Violation|1|||
42254255|NCT01657162|76080585|FG001|Overall Study|Protocol Violation|0|||
42254256|NCT01657162|76080584|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
42254257|NCT01657162|76080585|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
42254258|NCT01657162|76080584|FG000|Overall Study|Other than Specified|0|||
42254259|NCT01657162|76080585|FG001|Overall Study|Other than Specified|2|||
42254260|NCT01373294|76080610|FG000|Overall Study|Adverse Event|1|||
42254261|NCT01373294|76080611|FG001|Overall Study|Adverse Event|0|||
42346927|NCT01722669|76185951|FG004|Overall Study|Withdrawal by Subject|0|||
41992398|NCT01163032|75800510|FG000|Randomization Phase|Withdrawal by Subject|2|||
41992399|NCT01163032|75800511|FG001|Randomization Phase|Withdrawal by Subject|3|||
42254262|NCT01656304|76080617|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
42254263|NCT03023423|76080624|FG000|Overall Study|Death|5|||
42254264|NCT03023423|76080625|FG001|Overall Study|Death|12|||
42254265|NCT03023423|76080626|FG002|Overall Study|Death|20|||
42346928|NCT01722669|76185952|FG005|Overall Study|Withdrawal by Subject|2|||
42346929|NCT01707147|76185972|FG000|Overall Study|Administered Trajenta prior to contract|5|||
42346930|NCT01707147|76185972|FG000|Overall Study|Patients who have not taken Trajenta|1|||
42133047|NCT00556439|75943963|FG001|Study Entry to Week 12|Physician Decision|0|||
42133048|NCT00556439|75943964|FG002|Study Entry to Week 12|Physician Decision|0|||
42133049|NCT00556439|75943965|FG003|Study Entry to Week 12|Physician Decision|0|||
42133050|NCT00556439|75943962|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
42254266|NCT03023423|76080624|FG000|Overall Study|Other|0|||
42254267|NCT03023423|76080625|FG001|Overall Study|Other|2|||
41992400|NCT01163032|75800512|FG002|Randomization Phase|Withdrawal by Subject|0|||
41992401|NCT01163032|75800510|FG000|Randomization Phase|Adverse Event|3|||
41992402|NCT01163032|75800511|FG001|Randomization Phase|Adverse Event|3|||
41992403|NCT01163032|75800512|FG002|Randomization Phase|Adverse Event|0|||
41992404|NCT01163032|75800510|FG000|Randomization Phase|Protocol Violation|0|||
41992405|NCT01163032|75800511|FG001|Randomization Phase|Protocol Violation|1|||
41992406|NCT01163032|75800512|FG002|Randomization Phase|Protocol Violation|0|||
41992407|NCT01163032|75800510|FG000|Randomization Phase|Various*|5|||
42254268|NCT03023423|76080626|FG002|Overall Study|Other|2|||
42254269|NCT03023423|76080624|FG000|Overall Study|Ongoing|2|||
42311268|NCT02470403|76147262|FG000|Overall Study|Adverse Event|1|||
42311269|NCT02470403|76147263|FG001|Overall Study|Adverse Event|0|||
42311270|NCT02470403|76147264|FG002|Overall Study|Adverse Event|0|||
42311271|NCT02470403|76147265|FG003|Overall Study|Adverse Event|0|||
42311272|NCT02470403|76147266|FG004|Overall Study|Adverse Event|0|||
42311273|NCT02470403|76147262|FG000|Overall Study|Lost to Follow-up|0|||
42254270|NCT03023423|76080625|FG001|Overall Study|Ongoing|32|||
42254271|NCT03023423|76080626|FG002|Overall Study|Ongoing|24|||
42311274|NCT02470403|76147263|FG001|Overall Study|Lost to Follow-up|1|||
42311275|NCT02470403|76147264|FG002|Overall Study|Lost to Follow-up|0|||
42311276|NCT02470403|76147265|FG003|Overall Study|Lost to Follow-up|0|||
42311277|NCT02470403|76147266|FG004|Overall Study|Lost to Follow-up|0|||
42311278|NCT02470403|76147262|FG000|Overall Study|Subject/guardian decision|1|||
42311279|NCT02470403|76147263|FG001|Overall Study|Subject/guardian decision|0|||
42311280|NCT02470403|76147264|FG002|Overall Study|Subject/guardian decision|0|||
42311281|NCT02470403|76147265|FG003|Overall Study|Subject/guardian decision|4|||
42311282|NCT02470403|76147266|FG004|Overall Study|Subject/guardian decision|0|||
42311283|NCT01855750|76147283|FG000|Overall Study|Death|78|||
42311284|NCT01855750|76147284|FG001|Overall Study|Death|78|||
42311285|NCT01855750|76147283|FG000|Overall Study|Lost to Follow-up|9|||
42311286|NCT01855750|76147284|FG001|Overall Study|Lost to Follow-up|23|||
42311287|NCT01855750|76147283|FG000|Overall Study|Withdrawal by Subject|35|||
42311288|NCT01855750|76147284|FG001|Overall Study|Withdrawal by Subject|28|||
42311289|NCT01855750|76147283|FG000|Overall Study|Sponsor ends the study|297|||
42254272|NCT03185741|76080641|FG000|Baseline|Withdrawal by Subject|1|||
42254273|NCT03185741|76080642|FG001|Baseline|Withdrawal by Subject|3|||
42254274|NCT03185741|76080643|FG002|Baseline|Withdrawal by Subject|2|||
42254275|NCT03185741|76080641|FG000|Baseline|Lost to Follow-up|1|||
42254276|NCT03185741|76080642|FG001|Baseline|Lost to Follow-up|2|||
42254277|NCT03185741|76080643|FG002|Baseline|Lost to Follow-up|3|||
42254278|NCT03185741|76080641|FG000|3Month|Death|1|||
42254279|NCT03185741|76080642|FG001|3Month|Death|1|||
42254280|NCT03185741|76080643|FG002|3Month|Death|2|||
42254281|NCT03185741|76080641|FG000|3Month|Withdrawal by Subject|1|||
42254282|NCT03185741|76080642|FG001|3Month|Withdrawal by Subject|5|||
42254283|NCT03185741|76080643|FG002|3Month|Withdrawal by Subject|1|||
42254284|NCT03185741|76080641|FG000|3Month|Lost to Follow-up|7|||
42311290|NCT01855750|76147284|FG001|Overall Study|Sponsor ends the study|290|||
42311291|NCT01855126|76147292|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
42311292|NCT01855126|76147293|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
42311293|NCT01855126|76147292|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
41992408|NCT01163032|75800511|FG001|Randomization Phase|Various*|4|||
41992409|NCT01163032|75800512|FG002|Randomization Phase|Various*|0|||
41992410|NCT01163032|75800510|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
42254285|NCT03185741|76080642|FG001|3Month|Lost to Follow-up|9|||
42254286|NCT03185741|76080643|FG002|3Month|Lost to Follow-up|8|||
41992411|NCT01163032|75800511|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
42254287|NCT03185741|76080641|FG000|3Month|Unavailable for 3Month|11|||
42311294|NCT01855126|76147293|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
42311295|NCT01622673|76147309|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42254288|NCT03185741|76080642|FG001|3Month|Unavailable for 3Month|10|||
42254289|NCT03185741|76080643|FG002|3Month|Unavailable for 3Month|11|||
42254290|NCT03185741|76080641|FG000|3Month|Protocol Violation|0|||
42311296|NCT01622673|76147310|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42311297|NCT01622673|76147311|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42311298|NCT01622673|76147312|FG003|Treatment Period 1|Withdrawal by Subject|1|||
42311299|NCT01622673|76147313|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42311300|NCT01622673|76147314|FG005|Treatment Period 1|Withdrawal by Subject|0|||
42311301|NCT01622673|76147309|FG000|Treatment Period 1|Protocol Violation|0|||
42311302|NCT01622673|76147310|FG001|Treatment Period 1|Protocol Violation|1|||
42311303|NCT01622673|76147311|FG002|Treatment Period 1|Protocol Violation|0|||
42311304|NCT01622673|76147312|FG003|Treatment Period 1|Protocol Violation|0|||
42311305|NCT01622673|76147313|FG004|Treatment Period 1|Protocol Violation|0|||
42311306|NCT01622673|76147314|FG005|Treatment Period 1|Protocol Violation|0|||
42311307|NCT01622673|76147309|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42311308|NCT01622673|76147310|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42311309|NCT01622673|76147311|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42311310|NCT01622673|76147312|FG003|Treatment Period 2|Withdrawal by Subject|1|||
42311311|NCT01622673|76147313|FG004|Treatment Period 2|Withdrawal by Subject|0|||
42311312|NCT01622673|76147314|FG005|Treatment Period 2|Withdrawal by Subject|0|||
42311313|NCT01622673|76147309|FG000|Treatment Period 3|Protocol Violation|0|||
42311314|NCT01622673|76147310|FG001|Treatment Period 3|Protocol Violation|1|||
42311315|NCT01622673|76147311|FG002|Treatment Period 3|Protocol Violation|0|||
42311316|NCT01622673|76147312|FG003|Treatment Period 3|Protocol Violation|0|||
42311317|NCT01622673|76147313|FG004|Treatment Period 3|Protocol Violation|0|||
42311318|NCT01622673|76147314|FG005|Treatment Period 3|Protocol Violation|0|||
42311319|NCT01855048|76147339|FG000|Overall Study|Withdrawal by Subject|0|||
42311320|NCT01855048|76147340|FG001|Overall Study|Withdrawal by Subject|1|||
42311321|NCT01855048|76147341|FG002|Overall Study|Withdrawal by Subject|0|||
42311322|NCT01855048|76147342|FG003|Overall Study|Withdrawal by Subject|0|||
42311323|NCT01855048|76147343|FG004|Overall Study|Withdrawal by Subject|1|||
42311324|NCT01855048|76147344|FG005|Overall Study|Withdrawal by Subject|0|||
42311325|NCT02469857|76147370|FG000|Overall Study|Death|24|||
42311326|NCT02469857|76147371|FG001|Overall Study|Death|29|||
42311327|NCT02469857|76147370|FG000|Overall Study|Discontinuation|1|||
42311328|NCT02469857|76147371|FG001|Overall Study|Discontinuation|3|||
42311329|NCT02036853|76147381|FG000|Overall Study|Adverse Event|0|||
42311330|NCT02036853|76147382|FG001|Overall Study|Adverse Event|2|||
42311331|NCT02036853|76147381|FG000|Overall Study|Lack of Efficacy|0|||
42311332|NCT02036853|76147382|FG001|Overall Study|Lack of Efficacy|2|||
42311333|NCT02036853|76147381|FG000|Overall Study|Physician Decision|0|||
42311334|NCT02036853|76147382|FG001|Overall Study|Physician Decision|1|||
42311335|NCT02036853|76147381|FG000|Overall Study|Withdrawal by Subject|0|||
42311336|NCT02036853|76147382|FG001|Overall Study|Withdrawal by Subject|1|||
42311337|NCT02469623|76147388|FG000|Overall Study|Not consented for long-term follow-up|4|||
42311338|NCT02469623|76147388|FG000|Overall Study|Lost to Follow-up|4|||
42311339|NCT02469623|76147388|FG000|Overall Study|Withdrawal by Subject|2|||
42311340|NCT02469623|76147388|FG000|Overall Study|Death|3|||
42311341|NCT02469077|76147395|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
42311342|NCT02469077|76147396|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
42311343|NCT02469077|76147395|FG000|Post Randomization/Intervention Period|Relocated|1|||
42311344|NCT02469077|76147396|FG001|Post Randomization/Intervention Period|Relocated|1|||
42311345|NCT02469077|76147395|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
42311346|NCT02469077|76147396|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
42311347|NCT02469077|76147395|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
42311348|NCT02469077|76147396|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
42311349|NCT02486627|76147408|FG000|Overall Study|Death|1|||
42311350|NCT02486627|76147409|FG001|Overall Study|Death|0|||
42311351|NCT02486627|76147408|FG000|Overall Study|Other Unspecified|0|||
42311352|NCT02486627|76147409|FG001|Overall Study|Other Unspecified|2|||
42311353|NCT02486627|76147408|FG000|Overall Study|Consent Withdrawn by Participant|4|||
42311354|NCT02486627|76147409|FG001|Overall Study|Consent Withdrawn by Participant|3|||
42311355|NCT02486627|76147408|FG000|Overall Study|Significant Participant Noncompliance|1|||
42311356|NCT02486627|76147409|FG001|Overall Study|Significant Participant Noncompliance|1|||
42311357|NCT02486627|76147408|FG000|Overall Study|Lost to Follow-up|1|||
41992412|NCT01163032|75800512|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
41992413|NCT01163032|75800510|FG000|Open Label Extension Phase|Adverse Event|0|||
41992414|NCT01163032|75800511|FG001|Open Label Extension Phase|Adverse Event|0|||
42311358|NCT02486627|76147409|FG001|Overall Study|Lost to Follow-up|3|||
42311359|NCT01644565|76147415|FG000|Overall Study|Undisclosed Medical History|1|||
42311360|NCT01644565|76147416|FG001|Overall Study|Undisclosed Medical History|0|||
42311361|NCT01644565|76147417|FG002|Overall Study|Undisclosed Medical History|0|||
42311362|NCT01644565|76147418|FG003|Overall Study|Undisclosed Medical History|0|||
42311363|NCT01644565|76147419|FG004|Overall Study|Undisclosed Medical History|0|||
42311364|NCT01644565|76147420|FG005|Overall Study|Undisclosed Medical History|0|||
41992415|NCT01163032|75800512|FG002|Open Label Extension Phase|Adverse Event|3|||
42346931|NCT01707147|76185972|FG000|Overall Study|Follow-up failure|17|||
42311365|NCT01644565|76147421|FG006|Overall Study|Undisclosed Medical History|0|||
42311366|NCT01644565|76147422|FG007|Overall Study|Undisclosed Medical History|0|||
42311367|NCT01644565|76147423|FG008|Overall Study|Undisclosed Medical History|0|||
42311368|NCT01644565|76147415|FG000|Overall Study|Lost to Follow-up|0|||
42311369|NCT01644565|76147416|FG001|Overall Study|Lost to Follow-up|0|||
42311370|NCT01644565|76147417|FG002|Overall Study|Lost to Follow-up|0|||
42311371|NCT01644565|76147418|FG003|Overall Study|Lost to Follow-up|1|||
42311372|NCT01644565|76147419|FG004|Overall Study|Lost to Follow-up|0|||
42311373|NCT01644565|76147420|FG005|Overall Study|Lost to Follow-up|0|||
42311374|NCT01644565|76147421|FG006|Overall Study|Lost to Follow-up|0|||
42311375|NCT01644565|76147422|FG007|Overall Study|Lost to Follow-up|2|||
42311376|NCT01644565|76147423|FG008|Overall Study|Lost to Follow-up|0|||
42311377|NCT01644565|76147415|FG000|Overall Study|Family emergency|0|||
42311378|NCT01644565|76147416|FG001|Overall Study|Family emergency|0|||
42311379|NCT01644565|76147417|FG002|Overall Study|Family emergency|0|||
42311380|NCT01644565|76147418|FG003|Overall Study|Family emergency|0|||
42311381|NCT01644565|76147419|FG004|Overall Study|Family emergency|1|||
42311382|NCT01644565|76147420|FG005|Overall Study|Family emergency|0|||
42311383|NCT01644565|76147421|FG006|Overall Study|Family emergency|0|||
42311384|NCT01644565|76147422|FG007|Overall Study|Family emergency|0|||
42311385|NCT01644565|76147423|FG008|Overall Study|Family emergency|0|||
42311386|NCT01644565|76147415|FG000|Overall Study|Relocation|0|||
42311387|NCT01644565|76147416|FG001|Overall Study|Relocation|0|||
42311388|NCT01644565|76147417|FG002|Overall Study|Relocation|0|||
42311389|NCT01644565|76147418|FG003|Overall Study|Relocation|0|||
42311390|NCT01644565|76147419|FG004|Overall Study|Relocation|0|||
42311391|NCT01644565|76147420|FG005|Overall Study|Relocation|0|||
42311392|NCT01644565|76147421|FG006|Overall Study|Relocation|0|||
42311393|NCT01644565|76147422|FG007|Overall Study|Relocation|0|||
42311394|NCT01644565|76147423|FG008|Overall Study|Relocation|1|||
42311395|NCT02485925|76147443|FG000|Overall Study|Withdrawal by Subject|3|||
42311396|NCT02485925|76147443|FG000|Overall Study|Death|1|||
42311397|NCT02485925|76147443|FG000|Overall Study|Lost to Follow-up|11|||
42311398|NCT02282293|76147449|FG000|Overall Study|Lost to Follow-up|2|||
42311399|NCT02282293|76147450|FG001|Overall Study|Lost to Follow-up|2|||
42033386|NCT01185704|75841593|FG000|Overall Study|Ectopic pregnancy|0|||
42254291|NCT03185741|76080642|FG001|3Month|Protocol Violation|0|||
42311400|NCT02282293|76147449|FG000|Overall Study|Unable to comply with study procedures|1|||
42311401|NCT02282293|76147450|FG001|Overall Study|Unable to comply with study procedures|0|||
42311402|NCT02282293|76147449|FG000|Overall Study|Moved out of study area|0|||
42311403|NCT02282293|76147450|FG001|Overall Study|Moved out of study area|1|||
42311404|NCT01854658|76147460|FG000|Overall Study|Protocol Violation|6|||
42311405|NCT01854658|76147461|FG001|Overall Study|Protocol Violation|2|||
42311406|NCT01854658|76147462|FG002|Overall Study|Protocol Violation|2|||
42311407|NCT01854658|76147463|FG003|Overall Study|Protocol Violation|1|||
42311408|NCT01854658|76147460|FG000|Overall Study|Physician Decision|7|||
42311409|NCT01854658|76147461|FG001|Overall Study|Physician Decision|5|||
42311410|NCT01854658|76147462|FG002|Overall Study|Physician Decision|2|||
42033387|NCT01185704|75841594|FG001|Overall Study|Ectopic pregnancy|1|||
42254292|NCT03185741|76080643|FG002|3Month|Protocol Violation|3|||
42254293|NCT03185741|76080641|FG000|6Month|Death|1|||
42254294|NCT03185741|76080642|FG001|6Month|Death|1|||
42254295|NCT03185741|76080643|FG002|6Month|Death|2|||
42254296|NCT03185741|76080641|FG000|6Month|Withdrawal by Subject|2|||
42254297|NCT03185741|76080642|FG001|6Month|Withdrawal by Subject|3|||
42254298|NCT03185741|76080643|FG002|6Month|Withdrawal by Subject|1|||
42254299|NCT03185741|76080641|FG000|6Month|Lost to Follow-up|16|||
42254300|NCT03185741|76080642|FG001|6Month|Lost to Follow-up|15|||
42254301|NCT03185741|76080643|FG002|6Month|Lost to Follow-up|16|||
42311411|NCT01854658|76147463|FG003|Overall Study|Physician Decision|4|||
42311412|NCT01854658|76147460|FG000|Overall Study|Lost to Follow-up|8|||
42254302|NCT02672852|76080653|FG000|Part A1|Disease Worsening|1|||
42311413|NCT01854658|76147461|FG001|Overall Study|Lost to Follow-up|9|||
42311414|NCT01854658|76147462|FG002|Overall Study|Lost to Follow-up|8|||
42311415|NCT01854658|76147463|FG003|Overall Study|Lost to Follow-up|4|||
42311416|NCT01854658|76147460|FG000|Overall Study|Withdrawal by Subject|28|||
42311417|NCT01854658|76147461|FG001|Overall Study|Withdrawal by Subject|21|||
42311418|NCT01854658|76147462|FG002|Overall Study|Withdrawal by Subject|29|||
42311419|NCT01854658|76147463|FG003|Overall Study|Withdrawal by Subject|15|||
42311420|NCT01854658|76147460|FG000|Overall Study|Protocol-specified criteria|15|||
42311421|NCT01854658|76147461|FG001|Overall Study|Protocol-specified criteria|15|||
42311422|NCT01854658|76147462|FG002|Overall Study|Protocol-specified criteria|10|||
42311423|NCT01854658|76147463|FG003|Overall Study|Protocol-specified criteria|7|||
42311424|NCT01854658|76147460|FG000|Overall Study|Lack of Efficacy|3|||
42311425|NCT01854658|76147461|FG001|Overall Study|Lack of Efficacy|8|||
42311426|NCT01854658|76147462|FG002|Overall Study|Lack of Efficacy|4|||
42311427|NCT01854658|76147463|FG003|Overall Study|Lack of Efficacy|7|||
42311428|NCT01854658|76147460|FG000|Overall Study|Adverse Event|21|||
42311429|NCT01854658|76147461|FG001|Overall Study|Adverse Event|14|||
42311430|NCT01854658|76147462|FG002|Overall Study|Adverse Event|23|||
42311431|NCT01854658|76147463|FG003|Overall Study|Adverse Event|19|||
42311432|NCT01854658|76147460|FG000|Overall Study|Administrative reasons|5|||
42311433|NCT01854658|76147461|FG001|Overall Study|Administrative reasons|1|||
42311434|NCT01854658|76147462|FG002|Overall Study|Administrative reasons|2|||
42311435|NCT01854658|76147463|FG003|Overall Study|Administrative reasons|2|||
42311436|NCT01892020|76147473|FG000|Period 1|Adverse Event|1|||
42311437|NCT01892020|76147474|FG001|Period 1|Adverse Event|1|||
42311438|NCT01892020|76147473|FG000|Period 1|Protocol Violation|2|||
42311439|NCT01892020|76147474|FG001|Period 1|Protocol Violation|4|||
42311440|NCT01892020|76147473|FG000|Period 1|Unclassified|0|||
42311441|NCT01892020|76147474|FG001|Period 1|Unclassified|1|||
42311442|NCT01892020|76147473|FG000|Period 2|Protocol Violation|1|||
42311443|NCT01892020|76147474|FG001|Period 2|Protocol Violation|0|||
42311444|NCT02485691|76147482|FG000|Overall Study|Adverse Event|25|||
42311445|NCT02485691|76147483|FG001|Overall Study|Adverse Event|11|||
42311446|NCT02485691|76147482|FG000|Overall Study|Poor compliance to protocol|0|||
42311447|NCT02485691|76147483|FG001|Overall Study|Poor compliance to protocol|1|||
42311448|NCT02485691|76147482|FG000|Overall Study|Disease progression|57|||
42311449|NCT02485691|76147483|FG001|Overall Study|Disease progression|92|||
42311450|NCT02485691|76147482|FG000|Overall Study|Investigator's decision|23|||
42311451|NCT02485691|76147483|FG001|Overall Study|Investigator's decision|5|||
42311452|NCT02485691|76147482|FG000|Overall Study|Participant's request|13|||
42311453|NCT02485691|76147483|FG001|Overall Study|Participant's request|6|||
42311454|NCT02485691|76147482|FG000|Overall Study|Other reason|8|||
42311455|NCT02485691|76147483|FG001|Overall Study|Other reason|9|||
42311456|NCT02485691|76147482|FG000|Overall Study|Randomized and not treated|3|||
42311457|NCT02485691|76147483|FG001|Overall Study|Randomized and not treated|2|||
42311458|NCT02517515|76147492|FG000|Overall Study|Adverse Event|0|||
42311459|NCT02517515|76147493|FG001|Overall Study|Adverse Event|1|||
42311460|NCT02517515|76147492|FG000|Overall Study|Withdrew Consent|0|||
42311461|NCT02517515|76147493|FG001|Overall Study|Withdrew Consent|1|||
42311462|NCT02517515|76147492|FG000|Overall Study|Lost to Follow-up|1|||
42311463|NCT02517515|76147493|FG001|Overall Study|Lost to Follow-up|0|||
42311464|NCT02517515|76147492|FG000|Overall Study|Other|1|||
42311465|NCT02517515|76147493|FG001|Overall Study|Other|0|||
42311466|NCT02466659|76147502|FG000|Overall Study|Lost to Follow-up|5|||
42311467|NCT02466659|76147503|FG001|Overall Study|Lost to Follow-up|2|||
42311468|NCT01891864|76147511|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
42311469|NCT01891864|76147512|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
42311470|NCT01891864|76147513|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
42311471|NCT01891864|76147514|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
42311472|NCT01891864|76147515|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
42311473|NCT01891864|76147516|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
42311474|NCT01891864|76147511|FG000|Treatment Period 1|Physician Decision|0|||
42311475|NCT01891864|76147512|FG001|Treatment Period 1|Physician Decision|1|||
42311476|NCT01891864|76147513|FG002|Treatment Period 1|Physician Decision|0|||
42311477|NCT01891864|76147514|FG003|Treatment Period 1|Physician Decision|0|||
42311478|NCT01891864|76147515|FG004|Treatment Period 1|Physician Decision|0|||
42311479|NCT01891864|76147516|FG005|Treatment Period 1|Physician Decision|0|||
42311480|NCT01891864|76147511|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
42311481|NCT01891864|76147512|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
42311482|NCT01891864|76147513|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
42311483|NCT01891864|76147514|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
41992416|NCT01163032|75800510|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
41992417|NCT01163032|75800511|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
41992418|NCT01163032|75800512|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
41992419|NCT01163032|75800510|FG000|Open Label Extension Phase|Protocol Violation|0|||
41992420|NCT01163032|75800511|FG001|Open Label Extension Phase|Protocol Violation|0|||
41992421|NCT01163032|75800512|FG002|Open Label Extension Phase|Protocol Violation|1|||
41992422|NCT01163032|75800510|FG000|Open Label Extension Phase|Study Termination|0|||
41992423|NCT01163032|75800511|FG001|Open Label Extension Phase|Study Termination|0|||
42254303|NCT02672852|76080654|FG001|Part A1|Disease Worsening|0|||
42254304|NCT02672852|76080655|FG002|Part A1|Disease Worsening|0|||
42254305|NCT02672852|76080656|FG003|Part A1|Disease Worsening|0|||
42254306|NCT02672852|76080657|FG004|Part A1|Disease Worsening|0|||
42254307|NCT02672852|76080658|FG005|Part A1|Disease Worsening|0|||
42254308|NCT02672852|76080659|FG006|Part A1|Disease Worsening|0|||
41992424|NCT01163032|75800512|FG002|Open Label Extension Phase|Study Termination|7|||
42010560|NCT00993421|75817697|FG003|Overall Study|Sponsor Decision|30|||
42033388|NCT01128959|75841600|FG000|Lead in Period|Adverse Event|3|||
42033389|NCT01128959|75841600|FG000|Treatment Period|Adverse Event|3|||
42033390|NCT01128959|75841600|FG000|Treatment Period|Withdrawal by Subject|1|||
42033391|NCT00859573|75841608|FG000|Overall Study|Withdrawal by Subject|4|||
42033392|NCT00859573|75841609|FG001|Overall Study|Withdrawal by Subject|1|||
42254309|NCT02672852|76080653|FG000|Part A1|Adverse Event|0|||
42254310|NCT02672852|76080654|FG001|Part A1|Adverse Event|1|||
42254311|NCT02672852|76080655|FG002|Part A1|Adverse Event|0|||
42033393|NCT00859573|75841608|FG000|Overall Study|Physician Decision|1|||
42254312|NCT02672852|76080656|FG003|Part A1|Adverse Event|0|||
42254313|NCT02672852|76080657|FG004|Part A1|Adverse Event|0|||
42311484|NCT01891864|76147515|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
42311485|NCT01891864|76147516|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
42311486|NCT01891864|76147511|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
42311487|NCT01891864|76147512|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
42311488|NCT01891864|76147513|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
42311489|NCT01891864|76147514|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
42311490|NCT01891864|76147515|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
42311491|NCT01891864|76147516|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
42311492|NCT01891864|76147511|FG000|Treatment Period 1|Withdrawal by Subject|2|||
42311493|NCT01891864|76147512|FG001|Treatment Period 1|Withdrawal by Subject|5|||
42311494|NCT01891864|76147513|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42311495|NCT01891864|76147514|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42311496|NCT01891864|76147515|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42311497|NCT01891864|76147516|FG005|Treatment Period 1|Withdrawal by Subject|0|||
42311498|NCT01891864|76147511|FG000|Treatment Period 1|Lost to Follow-up|1|||
42311499|NCT01891864|76147512|FG001|Treatment Period 1|Lost to Follow-up|0|||
42311500|NCT01891864|76147513|FG002|Treatment Period 1|Lost to Follow-up|0|||
42311501|NCT01891864|76147514|FG003|Treatment Period 1|Lost to Follow-up|0|||
42311502|NCT01891864|76147515|FG004|Treatment Period 1|Lost to Follow-up|0|||
42311503|NCT01891864|76147516|FG005|Treatment Period 1|Lost to Follow-up|0|||
42311504|NCT01891864|76147511|FG000|Treatment Period 2|Protocol Violation|0|||
42311505|NCT01891864|76147512|FG001|Treatment Period 2|Protocol Violation|0|||
42311506|NCT01891864|76147513|FG002|Treatment Period 2|Protocol Violation|0|||
42311507|NCT01891864|76147514|FG003|Treatment Period 2|Protocol Violation|1|||
42311508|NCT01891864|76147515|FG004|Treatment Period 2|Protocol Violation|0|||
42311509|NCT01891864|76147516|FG005|Treatment Period 2|Protocol Violation|0|||
42311510|NCT01891864|76147511|FG000|Treatment Period 2|Physician Decision|0|||
42311511|NCT01891864|76147512|FG001|Treatment Period 2|Physician Decision|0|||
42311512|NCT01891864|76147513|FG002|Treatment Period 2|Physician Decision|1|||
42311513|NCT01891864|76147514|FG003|Treatment Period 2|Physician Decision|0|||
42311514|NCT01891864|76147515|FG004|Treatment Period 2|Physician Decision|0|||
42311515|NCT01891864|76147516|FG005|Treatment Period 2|Physician Decision|0|||
42311516|NCT01891864|76147511|FG000|Treatment Period 2|Site Termination|0|||
42311517|NCT01891864|76147512|FG001|Treatment Period 2|Site Termination|0|||
42311518|NCT01891864|76147513|FG002|Treatment Period 2|Site Termination|1|||
41992425|NCT01163032|75800510|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
41992426|NCT01163032|75800511|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
41992427|NCT01163032|75800512|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
41992428|NCT01162486|75800525|FG000|Overall Study|low ANC|1|||
41992429|NCT01162486|75800526|FG001|Overall Study|low ANC|0|||
41992430|NCT01162486|75800527|FG002|Overall Study|low ANC|0|||
41992431|NCT01162486|75800528|FG003|Overall Study|low ANC|0|||
41992432|NCT01162486|75800529|FG004|Overall Study|low ANC|0|||
41992433|NCT01162486|75800525|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
41992434|NCT01162486|75800526|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
41992435|NCT01162486|75800527|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
41992436|NCT01162486|75800528|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
41992437|NCT01162486|75800529|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
41992438|NCT01162486|75800525|FG000|Overall Study|elevated LFTs|0|||
41992439|NCT01162486|75800526|FG001|Overall Study|elevated LFTs|0|||
41992440|NCT01162486|75800527|FG002|Overall Study|elevated LFTs|1|||
41992441|NCT01162486|75800528|FG003|Overall Study|elevated LFTs|0|||
42311519|NCT01891864|76147514|FG003|Treatment Period 2|Site Termination|2|||
42311520|NCT01891864|76147515|FG004|Treatment Period 2|Site Termination|0|||
42311521|NCT01891864|76147516|FG005|Treatment Period 2|Site Termination|0|||
42311522|NCT01891864|76147511|FG000|Treatment Period 2|Lack of Efficacy|0|||
42311523|NCT01891864|76147512|FG001|Treatment Period 2|Lack of Efficacy|0|||
42311524|NCT01891864|76147513|FG002|Treatment Period 2|Lack of Efficacy|1|||
42311525|NCT01891864|76147514|FG003|Treatment Period 2|Lack of Efficacy|0|||
42311526|NCT01891864|76147515|FG004|Treatment Period 2|Lack of Efficacy|1|||
42311527|NCT01891864|76147516|FG005|Treatment Period 2|Lack of Efficacy|0|||
42311528|NCT01891864|76147511|FG000|Treatment Period 2|Adverse Event|0|||
42311529|NCT01891864|76147512|FG001|Treatment Period 2|Adverse Event|0|||
42311530|NCT01891864|76147513|FG002|Treatment Period 2|Adverse Event|1|||
42311531|NCT01891864|76147514|FG003|Treatment Period 2|Adverse Event|2|||
42311532|NCT01891864|76147515|FG004|Treatment Period 2|Adverse Event|0|||
42311533|NCT01891864|76147516|FG005|Treatment Period 2|Adverse Event|4|||
42311534|NCT01891864|76147511|FG000|Treatment Period 2|Termination of Site|0|||
42311535|NCT01891864|76147512|FG001|Treatment Period 2|Termination of Site|0|||
42311536|NCT01891864|76147513|FG002|Treatment Period 2|Termination of Site|0|||
42311537|NCT01891864|76147514|FG003|Treatment Period 2|Termination of Site|0|||
42311538|NCT01891864|76147515|FG004|Treatment Period 2|Termination of Site|2|||
42311539|NCT01891864|76147516|FG005|Treatment Period 2|Termination of Site|0|||
42311540|NCT01891864|76147511|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42311541|NCT01891864|76147512|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42311542|NCT01891864|76147513|FG002|Treatment Period 2|Withdrawal by Subject|3|||
42311543|NCT01891864|76147514|FG003|Treatment Period 2|Withdrawal by Subject|4|||
42311544|NCT01891864|76147515|FG004|Treatment Period 2|Withdrawal by Subject|1|||
41992442|NCT01162486|75800529|FG004|Overall Study|elevated LFTs|0|||
42311545|NCT01891864|76147516|FG005|Treatment Period 2|Withdrawal by Subject|1|||
42311546|NCT01891864|76147511|FG000|Extension Period|Lack of Efficacy|0|||
42311547|NCT01891864|76147512|FG001|Extension Period|Lack of Efficacy|0|||
42311548|NCT01891864|76147513|FG002|Extension Period|Lack of Efficacy|0|||
42311549|NCT01891864|76147514|FG003|Extension Period|Lack of Efficacy|1|||
42311550|NCT01891864|76147515|FG004|Extension Period|Lack of Efficacy|1|||
42311551|NCT01891864|76147516|FG005|Extension Period|Lack of Efficacy|0|||
42311552|NCT01891864|76147511|FG000|Extension Period|Pregnancy|0|||
42311553|NCT01891864|76147512|FG001|Extension Period|Pregnancy|0|||
42311554|NCT01891864|76147513|FG002|Extension Period|Pregnancy|1|||
42311555|NCT01891864|76147514|FG003|Extension Period|Pregnancy|0|||
42311556|NCT01891864|76147515|FG004|Extension Period|Pregnancy|0|||
42311557|NCT01891864|76147516|FG005|Extension Period|Pregnancy|0|||
42311558|NCT01891864|76147511|FG000|Extension Period|Adverse Event|0|||
42311559|NCT01891864|76147512|FG001|Extension Period|Adverse Event|0|||
42311560|NCT01891864|76147513|FG002|Extension Period|Adverse Event|4|||
42311561|NCT01891864|76147514|FG003|Extension Period|Adverse Event|2|||
42311562|NCT01891864|76147515|FG004|Extension Period|Adverse Event|2|||
42311563|NCT01891864|76147516|FG005|Extension Period|Adverse Event|0|||
42311564|NCT01891864|76147511|FG000|Extension Period|Withdrawal by Subject|0|||
42311565|NCT01891864|76147512|FG001|Extension Period|Withdrawal by Subject|0|||
42311566|NCT01891864|76147513|FG002|Extension Period|Withdrawal by Subject|1|||
42311567|NCT01891864|76147514|FG003|Extension Period|Withdrawal by Subject|2|||
42311568|NCT01891864|76147515|FG004|Extension Period|Withdrawal by Subject|4|||
42311569|NCT01891864|76147516|FG005|Extension Period|Withdrawal by Subject|0|||
42311570|NCT01891864|76147511|FG000|Extension Period|Lost to Follow-up|0|||
41992443|NCT01162486|75800525|FG000|Overall Study|Pregnancy|0|||
42311571|NCT01891864|76147512|FG001|Extension Period|Lost to Follow-up|0|||
42311572|NCT01891864|76147513|FG002|Extension Period|Lost to Follow-up|2|||
42311573|NCT01891864|76147514|FG003|Extension Period|Lost to Follow-up|0|||
41992444|NCT01162486|75800526|FG001|Overall Study|Pregnancy|0|||
41992445|NCT01162486|75800527|FG002|Overall Study|Pregnancy|0|||
42311574|NCT01891864|76147515|FG004|Extension Period|Lost to Follow-up|0|||
42311575|NCT01891864|76147516|FG005|Extension Period|Lost to Follow-up|0|||
42311576|NCT02485301|76147530|FG000|Overall Study|Serious Adverse Events|2|||
42311577|NCT02485301|76147531|FG001|Overall Study|Serious Adverse Events|1|||
42311578|NCT02485301|76147530|FG000|Overall Study|Protocol Violation|0|||
42311579|NCT02485301|76147531|FG001|Overall Study|Protocol Violation|1|||
42311580|NCT02485301|76147530|FG000|Overall Study|Withdrawal by Subject|6|||
42311581|NCT02485301|76147531|FG001|Overall Study|Withdrawal by Subject|7|||
41992446|NCT01162486|75800528|FG003|Overall Study|Pregnancy|1|||
42311582|NCT02485301|76147530|FG000|Overall Study|Migrated/moved from study area|10|||
42311583|NCT02485301|76147531|FG001|Overall Study|Migrated/moved from study area|19|||
42311584|NCT02485301|76147530|FG000|Overall Study|Lost to Follow-up|17|||
42311585|NCT02485301|76147531|FG001|Overall Study|Lost to Follow-up|17|||
42311586|NCT02485301|76147530|FG000|Overall Study|Other|3|||
42311587|NCT02485301|76147531|FG001|Overall Study|Other|4|||
42311588|NCT02484911|76147539|FG000|Overall Study|Withdrawal by Subject|2|||
42311589|NCT02484911|76147540|FG001|Overall Study|Withdrawal by Subject|1|||
42311590|NCT02484911|76147539|FG000|Overall Study|Protocol Violation|2|||
42311591|NCT02484911|76147540|FG001|Overall Study|Protocol Violation|1|||
42311592|NCT02466425|76147549|FG000|Overall Study|Adverse Event|3|||
42311593|NCT02466425|76147550|FG001|Overall Study|Adverse Event|11|||
42311594|NCT02466425|76147549|FG000|Overall Study|Lack of Efficacy|4|||
42311595|NCT02466425|76147550|FG001|Overall Study|Lack of Efficacy|1|||
42311596|NCT02466425|76147549|FG000|Overall Study|Lost to Follow-up|3|||
42311597|NCT02466425|76147550|FG001|Overall Study|Lost to Follow-up|0|||
42311598|NCT02466425|76147549|FG000|Overall Study|Protocol Violation|1|||
42311599|NCT02466425|76147550|FG001|Overall Study|Protocol Violation|0|||
42311600|NCT02466425|76147549|FG000|Overall Study|Withdrawal by Subject|0|||
42311601|NCT02466425|76147550|FG001|Overall Study|Withdrawal by Subject|1|||
42311602|NCT02466425|76147549|FG000|Overall Study|Other|1|||
42311603|NCT02466425|76147550|FG001|Overall Study|Other|3|||
42311604|NCT02466425|76147549|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
42311605|NCT02466425|76147550|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
42311606|NCT02451917|76147558|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
42311607|NCT02451917|76147559|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
42311608|NCT02451917|76147558|FG000|First Intervention (24 Weeks)|Death|0|||
42311609|NCT02451917|76147559|FG001|First Intervention (24 Weeks)|Death|1|||
42311610|NCT02451917|76147558|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
42311611|NCT02451917|76147559|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
42311612|NCT02349451|76147572|FG000|Overall Study|Withdrawal by Subject|0|||
42311613|NCT02349451|76147573|FG001|Overall Study|Withdrawal by Subject|1|||
42311614|NCT02349451|76147574|FG002|Overall Study|Withdrawal by Subject|2|||
42311615|NCT02349451|76147575|FG003|Overall Study|Withdrawal by Subject|1|||
42311616|NCT02409368|76147592|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
42311617|NCT02409368|76147593|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
42311618|NCT02409368|76147594|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
42311619|NCT02409368|76147595|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
42311620|NCT02409368|76147592|FG000|ECOG Reclassification|Death|1|||
42311621|NCT02409368|76147593|FG001|ECOG Reclassification|Death|5|||
42311622|NCT02409368|76147594|FG002|ECOG Reclassification|Death|0|||
42311623|NCT02409368|76147595|FG003|ECOG Reclassification|Death|0|||
42311624|NCT02409368|76147592|FG000|ECOG Reclassification|Disease Progression|113|||
42311625|NCT02409368|76147593|FG001|ECOG Reclassification|Disease Progression|382|||
42311626|NCT02409368|76147594|FG002|ECOG Reclassification|Disease Progression|70|||
42311627|NCT02409368|76147595|FG003|ECOG Reclassification|Disease Progression|1|||
42311628|NCT02409368|76147592|FG000|ECOG Reclassification|Lost to Follow-up|1|||
42311629|NCT02409368|76147593|FG001|ECOG Reclassification|Lost to Follow-up|5|||
42311630|NCT02409368|76147594|FG002|ECOG Reclassification|Lost to Follow-up|0|||
42311631|NCT02409368|76147595|FG003|ECOG Reclassification|Lost to Follow-up|0|||
42311632|NCT02409368|76147592|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
42311633|NCT02409368|76147593|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
42311634|NCT02409368|76147594|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
42311635|NCT02409368|76147595|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
42311636|NCT02409368|76147592|FG000|ECOG Reclassification|Poor/non-compliance|0|||
42311637|NCT02409368|76147593|FG001|ECOG Reclassification|Poor/non-compliance|3|||
42311638|NCT02409368|76147594|FG002|ECOG Reclassification|Poor/non-compliance|2|||
42311639|NCT02409368|76147595|FG003|ECOG Reclassification|Poor/non-compliance|0|||
42311640|NCT02409368|76147592|FG000|ECOG Reclassification|Study drug toxicity|17|||
42311641|NCT02409368|76147593|FG001|ECOG Reclassification|Study drug toxicity|42|||
42311642|NCT02409368|76147594|FG002|ECOG Reclassification|Study drug toxicity|7|||
42311643|NCT02409368|76147595|FG003|ECOG Reclassification|Study drug toxicity|0|||
42311644|NCT02409368|76147592|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
42311645|NCT02409368|76147593|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
42311646|NCT02409368|76147594|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
42311647|NCT02409368|76147595|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
42311648|NCT02409368|76147592|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
42311649|NCT02409368|76147593|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
42311650|NCT02409368|76147594|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
42311651|NCT02409368|76147595|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
42311652|NCT02409368|76147592|FG000|ECOG Reclassification|Participant withdrew consent|2|||
42311653|NCT02409368|76147593|FG001|ECOG Reclassification|Participant withdrew consent|3|||
42311654|NCT02409368|76147594|FG002|ECOG Reclassification|Participant withdrew consent|4|||
42311655|NCT02409368|76147595|FG003|ECOG Reclassification|Participant withdrew consent|0|||
42311656|NCT02409368|76147592|FG000|ECOG Reclassification|Other Reasons|5|||
42311657|NCT02409368|76147593|FG001|ECOG Reclassification|Other Reasons|26|||
42311658|NCT02409368|76147594|FG002|ECOG Reclassification|Other Reasons|2|||
42311659|NCT02409368|76147595|FG003|ECOG Reclassification|Other Reasons|0|||
42311660|NCT02409368|76147592|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
42311661|NCT02409368|76147593|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
42311662|NCT02409368|76147594|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
42311663|NCT02409368|76147595|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
42311664|NCT01853878|76147608|FG000|Overall Study|Recurrence|2|||
42311665|NCT01853878|76147609|FG001|Overall Study|Recurrence|0|||
42311666|NCT01853878|76147608|FG000|Overall Study|Adverse Event|2|||
42311667|NCT01853878|76147609|FG001|Overall Study|Adverse Event|0|||
42311668|NCT01853878|76147608|FG000|Overall Study|Withdrawal by Subject|3|||
42311669|NCT01853878|76147609|FG001|Overall Study|Withdrawal by Subject|1|||
42311670|NCT01853878|76147608|FG000|Overall Study|Migrated/moved from the study area|1|||
42311671|NCT01853878|76147609|FG001|Overall Study|Migrated/moved from the study area|0|||
42311672|NCT01853878|76147608|FG000|Overall Study|Other|55|||
42311673|NCT01853878|76147609|FG001|Overall Study|Other|43|||
42311674|NCT02342678|76147617|FG000|Overall Study|Lost to Follow-up|0|||
42311675|NCT02342678|76147618|FG001|Overall Study|Lost to Follow-up|1|||
42311676|NCT02342678|76147617|FG000|Overall Study|Too busy to complete study|0|||
42311677|NCT02342678|76147618|FG001|Overall Study|Too busy to complete study|2|||
42311678|NCT02342678|76147617|FG000|Overall Study|Family illness/emergency|0|||
42311679|NCT02342678|76147618|FG001|Overall Study|Family illness/emergency|1|||
42311680|NCT02342678|76147617|FG000|Overall Study|Illness/medical reason|1|||
42311681|NCT02342678|76147618|FG001|Overall Study|Illness/medical reason|1|||
42311682|NCT02342288|76147626|FG000|Overall Study|no protocol anesthesiologist available|3|||
42311683|NCT02342288|76147627|FG001|Overall Study|no protocol anesthesiologist available|2|||
42311684|NCT02342288|76147626|FG000|Overall Study|anesthesia leak in system|1|||
42311685|NCT02342288|76147627|FG001|Overall Study|anesthesia leak in system|0|||
42311686|NCT02342288|76147626|FG000|Overall Study|Withdrawal by Subject|1|||
42311687|NCT02342288|76147627|FG001|Overall Study|Withdrawal by Subject|0|||
42311688|NCT02342288|76147626|FG000|Overall Study|coordinator contaminated with blood|0|||
42311689|NCT02342288|76147627|FG001|Overall Study|coordinator contaminated with blood|1|||
42311690|NCT02342288|76147626|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
42311691|NCT02342288|76147627|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
42254314|NCT02672852|76080658|FG005|Part A1|Adverse Event|0|||
42254315|NCT02672852|76080659|FG006|Part A1|Adverse Event|0|||
42254316|NCT02672852|76080653|FG000|Part A1|Lost to Follow-up|1|||
42254317|NCT02672852|76080654|FG001|Part A1|Lost to Follow-up|2|||
42254318|NCT02672852|76080655|FG002|Part A1|Lost to Follow-up|0|||
42254319|NCT02672852|76080656|FG003|Part A1|Lost to Follow-up|0|||
42254320|NCT02672852|76080657|FG004|Part A1|Lost to Follow-up|0|||
42254321|NCT02672852|76080658|FG005|Part A1|Lost to Follow-up|0|||
42311692|NCT02342288|76147626|FG000|Overall Study|coordinator not available|0|||
42254322|NCT02672852|76080659|FG006|Part A1|Lost to Follow-up|0|||
42254323|NCT02672852|76080653|FG000|Part A1|Withdrawal by Subject|1|||
42311693|NCT02342288|76147627|FG001|Overall Study|coordinator not available|2|||
42311694|NCT01853644|76147633|FG000|Registration and Treatment Start|Did not start treatment|1|||
42254324|NCT02672852|76080654|FG001|Part A1|Withdrawal by Subject|1|||
42311695|NCT01853644|76147633|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
42311696|NCT01853644|76147633|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
42254325|NCT02672852|76080655|FG002|Part A1|Withdrawal by Subject|0|||
42254326|NCT02672852|76080656|FG003|Part A1|Withdrawal by Subject|0|||
42311697|NCT01853644|76147633|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
42311698|NCT01853644|76147633|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
42311699|NCT01853644|76147633|FG000|Continued Treatment After First Response|Adverse Event|2|||
42311700|NCT01853644|76147633|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
42311701|NCT02374346|76147637|FG000|Overall Study|operated or discharged during weekend|48|||
42311702|NCT01853254|76147643|FG000|Overall Study|Abnormal Laboratory Test|1|||
42311703|NCT01853254|76147643|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
42311704|NCT01853254|76147643|FG000|Overall Study|Death|1|||
42311705|NCT01853254|76147643|FG000|Overall Study|Failure to Return|43|||
42311706|NCT01853254|76147643|FG000|Overall Study|Insufficient Therapeutic Response|22|||
42311707|NCT01853254|76147643|FG000|Overall Study|Refusal of Treatment|1|||
41992447|NCT01162486|75800529|FG004|Overall Study|Pregnancy|0|||
41992448|NCT01162135|75800545|FG000|Overall Study|Withdrawal by Subject|1|||
41992449|NCT01162135|75800545|FG000|Overall Study|Severe back pain|1|||
41992450|NCT01162135|75800545|FG000|Overall Study|Ineligible|1|||
41992451|NCT01161628|75800549|FG000|Overall Study|Death|6|||
41992452|NCT01161628|75800549|FG000|Overall Study|Lack of Efficacy|2|||
41992453|NCT01161472|75800553|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
41992454|NCT01161472|75800554|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
41992455|NCT01161472|75800555|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
41992456|NCT01161472|75800556|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
41992457|NCT01161043|75800566|FG000|Overall Study|Withdrawal by Subject|3|||
41992458|NCT01160770|75800570|FG000|Overall Study|Adverse Event|10|||
41992459|NCT01160770|75800570|FG000|Overall Study|Protocol Violation|2|||
41992460|NCT01160770|75800570|FG000|Overall Study|Subject/parent/caregiver request|33|||
41992461|NCT01160770|75800570|FG000|Overall Study|Physician Decision|1|||
41992462|NCT01160770|75800570|FG000|Overall Study|Lost to Follow-up|7|||
41992463|NCT01160770|75800570|FG000|Overall Study|Study termination or sponsor request|1|||
42254327|NCT02672852|76080657|FG004|Part A1|Withdrawal by Subject|0|||
42254328|NCT02672852|76080658|FG005|Part A1|Withdrawal by Subject|0|||
42254329|NCT02672852|76080659|FG006|Part A1|Withdrawal by Subject|0|||
42254330|NCT02672852|76080653|FG000|Part A2|Disease worsening|0|||
42254331|NCT02672852|76080654|FG001|Part A2|Disease worsening|0|||
42254332|NCT02672852|76080655|FG002|Part A2|Disease worsening|1|||
42254333|NCT02672852|76080656|FG003|Part A2|Disease worsening|0|||
42311708|NCT01853254|76147643|FG000|Overall Study|Other Protocol Violation|1|||
42311709|NCT01853254|76147643|FG000|Overall Study|Withdrawal of Consent|16|||
42311710|NCT01853254|76147643|FG000|Overall Study|Administrative/Other|16|||
42311711|NCT02373098|76147649|FG000|Overall Study|Lost to Follow-up|1|||
42311712|NCT02373098|76147650|FG001|Overall Study|Lost to Follow-up|0|||
42311713|NCT02373098|76147649|FG000|Overall Study|Protocol Violation|3|||
42311714|NCT02373098|76147650|FG001|Overall Study|Protocol Violation|0|||
42311715|NCT02373098|76147649|FG000|Overall Study|Withdrawal by Subject|5|||
42311716|NCT02373098|76147650|FG001|Overall Study|Withdrawal by Subject|0|||
42311717|NCT02373098|76147649|FG000|Overall Study|Adverse Event|3|||
42311718|NCT02373098|76147650|FG001|Overall Study|Adverse Event|0|||
42311719|NCT01853176|76147664|FG000|Overall Study|Study terminated|4|||
42311720|NCT01853176|76147665|FG001|Overall Study|Study terminated|0|||
42311721|NCT02372396|76147673|FG000|Overall Study|Lost to Follow-up|7|||
42311722|NCT02372396|76147674|FG001|Overall Study|Lost to Follow-up|9|||
42311723|NCT01835548|76147682|FG000|Dose Optimization Period|Adverse Event|0|||
42254334|NCT02672852|76080657|FG004|Part A2|Disease worsening|0|||
42254335|NCT02672852|76080658|FG005|Part A2|Disease worsening|0|||
42254336|NCT02672852|76080659|FG006|Part A2|Disease worsening|0|||
42254337|NCT02672852|76080653|FG000|Part A2|Adverse Event|0|||
42254338|NCT02672852|76080654|FG001|Part A2|Adverse Event|0|||
42254339|NCT02672852|76080655|FG002|Part A2|Adverse Event|3|||
42311724|NCT01835548|76147683|FG001|Dose Optimization Period|Adverse Event|0|||
42311725|NCT01835548|76147684|FG002|Dose Optimization Period|Adverse Event|1|||
42311726|NCT01835548|76147682|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
42311727|NCT01835548|76147683|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
42311728|NCT01835548|76147684|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
42311729|NCT01835548|76147682|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42311730|NCT01835548|76147683|FG001|Double-Blind Treatment Period|Adverse Event|1|||
42311731|NCT01835548|76147684|FG002|Double-Blind Treatment Period|Adverse Event|0|||
42311732|NCT01835548|76147682|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42311733|NCT01835548|76147683|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
42311734|NCT01835548|76147684|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42311735|NCT01852942|76147698|FG000|Overall Study|Physician Decision|1|||
42311736|NCT01852942|76147699|FG001|Overall Study|Physician Decision|0|||
42311737|NCT01852942|76147698|FG000|Overall Study|Death|1|||
42311738|NCT01852942|76147699|FG001|Overall Study|Death|1|||
42311739|NCT01852942|76147698|FG000|Overall Study|Withdrawal by Subject|2|||
42311740|NCT01852942|76147699|FG001|Overall Study|Withdrawal by Subject|3|||
42311741|NCT01852942|76147698|FG000|Overall Study|Lost to Follow-up|1|||
42311742|NCT01852942|76147699|FG001|Overall Study|Lost to Follow-up|2|||
42311743|NCT01852162|76147708|FG000|Overall Study|Adverse Event|1|||
42311744|NCT01852162|76147709|FG001|Overall Study|Adverse Event|0|||
42311745|NCT01852162|76147708|FG000|Overall Study|Withdrawal by Subject|3|||
42311746|NCT01852162|76147709|FG001|Overall Study|Withdrawal by Subject|1|||
42311747|NCT01835470|76147715|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
42311748|NCT01835470|76147715|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
42311749|NCT02451137|76147722|FG000|Overall Study|Randomized but not treated|19|||
42311750|NCT02451137|76147723|FG001|Overall Study|Randomized but not treated|27|||
42311751|NCT02451137|76147722|FG000|Overall Study|Adverse Event|43|||
42311752|NCT02451137|76147723|FG001|Overall Study|Adverse Event|42|||
41992464|NCT01160770|75800570|FG000|Overall Study|Death|9|||
41992465|NCT01160770|75800570|FG000|Overall Study|Lack of Efficacy|15|||
41992466|NCT01160770|75800570|FG000|Overall Study|Other Reasons|1|||
42311753|NCT02451137|76147722|FG000|Overall Study|Lack of Efficacy|4|||
42311754|NCT02451137|76147723|FG001|Overall Study|Lack of Efficacy|9|||
41992467|NCT01160614|75800576|FG000|Overall Study|Withdrawal by Subject|0|||
41992468|NCT01160614|75800577|FG001|Overall Study|Withdrawal by Subject|2|||
41992469|NCT01159912|75800604|FG000|Overall Study|Adverse Event|2|||
41992470|NCT01159912|75800605|FG001|Overall Study|Adverse Event|2|||
41992471|NCT01159912|75800606|FG002|Overall Study|Adverse Event|3|||
41992472|NCT01159912|75800604|FG000|Overall Study|Lack of Efficacy|23|||
41992473|NCT01159912|75800605|FG001|Overall Study|Lack of Efficacy|15|||
41992474|NCT01159912|75800606|FG002|Overall Study|Lack of Efficacy|14|||
41992475|NCT01159912|75800604|FG000|Overall Study|Protocol Violation|1|||
41992476|NCT01159912|75800605|FG001|Overall Study|Protocol Violation|2|||
41992477|NCT01159912|75800606|FG002|Overall Study|Protocol Violation|3|||
41992478|NCT01159912|75800604|FG000|Overall Study|Lost to Follow-up|4|||
41992479|NCT01159912|75800605|FG001|Overall Study|Lost to Follow-up|0|||
41992480|NCT01159912|75800606|FG002|Overall Study|Lost to Follow-up|0|||
41992481|NCT01159912|75800604|FG000|Overall Study|Physician Decision|0|||
41992482|NCT01159912|75800605|FG001|Overall Study|Physician Decision|0|||
41992483|NCT01159912|75800606|FG002|Overall Study|Physician Decision|3|||
41992484|NCT01159912|75800604|FG000|Overall Study|Withdrawal by Subject|10|||
41992485|NCT01159912|75800605|FG001|Overall Study|Withdrawal by Subject|3|||
41992486|NCT01159912|75800606|FG002|Overall Study|Withdrawal by Subject|3|||
41992487|NCT01159600|75800622|FG000|Overall Study|Not treated|0|||
41992488|NCT01159600|75800623|FG001|Overall Study|Not treated|0|||
41992489|NCT01159600|75800624|FG002|Overall Study|Not treated|1|||
42254340|NCT02672852|76080656|FG003|Part A2|Adverse Event|0|||
42254341|NCT02672852|76080657|FG004|Part A2|Adverse Event|0|||
42254342|NCT02672852|76080658|FG005|Part A2|Adverse Event|0|||
42254343|NCT02672852|76080659|FG006|Part A2|Adverse Event|0|||
42254344|NCT02672852|76080653|FG000|Part A2|Lost to Follow-up|0|||
42254345|NCT02672852|76080654|FG001|Part A2|Lost to Follow-up|0|||
41992490|NCT01159600|75800625|FG003|Overall Study|Not treated|0|||
41992491|NCT01159600|75800626|FG004|Overall Study|Not treated|0|||
41992492|NCT01159600|75800627|FG005|Overall Study|Not treated|1|||
41992493|NCT01159600|75800628|FG006|Overall Study|Not treated|2|||
42254346|NCT02672852|76080655|FG002|Part A2|Lost to Follow-up|2|||
41992494|NCT01159600|75800629|FG007|Overall Study|Not treated|2|||
41992495|NCT01159600|75800622|FG000|Overall Study|Adverse Event|7|||
42254347|NCT02672852|76080656|FG003|Part A2|Lost to Follow-up|0|||
41992496|NCT01159600|75800623|FG001|Overall Study|Adverse Event|2|||
41992497|NCT01159600|75800624|FG002|Overall Study|Adverse Event|5|||
41992498|NCT01159600|75800625|FG003|Overall Study|Adverse Event|1|||
41992499|NCT01159600|75800626|FG004|Overall Study|Adverse Event|8|||
41992500|NCT01159600|75800627|FG005|Overall Study|Adverse Event|6|||
41992501|NCT01159600|75800628|FG006|Overall Study|Adverse Event|7|||
41992502|NCT01159600|75800629|FG007|Overall Study|Adverse Event|5|||
41992503|NCT01159600|75800622|FG000|Overall Study|Lack of Efficacy|0|||
41992504|NCT01159600|75800623|FG001|Overall Study|Lack of Efficacy|0|||
42254348|NCT02672852|76080657|FG004|Part A2|Lost to Follow-up|0|||
42254349|NCT02672852|76080658|FG005|Part A2|Lost to Follow-up|0|||
42254350|NCT02672852|76080659|FG006|Part A2|Lost to Follow-up|0|||
42254351|NCT02672852|76080653|FG000|Part A2|Withdrawal by Subject|0|||
42254352|NCT02672852|76080654|FG001|Part A2|Withdrawal by Subject|0|||
42254353|NCT02672852|76080655|FG002|Part A2|Withdrawal by Subject|1|||
42254354|NCT02672852|76080656|FG003|Part A2|Withdrawal by Subject|0|||
42254355|NCT02672852|76080657|FG004|Part A2|Withdrawal by Subject|0|||
42254356|NCT02672852|76080658|FG005|Part A2|Withdrawal by Subject|0|||
42254357|NCT02672852|76080659|FG006|Part A2|Withdrawal by Subject|0|||
42254358|NCT02672852|76080653|FG000|Part A2|Other|0|||
42254359|NCT02672852|76080654|FG001|Part A2|Other|0|||
42254360|NCT02672852|76080655|FG002|Part A2|Other|3|||
42254361|NCT02672852|76080656|FG003|Part A2|Other|0|||
41992505|NCT01159600|75800624|FG002|Overall Study|Lack of Efficacy|0|||
42254362|NCT02672852|76080657|FG004|Part A2|Other|0|||
42254363|NCT02672852|76080658|FG005|Part A2|Other|0|||
41992506|NCT01159600|75800625|FG003|Overall Study|Lack of Efficacy|0|||
41992507|NCT01159600|75800626|FG004|Overall Study|Lack of Efficacy|2|||
42254364|NCT02672852|76080659|FG006|Part A2|Other|0|||
42254365|NCT02672852|76080653|FG000|Part A2|Not entered in Part B|0|||
42254366|NCT02672852|76080654|FG001|Part A2|Not entered in Part B|0|||
42254367|NCT02672852|76080655|FG002|Part A2|Not entered in Part B|0|||
42254368|NCT02672852|76080656|FG003|Part A2|Not entered in Part B|4|||
42254369|NCT02672852|76080657|FG004|Part A2|Not entered in Part B|0|||
42254370|NCT02672852|76080658|FG005|Part A2|Not entered in Part B|0|||
42254371|NCT02672852|76080659|FG006|Part A2|Not entered in Part B|0|||
42254372|NCT02672852|76080653|FG000|Part B|Disease worsening|0|||
42254373|NCT02672852|76080654|FG001|Part B|Disease worsening|0|||
42254374|NCT02672852|76080655|FG002|Part B|Disease worsening|0|||
42254375|NCT02672852|76080656|FG003|Part B|Disease worsening|0|||
42254376|NCT02672852|76080657|FG004|Part B|Disease worsening|1|||
42254377|NCT02672852|76080658|FG005|Part B|Disease worsening|0|||
42254378|NCT02672852|76080659|FG006|Part B|Disease worsening|1|||
42254379|NCT02672852|76080653|FG000|Part B|Worsening pre-existing condition|0|||
42254380|NCT02672852|76080654|FG001|Part B|Worsening pre-existing condition|0|||
42254381|NCT02672852|76080655|FG002|Part B|Worsening pre-existing condition|0|||
42254382|NCT02672852|76080656|FG003|Part B|Worsening pre-existing condition|0|||
42254383|NCT02672852|76080657|FG004|Part B|Worsening pre-existing condition|0|||
42254384|NCT02672852|76080658|FG005|Part B|Worsening pre-existing condition|1|||
42254385|NCT02672852|76080659|FG006|Part B|Worsening pre-existing condition|0|||
42254386|NCT02672852|76080653|FG000|Part B|Other adverse event|0|||
42254387|NCT02672852|76080654|FG001|Part B|Other adverse event|0|||
42254388|NCT02672852|76080655|FG002|Part B|Other adverse event|0|||
42254389|NCT02672852|76080656|FG003|Part B|Other adverse event|0|||
42254390|NCT02672852|76080657|FG004|Part B|Other adverse event|3|||
42254391|NCT02672852|76080658|FG005|Part B|Other adverse event|5|||
42254392|NCT02672852|76080659|FG006|Part B|Other adverse event|1|||
42254393|NCT02672852|76080653|FG000|Part B|Lost to Follow-up|0|||
42254394|NCT02672852|76080654|FG001|Part B|Lost to Follow-up|0|||
42254395|NCT02672852|76080655|FG002|Part B|Lost to Follow-up|0|||
42254396|NCT02672852|76080656|FG003|Part B|Lost to Follow-up|0|||
42254397|NCT02672852|76080657|FG004|Part B|Lost to Follow-up|3|||
42254398|NCT02672852|76080658|FG005|Part B|Lost to Follow-up|4|||
42254399|NCT02672852|76080659|FG006|Part B|Lost to Follow-up|1|||
42254400|NCT02672852|76080653|FG000|Part B|Withdrawal by Subject|0|||
42254401|NCT02672852|76080654|FG001|Part B|Withdrawal by Subject|0|||
42254402|NCT02672852|76080655|FG002|Part B|Withdrawal by Subject|0|||
42254403|NCT02672852|76080656|FG003|Part B|Withdrawal by Subject|0|||
42254404|NCT02672852|76080657|FG004|Part B|Withdrawal by Subject|5|||
42254405|NCT02672852|76080658|FG005|Part B|Withdrawal by Subject|0|||
42254406|NCT02672852|76080659|FG006|Part B|Withdrawal by Subject|7|||
42254407|NCT02672852|76080653|FG000|Part B|Other|0|||
42254408|NCT02672852|76080654|FG001|Part B|Other|0|||
42254409|NCT02672852|76080655|FG002|Part B|Other|0|||
42254410|NCT02672852|76080656|FG003|Part B|Other|0|||
42254411|NCT02672852|76080657|FG004|Part B|Other|4|||
42254412|NCT02672852|76080658|FG005|Part B|Other|1|||
42254413|NCT02672852|76080659|FG006|Part B|Other|2|||
42254414|NCT02671760|76080670|FG000|Overall Study|Lost to Follow-up|0|||
42254415|NCT02671760|76080671|FG001|Overall Study|Lost to Follow-up|1|||
42254416|NCT02671760|76080672|FG002|Overall Study|Lost to Follow-up|0|||
42254417|NCT02667236|76080682|FG000|Overall Study|Adverse Event|1|||
42254418|NCT02667236|76080683|FG001|Overall Study|Adverse Event|1|||
42254419|NCT02667236|76080682|FG000|Overall Study|Withdrawal by Subject|2|||
42254420|NCT02667236|76080683|FG001|Overall Study|Withdrawal by Subject|0|||
42254421|NCT01126749|76080693|FG000|Phase 1b|Other|0|||
42254422|NCT01126749|76080694|FG001|Phase 1b|Other|1|||
42254423|NCT01126749|76080695|FG002|Phase 1b|Other|0|||
42254424|NCT01126749|76080696|FG003|Phase 1b|Other|0|||
42254425|NCT01126749|76080693|FG000|Phase 1b|Withdrawal by Subject|0|||
42254426|NCT01126749|76080694|FG001|Phase 1b|Withdrawal by Subject|1|||
42254427|NCT01126749|76080695|FG002|Phase 1b|Withdrawal by Subject|0|||
42254428|NCT01126749|76080696|FG003|Phase 1b|Withdrawal by Subject|0|||
42254429|NCT01126749|76080693|FG000|Phase 1b|Death|3|||
42254430|NCT01126749|76080694|FG001|Phase 1b|Death|4|||
42254431|NCT01126749|76080695|FG002|Phase 1b|Death|0|||
42254432|NCT01126749|76080696|FG003|Phase 1b|Death|0|||
42254433|NCT01126749|76080693|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
42254434|NCT01126749|76080694|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
42254435|NCT01126749|76080695|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
42254436|NCT01126749|76080696|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
42254437|NCT01126749|76080693|FG000|Phase 2|Study Termination by Sponsor|0|||
42254438|NCT01126749|76080694|FG001|Phase 2|Study Termination by Sponsor|0|||
42254439|NCT01126749|76080695|FG002|Phase 2|Study Termination by Sponsor|12|||
42254440|NCT01126749|76080696|FG003|Phase 2|Study Termination by Sponsor|6|||
42254441|NCT01126749|76080693|FG000|Phase 2|Other|0|||
42311755|NCT02451137|76147722|FG000|Overall Study|Participant decision:discontinue insulin|41|||
42311756|NCT02451137|76147723|FG001|Overall Study|Participant decision:discontinue insulin|43|||
42311757|NCT02451137|76147722|FG000|Overall Study|Hypoglycemia|2|||
42311758|NCT02451137|76147723|FG001|Overall Study|Hypoglycemia|1|||
42311759|NCT02451137|76147722|FG000|Overall Study|Investigator's decision|23|||
42311760|NCT02451137|76147723|FG001|Overall Study|Investigator's decision|19|||
42311761|NCT02451137|76147722|FG000|Overall Study|Lost to Follow-up|53|||
42311762|NCT02451137|76147723|FG001|Overall Study|Lost to Follow-up|61|||
42311763|NCT02451137|76147722|FG000|Overall Study|Physician Decision|6|||
42311764|NCT02451137|76147723|FG001|Overall Study|Physician Decision|5|||
42311765|NCT02451137|76147722|FG000|Overall Study|Sponsor decision|13|||
42311766|NCT02451137|76147723|FG001|Overall Study|Sponsor decision|25|||
42311767|NCT02451137|76147722|FG000|Overall Study|Withdrawal by Subject|40|||
42311768|NCT02451137|76147723|FG001|Overall Study|Withdrawal by Subject|63|||
42311769|NCT02451137|76147722|FG000|Overall Study|Other than specified above|2|||
42311770|NCT02451137|76147723|FG001|Overall Study|Other than specified above|3|||
42311771|NCT02372006|76147732|FG000|Overall Study|Progressive disease|8|||
42311772|NCT02372006|76147733|FG001|Overall Study|Progressive disease|7|||
42311773|NCT02372006|76147734|FG002|Overall Study|Progressive disease|34|||
42311774|NCT02372006|76147732|FG000|Overall Study|Dose limiting toxicity|0|||
42311775|NCT02372006|76147733|FG001|Overall Study|Dose limiting toxicity|1|||
42311776|NCT02372006|76147734|FG002|Overall Study|Dose limiting toxicity|0|||
42311777|NCT02372006|76147732|FG000|Overall Study|Adverse Event|0|||
42311778|NCT02372006|76147733|FG001|Overall Study|Adverse Event|0|||
42311779|NCT02372006|76147734|FG002|Overall Study|Adverse Event|3|||
42311780|NCT02372006|76147732|FG000|Overall Study|Withdrawal by Subject|0|||
42311781|NCT02372006|76147733|FG001|Overall Study|Withdrawal by Subject|1|||
42311782|NCT02372006|76147734|FG002|Overall Study|Withdrawal by Subject|1|||
42311783|NCT02372006|76147732|FG000|Overall Study|Other reason for not completing|0|||
42311784|NCT02372006|76147733|FG001|Overall Study|Other reason for not completing|0|||
42311785|NCT02372006|76147734|FG002|Overall Study|Other reason for not completing|1|||
42311786|NCT02406248|76147743|FG000|Overall Study|Death|7|||
42311787|NCT02406248|76147743|FG000|Overall Study|Withdrawal by Subject|2|||
42311788|NCT02450903|76147747|FG000|Overall Study|Adverse Event|3|||
42311789|NCT02450903|76147747|FG000|Overall Study|Progressive disease|15|||
42311790|NCT02450903|76147747|FG000|Overall Study|Switched to commercial drug|1|||
42311791|NCT02450903|76147747|FG000|Overall Study|Subject/guardian decision|1|||
42311792|NCT02371616|76147753|FG000|Overall Study|Protocol Violation|2|||
42311793|NCT02371616|76147754|FG001|Overall Study|Protocol Violation|1|||
42311794|NCT02371616|76147753|FG000|Overall Study|Adverse Event|0|||
42311795|NCT02371616|76147754|FG001|Overall Study|Adverse Event|1|||
42311796|NCT02371616|76147753|FG000|Overall Study|Withdrawal of Consent|1|||
42311797|NCT02371616|76147754|FG001|Overall Study|Withdrawal of Consent|0|||
42311798|NCT02371616|76147753|FG000|Overall Study|Other (Not specified)|1|||
42311799|NCT02371616|76147754|FG001|Overall Study|Other (Not specified)|5|||
42311800|NCT02370914|76147760|FG000|Overall Study|Protocol Violation|2|||
42311801|NCT02370602|76147770|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
42311802|NCT02370602|76147771|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
42311803|NCT02370602|76147772|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
42311804|NCT02370602|76147773|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
42311805|NCT02370602|76147774|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
42311806|NCT02370602|76147775|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
42311807|NCT02370368|76147794|FG000|Overall Study|Adverse Event|1|||
42311808|NCT02370368|76147795|FG001|Overall Study|Adverse Event|2|||
42311809|NCT02370368|76147794|FG000|Overall Study|Withdrawal by Subject|5|||
42311810|NCT02370368|76147795|FG001|Overall Study|Withdrawal by Subject|4|||
42311811|NCT02340806|76147803|FG000|Overall Study|Protocol Violation|2|||
42311812|NCT02340806|76147804|FG001|Overall Study|Protocol Violation|0|||
42311813|NCT02340806|76147803|FG000|Overall Study|epidural catheter replaced|2|||
42133051|NCT00556439|75943963|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
42133052|NCT00556439|75943964|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
42311814|NCT02340806|76147804|FG001|Overall Study|epidural catheter replaced|1|||
42311815|NCT02340806|76147803|FG000|Overall Study|history of chronic pain medication|1|||
42311816|NCT02340806|76147804|FG001|Overall Study|history of chronic pain medication|0|||
42311817|NCT02340806|76147803|FG000|Overall Study|re-dose < 90 min of CSE|1|||
42311818|NCT02340806|76147804|FG001|Overall Study|re-dose < 90 min of CSE|3|||
42311819|NCT02338154|76147810|FG000|Overall Study|Death|46|||
42311820|NCT02338154|76147810|FG000|Overall Study|Valve Implant Failure|17|||
42311821|NCT02338154|76147810|FG000|Overall Study|Valve Explant|11|||
42311822|NCT02338154|76147810|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
42311823|NCT02338154|76147810|FG000|Overall Study|Lost to Follow-up|8|||
42311824|NCT02338154|76147810|FG000|Overall Study|Other Reason|3|||
42311825|NCT02338154|76147810|FG000|Overall Study|Patients Without Exit Form|47|||
42311826|NCT02338154|76147810|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
42311827|NCT01835158|76147824|FG000|Overall Study|Withdrawal by Subject|1|||
42311828|NCT01835158|76147825|FG001|Overall Study|Withdrawal by Subject|6|||
42311829|NCT02337764|76147831|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
42311830|NCT02337764|76147831|FG000|Overall Study|Voluntary Withdrawal|12|||
42311831|NCT02337764|76147831|FG000|Overall Study|Lack of Efficacy|2|||
42311832|NCT01834222|76147835|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
42311833|NCT01833832|76147839|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
42311834|NCT01833520|76147845|FG000|Overall Study|Lack of Efficacy|3|||
42311835|NCT01833520|76147846|FG001|Overall Study|Lack of Efficacy|3|||
42311836|NCT01833520|76147847|FG002|Overall Study|Lack of Efficacy|8|||
42311837|NCT01833520|76147848|FG003|Overall Study|Lack of Efficacy|3|||
42311838|NCT01850602|76147862|FG000|Overall Study|Adverse Event|7|||
42311839|NCT01850602|76147863|FG001|Overall Study|Adverse Event|10|||
42311840|NCT01850602|76147862|FG000|Overall Study|Physician Decision|2|||
42311841|NCT01850602|76147863|FG001|Overall Study|Physician Decision|1|||
42311842|NCT01850602|76147862|FG000|Overall Study|Withdrawal by Subject|2|||
42311843|NCT01850602|76147863|FG001|Overall Study|Withdrawal by Subject|4|||
42311844|NCT01850602|76147862|FG000|Overall Study|Decrease in serum calcium|2|||
42311845|NCT01850602|76147863|FG001|Overall Study|Decrease in serum calcium|3|||
42133053|NCT00556439|75943965|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
42311846|NCT01850602|76147862|FG000|Overall Study|Increase in serum ferritin|1|||
42311847|NCT01850602|76147863|FG001|Overall Study|Increase in serum ferritin|0|||
42311848|NCT01832818|76147869|FG000|Overall Study|Lost to Follow-up|6|||
42311849|NCT02405780|76147877|FG000|Period I|Adverse Event|8|||
42311850|NCT02405780|76147878|FG001|Period I|Adverse Event|0|||
42311851|NCT02405780|76147879|FG002|Period I|Adverse Event|3|||
42311852|NCT02405780|76147880|FG003|Period I|Adverse Event|7|||
42254442|NCT01126749|76080694|FG001|Phase 2|Other|0|||
42254443|NCT01126749|76080695|FG002|Phase 2|Other|4|||
42254444|NCT01126749|76080696|FG003|Phase 2|Other|2|||
42311853|NCT02405780|76147877|FG000|Period I|Medical reasons|1|||
42311854|NCT02405780|76147878|FG001|Period I|Medical reasons|1|||
42311855|NCT02405780|76147879|FG002|Period I|Medical reasons|0|||
42311856|NCT02405780|76147880|FG003|Period I|Medical reasons|1|||
42311857|NCT02405780|76147877|FG000|Period I|Screening Failure|1|||
42311858|NCT02405780|76147878|FG001|Period I|Screening Failure|0|||
42311859|NCT02405780|76147879|FG002|Period I|Screening Failure|1|||
42311860|NCT02405780|76147880|FG003|Period I|Screening Failure|0|||
42311861|NCT02405780|76147877|FG000|Period I|Withdrawal by Subject|9|||
42311862|NCT02405780|76147878|FG001|Period I|Withdrawal by Subject|1|||
42311863|NCT02405780|76147879|FG002|Period I|Withdrawal by Subject|3|||
42311864|NCT02405780|76147880|FG003|Period I|Withdrawal by Subject|4|||
42311865|NCT02405780|76147877|FG000|Period I|Non-compliance with study procedures|8|||
42311866|NCT02405780|76147878|FG001|Period I|Non-compliance with study procedures|6|||
42311867|NCT02405780|76147879|FG002|Period I|Non-compliance with study procedures|8|||
42311868|NCT02405780|76147880|FG003|Period I|Non-compliance with study procedures|11|||
42311869|NCT02405780|76147877|FG000|Period II|Adverse Event|3|||
42254445|NCT01126749|76080693|FG000|Phase 2|Withdrawal by Subject|0|||
42254446|NCT01126749|76080694|FG001|Phase 2|Withdrawal by Subject|0|||
42254447|NCT01126749|76080695|FG002|Phase 2|Withdrawal by Subject|0|||
42254448|NCT01126749|76080696|FG003|Phase 2|Withdrawal by Subject|2|||
42254449|NCT01126749|76080693|FG000|Phase 2|Lost to Follow-up|0|||
42254450|NCT01126749|76080694|FG001|Phase 2|Lost to Follow-up|0|||
42254451|NCT01126749|76080695|FG002|Phase 2|Lost to Follow-up|0|||
42254452|NCT01126749|76080696|FG003|Phase 2|Lost to Follow-up|1|||
42254453|NCT01126749|76080693|FG000|Phase 2|Death|0|||
42311870|NCT02405780|76147878|FG001|Period II|Adverse Event|5|||
42311871|NCT02405780|76147879|FG002|Period II|Adverse Event|4|||
42311872|NCT02405780|76147880|FG003|Period II|Adverse Event|11|||
42311873|NCT02405780|76147877|FG000|Period II|Medical reason|0|||
42311874|NCT02405780|76147878|FG001|Period II|Medical reason|1|||
42311875|NCT02405780|76147879|FG002|Period II|Medical reason|0|||
42311876|NCT02405780|76147880|FG003|Period II|Medical reason|0|||
42311877|NCT02405780|76147877|FG000|Period II|Pregnancy|0|||
42311878|NCT02405780|76147878|FG001|Period II|Pregnancy|0|||
42311879|NCT02405780|76147879|FG002|Period II|Pregnancy|1|||
42311880|NCT02405780|76147880|FG003|Period II|Pregnancy|0|||
42311881|NCT02405780|76147877|FG000|Period II|Withdrawal by Subject|7|||
42311882|NCT02405780|76147878|FG001|Period II|Withdrawal by Subject|4|||
42311883|NCT02405780|76147879|FG002|Period II|Withdrawal by Subject|0|||
42311884|NCT02405780|76147880|FG003|Period II|Withdrawal by Subject|3|||
42311885|NCT02405780|76147877|FG000|Period II|Non-compliance with study procedures|5|||
42311886|NCT02405780|76147878|FG001|Period II|Non-compliance with study procedures|2|||
42311887|NCT02405780|76147879|FG002|Period II|Non-compliance with study procedures|7|||
42311888|NCT02405780|76147880|FG003|Period II|Non-compliance with study procedures|4|||
42311889|NCT02369510|76147908|FG000|Overall Study|Spilled Medication|1|||
42311890|NCT02369510|76147909|FG001|Overall Study|Spilled Medication|2|||
42311891|NCT02369510|76147910|FG002|Overall Study|Spilled Medication|1|||
42311892|NCT02369510|76147908|FG000|Overall Study|Epidural Activation|1|||
42311893|NCT02369510|76147909|FG001|Overall Study|Epidural Activation|1|||
42311894|NCT02369510|76147910|FG002|Overall Study|Epidural Activation|5|||
42311895|NCT01650194|76147918|FG000|Overall Study|Progressive Disease (PD)|35|||
42311896|NCT01650194|76147918|FG000|Overall Study|Withdrawal by Subject|2|||
42311897|NCT01650194|76147918|FG000|Overall Study|Miscellaneous|10|||
42311898|NCT02367716|76147923|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
42311899|NCT02366936|76147928|FG000|Overall Study|Withdrawal by Subject|2|||
42311900|NCT02366936|76147928|FG000|Overall Study|Lost to Follow-up|4|||
42311901|NCT02366936|76147928|FG000|Overall Study|Physician Decision|2|||
42311902|NCT01648166|76147934|FG000|Overall Study|inadequate toenail samples|53|||
42311903|NCT01648166|76147935|FG001|Overall Study|inadequate toenail samples|100|||
42254454|NCT01126749|76080694|FG001|Phase 2|Death|0|||
42311904|NCT02404220|76147945|FG000|Overall Study|Adverse Event|0|||
42311905|NCT02404220|76147946|FG001|Overall Study|Adverse Event|0|||
42311906|NCT02404220|76147947|FG002|Overall Study|Adverse Event|1|||
41992508|NCT01159600|75800627|FG005|Overall Study|Lack of Efficacy|0|||
42254455|NCT01126749|76080695|FG002|Phase 2|Death|22|||
42254456|NCT01126749|76080696|FG003|Phase 2|Death|22|||
42311907|NCT02404220|76147948|FG003|Overall Study|Adverse Event|0|||
42311908|NCT02404220|76147945|FG000|Overall Study|Death|5|||
42311909|NCT02404220|76147946|FG001|Overall Study|Death|5|||
42311910|NCT02404220|76147947|FG002|Overall Study|Death|3|||
42311911|NCT02404220|76147948|FG003|Overall Study|Death|8|||
41992509|NCT01159600|75800628|FG006|Overall Study|Lack of Efficacy|0|||
41992510|NCT01159600|75800629|FG007|Overall Study|Lack of Efficacy|1|||
41992511|NCT01159600|75800622|FG000|Overall Study|Non compliant with protocol|2|||
42311912|NCT02404220|76147945|FG000|Overall Study|Progressive Disease|0|||
42311913|NCT02404220|76147946|FG001|Overall Study|Progressive Disease|0|||
42311914|NCT02404220|76147947|FG002|Overall Study|Progressive Disease|1|||
42311915|NCT02404220|76147948|FG003|Overall Study|Progressive Disease|1|||
42254457|NCT01126749|76080693|FG000|Phase 2|Adverse Event|0|||
42254458|NCT01126749|76080694|FG001|Phase 2|Adverse Event|0|||
42254459|NCT01126749|76080695|FG002|Phase 2|Adverse Event|0|||
42254460|NCT01126749|76080696|FG003|Phase 2|Adverse Event|1|||
42254461|NCT02521948|76080706|FG000|Overall Study|Adverse Event|2|||
42254462|NCT02521948|76080706|FG000|Overall Study|Death|4|||
42254463|NCT02521948|76080706|FG000|Overall Study|Lost to Follow-up|1|||
42254464|NCT02521948|76080706|FG000|Overall Study|Did not attend one or both follow-ups|6|||
42254465|NCT04446429|76080715|FG000|Overall Study|Lost to Follow-up|6|||
42254466|NCT04446429|76080716|FG001|Overall Study|Lost to Follow-up|0|||
42254467|NCT02832687|76080724|FG000|Overall Study|Adverse Event|0|||
42254468|NCT02832687|76080725|FG001|Overall Study|Adverse Event|2|||
42254469|NCT01656850|76080750|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
42254470|NCT01656850|76080751|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
42254471|NCT03116685|76080763|FG000|Overall Study|Physician Decision|0|||
42254472|NCT03116685|76080764|FG001|Overall Study|Physician Decision|1|||
42254473|NCT02666222|76080784|FG000|Overall Study|Death|2|||
42254474|NCT00739401|76080788|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
42254475|NCT00739401|76080788|FG000|Overall Study|Death|3|||
42254476|NCT00739401|76080788|FG000|Overall Study|Withdrawal by Subject|4|||
42254477|NCT01365052|76080794|FG000|Overall Study|Adverse Event|4|||
42254478|NCT01365052|76080795|FG001|Overall Study|Adverse Event|4|||
42254479|NCT01372748|76080803|FG000|Overall Study|Lost to Follow-up|16|||
42254480|NCT01372748|76080804|FG001|Overall Study|Lost to Follow-up|34|||
42254481|NCT01372748|76080803|FG000|Overall Study|Withdrawal by Subject|7|||
42311916|NCT02404220|76147945|FG000|Overall Study|Study Terminated by Sponsor|0|||
42311917|NCT02404220|76147946|FG001|Overall Study|Study Terminated by Sponsor|0|||
42311918|NCT02404220|76147947|FG002|Overall Study|Study Terminated by Sponsor|2|||
42311919|NCT02404220|76147948|FG003|Overall Study|Study Terminated by Sponsor|1|||
42311920|NCT02404220|76147945|FG000|Overall Study|Withdrawal by Subject|0|||
42311921|NCT02404220|76147946|FG001|Overall Study|Withdrawal by Subject|1|||
42311922|NCT02404220|76147947|FG002|Overall Study|Withdrawal by Subject|0|||
42311923|NCT02404220|76147948|FG003|Overall Study|Withdrawal by Subject|0|||
42311924|NCT02404220|76147945|FG000|Overall Study|Enrolled but Never Treated|0|||
41992512|NCT01159600|75800623|FG001|Overall Study|Non compliant with protocol|1|||
41992513|NCT01159600|75800624|FG002|Overall Study|Non compliant with protocol|0|||
41992514|NCT01159600|75800625|FG003|Overall Study|Non compliant with protocol|0|||
41992515|NCT01159600|75800626|FG004|Overall Study|Non compliant with protocol|2|||
41992516|NCT01159600|75800627|FG005|Overall Study|Non compliant with protocol|0|||
41992517|NCT01159600|75800628|FG006|Overall Study|Non compliant with protocol|2|||
41992518|NCT01159600|75800629|FG007|Overall Study|Non compliant with protocol|0|||
41992519|NCT01159600|75800622|FG000|Overall Study|Lost to Follow-up|2|||
41992520|NCT01159600|75800623|FG001|Overall Study|Lost to Follow-up|3|||
41992521|NCT01159600|75800624|FG002|Overall Study|Lost to Follow-up|4|||
41992522|NCT01159600|75800625|FG003|Overall Study|Lost to Follow-up|3|||
41992523|NCT01159600|75800626|FG004|Overall Study|Lost to Follow-up|3|||
41992524|NCT01159600|75800627|FG005|Overall Study|Lost to Follow-up|0|||
41992525|NCT01159600|75800628|FG006|Overall Study|Lost to Follow-up|3|||
41992526|NCT01159600|75800629|FG007|Overall Study|Lost to Follow-up|2|||
41992527|NCT01159600|75800622|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
41992528|NCT01159600|75800623|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
41992529|NCT01159600|75800624|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
41992530|NCT01159600|75800625|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
41992531|NCT01159600|75800626|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
41992532|NCT01159600|75800627|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
41992533|NCT01159600|75800628|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
41992534|NCT01159600|75800629|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
41992535|NCT01159600|75800622|FG000|Overall Study|Other reason not defined above|3|||
41992536|NCT01159600|75800623|FG001|Overall Study|Other reason not defined above|0|||
41992537|NCT01159600|75800624|FG002|Overall Study|Other reason not defined above|4|||
42254482|NCT01372748|76080804|FG001|Overall Study|Withdrawal by Subject|5|||
42254483|NCT02736825|76080812|FG000|Overall Study|Lost to Follow-up|10|||
41992538|NCT01159600|75800625|FG003|Overall Study|Other reason not defined above|2|||
42254484|NCT02736825|76080813|FG001|Overall Study|Lost to Follow-up|11|||
41992539|NCT01159600|75800626|FG004|Overall Study|Other reason not defined above|5|||
42254485|NCT02736825|76080812|FG000|Overall Study|Early Termination|0|||
42254486|NCT02736825|76080813|FG001|Overall Study|Early Termination|1|||
42254487|NCT02670122|76080820|FG000|Overall Study|Lost to Follow-up|4|||
42254488|NCT03283371|76080833|FG000|Placebo-controlled|Adverse Event|1|||
42254489|NCT03283371|76080834|FG001|Placebo-controlled|Adverse Event|1|||
42254490|NCT03283371|76080835|FG002|Placebo-controlled|Adverse Event|0|||
42254491|NCT03283371|76080836|FG003|Placebo-controlled|Adverse Event|0|||
42254492|NCT03283371|76080833|FG000|Placebo-controlled|Lack of Efficacy|1|||
42254493|NCT03283371|76080834|FG001|Placebo-controlled|Lack of Efficacy|0|||
42254494|NCT03283371|76080835|FG002|Placebo-controlled|Lack of Efficacy|0|||
42254495|NCT03283371|76080836|FG003|Placebo-controlled|Lack of Efficacy|0|||
42254496|NCT03283371|76080833|FG000|Placebo-controlled|Withdrawal by Subject|1|||
42254497|NCT03283371|76080834|FG001|Placebo-controlled|Withdrawal by Subject|1|||
42254498|NCT03283371|76080835|FG002|Placebo-controlled|Withdrawal by Subject|0|||
42254499|NCT03283371|76080836|FG003|Placebo-controlled|Withdrawal by Subject|0|||
42254500|NCT03283371|76080833|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
42254501|NCT03283371|76080834|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
42254502|NCT03283371|76080835|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
42254503|NCT03283371|76080836|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
42254504|NCT03283371|76080833|FG000|Open-label Phase|Adverse Event|0|||
42254505|NCT03283371|76080834|FG001|Open-label Phase|Adverse Event|0|||
42311925|NCT02404220|76147946|FG001|Overall Study|Enrolled but Never Treated|2|||
42311926|NCT02404220|76147947|FG002|Overall Study|Enrolled but Never Treated|0|||
42311927|NCT02404220|76147948|FG003|Overall Study|Enrolled but Never Treated|0|||
42254506|NCT03283371|76080835|FG002|Open-label Phase|Adverse Event|2|||
42254507|NCT03283371|76080836|FG003|Open-label Phase|Adverse Event|0|||
42311928|NCT02335658|76147960|FG000|Overall Study|Adverse Event|18|||
42311929|NCT02335658|76147961|FG001|Overall Study|Adverse Event|12|||
42311930|NCT02335658|76147960|FG000|Overall Study|Lack of Efficacy|4|||
42311931|NCT02335658|76147961|FG001|Overall Study|Lack of Efficacy|5|||
42311932|NCT02335658|76147960|FG000|Overall Study|Pregnancy|1|||
42311933|NCT02335658|76147961|FG001|Overall Study|Pregnancy|0|||
42311934|NCT02335658|76147960|FG000|Overall Study|Withdrawal by Subject|13|||
42311935|NCT02335658|76147961|FG001|Overall Study|Withdrawal by Subject|21|||
42311936|NCT02335658|76147960|FG000|Overall Study|non-compliance|2|||
42311937|NCT02335658|76147961|FG001|Overall Study|non-compliance|3|||
42311938|NCT02335658|76147960|FG000|Overall Study|other reason|2|||
42311939|NCT02335658|76147961|FG001|Overall Study|other reason|3|||
42311940|NCT02366468|76147971|FG000|Overall Study|Adverse Event|2|||
42311941|NCT02366468|76147972|FG001|Overall Study|Adverse Event|0|||
42311942|NCT02366468|76147971|FG000|Overall Study|Withdrawal by Subject|1|||
42311943|NCT02366468|76147972|FG001|Overall Study|Withdrawal by Subject|5|||
42311944|NCT02366468|76147971|FG000|Overall Study|Lost to Follow-up|2|||
42311945|NCT02366468|76147972|FG001|Overall Study|Lost to Follow-up|0|||
42311946|NCT02366468|76147971|FG000|Overall Study|Death|1|||
42311947|NCT02366468|76147972|FG001|Overall Study|Death|2|||
42311948|NCT02366468|76147971|FG000|Overall Study|Other|0|||
42311949|NCT02366468|76147972|FG001|Overall Study|Other|2|||
42311950|NCT02366312|76147980|FG000|Overall Study|Lost to Follow-up|0|||
42311951|NCT02366312|76147981|FG001|Overall Study|Lost to Follow-up|1|||
42311952|NCT02335346|76147987|FG000|Overall Study|Adverse Event|11|||
42311953|NCT02335346|76147987|FG000|Overall Study|Withdrawal by Subject|1|||
41992540|NCT01159600|75800627|FG005|Overall Study|Other reason not defined above|7|||
41992541|NCT01159600|75800628|FG006|Overall Study|Other reason not defined above|3|||
41992542|NCT01159600|75800629|FG007|Overall Study|Other reason not defined above|3|||
42133054|NCT00556439|75943962|FG000|Study Entry to Week 12|Recurrent infection|1|||
42133055|NCT00556439|75943963|FG001|Study Entry to Week 12|Recurrent infection|0|||
42133056|NCT00556439|75943964|FG002|Study Entry to Week 12|Recurrent infection|0|||
42133057|NCT00556439|75943965|FG003|Study Entry to Week 12|Recurrent infection|0|||
42133058|NCT00556439|75943962|FG000|Study Entry to Week 12|Malignancy|0|||
42254508|NCT03283371|76080833|FG000|Open-label Phase|Withdrawal by Subject|0|||
42254509|NCT03283371|76080834|FG001|Open-label Phase|Withdrawal by Subject|0|||
42311954|NCT02403206|76147993|FG000|Overall Study|Lost to Follow-up|4|||
41992543|NCT01159171|75800648|FG000|Overall Study|Adverse Event|11|||
41992544|NCT01159171|75800648|FG000|Overall Study|Progression of Disease|28|||
42311955|NCT02403206|76147994|FG001|Overall Study|Lost to Follow-up|3|||
42311956|NCT02403206|76147993|FG000|Overall Study|Physician Decision|2|||
42311957|NCT02403206|76147994|FG001|Overall Study|Physician Decision|0|||
42311958|NCT02403206|76147993|FG000|Overall Study|Withdrawal by Subject|3|||
42133059|NCT00556439|75943963|FG001|Study Entry to Week 12|Malignancy|0|||
42311959|NCT02403206|76147994|FG001|Overall Study|Withdrawal by Subject|3|||
42311960|NCT02403206|76147993|FG000|Overall Study|Reason not given|2|||
42311961|NCT02403206|76147994|FG001|Overall Study|Reason not given|4|||
42133060|NCT00556439|75943964|FG002|Study Entry to Week 12|Malignancy|1|||
42311962|NCT02333630|76148003|FG000|Overall Study|Lost to Follow-up|5|||
42311963|NCT02333630|76148004|FG001|Overall Study|Lost to Follow-up|2|||
42311964|NCT02401412|76148016|FG000|Overall Study|Lost to Follow-up|1|||
42311965|NCT02401412|76148017|FG001|Overall Study|Lost to Follow-up|0|||
42311966|NCT02401412|76148016|FG000|Overall Study|Discontinued Intervention|15|||
42311967|NCT02401412|76148017|FG001|Overall Study|Discontinued Intervention|21|||
42311968|NCT02401412|76148016|FG000|Overall Study|Withdrawal by Subject|4|||
42311969|NCT02401412|76148017|FG001|Overall Study|Withdrawal by Subject|4|||
42311970|NCT02401412|76148016|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
42311971|NCT02401412|76148017|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
42311972|NCT02401412|76148016|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
42311973|NCT02401412|76148017|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
42311974|NCT02365298|76148023|FG000|Period 2|incorrect Rx dispensed|1|||
42311975|NCT02365298|76148024|FG001|Period 2|incorrect Rx dispensed|0|||
42311976|NCT02365298|76148023|FG000|Period 2|Discontinued at request of Sponsor|1|||
42311977|NCT02365298|76148024|FG001|Period 2|Discontinued at request of Sponsor|0|||
42311978|NCT02365298|76148023|FG000|Period 2|Test Article longer available|0|||
42311979|NCT02365298|76148024|FG001|Period 2|Test Article longer available|1|||
42311980|NCT02365298|76148023|FG000|Period 2|Protocol Violation|0|||
42311981|NCT02365298|76148024|FG001|Period 2|Protocol Violation|1|||
42311982|NCT02365064|76148032|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
42311983|NCT02365064|76148033|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
42311984|NCT02365064|76148032|FG000|Overall Study|Withdrawal by Subject|6|||
42311985|NCT02365064|76148033|FG001|Overall Study|Withdrawal by Subject|9|||
42311986|NCT02365064|76148032|FG000|Overall Study|Treatment intolerance|2|||
42311987|NCT02365064|76148033|FG001|Overall Study|Treatment intolerance|4|||
42311988|NCT02401256|76148039|FG000|Overall Study|Adverse Event|5|||
42311989|NCT02401256|76148039|FG000|Overall Study|Withdrawal by Subject|12|||
42311990|NCT02349295|76148048|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
42311991|NCT02349295|76148049|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
42311992|NCT02349295|76148050|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
42311993|NCT02349295|76148051|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
42311994|NCT02349295|76148052|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
42311995|NCT02349295|76148053|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
42311996|NCT02349295|76148054|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
42311997|NCT02349295|76148055|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
42311998|NCT02349295|76148056|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
42311999|NCT02349295|76148057|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
42312000|NCT02349295|76148058|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
42312001|NCT02349295|76148059|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
42312002|NCT02349295|76148060|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
42312003|NCT02349295|76148061|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
42312004|NCT02349295|76148048|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
42312005|NCT02349295|76148049|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
42312006|NCT02349295|76148050|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
42312007|NCT02349295|76148051|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
42312008|NCT02349295|76148052|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
42312009|NCT02349295|76148053|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
42312010|NCT02349295|76148054|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
42312011|NCT02349295|76148055|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
42254510|NCT03283371|76080835|FG002|Open-label Phase|Withdrawal by Subject|1|||
42254511|NCT03283371|76080836|FG003|Open-label Phase|Withdrawal by Subject|0|||
42254512|NCT03283371|76080833|FG000|Open-label Phase|Other|0|||
42254513|NCT03283371|76080834|FG001|Open-label Phase|Other|0|||
42254514|NCT03283371|76080835|FG002|Open-label Phase|Other|1|||
42254515|NCT03283371|76080836|FG003|Open-label Phase|Other|1|||
42254516|NCT03069417|76080848|FG000|Overall Study|Lost to Follow-up|2|||
42254517|NCT03069417|76080849|FG001|Overall Study|Lost to Follow-up|0|||
42254518|NCT03069417|76080848|FG000|Overall Study|Reason Unknown|4|||
42254519|NCT03069417|76080849|FG001|Overall Study|Reason Unknown|7|||
42254520|NCT04930263|76080858|FG000|Overall Study|Withdrawal by Subject|3|||
42254521|NCT04930263|76080859|FG001|Overall Study|Withdrawal by Subject|5|||
42254522|NCT02665286|76080868|FG000|Overall Study|Lost to Follow-up|3|||
42312012|NCT02349295|76148056|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
42312013|NCT02349295|76148057|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
42254523|NCT02665286|76080869|FG001|Overall Study|Lost to Follow-up|2|||
42312014|NCT02349295|76148058|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
42312015|NCT02349295|76148059|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
42312016|NCT02349295|76148060|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
42312017|NCT02349295|76148061|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
42312018|NCT02349295|76148048|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
42312019|NCT02349295|76148049|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
42312020|NCT02349295|76148050|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
42312021|NCT02349295|76148051|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
42312022|NCT02349295|76148052|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
42312023|NCT02349295|76148053|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
42312024|NCT02349295|76148054|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
42312025|NCT02349295|76148055|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
42312026|NCT02349295|76148056|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
42312027|NCT02349295|76148057|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
42312028|NCT02349295|76148058|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
42312029|NCT02349295|76148059|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
42312030|NCT02349295|76148060|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
42312031|NCT02349295|76148061|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
42312032|NCT02349295|76148048|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
42312033|NCT02349295|76148049|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
42312034|NCT02349295|76148050|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
42312035|NCT02349295|76148051|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
42312036|NCT02349295|76148052|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
42312037|NCT02349295|76148053|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
42312038|NCT02349295|76148054|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
42312039|NCT02349295|76148055|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
42312040|NCT02349295|76148056|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
42312041|NCT02349295|76148057|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
42312042|NCT02349295|76148058|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
42312043|NCT02349295|76148059|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
42312044|NCT02349295|76148060|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
42312045|NCT02349295|76148061|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
42312046|NCT02349295|76148048|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42312047|NCT02349295|76148049|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
42312048|NCT02349295|76148050|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
42312049|NCT02349295|76148051|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42033394|NCT00859573|75841609|FG001|Overall Study|Physician Decision|1|||
42033395|NCT01136291|75841617|FG000|Overall Study|Lost to Follow-up|1|||
42133061|NCT00556439|75943965|FG003|Study Entry to Week 12|Malignancy|0|||
42133062|NCT00556439|75943962|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
42254524|NCT02665286|76080870|FG002|Overall Study|Lost to Follow-up|1|||
42254525|NCT02911519|76080880|FG000|Overall Study|Lost to Follow-up|2|||
42254526|NCT02911519|76080881|FG001|Overall Study|Lost to Follow-up|2|||
42254527|NCT02911519|76080880|FG000|Overall Study|Death|0|||
42254528|NCT02911519|76080881|FG001|Overall Study|Death|2|||
42254529|NCT02911285|76080889|FG000|Overall Study|Lost to Follow-up|8|||
42254530|NCT02911285|76080890|FG001|Overall Study|Lost to Follow-up|5|||
42254531|NCT02911285|76080889|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
42254532|NCT02911285|76080890|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
42254533|NCT02910739|76080902|FG000|Overall Study|Adverse Event|1|||
42254534|NCT02910739|76080903|FG001|Overall Study|Adverse Event|0|||
42254535|NCT02910739|76080904|FG002|Overall Study|Adverse Event|0|||
42254536|NCT02910739|76080905|FG003|Overall Study|Adverse Event|0|||
42254537|NCT01069939|76080913|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
42254538|NCT01069939|76080914|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
42254539|NCT01069939|76080913|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
42254540|NCT01069939|76080914|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
42254541|NCT01069939|76080913|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
42254542|NCT01069939|76080914|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
42254543|NCT01069939|76080913|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
42254544|NCT01069939|76080914|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
42254545|NCT01069939|76080913|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
42254546|NCT01069939|76080914|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
42254547|NCT01069939|76080913|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
42254548|NCT01069939|76080914|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
42312050|NCT02349295|76148052|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42312051|NCT02349295|76148053|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42312052|NCT02349295|76148054|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42312053|NCT02349295|76148055|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42312054|NCT02349295|76148056|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42312055|NCT02349295|76148057|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42312056|NCT02349295|76148058|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42312057|NCT02349295|76148059|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42312058|NCT02349295|76148060|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42312059|NCT02349295|76148061|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
42312060|NCT02349295|76148048|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
42312061|NCT02349295|76148049|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
42312062|NCT02349295|76148050|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
42312063|NCT02349295|76148051|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
42312064|NCT02349295|76148052|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
42312065|NCT02349295|76148053|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
42312066|NCT02349295|76148054|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
42312067|NCT02349295|76148055|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
42312068|NCT02349295|76148056|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
42312069|NCT02349295|76148057|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
42312070|NCT02349295|76148058|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
42312071|NCT02349295|76148059|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
42254549|NCT01069939|76080913|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
42254550|NCT01069939|76080914|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
42254551|NCT01069939|76080913|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
42254552|NCT01069939|76080914|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
42254553|NCT01069939|76080913|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
42254554|NCT01069939|76080914|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
42254555|NCT01069939|76080913|FG000|Randomised and Included in the Analyses|Removal|1|||
42254556|NCT01069939|76080914|FG001|Randomised and Included in the Analyses|Removal|0|||
42254557|NCT01069705|76080920|FG000|Overall Study|Adverse Event|1|||
42254558|NCT01069705|76080920|FG000|Overall Study|Withdrawal by Subject|2|||
42254559|NCT01069627|76080924|FG000|Overall Study|Disease progression|7|||
42254560|NCT01069627|76080924|FG000|Overall Study|Adverse Event|12|||
42254561|NCT01069627|76080924|FG000|Overall Study|Protocol Violation|1|||
42254562|NCT03021551|76080928|FG000|Overall Study|Equipment Issues|2|||
42254563|NCT03021551|76080928|FG000|Overall Study|Protocol Violation|1|||
42254564|NCT01585025|76080935|FG000|Overall Study|Withdrawal by Subject|0|||
42254565|NCT01585025|76080936|FG001|Overall Study|Withdrawal by Subject|3|||
42254566|NCT01585025|76080937|FG002|Overall Study|Withdrawal by Subject|4|||
42254567|NCT01068769|76080945|FG000|Overall Study|Ineligible|1|||
42254568|NCT05114564|76080964|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
42254569|NCT05114564|76080965|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
42254570|NCT05114564|76080964|FG000|First Intervention|Adverse Event|0|||
42254571|NCT05114564|76080965|FG001|First Intervention|Adverse Event|1|||
42254572|NCT04706416|76080973|FG000|Overall Study|Lost to Follow-up|2|||
42254573|NCT04706416|76080974|FG001|Overall Study|Lost to Follow-up|0|||
42254574|NCT04683926|76080987|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
42254575|NCT04683926|76080988|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
42254576|NCT04683926|76080989|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
42254577|NCT04683926|76080990|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
42254578|NCT04343755|76081002|FG000|Overall Study|Death|11|||
42254579|NCT04343755|76081002|FG000|Overall Study|Screen Failure|1|||
42254580|NCT04285346|76081006|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
42254581|NCT04285346|76081007|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
42254582|NCT04285346|76081006|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
42312072|NCT02349295|76148060|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
42312073|NCT02349295|76148061|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
41992545|NCT01159171|75800648|FG000|Overall Study|Protocol Violation|1|||
42312074|NCT02349295|76148048|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
42312075|NCT02349295|76148049|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
42312076|NCT02349295|76148050|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
42312077|NCT02349295|76148051|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
42312078|NCT02349295|76148052|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
42312079|NCT02349295|76148053|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
42312080|NCT02349295|76148054|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
42312081|NCT02349295|76148055|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
42312082|NCT02349295|76148056|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
42312083|NCT02349295|76148057|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
42312084|NCT02349295|76148058|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
42312085|NCT02349295|76148059|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
42312086|NCT02349295|76148060|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
42312087|NCT02349295|76148061|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
42312088|NCT02349295|76148048|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
42312089|NCT02349295|76148049|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
42312090|NCT02349295|76148050|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
42312091|NCT02349295|76148051|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
42312092|NCT02349295|76148052|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
42312093|NCT02349295|76148053|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
42312094|NCT02349295|76148054|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
42312095|NCT02349295|76148055|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
42312096|NCT02349295|76148056|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
42312097|NCT02349295|76148057|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
42312098|NCT02349295|76148058|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
42312099|NCT02349295|76148059|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
42312100|NCT02349295|76148060|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
42312101|NCT02349295|76148061|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
42312102|NCT02349295|76148048|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42312103|NCT02349295|76148049|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42312104|NCT02349295|76148050|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42312105|NCT02349295|76148051|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42033396|NCT01136291|75841618|FG001|Overall Study|Lost to Follow-up|1|||
42033397|NCT01185548|75841624|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
42033398|NCT01128569|75841637|FG000|Washout Period 1|Adverse Event|0|||
42033399|NCT01128569|75841638|FG001|Washout Period 1|Adverse Event|0|||
42033400|NCT01128569|75841639|FG002|Washout Period 1|Adverse Event|1|||
42033401|NCT01128569|75841640|FG003|Washout Period 1|Adverse Event|0|||
42033402|NCT01128569|75841641|FG004|Washout Period 1|Adverse Event|0|||
42033403|NCT01128569|75841642|FG005|Washout Period 1|Adverse Event|0|||
42312106|NCT02349295|76148052|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42312107|NCT02349295|76148053|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42312108|NCT02349295|76148054|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42312109|NCT02349295|76148055|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
42312110|NCT02349295|76148056|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42312111|NCT02349295|76148057|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
42312112|NCT02349295|76148058|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42312113|NCT02349295|76148059|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42312114|NCT02349295|76148060|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42312115|NCT02349295|76148061|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
42312116|NCT02349295|76148048|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
42312117|NCT02349295|76148049|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
42312118|NCT02349295|76148050|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
42312119|NCT02349295|76148051|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
42312120|NCT02349295|76148052|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
42312121|NCT02349295|76148053|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
42312122|NCT02349295|76148054|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
42312123|NCT02349295|76148055|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
42312124|NCT02349295|76148056|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
42312125|NCT02349295|76148057|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
42312126|NCT02349295|76148058|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
42312127|NCT02349295|76148059|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
42312128|NCT02349295|76148060|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
42312129|NCT02349295|76148061|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
42312130|NCT02349295|76148048|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
42312131|NCT02349295|76148049|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
42312132|NCT02349295|76148050|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
42312133|NCT02349295|76148051|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
42312134|NCT02349295|76148052|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
42312135|NCT02349295|76148053|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
42312136|NCT02349295|76148054|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
42312137|NCT02349295|76148055|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
42312138|NCT02349295|76148056|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
42312139|NCT02349295|76148057|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
42312140|NCT02349295|76148058|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
42312141|NCT02349295|76148059|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
42312142|NCT02349295|76148060|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
42312143|NCT02349295|76148061|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
42312144|NCT02349295|76148048|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
41992546|NCT01159171|75800648|FG000|Overall Study|Need for Surgery|5|||
41992547|NCT01159171|75800648|FG000|Overall Study|Medical Decision|4|||
42254583|NCT04285346|76081007|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
42254584|NCT04285346|76081006|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
42254585|NCT04285346|76081007|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
42254586|NCT04148287|76081022|FG000|Overall Study|Death|2|||
42254587|NCT03772613|76081050|FG000|Overall Study|Lost to Follow-up|0|||
42254588|NCT03772613|76081051|FG001|Overall Study|Lost to Follow-up|1|||
42254589|NCT03772613|76081052|FG002|Overall Study|Lost to Follow-up|1|||
42254590|NCT03739437|76081062|FG000|Overall Study|Lost to Follow-up|2|||
42254591|NCT03739437|76081063|FG001|Overall Study|Lost to Follow-up|5|||
42254592|NCT03701555|76081105|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
42254593|NCT03701555|76081106|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
42254594|NCT03701555|76081107|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
42254595|NCT03701555|76081108|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
41992548|NCT01159171|75800648|FG000|Overall Study|Death|1|||
42254596|NCT03701555|76081109|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
42312145|NCT02349295|76148049|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
41992549|NCT01158118|75800655|FG000|Overall Study|Screen failure|1|||
42312146|NCT02349295|76148050|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
42312147|NCT02349295|76148051|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
42312148|NCT02349295|76148052|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
42312149|NCT02349295|76148053|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
42312150|NCT02349295|76148054|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
42312151|NCT02349295|76148055|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
42312152|NCT02349295|76148056|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
42312153|NCT02349295|76148057|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
42312154|NCT02349295|76148058|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
42312155|NCT02349295|76148059|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
42312156|NCT02349295|76148060|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
42312157|NCT02349295|76148061|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
42312158|NCT02349295|76148048|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312159|NCT02349295|76148049|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312160|NCT02349295|76148050|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312161|NCT02349295|76148051|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312162|NCT02349295|76148052|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312163|NCT02349295|76148053|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312164|NCT02349295|76148054|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312165|NCT02349295|76148055|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
42312166|NCT02349295|76148056|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
42312167|NCT02349295|76148057|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312168|NCT02349295|76148058|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312169|NCT02349295|76148059|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312170|NCT02349295|76148060|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312171|NCT02349295|76148061|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
42312172|NCT02349295|76148048|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
42312173|NCT02349295|76148049|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
42312174|NCT02349295|76148050|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
42312175|NCT02349295|76148051|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
42312176|NCT02349295|76148052|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
42312177|NCT02349295|76148053|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
42312178|NCT02349295|76148054|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
42312179|NCT02349295|76148055|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
42312180|NCT02349295|76148056|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
42312181|NCT02349295|76148057|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
42312182|NCT02349295|76148058|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
42312183|NCT02349295|76148059|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
42312184|NCT02349295|76148060|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
42312185|NCT02349295|76148061|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
42312186|NCT02349295|76148048|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42312187|NCT02349295|76148049|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42312188|NCT02349295|76148050|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42254597|NCT03701555|76081110|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
42254598|NCT03701555|76081111|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
42254599|NCT03701555|76081112|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
42254600|NCT03701555|76081113|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
41992550|NCT01158118|75800656|FG001|Overall Study|Screen failure|0|||
41992551|NCT01158118|75800655|FG000|Overall Study|Donor match was a screen failure|0|||
41992552|NCT01158118|75800656|FG001|Overall Study|Donor match was a screen failure|1|||
41992553|NCT01158118|75800655|FG000|Overall Study|Suffered stroke prior to transplant|0|||
42254601|NCT03701555|76081114|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
42254602|NCT03701555|76081115|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
42254603|NCT03701555|76081116|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
42254604|NCT03701555|76081117|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
42254605|NCT03701555|76081118|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
42254606|NCT03701555|76081119|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
42254607|NCT03701555|76081120|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
42254608|NCT03701555|76081121|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
42254609|NCT03701555|76081122|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
42254610|NCT03701555|76081123|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
42254611|NCT03701555|76081124|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
42254612|NCT03701555|76081125|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
42254613|NCT03701555|76081126|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
42254614|NCT03701555|76081127|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
42254615|NCT03701555|76081128|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
42254616|NCT03701555|76081129|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
42254617|NCT03701555|76081130|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
42312189|NCT02349295|76148051|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42312190|NCT02349295|76148052|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42312191|NCT02349295|76148053|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42312192|NCT02349295|76148054|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42312193|NCT02349295|76148055|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42312194|NCT02349295|76148056|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42312195|NCT02349295|76148057|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42312196|NCT02349295|76148058|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42312197|NCT02349295|76148059|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
42312198|NCT02349295|76148060|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
42312199|NCT02349295|76148061|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
42312200|NCT02349295|76148048|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312201|NCT02349295|76148049|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312202|NCT02349295|76148050|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312203|NCT02349295|76148051|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312204|NCT02349295|76148052|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312205|NCT02349295|76148053|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312206|NCT02349295|76148054|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312207|NCT02349295|76148055|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312208|NCT02349295|76148056|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312209|NCT02349295|76148057|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312210|NCT02349295|76148058|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312211|NCT02349295|76148059|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
42312212|NCT02349295|76148060|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
42312213|NCT02349295|76148061|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
42312214|NCT02349295|76148048|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42312215|NCT02349295|76148049|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42312216|NCT02349295|76148050|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42312217|NCT02349295|76148051|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42312218|NCT02349295|76148052|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42312219|NCT02349295|76148053|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42312220|NCT02349295|76148054|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42312221|NCT02349295|76148055|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42312222|NCT02349295|76148056|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42312223|NCT02349295|76148057|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42312224|NCT02349295|76148058|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42312225|NCT02349295|76148059|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
42312226|NCT02349295|76148060|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42033404|NCT01128569|75841637|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42033405|NCT01128569|75841638|FG001|Treatment Period 2|Withdrawal by Subject|1|||
42254618|NCT03701555|76081131|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
42254619|NCT03701555|76081132|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
42254620|NCT03701555|76081133|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
42254621|NCT03701555|76081134|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
42254622|NCT03701555|76081135|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
42254623|NCT03701555|76081136|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
42254624|NCT03701555|76081137|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
42254625|NCT03701555|76081138|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
42254626|NCT03701555|76081139|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
42254627|NCT03701555|76081140|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
42254628|NCT03701555|76081105|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
42312227|NCT02349295|76148061|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
42254629|NCT03701555|76081106|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
42312228|NCT02349295|76148048|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312229|NCT02349295|76148049|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312230|NCT02349295|76148050|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312231|NCT02349295|76148051|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312232|NCT02349295|76148052|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312233|NCT02349295|76148053|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312234|NCT02349295|76148054|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312235|NCT02349295|76148055|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312236|NCT02349295|76148056|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312237|NCT02349295|76148057|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312238|NCT02349295|76148058|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312239|NCT02349295|76148059|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
42312240|NCT02349295|76148060|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312241|NCT02349295|76148061|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
42312242|NCT02281357|76148088|FG000|Overall Study|Adverse Event|2|||
42312243|NCT02281357|76148089|FG001|Overall Study|Adverse Event|1|||
42312244|NCT02281357|76148088|FG000|Overall Study|Lost to Follow-up|1|||
42312245|NCT02281357|76148089|FG001|Overall Study|Lost to Follow-up|0|||
42312246|NCT02281357|76148088|FG000|Overall Study|Withdrawal by Subject|4|||
42312247|NCT02281357|76148089|FG001|Overall Study|Withdrawal by Subject|3|||
42312248|NCT02284243|76148097|FG000|Overall Study|Lack of Efficacy|3|||
42312249|NCT02284243|76148098|FG001|Overall Study|Lack of Efficacy|3|||
42312250|NCT02284243|76148097|FG000|Overall Study|Adverse Event|1|||
42312251|NCT02284243|76148098|FG001|Overall Study|Adverse Event|0|||
42312252|NCT02284009|76148106|FG000|Overall Study|Adverse Event|3|||
42312253|NCT02284009|76148107|FG001|Overall Study|Adverse Event|0|||
42312254|NCT02284009|76148106|FG000|Overall Study|Lost to Follow-up|1|||
42312255|NCT02284009|76148107|FG001|Overall Study|Lost to Follow-up|3|||
42312256|NCT02284009|76148106|FG000|Overall Study|Physician Decision|0|||
42312257|NCT02284009|76148107|FG001|Overall Study|Physician Decision|2|||
42033406|NCT01128569|75841639|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42254630|NCT03701555|76081107|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
42312258|NCT02284009|76148106|FG000|Overall Study|Withdrawal by Subject|2|||
42312259|NCT02284009|76148107|FG001|Overall Study|Withdrawal by Subject|5|||
42312260|NCT02280499|76148115|FG000|Overall Study|Death|14|||
42312261|NCT02280499|76148115|FG000|Overall Study|Lost to Follow-up|42|||
42312262|NCT02280499|76148115|FG000|Overall Study|Adverse Event|5|||
42312263|NCT02400476|76148125|FG000|Overall Study|Adverse Event|57|||
42312264|NCT02400476|76148126|FG001|Overall Study|Adverse Event|10|||
42312265|NCT02400476|76148127|FG002|Overall Study|Adverse Event|22|||
42312266|NCT02400476|76148128|FG003|Overall Study|Adverse Event|19|||
42312267|NCT02400476|76148129|FG004|Overall Study|Adverse Event|5|||
42312268|NCT02400476|76148130|FG005|Overall Study|Adverse Event|8|||
42312269|NCT02400476|76148125|FG000|Overall Study|Withdrawal by Subject|4|||
42033407|NCT01128569|75841640|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42033408|NCT01128569|75841641|FG004|Treatment Period 2|Withdrawal by Subject|0|||
42254631|NCT03701555|76081108|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
42254632|NCT03701555|76081109|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
42254633|NCT03701555|76081110|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
42254634|NCT03701555|76081111|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
42254635|NCT03701555|76081112|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
42254636|NCT03701555|76081113|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
42254637|NCT03701555|76081114|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
42254638|NCT03701555|76081115|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
42254639|NCT03701555|76081116|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
42254640|NCT03701555|76081117|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
42312270|NCT02400476|76148126|FG001|Overall Study|Withdrawal by Subject|1|||
42312271|NCT02400476|76148127|FG002|Overall Study|Withdrawal by Subject|12|||
42312272|NCT02400476|76148128|FG003|Overall Study|Withdrawal by Subject|7|||
42312273|NCT02400476|76148129|FG004|Overall Study|Withdrawal by Subject|5|||
42312274|NCT02400476|76148130|FG005|Overall Study|Withdrawal by Subject|5|||
42312275|NCT02400476|76148125|FG000|Overall Study|Lost to Follow-up|0|||
42312276|NCT02400476|76148126|FG001|Overall Study|Lost to Follow-up|0|||
42312277|NCT02400476|76148127|FG002|Overall Study|Lost to Follow-up|0|||
42312278|NCT02400476|76148128|FG003|Overall Study|Lost to Follow-up|1|||
42312279|NCT02400476|76148129|FG004|Overall Study|Lost to Follow-up|3|||
42312280|NCT02400476|76148130|FG005|Overall Study|Lost to Follow-up|1|||
42312281|NCT02400476|76148125|FG000|Overall Study|Physician Decision|0|||
42312282|NCT02400476|76148126|FG001|Overall Study|Physician Decision|0|||
42312283|NCT02400476|76148127|FG002|Overall Study|Physician Decision|1|||
42312284|NCT02400476|76148128|FG003|Overall Study|Physician Decision|1|||
42312285|NCT02400476|76148129|FG004|Overall Study|Physician Decision|0|||
42312286|NCT02400476|76148130|FG005|Overall Study|Physician Decision|1|||
42312287|NCT02400476|76148125|FG000|Overall Study|Other, Disease Progression|0|||
42312288|NCT02400476|76148126|FG001|Overall Study|Other, Disease Progression|1|||
42312289|NCT02400476|76148127|FG002|Overall Study|Other, Disease Progression|2|||
42312290|NCT02400476|76148128|FG003|Overall Study|Other, Disease Progression|1|||
42312291|NCT02400476|76148129|FG004|Overall Study|Other, Disease Progression|2|||
42312292|NCT02400476|76148130|FG005|Overall Study|Other, Disease Progression|1|||
42312293|NCT02400476|76148125|FG000|Overall Study|Other, Decreased Quality of Life|0|||
42312294|NCT02400476|76148126|FG001|Overall Study|Other, Decreased Quality of Life|0|||
42312295|NCT02400476|76148127|FG002|Overall Study|Other, Decreased Quality of Life|2|||
42312296|NCT02400476|76148128|FG003|Overall Study|Other, Decreased Quality of Life|0|||
42312297|NCT02400476|76148129|FG004|Overall Study|Other, Decreased Quality of Life|0|||
42312298|NCT02400476|76148130|FG005|Overall Study|Other, Decreased Quality of Life|0|||
42312299|NCT02400476|76148125|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
42312300|NCT02400476|76148126|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
42312301|NCT02400476|76148127|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
42312302|NCT02400476|76148128|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
42312303|NCT02400476|76148129|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
42312304|NCT02400476|76148130|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
42312305|NCT02363738|76148146|FG000|Overall Study|Adverse Event|5|||
42312306|NCT02363738|76148147|FG001|Overall Study|Adverse Event|2|||
42312307|NCT02363738|76148146|FG000|Overall Study|Lack of Efficacy|1|||
42312308|NCT02363738|76148147|FG001|Overall Study|Lack of Efficacy|2|||
42312309|NCT02363738|76148146|FG000|Overall Study|Lost to Follow-up|2|||
42312310|NCT02363738|76148147|FG001|Overall Study|Lost to Follow-up|1|||
42312311|NCT02331680|76148156|FG000|Overall Study|Adverse Event|3|||
42312312|NCT02331680|76148157|FG001|Overall Study|Adverse Event|0|||
42312313|NCT02331680|76148158|FG002|Overall Study|Adverse Event|2|||
42312314|NCT02331680|76148156|FG000|Overall Study|Physician Decision|1|||
42312315|NCT02331680|76148157|FG001|Overall Study|Physician Decision|1|||
42312316|NCT02331680|76148158|FG002|Overall Study|Physician Decision|2|||
42312317|NCT02331680|76148156|FG000|Overall Study|Withdrawal by Subject|0|||
42312318|NCT02331680|76148157|FG001|Overall Study|Withdrawal by Subject|1|||
42312319|NCT02331680|76148158|FG002|Overall Study|Withdrawal by Subject|2|||
42312320|NCT02331680|76148156|FG000|Overall Study|Met withdrawal criteria|2|||
42312321|NCT02331680|76148157|FG001|Overall Study|Met withdrawal criteria|2|||
42312322|NCT02331680|76148158|FG002|Overall Study|Met withdrawal criteria|5|||
42312323|NCT02331680|76148156|FG000|Overall Study|Non-compliance with study drug|0|||
42312324|NCT02331680|76148157|FG001|Overall Study|Non-compliance with study drug|0|||
42312325|NCT02331680|76148158|FG002|Overall Study|Non-compliance with study drug|1|||
42312326|NCT02331680|76148156|FG000|Overall Study|Protocol Violation|0|||
42312327|NCT02331680|76148157|FG001|Overall Study|Protocol Violation|0|||
42254641|NCT03701555|76081118|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
42254642|NCT03701555|76081119|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
42254643|NCT03701555|76081120|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
42254644|NCT03701555|76081121|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
42254645|NCT03701555|76081122|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
42254646|NCT03701555|76081123|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
42254647|NCT03701555|76081124|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
42254648|NCT03701555|76081125|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
42254649|NCT03701555|76081126|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
42312328|NCT02331680|76148158|FG002|Overall Study|Protocol Violation|3|||
42312329|NCT02331446|76148170|FG000|Overall Study|Lost to Follow-up|2|||
42312330|NCT02331446|76148171|FG001|Overall Study|Lost to Follow-up|1|||
42312331|NCT02331446|76148172|FG002|Overall Study|Lost to Follow-up|0|||
42312332|NCT02331446|76148173|FG003|Overall Study|Lost to Follow-up|1|||
42312333|NCT02331446|76148170|FG000|Overall Study|Personal Problem|2|||
42312334|NCT02331446|76148171|FG001|Overall Study|Personal Problem|0|||
42312335|NCT02331446|76148172|FG002|Overall Study|Personal Problem|0|||
42312336|NCT02331446|76148173|FG003|Overall Study|Personal Problem|0|||
42312337|NCT02331446|76148170|FG000|Overall Study|Disease|0|||
42312338|NCT02331446|76148171|FG001|Overall Study|Disease|2|||
42312339|NCT02331446|76148172|FG002|Overall Study|Disease|2|||
42312340|NCT02331446|76148173|FG003|Overall Study|Disease|1|||
42312341|NCT02331446|76148170|FG000|Overall Study|Physician Decision|0|||
42312342|NCT02331446|76148171|FG001|Overall Study|Physician Decision|1|||
42312343|NCT02331446|76148172|FG002|Overall Study|Physician Decision|0|||
42312344|NCT02331446|76148173|FG003|Overall Study|Physician Decision|1|||
42312345|NCT02331446|76148170|FG000|Overall Study|Lost before baseline analysis|0|||
42312346|NCT02331446|76148171|FG001|Overall Study|Lost before baseline analysis|1|||
42312347|NCT02331446|76148172|FG002|Overall Study|Lost before baseline analysis|1|||
42312348|NCT02331446|76148173|FG003|Overall Study|Lost before baseline analysis|0|||
42312349|NCT02349061|76148185|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
42312350|NCT02349061|76148186|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
42312351|NCT02349061|76148187|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
42312352|NCT02349061|76148185|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
42312353|NCT02349061|76148186|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
42312354|NCT02349061|76148187|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
42312355|NCT02349061|76148185|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
42312356|NCT02349061|76148186|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
42312357|NCT02349061|76148187|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
42312358|NCT02349061|76148185|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
42312359|NCT02349061|76148186|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
42312360|NCT02349061|76148187|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
42312361|NCT02349061|76148185|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
42312362|NCT02349061|76148186|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
42312363|NCT02349061|76148187|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
42312364|NCT02349061|76148185|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
42312365|NCT02349061|76148186|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
42312366|NCT02349061|76148187|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
42312367|NCT02349061|76148185|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
42312368|NCT02349061|76148186|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
42312369|NCT02349061|76148187|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
42312370|NCT02349061|76148185|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
42312371|NCT02349061|76148186|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
42312372|NCT02349061|76148187|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
42312373|NCT02349061|76148185|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
42312374|NCT02349061|76148186|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
42312375|NCT02349061|76148187|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
42312376|NCT02349061|76148185|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
42312377|NCT02349061|76148186|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
42312378|NCT02349061|76148187|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
42312379|NCT02349061|76148185|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
42312380|NCT02349061|76148186|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
42312381|NCT02349061|76148187|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
41992554|NCT01158118|75800656|FG001|Overall Study|Suffered stroke prior to transplant|1|||
41992555|NCT01158118|75800655|FG000|Overall Study|Death|0|||
42254650|NCT03701555|76081127|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
42254651|NCT03701555|76081128|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
42254652|NCT03701555|76081129|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
42254653|NCT03701555|76081130|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
42254654|NCT03701555|76081131|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
42254655|NCT03701555|76081132|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
42254656|NCT03701555|76081133|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
42254657|NCT03701555|76081134|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
42254658|NCT03701555|76081135|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
42254659|NCT03701555|76081136|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
42254660|NCT03701555|76081137|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
42254661|NCT03701555|76081138|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
42254662|NCT03701555|76081139|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
42254663|NCT03701555|76081140|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
42254664|NCT03701555|76081105|FG000|Part 2 (Day 1)|Other|0|||
42312382|NCT02349061|76148185|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
42312383|NCT02349061|76148186|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
42312384|NCT02349061|76148187|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
42312385|NCT02349061|76148185|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
42312386|NCT02349061|76148186|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
42312387|NCT02349061|76148187|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
42312388|NCT02331368|76148197|FG000|Overall Study|Withdrawal by Subject|3|||
42312389|NCT02362724|76148203|FG000|Overall Study|Withdrawal by Subject|3|||
42312390|NCT02362724|76148204|FG001|Overall Study|Withdrawal by Subject|1|||
42312391|NCT02362724|76148203|FG000|Overall Study|Adverse Event|3|||
42312392|NCT02362724|76148204|FG001|Overall Study|Adverse Event|0|||
42312393|NCT02362646|76148212|FG000|Overall Study|Death|15|||
42312394|NCT02362646|76148213|FG001|Overall Study|Death|8|||
42312395|NCT02362646|76148212|FG000|Overall Study|Withdrawal by Subject|2|||
42312396|NCT02362646|76148213|FG001|Overall Study|Withdrawal by Subject|2|||
42312397|NCT02362646|76148212|FG000|Overall Study|received transplant|21|||
42312398|NCT02362646|76148213|FG001|Overall Study|received transplant|14|||
42312399|NCT02280421|76148223|FG000|Washout (2 Weeks)|Adverse Event|0|||
42312400|NCT02280421|76148224|FG001|Washout (2 Weeks)|Adverse Event|1|||
42312401|NCT02280421|76148223|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
42312402|NCT02280421|76148224|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
42312403|NCT02362412|76148242|FG000|Treatment Period III|Lost to Follow-up|0|||
42312404|NCT02362412|76148243|FG001|Treatment Period III|Lost to Follow-up|1|||
42312405|NCT02280187|76148255|FG000|Overall Study|Lost to Follow-up|218|||
42312406|NCT02347813|76148261|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
42312407|NCT02347813|76148262|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
42312408|NCT02347813|76148261|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
42312409|NCT02347813|76148262|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
42312410|NCT02329730|76148272|FG000|Overall Study|Protocol Violation|0|||
42312411|NCT02329730|76148273|FG001|Overall Study|Protocol Violation|0|||
42312412|NCT02329730|76148274|FG002|Overall Study|Protocol Violation|0|||
42312413|NCT02329730|76148275|FG003|Overall Study|Protocol Violation|0|||
42312414|NCT02329730|76148276|FG004|Overall Study|Protocol Violation|2|||
42312415|NCT02329730|76148277|FG005|Overall Study|Protocol Violation|2|||
42312416|NCT02329730|76148278|FG006|Overall Study|Protocol Violation|0|||
42312417|NCT02329730|76148279|FG007|Overall Study|Protocol Violation|0|||
42312418|NCT02329730|76148280|FG008|Overall Study|Protocol Violation|0|||
41992556|NCT01158118|75800656|FG001|Overall Study|Death|1|||
41992557|NCT01157845|75800662|FG000|Overall Study|Lost to Follow-up|5|||
41992558|NCT01157845|75800662|FG000|Overall Study|Withdrawal by Subject|12|||
41992559|NCT01157845|75800662|FG000|Overall Study|Physician Decision|3|||
42133063|NCT00556439|75943963|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
42133064|NCT00556439|75943964|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
42133065|NCT00556439|75943965|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
42133066|NCT00556439|75943962|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
42133067|NCT00556439|75943963|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
42133068|NCT00556439|75943964|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
42133069|NCT00556439|75943965|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
42133070|NCT00556439|75943962|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
42133071|NCT00556439|75943963|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
42133072|NCT00556439|75943964|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
42133073|NCT00556439|75943965|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
42133074|NCT00556439|75943962|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
42133075|NCT00556439|75943963|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
42133076|NCT00556439|75943964|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
42133077|NCT00556439|75943965|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
42133078|NCT00387465|75943978|FG000|Overall Study|Withdrawal by Subject|0|||
42133079|NCT00387465|75943979|FG001|Overall Study|Withdrawal by Subject|1|||
42133080|NCT00387465|75943980|FG002|Overall Study|Withdrawal by Subject|0|||
42254665|NCT03701555|76081106|FG001|Part 2 (Day 1)|Other|0|||
42254666|NCT03701555|76081107|FG002|Part 2 (Day 1)|Other|0|||
42254667|NCT03701555|76081108|FG003|Part 2 (Day 1)|Other|0|||
42254668|NCT03701555|76081109|FG004|Part 2 (Day 1)|Other|0|||
42254669|NCT03701555|76081110|FG005|Part 2 (Day 1)|Other|0|||
42254670|NCT03701555|76081111|FG006|Part 2 (Day 1)|Other|0|||
42254671|NCT03701555|76081112|FG007|Part 2 (Day 1)|Other|0|||
42254672|NCT03701555|76081113|FG008|Part 2 (Day 1)|Other|0|||
42254673|NCT03701555|76081114|FG009|Part 2 (Day 1)|Other|0|||
42254674|NCT03701555|76081115|FG010|Part 2 (Day 1)|Other|3|||
42254675|NCT03701555|76081116|FG011|Part 2 (Day 1)|Other|1|||
42254676|NCT03701555|76081117|FG012|Part 2 (Day 1)|Other|0|||
42254677|NCT03701555|76081118|FG013|Part 2 (Day 1)|Other|1|||
42254678|NCT03701555|76081119|FG014|Part 2 (Day 1)|Other|0|||
42312419|NCT02329730|76148281|FG009|Overall Study|Protocol Violation|0|||
42312420|NCT02329730|76148282|FG010|Overall Study|Protocol Violation|0|||
42312421|NCT02329730|76148283|FG011|Overall Study|Protocol Violation|0|||
42312422|NCT02329730|76148272|FG000|Overall Study|Withdrawal by Subject|0|||
42312423|NCT02329730|76148273|FG001|Overall Study|Withdrawal by Subject|0|||
42312424|NCT02329730|76148274|FG002|Overall Study|Withdrawal by Subject|0|||
42312425|NCT02329730|76148275|FG003|Overall Study|Withdrawal by Subject|0|||
42312426|NCT02329730|76148276|FG004|Overall Study|Withdrawal by Subject|1|||
42312427|NCT02329730|76148277|FG005|Overall Study|Withdrawal by Subject|0|||
41992560|NCT01157845|75800662|FG000|Overall Study|Protocol Violation|13|||
42312428|NCT02329730|76148278|FG006|Overall Study|Withdrawal by Subject|1|||
42133081|NCT00387153|75943997|FG000|Overall Study|Adverse Event|1|||
42133082|NCT00387153|75943997|FG000|Overall Study|Disease Progression|3|||
42133083|NCT00387153|75943997|FG000|Overall Study|Lack of Response|4|||
42133084|NCT00386607|75944001|FG000|Core|Adverse Event|40|||
42133085|NCT00386607|75944002|FG001|Core|Adverse Event|0|||
42133086|NCT00386607|75944001|FG000|Core|Abnormal laboratory value(s)|3|||
42133087|NCT00386607|75944002|FG001|Core|Abnormal laboratory value(s)|0|||
42133088|NCT00386607|75944001|FG000|Core|Unsatisfactory therapeutic effect|23|||
42133089|NCT00386607|75944002|FG001|Core|Unsatisfactory therapeutic effect|0|||
42254679|NCT03701555|76081120|FG015|Part 2 (Day 1)|Other|2|||
42254680|NCT03701555|76081121|FG016|Part 2 (Day 1)|Other|2|||
42254681|NCT03701555|76081122|FG017|Part 2 (Day 1)|Other|0|||
42312429|NCT02329730|76148279|FG007|Overall Study|Withdrawal by Subject|1|||
42254682|NCT03701555|76081123|FG018|Part 2 (Day 1)|Other|0|||
42254683|NCT03701555|76081124|FG019|Part 2 (Day 1)|Other|0|||
42254684|NCT03701555|76081125|FG020|Part 2 (Day 1)|Other|0|||
42254685|NCT03701555|76081126|FG021|Part 2 (Day 1)|Other|0|||
42254686|NCT03701555|76081127|FG022|Part 2 (Day 1)|Other|0|||
42254687|NCT03701555|76081128|FG023|Part 2 (Day 1)|Other|0|||
42254688|NCT03701555|76081129|FG024|Part 2 (Day 1)|Other|0|||
42254689|NCT03701555|76081130|FG025|Part 2 (Day 1)|Other|0|||
42254690|NCT03701555|76081131|FG026|Part 2 (Day 1)|Other|0|||
42254691|NCT03701555|76081132|FG027|Part 2 (Day 1)|Other|0|||
42254692|NCT03701555|76081133|FG028|Part 2 (Day 1)|Other|0|||
42254693|NCT03701555|76081134|FG029|Part 2 (Day 1)|Other|0|||
42254694|NCT03701555|76081135|FG030|Part 2 (Day 1)|Other|0|||
42254695|NCT03701555|76081136|FG031|Part 2 (Day 1)|Other|0|||
42254696|NCT03701555|76081137|FG032|Part 2 (Day 1)|Other|0|||
42254697|NCT03701555|76081138|FG033|Part 2 (Day 1)|Other|0|||
42254698|NCT03701555|76081139|FG034|Part 2 (Day 1)|Other|0|||
42254699|NCT03701555|76081140|FG035|Part 2 (Day 1)|Other|0|||
42312430|NCT02329730|76148280|FG008|Overall Study|Withdrawal by Subject|1|||
42312431|NCT02329730|76148281|FG009|Overall Study|Withdrawal by Subject|1|||
42312432|NCT02329730|76148282|FG010|Overall Study|Withdrawal by Subject|0|||
42312433|NCT02329730|76148283|FG011|Overall Study|Withdrawal by Subject|0|||
42312434|NCT02328326|76148303|FG000|Overall Study|Withdrawal by Subject|10|||
42312435|NCT02328326|76148304|FG001|Overall Study|Withdrawal by Subject|3|||
42312436|NCT02328326|76148303|FG000|Overall Study|Death|2|||
42312437|NCT02328326|76148304|FG001|Overall Study|Death|1|||
42312438|NCT02328326|76148303|FG000|Overall Study|Lost to Follow-up|10|||
42312439|NCT02328326|76148304|FG001|Overall Study|Lost to Follow-up|4|||
42312440|NCT01649804|76148312|FG000|Overall Study|Administrative/Other|8|||
42312441|NCT02397278|76148318|FG000|Overall Study|Withdrawal by Subject|0|||
42312442|NCT02397278|76148319|FG001|Overall Study|Withdrawal by Subject|2|||
42312443|NCT02397278|76148318|FG000|Overall Study|Deemed ineligible following surgery|1|||
42312444|NCT02397278|76148319|FG001|Overall Study|Deemed ineligible following surgery|1|||
42312445|NCT02360228|76148328|FG000|Overall Study|Withdrawal by Subject|1|||
42312446|NCT02360228|76148329|FG001|Overall Study|Withdrawal by Subject|0|||
42312447|NCT02360228|76148330|FG002|Overall Study|Withdrawal by Subject|0|||
42312448|NCT02360228|76148328|FG000|Overall Study|Self-discontinued medication|0|||
42312449|NCT02360228|76148329|FG001|Overall Study|Self-discontinued medication|1|||
42312450|NCT02360228|76148330|FG002|Overall Study|Self-discontinued medication|0|||
42312451|NCT02360228|76148328|FG000|Overall Study|Unstable symptoms during screening|0|||
42312452|NCT02360228|76148329|FG001|Overall Study|Unstable symptoms during screening|0|||
42312453|NCT02360228|76148330|FG002|Overall Study|Unstable symptoms during screening|1|||
42312454|NCT02359994|76148340|FG000|Overall Population Study|Adverse Event|1|||
42312455|NCT02359994|76148341|FG001|Overall Population Study|Adverse Event|1|||
42254700|NCT03701555|76081105|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
42254701|NCT03701555|76081106|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
42312456|NCT02359994|76148340|FG000|Overall Population Study|Death|1|||
41992561|NCT01157845|75800662|FG000|Overall Study|Study was ended|1|||
42254702|NCT03701555|76081107|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
42254703|NCT03701555|76081108|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
42254704|NCT03701555|76081109|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
42254705|NCT03701555|76081110|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
42254706|NCT03701555|76081111|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
42254707|NCT03701555|76081112|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
42254708|NCT03701555|76081113|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
42254709|NCT03701555|76081114|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
42312457|NCT02359994|76148341|FG001|Overall Population Study|Death|5|||
42312458|NCT02359994|76148340|FG000|Overall Population Study|Lost to Follow-up|1|||
42312459|NCT02359994|76148341|FG001|Overall Population Study|Lost to Follow-up|1|||
42312460|NCT02359994|76148340|FG000|Overall Population Study|Withdrawal by Subject|1|||
42133090|NCT00386607|75944001|FG000|Core|Condition no longer requires study drug|4|||
42254710|NCT03701555|76081115|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
42254711|NCT03701555|76081116|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
42312461|NCT02359994|76148341|FG001|Overall Population Study|Withdrawal by Subject|0|||
42312462|NCT02359994|76148340|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
42312463|NCT02359994|76148341|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
42312464|NCT02359994|76148340|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
42312465|NCT02359994|76148341|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
42312466|NCT02359994|76148340|FG000|Extended Oncology 24-Month Survival|Death|19|||
42312467|NCT02359994|76148341|FG001|Extended Oncology 24-Month Survival|Death|21|||
42312468|NCT02359994|76148340|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
42312469|NCT02359994|76148341|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
42312470|NCT02326298|76148350|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312471|NCT02326298|76148351|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312472|NCT02326298|76148352|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
42312473|NCT02326298|76148353|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312474|NCT02326298|76148354|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312475|NCT02326298|76148355|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312476|NCT02326298|76148356|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312477|NCT02326298|76148357|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312478|NCT02326298|76148358|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312479|NCT02326298|76148359|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312480|NCT02326298|76148360|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312481|NCT02326298|76148361|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312482|NCT02326298|76148362|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312483|NCT02326298|76148363|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
42312484|NCT02326298|76148350|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
42312485|NCT02326298|76148351|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312486|NCT02326298|76148352|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312487|NCT02326298|76148353|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312488|NCT02326298|76148354|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312489|NCT02326298|76148355|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312490|NCT02326298|76148356|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312491|NCT02326298|76148357|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312492|NCT02326298|76148358|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312493|NCT02326298|76148359|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312494|NCT02326298|76148360|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312495|NCT02326298|76148361|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312496|NCT02326298|76148362|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312497|NCT02326298|76148363|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
42312498|NCT02326298|76148350|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
42312499|NCT02326298|76148351|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
42312500|NCT02326298|76148352|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42312501|NCT02326298|76148353|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42312502|NCT02326298|76148354|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42312503|NCT02326298|76148355|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42312504|NCT02326298|76148356|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42312505|NCT02326298|76148357|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42312506|NCT02326298|76148358|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42312507|NCT02326298|76148359|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42312508|NCT02326298|76148360|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42312509|NCT02326298|76148361|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
41992562|NCT01157845|75800662|FG000|Overall Study|Device malfunction|1|||
42254712|NCT03701555|76081117|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
42254713|NCT03701555|76081118|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
42254714|NCT03701555|76081119|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
42254715|NCT03701555|76081120|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
42254716|NCT03701555|76081121|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
42254717|NCT03701555|76081122|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
42254718|NCT03701555|76081123|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
42254719|NCT03701555|76081124|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
42254720|NCT03701555|76081125|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
42254721|NCT03701555|76081126|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
42254722|NCT03701555|76081127|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
42254723|NCT03701555|76081128|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
42312510|NCT02326298|76148362|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42312511|NCT02326298|76148363|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
42312512|NCT02326298|76148350|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
42312513|NCT02326298|76148351|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
42312514|NCT02326298|76148352|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42312515|NCT02326298|76148353|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42312516|NCT02326298|76148354|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42312517|NCT02326298|76148355|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42254724|NCT03701555|76081129|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
42254725|NCT03701555|76081130|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
42312518|NCT02326298|76148356|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42312519|NCT02326298|76148357|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42312520|NCT02326298|76148358|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42312521|NCT02326298|76148359|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42312522|NCT02326298|76148360|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42312523|NCT02326298|76148361|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42312524|NCT02326298|76148362|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42312525|NCT02326298|76148363|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
42312526|NCT02326298|76148350|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42312527|NCT02326298|76148351|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42312528|NCT02326298|76148352|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
42312529|NCT02326298|76148353|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42254726|NCT03701555|76081131|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
42254727|NCT03701555|76081132|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
42254728|NCT03701555|76081133|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
42254729|NCT03701555|76081134|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
42254730|NCT03701555|76081135|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
42254731|NCT03701555|76081136|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
42254732|NCT03701555|76081137|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
42254733|NCT03701555|76081138|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
42254734|NCT03701555|76081139|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
42254735|NCT03701555|76081140|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
42254736|NCT03701555|76081105|FG000|Part 3 (Day 1)|Subject Decision|0|||
42312530|NCT02326298|76148354|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42312531|NCT02326298|76148355|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42312532|NCT02326298|76148356|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42312533|NCT02326298|76148357|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42312534|NCT02326298|76148358|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42312535|NCT02326298|76148359|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42312536|NCT02326298|76148360|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42254737|NCT03701555|76081106|FG001|Part 3 (Day 1)|Subject Decision|0|||
42312537|NCT02326298|76148361|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42312538|NCT02326298|76148362|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42312539|NCT02326298|76148363|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
42312540|NCT02326298|76148350|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
42312541|NCT02326298|76148351|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
42312542|NCT02326298|76148352|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
42312543|NCT02326298|76148353|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
42312544|NCT02326298|76148354|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
42312545|NCT02326298|76148355|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
42312546|NCT02326298|76148356|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
42312547|NCT02326298|76148357|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
42312548|NCT02326298|76148358|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
42312549|NCT02326298|76148359|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
42312550|NCT02326298|76148360|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
42312551|NCT02326298|76148361|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
42312552|NCT02326298|76148362|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
42312553|NCT02326298|76148363|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
42312554|NCT02326298|76148350|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
42312555|NCT02326298|76148351|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
42312556|NCT02326298|76148352|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
42312557|NCT02326298|76148353|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
42312558|NCT02326298|76148354|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
42312559|NCT02326298|76148355|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
42312560|NCT02326298|76148356|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
42312561|NCT02326298|76148357|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
42312562|NCT02326298|76148358|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
42312563|NCT02326298|76148359|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
42312564|NCT02326298|76148360|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
42312565|NCT02326298|76148361|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
42312566|NCT02326298|76148362|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
42312567|NCT02326298|76148363|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
42312568|NCT02326298|76148350|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312569|NCT02326298|76148351|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312570|NCT02326298|76148352|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312571|NCT02326298|76148353|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312572|NCT02326298|76148354|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312573|NCT02326298|76148355|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
42312574|NCT02326298|76148356|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312575|NCT02326298|76148357|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312576|NCT02326298|76148358|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312577|NCT02326298|76148359|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42133091|NCT00386607|75944002|FG001|Core|Condition no longer requires study drug|0|||
42133092|NCT00386607|75944001|FG000|Core|Patient withdrew consent|15|||
42133093|NCT00386607|75944002|FG001|Core|Patient withdrew consent|0|||
42133094|NCT00386607|75944001|FG000|Core|Lost to Follow-up|23|||
42312578|NCT02326298|76148360|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312579|NCT02326298|76148361|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312580|NCT02326298|76148362|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312581|NCT02326298|76148363|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
42312582|NCT02326298|76148350|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312583|NCT02326298|76148351|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312584|NCT02326298|76148352|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312585|NCT02326298|76148353|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312586|NCT02326298|76148354|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312587|NCT02326298|76148355|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312588|NCT02326298|76148356|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
42133095|NCT00386607|75944002|FG001|Core|Lost to Follow-up|0|||
42133096|NCT00386607|75944001|FG000|Core|Administrative problems|1|||
42133097|NCT00386607|75944002|FG001|Core|Administrative problems|0|||
42312589|NCT02326298|76148357|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312590|NCT02326298|76148358|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312591|NCT02326298|76148359|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312592|NCT02326298|76148360|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312593|NCT02326298|76148361|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312594|NCT02326298|76148362|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312595|NCT02326298|76148363|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
42312596|NCT02326298|76148350|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312597|NCT02326298|76148351|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312598|NCT02326298|76148352|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312599|NCT02326298|76148353|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312600|NCT02326298|76148354|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312601|NCT02326298|76148355|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312602|NCT02326298|76148356|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312603|NCT02326298|76148357|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
42312604|NCT02326298|76148358|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312605|NCT02326298|76148359|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312606|NCT02326298|76148360|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312607|NCT02326298|76148361|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312608|NCT02326298|76148362|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312609|NCT02326298|76148363|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
42312610|NCT02326298|76148350|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42254738|NCT03701555|76081107|FG002|Part 3 (Day 1)|Subject Decision|0|||
42254739|NCT03701555|76081108|FG003|Part 3 (Day 1)|Subject Decision|0|||
42254740|NCT03701555|76081109|FG004|Part 3 (Day 1)|Subject Decision|0|||
42254741|NCT03701555|76081110|FG005|Part 3 (Day 1)|Subject Decision|0|||
42254742|NCT03701555|76081111|FG006|Part 3 (Day 1)|Subject Decision|0|||
42254743|NCT03701555|76081112|FG007|Part 3 (Day 1)|Subject Decision|0|||
42254744|NCT03701555|76081113|FG008|Part 3 (Day 1)|Subject Decision|0|||
42254745|NCT03701555|76081114|FG009|Part 3 (Day 1)|Subject Decision|0|||
42254746|NCT03701555|76081115|FG010|Part 3 (Day 1)|Subject Decision|0|||
42254747|NCT03701555|76081116|FG011|Part 3 (Day 1)|Subject Decision|0|||
42312611|NCT02326298|76148351|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42312612|NCT02326298|76148352|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42312613|NCT02326298|76148353|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42312614|NCT02326298|76148354|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42312615|NCT02326298|76148355|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42254748|NCT03701555|76081117|FG012|Part 3 (Day 1)|Subject Decision|0|||
42254749|NCT03701555|76081118|FG013|Part 3 (Day 1)|Subject Decision|0|||
42254750|NCT03701555|76081119|FG014|Part 3 (Day 1)|Subject Decision|0|||
42254751|NCT03701555|76081120|FG015|Part 3 (Day 1)|Subject Decision|0|||
42254752|NCT03701555|76081121|FG016|Part 3 (Day 1)|Subject Decision|0|||
42254753|NCT03701555|76081122|FG017|Part 3 (Day 1)|Subject Decision|0|||
42254754|NCT03701555|76081123|FG018|Part 3 (Day 1)|Subject Decision|0|||
42254755|NCT03701555|76081124|FG019|Part 3 (Day 1)|Subject Decision|0|||
42254756|NCT03701555|76081125|FG020|Part 3 (Day 1)|Subject Decision|0|||
42254757|NCT03701555|76081126|FG021|Part 3 (Day 1)|Subject Decision|0|||
42254758|NCT03701555|76081127|FG022|Part 3 (Day 1)|Subject Decision|0|||
42254759|NCT03701555|76081128|FG023|Part 3 (Day 1)|Subject Decision|0|||
42254760|NCT03701555|76081129|FG024|Part 3 (Day 1)|Subject Decision|0|||
42254761|NCT03701555|76081130|FG025|Part 3 (Day 1)|Subject Decision|0|||
42254762|NCT03701555|76081131|FG026|Part 3 (Day 1)|Subject Decision|1|||
42133098|NCT00386607|75944001|FG000|Core|Protocol Deviation|6|||
42133099|NCT00386607|75944002|FG001|Core|Protocol Deviation|0|||
42133100|NCT00386607|75944001|FG000|Extension|Adverse Event|0|||
42033409|NCT01128569|75841642|FG005|Treatment Period 2|Withdrawal by Subject|0|||
42033410|NCT01128413|75841652|FG000|Overall Study|Withdrawal by Subject|1|||
42133101|NCT00386607|75944002|FG001|Extension|Adverse Event|6|||
42133102|NCT00386607|75944001|FG000|Extension|Abnormal laboratory value(s)|0|||
42133103|NCT00386607|75944002|FG001|Extension|Abnormal laboratory value(s)|1|||
42133104|NCT00386607|75944001|FG000|Extension|Administrative problems|0|||
42133105|NCT00386607|75944002|FG001|Extension|Administrative problems|1|||
42133106|NCT00386607|75944001|FG000|Extension|Lost to Follow-up|0|||
42133107|NCT00386607|75944002|FG001|Extension|Lost to Follow-up|3|||
42133108|NCT00386607|75944001|FG000|Extension|Patient withdrew consent|0|||
42254763|NCT03701555|76081132|FG027|Part 3 (Day 1)|Subject Decision|0|||
42254764|NCT03701555|76081133|FG028|Part 3 (Day 1)|Subject Decision|0|||
42254765|NCT03701555|76081134|FG029|Part 3 (Day 1)|Subject Decision|0|||
42254766|NCT03701555|76081135|FG030|Part 3 (Day 1)|Subject Decision|0|||
42254767|NCT03701555|76081136|FG031|Part 3 (Day 1)|Subject Decision|2|||
42254768|NCT03701555|76081137|FG032|Part 3 (Day 1)|Subject Decision|1|||
42254769|NCT03701555|76081138|FG033|Part 3 (Day 1)|Subject Decision|1|||
42254770|NCT03701555|76081139|FG034|Part 3 (Day 1)|Subject Decision|0|||
42254771|NCT03701555|76081140|FG035|Part 3 (Day 1)|Subject Decision|0|||
42254772|NCT03701555|76081105|FG000|Part 3 (Day 1)|Other|0|||
42254773|NCT03701555|76081106|FG001|Part 3 (Day 1)|Other|0|||
42254774|NCT03701555|76081107|FG002|Part 3 (Day 1)|Other|0|||
42254775|NCT03701555|76081108|FG003|Part 3 (Day 1)|Other|0|||
42254776|NCT03701555|76081109|FG004|Part 3 (Day 1)|Other|0|||
42254777|NCT03701555|76081110|FG005|Part 3 (Day 1)|Other|0|||
42254778|NCT03701555|76081111|FG006|Part 3 (Day 1)|Other|0|||
42254779|NCT03701555|76081112|FG007|Part 3 (Day 1)|Other|0|||
42254780|NCT03701555|76081113|FG008|Part 3 (Day 1)|Other|0|||
42254781|NCT03701555|76081114|FG009|Part 3 (Day 1)|Other|0|||
42254782|NCT03701555|76081115|FG010|Part 3 (Day 1)|Other|0|||
42254783|NCT03701555|76081116|FG011|Part 3 (Day 1)|Other|0|||
42254784|NCT03701555|76081117|FG012|Part 3 (Day 1)|Other|0|||
42254785|NCT03701555|76081118|FG013|Part 3 (Day 1)|Other|0|||
42254786|NCT03701555|76081119|FG014|Part 3 (Day 1)|Other|0|||
42254787|NCT03701555|76081120|FG015|Part 3 (Day 1)|Other|0|||
42254788|NCT03701555|76081121|FG016|Part 3 (Day 1)|Other|0|||
42254789|NCT03701555|76081122|FG017|Part 3 (Day 1)|Other|0|||
42254790|NCT03701555|76081123|FG018|Part 3 (Day 1)|Other|0|||
42254791|NCT03701555|76081124|FG019|Part 3 (Day 1)|Other|0|||
42254792|NCT03701555|76081125|FG020|Part 3 (Day 1)|Other|0|||
42254793|NCT03701555|76081126|FG021|Part 3 (Day 1)|Other|0|||
42254794|NCT03701555|76081127|FG022|Part 3 (Day 1)|Other|0|||
42254795|NCT03701555|76081128|FG023|Part 3 (Day 1)|Other|0|||
42254796|NCT03701555|76081129|FG024|Part 3 (Day 1)|Other|1|||
42254797|NCT03701555|76081130|FG025|Part 3 (Day 1)|Other|1|||
42254798|NCT03701555|76081131|FG026|Part 3 (Day 1)|Other|0|||
42254799|NCT03701555|76081132|FG027|Part 3 (Day 1)|Other|0|||
42254800|NCT03701555|76081133|FG028|Part 3 (Day 1)|Other|0|||
42254801|NCT03701555|76081134|FG029|Part 3 (Day 1)|Other|1|||
42254802|NCT03701555|76081135|FG030|Part 3 (Day 1)|Other|1|||
42254803|NCT03701555|76081136|FG031|Part 3 (Day 1)|Other|0|||
42254804|NCT03701555|76081137|FG032|Part 3 (Day 1)|Other|1|||
42254805|NCT03701555|76081138|FG033|Part 3 (Day 1)|Other|1|||
42312616|NCT02326298|76148356|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
42133109|NCT00386607|75944002|FG001|Extension|Patient withdrew consent|5|||
42254806|NCT03701555|76081139|FG034|Part 3 (Day 1)|Other|0|||
42254807|NCT03701555|76081140|FG035|Part 3 (Day 1)|Other|0|||
42254808|NCT02178098|76081267|FG000|Overall Study|Withdrawal by Subject|0|||
42254809|NCT02178098|76081268|FG001|Overall Study|Withdrawal by Subject|6|||
42254810|NCT02178098|76081267|FG000|Overall Study|Adverse Event|1|||
42254811|NCT02178098|76081268|FG001|Overall Study|Adverse Event|2|||
42254812|NCT02178098|76081267|FG000|Overall Study|Protocol Violation|1|||
42254813|NCT02178098|76081268|FG001|Overall Study|Protocol Violation|1|||
42254814|NCT02178098|76081267|FG000|Overall Study|Lost to Follow-up|0|||
42254815|NCT02178098|76081268|FG001|Overall Study|Lost to Follow-up|1|||
42254816|NCT02178098|76081267|FG000|Overall Study|Sponsor Request|1|||
42254817|NCT02178098|76081268|FG001|Overall Study|Sponsor Request|0|||
42254818|NCT02178098|76081267|FG000|Overall Study|Other|2|||
42254819|NCT02178098|76081268|FG001|Overall Study|Other|2|||
42254820|NCT01915498|76081294|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
42312617|NCT02326298|76148357|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
42312618|NCT02326298|76148358|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42312619|NCT02326298|76148359|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42312620|NCT02326298|76148360|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42312621|NCT02326298|76148361|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42312622|NCT02326298|76148362|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42312623|NCT02326298|76148363|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
42312624|NCT02326298|76148350|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312625|NCT02326298|76148351|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312626|NCT02326298|76148352|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312627|NCT02326298|76148353|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312628|NCT02326298|76148354|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312629|NCT02326298|76148355|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312630|NCT02326298|76148356|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312631|NCT02326298|76148357|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
42312632|NCT02326298|76148358|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312633|NCT02326298|76148359|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312634|NCT02326298|76148360|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312635|NCT02326298|76148361|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312636|NCT02326298|76148362|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312637|NCT02326298|76148363|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
42312638|NCT02326298|76148350|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312639|NCT02326298|76148351|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312640|NCT02326298|76148352|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312641|NCT02326298|76148353|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312642|NCT02326298|76148354|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312643|NCT02326298|76148355|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
42312644|NCT02326298|76148356|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312645|NCT02326298|76148357|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312646|NCT02326298|76148358|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312647|NCT02326298|76148359|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312648|NCT02326298|76148360|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312649|NCT02326298|76148361|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312650|NCT02326298|76148362|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312651|NCT02326298|76148363|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
42312652|NCT02326298|76148350|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
42312653|NCT02326298|76148351|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
42312654|NCT02326298|76148352|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
42312655|NCT02326298|76148353|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
42312656|NCT02326298|76148354|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
42312657|NCT02326298|76148355|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
42312658|NCT02326298|76148356|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
42312659|NCT02326298|76148357|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
42312660|NCT02326298|76148358|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
42312661|NCT02326298|76148359|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
42312662|NCT02326298|76148360|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
42133110|NCT00386607|75944001|FG000|Extension|Unsatisfactory therapeutic effect|0|||
42133111|NCT00386607|75944002|FG001|Extension|Unsatisfactory therapeutic effect|1|||
42254821|NCT01915498|76081295|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
42254822|NCT01915498|76081296|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
42254823|NCT01915498|76081297|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
42254824|NCT01915498|76081298|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
42254825|NCT01915498|76081299|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
42254826|NCT01915498|76081300|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
42254827|NCT01915498|76081301|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
42254828|NCT01915498|76081302|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
42254829|NCT01915498|76081303|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
42312663|NCT02326298|76148361|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
42312664|NCT02326298|76148362|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
42312665|NCT02326298|76148363|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
42312666|NCT02326298|76148350|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312667|NCT02326298|76148351|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312668|NCT02326298|76148352|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312669|NCT02326298|76148353|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312670|NCT02326298|76148354|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312671|NCT02326298|76148355|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312672|NCT02326298|76148356|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312673|NCT02326298|76148357|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312674|NCT02326298|76148358|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312675|NCT02326298|76148359|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312676|NCT02326298|76148360|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312677|NCT02326298|76148361|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
42312678|NCT02326298|76148362|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
42312679|NCT02326298|76148363|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
42312680|NCT02326298|76148350|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
42312681|NCT02326298|76148351|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
42312682|NCT02326298|76148352|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
42312683|NCT02326298|76148353|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
41992563|NCT01157377|75800673|FG000|Overall Study|Lost to Follow-up|0|||
41992564|NCT01157377|75800674|FG001|Overall Study|Lost to Follow-up|0|||
41992565|NCT01157377|75800675|FG002|Overall Study|Lost to Follow-up|1|||
41992566|NCT01157377|75800676|FG003|Overall Study|Lost to Follow-up|0|||
41992567|NCT01157377|75800677|FG004|Overall Study|Lost to Follow-up|1|||
41992568|NCT01157377|75800678|FG005|Overall Study|Lost to Follow-up|1|||
41992569|NCT01157377|75800679|FG006|Overall Study|Lost to Follow-up|0|||
41992570|NCT01157377|75800673|FG000|Overall Study|Personal Reasons|2|||
41992571|NCT01157377|75800674|FG001|Overall Study|Personal Reasons|1|||
41992572|NCT01157377|75800675|FG002|Overall Study|Personal Reasons|0|||
41992573|NCT01157377|75800676|FG003|Overall Study|Personal Reasons|1|||
41992574|NCT01157377|75800677|FG004|Overall Study|Personal Reasons|0|||
41992575|NCT01157377|75800678|FG005|Overall Study|Personal Reasons|0|||
41992576|NCT01157377|75800679|FG006|Overall Study|Personal Reasons|0|||
41992577|NCT01157377|75800673|FG000|Overall Study|Protocol Violation|0|||
41992578|NCT01157377|75800674|FG001|Overall Study|Protocol Violation|0|||
41992579|NCT01157377|75800675|FG002|Overall Study|Protocol Violation|0|||
41992580|NCT01157377|75800676|FG003|Overall Study|Protocol Violation|0|||
41992581|NCT01157377|75800677|FG004|Overall Study|Protocol Violation|0|||
41992582|NCT01157377|75800678|FG005|Overall Study|Protocol Violation|1|||
41992583|NCT01157377|75800679|FG006|Overall Study|Protocol Violation|0|||
41992584|NCT01157377|75800673|FG000|Overall Study|Lack of Efficacy|0|||
41992585|NCT01157377|75800674|FG001|Overall Study|Lack of Efficacy|0|||
41992586|NCT01157377|75800675|FG002|Overall Study|Lack of Efficacy|0|||
41992587|NCT01157377|75800676|FG003|Overall Study|Lack of Efficacy|0|||
41992588|NCT01157377|75800677|FG004|Overall Study|Lack of Efficacy|0|||
41992589|NCT01157377|75800678|FG005|Overall Study|Lack of Efficacy|0|||
41992590|NCT01157377|75800679|FG006|Overall Study|Lack of Efficacy|1|||
41992591|NCT01157377|75800673|FG000|Overall Study|Other Miscellaneous Reasons|0|||
42312684|NCT02326298|76148354|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
42312685|NCT02326298|76148355|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
42312686|NCT02326298|76148356|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
42312687|NCT02326298|76148357|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
42312688|NCT02326298|76148358|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
42312689|NCT02326298|76148359|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
42312690|NCT02326298|76148360|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
42312691|NCT02326298|76148361|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
42312692|NCT02326298|76148362|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
42312693|NCT02326298|76148363|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
42312694|NCT02326298|76148350|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41992592|NCT01157377|75800674|FG001|Overall Study|Other Miscellaneous Reasons|2|||
41992593|NCT01157377|75800675|FG002|Overall Study|Other Miscellaneous Reasons|0|||
41992594|NCT01157377|75800676|FG003|Overall Study|Other Miscellaneous Reasons|0|||
41992595|NCT01157377|75800677|FG004|Overall Study|Other Miscellaneous Reasons|1|||
41992596|NCT01157377|75800678|FG005|Overall Study|Other Miscellaneous Reasons|1|||
41992597|NCT01157377|75800679|FG006|Overall Study|Other Miscellaneous Reasons|1|||
41992598|NCT01157182|75800697|FG000|Washout of 28 Days|Adverse Event|2|||
41992599|NCT01157182|75800698|FG001|Washout of 28 Days|Adverse Event|0|||
42312695|NCT02326298|76148351|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
42312696|NCT02326298|76148352|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
41992600|NCT01157065|75800706|FG000|Overall Study|Death|0|||
41992601|NCT01157065|75800707|FG001|Overall Study|Death|1|||
41992602|NCT01156792|75800713|FG000|Overall Study|Adverse Event|1|||
41992603|NCT01156792|75800713|FG000|Overall Study|Lack of Efficacy|36|||
41992604|NCT01156792|75800713|FG000|Overall Study|Protocol Violation|6|||
41992605|NCT01156792|75800713|FG000|Overall Study|Lost to Follow-up|3|||
41992606|NCT01156792|75800713|FG000|Overall Study|Physician Decision|3|||
42312697|NCT02326298|76148353|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
42312698|NCT02326298|76148354|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
42312699|NCT02326298|76148355|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
42312700|NCT02326298|76148356|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
42312701|NCT02326298|76148357|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
42312702|NCT02326298|76148358|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
42312703|NCT02326298|76148359|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
42312704|NCT02326298|76148360|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
42312705|NCT02326298|76148361|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
42312706|NCT02326298|76148362|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
42312707|NCT02326298|76148363|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
42312708|NCT02326298|76148350|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42312709|NCT02326298|76148351|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42312710|NCT02326298|76148352|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42312711|NCT02326298|76148353|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42312712|NCT02326298|76148354|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42312713|NCT02326298|76148355|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42312714|NCT02326298|76148356|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42312715|NCT02326298|76148357|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42312716|NCT02326298|76148358|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42312717|NCT02326298|76148359|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42312718|NCT02326298|76148360|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
42312719|NCT02326298|76148361|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
42312720|NCT02326298|76148362|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
42312721|NCT02326298|76148363|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
42312722|NCT02326298|76148350|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
42312723|NCT02326298|76148351|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
42312724|NCT02326298|76148352|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
42312725|NCT02326298|76148353|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
42312726|NCT02326298|76148354|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
42312727|NCT02326298|76148355|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
42312728|NCT02326298|76148356|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
42312729|NCT02326298|76148357|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
42312730|NCT02326298|76148358|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
42312731|NCT02326298|76148359|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
42312732|NCT02326298|76148360|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
42312733|NCT02326298|76148361|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
42312734|NCT02326298|76148362|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
42312735|NCT02326298|76148363|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
42312736|NCT02326298|76148350|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
42312737|NCT02326298|76148351|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
42312738|NCT02326298|76148352|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
42312739|NCT02326298|76148353|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
42312740|NCT02326298|76148354|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
42312741|NCT02326298|76148355|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
42312742|NCT02326298|76148356|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
42312743|NCT02326298|76148357|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
42312744|NCT02326298|76148358|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
42312745|NCT02326298|76148359|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
41992607|NCT01156792|75800713|FG000|Overall Study|Withdrawal by Subject|9|||
41992608|NCT01156792|75800713|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
41992609|NCT01156714|75800731|FG000|Overall Study|Withdrawal by Subject|9|||
41992610|NCT01156714|75800732|FG001|Overall Study|Withdrawal by Subject|4|||
41992611|NCT01156714|75800733|FG002|Overall Study|Withdrawal by Subject|3|||
41992612|NCT01156675|75800747|FG000|Overall Study|Death|5|||
41992613|NCT01156675|75800748|FG001|Overall Study|Death|3|||
41992614|NCT01156675|75800749|FG002|Overall Study|Death|0|||
41992615|NCT01156675|75800747|FG000|Overall Study|No data|29|||
41992616|NCT01156675|75800748|FG001|Overall Study|No data|22|||
41992617|NCT01156675|75800749|FG002|Overall Study|No data|2|||
41992618|NCT01156480|75800760|FG000|Overall Study|change in diagnosis|0|||
41992619|NCT01156480|75800761|FG001|Overall Study|change in diagnosis|1|||
41992620|NCT01156363|75800769|FG000|Overall Study|Adverse Event|6|||
41992621|NCT01156363|75800769|FG000|Overall Study|Insufficient Therapeutic Response|5|||
41992622|NCT01156363|75800769|FG000|Overall Study|Failure to Return|1|||
41992623|NCT01156363|75800769|FG000|Overall Study|Refused Treatment|4|||
41992624|NCT01156363|75800769|FG000|Overall Study|Other|6|||
41992625|NCT01156051|75800782|FG000|Overall Study|Lost to Follow-up|1|||
41992626|NCT01156051|75800783|FG001|Overall Study|Lost to Follow-up|0|||
41992627|NCT01156051|75800782|FG000|Overall Study|patient not compliant with protocol|0|||
41992628|NCT01156051|75800783|FG001|Overall Study|patient not compliant with protocol|1|||
41992629|NCT01156012|75800791|FG000|Overall Study|Adverse Event|3|||
41992630|NCT01156012|75800792|FG001|Overall Study|Adverse Event|1|||
41992631|NCT01156012|75800791|FG000|Overall Study|Lost to Follow-up|1|||
41992632|NCT01156012|75800792|FG001|Overall Study|Lost to Follow-up|0|||
41992633|NCT01156012|75800791|FG000|Overall Study|Withdrawal by Subject|1|||
42133112|NCT00410163|75944016|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
42133113|NCT00410163|75944017|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
42133114|NCT00410163|75944016|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
42254830|NCT01915498|76081304|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
42254831|NCT01915498|76081305|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
42254832|NCT01915498|76081306|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
42254833|NCT01915498|76081307|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
42254834|NCT01915498|76081308|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
42254835|NCT01915498|76081309|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
42254836|NCT01915498|76081310|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
42254837|NCT01915498|76081311|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
42254838|NCT01915498|76081312|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
42254839|NCT01915498|76081294|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
42254840|NCT01915498|76081295|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
42254841|NCT01915498|76081296|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
42254842|NCT01915498|76081297|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
42254843|NCT01915498|76081298|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
42254844|NCT01915498|76081299|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
42254845|NCT01915498|76081300|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
42254846|NCT01915498|76081301|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
42254847|NCT01915498|76081302|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
42254848|NCT01915498|76081303|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
42254849|NCT01915498|76081304|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
42254850|NCT01915498|76081305|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
42254851|NCT01915498|76081306|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
42254852|NCT01915498|76081307|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
42254853|NCT01915498|76081308|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
42254854|NCT01915498|76081309|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
42254855|NCT01915498|76081310|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
42254856|NCT01915498|76081311|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
42254857|NCT01915498|76081312|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
42254858|NCT01915498|76081294|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
42254859|NCT01915498|76081295|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
42254860|NCT01915498|76081296|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
41992634|NCT01156012|75800792|FG001|Overall Study|Withdrawal by Subject|0|||
41992635|NCT01156012|75800791|FG000|Overall Study|use of commercial drug instead of study|0|||
41992636|NCT01156012|75800792|FG001|Overall Study|use of commercial drug instead of study|1|||
42312746|NCT02326298|76148360|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
42312747|NCT02326298|76148361|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
42312748|NCT02326298|76148362|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
42312749|NCT02326298|76148363|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
42312750|NCT02396420|76148372|FG000|Overall Study|Death|1|||
42312751|NCT02279719|76148384|FG000|Overall Study|Patients randomized but never treated|0|||
42312752|NCT02279719|76148385|FG001|Overall Study|Patients randomized but never treated|0|||
42312753|NCT02279719|76148386|FG002|Overall Study|Patients randomized but never treated|0|||
42312754|NCT02279719|76148387|FG003|Overall Study|Patients randomized but never treated|0|||
42312755|NCT02279719|76148388|FG004|Overall Study|Patients randomized but never treated|3|||
42312756|NCT02279719|76148389|FG005|Overall Study|Patients randomized but never treated|0|||
42312757|NCT02279719|76148390|FG006|Overall Study|Patients randomized but never treated|3|||
42312758|NCT02279407|76148427|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
42312759|NCT02279407|76148428|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
42312760|NCT02279407|76148429|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
42312761|NCT02279407|76148430|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
42312762|NCT02279407|76148427|FG000|Overall Study|Withdrawal by Subject|1|||
42312763|NCT02279407|76148428|FG001|Overall Study|Withdrawal by Subject|0|||
42312764|NCT02279407|76148429|FG002|Overall Study|Withdrawal by Subject|1|||
42312765|NCT02279407|76148430|FG003|Overall Study|Withdrawal by Subject|1|||
42312766|NCT02279407|76148427|FG000|Overall Study|Adverse Event|1|||
42312767|NCT02279407|76148428|FG001|Overall Study|Adverse Event|1|||
42312768|NCT02279407|76148429|FG002|Overall Study|Adverse Event|2|||
42312769|NCT02279407|76148430|FG003|Overall Study|Adverse Event|0|||
42312770|NCT02326220|76148442|FG000|Double-blind Treatment Period|Adverse Event|1|||
42312771|NCT02326220|76148443|FG001|Double-blind Treatment Period|Adverse Event|2|||
42312772|NCT02326220|76148444|FG002|Double-blind Treatment Period|Adverse Event|0|||
42312773|NCT02326220|76148442|FG000|Double-blind Treatment Period|Protocol Violation|0|||
42312774|NCT02326220|76148443|FG001|Double-blind Treatment Period|Protocol Violation|1|||
42254861|NCT01915498|76081297|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
42254862|NCT01915498|76081298|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
42254863|NCT01915498|76081299|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
42254864|NCT01915498|76081300|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
42254865|NCT01915498|76081301|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
42254866|NCT01915498|76081302|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
42254867|NCT01915498|76081303|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
42254868|NCT01915498|76081304|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
42254869|NCT01915498|76081305|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
42254870|NCT01915498|76081306|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
42254871|NCT01915498|76081307|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
42254872|NCT01915498|76081308|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
42254873|NCT01915498|76081309|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
42254874|NCT01915498|76081310|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
42254875|NCT01915498|76081311|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
42254876|NCT01915498|76081312|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
42254877|NCT01915498|76081294|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254878|NCT01915498|76081295|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254879|NCT01915498|76081296|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42312775|NCT02326220|76148444|FG002|Double-blind Treatment Period|Protocol Violation|0|||
42312776|NCT02326220|76148442|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
42010561|NCT00993421|75817698|FG004|Overall Study|Sponsor Decision|38|||
42312777|NCT02326220|76148443|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
42312778|NCT02326220|76148444|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
42312779|NCT02326220|76148442|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
42312780|NCT02326220|76148443|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
42312781|NCT02326220|76148444|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
42312782|NCT02326220|76148442|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
42312783|NCT02326220|76148443|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
42312784|NCT02326220|76148444|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
42312785|NCT02279173|76148454|FG000|Overall Study|Protocol-specified Criteria|67|||
42312786|NCT02279173|76148454|FG000|Overall Study|Withdrawal by Subject|20|||
42312787|NCT02279173|76148454|FG000|Overall Study|Decision by Sponsor|4|||
42312788|NCT02279173|76148454|FG000|Overall Study|Lost to Follow-up|3|||
42312789|NCT02282917|76148460|FG000|Overall Study|Withdrawal by Subject|1|||
42312790|NCT02282917|76148460|FG000|Overall Study|Screen Failure/Not Eligible|1|||
42312791|NCT02358668|76148467|FG000|Overall Study|Adverse Event|2|||
42312792|NCT02358668|76148468|FG001|Overall Study|Adverse Event|0|||
42312793|NCT02358668|76148469|FG002|Overall Study|Adverse Event|0|||
42312794|NCT02358668|76148467|FG000|Overall Study|Withdrawal by Subject|0|||
42312795|NCT02358668|76148468|FG001|Overall Study|Withdrawal by Subject|1|||
42312796|NCT02358668|76148469|FG002|Overall Study|Withdrawal by Subject|0|||
42312797|NCT02282605|76148480|FG000|Overall Study|negative SA result on Day -1|3|||
42312798|NCT02282605|76148481|FG001|Overall Study|negative SA result on Day -1|0|||
42312799|NCT02282605|76148482|FG002|Overall Study|negative SA result on Day -1|0|||
42312800|NCT02282527|76148492|FG000|Overall Study|Lost to Follow-up|0|||
42312801|NCT02282527|76148493|FG001|Overall Study|Lost to Follow-up|1|||
42312802|NCT02282527|76148492|FG000|Overall Study|Lack of home health aid|1|||
42312803|NCT02282527|76148493|FG001|Overall Study|Lack of home health aid|0|||
42312804|NCT02278939|76148504|FG000|Overall Study|lack of time|1|||
42312805|NCT02278939|76148505|FG001|Overall Study|lack of time|0|||
42312806|NCT02278939|76148504|FG000|Overall Study|Lost to Follow-up|1|||
42312807|NCT02278939|76148505|FG001|Overall Study|Lost to Follow-up|1|||
42312808|NCT02278939|76148504|FG000|Overall Study|death in family|1|||
42312809|NCT02278939|76148505|FG001|Overall Study|death in family|0|||
42312810|NCT02278939|76148504|FG000|Overall Study|family emergency unable to commit|2|||
42312811|NCT02278939|76148505|FG001|Overall Study|family emergency unable to commit|0|||
42312812|NCT02278471|76148513|FG000|Overall Study|Lost to Follow-up|6|||
42312813|NCT02278471|76148514|FG001|Overall Study|Lost to Follow-up|15|||
42312814|NCT02278471|76148513|FG000|Overall Study|Death|2|||
42312815|NCT02278471|76148514|FG001|Overall Study|Death|2|||
42312816|NCT02278471|76148513|FG000|Overall Study|Withdrawal by Subject|0|||
42312817|NCT02278471|76148514|FG001|Overall Study|Withdrawal by Subject|3|||
42312818|NCT02278003|76148523|FG000|Overall Study|Withdrawal by Subject|11|||
42312819|NCT02278003|76148524|FG001|Overall Study|Withdrawal by Subject|0|||
42312820|NCT02278003|76148523|FG000|Overall Study|Not Treated|1|||
42312821|NCT02278003|76148524|FG001|Overall Study|Not Treated|0|||
42312822|NCT02278003|76148523|FG000|Overall Study|Recognition task improperly completed|7|||
42312823|NCT02278003|76148524|FG001|Overall Study|Recognition task improperly completed|0|||
42312824|NCT02277769|76148533|FG000|Overall Study|Protocol Violation|3|||
42312825|NCT02277769|76148534|FG001|Overall Study|Protocol Violation|3|||
42312826|NCT02277769|76148535|FG002|Overall Study|Protocol Violation|5|||
42312827|NCT02277769|76148533|FG000|Overall Study|Lack of Efficacy|17|||
42312828|NCT02277769|76148534|FG001|Overall Study|Lack of Efficacy|0|||
42312829|NCT02277769|76148535|FG002|Overall Study|Lack of Efficacy|4|||
42312830|NCT02277769|76148533|FG000|Overall Study|Adverse Event|14|||
42312831|NCT02277769|76148534|FG001|Overall Study|Adverse Event|2|||
42312832|NCT02277769|76148535|FG002|Overall Study|Adverse Event|4|||
42312833|NCT02277769|76148533|FG000|Overall Study|Other than specified above|12|||
42312834|NCT02277769|76148534|FG001|Overall Study|Other than specified above|8|||
42312835|NCT02277769|76148535|FG002|Overall Study|Other than specified above|5|||
42312836|NCT01641991|76148547|FG000|Overall Study|Physician Decision|0|||
42312837|NCT01641991|76148548|FG001|Overall Study|Physician Decision|1|||
42312838|NCT01641991|76148549|FG002|Overall Study|Physician Decision|7|||
42312839|NCT01641991|76148550|FG003|Overall Study|Physician Decision|5|||
42312840|NCT01641991|76148547|FG000|Overall Study|Withdrawal by Subject|4|||
42312841|NCT01641991|76148548|FG001|Overall Study|Withdrawal by Subject|2|||
42312842|NCT01641991|76148549|FG002|Overall Study|Withdrawal by Subject|1|||
42312843|NCT01641991|76148550|FG003|Overall Study|Withdrawal by Subject|5|||
42312844|NCT01641991|76148547|FG000|Overall Study|Adverse Event|2|||
42312845|NCT01641991|76148548|FG001|Overall Study|Adverse Event|1|||
42312846|NCT01641991|76148549|FG002|Overall Study|Adverse Event|2|||
42312847|NCT01641991|76148550|FG003|Overall Study|Adverse Event|1|||
42312848|NCT01641991|76148547|FG000|Overall Study|Lost to Follow-up|0|||
42312849|NCT01641991|76148548|FG001|Overall Study|Lost to Follow-up|2|||
42312850|NCT01641991|76148549|FG002|Overall Study|Lost to Follow-up|3|||
42312851|NCT01641991|76148550|FG003|Overall Study|Lost to Follow-up|1|||
42312852|NCT01641991|76148547|FG000|Overall Study|Protocol Violation|1|||
42312853|NCT01641991|76148548|FG001|Overall Study|Protocol Violation|1|||
42312854|NCT01641991|76148549|FG002|Overall Study|Protocol Violation|3|||
42312855|NCT01641991|76148550|FG003|Overall Study|Protocol Violation|0|||
42312856|NCT01641991|76148547|FG000|Overall Study|Pregnancy|0|||
42312857|NCT01641991|76148548|FG001|Overall Study|Pregnancy|0|||
42312858|NCT01641991|76148549|FG002|Overall Study|Pregnancy|1|||
42312859|NCT01641991|76148550|FG003|Overall Study|Pregnancy|0|||
42312860|NCT01641991|76148547|FG000|Overall Study|no longer eligible|2|||
42312861|NCT01641991|76148548|FG001|Overall Study|no longer eligible|1|||
42312862|NCT01641991|76148549|FG002|Overall Study|no longer eligible|0|||
42312863|NCT01641991|76148550|FG003|Overall Study|no longer eligible|4|||
42312864|NCT02277691|76148563|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
42312865|NCT02277691|76148563|FG000|Overall Study|Voluntary Withdrawal|7|||
42312866|NCT02277691|76148563|FG000|Overall Study|Lack of Efficacy|5|||
42312867|NCT02277691|76148563|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
42312868|NCT02395172|76148569|FG000|Overall Study|Participants randomized but not treated|3|||
42312869|NCT02395172|76148570|FG001|Overall Study|Participants randomized but not treated|31|||
42312870|NCT02276053|76148576|FG000|Overall Study|Death|2|||
42312871|NCT02276053|76148576|FG000|Overall Study|Adverse Event|5|||
42312872|NCT02276053|76148576|FG000|Overall Study|Lack of Efficacy|2|||
42312873|NCT02276053|76148576|FG000|Overall Study|Withdrawal by Subject|1|||
42312874|NCT02276053|76148576|FG000|Overall Study|Patient does not meet selection criteria|3|||
42312875|NCT02276053|76148576|FG000|Overall Study|Patient needs to increase baseline AED|1|||
42312876|NCT02275819|76148583|FG000|Overall Study|Adverse Event|0|||
42312877|NCT02275819|76148584|FG001|Overall Study|Adverse Event|1|||
42312878|NCT02358044|76148592|FG000|Overall Study|Adverse Event|0|||
42312879|NCT02358044|76148593|FG001|Overall Study|Adverse Event|1|||
41992637|NCT01156012|75800791|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
41992638|NCT01156012|75800792|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
41992639|NCT01155661|75800798|FG000|Overall Study|Adverse Event|101|||
41992640|NCT01155661|75800798|FG000|Overall Study|Death|1|||
41992641|NCT01155661|75800798|FG000|Overall Study|Lack of Efficacy|32|||
42254880|NCT01915498|76081297|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254881|NCT01915498|76081298|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254882|NCT01915498|76081299|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254883|NCT01915498|76081300|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254884|NCT01915498|76081301|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254885|NCT01915498|76081302|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254886|NCT01915498|76081303|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254887|NCT01915498|76081304|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
42254888|NCT01915498|76081305|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254889|NCT01915498|76081306|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254890|NCT01915498|76081307|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254891|NCT01915498|76081308|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254892|NCT01915498|76081309|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254893|NCT01915498|76081310|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254894|NCT01915498|76081311|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254895|NCT01915498|76081312|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
42254896|NCT01915498|76081294|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
42254897|NCT01915498|76081295|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
42254898|NCT01915498|76081296|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
42254899|NCT01915498|76081297|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
42254900|NCT01915498|76081298|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
42254901|NCT01915498|76081299|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
42254902|NCT01915498|76081300|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
42254903|NCT01915498|76081301|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
42254904|NCT01915498|76081302|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
42254905|NCT01915498|76081303|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
42254906|NCT01915498|76081304|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
42254907|NCT01915498|76081305|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
42254908|NCT01915498|76081306|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
42254909|NCT01915498|76081307|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
42254910|NCT01915498|76081308|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
42254911|NCT01915498|76081309|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
42312880|NCT02358044|76148592|FG000|Overall Study|Lost to Follow-up|2|||
42312881|NCT02358044|76148593|FG001|Overall Study|Lost to Follow-up|1|||
42312882|NCT02358044|76148592|FG000|Overall Study|Physician Decision|0|||
42254912|NCT01915498|76081310|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
42254913|NCT01915498|76081311|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
42312883|NCT02358044|76148593|FG001|Overall Study|Physician Decision|1|||
42312884|NCT02358044|76148592|FG000|Overall Study|Withdrawal by Subject|0|||
41992642|NCT01155661|75800798|FG000|Overall Study|Lost to Follow-up|22|||
42312885|NCT02358044|76148593|FG001|Overall Study|Withdrawal by Subject|4|||
42312886|NCT02275117|76148604|FG000|Overall Study|Adverse Event|0|||
42312887|NCT02275117|76148605|FG001|Overall Study|Adverse Event|0|||
42312888|NCT02275117|76148606|FG002|Overall Study|Adverse Event|0|||
42312889|NCT02275117|76148607|FG003|Overall Study|Adverse Event|0|||
42312890|NCT02275117|76148608|FG004|Overall Study|Adverse Event|1|||
42312891|NCT02275117|76148604|FG000|Overall Study|Lack of Efficacy|6|||
42312892|NCT02275117|76148605|FG001|Overall Study|Lack of Efficacy|7|||
42312893|NCT02275117|76148606|FG002|Overall Study|Lack of Efficacy|5|||
42312894|NCT02275117|76148607|FG003|Overall Study|Lack of Efficacy|2|||
42312895|NCT02275117|76148608|FG004|Overall Study|Lack of Efficacy|10|||
42312896|NCT02275117|76148604|FG000|Overall Study|Lost to Follow-up|11|||
42312897|NCT02275117|76148605|FG001|Overall Study|Lost to Follow-up|16|||
42312898|NCT02275117|76148606|FG002|Overall Study|Lost to Follow-up|15|||
42312899|NCT02275117|76148607|FG003|Overall Study|Lost to Follow-up|16|||
42312900|NCT02275117|76148608|FG004|Overall Study|Lost to Follow-up|8|||
42312901|NCT02275117|76148604|FG000|Overall Study|Physician Decision|0|||
42312902|NCT02275117|76148605|FG001|Overall Study|Physician Decision|1|||
42312903|NCT02275117|76148606|FG002|Overall Study|Physician Decision|1|||
42312904|NCT02275117|76148607|FG003|Overall Study|Physician Decision|0|||
42312905|NCT02275117|76148608|FG004|Overall Study|Physician Decision|1|||
42312906|NCT02275117|76148604|FG000|Overall Study|Protocol Violation|1|||
42312907|NCT02275117|76148605|FG001|Overall Study|Protocol Violation|0|||
42312908|NCT02275117|76148606|FG002|Overall Study|Protocol Violation|1|||
42312909|NCT02275117|76148607|FG003|Overall Study|Protocol Violation|1|||
42312910|NCT02275117|76148608|FG004|Overall Study|Protocol Violation|0|||
42312911|NCT02275117|76148604|FG000|Overall Study|Withdrawal by Subject|6|||
42312912|NCT02275117|76148605|FG001|Overall Study|Withdrawal by Subject|4|||
42312913|NCT02275117|76148606|FG002|Overall Study|Withdrawal by Subject|7|||
42312914|NCT02275117|76148607|FG003|Overall Study|Withdrawal by Subject|3|||
42312915|NCT02275117|76148608|FG004|Overall Study|Withdrawal by Subject|3|||
42312916|NCT02275117|76148604|FG000|Overall Study|Terminated by Sponsor|4|||
42312917|NCT02275117|76148605|FG001|Overall Study|Terminated by Sponsor|4|||
42312918|NCT02275117|76148606|FG002|Overall Study|Terminated by Sponsor|4|||
42312919|NCT02275117|76148607|FG003|Overall Study|Terminated by Sponsor|6|||
42312920|NCT02275117|76148608|FG004|Overall Study|Terminated by Sponsor|4|||
42312921|NCT02275117|76148604|FG000|Overall Study|Worsening of Study Indication|0|||
42312922|NCT02275117|76148605|FG001|Overall Study|Worsening of Study Indication|1|||
42312923|NCT02275117|76148606|FG002|Overall Study|Worsening of Study Indication|2|||
42312924|NCT02275117|76148607|FG003|Overall Study|Worsening of Study Indication|0|||
42312925|NCT02275117|76148608|FG004|Overall Study|Worsening of Study Indication|0|||
42312926|NCT02275117|76148604|FG000|Overall Study|Study Burden|5|||
42312927|NCT02275117|76148605|FG001|Overall Study|Study Burden|4|||
42312928|NCT02275117|76148606|FG002|Overall Study|Study Burden|7|||
42312929|NCT02275117|76148607|FG003|Overall Study|Study Burden|5|||
42312930|NCT02275117|76148608|FG004|Overall Study|Study Burden|7|||
42312931|NCT02275117|76148604|FG000|Overall Study|Other|1|||
42312932|NCT02275117|76148605|FG001|Overall Study|Other|0|||
42312933|NCT02275117|76148606|FG002|Overall Study|Other|0|||
42312934|NCT02275117|76148607|FG003|Overall Study|Other|0|||
41992643|NCT01155661|75800798|FG000|Overall Study|Physician Decision|3|||
42312935|NCT02275117|76148608|FG004|Overall Study|Other|2|||
42312936|NCT02274493|76148620|FG000|Overall Study|Withdrawal by Subject|1|||
42312937|NCT02273167|76148627|FG000|Overall Study|Adverse Event|1|||
42312938|NCT02273167|76148628|FG001|Overall Study|Adverse Event|0|||
42312939|NCT02273167|76148629|FG002|Overall Study|Adverse Event|0|||
42312940|NCT02273167|76148627|FG000|Overall Study|Protocol Violation|3|||
42312941|NCT02273167|76148628|FG001|Overall Study|Protocol Violation|1|||
42312942|NCT02273167|76148629|FG002|Overall Study|Protocol Violation|1|||
42312943|NCT02273167|76148627|FG000|Overall Study|Lost to Follow-up|0|||
42312944|NCT02273167|76148628|FG001|Overall Study|Lost to Follow-up|1|||
42312945|NCT02273167|76148629|FG002|Overall Study|Lost to Follow-up|1|||
42312946|NCT02273167|76148627|FG000|Overall Study|Withdrawal by Subject|10|||
42312947|NCT02273167|76148628|FG001|Overall Study|Withdrawal by Subject|12|||
42312948|NCT02273167|76148629|FG002|Overall Study|Withdrawal by Subject|11|||
42312949|NCT02273167|76148627|FG000|Overall Study|Various|10|||
42312950|NCT02273167|76148628|FG001|Overall Study|Various|9|||
42312951|NCT02273167|76148629|FG002|Overall Study|Various|8|||
42312952|NCT02272777|76148640|FG000|Overall Study|Adverse Event|0|||
42312953|NCT02272777|76148641|FG001|Overall Study|Adverse Event|1|||
42312954|NCT02272777|76148640|FG000|Overall Study|Withdrawal by Subject|0|||
42312955|NCT02272777|76148641|FG001|Overall Study|Withdrawal by Subject|3|||
42312956|NCT02272777|76148640|FG000|Overall Study|Lost to Follow-up|2|||
42312957|NCT02272777|76148641|FG001|Overall Study|Lost to Follow-up|0|||
42312958|NCT02272777|76148640|FG000|Overall Study|Other|2|||
42312959|NCT02272777|76148641|FG001|Overall Study|Other|0|||
42312960|NCT02357810|76148647|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
42312961|NCT02357810|76148647|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
42312962|NCT02357810|76148647|FG000|Reached 12 Weeks Response|Adverse Event|5|||
42312963|NCT02357810|76148647|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
42312964|NCT02357810|76148647|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
42312965|NCT02357810|76148647|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
42312966|NCT02357810|76148647|FG000|Reached 12 Weeks Response|Death|1|||
42312967|NCT02357810|76148647|FG000|Reached 12 Weeks Response|Physician Decision|1|||
42312968|NCT02357810|76148647|FG000|Reached 12 Weeks Response|Other|1|||
42312969|NCT02357810|76148647|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
42312970|NCT02357810|76148647|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
42312971|NCT02357810|76148647|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
42312972|NCT02357810|76148647|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
42312973|NCT02357810|76148647|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
42312974|NCT02357810|76148647|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
42312975|NCT02357576|76148653|FG000|Treatment Period|Withdrawal by Subject|0|||
42312976|NCT02357576|76148654|FG001|Treatment Period|Withdrawal by Subject|1|||
42312977|NCT02357576|76148653|FG000|Treatment Period|Physician Decision|0|||
42312978|NCT02357576|76148654|FG001|Treatment Period|Physician Decision|1|||
42312979|NCT02357576|76148653|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
42312980|NCT02357576|76148654|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
42312981|NCT02357576|76148653|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
42312982|NCT02357576|76148654|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
42033411|NCT01128413|75841653|FG001|Overall Study|Withdrawal by Subject|0|||
42254914|NCT01915498|76081312|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
42254915|NCT01915498|76081294|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254916|NCT01915498|76081295|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254917|NCT01915498|76081296|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254918|NCT01915498|76081297|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254919|NCT01915498|76081298|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
42254920|NCT01915498|76081299|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254921|NCT01915498|76081300|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254922|NCT01915498|76081301|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254923|NCT01915498|76081302|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254924|NCT01915498|76081303|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
42254925|NCT01915498|76081304|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254926|NCT01915498|76081305|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254927|NCT01915498|76081306|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254928|NCT01915498|76081307|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42312983|NCT02357576|76148653|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
42312984|NCT02357576|76148654|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
42312985|NCT02357576|76148653|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
42312986|NCT02357576|76148654|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
42312987|NCT01850446|76148662|FG000|Overall Study|Lack of Efficacy|1|||
42312988|NCT01850446|76148663|FG001|Overall Study|Lack of Efficacy|0|||
42312989|NCT01850446|76148662|FG000|Overall Study|Withdrawal by Subject|4|||
42312990|NCT01850446|76148663|FG001|Overall Study|Withdrawal by Subject|0|||
42312991|NCT01850446|76148662|FG000|Overall Study|Protocol Violation|0|||
42312992|NCT01850446|76148663|FG001|Overall Study|Protocol Violation|2|||
42312993|NCT02465567|76148673|FG000|Overall Study|Adverse Event|118|||
42312994|NCT02465567|76148674|FG001|Overall Study|Adverse Event|113|||
42312995|NCT02465567|76148675|FG002|Overall Study|Adverse Event|147|||
42312996|NCT02465567|76148676|FG003|Overall Study|Adverse Event|138|||
42312997|NCT02465567|76148673|FG000|Overall Study|Lack of Efficacy|103|||
42312998|NCT02465567|76148674|FG001|Overall Study|Lack of Efficacy|102|||
42312999|NCT02465567|76148675|FG002|Overall Study|Lack of Efficacy|171|||
42313000|NCT02465567|76148676|FG003|Overall Study|Lack of Efficacy|135|||
42313001|NCT02465567|76148673|FG000|Overall Study|Withdrawal by Subject|104|||
42313002|NCT02465567|76148674|FG001|Overall Study|Withdrawal by Subject|94|||
42313003|NCT02465567|76148675|FG002|Overall Study|Withdrawal by Subject|123|||
42313004|NCT02465567|76148676|FG003|Overall Study|Withdrawal by Subject|130|||
42313005|NCT02465567|76148673|FG000|Overall Study|Physician Decision|23|||
42313006|NCT02465567|76148674|FG001|Overall Study|Physician Decision|33|||
42313007|NCT02465567|76148675|FG002|Overall Study|Physician Decision|38|||
42313008|NCT02465567|76148676|FG003|Overall Study|Physician Decision|28|||
42313009|NCT02465567|76148673|FG000|Overall Study|Major Protocol Deviation|24|||
42313010|NCT02465567|76148674|FG001|Overall Study|Major Protocol Deviation|26|||
42313011|NCT02465567|76148675|FG002|Overall Study|Major Protocol Deviation|22|||
42313012|NCT02465567|76148676|FG003|Overall Study|Major Protocol Deviation|25|||
42313013|NCT02465567|76148673|FG000|Overall Study|Lost to Follow-up|25|||
42313014|NCT02465567|76148674|FG001|Overall Study|Lost to Follow-up|21|||
42313015|NCT02465567|76148675|FG002|Overall Study|Lost to Follow-up|19|||
42313016|NCT02465567|76148676|FG003|Overall Study|Lost to Follow-up|15|||
42313017|NCT02465567|76148673|FG000|Overall Study|Protocol Specified Criteria|20|||
42313018|NCT02465567|76148674|FG001|Overall Study|Protocol Specified Criteria|10|||
42313019|NCT02465567|76148675|FG002|Overall Study|Protocol Specified Criteria|9|||
42313020|NCT02465567|76148676|FG003|Overall Study|Protocol Specified Criteria|12|||
42313021|NCT02465567|76148673|FG000|Overall Study|Administrative Reasons|12|||
42313022|NCT02465567|76148674|FG001|Overall Study|Administrative Reasons|9|||
42313023|NCT02465567|76148675|FG002|Overall Study|Administrative Reasons|11|||
42313024|NCT02465567|76148676|FG003|Overall Study|Administrative Reasons|5|||
42313025|NCT02465567|76148673|FG000|Overall Study|Randomized but not treated|1|||
42313026|NCT02465567|76148674|FG001|Overall Study|Randomized but not treated|5|||
42313027|NCT02465567|76148675|FG002|Overall Study|Randomized but not treated|4|||
42313028|NCT02465567|76148676|FG003|Overall Study|Randomized but not treated|5|||
42313029|NCT02465567|76148673|FG000|Overall Study|enrolled in >1 studies|18|||
42313030|NCT02465567|76148674|FG001|Overall Study|enrolled in >1 studies|11|||
42313031|NCT02465567|76148675|FG002|Overall Study|enrolled in >1 studies|19|||
42313032|NCT02465567|76148676|FG003|Overall Study|enrolled in >1 studies|15|||
42313033|NCT02465567|76148673|FG000|Overall Study|missing PI Signature|1|||
42313034|NCT02465567|76148674|FG001|Overall Study|missing PI Signature|0|||
42313035|NCT02465567|76148675|FG002|Overall Study|missing PI Signature|0|||
42313036|NCT02465567|76148676|FG003|Overall Study|missing PI Signature|0|||
42313037|NCT01644175|76148688|FG000|Overall Study|Randomized But Not Treated|0|||
42313038|NCT01644175|76148689|FG001|Overall Study|Randomized But Not Treated|2|||
42313039|NCT01644175|76148688|FG000|Overall Study|Adverse Event|8|||
42313040|NCT01644175|76148689|FG001|Overall Study|Adverse Event|13|||
42313041|NCT01644175|76148688|FG000|Overall Study|Death|1|||
42313042|NCT01644175|76148689|FG001|Overall Study|Death|2|||
42313043|NCT01644175|76148688|FG000|Overall Study|Poor compliance to protocol|9|||
42313044|NCT01644175|76148689|FG001|Overall Study|Poor compliance to protocol|10|||
42254929|NCT01915498|76081308|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254930|NCT01915498|76081309|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254931|NCT01915498|76081310|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254932|NCT01915498|76081311|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254933|NCT01915498|76081312|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
42254934|NCT01915498|76081294|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
42254935|NCT01915498|76081295|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
42254936|NCT01915498|76081296|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
42254937|NCT01915498|76081297|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
42313045|NCT01644175|76148688|FG000|Overall Study|Physician Decision|1|||
42313046|NCT01644175|76148689|FG001|Overall Study|Physician Decision|2|||
42313047|NCT01644175|76148688|FG000|Overall Study|Participant Moved|1|||
42313048|NCT01644175|76148689|FG001|Overall Study|Participant Moved|2|||
42313049|NCT01644175|76148688|FG000|Overall Study|Consent withdrawn by participant|3|||
42313050|NCT01644175|76148689|FG001|Overall Study|Consent withdrawn by participant|4|||
42254938|NCT01915498|76081298|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
42313051|NCT01644175|76148688|FG000|Overall Study|Related to Autoinjector Administration|2|||
42313052|NCT01644175|76148689|FG001|Overall Study|Related to Autoinjector Administration|1|||
42313053|NCT01644175|76148688|FG000|Overall Study|Last visit outside protocol visit window|4|||
42313054|NCT01644175|76148689|FG001|Overall Study|Last visit outside protocol visit window|11|||
42313055|NCT01644175|76148688|FG000|Overall Study|Selection criteria finally not met|0|||
42313056|NCT01644175|76148689|FG001|Overall Study|Selection criteria finally not met|1|||
42313057|NCT01644175|76148688|FG000|Overall Study|Site closure|2|||
42313058|NCT01644175|76148689|FG001|Overall Study|Site closure|2|||
42313059|NCT01644175|76148688|FG000|Overall Study|Lost to Follow-up|1|||
42313060|NCT01644175|76148689|FG001|Overall Study|Lost to Follow-up|0|||
42313061|NCT01644175|76148688|FG000|Overall Study|Other than specified above|0|||
42313062|NCT01644175|76148689|FG001|Overall Study|Other than specified above|3|||
42313063|NCT02357420|76148699|FG000|Overall Study|Adverse Event|3|||
42313064|NCT02357420|76148700|FG001|Overall Study|Adverse Event|3|||
42313065|NCT02357420|76148701|FG002|Overall Study|Adverse Event|8|||
42313066|NCT02357420|76148702|FG003|Overall Study|Adverse Event|9|||
42313067|NCT02357420|76148699|FG000|Overall Study|Investigator Decision|1|||
42313068|NCT02357420|76148700|FG001|Overall Study|Investigator Decision|0|||
42313069|NCT02357420|76148701|FG002|Overall Study|Investigator Decision|0|||
42313070|NCT02357420|76148702|FG003|Overall Study|Investigator Decision|0|||
42313071|NCT02357420|76148699|FG000|Overall Study|Prohibited Medication|1|||
42313072|NCT02357420|76148700|FG001|Overall Study|Prohibited Medication|1|||
42313073|NCT02357420|76148701|FG002|Overall Study|Prohibited Medication|0|||
42313074|NCT02357420|76148702|FG003|Overall Study|Prohibited Medication|0|||
42313075|NCT02357420|76148699|FG000|Overall Study|Protocol Non-compliance|0|||
42313076|NCT02357420|76148700|FG001|Overall Study|Protocol Non-compliance|0|||
42313077|NCT02357420|76148701|FG002|Overall Study|Protocol Non-compliance|0|||
42313078|NCT02357420|76148702|FG003|Overall Study|Protocol Non-compliance|1|||
42313079|NCT02357420|76148699|FG000|Overall Study|Withdrawn Consent|4|||
42313080|NCT02357420|76148700|FG001|Overall Study|Withdrawn Consent|8|||
42313081|NCT02357420|76148701|FG002|Overall Study|Withdrawn Consent|6|||
42313082|NCT02357420|76148702|FG003|Overall Study|Withdrawn Consent|6|||
42313083|NCT02357420|76148699|FG000|Overall Study|Lost to Follow-up|3|||
42313084|NCT02357420|76148700|FG001|Overall Study|Lost to Follow-up|0|||
42313085|NCT02357420|76148701|FG002|Overall Study|Lost to Follow-up|2|||
42313086|NCT02357420|76148702|FG003|Overall Study|Lost to Follow-up|3|||
42313087|NCT01832038|76148712|FG000|Overall Study|Death|5|||
42313088|NCT01832038|76148712|FG000|Overall Study|Adverse Event|50|||
42313089|NCT01832038|76148712|FG000|Overall Study|Lack of Efficacy|81|||
42313090|NCT01832038|76148712|FG000|Overall Study|Protocol Violation|7|||
42313091|NCT01832038|76148712|FG000|Overall Study|Lost to Follow-up|10|||
42313092|NCT01832038|76148712|FG000|Overall Study|Withdrawal by Subject|49|||
42313093|NCT01832038|76148712|FG000|Overall Study|Visit non-compliance|2|||
42313094|NCT01832038|76148712|FG000|Overall Study|Subject refused to return visit|2|||
42313095|NCT01832038|76148712|FG000|Overall Study|Not convenient to come back to site|2|||
42313096|NCT01832038|76148712|FG000|Overall Study|Participant was asked to quit|5|||
42313097|NCT01832038|76148712|FG000|Overall Study|Back home|1|||
42254939|NCT01915498|76081299|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
42254940|NCT01915498|76081300|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
42254941|NCT01915498|76081301|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
42254942|NCT01915498|76081302|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
42254943|NCT01915498|76081303|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
42254944|NCT01915498|76081304|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
42254945|NCT01915498|76081305|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
42254946|NCT01915498|76081306|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
42254947|NCT01915498|76081307|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
42254948|NCT01915498|76081308|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
42254949|NCT01915498|76081309|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
42254950|NCT01915498|76081310|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
42254951|NCT01915498|76081311|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
42254952|NCT01915498|76081312|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
42254953|NCT01915498|76081294|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
42254954|NCT01915498|76081295|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
42254955|NCT01915498|76081296|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
42254956|NCT01915498|76081297|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
42254957|NCT01915498|76081298|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
42254958|NCT01915498|76081299|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
42254959|NCT01915498|76081300|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
42313098|NCT01832038|76148712|FG000|Overall Study|Pregnancy|1|||
42313099|NCT01832038|76148712|FG000|Overall Study|Low compliance|3|||
42313100|NCT01832038|76148712|FG000|Overall Study|Prohibit procedure|2|||
42313101|NCT01832038|76148712|FG000|Overall Study|Not possible to visit the hospital|1|||
42313102|NCT01832038|76148712|FG000|Overall Study|Changes of implementation system|3|||
42313103|NCT01832038|76148712|FG000|Overall Study|Plan to pregnancy|7|||
42313104|NCT01832038|76148712|FG000|Overall Study|Bad mood and has suicidal thought|1|||
42313105|NCT01832038|76148712|FG000|Overall Study|Prohibited concomitant medication|1|||
42313106|NCT01832038|76148712|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
42313107|NCT01832038|76148712|FG000|Overall Study|Subject considered the efficacy was poor|1|||
42313108|NCT01849588|76148717|FG000|Overall Study|Lack of Efficacy|3|||
42313109|NCT02357342|76148723|FG000|First 6 Months|Death|2|||
41992644|NCT01155661|75800798|FG000|Overall Study|Protocol Violation|35|||
42254960|NCT01915498|76081301|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
42254961|NCT01915498|76081302|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
42254962|NCT01915498|76081303|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
42254963|NCT01915498|76081304|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
42254964|NCT01915498|76081305|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
42254965|NCT01915498|76081306|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
42313110|NCT02357342|76148724|FG001|First 6 Months|Death|0|||
42313111|NCT02271529|76148730|FG000|Overall Study|Withdrawal by Subject|1|||
42313112|NCT02325518|76148736|FG000|Overall Study|Adverse Event|4|||
42313113|NCT02325518|76148737|FG001|Overall Study|Adverse Event|1|||
42313114|NCT02325518|76148736|FG000|Overall Study|Physician Decision|0|||
42313115|NCT02325518|76148737|FG001|Overall Study|Physician Decision|1|||
42313116|NCT02325518|76148736|FG000|Overall Study|Withdrawal by Subject|0|||
42313117|NCT02325518|76148737|FG001|Overall Study|Withdrawal by Subject|1|||
42313118|NCT02270983|76148747|FG000|Overall Study|Adverse Event|3|||
42313119|NCT02270983|76148748|FG001|Overall Study|Adverse Event|2|||
42313120|NCT02270983|76148749|FG002|Overall Study|Adverse Event|6|||
42313121|NCT02270983|76148747|FG000|Overall Study|Lack of Efficacy|2|||
42313122|NCT02270983|76148748|FG001|Overall Study|Lack of Efficacy|1|||
42313123|NCT02270983|76148749|FG002|Overall Study|Lack of Efficacy|1|||
42313124|NCT02270983|76148747|FG000|Overall Study|Withdrawal by Subject|1|||
42313125|NCT02270983|76148748|FG001|Overall Study|Withdrawal by Subject|0|||
42313126|NCT02270983|76148749|FG002|Overall Study|Withdrawal by Subject|2|||
42313127|NCT02270983|76148747|FG000|Overall Study|Lost to Follow-up|1|||
42313128|NCT02270983|76148748|FG001|Overall Study|Lost to Follow-up|1|||
42313129|NCT02270983|76148749|FG002|Overall Study|Lost to Follow-up|2|||
42313130|NCT02270983|76148747|FG000|Overall Study|Protocol Violation|1|||
42313131|NCT02270983|76148748|FG001|Overall Study|Protocol Violation|1|||
42313132|NCT02270983|76148749|FG002|Overall Study|Protocol Violation|1|||
42313133|NCT02270983|76148747|FG000|Overall Study|family emergency|0|||
42313134|NCT02270983|76148748|FG001|Overall Study|family emergency|1|||
42313135|NCT02270983|76148749|FG002|Overall Study|family emergency|0|||
42313136|NCT02270983|76148747|FG000|Overall Study|study procedure non-compliance|1|||
42313137|NCT02270983|76148748|FG001|Overall Study|study procedure non-compliance|0|||
42313138|NCT02270983|76148749|FG002|Overall Study|study procedure non-compliance|0|||
42313139|NCT02270983|76148747|FG000|Overall Study|moved away from study site|0|||
42313140|NCT02270983|76148748|FG001|Overall Study|moved away from study site|1|||
42313141|NCT02270983|76148749|FG002|Overall Study|moved away from study site|0|||
42313142|NCT02449889|76148760|FG000|Overall Study|Adverse Event|1|||
42313143|NCT02449889|76148761|FG001|Overall Study|Adverse Event|2|||
42313144|NCT02449889|76148762|FG002|Overall Study|Adverse Event|0|||
41992645|NCT01155661|75800798|FG000|Overall Study|Withdrawal by Subject|73|||
41992646|NCT01155661|75800798|FG000|Overall Study|Sponsor Decision|13|||
41992647|NCT01155583|75800813|FG000|Phase I|Screen failure - did not start treatment|0|||
41992648|NCT01155583|75800814|FG001|Phase I|Screen failure - did not start treatment|0|||
41992649|NCT01155583|75800815|FG002|Phase I|Screen failure - did not start treatment|0|||
41992650|NCT01155583|75800816|FG003|Phase I|Screen failure - did not start treatment|0|||
41992651|NCT01155583|75800817|FG004|Phase I|Screen failure - did not start treatment|1|||
41992652|NCT01155583|75800818|FG005|Phase I|Screen failure - did not start treatment|0|||
41992653|NCT01155583|75800819|FG006|Phase I|Screen failure - did not start treatment|0|||
41992654|NCT01155583|75800820|FG007|Phase I|Screen failure - did not start treatment|2|||
41992655|NCT01155583|75800821|FG008|Phase I|Screen failure - did not start treatment|0|||
41992656|NCT01155583|75800813|FG000|Phase I|Withdrawal by Subject|0|||
41992657|NCT01155583|75800814|FG001|Phase I|Withdrawal by Subject|0|||
41992658|NCT01155583|75800815|FG002|Phase I|Withdrawal by Subject|0|||
41992659|NCT01155583|75800816|FG003|Phase I|Withdrawal by Subject|0|||
41992660|NCT01155583|75800817|FG004|Phase I|Withdrawal by Subject|0|||
41992661|NCT01155583|75800818|FG005|Phase I|Withdrawal by Subject|0|||
41992662|NCT01155583|75800819|FG006|Phase I|Withdrawal by Subject|0|||
41992663|NCT01155583|75800820|FG007|Phase I|Withdrawal by Subject|1|||
41992664|NCT01155583|75800821|FG008|Phase I|Withdrawal by Subject|0|||
41992665|NCT01155466|75800842|FG000|Overall Study|Adverse Event|13|||
41992666|NCT01155466|75800843|FG001|Overall Study|Adverse Event|15|||
41992667|NCT01155466|75800844|FG002|Overall Study|Adverse Event|6|||
41992668|NCT01155466|75800845|FG003|Overall Study|Adverse Event|17|||
41992669|NCT01155466|75800846|FG004|Overall Study|Adverse Event|18|||
41992670|NCT01155466|75800842|FG000|Overall Study|Lost to Follow-up|0|||
41992671|NCT01155466|75800843|FG001|Overall Study|Lost to Follow-up|0|||
42033412|NCT01128413|75841652|FG000|Overall Study|NICOM Monitor Problems|2|||
42033413|NCT01128413|75841653|FG001|Overall Study|NICOM Monitor Problems|1|||
42033414|NCT01128413|75841652|FG000|Overall Study|Pt made DNR|1|||
42313145|NCT02449889|76148760|FG000|Overall Study|Protocol Violation|0|||
42313146|NCT02449889|76148761|FG001|Overall Study|Protocol Violation|4|||
42313147|NCT02449889|76148762|FG002|Overall Study|Protocol Violation|1|||
42313148|NCT01831804|76148779|FG000|Overall Study|Adverse Event|0|||
42313149|NCT01831804|76148780|FG001|Overall Study|Adverse Event|0|||
42313150|NCT01831804|76148781|FG002|Overall Study|Adverse Event|0|||
42313151|NCT01831804|76148782|FG003|Overall Study|Adverse Event|0|||
41992672|NCT01155466|75800844|FG002|Overall Study|Lost to Follow-up|0|||
41992673|NCT01155466|75800845|FG003|Overall Study|Lost to Follow-up|0|||
41992674|NCT01155466|75800846|FG004|Overall Study|Lost to Follow-up|2|||
42033415|NCT01128413|75841653|FG001|Overall Study|Pt made DNR|0|||
42033416|NCT01185080|75841662|FG000|Overall Study|Adverse Event|1|||
42313152|NCT01831804|76148783|FG004|Overall Study|Adverse Event|0|||
42313153|NCT01831804|76148784|FG005|Overall Study|Adverse Event|0|||
42313154|NCT01831804|76148785|FG006|Overall Study|Adverse Event|1|||
42313155|NCT01831804|76148786|FG007|Overall Study|Adverse Event|0|||
42313156|NCT01831804|76148787|FG008|Overall Study|Adverse Event|1|||
42313157|NCT01831804|76148779|FG000|Overall Study|Protocol Violation|0|||
42313158|NCT01831804|76148780|FG001|Overall Study|Protocol Violation|0|||
42313159|NCT01831804|76148781|FG002|Overall Study|Protocol Violation|2|||
42313160|NCT01831804|76148782|FG003|Overall Study|Protocol Violation|0|||
42313161|NCT01831804|76148783|FG004|Overall Study|Protocol Violation|0|||
42313162|NCT01831804|76148784|FG005|Overall Study|Protocol Violation|0|||
42313163|NCT01831804|76148785|FG006|Overall Study|Protocol Violation|0|||
42313164|NCT01831804|76148786|FG007|Overall Study|Protocol Violation|0|||
42313165|NCT01831804|76148787|FG008|Overall Study|Protocol Violation|0|||
42313166|NCT01831804|76148779|FG000|Overall Study|Protocol defined stopping criteria|1|||
42313167|NCT01831804|76148780|FG001|Overall Study|Protocol defined stopping criteria|1|||
41992675|NCT01155466|75800842|FG000|Overall Study|Withdrawal by Subject|7|||
41992676|NCT01155466|75800843|FG001|Overall Study|Withdrawal by Subject|5|||
42010562|NCT00993421|75817699|FG005|Overall Study|Sponsor Decision|30|||
42033417|NCT01185080|75841663|FG001|Overall Study|Adverse Event|1|||
42313168|NCT01831804|76148781|FG002|Overall Study|Protocol defined stopping criteria|3|||
42313169|NCT01831804|76148782|FG003|Overall Study|Protocol defined stopping criteria|0|||
42313170|NCT01831804|76148783|FG004|Overall Study|Protocol defined stopping criteria|1|||
41992677|NCT01155466|75800844|FG002|Overall Study|Withdrawal by Subject|9|||
41992678|NCT01155466|75800845|FG003|Overall Study|Withdrawal by Subject|4|||
41992679|NCT01155466|75800846|FG004|Overall Study|Withdrawal by Subject|4|||
41992680|NCT01155466|75800842|FG000|Overall Study|Protocol Violation|0|||
41992681|NCT01155466|75800843|FG001|Overall Study|Protocol Violation|0|||
41992682|NCT01155466|75800844|FG002|Overall Study|Protocol Violation|2|||
41992683|NCT01155466|75800845|FG003|Overall Study|Protocol Violation|0|||
41992684|NCT01155466|75800846|FG004|Overall Study|Protocol Violation|1|||
42033418|NCT01185080|75841664|FG002|Overall Study|Adverse Event|0|||
41992685|NCT01155466|75800842|FG000|Overall Study|Administrative|0|||
41992686|NCT01155466|75800843|FG001|Overall Study|Administrative|3|||
41992687|NCT01155466|75800844|FG002|Overall Study|Administrative|0|||
42254966|NCT01915498|76081307|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
42254967|NCT01915498|76081308|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
41992688|NCT01155466|75800845|FG003|Overall Study|Administrative|0|||
42133115|NCT00410163|75944017|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
42033419|NCT01185080|75841662|FG000|Overall Study|Personal reasons|0|||
42033420|NCT01185080|75841663|FG001|Overall Study|Personal reasons|0|||
42033421|NCT01185080|75841664|FG002|Overall Study|Personal reasons|1|||
42033422|NCT01128179|75841674|FG000|Overall Study|Death|1|||
41992689|NCT01155466|75800846|FG004|Overall Study|Administrative|0|||
41992690|NCT01155466|75800842|FG000|Overall Study|Randomized not treated|2|||
41992691|NCT01155466|75800843|FG001|Overall Study|Randomized not treated|2|||
41992692|NCT01155466|75800844|FG002|Overall Study|Randomized not treated|3|||
41992693|NCT01155466|75800845|FG003|Overall Study|Randomized not treated|0|||
41992694|NCT01155466|75800846|FG004|Overall Study|Randomized not treated|2|||
41992695|NCT01155388|75800860|FG000|Overall Study|Adverse Event|1|||
41992696|NCT01155388|75800861|FG001|Overall Study|Adverse Event|0|||
41992697|NCT01154452|75800872|FG000|Phase Ib|Not Treated|1|||
41992698|NCT01154452|75800873|FG001|Phase Ib|Not Treated|0|||
41992699|NCT01154452|75800874|FG002|Phase Ib|Not Treated|0|||
41992700|NCT01154452|75800875|FG003|Phase Ib|Not Treated|0|||
41992701|NCT01154452|75800872|FG000|Phase Ib|Adverse Event|2|||
41992702|NCT01154452|75800873|FG001|Phase Ib|Adverse Event|1|||
41992703|NCT01154452|75800874|FG002|Phase Ib|Adverse Event|0|||
41992704|NCT01154452|75800875|FG003|Phase Ib|Adverse Event|0|||
41992705|NCT01154452|75800872|FG000|Phase II|Withdrawal by Subject|0|||
41992706|NCT01154452|75800873|FG001|Phase II|Withdrawal by Subject|0|||
41992707|NCT01154452|75800874|FG002|Phase II|Withdrawal by Subject|1|||
42133116|NCT00410163|75944016|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
41992708|NCT01154452|75800875|FG003|Phase II|Withdrawal by Subject|2|||
41992709|NCT01154452|75800872|FG000|Phase II|Adverse Event|0|||
41992710|NCT01154452|75800873|FG001|Phase II|Adverse Event|0|||
41992711|NCT01154452|75800874|FG002|Phase II|Adverse Event|4|||
41992712|NCT01154452|75800875|FG003|Phase II|Adverse Event|4|||
41992713|NCT01154296|75800890|FG000|Randomization and Intervention|Decided to decline|1|||
42254968|NCT01915498|76081309|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
42254969|NCT01915498|76081310|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
41992714|NCT01154296|75800891|FG001|Randomization and Intervention|Decided to decline|1|||
41992715|NCT01154296|75800890|FG000|Randomization and Intervention|Declined by staff|1|||
41992716|NCT01154296|75800891|FG001|Randomization and Intervention|Declined by staff|0|||
42254970|NCT01915498|76081311|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
42254971|NCT01915498|76081312|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
42254972|NCT01915498|76081294|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254973|NCT01915498|76081295|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254974|NCT01915498|76081296|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254975|NCT01915498|76081297|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42313171|NCT01831804|76148784|FG005|Overall Study|Protocol defined stopping criteria|0|||
42254976|NCT01915498|76081298|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254977|NCT01915498|76081299|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254978|NCT01915498|76081300|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254979|NCT01915498|76081301|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254980|NCT01915498|76081302|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254981|NCT01915498|76081303|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254982|NCT01915498|76081304|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
42254983|NCT01915498|76081305|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254984|NCT01915498|76081306|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254985|NCT01915498|76081307|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
42254986|NCT01915498|76081308|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254987|NCT01915498|76081309|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254988|NCT01915498|76081310|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
42254989|NCT01915498|76081311|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
42254990|NCT01915498|76081312|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
42254991|NCT01915498|76081294|FG000|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
42313172|NCT01831804|76148785|FG006|Overall Study|Protocol defined stopping criteria|0|||
42313173|NCT01831804|76148786|FG007|Overall Study|Protocol defined stopping criteria|0|||
41992717|NCT01154296|75800890|FG000|Randomization and Intervention|Did not return|1|||
42313174|NCT01831804|76148787|FG008|Overall Study|Protocol defined stopping criteria|0|||
42313175|NCT01831804|76148779|FG000|Overall Study|Lost to Follow-up|0|||
42010563|NCT00993421|75817700|FG006|Overall Study|Sponsor Decision|29|||
41992718|NCT01154296|75800891|FG001|Randomization and Intervention|Did not return|0|||
41992719|NCT01154296|75800890|FG000|Randomization and Intervention|Left before test|0|||
41992720|NCT01154296|75800891|FG001|Randomization and Intervention|Left before test|1|||
41992721|NCT01154296|75800890|FG000|Randomization and Intervention|Left clinic early|2|||
42313176|NCT01831804|76148780|FG001|Overall Study|Lost to Follow-up|0|||
42313177|NCT01831804|76148781|FG002|Overall Study|Lost to Follow-up|1|||
42313178|NCT01831804|76148782|FG003|Overall Study|Lost to Follow-up|0|||
42313179|NCT01831804|76148783|FG004|Overall Study|Lost to Follow-up|0|||
42313180|NCT01831804|76148784|FG005|Overall Study|Lost to Follow-up|0|||
42313181|NCT01831804|76148785|FG006|Overall Study|Lost to Follow-up|0|||
42313182|NCT01831804|76148786|FG007|Overall Study|Lost to Follow-up|0|||
42313183|NCT01831804|76148787|FG008|Overall Study|Lost to Follow-up|1|||
42313184|NCT01831804|76148779|FG000|Overall Study|Investigator discretion|0|||
41992722|NCT01154296|75800891|FG001|Randomization and Intervention|Left clinic early|0|||
42313185|NCT01831804|76148780|FG001|Overall Study|Investigator discretion|0|||
42133117|NCT00410163|75944017|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
42133118|NCT00410163|75944016|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
42133119|NCT00410163|75944017|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
42133120|NCT00410163|75944016|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
42133121|NCT00410163|75944017|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
42133122|NCT00410163|75944016|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
41992723|NCT01154296|75800890|FG000|6-month Follow-up|Lost contact|269|||
41992724|NCT01154296|75800891|FG001|6-month Follow-up|Lost contact|275|||
41992725|NCT01154296|75800890|FG000|6-month Follow-up|Incarcerated|37|||
41992726|NCT01154296|75800891|FG001|6-month Follow-up|Incarcerated|32|||
41992727|NCT01154296|75800890|FG000|6-month Follow-up|Withdrew consent|14|||
41992728|NCT01154296|75800891|FG001|6-month Follow-up|Withdrew consent|15|||
41992729|NCT01154296|75800890|FG000|6-month Follow-up|Death|3|||
41992730|NCT01154296|75800891|FG001|6-month Follow-up|Death|2|||
41992731|NCT01154296|75800890|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
41992732|NCT01154296|75800891|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
42313186|NCT01831804|76148781|FG002|Overall Study|Investigator discretion|0|||
42313187|NCT01831804|76148782|FG003|Overall Study|Investigator discretion|0|||
42313188|NCT01831804|76148783|FG004|Overall Study|Investigator discretion|1|||
42313189|NCT01831804|76148784|FG005|Overall Study|Investigator discretion|0|||
42313190|NCT01831804|76148785|FG006|Overall Study|Investigator discretion|0|||
42133123|NCT00410163|75944017|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
42313191|NCT01831804|76148786|FG007|Overall Study|Investigator discretion|1|||
42313192|NCT01831804|76148787|FG008|Overall Study|Investigator discretion|0|||
42313193|NCT01831804|76148779|FG000|Overall Study|Withdrew Consent|0|||
42313194|NCT01831804|76148780|FG001|Overall Study|Withdrew Consent|1|||
41992733|NCT01154218|75800897|FG000|Third Intervention Period|Adverse Event|0|||
41992734|NCT01154218|75800898|FG001|Third Intervention Period|Adverse Event|1|||
41992735|NCT01154218|75800899|FG002|Third Intervention Period|Adverse Event|0|||
41992736|NCT01154218|75800900|FG003|Third Intervention Period|Adverse Event|0|||
41992737|NCT01154218|75800897|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
41992738|NCT01154218|75800898|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
41992739|NCT01154218|75800899|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
41992740|NCT01154218|75800900|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
41992741|NCT01154218|75800897|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
41992742|NCT01154218|75800898|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
42313195|NCT01831804|76148781|FG002|Overall Study|Withdrew Consent|0|||
42313196|NCT01831804|76148782|FG003|Overall Study|Withdrew Consent|0|||
42313197|NCT01831804|76148783|FG004|Overall Study|Withdrew Consent|0|||
42313198|NCT01831804|76148784|FG005|Overall Study|Withdrew Consent|0|||
42313199|NCT01831804|76148785|FG006|Overall Study|Withdrew Consent|0|||
42313200|NCT01831804|76148786|FG007|Overall Study|Withdrew Consent|2|||
42313201|NCT01831804|76148787|FG008|Overall Study|Withdrew Consent|0|||
42313202|NCT02270671|76148818|FG000|Overall Study|Withdrawal by Subject|1|||
42313203|NCT02270671|76148819|FG001|Overall Study|Withdrawal by Subject|1|||
42313204|NCT02270671|76148818|FG000|Overall Study|Protocol Violation|0|||
42313205|NCT02270671|76148819|FG001|Overall Study|Protocol Violation|1|||
42313206|NCT02270671|76148818|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
42313207|NCT02270671|76148819|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
42313208|NCT02270671|76148818|FG000|Overall Study|Lost to Follow-up|2|||
42313209|NCT02270671|76148819|FG001|Overall Study|Lost to Follow-up|1|||
42313210|NCT02324270|76148828|FG000|Overall Study|Withdrawal by Subject|0|||
42313211|NCT02324270|76148829|FG001|Overall Study|Withdrawal by Subject|1|||
42313212|NCT02324270|76148830|FG002|Overall Study|Withdrawal by Subject|0|||
42313213|NCT02324270|76148828|FG000|Overall Study|Lost to Follow-up|4|||
42313214|NCT02324270|76148829|FG001|Overall Study|Lost to Follow-up|3|||
42313215|NCT02324270|76148830|FG002|Overall Study|Lost to Follow-up|4|||
42313216|NCT02324270|76148828|FG000|Overall Study|Protocol Violation|0|||
42313217|NCT02324270|76148829|FG001|Overall Study|Protocol Violation|1|||
42313218|NCT02324270|76148830|FG002|Overall Study|Protocol Violation|1|||
42313219|NCT02324270|76148828|FG000|Overall Study|Non Compliance with Study Drug|1|||
42313220|NCT02324270|76148829|FG001|Overall Study|Non Compliance with Study Drug|2|||
42313221|NCT02324270|76148830|FG002|Overall Study|Non Compliance with Study Drug|0|||
42313222|NCT02270515|76148838|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
42313223|NCT02270515|76148838|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
42313224|NCT02270515|76148838|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
42313225|NCT02270515|76148838|FG000|Intervention Period 1: 0-6 Months|Death|7|||
42313226|NCT02270515|76148838|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
42313227|NCT02270515|76148838|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
42313228|NCT02270515|76148838|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
42313229|NCT02270515|76148838|FG000|Intervention Period 2: 6-12 Months|Death|5|||
42313230|NCT02270515|76148838|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
42313231|NCT02270515|76148838|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
42313232|NCT02270515|76148838|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
42313233|NCT02270515|76148838|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
42313234|NCT02270515|76148838|FG000|Intervention Period 3: 12-18 Months|Death|3|||
42313235|NCT02270515|76148838|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
42313236|NCT02448875|76148852|FG000|Overall Study|Adverse Event|2|||
42313237|NCT02448875|76148853|FG001|Overall Study|Adverse Event|1|||
42254992|NCT01915498|76081295|FG001|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42254993|NCT01915498|76081296|FG002|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42254994|NCT01915498|76081297|FG003|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42254995|NCT01915498|76081298|FG004|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42254996|NCT01915498|76081299|FG005|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
42254997|NCT01915498|76081300|FG006|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42254998|NCT01915498|76081301|FG007|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42254999|NCT01915498|76081302|FG008|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42255000|NCT01915498|76081303|FG009|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42313238|NCT02448875|76148854|FG002|Overall Study|Adverse Event|0|||
42313239|NCT02448875|76148852|FG000|Overall Study|Lost to Follow-up|1|||
42313240|NCT02448875|76148853|FG001|Overall Study|Lost to Follow-up|0|||
42313241|NCT02448875|76148854|FG002|Overall Study|Lost to Follow-up|0|||
41992743|NCT01154218|75800899|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
42313242|NCT02448875|76148852|FG000|Overall Study|Investigator Decision|3|||
42010564|NCT00993421|75817694|FG000|Overall Study|Lost to Follow-up|3|||
42313243|NCT02448875|76148853|FG001|Overall Study|Investigator Decision|0|||
42313244|NCT02448875|76148854|FG002|Overall Study|Investigator Decision|1|||
42313245|NCT02448875|76148852|FG000|Overall Study|Withdrawal by Subject|1|||
42313246|NCT02448875|76148853|FG001|Overall Study|Withdrawal by Subject|0|||
42313247|NCT02448875|76148854|FG002|Overall Study|Withdrawal by Subject|0|||
42313248|NCT01831726|76148865|FG000|Overall Study|Adverse Event|16|||
42313249|NCT01831726|76148865|FG000|Overall Study|Death|7|||
42313250|NCT01831726|76148865|FG000|Overall Study|Disease Progression|49|||
42313251|NCT01831726|76148865|FG000|Overall Study|Physician Decision|1|||
42313252|NCT01831726|76148865|FG000|Overall Study|Subject/guardian decision|7|||
42313253|NCT01831258|76148869|FG000|Overall Study|Withdrawal by Subject|2|||
42313254|NCT01831258|76148870|FG001|Overall Study|Withdrawal by Subject|1|||
42313255|NCT01831258|76148869|FG000|Overall Study|Lost to Follow-up|3|||
41992744|NCT01154218|75800900|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
41992745|NCT01154140|75800925|FG000|Overall Study|Death|71|||
41992746|NCT01154140|75800926|FG001|Overall Study|Death|81|||
42313256|NCT01831258|76148870|FG001|Overall Study|Lost to Follow-up|2|||
42313257|NCT01849276|76148878|FG000|Followed for Survival for 5 Years|Death|1|||
42313258|NCT01849276|76148878|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
42313259|NCT02465489|76148882|FG000|Overall Study|Adverse Event|5|||
42313260|NCT01829464|76148897|FG000|Overall Study|Adverse Event|1|||
42313261|NCT01829464|76148898|FG001|Overall Study|Adverse Event|0|||
42313262|NCT01829464|76148899|FG002|Overall Study|Adverse Event|0|||
42313263|NCT01829464|76148897|FG000|Overall Study|Lost to Follow-up|0|||
42313264|NCT01829464|76148898|FG001|Overall Study|Lost to Follow-up|0|||
42313265|NCT01829464|76148899|FG002|Overall Study|Lost to Follow-up|1|||
42313266|NCT01829464|76148897|FG000|Overall Study|Withdrawal by Subject|2|||
42313267|NCT01829464|76148898|FG001|Overall Study|Withdrawal by Subject|0|||
42313268|NCT01829464|76148899|FG002|Overall Study|Withdrawal by Subject|0|||
42313269|NCT01829464|76148897|FG000|Overall Study|Study terminated by sponsor|25|||
42313270|NCT01829464|76148898|FG001|Overall Study|Study terminated by sponsor|28|||
42313271|NCT01829464|76148899|FG002|Overall Study|Study terminated by sponsor|25|||
42313272|NCT01829464|76148897|FG000|Overall Study|Lack of Efficacy|0|||
42313273|NCT01829464|76148898|FG001|Overall Study|Lack of Efficacy|1|||
42313274|NCT01829464|76148899|FG002|Overall Study|Lack of Efficacy|0|||
42313275|NCT01847092|76148909|FG000|Overall Study|Adverse Event|12|||
42313276|NCT01847092|76148910|FG001|Overall Study|Adverse Event|3|||
42313277|NCT01847092|76148909|FG000|Overall Study|Withdrawal by Subject|5|||
42313278|NCT01847092|76148910|FG001|Overall Study|Withdrawal by Subject|5|||
42313279|NCT01847092|76148909|FG000|Overall Study|Protocol Specified|8|||
42313280|NCT01847092|76148910|FG001|Overall Study|Protocol Specified|0|||
42313281|NCT01847092|76148909|FG000|Overall Study|Physician Decision|1|||
42313282|NCT01847092|76148910|FG001|Overall Study|Physician Decision|1|||
42313283|NCT01847092|76148909|FG000|Overall Study|Protocol Violation|0|||
42313284|NCT01847092|76148910|FG001|Overall Study|Protocol Violation|2|||
42313285|NCT01601821|76148918|FG000|Overall Study|Death|2|||
42313286|NCT01601821|76148919|FG001|Overall Study|Death|5|||
41992747|NCT01154140|75800925|FG000|Overall Study|Lost to Follow-up|4|||
41992748|NCT01154140|75800926|FG001|Overall Study|Lost to Follow-up|5|||
41992749|NCT01154140|75800925|FG000|Overall Study|Withdrawal by Subject|12|||
41992750|NCT01154140|75800926|FG001|Overall Study|Withdrawal by Subject|13|||
41992751|NCT01154140|75800925|FG000|Overall Study|Other|3|||
42313287|NCT01601821|76148918|FG000|Overall Study|Protocol Violation|2|||
42313288|NCT01601821|76148919|FG001|Overall Study|Protocol Violation|2|||
42313289|NCT01601821|76148918|FG000|Overall Study|Lost to Follow-up|6|||
42313290|NCT01601821|76148919|FG001|Overall Study|Lost to Follow-up|14|||
41992752|NCT01154140|75800926|FG001|Overall Study|Other|1|||
42313291|NCT01601821|76148918|FG000|Overall Study|Withdrawal by Subject|1|||
42313292|NCT01601821|76148919|FG001|Overall Study|Withdrawal by Subject|0|||
42313293|NCT01601821|76148918|FG000|Overall Study|Graft Loss|6|||
42313294|NCT01601821|76148919|FG001|Overall Study|Graft Loss|6|||
42313295|NCT01601821|76148918|FG000|Overall Study|Study Events|7|||
42313296|NCT01601821|76148919|FG001|Overall Study|Study Events|1|||
42313297|NCT01601821|76148918|FG000|Overall Study|Other|5|||
42313298|NCT01601821|76148919|FG001|Overall Study|Other|1|||
42313299|NCT02323646|76148928|FG000|Treatment Course 1|Adverse Event|1|||
42313300|NCT02323646|76148929|FG001|Treatment Course 1|Adverse Event|0|||
42313301|NCT02323646|76148930|FG002|Treatment Course 1|Adverse Event|1|||
42313302|NCT02323646|76148928|FG000|Treatment Course 1|Heavy Bleeding|1|||
42313303|NCT02323646|76148929|FG001|Treatment Course 1|Heavy Bleeding|1|||
42313304|NCT02323646|76148930|FG002|Treatment Course 1|Heavy Bleeding|0|||
42313305|NCT02323646|76148928|FG000|Treatment Course 1|Lost to Follow-up|1|||
42313306|NCT02323646|76148929|FG001|Treatment Course 1|Lost to Follow-up|0|||
42313307|NCT02323646|76148930|FG002|Treatment Course 1|Lost to Follow-up|2|||
42313308|NCT02323646|76148928|FG000|Treatment Course 1|Withdrawal by Subject|0|||
42313309|NCT02323646|76148929|FG001|Treatment Course 1|Withdrawal by Subject|2|||
42313310|NCT02323646|76148930|FG002|Treatment Course 1|Withdrawal by Subject|0|||
42313311|NCT02323646|76148928|FG000|Treatment Course 2|Adverse Event|1|||
42313312|NCT02323646|76148929|FG001|Treatment Course 2|Adverse Event|0|||
42313313|NCT02323646|76148930|FG002|Treatment Course 2|Adverse Event|1|||
42313314|NCT02323646|76148928|FG000|Treatment Course 2|Lost to Follow-up|0|||
42313315|NCT02323646|76148929|FG001|Treatment Course 2|Lost to Follow-up|0|||
42313316|NCT02323646|76148930|FG002|Treatment Course 2|Lost to Follow-up|1|||
42313317|NCT02323646|76148928|FG000|Treatment Course 2|Non-compliance|0|||
42313318|NCT02323646|76148929|FG001|Treatment Course 2|Non-compliance|1|||
41992753|NCT01154140|75800925|FG000|Overall Study|Randomized but not treated|1|||
41992754|NCT01154140|75800926|FG001|Overall Study|Randomized but not treated|2|||
41992755|NCT01154101|75800937|FG000|Overall Study|Adverse Event|0|||
41992756|NCT01154101|75800938|FG001|Overall Study|Adverse Event|2|||
41992757|NCT01154101|75800939|FG002|Overall Study|Adverse Event|1|||
41992758|NCT01154101|75800940|FG003|Overall Study|Adverse Event|1|||
41992759|NCT01154101|75800941|FG004|Overall Study|Adverse Event|0|||
41992760|NCT01154101|75800937|FG000|Overall Study|Lost to Follow-up|0|||
41992761|NCT01154101|75800938|FG001|Overall Study|Lost to Follow-up|1|||
41992762|NCT01154101|75800939|FG002|Overall Study|Lost to Follow-up|0|||
41992763|NCT01154101|75800940|FG003|Overall Study|Lost to Follow-up|1|||
41992764|NCT01154101|75800941|FG004|Overall Study|Lost to Follow-up|0|||
41992765|NCT01154101|75800937|FG000|Overall Study|Withdrawal by Subject|0|||
41992766|NCT01154101|75800938|FG001|Overall Study|Withdrawal by Subject|1|||
41992767|NCT01154101|75800939|FG002|Overall Study|Withdrawal by Subject|2|||
41992768|NCT01154101|75800940|FG003|Overall Study|Withdrawal by Subject|0|||
41992769|NCT01154101|75800941|FG004|Overall Study|Withdrawal by Subject|1|||
41992770|NCT01153984|75800958|FG000|Overall Study|Withdrawal by Subject|1|||
41992771|NCT01153984|75800958|FG000|Overall Study|Adverse Event|1|||
41992772|NCT01153633|75800964|FG000|Overall Study|Protocol Violation|1|||
42313319|NCT02323646|76148930|FG002|Treatment Course 2|Non-compliance|1|||
41992773|NCT01153633|75800965|FG001|Overall Study|Protocol Violation|1|||
41992774|NCT01153633|75800964|FG000|Overall Study|Therapeutic failure|3|||
41992775|NCT01153633|75800965|FG001|Overall Study|Therapeutic failure|3|||
42255001|NCT01915498|76081304|FG010|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42255002|NCT01915498|76081305|FG011|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42255003|NCT01915498|76081306|FG012|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42255004|NCT01915498|76081307|FG013|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42255005|NCT01915498|76081308|FG014|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1|||
42255006|NCT01915498|76081309|FG015|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42255007|NCT01915498|76081310|FG016|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42255008|NCT01915498|76081311|FG017|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2|||
42255009|NCT01915498|76081312|FG018|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0|||
42255010|NCT01915498|76081294|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42255011|NCT01915498|76081295|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42255012|NCT01915498|76081296|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42255013|NCT01915498|76081297|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42255014|NCT01915498|76081298|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42313320|NCT01846624|76148938|FG000|Overall Study|Died during induction, no midostaurin|1|||
41992776|NCT01153516|75800975|FG000|Overall Study|Both subjects refused surgery|2|||
42313321|NCT01829230|76148944|FG000|Overall Study|Protocol Violation|0|||
42313322|NCT01829230|76148945|FG001|Overall Study|Protocol Violation|2|||
42313323|NCT01829230|76148944|FG000|Overall Study|Withdrawal by Subject|0|||
42313324|NCT01829230|76148945|FG001|Overall Study|Withdrawal by Subject|1|||
41992777|NCT01153516|75800976|FG001|Overall Study|Both subjects refused surgery|0|||
41992778|NCT01153321|75800984|FG000|Overall Study|Development of study withdrawal criteria|0|||
41992779|NCT01153321|75800985|FG001|Overall Study|Development of study withdrawal criteria|1|||
41992780|NCT01153321|75800984|FG000|Overall Study|Withdrawal by Subject|0|||
42313325|NCT01829230|76148944|FG000|Overall Study|Lost to Follow-up|1|||
42313326|NCT01829230|76148945|FG001|Overall Study|Lost to Follow-up|1|||
41992781|NCT01153321|75800985|FG001|Overall Study|Withdrawal by Subject|1|||
41992782|NCT01153321|75800984|FG000|Overall Study|Adverse Event|1|||
42313327|NCT02269657|76148951|FG000|Overall Study|Protocol Violation|3|||
42313328|NCT02269423|76148961|FG000|Overall Study|Discontinued due to change in residence|0|||
42313329|NCT02269423|76148962|FG001|Overall Study|Discontinued due to change in residence|1|||
42313330|NCT02269423|76148963|FG002|Overall Study|Discontinued due to change in residence|0|||
42313331|NCT02269423|76148964|FG003|Overall Study|Discontinued due to change in residence|1|||
42313332|NCT01827670|76148976|FG000|Overall Study|Withdrawal of Consent|3|||
42313333|NCT01827670|76148977|FG001|Overall Study|Withdrawal of Consent|2|||
42313334|NCT01827670|76148976|FG000|Overall Study|Lost to Follow-up|0|||
42313335|NCT01827670|76148977|FG001|Overall Study|Lost to Follow-up|1|||
42313336|NCT02267317|76148991|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
42313337|NCT02267317|76148992|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
42313338|NCT02267317|76148993|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
42313339|NCT02267317|76148994|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
42313340|NCT02267317|76148995|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
42313341|NCT02267317|76148996|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
41992783|NCT01153321|75800985|FG001|Overall Study|Adverse Event|1|||
41992784|NCT01153009|75800995|FG000|Overall Study|Adverse Event|4|||
42313342|NCT02267317|76148991|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
42313343|NCT02267317|76148992|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
41992785|NCT01153009|75800996|FG001|Overall Study|Adverse Event|14|||
41992786|NCT01153009|75800997|FG002|Overall Study|Adverse Event|14|||
41992787|NCT01153009|75800998|FG003|Overall Study|Adverse Event|10|||
41992788|NCT01153009|75800995|FG000|Overall Study|Lack of Efficacy|9|||
41992789|NCT01153009|75800996|FG001|Overall Study|Lack of Efficacy|0|||
41992790|NCT01153009|75800997|FG002|Overall Study|Lack of Efficacy|2|||
42313344|NCT02267317|76148993|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
42313345|NCT02267317|76148994|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
42313346|NCT02267317|76148995|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
42313347|NCT02267317|76148996|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
42313348|NCT01844830|76149012|FG000|Overall Study|Withdrawal by Subject|1|||
42313349|NCT01844830|76149013|FG001|Overall Study|Withdrawal by Subject|0|||
42313350|NCT01827592|76149022|FG000|Overall Study|Adverse Event|11|||
42313351|NCT01827592|76149023|FG001|Overall Study|Adverse Event|9|||
42313352|NCT01827592|76149024|FG002|Overall Study|Adverse Event|2|||
42313353|NCT01827592|76149022|FG000|Overall Study|Physician Decision|0|||
42313354|NCT01827592|76149023|FG001|Overall Study|Physician Decision|2|||
42313355|NCT01827592|76149024|FG002|Overall Study|Physician Decision|1|||
42313356|NCT01827592|76149022|FG000|Overall Study|Protocol Violation|2|||
42313357|NCT01827592|76149023|FG001|Overall Study|Protocol Violation|1|||
42313358|NCT01827592|76149024|FG002|Overall Study|Protocol Violation|0|||
42313359|NCT01827592|76149022|FG000|Overall Study|Lost to Follow-up|1|||
42313360|NCT01827592|76149023|FG001|Overall Study|Lost to Follow-up|2|||
42313361|NCT01827592|76149024|FG002|Overall Study|Lost to Follow-up|2|||
42313362|NCT01827592|76149022|FG000|Overall Study|Withdrawal by Subject|12|||
42313363|NCT01827592|76149023|FG001|Overall Study|Withdrawal by Subject|11|||
42313364|NCT01827592|76149024|FG002|Overall Study|Withdrawal by Subject|11|||
42313365|NCT01827592|76149022|FG000|Overall Study|Patient's substantial non-compliance|1|||
42313366|NCT01827592|76149023|FG001|Overall Study|Patient's substantial non-compliance|1|||
42313367|NCT01827592|76149024|FG002|Overall Study|Patient's substantial non-compliance|6|||
42313368|NCT01827592|76149022|FG000|Overall Study|Trial terminated by Sponsor|47|||
42313369|NCT01827592|76149023|FG001|Overall Study|Trial terminated by Sponsor|53|||
41992791|NCT01153009|75800998|FG003|Overall Study|Lack of Efficacy|1|||
41992792|NCT01153009|75800995|FG000|Overall Study|Noncompliance with Study Medication|1|||
41992793|NCT01153009|75800996|FG001|Overall Study|Noncompliance with Study Medication|3|||
41992794|NCT01153009|75800997|FG002|Overall Study|Noncompliance with Study Medication|4|||
42255015|NCT01915498|76081299|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
42255016|NCT01915498|76081300|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42255017|NCT01915498|76081301|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42255018|NCT01915498|76081302|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42255019|NCT01915498|76081303|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
42255020|NCT01915498|76081304|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42313370|NCT01827592|76149024|FG002|Overall Study|Trial terminated by Sponsor|51|||
42313371|NCT01827592|76149022|FG000|Overall Study|Others|0|||
42313372|NCT01827592|76149023|FG001|Overall Study|Others|1|||
42313373|NCT01827592|76149024|FG002|Overall Study|Others|3|||
41992795|NCT01153009|75800998|FG003|Overall Study|Noncompliance with Study Medication|1|||
41992796|NCT01153009|75800995|FG000|Overall Study|Protocol Deviations|4|||
41992797|NCT01153009|75800996|FG001|Overall Study|Protocol Deviations|3|||
41992798|NCT01153009|75800997|FG002|Overall Study|Protocol Deviations|3|||
42255021|NCT01915498|76081305|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42313374|NCT02323334|76149042|FG000|Period 3|Lost to Follow-up|0|||
42313375|NCT02323334|76149043|FG001|Period 3|Lost to Follow-up|0|||
42313376|NCT02323334|76149044|FG002|Period 3|Lost to Follow-up|1|||
42313377|NCT02323334|76149045|FG003|Period 3|Lost to Follow-up|0|||
42313378|NCT02323334|76149046|FG004|Period 3|Lost to Follow-up|0|||
42313379|NCT02323334|76149047|FG005|Period 3|Lost to Follow-up|0|||
42313380|NCT02323334|76149048|FG006|Period 3|Lost to Follow-up|0|||
42313381|NCT02323334|76149049|FG007|Period 3|Lost to Follow-up|0|||
42313382|NCT02323334|76149050|FG008|Period 3|Lost to Follow-up|0|||
42313383|NCT02323334|76149051|FG009|Period 3|Lost to Follow-up|0|||
42313384|NCT02323334|76149052|FG010|Period 3|Lost to Follow-up|0|||
42313385|NCT02323334|76149053|FG011|Period 3|Lost to Follow-up|0|||
42313386|NCT02323334|76149054|FG012|Period 3|Lost to Follow-up|0|||
42313387|NCT02323334|76149055|FG013|Period 3|Lost to Follow-up|0|||
42313388|NCT02323334|76149056|FG014|Period 3|Lost to Follow-up|0|||
42313389|NCT02323334|76149057|FG015|Period 3|Lost to Follow-up|0|||
42313390|NCT02323334|76149058|FG016|Period 3|Lost to Follow-up|0|||
42313391|NCT02323334|76149042|FG000|Period 3|Withdrawal by Subject|1|||
42313392|NCT02323334|76149043|FG001|Period 3|Withdrawal by Subject|0|||
42313393|NCT02323334|76149044|FG002|Period 3|Withdrawal by Subject|0|||
42313394|NCT02323334|76149045|FG003|Period 3|Withdrawal by Subject|0|||
42313395|NCT02323334|76149046|FG004|Period 3|Withdrawal by Subject|0|||
42313396|NCT02323334|76149047|FG005|Period 3|Withdrawal by Subject|0|||
42313397|NCT02323334|76149048|FG006|Period 3|Withdrawal by Subject|0|||
42313398|NCT02323334|76149049|FG007|Period 3|Withdrawal by Subject|0|||
42313399|NCT02323334|76149050|FG008|Period 3|Withdrawal by Subject|0|||
42313400|NCT02323334|76149051|FG009|Period 3|Withdrawal by Subject|0|||
42313401|NCT02323334|76149052|FG010|Period 3|Withdrawal by Subject|0|||
42313402|NCT02323334|76149053|FG011|Period 3|Withdrawal by Subject|0|||
42313403|NCT02323334|76149054|FG012|Period 3|Withdrawal by Subject|0|||
42313404|NCT02323334|76149055|FG013|Period 3|Withdrawal by Subject|0|||
42313405|NCT02323334|76149056|FG014|Period 3|Withdrawal by Subject|0|||
42313406|NCT02323334|76149057|FG015|Period 3|Withdrawal by Subject|0|||
42313407|NCT02323334|76149058|FG016|Period 3|Withdrawal by Subject|0|||
42313408|NCT02448719|76149131|FG000|Overall Study|Withdrawal by Subject|0|||
42313409|NCT02448719|76149132|FG001|Overall Study|Withdrawal by Subject|0|||
42313410|NCT02448719|76149133|FG002|Overall Study|Withdrawal by Subject|0|||
42313411|NCT02448719|76149134|FG003|Overall Study|Withdrawal by Subject|0|||
42313412|NCT02448719|76149135|FG004|Overall Study|Withdrawal by Subject|1|||
42313413|NCT02448719|76149136|FG005|Overall Study|Withdrawal by Subject|0|||
42313414|NCT02448719|76149137|FG006|Overall Study|Withdrawal by Subject|0|||
42313415|NCT02448719|76149138|FG007|Overall Study|Withdrawal by Subject|0|||
42313416|NCT02448719|76149139|FG008|Overall Study|Withdrawal by Subject|0|||
42313417|NCT02448719|76149140|FG009|Overall Study|Withdrawal by Subject|0|||
42313418|NCT02448719|76149141|FG010|Overall Study|Withdrawal by Subject|0|||
42313419|NCT02322866|76149204|FG000|Overall Study|Adverse Event|6|||
42313420|NCT02322866|76149205|FG001|Overall Study|Adverse Event|11|||
42313421|NCT02322866|76149204|FG000|Overall Study|Withdrawal of Consent|16|||
42313422|NCT02322866|76149205|FG001|Overall Study|Withdrawal of Consent|25|||
42313423|NCT02322866|76149204|FG000|Overall Study|Lost to Follow-up|36|||
42313424|NCT02322866|76149205|FG001|Overall Study|Lost to Follow-up|39|||
42313425|NCT02322866|76149204|FG000|Overall Study|Protocol Violation|1|||
42313426|NCT02322866|76149205|FG001|Overall Study|Protocol Violation|0|||
42313427|NCT02322866|76149204|FG000|Overall Study|Noncompliance with Treatment|3|||
42313428|NCT02322866|76149205|FG001|Overall Study|Noncompliance with Treatment|4|||
42313429|NCT02322866|76149204|FG000|Overall Study|Lack of Efficacy|3|||
42313430|NCT02322866|76149205|FG001|Overall Study|Lack of Efficacy|1|||
42313431|NCT02322866|76149204|FG000|Overall Study|Other Miscellaneous Reasons|6|||
42313432|NCT02322866|76149205|FG001|Overall Study|Other Miscellaneous Reasons|6|||
42033423|NCT01128179|75841675|FG001|Overall Study|Death|0|||
42033424|NCT01128179|75841674|FG000|Overall Study|Protocol Violation|1|||
42313433|NCT01640353|76149211|FG000|Overall Study|Withdrew prior to treatment|10|||
42313434|NCT01640353|76149211|FG000|Overall Study|Withdrawn from analysis at term site|12|||
42313435|NCT01640353|76149211|FG000|Overall Study|Withdrawal by Subject|5|||
42313436|NCT01640353|76149211|FG000|Overall Study|Death|2|||
42313437|NCT01640353|76149211|FG000|Overall Study|Early site termination|3|||
42313438|NCT01640353|76149211|FG000|Overall Study|Lost to Follow-up|12|||
42313439|NCT01640353|76149211|FG000|Overall Study|Physician Decision|1|||
42313440|NCT02463071|76149218|FG000|Overall Study|Adverse Event|3|||
42313441|NCT02463071|76149219|FG001|Overall Study|Adverse Event|5|||
42313442|NCT02463071|76149220|FG002|Overall Study|Adverse Event|1|||
42313443|NCT02463071|76149218|FG000|Overall Study|Death|1|||
42313444|NCT02463071|76149219|FG001|Overall Study|Death|0|||
42313445|NCT02463071|76149220|FG002|Overall Study|Death|0|||
42033425|NCT01128179|75841675|FG001|Overall Study|Protocol Violation|0|||
42313446|NCT02463071|76149218|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
42313447|NCT02463071|76149219|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
41992799|NCT01153009|75800998|FG003|Overall Study|Protocol Deviations|2|||
42255022|NCT01915498|76081306|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42255023|NCT01915498|76081307|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
42255024|NCT01915498|76081308|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
41992800|NCT01153009|75800995|FG000|Overall Study|Withdrawal of Consent|5|||
41992801|NCT01153009|75800996|FG001|Overall Study|Withdrawal of Consent|5|||
42255025|NCT01915498|76081309|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
42255026|NCT01915498|76081310|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
42255027|NCT01915498|76081311|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
42255028|NCT01915498|76081312|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
42255029|NCT01915498|76081294|FG000|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255030|NCT01915498|76081295|FG001|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
41992802|NCT01153009|75800997|FG002|Overall Study|Withdrawal of Consent|4|||
42313448|NCT02463071|76149220|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
42313449|NCT02463071|76149218|FG000|Overall Study|Reason not specified|7|||
42313450|NCT02463071|76149219|FG001|Overall Study|Reason not specified|9|||
42313451|NCT02463071|76149220|FG002|Overall Study|Reason not specified|4|||
42313452|NCT02463071|76149218|FG000|Overall Study|Protocol Violation|0|||
42313453|NCT02463071|76149219|FG001|Overall Study|Protocol Violation|2|||
42313454|NCT02463071|76149220|FG002|Overall Study|Protocol Violation|0|||
42313455|NCT02463071|76149218|FG000|Overall Study|Lost to Follow-up|0|||
42313456|NCT02463071|76149219|FG001|Overall Study|Lost to Follow-up|0|||
42313457|NCT02463071|76149220|FG002|Overall Study|Lost to Follow-up|1|||
42313458|NCT02266381|76149231|FG000|Overall Study|Physician Decision|3|||
42313459|NCT02266381|76149232|FG001|Overall Study|Physician Decision|5|||
42313460|NCT02266381|76149233|FG002|Overall Study|Physician Decision|4|||
42313461|NCT01827046|76149245|FG000|Overall Study|Lost to Follow-up|1|||
42313462|NCT01827046|76149246|FG001|Overall Study|Lost to Follow-up|5|||
42313463|NCT01827046|76149245|FG000|Overall Study|Withdrawal by Subject|0|||
42313464|NCT01827046|76149246|FG001|Overall Study|Withdrawal by Subject|4|||
42313465|NCT02356562|76149254|FG000|Overall Study|Withdrawal by Subject|0|||
42313466|NCT02356562|76149255|FG001|Overall Study|Withdrawal by Subject|1|||
42313467|NCT02356562|76149254|FG000|Overall Study|Re-entered treatment in a previous study|1|||
42313468|NCT02356562|76149255|FG001|Overall Study|Re-entered treatment in a previous study|0|||
42313469|NCT02356562|76149254|FG000|Overall Study|site closure|1|||
42313470|NCT02356562|76149255|FG001|Overall Study|site closure|0|||
42313471|NCT02448563|76149266|FG000|Overall Study|Lost to Follow-up|16|||
42313472|NCT02448563|76149267|FG001|Overall Study|Lost to Follow-up|10|||
42313473|NCT02448563|76149266|FG000|Overall Study|Withdrawal by Subject|0|||
42313474|NCT02448563|76149267|FG001|Overall Study|Withdrawal by Subject|1|||
42313475|NCT02266225|76149277|FG000|Overall Study|Lost to Follow-up|2|||
42313476|NCT02266225|76149277|FG000|Overall Study|Death|1|||
42313477|NCT02266225|76149277|FG000|Overall Study|Withdrawal by Subject|13|||
42313478|NCT02354690|76149282|FG000|Overall Study|Physician Decision|1|||
42313479|NCT02354222|76149288|FG000|Overall Study|Adverse Event|0|||
42313480|NCT02354222|76149289|FG001|Overall Study|Adverse Event|3|||
42313481|NCT02354222|76149288|FG000|Overall Study|Physician Decision|1|||
42313482|NCT02354222|76149289|FG001|Overall Study|Physician Decision|1|||
42313483|NCT02354222|76149288|FG000|Overall Study|Pregnancy|1|||
42313484|NCT02354222|76149289|FG001|Overall Study|Pregnancy|0|||
42313485|NCT02354222|76149288|FG000|Overall Study|Withdrawal by Subject|2|||
42313486|NCT02354222|76149289|FG001|Overall Study|Withdrawal by Subject|3|||
42313487|NCT02354222|76149288|FG000|Overall Study|Conflict with the stopping criteria|0|||
42313488|NCT02354222|76149289|FG001|Overall Study|Conflict with the stopping criteria|4|||
42313489|NCT02353442|76149297|FG000|Overall Study|Withdrawal by Subject|3|||
42313490|NCT02353442|76149298|FG001|Overall Study|Withdrawal by Subject|4|||
42313491|NCT02351960|76149306|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
42313492|NCT02351960|76149307|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
42313493|NCT02351960|76149306|FG000|Overall Study|Voluntary Withdrawal|5|||
42313494|NCT02351960|76149307|FG001|Overall Study|Voluntary Withdrawal|4|||
42313495|NCT02351960|76149306|FG000|Overall Study|Significant Protocol Deviation|0|||
42313496|NCT02351960|76149307|FG001|Overall Study|Significant Protocol Deviation|5|||
42313497|NCT02351180|76149316|FG000|Overall Study|Withdrawal by Subject|1|||
42313498|NCT02351180|76149317|FG001|Overall Study|Withdrawal by Subject|0|||
42313499|NCT02350478|76149325|FG000|Overall Study|Lost to Follow-up|5|||
42313500|NCT02350478|76149326|FG001|Overall Study|Lost to Follow-up|1|||
42313501|NCT02349542|76149332|FG000|Overall Study|Withdrawal by Subject|5|||
42313502|NCT02321930|76149336|FG000|Overall Study|Lost to Follow-up|1|||
42313503|NCT01647542|76149343|FG000|Overall Study|Major Protocol Deviation|1|||
42313504|NCT01647542|76149344|FG001|Overall Study|Major Protocol Deviation|0|||
42313505|NCT01647542|76149345|FG002|Overall Study|Major Protocol Deviation|0|||
42313506|NCT01647542|76149343|FG000|Overall Study|Adverse Event|4|||
42313507|NCT01647542|76149344|FG001|Overall Study|Adverse Event|5|||
42313508|NCT01647542|76149345|FG002|Overall Study|Adverse Event|4|||
42313509|NCT01647542|76149343|FG000|Overall Study|Lost to Follow-up|0|||
42313510|NCT01647542|76149344|FG001|Overall Study|Lost to Follow-up|2|||
42313511|NCT01647542|76149345|FG002|Overall Study|Lost to Follow-up|2|||
42313512|NCT01647542|76149343|FG000|Overall Study|Withdrawal by Subject|6|||
42313513|NCT01647542|76149344|FG001|Overall Study|Withdrawal by Subject|4|||
42313514|NCT01647542|76149345|FG002|Overall Study|Withdrawal by Subject|0|||
42313515|NCT01647542|76149343|FG000|Overall Study|Study Termination|64|||
42313516|NCT01647542|76149344|FG001|Overall Study|Study Termination|61|||
42313517|NCT01647542|76149345|FG002|Overall Study|Study Termination|65|||
42313518|NCT01647542|76149343|FG000|Overall Study|Lack of Efficacy|1|||
42313519|NCT01647542|76149344|FG001|Overall Study|Lack of Efficacy|1|||
42313520|NCT01647542|76149345|FG002|Overall Study|Lack of Efficacy|0|||
42313521|NCT01647542|76149343|FG000|Overall Study|Death|0|||
42313522|NCT01647542|76149344|FG001|Overall Study|Death|0|||
42313523|NCT01647542|76149345|FG002|Overall Study|Death|1|||
42313524|NCT02321462|76149355|FG000|Overall Study|Withdrawal by Subject|5|||
42313525|NCT02321462|76149356|FG001|Overall Study|Withdrawal by Subject|2|||
42313526|NCT02321462|76149355|FG000|Overall Study|Subject withdrawn before any treatment|1|||
42313527|NCT02321462|76149356|FG001|Overall Study|Subject withdrawn before any treatment|1|||
42313528|NCT02391584|76149365|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
42313529|NCT02391584|76149366|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
42313530|NCT02391584|76149365|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
42313531|NCT02391584|76149366|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
42313532|NCT02391584|76149365|FG000|3 Month|Lost to Follow-up|1|||
42313533|NCT02391584|76149366|FG001|3 Month|Lost to Follow-up|0|||
42313534|NCT02391584|76149365|FG000|6 Month|Withdrawal by Subject|1|||
42313535|NCT02391584|76149366|FG001|6 Month|Withdrawal by Subject|0|||
42313536|NCT02391584|76149365|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
42313537|NCT02391584|76149366|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
42313538|NCT02266147|76149379|FG000|PART 1: Dose Escalation|Physician Decision|0|||
42313539|NCT02266147|76149380|FG001|PART 1: Dose Escalation|Physician Decision|0|||
42313540|NCT02266147|76149381|FG002|PART 1: Dose Escalation|Physician Decision|1|||
42313541|NCT02266147|76149382|FG003|PART 1: Dose Escalation|Physician Decision|0|||
42313542|NCT02266147|76149379|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
42313543|NCT02266147|76149380|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
42313544|NCT02266147|76149381|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
42313545|NCT02266147|76149382|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
42313546|NCT02266147|76149379|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
42313547|NCT02266147|76149380|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
42313548|NCT02266147|76149381|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
42313549|NCT02266147|76149382|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
42313550|NCT02266147|76149379|FG000|PART 1: Dose Escalation|Other|1|||
42313551|NCT02266147|76149380|FG001|PART 1: Dose Escalation|Other|1|||
42313552|NCT02266147|76149381|FG002|PART 1: Dose Escalation|Other|0|||
42313553|NCT02266147|76149382|FG003|PART 1: Dose Escalation|Other|0|||
42313554|NCT02266147|76149379|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
42313555|NCT02266147|76149380|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
42313556|NCT02266147|76149381|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
42313557|NCT02266147|76149382|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
42313558|NCT02266147|76149379|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
42313559|NCT02266147|76149380|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
42313560|NCT02266147|76149381|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
42313561|NCT02266147|76149382|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
42313562|NCT02264977|76149394|FG000|Overall Study|Death|3|||
42313563|NCT02264977|76149394|FG000|Overall Study|Physician Decision|1|||
42313564|NCT02264977|76149394|FG000|Overall Study|Refuse to return|1|||
42313565|NCT02264821|76149401|FG000|Overall Study|Protocol Violation|1|||
42313566|NCT02264821|76149402|FG001|Overall Study|Protocol Violation|3|||
42313567|NCT02264821|76149403|FG002|Overall Study|Protocol Violation|6|||
42313568|NCT02261467|76149413|FG000|Overall Study|Enrolled in Error|1|||
42313569|NCT02261467|76149414|FG001|Overall Study|Enrolled in Error|0|||
42313570|NCT02261467|76149413|FG000|Overall Study|Protocol Violation|0|||
42313571|NCT02261467|76149414|FG001|Overall Study|Protocol Violation|1|||
42313572|NCT02261467|76149413|FG000|Overall Study|Personal Reasons|17|||
42313573|NCT02261467|76149414|FG001|Overall Study|Personal Reasons|22|||
42313574|NCT02261467|76149413|FG000|Overall Study|Lost to Follow-up|2|||
42313575|NCT02261467|76149414|FG001|Overall Study|Lost to Follow-up|13|||
42313576|NCT02261467|76149413|FG000|Overall Study|Adverse Event|1|||
42313577|NCT02261467|76149414|FG001|Overall Study|Adverse Event|1|||
42313578|NCT01643473|76149422|FG000|Overall Study|Lost to Follow-up|1|||
42313579|NCT01643473|76149423|FG001|Overall Study|Lost to Follow-up|0|||
42313580|NCT02320058|76149431|FG000|Overall Study|Death|25|||
42313581|NCT02320058|76149432|FG001|Overall Study|Death|10|||
42313582|NCT02320058|76149431|FG000|Overall Study|Lost to Follow-up|4|||
42313583|NCT02320058|76149432|FG001|Overall Study|Lost to Follow-up|0|||
42313584|NCT02320058|76149431|FG000|Overall Study|Other reasons|4|||
42313585|NCT02320058|76149432|FG001|Overall Study|Other reasons|1|||
42313586|NCT02320058|76149431|FG000|Overall Study|Withdrawal by Subject|8|||
42313587|NCT02320058|76149432|FG001|Overall Study|Withdrawal by Subject|2|||
42313588|NCT02320058|76149431|FG000|Overall Study|Not reported|1|||
42313589|NCT02320058|76149432|FG001|Overall Study|Not reported|0|||
42313590|NCT02319668|76149440|FG000|Overall Study|Other (Not specified)|0|||
42313591|NCT02319668|76149441|FG001|Overall Study|Other (Not specified)|2|||
42313592|NCT02092467|76149453|FG000|Overall Study|Death|49|||
42313593|NCT02092467|76149454|FG001|Overall Study|Death|66|||
42313594|NCT02092467|76149455|FG002|Overall Study|Death|38|||
42313595|NCT02092467|76149453|FG000|Overall Study|Lost to Follow-up|38|||
42313596|NCT02092467|76149454|FG001|Overall Study|Lost to Follow-up|35|||
42313597|NCT02092467|76149455|FG002|Overall Study|Lost to Follow-up|40|||
42313598|NCT02092467|76149453|FG000|Overall Study|Global Deterioration of Health Status|1|||
42313599|NCT02092467|76149454|FG001|Overall Study|Global Deterioration of Health Status|0|||
42313600|NCT02092467|76149455|FG002|Overall Study|Global Deterioration of Health Status|0|||
41992803|NCT01153009|75800998|FG003|Overall Study|Withdrawal of Consent|6|||
42313601|NCT02092467|76149453|FG000|Overall Study|Other|32|||
42313602|NCT02092467|76149454|FG001|Overall Study|Other|30|||
42313603|NCT02092467|76149455|FG002|Overall Study|Other|24|||
42313604|NCT02092467|76149453|FG000|Overall Study|Withdrawal by Subject|282|||
42313605|NCT02092467|76149454|FG001|Overall Study|Withdrawal by Subject|327|||
42313606|NCT02092467|76149455|FG002|Overall Study|Withdrawal by Subject|289|||
41992804|NCT01153009|75800995|FG000|Overall Study|Lost to Follow-up|8|||
41992805|NCT01153009|75800996|FG001|Overall Study|Lost to Follow-up|8|||
41992806|NCT01153009|75800997|FG002|Overall Study|Lost to Follow-up|11|||
41992807|NCT01153009|75800998|FG003|Overall Study|Lost to Follow-up|15|||
41992808|NCT01153009|75800995|FG000|Overall Study|Other|1|||
42255031|NCT01915498|76081296|FG002|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255032|NCT01915498|76081297|FG003|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255033|NCT01915498|76081298|FG004|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255034|NCT01915498|76081299|FG005|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255035|NCT01915498|76081300|FG006|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255036|NCT01915498|76081301|FG007|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255037|NCT01915498|76081302|FG008|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255038|NCT01915498|76081303|FG009|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255039|NCT01915498|76081304|FG010|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255040|NCT01915498|76081305|FG011|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255041|NCT01915498|76081306|FG012|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255042|NCT01915498|76081307|FG013|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255043|NCT01915498|76081308|FG014|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255044|NCT01915498|76081309|FG015|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255045|NCT01915498|76081310|FG016|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255046|NCT01915498|76081311|FG017|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0|||
42255047|NCT01915498|76081312|FG018|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2|||
42255048|NCT01798004|76081404|FG000|Overall Study|Death|2|||
42255049|NCT01798004|76081404|FG000|Overall Study|Lack of Efficacy|8|||
42255050|NCT01798004|76081404|FG000|Overall Study|Physician Decision|25|||
42255051|NCT01798004|76081404|FG000|Overall Study|Withdrawal by Subject|4|||
42255052|NCT01798004|76081404|FG000|Overall Study|Ineligible|4|||
42255053|NCT01798004|76081404|FG000|Overall Study|Patient/parent refusal|7|||
42255054|NCT01798004|76081404|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
42255055|NCT01798004|76081404|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
42313607|NCT02092467|76149453|FG000|Overall Study|Randomized but not treated|2|||
41992809|NCT01153009|75800996|FG001|Overall Study|Other|1|||
42255056|NCT01630434|76081410|FG000|Overall Study|Donor lungs turned down|1|||
42313608|NCT02092467|76149454|FG001|Overall Study|Randomized but not treated|1|||
42313609|NCT02092467|76149455|FG002|Overall Study|Randomized but not treated|7|||
42313610|NCT02462759|76149467|FG000|Part 1: Double Blind|Death|1|||
42313611|NCT02462759|76149468|FG001|Part 1: Double Blind|Death|0|||
42313612|NCT02462759|76149469|FG002|Part 1: Double Blind|Death|0|||
42313613|NCT02349386|76149484|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
42313614|NCT02349386|76149485|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
41992810|NCT01153009|75800997|FG002|Overall Study|Other|3|||
41992811|NCT01153009|75800998|FG003|Overall Study|Other|2|||
42313615|NCT02349386|76149486|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
42313616|NCT02349386|76149487|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
42313617|NCT02349386|76149484|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
42313618|NCT02349386|76149485|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
42313619|NCT02349386|76149486|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
42313620|NCT02349386|76149487|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
42313621|NCT02349386|76149484|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
42313622|NCT02349386|76149485|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
42313623|NCT02349386|76149486|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
42313624|NCT02349386|76149487|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
42313625|NCT02349386|76149484|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
42313626|NCT02349386|76149485|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
42313627|NCT02349386|76149486|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
42313628|NCT02349386|76149487|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
42313629|NCT02349386|76149484|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
42313630|NCT02349386|76149485|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
42313631|NCT02349386|76149486|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
42313632|NCT02349386|76149487|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
42313633|NCT02349386|76149484|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
42313634|NCT02349386|76149485|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
42313635|NCT02349386|76149486|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
42313636|NCT02349386|76149487|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
42313637|NCT02036775|76149497|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
42313638|NCT02036775|76149498|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
42313639|NCT02036775|76149499|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
42313640|NCT02036775|76149500|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
42313641|NCT02036775|76149501|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
42313642|NCT02036775|76149502|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
42313643|NCT02092389|76149510|FG000|Overall Study|Adverse Event|1|||
42313644|NCT02092389|76149510|FG000|Overall Study|Other|5|||
42313645|NCT02034591|76149514|FG000|Overall Study|Withdrawal by Subject|0|||
42313646|NCT02034591|76149515|FG001|Overall Study|Withdrawal by Subject|0|||
42313647|NCT02034591|76149516|FG002|Overall Study|Withdrawal by Subject|0|||
42313648|NCT02034591|76149517|FG003|Overall Study|Withdrawal by Subject|0|||
42313649|NCT02034591|76149518|FG004|Overall Study|Withdrawal by Subject|1|||
42313650|NCT02034591|76149519|FG005|Overall Study|Withdrawal by Subject|0|||
42313651|NCT02391116|76149528|FG000|Treatment|Withdrawal by Subject|1|||
42313652|NCT02391116|76149528|FG000|Treatment|Protocol Violation|1|||
42313653|NCT02391116|76149528|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
42313654|NCT02391116|76149528|FG000|Treatment|AE with Clinical PD|3|||
42313655|NCT02391116|76149528|FG000|Safety Follow-up|Adverse Event|1|||
42313656|NCT02391116|76149528|FG000|Safety Follow-up|Withdrawal by Subject|4|||
42313657|NCT02391116|76149528|FG000|Safety Follow-up|Switching to Other Therapy|4|||
42313658|NCT02391116|76149528|FG000|Safety Follow-up|No Follow Up|1|||
42313659|NCT02391116|76149528|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
42313660|NCT02391116|76149528|FG000|Active Follow-up|Withdrawal by Subject|1|||
42313661|NCT02391116|76149528|FG000|Active Follow-up|Switching to Other Therapy|2|||
42313662|NCT02391116|76149528|FG000|Survival Follow-up|Withdrawal by Subject|3|||
42313663|NCT02391116|76149528|FG000|Survival Follow-up|Switching to Other Therapy|1|||
42313664|NCT02091921|76149539|FG000|Overall Study|Adverse Event|3|||
42313665|NCT02447081|76149546|FG000|Overall Study|Death|161|||
42313666|NCT02447081|76149546|FG000|Overall Study|Lost to Follow-up|36|||
42255057|NCT01630434|76081411|FG001|Overall Study|Donor lungs turned down|0|||
42255058|NCT01630434|76081410|FG000|Overall Study|Protocol Violation|9|||
42255059|NCT01630434|76081411|FG001|Overall Study|Protocol Violation|4|||
42255060|NCT01630434|76081410|FG000|Overall Study|Death|20|||
42255061|NCT01630434|76081411|FG001|Overall Study|Death|26|||
42255062|NCT01256398|76081421|FG000|Overall Study|Withdrawal by Subject|1|||
42255063|NCT01151423|76081429|FG000|Overall Study|Study terminated by Sponsor|9|||
42255064|NCT01151423|76081430|FG001|Overall Study|Study terminated by Sponsor|10|||
42255065|NCT01151423|76081429|FG000|Overall Study|Protocol Violation|0|||
42313667|NCT02447081|76149546|FG000|Overall Study|Visit not completed|17|||
42313668|NCT02447081|76149546|FG000|Overall Study|unsuccessful implant procedure|10|||
42313669|NCT02391038|76149550|FG000|Overall Study|Progressive disease|3|||
42313670|NCT02391038|76149551|FG001|Overall Study|Progressive disease|3|||
42313671|NCT02391038|76149552|FG002|Overall Study|Progressive disease|6|||
42313672|NCT02260921|76149563|FG000|Overall Study|Adverse Event|1|||
42313673|NCT02260921|76149564|FG001|Overall Study|Adverse Event|0|||
42313674|NCT02260921|76149563|FG000|Overall Study|Lost to Follow-up|4|||
42313675|NCT02260921|76149564|FG001|Overall Study|Lost to Follow-up|3|||
42313676|NCT02260921|76149563|FG000|Overall Study|Withdraw Consent|4|||
42313677|NCT02260921|76149564|FG001|Overall Study|Withdraw Consent|1|||
42313678|NCT02260921|76149563|FG000|Overall Study|Death|1|||
42313679|NCT02260921|76149564|FG001|Overall Study|Death|0|||
42313680|NCT02260921|76149563|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
42313681|NCT02260921|76149564|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
42313682|NCT02462603|76149570|FG000|Overall Study|Investigator Decision|1|||
42313683|NCT02462603|76149570|FG000|Overall Study|Non-Compliance|1|||
42313684|NCT02462603|76149570|FG000|Overall Study|Withdrawal by Subject|2|||
42313685|NCT02034513|76149576|FG000|Overall Study|Adverse Event|11|||
42313686|NCT02034513|76149577|FG001|Overall Study|Adverse Event|10|||
42313687|NCT02034513|76149576|FG000|Overall Study|Lack of Efficacy|0|||
42313688|NCT02034513|76149577|FG001|Overall Study|Lack of Efficacy|1|||
42313689|NCT02034513|76149576|FG000|Overall Study|Lost to Follow-up|6|||
42313690|NCT02034513|76149577|FG001|Overall Study|Lost to Follow-up|7|||
42313691|NCT02034513|76149576|FG000|Overall Study|Pregnancy|0|||
42313692|NCT02034513|76149577|FG001|Overall Study|Pregnancy|3|||
42313693|NCT02034513|76149576|FG000|Overall Study|Protocol Violation|7|||
42313694|NCT02034513|76149577|FG001|Overall Study|Protocol Violation|10|||
42313695|NCT02034513|76149576|FG000|Overall Study|Withdrawal by Subject|25|||
42313696|NCT02034513|76149577|FG001|Overall Study|Withdrawal by Subject|25|||
42313697|NCT02034513|76149576|FG000|Overall Study|Unclassified|0|||
42313698|NCT02034513|76149577|FG001|Overall Study|Unclassified|1|||
42313699|NCT02348840|76149589|FG000|Overall Study|Withdrawal by Subject|2|||
41992812|NCT01152814|75801008|FG000|Overall Study|Lost to Follow-up|2|||
41992813|NCT01152580|75801014|FG000|Overall Study|Withdrawal by Subject|0|||
42313700|NCT02348840|76149590|FG001|Overall Study|Withdrawal by Subject|1|||
42313701|NCT02348840|76149591|FG002|Overall Study|Withdrawal by Subject|0|||
42313702|NCT02348840|76149592|FG003|Overall Study|Withdrawal by Subject|0|||
42313703|NCT02462057|76149607|FG000|Overall Study|Left Vitality|32|||
42313704|NCT02462057|76149608|FG001|Overall Study|Left Vitality|27|||
42313705|NCT02462057|76149609|FG002|Overall Study|Left Vitality|23|||
42313706|NCT02462057|76149610|FG003|Overall Study|Left Vitality|35|||
42313707|NCT02462057|76149611|FG004|Overall Study|Left Vitality|33|||
42313708|NCT02462057|76149607|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
42313709|NCT02462057|76149608|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
42313710|NCT02462057|76149609|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
42313711|NCT02462057|76149610|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
42313712|NCT02462057|76149611|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
42313713|NCT02461745|76149625|FG000|Overall Study|Lack of Efficacy|9|||
42313714|NCT02461745|76149626|FG001|Overall Study|Lack of Efficacy|1|||
42313715|NCT02461745|76149625|FG000|Overall Study|Lost to Follow-up|2|||
42313716|NCT02461745|76149626|FG001|Overall Study|Lost to Follow-up|2|||
42313717|NCT02461745|76149625|FG000|Overall Study|Withdrawal by Subject|3|||
41992814|NCT01152580|75801015|FG001|Overall Study|Withdrawal by Subject|1|||
41992815|NCT01152385|75801025|FG000|Overall Study|Withdrawal by Subject|3|||
41992816|NCT01152385|75801026|FG001|Overall Study|Withdrawal by Subject|1|||
41992817|NCT01152385|75801027|FG002|Overall Study|Withdrawal by Subject|1|||
41992818|NCT01152385|75801028|FG003|Overall Study|Withdrawal by Subject|1|||
41992819|NCT01152385|75801025|FG000|Overall Study|Protocol Violation|0|||
41992820|NCT01152385|75801026|FG001|Overall Study|Protocol Violation|0|||
41992821|NCT01152385|75801027|FG002|Overall Study|Protocol Violation|0|||
41992822|NCT01152385|75801028|FG003|Overall Study|Protocol Violation|1|||
41992823|NCT01152385|75801025|FG000|Overall Study|Adverse Event|1|||
41992824|NCT01152385|75801026|FG001|Overall Study|Adverse Event|1|||
41992825|NCT01152385|75801027|FG002|Overall Study|Adverse Event|0|||
41992826|NCT01152385|75801028|FG003|Overall Study|Adverse Event|0|||
41992827|NCT01152385|75801025|FG000|Overall Study|Study-specific withdrawal criteria|1|||
41992828|NCT01152385|75801026|FG001|Overall Study|Study-specific withdrawal criteria|1|||
41992829|NCT01152385|75801027|FG002|Overall Study|Study-specific withdrawal criteria|2|||
41992830|NCT01152385|75801028|FG003|Overall Study|Study-specific withdrawal criteria|0|||
41992831|NCT01152385|75801025|FG000|Overall Study|Other|4|||
41992832|NCT01152385|75801026|FG001|Overall Study|Other|3|||
42313718|NCT02461745|76149626|FG001|Overall Study|Withdrawal by Subject|1|||
42313719|NCT02034435|76149636|FG000|Overall Study|Withdrawal by Subject|1|||
42313720|NCT02034435|76149637|FG001|Overall Study|Withdrawal by Subject|0|||
42313721|NCT02034435|76149638|FG002|Overall Study|Withdrawal by Subject|0|||
42313722|NCT02034435|76149639|FG003|Overall Study|Withdrawal by Subject|0|||
42313723|NCT02034435|76149636|FG000|Overall Study|Illness|0|||
42313724|NCT02034435|76149637|FG001|Overall Study|Illness|2|||
42313725|NCT02034435|76149638|FG002|Overall Study|Illness|0|||
42313726|NCT02034435|76149639|FG003|Overall Study|Illness|0|||
42313727|NCT02034435|76149636|FG000|Overall Study|Inadequate IV access|1|||
42313728|NCT02034435|76149637|FG001|Overall Study|Inadequate IV access|0|||
42313729|NCT02034435|76149638|FG002|Overall Study|Inadequate IV access|0|||
42313730|NCT02034435|76149639|FG003|Overall Study|Inadequate IV access|1|||
42313731|NCT02033889|76149652|FG000|Overall Study|Adverse Event|3|||
42313732|NCT02033889|76149653|FG001|Overall Study|Adverse Event|1|||
42313733|NCT02033889|76149654|FG002|Overall Study|Adverse Event|3|||
42313734|NCT02033889|76149652|FG000|Overall Study|Death|3|||
42313735|NCT02033889|76149653|FG001|Overall Study|Death|1|||
42313736|NCT02033889|76149654|FG002|Overall Study|Death|2|||
42313737|NCT02033889|76149652|FG000|Overall Study|Excluded Medication|1|||
42313738|NCT02033889|76149653|FG001|Overall Study|Excluded Medication|1|||
42313739|NCT02033889|76149654|FG002|Overall Study|Excluded Medication|0|||
42313740|NCT02033889|76149652|FG000|Overall Study|Lost to Follow-up|8|||
42313741|NCT02033889|76149653|FG001|Overall Study|Lost to Follow-up|5|||
42313742|NCT02033889|76149654|FG002|Overall Study|Lost to Follow-up|6|||
42313743|NCT02033889|76149652|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42313744|NCT02033889|76149653|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42313745|NCT02033889|76149654|FG002|Overall Study|Non-Compliance With Study Drug|0|||
42313746|NCT02033889|76149652|FG000|Overall Study|Physician Decision|0|||
42313747|NCT02033889|76149653|FG001|Overall Study|Physician Decision|1|||
42313748|NCT02033889|76149654|FG002|Overall Study|Physician Decision|1|||
42313749|NCT02033889|76149652|FG000|Overall Study|Participant moved|0|||
42313750|NCT02033889|76149653|FG001|Overall Study|Participant moved|1|||
42313751|NCT02033889|76149654|FG002|Overall Study|Participant moved|0|||
42313752|NCT02033889|76149652|FG000|Overall Study|Withdrawal by Subject|18|||
42313753|NCT02033889|76149653|FG001|Overall Study|Withdrawal by Subject|10|||
42313754|NCT02033889|76149654|FG002|Overall Study|Withdrawal by Subject|13|||
42313755|NCT02447003|76149664|FG000|Overall Study|Other|0|||
42313756|NCT02447003|76149665|FG001|Overall Study|Other|4|||
42313757|NCT02447003|76149664|FG000|Overall Study|Site discontinued|0|||
42313758|NCT02447003|76149665|FG001|Overall Study|Site discontinued|2|||
42313759|NCT02447003|76149664|FG000|Overall Study|Physician Decision|0|||
42313760|NCT02447003|76149665|FG001|Overall Study|Physician Decision|1|||
42313761|NCT02447003|76149664|FG000|Overall Study|Withdrawal by Subject|4|||
42313762|NCT02447003|76149665|FG001|Overall Study|Withdrawal by Subject|3|||
42313763|NCT02447003|76149664|FG000|Overall Study|Sponsor Decision|6|||
42313764|NCT02447003|76149665|FG001|Overall Study|Sponsor Decision|11|||
42313765|NCT02447003|76149664|FG000|Overall Study|Progressive Disease|1|||
42313766|NCT02447003|76149665|FG001|Overall Study|Progressive Disease|0|||
42313767|NCT02447003|76149664|FG000|Overall Study|Lost to Follow-up|5|||
42313768|NCT02447003|76149665|FG001|Overall Study|Lost to Follow-up|0|||
42313769|NCT02447003|76149664|FG000|Overall Study|Death|154|||
42313770|NCT02447003|76149665|FG001|Overall Study|Death|63|||
42313771|NCT01844284|76149675|FG000|Overall Study|Lost to Follow-up|12|||
42313772|NCT01844284|76149676|FG001|Overall Study|Lost to Follow-up|7|||
42313773|NCT02054715|76149684|FG000|Baseline/Follow-up 1|Refused|1|||
42313774|NCT02054715|76149685|FG001|Baseline/Follow-up 1|Refused|3|||
42313775|NCT02054715|76149684|FG000|Baseline/Follow-up 1|Medical|0|||
42313776|NCT02054715|76149685|FG001|Baseline/Follow-up 1|Medical|1|||
42313777|NCT02054715|76149684|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
42313778|NCT02054715|76149685|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
42313779|NCT02054715|76149684|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
42313780|NCT02054715|76149685|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
42033426|NCT01181102|75841683|FG000|Overall Study|Adverse Event|28|||
42033427|NCT01181102|75841684|FG001|Overall Study|Adverse Event|26|||
42313781|NCT02054715|76149684|FG000|Baseline/Follow-up 1|No Reason|0|||
42313782|NCT02054715|76149685|FG001|Baseline/Follow-up 1|No Reason|1|||
42313783|NCT02054715|76149684|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
42313784|NCT02054715|76149685|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
42313785|NCT02054715|76149684|FG000|Baseline/Follow-up 1|Ineligible|3|||
42313786|NCT02054715|76149685|FG001|Baseline/Follow-up 1|Ineligible|0|||
42313787|NCT02054715|76149684|FG000|Baseline/Follow-up 1|Hospitalization|1|||
42313788|NCT02054715|76149685|FG001|Baseline/Follow-up 1|Hospitalization|0|||
42313789|NCT02054715|76149684|FG000|Baseline/Follow-up 1|Changed Mind|1|||
42313790|NCT02054715|76149685|FG001|Baseline/Follow-up 1|Changed Mind|0|||
42313791|NCT02054715|76149684|FG000|Follow-up 2|Lost to Followup|3|||
41992833|NCT01152385|75801027|FG002|Overall Study|Other|2|||
41992834|NCT01152385|75801028|FG003|Overall Study|Other|3|||
41992835|NCT01152190|75801044|FG000|Overall Study|Adverse Event|2|||
41992836|NCT01152190|75801045|FG001|Overall Study|Adverse Event|4|||
41992837|NCT01152190|75801044|FG000|Overall Study|Death|1|||
41992838|NCT01152190|75801045|FG001|Overall Study|Death|0|||
41992839|NCT01152190|75801044|FG000|Overall Study|Protocol Violation|1|||
41992840|NCT01152190|75801045|FG001|Overall Study|Protocol Violation|1|||
41992841|NCT01152190|75801044|FG000|Overall Study|Withdrawal by Subject|1|||
41992842|NCT01152190|75801045|FG001|Overall Study|Withdrawal by Subject|3|||
41992843|NCT01151410|75801053|FG000|Overall Study|Withdrawal by Subject|3|||
41992844|NCT01151410|75801054|FG001|Overall Study|Withdrawal by Subject|5|||
41992845|NCT01151410|75801053|FG000|Overall Study|Lost to Follow-up|3|||
41992846|NCT01151410|75801054|FG001|Overall Study|Lost to Follow-up|4|||
41992847|NCT01151410|75801053|FG000|Overall Study|Adverse Event|1|||
41992848|NCT01151410|75801054|FG001|Overall Study|Adverse Event|2|||
41992849|NCT01151410|75801053|FG000|Overall Study|Protocol deviation|2|||
41992850|NCT01151410|75801054|FG001|Overall Study|Protocol deviation|1|||
41992851|NCT01151410|75801053|FG000|Overall Study|Administrative problems|1|||
41992852|NCT01151410|75801054|FG001|Overall Study|Administrative problems|1|||
41992853|NCT01151410|75801053|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
41992854|NCT01151410|75801054|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
41992855|NCT01151410|75801053|FG000|Overall Study|Abnormal laboratory value(s)|0|||
41992856|NCT01151410|75801054|FG001|Overall Study|Abnormal laboratory value(s)|1|||
41992857|NCT01151215|75801063|FG000|Overall Study|Worsening of condition under study|1|||
41992858|NCT01151215|75801064|FG001|Overall Study|Worsening of condition under study|1|||
41992859|NCT01151215|75801065|FG002|Overall Study|Worsening of condition under study|1|||
41992860|NCT01151215|75801063|FG000|Overall Study|Death|16|||
41992861|NCT01151215|75801064|FG001|Overall Study|Death|20|||
41992862|NCT01151215|75801065|FG002|Overall Study|Death|11|||
41992863|NCT01151215|75801063|FG000|Overall Study|Lost to Follow-up|0|||
41992864|NCT01151215|75801064|FG001|Overall Study|Lost to Follow-up|0|||
41992865|NCT01151215|75801065|FG002|Overall Study|Lost to Follow-up|3|||
41992866|NCT01151215|75801063|FG000|Overall Study|Withdrawal by Subject|3|||
41992867|NCT01151215|75801064|FG001|Overall Study|Withdrawal by Subject|1|||
41992868|NCT01151215|75801065|FG002|Overall Study|Withdrawal by Subject|2|||
41992869|NCT01151215|75801063|FG000|Overall Study|Disease progression|0|||
42033428|NCT01181102|75841683|FG000|Overall Study|Lack of Efficacy|3|||
41992870|NCT01151215|75801064|FG001|Overall Study|Disease progression|1|||
41992871|NCT01151215|75801065|FG002|Overall Study|Disease progression|1|||
41992872|NCT01151215|75801063|FG000|Overall Study|Safety as judged by the investigator|0|||
42033429|NCT01181102|75841684|FG001|Overall Study|Lack of Efficacy|1|||
42033430|NCT01181102|75841683|FG000|Overall Study|Lost to Follow-up|2|||
42033431|NCT01181102|75841684|FG001|Overall Study|Lost to Follow-up|0|||
42033432|NCT01181102|75841683|FG000|Overall Study|Physician Decision|3|||
42033433|NCT01181102|75841684|FG001|Overall Study|Physician Decision|1|||
42033434|NCT01181102|75841683|FG000|Overall Study|Protocol Violation|5|||
42033435|NCT01181102|75841684|FG001|Overall Study|Protocol Violation|6|||
42033436|NCT01181102|75841683|FG000|Overall Study|Withdrawal by Subject|10|||
42033437|NCT01181102|75841684|FG001|Overall Study|Withdrawal by Subject|12|||
42033438|NCT00858637|75841692|FG000|Active Comparison Phase|Adverse Event|14|||
42033439|NCT00858637|75841693|FG001|Active Comparison Phase|Adverse Event|0|||
42313792|NCT02054715|76149685|FG001|Follow-up 2|Lost to Followup|1|||
42313793|NCT02054715|76149684|FG000|Follow-up 2|Refused|3|||
42313794|NCT02054715|76149685|FG001|Follow-up 2|Refused|2|||
42313795|NCT02054715|76149684|FG000|Follow-up 2|Followup Not Completed|3|||
42313796|NCT02054715|76149685|FG001|Follow-up 2|Followup Not Completed|4|||
42313797|NCT02054715|76149684|FG000|Follow-up 2|Ineligible|4|||
42313798|NCT02054715|76149685|FG001|Follow-up 2|Ineligible|5|||
42313799|NCT02054715|76149684|FG000|Follow-up 2|Death|3|||
42313800|NCT02054715|76149685|FG001|Follow-up 2|Death|3|||
42033440|NCT00858637|75841694|FG002|Active Comparison Phase|Adverse Event|0|||
42033441|NCT00858637|75841695|FG003|Active Comparison Phase|Adverse Event|9|||
42033442|NCT00858637|75841696|FG004|Active Comparison Phase|Adverse Event|0|||
42033443|NCT00858637|75841697|FG005|Active Comparison Phase|Adverse Event|0|||
42313801|NCT02054715|76149684|FG000|Follow-up 2|Hospitalization|0|||
41992873|NCT01151215|75801064|FG001|Overall Study|Safety as judged by the investigator|0|||
41992874|NCT01151215|75801065|FG002|Overall Study|Safety as judged by the investigator|1|||
41992875|NCT01151137|75801075|FG000|Overall Study|Death|15|||
41992876|NCT01151137|75801076|FG001|Overall Study|Death|27|||
41992877|NCT01151137|75801075|FG000|Overall Study|Lost to Follow-up|1|||
41992878|NCT01151137|75801076|FG001|Overall Study|Lost to Follow-up|1|||
41992879|NCT01151098|75801082|FG000|Overall Study|Adverse Event|82|||
42313802|NCT02054715|76149685|FG001|Follow-up 2|Hospitalization|2|||
42313803|NCT02054715|76149684|FG000|Follow-up 2|Changed MD/Facility|0|||
42313804|NCT02054715|76149685|FG001|Follow-up 2|Changed MD/Facility|1|||
42313805|NCT02054715|76149684|FG000|Follow-up 2|Changed Mind|0|||
42313806|NCT02054715|76149685|FG001|Follow-up 2|Changed Mind|1|||
42313807|NCT02054715|76149684|FG000|Follow-up 2|No Reason|2|||
42313808|NCT02054715|76149685|FG001|Follow-up 2|No Reason|0|||
42313809|NCT02054715|76149684|FG000|Follow-up 2|Treatment Change or Delay|1|||
42313810|NCT02054715|76149685|FG001|Follow-up 2|Treatment Change or Delay|0|||
42313811|NCT02446769|76149691|FG000|Screening Period|Screen Failure|11|||
42313812|NCT02446769|76149692|FG001|Screening Period|Screen Failure|0|||
42313813|NCT02446769|76149693|FG002|Screening Period|Screen Failure|0|||
42313814|NCT02446769|76149691|FG000|Study Period|Randomized in Error|0|||
42313815|NCT02446769|76149692|FG001|Study Period|Randomized in Error|2|||
42313816|NCT02446769|76149693|FG002|Study Period|Randomized in Error|0|||
42313817|NCT02420093|76149702|FG000|Overall Study|Withdrawal by Subject|1|||
42313818|NCT02420093|76149703|FG001|Overall Study|Withdrawal by Subject|1|||
42313819|NCT02419937|76149711|FG000|Overall Study|Lost to Follow-up|1|||
42313820|NCT02419937|76149712|FG001|Overall Study|Lost to Follow-up|0|||
42313821|NCT02054481|76149722|FG000|Overall Study|Adverse Event|1|||
42313822|NCT02054481|76149723|FG001|Overall Study|Adverse Event|1|||
42313823|NCT02054481|76149724|FG002|Overall Study|Adverse Event|0|||
42313824|NCT02054481|76149725|FG003|Overall Study|Adverse Event|1|||
42313825|NCT02054481|76149722|FG000|Overall Study|Lost to Follow-up|1|||
42313826|NCT02054481|76149723|FG001|Overall Study|Lost to Follow-up|0|||
42313827|NCT02054481|76149724|FG002|Overall Study|Lost to Follow-up|0|||
42313828|NCT02054481|76149725|FG003|Overall Study|Lost to Follow-up|0|||
42313829|NCT02054481|76149722|FG000|Overall Study|Other reason|2|||
42313830|NCT02054481|76149723|FG001|Overall Study|Other reason|1|||
42313831|NCT02054481|76149724|FG002|Overall Study|Other reason|2|||
42313832|NCT02054481|76149725|FG003|Overall Study|Other reason|0|||
42313833|NCT01610752|76149739|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
42313834|NCT01610752|76149740|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
42313835|NCT01610752|76149741|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
42313836|NCT02054325|76149751|FG000|Overall Study|Lost to Follow-up|8|||
41992880|NCT01151098|75801082|FG000|Overall Study|Lost to Follow-up|6|||
42255066|NCT01151423|76081430|FG001|Overall Study|Protocol Violation|1|||
42255067|NCT01151423|76081429|FG000|Overall Study|Physician Decision|1|||
42255068|NCT01151423|76081430|FG001|Overall Study|Physician Decision|1|||
42255069|NCT01151423|76081429|FG000|Overall Study|Pregnancy|0|||
42255070|NCT01151423|76081430|FG001|Overall Study|Pregnancy|1|||
42255071|NCT01151423|76081429|FG000|Overall Study|Death|0|||
42255072|NCT01151423|76081430|FG001|Overall Study|Death|1|||
42255073|NCT01151423|76081429|FG000|Overall Study|Adverse Event|3|||
42255074|NCT01151423|76081430|FG001|Overall Study|Adverse Event|0|||
42255075|NCT01151423|76081429|FG000|Overall Study|Withdrawal by Subject|1|||
42255076|NCT01151423|76081430|FG001|Overall Study|Withdrawal by Subject|3|||
42255077|NCT01151423|76081429|FG000|Overall Study|Lost to Follow-up|1|||
42255078|NCT01151423|76081430|FG001|Overall Study|Lost to Follow-up|0|||
42255079|NCT01151423|76081429|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
42255080|NCT01151423|76081430|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
42255081|NCT01151423|76081429|FG000|Overall Study|Participated in other clinical trial|1|||
42255082|NCT01151423|76081430|FG001|Overall Study|Participated in other clinical trial|0|||
42255083|NCT00565617|76081441|FG000|Overall Study|Withdrawal by Subject|1|||
42255084|NCT00453154|76081448|FG000|Double BIind Maintenance|Adverse Event|0|||
42255085|NCT00453154|76081449|FG001|Double BIind Maintenance|Adverse Event|0|||
42255086|NCT00453154|76081450|FG002|Double BIind Maintenance|Adverse Event|3|||
42255087|NCT00453154|76081451|FG003|Double BIind Maintenance|Adverse Event|12|||
42255088|NCT00453154|76081448|FG000|Double BIind Maintenance|Death|0|||
42255089|NCT00453154|76081449|FG001|Double BIind Maintenance|Death|0|||
42255090|NCT00453154|76081450|FG002|Double BIind Maintenance|Death|2|||
42255091|NCT00453154|76081451|FG003|Double BIind Maintenance|Death|1|||
42255092|NCT00453154|76081448|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
42255093|NCT00453154|76081449|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
42255094|NCT00453154|76081450|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
42255095|NCT00453154|76081451|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
42255096|NCT00453154|76081448|FG000|Double BIind Maintenance|Progression|0|||
41992881|NCT01151098|75801082|FG000|Overall Study|Lack of Efficacy|15|||
41992882|NCT01151098|75801082|FG000|Overall Study|Protocol Violation|1|||
41992883|NCT01151098|75801082|FG000|Overall Study|Miscellaneous|13|||
42255097|NCT00453154|76081449|FG001|Double BIind Maintenance|Progression|0|||
42255098|NCT00453154|76081450|FG002|Double BIind Maintenance|Progression|29|||
42255099|NCT00453154|76081451|FG003|Double BIind Maintenance|Progression|26|||
42255100|NCT00453154|76081448|FG000|Double BIind Maintenance|Medical Issues|0|||
42255101|NCT00453154|76081449|FG001|Double BIind Maintenance|Medical Issues|0|||
42255102|NCT00453154|76081450|FG002|Double BIind Maintenance|Medical Issues|3|||
42255103|NCT00453154|76081451|FG003|Double BIind Maintenance|Medical Issues|1|||
42313837|NCT02054325|76149752|FG001|Overall Study|Lost to Follow-up|5|||
42313838|NCT02446691|76149758|FG000|Overall Study|Withdrawal by Subject|2|||
41992884|NCT01151020|75801086|FG000|Overall Study|Death|25|||
42313839|NCT02446691|76149758|FG000|Overall Study|Lost to Follow-up|8|||
42313840|NCT02446691|76149758|FG000|Overall Study|Protocol Violation|1|||
42313841|NCT02091375|76149764|FG000|Overall Study|Adverse Event|8|||
42313842|NCT02091375|76149765|FG001|Overall Study|Adverse Event|1|||
42313843|NCT02091375|76149764|FG000|Overall Study|Lost to Follow-up|0|||
42313844|NCT02091375|76149765|FG001|Overall Study|Lost to Follow-up|1|||
42313845|NCT02091375|76149764|FG000|Overall Study|Withdrawal by Subject|0|||
42313846|NCT02091375|76149765|FG001|Overall Study|Withdrawal by Subject|1|||
42313847|NCT02091375|76149764|FG000|Overall Study|Withdrawn by the investigator|1|||
42313848|NCT02091375|76149765|FG001|Overall Study|Withdrawn by the investigator|0|||
42313849|NCT02032875|76149773|FG000|Treatment Period|Adverse Event|1|||
42313850|NCT02032875|76149774|FG001|Treatment Period|Adverse Event|0|||
42313851|NCT02032875|76149773|FG000|Treatment Period|Liver transplant, No extension needed|0|||
42313852|NCT02032875|76149774|FG001|Treatment Period|Liver transplant, No extension needed|1|||
42313853|NCT02032875|76149773|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
42313854|NCT02032875|76149774|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
42313855|NCT02032875|76149773|FG000|Follow-up Period|Death|0|||
42313856|NCT02032875|76149774|FG001|Follow-up Period|Death|1|||
42313857|NCT02032875|76149773|FG000|Follow-up Period|Virologic Relapse|3|||
42313858|NCT02032875|76149774|FG001|Follow-up Period|Virologic Relapse|10|||
42313859|NCT02032407|76149781|FG000|Overall Study|Lost to Follow-up|2|||
42313860|NCT02032407|76149781|FG000|Overall Study|Pregnancy|1|||
42313861|NCT02032407|76149781|FG000|Overall Study|Other Miscellaneous Reasons|2|||
42313862|NCT01843972|76149799|FG000|Overall Study|Withdrawal by Subject|0|||
42313863|NCT01843972|76149800|FG001|Overall Study|Withdrawal by Subject|0|||
42313864|NCT01843972|76149801|FG002|Overall Study|Withdrawal by Subject|0|||
42255104|NCT00453154|76081448|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
42255105|NCT00453154|76081449|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
42255106|NCT00453154|76081450|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
42255107|NCT00453154|76081451|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
42255108|NCT00258960|76081460|FG000|Overall Study|Death|2|||
42255109|NCT00258960|76081460|FG000|Overall Study|Disease Progression|7|||
42255110|NCT00258960|76081460|FG000|Overall Study|Adverse Event|4|||
42255111|NCT00258960|76081460|FG000|Overall Study|Physician Decision|1|||
42255112|NCT00258960|76081460|FG000|Overall Study|Withdrawal by Subject|1|||
42255113|NCT00258960|76081460|FG000|Overall Study|Mistake|2|||
42255114|NCT00121992|76081466|FG000|Overall Study|Treatment not received|2|||
42255115|NCT00121992|76081467|FG001|Overall Study|Treatment not received|11|||
42255116|NCT00070564|76081479|FG000|Overall Study|Progression|2|||
42255117|NCT00070564|76081480|FG001|Overall Study|Progression|4|||
42255118|NCT00070564|76081481|FG002|Overall Study|Progression|7|||
42255119|NCT00070564|76081482|FG003|Overall Study|Progression|7|||
42255120|NCT00070564|76081483|FG004|Overall Study|Progression|1|||
42255121|NCT00070564|76081484|FG005|Overall Study|Progression|0|||
42255122|NCT00070564|76081479|FG000|Overall Study|Delinquent|1|||
42313865|NCT01843972|76149802|FG003|Overall Study|Withdrawal by Subject|0|||
42313866|NCT01843972|76149803|FG004|Overall Study|Withdrawal by Subject|1|||
42313867|NCT01843972|76149804|FG005|Overall Study|Withdrawal by Subject|0|||
42313868|NCT01843972|76149805|FG006|Overall Study|Withdrawal by Subject|0|||
42313869|NCT01843972|76149806|FG007|Overall Study|Withdrawal by Subject|0|||
42313870|NCT01843972|76149807|FG008|Overall Study|Withdrawal by Subject|0|||
42313871|NCT01843972|76149808|FG009|Overall Study|Withdrawal by Subject|0|||
42313872|NCT01826422|76149846|FG000|Overall Study|Withdrawal by Subject|1|||
42313873|NCT01826422|76149847|FG001|Overall Study|Withdrawal by Subject|3|||
42313874|NCT01843660|76149853|FG000|Overall Study|Other|30|||
42313875|NCT02090283|76149860|FG000|Overall Study|Withdrawal by Subject|6|||
42313876|NCT02090283|76149861|FG001|Overall Study|Withdrawal by Subject|6|||
42313877|NCT02090283|76149862|FG002|Overall Study|Withdrawal by Subject|6|||
42313878|NCT02090283|76149860|FG000|Overall Study|Sponsor Terminated Study|6|||
42313879|NCT02090283|76149861|FG001|Overall Study|Sponsor Terminated Study|6|||
42313880|NCT02090283|76149862|FG002|Overall Study|Sponsor Terminated Study|1|||
42313881|NCT02090283|76149860|FG000|Overall Study|Lost to Follow-up|2|||
42313882|NCT02090283|76149861|FG001|Overall Study|Lost to Follow-up|2|||
42313883|NCT02090283|76149862|FG002|Overall Study|Lost to Follow-up|3|||
42313884|NCT02090283|76149860|FG000|Overall Study|Adverse Event|1|||
42313885|NCT02090283|76149861|FG001|Overall Study|Adverse Event|1|||
42313886|NCT02090283|76149862|FG002|Overall Study|Adverse Event|0|||
42313887|NCT02090283|76149860|FG000|Overall Study|Protocol Violation|2|||
42033444|NCT00858637|75841692|FG000|Active Comparison Phase|Death|1|||
42255123|NCT00070564|76081480|FG001|Overall Study|Delinquent|4|||
42255124|NCT00070564|76081481|FG002|Overall Study|Delinquent|2|||
42255125|NCT00070564|76081482|FG003|Overall Study|Delinquent|0|||
42313888|NCT02090283|76149861|FG001|Overall Study|Protocol Violation|0|||
42313889|NCT02090283|76149862|FG002|Overall Study|Protocol Violation|0|||
42313890|NCT02032173|76149870|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
42313891|NCT02031471|76149874|FG000|24 Week Treatment Period|Adverse Event|6|||
42313892|NCT02031471|76149874|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
42255126|NCT00070564|76081483|FG004|Overall Study|Delinquent|0|||
42313893|NCT02031471|76149874|FG000|24 Week Treatment Period|Protocol Violation|1|||
41992885|NCT01151020|75801086|FG000|Overall Study|Conversion to open repair|1|||
41992886|NCT01151020|75801086|FG000|Overall Study|Lost to Follow-up|4|||
41992887|NCT01151020|75801086|FG000|Overall Study|Withdrawal by Subject|22|||
41992888|NCT01151020|75801086|FG000|Overall Study|Patients did not receive the device|2|||
41992889|NCT01150474|75801092|FG000|Overall Study|Withdrawal by Subject|5|||
41992890|NCT01150474|75801093|FG001|Overall Study|Withdrawal by Subject|2|||
41992891|NCT01150474|75801092|FG000|Overall Study|Cancer found|1|||
41992892|NCT01150474|75801093|FG001|Overall Study|Cancer found|0|||
41992893|NCT01150474|75801092|FG000|Overall Study|Multiple Studies|0|||
41992894|NCT01150474|75801093|FG001|Overall Study|Multiple Studies|1|||
41992895|NCT01150474|75801092|FG000|Overall Study|Rectotomy|1|||
41992896|NCT01150474|75801093|FG001|Overall Study|Rectotomy|0|||
41992897|NCT01150474|75801092|FG000|Overall Study|Drug did not arrive in time|1|||
41992898|NCT01150474|75801093|FG001|Overall Study|Drug did not arrive in time|0|||
41992899|NCT01150474|75801092|FG000|Overall Study|Drug not administered|1|||
41992900|NCT01150474|75801093|FG001|Overall Study|Drug not administered|0|||
41992901|NCT01150474|75801092|FG000|Overall Study|Surgery Changed|1|||
41992902|NCT01150474|75801093|FG001|Overall Study|Surgery Changed|0|||
41992903|NCT01150357|75801102|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
41992904|NCT01150357|75801103|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
42033445|NCT00858637|75841693|FG001|Active Comparison Phase|Death|0|||
42255127|NCT00070564|76081484|FG005|Overall Study|Delinquent|0|||
42255128|NCT00070564|76081479|FG000|Overall Study|Adverse Event|150|||
42255129|NCT00070564|76081480|FG001|Overall Study|Adverse Event|142|||
42255130|NCT00070564|76081481|FG002|Overall Study|Adverse Event|120|||
42255131|NCT00070564|76081482|FG003|Overall Study|Adverse Event|108|||
42255132|NCT00070564|76081483|FG004|Overall Study|Adverse Event|63|||
42255133|NCT00070564|76081484|FG005|Overall Study|Adverse Event|36|||
42255134|NCT00070564|76081479|FG000|Overall Study|Death|4|||
42255135|NCT00070564|76081480|FG001|Overall Study|Death|1|||
42255136|NCT00070564|76081481|FG002|Overall Study|Death|5|||
42255137|NCT00070564|76081482|FG003|Overall Study|Death|3|||
42255138|NCT00070564|76081483|FG004|Overall Study|Death|0|||
42255139|NCT00070564|76081484|FG005|Overall Study|Death|1|||
42255140|NCT00070564|76081479|FG000|Overall Study|Other, not protocol specified|17|||
42255141|NCT00070564|76081480|FG001|Overall Study|Other, not protocol specified|15|||
42255142|NCT00070564|76081481|FG002|Overall Study|Other, not protocol specified|14|||
42255143|NCT00070564|76081482|FG003|Overall Study|Other, not protocol specified|19|||
42255144|NCT00070564|76081483|FG004|Overall Study|Other, not protocol specified|6|||
42255145|NCT00070564|76081484|FG005|Overall Study|Other, not protocol specified|7|||
42255146|NCT00070564|76081479|FG000|Overall Study|Withdrawal by Subject|26|||
42255147|NCT00070564|76081480|FG001|Overall Study|Withdrawal by Subject|37|||
42255148|NCT00070564|76081481|FG002|Overall Study|Withdrawal by Subject|23|||
42255149|NCT00070564|76081482|FG003|Overall Study|Withdrawal by Subject|30|||
42255150|NCT00070564|76081483|FG004|Overall Study|Withdrawal by Subject|8|||
42255151|NCT00070564|76081484|FG005|Overall Study|Withdrawal by Subject|8|||
42255152|NCT00070564|76081479|FG000|Overall Study|Not reported|0|||
42255153|NCT00070564|76081480|FG001|Overall Study|Not reported|0|||
42255154|NCT00070564|76081481|FG002|Overall Study|Not reported|0|||
42255155|NCT00070564|76081482|FG003|Overall Study|Not reported|0|||
42255156|NCT00070564|76081483|FG004|Overall Study|Not reported|1|||
42255157|NCT00070564|76081484|FG005|Overall Study|Not reported|0|||
42255158|NCT02738151|76081510|FG000|Overall Study|Randomized but not treated|4|||
42255159|NCT02738151|76081511|FG001|Overall Study|Randomized but not treated|1|||
42255160|NCT02738151|76081510|FG000|Overall Study|Adverse Event|4|||
42255161|NCT02738151|76081511|FG001|Overall Study|Adverse Event|5|||
42255162|NCT02738151|76081510|FG000|Overall Study|Hypoglycemia|0|||
42255163|NCT02738151|76081511|FG001|Overall Study|Hypoglycemia|1|||
42255164|NCT02738151|76081510|FG000|Overall Study|Poor Compliance to Protocol|4|||
42255165|NCT02738151|76081511|FG001|Overall Study|Poor Compliance to Protocol|3|||
42255166|NCT02738151|76081510|FG000|Overall Study|Other than specified above|11|||
42255167|NCT02738151|76081511|FG001|Overall Study|Other than specified above|21|||
42255168|NCT02915159|76081519|FG000|Overall Study|Participant no longer meets criteria|2|||
42255169|NCT02915159|76081520|FG001|Overall Study|Participant no longer meets criteria|0|||
42255170|NCT02915159|76081519|FG000|Overall Study|poor/non-compliance|1|||
41992905|NCT01150357|75801104|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
41992906|NCT01150357|75801102|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
42313894|NCT02031471|76149874|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
42033446|NCT00858637|75841694|FG002|Active Comparison Phase|Death|0|||
42033447|NCT00858637|75841695|FG003|Active Comparison Phase|Death|1|||
42033448|NCT00858637|75841696|FG004|Active Comparison Phase|Death|0|||
42033449|NCT00858637|75841697|FG005|Active Comparison Phase|Death|0|||
42033450|NCT00858637|75841692|FG000|Active Comparison Phase|Physician Decision|1|||
42033451|NCT00858637|75841693|FG001|Active Comparison Phase|Physician Decision|0|||
42033452|NCT00858637|75841694|FG002|Active Comparison Phase|Physician Decision|0|||
42033453|NCT00858637|75841695|FG003|Active Comparison Phase|Physician Decision|1|||
42033454|NCT00858637|75841696|FG004|Active Comparison Phase|Physician Decision|0|||
41992907|NCT01150357|75801103|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
41992908|NCT01150357|75801104|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
41992909|NCT01150357|75801102|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
41992910|NCT01150357|75801103|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
41992911|NCT01150357|75801104|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
41992912|NCT01150357|75801102|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
41992913|NCT01150357|75801103|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
41992914|NCT01150357|75801104|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
41992915|NCT01150357|75801102|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
41992916|NCT01150357|75801103|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
41992917|NCT01150357|75801104|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
41992918|NCT01150357|75801102|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
41992919|NCT01150357|75801103|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
41992920|NCT01150357|75801104|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
41992921|NCT01150357|75801102|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
41992922|NCT01150357|75801103|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
41992923|NCT01150357|75801104|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
41992924|NCT01150123|75801154|FG000|Overall Study|Withdrawal by Subject|1|||
41992925|NCT01150123|75801155|FG001|Overall Study|Withdrawal by Subject|1|||
41992926|NCT01150123|75801156|FG002|Overall Study|Withdrawal by Subject|2|||
41992927|NCT01150123|75801157|FG003|Overall Study|Withdrawal by Subject|1|||
41992928|NCT01150123|75801158|FG004|Overall Study|Withdrawal by Subject|1|||
41992929|NCT01150123|75801159|FG005|Overall Study|Withdrawal by Subject|1|||
41992930|NCT01150123|75801160|FG006|Overall Study|Withdrawal by Subject|0|||
41992931|NCT01150123|75801161|FG007|Overall Study|Withdrawal by Subject|3|||
41992932|NCT01150123|75801162|FG008|Overall Study|Withdrawal by Subject|2|||
41992933|NCT01150123|75801163|FG009|Overall Study|Withdrawal by Subject|0|||
41992934|NCT01150123|75801164|FG010|Overall Study|Withdrawal by Subject|1|||
41992935|NCT01150123|75801165|FG011|Overall Study|Withdrawal by Subject|0|||
41992936|NCT01150123|75801166|FG012|Overall Study|Withdrawal by Subject|1|||
41992937|NCT01150123|75801167|FG013|Overall Study|Withdrawal by Subject|0|||
42033455|NCT00858637|75841697|FG005|Active Comparison Phase|Physician Decision|0|||
42033456|NCT00858637|75841692|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
42313895|NCT02031471|76149874|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
42313896|NCT02031471|76149874|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
42313897|NCT02031471|76149874|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
42313898|NCT02461589|76149888|FG000|Overall Study|Withdrawal by Subject|5|||
42313899|NCT02461589|76149889|FG001|Overall Study|Withdrawal by Subject|1|||
42313900|NCT02461589|76149890|FG002|Overall Study|Withdrawal by Subject|3|||
42313901|NCT02461589|76149891|FG003|Overall Study|Withdrawal by Subject|2|||
42313902|NCT02461589|76149892|FG004|Overall Study|Withdrawal by Subject|1|||
42313903|NCT02461589|76149893|FG005|Overall Study|Withdrawal by Subject|2|||
42313904|NCT02461589|76149894|FG006|Overall Study|Withdrawal by Subject|1|||
42313905|NCT02461589|76149895|FG007|Overall Study|Withdrawal by Subject|3|||
42313906|NCT02461589|76149896|FG008|Overall Study|Withdrawal by Subject|3|||
41992938|NCT01150123|75801168|FG014|Overall Study|Withdrawal by Subject|0|||
42033457|NCT00858637|75841693|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
42255171|NCT02915159|76081520|FG001|Overall Study|poor/non-compliance|0|||
42255172|NCT02915159|76081519|FG000|Overall Study|Participant withdrew consent|5|||
42255173|NCT02915159|76081520|FG001|Overall Study|Participant withdrew consent|1|||
42255174|NCT02915159|76081519|FG000|Overall Study|Request to discontinue treatment|1|||
42255175|NCT02915159|76081520|FG001|Overall Study|Request to discontinue treatment|2|||
42255176|NCT02915159|76081519|FG000|Overall Study|Adverse Event|2|||
42255177|NCT02915159|76081520|FG001|Overall Study|Adverse Event|2|||
42255178|NCT02915159|76081519|FG000|Overall Study|Lack of Efficacy|0|||
42255179|NCT02915159|76081520|FG001|Overall Study|Lack of Efficacy|3|||
42255180|NCT02924051|76081532|FG000|Overall Study|Withdrawal by Subject|1|||
42255181|NCT02924051|76081533|FG001|Overall Study|Withdrawal by Subject|9|||
42255182|NCT02923427|76081547|FG000|Overall Study|convert to laparatomy|2|||
42313907|NCT02461589|76149897|FG009|Overall Study|Withdrawal by Subject|1|||
42313908|NCT02461589|76149888|FG000|Overall Study|Lost to Follow-up|0|||
42313909|NCT02461589|76149889|FG001|Overall Study|Lost to Follow-up|0|||
42313910|NCT02461589|76149890|FG002|Overall Study|Lost to Follow-up|2|||
42313911|NCT02461589|76149891|FG003|Overall Study|Lost to Follow-up|3|||
42313912|NCT02461589|76149892|FG004|Overall Study|Lost to Follow-up|1|||
42313913|NCT02461589|76149893|FG005|Overall Study|Lost to Follow-up|1|||
42313914|NCT02461589|76149894|FG006|Overall Study|Lost to Follow-up|3|||
42313915|NCT02461589|76149895|FG007|Overall Study|Lost to Follow-up|1|||
42313916|NCT02461589|76149896|FG008|Overall Study|Lost to Follow-up|3|||
42313917|NCT02461589|76149897|FG009|Overall Study|Lost to Follow-up|1|||
42313918|NCT02461589|76149888|FG000|Overall Study|Death|0|||
42313919|NCT02461589|76149889|FG001|Overall Study|Death|0|||
42313920|NCT02461589|76149890|FG002|Overall Study|Death|0|||
42313921|NCT02461589|76149891|FG003|Overall Study|Death|0|||
42313922|NCT02461589|76149892|FG004|Overall Study|Death|0|||
42313923|NCT02461589|76149893|FG005|Overall Study|Death|0|||
42313924|NCT02461589|76149894|FG006|Overall Study|Death|0|||
42313925|NCT02461589|76149895|FG007|Overall Study|Death|1|||
42313926|NCT02461589|76149896|FG008|Overall Study|Death|0|||
42313927|NCT02461589|76149897|FG009|Overall Study|Death|0|||
42313928|NCT02461589|76149888|FG000|Overall Study|Unclassified|0|||
42313929|NCT02461589|76149889|FG001|Overall Study|Unclassified|0|||
42313930|NCT02461589|76149890|FG002|Overall Study|Unclassified|0|||
42313931|NCT02461589|76149891|FG003|Overall Study|Unclassified|0|||
42313932|NCT02461589|76149892|FG004|Overall Study|Unclassified|0|||
42313933|NCT02461589|76149893|FG005|Overall Study|Unclassified|0|||
42313934|NCT02461589|76149894|FG006|Overall Study|Unclassified|1|||
42313935|NCT02461589|76149895|FG007|Overall Study|Unclassified|0|||
42313936|NCT02461589|76149896|FG008|Overall Study|Unclassified|0|||
42313937|NCT02461589|76149897|FG009|Overall Study|Unclassified|2|||
42313938|NCT02461589|76149888|FG000|Overall Study|Missing follow-up information|1|||
42313939|NCT02461589|76149889|FG001|Overall Study|Missing follow-up information|1|||
42313940|NCT02461589|76149890|FG002|Overall Study|Missing follow-up information|0|||
42313941|NCT02461589|76149891|FG003|Overall Study|Missing follow-up information|0|||
42313942|NCT02461589|76149892|FG004|Overall Study|Missing follow-up information|0|||
42313943|NCT02461589|76149893|FG005|Overall Study|Missing follow-up information|0|||
42313944|NCT02461589|76149894|FG006|Overall Study|Missing follow-up information|1|||
42313945|NCT02461589|76149895|FG007|Overall Study|Missing follow-up information|0|||
42313946|NCT02461589|76149896|FG008|Overall Study|Missing follow-up information|0|||
42313947|NCT02461589|76149897|FG009|Overall Study|Missing follow-up information|0|||
42313948|NCT02461589|76149888|FG000|Overall Study|Withdrawal from trial before exposure|0|||
42313949|NCT02461589|76149889|FG001|Overall Study|Withdrawal from trial before exposure|0|||
42313950|NCT02461589|76149890|FG002|Overall Study|Withdrawal from trial before exposure|0|||
42313951|NCT02461589|76149891|FG003|Overall Study|Withdrawal from trial before exposure|0|||
42313952|NCT02461589|76149892|FG004|Overall Study|Withdrawal from trial before exposure|0|||
42313953|NCT02461589|76149893|FG005|Overall Study|Withdrawal from trial before exposure|0|||
42313954|NCT02461589|76149894|FG006|Overall Study|Withdrawal from trial before exposure|0|||
42313955|NCT02461589|76149895|FG007|Overall Study|Withdrawal from trial before exposure|0|||
42313956|NCT02461589|76149896|FG008|Overall Study|Withdrawal from trial before exposure|0|||
42313957|NCT02461589|76149897|FG009|Overall Study|Withdrawal from trial before exposure|1|||
42313958|NCT02089737|76149919|FG000|Overall Study|Survey form not completed|5|||
42313959|NCT02089737|76149919|FG000|Overall Study|Not treated|1|||
42313960|NCT02460575|76149926|FG000|Overall Study|Lost to Follow-up|1|||
42313961|NCT02460575|76149927|FG001|Overall Study|Lost to Follow-up|0|||
42313962|NCT02089347|76149935|FG000|Overall Study|Protocol Violation|1|||
42313963|NCT02089347|76149936|FG001|Overall Study|Protocol Violation|0|||
42313964|NCT02445755|76149942|FG000|Overall Study|Withdrawal by Subject|2|||
42313965|NCT02445755|76149942|FG000|Overall Study|Protocol Violation|6|||
42313966|NCT02445755|76149942|FG000|Overall Study|Screen Failure|5|||
42313967|NCT02419469|76149949|FG000|Overall Study|Withdrawal by Subject|1|||
42313968|NCT02419313|76149953|FG000|First Intervention|Lost to Follow-up|2|||
42313969|NCT02419313|76149954|FG001|First Intervention|Lost to Follow-up|0|||
42313970|NCT02419313|76149953|FG000|Second Intervention|Lost to Follow-up|1|||
42313971|NCT02419313|76149954|FG001|Second Intervention|Lost to Follow-up|0|||
42313972|NCT02419001|76149962|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
42313973|NCT02419001|76149963|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
42313974|NCT02031237|76149971|FG000|Overall Study|Death|1|||
42313975|NCT02031237|76149972|FG001|Overall Study|Death|5|||
42313976|NCT02031237|76149973|FG002|Overall Study|Death|0|||
42313977|NCT02031237|76149971|FG000|Overall Study|Physician Decision|0|||
42313978|NCT02031237|76149972|FG001|Overall Study|Physician Decision|1|||
42313979|NCT02031237|76149973|FG002|Overall Study|Physician Decision|0|||
42313980|NCT02031237|76149971|FG000|Overall Study|Withdrawal by Subject|2|||
42313981|NCT02031237|76149972|FG001|Overall Study|Withdrawal by Subject|2|||
42313982|NCT02031237|76149973|FG002|Overall Study|Withdrawal by Subject|0|||
42313983|NCT02031237|76149971|FG000|Overall Study|Protocol Violation|2|||
42313984|NCT02031237|76149972|FG001|Overall Study|Protocol Violation|6|||
42313985|NCT02031237|76149973|FG002|Overall Study|Protocol Violation|0|||
42313986|NCT02031237|76149971|FG000|Overall Study|Alternate Treatment Given|0|||
42313987|NCT02031237|76149972|FG001|Overall Study|Alternate Treatment Given|0|||
42313988|NCT02031237|76149973|FG002|Overall Study|Alternate Treatment Given|3|||
42313989|NCT02088957|76149980|FG000|Overall Study|Lack of Efficacy|1|||
42313990|NCT02088957|76149981|FG001|Overall Study|Lack of Efficacy|0|||
42313991|NCT02418845|76149989|FG000|Overall Study|Lost to Follow-up|7|||
42313992|NCT02418845|76149990|FG001|Overall Study|Lost to Follow-up|2|||
42313993|NCT02418845|76149989|FG000|Overall Study|Lack of Efficacy|0|||
42313994|NCT02418845|76149990|FG001|Overall Study|Lack of Efficacy|3|||
42313995|NCT02418845|76149989|FG000|Overall Study|Physician Decision|5|||
42313996|NCT02418845|76149990|FG001|Overall Study|Physician Decision|5|||
42313997|NCT02418845|76149989|FG000|Overall Study|Protocol Violation|1|||
42313998|NCT02418845|76149990|FG001|Overall Study|Protocol Violation|0|||
41992939|NCT01150123|75801169|FG015|Overall Study|Withdrawal by Subject|1|||
41992940|NCT01150123|75801170|FG016|Overall Study|Withdrawal by Subject|0|||
42255183|NCT02923427|76081548|FG001|Overall Study|convert to laparatomy|2|||
42255184|NCT02923427|76081547|FG000|Overall Study|destaturation|1|||
42255185|NCT02923427|76081548|FG001|Overall Study|destaturation|0|||
42255186|NCT02923427|76081547|FG000|Overall Study|can not replace LMA|1|||
42255187|NCT02923427|76081548|FG001|Overall Study|can not replace LMA|0|||
42313999|NCT02418845|76149989|FG000|Overall Study|Withdrawal by Subject|3|||
42314000|NCT02418845|76149990|FG001|Overall Study|Withdrawal by Subject|2|||
42314001|NCT02088177|76149996|FG000|Overall Study|Lost to Follow-up|3|||
42314002|NCT02030535|76150000|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
42314003|NCT02029989|76150016|FG000|Overall Study|Withdrawal by Subject|1|||
41992941|NCT01150123|75801171|FG017|Overall Study|Withdrawal by Subject|1|||
42255188|NCT02669264|76081561|FG000|Overall Study|Death|5|||
42255189|NCT02669264|76081562|FG001|Overall Study|Death|5|||
42255190|NCT02669264|76081563|FG002|Overall Study|Death|3|||
41992942|NCT01150123|75801154|FG000|Overall Study|Lost to Follow-up|2|||
41992943|NCT01150123|75801155|FG001|Overall Study|Lost to Follow-up|1|||
42255191|NCT02669264|76081564|FG003|Overall Study|Death|3|||
42255192|NCT02669264|76081565|FG004|Overall Study|Death|3|||
42314004|NCT02029989|76150017|FG001|Overall Study|Withdrawal by Subject|0|||
42314005|NCT02029989|76150016|FG000|Overall Study|Withdrawal: Fear of needles|1|||
42314006|NCT02029989|76150017|FG001|Overall Study|Withdrawal: Fear of needles|0|||
42314007|NCT02029989|76150016|FG000|Overall Study|Change of location|2|||
42314008|NCT02029989|76150017|FG001|Overall Study|Change of location|3|||
42314009|NCT02029989|76150016|FG000|Overall Study|Physician Decision|2|||
42314010|NCT02029989|76150017|FG001|Overall Study|Physician Decision|0|||
41992944|NCT01150123|75801156|FG002|Overall Study|Lost to Follow-up|2|||
42314011|NCT02029989|76150016|FG000|Overall Study|Lost to Follow-up|9|||
42314012|NCT02029989|76150017|FG001|Overall Study|Lost to Follow-up|7|||
42314013|NCT02029989|76150016|FG000|Overall Study|Death|0|||
42314014|NCT02029989|76150017|FG001|Overall Study|Death|1|||
42314015|NCT02029989|76150016|FG000|Overall Study|Protocol Violation|1|||
42314016|NCT02029989|76150017|FG001|Overall Study|Protocol Violation|0|||
42314017|NCT02048241|76150025|FG000|Overall Study|Withdrawal by Subject|0|||
42314018|NCT02048241|76150026|FG001|Overall Study|Withdrawal by Subject|1|||
42314019|NCT02087943|76150035|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
42314020|NCT02087943|76150036|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
42314021|NCT02087943|76150037|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
42314022|NCT02087943|76150038|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
42314023|NCT02087943|76150039|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
42314024|NCT02087943|76150035|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
42314025|NCT02087943|76150036|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
42314026|NCT02087943|76150037|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
42314027|NCT02087943|76150038|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
42314028|NCT02087943|76150039|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
42314029|NCT02087943|76150035|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
42314030|NCT02087943|76150036|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
42314031|NCT02087943|76150037|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
42314032|NCT02087943|76150038|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
42314033|NCT02087943|76150039|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
42255193|NCT02669264|76081566|FG005|Overall Study|Death|6|||
42255194|NCT02669264|76081567|FG006|Overall Study|Death|3|||
42255195|NCT02669264|76081561|FG000|Overall Study|Withdrawal by Subject|0|||
42255196|NCT02669264|76081562|FG001|Overall Study|Withdrawal by Subject|1|||
42255197|NCT02669264|76081563|FG002|Overall Study|Withdrawal by Subject|0|||
42255198|NCT02669264|76081564|FG003|Overall Study|Withdrawal by Subject|0|||
42255199|NCT02669264|76081565|FG004|Overall Study|Withdrawal by Subject|1|||
42255200|NCT02669264|76081566|FG005|Overall Study|Withdrawal by Subject|0|||
42255201|NCT02669264|76081567|FG006|Overall Study|Withdrawal by Subject|0|||
42255202|NCT02669264|76081561|FG000|Overall Study|Lost to Follow-up|0|||
42255203|NCT02669264|76081562|FG001|Overall Study|Lost to Follow-up|0|||
42255204|NCT02669264|76081563|FG002|Overall Study|Lost to Follow-up|0|||
42255205|NCT02669264|76081564|FG003|Overall Study|Lost to Follow-up|0|||
42255206|NCT02669264|76081565|FG004|Overall Study|Lost to Follow-up|1|||
42255207|NCT02669264|76081566|FG005|Overall Study|Lost to Follow-up|0|||
42255208|NCT02669264|76081567|FG006|Overall Study|Lost to Follow-up|0|||
42255209|NCT02669264|76081561|FG000|Overall Study|Miscellaneous|0|||
42255210|NCT02669264|76081562|FG001|Overall Study|Miscellaneous|0|||
42255211|NCT02669264|76081563|FG002|Overall Study|Miscellaneous|0|||
42255212|NCT02669264|76081564|FG003|Overall Study|Miscellaneous|0|||
42255213|NCT02669264|76081565|FG004|Overall Study|Miscellaneous|0|||
42255214|NCT02669264|76081566|FG005|Overall Study|Miscellaneous|0|||
42255215|NCT02669264|76081567|FG006|Overall Study|Miscellaneous|2|||
42255216|NCT02521870|76081593|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
42255217|NCT02521870|76081594|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
42255218|NCT02521870|76081595|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
42255219|NCT02521870|76081596|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
42255220|NCT02521870|76081597|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
42255221|NCT02521870|76081598|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
42255222|NCT02521870|76081599|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
42255223|NCT02521870|76081600|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
42255224|NCT02521870|76081601|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
42255225|NCT02521870|76081602|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
42255226|NCT02521870|76081603|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
42255227|NCT02521870|76081604|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
42255228|NCT02521870|76081593|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
42255229|NCT02521870|76081594|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
42255230|NCT02521870|76081595|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
42314034|NCT02087943|76150035|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
42314035|NCT02087943|76150036|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
42255231|NCT02521870|76081596|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
42255232|NCT02521870|76081597|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
42255233|NCT02521870|76081598|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
42255234|NCT02521870|76081599|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
42255235|NCT02521870|76081600|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
42255236|NCT02521870|76081601|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
42255237|NCT02521870|76081602|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
42255238|NCT02521870|76081603|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
42314036|NCT02087943|76150037|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
42314037|NCT02087943|76150038|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
42255239|NCT02521870|76081604|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
42314038|NCT02087943|76150039|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
42314039|NCT02087943|76150035|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
42314040|NCT02087943|76150036|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
42314041|NCT02087943|76150037|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
42314042|NCT02087943|76150038|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
42314043|NCT02087943|76150039|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
42314044|NCT02087943|76150035|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
42314045|NCT02087943|76150036|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
42314046|NCT02087943|76150037|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
42314047|NCT02087943|76150038|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
42314048|NCT02087943|76150039|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
42314049|NCT02087943|76150035|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
42314050|NCT02087943|76150036|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
42314051|NCT02087943|76150037|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
42314052|NCT02087943|76150038|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
42314053|NCT02087943|76150039|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
42314054|NCT02087943|76150035|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
42314055|NCT02087943|76150036|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
42314056|NCT02087943|76150037|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
42314057|NCT02087943|76150038|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
42314058|NCT02087943|76150039|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
42314059|NCT02087943|76150035|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
42314060|NCT02087943|76150036|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
42314061|NCT02087943|76150037|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
42314062|NCT02087943|76150038|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
42314063|NCT02087943|76150039|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
42255240|NCT02521870|76081593|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
42255241|NCT02521870|76081594|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
42255242|NCT02521870|76081595|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
42255243|NCT02521870|76081596|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
42255244|NCT02521870|76081597|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
42255245|NCT02521870|76081598|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
42255246|NCT02521870|76081599|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
42255247|NCT02521870|76081600|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
42255248|NCT02521870|76081601|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
42255249|NCT02521870|76081602|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
42255250|NCT02521870|76081603|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
42255251|NCT02521870|76081604|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
42255252|NCT02521870|76081593|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
42255253|NCT02521870|76081594|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
42255254|NCT02521870|76081595|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
42255255|NCT02521870|76081596|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
42255256|NCT02521870|76081597|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
42255257|NCT02521870|76081598|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
42255258|NCT02521870|76081599|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
42255259|NCT02521870|76081600|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
42255260|NCT02521870|76081601|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
42255261|NCT02521870|76081602|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
42255262|NCT02521870|76081603|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
42255263|NCT02521870|76081604|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
42255264|NCT02521870|76081593|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
42255265|NCT02521870|76081594|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
42255266|NCT02521870|76081595|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
42255267|NCT02521870|76081596|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
42255268|NCT02521870|76081597|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
42255269|NCT02521870|76081598|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
42255270|NCT02521870|76081599|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
42255271|NCT02521870|76081600|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
42255272|NCT02521870|76081601|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
42255273|NCT02521870|76081602|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
42255274|NCT02521870|76081603|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
42255275|NCT02521870|76081604|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
42255276|NCT02521870|76081593|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
42314064|NCT02087943|76150035|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
42314065|NCT02087943|76150036|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
42314066|NCT02087943|76150037|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
42314067|NCT02087943|76150038|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
42255277|NCT02521870|76081594|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
42255278|NCT02521870|76081595|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
42314068|NCT02087943|76150039|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
42314069|NCT02029521|76150053|FG000|Overall Study|Protocol Violation|1|||
42314070|NCT02029521|76150054|FG001|Overall Study|Protocol Violation|0|||
42314071|NCT02029521|76150053|FG000|Overall Study|Withdrawal by Subject|1|||
42314072|NCT02029521|76150054|FG001|Overall Study|Withdrawal by Subject|1|||
42314073|NCT02443883|76150075|FG000|Overall Study|Adverse Event|0|||
42314074|NCT02443883|76150076|FG001|Overall Study|Adverse Event|1|||
42314075|NCT02443883|76150077|FG002|Overall Study|Adverse Event|0|||
42314076|NCT02443883|76150078|FG003|Overall Study|Adverse Event|0|||
42314077|NCT02443883|76150075|FG000|Overall Study|Lost to Follow-up|3|||
42314078|NCT02443883|76150076|FG001|Overall Study|Lost to Follow-up|2|||
42314079|NCT02443883|76150077|FG002|Overall Study|Lost to Follow-up|1|||
42314080|NCT02443883|76150078|FG003|Overall Study|Lost to Follow-up|0|||
42314081|NCT02443883|76150075|FG000|Overall Study|Physician Decision|1|||
42314082|NCT02443883|76150076|FG001|Overall Study|Physician Decision|1|||
42314083|NCT02443883|76150077|FG002|Overall Study|Physician Decision|0|||
42314084|NCT02443883|76150078|FG003|Overall Study|Physician Decision|3|||
42314085|NCT02443883|76150075|FG000|Overall Study|Withdrawal by Subject|1|||
42314086|NCT02443883|76150076|FG001|Overall Study|Withdrawal by Subject|0|||
42314087|NCT02443883|76150077|FG002|Overall Study|Withdrawal by Subject|0|||
42314088|NCT02443883|76150078|FG003|Overall Study|Withdrawal by Subject|2|||
42314089|NCT02443883|76150075|FG000|Overall Study|Randomized, but never treated|1|||
42314090|NCT02443883|76150076|FG001|Overall Study|Randomized, but never treated|0|||
42314091|NCT02443883|76150077|FG002|Overall Study|Randomized, but never treated|0|||
42314092|NCT02443883|76150078|FG003|Overall Study|Randomized, but never treated|0|||
42314093|NCT02460263|76150088|FG000|Transition Period|Withdrawal by Subject|1|||
42314094|NCT02460263|76150088|FG000|Transition Period|Death|1|||
42314095|NCT02443805|76150098|FG000|Overall Study|Adverse Event|100|||
42314096|NCT02443805|76150099|FG001|Overall Study|Adverse Event|18|||
42314097|NCT02443805|76150098|FG000|Overall Study|Withdrawal by Subject|73|||
42314098|NCT02443805|76150099|FG001|Overall Study|Withdrawal by Subject|74|||
42314099|NCT02443805|76150098|FG000|Overall Study|Lost to Follow-up|19|||
42314100|NCT02443805|76150099|FG001|Overall Study|Lost to Follow-up|14|||
42314101|NCT02443805|76150098|FG000|Overall Study|Pregnancy|6|||
42314102|NCT02443805|76150099|FG001|Overall Study|Pregnancy|5|||
42314103|NCT02443805|76150098|FG000|Overall Study|Protocol Violation|2|||
42314104|NCT02443805|76150099|FG001|Overall Study|Protocol Violation|4|||
42314105|NCT02443805|76150098|FG000|Overall Study|Lack of Efficacy|1|||
42314106|NCT02443805|76150099|FG001|Overall Study|Lack of Efficacy|1|||
42314107|NCT02443805|76150098|FG000|Overall Study|Non-compliance with study drug|6|||
42314108|NCT02443805|76150099|FG001|Overall Study|Non-compliance with study drug|4|||
42314109|NCT02443805|76150098|FG000|Overall Study|Withdrawal by parent/guardian|3|||
42255279|NCT02521870|76081596|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
42255280|NCT02521870|76081597|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
42255281|NCT02521870|76081598|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
42255282|NCT02521870|76081599|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
42255283|NCT02521870|76081600|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
42255284|NCT02521870|76081601|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
42255285|NCT02521870|76081602|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
42255286|NCT02521870|76081603|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
42255287|NCT02521870|76081604|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
42255288|NCT02521870|76081593|FG000|Phase 2: Dose Expansion|Death|0|||
42255289|NCT02521870|76081594|FG001|Phase 2: Dose Expansion|Death|0|||
42255290|NCT02521870|76081595|FG002|Phase 2: Dose Expansion|Death|0|||
42255291|NCT02521870|76081596|FG003|Phase 2: Dose Expansion|Death|0|||
42255292|NCT02521870|76081597|FG004|Phase 2: Dose Expansion|Death|1|||
42255293|NCT02521870|76081598|FG005|Phase 2: Dose Expansion|Death|1|||
42255294|NCT02521870|76081599|FG006|Phase 2: Dose Expansion|Death|3|||
42255295|NCT02521870|76081600|FG007|Phase 2: Dose Expansion|Death|1|||
42255296|NCT02521870|76081601|FG008|Phase 2: Dose Expansion|Death|1|||
42255297|NCT02521870|76081602|FG009|Phase 2: Dose Expansion|Death|5|||
42255298|NCT02521870|76081603|FG010|Phase 2: Dose Expansion|Death|2|||
42314110|NCT02443805|76150099|FG001|Overall Study|Withdrawal by parent/guardian|5|||
42314111|NCT02443805|76150098|FG000|Overall Study|Any other reason not above-mentioned|3|||
42314112|NCT02443805|76150099|FG001|Overall Study|Any other reason not above-mentioned|2|||
42314113|NCT01652885|76150105|FG000|Overall Study|Adverse Event|1|||
42314114|NCT02459951|76150109|FG000|Overall Study|Unable to meet holding requirement|1|||
42314115|NCT02087241|76150118|FG000|Overall Study|Death|2|||
42314116|NCT02087241|76150119|FG001|Overall Study|Death|1|||
42314117|NCT02087241|76150120|FG002|Overall Study|Death|1|||
42314118|NCT02087241|76150121|FG003|Overall Study|Death|1|||
42314119|NCT02087241|76150118|FG000|Overall Study|Withdrawal by Subject|1|||
42314120|NCT02087241|76150119|FG001|Overall Study|Withdrawal by Subject|0|||
42314121|NCT02087241|76150120|FG002|Overall Study|Withdrawal by Subject|0|||
42314122|NCT02087241|76150121|FG003|Overall Study|Withdrawal by Subject|1|||
42314123|NCT02087241|76150118|FG000|Overall Study|Progressive Disease|0|||
42314124|NCT02087241|76150119|FG001|Overall Study|Progressive Disease|0|||
41992945|NCT01150123|75801157|FG003|Overall Study|Lost to Follow-up|2|||
41992946|NCT01150123|75801158|FG004|Overall Study|Lost to Follow-up|2|||
41992947|NCT01150123|75801159|FG005|Overall Study|Lost to Follow-up|5|||
41992948|NCT01150123|75801160|FG006|Overall Study|Lost to Follow-up|0|||
41992949|NCT01150123|75801161|FG007|Overall Study|Lost to Follow-up|0|||
41992950|NCT01150123|75801162|FG008|Overall Study|Lost to Follow-up|3|||
41992951|NCT01150123|75801163|FG009|Overall Study|Lost to Follow-up|1|||
41992952|NCT01150123|75801164|FG010|Overall Study|Lost to Follow-up|1|||
41992953|NCT01150123|75801165|FG011|Overall Study|Lost to Follow-up|1|||
41992954|NCT01150123|75801166|FG012|Overall Study|Lost to Follow-up|2|||
41992955|NCT01150123|75801167|FG013|Overall Study|Lost to Follow-up|0|||
41992956|NCT01150123|75801168|FG014|Overall Study|Lost to Follow-up|0|||
41992957|NCT01150123|75801169|FG015|Overall Study|Lost to Follow-up|0|||
41992958|NCT01150123|75801170|FG016|Overall Study|Lost to Follow-up|0|||
41992959|NCT01150123|75801171|FG017|Overall Study|Lost to Follow-up|0|||
42033458|NCT00858637|75841694|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
42033459|NCT00858637|75841695|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
42033460|NCT00858637|75841696|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
42033461|NCT00858637|75841697|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
42033462|NCT00858637|75841692|FG000|Active Comparison Phase|Other Reasons|1|||
42033463|NCT00858637|75841693|FG001|Active Comparison Phase|Other Reasons|0|||
41992960|NCT01149655|75801230|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
42033464|NCT00858637|75841694|FG002|Active Comparison Phase|Other Reasons|0|||
42033465|NCT00858637|75841695|FG003|Active Comparison Phase|Other Reasons|1|||
42033466|NCT00858637|75841696|FG004|Active Comparison Phase|Other Reasons|0|||
42033467|NCT00858637|75841697|FG005|Active Comparison Phase|Other Reasons|0|||
42033468|NCT00858637|75841692|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
42033469|NCT00858637|75841693|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
42033470|NCT00858637|75841694|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
42033471|NCT00858637|75841695|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
42255299|NCT02521870|76081604|FG011|Phase 2: Dose Expansion|Death|2|||
42255300|NCT02521870|76081593|FG000|Phase 2: Dose Expansion|Other|0|||
42255301|NCT02521870|76081594|FG001|Phase 2: Dose Expansion|Other|0|||
42255302|NCT02521870|76081595|FG002|Phase 2: Dose Expansion|Other|0|||
42255303|NCT02521870|76081596|FG003|Phase 2: Dose Expansion|Other|0|||
42255304|NCT02521870|76081597|FG004|Phase 2: Dose Expansion|Other|10|||
42255305|NCT02521870|76081598|FG005|Phase 2: Dose Expansion|Other|3|||
42255306|NCT02521870|76081599|FG006|Phase 2: Dose Expansion|Other|2|||
42255307|NCT02521870|76081600|FG007|Phase 2: Dose Expansion|Other|0|||
42255308|NCT02521870|76081601|FG008|Phase 2: Dose Expansion|Other|10|||
42033472|NCT00858637|75841696|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
42033473|NCT00858637|75841697|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
42133124|NCT00410163|75944016|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
42133125|NCT00410163|75944017|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
42137800|NCT00416598|75948179|FG000|Induction & Intensification|Adverse Event|38|||
42255309|NCT02521870|76081602|FG009|Phase 2: Dose Expansion|Other|5|||
42255310|NCT02521870|76081603|FG010|Phase 2: Dose Expansion|Other|1|||
42255311|NCT02521870|76081604|FG011|Phase 2: Dose Expansion|Other|7|||
42255312|NCT02521870|76081593|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
42255313|NCT02521870|76081594|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
42255314|NCT02521870|76081595|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
42255315|NCT02521870|76081596|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
42255316|NCT02521870|76081597|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
42255317|NCT02521870|76081598|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
42255318|NCT02521870|76081599|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
42255319|NCT02521870|76081600|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
42255320|NCT02521870|76081601|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
42255321|NCT02521870|76081602|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
42255322|NCT02521870|76081603|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
42255323|NCT02521870|76081604|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
41992961|NCT01149655|75801231|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
42255324|NCT02521870|76081593|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
42255325|NCT02521870|76081594|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
42314125|NCT02087241|76150120|FG002|Overall Study|Progressive Disease|0|||
42314126|NCT02087241|76150121|FG003|Overall Study|Progressive Disease|1|||
42314127|NCT02087241|76150118|FG000|Overall Study|Study Terminated by Sponsor|0|||
42314128|NCT02087241|76150119|FG001|Overall Study|Study Terminated by Sponsor|2|||
42314129|NCT02087241|76150120|FG002|Overall Study|Study Terminated by Sponsor|0|||
42314130|NCT02087241|76150121|FG003|Overall Study|Study Terminated by Sponsor|4|||
42314131|NCT02087085|76150137|FG000|Overall Study|Adverse Event|10|||
42314132|NCT02087085|76150138|FG001|Overall Study|Adverse Event|14|||
42314133|NCT02087085|76150137|FG000|Overall Study|Lack of Efficacy|4|||
42314134|NCT02087085|76150138|FG001|Overall Study|Lack of Efficacy|3|||
42314135|NCT02087085|76150137|FG000|Overall Study|Lost to Follow-up|6|||
42314136|NCT02087085|76150138|FG001|Overall Study|Lost to Follow-up|4|||
42314137|NCT02087085|76150137|FG000|Overall Study|Withdrawal by Subject|9|||
42314138|NCT02087085|76150138|FG001|Overall Study|Withdrawal by Subject|11|||
42314139|NCT02087085|76150137|FG000|Overall Study|Protocol Violation|1|||
42314140|NCT02087085|76150138|FG001|Overall Study|Protocol Violation|0|||
42314141|NCT02087085|76150137|FG000|Overall Study|Study Terminated by Sponsor|87|||
42314142|NCT02087085|76150138|FG001|Overall Study|Study Terminated by Sponsor|80|||
42314143|NCT02087085|76150137|FG000|Overall Study|Other Miscellaneous Reasons|3|||
42314144|NCT02087085|76150138|FG001|Overall Study|Other Miscellaneous Reasons|4|||
42314145|NCT02443337|76150146|FG000|Overall Study|Adverse Event|0|||
42314146|NCT02443337|76150147|FG001|Overall Study|Adverse Event|1|||
42314147|NCT02443337|76150146|FG000|Overall Study|Clinical Progressive Disease|3|||
42314148|NCT02443337|76150147|FG001|Overall Study|Clinical Progressive Disease|0|||
42314149|NCT02443337|76150146|FG000|Overall Study|Withdrawal by Subject|2|||
42314150|NCT02443337|76150147|FG001|Overall Study|Withdrawal by Subject|1|||
42314151|NCT02443103|76150158|FG000|Overall Study|Adverse Event|2|||
42314152|NCT02443103|76150158|FG000|Overall Study|Noncompliance|1|||
42314153|NCT02022657|76150162|FG000|Overall Study|Withdrawal by Subject|2|||
42314154|NCT02022657|76150163|FG001|Overall Study|Withdrawal by Subject|0|||
42314155|NCT02022657|76150164|FG002|Overall Study|Withdrawal by Subject|1|||
42314156|NCT02022657|76150165|FG003|Overall Study|Withdrawal by Subject|0|||
42314157|NCT02022657|76150166|FG004|Overall Study|Withdrawal by Subject|0|||
42314158|NCT02022657|76150167|FG005|Overall Study|Withdrawal by Subject|0|||
42314159|NCT02022657|76150162|FG000|Overall Study|Physician Decision|0|||
42314160|NCT02022657|76150163|FG001|Overall Study|Physician Decision|0|||
42314161|NCT02022657|76150164|FG002|Overall Study|Physician Decision|0|||
42314162|NCT02022657|76150165|FG003|Overall Study|Physician Decision|0|||
42314163|NCT02022657|76150166|FG004|Overall Study|Physician Decision|0|||
42314164|NCT02022657|76150167|FG005|Overall Study|Physician Decision|1|||
42314165|NCT02418455|76150173|FG000|48-Week Treatment Period|Other- Not Specified|1|||
42314166|NCT02418455|76150173|FG000|Continuation Period|Sponsor Decision|7|||
41992962|NCT01149655|75801232|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
41992963|NCT01149655|75801233|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
41992964|NCT01149655|75801230|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
41992965|NCT01149655|75801231|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
41992966|NCT01149655|75801232|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
41992967|NCT01149655|75801233|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
41992968|NCT01149655|75801230|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
41992969|NCT01149655|75801231|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
41992970|NCT01149655|75801232|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
41992971|NCT01149655|75801233|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
41992972|NCT01149655|75801230|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
41992973|NCT01149655|75801231|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
41992974|NCT01149655|75801232|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
41992975|NCT01149655|75801233|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
42033474|NCT00858637|75841692|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
42255326|NCT02521870|76081595|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
42255327|NCT02521870|76081596|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
42255328|NCT02521870|76081597|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
42255329|NCT02521870|76081598|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
42255330|NCT02521870|76081599|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
42255331|NCT02521870|76081600|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
42255332|NCT02521870|76081601|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
42314167|NCT02417753|76150179|FG000|Overall Study|Death|1|||
42314168|NCT02417441|76150185|FG000|Overall Study|Inconclusive due to missing data|52|||
42314169|NCT02417441|76150186|FG001|Overall Study|Inconclusive due to missing data|19|||
42314170|NCT02021643|76150199|FG000|Overall Study|Enrolled but Never Treated|1|||
42314171|NCT02021643|76150200|FG001|Overall Study|Enrolled but Never Treated|0|||
42314172|NCT02021643|76150201|FG002|Overall Study|Enrolled but Never Treated|0|||
42314173|NCT02021643|76150202|FG003|Overall Study|Enrolled but Never Treated|0|||
42314174|NCT02021643|76150199|FG000|Overall Study|Adverse Event|0|||
42314175|NCT02021643|76150200|FG001|Overall Study|Adverse Event|1|||
42314176|NCT02021643|76150201|FG002|Overall Study|Adverse Event|0|||
42314177|NCT02021643|76150202|FG003|Overall Study|Adverse Event|0|||
42314178|NCT02021643|76150199|FG000|Overall Study|Death|0|||
41992976|NCT01149655|75801230|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
41992977|NCT01149655|75801231|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
41992978|NCT01149655|75801232|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
41992979|NCT01149655|75801233|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
41992980|NCT01149655|75801230|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
41992981|NCT01149655|75801231|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
41992982|NCT01149655|75801232|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
41992983|NCT01149655|75801233|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
41992984|NCT01149655|75801230|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
41992985|NCT01149655|75801231|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
41992986|NCT01149655|75801232|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
41992987|NCT01149655|75801233|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
41992988|NCT01149655|75801230|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
41992989|NCT01149655|75801231|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
41992990|NCT01149655|75801232|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
41992991|NCT01149655|75801233|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
41992992|NCT01149655|75801230|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
41992993|NCT01149655|75801231|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
41992994|NCT01149655|75801232|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
41992995|NCT01149655|75801233|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
41992996|NCT01149655|75801230|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
41992997|NCT01149655|75801231|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
42033475|NCT00858637|75841693|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
42033476|NCT00858637|75841694|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
42137801|NCT00416598|75948179|FG000|Induction & Intensification|Death|32|||
42255333|NCT02521870|76081602|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
42255334|NCT02521870|76081603|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
42255335|NCT02521870|76081604|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
42255336|NCT02923349|76081641|FG000|Overall Study|Other|1|||
42255337|NCT02923349|76081642|FG001|Overall Study|Other|2|||
42255338|NCT02923349|76081643|FG002|Overall Study|Other|4|||
42255339|NCT02923349|76081644|FG003|Overall Study|Other|1|||
42255340|NCT02923349|76081645|FG004|Overall Study|Other|3|||
42255341|NCT02923349|76081646|FG005|Overall Study|Other|0|||
42255342|NCT02923349|76081647|FG006|Overall Study|Other|1|||
42255343|NCT02923349|76081641|FG000|Overall Study|Withdrawal by Subject|2|||
42255344|NCT02923349|76081642|FG001|Overall Study|Withdrawal by Subject|2|||
42255345|NCT02923349|76081643|FG002|Overall Study|Withdrawal by Subject|8|||
42255346|NCT02923349|76081644|FG003|Overall Study|Withdrawal by Subject|10|||
42255347|NCT02923349|76081645|FG004|Overall Study|Withdrawal by Subject|12|||
42255348|NCT02923349|76081646|FG005|Overall Study|Withdrawal by Subject|3|||
42255349|NCT02923349|76081647|FG006|Overall Study|Withdrawal by Subject|0|||
42255350|NCT02923349|76081641|FG000|Overall Study|Physician Decision|0|||
42255351|NCT02923349|76081642|FG001|Overall Study|Physician Decision|0|||
42255352|NCT02923349|76081643|FG002|Overall Study|Physician Decision|0|||
42255353|NCT02923349|76081644|FG003|Overall Study|Physician Decision|1|||
42255354|NCT02923349|76081645|FG004|Overall Study|Physician Decision|1|||
42255355|NCT02923349|76081646|FG005|Overall Study|Physician Decision|0|||
42255356|NCT02923349|76081647|FG006|Overall Study|Physician Decision|2|||
42255357|NCT02923349|76081641|FG000|Overall Study|Lost to Follow-up|0|||
42255358|NCT02923349|76081642|FG001|Overall Study|Lost to Follow-up|0|||
42255359|NCT02923349|76081643|FG002|Overall Study|Lost to Follow-up|3|||
42255360|NCT02923349|76081644|FG003|Overall Study|Lost to Follow-up|0|||
42255361|NCT02923349|76081645|FG004|Overall Study|Lost to Follow-up|1|||
42255362|NCT02923349|76081646|FG005|Overall Study|Lost to Follow-up|1|||
42255363|NCT02923349|76081647|FG006|Overall Study|Lost to Follow-up|0|||
42255364|NCT02923349|76081641|FG000|Overall Study|Death|1|||
42255365|NCT02923349|76081642|FG001|Overall Study|Death|0|||
42010565|NCT00993421|75817695|FG001|Overall Study|Lost to Follow-up|5|||
42255366|NCT02923349|76081643|FG002|Overall Study|Death|2|||
42255367|NCT02923349|76081644|FG003|Overall Study|Death|4|||
42255368|NCT02923349|76081645|FG004|Overall Study|Death|2|||
42255369|NCT02923349|76081646|FG005|Overall Study|Death|3|||
42255370|NCT02923349|76081647|FG006|Overall Study|Death|0|||
42255371|NCT02521792|76081663|FG000|Overall Study|Study Terminated|6|||
42255372|NCT03020615|76081670|FG000|Overall Study|Physician Decision|3|||
42255373|NCT03020615|76081671|FG001|Overall Study|Physician Decision|1|||
42255374|NCT03020615|76081672|FG002|Overall Study|Physician Decision|2|||
42255375|NCT03020615|76081670|FG000|Overall Study|Parent/guardian/patient choice|3|||
42314179|NCT02021643|76150200|FG001|Overall Study|Death|1|||
42314180|NCT02021643|76150201|FG002|Overall Study|Death|0|||
42314181|NCT02021643|76150202|FG003|Overall Study|Death|0|||
42314182|NCT02021643|76150199|FG000|Overall Study|Investigator's Discretion|1|||
42314183|NCT02021643|76150200|FG001|Overall Study|Investigator's Discretion|0|||
42314184|NCT02021643|76150201|FG002|Overall Study|Investigator's Discretion|0|||
42314185|NCT02021643|76150202|FG003|Overall Study|Investigator's Discretion|0|||
42314186|NCT02021643|76150199|FG000|Overall Study|Lack of Efficacy|7|||
42314187|NCT02021643|76150200|FG001|Overall Study|Lack of Efficacy|6|||
42314188|NCT02021643|76150201|FG002|Overall Study|Lack of Efficacy|0|||
42314189|NCT02021643|76150202|FG003|Overall Study|Lack of Efficacy|12|||
42314190|NCT02021643|76150199|FG000|Overall Study|Lost to Follow-up|0|||
42314191|NCT02021643|76150200|FG001|Overall Study|Lost to Follow-up|1|||
42314192|NCT02021643|76150201|FG002|Overall Study|Lost to Follow-up|0|||
42314193|NCT02021643|76150202|FG003|Overall Study|Lost to Follow-up|0|||
42314194|NCT02021643|76150199|FG000|Overall Study|Withdrew Consent|0|||
42314195|NCT02021643|76150200|FG001|Overall Study|Withdrew Consent|1|||
42314196|NCT02021643|76150201|FG002|Overall Study|Withdrew Consent|0|||
42314197|NCT02021643|76150202|FG003|Overall Study|Withdrew Consent|0|||
42314198|NCT02415959|76150223|FG000|Overall Study|Adverse Event|0|||
42314199|NCT02415959|76150224|FG001|Overall Study|Adverse Event|1|||
42314200|NCT02415959|76150225|FG002|Overall Study|Adverse Event|0|||
42314201|NCT02415959|76150226|FG003|Overall Study|Adverse Event|0|||
42314202|NCT02415959|76150227|FG004|Overall Study|Adverse Event|0|||
42314203|NCT02415959|76150223|FG000|Overall Study|Protocol Violation|0|||
42314204|NCT02415959|76150224|FG001|Overall Study|Protocol Violation|0|||
42314205|NCT02415959|76150225|FG002|Overall Study|Protocol Violation|0|||
42314206|NCT02415959|76150226|FG003|Overall Study|Protocol Violation|1|||
42314207|NCT02415959|76150227|FG004|Overall Study|Protocol Violation|0|||
42314208|NCT02021565|76150241|FG000|Baseline Through Intervention|Death|0|||
42314209|NCT02021565|76150242|FG001|Baseline Through Intervention|Death|1|||
42314210|NCT02021565|76150241|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
42314211|NCT02021565|76150242|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
42314212|NCT02021565|76150241|FG000|Baseline Through Intervention|Protocol Violation|0|||
42314213|NCT02021565|76150242|FG001|Baseline Through Intervention|Protocol Violation|7|||
42314214|NCT02021565|76150241|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
42314215|NCT02021565|76150242|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
42314216|NCT02021565|76150241|FG000|3-month Follow-up|Death|3|||
42314217|NCT02021565|76150242|FG001|3-month Follow-up|Death|0|||
42314218|NCT02021565|76150241|FG000|3-month Follow-up|Withdrawal by Subject|4|||
42314219|NCT02021565|76150242|FG001|3-month Follow-up|Withdrawal by Subject|0|||
42314220|NCT02021565|76150241|FG000|3-month Follow-up|Protocol Violation|3|||
42314221|NCT02021565|76150242|FG001|3-month Follow-up|Protocol Violation|2|||
42314222|NCT02021331|76150252|FG000|Overall Study|Adverse Event|0|||
42314223|NCT02021331|76150253|FG001|Overall Study|Adverse Event|2|||
42314224|NCT02085135|76150261|FG000|Overall Study|Adverse Event|4|||
42314225|NCT02085135|76150262|FG001|Overall Study|Adverse Event|7|||
42314226|NCT02085135|76150261|FG000|Overall Study|Lost to Follow-up|2|||
42314227|NCT02085135|76150262|FG001|Overall Study|Lost to Follow-up|2|||
42314228|NCT02085135|76150261|FG000|Overall Study|Withdrawal by Subject|3|||
42314229|NCT02085135|76150262|FG001|Overall Study|Withdrawal by Subject|0|||
42314230|NCT02085135|76150261|FG000|Overall Study|Lack of Efficacy|2|||
42314231|NCT02085135|76150262|FG001|Overall Study|Lack of Efficacy|0|||
42314232|NCT02441309|76150271|FG000|Overall Study|Disease progression|2|||
42314233|NCT02441309|76150272|FG001|Overall Study|Disease progression|1|||
42314234|NCT02441309|76150273|FG002|Overall Study|Disease progression|2|||
42314235|NCT02441309|76150271|FG000|Overall Study|Adverse Event|0|||
42314236|NCT02441309|76150272|FG001|Overall Study|Adverse Event|1|||
42314237|NCT02441309|76150273|FG002|Overall Study|Adverse Event|0|||
42314238|NCT02441309|76150271|FG000|Overall Study|Withdrawal by Subject|1|||
42314239|NCT02441309|76150272|FG001|Overall Study|Withdrawal by Subject|0|||
42314240|NCT02441309|76150273|FG002|Overall Study|Withdrawal by Subject|1|||
42314241|NCT02027025|76150287|FG000|Overall Study|Adverse Event|0|||
42314242|NCT02027025|76150288|FG001|Overall Study|Adverse Event|1|||
41992998|NCT01149655|75801232|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
42010566|NCT00993421|75817696|FG002|Overall Study|Lost to Follow-up|5|||
42314243|NCT02027025|76150289|FG002|Overall Study|Adverse Event|1|||
42314244|NCT02027025|76150287|FG000|Overall Study|Protocol Violation|1|||
42314245|NCT02027025|76150288|FG001|Overall Study|Protocol Violation|0|||
42314246|NCT02027025|76150289|FG002|Overall Study|Protocol Violation|0|||
42314247|NCT02027025|76150287|FG000|Overall Study|Lost to Follow-up|0|||
42314248|NCT02027025|76150288|FG001|Overall Study|Lost to Follow-up|2|||
42314249|NCT02027025|76150289|FG002|Overall Study|Lost to Follow-up|0|||
42314250|NCT02027025|76150287|FG000|Overall Study|Withdrawal by Subject|0|||
42314251|NCT02027025|76150288|FG001|Overall Study|Withdrawal by Subject|1|||
42314252|NCT02027025|76150289|FG002|Overall Study|Withdrawal by Subject|0|||
42314253|NCT02027025|76150287|FG000|Overall Study|Sponsor's decision|0|||
42314254|NCT02027025|76150288|FG001|Overall Study|Sponsor's decision|1|||
42314255|NCT02027025|76150289|FG002|Overall Study|Sponsor's decision|0|||
42314256|NCT01652729|76150311|FG000|Overall Study|Withdrawal by Subject|14|||
42314257|NCT01652729|76150312|FG001|Overall Study|Withdrawal by Subject|7|||
42255376|NCT03020615|76081671|FG001|Overall Study|Parent/guardian/patient choice|0|||
42255377|NCT03020615|76081672|FG002|Overall Study|Parent/guardian/patient choice|4|||
42314258|NCT01652729|76150313|FG002|Overall Study|Withdrawal by Subject|7|||
42314259|NCT01652729|76150311|FG000|Overall Study|Adverse Event|4|||
42314260|NCT01652729|76150312|FG001|Overall Study|Adverse Event|0|||
42314261|NCT01652729|76150313|FG002|Overall Study|Adverse Event|3|||
42314262|NCT01652729|76150311|FG000|Overall Study|Physician Decision|1|||
42314263|NCT01652729|76150312|FG001|Overall Study|Physician Decision|0|||
42314264|NCT01652729|76150313|FG002|Overall Study|Physician Decision|1|||
42314265|NCT01652729|76150311|FG000|Overall Study|Protocol Violation|1|||
42314266|NCT01652729|76150312|FG001|Overall Study|Protocol Violation|0|||
42314267|NCT01652729|76150313|FG002|Overall Study|Protocol Violation|0|||
41992999|NCT01149655|75801233|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
41993000|NCT01149655|75801230|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
41993001|NCT01149655|75801231|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
41993002|NCT01149655|75801232|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
41993003|NCT01149655|75801233|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
41993004|NCT01149655|75801230|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
41993005|NCT01149655|75801231|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
41993006|NCT01149655|75801232|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
41993007|NCT01149655|75801233|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
41993008|NCT01149655|75801230|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
41993009|NCT01149655|75801231|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
41993010|NCT01149655|75801232|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
42033477|NCT00858637|75841695|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
42033478|NCT00858637|75841696|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
42033479|NCT00858637|75841697|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
42033480|NCT00858403|75841707|FG000|Overall Study|Withdrawal by Subject|1|||
42033481|NCT00858403|75841707|FG000|Overall Study|Death|3|||
42255378|NCT03020615|76081670|FG000|Overall Study|Screen failure|0|||
42255379|NCT03020615|76081671|FG001|Overall Study|Screen failure|0|||
42255380|NCT03020615|76081672|FG002|Overall Study|Screen failure|1|||
42255381|NCT03020615|76081670|FG000|Overall Study|Death|1|||
42255382|NCT03020615|76081671|FG001|Overall Study|Death|0|||
42255383|NCT03020615|76081672|FG002|Overall Study|Death|0|||
42255384|NCT03020615|76081670|FG000|Overall Study|Lost to Follow-up|0|||
42255385|NCT03020615|76081671|FG001|Overall Study|Lost to Follow-up|1|||
42255386|NCT03020615|76081672|FG002|Overall Study|Lost to Follow-up|0|||
42255387|NCT03020069|76081685|FG000|Overall Study|Lost to Follow-up|0|||
42255388|NCT03020069|76081686|FG001|Overall Study|Lost to Follow-up|1|||
42255389|NCT03693170|76081692|FG000|Overall Study|Disease Progression|48|||
42255390|NCT03693170|76081692|FG000|Overall Study|Adverse Event|16|||
42255391|NCT03693170|76081692|FG000|Overall Study|Physician Decision|6|||
42255392|NCT03693170|76081692|FG000|Overall Study|Protocol Violation|2|||
42255393|NCT03693170|76081692|FG000|Overall Study|Death|1|||
42255394|NCT03693170|76081692|FG000|Overall Study|Non compliance with study drug|1|||
42255395|NCT03693170|76081692|FG000|Overall Study|Withdrawal by Subject|1|||
42255396|NCT03021005|76081699|FG000|Overall Study|Lost to Follow-up|39|||
42255397|NCT03021005|76081700|FG001|Overall Study|Lost to Follow-up|26|||
42255398|NCT02914457|76081706|FG000|Overall Study|Withdrawal by Subject|1|||
42255399|NCT02914457|76081706|FG000|Overall Study|Physician Decision|1|||
42255400|NCT02914457|76081706|FG000|Overall Study|No veins available for lead placement|1|||
42255401|NCT02914457|76081706|FG000|Overall Study|Electrical instability of patient|1|||
42255402|NCT02914457|76081706|FG000|Overall Study|ECG acquisition error due to sweating|1|||
42255403|NCT02914457|76081706|FG000|Overall Study|Protocol Violation|1|||
42255404|NCT02665052|76081714|FG000|Overall Study|Lost to Follow-up|1|||
42314268|NCT01652729|76150311|FG000|Overall Study|Lost to Follow-up|6|||
42314269|NCT01652729|76150312|FG001|Overall Study|Lost to Follow-up|6|||
42314270|NCT01652729|76150313|FG002|Overall Study|Lost to Follow-up|3|||
42314271|NCT01652729|76150311|FG000|Overall Study|Administrative|1|||
42255405|NCT02665052|76081715|FG001|Overall Study|Lost to Follow-up|0|||
42314272|NCT01652729|76150312|FG001|Overall Study|Administrative|0|||
42314273|NCT01652729|76150313|FG002|Overall Study|Administrative|0|||
42314274|NCT02083965|76150323|FG000|Treatment Period|Other|1|||
42314275|NCT02083965|76150324|FG001|Treatment Period|Other|0|||
42314276|NCT02438813|76150332|FG000|Overall Study|Patient Decision|59|||
42314277|NCT02438813|76150332|FG000|Overall Study|Patient Lost to Follow-Up|137|||
42314278|NCT02438813|76150332|FG000|Overall Study|Study Ended by Sponsor|80|||
42314279|NCT02438813|76150332|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
42314280|NCT02437409|76150346|FG000|Overall Study|Withdrawal by Subject|3|||
42314281|NCT02437409|76150346|FG000|Overall Study|Screening failure|12|||
42314282|NCT02459093|76150353|FG000|Overall Study|Protocol Violation|6|||
42314283|NCT02459093|76150354|FG001|Overall Study|Protocol Violation|11|||
42314284|NCT02459093|76150353|FG000|Overall Study|Lost to Follow-up|6|||
42314285|NCT02459093|76150354|FG001|Overall Study|Lost to Follow-up|7|||
42314286|NCT02458469|76150360|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
42314287|NCT02458469|76150361|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
42314288|NCT02458469|76150362|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
42314289|NCT02458469|76150363|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
42314290|NCT02458469|76150364|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
42314291|NCT02458469|76150365|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
42314292|NCT02458469|76150360|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
42314293|NCT02458469|76150361|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
42314294|NCT02458469|76150362|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
42314295|NCT02458469|76150363|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
42314296|NCT02458469|76150364|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
42314297|NCT02458469|76150365|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
42314298|NCT02458469|76150360|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
42314299|NCT02458469|76150361|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
42314300|NCT02458469|76150362|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
42314301|NCT02458469|76150363|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
42314302|NCT02458469|76150364|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
42314303|NCT02458469|76150365|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
42314304|NCT01843348|76150376|FG000|Overall Study|Withdrawal by Subject|4|||
42314305|NCT01843348|76150377|FG001|Overall Study|Withdrawal by Subject|16|||
42314306|NCT01843348|76150378|FG002|Overall Study|Withdrawal by Subject|18|||
42314307|NCT01843348|76150376|FG000|Overall Study|Lost to Follow-up|5|||
42314308|NCT01843348|76150377|FG001|Overall Study|Lost to Follow-up|4|||
42314309|NCT01843348|76150378|FG002|Overall Study|Lost to Follow-up|2|||
42314310|NCT01843348|76150376|FG000|Overall Study|Death|5|||
42314311|NCT01843348|76150377|FG001|Overall Study|Death|3|||
42314312|NCT01843348|76150378|FG002|Overall Study|Death|4|||
42314313|NCT01843348|76150376|FG000|Overall Study|Graft loss/retransplantation|5|||
42314314|NCT01843348|76150377|FG001|Overall Study|Graft loss/retransplantation|8|||
42314315|NCT01843348|76150378|FG002|Overall Study|Graft loss/retransplantation|11|||
42314316|NCT01843348|76150376|FG000|Overall Study|Various reasons|4|||
42314317|NCT01843348|76150377|FG001|Overall Study|Various reasons|9|||
42314318|NCT01843348|76150378|FG002|Overall Study|Various reasons|6|||
42314319|NCT01843192|76150391|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
42314320|NCT01843192|76150392|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
42314321|NCT01843192|76150393|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
42314322|NCT01825876|76150401|FG000|Period 2|Withdrawal by Subject|0|||
42314323|NCT01825876|76150402|FG001|Period 2|Withdrawal by Subject|1|||
42314324|NCT01842958|76150413|FG000|Overall Study|Lost to Follow-up|1|||
42314325|NCT01842958|76150414|FG001|Overall Study|Lost to Follow-up|1|||
42314326|NCT02413229|76150428|FG000|Overall Study|Adverse Event|0|||
42314327|NCT02413229|76150429|FG001|Overall Study|Adverse Event|0|||
42314328|NCT02413229|76150430|FG002|Overall Study|Adverse Event|0|||
42314329|NCT02413229|76150431|FG003|Overall Study|Adverse Event|1|||
41993011|NCT01149655|75801233|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
41993012|NCT01149655|75801230|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
41993013|NCT01149655|75801231|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
41993014|NCT01149655|75801232|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
41993015|NCT01149655|75801233|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
41993016|NCT01149655|75801230|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
42314330|NCT02413229|76150432|FG004|Overall Study|Adverse Event|0|||
42010567|NCT00993421|75817697|FG003|Overall Study|Lost to Follow-up|0|||
42314331|NCT02413229|76150433|FG005|Overall Study|Adverse Event|0|||
42314332|NCT02413229|76150434|FG006|Overall Study|Adverse Event|0|||
42314333|NCT02413229|76150435|FG007|Overall Study|Adverse Event|1|||
42314334|NCT02413229|76150428|FG000|Overall Study|Lost to Follow-up|0|||
42314335|NCT02413229|76150429|FG001|Overall Study|Lost to Follow-up|0|||
42314336|NCT02413229|76150430|FG002|Overall Study|Lost to Follow-up|1|||
42314337|NCT02413229|76150431|FG003|Overall Study|Lost to Follow-up|0|||
42314338|NCT02413229|76150432|FG004|Overall Study|Lost to Follow-up|2|||
42314339|NCT02413229|76150433|FG005|Overall Study|Lost to Follow-up|0|||
42314340|NCT02413229|76150434|FG006|Overall Study|Lost to Follow-up|0|||
42314341|NCT02413229|76150435|FG007|Overall Study|Lost to Follow-up|0|||
42314342|NCT02413229|76150428|FG000|Overall Study|Withdrawal by Subject|1|||
42314343|NCT02413229|76150429|FG001|Overall Study|Withdrawal by Subject|1|||
42314344|NCT02413229|76150430|FG002|Overall Study|Withdrawal by Subject|0|||
42314345|NCT02413229|76150431|FG003|Overall Study|Withdrawal by Subject|0|||
42314346|NCT02413229|76150432|FG004|Overall Study|Withdrawal by Subject|1|||
42314347|NCT02413229|76150433|FG005|Overall Study|Withdrawal by Subject|0|||
42314348|NCT02413229|76150434|FG006|Overall Study|Withdrawal by Subject|0|||
42314349|NCT02413229|76150435|FG007|Overall Study|Withdrawal by Subject|2|||
42314350|NCT02413229|76150428|FG000|Overall Study|Progressive Disease|0|||
42314351|NCT02413229|76150429|FG001|Overall Study|Progressive Disease|0|||
42314352|NCT02413229|76150430|FG002|Overall Study|Progressive Disease|0|||
42314353|NCT02413229|76150431|FG003|Overall Study|Progressive Disease|0|||
42314354|NCT02413229|76150432|FG004|Overall Study|Progressive Disease|0|||
42314355|NCT02413229|76150433|FG005|Overall Study|Progressive Disease|0|||
42314356|NCT02413229|76150434|FG006|Overall Study|Progressive Disease|0|||
42314357|NCT02413229|76150435|FG007|Overall Study|Progressive Disease|1|||
42314358|NCT01825798|76150455|FG000|Overall Study|Adverse Event|1|||
42314359|NCT01825798|76150456|FG001|Overall Study|Adverse Event|5|||
42314360|NCT01825798|76150455|FG000|Overall Study|Lost to Follow-up|1|||
42314361|NCT01825798|76150456|FG001|Overall Study|Lost to Follow-up|0|||
42314362|NCT01824472|76150465|FG000|Overall Study|Lost to Follow-up|0|||
42314363|NCT01824472|76150466|FG001|Overall Study|Lost to Follow-up|0|||
42314364|NCT01824472|76150467|FG002|Overall Study|Lost to Follow-up|1|||
42314365|NCT01824472|76150465|FG000|Overall Study|Withdrawal by Subject|1|||
42314366|NCT01824472|76150466|FG001|Overall Study|Withdrawal by Subject|5|||
41993017|NCT01149655|75801231|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
42314367|NCT01824472|76150467|FG002|Overall Study|Withdrawal by Subject|3|||
42314368|NCT01824472|76150465|FG000|Overall Study|Ineligible post randomization&screening|0|||
42314369|NCT01824472|76150466|FG001|Overall Study|Ineligible post randomization&screening|2|||
42314370|NCT01824472|76150467|FG002|Overall Study|Ineligible post randomization&screening|0|||
42314371|NCT02412761|76150475|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
42314372|NCT02412761|76150476|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
42314373|NCT02412761|76150477|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
42314374|NCT02412761|76150478|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
42314375|NCT02412761|76150479|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
42314376|NCT02412761|76150480|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
42314377|NCT01842334|76150490|FG000|Overall Study|Withdrawal by Subject|3|||
42314378|NCT01842334|76150491|FG001|Overall Study|Withdrawal by Subject|3|||
42314379|NCT01842334|76150490|FG000|Overall Study|Moved away mid-study|0|||
42314380|NCT01842334|76150491|FG001|Overall Study|Moved away mid-study|1|||
42314381|NCT02457611|76150497|FG000|Overall Study|Lost to Follow-up|3|||
42314382|NCT02457065|76150503|FG000|Overall Study|Lost to Follow-up|9|||
42314383|NCT02457065|76150504|FG001|Overall Study|Lost to Follow-up|11|||
42314384|NCT02083653|76150513|FG000|Overall Study|Randomized but not Treated|0|||
42314385|NCT02083653|76150514|FG001|Overall Study|Randomized but not Treated|2|||
42314386|NCT02083653|76150515|FG002|Overall Study|Randomized but not Treated|7|||
42314387|NCT02083653|76150513|FG000|Overall Study|Adverse Event|12|||
42314388|NCT02083653|76150514|FG001|Overall Study|Adverse Event|5|||
41993018|NCT01149655|75801232|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
41993019|NCT01149655|75801233|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
41993020|NCT01149655|75801230|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
41993021|NCT01149655|75801231|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
41993022|NCT01149655|75801232|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
41993023|NCT01149655|75801233|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
41993024|NCT01149538|75801243|FG000|Overall Study|Lost to Follow-up|0|||
41993025|NCT01149538|75801244|FG001|Overall Study|Lost to Follow-up|1|||
41993026|NCT01149538|75801243|FG000|Overall Study|Withdrawal by Subject|5|||
41993027|NCT01149538|75801244|FG001|Overall Study|Withdrawal by Subject|3|||
41993028|NCT01149460|75801252|FG000|Overall Study|Withdrawal by Subject|0|||
41993029|NCT01149460|75801253|FG001|Overall Study|Withdrawal by Subject|2|||
41993030|NCT01149421|75801262|FG000|Overall Study|Adverse Event|22|||
41993031|NCT01149421|75801263|FG001|Overall Study|Adverse Event|6|||
41993032|NCT01149421|75801264|FG002|Overall Study|Adverse Event|11|||
42314389|NCT02083653|76150515|FG002|Overall Study|Adverse Event|4|||
42314390|NCT02083653|76150513|FG000|Overall Study|Lost to Follow-up|1|||
42314391|NCT02083653|76150514|FG001|Overall Study|Lost to Follow-up|0|||
42314392|NCT02083653|76150515|FG002|Overall Study|Lost to Follow-up|0|||
42314393|NCT02083653|76150513|FG000|Overall Study|Death|2|||
42314394|NCT02083653|76150514|FG001|Overall Study|Death|2|||
42314395|NCT02083653|76150515|FG002|Overall Study|Death|2|||
42314396|NCT02083653|76150513|FG000|Overall Study|Progressive Disease|65|||
42314397|NCT02083653|76150514|FG001|Overall Study|Progressive Disease|73|||
42314398|NCT02083653|76150515|FG002|Overall Study|Progressive Disease|63|||
42314399|NCT02083653|76150513|FG000|Overall Study|Withdrawal by Subject|2|||
41993033|NCT01149421|75801262|FG000|Overall Study|Withdrawal by Subject|20|||
41993034|NCT01149421|75801263|FG001|Overall Study|Withdrawal by Subject|12|||
41993035|NCT01149421|75801264|FG002|Overall Study|Withdrawal by Subject|13|||
41993036|NCT01149421|75801262|FG000|Overall Study|Sponsor Decision|0|||
41993037|NCT01149421|75801263|FG001|Overall Study|Sponsor Decision|1|||
41993038|NCT01149421|75801264|FG002|Overall Study|Sponsor Decision|1|||
41993039|NCT01149421|75801262|FG000|Overall Study|Lost to Follow-up|2|||
41993040|NCT01149421|75801263|FG001|Overall Study|Lost to Follow-up|4|||
41993041|NCT01149421|75801264|FG002|Overall Study|Lost to Follow-up|5|||
41993042|NCT01149421|75801262|FG000|Overall Study|Physician Decision|5|||
41993043|NCT01149421|75801263|FG001|Overall Study|Physician Decision|3|||
41993044|NCT01149421|75801264|FG002|Overall Study|Physician Decision|6|||
41993045|NCT01149421|75801262|FG000|Overall Study|Entry Criteria Not Met|1|||
41993046|NCT01149421|75801263|FG001|Overall Study|Entry Criteria Not Met|1|||
41993047|NCT01149421|75801264|FG002|Overall Study|Entry Criteria Not Met|2|||
41993048|NCT01149421|75801262|FG000|Overall Study|Protocol Violation|2|||
41993049|NCT01149421|75801263|FG001|Overall Study|Protocol Violation|2|||
41993050|NCT01149421|75801264|FG002|Overall Study|Protocol Violation|6|||
41993051|NCT01149343|75801282|FG000|Overall Study|Withdrawal by Subject|1|||
41993052|NCT01149343|75801283|FG001|Overall Study|Withdrawal by Subject|1|||
41993053|NCT01149343|75801284|FG002|Overall Study|Withdrawal by Subject|1|||
41993054|NCT01149343|75801285|FG003|Overall Study|Withdrawal by Subject|5|||
41993055|NCT01149343|75801282|FG000|Overall Study|Death|10|||
41993056|NCT01149343|75801283|FG001|Overall Study|Death|13|||
41993057|NCT01149343|75801284|FG002|Overall Study|Death|18|||
42033482|NCT00858403|75841707|FG000|Overall Study|Disease Progression|1|||
42255406|NCT02665052|76081716|FG002|Overall Study|Lost to Follow-up|0|||
42255407|NCT02665052|76081717|FG003|Overall Study|Lost to Follow-up|0|||
42255408|NCT02665052|76081714|FG000|Overall Study|Withdrawal by Subject|1|||
42255409|NCT02665052|76081715|FG001|Overall Study|Withdrawal by Subject|1|||
42033483|NCT00858247|75841713|FG000|Baseline Assessment|Withdrawal by Subject|1|||
42033484|NCT00858247|75841714|FG001|Baseline Assessment|Withdrawal by Subject|1|||
42255410|NCT02665052|76081716|FG002|Overall Study|Withdrawal by Subject|0|||
42255411|NCT02665052|76081717|FG003|Overall Study|Withdrawal by Subject|5|||
42255412|NCT02665052|76081714|FG000|Overall Study|Adverse Event|1|||
42255413|NCT02665052|76081715|FG001|Overall Study|Adverse Event|1|||
42255414|NCT02665052|76081716|FG002|Overall Study|Adverse Event|0|||
42255415|NCT02665052|76081717|FG003|Overall Study|Adverse Event|0|||
42255416|NCT03019289|76081737|FG000|Overall Study|Adverse Event|1|||
42255417|NCT03019289|76081738|FG001|Overall Study|Adverse Event|0|||
42255418|NCT03019289|76081739|FG002|Overall Study|Adverse Event|0|||
42255419|NCT03019289|76081740|FG003|Overall Study|Adverse Event|0|||
42255420|NCT03019289|76081741|FG004|Overall Study|Adverse Event|0|||
42255421|NCT03019289|76081742|FG005|Overall Study|Adverse Event|0|||
42314400|NCT02083653|76150514|FG001|Overall Study|Withdrawal by Subject|1|||
42314401|NCT02083653|76150515|FG002|Overall Study|Withdrawal by Subject|2|||
42314402|NCT02083653|76150513|FG000|Overall Study|Other Events|0|||
42314403|NCT02083653|76150514|FG001|Overall Study|Other Events|2|||
42314404|NCT02083653|76150515|FG002|Overall Study|Other Events|2|||
42314405|NCT02083653|76150513|FG000|Overall Study|Reason Missing|0|||
42314406|NCT02083653|76150514|FG001|Overall Study|Reason Missing|0|||
42314407|NCT02083653|76150515|FG002|Overall Study|Reason Missing|4|||
42314408|NCT02436239|76150527|FG000|Open-Lable Treatment Period|Adverse Event|12|||
42314409|NCT02436239|76150528|FG001|Open-Lable Treatment Period|Adverse Event|3|||
42314410|NCT02436239|76150529|FG002|Open-Lable Treatment Period|Adverse Event|4|||
42314411|NCT02436239|76150530|FG003|Open-Lable Treatment Period|Adverse Event|2|||
42314412|NCT02436239|76150527|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
42314413|NCT02436239|76150528|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
42314414|NCT02436239|76150529|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
42314415|NCT02436239|76150530|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
42314416|NCT02436239|76150527|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
41993058|NCT01149343|75801285|FG003|Overall Study|Death|18|||
41993059|NCT01149343|75801282|FG000|Overall Study|Lost to Follow-up|1|||
41993060|NCT01149343|75801283|FG001|Overall Study|Lost to Follow-up|0|||
42033485|NCT00858247|75841713|FG000|Baseline Assessment|Poor IV access|1|||
42033486|NCT00858247|75841714|FG001|Baseline Assessment|Poor IV access|0|||
42033487|NCT00858247|75841713|FG000|Baseline Assessment|Protocol Violation|0|||
42033488|NCT00858247|75841714|FG001|Baseline Assessment|Protocol Violation|1|||
42255422|NCT03019289|76081743|FG006|Overall Study|Adverse Event|0|||
42314417|NCT02436239|76150528|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
42314418|NCT02436239|76150529|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
42314419|NCT02436239|76150530|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
42314420|NCT02436239|76150527|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
42314421|NCT02436239|76150528|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
41993061|NCT01149343|75801284|FG002|Overall Study|Lost to Follow-up|0|||
41993062|NCT01149343|75801285|FG003|Overall Study|Lost to Follow-up|1|||
42255423|NCT03019289|76081744|FG007|Overall Study|Adverse Event|0|||
42255424|NCT03019289|76081745|FG008|Overall Study|Adverse Event|1|||
42314422|NCT02436239|76150529|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
42314423|NCT02436239|76150530|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
42314424|NCT02436239|76150527|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
42314425|NCT02436239|76150528|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
42314426|NCT02436239|76150529|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
42314427|NCT02436239|76150530|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
42314428|NCT02436239|76150527|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
42314429|NCT02436239|76150528|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
42314430|NCT02436239|76150529|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
42314431|NCT02436239|76150530|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
42314432|NCT02436239|76150527|FG000|Open-Lable Treatment Period|Other Reason|1|||
42314433|NCT02436239|76150528|FG001|Open-Lable Treatment Period|Other Reason|1|||
42314434|NCT02436239|76150529|FG002|Open-Lable Treatment Period|Other Reason|0|||
42314435|NCT02436239|76150530|FG003|Open-Lable Treatment Period|Other Reason|0|||
42314436|NCT02436239|76150527|FG000|Down-Taper Period|Withdrawal by Subject|4|||
42314437|NCT02436239|76150528|FG001|Down-Taper Period|Withdrawal by Subject|4|||
42314438|NCT02436239|76150529|FG002|Down-Taper Period|Withdrawal by Subject|1|||
42314439|NCT02436239|76150530|FG003|Down-Taper Period|Withdrawal by Subject|2|||
42314440|NCT02026011|76150542|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
42314441|NCT02026011|76150543|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
42314442|NCT02026011|76150542|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
42314443|NCT02026011|76150543|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
42314444|NCT02026011|76150542|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
42314445|NCT02026011|76150543|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
42314446|NCT02026011|76150542|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
42314447|NCT02026011|76150543|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
42314448|NCT02436005|76150552|FG000|Second Intervention|Adverse Event|0|||
42314449|NCT02436005|76150553|FG001|Second Intervention|Adverse Event|1|||
42314450|NCT02456909|76150561|FG000|Overall Study|Did not receive allocated intervention|24|||
42314451|NCT02456909|76150562|FG001|Overall Study|Did not receive allocated intervention|26|||
42314452|NCT02456909|76150561|FG000|Overall Study|Did not complete the primary outcome|0|||
42314453|NCT02456909|76150562|FG001|Overall Study|Did not complete the primary outcome|1|||
42314454|NCT02025621|76150570|FG000|Overall Study|Withdrawal by Subject|1|||
42314455|NCT02025621|76150571|FG001|Overall Study|Withdrawal by Subject|0|||
42314456|NCT02025621|76150570|FG000|Overall Study|Death|0|||
42314457|NCT02025621|76150571|FG001|Overall Study|Death|1|||
42314458|NCT02025621|76150570|FG000|Overall Study|No longer eligible|10|||
42314459|NCT02025621|76150571|FG001|Overall Study|No longer eligible|15|||
42314460|NCT02025621|76150570|FG000|Overall Study|Surgery initiated before infusion|3|||
42314461|NCT02025621|76150571|FG001|Overall Study|Surgery initiated before infusion|3|||
42314462|NCT02020941|76150577|FG000|Overall Study|Adverse Event|1|||
42314463|NCT02020941|76150577|FG000|Overall Study|Physician Decision|2|||
42314464|NCT02020941|76150577|FG000|Overall Study|Withdrawal by Subject|1|||
42314465|NCT02020941|76150577|FG000|Overall Study|Disease Progression|4|||
42314466|NCT02024529|76150583|FG000|Overall Study|Withdrawal by Subject|11|||
42314467|NCT02024529|76150584|FG001|Overall Study|Withdrawal by Subject|21|||
42314468|NCT02024529|76150583|FG000|Overall Study|Lost to Follow-up|2|||
42314469|NCT02024529|76150584|FG001|Overall Study|Lost to Follow-up|4|||
42314470|NCT02020863|76150592|FG000|Overall Study|Discovery of Metastatic disease|4|||
42314471|NCT02020863|76150592|FG000|Overall Study|Team chose not to place an a line|1|||
42314472|NCT01824394|76150599|FG000|Overall Study|Early Termination|1|||
42314473|NCT01824394|76150600|FG001|Overall Study|Early Termination|1|||
42314474|NCT01824394|76150601|FG002|Overall Study|Early Termination|3|||
42314475|NCT01824394|76150599|FG000|Overall Study|Withdrawn due to Study Termination|91|||
42314476|NCT01824394|76150600|FG001|Overall Study|Withdrawn due to Study Termination|83|||
42314477|NCT01824394|76150601|FG002|Overall Study|Withdrawn due to Study Termination|41|||
42314478|NCT01824394|76150599|FG000|Overall Study|Lost to Follow-up|0|||
42314479|NCT01824394|76150600|FG001|Overall Study|Lost to Follow-up|9|||
42314480|NCT01824394|76150601|FG002|Overall Study|Lost to Follow-up|3|||
42314481|NCT01824394|76150599|FG000|Overall Study|Death|3|||
42314482|NCT01824394|76150600|FG001|Overall Study|Death|2|||
42314483|NCT01824394|76150601|FG002|Overall Study|Death|4|||
42255425|NCT03019289|76081737|FG000|Overall Study|Other|1|||
42255426|NCT03019289|76081738|FG001|Overall Study|Other|0|||
42255427|NCT03019289|76081739|FG002|Overall Study|Other|0|||
42255428|NCT03019289|76081740|FG003|Overall Study|Other|0|||
42255429|NCT03019289|76081741|FG004|Overall Study|Other|0|||
42255430|NCT03019289|76081742|FG005|Overall Study|Other|0|||
42255431|NCT03019289|76081743|FG006|Overall Study|Other|0|||
42255432|NCT03019289|76081744|FG007|Overall Study|Other|0|||
42255433|NCT03019289|76081745|FG008|Overall Study|Other|0|||
42255434|NCT02520388|76081768|FG000|Overall Study|Physician Decision|1|||
42255435|NCT02520388|76081769|FG001|Overall Study|Physician Decision|0|||
42314484|NCT01824394|76150599|FG000|Overall Study|Discontinued Subjects|1|||
42314485|NCT01824394|76150600|FG001|Overall Study|Discontinued Subjects|1|||
42314486|NCT01824394|76150601|FG002|Overall Study|Discontinued Subjects|2|||
42314487|NCT01824394|76150599|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
42314488|NCT01824394|76150600|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
42314489|NCT01824394|76150601|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
42314490|NCT01823536|76150615|FG000|Overall Study|Lost to Follow-up|1|||
42314491|NCT01823536|76150616|FG001|Overall Study|Lost to Follow-up|0|||
42314492|NCT01823536|76150617|FG002|Overall Study|Lost to Follow-up|0|||
42314493|NCT01823536|76150618|FG003|Overall Study|Lost to Follow-up|1|||
42314494|NCT01823536|76150619|FG004|Overall Study|Lost to Follow-up|1|||
42314495|NCT01823536|76150620|FG005|Overall Study|Lost to Follow-up|0|||
42314496|NCT01823536|76150615|FG000|Overall Study|Protocol Violation|0|||
42314497|NCT01823536|76150616|FG001|Overall Study|Protocol Violation|1|||
42314498|NCT01823536|76150617|FG002|Overall Study|Protocol Violation|0|||
42314499|NCT01823536|76150618|FG003|Overall Study|Protocol Violation|0|||
42314500|NCT01823536|76150619|FG004|Overall Study|Protocol Violation|0|||
42314501|NCT01823536|76150620|FG005|Overall Study|Protocol Violation|0|||
42314502|NCT01823536|76150615|FG000|Overall Study|Withdrawal by Subject|1|||
42133126|NCT00410163|75944016|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
42133127|NCT00410163|75944017|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
42133128|NCT00410163|75944016|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
42133129|NCT00410163|75944017|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
42133130|NCT00410163|75944016|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
42133131|NCT00410163|75944017|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
42314503|NCT01823536|76150616|FG001|Overall Study|Withdrawal by Subject|1|||
42314504|NCT01823536|76150617|FG002|Overall Study|Withdrawal by Subject|0|||
42314505|NCT01823536|76150618|FG003|Overall Study|Withdrawal by Subject|0|||
42314506|NCT01823536|76150619|FG004|Overall Study|Withdrawal by Subject|0|||
42314507|NCT01823536|76150620|FG005|Overall Study|Withdrawal by Subject|0|||
42314508|NCT01823536|76150615|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
42314509|NCT01823536|76150616|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
42314510|NCT01823536|76150617|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
42314511|NCT01823536|76150618|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
42314512|NCT01823536|76150619|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
42314513|NCT01823536|76150620|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
42314514|NCT01823536|76150615|FG000|Overall Study|Met exclusion criterion No 6|0|||
42314515|NCT01823536|76150616|FG001|Overall Study|Met exclusion criterion No 6|0|||
42314516|NCT01823536|76150617|FG002|Overall Study|Met exclusion criterion No 6|0|||
42314517|NCT01823536|76150618|FG003|Overall Study|Met exclusion criterion No 6|1|||
42314518|NCT01823536|76150619|FG004|Overall Study|Met exclusion criterion No 6|0|||
42314519|NCT01823536|76150620|FG005|Overall Study|Met exclusion criterion No 6|0|||
42314520|NCT01823536|76150615|FG000|Overall Study|Subject moved out of the state|0|||
42314521|NCT01823536|76150616|FG001|Overall Study|Subject moved out of the state|0|||
42314522|NCT01823536|76150617|FG002|Overall Study|Subject moved out of the state|0|||
42314523|NCT01823536|76150618|FG003|Overall Study|Subject moved out of the state|0|||
42314524|NCT01823536|76150619|FG004|Overall Study|Subject moved out of the state|1|||
42314525|NCT01823536|76150620|FG005|Overall Study|Subject moved out of the state|0|||
42314526|NCT01841554|76150633|FG000|Overall Study|Death|7|||
42314527|NCT01841554|76150633|FG000|Overall Study|No Implantation|1|||
42133132|NCT00410163|75944016|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
42255436|NCT02520388|76081768|FG000|Overall Study|Subject or parent/guardian request|0|||
42255437|NCT02520388|76081769|FG001|Overall Study|Subject or parent/guardian request|6|||
42255438|NCT02520388|76081768|FG000|Overall Study|Adverse Event|1|||
42255439|NCT02520388|76081769|FG001|Overall Study|Adverse Event|4|||
42255440|NCT02520388|76081768|FG000|Overall Study|Lost to Follow-up|3|||
42255441|NCT02520388|76081769|FG001|Overall Study|Lost to Follow-up|2|||
42255442|NCT02520388|76081768|FG000|Overall Study|Other (reason not defined)|4|||
42255443|NCT02520388|76081769|FG001|Overall Study|Other (reason not defined)|4|||
42255444|NCT02668640|76081775|FG000|Overall Study|Lost to Follow-up|13|||
42255445|NCT02668640|76081775|FG000|Overall Study|Other, not specified|1|||
42255446|NCT03014453|76081779|FG000|Overall Study|Lost to Follow-up|12|||
42255447|NCT03014453|76081779|FG000|Overall Study|Discontinued GER|3|||
42255448|NCT03014453|76081779|FG000|Overall Study|Excluded|19|||
42314528|NCT01841554|76150633|FG000|Overall Study|Discontinued Follow Up|5|||
42133133|NCT00410163|75944017|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
42255449|NCT03014453|76081779|FG000|Overall Study|Refused to take part in|37|||
42255450|NCT02664272|76081783|FG000|Overall Study|Fluoroscopic images not made available|2|||
42314529|NCT01841554|76150633|FG000|Overall Study|Study exit due to secondary intervention|6|||
42314530|NCT01823224|76150639|FG000|Overall Study|Lost to Follow-up|5|||
42314531|NCT01823224|76150640|FG001|Overall Study|Lost to Follow-up|6|||
42314532|NCT01823224|76150639|FG000|Overall Study|didn't qualify|1|||
42314533|NCT01823224|76150640|FG001|Overall Study|didn't qualify|2|||
42314534|NCT01823224|76150639|FG000|Overall Study|pharmacy error|0|||
42314535|NCT01823224|76150640|FG001|Overall Study|pharmacy error|1|||
42314536|NCT01823224|76150639|FG000|Overall Study|missed med dose|0|||
42314537|NCT01823224|76150640|FG001|Overall Study|missed med dose|1|||
42314538|NCT01823224|76150639|FG000|Overall Study|Withdrawal by Subject|0|||
42314539|NCT01823224|76150640|FG001|Overall Study|Withdrawal by Subject|1|||
42314540|NCT01840228|76150650|FG000|Overall Study|Lost to Follow-up|1|||
42314541|NCT01840228|76150651|FG001|Overall Study|Lost to Follow-up|1|||
42314542|NCT01839916|76150661|FG000|Overall Study|Death|9|||
42314543|NCT01839916|76150661|FG000|Overall Study|Physician Decision|17|||
42314544|NCT01839916|76150661|FG000|Overall Study|Relapse|12|||
42314545|NCT01839916|76150661|FG000|Overall Study|GVHD|2|||
42314546|NCT01839916|76150661|FG000|Overall Study|Graft Failure|1|||
42314547|NCT01823146|76150667|FG000|Overall Study|Withdrawal by Subject|0|||
42314548|NCT01823146|76150668|FG001|Overall Study|Withdrawal by Subject|1|||
42314549|NCT01823146|76150667|FG000|Overall Study|Lost to Follow-up|2|||
42314550|NCT01823146|76150668|FG001|Overall Study|Lost to Follow-up|1|||
42314551|NCT02083185|76150677|FG000|Overall Study|Lost to Follow-up|0|||
42314552|NCT02083185|76150678|FG001|Overall Study|Lost to Follow-up|3|||
42314553|NCT02083185|76150679|FG002|Overall Study|Lost to Follow-up|0|||
42314554|NCT02083185|76150677|FG000|Overall Study|Withdrawal by Subject|9|||
42314555|NCT02083185|76150678|FG001|Overall Study|Withdrawal by Subject|15|||
42314556|NCT02083185|76150679|FG002|Overall Study|Withdrawal by Subject|1|||
42314557|NCT02083185|76150677|FG000|Overall Study|Death|2|||
42314558|NCT02083185|76150678|FG001|Overall Study|Death|2|||
42314559|NCT02083185|76150679|FG002|Overall Study|Death|1|||
42314560|NCT02083185|76150677|FG000|Overall Study|Reason not Specified|9|||
42314561|NCT02083185|76150678|FG001|Overall Study|Reason not Specified|6|||
42314562|NCT02083185|76150679|FG002|Overall Study|Reason not Specified|5|||
42314563|NCT02083185|76150677|FG000|Overall Study|Study Terminated by Sponsor|0|||
42314564|NCT02083185|76150678|FG001|Overall Study|Study Terminated by Sponsor|1|||
42314565|NCT02083185|76150679|FG002|Overall Study|Study Terminated by Sponsor|0|||
42314566|NCT02083185|76150677|FG000|Overall Study|Did not Receive Study Drug|0|||
42314567|NCT02083185|76150678|FG001|Overall Study|Did not Receive Study Drug|2|||
42314568|NCT02083185|76150679|FG002|Overall Study|Did not Receive Study Drug|0|||
42314569|NCT02019927|76150693|FG000|Overall Study|Lost to Follow-up|2|||
42314570|NCT02019927|76150694|FG001|Overall Study|Lost to Follow-up|4|||
42314571|NCT02019927|76150695|FG002|Overall Study|Lost to Follow-up|1|||
42314572|NCT02019927|76150696|FG003|Overall Study|Lost to Follow-up|2|||
42314573|NCT02019927|76150697|FG004|Overall Study|Lost to Follow-up|3|||
42314574|NCT02019927|76150698|FG005|Overall Study|Lost to Follow-up|1|||
42033489|NCT00858247|75841713|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
42033490|NCT00858247|75841714|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
42033491|NCT00838435|75841720|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
42033492|NCT00838435|75841720|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
42033493|NCT00838435|75841720|FG000|Part 2 (7 Years)|Adverse Event|2|||
42133134|NCT00410163|75944016|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
42255451|NCT02663882|76081789|FG000|Overall Study|Lost to Follow-up|4|||
42255452|NCT02663882|76081790|FG001|Overall Study|Lost to Follow-up|2|||
42255453|NCT03011333|76081803|FG000|Overall Study|Lost to Follow-up|0|||
42255454|NCT03011333|76081804|FG001|Overall Study|Lost to Follow-up|1|||
42255455|NCT03011333|76081805|FG002|Overall Study|Lost to Follow-up|0|||
42255456|NCT03011333|76081806|FG003|Overall Study|Lost to Follow-up|1|||
42255457|NCT03011333|76081807|FG004|Overall Study|Lost to Follow-up|4|||
42255458|NCT03011333|76081808|FG005|Overall Study|Lost to Follow-up|4|||
42255459|NCT03011333|76081809|FG006|Overall Study|Lost to Follow-up|5|||
42255460|NCT03011099|76081827|FG000|Overall Study|Withdrawal by Subject|0|||
42255461|NCT03011099|76081828|FG001|Overall Study|Withdrawal by Subject|2|||
42255462|NCT03013985|76081838|FG000|Overall Study|Protocol Violation|2|||
42255463|NCT03013985|76081839|FG001|Overall Study|Protocol Violation|2|||
42255464|NCT03013985|76081838|FG000|Overall Study|Withdrawal by Subject|14|||
42255465|NCT03013985|76081839|FG001|Overall Study|Withdrawal by Subject|17|||
42255466|NCT03016403|76081849|FG000|Baseline|Death|5|||
42255467|NCT03016403|76081850|FG001|Baseline|Death|8|||
42255468|NCT03016403|76081851|FG002|Baseline|Death|1|||
42255469|NCT03016403|76081852|FG003|Baseline|Death|0|||
42255470|NCT03016403|76081849|FG000|Baseline|Withdrawal by Subject|2|||
42314575|NCT02412371|76150722|FG000|Overall Study|Withdrawal by Subject|0|||
42314576|NCT02412371|76150723|FG001|Overall Study|Withdrawal by Subject|2|||
42314577|NCT02412371|76150724|FG002|Overall Study|Withdrawal by Subject|0|||
42314578|NCT02412371|76150725|FG003|Overall Study|Withdrawal by Subject|1|||
42314579|NCT02412371|76150726|FG004|Overall Study|Withdrawal by Subject|1|||
42314580|NCT02412371|76150727|FG005|Overall Study|Withdrawal by Subject|0|||
42314581|NCT02412371|76150722|FG000|Overall Study|Sponsor Discontinued Study|1|||
42314582|NCT02412371|76150723|FG001|Overall Study|Sponsor Discontinued Study|4|||
42314583|NCT02412371|76150724|FG002|Overall Study|Sponsor Discontinued Study|6|||
42255471|NCT03016403|76081850|FG001|Baseline|Withdrawal by Subject|8|||
42133135|NCT00410163|75944017|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
42255472|NCT03016403|76081851|FG002|Baseline|Withdrawal by Subject|4|||
42255473|NCT03016403|76081852|FG003|Baseline|Withdrawal by Subject|10|||
41993063|NCT01149343|75801282|FG000|Overall Study|Other|8|||
41993064|NCT01149343|75801283|FG001|Overall Study|Other|10|||
41993065|NCT01149343|75801284|FG002|Overall Study|Other|2|||
41993066|NCT01149343|75801285|FG003|Overall Study|Other|14|||
41993067|NCT01149343|75801282|FG000|Overall Study|Sponsor study termination|0|||
41993068|NCT01149343|75801283|FG001|Overall Study|Sponsor study termination|0|||
42255474|NCT03016403|76081849|FG000|Baseline|Lost to Follow-up|9|||
42255475|NCT03016403|76081850|FG001|Baseline|Lost to Follow-up|11|||
42255476|NCT03016403|76081851|FG002|Baseline|Lost to Follow-up|6|||
42255477|NCT03016403|76081852|FG003|Baseline|Lost to Follow-up|24|||
42255478|NCT03016403|76081849|FG000|6-week Follow-up|Death|1|||
42255479|NCT03016403|76081850|FG001|6-week Follow-up|Death|4|||
42255480|NCT03016403|76081851|FG002|6-week Follow-up|Death|0|||
42255481|NCT03016403|76081852|FG003|6-week Follow-up|Death|0|||
42255482|NCT03016403|76081849|FG000|6-week Follow-up|Lost to Follow-up|2|||
42255483|NCT03016403|76081850|FG001|6-week Follow-up|Lost to Follow-up|7|||
42255484|NCT03016403|76081851|FG002|6-week Follow-up|Lost to Follow-up|4|||
42255485|NCT03016403|76081852|FG003|6-week Follow-up|Lost to Follow-up|8|||
42255486|NCT03016403|76081849|FG000|6-week Follow-up|Withdrawal by Subject|0|||
42255487|NCT03016403|76081850|FG001|6-week Follow-up|Withdrawal by Subject|2|||
42255488|NCT03016403|76081851|FG002|6-week Follow-up|Withdrawal by Subject|0|||
42255489|NCT03016403|76081852|FG003|6-week Follow-up|Withdrawal by Subject|1|||
42255490|NCT03016403|76081849|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
41993069|NCT01149343|75801284|FG002|Overall Study|Sponsor study termination|0|||
41993070|NCT01149343|75801285|FG003|Overall Study|Sponsor study termination|2|||
41993071|NCT01149343|75801282|FG000|Overall Study|Recurrence / Progressive disease|0|||
42255491|NCT03016403|76081850|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
41993072|NCT01149343|75801283|FG001|Overall Study|Recurrence / Progressive disease|0|||
41993073|NCT01149343|75801284|FG002|Overall Study|Recurrence / Progressive disease|1|||
41993074|NCT01149343|75801285|FG003|Overall Study|Recurrence / Progressive disease|0|||
41993075|NCT01149148|75801301|FG000|Overall Study|Lost to Follow-up|1|||
41993076|NCT01149148|75801302|FG001|Overall Study|Lost to Follow-up|2|||
41993077|NCT01149148|75801301|FG000|Overall Study|Death|1|||
41993078|NCT01149148|75801302|FG001|Overall Study|Death|0|||
41993079|NCT01148017|75801313|FG000|Overall Study|Withdrawal by Subject|31|||
42255492|NCT03016403|76081851|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
42255493|NCT03016403|76081852|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
42255494|NCT03016403|76081849|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
42255495|NCT03016403|76081850|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
42255496|NCT03016403|76081851|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
42255497|NCT03016403|76081852|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
42255498|NCT03016403|76081849|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
42255499|NCT03016403|76081850|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
42255500|NCT03016403|76081851|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
42255501|NCT03016403|76081852|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
42255502|NCT02520310|76081864|FG000|At 6 Months Clinical Follow-up|Death|1|||
42255503|NCT02520310|76081864|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
42255504|NCT02520310|76081864|FG000|AT 3 Year Clinical Follow-up|Death|2|||
42255505|NCT02520310|76081864|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
42255506|NCT02520310|76081864|FG000|AT 4 Year Clinical Follow-up|Death|1|||
42255507|NCT02520310|76081864|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
42255508|NCT02662556|76081870|FG000|Overall Study|Adverse Event|4|||
42255509|NCT02662556|76081870|FG000|Overall Study|Lack of Efficacy|4|||
42255510|NCT02516098|76081877|FG000|Period 1|Protocol Violation|1|||
42255511|NCT02516098|76081878|FG001|Period 1|Protocol Violation|0|||
41993080|NCT01148017|75801314|FG001|Overall Study|Withdrawal by Subject|14|||
42255512|NCT02516098|76081877|FG000|Washout After Period 1|Adverse Event|0|||
42255513|NCT02516098|76081878|FG001|Washout After Period 1|Adverse Event|1|||
42255514|NCT02516098|76081877|FG000|Period 2|Withdrawal by Subject|0|||
42255515|NCT02516098|76081878|FG001|Period 2|Withdrawal by Subject|1|||
41993081|NCT01148017|75801315|FG002|Overall Study|Withdrawal by Subject|0|||
41993082|NCT01148017|75801316|FG003|Overall Study|Withdrawal by Subject|0|||
42255516|NCT01364428|76081886|FG000|Overall Study|Adverse Event|1|||
42255517|NCT01364428|76081887|FG001|Overall Study|Adverse Event|2|||
41993083|NCT01148017|75801313|FG000|Overall Study|Lost to Follow-up|23|||
42033494|NCT00838435|75841720|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
42033495|NCT00838435|75841720|FG000|Part 2 (7 Years)|Physician Decision|1|||
42033496|NCT00838435|75841720|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
42033497|NCT00838435|75841720|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
42255518|NCT01364428|76081886|FG000|Overall Study|Protocol Violation|2|||
42255519|NCT01364428|76081887|FG001|Overall Study|Protocol Violation|0|||
42255520|NCT01364428|76081886|FG000|Overall Study|Withdrawal Criteria|14|||
42255521|NCT01364428|76081887|FG001|Overall Study|Withdrawal Criteria|10|||
42255522|NCT01364428|76081886|FG000|Overall Study|Other|3|||
42255523|NCT01364428|76081887|FG001|Overall Study|Other|3|||
42255524|NCT02515942|76081896|FG000|Overall Study|Adverse Event|5|||
42033498|NCT00838201|75841729|FG000|Overall Study|Investigator decision, or other reasons|2|||
42033499|NCT00838201|75841730|FG001|Overall Study|Investigator decision, or other reasons|3|||
42133136|NCT00410163|75944016|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
42255525|NCT02515942|76081897|FG001|Overall Study|Adverse Event|0|||
42255526|NCT02515942|76081898|FG002|Overall Study|Adverse Event|0|||
42255527|NCT02515942|76081896|FG000|Overall Study|Death|0|||
42033500|NCT00838201|75841729|FG000|Overall Study|Noncompliance|0|||
42255528|NCT02515942|76081897|FG001|Overall Study|Death|0|||
42255529|NCT02515942|76081898|FG002|Overall Study|Death|1|||
42255530|NCT02515942|76081896|FG000|Overall Study|Lack of Efficacy|0|||
42255531|NCT02515942|76081897|FG001|Overall Study|Lack of Efficacy|0|||
42255532|NCT02515942|76081898|FG002|Overall Study|Lack of Efficacy|1|||
42255533|NCT02515942|76081896|FG000|Overall Study|Lost to Follow-up|2|||
41993084|NCT01148017|75801314|FG001|Overall Study|Lost to Follow-up|10|||
42255534|NCT02515942|76081897|FG001|Overall Study|Lost to Follow-up|0|||
42255535|NCT02515942|76081898|FG002|Overall Study|Lost to Follow-up|0|||
42255536|NCT02515942|76081896|FG000|Overall Study|Withdrawal by Subject|0|||
42314584|NCT02412371|76150725|FG003|Overall Study|Sponsor Discontinued Study|4|||
42314585|NCT02412371|76150726|FG004|Overall Study|Sponsor Discontinued Study|5|||
42314586|NCT02412371|76150727|FG005|Overall Study|Sponsor Discontinued Study|0|||
42314587|NCT02412371|76150722|FG000|Overall Study|Death|4|||
42314588|NCT02412371|76150723|FG001|Overall Study|Death|2|||
42314589|NCT02412371|76150724|FG002|Overall Study|Death|1|||
42314590|NCT02412371|76150725|FG003|Overall Study|Death|3|||
42314591|NCT02412371|76150726|FG004|Overall Study|Death|5|||
42314592|NCT02412371|76150727|FG005|Overall Study|Death|2|||
42314593|NCT02412371|76150722|FG000|Overall Study|Other|2|||
42314594|NCT02412371|76150723|FG001|Overall Study|Other|1|||
42314595|NCT02412371|76150724|FG002|Overall Study|Other|0|||
42314596|NCT02412371|76150725|FG003|Overall Study|Other|0|||
42314597|NCT02412371|76150726|FG004|Overall Study|Other|1|||
42314598|NCT02412371|76150727|FG005|Overall Study|Other|3|||
42314599|NCT02411747|76150744|FG000|Overall Study|Withdrawal by Subject|1|||
42314600|NCT02411747|76150745|FG001|Overall Study|Withdrawal by Subject|0|||
42314601|NCT02411747|76150744|FG000|Overall Study|Protocol Violation|2|||
42314602|NCT02411747|76150745|FG001|Overall Study|Protocol Violation|4|||
42314603|NCT01822756|76150756|FG000|Overall Study|Adverse Event|0|||
42314604|NCT01822756|76150757|FG001|Overall Study|Adverse Event|0|||
42314605|NCT01822756|76150758|FG002|Overall Study|Adverse Event|0|||
42314606|NCT01822756|76150759|FG003|Overall Study|Adverse Event|2|||
42314607|NCT01822756|76150760|FG004|Overall Study|Adverse Event|0|||
42314608|NCT01822756|76150756|FG000|Overall Study|Disease progression|11|||
42314609|NCT01822756|76150757|FG001|Overall Study|Disease progression|1|||
42314610|NCT01822756|76150758|FG002|Overall Study|Disease progression|7|||
42314611|NCT01822756|76150759|FG003|Overall Study|Disease progression|2|||
42314612|NCT01822756|76150760|FG004|Overall Study|Disease progression|6|||
42314613|NCT01822756|76150756|FG000|Overall Study|Death|2|||
41993085|NCT01148017|75801315|FG002|Overall Study|Lost to Follow-up|0|||
41993086|NCT01148017|75801316|FG003|Overall Study|Lost to Follow-up|0|||
41993087|NCT01148017|75801313|FG000|Overall Study|Inappropriate enrollment|1|||
41993088|NCT01148017|75801314|FG001|Overall Study|Inappropriate enrollment|0|||
41993089|NCT01148017|75801315|FG002|Overall Study|Inappropriate enrollment|0|||
41993090|NCT01148017|75801316|FG003|Overall Study|Inappropriate enrollment|0|||
41993091|NCT01148017|75801313|FG000|Overall Study|Administrative reason|22|||
41993092|NCT01148017|75801314|FG001|Overall Study|Administrative reason|9|||
41993093|NCT01148017|75801315|FG002|Overall Study|Administrative reason|0|||
42255537|NCT02515942|76081897|FG001|Overall Study|Withdrawal by Subject|3|||
42255538|NCT02515942|76081898|FG002|Overall Study|Withdrawal by Subject|2|||
42255539|NCT02991859|76081925|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42314614|NCT01822756|76150757|FG001|Overall Study|Death|2|||
42314615|NCT01822756|76150758|FG002|Overall Study|Death|1|||
42314616|NCT01822756|76150759|FG003|Overall Study|Death|0|||
42314617|NCT01822756|76150760|FG004|Overall Study|Death|0|||
42314618|NCT01822756|76150756|FG000|Overall Study|Lost to Follow-up|1|||
42314619|NCT01822756|76150757|FG001|Overall Study|Lost to Follow-up|0|||
42314620|NCT01822756|76150758|FG002|Overall Study|Lost to Follow-up|1|||
42314621|NCT01822756|76150759|FG003|Overall Study|Lost to Follow-up|0|||
42314622|NCT01822756|76150760|FG004|Overall Study|Lost to Follow-up|1|||
42314623|NCT01822756|76150756|FG000|Overall Study|Physician Decision|0|||
42314624|NCT01822756|76150757|FG001|Overall Study|Physician Decision|1|||
42314625|NCT01822756|76150758|FG002|Overall Study|Physician Decision|0|||
42314626|NCT01822756|76150759|FG003|Overall Study|Physician Decision|0|||
42314627|NCT01822756|76150760|FG004|Overall Study|Physician Decision|0|||
42314628|NCT01822756|76150756|FG000|Overall Study|disease progression & patient preference|2|||
42314629|NCT01822756|76150757|FG001|Overall Study|disease progression & patient preference|0|||
42314630|NCT01822756|76150758|FG002|Overall Study|disease progression & patient preference|1|||
42314631|NCT01822756|76150759|FG003|Overall Study|disease progression & patient preference|0|||
42314632|NCT01822756|76150760|FG004|Overall Study|disease progression & patient preference|0|||
42314633|NCT01822678|76150775|FG000|Overall Study|Withdrawal by Subject|5|||
42314634|NCT01822678|76150776|FG001|Overall Study|Withdrawal by Subject|4|||
42314635|NCT01822678|76150777|FG002|Overall Study|Withdrawal by Subject|4|||
42314636|NCT01822678|76150775|FG000|Overall Study|Adverse Event|4|||
42314637|NCT01822678|76150776|FG001|Overall Study|Adverse Event|3|||
42314638|NCT01822678|76150777|FG002|Overall Study|Adverse Event|1|||
42314639|NCT01822678|76150775|FG000|Overall Study|Lack of Efficacy|3|||
42314640|NCT01822678|76150776|FG001|Overall Study|Lack of Efficacy|6|||
42314641|NCT01822678|76150777|FG002|Overall Study|Lack of Efficacy|5|||
42314642|NCT01822678|76150775|FG000|Overall Study|Lost to Follow-up|0|||
42314643|NCT01822678|76150776|FG001|Overall Study|Lost to Follow-up|2|||
42314644|NCT01822678|76150777|FG002|Overall Study|Lost to Follow-up|1|||
42314645|NCT01822366|76150789|FG000|Overall Study|Lost to Follow-up|5|||
42314646|NCT01822366|76150790|FG001|Overall Study|Lost to Follow-up|1|||
42314647|NCT01822366|76150791|FG002|Overall Study|Lost to Follow-up|5|||
42314648|NCT01822366|76150792|FG003|Overall Study|Lost to Follow-up|1|||
42314649|NCT01822366|76150789|FG000|Overall Study|Withdrawal by Subject|0|||
42314650|NCT01822366|76150790|FG001|Overall Study|Withdrawal by Subject|6|||
42314651|NCT01822366|76150791|FG002|Overall Study|Withdrawal by Subject|0|||
42314652|NCT01822366|76150792|FG003|Overall Study|Withdrawal by Subject|6|||
42314653|NCT01822366|76150789|FG000|Overall Study|Partial Intervention Completion|0|||
42314654|NCT01822366|76150790|FG001|Overall Study|Partial Intervention Completion|15|||
42314655|NCT01822366|76150791|FG002|Overall Study|Partial Intervention Completion|0|||
42314656|NCT01822366|76150792|FG003|Overall Study|Partial Intervention Completion|15|||
42314657|NCT01838590|76150824|FG000|Overall Study|Lack of Efficacy|12|||
42314658|NCT01838590|76150825|FG001|Overall Study|Lack of Efficacy|4|||
41993094|NCT01148017|75801316|FG003|Overall Study|Administrative reason|0|||
41993095|NCT01148017|75801313|FG000|Overall Study|Unable to classify|3|||
41993096|NCT01148017|75801314|FG001|Overall Study|Unable to classify|1|||
41993097|NCT01148017|75801315|FG002|Overall Study|Unable to classify|0|||
41993098|NCT01148017|75801316|FG003|Overall Study|Unable to classify|0|||
41993099|NCT01147900|75801330|FG000|At Year 10|Lost to Follow-up|0|||
41993100|NCT01147900|75801331|FG001|At Year 10|Lost to Follow-up|1|||
41993101|NCT01147900|75801332|FG002|At Year 10|Lost to Follow-up|0|||
41993102|NCT01147744|75801347|FG000|Overall Study|Protocol Violation|1|||
41993103|NCT01147744|75801348|FG001|Overall Study|Protocol Violation|0|||
41993104|NCT01147744|75801349|FG002|Overall Study|Protocol Violation|1|||
41993105|NCT01147744|75801350|FG003|Overall Study|Protocol Violation|0|||
41993106|NCT01147744|75801351|FG004|Overall Study|Protocol Violation|1|||
42255540|NCT02991859|76081926|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
42255541|NCT02991859|76081927|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255542|NCT02991859|76081928|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255543|NCT02991859|76081929|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
42255544|NCT02991859|76081930|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255545|NCT02991859|76081931|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255546|NCT02991859|76081932|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255547|NCT02991859|76081933|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255548|NCT02991859|76081934|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255549|NCT02991859|76081935|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255550|NCT02991859|76081936|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255551|NCT02991859|76081937|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255552|NCT02991859|76081938|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42314659|NCT01838590|76150824|FG000|Overall Study|Lost to Follow-up|0|||
42314660|NCT01838590|76150825|FG001|Overall Study|Lost to Follow-up|1|||
42314661|NCT01611454|76150837|FG000|Overall Study|Lack of Efficacy|18|||
41993107|NCT01147744|75801352|FG005|Overall Study|Protocol Violation|3|||
41993108|NCT01147744|75801353|FG006|Overall Study|Protocol Violation|1|||
41993109|NCT01147744|75801347|FG000|Overall Study|Physician Decision|0|||
41993110|NCT01147744|75801348|FG001|Overall Study|Physician Decision|1|||
42133137|NCT00410163|75944017|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
42314662|NCT01611454|76150838|FG001|Overall Study|Lack of Efficacy|10|||
41993111|NCT01147744|75801349|FG002|Overall Study|Physician Decision|1|||
41993112|NCT01147744|75801350|FG003|Overall Study|Physician Decision|0|||
42314663|NCT01611298|76150848|FG000|Overall Study|Relapsed|2|||
42314664|NCT01822132|76150854|FG000|Overall Study|Lost to Follow-up|4|||
42314665|NCT01822132|76150855|FG001|Overall Study|Lost to Follow-up|2|||
42314666|NCT01821898|76150869|FG000|Overall Study|Withdrawal by Subject|2|||
42314667|NCT01821898|76150870|FG001|Overall Study|Withdrawal by Subject|1|||
42314668|NCT02411591|76150880|FG000|Overall Study|Adverse Event|0|||
42314669|NCT02411591|76150881|FG001|Overall Study|Adverse Event|4|||
42314670|NCT02411591|76150882|FG002|Overall Study|Adverse Event|2|||
42314671|NCT02411591|76150880|FG000|Overall Study|Withdrawal by Subject|0|||
42314672|NCT02411591|76150881|FG001|Overall Study|Withdrawal by Subject|3|||
42314673|NCT02411591|76150882|FG002|Overall Study|Withdrawal by Subject|0|||
42314674|NCT02411591|76150880|FG000|Overall Study|Physician Decision|0|||
42314675|NCT02411591|76150881|FG001|Overall Study|Physician Decision|3|||
42314676|NCT02411591|76150882|FG002|Overall Study|Physician Decision|1|||
42314677|NCT02454959|76150898|FG000|Overall Study|Protocol-Specified Criteria|3|||
42314678|NCT02454959|76150898|FG000|Overall Study|Physician Decision|1|||
42314679|NCT02454959|76150898|FG000|Overall Study|Withdrawal by Subject|3|||
42314680|NCT02454959|76150898|FG000|Overall Study|Adverse Event|2|||
42314681|NCT01821118|76150906|FG000|Overall Study|Death|0|||
42314682|NCT01821118|76150907|FG001|Overall Study|Death|1|||
42314683|NCT01650779|76150913|FG000|Overall Study|Withdrawal by Subject|1|||
42314684|NCT02411201|76150917|FG000|Overall Study|Adverse Event|2|||
42314685|NCT02411201|76150917|FG000|Overall Study|Withdrawal by Subject|2|||
42314686|NCT02411201|76150917|FG000|Overall Study|Age group completed|2|||
42314687|NCT01838044|76150925|FG000|Overall Study|Adverse Event|4|||
42314688|NCT01838044|76150926|FG001|Overall Study|Adverse Event|6|||
42314689|NCT01838044|76150925|FG000|Overall Study|Protocol Violation|3|||
42314690|NCT01838044|76150926|FG001|Overall Study|Protocol Violation|3|||
42314691|NCT01838044|76150925|FG000|Overall Study|Withdrawal by Subject|0|||
42314692|NCT01838044|76150926|FG001|Overall Study|Withdrawal by Subject|2|||
42314693|NCT01838044|76150925|FG000|Overall Study|Insufficient clinical response|1|||
42314694|NCT01838044|76150926|FG001|Overall Study|Insufficient clinical response|2|||
42314695|NCT01838044|76150925|FG000|Overall Study|Medication error without associated AE|0|||
42314696|NCT01838044|76150926|FG001|Overall Study|Medication error without associated AE|1|||
42314697|NCT01838044|76150925|FG000|Overall Study|Lost to Follow-up|0|||
42314698|NCT01838044|76150926|FG001|Overall Study|Lost to Follow-up|2|||
42314699|NCT02410811|76150937|FG000|Overall Study|Withdrawal by Subject|0|||
42314700|NCT02410811|76150938|FG001|Overall Study|Withdrawal by Subject|0|||
42314701|NCT02410811|76150939|FG002|Overall Study|Withdrawal by Subject|1|||
42314702|NCT02410811|76150940|FG003|Overall Study|Withdrawal by Subject|0|||
42314703|NCT02435381|76150950|FG000|Overall Study|Lost to Follow-up|2|||
41993113|NCT01147744|75801351|FG004|Overall Study|Physician Decision|0|||
41993114|NCT01147744|75801352|FG005|Overall Study|Physician Decision|0|||
41993115|NCT01147744|75801353|FG006|Overall Study|Physician Decision|1|||
42255553|NCT02991859|76081939|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255554|NCT02991859|76081940|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255555|NCT02991859|76081941|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
42255556|NCT02991859|76081925|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255557|NCT02991859|76081926|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255558|NCT02991859|76081927|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255559|NCT02991859|76081928|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255560|NCT02991859|76081929|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255561|NCT02991859|76081930|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255562|NCT02991859|76081931|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255563|NCT02991859|76081932|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255564|NCT02991859|76081933|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255565|NCT02991859|76081934|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255566|NCT02991859|76081935|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255567|NCT02991859|76081936|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42314704|NCT02435381|76150951|FG001|Overall Study|Lost to Follow-up|1|||
42314705|NCT01837966|76150967|FG000|Overall Study|Withdrawal by Subject|2|||
42314706|NCT01837966|76150968|FG001|Overall Study|Withdrawal by Subject|1|||
42314707|NCT02435147|76150974|FG000|Overall Study|non-evaluable DXA scan|11|||
42314708|NCT02435069|76150978|FG000|Dose Response - First Intervention|Adverse Event|0|||
42314709|NCT02435069|76150979|FG001|Dose Response - First Intervention|Adverse Event|1|||
42314710|NCT02435069|76150980|FG002|Dose Response - First Intervention|Adverse Event|1|||
41993116|NCT01147744|75801347|FG000|Overall Study|Lack of Efficacy|11|||
42314711|NCT02435069|76150981|FG003|Dose Response - First Intervention|Adverse Event|0|||
42314712|NCT02435069|76150982|FG004|Dose Response - First Intervention|Adverse Event|0|||
42314713|NCT02435069|76150978|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
42314714|NCT02435069|76150979|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
41993117|NCT01147744|75801348|FG001|Overall Study|Lack of Efficacy|11|||
41993118|NCT01147744|75801349|FG002|Overall Study|Lack of Efficacy|9|||
41993119|NCT01147744|75801350|FG003|Overall Study|Lack of Efficacy|11|||
42314715|NCT02435069|76150980|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
42314716|NCT02435069|76150981|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
42314717|NCT02435069|76150982|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
42314718|NCT02454101|76151004|FG000|Overall Study|Adverse Event|2|||
42314719|NCT02454101|76151005|FG001|Overall Study|Adverse Event|3|||
42314720|NCT02454101|76151004|FG000|Overall Study|Lost to Follow-up|3|||
42314721|NCT02454101|76151005|FG001|Overall Study|Lost to Follow-up|4|||
42314722|NCT02409719|76151013|FG000|Overall Study|Lost to Follow-up|3|||
42314723|NCT02409719|76151014|FG001|Overall Study|Lost to Follow-up|3|||
42314724|NCT01820572|76151022|FG000|Randomization|Not Treated|2|||
42314725|NCT01820572|76151023|FG001|Randomization|Not Treated|1|||
42314726|NCT01820572|76151022|FG000|Treatment Period|Adverse Event|12|||
42314727|NCT01820572|76151023|FG001|Treatment Period|Adverse Event|7|||
42314728|NCT01820572|76151022|FG000|Treatment Period|Death|3|||
42314729|NCT01820572|76151023|FG001|Treatment Period|Death|3|||
42314730|NCT01820572|76151022|FG000|Treatment Period|Lack of Efficacy|1|||
42314731|NCT01820572|76151023|FG001|Treatment Period|Lack of Efficacy|0|||
42314732|NCT01820572|76151022|FG000|Treatment Period|poor/non compliance|0|||
42314733|NCT01820572|76151023|FG001|Treatment Period|poor/non compliance|3|||
42314734|NCT01820572|76151022|FG000|Treatment Period|request to discontinue|6|||
42314735|NCT01820572|76151023|FG001|Treatment Period|request to discontinue|11|||
42314736|NCT01820572|76151022|FG000|Treatment Period|No longer meets study criteria|3|||
42314737|NCT01820572|76151023|FG001|Treatment Period|No longer meets study criteria|10|||
42314738|NCT01820572|76151022|FG000|Treatment Period|withdrew consent|1|||
42314739|NCT01820572|76151023|FG001|Treatment Period|withdrew consent|2|||
42314740|NCT01820260|76151043|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314741|NCT01820260|76151044|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314742|NCT01820260|76151045|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314743|NCT01820260|76151046|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314744|NCT01820260|76151047|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314745|NCT01820260|76151048|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314746|NCT01820260|76151049|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
42314747|NCT01820260|76151050|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314748|NCT01820260|76151051|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314749|NCT01820260|76151052|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314750|NCT01820260|76151053|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314751|NCT01820260|76151054|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314752|NCT01820260|76151055|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42314753|NCT01820260|76151056|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
42255568|NCT02991859|76081937|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
42255569|NCT02991859|76081938|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
42255570|NCT02991859|76081939|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255571|NCT02991859|76081940|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255572|NCT02991859|76081941|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
42255573|NCT02991859|76081925|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255574|NCT02991859|76081926|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255575|NCT02991859|76081927|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255576|NCT02991859|76081928|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42314754|NCT01820260|76151043|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314755|NCT01820260|76151044|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314756|NCT01820260|76151045|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42255577|NCT02991859|76081929|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42314757|NCT01820260|76151046|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314758|NCT01820260|76151047|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314759|NCT01820260|76151048|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314760|NCT01820260|76151049|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314761|NCT01820260|76151050|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314762|NCT01820260|76151051|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314763|NCT01820260|76151052|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
42314764|NCT01820260|76151053|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314765|NCT01820260|76151054|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314766|NCT01820260|76151055|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314767|NCT01820260|76151056|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
42314768|NCT01610596|76151094|FG000|Overall Study|Lost to Follow-up|0|||
42314769|NCT01610596|76151095|FG001|Overall Study|Lost to Follow-up|1|||
42314770|NCT01818700|76151101|FG000|Overall Study|Adverse Event|67|||
42314771|NCT01818700|76151101|FG000|Overall Study|Lack of Efficacy|2|||
42314772|NCT01818700|76151101|FG000|Overall Study|Lost to Follow-up|5|||
42314773|NCT01818700|76151101|FG000|Overall Study|Withdrawal by Subject|27|||
42314774|NCT01818700|76151101|FG000|Overall Study|Protocol Violation|2|||
42314775|NCT01818700|76151101|FG000|Overall Study|Other|1|||
42314776|NCT01817764|76151109|FG000|Overall Study|Adverse Event|7|||
42314777|NCT01817764|76151110|FG001|Overall Study|Adverse Event|10|||
42314778|NCT01817764|76151109|FG000|Overall Study|Lack of Efficacy|9|||
42314779|NCT01817764|76151110|FG001|Overall Study|Lack of Efficacy|7|||
42314780|NCT01817764|76151109|FG000|Overall Study|Protocol Violation|7|||
42314781|NCT01817764|76151110|FG001|Overall Study|Protocol Violation|5|||
42314782|NCT01817764|76151109|FG000|Overall Study|Lost to Follow-up|1|||
42314783|NCT01817764|76151110|FG001|Overall Study|Lost to Follow-up|4|||
41993120|NCT01147744|75801351|FG004|Overall Study|Lack of Efficacy|13|||
41993121|NCT01147744|75801352|FG005|Overall Study|Lack of Efficacy|8|||
41993122|NCT01147744|75801353|FG006|Overall Study|Lack of Efficacy|7|||
41993123|NCT01147744|75801347|FG000|Overall Study|Adverse Event|1|||
41993124|NCT01147744|75801348|FG001|Overall Study|Adverse Event|2|||
41993125|NCT01147744|75801349|FG002|Overall Study|Adverse Event|3|||
41993126|NCT01147744|75801350|FG003|Overall Study|Adverse Event|0|||
41993127|NCT01147744|75801351|FG004|Overall Study|Adverse Event|2|||
41993128|NCT01147744|75801352|FG005|Overall Study|Adverse Event|1|||
41993129|NCT01147744|75801353|FG006|Overall Study|Adverse Event|2|||
41993130|NCT01147744|75801347|FG000|Overall Study|Withdrawal by Subject|8|||
41993131|NCT01147744|75801348|FG001|Overall Study|Withdrawal by Subject|4|||
41993132|NCT01147744|75801349|FG002|Overall Study|Withdrawal by Subject|2|||
41993133|NCT01147744|75801350|FG003|Overall Study|Withdrawal by Subject|2|||
41993134|NCT01147744|75801351|FG004|Overall Study|Withdrawal by Subject|2|||
41993135|NCT01147744|75801352|FG005|Overall Study|Withdrawal by Subject|5|||
41993136|NCT01147744|75801353|FG006|Overall Study|Withdrawal by Subject|2|||
41993137|NCT01147744|75801347|FG000|Overall Study|Lost to Follow-up|0|||
41993138|NCT01147744|75801348|FG001|Overall Study|Lost to Follow-up|1|||
41993139|NCT01147744|75801349|FG002|Overall Study|Lost to Follow-up|0|||
41993140|NCT01147744|75801350|FG003|Overall Study|Lost to Follow-up|0|||
41993141|NCT01147744|75801351|FG004|Overall Study|Lost to Follow-up|0|||
41993142|NCT01147744|75801352|FG005|Overall Study|Lost to Follow-up|0|||
41993143|NCT01147744|75801353|FG006|Overall Study|Lost to Follow-up|0|||
41993144|NCT01147744|75801347|FG000|Overall Study|Sponsor decision to amend protocol|7|||
41993145|NCT01147744|75801348|FG001|Overall Study|Sponsor decision to amend protocol|4|||
41993146|NCT01147744|75801349|FG002|Overall Study|Sponsor decision to amend protocol|2|||
41993147|NCT01147744|75801350|FG003|Overall Study|Sponsor decision to amend protocol|5|||
41993148|NCT01147744|75801351|FG004|Overall Study|Sponsor decision to amend protocol|7|||
41993149|NCT01147744|75801352|FG005|Overall Study|Sponsor decision to amend protocol|2|||
41993150|NCT01147744|75801353|FG006|Overall Study|Sponsor decision to amend protocol|6|||
41993151|NCT01147744|75801347|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
41993152|NCT01147744|75801348|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
41993153|NCT01147744|75801349|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
41993154|NCT01147744|75801350|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
42033501|NCT00838201|75841730|FG001|Overall Study|Noncompliance|1|||
42033502|NCT00838201|75841729|FG000|Overall Study|Administrative decision|1|||
42033503|NCT00838201|75841730|FG001|Overall Study|Administrative decision|2|||
42133138|NCT00410163|75944016|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
42255578|NCT02991859|76081930|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
42255579|NCT02991859|76081931|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255580|NCT02991859|76081932|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255581|NCT02991859|76081933|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255582|NCT02991859|76081934|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255583|NCT02991859|76081935|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255584|NCT02991859|76081936|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255585|NCT02991859|76081937|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42314784|NCT01817764|76151109|FG000|Overall Study|Withdrawal by Subject|10|||
42314785|NCT01817764|76151110|FG001|Overall Study|Withdrawal by Subject|12|||
42314786|NCT01803880|76151119|FG000|Overall Study|Adverse Event|1|||
41993155|NCT01147744|75801351|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
41993156|NCT01147744|75801352|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
41993157|NCT01147744|75801353|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
41993158|NCT01147471|75801377|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
41993159|NCT01147471|75801378|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
41993160|NCT01147471|75801377|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
41993161|NCT01147471|75801378|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
42314787|NCT01803880|76151120|FG001|Overall Study|Adverse Event|0|||
42314788|NCT01803880|76151121|FG002|Overall Study|Adverse Event|0|||
42314789|NCT01803880|76151119|FG000|Overall Study|Withdrawal by Subject|1|||
41993162|NCT01147471|75801377|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
41993163|NCT01147471|75801378|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
41993164|NCT01147471|75801377|FG000|3 Month Follow Up|Lost to Follow-up|1|||
41993165|NCT01147471|75801378|FG001|3 Month Follow Up|Lost to Follow-up|1|||
42033504|NCT00838201|75841729|FG000|Overall Study|Disease progression|3|||
42033505|NCT00838201|75841730|FG001|Overall Study|Disease progression|3|||
41993166|NCT01147471|75801377|FG000|3 Month Follow Up|Physician Decision|0|||
41993167|NCT01147471|75801378|FG001|3 Month Follow Up|Physician Decision|1|||
41993168|NCT01147471|75801377|FG000|6 Month Follow Up|Lost to Follow-up|4|||
41993169|NCT01147471|75801378|FG001|6 Month Follow Up|Lost to Follow-up|2|||
41993170|NCT01147393|75801384|FG000|Dose Level 1|Dose limiting Toxicity|2|||
42033506|NCT00838201|75841729|FG000|Overall Study|Consent withdrawn|16|||
42033507|NCT00838201|75841730|FG001|Overall Study|Consent withdrawn|19|||
42033508|NCT00838201|75841729|FG000|Overall Study|Lost to Follow-up|4|||
42255586|NCT02991859|76081938|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255587|NCT02991859|76081939|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255588|NCT02991859|76081940|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255589|NCT02991859|76081941|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
42255590|NCT02991859|76081925|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255591|NCT02991859|76081926|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255592|NCT02991859|76081927|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255593|NCT02991859|76081928|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255594|NCT02991859|76081929|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255595|NCT02991859|76081930|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255596|NCT02991859|76081931|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255597|NCT02991859|76081932|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255598|NCT02991859|76081933|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255599|NCT02991859|76081934|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
42255600|NCT02991859|76081935|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255601|NCT02991859|76081936|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255602|NCT02991859|76081937|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255603|NCT02991859|76081938|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255604|NCT02991859|76081939|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255605|NCT02991859|76081940|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255606|NCT02991859|76081941|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
42255607|NCT02991859|76081925|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255608|NCT02991859|76081926|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255609|NCT02991859|76081927|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255610|NCT02991859|76081928|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255611|NCT02991859|76081929|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255612|NCT02991859|76081930|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255613|NCT02991859|76081931|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255614|NCT02991859|76081932|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255615|NCT02991859|76081933|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
42255616|NCT02991859|76081934|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255617|NCT02991859|76081935|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255618|NCT02991859|76081936|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255619|NCT02991859|76081937|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255620|NCT02991859|76081938|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255621|NCT02991859|76081939|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255622|NCT02991859|76081940|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255623|NCT02991859|76081941|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
42255624|NCT03016325|76082024|FG000|Treatment Period|Participant withdrew consent|0|||
42255625|NCT03016325|76082025|FG001|Treatment Period|Participant withdrew consent|1|||
42255626|NCT03016325|76082026|FG002|Treatment Period|Participant withdrew consent|0|||
42255627|NCT03016325|76082027|FG003|Treatment Period|Participant withdrew consent|0|||
42314790|NCT01803880|76151120|FG001|Overall Study|Withdrawal by Subject|1|||
42314791|NCT01803880|76151121|FG002|Overall Study|Withdrawal by Subject|4|||
42033509|NCT00838201|75841730|FG001|Overall Study|Lost to Follow-up|3|||
42033510|NCT00838201|75841729|FG000|Overall Study|Adverse Event|5|||
42314792|NCT01803880|76151119|FG000|Overall Study|Physician Decision|0|||
42314793|NCT01803880|76151120|FG001|Overall Study|Physician Decision|0|||
42314794|NCT01803880|76151121|FG002|Overall Study|Physician Decision|1|||
42314795|NCT01803880|76151119|FG000|Overall Study|Unable to return for follow-up visits|0|||
42314796|NCT01803880|76151120|FG001|Overall Study|Unable to return for follow-up visits|1|||
42314797|NCT01803880|76151121|FG002|Overall Study|Unable to return for follow-up visits|2|||
42314798|NCT01803880|76151119|FG000|Overall Study|Lost to Follow-up|1|||
42314799|NCT01803880|76151120|FG001|Overall Study|Lost to Follow-up|2|||
42314800|NCT01803880|76151121|FG002|Overall Study|Lost to Follow-up|3|||
42314801|NCT01803880|76151119|FG000|Overall Study|Protocol Violation|1|||
42314802|NCT01803880|76151120|FG001|Overall Study|Protocol Violation|0|||
42314803|NCT01803880|76151121|FG002|Overall Study|Protocol Violation|0|||
42314804|NCT01803880|76151119|FG000|Overall Study|Early study termination|0|||
42314805|NCT01803880|76151120|FG001|Overall Study|Early study termination|6|||
42314806|NCT01803880|76151121|FG002|Overall Study|Early study termination|5|||
42314807|NCT01803880|76151119|FG000|Overall Study|Incomplete data entry by sites|2|||
42314808|NCT01803880|76151120|FG001|Overall Study|Incomplete data entry by sites|0|||
42314809|NCT01803880|76151121|FG002|Overall Study|Incomplete data entry by sites|0|||
42314810|NCT01803646|76151133|FG000|Overall Study|Protocol Violation|1|||
42033511|NCT00838201|75841730|FG001|Overall Study|Adverse Event|9|||
42033512|NCT00838201|75841729|FG000|Overall Study|Death|11|||
42033513|NCT00838201|75841730|FG001|Overall Study|Death|13|||
42033514|NCT00837967|75841736|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
42033515|NCT00837967|75841737|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
42033516|NCT02756806|75841743|FG000|Overall Study|Study terminated early|5|||
42033517|NCT00942357|75841749|FG000|Overall Study|Ineligible|37|||
42033518|NCT00942357|75841750|FG001|Overall Study|Ineligible|40|||
42033519|NCT00939783|75841756|FG000|Overall Study|Death|6|||
42314811|NCT01803646|76151134|FG001|Overall Study|Protocol Violation|0|||
42314812|NCT01803646|76151133|FG000|Overall Study|Adverse Event|1|||
42314813|NCT01803646|76151134|FG001|Overall Study|Adverse Event|1|||
42314814|NCT01803646|76151133|FG000|Overall Study|Withdrawal by Subject|9|||
42314815|NCT01803646|76151134|FG001|Overall Study|Withdrawal by Subject|6|||
42314816|NCT01803646|76151133|FG000|Overall Study|Randomization error|1|||
42314817|NCT01803646|76151134|FG001|Overall Study|Randomization error|2|||
42314818|NCT01803646|76151133|FG000|Overall Study|Lost to Follow-up|5|||
42314819|NCT01803646|76151134|FG001|Overall Study|Lost to Follow-up|1|||
42314820|NCT01817530|76151148|FG000|Overall Study|Exclusionary Medication Received|0|||
42314821|NCT01817530|76151149|FG001|Overall Study|Exclusionary Medication Received|0|||
42314822|NCT01817530|76151150|FG002|Overall Study|Exclusionary Medication Received|0|||
42314823|NCT01817530|76151151|FG003|Overall Study|Exclusionary Medication Received|0|||
42314824|NCT01817530|76151152|FG004|Overall Study|Exclusionary Medication Received|1|||
42314825|NCT01817530|76151153|FG005|Overall Study|Exclusionary Medication Received|0|||
42314826|NCT01817530|76151154|FG006|Overall Study|Exclusionary Medication Received|0|||
42314827|NCT01817530|76151155|FG007|Overall Study|Exclusionary Medication Received|0|||
42314828|NCT01817530|76151148|FG000|Overall Study|Adverse Event|6|||
42314829|NCT01817530|76151149|FG001|Overall Study|Adverse Event|3|||
42314830|NCT01817530|76151150|FG002|Overall Study|Adverse Event|2|||
42314831|NCT01817530|76151151|FG003|Overall Study|Adverse Event|5|||
42314832|NCT01817530|76151152|FG004|Overall Study|Adverse Event|0|||
42314833|NCT01817530|76151153|FG005|Overall Study|Adverse Event|10|||
42314834|NCT01817530|76151154|FG006|Overall Study|Adverse Event|5|||
42314835|NCT01817530|76151155|FG007|Overall Study|Adverse Event|8|||
42314836|NCT01817530|76151148|FG000|Overall Study|Subject Noncompliant|3|||
42314837|NCT01817530|76151149|FG001|Overall Study|Subject Noncompliant|1|||
41993171|NCT01147393|75801384|FG000|Dose Level -1|Dose Limited Toxicity|1|||
41993172|NCT01146652|75801391|FG000|Overall Study|Adverse Event|506|||
41993173|NCT01146652|75801392|FG001|Overall Study|Adverse Event|15|||
41993174|NCT01146652|75801391|FG000|Overall Study|Lack of Efficacy|91|||
41993175|NCT01146652|75801392|FG001|Overall Study|Lack of Efficacy|7|||
41993176|NCT01146652|75801391|FG000|Overall Study|Poor compliance to protocol|38|||
41993177|NCT01146652|75801392|FG001|Overall Study|Poor compliance to protocol|1|||
41993178|NCT01146652|75801391|FG000|Overall Study|Other unspecified reasons|314|||
41993179|NCT01146652|75801392|FG001|Overall Study|Other unspecified reasons|22|||
41993180|NCT01146652|75801391|FG000|Overall Study|Enrolled but not treated|2|||
41993181|NCT01146652|75801392|FG001|Overall Study|Enrolled but not treated|0|||
42314838|NCT01817530|76151150|FG002|Overall Study|Subject Noncompliant|0|||
42314839|NCT01817530|76151151|FG003|Overall Study|Subject Noncompliant|4|||
42314840|NCT01817530|76151152|FG004|Overall Study|Subject Noncompliant|0|||
42314841|NCT01817530|76151153|FG005|Overall Study|Subject Noncompliant|1|||
42314842|NCT01817530|76151154|FG006|Overall Study|Subject Noncompliant|1|||
41993182|NCT01146613|75801407|FG000|Overall Study|Lost to Follow-up|3|||
41993183|NCT01146613|75801408|FG001|Overall Study|Lost to Follow-up|8|||
42314843|NCT01817530|76151155|FG007|Overall Study|Subject Noncompliant|1|||
42033520|NCT00939783|75841756|FG000|Overall Study|Adverse Event|39|||
42314844|NCT01817530|76151148|FG000|Overall Study|Lack of Efficacy|1|||
42314845|NCT01817530|76151149|FG001|Overall Study|Lack of Efficacy|0|||
42314846|NCT01817530|76151150|FG002|Overall Study|Lack of Efficacy|0|||
42314847|NCT01817530|76151151|FG003|Overall Study|Lack of Efficacy|0|||
42314848|NCT01817530|76151152|FG004|Overall Study|Lack of Efficacy|0|||
42314849|NCT01817530|76151153|FG005|Overall Study|Lack of Efficacy|1|||
42314850|NCT01817530|76151154|FG006|Overall Study|Lack of Efficacy|0|||
42314851|NCT01817530|76151155|FG007|Overall Study|Lack of Efficacy|1|||
42314852|NCT01817530|76151148|FG000|Overall Study|Pregnancy|0|||
42314853|NCT01817530|76151149|FG001|Overall Study|Pregnancy|0|||
42314854|NCT01817530|76151150|FG002|Overall Study|Pregnancy|0|||
42314855|NCT01817530|76151151|FG003|Overall Study|Pregnancy|0|||
42314856|NCT01817530|76151152|FG004|Overall Study|Pregnancy|0|||
42314857|NCT01817530|76151153|FG005|Overall Study|Pregnancy|1|||
42314858|NCT01817530|76151154|FG006|Overall Study|Pregnancy|0|||
42314859|NCT01817530|76151155|FG007|Overall Study|Pregnancy|0|||
42314860|NCT01817530|76151148|FG000|Overall Study|Other|0|||
42314861|NCT01817530|76151149|FG001|Overall Study|Other|1|||
42314862|NCT01817530|76151150|FG002|Overall Study|Other|0|||
42314863|NCT01817530|76151151|FG003|Overall Study|Other|0|||
42314864|NCT01817530|76151152|FG004|Overall Study|Other|1|||
42314865|NCT01817530|76151153|FG005|Overall Study|Other|0|||
42314866|NCT01817530|76151154|FG006|Overall Study|Other|5|||
42314867|NCT01817530|76151155|FG007|Overall Study|Other|0|||
42314868|NCT01817530|76151148|FG000|Overall Study|Surgery or Invasive Intervention|1|||
42314869|NCT01817530|76151149|FG001|Overall Study|Surgery or Invasive Intervention|0|||
42314870|NCT01817530|76151150|FG002|Overall Study|Surgery or Invasive Intervention|0|||
42314871|NCT01817530|76151151|FG003|Overall Study|Surgery or Invasive Intervention|0|||
42314872|NCT01817530|76151152|FG004|Overall Study|Surgery or Invasive Intervention|1|||
42314873|NCT01817530|76151153|FG005|Overall Study|Surgery or Invasive Intervention|1|||
42314874|NCT01817530|76151154|FG006|Overall Study|Surgery or Invasive Intervention|1|||
42314875|NCT01817530|76151155|FG007|Overall Study|Surgery or Invasive Intervention|0|||
42314876|NCT01817530|76151148|FG000|Overall Study|Consent Withdrawn by Subject|3|||
42314877|NCT01817530|76151149|FG001|Overall Study|Consent Withdrawn by Subject|4|||
42314878|NCT01817530|76151150|FG002|Overall Study|Consent Withdrawn by Subject|7|||
42314879|NCT01817530|76151151|FG003|Overall Study|Consent Withdrawn by Subject|3|||
42314880|NCT01817530|76151152|FG004|Overall Study|Consent Withdrawn by Subject|5|||
42314881|NCT01817530|76151153|FG005|Overall Study|Consent Withdrawn by Subject|3|||
42314882|NCT01817530|76151154|FG006|Overall Study|Consent Withdrawn by Subject|3|||
42314883|NCT01817530|76151155|FG007|Overall Study|Consent Withdrawn by Subject|10|||
42314884|NCT01817530|76151148|FG000|Overall Study|Lost to Follow-up|1|||
42314885|NCT01817530|76151149|FG001|Overall Study|Lost to Follow-up|4|||
42314886|NCT01817530|76151150|FG002|Overall Study|Lost to Follow-up|2|||
42314887|NCT01817530|76151151|FG003|Overall Study|Lost to Follow-up|1|||
42314888|NCT01817530|76151152|FG004|Overall Study|Lost to Follow-up|3|||
42314889|NCT01817530|76151153|FG005|Overall Study|Lost to Follow-up|2|||
41993184|NCT01146613|75801407|FG000|Overall Study|Lack of Efficacy|0|||
41993185|NCT01146613|75801408|FG001|Overall Study|Lack of Efficacy|1|||
41993186|NCT01146613|75801407|FG000|Overall Study|Death|1|||
41993187|NCT01146613|75801408|FG001|Overall Study|Death|0|||
41993188|NCT01146613|75801407|FG000|Overall Study|Physician Decision|1|||
42255628|NCT03016325|76082028|FG004|Treatment Period|Participant withdrew consent|0|||
42255629|NCT03016325|76082029|FG005|Treatment Period|Participant withdrew consent|0|||
42255630|NCT03016325|76082030|FG006|Treatment Period|Participant withdrew consent|0|||
42255631|NCT03016325|76082031|FG007|Treatment Period|Participant withdrew consent|0|||
42255632|NCT03016325|76082024|FG000|Treatment Period|Death|0|||
42255633|NCT03016325|76082025|FG001|Treatment Period|Death|0|||
42255634|NCT03016325|76082026|FG002|Treatment Period|Death|0|||
42255635|NCT03016325|76082027|FG003|Treatment Period|Death|0|||
42255636|NCT03016325|76082028|FG004|Treatment Period|Death|2|||
42255637|NCT03016325|76082029|FG005|Treatment Period|Death|0|||
42255638|NCT03016325|76082030|FG006|Treatment Period|Death|0|||
42255639|NCT03016325|76082031|FG007|Treatment Period|Death|0|||
42255640|NCT03016325|76082024|FG000|Treatment Period|Participant refuses assessments|0|||
42314890|NCT01817530|76151154|FG006|Overall Study|Lost to Follow-up|8|||
42314891|NCT01817530|76151155|FG007|Overall Study|Lost to Follow-up|4|||
42314892|NCT01816984|76151173|FG000|Overall Study|declining health status|1|||
42255641|NCT03016325|76082025|FG001|Treatment Period|Participant refuses assessments|0|||
42314893|NCT01816906|76151179|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
42314894|NCT01816906|76151180|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
42314895|NCT01816906|76151179|FG000|Six Months|Lost to Follow-up|14|||
42314896|NCT01816906|76151180|FG001|Six Months|Lost to Follow-up|16|||
42314897|NCT01816906|76151179|FG000|12 Months|Adverse Event|2|||
42314898|NCT01816906|76151180|FG001|12 Months|Adverse Event|2|||
42314899|NCT01816906|76151179|FG000|12 Months|Death|0|||
42314900|NCT01816906|76151180|FG001|12 Months|Death|2|||
42314901|NCT01816906|76151179|FG000|12 Months|Lost to Follow-up|2|||
42314902|NCT01816906|76151180|FG001|12 Months|Lost to Follow-up|1|||
42314903|NCT01816594|76151189|FG000|Overall Study|Local Progress|0|||
42314904|NCT01816594|76151190|FG001|Overall Study|Local Progress|2|||
42314905|NCT01816594|76151189|FG000|Overall Study|Adverse Event|9|||
42314906|NCT01816594|76151190|FG001|Overall Study|Adverse Event|0|||
42314907|NCT01816594|76151189|FG000|Overall Study|Withdrawal by Subject|1|||
42314908|NCT01816594|76151190|FG001|Overall Study|Withdrawal by Subject|0|||
42314909|NCT01816594|76151189|FG000|Overall Study|Physician Decision|1|||
42314910|NCT01816594|76151190|FG001|Overall Study|Physician Decision|0|||
42314911|NCT01802320|76151202|FG000|Overall Study|Death|1|||
42314912|NCT01802320|76151202|FG000|Overall Study|Withdrawal by Subject|1|||
42314913|NCT02453711|76151215|FG000|Overall Study|Withdrawal by Subject|5|||
42314914|NCT02453711|76151216|FG001|Overall Study|Withdrawal by Subject|4|||
42314915|NCT02453711|76151217|FG002|Overall Study|Withdrawal by Subject|6|||
42314916|NCT02453711|76151218|FG003|Overall Study|Withdrawal by Subject|4|||
42314917|NCT02453711|76151219|FG004|Overall Study|Withdrawal by Subject|1|||
42314918|NCT02453711|76151220|FG005|Overall Study|Withdrawal by Subject|1|||
42314919|NCT02453711|76151221|FG006|Overall Study|Withdrawal by Subject|0|||
42314920|NCT02453711|76151222|FG007|Overall Study|Withdrawal by Subject|1|||
42314921|NCT02453711|76151223|FG008|Overall Study|Withdrawal by Subject|7|||
42314922|NCT02453711|76151215|FG000|Overall Study|Lost to Follow-up|5|||
42314923|NCT02453711|76151216|FG001|Overall Study|Lost to Follow-up|3|||
42314924|NCT02453711|76151217|FG002|Overall Study|Lost to Follow-up|2|||
42314925|NCT02453711|76151218|FG003|Overall Study|Lost to Follow-up|3|||
42314926|NCT02453711|76151219|FG004|Overall Study|Lost to Follow-up|1|||
42314927|NCT02453711|76151220|FG005|Overall Study|Lost to Follow-up|5|||
42314928|NCT02453711|76151221|FG006|Overall Study|Lost to Follow-up|2|||
42314929|NCT02453711|76151222|FG007|Overall Study|Lost to Follow-up|6|||
42314930|NCT02453711|76151223|FG008|Overall Study|Lost to Follow-up|6|||
42314931|NCT02453711|76151215|FG000|Overall Study|Death|0|||
42314932|NCT02453711|76151216|FG001|Overall Study|Death|0|||
42314933|NCT02453711|76151217|FG002|Overall Study|Death|0|||
42314934|NCT02453711|76151218|FG003|Overall Study|Death|0|||
42314935|NCT02453711|76151219|FG004|Overall Study|Death|0|||
42314936|NCT02453711|76151220|FG005|Overall Study|Death|0|||
42314937|NCT02453711|76151221|FG006|Overall Study|Death|1|||
42314938|NCT02453711|76151222|FG007|Overall Study|Death|0|||
42314939|NCT02453711|76151223|FG008|Overall Study|Death|0|||
42314940|NCT02453711|76151215|FG000|Overall Study|Unclassified|1|||
42314941|NCT02453711|76151216|FG001|Overall Study|Unclassified|0|||
42314942|NCT02453711|76151217|FG002|Overall Study|Unclassified|1|||
42314943|NCT02453711|76151218|FG003|Overall Study|Unclassified|0|||
42314944|NCT02453711|76151219|FG004|Overall Study|Unclassified|0|||
42314945|NCT02453711|76151220|FG005|Overall Study|Unclassified|0|||
42314946|NCT02453711|76151221|FG006|Overall Study|Unclassified|0|||
42314947|NCT02453711|76151222|FG007|Overall Study|Unclassified|0|||
42314948|NCT02453711|76151223|FG008|Overall Study|Unclassified|0|||
42314949|NCT02453555|76151245|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
42314950|NCT02453555|76151246|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
42314951|NCT02453555|76151247|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
42314952|NCT02453555|76151248|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
42314953|NCT02453555|76151249|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
42314954|NCT02453555|76151250|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
42314955|NCT02453555|76151245|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
42314956|NCT02453555|76151246|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
42314957|NCT02453555|76151247|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
42314958|NCT02453555|76151248|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
42314959|NCT02453555|76151249|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
42314960|NCT02453555|76151250|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
42314961|NCT02453555|76151245|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
42314962|NCT02453555|76151246|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
42314963|NCT02453555|76151247|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
42314964|NCT02453555|76151248|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
42314965|NCT02453555|76151249|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
42314966|NCT02453555|76151250|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
42314967|NCT02453555|76151245|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
42314968|NCT02453555|76151246|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
42314969|NCT02453555|76151247|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
42314970|NCT02453555|76151248|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
42314971|NCT02453555|76151249|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
42314972|NCT02453555|76151250|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
42314973|NCT02453555|76151245|FG000|Extension Period|Adverse Event|0|||
42314974|NCT02453555|76151246|FG001|Extension Period|Adverse Event|0|||
42314975|NCT02453555|76151247|FG002|Extension Period|Adverse Event|1|||
42314976|NCT02453555|76151248|FG003|Extension Period|Adverse Event|2|||
42314977|NCT02453555|76151249|FG004|Extension Period|Adverse Event|1|||
42314978|NCT02453555|76151250|FG005|Extension Period|Adverse Event|1|||
42314979|NCT02453555|76151245|FG000|Extension Period|Protocol Violation|0|||
42314980|NCT02453555|76151246|FG001|Extension Period|Protocol Violation|0|||
42314981|NCT02453555|76151247|FG002|Extension Period|Protocol Violation|1|||
42314982|NCT02453555|76151248|FG003|Extension Period|Protocol Violation|0|||
42314983|NCT02453555|76151249|FG004|Extension Period|Protocol Violation|0|||
42314984|NCT02453555|76151250|FG005|Extension Period|Protocol Violation|0|||
42314985|NCT02453555|76151245|FG000|Extension Period|Withdrawal by Subject|0|||
42314986|NCT02453555|76151246|FG001|Extension Period|Withdrawal by Subject|0|||
42314987|NCT02453555|76151247|FG002|Extension Period|Withdrawal by Subject|1|||
42314988|NCT02453555|76151248|FG003|Extension Period|Withdrawal by Subject|0|||
42314989|NCT02453555|76151249|FG004|Extension Period|Withdrawal by Subject|0|||
42314990|NCT02453555|76151250|FG005|Extension Period|Withdrawal by Subject|0|||
42314991|NCT02453321|76151263|FG000|Overall Study|Weakness|1|||
42255642|NCT03016325|76082026|FG002|Treatment Period|Participant refuses assessments|1|||
42255643|NCT03016325|76082027|FG003|Treatment Period|Participant refuses assessments|0|||
42255644|NCT03016325|76082028|FG004|Treatment Period|Participant refuses assessments|0|||
42255645|NCT03016325|76082029|FG005|Treatment Period|Participant refuses assessments|0|||
42255646|NCT03016325|76082030|FG006|Treatment Period|Participant refuses assessments|0|||
42255647|NCT03016325|76082031|FG007|Treatment Period|Participant refuses assessments|0|||
42255648|NCT03016325|76082024|FG000|32-Day Follow-Up Period|Death|2|||
42255649|NCT03016325|76082025|FG001|32-Day Follow-Up Period|Death|0|||
42255650|NCT03016325|76082026|FG002|32-Day Follow-Up Period|Death|5|||
42255651|NCT03016325|76082027|FG003|32-Day Follow-Up Period|Death|6|||
42255652|NCT03016325|76082028|FG004|32-Day Follow-Up Period|Death|3|||
42255653|NCT03016325|76082029|FG005|32-Day Follow-Up Period|Death|0|||
42255654|NCT03016325|76082030|FG006|32-Day Follow-Up Period|Death|0|||
42255655|NCT03016325|76082031|FG007|32-Day Follow-Up Period|Death|0|||
42255656|NCT03016325|76082024|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
42255657|NCT03016325|76082025|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
42255658|NCT03016325|76082026|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
42255659|NCT03016325|76082027|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
42255660|NCT03016325|76082028|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
42255661|NCT03016325|76082029|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
42255662|NCT03016325|76082030|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
42255663|NCT03016325|76082031|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
42255664|NCT03016325|76082024|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
42255665|NCT03016325|76082025|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
42255666|NCT03016325|76082026|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
42255667|NCT03016325|76082027|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
42255668|NCT03016325|76082028|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
42255669|NCT03016325|76082029|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
42255670|NCT03016325|76082030|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
42255671|NCT03016325|76082031|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
42255672|NCT03016325|76082024|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
42255673|NCT03016325|76082025|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
42255674|NCT03016325|76082026|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
42255675|NCT03016325|76082027|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
42255676|NCT03016325|76082028|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
42255677|NCT03016325|76082029|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
42255678|NCT03016325|76082030|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
42255679|NCT03016325|76082031|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
42255680|NCT03016325|76082024|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
42314992|NCT02453321|76151264|FG001|Overall Study|Weakness|1|||
42314993|NCT02453321|76151265|FG002|Overall Study|Weakness|2|||
42314994|NCT02453321|76151263|FG000|Overall Study|Deep Venous Thrombosis|0|||
42314995|NCT02453321|76151264|FG001|Overall Study|Deep Venous Thrombosis|1|||
42255681|NCT03016325|76082025|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
42255682|NCT03016325|76082026|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
42255683|NCT03016325|76082027|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
42255684|NCT03016325|76082028|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
42314996|NCT02453321|76151265|FG002|Overall Study|Deep Venous Thrombosis|0|||
42255685|NCT03016325|76082029|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
42255686|NCT03016325|76082030|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
42255687|NCT03016325|76082031|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
42255688|NCT03016325|76082024|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
42255689|NCT03016325|76082025|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
42255690|NCT03016325|76082026|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
42255691|NCT03016325|76082027|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
42255692|NCT03016325|76082028|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
42255693|NCT03016325|76082029|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
42255694|NCT03016325|76082030|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
42255695|NCT03016325|76082031|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
42255696|NCT03016325|76082024|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
42255697|NCT03016325|76082025|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
42255698|NCT03016325|76082026|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
42255699|NCT03016325|76082027|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
42255700|NCT03016325|76082028|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
42255701|NCT03016325|76082029|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
42255702|NCT03016325|76082030|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
42255703|NCT03016325|76082031|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
42255704|NCT03016325|76082024|FG000|182-Day Follow-Up Period|Death|3|||
42255705|NCT03016325|76082025|FG001|182-Day Follow-Up Period|Death|3|||
42255706|NCT03016325|76082026|FG002|182-Day Follow-Up Period|Death|11|||
42255707|NCT03016325|76082027|FG003|182-Day Follow-Up Period|Death|12|||
42255708|NCT03016325|76082028|FG004|182-Day Follow-Up Period|Death|9|||
42255709|NCT03016325|76082029|FG005|182-Day Follow-Up Period|Death|0|||
42255710|NCT03016325|76082030|FG006|182-Day Follow-Up Period|Death|0|||
42255711|NCT03016325|76082031|FG007|182-Day Follow-Up Period|Death|1|||
42255712|NCT03016325|76082024|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
42255713|NCT03016325|76082025|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
42255714|NCT03016325|76082026|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
42255715|NCT03016325|76082027|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
42255716|NCT03016325|76082028|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
42255717|NCT03016325|76082029|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
42255718|NCT03016325|76082030|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
42255719|NCT03016325|76082031|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
42255720|NCT03016325|76082024|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
42255721|NCT03016325|76082025|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
42255722|NCT03016325|76082026|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
42255723|NCT03016325|76082027|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
42255724|NCT03016325|76082028|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
42255725|NCT03016325|76082029|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
42255726|NCT03016325|76082030|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
42255727|NCT03016325|76082031|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
42255728|NCT03016325|76082024|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
42255729|NCT03016325|76082025|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
41993189|NCT01146613|75801408|FG001|Overall Study|Physician Decision|0|||
41993190|NCT01146613|75801407|FG000|Overall Study|Withdrawal by Subject|0|||
41993191|NCT01146613|75801408|FG001|Overall Study|Withdrawal by Subject|3|||
41993192|NCT01146613|75801407|FG000|Overall Study|schedule conflict|1|||
41993193|NCT01146613|75801408|FG001|Overall Study|schedule conflict|0|||
41993194|NCT01146613|75801407|FG000|Overall Study|Outpatient detox|1|||
41993195|NCT01146613|75801408|FG001|Overall Study|Outpatient detox|0|||
41993196|NCT01145755|75801417|FG000|Overall Study|Adverse Event|2|||
41993197|NCT01145755|75801418|FG001|Overall Study|Adverse Event|4|||
41993198|NCT01145755|75801419|FG002|Overall Study|Adverse Event|2|||
41993199|NCT01145755|75801417|FG000|Overall Study|Withdrawal by Subject|2|||
41993200|NCT01145755|75801418|FG001|Overall Study|Withdrawal by Subject|2|||
41993201|NCT01145755|75801419|FG002|Overall Study|Withdrawal by Subject|2|||
41993202|NCT01145755|75801417|FG000|Overall Study|Lost to Follow-up|2|||
42033521|NCT00939783|75841756|FG000|Overall Study|Study Terminated by Sponsor|498|||
42133139|NCT00410163|75944017|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
42255730|NCT03016325|76082026|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
42255731|NCT03016325|76082027|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
42255732|NCT03016325|76082028|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
42255733|NCT03016325|76082029|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
42255734|NCT03016325|76082030|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
42255735|NCT03016325|76082031|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
42255736|NCT03016325|76082024|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
42255737|NCT03016325|76082025|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
42255738|NCT03016325|76082026|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
42255739|NCT03016325|76082027|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
42314997|NCT01610284|76151278|FG000|Randomization Phase|Adverse Event|1|||
42314998|NCT01610284|76151279|FG001|Randomization Phase|Adverse Event|0|||
42314999|NCT01610284|76151278|FG000|Randomization Phase|Physician Decision|1|||
42315000|NCT01610284|76151279|FG001|Randomization Phase|Physician Decision|1|||
42315001|NCT01610284|76151278|FG000|Randomization Phase|Death|0|||
42315002|NCT01610284|76151279|FG001|Randomization Phase|Death|1|||
42315003|NCT01610284|76151278|FG000|Treatment Phase|Adverse Event|80|||
42315004|NCT01610284|76151279|FG001|Treatment Phase|Adverse Event|12|||
42315005|NCT01610284|76151278|FG000|Treatment Phase|Lost to Follow-up|1|||
42315006|NCT01610284|76151279|FG001|Treatment Phase|Lost to Follow-up|0|||
42315007|NCT01610284|76151278|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
42315008|NCT01610284|76151279|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
42315009|NCT01610284|76151278|FG000|Treatment Phase|Physician Decision|27|||
42315010|NCT01610284|76151279|FG001|Treatment Phase|Physician Decision|24|||
42315011|NCT01610284|76151278|FG000|Treatment Phase|Progressive Disease|377|||
41993203|NCT01145755|75801418|FG001|Overall Study|Lost to Follow-up|3|||
41993204|NCT01145755|75801419|FG002|Overall Study|Lost to Follow-up|1|||
41993205|NCT01145755|75801417|FG000|Overall Study|Protocol Violation|0|||
41993206|NCT01145755|75801418|FG001|Overall Study|Protocol Violation|3|||
42255740|NCT03016325|76082028|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
42255741|NCT03016325|76082029|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
42255742|NCT03016325|76082030|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
42255743|NCT03016325|76082031|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
42255744|NCT03016325|76082024|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
42255745|NCT03016325|76082025|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
42255746|NCT03016325|76082026|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
42255747|NCT03016325|76082027|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
42255748|NCT03016325|76082028|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
42255749|NCT03016325|76082029|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
42255750|NCT03016325|76082030|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
42255751|NCT03016325|76082031|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
42255752|NCT03016325|76082024|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
42255753|NCT03016325|76082025|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
42255754|NCT03016325|76082026|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
42255755|NCT03016325|76082027|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
42255756|NCT03016325|76082028|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
42255757|NCT03016325|76082029|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
42255758|NCT03016325|76082030|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
42255759|NCT03016325|76082031|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
42255760|NCT03016325|76082024|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
42255761|NCT03016325|76082025|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
42255762|NCT03016325|76082026|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
42255763|NCT03016325|76082027|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
42315012|NCT01610284|76151279|FG001|Treatment Phase|Progressive Disease|486|||
42315013|NCT01610284|76151278|FG000|Treatment Phase|Protocol Deviation|2|||
42315014|NCT01610284|76151279|FG001|Treatment Phase|Protocol Deviation|3|||
42315015|NCT01610284|76151278|FG000|Treatment Phase|Study terminated by Sponsor|18|||
42315016|NCT01610284|76151279|FG001|Treatment Phase|Study terminated by Sponsor|15|||
42315017|NCT01610284|76151278|FG000|Treatment Phase|Subject/Guardian Decision|55|||
41993207|NCT01145755|75801419|FG002|Overall Study|Protocol Violation|1|||
41993208|NCT01145755|75801417|FG000|Overall Study|Study Closure|14|||
41993209|NCT01145755|75801418|FG001|Overall Study|Study Closure|14|||
41993210|NCT01145755|75801419|FG002|Overall Study|Study Closure|17|||
41993211|NCT01145755|75801417|FG000|Overall Study|Lack of Efficacy|0|||
41993212|NCT01145755|75801418|FG001|Overall Study|Lack of Efficacy|1|||
42315018|NCT01610284|76151279|FG001|Treatment Phase|Subject/Guardian Decision|23|||
42315019|NCT01610284|76151278|FG000|Treatment Phase|Death|6|||
42315020|NCT01610284|76151279|FG001|Treatment Phase|Death|5|||
41993213|NCT01145755|75801419|FG002|Overall Study|Lack of Efficacy|0|||
41993214|NCT01145755|75801417|FG000|Overall Study|Patient could not swollow medication|0|||
41993215|NCT01145755|75801418|FG001|Overall Study|Patient could not swollow medication|0|||
42315021|NCT01610284|76151278|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
42315022|NCT01610284|76151279|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
42315023|NCT01610284|76151278|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
42315024|NCT01610284|76151279|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
42315025|NCT01610284|76151278|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
42315026|NCT01610284|76151279|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
42315027|NCT01610284|76151278|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
42315028|NCT01610284|76151279|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
42315029|NCT01610284|76151278|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
42315030|NCT01610284|76151279|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
41993216|NCT01145755|75801419|FG002|Overall Study|Patient could not swollow medication|1|||
41993217|NCT01145755|75801417|FG000|Overall Study|Withdrawal by Subject|0|||
41993218|NCT01145755|75801418|FG001|Overall Study|Withdrawal by Subject|0|||
41993219|NCT01145755|75801419|FG002|Overall Study|Withdrawal by Subject|1|||
41993220|NCT01145755|75801417|FG000|Overall Study|Positive urine ethanol|0|||
41993221|NCT01145755|75801418|FG001|Overall Study|Positive urine ethanol|1|||
41993222|NCT01145755|75801419|FG002|Overall Study|Positive urine ethanol|0|||
41993223|NCT01145560|75801430|FG000|Overall Study|Withdrawal by Subject|2|||
41993224|NCT01145560|75801431|FG001|Overall Study|Withdrawal by Subject|1|||
41993225|NCT01145560|75801432|FG002|Overall Study|Withdrawal by Subject|0|||
41993226|NCT01145560|75801430|FG000|Overall Study|Lost to Follow-up|1|||
42255764|NCT03016325|76082028|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
42255765|NCT03016325|76082029|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
42255766|NCT03016325|76082030|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
42255767|NCT03016325|76082031|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
42255768|NCT02988115|76082054|FG000|Overall Study|Adverse Event|6|||
42255769|NCT02988115|76082055|FG001|Overall Study|Adverse Event|1|||
42255770|NCT02988115|76082054|FG000|Overall Study|Sponsor Decision|5|||
42255771|NCT02988115|76082055|FG001|Overall Study|Sponsor Decision|2|||
42255772|NCT02988115|76082054|FG000|Overall Study|Withdrawal by Subject|1|||
42255773|NCT02988115|76082055|FG001|Overall Study|Withdrawal by Subject|1|||
42255774|NCT02988115|76082054|FG000|Overall Study|Withdrawn by Mistake|1|||
42255775|NCT02988115|76082055|FG001|Overall Study|Withdrawn by Mistake|0|||
42255776|NCT02988115|76082054|FG000|Overall Study|Lost to Follow-up|1|||
42255777|NCT02988115|76082055|FG001|Overall Study|Lost to Follow-up|0|||
42255778|NCT02921425|76082061|FG000|Overall Study|Protocol Violation|9|||
42255779|NCT03008915|76082065|FG000|Treatment 1|Withdrawal by Subject|0|||
42255780|NCT03008915|76082066|FG001|Treatment 1|Withdrawal by Subject|1|||
42255781|NCT02920957|76082077|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
42255782|NCT02920957|76082078|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
42255783|NCT02920957|76082077|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
42255784|NCT02920957|76082078|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
42255785|NCT02920957|76082077|FG000|First Intervention : 1 Month|Adverse Event|1|||
42255786|NCT02920957|76082078|FG001|First Intervention : 1 Month|Adverse Event|0|||
42255787|NCT02920957|76082077|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
42255788|NCT02920957|76082078|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
42255789|NCT03006887|76082095|FG000|Overall Study|Adverse Event|1|||
42255790|NCT02514772|76082101|FG000|Overall Study|Adverse Event|1|||
42255791|NCT02514772|76082102|FG001|Overall Study|Adverse Event|0|||
42255792|NCT02514772|76082101|FG000|Overall Study|Death|0|||
42255793|NCT02514772|76082102|FG001|Overall Study|Death|1|||
42255794|NCT02514772|76082101|FG000|Overall Study|Withdrawal by Subject|2|||
42255795|NCT02514772|76082102|FG001|Overall Study|Withdrawal by Subject|1|||
42255796|NCT03000179|76082110|FG000|Overall Study|Lost to Follow-up|2|||
42255797|NCT02920177|76082116|FG000|Overall Study|Withdrawal by Subject|1|||
42255798|NCT02920177|76082117|FG001|Overall Study|Withdrawal by Subject|1|||
42255799|NCT02920177|76082116|FG000|Overall Study|Physician Decision|1|||
42255800|NCT02920177|76082117|FG001|Overall Study|Physician Decision|0|||
42255801|NCT02920177|76082116|FG000|Overall Study|Lost to Follow-up|0|||
42255802|NCT02920177|76082117|FG001|Overall Study|Lost to Follow-up|1|||
41993227|NCT01145560|75801431|FG001|Overall Study|Lost to Follow-up|1|||
42255803|NCT03006341|76082127|FG000|Overall Study|Not linked in the EMR|25069|||
42255804|NCT03006341|76082128|FG001|Overall Study|Not linked in the EMR|67505|||
42315031|NCT01610284|76151278|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
41993228|NCT01145560|75801432|FG002|Overall Study|Lost to Follow-up|1|||
42255805|NCT03006341|76082129|FG002|Overall Study|Not linked in the EMR|30993|||
42255806|NCT03006341|76082130|FG003|Overall Study|Not linked in the EMR|10685|||
42315032|NCT01610284|76151279|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
42315033|NCT02452463|76151288|FG000|Overall Study|Death|1|||
42315034|NCT02452463|76151289|FG001|Overall Study|Death|0|||
42315035|NCT02452463|76151290|FG002|Overall Study|Death|0|||
42315036|NCT02452463|76151288|FG000|Overall Study|Study Suspended|1|||
42315037|NCT02452463|76151289|FG001|Overall Study|Study Suspended|0|||
42315038|NCT02452463|76151290|FG002|Overall Study|Study Suspended|0|||
42315039|NCT02452463|76151288|FG000|Overall Study|Recommended by DSMB|0|||
42315040|NCT02452463|76151289|FG001|Overall Study|Recommended by DSMB|1|||
42315041|NCT02452463|76151290|FG002|Overall Study|Recommended by DSMB|0|||
42315042|NCT02452463|76151288|FG000|Overall Study|Withdrawal by Subject|0|||
42315043|NCT02452463|76151289|FG001|Overall Study|Withdrawal by Subject|1|||
42315044|NCT02452463|76151290|FG002|Overall Study|Withdrawal by Subject|0|||
42315045|NCT02432105|76151301|FG000|Overall Study|Lost to Follow-up|1|||
42315046|NCT02432105|76151302|FG001|Overall Study|Lost to Follow-up|1|||
42315047|NCT02432105|76151303|FG002|Overall Study|Lost to Follow-up|0|||
42315048|NCT02432105|76151301|FG000|Overall Study|Withdrawal by Subject|1|||
42315049|NCT02432105|76151302|FG001|Overall Study|Withdrawal by Subject|0|||
42315050|NCT02432105|76151303|FG002|Overall Study|Withdrawal by Subject|1|||
42315051|NCT02432105|76151301|FG000|Overall Study|Culture positive for yeast|0|||
42315052|NCT02432105|76151302|FG001|Overall Study|Culture positive for yeast|1|||
42315053|NCT02432105|76151303|FG002|Overall Study|Culture positive for yeast|0|||
42315054|NCT02432105|76151301|FG000|Overall Study|Randomized in error|0|||
42255807|NCT03935594|76082138|FG000|Overall Study|Physician Decision|3|||
42255808|NCT02512042|76082146|FG000|Overall Study|Adverse Event|0|||
42255809|NCT02512042|76082147|FG001|Overall Study|Adverse Event|4|||
42255810|NCT02512042|76082146|FG000|Overall Study|Withdrawal by Subject|6|||
42255811|NCT02512042|76082147|FG001|Overall Study|Withdrawal by Subject|6|||
42255812|NCT02512042|76082146|FG000|Overall Study|Non-compliance with study drug|1|||
42255813|NCT02512042|76082147|FG001|Overall Study|Non-compliance with study drug|2|||
42010568|NCT00993421|75817698|FG004|Overall Study|Lost to Follow-up|0|||
42133140|NCT00409617|75944053|FG000|Overall Study|Adverse Event|57|||
42255814|NCT02512042|76082146|FG000|Overall Study|Lost to Follow-up|5|||
42255815|NCT02512042|76082147|FG001|Overall Study|Lost to Follow-up|2|||
42255816|NCT02512042|76082146|FG000|Overall Study|Other|11|||
42255817|NCT02512042|76082147|FG001|Overall Study|Other|11|||
42255818|NCT02911025|76082153|FG000|Overall Study|Lost to Follow-up|3|||
42255819|NCT02919475|76082162|FG000|Overall Study|Adverse Event|3|||
42315055|NCT02432105|76151302|FG001|Overall Study|Randomized in error|0|||
42315056|NCT02432105|76151303|FG002|Overall Study|Randomized in error|2|||
42315057|NCT02431793|76151315|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
42315058|NCT02431793|76151316|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
42255820|NCT02919475|76082163|FG001|Overall Study|Adverse Event|3|||
42315059|NCT02431793|76151317|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
42315060|NCT02431793|76151315|FG000|Overall Study|Withdrawal by Subject|7|||
42315061|NCT02431793|76151316|FG001|Overall Study|Withdrawal by Subject|5|||
42315062|NCT02431793|76151317|FG002|Overall Study|Withdrawal by Subject|5|||
42315063|NCT02431793|76151315|FG000|Overall Study|Lost to Follow-up|101|||
42315064|NCT02431793|76151316|FG001|Overall Study|Lost to Follow-up|122|||
42315065|NCT02431793|76151317|FG002|Overall Study|Lost to Follow-up|104|||
42315066|NCT01801930|76151329|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
42315067|NCT01801930|76151330|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
42315068|NCT01801930|76151331|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
42315069|NCT01801930|76151332|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
42315070|NCT01801930|76151329|FG000|Overall Study|DLT occurs|0|||
42315071|NCT01801930|76151330|FG001|Overall Study|DLT occurs|1|||
42315072|NCT01801930|76151331|FG002|Overall Study|DLT occurs|0|||
42315073|NCT01801930|76151332|FG003|Overall Study|DLT occurs|0|||
42315074|NCT01610206|76151344|FG000|Overall Study|Adverse Event|10|||
42315075|NCT01610206|76151345|FG001|Overall Study|Adverse Event|30|||
42315076|NCT01816048|76151351|FG000|Overall Study|Adverse Event|1|||
42315077|NCT01816048|76151351|FG000|Overall Study|Death|1|||
42315078|NCT01816048|76151351|FG000|Overall Study|Withdrawal by Subject|1|||
42315079|NCT01816048|76151351|FG000|Overall Study|Disease Progression|3|||
42315080|NCT01612858|76151358|FG000|Overall Study|Withdrawal by Subject|5|||
42315081|NCT01612858|76151359|FG001|Overall Study|Withdrawal by Subject|1|||
42315082|NCT01612780|76151365|FG000|Overall Study|Treatment not completed|1|||
42315083|NCT01612780|76151365|FG000|Overall Study|Withdrawal by Subject|5|||
42315084|NCT01612702|76151371|FG000|Overall Study|Protocol Violation|11|||
42315085|NCT01612702|76151372|FG001|Overall Study|Protocol Violation|11|||
42315086|NCT02431559|76151382|FG000|Overall Study|Adverse Event|0|||
42315087|NCT02431559|76151383|FG001|Overall Study|Adverse Event|1|||
42315088|NCT02431559|76151384|FG002|Overall Study|Adverse Event|0|||
41993229|NCT01145560|75801430|FG000|Overall Study|No study drug by 24h after organ failure|1|||
41993230|NCT01145560|75801431|FG001|Overall Study|No study drug by 24h after organ failure|0|||
42010569|NCT00993421|75817699|FG005|Overall Study|Lost to Follow-up|0|||
42255821|NCT02919475|76082164|FG002|Overall Study|Adverse Event|3|||
42255822|NCT02919475|76082165|FG003|Overall Study|Adverse Event|9|||
42255823|NCT02919475|76082166|FG004|Overall Study|Adverse Event|2|||
42255824|NCT02919475|76082162|FG000|Overall Study|Death|0|||
42255825|NCT02919475|76082163|FG001|Overall Study|Death|1|||
42255826|NCT02919475|76082164|FG002|Overall Study|Death|0|||
42255827|NCT02919475|76082165|FG003|Overall Study|Death|0|||
42255828|NCT02919475|76082166|FG004|Overall Study|Death|0|||
42255829|NCT02919475|76082162|FG000|Overall Study|Lost to Follow-up|0|||
42255830|NCT02919475|76082163|FG001|Overall Study|Lost to Follow-up|0|||
42255831|NCT02919475|76082164|FG002|Overall Study|Lost to Follow-up|0|||
42255832|NCT02919475|76082165|FG003|Overall Study|Lost to Follow-up|1|||
42255833|NCT02919475|76082166|FG004|Overall Study|Lost to Follow-up|0|||
42255834|NCT02919475|76082162|FG000|Overall Study|Withdrawal by Subject|2|||
42255835|NCT02919475|76082163|FG001|Overall Study|Withdrawal by Subject|3|||
42255836|NCT02919475|76082164|FG002|Overall Study|Withdrawal by Subject|1|||
42255837|NCT02919475|76082165|FG003|Overall Study|Withdrawal by Subject|2|||
42255838|NCT02919475|76082166|FG004|Overall Study|Withdrawal by Subject|2|||
42315089|NCT02431559|76151385|FG003|Overall Study|Adverse Event|4|||
42315090|NCT02431559|76151382|FG000|Overall Study|Progressive disease|2|||
42315091|NCT02431559|76151383|FG001|Overall Study|Progressive disease|1|||
42315092|NCT02431559|76151384|FG002|Overall Study|Progressive disease|4|||
42315093|NCT02431559|76151385|FG003|Overall Study|Progressive disease|22|||
42315094|NCT02431559|76151382|FG000|Overall Study|Withdrawal by Subject|0|||
42315095|NCT02431559|76151383|FG001|Overall Study|Withdrawal by Subject|1|||
42315096|NCT02431559|76151384|FG002|Overall Study|Withdrawal by Subject|0|||
42315097|NCT02431559|76151385|FG003|Overall Study|Withdrawal by Subject|4|||
42255839|NCT02919475|76082162|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
42315098|NCT02431559|76151382|FG000|Overall Study|Physician Decision|0|||
42315099|NCT02431559|76151383|FG001|Overall Study|Physician Decision|0|||
42315100|NCT02431559|76151384|FG002|Overall Study|Physician Decision|0|||
42315101|NCT02431559|76151385|FG003|Overall Study|Physician Decision|1|||
42315102|NCT02388269|76151399|FG000|Overall Study|Adverse Event|2|||
42315103|NCT02388269|76151400|FG001|Overall Study|Adverse Event|0|||
42315104|NCT02388269|76151401|FG002|Overall Study|Adverse Event|0|||
42315105|NCT02388269|76151399|FG000|Overall Study|Withdrawal by Subject|1|||
42315106|NCT02388269|76151400|FG001|Overall Study|Withdrawal by Subject|2|||
42315107|NCT02388269|76151401|FG002|Overall Study|Withdrawal by Subject|0|||
42315108|NCT02388269|76151399|FG000|Overall Study|less than 50% stimulations|1|||
42315109|NCT02388269|76151400|FG001|Overall Study|less than 50% stimulations|0|||
42315110|NCT02388269|76151401|FG002|Overall Study|less than 50% stimulations|0|||
42315111|NCT02388269|76151399|FG000|Overall Study|no diary data|3|||
42315112|NCT02388269|76151400|FG001|Overall Study|no diary data|0|||
42315113|NCT02388269|76151401|FG002|Overall Study|no diary data|0|||
42315114|NCT02388269|76151399|FG000|Overall Study|Protocol Violation|2|||
42315115|NCT02388269|76151400|FG001|Overall Study|Protocol Violation|0|||
42315116|NCT02388269|76151401|FG002|Overall Study|Protocol Violation|0|||
42315117|NCT02388269|76151399|FG000|Overall Study|Screen Failure|0|||
42315118|NCT02388269|76151400|FG001|Overall Study|Screen Failure|0|||
42315119|NCT02388269|76151401|FG002|Overall Study|Screen Failure|10|||
42315120|NCT01652573|76151427|FG000|Overall Study|Adverse Event|0|||
42315121|NCT01652573|76151428|FG001|Overall Study|Adverse Event|1|||
42315122|NCT02388191|76151436|FG000|Overall Study|Patient did not receive IUD|1|||
41993231|NCT01145560|75801432|FG002|Overall Study|No study drug by 24h after organ failure|0|||
41993232|NCT01145560|75801430|FG000|Overall Study|Accidental unblinding of study treatment|0|||
41993233|NCT01145560|75801431|FG001|Overall Study|Accidental unblinding of study treatment|1|||
41993234|NCT01145560|75801432|FG002|Overall Study|Accidental unblinding of study treatment|0|||
41993235|NCT01145560|75801430|FG000|Overall Study|False insurance information|0|||
41993236|NCT01145560|75801431|FG001|Overall Study|False insurance information|1|||
41993237|NCT01145560|75801432|FG002|Overall Study|False insurance information|0|||
41993238|NCT01145560|75801430|FG000|Overall Study|Withdrawal of therapy|0|||
41993239|NCT01145560|75801431|FG001|Overall Study|Withdrawal of therapy|0|||
41993240|NCT01145560|75801432|FG002|Overall Study|Withdrawal of therapy|1|||
41993241|NCT01145482|75801442|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
42033522|NCT00939783|75841756|FG000|Overall Study|Withdrawal by Subject|78|||
42033523|NCT00939783|75841756|FG000|Overall Study|Other|16|||
42033524|NCT00939783|75841756|FG000|Overall Study|Lost to Follow-up|8|||
42033525|NCT00939783|75841756|FG000|Overall Study|Protocol Violation|3|||
42033526|NCT00939783|75841756|FG000|Overall Study|Enrolled but not treated|1|||
42033527|NCT00939627|75841762|FG000|Overall Study|Disease Progression|16|||
42133141|NCT00409617|75944053|FG000|Overall Study|Lack of Efficacy|54|||
42133142|NCT00409617|75944053|FG000|Overall Study|Lost to Follow-up|2|||
42255840|NCT02919475|76082163|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
42255841|NCT02919475|76082164|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
42255842|NCT02919475|76082165|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
42255843|NCT02919475|76082166|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42255844|NCT01066897|76082180|FG000|Overall Study|Withdrawal by Subject|1|||
42255845|NCT01066897|76082181|FG001|Overall Study|Withdrawal by Subject|0|||
42255846|NCT01066897|76082180|FG000|Overall Study|stopped study after developing the flu.|1|||
42255847|NCT01066897|76082181|FG001|Overall Study|stopped study after developing the flu.|0|||
42255848|NCT02985541|76082188|FG000|Overall Study|Withdrawal by Subject|33|||
42255849|NCT02985541|76082188|FG000|Overall Study|Lost to Follow-up|26|||
42255850|NCT02985541|76082188|FG000|Overall Study|Adverse Event|27|||
42255851|NCT02985541|76082188|FG000|Overall Study|Physician Decision|2|||
42255852|NCT02985541|76082188|FG000|Overall Study|Pregnancy|2|||
42255853|NCT02985541|76082188|FG000|Overall Study|Wish for pregnancy|44|||
42255854|NCT02985541|76082188|FG000|Overall Study|Other reason|5|||
42255855|NCT02985541|76082188|FG000|Overall Study|Not valid for analysis|2|||
42255856|NCT02910037|76082201|FG000|Overall Study|Withdrawal by Subject|4|||
42255857|NCT02910037|76082201|FG000|Overall Study|Lost to Follow-up|6|||
42255858|NCT02511184|76082236|FG000|Overall Study|Death|1|||
42255859|NCT02511184|76082237|FG001|Overall Study|Death|0|||
42315123|NCT02388191|76151437|FG001|Overall Study|Patient did not receive IUD|0|||
42315124|NCT01815736|76151445|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
42315125|NCT01815736|76151446|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
42315126|NCT01815736|76151445|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
42315127|NCT01815736|76151446|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
42315128|NCT01815736|76151445|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
42315129|NCT01815736|76151446|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
42315130|NCT01815736|76151445|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
42033528|NCT00939627|75841763|FG001|Overall Study|Disease Progression|12|||
42033529|NCT00939627|75841764|FG002|Overall Study|Disease Progression|0|||
42033530|NCT00939627|75841762|FG000|Overall Study|Adverse Event|6|||
42033531|NCT00939627|75841763|FG001|Overall Study|Adverse Event|7|||
42033532|NCT00939627|75841764|FG002|Overall Study|Adverse Event|0|||
42033533|NCT00939627|75841762|FG000|Overall Study|Death|0|||
42033534|NCT00939627|75841763|FG001|Overall Study|Death|2|||
42033535|NCT00939627|75841764|FG002|Overall Study|Death|0|||
41993242|NCT01145482|75801443|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
41993243|NCT01145053|75801449|FG000|Overall Study|Adverse Event|22|||
41993244|NCT01145053|75801449|FG000|Overall Study|Lost to Follow-up|28|||
41993245|NCT01145053|75801449|FG000|Overall Study|Withdrawal by Subject|25|||
41993246|NCT01145053|75801449|FG000|Overall Study|Other|18|||
41993247|NCT01144663|75801457|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
41993248|NCT01144663|75801458|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
41993249|NCT01144663|75801459|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
41993250|NCT01144663|75801460|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
41993251|NCT01144663|75801457|FG000|Primary Vaccination Phase|Adverse Event|1|||
41993252|NCT01144663|75801458|FG001|Primary Vaccination Phase|Adverse Event|0|||
41993253|NCT01144663|75801459|FG002|Primary Vaccination Phase|Adverse Event|0|||
41993254|NCT01144663|75801460|FG003|Primary Vaccination Phase|Adverse Event|1|||
41993255|NCT01144663|75801457|FG000|Primary Vaccination Phase|Protocol Violation|2|||
41993256|NCT01144663|75801458|FG001|Primary Vaccination Phase|Protocol Violation|0|||
41993257|NCT01144663|75801459|FG002|Primary Vaccination Phase|Protocol Violation|1|||
41993258|NCT01144663|75801460|FG003|Primary Vaccination Phase|Protocol Violation|0|||
41993259|NCT01144663|75801457|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
41993260|NCT01144663|75801458|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
41993261|NCT01144663|75801459|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
41993262|NCT01144663|75801460|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
42033536|NCT00939627|75841762|FG000|Overall Study|Withdrawal by Subject|2|||
42033537|NCT00939627|75841763|FG001|Overall Study|Withdrawal by Subject|4|||
41993263|NCT01144663|75801457|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
41993264|NCT01144663|75801458|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
41993265|NCT01144663|75801459|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
41993266|NCT01144663|75801460|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
41993267|NCT01144663|75801457|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
41993268|NCT01144663|75801458|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
41993269|NCT01144663|75801459|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
41993270|NCT01144663|75801460|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
41993271|NCT01144663|75801457|FG000|Primary Vaccination Phase|Other|0|||
41993272|NCT01144663|75801458|FG001|Primary Vaccination Phase|Other|1|||
41993273|NCT01144663|75801459|FG002|Primary Vaccination Phase|Other|0|||
41993274|NCT01144663|75801460|FG003|Primary Vaccination Phase|Other|2|||
41993275|NCT01144663|75801457|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
42033538|NCT00939627|75841764|FG002|Overall Study|Withdrawal by Subject|0|||
42033539|NCT00939627|75841762|FG000|Overall Study|Other complicating disease|1|||
42033540|NCT00939627|75841763|FG001|Overall Study|Other complicating disease|1|||
42033541|NCT00939627|75841764|FG002|Overall Study|Other complicating disease|0|||
42033542|NCT00939627|75841762|FG000|Overall Study|Not compliant|2|||
42033543|NCT00939627|75841763|FG001|Overall Study|Not compliant|0|||
42033544|NCT00939627|75841764|FG002|Overall Study|Not compliant|0|||
42033545|NCT00939627|75841762|FG000|Overall Study|No off-tx reason given|0|||
42033546|NCT00939627|75841763|FG001|Overall Study|No off-tx reason given|2|||
42033547|NCT00939627|75841764|FG002|Overall Study|No off-tx reason given|0|||
42033548|NCT00937833|75841772|FG000|Overall Study|Protocol Violation|1|||
42033549|NCT00937833|75841773|FG001|Overall Study|Protocol Violation|2|||
42033550|NCT00937833|75841772|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
42033551|NCT00937833|75841773|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
42033552|NCT00937833|75841772|FG000|Overall Study|Lost to Follow-up|10|||
42133143|NCT00409617|75944053|FG000|Overall Study|Protocol Violation|24|||
42133144|NCT00409617|75944053|FG000|Overall Study|Withdrawal by Subject|8|||
42133145|NCT00409617|75944053|FG000|Overall Study|Administrative reasons|1|||
42133146|NCT00409617|75944053|FG000|Overall Study|Not described|14|||
42133147|NCT00300274|75944060|FG000|Overall Study|Withdrawal by Subject|12|||
42133148|NCT00300274|75944061|FG001|Overall Study|Withdrawal by Subject|3|||
42255860|NCT02511184|76082236|FG000|Overall Study|Lost to Follow-up|0|||
42255861|NCT02511184|76082237|FG001|Overall Study|Lost to Follow-up|1|||
42255862|NCT02511184|76082236|FG000|Overall Study|Study terminated by sponsor|1|||
42255863|NCT02511184|76082237|FG001|Overall Study|Study terminated by sponsor|5|||
42255864|NCT02511184|76082236|FG000|Overall Study|Withdrawal by Subject|0|||
42255865|NCT02511184|76082237|FG001|Overall Study|Withdrawal by Subject|1|||
42255866|NCT02984995|76082246|FG000|Overall Study|Required stem cell transplant|13|||
42255867|NCT02984995|76082247|FG001|Overall Study|Required stem cell transplant|2|||
42133149|NCT00300274|75944062|FG002|Overall Study|Withdrawal by Subject|14|||
42033553|NCT00937833|75841773|FG001|Overall Study|Lost to Follow-up|8|||
42033554|NCT00937833|75841772|FG000|Overall Study|Withdrawal by Subject|4|||
42033555|NCT00937833|75841773|FG001|Overall Study|Withdrawal by Subject|6|||
42033556|NCT01135511|75841788|FG000|Overall Study|Adverse Event|0|||
42033557|NCT01135511|75841789|FG001|Overall Study|Adverse Event|1|||
42033558|NCT01135511|75841790|FG002|Overall Study|Adverse Event|2|||
42033559|NCT01135511|75841791|FG003|Overall Study|Adverse Event|0|||
42033560|NCT01135511|75841792|FG004|Overall Study|Adverse Event|0|||
42033561|NCT01135511|75841793|FG005|Overall Study|Adverse Event|1|||
42033562|NCT01135511|75841794|FG006|Overall Study|Adverse Event|0|||
42033563|NCT01135511|75841795|FG007|Overall Study|Adverse Event|1|||
42033564|NCT01135511|75841796|FG008|Overall Study|Adverse Event|0|||
42033565|NCT01135511|75841788|FG000|Overall Study|Lack of Efficacy|0|||
41993276|NCT01144663|75801458|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
41993277|NCT01144663|75801459|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
42033566|NCT01135511|75841789|FG001|Overall Study|Lack of Efficacy|1|||
42033567|NCT01135511|75841790|FG002|Overall Study|Lack of Efficacy|1|||
42033568|NCT01135511|75841791|FG003|Overall Study|Lack of Efficacy|2|||
42033569|NCT01135511|75841792|FG004|Overall Study|Lack of Efficacy|0|||
42033570|NCT01135511|75841793|FG005|Overall Study|Lack of Efficacy|0|||
42033571|NCT01135511|75841794|FG006|Overall Study|Lack of Efficacy|0|||
42033572|NCT01135511|75841795|FG007|Overall Study|Lack of Efficacy|0|||
42033573|NCT01135511|75841796|FG008|Overall Study|Lack of Efficacy|0|||
42033574|NCT01135511|75841788|FG000|Overall Study|Protocol Violation|0|||
42033575|NCT01135511|75841789|FG001|Overall Study|Protocol Violation|0|||
42033576|NCT01135511|75841790|FG002|Overall Study|Protocol Violation|3|||
42033577|NCT01135511|75841791|FG003|Overall Study|Protocol Violation|0|||
42033578|NCT01135511|75841792|FG004|Overall Study|Protocol Violation|0|||
42033579|NCT01135511|75841793|FG005|Overall Study|Protocol Violation|0|||
42033580|NCT01135511|75841794|FG006|Overall Study|Protocol Violation|0|||
42033581|NCT01135511|75841795|FG007|Overall Study|Protocol Violation|0|||
42033582|NCT01135511|75841796|FG008|Overall Study|Protocol Violation|0|||
42033583|NCT01135511|75841788|FG000|Overall Study|Pregnancy|0|||
42033584|NCT01135511|75841789|FG001|Overall Study|Pregnancy|0|||
42033585|NCT01135511|75841790|FG002|Overall Study|Pregnancy|0|||
42033586|NCT01135511|75841791|FG003|Overall Study|Pregnancy|1|||
42033587|NCT01135511|75841792|FG004|Overall Study|Pregnancy|0|||
42033588|NCT01135511|75841793|FG005|Overall Study|Pregnancy|0|||
42033589|NCT01135511|75841794|FG006|Overall Study|Pregnancy|0|||
42033590|NCT01135511|75841795|FG007|Overall Study|Pregnancy|0|||
42033591|NCT01135511|75841796|FG008|Overall Study|Pregnancy|0|||
42033592|NCT01135511|75841788|FG000|Overall Study|could not visit the clinic|0|||
42033593|NCT01135511|75841789|FG001|Overall Study|could not visit the clinic|1|||
42033594|NCT01135511|75841790|FG002|Overall Study|could not visit the clinic|2|||
41993278|NCT01144663|75801460|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
41993279|NCT01144663|75801457|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
41993280|NCT01144663|75801458|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
41993281|NCT01144663|75801459|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
41993282|NCT01144663|75801460|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
41993283|NCT01144663|75801457|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
41993284|NCT01144663|75801458|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
41993285|NCT01144663|75801459|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
41993286|NCT01144663|75801460|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
41993287|NCT01144663|75801457|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
41993288|NCT01144663|75801458|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
41993289|NCT01144663|75801459|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
41993290|NCT01144663|75801460|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
41993291|NCT01144663|75801457|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
41993292|NCT01144663|75801458|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
41993293|NCT01144663|75801459|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
41993294|NCT01144663|75801460|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
41993295|NCT01144663|75801457|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
42033595|NCT01135511|75841791|FG003|Overall Study|could not visit the clinic|0|||
42033596|NCT01135511|75841792|FG004|Overall Study|could not visit the clinic|0|||
42033597|NCT01135511|75841793|FG005|Overall Study|could not visit the clinic|0|||
42133150|NCT00300274|75944060|FG000|Overall Study|Lost to Follow-up|3|||
42133151|NCT00300274|75944061|FG001|Overall Study|Lost to Follow-up|4|||
42033598|NCT01135511|75841794|FG006|Overall Study|could not visit the clinic|0|||
42033599|NCT01135511|75841795|FG007|Overall Study|could not visit the clinic|0|||
42033600|NCT01135511|75841796|FG008|Overall Study|could not visit the clinic|0|||
42033601|NCT01135511|75841788|FG000|Overall Study|noncompliance with study drug taken|0|||
42033602|NCT01135511|75841789|FG001|Overall Study|noncompliance with study drug taken|0|||
42033603|NCT01135511|75841790|FG002|Overall Study|noncompliance with study drug taken|0|||
42033604|NCT01135511|75841791|FG003|Overall Study|noncompliance with study drug taken|0|||
42033605|NCT01135511|75841792|FG004|Overall Study|noncompliance with study drug taken|1|||
42033606|NCT01135511|75841793|FG005|Overall Study|noncompliance with study drug taken|0|||
42033607|NCT01135511|75841794|FG006|Overall Study|noncompliance with study drug taken|0|||
42033608|NCT01135511|75841795|FG007|Overall Study|noncompliance with study drug taken|0|||
42033609|NCT01135511|75841796|FG008|Overall Study|noncompliance with study drug taken|0|||
42033610|NCT01135511|75841788|FG000|Overall Study|Withdrawal by Subject|0|||
42033611|NCT01135511|75841789|FG001|Overall Study|Withdrawal by Subject|0|||
42033612|NCT01135511|75841790|FG002|Overall Study|Withdrawal by Subject|0|||
42033613|NCT01135511|75841791|FG003|Overall Study|Withdrawal by Subject|0|||
42033614|NCT01135511|75841792|FG004|Overall Study|Withdrawal by Subject|0|||
42033615|NCT01135511|75841793|FG005|Overall Study|Withdrawal by Subject|0|||
42033616|NCT01135511|75841794|FG006|Overall Study|Withdrawal by Subject|1|||
42033617|NCT01135511|75841795|FG007|Overall Study|Withdrawal by Subject|0|||
42033618|NCT01135511|75841796|FG008|Overall Study|Withdrawal by Subject|1|||
42033619|NCT01184846|75841825|FG000|Overall Study|Adverse Event|2|||
42033620|NCT01184846|75841825|FG000|Overall Study|Insufficient response|1|||
42033621|NCT01180400|75841833|FG000|Overall Study|Withdrawal by Subject|5|||
42033622|NCT01180400|75841834|FG001|Overall Study|Withdrawal by Subject|6|||
42033623|NCT01180400|75841833|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42033624|NCT01180400|75841834|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
42033625|NCT01180400|75841833|FG000|Overall Study|Adverse Event|12|||
42033626|NCT01180400|75841834|FG001|Overall Study|Adverse Event|10|||
42033627|NCT01180400|75841833|FG000|Overall Study|Severe non-compliance to protocol|1|||
42033628|NCT01180400|75841834|FG001|Overall Study|Severe non-compliance to protocol|2|||
42033629|NCT01180400|75841833|FG000|Overall Study|Condition under investigation worsened|2|||
42033630|NCT01180400|75841834|FG001|Overall Study|Condition under investigation worsened|1|||
42033631|NCT01180400|75841833|FG000|Overall Study|Lack of Efficacy|2|||
42033632|NCT01180400|75841834|FG001|Overall Study|Lack of Efficacy|0|||
42033633|NCT01180400|75841833|FG000|Overall Study|Study-specific withdrawal criteria|1|||
42033634|NCT01180400|75841834|FG001|Overall Study|Study-specific withdrawal criteria|2|||
42033635|NCT01180400|75841833|FG000|Overall Study|Lost to Follow-up|2|||
42033636|NCT01180400|75841834|FG001|Overall Study|Lost to Follow-up|3|||
42033637|NCT01180400|75841833|FG000|Overall Study|Other|0|||
42033638|NCT01180400|75841834|FG001|Overall Study|Other|1|||
42033639|NCT01180244|75841842|FG000|Overall Study|Lack of Efficacy|0|||
42033640|NCT01180244|75841843|FG001|Overall Study|Lack of Efficacy|7|||
42033641|NCT01180244|75841842|FG000|Overall Study|Physician Decision|3|||
42033642|NCT01180244|75841843|FG001|Overall Study|Physician Decision|0|||
42033643|NCT01180244|75841842|FG000|Overall Study|Adverse Event|1|||
42033644|NCT01180244|75841843|FG001|Overall Study|Adverse Event|0|||
42033645|NCT01180244|75841842|FG000|Overall Study|Withdrawal by Subject|0|||
42033646|NCT01180244|75841843|FG001|Overall Study|Withdrawal by Subject|1|||
42033647|NCT01180244|75841842|FG000|Overall Study|Protocol Violation|1|||
42033648|NCT01180244|75841843|FG001|Overall Study|Protocol Violation|0|||
42033649|NCT01180244|75841842|FG000|Overall Study|Lost to Follow-up|1|||
42033650|NCT01180244|75841843|FG001|Overall Study|Lost to Follow-up|0|||
41993296|NCT01144663|75801458|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
41993297|NCT01144663|75801459|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
41993298|NCT01144663|75801460|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
41993299|NCT01143337|75801472|FG000|Overall Study|Adverse Event|3|||
41993300|NCT01143337|75801473|FG001|Overall Study|Adverse Event|9|||
41993301|NCT01143337|75801474|FG002|Overall Study|Adverse Event|5|||
41993302|NCT01143337|75801472|FG000|Overall Study|Lack of Efficacy|6|||
41993303|NCT01143337|75801473|FG001|Overall Study|Lack of Efficacy|2|||
41993304|NCT01143337|75801474|FG002|Overall Study|Lack of Efficacy|1|||
41993305|NCT01143337|75801472|FG000|Overall Study|Protocol Violation|1|||
41993306|NCT01143337|75801473|FG001|Overall Study|Protocol Violation|0|||
41993307|NCT01143337|75801474|FG002|Overall Study|Protocol Violation|0|||
41993308|NCT01143337|75801472|FG000|Overall Study|Withdrawal by Subject|0|||
42033651|NCT01191086|75841849|FG000|Overall Study|Adverse Event|20|||
42033652|NCT01191086|75841849|FG000|Overall Study|Lack of Efficacy|10|||
42255868|NCT02984995|76082246|FG000|Overall Study|Progressive disease|11|||
42033653|NCT01191086|75841849|FG000|Overall Study|Lost to Follow-up|4|||
42033654|NCT01191086|75841849|FG000|Overall Study|Physician Decision|2|||
42033655|NCT01191086|75841849|FG000|Overall Study|Withdrawal by Subject|24|||
42033656|NCT01191086|75841849|FG000|Overall Study|Discontinuation criterion met|1|||
42033657|NCT01191086|75841849|FG000|Overall Study|Other|1|||
42033658|NCT01088412|75841856|FG000|Overall Study|Adverse Event|38|||
42033659|NCT01088412|75841857|FG001|Overall Study|Adverse Event|0|||
42033660|NCT01088412|75841858|FG002|Overall Study|Adverse Event|0|||
42033661|NCT01088412|75841856|FG000|Overall Study|Death|42|||
42033662|NCT01088412|75841857|FG001|Overall Study|Death|6|||
42033663|NCT01088412|75841858|FG002|Overall Study|Death|0|||
42033664|NCT01088412|75841856|FG000|Overall Study|Other Reason per Case Report Form|2089|||
42033665|NCT01088412|75841857|FG001|Overall Study|Other Reason per Case Report Form|103|||
42033666|NCT01088412|75841858|FG002|Overall Study|Other Reason per Case Report Form|9|||
42033667|NCT01088412|75841856|FG000|Overall Study|Withdrawal by Subject|1761|||
42033668|NCT01088412|75841857|FG001|Overall Study|Withdrawal by Subject|25|||
42033669|NCT01088412|75841858|FG002|Overall Study|Withdrawal by Subject|1|||
42033670|NCT01088412|75841856|FG000|Overall Study|Received Another GH Product|79|||
42033671|NCT01088412|75841857|FG001|Overall Study|Received Another GH Product|0|||
42033672|NCT01088412|75841858|FG002|Overall Study|Received Another GH Product|0|||
42033673|NCT01088412|75841856|FG000|Overall Study|Participant Moved|601|||
42033674|NCT01088412|75841857|FG001|Overall Study|Participant Moved|21|||
42033675|NCT01088412|75841858|FG002|Overall Study|Participant Moved|2|||
42033676|NCT01088412|75841856|FG000|Overall Study|Physician Decision|1041|||
42033677|NCT01088412|75841857|FG001|Overall Study|Physician Decision|8|||
42033678|NCT01088412|75841858|FG002|Overall Study|Physician Decision|4|||
42033679|NCT01088412|75841856|FG000|Overall Study|Sponsor Decision|4467|||
41993309|NCT01143337|75801473|FG001|Overall Study|Withdrawal by Subject|0|||
41993310|NCT01143337|75801474|FG002|Overall Study|Withdrawal by Subject|1|||
41993311|NCT01143337|75801472|FG000|Overall Study|Other reason|0|||
41993312|NCT01143337|75801473|FG001|Overall Study|Other reason|0|||
41993313|NCT01143337|75801474|FG002|Overall Study|Other reason|5|||
41993314|NCT01143259|75801491|FG000|Overall Study|Withdrawal by Subject|3|||
42033680|NCT01088412|75841857|FG001|Overall Study|Sponsor Decision|79|||
42033681|NCT01088412|75841858|FG002|Overall Study|Sponsor Decision|23|||
42033682|NCT01088412|75841856|FG000|Overall Study|Third Party Required to Change Brand|487|||
42033683|NCT01088412|75841857|FG001|Overall Study|Third Party Required to Change Brand|0|||
42033684|NCT01088412|75841858|FG002|Overall Study|Third Party Required to Change Brand|0|||
42033685|NCT01088412|75841856|FG000|Overall Study|Lost to Follow-up|3052|||
42033686|NCT01088412|75841857|FG001|Overall Study|Lost to Follow-up|130|||
42033687|NCT01088412|75841858|FG002|Overall Study|Lost to Follow-up|11|||
42033688|NCT01088412|75841856|FG000|Overall Study|Study Summary Not Completed|4360|||
42033689|NCT01088412|75841857|FG001|Overall Study|Study Summary Not Completed|64|||
42033690|NCT01088412|75841858|FG002|Overall Study|Study Summary Not Completed|22|||
42033691|NCT01086384|75841871|FG000|2-week Run-in Period|Adverse Event|1|||
42033692|NCT01086384|75841872|FG001|2-week Run-in Period|Adverse Event|0|||
42033693|NCT01086384|75841873|FG002|2-week Run-in Period|Adverse Event|0|||
42033694|NCT01086384|75841871|FG000|2-week Run-in Period|Protocol Violation|1|||
42033695|NCT01086384|75841872|FG001|2-week Run-in Period|Protocol Violation|0|||
41993315|NCT01143259|75801492|FG001|Overall Study|Withdrawal by Subject|2|||
41993316|NCT01143259|75801491|FG000|Overall Study|Protocol Violation|13|||
41993317|NCT01143259|75801492|FG001|Overall Study|Protocol Violation|9|||
41993318|NCT01143259|75801491|FG000|Overall Study|Screen Failure|7|||
41993319|NCT01143259|75801492|FG001|Overall Study|Screen Failure|9|||
41993320|NCT01142791|75801498|FG000|Overall Study|Alternative Treatment|1|||
41993321|NCT01142791|75801499|FG001|Overall Study|Alternative Treatment|0|||
41993322|NCT01142791|75801498|FG000|Overall Study|Lost to Follow-up|1|||
41993323|NCT01142791|75801499|FG001|Overall Study|Lost to Follow-up|0|||
42033696|NCT01086384|75841873|FG002|2-week Run-in Period|Protocol Violation|0|||
42033697|NCT01086384|75841871|FG000|2-week Run-in Period|Lost to Follow-up|1|||
42033698|NCT01086384|75841872|FG001|2-week Run-in Period|Lost to Follow-up|0|||
42033699|NCT01086384|75841873|FG002|2-week Run-in Period|Lost to Follow-up|0|||
42033700|NCT01086384|75841871|FG000|2-week Run-in Period|Physician Decision|6|||
42033701|NCT01086384|75841872|FG001|2-week Run-in Period|Physician Decision|0|||
42255869|NCT02984995|76082247|FG001|Overall Study|Progressive disease|1|||
42255870|NCT02984995|76082246|FG000|Overall Study|Adverse Event|1|||
42255871|NCT02984995|76082247|FG001|Overall Study|Adverse Event|0|||
42255872|NCT02984683|76082271|FG000|Overall Study|Adverse Event|3|||
42255873|NCT02984683|76082272|FG001|Overall Study|Adverse Event|3|||
42255874|NCT02984683|76082271|FG000|Overall Study|Withdrawal by Subject|1|||
41993324|NCT01142791|75801498|FG000|Overall Study|Withdrawal by Subject|5|||
41993325|NCT01142791|75801499|FG001|Overall Study|Withdrawal by Subject|0|||
41993326|NCT01142791|75801498|FG000|Overall Study|Received only 1 sonication|0|||
41993327|NCT01142791|75801499|FG001|Overall Study|Received only 1 sonication|6|||
41993328|NCT01142596|75801505|FG000|Overall Study|Withdrawal by Subject|9|||
41993329|NCT01142596|75801506|FG001|Overall Study|Withdrawal by Subject|35|||
42033702|NCT01086384|75841873|FG002|2-week Run-in Period|Physician Decision|0|||
42033703|NCT01086384|75841871|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
42033704|NCT01086384|75841872|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
42033705|NCT01086384|75841873|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
42033706|NCT01086384|75841871|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
42033707|NCT01086384|75841872|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
42033708|NCT01086384|75841873|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
42033709|NCT01086384|75841871|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
42033710|NCT01086384|75841872|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
42033711|NCT01086384|75841873|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
42033712|NCT01086384|75841871|FG000|2-week Run-in Period|Randomized in Error|1|||
42033713|NCT01086384|75841872|FG001|2-week Run-in Period|Randomized in Error|0|||
42033714|NCT01086384|75841873|FG002|2-week Run-in Period|Randomized in Error|0|||
42033715|NCT01086384|75841871|FG000|Treatment Period|Withdrawal by Subject|0|||
42033716|NCT01086384|75841872|FG001|Treatment Period|Withdrawal by Subject|53|||
42033717|NCT01086384|75841873|FG002|Treatment Period|Withdrawal by Subject|55|||
42033718|NCT01086384|75841871|FG000|Treatment Period|Protocol Violation|0|||
42033719|NCT01086384|75841872|FG001|Treatment Period|Protocol Violation|26|||
42033720|NCT01086384|75841873|FG002|Treatment Period|Protocol Violation|17|||
42033721|NCT01086384|75841871|FG000|Treatment Period|Lack of Efficacy|0|||
42033722|NCT01086384|75841872|FG001|Treatment Period|Lack of Efficacy|22|||
42033723|NCT01086384|75841873|FG002|Treatment Period|Lack of Efficacy|13|||
42033724|NCT01086384|75841871|FG000|Treatment Period|Adverse Event|0|||
42033725|NCT01086384|75841872|FG001|Treatment Period|Adverse Event|19|||
42033726|NCT01086384|75841873|FG002|Treatment Period|Adverse Event|15|||
42033727|NCT01086384|75841871|FG000|Treatment Period|Lost to Follow-up|0|||
42033728|NCT01086384|75841872|FG001|Treatment Period|Lost to Follow-up|11|||
42033729|NCT01086384|75841873|FG002|Treatment Period|Lost to Follow-up|9|||
42033730|NCT01086384|75841871|FG000|Treatment Period|Physician Decision|0|||
42033731|NCT01086384|75841872|FG001|Treatment Period|Physician Decision|9|||
42033732|NCT01086384|75841873|FG002|Treatment Period|Physician Decision|6|||
42033733|NCT01086384|75841871|FG000|Treatment Period|Study Closed/Terminated|0|||
42033734|NCT01086384|75841872|FG001|Treatment Period|Study Closed/Terminated|7|||
42033735|NCT01086384|75841873|FG002|Treatment Period|Study Closed/Terminated|8|||
42033736|NCT01086384|75841871|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
42033737|NCT01086384|75841872|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
42033738|NCT01086384|75841873|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
42033739|NCT01086384|75841871|FG000|Treatment Period|Received Treatment in Error|0|||
42033740|NCT01086384|75841872|FG001|Treatment Period|Received Treatment in Error|1|||
42033741|NCT01086384|75841873|FG002|Treatment Period|Received Treatment in Error|0|||
42033742|NCT01127633|75841881|FG000|Overall Study|Adverse Event|74|||
42033743|NCT01127633|75841882|FG001|Overall Study|Adverse Event|73|||
42033744|NCT01127633|75841881|FG000|Overall Study|Death|40|||
42033745|NCT01127633|75841882|FG001|Overall Study|Death|43|||
42033746|NCT01127633|75841881|FG000|Overall Study|Lost to Follow-up|4|||
42033747|NCT01127633|75841882|FG001|Overall Study|Lost to Follow-up|0|||
42033748|NCT01127633|75841881|FG000|Overall Study|Parent/Caregiver Decision|246|||
42033749|NCT01127633|75841882|FG001|Overall Study|Parent/Caregiver Decision|228|||
42033750|NCT01127633|75841881|FG000|Overall Study|Physician Decision|60|||
42033751|NCT01127633|75841882|FG001|Overall Study|Physician Decision|45|||
42033752|NCT01127633|75841881|FG000|Overall Study|Withdrawal by Subject|57|||
42033753|NCT01127633|75841882|FG001|Overall Study|Withdrawal by Subject|72|||
42033754|NCT01127633|75841881|FG000|Overall Study|Sponsor Decision|163|||
42033755|NCT01127633|75841882|FG001|Overall Study|Sponsor Decision|195|||
42033756|NCT01127633|75841881|FG000|Overall Study|Protocol Violation|8|||
42033757|NCT01127633|75841882|FG001|Overall Study|Protocol Violation|16|||
42033758|NCT01127633|75841881|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
42033759|NCT01127633|75841882|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
42033760|NCT01127633|75841881|FG000|Overall Study|Not treated|1|||
42033761|NCT01127633|75841882|FG001|Overall Study|Not treated|0|||
42033762|NCT01122173|75841888|FG000|Overall Study|Lost to Follow-up|3|||
42033763|NCT01122173|75841888|FG000|Overall Study|Withdrawal by Subject|3|||
42033764|NCT01122173|75841888|FG000|Overall Study|Left study for other reasons|3|||
42033765|NCT01127165|75841895|FG000|Overall Study|Adverse Event|2|||
41993330|NCT01142596|75801505|FG000|Overall Study|Adverse Event|8|||
41993331|NCT01142596|75801506|FG001|Overall Study|Adverse Event|35|||
41993332|NCT01142596|75801505|FG000|Overall Study|Lack of Efficacy|5|||
41993333|NCT01142596|75801506|FG001|Overall Study|Lack of Efficacy|9|||
41993334|NCT01142596|75801505|FG000|Overall Study|Lost to Follow-up|2|||
41993335|NCT01142596|75801506|FG001|Overall Study|Lost to Follow-up|3|||
41993336|NCT01142596|75801505|FG000|Overall Study|Other reason (not specified)|5|||
41993337|NCT01142596|75801506|FG001|Overall Study|Other reason (not specified)|4|||
41993338|NCT01142128|75801516|FG000|Overall Study|Physician Decision|1|||
42033766|NCT01127165|75841896|FG001|Overall Study|Adverse Event|2|||
42033767|NCT01127165|75841895|FG000|Overall Study|Lack of Efficacy|10|||
42033768|NCT01127165|75841896|FG001|Overall Study|Lack of Efficacy|8|||
42033769|NCT01127165|75841895|FG000|Overall Study|Lost to Follow-up|3|||
42033770|NCT01127165|75841896|FG001|Overall Study|Lost to Follow-up|5|||
41993339|NCT01142128|75801516|FG000|Overall Study|Lost to Follow-up|1|||
41993340|NCT01142128|75801516|FG000|Overall Study|Withdrawal by Subject|2|||
41993341|NCT01142089|75801528|FG000|Overall Study|Physician Decision|1|||
41993342|NCT01142089|75801529|FG001|Overall Study|Physician Decision|0|||
41993343|NCT01142089|75801528|FG000|Overall Study|Withdrawal by Subject|1|||
41993344|NCT01142089|75801529|FG001|Overall Study|Withdrawal by Subject|2|||
41993345|NCT01142089|75801528|FG000|Overall Study|Use of prohibited medications|0|||
42033771|NCT01127165|75841895|FG000|Overall Study|Withdrawal by Subject|1|||
42033772|NCT01127165|75841896|FG001|Overall Study|Withdrawal by Subject|3|||
42033773|NCT01127165|75841895|FG000|Overall Study|Protocol Violation|0|||
42033774|NCT01127165|75841896|FG001|Overall Study|Protocol Violation|1|||
42033775|NCT01126619|75841902|FG000|Overall Study|Not eligible for the study|2|||
42033776|NCT01126619|75841902|FG000|Overall Study|Investigator decision|4|||
41993346|NCT01142089|75801529|FG001|Overall Study|Use of prohibited medications|1|||
41993347|NCT01142089|75801528|FG000|Overall Study|Noncompliance with study procedures|2|||
41993348|NCT01142089|75801529|FG001|Overall Study|Noncompliance with study procedures|1|||
41993349|NCT01142089|75801528|FG000|Overall Study|Patient required rescue medication|8|||
41993350|NCT01142089|75801529|FG001|Overall Study|Patient required rescue medication|17|||
41993351|NCT01141660|75801537|FG000|Overall Study|Physician Decision|0|||
41993352|NCT01141660|75801538|FG001|Overall Study|Physician Decision|12|||
41993353|NCT01140880|75801546|FG000|Overall Study|Death|0|||
41993354|NCT01140880|75801547|FG001|Overall Study|Death|1|||
41993355|NCT01140880|75801546|FG000|Overall Study|Withdrawal by Subject|6|||
41993356|NCT01140880|75801547|FG001|Overall Study|Withdrawal by Subject|3|||
41993357|NCT01140880|75801546|FG000|Overall Study|Lost to Follow-up|8|||
41993358|NCT01140880|75801547|FG001|Overall Study|Lost to Follow-up|10|||
41993359|NCT01140880|75801546|FG000|Overall Study|Protocol Violation|0|||
41993360|NCT01140880|75801547|FG001|Overall Study|Protocol Violation|30|||
41993361|NCT01140646|75801553|FG000|Overall Study|Adverse Event|4|||
42033777|NCT01126619|75841902|FG000|Overall Study|Serious adverse event|1|||
42033778|NCT01126619|75841902|FG000|Overall Study|Withdrawal by Subject|9|||
42033779|NCT01126619|75841902|FG000|Overall Study|Non-compliance|1|||
42033780|NCT00941733|75841910|FG000|Overall Study|Death|24|||
42033781|NCT00941733|75841911|FG001|Overall Study|Death|10|||
42033782|NCT00941733|75841910|FG000|Overall Study|Withdrawal by Subject|14|||
42033783|NCT00941733|75841911|FG001|Overall Study|Withdrawal by Subject|6|||
42033784|NCT00941733|75841910|FG000|Overall Study|Adverse Event|20|||
42033785|NCT00941733|75841911|FG001|Overall Study|Adverse Event|4|||
42033786|NCT00941733|75841910|FG000|Overall Study|Lost to Follow-up|1|||
42033787|NCT00941733|75841911|FG001|Overall Study|Lost to Follow-up|2|||
42033788|NCT00941733|75841910|FG000|Overall Study|Protocol Violation|15|||
42033789|NCT00941733|75841911|FG001|Overall Study|Protocol Violation|6|||
42033790|NCT00941655|75841919|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
42033791|NCT00941655|75841920|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
42033792|NCT00941655|75841919|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
42033793|NCT00941655|75841920|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
42033794|NCT00941655|75841919|FG000|Overall Study|progressed while on chemo|0|||
42033795|NCT00941655|75841920|FG001|Overall Study|progressed while on chemo|2|||
41993362|NCT01140646|75801553|FG000|Overall Study|Refused Further Treatment|5|||
41993363|NCT01140568|75801557|FG000|Overall Study|disease progression|31|||
41993364|NCT01140568|75801557|FG000|Overall Study|Withdrawal by Subject|1|||
41993365|NCT01140568|75801557|FG000|Overall Study|Screen Fail|4|||
41993366|NCT01140451|75801563|FG000|Overall Study|Withdrawal by Subject|26|||
41993367|NCT01140451|75801564|FG001|Overall Study|Withdrawal by Subject|33|||
41993368|NCT01140451|75801563|FG000|Overall Study|Adverse Event|2|||
41993369|NCT01140451|75801564|FG001|Overall Study|Adverse Event|6|||
42033796|NCT00941655|75841919|FG000|Overall Study|refused further treatment|0|||
42033797|NCT00941655|75841920|FG001|Overall Study|refused further treatment|1|||
42033798|NCT00941655|75841919|FG000|Overall Study|withdrew consent|0|||
41993370|NCT01140451|75801563|FG000|Overall Study|Physician Decision|5|||
41993371|NCT01140451|75801564|FG001|Overall Study|Physician Decision|3|||
41993372|NCT01140451|75801563|FG000|Overall Study|Lost to Follow-up|2|||
41993373|NCT01140451|75801564|FG001|Overall Study|Lost to Follow-up|0|||
41993374|NCT01140451|75801563|FG000|Overall Study|Participants Planning Pregnancy|3|||
41993375|NCT01140451|75801564|FG001|Overall Study|Participants Planning Pregnancy|0|||
41993376|NCT01140061|75801581|FG000|Part I|Adverse Event|1|||
41993377|NCT01140061|75801582|FG001|Part I|Adverse Event|0|||
41993378|NCT01140061|75801583|FG002|Part I|Adverse Event|0|||
41993379|NCT01140061|75801584|FG003|Part I|Adverse Event|0|||
41993380|NCT01140061|75801585|FG004|Part I|Adverse Event|0|||
41993381|NCT01140061|75801586|FG005|Part I|Adverse Event|0|||
41993382|NCT01140061|75801587|FG006|Part I|Adverse Event|0|||
42033799|NCT00941655|75841920|FG001|Overall Study|withdrew consent|1|||
42033800|NCT00941655|75841919|FG000|Overall Study|non-compliant|0|||
42033801|NCT00941655|75841920|FG001|Overall Study|non-compliant|1|||
41993383|NCT01140061|75801588|FG007|Part I|Adverse Event|0|||
41993384|NCT01140061|75801589|FG008|Part I|Adverse Event|0|||
41993385|NCT01140061|75801590|FG009|Part I|Adverse Event|0|||
41993386|NCT01140061|75801581|FG000|Extension|Laboratory Adverse Event|0|||
42033802|NCT00939393|75841929|FG000|Overall Study|Withdrawal by Subject|1|||
42033803|NCT00939393|75841930|FG001|Overall Study|Withdrawal by Subject|0|||
42033804|NCT00939393|75841929|FG000|Overall Study|Lost to Follow-up|3|||
42033805|NCT00939393|75841930|FG001|Overall Study|Lost to Follow-up|0|||
42033806|NCT00936117|75841947|FG000|Overall Study|Adverse Event|7|||
42033807|NCT00936117|75841947|FG000|Overall Study|Unable to continue oral medication|3|||
42033808|NCT04088500|75841952|FG000|Overall Study|Reason unknown|1|||
42033809|NCT04088500|75841952|FG000|Overall Study|Participant withdrew consent|1|||
42033810|NCT04088500|75841952|FG000|Overall Study|Disease progression|3|||
42033811|NCT01082874|75841960|FG000|Overall Study|Lost to Follow-up|10|||
42033812|NCT01082874|75841961|FG001|Overall Study|Lost to Follow-up|10|||
42033813|NCT01082874|75841962|FG002|Overall Study|Lost to Follow-up|6|||
42033814|NCT01082874|75841963|FG003|Overall Study|Lost to Follow-up|10|||
42033815|NCT01082874|75841960|FG000|Overall Study|Withdrawal by Subject|1|||
42033816|NCT01082874|75841961|FG001|Overall Study|Withdrawal by Subject|2|||
42033817|NCT01082874|75841962|FG002|Overall Study|Withdrawal by Subject|5|||
42033818|NCT01082874|75841963|FG003|Overall Study|Withdrawal by Subject|3|||
42033819|NCT00933543|75841975|FG000|Overall Study|Adverse Event|2|||
42033820|NCT00933543|75841976|FG001|Overall Study|Adverse Event|1|||
42033821|NCT00933543|75841975|FG000|Overall Study|Lost to Follow-up|0|||
42033822|NCT00933543|75841976|FG001|Overall Study|Lost to Follow-up|1|||
42033823|NCT00933543|75841975|FG000|Overall Study|Withdrawal by Subject|0|||
42033824|NCT00933543|75841976|FG001|Overall Study|Withdrawal by Subject|1|||
42033825|NCT00933543|75841975|FG000|Overall Study|Lack of Efficacy|0|||
42033826|NCT00933543|75841976|FG001|Overall Study|Lack of Efficacy|3|||
42033827|NCT00933543|75841975|FG000|Overall Study|Other|1|||
42033828|NCT00933543|75841976|FG001|Overall Study|Other|1|||
42033829|NCT01082328|75841982|FG000|Overall Study|Adverse Event|1|||
42255875|NCT02984683|76082272|FG001|Overall Study|Withdrawal by Subject|0|||
42255876|NCT02984683|76082271|FG000|Overall Study|Disease progression|7|||
42255877|NCT02984683|76082272|FG001|Overall Study|Disease progression|9|||
42255878|NCT02909101|76082280|FG000|Overall Study|Lost to Follow-up|1|||
42255879|NCT02909101|76082281|FG001|Overall Study|Lost to Follow-up|1|||
42255880|NCT03004469|76082290|FG000|Overall Study|Adverse Event|6|||
42255881|NCT03004469|76082291|FG001|Overall Study|Adverse Event|4|||
42255882|NCT03004469|76082292|FG002|Overall Study|Adverse Event|6|||
42033830|NCT01079988|75841991|FG000|Overall Study|Lost to Follow-up|0|||
42033831|NCT01079988|75841992|FG001|Overall Study|Lost to Follow-up|0|||
42033832|NCT01079988|75841993|FG002|Overall Study|Lost to Follow-up|0|||
42033833|NCT01079988|75841994|FG003|Overall Study|Lost to Follow-up|1|||
42033834|NCT01079988|75841995|FG004|Overall Study|Lost to Follow-up|0|||
42255883|NCT03004469|76082290|FG000|Overall Study|Lack of Efficacy|1|||
42255884|NCT03004469|76082291|FG001|Overall Study|Lack of Efficacy|0|||
42255885|NCT03004469|76082292|FG002|Overall Study|Lack of Efficacy|1|||
42255886|NCT03004469|76082290|FG000|Overall Study|Lost to Follow-up|23|||
42255887|NCT03004469|76082291|FG001|Overall Study|Lost to Follow-up|14|||
42255888|NCT03004469|76082292|FG002|Overall Study|Lost to Follow-up|6|||
42255889|NCT03004469|76082290|FG000|Overall Study|Non-Compliance with Study Drug|2|||
42255890|NCT03004469|76082291|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42255891|NCT03004469|76082292|FG002|Overall Study|Non-Compliance with Study Drug|0|||
42255892|NCT03004469|76082290|FG000|Overall Study|Protocol Violation|0|||
42255893|NCT03004469|76082291|FG001|Overall Study|Protocol Violation|0|||
42255894|NCT03004469|76082292|FG002|Overall Study|Protocol Violation|1|||
42255895|NCT03004469|76082290|FG000|Overall Study|Withdrawal by Subject|29|||
42255896|NCT03004469|76082291|FG001|Overall Study|Withdrawal by Subject|27|||
42255897|NCT03004469|76082292|FG002|Overall Study|Withdrawal by Subject|10|||
42255898|NCT03004469|76082290|FG000|Overall Study|Other unspecified reason|0|||
42255899|NCT03004469|76082291|FG001|Overall Study|Other unspecified reason|4|||
42255900|NCT03004469|76082292|FG002|Overall Study|Other unspecified reason|1|||
42255901|NCT02910713|76082301|FG000|Overall Study|Protocol Violation|2|||
42255902|NCT02910713|76082301|FG000|Overall Study|Subject Choice|4|||
42255903|NCT02910713|76082301|FG000|Overall Study|Received One Application|10|||
42255904|NCT02910713|76082301|FG000|Overall Study|Received Neither Application|18|||
42255905|NCT02910713|76082301|FG000|Overall Study|Enrollment cap|7|||
42255906|NCT02910713|76082301|FG000|Overall Study|Investigator Discretion|1|||
42255907|NCT02998541|76082309|FG000|Overall Study|Adverse Event|4|||
42255908|NCT02998541|76082310|FG001|Overall Study|Adverse Event|5|||
42255909|NCT02998541|76082311|FG002|Overall Study|Adverse Event|1|||
42255910|NCT02998541|76082309|FG000|Overall Study|Protocol Violation|1|||
42255911|NCT02998541|76082310|FG001|Overall Study|Protocol Violation|0|||
42255912|NCT02998541|76082311|FG002|Overall Study|Protocol Violation|0|||
42255913|NCT02998541|76082309|FG000|Overall Study|Withdrawal by Subject|3|||
42255914|NCT02998541|76082310|FG001|Overall Study|Withdrawal by Subject|1|||
42255915|NCT02998541|76082311|FG002|Overall Study|Withdrawal by Subject|0|||
42255916|NCT02998541|76082309|FG000|Overall Study|Lost to Follow-up|0|||
42255917|NCT02998541|76082310|FG001|Overall Study|Lost to Follow-up|3|||
42033835|NCT01079988|75841991|FG000|Overall Study|Lack of Efficacy|1|||
42033836|NCT01079988|75841992|FG001|Overall Study|Lack of Efficacy|0|||
42033837|NCT01079988|75841993|FG002|Overall Study|Lack of Efficacy|0|||
42033838|NCT01079988|75841994|FG003|Overall Study|Lack of Efficacy|0|||
42255918|NCT02998541|76082311|FG002|Overall Study|Lost to Follow-up|1|||
42315131|NCT01815736|76151446|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
42315132|NCT01815736|76151445|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
42315133|NCT01815736|76151446|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
42315134|NCT01815736|76151445|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
42315135|NCT01815736|76151446|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
42315136|NCT01815736|76151445|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
42315137|NCT01815736|76151446|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
42315138|NCT01815736|76151445|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
42315139|NCT01815736|76151446|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
42315140|NCT01815736|76151445|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
42315141|NCT01815736|76151446|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
42315142|NCT01815736|76151445|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
42315143|NCT01815736|76151446|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
42315144|NCT01815736|76151445|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
42315145|NCT01815736|76151446|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
42315146|NCT01815736|76151445|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
42315147|NCT01815736|76151446|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
42315148|NCT01815736|76151445|FG000|Extension Treatment Phase- After Week 96|Death|1|||
42315149|NCT01815736|76151446|FG001|Extension Treatment Phase- After Week 96|Death|0|||
42315150|NCT01651949|76151457|FG000|Overall Study|Unknown status|4|||
42315151|NCT01651949|76151458|FG001|Overall Study|Unknown status|4|||
42315152|NCT01651949|76151459|FG002|Overall Study|Unknown status|0|||
42315153|NCT01651949|76151457|FG000|Overall Study|Lost to Follow-up|30|||
42315154|NCT01651949|76151458|FG001|Overall Study|Lost to Follow-up|56|||
42315155|NCT01651949|76151459|FG002|Overall Study|Lost to Follow-up|20|||
42315156|NCT01651949|76151457|FG000|Overall Study|Protocol Violation|0|||
42315157|NCT01651949|76151458|FG001|Overall Study|Protocol Violation|2|||
42315158|NCT01651949|76151459|FG002|Overall Study|Protocol Violation|1|||
42315159|NCT01651949|76151457|FG000|Overall Study|Physician Decision|0|||
42315160|NCT01651949|76151458|FG001|Overall Study|Physician Decision|2|||
42315161|NCT01651949|76151459|FG002|Overall Study|Physician Decision|0|||
42315162|NCT01651949|76151457|FG000|Overall Study|Adverse Event|0|||
42315163|NCT01651949|76151458|FG001|Overall Study|Adverse Event|2|||
42315164|NCT01651949|76151459|FG002|Overall Study|Adverse Event|1|||
42315165|NCT01651949|76151457|FG000|Overall Study|Screen failure|2|||
42315166|NCT01651949|76151458|FG001|Overall Study|Screen failure|2|||
42255919|NCT02998541|76082309|FG000|Overall Study|Physician Decision|0|||
42255920|NCT02998541|76082310|FG001|Overall Study|Physician Decision|0|||
42255921|NCT02998541|76082311|FG002|Overall Study|Physician Decision|3|||
42255922|NCT02998541|76082309|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42255923|NCT02998541|76082310|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
42255924|NCT02998541|76082311|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
42255925|NCT02998151|76082319|FG000|Overall Study|Withdrawal by Subject|3|||
42255926|NCT02998151|76082319|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
42255927|NCT02998151|76082319|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
42255928|NCT01066819|76082350|FG000|Overall Study|Adverse Event|18|||
42255929|NCT01066819|76082351|FG001|Overall Study|Adverse Event|1|||
42255930|NCT01066819|76082352|FG002|Overall Study|Adverse Event|6|||
42255931|NCT01066819|76082353|FG003|Overall Study|Adverse Event|0|||
42255932|NCT01066819|76082354|FG004|Overall Study|Adverse Event|0|||
42255933|NCT01066819|76082355|FG005|Overall Study|Adverse Event|0|||
42255934|NCT01066819|76082350|FG000|Overall Study|Death|5|||
42255935|NCT01066819|76082351|FG001|Overall Study|Death|0|||
42255936|NCT01066819|76082352|FG002|Overall Study|Death|1|||
42255937|NCT01066819|76082353|FG003|Overall Study|Death|0|||
42255938|NCT01066819|76082354|FG004|Overall Study|Death|0|||
42255939|NCT01066819|76082355|FG005|Overall Study|Death|0|||
42315167|NCT01651949|76151459|FG002|Overall Study|Screen failure|0|||
42315168|NCT01651949|76151457|FG000|Overall Study|Withdrawal by Subject|17|||
42315169|NCT01651949|76151458|FG001|Overall Study|Withdrawal by Subject|18|||
42315170|NCT01651949|76151459|FG002|Overall Study|Withdrawal by Subject|9|||
42315171|NCT02387957|76151470|FG000|Overall Study|The study was discontinued|21|||
42315172|NCT02387957|76151471|FG001|Overall Study|The study was discontinued|21|||
42315173|NCT02387957|76151472|FG002|Overall Study|The study was discontinued|20|||
42315174|NCT01800916|76151480|FG000|Test Period 1 (1 Week)|Convex product user|0|||
42010570|NCT00993421|75817700|FG006|Overall Study|Lost to Follow-up|6|||
42315175|NCT01800916|76151481|FG001|Test Period 1 (1 Week)|Convex product user|0|||
42315176|NCT01800916|76151482|FG002|Test Period 1 (1 Week)|Convex product user|0|||
42315177|NCT01800916|76151483|FG003|Test Period 1 (1 Week)|Convex product user|1|||
42315178|NCT01800916|76151484|FG004|Test Period 1 (1 Week)|Convex product user|0|||
42315179|NCT01800916|76151485|FG005|Test Period 1 (1 Week)|Convex product user|0|||
42315180|NCT01800916|76151486|FG006|Test Period 1 (1 Week)|Convex product user|0|||
42315181|NCT01800916|76151487|FG007|Test Period 1 (1 Week)|Convex product user|0|||
42315182|NCT01800916|76151488|FG008|Test Period 1 (1 Week)|Convex product user|0|||
42315183|NCT01800916|76151480|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
42315184|NCT01800916|76151481|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
42315185|NCT01800916|76151482|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
42315186|NCT01800916|76151483|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
42315187|NCT01800916|76151484|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
42315188|NCT01800916|76151485|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
42315189|NCT01800916|76151486|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
42315190|NCT01800916|76151487|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
42315191|NCT01800916|76151488|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
42315192|NCT01800058|76151498|FG000|Overall Study|Lost to Follow-up|1|||
42315193|NCT01815580|76151505|FG000|Overall Study|Lost to Follow-up|4|||
42315194|NCT01815580|76151506|FG001|Overall Study|Lost to Follow-up|7|||
42315195|NCT01815580|76151505|FG000|Overall Study|Withdrawal by Subject|3|||
42315196|NCT01815580|76151506|FG001|Overall Study|Withdrawal by Subject|4|||
42315197|NCT01815580|76151505|FG000|Overall Study|Excluded from analysis|5|||
42315198|NCT01815580|76151506|FG001|Overall Study|Excluded from analysis|4|||
42315199|NCT01799590|76151520|FG000|Overall Study|Adverse Event|13|||
42315200|NCT01799590|76151521|FG001|Overall Study|Adverse Event|7|||
42315201|NCT01799590|76151522|FG002|Overall Study|Adverse Event|5|||
42315202|NCT01799590|76151520|FG000|Overall Study|Pregnancy|2|||
42315203|NCT01799590|76151521|FG001|Overall Study|Pregnancy|0|||
42315204|NCT01799590|76151522|FG002|Overall Study|Pregnancy|0|||
42315205|NCT01799590|76151520|FG000|Overall Study|Lack of Efficacy|3|||
42315206|NCT01799590|76151521|FG001|Overall Study|Lack of Efficacy|1|||
42315207|NCT01799590|76151522|FG002|Overall Study|Lack of Efficacy|3|||
41993387|NCT01140061|75801582|FG001|Extension|Laboratory Adverse Event|0|||
42315208|NCT01799590|76151520|FG000|Overall Study|Participants convenience|4|||
42315209|NCT01799590|76151521|FG001|Overall Study|Participants convenience|4|||
42315210|NCT01799590|76151522|FG002|Overall Study|Participants convenience|2|||
42315211|NCT01799590|76151520|FG000|Overall Study|Aggravation of complications|0|||
42315212|NCT01799590|76151521|FG001|Overall Study|Aggravation of complications|1|||
42315213|NCT01799590|76151522|FG002|Overall Study|Aggravation of complications|1|||
42315214|NCT01799590|76151520|FG000|Overall Study|Using drugs with restricted days of use|0|||
42315215|NCT01799590|76151521|FG001|Overall Study|Using drugs with restricted days of use|3|||
42315216|NCT01799590|76151522|FG002|Overall Study|Using drugs with restricted days of use|2|||
42315217|NCT01799590|76151520|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
42315218|NCT01799590|76151521|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
42315219|NCT01799590|76151522|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
42315220|NCT01799590|76151520|FG000|Overall Study|Other|3|||
42315221|NCT01799590|76151521|FG001|Overall Study|Other|0|||
42315222|NCT01799590|76151522|FG002|Overall Study|Other|1|||
42315223|NCT01815424|76151533|FG000|Week 0 to 16|Adverse Event|1|||
42315224|NCT01815424|76151534|FG001|Week 0 to 16|Adverse Event|3|||
42315225|NCT01815424|76151535|FG002|Week 0 to 16|Adverse Event|3|||
42315226|NCT01815424|76151536|FG003|Week 0 to 16|Adverse Event|0|||
42315227|NCT01815424|76151537|FG004|Week 0 to 16|Adverse Event|0|||
42315228|NCT01815424|76151533|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
42315229|NCT01815424|76151534|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
42315230|NCT01815424|76151535|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
42315231|NCT01815424|76151536|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
42315232|NCT01815424|76151537|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
42315233|NCT01815424|76151533|FG000|Week 0 to 16|Lost to Follow-up|0|||
42315234|NCT01815424|76151534|FG001|Week 0 to 16|Lost to Follow-up|1|||
42315235|NCT01815424|76151535|FG002|Week 0 to 16|Lost to Follow-up|0|||
42315236|NCT01815424|76151536|FG003|Week 0 to 16|Lost to Follow-up|0|||
42315237|NCT01815424|76151537|FG004|Week 0 to 16|Lost to Follow-up|0|||
41993388|NCT01140061|75801583|FG002|Extension|Laboratory Adverse Event|0|||
41993389|NCT01140061|75801584|FG003|Extension|Laboratory Adverse Event|0|||
42315238|NCT01815424|76151533|FG000|Week 0 to 16|Withdrawal by Subject|0|||
41993390|NCT01140061|75801585|FG004|Extension|Laboratory Adverse Event|0|||
42315239|NCT01815424|76151534|FG001|Week 0 to 16|Withdrawal by Subject|0|||
42315240|NCT01815424|76151535|FG002|Week 0 to 16|Withdrawal by Subject|1|||
42315241|NCT01815424|76151536|FG003|Week 0 to 16|Withdrawal by Subject|0|||
42315242|NCT01815424|76151537|FG004|Week 0 to 16|Withdrawal by Subject|0|||
42315243|NCT01815424|76151533|FG000|Week 0 to 16|Other|1|||
42315244|NCT01815424|76151534|FG001|Week 0 to 16|Other|0|||
42315245|NCT01815424|76151535|FG002|Week 0 to 16|Other|3|||
42315246|NCT01815424|76151536|FG003|Week 0 to 16|Other|0|||
42315247|NCT01815424|76151537|FG004|Week 0 to 16|Other|0|||
42315248|NCT01815424|76151533|FG000|Week 0 to 16|Protocol Violation|1|||
42315249|NCT01815424|76151534|FG001|Week 0 to 16|Protocol Violation|0|||
42315250|NCT01815424|76151535|FG002|Week 0 to 16|Protocol Violation|0|||
42315251|NCT01815424|76151536|FG003|Week 0 to 16|Protocol Violation|0|||
42315252|NCT01815424|76151537|FG004|Week 0 to 16|Protocol Violation|0|||
42315253|NCT01815424|76151533|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
42315254|NCT01815424|76151534|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
42315255|NCT01815424|76151535|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
42315256|NCT01815424|76151536|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
42315257|NCT01815424|76151537|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
42315258|NCT01815424|76151533|FG000|Week 16 to 52|Other|0|||
42315259|NCT01815424|76151534|FG001|Week 16 to 52|Other|1|||
42315260|NCT01815424|76151535|FG002|Week 16 to 52|Other|0|||
42315261|NCT01815424|76151536|FG003|Week 16 to 52|Other|0|||
42315262|NCT01815424|76151537|FG004|Week 16 to 52|Other|0|||
42315263|NCT01815424|76151533|FG000|Week 16 to 52|Adverse Event|0|||
42315264|NCT01815424|76151534|FG001|Week 16 to 52|Adverse Event|0|||
42315265|NCT01815424|76151535|FG002|Week 16 to 52|Adverse Event|0|||
42315266|NCT01815424|76151536|FG003|Week 16 to 52|Adverse Event|0|||
42315267|NCT01815424|76151537|FG004|Week 16 to 52|Adverse Event|1|||
42315268|NCT01815424|76151533|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
42315269|NCT01815424|76151534|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
42315270|NCT01815424|76151535|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
42315271|NCT01815424|76151536|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
42315272|NCT01815424|76151537|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
42315273|NCT01815424|76151533|FG000|Week 16 to 52|Lost to Follow-up|0|||
42315274|NCT01815424|76151534|FG001|Week 16 to 52|Lost to Follow-up|2|||
42315275|NCT01815424|76151535|FG002|Week 16 to 52|Lost to Follow-up|0|||
42315276|NCT01815424|76151536|FG003|Week 16 to 52|Lost to Follow-up|2|||
42315277|NCT01815424|76151537|FG004|Week 16 to 52|Lost to Follow-up|1|||
42315278|NCT01815424|76151533|FG000|Week 16 to 52|Withdrawal by Subject|1|||
42315279|NCT01815424|76151534|FG001|Week 16 to 52|Withdrawal by Subject|2|||
42315280|NCT01815424|76151535|FG002|Week 16 to 52|Withdrawal by Subject|0|||
42315281|NCT01815424|76151536|FG003|Week 16 to 52|Withdrawal by Subject|0|||
42315282|NCT01815424|76151537|FG004|Week 16 to 52|Withdrawal by Subject|0|||
42315283|NCT02431247|76151552|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
42315284|NCT02431247|76151553|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
42315285|NCT02431247|76151554|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
42315286|NCT02431247|76151552|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
42315287|NCT02431247|76151553|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
42315288|NCT02431247|76151554|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
42315289|NCT02431247|76151552|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
42315290|NCT02431247|76151553|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
42315291|NCT02431247|76151554|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
42315292|NCT02431247|76151552|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
42315293|NCT02431247|76151553|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
42315294|NCT02431247|76151554|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
42315295|NCT02431247|76151552|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
42315296|NCT02431247|76151553|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
42315297|NCT02431247|76151554|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
41993391|NCT01140061|75801586|FG005|Extension|Laboratory Adverse Event|0|||
41993392|NCT01140061|75801587|FG006|Extension|Laboratory Adverse Event|0|||
41993393|NCT01140061|75801588|FG007|Extension|Laboratory Adverse Event|0|||
42315298|NCT02431247|76151552|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
42315299|NCT02431247|76151553|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
42315300|NCT02431247|76151554|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
42315301|NCT02431247|76151552|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
41993394|NCT01140061|75801589|FG008|Extension|Laboratory Adverse Event|0|||
42315302|NCT02431247|76151553|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
42315303|NCT02431247|76151554|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
42315304|NCT02431247|76151552|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
42315305|NCT02431247|76151553|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
42315306|NCT02431247|76151554|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
42315307|NCT02431247|76151552|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
42133152|NCT00300274|75944062|FG002|Overall Study|Lost to Follow-up|5|||
42133153|NCT00300274|75944060|FG000|Overall Study|Death|31|||
42133154|NCT00300274|75944061|FG001|Overall Study|Death|20|||
42315308|NCT02431247|76151553|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
42315309|NCT02431247|76151554|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
42315310|NCT02431247|76151552|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
42315311|NCT02431247|76151553|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
42315312|NCT02431247|76151554|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
42315313|NCT02431247|76151552|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
42315314|NCT02431247|76151553|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
42315315|NCT02431247|76151554|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
42315316|NCT02431247|76151552|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
42315317|NCT02431247|76151553|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
42315318|NCT02431247|76151554|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
42315319|NCT02431247|76151552|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
42315320|NCT02431247|76151553|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
42315321|NCT02431247|76151554|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
42315322|NCT02431247|76151552|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
42315323|NCT02431247|76151553|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
42315324|NCT02431247|76151554|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
42315325|NCT01814878|76151568|FG000|Overall Study|Adverse Event|16|||
42315326|NCT01814878|76151569|FG001|Overall Study|Adverse Event|5|||
42315327|NCT01814878|76151568|FG000|Overall Study|Withdrawal by Subject|20|||
42315328|NCT01814878|76151569|FG001|Overall Study|Withdrawal by Subject|16|||
42315329|NCT01814878|76151568|FG000|Overall Study|Protocol Violation|5|||
42315330|NCT01814878|76151569|FG001|Overall Study|Protocol Violation|5|||
42315331|NCT01814878|76151568|FG000|Overall Study|Physician Decision|3|||
42315332|NCT01814878|76151569|FG001|Overall Study|Physician Decision|1|||
42315333|NCT01814878|76151568|FG000|Overall Study|Screening failure (drop-out)|0|||
42315334|NCT01814878|76151569|FG001|Overall Study|Screening failure (drop-out)|3|||
42315335|NCT01814878|76151568|FG000|Overall Study|Other|2|||
42315336|NCT01814878|76151569|FG001|Overall Study|Other|0|||
42315337|NCT02407457|76151577|FG000|1 Month|Death|3|||
42315338|NCT02407457|76151578|FG001|1 Month|Death|0|||
42133155|NCT00300274|75944062|FG002|Overall Study|Death|25|||
42133156|NCT00300274|75944060|FG000|Overall Study|Re-transplant|0|||
42133157|NCT00300274|75944061|FG001|Overall Study|Re-transplant|0|||
42133158|NCT00300274|75944062|FG002|Overall Study|Re-transplant|1|||
42133159|NCT00299728|75944072|FG000|Overall Study|Lost to Follow-up|0|||
42315339|NCT02407457|76151577|FG000|1 Month|Lost to Follow-up|1|||
42315340|NCT02407457|76151578|FG001|1 Month|Lost to Follow-up|1|||
42315341|NCT02407457|76151577|FG000|1 Month|missed visit|2|||
42315342|NCT02407457|76151578|FG001|1 Month|missed visit|6|||
42315343|NCT02407457|76151577|FG000|6-Month|Death|2|||
42315344|NCT02407457|76151578|FG001|6-Month|Death|8|||
42315345|NCT02407457|76151577|FG000|6-Month|Lost to Follow-up|2|||
42133160|NCT00299728|75944073|FG001|Overall Study|Lost to Follow-up|1|||
42133161|NCT00299728|75944072|FG000|Overall Study|Withdrawal by Subject|0|||
42315346|NCT02407457|76151578|FG001|6-Month|Lost to Follow-up|2|||
42315347|NCT02407457|76151577|FG000|6-Month|missed visit|15|||
42315348|NCT02407457|76151578|FG001|6-Month|missed visit|12|||
42315349|NCT02407457|76151577|FG000|6-Month|Over Due|1|||
42315350|NCT02407457|76151578|FG001|6-Month|Over Due|2|||
42315351|NCT02407457|76151577|FG000|6-Month|Open Repair|0|||
42315352|NCT02407457|76151578|FG001|6-Month|Open Repair|1|||
42255940|NCT01066819|76082350|FG000|Overall Study|Lack of Efficacy|22|||
42255941|NCT01066819|76082351|FG001|Overall Study|Lack of Efficacy|1|||
42255942|NCT01066819|76082352|FG002|Overall Study|Lack of Efficacy|2|||
42255943|NCT01066819|76082353|FG003|Overall Study|Lack of Efficacy|1|||
42255944|NCT01066819|76082354|FG004|Overall Study|Lack of Efficacy|0|||
42255945|NCT01066819|76082355|FG005|Overall Study|Lack of Efficacy|0|||
42255946|NCT01066819|76082350|FG000|Overall Study|Physician Decision|6|||
42315353|NCT02407457|76151577|FG000|1 Year|Death|6|||
42315354|NCT02407457|76151578|FG001|1 Year|Death|11|||
42255947|NCT01066819|76082351|FG001|Overall Study|Physician Decision|2|||
42255948|NCT01066819|76082352|FG002|Overall Study|Physician Decision|3|||
42255949|NCT01066819|76082353|FG003|Overall Study|Physician Decision|0|||
42315355|NCT02407457|76151577|FG000|1 Year|Lost to Follow-up|3|||
42315356|NCT02407457|76151578|FG001|1 Year|Lost to Follow-up|2|||
42033839|NCT01079988|75841995|FG004|Overall Study|Lack of Efficacy|0|||
42315357|NCT02407457|76151577|FG000|1 Year|Missed Visit|18|||
42315358|NCT02407457|76151578|FG001|1 Year|Missed Visit|10|||
42315359|NCT02407457|76151577|FG000|1 Year|Over Due|6|||
42315360|NCT02407457|76151578|FG001|1 Year|Over Due|4|||
42315361|NCT02407457|76151577|FG000|1 Year|Open Repair|0|||
42033840|NCT01079988|75841991|FG000|Overall Study|Other|0|||
42255950|NCT01066819|76082354|FG004|Overall Study|Physician Decision|0|||
42255951|NCT01066819|76082355|FG005|Overall Study|Physician Decision|0|||
42315362|NCT02407457|76151578|FG001|1 Year|Open Repair|1|||
42315363|NCT02407457|76151577|FG000|2-year|Death|14|||
42315364|NCT02407457|76151578|FG001|2-year|Death|8|||
41993395|NCT01140061|75801590|FG009|Extension|Laboratory Adverse Event|1|||
42255952|NCT01066819|76082350|FG000|Overall Study|Protocol Violation|12|||
42255953|NCT01066819|76082351|FG001|Overall Study|Protocol Violation|6|||
42255954|NCT01066819|76082352|FG002|Overall Study|Protocol Violation|0|||
42255955|NCT01066819|76082353|FG003|Overall Study|Protocol Violation|0|||
42255956|NCT01066819|76082354|FG004|Overall Study|Protocol Violation|0|||
42255957|NCT01066819|76082355|FG005|Overall Study|Protocol Violation|0|||
42255958|NCT01066819|76082350|FG000|Overall Study|Withdrawal by Subject|29|||
42255959|NCT01066819|76082351|FG001|Overall Study|Withdrawal by Subject|11|||
42255960|NCT01066819|76082352|FG002|Overall Study|Withdrawal by Subject|6|||
42315365|NCT02407457|76151577|FG000|2-year|Lost to Follow-up|6|||
42315366|NCT02407457|76151578|FG001|2-year|Lost to Follow-up|9|||
42315367|NCT02407457|76151577|FG000|2-year|Missed Visit|13|||
42315368|NCT02407457|76151578|FG001|2-year|Missed Visit|11|||
42315369|NCT02407457|76151577|FG000|2-year|Over Due|1|||
42315370|NCT02407457|76151578|FG001|2-year|Over Due|5|||
42315371|NCT02407457|76151577|FG000|2-year|Open Repair|0|||
42315372|NCT02407457|76151578|FG001|2-year|Open Repair|2|||
42315373|NCT02407457|76151577|FG000|3-year|Death|11|||
42315374|NCT02407457|76151578|FG001|3-year|Death|10|||
42315375|NCT02407457|76151577|FG000|3-year|Lost to Follow-up|6|||
42315376|NCT02407457|76151578|FG001|3-year|Lost to Follow-up|9|||
42315377|NCT02407457|76151577|FG000|3-year|Missed Visit|21|||
42315378|NCT02407457|76151578|FG001|3-year|Missed Visit|16|||
42315379|NCT02407457|76151577|FG000|3-year|Over Due|4|||
42315380|NCT02407457|76151578|FG001|3-year|Over Due|3|||
42315381|NCT02407457|76151577|FG000|4-year|Death|14|||
42315382|NCT02407457|76151578|FG001|4-year|Death|7|||
42315383|NCT02407457|76151577|FG000|4-year|Lost to Follow-up|9|||
42315384|NCT02407457|76151578|FG001|4-year|Lost to Follow-up|12|||
42315385|NCT02407457|76151577|FG000|4-year|Over Due|10|||
42315386|NCT02407457|76151578|FG001|4-year|Over Due|5|||
42315387|NCT02407457|76151577|FG000|4-year|Missed Visit|13|||
42315388|NCT02407457|76151578|FG001|4-year|Missed Visit|13|||
42315389|NCT02407457|76151577|FG000|4-year|Pending visit|19|||
42315390|NCT02407457|76151578|FG001|4-year|Pending visit|14|||
42315391|NCT02407457|76151577|FG000|4-year|Not Due|16|||
42315392|NCT02407457|76151578|FG001|4-year|Not Due|10|||
42315393|NCT02407457|76151577|FG000|5-year|Death|6|||
42315394|NCT02407457|76151578|FG001|5-year|Death|1|||
42315395|NCT02407457|76151577|FG000|5-year|Lost to Follow-up|4|||
42315396|NCT02407457|76151578|FG001|5-year|Lost to Follow-up|4|||
42315397|NCT02407457|76151577|FG000|5-year|Missed Visit|10|||
42315398|NCT02407457|76151578|FG001|5-year|Missed Visit|9|||
42315399|NCT02407457|76151577|FG000|5-year|Pending Visit|18|||
42315400|NCT02407457|76151578|FG001|5-year|Pending Visit|17|||
42315401|NCT02407457|76151577|FG000|5-year|Not Due|54|||
42315402|NCT02407457|76151578|FG001|5-year|Not Due|46|||
42315403|NCT01814800|76151584|FG000|Overall Study|Adverse Event|2|||
42315404|NCT01814800|76151584|FG000|Overall Study|Pregnancy|1|||
42315405|NCT01814800|76151584|FG000|Overall Study|Sponsor decision|1|||
42315406|NCT01814800|76151584|FG000|Overall Study|Subject relocation|1|||
42315407|NCT01814332|76151590|FG000|Overall Study|Adverse Event|8|||
42315408|NCT01814332|76151591|FG001|Overall Study|Adverse Event|3|||
42315409|NCT01814332|76151590|FG000|Overall Study|Withdrawal by Subject|3|||
42315410|NCT01814332|76151591|FG001|Overall Study|Withdrawal by Subject|8|||
42315411|NCT01814332|76151590|FG000|Overall Study|Protocol Violation|0|||
42315412|NCT01814332|76151591|FG001|Overall Study|Protocol Violation|4|||
42315413|NCT01814332|76151590|FG000|Overall Study|Lost to Follow-up|5|||
41993396|NCT01139164|75801608|FG000|Overall Study|Withdrawn prior to study start|0|||
42255961|NCT01066819|76082353|FG003|Overall Study|Withdrawal by Subject|0|||
42255962|NCT01066819|76082354|FG004|Overall Study|Withdrawal by Subject|0|||
42255963|NCT01066819|76082355|FG005|Overall Study|Withdrawal by Subject|0|||
42255964|NCT01066819|76082350|FG000|Overall Study|Administrative|6|||
42255965|NCT01066819|76082351|FG001|Overall Study|Administrative|4|||
42255966|NCT01066819|76082352|FG002|Overall Study|Administrative|2|||
42255967|NCT01066819|76082353|FG003|Overall Study|Administrative|0|||
41993397|NCT01139164|75801609|FG001|Overall Study|Withdrawn prior to study start|2|||
41993398|NCT01139164|75801610|FG002|Overall Study|Withdrawn prior to study start|0|||
42255968|NCT01066819|76082354|FG004|Overall Study|Administrative|0|||
42255969|NCT01066819|76082355|FG005|Overall Study|Administrative|0|||
42255970|NCT01066819|76082350|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
42315414|NCT01814332|76151591|FG001|Overall Study|Lost to Follow-up|1|||
42315415|NCT02407223|76151600|FG000|Overall Study|Adverse Event|1|||
42315416|NCT02407223|76151601|FG001|Overall Study|Adverse Event|0|||
42315417|NCT02407223|76151602|FG002|Overall Study|Adverse Event|1|||
42315418|NCT02407223|76151600|FG000|Overall Study|Lack of Efficacy|6|||
42315419|NCT02407223|76151601|FG001|Overall Study|Lack of Efficacy|6|||
42315420|NCT02407223|76151602|FG002|Overall Study|Lack of Efficacy|4|||
42315421|NCT02407223|76151600|FG000|Overall Study|Lost to Follow-up|1|||
42315422|NCT02407223|76151601|FG001|Overall Study|Lost to Follow-up|0|||
42315423|NCT02407223|76151602|FG002|Overall Study|Lost to Follow-up|2|||
42315424|NCT02407223|76151600|FG000|Overall Study|Withdrawal by Subject|2|||
42315425|NCT02407223|76151601|FG001|Overall Study|Withdrawal by Subject|4|||
42315426|NCT02407223|76151602|FG002|Overall Study|Withdrawal by Subject|4|||
42255971|NCT01066819|76082351|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
42315427|NCT02407223|76151600|FG000|Overall Study|Study Terminated by Sponsor|77|||
42315428|NCT02407223|76151601|FG001|Overall Study|Study Terminated by Sponsor|80|||
42315429|NCT02407223|76151602|FG002|Overall Study|Study Terminated by Sponsor|86|||
42315430|NCT02407223|76151600|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
42315431|NCT02407223|76151601|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
42315432|NCT02407223|76151602|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
42315433|NCT02407223|76151600|FG000|Overall Study|Other|29|||
42255972|NCT01066819|76082352|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
41993399|NCT01139125|75801618|FG000|Overall Study|Withdrawal by Subject|1|||
41993400|NCT01139047|75801622|FG000|Overall Study|Withdrawal by Subject|1|||
41993401|NCT01139008|75801629|FG000|Overall Study|Withdrawal by Subject|5|||
41993402|NCT01139008|75801629|FG000|Overall Study|Non-compliant, lost product|1|||
41993403|NCT01138657|75801638|FG000|Overall Study|Adverse Event|3|||
41993404|NCT01138657|75801639|FG001|Overall Study|Adverse Event|10|||
41993405|NCT01138657|75801638|FG000|Overall Study|Lack of Efficacy|2|||
41993406|NCT01138657|75801639|FG001|Overall Study|Lack of Efficacy|1|||
41993407|NCT01138657|75801638|FG000|Overall Study|Lost to Follow-up|0|||
41993408|NCT01138657|75801639|FG001|Overall Study|Lost to Follow-up|3|||
41993409|NCT01138657|75801638|FG000|Overall Study|Miscellaneous Reasons|3|||
41993410|NCT01138657|75801639|FG001|Overall Study|Miscellaneous Reasons|4|||
41993411|NCT01138501|75801647|FG000|Overall Study|Protocol Violation|2|||
41993412|NCT01138501|75801647|FG000|Overall Study|Withdrawal by Subject|3|||
41993413|NCT01138150|75801653|FG000|Overall Study|blood unable to be processed|0|||
42255973|NCT01066819|76082353|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
42255974|NCT01066819|76082354|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
42255975|NCT01066819|76082355|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
42255976|NCT01066819|76082350|FG000|Overall Study|Early termination|2|||
42255977|NCT01066819|76082351|FG001|Overall Study|Early termination|0|||
42255978|NCT01066819|76082352|FG002|Overall Study|Early termination|0|||
42255979|NCT01066819|76082353|FG003|Overall Study|Early termination|0|||
42255980|NCT01066819|76082354|FG004|Overall Study|Early termination|0|||
42255981|NCT01066819|76082355|FG005|Overall Study|Early termination|0|||
42255982|NCT01066819|76082350|FG000|Overall Study|Failed to return|298|||
42255983|NCT01066819|76082351|FG001|Overall Study|Failed to return|107|||
42255984|NCT01066819|76082352|FG002|Overall Study|Failed to return|68|||
42255985|NCT01066819|76082353|FG003|Overall Study|Failed to return|7|||
42255986|NCT01066819|76082354|FG004|Overall Study|Failed to return|2|||
42255987|NCT01066819|76082355|FG005|Overall Study|Failed to return|3|||
42255988|NCT01066819|76082350|FG000|Overall Study|Lab test not done|9|||
42255989|NCT01066819|76082351|FG001|Overall Study|Lab test not done|0|||
42255990|NCT01066819|76082352|FG002|Overall Study|Lab test not done|2|||
42255991|NCT01066819|76082353|FG003|Overall Study|Lab test not done|1|||
42255992|NCT01066819|76082354|FG004|Overall Study|Lab test not done|0|||
42255993|NCT01066819|76082355|FG005|Overall Study|Lab test not done|0|||
42255994|NCT01066819|76082350|FG000|Overall Study|Miscellaneous|28|||
42255995|NCT01066819|76082351|FG001|Overall Study|Miscellaneous|10|||
42255996|NCT01066819|76082352|FG002|Overall Study|Miscellaneous|18|||
42255997|NCT01066819|76082353|FG003|Overall Study|Miscellaneous|1|||
42255998|NCT01066819|76082354|FG004|Overall Study|Miscellaneous|0|||
42255999|NCT01066819|76082355|FG005|Overall Study|Miscellaneous|0|||
42256000|NCT01066819|76082350|FG000|Overall Study|Non responders|123|||
42256001|NCT01066819|76082351|FG001|Overall Study|Non responders|2|||
42256002|NCT01066819|76082352|FG002|Overall Study|Non responders|7|||
42256003|NCT01066819|76082353|FG003|Overall Study|Non responders|2|||
42256004|NCT01066819|76082354|FG004|Overall Study|Non responders|0|||
42256005|NCT01066819|76082355|FG005|Overall Study|Non responders|1|||
42256006|NCT01066819|76082350|FG000|Overall Study|Not categorised|9|||
42256007|NCT01066819|76082351|FG001|Overall Study|Not categorised|2|||
42256008|NCT01066819|76082352|FG002|Overall Study|Not categorised|6|||
42256009|NCT01066819|76082353|FG003|Overall Study|Not categorised|1|||
42256010|NCT01066819|76082354|FG004|Overall Study|Not categorised|0|||
42256011|NCT01066819|76082355|FG005|Overall Study|Not categorised|0|||
42256012|NCT01066819|76082350|FG000|Overall Study|Relapse|16|||
42256013|NCT01066819|76082351|FG001|Overall Study|Relapse|4|||
42256014|NCT01066819|76082352|FG002|Overall Study|Relapse|3|||
42256015|NCT01066819|76082353|FG003|Overall Study|Relapse|0|||
42256016|NCT01066819|76082354|FG004|Overall Study|Relapse|0|||
42256017|NCT01066819|76082355|FG005|Overall Study|Relapse|0|||
42256018|NCT01066819|76082350|FG000|Overall Study|Results not available|1|||
42256019|NCT01066819|76082351|FG001|Overall Study|Results not available|0|||
42033841|NCT01079988|75841992|FG001|Overall Study|Other|0|||
42256020|NCT01066819|76082352|FG002|Overall Study|Results not available|0|||
42256021|NCT01066819|76082353|FG003|Overall Study|Results not available|0|||
42256022|NCT01066819|76082354|FG004|Overall Study|Results not available|0|||
42256023|NCT01066819|76082355|FG005|Overall Study|Results not available|0|||
42256024|NCT01066819|76082350|FG000|Overall Study|Screen failure|1|||
42256025|NCT01066819|76082351|FG001|Overall Study|Screen failure|0|||
42256026|NCT01066819|76082352|FG002|Overall Study|Screen failure|0|||
42256027|NCT01066819|76082353|FG003|Overall Study|Screen failure|0|||
42256028|NCT01066819|76082354|FG004|Overall Study|Screen failure|0|||
42256029|NCT01066819|76082355|FG005|Overall Study|Screen failure|0|||
42315434|NCT02407223|76151601|FG001|Overall Study|Other|27|||
42315435|NCT02407223|76151602|FG002|Overall Study|Other|25|||
42315436|NCT01797562|76151612|FG000|Overall Study|Protocol Violation|5|||
42315437|NCT01813474|76151620|FG000|Overall Study|Withdrawal by Subject|0|||
42315438|NCT01813474|76151621|FG001|Overall Study|Withdrawal by Subject|0|||
42315439|NCT01813474|76151622|FG002|Overall Study|Withdrawal by Subject|1|||
42315440|NCT01813474|76151620|FG000|Overall Study|Adverse Event|1|||
42315441|NCT01813474|76151621|FG001|Overall Study|Adverse Event|1|||
42315442|NCT01813474|76151622|FG002|Overall Study|Adverse Event|0|||
42315443|NCT01813474|76151620|FG000|Overall Study|Lack of Efficacy|2|||
42256030|NCT01066819|76082350|FG000|Overall Study|Spontaneous cure|1|||
42256031|NCT01066819|76082351|FG001|Overall Study|Spontaneous cure|0|||
42256032|NCT01066819|76082352|FG002|Overall Study|Spontaneous cure|0|||
42256033|NCT01066819|76082353|FG003|Overall Study|Spontaneous cure|0|||
42256034|NCT01066819|76082354|FG004|Overall Study|Spontaneous cure|0|||
42256035|NCT01066819|76082355|FG005|Overall Study|Spontaneous cure|0|||
42256036|NCT01066819|76082350|FG000|Overall Study|Treatment never started|85|||
42256037|NCT01066819|76082351|FG001|Overall Study|Treatment never started|19|||
42256038|NCT01066819|76082352|FG002|Overall Study|Treatment never started|19|||
42256039|NCT01066819|76082353|FG003|Overall Study|Treatment never started|3|||
42256040|NCT01066819|76082354|FG004|Overall Study|Treatment never started|2|||
42256041|NCT01066819|76082355|FG005|Overall Study|Treatment never started|2|||
42256042|NCT01066819|76082350|FG000|Overall Study|Treatment stopped|12|||
42256043|NCT01066819|76082351|FG001|Overall Study|Treatment stopped|1|||
42256044|NCT01066819|76082352|FG002|Overall Study|Treatment stopped|2|||
42256045|NCT01066819|76082353|FG003|Overall Study|Treatment stopped|1|||
42256046|NCT01066819|76082354|FG004|Overall Study|Treatment stopped|0|||
42256047|NCT01066819|76082355|FG005|Overall Study|Treatment stopped|0|||
42256048|NCT01066819|76082350|FG000|Overall Study|Other|5|||
42256049|NCT01066819|76082351|FG001|Overall Study|Other|1|||
42256050|NCT01066819|76082352|FG002|Overall Study|Other|1|||
42256051|NCT01066819|76082353|FG003|Overall Study|Other|0|||
42256052|NCT01066819|76082354|FG004|Overall Study|Other|0|||
42256053|NCT01066819|76082355|FG005|Overall Study|Other|0|||
42256054|NCT04056299|76082369|FG000|Overall Study|Sponsor discontinued study|3|||
42256055|NCT04056299|76082370|FG001|Overall Study|Sponsor discontinued study|3|||
42256056|NCT04057937|76082378|FG000|Placebo-controlled Phase|Adverse Event|3|||
42256057|NCT04057937|76082379|FG001|Placebo-controlled Phase|Adverse Event|0|||
42256058|NCT04057937|76082378|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
42256059|NCT04057937|76082379|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
42256060|NCT04057937|76082378|FG000|Active-treatment Phase|Pregnancy|0|||
42256061|NCT04057937|76082379|FG001|Active-treatment Phase|Pregnancy|1|||
42256062|NCT04057937|76082378|FG000|Active-treatment Phase|Physician Decision|0|||
42256063|NCT04057937|76082379|FG001|Active-treatment Phase|Physician Decision|1|||
42256064|NCT01069523|76082388|FG000|Overall Study|Withdrawal by Subject|4|||
42256065|NCT01069523|76082389|FG001|Overall Study|Withdrawal by Subject|7|||
42256066|NCT01069289|76082399|FG000|Overall Study|Withdrawal by Subject|15|||
42256067|NCT01069289|76082400|FG001|Overall Study|Withdrawal by Subject|26|||
42256068|NCT01069289|76082399|FG000|Overall Study|Adverse Event|21|||
42256069|NCT01069289|76082400|FG001|Overall Study|Adverse Event|28|||
42256070|NCT01069289|76082399|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
42256071|NCT01069289|76082400|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
42256072|NCT01069289|76082399|FG000|Overall Study|Severe non-compliance to protocol|3|||
42256073|NCT01069289|76082400|FG001|Overall Study|Severe non-compliance to protocol|2|||
42256074|NCT01069289|76082399|FG000|Overall Study|Due to deteriorating health condition|1|||
42256075|NCT01069289|76082400|FG001|Overall Study|Due to deteriorating health condition|0|||
42256076|NCT02510794|76082419|FG000|Overall Study|Adverse Event|0|||
42256077|NCT02510794|76082420|FG001|Overall Study|Adverse Event|1|||
42256078|NCT02510794|76082421|FG002|Overall Study|Adverse Event|0|||
42256079|NCT02510794|76082422|FG003|Overall Study|Adverse Event|0|||
42256080|NCT02510794|76082419|FG000|Overall Study|Death|1|||
42256081|NCT02510794|76082420|FG001|Overall Study|Death|2|||
42256082|NCT02510794|76082421|FG002|Overall Study|Death|1|||
42315444|NCT01813474|76151621|FG001|Overall Study|Lack of Efficacy|6|||
42256083|NCT02510794|76082422|FG003|Overall Study|Death|1|||
42256084|NCT02510794|76082419|FG000|Overall Study|Lack of Efficacy|3|||
42256085|NCT02510794|76082420|FG001|Overall Study|Lack of Efficacy|1|||
42256086|NCT02510794|76082421|FG002|Overall Study|Lack of Efficacy|1|||
42256087|NCT02510794|76082422|FG003|Overall Study|Lack of Efficacy|0|||
42315445|NCT01813474|76151622|FG002|Overall Study|Lack of Efficacy|9|||
42256088|NCT02510794|76082419|FG000|Overall Study|Participant moved out of the area|0|||
42315446|NCT01813474|76151620|FG000|Overall Study|Death|0|||
42315447|NCT01813474|76151621|FG001|Overall Study|Death|0|||
42315448|NCT01813474|76151622|FG002|Overall Study|Death|1|||
42315449|NCT01868542|76151633|FG000|Overall Study|Protocol Violation|0|||
42315450|NCT01868542|76151634|FG001|Overall Study|Protocol Violation|1|||
42315451|NCT01868542|76151633|FG000|Overall Study|Unclassified|0|||
42315452|NCT01868542|76151634|FG001|Overall Study|Unclassified|1|||
42315453|NCT01797094|76151642|FG000|Overall Study|Adverse Event|1|||
42315454|NCT01797094|76151643|FG001|Overall Study|Adverse Event|1|||
42315455|NCT01797094|76151642|FG000|Overall Study|Personal Reasons|4|||
42315456|NCT01797094|76151643|FG001|Overall Study|Personal Reasons|0|||
42315457|NCT01797094|76151642|FG000|Overall Study|Protocol Violation|0|||
42315458|NCT01797094|76151643|FG001|Overall Study|Protocol Violation|1|||
42315459|NCT01797094|76151642|FG000|Overall Study|Other Miscellaneous Reasons|1|||
42315460|NCT01797094|76151643|FG001|Overall Study|Other Miscellaneous Reasons|0|||
42315461|NCT02383589|76151651|FG000|Treatment Period|Adverse Event|1|||
42315462|NCT02383589|76151652|FG001|Treatment Period|Adverse Event|3|||
42315463|NCT02383589|76151651|FG000|Treatment Period|Lost to Follow-up|0|||
42315464|NCT02383589|76151652|FG001|Treatment Period|Lost to Follow-up|1|||
42315465|NCT02383589|76151651|FG000|Treatment Period|Withdrawal by Subject|0|||
42315466|NCT02383589|76151652|FG001|Treatment Period|Withdrawal by Subject|5|||
42315467|NCT02383589|76151651|FG000|Treatment Period|Non-compliance with study drug|0|||
42315468|NCT02383589|76151652|FG001|Treatment Period|Non-compliance with study drug|1|||
42315469|NCT02383589|76151651|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
42256089|NCT02510794|76082420|FG001|Overall Study|Participant moved out of the area|0|||
42256090|NCT02510794|76082421|FG002|Overall Study|Participant moved out of the area|0|||
42315470|NCT02383589|76151652|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
42315471|NCT02383589|76151651|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
42315472|NCT02383589|76151652|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
42315473|NCT02383589|76151651|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
42315474|NCT02383589|76151652|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
42315475|NCT01810432|76151660|FG000|Washout|Protocol Violation|0|||
42315476|NCT01810432|76151661|FG001|Washout|Protocol Violation|1|||
42315477|NCT01810432|76151660|FG000|Washout|Adverse Event|1|||
42315478|NCT01810432|76151661|FG001|Washout|Adverse Event|0|||
42315479|NCT01810432|76151660|FG000|Period 2|Withdrawal by Subject|2|||
42315480|NCT01810432|76151661|FG001|Period 2|Withdrawal by Subject|1|||
42315481|NCT01810432|76151660|FG000|Period 2|Physician Decision|1|||
42315482|NCT01810432|76151661|FG001|Period 2|Physician Decision|0|||
42315483|NCT01810432|76151660|FG000|Period 2|Lost to Follow-up|1|||
42315484|NCT01810432|76151661|FG001|Period 2|Lost to Follow-up|1|||
42315485|NCT01796860|76151667|FG000|Overall Study|Withdrawal by Subject|3|||
42315486|NCT01796548|76151671|FG000|Overall Study|Lost to Follow-up|1|||
42315487|NCT01796548|76151671|FG000|Overall Study|Other|2|||
42315488|NCT02406677|76151677|FG000|Overall Study|Death|16|||
42315489|NCT02406677|76151678|FG001|Overall Study|Death|8|||
42315490|NCT02406677|76151677|FG000|Overall Study|Discharged without P2Y12|1|||
42256091|NCT02510794|76082422|FG003|Overall Study|Participant moved out of the area|1|||
42256092|NCT02510794|76082419|FG000|Overall Study|Physician Decision|3|||
42256093|NCT02510794|76082420|FG001|Overall Study|Physician Decision|0|||
42256094|NCT02510794|76082421|FG002|Overall Study|Physician Decision|0|||
42256095|NCT02510794|76082422|FG003|Overall Study|Physician Decision|0|||
42256096|NCT02510794|76082419|FG000|Overall Study|Protocol Violation|0|||
42256097|NCT02510794|76082420|FG001|Overall Study|Protocol Violation|0|||
42256098|NCT02510794|76082421|FG002|Overall Study|Protocol Violation|1|||
42315491|NCT02406677|76151678|FG001|Overall Study|Discharged without P2Y12|3|||
42315492|NCT02406677|76151677|FG000|Overall Study|Discharged on prasugrel|283|||
42315493|NCT02406677|76151678|FG001|Overall Study|Discharged on prasugrel|587|||
42315494|NCT02406677|76151677|FG000|Overall Study|Withdrawal by Subject|1|||
42315495|NCT02406677|76151678|FG001|Overall Study|Withdrawal by Subject|0|||
42315496|NCT02404805|76151694|FG000|Overall Study|Withdrawal by Subject|1|||
42315497|NCT02404805|76151695|FG001|Overall Study|Withdrawal by Subject|0|||
42315498|NCT02404805|76151696|FG002|Overall Study|Withdrawal by Subject|0|||
42315499|NCT02404805|76151697|FG003|Overall Study|Withdrawal by Subject|0|||
42256099|NCT02510794|76082422|FG003|Overall Study|Protocol Violation|0|||
42256100|NCT02510794|76082419|FG000|Overall Study|Withdrawal by Subject|1|||
42315500|NCT02404805|76151698|FG004|Overall Study|Withdrawal by Subject|0|||
42315501|NCT02404805|76151699|FG005|Overall Study|Withdrawal by Subject|0|||
42315502|NCT02430311|76151710|FG000|Part A|Adverse Event|0|||
42315503|NCT02430311|76151711|FG001|Part A|Adverse Event|1|||
42315504|NCT02430311|76151710|FG000|Part A|Withdrawal by Subject|1|||
42315505|NCT02430311|76151711|FG001|Part A|Withdrawal by Subject|0|||
42315506|NCT02430311|76151710|FG000|Part B|Meet study-specific withdrawal criteria|6|||
42315507|NCT02430311|76151711|FG001|Part B|Meet study-specific withdrawal criteria|6|||
42315508|NCT02430311|76151710|FG000|Part B|Withdrawal by Subject|2|||
42315509|NCT02430311|76151711|FG001|Part B|Withdrawal by Subject|2|||
42315510|NCT02430311|76151710|FG000|Part B|Adverse Event|1|||
42315511|NCT02430311|76151711|FG001|Part B|Adverse Event|0|||
42315512|NCT02430311|76151710|FG000|Part B|Death|1|||
42315513|NCT02430311|76151711|FG001|Part B|Death|0|||
42315514|NCT02404649|76151728|FG000|Overall Study|Adverse Event|1|||
42315515|NCT02404649|76151729|FG001|Overall Study|Adverse Event|2|||
42315516|NCT02383355|76151737|FG000|Overall Study|Adverse Event|2|||
42315517|NCT02383355|76151738|FG001|Overall Study|Adverse Event|0|||
42315518|NCT02381795|76151744|FG000|Overall Study|Withdrawal by Subject|1|||
42315519|NCT02381795|76151744|FG000|Overall Study|Study Terminated|2|||
42315520|NCT02404493|76151750|FG000|Overall Study|Adverse Event|1|||
42315521|NCT02404493|76151751|FG001|Overall Study|Adverse Event|1|||
42315522|NCT02380859|76151759|FG000|Overall Study|Withdrawal by Subject|2|||
42315523|NCT02380859|76151760|FG001|Overall Study|Withdrawal by Subject|0|||
42315524|NCT02380703|76151768|FG000|Overall Study|Withdrawal by Subject|12|||
42315525|NCT02380703|76151769|FG001|Overall Study|Withdrawal by Subject|9|||
42315526|NCT02380703|76151768|FG000|Overall Study|Lost to Follow-up|12|||
42315527|NCT02380703|76151769|FG001|Overall Study|Lost to Follow-up|12|||
42315528|NCT02380703|76151768|FG000|Overall Study|Caregiver death|1|||
42315529|NCT02380703|76151769|FG001|Overall Study|Caregiver death|0|||
42315530|NCT02380703|76151768|FG000|Overall Study|Person with dementia (PWD) death|7|||
42315531|NCT02380703|76151769|FG001|Overall Study|Person with dementia (PWD) death|8|||
42315532|NCT02380703|76151768|FG000|Overall Study|Entered Long-term Care|4|||
42315533|NCT02380703|76151769|FG001|Overall Study|Entered Long-term Care|7|||
42315534|NCT02379923|76151775|FG000|Overall Study|Death|5|||
42315535|NCT02379221|76151782|FG000|Overall Study|Lost to Follow-up|1|||
42315536|NCT02404103|76151793|FG000|Overall Study|Adverse Event|1|||
42315537|NCT02404103|76151794|FG001|Overall Study|Adverse Event|0|||
42315538|NCT02404103|76151793|FG000|Overall Study|Lost to Follow-up|3|||
42315539|NCT02404103|76151794|FG001|Overall Study|Lost to Follow-up|3|||
42315540|NCT02404025|76151810|FG000|Overall Study|Adverse Event|1|||
42315541|NCT02404025|76151810|FG000|Overall Study|Lack of Efficacy|3|||
42315542|NCT02377817|76151816|FG000|Overall Study|Transportation/childcare barriers.|2|||
42315543|NCT02377817|76151817|FG001|Overall Study|Transportation/childcare barriers.|0|||
42315544|NCT02377817|76151816|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
42315545|NCT02377817|76151817|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
42315546|NCT02403635|76151825|FG000|Overall Study|Not eligible|9|||
42315547|NCT02402933|76151845|FG000|Overall Study|Withdrawal by Subject|4|||
42315548|NCT02402933|76151845|FG000|Overall Study|Discontinued; Site Termination|10|||
42315549|NCT01796470|76151854|FG000|Overall Study|Adverse Event|4|||
42315550|NCT01796470|76151855|FG001|Overall Study|Adverse Event|2|||
42315551|NCT01796470|76151856|FG002|Overall Study|Adverse Event|2|||
42315552|NCT01796470|76151857|FG003|Overall Study|Adverse Event|1|||
41993414|NCT01138150|75801654|FG001|Overall Study|blood unable to be processed|1|||
42315553|NCT01796470|76151858|FG004|Overall Study|Adverse Event|3|||
42315554|NCT01796470|76151854|FG000|Overall Study|Death|2|||
42315555|NCT01796470|76151855|FG001|Overall Study|Death|0|||
42315556|NCT01796470|76151856|FG002|Overall Study|Death|0|||
42315557|NCT01796470|76151857|FG003|Overall Study|Death|0|||
42315558|NCT01796470|76151858|FG004|Overall Study|Death|1|||
41993415|NCT01138150|75801653|FG000|Overall Study|Physician Decision|1|||
42315559|NCT01796470|76151854|FG000|Overall Study|Initiated New Therapy|9|||
42315560|NCT01796470|76151855|FG001|Overall Study|Initiated New Therapy|0|||
42315561|NCT01796470|76151856|FG002|Overall Study|Initiated New Therapy|0|||
42315562|NCT01796470|76151857|FG003|Overall Study|Initiated New Therapy|0|||
42315563|NCT01796470|76151858|FG004|Overall Study|Initiated New Therapy|2|||
42315564|NCT01796470|76151854|FG000|Overall Study|Lost to Follow-up|0|||
42315565|NCT01796470|76151855|FG001|Overall Study|Lost to Follow-up|1|||
42315566|NCT01796470|76151856|FG002|Overall Study|Lost to Follow-up|0|||
42315567|NCT01796470|76151857|FG003|Overall Study|Lost to Follow-up|0|||
42256101|NCT02510794|76082420|FG001|Overall Study|Withdrawal by Subject|2|||
42256102|NCT02510794|76082421|FG002|Overall Study|Withdrawal by Subject|4|||
42315568|NCT01796470|76151858|FG004|Overall Study|Lost to Follow-up|0|||
42315569|NCT01796470|76151854|FG000|Overall Study|Physician Decision|5|||
42315570|NCT01796470|76151855|FG001|Overall Study|Physician Decision|4|||
42315571|NCT01796470|76151856|FG002|Overall Study|Physician Decision|1|||
42315572|NCT01796470|76151857|FG003|Overall Study|Physician Decision|0|||
42315573|NCT01796470|76151858|FG004|Overall Study|Physician Decision|1|||
42315574|NCT01796470|76151854|FG000|Overall Study|Progressive Disease|7|||
42315575|NCT01796470|76151855|FG001|Overall Study|Progressive Disease|7|||
42315576|NCT01796470|76151856|FG002|Overall Study|Progressive Disease|3|||
42315577|NCT01796470|76151857|FG003|Overall Study|Progressive Disease|2|||
42315578|NCT01796470|76151858|FG004|Overall Study|Progressive Disease|0|||
42315579|NCT01796470|76151854|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
42315580|NCT01796470|76151855|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
42315581|NCT01796470|76151856|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
42315582|NCT01796470|76151857|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
42315583|NCT01796470|76151858|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
42315584|NCT01796470|76151854|FG000|Overall Study|Withdrawal by Subject|7|||
42315585|NCT01796470|76151855|FG001|Overall Study|Withdrawal by Subject|0|||
42315586|NCT01796470|76151856|FG002|Overall Study|Withdrawal by Subject|0|||
42315587|NCT01796470|76151857|FG003|Overall Study|Withdrawal by Subject|0|||
42315588|NCT01796470|76151858|FG004|Overall Study|Withdrawal by Subject|1|||
42315589|NCT01868074|76151876|FG000|Overall Study|Lost to Follow-up|3|||
42315590|NCT01868074|76151877|FG001|Overall Study|Lost to Follow-up|2|||
42315591|NCT01868074|76151876|FG000|Overall Study|Withdrawal by Subject|4|||
42315592|NCT01868074|76151877|FG001|Overall Study|Withdrawal by Subject|2|||
42315593|NCT01810042|76151883|FG000|Overall Study|Lost to Follow-up|10|||
42315594|NCT02424539|76151890|FG000|Overall Study|Adverse Event|0|||
42315595|NCT02424539|76151891|FG001|Overall Study|Adverse Event|0|||
42315596|NCT02424539|76151892|FG002|Overall Study|Adverse Event|1|||
42315597|NCT02424539|76151890|FG000|Overall Study|Physician Decision|0|||
41993416|NCT01138150|75801654|FG001|Overall Study|Physician Decision|0|||
41993417|NCT01138111|75801670|FG000|Overall Study|Withdrawal by Subject|5|||
42315598|NCT02424539|76151891|FG001|Overall Study|Physician Decision|0|||
42315599|NCT02424539|76151892|FG002|Overall Study|Physician Decision|1|||
42315600|NCT02424539|76151890|FG000|Overall Study|Withdrawal by Subject|3|||
42315601|NCT02424539|76151891|FG001|Overall Study|Withdrawal by Subject|1|||
42315602|NCT02424539|76151892|FG002|Overall Study|Withdrawal by Subject|0|||
42315603|NCT02424539|76151890|FG000|Overall Study|Other: Reached stopping criteria|11|||
42315604|NCT02424539|76151891|FG001|Overall Study|Other: Reached stopping criteria|7|||
42315605|NCT02424539|76151892|FG002|Overall Study|Other: Reached stopping criteria|6|||
42315606|NCT01809262|76151900|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
41993418|NCT01138111|75801670|FG000|Overall Study|Adverse Event|1|||
41993419|NCT01138111|75801670|FG000|Overall Study|Death|1|||
41993420|NCT01138111|75801670|FG000|Overall Study|Lost to Follow-up|2|||
41993421|NCT01137955|75801701|FG000|Overall Study|Withdrawal by Subject|5|||
41993422|NCT01137955|75801702|FG001|Overall Study|Withdrawal by Subject|4|||
41993423|NCT01137682|75801712|FG000|Overall Study|Adverse Event-CORE|2|||
42256103|NCT02510794|76082422|FG003|Overall Study|Withdrawal by Subject|3|||
41993424|NCT01137682|75801713|FG001|Overall Study|Adverse Event-CORE|4|||
41993425|NCT01137682|75801714|FG002|Overall Study|Adverse Event-CORE|0|||
41993426|NCT01137682|75801712|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
41993427|NCT01137682|75801713|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
41993428|NCT01137682|75801714|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
42256104|NCT02510014|76082447|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
42256105|NCT02510014|76082448|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
42256106|NCT02510014|76082447|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
42256107|NCT02510014|76082448|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
42256108|NCT02510014|76082447|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
42315607|NCT01809262|76151901|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
42315608|NCT01809262|76151902|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
42315609|NCT01809262|76151903|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
42315610|NCT01809262|76151904|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
42315611|NCT01809262|76151905|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
42315612|NCT01809262|76151906|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
42315613|NCT01809262|76151907|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
42315614|NCT01809262|76151908|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
42315615|NCT01809262|76151909|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
42315616|NCT01809262|76151900|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
42315617|NCT01809262|76151901|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
42315618|NCT01809262|76151902|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
42315619|NCT01809262|76151903|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
42315620|NCT01809262|76151904|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
42315621|NCT01809262|76151905|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
42315622|NCT01809262|76151906|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
42315623|NCT01809262|76151907|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
42315624|NCT01809262|76151908|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
42315625|NCT01809262|76151909|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
42315626|NCT01808248|76151923|FG000|Overall Study|Lack of Efficacy|3|||
42315627|NCT01808248|76151923|FG000|Overall Study|Withdrawal by Subject|1|||
41993429|NCT01137682|75801712|FG000|Overall Study|Administrative problems-CORE|2|||
41993430|NCT01137682|75801713|FG001|Overall Study|Administrative problems-CORE|1|||
41993431|NCT01137682|75801714|FG002|Overall Study|Administrative problems-CORE|0|||
41993432|NCT01137682|75801712|FG000|Overall Study|Protocol Violation-CORE|0|||
41993433|NCT01137682|75801713|FG001|Overall Study|Protocol Violation-CORE|1|||
42315628|NCT01808248|76151923|FG000|Overall Study|Lost to Follow-up|1|||
42315629|NCT02424383|76151929|FG000|Overall Study|Withdrawal by Subject|32|||
42315630|NCT02424383|76151929|FG000|Overall Study|Death|170|||
42315631|NCT02424383|76151929|FG000|Overall Study|Sponsor's decision|3|||
42315632|NCT02424383|76151929|FG000|Overall Study|Investigator's decision|44|||
41993434|NCT01137682|75801714|FG002|Overall Study|Protocol Violation-CORE|1|||
42315633|NCT02424383|76151929|FG000|Overall Study|Lost to Follow-up|81|||
42315634|NCT02424383|76151929|FG000|Overall Study|Other|7|||
42315635|NCT02424383|76151929|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
42315636|NCT01867294|76151937|FG000|Overall Study|Withdrawal by Subject|1|||
42315637|NCT01867294|76151938|FG001|Overall Study|Withdrawal by Subject|1|||
42315638|NCT01867294|76151939|FG002|Overall Study|Withdrawal by Subject|0|||
42315639|NCT01867294|76151940|FG003|Overall Study|Withdrawal by Subject|0|||
42315640|NCT02424149|76151950|FG000|Overall Study|surgery cancelled|2|||
42315641|NCT02424149|76151951|FG001|Overall Study|surgery cancelled|0|||
42315642|NCT02424149|76151950|FG000|Overall Study|Withdrawal by Subject|0|||
42315643|NCT02424149|76151951|FG001|Overall Study|Withdrawal by Subject|1|||
42315644|NCT02423291|76151957|FG000|Overall Study|Lack of Efficacy|14|||
42315645|NCT02423291|76151957|FG000|Overall Study|Adverse Event|1|||
42315646|NCT02401529|76151963|FG000|Overall Study|Lost to Follow-up|2|||
42315647|NCT02401529|76151964|FG001|Overall Study|Lost to Follow-up|1|||
42315648|NCT02401529|76151963|FG000|Overall Study|Physician Decision|2|||
42315649|NCT02401529|76151964|FG001|Overall Study|Physician Decision|6|||
42315650|NCT02401529|76151963|FG000|Overall Study|Protocol Violation|5|||
42315651|NCT02401529|76151964|FG001|Overall Study|Protocol Violation|0|||
42315652|NCT01867216|76151978|FG000|Overall Study|Withdrawal by Subject|2|||
42315653|NCT01867216|76151979|FG001|Overall Study|Withdrawal by Subject|0|||
42315654|NCT01867216|76151980|FG002|Overall Study|Withdrawal by Subject|0|||
42315655|NCT01867216|76151981|FG003|Overall Study|Withdrawal by Subject|0|||
42315656|NCT01867216|76151982|FG004|Overall Study|Withdrawal by Subject|1|||
42315657|NCT01867216|76151983|FG005|Overall Study|Withdrawal by Subject|0|||
42315658|NCT01867216|76151984|FG006|Overall Study|Withdrawal by Subject|1|||
42315659|NCT01867216|76151978|FG000|Overall Study|Physician Decision|1|||
42315660|NCT01867216|76151979|FG001|Overall Study|Physician Decision|0|||
42315661|NCT01867216|76151980|FG002|Overall Study|Physician Decision|0|||
41993435|NCT01137682|75801712|FG000|Overall Study|Adverse Event-Extension|4|||
41993436|NCT01137682|75801713|FG001|Overall Study|Adverse Event-Extension|8|||
42315662|NCT01867216|76151981|FG003|Overall Study|Physician Decision|0|||
42315663|NCT01867216|76151982|FG004|Overall Study|Physician Decision|0|||
42315664|NCT01867216|76151983|FG005|Overall Study|Physician Decision|0|||
42315665|NCT01867216|76151984|FG006|Overall Study|Physician Decision|0|||
42315666|NCT01867216|76151978|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
42315667|NCT01867216|76151979|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
42315668|NCT01867216|76151980|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
42315669|NCT01867216|76151981|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
42315670|NCT01867216|76151982|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
42315671|NCT01867216|76151983|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
42315672|NCT01867216|76151984|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
42315673|NCT01866826|76152006|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
42133162|NCT00299728|75944073|FG001|Overall Study|Withdrawal by Subject|1|||
42133163|NCT00299728|75944072|FG000|Overall Study|Progressive disease|0|||
42133164|NCT00299728|75944073|FG001|Overall Study|Progressive disease|1|||
42133165|NCT00396591|75944079|FG000|Overall Study|Disease Progression|13|||
42133166|NCT00396591|75944079|FG000|Overall Study|Adverse Event|2|||
42133167|NCT00396591|75944079|FG000|Overall Study|Participant request|1|||
42133168|NCT00316264|75944086|FG000|Overall Study|Lost to Follow-up|0|||
42133169|NCT00316264|75944087|FG001|Overall Study|Lost to Follow-up|1|||
42133170|NCT00316264|75944088|FG002|Overall Study|Lost to Follow-up|0|||
42133171|NCT00316264|75944086|FG000|Overall Study|Withdrawal of Consent|3|||
42133172|NCT00316264|75944087|FG001|Overall Study|Withdrawal of Consent|5|||
42133173|NCT00316264|75944088|FG002|Overall Study|Withdrawal of Consent|6|||
42133174|NCT00316264|75944086|FG000|Overall Study|Death|2|||
42133175|NCT00316264|75944087|FG001|Overall Study|Death|0|||
42133176|NCT00316264|75944088|FG002|Overall Study|Death|0|||
42133177|NCT00316264|75944086|FG000|Overall Study|Other|1|||
42133178|NCT00316264|75944087|FG001|Overall Study|Other|1|||
42133179|NCT00316264|75944088|FG002|Overall Study|Other|0|||
42133180|NCT00385827|75944099|FG000|Part 1|Adverse Event|1|||
42133181|NCT00385827|75944100|FG001|Part 1|Adverse Event|0|||
42133182|NCT00385827|75944101|FG002|Part 1|Adverse Event|0|||
42133183|NCT00385827|75944099|FG000|Part 1|Death|2|||
42133184|NCT00385827|75944100|FG001|Part 1|Death|0|||
42133185|NCT00385827|75944101|FG002|Part 1|Death|0|||
42133186|NCT00385827|75944099|FG000|Part 1|Lack of Efficacy|5|||
42133187|NCT00385827|75944100|FG001|Part 1|Lack of Efficacy|0|||
42133188|NCT00385827|75944101|FG002|Part 1|Lack of Efficacy|0|||
42133189|NCT00385827|75944099|FG000|Part 1|Other|1|||
42133190|NCT00385827|75944100|FG001|Part 1|Other|0|||
42133191|NCT00385827|75944101|FG002|Part 1|Other|0|||
42133192|NCT00385827|75944099|FG000|Part 2|Adverse Event|0|||
42133193|NCT00385827|75944100|FG001|Part 2|Adverse Event|6|||
42133194|NCT00385827|75944101|FG002|Part 2|Adverse Event|10|||
42133195|NCT00385827|75944099|FG000|Part 2|Death|0|||
42133196|NCT00385827|75944100|FG001|Part 2|Death|0|||
42133197|NCT00385827|75944101|FG002|Part 2|Death|2|||
42133198|NCT00385827|75944099|FG000|Part 2|Lack of Efficacy|0|||
42133199|NCT00385827|75944100|FG001|Part 2|Lack of Efficacy|14|||
42315674|NCT01866826|76152007|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
42315675|NCT01866826|76152006|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
42315676|NCT01866826|76152007|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
42315677|NCT01866826|76152006|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
42315678|NCT01866826|76152007|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
42315679|NCT01791244|76152024|FG000|Overall Study|Adverse Event|5|||
42315680|NCT01791244|76152025|FG001|Overall Study|Adverse Event|7|||
42315681|NCT01791244|76152024|FG000|Overall Study|Insufficient clinical response|10|||
42315682|NCT01791244|76152025|FG001|Overall Study|Insufficient clinical response|10|||
42315683|NCT01791244|76152024|FG000|Overall Study|Laboratory Abnormality|0|||
42315684|NCT01791244|76152025|FG001|Overall Study|Laboratory Abnormality|1|||
42315685|NCT01865812|76152033|FG000|Primary Treatment Phase|Adverse Event|2|||
42133200|NCT00385827|75944101|FG002|Part 2|Lack of Efficacy|13|||
42133201|NCT00385827|75944099|FG000|Part 2|Randomized but not treated|0|||
42133202|NCT00385827|75944100|FG001|Part 2|Randomized but not treated|2|||
42133203|NCT00385827|75944101|FG002|Part 2|Randomized but not treated|2|||
42133204|NCT00385827|75944099|FG000|Part 2|Other|0|||
42133205|NCT00385827|75944100|FG001|Part 2|Other|11|||
42133206|NCT00385827|75944101|FG002|Part 2|Other|21|||
42133207|NCT00498602|75944118|FG000|Overall Study|Death|0|||
42133208|NCT00498602|75944119|FG001|Overall Study|Death|0|||
42133209|NCT00498602|75944120|FG002|Overall Study|Death|0|||
42256109|NCT02510014|76082448|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
42256110|NCT02510014|76082447|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
42256111|NCT02510014|76082448|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
42256112|NCT02510014|76082447|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
42256113|NCT02510014|76082448|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
42256114|NCT02510014|76082447|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
42256115|NCT02510014|76082448|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
42256116|NCT02510014|76082447|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
42256117|NCT02510014|76082448|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
42256118|NCT02510014|76082447|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
42256119|NCT02510014|76082448|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
42256120|NCT02510014|76082447|FG000|Treatment Period|Adverse Event|11|||
42256121|NCT02510014|76082448|FG001|Treatment Period|Adverse Event|4|||
42256122|NCT02510014|76082447|FG000|Treatment Period|Withdrawal symptoms|3|||
42256123|NCT02510014|76082448|FG001|Treatment Period|Withdrawal symptoms|0|||
42256124|NCT02510014|76082447|FG000|Treatment Period|Lost to Follow-up|80|||
42256125|NCT02510014|76082448|FG001|Treatment Period|Lost to Follow-up|19|||
42256126|NCT02510014|76082447|FG000|Treatment Period|Physician Decision|5|||
42256127|NCT02510014|76082448|FG001|Treatment Period|Physician Decision|0|||
42256128|NCT02510014|76082447|FG000|Treatment Period|Withdrawal by Subject|67|||
42256129|NCT02510014|76082448|FG001|Treatment Period|Withdrawal by Subject|24|||
42256130|NCT02510014|76082447|FG000|Treatment Period|Withdrawn by the investigator|7|||
42256131|NCT02510014|76082448|FG001|Treatment Period|Withdrawn by the investigator|1|||
42256132|NCT02510014|76082447|FG000|Treatment Period|Protocol Violation|4|||
42256133|NCT02510014|76082448|FG001|Treatment Period|Protocol Violation|4|||
42256134|NCT02510014|76082447|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
42256135|NCT02510014|76082448|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
42256136|NCT02509312|76082456|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
42256137|NCT02509312|76082457|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
42256138|NCT02509312|76082456|FG000|Overall Study|Obstetrician refusal|0|||
42256139|NCT02509312|76082457|FG001|Overall Study|Obstetrician refusal|1|||
42256140|NCT02509312|76082456|FG000|Overall Study|Patient elected for TOLAC|1|||
42256141|NCT02509312|76082457|FG001|Overall Study|Patient elected for TOLAC|0|||
42256142|NCT02509312|76082456|FG000|Overall Study|Cesarean deemed stat|1|||
42256143|NCT02509312|76082457|FG001|Overall Study|Cesarean deemed stat|0|||
42256144|NCT02509312|76082456|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
42256145|NCT02509312|76082457|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
42256146|NCT02509156|76082467|FG000|Randomized Phase|Death|1|||
42256147|NCT02509156|76082468|FG001|Randomized Phase|Death|0|||
42256148|NCT02509156|76082467|FG000|Randomized Phase|Withdrawal by Subject|1|||
42256149|NCT02509156|76082468|FG001|Randomized Phase|Withdrawal by Subject|1|||
42256150|NCT01654666|76082477|FG000|Overall Study|Protocol Violation|7|||
42256151|NCT01654666|76082478|FG001|Overall Study|Protocol Violation|4|||
42256152|NCT01654666|76082479|FG002|Overall Study|Protocol Violation|8|||
42256153|NCT01654666|76082477|FG000|Overall Study|Lost to Follow-up|4|||
42256154|NCT01654666|76082478|FG001|Overall Study|Lost to Follow-up|5|||
42256155|NCT01654666|76082479|FG002|Overall Study|Lost to Follow-up|5|||
42256156|NCT01654666|76082477|FG000|Overall Study|Withdrawal by Subject|4|||
42256157|NCT01654666|76082478|FG001|Overall Study|Withdrawal by Subject|4|||
42256158|NCT01654666|76082479|FG002|Overall Study|Withdrawal by Subject|1|||
42256159|NCT02519842|76082489|FG000|Base Study: Cycle 1|Screening Failure|1|||
42256160|NCT02519842|76082490|FG001|Base Study: Cycle 1|Screening Failure|1|||
42256161|NCT02519842|76082491|FG002|Base Study: Cycle 1|Screening Failure|0|||
42256162|NCT02519842|76082489|FG000|Base Study: Cycle 1|Adverse Event|1|||
42256163|NCT02519842|76082490|FG001|Base Study: Cycle 1|Adverse Event|0|||
42256164|NCT02519842|76082491|FG002|Base Study: Cycle 1|Adverse Event|0|||
42256165|NCT02519842|76082489|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
42315686|NCT01865812|76152034|FG001|Primary Treatment Phase|Adverse Event|0|||
42315687|NCT01865812|76152033|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
42315688|NCT01865812|76152034|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
42315689|NCT01865812|76152033|FG000|Long-term Safety Extension Phase|Pruritus|0|||
42315690|NCT01865812|76152034|FG001|Long-term Safety Extension Phase|Pruritus|3|||
42315691|NCT01865812|76152033|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
42315692|NCT01865812|76152034|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
42315693|NCT01865812|76152033|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
42315694|NCT01865812|76152034|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
42315695|NCT01808092|76152043|FG000|Overall Study|Death|39|||
42133210|NCT00498602|75944121|FG003|Overall Study|Death|0|||
42133211|NCT00498602|75944122|FG004|Overall Study|Death|0|||
42133212|NCT00498602|75944123|FG005|Overall Study|Death|1|||
42133213|NCT00498602|75944124|FG006|Overall Study|Death|0|||
42133214|NCT00498602|75944118|FG000|Overall Study|Lack of Efficacy|1|||
42133215|NCT00498602|75944119|FG001|Overall Study|Lack of Efficacy|0|||
42133216|NCT00498602|75944120|FG002|Overall Study|Lack of Efficacy|0|||
42133217|NCT00498602|75944121|FG003|Overall Study|Lack of Efficacy|0|||
42133218|NCT00498602|75944122|FG004|Overall Study|Lack of Efficacy|0|||
42133219|NCT00498602|75944123|FG005|Overall Study|Lack of Efficacy|0|||
42133220|NCT00498602|75944124|FG006|Overall Study|Lack of Efficacy|0|||
42133221|NCT00498602|75944118|FG000|Overall Study|Lost to Follow-up|0|||
42133222|NCT00498602|75944119|FG001|Overall Study|Lost to Follow-up|2|||
42133223|NCT00498602|75944120|FG002|Overall Study|Lost to Follow-up|0|||
42133224|NCT00498602|75944121|FG003|Overall Study|Lost to Follow-up|2|||
42133225|NCT00498602|75944122|FG004|Overall Study|Lost to Follow-up|0|||
42133226|NCT00498602|75944123|FG005|Overall Study|Lost to Follow-up|0|||
42315696|NCT01808092|76152044|FG001|Overall Study|Death|29|||
42315697|NCT01808092|76152043|FG000|Overall Study|Lost to Follow-up|3|||
42315698|NCT01808092|76152044|FG001|Overall Study|Lost to Follow-up|7|||
42315699|NCT01808092|76152043|FG000|Overall Study|Withdrawal by Subject|9|||
42315700|NCT01808092|76152044|FG001|Overall Study|Withdrawal by Subject|4|||
42315701|NCT01808092|76152043|FG000|Overall Study|Other Eligibility criteria|3|||
42315702|NCT01808092|76152044|FG001|Overall Study|Other Eligibility criteria|5|||
42315703|NCT01774084|76152052|FG000|Overall Study|Personal reasons|1|||
42315704|NCT01774084|76152053|FG001|Overall Study|Personal reasons|0|||
42315705|NCT01807234|76152065|FG000|Overall Study|Lost to Follow-up|2|||
42315706|NCT01807234|76152066|FG001|Overall Study|Lost to Follow-up|5|||
42315707|NCT01807234|76152067|FG002|Overall Study|Lost to Follow-up|1|||
42315708|NCT01807234|76152068|FG003|Overall Study|Lost to Follow-up|1|||
42315709|NCT01807234|76152069|FG004|Overall Study|Lost to Follow-up|1|||
42315710|NCT01807234|76152070|FG005|Overall Study|Lost to Follow-up|2|||
42133227|NCT00498602|75944124|FG006|Overall Study|Lost to Follow-up|0|||
42256166|NCT02519842|76082490|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
42256167|NCT02519842|76082491|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
42256168|NCT02519842|76082489|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
42256169|NCT02519842|76082490|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
42256170|NCT02519842|76082491|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
42256171|NCT02519842|76082489|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
42256172|NCT02519842|76082490|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
42256173|NCT02519842|76082491|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
42256174|NCT02519842|76082489|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
42256175|NCT02519842|76082490|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
42256176|NCT02519842|76082491|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
42256177|NCT02519842|76082489|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
42315711|NCT01807234|76152065|FG000|Overall Study|Withdrawal by Subject|3|||
42315712|NCT01807234|76152066|FG001|Overall Study|Withdrawal by Subject|1|||
42315713|NCT01807234|76152067|FG002|Overall Study|Withdrawal by Subject|1|||
42315714|NCT01807234|76152068|FG003|Overall Study|Withdrawal by Subject|1|||
42256178|NCT02519842|76082490|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
42256179|NCT02519842|76082491|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
42133228|NCT00498602|75944118|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
42315715|NCT01807234|76152069|FG004|Overall Study|Withdrawal by Subject|2|||
42315716|NCT01807234|76152070|FG005|Overall Study|Withdrawal by Subject|1|||
42315717|NCT01807234|76152065|FG000|Overall Study|Lack of Efficacy|0|||
42315718|NCT01807234|76152066|FG001|Overall Study|Lack of Efficacy|0|||
42315719|NCT01807234|76152067|FG002|Overall Study|Lack of Efficacy|0|||
42315720|NCT01807234|76152068|FG003|Overall Study|Lack of Efficacy|0|||
42315721|NCT01807234|76152069|FG004|Overall Study|Lack of Efficacy|1|||
42315722|NCT01807234|76152070|FG005|Overall Study|Lack of Efficacy|1|||
42315723|NCT01790932|76152080|FG000|Overall Study|Disease Progression|41|||
42315724|NCT01790932|76152080|FG000|Overall Study|Adverse Event|7|||
42315725|NCT01790932|76152080|FG000|Overall Study|Physician Decision|1|||
42315726|NCT01790932|76152080|FG000|Overall Study|Withdrawal by Subject|1|||
42315727|NCT02377427|76152086|FG000|Part A (Up to Week 20)|Physician Decision|1|||
42315728|NCT02377427|76152087|FG001|Part A (Up to Week 20)|Physician Decision|0|||
42315729|NCT02377427|76152088|FG002|Part A (Up to Week 20)|Physician Decision|0|||
42315730|NCT02377427|76152089|FG003|Part A (Up to Week 20)|Physician Decision|0|||
42315731|NCT02377427|76152090|FG004|Part A (Up to Week 20)|Physician Decision|0|||
42315732|NCT02377427|76152086|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
42315733|NCT02377427|76152087|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
42315734|NCT02377427|76152088|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
42315735|NCT02377427|76152089|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
42315736|NCT02377427|76152090|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
42315737|NCT02377427|76152086|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
42315738|NCT02377427|76152087|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
42315739|NCT02377427|76152088|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
42315740|NCT02377427|76152089|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
42315741|NCT02377427|76152090|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
42315742|NCT02377427|76152086|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
42315743|NCT02377427|76152087|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
42315744|NCT02377427|76152088|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
42315745|NCT02377427|76152089|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
42315746|NCT02377427|76152090|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
42315747|NCT02421887|76152105|FG000|Overall Study|Lost to Follow-up|5|||
42315748|NCT02421887|76152106|FG001|Overall Study|Lost to Follow-up|0|||
42315749|NCT02421887|76152105|FG000|Overall Study|Withdrawal by Subject|8|||
42315750|NCT02421887|76152106|FG001|Overall Study|Withdrawal by Subject|5|||
42315751|NCT02421887|76152105|FG000|Overall Study|Physician Decision|2|||
42315752|NCT02421887|76152106|FG001|Overall Study|Physician Decision|4|||
42315753|NCT02421887|76152105|FG000|Overall Study|Adverse Event|2|||
42315754|NCT02421887|76152106|FG001|Overall Study|Adverse Event|0|||
42315755|NCT01609582|76152114|FG000|Overall Study|Adverse Event|20|||
42315756|NCT01609582|76152115|FG001|Overall Study|Adverse Event|18|||
42315757|NCT01609582|76152114|FG000|Overall Study|Lost to Follow-up|10|||
42315758|NCT01609582|76152115|FG001|Overall Study|Lost to Follow-up|10|||
42315759|NCT01609582|76152114|FG000|Overall Study|Withdrawal by Subject|21|||
42315760|NCT01609582|76152115|FG001|Overall Study|Withdrawal by Subject|15|||
42315761|NCT01609582|76152114|FG000|Overall Study|Study Terminated by Sponsor|1543|||
42315762|NCT01609582|76152115|FG001|Overall Study|Study Terminated by Sponsor|1548|||
42315763|NCT01609582|76152114|FG000|Overall Study|Other|9|||
42315764|NCT01609582|76152115|FG001|Overall Study|Other|10|||
42315765|NCT01609582|76152114|FG000|Overall Study|Randomized, but not treated|0|||
42315766|NCT01609582|76152115|FG001|Overall Study|Randomized, but not treated|3|||
42315767|NCT01789606|76152123|FG000|Overall Study|Participant not Purchased the Product|0|||
42315768|NCT01789606|76152124|FG001|Overall Study|Participant not Purchased the Product|20|||
42315769|NCT01789606|76152123|FG000|Overall Study|Withdrawal by Subject|0|||
42315770|NCT01789606|76152124|FG001|Overall Study|Withdrawal by Subject|1|||
42315771|NCT01789606|76152123|FG000|Overall Study|Ineligible|6|||
42315772|NCT01789606|76152124|FG001|Overall Study|Ineligible|2|||
42315773|NCT01789606|76152123|FG000|Overall Study|Administrative Reasons|17|||
42315774|NCT01789606|76152124|FG001|Overall Study|Administrative Reasons|6|||
42315775|NCT01789606|76152123|FG000|Overall Study|No Study Medication Taken|0|||
42315776|NCT01789606|76152124|FG001|Overall Study|No Study Medication Taken|1|||
42315777|NCT01789606|76152123|FG000|Overall Study|Protocol Violation|0|||
42315778|NCT01789606|76152124|FG001|Overall Study|Protocol Violation|55|||
42315779|NCT01789606|76152123|FG000|Overall Study|Adverse Event|0|||
42315780|NCT01789606|76152124|FG001|Overall Study|Adverse Event|3|||
42315781|NCT01789606|76152123|FG000|Overall Study|Lost to Follow-up|0|||
42315782|NCT01789606|76152124|FG001|Overall Study|Lost to Follow-up|14|||
42315783|NCT01789606|76152123|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
42315784|NCT01789606|76152124|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
42315785|NCT01788358|76152129|FG000|Overall Study|Other|11|||
42315786|NCT01788358|76152129|FG000|Overall Study|Logistical difficulties|1|||
42315787|NCT01788358|76152129|FG000|Overall Study|Lost to Follow-up|5|||
42315788|NCT01788358|76152129|FG000|Overall Study|Protocol Violation|3|||
42315789|NCT01788358|76152129|FG000|Overall Study|Withdrawal by Subject|26|||
42315790|NCT01788358|76152129|FG000|Overall Study|Lack of Efficacy|1|||
42315791|NCT01788358|76152129|FG000|Overall Study|Adverse Event|51|||
42315792|NCT01773226|76152133|FG000|Overall Study|Withdrawal by Subject|1|||
42315793|NCT01773070|76152137|FG000|Overall Study|Withdrawal by Subject|24|||
42315794|NCT01773070|76152137|FG000|Overall Study|Lost to Follow-up|39|||
42315795|NCT01773070|76152137|FG000|Overall Study|Other|15|||
42133229|NCT00498602|75944119|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
42315796|NCT01773070|76152137|FG000|Overall Study|Death (unrelated to study procedures)|3|||
42315797|NCT01772368|76152141|FG000|Overall Study|Adverse Event|1|||
42315798|NCT01772368|76152141|FG000|Overall Study|Withdrawal by Subject|3|||
42315799|NCT01772368|76152141|FG000|Overall Study|Protocol Violation|2|||
42315800|NCT01772368|76152141|FG000|Overall Study|Other|1|||
42315801|NCT01788046|76152159|FG000|Overall Study|Withdrawal by Subject|12|||
42315802|NCT01788046|76152160|FG001|Overall Study|Withdrawal by Subject|12|||
42315803|NCT01788046|76152159|FG000|Overall Study|Lost to Follow-up|12|||
41993437|NCT01137682|75801714|FG002|Overall Study|Adverse Event-Extension|7|||
41993438|NCT01137682|75801712|FG000|Overall Study|Lack of Efficacy-Extension|15|||
41993439|NCT01137682|75801713|FG001|Overall Study|Lack of Efficacy-Extension|9|||
41993440|NCT01137682|75801714|FG002|Overall Study|Lack of Efficacy-Extension|13|||
42256180|NCT02519842|76082489|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
42256181|NCT02519842|76082490|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
42256182|NCT02519842|76082491|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
42256183|NCT02519842|76082489|FG000|Optional Extension: Cycles 2-6|Death|0|||
42256184|NCT02519842|76082490|FG001|Optional Extension: Cycles 2-6|Death|0|||
42256185|NCT02519842|76082491|FG002|Optional Extension: Cycles 2-6|Death|1|||
42256186|NCT02519842|76082489|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
42256187|NCT02519842|76082490|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
42256188|NCT02519842|76082491|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
42256189|NCT02519842|76082489|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
42256190|NCT02519842|76082490|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
42256191|NCT02519842|76082491|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
42256192|NCT02519842|76082489|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
42256193|NCT02519842|76082490|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
42256194|NCT02519842|76082491|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
42256195|NCT02519842|76082489|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
42256196|NCT02519842|76082490|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
42256197|NCT02519842|76082491|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
42256198|NCT02509078|76082501|FG000|Overall Study|Protocol Violation|1|||
42256199|NCT02509078|76082502|FG001|Overall Study|Protocol Violation|1|||
42256200|NCT02993783|76082512|FG000|Overall Study|Reason not Specified|6|||
42256201|NCT02993783|76082513|FG001|Overall Study|Reason not Specified|9|||
42256202|NCT02993471|76082519|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
42256203|NCT02993471|76082519|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
42256204|NCT02988713|76082541|FG000|Overall Study|Withdrawal by Subject|1|||
42256205|NCT02988713|76082541|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
42256206|NCT01068743|76082545|FG000|Period 3|Adverse Event|0|||
42256207|NCT01068743|76082546|FG001|Period 3|Adverse Event|1|||
42256208|NCT01068743|76082547|FG002|Period 3|Adverse Event|0|||
42256209|NCT01068743|76082548|FG003|Period 3|Adverse Event|0|||
42256210|NCT02992691|76082561|FG000|Overall Study|Adverse Event|2|||
42256211|NCT02992691|76082561|FG000|Overall Study|Withdrawal by Subject|1|||
42256212|NCT02921087|76082578|FG000|Overall Study|Withdrawal by Subject|0|||
42256213|NCT02921087|76082579|FG001|Overall Study|Withdrawal by Subject|1|||
42256214|NCT02907619|76082598|FG000|Overall Study|Study terminated by sponsor|18|||
42256215|NCT02907619|76082599|FG001|Overall Study|Study terminated by sponsor|18|||
42256216|NCT02907619|76082600|FG002|Overall Study|Study terminated by sponsor|19|||
42256217|NCT02907619|76082598|FG000|Overall Study|Death|0|||
42256218|NCT02907619|76082599|FG001|Overall Study|Death|0|||
42256219|NCT02907619|76082600|FG002|Overall Study|Death|1|||
42256220|NCT02907619|76082598|FG000|Overall Study|Withdrawal by Subject|1|||
42256221|NCT02907619|76082599|FG001|Overall Study|Withdrawal by Subject|1|||
42256222|NCT02907619|76082600|FG002|Overall Study|Withdrawal by Subject|0|||
42256223|NCT02907619|76082598|FG000|Overall Study|Other|0|||
41993441|NCT01137682|75801712|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
42256224|NCT02907619|76082599|FG001|Overall Study|Other|1|||
42256225|NCT02907619|76082600|FG002|Overall Study|Other|0|||
42256226|NCT02986373|76082610|FG000|Overall Study|Adverse Event|4|||
42256227|NCT02986373|76082610|FG000|Overall Study|Lost to Follow-up|1|||
42256228|NCT02986373|76082610|FG000|Overall Study|Withdrawal by Subject|10|||
42315804|NCT01788046|76152160|FG001|Overall Study|Lost to Follow-up|19|||
42315805|NCT01788046|76152159|FG000|Overall Study|Death|7|||
42315806|NCT01788046|76152160|FG001|Overall Study|Death|5|||
42315807|NCT01788046|76152159|FG000|Overall Study|Protocol Specified Criteria|25|||
42315808|NCT01788046|76152160|FG001|Overall Study|Protocol Specified Criteria|1|||
42315809|NCT01806298|76152166|FG000|Overall Study|Adverse Event|3|||
41993442|NCT01137682|75801713|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
41993443|NCT01137682|75801714|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
41993444|NCT01137682|75801712|FG000|Overall Study|Lost to Follow Up-Extension|0|||
41993445|NCT01137682|75801713|FG001|Overall Study|Lost to Follow Up-Extension|1|||
41993446|NCT01137682|75801714|FG002|Overall Study|Lost to Follow Up-Extension|0|||
41993447|NCT01137682|75801712|FG000|Overall Study|Administrative problems-Extension|0|||
41993448|NCT01137682|75801713|FG001|Overall Study|Administrative problems-Extension|2|||
41993449|NCT01137682|75801714|FG002|Overall Study|Administrative problems-Extension|0|||
41993450|NCT01137682|75801712|FG000|Overall Study|Death-Extension|2|||
41993451|NCT01137682|75801713|FG001|Overall Study|Death-Extension|0|||
41993452|NCT01137682|75801714|FG002|Overall Study|Death-Extension|0|||
41993453|NCT01137682|75801712|FG000|Overall Study|Protocol Violation-Extension|2|||
41993454|NCT01137682|75801713|FG001|Overall Study|Protocol Violation-Extension|1|||
41993455|NCT01137682|75801714|FG002|Overall Study|Protocol Violation-Extension|0|||
41993456|NCT01137682|75801712|FG000|Overall Study|Did not enter extension|2|||
41993457|NCT01137682|75801713|FG001|Overall Study|Did not enter extension|3|||
41993458|NCT01137682|75801714|FG002|Overall Study|Did not enter extension|2|||
41993459|NCT01137682|75801712|FG000|Overall Study|Did not receive treatment in extension|0|||
41993460|NCT01137682|75801713|FG001|Overall Study|Did not receive treatment in extension|0|||
41993461|NCT01137682|75801714|FG002|Overall Study|Did not receive treatment in extension|1|||
42256229|NCT02986373|76082610|FG000|Overall Study|Other|24|||
42256230|NCT02986139|76082616|FG000|Overall Study|Sponsor Decision|1|||
42256231|NCT02986139|76082617|FG001|Overall Study|Sponsor Decision|2|||
42256232|NCT02986139|76082616|FG000|Overall Study|Withdrawal by Subject|0|||
42256233|NCT02986139|76082617|FG001|Overall Study|Withdrawal by Subject|1|||
42256234|NCT02986139|76082616|FG000|Overall Study|Lost to Follow-up|0|||
42256235|NCT02986139|76082617|FG001|Overall Study|Lost to Follow-up|1|||
42256236|NCT02989805|76082629|FG000|Overall Study|invalid consent|6|||
42256237|NCT02989805|76082630|FG001|Overall Study|invalid consent|4|||
42256238|NCT02907463|76082636|FG000|Overall Study|Lost to Follow-up|17|||
42256239|NCT02907463|76082636|FG000|Overall Study|Death|10|||
42256240|NCT02907463|76082636|FG000|Overall Study|Withdrawal by Subject|4|||
42256241|NCT02907463|76082636|FG000|Overall Study|MIS Approach was not used|2|||
42256242|NCT02907463|76082636|FG000|Overall Study|Not Implanted with Study Device|2|||
42256243|NCT02907463|76082636|FG000|Overall Study|Device Explanted|1|||
42256244|NCT02907463|76082636|FG000|Overall Study|Missing Exit Form|1|||
42256245|NCT02906917|76082650|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
42256246|NCT02906917|76082651|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
42256247|NCT02906917|76082650|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
42256248|NCT02906917|76082651|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
42256249|NCT02906917|76082650|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
42256250|NCT02906917|76082651|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
42256251|NCT02906917|76082650|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
41993462|NCT03452397|75801730|FG000|Overall Study|Adverse Event|1|||
41993463|NCT03452397|75801731|FG001|Overall Study|Adverse Event|0|||
42033842|NCT01079988|75841993|FG002|Overall Study|Other|0|||
42033843|NCT01079988|75841994|FG003|Overall Study|Other|2|||
42256252|NCT02906917|76082651|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
42256253|NCT02906917|76082650|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
42256254|NCT02906917|76082651|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
42256255|NCT02906917|76082650|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
42315810|NCT01806298|76152166|FG000|Overall Study|Protocol Non-compliance|1|||
42315811|NCT01806298|76152166|FG000|Overall Study|Withdrawal by Subject|1|||
41993464|NCT03452397|75801732|FG002|Overall Study|Adverse Event|0|||
42033844|NCT01079988|75841995|FG004|Overall Study|Other|1|||
42033845|NCT01074216|75842007|FG000|Overall Study|Physician Decision|1|||
42315812|NCT01806298|76152166|FG000|Overall Study|Other|5|||
42315813|NCT01772134|76152173|FG000|Overall Study|Adverse Event|6|||
42315814|NCT01772134|76152174|FG001|Overall Study|Adverse Event|5|||
42315815|NCT01772134|76152175|FG002|Overall Study|Adverse Event|10|||
42315816|NCT01772134|76152173|FG000|Overall Study|Withdrew Consent|3|||
42315817|NCT01772134|76152174|FG001|Overall Study|Withdrew Consent|1|||
42315818|NCT01772134|76152175|FG002|Overall Study|Withdrew Consent|5|||
42315819|NCT01772134|76152173|FG000|Overall Study|Lost to Follow-up|2|||
42315820|NCT01772134|76152174|FG001|Overall Study|Lost to Follow-up|0|||
42315821|NCT01772134|76152175|FG002|Overall Study|Lost to Follow-up|0|||
42315822|NCT01772134|76152173|FG000|Overall Study|Protocol Deviation|4|||
42315823|NCT01772134|76152174|FG001|Overall Study|Protocol Deviation|3|||
42315824|NCT01772134|76152175|FG002|Overall Study|Protocol Deviation|3|||
42315825|NCT01772134|76152173|FG000|Overall Study|Lack of Efficacy|11|||
42315826|NCT01772134|76152174|FG001|Overall Study|Lack of Efficacy|5|||
42315827|NCT01772134|76152175|FG002|Overall Study|Lack of Efficacy|3|||
42315828|NCT01772134|76152173|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
42315829|NCT01772134|76152174|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
42315830|NCT01772134|76152175|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
42315831|NCT01772134|76152173|FG000|Overall Study|Randomized Study Medication Not Received|2|||
42315832|NCT01772134|76152174|FG001|Overall Study|Randomized Study Medication Not Received|0|||
42315833|NCT01772134|76152175|FG002|Overall Study|Randomized Study Medication Not Received|1|||
42315834|NCT01994889|76152186|FG000|Overall Study|Adverse Event|5|||
42315835|NCT01994889|76152187|FG001|Overall Study|Adverse Event|12|||
42315836|NCT01994889|76152188|FG002|Overall Study|Adverse Event|11|||
42315837|NCT01994889|76152186|FG000|Overall Study|Cardiac Device Implantation|0|||
42315838|NCT01994889|76152187|FG001|Overall Study|Cardiac Device Implantation|2|||
42315839|NCT01994889|76152188|FG002|Overall Study|Cardiac Device Implantation|0|||
42315840|NCT01994889|76152186|FG000|Overall Study|Organ Transplantation|1|||
42315841|NCT01994889|76152187|FG001|Overall Study|Organ Transplantation|5|||
42315842|NCT01994889|76152188|FG002|Overall Study|Organ Transplantation|5|||
42315843|NCT01994889|76152186|FG000|Overall Study|No longer willing to participate|8|||
42315844|NCT01994889|76152187|FG001|Overall Study|No longer willing to participate|17|||
42315845|NCT01994889|76152188|FG002|Overall Study|No longer willing to participate|37|||
42315846|NCT01994889|76152186|FG000|Overall Study|Lost to Follow-up|0|||
42315847|NCT01994889|76152187|FG001|Overall Study|Lost to Follow-up|1|||
42315848|NCT01994889|76152188|FG002|Overall Study|Lost to Follow-up|0|||
42315849|NCT01994889|76152186|FG000|Overall Study|Protocol Violation|0|||
42315850|NCT01994889|76152187|FG001|Overall Study|Protocol Violation|1|||
42256256|NCT02906917|76082651|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
42256257|NCT02906917|76082650|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
42315851|NCT01994889|76152188|FG002|Overall Study|Protocol Violation|1|||
42315852|NCT01994889|76152186|FG000|Overall Study|Death|14|||
42315853|NCT01994889|76152187|FG001|Overall Study|Death|25|||
42315854|NCT01994889|76152188|FG002|Overall Study|Death|38|||
42315855|NCT02082483|76152197|FG000|Overall Study|Lost to Follow-up|1|||
42256258|NCT02906917|76082651|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
42256259|NCT02906917|76082650|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
42256260|NCT02906917|76082651|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
42256261|NCT02982187|76082659|FG000|Overall Study|Withdrawal by Subject|0|||
42256262|NCT02982187|76082660|FG001|Overall Study|Withdrawal by Subject|0|||
42256263|NCT02982187|76082661|FG002|Overall Study|Withdrawal by Subject|0|||
42256264|NCT02982187|76082662|FG003|Overall Study|Withdrawal by Subject|0|||
42256265|NCT02982187|76082663|FG004|Overall Study|Withdrawal by Subject|0|||
42256266|NCT02982187|76082664|FG005|Overall Study|Withdrawal by Subject|0|||
42256267|NCT02982187|76082665|FG006|Overall Study|Withdrawal by Subject|1|||
42256268|NCT02982187|76082666|FG007|Overall Study|Withdrawal by Subject|0|||
42256269|NCT02981953|76082676|FG000|Overall Study|Death|9|||
42256270|NCT02981953|76082676|FG000|Overall Study|Withdrawal by Subject|1|||
42315856|NCT02082483|76152198|FG001|Overall Study|Lost to Follow-up|1|||
42315857|NCT02082483|76152197|FG000|Overall Study|Withdrawal by Subject|2|||
42315858|NCT02082483|76152198|FG001|Overall Study|Withdrawal by Subject|1|||
42315859|NCT02082483|76152197|FG000|Overall Study|Physician Decision|1|||
42256271|NCT02981953|76082676|FG000|Overall Study|Withdrawal to non-compliance|1|||
42256272|NCT01066585|76082692|FG000|Overall Study|Protocol Violation|1|||
42256273|NCT01066585|76082693|FG001|Overall Study|Protocol Violation|0|||
42256274|NCT01066585|76082692|FG000|Overall Study|Withdrawal by Subject|0|||
42315860|NCT02082483|76152198|FG001|Overall Study|Physician Decision|1|||
42315861|NCT02082483|76152197|FG000|Overall Study|Death|2|||
42315862|NCT02082483|76152198|FG001|Overall Study|Death|3|||
42315863|NCT02017899|76152211|FG000|Overall Study|Withdrawal by Subject|0|||
42315864|NCT02017899|76152212|FG001|Overall Study|Withdrawal by Subject|0|||
42315865|NCT02017899|76152213|FG002|Overall Study|Withdrawal by Subject|0|||
42315866|NCT02017899|76152214|FG003|Overall Study|Withdrawal by Subject|1|||
42315867|NCT02017899|76152215|FG004|Overall Study|Withdrawal by Subject|1|||
42315868|NCT02017899|76152216|FG005|Overall Study|Withdrawal by Subject|0|||
42315869|NCT01993329|76152236|FG000|Period 2|Adverse Event|0|||
41993465|NCT03452397|75801733|FG003|Overall Study|Adverse Event|0|||
41993466|NCT03452397|75801730|FG000|Overall Study|Administrative reason|0|||
41993467|NCT03452397|75801731|FG001|Overall Study|Administrative reason|0|||
41993468|NCT03452397|75801732|FG002|Overall Study|Administrative reason|1|||
41993469|NCT03452397|75801733|FG003|Overall Study|Administrative reason|1|||
41993470|NCT03452397|75801730|FG000|Overall Study|Withdrawal by Subject|0|||
41993471|NCT03452397|75801731|FG001|Overall Study|Withdrawal by Subject|0|||
41993472|NCT03452397|75801732|FG002|Overall Study|Withdrawal by Subject|1|||
42256275|NCT01066585|76082693|FG001|Overall Study|Withdrawal by Subject|3|||
42256276|NCT02980783|76082699|FG000|Overall Study|Lost to Follow-up|1|||
42256277|NCT02980705|76082705|FG000|Overall Study|Adverse Event|0|||
42256278|NCT02980705|76082706|FG001|Overall Study|Adverse Event|1|||
42256279|NCT02980705|76082705|FG000|Overall Study|Withdrawal by Subject|6|||
42256280|NCT02980705|76082706|FG001|Overall Study|Withdrawal by Subject|9|||
42256281|NCT02980705|76082705|FG000|Overall Study|withdrew participation|0|||
42256282|NCT02980705|76082706|FG001|Overall Study|withdrew participation|1|||
42256283|NCT02980705|76082705|FG000|Overall Study|Lost to Follow-up|2|||
42256284|NCT02980705|76082706|FG001|Overall Study|Lost to Follow-up|0|||
42256285|NCT02989649|76082713|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
42256286|NCT02989649|76082713|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
42256287|NCT02989649|76082713|FG000|Overall Study|Lost For Observation During Study|3|||
42256288|NCT02989649|76082713|FG000|Overall Study|Reason Not Specified|13|||
42256289|NCT02905435|76082717|FG000|Overall Study|Death|2|||
42256290|NCT02905435|76082717|FG000|Overall Study|Physician Decision|1|||
42256291|NCT02905435|76082717|FG000|Overall Study|Lost to Follow-up|4|||
42256292|NCT02978833|76082724|FG000|Overall Study|Study terminated|1|||
42256293|NCT02978833|76082725|FG001|Overall Study|Study terminated|1|||
42256294|NCT01067339|76082734|FG000|Overall Study|Withdrawal by Subject|6|||
42256295|NCT01067339|76082735|FG001|Overall Study|Withdrawal by Subject|5|||
42256296|NCT02573259|76082748|FG000|Overall Study|Death|1|||
42256297|NCT02573259|76082749|FG001|Overall Study|Death|6|||
42256298|NCT02573259|76082750|FG002|Overall Study|Death|5|||
42256299|NCT02573259|76082751|FG003|Overall Study|Death|6|||
42256300|NCT02573259|76082752|FG004|Overall Study|Death|9|||
42256301|NCT02573259|76082753|FG005|Overall Study|Death|32|||
42256302|NCT02573259|76082754|FG006|Overall Study|Death|21|||
42256303|NCT02573259|76082748|FG000|Overall Study|Lost to Follow-up|0|||
42256304|NCT02573259|76082749|FG001|Overall Study|Lost to Follow-up|0|||
42256305|NCT02573259|76082750|FG002|Overall Study|Lost to Follow-up|0|||
42256306|NCT02573259|76082751|FG003|Overall Study|Lost to Follow-up|0|||
42256307|NCT02573259|76082752|FG004|Overall Study|Lost to Follow-up|0|||
42256308|NCT02573259|76082753|FG005|Overall Study|Lost to Follow-up|2|||
42256309|NCT02573259|76082754|FG006|Overall Study|Lost to Follow-up|1|||
42256310|NCT02573259|76082748|FG000|Overall Study|Participant refused further follow-up|0|||
42256311|NCT02573259|76082749|FG001|Overall Study|Participant refused further follow-up|2|||
42256312|NCT02573259|76082750|FG002|Overall Study|Participant refused further follow-up|1|||
42256313|NCT02573259|76082751|FG003|Overall Study|Participant refused further follow-up|0|||
42256314|NCT02573259|76082752|FG004|Overall Study|Participant refused further follow-up|3|||
42256315|NCT02573259|76082753|FG005|Overall Study|Participant refused further follow-up|20|||
42256316|NCT02573259|76082754|FG006|Overall Study|Participant refused further follow-up|7|||
42256317|NCT02573259|76082748|FG000|Overall Study|Other|0|||
42256318|NCT02573259|76082749|FG001|Overall Study|Other|0|||
42256319|NCT02573259|76082750|FG002|Overall Study|Other|0|||
42256320|NCT02573259|76082751|FG003|Overall Study|Other|0|||
42256321|NCT02573259|76082752|FG004|Overall Study|Other|1|||
42256322|NCT02573259|76082753|FG005|Overall Study|Other|4|||
42256323|NCT02573259|76082754|FG006|Overall Study|Other|5|||
42256324|NCT02977507|76082791|FG000|Overall Study|Protocol Deviation|1|||
42256325|NCT02977507|76082792|FG001|Overall Study|Protocol Deviation|0|||
42256326|NCT02977507|76082791|FG000|Overall Study|Lost to Follow-up|1|||
42256327|NCT02977507|76082792|FG001|Overall Study|Lost to Follow-up|0|||
42256328|NCT02976103|76082801|FG000|Overall Study|Withdrawal by Subject|1|||
42256329|NCT02976103|76082802|FG001|Overall Study|Withdrawal by Subject|0|||
42256330|NCT02976103|76082801|FG000|Overall Study|Lost to Follow-up|12|||
42256331|NCT02976103|76082802|FG001|Overall Study|Lost to Follow-up|8|||
42256332|NCT01066039|76082809|FG000|Overall Study|Adverse Event|6|||
42256333|NCT01066039|76082809|FG000|Overall Study|Withdrawal by Subject|17|||
42256334|NCT01066039|76082809|FG000|Overall Study|Protocol Violation|2|||
42256335|NCT01066039|76082809|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
42256336|NCT01066039|76082809|FG000|Overall Study|Investigator's Request|1|||
42256337|NCT01066039|76082809|FG000|Overall Study|Dropout due to Insulin Administration|1|||
42256338|NCT01066039|76082809|FG000|Overall Study|Additional Antihypertensive Required|4|||
42256339|NCT01066039|76082809|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
41993473|NCT03452397|75801733|FG003|Overall Study|Withdrawal by Subject|0|||
41993474|NCT00199875|75801767|FG000|Overall Study|Withdrawal by Subject|0|||
42256340|NCT01066039|76082809|FG000|Overall Study|Failure to Control Blood Pressure|1|||
41993475|NCT00199875|75801768|FG001|Overall Study|Withdrawal by Subject|0|||
41993476|NCT00199875|75801769|FG002|Overall Study|Withdrawal by Subject|0|||
41993477|NCT00199875|75801770|FG003|Overall Study|Withdrawal by Subject|0|||
41993478|NCT00199875|75801771|FG004|Overall Study|Withdrawal by Subject|1|||
41993479|NCT00199836|75801783|FG000|Overall Study|Progressive Disease|5|||
41993480|NCT00199836|75801783|FG000|Overall Study|Death|1|||
41993481|NCT00199797|75801788|FG000|Overall Study|Progressive Disease|1|||
41993482|NCT00199797|75801788|FG000|Overall Study|Adverse Event|1|||
41993483|NCT00199797|75801788|FG000|Overall Study|Physician Decision|1|||
42315870|NCT01993329|76152237|FG001|Period 2|Adverse Event|0|||
42315871|NCT01993329|76152238|FG002|Period 2|Adverse Event|0|||
42315872|NCT01993329|76152239|FG003|Period 2|Adverse Event|0|||
42315873|NCT01993329|76152240|FG004|Period 2|Adverse Event|0|||
42315874|NCT01993329|76152241|FG005|Period 2|Adverse Event|1|||
42315875|NCT01993329|76152236|FG000|Wash-out|Personal reasons|0|||
42315876|NCT01993329|76152237|FG001|Wash-out|Personal reasons|1|||
42315877|NCT01993329|76152238|FG002|Wash-out|Personal reasons|0|||
42315878|NCT01993329|76152239|FG003|Wash-out|Personal reasons|0|||
42315879|NCT01993329|76152240|FG004|Wash-out|Personal reasons|0|||
42315880|NCT01993329|76152241|FG005|Wash-out|Personal reasons|0|||
42315881|NCT02016183|76152253|FG000|Overall Study|Case Report Forms Uncollected|13|||
42315882|NCT02016183|76152253|FG000|Overall Study|Protocol Violation|52|||
42315883|NCT02377349|76152259|FG000|Overall Study|Serious Adverse Event|1|||
42315884|NCT02377349|76152260|FG001|Overall Study|Serious Adverse Event|0|||
42315885|NCT02377349|76152259|FG000|Overall Study|Protocol Violation|3|||
42315886|NCT02377349|76152260|FG001|Overall Study|Protocol Violation|2|||
42315887|NCT02377349|76152259|FG000|Overall Study|Withdrawal by Subject|5|||
42315888|NCT02377349|76152260|FG001|Overall Study|Withdrawal by Subject|3|||
42315889|NCT02377349|76152259|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
42315890|NCT02377349|76152260|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
42315891|NCT02377349|76152259|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
42315892|NCT02377349|76152260|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
42315893|NCT02377349|76152259|FG000|Overall Study|Other|0|||
42315894|NCT02377349|76152260|FG001|Overall Study|Other|1|||
42315895|NCT02421419|76152278|FG000|Overall Study|Physician Decision|0|||
42315896|NCT02421419|76152279|FG001|Overall Study|Physician Decision|0|||
42315897|NCT02421419|76152280|FG002|Overall Study|Physician Decision|1|||
41993484|NCT01137604|75801797|FG000|Overall Study|Adverse Event|3|||
41993485|NCT01137604|75801798|FG001|Overall Study|Adverse Event|6|||
42315898|NCT02016105|76152290|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
42315899|NCT02016105|76152291|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
42315900|NCT02016105|76152292|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
42315901|NCT02016105|76152293|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
42315902|NCT02016105|76152294|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
42315903|NCT02016105|76152295|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
42315904|NCT02016105|76152290|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
42315905|NCT02016105|76152291|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
42315906|NCT02016105|76152292|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
42315907|NCT02016105|76152293|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
42315908|NCT02016105|76152294|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
42315909|NCT02016105|76152295|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
42315910|NCT02016105|76152290|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
42315911|NCT02016105|76152291|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
42315912|NCT02016105|76152292|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
42315913|NCT02016105|76152293|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
42315914|NCT02016105|76152294|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
41993486|NCT01137604|75801799|FG002|Overall Study|Adverse Event|9|||
41993487|NCT01137604|75801800|FG003|Overall Study|Adverse Event|9|||
41993488|NCT01137604|75801797|FG000|Overall Study|Participant Choice|0|||
42315915|NCT02016105|76152295|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
42315916|NCT02016105|76152290|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
42315917|NCT02016105|76152291|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
42315918|NCT02016105|76152292|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
42315919|NCT02016105|76152293|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
41993489|NCT01137604|75801798|FG001|Overall Study|Participant Choice|2|||
41993490|NCT01137604|75801799|FG002|Overall Study|Participant Choice|2|||
41993491|NCT01137604|75801800|FG003|Overall Study|Participant Choice|0|||
41993492|NCT01137604|75801797|FG000|Overall Study|Withdrawal of consent|0|||
42315920|NCT02016105|76152294|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
42315921|NCT02016105|76152295|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
42315922|NCT02016105|76152290|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
42315923|NCT02016105|76152291|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
42315924|NCT02016105|76152292|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
42315925|NCT02016105|76152293|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
42315926|NCT02016105|76152294|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
42315927|NCT02016105|76152295|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
42315928|NCT02016105|76152290|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
42315929|NCT02016105|76152291|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
42315930|NCT02016105|76152292|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
42315931|NCT02016105|76152293|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
42315932|NCT02016105|76152294|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
42315933|NCT02016105|76152295|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
42315934|NCT02016105|76152290|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
42315935|NCT02016105|76152291|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
42315936|NCT02016105|76152292|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
42315937|NCT02016105|76152293|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
42315938|NCT02016105|76152294|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
42315939|NCT02016105|76152295|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
42315940|NCT02016105|76152290|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
42315941|NCT02016105|76152291|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
42315942|NCT02016105|76152292|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
42315943|NCT02016105|76152293|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
42315944|NCT02016105|76152294|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
42315945|NCT02016105|76152295|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
42315946|NCT02016105|76152290|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
42315947|NCT02016105|76152291|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
42315948|NCT02016105|76152292|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
42315949|NCT02016105|76152293|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
42315950|NCT02016105|76152294|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
42315951|NCT02016105|76152295|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
42315952|NCT02016105|76152290|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
42315953|NCT02016105|76152291|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
41993493|NCT01137604|75801798|FG001|Overall Study|Withdrawal of consent|0|||
41993494|NCT01137604|75801799|FG002|Overall Study|Withdrawal of consent|0|||
42256341|NCT01066039|76082809|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
42256342|NCT02919995|76082819|FG000|Overall Study|Adverse Event|0|||
42256343|NCT02919995|76082820|FG001|Overall Study|Adverse Event|0|||
42256344|NCT02919995|76082821|FG002|Overall Study|Adverse Event|0|||
42256345|NCT02919995|76082822|FG003|Overall Study|Adverse Event|0|||
42315954|NCT02016105|76152292|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
41993495|NCT01137604|75801800|FG003|Overall Study|Withdrawal of consent|2|||
41993496|NCT01137604|75801797|FG000|Overall Study|Clinical progression/deterioration|1|||
41993497|NCT01137604|75801798|FG001|Overall Study|Clinical progression/deterioration|2|||
42256346|NCT02919995|76082823|FG004|Overall Study|Adverse Event|0|||
42315955|NCT02016105|76152293|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
42315956|NCT02016105|76152294|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
42256347|NCT02919995|76082824|FG005|Overall Study|Adverse Event|1|||
42256348|NCT02919761|76082832|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
42256349|NCT02919761|76082833|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
42256350|NCT02919761|76082834|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
42315957|NCT02016105|76152295|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
42315958|NCT02016105|76152290|FG000|TREATMENT PERIOD 2|Death|0|||
42315959|NCT02016105|76152291|FG001|TREATMENT PERIOD 2|Death|0|||
42315960|NCT02016105|76152292|FG002|TREATMENT PERIOD 2|Death|0|||
42315961|NCT02016105|76152293|FG003|TREATMENT PERIOD 2|Death|0|||
42315962|NCT02016105|76152294|FG004|TREATMENT PERIOD 2|Death|0|||
42315963|NCT02016105|76152295|FG005|TREATMENT PERIOD 2|Death|1|||
42315964|NCT02016105|76152290|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
42315965|NCT02016105|76152291|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
42315966|NCT02016105|76152292|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
42315967|NCT02016105|76152293|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
42315968|NCT02016105|76152294|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
42315969|NCT02016105|76152295|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
42315970|NCT02016105|76152290|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
42315971|NCT02016105|76152291|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
42315972|NCT02016105|76152292|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
42315973|NCT02016105|76152293|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
42315974|NCT02016105|76152294|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
42315975|NCT02016105|76152295|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
42315976|NCT02016105|76152290|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
42315977|NCT02016105|76152291|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
42315978|NCT02016105|76152292|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
42315979|NCT02016105|76152293|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
42315980|NCT02016105|76152294|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
42315981|NCT02016105|76152295|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
42315982|NCT02016105|76152290|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
42315983|NCT02016105|76152291|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
42315984|NCT02016105|76152292|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
42315985|NCT02016105|76152293|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
42315986|NCT02016105|76152294|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
42315987|NCT02016105|76152295|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
42315988|NCT02016105|76152290|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
42315989|NCT02016105|76152291|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
42315990|NCT02016105|76152292|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
42315991|NCT02016105|76152293|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
42133230|NCT00498602|75944120|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
42256351|NCT02919761|76082832|FG000|Part 1: Open Label|Adverse Event|1|||
42256352|NCT02919761|76082833|FG001|Part 1: Open Label|Adverse Event|0|||
42256353|NCT02919761|76082834|FG002|Part 1: Open Label|Adverse Event|0|||
42256354|NCT02919761|76082832|FG000|Part 1: Open Label|Lost to Follow-up|1|||
42256355|NCT02919761|76082833|FG001|Part 1: Open Label|Lost to Follow-up|0|||
42256356|NCT02919761|76082834|FG002|Part 1: Open Label|Lost to Follow-up|0|||
42256357|NCT02919761|76082832|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
42256358|NCT02919761|76082833|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
42256359|NCT02919761|76082834|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
42256360|NCT02919761|76082832|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
42256361|NCT02919761|76082833|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
42256362|NCT02919761|76082834|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
42256363|NCT02919761|76082832|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
42256364|NCT02919761|76082833|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
42315992|NCT02016105|76152294|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
42315993|NCT02016105|76152295|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
42315994|NCT02016105|76152290|FG000|EXTENSION PERIOD|Adverse Event|0|||
42315995|NCT02016105|76152291|FG001|EXTENSION PERIOD|Adverse Event|0|||
42315996|NCT02016105|76152292|FG002|EXTENSION PERIOD|Adverse Event|2|||
42315997|NCT02016105|76152293|FG003|EXTENSION PERIOD|Adverse Event|0|||
42315998|NCT02016105|76152294|FG004|EXTENSION PERIOD|Adverse Event|1|||
42315999|NCT02016105|76152295|FG005|EXTENSION PERIOD|Adverse Event|0|||
42316000|NCT02016105|76152290|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
42316001|NCT02016105|76152291|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
42256365|NCT02919761|76082834|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
42316002|NCT02016105|76152292|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
42316003|NCT02016105|76152293|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
42316004|NCT02016105|76152294|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
42316005|NCT02016105|76152295|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
42316006|NCT02016105|76152290|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
42316007|NCT02016105|76152291|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
42316008|NCT02016105|76152292|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
42316009|NCT02016105|76152293|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
42316010|NCT02016105|76152294|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
42316011|NCT02016105|76152295|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
42316012|NCT02016105|76152290|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
42316013|NCT02016105|76152291|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
42316014|NCT02016105|76152292|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
42316015|NCT02016105|76152293|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
42316016|NCT02016105|76152294|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
42316017|NCT02016105|76152295|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
42316018|NCT02400905|76152309|FG000|Overall Study|Death|24|||
42316019|NCT02400905|76152309|FG000|Overall Study|Lost to Follow-up|18|||
42316020|NCT02400905|76152309|FG000|Overall Study|Withdrawal by Subject|16|||
42316021|NCT02400905|76152309|FG000|Overall Study|Physician Decision|4|||
42316022|NCT02400905|76152309|FG000|Overall Study|Other|1|||
42256366|NCT02919761|76082832|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
42256367|NCT02919761|76082833|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
42256368|NCT02919761|76082834|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
42256369|NCT02919761|76082832|FG000|Part 1: Open Label|Termination by Sponsor|1|||
42256370|NCT02919761|76082833|FG001|Part 1: Open Label|Termination by Sponsor|0|||
42256371|NCT02919761|76082834|FG002|Part 1: Open Label|Termination by Sponsor|0|||
42256372|NCT02919761|76082832|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
42256373|NCT02919761|76082833|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
42256374|NCT02919761|76082834|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
42256375|NCT02919761|76082832|FG000|Part 2: Double-blind|Adverse Event|0|||
42256376|NCT02919761|76082833|FG001|Part 2: Double-blind|Adverse Event|1|||
42256377|NCT02919761|76082834|FG002|Part 2: Double-blind|Adverse Event|0|||
42256378|NCT02919761|76082832|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
42256379|NCT02919761|76082833|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
42256380|NCT02919761|76082834|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
42256381|NCT02919761|76082832|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
42316023|NCT02400749|76152316|FG000|Week 0 -16|Withdrawal by Subject|5|||
42256382|NCT02919761|76082833|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
42256383|NCT02919761|76082834|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
42316024|NCT02400749|76152317|FG001|Week 0 -16|Withdrawal by Subject|5|||
42316025|NCT02400749|76152316|FG000|Week 0 -16|Adverse Event|3|||
42316026|NCT02400749|76152317|FG001|Week 0 -16|Adverse Event|1|||
42316027|NCT02400749|76152316|FG000|Week 0 -16|Lost to Follow-up|2|||
42316028|NCT02400749|76152317|FG001|Week 0 -16|Lost to Follow-up|0|||
42316029|NCT02400749|76152316|FG000|Week 0 -16|Protocol Violation|1|||
42316030|NCT02400749|76152317|FG001|Week 0 -16|Protocol Violation|0|||
42316031|NCT02400749|76152316|FG000|Week 17 - 32|Withdrawal by Subject|3|||
42316032|NCT02400749|76152317|FG001|Week 17 - 32|Withdrawal by Subject|2|||
42316033|NCT02400749|76152316|FG000|Week 17 - 32|Adverse Event|2|||
42316034|NCT02400749|76152317|FG001|Week 17 - 32|Adverse Event|1|||
42316035|NCT02420327|76152323|FG000|Overall Study|Adverse Event|7|||
42316036|NCT02420327|76152323|FG000|Overall Study|Pregnancy|1|||
42316037|NCT02420327|76152323|FG000|Overall Study|Withdrawal by Subject|6|||
42316038|NCT02420327|76152323|FG000|Overall Study|Lost to Follow-up|1|||
42316039|NCT02420327|76152323|FG000|Overall Study|Protocol Violation|1|||
42316040|NCT02374853|76152335|FG000|Overall Study|Surgery Cancelled|5|||
42316041|NCT02374853|76152336|FG001|Overall Study|Surgery Cancelled|11|||
42316042|NCT02015793|76152344|FG000|Overall Study|Adverse Event|3|||
42316043|NCT02015793|76152345|FG001|Overall Study|Adverse Event|3|||
42316044|NCT02015793|76152344|FG000|Overall Study|Withdrawal by Subject|1|||
42316045|NCT02015793|76152345|FG001|Overall Study|Withdrawal by Subject|1|||
42316046|NCT02347631|76152359|FG000|First Intervention (2 Months)|Adverse Event|1|||
42316047|NCT02347631|76152360|FG001|First Intervention (2 Months)|Adverse Event|1|||
42316048|NCT02347631|76152359|FG000|First Intervention (2 Months)|Pregnancy|1|||
42316049|NCT02347631|76152360|FG001|First Intervention (2 Months)|Pregnancy|0|||
42316050|NCT02347631|76152359|FG000|First Intervention (2 Months)|Moved out of area|0|||
42316051|NCT02347631|76152360|FG001|First Intervention (2 Months)|Moved out of area|2|||
42316052|NCT02347631|76152359|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
42316053|NCT02347631|76152360|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
42316054|NCT02347631|76152359|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
42316055|NCT02347631|76152360|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
42316056|NCT02347631|76152359|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
42316057|NCT02347631|76152360|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
42316058|NCT02347631|76152359|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
42316059|NCT02347631|76152360|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
42316060|NCT02347631|76152359|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
42316061|NCT02347631|76152360|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
42316062|NCT02015637|76152370|FG000|Overall Study|Lost to Follow-up|3|||
42316063|NCT02015637|76152371|FG001|Overall Study|Lost to Follow-up|5|||
42316064|NCT02015637|76152370|FG000|Overall Study|Adverse Event|3|||
42316065|NCT02015637|76152371|FG001|Overall Study|Adverse Event|0|||
42316066|NCT02015637|76152370|FG000|Overall Study|Did not take study drug|2|||
42316067|NCT02015637|76152371|FG001|Overall Study|Did not take study drug|0|||
42316068|NCT02347085|76152377|FG000|Overall Study|Adverse Event|2|||
42316069|NCT02347085|76152377|FG000|Overall Study|Lack of Efficacy|1|||
42316070|NCT02347085|76152377|FG000|Overall Study|Withdrawal by Subject|4|||
42316071|NCT02347085|76152377|FG000|Overall Study|Lost to Follow-up|1|||
42316072|NCT02347085|76152377|FG000|Overall Study|Protocol Criteria|2|||
42316073|NCT02374463|76152385|FG000|Overall Study|Withdrawal by Subject|3|||
42316074|NCT02374463|76152386|FG001|Overall Study|Withdrawal by Subject|3|||
42316075|NCT02015481|76152393|FG000|Overall Study|Death|1|||
41993498|NCT01137604|75801799|FG002|Overall Study|Clinical progression/deterioration|2|||
42256384|NCT02919761|76082832|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
42256385|NCT02919761|76082833|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
42256386|NCT02919761|76082834|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
42256387|NCT02919761|76082832|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
42256388|NCT02919761|76082833|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
42256389|NCT02919761|76082834|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
42256390|NCT02919761|76082832|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
42256391|NCT02919761|76082833|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
42256392|NCT02919761|76082834|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
42256393|NCT02919761|76082832|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
42256394|NCT02919761|76082833|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
42256395|NCT02919761|76082834|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
42256396|NCT02910167|76082845|FG000|Overall Study|Adverse Event|1|||
42256397|NCT02910167|76082845|FG000|Overall Study|Lost to Follow-up|18|||
42256398|NCT01067105|76082849|FG000|Overall Study|Adverse Event|14|||
42256399|NCT01067105|76082849|FG000|Overall Study|Protocol Violation|48|||
42316076|NCT02374307|76152400|FG000|3-months Follow-up|Lost to Follow-up|1|||
42316077|NCT02374307|76152401|FG001|3-months Follow-up|Lost to Follow-up|2|||
42316078|NCT02374307|76152400|FG000|3-months Follow-up|Withdrawal by Subject|1|||
42256400|NCT01067105|76082849|FG000|Overall Study|Withdrawal by Subject|36|||
42256401|NCT01067105|76082849|FG000|Overall Study|Lost to Follow-up|6|||
42256402|NCT01067105|76082849|FG000|Overall Study|Physician Decision|6|||
42316079|NCT02374307|76152401|FG001|3-months Follow-up|Withdrawal by Subject|4|||
42316080|NCT02374307|76152400|FG000|3-months Follow-up|Death|1|||
42316081|NCT02374307|76152401|FG001|3-months Follow-up|Death|2|||
42316082|NCT02374307|76152400|FG000|3-months Follow-up|Missed first follow-up|5|||
42316083|NCT02374307|76152401|FG001|3-months Follow-up|Missed first follow-up|1|||
41993499|NCT01137604|75801800|FG003|Overall Study|Clinical progression/deterioration|0|||
41993500|NCT00198822|75801813|FG000|Overall Study|Lost to Follow-up|14|||
41993501|NCT00198822|75801814|FG001|Overall Study|Lost to Follow-up|20|||
41993502|NCT00198822|75801815|FG002|Overall Study|Lost to Follow-up|21|||
41993503|NCT01137292|75801823|FG000|Overall Study|Death|30|||
41993504|NCT01137292|75801823|FG000|Overall Study|Adverse Event|3|||
41993505|NCT01137292|75801823|FG000|Overall Study|Lack of Efficacy|13|||
41993506|NCT01137292|75801823|FG000|Overall Study|Lost to Follow-up|1|||
42033846|NCT01074216|75842007|FG000|Overall Study|Not Treated|12|||
42033847|NCT01079832|75842011|FG000|Overall Study|Withdrawal by Subject|1|||
42256403|NCT01067105|76082849|FG000|Overall Study|Other|31|||
42256404|NCT02910089|76082859|FG000|Overall Study|Lost insurance eligibility|22|||
42256405|NCT02910089|76082860|FG001|Overall Study|Lost insurance eligibility|16|||
42256406|NCT02985515|76082868|FG000|Olfaction Testing|Lost to Follow-up|0|||
42256407|NCT02985515|76082869|FG001|Olfaction Testing|Lost to Follow-up|5|||
42256408|NCT02985515|76082868|FG000|Olfaction Testing|Protocol Violation|0|||
42256409|NCT02985515|76082869|FG001|Olfaction Testing|Protocol Violation|3|||
42256410|NCT02910011|76082882|FG000|Overall Study|Physician Decision|2|||
42256411|NCT02908841|76082890|FG000|Overall Study|Physician Decision|4|||
42256412|NCT02908841|76082891|FG001|Overall Study|Physician Decision|0|||
42256413|NCT02909153|76082902|FG000|Overall Study|Withdrawal by Subject|0|||
42256414|NCT02909153|76082903|FG001|Overall Study|Withdrawal by Subject|1|||
42256415|NCT02909153|76082904|FG002|Overall Study|Withdrawal by Subject|0|||
42256416|NCT02909153|76082905|FG003|Overall Study|Withdrawal by Subject|0|||
42256417|NCT02909153|76082906|FG004|Overall Study|Withdrawal by Subject|0|||
42256418|NCT02908529|76082918|FG000|Overall Study|Lost to Follow-up|0|||
42256419|NCT02908529|76082919|FG001|Overall Study|Lost to Follow-up|2|||
42256420|NCT02984267|76082929|FG000|Overall Study|Protocol Violation|1|||
42256421|NCT02984267|76082930|FG001|Overall Study|Protocol Violation|0|||
42256422|NCT02984267|76082929|FG000|Overall Study|Withdrawal by Subject|0|||
42256423|NCT02984267|76082930|FG001|Overall Study|Withdrawal by Subject|1|||
42256424|NCT02675751|76082936|FG000|Overall Study|Lost to Follow-up|16|||
42256425|NCT02974855|76082953|FG000|Overall Study|Adverse Event|0|||
42256426|NCT02974855|76082954|FG001|Overall Study|Adverse Event|1|||
42256427|NCT02974855|76082955|FG002|Overall Study|Adverse Event|0|||
42256428|NCT02974855|76082956|FG003|Overall Study|Adverse Event|1|||
42256429|NCT00455403|76082981|FG000|Overall Study|Lost to Follow-up|2|||
42256430|NCT00455403|76082982|FG001|Overall Study|Lost to Follow-up|1|||
42256431|NCT00455403|76082981|FG000|Overall Study|Withdrawal by Subject|1|||
42256432|NCT00455403|76082982|FG001|Overall Study|Withdrawal by Subject|3|||
42256433|NCT00455403|76082981|FG000|Overall Study|Protocol Violation|0|||
42256434|NCT00455403|76082982|FG001|Overall Study|Protocol Violation|2|||
42256435|NCT02979613|76082990|FG000|Double-Blind Phase|Withdrew Consent|2|||
42256436|NCT02979613|76082991|FG001|Double-Blind Phase|Withdrew Consent|4|||
42256437|NCT02979613|76082990|FG000|Double-Blind Phase|Pregnancy|2|||
42256438|NCT02979613|76082991|FG001|Double-Blind Phase|Pregnancy|2|||
42256439|NCT02979613|76082990|FG000|Double-Blind Phase|Adverse Event|2|||
42256440|NCT02979613|76082991|FG001|Double-Blind Phase|Adverse Event|0|||
42256441|NCT02979613|76082990|FG000|Double-Blind Phase|Lost to Follow-up|1|||
42256442|NCT02979613|76082991|FG001|Double-Blind Phase|Lost to Follow-up|1|||
42256443|NCT02979613|76082990|FG000|Double-Blind Phase|Protocol Violation|1|||
42256444|NCT02979613|76082991|FG001|Double-Blind Phase|Protocol Violation|1|||
42256445|NCT02979613|76082990|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
42256446|NCT02979613|76082991|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
42256447|NCT02979613|76082990|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
42256448|NCT02979613|76082991|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
42256449|NCT02979613|76082990|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
42256450|NCT02979613|76082991|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
42256451|NCT02979613|76082990|FG000|Open-Label Extension (OLE) Phase|Death|0|||
42256452|NCT02979613|76082991|FG001|Open-Label Extension (OLE) Phase|Death|1|||
42256453|NCT02979613|76082990|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
42256454|NCT02979613|76082991|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
42256455|NCT01064167|76083001|FG000|Overall Study|Protocol Violation|14|||
42256456|NCT01064167|76083002|FG001|Overall Study|Protocol Violation|15|||
42256457|NCT02974543|76083010|FG000|Overall Study|Withdrawal by Subject|1|||
42256458|NCT02974543|76083011|FG001|Overall Study|Withdrawal by Subject|0|||
42256459|NCT01064947|76083025|FG000|Overall Study|negative culture|41|||
42256460|NCT02974153|76083036|FG000|Overall Study|Adverse Event|6|||
42256461|NCT02974153|76083037|FG001|Overall Study|Adverse Event|0|||
42256462|NCT02974153|76083038|FG002|Overall Study|Adverse Event|1|||
42256463|NCT02974153|76083036|FG000|Overall Study|Lack of Efficacy|6|||
42256464|NCT02974153|76083037|FG001|Overall Study|Lack of Efficacy|5|||
42256465|NCT02974153|76083038|FG002|Overall Study|Lack of Efficacy|10|||
41993507|NCT01137292|75801823|FG000|Overall Study|Other|7|||
41993508|NCT00197496|75801829|FG000|Baseline to Discharge|not interested|1|||
41993509|NCT00197496|75801830|FG001|Baseline to Discharge|not interested|0|||
42033848|NCT01072344|75842017|FG000|Overall Study|Relasped-reached end point|7|||
42316084|NCT02374307|76152400|FG000|6-months Follow-up|Lost to Follow-up|1|||
42316085|NCT02374307|76152401|FG001|6-months Follow-up|Lost to Follow-up|2|||
42316086|NCT02374307|76152400|FG000|6-months Follow-up|Death|2|||
42316087|NCT02374307|76152401|FG001|6-months Follow-up|Death|1|||
42316088|NCT02374307|76152400|FG000|6-months Follow-up|Withdrawal by Subject|0|||
42316089|NCT02374307|76152401|FG001|6-months Follow-up|Withdrawal by Subject|3|||
42316090|NCT02397473|76152409|FG000|Treatment Phase|Adverse Event|1|||
42316091|NCT02397473|76152410|FG001|Treatment Phase|Adverse Event|2|||
42316092|NCT02397473|76152409|FG000|Treatment Phase|Lack of Efficacy|8|||
42316093|NCT02397473|76152410|FG001|Treatment Phase|Lack of Efficacy|1|||
42316094|NCT02397473|76152409|FG000|Treatment Phase|Lost to Follow-up|1|||
42316095|NCT02397473|76152410|FG001|Treatment Phase|Lost to Follow-up|0|||
42316096|NCT02397473|76152409|FG000|Treatment Phase|Withdrawal by Subject|2|||
42316097|NCT02397473|76152410|FG001|Treatment Phase|Withdrawal by Subject|1|||
42316098|NCT02397473|76152409|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
42316099|NCT02397473|76152410|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
42316100|NCT02397473|76152409|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
42316101|NCT02397473|76152410|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
42316102|NCT02397473|76152409|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
42316103|NCT02397473|76152410|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
42316104|NCT02397473|76152409|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
42316105|NCT02397473|76152410|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
42316106|NCT02397473|76152409|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
42316107|NCT02397473|76152410|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
42316108|NCT02344745|76152421|FG000|Overall Study|Data collection sheets were lost|2|||
42316109|NCT02344745|76152422|FG001|Overall Study|Data collection sheets were lost|0|||
42316110|NCT02370641|76152430|FG000|Overall Study|dropped study|4|||
42316111|NCT02370641|76152431|FG001|Overall Study|dropped study|2|||
42316112|NCT01621191|76152437|FG000|Overall Study|Adverse Event|9|||
42316113|NCT01621191|76152437|FG000|Overall Study|Withdrawal by Subject|8|||
42316114|NCT01621191|76152437|FG000|Overall Study|Lack of Efficacy|6|||
42316115|NCT01621191|76152437|FG000|Overall Study|Lost to Follow-up|1|||
42316116|NCT01621191|76152437|FG000|Overall Study|Site Removed From Study|1|||
42316117|NCT02343263|76152445|FG000|Overall Study|Physician Decision|5|||
42316118|NCT02343263|76152446|FG001|Overall Study|Physician Decision|3|||
42316119|NCT02343263|76152447|FG002|Overall Study|Physician Decision|1|||
42316120|NCT02081859|76152461|FG000|Overall Study|No fertilization|2|||
42316121|NCT02081859|76152462|FG001|Overall Study|No fertilization|2|||
42316122|NCT02081859|76152461|FG000|Overall Study|No sperm|1|||
42316123|NCT02081859|76152462|FG001|Overall Study|No sperm|0|||
42316124|NCT02081859|76152461|FG000|Overall Study|Unanticipated freeze all cycle|2|||
42316125|NCT02081859|76152462|FG001|Overall Study|Unanticipated freeze all cycle|6|||
42316126|NCT02081859|76152461|FG000|Overall Study|< 4 embryos|27|||
42316127|NCT02081859|76152462|FG001|Overall Study|< 4 embryos|23|||
42316128|NCT02081859|76152461|FG000|Overall Study|Other reasons|2|||
42316129|NCT02081859|76152462|FG001|Overall Study|Other reasons|0|||
42316130|NCT02342639|76152470|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
42316131|NCT02342639|76152471|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
42316132|NCT02342639|76152470|FG000|Overall Study|Protocol Violation|0|||
42316133|NCT02342639|76152471|FG001|Overall Study|Protocol Violation|2|||
42316134|NCT01625091|76152481|FG000|Intervention|Death|1|||
42316135|NCT01625091|76152482|FG001|Intervention|Death|1|||
42316136|NCT01625091|76152481|FG000|Intervention|Withdrawal by Subject|4|||
42316137|NCT01625091|76152482|FG001|Intervention|Withdrawal by Subject|1|||
42316138|NCT01625091|76152481|FG000|Intervention|Adverse Event|0|||
42316139|NCT01625091|76152482|FG001|Intervention|Adverse Event|2|||
42316140|NCT01625091|76152481|FG000|Intervention|Lost to Follow-up|4|||
42316141|NCT01625091|76152482|FG001|Intervention|Lost to Follow-up|4|||
42316142|NCT01625091|76152481|FG000|Intervention|Study termination|2|||
42316143|NCT01625091|76152482|FG001|Intervention|Study termination|3|||
42316144|NCT01625091|76152481|FG000|Post-intervention|Death|0|||
42316145|NCT01625091|76152482|FG001|Post-intervention|Death|1|||
42316146|NCT01625091|76152481|FG000|Post-intervention|Lost to Follow-up|2|||
42316147|NCT01625091|76152482|FG001|Post-intervention|Lost to Follow-up|0|||
42316148|NCT01625091|76152481|FG000|Post-intervention|Study termination|2|||
42316149|NCT01625091|76152482|FG001|Post-intervention|Study termination|1|||
42316150|NCT02396849|76152490|FG000|Overall Study|Lost to Follow-up|1|||
42316151|NCT02396849|76152491|FG001|Overall Study|Lost to Follow-up|1|||
42316152|NCT02396849|76152490|FG000|Overall Study|Did not tolerate intervention|1|||
42316153|NCT02396849|76152491|FG001|Overall Study|Did not tolerate intervention|1|||
42316154|NCT02370251|76152499|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
42316155|NCT02370251|76152499|FG000|Overall Study|Death|4|||
42316156|NCT02396537|76152505|FG000|Overall Study|Protocol Violation|0|||
41993510|NCT00197496|75801829|FG000|Baseline to Discharge|MRSA|1|||
41993511|NCT00197496|75801830|FG001|Baseline to Discharge|MRSA|0|||
41993512|NCT00197496|75801829|FG000|Baseline to Discharge|Physician Decision|0|||
41993513|NCT00197496|75801830|FG001|Baseline to Discharge|Physician Decision|1|||
41993514|NCT00197496|75801829|FG000|Baseline to Discharge|Protocol Violation|0|||
41993515|NCT00197496|75801830|FG001|Baseline to Discharge|Protocol Violation|1|||
41993516|NCT00197496|75801829|FG000|Follow-up|Lost to Follow-up|2|||
41993517|NCT00197496|75801830|FG001|Follow-up|Lost to Follow-up|1|||
41993518|NCT00197145|75801838|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
41993519|NCT00197145|75801839|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
41993520|NCT00197145|75801838|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
41993521|NCT00197145|75801839|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
41993522|NCT00197145|75801838|FG000|Period 1: Randomized Treatment Phase|Other|2|||
42133231|NCT00498602|75944121|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
42256466|NCT02974153|76083036|FG000|Overall Study|Lost to Follow-up|9|||
42256467|NCT02974153|76083037|FG001|Overall Study|Lost to Follow-up|10|||
42256468|NCT02974153|76083038|FG002|Overall Study|Lost to Follow-up|17|||
42256469|NCT02974153|76083036|FG000|Overall Study|Physician Decision|0|||
42256470|NCT02974153|76083037|FG001|Overall Study|Physician Decision|2|||
42256471|NCT02974153|76083038|FG002|Overall Study|Physician Decision|1|||
42256472|NCT02974153|76083036|FG000|Overall Study|Withdrawal by Subject|9|||
42256473|NCT02974153|76083037|FG001|Overall Study|Withdrawal by Subject|16|||
42256474|NCT02974153|76083038|FG002|Overall Study|Withdrawal by Subject|11|||
42256475|NCT02974153|76083036|FG000|Overall Study|Study Burden|8|||
42256476|NCT02974153|76083037|FG001|Overall Study|Study Burden|7|||
42256477|NCT02974153|76083038|FG002|Overall Study|Study Burden|3|||
42256478|NCT02974153|76083036|FG000|Overall Study|Other|14|||
42256479|NCT02974153|76083037|FG001|Overall Study|Other|8|||
42256480|NCT02974153|76083038|FG002|Overall Study|Other|7|||
42256481|NCT02508532|76083053|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
42256482|NCT02508532|76083054|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
42256483|NCT02508532|76083055|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
42256484|NCT02508532|76083056|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
42256485|NCT02508532|76083057|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
42256486|NCT02508532|76083058|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
42256487|NCT02508532|76083059|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
42256488|NCT02508532|76083060|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
42256489|NCT02508532|76083061|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
42256490|NCT02508532|76083053|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
42256491|NCT02508532|76083054|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
42256492|NCT02508532|76083055|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
42256493|NCT02508532|76083056|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
42256494|NCT02508532|76083057|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
42256495|NCT02508532|76083058|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
42256496|NCT02508532|76083059|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
42256497|NCT02508532|76083060|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
42256498|NCT02508532|76083061|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
42256499|NCT02508532|76083053|FG000|Part 2 - Treatment|Disease Progression|0|||
42256500|NCT02508532|76083054|FG001|Part 2 - Treatment|Disease Progression|0|||
42256501|NCT02508532|76083055|FG002|Part 2 - Treatment|Disease Progression|0|||
42256502|NCT02508532|76083056|FG003|Part 2 - Treatment|Disease Progression|0|||
42256503|NCT02508532|76083057|FG004|Part 2 - Treatment|Disease Progression|0|||
42256504|NCT02508532|76083058|FG005|Part 2 - Treatment|Disease Progression|0|||
41993523|NCT00197145|75801839|FG001|Period 1: Randomized Treatment Phase|Other|2|||
42316157|NCT02396537|76152506|FG001|Overall Study|Protocol Violation|1|||
42316158|NCT02342171|76152514|FG000|Overall Study|Death|4|||
41993524|NCT00197145|75801838|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
41993525|NCT00197145|75801839|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
41993526|NCT00197145|75801838|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
41993527|NCT00197145|75801839|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
41993528|NCT00197145|75801838|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
41993529|NCT00197145|75801839|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
41993530|NCT00197145|75801838|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
41993531|NCT00197145|75801839|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
41993532|NCT00197145|75801838|FG000|Period 2 : Open Label Phase|Other|1|||
41993533|NCT00197145|75801839|FG001|Period 2 : Open Label Phase|Other|0|||
41993534|NCT01136785|75801848|FG000|Overall Study|Protocol Violation|2|||
41993535|NCT01136785|75801849|FG001|Overall Study|Protocol Violation|1|||
41993536|NCT00197106|75801861|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
41993537|NCT00197106|75801862|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
41993538|NCT00197106|75801863|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
42316159|NCT02342171|76152515|FG001|Overall Study|Death|87|||
42316160|NCT02342171|76152514|FG000|Overall Study|Received favipiravir|10|||
42316161|NCT02342171|76152515|FG001|Overall Study|Received favipiravir|0|||
42316162|NCT02342171|76152514|FG000|Overall Study|Missing cycle treshold value|1|||
42316163|NCT02342171|76152515|FG001|Overall Study|Missing cycle treshold value|0|||
42316164|NCT02342171|76152514|FG000|Overall Study|Unknown outcome|0|||
42316165|NCT02342171|76152515|FG001|Overall Study|Unknown outcome|1|||
42316166|NCT02342171|76152514|FG000|Overall Study|Missing age data|0|||
42316167|NCT02342171|76152515|FG001|Overall Study|Missing age data|1|||
42316168|NCT01624467|76152520|FG000|Overall Study|Withdrawal by Subject|2|||
42316169|NCT01624467|76152520|FG000|Overall Study|Lost to Follow-up|1|||
42316170|NCT01624467|76152520|FG000|Overall Study|Adverse Event|7|||
42316171|NCT01624467|76152520|FG000|Overall Study|Progressive Disease|19|||
42316172|NCT01624467|76152520|FG000|Overall Study|Per Sponsor Requirement|1|||
42316173|NCT01624467|76152520|FG000|Overall Study|Subject Withdrew from Treatment|1|||
42316174|NCT01624233|76152526|FG000|Period 2 - Induction|Adverse Event|1|||
42316175|NCT01624233|76152526|FG000|Period 3 - Maintenance|Adverse Event|2|||
42316176|NCT01624233|76152526|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
42316177|NCT01624233|76152526|FG000|Period 3 - Maintenance|Physician Decision|2|||
42316178|NCT01624233|76152526|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
42316179|NCT01624233|76152526|FG000|Period 4 - Drug Free Period|Relapsed|61|||
42316180|NCT01624233|76152526|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
42316181|NCT01624233|76152526|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
42316182|NCT01624233|76152526|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
42316183|NCT01624233|76152526|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
42316184|NCT01624233|76152526|FG000|Period 6: Follow-up|Adverse Event|3|||
42316185|NCT01624233|76152526|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
42316186|NCT01624233|76152526|FG000|Period 6: Follow-up|Physician Decision|1|||
42316187|NCT01624233|76152526|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
42316188|NCT01993017|76152537|FG000|Overall Study|Death|23|||
42316189|NCT01993017|76152538|FG001|Overall Study|Death|26|||
42316190|NCT01993017|76152539|FG002|Overall Study|Death|18|||
42316191|NCT01993017|76152537|FG000|Overall Study|Could not be contacted|43|||
42316192|NCT01993017|76152538|FG001|Overall Study|Could not be contacted|42|||
42316193|NCT01993017|76152539|FG002|Overall Study|Could not be contacted|38|||
41993539|NCT00197106|75801861|FG000|Overall Treatment Period|Lack of Efficacy|0|||
41993540|NCT00197106|75801862|FG001|Overall Treatment Period|Lack of Efficacy|1|||
41993541|NCT00197106|75801863|FG002|Overall Treatment Period|Lack of Efficacy|0|||
42033849|NCT01072344|75842018|FG001|Overall Study|Relasped-reached end point|12|||
42256505|NCT02508532|76083059|FG006|Part 2 - Treatment|Disease Progression|0|||
42256506|NCT02508532|76083060|FG007|Part 2 - Treatment|Disease Progression|0|||
42256507|NCT02508532|76083061|FG008|Part 2 - Treatment|Disease Progression|118|||
42256508|NCT02508532|76083053|FG000|Part 2 - Treatment|Adverse Event|0|||
42256509|NCT02508532|76083054|FG001|Part 2 - Treatment|Adverse Event|0|||
42256510|NCT02508532|76083055|FG002|Part 2 - Treatment|Adverse Event|0|||
42256511|NCT02508532|76083056|FG003|Part 2 - Treatment|Adverse Event|0|||
42316194|NCT01993017|76152537|FG000|Overall Study|Dropped out|19|||
42316195|NCT01993017|76152538|FG001|Overall Study|Dropped out|6|||
42316196|NCT01993017|76152539|FG002|Overall Study|Dropped out|11|||
42316197|NCT01993017|76152537|FG000|Overall Study|Other reasons|17|||
42316198|NCT01993017|76152538|FG001|Overall Study|Other reasons|11|||
42316199|NCT01993017|76152539|FG002|Overall Study|Other reasons|7|||
42316200|NCT01993017|76152537|FG000|Overall Study|Ineligible after randomization|4|||
42033850|NCT01072344|75842017|FG000|Overall Study|Protocol Violation|1|||
42033851|NCT01072344|75842018|FG001|Overall Study|Protocol Violation|2|||
42256512|NCT02508532|76083057|FG004|Part 2 - Treatment|Adverse Event|0|||
42256513|NCT02508532|76083058|FG005|Part 2 - Treatment|Adverse Event|0|||
42256514|NCT02508532|76083059|FG006|Part 2 - Treatment|Adverse Event|0|||
42316201|NCT01993017|76152538|FG001|Overall Study|Ineligible after randomization|5|||
42316202|NCT01993017|76152539|FG002|Overall Study|Ineligible after randomization|5|||
42316203|NCT01992549|76152548|FG000|Overall Study|Lost to Follow-up|2|||
42316204|NCT01992549|76152548|FG000|Overall Study|Serious Adverse Event|1|||
42316205|NCT01992549|76152548|FG000|Overall Study|Product Switch to Extend Half Life|1|||
42316206|NCT01992159|76152562|FG000|Overall Study|Withdrawal by Subject|4|||
42316207|NCT01992159|76152563|FG001|Overall Study|Withdrawal by Subject|7|||
42316208|NCT01992159|76152564|FG002|Overall Study|Withdrawal by Subject|0|||
42316209|NCT01992159|76152565|FG003|Overall Study|Withdrawal by Subject|3|||
42316210|NCT01992159|76152562|FG000|Overall Study|Adverse Event|0|||
42316211|NCT01992159|76152563|FG001|Overall Study|Adverse Event|1|||
42316212|NCT01992159|76152564|FG002|Overall Study|Adverse Event|0|||
42316213|NCT01992159|76152565|FG003|Overall Study|Adverse Event|1|||
42316214|NCT01992159|76152562|FG000|Overall Study|Death|0|||
42316215|NCT01992159|76152563|FG001|Overall Study|Death|0|||
42316216|NCT01992159|76152564|FG002|Overall Study|Death|1|||
42316217|NCT01992159|76152565|FG003|Overall Study|Death|0|||
42316218|NCT01988493|76152580|FG000|Overall Study|Randomized but not treated|0|||
42316219|NCT01988493|76152581|FG001|Overall Study|Randomized but not treated|0|||
42316220|NCT01988493|76152582|FG002|Overall Study|Randomized but not treated|0|||
42316221|NCT01988493|76152583|FG003|Overall Study|Randomized but not treated|0|||
42316222|NCT01988493|76152584|FG004|Overall Study|Randomized but not treated|1|||
42316223|NCT02081079|76152600|FG000|Overall Study|Lack of Efficacy|3|||
42316224|NCT02081079|76152601|FG001|Overall Study|Lack of Efficacy|2|||
42316225|NCT02081079|76152600|FG000|Overall Study|Lost to Follow-up|1|||
42316226|NCT02081079|76152601|FG001|Overall Study|Lost to Follow-up|0|||
42316227|NCT02081001|76152613|FG000|Overall Study|Adverse Event|0|||
41993542|NCT00197106|75801861|FG000|Overall Treatment Period|Lost to Follow-up|0|||
41993543|NCT00197106|75801862|FG001|Overall Treatment Period|Lost to Follow-up|0|||
41993544|NCT00197106|75801863|FG002|Overall Treatment Period|Lost to Follow-up|2|||
41993545|NCT00197106|75801861|FG000|Overall Treatment Period|Protocol Violation|0|||
41993546|NCT00197106|75801862|FG001|Overall Treatment Period|Protocol Violation|0|||
42256515|NCT02508532|76083060|FG007|Part 2 - Treatment|Adverse Event|0|||
42256516|NCT02508532|76083061|FG008|Part 2 - Treatment|Adverse Event|49|||
42256517|NCT02508532|76083053|FG000|Part 2 - Treatment|Physician Decision|0|||
42256518|NCT02508532|76083054|FG001|Part 2 - Treatment|Physician Decision|0|||
42256519|NCT02508532|76083055|FG002|Part 2 - Treatment|Physician Decision|0|||
42256520|NCT02508532|76083056|FG003|Part 2 - Treatment|Physician Decision|0|||
42256521|NCT02508532|76083057|FG004|Part 2 - Treatment|Physician Decision|0|||
42256522|NCT02508532|76083058|FG005|Part 2 - Treatment|Physician Decision|0|||
42256523|NCT02508532|76083059|FG006|Part 2 - Treatment|Physician Decision|0|||
42256524|NCT02508532|76083060|FG007|Part 2 - Treatment|Physician Decision|0|||
42256525|NCT02508532|76083061|FG008|Part 2 - Treatment|Physician Decision|12|||
42256526|NCT02508532|76083053|FG000|Part 2 - Treatment|Administrative|0|||
42256527|NCT02508532|76083054|FG001|Part 2 - Treatment|Administrative|0|||
42256528|NCT02508532|76083055|FG002|Part 2 - Treatment|Administrative|0|||
42256529|NCT02508532|76083056|FG003|Part 2 - Treatment|Administrative|0|||
42256530|NCT02508532|76083057|FG004|Part 2 - Treatment|Administrative|0|||
42256531|NCT02508532|76083058|FG005|Part 2 - Treatment|Administrative|0|||
42256532|NCT02508532|76083059|FG006|Part 2 - Treatment|Administrative|0|||
42256533|NCT02508532|76083060|FG007|Part 2 - Treatment|Administrative|0|||
42256534|NCT02508532|76083061|FG008|Part 2 - Treatment|Administrative|3|||
42256535|NCT02508532|76083053|FG000|Part 2 - Treatment|Sponsor Decision|0|||
42256536|NCT02508532|76083054|FG001|Part 2 - Treatment|Sponsor Decision|0|||
42256537|NCT02508532|76083055|FG002|Part 2 - Treatment|Sponsor Decision|0|||
42256538|NCT02508532|76083056|FG003|Part 2 - Treatment|Sponsor Decision|0|||
42256539|NCT02508532|76083057|FG004|Part 2 - Treatment|Sponsor Decision|0|||
42256540|NCT02508532|76083058|FG005|Part 2 - Treatment|Sponsor Decision|0|||
42256541|NCT02508532|76083059|FG006|Part 2 - Treatment|Sponsor Decision|0|||
42256542|NCT02508532|76083060|FG007|Part 2 - Treatment|Sponsor Decision|0|||
42256543|NCT02508532|76083061|FG008|Part 2 - Treatment|Sponsor Decision|28|||
42256544|NCT02508532|76083053|FG000|Part 2 - Treatment|Death|0|||
42256545|NCT02508532|76083054|FG001|Part 2 - Treatment|Death|0|||
42256546|NCT02508532|76083055|FG002|Part 2 - Treatment|Death|0|||
42256547|NCT02508532|76083056|FG003|Part 2 - Treatment|Death|0|||
42256548|NCT02508532|76083057|FG004|Part 2 - Treatment|Death|0|||
42316228|NCT02081001|76152614|FG001|Overall Study|Adverse Event|0|||
42316229|NCT02081001|76152615|FG002|Overall Study|Adverse Event|0|||
42316230|NCT02081001|76152616|FG003|Overall Study|Adverse Event|0|||
42316231|NCT02081001|76152617|FG004|Overall Study|Adverse Event|1|||
42316232|NCT02081001|76152618|FG005|Overall Study|Adverse Event|0|||
42316233|NCT02081001|76152619|FG006|Overall Study|Adverse Event|0|||
42256549|NCT02508532|76083058|FG005|Part 2 - Treatment|Death|0|||
42256550|NCT02508532|76083059|FG006|Part 2 - Treatment|Death|0|||
42256551|NCT02508532|76083060|FG007|Part 2 - Treatment|Death|0|||
42316234|NCT02081001|76152620|FG007|Overall Study|Adverse Event|0|||
42316235|NCT02081001|76152621|FG008|Overall Study|Adverse Event|0|||
42316236|NCT02081001|76152622|FG009|Overall Study|Adverse Event|0|||
42316237|NCT02081001|76152623|FG010|Overall Study|Adverse Event|0|||
42316238|NCT02081001|76152624|FG011|Overall Study|Adverse Event|0|||
42316239|NCT02080221|76152635|FG000|Overall Study|Withdrawal by Subject|1|||
42316240|NCT02080221|76152635|FG000|Overall Study|Clinical Progression of Disease|1|||
42316241|NCT02079909|76152642|FG000|Overall Study|Adverse Event|23|||
42316242|NCT02079909|76152643|FG001|Overall Study|Adverse Event|23|||
42316243|NCT02079909|76152644|FG002|Overall Study|Adverse Event|7|||
42316244|NCT02079909|76152642|FG000|Overall Study|Withdrawal by Subject|9|||
42316245|NCT02079909|76152643|FG001|Overall Study|Withdrawal by Subject|17|||
42316246|NCT02079909|76152644|FG002|Overall Study|Withdrawal by Subject|4|||
42316247|NCT02079909|76152642|FG000|Overall Study|Lost to Follow-up|2|||
42316248|NCT02079909|76152643|FG001|Overall Study|Lost to Follow-up|3|||
42316249|NCT02079909|76152644|FG002|Overall Study|Lost to Follow-up|1|||
42316250|NCT02079909|76152642|FG000|Overall Study|Death|2|||
42316251|NCT02079909|76152643|FG001|Overall Study|Death|2|||
42316252|NCT02079909|76152644|FG002|Overall Study|Death|0|||
42316253|NCT02079909|76152642|FG000|Overall Study|Lack of Efficacy|0|||
42316254|NCT02079909|76152643|FG001|Overall Study|Lack of Efficacy|0|||
42316255|NCT02079909|76152644|FG002|Overall Study|Lack of Efficacy|1|||
42316256|NCT02079909|76152642|FG000|Overall Study|Protocol Violation|0|||
42316257|NCT02079909|76152643|FG001|Overall Study|Protocol Violation|1|||
42316258|NCT02079909|76152644|FG002|Overall Study|Protocol Violation|1|||
42316259|NCT02079909|76152642|FG000|Overall Study|Physician Decision|0|||
42316260|NCT02079909|76152643|FG001|Overall Study|Physician Decision|1|||
42316261|NCT02079909|76152644|FG002|Overall Study|Physician Decision|1|||
42316262|NCT02079909|76152642|FG000|Overall Study|Relocation etc.|2|||
42316263|NCT02079909|76152643|FG001|Overall Study|Relocation etc.|2|||
42316264|NCT02079909|76152644|FG002|Overall Study|Relocation etc.|3|||
42316265|NCT02014467|76152654|FG000|Overall Study|Adverse Event|4|||
42316266|NCT02014467|76152655|FG001|Overall Study|Adverse Event|0|||
42316267|NCT02014467|76152654|FG000|Overall Study|Protocol Violation|3|||
42316268|NCT02014467|76152655|FG001|Overall Study|Protocol Violation|0|||
42316269|NCT02014467|76152654|FG000|Overall Study|Physician Decision|2|||
42316270|NCT02014467|76152655|FG001|Overall Study|Physician Decision|3|||
42316271|NCT02014467|76152654|FG000|Overall Study|Withdrawal by Subject|16|||
42316272|NCT02014467|76152655|FG001|Overall Study|Withdrawal by Subject|4|||
42316273|NCT02013765|76152661|FG000|Overall Study|Trial was terminated by sponsor|1|||
42316274|NCT02013687|76152669|FG000|Overall Study|Lost to Follow-up|0|||
42316275|NCT02013687|76152670|FG001|Overall Study|Lost to Follow-up|0|||
42316276|NCT02013687|76152671|FG002|Overall Study|Lost to Follow-up|1|||
42316277|NCT02013687|76152672|FG003|Overall Study|Lost to Follow-up|0|||
42316278|NCT02013687|76152669|FG000|Overall Study|Protocol Violation|0|||
42316279|NCT02013687|76152670|FG001|Overall Study|Protocol Violation|0|||
42316280|NCT02013687|76152671|FG002|Overall Study|Protocol Violation|0|||
42316281|NCT02013687|76152672|FG003|Overall Study|Protocol Violation|1|||
42316282|NCT02013687|76152669|FG000|Overall Study|Withdrawal by Subject|0|||
42316283|NCT02013687|76152670|FG001|Overall Study|Withdrawal by Subject|0|||
42316284|NCT02013687|76152671|FG002|Overall Study|Withdrawal by Subject|0|||
42316285|NCT02013687|76152672|FG003|Overall Study|Withdrawal by Subject|1|||
42316286|NCT02013687|76152669|FG000|Overall Study|Missed visits due to patient travel|0|||
42316287|NCT02013687|76152670|FG001|Overall Study|Missed visits due to patient travel|0|||
42316288|NCT02013687|76152671|FG002|Overall Study|Missed visits due to patient travel|1|||
42316289|NCT02013687|76152672|FG003|Overall Study|Missed visits due to patient travel|0|||
42316290|NCT02013609|76152686|FG000|Overall Study|Withdrawal by Subject|9|||
42316291|NCT02013609|76152686|FG000|Overall Study|Lost to Follow-up|3|||
42316292|NCT02013609|76152686|FG000|Overall Study|Adverse Event|3|||
42316293|NCT02013609|76152686|FG000|Overall Study|Met Withdrawal Criteria|3|||
42316294|NCT01988337|76152690|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
42316295|NCT02013531|76152696|FG000|Overall Study|Lost to Follow-up|3|||
42316296|NCT02013531|76152696|FG000|Overall Study|Met Withdrawal Criteria|1|||
42316297|NCT02013531|76152696|FG000|Overall Study|Withdrawal by Subject|1|||
42316298|NCT01988103|76152703|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
42316299|NCT01988103|76152704|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
42316300|NCT01988103|76152705|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
42316301|NCT01988103|76152706|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
42316302|NCT01988103|76152707|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
42316303|NCT01988103|76152703|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
42316304|NCT01988103|76152704|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
42316305|NCT01988103|76152705|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
42316306|NCT01988103|76152706|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
42316307|NCT01988103|76152707|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
42316308|NCT01988103|76152703|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
42316309|NCT01988103|76152704|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
42316310|NCT01988103|76152705|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
41993547|NCT00197106|75801863|FG002|Overall Treatment Period|Protocol Violation|2|||
41993548|NCT00197106|75801861|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
41993549|NCT00197106|75801862|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
41993550|NCT00197106|75801863|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
42256552|NCT02508532|76083061|FG008|Part 2 - Treatment|Death|1|||
42256553|NCT02508532|76083053|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
42256554|NCT02508532|76083054|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
42256555|NCT02508532|76083055|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
42256556|NCT02508532|76083056|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
42256557|NCT02508532|76083057|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
42256558|NCT02508532|76083058|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
42256559|NCT02508532|76083059|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
42256560|NCT02508532|76083060|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
42256561|NCT02508532|76083061|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
42256562|NCT02508532|76083053|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
42256563|NCT02508532|76083054|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
42256564|NCT02508532|76083055|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
42256565|NCT02508532|76083056|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
42256566|NCT02508532|76083057|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
42256567|NCT02508532|76083058|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
42256568|NCT02508532|76083059|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
42256569|NCT02508532|76083060|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
42256570|NCT02508532|76083061|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
42256571|NCT02508532|76083053|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
42256572|NCT02508532|76083054|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
42256573|NCT02508532|76083055|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
42256574|NCT02508532|76083056|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
42256575|NCT02508532|76083057|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
42256576|NCT02508532|76083058|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
42256577|NCT02508532|76083059|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
42256578|NCT02508532|76083060|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
42256579|NCT02508532|76083061|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
42256580|NCT02508532|76083053|FG000|Part 1 and Part 2 End of Study|Death|0|||
42256581|NCT02508532|76083054|FG001|Part 1 and Part 2 End of Study|Death|4|||
42256582|NCT02508532|76083055|FG002|Part 1 and Part 2 End of Study|Death|2|||
42256583|NCT02508532|76083056|FG003|Part 1 and Part 2 End of Study|Death|4|||
42256584|NCT02508532|76083057|FG004|Part 1 and Part 2 End of Study|Death|3|||
42256585|NCT02508532|76083058|FG005|Part 1 and Part 2 End of Study|Death|0|||
42256586|NCT02508532|76083059|FG006|Part 1 and Part 2 End of Study|Death|0|||
42256587|NCT02508532|76083060|FG007|Part 1 and Part 2 End of Study|Death|1|||
42256588|NCT02508532|76083061|FG008|Part 1 and Part 2 End of Study|Death|111|||
42256589|NCT02508532|76083053|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
42256590|NCT02508532|76083054|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
42256591|NCT02508532|76083055|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
42256592|NCT02508532|76083056|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
42256593|NCT02508532|76083057|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
42256594|NCT02508532|76083058|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
42256595|NCT02508532|76083059|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
42256596|NCT02508532|76083060|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
42256597|NCT02508532|76083061|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
42256598|NCT02508532|76083053|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
42256599|NCT02508532|76083054|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
42256600|NCT02508532|76083055|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
42256601|NCT02508532|76083056|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
42256602|NCT02508532|76083057|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
42256603|NCT02508532|76083058|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
42256604|NCT02508532|76083059|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
42256605|NCT02508532|76083060|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
42256606|NCT02508532|76083061|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
42256607|NCT02508532|76083053|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
42256608|NCT02508532|76083054|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
42256609|NCT02508532|76083055|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
42256610|NCT02508532|76083056|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
42256611|NCT02508532|76083057|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
42256612|NCT02508532|76083058|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
42256613|NCT02508532|76083059|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
42256614|NCT02508532|76083060|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
41993551|NCT01136746|75801871|FG000|Overall Study|Lost to Follow-up|0|||
41993552|NCT01136746|75801872|FG001|Overall Study|Lost to Follow-up|2|||
42256615|NCT02508532|76083061|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
42256616|NCT02508532|76083053|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
42256617|NCT02508532|76083054|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
42256618|NCT02508532|76083055|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
42256619|NCT02508532|76083056|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
42256620|NCT02508532|76083057|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
42256621|NCT02508532|76083058|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
42256622|NCT02508532|76083059|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
42256623|NCT02508532|76083060|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
42256624|NCT02508532|76083061|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
42256625|NCT02508532|76083053|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
42256626|NCT02508532|76083054|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
42256627|NCT02508532|76083055|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
42256628|NCT02508532|76083056|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
42256629|NCT02508532|76083057|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
42256630|NCT02508532|76083058|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
42256631|NCT02508532|76083059|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
42256632|NCT02508532|76083060|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
42256633|NCT02508532|76083061|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
42256634|NCT02918071|76083090|FG000|Overall Study|Withdrawal by Subject|2|||
42256635|NCT02918071|76083090|FG000|Overall Study|Lost to Follow-up|1|||
42256636|NCT02507752|76083094|FG000|Overall Study|Adverse Event|1|||
42256637|NCT02507752|76083094|FG000|Overall Study|Protocol Violation|6|||
42256638|NCT02507752|76083094|FG000|Overall Study|Lost to Follow-up|7|||
42256639|NCT02507752|76083094|FG000|Overall Study|Infusion reaction at first infusion|1|||
42316311|NCT01988103|76152706|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
42316312|NCT01988103|76152707|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
42316313|NCT01988103|76152703|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
42316314|NCT01988103|76152704|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
42316315|NCT01988103|76152705|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
42033852|NCT01072344|75842017|FG000|Overall Study|Lost to Follow-up|3|||
42256640|NCT02507752|76083094|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
42033853|NCT01072344|75842018|FG001|Overall Study|Lost to Follow-up|4|||
42033854|NCT01071954|75842024|FG000|Overall Study|Noncompliance|4|||
42316316|NCT01988103|76152706|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
42316317|NCT01988103|76152707|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
42256641|NCT02507752|76083094|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
42256642|NCT02506816|76083098|FG000|Overall Study|Adverse Event|3|||
42256643|NCT02506036|76083104|FG000|First Intervention (4-6 Weeks)|Death|1|||
42256644|NCT02506036|76083105|FG001|First Intervention (4-6 Weeks)|Death|0|||
42316318|NCT01988103|76152703|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
42316319|NCT01988103|76152704|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
42316320|NCT01988103|76152705|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
42316321|NCT01988103|76152706|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
42316322|NCT01988103|76152707|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
42316323|NCT01988103|76152703|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
42316324|NCT01988103|76152704|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
42316325|NCT01988103|76152705|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
42316326|NCT01988103|76152706|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
42316327|NCT01988103|76152707|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
42316328|NCT01988103|76152703|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
42316329|NCT01988103|76152704|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
42256645|NCT02506036|76083104|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
42256646|NCT02506036|76083105|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
42256647|NCT02506036|76083104|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
42256648|NCT02506036|76083105|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
42256649|NCT01063855|76083113|FG000|Overall Study|Adverse Event|4|||
42256650|NCT01063855|76083114|FG001|Overall Study|Adverse Event|4|||
42256651|NCT01063855|76083113|FG000|Overall Study|Death|0|||
42256652|NCT01063855|76083114|FG001|Overall Study|Death|1|||
42256653|NCT01063855|76083113|FG000|Overall Study|Lost to Follow-up|8|||
42256654|NCT01063855|76083114|FG001|Overall Study|Lost to Follow-up|4|||
42256655|NCT01063855|76083113|FG000|Overall Study|Pregnancy|1|||
42256656|NCT01063855|76083114|FG001|Overall Study|Pregnancy|0|||
42256657|NCT01063855|76083113|FG000|Overall Study|Lack of Efficacy|0|||
42316330|NCT01988103|76152705|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
42316331|NCT01988103|76152706|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
42316332|NCT01988103|76152707|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
42316333|NCT02013375|76152722|FG000|Overall Study|Did not engraft|1|||
42316334|NCT02013375|76152722|FG000|Overall Study|Did not engraft|1|||
42316335|NCT02079519|76152727|FG000|Overall Study|Disease Progression|9|||
42316336|NCT02079519|76152727|FG000|Overall Study|Adverse Event|1|||
42256658|NCT01063855|76083114|FG001|Overall Study|Lack of Efficacy|1|||
42256659|NCT01063855|76083113|FG000|Overall Study|Withdrawal by Subject|11|||
42316337|NCT01987557|76152734|FG000|Overall Study|Protocol Violation|1|||
42316338|NCT01987557|76152735|FG001|Overall Study|Protocol Violation|0|||
42316339|NCT01987557|76152736|FG002|Overall Study|Protocol Violation|1|||
42316340|NCT01987557|76152734|FG000|Overall Study|Withdrawal by Subject|2|||
42316341|NCT01987557|76152735|FG001|Overall Study|Withdrawal by Subject|1|||
42316342|NCT01987557|76152736|FG002|Overall Study|Withdrawal by Subject|2|||
42316343|NCT01987557|76152734|FG000|Overall Study|Adverse Event|0|||
42316344|NCT01987557|76152735|FG001|Overall Study|Adverse Event|2|||
42316345|NCT01987557|76152736|FG002|Overall Study|Adverse Event|0|||
42316346|NCT02078817|76152744|FG000|Overall Study|Withdrawal by Subject|1|||
42316347|NCT02011893|76152748|FG000|Enrollment to Randomization|Adverse Event|2|||
42316348|NCT02011893|76152749|FG001|Enrollment to Randomization|Adverse Event|0|||
42316349|NCT02011893|76152750|FG002|Enrollment to Randomization|Adverse Event|0|||
42316350|NCT02011893|76152748|FG000|Enrollment to Randomization|Physician Decision|10|||
42316351|NCT02011893|76152749|FG001|Enrollment to Randomization|Physician Decision|0|||
42316352|NCT02011893|76152750|FG002|Enrollment to Randomization|Physician Decision|0|||
42316353|NCT02011893|76152748|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
42316354|NCT02011893|76152749|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
42316355|NCT02011893|76152750|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
42316356|NCT02011893|76152748|FG000|Enrollment to Randomization|Screening Failure|29|||
42316357|NCT02011893|76152749|FG001|Enrollment to Randomization|Screening Failure|0|||
42316358|NCT02011893|76152750|FG002|Enrollment to Randomization|Screening Failure|0|||
42316359|NCT02011893|76152748|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
42316360|NCT02011893|76152749|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
42316361|NCT02011893|76152750|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
42316362|NCT02011893|76152748|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
42316363|NCT02011893|76152749|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
42316364|NCT02011893|76152750|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
42316365|NCT02011893|76152748|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
42316366|NCT02011893|76152749|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
42316367|NCT02011893|76152750|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
42316368|NCT02011893|76152748|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
42316369|NCT02011893|76152749|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
42316370|NCT02011893|76152750|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
42316371|NCT02011893|76152748|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
42316372|NCT02011893|76152749|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
42316373|NCT02011893|76152750|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
42316374|NCT02011113|76152755|FG000|Overall Study|Adverse Event|4|||
42316375|NCT02011113|76152755|FG000|Overall Study|Disease Progression (DP)|16|||
42316376|NCT02011113|76152755|FG000|Overall Study|Death|1|||
42316377|NCT02011113|76152755|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
42316378|NCT02011113|76152755|FG000|Overall Study|Investigator's judgement- DP|3|||
42316379|NCT02011113|76152755|FG000|Overall Study|Study terminated by sponsor|11|||
42316380|NCT01807156|76152760|FG000|Overall Study|Physician Decision|1|||
42316381|NCT01987479|76152764|FG000|Overall Study|Protocol Violation|1|||
42316382|NCT01987479|76152764|FG000|Overall Study|Physician Decision|2|||
42316383|NCT01987479|76152764|FG000|Overall Study|Participant/legal guardian decision|1|||
42316384|NCT01987479|76152764|FG000|Overall Study|Other|5|||
42316385|NCT01987479|76152764|FG000|Overall Study|Lost to Follow-up|1|||
42316386|NCT01987479|76152764|FG000|Overall Study|Adverse Event|7|||
42316387|NCT01620489|76152770|FG000|Overall Study|Adverse Event|17|||
42316388|NCT01620489|76152771|FG001|Overall Study|Adverse Event|4|||
42316389|NCT01620489|76152770|FG000|Overall Study|Protocol Violation|0|||
42316390|NCT01620489|76152771|FG001|Overall Study|Protocol Violation|3|||
42316391|NCT01620489|76152770|FG000|Overall Study|Withdrawal Criteria|17|||
42316392|NCT01620489|76152771|FG001|Overall Study|Withdrawal Criteria|25|||
42316393|NCT01620489|76152770|FG000|Overall Study|Unclassified|1|||
42316394|NCT01620489|76152771|FG001|Overall Study|Unclassified|2|||
42316395|NCT02076165|76152779|FG000|Overall Study|Lost to Follow-up|7|||
42316396|NCT02076165|76152780|FG001|Overall Study|Lost to Follow-up|5|||
42316397|NCT02076165|76152779|FG000|Overall Study|Refused follow-up assessment|1|||
42316398|NCT02076165|76152780|FG001|Overall Study|Refused follow-up assessment|1|||
42316399|NCT01620255|76152791|FG000|Overall Study|Withdrawal by Subject|4|||
42316400|NCT01620255|76152792|FG001|Overall Study|Withdrawal by Subject|1|||
42316401|NCT01620255|76152793|FG002|Overall Study|Withdrawal by Subject|1|||
42316402|NCT01620255|76152794|FG003|Overall Study|Withdrawal by Subject|2|||
42316403|NCT01620255|76152795|FG004|Overall Study|Withdrawal by Subject|4|||
42316404|NCT01620255|76152791|FG000|Overall Study|Participant underwent fecal transplant|0|||
42316405|NCT01620255|76152792|FG001|Overall Study|Participant underwent fecal transplant|0|||
42316406|NCT01620255|76152793|FG002|Overall Study|Participant underwent fecal transplant|1|||
42316407|NCT01620255|76152794|FG003|Overall Study|Participant underwent fecal transplant|0|||
42316408|NCT01620255|76152795|FG004|Overall Study|Participant underwent fecal transplant|0|||
42316409|NCT01620255|76152791|FG000|Overall Study|Non-compliance|0|||
42316410|NCT01620255|76152792|FG001|Overall Study|Non-compliance|1|||
42316411|NCT01620255|76152793|FG002|Overall Study|Non-compliance|0|||
42316412|NCT01620255|76152794|FG003|Overall Study|Non-compliance|0|||
42316413|NCT01620255|76152795|FG004|Overall Study|Non-compliance|0|||
42316414|NCT01620255|76152791|FG000|Overall Study|Adverse Event|0|||
42316415|NCT01620255|76152792|FG001|Overall Study|Adverse Event|4|||
42316416|NCT01620255|76152793|FG002|Overall Study|Adverse Event|0|||
42316417|NCT01620255|76152794|FG003|Overall Study|Adverse Event|1|||
42316418|NCT01620255|76152795|FG004|Overall Study|Adverse Event|1|||
42316419|NCT01620255|76152791|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
42316420|NCT01620255|76152792|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
42316421|NCT01620255|76152793|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
42316422|NCT01620255|76152794|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
42316423|NCT01620255|76152795|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
42316424|NCT02010567|76152812|FG000|Overall Study|Adverse Event|0|||
42316425|NCT02010567|76152813|FG001|Overall Study|Adverse Event|0|||
42316426|NCT02010567|76152814|FG002|Overall Study|Adverse Event|1|||
42316427|NCT02010567|76152815|FG003|Overall Study|Adverse Event|0|||
42316428|NCT02010567|76152816|FG004|Overall Study|Adverse Event|1|||
42316429|NCT01806064|76152831|FG000|Overall Study|Randomized Not Enrolled|0|||
42316430|NCT01806064|76152832|FG001|Overall Study|Randomized Not Enrolled|0|||
42316431|NCT01806064|76152833|FG002|Overall Study|Randomized Not Enrolled|0|||
42316432|NCT01806064|76152834|FG003|Overall Study|Randomized Not Enrolled|1|||
42316433|NCT01806064|76152835|FG004|Overall Study|Randomized Not Enrolled|2|||
42316434|NCT01804582|76152853|FG000|Overall Study|Lost to Follow-up|47|||
42316435|NCT01804582|76152854|FG001|Overall Study|Lost to Follow-up|56|||
42316436|NCT01804582|76152853|FG000|Overall Study|Physician Decision|2|||
42316437|NCT01804582|76152854|FG001|Overall Study|Physician Decision|0|||
42316438|NCT01787188|76152864|FG000|Overall Study|Adverse Event|2|||
42316439|NCT01787188|76152865|FG001|Overall Study|Adverse Event|4|||
42316440|NCT01787188|76152866|FG002|Overall Study|Adverse Event|6|||
42316441|NCT01787188|76152864|FG000|Overall Study|Lack of Efficacy|7|||
42316442|NCT01787188|76152865|FG001|Overall Study|Lack of Efficacy|3|||
42316443|NCT01787188|76152866|FG002|Overall Study|Lack of Efficacy|5|||
42316444|NCT01787188|76152864|FG000|Overall Study|Non-compliance with Study Drug|0|||
42316445|NCT01787188|76152865|FG001|Overall Study|Non-compliance with Study Drug|1|||
42316446|NCT01787188|76152866|FG002|Overall Study|Non-compliance with Study Drug|0|||
42316447|NCT01787188|76152864|FG000|Overall Study|Withdrawal by Subject|4|||
42316448|NCT01787188|76152865|FG001|Overall Study|Withdrawal by Subject|3|||
42316449|NCT01787188|76152866|FG002|Overall Study|Withdrawal by Subject|2|||
42316450|NCT01787188|76152864|FG000|Overall Study|Protocol Violation|3|||
42316451|NCT01787188|76152865|FG001|Overall Study|Protocol Violation|2|||
42133232|NCT00498602|75944122|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
42256660|NCT01063855|76083114|FG001|Overall Study|Withdrawal by Subject|8|||
42256661|NCT01063855|76083113|FG000|Overall Study|Reason not specified|13|||
42256662|NCT01063855|76083114|FG001|Overall Study|Reason not specified|11|||
42256663|NCT01063153|76083126|FG000|Overall Study|Found Ineligible During Screening|2|||
42256664|NCT01063153|76083127|FG001|Overall Study|Found Ineligible During Screening|0|||
42256665|NCT01063153|76083126|FG000|Overall Study|Lost to Follow-up|0|||
42256666|NCT01063153|76083127|FG001|Overall Study|Lost to Follow-up|7|||
42256667|NCT01063153|76083126|FG000|Overall Study|Withdrawal by Subject|0|||
42256668|NCT01063153|76083127|FG001|Overall Study|Withdrawal by Subject|1|||
42256669|NCT01063153|76083126|FG000|Overall Study|Physician Decision|0|||
42256670|NCT01063153|76083127|FG001|Overall Study|Physician Decision|4|||
42256671|NCT01062841|76083139|FG000|Overall Study|Indwelling Device Removed|41|||
42256672|NCT01062841|76083140|FG001|Overall Study|Indwelling Device Removed|48|||
42256673|NCT01062841|76083139|FG000|Overall Study|Death|3|||
42256674|NCT01062841|76083140|FG001|Overall Study|Death|5|||
42256675|NCT01062841|76083139|FG000|Overall Study|Withdrawal by Subject|2|||
42256676|NCT01062841|76083140|FG001|Overall Study|Withdrawal by Subject|0|||
42256677|NCT01062841|76083139|FG000|Overall Study|Withdrawal by Study|3|||
42256678|NCT01062841|76083140|FG001|Overall Study|Withdrawal by Study|0|||
42316452|NCT01787188|76152866|FG002|Overall Study|Protocol Violation|3|||
42316453|NCT01787188|76152864|FG000|Overall Study|Lost to Follow-up|1|||
42316454|NCT01787188|76152865|FG001|Overall Study|Lost to Follow-up|2|||
42256679|NCT02505334|76083148|FG000|Main Treatment Period|Adverse Event|3|||
42256680|NCT02505334|76083149|FG001|Main Treatment Period|Adverse Event|3|||
42256681|NCT02505334|76083148|FG000|Main Treatment Period|Lack of Efficacy|7|||
42316455|NCT01787188|76152866|FG002|Overall Study|Lost to Follow-up|2|||
42316456|NCT01787188|76152864|FG000|Overall Study|Other, including patient moved|0|||
42316457|NCT01787188|76152865|FG001|Overall Study|Other, including patient moved|3|||
42316458|NCT01787188|76152866|FG002|Overall Study|Other, including patient moved|0|||
42316459|NCT01787032|76152880|FG000|Overall Study|Protocol Violation|0|||
42316460|NCT01787032|76152881|FG001|Overall Study|Protocol Violation|0|||
42316461|NCT01787032|76152882|FG002|Overall Study|Protocol Violation|0|||
42316462|NCT01787032|76152883|FG003|Overall Study|Protocol Violation|0|||
42316463|NCT01787032|76152884|FG004|Overall Study|Protocol Violation|1|||
42316464|NCT01787032|76152885|FG005|Overall Study|Protocol Violation|1|||
42316465|NCT01737268|76152895|FG000|Overall Study|Adverse Event|6|||
42316466|NCT01737268|76152895|FG000|Overall Study|Worsening of Target Disease|2|||
42316467|NCT01737268|76152895|FG000|Overall Study|In consideration of the patient's safety|1|||
42316468|NCT01769404|76152900|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
42316469|NCT01769404|76152901|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
42316470|NCT01769404|76152900|FG000|Treatment Period 1|Withdrawal by Subject|3|||
42316471|NCT01769404|76152901|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42316472|NCT01769404|76152900|FG000|Treatment Period 1|Sponsor decision|1|||
42316473|NCT01769404|76152901|FG001|Treatment Period 1|Sponsor decision|0|||
42316474|NCT01769404|76152900|FG000|Treatment Period 2|Sponsor decision|7|||
42316475|NCT01769404|76152901|FG001|Treatment Period 2|Sponsor decision|0|||
42316476|NCT01769326|76152913|FG000|Overall Study|Lost to Follow-up|1|||
42316477|NCT01769326|76152914|FG001|Overall Study|Lost to Follow-up|2|||
42316478|NCT01769326|76152915|FG002|Overall Study|Lost to Follow-up|0|||
42316479|NCT01769326|76152916|FG003|Overall Study|Lost to Follow-up|0|||
42316480|NCT01769326|76152913|FG000|Overall Study|unrelated injry|1|||
42316481|NCT01769326|76152914|FG001|Overall Study|unrelated injry|1|||
42316482|NCT01769326|76152915|FG002|Overall Study|unrelated injry|0|||
42316483|NCT01769326|76152916|FG003|Overall Study|unrelated injry|0|||
42316484|NCT01769326|76152913|FG000|Overall Study|got a job|0|||
42316485|NCT01769326|76152914|FG001|Overall Study|got a job|1|||
42316486|NCT01769326|76152915|FG002|Overall Study|got a job|0|||
42316487|NCT01769326|76152916|FG003|Overall Study|got a job|0|||
42316488|NCT01769326|76152913|FG000|Overall Study|Got sick and could not complete study|0|||
42316489|NCT01769326|76152914|FG001|Overall Study|Got sick and could not complete study|0|||
42316490|NCT01769326|76152915|FG002|Overall Study|Got sick and could not complete study|1|||
42316491|NCT01769326|76152916|FG003|Overall Study|Got sick and could not complete study|0|||
42316492|NCT01786564|76152926|FG000|Overall Study|Lost to Follow-up|47|||
42316493|NCT01786564|76152926|FG000|Overall Study|Ineligible|17|||
42316494|NCT01786330|76152932|FG000|Overall Study|Withdrawal by Subject|0|||
42316495|NCT01786330|76152933|FG001|Overall Study|Withdrawal by Subject|1|||
42316496|NCT01786330|76152932|FG000|Overall Study|Lost to Follow-up|0|||
42316497|NCT01786330|76152933|FG001|Overall Study|Lost to Follow-up|1|||
42316498|NCT01786330|76152932|FG000|Overall Study|Excluded intraoperatively|0|||
42316499|NCT01786330|76152933|FG001|Overall Study|Excluded intraoperatively|1|||
42316500|NCT01786330|76152932|FG000|Overall Study|Protocol Violation|1|||
42316501|NCT01786330|76152933|FG001|Overall Study|Protocol Violation|0|||
42316502|NCT01786174|76152941|FG000|Overall Study|Discontinued Study Drug|2|||
42316503|NCT01786174|76152942|FG001|Overall Study|Discontinued Study Drug|0|||
42316504|NCT01736566|76152953|FG000|Long Term Follow-up|Still collecting data|42|||
42316505|NCT01736566|76152954|FG001|Long Term Follow-up|Still collecting data|0|||
42256682|NCT02505334|76083149|FG001|Main Treatment Period|Lack of Efficacy|17|||
42316506|NCT01736566|76152955|FG002|Long Term Follow-up|Still collecting data|49|||
42316507|NCT01736566|76152956|FG003|Long Term Follow-up|Still collecting data|0|||
42316508|NCT01736566|76152957|FG004|Long Term Follow-up|Still collecting data|1|||
42316509|NCT01768858|76152982|FG000|Overall Study|Lost to Follow-up|9|||
42316510|NCT01768858|76152982|FG000|Overall Study|Lack of Efficacy|8|||
42316511|NCT01768858|76152982|FG000|Overall Study|Serious Adverse Event|1|||
42316512|NCT01768858|76152982|FG000|Overall Study|Participant moved to Germany|1|||
42256683|NCT02505334|76083148|FG000|Main Treatment Period|Protocol Violation|0|||
42256684|NCT02505334|76083149|FG001|Main Treatment Period|Protocol Violation|1|||
42256685|NCT02505334|76083148|FG000|Main Treatment Period|Withdrawal by Subject|1|||
42256686|NCT02505334|76083149|FG001|Main Treatment Period|Withdrawal by Subject|8|||
42256687|NCT02505334|76083148|FG000|Main Treatment Period|Unclassified|4|||
42256688|NCT02505334|76083149|FG001|Main Treatment Period|Unclassified|10|||
42316513|NCT01768858|76152982|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
42316514|NCT01768858|76152982|FG000|Overall Study|Exanthema|1|||
42316515|NCT01768858|76152982|FG000|Overall Study|Withdrawal by Subject|1|||
42316516|NCT01736254|76152986|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
42256689|NCT02505334|76083148|FG000|Extension Treatment Period|Adverse Event|5|||
42256690|NCT02505334|76083149|FG001|Extension Treatment Period|Adverse Event|0|||
42316517|NCT01736254|76152986|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
42316518|NCT01767376|76152997|FG000|Overall Study|Lost to Follow-up|3|||
42316519|NCT01767376|76152998|FG001|Overall Study|Lost to Follow-up|2|||
42316520|NCT01767376|76152999|FG002|Overall Study|Lost to Follow-up|0|||
42316521|NCT01767376|76152997|FG000|Overall Study|Withdrawal by Subject|1|||
41993553|NCT01136746|75801871|FG000|Overall Study|Protocol Violation|2|||
42316522|NCT01767376|76152998|FG001|Overall Study|Withdrawal by Subject|1|||
42316523|NCT01767376|76152999|FG002|Overall Study|Withdrawal by Subject|0|||
42316524|NCT01767142|76153009|FG000|Overall Study|Lost to Follow-up|3|||
42316525|NCT01785628|76153015|FG000|Overall Study|Lost to Follow-up|2|||
42316526|NCT01785628|76153016|FG001|Overall Study|Lost to Follow-up|3|||
42316527|NCT01785472|76153025|FG000|Overall Study|Adverse Event|5|||
42316528|NCT01785472|76153026|FG001|Overall Study|Adverse Event|4|||
42316529|NCT01785472|76153027|FG002|Overall Study|Adverse Event|6|||
42316530|NCT01785472|76153025|FG000|Overall Study|Lack of Efficacy|2|||
42316531|NCT01785472|76153026|FG001|Overall Study|Lack of Efficacy|0|||
42316532|NCT01785472|76153027|FG002|Overall Study|Lack of Efficacy|1|||
42316533|NCT01785472|76153025|FG000|Overall Study|Lost to Follow-up|1|||
42316534|NCT01785472|76153026|FG001|Overall Study|Lost to Follow-up|2|||
42316535|NCT01785472|76153027|FG002|Overall Study|Lost to Follow-up|0|||
42316536|NCT01785472|76153025|FG000|Overall Study|Physician Decision|1|||
42316537|NCT01785472|76153026|FG001|Overall Study|Physician Decision|1|||
42316538|NCT01785472|76153027|FG002|Overall Study|Physician Decision|1|||
42316539|NCT01785472|76153025|FG000|Overall Study|Protocol deviation|0|||
42316540|NCT01785472|76153026|FG001|Overall Study|Protocol deviation|2|||
42316541|NCT01785472|76153027|FG002|Overall Study|Protocol deviation|2|||
42316542|NCT01785472|76153025|FG000|Overall Study|Subject/guardian decision|15|||
42316543|NCT01785472|76153026|FG001|Overall Study|Subject/guardian decision|10|||
42316544|NCT01785472|76153027|FG002|Overall Study|Subject/guardian decision|11|||
42316545|NCT01785472|76153025|FG000|Overall Study|Technical problems|0|||
42316546|NCT01785472|76153026|FG001|Overall Study|Technical problems|0|||
42316547|NCT01785472|76153027|FG002|Overall Study|Technical problems|1|||
42316548|NCT01785160|76153037|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
42316549|NCT01785160|76153037|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
42316550|NCT01736176|76153043|FG000|Overall Study|Adverse Event|3|||
42316551|NCT01736176|76153043|FG000|Overall Study|Withdrawal by Subject|4|||
42316552|NCT01736176|76153043|FG000|Overall Study|Lack of Efficacy|3|||
42316553|NCT01736176|76153043|FG000|Overall Study|Unable to Complete PEG Placement|1|||
42316554|NCT01735630|76153053|FG000|Overall Study|Adverse Event|8|||
42316555|NCT01735630|76153054|FG001|Overall Study|Adverse Event|7|||
42316556|NCT01735630|76153053|FG000|Overall Study|Lost to Follow-up|1|||
42316557|NCT01735630|76153054|FG001|Overall Study|Lost to Follow-up|0|||
42316558|NCT01735630|76153053|FG000|Overall Study|Physician Decision|0|||
42316559|NCT01735630|76153054|FG001|Overall Study|Physician Decision|1|||
42316560|NCT01735630|76153053|FG000|Overall Study|Sponsor Decision|2|||
42316561|NCT01735630|76153054|FG001|Overall Study|Sponsor Decision|1|||
42316562|NCT01735630|76153053|FG000|Overall Study|Withdrawal by Subject|7|||
42316563|NCT01735630|76153054|FG001|Overall Study|Withdrawal by Subject|9|||
42316564|NCT01735396|76153060|FG000|Overall Study|not evaluable|1|||
42316565|NCT01766206|76153064|FG000|Overall Study|Withdrawal by Subject|22|||
42316566|NCT01766206|76153064|FG000|Overall Study|Lost to Follow-up|10|||
42316567|NCT01766206|76153064|FG000|Overall Study|Inappropriate enrollment|18|||
42316568|NCT01766206|76153064|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
42316569|NCT01734850|76153071|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
42316570|NCT01734850|76153072|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
42316571|NCT01734850|76153073|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
42316572|NCT01734850|76153071|FG000|Overall Study|Not infused due to manufacturing failure|0|||
42316573|NCT01734850|76153072|FG001|Overall Study|Not infused due to manufacturing failure|0|||
42316574|NCT01734850|76153073|FG002|Overall Study|Not infused due to manufacturing failure|1|||
42316575|NCT01766050|76153084|FG000|Overall Study|Adverse Event|1|||
42316576|NCT01766050|76153084|FG000|Overall Study|Lost to Follow-up|1|||
42316577|NCT01766050|76153084|FG000|Overall Study|Withdrawal by Subject|2|||
42316578|NCT02341625|76153112|FG000|Overall Study|Disease Progression|2|||
42316579|NCT02341625|76153113|FG001|Overall Study|Disease Progression|2|||
42316580|NCT02341625|76153114|FG002|Overall Study|Disease Progression|3|||
42316581|NCT02341625|76153115|FG003|Overall Study|Disease Progression|6|||
42316582|NCT02341625|76153116|FG004|Overall Study|Disease Progression|7|||
42316583|NCT02341625|76153117|FG005|Overall Study|Disease Progression|7|||
42316584|NCT02341625|76153118|FG006|Overall Study|Disease Progression|28|||
42316585|NCT02341625|76153119|FG007|Overall Study|Disease Progression|5|||
42316586|NCT02341625|76153120|FG008|Overall Study|Disease Progression|4|||
42316587|NCT02341625|76153121|FG009|Overall Study|Disease Progression|19|||
42316588|NCT02341625|76153112|FG000|Overall Study|Study Drug Toxicity|0|||
42316589|NCT02341625|76153113|FG001|Overall Study|Study Drug Toxicity|0|||
42316590|NCT02341625|76153114|FG002|Overall Study|Study Drug Toxicity|0|||
42316591|NCT02341625|76153115|FG003|Overall Study|Study Drug Toxicity|1|||
42316592|NCT02341625|76153116|FG004|Overall Study|Study Drug Toxicity|0|||
42316593|NCT02341625|76153117|FG005|Overall Study|Study Drug Toxicity|3|||
42316594|NCT02341625|76153118|FG006|Overall Study|Study Drug Toxicity|10|||
42316595|NCT02341625|76153119|FG007|Overall Study|Study Drug Toxicity|0|||
42316596|NCT02341625|76153120|FG008|Overall Study|Study Drug Toxicity|0|||
42316597|NCT02341625|76153121|FG009|Overall Study|Study Drug Toxicity|3|||
42316598|NCT02341625|76153112|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
42316599|NCT02341625|76153113|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
42316600|NCT02341625|76153114|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
42316601|NCT02341625|76153115|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
42316602|NCT02341625|76153116|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
42316603|NCT02341625|76153117|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
42316604|NCT02341625|76153118|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
42316605|NCT02341625|76153119|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
42316606|NCT02341625|76153120|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
42316607|NCT02341625|76153121|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
42316608|NCT02341625|76153112|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
42316609|NCT02341625|76153113|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
42316610|NCT02341625|76153114|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
42316611|NCT02341625|76153115|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
42316612|NCT02341625|76153116|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
42316613|NCT02341625|76153117|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
42316614|NCT02341625|76153118|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
42316615|NCT02341625|76153119|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
42316616|NCT02341625|76153120|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
42316617|NCT02341625|76153121|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
42316618|NCT02341625|76153112|FG000|Overall Study|Participant Withdrew Consent|0|||
42316619|NCT02341625|76153113|FG001|Overall Study|Participant Withdrew Consent|0|||
42316620|NCT02341625|76153114|FG002|Overall Study|Participant Withdrew Consent|0|||
42256691|NCT02505334|76083148|FG000|Extension Treatment Period|Lack of Efficacy|4|||
42256692|NCT02505334|76083149|FG001|Extension Treatment Period|Lack of Efficacy|0|||
42256693|NCT02505334|76083148|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
42256694|NCT02505334|76083149|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
42256695|NCT02505334|76083148|FG000|Extension Treatment Period|Unclassified|3|||
42256696|NCT02505334|76083149|FG001|Extension Treatment Period|Unclassified|0|||
42316621|NCT02341625|76153115|FG003|Overall Study|Participant Withdrew Consent|1|||
42316622|NCT02341625|76153116|FG004|Overall Study|Participant Withdrew Consent|0|||
42316623|NCT02341625|76153117|FG005|Overall Study|Participant Withdrew Consent|0|||
42316624|NCT02341625|76153118|FG006|Overall Study|Participant Withdrew Consent|0|||
42316625|NCT02341625|76153119|FG007|Overall Study|Participant Withdrew Consent|0|||
42316626|NCT02341625|76153120|FG008|Overall Study|Participant Withdrew Consent|0|||
42316627|NCT02341625|76153121|FG009|Overall Study|Participant Withdrew Consent|0|||
42316628|NCT02341625|76153112|FG000|Overall Study|Completed Treatment as per Protocol|0|||
42316629|NCT02341625|76153113|FG001|Overall Study|Completed Treatment as per Protocol|0|||
42316630|NCT02341625|76153114|FG002|Overall Study|Completed Treatment as per Protocol|0|||
42256697|NCT01062061|76083155|FG000|Overall Study|Enrolled more than once|2|||
42316631|NCT02341625|76153115|FG003|Overall Study|Completed Treatment as per Protocol|0|||
42316632|NCT02341625|76153116|FG004|Overall Study|Completed Treatment as per Protocol|0|||
42316633|NCT02341625|76153117|FG005|Overall Study|Completed Treatment as per Protocol|0|||
42316634|NCT02341625|76153118|FG006|Overall Study|Completed Treatment as per Protocol|0|||
42316635|NCT02341625|76153119|FG007|Overall Study|Completed Treatment as per Protocol|0|||
42316636|NCT02341625|76153120|FG008|Overall Study|Completed Treatment as per Protocol|0|||
42316637|NCT02341625|76153121|FG009|Overall Study|Completed Treatment as per Protocol|1|||
42316638|NCT02341625|76153112|FG000|Overall Study|Other Reasons|0|||
42316639|NCT02341625|76153113|FG001|Overall Study|Other Reasons|0|||
42316640|NCT02341625|76153114|FG002|Overall Study|Other Reasons|0|||
42316641|NCT02341625|76153115|FG003|Overall Study|Other Reasons|0|||
42316642|NCT02341625|76153116|FG004|Overall Study|Other Reasons|1|||
42316643|NCT02341625|76153117|FG005|Overall Study|Other Reasons|0|||
42316644|NCT02341625|76153118|FG006|Overall Study|Other Reasons|5|||
42316645|NCT02341625|76153119|FG007|Overall Study|Other Reasons|0|||
42316646|NCT02341625|76153120|FG008|Overall Study|Other Reasons|0|||
42316647|NCT02341625|76153121|FG009|Overall Study|Other Reasons|2|||
42316648|NCT02341625|76153112|FG000|Overall Study|Not Reported|0|||
42316649|NCT02341625|76153113|FG001|Overall Study|Not Reported|0|||
42316650|NCT02341625|76153114|FG002|Overall Study|Not Reported|0|||
42316651|NCT02341625|76153115|FG003|Overall Study|Not Reported|0|||
42316652|NCT02341625|76153116|FG004|Overall Study|Not Reported|0|||
42316653|NCT02341625|76153117|FG005|Overall Study|Not Reported|0|||
42316654|NCT02341625|76153118|FG006|Overall Study|Not Reported|0|||
42316655|NCT02341625|76153119|FG007|Overall Study|Not Reported|0|||
42316656|NCT02341625|76153120|FG008|Overall Study|Not Reported|0|||
42316657|NCT02341625|76153121|FG009|Overall Study|Not Reported|3|||
42316658|NCT02370095|76153168|FG000|Overall Study|Withdrawal by Subject|0|||
42316659|NCT02370095|76153169|FG001|Overall Study|Withdrawal by Subject|1|||
42316660|NCT01783678|76153181|FG000|Overall Study|Randomized but Not Treated|0|||
42316661|NCT01783678|76153182|FG001|Overall Study|Randomized but Not Treated|0|||
42316662|NCT01783678|76153183|FG002|Overall Study|Randomized but Not Treated|0|||
42316663|NCT01783678|76153184|FG003|Overall Study|Randomized but Not Treated|1|||
42316664|NCT01783678|76153185|FG004|Overall Study|Randomized but Not Treated|0|||
42316665|NCT01783678|76153186|FG005|Overall Study|Randomized but Not Treated|0|||
42316666|NCT01783678|76153181|FG000|Overall Study|Lack of Efficacy|1|||
42316667|NCT01783678|76153182|FG001|Overall Study|Lack of Efficacy|13|||
42316668|NCT01783678|76153183|FG002|Overall Study|Lack of Efficacy|1|||
42316669|NCT01783678|76153184|FG003|Overall Study|Lack of Efficacy|3|||
42316670|NCT01783678|76153185|FG004|Overall Study|Lack of Efficacy|6|||
42316671|NCT01783678|76153186|FG005|Overall Study|Lack of Efficacy|5|||
42316672|NCT01783678|76153181|FG000|Overall Study|Lost to Follow-up|0|||
42316673|NCT01783678|76153182|FG001|Overall Study|Lost to Follow-up|4|||
42316674|NCT01783678|76153183|FG002|Overall Study|Lost to Follow-up|0|||
42316675|NCT01783678|76153184|FG003|Overall Study|Lost to Follow-up|2|||
42316676|NCT01783678|76153185|FG004|Overall Study|Lost to Follow-up|1|||
42316677|NCT01783678|76153186|FG005|Overall Study|Lost to Follow-up|0|||
42316678|NCT01783678|76153181|FG000|Overall Study|Withdrew Consent|1|||
42256698|NCT01062061|76083155|FG000|Overall Study|Investigated before study start|13|||
42256699|NCT01062061|76083155|FG000|Overall Study|Outside chief indications|10|||
42256700|NCT01062061|76083155|FG000|Overall Study|Failed to meet inclusion criteria|2|||
42256701|NCT02504320|76083167|FG000|Treatment Period 1|Positive Drug Screen|0|||
42256702|NCT02504320|76083168|FG001|Treatment Period 1|Positive Drug Screen|0|||
42256703|NCT02504320|76083169|FG002|Treatment Period 1|Positive Drug Screen|1|||
42256704|NCT02504320|76083170|FG003|Treatment Period 1|Positive Drug Screen|0|||
42256705|NCT02504320|76083167|FG000|Treatment Period 2|Positive Drug Screen|0|||
42256706|NCT02504320|76083168|FG001|Treatment Period 2|Positive Drug Screen|1|||
42256707|NCT02504320|76083169|FG002|Treatment Period 2|Positive Drug Screen|0|||
42316679|NCT01783678|76153182|FG001|Overall Study|Withdrew Consent|1|||
42316680|NCT01783678|76153183|FG002|Overall Study|Withdrew Consent|0|||
42316681|NCT01783678|76153184|FG003|Overall Study|Withdrew Consent|2|||
42316682|NCT01783678|76153185|FG004|Overall Study|Withdrew Consent|0|||
42316683|NCT01783678|76153186|FG005|Overall Study|Withdrew Consent|0|||
42316684|NCT01734772|76153203|FG000|Overall Study|Adverse Event|1|||
42316685|NCT01734772|76153204|FG001|Overall Study|Adverse Event|2|||
42316686|NCT01734772|76153203|FG000|Overall Study|Withdrawal by Subject|0|||
42316687|NCT01734772|76153204|FG001|Overall Study|Withdrawal by Subject|1|||
42316688|NCT02340221|76153218|FG000|Overall Study|Death|100|||
42316689|NCT02340221|76153219|FG001|Overall Study|Death|197|||
42316690|NCT02340221|76153218|FG000|Overall Study|Withdrawal by Participant|24|||
42256708|NCT02504320|76083170|FG003|Treatment Period 2|Positive Drug Screen|0|||
42256709|NCT02504320|76083167|FG000|Treatment Period 3|Positive Drug Screen|0|||
42256710|NCT02504320|76083168|FG001|Treatment Period 3|Positive Drug Screen|0|||
42256711|NCT02504320|76083169|FG002|Treatment Period 3|Positive Drug Screen|0|||
42256712|NCT02504320|76083170|FG003|Treatment Period 3|Positive Drug Screen|1|||
42256713|NCT02504320|76083167|FG000|Treatment Period 3|Adverse Event|0|||
42256714|NCT02504320|76083168|FG001|Treatment Period 3|Adverse Event|0|||
42256715|NCT02504320|76083169|FG002|Treatment Period 3|Adverse Event|1|||
42256716|NCT02504320|76083170|FG003|Treatment Period 3|Adverse Event|0|||
42256717|NCT01061671|76083182|FG000|Overall Study|Withdrawal by Subject|16|||
42256718|NCT01061671|76083183|FG001|Overall Study|Withdrawal by Subject|20|||
42256719|NCT01061671|76083182|FG000|Overall Study|Lost to Follow-up|3|||
42256720|NCT01061671|76083183|FG001|Overall Study|Lost to Follow-up|5|||
42256721|NCT01061671|76083182|FG000|Overall Study|Death|28|||
42256722|NCT01061671|76083183|FG001|Overall Study|Death|30|||
42256723|NCT00709995|76083191|FG000|Overall Study|Adverse Event|4|||
42256724|NCT00709995|76083192|FG001|Overall Study|Adverse Event|2|||
42256725|NCT00709995|76083191|FG000|Overall Study|Withdrawal by Subject|1|||
42256726|NCT00709995|76083192|FG001|Overall Study|Withdrawal by Subject|3|||
42256727|NCT02503540|76083201|FG000|Overall Study|Death|2|||
42256728|NCT02503540|76083201|FG000|Overall Study|Withdrawal by Subject|1|||
42256729|NCT02502526|76083208|FG000|Overall Study|Lost to Follow-up|2|||
42256730|NCT02502526|76083209|FG001|Overall Study|Lost to Follow-up|2|||
42256731|NCT02502526|76083210|FG002|Overall Study|Lost to Follow-up|3|||
42256732|NCT02502526|76083208|FG000|Overall Study|Withdrawal by Subject|0|||
42256733|NCT02502526|76083209|FG001|Overall Study|Withdrawal by Subject|1|||
42256734|NCT02502526|76083210|FG002|Overall Study|Withdrawal by Subject|1|||
42256735|NCT02502526|76083208|FG000|Overall Study|Disqualified due to cataract grading|0|||
42256736|NCT02502526|76083209|FG001|Overall Study|Disqualified due to cataract grading|0|||
42256737|NCT02502526|76083210|FG002|Overall Study|Disqualified due to cataract grading|1|||
42256738|NCT02502526|76083208|FG000|Overall Study|Enrollment suspension|4|||
42256739|NCT02502526|76083209|FG001|Overall Study|Enrollment suspension|1|||
42256740|NCT02502526|76083210|FG002|Overall Study|Enrollment suspension|1|||
42256741|NCT02972515|76083219|FG000|Overall Study|Lost to Follow-up|78|||
42256742|NCT02972359|76083223|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
42256743|NCT02972359|76083223|FG000|Overall Study|Lack of Efficacy|1|||
42256744|NCT02972359|76083223|FG000|Overall Study|Adverse Event|4|||
42256745|NCT02972359|76083223|FG000|Overall Study|Death|1|||
42256746|NCT02972359|76083223|FG000|Overall Study|Withdrawal by Subject|30|||
42256747|NCT02972359|76083223|FG000|Overall Study|Protocol Violation|1|||
42256748|NCT02972359|76083223|FG000|Overall Study|Lost to Follow-up|26|||
42256749|NCT02972359|76083223|FG000|Overall Study|Other reasons|5|||
42256750|NCT02972359|76083223|FG000|Overall Study|Missing|1|||
42256751|NCT01060111|76083230|FG000|Overall Study|Adverse Event|9|||
42256752|NCT01060111|76083231|FG001|Overall Study|Adverse Event|5|||
42256753|NCT01060111|76083232|FG002|Overall Study|Adverse Event|18|||
42256754|NCT01060111|76083230|FG000|Overall Study|Lack of Efficacy|2|||
42256755|NCT01060111|76083231|FG001|Overall Study|Lack of Efficacy|1|||
42256756|NCT01060111|76083232|FG002|Overall Study|Lack of Efficacy|0|||
42256757|NCT01060111|76083230|FG000|Overall Study|Inappropriate participant|5|||
42256758|NCT01060111|76083231|FG001|Overall Study|Inappropriate participant|4|||
42256759|NCT01060111|76083232|FG002|Overall Study|Inappropriate participant|5|||
42256760|NCT01060111|76083230|FG000|Overall Study|Participants' evasion for hospital visit|0|||
42256761|NCT01060111|76083231|FG001|Overall Study|Participants' evasion for hospital visit|3|||
42256762|NCT01060111|76083232|FG002|Overall Study|Participants' evasion for hospital visit|2|||
42256763|NCT01060111|76083230|FG000|Overall Study|Participants' non-cooperation|8|||
42256764|NCT01060111|76083231|FG001|Overall Study|Participants' non-cooperation|6|||
42256765|NCT01060111|76083232|FG002|Overall Study|Participants' non-cooperation|6|||
42256766|NCT01060111|76083230|FG000|Overall Study|Adverse event and insufficient effect|0|||
42256767|NCT01060111|76083231|FG001|Overall Study|Adverse event and insufficient effect|1|||
42256768|NCT01060111|76083232|FG002|Overall Study|Adverse event and insufficient effect|0|||
42256769|NCT01060111|76083230|FG000|Overall Study|Participants' non-cooperation|1|||
42256770|NCT01060111|76083231|FG001|Overall Study|Participants' non-cooperation|0|||
42256771|NCT01060111|76083232|FG002|Overall Study|Participants' non-cooperation|0|||
42256772|NCT01060111|76083230|FG000|Overall Study|Other|2|||
42256773|NCT01060111|76083231|FG001|Overall Study|Other|3|||
42256774|NCT01060111|76083232|FG002|Overall Study|Other|4|||
42256775|NCT02969863|76083243|FG000|Overall Study|Physician Decision|1|||
42256776|NCT02969863|76083244|FG001|Overall Study|Physician Decision|0|||
42256777|NCT02969863|76083245|FG002|Overall Study|Physician Decision|0|||
42256778|NCT02969863|76083246|FG003|Overall Study|Physician Decision|0|||
42256779|NCT02969863|76083247|FG004|Overall Study|Physician Decision|0|||
42256780|NCT02969863|76083248|FG005|Overall Study|Physician Decision|0|||
42256781|NCT02969707|76083264|FG000|Overall Study|Adverse Event|1|||
42256782|NCT02969707|76083265|FG001|Overall Study|Adverse Event|2|||
42316691|NCT02340221|76153219|FG001|Overall Study|Withdrawal by Participant|37|||
42316692|NCT02340221|76153218|FG000|Overall Study|Lost to Follow-up|4|||
42316693|NCT02340221|76153219|FG001|Overall Study|Lost to Follow-up|15|||
42316694|NCT02340221|76153218|FG000|Overall Study|Reason Not Specified|85|||
42316695|NCT02340221|76153219|FG001|Overall Study|Reason Not Specified|165|||
42316696|NCT02340221|76153218|FG000|Overall Study|Study Terminated by Sponsor|1|||
42316697|NCT02340221|76153219|FG001|Overall Study|Study Terminated by Sponsor|3|||
42316698|NCT02395133|76153230|FG000|Overall Study|Adverse Event|4|||
42316699|NCT02395133|76153231|FG001|Overall Study|Adverse Event|1|||
42316700|NCT02395133|76153232|FG002|Overall Study|Adverse Event|3|||
42316701|NCT02395133|76153233|FG003|Overall Study|Adverse Event|0|||
42316702|NCT02395133|76153230|FG000|Overall Study|Lack of Efficacy|1|||
42316703|NCT02395133|76153231|FG001|Overall Study|Lack of Efficacy|0|||
42316704|NCT02395133|76153232|FG002|Overall Study|Lack of Efficacy|1|||
42316705|NCT02395133|76153233|FG003|Overall Study|Lack of Efficacy|1|||
42316706|NCT02395133|76153230|FG000|Overall Study|Protocol Violation|1|||
42316707|NCT02395133|76153231|FG001|Overall Study|Protocol Violation|1|||
42316708|NCT02395133|76153232|FG002|Overall Study|Protocol Violation|0|||
42316709|NCT02395133|76153233|FG003|Overall Study|Protocol Violation|3|||
42316710|NCT02395133|76153230|FG000|Overall Study|Lost to Follow-up|0|||
42316711|NCT02395133|76153231|FG001|Overall Study|Lost to Follow-up|1|||
42316712|NCT02395133|76153232|FG002|Overall Study|Lost to Follow-up|1|||
42316713|NCT02395133|76153233|FG003|Overall Study|Lost to Follow-up|0|||
42316714|NCT02395133|76153230|FG000|Overall Study|Pregnancy|0|||
42316715|NCT02395133|76153231|FG001|Overall Study|Pregnancy|0|||
42316716|NCT02395133|76153232|FG002|Overall Study|Pregnancy|3|||
42316717|NCT02395133|76153233|FG003|Overall Study|Pregnancy|0|||
42316718|NCT02395133|76153230|FG000|Overall Study|Consent withdrawn with no reason given|1|||
42256783|NCT02969707|76083264|FG000|Overall Study|Lost to Follow-up|3|||
42256784|NCT02969707|76083265|FG001|Overall Study|Lost to Follow-up|0|||
42256785|NCT02969707|76083264|FG000|Overall Study|Physician Decision|0|||
42316719|NCT02395133|76153231|FG001|Overall Study|Consent withdrawn with no reason given|3|||
42316720|NCT02395133|76153232|FG002|Overall Study|Consent withdrawn with no reason given|0|||
42316721|NCT02395133|76153233|FG003|Overall Study|Consent withdrawn with no reason given|2|||
41993554|NCT01136746|75801872|FG001|Overall Study|Protocol Violation|1|||
41993555|NCT01136746|75801871|FG000|Overall Study|Death|1|||
42256786|NCT02969707|76083265|FG001|Overall Study|Physician Decision|1|||
42256787|NCT02969707|76083264|FG000|Overall Study|Protocol Violation|1|||
42256788|NCT02969707|76083265|FG001|Overall Study|Protocol Violation|1|||
42256789|NCT02969707|76083264|FG000|Overall Study|Withdrawal by Subject|3|||
42256790|NCT02969707|76083265|FG001|Overall Study|Withdrawal by Subject|4|||
42316722|NCT02395133|76153230|FG000|Overall Study|Consent withdrawn with personal reason|0|||
42316723|NCT02395133|76153231|FG001|Overall Study|Consent withdrawn with personal reason|1|||
42316724|NCT02395133|76153232|FG002|Overall Study|Consent withdrawn with personal reason|0|||
42316725|NCT02395133|76153233|FG003|Overall Study|Consent withdrawn with personal reason|3|||
42316726|NCT02395133|76153230|FG000|Overall Study|Sponsor decision|2|||
42316727|NCT02395133|76153231|FG001|Overall Study|Sponsor decision|0|||
42316728|NCT02395133|76153232|FG002|Overall Study|Sponsor decision|0|||
42316729|NCT02395133|76153233|FG003|Overall Study|Sponsor decision|1|||
42316730|NCT02395133|76153230|FG000|Overall Study|Other than specified above|5|||
42316731|NCT02395133|76153231|FG001|Overall Study|Other than specified above|2|||
42316732|NCT02395133|76153232|FG002|Overall Study|Other than specified above|2|||
42316733|NCT02395133|76153233|FG003|Overall Study|Other than specified above|4|||
42316734|NCT02395055|76153245|FG000|Overall Study|Withdrawal by Subject|7|||
42316735|NCT02395055|76153246|FG001|Overall Study|Withdrawal by Subject|3|||
42316736|NCT02369159|76153254|FG000|Overall Study|Adverse Event|0|||
42316737|NCT02369159|76153255|FG001|Overall Study|Adverse Event|1|||
42316738|NCT02369159|76153254|FG000|Overall Study|Lost to Follow-up|1|||
42316739|NCT02369159|76153255|FG001|Overall Study|Lost to Follow-up|1|||
42316740|NCT02369159|76153254|FG000|Overall Study|Withdrawal by Subject|7|||
42316741|NCT02369159|76153255|FG001|Overall Study|Withdrawal by Subject|0|||
42316742|NCT02368691|76153272|FG000|Overall Study|Death|13|||
42316743|NCT02368691|76153272|FG000|Overall Study|Lack of Efficacy|15|||
42316744|NCT02368691|76153272|FG000|Overall Study|Physician Decision|4|||
42316745|NCT02394665|76153279|FG000|Overall Study|Physician Decision|1|||
42316746|NCT02394665|76153280|FG001|Overall Study|Physician Decision|0|||
42316747|NCT02394665|76153281|FG002|Overall Study|Physician Decision|0|||
42316748|NCT02367911|76153291|FG000|Overall Study|Withdrawal by Subject|3|||
42316749|NCT02367911|76153292|FG001|Overall Study|Withdrawal by Subject|2|||
42316750|NCT02367911|76153291|FG000|Overall Study|Lost to Follow-up|2|||
42316751|NCT02367911|76153292|FG001|Overall Study|Lost to Follow-up|2|||
42316752|NCT02339285|76153301|FG000|Overall Study|Withdrawal by Subject|0|||
42316753|NCT02339285|76153302|FG001|Overall Study|Withdrawal by Subject|1|||
42316754|NCT02339285|76153303|FG002|Overall Study|Withdrawal by Subject|1|||
42316755|NCT02339285|76153301|FG000|Overall Study|Lost to Follow-up|1|||
42316756|NCT02339285|76153302|FG001|Overall Study|Lost to Follow-up|1|||
42316757|NCT02339285|76153303|FG002|Overall Study|Lost to Follow-up|1|||
42256791|NCT02967055|76083276|FG000|Overall Study|Excluded|40|||
42256792|NCT02967055|76083276|FG000|Overall Study|Screen fail|3|||
42256793|NCT02967055|76083276|FG000|Overall Study|Lost to Follow-up|2|||
42256794|NCT02967055|76083276|FG000|Overall Study|Stopped due to side effects|3|||
42256795|NCT02967055|76083276|FG000|Overall Study|Stopped due to drug cost|1|||
42256796|NCT02904265|76083282|FG000|Overall Study|Physician Decision|1|||
42256797|NCT02904265|76083283|FG001|Overall Study|Physician Decision|2|||
42256798|NCT03461211|76083291|FG000|Overall Study|Adverse Event|1|||
42256799|NCT03461211|76083292|FG001|Overall Study|Adverse Event|1|||
42256800|NCT03461211|76083291|FG000|Overall Study|Lack of Efficacy|0|||
42316758|NCT02339285|76153301|FG000|Overall Study|Protocol Deviation|0|||
42316759|NCT02339285|76153302|FG001|Overall Study|Protocol Deviation|1|||
42316760|NCT02339285|76153303|FG002|Overall Study|Protocol Deviation|0|||
42316761|NCT02367833|76153314|FG000|Overall Study|Withdrawal by Subject|1|||
42316762|NCT02367833|76153315|FG001|Overall Study|Withdrawal by Subject|1|||
42133233|NCT00498602|75944123|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
42256801|NCT03461211|76083292|FG001|Overall Study|Lack of Efficacy|1|||
42256802|NCT02967679|76083300|FG000|Overall Study|Adverse Event|1|||
42316763|NCT02367833|76153316|FG002|Overall Study|Withdrawal by Subject|0|||
42316764|NCT02367521|76153326|FG000|Overall Study|severe headache after intervention|2|||
42316765|NCT02367521|76153327|FG001|Overall Study|severe headache after intervention|0|||
42316766|NCT02367521|76153326|FG000|Overall Study|unable to find transportation|2|||
42256803|NCT02966509|76083310|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
42256804|NCT02966509|76083311|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
42316767|NCT02367521|76153327|FG001|Overall Study|unable to find transportation|0|||
42316768|NCT02338193|76153336|FG000|Overall Study|Withdrawal by Subject|0|||
42316769|NCT02338193|76153337|FG001|Overall Study|Withdrawal by Subject|0|||
42316770|NCT02338193|76153338|FG002|Overall Study|Withdrawal by Subject|2|||
42316771|NCT02338193|76153336|FG000|Overall Study|Pregnancy|0|||
42316772|NCT02338193|76153337|FG001|Overall Study|Pregnancy|1|||
42316773|NCT02338193|76153338|FG002|Overall Study|Pregnancy|1|||
42316774|NCT02338193|76153336|FG000|Overall Study|Noncompliant with visits|2|||
42316775|NCT02338193|76153337|FG001|Overall Study|Noncompliant with visits|2|||
42316776|NCT02338193|76153338|FG002|Overall Study|Noncompliant with visits|7|||
42316777|NCT02338193|76153336|FG000|Overall Study|moved out of state|0|||
42316778|NCT02338193|76153337|FG001|Overall Study|moved out of state|1|||
42316779|NCT02338193|76153338|FG002|Overall Study|moved out of state|0|||
42316780|NCT02338193|76153336|FG000|Overall Study|intolerant of side effects|1|||
42316781|NCT02338193|76153337|FG001|Overall Study|intolerant of side effects|0|||
42316782|NCT02338193|76153338|FG002|Overall Study|intolerant of side effects|0|||
42316783|NCT01783444|76153349|FG000|Treatment Phase|Adverse Event|9|||
42316784|NCT01783444|76153350|FG001|Treatment Phase|Adverse Event|20|||
42316785|NCT01783444|76153351|FG002|Treatment Phase|Adverse Event|19|||
42316786|NCT01783444|76153349|FG000|Treatment Phase|Disease Progression|76|||
42316787|NCT01783444|76153350|FG001|Treatment Phase|Disease Progression|66|||
42316788|NCT01783444|76153351|FG002|Treatment Phase|Disease Progression|64|||
42316789|NCT01783444|76153349|FG000|Treatment Phase|Death|2|||
42316790|NCT01783444|76153350|FG001|Treatment Phase|Death|2|||
42316791|NCT01783444|76153351|FG002|Treatment Phase|Death|2|||
42316792|NCT01783444|76153349|FG000|Treatment Phase|Protocol Violation|1|||
42316793|NCT01783444|76153350|FG001|Treatment Phase|Protocol Violation|1|||
42316794|NCT01783444|76153351|FG002|Treatment Phase|Protocol Violation|2|||
42316795|NCT01783444|76153349|FG000|Treatment Phase|Withdrawal by Subject|6|||
42316796|NCT01783444|76153350|FG001|Treatment Phase|Withdrawal by Subject|8|||
42316797|NCT01783444|76153351|FG002|Treatment Phase|Withdrawal by Subject|9|||
42316798|NCT01783444|76153349|FG000|Treatment Phase|Administrative problems|2|||
42316799|NCT01783444|76153350|FG001|Treatment Phase|Administrative problems|0|||
42316800|NCT01783444|76153351|FG002|Treatment Phase|Administrative problems|1|||
42316801|NCT01783444|76153349|FG000|Treatment Phase|Physician Decision|8|||
42316802|NCT01783444|76153350|FG001|Treatment Phase|Physician Decision|6|||
42316803|NCT01783444|76153351|FG002|Treatment Phase|Physician Decision|5|||
42316804|NCT01783444|76153349|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
42316805|NCT01783444|76153350|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
42316806|NCT01783444|76153351|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
42316807|NCT01783444|76153349|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
42316808|NCT01783444|76153350|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
42316809|NCT01783444|76153351|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
42316810|NCT01783444|76153349|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
42316811|NCT01783444|76153350|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
42316812|NCT01783444|76153351|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
42316813|NCT01783444|76153349|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
42316814|NCT01783444|76153350|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
42316815|NCT01783444|76153351|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
42316816|NCT01783444|76153349|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
42316817|NCT01783444|76153350|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
42316818|NCT01783444|76153351|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
42316819|NCT01783444|76153349|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
42316820|NCT01783444|76153350|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
42316821|NCT01783444|76153351|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
42316822|NCT02367131|76153360|FG000|Overall Study|Adverse Event|64|||
42316823|NCT02367131|76153360|FG000|Overall Study|No visit since the first visit|4|||
42316824|NCT02367131|76153360|FG000|Overall Study|Request by patient|54|||
42316825|NCT02367131|76153360|FG000|Overall Study|Improvement/remission|2|||
42316826|NCT02367131|76153360|FG000|Overall Study|No change/progressive disease|78|||
42316827|NCT02367131|76153360|FG000|Overall Study|Other than stated above|20|||
42316828|NCT02394275|76153364|FG000|Overall Study|Adverse Event|22|||
42033855|NCT01071954|75842024|FG000|Overall Study|Adverse Event|1|||
42316829|NCT02394275|76153364|FG000|Overall Study|Lost to Follow-up|7|||
42316830|NCT01608724|76153369|FG000|Overall Study|Withdrawal by Subject|131|||
42316831|NCT01608724|76153369|FG000|Overall Study|Lost to Follow-up|41|||
42316832|NCT01608724|76153369|FG000|Overall Study|Study-specific discontinuation criteria|32|||
42316833|NCT01608724|76153369|FG000|Overall Study|Adverse Event|29|||
42316834|NCT01608724|76153369|FG000|Overall Study|Protocol Violation|6|||
42316835|NCT01608724|76153369|FG000|Overall Study|bood sugar too high, etc.|3|||
42316836|NCT01608724|76153369|FG000|Overall Study|Safety reasons|1|||
42316837|NCT02366195|76153373|FG000|Overall Study|Protocol-specified criteria|3|||
42316838|NCT02366195|76153373|FG000|Overall Study|Withdrawal by Subject|9|||
42316839|NCT02366195|76153373|FG000|Overall Study|Lost to Follow-up|1|||
42316840|NCT02366195|76153373|FG000|Overall Study|Death|41|||
42316841|NCT02364947|76153380|FG000|Overall Study|Withdrawal by Subject|10|||
42316842|NCT02364947|76153381|FG001|Overall Study|Withdrawal by Subject|8|||
42316843|NCT02364947|76153382|FG002|Overall Study|Withdrawal by Subject|9|||
42316844|NCT02364947|76153380|FG000|Overall Study|Adverse Event|45|||
42316845|NCT02364947|76153381|FG001|Overall Study|Adverse Event|33|||
42316846|NCT02364947|76153382|FG002|Overall Study|Adverse Event|11|||
42316847|NCT02364947|76153380|FG000|Overall Study|Protocol Violation|1|||
42316848|NCT02364947|76153381|FG001|Overall Study|Protocol Violation|1|||
42316849|NCT02364947|76153382|FG002|Overall Study|Protocol Violation|1|||
42316850|NCT02364947|76153380|FG000|Overall Study|Physician Decision|3|||
42316851|NCT02364947|76153381|FG001|Overall Study|Physician Decision|2|||
42316852|NCT02364947|76153382|FG002|Overall Study|Physician Decision|5|||
42316853|NCT02364947|76153380|FG000|Overall Study|Death|0|||
42316854|NCT02364947|76153381|FG001|Overall Study|Death|1|||
42316855|NCT02364947|76153382|FG002|Overall Study|Death|0|||
42316856|NCT02392481|76153394|FG000|Overall Study|Adverse Event|0|||
42316857|NCT02392481|76153395|FG001|Overall Study|Adverse Event|0|||
42316858|NCT02392481|76153396|FG002|Overall Study|Adverse Event|1|||
42316859|NCT02392481|76153397|FG003|Overall Study|Adverse Event|2|||
42316860|NCT02392481|76153394|FG000|Overall Study|Withdrawal by Subject|0|||
42316861|NCT02392481|76153395|FG001|Overall Study|Withdrawal by Subject|0|||
42316862|NCT02392481|76153396|FG002|Overall Study|Withdrawal by Subject|1|||
42316863|NCT02392481|76153397|FG003|Overall Study|Withdrawal by Subject|0|||
42316864|NCT02392403|76153407|FG000|Overall Study|Adverse Event|1|||
42316865|NCT02392403|76153407|FG000|Overall Study|Death|1|||
42316866|NCT02392403|76153407|FG000|Overall Study|Withdrawal by Subject|1|||
42316867|NCT02392247|76153411|FG000|Overall Study|Withdrawal by Subject|1|||
42316868|NCT02392247|76153411|FG000|Overall Study|Surgery cancelled; no data|1|||
42316869|NCT02337725|76153417|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
42316870|NCT02337725|76153418|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
42316871|NCT02337725|76153417|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
42316872|NCT02337725|76153418|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
42316873|NCT02337725|76153417|FG000|Overall Study|Major Protocol Deviation|0|||
42316874|NCT02337725|76153418|FG001|Overall Study|Major Protocol Deviation|1|||
41993556|NCT01136746|75801872|FG001|Overall Study|Death|0|||
42316875|NCT02337725|76153417|FG000|Overall Study|Voluntary Withdrawal|14|||
42316876|NCT02337725|76153418|FG001|Overall Study|Voluntary Withdrawal|3|||
42316877|NCT02337725|76153417|FG000|Overall Study|Lack of Efficacy|4|||
42316878|NCT02337725|76153418|FG001|Overall Study|Lack of Efficacy|0|||
42316879|NCT02337491|76153426|FG000|Overall Study|Death|1|||
42316880|NCT02337491|76153427|FG001|Overall Study|Death|1|||
42316881|NCT02337491|76153426|FG000|Overall Study|Adverse Event|0|||
42316882|NCT02337491|76153427|FG001|Overall Study|Adverse Event|1|||
42316883|NCT02337491|76153426|FG000|Overall Study|Withdrawal by Subject|3|||
42316884|NCT02337491|76153427|FG001|Overall Study|Withdrawal by Subject|0|||
42316885|NCT02337491|76153426|FG000|Overall Study|Progressive Disease|44|||
42316886|NCT02337491|76153427|FG001|Overall Study|Progressive Disease|28|||
42316887|NCT02337491|76153426|FG000|Overall Study|On Treatment|2|||
42316888|NCT02337491|76153427|FG001|Overall Study|On Treatment|0|||
42316889|NCT01765582|76153437|FG000|Overall Study|Other|3|||
42316890|NCT01765582|76153438|FG001|Overall Study|Other|6|||
42316891|NCT01765582|76153439|FG002|Overall Study|Other|9|||
42316892|NCT01765582|76153437|FG000|Overall Study|Lost to Follow-up|2|||
42316893|NCT01765582|76153438|FG001|Overall Study|Lost to Follow-up|2|||
42316894|NCT01765582|76153439|FG002|Overall Study|Lost to Follow-up|1|||
42316895|NCT01765582|76153437|FG000|Overall Study|Death|31|||
42316896|NCT01765582|76153438|FG001|Overall Study|Death|36|||
42316897|NCT01765582|76153439|FG002|Overall Study|Death|33|||
42316898|NCT01765582|76153437|FG000|Overall Study|Sponsor Decision|46|||
42316899|NCT01765582|76153438|FG001|Overall Study|Sponsor Decision|42|||
42316900|NCT01765582|76153439|FG002|Overall Study|Sponsor Decision|42|||
42316901|NCT01765582|76153437|FG000|Overall Study|Withdrawal of Consent|11|||
42316902|NCT01765582|76153438|FG001|Overall Study|Withdrawal of Consent|6|||
42316903|NCT01765582|76153439|FG002|Overall Study|Withdrawal of Consent|10|||
42316904|NCT01649375|76153451|FG000|Up to Week 16|Adverse Event|2|||
42316905|NCT01649375|76153452|FG001|Up to Week 16|Adverse Event|5|||
42316906|NCT01649375|76153453|FG002|Up to Week 16|Adverse Event|4|||
42316907|NCT01649375|76153454|FG003|Up to Week 16|Adverse Event|0|||
42316908|NCT01649375|76153455|FG004|Up to Week 16|Adverse Event|0|||
42316909|NCT01649375|76153451|FG000|Up to Week 16|Lack of Efficacy|0|||
42316910|NCT01649375|76153452|FG001|Up to Week 16|Lack of Efficacy|0|||
42316911|NCT01649375|76153453|FG002|Up to Week 16|Lack of Efficacy|1|||
42316912|NCT01649375|76153454|FG003|Up to Week 16|Lack of Efficacy|0|||
42316913|NCT01649375|76153455|FG004|Up to Week 16|Lack of Efficacy|0|||
42316914|NCT01649375|76153451|FG000|Up to Week 16|Physician Decision|0|||
42316915|NCT01649375|76153452|FG001|Up to Week 16|Physician Decision|0|||
42316916|NCT01649375|76153453|FG002|Up to Week 16|Physician Decision|1|||
42316917|NCT01649375|76153454|FG003|Up to Week 16|Physician Decision|0|||
42316918|NCT01649375|76153455|FG004|Up to Week 16|Physician Decision|0|||
42316919|NCT01649375|76153451|FG000|Up to Week 16|Withdrawal by Subject|2|||
42316920|NCT01649375|76153452|FG001|Up to Week 16|Withdrawal by Subject|1|||
42316921|NCT01649375|76153453|FG002|Up to Week 16|Withdrawal by Subject|2|||
42316922|NCT01649375|76153454|FG003|Up to Week 16|Withdrawal by Subject|0|||
42316923|NCT01649375|76153455|FG004|Up to Week 16|Withdrawal by Subject|0|||
42316924|NCT01649375|76153451|FG000|Up to Week 16|Death|1|||
42316925|NCT01649375|76153452|FG001|Up to Week 16|Death|0|||
42316926|NCT01649375|76153453|FG002|Up to Week 16|Death|0|||
42316927|NCT01649375|76153454|FG003|Up to Week 16|Death|0|||
42316928|NCT01649375|76153455|FG004|Up to Week 16|Death|0|||
42316929|NCT01649375|76153451|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
42316930|NCT01649375|76153452|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
42316931|NCT01649375|76153453|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
42316932|NCT01649375|76153454|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
42316933|NCT01649375|76153455|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
42316934|NCT01649375|76153451|FG000|Week 16 up to Week 260|Non-compliance|0|||
42316935|NCT01649375|76153452|FG001|Week 16 up to Week 260|Non-compliance|1|||
42316936|NCT01649375|76153453|FG002|Week 16 up to Week 260|Non-compliance|0|||
42316937|NCT01649375|76153454|FG003|Week 16 up to Week 260|Non-compliance|1|||
42316938|NCT01649375|76153455|FG004|Week 16 up to Week 260|Non-compliance|0|||
42316939|NCT01649375|76153451|FG000|Week 16 up to Week 260|Physician Decision|0|||
42316940|NCT01649375|76153452|FG001|Week 16 up to Week 260|Physician Decision|2|||
42316941|NCT01649375|76153453|FG002|Week 16 up to Week 260|Physician Decision|0|||
42316942|NCT01649375|76153454|FG003|Week 16 up to Week 260|Physician Decision|0|||
42316943|NCT01649375|76153455|FG004|Week 16 up to Week 260|Physician Decision|0|||
42316944|NCT01649375|76153451|FG000|Week 16 up to Week 260|Technical issues|0|||
42316945|NCT01649375|76153452|FG001|Week 16 up to Week 260|Technical issues|1|||
42316946|NCT01649375|76153453|FG002|Week 16 up to Week 260|Technical issues|0|||
42316947|NCT01649375|76153454|FG003|Week 16 up to Week 260|Technical issues|1|||
42316948|NCT01649375|76153455|FG004|Week 16 up to Week 260|Technical issues|0|||
42316949|NCT01649375|76153451|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
42316950|NCT01649375|76153452|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
42316951|NCT01649375|76153453|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
42316952|NCT01649375|76153454|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
42316953|NCT01649375|76153455|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
42316954|NCT01649375|76153451|FG000|Week 16 up to Week 260|Death|1|||
42316955|NCT01649375|76153452|FG001|Week 16 up to Week 260|Death|1|||
42316956|NCT01649375|76153453|FG002|Week 16 up to Week 260|Death|0|||
42316957|NCT01649375|76153454|FG003|Week 16 up to Week 260|Death|0|||
42316958|NCT01649375|76153455|FG004|Week 16 up to Week 260|Death|0|||
42316959|NCT01649375|76153451|FG000|Week 16 up to Week 260|Adverse Event|5|||
42316960|NCT01649375|76153452|FG001|Week 16 up to Week 260|Adverse Event|2|||
42316961|NCT01649375|76153453|FG002|Week 16 up to Week 260|Adverse Event|0|||
42316962|NCT01649375|76153454|FG003|Week 16 up to Week 260|Adverse Event|3|||
42316963|NCT01649375|76153455|FG004|Week 16 up to Week 260|Adverse Event|2|||
42316964|NCT02336555|76153465|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42316965|NCT02336555|76153466|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
42316966|NCT02336555|76153465|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
42316967|NCT02336555|76153466|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
42316968|NCT02336555|76153465|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
42316969|NCT02336555|76153466|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
42316970|NCT01648283|76153472|FG000|Overall Study|Withdrawal by Subject|14|||
42316971|NCT01649297|76153483|FG000|Overall Study|Adverse Event|5|||
42316972|NCT01649297|76153484|FG001|Overall Study|Adverse Event|5|||
42316973|NCT01649297|76153485|FG002|Overall Study|Adverse Event|4|||
42316974|NCT01649297|76153486|FG003|Overall Study|Adverse Event|13|||
42316975|NCT01649297|76153487|FG004|Overall Study|Adverse Event|1|||
42316976|NCT01649297|76153483|FG000|Overall Study|Lack of Efficacy|0|||
42316977|NCT01649297|76153484|FG001|Overall Study|Lack of Efficacy|0|||
42316978|NCT01649297|76153485|FG002|Overall Study|Lack of Efficacy|0|||
42316979|NCT01649297|76153486|FG003|Overall Study|Lack of Efficacy|0|||
42316980|NCT01649297|76153487|FG004|Overall Study|Lack of Efficacy|1|||
42316981|NCT01649297|76153483|FG000|Overall Study|Non compliant with Protocol|1|||
42316982|NCT01649297|76153484|FG001|Overall Study|Non compliant with Protocol|0|||
42316983|NCT01649297|76153485|FG002|Overall Study|Non compliant with Protocol|3|||
42316984|NCT01649297|76153486|FG003|Overall Study|Non compliant with Protocol|2|||
42316985|NCT01649297|76153487|FG004|Overall Study|Non compliant with Protocol|1|||
42316986|NCT01649297|76153483|FG000|Overall Study|Lost to Follow-up|1|||
42316987|NCT01649297|76153484|FG001|Overall Study|Lost to Follow-up|1|||
42316988|NCT01649297|76153485|FG002|Overall Study|Lost to Follow-up|4|||
42316989|NCT01649297|76153486|FG003|Overall Study|Lost to Follow-up|3|||
42316990|NCT01649297|76153487|FG004|Overall Study|Lost to Follow-up|0|||
42316991|NCT01649297|76153483|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
42316992|NCT01649297|76153484|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
42316993|NCT01649297|76153485|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
42316994|NCT01649297|76153486|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
42316995|NCT01649297|76153487|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
42316996|NCT01649297|76153483|FG000|Overall Study|For other reason|4|||
42256805|NCT02966509|76083310|FG000|Baseline Satisfaction Survey|Death|0|||
42256806|NCT02966509|76083311|FG001|Baseline Satisfaction Survey|Death|1|||
42256807|NCT02966509|76083310|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
42256808|NCT02966509|76083311|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
42256809|NCT02966509|76083310|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
42256810|NCT02966509|76083311|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
42256811|NCT02966509|76083310|FG000|6 Month Satisfaction Decision Survey|Death|22|||
42256812|NCT02966509|76083311|FG001|6 Month Satisfaction Decision Survey|Death|25|||
42256813|NCT02966509|76083310|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
42256814|NCT02966509|76083311|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
42316997|NCT01649297|76153484|FG001|Overall Study|For other reason|1|||
42316998|NCT01649297|76153485|FG002|Overall Study|For other reason|2|||
42256815|NCT02966509|76083310|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
42316999|NCT01649297|76153486|FG003|Overall Study|For other reason|0|||
42317000|NCT01649297|76153487|FG004|Overall Study|For other reason|0|||
42317001|NCT01648205|76153499|FG000|Placebo|Pregnancy|1|||
42317002|NCT01648205|76153499|FG000|Placebo|Withdrawal by Subject|1|||
42256816|NCT02966509|76083311|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
42317003|NCT01648205|76153499|FG000|Placebo|Protocol Violation|2|||
42317004|NCT01648205|76153499|FG000|Ranolazine|Death|1|||
42317005|NCT01648205|76153499|FG000|Ranolazine|Withdrawal by Subject|1|||
42317006|NCT01648205|76153499|FG000|Ranolazine|Protocol Violation|3|||
42317007|NCT02362451|76153509|FG000|Overall Study|Withdrawal by Subject|0|||
42317008|NCT02362451|76153510|FG001|Overall Study|Withdrawal by Subject|1|||
42317009|NCT02362451|76153509|FG000|Overall Study|Lack of Efficacy|2|||
42317010|NCT02362451|76153510|FG001|Overall Study|Lack of Efficacy|0|||
42317011|NCT02362451|76153509|FG000|Overall Study|Progression|1|||
42317012|NCT02362451|76153510|FG001|Overall Study|Progression|0|||
42317013|NCT02362451|76153509|FG000|Overall Study|Participant chose other therapy.|1|||
42317014|NCT02362451|76153510|FG001|Overall Study|Participant chose other therapy.|0|||
42317015|NCT01734382|76153519|FG000|Part 1|Adverse Event|2|||
42317016|NCT01734382|76153520|FG001|Part 1|Adverse Event|0|||
42033856|NCT01071954|75842024|FG000|Overall Study|Withdrawal by Subject|11|||
42033857|NCT01071954|75842024|FG000|Overall Study|Requirement for Alternative Therapy|5|||
42033858|NCT01071954|75842024|FG000|Overall Study|Administrative Decision|5|||
42256817|NCT02966509|76083310|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
42317017|NCT01734382|76153521|FG002|Part 1|Adverse Event|0|||
42317018|NCT01734382|76153519|FG000|Part 2|Adverse Event|0|||
42317019|NCT01734382|76153520|FG001|Part 2|Adverse Event|0|||
42317020|NCT01734382|76153521|FG002|Part 2|Adverse Event|1|||
42317021|NCT01734382|76153519|FG000|Part 2|Lack of Efficacy|0|||
42317022|NCT01734382|76153520|FG001|Part 2|Lack of Efficacy|1|||
42317023|NCT01734382|76153521|FG002|Part 2|Lack of Efficacy|1|||
42317024|NCT01734382|76153519|FG000|Part 2|Other|0|||
42317025|NCT01734382|76153520|FG001|Part 2|Other|0|||
42317026|NCT01734382|76153521|FG002|Part 2|Other|1|||
42317027|NCT01734382|76153519|FG000|Part 2|Physician Decision|0|||
42317028|NCT01734382|76153520|FG001|Part 2|Physician Decision|0|||
42256818|NCT02966509|76083311|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
42317029|NCT01734382|76153521|FG002|Part 2|Physician Decision|3|||
42317030|NCT01734382|76153519|FG000|Part 2|Protocol Violation|0|||
42317031|NCT01734382|76153520|FG001|Part 2|Protocol Violation|1|||
42317032|NCT01734382|76153521|FG002|Part 2|Protocol Violation|0|||
42317033|NCT01734382|76153519|FG000|Part 2|Withdrawal by Subject|0|||
42317034|NCT01734382|76153520|FG001|Part 2|Withdrawal by Subject|0|||
42317035|NCT01734382|76153521|FG002|Part 2|Withdrawal by Subject|1|||
42317036|NCT02391311|76153535|FG000|Overall Study|Lost to Follow-up|2|||
42317037|NCT02391311|76153536|FG001|Overall Study|Lost to Follow-up|1|||
42317038|NCT02391311|76153535|FG000|Overall Study|deemed ineligible after baseline|1|||
42317039|NCT02391311|76153536|FG001|Overall Study|deemed ineligible after baseline|1|||
42317040|NCT01765426|76153546|FG000|Overall Study|Lost to Follow-up|0|||
42317041|NCT01765426|76153547|FG001|Overall Study|Lost to Follow-up|1|||
42317042|NCT01765426|76153548|FG002|Overall Study|Lost to Follow-up|0|||
42317043|NCT01765426|76153549|FG003|Overall Study|Lost to Follow-up|0|||
42317044|NCT01765270|76153561|FG000|Overall Study|Physician Decision|1|||
42317045|NCT01765270|76153562|FG001|Overall Study|Physician Decision|0|||
42317046|NCT01765270|76153561|FG000|Overall Study|Withdrawal by Subject|0|||
42317047|NCT01765270|76153562|FG001|Overall Study|Withdrawal by Subject|1|||
42317048|NCT01733758|76153573|FG000|Overall Study|Adverse Event|5|||
42317049|NCT01733758|76153574|FG001|Overall Study|Adverse Event|7|||
42256819|NCT02966509|76083310|FG000|6 Month Satisfaction Survey|Death|36|||
42256820|NCT02966509|76083311|FG001|6 Month Satisfaction Survey|Death|33|||
42256821|NCT02966509|76083310|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
42256822|NCT02966509|76083311|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
42256823|NCT02966509|76083310|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
42256824|NCT02966509|76083311|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
42256825|NCT02966509|76083310|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
42256826|NCT02966509|76083311|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
42256827|NCT02966509|76083310|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
42317050|NCT01733758|76153575|FG002|Overall Study|Adverse Event|8|||
42317051|NCT01733758|76153576|FG003|Overall Study|Adverse Event|1|||
42317052|NCT01733758|76153573|FG000|Overall Study|Withdrawal by Subject|1|||
42317053|NCT01733758|76153574|FG001|Overall Study|Withdrawal by Subject|1|||
42317054|NCT01733758|76153575|FG002|Overall Study|Withdrawal by Subject|5|||
42317055|NCT01733758|76153576|FG003|Overall Study|Withdrawal by Subject|3|||
42317056|NCT01733758|76153573|FG000|Overall Study|Persistent Hyperglycemia|3|||
42317057|NCT01733758|76153574|FG001|Overall Study|Persistent Hyperglycemia|2|||
42256828|NCT02966509|76083311|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
42317058|NCT01733758|76153575|FG002|Overall Study|Persistent Hyperglycemia|0|||
42317059|NCT01733758|76153576|FG003|Overall Study|Persistent Hyperglycemia|0|||
42317060|NCT01733758|76153573|FG000|Overall Study|Protocol Violation|0|||
42317061|NCT01733758|76153574|FG001|Overall Study|Protocol Violation|1|||
42317062|NCT01733758|76153575|FG002|Overall Study|Protocol Violation|2|||
42317063|NCT01733758|76153576|FG003|Overall Study|Protocol Violation|2|||
42317064|NCT01733758|76153573|FG000|Overall Study|Non-compliance|1|||
42317065|NCT01733758|76153574|FG001|Overall Study|Non-compliance|0|||
42317066|NCT01733758|76153575|FG002|Overall Study|Non-compliance|0|||
42317067|NCT01733758|76153576|FG003|Overall Study|Non-compliance|0|||
42317068|NCT01733758|76153573|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
42317069|NCT01733758|76153574|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
42317070|NCT01733758|76153575|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
42317071|NCT01733758|76153576|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
42317072|NCT01733758|76153573|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
42317073|NCT01733758|76153574|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
42317074|NCT01733758|76153575|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
42317075|NCT01733758|76153576|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
42317076|NCT01607554|76153588|FG000|Overall Study|Disease progression|2|||
42317077|NCT01607476|76153595|FG000|Overall Study|Withdrawal by Subject|1|||
42317078|NCT01607476|76153596|FG001|Overall Study|Withdrawal by Subject|0|||
42317079|NCT01607476|76153597|FG002|Overall Study|Withdrawal by Subject|1|||
42317080|NCT01607476|76153595|FG000|Overall Study|Lost to Follow-up|0|||
42317081|NCT01607476|76153596|FG001|Overall Study|Lost to Follow-up|0|||
42317082|NCT01607476|76153597|FG002|Overall Study|Lost to Follow-up|2|||
42317083|NCT01765192|76153607|FG000|Treatment Period 1|Adverse Event|0|||
42317084|NCT01765192|76153608|FG001|Treatment Period 1|Adverse Event|1|||
42317085|NCT01765192|76153607|FG000|Washout Period|Voluntary Withdrawal|1|||
42317086|NCT01765192|76153608|FG001|Washout Period|Voluntary Withdrawal|1|||
42317087|NCT01765192|76153607|FG000|Washout Period|Reason not specified|1|||
42317088|NCT01765192|76153608|FG001|Washout Period|Reason not specified|0|||
42317089|NCT01765192|76153607|FG000|Treatment Period 2|Reason not specified|0|||
42317090|NCT01765192|76153608|FG001|Treatment Period 2|Reason not specified|2|||
42317091|NCT01765192|76153607|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
42317092|NCT01765192|76153608|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
42317093|NCT01733680|76153616|FG000|Overall Study|Withdrawal by Subject|0|||
42317094|NCT01733680|76153617|FG001|Overall Study|Withdrawal by Subject|1|||
42317095|NCT02336165|76153632|FG000|Overall Study|Death|3|||
42317096|NCT02336165|76153633|FG001|Overall Study|Death|0|||
42317097|NCT02336165|76153634|FG002|Overall Study|Death|0|||
42317098|NCT02336165|76153635|FG003|Overall Study|Death|0|||
42317099|NCT02336165|76153636|FG004|Overall Study|Death|1|||
42317100|NCT02336165|76153632|FG000|Overall Study|Physician Decision|2|||
42317101|NCT02336165|76153633|FG001|Overall Study|Physician Decision|2|||
42317102|NCT02336165|76153634|FG002|Overall Study|Physician Decision|1|||
42317103|NCT02336165|76153635|FG003|Overall Study|Physician Decision|1|||
42317104|NCT02336165|76153636|FG004|Overall Study|Physician Decision|0|||
42317105|NCT02336165|76153632|FG000|Overall Study|Withdrawal by Subject|0|||
42317106|NCT02336165|76153633|FG001|Overall Study|Withdrawal by Subject|0|||
42317107|NCT02336165|76153634|FG002|Overall Study|Withdrawal by Subject|1|||
42317108|NCT02336165|76153635|FG003|Overall Study|Withdrawal by Subject|0|||
42317109|NCT02336165|76153636|FG004|Overall Study|Withdrawal by Subject|1|||
42317110|NCT02336165|76153632|FG000|Overall Study|Adverse Event|4|||
42317111|NCT02336165|76153633|FG001|Overall Study|Adverse Event|1|||
42317112|NCT02336165|76153634|FG002|Overall Study|Adverse Event|2|||
42317113|NCT02336165|76153635|FG003|Overall Study|Adverse Event|4|||
42317114|NCT02336165|76153636|FG004|Overall Study|Adverse Event|1|||
42317115|NCT02336165|76153632|FG000|Overall Study|Progressive disease|23|||
42317116|NCT02336165|76153633|FG001|Overall Study|Progressive disease|22|||
42317117|NCT02336165|76153634|FG002|Overall Study|Progressive disease|27|||
42317118|NCT02336165|76153635|FG003|Overall Study|Progressive disease|24|||
42317119|NCT02336165|76153636|FG004|Overall Study|Progressive disease|19|||
42317120|NCT02336165|76153632|FG000|Overall Study|Non-compliance|1|||
42317121|NCT02336165|76153633|FG001|Overall Study|Non-compliance|0|||
42317122|NCT02336165|76153634|FG002|Overall Study|Non-compliance|0|||
42317123|NCT02336165|76153635|FG003|Overall Study|Non-compliance|1|||
42317124|NCT02336165|76153636|FG004|Overall Study|Non-compliance|0|||
42317125|NCT02336165|76153632|FG000|Overall Study|Other|1|||
42317126|NCT02336165|76153633|FG001|Overall Study|Other|0|||
42317127|NCT02336165|76153634|FG002|Overall Study|Other|0|||
42317128|NCT02336165|76153635|FG003|Overall Study|Other|1|||
42317129|NCT02336165|76153636|FG004|Overall Study|Other|0|||
42317130|NCT02360111|76153652|FG000|Overall Study|Death|2|||
42317131|NCT02334683|76153658|FG000|First 12 Week Period|Lost to Follow-up|1|||
42317132|NCT02334683|76153659|FG001|First 12 Week Period|Lost to Follow-up|0|||
42317133|NCT02334683|76153658|FG000|Second 12 Week Period|Adverse Event|0|||
42317134|NCT02334683|76153659|FG001|Second 12 Week Period|Adverse Event|1|||
42317135|NCT02319044|76153668|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
42317136|NCT02319044|76153669|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
42317137|NCT02319044|76153670|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
42317138|NCT02319044|76153668|FG000|Overall Study|Withdrawal by Subject|3|||
42317139|NCT02319044|76153669|FG001|Overall Study|Withdrawal by Subject|3|||
42317140|NCT02319044|76153670|FG002|Overall Study|Withdrawal by Subject|6|||
42317141|NCT02319044|76153668|FG000|Overall Study|Condition under investigation worsened|100|||
42317142|NCT02319044|76153669|FG001|Overall Study|Condition under investigation worsened|50|||
42317143|NCT02319044|76153670|FG002|Overall Study|Condition under investigation worsened|46|||
42317144|NCT02319044|76153668|FG000|Overall Study|Adverse Event|17|||
42317145|NCT02319044|76153669|FG001|Overall Study|Adverse Event|2|||
42317146|NCT02319044|76153670|FG002|Overall Study|Adverse Event|8|||
42317147|NCT02319044|76153668|FG000|Overall Study|Study specific discontinuation criteria|2|||
42317148|NCT02319044|76153669|FG001|Overall Study|Study specific discontinuation criteria|2|||
42317149|NCT02319044|76153670|FG002|Overall Study|Study specific discontinuation criteria|1|||
42317150|NCT02319044|76153668|FG000|Overall Study|Not treated|0|||
42317151|NCT02319044|76153669|FG001|Overall Study|Not treated|2|||
42317152|NCT02319044|76153670|FG002|Overall Study|Not treated|2|||
42317153|NCT01649765|76153681|FG000|Overall Study|Adverse Event|5|||
42317154|NCT01649765|76153682|FG001|Overall Study|Adverse Event|3|||
42317155|NCT01649765|76153681|FG000|Overall Study|Lack of Efficacy|1|||
42317156|NCT01649765|76153682|FG001|Overall Study|Lack of Efficacy|1|||
42317157|NCT01649765|76153681|FG000|Overall Study|Physician Decision|0|||
42317158|NCT01649765|76153682|FG001|Overall Study|Physician Decision|3|||
42317159|NCT01649765|76153681|FG000|Overall Study|Protocol Violation|1|||
42317160|NCT01649765|76153682|FG001|Overall Study|Protocol Violation|0|||
42317161|NCT01649765|76153681|FG000|Overall Study|Withdrawal by Subject|2|||
42317162|NCT01649765|76153682|FG001|Overall Study|Withdrawal by Subject|1|||
42317163|NCT02317562|76153689|FG000|Overall Study|Physician Decision|1|||
42317164|NCT02317562|76153689|FG000|Overall Study|early termination of the study|8|||
42317165|NCT02317562|76153689|FG000|Overall Study|Lack of Efficacy|4|||
42317166|NCT02317562|76153689|FG000|Overall Study|Withdrawal by Subject|1|||
42317167|NCT02317016|76153693|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
42317168|NCT02317016|76153693|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
42256829|NCT02966509|76083310|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
42256830|NCT02966509|76083311|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
42256831|NCT02966353|76083317|FG000|Overall Study|Withdrawal by Subject|7|||
42256832|NCT02966353|76083317|FG000|Overall Study|Adverse Event|4|||
42256833|NCT02966353|76083317|FG000|Overall Study|Death|4|||
42256834|NCT02966353|76083317|FG000|Overall Study|Physician Decision|3|||
42256835|NCT02966353|76083317|FG000|Overall Study|Progressive disease|2|||
42256836|NCT02966353|76083317|FG000|Overall Study|Protocol deviation|2|||
42256837|NCT02965573|76083350|FG000|Overall Study|Lack of Efficacy|1|||
42317169|NCT02317016|76153693|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
42317170|NCT02317016|76153693|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
42317171|NCT02317016|76153693|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
42317172|NCT02317016|76153693|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
42317173|NCT02317016|76153693|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
41993557|NCT01136356|75801878|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
41993558|NCT01136356|75801879|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
42317174|NCT02311478|76153701|FG000|Overall Study|Withdrawal by Subject|1|||
42256838|NCT02965573|76083351|FG001|Overall Study|Lack of Efficacy|0|||
42317175|NCT02311478|76153701|FG000|Overall Study|Lost to Follow-up|5|||
42317176|NCT02311478|76153701|FG000|Overall Study|Failed IUD Insertion|1|||
42317177|NCT02388932|76153706|FG000|Overall Study|Death|1|||
42317178|NCT02388776|76153711|FG000|Overall Study|Death|1|||
42317179|NCT02388776|76153711|FG000|Overall Study|Lost to Follow-up|1|||
42317180|NCT02316548|76153718|FG000|Overall Study|Protocol Violation|0|||
42317181|NCT02316548|76153719|FG001|Overall Study|Protocol Violation|1|||
42317182|NCT02281760|76153725|FG000|Overall Study|Withdrawal by Subject|1|||
42317183|NCT02390531|76153737|FG000|Overall Study|Death|0|||
42317184|NCT02390531|76153738|FG001|Overall Study|Death|2|||
42317185|NCT02390531|76153739|FG002|Overall Study|Death|0|||
42317186|NCT02390531|76153740|FG003|Overall Study|Death|1|||
42317187|NCT02390531|76153741|FG004|Overall Study|Death|0|||
42317188|NCT02390531|76153742|FG005|Overall Study|Death|0|||
42256839|NCT02964325|76083359|FG000|Overall Study|Lost to Follow-up|3|||
42256840|NCT02964325|76083360|FG001|Overall Study|Lost to Follow-up|3|||
42256841|NCT02964325|76083359|FG000|Overall Study|Physician Decision|5|||
42256842|NCT02964325|76083360|FG001|Overall Study|Physician Decision|4|||
42317189|NCT02390531|76153743|FG006|Overall Study|Death|0|||
42317190|NCT02390531|76153744|FG007|Overall Study|Death|1|||
42317191|NCT02390531|76153737|FG000|Overall Study|Protocol Violation|0|||
42317192|NCT02390531|76153738|FG001|Overall Study|Protocol Violation|0|||
42317193|NCT02390531|76153739|FG002|Overall Study|Protocol Violation|0|||
42317194|NCT02390531|76153740|FG003|Overall Study|Protocol Violation|0|||
42317195|NCT02390531|76153741|FG004|Overall Study|Protocol Violation|1|||
42317196|NCT02390531|76153742|FG005|Overall Study|Protocol Violation|0|||
42256843|NCT02964325|76083359|FG000|Overall Study|Death|1|||
42256844|NCT02964325|76083360|FG001|Overall Study|Death|3|||
42256845|NCT02964325|76083359|FG000|Overall Study|Withdrawal by Subject|2|||
42256846|NCT02964325|76083360|FG001|Overall Study|Withdrawal by Subject|1|||
42256847|NCT02964325|76083359|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
42256848|NCT02964325|76083360|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
42256849|NCT02964247|76083368|FG000|Overall Study|Lost to Follow-up|2|||
42256850|NCT02964247|76083369|FG001|Overall Study|Lost to Follow-up|0|||
42256851|NCT02964247|76083368|FG000|Overall Study|Withdrawal by Subject|1|||
42256852|NCT02964247|76083369|FG001|Overall Study|Withdrawal by Subject|2|||
42256853|NCT03654729|76083378|FG000|Overall Study|Death|9|||
42256854|NCT03654729|76083379|FG001|Overall Study|Death|9|||
42256855|NCT03654729|76083380|FG002|Overall Study|Death|16|||
42256856|NCT03654729|76083378|FG000|Overall Study|Withdrawal by Subject|8|||
42256857|NCT03654729|76083379|FG001|Overall Study|Withdrawal by Subject|6|||
42256858|NCT03654729|76083380|FG002|Overall Study|Withdrawal by Subject|4|||
42317197|NCT02390531|76153743|FG006|Overall Study|Protocol Violation|2|||
42317198|NCT02390531|76153744|FG007|Overall Study|Protocol Violation|0|||
42256859|NCT03654729|76083378|FG000|Overall Study|Study terminated by Sponsor|3|||
42317199|NCT02390219|76153780|FG000|Overall Study|Death|1|||
42317200|NCT02390219|76153780|FG000|Overall Study|Physician Decision|1|||
42317201|NCT02390219|76153780|FG000|Overall Study|Adverse Event|6|||
42317202|NCT02390219|76153780|FG000|Overall Study|Withdrawal by Subject|1|||
42317203|NCT02390219|76153780|FG000|Overall Study|Lost to Follow-up|2|||
42317204|NCT02390219|76153780|FG000|Overall Study|Other|2|||
42317205|NCT02334215|76153787|FG000|Overall Study|Death|1|||
42317206|NCT02334215|76153788|FG001|Overall Study|Death|1|||
42317207|NCT02334215|76153789|FG002|Overall Study|Death|0|||
42317208|NCT02334215|76153787|FG000|Overall Study|Lost to Follow-up|1|||
42317209|NCT02334215|76153788|FG001|Overall Study|Lost to Follow-up|0|||
42317210|NCT02334215|76153789|FG002|Overall Study|Lost to Follow-up|4|||
42317211|NCT02334215|76153787|FG000|Overall Study|Withdrawal by Subject|2|||
42317212|NCT02334215|76153788|FG001|Overall Study|Withdrawal by Subject|2|||
42317213|NCT02334215|76153789|FG002|Overall Study|Withdrawal by Subject|1|||
42317214|NCT02334215|76153787|FG000|Overall Study|Not released from incarceration on time|3|||
42317215|NCT02334215|76153788|FG001|Overall Study|Not released from incarceration on time|3|||
42317216|NCT02334215|76153789|FG002|Overall Study|Not released from incarceration on time|3|||
42317217|NCT02334215|76153787|FG000|Overall Study|Incarcerated|0|||
42317218|NCT02334215|76153788|FG001|Overall Study|Incarcerated|0|||
42317219|NCT02334215|76153789|FG002|Overall Study|Incarcerated|7|||
42317220|NCT02359877|76153801|FG000|Overall Study|Withdrawal by Subject|1|||
42317221|NCT02359877|76153802|FG001|Overall Study|Withdrawal by Subject|0|||
42256860|NCT03654729|76083379|FG001|Overall Study|Study terminated by Sponsor|5|||
42256861|NCT03654729|76083380|FG002|Overall Study|Study terminated by Sponsor|4|||
42317222|NCT02359877|76153803|FG002|Overall Study|Withdrawal by Subject|0|||
42256862|NCT03654729|76083378|FG000|Overall Study|Not reported|2|||
42317223|NCT02359877|76153804|FG003|Overall Study|Withdrawal by Subject|2|||
42317224|NCT02359877|76153801|FG000|Overall Study|Adverse Event|0|||
42317225|NCT02359877|76153802|FG001|Overall Study|Adverse Event|0|||
42317226|NCT02359877|76153803|FG002|Overall Study|Adverse Event|0|||
42317227|NCT02359877|76153804|FG003|Overall Study|Adverse Event|1|||
42317228|NCT02389829|76153834|FG000|Overall Study|Lost to Follow-up|0|||
42317229|NCT02389829|76153835|FG001|Overall Study|Lost to Follow-up|1|||
42317230|NCT02358863|76153841|FG000|Overall Study|Physician Decision|3|||
42317231|NCT02358473|76153845|FG000|Overall Study|Disease Progession|6|||
42317232|NCT02358473|76153845|FG000|Overall Study|Adverse Event|3|||
42317233|NCT02358473|76153845|FG000|Overall Study|Withdrawal by Subject|2|||
42317234|NCT02358473|76153845|FG000|Overall Study|Physician Decision|2|||
42317235|NCT02357459|76153852|FG000|Overall Study|Adverse Event|0|||
42317236|NCT02357459|76153853|FG001|Overall Study|Adverse Event|1|||
42317237|NCT02357459|76153854|FG002|Overall Study|Adverse Event|1|||
42317238|NCT02357459|76153852|FG000|Overall Study|Withdrawal by Subject|5|||
42317239|NCT02357459|76153853|FG001|Overall Study|Withdrawal by Subject|3|||
42317240|NCT02357459|76153854|FG002|Overall Study|Withdrawal by Subject|3|||
42317241|NCT02357459|76153852|FG000|Overall Study|Physician Decision|0|||
42317242|NCT02357459|76153853|FG001|Overall Study|Physician Decision|2|||
42317243|NCT02357459|76153854|FG002|Overall Study|Physician Decision|0|||
42317244|NCT02357459|76153852|FG000|Overall Study|Protocol Violation|1|||
42317245|NCT02357459|76153853|FG001|Overall Study|Protocol Violation|1|||
42317246|NCT02357459|76153854|FG002|Overall Study|Protocol Violation|0|||
42317247|NCT02357459|76153852|FG000|Overall Study|Lost to Follow-up|1|||
42317248|NCT02357459|76153853|FG001|Overall Study|Lost to Follow-up|3|||
42317249|NCT02357459|76153854|FG002|Overall Study|Lost to Follow-up|0|||
42317250|NCT02357459|76153852|FG000|Overall Study|Lack of Efficacy|7|||
42317251|NCT02357459|76153853|FG001|Overall Study|Lack of Efficacy|4|||
42317252|NCT02357459|76153854|FG002|Overall Study|Lack of Efficacy|4|||
42317253|NCT02357459|76153852|FG000|Overall Study|Patient Relocated|2|||
42317254|NCT02357459|76153853|FG001|Overall Study|Patient Relocated|0|||
42317255|NCT02357459|76153854|FG002|Overall Study|Patient Relocated|0|||
42317256|NCT02357459|76153852|FG000|Overall Study|Instruction from PCP|1|||
42256863|NCT03654729|76083379|FG001|Overall Study|Not reported|4|||
42256864|NCT03654729|76083380|FG002|Overall Study|Not reported|5|||
42256865|NCT03654729|76083378|FG000|Overall Study|Progressive disease|3|||
42256866|NCT03654729|76083379|FG001|Overall Study|Progressive disease|0|||
42256867|NCT03654729|76083380|FG002|Overall Study|Progressive disease|0|||
42256868|NCT03654729|76083378|FG000|Overall Study|Lost to Follow-up|2|||
42256869|NCT03654729|76083379|FG001|Overall Study|Lost to Follow-up|0|||
42256870|NCT03654729|76083380|FG002|Overall Study|Lost to Follow-up|0|||
42256871|NCT03654729|76083378|FG000|Overall Study|Physician Decision|2|||
42256872|NCT03654729|76083379|FG001|Overall Study|Physician Decision|0|||
42256873|NCT03654729|76083380|FG002|Overall Study|Physician Decision|0|||
42256874|NCT03654729|76083378|FG000|Overall Study|Protocol Violation|1|||
42256875|NCT03654729|76083379|FG001|Overall Study|Protocol Violation|1|||
42256876|NCT03654729|76083380|FG002|Overall Study|Protocol Violation|0|||
42256877|NCT03654729|76083378|FG000|Overall Study|Non-compliance with study drug|0|||
42256878|NCT03654729|76083379|FG001|Overall Study|Non-compliance with study drug|1|||
42033859|NCT01071954|75842024|FG000|Overall Study|Protocol Specified Criteria|1|||
42033860|NCT00837811|75842031|FG000|Overall Study|Adverse Event|4|||
42033861|NCT00837811|75842032|FG001|Overall Study|Adverse Event|6|||
42033862|NCT00837811|75842033|FG002|Overall Study|Adverse Event|0|||
42033863|NCT00837811|75842031|FG000|Overall Study|Death|1|||
42256879|NCT03654729|76083380|FG002|Overall Study|Non-compliance with study drug|0|||
42317257|NCT02357459|76153853|FG001|Overall Study|Instruction from PCP|0|||
42317258|NCT02357459|76153854|FG002|Overall Study|Instruction from PCP|0|||
42317259|NCT02357459|76153852|FG000|Overall Study|Incarceration|0|||
42317260|NCT02357459|76153853|FG001|Overall Study|Incarceration|0|||
42317261|NCT02357459|76153854|FG002|Overall Study|Incarceration|1|||
42317262|NCT02357459|76153852|FG000|Overall Study|Pre-planned Knee surgery|0|||
42256880|NCT03654729|76083378|FG000|Overall Study|Site terminated by Sponsor|1|||
42256881|NCT03654729|76083379|FG001|Overall Study|Site terminated by Sponsor|0|||
42256882|NCT03654729|76083380|FG002|Overall Study|Site terminated by Sponsor|0|||
42256883|NCT01377987|76083388|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
42256884|NCT01377987|76083389|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
42256885|NCT02898259|76083400|FG000|Overall Study|Adverse Event|0|||
42256886|NCT02898259|76083401|FG001|Overall Study|Adverse Event|0|||
42256887|NCT02898259|76083402|FG002|Overall Study|Adverse Event|1|||
42256888|NCT02898259|76083403|FG003|Overall Study|Adverse Event|0|||
42033864|NCT00837811|75842032|FG001|Overall Study|Death|1|||
42033865|NCT00837811|75842033|FG002|Overall Study|Death|0|||
42256889|NCT02898259|76083404|FG004|Overall Study|Adverse Event|0|||
42256890|NCT02898259|76083400|FG000|Overall Study|Lack of Efficacy|1|||
42256891|NCT02898259|76083401|FG001|Overall Study|Lack of Efficacy|1|||
42256892|NCT02898259|76083402|FG002|Overall Study|Lack of Efficacy|3|||
42256893|NCT02898259|76083403|FG003|Overall Study|Lack of Efficacy|0|||
42256894|NCT02898259|76083404|FG004|Overall Study|Lack of Efficacy|0|||
42317263|NCT02357459|76153853|FG001|Overall Study|Pre-planned Knee surgery|0|||
42317264|NCT02357459|76153854|FG002|Overall Study|Pre-planned Knee surgery|2|||
42317265|NCT02357459|76153852|FG000|Overall Study|Job Commitments|0|||
42317266|NCT02357459|76153853|FG001|Overall Study|Job Commitments|0|||
42317267|NCT02357459|76153854|FG002|Overall Study|Job Commitments|1|||
42317268|NCT02332889|76153865|FG000|Overall Study|Physician Decision|1|||
42317269|NCT02357147|76153871|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
42317270|NCT02357147|76153872|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
42317271|NCT02357147|76153871|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
42317272|NCT02357147|76153872|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
42317273|NCT02357147|76153871|FG000|Combination Treatment Phase|Investigator Discretion|1|||
42317274|NCT02357147|76153872|FG001|Combination Treatment Phase|Investigator Discretion|1|||
42317275|NCT02357147|76153871|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
42317276|NCT02357147|76153872|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
42317277|NCT02357147|76153871|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
42317278|NCT02357147|76153872|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
42317279|NCT02357147|76153871|FG000|Combination Treatment Phase|Adverse Event|12|||
42317280|NCT02357147|76153872|FG001|Combination Treatment Phase|Adverse Event|4|||
42317281|NCT02357147|76153871|FG000|Combination Treatment Phase|Death|1|||
42317282|NCT02357147|76153872|FG001|Combination Treatment Phase|Death|1|||
42317283|NCT02357147|76153871|FG000|Combination Treatment Phase|Sponsor Decision|0|||
42317284|NCT02357147|76153872|FG001|Combination Treatment Phase|Sponsor Decision|12|||
42317285|NCT02357147|76153871|FG000|Combination Treatment Phase|Other|1|||
42317286|NCT02357147|76153872|FG001|Combination Treatment Phase|Other|0|||
42317287|NCT02357147|76153871|FG000|Combination Treatment Phase|Not treated|0|||
42317288|NCT02357147|76153872|FG001|Combination Treatment Phase|Not treated|2|||
42317289|NCT02357147|76153871|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
42317290|NCT02357147|76153872|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
42317291|NCT02357147|76153871|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
42317292|NCT02357147|76153872|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
42317293|NCT02357147|76153871|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
42317294|NCT02357147|76153872|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
42317295|NCT02357147|76153871|FG000|Maintenance Treatment Phase|Adverse Event|0|||
42317296|NCT02357147|76153872|FG001|Maintenance Treatment Phase|Adverse Event|3|||
42317297|NCT02357147|76153871|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
42317298|NCT02357147|76153872|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
42317299|NCT02357147|76153871|FG000|Maintenance Treatment Phase|Not Treated|1|||
42317300|NCT02357147|76153872|FG001|Maintenance Treatment Phase|Not Treated|0|||
42317301|NCT02356211|76153884|FG000|Overall Study|Withdrawal by Subject|2|||
42317302|NCT02356211|76153885|FG001|Overall Study|Withdrawal by Subject|2|||
42317303|NCT02356211|76153884|FG000|Overall Study|ineligible|1|||
42317304|NCT02356211|76153885|FG001|Overall Study|ineligible|8|||
42317305|NCT02332655|76153891|FG000|Overall Study|Lack of Efficacy|1|||
42317306|NCT02388737|76153898|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
42317307|NCT02388737|76153899|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
42317308|NCT02388737|76153900|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
42317309|NCT02388737|76153898|FG000|Overall Study|Major Protocol Deviation|18|||
42317310|NCT02388737|76153899|FG001|Overall Study|Major Protocol Deviation|25|||
42256895|NCT02898259|76083400|FG000|Overall Study|Lost to Follow-up|0|||
42256896|NCT02898259|76083401|FG001|Overall Study|Lost to Follow-up|0|||
42256897|NCT02898259|76083402|FG002|Overall Study|Lost to Follow-up|1|||
42256898|NCT02898259|76083403|FG003|Overall Study|Lost to Follow-up|0|||
42256899|NCT02898259|76083404|FG004|Overall Study|Lost to Follow-up|0|||
42256900|NCT02898259|76083400|FG000|Overall Study|Transformation before study began|0|||
42256901|NCT02898259|76083401|FG001|Overall Study|Transformation before study began|0|||
42256902|NCT02898259|76083402|FG002|Overall Study|Transformation before study began|0|||
42256903|NCT02898259|76083403|FG003|Overall Study|Transformation before study began|1|||
42256904|NCT02898259|76083404|FG004|Overall Study|Transformation before study began|0|||
42256905|NCT02963935|76083419|FG000|Overall Study|Adverse Event|12|||
42256906|NCT02963935|76083420|FG001|Overall Study|Adverse Event|6|||
42256907|NCT02963935|76083419|FG000|Overall Study|Protocol Violation|2|||
42256908|NCT02963935|76083420|FG001|Overall Study|Protocol Violation|1|||
42256909|NCT02963935|76083419|FG000|Overall Study|Lack of Efficacy|0|||
42256910|NCT02963935|76083420|FG001|Overall Study|Lack of Efficacy|2|||
42256911|NCT02963935|76083419|FG000|Overall Study|Lost to Follow-up|1|||
42256912|NCT02963935|76083420|FG001|Overall Study|Lost to Follow-up|6|||
42256913|NCT02963935|76083419|FG000|Overall Study|Unclassified|13|||
42256914|NCT02963935|76083420|FG001|Overall Study|Unclassified|22|||
42256915|NCT02963701|76083428|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
42256916|NCT02963701|76083429|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
42256917|NCT01345591|76083435|FG000|Overall Study|Lost to Follow-up|1|||
42256918|NCT02961751|76083444|FG000|Overall Study|Lost to Follow-up|11|||
42317311|NCT02388737|76153900|FG002|Overall Study|Major Protocol Deviation|22|||
42317312|NCT02388737|76153898|FG000|Overall Study|Lost to Follow-up|5|||
41993559|NCT01136356|75801878|FG000|First 18-day Withdrawal|Physician Decision|1|||
42256919|NCT02961751|76083444|FG000|Overall Study|Physician Decision|2|||
42256920|NCT02961751|76083444|FG000|Overall Study|Not Eligible at Enrollment|1|||
42256921|NCT02961751|76083444|FG000|Overall Study|Protocol Violation|1|||
42317313|NCT02388737|76153899|FG001|Overall Study|Lost to Follow-up|1|||
42317314|NCT02388737|76153900|FG002|Overall Study|Lost to Follow-up|4|||
42317315|NCT02388737|76153898|FG000|Overall Study|Voluntary Withdrawal|10|||
42317316|NCT02388737|76153899|FG001|Overall Study|Voluntary Withdrawal|18|||
42317317|NCT02388737|76153900|FG002|Overall Study|Voluntary Withdrawal|17|||
42317318|NCT02388737|76153898|FG000|Overall Study|Lack of Efficacy|3|||
42317319|NCT02388737|76153899|FG001|Overall Study|Lack of Efficacy|0|||
42317320|NCT02388737|76153900|FG002|Overall Study|Lack of Efficacy|3|||
42317321|NCT02388737|76153898|FG000|Overall Study|Reason Not Specified|5|||
42317322|NCT02388737|76153899|FG001|Overall Study|Reason Not Specified|5|||
42317323|NCT02388737|76153900|FG002|Overall Study|Reason Not Specified|4|||
42317324|NCT02355743|76153908|FG000|Overall Study|Withdrawal by Subject|1|||
42317325|NCT02355743|76153908|FG000|Overall Study|Lost to Follow-up|1|||
42317326|NCT02388347|76153917|FG000|Overall Study|Withdrawal by Subject|0|||
42317327|NCT02388347|76153918|FG001|Overall Study|Withdrawal by Subject|0|||
42317328|NCT02388347|76153919|FG002|Overall Study|Withdrawal by Subject|1|||
42317329|NCT02388347|76153920|FG003|Overall Study|Withdrawal by Subject|0|||
42317330|NCT02388347|76153921|FG004|Overall Study|Withdrawal by Subject|0|||
42317331|NCT02355665|76153939|FG000|Overall Study|Adverse Event|16|||
42317332|NCT02355665|76153940|FG001|Overall Study|Adverse Event|24|||
42317333|NCT02355665|76153939|FG000|Overall Study|Protocol Violation|2|||
42317334|NCT02355665|76153940|FG001|Overall Study|Protocol Violation|0|||
42317335|NCT02355665|76153939|FG000|Overall Study|Withdrawal by Subject|90|||
42317336|NCT02355665|76153940|FG001|Overall Study|Withdrawal by Subject|100|||
42317337|NCT02355665|76153939|FG000|Overall Study|Lost to Follow-up|131|||
42317338|NCT02355665|76153940|FG001|Overall Study|Lost to Follow-up|103|||
42317339|NCT02355665|76153939|FG000|Overall Study|Death|4|||
42317340|NCT02355665|76153940|FG001|Overall Study|Death|2|||
42317341|NCT02355665|76153939|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
42317342|NCT02355665|76153940|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
42317343|NCT02010255|76153960|FG000|Overall Study|Death|0|||
42317344|NCT02010255|76153961|FG001|Overall Study|Death|1|||
42317345|NCT02010255|76153962|FG002|Overall Study|Death|4|||
42317346|NCT02010255|76153963|FG003|Overall Study|Death|4|||
42317347|NCT02010255|76153964|FG004|Overall Study|Death|2|||
42317348|NCT02010255|76153965|FG005|Overall Study|Death|0|||
42317349|NCT02010255|76153966|FG006|Overall Study|Death|1|||
42317350|NCT02010255|76153967|FG007|Overall Study|Death|1|||
42317351|NCT02010255|76153968|FG008|Overall Study|Death|1|||
42317352|NCT02010255|76153969|FG009|Overall Study|Death|0|||
42317353|NCT02010255|76153970|FG010|Overall Study|Death|1|||
42317354|NCT02010255|76153971|FG011|Overall Study|Death|1|||
42317355|NCT02010255|76153972|FG012|Overall Study|Death|0|||
42317356|NCT02010255|76153973|FG013|Overall Study|Death|0|||
42317357|NCT02010255|76153960|FG000|Overall Study|Lack of Efficacy|4|||
42256922|NCT02963311|76083448|FG000|Overall Study|Withdrawal by Subject|1|||
42256923|NCT02963311|76083448|FG000|Overall Study|Screen Failure|4|||
42256924|NCT02962765|76083452|FG000|Overall Study|Protocol Violation|9|||
42256925|NCT02962765|76083452|FG000|Overall Study|Withdrawal by Subject|3|||
42256926|NCT02962765|76083452|FG000|Overall Study|Lost to Follow-up|1|||
42256927|NCT02962765|76083452|FG000|Overall Study|Death|1|||
42256928|NCT02962765|76083452|FG000|Overall Study|Limited access to study medication|3|||
42256929|NCT00965757|76083465|FG000|Double-blind Phase|Progression of concomitant disease|1|||
42256930|NCT00965757|76083466|FG001|Double-blind Phase|Progression of concomitant disease|2|||
42317358|NCT02010255|76153961|FG001|Overall Study|Lack of Efficacy|1|||
42317359|NCT02010255|76153962|FG002|Overall Study|Lack of Efficacy|2|||
42317360|NCT02010255|76153963|FG003|Overall Study|Lack of Efficacy|1|||
42317361|NCT02010255|76153964|FG004|Overall Study|Lack of Efficacy|1|||
42317362|NCT02010255|76153965|FG005|Overall Study|Lack of Efficacy|0|||
42317363|NCT02010255|76153966|FG006|Overall Study|Lack of Efficacy|0|||
42256931|NCT00965757|76083467|FG002|Double-blind Phase|Progression of concomitant disease|0|||
42317364|NCT02010255|76153967|FG007|Overall Study|Lack of Efficacy|0|||
42317365|NCT02010255|76153968|FG008|Overall Study|Lack of Efficacy|0|||
42317366|NCT02010255|76153969|FG009|Overall Study|Lack of Efficacy|0|||
42317367|NCT02010255|76153970|FG010|Overall Study|Lack of Efficacy|1|||
42317368|NCT02010255|76153971|FG011|Overall Study|Lack of Efficacy|0|||
42317369|NCT02010255|76153972|FG012|Overall Study|Lack of Efficacy|0|||
42317370|NCT02010255|76153973|FG013|Overall Study|Lack of Efficacy|0|||
42317371|NCT02010255|76153960|FG000|Overall Study|Withdrew Consent|1|||
42317372|NCT02010255|76153961|FG001|Overall Study|Withdrew Consent|0|||
42317373|NCT02010255|76153962|FG002|Overall Study|Withdrew Consent|0|||
42317374|NCT02010255|76153963|FG003|Overall Study|Withdrew Consent|1|||
42317375|NCT02010255|76153964|FG004|Overall Study|Withdrew Consent|0|||
42317376|NCT02010255|76153965|FG005|Overall Study|Withdrew Consent|0|||
42317377|NCT02010255|76153966|FG006|Overall Study|Withdrew Consent|0|||
42317378|NCT02010255|76153967|FG007|Overall Study|Withdrew Consent|0|||
42317379|NCT02010255|76153968|FG008|Overall Study|Withdrew Consent|0|||
42317380|NCT02010255|76153969|FG009|Overall Study|Withdrew Consent|0|||
42317381|NCT02010255|76153970|FG010|Overall Study|Withdrew Consent|0|||
42317382|NCT02010255|76153971|FG011|Overall Study|Withdrew Consent|0|||
42317383|NCT02010255|76153972|FG012|Overall Study|Withdrew Consent|0|||
42317384|NCT02010255|76153973|FG013|Overall Study|Withdrew Consent|0|||
42317385|NCT02010255|76153960|FG000|Overall Study|Adverse Event|1|||
42317386|NCT02010255|76153961|FG001|Overall Study|Adverse Event|0|||
42317387|NCT02010255|76153962|FG002|Overall Study|Adverse Event|0|||
42317388|NCT02010255|76153963|FG003|Overall Study|Adverse Event|0|||
42317389|NCT02010255|76153964|FG004|Overall Study|Adverse Event|0|||
42317390|NCT02010255|76153965|FG005|Overall Study|Adverse Event|0|||
42317391|NCT02010255|76153966|FG006|Overall Study|Adverse Event|0|||
42317392|NCT02010255|76153967|FG007|Overall Study|Adverse Event|0|||
42317393|NCT02010255|76153968|FG008|Overall Study|Adverse Event|0|||
42317394|NCT02010255|76153969|FG009|Overall Study|Adverse Event|0|||
42317395|NCT02010255|76153970|FG010|Overall Study|Adverse Event|0|||
42317396|NCT02010255|76153971|FG011|Overall Study|Adverse Event|0|||
42317397|NCT02010255|76153972|FG012|Overall Study|Adverse Event|0|||
42317398|NCT02010255|76153973|FG013|Overall Study|Adverse Event|0|||
42317399|NCT02010255|76153960|FG000|Overall Study|Lost to Follow-up|0|||
42317400|NCT02010255|76153961|FG001|Overall Study|Lost to Follow-up|0|||
42317401|NCT02010255|76153962|FG002|Overall Study|Lost to Follow-up|1|||
42317402|NCT02010255|76153963|FG003|Overall Study|Lost to Follow-up|0|||
42317403|NCT02010255|76153964|FG004|Overall Study|Lost to Follow-up|1|||
42317404|NCT02010255|76153965|FG005|Overall Study|Lost to Follow-up|0|||
42317405|NCT02010255|76153966|FG006|Overall Study|Lost to Follow-up|0|||
42317406|NCT02010255|76153967|FG007|Overall Study|Lost to Follow-up|0|||
42317407|NCT02010255|76153968|FG008|Overall Study|Lost to Follow-up|0|||
42317408|NCT02010255|76153969|FG009|Overall Study|Lost to Follow-up|0|||
42317409|NCT02010255|76153970|FG010|Overall Study|Lost to Follow-up|0|||
42317410|NCT02010255|76153971|FG011|Overall Study|Lost to Follow-up|0|||
42317411|NCT02010255|76153972|FG012|Overall Study|Lost to Follow-up|0|||
42317412|NCT02010255|76153973|FG013|Overall Study|Lost to Follow-up|0|||
42317413|NCT02010255|76153960|FG000|Overall Study|Randomized but Not Treated|0|||
42317414|NCT02010255|76153961|FG001|Overall Study|Randomized but Not Treated|0|||
42317415|NCT02010255|76153962|FG002|Overall Study|Randomized but Not Treated|0|||
42317416|NCT02010255|76153963|FG003|Overall Study|Randomized but Not Treated|0|||
42317417|NCT02010255|76153964|FG004|Overall Study|Randomized but Not Treated|0|||
42317418|NCT02010255|76153965|FG005|Overall Study|Randomized but Not Treated|0|||
42317419|NCT02010255|76153966|FG006|Overall Study|Randomized but Not Treated|0|||
42317420|NCT02010255|76153967|FG007|Overall Study|Randomized but Not Treated|0|||
42317421|NCT02010255|76153968|FG008|Overall Study|Randomized but Not Treated|0|||
42317422|NCT02010255|76153969|FG009|Overall Study|Randomized but Not Treated|0|||
42317423|NCT02010255|76153970|FG010|Overall Study|Randomized but Not Treated|0|||
42317424|NCT02010255|76153971|FG011|Overall Study|Randomized but Not Treated|0|||
42317425|NCT02010255|76153972|FG012|Overall Study|Randomized but Not Treated|0|||
42317426|NCT02010255|76153973|FG013|Overall Study|Randomized but Not Treated|1|||
42317427|NCT02354417|76154028|FG000|Overall Study|Physician Decision|1|||
42317428|NCT02332187|76154034|FG000|Overall Study|Withdrawal by Subject|2|||
42317429|NCT02332187|76154035|FG001|Overall Study|Withdrawal by Subject|2|||
42317430|NCT02332187|76154034|FG000|Overall Study|Adverse Event|0|||
42317431|NCT02332187|76154035|FG001|Overall Study|Adverse Event|1|||
42317432|NCT02330549|76154043|FG000|Overall Study|Adverse Event|1|||
42317433|NCT02330549|76154044|FG001|Overall Study|Adverse Event|0|||
42317434|NCT02330549|76154043|FG000|Overall Study|Subject withdrew consent|2|||
42317435|NCT02330549|76154044|FG001|Overall Study|Subject withdrew consent|1|||
42317436|NCT02330549|76154043|FG000|Overall Study|Failure to meet randomization criteria|1|||
42317437|NCT02330549|76154044|FG001|Overall Study|Failure to meet randomization criteria|0|||
42317438|NCT02009865|76154052|FG000|Overall Study|Adverse Event|0|||
42317439|NCT02009865|76154053|FG001|Overall Study|Adverse Event|2|||
42317440|NCT02009865|76154052|FG000|Overall Study|Protocol Violation|0|||
42317441|NCT02009865|76154053|FG001|Overall Study|Protocol Violation|2|||
42317442|NCT02009865|76154052|FG000|Overall Study|Withdrawal by Subject|1|||
42317443|NCT02009865|76154053|FG001|Overall Study|Withdrawal by Subject|1|||
42317444|NCT01620177|76154059|FG000|Overall Study|Failure at Screening Visit|43|||
42317445|NCT01620177|76154059|FG000|Overall Study|Withdrawal by Subject|26|||
42317446|NCT01620177|76154059|FG000|Overall Study|Lost to Follow-up|7|||
42317447|NCT01620177|76154059|FG000|Overall Study|Physician Decision|2|||
42317448|NCT01620177|76154059|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
42317449|NCT02075541|76154078|FG000|Overall Study|Serious Adverse Event|1|||
42317450|NCT02075541|76154079|FG001|Overall Study|Serious Adverse Event|4|||
42317451|NCT02075541|76154078|FG000|Overall Study|Protocol Violation|1|||
42317452|NCT02075541|76154079|FG001|Overall Study|Protocol Violation|0|||
42317453|NCT02075541|76154078|FG000|Overall Study|Withdrawal by Subject|1|||
42317454|NCT02075541|76154079|FG001|Overall Study|Withdrawal by Subject|3|||
42317455|NCT02075541|76154078|FG000|Overall Study|Sponsor study termination|0|||
42317456|NCT02075541|76154079|FG001|Overall Study|Sponsor study termination|1|||
42317457|NCT02075541|76154078|FG000|Overall Study|Other- unable to perform study procedure|1|||
42317458|NCT02075541|76154079|FG001|Overall Study|Other- unable to perform study procedure|0|||
42317459|NCT02330081|76154085|FG000|Overall Study|Adverse Event|1|||
42317460|NCT02330081|76154085|FG000|Overall Study|Donation did not meet criteria|1|||
42317461|NCT02330081|76154085|FG000|Overall Study|Protocol Violation|6|||
42317462|NCT01986855|76154095|FG000|Overall Study|Adverse Event|1|||
42317463|NCT01986855|76154096|FG001|Overall Study|Adverse Event|0|||
42317464|NCT01986855|76154097|FG002|Overall Study|Adverse Event|0|||
42317465|NCT01986855|76154095|FG000|Overall Study|Death|3|||
42317466|NCT01986855|76154096|FG001|Overall Study|Death|4|||
42317467|NCT01986855|76154097|FG002|Overall Study|Death|4|||
42317468|NCT01986855|76154095|FG000|Overall Study|Lost to Follow-up|2|||
42317469|NCT01986855|76154096|FG001|Overall Study|Lost to Follow-up|1|||
42317470|NCT01986855|76154097|FG002|Overall Study|Lost to Follow-up|0|||
42317471|NCT01986855|76154095|FG000|Overall Study|Screen Failure|0|||
42317472|NCT01986855|76154096|FG001|Overall Study|Screen Failure|1|||
42317473|NCT01986855|76154097|FG002|Overall Study|Screen Failure|0|||
42317474|NCT01986855|76154095|FG000|Overall Study|Participant Moved|0|||
42256932|NCT00965757|76083468|FG003|Double-blind Phase|Progression of concomitant disease|0|||
42317475|NCT01986855|76154096|FG001|Overall Study|Participant Moved|0|||
42317476|NCT01986855|76154097|FG002|Overall Study|Participant Moved|2|||
42317477|NCT01986855|76154095|FG000|Overall Study|Withdrawal by Subject|7|||
42317478|NCT01986855|76154096|FG001|Overall Study|Withdrawal by Subject|8|||
42317479|NCT01986855|76154097|FG002|Overall Study|Withdrawal by Subject|5|||
42317480|NCT02075463|76154105|FG000|Overall Study|Adverse Event|3|||
42317481|NCT02075463|76154105|FG000|Overall Study|Par. reached stopping criteria|4|||
42317482|NCT02075463|76154105|FG000|Overall Study|Withdrawal by Subject|1|||
42317483|NCT02353871|76154112|FG000|Overall Study|Protocol deviation|0|||
42317484|NCT02353871|76154113|FG001|Overall Study|Protocol deviation|1|||
42317485|NCT02353871|76154112|FG000|Overall Study|Consent withdrawn|1|||
42317486|NCT02353871|76154113|FG001|Overall Study|Consent withdrawn|8|||
42317487|NCT02353871|76154112|FG000|Overall Study|Lost to Follow-up|2|||
42317488|NCT02353871|76154113|FG001|Overall Study|Lost to Follow-up|0|||
42317489|NCT02009397|76154119|FG000|Overall Study|Protocol Violation|6|||
42317490|NCT02009397|76154119|FG000|Overall Study|Death|8|||
41993560|NCT01136356|75801879|FG001|First 18-day Withdrawal|Physician Decision|0|||
41993561|NCT01136356|75801878|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
42256933|NCT00965757|76083465|FG000|Double-blind Phase|Adverse drug reaction|2|||
42256934|NCT00965757|76083466|FG001|Double-blind Phase|Adverse drug reaction|1|||
42256935|NCT00965757|76083467|FG002|Double-blind Phase|Adverse drug reaction|0|||
42256936|NCT00965757|76083468|FG003|Double-blind Phase|Adverse drug reaction|0|||
42256937|NCT00965757|76083465|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
42256938|NCT00965757|76083466|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
42256939|NCT00965757|76083467|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
42256940|NCT00965757|76083468|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
42256941|NCT00965757|76083465|FG000|Double-blind Phase|Lack of Efficacy|7|||
42256942|NCT00965757|76083466|FG001|Double-blind Phase|Lack of Efficacy|11|||
42256943|NCT00965757|76083467|FG002|Double-blind Phase|Lack of Efficacy|0|||
42256944|NCT00965757|76083468|FG003|Double-blind Phase|Lack of Efficacy|0|||
42256945|NCT00965757|76083465|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
42256946|NCT00965757|76083466|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
42256947|NCT00965757|76083467|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
42256948|NCT00965757|76083468|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
42256949|NCT00965757|76083465|FG000|Double-blind Phase|Lost to Follow-up|0|||
42256950|NCT00965757|76083466|FG001|Double-blind Phase|Lost to Follow-up|1|||
42256951|NCT00965757|76083467|FG002|Double-blind Phase|Lost to Follow-up|0|||
42256952|NCT00965757|76083468|FG003|Double-blind Phase|Lost to Follow-up|0|||
42256953|NCT00965757|76083465|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
42256954|NCT00965757|76083466|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
42256955|NCT00965757|76083467|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
42256956|NCT00965757|76083468|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
42256957|NCT00965757|76083465|FG000|Double-blind Phase|Other|1|||
42256958|NCT00965757|76083466|FG001|Double-blind Phase|Other|0|||
42256959|NCT00965757|76083467|FG002|Double-blind Phase|Other|0|||
42256960|NCT00965757|76083468|FG003|Double-blind Phase|Other|0|||
42256961|NCT00965757|76083465|FG000|Extension Phase|Progression of concomitant disease|0|||
42256962|NCT00965757|76083466|FG001|Extension Phase|Progression of concomitant disease|0|||
42256963|NCT00965757|76083467|FG002|Extension Phase|Progression of concomitant disease|4|||
42317491|NCT02009397|76154119|FG000|Overall Study|Lost to Follow-up|6|||
42317492|NCT02312219|76154125|FG000|Overall Study|Withdrawal by Subject|1|||
42317493|NCT02312219|76154126|FG001|Overall Study|Withdrawal by Subject|2|||
42317494|NCT02312219|76154125|FG000|Overall Study|could not schedule imaging in time|0|||
41993562|NCT01136356|75801879|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
41993563|NCT00196326|75801884|FG000|Overall Study|Did not meet protocol requirements|64|||
42256964|NCT00965757|76083468|FG003|Extension Phase|Progression of concomitant disease|2|||
42256965|NCT00965757|76083465|FG000|Extension Phase|Adverse drug reaction|0|||
42317495|NCT02312219|76154126|FG001|Overall Study|could not schedule imaging in time|2|||
42317496|NCT02312219|76154125|FG000|Overall Study|Other|0|||
42317497|NCT02312219|76154126|FG001|Overall Study|Other|1|||
42317498|NCT02312219|76154125|FG000|Overall Study|Not randomized. Ineligible|0|||
42317499|NCT02312219|76154126|FG001|Overall Study|Not randomized. Ineligible|1|||
42317500|NCT01986231|76154132|FG000|Overall Study|Adverse Event|1|||
42317501|NCT02312063|76154138|FG000|Overall Study|Withdrawal by Subject|0|||
42317502|NCT02312063|76154139|FG001|Overall Study|Withdrawal by Subject|1|||
42317503|NCT02353169|76154150|FG000|Overall Study|QTc > 450 msec|1|||
42317504|NCT02353169|76154151|FG001|Overall Study|QTc > 450 msec|1|||
42317505|NCT02353169|76154152|FG002|Overall Study|QTc > 450 msec|1|||
42317506|NCT02353169|76154153|FG003|Overall Study|QTc > 450 msec|1|||
42317507|NCT02353169|76154150|FG000|Overall Study|OR team declined|2|||
42317508|NCT02353169|76154151|FG001|Overall Study|OR team declined|0|||
42317509|NCT02353169|76154152|FG002|Overall Study|OR team declined|0|||
42317510|NCT02353169|76154153|FG003|Overall Study|OR team declined|0|||
42317511|NCT02353169|76154150|FG000|Overall Study|Inhalational induction|0|||
42317512|NCT02353169|76154151|FG001|Overall Study|Inhalational induction|2|||
42317513|NCT02353169|76154152|FG002|Overall Study|Inhalational induction|0|||
42317514|NCT02353169|76154153|FG003|Overall Study|Inhalational induction|0|||
42317515|NCT02353169|76154150|FG000|Overall Study|ECG data error|0|||
42317516|NCT02353169|76154151|FG001|Overall Study|ECG data error|3|||
42317517|NCT02353169|76154152|FG002|Overall Study|ECG data error|2|||
42317518|NCT02353169|76154153|FG003|Overall Study|ECG data error|2|||
42317519|NCT02353169|76154150|FG000|Overall Study|Pre-op medication|0|||
42317520|NCT02353169|76154151|FG001|Overall Study|Pre-op medication|0|||
42317521|NCT02353169|76154152|FG002|Overall Study|Pre-op medication|1|||
42317522|NCT02353169|76154153|FG003|Overall Study|Pre-op medication|0|||
42317523|NCT02009163|76154163|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
42317524|NCT02009163|76154164|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
42317525|NCT02009163|76154165|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
42317526|NCT02009163|76154163|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
42317527|NCT02009163|76154164|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
42317528|NCT02009163|76154165|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
42317529|NCT02009163|76154163|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
42317530|NCT02009163|76154164|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
42317531|NCT02009163|76154165|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
42317532|NCT02009163|76154163|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
42317533|NCT02009163|76154164|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
42317534|NCT02009163|76154165|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
42317535|NCT02009163|76154163|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
42317536|NCT02009163|76154164|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
42317537|NCT02009163|76154165|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
42317538|NCT02009163|76154163|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
42317539|NCT02009163|76154164|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
42317540|NCT02009163|76154165|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
42317541|NCT02009163|76154163|FG000|Open-label Period (Non-randomized)|Other|13|||
41993564|NCT00196326|75801884|FG000|Overall Study|Non-compliance with the protocol|81|||
41993565|NCT00196326|75801884|FG000|Overall Study|Physician Decision|3|||
41993566|NCT00196326|75801884|FG000|Overall Study|Withdrawal by Subject|225|||
41993567|NCT00196326|75801884|FG000|Overall Study|Adverse Event|253|||
41993568|NCT00196326|75801884|FG000|Overall Study|Pregnancy|34|||
41993569|NCT00196326|75801884|FG000|Overall Study|Lost to Follow-up|304|||
41993570|NCT00196326|75801884|FG000|Overall Study|Other|22|||
41993571|NCT00195663|75801891|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
41993572|NCT00195663|75801892|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
41993573|NCT00195663|75801893|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
41993574|NCT00195663|75801891|FG000|2-year Double-blind Treatment Period|Death|0|||
41993575|NCT00195663|75801892|FG001|2-year Double-blind Treatment Period|Death|2|||
41993576|NCT00195663|75801893|FG002|2-year Double-blind Treatment Period|Death|0|||
41993577|NCT00195663|75801891|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
41993578|NCT00195663|75801892|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
42317542|NCT02009163|76154164|FG001|Open-label Period (Non-randomized)|Other|0|||
42317543|NCT02009163|76154165|FG002|Open-label Period (Non-randomized)|Other|0|||
42317544|NCT02009163|76154163|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
42317545|NCT02009163|76154164|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
42317546|NCT02009163|76154165|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
41993579|NCT00195663|75801893|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
41993580|NCT00195663|75801891|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
41993581|NCT00195663|75801892|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
41993582|NCT00195663|75801893|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
41993583|NCT00195663|75801891|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
41993584|NCT00195663|75801892|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
41993585|NCT00195663|75801893|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
41993586|NCT00195663|75801891|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
41993587|NCT00195663|75801892|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
41993588|NCT00195663|75801893|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
41993589|NCT00195663|75801891|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
41993590|NCT00195663|75801892|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
41993591|NCT00195663|75801893|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
41993592|NCT00195663|75801891|FG000|2-year Double-blind Treatment Period|Recovery|1|||
41993593|NCT00195663|75801892|FG001|2-year Double-blind Treatment Period|Recovery|0|||
41993594|NCT00195663|75801893|FG002|2-year Double-blind Treatment Period|Recovery|1|||
41993595|NCT00195663|75801891|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
41993596|NCT00195663|75801892|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
41993597|NCT00195663|75801893|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
41993598|NCT00195663|75801891|FG000|Open-Label Extension Period|Adverse Event|21|||
41993599|NCT00195663|75801892|FG001|Open-Label Extension Period|Adverse Event|32|||
41993600|NCT00195663|75801893|FG002|Open-Label Extension Period|Adverse Event|36|||
41993601|NCT00195663|75801891|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
42317547|NCT02009163|76154163|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
42317548|NCT02009163|76154164|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
42317549|NCT02009163|76154165|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
42317550|NCT02009163|76154163|FG000|Randomized-withdrawal Period|Adverse Event|0|||
42317551|NCT02009163|76154164|FG001|Randomized-withdrawal Period|Adverse Event|0|||
42317552|NCT02009163|76154165|FG002|Randomized-withdrawal Period|Adverse Event|6|||
42317553|NCT02009163|76154163|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
42317554|NCT02009163|76154164|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
42317555|NCT02009163|76154165|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
42317556|NCT02009163|76154163|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
42317557|NCT02009163|76154164|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
42317558|NCT02009163|76154165|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
42317559|NCT02009163|76154163|FG000|Randomized-withdrawal Period|Pregnancy|0|||
42317560|NCT02009163|76154164|FG001|Randomized-withdrawal Period|Pregnancy|0|||
42317561|NCT02009163|76154165|FG002|Randomized-withdrawal Period|Pregnancy|2|||
42317562|NCT02009163|76154163|FG000|Randomized-withdrawal Period|Other|0|||
42317563|NCT02009163|76154164|FG001|Randomized-withdrawal Period|Other|9|||
42317564|NCT02009163|76154165|FG002|Randomized-withdrawal Period|Other|5|||
42317565|NCT01983969|76154178|FG000|Overall Study|Disease Progression|0|||
42317566|NCT01983969|76154179|FG001|Overall Study|Disease Progression|1|||
41993602|NCT00195663|75801892|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
41993603|NCT00195663|75801893|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
41993604|NCT00195663|75801891|FG000|Open-Label Extension Period|Recovery|0|||
42256966|NCT00965757|76083466|FG001|Extension Phase|Adverse drug reaction|0|||
42256967|NCT00965757|76083467|FG002|Extension Phase|Adverse drug reaction|6|||
42256968|NCT00965757|76083468|FG003|Extension Phase|Adverse drug reaction|3|||
42256969|NCT00965757|76083465|FG000|Extension Phase|Abnormal Laboratory Value|0|||
42256970|NCT00965757|76083466|FG001|Extension Phase|Abnormal Laboratory Value|0|||
42256971|NCT00965757|76083467|FG002|Extension Phase|Abnormal Laboratory Value|6|||
42256972|NCT00965757|76083468|FG003|Extension Phase|Abnormal Laboratory Value|1|||
42256973|NCT00965757|76083465|FG000|Extension Phase|Lack of Efficacy|0|||
42256974|NCT00965757|76083466|FG001|Extension Phase|Lack of Efficacy|0|||
42256975|NCT00965757|76083467|FG002|Extension Phase|Lack of Efficacy|8|||
42317567|NCT01983969|76154180|FG002|Overall Study|Disease Progression|0|||
42317568|NCT02008773|76154196|FG000|Overall Study|Adverse Event|3|||
42317569|NCT02008773|76154197|FG001|Overall Study|Adverse Event|3|||
42317570|NCT02008773|76154198|FG002|Overall Study|Adverse Event|1|||
42317571|NCT02008773|76154199|FG003|Overall Study|Adverse Event|2|||
42317572|NCT02008773|76154196|FG000|Overall Study|Medication Non-compliance|2|||
42317573|NCT02008773|76154197|FG001|Overall Study|Medication Non-compliance|1|||
42317574|NCT02008773|76154198|FG002|Overall Study|Medication Non-compliance|3|||
42317575|NCT02008773|76154199|FG003|Overall Study|Medication Non-compliance|2|||
42317576|NCT02008773|76154196|FG000|Overall Study|Withdrawal by Subject|8|||
42317577|NCT02008773|76154197|FG001|Overall Study|Withdrawal by Subject|4|||
42317578|NCT02008773|76154198|FG002|Overall Study|Withdrawal by Subject|7|||
42317579|NCT02008773|76154199|FG003|Overall Study|Withdrawal by Subject|6|||
42317580|NCT02008773|76154196|FG000|Overall Study|Lost to Follow-up|0|||
42317581|NCT02008773|76154197|FG001|Overall Study|Lost to Follow-up|1|||
42317582|NCT02008773|76154198|FG002|Overall Study|Lost to Follow-up|3|||
42317583|NCT02008773|76154199|FG003|Overall Study|Lost to Follow-up|2|||
42317584|NCT02257567|76154218|FG000|Overall Study|Adverse Event|0|||
42317585|NCT02257567|76154219|FG001|Overall Study|Adverse Event|0|||
42317586|NCT02257567|76154220|FG002|Overall Study|Adverse Event|0|||
42317587|NCT02257567|76154221|FG003|Overall Study|Adverse Event|1|||
42317588|NCT02257567|76154222|FG004|Overall Study|Adverse Event|1|||
42317589|NCT02257567|76154223|FG005|Overall Study|Adverse Event|0|||
42317590|NCT02257567|76154224|FG006|Overall Study|Adverse Event|0|||
42317591|NCT02257567|76154225|FG007|Overall Study|Adverse Event|0|||
42317592|NCT02257567|76154226|FG008|Overall Study|Adverse Event|1|||
42317593|NCT02257567|76154227|FG009|Overall Study|Adverse Event|0|||
42317594|NCT02257567|76154228|FG010|Overall Study|Adverse Event|0|||
42317595|NCT02257567|76154218|FG000|Overall Study|Death|2|||
42317596|NCT02257567|76154219|FG001|Overall Study|Death|2|||
41993605|NCT00195663|75801892|FG001|Open-Label Extension Period|Recovery|2|||
42317597|NCT02257567|76154220|FG002|Overall Study|Death|2|||
42317598|NCT02257567|76154221|FG003|Overall Study|Death|4|||
42317599|NCT02257567|76154222|FG004|Overall Study|Death|15|||
42317600|NCT02257567|76154223|FG005|Overall Study|Death|11|||
42317601|NCT02257567|76154224|FG006|Overall Study|Death|26|||
42317602|NCT02257567|76154225|FG007|Overall Study|Death|30|||
42317603|NCT02257567|76154226|FG008|Overall Study|Death|2|||
42317604|NCT02257567|76154227|FG009|Overall Study|Death|18|||
42317605|NCT02257567|76154228|FG010|Overall Study|Death|65|||
42317606|NCT02257567|76154218|FG000|Overall Study|Lost to Follow-up|0|||
42317607|NCT02257567|76154219|FG001|Overall Study|Lost to Follow-up|0|||
42317608|NCT02257567|76154220|FG002|Overall Study|Lost to Follow-up|0|||
42317609|NCT02257567|76154221|FG003|Overall Study|Lost to Follow-up|0|||
42317610|NCT02257567|76154222|FG004|Overall Study|Lost to Follow-up|2|||
42317611|NCT02257567|76154223|FG005|Overall Study|Lost to Follow-up|2|||
42317612|NCT02257567|76154224|FG006|Overall Study|Lost to Follow-up|0|||
42317613|NCT02257567|76154225|FG007|Overall Study|Lost to Follow-up|0|||
42256976|NCT00965757|76083468|FG003|Extension Phase|Lack of Efficacy|12|||
42256977|NCT00965757|76083465|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
42256978|NCT00965757|76083466|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
42256979|NCT00965757|76083467|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
42256980|NCT00965757|76083468|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
42256981|NCT00965757|76083465|FG000|Extension Phase|Lost to Follow-up|0|||
42256982|NCT00965757|76083466|FG001|Extension Phase|Lost to Follow-up|0|||
42256983|NCT00965757|76083467|FG002|Extension Phase|Lost to Follow-up|0|||
42256984|NCT00965757|76083468|FG003|Extension Phase|Lost to Follow-up|1|||
42256985|NCT00965757|76083465|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
42317614|NCT02257567|76154226|FG008|Overall Study|Lost to Follow-up|0|||
42317615|NCT02257567|76154227|FG009|Overall Study|Lost to Follow-up|1|||
42317616|NCT02257567|76154228|FG010|Overall Study|Lost to Follow-up|1|||
41993606|NCT00195663|75801893|FG002|Open-Label Extension Period|Recovery|2|||
42317617|NCT02257567|76154218|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
42317618|NCT02257567|76154219|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
42317619|NCT02257567|76154220|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
42317620|NCT02257567|76154221|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
42317621|NCT02257567|76154222|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
42033866|NCT00837811|75842031|FG000|Overall Study|Lack of Efficacy|0|||
42256986|NCT00965757|76083466|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
42256987|NCT00965757|76083467|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
42256988|NCT00965757|76083468|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
42256989|NCT00965757|76083465|FG000|Extension Phase|Protocol Violation|0|||
42256990|NCT00965757|76083466|FG001|Extension Phase|Protocol Violation|0|||
42256991|NCT00965757|76083467|FG002|Extension Phase|Protocol Violation|0|||
42256992|NCT00965757|76083468|FG003|Extension Phase|Protocol Violation|1|||
42256993|NCT00965757|76083465|FG000|Extension Phase|Other|0|||
42256994|NCT00965757|76083466|FG001|Extension Phase|Other|0|||
42256995|NCT00965757|76083467|FG002|Extension Phase|Other|2|||
42256996|NCT00965757|76083468|FG003|Extension Phase|Other|1|||
42256997|NCT03072459|76083476|FG000|Overall Study|Device revised/removed|1|||
42256998|NCT03072459|76083476|FG000|Overall Study|Subject not able to return|1|||
42256999|NCT01067521|76083482|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
42257000|NCT01067521|76083483|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
42257001|NCT01067521|76083482|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
42257002|NCT01067521|76083483|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
42257003|NCT01067521|76083482|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
42257004|NCT01067521|76083483|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
42257005|NCT01067521|76083482|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
42257006|NCT01067521|76083483|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
42257007|NCT01067521|76083482|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
42257008|NCT01067521|76083483|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
42257009|NCT01067521|76083482|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
42257010|NCT01067521|76083483|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
42257011|NCT01067521|76083482|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
42257012|NCT01067521|76083483|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
42257013|NCT01067521|76083482|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
42257014|NCT01067521|76083483|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
42257015|NCT01067521|76083482|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
42257016|NCT01067521|76083483|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
42257017|NCT01067521|76083482|FG000|Open-Label Period|Death|3|||
42257018|NCT01067521|76083483|FG001|Open-Label Period|Death|1|||
42257019|NCT01067521|76083482|FG000|Open-Label Period|Adverse Event|30|||
42257020|NCT01067521|76083483|FG001|Open-Label Period|Adverse Event|28|||
42257021|NCT01067521|76083482|FG000|Open-Label Period|Withdrawal by Subject|160|||
42257022|NCT01067521|76083483|FG001|Open-Label Period|Withdrawal by Subject|88|||
42257023|NCT01067521|76083482|FG000|Open-Label Period|Physician Decision|13|||
42257024|NCT01067521|76083483|FG001|Open-Label Period|Physician Decision|11|||
42257025|NCT01067521|76083482|FG000|Open-Label Period|Non-compliance with study drug|5|||
42257026|NCT01067521|76083483|FG001|Open-Label Period|Non-compliance with study drug|0|||
42257027|NCT01067521|76083482|FG000|Open-Label Period|Protocol Violation|3|||
42257028|NCT01067521|76083483|FG001|Open-Label Period|Protocol Violation|0|||
42257029|NCT01067521|76083482|FG000|Open-Label Period|Pregnancy|14|||
42257030|NCT01067521|76083483|FG001|Open-Label Period|Pregnancy|8|||
42257031|NCT01067521|76083482|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
42257032|NCT01067521|76083483|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
42257033|NCT01067521|76083482|FG000|Open-Label Period|Lost to Follow-up|21|||
42257034|NCT01067521|76083483|FG001|Open-Label Period|Lost to Follow-up|20|||
42257035|NCT02735577|76083494|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
42257036|NCT02735577|76083494|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
42257037|NCT01345123|76083501|FG000|Overall Study|participants no longer with health plan|79|||
42257038|NCT01345123|76083502|FG001|Overall Study|participants no longer with health plan|85|||
42257039|NCT01345123|76083503|FG002|Overall Study|participants no longer with health plan|88|||
42257040|NCT02735421|76083512|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
41993607|NCT00195663|75801891|FG000|Open-Label Extension Period|Protocol Violation|3|||
42257041|NCT02735421|76083512|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
42317622|NCT02257567|76154223|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
42317623|NCT02257567|76154224|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
42317624|NCT02257567|76154225|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
42317625|NCT02257567|76154226|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
42317626|NCT02257567|76154227|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
42317627|NCT02257567|76154228|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
42317628|NCT02257567|76154218|FG000|Overall Study|Physician Decision|0|||
42317629|NCT02257567|76154219|FG001|Overall Study|Physician Decision|0|||
42317630|NCT02257567|76154220|FG002|Overall Study|Physician Decision|0|||
42317631|NCT02257567|76154221|FG003|Overall Study|Physician Decision|0|||
42317632|NCT02257567|76154222|FG004|Overall Study|Physician Decision|0|||
42317633|NCT02257567|76154223|FG005|Overall Study|Physician Decision|0|||
42317634|NCT02257567|76154224|FG006|Overall Study|Physician Decision|0|||
42317635|NCT02257567|76154225|FG007|Overall Study|Physician Decision|2|||
42317636|NCT02257567|76154226|FG008|Overall Study|Physician Decision|0|||
42317637|NCT02257567|76154227|FG009|Overall Study|Physician Decision|1|||
42317638|NCT02257567|76154228|FG010|Overall Study|Physician Decision|0|||
42317639|NCT02257567|76154218|FG000|Overall Study|Withdrawal by Subject|0|||
42317640|NCT02257567|76154219|FG001|Overall Study|Withdrawal by Subject|0|||
42317641|NCT02257567|76154220|FG002|Overall Study|Withdrawal by Subject|2|||
42317642|NCT02257567|76154221|FG003|Overall Study|Withdrawal by Subject|0|||
42317643|NCT02257567|76154222|FG004|Overall Study|Withdrawal by Subject|0|||
42317644|NCT02257567|76154223|FG005|Overall Study|Withdrawal by Subject|6|||
42317645|NCT02257567|76154224|FG006|Overall Study|Withdrawal by Subject|6|||
42317646|NCT02257567|76154225|FG007|Overall Study|Withdrawal by Subject|6|||
42317647|NCT02257567|76154226|FG008|Overall Study|Withdrawal by Subject|1|||
42317648|NCT02257567|76154227|FG009|Overall Study|Withdrawal by Subject|1|||
42317649|NCT02257567|76154228|FG010|Overall Study|Withdrawal by Subject|10|||
42317650|NCT01642615|76154285|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
42317651|NCT01642615|76154286|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
42317652|NCT01642615|76154287|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
42317653|NCT01642615|76154285|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
42317654|NCT01642615|76154286|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
42317655|NCT01642615|76154287|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
42033867|NCT00837811|75842032|FG001|Overall Study|Lack of Efficacy|11|||
42033868|NCT00837811|75842033|FG002|Overall Study|Lack of Efficacy|0|||
42317656|NCT01642615|76154285|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
42317657|NCT01642615|76154286|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
42317658|NCT01642615|76154287|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
42317659|NCT01642615|76154285|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
42317660|NCT01642615|76154286|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
42317661|NCT01642615|76154287|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
42317662|NCT01642615|76154285|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
42317663|NCT01642615|76154286|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
42317664|NCT01642615|76154287|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
42033869|NCT00837811|75842031|FG000|Overall Study|Lost to Follow-up|1|||
42257042|NCT02735421|76083512|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
42257043|NCT02735421|76083512|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
42257044|NCT02735421|76083512|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
42257045|NCT02735421|76083512|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
42257046|NCT02735421|76083512|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
42257047|NCT02983799|76083529|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
42257048|NCT02983799|76083530|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
42257049|NCT02983799|76083531|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
42257050|NCT02983799|76083532|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
42257051|NCT02983799|76083533|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
42257052|NCT02983799|76083529|FG000|Overall Study|Death|20|||
42257053|NCT02983799|76083530|FG001|Overall Study|Death|5|||
42257054|NCT02983799|76083531|FG002|Overall Study|Death|23|||
42257055|NCT02983799|76083532|FG003|Overall Study|Death|47|||
42257056|NCT02983799|76083533|FG004|Overall Study|Death|7|||
42257057|NCT02983799|76083529|FG000|Overall Study|Withdrawal by Subject|1|||
42257058|NCT02983799|76083530|FG001|Overall Study|Withdrawal by Subject|0|||
42257059|NCT02983799|76083531|FG002|Overall Study|Withdrawal by Subject|3|||
42257060|NCT02983799|76083532|FG003|Overall Study|Withdrawal by Subject|4|||
42257061|NCT02983799|76083533|FG004|Overall Study|Withdrawal by Subject|1|||
42257062|NCT02983799|76083529|FG000|Overall Study|Protocol Violation|0|||
42257063|NCT02983799|76083530|FG001|Overall Study|Protocol Violation|1|||
42257064|NCT02983799|76083531|FG002|Overall Study|Protocol Violation|0|||
42257065|NCT02983799|76083532|FG003|Overall Study|Protocol Violation|0|||
42257066|NCT02983799|76083533|FG004|Overall Study|Protocol Violation|1|||
42257067|NCT02983799|76083529|FG000|Overall Study|Lost to Follow-up|1|||
42257068|NCT02983799|76083530|FG001|Overall Study|Lost to Follow-up|0|||
42257069|NCT02983799|76083531|FG002|Overall Study|Lost to Follow-up|1|||
42257070|NCT02983799|76083532|FG003|Overall Study|Lost to Follow-up|0|||
42257071|NCT02983799|76083533|FG004|Overall Study|Lost to Follow-up|0|||
42257072|NCT02186847|76083551|FG000|Overall Study|Protocol Violation|3|||
42257073|NCT02186847|76083552|FG001|Overall Study|Protocol Violation|0|||
42257074|NCT01066871|76083562|FG000|Overall Study|Lost to Follow-up|0|||
42257075|NCT01066871|76083563|FG001|Overall Study|Lost to Follow-up|2|||
42257076|NCT01066871|76083564|FG002|Overall Study|Lost to Follow-up|2|||
42257077|NCT01066871|76083565|FG003|Overall Study|Lost to Follow-up|0|||
42257078|NCT01066871|76083562|FG000|Overall Study|Protocol Violation|1|||
42257079|NCT01066871|76083563|FG001|Overall Study|Protocol Violation|0|||
42317665|NCT01642615|76154285|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
42317666|NCT01642615|76154286|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
42317667|NCT01642615|76154287|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
42317668|NCT01642615|76154285|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
42317669|NCT01642615|76154286|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
42317670|NCT01642615|76154287|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
42317671|NCT01642615|76154285|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
42317672|NCT01642615|76154286|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
42317673|NCT01642615|76154287|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
42317674|NCT01642615|76154285|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
42317675|NCT01642615|76154286|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
42317676|NCT01642615|76154287|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
42317677|NCT02311361|76154299|FG000|Overall Study|Did not receive treatment|0|||
42317678|NCT02311361|76154300|FG001|Overall Study|Did not receive treatment|1|||
42317679|NCT02311361|76154301|FG002|Overall Study|Did not receive treatment|0|||
42317680|NCT02311361|76154302|FG003|Overall Study|Did not receive treatment|1|||
42317681|NCT02352779|76154319|FG000|Overall Study|Personal Issues|1|||
42317682|NCT02352779|76154320|FG001|Overall Study|Personal Issues|1|||
42317683|NCT02352779|76154321|FG002|Overall Study|Personal Issues|0|||
42317684|NCT02352779|76154319|FG000|Overall Study|Too Many Forms|2|||
42317685|NCT02352779|76154320|FG001|Overall Study|Too Many Forms|0|||
42317686|NCT02352779|76154321|FG002|Overall Study|Too Many Forms|0|||
42317687|NCT02352779|76154319|FG000|Overall Study|Feeling Overwhelmed|1|||
42317688|NCT02352779|76154320|FG001|Overall Study|Feeling Overwhelmed|0|||
42317689|NCT02352779|76154321|FG002|Overall Study|Feeling Overwhelmed|0|||
42317690|NCT02352779|76154319|FG000|Overall Study|Disliked Intervention|1|||
42317691|NCT02352779|76154320|FG001|Overall Study|Disliked Intervention|0|||
42317692|NCT02352779|76154321|FG002|Overall Study|Disliked Intervention|0|||
42317693|NCT02352779|76154319|FG000|Overall Study|Changed Mind|1|||
42317694|NCT02352779|76154320|FG001|Overall Study|Changed Mind|0|||
42317695|NCT02352779|76154321|FG002|Overall Study|Changed Mind|0|||
42317696|NCT02352779|76154319|FG000|Overall Study|Study Related Symptoms|1|||
42317697|NCT02352779|76154320|FG001|Overall Study|Study Related Symptoms|0|||
42317698|NCT02352779|76154321|FG002|Overall Study|Study Related Symptoms|0|||
42317699|NCT02352779|76154319|FG000|Overall Study|Absence of Symptoms|1|||
42317700|NCT02352779|76154320|FG001|Overall Study|Absence of Symptoms|0|||
42317701|NCT02352779|76154321|FG002|Overall Study|Absence of Symptoms|0|||
42317702|NCT02352779|76154319|FG000|Overall Study|Other Medical Reason|0|||
42317703|NCT02352779|76154320|FG001|Overall Study|Other Medical Reason|0|||
42317704|NCT02352779|76154321|FG002|Overall Study|Other Medical Reason|1|||
42317705|NCT02352779|76154319|FG000|Overall Study|No Reason|0|||
42317706|NCT02352779|76154320|FG001|Overall Study|No Reason|0|||
42317707|NCT02352779|76154321|FG002|Overall Study|No Reason|1|||
42317708|NCT02257489|76154338|FG000|Overall Study|Withdrawal by Subject|0|||
42317709|NCT02257489|76154339|FG001|Overall Study|Withdrawal by Subject|0|||
42317710|NCT02257489|76154340|FG002|Overall Study|Withdrawal by Subject|0|||
42317711|NCT02257489|76154341|FG003|Overall Study|Withdrawal by Subject|1|||
42317712|NCT02257489|76154342|FG004|Overall Study|Withdrawal by Subject|0|||
42317713|NCT02257489|76154343|FG005|Overall Study|Withdrawal by Subject|0|||
42317714|NCT02257489|76154344|FG006|Overall Study|Withdrawal by Subject|0|||
41993608|NCT00195663|75801892|FG001|Open-Label Extension Period|Protocol Violation|4|||
42317715|NCT02257489|76154345|FG007|Overall Study|Withdrawal by Subject|0|||
42317716|NCT02257489|76154346|FG008|Overall Study|Withdrawal by Subject|0|||
42317717|NCT02329223|76154369|FG000|Overall Study|Withdrawal by Subject|1|||
42317718|NCT02329223|76154370|FG001|Overall Study|Withdrawal by Subject|2|||
42317719|NCT02329223|76154371|FG002|Overall Study|Withdrawal by Subject|5|||
42317720|NCT02329223|76154369|FG000|Overall Study|Physician Decision|0|||
42317721|NCT02329223|76154370|FG001|Overall Study|Physician Decision|0|||
42317722|NCT02329223|76154371|FG002|Overall Study|Physician Decision|1|||
42317723|NCT02329223|76154369|FG000|Overall Study|Adverse Event|0|||
42257080|NCT01066871|76083564|FG002|Overall Study|Protocol Violation|3|||
42257081|NCT01066871|76083565|FG003|Overall Study|Protocol Violation|2|||
42257082|NCT01066871|76083562|FG000|Overall Study|Lack of Efficacy|0|||
42257083|NCT01066871|76083563|FG001|Overall Study|Lack of Efficacy|0|||
42257084|NCT01066871|76083564|FG002|Overall Study|Lack of Efficacy|0|||
42257085|NCT01066871|76083565|FG003|Overall Study|Lack of Efficacy|1|||
42257086|NCT01066871|76083562|FG000|Overall Study|Withdrawal by Subject|3|||
42257087|NCT01066871|76083563|FG001|Overall Study|Withdrawal by Subject|1|||
42257088|NCT01066871|76083564|FG002|Overall Study|Withdrawal by Subject|0|||
42257089|NCT01066871|76083565|FG003|Overall Study|Withdrawal by Subject|0|||
42257090|NCT01066871|76083562|FG000|Overall Study|Other|0|||
42257091|NCT01066871|76083563|FG001|Overall Study|Other|2|||
42257092|NCT01066871|76083564|FG002|Overall Study|Other|1|||
42257093|NCT01066871|76083565|FG003|Overall Study|Other|2|||
42257094|NCT02982863|76083585|FG000|Overall Study|Not eligible patients|809|||
42257095|NCT02982863|76083586|FG001|Overall Study|Not eligible patients|4261|||
42317724|NCT02329223|76154370|FG001|Overall Study|Adverse Event|1|||
42317725|NCT02329223|76154371|FG002|Overall Study|Adverse Event|0|||
42317726|NCT01641601|76154381|FG000|Overall Study|Study discontinued.|3|||
42317727|NCT01641601|76154382|FG001|Overall Study|Study discontinued.|5|||
42317728|NCT02350127|76154390|FG000|4-Month Assessment|Withdrawal by Subject|10|||
42317729|NCT02350127|76154391|FG001|4-Month Assessment|Withdrawal by Subject|9|||
42317730|NCT02350127|76154390|FG000|4-Month Assessment|Death|1|||
42317731|NCT02350127|76154391|FG001|4-Month Assessment|Death|0|||
42317732|NCT02350127|76154390|FG000|8-Month Assessment|Death|1|||
42317733|NCT02350127|76154391|FG001|8-Month Assessment|Death|1|||
42317734|NCT02350127|76154390|FG000|8-Month Assessment|Withdrawal by Subject|5|||
42317735|NCT02350127|76154391|FG001|8-Month Assessment|Withdrawal by Subject|8|||
42317736|NCT02256553|76154398|FG000|Period I|Adverse Event|5|||
42317737|NCT02256553|76154398|FG000|Period I|Protocol Violation|1|||
42317738|NCT02256553|76154398|FG000|Period II|Adverse Event|1|||
42317739|NCT02256553|76154398|FG000|Period II|Subject Moved|1|||
42317740|NCT02256553|76154398|FG000|Period III|Adverse Event|3|||
42317741|NCT02349425|76154408|FG000|Period 1|Adverse Event|1|||
42317742|NCT02349425|76154409|FG001|Period 1|Adverse Event|1|||
42317743|NCT02349425|76154410|FG002|Period 1|Adverse Event|0|||
42317744|NCT02349425|76154411|FG003|Period 1|Adverse Event|0|||
42317745|NCT02349425|76154408|FG000|Period 2|Adverse Event|0|||
41993609|NCT00195663|75801893|FG002|Open-Label Extension Period|Protocol Violation|4|||
41993610|NCT00195663|75801891|FG000|Open-Label Extension Period|Death|2|||
41993611|NCT00195663|75801892|FG001|Open-Label Extension Period|Death|2|||
41993612|NCT00195663|75801893|FG002|Open-Label Extension Period|Death|2|||
41993613|NCT00195663|75801891|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
42033870|NCT00837811|75842032|FG001|Overall Study|Lost to Follow-up|3|||
42257096|NCT02982863|76083587|FG002|Overall Study|Not eligible patients|1852|||
42257097|NCT02982863|76083588|FG003|Overall Study|Not eligible patients|1400|||
42257098|NCT02982863|76083589|FG004|Overall Study|Not eligible patients|492|||
42257099|NCT04343651|76083632|FG000|Overall Study|Physician Decision|2|||
42257100|NCT04343651|76083633|FG001|Overall Study|Physician Decision|1|||
42257101|NCT04343651|76083632|FG000|Overall Study|Lost to Follow-up|2|||
42257102|NCT04343651|76083633|FG001|Overall Study|Lost to Follow-up|1|||
42257103|NCT04343651|76083632|FG000|Overall Study|Protocol Violation|4|||
42257104|NCT04343651|76083633|FG001|Overall Study|Protocol Violation|6|||
42257105|NCT04343651|76083632|FG000|Overall Study|Missing|3|||
42257106|NCT04343651|76083633|FG001|Overall Study|Missing|9|||
42257107|NCT04343651|76083632|FG000|Overall Study|Withdrawal by Subject|0|||
42257108|NCT04343651|76083633|FG001|Overall Study|Withdrawal by Subject|4|||
42257109|NCT04343651|76083632|FG000|Overall Study|Death|0|||
42257110|NCT04343651|76083633|FG001|Overall Study|Death|1|||
42257111|NCT04343651|76083632|FG000|Overall Study|Did not start treatment|1|||
42257112|NCT04343651|76083633|FG001|Overall Study|Did not start treatment|1|||
42257113|NCT04343651|76083632|FG000|Overall Study|Patient did not complete visits 3-6|0|||
42257114|NCT04343651|76083633|FG001|Overall Study|Patient did not complete visits 3-6|1|||
42257115|NCT02906579|76083641|FG000|Overall Study|Adverse Event|1|||
42257116|NCT02906579|76083641|FG000|Overall Study|Physician Decision|1|||
42257117|NCT01328535|76083661|FG000|Overall Study|Ineligible|1|||
42257118|NCT02905331|76083669|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
42257119|NCT02905331|76083670|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
42257120|NCT02905331|76083671|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
42257121|NCT02905331|76083669|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
42257122|NCT02905331|76083670|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
42317746|NCT02349425|76154409|FG001|Period 2|Adverse Event|1|||
42317747|NCT02349425|76154410|FG002|Period 2|Adverse Event|1|||
42317748|NCT02349425|76154411|FG003|Period 2|Adverse Event|0|||
42317749|NCT02310581|76154453|FG000|Overall Study|Adverse Event|1|||
42317750|NCT02310581|76154454|FG001|Overall Study|Adverse Event|1|||
42317751|NCT02310581|76154455|FG002|Overall Study|Adverse Event|1|||
42317752|NCT02310581|76154456|FG003|Overall Study|Adverse Event|0|||
42317753|NCT02310581|76154453|FG000|Overall Study|Withdrawal by Subject|2|||
42317754|NCT02310581|76154454|FG001|Overall Study|Withdrawal by Subject|1|||
42317755|NCT02310581|76154455|FG002|Overall Study|Withdrawal by Subject|0|||
42317756|NCT02310581|76154456|FG003|Overall Study|Withdrawal by Subject|1|||
42317757|NCT02309723|76154469|FG000|Overall Study|Withdrawal by Subject|24|||
42317758|NCT02309723|76154470|FG001|Overall Study|Withdrawal by Subject|23|||
42317759|NCT02309723|76154471|FG002|Overall Study|Withdrawal by Subject|24|||
42317760|NCT02309411|76154482|FG000|Overall Study|Physician Decision|1|||
42317761|NCT02309411|76154483|FG001|Overall Study|Physician Decision|0|||
42317762|NCT02309411|76154484|FG002|Overall Study|Physician Decision|0|||
42317763|NCT02309411|76154482|FG000|Overall Study|Withdrawal by Subject|1|||
42317764|NCT02309411|76154483|FG001|Overall Study|Withdrawal by Subject|1|||
42317765|NCT02309411|76154484|FG002|Overall Study|Withdrawal by Subject|0|||
42317766|NCT02008227|76154493|FG000|Overall Study|Lost to Follow-up|7|||
42317767|NCT02008227|76154494|FG001|Overall Study|Lost to Follow-up|9|||
42317768|NCT02008227|76154493|FG000|Overall Study|Death|494|||
42317769|NCT02008227|76154494|FG001|Overall Study|Death|485|||
42317770|NCT02008227|76154493|FG000|Overall Study|Withdrawal by Subject|67|||
42317771|NCT02008227|76154494|FG001|Overall Study|Withdrawal by Subject|36|||
42317772|NCT02008227|76154493|FG000|Overall Study|Study Terminated By Sponsor|44|||
42317773|NCT02008227|76154494|FG001|Overall Study|Study Terminated By Sponsor|83|||
42317774|NCT02006979|76154503|FG000|Overall Study|Withdrawal by Subject|1|||
42317775|NCT02006979|76154504|FG001|Overall Study|Withdrawal by Subject|1|||
42317776|NCT02006979|76154503|FG000|Overall Study|Protocol Violation|0|||
42317777|NCT02006979|76154504|FG001|Overall Study|Protocol Violation|1|||
42317778|NCT02348723|76154512|FG000|Overall Study|No ablation|21|||
42317779|NCT02348723|76154513|FG001|Overall Study|No ablation|20|||
42317780|NCT02348723|76154512|FG000|Overall Study|Non-compliant with Protocol|1|||
42317781|NCT02348723|76154513|FG001|Overall Study|Non-compliant with Protocol|0|||
42317782|NCT02348723|76154512|FG000|Overall Study|Lost to Follow-up|1|||
42317783|NCT02348723|76154513|FG001|Overall Study|Lost to Follow-up|1|||
42317784|NCT02348723|76154512|FG000|Overall Study|Consent withdrawn|1|||
42317785|NCT02348723|76154513|FG001|Overall Study|Consent withdrawn|3|||
42317786|NCT02348723|76154512|FG000|Overall Study|Reason other than specified|1|||
42317787|NCT02348723|76154513|FG001|Overall Study|Reason other than specified|1|||
42317788|NCT02348723|76154512|FG000|Overall Study|Adverse Event|3|||
42317789|NCT02348723|76154513|FG001|Overall Study|Adverse Event|1|||
42317790|NCT01967277|76154521|FG000|Overall Study|Lost to Follow-up|1|||
42317791|NCT01967277|76154522|FG001|Overall Study|Lost to Follow-up|2|||
42317792|NCT01967277|76154521|FG000|Overall Study|Unrelated illness|0|||
42317793|NCT01967277|76154522|FG001|Overall Study|Unrelated illness|1|||
42317794|NCT02326883|76154531|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
42317795|NCT02326883|76154532|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
42317796|NCT02326883|76154533|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
42317797|NCT02006667|76154541|FG000|Overall Study|Adverse Event|3|||
42317798|NCT02006667|76154541|FG000|Overall Study|Death|2|||
42317799|NCT02006667|76154541|FG000|Overall Study|Withdrawal by Subject|1|||
42317800|NCT01983111|76154547|FG000|Overall Study|Withdrawal by Subject|8|||
42317801|NCT01983111|76154548|FG001|Overall Study|Withdrawal by Subject|6|||
42317802|NCT01983111|76154547|FG000|Overall Study|Adverse Event|4|||
42317803|NCT01983111|76154548|FG001|Overall Study|Adverse Event|0|||
42317804|NCT01983111|76154547|FG000|Overall Study|Protocol Violation|0|||
42317805|NCT01983111|76154548|FG001|Overall Study|Protocol Violation|1|||
42317806|NCT02348489|76154556|FG000|Overall Study|Death|336|||
42317807|NCT02348489|76154557|FG001|Overall Study|Death|335|||
42317808|NCT02348489|76154556|FG000|Overall Study|Withdrawal by Subject|14|||
42317809|NCT02348489|76154557|FG001|Overall Study|Withdrawal by Subject|27|||
42317810|NCT02348489|76154556|FG000|Overall Study|Lost to Follow-up|3|||
42317811|NCT02348489|76154557|FG001|Overall Study|Lost to Follow-up|5|||
42317812|NCT02309099|76154567|FG000|Overall Study|Adverse Event|2|||
42317813|NCT02309099|76154568|FG001|Overall Study|Adverse Event|0|||
42317814|NCT01966107|76154576|FG000|Overall Study|excluded from FAS|21|||
42317815|NCT01966107|76154577|FG001|Overall Study|excluded from FAS|20|||
42317816|NCT01966107|76154576|FG000|Overall Study|discontinued treatment|345|||
42317817|NCT01966107|76154577|FG001|Overall Study|discontinued treatment|372|||
42317818|NCT01966107|76154576|FG000|Overall Study|due to study closure|164|||
42317819|NCT01966107|76154577|FG001|Overall Study|due to study closure|186|||
42317820|NCT01966107|76154576|FG000|Overall Study|withdrew from the study|272|||
42033871|NCT00837811|75842033|FG002|Overall Study|Lost to Follow-up|0|||
42317821|NCT01966107|76154577|FG001|Overall Study|withdrew from the study|303|||
42317822|NCT02347943|76154586|FG000|Overall Study|Study was cancelled|140|||
42317823|NCT02347943|76154587|FG001|Overall Study|Study was cancelled|67|||
42317824|NCT02347943|76154588|FG002|Overall Study|Study was cancelled|45|||
42317825|NCT01982331|76154598|FG000|Received Vaccination 2|Adverse Event|1|||
42317826|NCT01982331|76154599|FG001|Received Vaccination 2|Adverse Event|2|||
42317827|NCT01982331|76154598|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
42317828|NCT01982331|76154599|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
42317829|NCT01982331|76154598|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
42317830|NCT01982331|76154599|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
42317831|NCT02326025|76154607|FG000|Overall Study|Adverse Event|3|||
42317832|NCT02326025|76154608|FG001|Overall Study|Adverse Event|0|||
42317833|NCT02326025|76154607|FG000|Overall Study|Physician Decision|1|||
42317834|NCT02326025|76154608|FG001|Overall Study|Physician Decision|2|||
42317835|NCT02326025|76154607|FG000|Overall Study|Physician and Participant Decision|1|||
42317836|NCT02326025|76154608|FG001|Overall Study|Physician and Participant Decision|0|||
42317837|NCT02326025|76154607|FG000|Overall Study|Withdrawal by Subject|0|||
42317838|NCT02326025|76154608|FG001|Overall Study|Withdrawal by Subject|2|||
41993614|NCT00195663|75801892|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
41993615|NCT00195663|75801893|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
41993616|NCT00195663|75801891|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
41993617|NCT00195663|75801892|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
41993618|NCT00195663|75801893|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
41993619|NCT00195663|75801891|FG000|Open-Label Extension Period|Administrative reasons|11|||
41993620|NCT00195663|75801892|FG001|Open-Label Extension Period|Administrative reasons|11|||
41993621|NCT00195663|75801893|FG002|Open-Label Extension Period|Administrative reasons|13|||
41993622|NCT01135498|75801911|FG000|Overall Study|Adverse Event|20|||
41993623|NCT01135498|75801911|FG000|Overall Study|Progressive disease|38|||
41993624|NCT01135498|75801911|FG000|Overall Study|Investigator judgement|25|||
41993625|NCT01135498|75801911|FG000|Overall Study|Withdrawal by Subject|4|||
41993626|NCT01135498|75801911|FG000|Overall Study|Death|1|||
41993627|NCT01135498|75801911|FG000|Overall Study|Ongoing at time of analysis|2|||
41993628|NCT00195507|75801918|FG000|Overall Study|Adverse Event|24|||
41993629|NCT00195507|75801919|FG001|Overall Study|Adverse Event|13|||
41993630|NCT00195507|75801918|FG000|Overall Study|Death|0|||
41993631|NCT00195507|75801919|FG001|Overall Study|Death|1|||
41993632|NCT00195507|75801918|FG000|Overall Study|Failed to Return|4|||
41993633|NCT00195507|75801919|FG001|Overall Study|Failed to Return|3|||
41993634|NCT00195507|75801918|FG000|Overall Study|Physician Decision|1|||
41993635|NCT00195507|75801919|FG001|Overall Study|Physician Decision|2|||
41993636|NCT00195507|75801918|FG000|Overall Study|Lost to Follow-up|3|||
42317839|NCT02326025|76154607|FG000|Overall Study|Protocol Violation|0|||
42317840|NCT02326025|76154608|FG001|Overall Study|Protocol Violation|1|||
42317841|NCT01619865|76154627|FG000|Overall Study|Adverse Event|1|||
42317842|NCT01619865|76154627|FG000|Overall Study|Death|2|||
42317843|NCT01619865|76154627|FG000|Overall Study|subject not able to comply|1|||
42317844|NCT02006121|76154634|FG000|Double Blind Phase|Adverse Event|6|||
42317845|NCT02006121|76154635|FG001|Double Blind Phase|Adverse Event|0|||
42317846|NCT02006121|76154634|FG000|Double Blind Phase|Lack of Efficacy|1|||
41993637|NCT00195507|75801919|FG001|Overall Study|Lost to Follow-up|2|||
41993638|NCT00195507|75801918|FG000|Overall Study|Protocol Violation|5|||
41993639|NCT00195507|75801919|FG001|Overall Study|Protocol Violation|4|||
41993640|NCT00195507|75801918|FG000|Overall Study|Lack of Efficacy|40|||
42317847|NCT02006121|76154635|FG001|Double Blind Phase|Lack of Efficacy|16|||
42317848|NCT02006121|76154634|FG000|Double Blind Phase|Withdrawal by Subject|3|||
42317849|NCT02006121|76154635|FG001|Double Blind Phase|Withdrawal by Subject|4|||
42317850|NCT02006121|76154634|FG000|Double Blind Phase|Non-compliance with study drug|1|||
42317851|NCT02006121|76154635|FG001|Double Blind Phase|Non-compliance with study drug|3|||
42317852|NCT02006121|76154634|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
41993641|NCT00195507|75801919|FG001|Overall Study|Lack of Efficacy|67|||
41993642|NCT00195507|75801918|FG000|Overall Study|Withdrawal by Subject|16|||
42317853|NCT02006121|76154635|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
42317854|NCT02006121|76154634|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
42317855|NCT02006121|76154635|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
42317856|NCT02006121|76154634|FG000|Open Label Phase|Adverse Event|15|||
41993643|NCT00195507|75801919|FG001|Overall Study|Withdrawal by Subject|23|||
42033872|NCT00837811|75842031|FG000|Overall Study|Physician Decision|0|||
42033873|NCT00837811|75842032|FG001|Overall Study|Physician Decision|2|||
42033874|NCT00837811|75842033|FG002|Overall Study|Physician Decision|1|||
42033875|NCT00837811|75842031|FG000|Overall Study|Withdrawal by Subject|1|||
42033876|NCT00837811|75842032|FG001|Overall Study|Withdrawal by Subject|9|||
42033877|NCT00837811|75842033|FG002|Overall Study|Withdrawal by Subject|0|||
42033878|NCT00837811|75842031|FG000|Overall Study|Sponsor Decision|0|||
42033879|NCT00837811|75842032|FG001|Overall Study|Sponsor Decision|2|||
42033880|NCT00837811|75842033|FG002|Overall Study|Sponsor Decision|0|||
42033881|NCT00857389|75842050|FG000|Overall Study|Did not proceed to transplant|2|||
42033882|NCT01071798|75842054|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
42033883|NCT01071798|75842054|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
42033884|NCT01071798|75842054|FG000|Participants Who Received One Cycle|Patient requirement|20|||
42033885|NCT01071798|75842054|FG000|Participants Who Received One Cycle|Death|5|||
42033886|NCT01071798|75842054|FG000|Participants Who Received One Cycle|Change of therapy|6|||
42033887|NCT01071798|75842054|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
42033888|NCT01071798|75842054|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
42033889|NCT01071798|75842054|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
42033890|NCT01071798|75842054|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
42033891|NCT01071798|75842054|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
42033892|NCT00857311|75842072|FG000|Overall Study|Lost to Follow-up|1|||
42033893|NCT00857311|75842073|FG001|Overall Study|Lost to Follow-up|0|||
42033894|NCT00857311|75842074|FG002|Overall Study|Lost to Follow-up|0|||
42033895|NCT00857311|75842075|FG003|Overall Study|Lost to Follow-up|0|||
42033896|NCT00857233|75842081|FG000|Overall Study|Adverse Event|24|||
42033897|NCT00857233|75842081|FG000|Overall Study|Lack of Efficacy|1|||
42033898|NCT00857233|75842081|FG000|Overall Study|Non-compliance|1|||
42033899|NCT00857233|75842081|FG000|Overall Study|Withdrawal of Consent|9|||
41993644|NCT00195507|75801918|FG000|Overall Study|Protocol Deviation|6|||
41993645|NCT00195507|75801919|FG001|Overall Study|Protocol Deviation|3|||
41993646|NCT01134562|75801930|FG000|Overall Study|Adverse Event|0|||
41993647|NCT01134562|75801931|FG001|Overall Study|Adverse Event|1|||
41993648|NCT01134562|75801932|FG002|Overall Study|Adverse Event|0|||
42033900|NCT00857233|75842081|FG000|Overall Study|Lost to Follow-up|4|||
41993649|NCT01134562|75801933|FG003|Overall Study|Adverse Event|0|||
41993650|NCT01134562|75801934|FG004|Overall Study|Adverse Event|0|||
41993651|NCT00195351|75801961|FG000|Overall Study|Lost to Follow-up|9|||
41993652|NCT00195351|75801962|FG001|Overall Study|Lost to Follow-up|9|||
41993653|NCT00195351|75801961|FG000|Overall Study|Withdrawal by Subject|6|||
41993654|NCT00195351|75801962|FG001|Overall Study|Withdrawal by Subject|3|||
41993655|NCT00195351|75801961|FG000|Overall Study|Protocol Deviation|3|||
41993656|NCT00195351|75801962|FG001|Overall Study|Protocol Deviation|2|||
41993657|NCT00195351|75801961|FG000|Overall Study|Death|3|||
41993658|NCT00195351|75801962|FG001|Overall Study|Death|1|||
41993659|NCT00195351|75801961|FG000|Overall Study|Lack of Efficacy|0|||
42033901|NCT00857233|75842081|FG000|Overall Study|Nursing Home Placement|14|||
42033902|NCT00857233|75842081|FG000|Overall Study|Other Reasons|2|||
42033903|NCT00856999|75842085|FG000|Overall Study|Withdrawal by Subject|5|||
42033904|NCT01071252|75842095|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
42033905|NCT01071252|75842096|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
42033906|NCT01071252|75842097|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
42317857|NCT02006121|76154635|FG001|Open Label Phase|Adverse Event|0|||
42317858|NCT02006121|76154634|FG000|Open Label Phase|Lack of Efficacy|2|||
41993660|NCT00195351|75801962|FG001|Overall Study|Lack of Efficacy|1|||
42317859|NCT02006121|76154635|FG001|Open Label Phase|Lack of Efficacy|0|||
42317860|NCT02006121|76154634|FG000|Open Label Phase|Protocol Violation|2|||
42317861|NCT02006121|76154635|FG001|Open Label Phase|Protocol Violation|0|||
42317862|NCT02006121|76154634|FG000|Open Label Phase|Withdrawal by Subject|3|||
42317863|NCT02006121|76154635|FG001|Open Label Phase|Withdrawal by Subject|0|||
42317864|NCT02006121|76154634|FG000|Open Label Phase|Non-compliance with study drug|3|||
42317865|NCT02006121|76154635|FG001|Open Label Phase|Non-compliance with study drug|0|||
42317866|NCT02005887|76154647|FG000|Overall Study|Protocol Violation|0|||
42317867|NCT02005887|76154648|FG001|Overall Study|Protocol Violation|2|||
42317868|NCT01982253|76154657|FG000|Overall Study|Withdrawal by Subject|1|||
42317869|NCT01982253|76154658|FG001|Overall Study|Withdrawal by Subject|0|||
42317870|NCT01982253|76154659|FG002|Overall Study|Withdrawal by Subject|0|||
42317871|NCT01982253|76154657|FG000|Overall Study|Study terminated by sponsor|1|||
42317872|NCT01982253|76154658|FG001|Overall Study|Study terminated by sponsor|4|||
42317873|NCT01982253|76154659|FG002|Overall Study|Study terminated by sponsor|4|||
42317874|NCT01619787|76154669|FG000|Overall Study|Lost to Follow-up|5|||
42317875|NCT01981473|76154678|FG000|Overall Study|Incorrect diagnosis of RA|0|||
42317876|NCT01981473|76154679|FG001|Overall Study|Incorrect diagnosis of RA|0|||
42317877|NCT01981473|76154680|FG002|Overall Study|Incorrect diagnosis of RA|1|||
42317878|NCT01981473|76154678|FG000|Overall Study|Received treatment for < 6 months|0|||
42317879|NCT01981473|76154679|FG001|Overall Study|Received treatment for < 6 months|0|||
42317880|NCT01981473|76154680|FG002|Overall Study|Received treatment for < 6 months|1|||
42317881|NCT01981473|76154678|FG000|Overall Study|Received treatment for >24 months|2|||
42317882|NCT01981473|76154679|FG001|Overall Study|Received treatment for >24 months|0|||
42317883|NCT01981473|76154680|FG002|Overall Study|Received treatment for >24 months|6|||
42317884|NCT02005029|76154693|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
42317885|NCT02005029|76154694|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
42317886|NCT02325791|76154722|FG000|Overall Study|Adverse Event|0|||
42317887|NCT02325791|76154723|FG001|Overall Study|Adverse Event|1|||
42317888|NCT02325791|76154724|FG002|Overall Study|Adverse Event|1|||
42317889|NCT02325791|76154725|FG003|Overall Study|Adverse Event|0|||
42317890|NCT02325791|76154722|FG000|Overall Study|Death|0|||
42317891|NCT02325791|76154723|FG001|Overall Study|Death|3|||
42317892|NCT02325791|76154724|FG002|Overall Study|Death|0|||
42317893|NCT02325791|76154725|FG003|Overall Study|Death|1|||
41993661|NCT00195273|75801970|FG000|Overall Study|Adverse Event|9|||
41993662|NCT00195273|75801971|FG001|Overall Study|Adverse Event|9|||
41993663|NCT00195273|75801970|FG000|Overall Study|Protocol deviation|0|||
41993664|NCT00195273|75801971|FG001|Overall Study|Protocol deviation|1|||
41993665|NCT00195273|75801970|FG000|Overall Study|Lack of Efficacy|3|||
41993666|NCT00195273|75801971|FG001|Overall Study|Lack of Efficacy|1|||
41993667|NCT00195273|75801970|FG000|Overall Study|Procedural complications|9|||
41993668|NCT00195273|75801971|FG001|Overall Study|Procedural complications|3|||
41993669|NCT00193479|75801977|FG000|Induction Chemotherapy|Adverse Event|2|||
41993670|NCT00193479|75801977|FG000|Induction Chemotherapy|Disease Progression|1|||
41993671|NCT00193479|75801977|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
41993672|NCT00193479|75801977|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
41993673|NCT00193206|75801981|FG000|Preoperative Therapy|Lack of Efficacy|2|||
41993674|NCT00193206|75801981|FG000|Preoperative Therapy|Adverse Event|2|||
41993675|NCT00193206|75801981|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
41993676|NCT00193206|75801981|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
41993677|NCT00193206|75801981|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
41993678|NCT00193206|75801981|FG000|Postoperative Therapy|Physician Decision|3|||
41993679|NCT00193206|75801981|FG000|Postoperative Therapy|Intercurrent Illness|2|||
42257123|NCT02905331|76083671|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
42257124|NCT02905331|76083669|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
42257125|NCT02905331|76083670|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
42257126|NCT02905331|76083671|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
42257127|NCT02905331|76083669|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
42257128|NCT02905331|76083670|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
42257129|NCT02905331|76083671|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
42257130|NCT02905331|76083669|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
42257131|NCT02905331|76083670|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
42257132|NCT02905331|76083671|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
42257133|NCT02979197|76083682|FG000|Overall Study|Adverse Event|4|||
42257134|NCT02979197|76083683|FG001|Overall Study|Adverse Event|2|||
42257135|NCT02979197|76083684|FG002|Overall Study|Adverse Event|0|||
42257136|NCT02979197|76083682|FG000|Overall Study|Protocol Violation|0|||
42317894|NCT02325791|76154722|FG000|Overall Study|Lost to Follow-up|0|||
42317895|NCT02325791|76154723|FG001|Overall Study|Lost to Follow-up|15|||
42317896|NCT02325791|76154724|FG002|Overall Study|Lost to Follow-up|14|||
42317897|NCT02325791|76154725|FG003|Overall Study|Lost to Follow-up|9|||
42317898|NCT02325791|76154722|FG000|Overall Study|Physician Decision|0|||
42317899|NCT02325791|76154723|FG001|Overall Study|Physician Decision|1|||
42317900|NCT02325791|76154724|FG002|Overall Study|Physician Decision|1|||
42317901|NCT02325791|76154725|FG003|Overall Study|Physician Decision|0|||
42317902|NCT02325791|76154722|FG000|Overall Study|Protocol Violation|0|||
42317903|NCT02325791|76154723|FG001|Overall Study|Protocol Violation|0|||
42317904|NCT02325791|76154724|FG002|Overall Study|Protocol Violation|1|||
42317905|NCT02325791|76154725|FG003|Overall Study|Protocol Violation|0|||
42317906|NCT02325791|76154722|FG000|Overall Study|Withdrawal by Subject|0|||
42317907|NCT02325791|76154723|FG001|Overall Study|Withdrawal by Subject|5|||
42317908|NCT02325791|76154724|FG002|Overall Study|Withdrawal by Subject|8|||
42317909|NCT02325791|76154725|FG003|Overall Study|Withdrawal by Subject|16|||
42317910|NCT02004873|76154738|FG000|Overall Study|Implant unsuccessful|6|||
42317911|NCT02004873|76154738|FG000|Overall Study|Awaiting 6-month visit|390|||
42317912|NCT02004873|76154738|FG000|Overall Study|Missed 6-month visit|4|||
42317913|NCT02004873|76154738|FG000|Overall Study|Death|23|||
42317914|NCT02004873|76154738|FG000|Overall Study|Withdrawal by Subject|1|||
42317915|NCT02347787|76154747|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
41993680|NCT00193206|75801981|FG000|Postoperative Therapy|Lack of Efficacy|1|||
41993681|NCT00193206|75801981|FG000|Postoperative Therapy|Protocol Violation|1|||
41993682|NCT00193050|75801985|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
41993683|NCT00193050|75801985|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
41993684|NCT00193050|75801985|FG000|Neoadjuvant Treatment|Physician Decision|2|||
41993685|NCT00193050|75801985|FG000|Neoadjuvant Treatment|Adverse Event|2|||
41993686|NCT00193050|75801985|FG000|Adjuvant|Physician Decision|5|||
41993687|NCT00193050|75801985|FG000|Adjuvant|Intercurrent Hospitalization|3|||
41993688|NCT00193050|75801985|FG000|Adjuvant|Lack of Efficacy|2|||
41993689|NCT00192504|75801994|FG000|Overall Study|Lost to Follow-up|1|||
41993690|NCT00192504|75801995|FG001|Overall Study|Lost to Follow-up|0|||
41993691|NCT00192504|75801996|FG002|Overall Study|Lost to Follow-up|0|||
41993692|NCT00192504|75801997|FG003|Overall Study|Lost to Follow-up|0|||
41993693|NCT00192504|75801994|FG000|Overall Study|Dosing window missed|0|||
42257137|NCT02979197|76083683|FG001|Overall Study|Protocol Violation|1|||
42257138|NCT02979197|76083684|FG002|Overall Study|Protocol Violation|0|||
42257139|NCT02979197|76083682|FG000|Overall Study|Subject unable to commit to study dates|0|||
42257140|NCT02979197|76083683|FG001|Overall Study|Subject unable to commit to study dates|1|||
42257141|NCT02979197|76083684|FG002|Overall Study|Subject unable to commit to study dates|0|||
42257142|NCT02982239|76083694|FG000|Overall Study|Lost to Follow-up|3|||
42257143|NCT02982239|76083695|FG001|Overall Study|Lost to Follow-up|2|||
42257144|NCT01066793|76083708|FG000|Overall Study|Death|4|||
42257145|NCT01066793|76083709|FG001|Overall Study|Death|1|||
42257146|NCT01066793|76083710|FG002|Overall Study|Death|1|||
42257147|NCT01066793|76083711|FG003|Overall Study|Death|0|||
42257148|NCT01066793|76083712|FG004|Overall Study|Death|0|||
42257149|NCT01066793|76083713|FG005|Overall Study|Death|0|||
42257150|NCT01066793|76083708|FG000|Overall Study|Lack of Efficacy|2|||
42317916|NCT02347787|76154748|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
42317917|NCT02347787|76154747|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
42317918|NCT02347787|76154748|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
42317919|NCT02347787|76154747|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
42317920|NCT02347787|76154748|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
42317921|NCT02347787|76154747|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
42317922|NCT02347787|76154748|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
42317923|NCT01979835|76154759|FG000|Primary Outcome SA Measurment|failed insertion|18|||
42317924|NCT01979835|76154759|FG000|Follow-up|Lost to Follow-up|32|||
42317925|NCT02282345|76154765|FG000|Overall Study|Progression|0|||
42317926|NCT02282345|76154766|FG001|Overall Study|Progression|1|||
42317927|NCT01732822|76154777|FG000|Overall Study|Withdrawal by Subject|123|||
42317928|NCT01732822|76154778|FG001|Overall Study|Withdrawal by Subject|113|||
42317929|NCT02004093|76154808|FG000|Overall Study|Death|2|||
42317930|NCT02004093|76154809|FG001|Overall Study|Death|1|||
41993694|NCT00192504|75801995|FG001|Overall Study|Dosing window missed|0|||
41993695|NCT00192504|75801996|FG002|Overall Study|Dosing window missed|1|||
41993696|NCT00192504|75801997|FG003|Overall Study|Dosing window missed|0|||
42257151|NCT01066793|76083709|FG001|Overall Study|Lack of Efficacy|1|||
42317931|NCT02004093|76154808|FG000|Overall Study|Lack of Efficacy|66|||
42317932|NCT02004093|76154809|FG001|Overall Study|Lack of Efficacy|62|||
42317933|NCT02004093|76154808|FG000|Overall Study|Protocol Violation|0|||
42317934|NCT02004093|76154809|FG001|Overall Study|Protocol Violation|1|||
42317935|NCT02004093|76154808|FG000|Overall Study|Lost to Follow-up|0|||
42317936|NCT02004093|76154809|FG001|Overall Study|Lost to Follow-up|1|||
42317937|NCT02004093|76154808|FG000|Overall Study|Withdrawal by Subject|3|||
42317938|NCT02004093|76154809|FG001|Overall Study|Withdrawal by Subject|7|||
42317939|NCT02004093|76154808|FG000|Overall Study|Other|3|||
42317940|NCT02004093|76154809|FG001|Overall Study|Other|1|||
42317941|NCT01641367|76154824|FG000|Cohorts|Death|18|||
42317942|NCT01641367|76154825|FG001|Cohorts|Death|1|||
42317943|NCT01641367|76154826|FG002|Cohorts|Death|2|||
42317944|NCT01641367|76154827|FG003|Cohorts|Death|0|||
41993697|NCT00192114|75802007|FG000|Overall Study|Objective Tumor Progression|19|||
41993698|NCT00192114|75802007|FG000|Overall Study|Adverse Event|2|||
41993699|NCT00192114|75802007|FG000|Overall Study|Clinical Progression|2|||
41993700|NCT00192114|75802007|FG000|Overall Study|Death|1|||
41993701|NCT00192075|75802013|FG000|Overall Study|Disease Progression|23|||
41993702|NCT00192075|75802014|FG001|Overall Study|Disease Progression|6|||
42257152|NCT01066793|76083710|FG002|Overall Study|Lack of Efficacy|0|||
42257153|NCT01066793|76083711|FG003|Overall Study|Lack of Efficacy|0|||
42257154|NCT01066793|76083712|FG004|Overall Study|Lack of Efficacy|0|||
42257155|NCT01066793|76083713|FG005|Overall Study|Lack of Efficacy|0|||
42257156|NCT01066793|76083708|FG000|Overall Study|Lost to Follow-up|180|||
42257157|NCT01066793|76083709|FG001|Overall Study|Lost to Follow-up|39|||
42257158|NCT01066793|76083710|FG002|Overall Study|Lost to Follow-up|82|||
42317945|NCT01641367|76154828|FG004|Cohorts|Death|1|||
42317946|NCT01641367|76154829|FG005|Cohorts|Death|1|||
42317947|NCT01641367|76154830|FG006|Cohorts|Death|0|||
42317948|NCT01641367|76154831|FG007|Cohorts|Death|0|||
42317949|NCT01641367|76154824|FG000|Cohorts|Lost to Follow-up|16|||
42317950|NCT01641367|76154825|FG001|Cohorts|Lost to Follow-up|0|||
42257159|NCT01066793|76083711|FG003|Overall Study|Lost to Follow-up|16|||
42257160|NCT01066793|76083712|FG004|Overall Study|Lost to Follow-up|0|||
42257161|NCT01066793|76083713|FG005|Overall Study|Lost to Follow-up|1|||
42257162|NCT01066793|76083708|FG000|Overall Study|Physician Decision|3|||
42257163|NCT01066793|76083709|FG001|Overall Study|Physician Decision|0|||
42257164|NCT01066793|76083710|FG002|Overall Study|Physician Decision|0|||
42257165|NCT01066793|76083711|FG003|Overall Study|Physician Decision|0|||
42257166|NCT01066793|76083712|FG004|Overall Study|Physician Decision|0|||
42257167|NCT01066793|76083713|FG005|Overall Study|Physician Decision|0|||
42257168|NCT01066793|76083708|FG000|Overall Study|Protocol Violation|3|||
42257169|NCT01066793|76083709|FG001|Overall Study|Protocol Violation|2|||
42257170|NCT01066793|76083710|FG002|Overall Study|Protocol Violation|2|||
42317951|NCT01641367|76154826|FG002|Cohorts|Lost to Follow-up|2|||
42317952|NCT01641367|76154827|FG003|Cohorts|Lost to Follow-up|0|||
42317953|NCT01641367|76154828|FG004|Cohorts|Lost to Follow-up|2|||
42317954|NCT01641367|76154829|FG005|Cohorts|Lost to Follow-up|0|||
42317955|NCT01641367|76154830|FG006|Cohorts|Lost to Follow-up|0|||
42317956|NCT01641367|76154831|FG007|Cohorts|Lost to Follow-up|0|||
42317957|NCT01641367|76154824|FG000|Randomized Adherence Intervention|Death|0|||
42257171|NCT01066793|76083711|FG003|Overall Study|Protocol Violation|0|||
41993703|NCT00192075|75802013|FG000|Overall Study|Adverse Event|1|||
42033907|NCT01071252|75842098|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
42257172|NCT01066793|76083712|FG004|Overall Study|Protocol Violation|0|||
42317958|NCT01641367|76154825|FG001|Randomized Adherence Intervention|Death|0|||
41993704|NCT00192075|75802014|FG001|Overall Study|Adverse Event|3|||
42257173|NCT01066793|76083713|FG005|Overall Study|Protocol Violation|0|||
42317959|NCT01641367|76154826|FG002|Randomized Adherence Intervention|Death|0|||
42317960|NCT01641367|76154827|FG003|Randomized Adherence Intervention|Death|0|||
42317961|NCT01641367|76154828|FG004|Randomized Adherence Intervention|Death|0|||
42317962|NCT01641367|76154829|FG005|Randomized Adherence Intervention|Death|0|||
42317963|NCT01641367|76154830|FG006|Randomized Adherence Intervention|Death|11|||
42257174|NCT01066793|76083708|FG000|Overall Study|Withdrawal by Subject|7|||
42317964|NCT01641367|76154831|FG007|Randomized Adherence Intervention|Death|12|||
42317965|NCT01641367|76154824|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
42317966|NCT01641367|76154825|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
42317967|NCT01641367|76154826|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
42317968|NCT01641367|76154827|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
42317969|NCT01641367|76154828|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
42317970|NCT01641367|76154829|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
42317971|NCT01641367|76154830|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
42317972|NCT01641367|76154831|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
42317973|NCT02325713|76154870|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317974|NCT02325713|76154871|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317975|NCT02325713|76154872|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317976|NCT02325713|76154873|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317977|NCT02325713|76154874|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317978|NCT02325713|76154875|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317979|NCT02325713|76154876|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317980|NCT02325713|76154877|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317981|NCT02325713|76154878|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317982|NCT02325713|76154879|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317983|NCT02325713|76154880|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
42317984|NCT02325713|76154881|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317985|NCT02325713|76154882|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317986|NCT02325713|76154883|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317987|NCT02325713|76154884|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317988|NCT02325713|76154885|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
42317989|NCT02325713|76154870|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
42317990|NCT02325713|76154871|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42317991|NCT02325713|76154872|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42317992|NCT02325713|76154873|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42317993|NCT02325713|76154874|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42317994|NCT02325713|76154875|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42317995|NCT02325713|76154876|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42257175|NCT01066793|76083709|FG001|Overall Study|Withdrawal by Subject|4|||
42257176|NCT01066793|76083710|FG002|Overall Study|Withdrawal by Subject|1|||
42257177|NCT01066793|76083711|FG003|Overall Study|Withdrawal by Subject|0|||
42257178|NCT01066793|76083712|FG004|Overall Study|Withdrawal by Subject|0|||
42257179|NCT01066793|76083713|FG005|Overall Study|Withdrawal by Subject|0|||
42257180|NCT01066793|76083708|FG000|Overall Study|Early Termination|3|||
42257181|NCT01066793|76083709|FG001|Overall Study|Early Termination|0|||
42257182|NCT01066793|76083710|FG002|Overall Study|Early Termination|0|||
42257183|NCT01066793|76083711|FG003|Overall Study|Early Termination|0|||
42257184|NCT01066793|76083712|FG004|Overall Study|Early Termination|0|||
42257185|NCT01066793|76083713|FG005|Overall Study|Early Termination|0|||
42257186|NCT01066793|76083708|FG000|Overall Study|Lab test not done|7|||
42257187|NCT01066793|76083709|FG001|Overall Study|Lab test not done|0|||
42257188|NCT01066793|76083710|FG002|Overall Study|Lab test not done|0|||
42257189|NCT01066793|76083711|FG003|Overall Study|Lab test not done|1|||
42257190|NCT01066793|76083712|FG004|Overall Study|Lab test not done|0|||
42257191|NCT01066793|76083713|FG005|Overall Study|Lab test not done|0|||
42257192|NCT01066793|76083708|FG000|Overall Study|Miscellaneous|4|||
42257193|NCT01066793|76083709|FG001|Overall Study|Miscellaneous|5|||
42257194|NCT01066793|76083710|FG002|Overall Study|Miscellaneous|6|||
42257195|NCT01066793|76083711|FG003|Overall Study|Miscellaneous|0|||
42257196|NCT01066793|76083712|FG004|Overall Study|Miscellaneous|0|||
42317996|NCT02325713|76154877|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42257197|NCT01066793|76083713|FG005|Overall Study|Miscellaneous|0|||
42257198|NCT01066793|76083708|FG000|Overall Study|Non-responders|104|||
42317997|NCT02325713|76154878|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42257199|NCT01066793|76083709|FG001|Overall Study|Non-responders|5|||
42257200|NCT01066793|76083710|FG002|Overall Study|Non-responders|11|||
42257201|NCT01066793|76083711|FG003|Overall Study|Non-responders|25|||
42257202|NCT01066793|76083712|FG004|Overall Study|Non-responders|0|||
42317998|NCT02325713|76154879|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42317999|NCT02325713|76154880|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42318000|NCT02325713|76154881|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42318001|NCT02325713|76154882|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42318002|NCT02325713|76154883|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42318003|NCT02325713|76154884|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42318004|NCT02325713|76154885|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
42318005|NCT02325713|76154870|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318006|NCT02325713|76154871|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318007|NCT02325713|76154872|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
41993705|NCT00192075|75802013|FG000|Overall Study|Death|0|||
42257203|NCT01066793|76083713|FG005|Overall Study|Non-responders|0|||
42257204|NCT01066793|76083708|FG000|Overall Study|Other|15|||
42257205|NCT01066793|76083709|FG001|Overall Study|Other|5|||
42257206|NCT01066793|76083710|FG002|Overall Study|Other|6|||
42257207|NCT01066793|76083711|FG003|Overall Study|Other|2|||
42318008|NCT02325713|76154873|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318009|NCT02325713|76154874|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318010|NCT02325713|76154875|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318011|NCT02325713|76154876|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318012|NCT02325713|76154877|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318013|NCT02325713|76154878|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318014|NCT02325713|76154879|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
42318015|NCT02325713|76154880|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318016|NCT02325713|76154881|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318017|NCT02325713|76154882|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318018|NCT02325713|76154883|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318019|NCT02325713|76154884|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318020|NCT02325713|76154885|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
42318021|NCT02325401|76154900|FG000|Overall Study|Withdrawal by Subject|0|||
42318022|NCT02325401|76154901|FG001|Overall Study|Withdrawal by Subject|1|||
42318023|NCT02325401|76154902|FG002|Overall Study|Withdrawal by Subject|1|||
42318024|NCT02324699|76154916|FG000|Overall Study|study terminated|1|||
42318025|NCT01764256|76154924|FG000|Received All Vaccinations|Adverse Event|1|||
42318026|NCT01764256|76154925|FG001|Received All Vaccinations|Adverse Event|1|||
42318027|NCT01764256|76154926|FG002|Received All Vaccinations|Adverse Event|0|||
42318028|NCT01764256|76154927|FG003|Received All Vaccinations|Adverse Event|0|||
42318029|NCT01764256|76154924|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
42318030|NCT01764256|76154925|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
42318031|NCT01764256|76154926|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
42318032|NCT01764256|76154927|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
42318033|NCT01764256|76154924|FG000|Received All Vaccinations|Lost to Follow-up|1|||
42318034|NCT01764256|76154925|FG001|Received All Vaccinations|Lost to Follow-up|0|||
42318035|NCT01764256|76154926|FG002|Received All Vaccinations|Lost to Follow-up|0|||
42318036|NCT01764256|76154927|FG003|Received All Vaccinations|Lost to Follow-up|0|||
42318037|NCT01764256|76154924|FG000|Completed Study|Lost to Follow-up|0|||
42318038|NCT01764256|76154925|FG001|Completed Study|Lost to Follow-up|0|||
42318039|NCT01764256|76154926|FG002|Completed Study|Lost to Follow-up|0|||
42318040|NCT01764256|76154927|FG003|Completed Study|Lost to Follow-up|1|||
42318041|NCT01979523|76154943|FG000|Overall Study|Withdrawal by Subject|1|||
42318042|NCT01979523|76154944|FG001|Overall Study|Withdrawal by Subject|0|||
42318043|NCT02255461|76154956|FG000|Overall Study|Adverse Event|0|||
42318044|NCT02255461|76154957|FG001|Overall Study|Adverse Event|1|||
42318045|NCT02255461|76154958|FG002|Overall Study|Adverse Event|0|||
42318046|NCT02255461|76154959|FG003|Overall Study|Adverse Event|0|||
42318047|NCT02255461|76154960|FG004|Overall Study|Adverse Event|1|||
42318048|NCT02255461|76154956|FG000|Overall Study|Withdrawal by Subject|0|||
42318049|NCT02255461|76154957|FG001|Overall Study|Withdrawal by Subject|0|||
42318050|NCT02255461|76154958|FG002|Overall Study|Withdrawal by Subject|1|||
42318051|NCT02255461|76154959|FG003|Overall Study|Withdrawal by Subject|0|||
42318052|NCT02255461|76154960|FG004|Overall Study|Withdrawal by Subject|1|||
41993706|NCT00192075|75802014|FG001|Overall Study|Death|1|||
42257208|NCT01066793|76083712|FG004|Overall Study|Other|0|||
42257209|NCT01066793|76083713|FG005|Overall Study|Other|0|||
42257210|NCT01066793|76083708|FG000|Overall Study|Relapse|20|||
42257211|NCT01066793|76083709|FG001|Overall Study|Relapse|8|||
42257212|NCT01066793|76083710|FG002|Overall Study|Relapse|2|||
42257213|NCT01066793|76083711|FG003|Overall Study|Relapse|3|||
42257214|NCT01066793|76083712|FG004|Overall Study|Relapse|0|||
42257215|NCT01066793|76083713|FG005|Overall Study|Relapse|0|||
41993707|NCT00192075|75802013|FG000|Overall Study|Lack of Efficacy|0|||
42257216|NCT01066793|76083708|FG000|Overall Study|Result Not Available|1|||
42257217|NCT01066793|76083709|FG001|Overall Study|Result Not Available|0|||
42318053|NCT02255461|76154956|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
42318054|NCT02255461|76154957|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
42318055|NCT02255461|76154958|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
42318056|NCT02255461|76154959|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
42318057|NCT02255461|76154960|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
42318058|NCT01764022|76154979|FG000|Overall Study|Death|3|||
42318059|NCT01764022|76154980|FG001|Overall Study|Death|5|||
42318060|NCT01764022|76154979|FG000|Overall Study|Withdrawal by Subject|2|||
42318061|NCT01764022|76154980|FG001|Overall Study|Withdrawal by Subject|6|||
42318062|NCT01764022|76154979|FG000|Overall Study|Lack of Efficacy|0|||
42318063|NCT01764022|76154980|FG001|Overall Study|Lack of Efficacy|1|||
42318064|NCT01764022|76154979|FG000|Overall Study|Physician Decision|0|||
42318065|NCT01764022|76154980|FG001|Overall Study|Physician Decision|2|||
42318066|NCT01764022|76154979|FG000|Overall Study|Lost to Follow-up|2|||
42318067|NCT01764022|76154980|FG001|Overall Study|Lost to Follow-up|0|||
42318068|NCT01764022|76154979|FG000|Overall Study|Protocol Violation|1|||
42318069|NCT01764022|76154980|FG001|Overall Study|Protocol Violation|0|||
42318070|NCT02003391|76154990|FG000|Overall Study|Withdrawal by Subject|2|||
42318071|NCT02003391|76154991|FG001|Overall Study|Withdrawal by Subject|1|||
42318072|NCT02003391|76154990|FG000|Overall Study|Protocol Violation|0|||
42318073|NCT02003391|76154991|FG001|Overall Study|Protocol Violation|1|||
42318074|NCT02003391|76154990|FG000|Overall Study|Adverse Event|1|||
42318075|NCT02003391|76154991|FG001|Overall Study|Adverse Event|0|||
42318076|NCT02254681|76154997|FG000|Overall Study|Lack of Efficacy|6|||
42318077|NCT01965327|76155002|FG000|Overall Study|Physician Decision|2|||
42318078|NCT02002689|76155006|FG000|Overall Study|Disease Progression|7|||
42318079|NCT02002689|76155006|FG000|Overall Study|Adverse Event|3|||
42318080|NCT01639729|76155010|FG000|Overall Study|Withdrawal by Subject|1|||
42318081|NCT01639729|76155011|FG001|Overall Study|Withdrawal by Subject|0|||
42318082|NCT01639729|76155012|FG002|Overall Study|Withdrawal by Subject|1|||
42318083|NCT01639729|76155013|FG003|Overall Study|Withdrawal by Subject|1|||
42318084|NCT01639729|76155014|FG004|Overall Study|Withdrawal by Subject|0|||
42318085|NCT01639729|76155015|FG005|Overall Study|Withdrawal by Subject|0|||
42318086|NCT02002533|76155027|FG000|Overall Study|Withdrawal by Subject|6|||
42318087|NCT02002533|76155028|FG001|Overall Study|Withdrawal by Subject|13|||
42318088|NCT02002533|76155027|FG000|Overall Study|Protocol Violation|0|||
42318089|NCT02002533|76155028|FG001|Overall Study|Protocol Violation|1|||
42318090|NCT02002533|76155027|FG000|Overall Study|Adverse Event|0|||
42318091|NCT02002533|76155028|FG001|Overall Study|Adverse Event|3|||
42318092|NCT02002533|76155027|FG000|Overall Study|Lost to Follow-up|0|||
42318093|NCT02002533|76155028|FG001|Overall Study|Lost to Follow-up|1|||
42318094|NCT02002221|76155037|FG000|Overall Study|Adverse Event|2|||
42318095|NCT02002221|76155038|FG001|Overall Study|Adverse Event|1|||
42257218|NCT01066793|76083710|FG002|Overall Study|Result Not Available|0|||
42257219|NCT01066793|76083711|FG003|Overall Study|Result Not Available|0|||
42257220|NCT01066793|76083712|FG004|Overall Study|Result Not Available|0|||
42257221|NCT01066793|76083713|FG005|Overall Study|Result Not Available|0|||
42257222|NCT01066793|76083708|FG000|Overall Study|Treatment Interrupted|1|||
42257223|NCT01066793|76083709|FG001|Overall Study|Treatment Interrupted|1|||
42257224|NCT01066793|76083710|FG002|Overall Study|Treatment Interrupted|0|||
42257225|NCT01066793|76083711|FG003|Overall Study|Treatment Interrupted|0|||
42257226|NCT01066793|76083712|FG004|Overall Study|Treatment Interrupted|0|||
42257227|NCT01066793|76083713|FG005|Overall Study|Treatment Interrupted|0|||
42257228|NCT01066793|76083708|FG000|Overall Study|Treatment Never Started|18|||
42318096|NCT02002221|76155037|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
41993708|NCT00192075|75802014|FG001|Overall Study|Lack of Efficacy|0|||
42257229|NCT01066793|76083709|FG001|Overall Study|Treatment Never Started|5|||
42318097|NCT02002221|76155038|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
42318098|NCT02002221|76155037|FG000|Overall Study|Patient withdrew consent|0|||
42318099|NCT02002221|76155038|FG001|Overall Study|Patient withdrew consent|1|||
42318100|NCT01639495|76155044|FG000|Overall Study|Lost to Follow-up|6|||
42318101|NCT01639495|76155044|FG000|Overall Study|Consented but didn't have study catheter|4|||
42318102|NCT01639495|76155044|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
42257230|NCT01066793|76083710|FG002|Overall Study|Treatment Never Started|4|||
42257231|NCT01066793|76083711|FG003|Overall Study|Treatment Never Started|1|||
42257232|NCT01066793|76083712|FG004|Overall Study|Treatment Never Started|0|||
42318103|NCT01639495|76155044|FG000|Overall Study|No radiofrequency energy applied|2|||
42318104|NCT02001987|76155048|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
42318105|NCT02001987|76155048|FG000|Core Study Period (24 Weeks)|Death|1|||
42318106|NCT02001987|76155048|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
42318107|NCT02001987|76155048|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
42318108|NCT02001987|76155048|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
42318109|NCT02001987|76155048|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
42318110|NCT02001987|76155048|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
42318111|NCT02001987|76155048|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
42318112|NCT02001987|76155048|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
42318113|NCT02001987|76155048|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
42318114|NCT02001987|76155048|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
42318115|NCT02001987|76155048|FG000|LTE Period (52 Weeks)|Other|3|||
42318116|NCT01363765|76155059|FG000|Overall Study|non-diagnostic|2621|||
42318117|NCT01363765|76155060|FG001|Overall Study|non-diagnostic|1124|||
42318118|NCT01363765|76155059|FG000|Overall Study|duplicate records|736|||
42318119|NCT01363765|76155060|FG001|Overall Study|duplicate records|3177|||
42318120|NCT01363765|76155059|FG000|Overall Study|non-resident|156|||
42318121|NCT01363765|76155060|FG001|Overall Study|non-resident|76|||
42318122|NCT01363765|76155059|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
42318123|NCT01363765|76155060|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
42318124|NCT01363765|76155059|FG000|Overall Study|smear during intervention|2170|||
42318125|NCT01363765|76155060|FG001|Overall Study|smear during intervention|0|||
42318126|NCT02001051|76155070|FG000|Overall Study|Deemed not eligible following enrollment|0|||
42318127|NCT02001051|76155071|FG001|Overall Study|Deemed not eligible following enrollment|1|||
42318128|NCT01763164|76155079|FG000|Treatment Phase|Participant/Guardian decision|26|||
42318129|NCT01763164|76155080|FG001|Treatment Phase|Participant/Guardian decision|14|||
42318130|NCT01763164|76155079|FG000|Treatment Phase|Protocol Violation|1|||
42318131|NCT01763164|76155080|FG001|Treatment Phase|Protocol Violation|1|||
42318132|NCT01763164|76155079|FG000|Treatment Phase|Progressive Disease|142|||
42318133|NCT01763164|76155080|FG001|Treatment Phase|Progressive Disease|76|||
42318134|NCT01763164|76155079|FG000|Treatment Phase|Physician Decision|24|||
42318135|NCT01763164|76155080|FG001|Treatment Phase|Physician Decision|13|||
42318136|NCT01763164|76155079|FG000|Treatment Phase|Death|10|||
42318137|NCT01763164|76155080|FG001|Treatment Phase|Death|1|||
42318138|NCT01763164|76155079|FG000|Treatment Phase|Adverse Event|66|||
42318139|NCT01763164|76155080|FG001|Treatment Phase|Adverse Event|8|||
42318140|NCT01763164|76155079|FG000|Treatment Phase|Randomized but not Treated|0|||
42318141|NCT01763164|76155080|FG001|Treatment Phase|Randomized but not Treated|19|||
42318142|NCT01763164|76155079|FG000|Treatment Phase|Other|0|||
42318143|NCT01763164|76155080|FG001|Treatment Phase|Other|1|||
42318144|NCT01763164|76155079|FG000|Follow up Phase|New therapy for study indication|12|||
42318145|NCT01763164|76155080|FG001|Follow up Phase|New therapy for study indication|3|||
42318146|NCT01763164|76155079|FG000|Follow up Phase|Death|21|||
42318147|NCT01763164|76155080|FG001|Follow up Phase|Death|4|||
42318148|NCT01763164|76155079|FG000|Follow up Phase|Subject/guardian decision|9|||
42318149|NCT01763164|76155080|FG001|Follow up Phase|Subject/guardian decision|2|||
42318150|NCT01763164|76155079|FG000|Follow up Phase|Progressive disease|127|||
42318151|NCT01763164|76155080|FG001|Follow up Phase|Progressive disease|62|||
42318152|NCT01763164|76155079|FG000|Follow up Phase|Physician Decision|10|||
42318153|NCT01763164|76155080|FG001|Follow up Phase|Physician Decision|3|||
42318154|NCT01763164|76155079|FG000|Follow up Phase|Lost to Follow-up|1|||
42318155|NCT01763164|76155080|FG001|Follow up Phase|Lost to Follow-up|0|||
42318156|NCT01763164|76155079|FG000|Follow up Phase|Adverse Event|17|||
42318157|NCT01763164|76155080|FG001|Follow up Phase|Adverse Event|1|||
42318158|NCT01782742|76155088|FG000|Double-blind Treatment Phase|Adverse Event|1|||
42318159|NCT01782742|76155089|FG001|Double-blind Treatment Phase|Adverse Event|0|||
42318160|NCT01782664|76155103|FG000|Overall Study|Adverse Event|2|||
42318161|NCT01782664|76155104|FG001|Overall Study|Adverse Event|2|||
42318162|NCT01782664|76155105|FG002|Overall Study|Adverse Event|2|||
42318163|NCT01782664|76155106|FG003|Overall Study|Adverse Event|2|||
42318164|NCT01782664|76155107|FG004|Overall Study|Adverse Event|0|||
42318165|NCT01782664|76155108|FG005|Overall Study|Adverse Event|0|||
42318166|NCT01782664|76155103|FG000|Overall Study|Lack of Efficacy|2|||
42318167|NCT01782664|76155104|FG001|Overall Study|Lack of Efficacy|0|||
42318168|NCT01782664|76155105|FG002|Overall Study|Lack of Efficacy|2|||
42318169|NCT01782664|76155106|FG003|Overall Study|Lack of Efficacy|2|||
42318170|NCT01782664|76155107|FG004|Overall Study|Lack of Efficacy|0|||
42318171|NCT01782664|76155108|FG005|Overall Study|Lack of Efficacy|0|||
42318172|NCT01782664|76155103|FG000|Overall Study|Protocol Violation|0|||
42318173|NCT01782664|76155104|FG001|Overall Study|Protocol Violation|1|||
42318174|NCT01782664|76155105|FG002|Overall Study|Protocol Violation|0|||
42318175|NCT01782664|76155106|FG003|Overall Study|Protocol Violation|1|||
42318176|NCT01782664|76155107|FG004|Overall Study|Protocol Violation|0|||
42318177|NCT01782664|76155108|FG005|Overall Study|Protocol Violation|0|||
42318178|NCT01782664|76155103|FG000|Overall Study|Withdrawal by Subject|2|||
42318179|NCT01782664|76155104|FG001|Overall Study|Withdrawal by Subject|2|||
42318180|NCT01782664|76155105|FG002|Overall Study|Withdrawal by Subject|0|||
42318181|NCT01782664|76155106|FG003|Overall Study|Withdrawal by Subject|0|||
42318182|NCT01782664|76155107|FG004|Overall Study|Withdrawal by Subject|0|||
42318183|NCT01782664|76155108|FG005|Overall Study|Withdrawal by Subject|0|||
42318184|NCT01732588|76155125|FG000|First Intervention (7 Days)|Adverse Event|0|||
42318185|NCT01732588|76155126|FG001|First Intervention (7 Days)|Adverse Event|1|||
42318186|NCT01732588|76155127|FG002|First Intervention (7 Days)|Adverse Event|0|||
42318187|NCT01781962|76155135|FG000|Overall Study|Other Miscellaneous Reasons|5|||
42318188|NCT01639339|76155141|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
42318189|NCT01639339|76155142|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
42318190|NCT01639339|76155141|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
42318191|NCT01639339|76155142|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
42318192|NCT01639339|76155141|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
41993709|NCT00192075|75802013|FG000|Overall Study|Physician Decision|3|||
42318193|NCT01639339|76155142|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
42318194|NCT01639339|76155141|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
42318195|NCT01639339|76155142|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
42318196|NCT01639339|76155141|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
42318197|NCT01639339|76155142|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
42318198|NCT01639339|76155141|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
42318199|NCT01639339|76155142|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
42318200|NCT01639339|76155141|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
42318201|NCT01639339|76155142|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
42318202|NCT01639339|76155141|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
42318203|NCT01639339|76155142|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
42318204|NCT01639339|76155141|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
42318205|NCT01639339|76155142|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
41993710|NCT00192075|75802014|FG001|Overall Study|Physician Decision|0|||
41993711|NCT00192075|75802013|FG000|Overall Study|Withdrawal by Subject|5|||
41993712|NCT00192075|75802014|FG001|Overall Study|Withdrawal by Subject|5|||
41993713|NCT00192075|75802013|FG000|Overall Study|Patient Non-Compliance|0|||
41993714|NCT00192075|75802014|FG001|Overall Study|Patient Non-Compliance|1|||
41993715|NCT00192075|75802013|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
41993716|NCT00192075|75802014|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
41993717|NCT00192075|75802013|FG000|Overall Study|Other|5|||
41993718|NCT00192075|75802014|FG001|Overall Study|Other|2|||
41993719|NCT00192036|75802025|FG000|Overall Study|Protocol Violation|3|||
41993720|NCT00192036|75802025|FG000|Overall Study|Adverse Event|6|||
42257233|NCT01066793|76083713|FG005|Overall Study|Treatment Never Started|0|||
42257234|NCT01066793|76083708|FG000|Overall Study|Treatment Stopped|2|||
42257235|NCT01066793|76083709|FG001|Overall Study|Treatment Stopped|1|||
42257236|NCT01066793|76083710|FG002|Overall Study|Treatment Stopped|0|||
42257237|NCT01066793|76083711|FG003|Overall Study|Treatment Stopped|1|||
42257238|NCT01066793|76083712|FG004|Overall Study|Treatment Stopped|0|||
42257239|NCT01066793|76083713|FG005|Overall Study|Treatment Stopped|0|||
42257240|NCT03985293|76083734|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
42257241|NCT03985293|76083735|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
42257242|NCT03985293|76083736|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
42257243|NCT03985293|76083737|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
42257244|NCT03985293|76083738|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
42257245|NCT03985293|76083739|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
42257246|NCT03985293|76083734|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
42257247|NCT03985293|76083735|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
42257248|NCT03985293|76083736|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
42257249|NCT03985293|76083737|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
42257250|NCT03985293|76083738|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
42257251|NCT03985293|76083739|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
42257252|NCT03985293|76083734|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
42257253|NCT03985293|76083735|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
42257254|NCT03985293|76083736|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
41993721|NCT00192036|75802025|FG000|Overall Study|Patient/Physician Perception|1|||
41993722|NCT00192036|75802025|FG000|Overall Study|Objective Tumor Progression|4|||
42257255|NCT03985293|76083737|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
42257256|NCT03985293|76083738|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
42257257|NCT03985293|76083739|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
42318206|NCT01639339|76155141|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
42318207|NCT01639339|76155142|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
42318208|NCT02000817|76155156|FG000|Overall Study|Withdrawal by Subject|2|||
42318209|NCT02000817|76155157|FG001|Overall Study|Withdrawal by Subject|0|||
42318210|NCT02000817|76155158|FG002|Overall Study|Withdrawal by Subject|0|||
42318211|NCT02000817|76155159|FG003|Overall Study|Withdrawal by Subject|0|||
42318212|NCT02000817|76155156|FG000|Overall Study|Adverse Event|0|||
42318213|NCT02000817|76155157|FG001|Overall Study|Adverse Event|1|||
42318214|NCT02000817|76155158|FG002|Overall Study|Adverse Event|0|||
42318215|NCT02000817|76155159|FG003|Overall Study|Adverse Event|0|||
42318216|NCT02000817|76155156|FG000|Overall Study|Lost to Follow-up|0|||
42318217|NCT02000817|76155157|FG001|Overall Study|Lost to Follow-up|0|||
42257258|NCT03985293|76083734|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
42257259|NCT03985293|76083735|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
42318218|NCT02000817|76155158|FG002|Overall Study|Lost to Follow-up|1|||
42318219|NCT02000817|76155159|FG003|Overall Study|Lost to Follow-up|0|||
42318220|NCT01641133|76155175|FG000|Overall Study|Protocol Violation|0|||
42318221|NCT01641133|76155176|FG001|Overall Study|Protocol Violation|1|||
42318222|NCT01641133|76155177|FG002|Overall Study|Protocol Violation|1|||
42318223|NCT01641133|76155175|FG000|Overall Study|Migrated/moved from study area|5|||
42318224|NCT01641133|76155176|FG001|Overall Study|Migrated/moved from study area|3|||
42318225|NCT01641133|76155177|FG002|Overall Study|Migrated/moved from study area|1|||
42318226|NCT01641133|76155175|FG000|Overall Study|Adverse Event|0|||
42318227|NCT01641133|76155176|FG001|Overall Study|Adverse Event|0|||
42318228|NCT01641133|76155177|FG002|Overall Study|Adverse Event|1|||
42318229|NCT01641133|76155175|FG000|Overall Study|Withdrawal by Subject|5|||
42318230|NCT01641133|76155176|FG001|Overall Study|Withdrawal by Subject|3|||
42318231|NCT01641133|76155177|FG002|Overall Study|Withdrawal by Subject|3|||
42318232|NCT01641133|76155175|FG000|Overall Study|Lost to Follow-up|0|||
42318233|NCT01641133|76155176|FG001|Overall Study|Lost to Follow-up|2|||
42318234|NCT01641133|76155177|FG002|Overall Study|Lost to Follow-up|2|||
42318235|NCT02000427|76155185|FG000|Overall Study|Death|22|||
42318236|NCT01600885|76155189|FG000|First Period|Adverse Event|1|||
42318237|NCT01600885|76155190|FG001|First Period|Adverse Event|1|||
42318238|NCT01600885|76155189|FG000|First Period|moved out of area|1|||
42318239|NCT01600885|76155190|FG001|First Period|moved out of area|0|||
42318240|NCT01732510|76155203|FG000|Overall Study|Adverse Event|0|||
42318241|NCT01732510|76155204|FG001|Overall Study|Adverse Event|1|||
42318242|NCT01732510|76155205|FG002|Overall Study|Adverse Event|1|||
42318243|NCT01732510|76155206|FG003|Overall Study|Adverse Event|0|||
42318244|NCT01732510|76155207|FG004|Overall Study|Adverse Event|0|||
42318245|NCT01732510|76155208|FG005|Overall Study|Adverse Event|0|||
42318246|NCT01732510|76155209|FG006|Overall Study|Adverse Event|1|||
42318247|NCT01732510|76155203|FG000|Overall Study|Protocol Violation|0|||
42318248|NCT01732510|76155204|FG001|Overall Study|Protocol Violation|0|||
42318249|NCT01732510|76155205|FG002|Overall Study|Protocol Violation|0|||
42318250|NCT01732510|76155206|FG003|Overall Study|Protocol Violation|1|||
42318251|NCT01732510|76155207|FG004|Overall Study|Protocol Violation|0|||
42257260|NCT03985293|76083736|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
42257261|NCT03985293|76083737|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
42257262|NCT03985293|76083738|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
42257263|NCT03985293|76083739|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
42257264|NCT03985293|76083734|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
42257265|NCT03985293|76083735|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
42257266|NCT03985293|76083736|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
42257267|NCT03985293|76083737|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
42257268|NCT03985293|76083738|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
42257269|NCT03985293|76083739|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
42257270|NCT03985293|76083734|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
42318252|NCT01732510|76155208|FG005|Overall Study|Protocol Violation|0|||
42257271|NCT03985293|76083735|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
41993723|NCT00192036|75802025|FG000|Overall Study|Clinical Disease Progression|1|||
42257272|NCT03985293|76083736|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
42318253|NCT01732510|76155209|FG006|Overall Study|Protocol Violation|0|||
42318254|NCT01732510|76155203|FG000|Overall Study|Withdrawal by Subject|1|||
42318255|NCT01732510|76155204|FG001|Overall Study|Withdrawal by Subject|3|||
42318256|NCT01732510|76155205|FG002|Overall Study|Withdrawal by Subject|2|||
42318257|NCT01732510|76155206|FG003|Overall Study|Withdrawal by Subject|1|||
42318258|NCT01732510|76155207|FG004|Overall Study|Withdrawal by Subject|5|||
42318259|NCT01732510|76155208|FG005|Overall Study|Withdrawal by Subject|0|||
42318260|NCT01732510|76155209|FG006|Overall Study|Withdrawal by Subject|1|||
41993724|NCT00192036|75802025|FG000|Overall Study|Death|1|||
41993725|NCT00192036|75802025|FG000|Overall Study|Unknown or Not Specified|5|||
41993726|NCT00191724|75802034|FG000|Overall Study|Adverse Event|0|||
41993727|NCT00191724|75802035|FG001|Overall Study|Adverse Event|0|||
41993728|NCT00191724|75802036|FG002|Overall Study|Adverse Event|1|||
41993729|NCT00191724|75802037|FG003|Overall Study|Adverse Event|0|||
41993730|NCT00191724|75802038|FG004|Overall Study|Adverse Event|0|||
41993731|NCT00191724|75802034|FG000|Overall Study|Lost to Follow-up|1|||
41993732|NCT00191724|75802035|FG001|Overall Study|Lost to Follow-up|1|||
41993733|NCT00191724|75802036|FG002|Overall Study|Lost to Follow-up|0|||
41993734|NCT00191724|75802037|FG003|Overall Study|Lost to Follow-up|2|||
41993735|NCT00191724|75802038|FG004|Overall Study|Lost to Follow-up|3|||
41993736|NCT00191724|75802034|FG000|Overall Study|Withdrawal by Subject|0|||
41993737|NCT00191724|75802035|FG001|Overall Study|Withdrawal by Subject|0|||
41993738|NCT00191724|75802036|FG002|Overall Study|Withdrawal by Subject|0|||
41993739|NCT00191724|75802037|FG003|Overall Study|Withdrawal by Subject|1|||
41993740|NCT00191724|75802038|FG004|Overall Study|Withdrawal by Subject|0|||
41993741|NCT00191646|75802052|FG000|Overall Study|Toxicity|26|||
41993742|NCT00191646|75802053|FG001|Overall Study|Toxicity|37|||
41993743|NCT00191646|75802052|FG000|Overall Study|Disease Progression|5|||
41993744|NCT00191646|75802053|FG001|Overall Study|Disease Progression|6|||
42257273|NCT03985293|76083737|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
42257274|NCT03985293|76083738|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
42257275|NCT03985293|76083739|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
42257276|NCT03985293|76083734|FG000|FOLLOW-UP|Lost to Follow-up|0|||
42257277|NCT03985293|76083735|FG001|FOLLOW-UP|Lost to Follow-up|0|||
42257278|NCT03985293|76083736|FG002|FOLLOW-UP|Lost to Follow-up|1|||
42257279|NCT03985293|76083737|FG003|FOLLOW-UP|Lost to Follow-up|0|||
42257280|NCT03985293|76083738|FG004|FOLLOW-UP|Lost to Follow-up|0|||
42257281|NCT03985293|76083739|FG005|FOLLOW-UP|Lost to Follow-up|0|||
42257282|NCT03654755|76083756|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
42257283|NCT03654755|76083757|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
42257284|NCT03654755|76083758|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
42257285|NCT03654755|76083756|FG000|Overall Study|Withdrawal by Subject|2|||
42257286|NCT03654755|76083757|FG001|Overall Study|Withdrawal by Subject|4|||
42257287|NCT03654755|76083758|FG002|Overall Study|Withdrawal by Subject|8|||
42257288|NCT03654755|76083756|FG000|Overall Study|Lost to Follow-up|1|||
42257289|NCT03654755|76083757|FG001|Overall Study|Lost to Follow-up|3|||
42257290|NCT03654755|76083758|FG002|Overall Study|Lost to Follow-up|7|||
42257291|NCT03654755|76083756|FG000|Overall Study|Physician Decision|0|||
42257292|NCT03654755|76083757|FG001|Overall Study|Physician Decision|1|||
42257293|NCT03654755|76083758|FG002|Overall Study|Physician Decision|0|||
42257294|NCT03654755|76083756|FG000|Overall Study|Adverse Event|0|||
42257295|NCT03654755|76083757|FG001|Overall Study|Adverse Event|0|||
42257296|NCT03654755|76083758|FG002|Overall Study|Adverse Event|4|||
42257297|NCT03654755|76083756|FG000|Overall Study|Lack of Efficacy|0|||
42257298|NCT03654755|76083757|FG001|Overall Study|Lack of Efficacy|0|||
42257299|NCT03654755|76083758|FG002|Overall Study|Lack of Efficacy|1|||
42257300|NCT02980601|76083768|FG000|Overall Study|Lost to Follow-up|2|||
42257301|NCT02980601|76083769|FG001|Overall Study|Lost to Follow-up|2|||
42257302|NCT02980601|76083768|FG000|Overall Study|Death|0|||
42257303|NCT02980601|76083769|FG001|Overall Study|Death|1|||
42257304|NCT02980601|76083768|FG000|Overall Study|Graft loss|1|||
42257305|NCT02980601|76083769|FG001|Overall Study|Graft loss|0|||
42257306|NCT02980601|76083768|FG000|Overall Study|Failed to sign consent|2|||
42257307|NCT02980601|76083769|FG001|Overall Study|Failed to sign consent|0|||
42257308|NCT02980523|76083780|FG000|Overall Study|Lost to Follow-up|1|||
42257309|NCT02980523|76083781|FG001|Overall Study|Lost to Follow-up|4|||
42257310|NCT02980523|76083782|FG002|Overall Study|Lost to Follow-up|1|||
42257311|NCT02980523|76083783|FG003|Overall Study|Lost to Follow-up|2|||
42257312|NCT02980523|76083784|FG004|Overall Study|Lost to Follow-up|1|||
42257313|NCT02980523|76083780|FG000|Overall Study|Excluded from analysis|1|||
42257314|NCT02980523|76083781|FG001|Overall Study|Excluded from analysis|3|||
42257315|NCT02980523|76083782|FG002|Overall Study|Excluded from analysis|1|||
42257316|NCT02980523|76083783|FG003|Overall Study|Excluded from analysis|1|||
42257317|NCT02980523|76083784|FG004|Overall Study|Excluded from analysis|1|||
42318261|NCT01732510|76155203|FG000|Overall Study|Lost to Follow-up|0|||
42318262|NCT01732510|76155204|FG001|Overall Study|Lost to Follow-up|0|||
42318263|NCT01732510|76155205|FG002|Overall Study|Lost to Follow-up|1|||
42318264|NCT01732510|76155206|FG003|Overall Study|Lost to Follow-up|1|||
42318265|NCT01732510|76155207|FG004|Overall Study|Lost to Follow-up|0|||
42318266|NCT01732510|76155208|FG005|Overall Study|Lost to Follow-up|1|||
42318267|NCT01732510|76155209|FG006|Overall Study|Lost to Follow-up|0|||
42318268|NCT01732510|76155203|FG000|Overall Study|Physician Decision|0|||
42318269|NCT01732510|76155204|FG001|Overall Study|Physician Decision|1|||
42318270|NCT01732510|76155205|FG002|Overall Study|Physician Decision|0|||
42318271|NCT01732510|76155206|FG003|Overall Study|Physician Decision|0|||
42318272|NCT01732510|76155207|FG004|Overall Study|Physician Decision|0|||
42318273|NCT01732510|76155208|FG005|Overall Study|Physician Decision|0|||
42318274|NCT01732510|76155209|FG006|Overall Study|Physician Decision|0|||
42318275|NCT01732510|76155203|FG000|Overall Study|Pregnancy|0|||
42318276|NCT01732510|76155204|FG001|Overall Study|Pregnancy|0|||
42318277|NCT01732510|76155205|FG002|Overall Study|Pregnancy|0|||
42318278|NCT01732510|76155206|FG003|Overall Study|Pregnancy|1|||
42318279|NCT01732510|76155207|FG004|Overall Study|Pregnancy|0|||
42318280|NCT01732510|76155208|FG005|Overall Study|Pregnancy|0|||
42318281|NCT01732510|76155209|FG006|Overall Study|Pregnancy|0|||
42318282|NCT01732510|76155203|FG000|Overall Study|Study Terminated By Sponsor|0|||
42318283|NCT01732510|76155204|FG001|Overall Study|Study Terminated By Sponsor|0|||
42318284|NCT01732510|76155205|FG002|Overall Study|Study Terminated By Sponsor|0|||
42318285|NCT01732510|76155206|FG003|Overall Study|Study Terminated By Sponsor|1|||
42318286|NCT01732510|76155207|FG004|Overall Study|Study Terminated By Sponsor|0|||
42318287|NCT01732510|76155208|FG005|Overall Study|Study Terminated By Sponsor|12|||
42318288|NCT01732510|76155209|FG006|Overall Study|Study Terminated By Sponsor|6|||
42318289|NCT01637077|76155230|FG000|Overall Study|Cancel|1|||
42318290|NCT01637077|76155231|FG001|Overall Study|Cancel|1|||
42318291|NCT01637077|76155230|FG000|Overall Study|Withdrawal by Subject|1|||
42318292|NCT01637077|76155231|FG001|Overall Study|Withdrawal by Subject|0|||
42318293|NCT01637077|76155230|FG000|Overall Study|No cycle 1 questionnaire data|2|||
42318294|NCT01637077|76155231|FG001|Overall Study|No cycle 1 questionnaire data|0|||
42318295|NCT02308163|76155241|FG000|Overall Study|Not fulfill eligible criteria|1|||
42318296|NCT02308163|76155242|FG001|Overall Study|Not fulfill eligible criteria|2|||
42033908|NCT01071252|75842099|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
42033909|NCT01071252|75842095|FG000|Overall Study|Withdrawal by Subject|8|||
42033910|NCT01071252|75842096|FG001|Overall Study|Withdrawal by Subject|2|||
42033911|NCT01071252|75842097|FG002|Overall Study|Withdrawal by Subject|1|||
42257318|NCT02980523|76083780|FG000|Overall Study|Lack of Efficacy|1|||
42257319|NCT02980523|76083781|FG001|Overall Study|Lack of Efficacy|4|||
42257320|NCT02980523|76083782|FG002|Overall Study|Lack of Efficacy|4|||
42257321|NCT02980523|76083783|FG003|Overall Study|Lack of Efficacy|5|||
42257322|NCT02980523|76083784|FG004|Overall Study|Lack of Efficacy|8|||
42257323|NCT02980523|76083780|FG000|Overall Study|Did not receive intervention|0|||
42257324|NCT02980523|76083781|FG001|Overall Study|Did not receive intervention|0|||
42257325|NCT02980523|76083782|FG002|Overall Study|Did not receive intervention|0|||
42257326|NCT02980523|76083783|FG003|Overall Study|Did not receive intervention|1|||
42257327|NCT02980523|76083784|FG004|Overall Study|Did not receive intervention|0|||
42257328|NCT02980133|76083803|FG000|Overall Study|Other than specified|1|||
42257329|NCT02980133|76083804|FG001|Overall Study|Other than specified|1|||
42257330|NCT02980133|76083805|FG002|Overall Study|Other than specified|2|||
42257331|NCT02980133|76083806|FG003|Overall Study|Other than specified|2|||
42257332|NCT02980133|76083803|FG000|Overall Study|Lost to Follow-up|0|||
42257333|NCT02980133|76083804|FG001|Overall Study|Lost to Follow-up|0|||
42257334|NCT02980133|76083805|FG002|Overall Study|Lost to Follow-up|1|||
42257335|NCT02980133|76083806|FG003|Overall Study|Lost to Follow-up|3|||
42257336|NCT02980133|76083803|FG000|Overall Study|Protocol Violation|0|||
42257337|NCT02980133|76083804|FG001|Overall Study|Protocol Violation|1|||
42257338|NCT02980133|76083805|FG002|Overall Study|Protocol Violation|0|||
42257339|NCT02980133|76083806|FG003|Overall Study|Protocol Violation|0|||
42257340|NCT02980133|76083803|FG000|Overall Study|Withdrawal by parent/guardian|6|||
42257341|NCT02980133|76083804|FG001|Overall Study|Withdrawal by parent/guardian|3|||
42257342|NCT02980133|76083805|FG002|Overall Study|Withdrawal by parent/guardian|3|||
42257343|NCT02980133|76083806|FG003|Overall Study|Withdrawal by parent/guardian|1|||
42257344|NCT02980133|76083803|FG000|Overall Study|Withdrawal by Subject|0|||
42257345|NCT02980133|76083804|FG001|Overall Study|Withdrawal by Subject|0|||
42318297|NCT02308163|76155243|FG002|Overall Study|Not fulfill eligible criteria|0|||
42318298|NCT02308163|76155244|FG003|Overall Study|Not fulfill eligible criteria|1|||
42318299|NCT02308163|76155245|FG004|Overall Study|Not fulfill eligible criteria|1|||
42318300|NCT02308163|76155241|FG000|Overall Study|Adverse Event|9|||
42318301|NCT02308163|76155242|FG001|Overall Study|Adverse Event|5|||
42318302|NCT02308163|76155243|FG002|Overall Study|Adverse Event|2|||
42318303|NCT02308163|76155244|FG003|Overall Study|Adverse Event|2|||
42318304|NCT02308163|76155245|FG004|Overall Study|Adverse Event|11|||
42318305|NCT02308163|76155241|FG000|Overall Study|Lack of Efficacy|11|||
42318306|NCT02308163|76155242|FG001|Overall Study|Lack of Efficacy|3|||
42318307|NCT02308163|76155243|FG002|Overall Study|Lack of Efficacy|8|||
42318308|NCT02308163|76155244|FG003|Overall Study|Lack of Efficacy|4|||
42318309|NCT02308163|76155245|FG004|Overall Study|Lack of Efficacy|6|||
42318310|NCT02308163|76155241|FG000|Overall Study|Withdrawal of consent|2|||
42318311|NCT02308163|76155242|FG001|Overall Study|Withdrawal of consent|3|||
42318312|NCT02308163|76155243|FG002|Overall Study|Withdrawal of consent|0|||
42318313|NCT02308163|76155244|FG003|Overall Study|Withdrawal of consent|2|||
42318314|NCT02308163|76155245|FG004|Overall Study|Withdrawal of consent|6|||
42318315|NCT02308163|76155241|FG000|Overall Study|Protocol Violation|3|||
41993745|NCT00191646|75802052|FG000|Overall Study|Physician Decision|20|||
42257346|NCT02980133|76083805|FG002|Overall Study|Withdrawal by Subject|1|||
42257347|NCT02980133|76083806|FG003|Overall Study|Withdrawal by Subject|0|||
42257348|NCT02979431|76083823|FG000|Overall Study|Parent/guardian withdrew consent|2|||
42257349|NCT02979431|76083824|FG001|Overall Study|Parent/guardian withdrew consent|1|||
42257350|NCT02979431|76083825|FG002|Overall Study|Parent/guardian withdrew consent|1|||
42257351|NCT02979431|76083826|FG003|Overall Study|Parent/guardian withdrew consent|1|||
42257352|NCT02979431|76083823|FG000|Overall Study|Randomized but received no study drug|1|||
42257353|NCT02979431|76083824|FG001|Overall Study|Randomized but received no study drug|1|||
42257354|NCT02979431|76083825|FG002|Overall Study|Randomized but received no study drug|0|||
42257355|NCT02979431|76083826|FG003|Overall Study|Randomized but received no study drug|0|||
42257356|NCT02979431|76083823|FG000|Overall Study|Adverse Event|0|||
42257357|NCT02979431|76083824|FG001|Overall Study|Adverse Event|0|||
42257358|NCT02979431|76083825|FG002|Overall Study|Adverse Event|1|||
42257359|NCT02979431|76083826|FG003|Overall Study|Adverse Event|0|||
42257360|NCT02979431|76083823|FG000|Overall Study|Subject left country after Day14|1|||
42257361|NCT02979431|76083824|FG001|Overall Study|Subject left country after Day14|0|||
42318316|NCT02308163|76155242|FG001|Overall Study|Protocol Violation|3|||
42318317|NCT02308163|76155243|FG002|Overall Study|Protocol Violation|3|||
42318318|NCT02308163|76155244|FG003|Overall Study|Protocol Violation|2|||
42318319|NCT02308163|76155245|FG004|Overall Study|Protocol Violation|5|||
42318320|NCT02308163|76155241|FG000|Overall Study|Lab data met discontinuation criteria|3|||
42318321|NCT02308163|76155242|FG001|Overall Study|Lab data met discontinuation criteria|0|||
42318322|NCT02308163|76155243|FG002|Overall Study|Lab data met discontinuation criteria|0|||
42318323|NCT02308163|76155244|FG003|Overall Study|Lab data met discontinuation criteria|2|||
42318324|NCT02308163|76155245|FG004|Overall Study|Lab data met discontinuation criteria|0|||
42318325|NCT02308163|76155241|FG000|Overall Study|Miscellaneous|2|||
42318326|NCT02308163|76155242|FG001|Overall Study|Miscellaneous|2|||
42318327|NCT02308163|76155243|FG002|Overall Study|Miscellaneous|1|||
42133234|NCT00498602|75944124|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
42133235|NCT00498602|75944118|FG000|Overall Study|AE not related to Study Drug|1|||
42133236|NCT00498602|75944119|FG001|Overall Study|AE not related to Study Drug|3|||
42133237|NCT00498602|75944120|FG002|Overall Study|AE not related to Study Drug|0|||
42133238|NCT00498602|75944121|FG003|Overall Study|AE not related to Study Drug|0|||
42133239|NCT00498602|75944122|FG004|Overall Study|AE not related to Study Drug|2|||
42133240|NCT00498602|75944123|FG005|Overall Study|AE not related to Study Drug|2|||
42133241|NCT00498602|75944124|FG006|Overall Study|AE not related to Study Drug|1|||
42133242|NCT00498602|75944118|FG000|Overall Study|Caregiver Request|2|||
42133243|NCT00498602|75944119|FG001|Overall Study|Caregiver Request|2|||
42133244|NCT00498602|75944120|FG002|Overall Study|Caregiver Request|2|||
42133245|NCT00498602|75944121|FG003|Overall Study|Caregiver Request|0|||
42257362|NCT02979431|76083825|FG002|Overall Study|Subject left country after Day14|0|||
42257363|NCT02979431|76083826|FG003|Overall Study|Subject left country after Day14|0|||
42318328|NCT02308163|76155244|FG003|Overall Study|Miscellaneous|0|||
42318329|NCT02308163|76155245|FG004|Overall Study|Miscellaneous|5|||
42318330|NCT01999335|76155277|FG000|Overall Study|Discontinued before receiving treatment|0|||
42318331|NCT01999335|76155278|FG001|Overall Study|Discontinued before receiving treatment|0|||
42318332|NCT01999335|76155279|FG002|Overall Study|Discontinued before receiving treatment|0|||
42318333|NCT01999335|76155280|FG003|Overall Study|Discontinued before receiving treatment|0|||
42318334|NCT01999335|76155281|FG004|Overall Study|Discontinued before receiving treatment|2|||
42318335|NCT01978119|76155296|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
42318336|NCT01978119|76155297|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
42318337|NCT01978119|76155296|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
42318338|NCT01978119|76155297|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
42318339|NCT01978119|76155296|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42318340|NCT01978119|76155297|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
42318341|NCT01999179|76155303|FG000|Overall Study|Adverse Event|1|||
42318342|NCT01999179|76155303|FG000|Overall Study|Lost to Follow-up|1|||
42318343|NCT01999179|76155303|FG000|Overall Study|Change in Therapy|3|||
42318344|NCT01999179|76155303|FG000|Overall Study|New catheter|2|||
42318345|NCT01977729|76155307|FG000|Overall Study|Study terminated|1|||
42318346|NCT01998477|76155315|FG000|Overall Study|Lost to Follow-up|4|||
42318347|NCT01998477|76155316|FG001|Overall Study|Lost to Follow-up|5|||
42318348|NCT01998477|76155315|FG000|Overall Study|Withdrawal by Subject|6|||
42318349|NCT01998477|76155316|FG001|Overall Study|Withdrawal by Subject|0|||
42318350|NCT01998399|76155349|FG000|Overall Study|Lost to Follow-up|1|||
42318351|NCT01998399|76155350|FG001|Overall Study|Lost to Follow-up|3|||
42318352|NCT01998399|76155349|FG000|Overall Study|Death|4|||
42318353|NCT01998399|76155350|FG001|Overall Study|Death|2|||
42318354|NCT01998399|76155349|FG000|Overall Study|Study stopped before dosing completed|3|||
42318355|NCT01998399|76155350|FG001|Overall Study|Study stopped before dosing completed|3|||
42318356|NCT01998399|76155349|FG000|Overall Study|Withdrawal by Subject|0|||
42257364|NCT02978417|76083838|FG000|Overall Study|Lost to Follow-up|2|||
42257365|NCT02978417|76083839|FG001|Overall Study|Lost to Follow-up|2|||
42257366|NCT02733627|76083862|FG000|Overall Study|Adverse Event|0|||
42257367|NCT02733627|76083863|FG001|Overall Study|Adverse Event|1|||
42257368|NCT02733627|76083864|FG002|Overall Study|Adverse Event|1|||
42257369|NCT02733627|76083865|FG003|Overall Study|Adverse Event|0|||
42257370|NCT02733627|76083862|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
42257371|NCT02733627|76083863|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
42318357|NCT01998399|76155350|FG001|Overall Study|Withdrawal by Subject|1|||
42318358|NCT01781572|76155367|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
42318359|NCT01781572|76155368|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
42318360|NCT01781572|76155369|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
42318361|NCT01781572|76155367|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
42318362|NCT01781572|76155368|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
42257372|NCT02733627|76083864|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
42133246|NCT00498602|75944122|FG004|Overall Study|Caregiver Request|1|||
42133247|NCT00498602|75944123|FG005|Overall Study|Caregiver Request|2|||
42133248|NCT00498602|75944124|FG006|Overall Study|Caregiver Request|0|||
42133249|NCT00498602|75944118|FG000|Overall Study|Investigator Request|0|||
42133250|NCT00498602|75944119|FG001|Overall Study|Investigator Request|0|||
42257373|NCT02733627|76083865|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
42257374|NCT02958865|76083882|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
42257375|NCT02958865|76083883|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
42257376|NCT02958865|76083884|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
42257377|NCT02958865|76083885|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
42257378|NCT02958865|76083886|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
42257379|NCT02958865|76083887|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
42257380|NCT02958865|76083888|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
42257381|NCT02958865|76083889|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
42257382|NCT02958865|76083890|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
42257383|NCT02958865|76083891|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
42257384|NCT02958865|76083892|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
42257385|NCT02958865|76083893|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
42257386|NCT02958865|76083894|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
42257387|NCT02958865|76083895|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
42257388|NCT02958865|76083896|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
42257389|NCT02958865|76083897|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
42257390|NCT02958865|76083882|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
42257391|NCT02958865|76083883|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
42257392|NCT02958865|76083884|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
42257393|NCT02958865|76083885|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
42257394|NCT02958865|76083886|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
42257395|NCT02958865|76083887|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
42257396|NCT02958865|76083888|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
42257397|NCT02958865|76083889|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
42257398|NCT02958865|76083890|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
42257399|NCT02958865|76083891|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
42257400|NCT02958865|76083892|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
42257401|NCT02958865|76083893|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
42257402|NCT02958865|76083894|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
42257403|NCT02958865|76083895|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
42257404|NCT02958865|76083896|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
42257405|NCT02958865|76083897|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
42257406|NCT02958865|76083882|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
42257407|NCT02958865|76083883|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
42257408|NCT02958865|76083884|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257409|NCT02958865|76083885|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257410|NCT02958865|76083886|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
41993746|NCT00191646|75802053|FG001|Overall Study|Physician Decision|11|||
42257411|NCT02958865|76083887|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257412|NCT02958865|76083888|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42318363|NCT01781572|76155369|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
42318364|NCT01781572|76155367|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
42318365|NCT01781572|76155368|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
42318366|NCT01781572|76155369|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
42318367|NCT01781572|76155367|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
42318368|NCT01781572|76155368|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
42318369|NCT01781572|76155369|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
42318370|NCT01781572|76155367|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
42318371|NCT01781572|76155368|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
42318372|NCT01781572|76155369|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
42318373|NCT01781572|76155367|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
42318374|NCT01781572|76155368|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
42318375|NCT01781572|76155369|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
42318376|NCT01781572|76155367|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
42318377|NCT01781572|76155368|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
42318378|NCT01781572|76155369|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
42318379|NCT01781572|76155367|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
42257413|NCT02958865|76083889|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257414|NCT02958865|76083890|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257415|NCT02958865|76083891|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257416|NCT02958865|76083892|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257417|NCT02958865|76083893|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257418|NCT02958865|76083894|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257419|NCT02958865|76083895|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257420|NCT02958865|76083896|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257421|NCT02958865|76083897|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
42257422|NCT02958865|76083882|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
42257423|NCT02958865|76083883|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42257424|NCT02958865|76083884|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
42257425|NCT02958865|76083885|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
42318380|NCT01781572|76155368|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
42318381|NCT01781572|76155369|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
42318382|NCT01781572|76155367|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
42318383|NCT01781572|76155368|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
42318384|NCT01781572|76155369|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
42318385|NCT01781572|76155367|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
42318386|NCT01781572|76155368|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
42318387|NCT01781572|76155369|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
42318388|NCT01781572|76155367|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
41993747|NCT00191646|75802052|FG000|Overall Study|Withdrawal by Subject|58|||
41993748|NCT00191646|75802053|FG001|Overall Study|Withdrawal by Subject|39|||
42257426|NCT02958865|76083886|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
42257427|NCT02958865|76083887|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
42318389|NCT01781572|76155368|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
42318390|NCT01781572|76155369|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
42318391|NCT01781572|76155367|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
42318392|NCT01781572|76155368|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
42318393|NCT01781572|76155369|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
42318394|NCT01781572|76155367|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
42318395|NCT01781572|76155368|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
42318396|NCT01781572|76155369|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
42318397|NCT01781572|76155367|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
42318398|NCT01781572|76155368|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
42318399|NCT01781572|76155369|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
41993749|NCT00191646|75802052|FG000|Overall Study|Protocol Violation|5|||
41993750|NCT00191646|75802053|FG001|Overall Study|Protocol Violation|7|||
41993751|NCT00191646|75802052|FG000|Overall Study|Death|6|||
41993752|NCT00191646|75802053|FG001|Overall Study|Death|8|||
42318400|NCT01781572|76155367|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
42318401|NCT01781572|76155368|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
42318402|NCT01781572|76155369|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
42318403|NCT01781572|76155367|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
42318404|NCT01781572|76155368|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
42318405|NCT01781572|76155369|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
42318406|NCT01781572|76155367|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
42318407|NCT01781572|76155368|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
42318408|NCT01781572|76155369|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
42318409|NCT01781572|76155367|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
42318410|NCT01781572|76155368|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
42318411|NCT01781572|76155369|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
42318412|NCT01998243|76155400|FG000|Overall Study|Pregnancy|0|||
42318413|NCT01998243|76155401|FG001|Overall Study|Pregnancy|1|||
42318414|NCT01998243|76155400|FG000|Overall Study|Protocol Violation|5|||
42318415|NCT01998243|76155401|FG001|Overall Study|Protocol Violation|2|||
42318416|NCT01998243|76155400|FG000|Overall Study|Withdrawal by Subject|3|||
42318417|NCT01998243|76155401|FG001|Overall Study|Withdrawal by Subject|4|||
42318418|NCT01977573|76155413|FG000|Overall Study|Adverse Event|7|||
42318419|NCT01977573|76155414|FG001|Overall Study|Adverse Event|0|||
42318420|NCT01977573|76155415|FG002|Overall Study|Adverse Event|2|||
42318421|NCT01977573|76155416|FG003|Overall Study|Adverse Event|1|||
42318422|NCT01977573|76155413|FG000|Overall Study|Lost to Follow-up|1|||
42318423|NCT01977573|76155414|FG001|Overall Study|Lost to Follow-up|0|||
42318424|NCT01977573|76155415|FG002|Overall Study|Lost to Follow-up|0|||
42318425|NCT01977573|76155416|FG003|Overall Study|Lost to Follow-up|1|||
42318426|NCT01977573|76155413|FG000|Overall Study|Physician Decision|1|||
42318427|NCT01977573|76155414|FG001|Overall Study|Physician Decision|0|||
41993753|NCT00191646|75802052|FG000|Overall Study|Other|33|||
41993754|NCT00191646|75802053|FG001|Overall Study|Other|34|||
41993755|NCT00191646|75802052|FG000|Overall Study|Missing Data|18|||
41993756|NCT00191646|75802053|FG001|Overall Study|Missing Data|11|||
41993757|NCT00191451|75802070|FG000|Overall Study|Withdrawal by Subject|2|||
42318428|NCT01977573|76155415|FG002|Overall Study|Physician Decision|0|||
42318429|NCT01977573|76155416|FG003|Overall Study|Physician Decision|0|||
41993758|NCT00191451|75802071|FG001|Overall Study|Withdrawal by Subject|3|||
41993759|NCT00191451|75802072|FG002|Overall Study|Withdrawal by Subject|5|||
41993760|NCT00191451|75802070|FG000|Overall Study|Physician Decision|2|||
41993761|NCT00191451|75802071|FG001|Overall Study|Physician Decision|9|||
41993762|NCT00191451|75802072|FG002|Overall Study|Physician Decision|6|||
41993763|NCT00191451|75802070|FG000|Overall Study|Sponsor Decision|1|||
41993764|NCT00191451|75802071|FG001|Overall Study|Sponsor Decision|0|||
41993765|NCT00191451|75802072|FG002|Overall Study|Sponsor Decision|0|||
42033912|NCT01071252|75842098|FG003|Overall Study|Withdrawal by Subject|2|||
42318430|NCT01977573|76155413|FG000|Overall Study|Protocol Violation|3|||
42318431|NCT01977573|76155414|FG001|Overall Study|Protocol Violation|1|||
42318432|NCT01977573|76155415|FG002|Overall Study|Protocol Violation|0|||
42318433|NCT01977573|76155416|FG003|Overall Study|Protocol Violation|0|||
42318434|NCT01977573|76155413|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
42318435|NCT01977573|76155414|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
41993766|NCT00191451|75802070|FG000|Overall Study|Ineligible|0|||
42033913|NCT01071252|75842099|FG004|Overall Study|Withdrawal by Subject|3|||
42033914|NCT01071252|75842095|FG000|Overall Study|administrative problems|1|||
42318436|NCT01977573|76155415|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
42318437|NCT01977573|76155416|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
42318438|NCT01977573|76155413|FG000|Overall Study|Withdrawal by Subject|6|||
42318439|NCT01977573|76155414|FG001|Overall Study|Withdrawal by Subject|1|||
42318440|NCT01977573|76155415|FG002|Overall Study|Withdrawal by Subject|1|||
42318441|NCT01977573|76155416|FG003|Overall Study|Withdrawal by Subject|1|||
41993767|NCT00191451|75802071|FG001|Overall Study|Ineligible|1|||
41993768|NCT00191451|75802072|FG002|Overall Study|Ineligible|0|||
41993769|NCT00191451|75802070|FG000|Overall Study|Reason Not Specified|2|||
42033915|NCT01071252|75842096|FG001|Overall Study|administrative problems|1|||
42033916|NCT01071252|75842097|FG002|Overall Study|administrative problems|0|||
41993770|NCT00191451|75802071|FG001|Overall Study|Reason Not Specified|1|||
42318442|NCT01963767|76155429|FG000|Overall Study|Withdrawal by Subject|4|||
42318443|NCT01963767|76155430|FG001|Overall Study|Withdrawal by Subject|2|||
42318444|NCT01963767|76155429|FG000|Overall Study|Adverse Event|2|||
42318445|NCT01963767|76155430|FG001|Overall Study|Adverse Event|0|||
42318446|NCT01731886|76155438|FG000|Overall Study|Death|1|||
42318447|NCT01731886|76155439|FG001|Overall Study|Death|0|||
42318448|NCT01731886|76155438|FG000|Overall Study|Never started treatment|0|||
42318449|NCT01731886|76155439|FG001|Overall Study|Never started treatment|1|||
42318450|NCT01731886|76155438|FG000|Overall Study|Non-compliant|1|||
42318451|NCT01731886|76155439|FG001|Overall Study|Non-compliant|0|||
42257428|NCT02958865|76083888|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
42257429|NCT02958865|76083889|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42257430|NCT02958865|76083890|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42257431|NCT02958865|76083891|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42257432|NCT02958865|76083892|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42257433|NCT02958865|76083893|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42257434|NCT02958865|76083894|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42257435|NCT02958865|76083895|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42257436|NCT02958865|76083896|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42257437|NCT02958865|76083897|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42257438|NCT02958865|76083882|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42257439|NCT02958865|76083883|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42257440|NCT02958865|76083884|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42257441|NCT02958865|76083885|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
42257442|NCT02958865|76083886|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42257443|NCT02958865|76083887|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42318452|NCT01759420|76155446|FG000|Overall Study|Screen failure|5|||
42318453|NCT01759420|76155446|FG000|Overall Study|Inaccurate EKG machine readings|1|||
42318454|NCT01781026|76155450|FG000|Overall Study|Lack of Efficacy|2|||
42318455|NCT01607398|76155456|FG000|Overall Study|Adverse Event|0|||
42318456|NCT01607398|76155457|FG001|Overall Study|Adverse Event|2|||
42318457|NCT01607398|76155456|FG000|Overall Study|Severe COPD|2|||
42318458|NCT01607398|76155457|FG001|Overall Study|Severe COPD|0|||
42318459|NCT01779856|76155463|FG000|Overall Study|Withdrawal by Subject|15|||
42318460|NCT01779856|76155463|FG000|Overall Study|Death|3|||
42318461|NCT01779856|76155463|FG000|Overall Study|Physician Decision|1|||
42318462|NCT01779856|76155463|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
42318463|NCT01779856|76155463|FG000|Overall Study|Delays in scheduling implant|1|||
42318464|NCT01779856|76155463|FG000|Overall Study|Subject ineligible for Implant|2|||
42318465|NCT01729156|76155477|FG000|Overall Study|Withdrawal by Subject|1|||
42318466|NCT01729156|76155478|FG001|Overall Study|Withdrawal by Subject|0|||
42318467|NCT01729156|76155479|FG002|Overall Study|Withdrawal by Subject|0|||
42318468|NCT01779700|76155490|FG000|Overall Study|Adverse Event|4|||
42318469|NCT01779700|76155491|FG001|Overall Study|Adverse Event|3|||
42318470|NCT01779700|76155490|FG000|Overall Study|Withdrawal by Subject|0|||
42318471|NCT01779700|76155491|FG001|Overall Study|Withdrawal by Subject|2|||
42318472|NCT01778530|76155497|FG000|Overall Study|Progression on study|1|||
42318473|NCT01778530|76155497|FG000|Overall Study|Adverse event/side effect|1|||
42318474|NCT01778062|76155503|FG000|Overall Study|Adverse Event|1|||
42318475|NCT01778062|76155504|FG001|Overall Study|Adverse Event|3|||
42318476|NCT01778062|76155503|FG000|Overall Study|Consent Withdrawal|1|||
42318477|NCT01778062|76155504|FG001|Overall Study|Consent Withdrawal|5|||
42318478|NCT01778062|76155503|FG000|Overall Study|major protocol deviation|4|||
42318479|NCT01778062|76155504|FG001|Overall Study|major protocol deviation|3|||
42318480|NCT01759264|76155510|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
42318481|NCT01759264|76155510|FG000|Overall Study|Adverse Event|1|||
42318482|NCT01759264|76155510|FG000|Overall Study|Other|2|||
42318483|NCT01759264|76155510|FG000|Overall Study|Lost to Follow-up|2|||
42318484|NCT01759264|76155510|FG000|Overall Study|Withdrawal by Subject|3|||
42318485|NCT01759264|76155510|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
42318486|NCT01757704|76155517|FG000|Overall Study|Protocol Violation|1|||
42318487|NCT01757704|76155518|FG001|Overall Study|Protocol Violation|3|||
42318488|NCT01757392|76155524|FG000|Overall Study|Withdrawal by Subject|1|||
42318489|NCT01757392|76155524|FG000|Overall Study|Screen Fail|3|||
42318490|NCT01756846|76155530|FG000|Overall Study|Lost to Follow-up|5|||
42318491|NCT01756846|76155531|FG001|Overall Study|Lost to Follow-up|10|||
42257444|NCT02958865|76083888|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
42257445|NCT02958865|76083889|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42318492|NCT01756846|76155530|FG000|Overall Study|Withdrawal by Subject|1|||
42318493|NCT01756846|76155531|FG001|Overall Study|Withdrawal by Subject|2|||
42318494|NCT01963611|76155542|FG000|Overall Study|Adverse Event|1|||
42318495|NCT01963611|76155543|FG001|Overall Study|Adverse Event|1|||
42318496|NCT01963611|76155544|FG002|Overall Study|Adverse Event|3|||
42318497|NCT01963611|76155545|FG003|Overall Study|Adverse Event|4|||
42318498|NCT01963611|76155546|FG004|Overall Study|Adverse Event|3|||
42318499|NCT01963611|76155542|FG000|Overall Study|Protocol Violation|0|||
42318500|NCT01963611|76155543|FG001|Overall Study|Protocol Violation|0|||
42318501|NCT01963611|76155544|FG002|Overall Study|Protocol Violation|0|||
42318502|NCT01963611|76155545|FG003|Overall Study|Protocol Violation|1|||
42318503|NCT01963611|76155546|FG004|Overall Study|Protocol Violation|0|||
42318504|NCT01963611|76155542|FG000|Overall Study|Lack of Efficacy|0|||
42318505|NCT01963611|76155543|FG001|Overall Study|Lack of Efficacy|0|||
42318506|NCT01963611|76155544|FG002|Overall Study|Lack of Efficacy|0|||
42318507|NCT01963611|76155545|FG003|Overall Study|Lack of Efficacy|1|||
42318508|NCT01963611|76155546|FG004|Overall Study|Lack of Efficacy|0|||
42318509|NCT01963611|76155542|FG000|Overall Study|Withdrawal by Subject|3|||
42318510|NCT01963611|76155543|FG001|Overall Study|Withdrawal by Subject|2|||
42318511|NCT01963611|76155544|FG002|Overall Study|Withdrawal by Subject|1|||
42318512|NCT01963611|76155545|FG003|Overall Study|Withdrawal by Subject|1|||
42318513|NCT01963611|76155546|FG004|Overall Study|Withdrawal by Subject|3|||
42318514|NCT01963611|76155542|FG000|Overall Study|Other|47|||
42318515|NCT01963611|76155543|FG001|Overall Study|Other|46|||
42318516|NCT01963611|76155544|FG002|Overall Study|Other|48|||
42318517|NCT01963611|76155545|FG003|Overall Study|Other|45|||
42318518|NCT01963611|76155546|FG004|Overall Study|Other|45|||
42318519|NCT01975701|76155559|FG000|Overall Study|Lost to Follow-up|1|||
42318520|NCT01975701|76155559|FG000|Overall Study|Death|23|||
42318521|NCT01975701|76155559|FG000|Overall Study|Physician Decision|1|||
42318522|NCT01962987|76155566|FG000|Overall Study|Adverse Event|4|||
42318523|NCT01962987|76155567|FG001|Overall Study|Adverse Event|4|||
42318524|NCT01962987|76155568|FG002|Overall Study|Adverse Event|0|||
42318525|NCT01962987|76155566|FG000|Overall Study|Lost to Follow-up|0|||
42318526|NCT01962987|76155567|FG001|Overall Study|Lost to Follow-up|0|||
42318527|NCT01962987|76155568|FG002|Overall Study|Lost to Follow-up|1|||
42318528|NCT01962987|76155566|FG000|Overall Study|Non compliance with dosing requirements|4|||
42318529|NCT01962987|76155567|FG001|Overall Study|Non compliance with dosing requirements|2|||
42318530|NCT01962987|76155568|FG002|Overall Study|Non compliance with dosing requirements|0|||
42318531|NCT01962987|76155566|FG000|Overall Study|Miscellaneous|1|||
42318532|NCT01962987|76155567|FG001|Overall Study|Miscellaneous|9|||
42318533|NCT01962987|76155568|FG002|Overall Study|Miscellaneous|2|||
42318534|NCT01962987|76155566|FG000|Overall Study|Restricted medication|5|||
42318535|NCT01962987|76155567|FG001|Overall Study|Restricted medication|1|||
42318536|NCT01962987|76155568|FG002|Overall Study|Restricted medication|1|||
42318537|NCT01962987|76155566|FG000|Overall Study|Serious Adverse Event|1|||
42318538|NCT01962987|76155567|FG001|Overall Study|Serious Adverse Event|0|||
42318539|NCT01962987|76155568|FG002|Overall Study|Serious Adverse Event|0|||
42318540|NCT01962987|76155566|FG000|Overall Study|Withdrawal by Subject|11|||
42318541|NCT01962987|76155567|FG001|Overall Study|Withdrawal by Subject|10|||
42318542|NCT01962987|76155568|FG002|Overall Study|Withdrawal by Subject|6|||
42318543|NCT01962987|76155566|FG000|Overall Study|Randomized in Error|4|||
42318544|NCT01962987|76155567|FG001|Overall Study|Randomized in Error|2|||
42318545|NCT01962987|76155568|FG002|Overall Study|Randomized in Error|2|||
42318546|NCT01962441|76155579|FG000|Randomized Period|Randomized but Never Treated|4|||
42318547|NCT01962441|76155580|FG001|Randomized Period|Randomized but Never Treated|2|||
42318548|NCT01962441|76155581|FG002|Randomized Period|Randomized but Never Treated|3|||
42318549|NCT01962441|76155579|FG000|Randomized Period|Lost to Follow-up|2|||
42318550|NCT01962441|76155580|FG001|Randomized Period|Lost to Follow-up|4|||
42318551|NCT01962441|76155581|FG002|Randomized Period|Lost to Follow-up|4|||
42318552|NCT01962441|76155579|FG000|Randomized Period|Withdrew Consent|3|||
42318553|NCT01962441|76155580|FG001|Randomized Period|Withdrew Consent|3|||
42033917|NCT01071252|75842098|FG003|Overall Study|administrative problems|2|||
42033918|NCT01071252|75842099|FG004|Overall Study|administrative problems|1|||
42033919|NCT01071252|75842095|FG000|Overall Study|Lost to Follow-up|1|||
42033920|NCT01071252|75842096|FG001|Overall Study|Lost to Follow-up|0|||
42318554|NCT01962441|76155581|FG002|Randomized Period|Withdrew Consent|2|||
42318555|NCT01962441|76155579|FG000|Randomized Period|Adverse Event|1|||
42033921|NCT01071252|75842097|FG002|Overall Study|Lost to Follow-up|1|||
42033922|NCT01071252|75842098|FG003|Overall Study|Lost to Follow-up|2|||
42033923|NCT01071252|75842099|FG004|Overall Study|Lost to Follow-up|0|||
42033924|NCT01071252|75842095|FG000|Overall Study|Adverse Event|1|||
42033925|NCT01071252|75842096|FG001|Overall Study|Adverse Event|1|||
42033926|NCT01071252|75842097|FG002|Overall Study|Adverse Event|0|||
42033927|NCT01071252|75842098|FG003|Overall Study|Adverse Event|1|||
42318556|NCT01962441|76155580|FG001|Randomized Period|Adverse Event|1|||
42318557|NCT01962441|76155581|FG002|Randomized Period|Adverse Event|0|||
42318558|NCT01962441|76155579|FG000|Randomized Period|Death|0|||
42318559|NCT01962441|76155580|FG001|Randomized Period|Death|0|||
42318560|NCT01962441|76155581|FG002|Randomized Period|Death|2|||
42318561|NCT01962441|76155579|FG000|Randomized Period|Protocol Violation|0|||
42318562|NCT01962441|76155580|FG001|Randomized Period|Protocol Violation|1|||
42318563|NCT01962441|76155581|FG002|Randomized Period|Protocol Violation|0|||
42318564|NCT01962441|76155579|FG000|Retreatment Substudy|Lack of Efficacy|1|||
42318565|NCT01962441|76155580|FG001|Retreatment Substudy|Lack of Efficacy|0|||
42318566|NCT01962441|76155581|FG002|Retreatment Substudy|Lack of Efficacy|0|||
42318567|NCT01962441|76155579|FG000|Retreatment Substudy|Lost to Follow-up|1|||
42318568|NCT01962441|76155580|FG001|Retreatment Substudy|Lost to Follow-up|0|||
42318569|NCT01962441|76155581|FG002|Retreatment Substudy|Lost to Follow-up|0|||
42318570|NCT01638013|76155593|FG000|Overall Study|Adverse Event|36|||
42318571|NCT01638013|76155594|FG001|Overall Study|Adverse Event|29|||
42318572|NCT01638013|76155595|FG002|Overall Study|Adverse Event|48|||
42318573|NCT01638013|76155593|FG000|Overall Study|Lack of Efficacy|39|||
42318574|NCT01638013|76155594|FG001|Overall Study|Lack of Efficacy|11|||
42318575|NCT01638013|76155595|FG002|Overall Study|Lack of Efficacy|14|||
42318576|NCT01638013|76155593|FG000|Overall Study|Protocol Violation|10|||
42318577|NCT01638013|76155594|FG001|Overall Study|Protocol Violation|7|||
42318578|NCT01638013|76155595|FG002|Overall Study|Protocol Violation|11|||
42318579|NCT01638013|76155593|FG000|Overall Study|Met discontinuation criteria|4|||
42318580|NCT01638013|76155594|FG001|Overall Study|Met discontinuation criteria|0|||
42318581|NCT01638013|76155595|FG002|Overall Study|Met discontinuation criteria|7|||
42318582|NCT01638013|76155593|FG000|Overall Study|Subject Lost to Follow up|1|||
42318583|NCT01638013|76155594|FG001|Overall Study|Subject Lost to Follow up|0|||
42318584|NCT01638013|76155595|FG002|Overall Study|Subject Lost to Follow up|1|||
42318585|NCT01638013|76155593|FG000|Overall Study|Miscellaneous|25|||
42318586|NCT01638013|76155594|FG001|Overall Study|Miscellaneous|19|||
42318587|NCT01638013|76155595|FG002|Overall Study|Miscellaneous|23|||
42318588|NCT01638013|76155593|FG000|Overall Study|Withdrawal of Consent|16|||
42318589|NCT01638013|76155594|FG001|Overall Study|Withdrawal of Consent|12|||
42318590|NCT01638013|76155595|FG002|Overall Study|Withdrawal of Consent|16|||
42318591|NCT01638013|76155593|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
42318592|NCT01638013|76155594|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
42318593|NCT01638013|76155595|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
42318594|NCT01637623|76155610|FG000|Overall Study|Lost to Follow-up|0|||
42318595|NCT01637623|76155611|FG001|Overall Study|Lost to Follow-up|0|||
42318596|NCT01637623|76155612|FG002|Overall Study|Lost to Follow-up|2|||
42318597|NCT01637623|76155610|FG000|Overall Study|Physician Decision|1|||
42318598|NCT01637623|76155611|FG001|Overall Study|Physician Decision|0|||
42318599|NCT01637623|76155612|FG002|Overall Study|Physician Decision|1|||
42318600|NCT01962207|76155624|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
42318601|NCT01962207|76155625|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
42318602|NCT01962207|76155626|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
42318603|NCT01962207|76155627|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
42318604|NCT01962207|76155624|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
42318605|NCT01962207|76155625|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
42318606|NCT01962207|76155626|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
42318607|NCT01962207|76155627|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
42318608|NCT01962207|76155624|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
42318609|NCT01962207|76155625|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
42318610|NCT01962207|76155626|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
42318611|NCT01962207|76155627|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
42318612|NCT01962207|76155624|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
42318613|NCT01962207|76155625|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
42318614|NCT01962207|76155626|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
42318615|NCT01962207|76155627|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
42318616|NCT01962207|76155624|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
42318617|NCT01962207|76155625|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
42318618|NCT01962207|76155626|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
41993771|NCT00191451|75802072|FG002|Overall Study|Reason Not Specified|3|||
41993772|NCT00191334|75802080|FG000|Overall Study|Adverse Event|4|||
42318619|NCT01962207|76155627|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
42318620|NCT01962207|76155624|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
42318621|NCT01962207|76155625|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
42318622|NCT01962207|76155626|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
42318623|NCT01962207|76155627|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
42318624|NCT01995825|76155643|FG000|Overall Study|Withdrawal by Subject|1|||
42318625|NCT01995825|76155644|FG001|Overall Study|Withdrawal by Subject|0|||
42318626|NCT01995357|76155650|FG000|Period 5|Lack of Efficacy|1|||
42318627|NCT01995357|76155651|FG001|Period 5|Lack of Efficacy|0|||
42318628|NCT01995357|76155652|FG002|Period 5|Lack of Efficacy|0|||
42318629|NCT01995357|76155653|FG003|Period 5|Lack of Efficacy|0|||
41993773|NCT00191334|75802080|FG000|Overall Study|Disease Progression or Relapse|8|||
41993774|NCT00191334|75802080|FG000|Overall Study|Physician Decision|1|||
41993775|NCT00191334|75802080|FG000|Overall Study|Withdrawal by Subject|4|||
41993776|NCT00191139|75802086|FG000|Overall Study|Adverse Event|2|||
41993777|NCT00191139|75802087|FG001|Overall Study|Adverse Event|6|||
42318630|NCT01995357|76155654|FG004|Period 5|Lack of Efficacy|0|||
42318631|NCT01995357|76155655|FG005|Period 5|Lack of Efficacy|0|||
42318632|NCT01995357|76155650|FG000|Period 5|Adverse Event|1|||
42318633|NCT01995357|76155651|FG001|Period 5|Adverse Event|0|||
42318634|NCT01995357|76155652|FG002|Period 5|Adverse Event|1|||
41993778|NCT00191139|75802086|FG000|Overall Study|Death|2|||
41993779|NCT00191139|75802087|FG001|Overall Study|Death|0|||
41993780|NCT00191139|75802086|FG000|Overall Study|Withdrawal by Subject|0|||
41993781|NCT00191139|75802087|FG001|Overall Study|Withdrawal by Subject|3|||
41993782|NCT00191139|75802086|FG000|Overall Study|Disease Progression|0|||
42257446|NCT02958865|76083890|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42257447|NCT02958865|76083891|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42257448|NCT02958865|76083892|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42257449|NCT02958865|76083893|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42257450|NCT02958865|76083894|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42257451|NCT02958865|76083895|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42257452|NCT02958865|76083896|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42257453|NCT02958865|76083897|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
42318635|NCT01995357|76155653|FG003|Period 5|Adverse Event|0|||
42318636|NCT01995357|76155654|FG004|Period 5|Adverse Event|0|||
42318637|NCT01995357|76155655|FG005|Period 5|Adverse Event|0|||
42318638|NCT01638559|76155671|FG000|Overall Study|Lost to Follow-up|1|||
42318639|NCT01638559|76155671|FG000|Overall Study|Withdrawal by Subject|1|||
42318640|NCT01638559|76155671|FG000|Overall Study|Subject declined to travel for biopsy|1|||
42318641|NCT01756300|76155686|FG000|Overall Study|Death|1|||
42318642|NCT01756300|76155686|FG000|Overall Study|Withdrawal by Subject|1|||
42318643|NCT01995201|76155709|FG000|From Baseline Until Week 24|Adverse Event|4|||
42318644|NCT01995201|76155710|FG001|From Baseline Until Week 24|Adverse Event|15|||
42318645|NCT01995201|76155711|FG002|From Baseline Until Week 24|Adverse Event|0|||
42318646|NCT01995201|76155712|FG003|From Baseline Until Week 24|Adverse Event|0|||
42318647|NCT01995201|76155713|FG004|From Baseline Until Week 24|Adverse Event|0|||
42318648|NCT01995201|76155714|FG005|From Baseline Until Week 24|Adverse Event|0|||
42318649|NCT01995201|76155715|FG006|From Baseline Until Week 24|Adverse Event|0|||
42318650|NCT01995201|76155709|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
42318651|NCT01995201|76155710|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
42318652|NCT01995201|76155711|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
41993783|NCT00191139|75802087|FG001|Overall Study|Disease Progression|1|||
41993784|NCT00191139|75802086|FG000|Overall Study|Other|1|||
41993785|NCT00191139|75802087|FG001|Overall Study|Other|2|||
41993786|NCT00190983|75802093|FG000|Overall Study|Inevaluable (never treated)|2|||
41993787|NCT00190749|75802099|FG000|Overall Study|Lost to Follow-up|8|||
42033928|NCT01071252|75842099|FG004|Overall Study|Adverse Event|0|||
42318653|NCT01995201|76155712|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
42318654|NCT01995201|76155713|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
42318655|NCT01995201|76155714|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
41993788|NCT00190749|75802100|FG001|Overall Study|Lost to Follow-up|11|||
41993789|NCT00190749|75802099|FG000|Overall Study|Withdrawal by Subject|10|||
42318656|NCT01995201|76155715|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
42318657|NCT01995201|76155709|FG000|From Baseline Until Week 24|Death|0|||
42318658|NCT01995201|76155710|FG001|From Baseline Until Week 24|Death|1|||
42318659|NCT01995201|76155711|FG002|From Baseline Until Week 24|Death|0|||
42318660|NCT01995201|76155712|FG003|From Baseline Until Week 24|Death|0|||
42318661|NCT01995201|76155713|FG004|From Baseline Until Week 24|Death|0|||
42133251|NCT00498602|75944120|FG002|Overall Study|Investigator Request|1|||
42133252|NCT00498602|75944121|FG003|Overall Study|Investigator Request|0|||
42257454|NCT02958865|76083882|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257455|NCT02958865|76083883|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257456|NCT02958865|76083884|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
42257457|NCT02958865|76083885|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257458|NCT02958865|76083886|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257459|NCT02958865|76083887|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257460|NCT02958865|76083888|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257461|NCT02958865|76083889|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257462|NCT02958865|76083890|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257463|NCT02958865|76083891|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257464|NCT02958865|76083892|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257465|NCT02958865|76083893|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257466|NCT02958865|76083894|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257467|NCT02958865|76083895|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257468|NCT02958865|76083896|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257469|NCT02958865|76083897|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
42257470|NCT02958865|76083882|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
42257471|NCT02958865|76083883|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
42257472|NCT02958865|76083884|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
42257473|NCT02958865|76083885|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257474|NCT02958865|76083886|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257475|NCT02958865|76083887|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257476|NCT02958865|76083888|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257477|NCT02958865|76083889|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257478|NCT02958865|76083890|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257479|NCT02958865|76083891|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257480|NCT02958865|76083892|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257481|NCT02958865|76083893|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257482|NCT02958865|76083894|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257483|NCT02958865|76083895|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257484|NCT02958865|76083896|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257485|NCT02958865|76083897|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42257486|NCT02958865|76083882|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
42257487|NCT02958865|76083883|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
42257488|NCT02958865|76083884|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
42257489|NCT02958865|76083885|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
42257490|NCT02958865|76083886|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
42257491|NCT02958865|76083887|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
42257492|NCT02958865|76083888|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
42257493|NCT02958865|76083889|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
42257494|NCT02958865|76083890|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
42257495|NCT02958865|76083891|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
42318662|NCT01995201|76155714|FG005|From Baseline Until Week 24|Death|0|||
42318663|NCT01995201|76155715|FG006|From Baseline Until Week 24|Death|0|||
42257496|NCT02958865|76083892|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
42257497|NCT02958865|76083893|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
42318664|NCT01995201|76155709|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
42133253|NCT00498602|75944122|FG004|Overall Study|Investigator Request|0|||
41993790|NCT00190749|75802100|FG001|Overall Study|Withdrawal by Subject|6|||
42318665|NCT01995201|76155710|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
42318666|NCT01995201|76155711|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
42257498|NCT02958865|76083894|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
42257499|NCT02958865|76083895|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
42257500|NCT02958865|76083896|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
42257501|NCT02958865|76083897|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
42257502|NCT02958865|76083882|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42257503|NCT02958865|76083883|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42318667|NCT01995201|76155712|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
42318668|NCT01995201|76155713|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
42318669|NCT01995201|76155714|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
42318670|NCT01995201|76155715|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
42318671|NCT01995201|76155709|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
42318672|NCT01995201|76155710|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
42318673|NCT01995201|76155711|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
42318674|NCT01995201|76155712|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
42318675|NCT01995201|76155713|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
42318676|NCT01995201|76155714|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
42318677|NCT01995201|76155715|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
42318678|NCT01995201|76155709|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
42318679|NCT01995201|76155710|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
42318680|NCT01995201|76155711|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
42318681|NCT01995201|76155712|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
42318682|NCT01995201|76155713|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
42318683|NCT01995201|76155714|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
42318684|NCT01995201|76155715|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
42318685|NCT01995201|76155709|FG000|From Baseline Until Week 24|Physician Decision|0|||
42318686|NCT01995201|76155710|FG001|From Baseline Until Week 24|Physician Decision|2|||
42318687|NCT01995201|76155711|FG002|From Baseline Until Week 24|Physician Decision|0|||
42318688|NCT01995201|76155712|FG003|From Baseline Until Week 24|Physician Decision|0|||
42318689|NCT01995201|76155713|FG004|From Baseline Until Week 24|Physician Decision|0|||
42318690|NCT01995201|76155714|FG005|From Baseline Until Week 24|Physician Decision|0|||
42318691|NCT01995201|76155715|FG006|From Baseline Until Week 24|Physician Decision|0|||
42318692|NCT01995201|76155709|FG000|From Baseline Until Week 24|Protocol Violation|0|||
42318693|NCT01995201|76155710|FG001|From Baseline Until Week 24|Protocol Violation|9|||
42318694|NCT01995201|76155711|FG002|From Baseline Until Week 24|Protocol Violation|0|||
42318695|NCT01995201|76155712|FG003|From Baseline Until Week 24|Protocol Violation|0|||
42318696|NCT01995201|76155713|FG004|From Baseline Until Week 24|Protocol Violation|0|||
42318697|NCT01995201|76155714|FG005|From Baseline Until Week 24|Protocol Violation|0|||
42318698|NCT01995201|76155715|FG006|From Baseline Until Week 24|Protocol Violation|0|||
42318699|NCT01995201|76155709|FG000|From Week 24 Until Week 48|Adverse Event|0|||
42318700|NCT01995201|76155710|FG001|From Week 24 Until Week 48|Adverse Event|0|||
42318701|NCT01995201|76155711|FG002|From Week 24 Until Week 48|Adverse Event|2|||
42257504|NCT02958865|76083884|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42318702|NCT01995201|76155712|FG003|From Week 24 Until Week 48|Adverse Event|1|||
42318703|NCT01995201|76155713|FG004|From Week 24 Until Week 48|Adverse Event|1|||
42257505|NCT02958865|76083885|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42257506|NCT02958865|76083886|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
42257507|NCT02958865|76083887|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42257508|NCT02958865|76083888|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42257509|NCT02958865|76083889|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42257510|NCT02958865|76083890|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42257511|NCT02958865|76083891|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42257512|NCT02958865|76083892|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42257513|NCT02958865|76083893|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42257514|NCT02958865|76083894|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42257515|NCT02958865|76083895|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42318704|NCT01995201|76155714|FG005|From Week 24 Until Week 48|Adverse Event|3|||
42318705|NCT01995201|76155715|FG006|From Week 24 Until Week 48|Adverse Event|1|||
42318706|NCT01995201|76155709|FG000|From Week 24 Until Week 48|Death|0|||
42318707|NCT01995201|76155710|FG001|From Week 24 Until Week 48|Death|0|||
42318708|NCT01995201|76155711|FG002|From Week 24 Until Week 48|Death|0|||
41993791|NCT00190749|75802099|FG000|Overall Study|Protocol Violation|5|||
41993792|NCT00190749|75802100|FG001|Overall Study|Protocol Violation|4|||
41993793|NCT00190749|75802099|FG000|Overall Study|Adverse Event|0|||
41993794|NCT00190749|75802100|FG001|Overall Study|Adverse Event|5|||
41993795|NCT00190749|75802099|FG000|Overall Study|Lack of Efficacy|2|||
42257516|NCT02958865|76083896|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42318709|NCT01995201|76155712|FG003|From Week 24 Until Week 48|Death|0|||
42318710|NCT01995201|76155713|FG004|From Week 24 Until Week 48|Death|0|||
42318711|NCT01995201|76155714|FG005|From Week 24 Until Week 48|Death|2|||
42318712|NCT01995201|76155715|FG006|From Week 24 Until Week 48|Death|0|||
42318713|NCT01995201|76155709|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
42318714|NCT01995201|76155710|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
42318715|NCT01995201|76155711|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
42318716|NCT01995201|76155712|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
42318717|NCT01995201|76155713|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
42318718|NCT01995201|76155714|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
42133254|NCT00498602|75944123|FG005|Overall Study|Investigator Request|0|||
42257517|NCT02958865|76083897|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42318719|NCT01995201|76155715|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
42318720|NCT01995201|76155709|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
42318721|NCT01995201|76155710|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
42318722|NCT01995201|76155711|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
42318723|NCT01995201|76155712|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
42318724|NCT01995201|76155713|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
42318725|NCT01995201|76155714|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
42318726|NCT01995201|76155715|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
42318727|NCT01995201|76155709|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
42318728|NCT01995201|76155710|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
42318729|NCT01995201|76155711|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
42318730|NCT01995201|76155712|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
42318731|NCT01995201|76155713|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
42318732|NCT01995201|76155714|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
42318733|NCT01995201|76155715|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
42318734|NCT01995201|76155709|FG000|From Week 24 Until Week 48|Physician Decision|0|||
42318735|NCT01995201|76155710|FG001|From Week 24 Until Week 48|Physician Decision|0|||
42257518|NCT02958865|76083882|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
41993796|NCT00190749|75802100|FG001|Overall Study|Lack of Efficacy|3|||
41993797|NCT00190749|75802099|FG000|Overall Study|Reason Not Specified|0|||
41993798|NCT00190749|75802100|FG001|Overall Study|Reason Not Specified|2|||
41993799|NCT00190749|75802099|FG000|Overall Study|Sponsor Decision|1|||
41993800|NCT00190749|75802100|FG001|Overall Study|Sponsor Decision|0|||
41993801|NCT00190671|75802108|FG000|Overall Study|Satisfactory Response|4|||
42257519|NCT02958865|76083883|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
42318736|NCT01995201|76155711|FG002|From Week 24 Until Week 48|Physician Decision|0|||
42318737|NCT01995201|76155712|FG003|From Week 24 Until Week 48|Physician Decision|0|||
42318738|NCT01995201|76155713|FG004|From Week 24 Until Week 48|Physician Decision|1|||
42318739|NCT01995201|76155714|FG005|From Week 24 Until Week 48|Physician Decision|0|||
42318740|NCT01995201|76155715|FG006|From Week 24 Until Week 48|Physician Decision|0|||
42318741|NCT01995201|76155709|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
42318742|NCT01995201|76155710|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
42318743|NCT01995201|76155711|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
42318744|NCT01995201|76155712|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
42318745|NCT01995201|76155713|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
42318746|NCT01995201|76155714|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
42318747|NCT01995201|76155715|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
42318748|NCT01728454|76155739|FG000|Stage 1 and 2|Pregnancy|1|||
42318749|NCT01728454|76155740|FG001|Stage 1 and 2|Pregnancy|0|||
41993802|NCT00190671|75802109|FG001|Overall Study|Satisfactory Response|7|||
42257520|NCT02958865|76083884|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
42257521|NCT02958865|76083885|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
42257522|NCT02958865|76083886|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
42257523|NCT02958865|76083887|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
42257524|NCT02958865|76083888|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
42257525|NCT02958865|76083889|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
42257526|NCT02958865|76083890|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
42257527|NCT02958865|76083891|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
42257528|NCT02958865|76083892|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
42318750|NCT01728454|76155741|FG002|Stage 1 and 2|Pregnancy|0|||
42318751|NCT01728454|76155739|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
41993803|NCT00190671|75802108|FG000|Overall Study|Lack of Efficacy|19|||
41993804|NCT00190671|75802109|FG001|Overall Study|Lack of Efficacy|24|||
41993805|NCT00190671|75802108|FG000|Overall Study|Death from Study Disease|1|||
41993806|NCT00190671|75802109|FG001|Overall Study|Death from Study Disease|1|||
41993807|NCT00190671|75802108|FG000|Overall Study|Adverse Event|3|||
42257529|NCT02958865|76083893|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
42318752|NCT01728454|76155740|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
42318753|NCT01728454|76155741|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
42318754|NCT01728454|76155739|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
42318755|NCT01728454|76155740|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
42318756|NCT01728454|76155741|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
41993808|NCT00190671|75802109|FG001|Overall Study|Adverse Event|2|||
42257530|NCT02958865|76083894|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
42257531|NCT02958865|76083895|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
42257532|NCT02958865|76083896|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
42257533|NCT02958865|76083897|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
42257534|NCT02958865|76083882|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
42257535|NCT02958865|76083883|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
42257536|NCT02958865|76083884|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
42257537|NCT02958865|76083885|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
42257538|NCT02958865|76083886|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
42257539|NCT02958865|76083887|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
42257540|NCT02958865|76083888|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
42257541|NCT02958865|76083889|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
42257542|NCT02958865|76083890|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
42257543|NCT02958865|76083891|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
42257544|NCT02958865|76083892|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
42257545|NCT02958865|76083893|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
42257546|NCT02958865|76083894|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
42257547|NCT02958865|76083895|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
42257548|NCT02958865|76083896|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
42257549|NCT02958865|76083897|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
42257550|NCT02958865|76083882|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257551|NCT02958865|76083883|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257552|NCT02958865|76083884|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257553|NCT02958865|76083885|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257554|NCT02958865|76083886|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257555|NCT02958865|76083887|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257556|NCT02958865|76083888|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257557|NCT02958865|76083889|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257558|NCT02958865|76083890|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257559|NCT02958865|76083891|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
42257560|NCT02958865|76083892|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257561|NCT02958865|76083893|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257562|NCT02958865|76083894|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257563|NCT02958865|76083895|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257564|NCT02958865|76083896|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
42257565|NCT02958865|76083897|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
42257566|NCT02958865|76083882|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
42257567|NCT02958865|76083883|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
42257568|NCT02958865|76083884|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
42257569|NCT02958865|76083885|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
42257570|NCT02958865|76083886|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
42257571|NCT02958865|76083887|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
42257572|NCT02958865|76083888|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
42257573|NCT02958865|76083889|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
42257574|NCT02958865|76083890|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
42257575|NCT02958865|76083891|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
42257576|NCT02958865|76083892|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
42257577|NCT02958865|76083893|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
42318757|NCT01728454|76155739|FG000|Stage 1 and 2|Lost to Follow-up|1|||
42257578|NCT02958865|76083894|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
42257579|NCT02958865|76083895|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
42257580|NCT02958865|76083896|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
42257581|NCT02958865|76083897|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
42257582|NCT02958865|76083882|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
42257583|NCT02958865|76083883|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
42257584|NCT02958865|76083884|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
42257585|NCT02958865|76083885|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
42257586|NCT02958865|76083886|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
42257587|NCT02958865|76083887|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
42257588|NCT02958865|76083888|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
42257589|NCT02958865|76083889|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
42257590|NCT02958865|76083890|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
42257591|NCT02958865|76083891|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
42257592|NCT02958865|76083892|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
42257593|NCT02958865|76083893|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
42257594|NCT02958865|76083894|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
42257595|NCT02958865|76083895|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
42257596|NCT02958865|76083896|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
42257597|NCT02958865|76083897|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
42257598|NCT02958865|76083882|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257599|NCT02958865|76083883|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257600|NCT02958865|76083884|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257601|NCT02958865|76083885|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257602|NCT02958865|76083886|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257603|NCT02958865|76083887|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257604|NCT02958865|76083888|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257605|NCT02958865|76083889|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257606|NCT02958865|76083890|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257607|NCT02958865|76083891|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257608|NCT02958865|76083892|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257609|NCT02958865|76083893|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257610|NCT02958865|76083894|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257611|NCT02958865|76083895|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
42257612|NCT02958865|76083896|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257613|NCT02958865|76083897|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
42257614|NCT02958865|76083882|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257615|NCT02958865|76083883|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257616|NCT02958865|76083884|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257617|NCT02958865|76083885|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257618|NCT02958865|76083886|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257619|NCT02958865|76083887|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257620|NCT02958865|76083888|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257621|NCT02958865|76083889|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257622|NCT02958865|76083890|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257623|NCT02958865|76083891|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257624|NCT02958865|76083892|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257625|NCT02958865|76083893|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257626|NCT02958865|76083894|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257627|NCT02958865|76083895|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
42257628|NCT02958865|76083896|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257629|NCT02958865|76083897|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
42257630|NCT02958865|76083882|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
41993809|NCT00190671|75802108|FG000|Overall Study|Clinical Relapse|0|||
42257631|NCT02958865|76083883|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42257632|NCT02958865|76083884|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42257633|NCT02958865|76083885|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42257634|NCT02958865|76083886|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42318758|NCT01728454|76155740|FG001|Stage 1 and 2|Lost to Follow-up|1|||
41993810|NCT00190671|75802109|FG001|Overall Study|Clinical Relapse|1|||
42318759|NCT01728454|76155741|FG002|Stage 1 and 2|Lost to Follow-up|0|||
42318760|NCT01728454|76155739|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
42318761|NCT01728454|76155740|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
42318762|NCT01728454|76155741|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
42318763|NCT01728454|76155739|FG000|Stage 3|Reason Missing|0|||
42318764|NCT01728454|76155740|FG001|Stage 3|Reason Missing|0|||
42318765|NCT01728454|76155741|FG002|Stage 3|Reason Missing|1|||
42318766|NCT01728454|76155739|FG000|Stage 3|Subject Required Other Treatment|0|||
42318767|NCT01728454|76155740|FG001|Stage 3|Subject Required Other Treatment|1|||
42318768|NCT01728454|76155741|FG002|Stage 3|Subject Required Other Treatment|0|||
42318769|NCT01728454|76155739|FG000|Stage 3|Pregnancy|1|||
42318770|NCT01728454|76155740|FG001|Stage 3|Pregnancy|0|||
42318771|NCT01728454|76155741|FG002|Stage 3|Pregnancy|0|||
42318772|NCT01728454|76155739|FG000|Stage 3|Withdrew Consent|1|||
42318773|NCT01728454|76155740|FG001|Stage 3|Withdrew Consent|0|||
42318774|NCT01728454|76155741|FG002|Stage 3|Withdrew Consent|1|||
42318775|NCT01728454|76155739|FG000|Stage 3|Non-compliance with Protocol|0|||
42318776|NCT01728454|76155740|FG001|Stage 3|Non-compliance with Protocol|0|||
42318777|NCT01728454|76155741|FG002|Stage 3|Non-compliance with Protocol|1|||
42318778|NCT01728454|76155739|FG000|Stage 3|Lost to Follow-up|0|||
42318779|NCT01728454|76155740|FG001|Stage 3|Lost to Follow-up|3|||
42318780|NCT01728454|76155741|FG002|Stage 3|Lost to Follow-up|1|||
42318781|NCT01728454|76155739|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
42318782|NCT01728454|76155740|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
42318783|NCT01728454|76155741|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
42318784|NCT01636687|76155755|FG000|Induction Period|Withdrawal by Subject|1|||
42318785|NCT01636687|76155756|FG001|Induction Period|Withdrawal by Subject|0|||
42318786|NCT01636687|76155757|FG002|Induction Period|Withdrawal by Subject|0|||
42318787|NCT01636687|76155758|FG003|Induction Period|Withdrawal by Subject|0|||
42318788|NCT01636687|76155759|FG004|Induction Period|Withdrawal by Subject|0|||
42318789|NCT01636687|76155755|FG000|Induction Period|Adverse Event|1|||
42318790|NCT01636687|76155756|FG001|Induction Period|Adverse Event|0|||
42318791|NCT01636687|76155757|FG002|Induction Period|Adverse Event|0|||
42318792|NCT01636687|76155758|FG003|Induction Period|Adverse Event|0|||
42257635|NCT02958865|76083887|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42257636|NCT02958865|76083888|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42257637|NCT02958865|76083889|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42318793|NCT01636687|76155759|FG004|Induction Period|Adverse Event|1|||
42318794|NCT01636687|76155755|FG000|Induction Period|Lack of Efficacy|0|||
42318795|NCT01636687|76155756|FG001|Induction Period|Lack of Efficacy|0|||
42318796|NCT01636687|76155757|FG002|Induction Period|Lack of Efficacy|0|||
42318797|NCT01636687|76155758|FG003|Induction Period|Lack of Efficacy|0|||
42318798|NCT01636687|76155759|FG004|Induction Period|Lack of Efficacy|1|||
42318799|NCT01636687|76155755|FG000|Induction Period|Physician Decision|1|||
42318800|NCT01636687|76155756|FG001|Induction Period|Physician Decision|0|||
42318801|NCT01636687|76155757|FG002|Induction Period|Physician Decision|0|||
42318802|NCT01636687|76155758|FG003|Induction Period|Physician Decision|0|||
42318803|NCT01636687|76155759|FG004|Induction Period|Physician Decision|0|||
42318804|NCT01636687|76155755|FG000|Maintenance Period|Withdrawal by Subject|2|||
41993811|NCT00190671|75802108|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
42257638|NCT02958865|76083890|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42318805|NCT01636687|76155756|FG001|Maintenance Period|Withdrawal by Subject|0|||
42318806|NCT01636687|76155757|FG002|Maintenance Period|Withdrawal by Subject|2|||
41993812|NCT00190671|75802109|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
41993813|NCT00190671|75802108|FG000|Overall Study|Death from Other Causes|0|||
41993814|NCT00190671|75802109|FG001|Overall Study|Death from Other Causes|2|||
41993815|NCT00190671|75802108|FG000|Overall Study|Protocol Violation|0|||
42257639|NCT02958865|76083891|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
42257640|NCT02958865|76083892|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42257641|NCT02958865|76083893|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42318807|NCT01636687|76155758|FG003|Maintenance Period|Withdrawal by Subject|0|||
42318808|NCT01636687|76155759|FG004|Maintenance Period|Withdrawal by Subject|0|||
42318809|NCT01636687|76155755|FG000|Maintenance Period|Adverse Event|1|||
42318810|NCT01636687|76155756|FG001|Maintenance Period|Adverse Event|0|||
42318811|NCT01636687|76155757|FG002|Maintenance Period|Adverse Event|0|||
42318812|NCT01636687|76155758|FG003|Maintenance Period|Adverse Event|0|||
41993816|NCT00190671|75802109|FG001|Overall Study|Protocol Violation|1|||
41993817|NCT00190671|75802108|FG000|Overall Study|Withdrawal by Subject|0|||
42318813|NCT01636687|76155759|FG004|Maintenance Period|Adverse Event|0|||
42318814|NCT01636687|76155755|FG000|Maintenance Period|Lack of Efficacy|4|||
42318815|NCT01636687|76155756|FG001|Maintenance Period|Lack of Efficacy|1|||
42318816|NCT01636687|76155757|FG002|Maintenance Period|Lack of Efficacy|0|||
42318817|NCT01636687|76155758|FG003|Maintenance Period|Lack of Efficacy|0|||
42318818|NCT01636687|76155759|FG004|Maintenance Period|Lack of Efficacy|0|||
42318819|NCT01636687|76155755|FG000|Maintenance Period|Lost to Follow-up|1|||
42318820|NCT01636687|76155756|FG001|Maintenance Period|Lost to Follow-up|1|||
42318821|NCT01636687|76155757|FG002|Maintenance Period|Lost to Follow-up|0|||
42318822|NCT01636687|76155758|FG003|Maintenance Period|Lost to Follow-up|0|||
42318823|NCT01636687|76155759|FG004|Maintenance Period|Lost to Follow-up|1|||
42318824|NCT01636687|76155755|FG000|Maintenance Period|Physician Decision|0|||
42318825|NCT01636687|76155756|FG001|Maintenance Period|Physician Decision|0|||
42318826|NCT01636687|76155757|FG002|Maintenance Period|Physician Decision|0|||
42318827|NCT01636687|76155758|FG003|Maintenance Period|Physician Decision|0|||
42318828|NCT01636687|76155759|FG004|Maintenance Period|Physician Decision|1|||
42318829|NCT01636687|76155755|FG000|Extension Period|technical problems|0|||
41993818|NCT00190671|75802109|FG001|Overall Study|Withdrawal by Subject|2|||
41993819|NCT00477165|75802131|FG000|Overall Study|Adverse Event|7|||
42133255|NCT00498602|75944124|FG006|Overall Study|Investigator Request|0|||
42133256|NCT00498602|75944118|FG000|Overall Study|Subject Request|3|||
42318830|NCT01636687|76155756|FG001|Extension Period|technical problems|1|||
42318831|NCT01636687|76155757|FG002|Extension Period|technical problems|2|||
42318832|NCT01636687|76155758|FG003|Extension Period|technical problems|1|||
42318833|NCT01636687|76155759|FG004|Extension Period|technical problems|0|||
42318834|NCT01636687|76155755|FG000|Extension Period|Adverse Event|4|||
42318835|NCT01636687|76155756|FG001|Extension Period|Adverse Event|3|||
42318836|NCT01636687|76155757|FG002|Extension Period|Adverse Event|2|||
42318837|NCT01636687|76155758|FG003|Extension Period|Adverse Event|1|||
42318838|NCT01636687|76155759|FG004|Extension Period|Adverse Event|0|||
42318839|NCT01636687|76155755|FG000|Extension Period|Lack of Efficacy|7|||
42318840|NCT01636687|76155756|FG001|Extension Period|Lack of Efficacy|0|||
42318841|NCT01636687|76155757|FG002|Extension Period|Lack of Efficacy|2|||
42318842|NCT01636687|76155758|FG003|Extension Period|Lack of Efficacy|1|||
42318843|NCT01636687|76155759|FG004|Extension Period|Lack of Efficacy|0|||
42318844|NCT01636687|76155755|FG000|Extension Period|Lost to Follow-up|1|||
42318845|NCT01636687|76155756|FG001|Extension Period|Lost to Follow-up|0|||
42318846|NCT01636687|76155757|FG002|Extension Period|Lost to Follow-up|1|||
42318847|NCT01636687|76155758|FG003|Extension Period|Lost to Follow-up|0|||
42318848|NCT01636687|76155759|FG004|Extension Period|Lost to Follow-up|0|||
42318849|NCT01636687|76155755|FG000|Extension Period|Physician Decision|1|||
42318850|NCT01636687|76155756|FG001|Extension Period|Physician Decision|0|||
42318851|NCT01636687|76155757|FG002|Extension Period|Physician Decision|0|||
42318852|NCT01636687|76155758|FG003|Extension Period|Physician Decision|1|||
42318853|NCT01636687|76155759|FG004|Extension Period|Physician Decision|0|||
42133257|NCT00498602|75944119|FG001|Overall Study|Subject Request|0|||
42133258|NCT00498602|75944120|FG002|Overall Study|Subject Request|1|||
42133259|NCT00498602|75944121|FG003|Overall Study|Subject Request|1|||
42133260|NCT00498602|75944122|FG004|Overall Study|Subject Request|1|||
42133261|NCT00498602|75944123|FG005|Overall Study|Subject Request|4|||
42133262|NCT00498602|75944124|FG006|Overall Study|Subject Request|1|||
42133263|NCT00498602|75944118|FG000|Overall Study|Other|2|||
42133264|NCT00498602|75944119|FG001|Overall Study|Other|3|||
42318854|NCT01636687|76155755|FG000|Extension Period|study terminated by sponsor|33|||
42318855|NCT01636687|76155756|FG001|Extension Period|study terminated by sponsor|50|||
42318856|NCT01636687|76155757|FG002|Extension Period|study terminated by sponsor|17|||
42318857|NCT01636687|76155758|FG003|Extension Period|study terminated by sponsor|23|||
42318858|NCT01636687|76155759|FG004|Extension Period|study terminated by sponsor|0|||
42318859|NCT01636687|76155755|FG000|Extension Period|Withdrawal by Subject|1|||
42318860|NCT01636687|76155756|FG001|Extension Period|Withdrawal by Subject|0|||
42318861|NCT01636687|76155757|FG002|Extension Period|Withdrawal by Subject|1|||
42133265|NCT00498602|75944120|FG002|Overall Study|Other|1|||
42133266|NCT00498602|75944121|FG003|Overall Study|Other|0|||
42133267|NCT00498602|75944122|FG004|Overall Study|Other|0|||
42318862|NCT01636687|76155758|FG003|Extension Period|Withdrawal by Subject|1|||
42318863|NCT01636687|76155759|FG004|Extension Period|Withdrawal by Subject|0|||
42318864|NCT01636687|76155755|FG000|Follow-up Period|Withdrawal by Subject|1|||
42133268|NCT00498602|75944123|FG005|Overall Study|Other|3|||
42133269|NCT00498602|75944124|FG006|Overall Study|Other|0|||
41993820|NCT00477165|75802132|FG001|Overall Study|Adverse Event|2|||
41993821|NCT00476229|75802138|FG000|Overall Study|Progressive shortness of breath|1|||
41993822|NCT00476151|75802144|FG000|Overall Study|Adverse Event|0|||
41993823|NCT00476151|75802145|FG001|Overall Study|Adverse Event|2|||
41993824|NCT00476151|75802144|FG000|Overall Study|Protocol Violation|1|||
41993825|NCT00476151|75802145|FG001|Overall Study|Protocol Violation|3|||
41993826|NCT00476151|75802144|FG000|Overall Study|Withdrawal by Subject|2|||
41993827|NCT00476151|75802145|FG001|Overall Study|Withdrawal by Subject|0|||
41993828|NCT00476151|75802144|FG000|Overall Study|Physician Decision|0|||
41993829|NCT00476151|75802145|FG001|Overall Study|Physician Decision|2|||
41993830|NCT00475644|75802151|FG000|Overall Study|Protocol Violation|13|||
41993831|NCT00474903|75802158|FG000|Overall Study|Protocol Violation|1|||
41993832|NCT00474903|75802159|FG001|Overall Study|Protocol Violation|5|||
41993833|NCT00474903|75802160|FG002|Overall Study|Protocol Violation|2|||
41993834|NCT01134055|75802175|FG000|Overall Study|Adverse Event|5|||
41993835|NCT01134055|75802176|FG001|Overall Study|Adverse Event|2|||
41993836|NCT01134055|75802177|FG002|Overall Study|Adverse Event|2|||
41993837|NCT01134055|75802178|FG003|Overall Study|Adverse Event|2|||
41993838|NCT01134055|75802179|FG004|Overall Study|Adverse Event|5|||
41993839|NCT01134055|75802180|FG005|Overall Study|Adverse Event|7|||
41993840|NCT01134055|75802181|FG006|Overall Study|Adverse Event|2|||
41993841|NCT01134055|75802175|FG000|Overall Study|Lost to Follow-up|0|||
41993842|NCT01134055|75802176|FG001|Overall Study|Lost to Follow-up|1|||
41993843|NCT01134055|75802177|FG002|Overall Study|Lost to Follow-up|0|||
42257642|NCT02958865|76083894|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42257643|NCT02958865|76083895|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42257644|NCT02958865|76083896|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42257645|NCT02958865|76083897|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
42257646|NCT02958553|76083949|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
42257647|NCT02958553|76083949|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
42257648|NCT02501902|76083962|FG000|Overall Study|Subject Refused Further Follow-up|0|||
42257649|NCT02501902|76083963|FG001|Overall Study|Subject Refused Further Follow-up|0|||
42257650|NCT02501902|76083964|FG002|Overall Study|Subject Refused Further Follow-up|0|||
42257651|NCT02501902|76083965|FG003|Overall Study|Subject Refused Further Follow-up|0|||
42318865|NCT01636687|76155756|FG001|Follow-up Period|Withdrawal by Subject|0|||
41993844|NCT01134055|75802178|FG003|Overall Study|Lost to Follow-up|1|||
41993845|NCT01134055|75802179|FG004|Overall Study|Lost to Follow-up|0|||
42257652|NCT02501902|76083966|FG004|Overall Study|Subject Refused Further Follow-up|0|||
42033929|NCT01071252|75842095|FG000|Overall Study|Death|0|||
42033930|NCT01071252|75842096|FG001|Overall Study|Death|0|||
42033931|NCT01071252|75842097|FG002|Overall Study|Death|0|||
42033932|NCT01071252|75842098|FG003|Overall Study|Death|0|||
42033933|NCT01071252|75842099|FG004|Overall Study|Death|1|||
42033934|NCT00856843|75842113|FG000|Overall Study|Withdrawal by Subject|1|||
42033935|NCT00856843|75842114|FG001|Overall Study|Withdrawal by Subject|5|||
42033936|NCT00856843|75842113|FG000|Overall Study|Lack of Efficacy|1|||
42033937|NCT00856843|75842114|FG001|Overall Study|Lack of Efficacy|0|||
42033938|NCT00856609|75842122|FG000|Overall Study|Adverse Event|1|||
42033939|NCT00856609|75842123|FG001|Overall Study|Adverse Event|0|||
42033940|NCT01071096|75842129|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
42033941|NCT01071096|75842130|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
42033942|NCT00856375|75842149|FG000|Overall Study|Other|0|||
42033943|NCT00856375|75842150|FG001|Overall Study|Other|1|||
42033944|NCT00856375|75842149|FG000|Overall Study|Death|32|||
42257653|NCT02501902|76083967|FG005|Overall Study|Subject Refused Further Follow-up|0|||
42257654|NCT02501902|76083968|FG006|Overall Study|Subject Refused Further Follow-up|0|||
42257655|NCT02501902|76083969|FG007|Overall Study|Subject Refused Further Follow-up|1|||
42257656|NCT02501902|76083962|FG000|Overall Study|Study Terminated by Sponsor|0|||
41993846|NCT01134055|75802180|FG005|Overall Study|Lost to Follow-up|0|||
41993847|NCT01134055|75802181|FG006|Overall Study|Lost to Follow-up|0|||
41993848|NCT01134055|75802175|FG000|Overall Study|Withdrawal by Subject|3|||
41993849|NCT01134055|75802176|FG001|Overall Study|Withdrawal by Subject|3|||
41993850|NCT01134055|75802177|FG002|Overall Study|Withdrawal by Subject|1|||
41993851|NCT01134055|75802178|FG003|Overall Study|Withdrawal by Subject|2|||
41993852|NCT01134055|75802179|FG004|Overall Study|Withdrawal by Subject|0|||
41993853|NCT01134055|75802180|FG005|Overall Study|Withdrawal by Subject|0|||
41993854|NCT01134055|75802181|FG006|Overall Study|Withdrawal by Subject|8|||
41993855|NCT01134055|75802175|FG000|Overall Study|Protocol Violation|0|||
41993856|NCT01134055|75802176|FG001|Overall Study|Protocol Violation|0|||
41993857|NCT01134055|75802177|FG002|Overall Study|Protocol Violation|0|||
41993858|NCT01134055|75802178|FG003|Overall Study|Protocol Violation|1|||
42033945|NCT00856375|75842150|FG001|Overall Study|Death|30|||
42033946|NCT00856375|75842149|FG000|Overall Study|Sponsor Terminated Study|7|||
42257657|NCT02501902|76083963|FG001|Overall Study|Study Terminated by Sponsor|3|||
42257658|NCT02501902|76083964|FG002|Overall Study|Study Terminated by Sponsor|0|||
42257659|NCT02501902|76083965|FG003|Overall Study|Study Terminated by Sponsor|1|||
42257660|NCT02501902|76083966|FG004|Overall Study|Study Terminated by Sponsor|1|||
42257661|NCT02501902|76083967|FG005|Overall Study|Study Terminated by Sponsor|0|||
42257662|NCT02501902|76083968|FG006|Overall Study|Study Terminated by Sponsor|2|||
42257663|NCT02501902|76083969|FG007|Overall Study|Study Terminated by Sponsor|4|||
42257664|NCT02501902|76083962|FG000|Overall Study|Death|3|||
42257665|NCT02501902|76083963|FG001|Overall Study|Death|4|||
42257666|NCT02501902|76083964|FG002|Overall Study|Death|4|||
42257667|NCT02501902|76083965|FG003|Overall Study|Death|10|||
42033947|NCT00856375|75842150|FG001|Overall Study|Sponsor Terminated Study|7|||
42257668|NCT02501902|76083966|FG004|Overall Study|Death|10|||
42318866|NCT01636687|76155757|FG002|Follow-up Period|Withdrawal by Subject|0|||
42318867|NCT01636687|76155758|FG003|Follow-up Period|Withdrawal by Subject|0|||
42318868|NCT01636687|76155759|FG004|Follow-up Period|Withdrawal by Subject|1|||
42318869|NCT01634659|76155779|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
42318870|NCT01634659|76155780|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
42318871|NCT01634659|76155779|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
42318872|NCT01634659|76155780|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
42318873|NCT04863248|76155792|FG000|Overall Study|Sponsor Terminated|4|||
42318874|NCT04863248|76155793|FG001|Overall Study|Sponsor Terminated|1|||
42318875|NCT04863248|76155792|FG000|Overall Study|Death|0|||
42318876|NCT04863248|76155793|FG001|Overall Study|Death|1|||
42318877|NCT04863248|76155792|FG000|Overall Study|Withdrawal by Subject|0|||
42318878|NCT04863248|76155793|FG001|Overall Study|Withdrawal by Subject|1|||
42318879|NCT04285229|76155801|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
42318880|NCT04285229|76155802|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42318881|NCT04285229|76155803|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42318882|NCT04285229|76155804|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42318883|NCT04285229|76155805|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42318884|NCT04285229|76155806|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42318885|NCT04285229|76155801|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
42318886|NCT04285229|76155802|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
42318887|NCT04285229|76155803|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
42318888|NCT04285229|76155804|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
42318889|NCT04285229|76155805|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
42318890|NCT04285229|76155806|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
42318891|NCT04285229|76155801|FG000|Extended Treatment Period|Adverse Event|0|||
42318892|NCT04285229|76155802|FG001|Extended Treatment Period|Adverse Event|0|||
42318893|NCT04285229|76155803|FG002|Extended Treatment Period|Adverse Event|0|||
42318894|NCT04285229|76155804|FG003|Extended Treatment Period|Adverse Event|1|||
42318895|NCT04285229|76155805|FG004|Extended Treatment Period|Adverse Event|0|||
42318896|NCT04285229|76155806|FG005|Extended Treatment Period|Adverse Event|0|||
41993859|NCT01134055|75802179|FG004|Overall Study|Protocol Violation|1|||
41993860|NCT01134055|75802180|FG005|Overall Study|Protocol Violation|0|||
41993861|NCT01134055|75802181|FG006|Overall Study|Protocol Violation|0|||
42257669|NCT02501902|76083967|FG005|Overall Study|Death|11|||
42257670|NCT02501902|76083968|FG006|Overall Study|Death|7|||
42257671|NCT02501902|76083969|FG007|Overall Study|Death|15|||
42257672|NCT01955109|76083994|FG000|Overall Study|Adverse Event|2|||
42257673|NCT01955109|76083995|FG001|Overall Study|Adverse Event|0|||
42257674|NCT01955109|76083994|FG000|Overall Study|Participant unwilling to continue|35|||
42257675|NCT01955109|76083995|FG001|Overall Study|Participant unwilling to continue|7|||
42257676|NCT01955109|76083994|FG000|Overall Study|Physician Decision|2|||
42257677|NCT01955109|76083995|FG001|Overall Study|Physician Decision|0|||
42257678|NCT01955109|76083994|FG000|Overall Study|Lost to Follow-up|3|||
42257679|NCT01955109|76083995|FG001|Overall Study|Lost to Follow-up|1|||
42257680|NCT01955109|76083994|FG000|Overall Study|Non-compliance|3|||
42257681|NCT01955109|76083995|FG001|Overall Study|Non-compliance|1|||
42257682|NCT02500732|76084003|FG000|Overall Study|Physician Decision|0|||
42257683|NCT02500732|76084004|FG001|Overall Study|Physician Decision|1|||
42257684|NCT02518048|76084010|FG000|Overall Study|Withdrawal by Subject|1|||
42257685|NCT02499952|76084015|FG000|Overall Study|Lost to Follow-up|1|||
42257686|NCT02499952|76084015|FG000|Overall Study|Death|9|||
42257687|NCT02499406|76084019|FG000|Overall Study|missed 3 treatment sessions|4|||
42257688|NCT02498392|76084025|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
42257689|NCT02498392|76084026|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
42257690|NCT02498392|76084025|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
42257691|NCT02498392|76084026|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
42257692|NCT02498392|76084025|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
41993862|NCT01134055|75802175|FG000|Overall Study|Physician Decision|0|||
41993863|NCT01134055|75802176|FG001|Overall Study|Physician Decision|0|||
41993864|NCT01134055|75802177|FG002|Overall Study|Physician Decision|0|||
41993865|NCT01134055|75802178|FG003|Overall Study|Physician Decision|0|||
42133270|NCT00507728|75944143|FG000|Randomization to Month 3|Lost to Follow-up|15|||
42318897|NCT04285229|76155801|FG000|Extended Treatment Period|Physician Decision|0|||
42318898|NCT04285229|76155802|FG001|Extended Treatment Period|Physician Decision|0|||
41993866|NCT01134055|75802179|FG004|Overall Study|Physician Decision|0|||
42033948|NCT00856375|75842149|FG000|Overall Study|Withdrawal by Subject|2|||
42033949|NCT00856375|75842150|FG001|Overall Study|Withdrawal by Subject|1|||
42257693|NCT02498392|76084026|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
42257694|NCT02498392|76084025|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
42257695|NCT02498392|76084026|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
42257696|NCT02498392|76084025|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
42318899|NCT04285229|76155803|FG002|Extended Treatment Period|Physician Decision|1|||
42318900|NCT04285229|76155804|FG003|Extended Treatment Period|Physician Decision|0|||
42318901|NCT04285229|76155805|FG004|Extended Treatment Period|Physician Decision|0|||
42318902|NCT04285229|76155806|FG005|Extended Treatment Period|Physician Decision|0|||
42318903|NCT04285229|76155801|FG000|Follow-up Period|Adverse Event|0|||
42318904|NCT04285229|76155802|FG001|Follow-up Period|Adverse Event|0|||
42318905|NCT04285229|76155803|FG002|Follow-up Period|Adverse Event|0|||
42318906|NCT04285229|76155804|FG003|Follow-up Period|Adverse Event|0|||
42318907|NCT04285229|76155805|FG004|Follow-up Period|Adverse Event|1|||
42318908|NCT04285229|76155806|FG005|Follow-up Period|Adverse Event|4|||
42318909|NCT04285229|76155801|FG000|Follow-up Period|Withdrawal by Subject|0|||
42318910|NCT04285229|76155802|FG001|Follow-up Period|Withdrawal by Subject|0|||
42318911|NCT04285229|76155803|FG002|Follow-up Period|Withdrawal by Subject|0|||
42318912|NCT04285229|76155804|FG003|Follow-up Period|Withdrawal by Subject|0|||
42318913|NCT04285229|76155805|FG004|Follow-up Period|Withdrawal by Subject|0|||
42318914|NCT04285229|76155806|FG005|Follow-up Period|Withdrawal by Subject|5|||
42318915|NCT04285229|76155801|FG000|Follow-up Period|Covid-19|0|||
42318916|NCT04285229|76155802|FG001|Follow-up Period|Covid-19|0|||
42318917|NCT04285229|76155803|FG002|Follow-up Period|Covid-19|0|||
42318918|NCT04285229|76155804|FG003|Follow-up Period|Covid-19|0|||
42318919|NCT04285229|76155805|FG004|Follow-up Period|Covid-19|0|||
42318920|NCT04285229|76155806|FG005|Follow-up Period|Covid-19|2|||
42318921|NCT04285229|76155801|FG000|Follow-up Period|Physician Decision|0|||
42318922|NCT04285229|76155802|FG001|Follow-up Period|Physician Decision|0|||
42318923|NCT04285229|76155803|FG002|Follow-up Period|Physician Decision|0|||
42257697|NCT02498392|76084026|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
42257698|NCT02498392|76084025|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
42257699|NCT02498392|76084026|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
42318924|NCT04285229|76155804|FG003|Follow-up Period|Physician Decision|0|||
42318925|NCT04285229|76155805|FG004|Follow-up Period|Physician Decision|0|||
42318926|NCT04285229|76155806|FG005|Follow-up Period|Physician Decision|1|||
42318927|NCT04263454|76155823|FG000|Overall Study|Adverse Event|0|||
42318928|NCT04263454|76155824|FG001|Overall Study|Adverse Event|2|||
42318929|NCT04263454|76155823|FG000|Overall Study|Physician Decision|3|||
42318930|NCT04263454|76155824|FG001|Overall Study|Physician Decision|5|||
42318931|NCT04263454|76155823|FG000|Overall Study|Poor Data Quality|0|||
42318932|NCT04263454|76155824|FG001|Overall Study|Poor Data Quality|1|||
42318933|NCT04155463|76155834|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
42318934|NCT04155463|76155835|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
42318935|NCT04056611|76155841|FG000|Overall Study|Physician Decision|1|||
42318936|NCT04001803|76155845|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
42318937|NCT04001803|76155845|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
42318938|NCT04001803|76155845|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
42318939|NCT04001803|76155845|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
42318940|NCT04001803|76155845|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
42318941|NCT04001803|76155845|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
42318942|NCT04001803|76155845|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
42318943|NCT04001803|76155845|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
42257700|NCT03205605|76084034|FG000|Overall Study|Withdrawal by Subject|1|||
42257701|NCT02498236|76084052|FG000|Overall Study|Did not show for testing|1|||
42257702|NCT02498236|76084053|FG001|Overall Study|Did not show for testing|0|||
42257703|NCT02498236|76084054|FG002|Overall Study|Did not show for testing|0|||
42257704|NCT02498236|76084055|FG003|Overall Study|Did not show for testing|0|||
42257705|NCT02498236|76084056|FG004|Overall Study|Did not show for testing|0|||
42257706|NCT02498236|76084057|FG005|Overall Study|Did not show for testing|0|||
42257707|NCT02498236|76084058|FG006|Overall Study|Did not show for testing|0|||
42257708|NCT02498236|76084059|FG007|Overall Study|Did not show for testing|1|||
42257709|NCT02498236|76084052|FG000|Overall Study|Equipment failure|0|||
42257710|NCT02498236|76084053|FG001|Overall Study|Equipment failure|0|||
42257711|NCT02498236|76084054|FG002|Overall Study|Equipment failure|0|||
42257712|NCT02498236|76084055|FG003|Overall Study|Equipment failure|0|||
42257713|NCT02498236|76084056|FG004|Overall Study|Equipment failure|0|||
42318944|NCT04001803|76155845|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
42318945|NCT04001803|76155845|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
42318946|NCT03768427|76155854|FG000|Overall Study|Death|0|||
42318947|NCT03768427|76155855|FG001|Overall Study|Death|0|||
42318948|NCT03768427|76155856|FG002|Overall Study|Death|1|||
41993867|NCT01134055|75802180|FG005|Overall Study|Physician Decision|0|||
42257714|NCT02498236|76084057|FG005|Overall Study|Equipment failure|0|||
42257715|NCT02498236|76084058|FG006|Overall Study|Equipment failure|1|||
42257716|NCT02498236|76084059|FG007|Overall Study|Equipment failure|0|||
42257717|NCT02498236|76084052|FG000|Overall Study|Withdrawal by Subject|0|||
42257718|NCT02498236|76084053|FG001|Overall Study|Withdrawal by Subject|0|||
42318949|NCT03768427|76155857|FG003|Overall Study|Death|0|||
42318950|NCT03768427|76155854|FG000|Overall Study|Lost to Follow-up|2|||
42318951|NCT03768427|76155855|FG001|Overall Study|Lost to Follow-up|0|||
42318952|NCT03768427|76155856|FG002|Overall Study|Lost to Follow-up|0|||
42318953|NCT03768427|76155857|FG003|Overall Study|Lost to Follow-up|0|||
42318954|NCT03768427|76155854|FG000|Overall Study|Physician Decision|3|||
42318955|NCT03768427|76155855|FG001|Overall Study|Physician Decision|2|||
42318956|NCT03768427|76155856|FG002|Overall Study|Physician Decision|4|||
42318957|NCT03768427|76155857|FG003|Overall Study|Physician Decision|4|||
42318958|NCT03768427|76155854|FG000|Overall Study|Withdrawal by Subject|7|||
42318959|NCT03768427|76155855|FG001|Overall Study|Withdrawal by Subject|2|||
42318960|NCT03768427|76155856|FG002|Overall Study|Withdrawal by Subject|6|||
42318961|NCT03768427|76155857|FG003|Overall Study|Withdrawal by Subject|7|||
42318962|NCT03595228|76155871|FG000|Overall Study|Death|2|||
42318963|NCT03595228|76155871|FG000|Overall Study|Lack of Efficacy|13|||
42318964|NCT03595228|76155871|FG000|Overall Study|Withdrawal by Subject|3|||
42318965|NCT03595228|76155871|FG000|Overall Study|Withdrawal by Sponsor|1|||
42257719|NCT02498236|76084054|FG002|Overall Study|Withdrawal by Subject|0|||
42257720|NCT02498236|76084055|FG003|Overall Study|Withdrawal by Subject|0|||
42257721|NCT02498236|76084056|FG004|Overall Study|Withdrawal by Subject|1|||
42257722|NCT02498236|76084057|FG005|Overall Study|Withdrawal by Subject|0|||
42257723|NCT02498236|76084058|FG006|Overall Study|Withdrawal by Subject|0|||
42257724|NCT02498236|76084059|FG007|Overall Study|Withdrawal by Subject|0|||
42257725|NCT02496676|76084082|FG000|Phase 1 - Period 1|Adverse Event|0|||
42257726|NCT02496676|76084083|FG001|Phase 1 - Period 1|Adverse Event|1|||
42257727|NCT02496676|76084082|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
42257728|NCT02496676|76084083|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
42257729|NCT02517268|76084099|FG000|Overall Study|Withdrawal by Subject|1|||
42257730|NCT02517268|76084100|FG001|Overall Study|Withdrawal by Subject|0|||
42257731|NCT01160211|76084109|FG000|Overall Study|ongoing|90|||
42257732|NCT01160211|76084110|FG001|Overall Study|ongoing|75|||
42257733|NCT01160211|76084111|FG002|Overall Study|ongoing|79|||
42257734|NCT01160211|76084109|FG000|Overall Study|Withdrawal by Subject|3|||
42257735|NCT01160211|76084110|FG001|Overall Study|Withdrawal by Subject|5|||
42257736|NCT01160211|76084111|FG002|Overall Study|Withdrawal by Subject|3|||
42257737|NCT01160211|76084109|FG000|Overall Study|Physician Decision|2|||
42257738|NCT01160211|76084110|FG001|Overall Study|Physician Decision|0|||
42257739|NCT01160211|76084111|FG002|Overall Study|Physician Decision|0|||
42257740|NCT01160211|76084109|FG000|Overall Study|Lost to Follow-up|4|||
42257741|NCT01160211|76084110|FG001|Overall Study|Lost to Follow-up|7|||
42257742|NCT01160211|76084111|FG002|Overall Study|Lost to Follow-up|5|||
42257743|NCT01064687|76084124|FG000|Overall Study|Adverse Event|9|||
42257744|NCT01064687|76084125|FG001|Overall Study|Adverse Event|4|||
42257745|NCT01064687|76084126|FG002|Overall Study|Adverse Event|10|||
42257746|NCT01064687|76084127|FG003|Overall Study|Adverse Event|3|||
42257747|NCT01064687|76084124|FG000|Overall Study|Death|1|||
42257748|NCT01064687|76084125|FG001|Overall Study|Death|1|||
42257749|NCT01064687|76084126|FG002|Overall Study|Death|0|||
42257750|NCT01064687|76084127|FG003|Overall Study|Death|0|||
42257751|NCT01064687|76084124|FG000|Overall Study|Entry Criteria Not Met|3|||
42257752|NCT01064687|76084125|FG001|Overall Study|Entry Criteria Not Met|0|||
42257753|NCT01064687|76084126|FG002|Overall Study|Entry Criteria Not Met|0|||
42257754|NCT01064687|76084127|FG003|Overall Study|Entry Criteria Not Met|0|||
42257755|NCT01064687|76084124|FG000|Overall Study|Lack of Efficacy|1|||
42257756|NCT01064687|76084125|FG001|Overall Study|Lack of Efficacy|0|||
42257757|NCT01064687|76084126|FG002|Overall Study|Lack of Efficacy|2|||
42318966|NCT03572933|76155877|FG000|Overall Study|Adverse Event|4|||
42318967|NCT03572933|76155878|FG001|Overall Study|Adverse Event|1|||
42318968|NCT03572933|76155877|FG000|Overall Study|Withdrawal by Subject|0|||
42318969|NCT03572933|76155878|FG001|Overall Study|Withdrawal by Subject|1|||
41993868|NCT01134055|75802181|FG006|Overall Study|Physician Decision|1|||
42257758|NCT01064687|76084127|FG003|Overall Study|Lack of Efficacy|3|||
42257759|NCT01064687|76084124|FG000|Overall Study|Lost to Follow-up|7|||
42257760|NCT01064687|76084125|FG001|Overall Study|Lost to Follow-up|10|||
42257761|NCT01064687|76084126|FG002|Overall Study|Lost to Follow-up|13|||
42257762|NCT01064687|76084127|FG003|Overall Study|Lost to Follow-up|5|||
42257763|NCT01064687|76084124|FG000|Overall Study|Physician Decision|2|||
42257764|NCT01064687|76084125|FG001|Overall Study|Physician Decision|2|||
42257765|NCT01064687|76084126|FG002|Overall Study|Physician Decision|0|||
42257766|NCT01064687|76084127|FG003|Overall Study|Physician Decision|0|||
42257767|NCT01064687|76084124|FG000|Overall Study|Protocol Violation|1|||
42318970|NCT03558152|76155889|FG000|Overall Study|Adverse Event|0|||
42318971|NCT03558152|76155890|FG001|Overall Study|Adverse Event|0|||
42318972|NCT03558152|76155891|FG002|Overall Study|Adverse Event|1|||
42318973|NCT03558152|76155892|FG003|Overall Study|Adverse Event|1|||
42318974|NCT03558152|76155893|FG004|Overall Study|Adverse Event|2|||
42318975|NCT03558152|76155894|FG005|Overall Study|Adverse Event|1|||
42318976|NCT03558152|76155895|FG006|Overall Study|Adverse Event|1|||
42318977|NCT03558152|76155896|FG007|Overall Study|Adverse Event|0|||
42318978|NCT03558152|76155889|FG000|Overall Study|Death|0|||
42318979|NCT03558152|76155890|FG001|Overall Study|Death|0|||
42318980|NCT03558152|76155891|FG002|Overall Study|Death|0|||
42318981|NCT03558152|76155892|FG003|Overall Study|Death|0|||
42318982|NCT03558152|76155893|FG004|Overall Study|Death|1|||
42318983|NCT03558152|76155894|FG005|Overall Study|Death|0|||
42318984|NCT03558152|76155895|FG006|Overall Study|Death|0|||
42033950|NCT00856375|75842149|FG000|Overall Study|Lost to Follow-up|1|||
42318985|NCT03558152|76155896|FG007|Overall Study|Death|0|||
42033951|NCT00856375|75842150|FG001|Overall Study|Lost to Follow-up|2|||
42033952|NCT01070784|75842158|FG000|Overall Study|Withdrawal by Subject|6|||
42033953|NCT01070784|75842159|FG001|Overall Study|Withdrawal by Subject|9|||
42033954|NCT01070784|75842158|FG000|Overall Study|Adverse Event|14|||
42033955|NCT01070784|75842159|FG001|Overall Study|Adverse Event|9|||
42033956|NCT00837577|75842167|FG000|Double-blind Period|Clinical Adverse Event|1|||
42133271|NCT00507728|75944144|FG001|Randomization to Month 3|Lost to Follow-up|14|||
42033957|NCT00837577|75842168|FG001|Double-blind Period|Clinical Adverse Event|0|||
42033958|NCT00837577|75842167|FG000|Double-blind Period|Withdrawal by Subject|1|||
42033959|NCT00837577|75842168|FG001|Double-blind Period|Withdrawal by Subject|0|||
42033960|NCT00837577|75842167|FG000|Open-label Period|Clinical Adverse Event|2|||
42133272|NCT00507728|75944145|FG002|Randomization to Month 3|Lost to Follow-up|20|||
42133273|NCT00507728|75944143|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
42257768|NCT01064687|76084125|FG001|Overall Study|Protocol Violation|1|||
42257769|NCT01064687|76084126|FG002|Overall Study|Protocol Violation|0|||
42257770|NCT01064687|76084127|FG003|Overall Study|Protocol Violation|1|||
42257771|NCT01064687|76084124|FG000|Overall Study|Sponsor Decision|0|||
42257772|NCT01064687|76084125|FG001|Overall Study|Sponsor Decision|0|||
42257773|NCT01064687|76084126|FG002|Overall Study|Sponsor Decision|3|||
42257774|NCT01064687|76084127|FG003|Overall Study|Sponsor Decision|0|||
42257775|NCT01064687|76084124|FG000|Overall Study|Withdrawal by Subject|9|||
42257776|NCT01064687|76084125|FG001|Overall Study|Withdrawal by Subject|7|||
42257777|NCT01064687|76084126|FG002|Overall Study|Withdrawal by Subject|12|||
42257778|NCT01064687|76084127|FG003|Overall Study|Withdrawal by Subject|5|||
42257779|NCT01064687|76084124|FG000|Overall Study|Treatment Noncompliance|1|||
42257780|NCT01064687|76084125|FG001|Overall Study|Treatment Noncompliance|1|||
42257781|NCT01064687|76084126|FG002|Overall Study|Treatment Noncompliance|1|||
42257782|NCT01064687|76084127|FG003|Overall Study|Treatment Noncompliance|0|||
42257783|NCT02493946|76084151|FG000|DB Period|Withdrawal by Subject|8|||
42257784|NCT02493946|76084152|FG001|DB Period|Withdrawal by Subject|5|||
42257785|NCT02493946|76084153|FG002|DB Period|Withdrawal by Subject|0|||
42257786|NCT02493946|76084151|FG000|Open Label Period|Withdrawal by Subject|0|||
42257787|NCT02493946|76084152|FG001|Open Label Period|Withdrawal by Subject|0|||
42033961|NCT00837577|75842168|FG001|Open-label Period|Clinical Adverse Event|2|||
42033962|NCT00837577|75842167|FG000|Open-label Period|Laboratory Adverse Event|0|||
42033963|NCT00837577|75842168|FG001|Open-label Period|Laboratory Adverse Event|1|||
42033964|NCT00837577|75842167|FG000|Open-label Period|Lack of Efficacy|4|||
42033965|NCT00837577|75842168|FG001|Open-label Period|Lack of Efficacy|3|||
42033966|NCT00837577|75842167|FG000|Open-label Period|Withdrawal by Subject|1|||
42033967|NCT00837577|75842168|FG001|Open-label Period|Withdrawal by Subject|2|||
42033968|NCT00837577|75842167|FG000|Open-label Period|Other Reason|1|||
42033969|NCT00837577|75842168|FG001|Open-label Period|Other Reason|1|||
42033970|NCT01070550|75842181|FG000|Overall Study|Adverse Event|43|||
42033971|NCT01070550|75842182|FG001|Overall Study|Adverse Event|1|||
42033972|NCT01070550|75842183|FG002|Overall Study|Adverse Event|3|||
42033973|NCT01070550|75842184|FG003|Overall Study|Adverse Event|0|||
42033974|NCT01070550|75842185|FG004|Overall Study|Adverse Event|0|||
42033975|NCT01070550|75842186|FG005|Overall Study|Adverse Event|0|||
42133274|NCT00507728|75944144|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
42318986|NCT03558152|76155889|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
42318987|NCT03558152|76155890|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
42033976|NCT01070550|75842181|FG000|Overall Study|Death|20|||
42033977|NCT01070550|75842182|FG001|Overall Study|Death|4|||
42033978|NCT01070550|75842183|FG002|Overall Study|Death|3|||
42257788|NCT02493946|76084153|FG002|Open Label Period|Withdrawal by Subject|74|||
42257789|NCT02493946|76084151|FG000|Open Label Period|Adverse Event|0|||
42033979|NCT01070550|75842184|FG003|Overall Study|Death|0|||
42033980|NCT01070550|75842185|FG004|Overall Study|Death|0|||
42257790|NCT02493946|76084152|FG001|Open Label Period|Adverse Event|0|||
42257791|NCT02493946|76084153|FG002|Open Label Period|Adverse Event|4|||
42318988|NCT03558152|76155891|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
42318989|NCT03558152|76155892|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
42318990|NCT03558152|76155893|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
41993869|NCT00474708|75802205|FG000|Overall Study|Lack of Efficacy|11|||
42318991|NCT03558152|76155894|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
42318992|NCT03558152|76155895|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
42318993|NCT03558152|76155896|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
42318994|NCT03558152|76155889|FG000|Overall Study|Miscalculation in mmcs|0|||
42318995|NCT03558152|76155890|FG001|Overall Study|Miscalculation in mmcs|0|||
42318996|NCT03558152|76155891|FG002|Overall Study|Miscalculation in mmcs|0|||
42318997|NCT03558152|76155892|FG003|Overall Study|Miscalculation in mmcs|0|||
42318998|NCT03558152|76155893|FG004|Overall Study|Miscalculation in mmcs|0|||
42318999|NCT03558152|76155894|FG005|Overall Study|Miscalculation in mmcs|0|||
42319000|NCT03558152|76155895|FG006|Overall Study|Miscalculation in mmcs|1|||
42319001|NCT03558152|76155896|FG007|Overall Study|Miscalculation in mmcs|0|||
42319002|NCT03558152|76155889|FG000|Overall Study|Mistake in calculation|0|||
42319003|NCT03558152|76155890|FG001|Overall Study|Mistake in calculation|0|||
42319004|NCT03558152|76155891|FG002|Overall Study|Mistake in calculation|0|||
42319005|NCT03558152|76155892|FG003|Overall Study|Mistake in calculation|1|||
42319006|NCT03558152|76155893|FG004|Overall Study|Mistake in calculation|0|||
42319007|NCT03558152|76155894|FG005|Overall Study|Mistake in calculation|0|||
42319008|NCT03558152|76155895|FG006|Overall Study|Mistake in calculation|0|||
42319009|NCT03558152|76155896|FG007|Overall Study|Mistake in calculation|0|||
42319010|NCT03558152|76155889|FG000|Overall Study|Mistake in evaluation of disease status|0|||
42319011|NCT03558152|76155890|FG001|Overall Study|Mistake in evaluation of disease status|0|||
42319012|NCT03558152|76155891|FG002|Overall Study|Mistake in evaluation of disease status|0|||
42319013|NCT03558152|76155892|FG003|Overall Study|Mistake in evaluation of disease status|0|||
42319014|NCT03558152|76155893|FG004|Overall Study|Mistake in evaluation of disease status|0|||
42319015|NCT03558152|76155894|FG005|Overall Study|Mistake in evaluation of disease status|0|||
42319016|NCT03558152|76155895|FG006|Overall Study|Mistake in evaluation of disease status|0|||
42319017|NCT03558152|76155896|FG007|Overall Study|Mistake in evaluation of disease status|1|||
42319018|NCT03558152|76155889|FG000|Overall Study|Physician Decision|0|||
42319019|NCT03558152|76155890|FG001|Overall Study|Physician Decision|0|||
42319020|NCT03558152|76155891|FG002|Overall Study|Physician Decision|0|||
42319021|NCT03558152|76155892|FG003|Overall Study|Physician Decision|0|||
42319022|NCT03558152|76155893|FG004|Overall Study|Physician Decision|0|||
42319023|NCT03558152|76155894|FG005|Overall Study|Physician Decision|0|||
42319024|NCT03558152|76155895|FG006|Overall Study|Physician Decision|1|||
42319025|NCT03558152|76155896|FG007|Overall Study|Physician Decision|0|||
42319026|NCT03558152|76155889|FG000|Overall Study|Withdrawal by Subject|2|||
42319027|NCT03558152|76155890|FG001|Overall Study|Withdrawal by Subject|3|||
42319028|NCT03558152|76155891|FG002|Overall Study|Withdrawal by Subject|2|||
41993870|NCT00474708|75802206|FG001|Overall Study|Lack of Efficacy|5|||
41993871|NCT00474708|75802205|FG000|Overall Study|Suicide ideation/behavior|0|||
41993872|NCT00474708|75802206|FG001|Overall Study|Suicide ideation/behavior|1|||
41993873|NCT00474708|75802205|FG000|Overall Study|Withdrawal by Subject|7|||
41993874|NCT00474708|75802206|FG001|Overall Study|Withdrawal by Subject|0|||
42319029|NCT03558152|76155892|FG003|Overall Study|Withdrawal by Subject|1|||
42319030|NCT03558152|76155893|FG004|Overall Study|Withdrawal by Subject|1|||
42319031|NCT03558152|76155894|FG005|Overall Study|Withdrawal by Subject|1|||
41993875|NCT00474708|75802205|FG000|Overall Study|Lack of compliance|12|||
41993876|NCT00474708|75802206|FG001|Overall Study|Lack of compliance|4|||
41993877|NCT00474708|75802205|FG000|Overall Study|Lost to Follow-up|18|||
41993878|NCT00474708|75802206|FG001|Overall Study|Lost to Follow-up|9|||
41993879|NCT00474708|75802205|FG000|Overall Study|Physician Decision|9|||
41993880|NCT00474708|75802206|FG001|Overall Study|Physician Decision|6|||
42319032|NCT03558152|76155895|FG006|Overall Study|Withdrawal by Subject|3|||
42319033|NCT03558152|76155896|FG007|Overall Study|Withdrawal by Subject|2|||
42319034|NCT03558152|76155889|FG000|Overall Study|Lack of Efficacy|11|||
42319035|NCT03558152|76155890|FG001|Overall Study|Lack of Efficacy|11|||
42319036|NCT03558152|76155891|FG002|Overall Study|Lack of Efficacy|10|||
42319037|NCT03558152|76155892|FG003|Overall Study|Lack of Efficacy|11|||
42319038|NCT03558152|76155893|FG004|Overall Study|Lack of Efficacy|14|||
42319039|NCT03558152|76155894|FG005|Overall Study|Lack of Efficacy|12|||
42319040|NCT03558152|76155895|FG006|Overall Study|Lack of Efficacy|14|||
42319041|NCT03558152|76155896|FG007|Overall Study|Lack of Efficacy|13|||
42319042|NCT03558152|76155889|FG000|Overall Study|Protocol Violation|1|||
42319043|NCT03558152|76155890|FG001|Overall Study|Protocol Violation|1|||
42319044|NCT03558152|76155891|FG002|Overall Study|Protocol Violation|0|||
42319045|NCT03558152|76155892|FG003|Overall Study|Protocol Violation|1|||
42319046|NCT03558152|76155893|FG004|Overall Study|Protocol Violation|1|||
42319047|NCT03558152|76155894|FG005|Overall Study|Protocol Violation|0|||
42319048|NCT03558152|76155895|FG006|Overall Study|Protocol Violation|2|||
42319049|NCT03558152|76155896|FG007|Overall Study|Protocol Violation|0|||
42319050|NCT03461406|76155936|FG000|Overall Study|Death|1|||
42319051|NCT03461406|76155937|FG001|Overall Study|Death|2|||
42319052|NCT03461406|76155936|FG000|Overall Study|Consent Withdrawn by Participant|0|||
42319053|NCT03461406|76155937|FG001|Overall Study|Consent Withdrawn by Participant|1|||
42319054|NCT03461406|76155936|FG000|Overall Study|Screen Failure|3|||
42319055|NCT03461406|76155937|FG001|Overall Study|Screen Failure|1|||
42319056|NCT03461406|76155936|FG000|Overall Study|Reason not Specified|1|||
42319057|NCT03461406|76155937|FG001|Overall Study|Reason not Specified|3|||
42319058|NCT03461406|76155936|FG000|Overall Study|Lost to Follow-up|3|||
42319059|NCT03461406|76155937|FG001|Overall Study|Lost to Follow-up|0|||
42319060|NCT03408899|76155952|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
42319061|NCT02528643|76155973|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
42319062|NCT02528643|76155974|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
42319063|NCT02528643|76155973|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
42319064|NCT02528643|76155974|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
42319065|NCT02528643|76155973|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
42319066|NCT02528643|76155974|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
42257792|NCT02493946|76084151|FG000|Open Label Period|Lost to Follow-up|0|||
42257793|NCT02493946|76084152|FG001|Open Label Period|Lost to Follow-up|0|||
42257794|NCT02493946|76084153|FG002|Open Label Period|Lost to Follow-up|1|||
42257795|NCT02493946|76084151|FG000|Open Label Period|Investigator decision, non-compliance|0|||
42257796|NCT02493946|76084152|FG001|Open Label Period|Investigator decision, non-compliance|0|||
42257797|NCT02493946|76084153|FG002|Open Label Period|Investigator decision, non-compliance|2|||
42257798|NCT02493946|76084151|FG000|Open Label Period|Investigator decision, non-availability|0|||
42257799|NCT02493946|76084152|FG001|Open Label Period|Investigator decision, non-availability|0|||
42257800|NCT02493946|76084153|FG002|Open Label Period|Investigator decision, non-availability|1|||
42257801|NCT02493946|76084151|FG000|Open Label Period|Pregnancy|0|||
42257802|NCT02493946|76084152|FG001|Open Label Period|Pregnancy|0|||
42257803|NCT02493946|76084153|FG002|Open Label Period|Pregnancy|3|||
42319067|NCT02528643|76155973|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
42319068|NCT02528643|76155974|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
42319069|NCT02528643|76155973|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
42319070|NCT02528643|76155974|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
42319071|NCT02528643|76155973|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
42319072|NCT02528643|76155974|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
42033981|NCT01070550|75842186|FG005|Overall Study|Death|0|||
42257804|NCT02493946|76084151|FG000|Open Label Period|Site error|0|||
42257805|NCT02493946|76084152|FG001|Open Label Period|Site error|0|||
42257806|NCT02493946|76084153|FG002|Open Label Period|Site error|1|||
42257807|NCT01064531|76084163|FG000|Overall Study|Lost to Follow-up|0|||
42257808|NCT01064531|76084164|FG001|Overall Study|Lost to Follow-up|2|||
42319073|NCT02528643|76155973|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
42319074|NCT02528643|76155974|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
42319075|NCT02175680|76155995|FG000|Overall Study|non-compliance|1|||
42319076|NCT02175680|76155995|FG000|Overall Study|other non-medical reason|1|||
42319077|NCT01983462|76156009|FG000|Overall Study|Adverse Event|1|||
42319078|NCT01983462|76156010|FG001|Overall Study|Adverse Event|0|||
42319079|NCT01983462|76156011|FG002|Overall Study|Adverse Event|0|||
42319080|NCT01559935|76156030|FG000|Car Phase|Toxicity|4|||
42319081|NCT01559935|76156030|FG000|Car Phase|Death|1|||
42319082|NCT01559935|76156030|FG000|Car Phase|Lack of Efficacy|2|||
42257809|NCT01064531|76084163|FG000|Overall Study|Physician Decision|0|||
42257810|NCT01064531|76084164|FG001|Overall Study|Physician Decision|1|||
42257811|NCT01064531|76084163|FG000|Overall Study|Withdrawal by Subject|2|||
42319083|NCT01559935|76156030|FG000|Car Phase|Lost to Follow-up|1|||
42319084|NCT01559935|76156030|FG000|Car Phase|Physician Decision|1|||
42319085|NCT01559935|76156030|FG000|Car Phase|Withdrawal by Subject|2|||
42319086|NCT01559935|76156030|FG000|Car Phase|Per protocol|1|||
42319087|NCT01559935|76156030|FG000|Car Phase|Insurance|1|||
42319088|NCT01559935|76156030|FG000|Car Phase|non-compliance|1|||
42319089|NCT01559935|76156030|FG000|BiRD Phase|Toxicity|1|||
42319090|NCT01559935|76156030|FG000|BiRD Phase|Lack of Efficacy|1|||
42319091|NCT01559935|76156030|FG000|BiRD Phase|Withdrawal by Subject|2|||
42319092|NCT01559935|76156030|FG000|Maintenance Phase|Remains on study|28|||
42319093|NCT01559935|76156030|FG000|Maintenance Phase|Toxicity|1|||
42319094|NCT01559935|76156030|FG000|Maintenance Phase|Lack of Efficacy|18|||
42319095|NCT01559935|76156030|FG000|Maintenance Phase|Withdrawal by Subject|5|||
42319096|NCT01559935|76156030|FG000|Maintenance Phase|Non-compliance|2|||
42319097|NCT00981058|76156036|FG000|Overall Study|Adverse Event|1|||
42319098|NCT00981058|76156037|FG001|Overall Study|Adverse Event|1|||
42257812|NCT01064531|76084164|FG001|Overall Study|Withdrawal by Subject|2|||
42257813|NCT01064531|76084163|FG000|Overall Study|Revision due to femoral stem loosening|1|||
42257814|NCT01064531|76084164|FG001|Overall Study|Revision due to femoral stem loosening|0|||
42257815|NCT01064531|76084163|FG000|Overall Study|Revision due to dislocation|0|||
42257816|NCT01064531|76084164|FG001|Overall Study|Revision due to dislocation|1|||
42257817|NCT01064531|76084163|FG000|Overall Study|Death|0|||
42257818|NCT01064531|76084164|FG001|Overall Study|Death|1|||
42257819|NCT02220855|76084170|FG000|Overall Study|Adverse Event|8|||
42257820|NCT02220855|76084170|FG000|Overall Study|Disease Progression|5|||
42257821|NCT02220855|76084170|FG000|Overall Study|Withdrawal by Subject|1|||
42257822|NCT02918279|76084176|FG000|Overall Study|Lost to Follow-up|3|||
42033982|NCT01070550|75842181|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
42257823|NCT02918279|76084177|FG001|Overall Study|Lost to Follow-up|6|||
42257824|NCT02918279|76084176|FG000|Overall Study|Withdrawal by Subject|5|||
42257825|NCT02918279|76084177|FG001|Overall Study|Withdrawal by Subject|15|||
42257826|NCT02918279|76084176|FG000|Overall Study|Withdrawal by parent/guardian|2|||
42033983|NCT01070550|75842182|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
42257827|NCT02918279|76084177|FG001|Overall Study|Withdrawal by parent/guardian|1|||
42257828|NCT02918279|76084176|FG000|Overall Study|Other|3|||
42319099|NCT00981058|76156036|FG000|Overall Study|Progressive Disease|61|||
42319100|NCT00981058|76156037|FG001|Overall Study|Progressive Disease|49|||
42319101|NCT00981058|76156036|FG000|Overall Study|Lost to Follow-up|16|||
42319102|NCT00981058|76156037|FG001|Overall Study|Lost to Follow-up|15|||
42319103|NCT00981058|76156036|FG000|Overall Study|New Anticancer Therapy|6|||
42319104|NCT00981058|76156037|FG001|Overall Study|New Anticancer Therapy|6|||
42319105|NCT00981058|76156036|FG000|Overall Study|Noncompliance|1|||
42319106|NCT00981058|76156037|FG001|Overall Study|Noncompliance|0|||
42319107|NCT00981058|76156036|FG000|Overall Study|Radiologist Error|0|||
42319108|NCT00981058|76156037|FG001|Overall Study|Radiologist Error|1|||
42319109|NCT00981058|76156036|FG000|Overall Study|Randomization Error|1|||
42319110|NCT00981058|76156037|FG001|Overall Study|Randomization Error|2|||
42319111|NCT00981058|76156036|FG000|Overall Study|Withdrawal by Subject|25|||
42319112|NCT00981058|76156037|FG001|Overall Study|Withdrawal by Subject|23|||
42319113|NCT00981058|76156036|FG000|Overall Study|On study treatment at conclusion|9|||
42319114|NCT00981058|76156037|FG001|Overall Study|On study treatment at conclusion|0|||
42257829|NCT02918279|76084177|FG001|Overall Study|Other|1|||
42257830|NCT04268745|76084185|FG000|Overall Study|Lost to Follow-up|2|||
42257831|NCT04268745|76084186|FG001|Overall Study|Lost to Follow-up|3|||
42257832|NCT04268745|76084185|FG000|Overall Study|Withdrawal by Subject|4|||
42257833|NCT04268745|76084186|FG001|Overall Study|Withdrawal by Subject|2|||
42257834|NCT04268745|76084185|FG000|Overall Study|Death in the family|1|||
42257835|NCT04268745|76084186|FG001|Overall Study|Death in the family|0|||
42257836|NCT02956837|76084196|FG000|Overall Study|Serious Adverse Events|0|||
42257837|NCT02956837|76084197|FG001|Overall Study|Serious Adverse Events|1|||
42257838|NCT02956837|76084198|FG002|Overall Study|Serious Adverse Events|0|||
42257839|NCT02956837|76084199|FG003|Overall Study|Serious Adverse Events|0|||
42257840|NCT02956837|76084196|FG000|Overall Study|Withdrawal by Subject|0|||
42257841|NCT02956837|76084197|FG001|Overall Study|Withdrawal by Subject|1|||
42257842|NCT02956837|76084198|FG002|Overall Study|Withdrawal by Subject|0|||
42257843|NCT02956837|76084199|FG003|Overall Study|Withdrawal by Subject|3|||
42257844|NCT02956837|76084196|FG000|Overall Study|Lost to Follow-up|0|||
42257845|NCT02956837|76084197|FG001|Overall Study|Lost to Follow-up|1|||
42257846|NCT02956837|76084198|FG002|Overall Study|Lost to Follow-up|2|||
42257847|NCT02956837|76084199|FG003|Overall Study|Lost to Follow-up|0|||
42257848|NCT01063595|76084212|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
42257849|NCT01063595|76084213|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
42257850|NCT01063595|76084212|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
42257851|NCT01063595|76084213|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
42257852|NCT01063595|76084212|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
42257853|NCT01063595|76084213|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
42257854|NCT01063595|76084212|FG000|First Intervention|Adverse Event|1|||
42319115|NCT00565851|76156051|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
42319116|NCT00565851|76156052|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
42133275|NCT00507728|75944145|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
42319117|NCT00565851|76156053|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
42319118|NCT00565851|76156054|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
42257855|NCT01063595|76084213|FG001|First Intervention|Adverse Event|4|||
42257856|NCT01063595|76084212|FG000|First Intervention|Withdrawal by Subject|1|||
42257857|NCT01063595|76084213|FG001|First Intervention|Withdrawal by Subject|0|||
42257858|NCT01063595|76084212|FG000|First Intervention|Reason not Specified|0|||
42257859|NCT01063595|76084213|FG001|First Intervention|Reason not Specified|1|||
42257860|NCT01063283|76084221|FG000|Cycle 1|Adverse Event|2|||
42257861|NCT01063283|76084222|FG001|Cycle 1|Adverse Event|0|||
42257862|NCT01063283|76084223|FG002|Cycle 1|Adverse Event|0|||
42257863|NCT01063283|76084221|FG000|Cycle 1|Technical failure in data collection|1|||
42257864|NCT01063283|76084222|FG001|Cycle 1|Technical failure in data collection|0|||
42257865|NCT01063283|76084223|FG002|Cycle 1|Technical failure in data collection|0|||
42257866|NCT01062971|76084231|FG000|Overall Study|Protocol Violation|1|||
42257867|NCT01062971|76084232|FG001|Overall Study|Protocol Violation|3|||
42033984|NCT01070550|75842183|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
42257868|NCT01062971|76084231|FG000|Overall Study|Lost to Follow-up|3|||
42257869|NCT01062971|76084232|FG001|Overall Study|Lost to Follow-up|4|||
42257870|NCT01348165|76084245|FG000|Overall Study|Adverse Event|0|||
42319119|NCT00565851|76156055|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
42319120|NCT00565851|76156056|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
42319121|NCT00565851|76156057|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
42319122|NCT00565851|76156058|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
42319123|NCT00565851|76156051|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
42319124|NCT00565851|76156052|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
42319125|NCT00565851|76156053|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
42319126|NCT00565851|76156054|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
42319127|NCT00565851|76156055|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
42319128|NCT00565851|76156056|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
42319129|NCT00565851|76156057|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
42319130|NCT00565851|76156058|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
42319131|NCT00305227|76156082|FG000|Overall Study|Lost to Follow-up|7|||
42319132|NCT00305227|76156083|FG001|Overall Study|Lost to Follow-up|6|||
42319133|NCT01599793|76156091|FG000|Overall Study|Adverse Event|2|||
42319134|NCT01755598|76156106|FG000|Overall Study|Other|109|||
42319135|NCT01755598|76156107|FG001|Overall Study|Other|109|||
42319136|NCT01755598|76156106|FG000|Overall Study|Lost to Follow-up|32|||
42319137|NCT01755598|76156107|FG001|Overall Study|Lost to Follow-up|43|||
42319138|NCT01755598|76156106|FG000|Overall Study|Migrated/moved from study area|76|||
42319139|NCT01755598|76156107|FG001|Overall Study|Migrated/moved from study area|65|||
42319140|NCT01755598|76156106|FG000|Overall Study|Withdrawal by Subject|22|||
42319141|NCT01755598|76156107|FG001|Overall Study|Withdrawal by Subject|31|||
42319142|NCT01755598|76156106|FG000|Overall Study|Protocol Violation|7|||
42319143|NCT01755598|76156107|FG001|Overall Study|Protocol Violation|7|||
42319144|NCT01755598|76156106|FG000|Overall Study|Adverse Event|19|||
42319145|NCT01755598|76156107|FG001|Overall Study|Adverse Event|28|||
42319146|NCT01606306|76156119|FG000|Overall Study|Lack of Efficacy|2|||
42319147|NCT01606306|76156120|FG001|Overall Study|Lack of Efficacy|1|||
42319148|NCT01606306|76156121|FG002|Overall Study|Lack of Efficacy|4|||
42319149|NCT01606306|76156122|FG003|Overall Study|Lack of Efficacy|4|||
42319150|NCT01606306|76156123|FG004|Overall Study|Lack of Efficacy|1|||
42319151|NCT01606306|76156124|FG005|Overall Study|Lack of Efficacy|2|||
42319152|NCT01606306|76156119|FG000|Overall Study|Adverse Event|1|||
42319153|NCT01606306|76156120|FG001|Overall Study|Adverse Event|0|||
42319154|NCT01606306|76156121|FG002|Overall Study|Adverse Event|1|||
42319155|NCT01606306|76156122|FG003|Overall Study|Adverse Event|1|||
42257871|NCT01348165|76084246|FG001|Overall Study|Adverse Event|0|||
42257872|NCT01348165|76084247|FG002|Overall Study|Adverse Event|0|||
42257873|NCT01348165|76084248|FG003|Overall Study|Adverse Event|0|||
42257874|NCT01348165|76084249|FG004|Overall Study|Adverse Event|0|||
42257875|NCT01348165|76084250|FG005|Overall Study|Adverse Event|0|||
42257876|NCT01348165|76084251|FG006|Overall Study|Adverse Event|1|||
42257877|NCT02493868|76084271|FG000|Induction Phase: DE Participants|Adverse Event|22|||
42257878|NCT02493868|76084272|FG001|Induction Phase: DE Participants|Adverse Event|0|||
42257879|NCT02493868|76084271|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
42257880|NCT02493868|76084272|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
42257881|NCT02493868|76084271|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
42257882|NCT02493868|76084272|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
42257883|NCT02493868|76084271|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
42257884|NCT02493868|76084272|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
42319156|NCT01606306|76156123|FG004|Overall Study|Adverse Event|2|||
42319157|NCT01606306|76156124|FG005|Overall Study|Adverse Event|0|||
42133276|NCT00498368|75944161|FG000|Overall Study|Withdrawal by Subject|3|||
42133277|NCT00498368|75944162|FG001|Overall Study|Withdrawal by Subject|2|||
42133278|NCT00385671|75944171|FG000|Overall Study|Adverse Event|14|||
42257885|NCT02493868|76084271|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
42319158|NCT01606306|76156119|FG000|Overall Study|Lost to Follow-up|7|||
42319159|NCT01606306|76156120|FG001|Overall Study|Lost to Follow-up|4|||
42319160|NCT01606306|76156121|FG002|Overall Study|Lost to Follow-up|5|||
42319161|NCT01606306|76156122|FG003|Overall Study|Lost to Follow-up|4|||
42319162|NCT01606306|76156123|FG004|Overall Study|Lost to Follow-up|3|||
42319163|NCT01606306|76156124|FG005|Overall Study|Lost to Follow-up|5|||
42319164|NCT01606306|76156119|FG000|Overall Study|Withdrawal by Subject|4|||
42319165|NCT01606306|76156120|FG001|Overall Study|Withdrawal by Subject|3|||
42319166|NCT01606306|76156121|FG002|Overall Study|Withdrawal by Subject|4|||
42319167|NCT01606306|76156122|FG003|Overall Study|Withdrawal by Subject|4|||
42319168|NCT01606306|76156123|FG004|Overall Study|Withdrawal by Subject|5|||
42319169|NCT01606306|76156124|FG005|Overall Study|Withdrawal by Subject|4|||
42319170|NCT01606306|76156119|FG000|Overall Study|Physician Decision|1|||
42319171|NCT01606306|76156120|FG001|Overall Study|Physician Decision|2|||
42319172|NCT01606306|76156121|FG002|Overall Study|Physician Decision|0|||
42319173|NCT01606306|76156122|FG003|Overall Study|Physician Decision|0|||
42319174|NCT01606306|76156123|FG004|Overall Study|Physician Decision|0|||
42319175|NCT01606306|76156124|FG005|Overall Study|Physician Decision|0|||
42319176|NCT01754194|76156132|FG000|Overall Study|Lost to Follow-up|39|||
42319177|NCT01754194|76156133|FG001|Overall Study|Lost to Follow-up|14|||
42319178|NCT01754194|76156132|FG000|Overall Study|Withdrawal by Subject|4|||
42319179|NCT01754194|76156133|FG001|Overall Study|Withdrawal by Subject|5|||
42319180|NCT01754194|76156132|FG000|Overall Study|Other|9|||
42319181|NCT01754194|76156133|FG001|Overall Study|Other|8|||
42319182|NCT01753570|76156144|FG000|Overall Study|Adverse Event|1|||
42319183|NCT01753570|76156145|FG001|Overall Study|Adverse Event|0|||
42319184|NCT01753570|76156146|FG002|Overall Study|Adverse Event|1|||
42319185|NCT01753570|76156144|FG000|Overall Study|Physician Decision|0|||
42319186|NCT01753570|76156145|FG001|Overall Study|Physician Decision|1|||
42319187|NCT01753570|76156146|FG002|Overall Study|Physician Decision|0|||
42319188|NCT01753570|76156144|FG000|Overall Study|Withdrawal by Subject|1|||
42319189|NCT01753570|76156145|FG001|Overall Study|Withdrawal by Subject|4|||
42319190|NCT01753570|76156146|FG002|Overall Study|Withdrawal by Subject|0|||
42319191|NCT01753336|76156155|FG000|Overall Study|Patient decision|12|||
42319192|NCT01753336|76156155|FG000|Overall Study|Lost to Follow-up|3|||
42319193|NCT01753336|76156155|FG000|Overall Study|Physician Decision|2|||
42319194|NCT01753336|76156155|FG000|Overall Study|Sponsor's decision|2|||
42319195|NCT01753336|76156155|FG000|Overall Study|Withdrawal by Subject|1|||
42319196|NCT01777282|76156164|FG000|Overall Study|Persistent Hyperglycemia|0|||
42319197|NCT01777282|76156165|FG001|Overall Study|Persistent Hyperglycemia|0|||
42319198|NCT01777282|76156166|FG002|Overall Study|Persistent Hyperglycemia|1|||
42319199|NCT01777282|76156167|FG003|Overall Study|Persistent Hyperglycemia|0|||
42319200|NCT01777282|76156168|FG004|Overall Study|Persistent Hyperglycemia|0|||
42319201|NCT01777282|76156164|FG000|Overall Study|New Antidiabetic Medication|0|||
42257886|NCT02493868|76084272|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
42257887|NCT02493868|76084271|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
42257888|NCT02493868|76084272|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
42257889|NCT02493868|76084271|FG000|Induction Phase: DE Participants|Other|8|||
42257890|NCT02493868|76084272|FG001|Induction Phase: DE Participants|Other|0|||
42257891|NCT02493868|76084271|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
42257892|NCT02493868|76084272|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
42257893|NCT02493868|76084271|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
42319202|NCT01777282|76156165|FG001|Overall Study|New Antidiabetic Medication|0|||
42319203|NCT01777282|76156166|FG002|Overall Study|New Antidiabetic Medication|1|||
42319204|NCT01777282|76156167|FG003|Overall Study|New Antidiabetic Medication|0|||
42319205|NCT01777282|76156168|FG004|Overall Study|New Antidiabetic Medication|0|||
42319206|NCT01777282|76156164|FG000|Overall Study|Adverse Event|4|||
42319207|NCT01777282|76156165|FG001|Overall Study|Adverse Event|4|||
42319208|NCT01777282|76156166|FG002|Overall Study|Adverse Event|2|||
42319209|NCT01777282|76156167|FG003|Overall Study|Adverse Event|1|||
42319210|NCT01777282|76156168|FG004|Overall Study|Adverse Event|3|||
42319211|NCT01777282|76156164|FG000|Overall Study|Withdrawal by Subject|4|||
42319212|NCT01777282|76156165|FG001|Overall Study|Withdrawal by Subject|0|||
42133279|NCT00385671|75944172|FG001|Overall Study|Adverse Event|27|||
42133280|NCT00385671|75944173|FG002|Overall Study|Adverse Event|18|||
42257894|NCT02493868|76084272|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
42257895|NCT02493868|76084271|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
42257896|NCT02493868|76084272|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
42257897|NCT02493868|76084271|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
42257898|NCT02493868|76084272|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
42257899|NCT02493868|76084271|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
42257900|NCT02493868|76084272|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
42257901|NCT02493868|76084271|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
42257902|NCT02493868|76084272|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
42257903|NCT02493868|76084271|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
42257904|NCT02493868|76084272|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
42257905|NCT02493868|76084271|FG000|Optimization Phase: DE+TE Participants|Other|10|||
42257906|NCT02493868|76084272|FG001|Optimization Phase: DE+TE Participants|Other|2|||
42257907|NCT02493868|76084271|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
42257908|NCT02493868|76084272|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
42257909|NCT02493868|76084271|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
42257910|NCT02493868|76084272|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
42257911|NCT02493868|76084271|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
42257912|NCT02493868|76084272|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
42257913|NCT02493868|76084271|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
42257914|NCT02493868|76084272|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
42257915|NCT02493868|76084271|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
42257916|NCT02493868|76084272|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
42257917|NCT02493868|76084271|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
42257918|NCT02493868|76084272|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
42257919|NCT02493868|76084271|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
42257920|NCT02493868|76084272|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
42257921|NCT02493868|76084271|FG000|Follow-up Phase|Lost to Follow-up|1|||
42257922|NCT02493868|76084272|FG001|Follow-up Phase|Lost to Follow-up|0|||
42257923|NCT02493868|76084271|FG000|Follow-up Phase|Withdrawal by Subject|3|||
42257924|NCT02493868|76084272|FG001|Follow-up Phase|Withdrawal by Subject|0|||
42257925|NCT02493868|76084271|FG000|Follow-up Phase|Investigator Decision|5|||
42257926|NCT02493868|76084272|FG001|Follow-up Phase|Investigator Decision|1|||
42257927|NCT02493868|76084271|FG000|Follow-up Phase|Other|2|||
42257928|NCT02493868|76084272|FG001|Follow-up Phase|Other|1|||
42257929|NCT02516410|76084286|FG000|Overall Study|Adverse Event|0|||
42257930|NCT02516410|76084287|FG001|Overall Study|Adverse Event|1|||
42257931|NCT02516410|76084286|FG000|Overall Study|Withdrawal by Subject|0|||
42257932|NCT02516410|76084287|FG001|Overall Study|Withdrawal by Subject|1|||
42257933|NCT02493712|76084297|FG000|Overall Study|Withdrawal by Subject|1|||
42257934|NCT02493712|76084298|FG001|Overall Study|Withdrawal by Subject|0|||
42257935|NCT02493712|76084299|FG002|Overall Study|Withdrawal by Subject|2|||
42257936|NCT02493712|76084297|FG000|Overall Study|Protocol Violation|0|||
42257937|NCT02493712|76084298|FG001|Overall Study|Protocol Violation|0|||
42257938|NCT02493712|76084299|FG002|Overall Study|Protocol Violation|1|||
42257939|NCT02493712|76084297|FG000|Overall Study|Lost to Follow-up|1|||
42257940|NCT02493712|76084298|FG001|Overall Study|Lost to Follow-up|0|||
42257941|NCT02493712|76084299|FG002|Overall Study|Lost to Follow-up|0|||
42257942|NCT02493712|76084297|FG000|Overall Study|Physician Decision|0|||
42257943|NCT02493712|76084298|FG001|Overall Study|Physician Decision|1|||
42257944|NCT02493712|76084299|FG002|Overall Study|Physician Decision|0|||
42257945|NCT02493712|76084297|FG000|Overall Study|Lack of Efficacy|0|||
42257946|NCT02493712|76084298|FG001|Overall Study|Lack of Efficacy|5|||
42257947|NCT02493712|76084299|FG002|Overall Study|Lack of Efficacy|3|||
42257948|NCT02516332|76084310|FG000|Overall Study|Withdrawal by Subject|2|||
42257949|NCT02516332|76084311|FG001|Overall Study|Withdrawal by Subject|1|||
42257950|NCT02516332|76084312|FG002|Overall Study|Withdrawal by Subject|2|||
42257951|NCT02483572|76084322|FG000|Overall Study|Withdrawal by Subject|1|||
42257952|NCT02483572|76084323|FG001|Overall Study|Withdrawal by Subject|0|||
42257953|NCT02483572|76084322|FG000|Overall Study|Lost to Follow-up|1|||
42257954|NCT02483572|76084323|FG001|Overall Study|Lost to Follow-up|0|||
42257955|NCT02483572|76084322|FG000|Overall Study|Physician Decision|0|||
42257956|NCT02483572|76084323|FG001|Overall Study|Physician Decision|1|||
42319213|NCT01777282|76156166|FG002|Overall Study|Withdrawal by Subject|0|||
42319214|NCT01777282|76156167|FG003|Overall Study|Withdrawal by Subject|1|||
42319215|NCT01777282|76156168|FG004|Overall Study|Withdrawal by Subject|2|||
42319216|NCT01777282|76156164|FG000|Overall Study|Protocol Violation|2|||
42319217|NCT01777282|76156165|FG001|Overall Study|Protocol Violation|0|||
42319218|NCT01777282|76156166|FG002|Overall Study|Protocol Violation|1|||
42319219|NCT01777282|76156167|FG003|Overall Study|Protocol Violation|0|||
42319220|NCT01777282|76156168|FG004|Overall Study|Protocol Violation|2|||
42319221|NCT01777282|76156164|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
42319222|NCT01777282|76156165|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
42319223|NCT01777282|76156166|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
42319224|NCT01777282|76156167|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
42319225|NCT01777282|76156168|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
42319226|NCT01975389|76156182|FG000|Overall Study|Adverse Event|10|||
42319227|NCT01975389|76156183|FG001|Overall Study|Adverse Event|6|||
42319228|NCT01975389|76156182|FG000|Overall Study|Death|61|||
42319229|NCT01975389|76156183|FG001|Overall Study|Death|54|||
42319230|NCT01975389|76156182|FG000|Overall Study|Lost to Follow-up|81|||
42319231|NCT01975389|76156183|FG001|Overall Study|Lost to Follow-up|86|||
42319232|NCT01975389|76156182|FG000|Overall Study|Withdrawal by Subject|90|||
42319233|NCT01975389|76156183|FG001|Overall Study|Withdrawal by Subject|76|||
42319234|NCT01975389|76156182|FG000|Overall Study|Other|6|||
42319235|NCT01975389|76156183|FG001|Overall Study|Other|9|||
42319236|NCT01975389|76156182|FG000|Overall Study|Randomized, not treated|4|||
42319237|NCT01975389|76156183|FG001|Overall Study|Randomized, not treated|5|||
42319238|NCT01974141|76156191|FG000|Overall Study|Other Reasons|28|||
42319239|NCT01974141|76156192|FG001|Overall Study|Other Reasons|18|||
42319240|NCT01974141|76156191|FG000|Overall Study|Protocol Violation|2|||
42319241|NCT01974141|76156192|FG001|Overall Study|Protocol Violation|6|||
42319242|NCT01974141|76156191|FG000|Overall Study|Personal Reasons|21|||
42319243|NCT01974141|76156192|FG001|Overall Study|Personal Reasons|20|||
42319244|NCT01974141|76156191|FG000|Overall Study|Lost to Follow-up|38|||
42319245|NCT01974141|76156192|FG001|Overall Study|Lost to Follow-up|29|||
42319246|NCT01974141|76156191|FG000|Overall Study|Pregnancy|3|||
42257957|NCT01062425|76084331|FG000|Overall Study|Protocol Violation|3|||
42257958|NCT01062425|76084332|FG001|Overall Study|Protocol Violation|6|||
42257959|NCT01060553|76084338|FG000|Overall Study|Lost to Follow-up|3|||
42257960|NCT01060553|76084339|FG001|Overall Study|Lost to Follow-up|5|||
42257961|NCT01060553|76084338|FG000|Overall Study|Withdrawal by Subject|5|||
42257962|NCT01060553|76084339|FG001|Overall Study|Withdrawal by Subject|5|||
42257963|NCT01060553|76084338|FG000|Overall Study|Lack of Efficacy|1|||
42257964|NCT01060553|76084339|FG001|Overall Study|Lack of Efficacy|0|||
42257965|NCT02491684|76084346|FG000|Treatment Phase|Adverse Event|2|||
42257966|NCT02491684|76084347|FG001|Treatment Phase|Adverse Event|2|||
42257967|NCT02491684|76084346|FG000|Treatment Phase|Incorrect randomisation|1|||
42257968|NCT02491684|76084347|FG001|Treatment Phase|Incorrect randomisation|0|||
42257969|NCT02491684|76084346|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
42257970|NCT02491684|76084347|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
42257971|NCT01061723|76084359|FG000|Overall Study|Adverse Event|0|||
42257972|NCT01061723|76084360|FG001|Overall Study|Adverse Event|2|||
42257973|NCT01061723|76084361|FG002|Overall Study|Adverse Event|5|||
42257974|NCT01061723|76084362|FG003|Overall Study|Adverse Event|5|||
42257975|NCT01061723|76084363|FG004|Overall Study|Adverse Event|2|||
42257976|NCT01061723|76084364|FG005|Overall Study|Adverse Event|6|||
42257977|NCT01061723|76084359|FG000|Overall Study|Lack of Efficacy|2|||
42257978|NCT01061723|76084360|FG001|Overall Study|Lack of Efficacy|3|||
42257979|NCT01061723|76084361|FG002|Overall Study|Lack of Efficacy|4|||
42257980|NCT01061723|76084362|FG003|Overall Study|Lack of Efficacy|2|||
42257981|NCT01061723|76084363|FG004|Overall Study|Lack of Efficacy|1|||
42257982|NCT01061723|76084364|FG005|Overall Study|Lack of Efficacy|1|||
42257983|NCT01061723|76084359|FG000|Overall Study|Randomized but not treated|0|||
42257984|NCT01061723|76084360|FG001|Overall Study|Randomized but not treated|0|||
42257985|NCT01061723|76084361|FG002|Overall Study|Randomized but not treated|0|||
42319247|NCT01974141|76156192|FG001|Overall Study|Pregnancy|3|||
42319248|NCT01974141|76156191|FG000|Overall Study|Lack of Efficacy|0|||
42319249|NCT01974141|76156192|FG001|Overall Study|Lack of Efficacy|1|||
42257986|NCT01061723|76084362|FG003|Overall Study|Randomized but not treated|0|||
42257987|NCT01061723|76084363|FG004|Overall Study|Randomized but not treated|0|||
42257988|NCT01061723|76084364|FG005|Overall Study|Randomized but not treated|1|||
42257989|NCT01061723|76084359|FG000|Overall Study|Other than specified above|2|||
42319250|NCT01974141|76156191|FG000|Overall Study|Adverse Event|4|||
42319251|NCT01974141|76156192|FG001|Overall Study|Adverse Event|5|||
42319252|NCT01945593|76156202|FG000|Overall Study|Adverse Event|0|||
42319253|NCT01945593|76156203|FG001|Overall Study|Adverse Event|0|||
42257990|NCT01061723|76084360|FG001|Overall Study|Other than specified above|1|||
42133281|NCT00385671|75944171|FG000|Overall Study|Lack of Efficacy|5|||
42133282|NCT00385671|75944172|FG001|Overall Study|Lack of Efficacy|9|||
42257991|NCT01061723|76084361|FG002|Overall Study|Other than specified above|1|||
42319254|NCT01945593|76156204|FG002|Overall Study|Adverse Event|0|||
42319255|NCT01945593|76156205|FG003|Overall Study|Adverse Event|5|||
42319256|NCT01945593|76156202|FG000|Overall Study|Physician Decision|0|||
42319257|NCT01945593|76156203|FG001|Overall Study|Physician Decision|0|||
42319258|NCT01945593|76156204|FG002|Overall Study|Physician Decision|1|||
42319259|NCT01945593|76156205|FG003|Overall Study|Physician Decision|1|||
42319260|NCT01945593|76156202|FG000|Overall Study|Withdrawal by Subject|0|||
42319261|NCT01945593|76156203|FG001|Overall Study|Withdrawal by Subject|2|||
42257992|NCT01061723|76084362|FG003|Overall Study|Other than specified above|1|||
42257993|NCT01061723|76084363|FG004|Overall Study|Other than specified above|0|||
42319262|NCT01945593|76156204|FG002|Overall Study|Withdrawal by Subject|0|||
42319263|NCT01945593|76156205|FG003|Overall Study|Withdrawal by Subject|4|||
42319264|NCT01945593|76156202|FG000|Overall Study|Protocol Violation|0|||
42319265|NCT01945593|76156203|FG001|Overall Study|Protocol Violation|2|||
42319266|NCT01945593|76156204|FG002|Overall Study|Protocol Violation|1|||
42319267|NCT01945593|76156205|FG003|Overall Study|Protocol Violation|3|||
42319268|NCT01945593|76156202|FG000|Overall Study|Death|0|||
42319269|NCT01945593|76156203|FG001|Overall Study|Death|0|||
42319270|NCT01945593|76156204|FG002|Overall Study|Death|1|||
42319271|NCT01945593|76156205|FG003|Overall Study|Death|0|||
42319272|NCT01945593|76156202|FG000|Overall Study|Other: Terminated|0|||
42319273|NCT01945593|76156203|FG001|Overall Study|Other: Terminated|0|||
42319274|NCT01945593|76156204|FG002|Overall Study|Other: Terminated|0|||
42319275|NCT01945593|76156205|FG003|Overall Study|Other: Terminated|1|||
42319276|NCT01945593|76156202|FG000|Overall Study|Other: Surgical Procedure|0|||
42319277|NCT01945593|76156203|FG001|Overall Study|Other: Surgical Procedure|2|||
42319278|NCT01945593|76156204|FG002|Overall Study|Other: Surgical Procedure|0|||
42257994|NCT01061723|76084364|FG005|Overall Study|Other than specified above|1|||
42257995|NCT01061567|76084383|FG000|Overall Study|Adverse Event|32|||
42257996|NCT01061567|76084383|FG000|Overall Study|Death|2|||
42257997|NCT01061567|76084383|FG000|Overall Study|Lack of Efficacy|3|||
42257998|NCT01061567|76084383|FG000|Overall Study|Lost to Follow-up|24|||
42257999|NCT01061567|76084383|FG000|Overall Study|Protocol Violation|1|||
42258000|NCT01061567|76084383|FG000|Overall Study|Withdrawal by Subject|11|||
42258001|NCT01061567|76084383|FG000|Overall Study|Other reason than stated above|3|||
42258002|NCT01061333|76084387|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
42258003|NCT01061333|76084388|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
42258004|NCT02489968|76084401|FG000|Open-label Treatment Period|Adverse Event|14|||
42258005|NCT02489968|76084402|FG001|Open-label Treatment Period|Adverse Event|7|||
42258006|NCT02489968|76084403|FG002|Open-label Treatment Period|Adverse Event|0|||
42258007|NCT02489968|76084404|FG003|Open-label Treatment Period|Adverse Event|0|||
42258008|NCT02489968|76084405|FG004|Open-label Treatment Period|Adverse Event|0|||
42258009|NCT02489968|76084406|FG005|Open-label Treatment Period|Adverse Event|0|||
42258010|NCT02489968|76084401|FG000|Open-label Treatment Period|Protocol Violation|2|||
42258011|NCT02489968|76084402|FG001|Open-label Treatment Period|Protocol Violation|2|||
42258012|NCT02489968|76084403|FG002|Open-label Treatment Period|Protocol Violation|0|||
42258013|NCT02489968|76084404|FG003|Open-label Treatment Period|Protocol Violation|0|||
42319279|NCT01945593|76156205|FG003|Overall Study|Other: Surgical Procedure|6|||
42319280|NCT01945593|76156202|FG000|Overall Study|Other: Screen Failure|0|||
42319281|NCT01945593|76156203|FG001|Overall Study|Other: Screen Failure|2|||
42319282|NCT01945593|76156204|FG002|Overall Study|Other: Screen Failure|0|||
42258014|NCT02489968|76084405|FG004|Open-label Treatment Period|Protocol Violation|0|||
42258015|NCT02489968|76084406|FG005|Open-label Treatment Period|Protocol Violation|0|||
42258016|NCT02489968|76084401|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
42258017|NCT02489968|76084402|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
42319283|NCT01945593|76156205|FG003|Overall Study|Other: Screen Failure|0|||
42319284|NCT01945281|76156222|FG000|Overall Study|Adverse Event|1|||
42133283|NCT00385671|75944173|FG002|Overall Study|Lack of Efficacy|5|||
42133284|NCT00385671|75944171|FG000|Overall Study|Lost to Follow-up|6|||
42133285|NCT00385671|75944172|FG001|Overall Study|Lost to Follow-up|6|||
42133286|NCT00385671|75944173|FG002|Overall Study|Lost to Follow-up|5|||
42133287|NCT00385671|75944171|FG000|Overall Study|Physician Decision|2|||
42133288|NCT00385671|75944172|FG001|Overall Study|Physician Decision|1|||
42133289|NCT00385671|75944173|FG002|Overall Study|Physician Decision|2|||
42133290|NCT00385671|75944171|FG000|Overall Study|Protocol Violation|5|||
42133291|NCT00385671|75944172|FG001|Overall Study|Protocol Violation|2|||
42133292|NCT00385671|75944173|FG002|Overall Study|Protocol Violation|1|||
42133293|NCT00385671|75944171|FG000|Overall Study|Sponsor Decision|2|||
42133294|NCT00385671|75944172|FG001|Overall Study|Sponsor Decision|2|||
42133295|NCT00385671|75944173|FG002|Overall Study|Sponsor Decision|1|||
42133296|NCT00385671|75944171|FG000|Overall Study|Withdrawal by Subject|4|||
42133297|NCT00385671|75944172|FG001|Overall Study|Withdrawal by Subject|4|||
42133298|NCT00385671|75944173|FG002|Overall Study|Withdrawal by Subject|4|||
42258018|NCT02489968|76084403|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
42258019|NCT02489968|76084404|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
42258020|NCT02489968|76084405|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
42258021|NCT02489968|76084406|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
42258022|NCT02489968|76084401|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
42258023|NCT02489968|76084402|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
42319285|NCT01945281|76156223|FG001|Overall Study|Adverse Event|0|||
42319286|NCT01945281|76156222|FG000|Overall Study|Death|3|||
42319287|NCT01945281|76156223|FG001|Overall Study|Death|3|||
42319288|NCT01945281|76156222|FG000|Overall Study|Physician Decision|1|||
42319289|NCT01945281|76156223|FG001|Overall Study|Physician Decision|1|||
42319290|NCT01945281|76156222|FG000|Overall Study|Technical Problems|1|||
42319291|NCT01945281|76156223|FG001|Overall Study|Technical Problems|0|||
42319292|NCT01961349|76156232|FG000|Overall Study|Withdrawal by Subject|1|||
42258024|NCT02489968|76084403|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
42258025|NCT02489968|76084404|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
42258026|NCT02489968|76084405|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
42258027|NCT02489968|76084406|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
42258028|NCT02489968|76084401|FG000|Open-label Treatment Period|Other than specified above|204|||
42258029|NCT02489968|76084402|FG001|Open-label Treatment Period|Other than specified above|189|||
42258030|NCT02489968|76084403|FG002|Open-label Treatment Period|Other than specified above|0|||
42258031|NCT02489968|76084404|FG003|Open-label Treatment Period|Other than specified above|0|||
42258032|NCT02489968|76084405|FG004|Open-label Treatment Period|Other than specified above|0|||
42258033|NCT02489968|76084406|FG005|Open-label Treatment Period|Other than specified above|0|||
42258034|NCT02489968|76084401|FG000|Double-blind Treatment Period|Adverse Event|0|||
42258035|NCT02489968|76084402|FG001|Double-blind Treatment Period|Adverse Event|0|||
42258036|NCT02489968|76084403|FG002|Double-blind Treatment Period|Adverse Event|2|||
42258037|NCT02489968|76084404|FG003|Double-blind Treatment Period|Adverse Event|6|||
42258038|NCT02489968|76084405|FG004|Double-blind Treatment Period|Adverse Event|4|||
42258039|NCT02489968|76084406|FG005|Double-blind Treatment Period|Adverse Event|5|||
42258040|NCT02489968|76084401|FG000|Double-blind Treatment Period|Protocol Violation|0|||
42258041|NCT02489968|76084402|FG001|Double-blind Treatment Period|Protocol Violation|0|||
42258042|NCT02489968|76084403|FG002|Double-blind Treatment Period|Protocol Violation|0|||
42258043|NCT02489968|76084404|FG003|Double-blind Treatment Period|Protocol Violation|0|||
42258044|NCT02489968|76084405|FG004|Double-blind Treatment Period|Protocol Violation|1|||
42258045|NCT02489968|76084406|FG005|Double-blind Treatment Period|Protocol Violation|1|||
42258046|NCT02489968|76084401|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
42258047|NCT02489968|76084402|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
42258048|NCT02489968|76084403|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
42319293|NCT01961349|76156233|FG001|Overall Study|Withdrawal by Subject|4|||
42319294|NCT01961349|76156234|FG002|Overall Study|Withdrawal by Subject|0|||
42319295|NCT01961349|76156232|FG000|Overall Study|Adverse Event|0|||
42133299|NCT00497198|75944185|FG000|Overall Study|Adverse Event|4|||
41993881|NCT00474240|75802218|FG000|Overall Study|Withdrawal by Subject|1|||
42133300|NCT00497198|75944186|FG001|Overall Study|Adverse Event|2|||
42258049|NCT02489968|76084404|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
42258050|NCT02489968|76084405|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
42258051|NCT02489968|76084406|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
42258052|NCT02489968|76084401|FG000|Double-blind Treatment Period|Other than specified above|0|||
42133301|NCT00497198|75944185|FG000|Overall Study|Physician Decision|1|||
42133302|NCT00497198|75944186|FG001|Overall Study|Physician Decision|2|||
42133303|NCT00497198|75944185|FG000|Overall Study|Withdrawal by Subject|0|||
42319296|NCT01961349|76156233|FG001|Overall Study|Adverse Event|0|||
42319297|NCT01961349|76156234|FG002|Overall Study|Adverse Event|1|||
42319298|NCT01961349|76156232|FG000|Overall Study|registration error, personal reason etc|2|||
42319299|NCT01961349|76156233|FG001|Overall Study|registration error, personal reason etc|2|||
42319300|NCT01961349|76156234|FG002|Overall Study|registration error, personal reason etc|1|||
42319301|NCT01973595|76156246|FG000|Washout|Withdrawal by Subject|1|||
42319302|NCT01973595|76156247|FG001|Washout|Withdrawal by Subject|0|||
42319303|NCT01973595|76156248|FG002|Washout|Withdrawal by Subject|1|||
42319304|NCT01973595|76156249|FG003|Washout|Withdrawal by Subject|0|||
42319305|NCT01944969|76156260|FG000|Overall Study|Adverse Event|1|||
42319306|NCT01944969|76156260|FG000|Overall Study|Lack of Efficacy|1|||
42319307|NCT01944969|76156260|FG000|Overall Study|Non-compliance with IMP|1|||
42319308|NCT01944969|76156260|FG000|Overall Study|Administrative or other reasons|23|||
42319309|NCT01961115|76156269|FG000|Overall Study|Disease Progression|1|||
42319310|NCT01961115|76156270|FG001|Overall Study|Disease Progression|0|||
42319311|NCT01961115|76156271|FG002|Overall Study|Disease Progression|3|||
42319312|NCT01961115|76156269|FG000|Overall Study|Adverse Event|1|||
42319313|NCT01961115|76156270|FG001|Overall Study|Adverse Event|0|||
42319314|NCT01961115|76156271|FG002|Overall Study|Adverse Event|1|||
42319315|NCT01973439|76156279|FG000|Overall Study|Lost samples from one PK Day|2|||
42319316|NCT01973439|76156279|FG000|Overall Study|Vomiting after commencing once daily|1|||
42319317|NCT01973439|76156279|FG000|Overall Study|PK curve incomplete|2|||
42319318|NCT01973283|76156283|FG000|Overall Study|Lost to Follow-up|4|||
42319319|NCT01943799|76156293|FG000|Overall Study|Lost to Follow-up|0|||
42319320|NCT01943799|76156294|FG001|Overall Study|Lost to Follow-up|1|||
42319321|NCT01943799|76156295|FG002|Overall Study|Lost to Follow-up|1|||
42319322|NCT01943799|76156296|FG003|Overall Study|Lost to Follow-up|0|||
42319323|NCT01943799|76156293|FG000|Overall Study|Protocol Violation|1|||
42319324|NCT01943799|76156294|FG001|Overall Study|Protocol Violation|0|||
42319325|NCT01943799|76156295|FG002|Overall Study|Protocol Violation|0|||
42319326|NCT01943799|76156296|FG003|Overall Study|Protocol Violation|0|||
42319327|NCT01943799|76156293|FG000|Overall Study|Withdrawal by Subject|4|||
42319328|NCT01943799|76156294|FG001|Overall Study|Withdrawal by Subject|2|||
42319329|NCT01943799|76156295|FG002|Overall Study|Withdrawal by Subject|1|||
42319330|NCT01943799|76156296|FG003|Overall Study|Withdrawal by Subject|0|||
42319331|NCT01972659|76156308|FG000|Overall Study|Protocol Violation|2|||
42258053|NCT02489968|76084402|FG001|Double-blind Treatment Period|Other than specified above|0|||
42258054|NCT02489968|76084403|FG002|Double-blind Treatment Period|Other than specified above|0|||
42258055|NCT02489968|76084404|FG003|Double-blind Treatment Period|Other than specified above|0|||
42258056|NCT02489968|76084405|FG004|Double-blind Treatment Period|Other than specified above|1|||
42258057|NCT02489968|76084406|FG005|Double-blind Treatment Period|Other than specified above|0|||
42258058|NCT02483416|76084420|FG000|Overall Study|Other reason|0|||
42258059|NCT02483416|76084421|FG001|Overall Study|Other reason|1|||
42258060|NCT02483416|76084420|FG000|Overall Study|Treatment stop|3|||
42258061|NCT02483416|76084421|FG001|Overall Study|Treatment stop|0|||
42319332|NCT01972659|76156309|FG001|Overall Study|Protocol Violation|2|||
42319333|NCT01972659|76156308|FG000|Overall Study|problems realted to acceleromyograph|2|||
42319334|NCT01972659|76156309|FG001|Overall Study|problems realted to acceleromyograph|1|||
42319335|NCT01971723|76156317|FG000|Overall Study|Withdrawal by Subject|1|||
42319336|NCT01971723|76156318|FG001|Overall Study|Withdrawal by Subject|1|||
42319337|NCT01971723|76156317|FG000|Overall Study|Protocol Violation|1|||
42258062|NCT01061177|76084428|FG000|Overall Study|Adverse Event|117|||
42258063|NCT01061177|76084428|FG000|Overall Study|Withdrawal by Subject|27|||
42258064|NCT01061177|76084428|FG000|Overall Study|Disease progression|17|||
42319338|NCT01971723|76156318|FG001|Overall Study|Protocol Violation|2|||
42319339|NCT01942785|76156324|FG000|Overall Study|Adverse Event|2|||
42319340|NCT01942785|76156324|FG000|Overall Study|Withdrawal by Subject|1|||
42319341|NCT01942785|76156324|FG000|Overall Study|Protocol Violation|1|||
42319342|NCT01774786|76156332|FG000|Overall Study|Death|300|||
42319343|NCT01774786|76156333|FG001|Overall Study|Death|319|||
42319344|NCT01774786|76156332|FG000|Overall Study|Lost to Follow-up|6|||
42319345|NCT01774786|76156333|FG001|Overall Study|Lost to Follow-up|7|||
42319346|NCT01774786|76156332|FG000|Overall Study|Withdrawal by Subject|18|||
42319347|NCT01774786|76156333|FG001|Overall Study|Withdrawal by Subject|14|||
42319348|NCT01774786|76156332|FG000|Overall Study|Physician Decision|2|||
42319349|NCT01774786|76156333|FG001|Overall Study|Physician Decision|0|||
42319350|NCT01774786|76156332|FG000|Overall Study|Non-compliance|0|||
42319351|NCT01774786|76156333|FG001|Overall Study|Non-compliance|1|||
42319352|NCT01774786|76156332|FG000|Overall Study|Reason Not Specified|2|||
42319353|NCT01774786|76156333|FG001|Overall Study|Reason Not Specified|5|||
42319354|NCT01960725|76156341|FG000|Overall Study|Lost to Follow-up|4|||
42319355|NCT01960725|76156342|FG001|Overall Study|Lost to Follow-up|3|||
42319356|NCT01960725|76156341|FG000|Overall Study|Withdrawal by Subject|1|||
42319357|NCT01960725|76156342|FG001|Overall Study|Withdrawal by Subject|0|||
42319358|NCT01960725|76156341|FG000|Overall Study|unable to obtain blood sample|1|||
42319359|NCT01960725|76156342|FG001|Overall Study|unable to obtain blood sample|2|||
42319360|NCT01942161|76156351|FG000|Overall Study|Adverse Event|1|||
42319361|NCT01942161|76156352|FG001|Overall Study|Adverse Event|2|||
42319362|NCT01942161|76156353|FG002|Overall Study|Adverse Event|5|||
42319363|NCT01942161|76156351|FG000|Overall Study|Physician Decision|3|||
42319364|NCT01942161|76156352|FG001|Overall Study|Physician Decision|1|||
41993882|NCT00474240|75802219|FG001|Overall Study|Withdrawal by Subject|1|||
41993883|NCT00474240|75802220|FG002|Overall Study|Withdrawal by Subject|0|||
41993884|NCT00474240|75802221|FG003|Overall Study|Withdrawal by Subject|2|||
41993885|NCT00474240|75802222|FG004|Overall Study|Withdrawal by Subject|3|||
41993886|NCT00474240|75802223|FG005|Overall Study|Withdrawal by Subject|1|||
41993887|NCT00474240|75802218|FG000|Overall Study|Adverse Event|0|||
41993888|NCT00474240|75802219|FG001|Overall Study|Adverse Event|0|||
42319365|NCT01942161|76156353|FG002|Overall Study|Physician Decision|0|||
42319366|NCT01942161|76156351|FG000|Overall Study|Protocol Violation|1|||
42319367|NCT01942161|76156352|FG001|Overall Study|Protocol Violation|0|||
42319368|NCT01942161|76156353|FG002|Overall Study|Protocol Violation|0|||
42319369|NCT01942161|76156351|FG000|Overall Study|Withdrawal by Subject|3|||
42319370|NCT01942161|76156352|FG001|Overall Study|Withdrawal by Subject|3|||
42319371|NCT01942161|76156353|FG002|Overall Study|Withdrawal by Subject|1|||
42319372|NCT01971645|76156364|FG000|Overall Study|Adverse Event|1|||
42319373|NCT01971645|76156365|FG001|Overall Study|Adverse Event|0|||
42319374|NCT01971645|76156366|FG002|Overall Study|Adverse Event|0|||
42319375|NCT01971645|76156364|FG000|Overall Study|Lost to Follow-up|1|||
42319376|NCT01971645|76156365|FG001|Overall Study|Lost to Follow-up|0|||
42319377|NCT01971645|76156366|FG002|Overall Study|Lost to Follow-up|1|||
42319378|NCT01971645|76156364|FG000|Overall Study|Protocol Violation|0|||
42319379|NCT01971645|76156365|FG001|Overall Study|Protocol Violation|0|||
42319380|NCT01971645|76156366|FG002|Overall Study|Protocol Violation|1|||
42319381|NCT01941537|76156376|FG000|Overall Study|Lack of Efficacy|1|||
42319382|NCT01941537|76156377|FG001|Overall Study|Lack of Efficacy|2|||
42319383|NCT01941537|76156376|FG000|Overall Study|Lost to Follow-up|1|||
42319384|NCT01941537|76156377|FG001|Overall Study|Lost to Follow-up|0|||
42319385|NCT01941537|76156376|FG000|Overall Study|Pregnancy|1|||
42319386|NCT01941537|76156377|FG001|Overall Study|Pregnancy|0|||
42319387|NCT01941537|76156376|FG000|Overall Study|Adverse Event|1|||
42319388|NCT01941537|76156377|FG001|Overall Study|Adverse Event|0|||
42319389|NCT01941537|76156376|FG000|Overall Study|Withdrawal by Subject|0|||
42319390|NCT01941537|76156377|FG001|Overall Study|Withdrawal by Subject|1|||
42319391|NCT01971567|76156386|FG000|Overall Study|Withdrawal by Subject|3|||
42319392|NCT01971567|76156387|FG001|Overall Study|Withdrawal by Subject|2|||
42319393|NCT01971567|76156386|FG000|Overall Study|Lost to Follow-up|1|||
42319394|NCT01971567|76156387|FG001|Overall Study|Lost to Follow-up|0|||
42319395|NCT01960413|76156395|FG000|Overall Study|Withdrawal by Subject|1|||
42319396|NCT01960413|76156396|FG001|Overall Study|Withdrawal by Subject|1|||
42319397|NCT01960413|76156395|FG000|Overall Study|Physician Decision|1|||
42319398|NCT01960413|76156396|FG001|Overall Study|Physician Decision|0|||
42319399|NCT01960413|76156395|FG000|Overall Study|Lost to Follow-up|2|||
42319400|NCT01960413|76156396|FG001|Overall Study|Lost to Follow-up|0|||
42319401|NCT01970475|76156404|FG000|Overall Study|Withdrawal by Subject|11|||
42319402|NCT01970475|76156405|FG001|Overall Study|Withdrawal by Subject|6|||
42319403|NCT01970475|76156404|FG000|Overall Study|Adverse Event|7|||
42319404|NCT01970475|76156405|FG001|Overall Study|Adverse Event|3|||
42319405|NCT01970475|76156404|FG000|Overall Study|Lost to Follow-up|2|||
42319406|NCT01970475|76156405|FG001|Overall Study|Lost to Follow-up|2|||
42319407|NCT01970475|76156404|FG000|Overall Study|Protocol Violation|1|||
42319408|NCT01970475|76156405|FG001|Overall Study|Protocol Violation|0|||
42319409|NCT01939977|76156413|FG000|Overall Study|Adverse Event|4|||
42319410|NCT01939977|76156414|FG001|Overall Study|Adverse Event|3|||
42319411|NCT01939977|76156413|FG000|Overall Study|Lack of Efficacy|3|||
42319412|NCT01939977|76156414|FG001|Overall Study|Lack of Efficacy|0|||
42319413|NCT01939977|76156413|FG000|Overall Study|Physician Decision|1|||
42319414|NCT01939977|76156414|FG001|Overall Study|Physician Decision|1|||
42319415|NCT01939977|76156413|FG000|Overall Study|Withdrawal by Subject|0|||
42319416|NCT01939977|76156414|FG001|Overall Study|Withdrawal by Subject|2|||
42319417|NCT01939977|76156413|FG000|Overall Study|Did not meet inclusion criteria|1|||
42319418|NCT01939977|76156414|FG001|Overall Study|Did not meet inclusion criteria|0|||
42319419|NCT01939977|76156413|FG000|Overall Study|Did not receive study medication|0|||
42319420|NCT01939977|76156414|FG001|Overall Study|Did not receive study medication|1|||
42319421|NCT01939899|76156425|FG000|Lead-in Dose Finding Phase|Death|0|||
42319422|NCT01939899|76156426|FG001|Lead-in Dose Finding Phase|Death|3|||
42319423|NCT01939899|76156427|FG002|Lead-in Dose Finding Phase|Death|1|||
42319424|NCT01939899|76156428|FG003|Lead-in Dose Finding Phase|Death|0|||
42319425|NCT01939899|76156429|FG004|Lead-in Dose Finding Phase|Death|0|||
42319426|NCT01939899|76156425|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
42319427|NCT01939899|76156426|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
42319428|NCT01939899|76156427|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
42319429|NCT01939899|76156428|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
42319430|NCT01939899|76156429|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
42319431|NCT01939899|76156425|FG000|Lead-in Dose Finding Phase|Other|0|||
42319432|NCT01939899|76156426|FG001|Lead-in Dose Finding Phase|Other|0|||
42319433|NCT01939899|76156427|FG002|Lead-in Dose Finding Phase|Other|1|||
42319434|NCT01939899|76156428|FG003|Lead-in Dose Finding Phase|Other|0|||
42319435|NCT01939899|76156429|FG004|Lead-in Dose Finding Phase|Other|0|||
42319436|NCT01939899|76156425|FG000|Phase 2|Withdrawal by Subject|0|||
42319437|NCT01939899|76156426|FG001|Phase 2|Withdrawal by Subject|0|||
42319438|NCT01939899|76156427|FG002|Phase 2|Withdrawal by Subject|0|||
42319439|NCT01939899|76156428|FG003|Phase 2|Withdrawal by Subject|2|||
42319440|NCT01939899|76156429|FG004|Phase 2|Withdrawal by Subject|0|||
42319441|NCT01939899|76156425|FG000|Phase 2|Disease Progression|0|||
42133304|NCT00497198|75944186|FG001|Overall Study|Withdrawal by Subject|1|||
42133305|NCT00496964|75944194|FG000|Overall Study|Withdrawal by Subject|0|||
42319442|NCT01939899|76156426|FG001|Phase 2|Disease Progression|0|||
42319443|NCT01939899|76156427|FG002|Phase 2|Disease Progression|0|||
42319444|NCT01939899|76156428|FG003|Phase 2|Disease Progression|9|||
42319445|NCT01939899|76156429|FG004|Phase 2|Disease Progression|1|||
42319446|NCT01970397|76156449|FG000|Overall Study|Adverse Event|0|||
42319447|NCT01970397|76156450|FG001|Overall Study|Adverse Event|1|||
42319448|NCT01970397|76156449|FG000|Overall Study|Lost to Follow-up|0|||
42319449|NCT01970397|76156450|FG001|Overall Study|Lost to Follow-up|1|||
42319450|NCT01970397|76156449|FG000|Overall Study|Personal Reasons|1|||
42319451|NCT01970397|76156450|FG001|Overall Study|Personal Reasons|2|||
42319452|NCT01970397|76156449|FG000|Overall Study|Protocol Violation|1|||
42319453|NCT01970397|76156450|FG001|Overall Study|Protocol Violation|1|||
42319454|NCT01970241|76156458|FG000|Overall Study|Withdrawal by Subject|2|||
42319455|NCT01970241|76156459|FG001|Overall Study|Withdrawal by Subject|0|||
42319456|NCT01970241|76156458|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
42319457|NCT01970241|76156459|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
42319458|NCT01939353|76156467|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
42319459|NCT01939353|76156467|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
42319460|NCT01939353|76156467|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
42319461|NCT01939353|76156467|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
42319462|NCT01939353|76156467|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
42319463|NCT01970007|76156471|FG000|Overall Study|Death|5|||
42319464|NCT01970007|76156471|FG000|Overall Study|Withdrawal by Subject|23|||
42319465|NCT01970007|76156471|FG000|Overall Study|Lost to Follow-up|24|||
42319466|NCT01970007|76156471|FG000|Overall Study|"Other endpoint"|3|||
42319467|NCT01728376|76156481|FG000|Overall Study|Adverse Event|1|||
42319468|NCT01728376|76156482|FG001|Overall Study|Adverse Event|1|||
42319469|NCT01728376|76156483|FG002|Overall Study|Adverse Event|1|||
42319470|NCT01728376|76156484|FG003|Overall Study|Adverse Event|1|||
42319471|NCT01728376|76156485|FG004|Overall Study|Adverse Event|1|||
42319472|NCT01728376|76156486|FG005|Overall Study|Adverse Event|0|||
42319473|NCT01728376|76156481|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
42319474|NCT01728376|76156482|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
42319475|NCT01728376|76156483|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
42319476|NCT01728376|76156484|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
42319477|NCT01728376|76156485|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
42033985|NCT01070550|75842184|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
42033986|NCT01070550|75842185|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
42319478|NCT01728376|76156486|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
42319479|NCT01728376|76156481|FG000|Overall Study|No relevant bacteria|2|||
42319480|NCT01728376|76156482|FG001|Overall Study|No relevant bacteria|0|||
42319481|NCT01728376|76156483|FG002|Overall Study|No relevant bacteria|0|||
42033987|NCT01070550|75842186|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
42319482|NCT01728376|76156484|FG003|Overall Study|No relevant bacteria|0|||
42319483|NCT01728376|76156485|FG004|Overall Study|No relevant bacteria|1|||
42319484|NCT01728376|76156486|FG005|Overall Study|No relevant bacteria|1|||
42319485|NCT01728376|76156481|FG000|Overall Study|Did not receive treatment|0|||
42319486|NCT01728376|76156482|FG001|Overall Study|Did not receive treatment|1|||
42319487|NCT01728376|76156483|FG002|Overall Study|Did not receive treatment|0|||
42319488|NCT01728376|76156484|FG003|Overall Study|Did not receive treatment|0|||
42319489|NCT01728376|76156485|FG004|Overall Study|Did not receive treatment|0|||
42319490|NCT01728376|76156486|FG005|Overall Study|Did not receive treatment|0|||
42319491|NCT01728376|76156481|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
42319492|NCT01728376|76156482|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
42319493|NCT01728376|76156483|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
42319494|NCT01728376|76156484|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
42319495|NCT01728376|76156485|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
42319496|NCT01728376|76156486|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
42319497|NCT01708174|76156503|FG000|Treatment Period|Withdrawal by Subject|1|||
42319498|NCT01708174|76156504|FG001|Treatment Period|Withdrawal by Subject|0|||
42319499|NCT01708174|76156505|FG002|Treatment Period|Withdrawal by Subject|0|||
42319500|NCT01708174|76156503|FG000|Treatment Period|Progressive disease|0|||
42319501|NCT01708174|76156504|FG001|Treatment Period|Progressive disease|1|||
42319502|NCT01708174|76156505|FG002|Treatment Period|Progressive disease|0|||
42319503|NCT01708174|76156503|FG000|Treatment Period|Death|0|||
42319504|NCT01708174|76156504|FG001|Treatment Period|Death|0|||
42319505|NCT01708174|76156505|FG002|Treatment Period|Death|1|||
42319506|NCT01708174|76156503|FG000|Treatment Period|Adverse Event|0|||
42319507|NCT01708174|76156504|FG001|Treatment Period|Adverse Event|1|||
42319508|NCT01708174|76156505|FG002|Treatment Period|Adverse Event|0|||
42319509|NCT01605916|76156519|FG000|Overall Study|Adverse Event|1|||
42319510|NCT01605916|76156520|FG001|Overall Study|Adverse Event|0|||
42319511|NCT01605916|76156521|FG002|Overall Study|Adverse Event|0|||
42319512|NCT01605916|76156522|FG003|Overall Study|Adverse Event|1|||
42319513|NCT01605916|76156523|FG004|Overall Study|Adverse Event|0|||
42319514|NCT01605916|76156519|FG000|Overall Study|Lack of Efficacy|2|||
42319515|NCT01605916|76156520|FG001|Overall Study|Lack of Efficacy|3|||
42319516|NCT01605916|76156521|FG002|Overall Study|Lack of Efficacy|3|||
42319517|NCT01605916|76156522|FG003|Overall Study|Lack of Efficacy|5|||
42258065|NCT01061177|76084428|FG000|Overall Study|Protocol Violation|11|||
42258066|NCT01061177|76084428|FG000|Overall Study|Lost to Follow-up|9|||
42258067|NCT01061177|76084428|FG000|Overall Study|New cancer therapy|9|||
42258068|NCT01061177|76084428|FG000|Overall Study|Abnormal laboratory values|6|||
42258069|NCT01061177|76084428|FG000|Overall Study|Abnormal test procedure results|4|||
42258070|NCT01061177|76084428|FG000|Overall Study|Administratie problems|4|||
42258071|NCT01061177|76084428|FG000|Overall Study|Death|4|||
42258072|NCT02481934|76084432|FG000|Overall Study|Death|2|||
42258073|NCT02973425|76084438|FG000|Overall Study|Lost to Follow-up|49|||
42258074|NCT02973425|76084439|FG001|Overall Study|Lost to Follow-up|53|||
42258075|NCT02489500|76084448|FG000|Overall Study|Death|1|||
42258076|NCT02489500|76084449|FG001|Overall Study|Death|1|||
42258077|NCT02732847|76084457|FG000|Overall Study|some filled early|42|||
42258078|NCT02732847|76084458|FG001|Overall Study|some filled early|42|||
42258079|NCT02489344|76084464|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
42258080|NCT02489344|76084464|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
42258081|NCT02489344|76084464|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
42258082|NCT02489344|76084464|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
42258083|NCT02488330|76084468|FG000|Overall Study|Adverse Event|1|||
42319518|NCT01605916|76156523|FG004|Overall Study|Lack of Efficacy|4|||
42319519|NCT01605916|76156519|FG000|Overall Study|Withdrawal by Subject|1|||
42258084|NCT02488330|76084468|FG000|Overall Study|Physician Decision|2|||
42258085|NCT02488330|76084468|FG000|Overall Study|Death|2|||
42258086|NCT02488330|76084468|FG000|Overall Study|Disease Progression|3|||
42258087|NCT02488330|76084468|FG000|Overall Study|Study Termination by Sponsor|4|||
42319520|NCT01605916|76156520|FG001|Overall Study|Withdrawal by Subject|1|||
42319521|NCT01605916|76156521|FG002|Overall Study|Withdrawal by Subject|0|||
42319522|NCT01605916|76156522|FG003|Overall Study|Withdrawal by Subject|0|||
42319523|NCT01605916|76156523|FG004|Overall Study|Withdrawal by Subject|2|||
42319524|NCT01635283|76156536|FG000|Overall Study|Tumor Progression|3|||
42319525|NCT01635283|76156536|FG000|Overall Study|Lost to Follow-up|1|||
42319526|NCT01707004|76156543|FG000|Overall Study|Physician Decision|3|||
42319527|NCT01939197|76156555|FG000|Overall Study|Withdrawal by Subject|1|||
42319528|NCT01939197|76156556|FG001|Overall Study|Withdrawal by Subject|0|||
42319529|NCT01939197|76156557|FG002|Overall Study|Withdrawal by Subject|0|||
42319530|NCT01939197|76156558|FG003|Overall Study|Withdrawal by Subject|0|||
42319531|NCT01939197|76156559|FG004|Overall Study|Withdrawal by Subject|1|||
42319532|NCT01939197|76156560|FG005|Overall Study|Withdrawal by Subject|0|||
42319533|NCT01939197|76156561|FG006|Overall Study|Withdrawal by Subject|0|||
42319534|NCT01939197|76156555|FG000|Overall Study|Lost to Follow-up|0|||
42319535|NCT01939197|76156556|FG001|Overall Study|Lost to Follow-up|1|||
42319536|NCT01939197|76156557|FG002|Overall Study|Lost to Follow-up|0|||
42319537|NCT01939197|76156558|FG003|Overall Study|Lost to Follow-up|1|||
42319538|NCT01939197|76156559|FG004|Overall Study|Lost to Follow-up|3|||
42319539|NCT01939197|76156560|FG005|Overall Study|Lost to Follow-up|1|||
42319540|NCT01939197|76156561|FG006|Overall Study|Lost to Follow-up|2|||
42319541|NCT01969851|76156594|FG000|Overall Study|Adverse Event|0|||
42319542|NCT01969851|76156595|FG001|Overall Study|Adverse Event|0|||
42319543|NCT01969851|76156596|FG002|Overall Study|Adverse Event|3|||
42319544|NCT01969851|76156594|FG000|Overall Study|Lack of Efficacy|0|||
42319545|NCT01969851|76156595|FG001|Overall Study|Lack of Efficacy|3|||
42319546|NCT01969851|76156596|FG002|Overall Study|Lack of Efficacy|1|||
42319547|NCT01969851|76156594|FG000|Overall Study|Withdrawal by Subject|1|||
42319548|NCT01969851|76156595|FG001|Overall Study|Withdrawal by Subject|0|||
42319549|NCT01969851|76156596|FG002|Overall Study|Withdrawal by Subject|1|||
42319550|NCT01969851|76156594|FG000|Overall Study|No effective dose in Titration period|0|||
42319551|NCT01969851|76156595|FG001|Overall Study|No effective dose in Titration period|0|||
42319552|NCT01969851|76156596|FG002|Overall Study|No effective dose in Titration period|1|||
42319553|NCT01969851|76156594|FG000|Overall Study|Sponsor decision|0|||
42319554|NCT01969851|76156595|FG001|Overall Study|Sponsor decision|0|||
42133306|NCT00496964|75944195|FG001|Overall Study|Withdrawal by Subject|1|||
42133307|NCT00490490|75944203|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
42319555|NCT01969851|76156596|FG002|Overall Study|Sponsor decision|1|||
42319556|NCT01938573|76156604|FG000|Overall Study|Lack of Efficacy|1|||
42319557|NCT01938573|76156605|FG001|Overall Study|Lack of Efficacy|0|||
42319558|NCT01938573|76156604|FG000|Overall Study|Operation at other hospital|1|||
42319559|NCT01938573|76156605|FG001|Overall Study|Operation at other hospital|0|||
42319560|NCT01937871|76156613|FG000|Overall Study|Adverse Event|6|||
42319561|NCT01937871|76156614|FG001|Overall Study|Adverse Event|6|||
42319562|NCT01937871|76156615|FG002|Overall Study|Adverse Event|2|||
42319563|NCT01937871|76156613|FG000|Overall Study|Lost to Follow-up|8|||
42319564|NCT01937871|76156614|FG001|Overall Study|Lost to Follow-up|2|||
42319565|NCT01937871|76156615|FG002|Overall Study|Lost to Follow-up|4|||
42319566|NCT01937871|76156613|FG000|Overall Study|Withdrawal by Subject|9|||
42319567|NCT01937871|76156614|FG001|Overall Study|Withdrawal by Subject|6|||
42319568|NCT01937871|76156615|FG002|Overall Study|Withdrawal by Subject|4|||
42319569|NCT01937871|76156613|FG000|Overall Study|Physician Decision|0|||
42319570|NCT01937871|76156614|FG001|Overall Study|Physician Decision|1|||
42319571|NCT01937871|76156615|FG002|Overall Study|Physician Decision|0|||
42319572|NCT01937871|76156613|FG000|Overall Study|Entry Criteria Not Met|1|||
42319573|NCT01937871|76156614|FG001|Overall Study|Entry Criteria Not Met|2|||
42319574|NCT01937871|76156615|FG002|Overall Study|Entry Criteria Not Met|1|||
42319575|NCT01269463|76156626|FG000|First Intervention|Withdrawal by Subject|1|||
42319576|NCT01269463|76156627|FG001|First Intervention|Withdrawal by Subject|0|||
42319577|NCT01269463|76156626|FG000|First Intervention|Adverse Event|1|||
42319578|NCT01269463|76156627|FG001|First Intervention|Adverse Event|0|||
42319579|NCT01269463|76156626|FG000|First Intervention|Lack of Efficacy|0|||
42319580|NCT01269463|76156627|FG001|First Intervention|Lack of Efficacy|1|||
42319581|NCT01269463|76156626|FG000|First Intervention|Physician Decision|0|||
42319582|NCT01269463|76156627|FG001|First Intervention|Physician Decision|1|||
42319583|NCT01706926|76156642|FG000|Overall Study|Lost to Follow-up|0|||
42319584|NCT01706926|76156643|FG001|Overall Study|Lost to Follow-up|0|||
42319585|NCT01706926|76156644|FG002|Overall Study|Lost to Follow-up|1|||
42319586|NCT01706926|76156645|FG003|Overall Study|Lost to Follow-up|0|||
42319587|NCT01706926|76156642|FG000|Overall Study|Withdrawal by Subject|2|||
42319588|NCT01706926|76156643|FG001|Overall Study|Withdrawal by Subject|0|||
42319589|NCT01706926|76156644|FG002|Overall Study|Withdrawal by Subject|1|||
42319590|NCT01706926|76156645|FG003|Overall Study|Withdrawal by Subject|2|||
42319591|NCT01706926|76156642|FG000|Overall Study|Other|4|||
42319592|NCT01706926|76156643|FG001|Overall Study|Other|4|||
42319593|NCT01706926|76156644|FG002|Overall Study|Other|4|||
42319594|NCT01706926|76156645|FG003|Overall Study|Other|3|||
42319595|NCT01634113|76156661|FG000|Overall Study|Not treated|0|||
42319596|NCT01634113|76156662|FG001|Overall Study|Not treated|0|||
42319597|NCT01634113|76156663|FG002|Overall Study|Not treated|1|||
42319598|NCT01706770|76156673|FG000|Overall Study|Lost to Follow-up|1|||
42319599|NCT01706770|76156674|FG001|Overall Study|Lost to Follow-up|0|||
42319600|NCT01706770|76156673|FG000|Overall Study|Physician Decision|1|||
42319601|NCT01706770|76156674|FG001|Overall Study|Physician Decision|0|||
42319602|NCT01937715|76156685|FG000|Overall Study|Death|0|||
42319603|NCT01937715|76156686|FG001|Overall Study|Death|0|||
42319604|NCT01937715|76156687|FG002|Overall Study|Death|0|||
42258088|NCT02481310|76084475|FG000|Follow up|Still in follow up|0|||
42258089|NCT02481310|76084476|FG001|Follow up|Still in follow up|3|||
42258090|NCT02481310|76084477|FG002|Follow up|Still in follow up|0|||
42258091|NCT02480764|76084484|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
42258092|NCT02480764|76084485|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
42258093|NCT02480764|76084486|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
42258094|NCT02480764|76084484|FG000|Overall Study|Major Protocol Deviation|1|||
42258095|NCT02480764|76084485|FG001|Overall Study|Major Protocol Deviation|4|||
42258096|NCT02480764|76084486|FG002|Overall Study|Major Protocol Deviation|3|||
42258097|NCT02480764|76084484|FG000|Overall Study|Lost to Follow-up|0|||
42258098|NCT02480764|76084485|FG001|Overall Study|Lost to Follow-up|1|||
42258099|NCT02480764|76084486|FG002|Overall Study|Lost to Follow-up|2|||
42258100|NCT02480764|76084484|FG000|Overall Study|Voluntary Withdrawal|6|||
42258101|NCT02480764|76084485|FG001|Overall Study|Voluntary Withdrawal|5|||
42258102|NCT02480764|76084486|FG002|Overall Study|Voluntary Withdrawal|10|||
42258103|NCT02480764|76084484|FG000|Overall Study|Lack of Efficacy|0|||
42258104|NCT02480764|76084485|FG001|Overall Study|Lack of Efficacy|3|||
42258105|NCT02480764|76084486|FG002|Overall Study|Lack of Efficacy|3|||
42258106|NCT02480764|76084484|FG000|Overall Study|Reason not Specified|0|||
42258107|NCT02480764|76084485|FG001|Overall Study|Reason not Specified|1|||
42133308|NCT00490490|75944203|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
42133309|NCT00385593|75944209|FG000|Overall Study|Adverse Event|3|||
42258108|NCT02480764|76084486|FG002|Overall Study|Reason not Specified|0|||
42258109|NCT02487472|76084494|FG000|Overall Study|Did not complete telephonic interviews|9|||
42319605|NCT01937715|76156688|FG003|Overall Study|Death|1|||
42319606|NCT01937715|76156689|FG004|Overall Study|Death|0|||
42258110|NCT02487472|76084494|FG000|Overall Study|Other|2|||
42258111|NCT02451670|76084502|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
42258112|NCT02451670|76084503|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
42258113|NCT02486692|76084511|FG000|Overall Study|did not login for randomization|4|||
42258114|NCT02486692|76084512|FG001|Overall Study|did not login for randomization|7|||
42258115|NCT01060007|76084529|FG000|Overall Study|Withdrawal by Subject|1|||
42258116|NCT01060007|76084529|FG000|Overall Study|Inevaluable for response at surgery|3|||
42258117|NCT02971163|76084538|FG000|Overall Study|Lost to Follow-up|4|||
42258118|NCT02971163|76084539|FG001|Overall Study|Lost to Follow-up|2|||
42319607|NCT01937715|76156685|FG000|Overall Study|Withdrawal by Subject|0|||
42319608|NCT01937715|76156686|FG001|Overall Study|Withdrawal by Subject|1|||
42319609|NCT01937715|76156687|FG002|Overall Study|Withdrawal by Subject|0|||
42319610|NCT01937715|76156688|FG003|Overall Study|Withdrawal by Subject|0|||
42319611|NCT01937715|76156689|FG004|Overall Study|Withdrawal by Subject|2|||
42319612|NCT01937715|76156685|FG000|Overall Study|Other|0|||
42319613|NCT01937715|76156686|FG001|Overall Study|Other|0|||
42319614|NCT01937715|76156687|FG002|Overall Study|Other|0|||
42319615|NCT01937715|76156688|FG003|Overall Study|Other|3|||
42319616|NCT01937715|76156689|FG004|Overall Study|Other|0|||
42319617|NCT01937559|76156704|FG000|Overall Study|Physician Decision|3|||
42319618|NCT01937559|76156705|FG001|Overall Study|Physician Decision|3|||
42319619|NCT01937559|76156706|FG002|Overall Study|Physician Decision|0|||
42319620|NCT01937559|76156704|FG000|Overall Study|Withdrawal by Subject|6|||
42319621|NCT01937559|76156705|FG001|Overall Study|Withdrawal by Subject|4|||
42319622|NCT01937559|76156706|FG002|Overall Study|Withdrawal by Subject|0|||
42319623|NCT01937559|76156704|FG000|Overall Study|screen fail|2|||
42319624|NCT01937559|76156705|FG001|Overall Study|screen fail|4|||
42319625|NCT01937559|76156706|FG002|Overall Study|screen fail|0|||
42319626|NCT01960257|76156718|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
42319627|NCT01960257|76156719|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
42319628|NCT01960257|76156720|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
42319629|NCT01960257|76156718|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
42319630|NCT01960257|76156719|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
42319631|NCT01960257|76156720|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
42319632|NCT01960257|76156718|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
42319633|NCT01960257|76156719|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
42319634|NCT01960257|76156720|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
42319635|NCT01918371|76156732|FG000|Overall Study|Missing Data|1|||
42319636|NCT01918371|76156733|FG001|Overall Study|Missing Data|1|||
42319637|NCT01917747|76156741|FG000|Overall Study|Withdrawal by Subject|1|||
42319638|NCT01917747|76156742|FG001|Overall Study|Withdrawal by Subject|2|||
42319639|NCT01917747|76156741|FG000|Overall Study|Lost to Follow-up|18|||
42319640|NCT01917747|76156742|FG001|Overall Study|Lost to Follow-up|9|||
42319641|NCT01597791|76156754|FG000|Overall Study|Physician Decision|2|||
42319642|NCT01597791|76156755|FG001|Overall Study|Physician Decision|1|||
42319643|NCT01597791|76156754|FG000|Overall Study|Cesarean Section|6|||
42319644|NCT01597791|76156755|FG001|Overall Study|Cesarean Section|7|||
42319645|NCT01597791|76156754|FG000|Overall Study|Subject withdrawal|0|||
42319646|NCT01597791|76156755|FG001|Overall Study|Subject withdrawal|1|||
42319647|NCT01597791|76156754|FG000|Overall Study|Protocol Violation|0|||
42319648|NCT01597791|76156755|FG001|Overall Study|Protocol Violation|1|||
42319649|NCT01916967|76156764|FG000|Overall Study|Adverse Event|0|||
42319650|NCT01916967|76156765|FG001|Overall Study|Adverse Event|0|||
42319651|NCT01916967|76156766|FG002|Overall Study|Adverse Event|2|||
42319652|NCT01916967|76156764|FG000|Overall Study|Lack of Efficacy|0|||
42319653|NCT01916967|76156765|FG001|Overall Study|Lack of Efficacy|0|||
42319654|NCT01916967|76156766|FG002|Overall Study|Lack of Efficacy|6|||
42319655|NCT01916967|76156764|FG000|Overall Study|Physician Decision|0|||
42319656|NCT01916967|76156765|FG001|Overall Study|Physician Decision|0|||
42319657|NCT01916967|76156766|FG002|Overall Study|Physician Decision|1|||
42319658|NCT01916967|76156764|FG000|Overall Study|Protocol Violation|0|||
42319659|NCT01916967|76156765|FG001|Overall Study|Protocol Violation|1|||
42319660|NCT01916967|76156766|FG002|Overall Study|Protocol Violation|0|||
42319661|NCT01936623|76156778|FG000|Overall Study|Lost to Follow-up|0|||
42319662|NCT01936623|76156779|FG001|Overall Study|Lost to Follow-up|5|||
42319663|NCT01959243|76156787|FG000|Overall Study|Investigator Decision|3|||
42319664|NCT01959243|76156788|FG001|Overall Study|Investigator Decision|0|||
42319665|NCT01959243|76156787|FG000|Overall Study|Adverse Event|5|||
42319666|NCT01959243|76156788|FG001|Overall Study|Adverse Event|2|||
42319667|NCT01959243|76156787|FG000|Overall Study|Administrative reasons|2|||
42319668|NCT01959243|76156788|FG001|Overall Study|Administrative reasons|1|||
42319669|NCT01959243|76156787|FG000|Overall Study|Lost to Follow-up|3|||
42319670|NCT01959243|76156788|FG001|Overall Study|Lost to Follow-up|1|||
42319671|NCT01959165|76156798|FG000|Overall Study|Adverse Event|0|||
42319672|NCT01959165|76156799|FG001|Overall Study|Adverse Event|0|||
42319673|NCT01959165|76156800|FG002|Overall Study|Adverse Event|0|||
42319674|NCT01959165|76156801|FG003|Overall Study|Adverse Event|1|||
42319675|NCT01959165|76156798|FG000|Overall Study|Lack of Efficacy|1|||
42319676|NCT01959165|76156799|FG001|Overall Study|Lack of Efficacy|0|||
42319677|NCT01959165|76156800|FG002|Overall Study|Lack of Efficacy|0|||
42319678|NCT01959165|76156801|FG003|Overall Study|Lack of Efficacy|0|||
42319679|NCT01959165|76156798|FG000|Overall Study|overdose|0|||
42319680|NCT01959165|76156799|FG001|Overall Study|overdose|0|||
42319681|NCT01959165|76156800|FG002|Overall Study|overdose|0|||
42319682|NCT01959165|76156801|FG003|Overall Study|overdose|1|||
42319683|NCT01959165|76156798|FG000|Overall Study|Welfare recipient|0|||
42319684|NCT01959165|76156799|FG001|Overall Study|Welfare recipient|1|||
42319685|NCT01959165|76156800|FG002|Overall Study|Welfare recipient|0|||
42319686|NCT01959165|76156801|FG003|Overall Study|Welfare recipient|0|||
42319687|NCT01916109|76156811|FG000|Overall Study|Withdrawal by Subject|1|||
42319688|NCT01915095|76156822|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
42319689|NCT01915095|76156823|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
42319690|NCT01915095|76156824|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
42319691|NCT01915095|76156825|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
42319692|NCT01915095|76156826|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
42319693|NCT01958619|76156851|FG000|Overall Study|Protocol Violation|2|||
42319694|NCT01958619|76156852|FG001|Overall Study|Protocol Violation|0|||
42319695|NCT01958619|76156853|FG002|Overall Study|Protocol Violation|1|||
42319696|NCT01958619|76156854|FG003|Overall Study|Protocol Violation|0|||
42319697|NCT01752634|76156870|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
42319698|NCT01752634|76156871|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
42319699|NCT01752634|76156872|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
42319700|NCT01752634|76156873|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
42319701|NCT01752634|76156874|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
42319702|NCT01752634|76156875|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
42319703|NCT01752634|76156870|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
42319704|NCT01752634|76156871|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
42319705|NCT01752634|76156872|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
42319706|NCT01752634|76156873|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
42319707|NCT01752634|76156874|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
42319708|NCT01752634|76156875|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
42319709|NCT01752634|76156870|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
42319710|NCT01752634|76156871|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
42319711|NCT01752634|76156872|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
42319712|NCT01752634|76156873|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
42319713|NCT01752634|76156874|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
42319714|NCT01752634|76156875|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
42319715|NCT01752634|76156870|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
42319716|NCT01752634|76156871|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
42319717|NCT01752634|76156872|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
42258119|NCT02971007|76084548|FG000|Overall Study|Adverse Event|1|||
42258120|NCT02971007|76084549|FG001|Overall Study|Adverse Event|0|||
42258121|NCT02971007|76084550|FG002|Overall Study|Adverse Event|0|||
42258122|NCT02971007|76084548|FG000|Overall Study|Lost to Follow-up|0|||
42258123|NCT02971007|76084549|FG001|Overall Study|Lost to Follow-up|1|||
42258124|NCT02971007|76084550|FG002|Overall Study|Lost to Follow-up|1|||
42258125|NCT02971007|76084548|FG000|Overall Study|Withdrawal by Subject|0|||
42258126|NCT02971007|76084549|FG001|Overall Study|Withdrawal by Subject|1|||
42258127|NCT02971007|76084550|FG002|Overall Study|Withdrawal by Subject|0|||
42258128|NCT02971007|76084548|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
42258129|NCT02971007|76084549|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
42319718|NCT01752634|76156873|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
42258130|NCT02971007|76084550|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
42258131|NCT02971007|76084548|FG000|Overall Study|Patient discontinued study drug|0|||
42319719|NCT01752634|76156874|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
42319720|NCT01752634|76156875|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
42258132|NCT02971007|76084549|FG001|Overall Study|Patient discontinued study drug|1|||
42319721|NCT01752634|76156870|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
42319722|NCT01752634|76156871|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
42319723|NCT01752634|76156872|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
42319724|NCT01752634|76156873|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
42319725|NCT01752634|76156874|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
41993889|NCT00474240|75802220|FG002|Overall Study|Adverse Event|9|||
41993890|NCT00474240|75802221|FG003|Overall Study|Adverse Event|14|||
41993891|NCT00474240|75802222|FG004|Overall Study|Adverse Event|5|||
41993892|NCT00474240|75802223|FG005|Overall Study|Adverse Event|16|||
41993893|NCT00474240|75802218|FG000|Overall Study|Removed due to lab value|0|||
41993894|NCT00474240|75802219|FG001|Overall Study|Removed due to lab value|0|||
41993895|NCT00474240|75802220|FG002|Overall Study|Removed due to lab value|0|||
41993896|NCT00474240|75802221|FG003|Overall Study|Removed due to lab value|0|||
41993897|NCT00474240|75802222|FG004|Overall Study|Removed due to lab value|0|||
41993898|NCT00474240|75802223|FG005|Overall Study|Removed due to lab value|1|||
41993899|NCT00473889|75802239|FG000|Overall Study|Did not receive study medication|1|||
41993900|NCT00473889|75802240|FG001|Overall Study|Did not receive study medication|4|||
41993901|NCT00473889|75802239|FG000|Overall Study|Adverse Event|30|||
41993902|NCT00473889|75802240|FG001|Overall Study|Adverse Event|17|||
41993903|NCT00473889|75802239|FG000|Overall Study|Protocol Violation|4|||
41993904|NCT00473889|75802240|FG001|Overall Study|Protocol Violation|2|||
41993905|NCT00473889|75802239|FG000|Overall Study|Lack of Efficacy|28|||
41993906|NCT00473889|75802240|FG001|Overall Study|Lack of Efficacy|29|||
41993907|NCT00473889|75802239|FG000|Overall Study|Lost to Follow-up|2|||
41993908|NCT00473889|75802240|FG001|Overall Study|Lost to Follow-up|1|||
41993909|NCT00473889|75802239|FG000|Overall Study|Physician Decision|10|||
41993910|NCT00473889|75802240|FG001|Overall Study|Physician Decision|5|||
41993911|NCT00473889|75802239|FG000|Overall Study|Trial Terminated|3|||
42258133|NCT02971007|76084550|FG002|Overall Study|Patient discontinued study drug|0|||
42258134|NCT03881553|76084561|FG000|Overall Study|Discharged prior to participation|1|||
42258135|NCT03881553|76084562|FG001|Overall Study|Discharged prior to participation|1|||
42258136|NCT03881553|76084563|FG002|Overall Study|Discharged prior to participation|0|||
42258137|NCT03881553|76084561|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
42258138|NCT03881553|76084562|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
42258139|NCT03881553|76084563|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
42258140|NCT02970929|76084571|FG000|Overall Study|Adverse Event|18|||
42258141|NCT02970929|76084571|FG000|Overall Study|Lack of Efficacy|8|||
42258142|NCT02970929|76084571|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
42258143|NCT02970929|76084571|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
42258144|NCT02970929|76084571|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
42258145|NCT02970929|76084571|FG000|Overall Study|LOST TO FOLLOWUP|6|||
41993912|NCT00473889|75802240|FG001|Overall Study|Trial Terminated|6|||
41993913|NCT00473889|75802239|FG000|Overall Study|Withdrawal by Subject|5|||
41993914|NCT00473889|75802240|FG001|Overall Study|Withdrawal by Subject|0|||
42258146|NCT02970929|76084571|FG000|Overall Study|MOVED OUT OF STATE|1|||
41993915|NCT00473694|75802250|FG000|Overall Study|Adverse Event|0|||
41993916|NCT00473694|75802251|FG001|Overall Study|Adverse Event|1|||
42319726|NCT01752634|76156875|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
42319727|NCT01752634|76156870|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
42319728|NCT01752634|76156871|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
42319729|NCT01752634|76156872|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
42319730|NCT01752634|76156873|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
42319731|NCT01752634|76156874|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
42319732|NCT01752634|76156875|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
42319733|NCT01752634|76156870|FG000|Week 24 to Week 260|Physician Decision|1|||
42319734|NCT01752634|76156871|FG001|Week 24 to Week 260|Physician Decision|2|||
42319735|NCT01752634|76156872|FG002|Week 24 to Week 260|Physician Decision|4|||
42319736|NCT01752634|76156873|FG003|Week 24 to Week 260|Physician Decision|2|||
42319737|NCT01752634|76156874|FG004|Week 24 to Week 260|Physician Decision|1|||
42319738|NCT01752634|76156875|FG005|Week 24 to Week 260|Physician Decision|0|||
42319739|NCT01752634|76156870|FG000|Week 24 to Week 260|Death|0|||
42319740|NCT01752634|76156871|FG001|Week 24 to Week 260|Death|1|||
42258147|NCT02970929|76084571|FG000|Overall Study|Withdrawal by Subject|16|||
42319741|NCT01752634|76156872|FG002|Week 24 to Week 260|Death|0|||
42319742|NCT01752634|76156873|FG003|Week 24 to Week 260|Death|0|||
42319743|NCT01752634|76156874|FG004|Week 24 to Week 260|Death|0|||
42319744|NCT01752634|76156875|FG005|Week 24 to Week 260|Death|0|||
42319745|NCT01752634|76156870|FG000|Week 24 to Week 260|Pregnancy|0|||
42319746|NCT01752634|76156871|FG001|Week 24 to Week 260|Pregnancy|0|||
42319747|NCT01752634|76156872|FG002|Week 24 to Week 260|Pregnancy|1|||
41993917|NCT00473694|75802252|FG002|Overall Study|Adverse Event|0|||
42258148|NCT02970305|76084588|FG000|Overall Study|Adverse Event|10|||
42258149|NCT02970305|76084589|FG001|Overall Study|Adverse Event|6|||
42319748|NCT01752634|76156873|FG003|Week 24 to Week 260|Pregnancy|0|||
42319749|NCT01752634|76156874|FG004|Week 24 to Week 260|Pregnancy|0|||
41993918|NCT00473694|75802253|FG003|Overall Study|Adverse Event|0|||
42258150|NCT02970305|76084588|FG000|Overall Study|Lack of Efficacy|1|||
42258151|NCT02970305|76084589|FG001|Overall Study|Lack of Efficacy|1|||
42258152|NCT02970305|76084588|FG000|Overall Study|Noncompliance with study drug|2|||
42258153|NCT02970305|76084589|FG001|Overall Study|Noncompliance with study drug|4|||
42258154|NCT02970305|76084588|FG000|Overall Study|Protocol Violation|2|||
42258155|NCT02970305|76084589|FG001|Overall Study|Protocol Violation|2|||
42258156|NCT02970305|76084588|FG000|Overall Study|Withdrawal by Subject|12|||
42258157|NCT02970305|76084589|FG001|Overall Study|Withdrawal by Subject|11|||
42258158|NCT02970305|76084588|FG000|Overall Study|Not further specified|1|||
42258159|NCT02970305|76084589|FG001|Overall Study|Not further specified|2|||
42258160|NCT02970305|76084588|FG000|Overall Study|Lost to Follow-up|1|||
42258161|NCT02970305|76084589|FG001|Overall Study|Lost to Follow-up|2|||
42258162|NCT02022033|76084608|FG000|Overall Study|Physician Decision|1|||
42258163|NCT03505671|76084614|FG000|Overall Study|Withdrawal by Subject|2|||
42258164|NCT03505671|76084615|FG001|Overall Study|Withdrawal by Subject|1|||
42258165|NCT03505671|76084614|FG000|Overall Study|Lost to Follow-up|1|||
42319750|NCT01752634|76156875|FG005|Week 24 to Week 260|Pregnancy|0|||
42319751|NCT01752634|76156870|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
42319752|NCT01752634|76156871|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
41993919|NCT00473694|75802250|FG000|Overall Study|Participants did not receive treatment|11|||
42258166|NCT03505671|76084615|FG001|Overall Study|Lost to Follow-up|0|||
42258167|NCT01103349|76084636|FG000|Overall Study|Adverse Event|8|||
42258168|NCT01103349|76084637|FG001|Overall Study|Adverse Event|5|||
42319753|NCT01752634|76156872|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
42319754|NCT01752634|76156873|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
42258169|NCT01103349|76084638|FG002|Overall Study|Adverse Event|3|||
42258170|NCT01103349|76084636|FG000|Overall Study|Consent withdrawn|1|||
42258171|NCT01103349|76084637|FG001|Overall Study|Consent withdrawn|0|||
42258172|NCT01103349|76084638|FG002|Overall Study|Consent withdrawn|0|||
42258173|NCT01103349|76084636|FG000|Overall Study|Incorrectly included in the trial|1|||
42258174|NCT01103349|76084637|FG001|Overall Study|Incorrectly included in the trial|0|||
42258175|NCT01103349|76084638|FG002|Overall Study|Incorrectly included in the trial|0|||
42258176|NCT01103349|76084636|FG000|Overall Study|Withdrawal by Subject|1|||
42258177|NCT01103349|76084637|FG001|Overall Study|Withdrawal by Subject|1|||
42258178|NCT01103349|76084638|FG002|Overall Study|Withdrawal by Subject|0|||
42258179|NCT01103349|76084636|FG000|Overall Study|did not want to take trial medication|0|||
42258180|NCT01103349|76084637|FG001|Overall Study|did not want to take trial medication|1|||
42258181|NCT01103349|76084638|FG002|Overall Study|did not want to take trial medication|0|||
42258182|NCT01103349|76084636|FG000|Overall Study|forgot to take medication|0|||
42258183|NCT01103349|76084637|FG001|Overall Study|forgot to take medication|0|||
42258184|NCT01103349|76084638|FG002|Overall Study|forgot to take medication|1|||
42258185|NCT02959177|76084649|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
42258186|NCT02959177|76084650|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
42258187|NCT02959177|76084651|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
42258188|NCT02959177|76084649|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
42258189|NCT02959177|76084650|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
42258190|NCT02959177|76084651|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
42258191|NCT02959177|76084649|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
42258192|NCT02959177|76084650|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
42258193|NCT02959177|76084651|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
42258194|NCT02959177|76084649|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
42258195|NCT02959177|76084650|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
42258196|NCT02959177|76084651|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
42258197|NCT02959177|76084649|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
42258198|NCT02959177|76084650|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
42258199|NCT02959177|76084651|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
42258200|NCT02959177|76084649|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
42258201|NCT02959177|76084650|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
42258202|NCT02959177|76084651|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
42258203|NCT02959177|76084649|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
42258204|NCT02959177|76084650|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
42258205|NCT02959177|76084651|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
42258206|NCT04706403|76084668|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
42258207|NCT04706403|76084669|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
42258208|NCT04706403|76084670|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
42258209|NCT04706403|76084671|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
42258210|NCT04706403|76084672|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
42258211|NCT02983617|76084686|FG000|Overall Study|Adverse Event|0|||
42258212|NCT02983617|76084687|FG001|Overall Study|Adverse Event|7|||
42258213|NCT02983617|76084686|FG000|Overall Study|Death|0|||
42258214|NCT02983617|76084687|FG001|Overall Study|Death|1|||
42258215|NCT02983617|76084686|FG000|Overall Study|Investigator's Discretion|0|||
42258216|NCT02983617|76084687|FG001|Overall Study|Investigator's Discretion|1|||
42258217|NCT02873689|76084695|FG000|Overall Study|Lack of Efficacy|1|||
42258218|NCT02873689|76084696|FG001|Overall Study|Lack of Efficacy|0|||
42258219|NCT02873689|76084695|FG000|Overall Study|Withdrawal by Subject|2|||
42258220|NCT02873689|76084696|FG001|Overall Study|Withdrawal by Subject|2|||
42258221|NCT02873689|76084695|FG000|Overall Study|Protocol Violation|1|||
42258222|NCT02873689|76084696|FG001|Overall Study|Protocol Violation|0|||
42258223|NCT02873689|76084695|FG000|Overall Study|Adverse Event|2|||
42258224|NCT02873689|76084696|FG001|Overall Study|Adverse Event|2|||
42258225|NCT02873689|76084695|FG000|Overall Study|Randomized but not Treated|1|||
42258226|NCT02873689|76084696|FG001|Overall Study|Randomized but not Treated|1|||
42258227|NCT02901431|76084710|FG000|PK Part|Adverse Event|0|||
42258228|NCT02901431|76084711|FG001|PK Part|Adverse Event|1|||
42258229|NCT02901431|76084712|FG002|PK Part|Adverse Event|0|||
41993920|NCT00473694|75802251|FG001|Overall Study|Participants did not receive treatment|3|||
42033988|NCT01070550|75842181|FG000|Overall Study|Early termination|3|||
42258230|NCT02901431|76084713|FG003|PK Part|Adverse Event|0|||
42258231|NCT02901431|76084714|FG004|PK Part|Adverse Event|0|||
42258232|NCT02901431|76084715|FG005|PK Part|Adverse Event|0|||
42258233|NCT02901431|76084716|FG006|PK Part|Adverse Event|0|||
42258234|NCT02901431|76084717|FG007|PK Part|Adverse Event|0|||
42258235|NCT02901431|76084718|FG008|PK Part|Adverse Event|0|||
42258236|NCT02901431|76084719|FG009|PK Part|Adverse Event|0|||
42258237|NCT02901431|76084720|FG010|PK Part|Adverse Event|0|||
42319755|NCT01752634|76156874|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
42319756|NCT01752634|76156875|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
42319757|NCT01752634|76156870|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
42319758|NCT01752634|76156871|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
42319759|NCT01752634|76156872|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
42319760|NCT01752634|76156873|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
42319761|NCT01752634|76156874|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
42319762|NCT01752634|76156875|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
42319763|NCT01752634|76156870|FG000|Week 24 to Week 260|Adverse Event|4|||
42319764|NCT01752634|76156871|FG001|Week 24 to Week 260|Adverse Event|8|||
42319765|NCT01752634|76156872|FG002|Week 24 to Week 260|Adverse Event|8|||
42319766|NCT01752634|76156873|FG003|Week 24 to Week 260|Adverse Event|4|||
42319767|NCT01752634|76156874|FG004|Week 24 to Week 260|Adverse Event|2|||
42319768|NCT01752634|76156875|FG005|Week 24 to Week 260|Adverse Event|0|||
42319769|NCT01726270|76156885|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
42319770|NCT01726270|76156885|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
42319771|NCT01726270|76156885|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
42319772|NCT01726270|76156885|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
42319773|NCT01726270|76156885|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
42319774|NCT01726270|76156885|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
42319775|NCT01914393|76156894|FG000|Overall Study|Protocol Violation|11|||
42133310|NCT00385593|75944210|FG001|Overall Study|Adverse Event|2|||
42133311|NCT00385593|75944209|FG000|Overall Study|Withdrawal by Subject|17|||
42133312|NCT00385593|75944210|FG001|Overall Study|Withdrawal by Subject|7|||
42133313|NCT00385593|75944209|FG000|Overall Study|Lost to Follow-up|12|||
42133314|NCT00385593|75944210|FG001|Overall Study|Lost to Follow-up|8|||
42133315|NCT00385593|75944209|FG000|Overall Study|Protocol Violation|7|||
42319776|NCT01914393|76156895|FG001|Overall Study|Protocol Violation|3|||
42319777|NCT01914393|76156896|FG002|Overall Study|Protocol Violation|19|||
42319778|NCT01914393|76156894|FG000|Overall Study|Lack of Efficacy|11|||
42319779|NCT01914393|76156895|FG001|Overall Study|Lack of Efficacy|16|||
42319780|NCT01914393|76156896|FG002|Overall Study|Lack of Efficacy|5|||
42319781|NCT01914393|76156894|FG000|Overall Study|no reason given|14|||
42319782|NCT01914393|76156895|FG001|Overall Study|no reason given|8|||
42319783|NCT01914393|76156896|FG002|Overall Study|no reason given|16|||
42319784|NCT01914393|76156894|FG000|Overall Study|Adverse Event|29|||
42319785|NCT01914393|76156895|FG001|Overall Study|Adverse Event|18|||
42319786|NCT01914393|76156896|FG002|Overall Study|Adverse Event|31|||
42319787|NCT01914393|76156894|FG000|Overall Study|Withdrawal by Subject|38|||
42319788|NCT01914393|76156895|FG001|Overall Study|Withdrawal by Subject|20|||
42319789|NCT01914393|76156896|FG002|Overall Study|Withdrawal by Subject|47|||
42319790|NCT01914393|76156894|FG000|Overall Study|Lost to Follow-up|12|||
42319791|NCT01914393|76156895|FG001|Overall Study|Lost to Follow-up|6|||
42319792|NCT01914393|76156896|FG002|Overall Study|Lost to Follow-up|19|||
42319793|NCT01914393|76156894|FG000|Overall Study|subject never dosed|0|||
42319794|NCT01914393|76156895|FG001|Overall Study|subject never dosed|0|||
42319795|NCT01914393|76156896|FG002|Overall Study|subject never dosed|1|||
42319796|NCT01931865|76156908|FG000|Overall Study|Lost to Follow-up|2|||
42319797|NCT01931865|76156908|FG000|Overall Study|Withdrawal by Subject|2|||
42319798|NCT01617447|76156915|FG000|Overall Study|Adverse Event|0|||
42319799|NCT01617447|76156916|FG001|Overall Study|Adverse Event|1|||
42319800|NCT01617447|76156915|FG000|Overall Study|Physician Decision|0|||
42319801|NCT01617447|76156916|FG001|Overall Study|Physician Decision|2|||
42319802|NCT00432679|76156924|FG000|Overall Study|Adverse Event|2|||
42319803|NCT00432679|76156925|FG001|Overall Study|Adverse Event|1|||
42319804|NCT00432679|76156924|FG000|Overall Study|Withdrawal by Subject|3|||
42319805|NCT00432679|76156925|FG001|Overall Study|Withdrawal by Subject|2|||
42319806|NCT01600105|76156933|FG000|Total Participants|Withdrawal by Subject|1|||
42319807|NCT01600105|76156934|FG001|Total Participants|Withdrawal by Subject|0|||
42319808|NCT01600105|76156933|FG000|Total Participants|No images in PACS|10|||
42319809|NCT01600105|76156934|FG001|Total Participants|No images in PACS|0|||
42319810|NCT01600105|76156933|FG000|Total Participants|Insufficient image quality|30|||
42319811|NCT01600105|76156934|FG001|Total Participants|Insufficient image quality|10|||
42319812|NCT01600105|76156933|FG000|Sub Study I|Insufficient image quality|0|||
42319813|NCT01600105|76156934|FG001|Sub Study I|Insufficient image quality|10|||
42319814|NCT01600105|76156933|FG000|Sub Study II|Withdrawal by Subject|1|||
42319815|NCT01600105|76156934|FG001|Sub Study II|Withdrawal by Subject|0|||
42319816|NCT01600105|76156933|FG000|Sub Study II|No images in PACS|1|||
42319817|NCT01600105|76156934|FG001|Sub Study II|No images in PACS|0|||
42133316|NCT00385593|75944210|FG001|Overall Study|Protocol Violation|4|||
42319818|NCT01600105|76156933|FG000|Sub Study II|Insufficient image quality|3|||
42319819|NCT01600105|76156934|FG001|Sub Study II|Insufficient image quality|0|||
42319820|NCT01600105|76156933|FG000|Sub Study III|Insufficient image quality|5|||
42319821|NCT01600105|76156934|FG001|Sub Study III|Insufficient image quality|0|||
42319822|NCT01600105|76156933|FG000|Sub Study V|Poor Image Quality|2|||
42319823|NCT01600105|76156934|FG001|Sub Study V|Poor Image Quality|0|||
42319824|NCT02246647|76156946|FG000|Overall Study|Withdrawal by Subject|1|||
42319825|NCT02246647|76156947|FG001|Overall Study|Withdrawal by Subject|1|||
42319826|NCT01933113|76156967|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
42319827|NCT02244619|76156973|FG000|Overall Study|Did not receive study intervention|8|||
42319828|NCT02244619|76156974|FG001|Overall Study|Did not receive study intervention|21|||
42319829|NCT02243371|76156982|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
42319830|NCT02243371|76156983|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
42258238|NCT02901431|76084721|FG011|PK Part|Adverse Event|0|||
42258239|NCT02901431|76084722|FG012|PK Part|Adverse Event|0|||
42258240|NCT02901431|76084710|FG000|PK Part|Lost to Follow-up|0|||
42258241|NCT02901431|76084711|FG001|PK Part|Lost to Follow-up|0|||
42258242|NCT02901431|76084712|FG002|PK Part|Lost to Follow-up|1|||
42258243|NCT02901431|76084713|FG003|PK Part|Lost to Follow-up|0|||
42258244|NCT02901431|76084714|FG004|PK Part|Lost to Follow-up|0|||
42258245|NCT02901431|76084715|FG005|PK Part|Lost to Follow-up|0|||
42258246|NCT02901431|76084716|FG006|PK Part|Lost to Follow-up|0|||
42258247|NCT02901431|76084717|FG007|PK Part|Lost to Follow-up|0|||
42258248|NCT02901431|76084718|FG008|PK Part|Lost to Follow-up|0|||
42258249|NCT02901431|76084719|FG009|PK Part|Lost to Follow-up|0|||
42258250|NCT02901431|76084720|FG010|PK Part|Lost to Follow-up|0|||
42258251|NCT02901431|76084721|FG011|PK Part|Lost to Follow-up|0|||
42258252|NCT02901431|76084722|FG012|PK Part|Lost to Follow-up|0|||
42258253|NCT02901431|76084710|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
42258254|NCT02901431|76084711|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
42258255|NCT02901431|76084712|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
42258256|NCT02901431|76084713|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
41993921|NCT00473694|75802252|FG002|Overall Study|Participants did not receive treatment|5|||
41993922|NCT00473694|75802253|FG003|Overall Study|Participants did not receive treatment|6|||
41993923|NCT00473694|75802250|FG000|Overall Study|Lost to Follow-up|0|||
41993924|NCT00473694|75802251|FG001|Overall Study|Lost to Follow-up|0|||
41993925|NCT00473694|75802252|FG002|Overall Study|Lost to Follow-up|0|||
41993926|NCT00473694|75802253|FG003|Overall Study|Lost to Follow-up|1|||
41993927|NCT00473655|75802269|FG000|Overall Study|Lost to Follow-up|9|||
41993928|NCT00473655|75802270|FG001|Overall Study|Lost to Follow-up|5|||
41993929|NCT00473655|75802271|FG002|Overall Study|Lost to Follow-up|8|||
42258257|NCT02901431|76084714|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
42319831|NCT02243371|76156982|FG000|Overall Study|Death (unrelated)|2|||
42319832|NCT02243371|76156983|FG001|Overall Study|Death (unrelated)|4|||
42319833|NCT02243371|76156982|FG000|Overall Study|Adverse Event (unrelated)|0|||
42319834|NCT02243371|76156983|FG001|Overall Study|Adverse Event (unrelated)|1|||
42319835|NCT02243371|76156982|FG000|Overall Study|Lack of Clinical Benefit|0|||
42319836|NCT02243371|76156983|FG001|Overall Study|Lack of Clinical Benefit|1|||
42319837|NCT02243371|76156982|FG000|Overall Study|Withdrawal by Subject|0|||
42319838|NCT02243371|76156983|FG001|Overall Study|Withdrawal by Subject|2|||
42319839|NCT01931475|76156991|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
42319840|NCT01931475|76156992|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
42319841|NCT01931475|76156991|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
42319842|NCT01931475|76156992|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
42319843|NCT01931475|76156991|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
42319844|NCT01931475|76156992|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
42319845|NCT01931475|76156991|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
42319846|NCT01931475|76156992|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
42319847|NCT01931475|76156991|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
42319848|NCT01931475|76156992|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
41993930|NCT00473382|75802282|FG000|Core Study|Adverse Event|3|||
41993931|NCT00473382|75802283|FG001|Core Study|Adverse Event|1|||
42258258|NCT02901431|76084715|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
42258259|NCT02901431|76084716|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
42258260|NCT02901431|76084717|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
42258261|NCT02901431|76084718|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
42258262|NCT02901431|76084719|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
42258263|NCT02901431|76084720|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
42258264|NCT02901431|76084721|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
42258265|NCT02901431|76084722|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
42258266|NCT02901431|76084710|FG000|PK Part|Pending dose confirmation|0|||
42258267|NCT02901431|76084711|FG001|PK Part|Pending dose confirmation|1|||
42258268|NCT02901431|76084712|FG002|PK Part|Pending dose confirmation|0|||
42258269|NCT02901431|76084713|FG003|PK Part|Pending dose confirmation|0|||
42258270|NCT02901431|76084714|FG004|PK Part|Pending dose confirmation|0|||
42258271|NCT02901431|76084715|FG005|PK Part|Pending dose confirmation|0|||
42258272|NCT02901431|76084716|FG006|PK Part|Pending dose confirmation|0|||
42258273|NCT02901431|76084717|FG007|PK Part|Pending dose confirmation|0|||
41993932|NCT00473382|75802284|FG002|Core Study|Adverse Event|1|||
41993933|NCT00473382|75802282|FG000|Core Study|Death|3|||
41993934|NCT00473382|75802283|FG001|Core Study|Death|5|||
41993935|NCT00473382|75802284|FG002|Core Study|Death|10|||
42258274|NCT02901431|76084718|FG008|PK Part|Pending dose confirmation|0|||
42258275|NCT02901431|76084719|FG009|PK Part|Pending dose confirmation|0|||
42258276|NCT02901431|76084720|FG010|PK Part|Pending dose confirmation|0|||
42258277|NCT02901431|76084721|FG011|PK Part|Pending dose confirmation|0|||
42258278|NCT02901431|76084722|FG012|PK Part|Pending dose confirmation|0|||
42258279|NCT02901431|76084710|FG000|PK Part|8 weeks of treatment ran out|2|||
42258280|NCT02901431|76084711|FG001|PK Part|8 weeks of treatment ran out|0|||
42258281|NCT02901431|76084712|FG002|PK Part|8 weeks of treatment ran out|0|||
42258282|NCT02901431|76084713|FG003|PK Part|8 weeks of treatment ran out|0|||
42258283|NCT02901431|76084714|FG004|PK Part|8 weeks of treatment ran out|0|||
42258284|NCT02901431|76084715|FG005|PK Part|8 weeks of treatment ran out|0|||
42258285|NCT02901431|76084716|FG006|PK Part|8 weeks of treatment ran out|0|||
42258286|NCT02901431|76084717|FG007|PK Part|8 weeks of treatment ran out|0|||
42258287|NCT02901431|76084718|FG008|PK Part|8 weeks of treatment ran out|0|||
42258288|NCT02901431|76084719|FG009|PK Part|8 weeks of treatment ran out|0|||
42258289|NCT02901431|76084720|FG010|PK Part|8 weeks of treatment ran out|0|||
42258290|NCT02901431|76084721|FG011|PK Part|8 weeks of treatment ran out|0|||
42258291|NCT02901431|76084722|FG012|PK Part|8 weeks of treatment ran out|0|||
42258292|NCT02901431|76084710|FG000|PK Part|Stopped treatment after 8 weeks|1|||
42258293|NCT02901431|76084711|FG001|PK Part|Stopped treatment after 8 weeks|0|||
42258294|NCT02901431|76084712|FG002|PK Part|Stopped treatment after 8 weeks|1|||
41993936|NCT00473382|75802282|FG000|Core Study|Lost to Follow-up|3|||
41993937|NCT00473382|75802283|FG001|Core Study|Lost to Follow-up|3|||
41993938|NCT00473382|75802284|FG002|Core Study|Lost to Follow-up|3|||
41993939|NCT00473382|75802282|FG000|Core Study|Physician Decision|1|||
41993940|NCT00473382|75802283|FG001|Core Study|Physician Decision|2|||
41993941|NCT00473382|75802284|FG002|Core Study|Physician Decision|2|||
41993942|NCT00473382|75802282|FG000|Core Study|Subject non-compliance|5|||
41993943|NCT00473382|75802283|FG001|Core Study|Subject non-compliance|2|||
41993944|NCT00473382|75802284|FG002|Core Study|Subject non-compliance|1|||
42258295|NCT02901431|76084713|FG003|PK Part|Stopped treatment after 8 weeks|0|||
42258296|NCT02901431|76084714|FG004|PK Part|Stopped treatment after 8 weeks|0|||
42258297|NCT02901431|76084715|FG005|PK Part|Stopped treatment after 8 weeks|0|||
42258298|NCT02901431|76084716|FG006|PK Part|Stopped treatment after 8 weeks|0|||
42258299|NCT02901431|76084717|FG007|PK Part|Stopped treatment after 8 weeks|0|||
42258300|NCT02901431|76084718|FG008|PK Part|Stopped treatment after 8 weeks|0|||
42258301|NCT02901431|76084719|FG009|PK Part|Stopped treatment after 8 weeks|0|||
41993945|NCT00473382|75802282|FG000|Core Study|Subject needed other treatment|1|||
41993946|NCT00473382|75802283|FG001|Core Study|Subject needed other treatment|3|||
41993947|NCT00473382|75802284|FG002|Core Study|Subject needed other treatment|2|||
41993948|NCT00473382|75802282|FG000|Core Study|Subject's decision|12|||
41993949|NCT00473382|75802283|FG001|Core Study|Subject's decision|11|||
42258302|NCT02901431|76084720|FG010|PK Part|Stopped treatment after 8 weeks|0|||
42258303|NCT02901431|76084721|FG011|PK Part|Stopped treatment after 8 weeks|0|||
42258304|NCT02901431|76084722|FG012|PK Part|Stopped treatment after 8 weeks|0|||
42258305|NCT02901431|76084710|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
42258306|NCT02901431|76084711|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
42258307|NCT02901431|76084712|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
42258308|NCT02901431|76084713|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
42258309|NCT02901431|76084714|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
42258310|NCT02901431|76084715|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
42258311|NCT02901431|76084716|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
42258312|NCT02901431|76084717|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
42258313|NCT02901431|76084718|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
42258314|NCT02901431|76084719|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
42258315|NCT02901431|76084720|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
42258316|NCT02901431|76084721|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
42258317|NCT02901431|76084722|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
42258318|NCT02901431|76084710|FG000|PK Part|Discontinued per Sponsor|0|||
42258319|NCT02901431|76084711|FG001|PK Part|Discontinued per Sponsor|3|||
42258320|NCT02901431|76084712|FG002|PK Part|Discontinued per Sponsor|0|||
42258321|NCT02901431|76084713|FG003|PK Part|Discontinued per Sponsor|0|||
42258322|NCT02901431|76084714|FG004|PK Part|Discontinued per Sponsor|0|||
42258323|NCT02901431|76084715|FG005|PK Part|Discontinued per Sponsor|0|||
42258324|NCT02901431|76084716|FG006|PK Part|Discontinued per Sponsor|0|||
42258325|NCT02901431|76084717|FG007|PK Part|Discontinued per Sponsor|0|||
42258326|NCT02901431|76084718|FG008|PK Part|Discontinued per Sponsor|0|||
42258327|NCT02901431|76084719|FG009|PK Part|Discontinued per Sponsor|0|||
42258328|NCT02901431|76084720|FG010|PK Part|Discontinued per Sponsor|0|||
42258329|NCT02901431|76084721|FG011|PK Part|Discontinued per Sponsor|0|||
42258330|NCT02901431|76084722|FG012|PK Part|Discontinued per Sponsor|0|||
42258331|NCT02901431|76084710|FG000|PK Part|Withdrawal by Subject|1|||
42258332|NCT02901431|76084711|FG001|PK Part|Withdrawal by Subject|1|||
42258333|NCT02901431|76084712|FG002|PK Part|Withdrawal by Subject|3|||
42258334|NCT02901431|76084713|FG003|PK Part|Withdrawal by Subject|0|||
42258335|NCT02901431|76084714|FG004|PK Part|Withdrawal by Subject|0|||
42258336|NCT02901431|76084715|FG005|PK Part|Withdrawal by Subject|0|||
42258337|NCT02901431|76084716|FG006|PK Part|Withdrawal by Subject|0|||
42258338|NCT02901431|76084717|FG007|PK Part|Withdrawal by Subject|0|||
42258339|NCT02901431|76084718|FG008|PK Part|Withdrawal by Subject|0|||
42258340|NCT02901431|76084719|FG009|PK Part|Withdrawal by Subject|0|||
42258341|NCT02901431|76084720|FG010|PK Part|Withdrawal by Subject|0|||
42258342|NCT02901431|76084721|FG011|PK Part|Withdrawal by Subject|0|||
42258343|NCT02901431|76084722|FG012|PK Part|Withdrawal by Subject|0|||
42258344|NCT02901431|76084710|FG000|Main Treatment Part|Adverse Event|0|||
42258345|NCT02901431|76084711|FG001|Main Treatment Part|Adverse Event|0|||
42258346|NCT02901431|76084712|FG002|Main Treatment Part|Adverse Event|0|||
42258347|NCT02901431|76084713|FG003|Main Treatment Part|Adverse Event|3|||
42258348|NCT02901431|76084714|FG004|Main Treatment Part|Adverse Event|3|||
42258349|NCT02901431|76084715|FG005|Main Treatment Part|Adverse Event|4|||
42258350|NCT02901431|76084716|FG006|Main Treatment Part|Adverse Event|1|||
42258351|NCT02901431|76084717|FG007|Main Treatment Part|Adverse Event|0|||
42258352|NCT02901431|76084718|FG008|Main Treatment Part|Adverse Event|0|||
42258353|NCT02901431|76084719|FG009|Main Treatment Part|Adverse Event|0|||
42258354|NCT02901431|76084720|FG010|Main Treatment Part|Adverse Event|0|||
41993950|NCT00473382|75802284|FG002|Core Study|Subject's decision|10|||
42258355|NCT02901431|76084721|FG011|Main Treatment Part|Adverse Event|0|||
41993951|NCT00473382|75802282|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
42258356|NCT02901431|76084722|FG012|Main Treatment Part|Adverse Event|0|||
42258357|NCT02901431|76084710|FG000|Main Treatment Part|Lack of Efficacy|0|||
42258358|NCT02901431|76084711|FG001|Main Treatment Part|Lack of Efficacy|0|||
42258359|NCT02901431|76084712|FG002|Main Treatment Part|Lack of Efficacy|0|||
41993952|NCT00473382|75802283|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
42258360|NCT02901431|76084713|FG003|Main Treatment Part|Lack of Efficacy|1|||
42258361|NCT02901431|76084714|FG004|Main Treatment Part|Lack of Efficacy|0|||
42258362|NCT02901431|76084715|FG005|Main Treatment Part|Lack of Efficacy|0|||
42258363|NCT02901431|76084716|FG006|Main Treatment Part|Lack of Efficacy|0|||
42258364|NCT02901431|76084717|FG007|Main Treatment Part|Lack of Efficacy|0|||
42258365|NCT02901431|76084718|FG008|Main Treatment Part|Lack of Efficacy|0|||
42258366|NCT02901431|76084719|FG009|Main Treatment Part|Lack of Efficacy|0|||
42258367|NCT02901431|76084720|FG010|Main Treatment Part|Lack of Efficacy|0|||
42258368|NCT02901431|76084721|FG011|Main Treatment Part|Lack of Efficacy|0|||
42258369|NCT02901431|76084722|FG012|Main Treatment Part|Lack of Efficacy|0|||
42258370|NCT02901431|76084710|FG000|Main Treatment Part|Lost to Follow-up|0|||
42258371|NCT02901431|76084711|FG001|Main Treatment Part|Lost to Follow-up|0|||
42258372|NCT02901431|76084712|FG002|Main Treatment Part|Lost to Follow-up|0|||
42258373|NCT02901431|76084713|FG003|Main Treatment Part|Lost to Follow-up|3|||
42258374|NCT02901431|76084714|FG004|Main Treatment Part|Lost to Follow-up|1|||
42258375|NCT02901431|76084715|FG005|Main Treatment Part|Lost to Follow-up|2|||
42258376|NCT02901431|76084716|FG006|Main Treatment Part|Lost to Follow-up|3|||
42258377|NCT02901431|76084717|FG007|Main Treatment Part|Lost to Follow-up|0|||
42258378|NCT02901431|76084718|FG008|Main Treatment Part|Lost to Follow-up|0|||
42258379|NCT02901431|76084719|FG009|Main Treatment Part|Lost to Follow-up|0|||
42258380|NCT02901431|76084720|FG010|Main Treatment Part|Lost to Follow-up|0|||
42258381|NCT02901431|76084721|FG011|Main Treatment Part|Lost to Follow-up|0|||
42258382|NCT02901431|76084722|FG012|Main Treatment Part|Lost to Follow-up|0|||
42258383|NCT02901431|76084710|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
42258384|NCT02901431|76084711|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
42258385|NCT02901431|76084712|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
42258386|NCT02901431|76084713|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
42258387|NCT02901431|76084714|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
42258388|NCT02901431|76084715|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
41993953|NCT00473382|75802284|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
41993954|NCT00473382|75802282|FG000|Open-label Extension Through Month 48|Death|1|||
42258389|NCT02901431|76084716|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
42258390|NCT02901431|76084717|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
42258391|NCT02901431|76084718|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
42258392|NCT02901431|76084719|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
42258393|NCT02901431|76084720|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
42258394|NCT02901431|76084721|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
42258395|NCT02901431|76084722|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
42258396|NCT02901431|76084710|FG000|Main Treatment Part|Physician Decision|0|||
42258397|NCT02901431|76084711|FG001|Main Treatment Part|Physician Decision|0|||
42258398|NCT02901431|76084712|FG002|Main Treatment Part|Physician Decision|0|||
42258399|NCT02901431|76084713|FG003|Main Treatment Part|Physician Decision|1|||
42258400|NCT02901431|76084714|FG004|Main Treatment Part|Physician Decision|0|||
42258401|NCT02901431|76084715|FG005|Main Treatment Part|Physician Decision|0|||
42258402|NCT02901431|76084716|FG006|Main Treatment Part|Physician Decision|1|||
42258403|NCT02901431|76084717|FG007|Main Treatment Part|Physician Decision|0|||
42258404|NCT02901431|76084718|FG008|Main Treatment Part|Physician Decision|0|||
42258405|NCT02901431|76084719|FG009|Main Treatment Part|Physician Decision|0|||
42258406|NCT02901431|76084720|FG010|Main Treatment Part|Physician Decision|0|||
42258407|NCT02901431|76084721|FG011|Main Treatment Part|Physician Decision|0|||
42033989|NCT01070550|75842182|FG001|Overall Study|Early termination|0|||
42258408|NCT02901431|76084722|FG012|Main Treatment Part|Physician Decision|0|||
42258409|NCT02901431|76084710|FG000|Main Treatment Part|Withdrawal by Subject|0|||
42258410|NCT02901431|76084711|FG001|Main Treatment Part|Withdrawal by Subject|0|||
42258411|NCT02901431|76084712|FG002|Main Treatment Part|Withdrawal by Subject|0|||
42258412|NCT02901431|76084713|FG003|Main Treatment Part|Withdrawal by Subject|18|||
42258413|NCT02901431|76084714|FG004|Main Treatment Part|Withdrawal by Subject|3|||
42258414|NCT02901431|76084715|FG005|Main Treatment Part|Withdrawal by Subject|5|||
42258415|NCT02901431|76084716|FG006|Main Treatment Part|Withdrawal by Subject|6|||
42258416|NCT02901431|76084717|FG007|Main Treatment Part|Withdrawal by Subject|0|||
42258417|NCT02901431|76084718|FG008|Main Treatment Part|Withdrawal by Subject|0|||
42258418|NCT02901431|76084719|FG009|Main Treatment Part|Withdrawal by Subject|0|||
42258419|NCT02901431|76084720|FG010|Main Treatment Part|Withdrawal by Subject|0|||
42258420|NCT02901431|76084721|FG011|Main Treatment Part|Withdrawal by Subject|0|||
42258421|NCT02901431|76084722|FG012|Main Treatment Part|Withdrawal by Subject|0|||
42258422|NCT02901431|76084710|FG000|Open Label Part|Adverse Event|0|||
42258423|NCT02901431|76084711|FG001|Open Label Part|Adverse Event|0|||
42258424|NCT02901431|76084712|FG002|Open Label Part|Adverse Event|0|||
42258425|NCT02901431|76084713|FG003|Open Label Part|Adverse Event|0|||
42258426|NCT02901431|76084714|FG004|Open Label Part|Adverse Event|0|||
42258427|NCT02901431|76084715|FG005|Open Label Part|Adverse Event|0|||
42258428|NCT02901431|76084716|FG006|Open Label Part|Adverse Event|0|||
42258429|NCT02901431|76084717|FG007|Open Label Part|Adverse Event|0|||
42258430|NCT02901431|76084718|FG008|Open Label Part|Adverse Event|4|||
42258431|NCT02901431|76084719|FG009|Open Label Part|Adverse Event|4|||
42258432|NCT02901431|76084720|FG010|Open Label Part|Adverse Event|0|||
42258433|NCT02901431|76084721|FG011|Open Label Part|Adverse Event|4|||
42258434|NCT02901431|76084722|FG012|Open Label Part|Adverse Event|1|||
42258435|NCT02901431|76084710|FG000|Open Label Part|Lost to Follow-up|0|||
42258436|NCT02901431|76084711|FG001|Open Label Part|Lost to Follow-up|0|||
41993955|NCT00473382|75802283|FG001|Open-label Extension Through Month 48|Death|3|||
41993956|NCT00473382|75802284|FG002|Open-label Extension Through Month 48|Death|3|||
42258437|NCT02901431|76084712|FG002|Open Label Part|Lost to Follow-up|0|||
42258438|NCT02901431|76084713|FG003|Open Label Part|Lost to Follow-up|0|||
42258439|NCT02901431|76084714|FG004|Open Label Part|Lost to Follow-up|0|||
42258440|NCT02901431|76084715|FG005|Open Label Part|Lost to Follow-up|0|||
42258441|NCT02901431|76084716|FG006|Open Label Part|Lost to Follow-up|0|||
42258442|NCT02901431|76084717|FG007|Open Label Part|Lost to Follow-up|0|||
42258443|NCT02901431|76084718|FG008|Open Label Part|Lost to Follow-up|2|||
42258444|NCT02901431|76084719|FG009|Open Label Part|Lost to Follow-up|2|||
42258445|NCT02901431|76084720|FG010|Open Label Part|Lost to Follow-up|1|||
42258446|NCT02901431|76084721|FG011|Open Label Part|Lost to Follow-up|1|||
41993957|NCT00473382|75802282|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
41993958|NCT00473382|75802283|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
41993959|NCT00473382|75802284|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
41993960|NCT00473382|75802282|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
41993961|NCT00473382|75802283|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
41993962|NCT00473382|75802284|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
41993963|NCT00473382|75802282|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
41993964|NCT00473382|75802283|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
41993965|NCT00473382|75802284|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
42258447|NCT02901431|76084722|FG012|Open Label Part|Lost to Follow-up|1|||
42258448|NCT02901431|76084710|FG000|Open Label Part|Physician Decision|0|||
42258449|NCT02901431|76084711|FG001|Open Label Part|Physician Decision|0|||
42258450|NCT02901431|76084712|FG002|Open Label Part|Physician Decision|0|||
42258451|NCT02901431|76084713|FG003|Open Label Part|Physician Decision|0|||
42258452|NCT02901431|76084714|FG004|Open Label Part|Physician Decision|0|||
42258453|NCT02901431|76084715|FG005|Open Label Part|Physician Decision|0|||
42258454|NCT02901431|76084716|FG006|Open Label Part|Physician Decision|0|||
42258455|NCT02901431|76084717|FG007|Open Label Part|Physician Decision|0|||
42258456|NCT02901431|76084718|FG008|Open Label Part|Physician Decision|1|||
42258457|NCT02901431|76084719|FG009|Open Label Part|Physician Decision|1|||
42258458|NCT02901431|76084720|FG010|Open Label Part|Physician Decision|0|||
42258459|NCT02901431|76084721|FG011|Open Label Part|Physician Decision|0|||
42258460|NCT02901431|76084722|FG012|Open Label Part|Physician Decision|0|||
42258461|NCT02901431|76084710|FG000|Open Label Part|Study Terminated By Sponsor|0|||
42258462|NCT02901431|76084711|FG001|Open Label Part|Study Terminated By Sponsor|0|||
41993966|NCT00473382|75802282|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
42033990|NCT01070550|75842183|FG002|Overall Study|Early termination|0|||
42258463|NCT02901431|76084712|FG002|Open Label Part|Study Terminated By Sponsor|0|||
42258464|NCT02901431|76084713|FG003|Open Label Part|Study Terminated By Sponsor|0|||
42258465|NCT02901431|76084714|FG004|Open Label Part|Study Terminated By Sponsor|0|||
42258466|NCT02901431|76084715|FG005|Open Label Part|Study Terminated By Sponsor|0|||
42258467|NCT02901431|76084716|FG006|Open Label Part|Study Terminated By Sponsor|0|||
42258468|NCT02901431|76084717|FG007|Open Label Part|Study Terminated By Sponsor|0|||
42258469|NCT02901431|76084718|FG008|Open Label Part|Study Terminated By Sponsor|35|||
42258470|NCT02901431|76084719|FG009|Open Label Part|Study Terminated By Sponsor|12|||
42258471|NCT02901431|76084720|FG010|Open Label Part|Study Terminated By Sponsor|21|||
42258472|NCT02901431|76084721|FG011|Open Label Part|Study Terminated By Sponsor|31|||
42258473|NCT02901431|76084722|FG012|Open Label Part|Study Terminated By Sponsor|0|||
42258474|NCT02901431|76084710|FG000|Open Label Part|Withdrawal by Subject|0|||
41993967|NCT00473382|75802283|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
41993968|NCT00473382|75802284|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
41993969|NCT00473382|75802282|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
41993970|NCT00473382|75802283|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
41993971|NCT00473382|75802284|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
41993972|NCT00473382|75802282|FG000|Open-label Extension Through Month 60|Death|1|||
41993973|NCT00473382|75802283|FG001|Open-label Extension Through Month 60|Death|7|||
41993974|NCT00473382|75802284|FG002|Open-label Extension Through Month 60|Death|4|||
41993975|NCT00473382|75802282|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
42258475|NCT02901431|76084711|FG001|Open Label Part|Withdrawal by Subject|0|||
42258476|NCT02901431|76084712|FG002|Open Label Part|Withdrawal by Subject|0|||
42258477|NCT02901431|76084713|FG003|Open Label Part|Withdrawal by Subject|0|||
41993976|NCT00473382|75802283|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
42258478|NCT02901431|76084714|FG004|Open Label Part|Withdrawal by Subject|0|||
42258479|NCT02901431|76084715|FG005|Open Label Part|Withdrawal by Subject|0|||
42258480|NCT02901431|76084716|FG006|Open Label Part|Withdrawal by Subject|0|||
42258481|NCT02901431|76084717|FG007|Open Label Part|Withdrawal by Subject|0|||
41993977|NCT00473382|75802284|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
42258482|NCT02901431|76084718|FG008|Open Label Part|Withdrawal by Subject|6|||
42258483|NCT02901431|76084719|FG009|Open Label Part|Withdrawal by Subject|5|||
41993978|NCT00473382|75802282|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
41993979|NCT00473382|75802283|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
41993980|NCT00473382|75802284|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
41993981|NCT00473382|75802282|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
41993982|NCT00473382|75802283|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
42258484|NCT02901431|76084720|FG010|Open Label Part|Withdrawal by Subject|7|||
42258485|NCT02901431|76084721|FG011|Open Label Part|Withdrawal by Subject|3|||
42258486|NCT02901431|76084722|FG012|Open Label Part|Withdrawal by Subject|1|||
42258487|NCT02873377|76084749|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
42258488|NCT02873377|76084750|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
42258489|NCT02873377|76084749|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
42258490|NCT02873377|76084750|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
42258491|NCT02966795|76084759|FG000|Overall Study|Patient Left the Country|0|||
42258492|NCT02966795|76084760|FG001|Overall Study|Patient Left the Country|1|||
42258493|NCT02873221|76084768|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
42258494|NCT02873221|76084769|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
42258495|NCT02873221|76084770|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
42258496|NCT02873221|76084768|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
42258497|NCT02873221|76084769|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
42258498|NCT02873221|76084770|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
42258499|NCT02873221|76084768|FG000|Treatment Period|Protocol Violation|2|||
42258500|NCT02873221|76084769|FG001|Treatment Period|Protocol Violation|5|||
42258501|NCT02873221|76084770|FG002|Treatment Period|Protocol Violation|8|||
42258502|NCT02873221|76084768|FG000|Treatment Period|Pregnancy|4|||
42258503|NCT02873221|76084769|FG001|Treatment Period|Pregnancy|6|||
42258504|NCT02873221|76084770|FG002|Treatment Period|Pregnancy|3|||
42258505|NCT02873221|76084768|FG000|Treatment Period|Lack of Qualifying Event|0|||
42258506|NCT02873221|76084769|FG001|Treatment Period|Lack of Qualifying Event|3|||
42258507|NCT02873221|76084770|FG002|Treatment Period|Lack of Qualifying Event|1|||
42258508|NCT02873221|76084768|FG000|Treatment Period|Withdrawal of Consent|52|||
42258509|NCT02873221|76084769|FG001|Treatment Period|Withdrawal of Consent|51|||
42258510|NCT02873221|76084770|FG002|Treatment Period|Withdrawal of Consent|41|||
42258511|NCT02873221|76084768|FG000|Treatment Period|Lack of Efficacy|0|||
41993983|NCT00473382|75802284|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
41993984|NCT00473382|75802282|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
41993985|NCT00473382|75802283|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
41993986|NCT00473382|75802284|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
41993987|NCT00473265|75802310|FG000|Overall Study|Unrelated adverse event|5|||
41993988|NCT00473265|75802310|FG000|Overall Study|Off treatment early|15|||
41993989|NCT00472641|75802314|FG000|Overall Study|Lack of Efficacy|3|||
41993990|NCT00472641|75802314|FG000|Overall Study|Adverse Event|3|||
41993991|NCT00472641|75802314|FG000|Overall Study|Lost to Follow-up|1|||
41993992|NCT01133977|75802323|FG000|Overall Study|Adverse Event|0|||
41993993|NCT01133977|75802324|FG001|Overall Study|Adverse Event|0|||
41993994|NCT01133977|75802325|FG002|Overall Study|Adverse Event|1|||
41993995|NCT01133977|75802326|FG003|Overall Study|Adverse Event|0|||
41993996|NCT01133977|75802327|FG004|Overall Study|Adverse Event|0|||
41993997|NCT01133977|75802323|FG000|Overall Study|Death|1|||
41993998|NCT01133977|75802324|FG001|Overall Study|Death|1|||
41993999|NCT01133977|75802325|FG002|Overall Study|Death|1|||
41994000|NCT01133977|75802326|FG003|Overall Study|Death|7|||
41994001|NCT01133977|75802327|FG004|Overall Study|Death|3|||
41994002|NCT01133977|75802323|FG000|Overall Study|Started a New Line of Therapy|2|||
41994003|NCT01133977|75802324|FG001|Overall Study|Started a New Line of Therapy|6|||
41994004|NCT01133977|75802325|FG002|Overall Study|Started a New Line of Therapy|4|||
41994005|NCT01133977|75802326|FG003|Overall Study|Started a New Line of Therapy|25|||
41994006|NCT01133977|75802327|FG004|Overall Study|Started a New Line of Therapy|33|||
41994007|NCT01133977|75802323|FG000|Overall Study|Lost to Follow-up|0|||
41994008|NCT01133977|75802324|FG001|Overall Study|Lost to Follow-up|0|||
41994009|NCT01133977|75802325|FG002|Overall Study|Lost to Follow-up|0|||
41994010|NCT01133977|75802326|FG003|Overall Study|Lost to Follow-up|2|||
41994011|NCT01133977|75802327|FG004|Overall Study|Lost to Follow-up|1|||
41994012|NCT01133977|75802323|FG000|Overall Study|Withdrawal by Subject|0|||
41994013|NCT01133977|75802324|FG001|Overall Study|Withdrawal by Subject|0|||
41994014|NCT01133977|75802325|FG002|Overall Study|Withdrawal by Subject|0|||
41994015|NCT01133977|75802326|FG003|Overall Study|Withdrawal by Subject|5|||
41994016|NCT01133977|75802327|FG004|Overall Study|Withdrawal by Subject|1|||
41994017|NCT01133821|75802344|FG000|Overall Study|Lost to Follow-up|8|||
42258512|NCT02873221|76084769|FG001|Treatment Period|Lack of Efficacy|17|||
42258513|NCT02873221|76084770|FG002|Treatment Period|Lack of Efficacy|12|||
42258514|NCT02873221|76084768|FG000|Treatment Period|Adverse Event|4|||
42258515|NCT02873221|76084769|FG001|Treatment Period|Adverse Event|9|||
42258516|NCT02873221|76084770|FG002|Treatment Period|Adverse Event|11|||
42258517|NCT02873221|76084768|FG000|Treatment Period|Lost to Follow-up|26|||
42258518|NCT02873221|76084769|FG001|Treatment Period|Lost to Follow-up|30|||
42258519|NCT02873221|76084770|FG002|Treatment Period|Lost to Follow-up|26|||
42258520|NCT02873221|76084768|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
42258521|NCT02873221|76084769|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
42133317|NCT00385593|75944209|FG000|Overall Study|Several reasons|17|||
42133318|NCT00385593|75944210|FG001|Overall Study|Several reasons|15|||
42133319|NCT00385593|75944209|FG000|Overall Study|Incorrect inclusion|2|||
42133320|NCT00385593|75944210|FG001|Overall Study|Incorrect inclusion|0|||
42133321|NCT00385593|75944209|FG000|Overall Study|Incorrect randomization|0|||
42133322|NCT00385593|75944210|FG001|Overall Study|Incorrect randomization|1|||
42133323|NCT00495794|75944218|FG000|Overall Study|Pharmacist did not activate patient|522|||
42133324|NCT00495794|75944219|FG001|Overall Study|Pharmacist did not activate patient|0|||
42133325|NCT00495170|75944225|FG000|Overall Study|Lost to Follow-up|9|||
42133326|NCT00495170|75944225|FG000|Overall Study|Withdrawal by Subject|3|||
42133327|NCT00495170|75944225|FG000|Overall Study|Inappropriate staging|8|||
42133328|NCT03853148|75944233|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
42133329|NCT03853148|75944234|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
42133330|NCT03853148|75944235|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
41994018|NCT01133821|75802345|FG001|Overall Study|Lost to Follow-up|11|||
42133331|NCT03853148|75944236|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
42133332|NCT00385203|75944248|FG000|Overall Study|Adverse Event|5|||
42133333|NCT00385203|75944249|FG001|Overall Study|Adverse Event|4|||
42133334|NCT00385203|75944248|FG000|Overall Study|Death|1|||
42133335|NCT00385203|75944249|FG001|Overall Study|Death|0|||
42133336|NCT00385203|75944248|FG000|Overall Study|Condition under investigation worsened|18|||
42133337|NCT00385203|75944249|FG001|Overall Study|Condition under investigation worsened|3|||
42133338|NCT00385203|75944248|FG000|Overall Study|Incorrect enrollment|2|||
42133339|NCT00385203|75944249|FG001|Overall Study|Incorrect enrollment|0|||
42133340|NCT00408993|75944258|FG000|Overall Study|Adverse Event|15|||
42319849|NCT01931475|76156991|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
42133341|NCT00408993|75944259|FG001|Overall Study|Adverse Event|4|||
42258522|NCT02873221|76084770|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
42258523|NCT02873221|76084768|FG000|Safety Follow-up Period|Protocol Violation|0|||
41994019|NCT01133821|75802344|FG000|Overall Study|Withdrawal by Subject|8|||
41994020|NCT01133821|75802345|FG001|Overall Study|Withdrawal by Subject|3|||
41994021|NCT01133821|75802344|FG000|Overall Study|preferred other treatment|1|||
42133342|NCT00408993|75944258|FG000|Overall Study|Protocol Violation|1|||
42133343|NCT00408993|75944259|FG001|Overall Study|Protocol Violation|6|||
42133344|NCT00408993|75944258|FG000|Overall Study|Lack of Efficacy|1|||
42133345|NCT00408993|75944259|FG001|Overall Study|Lack of Efficacy|4|||
42133346|NCT00408993|75944258|FG000|Overall Study|Withdrawal by Subject|2|||
42133347|NCT00408993|75944259|FG001|Overall Study|Withdrawal by Subject|3|||
42133348|NCT00395967|75944269|FG000|Treatment Period|Failed Mobilization|1|||
42133349|NCT00395967|75944269|FG000|Follow-up Period|Death|1|||
42133350|NCT00395967|75944269|FG000|Follow-up Period|Lost to Follow-up|1|||
42133351|NCT00395733|75944275|FG000|Period 2|Withdrawal by Subject|1|||
42133352|NCT00395733|75944276|FG001|Period 2|Withdrawal by Subject|2|||
42133353|NCT00395733|75944275|FG000|Period 2|Protocol Violation|0|||
42133354|NCT00395733|75944276|FG001|Period 2|Protocol Violation|1|||
42133355|NCT00395733|75944275|FG000|Period 2|Adverse Event|0|||
42133356|NCT00395733|75944276|FG001|Period 2|Adverse Event|2|||
42133357|NCT00395733|75944275|FG000|Period 2|Technical problems|1|||
42133358|NCT00395733|75944276|FG001|Period 2|Technical problems|0|||
42133359|NCT00395343|75944284|FG000|Overall Study|Adverse Event|13|||
42133360|NCT00395343|75944285|FG001|Overall Study|Adverse Event|5|||
42133361|NCT00395343|75944284|FG000|Overall Study|Lack of Efficacy|0|||
42133362|NCT00395343|75944285|FG001|Overall Study|Lack of Efficacy|1|||
42133363|NCT00395343|75944284|FG000|Overall Study|Lost to Follow-up|4|||
42133364|NCT00395343|75944285|FG001|Overall Study|Lost to Follow-up|4|||
42133365|NCT00395343|75944284|FG000|Overall Study|Physician Decision|2|||
42133366|NCT00395343|75944285|FG001|Overall Study|Physician Decision|4|||
42133367|NCT00395343|75944284|FG000|Overall Study|Protocol Violation|6|||
42133368|NCT00395343|75944285|FG001|Overall Study|Protocol Violation|8|||
42133369|NCT00395343|75944284|FG000|Overall Study|Withdrawal by Subject|11|||
42133370|NCT00395343|75944285|FG001|Overall Study|Withdrawal by Subject|12|||
42133371|NCT00395343|75944284|FG000|Overall Study|Other|5|||
42133372|NCT00395343|75944285|FG001|Overall Study|Other|2|||
42133373|NCT00560573|75944291|FG000|Overall Study|Death|4|||
42133374|NCT00560573|75944292|FG001|Overall Study|Death|1|||
42133375|NCT00560573|75944293|FG002|Overall Study|Death|4|||
42133376|NCT00560573|75944294|FG003|Overall Study|Death|5|||
42133377|NCT00560573|75944295|FG004|Overall Study|Death|1|||
42133378|NCT00560573|75944296|FG005|Overall Study|Death|10|||
42133379|NCT00560573|75944291|FG000|Overall Study|Lost to Follow-up|0|||
41994022|NCT01133821|75802345|FG001|Overall Study|preferred other treatment|1|||
41994023|NCT01133821|75802344|FG000|Overall Study|Protocol Violation|0|||
41994024|NCT01133821|75802345|FG001|Overall Study|Protocol Violation|1|||
42133380|NCT00560573|75944292|FG001|Overall Study|Lost to Follow-up|0|||
42133381|NCT00560573|75944293|FG002|Overall Study|Lost to Follow-up|0|||
42133382|NCT00560573|75944294|FG003|Overall Study|Lost to Follow-up|1|||
42133383|NCT00560573|75944295|FG004|Overall Study|Lost to Follow-up|1|||
42133384|NCT00560573|75944296|FG005|Overall Study|Lost to Follow-up|0|||
42133385|NCT00560573|75944291|FG000|Overall Study|Withdrawal by Subject|0|||
42133386|NCT00560573|75944292|FG001|Overall Study|Withdrawal by Subject|0|||
42133387|NCT00560573|75944293|FG002|Overall Study|Withdrawal by Subject|0|||
42133388|NCT00560573|75944294|FG003|Overall Study|Withdrawal by Subject|1|||
42133389|NCT00560573|75944295|FG004|Overall Study|Withdrawal by Subject|1|||
42133390|NCT00560573|75944296|FG005|Overall Study|Withdrawal by Subject|0|||
42133391|NCT00560573|75944291|FG000|Overall Study|Other|2|||
42133392|NCT00560573|75944292|FG001|Overall Study|Other|2|||
41994025|NCT01133821|75802344|FG000|Overall Study|Refused participation|1|||
41994026|NCT01133821|75802345|FG001|Overall Study|Refused participation|3|||
42133393|NCT00560573|75944293|FG002|Overall Study|Other|2|||
42133394|NCT00560573|75944294|FG003|Overall Study|Other|3|||
42133395|NCT00560573|75944295|FG004|Overall Study|Other|3|||
42133396|NCT00560573|75944296|FG005|Overall Study|Other|3|||
42133397|NCT00560573|75944291|FG000|Overall Study|Enrolled, not treated|0|||
42133398|NCT00560573|75944292|FG001|Overall Study|Enrolled, not treated|0|||
42133399|NCT00560573|75944293|FG002|Overall Study|Enrolled, not treated|0|||
42133400|NCT00560573|75944294|FG003|Overall Study|Enrolled, not treated|0|||
42133401|NCT00560573|75944295|FG004|Overall Study|Enrolled, not treated|1|||
42133402|NCT00560573|75944296|FG005|Overall Study|Enrolled, not treated|0|||
41994027|NCT00472446|75802355|FG000|Overall Study|Protocol Violation|0|||
41994028|NCT00472446|75802356|FG001|Overall Study|Protocol Violation|0|||
42133403|NCT03961529|75944329|FG000|Overall Study|Adverse Event|13|||
41994029|NCT00472446|75802357|FG002|Overall Study|Protocol Violation|0|||
42133404|NCT03961529|75944330|FG001|Overall Study|Adverse Event|5|||
42133405|NCT03961529|75944331|FG002|Overall Study|Adverse Event|2|||
42133406|NCT03961529|75944329|FG000|Overall Study|Withdrawal by Subject|17|||
42133407|NCT03961529|75944330|FG001|Overall Study|Withdrawal by Subject|2|||
42133408|NCT03961529|75944331|FG002|Overall Study|Withdrawal by Subject|1|||
42133409|NCT03961529|75944329|FG000|Overall Study|Withdrawal by parent/guardian|0|||
42133410|NCT03961529|75944330|FG001|Overall Study|Withdrawal by parent/guardian|7|||
42133411|NCT03961529|75944331|FG002|Overall Study|Withdrawal by parent/guardian|0|||
42133412|NCT03961529|75944329|FG000|Overall Study|Physician Decision|2|||
42133413|NCT03961529|75944330|FG001|Overall Study|Physician Decision|1|||
42133414|NCT03961529|75944331|FG002|Overall Study|Physician Decision|1|||
42133415|NCT03961529|75944329|FG000|Overall Study|Lost to Follow-up|2|||
42133416|NCT03961529|75944330|FG001|Overall Study|Lost to Follow-up|1|||
42133417|NCT03961529|75944331|FG002|Overall Study|Lost to Follow-up|0|||
42133418|NCT03961529|75944329|FG000|Overall Study|Lack of Efficacy|2|||
42133419|NCT03961529|75944330|FG001|Overall Study|Lack of Efficacy|0|||
42133420|NCT03961529|75944331|FG002|Overall Study|Lack of Efficacy|1|||
42133421|NCT03961529|75944329|FG000|Overall Study|Other|6|||
42133422|NCT03961529|75944330|FG001|Overall Study|Other|1|||
42133423|NCT03961529|75944331|FG002|Overall Study|Other|0|||
42133424|NCT00494780|75944341|FG000|Overall Study|Adverse Event|1|||
42133425|NCT00494780|75944342|FG001|Overall Study|Adverse Event|0|||
42133426|NCT00494780|75944341|FG000|Overall Study|Withdrew before Dosed|0|||
42133427|NCT00494780|75944342|FG001|Overall Study|Withdrew before Dosed|1|||
42133428|NCT00494780|75944341|FG000|Overall Study|Progression of Study Disease|7|||
42319850|NCT01931475|76156992|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
41994030|NCT00472446|75802358|FG003|Overall Study|Protocol Violation|1|||
41994031|NCT00472446|75802355|FG000|Overall Study|Reintervention|0|||
41994032|NCT00472446|75802356|FG001|Overall Study|Reintervention|0|||
41994033|NCT00472446|75802357|FG002|Overall Study|Reintervention|1|||
42319851|NCT01931475|76156991|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
42319852|NCT01931475|76156992|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
42319853|NCT01931475|76156991|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
42319854|NCT01931475|76156992|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
42319855|NCT01931475|76156991|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
42319856|NCT01931475|76156992|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
42319857|NCT01931475|76156991|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
42319858|NCT01931475|76156992|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
42319859|NCT01931475|76156991|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
42319860|NCT01931475|76156992|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
42319861|NCT01931397|76157003|FG000|Overall Study|Physician Decision|2|||
42319862|NCT01931397|76157003|FG000|Overall Study|Withdrawal by Subject|8|||
42319863|NCT01931397|76157003|FG000|Overall Study|moved out of state|1|||
42319864|NCT01929993|76157013|FG000|Overall Study|Protocol Violation|4|||
42319865|NCT01929993|76157014|FG001|Overall Study|Protocol Violation|6|||
42319866|NCT01929993|76157013|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
42319867|NCT01929993|76157014|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
42319868|NCT01912599|76157022|FG000|Overall Study|Withdrawal by Subject|0|||
42133429|NCT00494780|75944342|FG001|Overall Study|Progression of Study Disease|8|||
42133430|NCT00494780|75944341|FG000|Overall Study|New Treatment|2|||
42133431|NCT00494780|75944342|FG001|Overall Study|New Treatment|2|||
42133432|NCT00494780|75944341|FG000|Overall Study|Non-compliance|1|||
42133433|NCT00494780|75944342|FG001|Overall Study|Non-compliance|0|||
42133434|NCT00494780|75944341|FG000|Overall Study|Residual Tumour Mass|0|||
42133435|NCT00494780|75944342|FG001|Overall Study|Residual Tumour Mass|1|||
42258524|NCT02873221|76084769|FG001|Safety Follow-up Period|Protocol Violation|0|||
42258525|NCT02873221|76084770|FG002|Safety Follow-up Period|Protocol Violation|1|||
42258526|NCT02873221|76084768|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
42258527|NCT02873221|76084769|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
42258528|NCT02873221|76084770|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
42258529|NCT02873221|76084768|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
42258530|NCT02873221|76084769|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
42258531|NCT02873221|76084770|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
42258532|NCT02968979|76084778|FG000|Overall Study|Protocol Violation|7|||
42258533|NCT02968979|76084778|FG000|Overall Study|Withdrawal by Subject|1|||
42258534|NCT02966015|76084830|FG000|Inclusion Visit|did not answer questionnaire|8|||
42258535|NCT02966015|76084831|FG001|Inclusion Visit|did not answer questionnaire|3|||
42258536|NCT02968433|76084837|FG000|Overall Study|Withdrawal by Subject|1|||
42133436|NCT00494780|75944341|FG000|Overall Study|Insurance Issues|0|||
42319869|NCT01912599|76157023|FG001|Overall Study|Withdrawal by Subject|1|||
42133437|NCT00494780|75944342|FG001|Overall Study|Insurance Issues|1|||
42133438|NCT00490022|75944352|FG000|Overall Study|Adverse Event|0|||
41994034|NCT00472446|75802358|FG003|Overall Study|Reintervention|1|||
42133439|NCT00490022|75944353|FG001|Overall Study|Adverse Event|2|||
42258537|NCT02872285|76084849|FG000|Overall Study|Withdrawal by Subject|2|||
42258538|NCT02872285|76084850|FG001|Overall Study|Withdrawal by Subject|0|||
42258539|NCT02872285|76084849|FG000|Overall Study|Lost to Follow-up|2|||
42258540|NCT02872285|76084850|FG001|Overall Study|Lost to Follow-up|2|||
42319870|NCT01929681|76157031|FG000|Overall Study|Withdrawal by Subject|1|||
42319871|NCT01929681|76157032|FG001|Overall Study|Withdrawal by Subject|0|||
42319872|NCT01929681|76157031|FG000|Overall Study|Physician Decision|1|||
42319873|NCT01929681|76157032|FG001|Overall Study|Physician Decision|1|||
42133440|NCT00490022|75944352|FG000|Overall Study|Withdrawal by Subject|1|||
42133441|NCT00490022|75944353|FG001|Overall Study|Withdrawal by Subject|0|||
42133442|NCT00490022|75944352|FG000|Overall Study|Subject failed to disclose concommitant|0|||
42133443|NCT00490022|75944353|FG001|Overall Study|Subject failed to disclose concommitant|1|||
42133444|NCT00493454|75944359|FG000|Overall Study|Withdrawal by Subject|1|||
42133445|NCT00493220|75944369|FG000|Third Intervention|Withdrawal by Subject|1|||
42133446|NCT00493220|75944370|FG001|Third Intervention|Withdrawal by Subject|0|||
42133447|NCT00493220|75944371|FG002|Third Intervention|Withdrawal by Subject|0|||
42133448|NCT00493220|75944372|FG003|Third Intervention|Withdrawal by Subject|0|||
42319874|NCT01646177|76157042|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
42319875|NCT01646177|76157043|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
42133449|NCT00493220|75944373|FG004|Third Intervention|Withdrawal by Subject|0|||
42133450|NCT00493220|75944374|FG005|Third Intervention|Withdrawal by Subject|0|||
42133451|NCT00394953|75944386|FG000|First Treatment Period|Adverse Event|1|||
42319876|NCT01646177|76157044|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
42319877|NCT01646177|76157045|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
42319878|NCT01646177|76157046|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
42319879|NCT01646177|76157047|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
42319880|NCT01646177|76157048|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
42319881|NCT01646177|76157049|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
42319882|NCT01646177|76157050|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
42319883|NCT01646177|76157051|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
42319884|NCT01646177|76157052|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
42319885|NCT01646177|76157053|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
42319886|NCT01646177|76157042|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
42319887|NCT01646177|76157043|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
42319888|NCT01646177|76157044|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
42319889|NCT01646177|76157045|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
42319890|NCT01646177|76157046|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
42319891|NCT01646177|76157047|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
42319892|NCT01646177|76157048|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
42319893|NCT01646177|76157049|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
42319894|NCT01646177|76157050|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
42319895|NCT01646177|76157051|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
42319896|NCT01646177|76157052|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
42319897|NCT01646177|76157053|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
42319898|NCT01646177|76157042|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
42319899|NCT01646177|76157043|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
42319900|NCT01646177|76157044|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
42319901|NCT01646177|76157045|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
42319902|NCT01646177|76157046|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
42319903|NCT01646177|76157047|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
42319904|NCT01646177|76157048|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
42319905|NCT01646177|76157049|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
42319906|NCT01646177|76157050|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
42319907|NCT01646177|76157051|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
42319908|NCT01646177|76157052|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
42319909|NCT01646177|76157053|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
42319910|NCT01646177|76157042|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
42319911|NCT01646177|76157043|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
42319912|NCT01646177|76157044|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
42319913|NCT01646177|76157045|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
42319914|NCT01646177|76157046|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
42319915|NCT01646177|76157047|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
42319916|NCT01646177|76157048|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
42319917|NCT01646177|76157049|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
42319918|NCT01646177|76157050|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
42319919|NCT01646177|76157051|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
42319920|NCT01646177|76157052|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
42319921|NCT01646177|76157053|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
42319922|NCT01646177|76157042|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
42319923|NCT01646177|76157043|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
42033991|NCT01070550|75842184|FG003|Overall Study|Early termination|0|||
42319924|NCT01646177|76157044|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
42319925|NCT01646177|76157045|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
42319926|NCT01646177|76157046|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
42319927|NCT01646177|76157047|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
42319928|NCT01646177|76157048|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
42319929|NCT01646177|76157049|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
42319930|NCT01646177|76157050|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
42319931|NCT01646177|76157051|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
42319932|NCT01646177|76157052|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
42319933|NCT01646177|76157053|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
42319934|NCT01646177|76157042|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
42319935|NCT01646177|76157043|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
42319936|NCT01646177|76157044|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
42319937|NCT01646177|76157045|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
42319938|NCT01646177|76157046|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
42319939|NCT01646177|76157047|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
42319940|NCT01646177|76157048|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
42319941|NCT01646177|76157049|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
42319942|NCT01646177|76157050|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
42319943|NCT01646177|76157051|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
42319944|NCT01646177|76157052|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
42319945|NCT01646177|76157053|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
42319946|NCT01646177|76157042|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
42319947|NCT01646177|76157043|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
42319948|NCT01646177|76157044|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
42319949|NCT01646177|76157045|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
42319950|NCT01646177|76157046|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
42319951|NCT01646177|76157047|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
42319952|NCT01646177|76157048|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
42319953|NCT01646177|76157049|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
42319954|NCT01646177|76157050|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
42319955|NCT01646177|76157051|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
42319956|NCT01646177|76157052|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
42319957|NCT01646177|76157053|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
42319958|NCT01646177|76157042|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
42319959|NCT01646177|76157043|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
42319960|NCT01646177|76157044|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
42319961|NCT01646177|76157045|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
42319962|NCT01646177|76157046|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
42319963|NCT01646177|76157047|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
42319964|NCT01646177|76157048|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
42319965|NCT01646177|76157049|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
42319966|NCT01646177|76157050|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
42319967|NCT01646177|76157051|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
42319968|NCT01646177|76157052|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
42319969|NCT01646177|76157053|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
42319970|NCT01646177|76157042|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
42319971|NCT01646177|76157043|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
42319972|NCT01646177|76157044|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
42319973|NCT01646177|76157045|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
42319974|NCT01646177|76157046|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
42319975|NCT01646177|76157047|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
42319976|NCT01646177|76157048|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
42258541|NCT02872285|76084849|FG000|Overall Study|Discontinued due to back surgery|1|||
42258542|NCT02872285|76084850|FG001|Overall Study|Discontinued due to back surgery|0|||
42258543|NCT02871739|76084860|FG000|Overall Study|Lost to Follow-up|3|||
42258544|NCT02871739|76084861|FG001|Overall Study|Lost to Follow-up|2|||
42258545|NCT02871739|76084862|FG002|Overall Study|Lost to Follow-up|0|||
42258546|NCT02871739|76084863|FG003|Overall Study|Lost to Follow-up|2|||
42258547|NCT02896361|76084873|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
42258548|NCT02896361|76084874|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
42319977|NCT01646177|76157049|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
42319978|NCT01646177|76157050|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
42258549|NCT02896361|76084875|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
42258550|NCT02896361|76084873|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
42319979|NCT01646177|76157051|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
42319980|NCT01646177|76157052|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
42319981|NCT01646177|76157053|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
42319982|NCT01646177|76157042|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
42319983|NCT01646177|76157043|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
42319984|NCT01646177|76157044|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
42319985|NCT01646177|76157045|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
42319986|NCT01646177|76157046|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
42319987|NCT01646177|76157047|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
42319988|NCT01646177|76157048|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
42319989|NCT01646177|76157049|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
42319990|NCT01646177|76157050|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
42319991|NCT01646177|76157051|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
42319992|NCT01646177|76157052|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
42319993|NCT01646177|76157053|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
42319994|NCT01646177|76157042|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
42319995|NCT01646177|76157043|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
42319996|NCT01646177|76157044|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
42319997|NCT01646177|76157045|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
42319998|NCT01646177|76157046|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
42319999|NCT01646177|76157047|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
42320000|NCT01646177|76157048|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
42320001|NCT01646177|76157049|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
42320002|NCT01646177|76157050|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
42320003|NCT01646177|76157051|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
42320004|NCT01646177|76157052|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
42320005|NCT01646177|76157053|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
42320006|NCT01646177|76157042|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
42320007|NCT01646177|76157043|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
42320008|NCT01646177|76157044|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
42320009|NCT01646177|76157045|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
42320010|NCT01646177|76157046|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
42320011|NCT01646177|76157047|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
42320012|NCT01646177|76157048|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
42320013|NCT01646177|76157049|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
42320014|NCT01646177|76157050|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
42320015|NCT01646177|76157051|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
42320016|NCT01646177|76157052|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
42320017|NCT01646177|76157053|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
42320018|NCT01646177|76157042|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
42320019|NCT01646177|76157043|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
42320020|NCT01646177|76157044|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
42320021|NCT01646177|76157045|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
42320022|NCT01646177|76157046|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
42320023|NCT01646177|76157047|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
42320024|NCT01646177|76157048|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
42320025|NCT01646177|76157049|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
42320026|NCT01646177|76157050|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
42320027|NCT01646177|76157051|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
42320028|NCT01646177|76157052|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
42320029|NCT01646177|76157053|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
42320030|NCT01646177|76157042|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
42320031|NCT01646177|76157043|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
42320032|NCT01646177|76157044|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
42320033|NCT01646177|76157045|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
42320034|NCT01646177|76157046|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
42320035|NCT01646177|76157047|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
42320036|NCT01646177|76157048|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
41994035|NCT00472446|75802355|FG000|Overall Study|Questionnaires not returned|5|||
41994036|NCT00472446|75802356|FG001|Overall Study|Questionnaires not returned|6|||
41994037|NCT00472446|75802357|FG002|Overall Study|Questionnaires not returned|6|||
41994038|NCT00472446|75802358|FG003|Overall Study|Questionnaires not returned|4|||
41994039|NCT00472290|75802368|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
42320037|NCT01646177|76157049|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
42320038|NCT01646177|76157050|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
42320039|NCT01646177|76157051|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
42320040|NCT01646177|76157052|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
42320041|NCT01646177|76157053|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
42320042|NCT01646177|76157042|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
42320043|NCT01646177|76157043|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
42320044|NCT01646177|76157044|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
42320045|NCT01646177|76157045|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
42320046|NCT01646177|76157046|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
42320047|NCT01646177|76157047|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
42320048|NCT01646177|76157048|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
42320049|NCT01646177|76157049|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
42320050|NCT01646177|76157050|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
42320051|NCT01646177|76157051|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
42320052|NCT01646177|76157052|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
42320053|NCT01646177|76157053|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
42320054|NCT01646177|76157042|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
42320055|NCT01646177|76157043|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
42320056|NCT01646177|76157044|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
42320057|NCT01646177|76157045|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
42320058|NCT01646177|76157046|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
42320059|NCT01646177|76157047|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
42133452|NCT00394953|75944387|FG001|First Treatment Period|Adverse Event|2|||
42133453|NCT00394953|75944386|FG000|First Treatment Period|Death|6|||
42320060|NCT01646177|76157048|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
42320061|NCT01646177|76157049|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
42320062|NCT01646177|76157050|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
42320063|NCT01646177|76157051|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
42320064|NCT01646177|76157052|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
42320065|NCT01646177|76157053|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
42320066|NCT01646177|76157042|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
42320067|NCT01646177|76157043|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
42320068|NCT01646177|76157044|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
42320069|NCT01646177|76157045|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
42320070|NCT01646177|76157046|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
42320071|NCT01646177|76157047|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
42320072|NCT01646177|76157048|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
42320073|NCT01646177|76157049|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
42320074|NCT01646177|76157050|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
42320075|NCT01646177|76157051|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
42320076|NCT01646177|76157052|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
42320077|NCT01646177|76157053|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
42320078|NCT01646177|76157042|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
42320079|NCT01646177|76157043|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
42320080|NCT01646177|76157044|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
42320081|NCT01646177|76157045|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
42320082|NCT01646177|76157046|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
42320083|NCT01646177|76157047|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
42320084|NCT01646177|76157048|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
42320085|NCT01646177|76157049|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
42320086|NCT01646177|76157050|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
42320087|NCT01646177|76157051|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
42133454|NCT00394953|75944387|FG001|First Treatment Period|Death|7|||
42133455|NCT00394953|75944386|FG000|First Treatment Period|Lack of Efficacy|1|||
42133456|NCT00394953|75944387|FG001|First Treatment Period|Lack of Efficacy|1|||
42133457|NCT00394953|75944386|FG000|First Treatment Period|Withdrawal by Subject|6|||
42320088|NCT01646177|76157052|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
41994040|NCT00472290|75802368|FG000|Overall Study|Protocol Specified Criteria|7|||
41994041|NCT00472290|75802368|FG000|Overall Study|Administrative Decision|37|||
42320089|NCT01646177|76157053|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
42320090|NCT01646177|76157042|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
42320091|NCT01646177|76157043|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
42320092|NCT01646177|76157044|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
42320093|NCT01646177|76157045|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
42320094|NCT01646177|76157046|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
42320095|NCT01646177|76157047|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
42320096|NCT01646177|76157048|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
42320097|NCT01646177|76157049|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
42320098|NCT01646177|76157050|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
41994042|NCT00472290|75802368|FG000|Overall Study|Death|3|||
41994043|NCT00472290|75802368|FG000|Overall Study|Lost to Follow-up|1|||
41994044|NCT00472290|75802368|FG000|Overall Study|Lack of Efficacy|1|||
41994045|NCT00472290|75802368|FG000|Overall Study|Disease Progression|4|||
41994046|NCT00472290|75802368|FG000|Overall Study|Withdrawal by Subject|5|||
41994047|NCT00472290|75802368|FG000|Overall Study|Adverse Event|6|||
41994048|NCT00472290|75802368|FG000|Overall Study|Requirement for alternative therapy|7|||
41994049|NCT01133704|75802374|FG000|Overall Study|Death|44|||
41994050|NCT01133704|75802375|FG001|Overall Study|Death|26|||
41994051|NCT01133704|75802374|FG000|Overall Study|Patient refused to continue|4|||
41994052|NCT01133704|75802375|FG001|Overall Study|Patient refused to continue|0|||
41994053|NCT01133704|75802374|FG000|Overall Study|Study Closure|1|||
41994054|NCT01133704|75802375|FG001|Overall Study|Study Closure|0|||
42133458|NCT00394953|75944387|FG001|First Treatment Period|Withdrawal by Subject|3|||
42258551|NCT02896361|76084874|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
41994055|NCT01133665|75802381|FG000|Overall Study|Physician Decision|2|||
41994056|NCT01133626|75802388|FG000|Overall Study|Adverse Event|0|||
41994057|NCT01133626|75802389|FG001|Overall Study|Adverse Event|1|||
41994058|NCT01133626|75802390|FG002|Overall Study|Adverse Event|0|||
41994059|NCT01133626|75802388|FG000|Overall Study|Withdrawal by Subject|1|||
41994060|NCT01133626|75802389|FG001|Overall Study|Withdrawal by Subject|2|||
42258552|NCT02896361|76084875|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
42258553|NCT02962739|76084898|FG000|Overall Study|Withdrawal by Subject|0|||
42258554|NCT02962739|76084899|FG001|Overall Study|Withdrawal by Subject|1|||
42258555|NCT02962739|76084900|FG002|Overall Study|Withdrawal by Subject|0|||
42258556|NCT02962739|76084901|FG003|Overall Study|Withdrawal by Subject|0|||
42258557|NCT02962739|76084902|FG004|Overall Study|Withdrawal by Subject|0|||
42258558|NCT02962739|76084903|FG005|Overall Study|Withdrawal by Subject|0|||
42258559|NCT02962739|76084898|FG000|Overall Study|Protocol Violation|0|||
42258560|NCT02962739|76084899|FG001|Overall Study|Protocol Violation|0|||
42258561|NCT02962739|76084900|FG002|Overall Study|Protocol Violation|1|||
42258562|NCT02962739|76084901|FG003|Overall Study|Protocol Violation|0|||
42258563|NCT02962739|76084902|FG004|Overall Study|Protocol Violation|1|||
42258564|NCT02962739|76084903|FG005|Overall Study|Protocol Violation|0|||
42258565|NCT01344629|76084911|FG000|Crossover Period 2|Withdrawal by Subject|0|||
42258566|NCT01344629|76084912|FG001|Crossover Period 2|Withdrawal by Subject|1|||
42258567|NCT01092117|76084918|FG000|Index Procedure to 1 Month|Death|1|||
42258568|NCT01092117|76084918|FG000|1 Month|Death|1|||
42258569|NCT01092117|76084918|FG000|1 Month|Withdrawal by Subject|1|||
42258570|NCT01092117|76084918|FG000|1 Month|Lost to Follow-up|1|||
42258571|NCT01092117|76084918|FG000|6 Months|Death|2|||
42258572|NCT01092117|76084918|FG000|6 Months|Withdrawal by Subject|3|||
42258573|NCT01092117|76084918|FG000|12 Month|Death|11|||
42258574|NCT01092117|76084918|FG000|12 Month|Withdrawal by Subject|2|||
42258575|NCT01092117|76084918|FG000|12 Month|Lost to Follow-up|1|||
42258576|NCT01092117|76084918|FG000|Year 2|Death|5|||
42258577|NCT01092117|76084918|FG000|Year 2|Withdrawal by Subject|4|||
42258578|NCT01092117|76084918|FG000|Year 2|Lost to Follow-up|1|||
42258579|NCT01092117|76084918|FG000|Year 3|Death|7|||
42258580|NCT01092117|76084918|FG000|Year 3|Withdrawal by Subject|9|||
42258581|NCT01092117|76084918|FG000|Year 3|Lost to Follow-up|3|||
42258582|NCT01092117|76084918|FG000|Year 4|Death|8|||
42258583|NCT01092117|76084918|FG000|Year 4|Withdrawal by Subject|4|||
42258584|NCT01092117|76084918|FG000|Year 4|Lost to Follow-up|4|||
42258585|NCT01065779|76084931|FG000|Overall Study|Duplicate Investigation|1|||
41994061|NCT01133626|75802390|FG002|Overall Study|Withdrawal by Subject|2|||
41994062|NCT01133626|75802388|FG000|Overall Study|Other|0|||
41994063|NCT01133626|75802389|FG001|Overall Study|Other|2|||
41994064|NCT01133626|75802390|FG002|Overall Study|Other|0|||
41994065|NCT01133392|75802400|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
42258586|NCT01065779|76084931|FG000|Overall Study|Investigation Before Contract Date|37|||
42258587|NCT01065779|76084931|FG000|Overall Study|Non-enrollment Period Administration|10|||
42258588|NCT01065779|76084931|FG000|Overall Study|Not Administered With Study Drug|17|||
42258589|NCT01065779|76084931|FG000|Overall Study|Failed to Follow-up|10|||
42258590|NCT01065779|76084931|FG000|Overall Study|Inclusion Criteria Violation|7|||
42258591|NCT02963441|76084935|FG000|Overall Study|Protocol violation or withdrawn|8|||
42320099|NCT01646177|76157051|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
42320100|NCT01646177|76157052|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
42320101|NCT01646177|76157053|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
42320102|NCT01646177|76157042|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
42320103|NCT01646177|76157043|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
42320104|NCT01646177|76157044|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
41994066|NCT01133392|75802401|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
41994067|NCT01133392|75802400|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
42320105|NCT01646177|76157045|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
42320106|NCT01646177|76157046|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
42320107|NCT01646177|76157047|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
42320108|NCT01646177|76157048|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
42320109|NCT01646177|76157049|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
42320110|NCT01646177|76157050|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
42320111|NCT01646177|76157051|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
42320112|NCT01646177|76157052|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
42320113|NCT01646177|76157053|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
42320114|NCT01646177|76157042|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
42320115|NCT01646177|76157043|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
42320116|NCT01646177|76157044|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
42320117|NCT01646177|76157045|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
42320118|NCT01646177|76157046|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
42320119|NCT01646177|76157047|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
42320120|NCT01646177|76157048|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
42320121|NCT01646177|76157049|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
42320122|NCT01646177|76157050|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
42320123|NCT01646177|76157051|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
42320124|NCT01646177|76157052|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
42320125|NCT01646177|76157053|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
42320126|NCT01646177|76157042|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
42320127|NCT01646177|76157043|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
42320128|NCT01646177|76157044|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
42320129|NCT01646177|76157045|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
42320130|NCT01646177|76157046|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
42320131|NCT01646177|76157047|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
42320132|NCT01646177|76157048|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
42320133|NCT01646177|76157049|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
42320134|NCT01646177|76157050|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
42320135|NCT01646177|76157051|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
42320136|NCT01646177|76157052|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
42320137|NCT01646177|76157053|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
42320138|NCT01646177|76157042|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
42320139|NCT01646177|76157043|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
42320140|NCT01646177|76157044|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
42320141|NCT01646177|76157045|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
42320142|NCT01646177|76157046|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
42320143|NCT01646177|76157047|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
42320144|NCT01646177|76157048|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
42320145|NCT01646177|76157049|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
42320146|NCT01646177|76157050|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
42320147|NCT01646177|76157051|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
42320148|NCT01646177|76157052|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
42320149|NCT01646177|76157053|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
42320150|NCT01646177|76157042|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
42320151|NCT01646177|76157043|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
42320152|NCT01646177|76157044|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
42320153|NCT01646177|76157045|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
42320154|NCT01646177|76157046|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
42320155|NCT01646177|76157047|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
42320156|NCT01646177|76157048|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
42320157|NCT01646177|76157049|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
42320158|NCT01646177|76157050|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
42320159|NCT01646177|76157051|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
42320160|NCT01646177|76157052|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
41994068|NCT01133392|75802401|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
42133459|NCT00394953|75944386|FG000|First Treatment Period|Lost to Follow-up|0|||
42133460|NCT00394953|75944387|FG001|First Treatment Period|Lost to Follow-up|1|||
42258592|NCT02963441|76084935|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
42258593|NCT02963441|76084935|FG000|Overall Study|IDx-DR insufficient quality|33|||
42258594|NCT01345253|76084942|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
42033992|NCT01070550|75842185|FG004|Overall Study|Early termination|0|||
41994069|NCT00471354|75802407|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
41994070|NCT00471354|75802407|FG000|Overall Study|Adverse Event|13|||
41994071|NCT00471354|75802407|FG000|Overall Study|Protocol Violation|12|||
41994072|NCT00471354|75802407|FG000|Overall Study|Withdrawal by Subject|1|||
42258595|NCT01345253|76084943|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
41994073|NCT00471354|75802407|FG000|Overall Study|Physician Decision|4|||
41994074|NCT00471354|75802407|FG000|Overall Study|Sponsor Decision|1|||
41994075|NCT00471354|75802407|FG000|Overall Study|Lost to Follow-up|3|||
42258596|NCT01345253|76084942|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
42258597|NCT01345253|76084943|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
41994076|NCT00471354|75802407|FG000|Overall Study|Lack of Efficacy|5|||
41994077|NCT00471354|75802407|FG000|Overall Study|Patient/Caregiver Decision|12|||
41994078|NCT00471315|75802411|FG000|Overall Study|Adverse Event|7|||
42320161|NCT01646177|76157053|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
42320162|NCT01646177|76157042|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
42320163|NCT01646177|76157043|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
42320164|NCT01646177|76157044|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
42320165|NCT01646177|76157045|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
42320166|NCT01646177|76157046|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
41994079|NCT00471315|75802411|FG000|Overall Study|Withdrawal by Subject|1|||
41994080|NCT00471237|75802422|FG000|Overall Study|Adverse Event|6|||
41994081|NCT00471237|75802423|FG001|Overall Study|Adverse Event|5|||
41994082|NCT00471237|75802424|FG002|Overall Study|Adverse Event|4|||
42320167|NCT01646177|76157047|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
42320168|NCT01646177|76157048|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
42320169|NCT01646177|76157049|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
42320170|NCT01646177|76157050|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
42320171|NCT01646177|76157051|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
42320172|NCT01646177|76157052|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
42320173|NCT01646177|76157053|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
42320174|NCT01646177|76157042|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
42320175|NCT01646177|76157043|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
42320176|NCT01646177|76157044|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
42320177|NCT01646177|76157045|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
41994083|NCT00471237|75802425|FG003|Overall Study|Adverse Event|8|||
41994084|NCT00471237|75802426|FG004|Overall Study|Adverse Event|7|||
41994085|NCT00471237|75802427|FG005|Overall Study|Adverse Event|5|||
41994086|NCT00471237|75802428|FG006|Overall Study|Adverse Event|0|||
42033993|NCT01070550|75842186|FG005|Overall Study|Early termination|0|||
42033994|NCT01070550|75842181|FG000|Overall Study|Failed to return|450|||
42033995|NCT01070550|75842182|FG001|Overall Study|Failed to return|33|||
42033996|NCT01070550|75842183|FG002|Overall Study|Failed to return|144|||
42033997|NCT01070550|75842184|FG003|Overall Study|Failed to return|40|||
42033998|NCT01070550|75842185|FG004|Overall Study|Failed to return|1|||
42033999|NCT01070550|75842186|FG005|Overall Study|Failed to return|2|||
42034000|NCT01070550|75842181|FG000|Overall Study|Incomplete treatment|2|||
42034001|NCT01070550|75842182|FG001|Overall Study|Incomplete treatment|0|||
42034002|NCT01070550|75842183|FG002|Overall Study|Incomplete treatment|0|||
42034003|NCT01070550|75842184|FG003|Overall Study|Incomplete treatment|0|||
42034004|NCT01070550|75842185|FG004|Overall Study|Incomplete treatment|0|||
42034005|NCT01070550|75842186|FG005|Overall Study|Incomplete treatment|0|||
42034006|NCT01070550|75842181|FG000|Overall Study|Lab test not done|22|||
42034007|NCT01070550|75842182|FG001|Overall Study|Lab test not done|3|||
42034008|NCT01070550|75842183|FG002|Overall Study|Lab test not done|4|||
42034009|NCT01070550|75842184|FG003|Overall Study|Lab test not done|1|||
42258598|NCT01345253|76084942|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
42258599|NCT01345253|76084943|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
42258600|NCT01345253|76084942|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
42258601|NCT01345253|76084943|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
42034010|NCT01070550|75842185|FG004|Overall Study|Lab test not done|0|||
42034011|NCT01070550|75842186|FG005|Overall Study|Lab test not done|1|||
42034012|NCT01070550|75842181|FG000|Overall Study|Lack of Efficacy|65|||
42034013|NCT01070550|75842182|FG001|Overall Study|Lack of Efficacy|1|||
42034014|NCT01070550|75842183|FG002|Overall Study|Lack of Efficacy|5|||
42034015|NCT01070550|75842184|FG003|Overall Study|Lack of Efficacy|5|||
42034016|NCT01070550|75842185|FG004|Overall Study|Lack of Efficacy|0|||
42034017|NCT01070550|75842186|FG005|Overall Study|Lack of Efficacy|1|||
42034018|NCT01070550|75842181|FG000|Overall Study|Miscellaneous|12|||
42034019|NCT01070550|75842182|FG001|Overall Study|Miscellaneous|2|||
42034020|NCT01070550|75842183|FG002|Overall Study|Miscellaneous|3|||
42034021|NCT01070550|75842184|FG003|Overall Study|Miscellaneous|1|||
42034022|NCT01070550|75842185|FG004|Overall Study|Miscellaneous|0|||
42034023|NCT01070550|75842186|FG005|Overall Study|Miscellaneous|0|||
42034024|NCT01070550|75842181|FG000|Overall Study|New treatment started|3|||
42034025|NCT01070550|75842182|FG001|Overall Study|New treatment started|1|||
42034026|NCT01070550|75842183|FG002|Overall Study|New treatment started|0|||
42034027|NCT01070550|75842184|FG003|Overall Study|New treatment started|2|||
42034028|NCT01070550|75842185|FG004|Overall Study|New treatment started|0|||
42034029|NCT01070550|75842186|FG005|Overall Study|New treatment started|0|||
42034030|NCT01070550|75842181|FG000|Overall Study|Non-responders|493|||
42034031|NCT01070550|75842182|FG001|Overall Study|Non-responders|4|||
42034032|NCT01070550|75842183|FG002|Overall Study|Non-responders|21|||
42034033|NCT01070550|75842184|FG003|Overall Study|Non-responders|20|||
42034034|NCT01070550|75842185|FG004|Overall Study|Non-responders|0|||
42034035|NCT01070550|75842186|FG005|Overall Study|Non-responders|2|||
42034036|NCT01070550|75842181|FG000|Overall Study|Not categorized|33|||
42034037|NCT01070550|75842182|FG001|Overall Study|Not categorized|2|||
42034038|NCT01070550|75842183|FG002|Overall Study|Not categorized|6|||
42034039|NCT01070550|75842184|FG003|Overall Study|Not categorized|1|||
42034040|NCT01070550|75842185|FG004|Overall Study|Not categorized|0|||
42034041|NCT01070550|75842186|FG005|Overall Study|Not categorized|1|||
42034042|NCT01070550|75842181|FG000|Overall Study|Protocol Violation|15|||
42034043|NCT01070550|75842182|FG001|Overall Study|Protocol Violation|1|||
42034044|NCT01070550|75842183|FG002|Overall Study|Protocol Violation|1|||
42034045|NCT01070550|75842184|FG003|Overall Study|Protocol Violation|1|||
42258602|NCT01345253|76084942|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
42258603|NCT01345253|76084943|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
42258604|NCT01345253|76084942|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
41994087|NCT00471237|75802422|FG000|Overall Study|Lost to Follow-up|1|||
41994088|NCT00471237|75802423|FG001|Overall Study|Lost to Follow-up|1|||
41994089|NCT00471237|75802424|FG002|Overall Study|Lost to Follow-up|0|||
41994090|NCT00471237|75802425|FG003|Overall Study|Lost to Follow-up|2|||
41994091|NCT00471237|75802426|FG004|Overall Study|Lost to Follow-up|3|||
41994092|NCT00471237|75802427|FG005|Overall Study|Lost to Follow-up|0|||
41994093|NCT00471237|75802428|FG006|Overall Study|Lost to Follow-up|0|||
41994094|NCT00471237|75802422|FG000|Overall Study|Protocol Violation|3|||
41994095|NCT00471237|75802423|FG001|Overall Study|Protocol Violation|6|||
41994096|NCT00471237|75802424|FG002|Overall Study|Protocol Violation|3|||
41994097|NCT00471237|75802425|FG003|Overall Study|Protocol Violation|2|||
41994098|NCT00471237|75802426|FG004|Overall Study|Protocol Violation|2|||
41994099|NCT00471237|75802427|FG005|Overall Study|Protocol Violation|4|||
41994100|NCT00471237|75802428|FG006|Overall Study|Protocol Violation|1|||
41994101|NCT00471237|75802422|FG000|Overall Study|Withdrawal by Subject|8|||
41994102|NCT00471237|75802423|FG001|Overall Study|Withdrawal by Subject|6|||
42320178|NCT01646177|76157046|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
42320179|NCT01646177|76157047|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
42320180|NCT01646177|76157048|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
42320181|NCT01646177|76157049|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
42320182|NCT01646177|76157050|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
42320183|NCT01646177|76157051|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
42320184|NCT01646177|76157052|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
42320185|NCT01646177|76157053|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
42320186|NCT01646177|76157042|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
42320187|NCT01646177|76157043|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
41994103|NCT00471237|75802424|FG002|Overall Study|Withdrawal by Subject|5|||
42320188|NCT01646177|76157044|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
42320189|NCT01646177|76157045|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
42320190|NCT01646177|76157046|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
42320191|NCT01646177|76157047|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
42320192|NCT01646177|76157048|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
42320193|NCT01646177|76157049|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
42320194|NCT01646177|76157050|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
42320195|NCT01646177|76157051|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
42320196|NCT01646177|76157052|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
42320197|NCT01646177|76157053|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
42320198|NCT01912287|76157076|FG000|Overall Study|Ineligible|1|||
42320199|NCT01912287|76157077|FG001|Overall Study|Ineligible|0|||
42320200|NCT01912287|76157078|FG002|Overall Study|Ineligible|1|||
42320201|NCT01912287|76157076|FG000|Overall Study|No-show|0|||
42320202|NCT01912287|76157077|FG001|Overall Study|No-show|0|||
42320203|NCT01912287|76157078|FG002|Overall Study|No-show|1|||
42320204|NCT01912287|76157076|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
42320205|NCT01912287|76157077|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
42320206|NCT01912287|76157078|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
42320207|NCT01912287|76157076|FG000|Overall Study|Felt treatment no longer needed|0|||
42320208|NCT01912287|76157077|FG001|Overall Study|Felt treatment no longer needed|1|||
42320209|NCT01912287|76157078|FG002|Overall Study|Felt treatment no longer needed|0|||
42320210|NCT01912287|76157076|FG000|Overall Study|Life circumstances|4|||
42320211|NCT01912287|76157077|FG001|Overall Study|Life circumstances|2|||
42320212|NCT01912287|76157078|FG002|Overall Study|Life circumstances|0|||
41994104|NCT00471237|75802425|FG003|Overall Study|Withdrawal by Subject|8|||
41994105|NCT00471237|75802426|FG004|Overall Study|Withdrawal by Subject|7|||
41994106|NCT00471237|75802427|FG005|Overall Study|Withdrawal by Subject|4|||
41994107|NCT00471237|75802428|FG006|Overall Study|Withdrawal by Subject|2|||
41994108|NCT00471237|75802422|FG000|Overall Study|Sponsor terminated study|20|||
41994109|NCT00471237|75802423|FG001|Overall Study|Sponsor terminated study|23|||
41994110|NCT00471237|75802424|FG002|Overall Study|Sponsor terminated study|19|||
41994111|NCT00471237|75802425|FG003|Overall Study|Sponsor terminated study|22|||
41994112|NCT00471237|75802426|FG004|Overall Study|Sponsor terminated study|18|||
41994113|NCT00471237|75802427|FG005|Overall Study|Sponsor terminated study|24|||
41994114|NCT00471237|75802428|FG006|Overall Study|Sponsor terminated study|0|||
41994115|NCT00471237|75802422|FG000|Overall Study|Non-compliance|0|||
41994116|NCT00471237|75802423|FG001|Overall Study|Non-compliance|1|||
41994117|NCT00471237|75802424|FG002|Overall Study|Non-compliance|0|||
42034046|NCT01070550|75842185|FG004|Overall Study|Protocol Violation|0|||
42320213|NCT01912287|76157076|FG000|Overall Study|Lost Interest|1|||
42320214|NCT01912287|76157077|FG001|Overall Study|Lost Interest|0|||
41994118|NCT00471237|75802425|FG003|Overall Study|Non-compliance|1|||
42258605|NCT01345253|76084943|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
42258606|NCT01345253|76084942|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
42258607|NCT01345253|76084943|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
42258608|NCT01345253|76084942|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
42258609|NCT01345253|76084943|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
42258610|NCT01345253|76084942|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
42258611|NCT01345253|76084943|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
42258612|NCT01345253|76084942|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
42320215|NCT01912287|76157078|FG002|Overall Study|Lost Interest|0|||
42320216|NCT01912287|76157076|FG000|Overall Study|Uknown reason - subject drop out|5|||
42320217|NCT01912287|76157077|FG001|Overall Study|Uknown reason - subject drop out|7|||
42320218|NCT01912287|76157078|FG002|Overall Study|Uknown reason - subject drop out|3|||
42320219|NCT01912287|76157076|FG000|Overall Study|Missed Assesment|1|||
42320220|NCT01912287|76157077|FG001|Overall Study|Missed Assesment|1|||
42320221|NCT01912287|76157078|FG002|Overall Study|Missed Assesment|1|||
42320222|NCT01912287|76157076|FG000|Overall Study|Scheduling/change in availability|17|||
42320223|NCT01912287|76157077|FG001|Overall Study|Scheduling/change in availability|10|||
42320224|NCT01912287|76157078|FG002|Overall Study|Scheduling/change in availability|8|||
42320225|NCT01929135|76157088|FG000|Overall Study|Lost to Follow-up|1|||
42320226|NCT01929135|76157089|FG001|Overall Study|Lost to Follow-up|1|||
42320227|NCT01911819|76157100|FG000|Overall Study|Adverse Event|0|||
42320228|NCT01911819|76157101|FG001|Overall Study|Adverse Event|1|||
42320229|NCT01911819|76157102|FG002|Overall Study|Adverse Event|0|||
42320230|NCT01911819|76157100|FG000|Overall Study|Withdrawal by Subject|1|||
42320231|NCT01911819|76157101|FG001|Overall Study|Withdrawal by Subject|1|||
42320232|NCT01911819|76157102|FG002|Overall Study|Withdrawal by Subject|0|||
42320233|NCT02280863|76157112|FG000|Integrated Platform|Met stopping criteria|0|||
42320234|NCT02280863|76157113|FG001|Integrated Platform|Met stopping criteria|1|||
42320235|NCT01911429|76157126|FG000|Overall Study|Adverse Event|5|||
42320236|NCT01911429|76157127|FG001|Overall Study|Adverse Event|3|||
42320237|NCT01911429|76157128|FG002|Overall Study|Adverse Event|9|||
42320238|NCT01911429|76157126|FG000|Overall Study|Lack of Efficacy|1|||
42320239|NCT01911429|76157127|FG001|Overall Study|Lack of Efficacy|2|||
42320240|NCT01911429|76157128|FG002|Overall Study|Lack of Efficacy|4|||
42320241|NCT01911429|76157126|FG000|Overall Study|Lost to Follow-up|0|||
42320242|NCT01911429|76157127|FG001|Overall Study|Lost to Follow-up|0|||
42320243|NCT01911429|76157128|FG002|Overall Study|Lost to Follow-up|1|||
42320244|NCT01911429|76157126|FG000|Overall Study|Protocol Violation|0|||
42320245|NCT01911429|76157127|FG001|Overall Study|Protocol Violation|0|||
42320246|NCT01911429|76157128|FG002|Overall Study|Protocol Violation|1|||
42320247|NCT01911429|76157126|FG000|Overall Study|Withdrawal by Subject|5|||
42320248|NCT01911429|76157127|FG001|Overall Study|Withdrawal by Subject|5|||
42320249|NCT01911429|76157128|FG002|Overall Study|Withdrawal by Subject|4|||
42320250|NCT01911429|76157126|FG000|Overall Study|Accidental randomization|0|||
42320251|NCT01911429|76157127|FG001|Overall Study|Accidental randomization|0|||
42320252|NCT01911429|76157128|FG002|Overall Study|Accidental randomization|1|||
42320253|NCT01911429|76157126|FG000|Overall Study|subject left study|1|||
42320254|NCT01911429|76157127|FG001|Overall Study|subject left study|0|||
42320255|NCT01911429|76157128|FG002|Overall Study|subject left study|0|||
42320256|NCT02324465|76157138|FG000|Overall Study|device failure|0|||
42320257|NCT02324465|76157139|FG001|Overall Study|device failure|1|||
42320258|NCT02324153|76157147|FG000|Overall Study|Withdrawal by Subject|4|||
42320259|NCT02324153|76157148|FG001|Overall Study|Withdrawal by Subject|1|||
42320260|NCT02324153|76157147|FG000|Overall Study|Surgery postponed after randomization|3|||
42320261|NCT02324153|76157148|FG001|Overall Study|Surgery postponed after randomization|0|||
42320262|NCT02324153|76157147|FG000|Overall Study|Developed delirium preoperatively|1|||
42320263|NCT02324153|76157148|FG001|Overall Study|Developed delirium preoperatively|0|||
42320264|NCT02280473|76157156|FG000|Overall Study|Adverse Event|1|||
42320265|NCT02280473|76157157|FG001|Overall Study|Adverse Event|1|||
42320266|NCT02280473|76157156|FG000|Overall Study|Lack of Efficacy|0|||
42320267|NCT02280473|76157157|FG001|Overall Study|Lack of Efficacy|1|||
42258613|NCT01345253|76084943|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
42258614|NCT01345253|76084942|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
42258615|NCT01345253|76084943|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
42258616|NCT01345253|76084942|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
42258617|NCT01345253|76084943|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
42258618|NCT01345253|76084942|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
42258619|NCT01345253|76084943|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
42258620|NCT01345253|76084942|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
42258621|NCT01345253|76084943|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
42258622|NCT01345253|76084942|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
42258623|NCT01345253|76084943|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
42258624|NCT02477800|76084954|FG000|Placebo-Controlled Period|Adverse Event|16|||
42258625|NCT02477800|76084955|FG001|Placebo-Controlled Period|Adverse Event|25|||
42258626|NCT02477800|76084956|FG002|Placebo-Controlled Period|Adverse Event|28|||
42320268|NCT02280473|76157156|FG000|Overall Study|Lost to Follow-up|0|||
42320269|NCT02280473|76157157|FG001|Overall Study|Lost to Follow-up|1|||
42320270|NCT01911273|76157165|FG000|Overall Study|Progression of Disease|1|||
42320271|NCT01911273|76157166|FG001|Overall Study|Progression of Disease|0|||
42320272|NCT01911273|76157165|FG000|Overall Study|Withdrawal by Subject|0|||
42320273|NCT01911273|76157166|FG001|Overall Study|Withdrawal by Subject|2|||
42320274|NCT02308007|76157175|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
42320275|NCT02308007|76157176|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
42320276|NCT02308007|76157177|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
42320277|NCT02308007|76157175|FG000|Overall Study|Positive for STD at Baseline|7|||
42258627|NCT02477800|76084957|FG003|Placebo-Controlled Period|Adverse Event|0|||
42258628|NCT02477800|76084958|FG004|Placebo-Controlled Period|Adverse Event|0|||
42258629|NCT02477800|76084959|FG005|Placebo-Controlled Period|Adverse Event|0|||
42320278|NCT02308007|76157176|FG001|Overall Study|Positive for STD at Baseline|11|||
42320279|NCT02308007|76157177|FG002|Overall Study|Positive for STD at Baseline|7|||
42320280|NCT02308007|76157175|FG000|Overall Study|Lost to Follow-up|3|||
42320281|NCT02308007|76157176|FG001|Overall Study|Lost to Follow-up|0|||
42320282|NCT02308007|76157177|FG002|Overall Study|Lost to Follow-up|1|||
42320283|NCT02278367|76157187|FG000|Overall Study|Physician Decision|5|||
42320284|NCT02278367|76157188|FG001|Overall Study|Physician Decision|0|||
42320285|NCT02278367|76157187|FG000|Overall Study|Withdrawal by Subject|5|||
42320286|NCT02278367|76157188|FG001|Overall Study|Withdrawal by Subject|0|||
42320287|NCT01910181|76157194|FG000|Overall Study|Death|37|||
42320288|NCT01910181|76157194|FG000|Overall Study|Lost to Follow-up|3|||
42320289|NCT01910181|76157194|FG000|Overall Study|Study Terminated by Sponsor|6|||
42320290|NCT01957215|76157201|FG000|Overall Study|Adverse Event|2|||
42320291|NCT01957215|76157202|FG001|Overall Study|Adverse Event|2|||
42320292|NCT01957215|76157201|FG000|Overall Study|Lost to Follow-up|3|||
42320293|NCT01957215|76157202|FG001|Overall Study|Lost to Follow-up|3|||
42320294|NCT01957215|76157201|FG000|Overall Study|Protocol Violation|1|||
42320295|NCT01957215|76157202|FG001|Overall Study|Protocol Violation|2|||
42320296|NCT01957215|76157201|FG000|Overall Study|Withdrawal by Subject|7|||
42320297|NCT01957215|76157202|FG001|Overall Study|Withdrawal by Subject|5|||
42320298|NCT02322749|76157212|FG000|Period 2|Adverse Event|0|||
42320299|NCT02322749|76157213|FG001|Period 2|Adverse Event|0|||
42320300|NCT02322749|76157214|FG002|Period 2|Adverse Event|0|||
42320301|NCT02322749|76157215|FG003|Period 2|Adverse Event|1|||
42320302|NCT02322749|76157216|FG004|Period 2|Adverse Event|0|||
42320303|NCT02322749|76157217|FG005|Period 2|Adverse Event|0|||
42320304|NCT02322749|76157212|FG000|Period 2|Withdrawal by Subject|0|||
42320305|NCT02322749|76157213|FG001|Period 2|Withdrawal by Subject|0|||
42320306|NCT02322749|76157214|FG002|Period 2|Withdrawal by Subject|0|||
42320307|NCT02322749|76157215|FG003|Period 2|Withdrawal by Subject|1|||
42320308|NCT02322749|76157216|FG004|Period 2|Withdrawal by Subject|0|||
42320309|NCT02322749|76157217|FG005|Period 2|Withdrawal by Subject|0|||
42320310|NCT02322749|76157212|FG000|Period 3|Withdrawal by Subject|0|||
42320311|NCT02322749|76157213|FG001|Period 3|Withdrawal by Subject|0|||
42320312|NCT02322749|76157214|FG002|Period 3|Withdrawal by Subject|1|||
42320313|NCT02322749|76157215|FG003|Period 3|Withdrawal by Subject|0|||
42320314|NCT02322749|76157216|FG004|Period 3|Withdrawal by Subject|0|||
42320315|NCT02322749|76157217|FG005|Period 3|Withdrawal by Subject|0|||
42320316|NCT01957137|76157226|FG000|Randomized Portion|Adverse Event|1|||
42320317|NCT01957137|76157226|FG000|Randomized Portion|Withdrawal by Subject|1|||
42320318|NCT01928433|76157241|FG000|Overall Study|Adverse Event|5|||
42320319|NCT01928433|76157242|FG001|Overall Study|Adverse Event|2|||
42320320|NCT01928433|76157243|FG002|Overall Study|Adverse Event|5|||
42320321|NCT01928433|76157241|FG000|Overall Study|Protocol Violation|0|||
42320322|NCT01928433|76157242|FG001|Overall Study|Protocol Violation|0|||
42320323|NCT01928433|76157243|FG002|Overall Study|Protocol Violation|2|||
42320324|NCT01928433|76157241|FG000|Overall Study|Lack of Efficacy|5|||
42258630|NCT02477800|76084960|FG006|Placebo-Controlled Period|Adverse Event|0|||
42258631|NCT02477800|76084954|FG000|Placebo-Controlled Period|Change of Treatment|1|||
42258632|NCT02477800|76084955|FG001|Placebo-Controlled Period|Change of Treatment|2|||
42258633|NCT02477800|76084956|FG002|Placebo-Controlled Period|Change of Treatment|1|||
42258634|NCT02477800|76084957|FG003|Placebo-Controlled Period|Change of Treatment|0|||
42258635|NCT02477800|76084958|FG004|Placebo-Controlled Period|Change of Treatment|0|||
42258636|NCT02477800|76084959|FG005|Placebo-Controlled Period|Change of Treatment|0|||
42258637|NCT02477800|76084960|FG006|Placebo-Controlled Period|Change of Treatment|0|||
42258638|NCT02477800|76084954|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
42258639|NCT02477800|76084955|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
42258640|NCT02477800|76084956|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
42320325|NCT01928433|76157242|FG001|Overall Study|Lack of Efficacy|4|||
42320326|NCT01928433|76157243|FG002|Overall Study|Lack of Efficacy|4|||
42320327|NCT01928433|76157241|FG000|Overall Study|Withdrawal by Subject|0|||
42320328|NCT01928433|76157242|FG001|Overall Study|Withdrawal by Subject|4|||
42258641|NCT02477800|76084957|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
42320329|NCT01928433|76157243|FG002|Overall Study|Withdrawal by Subject|0|||
42320330|NCT01928433|76157241|FG000|Overall Study|Negative screening urine culture|7|||
42320331|NCT01928433|76157242|FG001|Overall Study|Negative screening urine culture|6|||
42320332|NCT01928433|76157243|FG002|Overall Study|Negative screening urine culture|10|||
42320333|NCT01928433|76157241|FG000|Overall Study|Lost to Follow-up|0|||
42320334|NCT01928433|76157242|FG001|Overall Study|Lost to Follow-up|2|||
42320335|NCT01928433|76157243|FG002|Overall Study|Lost to Follow-up|3|||
42320336|NCT01928433|76157241|FG000|Overall Study|Other reasons|3|||
42320337|NCT01928433|76157242|FG001|Overall Study|Other reasons|3|||
42320338|NCT01928433|76157243|FG002|Overall Study|Other reasons|4|||
42320339|NCT02322281|76157257|FG000|Overall Study|Progressive Disease|42|||
42320340|NCT02322281|76157258|FG001|Overall Study|Progressive Disease|14|||
42320341|NCT02322281|76157259|FG002|Overall Study|Progressive Disease|49|||
42320342|NCT02322281|76157257|FG000|Overall Study|Adverse Event|3|||
42320343|NCT02322281|76157258|FG001|Overall Study|Adverse Event|4|||
42320344|NCT02322281|76157259|FG002|Overall Study|Adverse Event|6|||
42320345|NCT02322281|76157257|FG000|Overall Study|Death|3|||
42320346|NCT02322281|76157258|FG001|Overall Study|Death|3|||
42320347|NCT02322281|76157259|FG002|Overall Study|Death|3|||
42320348|NCT02322281|76157257|FG000|Overall Study|Withdrawal by Subject|1|||
42320349|NCT02322281|76157258|FG001|Overall Study|Withdrawal by Subject|1|||
42258642|NCT02477800|76084958|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
42258643|NCT02477800|76084959|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
42258644|NCT02477800|76084960|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
42258645|NCT02477800|76084954|FG000|Placebo-Controlled Period|Death|0|||
42258646|NCT02477800|76084955|FG001|Placebo-Controlled Period|Death|3|||
42258647|NCT02477800|76084956|FG002|Placebo-Controlled Period|Death|2|||
42258648|NCT02477800|76084957|FG003|Placebo-Controlled Period|Death|0|||
42258649|NCT02477800|76084958|FG004|Placebo-Controlled Period|Death|0|||
42258650|NCT02477800|76084959|FG005|Placebo-Controlled Period|Death|0|||
42258651|NCT02477800|76084960|FG006|Placebo-Controlled Period|Death|0|||
42258652|NCT02477800|76084954|FG000|Placebo-Controlled Period|Disease Progression|1|||
42258653|NCT02477800|76084955|FG001|Placebo-Controlled Period|Disease Progression|0|||
42258654|NCT02477800|76084956|FG002|Placebo-Controlled Period|Disease Progression|1|||
42258655|NCT02477800|76084957|FG003|Placebo-Controlled Period|Disease Progression|0|||
42258656|NCT02477800|76084958|FG004|Placebo-Controlled Period|Disease Progression|0|||
42258657|NCT02477800|76084959|FG005|Placebo-Controlled Period|Disease Progression|0|||
42258658|NCT02477800|76084960|FG006|Placebo-Controlled Period|Disease Progression|0|||
42258659|NCT02477800|76084954|FG000|Placebo-Controlled Period|Investigator Decision|3|||
42258660|NCT02477800|76084955|FG001|Placebo-Controlled Period|Investigator Decision|2|||
42320350|NCT02322281|76157259|FG002|Overall Study|Withdrawal by Subject|6|||
42320351|NCT02322281|76157257|FG000|Overall Study|Physician Decision|2|||
42320352|NCT02322281|76157258|FG001|Overall Study|Physician Decision|0|||
42320353|NCT02322281|76157259|FG002|Overall Study|Physician Decision|5|||
41994119|NCT00471237|75802426|FG004|Overall Study|Non-compliance|0|||
41994120|NCT00471237|75802427|FG005|Overall Study|Non-compliance|0|||
41994121|NCT00471237|75802428|FG006|Overall Study|Non-compliance|0|||
41994122|NCT00471237|75802422|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
41994123|NCT00471237|75802423|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
41994124|NCT00471237|75802424|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
41994125|NCT00471237|75802425|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
41994126|NCT00471237|75802426|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
41994127|NCT00471237|75802427|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
41994128|NCT00471237|75802428|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
41994129|NCT00471237|75802422|FG000|Overall Study|Early stopping due to non-efficacy|1|||
41994130|NCT00471237|75802423|FG001|Overall Study|Early stopping due to non-efficacy|0|||
41994131|NCT00471237|75802424|FG002|Overall Study|Early stopping due to non-efficacy|0|||
41994132|NCT00471237|75802425|FG003|Overall Study|Early stopping due to non-efficacy|0|||
41994133|NCT00471237|75802426|FG004|Overall Study|Early stopping due to non-efficacy|1|||
41994134|NCT00471237|75802427|FG005|Overall Study|Early stopping due to non-efficacy|0|||
41994135|NCT00471237|75802428|FG006|Overall Study|Early stopping due to non-efficacy|0|||
41994136|NCT00471237|75802422|FG000|Overall Study|Participant planned to travel to abraod|1|||
41994137|NCT00471237|75802423|FG001|Overall Study|Participant planned to travel to abraod|0|||
41994138|NCT00471237|75802424|FG002|Overall Study|Participant planned to travel to abraod|0|||
41994139|NCT00471237|75802425|FG003|Overall Study|Participant planned to travel to abraod|0|||
42258661|NCT02477800|76084956|FG002|Placebo-Controlled Period|Investigator Decision|1|||
42258662|NCT02477800|76084957|FG003|Placebo-Controlled Period|Investigator Decision|0|||
42258663|NCT02477800|76084958|FG004|Placebo-Controlled Period|Investigator Decision|0|||
42258664|NCT02477800|76084959|FG005|Placebo-Controlled Period|Investigator Decision|0|||
42258665|NCT02477800|76084960|FG006|Placebo-Controlled Period|Investigator Decision|0|||
42258666|NCT02477800|76084954|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
42258667|NCT02477800|76084955|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
42258668|NCT02477800|76084956|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
42258669|NCT02477800|76084957|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
42258670|NCT02477800|76084958|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
41994140|NCT00471237|75802426|FG004|Overall Study|Participant planned to travel to abraod|0|||
42258671|NCT02477800|76084959|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
42258672|NCT02477800|76084960|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
41994141|NCT00471237|75802427|FG005|Overall Study|Participant planned to travel to abraod|1|||
41994142|NCT00471237|75802428|FG006|Overall Study|Participant planned to travel to abraod|0|||
41994143|NCT00471237|75802422|FG000|Overall Study|High parathyroid hormone|0|||
41994144|NCT00471237|75802423|FG001|Overall Study|High parathyroid hormone|0|||
41994145|NCT00471237|75802424|FG002|Overall Study|High parathyroid hormone|1|||
41994146|NCT00471237|75802425|FG003|Overall Study|High parathyroid hormone|0|||
41994147|NCT00471237|75802426|FG004|Overall Study|High parathyroid hormone|0|||
41994148|NCT00471237|75802427|FG005|Overall Study|High parathyroid hormone|0|||
41994149|NCT00471237|75802428|FG006|Overall Study|High parathyroid hormone|0|||
41994150|NCT00471237|75802422|FG000|Overall Study|Participant lost medication|0|||
41994151|NCT00471237|75802423|FG001|Overall Study|Participant lost medication|0|||
41994152|NCT00471237|75802424|FG002|Overall Study|Participant lost medication|0|||
41994153|NCT00471237|75802425|FG003|Overall Study|Participant lost medication|0|||
42320354|NCT02322281|76157257|FG000|Overall Study|Study Terminated by Sponsor|2|||
42320355|NCT02322281|76157258|FG001|Overall Study|Study Terminated by Sponsor|0|||
42320356|NCT02322281|76157259|FG002|Overall Study|Study Terminated by Sponsor|0|||
42320357|NCT02322281|76157257|FG000|Overall Study|Missing|0|||
42320358|NCT02322281|76157258|FG001|Overall Study|Missing|0|||
42320359|NCT02322281|76157259|FG002|Overall Study|Missing|1|||
42320360|NCT02322281|76157257|FG000|Overall Study|Miscellaneous|0|||
42320361|NCT02322281|76157258|FG001|Overall Study|Miscellaneous|0|||
42320362|NCT02322281|76157259|FG002|Overall Study|Miscellaneous|4|||
42320363|NCT02322125|76157269|FG000|Overall Study|Withdrawal by Subject|2|||
42320364|NCT02243293|76157290|FG000|Overall Study|Adverse Event|1|||
42320365|NCT02243293|76157291|FG001|Overall Study|Adverse Event|0|||
42320366|NCT02243293|76157292|FG002|Overall Study|Adverse Event|0|||
42320367|NCT02243293|76157293|FG003|Overall Study|Adverse Event|0|||
42320368|NCT02243293|76157294|FG004|Overall Study|Adverse Event|0|||
42320369|NCT02243293|76157295|FG005|Overall Study|Adverse Event|0|||
42320370|NCT02243293|76157296|FG006|Overall Study|Adverse Event|0|||
42320371|NCT02243293|76157297|FG007|Overall Study|Adverse Event|0|||
42320372|NCT02243293|76157298|FG008|Overall Study|Adverse Event|0|||
42320373|NCT02243293|76157299|FG009|Overall Study|Adverse Event|0|||
42320374|NCT02243293|76157300|FG010|Overall Study|Adverse Event|0|||
42320375|NCT02243293|76157301|FG011|Overall Study|Adverse Event|0|||
42320376|NCT02243293|76157302|FG012|Overall Study|Adverse Event|0|||
42320377|NCT02243293|76157303|FG013|Overall Study|Adverse Event|0|||
42320378|NCT02243293|76157304|FG014|Overall Study|Adverse Event|0|||
42320379|NCT02243293|76157305|FG015|Overall Study|Adverse Event|1|||
42320380|NCT02243293|76157306|FG016|Overall Study|Adverse Event|0|||
42320381|NCT02243293|76157307|FG017|Overall Study|Adverse Event|0|||
42320382|NCT02243293|76157308|FG018|Overall Study|Adverse Event|0|||
42320383|NCT02243293|76157309|FG019|Overall Study|Adverse Event|0|||
42320384|NCT02243293|76157310|FG020|Overall Study|Adverse Event|1|||
42320385|NCT02243293|76157311|FG021|Overall Study|Adverse Event|0|||
42320386|NCT02243293|76157290|FG000|Overall Study|Withdrawal by Subject|1|||
41994154|NCT00471237|75802426|FG004|Overall Study|Participant lost medication|1|||
41994155|NCT00471237|75802427|FG005|Overall Study|Participant lost medication|0|||
41994156|NCT00471237|75802428|FG006|Overall Study|Participant lost medication|0|||
42258673|NCT02477800|76084954|FG000|Placebo-Controlled Period|Relocation|2|||
42258674|NCT02477800|76084955|FG001|Placebo-Controlled Period|Relocation|0|||
42258675|NCT02477800|76084956|FG002|Placebo-Controlled Period|Relocation|0|||
42258676|NCT02477800|76084957|FG003|Placebo-Controlled Period|Relocation|0|||
42258677|NCT02477800|76084958|FG004|Placebo-Controlled Period|Relocation|0|||
42258678|NCT02477800|76084959|FG005|Placebo-Controlled Period|Relocation|0|||
42258679|NCT02477800|76084960|FG006|Placebo-Controlled Period|Relocation|0|||
42258680|NCT02477800|76084954|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
42258681|NCT02477800|76084955|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
42258682|NCT02477800|76084956|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
42258683|NCT02477800|76084957|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
42258684|NCT02477800|76084958|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
42258685|NCT02477800|76084959|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
42258686|NCT02477800|76084960|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
41994157|NCT00471237|75802422|FG000|Overall Study|Administration of prohibited medicine|0|||
41994158|NCT00471237|75802423|FG001|Overall Study|Administration of prohibited medicine|0|||
42258687|NCT02477800|76084954|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
42258688|NCT02477800|76084955|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
42320387|NCT02243293|76157291|FG001|Overall Study|Withdrawal by Subject|0|||
42320388|NCT02243293|76157292|FG002|Overall Study|Withdrawal by Subject|0|||
41994159|NCT00471237|75802424|FG002|Overall Study|Administration of prohibited medicine|0|||
41994160|NCT00471237|75802425|FG003|Overall Study|Administration of prohibited medicine|0|||
42320389|NCT02243293|76157293|FG003|Overall Study|Withdrawal by Subject|0|||
42320390|NCT02243293|76157294|FG004|Overall Study|Withdrawal by Subject|0|||
42320391|NCT02243293|76157295|FG005|Overall Study|Withdrawal by Subject|0|||
42320392|NCT02243293|76157296|FG006|Overall Study|Withdrawal by Subject|0|||
42320393|NCT02243293|76157297|FG007|Overall Study|Withdrawal by Subject|0|||
42320394|NCT02243293|76157298|FG008|Overall Study|Withdrawal by Subject|0|||
42320395|NCT02243293|76157299|FG009|Overall Study|Withdrawal by Subject|1|||
42320396|NCT02243293|76157300|FG010|Overall Study|Withdrawal by Subject|0|||
42320397|NCT02243293|76157301|FG011|Overall Study|Withdrawal by Subject|1|||
42320398|NCT02243293|76157302|FG012|Overall Study|Withdrawal by Subject|0|||
41994161|NCT00471237|75802426|FG004|Overall Study|Administration of prohibited medicine|1|||
42320399|NCT02243293|76157303|FG013|Overall Study|Withdrawal by Subject|0|||
42320400|NCT02243293|76157304|FG014|Overall Study|Withdrawal by Subject|0|||
42320401|NCT02243293|76157305|FG015|Overall Study|Withdrawal by Subject|0|||
42320402|NCT02243293|76157306|FG016|Overall Study|Withdrawal by Subject|0|||
42320403|NCT02243293|76157307|FG017|Overall Study|Withdrawal by Subject|0|||
42320404|NCT02243293|76157308|FG018|Overall Study|Withdrawal by Subject|0|||
42320405|NCT02243293|76157309|FG019|Overall Study|Withdrawal by Subject|0|||
42320406|NCT02243293|76157310|FG020|Overall Study|Withdrawal by Subject|0|||
42320407|NCT02243293|76157311|FG021|Overall Study|Withdrawal by Subject|1|||
42320408|NCT02243293|76157290|FG000|Overall Study|Lost to Follow-up|0|||
42320409|NCT02243293|76157291|FG001|Overall Study|Lost to Follow-up|1|||
42320410|NCT02243293|76157292|FG002|Overall Study|Lost to Follow-up|1|||
42320411|NCT02243293|76157293|FG003|Overall Study|Lost to Follow-up|1|||
42320412|NCT02243293|76157294|FG004|Overall Study|Lost to Follow-up|0|||
42320413|NCT02243293|76157295|FG005|Overall Study|Lost to Follow-up|0|||
42320414|NCT02243293|76157296|FG006|Overall Study|Lost to Follow-up|3|||
42320415|NCT02243293|76157297|FG007|Overall Study|Lost to Follow-up|0|||
42320416|NCT02243293|76157298|FG008|Overall Study|Lost to Follow-up|0|||
42320417|NCT02243293|76157299|FG009|Overall Study|Lost to Follow-up|0|||
42320418|NCT02243293|76157300|FG010|Overall Study|Lost to Follow-up|0|||
42320419|NCT02243293|76157301|FG011|Overall Study|Lost to Follow-up|2|||
42320420|NCT02243293|76157302|FG012|Overall Study|Lost to Follow-up|0|||
42320421|NCT02243293|76157303|FG013|Overall Study|Lost to Follow-up|0|||
42320422|NCT02243293|76157304|FG014|Overall Study|Lost to Follow-up|0|||
42320423|NCT02243293|76157305|FG015|Overall Study|Lost to Follow-up|0|||
41994162|NCT00471237|75802427|FG005|Overall Study|Administration of prohibited medicine|0|||
41994163|NCT00471237|75802428|FG006|Overall Study|Administration of prohibited medicine|0|||
42320424|NCT02243293|76157306|FG016|Overall Study|Lost to Follow-up|3|||
42320425|NCT02243293|76157307|FG017|Overall Study|Lost to Follow-up|1|||
42320426|NCT02243293|76157308|FG018|Overall Study|Lost to Follow-up|0|||
42320427|NCT02243293|76157309|FG019|Overall Study|Lost to Follow-up|0|||
42320428|NCT02243293|76157310|FG020|Overall Study|Lost to Follow-up|1|||
41994164|NCT00471237|75802422|FG000|Overall Study|Participant shifted residence|0|||
41994165|NCT00471237|75802423|FG001|Overall Study|Participant shifted residence|0|||
41994166|NCT00471237|75802424|FG002|Overall Study|Participant shifted residence|0|||
41994167|NCT00471237|75802425|FG003|Overall Study|Participant shifted residence|0|||
42258689|NCT02477800|76084956|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
42258690|NCT02477800|76084957|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
42320429|NCT02243293|76157311|FG021|Overall Study|Lost to Follow-up|2|||
42320430|NCT02243293|76157290|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
42320431|NCT02243293|76157291|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
42320432|NCT02243293|76157292|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
42320433|NCT02243293|76157293|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
42320434|NCT02243293|76157294|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
41994168|NCT00471237|75802426|FG004|Overall Study|Participant shifted residence|1|||
41994169|NCT00471237|75802427|FG005|Overall Study|Participant shifted residence|0|||
42258691|NCT02477800|76084958|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
42258692|NCT02477800|76084959|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
42258693|NCT02477800|76084960|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
42258694|NCT02477800|76084954|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
42258695|NCT02477800|76084955|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
42258696|NCT02477800|76084956|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
42258697|NCT02477800|76084957|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
42258698|NCT02477800|76084958|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
42258699|NCT02477800|76084959|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
41994170|NCT00471237|75802428|FG006|Overall Study|Participant shifted residence|0|||
41994171|NCT00471237|75802422|FG000|Overall Study|Participant's decision|0|||
42258700|NCT02477800|76084960|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
42320435|NCT02243293|76157295|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
42320436|NCT02243293|76157296|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
42320437|NCT02243293|76157297|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
42320438|NCT02243293|76157298|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
42320439|NCT02243293|76157299|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
42320440|NCT02243293|76157300|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
42320441|NCT02243293|76157301|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
41994172|NCT00471237|75802423|FG001|Overall Study|Participant's decision|0|||
41994173|NCT00471237|75802424|FG002|Overall Study|Participant's decision|0|||
41994174|NCT00471237|75802425|FG003|Overall Study|Participant's decision|0|||
41994175|NCT00471237|75802426|FG004|Overall Study|Participant's decision|0|||
41994176|NCT00471237|75802427|FG005|Overall Study|Participant's decision|1|||
41994177|NCT00471237|75802428|FG006|Overall Study|Participant's decision|0|||
41994178|NCT00471081|75802450|FG000|Active Phase|Protocol Violation|1|||
41994179|NCT00471081|75802451|FG001|Active Phase|Protocol Violation|1|||
41994180|NCT00471081|75802450|FG000|Active Phase|Withdrawal by Subject|0|||
41994181|NCT00471081|75802451|FG001|Active Phase|Withdrawal by Subject|3|||
41994182|NCT00471081|75802450|FG000|Active Phase|Lost to Follow-up|0|||
42258701|NCT02477800|76084954|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
42258702|NCT02477800|76084955|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
42258703|NCT02477800|76084956|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
42258704|NCT02477800|76084957|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
42258705|NCT02477800|76084958|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
42258706|NCT02477800|76084959|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
42258707|NCT02477800|76084960|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
42258708|NCT02477800|76084954|FG000|Placebo-Controlled Period|Reason not Specified|161|||
42258709|NCT02477800|76084955|FG001|Placebo-Controlled Period|Reason not Specified|161|||
42258710|NCT02477800|76084956|FG002|Placebo-Controlled Period|Reason not Specified|189|||
42258711|NCT02477800|76084957|FG003|Placebo-Controlled Period|Reason not Specified|0|||
42258712|NCT02477800|76084958|FG004|Placebo-Controlled Period|Reason not Specified|0|||
42258713|NCT02477800|76084959|FG005|Placebo-Controlled Period|Reason not Specified|0|||
42258714|NCT02477800|76084960|FG006|Placebo-Controlled Period|Reason not Specified|0|||
42258715|NCT02477800|76084954|FG000|Long Term Extension Period|Adverse Event|0|||
42258716|NCT02477800|76084955|FG001|Long Term Extension Period|Adverse Event|0|||
42258717|NCT02477800|76084956|FG002|Long Term Extension Period|Adverse Event|0|||
42258718|NCT02477800|76084957|FG003|Long Term Extension Period|Adverse Event|6|||
42258719|NCT02477800|76084958|FG004|Long Term Extension Period|Adverse Event|2|||
42258720|NCT02477800|76084959|FG005|Long Term Extension Period|Adverse Event|4|||
42258721|NCT02477800|76084960|FG006|Long Term Extension Period|Adverse Event|3|||
42258722|NCT02477800|76084954|FG000|Long Term Extension Period|Death|0|||
42258723|NCT02477800|76084955|FG001|Long Term Extension Period|Death|0|||
42258724|NCT02477800|76084956|FG002|Long Term Extension Period|Death|0|||
42258725|NCT02477800|76084957|FG003|Long Term Extension Period|Death|1|||
42258726|NCT02477800|76084958|FG004|Long Term Extension Period|Death|1|||
42258727|NCT02477800|76084959|FG005|Long Term Extension Period|Death|1|||
42258728|NCT02477800|76084960|FG006|Long Term Extension Period|Death|2|||
42258729|NCT02477800|76084954|FG000|Long Term Extension Period|Consent Withdrawn|0|||
42258730|NCT02477800|76084955|FG001|Long Term Extension Period|Consent Withdrawn|0|||
42258731|NCT02477800|76084956|FG002|Long Term Extension Period|Consent Withdrawn|0|||
42258732|NCT02477800|76084957|FG003|Long Term Extension Period|Consent Withdrawn|10|||
42258733|NCT02477800|76084958|FG004|Long Term Extension Period|Consent Withdrawn|4|||
42258734|NCT02477800|76084959|FG005|Long Term Extension Period|Consent Withdrawn|13|||
42258735|NCT02477800|76084960|FG006|Long Term Extension Period|Consent Withdrawn|16|||
42258736|NCT02477800|76084954|FG000|Long Term Extension Period|Disease Progression|0|||
42258737|NCT02477800|76084955|FG001|Long Term Extension Period|Disease Progression|0|||
42258738|NCT02477800|76084956|FG002|Long Term Extension Period|Disease Progression|0|||
42258739|NCT02477800|76084957|FG003|Long Term Extension Period|Disease Progression|3|||
42258740|NCT02477800|76084958|FG004|Long Term Extension Period|Disease Progression|1|||
42258741|NCT02477800|76084959|FG005|Long Term Extension Period|Disease Progression|1|||
42258742|NCT02477800|76084960|FG006|Long Term Extension Period|Disease Progression|0|||
42258743|NCT02477800|76084954|FG000|Long Term Extension Period|Investigator Decision|0|||
42258744|NCT02477800|76084955|FG001|Long Term Extension Period|Investigator Decision|0|||
42258745|NCT02477800|76084956|FG002|Long Term Extension Period|Investigator Decision|0|||
42258746|NCT02477800|76084957|FG003|Long Term Extension Period|Investigator Decision|0|||
42258747|NCT02477800|76084958|FG004|Long Term Extension Period|Investigator Decision|0|||
41994183|NCT00471081|75802451|FG001|Active Phase|Lost to Follow-up|1|||
42258748|NCT02477800|76084959|FG005|Long Term Extension Period|Investigator Decision|0|||
42258749|NCT02477800|76084960|FG006|Long Term Extension Period|Investigator Decision|2|||
42258750|NCT02477800|76084954|FG000|Long Term Extension Period|Lost to Follow-up|0|||
42258751|NCT02477800|76084955|FG001|Long Term Extension Period|Lost to Follow-up|0|||
41994184|NCT00471081|75802450|FG000|Active Phase|Lost health plan/insurance|1|||
41994185|NCT00471081|75802451|FG001|Active Phase|Lost health plan/insurance|8|||
41994186|NCT00471081|75802450|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
42258752|NCT02477800|76084956|FG002|Long Term Extension Period|Lost to Follow-up|0|||
42258753|NCT02477800|76084957|FG003|Long Term Extension Period|Lost to Follow-up|0|||
42258754|NCT02477800|76084958|FG004|Long Term Extension Period|Lost to Follow-up|1|||
42258755|NCT02477800|76084959|FG005|Long Term Extension Period|Lost to Follow-up|3|||
42258756|NCT02477800|76084960|FG006|Long Term Extension Period|Lost to Follow-up|0|||
42258757|NCT02477800|76084954|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
41994187|NCT00471081|75802451|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
41994188|NCT00471081|75802450|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
41994189|NCT00471081|75802451|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
41994190|NCT00471081|75802450|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
41994191|NCT00471081|75802451|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
42320442|NCT02243293|76157302|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
42320443|NCT02243293|76157303|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
42320444|NCT02243293|76157304|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
42320445|NCT02243293|76157305|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
42320446|NCT02243293|76157306|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
42320447|NCT02243293|76157307|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
42320448|NCT02243293|76157308|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
42320449|NCT02243293|76157309|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
42320450|NCT02243293|76157310|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
42320451|NCT02243293|76157311|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
42320452|NCT02243293|76157290|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
42320453|NCT02243293|76157291|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
42320454|NCT02243293|76157292|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
42320455|NCT02243293|76157293|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
42320456|NCT02243293|76157294|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
42320457|NCT02243293|76157295|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
42320458|NCT02243293|76157296|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
42320459|NCT02243293|76157297|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
42320460|NCT02243293|76157298|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
42320461|NCT02243293|76157299|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
42320462|NCT02243293|76157300|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
42320463|NCT02243293|76157301|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
42320464|NCT02243293|76157302|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
42320465|NCT02243293|76157303|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
42320466|NCT02243293|76157304|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
42320467|NCT02243293|76157305|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
42320468|NCT02243293|76157306|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
42320469|NCT02243293|76157307|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
42320470|NCT02243293|76157308|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
42320471|NCT02243293|76157309|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
42320472|NCT02243293|76157310|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
42320473|NCT02243293|76157311|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
42320474|NCT02322047|76157352|FG000|Overall Study|Physician Decision|1|||
42320475|NCT02322047|76157353|FG001|Overall Study|Physician Decision|0|||
42320476|NCT02322047|76157354|FG002|Overall Study|Physician Decision|0|||
41994192|NCT00470847|75802458|FG000|Overall Study|Pt still receiving treatment|1|||
42320477|NCT02322047|76157355|FG003|Overall Study|Physician Decision|0|||
42320478|NCT02322047|76157352|FG000|Overall Study|Withdrawal by Subject|1|||
42320479|NCT02322047|76157353|FG001|Overall Study|Withdrawal by Subject|0|||
41994193|NCT00470535|75802464|FG000|Overall Study|Disease Progression|13|||
42320480|NCT02322047|76157354|FG002|Overall Study|Withdrawal by Subject|0|||
41994194|NCT00470535|75802464|FG000|Overall Study|Withdrawal by Subject|1|||
41994195|NCT00470535|75802464|FG000|Overall Study|Adverse Event|1|||
42320481|NCT02322047|76157355|FG003|Overall Study|Withdrawal by Subject|1|||
42320482|NCT02322047|76157352|FG000|Overall Study|Adverse Event|0|||
42320483|NCT02322047|76157353|FG001|Overall Study|Adverse Event|1|||
42320484|NCT02322047|76157354|FG002|Overall Study|Adverse Event|0|||
42320485|NCT02322047|76157355|FG003|Overall Study|Adverse Event|0|||
42320486|NCT02322047|76157352|FG000|Overall Study|Lost to Follow-up|0|||
42320487|NCT02322047|76157353|FG001|Overall Study|Lost to Follow-up|0|||
42320488|NCT02322047|76157354|FG002|Overall Study|Lost to Follow-up|1|||
42320489|NCT02322047|76157355|FG003|Overall Study|Lost to Follow-up|1|||
42320490|NCT02254291|76157368|FG000|Overall Study|Withdrawal by Subject|0|||
42320491|NCT02254291|76157369|FG001|Overall Study|Withdrawal by Subject|3|||
42320492|NCT02254291|76157370|FG002|Overall Study|Withdrawal by Subject|1|||
42320493|NCT02254291|76157368|FG000|Overall Study|Missing follow-up information|0|||
42320494|NCT02254291|76157369|FG001|Overall Study|Missing follow-up information|0|||
42320495|NCT02254291|76157370|FG002|Overall Study|Missing follow-up information|1|||
42320496|NCT02253433|76157380|FG000|Overall Study|Unable to Contact|9|||
42320497|NCT02253433|76157381|FG001|Overall Study|Unable to Contact|16|||
42320498|NCT02253433|76157380|FG000|Overall Study|Death|1|||
42320499|NCT02253433|76157381|FG001|Overall Study|Death|1|||
42320500|NCT02253433|76157380|FG000|Overall Study|No Longer Interested|3|||
42320501|NCT02253433|76157381|FG001|Overall Study|No Longer Interested|15|||
42320502|NCT02253433|76157380|FG000|Overall Study|Out of Study Area|2|||
42320503|NCT02253433|76157381|FG001|Overall Study|Out of Study Area|7|||
42320504|NCT02253433|76157380|FG000|Overall Study|Uncomfortable with home visitors|0|||
42320505|NCT02253433|76157381|FG001|Overall Study|Uncomfortable with home visitors|3|||
42258758|NCT02477800|76084955|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
42258759|NCT02477800|76084956|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
42258760|NCT02477800|76084957|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
42258761|NCT02477800|76084958|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
41994196|NCT00470535|75802464|FG000|Overall Study|Death|1|||
42258762|NCT02477800|76084959|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
42258763|NCT02477800|76084960|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
42258764|NCT02477800|76084954|FG000|Long Term Extension Period|Study Visit Burden|0|||
42258765|NCT02477800|76084955|FG001|Long Term Extension Period|Study Visit Burden|0|||
42258766|NCT02477800|76084956|FG002|Long Term Extension Period|Study Visit Burden|0|||
42258767|NCT02477800|76084957|FG003|Long Term Extension Period|Study Visit Burden|3|||
42258768|NCT02477800|76084958|FG004|Long Term Extension Period|Study Visit Burden|0|||
42320506|NCT02253433|76157380|FG000|Overall Study|Unstable Housing/Homeless|0|||
42320507|NCT02253433|76157381|FG001|Overall Study|Unstable Housing/Homeless|7|||
42320508|NCT02253433|76157380|FG000|Overall Study|Too Busy|0|||
42320509|NCT02253433|76157381|FG001|Overall Study|Too Busy|4|||
42320510|NCT02253433|76157380|FG000|Overall Study|Medical or Other Concerns|1|||
41994197|NCT00470535|75802464|FG000|Overall Study|Other|2|||
41994198|NCT00470418|75802470|FG000|Overall Study|Withdrawal by Subject|1|||
41994199|NCT00470418|75802471|FG001|Overall Study|Withdrawal by Subject|0|||
42258769|NCT02477800|76084959|FG005|Long Term Extension Period|Study Visit Burden|2|||
42258770|NCT02477800|76084960|FG006|Long Term Extension Period|Study Visit Burden|2|||
42258771|NCT02477800|76084954|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
42258772|NCT02477800|76084955|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
42258773|NCT02477800|76084956|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
42258774|NCT02477800|76084957|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
42258775|NCT02477800|76084958|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
42320511|NCT02253433|76157381|FG001|Overall Study|Medical or Other Concerns|2|||
42320512|NCT02242981|76157388|FG000|Overall Study|Withdrawal by Subject|1|||
42320513|NCT02277743|76157395|FG000|Overall Study|Protocol Violation|1|||
42320514|NCT02277743|76157396|FG001|Overall Study|Protocol Violation|1|||
42320515|NCT02277743|76157397|FG002|Overall Study|Protocol Violation|1|||
42320516|NCT02277743|76157395|FG000|Overall Study|Adverse Event|10|||
42320517|NCT02277743|76157396|FG001|Overall Study|Adverse Event|6|||
42320518|NCT02277743|76157397|FG002|Overall Study|Adverse Event|6|||
42320519|NCT02277743|76157395|FG000|Overall Study|Lack of Efficacy|11|||
42320520|NCT02277743|76157396|FG001|Overall Study|Lack of Efficacy|4|||
42320521|NCT02277743|76157397|FG002|Overall Study|Lack of Efficacy|3|||
42320522|NCT02277743|76157395|FG000|Overall Study|Other than specified above|18|||
42320523|NCT02277743|76157396|FG001|Overall Study|Other than specified above|5|||
42320524|NCT02277743|76157397|FG002|Overall Study|Other than specified above|16|||
42320525|NCT02242903|76157412|FG000|Overall Study|Withdrawal by Subject|1|||
42320526|NCT02242903|76157413|FG001|Overall Study|Withdrawal by Subject|0|||
42320527|NCT02242903|76157414|FG002|Overall Study|Withdrawal by Subject|0|||
42320528|NCT02242903|76157415|FG003|Overall Study|Withdrawal by Subject|0|||
42320529|NCT02242903|76157416|FG004|Overall Study|Withdrawal by Subject|0|||
42320530|NCT02242903|76157417|FG005|Overall Study|Withdrawal by Subject|0|||
42320531|NCT02242903|76157418|FG006|Overall Study|Withdrawal by Subject|0|||
42320532|NCT02320721|76157442|FG000|Overall Study|Adverse Event|6|||
42320533|NCT02320721|76157443|FG001|Overall Study|Adverse Event|6|||
42320534|NCT02320721|76157442|FG000|Overall Study|Lack of Efficacy|2|||
42320535|NCT02320721|76157443|FG001|Overall Study|Lack of Efficacy|0|||
42320536|NCT02320721|76157442|FG000|Overall Study|Poor compliance to protocol|3|||
42320537|NCT02320721|76157443|FG001|Overall Study|Poor compliance to protocol|7|||
42320538|NCT02320721|76157442|FG000|Overall Study|Randomized but not treated|0|||
42320539|NCT02320721|76157443|FG001|Overall Study|Randomized but not treated|1|||
42320540|NCT02320721|76157442|FG000|Overall Study|Hypoglycemia|1|||
42320541|NCT02320721|76157443|FG001|Overall Study|Hypoglycemia|0|||
42320542|NCT02320721|76157442|FG000|Overall Study|Other than specified above|15|||
42320543|NCT02320721|76157443|FG001|Overall Study|Other than specified above|20|||
42320544|NCT02320487|76157449|FG000|Overall Study|Reason not Specified|1|||
42320545|NCT02320487|76157449|FG000|Overall Study|Physician Decision|5|||
42320546|NCT02320487|76157449|FG000|Overall Study|Withdrawal by Subject|1|||
42320547|NCT02320487|76157449|FG000|Overall Study|Death|3|||
42320548|NCT02320487|76157449|FG000|Overall Study|Adverse Event|11|||
42320549|NCT02277119|76157456|FG000|Overall Study|Lack of Efficacy|1|||
42320550|NCT02277119|76157457|FG001|Overall Study|Lack of Efficacy|1|||
42320551|NCT02277119|76157458|FG002|Overall Study|Lack of Efficacy|1|||
42320552|NCT02277119|76157456|FG000|Overall Study|Protocol Violation|2|||
42320553|NCT02277119|76157457|FG001|Overall Study|Protocol Violation|3|||
42320554|NCT02277119|76157458|FG002|Overall Study|Protocol Violation|7|||
42320555|NCT02320253|76157469|FG000|Overall Study|Withdrawal by Subject|3|||
42320556|NCT02320253|76157470|FG001|Overall Study|Withdrawal by Subject|0|||
41994200|NCT01133275|75802477|FG000|Overall Study|Withdrawal by Subject|1|||
42320557|NCT02320253|76157471|FG002|Overall Study|Withdrawal by Subject|0|||
42320558|NCT02320253|76157469|FG000|Overall Study|Lost to Follow-up|2|||
42320559|NCT02320253|76157470|FG001|Overall Study|Lost to Follow-up|2|||
42320560|NCT02320253|76157471|FG002|Overall Study|Lost to Follow-up|1|||
42320561|NCT02320253|76157469|FG000|Overall Study|Death|1|||
42320562|NCT02320253|76157470|FG001|Overall Study|Death|0|||
42320563|NCT02320253|76157471|FG002|Overall Study|Death|1|||
42320564|NCT02276807|76157481|FG000|Overall Study|Withdrawal by Subject|8|||
42320565|NCT02276807|76157482|FG001|Overall Study|Withdrawal by Subject|7|||
42320566|NCT02276807|76157481|FG000|Overall Study|Lost to Follow-up|10|||
42258776|NCT02477800|76084959|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
42320567|NCT02276807|76157482|FG001|Overall Study|Lost to Follow-up|10|||
42320568|NCT02252965|76157490|FG000|Overall Study|Adverse Event|9|||
42320569|NCT02252965|76157491|FG001|Overall Study|Adverse Event|14|||
42320570|NCT02252965|76157490|FG000|Overall Study|Lost to Follow-up|16|||
42320571|NCT02252965|76157491|FG001|Overall Study|Lost to Follow-up|8|||
42320572|NCT02252965|76157490|FG000|Overall Study|Protocol Violation|4|||
42320573|NCT02252965|76157491|FG001|Overall Study|Protocol Violation|5|||
42320574|NCT02252965|76157490|FG000|Overall Study|Lack of Efficacy|0|||
42320575|NCT02252965|76157491|FG001|Overall Study|Lack of Efficacy|2|||
42320576|NCT02252965|76157490|FG000|Overall Study|Withdrawal by Subject|7|||
42320577|NCT02252965|76157491|FG001|Overall Study|Withdrawal by Subject|9|||
42320578|NCT02252965|76157490|FG000|Overall Study|Other|4|||
42320579|NCT02252965|76157491|FG001|Overall Study|Other|5|||
42320580|NCT02242435|76157501|FG000|Overall Study|Lost to Follow-up|3|||
42320581|NCT02242435|76157502|FG001|Overall Study|Lost to Follow-up|4|||
42320582|NCT02242435|76157501|FG000|Overall Study|Adverse Event|3|||
42320583|NCT02242435|76157502|FG001|Overall Study|Adverse Event|2|||
42320584|NCT02242435|76157501|FG000|Overall Study|Withdrawal by Subject|13|||
42320585|NCT02242435|76157502|FG001|Overall Study|Withdrawal by Subject|8|||
42320586|NCT02242435|76157501|FG000|Overall Study|Death|0|||
42320587|NCT02242435|76157502|FG001|Overall Study|Death|1|||
42320588|NCT02242435|76157501|FG000|Overall Study|Protocol Violation|1|||
42320589|NCT02242435|76157502|FG001|Overall Study|Protocol Violation|0|||
42320590|NCT02242435|76157501|FG000|Overall Study|Physician Decision|0|||
42320591|NCT02242435|76157502|FG001|Overall Study|Physician Decision|1|||
42320592|NCT02251717|76157510|FG000|Overall Study|Adverse Event|0|||
42320593|NCT02251717|76157511|FG001|Overall Study|Adverse Event|1|||
42320594|NCT02251717|76157510|FG000|Overall Study|Withdrew Consent|1|||
42320595|NCT02251717|76157511|FG001|Overall Study|Withdrew Consent|0|||
42320596|NCT02242201|76157520|FG000|Overall Study|preoperative identified neuropathy|2|||
42320597|NCT02242201|76157521|FG001|Overall Study|preoperative identified neuropathy|0|||
42320598|NCT02242201|76157522|FG002|Overall Study|preoperative identified neuropathy|0|||
42320599|NCT02242201|76157520|FG000|Overall Study|planned post-op anticoagulation|1|||
42320600|NCT02242201|76157521|FG001|Overall Study|planned post-op anticoagulation|0|||
42320601|NCT02242201|76157522|FG002|Overall Study|planned post-op anticoagulation|0|||
42320602|NCT02242201|76157520|FG000|Overall Study|changed surgical procedure|1|||
42320603|NCT02242201|76157521|FG001|Overall Study|changed surgical procedure|0|||
42320604|NCT02242201|76157522|FG002|Overall Study|changed surgical procedure|0|||
42320605|NCT02242201|76157520|FG000|Overall Study|postponed surgery|0|||
42320606|NCT02242201|76157521|FG001|Overall Study|postponed surgery|0|||
42320607|NCT02242201|76157522|FG002|Overall Study|postponed surgery|1|||
42320608|NCT02242201|76157520|FG000|Overall Study|preoperative opioid consumption|0|||
42320609|NCT02242201|76157521|FG001|Overall Study|preoperative opioid consumption|1|||
42320610|NCT02242201|76157522|FG002|Overall Study|preoperative opioid consumption|0|||
42320611|NCT02242045|76157530|FG000|Overall Study|Investigator's Discretion|1|||
42320612|NCT02242045|76157530|FG000|Overall Study|Progressive Disease|2|||
41994201|NCT01133275|75802477|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
41994202|NCT00470184|75802481|FG000|Overall Study|Not Treated(became ineligible)|4|||
42258777|NCT02477800|76084960|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
42258778|NCT02477800|76084954|FG000|Long Term Extension Period|Reason not Specified|0|||
42258779|NCT02477800|76084955|FG001|Long Term Extension Period|Reason not Specified|0|||
42258780|NCT02477800|76084956|FG002|Long Term Extension Period|Reason not Specified|0|||
42258781|NCT02477800|76084957|FG003|Long Term Extension Period|Reason not Specified|126|||
42258782|NCT02477800|76084958|FG004|Long Term Extension Period|Reason not Specified|140|||
42258783|NCT02477800|76084959|FG005|Long Term Extension Period|Reason not Specified|270|||
42258784|NCT02477800|76084960|FG006|Long Term Extension Period|Reason not Specified|224|||
42258785|NCT02957747|76084974|FG000|Overall Study|Withdrawal by Subject|0|||
42320613|NCT02242045|76157530|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
42320614|NCT02242045|76157530|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
42320615|NCT02241889|76157534|FG000|Overall Study|device issues|0|||
42320616|NCT02241889|76157535|FG001|Overall Study|device issues|0|||
42320617|NCT02241889|76157536|FG002|Overall Study|device issues|1|||
42320618|NCT02241889|76157537|FG003|Overall Study|device issues|0|||
42320619|NCT02241889|76157538|FG004|Overall Study|device issues|0|||
42320620|NCT02241889|76157539|FG005|Overall Study|device issues|0|||
42320621|NCT02241889|76157534|FG000|Overall Study|Withdrawal by Subject|0|||
42320622|NCT02241889|76157535|FG001|Overall Study|Withdrawal by Subject|0|||
42320623|NCT02241889|76157536|FG002|Overall Study|Withdrawal by Subject|0|||
42320624|NCT02241889|76157537|FG003|Overall Study|Withdrawal by Subject|0|||
42320625|NCT02241889|76157538|FG004|Overall Study|Withdrawal by Subject|0|||
42320626|NCT02241889|76157539|FG005|Overall Study|Withdrawal by Subject|1|||
42320627|NCT02241733|76157549|FG000|Overall Study|Lost to Follow-up|9|||
42320628|NCT02241733|76157550|FG001|Overall Study|Lost to Follow-up|4|||
42320629|NCT02241733|76157549|FG000|Overall Study|Physician Decision|6|||
42320630|NCT02241733|76157550|FG001|Overall Study|Physician Decision|2|||
42320631|NCT02241733|76157549|FG000|Overall Study|Withdrawal by Subject|0|||
42320632|NCT02241733|76157550|FG001|Overall Study|Withdrawal by Subject|2|||
42320633|NCT02241733|76157549|FG000|Overall Study|Death|0|||
42320634|NCT02241733|76157550|FG001|Overall Study|Death|2|||
41994203|NCT00470184|75802481|FG000|Overall Study|Not treated (other)|1|||
41994204|NCT00470184|75802481|FG000|Overall Study|disease Progression|4|||
41994205|NCT00470184|75802481|FG000|Overall Study|Adverse Event|3|||
41994206|NCT00470184|75802481|FG000|Overall Study|Withdrawal by Subject|4|||
41994207|NCT00470184|75802481|FG000|Overall Study|other|5|||
41994208|NCT00470184|75802481|FG000|Overall Study|recurrence|1|||
41994209|NCT00470067|75802486|FG000|Overall Study|Death|1|||
41994210|NCT00470067|75802486|FG000|Overall Study|Disease Progression|6|||
41994211|NCT00475020|75802490|FG000|Overall Study|Physician Decision|3|||
41994212|NCT00475020|75802490|FG000|Overall Study|Insurance Denial|1|||
42034047|NCT01070550|75842186|FG005|Overall Study|Protocol Violation|0|||
42034048|NCT01070550|75842181|FG000|Overall Study|Relapse|44|||
42034049|NCT01070550|75842182|FG001|Overall Study|Relapse|5|||
42258786|NCT02957747|76084975|FG001|Overall Study|Withdrawal by Subject|3|||
42258787|NCT02957747|76084974|FG000|Overall Study|Lost to Follow-up|10|||
42258788|NCT02957747|76084975|FG001|Overall Study|Lost to Follow-up|5|||
42258789|NCT01344161|76084984|FG000|Overall Study|Lost to Follow-up|4|||
42258790|NCT01344161|76084985|FG001|Overall Study|Lost to Follow-up|1|||
42258791|NCT01344161|76084984|FG000|Overall Study|Pregnancy|0|||
42258792|NCT01344161|76084985|FG001|Overall Study|Pregnancy|1|||
42258793|NCT01344161|76084984|FG000|Overall Study|Protocol Violation|1|||
42258794|NCT01344161|76084985|FG001|Overall Study|Protocol Violation|1|||
42258795|NCT02451358|76084995|FG000|Overall Study|Withdrawal by Subject|1|||
42258796|NCT02451358|76084996|FG001|Overall Study|Withdrawal by Subject|1|||
42258797|NCT02451358|76084997|FG002|Overall Study|Withdrawal by Subject|0|||
42258798|NCT02451358|76084998|FG003|Overall Study|Withdrawal by Subject|0|||
42258799|NCT02451358|76084995|FG000|Overall Study|Protocol Violation|0|||
42258800|NCT02451358|76084996|FG001|Overall Study|Protocol Violation|1|||
42258801|NCT02451358|76084997|FG002|Overall Study|Protocol Violation|1|||
42258802|NCT02451358|76084998|FG003|Overall Study|Protocol Violation|0|||
42258803|NCT02749721|76085008|FG000|Screening|Withdrawal by Subject|1|||
42258804|NCT02749721|76085008|FG000|Screening|Lost to Follow-up|2|||
42258805|NCT02749721|76085008|FG000|Screening|Protocol Violation|3|||
42258806|NCT02749721|76085008|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
42258807|NCT02749721|76085008|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
42258808|NCT01348139|76085014|FG000|Period 1|Adverse Event|1|||
42320635|NCT02241343|76157556|FG000|Overall Study|Adverse Event|1|||
42320636|NCT02241187|76157561|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
41994213|NCT00475020|75802490|FG000|Overall Study|Donor not able to donate the last minute|1|||
41994214|NCT02484456|75802496|FG000|Washout Period|Withdrawal by Subject|0|||
41994215|NCT02484456|75802497|FG001|Washout Period|Withdrawal by Subject|1|||
42034050|NCT01070550|75842183|FG002|Overall Study|Relapse|14|||
42034051|NCT01070550|75842184|FG003|Overall Study|Relapse|4|||
42258809|NCT01348139|76085015|FG001|Period 1|Adverse Event|0|||
42320637|NCT02249767|76157568|FG000|Overall Study|Did not use medication|8|||
42320638|NCT02249767|76157569|FG001|Overall Study|Did not use medication|9|||
42320639|NCT02249767|76157570|FG002|Overall Study|Did not use medication|8|||
42320640|NCT02239939|76157580|FG000|Overall Study|Adverse Event|1|||
42320641|NCT02239939|76157581|FG001|Overall Study|Adverse Event|0|||
42320642|NCT02239939|76157580|FG000|Overall Study|Withdrawal by Subject|1|||
42320643|NCT02239939|76157581|FG001|Overall Study|Withdrawal by Subject|1|||
42320644|NCT02239939|76157580|FG000|Overall Study|Lost to Follow-up|0|||
42320645|NCT02239939|76157581|FG001|Overall Study|Lost to Follow-up|1|||
42320646|NCT02248675|76157591|FG000|Overall Study|Lost to Follow-up|3|||
42320647|NCT02248675|76157592|FG001|Overall Study|Lost to Follow-up|1|||
42320648|NCT02238379|76157600|FG000|Overall Study|Lost to Follow-up|1|||
42320649|NCT02238379|76157601|FG001|Overall Study|Lost to Follow-up|0|||
42320650|NCT02238067|76157607|FG000|Overall Study|Not completed survey at Month 6|45|||
42320651|NCT02237911|76157614|FG000|Overall Study|Withdrawal by Subject|4|||
42320652|NCT02237911|76157615|FG001|Overall Study|Withdrawal by Subject|7|||
41994216|NCT02484456|75802496|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
42258810|NCT01348139|76085016|FG002|Period 1|Adverse Event|0|||
42258811|NCT01348139|76085017|FG003|Period 1|Adverse Event|0|||
42258812|NCT01348139|76085018|FG004|Period 1|Adverse Event|0|||
42320653|NCT02237911|76157616|FG002|Overall Study|Withdrawal by Subject|2|||
42320654|NCT02237911|76157614|FG000|Overall Study|Lost to Follow-up|3|||
42320655|NCT02237911|76157615|FG001|Overall Study|Lost to Follow-up|1|||
42320656|NCT02237911|76157616|FG002|Overall Study|Lost to Follow-up|1|||
42320657|NCT02234479|76157626|FG000|Overall Study|Withdrawal by Subject|1|||
42320658|NCT02234479|76157627|FG001|Overall Study|Withdrawal by Subject|3|||
42320659|NCT02207491|76157635|FG000|Overall Study|Adverse Event|20|||
42320660|NCT02207491|76157636|FG001|Overall Study|Adverse Event|4|||
42320661|NCT02207491|76157635|FG000|Overall Study|Withdrawal by Subject|3|||
42258813|NCT01348139|76085019|FG005|Period 1|Adverse Event|0|||
42258814|NCT02868229|76085037|FG000|Overall Study|Adverse Event|1|||
42258815|NCT02868229|76085038|FG001|Overall Study|Adverse Event|0|||
42258816|NCT02868229|76085039|FG002|Overall Study|Adverse Event|0|||
42258817|NCT02868229|76085040|FG003|Overall Study|Adverse Event|1|||
42258818|NCT02868229|76085037|FG000|Overall Study|Death|0|||
42258819|NCT02868229|76085038|FG001|Overall Study|Death|0|||
42258820|NCT02868229|76085039|FG002|Overall Study|Death|1|||
42258821|NCT02868229|76085040|FG003|Overall Study|Death|1|||
42258822|NCT02868229|76085037|FG000|Overall Study|Missed dose|0|||
42258823|NCT02868229|76085038|FG001|Overall Study|Missed dose|0|||
42258824|NCT02868229|76085039|FG002|Overall Study|Missed dose|0|||
42258825|NCT02868229|76085040|FG003|Overall Study|Missed dose|3|||
42258826|NCT02956967|76085055|FG000|Overall Study|Adverse Event|3|||
42258827|NCT02956967|76085055|FG000|Overall Study|Reason non-related to neutropenia|10|||
42258828|NCT02956967|76085055|FG000|Overall Study|Lost to Follow-up|5|||
42258829|NCT02956967|76085055|FG000|Overall Study|Missing|1|||
42258830|NCT02956967|76085055|FG000|Overall Study|Termination of Nivestim administration|29|||
42258831|NCT02867995|76085079|FG000|Overall Study|Withdrawal by Subject|0|||
42258832|NCT02867995|76085080|FG001|Overall Study|Withdrawal by Subject|1|||
42258833|NCT02867995|76085079|FG000|Overall Study|Lost to Follow-up|0|||
42258834|NCT02867995|76085080|FG001|Overall Study|Lost to Follow-up|2|||
42258835|NCT03392883|76085093|FG000|Overall Study|Lost to Follow-up|122|||
42258836|NCT03392883|76085094|FG001|Overall Study|Lost to Follow-up|13|||
42320662|NCT02207491|76157636|FG001|Overall Study|Withdrawal by Subject|2|||
42320663|NCT02207491|76157635|FG000|Overall Study|Non-compliant|0|||
42320664|NCT02207491|76157636|FG001|Overall Study|Non-compliant|1|||
42320665|NCT02207491|76157635|FG000|Overall Study|Lost to Follow-up|0|||
42320666|NCT02207491|76157636|FG001|Overall Study|Lost to Follow-up|1|||
42320667|NCT02207491|76157635|FG000|Overall Study|Lack of Efficacy|3|||
42258837|NCT03392883|76085095|FG002|Overall Study|Lost to Follow-up|9|||
42258838|NCT03392883|76085093|FG000|Overall Study|Death|4|||
42258839|NCT03392883|76085094|FG001|Overall Study|Death|0|||
42258840|NCT03392883|76085095|FG002|Overall Study|Death|0|||
42258841|NCT03392883|76085093|FG000|Overall Study|Lack of Efficacy|29|||
42320668|NCT02207491|76157636|FG001|Overall Study|Lack of Efficacy|0|||
42320669|NCT02207491|76157635|FG000|Overall Study|Physician Decision|2|||
42320670|NCT02207491|76157636|FG001|Overall Study|Physician Decision|0|||
42320671|NCT02207491|76157635|FG000|Overall Study|Protocol Violation|3|||
42320672|NCT02207491|76157636|FG001|Overall Study|Protocol Violation|5|||
42320673|NCT02315066|76157656|FG000|Overall Study|Lost to Follow-up|0|||
42320674|NCT02315066|76157657|FG001|Overall Study|Lost to Follow-up|1|||
42320675|NCT02315066|76157658|FG002|Overall Study|Lost to Follow-up|1|||
42320676|NCT02315066|76157659|FG003|Overall Study|Lost to Follow-up|0|||
42320677|NCT02315066|76157660|FG004|Overall Study|Lost to Follow-up|1|||
42320678|NCT02315066|76157661|FG005|Overall Study|Lost to Follow-up|0|||
42320679|NCT02315066|76157662|FG006|Overall Study|Lost to Follow-up|2|||
42320680|NCT02315066|76157663|FG007|Overall Study|Lost to Follow-up|1|||
42320681|NCT02315066|76157664|FG008|Overall Study|Lost to Follow-up|0|||
42320682|NCT02315066|76157665|FG009|Overall Study|Lost to Follow-up|0|||
42320683|NCT02315066|76157666|FG010|Overall Study|Lost to Follow-up|1|||
42320684|NCT02315066|76157667|FG011|Overall Study|Lost to Follow-up|2|||
42320685|NCT02315066|76157668|FG012|Overall Study|Lost to Follow-up|0|||
42320686|NCT02315066|76157669|FG013|Overall Study|Lost to Follow-up|4|||
42320687|NCT02315066|76157656|FG000|Overall Study|Death|2|||
42320688|NCT02315066|76157657|FG001|Overall Study|Death|7|||
42320689|NCT02315066|76157658|FG002|Overall Study|Death|6|||
42320690|NCT02315066|76157659|FG003|Overall Study|Death|11|||
42320691|NCT02315066|76157660|FG004|Overall Study|Death|10|||
42320692|NCT02315066|76157661|FG005|Overall Study|Death|3|||
42320693|NCT02315066|76157662|FG006|Overall Study|Death|9|||
42320694|NCT02315066|76157663|FG007|Overall Study|Death|9|||
42320695|NCT02315066|76157664|FG008|Overall Study|Death|10|||
42320696|NCT02315066|76157665|FG009|Overall Study|Death|8|||
42320697|NCT02315066|76157666|FG010|Overall Study|Death|10|||
42320698|NCT02315066|76157667|FG011|Overall Study|Death|7|||
42320699|NCT02315066|76157668|FG012|Overall Study|Death|8|||
42320700|NCT02315066|76157669|FG013|Overall Study|Death|21|||
42320701|NCT02315066|76157656|FG000|Overall Study|Other|0|||
42320702|NCT02315066|76157657|FG001|Overall Study|Other|0|||
42320703|NCT02315066|76157658|FG002|Overall Study|Other|0|||
42320704|NCT02315066|76157659|FG003|Overall Study|Other|0|||
42320705|NCT02315066|76157660|FG004|Overall Study|Other|0|||
42320706|NCT02315066|76157661|FG005|Overall Study|Other|0|||
42320707|NCT02315066|76157662|FG006|Overall Study|Other|0|||
41994217|NCT02484456|75802497|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
41994218|NCT02484456|75802496|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
41994219|NCT02484456|75802497|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
42034052|NCT01070550|75842185|FG004|Overall Study|Relapse|0|||
42320708|NCT02315066|76157663|FG007|Overall Study|Other|1|||
42320709|NCT02315066|76157664|FG008|Overall Study|Other|1|||
42320710|NCT02315066|76157665|FG009|Overall Study|Other|2|||
42320711|NCT02315066|76157666|FG010|Overall Study|Other|0|||
42320712|NCT02315066|76157667|FG011|Overall Study|Other|0|||
42320713|NCT02315066|76157668|FG012|Overall Study|Other|0|||
42320714|NCT02315066|76157669|FG013|Overall Study|Other|0|||
42320715|NCT02315066|76157656|FG000|Overall Study|Subject refused further follow-up|0|||
42320716|NCT02315066|76157657|FG001|Overall Study|Subject refused further follow-up|2|||
42320717|NCT02315066|76157658|FG002|Overall Study|Subject refused further follow-up|2|||
42320718|NCT02315066|76157659|FG003|Overall Study|Subject refused further follow-up|0|||
42320719|NCT02315066|76157660|FG004|Overall Study|Subject refused further follow-up|0|||
42320720|NCT02315066|76157661|FG005|Overall Study|Subject refused further follow-up|0|||
42320721|NCT02315066|76157662|FG006|Overall Study|Subject refused further follow-up|2|||
42320722|NCT02315066|76157663|FG007|Overall Study|Subject refused further follow-up|3|||
42320723|NCT02315066|76157664|FG008|Overall Study|Subject refused further follow-up|0|||
42320724|NCT02315066|76157665|FG009|Overall Study|Subject refused further follow-up|1|||
42320725|NCT02315066|76157666|FG010|Overall Study|Subject refused further follow-up|1|||
42320726|NCT02315066|76157667|FG011|Overall Study|Subject refused further follow-up|2|||
42320727|NCT02315066|76157668|FG012|Overall Study|Subject refused further follow-up|2|||
42320728|NCT02315066|76157669|FG013|Overall Study|Subject refused further follow-up|4|||
42320729|NCT02315066|76157656|FG000|Overall Study|Study ongoing at date of cut-off|0|||
42320730|NCT02315066|76157657|FG001|Overall Study|Study ongoing at date of cut-off|0|||
42320731|NCT02315066|76157658|FG002|Overall Study|Study ongoing at date of cut-off|0|||
42320732|NCT02315066|76157659|FG003|Overall Study|Study ongoing at date of cut-off|0|||
42320733|NCT02315066|76157660|FG004|Overall Study|Study ongoing at date of cut-off|0|||
42320734|NCT02315066|76157661|FG005|Overall Study|Study ongoing at date of cut-off|0|||
42320735|NCT02315066|76157662|FG006|Overall Study|Study ongoing at date of cut-off|0|||
42320736|NCT02315066|76157663|FG007|Overall Study|Study ongoing at date of cut-off|0|||
42320737|NCT02315066|76157664|FG008|Overall Study|Study ongoing at date of cut-off|0|||
42320738|NCT02315066|76157665|FG009|Overall Study|Study ongoing at date of cut-off|0|||
42320739|NCT02315066|76157666|FG010|Overall Study|Study ongoing at date of cut-off|0|||
42320740|NCT02315066|76157667|FG011|Overall Study|Study ongoing at date of cut-off|0|||
42320741|NCT02315066|76157668|FG012|Overall Study|Study ongoing at date of cut-off|0|||
42320742|NCT02315066|76157669|FG013|Overall Study|Study ongoing at date of cut-off|1|||
42320743|NCT02207413|76157705|FG000|Overall Study|Withdrawal by Subject|1|||
42320744|NCT02207413|76157706|FG001|Overall Study|Withdrawal by Subject|0|||
42320745|NCT02207413|76157707|FG002|Overall Study|Withdrawal by Subject|0|||
42320746|NCT02207413|76157708|FG003|Overall Study|Withdrawal by Subject|0|||
42320747|NCT02207413|76157709|FG004|Overall Study|Withdrawal by Subject|3|||
42320748|NCT02207413|76157710|FG005|Overall Study|Withdrawal by Subject|7|||
42320749|NCT02207413|76157705|FG000|Overall Study|Lost to Follow-up|0|||
41994220|NCT02484456|75802496|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
41994221|NCT02484456|75802497|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
41994222|NCT01132807|75802504|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
41994223|NCT01132807|75802505|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
41994224|NCT01132807|75802506|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
41994225|NCT01132807|75802504|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
41994226|NCT01132807|75802505|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
41994227|NCT01132807|75802506|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
42258842|NCT03392883|76085094|FG001|Overall Study|Lack of Efficacy|0|||
42258843|NCT03392883|76085095|FG002|Overall Study|Lack of Efficacy|0|||
42258844|NCT03392883|76085093|FG000|Overall Study|Withdrawal by Subject|180|||
42258845|NCT03392883|76085094|FG001|Overall Study|Withdrawal by Subject|0|||
42258846|NCT03392883|76085095|FG002|Overall Study|Withdrawal by Subject|0|||
42258847|NCT03392883|76085093|FG000|Overall Study|Adverse Event|1|||
42258848|NCT03392883|76085094|FG001|Overall Study|Adverse Event|0|||
42258849|NCT03392883|76085095|FG002|Overall Study|Adverse Event|0|||
42258850|NCT02748863|76085106|FG000|Treatment Period 1|Adverse Event|0|||
42258851|NCT02748863|76085107|FG001|Treatment Period 1|Adverse Event|1|||
42258852|NCT02748863|76085108|FG002|Treatment Period 1|Adverse Event|0|||
42258853|NCT02748863|76085109|FG003|Treatment Period 1|Adverse Event|0|||
41994228|NCT01132651|75802516|FG000|Overall Study|Lost to Follow-up|1|||
41994229|NCT01132651|75802517|FG001|Overall Study|Lost to Follow-up|1|||
41994230|NCT01089543|75802527|FG000|Overall Study|Withdrawal by Subject|2|||
41994231|NCT01089543|75802528|FG001|Overall Study|Withdrawal by Subject|3|||
41994232|NCT01089543|75802529|FG002|Overall Study|Withdrawal by Subject|3|||
42258854|NCT02748863|76085110|FG004|Treatment Period 1|Adverse Event|0|||
42258855|NCT02748863|76085106|FG000|Treatment Period 1|Lack of Efficacy|0|||
42258856|NCT02748863|76085107|FG001|Treatment Period 1|Lack of Efficacy|0|||
42258857|NCT02748863|76085108|FG002|Treatment Period 1|Lack of Efficacy|1|||
42320750|NCT02207413|76157706|FG001|Overall Study|Lost to Follow-up|0|||
42320751|NCT02207413|76157707|FG002|Overall Study|Lost to Follow-up|0|||
42258858|NCT02748863|76085109|FG003|Treatment Period 1|Lack of Efficacy|0|||
42320752|NCT02207413|76157708|FG003|Overall Study|Lost to Follow-up|1|||
42320753|NCT02207413|76157709|FG004|Overall Study|Lost to Follow-up|1|||
42320754|NCT02207413|76157710|FG005|Overall Study|Lost to Follow-up|5|||
42320755|NCT02207413|76157705|FG000|Overall Study|Adverse Event|0|||
42320756|NCT02207413|76157706|FG001|Overall Study|Adverse Event|0|||
42320757|NCT02207413|76157707|FG002|Overall Study|Adverse Event|0|||
42320758|NCT02207413|76157708|FG003|Overall Study|Adverse Event|0|||
42320759|NCT02207413|76157709|FG004|Overall Study|Adverse Event|2|||
42320760|NCT02207413|76157710|FG005|Overall Study|Adverse Event|1|||
42320761|NCT02207413|76157705|FG000|Overall Study|Migrated/moved from study area|0|||
42320762|NCT02207413|76157706|FG001|Overall Study|Migrated/moved from study area|0|||
42320763|NCT02207413|76157707|FG002|Overall Study|Migrated/moved from study area|0|||
42320764|NCT02207413|76157708|FG003|Overall Study|Migrated/moved from study area|0|||
42320765|NCT02207413|76157709|FG004|Overall Study|Migrated/moved from study area|1|||
42320766|NCT02207413|76157710|FG005|Overall Study|Migrated/moved from study area|0|||
42320767|NCT02309372|76157732|FG000|Overall Study|Lost to Follow-up|3|||
42320768|NCT02309372|76157733|FG001|Overall Study|Lost to Follow-up|2|||
42320769|NCT02276027|76157743|FG000|Overall Study|Death|1|||
42320770|NCT02276027|76157744|FG001|Overall Study|Death|0|||
42320771|NCT02276027|76157745|FG002|Overall Study|Death|0|||
42320772|NCT02276027|76157746|FG003|Overall Study|Death|2|||
42320773|NCT02276027|76157743|FG000|Overall Study|Physician Decision|0|||
42320774|NCT02276027|76157744|FG001|Overall Study|Physician Decision|0|||
42320775|NCT02276027|76157745|FG002|Overall Study|Physician Decision|0|||
42320776|NCT02276027|76157746|FG003|Overall Study|Physician Decision|1|||
42320777|NCT02276027|76157743|FG000|Overall Study|Progressive disease|1|||
42320778|NCT02276027|76157744|FG001|Overall Study|Progressive disease|13|||
42258859|NCT02748863|76085110|FG004|Treatment Period 1|Lack of Efficacy|0|||
42258860|NCT02748863|76085106|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42258861|NCT02748863|76085107|FG001|Treatment Period 1|Withdrawal by Subject|1|||
42258862|NCT02748863|76085108|FG002|Treatment Period 1|Withdrawal by Subject|1|||
42258863|NCT02748863|76085109|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42258864|NCT02748863|76085110|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42258865|NCT02748863|76085106|FG000|Treatment Period 2|Lost to Follow-up|2|||
42258866|NCT02748863|76085107|FG001|Treatment Period 2|Lost to Follow-up|0|||
42258867|NCT02748863|76085108|FG002|Treatment Period 2|Lost to Follow-up|0|||
42258868|NCT02748863|76085109|FG003|Treatment Period 2|Lost to Follow-up|0|||
42258869|NCT02748863|76085110|FG004|Treatment Period 2|Lost to Follow-up|0|||
42258870|NCT02748863|76085106|FG000|Treatment Period 2|Adverse Event|3|||
42258871|NCT02748863|76085107|FG001|Treatment Period 2|Adverse Event|2|||
42258872|NCT02748863|76085108|FG002|Treatment Period 2|Adverse Event|0|||
42258873|NCT02748863|76085109|FG003|Treatment Period 2|Adverse Event|2|||
42258874|NCT02748863|76085110|FG004|Treatment Period 2|Adverse Event|0|||
42258875|NCT02748863|76085106|FG000|Treatment Period 2|Lack of Efficacy|0|||
42258876|NCT02748863|76085107|FG001|Treatment Period 2|Lack of Efficacy|1|||
42258877|NCT02748863|76085108|FG002|Treatment Period 2|Lack of Efficacy|0|||
42258878|NCT02748863|76085109|FG003|Treatment Period 2|Lack of Efficacy|0|||
42258879|NCT02748863|76085110|FG004|Treatment Period 2|Lack of Efficacy|0|||
42258880|NCT02748863|76085106|FG000|Treatment Period 2|Pregnancy|0|||
42258881|NCT02748863|76085107|FG001|Treatment Period 2|Pregnancy|0|||
42258882|NCT02748863|76085108|FG002|Treatment Period 2|Pregnancy|0|||
42258883|NCT02748863|76085109|FG003|Treatment Period 2|Pregnancy|0|||
42320779|NCT02276027|76157745|FG002|Overall Study|Progressive disease|12|||
42320780|NCT02276027|76157746|FG003|Overall Study|Progressive disease|14|||
42320781|NCT02276027|76157743|FG000|Overall Study|Subject/guardian decision|0|||
42320782|NCT02276027|76157744|FG001|Overall Study|Subject/guardian decision|1|||
41994233|NCT01089543|75802530|FG003|Overall Study|Withdrawal by Subject|1|||
41994234|NCT01089543|75802527|FG000|Overall Study|Physician Decision|1|||
41994235|NCT01089543|75802528|FG001|Overall Study|Physician Decision|0|||
42258884|NCT02748863|76085110|FG004|Treatment Period 2|Pregnancy|1|||
42258885|NCT02865499|76085131|FG000|Baseline|Adverse Event|1|||
42258886|NCT02865499|76085131|FG000|Baseline|Withdrawal by Subject|1|||
42258887|NCT02870933|76085137|FG000|Overall Study|Death|2|||
42320783|NCT02276027|76157745|FG002|Overall Study|Subject/guardian decision|0|||
42320784|NCT02276027|76157746|FG003|Overall Study|Subject/guardian decision|3|||
42258888|NCT02870933|76085138|FG001|Overall Study|Death|1|||
42258889|NCT02870933|76085137|FG000|Overall Study|Withdrawal by Subject|0|||
42258890|NCT02870933|76085138|FG001|Overall Study|Withdrawal by Subject|1|||
42320785|NCT02276027|76157743|FG000|Overall Study|Adverse Event|0|||
42320786|NCT02276027|76157744|FG001|Overall Study|Adverse Event|2|||
42320787|NCT02276027|76157745|FG002|Overall Study|Adverse Event|8|||
42320788|NCT02276027|76157746|FG003|Overall Study|Adverse Event|2|||
42320789|NCT02309294|76157756|FG000|Overall Study|Withdrawal by Subject|2|||
42320790|NCT02233543|76157760|FG000|Period 1|Withdrawal by Subject|1|||
42320791|NCT02233543|76157761|FG001|Period 1|Withdrawal by Subject|0|||
42320792|NCT02233543|76157760|FG000|Period 1|Participants required other treatment.|2|||
42320793|NCT02233543|76157761|FG001|Period 1|Participants required other treatment.|3|||
42320794|NCT02233543|76157760|FG000|Period 2|Adverse Event|1|||
42320795|NCT02233543|76157761|FG001|Period 2|Adverse Event|0|||
42320796|NCT02233543|76157760|FG000|Period 2|Participant required other treatment.|0|||
42320797|NCT02233543|76157761|FG001|Period 2|Participant required other treatment.|1|||
42320798|NCT02233543|76157760|FG000|Period 2|COPD exacerbation|1|||
42320799|NCT02233543|76157761|FG001|Period 2|COPD exacerbation|0|||
42320800|NCT02309138|76157769|FG000|Overall Study|Withdrawal by Subject|44|||
42320801|NCT02309138|76157770|FG001|Overall Study|Withdrawal by Subject|15|||
42320802|NCT02309138|76157769|FG000|Overall Study|Protocol Violation|4|||
42320803|NCT02309138|76157770|FG001|Overall Study|Protocol Violation|2|||
42320804|NCT02309138|76157769|FG000|Overall Study|delivered before visit 2|0|||
42320805|NCT02309138|76157770|FG001|Overall Study|delivered before visit 2|1|||
42320806|NCT02233309|76157786|FG000|Overall Study|Physician Decision|5|||
42320807|NCT02204917|76157790|FG000|Overall Study|Protocol Violation|1|||
42320808|NCT02280044|76157799|FG000|Overall Study|Planned alternate|0|||
42320809|NCT02280044|76157800|FG001|Overall Study|Planned alternate|2|||
42320810|NCT02308748|76157806|FG000|Period 1|Withdrawal by Subject|0|||
42320811|NCT02308748|76157807|FG001|Period 1|Withdrawal by Subject|0|||
42320812|NCT02308748|76157808|FG002|Period 1|Withdrawal by Subject|1|||
42320813|NCT02308748|76157809|FG003|Period 1|Withdrawal by Subject|0|||
42320814|NCT02308748|76157810|FG004|Period 1|Withdrawal by Subject|0|||
42320815|NCT02308748|76157811|FG005|Period 1|Withdrawal by Subject|0|||
42320816|NCT02308748|76157812|FG006|Period 1|Withdrawal by Subject|0|||
42320817|NCT02308748|76157813|FG007|Period 1|Withdrawal by Subject|0|||
42320818|NCT02308748|76157814|FG008|Period 1|Withdrawal by Subject|0|||
42320819|NCT02308748|76157815|FG009|Period 1|Withdrawal by Subject|0|||
42320820|NCT02308748|76157806|FG000|Period 2|Adverse Event|0|||
42320821|NCT02308748|76157807|FG001|Period 2|Adverse Event|0|||
42320822|NCT02308748|76157808|FG002|Period 2|Adverse Event|0|||
42320823|NCT02308748|76157809|FG003|Period 2|Adverse Event|0|||
42320824|NCT02308748|76157810|FG004|Period 2|Adverse Event|0|||
42320825|NCT02308748|76157811|FG005|Period 2|Adverse Event|0|||
42258891|NCT02864407|76085145|FG000|Overall Study|Protocol Violation|3|||
42258892|NCT02864407|76085145|FG000|Overall Study|Lost to Follow-up|115|||
41994236|NCT01089543|75802529|FG002|Overall Study|Physician Decision|0|||
41994237|NCT01089543|75802530|FG003|Overall Study|Physician Decision|1|||
41994238|NCT01089543|75802527|FG000|Overall Study|Adverse Event|0|||
42258893|NCT02864407|76085145|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
42258894|NCT02864407|76085145|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
42258895|NCT02864407|76085145|FG000|Overall Study|Consent prior to the contract date|1|||
42258896|NCT02873429|76085151|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
42258897|NCT02873429|76085152|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
42258898|NCT02873429|76085151|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
42258899|NCT02873429|76085152|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
42258900|NCT02873429|76085151|FG000|16 Weeks|Lost to Follow-up|3|||
42258901|NCT02873429|76085152|FG001|16 Weeks|Lost to Follow-up|0|||
42258902|NCT02486302|76085158|FG000|Overall Study|Discontinued prematurely|410|||
42320826|NCT02308748|76157812|FG006|Period 2|Adverse Event|0|||
42320827|NCT02308748|76157813|FG007|Period 2|Adverse Event|1|||
42320828|NCT02308748|76157814|FG008|Period 2|Adverse Event|0|||
42320829|NCT02308748|76157815|FG009|Period 2|Adverse Event|0|||
42320830|NCT02308748|76157806|FG000|Period 3|Protocol Violation|0|||
42320831|NCT02308748|76157807|FG001|Period 3|Protocol Violation|0|||
42320832|NCT02308748|76157808|FG002|Period 3|Protocol Violation|0|||
42320833|NCT02308748|76157809|FG003|Period 3|Protocol Violation|0|||
42320834|NCT02308748|76157810|FG004|Period 3|Protocol Violation|0|||
42320835|NCT02308748|76157811|FG005|Period 3|Protocol Violation|0|||
42320836|NCT02308748|76157812|FG006|Period 3|Protocol Violation|0|||
42320837|NCT02308748|76157813|FG007|Period 3|Protocol Violation|0|||
42320838|NCT02308748|76157814|FG008|Period 3|Protocol Violation|0|||
42320839|NCT02308748|76157815|FG009|Period 3|Protocol Violation|1|||
42320840|NCT02308748|76157806|FG000|Period 5|Adverse Event|1|||
42320841|NCT02308748|76157807|FG001|Period 5|Adverse Event|0|||
42320842|NCT02308748|76157808|FG002|Period 5|Adverse Event|0|||
41994239|NCT01089543|75802528|FG001|Overall Study|Adverse Event|1|||
41994240|NCT01089543|75802529|FG002|Overall Study|Adverse Event|0|||
41994241|NCT01089543|75802530|FG003|Overall Study|Adverse Event|0|||
41994242|NCT01089504|75802542|FG000|Overall Study|Lost to Follow-up|1|||
41994243|NCT01089504|75802543|FG001|Overall Study|Lost to Follow-up|1|||
41994244|NCT01089504|75802542|FG000|Overall Study|Withdrawal by Subject|2|||
41994245|NCT01089504|75802543|FG001|Overall Study|Withdrawal by Subject|0|||
41994246|NCT01088997|75802551|FG000|Overall Study|Physician Decision|1|||
41994247|NCT01088997|75802552|FG001|Overall Study|Physician Decision|1|||
41994248|NCT01088997|75802551|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
41994249|NCT01088997|75802552|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
41994250|NCT01088997|75802551|FG000|Overall Study|Excluded prior to receiving drug|1|||
41994251|NCT01088997|75802552|FG001|Overall Study|Excluded prior to receiving drug|1|||
42034053|NCT01070550|75842186|FG005|Overall Study|Relapse|0|||
42034054|NCT01070550|75842181|FG000|Overall Study|Result not available|3|||
42320843|NCT02308748|76157809|FG003|Period 5|Adverse Event|0|||
42320844|NCT02308748|76157810|FG004|Period 5|Adverse Event|0|||
42320845|NCT02308748|76157811|FG005|Period 5|Adverse Event|0|||
42320846|NCT02308748|76157812|FG006|Period 5|Adverse Event|0|||
42320847|NCT02308748|76157813|FG007|Period 5|Adverse Event|0|||
42320848|NCT02308748|76157814|FG008|Period 5|Adverse Event|1|||
42320849|NCT02308748|76157815|FG009|Period 5|Adverse Event|0|||
42320850|NCT01646216|76157829|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
42320851|NCT01646216|76157830|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
42320852|NCT01646216|76157829|FG000|Overall Study|Did not complete training|0|||
42320853|NCT01646216|76157830|FG001|Overall Study|Did not complete training|2|||
42320854|NCT01646216|76157829|FG000|Overall Study|Investigator decision|1|||
42320855|NCT01646216|76157830|FG001|Overall Study|Investigator decision|1|||
42320856|NCT02308124|76157843|FG000|Overall Study|Lost to Follow-up|6|||
42320857|NCT02308124|76157844|FG001|Overall Study|Lost to Follow-up|6|||
42320858|NCT02308124|76157845|FG002|Overall Study|Lost to Follow-up|6|||
42320859|NCT02308124|76157843|FG000|Overall Study|Adverse Event|0|||
42320860|NCT02308124|76157844|FG001|Overall Study|Adverse Event|2|||
42320861|NCT02308124|76157845|FG002|Overall Study|Adverse Event|2|||
42320862|NCT02232061|76157853|FG000|Overall Study|Administrative problems|1|||
42320863|NCT02232061|76157853|FG000|Overall Study|Withdrawal by Subject|1|||
42320864|NCT02275481|76157859|FG000|Overall Study|Death|2|||
42320865|NCT02275481|76157860|FG001|Overall Study|Death|1|||
42320866|NCT02275481|76157859|FG000|Overall Study|Lost to Follow-up|2|||
42320867|NCT02275481|76157860|FG001|Overall Study|Lost to Follow-up|0|||
42320868|NCT02275481|76157859|FG000|Overall Study|Withdrawal by Subject|3|||
42320869|NCT02275481|76157860|FG001|Overall Study|Withdrawal by Subject|0|||
42320870|NCT02275481|76157859|FG000|Overall Study|all other reasons combined|2|||
42320871|NCT02275481|76157860|FG001|Overall Study|all other reasons combined|1|||
42320872|NCT02275481|76157859|FG000|Overall Study|Physician Decision|0|||
42320873|NCT02275481|76157860|FG001|Overall Study|Physician Decision|1|||
42320874|NCT02204449|76157868|FG000|Overall Study|Lost to Follow-up|7|||
42320875|NCT02204449|76157869|FG001|Overall Study|Lost to Follow-up|9|||
42320876|NCT02204449|76157868|FG000|Overall Study|Death|0|||
42320877|NCT02204449|76157869|FG001|Overall Study|Death|1|||
42320878|NCT02204449|76157868|FG000|Overall Study|Withdrawal by Subject|0|||
42320879|NCT02204449|76157869|FG001|Overall Study|Withdrawal by Subject|1|||
42320880|NCT02308046|76157877|FG000|Overall Study|Negative yeast culture at Baseline|32|||
42320881|NCT02308046|76157878|FG001|Overall Study|Negative yeast culture at Baseline|33|||
42320882|NCT02308046|76157877|FG000|Overall Study|Positive for STD at Baseline|1|||
42320883|NCT02308046|76157878|FG001|Overall Study|Positive for STD at Baseline|2|||
42320884|NCT02308046|76157877|FG000|Overall Study|Lost to Follow-up|1|||
42320885|NCT02308046|76157878|FG001|Overall Study|Lost to Follow-up|3|||
42320886|NCT02318693|76157886|FG000|Overall Study|Protocol Violation|0|||
42320887|NCT02318693|76157887|FG001|Overall Study|Protocol Violation|1|||
41994252|NCT01088529|75802563|FG000|Overall Study|Did not receive study treatment|0|||
42320888|NCT02230891|76157896|FG000|Baseline|Did not meet inclusion|0|||
42320889|NCT02230891|76157897|FG001|Baseline|Did not meet inclusion|1|||
42320890|NCT02230891|76157898|FG002|Baseline|Did not meet inclusion|1|||
42320891|NCT02230891|76157896|FG000|2 Week|Withdrawal by Subject|2|||
42320892|NCT02230891|76157897|FG001|2 Week|Withdrawal by Subject|2|||
42320893|NCT02230891|76157898|FG002|2 Week|Withdrawal by Subject|0|||
42320894|NCT02230891|76157896|FG000|2 Week|Consent withdrawn|1|||
42320895|NCT02230891|76157897|FG001|2 Week|Consent withdrawn|0|||
41994253|NCT01088529|75802564|FG001|Overall Study|Did not receive study treatment|1|||
42320896|NCT02230891|76157898|FG002|2 Week|Consent withdrawn|0|||
42320897|NCT02230891|76157896|FG000|6 Month|Withdrawal by Subject|1|||
42320898|NCT02230891|76157897|FG001|6 Month|Withdrawal by Subject|1|||
42320899|NCT02230891|76157898|FG002|6 Month|Withdrawal by Subject|1|||
42320900|NCT02230891|76157896|FG000|6 Month|Physician Decision|0|||
42320901|NCT02230891|76157897|FG001|6 Month|Physician Decision|2|||
42320902|NCT02230891|76157898|FG002|6 Month|Physician Decision|0|||
42258903|NCT02486302|76085158|FG000|Overall Study|Documentation not completed|255|||
42320903|NCT02230891|76157896|FG000|12 Month|Death|1|||
42320904|NCT02230891|76157897|FG001|12 Month|Death|0|||
41994254|NCT01087944|75802570|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
41994255|NCT01087944|75802571|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
41994256|NCT01087944|75802570|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
42320905|NCT02230891|76157898|FG002|12 Month|Death|0|||
41994257|NCT01087944|75802571|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
41994258|NCT01132612|75802580|FG000|Overall Study|Death|0|||
41994259|NCT01132612|75802581|FG001|Overall Study|Death|0|||
41994260|NCT01132612|75802582|FG002|Overall Study|Death|1|||
41994261|NCT01132612|75802580|FG000|Overall Study|Protocol deviation|0|||
41994262|NCT01132612|75802581|FG001|Overall Study|Protocol deviation|0|||
41994263|NCT01132612|75802582|FG002|Overall Study|Protocol deviation|3|||
41994264|NCT01132612|75802580|FG000|Overall Study|Lost to Follow-up|2|||
41994265|NCT01132612|75802581|FG001|Overall Study|Lost to Follow-up|2|||
41994266|NCT01132612|75802582|FG002|Overall Study|Lost to Follow-up|7|||
41994267|NCT01132612|75802580|FG000|Overall Study|Adverse Event|5|||
41994268|NCT01132612|75802581|FG001|Overall Study|Adverse Event|2|||
41994269|NCT01132612|75802582|FG002|Overall Study|Adverse Event|15|||
41994270|NCT01132612|75802580|FG000|Overall Study|Withdrawal by Subject|5|||
41994271|NCT01132612|75802581|FG001|Overall Study|Withdrawal by Subject|8|||
41994272|NCT01132612|75802582|FG002|Overall Study|Withdrawal by Subject|19|||
42258904|NCT02486302|76085158|FG000|Overall Study|Excluded due to legal reasons|8|||
42258905|NCT02486302|76085158|FG000|Overall Study|Not treated|3|||
42320906|NCT02230891|76157896|FG000|12 Month|Lost to Follow-up|0|||
42320907|NCT02230891|76157897|FG001|12 Month|Lost to Follow-up|1|||
42320908|NCT02230891|76157898|FG002|12 Month|Lost to Follow-up|0|||
42320909|NCT02230891|76157896|FG000|12 Month|Withdrawal by Subject|0|||
42320910|NCT02230891|76157897|FG001|12 Month|Withdrawal by Subject|2|||
42320911|NCT02230891|76157898|FG002|12 Month|Withdrawal by Subject|0|||
42320912|NCT02230891|76157896|FG000|18 Month End of Study|Death|0|||
42320913|NCT02230891|76157897|FG001|18 Month End of Study|Death|0|||
42258906|NCT02747875|76085173|FG000|Overall Study|Physician Decision|1|||
42258907|NCT02747875|76085174|FG001|Overall Study|Physician Decision|0|||
42258908|NCT02747875|76085173|FG000|Overall Study|Adverse Event|0|||
42258909|NCT02747875|76085174|FG001|Overall Study|Adverse Event|1|||
42258910|NCT02451124|76085200|FG000|Overall Study|Withdrawal by Subject|1|||
42258911|NCT02450578|76085212|FG000|Overall Study|ECG abnormality so not treated|1|||
42258912|NCT02450578|76085213|FG001|Overall Study|ECG abnormality so not treated|0|||
42258913|NCT02450578|76085214|FG002|Overall Study|ECG abnormality so not treated|0|||
42258914|NCT02450578|76085215|FG003|Overall Study|ECG abnormality so not treated|0|||
42258915|NCT02449018|76085242|FG000|Overall Study|Abnormal laboratory value|0|||
42258916|NCT02449018|76085243|FG001|Overall Study|Abnormal laboratory value|1|||
42258917|NCT02449018|76085242|FG000|Overall Study|Administrative problems|1|||
42258918|NCT02449018|76085243|FG001|Overall Study|Administrative problems|0|||
42258919|NCT02449018|76085242|FG000|Overall Study|Adverse Event|5|||
42258920|NCT02449018|76085243|FG001|Overall Study|Adverse Event|1|||
42320914|NCT02230891|76157898|FG002|18 Month End of Study|Death|1|||
42320915|NCT02230891|76157896|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
42320916|NCT02230891|76157897|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
42320917|NCT02230891|76157898|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
42320918|NCT01646138|76157913|FG000|Overall Study|Lost to Follow-up|0|||
41994273|NCT01132612|75802580|FG000|Overall Study|Administrative problems|5|||
41994274|NCT01132612|75802581|FG001|Overall Study|Administrative problems|1|||
41994275|NCT01132612|75802582|FG002|Overall Study|Administrative problems|52|||
41994276|NCT01132612|75802580|FG000|Overall Study|Lack of Efficacy|23|||
41994277|NCT01132612|75802581|FG001|Overall Study|Lack of Efficacy|22|||
41994278|NCT01132612|75802582|FG002|Overall Study|Lack of Efficacy|73|||
42258921|NCT02449018|76085242|FG000|Overall Study|Protocol deviation|4|||
42258922|NCT02449018|76085243|FG001|Overall Study|Protocol deviation|0|||
42258923|NCT02449018|76085242|FG000|Overall Study|Patient decision|2|||
42258924|NCT02449018|76085243|FG001|Overall Study|Patient decision|0|||
42258925|NCT02859415|76085251|FG000|Overall Study|Physician Decision|1|||
42258926|NCT02859415|76085252|FG001|Overall Study|Physician Decision|0|||
42320919|NCT01646138|76157914|FG001|Overall Study|Lost to Follow-up|0|||
42320920|NCT01646138|76157915|FG002|Overall Study|Lost to Follow-up|0|||
42320921|NCT01646138|76157916|FG003|Overall Study|Lost to Follow-up|0|||
41994279|NCT01132495|75802594|FG000|Overall Study|Various reasons|40|||
41994280|NCT01132495|75802595|FG001|Overall Study|Various reasons|38|||
42320922|NCT01646138|76157917|FG004|Overall Study|Lost to Follow-up|2|||
42320923|NCT02204371|76157929|FG000|Overall Study|Adverse Event|1|||
42320924|NCT02274857|76157935|FG000|Overall Study|Adverse Event|1|||
42320925|NCT02274857|76157936|FG001|Overall Study|Adverse Event|0|||
42320926|NCT02274857|76157935|FG000|Overall Study|Death|1|||
42320927|NCT02274857|76157936|FG001|Overall Study|Death|2|||
42320928|NCT02274857|76157935|FG000|Overall Study|Lost to Follow-up|3|||
42320929|NCT02274857|76157936|FG001|Overall Study|Lost to Follow-up|0|||
42320930|NCT02274857|76157935|FG000|Overall Study|Physician Decision|2|||
42320931|NCT02274857|76157936|FG001|Overall Study|Physician Decision|0|||
42320932|NCT02274857|76157935|FG000|Overall Study|Trial screen failure|0|||
42320933|NCT02274857|76157936|FG001|Overall Study|Trial screen failure|2|||
42320934|NCT02274857|76157935|FG000|Overall Study|Withdrawal by Subject|11|||
42320935|NCT02274857|76157936|FG001|Overall Study|Withdrawal by Subject|2|||
42320936|NCT02274857|76157935|FG000|Overall Study|Other|2|||
42320937|NCT02274857|76157936|FG001|Overall Study|Other|0|||
42320938|NCT02302859|76157945|FG000|Overall Study|Lost Phone|1|||
42320939|NCT02302859|76157946|FG001|Overall Study|Lost Phone|1|||
42320940|NCT02302859|76157945|FG000|Overall Study|Withdrawal by Subject|0|||
42320941|NCT02302859|76157946|FG001|Overall Study|Withdrawal by Subject|1|||
42320942|NCT02274311|76157952|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
42320943|NCT02316353|76157960|FG000|Overall Study|Pregnancy|1|||
42320944|NCT02316353|76157961|FG001|Overall Study|Pregnancy|3|||
42320945|NCT02316353|76157960|FG000|Overall Study|Adverse Event|1|||
42320946|NCT02316353|76157961|FG001|Overall Study|Adverse Event|3|||
42320947|NCT02316353|76157960|FG000|Overall Study|Withdrawal by Subject|6|||
42320948|NCT02316353|76157961|FG001|Overall Study|Withdrawal by Subject|2|||
42320949|NCT02273141|76157972|FG000|Overall Study|Adverse Event|0|||
42320950|NCT02273141|76157973|FG001|Overall Study|Adverse Event|1|||
42320951|NCT02273141|76157972|FG000|Overall Study|Lost to Follow-up|1|||
41994281|NCT01132495|75802596|FG002|Overall Study|Various reasons|20|||
41994282|NCT01132495|75802597|FG003|Overall Study|Various reasons|12|||
41994283|NCT01087905|75802616|FG000|Overall Study|Lost to Follow-up|24|||
41994284|NCT01087905|75802617|FG001|Overall Study|Lost to Follow-up|28|||
41994285|NCT01087905|75802618|FG002|Overall Study|Lost to Follow-up|18|||
41994286|NCT01087905|75802619|FG003|Overall Study|Lost to Follow-up|31|||
42258927|NCT02859415|76085251|FG000|Overall Study|Off treatment due to cardiac event|0|||
42320952|NCT02273141|76157973|FG001|Overall Study|Lost to Follow-up|3|||
42258928|NCT02859415|76085252|FG001|Overall Study|Off treatment due to cardiac event|1|||
42258929|NCT02871791|76085262|FG000|Phase 1b|Death|0|||
42258930|NCT02871791|76085263|FG001|Phase 1b|Death|1|||
42258931|NCT02871791|76085262|FG000|Phase 1b|progressive disease|6|||
42258932|NCT02871791|76085263|FG001|Phase 1b|progressive disease|2|||
42258933|NCT02871791|76085262|FG000|Phase 2|Death|1|||
42258934|NCT02871791|76085263|FG001|Phase 2|Death|0|||
42258935|NCT02871791|76085262|FG000|Phase 2|Lost to Follow-up|2|||
42258936|NCT02871791|76085263|FG001|Phase 2|Lost to Follow-up|0|||
42320953|NCT02273141|76157972|FG000|Overall Study|Withdrawal by Subject|10|||
42320954|NCT02273141|76157973|FG001|Overall Study|Withdrawal by Subject|15|||
41994287|NCT01087905|75802620|FG004|Overall Study|Lost to Follow-up|27|||
42258937|NCT02871635|76085271|FG000|Overall Study|Primary lack of efficacy|4|||
42320955|NCT02273141|76157972|FG000|Overall Study|Various|6|||
42320956|NCT02273141|76157973|FG001|Overall Study|Various|6|||
42320957|NCT02314052|76157979|FG000|Cycle One|Adverse Event|0|||
42320958|NCT02314052|76157980|FG001|Cycle One|Adverse Event|0|||
41994288|NCT01087905|75802621|FG005|Overall Study|Lost to Follow-up|25|||
42320959|NCT02314052|76157981|FG002|Cycle One|Adverse Event|0|||
42320960|NCT02314052|76157982|FG003|Cycle One|Adverse Event|1|||
41994289|NCT01087905|75802622|FG006|Overall Study|Lost to Follow-up|20|||
41994290|NCT01087905|75802623|FG007|Overall Study|Lost to Follow-up|24|||
42258938|NCT02871635|76085272|FG001|Overall Study|Primary lack of efficacy|4|||
42258939|NCT02871635|76085271|FG000|Overall Study|Protocol Violation|3|||
42258940|NCT02871635|76085272|FG001|Overall Study|Protocol Violation|1|||
42258941|NCT02871635|76085271|FG000|Overall Study|Lost to Follow-up|1|||
42320961|NCT02314052|76157983|FG004|Cycle One|Adverse Event|0|||
42320962|NCT02314052|76157984|FG005|Cycle One|Adverse Event|0|||
42320963|NCT02279732|76158000|FG000|Overall Study|Death|23|||
42320964|NCT02279732|76158001|FG001|Overall Study|Death|20|||
42320965|NCT02279732|76158000|FG000|Overall Study|Disease Progression|13|||
41994291|NCT01087905|75802616|FG000|Overall Study|Withdrawal by Subject|5|||
42320966|NCT02279732|76158001|FG001|Overall Study|Disease Progression|3|||
42320967|NCT02279732|76158000|FG000|Overall Study|Withdrawal by Subject|2|||
42320968|NCT02279732|76158001|FG001|Overall Study|Withdrawal by Subject|7|||
41994292|NCT01087905|75802617|FG001|Overall Study|Withdrawal by Subject|4|||
41994293|NCT01087905|75802618|FG002|Overall Study|Withdrawal by Subject|4|||
41994294|NCT01087905|75802619|FG003|Overall Study|Withdrawal by Subject|5|||
41994295|NCT01087905|75802620|FG004|Overall Study|Withdrawal by Subject|4|||
41994296|NCT01087905|75802621|FG005|Overall Study|Withdrawal by Subject|3|||
41994297|NCT01087905|75802622|FG006|Overall Study|Withdrawal by Subject|3|||
41994298|NCT01087905|75802623|FG007|Overall Study|Withdrawal by Subject|5|||
41994299|NCT01087788|75802642|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
41994300|NCT01087788|75802643|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
41994301|NCT01087788|75802644|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
41994302|NCT01087788|75802642|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
41994303|NCT01087788|75802643|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
41994304|NCT01087788|75802644|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
41994305|NCT01087788|75802642|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
41994306|NCT01087788|75802643|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
41994307|NCT01087788|75802644|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
41994308|NCT01087788|75802642|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
41994309|NCT01087788|75802643|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
41994310|NCT01087788|75802644|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
41994311|NCT01087788|75802642|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
41994312|NCT01087788|75802643|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
41994313|NCT01087788|75802644|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
41994314|NCT01087788|75802642|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
41994315|NCT01087788|75802643|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
41994316|NCT01087788|75802644|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
41994317|NCT01087788|75802642|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
41994318|NCT01087788|75802643|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
41994319|NCT01087788|75802644|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
41994320|NCT01087788|75802642|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
41994321|NCT01087788|75802643|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
41994322|NCT01087788|75802644|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
41994323|NCT01087788|75802642|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
41994324|NCT01087788|75802643|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
41994325|NCT01087788|75802644|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
41994326|NCT01087788|75802642|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
41994327|NCT01087788|75802643|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
41994328|NCT01087788|75802644|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
41994329|NCT01087788|75802642|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
41994330|NCT01087788|75802643|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
41994331|NCT01087788|75802644|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
42320969|NCT02279732|76158000|FG000|Overall Study|Adverse Event|1|||
42320970|NCT02279732|76158001|FG001|Overall Study|Adverse Event|2|||
41994332|NCT01087788|75802642|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
41994333|NCT01087788|75802643|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
42258942|NCT02871635|76085272|FG001|Overall Study|Lost to Follow-up|2|||
42258943|NCT02871635|76085271|FG000|Overall Study|Pregnancy|0|||
42258944|NCT02871635|76085272|FG001|Overall Study|Pregnancy|2|||
42258945|NCT02871635|76085271|FG000|Overall Study|Physician Decision|1|||
42258946|NCT02871635|76085272|FG001|Overall Study|Physician Decision|1|||
42258947|NCT02871635|76085271|FG000|Overall Study|Withdrawal by Subject|3|||
42258948|NCT02871635|76085272|FG001|Overall Study|Withdrawal by Subject|4|||
42258949|NCT02871635|76085271|FG000|Overall Study|Adverse Event|4|||
42258950|NCT02871635|76085272|FG001|Overall Study|Adverse Event|4|||
42258951|NCT02871635|76085271|FG000|Overall Study|Secondary lack of efficacy|2|||
42258952|NCT02871635|76085272|FG001|Overall Study|Secondary lack of efficacy|1|||
42320971|NCT02279732|76158000|FG000|Overall Study|Administrative Reason By Sponsor|0|||
41994334|NCT01087788|75802644|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
41994335|NCT01087788|75802642|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
41994336|NCT01087788|75802643|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
42258953|NCT02477332|76085286|FG000|Overall Study|Adverse Event|0|||
42258954|NCT02477332|76085287|FG001|Overall Study|Adverse Event|1|||
42258955|NCT02477332|76085288|FG002|Overall Study|Adverse Event|1|||
42258956|NCT02477332|76085289|FG003|Overall Study|Adverse Event|2|||
42258957|NCT02477332|76085290|FG004|Overall Study|Adverse Event|1|||
42258958|NCT02477332|76085291|FG005|Overall Study|Adverse Event|2|||
42258959|NCT02477332|76085286|FG000|Overall Study|Lack of Efficacy|1|||
42320972|NCT02279732|76158001|FG001|Overall Study|Administrative Reason By Sponsor|2|||
42320973|NCT02279732|76158000|FG000|Overall Study|Study Drug Toxicity|2|||
42320974|NCT02279732|76158001|FG001|Overall Study|Study Drug Toxicity|0|||
42320975|NCT02279732|76158000|FG000|Overall Study|Lost to Follow-up|0|||
42320976|NCT02279732|76158001|FG001|Overall Study|Lost to Follow-up|1|||
42320977|NCT02279732|76158000|FG000|Overall Study|Maximum Clinical Benefit|1|||
42320978|NCT02279732|76158001|FG001|Overall Study|Maximum Clinical Benefit|0|||
42320979|NCT02279732|76158000|FG000|Overall Study|Subject Requested to Discontinue|0|||
42320980|NCT02279732|76158001|FG001|Overall Study|Subject Requested to Discontinue|1|||
42320981|NCT02279732|76158000|FG000|Overall Study|Other|53|||
42320982|NCT02279732|76158001|FG001|Overall Study|Other|67|||
42320983|NCT02279732|76158000|FG000|Overall Study|Other|3|||
42320984|NCT02279732|76158001|FG001|Overall Study|Other|3|||
42320985|NCT02279498|76158009|FG000|Overall Study|Adverse Event|3|||
42320986|NCT02279498|76158010|FG001|Overall Study|Adverse Event|0|||
42320987|NCT02279498|76158009|FG000|Overall Study|Lack of Efficacy|4|||
42320988|NCT02279498|76158010|FG001|Overall Study|Lack of Efficacy|0|||
42320989|NCT02279498|76158009|FG000|Overall Study|Lost to Follow-up|0|||
42320990|NCT02279498|76158010|FG001|Overall Study|Lost to Follow-up|1|||
42320991|NCT02279498|76158009|FG000|Overall Study|Withdrawal by Subject|9|||
42320992|NCT02279498|76158010|FG001|Overall Study|Withdrawal by Subject|2|||
42320993|NCT02279498|76158009|FG000|Overall Study|Undefined|2|||
42320994|NCT02279498|76158010|FG001|Overall Study|Undefined|1|||
42320995|NCT02307266|76158020|FG000|Overall Study|Adverse Event|3|||
42320996|NCT02307266|76158021|FG001|Overall Study|Adverse Event|1|||
42320997|NCT02307266|76158022|FG002|Overall Study|Adverse Event|5|||
42320998|NCT02307266|76158020|FG000|Overall Study|Withdrawal by Subject|2|||
42320999|NCT02307266|76158021|FG001|Overall Study|Withdrawal by Subject|0|||
42321000|NCT02307266|76158022|FG002|Overall Study|Withdrawal by Subject|1|||
42321001|NCT02307266|76158020|FG000|Overall Study|Lost to Follow-up|3|||
42321002|NCT02307266|76158021|FG001|Overall Study|Lost to Follow-up|0|||
42321003|NCT02307266|76158022|FG002|Overall Study|Lost to Follow-up|0|||
42321004|NCT02279420|76158030|FG000|Overall Study|Lost to Follow-up|23|||
42321005|NCT02278952|76158034|FG000|Overall Study|Insufficient Sample|6|||
42321006|NCT02278328|76158044|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
42321007|NCT02278328|76158045|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
42321008|NCT02278328|76158046|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
42321009|NCT02278328|76158044|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
42321010|NCT02278328|76158045|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
42321011|NCT02278328|76158046|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
42321012|NCT02278328|76158044|FG000|Neuropsych Screening|incomplete consent|0|||
42321013|NCT02278328|76158045|FG001|Neuropsych Screening|incomplete consent|0|||
42321014|NCT02278328|76158046|FG002|Neuropsych Screening|incomplete consent|2|||
42321015|NCT02314637|76158054|FG000|Overall Study|Adverse Event|4|||
42321016|NCT02314637|76158055|FG001|Overall Study|Adverse Event|8|||
42321017|NCT02314637|76158054|FG000|Overall Study|Lack of Efficacy|1|||
42321018|NCT02314637|76158055|FG001|Overall Study|Lack of Efficacy|0|||
42321019|NCT02314637|76158054|FG000|Overall Study|Physician Decision|5|||
42321020|NCT02314637|76158055|FG001|Overall Study|Physician Decision|2|||
42321021|NCT02314637|76158054|FG000|Overall Study|Withdrawal by Subject|5|||
42321022|NCT02314637|76158055|FG001|Overall Study|Withdrawal by Subject|4|||
42321023|NCT02314637|76158054|FG000|Overall Study|Other Reason|1|||
42321024|NCT02314637|76158055|FG001|Overall Study|Other Reason|0|||
42321025|NCT01646645|76158061|FG000|Overall Study|No Treated|1|||
42321026|NCT01646645|76158061|FG000|Overall Study|Inevaluable Donor|29|||
42321027|NCT02272985|76158065|FG000|Overall Study|Withdrawal by Subject|1|||
42321028|NCT02272985|76158065|FG000|Overall Study|hip fracture|1|||
42321029|NCT02272985|76158065|FG000|Overall Study|kidney transplantation|1|||
42321030|NCT01644149|76158072|FG000|Overall Study|Withdrawal by Subject|1|||
42321031|NCT01644149|76158073|FG001|Overall Study|Withdrawal by Subject|0|||
42321032|NCT01644149|76158072|FG000|Overall Study|Lost to Follow-up|3|||
42321033|NCT01644149|76158073|FG001|Overall Study|Lost to Follow-up|1|||
42321034|NCT02313233|76158082|FG000|Overall Study|Withdrawal by Subject|1|||
42321035|NCT02313233|76158083|FG001|Overall Study|Withdrawal by Subject|2|||
42321036|NCT02313233|76158082|FG000|Overall Study|Administrative reason|1|||
42321037|NCT02313233|76158083|FG001|Overall Study|Administrative reason|1|||
42321038|NCT02313155|76158093|FG000|Overall Study|Lost to Follow-up|0|||
42321039|NCT02313155|76158094|FG001|Overall Study|Lost to Follow-up|1|||
42321040|NCT02204293|76158102|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
42321041|NCT02204293|76158103|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
42321042|NCT02204293|76158104|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
42321043|NCT02204293|76158105|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
42321044|NCT02204293|76158106|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
42321045|NCT02204293|76158107|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
42321046|NCT02204293|76158102|FG000|Core Study Part I|Adverse Event|1|||
42321047|NCT02204293|76158103|FG001|Core Study Part I|Adverse Event|0|||
42321048|NCT02204293|76158104|FG002|Core Study Part I|Adverse Event|0|||
42321049|NCT02204293|76158105|FG003|Core Study Part I|Adverse Event|0|||
42321050|NCT02204293|76158106|FG004|Core Study Part I|Adverse Event|0|||
42321051|NCT02204293|76158107|FG005|Core Study Part I|Adverse Event|0|||
42321052|NCT02204293|76158102|FG000|Core Study Part I|Physician Decision|0|||
42321053|NCT02204293|76158103|FG001|Core Study Part I|Physician Decision|3|||
42321054|NCT02204293|76158104|FG002|Core Study Part I|Physician Decision|0|||
42321055|NCT02204293|76158105|FG003|Core Study Part I|Physician Decision|0|||
42321056|NCT02204293|76158106|FG004|Core Study Part I|Physician Decision|0|||
42321057|NCT02204293|76158107|FG005|Core Study Part I|Physician Decision|0|||
42321058|NCT02204293|76158102|FG000|LTE Phase|Study Suspended|0|||
42321059|NCT02204293|76158103|FG001|LTE Phase|Study Suspended|0|||
42321060|NCT02204293|76158104|FG002|LTE Phase|Study Suspended|0|||
42321061|NCT02204293|76158105|FG003|LTE Phase|Study Suspended|0|||
42321062|NCT02204293|76158106|FG004|LTE Phase|Study Suspended|0|||
42321063|NCT02204293|76158107|FG005|LTE Phase|Study Suspended|7|||
42321064|NCT02304926|76158123|FG000|Overall Study|Lost to Follow-up|2|||
42321065|NCT02304926|76158124|FG001|Overall Study|Lost to Follow-up|1|||
42321066|NCT01646255|76158134|FG000|Overall Study|Adverse Event|7|||
42321067|NCT01646255|76158135|FG001|Overall Study|Adverse Event|8|||
42321068|NCT01646255|76158134|FG000|Overall Study|Lack of Efficacy|2|||
42321069|NCT01646255|76158135|FG001|Overall Study|Lack of Efficacy|0|||
42321070|NCT01646255|76158134|FG000|Overall Study|Withdrawal by Subject|10|||
42321071|NCT01646255|76158135|FG001|Overall Study|Withdrawal by Subject|6|||
42321072|NCT01646255|76158134|FG000|Overall Study|Compliance is not well|1|||
42321073|NCT01646255|76158135|FG001|Overall Study|Compliance is not well|0|||
42321074|NCT01646255|76158134|FG000|Overall Study|Inclusion Criteria Deviation|1|||
42321075|NCT01646255|76158135|FG001|Overall Study|Inclusion Criteria Deviation|0|||
42321076|NCT02304380|76158148|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
42321077|NCT02304380|76158149|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
42258960|NCT02477332|76085287|FG001|Overall Study|Lack of Efficacy|2|||
42258961|NCT02477332|76085288|FG002|Overall Study|Lack of Efficacy|1|||
42258962|NCT02477332|76085289|FG003|Overall Study|Lack of Efficacy|2|||
42258963|NCT02477332|76085290|FG004|Overall Study|Lack of Efficacy|1|||
42258964|NCT02477332|76085291|FG005|Overall Study|Lack of Efficacy|1|||
42258965|NCT02477332|76085286|FG000|Overall Study|Non-compliance with study treatment|0|||
42258966|NCT02477332|76085287|FG001|Overall Study|Non-compliance with study treatment|1|||
42258967|NCT02477332|76085288|FG002|Overall Study|Non-compliance with study treatment|2|||
42258968|NCT02477332|76085289|FG003|Overall Study|Non-compliance with study treatment|0|||
42258969|NCT02477332|76085290|FG004|Overall Study|Non-compliance with study treatment|0|||
42258970|NCT02477332|76085291|FG005|Overall Study|Non-compliance with study treatment|0|||
42258971|NCT02477332|76085286|FG000|Overall Study|Pregnancy|0|||
42258972|NCT02477332|76085287|FG001|Overall Study|Pregnancy|0|||
42258973|NCT02477332|76085288|FG002|Overall Study|Pregnancy|0|||
42258974|NCT02477332|76085289|FG003|Overall Study|Pregnancy|1|||
42258975|NCT02477332|76085290|FG004|Overall Study|Pregnancy|0|||
42258976|NCT02477332|76085291|FG005|Overall Study|Pregnancy|0|||
42258977|NCT02477332|76085286|FG000|Overall Study|Protocol Violation|2|||
42258978|NCT02477332|76085287|FG001|Overall Study|Protocol Violation|0|||
42321078|NCT02304380|76158150|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
42321079|NCT02304380|76158151|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
42321080|NCT02304380|76158152|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
42321081|NCT02304380|76158153|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
42321082|NCT02203591|76158175|FG000|Overall Study|Did not meet treatment day baseline|147|||
42321083|NCT02203591|76158176|FG001|Overall Study|Did not meet treatment day baseline|141|||
42321084|NCT02203591|76158177|FG002|Overall Study|Did not meet treatment day baseline|150|||
42321085|NCT02203591|76158178|FG003|Overall Study|Did not meet treatment day baseline|45|||
42321086|NCT02203591|76158179|FG004|Overall Study|Did not meet treatment day baseline|33|||
42321087|NCT02203591|76158180|FG005|Overall Study|Did not meet treatment day baseline|35|||
42321088|NCT02203591|76158181|FG006|Overall Study|Did not meet treatment day baseline|29|||
42321089|NCT02203591|76158182|FG007|Overall Study|Did not meet treatment day baseline|12|||
42321090|NCT02203591|76158175|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
42258979|NCT02477332|76085288|FG002|Overall Study|Protocol Violation|3|||
42258980|NCT02477332|76085289|FG003|Overall Study|Protocol Violation|3|||
42258981|NCT02477332|76085290|FG004|Overall Study|Protocol Violation|1|||
42321091|NCT02203591|76158176|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
42321092|NCT02203591|76158177|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
42321093|NCT02203591|76158178|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
42321094|NCT02203591|76158179|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
42321095|NCT02203591|76158180|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
42321096|NCT02203591|76158181|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
42321097|NCT02203591|76158182|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
42321098|NCT01642277|76158206|FG000|Overall Study|Adverse Event|10|||
42321099|NCT01642277|76158207|FG001|Overall Study|Adverse Event|0|||
42321100|NCT01642277|76158206|FG000|Overall Study|Physician Decision|2|||
42321101|NCT01642277|76158207|FG001|Overall Study|Physician Decision|0|||
42321102|NCT01642277|76158206|FG000|Overall Study|Protocol Violation|1|||
42321103|NCT01642277|76158207|FG001|Overall Study|Protocol Violation|0|||
42321104|NCT01642277|76158206|FG000|Overall Study|Withdrawal by Subject|11|||
42321105|NCT01642277|76158207|FG001|Overall Study|Withdrawal by Subject|0|||
42321106|NCT02230189|76158217|FG000|Overall Study|Withdrawal by Subject|3|||
42321107|NCT02230189|76158218|FG001|Overall Study|Withdrawal by Subject|0|||
42321108|NCT02230189|76158219|FG002|Overall Study|Withdrawal by Subject|1|||
42321109|NCT02230189|76158217|FG000|Overall Study|Lost to Follow-up|1|||
42321110|NCT02230189|76158218|FG001|Overall Study|Lost to Follow-up|0|||
42321111|NCT02230189|76158219|FG002|Overall Study|Lost to Follow-up|0|||
42321112|NCT02230189|76158217|FG000|Overall Study|Physician Decision|1|||
42321113|NCT02230189|76158218|FG001|Overall Study|Physician Decision|0|||
42321114|NCT02230189|76158219|FG002|Overall Study|Physician Decision|0|||
42321115|NCT02304302|76158230|FG000|Overall Study|Adverse Event|2|||
42321116|NCT02304302|76158231|FG001|Overall Study|Adverse Event|3|||
42321117|NCT02304302|76158230|FG000|Overall Study|Lost to Follow-up|1|||
42321118|NCT02304302|76158231|FG001|Overall Study|Lost to Follow-up|4|||
42321119|NCT02304302|76158230|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
42321120|NCT02304302|76158231|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
42321121|NCT02276612|76158243|FG000|Overall Study|Death|1|||
42321122|NCT02276612|76158244|FG001|Overall Study|Death|0|||
42321123|NCT02276612|76158243|FG000|Overall Study|Pregnancy|1|||
42321124|NCT02276612|76158244|FG001|Overall Study|Pregnancy|0|||
42321125|NCT02276612|76158243|FG000|Overall Study|Withdrew Consent|1|||
42321126|NCT02276612|76158244|FG001|Overall Study|Withdrew Consent|0|||
42321127|NCT02276612|76158243|FG000|Overall Study|Lost to Follow-up|1|||
42321128|NCT02276612|76158244|FG001|Overall Study|Lost to Follow-up|0|||
42321129|NCT02301143|76158250|FG000|Induction Period|Enrolled But Not Treated|1|||
42321130|NCT02301143|76158251|FG001|Induction Period|Enrolled But Not Treated|0|||
42321131|NCT02301143|76158250|FG000|Induction Period|Death|1|||
42321132|NCT02301143|76158251|FG001|Induction Period|Death|0|||
42321133|NCT02301143|76158250|FG000|Induction Period|Adverse Event|22|||
42321134|NCT02301143|76158251|FG001|Induction Period|Adverse Event|0|||
42321135|NCT02301143|76158250|FG000|Induction Period|Progressive Disease|8|||
42321136|NCT02301143|76158251|FG001|Induction Period|Progressive Disease|0|||
42321137|NCT02301143|76158250|FG000|Induction Period|Withdrawal by Subject|3|||
42321138|NCT02301143|76158251|FG001|Induction Period|Withdrawal by Subject|0|||
42321139|NCT02301143|76158250|FG000|Induction Period|Noncompliance with Study Drug|1|||
42321140|NCT02301143|76158251|FG001|Induction Period|Noncompliance with Study Drug|0|||
42321141|NCT02301143|76158250|FG000|Induction Period|Physician Decision|4|||
42258982|NCT02477332|76085291|FG005|Overall Study|Protocol Violation|1|||
42258983|NCT02477332|76085286|FG000|Overall Study|Technical problems|0|||
42258984|NCT02477332|76085287|FG001|Overall Study|Technical problems|0|||
42258985|NCT02477332|76085288|FG002|Overall Study|Technical problems|1|||
42258986|NCT02477332|76085289|FG003|Overall Study|Technical problems|0|||
42258987|NCT02477332|76085290|FG004|Overall Study|Technical problems|0|||
42258988|NCT02477332|76085291|FG005|Overall Study|Technical problems|0|||
42258989|NCT02477332|76085286|FG000|Overall Study|Lost to Follow-up|0|||
42321142|NCT02301143|76158251|FG001|Induction Period|Physician Decision|0|||
42321143|NCT02301143|76158250|FG000|Induction Period|Symptomatic Deterioration|2|||
42321144|NCT02301143|76158251|FG001|Induction Period|Symptomatic Deterioration|0|||
42321145|NCT02301143|76158250|FG000|Induction Period|Protocol Violation|2|||
42321146|NCT02301143|76158251|FG001|Induction Period|Protocol Violation|0|||
42258990|NCT02477332|76085287|FG001|Overall Study|Lost to Follow-up|0|||
42321147|NCT02301143|76158250|FG000|Induction Period|Other|1|||
42258991|NCT02477332|76085288|FG002|Overall Study|Lost to Follow-up|2|||
42258992|NCT02477332|76085289|FG003|Overall Study|Lost to Follow-up|0|||
42321148|NCT02301143|76158251|FG001|Induction Period|Other|0|||
42321149|NCT02301143|76158250|FG000|Investigator's Choice|Adverse Event|0|||
42258993|NCT02477332|76085290|FG004|Overall Study|Lost to Follow-up|0|||
42321150|NCT02301143|76158251|FG001|Investigator's Choice|Adverse Event|3|||
42321151|NCT02301143|76158250|FG000|Investigator's Choice|Progressive Disease|0|||
42321152|NCT02301143|76158251|FG001|Investigator's Choice|Progressive Disease|3|||
42321153|NCT02301143|76158250|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
42034055|NCT01070550|75842182|FG001|Overall Study|Result not available|1|||
42034056|NCT01070550|75842183|FG002|Overall Study|Result not available|3|||
42034057|NCT01070550|75842184|FG003|Overall Study|Result not available|0|||
42034058|NCT01070550|75842185|FG004|Overall Study|Result not available|0|||
42034059|NCT01070550|75842186|FG005|Overall Study|Result not available|0|||
42034060|NCT01070550|75842181|FG000|Overall Study|Screen failure|1|||
42034061|NCT01070550|75842182|FG001|Overall Study|Screen failure|0|||
42034062|NCT01070550|75842183|FG002|Overall Study|Screen failure|0|||
42034063|NCT01070550|75842184|FG003|Overall Study|Screen failure|0|||
42034064|NCT01070550|75842185|FG004|Overall Study|Screen failure|0|||
42133461|NCT00394953|75944386|FG000|First Treatment Period|Renal transplant|11|||
42258994|NCT02477332|76085291|FG005|Overall Study|Lost to Follow-up|0|||
42258995|NCT02477332|76085286|FG000|Overall Study|Physician Decision|0|||
42258996|NCT02477332|76085287|FG001|Overall Study|Physician Decision|0|||
42258997|NCT02477332|76085288|FG002|Overall Study|Physician Decision|1|||
42258998|NCT02477332|76085289|FG003|Overall Study|Physician Decision|3|||
42258999|NCT02477332|76085290|FG004|Overall Study|Physician Decision|0|||
42259000|NCT02477332|76085291|FG005|Overall Study|Physician Decision|1|||
42259001|NCT02477332|76085286|FG000|Overall Study|Withdrawal by Subject|0|||
42259002|NCT02477332|76085287|FG001|Overall Study|Withdrawal by Subject|3|||
42259003|NCT02477332|76085288|FG002|Overall Study|Withdrawal by Subject|1|||
42259004|NCT02477332|76085289|FG003|Overall Study|Withdrawal by Subject|2|||
42259005|NCT02477332|76085290|FG004|Overall Study|Withdrawal by Subject|1|||
42259006|NCT02477332|76085291|FG005|Overall Study|Withdrawal by Subject|0|||
42259007|NCT02477020|76085309|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
42321154|NCT02301143|76158251|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
42321155|NCT02301143|76158250|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
42321156|NCT02301143|76158251|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
42321157|NCT02301143|76158250|FG000|Investigator's Choice|Other|0|||
42321158|NCT02301143|76158251|FG001|Investigator's Choice|Other|1|||
42321159|NCT02301143|76158250|FG000|Investigator's Choice|Unresectable Surgery|0|||
42321160|NCT02301143|76158251|FG001|Investigator's Choice|Unresectable Surgery|1|||
42321161|NCT02276222|76158264|FG000|Overall Study|Adverse Event|62|||
42321162|NCT02276222|76158265|FG001|Overall Study|Adverse Event|11|||
41994337|NCT01087788|75802644|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
41994338|NCT01087788|75802642|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
41994339|NCT01087788|75802643|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
41994340|NCT01087788|75802644|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
41994341|NCT01087788|75802642|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
41994342|NCT01087788|75802643|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
41994343|NCT01087788|75802644|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
41994344|NCT01087788|75802642|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
41994345|NCT01087788|75802643|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
41994346|NCT01087788|75802644|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
41994347|NCT01087788|75802642|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
41994348|NCT01087788|75802643|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
41994349|NCT01087788|75802644|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
41994350|NCT01087788|75802642|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
41994351|NCT01087788|75802643|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
42133462|NCT00394953|75944387|FG001|First Treatment Period|Renal transplant|7|||
42321163|NCT02276222|76158264|FG000|Overall Study|Death|3|||
42034065|NCT01070550|75842186|FG005|Overall Study|Screen failure|0|||
42034066|NCT01070550|75842181|FG000|Overall Study|Sponsor decision|1|||
42133463|NCT00394953|75944386|FG000|First Treatment Period|Not defined|4|||
42259008|NCT02477020|76085310|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
42259009|NCT02477020|76085309|FG000|Overall Study|Voluntary Withdrawal|7|||
42259010|NCT02477020|76085310|FG001|Overall Study|Voluntary Withdrawal|16|||
41994352|NCT01087788|75802644|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
42133464|NCT00394953|75944387|FG001|First Treatment Period|Not defined|1|||
42133465|NCT00394953|75944386|FG000|Second Treatment Period|Adverse Event|2|||
42133466|NCT00394953|75944387|FG001|Second Treatment Period|Adverse Event|5|||
42259011|NCT02477020|76085309|FG000|Overall Study|Reason not Specified|3|||
42259012|NCT02477020|76085310|FG001|Overall Study|Reason not Specified|1|||
42259013|NCT02477020|76085309|FG000|Overall Study|Lack of Efficacy|14|||
42259014|NCT02477020|76085310|FG001|Overall Study|Lack of Efficacy|5|||
42259015|NCT02862535|76085320|FG000|Overall Study|Death|7|||
42259016|NCT02862535|76085321|FG001|Overall Study|Death|3|||
42259017|NCT02862535|76085322|FG002|Overall Study|Death|2|||
42259018|NCT02862535|76085323|FG003|Overall Study|Death|5|||
42259019|NCT02862535|76085320|FG000|Overall Study|Study Terminated by Sponsor|1|||
42259020|NCT02862535|76085321|FG001|Overall Study|Study Terminated by Sponsor|3|||
42259021|NCT02862535|76085322|FG002|Overall Study|Study Terminated by Sponsor|8|||
42259022|NCT02862535|76085323|FG003|Overall Study|Study Terminated by Sponsor|5|||
42259023|NCT02862535|76085320|FG000|Overall Study|Enrolled, not Treated|1|||
42259024|NCT02862535|76085321|FG001|Overall Study|Enrolled, not Treated|0|||
42259025|NCT02862535|76085322|FG002|Overall Study|Enrolled, not Treated|0|||
42259026|NCT02862535|76085323|FG003|Overall Study|Enrolled, not Treated|1|||
42259027|NCT02448706|76085333|FG000|Overall Study|Withdrawal by Subject|4|||
42259028|NCT02448706|76085334|FG001|Overall Study|Withdrawal by Subject|3|||
42259029|NCT02448706|76085333|FG000|Overall Study|Protocol Violation|1|||
42259030|NCT02448706|76085334|FG001|Overall Study|Protocol Violation|1|||
42259031|NCT02868281|76085344|FG000|Overall Study|Adverse Event|2|||
42259032|NCT02868281|76085345|FG001|Overall Study|Adverse Event|2|||
42259033|NCT02868281|76085344|FG000|Overall Study|Protocol Violation|13|||
42259034|NCT02868281|76085345|FG001|Overall Study|Protocol Violation|10|||
42259035|NCT02868281|76085344|FG000|Overall Study|Lost to Follow-up|3|||
42259036|NCT02868281|76085345|FG001|Overall Study|Lost to Follow-up|6|||
42259037|NCT02868281|76085344|FG000|Overall Study|Withdrawal by Subject|11|||
42259038|NCT02868281|76085345|FG001|Overall Study|Withdrawal by Subject|15|||
42259039|NCT02868281|76085344|FG000|Overall Study|Physician Decision|2|||
42259040|NCT02868281|76085345|FG001|Overall Study|Physician Decision|0|||
42259041|NCT02868281|76085344|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
42259042|NCT02868281|76085345|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
42259043|NCT02868281|76085344|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
42259044|NCT02868281|76085345|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
42259045|NCT02868281|76085344|FG000|Overall Study|Long journey/moving away|1|||
42259046|NCT02868281|76085345|FG001|Overall Study|Long journey/moving away|1|||
42259047|NCT02476006|76085351|FG000|Overall Study|Death|4|||
42259048|NCT02476006|76085351|FG000|Overall Study|Lack of treatment efficacy|2|||
42259049|NCT02476006|76085351|FG000|Overall Study|Pregnancy|1|||
42259050|NCT02476006|76085351|FG000|Overall Study|Participant did not wish to continue|39|||
42259051|NCT02476006|76085351|FG000|Overall Study|Adverse Event|41|||
42259052|NCT02476006|76085351|FG000|Overall Study|Poor compliance to study protocol|3|||
42259053|NCT02476006|76085351|FG000|Overall Study|Sponsor decision|6|||
42259054|NCT02476006|76085351|FG000|Overall Study|Lost to Follow-up|5|||
42259055|NCT02476006|76085351|FG000|Overall Study|Physician Decision|5|||
42259056|NCT02476006|76085351|FG000|Overall Study|Study ended treatment not available|4|||
42259057|NCT02476006|76085351|FG000|Overall Study|Switched to commercial drug|4|||
42259058|NCT02476006|76085351|FG000|Overall Study|Excluded from study|1|||
42259059|NCT02476006|76085351|FG000|Overall Study|Protocol Violation|1|||
42259060|NCT02476006|76085351|FG000|Overall Study|Enrolled but not treated|4|||
42259061|NCT02475850|76085357|FG000|Overall Study|Death|155|||
42259062|NCT02475850|76085358|FG001|Overall Study|Death|141|||
42259063|NCT02475850|76085357|FG000|Overall Study|Lost to Follow-up|217|||
42259064|NCT02475850|76085358|FG001|Overall Study|Lost to Follow-up|188|||
42259065|NCT02475850|76085357|FG000|Overall Study|Withdrawal by Subject|221|||
42133467|NCT00394953|75944386|FG000|Second Treatment Period|Death|8|||
42259066|NCT02475850|76085358|FG001|Overall Study|Withdrawal by Subject|155|||
42259067|NCT02419612|76085367|FG000|Short-term Treatment Period|Adverse Event|1|||
42259068|NCT02419612|76085368|FG001|Short-term Treatment Period|Adverse Event|1|||
42259069|NCT02419612|76085367|FG000|Short-term Treatment Period|Death|0|||
42259070|NCT02419612|76085368|FG001|Short-term Treatment Period|Death|2|||
42259071|NCT02419612|76085367|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
42259072|NCT02419612|76085368|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
42259073|NCT02419612|76085367|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
42034067|NCT01070550|75842182|FG001|Overall Study|Sponsor decision|0|||
42321164|NCT02276222|76158265|FG001|Overall Study|Death|4|||
42321165|NCT02276222|76158264|FG000|Overall Study|Lack of Efficacy|13|||
42321166|NCT02276222|76158265|FG001|Overall Study|Lack of Efficacy|3|||
42321167|NCT02276222|76158264|FG000|Overall Study|Protocol Violation|3|||
42321168|NCT02276222|76158265|FG001|Overall Study|Protocol Violation|2|||
42321169|NCT02276222|76158264|FG000|Overall Study|Withdrawal by Subject|79|||
42321170|NCT02276222|76158265|FG001|Overall Study|Withdrawal by Subject|33|||
42321171|NCT02276222|76158264|FG000|Overall Study|non compliance with study medication|6|||
42321172|NCT02276222|76158265|FG001|Overall Study|non compliance with study medication|2|||
42321173|NCT02276222|76158264|FG000|Overall Study|sponsor decision|0|||
42321174|NCT02276222|76158265|FG001|Overall Study|sponsor decision|3|||
42321175|NCT02276222|76158264|FG000|Overall Study|Lost to Follow-up|15|||
42321176|NCT02276222|76158265|FG001|Overall Study|Lost to Follow-up|5|||
42321177|NCT02276222|76158264|FG000|Overall Study|Physician Decision|2|||
42321178|NCT02276222|76158265|FG001|Overall Study|Physician Decision|1|||
42321179|NCT02276222|76158264|FG000|Overall Study|sheduling conflict|1|||
42321180|NCT02276222|76158265|FG001|Overall Study|sheduling conflict|0|||
42321181|NCT02276222|76158264|FG000|Overall Study|subject withdrew after randomization|1|||
42321182|NCT02276222|76158265|FG001|Overall Study|subject withdrew after randomization|0|||
42321183|NCT02275364|76158271|FG000|Period 1|Withdrawal by Subject|1|||
42321184|NCT02275364|76158272|FG001|Period 1|Withdrawal by Subject|0|||
42321185|NCT02275364|76158271|FG000|Period 1|Other reason|1|||
42321186|NCT02275364|76158272|FG001|Period 1|Other reason|0|||
42321187|NCT02275052|76158289|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42321188|NCT02275052|76158290|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
42321189|NCT02275052|76158291|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42321190|NCT02275052|76158292|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42321191|NCT02275052|76158289|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
42321192|NCT02275052|76158290|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
42321193|NCT02275052|76158291|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
42321194|NCT02275052|76158292|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
42321195|NCT02275052|76158289|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
42321196|NCT02275052|76158290|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
42321197|NCT02275052|76158291|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
42321198|NCT02275052|76158292|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
42321199|NCT02275052|76158289|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
42321200|NCT02275052|76158290|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
42321201|NCT02275052|76158291|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
42321202|NCT02275052|76158292|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
42321203|NCT02275052|76158289|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
42321204|NCT02275052|76158290|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
42321205|NCT02275052|76158291|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
42321206|NCT02275052|76158292|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
42321207|NCT02275052|76158289|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
42321208|NCT02275052|76158290|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
42321209|NCT02275052|76158291|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
42321210|NCT02275052|76158292|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
42321211|NCT02275052|76158289|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
42321212|NCT02275052|76158290|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
42321213|NCT02275052|76158291|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
42321214|NCT02275052|76158292|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
42321215|NCT02275052|76158289|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
42321216|NCT02275052|76158290|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
42321217|NCT02275052|76158291|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
42321218|NCT02275052|76158292|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
42321219|NCT02275052|76158289|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42321220|NCT02275052|76158290|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42321221|NCT02275052|76158291|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
42321222|NCT02275052|76158292|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
42321223|NCT02275052|76158289|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
42321224|NCT02275052|76158290|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
42321225|NCT02275052|76158291|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
42321226|NCT02275052|76158292|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
42321227|NCT02275052|76158289|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
42321228|NCT02275052|76158290|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
42321229|NCT02275052|76158291|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
42321230|NCT02275052|76158292|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
42321231|NCT02274038|76158298|FG000|Overall Study|Death|1|||
42321232|NCT02300558|76158304|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
42321233|NCT02300558|76158304|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
42321234|NCT02300558|76158304|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
42321235|NCT02300558|76158304|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
42321236|NCT02273960|76158316|FG000|Short Term Period|Lost to Follow-up|1|||
42321237|NCT02273960|76158317|FG001|Short Term Period|Lost to Follow-up|0|||
42321238|NCT02273960|76158318|FG002|Short Term Period|Lost to Follow-up|0|||
42321239|NCT02273960|76158319|FG003|Short Term Period|Lost to Follow-up|0|||
42321240|NCT02273960|76158316|FG000|Short Term Period|Lack of Efficacy|0|||
42321241|NCT02273960|76158317|FG001|Short Term Period|Lack of Efficacy|0|||
42321242|NCT02273960|76158318|FG002|Short Term Period|Lack of Efficacy|0|||
42321243|NCT02273960|76158319|FG003|Short Term Period|Lack of Efficacy|1|||
42321244|NCT02273960|76158316|FG000|Short Term Period|ST complete, not entering LTE|4|||
42321245|NCT02273960|76158317|FG001|Short Term Period|ST complete, not entering LTE|6|||
42321246|NCT02273960|76158318|FG002|Short Term Period|ST complete, not entering LTE|4|||
42321247|NCT02273960|76158319|FG003|Short Term Period|ST complete, not entering LTE|5|||
42321248|NCT02273960|76158316|FG000|Long Term Extension|Death|0|||
42321249|NCT02273960|76158317|FG001|Long Term Extension|Death|0|||
42321250|NCT02273960|76158318|FG002|Long Term Extension|Death|0|||
42321251|NCT02273960|76158319|FG003|Long Term Extension|Death|1|||
42321252|NCT01646021|76158331|FG000|Overall Study|Death|77|||
42321253|NCT01646021|76158332|FG001|Overall Study|Death|83|||
42321254|NCT01646021|76158331|FG000|Overall Study|Study Terminated by Sponsor|50|||
42321255|NCT01646021|76158332|FG001|Overall Study|Study Terminated by Sponsor|41|||
42321256|NCT01646021|76158331|FG000|Overall Study|Lost to Follow-up|2|||
42321257|NCT01646021|76158332|FG001|Overall Study|Lost to Follow-up|2|||
42321258|NCT01646021|76158331|FG000|Overall Study|Withdrawal by Subject|10|||
42321259|NCT01646021|76158332|FG001|Overall Study|Withdrawal by Subject|15|||
42321260|NCT01750918|76158349|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
42321261|NCT01750918|76158350|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
42321262|NCT01750918|76158351|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
42321263|NCT01750918|76158352|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
42321264|NCT01750918|76158353|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
42321265|NCT01750918|76158354|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
42259074|NCT02419612|76085368|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
42259075|NCT02419612|76085367|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
42259076|NCT02419612|76085368|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
42259077|NCT02419612|76085367|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
42259078|NCT02419612|76085368|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
42259079|NCT02419612|76085367|FG000|Short-term Treatment Period|Worsening of liver function|0|||
42259080|NCT02419612|76085368|FG001|Short-term Treatment Period|Worsening of liver function|1|||
42321266|NCT01750918|76158355|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
42321267|NCT01750918|76158356|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
42321268|NCT01750918|76158349|FG000|Overall Study|Lost to Follow-up|0|||
42259081|NCT02419612|76085367|FG000|Short-term Treatment Period|Subject moved out of state|0|||
42259082|NCT02419612|76085368|FG001|Short-term Treatment Period|Subject moved out of state|1|||
42259083|NCT02419612|76085367|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
42259084|NCT02419612|76085368|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
42259085|NCT02419612|76085367|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
42259086|NCT02419612|76085368|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
42321269|NCT01750918|76158350|FG001|Overall Study|Lost to Follow-up|0|||
42321270|NCT01750918|76158351|FG002|Overall Study|Lost to Follow-up|2|||
42321271|NCT01750918|76158352|FG003|Overall Study|Lost to Follow-up|2|||
42321272|NCT01750918|76158353|FG004|Overall Study|Lost to Follow-up|0|||
42321273|NCT01750918|76158354|FG005|Overall Study|Lost to Follow-up|0|||
42321274|NCT01750918|76158355|FG006|Overall Study|Lost to Follow-up|0|||
42321275|NCT01750918|76158356|FG007|Overall Study|Lost to Follow-up|1|||
42321276|NCT01750918|76158349|FG000|Overall Study|Withdrawal by Subject|0|||
42321277|NCT01750918|76158350|FG001|Overall Study|Withdrawal by Subject|0|||
42321278|NCT01750918|76158351|FG002|Overall Study|Withdrawal by Subject|1|||
42321279|NCT01750918|76158352|FG003|Overall Study|Withdrawal by Subject|2|||
42321280|NCT01750918|76158353|FG004|Overall Study|Withdrawal by Subject|1|||
42321281|NCT01750918|76158354|FG005|Overall Study|Withdrawal by Subject|1|||
42321282|NCT01750918|76158355|FG006|Overall Study|Withdrawal by Subject|2|||
42321283|NCT01750918|76158356|FG007|Overall Study|Withdrawal by Subject|2|||
42321284|NCT02300987|76158388|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
42321285|NCT02300987|76158389|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
42321286|NCT02300987|76158388|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
42321287|NCT02300987|76158389|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
42321288|NCT02300987|76158388|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
42321289|NCT02300987|76158389|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
42321290|NCT02300987|76158388|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
42321291|NCT02300987|76158389|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
42321292|NCT02300987|76158388|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
42321293|NCT02300987|76158389|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
42321294|NCT01750840|76158396|FG000|Overall Study|Lost to Follow-up|4|||
42321295|NCT01606228|76158401|FG000|Overall Study|Lost to Follow-up|20|||
42321296|NCT01606228|76158401|FG000|Overall Study|Withdrawal by Subject|3|||
42321297|NCT01606228|76158401|FG000|Overall Study|Non-compliant|3|||
42321298|NCT01606228|76158401|FG000|Overall Study|Lack of Efficacy|2|||
42321299|NCT01606228|76158401|FG000|Overall Study|Adverse Event|1|||
42321300|NCT01706536|76158410|FG000|Overall Study|Withdrawal by Subject|1|||
42321301|NCT01706536|76158411|FG001|Overall Study|Withdrawal by Subject|0|||
42321302|NCT01706536|76158412|FG002|Overall Study|Withdrawal by Subject|1|||
42321303|NCT01706536|76158413|FG003|Overall Study|Withdrawal by Subject|0|||
42321304|NCT01706536|76158414|FG004|Overall Study|Withdrawal by Subject|0|||
42321305|NCT01706536|76158410|FG000|Overall Study|Adverse Event|2|||
42321306|NCT01706536|76158411|FG001|Overall Study|Adverse Event|3|||
42321307|NCT01706536|76158412|FG002|Overall Study|Adverse Event|4|||
42321308|NCT01706536|76158413|FG003|Overall Study|Adverse Event|3|||
42321309|NCT01706536|76158414|FG004|Overall Study|Adverse Event|2|||
42321310|NCT01706536|76158410|FG000|Overall Study|Lack of Efficacy|1|||
42321311|NCT01706536|76158411|FG001|Overall Study|Lack of Efficacy|0|||
42321312|NCT01706536|76158412|FG002|Overall Study|Lack of Efficacy|0|||
42321313|NCT01706536|76158413|FG003|Overall Study|Lack of Efficacy|1|||
42321314|NCT01706536|76158414|FG004|Overall Study|Lack of Efficacy|0|||
42321315|NCT01706536|76158410|FG000|Overall Study|non compliance|0|||
42321316|NCT01706536|76158411|FG001|Overall Study|non compliance|1|||
42321317|NCT01706536|76158412|FG002|Overall Study|non compliance|0|||
42321318|NCT01706536|76158413|FG003|Overall Study|non compliance|0|||
42321319|NCT01706536|76158414|FG004|Overall Study|non compliance|0|||
42259087|NCT02419612|76085367|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
42259088|NCT02419612|76085368|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
42259089|NCT02419612|76085367|FG000|Long-term Treatment Period|Death|0|||
42259090|NCT02419612|76085368|FG001|Long-term Treatment Period|Death|1|||
42259091|NCT02419612|76085367|FG000|Long-term Treatment Period|Adverse Event|0|||
42259092|NCT02419612|76085368|FG001|Long-term Treatment Period|Adverse Event|5|||
42259093|NCT02419612|76085367|FG000|Long-term Treatment Period|Other|4|||
42259094|NCT02419612|76085368|FG001|Long-term Treatment Period|Other|4|||
42259095|NCT02419612|76085367|FG000|Long-term Treatment Period|Subject Decision|2|||
42259096|NCT02419612|76085368|FG001|Long-term Treatment Period|Subject Decision|4|||
42259097|NCT02419612|76085367|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
42034068|NCT01070550|75842183|FG002|Overall Study|Sponsor decision|0|||
42259098|NCT02419612|76085368|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
42259099|NCT02447848|76085374|FG000|Overall Study|Patient discharged|3|||
42321320|NCT02269943|76158429|FG000|Treatment Period|Death|0|||
42321321|NCT02269943|76158430|FG001|Treatment Period|Death|1|||
42321322|NCT02269943|76158429|FG000|Treatment Period|Adverse Event|1|||
42321323|NCT02269943|76158430|FG001|Treatment Period|Adverse Event|10|||
42321324|NCT02269943|76158429|FG000|Treatment Period|Progressive Disease|5|||
42321325|NCT02269943|76158430|FG001|Treatment Period|Progressive Disease|17|||
42321326|NCT02269943|76158429|FG000|Treatment Period|Symptomatic Deterioration|0|||
42321327|NCT02269943|76158430|FG001|Treatment Period|Symptomatic Deterioration|2|||
42321328|NCT02269943|76158429|FG000|Follow-Up Survival Period|Death|3|||
42321329|NCT02269943|76158430|FG001|Follow-Up Survival Period|Death|16|||
42321330|NCT02269943|76158429|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
42321331|NCT02269943|76158430|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
42321332|NCT02269943|76158429|FG000|Follow-Up Survival Period|Alive|2|||
42321333|NCT02269943|76158430|FG001|Follow-Up Survival Period|Alive|8|||
42321334|NCT01706458|76158438|FG000|Overall Study|Physician Decision|3|||
42321335|NCT01706458|76158439|FG001|Overall Study|Physician Decision|4|||
42321336|NCT02269787|76158447|FG000|Overall Study|Lost to Follow-up|20|||
42321337|NCT02269787|76158448|FG001|Overall Study|Lost to Follow-up|6|||
42321338|NCT02269787|76158447|FG000|Overall Study|Death|2|||
42321339|NCT02269787|76158448|FG001|Overall Study|Death|3|||
42321340|NCT02269787|76158447|FG000|Overall Study|Incapacitated|0|||
42321341|NCT02269787|76158448|FG001|Overall Study|Incapacitated|1|||
42321342|NCT01605370|76158456|FG000|Overall Study|Adverse Event|1|||
42259100|NCT02447848|76085374|FG000|Overall Study|Lack of Efficacy|4|||
42321343|NCT01605370|76158457|FG001|Overall Study|Adverse Event|0|||
42321344|NCT02269709|76158463|FG000|Time of Enrollment|Withdrawal by Subject|3|||
42321345|NCT02269709|76158463|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
42321346|NCT02269709|76158463|FG000|Six Month Follow-up|Lost to Follow-up|12|||
42321347|NCT02269475|76158470|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
42321348|NCT02269475|76158471|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
42321349|NCT02269475|76158470|FG000|Overall Study|Withdrawal by Subject|0|||
42321350|NCT02269475|76158471|FG001|Overall Study|Withdrawal by Subject|1|||
42321351|NCT01605136|76158480|FG000|Study Period|Withdrawal by Subject|2|||
42321352|NCT01605136|76158481|FG001|Study Period|Withdrawal by Subject|0|||
42321353|NCT01605136|76158480|FG000|Study Period|Physician Decision|1|||
42321354|NCT01605136|76158481|FG001|Study Period|Physician Decision|1|||
42321355|NCT01605136|76158480|FG000|Study Period|Lost to Follow-up|0|||
42321356|NCT01605136|76158481|FG001|Study Period|Lost to Follow-up|2|||
42321357|NCT01605136|76158480|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
42321358|NCT01605136|76158481|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
42321359|NCT01706146|76158487|FG000|Overall Study|Withdrawal by Subject|1|||
42321360|NCT01706146|76158487|FG000|Overall Study|Adverse Event|3|||
42321361|NCT01706146|76158487|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
42321362|NCT02269241|76158491|FG000|Overall Study|Lost to Follow-up|269|||
42321363|NCT02269241|76158491|FG000|Overall Study|Withdrawal by Subject|155|||
42321364|NCT02269241|76158491|FG000|Overall Study|Protocol Violation|1|||
42321365|NCT02269241|76158491|FG000|Overall Study|Physician Decision|7|||
42321366|NCT02269241|76158491|FG000|Overall Study|Pregnancy|15|||
42321367|NCT02269241|76158491|FG000|Overall Study|Wish for pregnancy|5|||
42259101|NCT02447848|76085374|FG000|Overall Study|Withdrawal by Subject|4|||
42259102|NCT02418910|76085378|FG000|Overall Study|Lost to Follow-up|3|||
42259103|NCT02418910|76085378|FG000|Overall Study|Withdrawal by Subject|4|||
42259104|NCT02418754|76085394|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
42259105|NCT02418754|76085395|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
42259106|NCT02418754|76085396|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
42259107|NCT02418754|76085397|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
42259108|NCT02418754|76085398|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
42259109|NCT02418754|76085394|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
42259110|NCT02418754|76085395|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
42259111|NCT02418754|76085396|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
42259112|NCT02418754|76085397|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
42259113|NCT02418754|76085398|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
42259114|NCT02418754|76085394|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
42259115|NCT02418754|76085395|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
42259116|NCT02418754|76085396|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
42321368|NCT02269241|76158491|FG000|Overall Study|Development of an exclusion criteria|16|||
42259117|NCT02418754|76085397|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
42321369|NCT02269241|76158491|FG000|Overall Study|Adverse Event|113|||
42321370|NCT02269241|76158491|FG000|Overall Study|At the specific request of the sponsor|20|||
42321371|NCT02269241|76158491|FG000|Overall Study|Several reasons not classified|53|||
42321372|NCT02269241|76158491|FG000|Overall Study|Screening failures|546|||
42321373|NCT01750684|76158498|FG000|Overall Study|Death|1|||
42321374|NCT01750684|76158499|FG001|Overall Study|Death|0|||
42259118|NCT02418754|76085398|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
42259119|NCT02418754|76085394|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
42321375|NCT01750684|76158498|FG000|Overall Study|Non-compliance with Study Drug|0|||
42321376|NCT01750684|76158499|FG001|Overall Study|Non-compliance with Study Drug|1|||
42321377|NCT01750684|76158498|FG000|Overall Study|Withdrawn by Sponsor|0|||
42321378|NCT01750684|76158499|FG001|Overall Study|Withdrawn by Sponsor|1|||
42321379|NCT01750684|76158498|FG000|Overall Study|Protocol Violation|1|||
42321380|NCT01750684|76158499|FG001|Overall Study|Protocol Violation|0|||
42321381|NCT01750294|76158506|FG000|Overall Study|Withdrawal by Subject|1|||
42321382|NCT01750294|76158506|FG000|Overall Study|Safety Endpoint|1|||
42321383|NCT01749982|76158514|FG000|Overall Study|Physician Decision|0|||
42321384|NCT01749982|76158515|FG001|Overall Study|Physician Decision|0|||
42321385|NCT01749982|76158516|FG002|Overall Study|Physician Decision|0|||
42321386|NCT01749982|76158517|FG003|Overall Study|Physician Decision|1|||
42321387|NCT01749982|76158514|FG000|Overall Study|Lost to Follow-up|0|||
42321388|NCT01749982|76158515|FG001|Overall Study|Lost to Follow-up|0|||
42321389|NCT01749982|76158516|FG002|Overall Study|Lost to Follow-up|0|||
42321390|NCT01749982|76158517|FG003|Overall Study|Lost to Follow-up|1|||
42321391|NCT01749982|76158514|FG000|Overall Study|Withdrawal by Subject|0|||
42321392|NCT01749982|76158515|FG001|Overall Study|Withdrawal by Subject|0|||
42321393|NCT01749982|76158516|FG002|Overall Study|Withdrawal by Subject|0|||
42321394|NCT01749982|76158517|FG003|Overall Study|Withdrawal by Subject|1|||
42321395|NCT02269163|76158529|FG000|Overall Study|Lost to Follow-up|1|||
42321396|NCT02269163|76158530|FG001|Overall Study|Lost to Follow-up|0|||
42321397|NCT02269163|76158529|FG000|Overall Study|Major protocol violation|0|||
42321398|NCT02269163|76158530|FG001|Overall Study|Major protocol violation|1|||
42321399|NCT02269163|76158529|FG000|Overall Study|Other|2|||
42321400|NCT02269163|76158530|FG001|Overall Study|Other|2|||
42321401|NCT02269163|76158529|FG000|Overall Study|Withdrawal by Subject|0|||
42321402|NCT02269163|76158530|FG001|Overall Study|Withdrawal by Subject|3|||
42321403|NCT02269163|76158529|FG000|Overall Study|Physician Decision|0|||
42321404|NCT02269163|76158530|FG001|Overall Study|Physician Decision|1|||
42321405|NCT01749826|76158540|FG000|Overall Study|Study Terminated|20|||
42321406|NCT01749826|76158541|FG001|Overall Study|Study Terminated|0|||
42321407|NCT02300129|76158547|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
42321408|NCT02300129|76158548|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
42321409|NCT02300129|76158549|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
42321410|NCT02300129|76158550|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
42321411|NCT02300129|76158547|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
42321412|NCT02300129|76158548|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
42321413|NCT02300129|76158549|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
42321414|NCT02300129|76158550|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
42321415|NCT02300129|76158547|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
42321416|NCT02300129|76158548|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
42321417|NCT02300129|76158549|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
42321418|NCT02300129|76158550|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
42321419|NCT02267135|76158562|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
42321420|NCT02267135|76158563|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
42321421|NCT02267135|76158562|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
42321422|NCT02267135|76158563|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
42321423|NCT02267135|76158562|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
42321424|NCT02267135|76158563|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
42321425|NCT02267135|76158562|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
42321426|NCT02267135|76158563|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
42321427|NCT02267135|76158562|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
42321428|NCT02267135|76158563|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
42321429|NCT02299427|76158574|FG000|Overall Study|Withdrawal by Subject|1|||
42321430|NCT02299427|76158575|FG001|Overall Study|Withdrawal by Subject|0|||
42321431|NCT02299427|76158574|FG000|Overall Study|Lost to Follow-up|1|||
42321432|NCT02299427|76158575|FG001|Overall Study|Lost to Follow-up|3|||
42321433|NCT02299427|76158574|FG000|Overall Study|not adherent to dog website use|21|||
42321434|NCT02299427|76158575|FG001|Overall Study|not adherent to dog website use|0|||
42321435|NCT01724866|76158585|FG000|Overall Study|Adverse Event|0|||
42321436|NCT01724866|76158586|FG001|Overall Study|Adverse Event|0|||
42321437|NCT01724866|76158587|FG002|Overall Study|Adverse Event|1|||
42321438|NCT01724866|76158588|FG003|Overall Study|Adverse Event|1|||
42321439|NCT01724866|76158585|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
42321440|NCT01724866|76158586|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
42321441|NCT01724866|76158587|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
42321442|NCT01724866|76158588|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
42321443|NCT01724866|76158585|FG000|Overall Study|Investigator's Discretion|0|||
42321444|NCT01724866|76158586|FG001|Overall Study|Investigator's Discretion|1|||
41994353|NCT01087788|75802642|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
42321445|NCT01724866|76158587|FG002|Overall Study|Investigator's Discretion|1|||
42321446|NCT01724866|76158588|FG003|Overall Study|Investigator's Discretion|0|||
42321447|NCT01724866|76158585|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
42321448|NCT01724866|76158586|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
42321449|NCT01724866|76158587|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
41994354|NCT01087788|75802643|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
41994355|NCT01087788|75802644|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
41994356|NCT01087788|75802642|FG000|24-weeks Dose-blind Period|Patient moved|0|||
42321450|NCT01724866|76158588|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
42321451|NCT01724866|76158585|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
42321452|NCT01724866|76158586|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
42321453|NCT01724866|76158587|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
42321454|NCT01724866|76158588|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
42321455|NCT02266433|76158600|FG000|Overall Study|Lost to Follow-up|54|||
42321456|NCT02266433|76158601|FG001|Overall Study|Lost to Follow-up|46|||
41994357|NCT01087788|75802643|FG001|24-weeks Dose-blind Period|Patient moved|0|||
41994358|NCT01087788|75802644|FG002|24-weeks Dose-blind Period|Patient moved|1|||
42259120|NCT02418754|76085395|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
42259121|NCT02418754|76085396|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
42259122|NCT02418754|76085397|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
42259123|NCT02418754|76085398|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
42259124|NCT02418754|76085394|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
42259125|NCT02418754|76085395|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
42259126|NCT02418754|76085396|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
42259127|NCT02418754|76085397|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
42259128|NCT02418754|76085398|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
42259129|NCT02418754|76085394|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
41994359|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
41994360|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
41994361|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
41994362|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
42259130|NCT02418754|76085395|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
42259131|NCT02418754|76085396|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
42259132|NCT02418754|76085397|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
42259133|NCT02418754|76085398|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
42259134|NCT02418754|76085394|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
42259135|NCT02418754|76085395|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
42259136|NCT02418754|76085396|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
42259137|NCT02418754|76085397|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
42259138|NCT02418754|76085398|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
42259139|NCT02418754|76085394|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
42259140|NCT02418754|76085395|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
42259141|NCT02418754|76085396|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
42259142|NCT02418754|76085397|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
42259143|NCT02418754|76085398|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
42259144|NCT02418754|76085394|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
42259145|NCT02418754|76085395|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
42259146|NCT02418754|76085396|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
42259147|NCT02418754|76085397|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
42259148|NCT02418754|76085398|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
42259149|NCT02418754|76085394|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
42259150|NCT02418754|76085395|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
41994363|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
41994364|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
41994365|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
41994366|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
41994367|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
41994368|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
41994369|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
41994370|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
42034069|NCT01070550|75842184|FG003|Overall Study|Sponsor decision|0|||
41994371|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
41994372|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
41994373|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
41994374|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
42034070|NCT01070550|75842185|FG004|Overall Study|Sponsor decision|0|||
42034071|NCT01070550|75842186|FG005|Overall Study|Sponsor decision|0|||
42034072|NCT01070550|75842181|FG000|Overall Study|Treatment duration shortened|1|||
42034073|NCT01070550|75842182|FG001|Overall Study|Treatment duration shortened|0|||
42034074|NCT01070550|75842183|FG002|Overall Study|Treatment duration shortened|0|||
41994375|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
41994376|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
41994377|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
41994378|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
41994379|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
41994380|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
41994381|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
41994382|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
41994383|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
42034075|NCT01070550|75842184|FG003|Overall Study|Treatment duration shortened|0|||
42034076|NCT01070550|75842185|FG004|Overall Study|Treatment duration shortened|0|||
42034077|NCT01070550|75842186|FG005|Overall Study|Treatment duration shortened|0|||
42034078|NCT01070550|75842181|FG000|Overall Study|Treatment interrupted|7|||
42034079|NCT01070550|75842182|FG001|Overall Study|Treatment interrupted|0|||
42034080|NCT01070550|75842183|FG002|Overall Study|Treatment interrupted|1|||
42034081|NCT01070550|75842184|FG003|Overall Study|Treatment interrupted|1|||
42034082|NCT01070550|75842185|FG004|Overall Study|Treatment interrupted|0|||
42034083|NCT01070550|75842186|FG005|Overall Study|Treatment interrupted|0|||
42034084|NCT01070550|75842181|FG000|Overall Study|Treatment not started|14|||
42034085|NCT01070550|75842182|FG001|Overall Study|Treatment not started|2|||
42034086|NCT01070550|75842183|FG002|Overall Study|Treatment not started|4|||
42034087|NCT01070550|75842184|FG003|Overall Study|Treatment not started|0|||
42034088|NCT01070550|75842185|FG004|Overall Study|Treatment not started|0|||
42034089|NCT01070550|75842186|FG005|Overall Study|Treatment not started|0|||
42034090|NCT01070550|75842181|FG000|Overall Study|Treatment restarted|0|||
42034091|NCT01070550|75842182|FG001|Overall Study|Treatment restarted|1|||
42034092|NCT01070550|75842183|FG002|Overall Study|Treatment restarted|0|||
42034093|NCT01070550|75842184|FG003|Overall Study|Treatment restarted|0|||
42034094|NCT01070550|75842185|FG004|Overall Study|Treatment restarted|0|||
42034095|NCT01070550|75842186|FG005|Overall Study|Treatment restarted|0|||
42034096|NCT01070550|75842181|FG000|Overall Study|Treatment stopped|3|||
42034097|NCT01070550|75842182|FG001|Overall Study|Treatment stopped|0|||
42034098|NCT01070550|75842183|FG002|Overall Study|Treatment stopped|0|||
42259151|NCT02418754|76085396|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
42259152|NCT02418754|76085397|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
42259153|NCT02418754|76085398|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
42259154|NCT02418754|76085394|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
42259155|NCT02418754|76085395|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
42259156|NCT02418754|76085396|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
42259157|NCT02418754|76085397|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
42321457|NCT02266433|76158600|FG000|Overall Study|Withdrawal by Subject|5|||
42321458|NCT02266433|76158601|FG001|Overall Study|Withdrawal by Subject|7|||
42321459|NCT01748890|76158608|FG000|Overall Study|Insufficient recruitment for analysis|4|||
42321460|NCT01747876|76158615|FG000|Overall Study|Adverse Event|1|||
42321461|NCT01747876|76158616|FG001|Overall Study|Adverse Event|0|||
42321462|NCT01747876|76158617|FG002|Overall Study|Adverse Event|2|||
42321463|NCT01747876|76158615|FG000|Overall Study|Withdrawal by Subject|0|||
42321464|NCT01747876|76158616|FG001|Overall Study|Withdrawal by Subject|1|||
41994384|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
41994385|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
41994386|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
41994387|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
42321465|NCT01747876|76158617|FG002|Overall Study|Withdrawal by Subject|1|||
42321466|NCT01747876|76158615|FG000|Overall Study|Disease progression|4|||
42321467|NCT01747876|76158616|FG001|Overall Study|Disease progression|13|||
42321468|NCT01747876|76158617|FG002|Overall Study|Disease progression|8|||
42321469|NCT01747876|76158615|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
42321470|NCT01747876|76158616|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
41994388|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
41994389|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
41994390|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
42259158|NCT02418754|76085398|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
42259159|NCT02447458|76085414|FG000|Overall Study|Other|0|||
42259160|NCT02447458|76085415|FG001|Overall Study|Other|0|||
42259161|NCT02447458|76085416|FG002|Overall Study|Other|1|||
42259162|NCT02447458|76085417|FG003|Overall Study|Other|0|||
42259163|NCT02447458|76085418|FG004|Overall Study|Other|0|||
42259164|NCT02447458|76085419|FG005|Overall Study|Other|0|||
42259165|NCT02862457|76085445|FG000|Overall Study|Death|1|||
42259166|NCT02862457|76085446|FG001|Overall Study|Death|3|||
42259167|NCT02862457|76085447|FG002|Overall Study|Death|2|||
42259168|NCT02862457|76085448|FG003|Overall Study|Death|3|||
41994391|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
41994392|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
42034099|NCT01070550|75842184|FG003|Overall Study|Treatment stopped|0|||
42034100|NCT01070550|75842185|FG004|Overall Study|Treatment stopped|0|||
42034101|NCT01070550|75842186|FG005|Overall Study|Treatment stopped|0|||
42034102|NCT01070550|75842181|FG000|Overall Study|Treatment unavailable|1|||
42321471|NCT01747876|76158617|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
42321472|NCT02273726|76158630|FG000|Overall Study|Death|70|||
42321473|NCT02273726|76158631|FG001|Overall Study|Death|62|||
42321474|NCT02273726|76158630|FG000|Overall Study|Withdrawal by Subject|41|||
42321475|NCT02273726|76158631|FG001|Overall Study|Withdrawal by Subject|29|||
42321476|NCT02273726|76158630|FG000|Overall Study|Kidney transplant|31|||
42321477|NCT02273726|76158631|FG001|Overall Study|Kidney transplant|39|||
42321478|NCT02273726|76158630|FG000|Overall Study|Physician Decision|30|||
42321479|NCT02273726|76158631|FG001|Overall Study|Physician Decision|15|||
42321480|NCT02273726|76158630|FG000|Overall Study|Adverse Event|27|||
42321481|NCT02273726|76158631|FG001|Overall Study|Adverse Event|9|||
42321482|NCT02273726|76158630|FG000|Overall Study|Lost to Follow-up|6|||
42321483|NCT02273726|76158631|FG001|Overall Study|Lost to Follow-up|3|||
42321484|NCT02273726|76158630|FG000|Overall Study|Lack of Efficacy|6|||
42321485|NCT02273726|76158631|FG001|Overall Study|Lack of Efficacy|1|||
42321486|NCT02273726|76158630|FG000|Overall Study|Protocol Violation|4|||
42321487|NCT02273726|76158631|FG001|Overall Study|Protocol Violation|0|||
42321488|NCT02273726|76158630|FG000|Overall Study|Other than specified|28|||
42321489|NCT02273726|76158631|FG001|Overall Study|Other than specified|30|||
42321490|NCT01723228|76158639|FG000|Overall Study|Adverse Event|2|||
42321491|NCT01723228|76158640|FG001|Overall Study|Adverse Event|6|||
42321492|NCT01723228|76158639|FG000|Overall Study|Withdrawal by Subject|2|||
42321493|NCT01723228|76158640|FG001|Overall Study|Withdrawal by Subject|1|||
42321494|NCT01723228|76158639|FG000|Overall Study|Protocol Violation|0|||
42321495|NCT01723228|76158640|FG001|Overall Study|Protocol Violation|2|||
42321496|NCT01723228|76158639|FG000|Overall Study|Lost to Follow-up|2|||
42321497|NCT01723228|76158640|FG001|Overall Study|Lost to Follow-up|1|||
42321498|NCT01723228|76158639|FG000|Overall Study|Other|2|||
42321499|NCT01723228|76158640|FG001|Overall Study|Other|1|||
42321500|NCT02273180|76158648|FG000|Overall Study|Adverse Event|2|||
42321501|NCT02273180|76158649|FG001|Overall Study|Adverse Event|2|||
42321502|NCT02273180|76158648|FG000|Overall Study|Lack of Efficacy|1|||
42321503|NCT02273180|76158649|FG001|Overall Study|Lack of Efficacy|0|||
42321504|NCT02273180|76158648|FG000|Overall Study|Protocol Violation|1|||
42321505|NCT02273180|76158649|FG001|Overall Study|Protocol Violation|7|||
42321506|NCT02273180|76158648|FG000|Overall Study|Randomized but not treated|1|||
42321507|NCT02273180|76158649|FG001|Overall Study|Randomized but not treated|0|||
42321508|NCT02273180|76158648|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
42321509|NCT02273180|76158649|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
42321510|NCT02273180|76158648|FG000|Overall Study|Other than specified above|21|||
42321511|NCT02273180|76158649|FG001|Overall Study|Other than specified above|10|||
42321512|NCT01746862|76158657|FG000|Overall Study|Withdrawal by Subject|1|||
42321513|NCT01746862|76158658|FG001|Overall Study|Withdrawal by Subject|1|||
42321514|NCT01746862|76158657|FG000|Overall Study|Protocol Violation|1|||
42321515|NCT01746862|76158658|FG001|Overall Study|Protocol Violation|0|||
42321516|NCT01746862|76158657|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
42321517|NCT01746862|76158658|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
42321518|NCT01746862|76158657|FG000|Overall Study|Entered puberty during the study|1|||
42321519|NCT01746862|76158658|FG001|Overall Study|Entered puberty during the study|0|||
42321520|NCT01745848|76158665|FG000|Overall Study|Adverse Event|6|||
42321521|NCT01745380|76158671|FG000|Overall Study|Lost to Follow-up|1|||
42321522|NCT01745380|76158672|FG001|Overall Study|Lost to Follow-up|0|||
42321523|NCT01745380|76158671|FG000|Overall Study|Lack of Efficacy|0|||
42321524|NCT01745380|76158672|FG001|Overall Study|Lack of Efficacy|1|||
42321525|NCT01745146|76158680|FG000|Overall Study|Withdrawal by Subject|1|||
42321526|NCT01745146|76158681|FG001|Overall Study|Withdrawal by Subject|3|||
42321527|NCT01745146|76158680|FG000|Overall Study|Lost to Follow-up|2|||
42321528|NCT01745146|76158681|FG001|Overall Study|Lost to Follow-up|0|||
42321529|NCT02203513|76158693|FG000|Overall Study|Refused further treatment|2|||
42321530|NCT02203513|76158694|FG001|Overall Study|Refused further treatment|0|||
42321531|NCT02203513|76158695|FG002|Overall Study|Refused further treatment|1|||
42321532|NCT02203513|76158696|FG003|Overall Study|Refused further treatment|0|||
42321533|NCT02203513|76158697|FG004|Overall Study|Refused further treatment|0|||
42321534|NCT02203513|76158693|FG000|Overall Study|Switched to alternative treatment|3|||
42321535|NCT02203513|76158694|FG001|Overall Study|Switched to alternative treatment|4|||
42321536|NCT02203513|76158695|FG002|Overall Study|Switched to alternative treatment|0|||
42321537|NCT02203513|76158696|FG003|Overall Study|Switched to alternative treatment|0|||
42321538|NCT02203513|76158697|FG004|Overall Study|Switched to alternative treatment|4|||
42321539|NCT02203513|76158693|FG000|Overall Study|Did not receive investigational product (IP)|0|||
42321540|NCT02203513|76158694|FG001|Overall Study|Did not receive investigational product (IP)|1|||
42321541|NCT02203513|76158695|FG002|Overall Study|Did not receive investigational product (IP)|0|||
42321542|NCT02203513|76158696|FG003|Overall Study|Did not receive investigational product (IP)|0|||
42321543|NCT02203513|76158697|FG004|Overall Study|Did not receive investigational product (IP)|0|||
42321544|NCT02203513|76158693|FG000|Overall Study|Death (unrelated to study therapy)|1|||
42321545|NCT02203513|76158694|FG001|Overall Study|Death (unrelated to study therapy)|3|||
42321546|NCT02203513|76158695|FG002|Overall Study|Death (unrelated to study therapy)|1|||
42321547|NCT02203513|76158696|FG003|Overall Study|Death (unrelated to study therapy)|0|||
42321548|NCT02203513|76158697|FG004|Overall Study|Death (unrelated to study therapy)|2|||
42321549|NCT02203513|76158693|FG000|Overall Study|Lost to Follow-up|0|||
42321550|NCT02203513|76158694|FG001|Overall Study|Lost to Follow-up|0|||
42321551|NCT02203513|76158695|FG002|Overall Study|Lost to Follow-up|1|||
42321552|NCT02203513|76158696|FG003|Overall Study|Lost to Follow-up|1|||
42321553|NCT02203513|76158697|FG004|Overall Study|Lost to Follow-up|0|||
42321554|NCT02299934|76158711|FG000|Overall Study|Termination of study|13|||
42321555|NCT01703260|76158718|FG000|Overall Study|Adverse Event|1|||
42321556|NCT01703260|76158719|FG001|Overall Study|Adverse Event|2|||
42321557|NCT01703260|76158720|FG002|Overall Study|Adverse Event|2|||
42321558|NCT01703260|76158718|FG000|Overall Study|Lost to Follow-up|1|||
42321559|NCT01703260|76158719|FG001|Overall Study|Lost to Follow-up|0|||
42321560|NCT01703260|76158720|FG002|Overall Study|Lost to Follow-up|0|||
42321561|NCT01703260|76158718|FG000|Overall Study|Withdrawal by Subject|0|||
42321562|NCT01703260|76158719|FG001|Overall Study|Withdrawal by Subject|0|||
42321563|NCT01703260|76158720|FG002|Overall Study|Withdrawal by Subject|1|||
42321564|NCT01703260|76158718|FG000|Overall Study|Study Termination|1|||
42321565|NCT01703260|76158719|FG001|Overall Study|Study Termination|2|||
42321566|NCT01703260|76158720|FG002|Overall Study|Study Termination|0|||
42321567|NCT02203357|76158731|FG000|Overall Study|Lost to Follow-up|58|||
42321568|NCT02203357|76158732|FG001|Overall Study|Lost to Follow-up|66|||
42321569|NCT02203357|76158733|FG002|Overall Study|Lost to Follow-up|70|||
42321570|NCT02299388|76158746|FG000|Overall Study|Withdrawal by Subject|0|||
42321571|NCT02299388|76158747|FG001|Overall Study|Withdrawal by Subject|1|||
42321572|NCT02202577|76158755|FG000|Overall Study|Lost to Follow-up|6|||
42321573|NCT02202577|76158756|FG001|Overall Study|Lost to Follow-up|16|||
42321574|NCT02202577|76158755|FG000|Overall Study|Protocol Violation|7|||
42321575|NCT02202577|76158756|FG001|Overall Study|Protocol Violation|3|||
42321576|NCT02299076|76158764|FG000|Overall Study|Fraudulent Entries|20|||
42321577|NCT02299076|76158765|FG001|Overall Study|Fraudulent Entries|14|||
42321578|NCT01723072|76158773|FG000|Overall Study|Withdrawal by Subject|7|||
42321579|NCT01723072|76158774|FG001|Overall Study|Withdrawal by Subject|13|||
42321580|NCT01723072|76158773|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
42321581|NCT01723072|76158774|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
42321582|NCT01723072|76158773|FG000|Overall Study|Other|4|||
42321583|NCT01723072|76158774|FG001|Overall Study|Other|3|||
42321584|NCT01722994|76158782|FG000|Overall Study|Missing data|25|||
42321585|NCT01722994|76158783|FG001|Overall Study|Missing data|17|||
42321586|NCT02228395|76158791|FG000|First Intervention Period|No longer willing to participate|1|||
42321587|NCT02228395|76158792|FG001|First Intervention Period|No longer willing to participate|0|||
42321588|NCT02228395|76158793|FG002|First Intervention Period|No longer willing to participate|0|||
42321589|NCT02228395|76158791|FG000|First Intervention Period|Unable to comply with study dates|0|||
42321590|NCT02228395|76158792|FG001|First Intervention Period|Unable to comply with study dates|1|||
42321591|NCT02228395|76158793|FG002|First Intervention Period|Unable to comply with study dates|1|||
42321592|NCT02170051|76158805|FG000|Overall Study|Withdrawal by Subject|10|||
42321593|NCT02170051|76158806|FG001|Overall Study|Withdrawal by Subject|10|||
42321594|NCT02170051|76158805|FG000|Overall Study|Lost to Follow-up|1|||
42321595|NCT02170051|76158806|FG001|Overall Study|Lost to Follow-up|3|||
42321596|NCT02169739|76158814|FG000|Overall Study|Lost to Follow-up|0|||
42321597|NCT02169739|76158815|FG001|Overall Study|Lost to Follow-up|4|||
42321598|NCT02169505|76158822|FG000|Overall Study|Withdrawal by Subject|1|||
42321599|NCT01909791|76158829|FG000|Overall Study|Death|9|||
42321600|NCT01909791|76158830|FG001|Overall Study|Death|8|||
42321601|NCT01909791|76158831|FG002|Overall Study|Death|4|||
42321602|NCT01909791|76158829|FG000|Overall Study|Withdrawal by Subject|5|||
41994393|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
41994394|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
41994395|NCT01087788|75802642|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
41994396|NCT01087788|75802643|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
41994397|NCT01087788|75802644|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
41994398|NCT01086969|75802656|FG000|Overall Study|Withdrawal by Subject|1|||
41994399|NCT01086969|75802657|FG001|Overall Study|Withdrawal by Subject|2|||
42259169|NCT02862457|76085449|FG004|Overall Study|Death|0|||
42259170|NCT02862457|76085450|FG005|Overall Study|Death|2|||
42259171|NCT02862457|76085451|FG006|Overall Study|Death|1|||
42259172|NCT02862457|76085445|FG000|Overall Study|Lost to Follow-up|1|||
42259173|NCT02862457|76085446|FG001|Overall Study|Lost to Follow-up|0|||
42259174|NCT02862457|76085447|FG002|Overall Study|Lost to Follow-up|0|||
42259175|NCT02862457|76085448|FG003|Overall Study|Lost to Follow-up|1|||
42259176|NCT02862457|76085449|FG004|Overall Study|Lost to Follow-up|0|||
42259177|NCT02862457|76085450|FG005|Overall Study|Lost to Follow-up|0|||
42259178|NCT02862457|76085451|FG006|Overall Study|Lost to Follow-up|0|||
42321603|NCT01909791|76158830|FG001|Overall Study|Withdrawal by Subject|9|||
42321604|NCT01909791|76158831|FG002|Overall Study|Withdrawal by Subject|13|||
42321605|NCT01909791|76158829|FG000|Overall Study|Lost to Follow-up|5|||
42321606|NCT01909791|76158830|FG001|Overall Study|Lost to Follow-up|11|||
42321607|NCT01909791|76158831|FG002|Overall Study|Lost to Follow-up|10|||
42321608|NCT01909791|76158829|FG000|Overall Study|Missed Visit|2|||
42321609|NCT01909791|76158830|FG001|Overall Study|Missed Visit|0|||
42321610|NCT01909791|76158831|FG002|Overall Study|Missed Visit|1|||
42321611|NCT02202499|76158847|FG000|Overall Study|Cancer diagnosis|0|||
42321612|NCT02202499|76158848|FG001|Overall Study|Cancer diagnosis|0|||
42321613|NCT02202499|76158849|FG002|Overall Study|Cancer diagnosis|1|||
42321614|NCT02202499|76158847|FG000|Overall Study|Moved from area|0|||
42321615|NCT02202499|76158848|FG001|Overall Study|Moved from area|0|||
42321616|NCT02202499|76158849|FG002|Overall Study|Moved from area|1|||
42321617|NCT02202499|76158847|FG000|Overall Study|Declined before randomization|1|||
42321618|NCT02202499|76158848|FG001|Overall Study|Declined before randomization|0|||
42321619|NCT02202499|76158849|FG002|Overall Study|Declined before randomization|0|||
42321620|NCT02202499|76158847|FG000|Overall Study|Auto accident|1|||
42321621|NCT02202499|76158848|FG001|Overall Study|Auto accident|0|||
42321622|NCT02202499|76158849|FG002|Overall Study|Auto accident|0|||
42321623|NCT02202109|76158864|FG000|Overall Study|Lost to Follow-up|88|||
42321624|NCT02202109|76158865|FG001|Overall Study|Lost to Follow-up|87|||
42321625|NCT02202109|76158864|FG000|Overall Study|Withdrawal by Subject|2|||
42321626|NCT02202109|76158865|FG001|Overall Study|Withdrawal by Subject|0|||
41994400|NCT01086969|75802658|FG002|Overall Study|Withdrawal by Subject|0|||
41994401|NCT01086423|75802669|FG000|Overall Study|Protocol Violation|0|||
41994402|NCT01086423|75802670|FG001|Overall Study|Protocol Violation|0|||
41994403|NCT01086423|75802671|FG002|Overall Study|Protocol Violation|1|||
41994404|NCT01086423|75802669|FG000|Overall Study|Migrated/moved from study area|2|||
41994405|NCT01086423|75802670|FG001|Overall Study|Migrated/moved from study area|0|||
41994406|NCT01086423|75802671|FG002|Overall Study|Migrated/moved from study area|4|||
41994407|NCT01086423|75802669|FG000|Overall Study|Adverse event, fatal|1|||
41994408|NCT01086423|75802670|FG001|Overall Study|Adverse event, fatal|1|||
41994409|NCT01086423|75802671|FG002|Overall Study|Adverse event, fatal|0|||
41994410|NCT01086423|75802669|FG000|Overall Study|Adverse event, non-fatal|2|||
41994411|NCT01086423|75802670|FG001|Overall Study|Adverse event, non-fatal|1|||
41994412|NCT01086423|75802671|FG002|Overall Study|Adverse event, non-fatal|0|||
41994413|NCT01086423|75802669|FG000|Overall Study|Withdrawal by Subject|5|||
41994414|NCT01086423|75802670|FG001|Overall Study|Withdrawal by Subject|1|||
41994415|NCT01086423|75802671|FG002|Overall Study|Withdrawal by Subject|3|||
41994416|NCT01086423|75802669|FG000|Overall Study|Lost to Follow-up|0|||
41994417|NCT01086423|75802670|FG001|Overall Study|Lost to Follow-up|0|||
41994418|NCT01086423|75802671|FG002|Overall Study|Lost to Follow-up|1|||
41994419|NCT01086150|75802682|FG000|Overall Study|Withdrawal by Subject|0|||
41994420|NCT01086150|75802683|FG001|Overall Study|Withdrawal by Subject|4|||
41994421|NCT01086150|75802684|FG002|Overall Study|Withdrawal by Subject|1|||
41994422|NCT01086150|75802682|FG000|Overall Study|Lost to Follow-up|0|||
41994423|NCT01086150|75802683|FG001|Overall Study|Lost to Follow-up|1|||
41994424|NCT01086150|75802684|FG002|Overall Study|Lost to Follow-up|0|||
41994425|NCT01086150|75802682|FG000|Overall Study|Screen Failure|0|||
41994426|NCT01086150|75802683|FG001|Overall Study|Screen Failure|1|||
41994427|NCT01086150|75802684|FG002|Overall Study|Screen Failure|0|||
41994428|NCT01086033|75802692|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
41994429|NCT01086033|75802692|FG000|Overall Study|Lost to Follow-up|86|||
42034103|NCT01070550|75842182|FG001|Overall Study|Treatment unavailable|0|||
42259179|NCT02862457|76085445|FG000|Overall Study|Withdrawal by Subject|0|||
42259180|NCT02862457|76085446|FG001|Overall Study|Withdrawal by Subject|0|||
42259181|NCT02862457|76085447|FG002|Overall Study|Withdrawal by Subject|1|||
42259182|NCT02862457|76085448|FG003|Overall Study|Withdrawal by Subject|0|||
42259183|NCT02862457|76085449|FG004|Overall Study|Withdrawal by Subject|0|||
42259184|NCT02862457|76085450|FG005|Overall Study|Withdrawal by Subject|1|||
42259185|NCT02862457|76085451|FG006|Overall Study|Withdrawal by Subject|0|||
42321627|NCT02227849|76158871|FG000|Overall Study|Adverse Event|4|||
41994430|NCT01086033|75802692|FG000|Overall Study|Adverse Event|42|||
41994431|NCT01086033|75802692|FG000|Overall Study|Withdrawal by Subject|41|||
41994432|NCT01086033|75802692|FG000|Overall Study|Other|14|||
42034104|NCT01070550|75842183|FG002|Overall Study|Treatment unavailable|0|||
41994433|NCT01086033|75802692|FG000|Overall Study|Other|13|||
41994434|NCT01086033|75802692|FG000|Overall Study|AE and Withdrew Consent|5|||
41994435|NCT01086033|75802692|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
42034105|NCT01070550|75842184|FG003|Overall Study|Treatment unavailable|0|||
42259186|NCT02447302|76085478|FG000|Overall Study|Physician Decision|1|||
42259187|NCT02447302|76085479|FG001|Overall Study|Physician Decision|0|||
42321628|NCT02227849|76158871|FG000|Overall Study|Physician Decision|1|||
42321629|NCT02227849|76158871|FG000|Overall Study|Withdrawal by Subject|3|||
42321630|NCT01927497|76158877|FG000|Overall Study|Death|0|||
42321631|NCT01927497|76158878|FG001|Overall Study|Death|1|||
41994436|NCT01086033|75802692|FG000|Overall Study|Withdrew consent and Other Reason|4|||
41994437|NCT01086033|75802692|FG000|Overall Study|AE and Lack of Efficacy|4|||
42321632|NCT01927497|76158877|FG000|Overall Study|Protocol Violation|2|||
42321633|NCT01927497|76158878|FG001|Overall Study|Protocol Violation|0|||
42321634|NCT02169271|76158886|FG000|Overall Study|Protocol Violation|1|||
42321635|NCT02169271|76158887|FG001|Overall Study|Protocol Violation|2|||
42321636|NCT02202031|76158895|FG000|Overall Study|Lost to Follow-up|1|||
42321637|NCT02202031|76158896|FG001|Overall Study|Lost to Follow-up|0|||
42321638|NCT02202031|76158895|FG000|Overall Study|Too Busy|1|||
42321639|NCT02202031|76158896|FG001|Overall Study|Too Busy|3|||
42321640|NCT02202031|76158895|FG000|Overall Study|Illness/Medical Reason|0|||
42321641|NCT02202031|76158896|FG001|Overall Study|Illness/Medical Reason|2|||
42321642|NCT02202031|76158895|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
42321643|NCT02202031|76158896|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
42321644|NCT01644188|76158904|FG000|Overall Study|Adverse Event|44|||
42321645|NCT01644188|76158905|FG001|Overall Study|Adverse Event|20|||
42321646|NCT01644188|76158904|FG000|Overall Study|Poor compliance to protocol|26|||
42321647|NCT01644188|76158905|FG001|Overall Study|Poor compliance to protocol|14|||
42321648|NCT01644188|76158904|FG000|Overall Study|Physician Decision|1|||
42321649|NCT01644188|76158905|FG001|Overall Study|Physician Decision|3|||
42321650|NCT01644188|76158904|FG000|Overall Study|Participant moved|7|||
42321651|NCT01644188|76158905|FG001|Overall Study|Participant moved|2|||
42321652|NCT01644188|76158904|FG000|Overall Study|Related to auto-injector administration|2|||
42321653|NCT01644188|76158905|FG001|Overall Study|Related to auto-injector administration|2|||
42321654|NCT01644188|76158904|FG000|Overall Study|Consent withdrawn by participant|14|||
42321655|NCT01644188|76158905|FG001|Overall Study|Consent withdrawn by participant|7|||
42321656|NCT01644188|76158904|FG000|Overall Study|Selection criteria finally not met|2|||
42321657|NCT01644188|76158905|FG001|Overall Study|Selection criteria finally not met|0|||
42321658|NCT01644188|76158904|FG000|Overall Study|Lost to Follow-up|1|||
42321659|NCT01644188|76158905|FG001|Overall Study|Lost to Follow-up|0|||
41994438|NCT01086033|75802692|FG000|Overall Study|Death|1|||
41994439|NCT01086033|75802692|FG000|Overall Study|AE and Lost to Follow-up|1|||
41994440|NCT01086033|75802692|FG000|Overall Study|AE and Other Reason|1|||
41994441|NCT01086033|75802692|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
42259188|NCT02447302|76085480|FG002|Overall Study|Physician Decision|0|||
42259189|NCT02447302|76085478|FG000|Overall Study|Adverse Event|4|||
42259190|NCT02447302|76085479|FG001|Overall Study|Adverse Event|3|||
42259191|NCT02447302|76085480|FG002|Overall Study|Adverse Event|0|||
42259192|NCT02447302|76085478|FG000|Overall Study|Withdrawal by Subject|0|||
42259193|NCT02447302|76085479|FG001|Overall Study|Withdrawal by Subject|1|||
42259194|NCT02447302|76085480|FG002|Overall Study|Withdrawal by Subject|5|||
42259195|NCT02447302|76085478|FG000|Overall Study|Sponsor Decision|0|||
42259196|NCT02447302|76085479|FG001|Overall Study|Sponsor Decision|0|||
42259197|NCT02447302|76085480|FG002|Overall Study|Sponsor Decision|1|||
42259198|NCT02454517|76085490|FG000|Overall Study|Withdrawal by Subject|3|||
42259199|NCT02454517|76085491|FG001|Overall Study|Withdrawal by Subject|0|||
42259200|NCT02454517|76085490|FG000|Overall Study|Lost to Follow-up|4|||
42259201|NCT02454517|76085491|FG001|Overall Study|Lost to Follow-up|7|||
42259202|NCT02454517|76085490|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
42259203|NCT02454517|76085491|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
42259204|NCT03861039|76085502|FG000|Overall Study|Adverse Event|2|||
42259205|NCT03861039|76085503|FG001|Overall Study|Adverse Event|5|||
42259206|NCT03861039|76085504|FG002|Overall Study|Adverse Event|11|||
42259207|NCT03861039|76085502|FG000|Overall Study|Withdrawal by Subject|1|||
42259208|NCT03861039|76085503|FG001|Overall Study|Withdrawal by Subject|3|||
42259209|NCT03861039|76085504|FG002|Overall Study|Withdrawal by Subject|4|||
42259210|NCT02731755|76085514|FG000|First Intervention|Withdrawal by Subject|0|||
42259211|NCT02731755|76085515|FG001|First Intervention|Withdrawal by Subject|2|||
42259212|NCT02866175|76085544|FG000|Overall Study|Adverse Event|56|||
42259213|NCT02866175|76085545|FG001|Overall Study|Adverse Event|54|||
42259214|NCT02866175|76085544|FG000|Overall Study|Withdrawal by Subject|31|||
42321660|NCT01644188|76158904|FG000|Overall Study|Death|4|||
42321661|NCT01644188|76158905|FG001|Overall Study|Death|3|||
42321662|NCT01644188|76158904|FG000|Overall Study|Last visit outside protocol visit window|14|||
42259215|NCT02866175|76085545|FG001|Overall Study|Withdrawal by Subject|52|||
42259216|NCT02866175|76085544|FG000|Overall Study|Death|30|||
42321663|NCT01644188|76158905|FG001|Overall Study|Last visit outside protocol visit window|16|||
42133468|NCT00394953|75944387|FG001|Second Treatment Period|Death|4|||
42259217|NCT02866175|76085545|FG001|Overall Study|Death|23|||
42321664|NCT01644188|76158904|FG000|Overall Study|Site closure|1|||
42321665|NCT01644188|76158905|FG001|Overall Study|Site closure|1|||
42321666|NCT01644188|76158904|FG000|Overall Study|Other than specified above|6|||
42321667|NCT01644188|76158905|FG001|Overall Study|Other than specified above|7|||
42321668|NCT02201953|76158913|FG000|Overall Study|Randomized but Never Treated|1|||
42321669|NCT02201953|76158914|FG001|Overall Study|Randomized but Never Treated|5|||
42321670|NCT02201953|76158913|FG000|Overall Study|Lack of Efficacy|9|||
42321671|NCT02201953|76158914|FG001|Overall Study|Lack of Efficacy|30|||
42321672|NCT02201953|76158913|FG000|Overall Study|Lost to Follow-up|8|||
42321673|NCT02201953|76158914|FG001|Overall Study|Lost to Follow-up|8|||
42321674|NCT02201953|76158913|FG000|Overall Study|Withdrew Consent|2|||
42321675|NCT02201953|76158914|FG001|Overall Study|Withdrew Consent|5|||
42321676|NCT02201953|76158913|FG000|Overall Study|Adverse Event|0|||
42321677|NCT02201953|76158914|FG001|Overall Study|Adverse Event|5|||
42321678|NCT02201953|76158913|FG000|Overall Study|Death|0|||
42321679|NCT02201953|76158914|FG001|Overall Study|Death|3|||
42321680|NCT02271854|76158920|FG000|Overall Study|Withdrawal by Subject|2|||
42321681|NCT02271854|76158920|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
42321682|NCT02271854|76158920|FG000|Overall Study|Lost to Follow-up|1|||
42321683|NCT02296892|76158928|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
42321684|NCT02296892|76158929|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
42321685|NCT02296892|76158930|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
42321686|NCT02296892|76158928|FG000|Overall Study|Lost to Follow-up|5|||
42321687|NCT02296892|76158929|FG001|Overall Study|Lost to Follow-up|0|||
42321688|NCT02296892|76158930|FG002|Overall Study|Lost to Follow-up|1|||
42321689|NCT02270684|76158940|FG000|Overall Study|Lost to Follow-up|0|||
42321690|NCT02270684|76158941|FG001|Overall Study|Lost to Follow-up|3|||
42321691|NCT02270684|76158940|FG000|Overall Study|Study terminated|1|||
42321692|NCT02270684|76158941|FG001|Overall Study|Study terminated|0|||
42321693|NCT02168803|76158950|FG000|Overall Study|Lost to Follow-up|1|||
42321694|NCT02168803|76158951|FG001|Overall Study|Lost to Follow-up|0|||
42321695|NCT02168803|76158952|FG002|Overall Study|Lost to Follow-up|1|||
42321696|NCT02168803|76158950|FG000|Overall Study|Withdrawal by Subject|1|||
42321697|NCT02168803|76158951|FG001|Overall Study|Withdrawal by Subject|1|||
42321698|NCT02168803|76158952|FG002|Overall Study|Withdrawal by Subject|2|||
42321699|NCT02168803|76158950|FG000|Overall Study|Physician Decision|0|||
42321700|NCT02168803|76158951|FG001|Overall Study|Physician Decision|1|||
42321701|NCT02168803|76158952|FG002|Overall Study|Physician Decision|0|||
42321702|NCT02168803|76158950|FG000|Overall Study|Adverse Event|0|||
42321703|NCT02168803|76158951|FG001|Overall Study|Adverse Event|1|||
42321704|NCT02168803|76158952|FG002|Overall Study|Adverse Event|1|||
42321705|NCT02168803|76158950|FG000|Overall Study|Death|0|||
42321706|NCT02168803|76158951|FG001|Overall Study|Death|0|||
42321707|NCT02168803|76158952|FG002|Overall Study|Death|1|||
42321708|NCT02168803|76158950|FG000|Overall Study|Sponsor Decision|0|||
42321709|NCT02168803|76158951|FG001|Overall Study|Sponsor Decision|0|||
42321710|NCT02168803|76158952|FG002|Overall Study|Sponsor Decision|1|||
42321711|NCT02201329|76158967|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
42321712|NCT02201329|76158967|FG000|Overall Study|Withdrawal by Subject|2|||
42321713|NCT01927419|76158973|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
42321714|NCT01927419|76158974|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
42321715|NCT01927419|76158973|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
42321716|NCT01927419|76158974|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
42321717|NCT01927419|76158973|FG000|Treatment Period|Disease progression|17|||
42321718|NCT01927419|76158974|FG001|Treatment Period|Disease progression|20|||
42321719|NCT01927419|76158973|FG000|Treatment Period|Study drug toxicity|48|||
42321720|NCT01927419|76158974|FG001|Treatment Period|Study drug toxicity|10|||
41994442|NCT01085682|75802701|FG000|Overall Study|Withdrawal by Subject|25|||
41994443|NCT01085682|75802702|FG001|Overall Study|Withdrawal by Subject|25|||
42321721|NCT01927419|76158973|FG000|Treatment Period|Death|0|||
42321722|NCT01927419|76158974|FG001|Treatment Period|Death|1|||
42321723|NCT01927419|76158973|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
42321724|NCT01927419|76158974|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
42321725|NCT01927419|76158973|FG000|Treatment Period|Participant request to discontinue|12|||
41994444|NCT01085214|75802708|FG000|Overall Study|Alternate treatment required|1|||
42321726|NCT01927419|76158974|FG001|Treatment Period|Participant request to discontinue|4|||
42321727|NCT01927419|76158973|FG000|Treatment Period|Withdrawal by Subject|1|||
42321728|NCT01927419|76158974|FG001|Treatment Period|Withdrawal by Subject|1|||
42321729|NCT01927419|76158973|FG000|Treatment Period|Maximum Clinical Benefit|6|||
42321730|NCT01927419|76158974|FG001|Treatment Period|Maximum Clinical Benefit|2|||
42321731|NCT01927419|76158973|FG000|Treatment Period|Other reasons|3|||
42321732|NCT01927419|76158974|FG001|Treatment Period|Other reasons|4|||
42321733|NCT01927419|76158973|FG000|Treatment Period|Not Reported|1|||
41994445|NCT01085136|75802712|FG000|Part A|Other Adverse event|223|||
42321734|NCT01927419|76158974|FG001|Treatment Period|Not Reported|1|||
42321735|NCT02168491|76158980|FG000|Overall Study|Withdrawal by Subject|1|||
42321736|NCT02225743|76158984|FG000|Overall Study|Withdrawal by Subject|18|||
42321737|NCT01721746|76158990|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
42321738|NCT01721746|76158991|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
42321739|NCT01721746|76158990|FG000|Pre-Treatment|Withdrawal by Subject|1|||
42321740|NCT01721746|76158991|FG001|Pre-Treatment|Withdrawal by Subject|16|||
42321741|NCT01721746|76158990|FG000|Pre-Treatment|Poor/Non-compliance|1|||
42321742|NCT01721746|76158991|FG001|Pre-Treatment|Poor/Non-compliance|0|||
42321743|NCT01721746|76158990|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
42321744|NCT01721746|76158991|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
42321745|NCT01721746|76158990|FG000|Treatment|Disease Progression|192|||
42321746|NCT01721746|76158991|FG001|Treatment|Disease Progression|74|||
42321747|NCT01721746|76158990|FG000|Treatment|Study Drug Toxicity|19|||
42321748|NCT01721746|76158991|FG001|Treatment|Study Drug Toxicity|11|||
42321749|NCT01721746|76158990|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
42321750|NCT01721746|76158991|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
42321751|NCT01721746|76158990|FG000|Treatment|Participant request to discontinue Study treatment|26|||
42321752|NCT01721746|76158991|FG001|Treatment|Participant request to discontinue Study treatment|7|||
42321753|NCT01721746|76158990|FG000|Treatment|Participant withdrew consent|4|||
42321754|NCT01721746|76158991|FG001|Treatment|Participant withdrew consent|2|||
42321755|NCT01721746|76158990|FG000|Treatment|Maximum Clinical Benefit|9|||
42321756|NCT01721746|76158991|FG001|Treatment|Maximum Clinical Benefit|3|||
42321757|NCT01721746|76158990|FG000|Treatment|Poor/Non-compliance|2|||
42321758|NCT01721746|76158991|FG001|Treatment|Poor/Non-compliance|0|||
42321759|NCT01721746|76158990|FG000|Treatment|Participant no longer met Study criteria|4|||
42321760|NCT01721746|76158991|FG001|Treatment|Participant no longer met Study criteria|0|||
42321761|NCT01721746|76158990|FG000|Treatment|Other reasons|6|||
42321762|NCT01721746|76158991|FG001|Treatment|Other reasons|2|||
42321763|NCT02225665|76159000|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
42321764|NCT02225665|76159001|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
42321765|NCT02225665|76159000|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
42321766|NCT02225665|76159001|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
42321767|NCT01721200|76159009|FG000|Overall Study|Lost to Follow-up|3|||
42321768|NCT01721200|76159010|FG001|Overall Study|Lost to Follow-up|5|||
42321769|NCT02225587|76159023|FG000|Overall Study|Adverse Event|5|||
42321770|NCT02225587|76159024|FG001|Overall Study|Adverse Event|5|||
42321771|NCT02225587|76159023|FG000|Overall Study|Lost to Follow-up|5|||
42321772|NCT02225587|76159024|FG001|Overall Study|Lost to Follow-up|5|||
42321773|NCT02225587|76159023|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42321774|NCT02225587|76159024|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42321775|NCT02225587|76159023|FG000|Overall Study|Physician Decision|2|||
42321776|NCT02225587|76159024|FG001|Overall Study|Physician Decision|0|||
42321777|NCT02225587|76159023|FG000|Overall Study|Protocol Violation|1|||
42321778|NCT02225587|76159024|FG001|Overall Study|Protocol Violation|0|||
42321779|NCT02225587|76159023|FG000|Overall Study|Participant Moved|1|||
42321780|NCT02225587|76159024|FG001|Overall Study|Participant Moved|0|||
42321781|NCT02225587|76159023|FG000|Overall Study|Withdrawal by Subject|13|||
42321782|NCT02225587|76159024|FG001|Overall Study|Withdrawal by Subject|28|||
42321783|NCT02296424|76159032|FG000|Part 1|New therapy for study indication|0|||
42321784|NCT02296424|76159033|FG001|Part 1|New therapy for study indication|1|||
42321785|NCT02296424|76159034|FG002|Part 1|New therapy for study indication|0|||
42321786|NCT02296424|76159035|FG003|Part 1|New therapy for study indication|0|||
42321787|NCT02296424|76159032|FG000|Part 1|Protocol Violation|0|||
42321788|NCT02296424|76159033|FG001|Part 1|Protocol Violation|1|||
42321789|NCT02296424|76159034|FG002|Part 1|Protocol Violation|0|||
42321790|NCT02296424|76159035|FG003|Part 1|Protocol Violation|0|||
42321791|NCT02296424|76159032|FG000|Part 1|Withdrawal by Subject|0|||
42321792|NCT02296424|76159033|FG001|Part 1|Withdrawal by Subject|2|||
42321793|NCT02296424|76159034|FG002|Part 1|Withdrawal by Subject|0|||
42321794|NCT02296424|76159035|FG003|Part 1|Withdrawal by Subject|0|||
42321795|NCT02296424|76159032|FG000|Part 1|Study terminated by sponsor|0|||
42321796|NCT02296424|76159033|FG001|Part 1|Study terminated by sponsor|1|||
42321797|NCT02296424|76159034|FG002|Part 1|Study terminated by sponsor|0|||
42321798|NCT02296424|76159035|FG003|Part 1|Study terminated by sponsor|0|||
42321799|NCT02296424|76159032|FG000|Part 1|Adverse Event|2|||
42321800|NCT02296424|76159033|FG001|Part 1|Adverse Event|11|||
42321801|NCT02296424|76159034|FG002|Part 1|Adverse Event|0|||
42321802|NCT02296424|76159035|FG003|Part 1|Adverse Event|0|||
42321803|NCT02296424|76159032|FG000|Part 1|Lack of Efficacy|5|||
42321804|NCT02296424|76159033|FG001|Part 1|Lack of Efficacy|17|||
42321805|NCT02296424|76159034|FG002|Part 1|Lack of Efficacy|0|||
42321806|NCT02296424|76159035|FG003|Part 1|Lack of Efficacy|0|||
42321807|NCT02296424|76159032|FG000|Part 1|16 directly started part II|16|||
42321808|NCT02296424|76159033|FG001|Part 1|16 directly started part II|0|||
42321809|NCT02296424|76159034|FG002|Part 1|16 directly started part II|0|||
42321810|NCT02296424|76159035|FG003|Part 1|16 directly started part II|0|||
42321811|NCT02296424|76159032|FG000|Part 2|Lack of Efficacy|0|||
41994446|NCT01085136|75802713|FG001|Part A|Other Adverse event|0|||
41994447|NCT01085136|75802714|FG002|Part A|Other Adverse event|0|||
41994448|NCT01085136|75802712|FG000|Part A|Protocol Violation|3|||
41994449|NCT01085136|75802713|FG001|Part A|Protocol Violation|0|||
42133469|NCT00394953|75944386|FG000|Second Treatment Period|Lack of Efficacy|9|||
42133470|NCT00394953|75944387|FG001|Second Treatment Period|Lack of Efficacy|47|||
42133471|NCT00394953|75944386|FG000|Second Treatment Period|Withdrawal by Subject|3|||
42133472|NCT00394953|75944387|FG001|Second Treatment Period|Withdrawal by Subject|3|||
42259218|NCT02866175|76085544|FG000|Overall Study|Other|7|||
42259219|NCT02866175|76085545|FG001|Overall Study|Other|14|||
42259220|NCT02866175|76085544|FG000|Overall Study|Progressive disease|1|||
42259221|NCT02866175|76085545|FG001|Overall Study|Progressive disease|1|||
42133473|NCT00394953|75944386|FG000|Second Treatment Period|Lost to Follow-up|0|||
42133474|NCT00394953|75944387|FG001|Second Treatment Period|Lost to Follow-up|1|||
42259222|NCT02866175|76085544|FG000|Overall Study|Lost to Follow-up|2|||
42133475|NCT00394953|75944386|FG000|Second Treatment Period|Renal transplant|4|||
42133476|NCT00394953|75944387|FG001|Second Treatment Period|Renal transplant|6|||
42259223|NCT02866175|76085545|FG001|Overall Study|Lost to Follow-up|0|||
42259224|NCT02866175|76085544|FG000|Overall Study|Lack of Efficacy|0|||
42259225|NCT02866175|76085545|FG001|Overall Study|Lack of Efficacy|1|||
42259226|NCT02866175|76085544|FG000|Overall Study|Physician Decision|3|||
42259227|NCT02866175|76085545|FG001|Overall Study|Physician Decision|15|||
42259228|NCT02866175|76085544|FG000|Overall Study|Did not receive treatment|5|||
42259229|NCT02866175|76085545|FG001|Overall Study|Did not receive treatment|15|||
42259230|NCT01336205|76085558|FG000|Overall Study|Other|22|||
42259231|NCT01336205|76085559|FG001|Overall Study|Other|9|||
42259232|NCT01336205|76085558|FG000|Overall Study|Lost to Follow-up|40|||
42259233|NCT01336205|76085559|FG001|Overall Study|Lost to Follow-up|20|||
42259234|NCT01336205|76085558|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
42259235|NCT01336205|76085559|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
41994450|NCT01085136|75802714|FG002|Part A|Protocol Violation|0|||
42259236|NCT01336205|76085558|FG000|Overall Study|Lack of Efficacy|4|||
42259237|NCT01336205|76085559|FG001|Overall Study|Lack of Efficacy|0|||
42259238|NCT01336205|76085558|FG000|Overall Study|Severe noncompliance with protocol|9|||
42259239|NCT01336205|76085559|FG001|Overall Study|Severe noncompliance with protocol|2|||
42259240|NCT01336205|76085558|FG000|Overall Study|Adverse Event|56|||
42259241|NCT01336205|76085559|FG001|Overall Study|Adverse Event|6|||
42259242|NCT01336205|76085558|FG000|Overall Study|Death|1|||
42321812|NCT02296424|76159033|FG001|Part 2|Lack of Efficacy|0|||
42321813|NCT02296424|76159034|FG002|Part 2|Lack of Efficacy|1|||
42321814|NCT02296424|76159035|FG003|Part 2|Lack of Efficacy|0|||
42321815|NCT02296424|76159032|FG000|Part 2|Adverse Event|0|||
42321816|NCT02296424|76159033|FG001|Part 2|Adverse Event|0|||
42321817|NCT02296424|76159034|FG002|Part 2|Adverse Event|1|||
42321818|NCT02296424|76159035|FG003|Part 2|Adverse Event|0|||
42321819|NCT02296424|76159032|FG000|Part 2|Lost to Follow-up|0|||
42321820|NCT02296424|76159033|FG001|Part 2|Lost to Follow-up|0|||
42321821|NCT02296424|76159034|FG002|Part 2|Lost to Follow-up|1|||
42321822|NCT02296424|76159035|FG003|Part 2|Lost to Follow-up|0|||
42321823|NCT02296190|76159049|FG000|Overall Study|Lost to Follow-up|0|||
42321824|NCT02296190|76159050|FG001|Overall Study|Lost to Follow-up|0|||
42321825|NCT02296190|76159051|FG002|Overall Study|Lost to Follow-up|0|||
42133477|NCT00394953|75944386|FG000|Second Treatment Period|Not defined|3|||
42133478|NCT00394953|75944387|FG001|Second Treatment Period|Not defined|8|||
42133479|NCT00485732|75944395|FG000|Overall Study|Protocol Violation|1|||
42259243|NCT01336205|76085559|FG001|Overall Study|Death|1|||
42259244|NCT01336205|76085558|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
42259245|NCT01336205|76085559|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
42259246|NCT01336205|76085558|FG000|Overall Study|Withdrawal by Subject|72|||
42259247|NCT01336205|76085559|FG001|Overall Study|Withdrawal by Subject|38|||
42259248|NCT01336205|76085558|FG000|Overall Study|Did not receive treatment|4|||
42321826|NCT02296190|76159052|FG003|Overall Study|Lost to Follow-up|0|||
42321827|NCT02296190|76159053|FG004|Overall Study|Lost to Follow-up|1|||
42321828|NCT02296190|76159054|FG005|Overall Study|Lost to Follow-up|0|||
42321829|NCT02296190|76159049|FG000|Overall Study|Failure to induce PSVT|6|||
42321830|NCT02296190|76159050|FG001|Overall Study|Failure to induce PSVT|10|||
42321831|NCT02296190|76159051|FG002|Overall Study|Failure to induce PSVT|5|||
42321832|NCT02296190|76159052|FG003|Overall Study|Failure to induce PSVT|13|||
42321833|NCT02296190|76159053|FG004|Overall Study|Failure to induce PSVT|8|||
42321834|NCT02296190|76159054|FG005|Overall Study|Failure to induce PSVT|0|||
42321835|NCT02296190|76159049|FG000|Overall Study|Physician Decision|1|||
42321836|NCT02296190|76159050|FG001|Overall Study|Physician Decision|1|||
42321837|NCT02296190|76159051|FG002|Overall Study|Physician Decision|0|||
42321838|NCT02296190|76159052|FG003|Overall Study|Physician Decision|1|||
42321839|NCT02296190|76159053|FG004|Overall Study|Physician Decision|2|||
42321840|NCT02296190|76159054|FG005|Overall Study|Physician Decision|0|||
42321841|NCT02296190|76159049|FG000|Overall Study|Withdrawal by Subject|0|||
42321842|NCT02296190|76159050|FG001|Overall Study|Withdrawal by Subject|1|||
42321843|NCT02296190|76159051|FG002|Overall Study|Withdrawal by Subject|0|||
42321844|NCT02296190|76159052|FG003|Overall Study|Withdrawal by Subject|0|||
42321845|NCT02296190|76159053|FG004|Overall Study|Withdrawal by Subject|0|||
42321846|NCT02296190|76159054|FG005|Overall Study|Withdrawal by Subject|0|||
42321847|NCT02296190|76159049|FG000|Overall Study|PSVT < 5 minutes|5|||
42321848|NCT02296190|76159050|FG001|Overall Study|PSVT < 5 minutes|6|||
42321849|NCT02296190|76159051|FG002|Overall Study|PSVT < 5 minutes|6|||
42321850|NCT02296190|76159052|FG003|Overall Study|PSVT < 5 minutes|6|||
42321851|NCT02296190|76159053|FG004|Overall Study|PSVT < 5 minutes|5|||
42321852|NCT02296190|76159054|FG005|Overall Study|PSVT < 5 minutes|0|||
42321853|NCT02296190|76159049|FG000|Overall Study|Patient was given Propofol|0|||
42321854|NCT02296190|76159050|FG001|Overall Study|Patient was given Propofol|1|||
42321855|NCT02296190|76159051|FG002|Overall Study|Patient was given Propofol|0|||
42321856|NCT02296190|76159052|FG003|Overall Study|Patient was given Propofol|1|||
42321857|NCT02296190|76159053|FG004|Overall Study|Patient was given Propofol|0|||
42321858|NCT02296190|76159054|FG005|Overall Study|Patient was given Propofol|0|||
42321859|NCT02296190|76159049|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
42321860|NCT02296190|76159050|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
42321861|NCT02296190|76159051|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
42321862|NCT02296190|76159052|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
42321863|NCT02296190|76159053|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
42321864|NCT02296190|76159054|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
42321865|NCT02296190|76159049|FG000|Overall Study|Blood pressure <100 after sedation|0|||
42321866|NCT02296190|76159050|FG001|Overall Study|Blood pressure <100 after sedation|0|||
42321867|NCT02296190|76159051|FG002|Overall Study|Blood pressure <100 after sedation|0|||
42321868|NCT02296190|76159052|FG003|Overall Study|Blood pressure <100 after sedation|1|||
41994451|NCT01085136|75802712|FG000|Part A|Lost to Follow-up|3|||
41994452|NCT01085136|75802713|FG001|Part A|Lost to Follow-up|0|||
41994453|NCT01085136|75802714|FG002|Part A|Lost to Follow-up|0|||
41994454|NCT01085136|75802712|FG000|Part A|Refusal to continue trial medication|64|||
41994455|NCT01085136|75802713|FG001|Part A|Refusal to continue trial medication|0|||
41994456|NCT01085136|75802714|FG002|Part A|Refusal to continue trial medication|0|||
41994457|NCT01085136|75802712|FG000|Part A|Other reason not defined above|30|||
41994458|NCT01085136|75802713|FG001|Part A|Other reason not defined above|0|||
41994459|NCT01085136|75802714|FG002|Part A|Other reason not defined above|0|||
41994460|NCT01085136|75802712|FG000|Part B|Other AE|0|||
41994461|NCT01085136|75802713|FG001|Part B|Other AE|29|||
41994462|NCT01085136|75802714|FG002|Part B|Other AE|8|||
41994463|NCT01085136|75802712|FG000|Part B|Refusal to continue trial medication|0|||
41994464|NCT01085136|75802713|FG001|Part B|Refusal to continue trial medication|12|||
41994465|NCT01085136|75802714|FG002|Part B|Refusal to continue trial medication|7|||
41994466|NCT01085136|75802712|FG000|Part B|Not treated|0|||
41994467|NCT01085136|75802713|FG001|Part B|Not treated|4|||
41994468|NCT01085136|75802714|FG002|Part B|Not treated|8|||
41994469|NCT01085136|75802712|FG000|Part B|Other reason not defined above|0|||
41994470|NCT01085136|75802713|FG001|Part B|Other reason not defined above|6|||
41994471|NCT01085136|75802714|FG002|Part B|Other reason not defined above|3|||
41994472|NCT01084707|75802724|FG000|Overall Study|Withdrawal by Subject|6|||
41994473|NCT01084668|75802736|FG000|Overall Study|Lack of Efficacy|5|||
41994474|NCT01084668|75802736|FG000|Overall Study|Withdrawal by Subject|2|||
41994475|NCT01084668|75802736|FG000|Overall Study|Pregnancy|1|||
41994476|NCT01084668|75802736|FG000|Overall Study|Non-compliance|1|||
41994477|NCT01084551|75802745|FG000|Overall Study|Adverse Event|2|||
42321869|NCT02296190|76159053|FG004|Overall Study|Blood pressure <100 after sedation|0|||
41994478|NCT01084551|75802746|FG001|Overall Study|Adverse Event|9|||
41994479|NCT01084551|75802747|FG002|Overall Study|Adverse Event|4|||
41994480|NCT01084551|75802745|FG000|Overall Study|Lack of Efficacy|2|||
41994481|NCT01084551|75802746|FG001|Overall Study|Lack of Efficacy|0|||
41994482|NCT01084551|75802747|FG002|Overall Study|Lack of Efficacy|1|||
41994483|NCT01084551|75802745|FG000|Overall Study|Withdrawal by Subject|2|||
41994484|NCT01084551|75802746|FG001|Overall Study|Withdrawal by Subject|1|||
41994485|NCT01084551|75802747|FG002|Overall Study|Withdrawal by Subject|0|||
41994486|NCT01084551|75802745|FG000|Overall Study|Protocol Violation|2|||
41994487|NCT01084551|75802746|FG001|Overall Study|Protocol Violation|4|||
41994488|NCT01084551|75802747|FG002|Overall Study|Protocol Violation|0|||
41994489|NCT01084551|75802745|FG000|Overall Study|Lost to Follow-up|0|||
41994490|NCT01084551|75802746|FG001|Overall Study|Lost to Follow-up|0|||
41994491|NCT01084551|75802747|FG002|Overall Study|Lost to Follow-up|3|||
41994492|NCT01084551|75802745|FG000|Overall Study|Physician Decision|1|||
41994493|NCT01084551|75802746|FG001|Overall Study|Physician Decision|0|||
41994494|NCT01084551|75802747|FG002|Overall Study|Physician Decision|0|||
41994495|NCT01084005|75802757|FG000|Overall Study|Adverse Event|1|||
41994496|NCT01084005|75802758|FG001|Overall Study|Adverse Event|8|||
41994497|NCT01084005|75802757|FG000|Overall Study|Protocol Violation|3|||
41994498|NCT01084005|75802758|FG001|Overall Study|Protocol Violation|7|||
41994499|NCT01084005|75802757|FG000|Overall Study|Withdrawal by Subject|1|||
41994500|NCT01084005|75802758|FG001|Overall Study|Withdrawal by Subject|1|||
41994501|NCT01083810|75802767|FG000|Overall Study|Lost to Follow-up|23|||
41994502|NCT01083810|75802768|FG001|Overall Study|Lost to Follow-up|11|||
41994503|NCT01083810|75802769|FG002|Overall Study|Lost to Follow-up|4|||
41994504|NCT01083810|75802767|FG000|Overall Study|Adverse Event|15|||
41994505|NCT01083810|75802768|FG001|Overall Study|Adverse Event|11|||
41994506|NCT01083810|75802769|FG002|Overall Study|Adverse Event|4|||
41994507|NCT01083810|75802767|FG000|Overall Study|Withdrawal by Subject|7|||
41994508|NCT01083810|75802768|FG001|Overall Study|Withdrawal by Subject|2|||
41994509|NCT01083810|75802769|FG002|Overall Study|Withdrawal by Subject|4|||
41994510|NCT01083810|75802767|FG000|Overall Study|Reason not reported|6|||
41994511|NCT01083810|75802768|FG001|Overall Study|Reason not reported|1|||
41994512|NCT01083810|75802769|FG002|Overall Study|Reason not reported|1|||
41994513|NCT01083810|75802767|FG000|Overall Study|Non-compliance|4|||
41994514|NCT01083810|75802768|FG001|Overall Study|Non-compliance|7|||
41994515|NCT01083810|75802769|FG002|Overall Study|Non-compliance|2|||
41994516|NCT01083810|75802767|FG000|Overall Study|Simplification|4|||
41994517|NCT01083810|75802768|FG001|Overall Study|Simplification|1|||
41994518|NCT01083810|75802769|FG002|Overall Study|Simplification|0|||
41994519|NCT01083810|75802767|FG000|Overall Study|Death|2|||
41994520|NCT01083810|75802768|FG001|Overall Study|Death|2|||
41994521|NCT01083810|75802769|FG002|Overall Study|Death|3|||
41994522|NCT01083810|75802767|FG000|Overall Study|Co-morbidities|1|||
41994523|NCT01083810|75802768|FG001|Overall Study|Co-morbidities|0|||
41994524|NCT01083810|75802769|FG002|Overall Study|Co-morbidities|0|||
41994525|NCT01083810|75802767|FG000|Overall Study|Participation in study|1|||
41994526|NCT01083810|75802768|FG001|Overall Study|Participation in study|0|||
41994527|NCT01083810|75802769|FG002|Overall Study|Participation in study|0|||
41994528|NCT01083810|75802767|FG000|Overall Study|Therapy break|1|||
41994529|NCT01083810|75802768|FG001|Overall Study|Therapy break|2|||
41994530|NCT01083810|75802769|FG002|Overall Study|Therapy break|2|||
41994531|NCT01083810|75802767|FG000|Overall Study|Virologic failure|1|||
41994532|NCT01083810|75802768|FG001|Overall Study|Virologic failure|8|||
41994533|NCT01083810|75802769|FG002|Overall Study|Virologic failure|0|||
41994534|NCT01083771|75802775|FG000|Overall Study|non-compliant|2|||
41994535|NCT01083771|75802775|FG000|Overall Study|Withdrawal by Subject|3|||
41994536|NCT01083693|75802782|FG000|Overall Study|Adverse Event|1|||
41994537|NCT01083693|75802783|FG001|Overall Study|Adverse Event|1|||
41994538|NCT01083693|75802784|FG002|Overall Study|Adverse Event|0|||
41994539|NCT01083693|75802782|FG000|Overall Study|Lost to Follow-up|2|||
41994540|NCT01083693|75802783|FG001|Overall Study|Lost to Follow-up|0|||
41994541|NCT01083693|75802784|FG002|Overall Study|Lost to Follow-up|2|||
41994542|NCT01083693|75802782|FG000|Overall Study|Lack of effectiveness|13|||
41994543|NCT01083693|75802783|FG001|Overall Study|Lack of effectiveness|2|||
41994544|NCT01083693|75802784|FG002|Overall Study|Lack of effectiveness|2|||
41994545|NCT01083693|75802782|FG000|Overall Study|Patient Moved|0|||
41994546|NCT01083693|75802783|FG001|Overall Study|Patient Moved|1|||
41994547|NCT01083693|75802784|FG002|Overall Study|Patient Moved|0|||
41994548|NCT01083693|75802782|FG000|Overall Study|Complete remission|0|||
41994549|NCT01083693|75802783|FG001|Overall Study|Complete remission|1|||
41994550|NCT01083693|75802784|FG002|Overall Study|Complete remission|0|||
41994551|NCT01083693|75802782|FG000|Overall Study|Other medical condition/surgery|1|||
41994552|NCT01083693|75802783|FG001|Overall Study|Other medical condition/surgery|1|||
41994553|NCT01083693|75802784|FG002|Overall Study|Other medical condition/surgery|0|||
41994554|NCT01083693|75802782|FG000|Overall Study|Withdrawal by Subject|3|||
41994555|NCT01083693|75802783|FG001|Overall Study|Withdrawal by Subject|0|||
41994556|NCT01083693|75802784|FG002|Overall Study|Withdrawal by Subject|2|||
41994557|NCT01083693|75802782|FG000|Overall Study|Reason unknown|0|||
41994558|NCT01083693|75802783|FG001|Overall Study|Reason unknown|0|||
41994559|NCT01083693|75802784|FG002|Overall Study|Reason unknown|1|||
41994560|NCT01083576|75802798|FG000|Overall Study|Treatment Failure|6|||
41994561|NCT01083576|75802799|FG001|Overall Study|Treatment Failure|1|||
41994562|NCT01083186|75802806|FG000|Overall Study|Lost to Follow-up|48|||
41994563|NCT01083186|75802806|FG000|Overall Study|Consent Withdrawal|7|||
41994564|NCT01083186|75802806|FG000|Overall Study|Death|3|||
41994565|NCT01083186|75802806|FG000|Overall Study|Adverse Event|3|||
42321870|NCT02296190|76159054|FG005|Overall Study|Blood pressure <100 after sedation|0|||
42321871|NCT02296190|76159049|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
42321872|NCT02296190|76159050|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
42321873|NCT02296190|76159051|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
42321874|NCT02296190|76159052|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
42321875|NCT02296190|76159053|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
42321876|NCT02296190|76159054|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
42321877|NCT02296190|76159049|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
42321878|NCT02296190|76159050|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
42321879|NCT02296190|76159051|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
41994566|NCT01083186|75802806|FG000|Overall Study|Lack of Efficacy|2|||
41994567|NCT01083186|75802806|FG000|Overall Study|Hemodialysis Initiation|28|||
41994568|NCT01083186|75802806|FG000|Overall Study|Administrative Reasons|2|||
42321880|NCT02296190|76159052|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
42321881|NCT02296190|76159053|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
42321882|NCT02296190|76159054|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
42321883|NCT02296190|76159049|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
42321884|NCT02296190|76159050|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
42321885|NCT02296190|76159051|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
42321886|NCT02296190|76159052|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
41994569|NCT01083186|75802806|FG000|Overall Study|Non-compliance to Study Treatment|1|||
41994570|NCT01082640|75802833|FG000|Overall Study|Adverse Event|9|||
41994571|NCT01082640|75802834|FG001|Overall Study|Adverse Event|5|||
41994572|NCT01082640|75802835|FG002|Overall Study|Adverse Event|3|||
41994573|NCT01082640|75802833|FG000|Overall Study|Withdrawal by Subject|3|||
41994574|NCT01082640|75802834|FG001|Overall Study|Withdrawal by Subject|3|||
41994575|NCT01082640|75802835|FG002|Overall Study|Withdrawal by Subject|2|||
42321887|NCT02296190|76159053|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
42321888|NCT02296190|76159054|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
42321889|NCT02296190|76159049|FG000|Overall Study|Lab result not available in time|1|||
42321890|NCT02296190|76159050|FG001|Overall Study|Lab result not available in time|0|||
42321891|NCT02296190|76159051|FG002|Overall Study|Lab result not available in time|0|||
42321892|NCT02296190|76159052|FG003|Overall Study|Lab result not available in time|0|||
42321893|NCT02296190|76159053|FG004|Overall Study|Lab result not available in time|0|||
42321894|NCT02296190|76159054|FG005|Overall Study|Lab result not available in time|0|||
42321895|NCT02296112|76159067|FG000|Overall Study|Disease progression|7|||
42321896|NCT02296112|76159067|FG000|Overall Study|Toxicity|1|||
42321897|NCT02296112|76159067|FG000|Overall Study|Began an alternate therapy|1|||
42321898|NCT02295644|76159080|FG000|Overall Study|Did not meet inclusion criterion|0|||
42321899|NCT02295644|76159081|FG001|Overall Study|Did not meet inclusion criterion|0|||
42321900|NCT02295644|76159082|FG002|Overall Study|Did not meet inclusion criterion|1|||
42321901|NCT02295644|76159083|FG003|Overall Study|Did not meet inclusion criterion|2|||
42321902|NCT02269670|76159093|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
42321903|NCT02225353|76159100|FG000|Overall Study|Lost to Follow-up|0|||
42321904|NCT02225353|76159101|FG001|Overall Study|Lost to Follow-up|1|||
42321905|NCT02225353|76159102|FG002|Overall Study|Lost to Follow-up|3|||
42321906|NCT02225353|76159100|FG000|Overall Study|Protocol Violation|4|||
42321907|NCT02225353|76159101|FG001|Overall Study|Protocol Violation|5|||
42321908|NCT02225353|76159102|FG002|Overall Study|Protocol Violation|12|||
42321909|NCT01641926|76159117|FG000|Overall Study|Adverse Event|5|||
42321910|NCT01641926|76159118|FG001|Overall Study|Adverse Event|2|||
42321911|NCT01641926|76159119|FG002|Overall Study|Adverse Event|3|||
42321912|NCT01641926|76159120|FG003|Overall Study|Adverse Event|1|||
42321913|NCT01641926|76159117|FG000|Overall Study|Lost to Follow-up|2|||
42321914|NCT01641926|76159118|FG001|Overall Study|Lost to Follow-up|2|||
42321915|NCT01641926|76159119|FG002|Overall Study|Lost to Follow-up|1|||
42321916|NCT01641926|76159120|FG003|Overall Study|Lost to Follow-up|0|||
42321917|NCT01641926|76159117|FG000|Overall Study|Physician Decision|6|||
42321918|NCT01641926|76159118|FG001|Overall Study|Physician Decision|5|||
42321919|NCT01641926|76159119|FG002|Overall Study|Physician Decision|0|||
42321920|NCT01641926|76159120|FG003|Overall Study|Physician Decision|1|||
42321921|NCT01641926|76159117|FG000|Overall Study|Protocol Violation|1|||
42321922|NCT01641926|76159118|FG001|Overall Study|Protocol Violation|0|||
42321923|NCT01641926|76159119|FG002|Overall Study|Protocol Violation|0|||
42321924|NCT01641926|76159120|FG003|Overall Study|Protocol Violation|1|||
42321925|NCT01641926|76159117|FG000|Overall Study|Withdrawal by Subject|13|||
42321926|NCT01641926|76159118|FG001|Overall Study|Withdrawal by Subject|5|||
42321927|NCT01641926|76159119|FG002|Overall Study|Withdrawal by Subject|6|||
42321928|NCT01641926|76159120|FG003|Overall Study|Withdrawal by Subject|1|||
42321929|NCT01641926|76159117|FG000|Overall Study|Not Treated|1|||
42321930|NCT01641926|76159118|FG001|Overall Study|Not Treated|1|||
42321931|NCT01641926|76159119|FG002|Overall Study|Not Treated|1|||
42321932|NCT01641926|76159120|FG003|Overall Study|Not Treated|0|||
42321933|NCT02295020|76159132|FG000|Overall Study|Adverse Event|0|||
42321934|NCT02295020|76159133|FG001|Overall Study|Adverse Event|1|||
42321935|NCT02295020|76159132|FG000|Overall Study|Withdrawal by Subject|3|||
42321936|NCT02295020|76159133|FG001|Overall Study|Withdrawal by Subject|2|||
42321937|NCT02200939|76159147|FG000|Overall Study|Participant withdrew consent|0|||
42321938|NCT02200939|76159148|FG001|Overall Study|Participant withdrew consent|1|||
42321939|NCT02200939|76159147|FG000|Overall Study|Lost to Follow-up|2|||
42321940|NCT02200939|76159148|FG001|Overall Study|Lost to Follow-up|9|||
42321941|NCT02200939|76159147|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
42321942|NCT02200939|76159148|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
42321943|NCT02294786|76159160|FG000|Overall Study|Withdrawal by Subject|0|||
42321944|NCT02294786|76159161|FG001|Overall Study|Withdrawal by Subject|1|||
42321945|NCT02294786|76159160|FG000|Overall Study|Physician Decision|6|||
42321946|NCT02294786|76159161|FG001|Overall Study|Physician Decision|7|||
42321947|NCT02294786|76159160|FG000|Overall Study|Lost to Follow-up|1|||
42321948|NCT02294786|76159161|FG001|Overall Study|Lost to Follow-up|2|||
42321949|NCT02294786|76159160|FG000|Overall Study|Protocol Violation|1|||
42321950|NCT02294786|76159161|FG001|Overall Study|Protocol Violation|0|||
42321951|NCT02294786|76159160|FG000|Overall Study|Adverse Event|1|||
42321952|NCT02294786|76159161|FG001|Overall Study|Adverse Event|1|||
42321953|NCT02294786|76159160|FG000|Overall Study|Death|2|||
42321954|NCT02294786|76159161|FG001|Overall Study|Death|3|||
42321955|NCT02269124|76159170|FG000|Overall Study|Lost to Follow-up|1|||
42321956|NCT02269124|76159171|FG001|Overall Study|Lost to Follow-up|0|||
42321957|NCT02269124|76159170|FG000|Overall Study|Withdrawal by Subject|0|||
42321958|NCT02269124|76159171|FG001|Overall Study|Withdrawal by Subject|2|||
42321959|NCT01927341|76159183|FG000|Phase 1b|Lost to Follow-up|1|||
42321960|NCT01927341|76159184|FG001|Phase 1b|Lost to Follow-up|0|||
42321961|NCT01927341|76159185|FG002|Phase 1b|Lost to Follow-up|0|||
42321962|NCT01927341|76159186|FG003|Phase 1b|Lost to Follow-up|0|||
42321963|NCT01927341|76159187|FG004|Phase 1b|Lost to Follow-up|0|||
42321964|NCT01927341|76159183|FG000|Phase 1b|Death|2|||
42321965|NCT01927341|76159184|FG001|Phase 1b|Death|0|||
42321966|NCT01927341|76159185|FG002|Phase 1b|Death|0|||
42321967|NCT01927341|76159186|FG003|Phase 1b|Death|0|||
42321968|NCT01927341|76159187|FG004|Phase 1b|Death|0|||
42321969|NCT01927341|76159183|FG000|Phase 1b|Follow-up completed|7|||
42321970|NCT01927341|76159184|FG001|Phase 1b|Follow-up completed|0|||
42321971|NCT01927341|76159185|FG002|Phase 1b|Follow-up completed|0|||
42321972|NCT01927341|76159186|FG003|Phase 1b|Follow-up completed|0|||
42321973|NCT01927341|76159187|FG004|Phase 1b|Follow-up completed|0|||
42321974|NCT01927341|76159183|FG000|Phase 2|Lost to Follow-up|0|||
42321975|NCT01927341|76159184|FG001|Phase 2|Lost to Follow-up|1|||
42321976|NCT01927341|76159185|FG002|Phase 2|Lost to Follow-up|0|||
42321977|NCT01927341|76159186|FG003|Phase 2|Lost to Follow-up|0|||
42321978|NCT01927341|76159187|FG004|Phase 2|Lost to Follow-up|0|||
42321979|NCT01927341|76159183|FG000|Phase 2|Participant withdrew consent|0|||
42321980|NCT01927341|76159184|FG001|Phase 2|Participant withdrew consent|2|||
42321981|NCT01927341|76159185|FG002|Phase 2|Participant withdrew consent|1|||
42321982|NCT01927341|76159186|FG003|Phase 2|Participant withdrew consent|2|||
42321983|NCT01927341|76159187|FG004|Phase 2|Participant withdrew consent|3|||
42321984|NCT01927341|76159183|FG000|Phase 2|Death|0|||
42321985|NCT01927341|76159184|FG001|Phase 2|Death|4|||
42321986|NCT01927341|76159185|FG002|Phase 2|Death|0|||
42321987|NCT01927341|76159186|FG003|Phase 2|Death|3|||
42321988|NCT01927341|76159187|FG004|Phase 2|Death|2|||
42321989|NCT01927341|76159183|FG000|Phase 2|New cancer therapy|0|||
42321990|NCT01927341|76159184|FG001|Phase 2|New cancer therapy|1|||
42321991|NCT01927341|76159185|FG002|Phase 2|New cancer therapy|0|||
42321992|NCT01927341|76159186|FG003|Phase 2|New cancer therapy|4|||
42321993|NCT01927341|76159187|FG004|Phase 2|New cancer therapy|1|||
42321994|NCT01927341|76159183|FG000|Phase 2|Disease progression|0|||
42321995|NCT01927341|76159184|FG001|Phase 2|Disease progression|1|||
42321996|NCT01927341|76159185|FG002|Phase 2|Disease progression|1|||
42321997|NCT01927341|76159186|FG003|Phase 2|Disease progression|1|||
42321998|NCT01927341|76159187|FG004|Phase 2|Disease progression|0|||
42321999|NCT01927341|76159183|FG000|Phase 2|Follow-up completed|0|||
42322000|NCT01927341|76159184|FG001|Phase 2|Follow-up completed|6|||
42322001|NCT01927341|76159185|FG002|Phase 2|Follow-up completed|3|||
42322002|NCT01927341|76159186|FG003|Phase 2|Follow-up completed|5|||
42322003|NCT01927341|76159187|FG004|Phase 2|Follow-up completed|2|||
42322004|NCT02294474|76159205|FG000|Overall Study|Adverse Event|7|||
42322005|NCT02294474|76159206|FG001|Overall Study|Adverse Event|7|||
42322006|NCT02294474|76159205|FG000|Overall Study|Lack of Efficacy|2|||
42322007|NCT02294474|76159206|FG001|Overall Study|Lack of Efficacy|1|||
42322008|NCT02294474|76159205|FG000|Overall Study|Protocol Violation|4|||
42322009|NCT02294474|76159206|FG001|Overall Study|Protocol Violation|2|||
42322010|NCT02294474|76159205|FG000|Overall Study|Other than specified above|12|||
42322011|NCT02294474|76159206|FG001|Overall Study|Other than specified above|12|||
42322012|NCT02168101|76159216|FG000|Overall Study|Death|2|||
42322013|NCT02168101|76159217|FG001|Overall Study|Death|2|||
42322014|NCT02168101|76159218|FG002|Overall Study|Death|1|||
42322015|NCT02298179|76159239|FG000|Overall Study|Lost to Follow-up|0|||
42322016|NCT02298179|76159240|FG001|Overall Study|Lost to Follow-up|0|||
42322017|NCT02298179|76159241|FG002|Overall Study|Lost to Follow-up|1|||
42322018|NCT02298179|76159242|FG003|Overall Study|Lost to Follow-up|0|||
42322019|NCT02298179|76159243|FG004|Overall Study|Lost to Follow-up|0|||
42322020|NCT02298179|76159244|FG005|Overall Study|Lost to Follow-up|0|||
42322021|NCT02298179|76159245|FG006|Overall Study|Lost to Follow-up|0|||
42322022|NCT02298179|76159246|FG007|Overall Study|Lost to Follow-up|1|||
42322023|NCT02298179|76159247|FG008|Overall Study|Lost to Follow-up|0|||
42322024|NCT02298179|76159248|FG009|Overall Study|Lost to Follow-up|0|||
42322025|NCT02298179|76159249|FG010|Overall Study|Lost to Follow-up|0|||
42322026|NCT02298179|76159250|FG011|Overall Study|Lost to Follow-up|0|||
42322027|NCT02298023|76159279|FG000|Overall Study|Withdrawal by Subject|1|||
42322028|NCT02298023|76159280|FG001|Overall Study|Withdrawal by Subject|0|||
42322029|NCT02298023|76159281|FG002|Overall Study|Withdrawal by Subject|0|||
42322030|NCT02296931|76159294|FG000|Overall Study|Protocol Violation|0|||
42322031|NCT02296931|76159295|FG001|Overall Study|Protocol Violation|2|||
42322032|NCT02166697|76159301|FG000|Overall Study|Protocol Violation|347|||
42322033|NCT01909479|76159307|FG000|From Baseline to Week 26|Adverse Event|3|||
42322034|NCT01909479|76159308|FG001|From Baseline to Week 26|Adverse Event|2|||
42322035|NCT01909479|76159307|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
42322036|NCT01909479|76159308|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
42322037|NCT01909479|76159307|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
42322038|NCT01909479|76159308|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
42322039|NCT01909479|76159307|FG000|26 - 52 Weeks|Adverse Event|0|||
42322040|NCT01909479|76159308|FG001|26 - 52 Weeks|Adverse Event|1|||
42322041|NCT01909479|76159307|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
42322042|NCT01909479|76159308|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
42322043|NCT01909479|76159307|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
42322044|NCT01909479|76159308|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
42322045|NCT01909479|76159307|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
42322046|NCT01909479|76159308|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
42322047|NCT01909479|76159307|FG000|52 Weeks to End of Study|Adverse Event|2|||
42322048|NCT01909479|76159308|FG001|52 Weeks to End of Study|Adverse Event|1|||
42322049|NCT01909479|76159307|FG000|52 Weeks to End of Study|Death|0|||
42322050|NCT01909479|76159308|FG001|52 Weeks to End of Study|Death|1|||
42322051|NCT01909479|76159307|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
42322052|NCT01909479|76159308|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
42322053|NCT01909479|76159307|FG000|52 Weeks to End of Study|Protocol Violation|1|||
42322054|NCT01909479|76159308|FG001|52 Weeks to End of Study|Protocol Violation|0|||
42322055|NCT01909479|76159307|FG000|52 Weeks to End of Study|Progressive disease|1|||
42322056|NCT01909479|76159308|FG001|52 Weeks to End of Study|Progressive disease|1|||
42322057|NCT01909479|76159307|FG000|52 Weeks to End of Study|Personal reasons|2|||
42322058|NCT01909479|76159308|FG001|52 Weeks to End of Study|Personal reasons|1|||
42322059|NCT01909479|76159307|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
42322060|NCT01909479|76159308|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
42322061|NCT01909479|76159307|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
42322062|NCT01909479|76159308|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
42322063|NCT01909479|76159307|FG000|52 Weeks to End of Study|Lack of contact|1|||
42322064|NCT01909479|76159308|FG001|52 Weeks to End of Study|Lack of contact|0|||
42322065|NCT01909479|76159307|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
42322066|NCT01909479|76159308|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
42322067|NCT01909479|76159307|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
42322068|NCT01909479|76159308|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
42322069|NCT01955733|76159321|FG000|Period 1|Lost to Follow-up|1|||
42322070|NCT01955733|76159322|FG001|Period 1|Lost to Follow-up|0|||
42322071|NCT01955733|76159323|FG002|Period 1|Lost to Follow-up|0|||
42322072|NCT01955733|76159321|FG000|Period 2|Adverse Event|1|||
42322073|NCT01955733|76159322|FG001|Period 2|Adverse Event|0|||
42322074|NCT01955733|76159323|FG002|Period 2|Adverse Event|0|||
42322075|NCT01955733|76159321|FG000|Period 2|Physician Decision|0|||
42322076|NCT01955733|76159322|FG001|Period 2|Physician Decision|0|||
42322077|NCT01955733|76159323|FG002|Period 2|Physician Decision|1|||
42034106|NCT01070550|75842185|FG004|Overall Study|Treatment unavailable|0|||
42034107|NCT01070550|75842186|FG005|Overall Study|Treatment unavailable|0|||
42034108|NCT01070550|75842181|FG000|Overall Study|Treatment was stopped early|7|||
42034109|NCT01070550|75842182|FG001|Overall Study|Treatment was stopped early|0|||
42034110|NCT01070550|75842183|FG002|Overall Study|Treatment was stopped early|0|||
42322078|NCT01955733|76159321|FG000|Period 2|Withdrawal by Subject|1|||
42322079|NCT01955733|76159322|FG001|Period 2|Withdrawal by Subject|3|||
42322080|NCT01955733|76159323|FG002|Period 2|Withdrawal by Subject|2|||
42322081|NCT01955733|76159321|FG000|Period 2|Study terminated by sponsor|8|||
42322082|NCT01955733|76159322|FG001|Period 2|Study terminated by sponsor|14|||
42322083|NCT01955733|76159323|FG002|Period 2|Study terminated by sponsor|16|||
42322084|NCT01955733|76159321|FG000|Period 2|Lost to Follow-up|2|||
42322085|NCT01955733|76159322|FG001|Period 2|Lost to Follow-up|0|||
42322086|NCT01955733|76159323|FG002|Period 2|Lost to Follow-up|0|||
42322087|NCT01955733|76159321|FG000|Period 2|Other not defined above|0|||
42322088|NCT01955733|76159322|FG001|Period 2|Other not defined above|2|||
42322089|NCT01955733|76159323|FG002|Period 2|Other not defined above|2|||
42322090|NCT02197897|76159331|FG000|Overall Study|not eligible|1|||
42322091|NCT02223793|76159338|FG000|Overall Study|Lost to Follow-up|10|||
42322092|NCT02223793|76159339|FG001|Overall Study|Lost to Follow-up|1|||
42322093|NCT02223793|76159340|FG002|Overall Study|Lost to Follow-up|2|||
42322094|NCT02223793|76159338|FG000|Overall Study|Withdrawal by Subject|3|||
42322095|NCT02223793|76159339|FG001|Overall Study|Withdrawal by Subject|2|||
42322096|NCT02223793|76159340|FG002|Overall Study|Withdrawal by Subject|3|||
42322097|NCT02223793|76159338|FG000|Overall Study|Moved/studycenter unable to participate|4|||
42322098|NCT02223793|76159339|FG001|Overall Study|Moved/studycenter unable to participate|6|||
42322099|NCT02223793|76159340|FG002|Overall Study|Moved/studycenter unable to participate|8|||
42322100|NCT01926015|76159350|FG000|Overall Study|Withdrawal by parent/guardian|0|||
42322101|NCT01926015|76159351|FG001|Overall Study|Withdrawal by parent/guardian|1|||
42322102|NCT01926015|76159350|FG000|Overall Study|Randomized not treated|2|||
42322103|NCT01926015|76159351|FG001|Overall Study|Randomized not treated|0|||
42322104|NCT02223715|76159357|FG000|Overall Study|Death|31|||
42322105|NCT02223715|76159357|FG000|Overall Study|Lost to Follow-up|73|||
42322106|NCT02196259|76159367|FG000|Overall Study|Researcher choice|0|||
42322107|NCT02196259|76159368|FG001|Overall Study|Researcher choice|0|||
42322108|NCT02196259|76159369|FG002|Overall Study|Researcher choice|1|||
42322109|NCT02196259|76159367|FG000|Overall Study|Partial data analysis|0|||
42322110|NCT02196259|76159368|FG001|Overall Study|Partial data analysis|3|||
42322111|NCT02196259|76159369|FG002|Overall Study|Partial data analysis|0|||
42322112|NCT02294396|76159380|FG000|Overall Study|Adverse Event|26|||
42322113|NCT02294396|76159381|FG001|Overall Study|Adverse Event|25|||
42322114|NCT02294396|76159382|FG002|Overall Study|Adverse Event|21|||
42322115|NCT02294396|76159383|FG003|Overall Study|Adverse Event|24|||
42322116|NCT02294396|76159380|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
42322117|NCT02294396|76159381|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
42322118|NCT02294396|76159382|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
42322119|NCT02294396|76159383|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
42322120|NCT02294396|76159380|FG000|Overall Study|Withdrawal by Subject|8|||
42322121|NCT02294396|76159381|FG001|Overall Study|Withdrawal by Subject|6|||
42322122|NCT02294396|76159382|FG002|Overall Study|Withdrawal by Subject|6|||
42322123|NCT02294396|76159383|FG003|Overall Study|Withdrawal by Subject|8|||
42322124|NCT02294396|76159380|FG000|Overall Study|Lost to Follow-up|0|||
42322125|NCT02294396|76159381|FG001|Overall Study|Lost to Follow-up|0|||
42133480|NCT00485732|75944396|FG001|Overall Study|Protocol Violation|3|||
42259249|NCT01336205|76085559|FG001|Overall Study|Did not receive treatment|0|||
42259250|NCT02865395|76085568|FG000|Overall Study|Physician Decision|6|||
42259251|NCT02865395|76085569|FG001|Overall Study|Physician Decision|10|||
42259252|NCT02865395|76085570|FG002|Overall Study|Physician Decision|7|||
42259253|NCT01123707|76085582|FG000|Overall Study|Lost to Follow-up|3|||
42259254|NCT01123707|76085583|FG001|Overall Study|Lost to Follow-up|1|||
42259255|NCT01123707|76085584|FG002|Overall Study|Lost to Follow-up|3|||
42322126|NCT02294396|76159382|FG002|Overall Study|Lost to Follow-up|1|||
42322127|NCT02294396|76159383|FG003|Overall Study|Lost to Follow-up|1|||
42322128|NCT02294396|76159380|FG000|Overall Study|Protocol Deviation|3|||
42322129|NCT02294396|76159381|FG001|Overall Study|Protocol Deviation|2|||
42259256|NCT01123707|76085585|FG003|Overall Study|Lost to Follow-up|2|||
42259257|NCT01123707|76085582|FG000|Overall Study|Adverse Event|5|||
42322130|NCT02294396|76159382|FG002|Overall Study|Protocol Deviation|2|||
42322131|NCT02294396|76159383|FG003|Overall Study|Protocol Deviation|1|||
42322132|NCT02294396|76159380|FG000|Overall Study|Miscellaneous|2|||
42322133|NCT02294396|76159381|FG001|Overall Study|Miscellaneous|0|||
42322134|NCT02294396|76159382|FG002|Overall Study|Miscellaneous|5|||
42322135|NCT02294396|76159383|FG003|Overall Study|Miscellaneous|2|||
42322136|NCT01721044|76159396|FG000|Treatment Period|Adverse Event|7|||
42322137|NCT01721044|76159397|FG001|Treatment Period|Adverse Event|7|||
42322138|NCT01721044|76159398|FG002|Treatment Period|Adverse Event|10|||
42322139|NCT01721044|76159396|FG000|Treatment Period|Death|0|||
42322140|NCT01721044|76159397|FG001|Treatment Period|Death|0|||
42322141|NCT01721044|76159398|FG002|Treatment Period|Death|1|||
42322142|NCT01721044|76159396|FG000|Treatment Period|Lack of Efficacy|16|||
42322143|NCT01721044|76159397|FG001|Treatment Period|Lack of Efficacy|4|||
42322144|NCT01721044|76159398|FG002|Treatment Period|Lack of Efficacy|4|||
42322145|NCT01721044|76159396|FG000|Treatment Period|Lost to Follow-up|0|||
42322146|NCT01721044|76159397|FG001|Treatment Period|Lost to Follow-up|0|||
42322147|NCT01721044|76159398|FG002|Treatment Period|Lost to Follow-up|1|||
42322148|NCT01721044|76159396|FG000|Treatment Period|Physician Decision|1|||
42322149|NCT01721044|76159397|FG001|Treatment Period|Physician Decision|0|||
42322150|NCT01721044|76159398|FG002|Treatment Period|Physician Decision|2|||
42322151|NCT01721044|76159396|FG000|Treatment Period|Protocol Violation|1|||
42322152|NCT01721044|76159397|FG001|Treatment Period|Protocol Violation|0|||
42322153|NCT01721044|76159398|FG002|Treatment Period|Protocol Violation|0|||
42322154|NCT01721044|76159396|FG000|Treatment Period|Withdrawal by Subject|7|||
42322155|NCT01721044|76159397|FG001|Treatment Period|Withdrawal by Subject|6|||
42322156|NCT01721044|76159398|FG002|Treatment Period|Withdrawal by Subject|1|||
42322157|NCT02164981|76159420|FG000|Started|Withdrawal by Subject|2|||
42322158|NCT02164981|76159421|FG001|Started|Withdrawal by Subject|1|||
42322159|NCT02164981|76159422|FG002|Started|Withdrawal by Subject|0|||
42322160|NCT02164981|76159420|FG000|Started|Protocol Violation|2|||
42322161|NCT02164981|76159421|FG001|Started|Protocol Violation|0|||
42322162|NCT02164981|76159422|FG002|Started|Protocol Violation|0|||
42322163|NCT02164981|76159420|FG000|Started|Adverse Event|1|||
42322164|NCT02164981|76159421|FG001|Started|Adverse Event|2|||
42322165|NCT02164981|76159422|FG002|Started|Adverse Event|0|||
42322166|NCT02164981|76159420|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
42322167|NCT02164981|76159421|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
42322168|NCT02164981|76159422|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
41994576|NCT01082640|75802833|FG000|Overall Study|Major protocol deviation|3|||
41994577|NCT01082640|75802834|FG001|Overall Study|Major protocol deviation|3|||
41994578|NCT01082640|75802835|FG002|Overall Study|Major protocol deviation|0|||
42322169|NCT02164981|76159420|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
42322170|NCT02164981|76159421|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
42322171|NCT02164981|76159422|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
42322172|NCT02164981|76159420|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
42322173|NCT02164981|76159421|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
42322174|NCT02164981|76159422|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
42322175|NCT02195869|76159443|FG000|Overall Study|cGVHD Progression|5|||
42322176|NCT02195869|76159443|FG000|Overall Study|Malignancy Progression/relapse|2|||
42322177|NCT02195869|76159443|FG000|Overall Study|Adverse Event|15|||
42322178|NCT02195869|76159443|FG000|Overall Study|Withdrawal by Subject|7|||
42322179|NCT02195869|76159443|FG000|Overall Study|Physician Decision|4|||
42322180|NCT02195869|76159443|FG000|Overall Study|Study Terminated by Sponsor|7|||
42322181|NCT02195869|76159443|FG000|Overall Study|Noncompliance with study drug|2|||
42322182|NCT01908699|76159452|FG000|Overall Study|Adverse Event|8|||
42322183|NCT01908699|76159453|FG001|Overall Study|Adverse Event|12|||
42322184|NCT01908699|76159452|FG000|Overall Study|Lack of Efficacy|2|||
42322185|NCT01908699|76159453|FG001|Overall Study|Lack of Efficacy|2|||
42322186|NCT01908699|76159452|FG000|Overall Study|Lost to Follow-up|2|||
42322187|NCT01908699|76159453|FG001|Overall Study|Lost to Follow-up|4|||
42322188|NCT01908699|76159452|FG000|Overall Study|Physician Decision|8|||
42322189|NCT01908699|76159453|FG001|Overall Study|Physician Decision|8|||
42322190|NCT01908699|76159452|FG000|Overall Study|Withdrawal by Subject|15|||
42322191|NCT01908699|76159453|FG001|Overall Study|Withdrawal by Subject|10|||
42322192|NCT01908699|76159452|FG000|Overall Study|Pregnancy|0|||
42322193|NCT01908699|76159453|FG001|Overall Study|Pregnancy|1|||
42322194|NCT01908699|76159452|FG000|Overall Study|Randomized in Error|1|||
42322195|NCT01908699|76159453|FG001|Overall Study|Randomized in Error|0|||
42322196|NCT01908699|76159452|FG000|Overall Study|Death|9|||
42322197|NCT01908699|76159453|FG001|Overall Study|Death|12|||
42322198|NCT01908699|76159452|FG000|Overall Study|Progressive Disease|30|||
42322199|NCT01908699|76159453|FG001|Overall Study|Progressive Disease|29|||
42322200|NCT01599637|76159462|FG000|Overall Study|administrative problems|0|||
42322201|NCT01599637|76159463|FG001|Overall Study|administrative problems|2|||
42322202|NCT01599637|76159464|FG002|Overall Study|administrative problems|0|||
42322203|NCT01599637|76159462|FG000|Overall Study|Adverse Event|1|||
42322204|NCT01599637|76159463|FG001|Overall Study|Adverse Event|0|||
42322205|NCT01599637|76159464|FG002|Overall Study|Adverse Event|0|||
42322206|NCT02264639|76159479|FG000|Overall Study|Death (after completing single-dose phase)|1|||
42322207|NCT02264639|76159480|FG001|Overall Study|Death (after completing single-dose phase)|0|||
42322208|NCT02264639|76159481|FG002|Overall Study|Death (after completing single-dose phase)|0|||
42322209|NCT02264639|76159482|FG003|Overall Study|Death (after completing single-dose phase)|0|||
42322210|NCT02264639|76159483|FG004|Overall Study|Death (after completing single-dose phase)|0|||
42322211|NCT02264639|76159479|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
42322212|NCT02264639|76159480|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
42322213|NCT02264639|76159481|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
42322214|NCT02264639|76159482|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
42322215|NCT02264639|76159483|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
42322216|NCT02264639|76159479|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
42322217|NCT02264639|76159480|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
42322218|NCT02264639|76159481|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
42322219|NCT02264639|76159482|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
42322220|NCT02264639|76159483|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
42322221|NCT02264639|76159479|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
42322222|NCT02264639|76159480|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
42322223|NCT02264639|76159481|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
42322224|NCT02264639|76159482|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
42322225|NCT02264639|76159483|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
42322226|NCT01363011|76159500|FG000|Main Study|Adverse Event|2|||
42322227|NCT01363011|76159501|FG001|Main Study|Adverse Event|3|||
42322228|NCT01363011|76159500|FG000|Main Study|Investigator's Discretion|1|||
42322229|NCT01363011|76159501|FG001|Main Study|Investigator's Discretion|1|||
42322230|NCT01363011|76159500|FG000|Main Study|Withdrew Consent|1|||
42322231|NCT01363011|76159501|FG001|Main Study|Withdrew Consent|4|||
42322232|NCT01363011|76159500|FG000|Main Study|Protocol Violation|0|||
42322233|NCT01363011|76159501|FG001|Main Study|Protocol Violation|1|||
42322234|NCT01363011|76159500|FG000|Extension Phase|Adverse Event|1|||
42322235|NCT01363011|76159501|FG001|Extension Phase|Adverse Event|1|||
42322236|NCT01363011|76159500|FG000|Extension Phase|Lack of Efficacy|0|||
42322237|NCT01363011|76159501|FG001|Extension Phase|Lack of Efficacy|1|||
42322238|NCT01363011|76159500|FG000|Extension Phase|Investigator's Discretion|2|||
42322239|NCT01363011|76159501|FG001|Extension Phase|Investigator's Discretion|2|||
42322240|NCT01363011|76159500|FG000|Extension Phase|Withdrew Consent|0|||
42322241|NCT01363011|76159501|FG001|Extension Phase|Withdrew Consent|1|||
42322242|NCT01363011|76159500|FG000|Extension Phase|Lost to Follow-up|0|||
42322243|NCT01363011|76159501|FG001|Extension Phase|Lost to Follow-up|2|||
42322244|NCT01363011|76159500|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
42322245|NCT01363011|76159501|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
42322246|NCT02263547|76159507|FG000|Overall Study|Adverse Event|1|||
42322247|NCT02263547|76159507|FG000|Overall Study|Lost to Follow-up|2|||
41994579|NCT01082640|75802833|FG000|Overall Study|Lost to Follow-up|0|||
41994580|NCT01082640|75802834|FG001|Overall Study|Lost to Follow-up|3|||
41994581|NCT01082640|75802835|FG002|Overall Study|Lost to Follow-up|0|||
41994582|NCT01082640|75802833|FG000|Overall Study|Other|2|||
42133481|NCT00485732|75944395|FG000|Overall Study|Withdrawal by Subject|5|||
41994583|NCT01082640|75802834|FG001|Overall Study|Other|1|||
41994584|NCT01082640|75802835|FG002|Overall Study|Other|3|||
41994585|NCT01082367|75802848|FG000|Double-blind Period|Administrative problems|0|||
41994586|NCT01082367|75802849|FG001|Double-blind Period|Administrative problems|1|||
41994587|NCT01082367|75802848|FG000|Double-blind Period|Lack of Efficacy|5|||
41994588|NCT01082367|75802849|FG001|Double-blind Period|Lack of Efficacy|11|||
41994589|NCT01082367|75802848|FG000|Double-blind Period|Adverse Event|0|||
41994590|NCT01082367|75802849|FG001|Double-blind Period|Adverse Event|1|||
41994591|NCT01082367|75802848|FG000|Follow-up (F-U) Period|Administrative problems|1|||
41994592|NCT01082367|75802849|FG001|Follow-up (F-U) Period|Administrative problems|0|||
42322248|NCT01925703|76159511|FG000|Overall Study|Physician Decision|1|||
42322249|NCT01925703|76159511|FG000|Overall Study|Lost to Follow-up|2|||
42322250|NCT01925703|76159511|FG000|Overall Study|Discharge prior to full iron repletion|1|||
42322251|NCT01617681|76159519|FG000|Period 1 Double Blind|Adverse Event|2|||
42322252|NCT01617681|76159520|FG001|Period 1 Double Blind|Adverse Event|0|||
42322253|NCT01617681|76159521|FG002|Period 1 Double Blind|Adverse Event|0|||
42322254|NCT01617681|76159522|FG003|Period 1 Double Blind|Adverse Event|2|||
42322255|NCT01617681|76159523|FG004|Period 1 Double Blind|Adverse Event|0|||
42322256|NCT01617681|76159519|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
42322257|NCT01617681|76159520|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
42322258|NCT01617681|76159521|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
42322259|NCT01617681|76159522|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
42322260|NCT01617681|76159523|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
42322261|NCT01617681|76159519|FG000|Period 2 Open Label|Adverse Event|0|||
42322262|NCT01617681|76159520|FG001|Period 2 Open Label|Adverse Event|0|||
42322263|NCT01617681|76159521|FG002|Period 2 Open Label|Adverse Event|0|||
42322264|NCT01617681|76159522|FG003|Period 2 Open Label|Adverse Event|0|||
42322265|NCT01617681|76159523|FG004|Period 2 Open Label|Adverse Event|3|||
42322266|NCT01617681|76159519|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
42322267|NCT01617681|76159520|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
42322268|NCT01617681|76159521|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
42322269|NCT01617681|76159522|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
42322270|NCT01617681|76159523|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
42322271|NCT02263079|76159535|FG000|Overall Study|Physician Decision|1|||
42322272|NCT02263079|76159536|FG001|Overall Study|Physician Decision|0|||
42322273|NCT02263079|76159537|FG002|Overall Study|Physician Decision|0|||
42322274|NCT02263079|76159535|FG000|Overall Study|Withdrawal by Subject|2|||
42322275|NCT02263079|76159536|FG001|Overall Study|Withdrawal by Subject|8|||
42322276|NCT02263079|76159537|FG002|Overall Study|Withdrawal by Subject|0|||
42322277|NCT02295995|76159547|FG000|Overall Study|Lost to Follow-up|5|||
42322278|NCT02295995|76159548|FG001|Overall Study|Lost to Follow-up|1|||
42322279|NCT02294981|76159555|FG000|Overall Study|Lost to Follow-up|1|||
42322280|NCT02262377|76159561|FG000|Overall Study|Lost to Follow-up|5|||
42322281|NCT02262377|76159562|FG001|Overall Study|Lost to Follow-up|6|||
42322282|NCT02262377|76159561|FG000|Overall Study|Found ineligible after enrollment|3|||
42322283|NCT02262377|76159562|FG001|Overall Study|Found ineligible after enrollment|0|||
42322284|NCT02262377|76159561|FG000|Overall Study|Withdrawal by Subject|4|||
42322285|NCT02262377|76159562|FG001|Overall Study|Withdrawal by Subject|0|||
42322286|NCT02260817|76159571|FG000|Overall Study|Lost to Follow-up|0|||
42322287|NCT02260817|76159572|FG001|Overall Study|Lost to Follow-up|14|||
42322288|NCT02260817|76159571|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
42322289|NCT02260817|76159572|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
42322290|NCT02260817|76159571|FG000|Overall Study|Observation, no biopsy|0|||
42322291|NCT02260817|76159572|FG001|Overall Study|Observation, no biopsy|1|||
42322292|NCT02260817|76159571|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
42322293|NCT02260817|76159572|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
42322294|NCT02260817|76159571|FG000|Overall Study|Protocol Violation|0|||
42322295|NCT02260817|76159572|FG001|Overall Study|Protocol Violation|14|||
42322296|NCT01642589|76159580|FG000|Overall Study|Withdrawal by Subject|1|||
42322297|NCT01642589|76159581|FG001|Overall Study|Withdrawal by Subject|1|||
42322298|NCT02268812|76159591|FG000|Overall Study|Adverse Event|8|||
42322299|NCT02268812|76159592|FG001|Overall Study|Adverse Event|26|||
42322300|NCT02268812|76159593|FG002|Overall Study|Adverse Event|7|||
42322301|NCT02268812|76159594|FG003|Overall Study|Adverse Event|10|||
42322302|NCT02268812|76159591|FG000|Overall Study|Protocol deviation|0|||
42322303|NCT02268812|76159592|FG001|Overall Study|Protocol deviation|0|||
41994593|NCT01082367|75802848|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
42259258|NCT01123707|76085583|FG001|Overall Study|Adverse Event|7|||
42322304|NCT02268812|76159593|FG002|Overall Study|Protocol deviation|1|||
42322305|NCT02268812|76159594|FG003|Overall Study|Protocol deviation|0|||
42322306|NCT02268812|76159591|FG000|Overall Study|Withdrawal by Subject|0|||
42322307|NCT02268812|76159592|FG001|Overall Study|Withdrawal by Subject|1|||
42322308|NCT02268812|76159593|FG002|Overall Study|Withdrawal by Subject|0|||
42322309|NCT02268812|76159594|FG003|Overall Study|Withdrawal by Subject|0|||
41994594|NCT01082367|75802849|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
42322310|NCT02268812|76159591|FG000|Overall Study|Physician Decision|3|||
42322311|NCT02268812|76159592|FG001|Overall Study|Physician Decision|1|||
42322312|NCT02268812|76159593|FG002|Overall Study|Physician Decision|0|||
42322313|NCT02268812|76159594|FG003|Overall Study|Physician Decision|1|||
42322314|NCT02268812|76159591|FG000|Overall Study|Other|5|||
42322315|NCT02268812|76159592|FG001|Overall Study|Other|4|||
42322316|NCT02268812|76159593|FG002|Overall Study|Other|1|||
42322317|NCT02268812|76159594|FG003|Overall Study|Other|3|||
42322318|NCT01954251|76159606|FG000|Overall Study|Adverse Event|5|||
42322319|NCT01954251|76159607|FG001|Overall Study|Adverse Event|7|||
42322320|NCT01954251|76159606|FG000|Overall Study|Lost to Follow-up|6|||
42322321|NCT01954251|76159607|FG001|Overall Study|Lost to Follow-up|6|||
42322322|NCT01954251|76159606|FG000|Overall Study|Withdrawal by Subject|2|||
42322323|NCT01954251|76159607|FG001|Overall Study|Withdrawal by Subject|6|||
42322324|NCT01644617|76159617|FG000|Overall Study|Withdrawal by Subject|3|||
42322325|NCT01644617|76159618|FG001|Overall Study|Withdrawal by Subject|4|||
42322326|NCT01644617|76159619|FG002|Overall Study|Withdrawal by Subject|1|||
42322327|NCT01644617|76159617|FG000|Overall Study|Lost to Follow-up|0|||
42322328|NCT01644617|76159618|FG001|Overall Study|Lost to Follow-up|1|||
42322329|NCT01644617|76159619|FG002|Overall Study|Lost to Follow-up|0|||
42322330|NCT01644617|76159617|FG000|Overall Study|Adverse Event|3|||
42322331|NCT01644617|76159618|FG001|Overall Study|Adverse Event|0|||
42322332|NCT01644617|76159619|FG002|Overall Study|Adverse Event|6|||
42322333|NCT02294318|76159629|FG000|Overall Study|Worsening of drinking|3|||
42322334|NCT02294318|76159630|FG001|Overall Study|Worsening of drinking|0|||
42322335|NCT02294318|76159629|FG000|Overall Study|Not exposed to intervention|0|||
42322336|NCT02294318|76159630|FG001|Overall Study|Not exposed to intervention|2|||
42322337|NCT02293499|76159639|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
42322338|NCT02293499|76159640|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
42322339|NCT02293499|76159641|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
42322340|NCT02293499|76159639|FG000|Intervention - Camp|Withdrawal by Subject|3|||
42322341|NCT02293499|76159640|FG001|Intervention - Camp|Withdrawal by Subject|6|||
42322342|NCT02293499|76159641|FG002|Intervention - Camp|Withdrawal by Subject|2|||
42322343|NCT02293499|76159639|FG000|Intervention - Camp|these are those not showing up at camp|24|||
42322344|NCT02293499|76159640|FG001|Intervention - Camp|these are those not showing up at camp|28|||
42322345|NCT02293499|76159641|FG002|Intervention - Camp|these are those not showing up at camp|4|||
42322346|NCT02293499|76159639|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
42322347|NCT02293499|76159640|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
42322348|NCT02293499|76159641|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
42322349|NCT02293499|76159639|FG000|3 Month Follow Up|Lost to Follow-up|14|||
42322350|NCT02293499|76159640|FG001|3 Month Follow Up|Lost to Follow-up|15|||
42322351|NCT02293499|76159641|FG002|3 Month Follow Up|Lost to Follow-up|6|||
42322352|NCT02293499|76159639|FG000|6 Month Follow Up|Lost to Follow-up|17|||
42322353|NCT02293499|76159640|FG001|6 Month Follow Up|Lost to Follow-up|27|||
42322354|NCT02293499|76159641|FG002|6 Month Follow Up|Lost to Follow-up|6|||
42322355|NCT02293499|76159639|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
42322356|NCT02293499|76159640|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
42322357|NCT02293499|76159641|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
42322358|NCT02293499|76159639|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
42322359|NCT02293499|76159640|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
42322360|NCT02293499|76159641|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
42322361|NCT02293499|76159639|FG000|9 Month Follow Up|Lost to Follow-up|24|||
42322362|NCT02293499|76159640|FG001|9 Month Follow Up|Lost to Follow-up|28|||
42259259|NCT01123707|76085584|FG002|Overall Study|Adverse Event|5|||
42259260|NCT01123707|76085585|FG003|Overall Study|Adverse Event|3|||
42259261|NCT01123707|76085582|FG000|Overall Study|Sponsor Discontinued Study|30|||
42259262|NCT01123707|76085583|FG001|Overall Study|Sponsor Discontinued Study|24|||
42259263|NCT01123707|76085584|FG002|Overall Study|Sponsor Discontinued Study|25|||
42259264|NCT01123707|76085585|FG003|Overall Study|Sponsor Discontinued Study|40|||
42259265|NCT01123707|76085582|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
42259266|NCT01123707|76085583|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
42259267|NCT01123707|76085584|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
42259268|NCT01123707|76085585|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
42259269|NCT01123707|76085582|FG000|Overall Study|Investigator Withdrew Participant|0|||
42259270|NCT01123707|76085583|FG001|Overall Study|Investigator Withdrew Participant|1|||
42259271|NCT01123707|76085584|FG002|Overall Study|Investigator Withdrew Participant|1|||
42259272|NCT01123707|76085585|FG003|Overall Study|Investigator Withdrew Participant|1|||
42259273|NCT01123707|76085582|FG000|Overall Study|Subject Withdrew Consent|4|||
42259274|NCT01123707|76085583|FG001|Overall Study|Subject Withdrew Consent|5|||
42322363|NCT02293499|76159641|FG002|9 Month Follow Up|Lost to Follow-up|4|||
42322364|NCT02293499|76159639|FG000|12 Month Follow Up|Lost to Follow-up|26|||
42322365|NCT02293499|76159640|FG001|12 Month Follow Up|Lost to Follow-up|25|||
42322366|NCT02293499|76159641|FG002|12 Month Follow Up|Lost to Follow-up|6|||
42322367|NCT02293499|76159639|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
42322368|NCT02293499|76159640|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
42322369|NCT02293499|76159641|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
42322370|NCT02293499|76159639|FG000|15 Month Follow Up|Lost to Follow-up|22|||
42322371|NCT02293499|76159640|FG001|15 Month Follow Up|Lost to Follow-up|22|||
42322372|NCT02293499|76159641|FG002|15 Month Follow Up|Lost to Follow-up|7|||
42322373|NCT02257385|76159652|FG000|Overall Study|Adverse Event|12|||
42322374|NCT02257385|76159653|FG001|Overall Study|Adverse Event|8|||
42322375|NCT02257385|76159652|FG000|Overall Study|Lack of Efficacy|1|||
42322376|NCT02257385|76159653|FG001|Overall Study|Lack of Efficacy|2|||
42322377|NCT02257385|76159652|FG000|Overall Study|Protocol Violation|5|||
42322378|NCT02257385|76159653|FG001|Overall Study|Protocol Violation|7|||
42322379|NCT02257385|76159652|FG000|Overall Study|Lost to Follow-up|0|||
42322380|NCT02257385|76159653|FG001|Overall Study|Lost to Follow-up|1|||
42322381|NCT02257385|76159652|FG000|Overall Study|Withdrawal by Subject|4|||
42322382|NCT02257385|76159653|FG001|Overall Study|Withdrawal by Subject|4|||
42322383|NCT01629667|76159662|FG000|Overall Study|Lost to Follow-up|0|||
42322384|NCT01629667|76159663|FG001|Overall Study|Lost to Follow-up|1|||
42322385|NCT01629667|76159664|FG002|Overall Study|Lost to Follow-up|1|||
42322386|NCT01629667|76159662|FG000|Overall Study|Withdrawal by Subject|31|||
42322387|NCT01629667|76159663|FG001|Overall Study|Withdrawal by Subject|20|||
42322388|NCT01629667|76159664|FG002|Overall Study|Withdrawal by Subject|28|||
42322389|NCT01629667|76159662|FG000|Overall Study|Death|1|||
42322390|NCT01629667|76159663|FG001|Overall Study|Death|5|||
42322391|NCT01629667|76159664|FG002|Overall Study|Death|3|||
42322392|NCT01629667|76159662|FG000|Overall Study|Randomized, not treated|2|||
42322393|NCT01629667|76159663|FG001|Overall Study|Randomized, not treated|1|||
42322394|NCT01629667|76159664|FG002|Overall Study|Randomized, not treated|0|||
42322395|NCT01629667|76159662|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
42322396|NCT01629667|76159663|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
42322397|NCT01629667|76159664|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
42322398|NCT01629667|76159662|FG000|Overall Study|Requiring lung transplant|2|||
42322399|NCT01629667|76159663|FG001|Overall Study|Requiring lung transplant|1|||
42322400|NCT01629667|76159664|FG002|Overall Study|Requiring lung transplant|3|||
42322401|NCT01629667|76159662|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
42322402|NCT01629667|76159663|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
42322403|NCT01629667|76159664|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
42322404|NCT01629667|76159662|FG000|Overall Study|Started other medicine|1|||
42322405|NCT01629667|76159663|FG001|Overall Study|Started other medicine|0|||
42322406|NCT01629667|76159664|FG002|Overall Study|Started other medicine|1|||
42259275|NCT01123707|76085584|FG002|Overall Study|Subject Withdrew Consent|1|||
42259276|NCT01123707|76085585|FG003|Overall Study|Subject Withdrew Consent|2|||
42259277|NCT01123707|76085582|FG000|Overall Study|Lack of Efficacy|1|||
42259278|NCT01123707|76085583|FG001|Overall Study|Lack of Efficacy|2|||
42259279|NCT01123707|76085584|FG002|Overall Study|Lack of Efficacy|1|||
42259280|NCT01123707|76085585|FG003|Overall Study|Lack of Efficacy|0|||
42259281|NCT01123707|76085582|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
42259282|NCT01123707|76085583|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
42259283|NCT01123707|76085584|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
42259284|NCT01123707|76085585|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
42259285|NCT02755103|76085597|FG000|Overall Study|Lost to Follow-up|17|||
42259286|NCT02755103|76085598|FG001|Overall Study|Lost to Follow-up|15|||
42322407|NCT01629667|76159662|FG000|Overall Study|Site error in safety follow-up|0|||
42322408|NCT01629667|76159663|FG001|Overall Study|Site error in safety follow-up|0|||
42322409|NCT01629667|76159664|FG002|Overall Study|Site error in safety follow-up|1|||
42322410|NCT01629667|76159662|FG000|Overall Study|Enrolled in another clinical study|0|||
42322411|NCT01629667|76159663|FG001|Overall Study|Enrolled in another clinical study|1|||
42322412|NCT01629667|76159664|FG002|Overall Study|Enrolled in another clinical study|0|||
42322413|NCT01629667|76159662|FG000|Overall Study|Code break|1|||
42322414|NCT01629667|76159663|FG001|Overall Study|Code break|0|||
42322415|NCT01629667|76159664|FG002|Overall Study|Code break|0|||
42322416|NCT01645280|76159679|FG000|Overall Study|Death|0|||
42322417|NCT01645280|76159680|FG001|Overall Study|Death|1|||
42322418|NCT01645280|76159681|FG002|Overall Study|Death|0|||
42322419|NCT01645280|76159682|FG003|Overall Study|Death|0|||
42322420|NCT01645280|76159683|FG004|Overall Study|Death|0|||
42322421|NCT01645280|76159679|FG000|Overall Study|Withdrawal by Subject|4|||
42322422|NCT01645280|76159680|FG001|Overall Study|Withdrawal by Subject|0|||
42322423|NCT01645280|76159681|FG002|Overall Study|Withdrawal by Subject|2|||
42322424|NCT01645280|76159682|FG003|Overall Study|Withdrawal by Subject|4|||
42322425|NCT01645280|76159683|FG004|Overall Study|Withdrawal by Subject|5|||
42322426|NCT01645280|76159679|FG000|Overall Study|Lost to Follow-up|0|||
42322427|NCT01645280|76159680|FG001|Overall Study|Lost to Follow-up|0|||
42322428|NCT01645280|76159681|FG002|Overall Study|Lost to Follow-up|0|||
42322429|NCT01645280|76159682|FG003|Overall Study|Lost to Follow-up|2|||
42322430|NCT01645280|76159683|FG004|Overall Study|Lost to Follow-up|1|||
42322431|NCT01645280|76159679|FG000|Overall Study|Other|1|||
42322432|NCT01645280|76159680|FG001|Overall Study|Other|1|||
42322433|NCT01645280|76159681|FG002|Overall Study|Other|2|||
42322434|NCT01645280|76159682|FG003|Overall Study|Other|0|||
42322435|NCT01645280|76159683|FG004|Overall Study|Other|0|||
42322436|NCT01645280|76159679|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
42322437|NCT01645280|76159680|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
42322438|NCT01645280|76159681|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
42322439|NCT01645280|76159682|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
42322440|NCT01645280|76159683|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
42322441|NCT02256917|76159696|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
42322442|NCT02256917|76159696|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
42322443|NCT02256917|76159696|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
42322444|NCT02256917|76159696|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
42322445|NCT02256917|76159696|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
42322446|NCT01629589|76159709|FG000|Overall Study|Protocol Violation|4|||
42322447|NCT01629589|76159710|FG001|Overall Study|Protocol Violation|2|||
42322448|NCT01629589|76159709|FG000|Overall Study|Lost to Follow-up|2|||
42322449|NCT01629589|76159710|FG001|Overall Study|Lost to Follow-up|1|||
42322450|NCT01629589|76159709|FG000|Overall Study|Withdrawal by Subject|2|||
42322451|NCT01629589|76159710|FG001|Overall Study|Withdrawal by Subject|3|||
42322452|NCT01629589|76159709|FG000|Overall Study|Did not receive study vaccine|0|||
42322453|NCT01629589|76159710|FG001|Overall Study|Did not receive study vaccine|1|||
42322454|NCT02256839|76159718|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
42322455|NCT02256839|76159719|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
42322456|NCT02220907|76159725|FG000|Overall Study|Adverse Event|7|||
42322457|NCT02220907|76159725|FG000|Overall Study|Physician Decision|1|||
42322458|NCT02220907|76159725|FG000|Overall Study|Withdrawal by Subject|2|||
42322459|NCT02220907|76159725|FG000|Overall Study|Conflict with the stopping criteria|1|||
42322460|NCT02255981|76159729|FG000|Overall Study|Lost to Follow-up|3|||
42322461|NCT02255981|76159729|FG000|Overall Study|Withdrawal by Subject|1|||
42259287|NCT02755103|76085597|FG000|Overall Study|Death|0|||
42259288|NCT02755103|76085598|FG001|Overall Study|Death|1|||
42259289|NCT02755103|76085597|FG000|Overall Study|Physician Decision|0|||
42259290|NCT02755103|76085598|FG001|Overall Study|Physician Decision|1|||
42259291|NCT02755103|76085597|FG000|Overall Study|Pregnancy|0|||
42259292|NCT02755103|76085598|FG001|Overall Study|Pregnancy|1|||
42259293|NCT02755103|76085597|FG000|Overall Study|Withdrawal by Subject|3|||
42259294|NCT02755103|76085598|FG001|Overall Study|Withdrawal by Subject|0|||
42259295|NCT01258803|76085608|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
42259296|NCT01258803|76085609|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
42259297|NCT01258803|76085610|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
42259298|NCT01258803|76085611|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
42259299|NCT01258803|76085612|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
42259300|NCT01258803|76085613|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
42322462|NCT01601873|76159741|FG000|Overall Study|Lost to Follow-up|2|||
42322463|NCT01601873|76159742|FG001|Overall Study|Lost to Follow-up|3|||
42322464|NCT02194933|76159750|FG000|Overall Study|Lost to Follow-up|1|||
42322465|NCT02194933|76159751|FG001|Overall Study|Lost to Follow-up|2|||
42322466|NCT02194933|76159750|FG000|Overall Study|Participant met withdrawal criteria|1|||
42322467|NCT02194933|76159751|FG001|Overall Study|Participant met withdrawal criteria|3|||
42322468|NCT02194933|76159750|FG000|Overall Study|Withdrawal by Subject|0|||
42322469|NCT02194933|76159751|FG001|Overall Study|Withdrawal by Subject|2|||
42322470|NCT02194933|76159750|FG000|Overall Study|Lack of Efficacy|1|||
42322471|NCT02194933|76159751|FG001|Overall Study|Lack of Efficacy|2|||
42322472|NCT01644890|76159761|FG000|Overall Study|Adverse Event|7|||
42322473|NCT01644890|76159762|FG001|Overall Study|Adverse Event|20|||
42322474|NCT01644890|76159761|FG000|Overall Study|Death|1|||
42322475|NCT01644890|76159762|FG001|Overall Study|Death|3|||
42322476|NCT01644890|76159761|FG000|Overall Study|Physician Decision|3|||
42322477|NCT01644890|76159762|FG001|Overall Study|Physician Decision|9|||
42322478|NCT01644890|76159761|FG000|Overall Study|Protocol Violation|6|||
42133482|NCT00485732|75944396|FG001|Overall Study|Withdrawal by Subject|4|||
42133483|NCT00485732|75944395|FG000|Overall Study|Lost to Follow-up|2|||
42133484|NCT00485732|75944396|FG001|Overall Study|Lost to Follow-up|2|||
42133485|NCT00489554|75944402|FG000|Overall Study|Adverse Event|2|||
42133486|NCT00489554|75944402|FG000|Overall Study|Withdrawal by Subject|1|||
42133487|NCT00489554|75944402|FG000|Overall Study|Lost to Follow-up|1|||
42133488|NCT00408681|75944406|FG000|Overall Study|Lack of Efficacy|2|||
42133489|NCT00408681|75944406|FG000|Overall Study|Adverse Event|7|||
42133490|NCT00560417|75944413|FG000|Overall Study|Adverse Event|3|||
42133491|NCT00560417|75944414|FG001|Overall Study|Adverse Event|2|||
42133492|NCT00560417|75944413|FG000|Overall Study|Entry Criteria Not Met|1|||
42133493|NCT00560417|75944414|FG001|Overall Study|Entry Criteria Not Met|0|||
42133494|NCT00560417|75944413|FG000|Overall Study|Lost to Follow-up|0|||
42133495|NCT00560417|75944414|FG001|Overall Study|Lost to Follow-up|1|||
42133496|NCT00560417|75944413|FG000|Overall Study|Physician Decision|2|||
42133497|NCT00560417|75944414|FG001|Overall Study|Physician Decision|6|||
42133498|NCT00560417|75944413|FG000|Overall Study|Protocol Violation|6|||
42133499|NCT00560417|75944414|FG001|Overall Study|Protocol Violation|5|||
42133500|NCT00560417|75944413|FG000|Overall Study|Sponsor Decision|2|||
42133501|NCT00560417|75944414|FG001|Overall Study|Sponsor Decision|0|||
42133502|NCT00560417|75944413|FG000|Overall Study|Withdrawal by Subject|3|||
42133503|NCT00560417|75944414|FG001|Overall Study|Withdrawal by Subject|3|||
42133504|NCT03968159|75944427|FG000|Overall Study|Adverse Event|4|||
42133505|NCT03968159|75944428|FG001|Overall Study|Adverse Event|4|||
42133506|NCT03968159|75944427|FG000|Overall Study|Lost to Follow-up|1|||
42133507|NCT03968159|75944428|FG001|Overall Study|Lost to Follow-up|1|||
42133508|NCT03968159|75944427|FG000|Overall Study|Use of prohibited medication|0|||
42133509|NCT03968159|75944428|FG001|Overall Study|Use of prohibited medication|1|||
42133510|NCT03968159|75944427|FG000|Overall Study|Protocol Violation|2|||
42133511|NCT03968159|75944428|FG001|Overall Study|Protocol Violation|2|||
42133512|NCT03968159|75944427|FG000|Overall Study|Withdrawal by Subject|4|||
42259301|NCT01258803|76085608|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
42259302|NCT01258803|76085609|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
42259303|NCT01258803|76085610|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
42259304|NCT01258803|76085611|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
42259305|NCT01258803|76085612|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
42259306|NCT01258803|76085613|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
42259307|NCT01258803|76085608|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
42259308|NCT01258803|76085609|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
42259309|NCT01258803|76085610|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
42259310|NCT01258803|76085611|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
42259311|NCT01258803|76085612|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
42259312|NCT01258803|76085613|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
42259313|NCT02865083|76085629|FG000|Overall Study|Early Termination|3|||
42322479|NCT01644890|76159762|FG001|Overall Study|Protocol Violation|7|||
42259314|NCT02865083|76085630|FG001|Overall Study|Early Termination|1|||
42322480|NCT01644890|76159761|FG000|Overall Study|Withdrawal by Subject|19|||
42133513|NCT03968159|75944428|FG001|Overall Study|Withdrawal by Subject|6|||
42133514|NCT03968159|75944427|FG000|Overall Study|Lack of Efficacy|0|||
42133515|NCT03968159|75944428|FG001|Overall Study|Lack of Efficacy|1|||
42133516|NCT03968159|75944427|FG000|Overall Study|Not further specified|2|||
42133517|NCT03968159|75944428|FG001|Overall Study|Not further specified|0|||
42133518|NCT03966911|75944436|FG000|Overall Study|Adverse Event|1|||
42133519|NCT03966911|75944437|FG001|Overall Study|Adverse Event|1|||
42133520|NCT03966911|75944436|FG000|Overall Study|Withdrawal by Subject|8|||
42133521|NCT03966911|75944437|FG001|Overall Study|Withdrawal by Subject|2|||
42133522|NCT03966911|75944436|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
42133523|NCT03966911|75944437|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
42133524|NCT03966365|75944447|FG000|Overall Study|Protocol Violation|1|||
42133525|NCT03966365|75944448|FG001|Overall Study|Protocol Violation|0|||
42133526|NCT00375219|75944457|FG000|Overall Study|Failure to achieve a response|16|||
42133527|NCT00375219|75944458|FG001|Overall Study|Failure to achieve a response|2|||
42133528|NCT00375219|75944459|FG002|Overall Study|Failure to achieve a response|0|||
42133529|NCT00375219|75944457|FG000|Overall Study|Adverse Event|8|||
42133530|NCT00375219|75944458|FG001|Overall Study|Adverse Event|2|||
42133531|NCT00375219|75944459|FG002|Overall Study|Adverse Event|1|||
42133532|NCT00375219|75944457|FG000|Overall Study|Protocol Violation|1|||
42133533|NCT00375219|75944458|FG001|Overall Study|Protocol Violation|0|||
42133534|NCT00375219|75944459|FG002|Overall Study|Protocol Violation|1|||
42259315|NCT00862251|76085639|FG000|Overall Study|Adverse Event|8|||
42259316|NCT00862251|76085640|FG001|Overall Study|Adverse Event|3|||
42259317|NCT00862251|76085641|FG002|Overall Study|Adverse Event|1|||
42259318|NCT00862251|76085639|FG000|Overall Study|Lost to Follow-up|0|||
41994595|NCT01082367|75802848|FG000|Follow-up (F-U) Period|Adverse Event|0|||
41994596|NCT01082367|75802849|FG001|Follow-up (F-U) Period|Adverse Event|1|||
41994597|NCT01082211|75802859|FG000|Overall Study|Protocol Violation|4|||
41994598|NCT01082211|75802859|FG000|Overall Study|No protocol treatment received|3|||
41994599|NCT01081665|75802866|FG000|Overall Study|Death|41|||
41994600|NCT01081665|75802866|FG000|Overall Study|Lost to Follow-up|18|||
41994601|NCT01081665|75802866|FG000|Overall Study|Withdrawal by Subject|17|||
41994602|NCT01081665|75802866|FG000|Overall Study|Change of dialysis unit|10|||
41994603|NCT01081665|75802866|FG000|Overall Study|Regulation of iPTH|5|||
41994604|NCT01081665|75802866|FG000|Overall Study|Change in renal replacement therapy|2|||
41994605|NCT01081665|75802866|FG000|Overall Study|Adverse Event|1|||
41994606|NCT01081665|75802866|FG000|Overall Study|Lack of Efficacy|1|||
41994607|NCT01081626|75802872|FG000|Overall Study|Dosing error|1|||
41994608|NCT01081626|75802873|FG001|Overall Study|Dosing error|1|||
41994609|NCT01081626|75802872|FG000|Overall Study|Missing Estradiol|25|||
41994610|NCT01081626|75802873|FG001|Overall Study|Missing Estradiol|28|||
41994611|NCT01081626|75802872|FG000|Overall Study|Low antral follicle count|1|||
41994612|NCT01081626|75802873|FG001|Overall Study|Low antral follicle count|0|||
41994613|NCT01081626|75802872|FG000|Overall Study|Overstimulation|0|||
41994614|NCT01081626|75802873|FG001|Overall Study|Overstimulation|1|||
41994615|NCT01081626|75802872|FG000|Overall Study|Lost to Follow-up|0|||
41994616|NCT01081626|75802873|FG001|Overall Study|Lost to Follow-up|1|||
41994617|NCT01081626|75802872|FG000|Overall Study|Other|33|||
41994618|NCT01081626|75802873|FG001|Overall Study|Other|30|||
41994619|NCT01080768|75802881|FG000|Overall Study|Protocol Deviation|2|||
41994620|NCT01080768|75802882|FG001|Overall Study|Protocol Deviation|1|||
41994621|NCT01080300|75802890|FG000|Overall Study|Adverse Event|49|||
41994622|NCT01080300|75802891|FG001|Overall Study|Adverse Event|35|||
41994623|NCT01080300|75802890|FG000|Overall Study|Lack of Efficacy|12|||
41994624|NCT01080300|75802891|FG001|Overall Study|Lack of Efficacy|15|||
41994625|NCT01080300|75802890|FG000|Overall Study|Protocol Violation|7|||
41994626|NCT01080300|75802891|FG001|Overall Study|Protocol Violation|13|||
41994627|NCT01080300|75802890|FG000|Overall Study|Lost to Follow-up|10|||
41994628|NCT01080300|75802891|FG001|Overall Study|Lost to Follow-up|6|||
41994629|NCT01080300|75802890|FG000|Overall Study|Death|0|||
42259319|NCT00862251|76085640|FG001|Overall Study|Lost to Follow-up|0|||
42259320|NCT00862251|76085641|FG002|Overall Study|Lost to Follow-up|1|||
42133535|NCT00375219|75944457|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
42133536|NCT00375219|75944458|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
42259321|NCT00862251|76085639|FG000|Overall Study|Protocol Violation|2|||
42322481|NCT01644890|76159762|FG001|Overall Study|Withdrawal by Subject|27|||
41994630|NCT01080300|75802891|FG001|Overall Study|Death|1|||
41994631|NCT01080300|75802890|FG000|Overall Study|Withdrawal by Subject|12|||
41994632|NCT01080300|75802891|FG001|Overall Study|Withdrawal by Subject|28|||
41994633|NCT01080300|75802890|FG000|Overall Study|Reasons not specified|4|||
41994634|NCT01080300|75802891|FG001|Overall Study|Reasons not specified|6|||
41994635|NCT01085097|75802902|FG000|Overall Study|Adverse Event|0|||
41994636|NCT01085097|75802903|FG001|Overall Study|Adverse Event|0|||
42133537|NCT00375219|75944459|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
42133538|NCT00375219|75944457|FG000|Overall Study|Lost to Follow-up|1|||
41994637|NCT01085097|75802904|FG002|Overall Study|Adverse Event|2|||
41994638|NCT01085097|75802902|FG000|Overall Study|Treatment failure|2|||
41994639|NCT01085097|75802903|FG001|Overall Study|Treatment failure|0|||
41994640|NCT01085097|75802904|FG002|Overall Study|Treatment failure|0|||
41994641|NCT03450629|75802918|FG000|Overall Study|Adverse Event|15|||
41994642|NCT03450629|75802919|FG001|Overall Study|Adverse Event|14|||
42322482|NCT01644890|76159761|FG000|Overall Study|Progression Disease|160|||
42322483|NCT01644890|76159762|FG001|Overall Study|Progression Disease|131|||
42322484|NCT01644890|76159761|FG000|Overall Study|Clinical Progression|6|||
42322485|NCT01644890|76159762|FG001|Overall Study|Clinical Progression|6|||
42322486|NCT01644890|76159761|FG000|Overall Study|> 28 days since last dose of study drug|6|||
42322487|NCT01644890|76159762|FG001|Overall Study|> 28 days since last dose of study drug|3|||
42322488|NCT01644890|76159761|FG000|Overall Study|Other|8|||
42322489|NCT01644890|76159762|FG001|Overall Study|Other|9|||
42322490|NCT01628965|76159768|FG000|Overall Study|Adverse Event|30|||
42322491|NCT01628965|76159768|FG000|Overall Study|Lack of Efficacy|7|||
42322492|NCT01628965|76159768|FG000|Overall Study|Withdrawal by Subject|3|||
42322493|NCT01628965|76159768|FG000|Overall Study|Lost to Follow-up|1|||
42322494|NCT01628965|76159768|FG000|Overall Study|Discontinuation criteria|8|||
42322495|NCT01644734|76159772|FG000|Overall Study|Adverse Event|4|||
42322496|NCT01644734|76159772|FG000|Overall Study|Lost to Follow-up|17|||
42322497|NCT01644734|76159772|FG000|Overall Study|Reasons other than stated above|7|||
42322498|NCT01644734|76159772|FG000|Overall Study|Missing documentation|238|||
41994643|NCT03450629|75802918|FG000|Overall Study|Physician Decision|2|||
42322499|NCT02255279|76159778|FG000|Overall Study|Lost to Follow-up|2|||
41994644|NCT03450629|75802919|FG001|Overall Study|Physician Decision|2|||
42322500|NCT02255279|76159779|FG001|Overall Study|Lost to Follow-up|2|||
42322501|NCT02255279|76159778|FG000|Overall Study|Protocol Violation|0|||
42322502|NCT02255279|76159779|FG001|Overall Study|Protocol Violation|1|||
42322503|NCT02255279|76159778|FG000|Overall Study|Withdrawal by Subject|3|||
42322504|NCT02255279|76159779|FG001|Overall Study|Withdrawal by Subject|6|||
42322505|NCT01643798|76159799|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
42322506|NCT01643798|76159800|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
42322507|NCT02194699|76159813|FG000|Randomised|Did not receive treatment|1|||
42322508|NCT02194699|76159814|FG001|Randomised|Did not receive treatment|5|||
42322509|NCT02194699|76159813|FG000|Randomised|Without potential for 52 weeks of IP|5|||
42322510|NCT02194699|76159814|FG001|Randomised|Without potential for 52 weeks of IP|5|||
42322511|NCT02194699|76159813|FG000|Randomised|Duplicate patient|2|||
42322512|NCT02194699|76159814|FG001|Randomised|Duplicate patient|1|||
42322513|NCT02194699|76159813|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
42322514|NCT02194699|76159814|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
42322515|NCT02194699|76159813|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
42322516|NCT02194699|76159814|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
42322517|NCT02194699|76159813|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
42322518|NCT02194699|76159814|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
42322519|NCT02194699|76159813|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
42322520|NCT02194699|76159814|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
42322521|NCT02194699|76159813|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
42322522|NCT02194699|76159814|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
42322523|NCT02194699|76159813|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
42322524|NCT02194699|76159814|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
42322525|NCT02293538|76159830|FG000|Overall Study|Adverse Event|0|||
41994645|NCT03450629|75802918|FG000|Overall Study|Lack of Efficacy|2|||
41994646|NCT03450629|75802919|FG001|Overall Study|Lack of Efficacy|0|||
41994647|NCT03450629|75802918|FG000|Overall Study|Lost to Follow-up|4|||
41994648|NCT03450629|75802919|FG001|Overall Study|Lost to Follow-up|2|||
41994649|NCT03450629|75802918|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
41994650|NCT03450629|75802919|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
41994651|NCT03450629|75802918|FG000|Overall Study|Non-Compliance With Study Drug|2|||
41994652|NCT03450629|75802919|FG001|Overall Study|Non-Compliance With Study Drug|1|||
41994653|NCT03450629|75802918|FG000|Overall Study|Protocol Violation|11|||
41994654|NCT03450629|75802919|FG001|Overall Study|Protocol Violation|8|||
41994655|NCT03450629|75802918|FG000|Overall Study|Withdrawal by Subject|12|||
41994656|NCT03450629|75802919|FG001|Overall Study|Withdrawal by Subject|6|||
41994657|NCT00198029|75802925|FG000|Overall Study|Withdrawal by Subject|4|||
41994658|NCT00197054|75802932|FG000|Overall Study|Withdrawal by Subject|9|||
41994659|NCT00197054|75802933|FG001|Overall Study|Withdrawal by Subject|3|||
41994660|NCT00197054|75802934|FG002|Overall Study|Withdrawal by Subject|3|||
41994661|NCT00197054|75802932|FG000|Overall Study|Moved from area|7|||
41994662|NCT00197054|75802933|FG001|Overall Study|Moved from area|14|||
41994663|NCT00197054|75802934|FG002|Overall Study|Moved from area|9|||
41994664|NCT00197054|75802932|FG000|Overall Study|Lost to Follow-up|1|||
41994665|NCT00197054|75802933|FG001|Overall Study|Lost to Follow-up|4|||
41994666|NCT00197054|75802934|FG002|Overall Study|Lost to Follow-up|0|||
41994667|NCT00197015|75802955|FG000|Overall Study|Adverse Event|3|||
41994668|NCT00197015|75802956|FG001|Overall Study|Adverse Event|0|||
41994669|NCT00197015|75802957|FG002|Overall Study|Adverse Event|1|||
41994670|NCT00197015|75802955|FG000|Overall Study|Protocol Violation|0|||
42322526|NCT02293538|76159831|FG001|Overall Study|Adverse Event|1|||
42322527|NCT02293538|76159830|FG000|Overall Study|Lost to Follow-up|1|||
42322528|NCT02293538|76159831|FG001|Overall Study|Lost to Follow-up|0|||
42322529|NCT02293538|76159830|FG000|Overall Study|Withdrawal by Subject|0|||
42322530|NCT02293538|76159831|FG001|Overall Study|Withdrawal by Subject|1|||
42322531|NCT02194621|76159841|FG000|Overall Study|6 withdrew prior to randomization|2|||
42322532|NCT02194621|76159842|FG001|Overall Study|6 withdrew prior to randomization|2|||
42322533|NCT02194621|76159843|FG002|Overall Study|6 withdrew prior to randomization|2|||
42322534|NCT02194621|76159841|FG000|Overall Study|Withdrawal by Subject|4|||
42322535|NCT02194621|76159842|FG001|Overall Study|Withdrawal by Subject|4|||
42322536|NCT02194621|76159843|FG002|Overall Study|Withdrawal by Subject|7|||
41994671|NCT00197015|75802956|FG001|Overall Study|Protocol Violation|3|||
41994672|NCT00197015|75802957|FG002|Overall Study|Protocol Violation|3|||
41994673|NCT00197015|75802955|FG000|Overall Study|Withdrawal by Subject|17|||
41994674|NCT00197015|75802956|FG001|Overall Study|Withdrawal by Subject|37|||
41994675|NCT00197015|75802957|FG002|Overall Study|Withdrawal by Subject|34|||
41994676|NCT00197015|75802955|FG000|Overall Study|Lost to Follow-up|28|||
41994677|NCT00197015|75802956|FG001|Overall Study|Lost to Follow-up|46|||
41994678|NCT00197015|75802957|FG002|Overall Study|Lost to Follow-up|37|||
41994679|NCT00197015|75802955|FG000|Overall Study|Other|2|||
41994680|NCT00197015|75802956|FG001|Overall Study|Other|3|||
41994681|NCT00197015|75802957|FG002|Overall Study|Other|2|||
42322537|NCT02220205|76159853|FG000|Overall Study|Withdrawal by Subject|1|||
42322538|NCT02220205|76159854|FG001|Overall Study|Withdrawal by Subject|0|||
42322539|NCT02266706|76159869|FG000|Overall Study|Withdrawal by Subject|0|||
42322540|NCT02266706|76159870|FG001|Overall Study|Withdrawal by Subject|1|||
42322541|NCT02266706|76159871|FG002|Overall Study|Withdrawal by Subject|1|||
42322542|NCT02266706|76159872|FG003|Overall Study|Withdrawal by Subject|0|||
42322543|NCT02266706|76159873|FG004|Overall Study|Withdrawal by Subject|0|||
42322544|NCT02266706|76159874|FG005|Overall Study|Withdrawal by Subject|1|||
42322545|NCT02266706|76159875|FG006|Overall Study|Withdrawal by Subject|0|||
42322546|NCT02266706|76159876|FG007|Overall Study|Withdrawal by Subject|0|||
42322547|NCT02266706|76159877|FG008|Overall Study|Withdrawal by Subject|0|||
42322548|NCT02266706|76159869|FG000|Overall Study|Screen failure|0|||
42322549|NCT02266706|76159870|FG001|Overall Study|Screen failure|0|||
42322550|NCT02266706|76159871|FG002|Overall Study|Screen failure|0|||
42322551|NCT02266706|76159872|FG003|Overall Study|Screen failure|0|||
42322552|NCT02266706|76159873|FG004|Overall Study|Screen failure|0|||
42322553|NCT02266706|76159874|FG005|Overall Study|Screen failure|1|||
42322554|NCT02266706|76159875|FG006|Overall Study|Screen failure|1|||
42322555|NCT02266706|76159876|FG007|Overall Study|Screen failure|0|||
42322556|NCT02266706|76159877|FG008|Overall Study|Screen failure|0|||
42322557|NCT02266706|76159869|FG000|Overall Study|Enrollment in another study|0|||
42322558|NCT02266706|76159870|FG001|Overall Study|Enrollment in another study|0|||
42322559|NCT02266706|76159871|FG002|Overall Study|Enrollment in another study|0|||
41994682|NCT00196976|75802979|FG000|Primary Study|Migrated from study area|0|||
41994683|NCT00196976|75802980|FG001|Primary Study|Migrated from study area|0|||
41994684|NCT00196976|75802981|FG002|Primary Study|Migrated from study area|0|||
41994685|NCT00196976|75802982|FG003|Primary Study|Migrated from study area|0|||
41994686|NCT00196976|75802983|FG004|Primary Study|Migrated from study area|0|||
41994687|NCT00196976|75802984|FG005|Primary Study|Migrated from study area|0|||
41994688|NCT00196976|75802985|FG006|Primary Study|Migrated from study area|0|||
41994689|NCT00196976|75802986|FG007|Primary Study|Migrated from study area|1|||
41994690|NCT00196976|75802987|FG008|Primary Study|Migrated from study area|0|||
41994691|NCT00196976|75802988|FG009|Primary Study|Migrated from study area|0|||
41994692|NCT00196976|75802989|FG010|Primary Study|Migrated from study area|0|||
41994693|NCT00196976|75802990|FG011|Primary Study|Migrated from study area|0|||
41994694|NCT00196976|75802991|FG012|Primary Study|Migrated from study area|0|||
41994695|NCT00196976|75802992|FG013|Primary Study|Migrated from study area|0|||
42322560|NCT02266706|76159872|FG003|Overall Study|Enrollment in another study|1|||
42322561|NCT02266706|76159873|FG004|Overall Study|Enrollment in another study|0|||
42322562|NCT02266706|76159874|FG005|Overall Study|Enrollment in another study|0|||
42322563|NCT02266706|76159875|FG006|Overall Study|Enrollment in another study|0|||
42322564|NCT02266706|76159876|FG007|Overall Study|Enrollment in another study|0|||
42322565|NCT02266706|76159877|FG008|Overall Study|Enrollment in another study|0|||
42322566|NCT02293460|76159897|FG000|Overall Study|Protocol Violation|1|||
42322567|NCT02293460|76159897|FG000|Overall Study|Lack of Efficacy|2|||
42322568|NCT02293460|76159897|FG000|Overall Study|Adverse Event|2|||
41994696|NCT00196976|75802979|FG000|Primary Study|Protocol Violation|0|||
41994697|NCT00196976|75802980|FG001|Primary Study|Protocol Violation|1|||
42322569|NCT02293460|76159897|FG000|Overall Study|Withdrawal by Subject|1|||
41994698|NCT00196976|75802981|FG002|Primary Study|Protocol Violation|1|||
41994699|NCT00196976|75802982|FG003|Primary Study|Protocol Violation|0|||
41994700|NCT00196976|75802983|FG004|Primary Study|Protocol Violation|0|||
42322570|NCT02266004|76159901|FG000|Overall Study|unrelated adverse event|1|||
42322571|NCT02266004|76159901|FG000|Overall Study|Physician Decision|1|||
42322572|NCT02292719|76159911|FG000|Overall Study|Withdrawal by Subject|0|||
41994701|NCT00196976|75802984|FG005|Primary Study|Protocol Violation|0|||
41994702|NCT00196976|75802985|FG006|Primary Study|Protocol Violation|0|||
41994703|NCT00196976|75802986|FG007|Primary Study|Protocol Violation|0|||
41994704|NCT00196976|75802987|FG008|Primary Study|Protocol Violation|0|||
41994705|NCT00196976|75802988|FG009|Primary Study|Protocol Violation|0|||
41994706|NCT00196976|75802989|FG010|Primary Study|Protocol Violation|0|||
41994707|NCT00196976|75802990|FG011|Primary Study|Protocol Violation|0|||
41994708|NCT00196976|75802991|FG012|Primary Study|Protocol Violation|0|||
41994709|NCT00196976|75802992|FG013|Primary Study|Protocol Violation|0|||
41994710|NCT00196976|75802979|FG000|Primary Study|Withdrawal by Subject|1|||
41994711|NCT00196976|75802980|FG001|Primary Study|Withdrawal by Subject|0|||
41994712|NCT00196976|75802981|FG002|Primary Study|Withdrawal by Subject|1|||
42322573|NCT02292719|76159912|FG001|Overall Study|Withdrawal by Subject|0|||
42322574|NCT02292719|76159913|FG002|Overall Study|Withdrawal by Subject|0|||
42322575|NCT02292719|76159914|FG003|Overall Study|Withdrawal by Subject|1|||
41994713|NCT00196976|75802982|FG003|Primary Study|Withdrawal by Subject|1|||
42322576|NCT02292719|76159915|FG004|Overall Study|Withdrawal by Subject|1|||
42322577|NCT02292719|76159916|FG005|Overall Study|Withdrawal by Subject|0|||
42322578|NCT02292719|76159911|FG000|Overall Study|Subject enrolled in new study.|0|||
42322579|NCT02292719|76159912|FG001|Overall Study|Subject enrolled in new study.|0|||
42322580|NCT02292719|76159913|FG002|Overall Study|Subject enrolled in new study.|1|||
42322581|NCT02292719|76159914|FG003|Overall Study|Subject enrolled in new study.|0|||
41994714|NCT00196976|75802983|FG004|Primary Study|Withdrawal by Subject|2|||
41994715|NCT00196976|75802984|FG005|Primary Study|Withdrawal by Subject|1|||
41994716|NCT00196976|75802985|FG006|Primary Study|Withdrawal by Subject|0|||
41994717|NCT00196976|75802986|FG007|Primary Study|Withdrawal by Subject|0|||
41994718|NCT00196976|75802987|FG008|Primary Study|Withdrawal by Subject|0|||
41994719|NCT00196976|75802988|FG009|Primary Study|Withdrawal by Subject|1|||
41994720|NCT00196976|75802989|FG010|Primary Study|Withdrawal by Subject|0|||
41994721|NCT00196976|75802990|FG011|Primary Study|Withdrawal by Subject|0|||
41994722|NCT00196976|75802991|FG012|Primary Study|Withdrawal by Subject|0|||
41994723|NCT00196976|75802992|FG013|Primary Study|Withdrawal by Subject|0|||
41994724|NCT00196976|75802979|FG000|Primary Study|Lost to Follow-up|0|||
41994725|NCT00196976|75802980|FG001|Primary Study|Lost to Follow-up|0|||
41994726|NCT00196976|75802981|FG002|Primary Study|Lost to Follow-up|0|||
41994727|NCT00196976|75802982|FG003|Primary Study|Lost to Follow-up|0|||
41994728|NCT00196976|75802983|FG004|Primary Study|Lost to Follow-up|1|||
41994729|NCT00196976|75802984|FG005|Primary Study|Lost to Follow-up|1|||
41994730|NCT00196976|75802985|FG006|Primary Study|Lost to Follow-up|0|||
41994731|NCT00196976|75802986|FG007|Primary Study|Lost to Follow-up|2|||
41994732|NCT00196976|75802987|FG008|Primary Study|Lost to Follow-up|0|||
41994733|NCT00196976|75802988|FG009|Primary Study|Lost to Follow-up|0|||
41994734|NCT00196976|75802989|FG010|Primary Study|Lost to Follow-up|0|||
41994735|NCT00196976|75802990|FG011|Primary Study|Lost to Follow-up|0|||
41994736|NCT00196976|75802991|FG012|Primary Study|Lost to Follow-up|0|||
41994737|NCT00196976|75802992|FG013|Primary Study|Lost to Follow-up|0|||
41994738|NCT00196976|75802979|FG000|Primary Study|Other|0|||
41994739|NCT00196976|75802980|FG001|Primary Study|Other|0|||
41994740|NCT00196976|75802981|FG002|Primary Study|Other|2|||
41994741|NCT00196976|75802982|FG003|Primary Study|Other|0|||
41994742|NCT00196976|75802983|FG004|Primary Study|Other|0|||
41994743|NCT00196976|75802984|FG005|Primary Study|Other|0|||
42322582|NCT02292719|76159915|FG004|Overall Study|Subject enrolled in new study.|0|||
42322583|NCT02292719|76159916|FG005|Overall Study|Subject enrolled in new study.|0|||
42322584|NCT02291861|76159934|FG000|Overall Study|Adverse Event|2|||
42322585|NCT02291861|76159935|FG001|Overall Study|Adverse Event|4|||
42322586|NCT02291861|76159936|FG002|Overall Study|Adverse Event|1|||
42322587|NCT02291861|76159937|FG003|Overall Study|Adverse Event|2|||
42322588|NCT02291861|76159934|FG000|Overall Study|Death|0|||
41994744|NCT00196976|75802985|FG006|Primary Study|Other|0|||
41994745|NCT00196976|75802986|FG007|Primary Study|Other|0|||
41994746|NCT00196976|75802987|FG008|Primary Study|Other|0|||
41994747|NCT00196976|75802988|FG009|Primary Study|Other|0|||
41994748|NCT00196976|75802989|FG010|Primary Study|Other|0|||
41994749|NCT00196976|75802990|FG011|Primary Study|Other|0|||
41994750|NCT00196976|75802991|FG012|Primary Study|Other|0|||
41994751|NCT00196976|75802992|FG013|Primary Study|Other|0|||
41994752|NCT00196976|75802979|FG000|Booster Study|Withdrawal by Subject|0|||
42322589|NCT02291861|76159935|FG001|Overall Study|Death|0|||
42322590|NCT02291861|76159936|FG002|Overall Study|Death|1|||
42322591|NCT02291861|76159937|FG003|Overall Study|Death|1|||
42322592|NCT02291861|76159934|FG000|Overall Study|Protocol Violation|1|||
41994753|NCT00196976|75802980|FG001|Booster Study|Withdrawal by Subject|0|||
41994754|NCT00196976|75802981|FG002|Booster Study|Withdrawal by Subject|0|||
42322593|NCT02291861|76159935|FG001|Overall Study|Protocol Violation|0|||
42322594|NCT02291861|76159936|FG002|Overall Study|Protocol Violation|0|||
42322595|NCT02291861|76159937|FG003|Overall Study|Protocol Violation|1|||
41994755|NCT00196976|75802982|FG003|Booster Study|Withdrawal by Subject|0|||
41994756|NCT00196976|75802983|FG004|Booster Study|Withdrawal by Subject|0|||
41994757|NCT00196976|75802984|FG005|Booster Study|Withdrawal by Subject|0|||
41994758|NCT00196976|75802985|FG006|Booster Study|Withdrawal by Subject|0|||
41994759|NCT00196976|75802986|FG007|Booster Study|Withdrawal by Subject|0|||
41994760|NCT00196976|75802987|FG008|Booster Study|Withdrawal by Subject|0|||
42259322|NCT00862251|76085640|FG001|Overall Study|Protocol Violation|0|||
42259323|NCT00862251|76085641|FG002|Overall Study|Protocol Violation|1|||
42259324|NCT00862251|76085639|FG000|Overall Study|Withdrawal by Subject|9|||
42259325|NCT00862251|76085640|FG001|Overall Study|Withdrawal by Subject|2|||
42259326|NCT00862251|76085641|FG002|Overall Study|Withdrawal by Subject|6|||
42259327|NCT02864381|76085670|FG000|Overall Study|Death|58|||
42259328|NCT02864381|76085671|FG001|Overall Study|Death|61|||
42259329|NCT02864381|76085670|FG000|Overall Study|Withdrew Consent|5|||
42259330|NCT02864381|76085671|FG001|Overall Study|Withdrew Consent|6|||
42259331|NCT02864381|76085670|FG000|Overall Study|Reason Unknown|7|||
42259332|NCT02864381|76085671|FG001|Overall Study|Reason Unknown|3|||
42259333|NCT02864381|76085670|FG000|Overall Study|Lost to Follow-up|1|||
42259334|NCT02864381|76085671|FG001|Overall Study|Lost to Follow-up|1|||
42259335|NCT02864381|76085670|FG000|Overall Study|Investigator's Discretion|1|||
42259336|NCT02864381|76085671|FG001|Overall Study|Investigator's Discretion|0|||
42259337|NCT02864381|76085670|FG000|Overall Study|Protocol Violation|0|||
42259338|NCT02864381|76085671|FG001|Overall Study|Protocol Violation|1|||
42259339|NCT02860169|76085679|FG000|Part A|Withdrawal by Subject|1|||
42259340|NCT02860169|76085679|FG000|Part A|Other (Screening failure)|6|||
42259341|NCT02860169|76085679|FG000|Part A|Other (Survey not completed)|3|||
42259342|NCT02860169|76085679|FG000|Part A|Other (did not completed consent)|1|||
42259343|NCT02860169|76085679|FG000|Part B|Other (Screening failure)|10|||
42259344|NCT02860169|76085679|FG000|Part B|Withdrawal by Subject|1|||
42259345|NCT02860169|76085679|FG000|Part C|Other (Screening failure)|1|||
42259346|NCT00409773|76085690|FG000|Overall Study|Adverse Event|3|||
42259347|NCT00409773|76085691|FG001|Overall Study|Adverse Event|4|||
42259348|NCT00409773|76085692|FG002|Overall Study|Adverse Event|4|||
42259349|NCT00409773|76085693|FG003|Overall Study|Adverse Event|2|||
42259350|NCT00409773|76085694|FG004|Overall Study|Adverse Event|6|||
42259351|NCT00409773|76085690|FG000|Overall Study|Lost to Follow-up|6|||
42259352|NCT00409773|76085691|FG001|Overall Study|Lost to Follow-up|1|||
42259353|NCT00409773|76085692|FG002|Overall Study|Lost to Follow-up|2|||
42259354|NCT00409773|76085693|FG003|Overall Study|Lost to Follow-up|3|||
42259355|NCT00409773|76085694|FG004|Overall Study|Lost to Follow-up|1|||
42259356|NCT00409773|76085690|FG000|Overall Study|Physician Decision|0|||
42259357|NCT00409773|76085691|FG001|Overall Study|Physician Decision|0|||
42259358|NCT00409773|76085692|FG002|Overall Study|Physician Decision|0|||
42259359|NCT00409773|76085693|FG003|Overall Study|Physician Decision|2|||
42259360|NCT00409773|76085694|FG004|Overall Study|Physician Decision|0|||
42259361|NCT00409773|76085690|FG000|Overall Study|Protocol Violation|0|||
42259362|NCT00409773|76085691|FG001|Overall Study|Protocol Violation|2|||
42259363|NCT00409773|76085692|FG002|Overall Study|Protocol Violation|3|||
42259364|NCT00409773|76085693|FG003|Overall Study|Protocol Violation|3|||
42259365|NCT00409773|76085694|FG004|Overall Study|Protocol Violation|1|||
42259366|NCT00409773|76085690|FG000|Overall Study|Withdrawal by Subject|0|||
42259367|NCT00409773|76085691|FG001|Overall Study|Withdrawal by Subject|0|||
42259368|NCT00409773|76085692|FG002|Overall Study|Withdrawal by Subject|0|||
42259369|NCT00409773|76085693|FG003|Overall Study|Withdrawal by Subject|2|||
42259370|NCT00409773|76085694|FG004|Overall Study|Withdrawal by Subject|1|||
42259371|NCT00409773|76085690|FG000|Overall Study|Lack of Eligibility|0|||
42259372|NCT00409773|76085691|FG001|Overall Study|Lack of Eligibility|0|||
42259373|NCT00409773|76085692|FG002|Overall Study|Lack of Eligibility|0|||
42259374|NCT00409773|76085693|FG003|Overall Study|Lack of Eligibility|0|||
42259375|NCT00409773|76085694|FG004|Overall Study|Lack of Eligibility|1|||
42259376|NCT02861807|76085708|FG000|Overall Study|Lost to Follow-up|7|||
42259377|NCT02861807|76085709|FG001|Overall Study|Lost to Follow-up|6|||
42259378|NCT02861807|76085708|FG000|Overall Study|Withdrawal by Subject|5|||
42259379|NCT02861807|76085709|FG001|Overall Study|Withdrawal by Subject|8|||
42259380|NCT02858401|76085722|FG000|Overall Study|Withdrew Consent|0|||
42259381|NCT02858401|76085723|FG001|Overall Study|Withdrew Consent|0|||
42259382|NCT02858401|76085724|FG002|Overall Study|Withdrew Consent|0|||
42259383|NCT02858401|76085725|FG003|Overall Study|Withdrew Consent|0|||
42322596|NCT02291861|76159934|FG000|Overall Study|Withdrawal by Subject|1|||
42322597|NCT02291861|76159935|FG001|Overall Study|Withdrawal by Subject|2|||
42322598|NCT02291861|76159936|FG002|Overall Study|Withdrawal by Subject|1|||
41994761|NCT00196976|75802988|FG009|Booster Study|Withdrawal by Subject|0|||
41994762|NCT00196976|75802989|FG010|Booster Study|Withdrawal by Subject|1|||
41994763|NCT00196976|75802990|FG011|Booster Study|Withdrawal by Subject|0|||
41994764|NCT00196976|75802991|FG012|Booster Study|Withdrawal by Subject|0|||
41994765|NCT00196976|75802992|FG013|Booster Study|Withdrawal by Subject|0|||
41994766|NCT00196976|75802979|FG000|Booster Study|Lost to Follow-up|0|||
41994767|NCT00196976|75802980|FG001|Booster Study|Lost to Follow-up|0|||
41994768|NCT00196976|75802981|FG002|Booster Study|Lost to Follow-up|0|||
41994769|NCT00196976|75802982|FG003|Booster Study|Lost to Follow-up|0|||
42259384|NCT02858401|76085726|FG004|Overall Study|Withdrew Consent|0|||
42259385|NCT02858401|76085727|FG005|Overall Study|Withdrew Consent|1|||
42259386|NCT02858401|76085728|FG006|Overall Study|Withdrew Consent|0|||
42259387|NCT02858401|76085722|FG000|Overall Study|Lost to Follow-up|0|||
42259388|NCT02858401|76085723|FG001|Overall Study|Lost to Follow-up|1|||
42259389|NCT02858401|76085724|FG002|Overall Study|Lost to Follow-up|0|||
42259390|NCT02858401|76085725|FG003|Overall Study|Lost to Follow-up|0|||
42259391|NCT02858401|76085726|FG004|Overall Study|Lost to Follow-up|0|||
42259392|NCT02858401|76085727|FG005|Overall Study|Lost to Follow-up|0|||
42259393|NCT02858401|76085728|FG006|Overall Study|Lost to Follow-up|0|||
42259394|NCT02857283|76085755|FG000|First Exposure|Withdrawal by Subject|1|||
42259395|NCT02857283|76085756|FG001|First Exposure|Withdrawal by Subject|0|||
42259396|NCT02746679|76085774|FG000|Overall Study|Lost to Follow-up|4|||
42259397|NCT02746679|76085775|FG001|Overall Study|Lost to Follow-up|6|||
42259398|NCT02731131|76085783|FG000|Overall Study|Psychiatric Disorder|0|||
42259399|NCT02731131|76085784|FG001|Overall Study|Psychiatric Disorder|1|||
42259400|NCT02731131|76085783|FG000|Overall Study|Refused Therapy|0|||
42259401|NCT02731131|76085784|FG001|Overall Study|Refused Therapy|1|||
42259402|NCT02746705|76085792|FG000|Overall Study|Physician Decision|1|||
42259403|NCT02746705|76085793|FG001|Overall Study|Physician Decision|1|||
42259404|NCT02746705|76085792|FG000|Overall Study|Lost to Follow-up|1|||
42259405|NCT02746705|76085793|FG001|Overall Study|Lost to Follow-up|0|||
42259406|NCT02746705|76085792|FG000|Overall Study|outlier scores deemed not valid|0|||
42259407|NCT02746705|76085793|FG001|Overall Study|outlier scores deemed not valid|1|||
42259408|NCT02746627|76085802|FG000|Overall Study|Withdrawal by Subject|1|||
42259409|NCT02746627|76085803|FG001|Overall Study|Withdrawal by Subject|1|||
42259410|NCT02746627|76085804|FG002|Overall Study|Withdrawal by Subject|1|||
42259411|NCT02856113|76085814|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
42259412|NCT02856113|76085815|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
42133539|NCT00375219|75944458|FG001|Overall Study|Lost to Follow-up|1|||
42259413|NCT02856113|76085814|FG000|Overall Study|Significant Protocol Deviation|1|||
42259414|NCT02856113|76085815|FG001|Overall Study|Significant Protocol Deviation|0|||
42259415|NCT02856113|76085814|FG000|Overall Study|Lost to Follow-up|3|||
42259416|NCT02856113|76085815|FG001|Overall Study|Lost to Follow-up|5|||
42322599|NCT02291861|76159937|FG003|Overall Study|Withdrawal by Subject|4|||
42322600|NCT02291861|76159934|FG000|Overall Study|Noncompliance|1|||
42322601|NCT02291861|76159935|FG001|Overall Study|Noncompliance|1|||
42322602|NCT02291861|76159936|FG002|Overall Study|Noncompliance|2|||
42322603|NCT02291861|76159937|FG003|Overall Study|Noncompliance|1|||
42322604|NCT02291861|76159934|FG000|Overall Study|Lost to Follow-up|2|||
42322605|NCT02291861|76159935|FG001|Overall Study|Lost to Follow-up|1|||
42322606|NCT02291861|76159936|FG002|Overall Study|Lost to Follow-up|4|||
42322607|NCT02291861|76159937|FG003|Overall Study|Lost to Follow-up|0|||
42322608|NCT02291861|76159934|FG000|Overall Study|Other|0|||
42322609|NCT02291861|76159935|FG001|Overall Study|Other|0|||
42322610|NCT02291861|76159936|FG002|Overall Study|Other|0|||
42322611|NCT02291861|76159937|FG003|Overall Study|Other|1|||
42322612|NCT02291549|76159949|FG000|Overall Study|Lost to Follow-up|1|||
42322613|NCT02291549|76159950|FG001|Overall Study|Lost to Follow-up|0|||
42322614|NCT02291549|76159949|FG000|Overall Study|Withdrawal by Subject|0|||
42322615|NCT02291549|76159950|FG001|Overall Study|Withdrawal by Subject|1|||
42322616|NCT02264990|76159960|FG000|Overall Study|Death|255|||
42322617|NCT02264990|76159961|FG001|Overall Study|Death|250|||
42322618|NCT02264990|76159960|FG000|Overall Study|Withdrawal by Subject|4|||
42322619|NCT02264990|76159961|FG001|Overall Study|Withdrawal by Subject|5|||
42322620|NCT02264990|76159960|FG000|Overall Study|Lost to Follow-up|1|||
42322621|NCT02264990|76159961|FG001|Overall Study|Lost to Follow-up|3|||
42322622|NCT02264990|76159960|FG000|Overall Study|Other|0|||
42322623|NCT02264990|76159961|FG001|Overall Study|Other|1|||
42322624|NCT02291237|76159970|FG000|Overall Study|Study Terminated by Sponsor|72|||
42322625|NCT02291237|76159971|FG001|Overall Study|Study Terminated by Sponsor|67|||
42322626|NCT02291237|76159970|FG000|Overall Study|Adverse Event|1|||
42322627|NCT02291237|76159971|FG001|Overall Study|Adverse Event|3|||
42322628|NCT02291237|76159970|FG000|Overall Study|Investigator's Discretion|0|||
42322629|NCT02291237|76159971|FG001|Overall Study|Investigator's Discretion|3|||
42322630|NCT02291237|76159970|FG000|Overall Study|Withdrew Consent|11|||
42322631|NCT02291237|76159971|FG001|Overall Study|Withdrew Consent|11|||
42322632|NCT02291237|76159970|FG000|Overall Study|Lost to Follow-up|0|||
42322633|NCT02291237|76159971|FG001|Overall Study|Lost to Follow-up|2|||
42322634|NCT02291237|76159970|FG000|Overall Study|Subject Required Prohibited Medication|2|||
42322635|NCT02291237|76159971|FG001|Overall Study|Subject Required Prohibited Medication|0|||
42322636|NCT02292446|76159977|FG000|Overall Study|Adverse Event|12|||
42322637|NCT02292446|76159977|FG000|Overall Study|Death|1|||
42322638|NCT02292446|76159977|FG000|Overall Study|Disease progression|2|||
42322639|NCT02292446|76159977|FG000|Overall Study|Subject/guardian decision|2|||
42322640|NCT02292446|76159977|FG000|Overall Study|Withdrawal by Subject|3|||
41994770|NCT00196976|75802983|FG004|Booster Study|Lost to Follow-up|0|||
42259417|NCT02856113|76085814|FG000|Overall Study|Voluntary Withdrawal|3|||
42259418|NCT02856113|76085815|FG001|Overall Study|Voluntary Withdrawal|5|||
42322641|NCT02290925|76159986|FG000|First Period of Three Months|Lost to Follow-up|2|||
42322642|NCT02290925|76159987|FG001|First Period of Three Months|Lost to Follow-up|1|||
42322643|NCT02290925|76159986|FG000|First Period of Three Months|Death|1|||
42322644|NCT02290925|76159987|FG001|First Period of Three Months|Death|0|||
42322645|NCT02290925|76159986|FG000|First Period of Three Months|Insulin Started|1|||
42322646|NCT02290925|76159987|FG001|First Period of Three Months|Insulin Started|1|||
42322647|NCT02290925|76159986|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
42259419|NCT02856113|76085814|FG000|Overall Study|Pregnancy|0|||
42259420|NCT02856113|76085815|FG001|Overall Study|Pregnancy|1|||
42259421|NCT02856113|76085814|FG000|Overall Study|Principal Investigator Discretion|2|||
42259422|NCT02856113|76085815|FG001|Overall Study|Principal Investigator Discretion|1|||
42259423|NCT02856113|76085814|FG000|Overall Study|Randomized but not Treated|1|||
42259424|NCT02856113|76085815|FG001|Overall Study|Randomized but not Treated|0|||
42322648|NCT02290925|76159987|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
41994771|NCT00196976|75802984|FG005|Booster Study|Lost to Follow-up|0|||
42259425|NCT02856113|76085814|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
42322649|NCT02290925|76159986|FG000|Second Period of 3 Months|insulin started|0|||
42322650|NCT02290925|76159987|FG001|Second Period of 3 Months|insulin started|1|||
41994772|NCT00196976|75802985|FG006|Booster Study|Lost to Follow-up|0|||
42322651|NCT02290691|76159997|FG000|Overall Study|Noncompliance|0|||
42322652|NCT02290691|76159998|FG001|Overall Study|Noncompliance|1|||
42322653|NCT02290691|76159997|FG000|Overall Study|Withdrawal by Subject|1|||
42322654|NCT02290691|76159998|FG001|Overall Study|Withdrawal by Subject|1|||
42322655|NCT02290691|76159997|FG000|Overall Study|Lost to Follow-up|7|||
42322656|NCT02290691|76159998|FG001|Overall Study|Lost to Follow-up|7|||
42322657|NCT02292212|76160004|FG000|ViE Phase|Withdrawal by Subject|1|||
42322658|NCT02292212|76160004|FG000|ViE Phase|Protocol Violation|2|||
42259426|NCT02856113|76085815|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
42259427|NCT02855411|76085822|FG000|Overall Study|Study terminated by sponsor|21|||
42259428|NCT02855411|76085822|FG000|Overall Study|Does not meet entrance criteria|14|||
42259429|NCT02745145|76085829|FG000|Overall Study|Adverse Event|1|||
42259430|NCT02745145|76085830|FG001|Overall Study|Adverse Event|0|||
42259431|NCT02745145|76085831|FG002|Overall Study|Adverse Event|0|||
42259432|NCT02745145|76085829|FG000|Overall Study|Death|0|||
42259433|NCT02745145|76085830|FG001|Overall Study|Death|1|||
42259434|NCT02745145|76085831|FG002|Overall Study|Death|0|||
42259435|NCT02745145|76085829|FG000|Overall Study|Progressive disease|0|||
42259436|NCT02745145|76085830|FG001|Overall Study|Progressive disease|0|||
42259437|NCT02745145|76085831|FG002|Overall Study|Progressive disease|1|||
42259438|NCT02745145|76085829|FG000|Overall Study|Withdrew consent|1|||
42259439|NCT02745145|76085830|FG001|Overall Study|Withdrew consent|1|||
42259440|NCT02745145|76085831|FG002|Overall Study|Withdrew consent|1|||
42259441|NCT02745145|76085829|FG000|Overall Study|Study Termination|8|||
42259442|NCT02745145|76085830|FG001|Overall Study|Study Termination|3|||
42259443|NCT02745145|76085831|FG002|Overall Study|Study Termination|7|||
42259444|NCT02854631|76085850|FG000|Overall Study|Adverse Event|1|||
42259445|NCT02854631|76085851|FG001|Overall Study|Adverse Event|2|||
42259446|NCT02854631|76085850|FG000|Overall Study|Withdrew Consent|3|||
42259447|NCT02854631|76085851|FG001|Overall Study|Withdrew Consent|2|||
42259448|NCT02854631|76085850|FG000|Overall Study|Investigator's Discretion|2|||
42259449|NCT02854631|76085851|FG001|Overall Study|Investigator's Discretion|0|||
42259450|NCT02854631|76085850|FG000|Overall Study|Death|12|||
42259451|NCT02854631|76085851|FG001|Overall Study|Death|8|||
42259452|NCT02854631|76085850|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
42259453|NCT02854631|76085851|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
42259454|NCT02854631|76085850|FG000|Overall Study|Protocol Violation|0|||
42259455|NCT02854631|76085851|FG001|Overall Study|Protocol Violation|1|||
42259456|NCT02854631|76085850|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
42259457|NCT02854631|76085851|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
42259458|NCT02854631|76085850|FG000|Overall Study|Lost to Follow-up|4|||
42259459|NCT02854631|76085851|FG001|Overall Study|Lost to Follow-up|2|||
42259460|NCT02855359|76085859|FG000|Overall Study|Death|2|||
42259461|NCT02855359|76085860|FG001|Overall Study|Death|2|||
42259462|NCT02855359|76085861|FG002|Overall Study|Death|0|||
42259463|NCT02855359|76085862|FG003|Overall Study|Death|0|||
42259464|NCT02855359|76085859|FG000|Overall Study|Study Termination by Sponsor|9|||
42259465|NCT02855359|76085860|FG001|Overall Study|Study Termination by Sponsor|11|||
42259466|NCT02855359|76085861|FG002|Overall Study|Study Termination by Sponsor|0|||
42259467|NCT02855359|76085862|FG003|Overall Study|Study Termination by Sponsor|0|||
42259468|NCT02853929|76085876|FG000|Overall Study|Lost to Follow-up|3|||
42259469|NCT02853929|76085877|FG001|Overall Study|Lost to Follow-up|0|||
42259470|NCT02853929|76085876|FG000|Overall Study|Withdrawal by Subject|1|||
42259471|NCT02853929|76085877|FG001|Overall Study|Withdrawal by Subject|0|||
42259472|NCT02853929|76085876|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
42259473|NCT02853929|76085877|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
42259474|NCT02730819|76085913|FG000|Overall Study|Lost to Follow-up|9|||
42259475|NCT02038946|76085917|FG000|Overall Study|Death|5|||
42259476|NCT02038946|76085917|FG000|Overall Study|Withdrawal by Subject|3|||
42259477|NCT02038946|76085917|FG000|Overall Study|Lost to Follow-up|2|||
42259478|NCT02038946|76085917|FG000|Overall Study|Other reasons|2|||
42259479|NCT03143829|76085923|FG000|Overall Study|Withdrawal by Subject|2|||
42259480|NCT03143829|76085924|FG001|Overall Study|Withdrawal by Subject|5|||
42259481|NCT03143829|76085923|FG000|Overall Study|Lost to Follow-up|0|||
42322659|NCT02291510|76160019|FG000|Overall Study|Adverse Event|0|||
42322660|NCT02291510|76160020|FG001|Overall Study|Adverse Event|0|||
42259482|NCT03143829|76085924|FG001|Overall Study|Lost to Follow-up|2|||
42259483|NCT03143829|76085923|FG000|Overall Study|Death|1|||
42259484|NCT03143829|76085924|FG001|Overall Study|Death|1|||
42259485|NCT03143829|76085923|FG000|Overall Study|changed treatment, no longer eligible|2|||
42259486|NCT03143829|76085924|FG001|Overall Study|changed treatment, no longer eligible|2|||
42259487|NCT02853331|76085932|FG000|Overall Study|Death|59|||
42259488|NCT02853331|76085933|FG001|Overall Study|Death|95|||
42259489|NCT02853331|76085932|FG000|Overall Study|Withdrawal by Subject|5|||
42259490|NCT02853331|76085933|FG001|Overall Study|Withdrawal by Subject|9|||
42259491|NCT02853331|76085932|FG000|Overall Study|Ongoing in study|368|||
42259492|NCT02853331|76085933|FG001|Overall Study|Ongoing in study|325|||
42259493|NCT05896761|76085941|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
42259494|NCT05896761|76085942|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
42322661|NCT02291510|76160021|FG002|Overall Study|Adverse Event|0|||
42322662|NCT02291510|76160022|FG003|Overall Study|Adverse Event|1|||
42322663|NCT02290223|76160034|FG000|6 Months|Lost to Follow-up|9|||
42322664|NCT02290223|76160035|FG001|6 Months|Lost to Follow-up|6|||
42322665|NCT02290223|76160034|FG000|6 Months|Withdrawal by Subject|5|||
42322666|NCT02290223|76160035|FG001|6 Months|Withdrawal by Subject|0|||
42322667|NCT02290223|76160034|FG000|6 Months|deceased (not related to study)|2|||
42322668|NCT02290223|76160035|FG001|6 Months|deceased (not related to study)|0|||
42322669|NCT02290223|76160034|FG000|12 Months|Lost to Follow-up|16|||
42322670|NCT02290223|76160035|FG001|12 Months|Lost to Follow-up|10|||
42322671|NCT02290223|76160034|FG000|12 Months|Refusal|0|||
42322672|NCT02290223|76160035|FG001|12 Months|Refusal|1|||
42322673|NCT02289833|76160043|FG000|Overall Study|Study discontinuation|0|||
42322674|NCT02289833|76160044|FG001|Overall Study|Study discontinuation|1|||
42322675|NCT02289833|76160043|FG000|Overall Study|Lost to Follow-up|4|||
42322676|NCT02289833|76160044|FG001|Overall Study|Lost to Follow-up|0|||
42322677|NCT02289833|76160043|FG000|Overall Study|Death|23|||
42322678|NCT02289833|76160044|FG001|Overall Study|Death|16|||
42322679|NCT01702558|76160057|FG000|Overall Study|Withdrawal by Subject|0|||
42322680|NCT01702558|76160058|FG001|Overall Study|Withdrawal by Subject|0|||
42322681|NCT01702558|76160059|FG002|Overall Study|Withdrawal by Subject|0|||
42322682|NCT01702558|76160060|FG003|Overall Study|Withdrawal by Subject|12|||
42322683|NCT01702558|76160061|FG004|Overall Study|Withdrawal by Subject|4|||
42322684|NCT01702558|76160057|FG000|Overall Study|Lost to Follow-up|0|||
42322685|NCT01702558|76160058|FG001|Overall Study|Lost to Follow-up|0|||
42322686|NCT01702558|76160059|FG002|Overall Study|Lost to Follow-up|0|||
42322687|NCT01702558|76160060|FG003|Overall Study|Lost to Follow-up|3|||
42322688|NCT01702558|76160061|FG004|Overall Study|Lost to Follow-up|0|||
42322689|NCT01702558|76160057|FG000|Overall Study|Death|4|||
42322690|NCT01702558|76160058|FG001|Overall Study|Death|3|||
42322691|NCT01702558|76160059|FG002|Overall Study|Death|3|||
42322692|NCT01702558|76160060|FG003|Overall Study|Death|16|||
42322693|NCT01702558|76160061|FG004|Overall Study|Death|20|||
42322694|NCT01702558|76160057|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
42322695|NCT01702558|76160058|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
42322696|NCT01702558|76160059|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
42322697|NCT01702558|76160060|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
42322698|NCT01702558|76160061|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
42322699|NCT01702558|76160057|FG000|Overall Study|Study Terminated by Sponsor|0|||
42322700|NCT01702558|76160058|FG001|Overall Study|Study Terminated by Sponsor|1|||
42322701|NCT01702558|76160059|FG002|Overall Study|Study Terminated by Sponsor|0|||
42322702|NCT01702558|76160060|FG003|Overall Study|Study Terminated by Sponsor|0|||
42322703|NCT01702558|76160061|FG004|Overall Study|Study Terminated by Sponsor|1|||
42322704|NCT01702558|76160057|FG000|Overall Study|Other|0|||
42322705|NCT01702558|76160058|FG001|Overall Study|Other|0|||
42322706|NCT01702558|76160059|FG002|Overall Study|Other|0|||
42322707|NCT01702558|76160060|FG003|Overall Study|Other|16|||
42322708|NCT01702558|76160061|FG004|Overall Study|Other|17|||
42322709|NCT02287883|76160076|FG000|Overall Study|Death|8|||
42322710|NCT02287883|76160077|FG001|Overall Study|Death|7|||
42322711|NCT02287883|76160076|FG000|Overall Study|No longer eligible|222|||
42322712|NCT02287883|76160077|FG001|Overall Study|No longer eligible|182|||
42322713|NCT02287883|76160076|FG000|Overall Study|Non-response to survey|229|||
42322714|NCT02287883|76160077|FG001|Overall Study|Non-response to survey|237|||
42322715|NCT01743040|76160083|FG000|Overall Study|Death|1|||
42322716|NCT01743040|76160083|FG000|Overall Study|Lost to Follow-up|66|||
42322717|NCT01743040|76160083|FG000|Overall Study|Physician Decision|40|||
42322718|NCT01743040|76160083|FG000|Overall Study|Protocol Violation|1|||
42322719|NCT01743040|76160083|FG000|Overall Study|Withdrawal by Subject|121|||
42322720|NCT02194465|76160094|FG000|Overall Study|Adverse Event|6|||
42322721|NCT02194465|76160095|FG001|Overall Study|Adverse Event|1|||
42322722|NCT02194465|76160096|FG002|Overall Study|Adverse Event|4|||
42322723|NCT02194465|76160097|FG003|Overall Study|Adverse Event|4|||
42322724|NCT02194465|76160098|FG004|Overall Study|Adverse Event|4|||
42322725|NCT02194465|76160099|FG005|Overall Study|Adverse Event|2|||
42259495|NCT05896761|76085941|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
42259496|NCT05896761|76085942|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
42259497|NCT05048784|76085967|FG000|Period 1|Adverse Event|3|||
42259498|NCT05048784|76085968|FG001|Period 1|Adverse Event|1|||
42259499|NCT05048784|76085969|FG002|Period 1|Adverse Event|0|||
42259500|NCT05048784|76085970|FG003|Period 1|Adverse Event|0|||
42259501|NCT05048784|76085967|FG000|Period 2|Lost to Follow-up|0|||
42259502|NCT05048784|76085968|FG001|Period 2|Lost to Follow-up|1|||
42259503|NCT05048784|76085969|FG002|Period 2|Lost to Follow-up|0|||
42322726|NCT02194465|76160100|FG006|Overall Study|Adverse Event|0|||
42259504|NCT05048784|76085970|FG003|Period 2|Lost to Follow-up|0|||
42322727|NCT02194465|76160094|FG000|Overall Study|Lost to Follow-up|0|||
42322728|NCT02194465|76160095|FG001|Overall Study|Lost to Follow-up|0|||
42322729|NCT02194465|76160096|FG002|Overall Study|Lost to Follow-up|0|||
42259505|NCT04700280|76085999|FG000|Overall Study|Adverse Event|4|||
42322730|NCT02194465|76160097|FG003|Overall Study|Lost to Follow-up|1|||
42322731|NCT02194465|76160098|FG004|Overall Study|Lost to Follow-up|0|||
42322732|NCT02194465|76160099|FG005|Overall Study|Lost to Follow-up|1|||
42322733|NCT02194465|76160100|FG006|Overall Study|Lost to Follow-up|0|||
42322734|NCT02194465|76160094|FG000|Overall Study|Physician Decision|1|||
42322735|NCT02194465|76160095|FG001|Overall Study|Physician Decision|0|||
42322736|NCT02194465|76160096|FG002|Overall Study|Physician Decision|0|||
42322737|NCT02194465|76160097|FG003|Overall Study|Physician Decision|0|||
42322738|NCT02194465|76160098|FG004|Overall Study|Physician Decision|0|||
42322739|NCT02194465|76160099|FG005|Overall Study|Physician Decision|0|||
42322740|NCT02194465|76160100|FG006|Overall Study|Physician Decision|0|||
42322741|NCT02194465|76160094|FG000|Overall Study|Protocol Violation|1|||
42322742|NCT02194465|76160095|FG001|Overall Study|Protocol Violation|1|||
42322743|NCT02194465|76160096|FG002|Overall Study|Protocol Violation|2|||
42322744|NCT02194465|76160097|FG003|Overall Study|Protocol Violation|1|||
42322745|NCT02194465|76160098|FG004|Overall Study|Protocol Violation|1|||
42322746|NCT02194465|76160099|FG005|Overall Study|Protocol Violation|0|||
42322747|NCT02194465|76160100|FG006|Overall Study|Protocol Violation|0|||
42322748|NCT02194465|76160094|FG000|Overall Study|Withdrawal by Subject|1|||
42322749|NCT02194465|76160095|FG001|Overall Study|Withdrawal by Subject|3|||
42322750|NCT02194465|76160096|FG002|Overall Study|Withdrawal by Subject|1|||
42322751|NCT02194465|76160097|FG003|Overall Study|Withdrawal by Subject|2|||
42322752|NCT02194465|76160098|FG004|Overall Study|Withdrawal by Subject|2|||
42322753|NCT02194465|76160099|FG005|Overall Study|Withdrawal by Subject|1|||
42322754|NCT02194465|76160100|FG006|Overall Study|Withdrawal by Subject|2|||
42322755|NCT02194465|76160094|FG000|Overall Study|Discontinued follow-up period|0|||
42322756|NCT02194465|76160095|FG001|Overall Study|Discontinued follow-up period|2|||
42322757|NCT02194465|76160096|FG002|Overall Study|Discontinued follow-up period|1|||
42322758|NCT02194465|76160097|FG003|Overall Study|Discontinued follow-up period|0|||
42322759|NCT02194465|76160098|FG004|Overall Study|Discontinued follow-up period|2|||
42322760|NCT02194465|76160099|FG005|Overall Study|Discontinued follow-up period|0|||
42322761|NCT02194465|76160100|FG006|Overall Study|Discontinued follow-up period|0|||
42322762|NCT02287025|76160122|FG000|Overall Study|Not treated|2|||
42322763|NCT02287025|76160123|FG001|Overall Study|Not treated|0|||
42322764|NCT02287025|76160122|FG000|Overall Study|Progression of disease|3|||
42322765|NCT02287025|76160123|FG001|Overall Study|Progression of disease|2|||
42322766|NCT02287025|76160122|FG000|Overall Study|Adverse Event|2|||
42322767|NCT02287025|76160123|FG001|Overall Study|Adverse Event|4|||
42322768|NCT02287025|76160122|FG000|Overall Study|Withdrawal by Subject|2|||
42322769|NCT02287025|76160123|FG001|Overall Study|Withdrawal by Subject|2|||
42322770|NCT02287025|76160122|FG000|Overall Study|Screening failed|1|||
42322771|NCT02287025|76160123|FG001|Overall Study|Screening failed|1|||
42322772|NCT01720264|76160127|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
42322773|NCT01720264|76160127|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
42322774|NCT01720264|76160127|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
42034111|NCT01070550|75842184|FG003|Overall Study|Treatment was stopped early|0|||
42259506|NCT04700280|76086000|FG001|Overall Study|Adverse Event|0|||
42259507|NCT04700280|76085999|FG000|Overall Study|Lack of Efficacy|1|||
42259508|NCT04700280|76086000|FG001|Overall Study|Lack of Efficacy|0|||
42259509|NCT04700280|76085999|FG000|Overall Study|Study terminated by sponsor|5|||
42259510|NCT04700280|76086000|FG001|Overall Study|Study terminated by sponsor|3|||
42259511|NCT04700280|76085999|FG000|Overall Study|Other than specified|1|||
42259512|NCT04700280|76086000|FG001|Overall Study|Other than specified|0|||
42259513|NCT04679675|76086010|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
42259514|NCT04679675|76086011|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
42259515|NCT04679675|76086012|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
42259516|NCT04679675|76086013|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
42259517|NCT04679675|76086010|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
42259518|NCT04679675|76086011|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
42259519|NCT04679675|76086012|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
42259520|NCT04679675|76086013|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
42259521|NCT04626128|76086027|FG000|Overall Study|Withdrawal by Subject|0|||
42259522|NCT04626128|76086028|FG001|Overall Study|Withdrawal by Subject|1|||
42259523|NCT04626128|76086029|FG002|Overall Study|Withdrawal by Subject|0|||
42259524|NCT04626128|76086030|FG003|Overall Study|Withdrawal by Subject|0|||
42322775|NCT01702246|76160131|FG000|Overall Study|Lost to Follow-up|2|||
42322776|NCT01702246|76160131|FG000|Overall Study|Withdrawal by Subject|2|||
42322777|NCT01702246|76160131|FG000|Overall Study|Physician Decision|1|||
42322778|NCT01631227|76160140|FG000|Overall Study|withdrawn consent|27|||
42322779|NCT01631227|76160141|FG001|Overall Study|withdrawn consent|21|||
42322780|NCT01631227|76160140|FG000|Overall Study|Adverse Event|1|||
42322781|NCT01631227|76160141|FG001|Overall Study|Adverse Event|0|||
42322782|NCT01631227|76160140|FG000|Overall Study|administrative|2|||
42322783|NCT01631227|76160141|FG001|Overall Study|administrative|1|||
42322784|NCT01719172|76160147|FG000|Overall Study|Lost to Follow-up|1|||
42322785|NCT01719172|76160147|FG000|Overall Study|Death|1|||
42322786|NCT02286947|76160151|FG000|Overall Study|Withdrawal by Subject|2|||
42322787|NCT02286713|76160159|FG000|One Week Follow-Up|Death|1|||
42322788|NCT02286713|76160160|FG001|One Week Follow-Up|Death|0|||
42322789|NCT02286713|76160159|FG000|One Week Follow-Up|Lost to Follow-up|17|||
42322790|NCT02286713|76160160|FG001|One Week Follow-Up|Lost to Follow-up|21|||
42322791|NCT02286713|76160159|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
42322792|NCT02286713|76160160|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
42322793|NCT02286713|76160159|FG000|Three Month Follow-Up|Death|1|||
42322794|NCT02286713|76160160|FG001|Three Month Follow-Up|Death|1|||
42322795|NCT02286713|76160159|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
42322796|NCT02286713|76160160|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
42322797|NCT02286713|76160159|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
42322798|NCT02286713|76160160|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
42322799|NCT02286713|76160159|FG000|Six Month Follow-Up|Death|2|||
42322800|NCT02286713|76160160|FG001|Six Month Follow-Up|Death|0|||
42322801|NCT02286713|76160159|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
42322802|NCT02286713|76160160|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
42322803|NCT02285855|76160168|FG000|Overall Study|Withdrawal by Subject|2|||
42322804|NCT02285855|76160169|FG001|Overall Study|Withdrawal by Subject|1|||
42322805|NCT02285777|76160177|FG000|Overall Study|Withdrawal by Subject|1|||
42322806|NCT02285777|76160178|FG001|Overall Study|Withdrawal by Subject|1|||
42322807|NCT02285777|76160177|FG000|Overall Study|Lost to Follow-up|4|||
42322808|NCT02285777|76160178|FG001|Overall Study|Lost to Follow-up|2|||
42322809|NCT02285153|76160186|FG000|Overall Study|Adverse Event|1|||
42322810|NCT02285153|76160187|FG001|Overall Study|Adverse Event|0|||
42322811|NCT02284373|76160196|FG000|Overall Study|Withdrawal by Subject|0|||
42322812|NCT02284373|76160197|FG001|Overall Study|Withdrawal by Subject|1|||
42322813|NCT02284373|76160198|FG002|Overall Study|Withdrawal by Subject|0|||
42322814|NCT02284373|76160196|FG000|Overall Study|Other|0|||
42322815|NCT02284373|76160197|FG001|Overall Study|Other|1|||
42322816|NCT02284373|76160198|FG002|Overall Study|Other|0|||
42322817|NCT02284373|76160196|FG000|Overall Study|Lost to Follow-up|0|||
42322818|NCT02284373|76160197|FG001|Overall Study|Lost to Follow-up|1|||
42322819|NCT02284373|76160198|FG002|Overall Study|Lost to Follow-up|0|||
42322820|NCT01632241|76160208|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
42322821|NCT01632241|76160209|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
42322822|NCT01632241|76160208|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
42322823|NCT01632241|76160209|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
42322824|NCT01632241|76160208|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
42322825|NCT01632241|76160209|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
42322826|NCT01632241|76160208|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
42322827|NCT01632241|76160209|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
42322828|NCT01632241|76160208|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
42322829|NCT01632241|76160209|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
42322830|NCT01632241|76160208|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
42322831|NCT01632241|76160209|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
42322832|NCT01632241|76160208|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
42322833|NCT01632241|76160209|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
42322834|NCT01632241|76160208|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
42322835|NCT01632241|76160209|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
42322836|NCT01632241|76160208|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
42322837|NCT01632241|76160209|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
42322838|NCT01632241|76160208|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
42322839|NCT01632241|76160209|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
42322840|NCT01632241|76160208|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
42322841|NCT01632241|76160209|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
42322842|NCT01632241|76160208|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
42322843|NCT01632241|76160209|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
42322844|NCT01632241|76160208|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
42322845|NCT01632241|76160209|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
42322846|NCT01632241|76160208|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
42322847|NCT01632241|76160209|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
42322848|NCT02263508|76160224|FG000|Overall Study|Withdrawal by Subject|1|||
42322849|NCT02263508|76160225|FG001|Overall Study|Withdrawal by Subject|23|||
42322850|NCT02263508|76160226|FG002|Overall Study|Withdrawal by Subject|17|||
42322851|NCT02263508|76160224|FG000|Overall Study|Sponsor Decision|12|||
42322852|NCT02263508|76160225|FG001|Overall Study|Sponsor Decision|165|||
42322853|NCT02263508|76160226|FG002|Overall Study|Sponsor Decision|182|||
42322854|NCT02263508|76160224|FG000|Overall Study|Lost to Follow-up|2|||
42259525|NCT04581824|76086042|FG000|Overall Study|Ongoing|75|||
42259526|NCT04581824|76086043|FG001|Overall Study|Ongoing|69|||
42259527|NCT04581824|76086042|FG000|Overall Study|Withdrawal by Subject|3|||
42259528|NCT04581824|76086043|FG001|Overall Study|Withdrawal by Subject|5|||
42259529|NCT04581824|76086042|FG000|Overall Study|Lost to Follow-up|1|||
42259530|NCT04581824|76086043|FG001|Overall Study|Lost to Follow-up|0|||
42259531|NCT04523571|76086055|FG000|Received 2 Doses|Withdrawal by Subject|0|||
42259532|NCT04523571|76086056|FG001|Received 2 Doses|Withdrawal by Subject|0|||
42259533|NCT04523571|76086057|FG002|Received 2 Doses|Withdrawal by Subject|0|||
42259534|NCT04523571|76086058|FG003|Received 2 Doses|Withdrawal by Subject|1|||
42259535|NCT04523571|76086059|FG004|Received 2 Doses|Withdrawal by Subject|1|||
42259536|NCT04523571|76086060|FG005|Received 2 Doses|Withdrawal by Subject|0|||
42259537|NCT04523571|76086055|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
42259538|NCT04523571|76086056|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
42259539|NCT04523571|76086057|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
42259540|NCT04523571|76086058|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
42259541|NCT04523571|76086059|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
42259542|NCT04523571|76086060|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
42259543|NCT04523571|76086055|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
42259544|NCT04523571|76086056|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
42259545|NCT04523571|76086057|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
42259546|NCT04523571|76086058|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
42259547|NCT04523571|76086059|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
42259548|NCT04523571|76086060|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
42259549|NCT04523571|76086055|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
42259550|NCT04523571|76086056|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
42259551|NCT04523571|76086057|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
42259552|NCT04523571|76086058|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
42259553|NCT04523571|76086059|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
42259554|NCT04523571|76086060|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
42259555|NCT04361617|76086076|FG000|Overall Study|Withdrawal by Subject|0|||
42259556|NCT04361617|76086077|FG001|Overall Study|Withdrawal by Subject|1|||
42259557|NCT04021914|76086083|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
42259558|NCT03850444|76086109|FG000|Overall Study|Adverse Event|16|||
42259559|NCT03850444|76086110|FG001|Overall Study|Adverse Event|10|||
42259560|NCT03850444|76086109|FG000|Overall Study|Death|87|||
42259561|NCT03850444|76086110|FG001|Overall Study|Death|107|||
42259562|NCT03850444|76086109|FG000|Overall Study|Lost to Follow-up|1|||
42259563|NCT03850444|76086110|FG001|Overall Study|Lost to Follow-up|1|||
42259564|NCT03850444|76086109|FG000|Overall Study|Withdrawal by Subject|1|||
42259565|NCT03850444|76086110|FG001|Overall Study|Withdrawal by Subject|5|||
42259566|NCT03850444|76086109|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
42259567|NCT03850444|76086110|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
42259568|NCT03781804|76086120|FG000|Overall Study|Adverse Event|2|||
42259569|NCT03781804|76086121|FG001|Overall Study|Adverse Event|2|||
42259570|NCT03781804|76086122|FG002|Overall Study|Adverse Event|3|||
42259571|NCT03781804|76086120|FG000|Overall Study|Lost to Follow-up|1|||
42259572|NCT03781804|76086121|FG001|Overall Study|Lost to Follow-up|1|||
42259573|NCT03781804|76086122|FG002|Overall Study|Lost to Follow-up|2|||
42259574|NCT03781804|76086120|FG000|Overall Study|Lack of Efficacy|4|||
42259575|NCT03781804|76086121|FG001|Overall Study|Lack of Efficacy|2|||
42259576|NCT03781804|76086122|FG002|Overall Study|Lack of Efficacy|9|||
42259577|NCT03781804|76086120|FG000|Overall Study|Protocol Violation|0|||
42259578|NCT03781804|76086121|FG001|Overall Study|Protocol Violation|0|||
42322855|NCT02263508|76160225|FG001|Overall Study|Lost to Follow-up|7|||
41994773|NCT00196976|75802986|FG007|Booster Study|Lost to Follow-up|0|||
41994774|NCT00196976|75802987|FG008|Booster Study|Lost to Follow-up|0|||
41994775|NCT00196976|75802988|FG009|Booster Study|Lost to Follow-up|0|||
41994776|NCT00196976|75802989|FG010|Booster Study|Lost to Follow-up|1|||
41994777|NCT00196976|75802990|FG011|Booster Study|Lost to Follow-up|2|||
41994778|NCT00196976|75802991|FG012|Booster Study|Lost to Follow-up|0|||
41994779|NCT00196976|75802992|FG013|Booster Study|Lost to Follow-up|0|||
41994780|NCT00196313|75803034|FG000|Overall Study|Protocol Violation|2|||
42259579|NCT03781804|76086122|FG002|Overall Study|Protocol Violation|1|||
42259580|NCT03781804|76086120|FG000|Overall Study|Withdrawal by Subject|0|||
42259581|NCT03781804|76086121|FG001|Overall Study|Withdrawal by Subject|1|||
42259582|NCT03781804|76086122|FG002|Overall Study|Withdrawal by Subject|1|||
42322856|NCT02263508|76160226|FG002|Overall Study|Lost to Follow-up|7|||
41994781|NCT00196313|75803035|FG001|Overall Study|Protocol Violation|3|||
42259583|NCT03781804|76086120|FG000|Overall Study|Reason not provided|2|||
42322857|NCT02263508|76160224|FG000|Overall Study|Death|6|||
41994782|NCT00196313|75803034|FG000|Overall Study|Withdrawal by Subject|3|||
42133540|NCT00375219|75944459|FG002|Overall Study|Lost to Follow-up|0|||
42322858|NCT02263508|76160225|FG001|Overall Study|Death|151|||
42322859|NCT02263508|76160226|FG002|Overall Study|Death|140|||
42322860|NCT02291432|76160237|FG000|Overall Study|Withdrawal by Subject|2|||
42322861|NCT02290340|76160245|FG000|Overall Study|Lost to Follow-up|0|||
42322862|NCT02290340|76160246|FG001|Overall Study|Lost to Follow-up|0|||
42322863|NCT02290340|76160247|FG002|Overall Study|Lost to Follow-up|0|||
42322864|NCT02290340|76160248|FG003|Overall Study|Lost to Follow-up|1|||
42322865|NCT02290340|76160245|FG000|Overall Study|Withdrawal by Subject|1|||
42322866|NCT02290340|76160246|FG001|Overall Study|Withdrawal by Subject|0|||
42322867|NCT02290340|76160247|FG002|Overall Study|Withdrawal by Subject|0|||
42322868|NCT02290340|76160248|FG003|Overall Study|Withdrawal by Subject|0|||
42322869|NCT02290340|76160245|FG000|Overall Study|Other|1|||
42322870|NCT02290340|76160246|FG001|Overall Study|Other|0|||
42322871|NCT02290340|76160247|FG002|Overall Study|Other|0|||
42322872|NCT02290340|76160248|FG003|Overall Study|Other|1|||
42322873|NCT02290028|76160261|FG000|Overall Study|Death|217|||
42322874|NCT02290028|76160261|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
42322875|NCT02290028|76160261|FG000|Overall Study|No longer under care of study physician|76|||
42322876|NCT02290028|76160261|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
42322877|NCT02290028|76160261|FG000|Overall Study|Withdrawal by Subject|52|||
41994783|NCT00196313|75803035|FG001|Overall Study|Withdrawal by Subject|1|||
41994784|NCT00196313|75803034|FG000|Overall Study|Adverse Event|3|||
42259584|NCT03781804|76086121|FG001|Overall Study|Reason not provided|2|||
42259585|NCT03781804|76086122|FG002|Overall Study|Reason not provided|0|||
42259586|NCT03623386|76086133|FG000|Overall Study|Protocol Violation|3|||
42259587|NCT03623386|76086134|FG001|Overall Study|Protocol Violation|2|||
42259588|NCT03623386|76086135|FG002|Overall Study|Protocol Violation|0|||
42259589|NCT03623386|76086133|FG000|Overall Study|Physician Decision|1|||
42259590|NCT03623386|76086134|FG001|Overall Study|Physician Decision|1|||
42259591|NCT03623386|76086135|FG002|Overall Study|Physician Decision|0|||
42259592|NCT03623386|76086133|FG000|Overall Study|Lost to Follow-up|0|||
42259593|NCT03623386|76086134|FG001|Overall Study|Lost to Follow-up|2|||
42259594|NCT03623386|76086135|FG002|Overall Study|Lost to Follow-up|0|||
42259595|NCT03623386|76086133|FG000|Overall Study|COVID-19|0|||
42259596|NCT03623386|76086134|FG001|Overall Study|COVID-19|1|||
42259597|NCT03623386|76086135|FG002|Overall Study|COVID-19|0|||
42259598|NCT03507686|76086146|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
42259599|NCT03507686|76086147|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
42259600|NCT03507686|76086146|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
42259601|NCT03507686|76086147|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
42259602|NCT03507686|76086146|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
42259603|NCT03507686|76086147|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
42133541|NCT00375219|75944457|FG000|Overall Study|Disease progression|18|||
42133542|NCT00375219|75944458|FG001|Overall Study|Disease progression|9|||
42133543|NCT00375219|75944459|FG002|Overall Study|Disease progression|12|||
42133544|NCT00375219|75944457|FG000|Overall Study|Death|4|||
42133545|NCT00375219|75944458|FG001|Overall Study|Death|3|||
42133546|NCT00375219|75944459|FG002|Overall Study|Death|7|||
42259604|NCT03507686|76086146|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
42322878|NCT02290028|76160261|FG000|Overall Study|Study site closure|44|||
42322879|NCT02290028|76160261|FG000|Overall Study|Lost to Follow-up|34|||
42322880|NCT02290028|76160261|FG000|Overall Study|Miscellaneous|10|||
42322881|NCT02290028|76160261|FG000|Overall Study|Transition to EP PASSION|1295|||
42322882|NCT02290028|76160261|FG000|Overall Study|Planned study completion at 12 months|257|||
42322883|NCT01741792|76160271|FG000|Overall Study|Death|6|||
42322884|NCT01741792|76160272|FG001|Overall Study|Death|1|||
42322885|NCT01741792|76160273|FG002|Overall Study|Death|12|||
42322886|NCT02289950|76160289|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
42322887|NCT02289950|76160290|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
42322888|NCT02289950|76160289|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
42322889|NCT02289950|76160290|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
42259605|NCT03507686|76086147|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
42259606|NCT03507686|76086146|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
42322890|NCT02289950|76160289|FG000|Overall Study|Lost to Follow-up|1|||
42322891|NCT02289950|76160290|FG001|Overall Study|Lost to Follow-up|0|||
42322892|NCT02289950|76160289|FG000|Overall Study|Physician Decision|9|||
41994785|NCT00196313|75803035|FG001|Overall Study|Adverse Event|1|||
41994786|NCT00196313|75803034|FG000|Overall Study|Subject Pregnant|1|||
42133547|NCT00375219|75944457|FG000|Overall Study|Hematologic resistance|1|||
42259607|NCT03507686|76086147|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
42322893|NCT02289950|76160290|FG001|Overall Study|Physician Decision|3|||
42322894|NCT02289950|76160289|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
42322895|NCT02289950|76160290|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
42322896|NCT02289950|76160289|FG000|Overall Study|Withdrawal by Subject|1|||
42133548|NCT00375219|75944458|FG001|Overall Study|Hematologic resistance|0|||
42322897|NCT02289950|76160290|FG001|Overall Study|Withdrawal by Subject|3|||
42322898|NCT02289950|76160289|FG000|Overall Study|Test article held for greater than 28 days|0|||
42322899|NCT02289950|76160290|FG001|Overall Study|Test article held for greater than 28 days|1|||
42322900|NCT02289950|76160289|FG000|Overall Study|Adverse Event|11|||
42322901|NCT02289950|76160290|FG001|Overall Study|Adverse Event|3|||
42322902|NCT02289950|76160289|FG000|Overall Study|Death|1|||
42322903|NCT02289950|76160290|FG001|Overall Study|Death|1|||
42322904|NCT02289950|76160289|FG000|Overall Study|Other|5|||
42322905|NCT02289950|76160290|FG001|Overall Study|Other|2|||
42322906|NCT02289950|76160289|FG000|Overall Study|Not Treated|2|||
42322907|NCT02289950|76160290|FG001|Overall Study|Not Treated|1|||
42322908|NCT01741012|76160296|FG000|Overall Study|Lost to Follow-up|1|||
42322909|NCT01741012|76160296|FG000|Overall Study|Withdrawal by Subject|2|||
42322910|NCT02288312|76160304|FG000|Overall Study|Pregnancy|1|||
42322911|NCT02288312|76160305|FG001|Overall Study|Pregnancy|0|||
42322912|NCT02288312|76160306|FG002|Overall Study|Pregnancy|0|||
42322913|NCT01740388|76160316|FG000|Overall Study|Withdrawal by Subject|1|||
42322914|NCT01740388|76160317|FG001|Overall Study|Withdrawal by Subject|2|||
42322915|NCT01740388|76160316|FG000|Overall Study|Lost to Follow-up|2|||
42322916|NCT01740388|76160317|FG001|Overall Study|Lost to Follow-up|0|||
42322917|NCT01740388|76160316|FG000|Overall Study|Physician Decision|2|||
42322918|NCT01740388|76160317|FG001|Overall Study|Physician Decision|6|||
42322919|NCT01740388|76160316|FG000|Overall Study|Subjects missing data, completed|41|||
42322920|NCT01740388|76160317|FG001|Overall Study|Subjects missing data, completed|36|||
42322921|NCT01740154|76160323|FG000|Overall Study|Adverse Event|1|||
42322922|NCT02287922|76160331|FG000|Overall Study|Adverse Event|1|||
42322923|NCT02287922|76160332|FG001|Overall Study|Adverse Event|1|||
42322924|NCT02287922|76160333|FG002|Overall Study|Adverse Event|3|||
42322925|NCT02287922|76160334|FG003|Overall Study|Adverse Event|4|||
42322926|NCT02287922|76160331|FG000|Overall Study|Withdrawal by Subject|1|||
42322927|NCT02287922|76160332|FG001|Overall Study|Withdrawal by Subject|1|||
42322928|NCT02287922|76160333|FG002|Overall Study|Withdrawal by Subject|1|||
42322929|NCT02287922|76160334|FG003|Overall Study|Withdrawal by Subject|2|||
42322930|NCT02287922|76160331|FG000|Overall Study|Lost to Follow-up|0|||
42322931|NCT02287922|76160332|FG001|Overall Study|Lost to Follow-up|0|||
41994787|NCT00196313|75803035|FG001|Overall Study|Subject Pregnant|1|||
41994788|NCT00196313|75803034|FG000|Overall Study|Lost to Follow-up|2|||
41994789|NCT00196313|75803035|FG001|Overall Study|Lost to Follow-up|2|||
41994790|NCT00196196|75803042|FG000|Overall Study|Withdrawal by Subject|2|||
42322932|NCT02287922|76160333|FG002|Overall Study|Lost to Follow-up|1|||
42322933|NCT02287922|76160334|FG003|Overall Study|Lost to Follow-up|0|||
42322934|NCT02287922|76160331|FG000|Overall Study|Sponsor's decision|0|||
42322935|NCT02287922|76160332|FG001|Overall Study|Sponsor's decision|0|||
42322936|NCT02287922|76160333|FG002|Overall Study|Sponsor's decision|0|||
42322937|NCT02287922|76160334|FG003|Overall Study|Sponsor's decision|1|||
42322938|NCT02287922|76160331|FG000|Overall Study|Other|1|||
41994791|NCT00196196|75803042|FG000|Overall Study|Did not have required condition (hydroce|5|||
41994792|NCT00195650|75803046|FG000|Overall Study|Adverse Event|194|||
41994793|NCT00195650|75803046|FG000|Overall Study|Lack of Efficacy|99|||
41994794|NCT00195650|75803046|FG000|Overall Study|Withdrawal by Subject|67|||
41994795|NCT00195650|75803046|FG000|Overall Study|Lost to Follow-up|44|||
41994796|NCT00195650|75803046|FG000|Overall Study|Death|23|||
42259608|NCT03507686|76086146|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
42259609|NCT03507686|76086147|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
42259610|NCT03471507|76086155|FG000|Overall Study|Lost to Follow-up|1|||
42259611|NCT03471507|76086156|FG001|Overall Study|Lost to Follow-up|3|||
42259612|NCT03471507|76086155|FG000|Overall Study|Physician Decision|0|||
42259613|NCT03471507|76086156|FG001|Overall Study|Physician Decision|1|||
42259614|NCT03471507|76086155|FG000|Overall Study|Withdrawal by Subject|2|||
42259615|NCT03471507|76086156|FG001|Overall Study|Withdrawal by Subject|1|||
42259616|NCT03338894|76086162|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
42259617|NCT03138564|76086170|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
42259618|NCT03138564|76086171|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
42259619|NCT03138564|76086170|FG000|Overall Study|Lost to Follow-up|16|||
42259620|NCT03138564|76086171|FG001|Overall Study|Lost to Follow-up|2|||
42259621|NCT03138564|76086170|FG000|Overall Study|Withdrawal by Subject|48|||
42259622|NCT03138564|76086171|FG001|Overall Study|Withdrawal by Subject|4|||
42259623|NCT03138564|76086170|FG000|Overall Study|No longer met eligibility criteria|2|||
42259624|NCT03138564|76086171|FG001|Overall Study|No longer met eligibility criteria|0|||
42259625|NCT03138564|76086170|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
42259626|NCT03138564|76086171|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
42259627|NCT03138564|76086170|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
42259628|NCT03138564|76086171|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
42322939|NCT02287922|76160332|FG001|Overall Study|Other|0|||
42322940|NCT02287922|76160333|FG002|Overall Study|Other|2|||
42322941|NCT02287922|76160334|FG003|Overall Study|Other|0|||
42322942|NCT02287610|76160345|FG000|Overall Study|Lost to Follow-up|3|||
42322943|NCT02287610|76160345|FG000|Overall Study|Withdrawal by Subject|8|||
42322944|NCT02287610|76160345|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
42322945|NCT02262728|76160351|FG000|Follow-up Phase (3 Years)|Death|0|||
42322946|NCT02262728|76160352|FG001|Follow-up Phase (3 Years)|Death|1|||
42322947|NCT02262728|76160351|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
42322948|NCT02262728|76160352|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
42322949|NCT02262728|76160351|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
42322950|NCT02262728|76160352|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
42322951|NCT02262260|76160360|FG000|Overall Study|Adverse Event|4|||
42322952|NCT02262260|76160361|FG001|Overall Study|Adverse Event|1|||
42322953|NCT02262260|76160360|FG000|Overall Study|Withdrawal of consent|4|||
42322954|NCT02262260|76160361|FG001|Overall Study|Withdrawal of consent|2|||
42322955|NCT02262260|76160360|FG000|Overall Study|Lost to Follow-up|1|||
42322956|NCT02262260|76160361|FG001|Overall Study|Lost to Follow-up|2|||
42322957|NCT02262260|76160360|FG000|Overall Study|Protocol deviation|2|||
42322958|NCT02262260|76160361|FG001|Overall Study|Protocol deviation|5|||
42322959|NCT02285270|76160367|FG000|Overall Study|Lost to Follow-up|1|||
41994797|NCT00195650|75803046|FG000|Overall Study|Protocol Violation|15|||
41994798|NCT00195650|75803046|FG000|Overall Study|Administrative reasons|83|||
42259629|NCT03138564|76086170|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
42259630|NCT03138564|76086171|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
42259631|NCT03138564|76086170|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
42259632|NCT03138564|76086171|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
42259633|NCT02923180|76086194|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
42259634|NCT02923180|76086194|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
42259635|NCT02836717|76086201|FG000|Test Phase|Lack of Efficacy|14|||
42259636|NCT02836717|76086202|FG001|Test Phase|Lack of Efficacy|8|||
42259637|NCT02836717|76086203|FG002|Test Phase|Lack of Efficacy|0|||
42259638|NCT02836717|76086201|FG000|Study Phase|Adverse Event|2|||
42259639|NCT02836717|76086202|FG001|Study Phase|Adverse Event|0|||
42259640|NCT02836717|76086203|FG002|Study Phase|Adverse Event|0|||
42259641|NCT02836717|76086201|FG000|Study Phase|Lack of Efficacy|8|||
42259642|NCT02836717|76086202|FG001|Study Phase|Lack of Efficacy|6|||
42259643|NCT02836717|76086203|FG002|Study Phase|Lack of Efficacy|1|||
42259644|NCT02836717|76086201|FG000|Study Phase|Withdrawal by Subject|1|||
42259645|NCT02836717|76086202|FG001|Study Phase|Withdrawal by Subject|0|||
42259646|NCT02836717|76086203|FG002|Study Phase|Withdrawal by Subject|0|||
42259647|NCT02836717|76086201|FG000|Study Phase|Death|1|||
42259648|NCT02836717|76086202|FG001|Study Phase|Death|0|||
42259649|NCT02836717|76086203|FG002|Study Phase|Death|0|||
42259650|NCT02836717|76086201|FG000|Study Phase|abdominal surgeries|2|||
42259651|NCT02836717|76086202|FG001|Study Phase|abdominal surgeries|1|||
42259652|NCT02836717|76086203|FG002|Study Phase|abdominal surgeries|0|||
42259653|NCT02743494|76086214|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
42259654|NCT02743494|76086215|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
42259655|NCT02743494|76086214|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
42259656|NCT02743494|76086215|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
42259657|NCT02743494|76086214|FG000|Treatment Period|Completed treatment|229|||
42259658|NCT02743494|76086215|FG001|Treatment Period|Completed treatment|99|||
42259659|NCT02743494|76086214|FG000|Treatment Period|Disease recurrence|149|||
42259660|NCT02743494|76086215|FG001|Treatment Period|Disease recurrence|113|||
42259661|NCT02743494|76086214|FG000|Treatment Period|Study drug toxicity|57|||
42259662|NCT02743494|76086215|FG001|Treatment Period|Study drug toxicity|8|||
42259663|NCT02743494|76086214|FG000|Treatment Period|Death|1|||
42259664|NCT02743494|76086215|FG001|Treatment Period|Death|0|||
42259665|NCT02743494|76086214|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
42259666|NCT02743494|76086215|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
42259667|NCT02743494|76086214|FG000|Treatment Period|Participant request to discontinue treatment|30|||
42259668|NCT02743494|76086215|FG001|Treatment Period|Participant request to discontinue treatment|5|||
42259669|NCT02743494|76086214|FG000|Treatment Period|Participant withdrew consent|12|||
42259670|NCT02743494|76086215|FG001|Treatment Period|Participant withdrew consent|4|||
42259671|NCT02743494|76086214|FG000|Treatment Period|Lost to Follow-up|0|||
42259672|NCT02743494|76086215|FG001|Treatment Period|Lost to Follow-up|1|||
42259673|NCT02743494|76086214|FG000|Treatment Period|Poor/Non-compliance|1|||
42259674|NCT02743494|76086215|FG001|Treatment Period|Poor/Non-compliance|0|||
42259675|NCT02743494|76086214|FG000|Treatment Period|Other reasons|7|||
42259676|NCT02743494|76086215|FG001|Treatment Period|Other reasons|2|||
42259677|NCT02336282|76086221|FG000|Overall Study|Unrelated illness|1|||
42322960|NCT02285270|76160367|FG000|Overall Study|Physician Decision|3|||
42322961|NCT02285270|76160367|FG000|Overall Study|Determined to be ineligible|1|||
41994799|NCT00195494|75803052|FG000|Year 1|Adverse Event|0|||
42259678|NCT02336282|76086221|FG000|Overall Study|Uncomfortable with technology|1|||
42259679|NCT02336282|76086221|FG000|Overall Study|Lost to Follow-up|1|||
42322962|NCT01717768|76160381|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
42322963|NCT01717768|76160382|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
42322964|NCT01717768|76160383|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
42322965|NCT01717768|76160384|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
42322966|NCT01717768|76160385|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
41994800|NCT00195494|75803053|FG001|Year 1|Adverse Event|0|||
42259680|NCT02336282|76086221|FG000|Overall Study|Not enough time to complete sessions|2|||
42259681|NCT02272842|76086235|FG000|Overall Study|Lost to Follow-up|8|||
42259682|NCT02272842|76086236|FG001|Overall Study|Lost to Follow-up|8|||
42259683|NCT02272842|76086235|FG000|Overall Study|Withdrawal by Subject|8|||
42259684|NCT02272842|76086236|FG001|Overall Study|Withdrawal by Subject|2|||
42259685|NCT02258659|76086243|FG000|Overall Study|Withdrawal by Subject|1|||
42259686|NCT01990300|76086247|FG000|Overall Study|Case Report Forms Uncollected|89|||
42259687|NCT01990300|76086247|FG000|Overall Study|Protocol Deviation|53|||
42259688|NCT01909934|76086251|FG000|Overall Study|Ongoing|23|||
42259689|NCT01909934|76086251|FG000|Overall Study|Withdrawal by Subject|3|||
42259690|NCT01909934|76086251|FG000|Overall Study|Lost to Follow-up|1|||
42259691|NCT01909934|76086251|FG000|Overall Study|Withdrawal of Informed Consent|1|||
42322967|NCT01717768|76160386|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
42259692|NCT01909934|76086251|FG000|Overall Study|Death|22|||
42322968|NCT01717768|76160387|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
42322969|NCT01717768|76160388|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
42322970|NCT01717768|76160389|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
42259693|NCT01076400|76086280|FG000|Overall Study|Adverse Event|2|||
42259694|NCT01076400|76086281|FG001|Overall Study|Adverse Event|0|||
42259695|NCT01076400|76086282|FG002|Overall Study|Adverse Event|0|||
42259696|NCT01076400|76086280|FG000|Overall Study|Progressive Disease|5|||
42322971|NCT01717768|76160390|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
42322972|NCT01717768|76160391|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
41994801|NCT00195494|75803054|FG002|Year 1|Adverse Event|0|||
42322973|NCT01717768|76160392|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
42322974|NCT01717768|76160381|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
42322975|NCT01717768|76160382|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
42322976|NCT01717768|76160383|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
42322977|NCT01717768|76160384|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
42322978|NCT01717768|76160385|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
42322979|NCT01717768|76160386|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
42322980|NCT01717768|76160387|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
42322981|NCT01717768|76160388|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
42322982|NCT01717768|76160389|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
42322983|NCT01717768|76160390|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
42322984|NCT01717768|76160391|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
41994802|NCT00195494|75803055|FG003|Year 1|Adverse Event|0|||
42259697|NCT01076400|76086281|FG001|Overall Study|Progressive Disease|0|||
42259698|NCT01076400|76086282|FG002|Overall Study|Progressive Disease|0|||
42322985|NCT01717768|76160392|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
42322986|NCT01717768|76160381|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
42322987|NCT01717768|76160382|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
42322988|NCT01717768|76160383|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
42322989|NCT01717768|76160384|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
42322990|NCT01717768|76160385|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
42322991|NCT01717768|76160386|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
42322992|NCT01717768|76160387|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
42322993|NCT01717768|76160388|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
42322994|NCT01717768|76160389|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
42322995|NCT01717768|76160390|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
42322996|NCT01717768|76160391|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
42322997|NCT01717768|76160392|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
42322998|NCT01717768|76160381|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
42322999|NCT01717768|76160382|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
42323000|NCT01717768|76160383|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
42323001|NCT01717768|76160384|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
42323002|NCT01717768|76160385|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
42323003|NCT01717768|76160386|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
42323004|NCT01717768|76160387|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
42323005|NCT01717768|76160388|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
42323006|NCT01717768|76160389|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
42323007|NCT01717768|76160390|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
42323008|NCT01717768|76160391|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
42323009|NCT01717768|76160392|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
42323010|NCT02260934|76160420|FG000|Overall Study|Lost to Follow-up|2|||
42323011|NCT02260934|76160421|FG001|Overall Study|Lost to Follow-up|1|||
42323012|NCT02260934|76160420|FG000|Overall Study|Withdrawal by Subject|0|||
42323013|NCT02260934|76160421|FG001|Overall Study|Withdrawal by Subject|2|||
42323014|NCT02260934|76160420|FG000|Overall Study|Participant Relocated|1|||
42323015|NCT02260934|76160421|FG001|Overall Study|Participant Relocated|0|||
42323016|NCT02260934|76160420|FG000|Overall Study|Site error|0|||
42323017|NCT02260934|76160421|FG001|Overall Study|Site error|1|||
42323018|NCT02260388|76160438|FG000|Overall Study|Lost to Follow-up|2|||
42323019|NCT02260388|76160439|FG001|Overall Study|Lost to Follow-up|8|||
42323020|NCT02260388|76160440|FG002|Overall Study|Lost to Follow-up|3|||
42323021|NCT02260388|76160441|FG003|Overall Study|Lost to Follow-up|4|||
42323022|NCT02260154|76160451|FG000|Overall Study|Screening failure|2|||
42259699|NCT01000051|76086288|FG000|Overall Study|Withdrawal by Subject|1|||
42259700|NCT01000051|76086289|FG001|Overall Study|Withdrawal by Subject|1|||
42259701|NCT01000051|76086288|FG000|Overall Study|Disease Progression|1|||
42259702|NCT01000051|76086289|FG001|Overall Study|Disease Progression|0|||
42259703|NCT01000051|76086288|FG000|Overall Study|Serious noncompliance|1|||
42259704|NCT01000051|76086289|FG001|Overall Study|Serious noncompliance|0|||
42259705|NCT00953160|76086295|FG000|Overall Study|Lost to Follow-up|23|||
42259706|NCT00953160|76086295|FG000|Overall Study|Withdrawal by Subject|4|||
42259707|NCT00913497|76086322|FG000|Overall Study|Adverse Event|1|||
42259708|NCT00913497|76086322|FG000|Overall Study|Withdrawal by Subject|2|||
42259709|NCT00874822|76086328|FG000|Overall Study|excluded by criteria|8|||
42259710|NCT00556933|76086345|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
42259711|NCT00556933|76086346|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
42259712|NCT00556933|76086347|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
42259713|NCT00556933|76086348|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
42259714|NCT00556933|76086345|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
42259715|NCT00556933|76086346|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
42259716|NCT00556933|76086347|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
42259717|NCT00556933|76086348|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
42259718|NCT00556933|76086345|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
42323023|NCT02284178|76160458|FG000|Overall Study|Met exclusion criteria|49|||
42323024|NCT02284178|76160459|FG001|Overall Study|Met exclusion criteria|54|||
42323025|NCT01643408|76160465|FG000|Overall Study|Adverse Event|12|||
42259719|NCT00556933|76086346|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
42323026|NCT01643408|76160465|FG000|Overall Study|Other|2|||
42323027|NCT02283788|76160473|FG000|Overall Study|Adverse Event|1|||
42323028|NCT02283788|76160474|FG001|Overall Study|Adverse Event|3|||
42323029|NCT02283788|76160475|FG002|Overall Study|Adverse Event|5|||
42323030|NCT02283788|76160476|FG003|Overall Study|Adverse Event|1|||
42323031|NCT02283788|76160473|FG000|Overall Study|Withdrawal by Subject|0|||
42323032|NCT02283788|76160474|FG001|Overall Study|Withdrawal by Subject|1|||
42323033|NCT02283788|76160475|FG002|Overall Study|Withdrawal by Subject|0|||
42323034|NCT02283788|76160476|FG003|Overall Study|Withdrawal by Subject|1|||
42323035|NCT01739764|76160489|FG000|Overall Study|Adverse Event|0|||
42323036|NCT01739764|76160490|FG001|Overall Study|Adverse Event|3|||
42323037|NCT01739764|76160491|FG002|Overall Study|Adverse Event|4|||
42323038|NCT01739764|76160489|FG000|Overall Study|Death|4|||
42323039|NCT01739764|76160490|FG001|Overall Study|Death|6|||
42323040|NCT01739764|76160491|FG002|Overall Study|Death|38|||
42323041|NCT01739764|76160489|FG000|Overall Study|Lost to Follow-up|0|||
42323042|NCT01739764|76160490|FG001|Overall Study|Lost to Follow-up|0|||
42323043|NCT01739764|76160491|FG002|Overall Study|Lost to Follow-up|5|||
42323044|NCT01739764|76160489|FG000|Overall Study|Non-Compliance|0|||
42323045|NCT01739764|76160490|FG001|Overall Study|Non-Compliance|0|||
42323046|NCT01739764|76160491|FG002|Overall Study|Non-Compliance|1|||
42323047|NCT01739764|76160489|FG000|Overall Study|Multiple Reasons|3|||
42323048|NCT01739764|76160490|FG001|Overall Study|Multiple Reasons|2|||
42323049|NCT01739764|76160491|FG002|Overall Study|Multiple Reasons|3|||
42323050|NCT01739764|76160489|FG000|Overall Study|Physician Decision|2|||
42323051|NCT01739764|76160490|FG001|Overall Study|Physician Decision|2|||
42323052|NCT01739764|76160491|FG002|Overall Study|Physician Decision|4|||
42323053|NCT01739764|76160489|FG000|Overall Study|Progressive Disease|3|||
42323054|NCT01739764|76160490|FG001|Overall Study|Progressive Disease|5|||
42323055|NCT01739764|76160491|FG002|Overall Study|Progressive Disease|16|||
42323056|NCT01739764|76160489|FG000|Overall Study|Protocol Violation|0|||
42323057|NCT01739764|76160490|FG001|Overall Study|Protocol Violation|0|||
42323058|NCT01739764|76160491|FG002|Overall Study|Protocol Violation|2|||
42323059|NCT01739764|76160489|FG000|Overall Study|Study Terminated by Sponsor|8|||
42323060|NCT01739764|76160490|FG001|Overall Study|Study Terminated by Sponsor|13|||
42323061|NCT01739764|76160491|FG002|Overall Study|Study Terminated by Sponsor|26|||
42323062|NCT01739764|76160489|FG000|Overall Study|Withdrawal by Subject|6|||
42323063|NCT01739764|76160490|FG001|Overall Study|Withdrawal by Subject|5|||
42323064|NCT01739764|76160491|FG002|Overall Study|Withdrawal by Subject|27|||
42323065|NCT01700530|76160502|FG000|Overall Study|Withdrawal by Subject|0|||
42323066|NCT01700530|76160503|FG001|Overall Study|Withdrawal by Subject|3|||
42323067|NCT01700530|76160504|FG002|Overall Study|Withdrawal by Subject|1|||
42323068|NCT01700140|76160515|FG000|Overall Study|Use of rescue drugs|3|||
42323069|NCT01700140|76160516|FG001|Overall Study|Use of rescue drugs|3|||
42323070|NCT01700140|76160517|FG002|Overall Study|Use of rescue drugs|1|||
42323071|NCT01700140|76160515|FG000|Overall Study|Discontinuation of radiotherapy|1|||
42323072|NCT01700140|76160516|FG001|Overall Study|Discontinuation of radiotherapy|0|||
42323073|NCT01700140|76160517|FG002|Overall Study|Discontinuation of radiotherapy|0|||
42259720|NCT00556933|76086347|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
42259721|NCT00556933|76086348|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
42259722|NCT00556933|76086345|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
42259723|NCT00556933|76086346|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
42259724|NCT00556933|76086347|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
42259725|NCT00556933|76086348|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
42259726|NCT00556933|76086345|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
42259727|NCT00556933|76086346|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
42259728|NCT00556933|76086347|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
42259729|NCT00556933|76086348|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
42259730|NCT00556933|76086345|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
42259731|NCT00556933|76086346|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
42259732|NCT00556933|76086347|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
42259733|NCT00556933|76086348|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
42323074|NCT01700140|76160515|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
42323075|NCT01700140|76160516|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
42323076|NCT01700140|76160517|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
42323077|NCT01700140|76160515|FG000|Overall Study|Aggravation of symptoms|1|||
42323078|NCT01700140|76160516|FG001|Overall Study|Aggravation of symptoms|0|||
42323079|NCT01700140|76160517|FG002|Overall Study|Aggravation of symptoms|0|||
42323080|NCT01700140|76160515|FG000|Overall Study|Adverse Event|0|||
42323081|NCT01700140|76160516|FG001|Overall Study|Adverse Event|1|||
42323082|NCT01700140|76160517|FG002|Overall Study|Adverse Event|0|||
41994803|NCT00195494|75803056|FG004|Year 1|Adverse Event|34|||
41994804|NCT00195494|75803057|FG005|Year 1|Adverse Event|27|||
42323083|NCT01700140|76160515|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
42323084|NCT01700140|76160516|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
42323085|NCT01700140|76160517|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
42323086|NCT01717456|76160530|FG000|End of Treatment|Physician Decision|0|||
42323087|NCT01717456|76160531|FG001|End of Treatment|Physician Decision|1|||
42323088|NCT01717456|76160530|FG000|End of Treatment|Lost to Follow-up|0|||
42323089|NCT01717456|76160531|FG001|End of Treatment|Lost to Follow-up|1|||
42323090|NCT01717456|76160530|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
42323091|NCT01717456|76160531|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
42323092|NCT01699750|76160540|FG000|Overall Study|Withdrew Consent|0|||
42323093|NCT01699750|76160541|FG001|Overall Study|Withdrew Consent|1|||
42323094|NCT01699750|76160540|FG000|Overall Study|Other|0|||
42323095|NCT01699750|76160541|FG001|Overall Study|Other|2|||
42323096|NCT01716754|76160555|FG000|Overall Study|Death|0|||
42323097|NCT01716754|76160556|FG001|Overall Study|Death|0|||
42323098|NCT01716754|76160557|FG002|Overall Study|Death|0|||
42323099|NCT01716754|76160558|FG003|Overall Study|Death|1|||
42323100|NCT01716754|76160555|FG000|Overall Study|Protocol deviation|0|||
42323101|NCT01716754|76160556|FG001|Overall Study|Protocol deviation|2|||
42323102|NCT01716754|76160557|FG002|Overall Study|Protocol deviation|7|||
42323103|NCT01716754|76160558|FG003|Overall Study|Protocol deviation|2|||
42323104|NCT01716754|76160555|FG000|Overall Study|Non-compliance with study treatment|0|||
42323105|NCT01716754|76160556|FG001|Overall Study|Non-compliance with study treatment|0|||
42323106|NCT01716754|76160557|FG002|Overall Study|Non-compliance with study treatment|1|||
42323107|NCT01716754|76160558|FG003|Overall Study|Non-compliance with study treatment|0|||
42323108|NCT01716754|76160555|FG000|Overall Study|Physician Decision|1|||
42323109|NCT01716754|76160556|FG001|Overall Study|Physician Decision|0|||
42323110|NCT01716754|76160557|FG002|Overall Study|Physician Decision|0|||
42323111|NCT01716754|76160558|FG003|Overall Study|Physician Decision|0|||
42323112|NCT01716754|76160555|FG000|Overall Study|Lost to Follow-up|1|||
42323113|NCT01716754|76160556|FG001|Overall Study|Lost to Follow-up|0|||
42323114|NCT01716754|76160557|FG002|Overall Study|Lost to Follow-up|0|||
42323115|NCT01716754|76160558|FG003|Overall Study|Lost to Follow-up|1|||
42323116|NCT01716754|76160555|FG000|Overall Study|Adverse Event|4|||
42323117|NCT01716754|76160556|FG001|Overall Study|Adverse Event|2|||
42323118|NCT01716754|76160557|FG002|Overall Study|Adverse Event|2|||
42323119|NCT01716754|76160558|FG003|Overall Study|Adverse Event|1|||
42323120|NCT01716754|76160555|FG000|Overall Study|Withdrawal by Subject|5|||
42323121|NCT01716754|76160556|FG001|Overall Study|Withdrawal by Subject|0|||
42323122|NCT01716754|76160557|FG002|Overall Study|Withdrawal by Subject|4|||
42323123|NCT01716754|76160558|FG003|Overall Study|Withdrawal by Subject|3|||
42323124|NCT01698814|76160569|FG000|Overall Study|Adverse Event|0|||
42323125|NCT01698814|76160570|FG001|Overall Study|Adverse Event|2|||
42323126|NCT01698814|76160569|FG000|Overall Study|Lost to Follow-up|0|||
41994805|NCT00195494|75803052|FG000|Year 1|System Toxicity|0|||
41994806|NCT00195494|75803053|FG001|Year 1|System Toxicity|0|||
41994807|NCT00195494|75803054|FG002|Year 1|System Toxicity|0|||
42323127|NCT01698814|76160570|FG001|Overall Study|Lost to Follow-up|1|||
42323128|NCT01698814|76160569|FG000|Overall Study|Pregnancy|1|||
42323129|NCT01698814|76160570|FG001|Overall Study|Pregnancy|0|||
42323130|NCT01698814|76160569|FG000|Overall Study|Randomized in error|1|||
42323131|NCT01698814|76160570|FG001|Overall Study|Randomized in error|0|||
42323132|NCT01738984|76160578|FG000|Overall Study|Pregnancy|4|||
42323133|NCT01738984|76160579|FG001|Overall Study|Pregnancy|0|||
42323134|NCT01738984|76160578|FG000|Overall Study|Withdrawal by Subject|1|||
42323135|NCT01738984|76160579|FG001|Overall Study|Withdrawal by Subject|0|||
42323136|NCT01738984|76160578|FG000|Overall Study|Lost to Follow-up|59|||
42323137|NCT01738984|76160579|FG001|Overall Study|Lost to Follow-up|39|||
42323138|NCT01738594|76160588|FG000|Registration and Treatment Start|Adverse Event|0|||
42323139|NCT01738594|76160589|FG001|Registration and Treatment Start|Adverse Event|1|||
42323140|NCT01738594|76160590|FG002|Registration and Treatment Start|Adverse Event|0|||
42323141|NCT01738594|76160591|FG003|Registration and Treatment Start|Adverse Event|0|||
42323142|NCT01738594|76160592|FG004|Registration and Treatment Start|Adverse Event|0|||
42323143|NCT01738594|76160593|FG005|Registration and Treatment Start|Adverse Event|0|||
42323144|NCT01738594|76160594|FG006|Registration and Treatment Start|Adverse Event|0|||
42323145|NCT01738594|76160595|FG007|Registration and Treatment Start|Adverse Event|0|||
42323146|NCT01738594|76160588|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
42323147|NCT01738594|76160589|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
42323148|NCT01738594|76160590|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
42323149|NCT01738594|76160591|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
42323150|NCT01738594|76160592|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
42323151|NCT01738594|76160593|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
42323152|NCT01738594|76160594|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
42323153|NCT01738594|76160595|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
42323154|NCT01738594|76160588|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
42323155|NCT01738594|76160589|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
42323156|NCT01738594|76160590|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
42323157|NCT01738594|76160591|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
42323158|NCT01738594|76160592|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
42323159|NCT01738594|76160593|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
42323160|NCT01738594|76160594|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
42323161|NCT01738594|76160595|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
42323162|NCT01738594|76160588|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
42323163|NCT01738594|76160589|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
42323164|NCT01738594|76160590|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
42323165|NCT01738594|76160591|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
42323166|NCT01738594|76160592|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
42323167|NCT01738594|76160593|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
42323168|NCT01738594|76160594|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
42323169|NCT01738594|76160595|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
42323170|NCT01738594|76160588|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
42259734|NCT00556933|76086345|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
42259735|NCT00556933|76086346|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
42259736|NCT00556933|76086347|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
42259737|NCT00556933|76086348|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
42259738|NCT00556933|76086345|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
42259739|NCT00556933|76086346|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
42259740|NCT00556933|76086347|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
42259741|NCT00556933|76086348|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
42259742|NCT00556933|76086345|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
42259743|NCT00556933|76086346|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
42259744|NCT00556933|76086347|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
42259745|NCT00556933|76086348|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
42259746|NCT00556933|76086345|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
42259747|NCT00556933|76086346|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
42259748|NCT00556933|76086347|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
42259749|NCT00556933|76086348|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
42259750|NCT00556933|76086345|FG000|CNI Withdrawal vs. Minimization|Death|0|||
42259751|NCT00556933|76086346|FG001|CNI Withdrawal vs. Minimization|Death|0|||
42259752|NCT00556933|76086347|FG002|CNI Withdrawal vs. Minimization|Death|0|||
42259753|NCT00556933|76086348|FG003|CNI Withdrawal vs. Minimization|Death|1|||
42259754|NCT00280917|76086387|FG000|Overall Study|Adverse Event|1|||
42259755|NCT00280917|76086388|FG001|Overall Study|Adverse Event|1|||
42259756|NCT00280917|76086389|FG002|Overall Study|Adverse Event|4|||
42259757|NCT00280917|76086390|FG003|Overall Study|Adverse Event|1|||
42259758|NCT00280917|76086387|FG000|Overall Study|Change Therapy|1|||
42259759|NCT00280917|76086388|FG001|Overall Study|Change Therapy|2|||
42259760|NCT00280917|76086389|FG002|Overall Study|Change Therapy|0|||
42259761|NCT00280917|76086390|FG003|Overall Study|Change Therapy|0|||
42259762|NCT00280917|76086387|FG000|Overall Study|Withdrawal by Subject|0|||
42259763|NCT00280917|76086388|FG001|Overall Study|Withdrawal by Subject|2|||
42259764|NCT00280917|76086389|FG002|Overall Study|Withdrawal by Subject|0|||
42259765|NCT00280917|76086390|FG003|Overall Study|Withdrawal by Subject|1|||
42259766|NCT00280917|76086387|FG000|Overall Study|Noncompliance|0|||
42259767|NCT00280917|76086388|FG001|Overall Study|Noncompliance|1|||
42259768|NCT00280917|76086389|FG002|Overall Study|Noncompliance|2|||
42259769|NCT00280917|76086390|FG003|Overall Study|Noncompliance|0|||
42323171|NCT01738594|76160589|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
42323172|NCT01738594|76160590|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
42323173|NCT01738594|76160591|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
42323174|NCT01738594|76160592|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
42323175|NCT01738594|76160593|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
42323176|NCT01738594|76160594|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
42323177|NCT01738594|76160595|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
42323178|NCT01738594|76160588|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
42323179|NCT01738594|76160589|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
42323180|NCT01738594|76160590|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
42323181|NCT01738594|76160591|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
42323182|NCT01738594|76160592|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
42323183|NCT01738594|76160593|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
42323184|NCT01738594|76160594|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
42323185|NCT01738594|76160595|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
42323186|NCT01738594|76160588|FG000|Follow up for 1 Year|Death|0|||
42323187|NCT01738594|76160589|FG001|Follow up for 1 Year|Death|0|||
42323188|NCT01738594|76160590|FG002|Follow up for 1 Year|Death|0|||
42323189|NCT01738594|76160591|FG003|Follow up for 1 Year|Death|0|||
42323190|NCT01738594|76160592|FG004|Follow up for 1 Year|Death|0|||
42323191|NCT01738594|76160593|FG005|Follow up for 1 Year|Death|1|||
42323192|NCT01738594|76160594|FG006|Follow up for 1 Year|Death|0|||
42323193|NCT01738594|76160595|FG007|Follow up for 1 Year|Death|0|||
42323194|NCT01738594|76160588|FG000|Follow up for 1 Year|Other|0|||
42323195|NCT01738594|76160589|FG001|Follow up for 1 Year|Other|0|||
42323196|NCT01738594|76160590|FG002|Follow up for 1 Year|Other|0|||
42323197|NCT01738594|76160591|FG003|Follow up for 1 Year|Other|0|||
42323198|NCT01738594|76160592|FG004|Follow up for 1 Year|Other|0|||
42323199|NCT01738594|76160593|FG005|Follow up for 1 Year|Other|2|||
42323200|NCT01738594|76160594|FG006|Follow up for 1 Year|Other|0|||
42323201|NCT01738594|76160595|FG007|Follow up for 1 Year|Other|0|||
42323202|NCT01738438|76160605|FG000|Overall Study|Disease Progression|32|||
42323203|NCT01738438|76160605|FG000|Overall Study|Adverse Event|3|||
42323204|NCT01716520|76160609|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
42323205|NCT01716520|76160610|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
42323206|NCT01716520|76160611|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
42323207|NCT01716520|76160612|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
42323208|NCT01716520|76160613|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
42323209|NCT01716520|76160614|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
42323210|NCT01716520|76160609|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
42323211|NCT01716520|76160610|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
42323212|NCT01716520|76160611|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
42323213|NCT01716520|76160612|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
42323214|NCT01716520|76160613|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
42323215|NCT01716520|76160614|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
42323216|NCT01716520|76160609|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42323217|NCT01716520|76160610|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
42323218|NCT01716520|76160611|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42323219|NCT01716520|76160612|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42323220|NCT01716520|76160613|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42323221|NCT01716520|76160614|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42323222|NCT01716520|76160609|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
42323223|NCT01716520|76160610|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
42323224|NCT01716520|76160611|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
42323225|NCT01716520|76160612|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
42323226|NCT01716520|76160613|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
42323227|NCT01716520|76160614|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
42323228|NCT01716520|76160609|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
41994808|NCT00195494|75803055|FG003|Year 1|System Toxicity|0|||
41994809|NCT00195494|75803056|FG004|Year 1|System Toxicity|0|||
41994810|NCT00195494|75803057|FG005|Year 1|System Toxicity|1|||
41994811|NCT00195494|75803052|FG000|Year 1|Lack of Efficacy|0|||
41994812|NCT00195494|75803053|FG001|Year 1|Lack of Efficacy|0|||
42323229|NCT01716520|76160610|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
42323230|NCT01716520|76160611|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
42323231|NCT01716520|76160612|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
42323232|NCT01716520|76160613|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
41994813|NCT00195494|75803054|FG002|Year 1|Lack of Efficacy|0|||
42323233|NCT01716520|76160614|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
42323234|NCT01716520|76160609|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
41994814|NCT00195494|75803055|FG003|Year 1|Lack of Efficacy|0|||
42323235|NCT01716520|76160610|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
42323236|NCT01716520|76160611|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
42323237|NCT01716520|76160612|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
42323238|NCT01716520|76160613|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
42323239|NCT01716520|76160614|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
42323240|NCT01716520|76160609|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
42323241|NCT01716520|76160610|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
42323242|NCT01716520|76160611|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
42323243|NCT01716520|76160612|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
42323244|NCT01716520|76160613|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
42323245|NCT01716520|76160614|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
42323246|NCT01716520|76160609|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
42323247|NCT01716520|76160610|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
42323248|NCT01716520|76160611|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
42323249|NCT01716520|76160612|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
42323250|NCT01716520|76160613|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
42323251|NCT01716520|76160614|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
42323252|NCT01716520|76160609|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
42323253|NCT01716520|76160610|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
42323254|NCT01716520|76160611|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
42323255|NCT01716520|76160612|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
42323256|NCT01716520|76160613|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
42323257|NCT01716520|76160614|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
42323258|NCT01716520|76160609|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
42323259|NCT01716520|76160610|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
42323260|NCT01716520|76160611|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
42323261|NCT01716520|76160612|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
42323262|NCT01716520|76160613|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
42323263|NCT01716520|76160614|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
42323264|NCT01716520|76160609|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
42323265|NCT01716520|76160610|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
42323266|NCT01716520|76160611|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
42323267|NCT01716520|76160612|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
42323268|NCT01716520|76160613|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
42323269|NCT01716520|76160614|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
42323270|NCT01716520|76160609|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
42323271|NCT01716520|76160610|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
42323272|NCT01716520|76160611|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
42323273|NCT01716520|76160612|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
42323274|NCT01716520|76160613|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
42323275|NCT01716520|76160614|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
42323276|NCT01716520|76160609|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
42323277|NCT01716520|76160610|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
42323278|NCT01716520|76160611|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
42323279|NCT01716520|76160612|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
42323280|NCT01716520|76160613|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
42323281|NCT01716520|76160614|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
42323282|NCT01716520|76160609|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42323283|NCT01716520|76160610|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42323284|NCT01716520|76160611|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42323285|NCT01716520|76160612|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42323286|NCT01716520|76160613|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42323287|NCT01716520|76160614|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
42323288|NCT01716520|76160609|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
42323289|NCT01716520|76160610|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
42323290|NCT01716520|76160611|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
42323291|NCT01716520|76160612|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
42323292|NCT01716520|76160613|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
42323293|NCT01716520|76160614|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
42323294|NCT01698268|76160624|FG000|Overall Study|Physician Decision|2|||
42323295|NCT01698268|76160625|FG001|Overall Study|Physician Decision|1|||
42323296|NCT01697956|76160633|FG000|Overall Study|Protocol Violation|1|||
42323297|NCT01697956|76160634|FG001|Overall Study|Protocol Violation|1|||
42323298|NCT01697800|76160648|FG000|Overall Study|Death|0|||
42323299|NCT01697800|76160649|FG001|Overall Study|Death|1|||
42323300|NCT01644500|76160658|FG000|Overall Study|Adverse Event|6|||
42323301|NCT01644500|76160659|FG001|Overall Study|Adverse Event|1|||
42323302|NCT01644500|76160660|FG002|Overall Study|Adverse Event|2|||
42323303|NCT01644500|76160658|FG000|Overall Study|Death|0|||
42323304|NCT01644500|76160659|FG001|Overall Study|Death|1|||
42323305|NCT01644500|76160660|FG002|Overall Study|Death|0|||
42323306|NCT01644500|76160658|FG000|Overall Study|Lost to Follow-up|3|||
42323307|NCT01644500|76160659|FG001|Overall Study|Lost to Follow-up|8|||
42323308|NCT01644500|76160660|FG002|Overall Study|Lost to Follow-up|0|||
42323309|NCT01644500|76160658|FG000|Overall Study|Protocol Violation|1|||
42323310|NCT01644500|76160659|FG001|Overall Study|Protocol Violation|1|||
42323311|NCT01644500|76160660|FG002|Overall Study|Protocol Violation|0|||
42323312|NCT01644500|76160658|FG000|Overall Study|Withdrawal by Subject|11|||
42323313|NCT01644500|76160659|FG001|Overall Study|Withdrawal by Subject|12|||
42323314|NCT01644500|76160660|FG002|Overall Study|Withdrawal by Subject|12|||
42323315|NCT01644500|76160658|FG000|Overall Study|Physician Decision|1|||
42323316|NCT01644500|76160659|FG001|Overall Study|Physician Decision|1|||
42323317|NCT01644500|76160660|FG002|Overall Study|Physician Decision|1|||
42323318|NCT01604824|76160672|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
42323319|NCT01604824|76160673|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
42323320|NCT01604824|76160674|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
42323321|NCT01604824|76160675|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
42323322|NCT01604824|76160676|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
42323323|NCT01604824|76160677|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
42323324|NCT01604824|76160672|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
42323325|NCT01604824|76160673|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
42323326|NCT01604824|76160674|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
42323327|NCT01604824|76160675|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
42323328|NCT01604824|76160676|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
42323329|NCT01604824|76160677|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
42323330|NCT01716052|76160691|FG000|Overall Study|Withdrawal of funding|1|||
42323331|NCT01716052|76160692|FG001|Overall Study|Withdrawal of funding|1|||
42323332|NCT01641692|76160698|FG000|Treatment Period 1|Adverse Event|1|||
42323333|NCT01641692|76160699|FG001|Treatment Period 1|Adverse Event|0|||
42323334|NCT01641692|76160700|FG002|Treatment Period 1|Adverse Event|0|||
42323335|NCT01641692|76160701|FG003|Treatment Period 1|Adverse Event|0|||
42323336|NCT01641692|76160702|FG004|Treatment Period 1|Adverse Event|0|||
42323337|NCT01641692|76160703|FG005|Treatment Period 1|Adverse Event|0|||
42323338|NCT01641692|76160704|FG006|Treatment Period 1|Adverse Event|0|||
42323339|NCT01641692|76160705|FG007|Treatment Period 1|Adverse Event|0|||
42323340|NCT01641692|76160698|FG000|Treatment Period 1|Lack of Efficacy|0|||
42323341|NCT01641692|76160699|FG001|Treatment Period 1|Lack of Efficacy|0|||
42323342|NCT01641692|76160700|FG002|Treatment Period 1|Lack of Efficacy|0|||
42323343|NCT01641692|76160701|FG003|Treatment Period 1|Lack of Efficacy|0|||
42323344|NCT01641692|76160702|FG004|Treatment Period 1|Lack of Efficacy|0|||
42323345|NCT01641692|76160703|FG005|Treatment Period 1|Lack of Efficacy|0|||
42323346|NCT01641692|76160704|FG006|Treatment Period 1|Lack of Efficacy|0|||
42323347|NCT01641692|76160705|FG007|Treatment Period 1|Lack of Efficacy|1|||
42323348|NCT01641692|76160698|FG000|Treatment Period 1|Protocol Violation|1|||
42323349|NCT01641692|76160699|FG001|Treatment Period 1|Protocol Violation|0|||
42323350|NCT01641692|76160700|FG002|Treatment Period 1|Protocol Violation|0|||
42323351|NCT01641692|76160701|FG003|Treatment Period 1|Protocol Violation|0|||
41994815|NCT00195494|75803056|FG004|Year 1|Lack of Efficacy|24|||
41994816|NCT00195494|75803057|FG005|Year 1|Lack of Efficacy|9|||
41994817|NCT00195494|75803052|FG000|Year 1|Compliance|0|||
41994818|NCT00195494|75803053|FG001|Year 1|Compliance|0|||
41994819|NCT00195494|75803054|FG002|Year 1|Compliance|0|||
42259770|NCT00006478|76086409|FG000|Overall Study|Vaccine could not be produced|1|||
42259771|NCT00006478|76086409|FG000|Overall Study|Physician Decision|6|||
42259772|NCT05718466|76086415|FG000|Overall Study|Withdrawal by Subject|1|||
42259773|NCT05718466|76086416|FG001|Overall Study|Withdrawal by Subject|2|||
42259774|NCT05718466|76086415|FG000|Overall Study|Death|0|||
42259775|NCT05718466|76086416|FG001|Overall Study|Death|1|||
42259776|NCT04938453|76086424|FG000|Washout Period 1|Adverse Event|1|||
42259777|NCT04938453|76086425|FG001|Washout Period 1|Adverse Event|0|||
42259778|NCT04938453|76086424|FG000|Washout Period 1|Physician Decision|0|||
42259779|NCT04938453|76086425|FG001|Washout Period 1|Physician Decision|1|||
42323352|NCT01641692|76160702|FG004|Treatment Period 1|Protocol Violation|2|||
42323353|NCT01641692|76160703|FG005|Treatment Period 1|Protocol Violation|0|||
42323354|NCT01641692|76160704|FG006|Treatment Period 1|Protocol Violation|0|||
42323355|NCT01641692|76160705|FG007|Treatment Period 1|Protocol Violation|0|||
41994820|NCT00195494|75803055|FG003|Year 1|Compliance|0|||
41994821|NCT00195494|75803056|FG004|Year 1|Compliance|5|||
41994822|NCT00195494|75803057|FG005|Year 1|Compliance|1|||
42259780|NCT04147260|76086470|FG000|Overall Study|Adverse Event|1|||
42259781|NCT04147260|76086471|FG001|Overall Study|Adverse Event|0|||
42259782|NCT04147260|76086472|FG002|Overall Study|Adverse Event|1|||
41994823|NCT00195494|75803052|FG000|Year 1|Lost to Follow-up|0|||
41994824|NCT00195494|75803053|FG001|Year 1|Lost to Follow-up|0|||
41994825|NCT00195494|75803054|FG002|Year 1|Lost to Follow-up|0|||
41994826|NCT00195494|75803055|FG003|Year 1|Lost to Follow-up|0|||
41994827|NCT00195494|75803056|FG004|Year 1|Lost to Follow-up|1|||
42133549|NCT00375219|75944459|FG002|Overall Study|Hematologic resistance|0|||
42133550|NCT00375219|75944457|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
42133551|NCT00375219|75944458|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
42259783|NCT04147260|76086473|FG003|Overall Study|Adverse Event|2|||
42259784|NCT04147260|76086474|FG004|Overall Study|Adverse Event|0|||
41994828|NCT00195494|75803057|FG005|Year 1|Lost to Follow-up|0|||
41994829|NCT00195494|75803052|FG000|Year 1|Missed >4 consecutive doses|0|||
41994830|NCT00195494|75803053|FG001|Year 1|Missed >4 consecutive doses|0|||
41994831|NCT00195494|75803054|FG002|Year 1|Missed >4 consecutive doses|0|||
41994832|NCT00195494|75803055|FG003|Year 1|Missed >4 consecutive doses|0|||
41994833|NCT00195494|75803056|FG004|Year 1|Missed >4 consecutive doses|3|||
41994834|NCT00195494|75803057|FG005|Year 1|Missed >4 consecutive doses|2|||
41994835|NCT00195494|75803052|FG000|Year 1|Protocol deviation|0|||
41994836|NCT00195494|75803053|FG001|Year 1|Protocol deviation|0|||
41994837|NCT00195494|75803054|FG002|Year 1|Protocol deviation|0|||
41994838|NCT00195494|75803055|FG003|Year 1|Protocol deviation|0|||
41994839|NCT00195494|75803056|FG004|Year 1|Protocol deviation|2|||
41994840|NCT00195494|75803057|FG005|Year 1|Protocol deviation|3|||
41994841|NCT00195494|75803052|FG000|Year 1|Physician Decision|0|||
41994842|NCT00195494|75803053|FG001|Year 1|Physician Decision|0|||
41994843|NCT00195494|75803054|FG002|Year 1|Physician Decision|0|||
41994844|NCT00195494|75803055|FG003|Year 1|Physician Decision|0|||
41994845|NCT00195494|75803056|FG004|Year 1|Physician Decision|1|||
41994846|NCT00195494|75803057|FG005|Year 1|Physician Decision|0|||
41994847|NCT00195494|75803052|FG000|Year 1|Withdrawal by Subject|0|||
41994848|NCT00195494|75803053|FG001|Year 1|Withdrawal by Subject|0|||
41994849|NCT00195494|75803054|FG002|Year 1|Withdrawal by Subject|0|||
41994850|NCT00195494|75803055|FG003|Year 1|Withdrawal by Subject|0|||
41994851|NCT00195494|75803056|FG004|Year 1|Withdrawal by Subject|8|||
41994852|NCT00195494|75803057|FG005|Year 1|Withdrawal by Subject|9|||
41994853|NCT00195494|75803052|FG000|Year 1|Protocol Violation|0|||
41994854|NCT00195494|75803053|FG001|Year 1|Protocol Violation|0|||
41994855|NCT00195494|75803054|FG002|Year 1|Protocol Violation|0|||
41994856|NCT00195494|75803055|FG003|Year 1|Protocol Violation|0|||
41994857|NCT00195494|75803056|FG004|Year 1|Protocol Violation|1|||
42259785|NCT04147260|76086470|FG000|Overall Study|Withdrawal by Subject|0|||
42259786|NCT04147260|76086471|FG001|Overall Study|Withdrawal by Subject|0|||
42259787|NCT04147260|76086472|FG002|Overall Study|Withdrawal by Subject|1|||
42259788|NCT04147260|76086473|FG003|Overall Study|Withdrawal by Subject|1|||
42259789|NCT04147260|76086474|FG004|Overall Study|Withdrawal by Subject|0|||
42259790|NCT04134728|76086491|FG000|Overall Study|Adverse Event|3|||
42259791|NCT04134728|76086492|FG001|Overall Study|Adverse Event|2|||
42259792|NCT04134728|76086493|FG002|Overall Study|Adverse Event|9|||
42259793|NCT04134728|76086494|FG003|Overall Study|Adverse Event|0|||
42259794|NCT04134728|76086495|FG004|Overall Study|Adverse Event|0|||
42259795|NCT04134728|76086496|FG005|Overall Study|Adverse Event|0|||
42259796|NCT04134728|76086491|FG000|Overall Study|Lack of Efficacy|3|||
42259797|NCT04134728|76086492|FG001|Overall Study|Lack of Efficacy|3|||
42259798|NCT04134728|76086493|FG002|Overall Study|Lack of Efficacy|1|||
42259799|NCT04134728|76086494|FG003|Overall Study|Lack of Efficacy|2|||
42259800|NCT04134728|76086495|FG004|Overall Study|Lack of Efficacy|0|||
42259801|NCT04134728|76086496|FG005|Overall Study|Lack of Efficacy|0|||
42259802|NCT04134728|76086491|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
42259803|NCT04134728|76086492|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
42323356|NCT01641692|76160698|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
41994858|NCT00195494|75803057|FG005|Year 1|Protocol Violation|1|||
41994859|NCT00195494|75803052|FG000|Year 2|Adverse Event|3|||
41994860|NCT00195494|75803053|FG001|Year 2|Adverse Event|7|||
41994861|NCT00195494|75803054|FG002|Year 2|Adverse Event|5|||
41994862|NCT00195494|75803055|FG003|Year 2|Adverse Event|9|||
42259804|NCT04134728|76086493|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
41994863|NCT00195494|75803056|FG004|Year 2|Adverse Event|0|||
41994864|NCT00195494|75803057|FG005|Year 2|Adverse Event|0|||
41994865|NCT00195494|75803052|FG000|Year 2|Lack of Efficacy|0|||
41994866|NCT00195494|75803053|FG001|Year 2|Lack of Efficacy|1|||
41994867|NCT00195494|75803054|FG002|Year 2|Lack of Efficacy|7|||
41994868|NCT00195494|75803055|FG003|Year 2|Lack of Efficacy|7|||
41994869|NCT00195494|75803056|FG004|Year 2|Lack of Efficacy|0|||
41994870|NCT00195494|75803057|FG005|Year 2|Lack of Efficacy|0|||
42259805|NCT04134728|76086494|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
42259806|NCT04134728|76086495|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
42259807|NCT04134728|76086496|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
42323357|NCT01641692|76160699|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
42323358|NCT01641692|76160700|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
42323359|NCT01641692|76160701|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
42323360|NCT01641692|76160702|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
42323361|NCT01641692|76160703|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
42323362|NCT01641692|76160704|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
42323363|NCT01641692|76160705|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
42323364|NCT01641692|76160698|FG000|Treatment Period 1|Lost to Follow-up|0|||
42323365|NCT01641692|76160699|FG001|Treatment Period 1|Lost to Follow-up|0|||
42323366|NCT01641692|76160700|FG002|Treatment Period 1|Lost to Follow-up|1|||
42323367|NCT01641692|76160701|FG003|Treatment Period 1|Lost to Follow-up|0|||
42323368|NCT01641692|76160702|FG004|Treatment Period 1|Lost to Follow-up|0|||
42323369|NCT01641692|76160703|FG005|Treatment Period 1|Lost to Follow-up|0|||
42323370|NCT01641692|76160704|FG006|Treatment Period 1|Lost to Follow-up|0|||
42323371|NCT01641692|76160705|FG007|Treatment Period 1|Lost to Follow-up|0|||
42323372|NCT01641692|76160698|FG000|Treatment Period 1|Physician Decision|0|||
42323373|NCT01641692|76160699|FG001|Treatment Period 1|Physician Decision|0|||
42323374|NCT01641692|76160700|FG002|Treatment Period 1|Physician Decision|0|||
42323375|NCT01641692|76160701|FG003|Treatment Period 1|Physician Decision|0|||
42323376|NCT01641692|76160702|FG004|Treatment Period 1|Physician Decision|1|||
42323377|NCT01641692|76160703|FG005|Treatment Period 1|Physician Decision|0|||
42323378|NCT01641692|76160704|FG006|Treatment Period 1|Physician Decision|0|||
42323379|NCT01641692|76160705|FG007|Treatment Period 1|Physician Decision|0|||
42323380|NCT01641692|76160698|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42323381|NCT01641692|76160699|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42323382|NCT01641692|76160700|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42323383|NCT01641692|76160701|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42323384|NCT01641692|76160702|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42323385|NCT01641692|76160703|FG005|Treatment Period 1|Withdrawal by Subject|2|||
42323386|NCT01641692|76160704|FG006|Treatment Period 1|Withdrawal by Subject|0|||
42323387|NCT01641692|76160705|FG007|Treatment Period 1|Withdrawal by Subject|1|||
42323388|NCT01641692|76160698|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
42323389|NCT01641692|76160699|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
42323390|NCT01641692|76160700|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
42323391|NCT01641692|76160701|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
42323392|NCT01641692|76160702|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
42323393|NCT01641692|76160703|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
42323394|NCT01641692|76160704|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
42323395|NCT01641692|76160705|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
42323396|NCT01641692|76160698|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
42323397|NCT01641692|76160699|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
42323398|NCT01641692|76160700|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
42323399|NCT01641692|76160701|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
42323400|NCT01641692|76160702|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
42323401|NCT01641692|76160703|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
42323402|NCT01641692|76160704|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
42323403|NCT01641692|76160705|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
42323404|NCT01641692|76160698|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
42323405|NCT01641692|76160699|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
42259808|NCT04134728|76086491|FG000|Overall Study|Protocol Deviation|0|||
42259809|NCT04134728|76086492|FG001|Overall Study|Protocol Deviation|0|||
42323406|NCT01641692|76160700|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
42323407|NCT01641692|76160701|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
42323408|NCT01641692|76160702|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
42323409|NCT01641692|76160703|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
42323410|NCT01641692|76160704|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
42323411|NCT01641692|76160705|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
42323412|NCT01641692|76160698|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
42259810|NCT04134728|76086493|FG002|Overall Study|Protocol Deviation|1|||
42259811|NCT04134728|76086494|FG003|Overall Study|Protocol Deviation|0|||
42259812|NCT04134728|76086495|FG004|Overall Study|Protocol Deviation|0|||
42259813|NCT04134728|76086496|FG005|Overall Study|Protocol Deviation|0|||
42259814|NCT04134728|76086491|FG000|Overall Study|Informed Consent Withdrawn|3|||
42323413|NCT01641692|76160699|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
42323414|NCT01641692|76160700|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
41994871|NCT00195494|75803052|FG000|Year 2|Compliance|1|||
41994872|NCT00195494|75803053|FG001|Year 2|Compliance|0|||
42323415|NCT01641692|76160701|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
42323416|NCT01641692|76160702|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
42323417|NCT01641692|76160703|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
42259815|NCT04134728|76086492|FG001|Overall Study|Informed Consent Withdrawn|6|||
42323418|NCT01641692|76160704|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
42323419|NCT01641692|76160705|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
42323420|NCT01641692|76160698|FG000|Treatment Period 2|Lack of Efficacy|1|||
42323421|NCT01641692|76160699|FG001|Treatment Period 2|Lack of Efficacy|0|||
42323422|NCT01641692|76160700|FG002|Treatment Period 2|Lack of Efficacy|0|||
42323423|NCT01641692|76160701|FG003|Treatment Period 2|Lack of Efficacy|0|||
42323424|NCT01641692|76160702|FG004|Treatment Period 2|Lack of Efficacy|0|||
42323425|NCT01641692|76160703|FG005|Treatment Period 2|Lack of Efficacy|0|||
42323426|NCT01641692|76160704|FG006|Treatment Period 2|Lack of Efficacy|0|||
42323427|NCT01641692|76160705|FG007|Treatment Period 2|Lack of Efficacy|0|||
42323428|NCT01641692|76160698|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
42323429|NCT01641692|76160699|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42323430|NCT01641692|76160700|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42323431|NCT01641692|76160701|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42323432|NCT01641692|76160702|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42259816|NCT04134728|76086493|FG002|Overall Study|Informed Consent Withdrawn|8|||
42323433|NCT01641692|76160703|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42323434|NCT01641692|76160704|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42323435|NCT01641692|76160705|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42323436|NCT01641692|76160698|FG000|Treatment Period 2|Lost to Follow-up|0|||
42323437|NCT01641692|76160699|FG001|Treatment Period 2|Lost to Follow-up|0|||
42323438|NCT01641692|76160700|FG002|Treatment Period 2|Lost to Follow-up|0|||
42323439|NCT01641692|76160701|FG003|Treatment Period 2|Lost to Follow-up|0|||
42323440|NCT01641692|76160702|FG004|Treatment Period 2|Lost to Follow-up|0|||
42323441|NCT01641692|76160703|FG005|Treatment Period 2|Lost to Follow-up|1|||
42323442|NCT01641692|76160704|FG006|Treatment Period 2|Lost to Follow-up|0|||
42323443|NCT01641692|76160705|FG007|Treatment Period 2|Lost to Follow-up|0|||
42323444|NCT01641692|76160698|FG000|Treatment Period 2|Withdrawal by Subject|1|||
42323445|NCT01641692|76160699|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42323446|NCT01641692|76160700|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42323447|NCT01641692|76160701|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42323448|NCT01641692|76160702|FG004|Treatment Period 2|Withdrawal by Subject|0|||
42323449|NCT01641692|76160703|FG005|Treatment Period 2|Withdrawal by Subject|1|||
42323450|NCT01641692|76160704|FG006|Treatment Period 2|Withdrawal by Subject|0|||
42259817|NCT04134728|76086494|FG003|Overall Study|Informed Consent Withdrawn|1|||
42259818|NCT04134728|76086495|FG004|Overall Study|Informed Consent Withdrawn|1|||
42259819|NCT04134728|76086496|FG005|Overall Study|Informed Consent Withdrawn|0|||
42259820|NCT04134728|76086491|FG000|Overall Study|Physician Decision|2|||
42259821|NCT04134728|76086492|FG001|Overall Study|Physician Decision|0|||
42259822|NCT04134728|76086493|FG002|Overall Study|Physician Decision|0|||
42259823|NCT04134728|76086494|FG003|Overall Study|Physician Decision|0|||
42259824|NCT04134728|76086495|FG004|Overall Study|Physician Decision|0|||
42259825|NCT04134728|76086496|FG005|Overall Study|Physician Decision|0|||
42259826|NCT04134728|76086491|FG000|Overall Study|Lost to Follow-up|1|||
42259827|NCT04134728|76086492|FG001|Overall Study|Lost to Follow-up|2|||
42259828|NCT04134728|76086493|FG002|Overall Study|Lost to Follow-up|1|||
42259829|NCT04134728|76086494|FG003|Overall Study|Lost to Follow-up|0|||
42259830|NCT04134728|76086495|FG004|Overall Study|Lost to Follow-up|0|||
42259831|NCT04134728|76086496|FG005|Overall Study|Lost to Follow-up|1|||
42259832|NCT04134728|76086491|FG000|Overall Study|Investigator Site Closed|0|||
42259833|NCT04134728|76086492|FG001|Overall Study|Investigator Site Closed|1|||
42259834|NCT04134728|76086493|FG002|Overall Study|Investigator Site Closed|1|||
42259835|NCT04134728|76086494|FG003|Overall Study|Investigator Site Closed|0|||
42259836|NCT04134728|76086495|FG004|Overall Study|Investigator Site Closed|0|||
42259837|NCT04134728|76086496|FG005|Overall Study|Investigator Site Closed|0|||
42323451|NCT01641692|76160705|FG007|Treatment Period 2|Withdrawal by Subject|1|||
42323452|NCT01641692|76160698|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
42323453|NCT01641692|76160699|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
42259838|NCT03886272|76086530|FG000|Period 1|Withdrawal by Subject|0|||
42259839|NCT03886272|76086531|FG001|Period 1|Withdrawal by Subject|0|||
42259840|NCT03886272|76086532|FG002|Period 1|Withdrawal by Subject|0|||
42259841|NCT03886272|76086533|FG003|Period 1|Withdrawal by Subject|0|||
42259842|NCT03886272|76086534|FG004|Period 1|Withdrawal by Subject|0|||
42259843|NCT03886272|76086535|FG005|Period 1|Withdrawal by Subject|1|||
42259844|NCT03886272|76086536|FG006|Period 1|Withdrawal by Subject|0|||
42323454|NCT01641692|76160700|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
42259845|NCT03732833|76086555|FG000|Overall Study|Adverse Event|0|||
42259846|NCT03732833|76086556|FG001|Overall Study|Adverse Event|3|||
42259847|NCT03732833|76086557|FG002|Overall Study|Adverse Event|1|||
42259848|NCT03732833|76086555|FG000|Overall Study|Withdrawal by Subject|11|||
42259849|NCT03732833|76086556|FG001|Overall Study|Withdrawal by Subject|13|||
42259850|NCT03732833|76086557|FG002|Overall Study|Withdrawal by Subject|8|||
41994873|NCT00195494|75803054|FG002|Year 2|Compliance|0|||
42259851|NCT03732833|76086555|FG000|Overall Study|Lost to Follow-up|3|||
42259852|NCT03732833|76086556|FG001|Overall Study|Lost to Follow-up|5|||
42259853|NCT03732833|76086557|FG002|Overall Study|Lost to Follow-up|4|||
42259854|NCT03732833|76086555|FG000|Overall Study|Pregnancy|0|||
42259855|NCT03732833|76086556|FG001|Overall Study|Pregnancy|2|||
42259856|NCT03732833|76086557|FG002|Overall Study|Pregnancy|0|||
42259857|NCT03732833|76086555|FG000|Overall Study|Physician Decision|2|||
42259858|NCT03732833|76086556|FG001|Overall Study|Physician Decision|3|||
41994874|NCT00195494|75803055|FG003|Year 2|Compliance|2|||
41994875|NCT00195494|75803056|FG004|Year 2|Compliance|0|||
41994876|NCT00195494|75803057|FG005|Year 2|Compliance|0|||
41994877|NCT00195494|75803052|FG000|Year 2|Lost to Follow-up|0|||
41994878|NCT00195494|75803053|FG001|Year 2|Lost to Follow-up|0|||
41994879|NCT00195494|75803054|FG002|Year 2|Lost to Follow-up|1|||
41994880|NCT00195494|75803055|FG003|Year 2|Lost to Follow-up|1|||
41994881|NCT00195494|75803056|FG004|Year 2|Lost to Follow-up|0|||
41994882|NCT00195494|75803057|FG005|Year 2|Lost to Follow-up|0|||
41994883|NCT00195494|75803052|FG000|Year 2|Missed >4 consecutive doses|1|||
41994884|NCT00195494|75803053|FG001|Year 2|Missed >4 consecutive doses|1|||
41994885|NCT00195494|75803054|FG002|Year 2|Missed >4 consecutive doses|1|||
42323455|NCT01641692|76160701|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
42323456|NCT01641692|76160702|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
42323457|NCT01641692|76160703|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
42323458|NCT01641692|76160704|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
42323459|NCT01641692|76160705|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
42323460|NCT01641692|76160698|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
42323461|NCT01641692|76160699|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
42323462|NCT01641692|76160700|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
42323463|NCT01641692|76160701|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
42323464|NCT01641692|76160702|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
42323465|NCT01641692|76160703|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
42323466|NCT01641692|76160704|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
42323467|NCT01641692|76160705|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
42323468|NCT01641692|76160698|FG000|Treatment Period 3|Adverse Event|0|||
42323469|NCT01641692|76160699|FG001|Treatment Period 3|Adverse Event|0|||
42323470|NCT01641692|76160700|FG002|Treatment Period 3|Adverse Event|0|||
42323471|NCT01641692|76160701|FG003|Treatment Period 3|Adverse Event|0|||
42323472|NCT01641692|76160702|FG004|Treatment Period 3|Adverse Event|0|||
42323473|NCT01641692|76160703|FG005|Treatment Period 3|Adverse Event|0|||
42323474|NCT01641692|76160704|FG006|Treatment Period 3|Adverse Event|1|||
42323475|NCT01641692|76160705|FG007|Treatment Period 3|Adverse Event|0|||
42323476|NCT01641692|76160698|FG000|Treatment Period 3|Protocol Violation|0|||
42323477|NCT01641692|76160699|FG001|Treatment Period 3|Protocol Violation|0|||
42323478|NCT01641692|76160700|FG002|Treatment Period 3|Protocol Violation|1|||
42323479|NCT01641692|76160701|FG003|Treatment Period 3|Protocol Violation|0|||
42323480|NCT01641692|76160702|FG004|Treatment Period 3|Protocol Violation|0|||
42323481|NCT01641692|76160703|FG005|Treatment Period 3|Protocol Violation|0|||
42323482|NCT01641692|76160704|FG006|Treatment Period 3|Protocol Violation|0|||
42323483|NCT01641692|76160705|FG007|Treatment Period 3|Protocol Violation|0|||
42323484|NCT01641692|76160698|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42323485|NCT01641692|76160699|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42323486|NCT01641692|76160700|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
41994886|NCT00195494|75803055|FG003|Year 2|Missed >4 consecutive doses|0|||
41994887|NCT00195494|75803056|FG004|Year 2|Missed >4 consecutive doses|0|||
41994888|NCT00195494|75803057|FG005|Year 2|Missed >4 consecutive doses|0|||
41994889|NCT00195494|75803052|FG000|Year 2|Protocol deviation|0|||
42323487|NCT01641692|76160701|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42323488|NCT01641692|76160702|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
41994890|NCT00195494|75803053|FG001|Year 2|Protocol deviation|1|||
41994891|NCT00195494|75803054|FG002|Year 2|Protocol deviation|0|||
42323489|NCT01641692|76160703|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42323490|NCT01641692|76160704|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
42323491|NCT01641692|76160705|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42323492|NCT01641692|76160698|FG000|Treatment Period 3|Lost to Follow-up|0|||
42323493|NCT01641692|76160699|FG001|Treatment Period 3|Lost to Follow-up|1|||
42323494|NCT01641692|76160700|FG002|Treatment Period 3|Lost to Follow-up|0|||
42323495|NCT01641692|76160701|FG003|Treatment Period 3|Lost to Follow-up|0|||
42323496|NCT01641692|76160702|FG004|Treatment Period 3|Lost to Follow-up|0|||
41994892|NCT00195494|75803055|FG003|Year 2|Protocol deviation|0|||
41994893|NCT00195494|75803056|FG004|Year 2|Protocol deviation|0|||
41994894|NCT00195494|75803057|FG005|Year 2|Protocol deviation|0|||
41994895|NCT00195494|75803052|FG000|Year 2|Physician Decision|1|||
41994896|NCT00195494|75803053|FG001|Year 2|Physician Decision|1|||
41994897|NCT00195494|75803054|FG002|Year 2|Physician Decision|0|||
41994898|NCT00195494|75803055|FG003|Year 2|Physician Decision|0|||
41994899|NCT00195494|75803056|FG004|Year 2|Physician Decision|0|||
41994900|NCT00195494|75803057|FG005|Year 2|Physician Decision|0|||
41994901|NCT00195494|75803052|FG000|Year 2|Withdrawal by Subject|1|||
41994902|NCT00195494|75803053|FG001|Year 2|Withdrawal by Subject|5|||
41994903|NCT00195494|75803054|FG002|Year 2|Withdrawal by Subject|4|||
41994904|NCT00195494|75803055|FG003|Year 2|Withdrawal by Subject|3|||
41994905|NCT00195494|75803056|FG004|Year 2|Withdrawal by Subject|0|||
41994906|NCT00195494|75803057|FG005|Year 2|Withdrawal by Subject|0|||
42323497|NCT01641692|76160703|FG005|Treatment Period 3|Lost to Follow-up|0|||
42323498|NCT01641692|76160704|FG006|Treatment Period 3|Lost to Follow-up|0|||
42323499|NCT01641692|76160705|FG007|Treatment Period 3|Lost to Follow-up|0|||
42133552|NCT00375219|75944459|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
41994907|NCT00195494|75803052|FG000|Year 2|System toxicity|0|||
41994908|NCT00195494|75803053|FG001|Year 2|System toxicity|0|||
41994909|NCT00195494|75803054|FG002|Year 2|System toxicity|0|||
41994910|NCT00195494|75803055|FG003|Year 2|System toxicity|1|||
41994911|NCT00195494|75803056|FG004|Year 2|System toxicity|0|||
41994912|NCT00195494|75803057|FG005|Year 2|System toxicity|0|||
41994913|NCT00194987|75803075|FG000|Overall Study|Withdrawal by Subject|0|||
41994914|NCT00194987|75803076|FG001|Overall Study|Withdrawal by Subject|3|||
41994915|NCT00194792|75803084|FG000|Overall Study|Withdrawal by Subject|1|||
41994916|NCT00194675|75803099|FG000|Overall Study|Lost to Follow-up|1|||
41994917|NCT00194675|75803100|FG001|Overall Study|Lost to Follow-up|1|||
41994918|NCT00194675|75803099|FG000|Overall Study|lack of interest|1|||
41994919|NCT00194675|75803100|FG001|Overall Study|lack of interest|1|||
41994920|NCT00194675|75803099|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
41994921|NCT00194675|75803100|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
41994922|NCT00194675|75803099|FG000|Overall Study|Protocol Violation|1|||
41994923|NCT00194675|75803100|FG001|Overall Study|Protocol Violation|0|||
41994924|NCT00194675|75803099|FG000|Overall Study|Death|1|||
41994925|NCT00194675|75803100|FG001|Overall Study|Death|0|||
41994926|NCT00194012|75803110|FG000|Randomized Phase|Lack of Efficacy|8|||
41994927|NCT00194012|75803111|FG001|Randomized Phase|Lack of Efficacy|18|||
41994928|NCT00194012|75803110|FG000|Randomized Phase|Study nonadherence|2|||
41994929|NCT00194012|75803111|FG001|Randomized Phase|Study nonadherence|1|||
41994930|NCT00194012|75803110|FG000|Randomized Phase|Withdrawal by Subject|3|||
42259859|NCT03732833|76086557|FG002|Overall Study|Physician Decision|1|||
42259860|NCT03732833|76086555|FG000|Overall Study|Covid-19 related and other reasons|2|||
42259861|NCT03732833|76086556|FG001|Overall Study|Covid-19 related and other reasons|7|||
42259862|NCT03732833|76086557|FG002|Overall Study|Covid-19 related and other reasons|3|||
42259863|NCT03493919|76086574|FG000|Overall Study|Other|2|||
42259864|NCT03493919|76086575|FG001|Overall Study|Other|0|||
42259865|NCT03493919|76086576|FG002|Overall Study|Other|1|||
42259866|NCT03493919|76086577|FG003|Overall Study|Other|0|||
42259867|NCT03493919|76086574|FG000|Overall Study|Withdrawal by Subject|9|||
42323500|NCT01641692|76160698|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
42323501|NCT01641692|76160699|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
42323502|NCT01641692|76160700|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
42323503|NCT01641692|76160701|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
42323504|NCT01641692|76160702|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
41994931|NCT00194012|75803111|FG001|Randomized Phase|Withdrawal by Subject|3|||
41994932|NCT00194012|75803110|FG000|Randomized Phase|Adverse Event|2|||
41994933|NCT00194012|75803111|FG001|Randomized Phase|Adverse Event|1|||
41994934|NCT00194012|75803110|FG000|Randomized Phase|Participant reported having a rash|1|||
41994935|NCT00194012|75803111|FG001|Randomized Phase|Participant reported having a rash|0|||
41994936|NCT00194012|75803110|FG000|Randomized Phase|Emesis and enuresis|0|||
41994937|NCT00194012|75803111|FG001|Randomized Phase|Emesis and enuresis|1|||
41994938|NCT00194012|75803110|FG000|Randomized Phase|Oral/nasal twitching|0|||
42133553|NCT00375219|75944457|FG000|Overall Study|Allograft|2|||
42133554|NCT00375219|75944458|FG001|Overall Study|Allograft|0|||
42259868|NCT03493919|76086575|FG001|Overall Study|Withdrawal by Subject|3|||
42259869|NCT03493919|76086576|FG002|Overall Study|Withdrawal by Subject|1|||
42323505|NCT01641692|76160703|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
42323506|NCT01641692|76160704|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
42323507|NCT01641692|76160705|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
42323508|NCT01641692|76160698|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
42133555|NCT00375219|75944459|FG002|Overall Study|Allograft|0|||
42133556|NCT00375219|75944457|FG000|Overall Study|Cord blood transplantation|1|||
42323509|NCT01641692|76160699|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
42323510|NCT01641692|76160700|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
42323511|NCT01641692|76160701|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
42323512|NCT01641692|76160702|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
42323513|NCT01641692|76160703|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
42323514|NCT01641692|76160704|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
42323515|NCT01641692|76160705|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
42323516|NCT01682512|76160727|FG000|Overall Study|Adverse Event|6|||
42323517|NCT01682512|76160728|FG001|Overall Study|Adverse Event|5|||
42323518|NCT01682512|76160729|FG002|Overall Study|Adverse Event|2|||
42323519|NCT01682512|76160727|FG000|Overall Study|Withdrawal by Subject|2|||
42323520|NCT01682512|76160728|FG001|Overall Study|Withdrawal by Subject|6|||
42323521|NCT01682512|76160729|FG002|Overall Study|Withdrawal by Subject|3|||
42323522|NCT01682512|76160727|FG000|Overall Study|Physician Decision|0|||
42323523|NCT01682512|76160728|FG001|Overall Study|Physician Decision|2|||
42323524|NCT01682512|76160729|FG002|Overall Study|Physician Decision|0|||
42323525|NCT01682512|76160727|FG000|Overall Study|Study terminated by sponsor|46|||
42323526|NCT01682512|76160728|FG001|Overall Study|Study terminated by sponsor|43|||
42323527|NCT01682512|76160729|FG002|Overall Study|Study terminated by sponsor|0|||
42323528|NCT01682512|76160727|FG000|Overall Study|Lost to Follow-up|3|||
42323529|NCT01682512|76160728|FG001|Overall Study|Lost to Follow-up|0|||
42323530|NCT01682512|76160729|FG002|Overall Study|Lost to Follow-up|2|||
42323531|NCT01682512|76160727|FG000|Overall Study|Protocol Violation|2|||
42034112|NCT01070550|75842185|FG004|Overall Study|Treatment was stopped early|0|||
42133557|NCT00375219|75944458|FG001|Overall Study|Cord blood transplantation|0|||
42133558|NCT00375219|75944459|FG002|Overall Study|Cord blood transplantation|0|||
42133559|NCT00375219|75944457|FG000|Overall Study|Withdrawal by Subject|1|||
42133560|NCT00375219|75944458|FG001|Overall Study|Withdrawal by Subject|0|||
42259870|NCT03493919|76086577|FG003|Overall Study|Withdrawal by Subject|1|||
42259871|NCT03493919|76086574|FG000|Overall Study|Lost to Follow-up|5|||
42259872|NCT03493919|76086575|FG001|Overall Study|Lost to Follow-up|0|||
42259873|NCT03493919|76086576|FG002|Overall Study|Lost to Follow-up|0|||
42259874|NCT03493919|76086577|FG003|Overall Study|Lost to Follow-up|3|||
42259875|NCT03493919|76086574|FG000|Overall Study|Adverse Event|0|||
42259876|NCT03493919|76086575|FG001|Overall Study|Adverse Event|1|||
42259877|NCT03493919|76086576|FG002|Overall Study|Adverse Event|0|||
42259878|NCT03493919|76086577|FG003|Overall Study|Adverse Event|0|||
42259879|NCT03280628|76086595|FG000|Overall Study|Lost to Follow-up|8|||
42259880|NCT03280628|76086596|FG001|Overall Study|Lost to Follow-up|6|||
42259881|NCT03280628|76086597|FG002|Overall Study|Lost to Follow-up|11|||
42259882|NCT03058146|76086624|FG000|Overall Study|Withdrawal by Subject|4|||
42259883|NCT03058146|76086625|FG001|Overall Study|Withdrawal by Subject|1|||
42259884|NCT03058146|76086624|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
42259885|NCT03058146|76086625|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
42259886|NCT02851511|76086637|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
42259887|NCT02851511|76086638|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
42259888|NCT02851511|76086639|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
42259889|NCT02851511|76086640|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
42259890|NCT02851511|76086637|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
42259891|NCT02851511|76086638|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
42259892|NCT02851511|76086639|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
42259893|NCT02851511|76086640|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
42259894|NCT02851511|76086637|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
42259895|NCT02851511|76086638|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
42323532|NCT01682512|76160728|FG001|Overall Study|Protocol Violation|3|||
42323533|NCT01682512|76160729|FG002|Overall Study|Protocol Violation|2|||
42323534|NCT01682512|76160727|FG000|Overall Study|Primary lack of efficacy|10|||
42323535|NCT01682512|76160728|FG001|Overall Study|Primary lack of efficacy|7|||
42323536|NCT01682512|76160729|FG002|Overall Study|Primary lack of efficacy|7|||
42323537|NCT01682512|76160727|FG000|Overall Study|Secondary lack of efficacy|1|||
42323538|NCT01682512|76160728|FG001|Overall Study|Secondary lack of efficacy|1|||
42323539|NCT01682512|76160729|FG002|Overall Study|Secondary lack of efficacy|0|||
42323540|NCT01682512|76160727|FG000|Overall Study|Other than stated above|2|||
42323541|NCT01682512|76160728|FG001|Overall Study|Other than stated above|4|||
42323542|NCT01682512|76160729|FG002|Overall Study|Other than stated above|2|||
42323543|NCT02256488|76160741|FG000|Overall Study|Lost to Follow-up|6|||
42133561|NCT00375219|75944459|FG002|Overall Study|Withdrawal by Subject|0|||
42133562|NCT03965351|75944468|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
42323544|NCT02256488|76160742|FG001|Overall Study|Lost to Follow-up|6|||
42323545|NCT02256488|76160743|FG002|Overall Study|Lost to Follow-up|9|||
42323546|NCT02256488|76160744|FG003|Overall Study|Lost to Follow-up|3|||
41994939|NCT00194012|75803111|FG001|Randomized Phase|Oral/nasal twitching|1|||
41994940|NCT00194012|75803110|FG000|Open Label Extension (OLE)|Weight Gain|1|||
41994941|NCT00194012|75803111|FG001|Open Label Extension (OLE)|Weight Gain|0|||
41994942|NCT00194012|75803110|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
41994943|NCT00194012|75803111|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
41994944|NCT00194012|75803110|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
41994945|NCT00194012|75803111|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
42133563|NCT03965351|75944469|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
42133564|NCT03965351|75944468|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
42133565|NCT03965351|75944469|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
42133566|NCT00554801|75944477|FG000|Overall Study|left area before completion|5|||
42133567|NCT00554801|75944478|FG001|Overall Study|left area before completion|0|||
42133568|NCT00554801|75944477|FG000|Overall Study|Withdrawal by Subject|14|||
42133569|NCT00554801|75944478|FG001|Overall Study|Withdrawal by Subject|0|||
42133570|NCT00374907|75944488|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
42133571|NCT00374907|75944489|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
42133572|NCT00374907|75944488|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
42133573|NCT00374907|75944489|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
42133574|NCT00374907|75944488|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
42133575|NCT00374907|75944489|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
42133576|NCT00374907|75944488|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
42133577|NCT00374907|75944489|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
42133578|NCT00374907|75944488|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
42133579|NCT00374907|75944489|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
42133580|NCT00374127|75944497|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
42133581|NCT00374127|75944497|FG000|Overall Study|Blood could not be drawn.|2|||
42133582|NCT00374127|75944497|FG000|Overall Study|Protocol Violation|5|||
42133583|NCT00374127|75944497|FG000|Overall Study|Pregnancy|1|||
42133584|NCT00553787|75944510|FG000|Overall Study|Adverse Event|34|||
42259896|NCT02851511|76086639|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
42259897|NCT02851511|76086640|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
42259898|NCT02851511|76086637|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
42259899|NCT02851511|76086638|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
42259900|NCT02851511|76086639|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
42259901|NCT02851511|76086640|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
42259902|NCT02851511|76086637|FG000|Phase I|Physician Decision|0|||
42259903|NCT02851511|76086638|FG001|Phase I|Physician Decision|0|||
42259904|NCT02851511|76086639|FG002|Phase I|Physician Decision|0|||
41994946|NCT00194012|75803110|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
41994947|NCT00194012|75803111|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
41994948|NCT00192647|75803125|FG000|Overall Study|Death|1|||
41994949|NCT00192647|75803126|FG001|Overall Study|Death|1|||
41994950|NCT00192647|75803125|FG000|Overall Study|Adverse Event|35|||
41994951|NCT00192647|75803126|FG001|Overall Study|Adverse Event|29|||
41994952|NCT00192647|75803125|FG000|Overall Study|Laboratory Test Abnormality|4|||
42133585|NCT00553787|75944511|FG001|Overall Study|Adverse Event|21|||
42133586|NCT00553787|75944512|FG002|Overall Study|Adverse Event|67|||
42259905|NCT02851511|76086640|FG003|Phase I|Physician Decision|1|||
42259906|NCT02851511|76086637|FG000|Phase I|Withdrawal by Subject|2|||
42259907|NCT02851511|76086638|FG001|Phase I|Withdrawal by Subject|1|||
42259908|NCT02851511|76086639|FG002|Phase I|Withdrawal by Subject|0|||
42133587|NCT00553787|75944510|FG000|Overall Study|Lost to Follow-up|132|||
42259909|NCT02851511|76086640|FG003|Phase I|Withdrawal by Subject|3|||
42259910|NCT02851511|76086637|FG000|Phase II|Physician Decision|18|||
42259911|NCT02851511|76086638|FG001|Phase II|Physician Decision|16|||
42259912|NCT02851511|76086639|FG002|Phase II|Physician Decision|0|||
42133588|NCT00553787|75944511|FG001|Overall Study|Lost to Follow-up|44|||
42133589|NCT00553787|75944512|FG002|Overall Study|Lost to Follow-up|78|||
41994953|NCT00192647|75803126|FG001|Overall Study|Laboratory Test Abnormality|2|||
41994954|NCT00192647|75803125|FG000|Overall Study|Insufficient Therapeutic Response|53|||
41994955|NCT00192647|75803126|FG001|Overall Study|Insufficient Therapeutic Response|83|||
41994956|NCT00192647|75803125|FG000|Overall Study|Entry Criteria Violation|6|||
41994957|NCT00192647|75803126|FG001|Overall Study|Entry Criteria Violation|6|||
41994958|NCT00192647|75803125|FG000|Overall Study|Protocol Violation|3|||
41994959|NCT00192647|75803126|FG001|Overall Study|Protocol Violation|1|||
42323547|NCT02256488|76160741|FG000|Overall Study|OTHER|1|||
42323548|NCT02256488|76160742|FG001|Overall Study|OTHER|0|||
42323549|NCT02256488|76160743|FG002|Overall Study|OTHER|1|||
42323550|NCT02256488|76160744|FG003|Overall Study|OTHER|1|||
42323551|NCT02256488|76160741|FG000|Overall Study|Withdrawal by Subject|1|||
42323552|NCT02256488|76160742|FG001|Overall Study|Withdrawal by Subject|0|||
42323553|NCT02256488|76160743|FG002|Overall Study|Withdrawal by Subject|0|||
42323554|NCT02256488|76160744|FG003|Overall Study|Withdrawal by Subject|2|||
42323555|NCT01715896|76160757|FG000|Overall Study|Lost to Follow-up|0|||
42323556|NCT01715896|76160758|FG001|Overall Study|Lost to Follow-up|2|||
42323557|NCT01715896|76160757|FG000|Overall Study|Withdrawal by Subject|1|||
42323558|NCT01715896|76160758|FG001|Overall Study|Withdrawal by Subject|4|||
42133590|NCT00553787|75944510|FG000|Overall Study|Withdrawal by Subject|151|||
42323559|NCT01715896|76160757|FG000|Overall Study|Other|2|||
41994960|NCT00192647|75803125|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
42133591|NCT00553787|75944511|FG001|Overall Study|Withdrawal by Subject|40|||
42133592|NCT00553787|75944512|FG002|Overall Study|Withdrawal by Subject|83|||
42133593|NCT00553787|75944510|FG000|Overall Study|Lack of Efficacy|31|||
42323560|NCT01715896|76160758|FG001|Overall Study|Other|5|||
42323561|NCT02255552|76160767|FG000|Overall Study|Participants enrolled into another study|0|||
42323562|NCT02255552|76160768|FG001|Overall Study|Participants enrolled into another study|11|||
42323563|NCT02255552|76160767|FG000|Overall Study|Withdrawal by Subject|1|||
42323564|NCT02255552|76160768|FG001|Overall Study|Withdrawal by Subject|4|||
41994961|NCT00192647|75803126|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
41994962|NCT00192647|75803125|FG000|Overall Study|Failure to Return|11|||
42034113|NCT01070550|75842186|FG005|Overall Study|Treatment was stopped early|0|||
42034114|NCT01070550|75842181|FG000|Overall Study|Other|5|||
42034115|NCT01070550|75842182|FG001|Overall Study|Other|0|||
42133594|NCT00553787|75944511|FG001|Overall Study|Lack of Efficacy|1|||
41994963|NCT00192647|75803126|FG001|Overall Study|Failure to Return|13|||
41994964|NCT00192647|75803125|FG000|Overall Study|Other/Administrative|5|||
41994965|NCT00192647|75803126|FG001|Overall Study|Other/Administrative|3|||
41994966|NCT00192296|75803136|FG000|Overall Study|Withdrawal by Subject|0|||
41994967|NCT00192296|75803137|FG001|Overall Study|Withdrawal by Subject|1|||
41994968|NCT00192296|75803138|FG002|Overall Study|Withdrawal by Subject|0|||
41994969|NCT00192296|75803139|FG003|Overall Study|Withdrawal by Subject|0|||
41994970|NCT00192023|75803151|FG000|Period III - Double-Blind|Adverse Event|3|||
41994971|NCT00192023|75803152|FG001|Period III - Double-Blind|Adverse Event|0|||
41994972|NCT00192023|75803151|FG000|Period III - Double-Blind|Physician Decision|2|||
41994973|NCT00192023|75803152|FG001|Period III - Double-Blind|Physician Decision|0|||
41994974|NCT00192023|75803151|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
41994975|NCT00192023|75803152|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
41994976|NCT00192023|75803151|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
41994977|NCT00192023|75803152|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
41994978|NCT00192023|75803151|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
41994979|NCT00192023|75803152|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
41994980|NCT00192023|75803151|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
41994981|NCT00192023|75803152|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
41994982|NCT00192023|75803151|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
41994983|NCT00192023|75803152|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
41994984|NCT00192023|75803151|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
41994985|NCT00192023|75803152|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
41994986|NCT00192023|75803151|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
41994987|NCT00192023|75803152|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
41994988|NCT00192023|75803151|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
41994989|NCT00192023|75803152|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
41994990|NCT00191984|75803158|FG000|Overall Study|Disease Progression|21|||
41994991|NCT00191984|75803158|FG000|Overall Study|Adverse Event|4|||
41994992|NCT00191984|75803158|FG000|Overall Study|Death|2|||
41994993|NCT00191984|75803158|FG000|Overall Study|Entry Criteria Exclusion|1|||
41994994|NCT00191984|75803158|FG000|Overall Study|Withdrawal by Subject|7|||
41994995|NCT00191984|75803158|FG000|Overall Study|Physician Decision|4|||
41994996|NCT00191906|75803166|FG000|Study Period II|Adverse Event|0|||
41994997|NCT00191906|75803167|FG001|Study Period II|Adverse Event|1|||
41994998|NCT00191906|75803168|FG002|Study Period II|Adverse Event|0|||
41994999|NCT00191906|75803169|FG003|Study Period II|Adverse Event|0|||
41995000|NCT00191906|75803166|FG000|Study Period II|Withdrawal by Subject|0|||
41995001|NCT00191906|75803167|FG001|Study Period II|Withdrawal by Subject|3|||
41995002|NCT00191906|75803168|FG002|Study Period II|Withdrawal by Subject|0|||
41995003|NCT00191906|75803169|FG003|Study Period II|Withdrawal by Subject|0|||
41995004|NCT00191906|75803166|FG000|Study Period II|Parent/Caregiver Decision|0|||
41995005|NCT00191906|75803167|FG001|Study Period II|Parent/Caregiver Decision|1|||
42034116|NCT01070550|75842183|FG002|Overall Study|Other|0|||
42034117|NCT01070550|75842184|FG003|Overall Study|Other|1|||
42034118|NCT01070550|75842185|FG004|Overall Study|Other|0|||
41995006|NCT00191906|75803168|FG002|Study Period II|Parent/Caregiver Decision|0|||
42034119|NCT01070550|75842186|FG005|Overall Study|Other|0|||
42034120|NCT01070550|75842181|FG000|Overall Study|Withdrawal by Subject|35|||
42034121|NCT01070550|75842182|FG001|Overall Study|Withdrawal by Subject|0|||
42034122|NCT01070550|75842183|FG002|Overall Study|Withdrawal by Subject|3|||
41995007|NCT00191906|75803169|FG003|Study Period II|Parent/Caregiver Decision|0|||
41995008|NCT00191906|75803166|FG000|Study Period II|Entry Criteria Exclusion|0|||
41995009|NCT00191906|75803167|FG001|Study Period II|Entry Criteria Exclusion|0|||
41995010|NCT00191906|75803168|FG002|Study Period II|Entry Criteria Exclusion|1|||
42034123|NCT01070550|75842184|FG003|Overall Study|Withdrawal by Subject|0|||
42034124|NCT01070550|75842185|FG004|Overall Study|Withdrawal by Subject|0|||
42034125|NCT01070550|75842186|FG005|Overall Study|Withdrawal by Subject|0|||
42034126|NCT00848107|75842201|FG000|Overall Study|Lost to Follow-up|2|||
42034127|NCT00848107|75842201|FG000|Overall Study|Withdrawal by Subject|8|||
42034128|NCT00848107|75842201|FG000|Overall Study|Adverse Event|9|||
42034129|NCT00848107|75842201|FG000|Overall Study|Death|1|||
42034130|NCT00848107|75842201|FG000|Overall Study|Pregnancy|1|||
42034131|NCT00856297|75842210|FG000|Overall Study|Unable to classify|2|||
42034132|NCT00856297|75842211|FG001|Overall Study|Unable to classify|0|||
42034133|NCT00856297|75842212|FG002|Overall Study|Unable to classify|0|||
42034134|NCT00856297|75842213|FG003|Overall Study|Unable to classify|0|||
42034135|NCT00856297|75842214|FG004|Overall Study|Unable to classify|0|||
42034136|NCT01046136|75842233|FG000|Overall Study|Withdrawal by Subject|0|||
42034137|NCT01046136|75842234|FG001|Overall Study|Withdrawal by Subject|4|||
42034138|NCT01046136|75842233|FG000|Overall Study|Physician Decision|1|||
42034139|NCT01046136|75842234|FG001|Overall Study|Physician Decision|1|||
42034140|NCT01046136|75842233|FG000|Overall Study|Lost to Follow-up|3|||
42034141|NCT01046136|75842234|FG001|Overall Study|Lost to Follow-up|3|||
42034142|NCT01070394|75842242|FG000|Overall Study|Adverse Event|6|||
42034143|NCT01070394|75842242|FG000|Overall Study|Withdrawal by Subject|1|||
42034144|NCT00836953|75842248|FG000|Overall Study|Withdrawal by Subject|1|||
42034145|NCT00836953|75842248|FG000|Overall Study|Lost to Follow-up|1|||
42034146|NCT01070316|75842252|FG000|Extension Phase|Lack of Efficacy|3|||
42034147|NCT01070316|75842252|FG000|Extension Phase|Withdrawal by Subject|1|||
42034148|NCT01126541|75842259|FG000|Overall Study|Adverse Event|0|||
42034149|NCT01126541|75842260|FG001|Overall Study|Adverse Event|2|||
42034150|NCT01126541|75842261|FG002|Overall Study|Adverse Event|4|||
42034151|NCT01126541|75842259|FG000|Overall Study|Death|0|||
42034152|NCT01126541|75842260|FG001|Overall Study|Death|1|||
42034153|NCT01126541|75842261|FG002|Overall Study|Death|0|||
42034154|NCT01126541|75842259|FG000|Overall Study|Lack of Efficacy|6|||
42034155|NCT01126541|75842260|FG001|Overall Study|Lack of Efficacy|1|||
42034156|NCT01126541|75842261|FG002|Overall Study|Lack of Efficacy|11|||
42034157|NCT01126541|75842259|FG000|Overall Study|Lost to Follow-up|1|||
42034158|NCT01126541|75842260|FG001|Overall Study|Lost to Follow-up|2|||
42034159|NCT01126541|75842261|FG002|Overall Study|Lost to Follow-up|2|||
42034160|NCT01126541|75842259|FG000|Overall Study|Withdrawal by Subject|2|||
42034161|NCT01126541|75842260|FG001|Overall Study|Withdrawal by Subject|5|||
42034162|NCT01126541|75842261|FG002|Overall Study|Withdrawal by Subject|6|||
42034163|NCT01126541|75842259|FG000|Overall Study|Protocol Violation|0|||
42034164|NCT01126541|75842260|FG001|Overall Study|Protocol Violation|0|||
42034165|NCT01126541|75842261|FG002|Overall Study|Protocol Violation|1|||
42034166|NCT01126541|75842259|FG000|Overall Study|Administrative reason or other|1|||
42034167|NCT01126541|75842260|FG001|Overall Study|Administrative reason or other|1|||
42034168|NCT01126541|75842261|FG002|Overall Study|Administrative reason or other|2|||
42034169|NCT00836875|75842273|FG000|Overall Study|Death|3|||
42034170|NCT00836875|75842274|FG001|Overall Study|Death|2|||
42034171|NCT00836875|75842273|FG000|Overall Study|Withdrawal by Subject|0|||
42133595|NCT00553787|75944512|FG002|Overall Study|Lack of Efficacy|3|||
41995011|NCT00191906|75803169|FG003|Study Period II|Entry Criteria Exclusion|0|||
41995012|NCT00191906|75803166|FG000|Study Period III|Adverse Event|1|||
41995013|NCT00191906|75803167|FG001|Study Period III|Adverse Event|0|||
41995014|NCT00191906|75803168|FG002|Study Period III|Adverse Event|0|||
41995015|NCT00191906|75803169|FG003|Study Period III|Adverse Event|0|||
41995016|NCT00191906|75803166|FG000|Study Period III|Lost to Follow-up|0|||
41995017|NCT00191906|75803167|FG001|Study Period III|Lost to Follow-up|1|||
41995018|NCT00191906|75803168|FG002|Study Period III|Lost to Follow-up|0|||
41995019|NCT00191906|75803169|FG003|Study Period III|Lost to Follow-up|0|||
42034172|NCT00836875|75842274|FG001|Overall Study|Withdrawal by Subject|1|||
42034173|NCT01125917|75842280|FG000|Overall Study|Adverse Event|43|||
42034174|NCT01125917|75842280|FG000|Overall Study|Lost to Follow-up|23|||
42034175|NCT01125917|75842280|FG000|Overall Study|Withdrawal by Subject|31|||
42034176|NCT01125917|75842280|FG000|Overall Study|Administrative|223|||
42034177|NCT01125917|75842280|FG000|Overall Study|Lack of Efficacy|19|||
42034178|NCT00847561|75842286|FG000|Overall Study|Withdrawal by Subject|4|||
42034179|NCT00847561|75842287|FG001|Overall Study|Withdrawal by Subject|3|||
42034180|NCT00847561|75842286|FG000|Overall Study|Unable to schedule|9|||
42034181|NCT00847561|75842287|FG001|Overall Study|Unable to schedule|1|||
42133596|NCT00553787|75944510|FG000|Overall Study|Pregnancy|0|||
42133597|NCT00553787|75944511|FG001|Overall Study|Pregnancy|1|||
41995020|NCT00191906|75803166|FG000|Study Period III|Parent/Caregiver Decision|1|||
41995021|NCT00191906|75803167|FG001|Study Period III|Parent/Caregiver Decision|0|||
41995022|NCT00191906|75803168|FG002|Study Period III|Parent/Caregiver Decision|0|||
41995023|NCT00191906|75803169|FG003|Study Period III|Parent/Caregiver Decision|0|||
41995024|NCT00191906|75803166|FG000|Study Period III|Lack of Efficacy|3|||
41995025|NCT00191906|75803167|FG001|Study Period III|Lack of Efficacy|3|||
41995026|NCT00191906|75803168|FG002|Study Period III|Lack of Efficacy|0|||
41995027|NCT00191906|75803169|FG003|Study Period III|Lack of Efficacy|0|||
41995028|NCT00191789|75803185|FG000|Overall Study|Adverse Event|5|||
41995029|NCT00191789|75803185|FG000|Overall Study|Patient: Satisfactory Response|5|||
41995030|NCT00191789|75803185|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
42323565|NCT01714726|76160776|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
42323566|NCT01714726|76160777|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
42034182|NCT01121549|75842293|FG000|Overall Study|Adverse Event|10|||
41995031|NCT00191789|75803185|FG000|Overall Study|Withdrawal by Subject|4|||
41995032|NCT00191789|75803185|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
41995033|NCT00191789|75803185|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
41995034|NCT00191789|75803185|FG000|Overall Study|Death - Not Study-Drug Related|1|||
41995035|NCT00191282|75803191|FG000|Overall Study|Adverse Event|5|||
41995036|NCT00191282|75803192|FG001|Overall Study|Adverse Event|6|||
41995037|NCT00191282|75803191|FG000|Overall Study|Death|51|||
41995038|NCT00191282|75803192|FG001|Overall Study|Death|51|||
41995039|NCT00191282|75803191|FG000|Overall Study|Lack of Efficacy|11|||
41995040|NCT00191282|75803192|FG001|Overall Study|Lack of Efficacy|6|||
41995041|NCT00191282|75803191|FG000|Overall Study|Noncompliance|14|||
41995042|NCT00191282|75803192|FG001|Overall Study|Noncompliance|17|||
41995043|NCT00191282|75803191|FG000|Overall Study|Patient moved|11|||
42034183|NCT01121549|75842293|FG000|Overall Study|Lack of Efficacy|11|||
42034184|NCT01121549|75842293|FG000|Overall Study|Lost to Follow-up|12|||
42034185|NCT01121549|75842293|FG000|Overall Study|Did not meet entrance criteria|9|||
42034186|NCT01121549|75842293|FG000|Overall Study|Study terminated by sponsor|197|||
42034187|NCT01121549|75842293|FG000|Overall Study|Pregnancy|1|||
42034188|NCT01121549|75842293|FG000|Overall Study|Protocol Violation|33|||
42034189|NCT01121549|75842293|FG000|Overall Study|Withdrawal by Subject|16|||
42034190|NCT01121549|75842293|FG000|Overall Study|Other|58|||
42034191|NCT00847405|75842299|FG000|First Intervention|Adverse Event|0|||
41995044|NCT00191282|75803192|FG001|Overall Study|Patient moved|14|||
42034192|NCT00847405|75842300|FG001|First Intervention|Adverse Event|1|||
42034193|NCT00847405|75842299|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
42133598|NCT00553787|75944512|FG002|Overall Study|Pregnancy|2|||
41995045|NCT00191282|75803191|FG000|Overall Study|Withdrawal by Subject|59|||
41995046|NCT00191282|75803192|FG001|Overall Study|Withdrawal by Subject|44|||
41995047|NCT00191282|75803191|FG000|Overall Study|Physician Decision|18|||
41995048|NCT00191282|75803192|FG001|Overall Study|Physician Decision|15|||
41995049|NCT00191282|75803191|FG000|Overall Study|Protocol entry criteria not met|14|||
41995050|NCT00191282|75803192|FG001|Overall Study|Protocol entry criteria not met|9|||
41995051|NCT00191282|75803191|FG000|Overall Study|Protocol Violation|9|||
42133599|NCT00553787|75944510|FG000|Overall Study|non compliance|4|||
42133600|NCT00553787|75944511|FG001|Overall Study|non compliance|0|||
42133601|NCT00553787|75944512|FG002|Overall Study|non compliance|11|||
42133602|NCT00553787|75944510|FG000|Overall Study|Requirement for restricted medication|8|||
42133603|NCT00553787|75944511|FG001|Overall Study|Requirement for restricted medication|7|||
41995052|NCT00191282|75803192|FG001|Overall Study|Protocol Violation|12|||
41995053|NCT00191282|75803191|FG000|Overall Study|Severity of outcome|2|||
41995054|NCT00191282|75803192|FG001|Overall Study|Severity of outcome|5|||
41995055|NCT00191282|75803191|FG000|Overall Study|Sponsor's decision|2|||
41995056|NCT00191282|75803192|FG001|Overall Study|Sponsor's decision|2|||
41995057|NCT00191282|75803191|FG000|Overall Study|Lost to Follow-up|24|||
42034194|NCT00847405|75842300|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
42034195|NCT00836095|75842306|FG000|Overall Study|Physician Decision|0|||
42034196|NCT00836095|75842307|FG001|Overall Study|Physician Decision|3|||
41995058|NCT00191282|75803192|FG001|Overall Study|Lost to Follow-up|31|||
41995059|NCT00191165|75803200|FG000|Overall Study|Adverse Event|2|||
41995060|NCT00191165|75803201|FG001|Overall Study|Adverse Event|0|||
41995061|NCT00191165|75803200|FG000|Overall Study|Protocol Violation|0|||
41995062|NCT00191165|75803201|FG001|Overall Study|Protocol Violation|1|||
41995063|NCT00191165|75803200|FG000|Overall Study|Participant Moved Away|0|||
41995064|NCT00191165|75803201|FG001|Overall Study|Participant Moved Away|1|||
41995065|NCT00190775|75803209|FG000|Overall Study|Adverse Event|57|||
41995066|NCT00190775|75803210|FG001|Overall Study|Adverse Event|22|||
41995067|NCT00190775|75803209|FG000|Overall Study|Satisfactory Response|1|||
41995068|NCT00190775|75803210|FG001|Overall Study|Satisfactory Response|0|||
41995069|NCT00190775|75803209|FG000|Overall Study|Lack of Efficacy|28|||
41995070|NCT00190775|75803210|FG001|Overall Study|Lack of Efficacy|32|||
41995071|NCT00190775|75803209|FG000|Overall Study|Lost to Follow-up|31|||
41995072|NCT00190775|75803210|FG001|Overall Study|Lost to Follow-up|23|||
41995073|NCT00190775|75803209|FG000|Overall Study|Participant Moved|0|||
41995074|NCT00190775|75803210|FG001|Overall Study|Participant Moved|1|||
41995075|NCT00190775|75803209|FG000|Overall Study|Withdrawal by Subject|24|||
41995076|NCT00190775|75803210|FG001|Overall Study|Withdrawal by Subject|13|||
41995077|NCT00190775|75803209|FG000|Overall Study|Sponsor Decision|1|||
41995078|NCT00190775|75803210|FG001|Overall Study|Sponsor Decision|0|||
41995079|NCT00190775|75803209|FG000|Overall Study|Physician Decision|3|||
41995080|NCT00190775|75803210|FG001|Overall Study|Physician Decision|0|||
41995081|NCT00190775|75803209|FG000|Overall Study|Noncompliance|3|||
41995082|NCT00190775|75803210|FG001|Overall Study|Noncompliance|5|||
41995083|NCT00190775|75803209|FG000|Overall Study|Protocol Violation|0|||
41995084|NCT00190775|75803210|FG001|Overall Study|Protocol Violation|1|||
41995085|NCT00190775|75803209|FG000|Overall Study|Exclusion Criteria Met|1|||
41995086|NCT00190775|75803210|FG001|Overall Study|Exclusion Criteria Met|3|||
41995087|NCT00199901|75803225|FG000|Overall Study|Protocol Violation|2|||
41995088|NCT00199901|75803226|FG001|Overall Study|Protocol Violation|0|||
41995089|NCT00199901|75803225|FG000|Overall Study|Withdrawal by Subject|1|||
41995090|NCT00199901|75803226|FG001|Overall Study|Withdrawal by Subject|0|||
41995091|NCT00199901|75803225|FG000|Overall Study|Progressive Disease|24|||
41995092|NCT00199901|75803226|FG001|Overall Study|Progressive Disease|24|||
41995093|NCT00198107|75803236|FG000|Double-Blind Period|Adverse Event|1|||
41995094|NCT00198107|75803237|FG001|Double-Blind Period|Adverse Event|1|||
41995095|NCT00198107|75803238|FG002|Double-Blind Period|Adverse Event|0|||
41995096|NCT00198107|75803236|FG000|Double-Blind Period|Lack of Efficacy|2|||
41995097|NCT00198107|75803237|FG001|Double-Blind Period|Lack of Efficacy|0|||
41995098|NCT00198107|75803238|FG002|Double-Blind Period|Lack of Efficacy|0|||
41995099|NCT00198107|75803236|FG000|Double-Blind Period|Lost to Follow-up|2|||
41995100|NCT00198107|75803237|FG001|Double-Blind Period|Lost to Follow-up|1|||
41995101|NCT00198107|75803238|FG002|Double-Blind Period|Lost to Follow-up|0|||
41995102|NCT00198107|75803236|FG000|Double-Blind Period|Physician Decision|1|||
41995103|NCT00198107|75803237|FG001|Double-Blind Period|Physician Decision|0|||
41995104|NCT00198107|75803238|FG002|Double-Blind Period|Physician Decision|0|||
41995105|NCT00198107|75803236|FG000|Double-Blind Period|Withdrawal by Subject|0|||
41995106|NCT00198107|75803237|FG001|Double-Blind Period|Withdrawal by Subject|1|||
41995107|NCT00198107|75803238|FG002|Double-Blind Period|Withdrawal by Subject|0|||
41995108|NCT00198107|75803236|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
41995109|NCT00198107|75803237|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
41995110|NCT00198107|75803238|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
41995111|NCT00179660|75803246|FG000|Overall Study|Adverse Event|7|||
41995112|NCT00179660|75803246|FG000|Overall Study|Lack of therapeutic effect|28|||
41995113|NCT00179660|75803246|FG000|Overall Study|Withdrawal by Subject|2|||
41995114|NCT00179660|75803246|FG000|Overall Study|Lost to Follow-up|1|||
41995115|NCT00179660|75803246|FG000|Overall Study|Death|3|||
41995116|NCT00179660|75803246|FG000|Overall Study|Other - Unspecified|9|||
41995117|NCT00178256|75803250|FG000|Overall Study|Adverse Event|2|||
41995118|NCT00178256|75803251|FG001|Overall Study|Adverse Event|0|||
42034197|NCT00835237|75842324|FG000|Overall Study|Lost to Follow-up|4|||
41995119|NCT00178256|75803252|FG002|Overall Study|Adverse Event|0|||
41995120|NCT00178256|75803253|FG003|Overall Study|Adverse Event|0|||
41995121|NCT00178256|75803250|FG000|Overall Study|Death|0|||
41995122|NCT00178256|75803251|FG001|Overall Study|Death|1|||
41995123|NCT00178256|75803252|FG002|Overall Study|Death|0|||
41995124|NCT00178256|75803253|FG003|Overall Study|Death|1|||
41995125|NCT00178256|75803250|FG000|Overall Study|Cancer progression|2|||
41995126|NCT00178256|75803251|FG001|Overall Study|Cancer progression|0|||
41995127|NCT00178256|75803252|FG002|Overall Study|Cancer progression|0|||
41995128|NCT00178256|75803253|FG003|Overall Study|Cancer progression|1|||
41995129|NCT00177164|75803262|FG000|Overall Study|Protocol Violation|0|||
41995130|NCT00177164|75803263|FG001|Overall Study|Protocol Violation|7|||
41995131|NCT00177164|75803262|FG000|Overall Study|Lost to Follow-up|4|||
41995132|NCT00177164|75803263|FG001|Overall Study|Lost to Follow-up|5|||
41995133|NCT00177164|75803262|FG000|Overall Study|increase in alcohol and drug use|1|||
41995134|NCT00177164|75803263|FG001|Overall Study|increase in alcohol and drug use|2|||
42259913|NCT02851511|76086640|FG003|Phase II|Physician Decision|0|||
42259914|NCT02851511|76086637|FG000|Phase II|Withdrawal by Subject|18|||
42259915|NCT02851511|76086638|FG001|Phase II|Withdrawal by Subject|16|||
42259916|NCT02851511|76086639|FG002|Phase II|Withdrawal by Subject|0|||
42259917|NCT02851511|76086640|FG003|Phase II|Withdrawal by Subject|0|||
42259918|NCT02851511|76086637|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
42259919|NCT02851511|76086638|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
41995135|NCT00177164|75803262|FG000|Overall Study|Adverse Event|1|||
41995136|NCT00177164|75803263|FG001|Overall Study|Adverse Event|0|||
41995137|NCT00177164|75803262|FG000|Overall Study|discharge from hospital|1|||
41995138|NCT00177164|75803263|FG001|Overall Study|discharge from hospital|0|||
41995139|NCT00177164|75803262|FG000|Overall Study|Lack of Efficacy|2|||
41995140|NCT00177164|75803263|FG001|Overall Study|Lack of Efficacy|1|||
41995141|NCT00177164|75803262|FG000|Overall Study|Pregnancy|0|||
41995142|NCT00177164|75803263|FG001|Overall Study|Pregnancy|1|||
41995143|NCT02489942|75803286|FG000|Overall Study|Request by patient|602|||
41995144|NCT02489942|75803286|FG000|Overall Study|Improvement/remission|157|||
41995145|NCT02489942|75803286|FG000|Overall Study|No change/Progressive disease|263|||
41995146|NCT02489942|75803286|FG000|Overall Study|Adverse Event|522|||
41995147|NCT02489942|75803286|FG000|Overall Study|Other personal reasons|1218|||
41995148|NCT02489942|75803286|FG000|Overall Study|Lost to Follow-up|456|||
42259920|NCT02851511|76086639|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
41995149|NCT02489942|75803286|FG000|Overall Study|Not continuously investigated|7|||
41995150|NCT02489942|75803286|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
41995151|NCT02489942|75803286|FG000|Overall Study|Multiple registration|1|||
42259921|NCT02851511|76086640|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
42259922|NCT02851511|76086637|FG000|Phase II|Lost to Follow-up|0|||
42259923|NCT02851511|76086638|FG001|Phase II|Lost to Follow-up|1|||
42259924|NCT02851511|76086639|FG002|Phase II|Lost to Follow-up|0|||
42259925|NCT02851511|76086640|FG003|Phase II|Lost to Follow-up|0|||
42259926|NCT02478320|76086661|FG000|Overall Study|Adverse Event|2|||
42259927|NCT02478320|76086662|FG001|Overall Study|Adverse Event|0|||
42259928|NCT02478320|76086661|FG000|Overall Study|Death|1|||
42259929|NCT02478320|76086662|FG001|Overall Study|Death|0|||
42323567|NCT01714726|76160778|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
42323568|NCT01714726|76160779|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
42323569|NCT01714726|76160776|FG000|Double-Blinded Induction Period|Adverse Event|0|||
42323570|NCT01714726|76160777|FG001|Double-Blinded Induction Period|Adverse Event|1|||
42323571|NCT01714726|76160778|FG002|Double-Blinded Induction Period|Adverse Event|0|||
42323572|NCT01714726|76160779|FG003|Double-Blinded Induction Period|Adverse Event|0|||
41995152|NCT02489942|75803286|FG000|Overall Study|No patient visit after entry|100|||
41995153|NCT02489942|75803286|FG000|Overall Study|No treatment with Jardiance|2|||
41995154|NCT02489942|75803286|FG000|Overall Study|Patient received Jardiance before registration|1|||
41995155|NCT02489942|75803286|FG000|Overall Study|No CRF collected|86|||
41995156|NCT00176462|75803292|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
41995157|NCT00176462|75803293|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
42259930|NCT02478320|76086661|FG000|Overall Study|Lack of Efficacy|4|||
42259931|NCT02478320|76086662|FG001|Overall Study|Lack of Efficacy|0|||
42259932|NCT02478320|76086661|FG000|Overall Study|Withdrawal by Subject|2|||
42259933|NCT02478320|76086662|FG001|Overall Study|Withdrawal by Subject|0|||
42259934|NCT02478320|76086661|FG000|Overall Study|Screen Failure|3|||
42323573|NCT01714726|76160776|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
42323574|NCT01714726|76160777|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
42323575|NCT01714726|76160778|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
42323576|NCT01714726|76160779|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
42323577|NCT01714726|76160776|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
42323578|NCT01714726|76160777|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
42323579|NCT01714726|76160778|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
42323580|NCT01714726|76160779|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
42323581|NCT01714726|76160776|FG000|Open-Label Period|Other|0|||
41995158|NCT00176462|75803292|FG000|Induction (4 Weeks)|Death|1|||
41995159|NCT00176462|75803293|FG001|Induction (4 Weeks)|Death|2|||
41995160|NCT00176462|75803292|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
41995161|NCT00176462|75803293|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
41995162|NCT00176462|75803292|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
41995163|NCT00176462|75803293|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
41995164|NCT00176462|75803292|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
41995165|NCT00176462|75803293|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
41995166|NCT00176462|75803292|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
41995167|NCT00176462|75803293|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
41995168|NCT00176462|75803292|FG000|Consolidation (12 Weeks)|Not documented|0|||
42259935|NCT02478320|76086662|FG001|Overall Study|Screen Failure|0|||
42034198|NCT00835237|75842325|FG001|Overall Study|Lost to Follow-up|0|||
42034199|NCT00835237|75842324|FG000|Overall Study|Withdrawal by Subject|2|||
42034200|NCT00835237|75842325|FG001|Overall Study|Withdrawal by Subject|0|||
42034201|NCT01072500|75842333|FG000|Overall Study|Death|2|||
42034202|NCT01072500|75842334|FG001|Overall Study|Death|2|||
42034203|NCT01072500|75842333|FG000|Overall Study|Lost to Follow-up|5|||
42034204|NCT01072500|75842334|FG001|Overall Study|Lost to Follow-up|2|||
42034205|NCT01072500|75842333|FG000|Overall Study|Withdrawal by Subject|17|||
41995169|NCT00176462|75803293|FG001|Consolidation (12 Weeks)|Not documented|1|||
41995170|NCT00176462|75803292|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
42034206|NCT01072500|75842334|FG001|Overall Study|Withdrawal by Subject|10|||
42034207|NCT00847015|75842342|FG000|Overall Study|Withdrawal by Subject|1|||
42034208|NCT00847015|75842342|FG000|Overall Study|declined any surgery|1|||
42034209|NCT00847015|75842342|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
42034210|NCT00855595|75842348|FG000|Overall Study|Withdrawal by Subject|1|||
42034211|NCT00855595|75842349|FG001|Overall Study|Withdrawal by Subject|2|||
42034212|NCT00855595|75842348|FG000|Overall Study|Lost to Follow-up|3|||
42034213|NCT00855595|75842349|FG001|Overall Study|Lost to Follow-up|3|||
42034214|NCT00855595|75842348|FG000|Overall Study|Adverse Event|1|||
42034215|NCT00855595|75842349|FG001|Overall Study|Adverse Event|1|||
42034216|NCT00855595|75842348|FG000|Overall Study|patient moved out of state|1|||
42034217|NCT00855595|75842349|FG001|Overall Study|patient moved out of state|0|||
42034218|NCT00855595|75842348|FG000|Overall Study|patient left country|0|||
42034219|NCT00855595|75842349|FG001|Overall Study|patient left country|1|||
42034220|NCT00855439|75842357|FG000|Overall Study|Withdrawal by Subject|2|||
42034221|NCT00855439|75842358|FG001|Overall Study|Withdrawal by Subject|0|||
42034222|NCT00855439|75842357|FG000|Overall Study|Pregnancy|1|||
42034223|NCT00855439|75842358|FG001|Overall Study|Pregnancy|0|||
42034224|NCT01064856|75842366|FG000|Double-blind (DB) Period|Adverse Event|1|||
42034225|NCT01064856|75842367|FG001|Double-blind (DB) Period|Adverse Event|0|||
42034226|NCT01064856|75842368|FG002|Double-blind (DB) Period|Adverse Event|0|||
42034227|NCT01064856|75842369|FG003|Double-blind (DB) Period|Adverse Event|0|||
42034228|NCT01064856|75842366|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
42034229|NCT01064856|75842367|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
42034230|NCT01064856|75842368|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
42034231|NCT01064856|75842369|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
42034232|NCT01064856|75842366|FG000|Open-label (OL) Period|Adverse Event|0|||
42034233|NCT01064856|75842367|FG001|Open-label (OL) Period|Adverse Event|0|||
42034234|NCT01064856|75842368|FG002|Open-label (OL) Period|Adverse Event|12|||
42034235|NCT01064856|75842369|FG003|Open-label (OL) Period|Adverse Event|6|||
42034236|NCT01064856|75842366|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
42034237|NCT01064856|75842367|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
42034238|NCT01064856|75842368|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
42034239|NCT01064856|75842369|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
42034240|NCT01064856|75842366|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
42034241|NCT01064856|75842367|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
42034242|NCT01064856|75842368|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
42034243|NCT01064856|75842369|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
42034244|NCT01064856|75842366|FG000|Open-label (OL) Period|Other|0|||
41995171|NCT00176462|75803293|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
41995172|NCT00176462|75803292|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
41995173|NCT00176462|75803293|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
41995174|NCT00175019|75803303|FG000|Overall Study|Adverse Event|54|||
41995175|NCT00175019|75803304|FG001|Overall Study|Adverse Event|22|||
41995176|NCT00175019|75803305|FG002|Overall Study|Adverse Event|2|||
41995177|NCT00175019|75803303|FG000|Overall Study|Protocol Violation|6|||
41995178|NCT00175019|75803304|FG001|Overall Study|Protocol Violation|3|||
41995179|NCT00175019|75803305|FG002|Overall Study|Protocol Violation|3|||
42034245|NCT01064856|75842367|FG001|Open-label (OL) Period|Other|0|||
42034246|NCT01064856|75842368|FG002|Open-label (OL) Period|Other|7|||
42034247|NCT01064856|75842369|FG003|Open-label (OL) Period|Other|7|||
42034248|NCT00846391|75842379|FG000|Overall Study|Physician Decision|0|||
42034249|NCT00846391|75842380|FG001|Overall Study|Physician Decision|0|||
42034250|NCT00846391|75842381|FG002|Overall Study|Physician Decision|1|||
42034251|NCT00846391|75842379|FG000|Overall Study|Study Terminated by Sponsor|1|||
42034252|NCT00846391|75842380|FG001|Overall Study|Study Terminated by Sponsor|2|||
42034253|NCT00846391|75842381|FG002|Overall Study|Study Terminated by Sponsor|2|||
42034254|NCT01042392|75842391|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
42034255|NCT01042392|75842392|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
42034256|NCT01042392|75842393|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
42034257|NCT01042392|75842394|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
42034258|NCT01042392|75842391|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
42034259|NCT01042392|75842392|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
42034260|NCT01042392|75842393|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
42034261|NCT01042392|75842394|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
42034262|NCT01042392|75842391|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
42034263|NCT01042392|75842392|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
42034264|NCT01042392|75842393|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
42034265|NCT01042392|75842394|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
42034266|NCT01042392|75842391|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
42034267|NCT01042392|75842392|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
42034268|NCT01042392|75842393|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
42259936|NCT02252042|76086687|FG000|Overall Study|Adverse Event|9|||
41995180|NCT00175019|75803303|FG000|Overall Study|Lost to Follow-up|42|||
41995181|NCT00175019|75803304|FG001|Overall Study|Lost to Follow-up|39|||
41995182|NCT00175019|75803305|FG002|Overall Study|Lost to Follow-up|9|||
41995183|NCT00175019|75803303|FG000|Overall Study|Did not continue under Amendment 4|1|||
41995184|NCT00175019|75803304|FG001|Overall Study|Did not continue under Amendment 4|1|||
41995185|NCT00175019|75803305|FG002|Overall Study|Did not continue under Amendment 4|2|||
41995186|NCT00175019|75803303|FG000|Overall Study|Personal Reason(s)|39|||
41995187|NCT00175019|75803304|FG001|Overall Study|Personal Reason(s)|31|||
41995188|NCT00175019|75803305|FG002|Overall Study|Personal Reason(s)|8|||
41995189|NCT00175019|75803303|FG000|Overall Study|Therapeutic Failure|10|||
41995190|NCT00175019|75803304|FG001|Overall Study|Therapeutic Failure|38|||
41995191|NCT00175019|75803305|FG002|Overall Study|Therapeutic Failure|22|||
41995192|NCT00175019|75803303|FG000|Overall Study|Gout Flare|2|||
41995193|NCT00175019|75803304|FG001|Overall Study|Gout Flare|3|||
41995194|NCT00175019|75803305|FG002|Overall Study|Gout Flare|0|||
41995195|NCT00175019|75803303|FG000|Overall Study|Reason Not Specified|40|||
41995196|NCT00175019|75803304|FG001|Overall Study|Reason Not Specified|34|||
41995197|NCT00175019|75803305|FG002|Overall Study|Reason Not Specified|11|||
41995198|NCT00174941|75803316|FG000|Overall Study|Adverse Event|1|||
41995199|NCT00174941|75803317|FG001|Overall Study|Adverse Event|10|||
41995200|NCT00174941|75803318|FG002|Overall Study|Adverse Event|2|||
41995201|NCT00174941|75803319|FG003|Overall Study|Adverse Event|13|||
41995202|NCT00174941|75803316|FG000|Overall Study|Protocol Violation|0|||
41995203|NCT00174941|75803317|FG001|Overall Study|Protocol Violation|1|||
41995204|NCT00174941|75803318|FG002|Overall Study|Protocol Violation|0|||
41995205|NCT00174941|75803319|FG003|Overall Study|Protocol Violation|1|||
41995206|NCT00174941|75803316|FG000|Overall Study|Lost to Follow-up|0|||
41995207|NCT00174941|75803317|FG001|Overall Study|Lost to Follow-up|3|||
41995208|NCT00174941|75803318|FG002|Overall Study|Lost to Follow-up|2|||
41995209|NCT00174941|75803319|FG003|Overall Study|Lost to Follow-up|5|||
41995210|NCT00174941|75803316|FG000|Overall Study|Personal Reason(s)|0|||
41995211|NCT00174941|75803317|FG001|Overall Study|Personal Reason(s)|14|||
41995212|NCT00174941|75803318|FG002|Overall Study|Personal Reason(s)|8|||
41995213|NCT00174941|75803319|FG003|Overall Study|Personal Reason(s)|22|||
41995214|NCT00174941|75803316|FG000|Overall Study|Gout Flare|0|||
41995215|NCT00174941|75803317|FG001|Overall Study|Gout Flare|4|||
41995216|NCT00174941|75803318|FG002|Overall Study|Gout Flare|4|||
41995217|NCT00174941|75803319|FG003|Overall Study|Gout Flare|8|||
41995218|NCT00174941|75803316|FG000|Overall Study|Reason Not Specified|1|||
41995219|NCT00174941|75803317|FG001|Overall Study|Reason Not Specified|6|||
41995220|NCT00174941|75803318|FG002|Overall Study|Reason Not Specified|2|||
41995221|NCT00174941|75803319|FG003|Overall Study|Reason Not Specified|9|||
41995222|NCT00171704|75803331|FG000|Overall Study|Adverse Event|24|||
41995223|NCT00171704|75803332|FG001|Overall Study|Adverse Event|33|||
41995224|NCT00171704|75803331|FG000|Overall Study|Disease Progression|14|||
41995225|NCT00171704|75803332|FG001|Overall Study|Disease Progression|9|||
42034269|NCT01042392|75842394|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
42034270|NCT01042392|75842391|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
42034271|NCT01042392|75842392|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
42034272|NCT01042392|75842393|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
42034273|NCT01042392|75842394|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
42034274|NCT01042392|75842391|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
42034275|NCT01042392|75842392|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
42034276|NCT01042392|75842393|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
42034277|NCT01042392|75842394|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
42034278|NCT01042392|75842391|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
42034279|NCT01042392|75842392|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
42034280|NCT01042392|75842393|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
42034281|NCT01042392|75842394|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
42034282|NCT01042392|75842391|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
42034283|NCT01042392|75842392|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
42034284|NCT01042392|75842393|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
42034285|NCT01042392|75842394|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
42034286|NCT01042392|75842391|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
42034287|NCT01042392|75842392|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
42034288|NCT01042392|75842393|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
42034289|NCT01042392|75842394|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
42034290|NCT01064310|75842408|FG000|Period 1|Adverse Event|7|||
42034291|NCT01064310|75842409|FG001|Period 1|Adverse Event|10|||
42034292|NCT01064310|75842410|FG002|Period 1|Adverse Event|0|||
42034293|NCT01064310|75842408|FG000|Period 1|Physician Decision|1|||
42034294|NCT01064310|75842409|FG001|Period 1|Physician Decision|0|||
42034295|NCT01064310|75842410|FG002|Period 1|Physician Decision|0|||
42034296|NCT01064310|75842408|FG000|Period 1|Withdrawal by Subject|2|||
42034297|NCT01064310|75842409|FG001|Period 1|Withdrawal by Subject|2|||
42034298|NCT01064310|75842410|FG002|Period 1|Withdrawal by Subject|0|||
42034299|NCT01064310|75842408|FG000|Period 1|Lack of Efficacy|3|||
42034300|NCT01064310|75842409|FG001|Period 1|Lack of Efficacy|5|||
42034301|NCT01064310|75842410|FG002|Period 1|Lack of Efficacy|0|||
42034302|NCT01064310|75842408|FG000|Period 1|Entered Open-label Period|1|||
42034303|NCT01064310|75842409|FG001|Period 1|Entered Open-label Period|1|||
42034304|NCT01064310|75842410|FG002|Period 1|Entered Open-label Period|0|||
42034305|NCT01064310|75842408|FG000|Period 2|Adverse Event|2|||
42034306|NCT01064310|75842409|FG001|Period 2|Adverse Event|1|||
42034307|NCT01064310|75842410|FG002|Period 2|Adverse Event|0|||
42034308|NCT01064310|75842408|FG000|Period 2|Physician Decision|0|||
42034309|NCT01064310|75842409|FG001|Period 2|Physician Decision|1|||
42034310|NCT01064310|75842410|FG002|Period 2|Physician Decision|0|||
42034311|NCT01064310|75842408|FG000|Period 2|Entered Open-label Period|1|||
41995226|NCT00171704|75803331|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
41995227|NCT00171704|75803332|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
41995228|NCT00171704|75803331|FG000|Overall Study|Administrative Problems|2|||
41995229|NCT00171704|75803332|FG001|Overall Study|Administrative Problems|1|||
41995230|NCT00171704|75803331|FG000|Overall Study|Death|2|||
42034312|NCT01064310|75842409|FG001|Period 2|Entered Open-label Period|0|||
42034313|NCT01064310|75842410|FG002|Period 2|Entered Open-label Period|0|||
42034314|NCT01064310|75842408|FG000|Period 2|Lack of Efficacy|1|||
42034315|NCT01064310|75842409|FG001|Period 2|Lack of Efficacy|4|||
42034316|NCT01064310|75842410|FG002|Period 2|Lack of Efficacy|0|||
42034317|NCT01064310|75842408|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
42034318|NCT01064310|75842409|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
42034319|NCT01064310|75842410|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
42034320|NCT01064310|75842408|FG000|Open Label Pazopinib|Adverse Event|0|||
42034321|NCT01064310|75842409|FG001|Open Label Pazopinib|Adverse Event|0|||
42034322|NCT01064310|75842410|FG002|Open Label Pazopinib|Adverse Event|12|||
42034323|NCT01064310|75842408|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
42034324|NCT01064310|75842409|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
42034325|NCT01064310|75842410|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
42034326|NCT01064310|75842408|FG000|Open Label Pazopinib|Physician Decision|0|||
42034327|NCT01064310|75842409|FG001|Open Label Pazopinib|Physician Decision|0|||
42034328|NCT01064310|75842410|FG002|Open Label Pazopinib|Physician Decision|20|||
42034329|NCT01037244|75842423|FG000|Overall Study|Adverse Event|3|||
42034330|NCT01037244|75842424|FG001|Overall Study|Adverse Event|2|||
42034331|NCT01037244|75842425|FG002|Overall Study|Adverse Event|6|||
42034332|NCT01037244|75842426|FG003|Overall Study|Adverse Event|3|||
42034333|NCT01037244|75842423|FG000|Overall Study|Lack of Efficacy|1|||
42034334|NCT01037244|75842424|FG001|Overall Study|Lack of Efficacy|1|||
42034335|NCT01037244|75842425|FG002|Overall Study|Lack of Efficacy|0|||
42034336|NCT01037244|75842426|FG003|Overall Study|Lack of Efficacy|1|||
42259937|NCT02252042|76086688|FG001|Overall Study|Adverse Event|6|||
41995231|NCT00171704|75803332|FG001|Overall Study|Death|2|||
42259938|NCT02252042|76086687|FG000|Overall Study|Death|209|||
42259939|NCT02252042|76086688|FG001|Overall Study|Death|217|||
42259940|NCT02252042|76086687|FG000|Overall Study|Physician Decision|0|||
42259941|NCT02252042|76086688|FG001|Overall Study|Physician Decision|2|||
42259942|NCT02252042|76086687|FG000|Overall Study|Transferred to Extension Study|7|||
42259943|NCT02252042|76086688|FG001|Overall Study|Transferred to Extension Study|1|||
42259944|NCT02252042|76086687|FG000|Overall Study|Did Not Continue on Extension Study|7|||
42259945|NCT02252042|76086688|FG001|Overall Study|Did Not Continue on Extension Study|2|||
42259946|NCT02252042|76086687|FG000|Overall Study|Withdrawal by Subject|15|||
42259947|NCT02252042|76086688|FG001|Overall Study|Withdrawal by Subject|20|||
42259948|NCT00378482|76086715|FG000|Overall Study|Lost to Follow-up|1|||
42259949|NCT00378482|76086715|FG000|Overall Study|Lack of Efficacy|8|||
42272692|NCT00857285|76103028|FG000|Overall Study|Withdrawal by Subject|4|||
41995232|NCT00171704|75803331|FG000|Overall Study|Withdrawal by Subject|1|||
41995233|NCT00171704|75803332|FG001|Overall Study|Withdrawal by Subject|3|||
41995234|NCT00171704|75803331|FG000|Overall Study|Protocol Violation|0|||
41995235|NCT00171704|75803332|FG001|Overall Study|Protocol Violation|1|||
41995236|NCT00171314|75803340|FG000|Overall Study|Adverse Event|44|||
41995237|NCT00171314|75803341|FG001|Overall Study|Adverse Event|41|||
41995238|NCT00171314|75803340|FG000|Overall Study|Lack of Efficacy|19|||
41995239|NCT00171314|75803341|FG001|Overall Study|Lack of Efficacy|14|||
41995240|NCT00171314|75803340|FG000|Overall Study|Withdrawal by Subject|9|||
41995241|NCT00171314|75803341|FG001|Overall Study|Withdrawal by Subject|6|||
41995242|NCT00171314|75803340|FG000|Overall Study|Abnormal Test Procedure Results|9|||
41995243|NCT00171314|75803341|FG001|Overall Study|Abnormal Test Procedure Results|3|||
41995244|NCT00171314|75803340|FG000|Overall Study|Protocol Violation|3|||
41995245|NCT00171314|75803341|FG001|Overall Study|Protocol Violation|7|||
41995246|NCT00171314|75803340|FG000|Overall Study|Administrative Problems|4|||
41995247|NCT00171314|75803341|FG001|Overall Study|Administrative Problems|3|||
41995248|NCT00171314|75803340|FG000|Overall Study|Lost to Follow-up|1|||
41995249|NCT00171314|75803341|FG001|Overall Study|Lost to Follow-up|3|||
41995250|NCT00171314|75803340|FG000|Overall Study|Death|2|||
41995251|NCT00171314|75803341|FG001|Overall Study|Death|1|||
41995252|NCT00171158|75803347|FG000|Core Study|Death|27|||
42034337|NCT01037244|75842423|FG000|Overall Study|Lost to Follow-up|3|||
42034338|NCT01037244|75842424|FG001|Overall Study|Lost to Follow-up|3|||
42034339|NCT01037244|75842425|FG002|Overall Study|Lost to Follow-up|4|||
42034340|NCT01037244|75842426|FG003|Overall Study|Lost to Follow-up|4|||
42034341|NCT01037244|75842423|FG000|Overall Study|Withdrawal by Subject|1|||
42034342|NCT01037244|75842424|FG001|Overall Study|Withdrawal by Subject|5|||
42323582|NCT01714726|76160777|FG001|Open-Label Period|Other|0|||
42323583|NCT01714726|76160778|FG002|Open-Label Period|Other|1|||
42323584|NCT01714726|76160779|FG003|Open-Label Period|Other|3|||
42323585|NCT01714726|76160776|FG000|Open-Label Period|Adverse Event|0|||
42323586|NCT01714726|76160777|FG001|Open-Label Period|Adverse Event|0|||
42323587|NCT01714726|76160778|FG002|Open-Label Period|Adverse Event|1|||
42323588|NCT01714726|76160779|FG003|Open-Label Period|Adverse Event|0|||
42323589|NCT01714726|76160776|FG000|Open-Label Period|Withdrawal by Subject|0|||
42323590|NCT01714726|76160777|FG001|Open-Label Period|Withdrawal by Subject|0|||
42323591|NCT01714726|76160778|FG002|Open-Label Period|Withdrawal by Subject|9|||
42323592|NCT01714726|76160779|FG003|Open-Label Period|Withdrawal by Subject|19|||
42323593|NCT01714726|76160776|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
42323594|NCT01714726|76160777|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
42323595|NCT01714726|76160778|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
42323596|NCT01714726|76160779|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
42323597|NCT01714726|76160776|FG000|Open-Label Period|Lost to Follow-up|0|||
42323598|NCT01714726|76160777|FG001|Open-Label Period|Lost to Follow-up|0|||
42323599|NCT01714726|76160778|FG002|Open-Label Period|Lost to Follow-up|3|||
42323600|NCT01714726|76160779|FG003|Open-Label Period|Lost to Follow-up|4|||
42323601|NCT02255474|76160792|FG000|Overall Study|Lost to Follow-up|1|||
42323602|NCT02255474|76160793|FG001|Overall Study|Lost to Follow-up|1|||
42323603|NCT02255474|76160794|FG002|Overall Study|Lost to Follow-up|3|||
42323604|NCT02255474|76160792|FG000|Overall Study|Withdrawal by Subject|1|||
42323605|NCT02255474|76160793|FG001|Overall Study|Withdrawal by Subject|1|||
42323606|NCT02255474|76160794|FG002|Overall Study|Withdrawal by Subject|0|||
42323607|NCT02254772|76160803|FG000|Overall Study|Ineligible|1|||
42323608|NCT02254772|76160803|FG000|Overall Study|Withdrawal by Subject|1|||
42323609|NCT02254460|76160807|FG000|Overall Study|Adverse Event|1|||
42323610|NCT02254460|76160808|FG001|Overall Study|Adverse Event|0|||
42323611|NCT01682044|76160814|FG000|Overall Study|Death|1|||
42323612|NCT01682044|76160814|FG000|Overall Study|Progression|3|||
42323613|NCT01696942|76160820|FG000|Overall Study|Withdrawal by Subject|1|||
42323614|NCT01696942|76160821|FG001|Overall Study|Withdrawal by Subject|0|||
42323615|NCT01696942|76160820|FG000|Overall Study|Protocol Violation|1|||
42323616|NCT01696942|76160821|FG001|Overall Study|Protocol Violation|2|||
42323617|NCT01696942|76160820|FG000|Overall Study|screen failure|0|||
42323618|NCT01696942|76160821|FG001|Overall Study|screen failure|1|||
42323619|NCT01640366|76160827|FG000|Overall Study|Withdrawal by Subject|1|||
42323620|NCT01640366|76160827|FG000|Overall Study|Protocol Violation|16|||
42323621|NCT01640366|76160827|FG000|Overall Study|Lost to Follow-up|5|||
42323622|NCT01640288|76160835|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
42323623|NCT01640288|76160836|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
42323624|NCT01640288|76160835|FG000|Overall Study|Screen Failure|20|||
42323625|NCT01640288|76160836|FG001|Overall Study|Screen Failure|18|||
42323626|NCT01640288|76160835|FG000|Overall Study|Withdrawn by PI|5|||
42323627|NCT01640288|76160836|FG001|Overall Study|Withdrawn by PI|0|||
42323628|NCT01640288|76160835|FG000|Overall Study|Withdrawal by Subject|1|||
42323629|NCT01640288|76160836|FG001|Overall Study|Withdrawal by Subject|0|||
42323630|NCT01639040|76160845|FG000|Overall Study|Adverse Event|1|||
42323631|NCT01639040|76160846|FG001|Overall Study|Adverse Event|0|||
42323632|NCT01640054|76160855|FG000|Overall Study|Study-specific disc criteria|1|||
42323633|NCT01640054|76160855|FG000|Overall Study|Lack of Efficacy|3|||
42323634|NCT01640054|76160855|FG000|Overall Study|Adverse Event|2|||
42323635|NCT01600586|76160861|FG000|Overall Study|Physician Decision|3|||
42323636|NCT01600586|76160862|FG001|Overall Study|Physician Decision|3|||
42323637|NCT01639742|76160875|FG000|Overall Study|Study Ongoing|17|||
42323638|NCT01639742|76160875|FG000|Overall Study|Lost to Follow-up|1|||
42323639|NCT02164513|76160882|FG000|Overall Study|Adverse Event|162|||
42323640|NCT02164513|76160883|FG001|Overall Study|Adverse Event|180|||
42323641|NCT02164513|76160884|FG002|Overall Study|Adverse Event|111|||
42323642|NCT02164513|76160882|FG000|Overall Study|Other: Study Closed or terminated|5|||
42323643|NCT02164513|76160883|FG001|Overall Study|Other: Study Closed or terminated|2|||
42323644|NCT02164513|76160884|FG002|Overall Study|Other: Study Closed or terminated|4|||
42323645|NCT02164513|76160882|FG000|Overall Study|Lost to Follow-up|30|||
42034343|NCT01037244|75842425|FG002|Overall Study|Withdrawal by Subject|3|||
42034344|NCT01037244|75842426|FG003|Overall Study|Withdrawal by Subject|5|||
42034345|NCT01037244|75842423|FG000|Overall Study|Partner Withdrew Consent|2|||
42034346|NCT01037244|75842424|FG001|Overall Study|Partner Withdrew Consent|1|||
42259950|NCT00378482|76086715|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
42034347|NCT01037244|75842425|FG002|Overall Study|Partner Withdrew Consent|0|||
42034348|NCT01037244|75842426|FG003|Overall Study|Partner Withdrew Consent|0|||
42259951|NCT00378482|76086715|FG000|Overall Study|Withdrawal by Subject|4|||
42259952|NCT00378482|76086715|FG000|Overall Study|Adverse Event|9|||
42259953|NCT05288673|76086722|FG000|Overall Study|Consent withdrawn by subject|0|||
42259954|NCT05288673|76086723|FG001|Overall Study|Consent withdrawn by subject|0|||
42259955|NCT05288673|76086724|FG002|Overall Study|Consent withdrawn by subject|1|||
42259956|NCT04604795|76086770|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
42034349|NCT01037244|75842423|FG000|Overall Study|Various|3|||
42034350|NCT01037244|75842424|FG001|Overall Study|Various|2|||
42034351|NCT01037244|75842425|FG002|Overall Study|Various|1|||
42034352|NCT01037244|75842426|FG003|Overall Study|Various|1|||
42034353|NCT00833989|75842440|FG000|Overall Study|Physician Decision|0|||
42034354|NCT00833989|75842441|FG001|Overall Study|Physician Decision|0|||
42259957|NCT04604795|76086771|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
42259958|NCT04604795|76086772|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
42259959|NCT04604795|76086773|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
42259960|NCT04604795|76086774|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
42259961|NCT04604795|76086775|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
42259962|NCT04604795|76086776|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
42259963|NCT04604795|76086777|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
42259964|NCT04604795|76086778|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
42259965|NCT04604795|76086779|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
42259966|NCT04604795|76086770|FG000|Part B: Up to Day 14|Adverse Event|0|||
42259967|NCT04604795|76086771|FG001|Part B: Up to Day 14|Adverse Event|0|||
42259968|NCT04604795|76086772|FG002|Part B: Up to Day 14|Adverse Event|0|||
42259969|NCT04604795|76086773|FG003|Part B: Up to Day 14|Adverse Event|0|||
42259970|NCT04604795|76086774|FG004|Part B: Up to Day 14|Adverse Event|2|||
42259971|NCT04604795|76086775|FG005|Part B: Up to Day 14|Adverse Event|1|||
42259972|NCT04604795|76086776|FG006|Part B: Up to Day 14|Adverse Event|0|||
42259973|NCT04604795|76086777|FG007|Part B: Up to Day 14|Adverse Event|0|||
42259974|NCT04604795|76086778|FG008|Part B: Up to Day 14|Adverse Event|0|||
42259975|NCT04604795|76086779|FG009|Part B: Up to Day 14|Adverse Event|0|||
42259976|NCT04604795|76086770|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
42259977|NCT04604795|76086771|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
42259978|NCT04604795|76086772|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
42259979|NCT04604795|76086773|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
42259980|NCT04604795|76086774|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
42259981|NCT04604795|76086775|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
42259982|NCT04604795|76086776|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
42259983|NCT04604795|76086777|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
42259984|NCT04604795|76086778|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
42259985|NCT04604795|76086779|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
42259986|NCT04604795|76086770|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
42259987|NCT04604795|76086771|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
41995253|NCT00171158|75803347|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
41995254|NCT00171158|75803347|FG000|Core Study|Protocol Violation|4|||
41995255|NCT00171158|75803347|FG000|Core Study|Administrative problems|1|||
41995256|NCT00171158|75803347|FG000|Core Study|Adverse event, non-fatal|21|||
41995257|NCT00171158|75803347|FG000|Core Study|Consent withdrawn by subject|6|||
41995258|NCT00171158|75803347|FG000|Core Study|No longer required drug (BMT)|14|||
41995259|NCT00171158|75803347|FG000|Core Study|Abnormal Laboratory Values|2|||
41995260|NCT00171158|75803347|FG000|Core Study|Lost to Follow-up|1|||
41995261|NCT00171158|75803347|FG000|E2 Extension|Other|7|||
41995262|NCT00170846|75803354|FG000|Overall Study|Subject withdrew Informed Consent|5|||
41995263|NCT00170846|75803355|FG001|Overall Study|Subject withdrew Informed Consent|12|||
42034355|NCT00833989|75842442|FG002|Overall Study|Physician Decision|0|||
42034356|NCT00833989|75842443|FG003|Overall Study|Physician Decision|1|||
42323646|NCT02164513|76160883|FG001|Overall Study|Lost to Follow-up|36|||
42323647|NCT02164513|76160884|FG002|Overall Study|Lost to Follow-up|22|||
42323648|NCT02164513|76160882|FG000|Overall Study|Physician Decision|47|||
42323649|NCT02164513|76160883|FG001|Overall Study|Physician Decision|57|||
42323650|NCT02164513|76160884|FG002|Overall Study|Physician Decision|28|||
42323651|NCT02164513|76160882|FG000|Overall Study|Withdrawal by Subject|192|||
42323652|NCT02164513|76160883|FG001|Overall Study|Withdrawal by Subject|261|||
42323653|NCT02164513|76160884|FG002|Overall Study|Withdrawal by Subject|130|||
42323654|NCT02164513|76160882|FG000|Overall Study|Other: Reason not provided by site|1|||
42323655|NCT02164513|76160883|FG001|Overall Study|Other: Reason not provided by site|0|||
42323656|NCT02164513|76160884|FG002|Overall Study|Other: Reason not provided by site|0|||
42323657|NCT02218489|76160904|FG000|Overall Study|Withdrawal by Subject|4|||
42323658|NCT02218489|76160905|FG001|Overall Study|Withdrawal by Subject|3|||
42323659|NCT02218489|76160904|FG000|Overall Study|Lost to Follow-up|1|||
42323660|NCT02218489|76160905|FG001|Overall Study|Lost to Follow-up|0|||
42323661|NCT02192905|76160912|FG000|Overall Study|Lost to Follow-up|1|||
42323662|NCT01713946|76160920|FG000|Overall Study|Death|0|||
42323663|NCT01713946|76160921|FG001|Overall Study|Death|2|||
41995264|NCT00170846|75803356|FG002|Overall Study|Subject withdrew Informed Consent|8|||
41995265|NCT00170846|75803354|FG000|Overall Study|Lost to Follow-up|6|||
42034357|NCT00833989|75842440|FG000|Overall Study|Withdrawal by Subject|3|||
42259988|NCT04604795|76086772|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
42259989|NCT04604795|76086773|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
42259990|NCT04604795|76086774|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
42259991|NCT04604795|76086775|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
42259992|NCT04604795|76086776|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
42259993|NCT04604795|76086777|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
42259994|NCT04604795|76086778|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
42259995|NCT04604795|76086779|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
41995266|NCT00170846|75803355|FG001|Overall Study|Lost to Follow-up|3|||
41995267|NCT00170846|75803356|FG002|Overall Study|Lost to Follow-up|2|||
41995268|NCT00170846|75803354|FG000|Overall Study|Death|0|||
41995269|NCT00170846|75803355|FG001|Overall Study|Death|3|||
41995270|NCT00170846|75803356|FG002|Overall Study|Death|3|||
42259996|NCT04604795|76086770|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
42259997|NCT04604795|76086771|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
42259998|NCT04604795|76086772|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
42259999|NCT04604795|76086773|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
42260000|NCT04604795|76086774|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
42260001|NCT04604795|76086775|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
42260002|NCT04604795|76086776|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
42260003|NCT04604795|76086777|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
42260004|NCT04604795|76086778|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
42260005|NCT04604795|76086779|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
42260006|NCT04604795|76086770|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
42260007|NCT04604795|76086771|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
42260008|NCT04604795|76086772|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
42260009|NCT04604795|76086773|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
42260010|NCT04604795|76086774|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
42260011|NCT04604795|76086775|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
42260012|NCT04604795|76086776|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
42260013|NCT04604795|76086777|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
42323664|NCT01713946|76160922|FG002|Overall Study|Death|2|||
42323665|NCT01713946|76160920|FG000|Overall Study|Adverse Event|19|||
42323666|NCT01713946|76160921|FG001|Overall Study|Adverse Event|14|||
42323667|NCT01713946|76160922|FG002|Overall Study|Adverse Event|13|||
42323668|NCT01713946|76160920|FG000|Overall Study|Withdrawal by Subject|12|||
42323669|NCT01713946|76160921|FG001|Overall Study|Withdrawal by Subject|12|||
42323670|NCT01713946|76160922|FG002|Overall Study|Withdrawal by Subject|8|||
42323671|NCT01713946|76160920|FG000|Overall Study|Lack of Efficacy|8|||
42323672|NCT01713946|76160921|FG001|Overall Study|Lack of Efficacy|8|||
41995271|NCT00170846|75803354|FG000|Overall Study|Reason Missing|0|||
41995272|NCT00170846|75803355|FG001|Overall Study|Reason Missing|1|||
41995273|NCT00170846|75803356|FG002|Overall Study|Reason Missing|0|||
41995274|NCT00479882|75803368|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
41995275|NCT00479882|75803369|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
41995276|NCT00479882|75803370|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
42034358|NCT00833989|75842441|FG001|Overall Study|Withdrawal by Subject|0|||
42260014|NCT04604795|76086778|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
41995277|NCT00479882|75803371|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
42323673|NCT01713946|76160922|FG002|Overall Study|Lack of Efficacy|14|||
42323674|NCT01713946|76160920|FG000|Overall Study|Protocol Violation|2|||
42323675|NCT01713946|76160921|FG001|Overall Study|Protocol Violation|4|||
42323676|NCT01713946|76160922|FG002|Overall Study|Protocol Violation|1|||
42323677|NCT01713946|76160920|FG000|Overall Study|Lost to Follow-up|0|||
42323678|NCT01713946|76160921|FG001|Overall Study|Lost to Follow-up|0|||
42323679|NCT01713946|76160922|FG002|Overall Study|Lost to Follow-up|1|||
42323680|NCT01713946|76160920|FG000|Overall Study|Administrative problems|1|||
42323681|NCT01713946|76160921|FG001|Overall Study|Administrative problems|0|||
42323682|NCT01713946|76160922|FG002|Overall Study|Administrative problems|0|||
42323683|NCT01713946|76160920|FG000|Overall Study|Did not continue in Ext|0|||
42323684|NCT01713946|76160921|FG001|Overall Study|Did not continue in Ext|3|||
42323685|NCT01713946|76160922|FG002|Overall Study|Did not continue in Ext|0|||
42323686|NCT01713946|76160920|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
42323687|NCT01713946|76160921|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
42323688|NCT01713946|76160922|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
42323689|NCT01713946|76160920|FG000|Overall Study|Patients never switched to everolimus|0|||
42323690|NCT01713946|76160921|FG001|Overall Study|Patients never switched to everolimus|0|||
42323691|NCT01713946|76160922|FG002|Overall Study|Patients never switched to everolimus|5|||
42323692|NCT02163499|76160948|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
42323693|NCT02163499|76160948|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
42323694|NCT02163499|76160948|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
42323695|NCT02163499|76160948|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
42323696|NCT02163499|76160948|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
42323697|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
42323698|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
42323699|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
42323700|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
42323701|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
42323702|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
42323703|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
42323704|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
42323705|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
42323706|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Death|8|||
42323707|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
42323708|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
42323709|NCT02163499|76160948|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
42323710|NCT02163187|76160958|FG000|Overall Study|Device removed|1|||
42323711|NCT02163187|76160959|FG001|Overall Study|Device removed|0|||
42323712|NCT02163187|76160958|FG000|Overall Study|Progressive disease|1|||
42323713|NCT02163187|76160959|FG001|Overall Study|Progressive disease|0|||
42323714|NCT02191579|76160967|FG000|Treatment 1|Multiple Reasons Specified|27|||
42323715|NCT02191579|76160968|FG001|Treatment 1|Multiple Reasons Specified|58|||
42323716|NCT02191579|76160967|FG000|Treatment 2|Multiple Reasons Specified|0|||
42323717|NCT02191579|76160968|FG001|Treatment 2|Multiple Reasons Specified|25|||
42323718|NCT01363700|76160977|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
42323719|NCT01363700|76160978|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
42323720|NCT01363700|76160979|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
42323721|NCT01363700|76160980|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
42323722|NCT01363700|76160981|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
42323723|NCT01637402|76160992|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
42323724|NCT01637402|76160993|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
42323725|NCT01637402|76160992|FG000|Standard Dose Regimen|Adverse Event|1|||
42323726|NCT01637402|76160993|FG001|Standard Dose Regimen|Adverse Event|0|||
42323727|NCT01637402|76160992|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
42323728|NCT01637402|76160993|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
42323729|NCT01637402|76160992|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
42323730|NCT01637402|76160993|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
42323731|NCT01637402|76160992|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
42323732|NCT01637402|76160993|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
42260015|NCT04604795|76086779|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
42323733|NCT01637402|76160992|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
42323734|NCT01637402|76160993|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
42323735|NCT02217475|76161021|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
42323736|NCT02217475|76161022|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
42323737|NCT02217475|76161023|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
42323738|NCT02217475|76161021|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
42323739|NCT02217475|76161022|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
42323740|NCT02217475|76161023|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
42323741|NCT02217475|76161021|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
42323742|NCT02217475|76161022|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
42323743|NCT02217475|76161023|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
42323744|NCT02217475|76161021|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
42323745|NCT02217475|76161022|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
42323746|NCT02217475|76161023|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
41995278|NCT00479882|75803368|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
42133604|NCT00553787|75944512|FG002|Overall Study|Requirement for restricted medication|5|||
42260016|NCT04314284|76086875|FG000|Overall Study|Withdrawal by Subject|4|||
42260017|NCT04314284|76086876|FG001|Overall Study|Withdrawal by Subject|7|||
42260018|NCT04314284|76086875|FG000|Overall Study|Consented but did not complete survey|0|||
42260019|NCT04314284|76086876|FG001|Overall Study|Consented but did not complete survey|6|||
42260020|NCT04203823|76086884|FG000|Overall Study|Withdrawal by Subject|2|||
42260021|NCT04203823|76086885|FG001|Overall Study|Withdrawal by Subject|2|||
42260022|NCT04203823|76086884|FG000|Overall Study|Adverse Event|1|||
42260023|NCT04203823|76086885|FG001|Overall Study|Adverse Event|1|||
42260024|NCT04203823|76086884|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42260025|NCT04203823|76086885|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
42260026|NCT03703466|76086938|FG000|Overall Study|Death|2|||
42260027|NCT03703466|76086939|FG001|Overall Study|Death|1|||
42260028|NCT03703466|76086940|FG002|Overall Study|Death|0|||
42260029|NCT03703466|76086938|FG000|Overall Study|Protocol Violation|1|||
42260030|NCT03703466|76086939|FG001|Overall Study|Protocol Violation|0|||
42260031|NCT03703466|76086940|FG002|Overall Study|Protocol Violation|0|||
42260032|NCT03703466|76086938|FG000|Overall Study|Withdrawal by Subject|0|||
42260033|NCT03703466|76086939|FG001|Overall Study|Withdrawal by Subject|3|||
42260034|NCT03703466|76086940|FG002|Overall Study|Withdrawal by Subject|0|||
42260035|NCT03703466|76086938|FG000|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1|||
42260036|NCT03703466|76086939|FG001|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
42260037|NCT03703466|76086940|FG002|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2|||
42260038|NCT03248128|76086999|FG000|Overall Study|Lost to Follow-up|1|||
42260039|NCT03248128|76087000|FG001|Overall Study|Lost to Follow-up|0|||
42260040|NCT03248128|76086999|FG000|Overall Study|Withdrawal by Subject|16|||
42260041|NCT03248128|76087000|FG001|Overall Study|Withdrawal by Subject|14|||
42260042|NCT03248128|76086999|FG000|Overall Study|Site Closed|4|||
42260043|NCT03248128|76087000|FG001|Overall Study|Site Closed|3|||
42260044|NCT03248128|76086999|FG000|Overall Study|Randomized, but did not receive treatment|1|||
42260045|NCT03248128|76087000|FG001|Overall Study|Randomized, but did not receive treatment|3|||
42260046|NCT02802631|76087043|FG000|Overall Study|Withdrawal by Subject|1|||
42260047|NCT02802631|76087044|FG001|Overall Study|Withdrawal by Subject|0|||
42260048|NCT02802631|76087045|FG002|Overall Study|Withdrawal by Subject|0|||
42133605|NCT00553787|75944510|FG000|Overall Study|Other|18|||
42133606|NCT00553787|75944511|FG001|Overall Study|Other|10|||
42133607|NCT00553787|75944512|FG002|Overall Study|Other|13|||
42133608|NCT00407745|75944522|FG000|Overall Study|Lack of Efficacy|1|||
42133609|NCT00407745|75944523|FG001|Overall Study|Lack of Efficacy|2|||
42133610|NCT00407745|75944522|FG000|Overall Study|Withdrawal by Subject|3|||
42133611|NCT00407745|75944523|FG001|Overall Study|Withdrawal by Subject|3|||
42260049|NCT02802631|76087046|FG003|Overall Study|Withdrawal by Subject|0|||
42260050|NCT02802631|76087047|FG004|Overall Study|Withdrawal by Subject|0|||
42260051|NCT02802631|76087048|FG005|Overall Study|Withdrawal by Subject|0|||
42260052|NCT02802631|76087049|FG006|Overall Study|Withdrawal by Subject|0|||
42260053|NCT02802631|76087050|FG007|Overall Study|Withdrawal by Subject|0|||
42260054|NCT02802631|76087043|FG000|Overall Study|Physician Decision|1|||
42323747|NCT02217475|76161021|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
42323748|NCT02217475|76161022|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
42323749|NCT02217475|76161023|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
41995279|NCT00479882|75803369|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
41995280|NCT00479882|75803370|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
42323750|NCT02217475|76161021|FG000|Discontinued After Period 1|Adverse Event|1|||
42323751|NCT02217475|76161022|FG001|Discontinued After Period 1|Adverse Event|2|||
42323752|NCT02217475|76161023|FG002|Discontinued After Period 1|Adverse Event|0|||
42323753|NCT02217475|76161021|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
42323754|NCT02217475|76161022|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
42323755|NCT02217475|76161023|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
42323756|NCT02217475|76161021|FG000|Discontinued After Period 1|Physician Decision|0|||
42323757|NCT02217475|76161022|FG001|Discontinued After Period 1|Physician Decision|0|||
42323758|NCT02217475|76161023|FG002|Discontinued After Period 1|Physician Decision|1|||
42323759|NCT02217475|76161021|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
42323760|NCT02217475|76161022|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
42323761|NCT02217475|76161023|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
42323762|NCT02217475|76161021|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
42323763|NCT02217475|76161022|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
42323764|NCT02217475|76161023|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
42260055|NCT02802631|76087044|FG001|Overall Study|Physician Decision|0|||
42260056|NCT02802631|76087045|FG002|Overall Study|Physician Decision|0|||
42260057|NCT02802631|76087046|FG003|Overall Study|Physician Decision|0|||
42260058|NCT02802631|76087047|FG004|Overall Study|Physician Decision|0|||
41995281|NCT00479882|75803371|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
41995282|NCT00479882|75803368|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
41995283|NCT00479882|75803369|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
42260059|NCT02802631|76087048|FG005|Overall Study|Physician Decision|0|||
42260060|NCT02802631|76087049|FG006|Overall Study|Physician Decision|1|||
42260061|NCT02802631|76087050|FG007|Overall Study|Physician Decision|0|||
42260062|NCT02802631|76087043|FG000|Overall Study|Adverse Event|0|||
42260063|NCT02802631|76087044|FG001|Overall Study|Adverse Event|2|||
42260064|NCT02802631|76087045|FG002|Overall Study|Adverse Event|0|||
42260065|NCT02802631|76087046|FG003|Overall Study|Adverse Event|1|||
42260066|NCT02802631|76087047|FG004|Overall Study|Adverse Event|6|||
42260067|NCT02802631|76087048|FG005|Overall Study|Adverse Event|1|||
42260068|NCT02802631|76087049|FG006|Overall Study|Adverse Event|4|||
42260069|NCT02802631|76087050|FG007|Overall Study|Adverse Event|0|||
42260070|NCT02802631|76087043|FG000|Overall Study|Sponsor Decision|0|||
42260071|NCT02802631|76087044|FG001|Overall Study|Sponsor Decision|0|||
42260072|NCT02802631|76087045|FG002|Overall Study|Sponsor Decision|6|||
42260073|NCT02802631|76087046|FG003|Overall Study|Sponsor Decision|0|||
42260074|NCT02802631|76087047|FG004|Overall Study|Sponsor Decision|2|||
42260075|NCT02802631|76087048|FG005|Overall Study|Sponsor Decision|0|||
42260076|NCT02802631|76087049|FG006|Overall Study|Sponsor Decision|0|||
42260077|NCT02802631|76087050|FG007|Overall Study|Sponsor Decision|4|||
42260078|NCT02754479|76087082|FG000|Overall Study|Lost to Follow-up|1|||
42260079|NCT02036476|76087095|FG000|Overall Study|Withdrawal by Subject|2|||
42260080|NCT02036476|76087095|FG000|Overall Study|Progressive Disease|4|||
42260081|NCT02036476|76087095|FG000|Overall Study|Unacceptable Toxicity|2|||
42260082|NCT00643994|76087120|FG000|Overall Study|Death|24|||
42260083|NCT00643994|76087120|FG000|Overall Study|Lost to Follow-up|72|||
42323765|NCT02217475|76161021|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
42323766|NCT02217475|76161022|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
42323767|NCT02217475|76161023|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
42323768|NCT02217475|76161021|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
42260084|NCT00643617|76087126|FG000|Overall Study|Death|6|||
42260085|NCT00643617|76087127|FG001|Overall Study|Death|9|||
42260086|NCT00643617|76087126|FG000|Overall Study|Lost to Follow-up|42|||
42260087|NCT00643617|76087127|FG001|Overall Study|Lost to Follow-up|51|||
42260088|NCT00504582|76087154|FG000|Overall Study|Lost to Follow-up|1|||
42260089|NCT00504582|76087155|FG001|Overall Study|Lost to Follow-up|0|||
41995284|NCT00479882|75803370|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
41995285|NCT00479882|75803371|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
41995286|NCT00479882|75803368|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
41995287|NCT00479882|75803369|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
41995288|NCT00479882|75803370|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
41995289|NCT00479882|75803371|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
41995290|NCT00479882|75803368|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
41995291|NCT00479882|75803369|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
41995292|NCT00479882|75803370|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
41995293|NCT00479882|75803371|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
41995294|NCT00479882|75803368|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
41995295|NCT00479882|75803369|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
41995296|NCT00479882|75803370|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
41995297|NCT00479882|75803371|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
41995298|NCT00479882|75803368|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
41995299|NCT00479882|75803369|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
41995300|NCT00479882|75803370|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
41995301|NCT00479882|75803371|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
41995302|NCT00479882|75803368|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
41995303|NCT00479882|75803369|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
41995304|NCT00479882|75803370|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
41995305|NCT00479882|75803371|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
41995306|NCT00479882|75803368|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
41995307|NCT00479882|75803369|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
41995308|NCT00479882|75803370|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
41995309|NCT00479882|75803371|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
41995310|NCT00479882|75803368|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
41995311|NCT00479882|75803369|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
41995312|NCT00479882|75803370|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
41995313|NCT00479882|75803371|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
41995314|NCT00479882|75803368|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
41995315|NCT00479882|75803369|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
41995316|NCT00479882|75803370|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
42034359|NCT00833989|75842442|FG002|Overall Study|Withdrawal by Subject|1|||
42260090|NCT00504582|76087156|FG002|Overall Study|Lost to Follow-up|0|||
42260091|NCT00314366|76087179|FG000|Overall Study|not treated due to patient medical condi|1|||
42260092|NCT00314366|76087180|FG001|Overall Study|not treated due to patient medical condi|0|||
42260093|NCT01595061|76087189|FG000|Overall Study|Never Treated|3|||
42260094|NCT01595061|76087189|FG000|Overall Study|Inadequate Pathology|1|||
42260095|NCT02852005|76087198|FG000|Overall Study|Lost to Follow-up|0|||
42260096|NCT02852005|76087199|FG001|Overall Study|Lost to Follow-up|0|||
42260097|NCT02852005|76087200|FG002|Overall Study|Lost to Follow-up|0|||
42260098|NCT02852005|76087201|FG003|Overall Study|Lost to Follow-up|0|||
42260099|NCT02852005|76087202|FG004|Overall Study|Lost to Follow-up|1|||
42260100|NCT02852005|76087198|FG000|Overall Study|Withdrawal by Subject|1|||
42260101|NCT02852005|76087199|FG001|Overall Study|Withdrawal by Subject|0|||
42260102|NCT02852005|76087200|FG002|Overall Study|Withdrawal by Subject|0|||
42260103|NCT02852005|76087201|FG003|Overall Study|Withdrawal by Subject|0|||
42260104|NCT02852005|76087202|FG004|Overall Study|Withdrawal by Subject|0|||
42260105|NCT02851615|76087218|FG000|Overall Study|Cognitive Issue|1|||
42260106|NCT02851615|76087219|FG001|Overall Study|Cognitive Issue|0|||
42260107|NCT02851615|76087218|FG000|Overall Study|Lost to Follow-up|0|||
42260108|NCT02851615|76087219|FG001|Overall Study|Lost to Follow-up|4|||
42260109|NCT02849743|76087228|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
42260110|NCT02849743|76087229|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
42260111|NCT02849743|76087228|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
42260112|NCT02849743|76087229|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
42260113|NCT02851069|76087264|FG000|Overall Study|Failure to Return|3|||
42260114|NCT02851069|76087264|FG000|Overall Study|Other|3|||
42323769|NCT02217475|76161022|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
42323770|NCT02217475|76161023|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
42260115|NCT02849509|76087272|FG000|Overall Study|Worsening of disease under study|1|||
42260116|NCT02849509|76087273|FG001|Overall Study|Worsening of disease under study|1|||
42260117|NCT02849509|76087274|FG002|Overall Study|Worsening of disease under study|1|||
42260118|NCT02849509|76087272|FG000|Overall Study|Worsening of other pre-existing disease|0|||
42260119|NCT02849509|76087273|FG001|Overall Study|Worsening of other pre-existing disease|1|||
42260120|NCT02849509|76087274|FG002|Overall Study|Worsening of other pre-existing disease|2|||
42323771|NCT02217475|76161021|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
42323772|NCT02217475|76161022|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
42323773|NCT02217475|76161023|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
41995317|NCT00479882|75803371|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
41995318|NCT00479882|75803368|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
41995319|NCT00479882|75803369|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
41995320|NCT00479882|75803370|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
42323774|NCT02191267|76161043|FG000|Overall Study|Withdrawal by Subject|1|||
42323775|NCT02191267|76161044|FG001|Overall Study|Withdrawal by Subject|0|||
42323776|NCT02191267|76161045|FG002|Overall Study|Withdrawal by Subject|0|||
42323777|NCT02189941|76161053|FG000|Overall Study|Non-compliance|0|||
42323778|NCT02189941|76161054|FG001|Overall Study|Non-compliance|0|||
42323779|NCT02189941|76161055|FG002|Overall Study|Non-compliance|1|||
42323780|NCT02216773|76161065|FG000|Overall Study|Disease progression|4|||
42323781|NCT02216773|76161066|FG001|Overall Study|Disease progression|2|||
42323782|NCT02216773|76161065|FG000|Overall Study|Insufficient FLRV|4|||
42323783|NCT02216773|76161066|FG001|Overall Study|Insufficient FLRV|0|||
42323784|NCT02216773|76161065|FG000|Overall Study|Abandoned|4|||
42323785|NCT02216773|76161066|FG001|Overall Study|Abandoned|3|||
42323786|NCT01601132|76161072|FG000|Overall Study|Patient withdrew consent|1|||
42323787|NCT01601132|76161072|FG000|Overall Study|Protocol deviation|1|||
42133612|NCT00407745|75944522|FG000|Overall Study|Protocol Violation|5|||
42133613|NCT00407745|75944523|FG001|Overall Study|Protocol Violation|3|||
42133614|NCT00407745|75944522|FG000|Overall Study|Adverse Event|8|||
42133615|NCT00407745|75944523|FG001|Overall Study|Adverse Event|8|||
42133616|NCT00407745|75944522|FG000|Overall Study|Other|2|||
42133617|NCT00407745|75944523|FG001|Overall Study|Other|0|||
41995321|NCT00479882|75803371|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
41995322|NCT00479882|75803368|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
41995323|NCT00479882|75803369|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
41995324|NCT00479882|75803370|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
41995325|NCT00479882|75803371|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
41995326|NCT00479882|75803368|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
41995327|NCT00479882|75803369|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
41995328|NCT00479882|75803370|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
41995329|NCT00479882|75803371|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
41995330|NCT00479765|75803397|FG000|Overall Study|study terminated|4|||
41995331|NCT00479687|75803403|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
41995332|NCT00479687|75803404|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
41995333|NCT00479687|75803405|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
41995334|NCT00479687|75803403|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
41995335|NCT00479687|75803404|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
42034360|NCT00833989|75842443|FG003|Overall Study|Withdrawal by Subject|1|||
42034361|NCT01037088|75842456|FG000|Overall Study|Withdrawal by Subject|3|||
42034362|NCT01042236|75842465|FG000|Treatment Period 1|Adverse Event|0|||
42034363|NCT01042236|75842466|FG001|Treatment Period 1|Adverse Event|1|||
42034364|NCT01042236|75842467|FG002|Treatment Period 1|Adverse Event|0|||
42034365|NCT01042236|75842468|FG003|Treatment Period 1|Adverse Event|0|||
42133618|NCT00407745|75944522|FG000|Overall Study|Randomized, unknown if treated|0|||
42133619|NCT00407745|75944523|FG001|Overall Study|Randomized, unknown if treated|1|||
42133620|NCT03958955|75944529|FG000|Overall Study|Adverse Event|1|||
42133621|NCT00464334|75944546|FG000|Overall Study|Adverse Event|0|||
42323788|NCT02162719|76161081|FG000|Overall Study|Death|41|||
42034366|NCT01042236|75842469|FG004|Treatment Period 1|Adverse Event|1|||
42133622|NCT00464334|75944547|FG001|Overall Study|Adverse Event|0|||
41995336|NCT00479687|75803405|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
42034367|NCT01042236|75842470|FG005|Treatment Period 1|Adverse Event|0|||
42034368|NCT01042236|75842465|FG000|Treatment Period 3|Adverse Event|0|||
42133623|NCT00464334|75944548|FG002|Overall Study|Adverse Event|0|||
42323789|NCT02162719|76161082|FG001|Overall Study|Death|46|||
42323790|NCT02162719|76161081|FG000|Overall Study|Lost to Follow-up|1|||
42323791|NCT02162719|76161082|FG001|Overall Study|Lost to Follow-up|3|||
42323792|NCT02162719|76161081|FG000|Overall Study|Disease Progression|2|||
42323793|NCT02162719|76161082|FG001|Overall Study|Disease Progression|1|||
42323794|NCT02162719|76161081|FG000|Overall Study|Withdrawal by Subject|8|||
42133624|NCT00464334|75944549|FG003|Overall Study|Adverse Event|1|||
42323795|NCT02162719|76161082|FG001|Overall Study|Withdrawal by Subject|2|||
42323796|NCT02162719|76161081|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
42133625|NCT00464334|75944550|FG004|Overall Study|Adverse Event|1|||
42133626|NCT00464334|75944551|FG005|Overall Study|Adverse Event|1|||
42133627|NCT00464334|75944552|FG006|Overall Study|Adverse Event|0|||
42133628|NCT00464334|75944553|FG007|Overall Study|Adverse Event|0|||
42133629|NCT00464334|75944554|FG008|Overall Study|Adverse Event|2|||
42133630|NCT00464334|75944555|FG009|Overall Study|Adverse Event|1|||
42133631|NCT00464334|75944556|FG010|Overall Study|Adverse Event|2|||
42133632|NCT00464334|75944546|FG000|Overall Study|Lack of Efficacy|0|||
42323797|NCT02162719|76161082|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
42323798|NCT02161549|76161090|FG000|Overall Study|Physician Decision|6|||
42323799|NCT02161549|76161091|FG001|Overall Study|Physician Decision|2|||
42323800|NCT02189863|76161097|FG000|First 2 Weeks|Motion Sickness|4|||
42323801|NCT02189863|76161098|FG001|First 2 Weeks|Motion Sickness|2|||
42323802|NCT02189473|76161109|FG000|Overall Study|Death|22|||
42323803|NCT02189473|76161110|FG001|Overall Study|Death|23|||
41995337|NCT00479687|75803403|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
42323804|NCT02189473|76161109|FG000|Overall Study|Lost to Follow-up|1|||
42323805|NCT02189473|76161110|FG001|Overall Study|Lost to Follow-up|2|||
42323806|NCT02188849|76161118|FG000|Overall Study|Lost to Follow-up|3|||
42323807|NCT02188849|76161119|FG001|Overall Study|Lost to Follow-up|8|||
42323808|NCT01636076|76161127|FG000|Overall Study|Terminated by sponsor|1|||
42323809|NCT01636076|76161128|FG001|Overall Study|Terminated by sponsor|1|||
42323810|NCT01636076|76161127|FG000|Overall Study|Lack of Efficacy|0|||
42323811|NCT01636076|76161128|FG001|Overall Study|Lack of Efficacy|1|||
42323812|NCT01636076|76161127|FG000|Overall Study|Lost to Follow-up|1|||
42323813|NCT01636076|76161128|FG001|Overall Study|Lost to Follow-up|0|||
42323814|NCT01636076|76161127|FG000|Overall Study|Physician Decision|1|||
42323815|NCT01636076|76161128|FG001|Overall Study|Physician Decision|1|||
42323816|NCT01636076|76161127|FG000|Overall Study|Non-compliance with study treatment|1|||
42323817|NCT01636076|76161128|FG001|Overall Study|Non-compliance with study treatment|1|||
42323818|NCT01636076|76161127|FG000|Overall Study|Adverse Event|6|||
42323819|NCT01636076|76161128|FG001|Overall Study|Adverse Event|11|||
42323820|NCT01636076|76161127|FG000|Overall Study|Withdrawal by Subject|7|||
42323821|NCT01636076|76161128|FG001|Overall Study|Withdrawal by Subject|10|||
42323822|NCT01635998|76161143|FG000|Overall Study|Death|1|||
42323823|NCT01635998|76161144|FG001|Overall Study|Death|1|||
42323824|NCT01635998|76161143|FG000|Overall Study|Lost to Follow-up|2|||
42323825|NCT01635998|76161144|FG001|Overall Study|Lost to Follow-up|1|||
42323826|NCT01635998|76161143|FG000|Overall Study|Withdrawal by Subject|1|||
42323827|NCT01635998|76161144|FG001|Overall Study|Withdrawal by Subject|5|||
42323828|NCT01635920|76161152|FG000|Overall Study|Adverse Event|1|||
42323829|NCT01635920|76161153|FG001|Overall Study|Adverse Event|0|||
41995338|NCT00479687|75803404|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
41995339|NCT00479687|75803405|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
41995340|NCT00479687|75803403|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
42323830|NCT01635920|76161152|FG000|Overall Study|Lost to Follow-up|0|||
42323831|NCT01635920|76161153|FG001|Overall Study|Lost to Follow-up|1|||
42323832|NCT01635920|76161152|FG000|Overall Study|Subject decision|2|||
42323833|NCT01635920|76161153|FG001|Overall Study|Subject decision|0|||
42323834|NCT02160145|76161170|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
42323835|NCT02160145|76161171|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
42323836|NCT02160145|76161172|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
42323837|NCT02160145|76161170|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
42323838|NCT02160145|76161171|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
42323839|NCT02160145|76161172|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
42323840|NCT02160145|76161170|FG000|Randomized Double-blind Period|Subject decision|0|||
41995341|NCT00479687|75803404|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
42133633|NCT00464334|75944547|FG001|Overall Study|Lack of Efficacy|1|||
42133634|NCT00464334|75944548|FG002|Overall Study|Lack of Efficacy|0|||
42133635|NCT00464334|75944549|FG003|Overall Study|Lack of Efficacy|0|||
42323841|NCT02160145|76161171|FG001|Randomized Double-blind Period|Subject decision|21|||
42323842|NCT02160145|76161172|FG002|Randomized Double-blind Period|Subject decision|20|||
42323843|NCT02160145|76161170|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
42323844|NCT02160145|76161171|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
42323845|NCT02160145|76161172|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
42323846|NCT02160145|76161170|FG000|Randomized Double-blind Period|Physician Decision|0|||
42323847|NCT02160145|76161171|FG001|Randomized Double-blind Period|Physician Decision|7|||
42323848|NCT02160145|76161172|FG002|Randomized Double-blind Period|Physician Decision|5|||
41995342|NCT00479687|75803405|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
41995343|NCT00479687|75803403|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
41995344|NCT00479687|75803404|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
41995345|NCT00479687|75803405|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
42323849|NCT01696396|76161183|FG000|Overall Study|Withdrawal by Subject|19|||
42323850|NCT01696396|76161184|FG001|Overall Study|Withdrawal by Subject|5|||
42323851|NCT01696396|76161185|FG002|Overall Study|Withdrawal by Subject|19|||
42323852|NCT01696396|76161186|FG003|Overall Study|Withdrawal by Subject|11|||
42323853|NCT01696396|76161183|FG000|Overall Study|Decision by Sponsor|3|||
42323854|NCT01696396|76161184|FG001|Overall Study|Decision by Sponsor|1|||
42323855|NCT01696396|76161185|FG002|Overall Study|Decision by Sponsor|2|||
42323856|NCT01696396|76161186|FG003|Overall Study|Decision by Sponsor|2|||
42323857|NCT01696396|76161183|FG000|Overall Study|Lost to Follow-up|9|||
42323858|NCT01696396|76161184|FG001|Overall Study|Lost to Follow-up|1|||
42323859|NCT01696396|76161185|FG002|Overall Study|Lost to Follow-up|4|||
42323860|NCT01696396|76161186|FG003|Overall Study|Lost to Follow-up|1|||
42323861|NCT01696396|76161183|FG000|Overall Study|Death|0|||
42323862|NCT01696396|76161184|FG001|Overall Study|Death|0|||
42323863|NCT01696396|76161185|FG002|Overall Study|Death|1|||
42323864|NCT01696396|76161186|FG003|Overall Study|Death|0|||
42323865|NCT02216071|76161202|FG000|Overall Study|Withdrawal by Subject|7|||
42323866|NCT02216071|76161203|FG001|Overall Study|Withdrawal by Subject|2|||
42323867|NCT02216071|76161202|FG000|Overall Study|Lost to Follow-up|3|||
42323868|NCT02216071|76161203|FG001|Overall Study|Lost to Follow-up|3|||
42323869|NCT02216071|76161202|FG000|Overall Study|Protocol Violation|3|||
42323870|NCT02216071|76161203|FG001|Overall Study|Protocol Violation|5|||
42323871|NCT02216071|76161202|FG000|Overall Study|Other|2|||
42323872|NCT02216071|76161203|FG001|Overall Study|Other|2|||
41995346|NCT00479687|75803403|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
41995347|NCT00479687|75803404|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
41995348|NCT00479687|75803405|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
42260121|NCT02849509|76087272|FG000|Overall Study|Other adverse event|36|||
42260122|NCT02849509|76087273|FG001|Overall Study|Other adverse event|41|||
42260123|NCT02849509|76087274|FG002|Overall Study|Other adverse event|8|||
42260124|NCT02849509|76087272|FG000|Overall Study|Withdrawal by Subject|6|||
42260125|NCT02849509|76087273|FG001|Overall Study|Withdrawal by Subject|17|||
42260126|NCT02849509|76087274|FG002|Overall Study|Withdrawal by Subject|12|||
42260127|NCT02849509|76087272|FG000|Overall Study|Lost to Follow-up|27|||
42260128|NCT02849509|76087273|FG001|Overall Study|Lost to Follow-up|67|||
42260129|NCT02849509|76087274|FG002|Overall Study|Lost to Follow-up|36|||
42260130|NCT02849509|76087272|FG000|Overall Study|Other, reason not specified|14|||
42260131|NCT02849509|76087273|FG001|Overall Study|Other, reason not specified|29|||
42260132|NCT02849509|76087274|FG002|Overall Study|Other, reason not specified|25|||
42260133|NCT02849509|76087272|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
42260134|NCT02849509|76087273|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
42260135|NCT02849509|76087274|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
42260136|NCT02848729|76087286|FG000|Overall Study|Withdrawal by Subject|1|||
42260137|NCT02848729|76087287|FG001|Overall Study|Withdrawal by Subject|0|||
42260138|NCT02848729|76087286|FG000|Overall Study|Emesis|15|||
42260139|NCT02848729|76087287|FG001|Overall Study|Emesis|11|||
42260140|NCT00158756|76087305|FG000|Overall Study|Withdrawal by Subject|5|||
42260141|NCT00158756|76087306|FG001|Overall Study|Withdrawal by Subject|0|||
42323873|NCT01681576|76161211|FG000|Period 1|Adverse Event|1|||
42323874|NCT01681576|76161212|FG001|Period 1|Adverse Event|0|||
42323875|NCT01681576|76161211|FG000|Period 1|Protocol Deviation|1|||
42323876|NCT01681576|76161212|FG001|Period 1|Protocol Deviation|0|||
42323877|NCT01681576|76161211|FG000|Period 2|subject/guardian decision|3|||
42323878|NCT01681576|76161212|FG001|Period 2|subject/guardian decision|1|||
42323879|NCT01681576|76161211|FG000|Period 2|Non-compliance with study treatment|1|||
42323880|NCT01681576|76161212|FG001|Period 2|Non-compliance with study treatment|0|||
42323881|NCT02188459|76161222|FG000|Overall Study|Lost to Follow-up|3|||
42323882|NCT02188459|76161223|FG001|Overall Study|Lost to Follow-up|4|||
42323883|NCT02188459|76161222|FG000|Overall Study|Early Termination|0|||
42323884|NCT02188459|76161223|FG001|Overall Study|Early Termination|3|||
42323885|NCT02214121|76161245|FG000|Part A|Patient decision|2|||
42323886|NCT02214121|76161246|FG001|Part A|Patient decision|0|||
42323887|NCT02214121|76161247|FG002|Part A|Patient decision|0|||
42323888|NCT02214121|76161245|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
42323889|NCT02214121|76161246|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
42323890|NCT02214121|76161247|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
42323891|NCT02214121|76161245|FG000|Part A|Other|1|||
42323892|NCT02214121|76161246|FG001|Part A|Other|0|||
42323893|NCT02214121|76161247|FG002|Part A|Other|0|||
42323894|NCT02214121|76161245|FG000|Part B|Patient decision|0|||
42323895|NCT02214121|76161246|FG001|Part B|Patient decision|1|||
42323896|NCT02214121|76161247|FG002|Part B|Patient decision|0|||
42323897|NCT02214121|76161245|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
42323898|NCT02214121|76161246|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
42323899|NCT02214121|76161247|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
41995349|NCT00479687|75803403|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
41995350|NCT00479687|75803404|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
41995351|NCT00479687|75803405|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
41995352|NCT00479687|75803403|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
41995353|NCT00479687|75803404|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
41995354|NCT00479687|75803405|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
41995355|NCT00479687|75803403|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
41995356|NCT00479687|75803404|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
41995357|NCT00479687|75803405|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
41995358|NCT00479336|75803416|FG000|Overall Study|Adverse Event|1|||
41995359|NCT00479336|75803417|FG001|Overall Study|Adverse Event|1|||
41995360|NCT00479336|75803418|FG002|Overall Study|Adverse Event|1|||
42323900|NCT02214121|76161245|FG000|Part B|Lost to Follow-up|0|||
42323901|NCT02214121|76161246|FG001|Part B|Lost to Follow-up|0|||
42323902|NCT02214121|76161247|FG002|Part B|Lost to Follow-up|1|||
42323903|NCT01681186|76161275|FG000|Washout Period From Second Intervention|Adverse Event|0|||
42323904|NCT01681186|76161276|FG001|Washout Period From Second Intervention|Adverse Event|0|||
41995361|NCT00479336|75803419|FG003|Overall Study|Adverse Event|3|||
41995362|NCT00479336|75803416|FG000|Overall Study|Lack of Efficacy|1|||
41995363|NCT00479336|75803417|FG001|Overall Study|Lack of Efficacy|0|||
42323905|NCT01681186|76161277|FG002|Washout Period From Second Intervention|Adverse Event|0|||
42323906|NCT01681186|76161278|FG003|Washout Period From Second Intervention|Adverse Event|0|||
42323907|NCT01681186|76161279|FG004|Washout Period From Second Intervention|Adverse Event|0|||
42323908|NCT01681186|76161280|FG005|Washout Period From Second Intervention|Adverse Event|0|||
41995364|NCT00479336|75803418|FG002|Overall Study|Lack of Efficacy|0|||
41995365|NCT00479336|75803419|FG003|Overall Study|Lack of Efficacy|0|||
41995366|NCT00479336|75803416|FG000|Overall Study|Protocol Violation|0|||
41995367|NCT00479336|75803417|FG001|Overall Study|Protocol Violation|1|||
41995368|NCT00479336|75803418|FG002|Overall Study|Protocol Violation|0|||
41995369|NCT00479336|75803419|FG003|Overall Study|Protocol Violation|0|||
41995370|NCT00479336|75803416|FG000|Overall Study|Withdrawal by Subject|1|||
41995371|NCT00479336|75803417|FG001|Overall Study|Withdrawal by Subject|2|||
41995372|NCT00479336|75803418|FG002|Overall Study|Withdrawal by Subject|0|||
42323909|NCT01681186|76161281|FG006|Washout Period From Second Intervention|Adverse Event|1|||
42323910|NCT01681186|76161282|FG007|Washout Period From Second Intervention|Adverse Event|0|||
42323911|NCT01681186|76161275|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
42323912|NCT01681186|76161276|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
42323913|NCT01681186|76161277|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
42323914|NCT01681186|76161278|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
41995373|NCT00479336|75803419|FG003|Overall Study|Withdrawal by Subject|0|||
41995374|NCT00479336|75803416|FG000|Overall Study|Physician Decision|0|||
41995375|NCT00479336|75803417|FG001|Overall Study|Physician Decision|1|||
41995376|NCT00479336|75803418|FG002|Overall Study|Physician Decision|0|||
41995377|NCT00479336|75803419|FG003|Overall Study|Physician Decision|2|||
41995378|NCT00479336|75803416|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
41995379|NCT00479336|75803417|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
41995380|NCT00479336|75803418|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
42323915|NCT01681186|76161279|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
42323916|NCT01681186|76161280|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
42323917|NCT01681186|76161281|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
42323918|NCT01681186|76161282|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
42323919|NCT01681186|76161275|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
42323920|NCT01681186|76161276|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
41995381|NCT00479336|75803419|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
41995382|NCT00478244|75803429|FG000|Overall Study|Did not receive transplant|1|||
41995383|NCT00478205|75803435|FG000|Overall Study|Adverse Event|182|||
41995384|NCT00478205|75803436|FG001|Overall Study|Adverse Event|39|||
41995385|NCT00478205|75803435|FG000|Overall Study|Medication Non-compliance|9|||
41995386|NCT00478205|75803436|FG001|Overall Study|Medication Non-compliance|4|||
41995387|NCT00478205|75803435|FG000|Overall Study|Protocol Violation|15|||
41995388|NCT00478205|75803436|FG001|Overall Study|Protocol Violation|5|||
41995389|NCT00478205|75803435|FG000|Overall Study|Request of Investigator or Sponsor|4|||
41995390|NCT00478205|75803436|FG001|Overall Study|Request of Investigator or Sponsor|5|||
41995391|NCT00478205|75803435|FG000|Overall Study|Withdrawal by Subject|61|||
41995392|NCT00478205|75803436|FG001|Overall Study|Withdrawal by Subject|22|||
41995393|NCT00478205|75803435|FG000|Overall Study|Lack of Efficacy|1|||
41995394|NCT00478205|75803436|FG001|Overall Study|Lack of Efficacy|0|||
41995395|NCT00478205|75803435|FG000|Overall Study|Other|24|||
41995396|NCT00478205|75803436|FG001|Overall Study|Other|12|||
41995397|NCT00477971|75803444|FG000|Overall Study|Disease progression|6|||
41995398|NCT00477971|75803445|FG001|Overall Study|Disease progression|0|||
41995399|NCT00477971|75803444|FG000|Overall Study|Withdrawal by Subject|3|||
41995400|NCT00477971|75803445|FG001|Overall Study|Withdrawal by Subject|1|||
42034369|NCT01042236|75842466|FG001|Treatment Period 3|Adverse Event|0|||
42034370|NCT01042236|75842467|FG002|Treatment Period 3|Adverse Event|0|||
42323921|NCT01681186|76161277|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
42323922|NCT01681186|76161278|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
42323923|NCT01681186|76161279|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
42323924|NCT01681186|76161280|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
42323925|NCT01681186|76161281|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
42034371|NCT01042236|75842468|FG003|Treatment Period 3|Adverse Event|1|||
42034372|NCT01042236|75842469|FG004|Treatment Period 3|Adverse Event|0|||
42260142|NCT00158756|76087307|FG002|Overall Study|Withdrawal by Subject|6|||
42260143|NCT00158756|76087308|FG003|Overall Study|Withdrawal by Subject|1|||
42260144|NCT00158756|76087309|FG004|Overall Study|Withdrawal by Subject|3|||
42260145|NCT00158756|76087305|FG000|Overall Study|Adverse Event|0|||
42260146|NCT00158756|76087306|FG001|Overall Study|Adverse Event|0|||
42260147|NCT00158756|76087307|FG002|Overall Study|Adverse Event|1|||
42260148|NCT00158756|76087308|FG003|Overall Study|Adverse Event|0|||
42260149|NCT00158756|76087309|FG004|Overall Study|Adverse Event|0|||
42260150|NCT00158756|76087305|FG000|Overall Study|Serious adverse event|0|||
42260151|NCT00158756|76087306|FG001|Overall Study|Serious adverse event|0|||
42260152|NCT00158756|76087307|FG002|Overall Study|Serious adverse event|1|||
42260153|NCT00158756|76087308|FG003|Overall Study|Serious adverse event|0|||
42260154|NCT00158756|76087309|FG004|Overall Study|Serious adverse event|0|||
42260155|NCT02730195|76087321|FG000|Overall Study|Withdrawal by Subject|1|||
42260156|NCT02730351|76087329|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
42260157|NCT02730351|76087330|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
42260158|NCT02730351|76087329|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
42260159|NCT02730351|76087330|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
42260160|NCT02730351|76087329|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
42260161|NCT02730351|76087330|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
42260162|NCT02730351|76087329|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
42260163|NCT02730351|76087330|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
42260164|NCT02730351|76087329|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
42260165|NCT02730351|76087330|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
42260166|NCT01376349|76087339|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
42260167|NCT01376349|76087340|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
42260168|NCT01376349|76087341|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
42260169|NCT01376349|76087339|FG000|Raondomized Treatment|Adverse Event|13|||
42260170|NCT01376349|76087340|FG001|Raondomized Treatment|Adverse Event|17|||
42260171|NCT01376349|76087341|FG002|Raondomized Treatment|Adverse Event|14|||
42260172|NCT01376349|76087339|FG000|Raondomized Treatment|Unkown|1|||
42260173|NCT01376349|76087340|FG001|Raondomized Treatment|Unkown|2|||
42260174|NCT01376349|76087341|FG002|Raondomized Treatment|Unkown|1|||
42260175|NCT01376349|76087339|FG000|Raondomized Treatment|Alternative Treatment|0|||
42260176|NCT01376349|76087340|FG001|Raondomized Treatment|Alternative Treatment|0|||
41995401|NCT00477971|75803444|FG000|Overall Study|Adverse Event|3|||
42260177|NCT01376349|76087341|FG002|Raondomized Treatment|Alternative Treatment|1|||
42260178|NCT03030261|76087350|FG000|Overall Study|Still receiving continuation therapy|5|||
42260179|NCT00158600|76087385|FG000|Overall Study|unable to commit time to study|0|||
42260180|NCT00158600|76087386|FG001|Overall Study|unable to commit time to study|1|||
42260181|NCT00158600|76087385|FG000|Overall Study|Adverse Event|2|||
42260182|NCT00158600|76087386|FG001|Overall Study|Adverse Event|1|||
42323926|NCT01681186|76161282|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
42323927|NCT01681186|76161275|FG000|Fourth Intervention|Protocol Violation|0|||
41995402|NCT00477971|75803445|FG001|Overall Study|Adverse Event|0|||
42034373|NCT01042236|75842470|FG005|Treatment Period 3|Adverse Event|0|||
41995403|NCT00477971|75803444|FG000|Overall Study|Death|2|||
41995404|NCT00477971|75803445|FG001|Overall Study|Death|4|||
41995405|NCT00477971|75803444|FG000|Overall Study|Alternative treatment|3|||
41995406|NCT00477971|75803445|FG001|Overall Study|Alternative treatment|1|||
41995407|NCT00477464|75803451|FG000|Overall Study|Lost to Follow-up|1|||
41995408|NCT00477464|75803451|FG000|Overall Study|Death|36|||
41995409|NCT00477464|75803451|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
41995410|NCT00477386|75803459|FG000|Overall Study|Adverse Event|4|||
41995411|NCT00477386|75803460|FG001|Overall Study|Adverse Event|8|||
41995412|NCT00477386|75803459|FG000|Overall Study|Disease progression, relapse|3|||
41995413|NCT00477386|75803460|FG001|Overall Study|Disease progression, relapse|4|||
41995414|NCT00477386|75803459|FG000|Overall Study|Disease progression, refractory|1|||
41995415|NCT00477386|75803460|FG001|Overall Study|Disease progression, refractory|3|||
41995416|NCT00477386|75803459|FG000|Overall Study|Other|1|||
41995417|NCT00477386|75803460|FG001|Overall Study|Other|2|||
41995418|NCT00477386|75803459|FG000|Overall Study|Physician Decision|1|||
41995419|NCT00477386|75803460|FG001|Overall Study|Physician Decision|0|||
41995420|NCT00477386|75803459|FG000|Overall Study|Withdrawal by Subject|1|||
41995421|NCT00477386|75803460|FG001|Overall Study|Withdrawal by Subject|0|||
41995422|NCT00477269|75803468|FG000|Core Study|Adverse Event|6|||
41995423|NCT00477269|75803469|FG001|Core Study|Adverse Event|4|||
41995424|NCT00477269|75803470|FG002|Core Study|Adverse Event|0|||
41995425|NCT00477269|75803468|FG000|Core Study|Death|3|||
41995426|NCT00477269|75803469|FG001|Core Study|Death|3|||
41995427|NCT00477269|75803470|FG002|Core Study|Death|0|||
41995428|NCT00477269|75803468|FG000|Core Study|Withdrawn Consent|0|||
42260183|NCT00158600|76087385|FG000|Overall Study|Death|1|||
42260184|NCT00158600|76087386|FG001|Overall Study|Death|0|||
42260185|NCT00158600|76087385|FG000|Overall Study|Withdrawal by Subject|2|||
42260186|NCT00158600|76087386|FG001|Overall Study|Withdrawal by Subject|2|||
42260187|NCT01680458|76087393|FG000|Overall Study|Protocol Violation|3|||
42260188|NCT04543136|76087397|FG000|Overall Study|Withdrawal by Subject|0|||
42260189|NCT04543136|76087398|FG001|Overall Study|Withdrawal by Subject|1|||
42260190|NCT04543136|76087399|FG002|Overall Study|Withdrawal by Subject|0|||
42260191|NCT04543136|76087400|FG003|Overall Study|Withdrawal by Subject|1|||
42260192|NCT04543136|76087401|FG004|Overall Study|Withdrawal by Subject|0|||
42260193|NCT04543136|76087402|FG005|Overall Study|Withdrawal by Subject|0|||
42260194|NCT00709761|76087410|FG000|Overall Study|Withdrawal by Subject|8|||
42260195|NCT00709761|76087410|FG000|Overall Study|study closed/terminated|17|||
42323928|NCT01681186|76161276|FG001|Fourth Intervention|Protocol Violation|0|||
42323929|NCT01681186|76161277|FG002|Fourth Intervention|Protocol Violation|0|||
42323930|NCT01681186|76161278|FG003|Fourth Intervention|Protocol Violation|0|||
42323931|NCT01681186|76161279|FG004|Fourth Intervention|Protocol Violation|0|||
42323932|NCT01681186|76161280|FG005|Fourth Intervention|Protocol Violation|0|||
42323933|NCT01681186|76161281|FG006|Fourth Intervention|Protocol Violation|0|||
42323934|NCT01681186|76161282|FG007|Fourth Intervention|Protocol Violation|1|||
42323935|NCT03597464|76161314|FG000|Overall Study|Withdrawal by Subject|4|||
42323936|NCT03597464|76161315|FG001|Overall Study|Withdrawal by Subject|5|||
41995429|NCT00477269|75803469|FG001|Core Study|Withdrawn Consent|1|||
42260196|NCT00709761|76087410|FG000|Overall Study|Lost to Follow-up|2|||
42260197|NCT02848651|76087420|FG000|Overall Study|Death|85|||
42260198|NCT02848651|76087420|FG000|Overall Study|Lost to Follow-up|1|||
42260199|NCT02848651|76087420|FG000|Overall Study|Non-Compliance|1|||
41995430|NCT00477269|75803470|FG002|Core Study|Withdrawn Consent|0|||
41995431|NCT00477269|75803468|FG000|Open Label Extension|Adverse Event|0|||
41995432|NCT00477269|75803469|FG001|Open Label Extension|Adverse Event|0|||
41995433|NCT00477269|75803470|FG002|Open Label Extension|Adverse Event|4|||
41995434|NCT00477269|75803468|FG000|Open Label Extension|Abnormal laboratory values|0|||
41995435|NCT00477269|75803469|FG001|Open Label Extension|Abnormal laboratory values|0|||
41995436|NCT00477269|75803470|FG002|Open Label Extension|Abnormal laboratory values|1|||
41995437|NCT00477269|75803468|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
41995438|NCT00477269|75803469|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
41995439|NCT00477269|75803470|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
41995440|NCT00477269|75803468|FG000|Open Label Extension|Adminiatrative problems|0|||
41995441|NCT00477269|75803469|FG001|Open Label Extension|Adminiatrative problems|0|||
41995442|NCT00477269|75803470|FG002|Open Label Extension|Adminiatrative problems|2|||
42260200|NCT02848651|76087420|FG000|Overall Study|Symptomatic Deterioration|1|||
42323937|NCT03597464|76161314|FG000|Overall Study|Lost to Follow-up|3|||
41995443|NCT00477269|75803468|FG000|Open Label Extension|Death|0|||
41995444|NCT00477269|75803469|FG001|Open Label Extension|Death|0|||
42323938|NCT03597464|76161315|FG001|Overall Study|Lost to Follow-up|1|||
41995445|NCT00477269|75803470|FG002|Open Label Extension|Death|4|||
42260201|NCT02848651|76087420|FG000|Overall Study|Physician Decision|4|||
42260202|NCT02848651|76087420|FG000|Overall Study|Withdrawal by Subject|14|||
42260203|NCT00709059|76087440|FG000|Overall Study|Lost to Follow-up|34|||
42323939|NCT03597464|76161314|FG000|Overall Study|Pregnancy|3|||
42323940|NCT03597464|76161315|FG001|Overall Study|Pregnancy|1|||
42323941|NCT03597464|76161314|FG000|Overall Study|Lack of Efficacy|2|||
41995446|NCT00477152|75803478|FG000|Overall Study|Parent withdrew consent|2|||
41995447|NCT00477152|75803478|FG000|Overall Study|Adverse Event|1|||
41995448|NCT00476996|75803485|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
41995449|NCT00476996|75803486|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
41995450|NCT00476996|75803487|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
41995451|NCT00476996|75803488|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
41995452|NCT00476996|75803485|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
41995453|NCT00476996|75803486|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
41995454|NCT00476996|75803487|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
41995455|NCT00476996|75803488|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
41995456|NCT00476996|75803485|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
41995457|NCT00476996|75803486|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
41995458|NCT00476996|75803487|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
41995459|NCT00476996|75803488|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
41995460|NCT00476996|75803485|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
41995461|NCT00476996|75803486|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
41995462|NCT00476996|75803487|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
41995463|NCT00476996|75803488|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
41995464|NCT00476996|75803485|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
41995465|NCT00476996|75803486|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
41995466|NCT00476996|75803487|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
41995467|NCT00476996|75803488|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
41995468|NCT00476996|75803485|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
41995469|NCT00476996|75803486|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
41995470|NCT00476996|75803487|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
41995471|NCT00476996|75803488|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
41995472|NCT00476996|75803485|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
41995473|NCT00476996|75803486|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
41995474|NCT00476996|75803487|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
41995475|NCT00476996|75803488|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
42260204|NCT00709059|76087440|FG000|Overall Study|Withdrawal by Subject|19|||
42260205|NCT00709059|76087440|FG000|Overall Study|Physician Decision|7|||
42260206|NCT00709059|76087440|FG000|Overall Study|Disease complication|3|||
42260207|NCT00709059|76087440|FG000|Overall Study|Side effects|20|||
42260208|NCT00709059|76087440|FG000|Overall Study|Serious side effects|11|||
42260209|NCT01678820|76087447|FG000|Overall Study|Study Terminated by Sponsor|45|||
42260210|NCT01678820|76087448|FG001|Overall Study|Study Terminated by Sponsor|43|||
42260211|NCT01678820|76087449|FG002|Overall Study|Study Terminated by Sponsor|43|||
42260212|NCT01678820|76087447|FG000|Overall Study|Withdrawal by Subject|2|||
42260213|NCT01678820|76087448|FG001|Overall Study|Withdrawal by Subject|5|||
42260214|NCT01678820|76087449|FG002|Overall Study|Withdrawal by Subject|2|||
42260215|NCT01678820|76087447|FG000|Overall Study|Protocol Specified Criteria|2|||
42260216|NCT01678820|76087448|FG001|Overall Study|Protocol Specified Criteria|3|||
42260217|NCT01678820|76087449|FG002|Overall Study|Protocol Specified Criteria|1|||
42260218|NCT01678820|76087447|FG000|Overall Study|Adverse Event|2|||
42260219|NCT01678820|76087448|FG001|Overall Study|Adverse Event|2|||
42260220|NCT01678820|76087449|FG002|Overall Study|Adverse Event|2|||
42260221|NCT01678820|76087447|FG000|Overall Study|Lost to Follow-up|7|||
42260222|NCT01678820|76087448|FG001|Overall Study|Lost to Follow-up|2|||
42260223|NCT01678820|76087449|FG002|Overall Study|Lost to Follow-up|2|||
42260224|NCT01678820|76087447|FG000|Overall Study|Non-compliance with study drug|0|||
42260225|NCT01678820|76087448|FG001|Overall Study|Non-compliance with study drug|1|||
42260226|NCT01678820|76087449|FG002|Overall Study|Non-compliance with study drug|0|||
42260227|NCT01678820|76087447|FG000|Overall Study|Physician Decision|0|||
42260228|NCT01678820|76087448|FG001|Overall Study|Physician Decision|0|||
42260229|NCT01678820|76087449|FG002|Overall Study|Physician Decision|1|||
42260230|NCT01678820|76087447|FG000|Overall Study|Protocol Violation|4|||
42260231|NCT01678820|76087448|FG001|Overall Study|Protocol Violation|5|||
42260232|NCT01678820|76087449|FG002|Overall Study|Protocol Violation|4|||
42260233|NCT01678820|76087447|FG000|Overall Study|Not treated with double-blind study drug|0|||
42260234|NCT01678820|76087448|FG001|Overall Study|Not treated with double-blind study drug|2|||
42260235|NCT01678820|76087449|FG002|Overall Study|Not treated with double-blind study drug|2|||
42260236|NCT02660138|76087461|FG000|Overall Study|Adverse Event|0|||
42260237|NCT02660138|76087462|FG001|Overall Study|Adverse Event|3|||
42260238|NCT02660138|76087463|FG002|Overall Study|Adverse Event|2|||
42260239|NCT02660138|76087461|FG000|Overall Study|Lack of Efficacy|1|||
42260240|NCT02660138|76087462|FG001|Overall Study|Lack of Efficacy|2|||
42260241|NCT02660138|76087463|FG002|Overall Study|Lack of Efficacy|1|||
42260242|NCT02660138|76087461|FG000|Overall Study|Withdrawal by Subject|7|||
42260243|NCT02660138|76087462|FG001|Overall Study|Withdrawal by Subject|6|||
42323942|NCT03597464|76161315|FG001|Overall Study|Lack of Efficacy|0|||
42323943|NCT03597464|76161314|FG000|Overall Study|Physician Decision|2|||
42323944|NCT03597464|76161315|FG001|Overall Study|Physician Decision|2|||
42323945|NCT03597464|76161314|FG000|Overall Study|Protocol Violation|1|||
42323946|NCT03597464|76161315|FG001|Overall Study|Protocol Violation|1|||
42323947|NCT03597464|76161314|FG000|Overall Study|Adverse Event|0|||
42323948|NCT03597464|76161315|FG001|Overall Study|Adverse Event|2|||
42323949|NCT03597464|76161314|FG000|Overall Study|Death|0|||
42323950|NCT03597464|76161315|FG001|Overall Study|Death|3|||
42323951|NCT01695772|76161323|FG000|Overall Study|Withdrawal by Subject|18|||
42323952|NCT01695772|76161323|FG000|Overall Study|Progressive Disease|8|||
42323953|NCT01695772|76161323|FG000|Overall Study|Investigator Decision|5|||
42323954|NCT01695772|76161323|FG000|Overall Study|Lost to Follow-up|4|||
42323955|NCT01695772|76161323|FG000|Overall Study|Protocol Violation|2|||
42323956|NCT01695772|76161323|FG000|Overall Study|Unspecified Reason|1|||
42323957|NCT02159521|76161327|FG000|Overall Study|Enrolled but not treated|3|||
41995476|NCT00476996|75803485|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
41995477|NCT00476996|75803486|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
41995478|NCT00476996|75803487|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
41995479|NCT00476996|75803488|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
41995480|NCT00476996|75803485|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
41995481|NCT00476996|75803486|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
41995482|NCT00476996|75803487|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
41995483|NCT00476996|75803488|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
41995484|NCT00476996|75803485|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
41995485|NCT00476996|75803486|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
41995486|NCT00476996|75803487|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
41995487|NCT00476996|75803488|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
41995488|NCT00476996|75803485|FG000|OLE Phase (From Week 48)|Death|0|||
41995489|NCT00476996|75803486|FG001|OLE Phase (From Week 48)|Death|0|||
41995490|NCT00476996|75803487|FG002|OLE Phase (From Week 48)|Death|0|||
41995491|NCT00476996|75803488|FG003|OLE Phase (From Week 48)|Death|7|||
42323958|NCT02159521|76161327|FG000|Overall Study|Withdrawal by Subject|7|||
41995492|NCT00476996|75803485|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
42323959|NCT02159521|76161327|FG000|Overall Study|Lost to Follow-up|6|||
42323960|NCT02159521|76161327|FG000|Overall Study|Death|1|||
42323961|NCT02159521|76161327|FG000|Overall Study|Other than specified|1|||
42323962|NCT01636934|76161333|FG000|Overall Study|Withdrawal by Subject|3|||
42323963|NCT01636934|76161334|FG001|Overall Study|Withdrawal by Subject|2|||
42323964|NCT01636934|76161333|FG000|Overall Study|Chemo cancel|1|||
42133636|NCT00464334|75944550|FG004|Overall Study|Lack of Efficacy|0|||
42133637|NCT00464334|75944551|FG005|Overall Study|Lack of Efficacy|0|||
42133638|NCT00464334|75944552|FG006|Overall Study|Lack of Efficacy|0|||
42133639|NCT00464334|75944553|FG007|Overall Study|Lack of Efficacy|0|||
42260244|NCT02660138|76087463|FG002|Overall Study|Withdrawal by Subject|6|||
42260245|NCT02660138|76087461|FG000|Overall Study|Lost to Follow-up|4|||
42260246|NCT02660138|76087462|FG001|Overall Study|Lost to Follow-up|4|||
42260247|NCT02660138|76087463|FG002|Overall Study|Lost to Follow-up|1|||
42260248|NCT02660138|76087461|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
42260249|NCT02660138|76087462|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
42260250|NCT02660138|76087463|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
42260251|NCT02660138|76087461|FG000|Overall Study|Other|1|||
42260252|NCT02660138|76087462|FG001|Overall Study|Other|1|||
42260253|NCT02660138|76087463|FG002|Overall Study|Other|0|||
42260254|NCT02660138|76087461|FG000|Overall Study|Not treated|0|||
42260255|NCT02660138|76087462|FG001|Overall Study|Not treated|1|||
42260256|NCT02660138|76087463|FG002|Overall Study|Not treated|0|||
42323965|NCT01636934|76161334|FG001|Overall Study|Chemo cancel|0|||
41995493|NCT00476996|75803486|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
41995494|NCT00476996|75803487|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
42133640|NCT00464334|75944554|FG008|Overall Study|Lack of Efficacy|0|||
42133641|NCT00464334|75944555|FG009|Overall Study|Lack of Efficacy|0|||
42260257|NCT01603394|76087474|FG000|Overall Study|Adverse Event|1|||
42323966|NCT01636934|76161333|FG000|Overall Study|Too ill to continue|1|||
41995495|NCT00476996|75803488|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
42260258|NCT02729025|76087480|FG000|Overall Study|Sponsor Decision|0|||
42260259|NCT02729025|76087481|FG001|Overall Study|Sponsor Decision|1|||
42323967|NCT01636934|76161334|FG001|Overall Study|Too ill to continue|0|||
42323968|NCT01636934|76161333|FG000|Overall Study|Never started study medication|1|||
42323969|NCT01636934|76161334|FG001|Overall Study|Never started study medication|1|||
42323970|NCT01712854|76161340|FG000|Overall Study|Physician Decision|1|||
42323971|NCT01693120|76161344|FG000|Enrollment|Lost to Follow-up|1|||
42323972|NCT01693120|76161344|FG000|Enrollment|Withdrawal by Subject|10|||
42323973|NCT01693120|76161344|FG000|Enrollment|Protocol Violation|46|||
42323974|NCT01693120|76161344|FG000|Enrollment|Physician Decision|3|||
42323975|NCT01693120|76161344|FG000|Enrollment|Adverse Event|1|||
42323976|NCT01693120|76161344|FG000|Enrollment|Study closed|8|||
42323977|NCT01693120|76161344|FG000|Enrollment|Other|1|||
42323978|NCT01693120|76161344|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
42323979|NCT01693120|76161344|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
42323980|NCT01693120|76161344|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
42323981|NCT01693120|76161344|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
42323982|NCT01693120|76161344|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
42323983|NCT02159365|76161348|FG000|Overall Study|Disease Progression|23|||
42323984|NCT02159365|76161348|FG000|Overall Study|Other reasons|11|||
42323985|NCT02159365|76161348|FG000|Overall Study|Administrative reason by Sponsor|9|||
42323986|NCT02159365|76161348|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
42323987|NCT02159365|76161348|FG000|Overall Study|Study drug toxicity|7|||
42323988|NCT02159365|76161348|FG000|Overall Study|Maximum clinical benefit|3|||
42323989|NCT02159365|76161348|FG000|Overall Study|Subject request to discontinue treatment|3|||
42323990|NCT02159365|76161348|FG000|Overall Study|Subject withdrew consent|3|||
42323991|NCT02159365|76161348|FG000|Overall Study|Death|1|||
42323992|NCT02159365|76161348|FG000|Overall Study|Lost to Follow-up|1|||
42323993|NCT01712074|76161355|FG000|Placebo Run-in Period|Adverse Event|2|||
42323994|NCT01712074|76161356|FG001|Placebo Run-in Period|Adverse Event|0|||
42323995|NCT01712074|76161357|FG002|Placebo Run-in Period|Adverse Event|0|||
41995496|NCT00476996|75803485|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
41995497|NCT00476996|75803486|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
42260260|NCT01603082|76087489|FG000|Overall Study|Adverse Event|0|||
42260261|NCT01603082|76087490|FG001|Overall Study|Adverse Event|1|||
42260262|NCT01603082|76087489|FG000|Overall Study|Withdrawal by Subject|1|||
42260263|NCT01603082|76087490|FG001|Overall Study|Withdrawal by Subject|0|||
42260264|NCT01603082|76087489|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
42260265|NCT01603082|76087490|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
42260266|NCT02846779|76087503|FG000|Overall Study|Lost Enrollment|83|||
42260267|NCT02846779|76087504|FG001|Overall Study|Lost Enrollment|82|||
42260268|NCT02846779|76087505|FG002|Overall Study|Lost Enrollment|86|||
42260269|NCT02846779|76087503|FG000|Overall Study|Less than 31 days of follow-up|56|||
42260270|NCT02846779|76087504|FG001|Overall Study|Less than 31 days of follow-up|45|||
42260271|NCT02846779|76087505|FG002|Overall Study|Less than 31 days of follow-up|52|||
42260272|NCT00406393|76087515|FG000|Overall Study|Did not undergo transplantation|2|||
42260273|NCT00406393|76087516|FG001|Overall Study|Did not undergo transplantation|1|||
42260274|NCT02845375|76087525|FG000|Overall Study|upper airway obstruction|1|||
42260275|NCT02845375|76087526|FG001|Overall Study|upper airway obstruction|2|||
42260276|NCT02845375|76087527|FG002|Overall Study|upper airway obstruction|1|||
42260277|NCT02658734|76087535|FG000|Overall Study|Adverse Event|2|||
42260278|NCT02658734|76087535|FG000|Overall Study|Death|4|||
42260279|NCT02658734|76087535|FG000|Overall Study|Lost to Follow-up|7|||
42260280|NCT02658734|76087535|FG000|Overall Study|Withdrawal of Consent|16|||
42260281|NCT02658734|76087535|FG000|Overall Study|Disease Progression|28|||
42260282|NCT02844439|76087539|FG000|Overall Study|Withdrawal by Subject|1|||
42260283|NCT02844439|76087539|FG000|Overall Study|Lost to Follow-up|2|||
42260284|NCT02844439|76087539|FG000|Overall Study|Termination by Sponsor|4|||
42260285|NCT02844439|76087539|FG000|Overall Study|Death|28|||
42260286|NCT02844439|76087539|FG000|Overall Study|Other|5|||
41995498|NCT00476996|75803487|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
41995499|NCT00476996|75803488|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
41995500|NCT00476996|75803485|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
41995501|NCT00476996|75803486|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
42260287|NCT01677182|76087553|FG000|Overall Study|Adverse Event|2|||
42260288|NCT01677182|76087554|FG001|Overall Study|Adverse Event|1|||
42260289|NCT01677182|76087555|FG002|Overall Study|Adverse Event|8|||
42260290|NCT01677182|76087553|FG000|Overall Study|Protocol Violation|5|||
42260291|NCT01677182|76087554|FG001|Overall Study|Protocol Violation|1|||
42260292|NCT01677182|76087555|FG002|Overall Study|Protocol Violation|4|||
42323996|NCT01712074|76161355|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
42133642|NCT00464334|75944556|FG010|Overall Study|Lack of Efficacy|0|||
42133643|NCT00464334|75944546|FG000|Overall Study|Lost to Follow-up|0|||
42133644|NCT00464334|75944547|FG001|Overall Study|Lost to Follow-up|0|||
42133645|NCT00464334|75944548|FG002|Overall Study|Lost to Follow-up|1|||
42133646|NCT00464334|75944549|FG003|Overall Study|Lost to Follow-up|0|||
42133647|NCT00464334|75944550|FG004|Overall Study|Lost to Follow-up|1|||
42133648|NCT00464334|75944551|FG005|Overall Study|Lost to Follow-up|0|||
42133649|NCT00464334|75944552|FG006|Overall Study|Lost to Follow-up|1|||
42133650|NCT00464334|75944553|FG007|Overall Study|Lost to Follow-up|0|||
42133651|NCT00464334|75944554|FG008|Overall Study|Lost to Follow-up|0|||
42133652|NCT00464334|75944555|FG009|Overall Study|Lost to Follow-up|0|||
42133653|NCT00464334|75944556|FG010|Overall Study|Lost to Follow-up|2|||
42133654|NCT00464334|75944546|FG000|Overall Study|Progressive Disease|0|||
42133655|NCT00464334|75944547|FG001|Overall Study|Progressive Disease|0|||
42133656|NCT00464334|75944548|FG002|Overall Study|Progressive Disease|0|||
42133657|NCT00464334|75944549|FG003|Overall Study|Progressive Disease|0|||
42133658|NCT00464334|75944550|FG004|Overall Study|Progressive Disease|0|||
42133659|NCT00464334|75944551|FG005|Overall Study|Progressive Disease|1|||
42133660|NCT00464334|75944552|FG006|Overall Study|Progressive Disease|0|||
42133661|NCT00464334|75944553|FG007|Overall Study|Progressive Disease|0|||
42133662|NCT00464334|75944554|FG008|Overall Study|Progressive Disease|1|||
42133663|NCT00464334|75944555|FG009|Overall Study|Progressive Disease|0|||
42133664|NCT00464334|75944556|FG010|Overall Study|Progressive Disease|0|||
42133665|NCT00464334|75944546|FG000|Overall Study|Study Terminated by Sponsor|0|||
42133666|NCT00464334|75944547|FG001|Overall Study|Study Terminated by Sponsor|0|||
42133667|NCT00464334|75944548|FG002|Overall Study|Study Terminated by Sponsor|0|||
42133668|NCT00464334|75944549|FG003|Overall Study|Study Terminated by Sponsor|1|||
42323997|NCT01712074|76161356|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
42323998|NCT01712074|76161357|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
42323999|NCT01712074|76161355|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
42324000|NCT01712074|76161356|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
42324001|NCT01712074|76161357|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
42324002|NCT01712074|76161355|FG000|Placebo Run-in Period|Other|1|||
42324003|NCT01712074|76161356|FG001|Placebo Run-in Period|Other|0|||
42324004|NCT01712074|76161357|FG002|Placebo Run-in Period|Other|0|||
42324005|NCT01712074|76161355|FG000|Placebo Run-in Period|No longer willing to participate|1|||
42324006|NCT01712074|76161356|FG001|Placebo Run-in Period|No longer willing to participate|0|||
42324007|NCT01712074|76161357|FG002|Placebo Run-in Period|No longer willing to participate|0|||
42324008|NCT01712074|76161355|FG000|Double Blind Period|Adverse Event|0|||
42324009|NCT01712074|76161356|FG001|Double Blind Period|Adverse Event|2|||
42324010|NCT01712074|76161357|FG002|Double Blind Period|Adverse Event|1|||
42324011|NCT01712074|76161355|FG000|Double Blind Period|No longer willing to participate|0|||
42324012|NCT01712074|76161356|FG001|Double Blind Period|No longer willing to participate|2|||
42324013|NCT01712074|76161357|FG002|Double Blind Period|No longer willing to participate|4|||
42324014|NCT01712074|76161355|FG000|Double Blind Period|Death|0|||
42324015|NCT01712074|76161356|FG001|Double Blind Period|Death|1|||
42324016|NCT01712074|76161357|FG002|Double Blind Period|Death|0|||
42324017|NCT01712074|76161355|FG000|Double Blind Period|Lost to Follow-up|0|||
42324018|NCT01712074|76161356|FG001|Double Blind Period|Lost to Follow-up|2|||
42324019|NCT01712074|76161357|FG002|Double Blind Period|Lost to Follow-up|1|||
42324020|NCT01712074|76161355|FG000|Double Blind Period|Other|0|||
42324021|NCT01712074|76161356|FG001|Double Blind Period|Other|4|||
42324022|NCT01712074|76161357|FG002|Double Blind Period|Other|1|||
42133669|NCT00464334|75944550|FG004|Overall Study|Study Terminated by Sponsor|0|||
42133670|NCT00464334|75944551|FG005|Overall Study|Study Terminated by Sponsor|0|||
42133671|NCT00464334|75944552|FG006|Overall Study|Study Terminated by Sponsor|0|||
42133672|NCT00464334|75944553|FG007|Overall Study|Study Terminated by Sponsor|0|||
42324023|NCT01712074|76161355|FG000|Double Blind Period|Protocol Violation|0|||
42324024|NCT01712074|76161356|FG001|Double Blind Period|Protocol Violation|0|||
42133673|NCT00464334|75944554|FG008|Overall Study|Study Terminated by Sponsor|0|||
42133674|NCT00464334|75944555|FG009|Overall Study|Study Terminated by Sponsor|0|||
42133675|NCT00464334|75944556|FG010|Overall Study|Study Terminated by Sponsor|0|||
42133676|NCT00464334|75944546|FG000|Overall Study|Withdrawal by Subject|1|||
42133677|NCT00464334|75944547|FG001|Overall Study|Withdrawal by Subject|7|||
42133678|NCT00464334|75944548|FG002|Overall Study|Withdrawal by Subject|4|||
42324025|NCT01712074|76161357|FG002|Double Blind Period|Protocol Violation|1|||
42324026|NCT01712074|76161355|FG000|Double Blind Period|No longer met eligibility criteria|0|||
42324027|NCT01712074|76161356|FG001|Double Blind Period|No longer met eligibility criteria|3|||
42324028|NCT01712074|76161357|FG002|Double Blind Period|No longer met eligibility criteria|0|||
42324029|NCT01711216|76161372|FG000|Overall Study|Adverse Event|4|||
42324030|NCT01711216|76161372|FG000|Overall Study|Pregnancy|56|||
42324031|NCT01711216|76161372|FG000|Overall Study|Withdrawal by Subject|6|||
42324032|NCT01711216|76161372|FG000|Overall Study|Lost to Follow-up|46|||
42324033|NCT01711216|76161372|FG000|Overall Study|variety of other minor reasons|83|||
42324034|NCT01711216|76161372|FG000|Overall Study|no reason specified|22|||
42324035|NCT01692730|76161382|FG000|Overall Study|Lost to Follow-up|225|||
42324036|NCT01692730|76161383|FG001|Overall Study|Lost to Follow-up|227|||
42324037|NCT01691794|76161392|FG000|Overall Study|Poor/Non-Compliance|1|||
42324038|NCT01691794|76161393|FG001|Overall Study|Poor/Non-Compliance|4|||
42324039|NCT01691794|76161394|FG002|Overall Study|Poor/Non-Compliance|1|||
42324040|NCT01691794|76161392|FG000|Overall Study|Death|0|||
42324041|NCT01691794|76161393|FG001|Overall Study|Death|0|||
42324042|NCT01691794|76161394|FG002|Overall Study|Death|1|||
42324043|NCT01691794|76161392|FG000|Overall Study|Lack of Efficacy|0|||
42324044|NCT01691794|76161393|FG001|Overall Study|Lack of Efficacy|7|||
42324045|NCT01691794|76161394|FG002|Overall Study|Lack of Efficacy|1|||
42324046|NCT01691794|76161392|FG000|Overall Study|Participant request to discontinue|0|||
42324047|NCT01691794|76161393|FG001|Overall Study|Participant request to discontinue|1|||
42324048|NCT01691794|76161394|FG002|Overall Study|Participant request to discontinue|0|||
42324049|NCT01691794|76161392|FG000|Overall Study|Adverse Event|0|||
41995502|NCT00476996|75803487|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
42324050|NCT01691794|76161393|FG001|Overall Study|Adverse Event|1|||
42324051|NCT01691794|76161394|FG002|Overall Study|Adverse Event|1|||
42324052|NCT01691794|76161392|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
42324053|NCT01691794|76161393|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
42324054|NCT01691794|76161394|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
42324055|NCT01691794|76161392|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
42324056|NCT01691794|76161393|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
42324057|NCT01691794|76161394|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
42324058|NCT01710514|76161404|FG000|Overall Study|Adverse Event|6|||
42324059|NCT01710514|76161405|FG001|Overall Study|Adverse Event|7|||
42324060|NCT01710514|76161404|FG000|Overall Study|Withdrawal by Subject|1|||
42324061|NCT01710514|76161405|FG001|Overall Study|Withdrawal by Subject|0|||
42324062|NCT01592344|76161416|FG000|Overall Study|Adverse Event|1|||
42324063|NCT01592344|76161417|FG001|Overall Study|Adverse Event|1|||
42324064|NCT01592344|76161416|FG000|Overall Study|Lack of Efficacy|1|||
42324065|NCT01592344|76161417|FG001|Overall Study|Lack of Efficacy|0|||
42324066|NCT01592344|76161416|FG000|Overall Study|not available at primary outcome visit|2|||
42324067|NCT01592344|76161417|FG001|Overall Study|not available at primary outcome visit|4|||
41995503|NCT00476996|75803488|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
41995504|NCT00476996|75803485|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
42324068|NCT01636778|76161423|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
42324069|NCT01636778|76161424|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
42324070|NCT01636778|76161425|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
42324071|NCT01636778|76161423|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
42324072|NCT01636778|76161424|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
41995505|NCT00476996|75803486|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
41995506|NCT00476996|75803487|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
41995507|NCT00476996|75803488|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
41995508|NCT00476957|75803499|FG000|Overall Study|Lost to Follow-up|176|||
41995509|NCT00476957|75803500|FG001|Overall Study|Lost to Follow-up|193|||
41995510|NCT00475865|75803509|FG000|Overall Study|Adverse Event|0|||
42324073|NCT01636778|76161425|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
42324074|NCT01636778|76161423|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
42324075|NCT01636778|76161424|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
42324076|NCT01636778|76161425|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
42324077|NCT01636778|76161423|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
42324078|NCT01636778|76161424|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
42324079|NCT01636778|76161425|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
42324080|NCT01636778|76161423|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
42324081|NCT01636778|76161424|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
42324082|NCT01636778|76161425|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
42324083|NCT01636778|76161423|FG000|Follow-up Period After Part 2|Other|0|||
42324084|NCT01636778|76161424|FG001|Follow-up Period After Part 2|Other|0|||
42324085|NCT01636778|76161425|FG002|Follow-up Period After Part 2|Other|1|||
42324086|NCT01636778|76161423|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
42324087|NCT01636778|76161424|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
42324088|NCT01636778|76161425|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
42324089|NCT01636778|76161423|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
42324090|NCT01636778|76161424|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
42324091|NCT01636778|76161425|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
42324092|NCT02159053|76161436|FG000|Overall Study|Death|2|||
42324093|NCT02159053|76161437|FG001|Overall Study|Death|0|||
42324094|NCT02159053|76161438|FG002|Overall Study|Death|1|||
41995511|NCT00475865|75803510|FG001|Overall Study|Adverse Event|3|||
41995512|NCT00475865|75803511|FG002|Overall Study|Adverse Event|4|||
41995513|NCT00475865|75803509|FG000|Overall Study|Lack of Efficacy|1|||
41995514|NCT00475865|75803510|FG001|Overall Study|Lack of Efficacy|0|||
41995515|NCT00475865|75803511|FG002|Overall Study|Lack of Efficacy|0|||
41995516|NCT00475865|75803509|FG000|Overall Study|Progressive disease|0|||
41995517|NCT00475865|75803510|FG001|Overall Study|Progressive disease|1|||
41995518|NCT00475865|75803511|FG002|Overall Study|Progressive disease|2|||
42260293|NCT01677182|76087553|FG000|Overall Study|Lost to Follow-up|4|||
42260294|NCT01677182|76087554|FG001|Overall Study|Lost to Follow-up|0|||
42260295|NCT01677182|76087555|FG002|Overall Study|Lost to Follow-up|3|||
42260296|NCT01677182|76087553|FG000|Overall Study|Withdrawal by Subject|7|||
42260297|NCT01677182|76087554|FG001|Overall Study|Withdrawal by Subject|12|||
42260298|NCT01677182|76087555|FG002|Overall Study|Withdrawal by Subject|10|||
42260299|NCT01677182|76087553|FG000|Overall Study|Study termination|12|||
42324095|NCT02159053|76161436|FG000|Overall Study|Physician Decision|0|||
42324096|NCT02159053|76161437|FG001|Overall Study|Physician Decision|1|||
42324097|NCT02159053|76161438|FG002|Overall Study|Physician Decision|1|||
42324098|NCT02159053|76161436|FG000|Overall Study|Lack of Efficacy|3|||
42324099|NCT02159053|76161437|FG001|Overall Study|Lack of Efficacy|4|||
42324100|NCT02159053|76161438|FG002|Overall Study|Lack of Efficacy|7|||
42324101|NCT02159053|76161436|FG000|Overall Study|Adverse Event|7|||
42324102|NCT02159053|76161437|FG001|Overall Study|Adverse Event|6|||
42324103|NCT02159053|76161438|FG002|Overall Study|Adverse Event|5|||
42324104|NCT02159053|76161436|FG000|Overall Study|Participants/guardian decision|8|||
42324105|NCT02159053|76161437|FG001|Overall Study|Participants/guardian decision|10|||
42324106|NCT02159053|76161438|FG002|Overall Study|Participants/guardian decision|6|||
42324107|NCT02158975|76161448|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
42324108|NCT02158663|76161455|FG000|Overall Study|Withdrawal by Subject|5|||
42324109|NCT02158663|76161456|FG001|Overall Study|Withdrawal by Subject|4|||
42324110|NCT02158039|76161464|FG000|Overall Study|Withdrawal by Subject|1|||
41995519|NCT00475865|75803509|FG000|Overall Study|Participant did not wish to continue|1|||
41995520|NCT00475865|75803510|FG001|Overall Study|Participant did not wish to continue|0|||
41995521|NCT00475865|75803511|FG002|Overall Study|Participant did not wish to continue|0|||
42260300|NCT01677182|76087554|FG001|Overall Study|Study termination|9|||
42260301|NCT01677182|76087555|FG002|Overall Study|Study termination|11|||
42260302|NCT01677182|76087553|FG000|Overall Study|Lack of Efficacy|3|||
42260303|NCT01677182|76087554|FG001|Overall Study|Lack of Efficacy|0|||
42260304|NCT01677182|76087555|FG002|Overall Study|Lack of Efficacy|1|||
42260305|NCT01677182|76087553|FG000|Overall Study|Other reasons|1|||
42260306|NCT01677182|76087554|FG001|Overall Study|Other reasons|5|||
42260307|NCT01677182|76087555|FG002|Overall Study|Other reasons|2|||
42260308|NCT02843659|76087566|FG000|Overall Study|Subject Withdrew Consent|0|||
41995522|NCT00475865|75803509|FG000|Overall Study|Other than above|0|||
41995523|NCT00475865|75803510|FG001|Overall Study|Other than above|1|||
42260309|NCT02843659|76087567|FG001|Overall Study|Subject Withdrew Consent|0|||
42260310|NCT02843659|76087568|FG002|Overall Study|Subject Withdrew Consent|1|||
42324111|NCT02158039|76161464|FG000|Overall Study|Screen Failure|9|||
41995524|NCT00475865|75803511|FG002|Overall Study|Other than above|0|||
42260311|NCT02843659|76087566|FG000|Overall Study|Administrative Reason by Sponsor|4|||
42260312|NCT02843659|76087567|FG001|Overall Study|Administrative Reason by Sponsor|5|||
42260313|NCT02843659|76087568|FG002|Overall Study|Administrative Reason by Sponsor|4|||
42324112|NCT01635764|76161482|FG000|Overall Study|Adverse Event|46|||
42324113|NCT01635764|76161482|FG000|Overall Study|Lack of Efficacy|76|||
41995525|NCT00475709|75803521|FG000|Overall Study|Did not meet eligibility criteria|8|||
41995526|NCT00475709|75803521|FG000|Overall Study|Death|41|||
42324114|NCT01635764|76161482|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
42324115|NCT01635764|76161482|FG000|Overall Study|Protocol Deviation|1|||
42324116|NCT01635764|76161482|FG000|Overall Study|Withdrew Consent|67|||
42324117|NCT01635764|76161482|FG000|Overall Study|Lost to Follow-up|53|||
42324118|NCT01635764|76161482|FG000|Overall Study|Other|28|||
42324119|NCT03432260|76161498|FG000|Overall Study|Lost to Follow-up|1|||
42324120|NCT03432260|76161499|FG001|Overall Study|Lost to Follow-up|1|||
42324121|NCT03432260|76161500|FG002|Overall Study|Lost to Follow-up|0|||
42324122|NCT03432260|76161501|FG003|Overall Study|Lost to Follow-up|0|||
42324123|NCT03432260|76161502|FG004|Overall Study|Lost to Follow-up|1|||
42324124|NCT01634360|76161516|FG000|Overall Study|Adverse Event|10|||
42324125|NCT01634360|76161517|FG001|Overall Study|Adverse Event|34|||
42324126|NCT01634360|76161516|FG000|Overall Study|subject withdrew consent|13|||
42324127|NCT01634360|76161517|FG001|Overall Study|subject withdrew consent|23|||
42324128|NCT01634360|76161516|FG000|Overall Study|Protocol Violation|1|||
42324129|NCT01634360|76161517|FG001|Overall Study|Protocol Violation|1|||
42324130|NCT01634360|76161516|FG000|Overall Study|Lack of Efficacy|4|||
42324131|NCT01634360|76161517|FG001|Overall Study|Lack of Efficacy|14|||
42324132|NCT01634360|76161516|FG000|Overall Study|Other|3|||
42324133|NCT01634360|76161517|FG001|Overall Study|Other|20|||
42324134|NCT01634360|76161516|FG000|Overall Study|Study termination by sponsor|18|||
42324135|NCT01634360|76161517|FG001|Overall Study|Study termination by sponsor|44|||
42324136|NCT01635218|76161534|FG000|Overall Study|Lost to Follow-up|3|||
42324137|NCT01635218|76161535|FG001|Overall Study|Lost to Follow-up|7|||
42324138|NCT01635218|76161536|FG002|Overall Study|Lost to Follow-up|6|||
42324139|NCT02049866|76161544|FG000|Overall Study|Withdrawal by Subject|1|||
42324140|NCT04307186|76161548|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
42324141|NCT04307186|76161548|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
42324142|NCT04307186|76161548|FG000|Washout 3-14 Days|Progressive disease|1|||
42324143|NCT04307186|76161548|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
42324144|NCT04307186|76161548|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
42324145|NCT04274894|76161560|FG000|Overall Study|Adverse Event|7|||
42324146|NCT04274894|76161560|FG000|Overall Study|Withdrew consent|5|||
42324147|NCT04274894|76161560|FG000|Overall Study|Lost to Follow-up|9|||
42324148|NCT04274894|76161560|FG000|Overall Study|COVID-19 infection|1|||
42324149|NCT04274894|76161560|FG000|Overall Study|Other, not specified|20|||
42324150|NCT02213263|76161566|FG000|Overall Study|Insufficient clinical response|4|||
42324151|NCT02213263|76161567|FG001|Overall Study|Insufficient clinical response|3|||
42324152|NCT02213263|76161566|FG000|Overall Study|Lost to Follow-up|0|||
42324153|NCT02213263|76161567|FG001|Overall Study|Lost to Follow-up|1|||
42324154|NCT02213263|76161566|FG000|Overall Study|No longer willing to participate|3|||
42324155|NCT02213263|76161567|FG001|Overall Study|No longer willing to participate|4|||
42324156|NCT02213263|76161566|FG000|Overall Study|Progressive disease|20|||
42260314|NCT02843659|76087566|FG000|Overall Study|Adverse Event|0|||
42260315|NCT02843659|76087567|FG001|Overall Study|Adverse Event|1|||
42260316|NCT02843659|76087568|FG002|Overall Study|Adverse Event|0|||
42260317|NCT00708435|76087578|FG000|Overall Study|Death / Serious Adverse Event|10|||
42260318|NCT00708435|76087579|FG001|Overall Study|Death / Serious Adverse Event|5|||
42260319|NCT00708435|76087578|FG000|Overall Study|Lost to Follow-up|9|||
42260320|NCT00708435|76087579|FG001|Overall Study|Lost to Follow-up|4|||
42260321|NCT00708435|76087578|FG000|Overall Study|Withdrawal by Subject|3|||
42260322|NCT00708435|76087579|FG001|Overall Study|Withdrawal by Subject|7|||
42260323|NCT00708435|76087578|FG000|Overall Study|Adverse Event|1|||
42324157|NCT02213263|76161567|FG001|Overall Study|Progressive disease|14|||
42324158|NCT02213263|76161566|FG000|Overall Study|Protocol Violation|0|||
42324159|NCT02213263|76161567|FG001|Overall Study|Protocol Violation|1|||
42324160|NCT02213263|76161566|FG000|Overall Study|Adverse Event|1|||
42324161|NCT02213263|76161567|FG001|Overall Study|Adverse Event|3|||
42324162|NCT02211313|76161575|FG000|Overall Study|Treatment Failure|5|||
42324163|NCT02211313|76161576|FG001|Overall Study|Treatment Failure|2|||
42324164|NCT02211313|76161575|FG000|Overall Study|No Follow up Questionnaires|1|||
42324165|NCT02211313|76161576|FG001|Overall Study|No Follow up Questionnaires|1|||
42324166|NCT02210689|76161585|FG000|Overall Study|Withdrawal by Subject|7|||
42324167|NCT02210689|76161586|FG001|Overall Study|Withdrawal by Subject|4|||
42324168|NCT02210689|76161587|FG002|Overall Study|Withdrawal by Subject|2|||
42324169|NCT02210689|76161585|FG000|Overall Study|Adverse Event|0|||
42324170|NCT02210689|76161586|FG001|Overall Study|Adverse Event|1|||
42260324|NCT00708435|76087579|FG001|Overall Study|Adverse Event|0|||
42260325|NCT00708435|76087578|FG000|Overall Study|Protocol Violation|0|||
42260326|NCT00708435|76087579|FG001|Overall Study|Protocol Violation|1|||
42324171|NCT02210689|76161587|FG002|Overall Study|Adverse Event|0|||
42324172|NCT02210689|76161585|FG000|Overall Study|Protocol Violation|1|||
42324173|NCT02210689|76161586|FG001|Overall Study|Protocol Violation|0|||
42324174|NCT02210689|76161587|FG002|Overall Study|Protocol Violation|0|||
42324175|NCT02210689|76161585|FG000|Overall Study|Lost to Follow-up|11|||
42324176|NCT02210689|76161586|FG001|Overall Study|Lost to Follow-up|9|||
42324177|NCT02210689|76161587|FG002|Overall Study|Lost to Follow-up|5|||
42324178|NCT02210689|76161585|FG000|Overall Study|Pregnancy|0|||
42324179|NCT02210689|76161586|FG001|Overall Study|Pregnancy|1|||
42324180|NCT02210689|76161587|FG002|Overall Study|Pregnancy|0|||
42324181|NCT02210689|76161585|FG000|Overall Study|Lack of Efficacy|0|||
42324182|NCT02210689|76161586|FG001|Overall Study|Lack of Efficacy|1|||
42324183|NCT02210689|76161587|FG002|Overall Study|Lack of Efficacy|5|||
42324184|NCT02210689|76161585|FG000|Overall Study|Prohibited medication|2|||
42324185|NCT02210689|76161586|FG001|Overall Study|Prohibited medication|8|||
42324186|NCT02210689|76161587|FG002|Overall Study|Prohibited medication|1|||
42324187|NCT02210689|76161585|FG000|Overall Study|Negative Nugent score at baseline|6|||
42324188|NCT02210689|76161586|FG001|Overall Study|Negative Nugent score at baseline|2|||
42324189|NCT02210689|76161587|FG002|Overall Study|Negative Nugent score at baseline|2|||
42324190|NCT02210689|76161585|FG000|Overall Study|Other|25|||
42324191|NCT02210689|76161586|FG001|Overall Study|Other|21|||
42324192|NCT02210689|76161587|FG002|Overall Study|Other|8|||
41995527|NCT00475709|75803521|FG000|Overall Study|Device Explant|6|||
41995528|NCT00475709|75803521|FG000|Overall Study|Lost to Follow-up|21|||
41995529|NCT00475670|75803527|FG000|Overall Study|Death|0|||
41995530|NCT00475670|75803528|FG001|Overall Study|Death|1|||
41995531|NCT00475670|75803527|FG000|Overall Study|Lack of Efficacy|3|||
41995532|NCT00475670|75803528|FG001|Overall Study|Lack of Efficacy|34|||
41995533|NCT00475670|75803527|FG000|Overall Study|Refused treatment|0|||
41995534|NCT00475670|75803528|FG001|Overall Study|Refused treatment|2|||
41995535|NCT00475670|75803527|FG000|Overall Study|Failure to Return|0|||
41995536|NCT00475670|75803528|FG001|Overall Study|Failure to Return|1|||
41995537|NCT00475670|75803527|FG000|Overall Study|Other|0|||
41995538|NCT00475670|75803528|FG001|Overall Study|Other|3|||
41995539|NCT00474968|75803536|FG000|Overall Study|Withdrawal by Subject|8|||
41995540|NCT00474968|75803537|FG001|Overall Study|Withdrawal by Subject|7|||
41995541|NCT00474968|75803536|FG000|Overall Study|Protocol Violation|9|||
41995542|NCT00474968|75803537|FG001|Overall Study|Protocol Violation|8|||
41995543|NCT00474968|75803536|FG000|Overall Study|Sample not collected|1|||
42260327|NCT00708435|76087578|FG000|Overall Study|Intervention by primary care physician|1|||
42260328|NCT00708435|76087579|FG001|Overall Study|Intervention by primary care physician|0|||
42260329|NCT00708435|76087578|FG000|Overall Study|Refused hospitalization|1|||
42260330|NCT00708435|76087579|FG001|Overall Study|Refused hospitalization|0|||
42260331|NCT02841787|76087590|FG000|Overall Study|Lost to Follow-up|1|||
42260332|NCT02841787|76087591|FG001|Overall Study|Lost to Follow-up|0|||
42260333|NCT02841787|76087592|FG002|Overall Study|Lost to Follow-up|0|||
42260334|NCT02841787|76087590|FG000|Overall Study|Symptoms dropped below threshold|1|||
42260335|NCT02841787|76087591|FG001|Overall Study|Symptoms dropped below threshold|0|||
42260336|NCT02841787|76087592|FG002|Overall Study|Symptoms dropped below threshold|0|||
42260337|NCT02841787|76087590|FG000|Overall Study|Withdrawal by Subject|1|||
42260338|NCT02841787|76087591|FG001|Overall Study|Withdrawal by Subject|4|||
42260339|NCT02841787|76087592|FG002|Overall Study|Withdrawal by Subject|0|||
42260340|NCT01376037|76087602|FG000|Overall Study|Lost to Follow-up|0|||
42260341|NCT01376037|76087603|FG001|Overall Study|Lost to Follow-up|2|||
42260342|NCT02657408|76087611|FG000|Overall Study|Adverse Event|3|||
42260343|NCT02657408|76087612|FG001|Overall Study|Adverse Event|7|||
42260344|NCT02841709|76087618|FG000|5th Intervention|Adverse Event|2|||
42260345|NCT02841709|76087619|FG001|5th Intervention|Adverse Event|0|||
42324193|NCT02209597|76161595|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
41995544|NCT00474968|75803537|FG001|Overall Study|Sample not collected|1|||
41995545|NCT00474929|75803548|FG000|Overall Study|Withdrawal by Subject|0|||
41995546|NCT00474929|75803549|FG001|Overall Study|Withdrawal by Subject|1|||
42260346|NCT02841709|76087620|FG002|5th Intervention|Adverse Event|0|||
42324194|NCT02209597|76161595|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
42324195|NCT02209597|76161595|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
41995547|NCT00474929|75803550|FG002|Overall Study|Withdrawal by Subject|0|||
41995548|NCT00474929|75803551|FG003|Overall Study|Withdrawal by Subject|0|||
41995549|NCT00474929|75803552|FG004|Overall Study|Withdrawal by Subject|0|||
41995550|NCT00474929|75803548|FG000|Overall Study|Unrelated medical condition|0|||
41995551|NCT00474929|75803549|FG001|Overall Study|Unrelated medical condition|0|||
41995552|NCT00474929|75803550|FG002|Overall Study|Unrelated medical condition|1|||
41995553|NCT00474929|75803551|FG003|Overall Study|Unrelated medical condition|0|||
41995554|NCT00474929|75803552|FG004|Overall Study|Unrelated medical condition|0|||
41995555|NCT00474929|75803548|FG000|Overall Study|Physician Decision|0|||
42324196|NCT02209597|76161595|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
42324197|NCT02188303|76161624|FG000|Overall Study|Adverse Event|0|||
42324198|NCT02188303|76161625|FG001|Overall Study|Adverse Event|0|||
42324199|NCT02188303|76161626|FG002|Overall Study|Adverse Event|0|||
42324200|NCT02188303|76161627|FG003|Overall Study|Adverse Event|0|||
42324201|NCT02188303|76161628|FG004|Overall Study|Adverse Event|0|||
42324202|NCT02188303|76161629|FG005|Overall Study|Adverse Event|2|||
42324203|NCT02188303|76161630|FG006|Overall Study|Adverse Event|0|||
42324204|NCT02188303|76161631|FG007|Overall Study|Adverse Event|2|||
42324205|NCT02188303|76161624|FG000|Overall Study|Dose Termination Criteria Met|0|||
42324206|NCT02188303|76161625|FG001|Overall Study|Dose Termination Criteria Met|0|||
42324207|NCT02188303|76161626|FG002|Overall Study|Dose Termination Criteria Met|0|||
42324208|NCT02188303|76161627|FG003|Overall Study|Dose Termination Criteria Met|0|||
42324209|NCT02188303|76161628|FG004|Overall Study|Dose Termination Criteria Met|0|||
42324210|NCT02188303|76161629|FG005|Overall Study|Dose Termination Criteria Met|0|||
41995556|NCT00474929|75803549|FG001|Overall Study|Physician Decision|0|||
41995557|NCT00474929|75803550|FG002|Overall Study|Physician Decision|1|||
42260347|NCT02841709|76087621|FG003|5th Intervention|Adverse Event|0|||
42260348|NCT02841709|76087622|FG004|5th Intervention|Adverse Event|2|||
42260349|NCT01353859|76087635|FG000|Overall Study|Adverse Event|3|||
42260350|NCT01353859|76087635|FG000|Overall Study|Lack of Efficacy|1|||
42260351|NCT02850965|76087641|FG000|Overall Study|Other than listed|3|||
42260352|NCT02850965|76087642|FG001|Overall Study|Other than listed|4|||
42260353|NCT02850965|76087641|FG000|Overall Study|Protocol Violation|0|||
42260354|NCT02850965|76087642|FG001|Overall Study|Protocol Violation|2|||
42260355|NCT02850965|76087641|FG000|Overall Study|Lost to Follow-up|5|||
42260356|NCT02850965|76087642|FG001|Overall Study|Lost to Follow-up|3|||
42260357|NCT02850965|76087641|FG000|Overall Study|Lack of Efficacy|4|||
42260358|NCT02850965|76087642|FG001|Overall Study|Lack of Efficacy|8|||
42324211|NCT02188303|76161630|FG006|Overall Study|Dose Termination Criteria Met|2|||
42324212|NCT02188303|76161631|FG007|Overall Study|Dose Termination Criteria Met|4|||
42324213|NCT04867382|76161657|FG000|Overall Study|Did not complete the survey|2|||
42324214|NCT04867382|76161658|FG001|Overall Study|Did not complete the survey|1|||
42324215|NCT02187055|76161667|FG000|Overall Study|Lack of Efficacy|10|||
42324216|NCT02187055|76161668|FG001|Overall Study|Lack of Efficacy|3|||
42324217|NCT02187055|76161669|FG002|Overall Study|Lack of Efficacy|7|||
42324218|NCT02187055|76161667|FG000|Overall Study|Lost to Follow-up|2|||
42324219|NCT02187055|76161668|FG001|Overall Study|Lost to Follow-up|7|||
42324220|NCT02187055|76161669|FG002|Overall Study|Lost to Follow-up|3|||
42324221|NCT02187055|76161667|FG000|Overall Study|No longer meets eligibility criteria|0|||
42324222|NCT02187055|76161668|FG001|Overall Study|No longer meets eligibility criteria|2|||
42324223|NCT02187055|76161669|FG002|Overall Study|No longer meets eligibility criteria|0|||
42324224|NCT02187055|76161667|FG000|Overall Study|No longer willing to participate|6|||
42324225|NCT02187055|76161668|FG001|Overall Study|No longer willing to participate|8|||
42324226|NCT02187055|76161669|FG002|Overall Study|No longer willing to participate|10|||
42324227|NCT02187055|76161667|FG000|Overall Study|Other|5|||
42324228|NCT02187055|76161668|FG001|Overall Study|Other|6|||
42324229|NCT02187055|76161669|FG002|Overall Study|Other|3|||
42324230|NCT02187055|76161667|FG000|Overall Study|Protocol Violation|9|||
42324231|NCT02187055|76161668|FG001|Overall Study|Protocol Violation|9|||
42324232|NCT02187055|76161669|FG002|Overall Study|Protocol Violation|4|||
42324233|NCT02187055|76161667|FG000|Overall Study|Pregnancy|3|||
42324234|NCT02187055|76161668|FG001|Overall Study|Pregnancy|1|||
42324235|NCT02187055|76161669|FG002|Overall Study|Pregnancy|0|||
42324236|NCT02187055|76161667|FG000|Overall Study|Withdrawal by Subject|11|||
42324237|NCT02187055|76161668|FG001|Overall Study|Withdrawal by Subject|11|||
42324238|NCT02187055|76161669|FG002|Overall Study|Withdrawal by Subject|11|||
42324239|NCT02187055|76161667|FG000|Overall Study|Adverse Event|21|||
41995558|NCT00474929|75803551|FG003|Overall Study|Physician Decision|2|||
41995559|NCT00474929|75803552|FG004|Overall Study|Physician Decision|0|||
42260359|NCT02850965|76087641|FG000|Overall Study|Adverse Event|3|||
41995560|NCT00474812|75803565|FG000|Overall Study|Withdrawal by Subject|5|||
41995561|NCT00474812|75803565|FG000|Overall Study|No Initiation of treatment|2|||
41995562|NCT00474383|75803569|FG000|Main Study|Adverse Event|11|||
41995563|NCT00474383|75803570|FG001|Main Study|Adverse Event|0|||
41995564|NCT00474383|75803569|FG000|Main Study|Symptomatic Deterioration|1|||
41995565|NCT00474383|75803570|FG001|Main Study|Symptomatic Deterioration|0|||
41995566|NCT00474383|75803569|FG000|Main Study|Progressive Disease|23|||
41995567|NCT00474383|75803570|FG001|Main Study|Progressive Disease|0|||
41995568|NCT00474383|75803569|FG000|Main Study|Other|1|||
41995569|NCT00474383|75803570|FG001|Main Study|Other|0|||
41995570|NCT00474383|75803569|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
41995571|NCT00474383|75803570|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
41995572|NCT00474383|75803569|FG000|Extension|Progressive Disease|0|||
41995573|NCT00474383|75803570|FG001|Extension|Progressive Disease|5|||
41995574|NCT00474266|75803578|FG000|Overall Study|Withdrawal by Subject|7|||
41995575|NCT00474266|75803579|FG001|Overall Study|Withdrawal by Subject|20|||
41995576|NCT00474266|75803580|FG002|Overall Study|Withdrawal by Subject|4|||
41995577|NCT00474266|75803581|FG003|Overall Study|Withdrawal by Subject|7|||
41995578|NCT00473564|75803594|FG000|Overall Study|robot surgery aborted in OR|23|||
41995579|NCT00472199|75803600|FG000|Overall Study|Adverse Event|19|||
41995580|NCT00472199|75803601|FG001|Overall Study|Adverse Event|23|||
41995581|NCT00472199|75803600|FG000|Overall Study|Lack of Efficacy|4|||
41995582|NCT00472199|75803601|FG001|Overall Study|Lack of Efficacy|25|||
41995583|NCT00472199|75803600|FG000|Overall Study|Lost to Follow-up|2|||
41995584|NCT00472199|75803601|FG001|Overall Study|Lost to Follow-up|4|||
41995585|NCT00472199|75803600|FG000|Overall Study|Protocol Violation|3|||
41995586|NCT00472199|75803601|FG001|Overall Study|Protocol Violation|2|||
41995587|NCT00472199|75803600|FG000|Overall Study|Withdrawal by Subject|6|||
41995588|NCT00472199|75803601|FG001|Overall Study|Withdrawal by Subject|5|||
42260360|NCT02850965|76087642|FG001|Overall Study|Adverse Event|2|||
42260361|NCT02850965|76087641|FG000|Overall Study|Withdrawal by Subject|3|||
42260362|NCT02850965|76087642|FG001|Overall Study|Withdrawal by Subject|4|||
42324240|NCT02187055|76161668|FG001|Overall Study|Adverse Event|26|||
42324241|NCT02187055|76161669|FG002|Overall Study|Adverse Event|36|||
42324242|NCT02187055|76161667|FG000|Overall Study|Death|2|||
42324243|NCT02187055|76161668|FG001|Overall Study|Death|0|||
42324244|NCT02187055|76161669|FG002|Overall Study|Death|0|||
42324245|NCT02246660|76161709|FG000|Overall Study|Withdrawal by Subject|0|||
42324246|NCT02246660|76161710|FG001|Overall Study|Withdrawal by Subject|1|||
42324247|NCT02246660|76161711|FG002|Overall Study|Withdrawal by Subject|0|||
42260363|NCT02850965|76087641|FG000|Overall Study|Physician Decision|0|||
42260364|NCT02850965|76087642|FG001|Overall Study|Physician Decision|1|||
42260365|NCT02850965|76087641|FG000|Overall Study|Randomized but not treated|0|||
42260366|NCT02850965|76087642|FG001|Overall Study|Randomized but not treated|1|||
42260367|NCT01375959|76087650|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
42260368|NCT01375959|76087651|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
42260369|NCT01375959|76087650|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
42260370|NCT01375959|76087651|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
42260371|NCT01375959|76087650|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
42260372|NCT01375959|76087651|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
42260373|NCT00708201|76087661|FG000|Overall Study|Adverse Event|4|||
42260374|NCT00708201|76087662|FG001|Overall Study|Adverse Event|4|||
42260375|NCT00708201|76087661|FG000|Overall Study|Withdrawal by Subject|1|||
42260376|NCT00708201|76087662|FG001|Overall Study|Withdrawal by Subject|1|||
42260377|NCT00708201|76087661|FG000|Overall Study|Lost to Follow-up|2|||
42260378|NCT00708201|76087662|FG001|Overall Study|Lost to Follow-up|0|||
42260379|NCT00708201|76087661|FG000|Overall Study|Protocol Violation|0|||
42260380|NCT00708201|76087662|FG001|Overall Study|Protocol Violation|1|||
42260381|NCT02848313|76087670|FG000|Overall Study|Adverse Event|1|||
42260382|NCT02848313|76087671|FG001|Overall Study|Adverse Event|2|||
42324248|NCT02246660|76161709|FG000|Overall Study|Death|0|||
42324249|NCT02246660|76161710|FG001|Overall Study|Death|0|||
41995589|NCT00472199|75803600|FG000|Overall Study|personal reason|0|||
41995590|NCT00472199|75803601|FG001|Overall Study|personal reason|1|||
41995591|NCT00472199|75803600|FG000|Overall Study|patient was asymptomatic|1|||
42034374|NCT01042236|75842465|FG000|Treatment Period 3|Protocol Violation|0|||
42260383|NCT02848313|76087670|FG000|Overall Study|Lack of Efficacy|0|||
42324250|NCT02246660|76161711|FG002|Overall Study|Death|1|||
42324251|NCT02246582|76161719|FG000|Overall Study|Withdrawal by Subject|3|||
42324252|NCT02246582|76161720|FG001|Overall Study|Withdrawal by Subject|4|||
42324253|NCT02137369|76161726|FG000|Overall Study|Withdrawal by Subject|3|||
41995592|NCT00472199|75803601|FG001|Overall Study|patient was asymptomatic|0|||
41995593|NCT00472082|75803607|FG000|Overall Study|Study prematurely terminated|5|||
41995594|NCT00471887|75803611|FG000|Overall Study|Adverse Event|9|||
41995595|NCT00471536|75803615|FG000|Overall Study|Withdrawal by Subject|1|||
41995596|NCT00470834|75803621|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
41995597|NCT00470834|75803622|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
41995598|NCT00470834|75803621|FG000|Treatment Period (18 Months)|Adverse Event|7|||
41995599|NCT00470834|75803622|FG001|Treatment Period (18 Months)|Adverse Event|6|||
41995600|NCT00470834|75803621|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
41995601|NCT00470834|75803622|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
41995602|NCT00470834|75803621|FG000|Treatment Period (18 Months)|Physician Decision|4|||
41995603|NCT00470834|75803622|FG001|Treatment Period (18 Months)|Physician Decision|4|||
41995604|NCT00470834|75803621|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
41995605|NCT00470834|75803622|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
41995606|NCT00470834|75803621|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
41995607|NCT00470834|75803622|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
41995608|NCT00470834|75803621|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
41995609|NCT00470834|75803622|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
41995610|NCT00470834|75803621|FG000|Treatment Period (18 Months)|Non-compliance|1|||
41995611|NCT00470834|75803622|FG001|Treatment Period (18 Months)|Non-compliance|0|||
41995612|NCT00470834|75803621|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
41995613|NCT00470834|75803622|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
42034375|NCT01042236|75842466|FG001|Treatment Period 3|Protocol Violation|0|||
42034376|NCT01042236|75842467|FG002|Treatment Period 3|Protocol Violation|0|||
42133679|NCT00464334|75944549|FG003|Overall Study|Withdrawal by Subject|2|||
42133680|NCT00464334|75944550|FG004|Overall Study|Withdrawal by Subject|2|||
42260384|NCT02848313|76087671|FG001|Overall Study|Lack of Efficacy|1|||
42260385|NCT02848313|76087670|FG000|Overall Study|Withdrawal by Subject|1|||
42260386|NCT02848313|76087671|FG001|Overall Study|Withdrawal by Subject|1|||
42260387|NCT02848313|76087670|FG000|Overall Study|Lost to follow up|1|||
42260388|NCT02848313|76087671|FG001|Overall Study|Lost to follow up|0|||
42260389|NCT02728089|76087677|FG000|Overall Study|Physician Decision|2|||
42260390|NCT02728089|76087677|FG000|Overall Study|Withdrawal by Subject|1|||
42260391|NCT02840461|76087684|FG000|Overall Study|Adverse Event|1|||
42260392|NCT02840461|76087685|FG001|Overall Study|Adverse Event|5|||
42260393|NCT02840461|76087686|FG002|Overall Study|Adverse Event|3|||
42260394|NCT02840461|76087684|FG000|Overall Study|Lost to Follow-up|10|||
42260395|NCT02840461|76087685|FG001|Overall Study|Lost to Follow-up|7|||
42260396|NCT02840461|76087686|FG002|Overall Study|Lost to Follow-up|6|||
42260397|NCT02840461|76087684|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
42260398|NCT02840461|76087685|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
42260399|NCT02840461|76087686|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
42324254|NCT02137369|76161727|FG001|Overall Study|Withdrawal by Subject|2|||
42324255|NCT02137369|76161726|FG000|Overall Study|Adverse Event|2|||
42324256|NCT02137369|76161727|FG001|Overall Study|Adverse Event|0|||
42324257|NCT02137369|76161726|FG000|Overall Study|Lost to Follow-up|1|||
42324258|NCT02137369|76161727|FG001|Overall Study|Lost to Follow-up|0|||
42324259|NCT02137369|76161726|FG000|Overall Study|Moved away|2|||
42324260|NCT02137369|76161727|FG001|Overall Study|Moved away|0|||
42324261|NCT02155309|76161736|FG000|Overall Study|Protocol Violation|0|||
42324262|NCT02155309|76161737|FG001|Overall Study|Protocol Violation|0|||
42324263|NCT02155309|76161738|FG002|Overall Study|Protocol Violation|1|||
42324264|NCT02186821|76161745|FG000|Overall Study|Adverse Event|9|||
42324265|NCT02186821|76161745|FG000|Overall Study|Death|2|||
42324266|NCT02186821|76161745|FG000|Overall Study|Disease progression|32|||
42324267|NCT02186821|76161745|FG000|Overall Study|Protocol Violation|1|||
42324268|NCT02186821|76161745|FG000|Overall Study|Physician Decision|1|||
42324269|NCT02186821|76161745|FG000|Overall Study|Study terminated by sponsor|2|||
42324270|NCT01710358|76161752|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
42324271|NCT01710358|76161753|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
42324272|NCT01710358|76161754|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
42324273|NCT01710358|76161752|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
42324274|NCT01710358|76161753|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
42324275|NCT01710358|76161754|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
42324276|NCT01710358|76161752|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
42324277|NCT01710358|76161753|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
42324278|NCT01710358|76161754|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
42324279|NCT01710358|76161752|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
42260400|NCT02840461|76087684|FG000|Overall Study|Protocol Violation|2|||
42260401|NCT02840461|76087685|FG001|Overall Study|Protocol Violation|3|||
42260402|NCT02840461|76087686|FG002|Overall Study|Protocol Violation|1|||
42324280|NCT01710358|76161753|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
42324281|NCT01710358|76161754|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
42260403|NCT02840461|76087684|FG000|Overall Study|Withdrawal by Subject|10|||
42260404|NCT02840461|76087685|FG001|Overall Study|Withdrawal by Subject|6|||
42324282|NCT01710358|76161752|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
42324283|NCT01710358|76161753|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
41995614|NCT00470834|75803621|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
42034377|NCT01042236|75842468|FG003|Treatment Period 3|Protocol Violation|1|||
42324284|NCT01710358|76161754|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
42324285|NCT01710358|76161752|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
42324286|NCT01710358|76161753|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
42324287|NCT01710358|76161754|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
42324288|NCT01710358|76161752|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
42324289|NCT01710358|76161753|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
42324290|NCT01710358|76161754|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
42324291|NCT01710358|76161752|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
42324292|NCT01710358|76161753|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
42324293|NCT01710358|76161754|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
42324294|NCT01710358|76161752|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
42324295|NCT01710358|76161753|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
42324296|NCT01710358|76161754|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
42324297|NCT01710358|76161752|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
42324298|NCT01710358|76161753|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
42324299|NCT01710358|76161754|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
42324300|NCT01710358|76161752|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
42324301|NCT01710358|76161753|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
42324302|NCT01710358|76161754|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
42324303|NCT01710358|76161752|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
42324304|NCT01710358|76161753|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
42324305|NCT01710358|76161754|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
42324306|NCT01710358|76161752|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
42324307|NCT01710358|76161753|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
42324308|NCT01710358|76161754|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
42324309|NCT01710358|76161752|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
42324310|NCT01710358|76161753|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
42324311|NCT01710358|76161754|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
42324312|NCT01710358|76161752|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
42324313|NCT01710358|76161753|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
42324314|NCT01710358|76161754|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
42324315|NCT01710358|76161752|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
42324316|NCT01710358|76161753|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
42324317|NCT01710358|76161754|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
42324318|NCT01710358|76161752|FG000|Rescue Period|Adverse Event|0|||
42324319|NCT01710358|76161753|FG001|Rescue Period|Adverse Event|15|||
42324320|NCT01710358|76161754|FG002|Rescue Period|Adverse Event|0|||
42324321|NCT01710358|76161752|FG000|Rescue Period|Death|0|||
42324322|NCT01710358|76161753|FG001|Rescue Period|Death|1|||
42324323|NCT01710358|76161754|FG002|Rescue Period|Death|0|||
42324324|NCT01710358|76161752|FG000|Rescue Period|Lack of Efficacy|0|||
42324325|NCT01710358|76161753|FG001|Rescue Period|Lack of Efficacy|7|||
42324326|NCT01710358|76161754|FG002|Rescue Period|Lack of Efficacy|0|||
42324327|NCT01710358|76161752|FG000|Rescue Period|Withdrawal by Subject|0|||
42324328|NCT01710358|76161753|FG001|Rescue Period|Withdrawal by Subject|8|||
42324329|NCT01710358|76161754|FG002|Rescue Period|Withdrawal by Subject|0|||
42324330|NCT01633112|76161778|FG000|Overall Study|Lack of Efficacy|1|||
42324331|NCT01633112|76161779|FG001|Overall Study|Lack of Efficacy|6|||
42324332|NCT01633112|76161780|FG002|Overall Study|Lack of Efficacy|13|||
42324333|NCT01633112|76161778|FG000|Overall Study|Abnormal laboratory value(s)|3|||
42324334|NCT01633112|76161779|FG001|Overall Study|Abnormal laboratory value(s)|1|||
42324335|NCT01633112|76161780|FG002|Overall Study|Abnormal laboratory value(s)|0|||
42260405|NCT02840461|76087686|FG002|Overall Study|Withdrawal by Subject|2|||
42260406|NCT02840461|76087684|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
42260407|NCT02840461|76087685|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
42260408|NCT02840461|76087686|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
42260409|NCT02839681|76087695|FG000|Overall Study|Death|2|||
42260410|NCT01676012|76087699|FG000|Overall Study|Adverse Event|2|||
42260411|NCT01676012|76087699|FG000|Overall Study|incomplete set of videos|1|||
42260412|NCT02727777|76087715|FG000|Overall Study|Screen Failure|2|||
42260413|NCT02727777|76087716|FG001|Overall Study|Screen Failure|0|||
42260414|NCT02727777|76087717|FG002|Overall Study|Screen Failure|0|||
42260415|NCT02727777|76087715|FG000|Overall Study|Progressive disease|2|||
42260416|NCT02727777|76087716|FG001|Overall Study|Progressive disease|0|||
42260417|NCT02727777|76087717|FG002|Overall Study|Progressive disease|0|||
42260418|NCT00707577|76087727|FG000|Overall Study|Withdrawal by Subject|3|||
42260419|NCT00707577|76087728|FG001|Overall Study|Withdrawal by Subject|2|||
42260420|NCT00707577|76087727|FG000|Overall Study|Lost to Follow-up|34|||
42260421|NCT00707577|76087728|FG001|Overall Study|Lost to Follow-up|25|||
42324336|NCT01633112|76161778|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42324337|NCT01633112|76161779|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42324338|NCT01633112|76161780|FG002|Overall Study|Abnormal test procedure result(s)|0|||
42324339|NCT01633112|76161778|FG000|Overall Study|Administrative problems|1|||
42324340|NCT01633112|76161779|FG001|Overall Study|Administrative problems|2|||
42324341|NCT01633112|76161780|FG002|Overall Study|Administrative problems|5|||
42324342|NCT01633112|76161778|FG000|Overall Study|Adverse Event|16|||
42324343|NCT01633112|76161779|FG001|Overall Study|Adverse Event|18|||
42324344|NCT01633112|76161780|FG002|Overall Study|Adverse Event|20|||
42324345|NCT01633112|76161778|FG000|Overall Study|Lost to Follow-up|7|||
42324346|NCT01633112|76161779|FG001|Overall Study|Lost to Follow-up|19|||
42324347|NCT01633112|76161780|FG002|Overall Study|Lost to Follow-up|6|||
42324348|NCT01633112|76161778|FG000|Overall Study|Protocol Violation|4|||
42324349|NCT01633112|76161779|FG001|Overall Study|Protocol Violation|0|||
42324350|NCT01633112|76161780|FG002|Overall Study|Protocol Violation|2|||
42324351|NCT01633112|76161778|FG000|Overall Study|Subject no longer requires study drug|0|||
42324352|NCT01633112|76161779|FG001|Overall Study|Subject no longer requires study drug|0|||
42324353|NCT01633112|76161780|FG002|Overall Study|Subject no longer requires study drug|1|||
42324354|NCT01633112|76161778|FG000|Overall Study|Withdrawal by Subject|20|||
42324355|NCT01633112|76161779|FG001|Overall Study|Withdrawal by Subject|12|||
42324356|NCT01633112|76161780|FG002|Overall Study|Withdrawal by Subject|41|||
42324357|NCT01633112|76161778|FG000|Overall Study|missing Study Completion CRF|1|||
42324358|NCT01633112|76161779|FG001|Overall Study|missing Study Completion CRF|1|||
42324359|NCT01633112|76161780|FG002|Overall Study|missing Study Completion CRF|4|||
42324360|NCT01691482|76161789|FG000|Treatment Period 2|Adverse Event|0|||
42324361|NCT01691482|76161790|FG001|Treatment Period 2|Adverse Event|1|||
42324362|NCT01691482|76161789|FG000|Treatment Period 2|Protocol Violation|1|||
42324363|NCT01691482|76161790|FG001|Treatment Period 2|Protocol Violation|1|||
42324364|NCT02246114|76161799|FG000|Overall Study|miscarriage|1|||
42324365|NCT02246114|76161800|FG001|Overall Study|miscarriage|0|||
42324366|NCT01710046|76161808|FG000|Overall Study|Lost to Follow-up|1|||
42324367|NCT01710046|76161809|FG001|Overall Study|Lost to Follow-up|0|||
42324368|NCT02154529|76161819|FG000|Overall Study|Death|1|||
42324369|NCT02154529|76161820|FG001|Overall Study|Death|1|||
42324370|NCT02154529|76161821|FG002|Overall Study|Death|5|||
42324371|NCT02154529|76161822|FG003|Overall Study|Death|1|||
42324372|NCT02154529|76161819|FG000|Overall Study|Termination of study by sponsor|2|||
42324373|NCT02154529|76161820|FG001|Overall Study|Termination of study by sponsor|2|||
42324374|NCT02154529|76161821|FG002|Overall Study|Termination of study by sponsor|3|||
42324375|NCT02154529|76161822|FG003|Overall Study|Termination of study by sponsor|1|||
42324376|NCT02154529|76161819|FG000|Overall Study|Lost to Follow-up|1|||
42324377|NCT02154529|76161820|FG001|Overall Study|Lost to Follow-up|0|||
42324378|NCT02154529|76161821|FG002|Overall Study|Lost to Follow-up|0|||
42324379|NCT02154529|76161822|FG003|Overall Study|Lost to Follow-up|0|||
42324380|NCT01954017|76161837|FG000|Overall Study|Adverse Event|0|||
42260422|NCT00707577|76087727|FG000|Overall Study|Left employment|13|||
42260423|NCT00707577|76087728|FG001|Overall Study|Left employment|10|||
42260424|NCT00707577|76087727|FG000|Overall Study|Pregnancy|4|||
42260425|NCT00707577|76087728|FG001|Overall Study|Pregnancy|1|||
42260426|NCT01675622|76087736|FG000|Overall Study|Withdrawal by Subject|2|||
42260427|NCT01675622|76087737|FG001|Overall Study|Withdrawal by Subject|2|||
42260428|NCT01675622|76087736|FG000|Overall Study|Adverse Event|12|||
42260429|NCT01675622|76087737|FG001|Overall Study|Adverse Event|10|||
42260430|NCT01675622|76087736|FG000|Overall Study|Protocol Violation|4|||
42260431|NCT01675622|76087737|FG001|Overall Study|Protocol Violation|1|||
42260432|NCT01675622|76087736|FG000|Overall Study|Lack of Efficacy|2|||
42260433|NCT01675622|76087737|FG001|Overall Study|Lack of Efficacy|4|||
42260434|NCT01675622|76087736|FG000|Overall Study|Lost to Follow-up|1|||
42260435|NCT01675622|76087737|FG001|Overall Study|Lost to Follow-up|3|||
42260436|NCT01675622|76087736|FG000|Overall Study|Other|5|||
42260437|NCT01675622|76087737|FG001|Overall Study|Other|4|||
42324381|NCT01954017|76161838|FG001|Overall Study|Adverse Event|0|||
42324382|NCT01954017|76161839|FG002|Overall Study|Adverse Event|1|||
42324383|NCT01954017|76161837|FG000|Overall Study|Death|2|||
42324384|NCT01954017|76161838|FG001|Overall Study|Death|1|||
42324385|NCT01954017|76161839|FG002|Overall Study|Death|1|||
42324386|NCT01954017|76161837|FG000|Overall Study|Withdrawal by Subject|0|||
42324387|NCT01954017|76161838|FG001|Overall Study|Withdrawal by Subject|1|||
42324388|NCT01954017|76161839|FG002|Overall Study|Withdrawal by Subject|0|||
41995615|NCT00470834|75803622|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
41995616|NCT00470834|75803621|FG000|Extension Period (24 Months)|Adverse Event|3|||
41995617|NCT00470834|75803622|FG001|Extension Period (24 Months)|Adverse Event|4|||
41995618|NCT00470834|75803621|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
41995619|NCT00470834|75803622|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
41995620|NCT00470834|75803621|FG000|Extension Period (24 Months)|Physician Decision|4|||
41995621|NCT00470834|75803622|FG001|Extension Period (24 Months)|Physician Decision|3|||
41995622|NCT00470834|75803621|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
41995623|NCT00470834|75803622|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
41995624|NCT00470834|75803621|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
42324389|NCT01954017|76161837|FG000|Overall Study|Protocol Violation|0|||
41995625|NCT00470834|75803622|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
41995626|NCT00470834|75803621|FG000|Extension Period (24 Months)|Non-compliance|0|||
41995627|NCT00470834|75803622|FG001|Extension Period (24 Months)|Non-compliance|1|||
41995628|NCT00470834|75803621|FG000|Extension Period (24 Months)|Disease Progression|0|||
41995629|NCT00470834|75803622|FG001|Extension Period (24 Months)|Disease Progression|1|||
42260438|NCT02655224|76087745|FG000|Overall Study|Adverse Event|1|||
42260439|NCT02655224|76087746|FG001|Overall Study|Adverse Event|1|||
42260440|NCT01675544|76087752|FG000|Overall Study|Withdrawal by Subject|2|||
42260441|NCT02838901|76087795|FG000|Overall Study|Withdrawal by Subject|1|||
42260442|NCT02838901|76087796|FG001|Overall Study|Withdrawal by Subject|1|||
42260443|NCT02838901|76087795|FG000|Overall Study|Lost to Follow-up|1|||
42260444|NCT02838901|76087796|FG001|Overall Study|Lost to Follow-up|1|||
42260445|NCT00706797|76087824|FG000|Overall Study|Lack of Efficacy|3|||
42260446|NCT00706797|76087825|FG001|Overall Study|Lack of Efficacy|0|||
42260447|NCT00706797|76087824|FG000|Overall Study|Adverse Event|0|||
42034378|NCT01042236|75842469|FG004|Treatment Period 3|Protocol Violation|0|||
42324390|NCT01954017|76161838|FG001|Overall Study|Protocol Violation|3|||
42260448|NCT00706797|76087825|FG001|Overall Study|Adverse Event|3|||
42324391|NCT01954017|76161839|FG002|Overall Study|Protocol Violation|2|||
42324392|NCT01954017|76161837|FG000|Overall Study|Necrotizing enterocolitis|1|||
42324393|NCT01954017|76161838|FG001|Overall Study|Necrotizing enterocolitis|0|||
42324394|NCT01954017|76161839|FG002|Overall Study|Necrotizing enterocolitis|1|||
42324395|NCT01954017|76161837|FG000|Overall Study|Enteral intake stopped >7 days|0|||
42324396|NCT01954017|76161838|FG001|Overall Study|Enteral intake stopped >7 days|1|||
42324397|NCT01954017|76161839|FG002|Overall Study|Enteral intake stopped >7 days|1|||
42324398|NCT01954017|76161837|FG000|Overall Study|All other reasons|2|||
42324399|NCT01954017|76161838|FG001|Overall Study|All other reasons|2|||
42324400|NCT01954017|76161839|FG002|Overall Study|All other reasons|7|||
42324401|NCT02154139|76161873|FG000|Overall Study|Injection not administered|2|||
42324402|NCT02154139|76161873|FG000|Overall Study|Other|2|||
42324403|NCT02154139|76161873|FG000|Overall Study|Investigator transferred|3|||
42324404|NCT02245568|76161877|FG000|Overall Study|Study terminated by Sponsor|346|||
42324405|NCT02245568|76161877|FG000|Overall Study|Adverse Event|144|||
42324406|NCT02245568|76161877|FG000|Overall Study|Lack of Efficacy|98|||
42324407|NCT02245568|76161877|FG000|Overall Study|Withdrawal by Caregiver|85|||
42324408|NCT02245568|76161877|FG000|Overall Study|Withdrawal by Subject|77|||
42324409|NCT02245568|76161877|FG000|Overall Study|Withdrawal by Legal Representative|31|||
42324410|NCT02245568|76161877|FG000|Overall Study|Missing (Site closure)|16|||
42324411|NCT02245568|76161877|FG000|Overall Study|Physician Decision|14|||
42324412|NCT02245568|76161877|FG000|Overall Study|Non-compliance with study drug|11|||
42324413|NCT02245568|76161877|FG000|Overall Study|Death|9|||
42324414|NCT02245568|76161877|FG000|Overall Study|Blue staining|6|||
42324415|NCT02245568|76161877|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
42324416|NCT02245568|76161877|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
42324417|NCT02245568|76161877|FG000|Overall Study|Lost to Follow-up|5|||
42324418|NCT02154061|76161883|FG000|Overall Study|Pregnancy|1|||
42324419|NCT02154061|76161884|FG001|Overall Study|Pregnancy|0|||
42324420|NCT02154061|76161883|FG000|Overall Study|enrolled but not vaccinated|1|||
42324421|NCT02154061|76161884|FG001|Overall Study|enrolled but not vaccinated|0|||
42324422|NCT01907217|76161892|FG000|Overall Study|Withdrawal by Subject|0|||
42260449|NCT00706797|76087824|FG000|Overall Study|Withdrawal by Subject|8|||
42260450|NCT00706797|76087825|FG001|Overall Study|Withdrawal by Subject|1|||
42260451|NCT00706797|76087824|FG000|Overall Study|Death|1|||
42260452|NCT00706797|76087825|FG001|Overall Study|Death|0|||
42260453|NCT00706797|76087824|FG000|Overall Study|Discontinuation of study by sponsor|52|||
42260454|NCT00706797|76087825|FG001|Overall Study|Discontinuation of study by sponsor|63|||
42260455|NCT00706797|76087824|FG000|Overall Study|Protocol Violation|3|||
42260456|NCT00706797|76087825|FG001|Overall Study|Protocol Violation|2|||
42260457|NCT00706797|76087824|FG000|Overall Study|Lost to Follow-up|1|||
42260458|NCT00706797|76087825|FG001|Overall Study|Lost to Follow-up|2|||
42260459|NCT00706797|76087824|FG000|Overall Study|Other|1|||
42260460|NCT00706797|76087825|FG001|Overall Study|Other|0|||
42260461|NCT00706641|76087831|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
42260462|NCT00706641|76087831|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
42260463|NCT00706641|76087831|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
42260464|NCT01362530|76087837|FG000|Base Study (Cycle 1)|Adverse Event|2|||
42260465|NCT01362530|76087838|FG001|Base Study (Cycle 1)|Adverse Event|0|||
42260466|NCT01362530|76087837|FG000|Base Study (Cycle 1)|Physician Decision|0|||
42260467|NCT01362530|76087838|FG001|Base Study (Cycle 1)|Physician Decision|1|||
42260468|NCT01362530|76087837|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
42260469|NCT01362530|76087838|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
42260470|NCT01362530|76087837|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
42260471|NCT01362530|76087838|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
42260472|NCT01362530|76087837|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
42260473|NCT01362530|76087838|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
42260474|NCT01362530|76087837|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
42260475|NCT01362530|76087838|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
42260476|NCT01362530|76087837|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
42260477|NCT01362530|76087838|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
42260478|NCT01362530|76087837|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
42260479|NCT01362530|76087838|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
42260480|NCT01362530|76087837|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
42260481|NCT01362530|76087838|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
42260482|NCT01362530|76087837|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
42260483|NCT01362530|76087838|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
42260484|NCT01362530|76087837|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
42260485|NCT01362530|76087838|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
42260486|NCT01362530|76087837|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
42260487|NCT01362530|76087838|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
42260488|NCT01362530|76087837|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
42260489|NCT01362530|76087838|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
42260490|NCT02654054|76087848|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
42260491|NCT02654054|76087849|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
42260492|NCT02654054|76087850|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
42260493|NCT02654054|76087848|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
42260494|NCT02654054|76087849|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42260495|NCT02654054|76087850|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
42324423|NCT01907217|76161893|FG001|Overall Study|Withdrawal by Subject|2|||
42324424|NCT01953783|76161901|FG000|Overall Study|Progressive disease|2|||
42324425|NCT02134015|76161907|FG000|Overall Study|Protocol Violation|0|||
42324426|NCT02134015|76161908|FG001|Overall Study|Protocol Violation|1|||
42260496|NCT02654054|76087848|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
42260497|NCT02654054|76087849|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
42324427|NCT02134015|76161907|FG000|Overall Study|Death|2|||
42324428|NCT02134015|76161908|FG001|Overall Study|Death|1|||
42324429|NCT02134015|76161907|FG000|Overall Study|Reason not provided|1|||
42324430|NCT02134015|76161908|FG001|Overall Study|Reason not provided|2|||
42324431|NCT02134015|76161907|FG000|Overall Study|Clinical progression|14|||
42324432|NCT02134015|76161908|FG001|Overall Study|Clinical progression|7|||
42260498|NCT02654054|76087850|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
42260499|NCT02654054|76087848|FG000|Post-Treatment Follow-Up Period|Other|1|||
42260500|NCT02654054|76087849|FG001|Post-Treatment Follow-Up Period|Other|0|||
42260501|NCT02654054|76087850|FG002|Post-Treatment Follow-Up Period|Other|4|||
42260502|NCT02654054|76087848|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
42260503|NCT02654054|76087849|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
42324433|NCT02134015|76161907|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
42324434|NCT02134015|76161908|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
42324435|NCT02134015|76161907|FG000|Overall Study|Study terminated by sponsor|2|||
42324436|NCT02134015|76161908|FG001|Overall Study|Study terminated by sponsor|3|||
42324437|NCT02134015|76161907|FG000|Overall Study|Adverse Event|9|||
42324438|NCT02134015|76161908|FG001|Overall Study|Adverse Event|10|||
42324439|NCT02134015|76161907|FG000|Overall Study|Withdrawal by Subject|3|||
42324440|NCT02134015|76161908|FG001|Overall Study|Withdrawal by Subject|7|||
41995630|NCT00470366|75803628|FG000|Overall Study|Adverse Event|3|||
41995631|NCT00470366|75803628|FG000|Overall Study|Poor compliance|1|||
41995632|NCT00470093|75803632|FG000|Overall Study|Adverse Event|2|||
41995633|NCT00470054|75803636|FG000|Overall Study|Ineligible|1|||
41995634|NCT00474188|75803640|FG000|Overall Study|Withdrawal by Subject|1|||
41995635|NCT00474188|75803640|FG000|Overall Study|Study discontinued by sponsor|5|||
41995636|NCT00475982|75803645|FG000|Overall Study|surgery rescheduled|7|||
41995637|NCT00475982|75803646|FG001|Overall Study|surgery rescheduled|3|||
41995638|NCT01089647|75803654|FG000|Overall Study|Lost to Follow-up|2|||
41995639|NCT01089647|75803655|FG001|Overall Study|Lost to Follow-up|2|||
41995640|NCT01089647|75803654|FG000|Overall Study|Withdrawal by Subject|2|||
41995641|NCT01089647|75803655|FG001|Overall Study|Withdrawal by Subject|1|||
41995642|NCT01089647|75803654|FG000|Overall Study|Adverse Event|0|||
41995643|NCT01089647|75803655|FG001|Overall Study|Adverse Event|1|||
41995644|NCT01089608|75803663|FG000|Overall Study|Adverse Event|0|||
41995645|NCT01089608|75803664|FG001|Overall Study|Adverse Event|4|||
41995646|NCT01089608|75803663|FG000|Overall Study|Lost to Follow-up|0|||
41995647|NCT01089608|75803664|FG001|Overall Study|Lost to Follow-up|2|||
41995648|NCT01089413|75803673|FG000|Overall Study|Lost to Follow-up|1|||
41995649|NCT01089413|75803673|FG000|Overall Study|Progressive Disease|93|||
41995650|NCT01089413|75803673|FG000|Overall Study|Participant Withdrew Consent|1|||
41995651|NCT01089413|75803673|FG000|Overall Study|Unacceptable Toxicity|12|||
41995652|NCT01089413|75803673|FG000|Overall Study|Death|10|||
41995653|NCT01089413|75803673|FG000|Overall Study|Metastasectomy|13|||
41995654|NCT01089413|75803673|FG000|Overall Study|Other|71|||
41995655|NCT01089023|75803683|FG000|Overall Study|Lost to Follow-up|3|||
41995656|NCT01089023|75803683|FG000|Overall Study|Adverse Event|1|||
41995657|NCT01089023|75803683|FG000|Overall Study|Withdrawal by Subject|1|||
41995658|NCT01089023|75803683|FG000|Overall Study|Protocol Violation|1|||
41995659|NCT01089023|75803683|FG000|Overall Study|Lack of Efficacy|1|||
41995660|NCT01088984|75803689|FG000|Phase 1|Death|2|||
41995661|NCT01088984|75803690|FG001|Phase 1|Death|1|||
41995662|NCT01088984|75803689|FG000|Phase 1|Disease Progression|2|||
41995663|NCT01088984|75803690|FG001|Phase 1|Disease Progression|4|||
41995664|NCT01088984|75803689|FG000|Phase 1|Other|1|||
42034379|NCT01042236|75842470|FG005|Treatment Period 3|Protocol Violation|0|||
42260504|NCT02654054|76087850|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
42260505|NCT02653664|76087871|FG000|Post-Treatment|Withdrawal by Subject|6|||
42260506|NCT02653664|76087872|FG001|Post-Treatment|Withdrawal by Subject|5|||
42260507|NCT02653664|76087873|FG002|Post-Treatment|Withdrawal by Subject|7|||
42260508|NCT02653664|76087871|FG000|Post-Treatment|Lost to Follow-up|8|||
42324441|NCT01924845|76161914|FG000|Overall Study|Adverse Event|3|||
42324442|NCT01924845|76161914|FG000|Overall Study|Withdrawal by Subject|2|||
42324443|NCT01924845|76161914|FG000|Overall Study|Protocol Violation|1|||
41995665|NCT01088984|75803690|FG001|Phase 1|Other|1|||
41995666|NCT01088984|75803689|FG000|Phase 2|Death|0|||
42324444|NCT01630135|76161920|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
42324445|NCT01630135|76161921|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
41995667|NCT01088984|75803690|FG001|Phase 2|Death|5|||
41995668|NCT01088984|75803689|FG000|Phase 2|Withdrawal by Subject|0|||
41995669|NCT01088984|75803690|FG001|Phase 2|Withdrawal by Subject|1|||
42324446|NCT01691248|76161929|FG000|Overall Study|Protocol Violation|43|||
41995670|NCT01088984|75803689|FG000|Phase 2|DIsease Progression|0|||
41995671|NCT01088984|75803690|FG001|Phase 2|DIsease Progression|25|||
41995672|NCT01088984|75803689|FG000|Phase 2|Other|0|||
41995673|NCT01088984|75803690|FG001|Phase 2|Other|1|||
41995674|NCT01088438|75803701|FG000|Overall Study|Withdrawal by Subject|11|||
41995675|NCT01088438|75803702|FG001|Overall Study|Withdrawal by Subject|6|||
41995676|NCT01088438|75803701|FG000|Overall Study|Lost to Follow-up|18|||
42260509|NCT02653664|76087872|FG001|Post-Treatment|Lost to Follow-up|1|||
42260510|NCT02653664|76087873|FG002|Post-Treatment|Lost to Follow-up|7|||
42260511|NCT02653664|76087871|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
42324447|NCT01691248|76161930|FG001|Overall Study|Protocol Violation|27|||
42324448|NCT01691248|76161929|FG000|Overall Study|Adverse Event|24|||
42324449|NCT01691248|76161930|FG001|Overall Study|Adverse Event|22|||
42324450|NCT01691248|76161929|FG000|Overall Study|Withdrawal by Subject|20|||
42324451|NCT01691248|76161930|FG001|Overall Study|Withdrawal by Subject|18|||
42324452|NCT01691248|76161929|FG000|Overall Study|Confirmed CDAD|14|||
42324453|NCT01691248|76161930|FG001|Overall Study|Confirmed CDAD|31|||
42324454|NCT01691248|76161929|FG000|Overall Study|Lost to Follow-up|2|||
42324455|NCT01691248|76161930|FG001|Overall Study|Lost to Follow-up|5|||
42324456|NCT01691248|76161929|FG000|Overall Study|Reason not provided|4|||
42324457|NCT01691248|76161930|FG001|Overall Study|Reason not provided|4|||
42324458|NCT01691248|76161929|FG000|Overall Study|Not Treated|4|||
42324459|NCT01691248|76161930|FG001|Overall Study|Not Treated|7|||
42324460|NCT01924767|76161941|FG000|Overall Study|Adverse Event|1|||
42324461|NCT01924767|76161942|FG001|Overall Study|Adverse Event|0|||
42324462|NCT01924767|76161943|FG002|Overall Study|Adverse Event|1|||
42324463|NCT01924767|76161944|FG003|Overall Study|Adverse Event|0|||
42324464|NCT01924767|76161945|FG004|Overall Study|Adverse Event|0|||
42324465|NCT01691092|76161962|FG000|Overall Study|Lost to Follow-up|10|||
42324466|NCT01691092|76161962|FG000|Overall Study|Physician Decision|4|||
42324467|NCT01691092|76161962|FG000|Overall Study|Withdrawal by Subject|3|||
42324468|NCT01691092|76161962|FG000|Overall Study|non-compliance|3|||
42324469|NCT01691092|76161962|FG000|Overall Study|used for different study|2|||
42324470|NCT01691092|76161962|FG000|Overall Study|screen fail|19|||
42324471|NCT02133001|76161968|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
42260512|NCT02653664|76087872|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
42260513|NCT02653664|76087873|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
42260514|NCT02653664|76087871|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
42260515|NCT02653664|76087872|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
42260516|NCT02653664|76087873|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
42260517|NCT02653664|76087871|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
42260518|NCT02653664|76087872|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
42324472|NCT02133001|76161969|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
42324473|NCT02133001|76161968|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
42324474|NCT02133001|76161969|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
42324475|NCT02133001|76161968|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
42324476|NCT02133001|76161969|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
41995677|NCT01088438|75803702|FG001|Overall Study|Lost to Follow-up|30|||
41995678|NCT01088243|75803710|FG000|Overall Study|Adverse Event|1|||
42260519|NCT02653664|76087873|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
42272693|NCT00857285|76103029|FG001|Overall Study|Withdrawal by Subject|0|||
42324477|NCT02133001|76161968|FG000|Double Blind (Day 1-25)|Other|2|||
42324478|NCT02133001|76161969|FG001|Double Blind (Day 1-25)|Other|2|||
42324479|NCT02133001|76161968|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
41995679|NCT01088243|75803711|FG001|Overall Study|Adverse Event|0|||
41995680|NCT01088048|75803727|FG000|Overall Study|Adverse Event|7|||
41995681|NCT01088048|75803728|FG001|Overall Study|Adverse Event|9|||
41995682|NCT01088048|75803729|FG002|Overall Study|Adverse Event|7|||
41995683|NCT01088048|75803730|FG003|Overall Study|Adverse Event|5|||
41995684|NCT01088048|75803731|FG004|Overall Study|Adverse Event|6|||
41995685|NCT01088048|75803732|FG005|Overall Study|Adverse Event|3|||
41995686|NCT01088048|75803733|FG006|Overall Study|Adverse Event|3|||
41995687|NCT01088048|75803734|FG007|Overall Study|Adverse Event|0|||
41995688|NCT01088048|75803735|FG008|Overall Study|Adverse Event|2|||
41995689|NCT01088048|75803736|FG009|Overall Study|Adverse Event|2|||
41995690|NCT01088048|75803727|FG000|Overall Study|Withdrew Consent|1|||
41995691|NCT01088048|75803728|FG001|Overall Study|Withdrew Consent|1|||
41995692|NCT01088048|75803729|FG002|Overall Study|Withdrew Consent|1|||
41995693|NCT01088048|75803730|FG003|Overall Study|Withdrew Consent|1|||
41995694|NCT01088048|75803731|FG004|Overall Study|Withdrew Consent|2|||
41995695|NCT01088048|75803732|FG005|Overall Study|Withdrew Consent|1|||
42324480|NCT02133001|76161969|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
42324481|NCT02133001|76161968|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
42324482|NCT02133001|76161969|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
42324483|NCT02133001|76161968|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
42324484|NCT02133001|76161969|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
42324485|NCT02133001|76161968|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
42324486|NCT02133001|76161969|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
42324487|NCT01709578|76161980|FG000|Overall Study|Rescued and entered in long term safety|63|||
42034380|NCT00592501|75842478|FG000|Overall Study|Withdrawal by Subject|1|||
42034381|NCT00592501|75842478|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
42260520|NCT02653664|76087871|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
42260521|NCT02653664|76087872|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
42260522|NCT02653664|76087873|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
42260523|NCT02653664|76087871|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
42260524|NCT02653664|76087872|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
42260525|NCT02653664|76087873|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
42260526|NCT02653664|76087871|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
42260527|NCT02653664|76087872|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
42260528|NCT02653664|76087873|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
42260529|NCT02653664|76087871|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
42260530|NCT02653664|76087872|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
42260531|NCT02653664|76087873|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
42260532|NCT02653664|76087871|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
42260533|NCT02653664|76087872|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
42260534|NCT02653664|76087873|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
42260535|NCT02488629|76087891|FG000|Overall Study|Lack of Efficacy|3|||
42260536|NCT02488629|76087892|FG001|Overall Study|Lack of Efficacy|1|||
42260537|NCT02488629|76087893|FG002|Overall Study|Lack of Efficacy|0|||
42260538|NCT02488629|76087894|FG003|Overall Study|Lack of Efficacy|0|||
42260539|NCT02488629|76087891|FG000|Overall Study|Withdrawal by Subject|0|||
42260540|NCT02488629|76087892|FG001|Overall Study|Withdrawal by Subject|1|||
42260541|NCT02488629|76087893|FG002|Overall Study|Withdrawal by Subject|0|||
42260542|NCT02488629|76087894|FG003|Overall Study|Withdrawal by Subject|0|||
42260543|NCT02727699|76087905|FG000|Overall Study|Adverse Event|2|||
42324488|NCT01709578|76161981|FG001|Overall Study|Rescued and entered in long term safety|25|||
42324489|NCT01709578|76161982|FG002|Overall Study|Rescued and entered in long term safety|26|||
41995696|NCT01088048|75803733|FG006|Overall Study|Withdrew Consent|0|||
41995697|NCT01088048|75803734|FG007|Overall Study|Withdrew Consent|2|||
41995698|NCT01088048|75803735|FG008|Overall Study|Withdrew Consent|2|||
42324490|NCT01709578|76161980|FG000|Overall Study|Adverse Event|9|||
41995699|NCT01088048|75803736|FG009|Overall Study|Withdrew Consent|1|||
41995700|NCT01088048|75803727|FG000|Overall Study|Concomitant Medication Prohibited|1|||
42324491|NCT01709578|76161981|FG001|Overall Study|Adverse Event|18|||
42324492|NCT01709578|76161982|FG002|Overall Study|Adverse Event|17|||
41995701|NCT01088048|75803728|FG001|Overall Study|Concomitant Medication Prohibited|0|||
41995702|NCT01088048|75803729|FG002|Overall Study|Concomitant Medication Prohibited|0|||
41995703|NCT01088048|75803730|FG003|Overall Study|Concomitant Medication Prohibited|0|||
41995704|NCT01088048|75803731|FG004|Overall Study|Concomitant Medication Prohibited|0|||
41995705|NCT01088048|75803732|FG005|Overall Study|Concomitant Medication Prohibited|0|||
41995706|NCT01088048|75803733|FG006|Overall Study|Concomitant Medication Prohibited|0|||
41995707|NCT01088048|75803734|FG007|Overall Study|Concomitant Medication Prohibited|0|||
41995708|NCT01088048|75803735|FG008|Overall Study|Concomitant Medication Prohibited|0|||
41995709|NCT01088048|75803736|FG009|Overall Study|Concomitant Medication Prohibited|0|||
41995710|NCT01088048|75803727|FG000|Overall Study|Investigator Request|2|||
41995711|NCT01088048|75803728|FG001|Overall Study|Investigator Request|2|||
41995712|NCT01088048|75803729|FG002|Overall Study|Investigator Request|0|||
41995713|NCT01088048|75803730|FG003|Overall Study|Investigator Request|0|||
41995714|NCT01088048|75803731|FG004|Overall Study|Investigator Request|3|||
41995715|NCT01088048|75803732|FG005|Overall Study|Investigator Request|1|||
41995716|NCT01088048|75803733|FG006|Overall Study|Investigator Request|1|||
42324493|NCT01709578|76161980|FG000|Overall Study|Lack of Efficacy|5|||
42324494|NCT01709578|76161981|FG001|Overall Study|Lack of Efficacy|4|||
42324495|NCT01709578|76161982|FG002|Overall Study|Lack of Efficacy|2|||
42324496|NCT01709578|76161980|FG000|Overall Study|Poor compliance to protocol|1|||
42324497|NCT01709578|76161981|FG001|Overall Study|Poor compliance to protocol|2|||
42324498|NCT01709578|76161982|FG002|Overall Study|Poor compliance to protocol|1|||
42324499|NCT01709578|76161980|FG000|Overall Study|Other, not related to safety or efficacy|2|||
42324500|NCT01709578|76161981|FG001|Overall Study|Other, not related to safety or efficacy|7|||
42324501|NCT01709578|76161982|FG002|Overall Study|Other, not related to safety or efficacy|5|||
42324502|NCT02132767|76161992|FG000|Overall Study|Death|3|||
42324503|NCT02132767|76161993|FG001|Overall Study|Death|2|||
42324504|NCT02132767|76161992|FG000|Overall Study|Withdrawal by Subject|10|||
42324505|NCT02132767|76161993|FG001|Overall Study|Withdrawal by Subject|9|||
42324506|NCT02132767|76161992|FG000|Overall Study|Lost to Follow-up|4|||
42324507|NCT02132767|76161993|FG001|Overall Study|Lost to Follow-up|4|||
42324508|NCT02153905|76162001|FG000|Overall Study|Death|1|||
42324509|NCT02153905|76162002|FG001|Overall Study|Death|0|||
42324510|NCT02153827|76162010|FG000|Overall Study|Lost to Follow-up|3|||
42324511|NCT02153827|76162011|FG001|Overall Study|Lost to Follow-up|9|||
42324512|NCT02153359|76162017|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
42324513|NCT02153359|76162018|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
42324514|NCT01691014|76162031|FG000|Overall Study|Premature Termination|1|||
42324515|NCT01691014|76162032|FG001|Overall Study|Premature Termination|6|||
42324516|NCT01691014|76162033|FG002|Overall Study|Premature Termination|0|||
42324517|NCT01691014|76162034|FG003|Overall Study|Premature Termination|3|||
42324518|NCT01691014|76162031|FG000|Overall Study|Other|0|||
42324519|NCT01691014|76162032|FG001|Overall Study|Other|0|||
42324520|NCT01691014|76162033|FG002|Overall Study|Other|2|||
41995717|NCT01088048|75803734|FG007|Overall Study|Investigator Request|0|||
42260544|NCT02727699|76087906|FG001|Overall Study|Adverse Event|0|||
42260545|NCT02727699|76087905|FG000|Overall Study|Withdrawal by Subject|5|||
42260546|NCT02727699|76087906|FG001|Overall Study|Withdrawal by Subject|3|||
42260547|NCT02727699|76087905|FG000|Overall Study|Protocol Violation|0|||
42260548|NCT02727699|76087906|FG001|Overall Study|Protocol Violation|1|||
42260549|NCT02727699|76087905|FG000|Overall Study|Physician Decision|0|||
42260550|NCT02727699|76087906|FG001|Overall Study|Physician Decision|1|||
42260551|NCT02727699|76087905|FG000|Overall Study|Lost to Follow-up|1|||
42260552|NCT02727699|76087906|FG001|Overall Study|Lost to Follow-up|0|||
42034382|NCT01040832|75842484|FG000|Overall Study|Adverse Event|4|||
42034383|NCT01040832|75842485|FG001|Overall Study|Adverse Event|5|||
42260553|NCT02727699|76087905|FG000|Overall Study|Sponsor Decision|1|||
42324521|NCT01691014|76162034|FG003|Overall Study|Other|0|||
42324522|NCT01691014|76162031|FG000|Overall Study|Withdrawal by Subject|0|||
42324523|NCT01691014|76162032|FG001|Overall Study|Withdrawal by Subject|1|||
42260554|NCT02727699|76087906|FG001|Overall Study|Sponsor Decision|0|||
42324524|NCT01691014|76162033|FG002|Overall Study|Withdrawal by Subject|1|||
42324525|NCT01691014|76162034|FG003|Overall Study|Withdrawal by Subject|1|||
41995718|NCT01088048|75803735|FG008|Overall Study|Investigator Request|0|||
42324526|NCT01691014|76162031|FG000|Overall Study|Adverse Event|0|||
41995719|NCT01088048|75803736|FG009|Overall Study|Investigator Request|0|||
41995720|NCT01088048|75803727|FG000|Overall Study|Patient Non-compliance|0|||
42034384|NCT01040832|75842484|FG000|Overall Study|Death|4|||
42324527|NCT01691014|76162032|FG001|Overall Study|Adverse Event|5|||
42324528|NCT01691014|76162033|FG002|Overall Study|Adverse Event|1|||
42324529|NCT01691014|76162034|FG003|Overall Study|Adverse Event|1|||
42324530|NCT01691014|76162031|FG000|Overall Study|Lack of Efficacy|2|||
42324531|NCT01691014|76162032|FG001|Overall Study|Lack of Efficacy|3|||
42324532|NCT01691014|76162033|FG002|Overall Study|Lack of Efficacy|7|||
42324533|NCT01691014|76162034|FG003|Overall Study|Lack of Efficacy|0|||
42260555|NCT03576716|76087924|FG000|Overall Study|Withdrawal by Subject|0|||
42260556|NCT03576716|76087925|FG001|Overall Study|Withdrawal by Subject|1|||
42260557|NCT02847637|76087944|FG000|Overall Study|Withdrawal by Subject|0|||
42260558|NCT02847637|76087945|FG001|Overall Study|Withdrawal by Subject|1|||
42260559|NCT02847637|76087946|FG002|Overall Study|Withdrawal by Subject|1|||
42260560|NCT02847637|76087947|FG003|Overall Study|Withdrawal by Subject|0|||
42260561|NCT02847637|76087944|FG000|Overall Study|Lost to Follow-up|1|||
42260562|NCT02847637|76087945|FG001|Overall Study|Lost to Follow-up|1|||
42260563|NCT02847637|76087946|FG002|Overall Study|Lost to Follow-up|0|||
42260564|NCT02847637|76087947|FG003|Overall Study|Lost to Follow-up|0|||
42260565|NCT00706095|76087974|FG000|Overall Study|Progressive Disease|4|||
42260566|NCT00706095|76087975|FG001|Overall Study|Progressive Disease|5|||
42260567|NCT00706095|76087976|FG002|Overall Study|Progressive Disease|3|||
42260568|NCT00706095|76087974|FG000|Overall Study|Clinical Progression|1|||
42260569|NCT00706095|76087975|FG001|Overall Study|Clinical Progression|2|||
42260570|NCT00706095|76087976|FG002|Overall Study|Clinical Progression|2|||
42260571|NCT00706095|76087974|FG000|Overall Study|Withdrawal by Subject|1|||
42260572|NCT00706095|76087975|FG001|Overall Study|Withdrawal by Subject|0|||
42260573|NCT00706095|76087976|FG002|Overall Study|Withdrawal by Subject|0|||
42260574|NCT02837731|76087986|FG000|Allocation|Admitted to General Floor|3|||
42260575|NCT02837731|76087987|FG001|Allocation|Admitted to General Floor|4|||
42260576|NCT02837731|76087986|FG000|Allocation|Immediate surgery/withdrew|2|||
42260577|NCT02837731|76087987|FG001|Allocation|Immediate surgery/withdrew|0|||
42260578|NCT02837731|76087986|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
42260579|NCT02837731|76087987|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
42260580|NCT02837731|76087986|FG000|Allocation|Withdrawal by Subject|2|||
42260581|NCT02837731|76087987|FG001|Allocation|Withdrawal by Subject|0|||
42260582|NCT02837731|76087986|FG000|Allocation|Device not available|1|||
42260583|NCT02837731|76087987|FG001|Allocation|Device not available|0|||
42260584|NCT02837731|76087986|FG000|Allocation|Protocol not implemented|7|||
42260585|NCT02837731|76087987|FG001|Allocation|Protocol not implemented|0|||
42260586|NCT02837731|76087986|FG000|Allocation|Moribund/Do not resuscitate|2|||
42260587|NCT02837731|76087987|FG001|Allocation|Moribund/Do not resuscitate|0|||
42260588|NCT02837731|76087986|FG000|Allocation|Did not meet sepsis criteria|1|||
42260589|NCT02837731|76087987|FG001|Allocation|Did not meet sepsis criteria|2|||
42260590|NCT02837731|76087986|FG000|Allocation|Known aortic abnormalities|0|||
42260591|NCT02837731|76087987|FG001|Allocation|Known aortic abnormalities|1|||
42260592|NCT02836873|76087995|FG000|Overall Study|Protocol Violation|0|||
42260593|NCT02836873|76087996|FG001|Overall Study|Protocol Violation|1|||
42260594|NCT02836873|76087995|FG000|Overall Study|Adverse Event|1|||
42260595|NCT02836873|76087996|FG001|Overall Study|Adverse Event|4|||
42260596|NCT02836873|76087995|FG000|Overall Study|Withdrawal by Subject|2|||
42260597|NCT02836873|76087996|FG001|Overall Study|Withdrawal by Subject|2|||
42260598|NCT02836873|76087995|FG000|Overall Study|Lost to Follow-up|1|||
42260599|NCT02836873|76087996|FG001|Overall Study|Lost to Follow-up|3|||
42260600|NCT02836873|76087995|FG000|Overall Study|Physician Decision|0|||
42260601|NCT02836873|76087996|FG001|Overall Study|Physician Decision|1|||
42260602|NCT02836873|76087995|FG000|Overall Study|Other|1|||
42260603|NCT02836873|76087996|FG001|Overall Study|Other|0|||
42260604|NCT01342081|76088014|FG000|Overall Study|Did not receive allocated intervention|0|||
42260605|NCT01342081|76088015|FG001|Overall Study|Did not receive allocated intervention|0|||
42260606|NCT01342081|76088016|FG002|Overall Study|Did not receive allocated intervention|1|||
42260607|NCT01342081|76088014|FG000|Overall Study|Adverse Event|1|||
42324534|NCT02245412|76162047|FG000|Treatment Period|Death|1|||
42324535|NCT02245412|76162048|FG001|Treatment Period|Death|1|||
42324536|NCT02245412|76162049|FG002|Treatment Period|Death|0|||
42324537|NCT02245412|76162047|FG000|Treatment Period|Physician Decision|1|||
42260608|NCT01342081|76088015|FG001|Overall Study|Adverse Event|0|||
42260609|NCT01342081|76088016|FG002|Overall Study|Adverse Event|0|||
42260610|NCT01342081|76088014|FG000|Overall Study|Physician Decision|0|||
42260611|NCT01342081|76088015|FG001|Overall Study|Physician Decision|1|||
42324538|NCT02245412|76162048|FG001|Treatment Period|Physician Decision|1|||
42324539|NCT02245412|76162049|FG002|Treatment Period|Physician Decision|0|||
42260612|NCT01342081|76088016|FG002|Overall Study|Physician Decision|0|||
42260613|NCT01342081|76088014|FG000|Overall Study|Withdrawal by Subject|1|||
42260614|NCT01342081|76088015|FG001|Overall Study|Withdrawal by Subject|1|||
42260615|NCT01342081|76088016|FG002|Overall Study|Withdrawal by Subject|0|||
42260616|NCT01341457|76088026|FG000|Overall Study|Adverse Event|2|||
42324540|NCT02245412|76162047|FG000|Treatment Period|Withdrawal by Subject|2|||
42324541|NCT02245412|76162048|FG001|Treatment Period|Withdrawal by Subject|1|||
42324542|NCT02245412|76162049|FG002|Treatment Period|Withdrawal by Subject|0|||
42324543|NCT02245412|76162047|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
42324544|NCT02245412|76162048|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
42324545|NCT02245412|76162049|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
42324546|NCT02245412|76162047|FG000|Follow-Up Period|Death|4|||
42324547|NCT02245412|76162048|FG001|Follow-Up Period|Death|2|||
42324548|NCT02245412|76162049|FG002|Follow-Up Period|Death|1|||
42324549|NCT02245412|76162047|FG000|Follow-Up Period|Physician Decision|1|||
42324550|NCT02245412|76162048|FG001|Follow-Up Period|Physician Decision|0|||
42324551|NCT02245412|76162049|FG002|Follow-Up Period|Physician Decision|0|||
42324552|NCT02245412|76162047|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
42324553|NCT02245412|76162048|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
41995721|NCT01088048|75803728|FG001|Overall Study|Patient Non-compliance|1|||
41995722|NCT01088048|75803729|FG002|Overall Study|Patient Non-compliance|0|||
42324554|NCT02245412|76162049|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
42324555|NCT02244944|76162057|FG000|Overall Study|Withdrawal by Subject|1|||
42324556|NCT02244944|76162057|FG000|Overall Study|Study Terminated|1|||
42324557|NCT01689532|76162063|FG000|Overall Study|Adverse Event|9|||
42324558|NCT01689532|76162064|FG001|Overall Study|Adverse Event|5|||
42324559|NCT01689532|76162063|FG000|Overall Study|Lack of Efficacy|2|||
42324560|NCT01689532|76162064|FG001|Overall Study|Lack of Efficacy|2|||
42324561|NCT01689532|76162063|FG000|Overall Study|Withdrawal by Subject|1|||
41995723|NCT01088048|75803730|FG003|Overall Study|Patient Non-compliance|0|||
41995724|NCT01088048|75803731|FG004|Overall Study|Patient Non-compliance|0|||
41995725|NCT01088048|75803732|FG005|Overall Study|Patient Non-compliance|0|||
41995726|NCT01088048|75803733|FG006|Overall Study|Patient Non-compliance|0|||
41995727|NCT01088048|75803734|FG007|Overall Study|Patient Non-compliance|0|||
41995728|NCT01088048|75803735|FG008|Overall Study|Patient Non-compliance|0|||
41995729|NCT01088048|75803736|FG009|Overall Study|Patient Non-compliance|0|||
41995730|NCT01088048|75803727|FG000|Overall Study|Disease Progression|7|||
41995731|NCT01088048|75803728|FG001|Overall Study|Disease Progression|4|||
41995732|NCT01088048|75803729|FG002|Overall Study|Disease Progression|3|||
41995733|NCT01088048|75803730|FG003|Overall Study|Disease Progression|5|||
41995734|NCT01088048|75803731|FG004|Overall Study|Disease Progression|3|||
41995735|NCT01088048|75803732|FG005|Overall Study|Disease Progression|3|||
41995736|NCT01088048|75803733|FG006|Overall Study|Disease Progression|2|||
41995737|NCT01088048|75803734|FG007|Overall Study|Disease Progression|1|||
41995738|NCT01088048|75803735|FG008|Overall Study|Disease Progression|0|||
41995739|NCT01088048|75803736|FG009|Overall Study|Disease Progression|0|||
41995740|NCT01088048|75803727|FG000|Overall Study|Death|1|||
41995741|NCT01088048|75803728|FG001|Overall Study|Death|5|||
41995742|NCT01088048|75803729|FG002|Overall Study|Death|3|||
41995743|NCT01088048|75803730|FG003|Overall Study|Death|3|||
41995744|NCT01088048|75803731|FG004|Overall Study|Death|1|||
41995745|NCT01088048|75803732|FG005|Overall Study|Death|3|||
41995746|NCT01088048|75803733|FG006|Overall Study|Death|0|||
41995747|NCT01088048|75803734|FG007|Overall Study|Death|0|||
41995748|NCT01088048|75803735|FG008|Overall Study|Death|3|||
41995749|NCT01088048|75803736|FG009|Overall Study|Death|1|||
42324562|NCT01689532|76162064|FG001|Overall Study|Withdrawal by Subject|2|||
42324563|NCT01689532|76162063|FG000|Overall Study|Physician Decision|2|||
42324564|NCT01689532|76162064|FG001|Overall Study|Physician Decision|0|||
42324565|NCT01924689|76162076|FG000|Overall Study|Death|0|||
41995750|NCT01088048|75803727|FG000|Overall Study|Other|3|||
41995751|NCT01088048|75803728|FG001|Overall Study|Other|5|||
41995752|NCT01088048|75803729|FG002|Overall Study|Other|0|||
42324566|NCT01924689|76162077|FG001|Overall Study|Death|1|||
41995753|NCT01088048|75803730|FG003|Overall Study|Other|0|||
41995754|NCT01088048|75803731|FG004|Overall Study|Other|2|||
41995755|NCT01088048|75803732|FG005|Overall Study|Other|0|||
41995756|NCT01088048|75803733|FG006|Overall Study|Other|0|||
41995757|NCT01088048|75803734|FG007|Overall Study|Other|2|||
42324567|NCT01924689|76162078|FG002|Overall Study|Death|0|||
42324568|NCT01924689|76162079|FG003|Overall Study|Death|1|||
41995758|NCT01088048|75803735|FG008|Overall Study|Other|0|||
41995759|NCT01088048|75803736|FG009|Overall Study|Other|0|||
41995760|NCT01087970|75803769|FG000|Overall Study|Protocol Violation|2|||
41995761|NCT01087814|75803776|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
42324569|NCT01924689|76162080|FG004|Overall Study|Death|0|||
42324570|NCT01924689|76162081|FG005|Overall Study|Death|0|||
42324571|NCT01924689|76162076|FG000|Overall Study|Disease progression|0|||
42324572|NCT01924689|76162077|FG001|Overall Study|Disease progression|0|||
42260617|NCT01341457|76088027|FG001|Overall Study|Adverse Event|0|||
42260618|NCT02832037|76088039|FG000|Overall Study|Administrative reasons|0|||
42260619|NCT02832037|76088040|FG001|Overall Study|Administrative reasons|0|||
42260620|NCT02832037|76088041|FG002|Overall Study|Administrative reasons|1|||
42260621|NCT02832037|76088042|FG003|Overall Study|Administrative reasons|0|||
42260622|NCT02832037|76088043|FG004|Overall Study|Administrative reasons|0|||
42260623|NCT02832037|76088039|FG000|Overall Study|Protocol Violation|3|||
42260624|NCT02832037|76088040|FG001|Overall Study|Protocol Violation|0|||
42324573|NCT01924689|76162078|FG002|Overall Study|Disease progression|2|||
42324574|NCT01924689|76162079|FG003|Overall Study|Disease progression|0|||
42324575|NCT01924689|76162080|FG004|Overall Study|Disease progression|3|||
42324576|NCT01924689|76162081|FG005|Overall Study|Disease progression|2|||
42324577|NCT01924689|76162076|FG000|Overall Study|New therapy or study|3|||
42324578|NCT01924689|76162077|FG001|Overall Study|New therapy or study|2|||
42324579|NCT01924689|76162078|FG002|Overall Study|New therapy or study|1|||
42324580|NCT01924689|76162079|FG003|Overall Study|New therapy or study|4|||
42324581|NCT01924689|76162080|FG004|Overall Study|New therapy or study|2|||
42324582|NCT01924689|76162081|FG005|Overall Study|New therapy or study|0|||
42324583|NCT01924689|76162076|FG000|Overall Study|Withdrawal of consent|0|||
42324584|NCT01924689|76162077|FG001|Overall Study|Withdrawal of consent|0|||
42324585|NCT01924689|76162078|FG002|Overall Study|Withdrawal of consent|1|||
42324586|NCT01924689|76162079|FG003|Overall Study|Withdrawal of consent|1|||
42324587|NCT01924689|76162080|FG004|Overall Study|Withdrawal of consent|0|||
42324588|NCT01924689|76162081|FG005|Overall Study|Withdrawal of consent|0|||
42324589|NCT01924689|76162076|FG000|Overall Study|Other|0|||
42324590|NCT01924689|76162077|FG001|Overall Study|Other|0|||
42324591|NCT01924689|76162078|FG002|Overall Study|Other|0|||
42324592|NCT01924689|76162079|FG003|Overall Study|Other|0|||
42324593|NCT01924689|76162080|FG004|Overall Study|Other|1|||
42324594|NCT01924689|76162081|FG005|Overall Study|Other|0|||
42324595|NCT01591330|76162099|FG000|Period 1|Adverse Event|1|||
42324596|NCT01591330|76162100|FG001|Period 1|Adverse Event|0|||
42324597|NCT01591330|76162101|FG002|Period 1|Adverse Event|0|||
42324598|NCT01591330|76162102|FG003|Period 1|Adverse Event|0|||
42324599|NCT01591330|76162099|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
42324600|NCT01591330|76162100|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
42324601|NCT01591330|76162101|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
42324602|NCT01591330|76162102|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
42324603|NCT01591330|76162099|FG000|Period 2|Adverse Event|1|||
42324604|NCT01591330|76162100|FG001|Period 2|Adverse Event|0|||
41995762|NCT01087814|75803777|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
41995763|NCT01087814|75803776|FG000|Second Intervention (5 Days)|Physician Decision|1|||
42324605|NCT01591330|76162101|FG002|Period 2|Adverse Event|0|||
42324606|NCT01591330|76162102|FG003|Period 2|Adverse Event|0|||
42324607|NCT01591096|76162112|FG000|Overall Study|Adverse Event|1|||
42324608|NCT01953003|76162118|FG000|Overall Study|Not treated|0|||
42324609|NCT01953003|76162119|FG001|Overall Study|Not treated|1|||
42324610|NCT01953003|76162118|FG000|Overall Study|Progressive disease|35|||
42324611|NCT01953003|76162119|FG001|Overall Study|Progressive disease|45|||
42324612|NCT01953003|76162118|FG000|Overall Study|Related Adverse events|7|||
42324613|NCT01953003|76162119|FG001|Overall Study|Related Adverse events|2|||
42324614|NCT01953003|76162118|FG000|Overall Study|Non-related adverse events|0|||
42324615|NCT01953003|76162119|FG001|Overall Study|Non-related adverse events|2|||
42324616|NCT01953003|76162118|FG000|Overall Study|Protocol Violation|0|||
42324617|NCT01953003|76162119|FG001|Overall Study|Protocol Violation|1|||
42324618|NCT01953003|76162118|FG000|Overall Study|Withdrawal by Subject|14|||
42324619|NCT01953003|76162119|FG001|Overall Study|Withdrawal by Subject|4|||
42324620|NCT01952691|76162125|FG000|Overall Study|Lost to Follow-up|2|||
42324621|NCT01709500|76162131|FG000|Overall Study|Randomized but not treated|0|||
42324622|NCT01709500|76162132|FG001|Overall Study|Randomized but not treated|1|||
42324623|NCT01709500|76162131|FG000|Overall Study|Adverse Event|5|||
42324624|NCT01709500|76162132|FG001|Overall Study|Adverse Event|1|||
42324625|NCT01709500|76162131|FG000|Overall Study|Poor compliance to protocol|2|||
42324626|NCT01709500|76162132|FG001|Overall Study|Poor compliance to protocol|1|||
42324627|NCT01709500|76162131|FG000|Overall Study|Other|3|||
42324628|NCT01709500|76162132|FG001|Overall Study|Other|1|||
42324629|NCT01709500|76162131|FG000|Overall Study|Related to IMP administration|1|||
42324630|NCT01709500|76162132|FG001|Overall Study|Related to IMP administration|0|||
42324631|NCT01709500|76162131|FG000|Overall Study|Treatment ongoing|156|||
42324632|NCT01709500|76162132|FG001|Overall Study|Treatment ongoing|78|||
42260625|NCT02832037|76088041|FG002|Overall Study|Protocol Violation|4|||
42324633|NCT01599806|76162140|FG000|Overall Study|Lost to Follow-up|20|||
42324634|NCT01599806|76162141|FG001|Overall Study|Lost to Follow-up|20|||
42324635|NCT01599806|76162140|FG000|Overall Study|Withdrawal by Subject|12|||
41995764|NCT01087814|75803777|FG001|Second Intervention (5 Days)|Physician Decision|0|||
42324636|NCT01599806|76162141|FG001|Overall Study|Withdrawal by Subject|12|||
42324637|NCT01599806|76162140|FG000|Overall Study|Other Eligibility criteria|11|||
42324638|NCT01599806|76162141|FG001|Overall Study|Other Eligibility criteria|9|||
42260626|NCT02832037|76088042|FG003|Overall Study|Protocol Violation|1|||
42260627|NCT02832037|76088043|FG004|Overall Study|Protocol Violation|2|||
42260628|NCT02832037|76088039|FG000|Overall Study|Lost to Follow-up|2|||
42260629|NCT02832037|76088040|FG001|Overall Study|Lost to Follow-up|0|||
42260630|NCT02832037|76088041|FG002|Overall Study|Lost to Follow-up|3|||
42260631|NCT02832037|76088042|FG003|Overall Study|Lost to Follow-up|0|||
42260632|NCT02832037|76088043|FG004|Overall Study|Lost to Follow-up|5|||
42260633|NCT02832037|76088039|FG000|Overall Study|Withdrawal by Subject|9|||
42324639|NCT01599325|76162147|FG000|Primary Parent Phase|Adverse Event|5|||
42324640|NCT01599325|76162147|FG000|Primary Parent Phase|Disease Progression|7|||
42324641|NCT01599325|76162147|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
42324642|NCT01599325|76162147|FG000|Primary Parent Phase|Death|13|||
42324643|NCT01599325|76162147|FG000|Primary Parent Phase|Protocol Violation|1|||
42324644|NCT01599325|76162147|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
42324645|NCT01599325|76162147|FG000|Primary Parent Phase|Other|2|||
42324646|NCT01599325|76162147|FG000|Extension Phase|Study Closure|1|||
42324647|NCT01599325|76162147|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
42324648|NCT01599325|76162147|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
42324649|NCT01599325|76162147|FG000|Extension Phase|Disease Progression|1|||
42324650|NCT01599325|76162147|FG000|Extension Phase|Withdrawal by Subject|8|||
42324651|NCT01924299|76162154|FG000|Period 2|Withdrawal by Subject|1|||
42324652|NCT01924299|76162155|FG001|Period 2|Withdrawal by Subject|0|||
41995765|NCT01087775|75803783|FG000|Overall Study|failed inclusion criteria|2|||
41995766|NCT01087502|75803790|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
41995767|NCT01087502|75803791|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
41995768|NCT01087502|75803790|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
41995769|NCT01087502|75803791|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
41995770|NCT01087502|75803790|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
41995771|NCT01087502|75803791|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
41995772|NCT01087502|75803790|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
41995773|NCT01087502|75803791|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
41995774|NCT01087502|75803790|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
42324653|NCT01924299|76162154|FG000|Period 2|Adverse Event|0|||
42324654|NCT01924299|76162155|FG001|Period 2|Adverse Event|1|||
42324655|NCT02182999|76162169|FG000|Overall Study|Adverse Event|4|||
42324656|NCT02182999|76162170|FG001|Overall Study|Adverse Event|3|||
42324657|NCT02182999|76162169|FG000|Overall Study|Physician Decision|1|||
42324658|NCT02182999|76162170|FG001|Overall Study|Physician Decision|0|||
42324659|NCT02243696|76162176|FG000|Overall Study|Death|282|||
42324660|NCT02243696|76162176|FG000|Overall Study|Withdrawal by Subject|79|||
42324661|NCT02243696|76162176|FG000|Overall Study|Lost to Follow-up|57|||
41995775|NCT01087502|75803791|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
41995776|NCT01087502|75803790|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
41995777|NCT01087502|75803791|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
41995778|NCT01087502|75803790|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
41995779|NCT01087502|75803791|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
41995780|NCT01087502|75803790|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
42260634|NCT02832037|76088040|FG001|Overall Study|Withdrawal by Subject|8|||
42260635|NCT02832037|76088041|FG002|Overall Study|Withdrawal by Subject|0|||
42260636|NCT02832037|76088042|FG003|Overall Study|Withdrawal by Subject|4|||
42260637|NCT02832037|76088043|FG004|Overall Study|Withdrawal by Subject|8|||
42260638|NCT02832037|76088039|FG000|Overall Study|Adverse Event|5|||
42260639|NCT02832037|76088040|FG001|Overall Study|Adverse Event|4|||
42260640|NCT02832037|76088041|FG002|Overall Study|Adverse Event|0|||
42260641|NCT02832037|76088042|FG003|Overall Study|Adverse Event|2|||
42260642|NCT02832037|76088043|FG004|Overall Study|Adverse Event|4|||
42324662|NCT02243696|76162176|FG000|Overall Study|Subject No Longer has Study System|42|||
42324663|NCT02243696|76162176|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
42324664|NCT02243696|76162176|FG000|Overall Study|Study Terminated for EP PASSION|961|||
42324665|NCT01598311|76162182|FG000|Overall Study|Physician Decision|4|||
42324666|NCT01598311|76162183|FG001|Overall Study|Physician Decision|5|||
41995781|NCT01087502|75803791|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
41995782|NCT01087502|75803790|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
42260643|NCT01675154|76088059|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
42260644|NCT01675154|76088060|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
42260645|NCT01675154|76088061|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
42324667|NCT01598311|76162182|FG000|Overall Study|Adverse Event|9|||
42324668|NCT01598311|76162183|FG001|Overall Study|Adverse Event|13|||
42324669|NCT01598311|76162182|FG000|Overall Study|Lost to Follow-up|7|||
42324670|NCT01598311|76162183|FG001|Overall Study|Lost to Follow-up|12|||
41995783|NCT01087502|75803791|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
41995784|NCT01087502|75803790|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
42324671|NCT01598311|76162182|FG000|Overall Study|Withdrawal by Subject|9|||
42324672|NCT01598311|76162183|FG001|Overall Study|Withdrawal by Subject|13|||
42324673|NCT01598311|76162182|FG000|Overall Study|No reason provided.|0|||
42324674|NCT01598311|76162183|FG001|Overall Study|No reason provided.|5|||
41995785|NCT01087502|75803791|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
42324675|NCT01598311|76162182|FG000|Overall Study|Randomized but never treated|8|||
42324676|NCT01598311|76162183|FG001|Overall Study|Randomized but never treated|5|||
42324677|NCT01598311|76162182|FG000|Overall Study|Treated but no confirmed CDAD|9|||
42324678|NCT01598311|76162183|FG001|Overall Study|Treated but no confirmed CDAD|8|||
42324679|NCT01598311|76162182|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
42324680|NCT01598311|76162183|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
42324681|NCT02182843|76162189|FG000|Overall Study|Withdrawal by Subject|7|||
41995786|NCT01087502|75803790|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
41995787|NCT01087502|75803791|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
41995788|NCT01087502|75803790|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
41995789|NCT01087502|75803791|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
41995790|NCT01086410|75803803|FG000|Overall Study|Adverse Event|1|||
41995791|NCT01086410|75803804|FG001|Overall Study|Adverse Event|0|||
41995792|NCT01086410|75803805|FG002|Overall Study|Adverse Event|0|||
42133681|NCT00464334|75944551|FG005|Overall Study|Withdrawal by Subject|2|||
42133682|NCT00464334|75944552|FG006|Overall Study|Withdrawal by Subject|2|||
42133683|NCT00464334|75944553|FG007|Overall Study|Withdrawal by Subject|1|||
42133684|NCT00464334|75944554|FG008|Overall Study|Withdrawal by Subject|3|||
42260646|NCT01675154|76088062|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
42260647|NCT02744755|76088086|FG000|Study Period 1|Protocol Violation|2|||
42260648|NCT02744755|76088087|FG001|Study Period 1|Protocol Violation|1|||
42260649|NCT02744755|76088086|FG000|Study Period 1|not defined|0|||
42260650|NCT02744755|76088087|FG001|Study Period 1|not defined|1|||
42260651|NCT02744755|76088086|FG000|Study Period 1|Pregnancy|1|||
42260652|NCT02744755|76088087|FG001|Study Period 1|Pregnancy|0|||
42260653|NCT02744755|76088086|FG000|Study Period 1|Adverse Event|1|||
42260654|NCT02744755|76088087|FG001|Study Period 1|Adverse Event|1|||
42260655|NCT02744755|76088086|FG000|Study Period 1|Lost to Follow-up|1|||
42260656|NCT02744755|76088087|FG001|Study Period 1|Lost to Follow-up|1|||
42260657|NCT02744755|76088086|FG000|Study Period 1|Lack of Efficacy|1|||
42260658|NCT02744755|76088087|FG001|Study Period 1|Lack of Efficacy|0|||
42260659|NCT02744755|76088086|FG000|Study Period 1|Withdrawal by Subject|8|||
42260660|NCT02744755|76088087|FG001|Study Period 1|Withdrawal by Subject|4|||
42260661|NCT02744755|76088086|FG000|Study Period 2|Adverse Event|5|||
41995793|NCT01086410|75803806|FG003|Overall Study|Adverse Event|2|||
42034385|NCT01040832|75842485|FG001|Overall Study|Death|6|||
42034386|NCT01040832|75842484|FG000|Overall Study|Withdrawal by Subject|2|||
42260662|NCT02744755|76088087|FG001|Study Period 2|Adverse Event|0|||
42260663|NCT02744755|76088086|FG000|Study Period 2|Protocol Violation|1|||
42133685|NCT00464334|75944555|FG009|Overall Study|Withdrawal by Subject|0|||
42133686|NCT00464334|75944556|FG010|Overall Study|Withdrawal by Subject|0|||
42133687|NCT00299494|75944597|FG000|Overall Study|Withdrawal by Subject|0|||
42133688|NCT00299494|75944598|FG001|Overall Study|Withdrawal by Subject|0|||
42133689|NCT00299494|75944599|FG002|Overall Study|Withdrawal by Subject|0|||
42133690|NCT00299494|75944600|FG003|Overall Study|Withdrawal by Subject|3|||
42133691|NCT00299494|75944601|FG004|Overall Study|Withdrawal by Subject|1|||
42133692|NCT00299494|75944602|FG005|Overall Study|Withdrawal by Subject|4|||
42133693|NCT00299494|75944597|FG000|Overall Study|Physician Decision|0|||
42133694|NCT00299494|75944598|FG001|Overall Study|Physician Decision|0|||
42133695|NCT00299494|75944599|FG002|Overall Study|Physician Decision|0|||
42133696|NCT00299494|75944600|FG003|Overall Study|Physician Decision|0|||
42133697|NCT00299494|75944601|FG004|Overall Study|Physician Decision|1|||
42133698|NCT00299494|75944602|FG005|Overall Study|Physician Decision|0|||
42133699|NCT00299494|75944597|FG000|Overall Study|Death|3|||
42133700|NCT00299494|75944598|FG001|Overall Study|Death|1|||
42133701|NCT00299494|75944599|FG002|Overall Study|Death|4|||
42260664|NCT02744755|76088087|FG001|Study Period 2|Protocol Violation|0|||
42260665|NCT02744755|76088086|FG000|Study Period 2|not defined|3|||
42260666|NCT02744755|76088087|FG001|Study Period 2|not defined|2|||
42260667|NCT02744755|76088086|FG000|Study Period 2|Lost to Follow-up|0|||
42260668|NCT02744755|76088087|FG001|Study Period 2|Lost to Follow-up|2|||
42260669|NCT02744755|76088086|FG000|Study Period 2|Withdrawal by Subject|2|||
42260670|NCT02744755|76088087|FG001|Study Period 2|Withdrawal by Subject|2|||
42260671|NCT02744755|76088086|FG000|Study Period 2|Lack of Efficacy|3|||
42260672|NCT02744755|76088087|FG001|Study Period 2|Lack of Efficacy|2|||
42260673|NCT01356589|76088101|FG000|Overall Study|Enrolled, but not treated|3|||
42260674|NCT01356589|76088101|FG000|Overall Study|Dose data not recorded|2|||
42260675|NCT02830087|76088111|FG000|Overall Study|No study staff to follow-up patients|4|||
42260676|NCT02830087|76088112|FG001|Overall Study|No study staff to follow-up patients|4|||
42260677|NCT02830087|76088113|FG002|Overall Study|No study staff to follow-up patients|4|||
42260678|NCT02830087|76088114|FG003|Overall Study|No study staff to follow-up patients|3|||
42260679|NCT02830087|76088115|FG004|Overall Study|No study staff to follow-up patients|3|||
42260680|NCT02830087|76088116|FG005|Overall Study|No study staff to follow-up patients|3|||
42260681|NCT02829775|76088139|FG000|Overall Study|Death|1|||
42260682|NCT02829775|76088139|FG000|Overall Study|Withdrawal by Subject|3|||
42260683|NCT02829775|76088139|FG000|Overall Study|Disease remission|1|||
42260684|NCT01355497|76088160|FG000|Overall Study|Death|19|||
42260685|NCT01355497|76088161|FG001|Overall Study|Death|18|||
42260686|NCT01355497|76088160|FG000|Overall Study|Lost to Follow-up|3|||
42260687|NCT01355497|76088161|FG001|Overall Study|Lost to Follow-up|0|||
42324682|NCT02182843|76162189|FG000|Overall Study|Lost to Follow-up|2|||
42324683|NCT02182843|76162189|FG000|Overall Study|Adverse Event|1|||
41995794|NCT01086410|75803803|FG000|Overall Study|Lack of Efficacy|1|||
41995795|NCT01086410|75803804|FG001|Overall Study|Lack of Efficacy|1|||
41995796|NCT01086410|75803805|FG002|Overall Study|Lack of Efficacy|0|||
41995797|NCT01086410|75803806|FG003|Overall Study|Lack of Efficacy|0|||
42260688|NCT01355497|76088160|FG000|Overall Study|Protocol Violation|0|||
42260689|NCT01355497|76088161|FG001|Overall Study|Protocol Violation|1|||
42260690|NCT01355497|76088160|FG000|Overall Study|other-not provided|9|||
42260691|NCT01355497|76088161|FG001|Overall Study|other-not provided|4|||
42133702|NCT00299494|75944600|FG003|Overall Study|Death|6|||
42133703|NCT00299494|75944601|FG004|Overall Study|Death|18|||
42133704|NCT00299494|75944602|FG005|Overall Study|Death|19|||
42133705|NCT00299494|75944597|FG000|Overall Study|Lost to Follow-up|0|||
42133706|NCT00299494|75944598|FG001|Overall Study|Lost to Follow-up|0|||
41995798|NCT01086410|75803803|FG000|Overall Study|Protocol Violation|1|||
42260692|NCT01355497|76088160|FG000|Overall Study|Withdrawal by Subject|12|||
42260693|NCT01355497|76088161|FG001|Overall Study|Withdrawal by Subject|20|||
42324684|NCT02208050|76162195|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
42324685|NCT02208050|76162196|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
42324686|NCT02978222|76162218|FG000|Overall Study|Withdrawal by Subject|2|||
42324687|NCT02978222|76162219|FG001|Overall Study|Withdrawal by Subject|2|||
42324688|NCT02978222|76162218|FG000|Overall Study|Physician Decision|2|||
42324689|NCT02978222|76162219|FG001|Overall Study|Physician Decision|0|||
42324690|NCT02978222|76162218|FG000|Overall Study|Adverse Event|0|||
42324691|NCT02978222|76162219|FG001|Overall Study|Adverse Event|1|||
42324692|NCT02978222|76162218|FG000|Overall Study|Death|1|||
42324693|NCT02978222|76162219|FG001|Overall Study|Death|0|||
42324694|NCT02978222|76162218|FG000|Overall Study|Disease Progression|32|||
42324695|NCT02978222|76162219|FG001|Overall Study|Disease Progression|32|||
42324696|NCT02978222|76162218|FG000|Overall Study|Early Study Termination|24|||
42324697|NCT02978222|76162219|FG001|Overall Study|Early Study Termination|21|||
41995799|NCT01086410|75803804|FG001|Overall Study|Protocol Violation|1|||
41995800|NCT01086410|75803805|FG002|Overall Study|Protocol Violation|0|||
41995801|NCT01086410|75803806|FG003|Overall Study|Protocol Violation|0|||
42260694|NCT01355497|76088160|FG000|Overall Study|noncompliance|1|||
42260695|NCT01355497|76088161|FG001|Overall Study|noncompliance|2|||
42260696|NCT01355497|76088160|FG000|Overall Study|progressive disease|11|||
42260697|NCT01355497|76088161|FG001|Overall Study|progressive disease|8|||
42260698|NCT01355497|76088160|FG000|Overall Study|Adverse Event|11|||
42260699|NCT01355497|76088161|FG001|Overall Study|Adverse Event|10|||
42260700|NCT01355575|76088167|FG000|Overall Study|Withdrawal by Subject|2|||
42324698|NCT02181673|76162227|FG000|Up to Week 24|Adverse Event|2|||
42324699|NCT02181673|76162228|FG001|Up to Week 24|Adverse Event|0|||
41995802|NCT01086410|75803803|FG000|Overall Study|Lost to Follow-up|0|||
41995803|NCT01086410|75803804|FG001|Overall Study|Lost to Follow-up|0|||
41995804|NCT01086410|75803805|FG002|Overall Study|Lost to Follow-up|1|||
41995805|NCT01086410|75803806|FG003|Overall Study|Lost to Follow-up|0|||
42324700|NCT02181673|76162229|FG002|Up to Week 24|Adverse Event|3|||
42324701|NCT02181673|76162227|FG000|Up to Week 24|Death|1|||
42324702|NCT02181673|76162228|FG001|Up to Week 24|Death|0|||
41995806|NCT04553679|75803818|FG000|Overall Study|Withdrawal by Subject|2|||
41995807|NCT04553679|75803819|FG001|Overall Study|Withdrawal by Subject|0|||
41995808|NCT04553679|75803818|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
42260701|NCT02826421|76088179|FG000|Overall Study|Adverse Event|1|||
42260702|NCT02826421|76088180|FG001|Overall Study|Adverse Event|0|||
42260703|NCT02826421|76088181|FG002|Overall Study|Adverse Event|0|||
42260704|NCT02826421|76088182|FG003|Overall Study|Adverse Event|1|||
42324703|NCT02181673|76162229|FG002|Up to Week 24|Death|0|||
42324704|NCT02181673|76162227|FG000|Up to Week 24|Lack of Efficacy|1|||
42324705|NCT02181673|76162228|FG001|Up to Week 24|Lack of Efficacy|0|||
42324706|NCT02181673|76162229|FG002|Up to Week 24|Lack of Efficacy|0|||
42324707|NCT02181673|76162227|FG000|Up to Week 24|Lost to Follow-up|1|||
42324708|NCT02181673|76162228|FG001|Up to Week 24|Lost to Follow-up|0|||
42324709|NCT02181673|76162229|FG002|Up to Week 24|Lost to Follow-up|0|||
42324710|NCT02181673|76162227|FG000|Up to Week 24|Physician Decision|0|||
42324711|NCT02181673|76162228|FG001|Up to Week 24|Physician Decision|0|||
42324712|NCT02181673|76162229|FG002|Up to Week 24|Physician Decision|3|||
42324713|NCT02181673|76162227|FG000|Up to Week 24|Withdrawal by Subject|10|||
42324714|NCT02181673|76162228|FG001|Up to Week 24|Withdrawal by Subject|0|||
42324715|NCT02181673|76162229|FG002|Up to Week 24|Withdrawal by Subject|1|||
42324716|NCT02181673|76162227|FG000|Up to Week 24|Other|2|||
42324717|NCT02181673|76162228|FG001|Up to Week 24|Other|0|||
42324718|NCT02181673|76162229|FG002|Up to Week 24|Other|3|||
42324719|NCT02181673|76162227|FG000|Up to Week 24|Randomized not Treated|0|||
42324720|NCT02181673|76162228|FG001|Up to Week 24|Randomized not Treated|0|||
42324721|NCT02181673|76162229|FG002|Up to Week 24|Randomized not Treated|1|||
42324722|NCT02181673|76162227|FG000|Week 24-Week 60|Adverse Event|0|||
42324723|NCT02181673|76162228|FG001|Week 24-Week 60|Adverse Event|4|||
42324724|NCT02181673|76162229|FG002|Week 24-Week 60|Adverse Event|10|||
42324725|NCT02181673|76162227|FG000|Week 24-Week 60|Other|0|||
42324726|NCT02181673|76162228|FG001|Week 24-Week 60|Other|2|||
42324727|NCT02181673|76162229|FG002|Week 24-Week 60|Other|1|||
42324728|NCT02181673|76162227|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
42133707|NCT00299494|75944599|FG002|Overall Study|Lost to Follow-up|0|||
42133708|NCT00299494|75944600|FG003|Overall Study|Lost to Follow-up|0|||
42260705|NCT02826421|76088179|FG000|Overall Study|Withdrawal by Subject|1|||
42260706|NCT02826421|76088180|FG001|Overall Study|Withdrawal by Subject|3|||
42260707|NCT02826421|76088181|FG002|Overall Study|Withdrawal by Subject|1|||
42260708|NCT02826421|76088182|FG003|Overall Study|Withdrawal by Subject|1|||
42260709|NCT02826421|76088179|FG000|Overall Study|Reason not given|1|||
42260710|NCT02826421|76088180|FG001|Overall Study|Reason not given|0|||
42260711|NCT02826421|76088181|FG002|Overall Study|Reason not given|1|||
42260712|NCT02826421|76088182|FG003|Overall Study|Reason not given|0|||
42260713|NCT02825251|76088195|FG000|Overall Study|Adverse Event|0|||
42260714|NCT02825251|76088196|FG001|Overall Study|Adverse Event|1|||
42260715|NCT02825251|76088195|FG000|Overall Study|Lost to Follow-up|0|||
42260716|NCT02825251|76088196|FG001|Overall Study|Lost to Follow-up|1|||
42260717|NCT02825251|76088195|FG000|Overall Study|Withdrawal by Subject|1|||
42260718|NCT02825251|76088196|FG001|Overall Study|Withdrawal by Subject|4|||
42260719|NCT02825251|76088195|FG000|Overall Study|Unclassified|2|||
42260720|NCT02825251|76088196|FG001|Overall Study|Unclassified|0|||
42260721|NCT04860505|76088202|FG000|Overall Study|Lost to Follow-up|2|||
42260722|NCT04063865|76088208|FG000|Overall Study|Physician Decision|1|||
42260723|NCT04063865|76088209|FG001|Overall Study|Physician Decision|3|||
42260724|NCT04063865|76088208|FG000|Overall Study|Study Closed Prior to Completion|4|||
42260725|NCT04063865|76088209|FG001|Overall Study|Study Closed Prior to Completion|4|||
42260726|NCT04063865|76088208|FG000|Overall Study|Withdrawal by Subject|1|||
42260727|NCT04063865|76088209|FG001|Overall Study|Withdrawal by Subject|1|||
42260728|NCT03994211|76088217|FG000|Core Phase|Adverse Event|0|||
42260729|NCT03994211|76088218|FG001|Core Phase|Adverse Event|1|||
42324729|NCT02181673|76162228|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
42324730|NCT02181673|76162229|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
42324731|NCT02181673|76162227|FG000|Week 24-Week 60|Pregnancy|0|||
42260730|NCT03994211|76088219|FG002|Core Phase|Adverse Event|0|||
42260731|NCT03994211|76088217|FG000|Extension Phase|Adverse Event|0|||
42260732|NCT03994211|76088218|FG001|Extension Phase|Adverse Event|0|||
42324732|NCT02181673|76162228|FG001|Week 24-Week 60|Pregnancy|0|||
42324733|NCT02181673|76162229|FG002|Week 24-Week 60|Pregnancy|1|||
42324734|NCT02181673|76162227|FG000|Week 24-Week 60|Lack of Efficacy|0|||
42324735|NCT02181673|76162228|FG001|Week 24-Week 60|Lack of Efficacy|0|||
41995809|NCT04553679|75803819|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
42260733|NCT03994211|76088219|FG002|Extension Phase|Adverse Event|1|||
42260734|NCT03994211|76088217|FG000|Extension Phase|Physician Decision|0|||
42260735|NCT03994211|76088218|FG001|Extension Phase|Physician Decision|0|||
42260736|NCT03994211|76088219|FG002|Extension Phase|Physician Decision|1|||
42260737|NCT03994211|76088217|FG000|Extension Phase|Progressive Disease|0|||
42324736|NCT02181673|76162229|FG002|Week 24-Week 60|Lack of Efficacy|1|||
42260738|NCT03994211|76088218|FG001|Extension Phase|Progressive Disease|0|||
42260739|NCT03994211|76088219|FG002|Extension Phase|Progressive Disease|20|||
42324737|NCT02181673|76162227|FG000|Week 24-Week 60|Lost to Follow-up|0|||
42034387|NCT01040832|75842485|FG001|Overall Study|Withdrawal by Subject|3|||
42133709|NCT00299494|75944601|FG004|Overall Study|Lost to Follow-up|3|||
42133710|NCT00299494|75944602|FG005|Overall Study|Lost to Follow-up|1|||
42133711|NCT00299494|75944597|FG000|Overall Study|Other - Unspecified|0|||
42133712|NCT00299494|75944598|FG001|Overall Study|Other - Unspecified|0|||
42133713|NCT00299494|75944599|FG002|Overall Study|Other - Unspecified|0|||
42133714|NCT00299494|75944600|FG003|Overall Study|Other - Unspecified|0|||
42133715|NCT00299494|75944601|FG004|Overall Study|Other - Unspecified|3|||
42133716|NCT00299494|75944602|FG005|Overall Study|Other - Unspecified|1|||
42133717|NCT00299494|75944597|FG000|Overall Study|Other - site closure|0|||
42133718|NCT00299494|75944598|FG001|Overall Study|Other - site closure|0|||
42133719|NCT00299494|75944599|FG002|Overall Study|Other - site closure|0|||
42133720|NCT00299494|75944600|FG003|Overall Study|Other - site closure|1|||
42133721|NCT00299494|75944601|FG004|Overall Study|Other - site closure|1|||
42133722|NCT00299494|75944602|FG005|Overall Study|Other - site closure|1|||
42133723|NCT00453180|75944629|FG000|Overall Study|Lost to Follow-up|2|||
42133724|NCT00453180|75944630|FG001|Overall Study|Lost to Follow-up|1|||
42133725|NCT00453180|75944629|FG000|Overall Study|Adverse Event|1|||
42133726|NCT00453180|75944630|FG001|Overall Study|Adverse Event|2|||
42133727|NCT00464178|75944636|FG000|Overall Study|Protocol Violation|1|||
42133728|NCT00464178|75944636|FG000|Overall Study|Withdrawal by Subject|1|||
42034388|NCT01040832|75842484|FG000|Overall Study|Progressive disease|32|||
42034389|NCT01040832|75842485|FG001|Overall Study|Progressive disease|17|||
42034390|NCT01040832|75842484|FG000|Overall Study|Symptomatic deterioration|2|||
42133729|NCT00560105|75944643|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
42133730|NCT00560105|75944644|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
42133731|NCT00467610|75944650|FG000|Overall Study|Withdrawal by Subject|1|||
42034391|NCT01040832|75842485|FG001|Overall Study|Symptomatic deterioration|5|||
42133732|NCT00316186|75944654|FG000|Overall Study|Adverse Event|6|||
42133733|NCT00316186|75944654|FG000|Overall Study|Disease Progression|4|||
42133734|NCT00316186|75944654|FG000|Overall Study|Lost to Follow-up|1|||
42133735|NCT00316186|75944654|FG000|Overall Study|Other|1|||
42133736|NCT00453102|75944658|FG000|Overall Study|Withdrawal by Subject|2|||
42133737|NCT00299182|75944669|FG000|Overall Study|Withdrawal by Subject|0|||
42133738|NCT00299182|75944670|FG001|Overall Study|Withdrawal by Subject|0|||
42133739|NCT00299182|75944671|FG002|Overall Study|Withdrawal by Subject|1|||
42133740|NCT00299182|75944672|FG003|Overall Study|Withdrawal by Subject|0|||
42133741|NCT00299182|75944673|FG004|Overall Study|Withdrawal by Subject|1|||
42133742|NCT00299182|75944674|FG005|Overall Study|Withdrawal by Subject|2|||
42133743|NCT00299182|75944675|FG006|Overall Study|Withdrawal by Subject|0|||
42133744|NCT00299182|75944669|FG000|Overall Study|Chemotherapy Changed|0|||
42133745|NCT00299182|75944670|FG001|Overall Study|Chemotherapy Changed|0|||
42133746|NCT00299182|75944671|FG002|Overall Study|Chemotherapy Changed|1|||
42133747|NCT00299182|75944672|FG003|Overall Study|Chemotherapy Changed|0|||
42133748|NCT00299182|75944673|FG004|Overall Study|Chemotherapy Changed|1|||
42133749|NCT00299182|75944674|FG005|Overall Study|Chemotherapy Changed|0|||
42133750|NCT00299182|75944675|FG006|Overall Study|Chemotherapy Changed|1|||
42133751|NCT00299182|75944669|FG000|Overall Study|Adverse Event|0|||
42133752|NCT00299182|75944670|FG001|Overall Study|Adverse Event|0|||
42133753|NCT00299182|75944671|FG002|Overall Study|Adverse Event|0|||
42133754|NCT00299182|75944672|FG003|Overall Study|Adverse Event|0|||
42133755|NCT00299182|75944673|FG004|Overall Study|Adverse Event|0|||
42260740|NCT03994211|76088217|FG000|Extension Phase|Withdrawal by Subject|0|||
42034392|NCT01040832|75842484|FG000|Overall Study|Other|2|||
42034393|NCT01040832|75842485|FG001|Overall Study|Other|1|||
42034394|NCT00854581|75842491|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
42034395|NCT00854581|75842491|FG000|Induction (Up to Day 21)|Death|1|||
42034396|NCT00854581|75842491|FG000|Induction (Up to Day 21)|Physician Decision|1|||
42034397|NCT00854581|75842491|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
42133756|NCT00299182|75944674|FG005|Overall Study|Adverse Event|1|||
42133757|NCT00299182|75944675|FG006|Overall Study|Adverse Event|0|||
42133758|NCT00299182|75944669|FG000|Overall Study|Not Eligible|0|||
42133759|NCT00299182|75944670|FG001|Overall Study|Not Eligible|0|||
42260741|NCT03994211|76088218|FG001|Extension Phase|Withdrawal by Subject|0|||
42260742|NCT03994211|76088219|FG002|Extension Phase|Withdrawal by Subject|2|||
42260743|NCT03818607|76088234|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
42034398|NCT00833911|75842500|FG000|Titration|Adverse Event|18|||
42034399|NCT00833911|75842500|FG000|Titration|Withdrawal by Subject|3|||
42034400|NCT00833911|75842500|FG000|Maintenance Phase I|Adverse Event|73|||
42034401|NCT00833911|75842500|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
42034402|NCT00833911|75842500|FG000|Maintenance Phase I|Physician Decision|10|||
42133760|NCT00299182|75944671|FG002|Overall Study|Not Eligible|0|||
42133761|NCT00299182|75944672|FG003|Overall Study|Not Eligible|0|||
42133762|NCT00299182|75944673|FG004|Overall Study|Not Eligible|1|||
42133763|NCT00299182|75944674|FG005|Overall Study|Not Eligible|0|||
42133764|NCT00299182|75944675|FG006|Overall Study|Not Eligible|0|||
42133765|NCT00467142|75944693|FG000|Overall Study|Withdrawal by Subject|1|||
42133766|NCT00467142|75944693|FG000|Overall Study|Adverse Event|1|||
42324738|NCT02181673|76162228|FG001|Week 24-Week 60|Lost to Follow-up|0|||
42324739|NCT02181673|76162229|FG002|Week 24-Week 60|Lost to Follow-up|1|||
42324740|NCT02181673|76162227|FG000|Week 24-Week 60|Physician Decision|0|||
42324741|NCT02181673|76162228|FG001|Week 24-Week 60|Physician Decision|0|||
42324742|NCT02181673|76162229|FG002|Week 24-Week 60|Physician Decision|1|||
42324743|NCT02131129|76162238|FG000|Overall Study|Withdrawal by Subject|1|||
42324744|NCT02131129|76162239|FG001|Overall Study|Withdrawal by Subject|0|||
42324745|NCT02152345|76162247|FG000|Overall Study|Case Cancellations|2|||
42324746|NCT02152345|76162248|FG001|Overall Study|Case Cancellations|4|||
42324747|NCT02152345|76162247|FG000|Overall Study|Withdrawal by Subject|2|||
42324748|NCT02152345|76162248|FG001|Overall Study|Withdrawal by Subject|1|||
42324749|NCT02180659|76162256|FG000|Overall Study|Adverse Event|1|||
42324750|NCT02180659|76162257|FG001|Overall Study|Adverse Event|0|||
42133767|NCT00467142|75944693|FG000|Overall Study|Protocol Violation|1|||
42133768|NCT00553475|75944700|FG000|Overall Study|Adverse Event|7|||
42133769|NCT00553475|75944701|FG001|Overall Study|Adverse Event|17|||
42133770|NCT00553475|75944702|FG002|Overall Study|Adverse Event|13|||
42133771|NCT00553475|75944700|FG000|Overall Study|Lack of Efficacy|7|||
42133772|NCT00553475|75944701|FG001|Overall Study|Lack of Efficacy|1|||
42133773|NCT00553475|75944702|FG002|Overall Study|Lack of Efficacy|0|||
42133774|NCT00553475|75944700|FG000|Overall Study|Withdrawal by Subject|1|||
42260744|NCT03818607|76088235|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
42260745|NCT03818607|76088234|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
42324751|NCT02180659|76162256|FG000|Overall Study|Lost to Follow-up|4|||
42324752|NCT02180659|76162257|FG001|Overall Study|Lost to Follow-up|2|||
42260746|NCT03818607|76088235|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
42260747|NCT03818607|76088234|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
42260748|NCT03818607|76088235|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
42260749|NCT02422615|76088275|FG000|Treatment Period|Progressive disease|314|||
42260750|NCT02422615|76088276|FG001|Treatment Period|Progressive disease|200|||
42260751|NCT02422615|76088275|FG000|Treatment Period|Adverse Event|51|||
42260752|NCT02422615|76088276|FG001|Treatment Period|Adverse Event|9|||
42260753|NCT02422615|76088275|FG000|Treatment Period|Physician Decision|32|||
42260754|NCT02422615|76088276|FG001|Treatment Period|Physician Decision|8|||
42260755|NCT02422615|76088275|FG000|Treatment Period|Subject/guardian decision|38|||
42260756|NCT02422615|76088276|FG001|Treatment Period|Subject/guardian decision|8|||
42260757|NCT02422615|76088275|FG000|Treatment Period|Death|2|||
42260758|NCT02422615|76088276|FG001|Treatment Period|Death|1|||
42260759|NCT02422615|76088275|FG000|Treatment Period|Technical problems|0|||
42260760|NCT02422615|76088276|FG001|Treatment Period|Technical problems|1|||
42260761|NCT02422615|76088275|FG000|Treatment Period|Protocol deviation|1|||
42260762|NCT02422615|76088276|FG001|Treatment Period|Protocol deviation|1|||
42260763|NCT02422615|76088275|FG000|Treatment Period|Study terminated as per protocol|46|||
42260764|NCT02422615|76088276|FG001|Treatment Period|Study terminated as per protocol|14|||
42260765|NCT02422615|76088275|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
42260766|NCT02422615|76088276|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
42324753|NCT02180659|76162256|FG000|Overall Study|Subject incarcerated during conduct|1|||
42260767|NCT02422615|76088275|FG000|Post-treatment Efficacy Follow-up|Death|2|||
42260768|NCT02422615|76088276|FG001|Post-treatment Efficacy Follow-up|Death|1|||
42260769|NCT02422615|76088275|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
42260770|NCT02422615|76088276|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
42324754|NCT02180659|76162257|FG001|Overall Study|Subject incarcerated during conduct|0|||
42324755|NCT02180659|76162256|FG000|Overall Study|Withdrawal by Subject|0|||
42133775|NCT00553475|75944701|FG001|Overall Study|Withdrawal by Subject|1|||
42133776|NCT00553475|75944702|FG002|Overall Study|Withdrawal by Subject|0|||
42324756|NCT02180659|76162257|FG001|Overall Study|Withdrawal by Subject|2|||
42324757|NCT02180659|76162256|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
42324758|NCT02180659|76162257|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
42324759|NCT02130427|76162263|FG000|Overall Study|Imaging results not interpretable|30|||
42324760|NCT02207816|76162270|FG000|Overall Study|Serious Adverse Event|0|||
42324761|NCT02207816|76162271|FG001|Overall Study|Serious Adverse Event|5|||
42324762|NCT02207816|76162272|FG002|Overall Study|Serious Adverse Event|2|||
42133777|NCT00553475|75944700|FG000|Overall Study|Physician Decision|1|||
42133778|NCT00553475|75944701|FG001|Overall Study|Physician Decision|0|||
42133779|NCT00553475|75944702|FG002|Overall Study|Physician Decision|0|||
42133780|NCT00553475|75944700|FG000|Overall Study|Due to moving|0|||
42133781|NCT00553475|75944701|FG001|Overall Study|Due to moving|1|||
42133782|NCT00553475|75944702|FG002|Overall Study|Due to moving|0|||
42133783|NCT00329602|75944714|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
42133784|NCT00329602|75944715|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
42133785|NCT00329602|75944716|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
42324763|NCT02207816|76162270|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
42324764|NCT02207816|76162271|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
42133786|NCT00329602|75944714|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
42133787|NCT00329602|75944715|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
42260771|NCT02422615|76088275|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
42260772|NCT02422615|76088276|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
42260773|NCT02422615|76088275|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
42260774|NCT02422615|76088276|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
42260775|NCT02422615|76088275|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
42260776|NCT02422615|76088276|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
42260777|NCT02382406|76088291|FG000|Study Treatment|Disease Progression|8|||
42260778|NCT02382406|76088292|FG001|Study Treatment|Disease Progression|0|||
42260779|NCT02382406|76088293|FG002|Study Treatment|Disease Progression|20|||
42260780|NCT02382406|76088291|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
42260781|NCT02382406|76088292|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
42260782|NCT02382406|76088293|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
42260783|NCT02382406|76088291|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
42260784|NCT02382406|76088292|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
42260785|NCT02382406|76088293|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
42260786|NCT02382406|76088291|FG000|Study Treatment|symptomatic deterioration|1|||
42260787|NCT02382406|76088292|FG001|Study Treatment|symptomatic deterioration|0|||
42324765|NCT02207816|76162272|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
42324766|NCT02207816|76162270|FG000|Overall Study|Withdrawal by Subject|4|||
42324767|NCT02207816|76162271|FG001|Overall Study|Withdrawal by Subject|9|||
42324768|NCT02207816|76162272|FG002|Overall Study|Withdrawal by Subject|7|||
42324769|NCT02207816|76162270|FG000|Overall Study|Migrated/Moved From Study Area|41|||
42324770|NCT02207816|76162271|FG001|Overall Study|Migrated/Moved From Study Area|60|||
42324771|NCT02207816|76162272|FG002|Overall Study|Migrated/Moved From Study Area|51|||
42324772|NCT02207816|76162270|FG000|Overall Study|Lost to Follow-up|3|||
42324773|NCT02207816|76162271|FG001|Overall Study|Lost to Follow-up|9|||
42324774|NCT02207816|76162272|FG002|Overall Study|Lost to Follow-up|1|||
42324775|NCT02207816|76162270|FG000|Overall Study|Other|1|||
42324776|NCT02207816|76162271|FG001|Overall Study|Other|2|||
42324777|NCT02207816|76162272|FG002|Overall Study|Other|4|||
42324778|NCT02241512|76162285|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
42324779|NCT02241512|76162286|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
42324780|NCT02205476|76162294|FG000|Overall Study|Study termination by Sponsor|7|||
42324781|NCT02205476|76162295|FG001|Overall Study|Study termination by Sponsor|3|||
42324782|NCT01709110|76162309|FG000|Overall Study|Adverse Event|56|||
42324783|NCT01709110|76162310|FG001|Overall Study|Adverse Event|48|||
42324784|NCT01709110|76162309|FG000|Overall Study|Death|14|||
42324785|NCT01709110|76162310|FG001|Overall Study|Death|6|||
42324786|NCT01709110|76162309|FG000|Overall Study|Lost to Follow-up|7|||
42324787|NCT01709110|76162310|FG001|Overall Study|Lost to Follow-up|5|||
42324788|NCT01709110|76162309|FG000|Overall Study|Protocol Violation|4|||
42324789|NCT01709110|76162310|FG001|Overall Study|Protocol Violation|6|||
42324790|NCT01709110|76162309|FG000|Overall Study|Withdrawal by Subject|96|||
42324791|NCT01709110|76162310|FG001|Overall Study|Withdrawal by Subject|89|||
42324792|NCT01709110|76162309|FG000|Overall Study|Physician Decision|4|||
42324793|NCT01709110|76162310|FG001|Overall Study|Physician Decision|10|||
42324794|NCT01709110|76162309|FG000|Overall Study|Sponsor Decision|2|||
42324795|NCT01709110|76162310|FG001|Overall Study|Sponsor Decision|2|||
42324796|NCT01709110|76162309|FG000|Overall Study|Lack of Efficacy|1|||
42324797|NCT01709110|76162310|FG001|Overall Study|Lack of Efficacy|1|||
42324798|NCT01709110|76162309|FG000|Overall Study|Caregiver Decision|1|||
42324799|NCT01709110|76162310|FG001|Overall Study|Caregiver Decision|1|||
42324800|NCT02240108|76162318|FG000|Overall Study|Other than specified|8|||
42324801|NCT02240108|76162319|FG001|Overall Study|Other than specified|6|||
42324802|NCT02240108|76162318|FG000|Overall Study|Adverse Event|1|||
42324803|NCT02240108|76162319|FG001|Overall Study|Adverse Event|9|||
42324804|NCT02240108|76162318|FG000|Overall Study|Pregnancy|1|||
42324805|NCT02240108|76162319|FG001|Overall Study|Pregnancy|0|||
42324806|NCT02240108|76162318|FG000|Overall Study|Withdrawal by Subject|4|||
42324807|NCT02240108|76162319|FG001|Overall Study|Withdrawal by Subject|9|||
42324808|NCT02240108|76162318|FG000|Overall Study|StudyTerminated by Sponsor|0|||
42324809|NCT02240108|76162319|FG001|Overall Study|StudyTerminated by Sponsor|1|||
42324810|NCT02239640|76162325|FG000|Overall Study|Withdrawal by Subject|3|||
42324811|NCT02239640|76162325|FG000|Overall Study|Lost to Follow-up|72|||
41995810|NCT01086215|75803833|FG000|Overall Study|Death|14|||
41995811|NCT01086215|75803834|FG001|Overall Study|Death|8|||
41995812|NCT01086215|75803835|FG002|Overall Study|Death|8|||
41995813|NCT01086215|75803836|FG003|Overall Study|Death|1|||
41995814|NCT01086215|75803833|FG000|Overall Study|Lost to Follow-up|22|||
41995815|NCT01086215|75803834|FG001|Overall Study|Lost to Follow-up|39|||
41995816|NCT01086215|75803835|FG002|Overall Study|Lost to Follow-up|18|||
41995817|NCT01086215|75803836|FG003|Overall Study|Lost to Follow-up|2|||
41995818|NCT01085591|75803849|FG000|Overall Study|Adverse Event|0|||
41995819|NCT01085591|75803850|FG001|Overall Study|Adverse Event|1|||
41995820|NCT01085591|75803851|FG002|Overall Study|Adverse Event|3|||
41995821|NCT01085591|75803849|FG000|Overall Study|Physician Decision|1|||
41995822|NCT01085591|75803850|FG001|Overall Study|Physician Decision|0|||
41995823|NCT01085591|75803851|FG002|Overall Study|Physician Decision|1|||
41995824|NCT01085591|75803849|FG000|Overall Study|Withdrawal by Subject|0|||
41995825|NCT01085591|75803850|FG001|Overall Study|Withdrawal by Subject|2|||
41995826|NCT01085591|75803851|FG002|Overall Study|Withdrawal by Subject|1|||
41995827|NCT01085591|75803849|FG000|Overall Study|Lost to Follow-up|0|||
41995828|NCT01085591|75803850|FG001|Overall Study|Lost to Follow-up|1|||
41995829|NCT01085591|75803851|FG002|Overall Study|Lost to Follow-up|1|||
41995830|NCT01085591|75803849|FG000|Overall Study|Protocol Violation|1|||
42324812|NCT02239640|76162325|FG000|Overall Study|Death|142|||
42324813|NCT01590628|76162337|FG000|Overall Study|Death|2|||
42324814|NCT01590628|76162338|FG001|Overall Study|Death|0|||
42324815|NCT02130193|76162350|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
42324816|NCT02130193|76162351|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
41995831|NCT01085591|75803850|FG001|Overall Study|Protocol Violation|1|||
41995832|NCT01085591|75803851|FG002|Overall Study|Protocol Violation|1|||
41995833|NCT01085591|75803849|FG000|Overall Study|Other|0|||
41995834|NCT01085591|75803850|FG001|Overall Study|Other|1|||
41995835|NCT01085591|75803851|FG002|Overall Study|Other|0|||
42324817|NCT02130193|76162352|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
42324818|NCT02130193|76162350|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
42324819|NCT02130193|76162351|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
41995836|NCT01085591|75803849|FG000|Overall Study|Not Properly Consented|1|||
41995837|NCT01085591|75803850|FG001|Overall Study|Not Properly Consented|0|||
42324820|NCT02130193|76162352|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
42324821|NCT02130193|76162350|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
41995838|NCT01085591|75803851|FG002|Overall Study|Not Properly Consented|0|||
41995839|NCT01085357|75803862|FG000|Overall Study|Adverse Event|1|||
41995840|NCT01085357|75803863|FG001|Overall Study|Adverse Event|1|||
42324822|NCT02130193|76162351|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
42324823|NCT02130193|76162352|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
42324824|NCT02130193|76162350|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
42324825|NCT02130193|76162351|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
42324826|NCT02130193|76162352|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
42324827|NCT01590082|76162363|FG000|Overall Study|Withdrawal by Subject|1|||
42324828|NCT01590082|76162364|FG001|Overall Study|Withdrawal by Subject|0|||
42324829|NCT01590082|76162363|FG000|Overall Study|Ineligible|1|||
42324830|NCT01590082|76162364|FG001|Overall Study|Ineligible|0|||
42324831|NCT01631474|76162375|FG000|Overall Study|Lost to Follow-up|8|||
42324832|NCT01631474|76162376|FG001|Overall Study|Lost to Follow-up|5|||
42324833|NCT01631474|76162377|FG002|Overall Study|Lost to Follow-up|7|||
42324834|NCT01631474|76162378|FG003|Overall Study|Lost to Follow-up|5|||
42324835|NCT01631474|76162379|FG004|Overall Study|Lost to Follow-up|5|||
42324836|NCT01631474|76162375|FG000|Overall Study|Withdrawal by Subject|4|||
42324837|NCT01631474|76162376|FG001|Overall Study|Withdrawal by Subject|4|||
42324838|NCT01631474|76162377|FG002|Overall Study|Withdrawal by Subject|2|||
42324839|NCT01631474|76162378|FG003|Overall Study|Withdrawal by Subject|6|||
42324840|NCT01631474|76162379|FG004|Overall Study|Withdrawal by Subject|5|||
42324841|NCT01631474|76162375|FG000|Overall Study|Lack of Efficacy|2|||
42324842|NCT01631474|76162376|FG001|Overall Study|Lack of Efficacy|2|||
42324843|NCT01631474|76162377|FG002|Overall Study|Lack of Efficacy|0|||
42324844|NCT01631474|76162378|FG003|Overall Study|Lack of Efficacy|0|||
42324845|NCT01631474|76162379|FG004|Overall Study|Lack of Efficacy|2|||
42324846|NCT01631474|76162375|FG000|Overall Study|Noncompliance with Study Drug|0|||
42324847|NCT01631474|76162376|FG001|Overall Study|Noncompliance with Study Drug|0|||
42324848|NCT01631474|76162377|FG002|Overall Study|Noncompliance with Study Drug|0|||
42324849|NCT01631474|76162378|FG003|Overall Study|Noncompliance with Study Drug|0|||
42324850|NCT01631474|76162379|FG004|Overall Study|Noncompliance with Study Drug|1|||
42324851|NCT01631474|76162375|FG000|Overall Study|Adverse Event|0|||
42324852|NCT01631474|76162376|FG001|Overall Study|Adverse Event|1|||
42324853|NCT01631474|76162377|FG002|Overall Study|Adverse Event|0|||
42324854|NCT01631474|76162378|FG003|Overall Study|Adverse Event|0|||
42324855|NCT01631474|76162379|FG004|Overall Study|Adverse Event|0|||
42324856|NCT02203916|76162394|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
42324857|NCT02203916|76162395|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
42324858|NCT02203916|76162396|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
42324859|NCT02203916|76162394|FG000|Overall Study|Major Protocol Deviation|1|||
42324860|NCT02203916|76162395|FG001|Overall Study|Major Protocol Deviation|1|||
42324861|NCT02203916|76162396|FG002|Overall Study|Major Protocol Deviation|0|||
42324862|NCT02203916|76162394|FG000|Overall Study|Lost to Follow-up|0|||
42324863|NCT02203916|76162395|FG001|Overall Study|Lost to Follow-up|1|||
42324864|NCT02203916|76162396|FG002|Overall Study|Lost to Follow-up|0|||
42324865|NCT02203916|76162394|FG000|Overall Study|Voluntary Withdrawal|3|||
42324866|NCT02203916|76162395|FG001|Overall Study|Voluntary Withdrawal|3|||
42324867|NCT02203916|76162396|FG002|Overall Study|Voluntary Withdrawal|8|||
42324868|NCT02203916|76162394|FG000|Overall Study|Lack of Efficacy|3|||
41995841|NCT01085357|75803862|FG000|Overall Study|Subject Decision|4|||
41995842|NCT01085357|75803863|FG001|Overall Study|Subject Decision|3|||
41995843|NCT01085357|75803862|FG000|Overall Study|Investigator Decision|1|||
41995844|NCT01085357|75803863|FG001|Overall Study|Investigator Decision|1|||
41995845|NCT01085357|75803862|FG000|Overall Study|Death|11|||
41995846|NCT01085357|75803863|FG001|Overall Study|Death|1|||
41995847|NCT01085357|75803862|FG000|Overall Study|Lost to Follow-up|2|||
41995848|NCT01085357|75803863|FG001|Overall Study|Lost to Follow-up|0|||
41995849|NCT01085201|75803874|FG000|Overall Study|Scheduling conflict|1|||
41995850|NCT01085201|75803875|FG001|Overall Study|Scheduling conflict|0|||
41995851|NCT01085201|75803876|FG002|Overall Study|Scheduling conflict|1|||
41995852|NCT01085201|75803877|FG003|Overall Study|Scheduling conflict|0|||
41995853|NCT01085201|75803878|FG004|Overall Study|Scheduling conflict|0|||
42324869|NCT02203916|76162395|FG001|Overall Study|Lack of Efficacy|0|||
42324870|NCT02203916|76162396|FG002|Overall Study|Lack of Efficacy|0|||
42324871|NCT02203916|76162394|FG000|Overall Study|Reason Not Specified|0|||
42324872|NCT02203916|76162395|FG001|Overall Study|Reason Not Specified|2|||
42324873|NCT02203916|76162396|FG002|Overall Study|Reason Not Specified|1|||
42324874|NCT02179177|76162420|FG000|Overall Study|Lost to Follow-up|1|||
42324875|NCT02179177|76162421|FG001|Overall Study|Lost to Follow-up|1|||
41995854|NCT01085201|75803874|FG000|Overall Study|Unknown- no study drug|2|||
42324876|NCT02179177|76162420|FG000|Overall Study|Withdrawal by Subject|1|||
42324877|NCT02179177|76162421|FG001|Overall Study|Withdrawal by Subject|1|||
42324878|NCT02239328|76162427|FG000|Overall Study|Benign disease noted at time of surgery|6|||
42324879|NCT02239328|76162427|FG000|Overall Study|Equipment or website malfunction|2|||
42324880|NCT02129803|76162433|FG000|Overall Study|Protocol Violation|4|||
42324881|NCT02129803|76162434|FG001|Overall Study|Protocol Violation|0|||
42324882|NCT02129803|76162433|FG000|Overall Study|Physician Decision|0|||
42324883|NCT02129803|76162434|FG001|Overall Study|Physician Decision|1|||
42324884|NCT02129803|76162433|FG000|Overall Study|Difficulty sleeping|1|||
41995855|NCT01085201|75803875|FG001|Overall Study|Unknown- no study drug|0|||
41995856|NCT01085201|75803876|FG002|Overall Study|Unknown- no study drug|0|||
42133788|NCT00329602|75944716|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
42133789|NCT00329602|75944714|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
42133790|NCT00329602|75944715|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
42133791|NCT00329602|75944716|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
42133792|NCT00329602|75944714|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
42133793|NCT00329602|75944715|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
42133794|NCT00329602|75944716|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
42260788|NCT02382406|76088293|FG002|Study Treatment|symptomatic deterioration|1|||
42260789|NCT02382406|76088291|FG000|Study Treatment|Death|0|||
42260790|NCT02382406|76088292|FG001|Study Treatment|Death|0|||
42260791|NCT02382406|76088293|FG002|Study Treatment|Death|2|||
42260792|NCT02382406|76088291|FG000|Follow up|Death|11|||
42260793|NCT02382406|76088292|FG001|Follow up|Death|0|||
42260794|NCT02382406|76088293|FG002|Follow up|Death|19|||
42260795|NCT02382406|76088291|FG000|Follow up|Symptomatic deterioration|1|||
42260796|NCT02382406|76088292|FG001|Follow up|Symptomatic deterioration|0|||
42260797|NCT02382406|76088293|FG002|Follow up|Symptomatic deterioration|1|||
42260798|NCT02382406|76088291|FG000|Follow up|Patient Refused Follow-up|1|||
42260799|NCT02382406|76088292|FG001|Follow up|Patient Refused Follow-up|0|||
42260800|NCT02382406|76088293|FG002|Follow up|Patient Refused Follow-up|0|||
42260801|NCT02382406|76088291|FG000|Follow up|Study Terminated|1|||
42260802|NCT02382406|76088292|FG001|Follow up|Study Terminated|0|||
42260803|NCT02382406|76088293|FG002|Follow up|Study Terminated|8|||
42260804|NCT02382406|76088291|FG000|Follow up|Withdrawal by Subject|0|||
42260805|NCT02382406|76088292|FG001|Follow up|Withdrawal by Subject|0|||
42260806|NCT02382406|76088293|FG002|Follow up|Withdrawal by Subject|2|||
42260807|NCT02101268|76088313|FG000|Randomized Treatment Phase|Subject Decision|8|||
42260808|NCT02101268|76088314|FG001|Randomized Treatment Phase|Subject Decision|4|||
42260809|NCT02101268|76088315|FG002|Randomized Treatment Phase|Subject Decision|0|||
42260810|NCT02101268|76088316|FG003|Randomized Treatment Phase|Subject Decision|0|||
42260811|NCT02101268|76088313|FG000|Randomized Treatment Phase|Physician Decision|4|||
42260812|NCT02101268|76088314|FG001|Randomized Treatment Phase|Physician Decision|1|||
42260813|NCT02101268|76088315|FG002|Randomized Treatment Phase|Physician Decision|0|||
42260814|NCT02101268|76088316|FG003|Randomized Treatment Phase|Physician Decision|0|||
42260815|NCT02101268|76088313|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
42260816|NCT02101268|76088314|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
42260817|NCT02101268|76088315|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
42260818|NCT02101268|76088316|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
42260819|NCT02101268|76088313|FG000|Randomized Treatment Phase|Adverse Event|6|||
42260820|NCT02101268|76088314|FG001|Randomized Treatment Phase|Adverse Event|0|||
42260821|NCT02101268|76088315|FG002|Randomized Treatment Phase|Adverse Event|0|||
42260822|NCT02101268|76088316|FG003|Randomized Treatment Phase|Adverse Event|0|||
42260823|NCT02101268|76088313|FG000|Randomized Treatment Phase|Death|5|||
42133795|NCT00329602|75944714|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
42260824|NCT02101268|76088314|FG001|Randomized Treatment Phase|Death|4|||
42260825|NCT02101268|76088315|FG002|Randomized Treatment Phase|Death|0|||
42260826|NCT02101268|76088316|FG003|Randomized Treatment Phase|Death|0|||
42260827|NCT02101268|76088313|FG000|Randomized Treatment Phase|Disease Progression|4|||
42260828|NCT02101268|76088314|FG001|Randomized Treatment Phase|Disease Progression|1|||
42260829|NCT02101268|76088315|FG002|Randomized Treatment Phase|Disease Progression|0|||
42133796|NCT00329602|75944715|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
42133797|NCT00329602|75944716|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
42133798|NCT00329602|75944714|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
42133799|NCT00329602|75944715|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
42133800|NCT00329602|75944716|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
42133801|NCT00463866|75944734|FG000|Overall Study|Adverse Event|70|||
42133802|NCT00463866|75944735|FG001|Overall Study|Adverse Event|93|||
42133803|NCT00463866|75944734|FG000|Overall Study|Withdrawal by Subject|81|||
42133804|NCT00463866|75944735|FG001|Overall Study|Withdrawal by Subject|79|||
42133805|NCT00463866|75944734|FG000|Overall Study|Lost to Follow-up|46|||
42133806|NCT00463866|75944735|FG001|Overall Study|Lost to Follow-up|55|||
42133807|NCT00463866|75944734|FG000|Overall Study|Incorrect Enrolment|64|||
42133808|NCT00463866|75944735|FG001|Overall Study|Incorrect Enrolment|66|||
42133809|NCT00463866|75944734|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
42133810|NCT00463866|75944735|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
42260830|NCT02101268|76088316|FG003|Randomized Treatment Phase|Disease Progression|0|||
42260831|NCT02101268|76088313|FG000|Extended Treatment Phase|Subject Decision|0|||
42260832|NCT02101268|76088314|FG001|Extended Treatment Phase|Subject Decision|0|||
42260833|NCT02101268|76088315|FG002|Extended Treatment Phase|Subject Decision|3|||
42260834|NCT02101268|76088316|FG003|Extended Treatment Phase|Subject Decision|2|||
42324885|NCT02129803|76162434|FG001|Overall Study|Difficulty sleeping|0|||
42324886|NCT02129803|76162433|FG000|Overall Study|Morning headache|0|||
42324887|NCT02129803|76162434|FG001|Overall Study|Morning headache|1|||
42324888|NCT02129803|76162433|FG000|Overall Study|Withdrawal by Subject|1|||
42324889|NCT02129803|76162434|FG001|Overall Study|Withdrawal by Subject|1|||
42324890|NCT02239094|76162440|FG000|Overall Study|Withdrawal by Subject|1|||
42324891|NCT02239094|76162440|FG000|Overall Study|Remitted before started|1|||
42324892|NCT02129647|76162444|FG000|Overall Study|Adverse Event|2|||
42324893|NCT02129647|76162444|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
42324894|NCT02238626|76162452|FG000|Overall Study|Adverse Event|3|||
42324895|NCT02238626|76162453|FG001|Overall Study|Adverse Event|5|||
42324896|NCT02238626|76162454|FG002|Overall Study|Adverse Event|0|||
42324897|NCT02238626|76162455|FG003|Overall Study|Adverse Event|3|||
42034403|NCT00833911|75842500|FG000|Maintenance Phase I|Lack of Efficacy|4|||
42260835|NCT02101268|76088313|FG000|Extended Treatment Phase|Physician Decision|0|||
42260836|NCT02101268|76088314|FG001|Extended Treatment Phase|Physician Decision|0|||
42260837|NCT02101268|76088315|FG002|Extended Treatment Phase|Physician Decision|5|||
42260838|NCT02101268|76088316|FG003|Extended Treatment Phase|Physician Decision|2|||
42260839|NCT02101268|76088313|FG000|Extended Treatment Phase|Adverse Event|0|||
42260840|NCT02101268|76088314|FG001|Extended Treatment Phase|Adverse Event|0|||
42260841|NCT02101268|76088315|FG002|Extended Treatment Phase|Adverse Event|14|||
42260842|NCT02101268|76088316|FG003|Extended Treatment Phase|Adverse Event|18|||
42260843|NCT02101268|76088313|FG000|Extended Treatment Phase|Death|0|||
42260844|NCT02101268|76088314|FG001|Extended Treatment Phase|Death|0|||
42260845|NCT02101268|76088315|FG002|Extended Treatment Phase|Death|5|||
42260846|NCT02101268|76088316|FG003|Extended Treatment Phase|Death|1|||
42260847|NCT02101268|76088313|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
42260848|NCT02101268|76088314|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
42260849|NCT02101268|76088315|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
42260850|NCT02101268|76088316|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
42260851|NCT02101268|76088313|FG000|Extended Treatment Phase|Disease Progression|0|||
42260852|NCT02101268|76088314|FG001|Extended Treatment Phase|Disease Progression|0|||
42260853|NCT02101268|76088315|FG002|Extended Treatment Phase|Disease Progression|13|||
42260854|NCT02101268|76088316|FG003|Extended Treatment Phase|Disease Progression|6|||
42260855|NCT02101268|76088313|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
42260856|NCT02101268|76088314|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
42260857|NCT02101268|76088315|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
42260858|NCT02101268|76088316|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
42260859|NCT01898650|76088333|FG000|Overall Study|the subject would not lie still for imaging|1|||
42260860|NCT01880515|76088339|FG000|Overall Study|Lost to Follow-up|3|||
42260861|NCT01880515|76088340|FG001|Overall Study|Lost to Follow-up|2|||
42260862|NCT01880515|76088339|FG000|Overall Study|Disease Progression|5|||
42324898|NCT02238626|76162452|FG000|Overall Study|Lost to Follow-up|2|||
42260863|NCT01880515|76088340|FG001|Overall Study|Disease Progression|7|||
42324899|NCT02238626|76162453|FG001|Overall Study|Lost to Follow-up|4|||
42324900|NCT02238626|76162454|FG002|Overall Study|Lost to Follow-up|2|||
42133811|NCT00463866|75944734|FG000|Overall Study|Safety Reason|1|||
42133812|NCT00463866|75944735|FG001|Overall Study|Safety Reason|3|||
42133813|NCT00463866|75944734|FG000|Overall Study|Mis-Randomization of subject|0|||
42260864|NCT01668719|76088350|FG000|Phase I|On treatment|1|||
42260865|NCT01668719|76088351|FG001|Phase I|On treatment|0|||
42324901|NCT02238626|76162455|FG003|Overall Study|Lost to Follow-up|2|||
42034404|NCT00833911|75842500|FG000|Maintenance Phase II|Adverse Event|6|||
42324902|NCT02238626|76162452|FG000|Overall Study|Withdrawal by Subject|0|||
42324903|NCT02238626|76162453|FG001|Overall Study|Withdrawal by Subject|3|||
42324904|NCT02238626|76162454|FG002|Overall Study|Withdrawal by Subject|0|||
42324905|NCT02238626|76162455|FG003|Overall Study|Withdrawal by Subject|1|||
42324906|NCT02238626|76162452|FG000|Overall Study|Death|0|||
42324907|NCT02238626|76162453|FG001|Overall Study|Death|0|||
42324908|NCT02238626|76162454|FG002|Overall Study|Death|1|||
42324909|NCT02238626|76162455|FG003|Overall Study|Death|1|||
42324910|NCT02238626|76162452|FG000|Overall Study|Other|0|||
42324911|NCT02238626|76162453|FG001|Overall Study|Other|2|||
42324912|NCT02238626|76162454|FG002|Overall Study|Other|0|||
42324913|NCT02238626|76162455|FG003|Overall Study|Other|0|||
42324914|NCT02151643|76162481|FG000|Overall Study|Adverse Event|2|||
42324915|NCT02151643|76162482|FG001|Overall Study|Adverse Event|0|||
42324916|NCT02151643|76162483|FG002|Overall Study|Adverse Event|1|||
42324917|NCT02151643|76162484|FG003|Overall Study|Adverse Event|4|||
42324918|NCT02151643|76162485|FG004|Overall Study|Adverse Event|0|||
42324919|NCT02151643|76162481|FG000|Overall Study|Withdrawal by Subject|0|||
42324920|NCT02151643|76162482|FG001|Overall Study|Withdrawal by Subject|1|||
42324921|NCT02151643|76162483|FG002|Overall Study|Withdrawal by Subject|1|||
42324922|NCT02151643|76162484|FG003|Overall Study|Withdrawal by Subject|1|||
42324923|NCT02151643|76162485|FG004|Overall Study|Withdrawal by Subject|1|||
42324924|NCT02151643|76162481|FG000|Overall Study|Hyperphosphataemia|1|||
42324925|NCT02151643|76162482|FG001|Overall Study|Hyperphosphataemia|0|||
42324926|NCT02151643|76162483|FG002|Overall Study|Hyperphosphataemia|0|||
42324927|NCT02151643|76162484|FG003|Overall Study|Hyperphosphataemia|0|||
42324928|NCT02151643|76162485|FG004|Overall Study|Hyperphosphataemia|1|||
42324929|NCT02151643|76162481|FG000|Overall Study|High Ferritin levels|3|||
42324930|NCT02151643|76162482|FG001|Overall Study|High Ferritin levels|3|||
42324931|NCT02151643|76162483|FG002|Overall Study|High Ferritin levels|2|||
42324932|NCT02151643|76162484|FG003|Overall Study|High Ferritin levels|2|||
42324933|NCT02151643|76162485|FG004|Overall Study|High Ferritin levels|1|||
42324934|NCT02203838|76162501|FG000|Overall Study|Lack of Efficacy|7|||
41995857|NCT01085201|75803877|FG003|Overall Study|Unknown- no study drug|0|||
41995858|NCT01085201|75803878|FG004|Overall Study|Unknown- no study drug|0|||
42260866|NCT01668719|76088352|FG002|Phase I|On treatment|0|||
42260867|NCT01668719|76088350|FG000|Phase I|Adverse Event|2|||
42260868|NCT01668719|76088351|FG001|Phase I|Adverse Event|0|||
42260869|NCT01668719|76088352|FG002|Phase I|Adverse Event|0|||
42260870|NCT01668719|76088350|FG000|Phase I|Progression/relapse|1|||
42260871|NCT01668719|76088351|FG001|Phase I|Progression/relapse|0|||
42260872|NCT01668719|76088352|FG002|Phase I|Progression/relapse|0|||
42260873|NCT01668719|76088350|FG000|Phase I|not protocol specified|2|||
42260874|NCT01668719|76088351|FG001|Phase I|not protocol specified|0|||
42260875|NCT01668719|76088352|FG002|Phase I|not protocol specified|0|||
42260876|NCT01668719|76088350|FG000|Phase II|On treatment|0|||
42260877|NCT01668719|76088351|FG001|Phase II|On treatment|4|||
42324935|NCT02203838|76162502|FG001|Overall Study|Lack of Efficacy|0|||
42324936|NCT02203838|76162503|FG002|Overall Study|Lack of Efficacy|1|||
42324937|NCT02203838|76162504|FG003|Overall Study|Lack of Efficacy|1|||
42324938|NCT02203838|76162501|FG000|Overall Study|Adverse Event|46|||
42324939|NCT02203838|76162502|FG001|Overall Study|Adverse Event|6|||
42324940|NCT02203838|76162503|FG002|Overall Study|Adverse Event|3|||
42324941|NCT02203838|76162504|FG003|Overall Study|Adverse Event|2|||
42324942|NCT02203838|76162501|FG000|Overall Study|Lost to Follow-up|39|||
42324943|NCT02203838|76162502|FG001|Overall Study|Lost to Follow-up|3|||
42260878|NCT01668719|76088352|FG002|Phase II|On treatment|3|||
42260879|NCT01668719|76088350|FG000|Phase II|Adverse Event|0|||
42260880|NCT01668719|76088351|FG001|Phase II|Adverse Event|18|||
42324944|NCT02203838|76162503|FG002|Overall Study|Lost to Follow-up|2|||
42324945|NCT02203838|76162504|FG003|Overall Study|Lost to Follow-up|1|||
42324946|NCT02203838|76162501|FG000|Overall Study|Protocol Violation|7|||
42324947|NCT02203838|76162502|FG001|Overall Study|Protocol Violation|3|||
42324948|NCT02203838|76162503|FG002|Overall Study|Protocol Violation|0|||
42324949|NCT02203838|76162504|FG003|Overall Study|Protocol Violation|0|||
42324950|NCT02203838|76162501|FG000|Overall Study|Withdrawal by Subject|83|||
42324951|NCT02203838|76162502|FG001|Overall Study|Withdrawal by Subject|10|||
42324952|NCT02203838|76162503|FG002|Overall Study|Withdrawal by Subject|8|||
42324953|NCT02203838|76162504|FG003|Overall Study|Withdrawal by Subject|11|||
42324954|NCT02203838|76162501|FG000|Overall Study|Physician Decision|27|||
42324955|NCT02203838|76162502|FG001|Overall Study|Physician Decision|0|||
42324956|NCT02203838|76162503|FG002|Overall Study|Physician Decision|2|||
42324957|NCT02203838|76162504|FG003|Overall Study|Physician Decision|3|||
42133814|NCT00463866|75944735|FG001|Overall Study|Mis-Randomization of subject|1|||
42133815|NCT00463866|75944734|FG000|Overall Study|Other|22|||
42133816|NCT00463866|75944735|FG001|Overall Study|Other|22|||
42133817|NCT00313846|75944743|FG000|Overall Study|Withdrawal by Subject|2|||
42133818|NCT00313846|75944744|FG001|Overall Study|Withdrawal by Subject|0|||
42133819|NCT00313846|75944743|FG000|Overall Study|Adverse Event|1|||
42133820|NCT00313846|75944744|FG001|Overall Study|Adverse Event|8|||
42133821|NCT00313846|75944743|FG000|Overall Study|Administrative|2|||
42133822|NCT00313846|75944744|FG001|Overall Study|Administrative|3|||
42133823|NCT00551135|75944755|FG000|Overall Study|Adverse Event|1|||
42133824|NCT00551135|75944756|FG001|Overall Study|Adverse Event|0|||
42133825|NCT00551135|75944757|FG002|Overall Study|Adverse Event|1|||
42133826|NCT00551135|75944758|FG003|Overall Study|Adverse Event|1|||
42133827|NCT00551135|75944755|FG000|Overall Study|Lost to Follow-up|0|||
42133828|NCT00551135|75944756|FG001|Overall Study|Lost to Follow-up|0|||
42133829|NCT00551135|75944757|FG002|Overall Study|Lost to Follow-up|0|||
42133830|NCT00551135|75944758|FG003|Overall Study|Lost to Follow-up|1|||
42133831|NCT00551135|75944755|FG000|Overall Study|Other|3|||
42133832|NCT00551135|75944756|FG001|Overall Study|Other|2|||
42133833|NCT00551135|75944757|FG002|Overall Study|Other|1|||
42133834|NCT00551135|75944758|FG003|Overall Study|Other|2|||
42133835|NCT00551135|75944755|FG000|Overall Study|Withdrawal by Subject|1|||
42324958|NCT02203838|76162501|FG000|Overall Study|Other|1|||
42324959|NCT02203838|76162502|FG001|Overall Study|Other|0|||
42324960|NCT02203838|76162503|FG002|Overall Study|Other|0|||
42324961|NCT02203838|76162504|FG003|Overall Study|Other|0|||
42133836|NCT00551135|75944756|FG001|Overall Study|Withdrawal by Subject|0|||
42133837|NCT00551135|75944757|FG002|Overall Study|Withdrawal by Subject|3|||
42133838|NCT00551135|75944758|FG003|Overall Study|Withdrawal by Subject|1|||
42133839|NCT00299104|75944771|FG000|Treatment Period|Adverse Event|14|||
42133840|NCT00299104|75944772|FG001|Treatment Period|Adverse Event|9|||
42133841|NCT00299104|75944773|FG002|Treatment Period|Adverse Event|7|||
42133842|NCT00299104|75944771|FG000|Treatment Period|Death|1|||
42133843|NCT00299104|75944772|FG001|Treatment Period|Death|1|||
42260881|NCT01668719|76088352|FG002|Phase II|Adverse Event|18|||
42260882|NCT01668719|76088350|FG000|Phase II|Refusal unrelated to adverse event|0|||
42260883|NCT01668719|76088351|FG001|Phase II|Refusal unrelated to adverse event|4|||
42260884|NCT01668719|76088352|FG002|Phase II|Refusal unrelated to adverse event|1|||
42260885|NCT01668719|76088350|FG000|Phase II|Progression/relapse|0|||
42260886|NCT01668719|76088351|FG001|Phase II|Progression/relapse|13|||
42260887|NCT01668719|76088352|FG002|Phase II|Progression/relapse|17|||
42260888|NCT01668719|76088350|FG000|Phase II|Death|0|||
42260889|NCT01668719|76088351|FG001|Phase II|Death|0|||
42260890|NCT01668719|76088352|FG002|Phase II|Death|2|||
42260891|NCT01668719|76088350|FG000|Phase II|not protocol specified|0|||
42260892|NCT01668719|76088351|FG001|Phase II|not protocol specified|13|||
41995859|NCT01085201|75803874|FG000|Overall Study|Fond ineligible after consent|0|||
42133844|NCT00299104|75944773|FG002|Treatment Period|Death|1|||
42260893|NCT01668719|76088352|FG002|Phase II|not protocol specified|7|||
42260894|NCT01642901|76088364|FG000|12-month Follow-up|Withdrawal by Subject|1|||
42324962|NCT02178787|76162516|FG000|Overall Study|Lost to Follow-up|1|||
42133845|NCT00299104|75944771|FG000|Treatment Period|Insufficient therapeutic response|34|||
41995860|NCT01085201|75803875|FG001|Overall Study|Fond ineligible after consent|1|||
42133846|NCT00299104|75944772|FG001|Treatment Period|Insufficient therapeutic response|13|||
42133847|NCT00299104|75944773|FG002|Treatment Period|Insufficient therapeutic response|8|||
42133848|NCT00299104|75944771|FG000|Treatment Period|Failure to return|9|||
42133849|NCT00299104|75944772|FG001|Treatment Period|Failure to return|8|||
42133850|NCT00299104|75944773|FG002|Treatment Period|Failure to return|8|||
42133851|NCT00299104|75944771|FG000|Treatment Period|Violation of selection criteria|1|||
42133852|NCT00299104|75944772|FG001|Treatment Period|Violation of selection criteria|2|||
42260895|NCT01642901|76088365|FG001|12-month Follow-up|Withdrawal by Subject|0|||
42260896|NCT01488045|76088373|FG000|Overall Study|Withdrawal by Subject|6|||
42324963|NCT02178787|76162517|FG001|Overall Study|Lost to Follow-up|0|||
42324964|NCT02178787|76162516|FG000|Overall Study|Withdrawal by Subject|0|||
42324965|NCT02178787|76162517|FG001|Overall Study|Withdrawal by Subject|2|||
42133853|NCT00299104|75944773|FG002|Treatment Period|Violation of selection criteria|0|||
42133854|NCT00299104|75944771|FG000|Treatment Period|Protocol Violation|1|||
42133855|NCT00299104|75944772|FG001|Treatment Period|Protocol Violation|1|||
42324966|NCT02178787|76162516|FG000|Overall Study|No TCD window|3|||
42324967|NCT02178787|76162517|FG001|Overall Study|No TCD window|7|||
42324968|NCT02178787|76162516|FG000|Overall Study|Physician Decision|1|||
42324969|NCT02178787|76162517|FG001|Overall Study|Physician Decision|0|||
42324970|NCT02178709|76162525|FG000|Overall Study|Adverse Event|5|||
42324971|NCT02178709|76162525|FG000|Overall Study|Death|2|||
42324972|NCT02178709|76162525|FG000|Overall Study|Withdrawal by Subject|2|||
42324973|NCT02178709|76162525|FG000|Overall Study|Physician Decision|2|||
42324974|NCT02178709|76162525|FG000|Overall Study|Disease Progression|5|||
42324975|NCT02238080|76162529|FG000|Overall Study|Death|13|||
42324976|NCT02238080|76162529|FG000|Overall Study|Treatment interrupted|6|||
42324977|NCT02238080|76162529|FG000|Overall Study|Withdrawal by Subject|2|||
42324978|NCT02238080|76162529|FG000|Overall Study|Other|4|||
42324979|NCT02150863|76162536|FG000|Overall Study|Lost to Follow-up|0|||
42133856|NCT00299104|75944773|FG002|Treatment Period|Protocol Violation|0|||
42260897|NCT01488045|76088374|FG001|Overall Study|Withdrawal by Subject|11|||
42324980|NCT02150863|76162537|FG001|Overall Study|Lost to Follow-up|1|||
42324981|NCT02150863|76162538|FG002|Overall Study|Lost to Follow-up|0|||
42324982|NCT02178553|76162548|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
42324983|NCT02178553|76162549|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
42324984|NCT02178553|76162548|FG000|Overall Study|Physician Decision|0|||
42324985|NCT02178553|76162549|FG001|Overall Study|Physician Decision|4|||
42324986|NCT02178553|76162548|FG000|Overall Study|Technical problem with injection|1|||
42324987|NCT02178553|76162549|FG001|Overall Study|Technical problem with injection|3|||
42324988|NCT01627327|76162557|FG000|Overall Study|Adverse Event|6|||
42324989|NCT01627327|76162558|FG001|Overall Study|Adverse Event|12|||
42324990|NCT01627327|76162557|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
42324991|NCT01627327|76162558|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
42324992|NCT01627327|76162557|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
42324993|NCT01627327|76162558|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
42260898|NCT01488045|76088373|FG000|Overall Study|Failure to present for colonoscopy|3|||
42260899|NCT01488045|76088374|FG001|Overall Study|Failure to present for colonoscopy|6|||
42260900|NCT01488045|76088373|FG000|Overall Study|Failure to report exclusion criteria|0|||
42260901|NCT01488045|76088374|FG001|Overall Study|Failure to report exclusion criteria|1|||
42260902|NCT00946712|76088393|FG000|Overall Study|Adverse Event|118|||
42260903|NCT00946712|76088394|FG001|Overall Study|Adverse Event|124|||
42260904|NCT00946712|76088393|FG000|Overall Study|Disease progression|308|||
42260905|NCT00946712|76088394|FG001|Overall Study|Disease progression|404|||
41995861|NCT01085201|75803876|FG002|Overall Study|Fond ineligible after consent|1|||
41995862|NCT01085201|75803877|FG003|Overall Study|Fond ineligible after consent|0|||
41995863|NCT01085201|75803878|FG004|Overall Study|Fond ineligible after consent|0|||
41995864|NCT01085084|75803898|FG000|Overall Study|Withdrawal by Subject|1|||
41995865|NCT01085084|75803899|FG001|Overall Study|Withdrawal by Subject|0|||
41995866|NCT01085084|75803900|FG002|Overall Study|Withdrawal by Subject|0|||
41995867|NCT01085084|75803898|FG000|Overall Study|Lost to Follow-up|2|||
41995868|NCT01085084|75803899|FG001|Overall Study|Lost to Follow-up|1|||
42133857|NCT00299104|75944771|FG000|Treatment Period|Refused treatment|9|||
42260906|NCT00946712|76088393|FG000|Overall Study|Death|21|||
42260907|NCT00946712|76088394|FG001|Overall Study|Death|22|||
42260908|NCT00946712|76088393|FG000|Overall Study|No treatment given|25|||
42260909|NCT00946712|76088394|FG001|Overall Study|No treatment given|29|||
42260910|NCT00946712|76088393|FG000|Overall Study|Other reasons|61|||
42260911|NCT00946712|76088394|FG001|Overall Study|Other reasons|73|||
42260912|NCT00946712|76088393|FG000|Overall Study|On Treatment|0|||
42260913|NCT00946712|76088394|FG001|Overall Study|On Treatment|4|||
42260914|NCT00946712|76088393|FG000|Overall Study|Ineligible|14|||
42324994|NCT01627327|76162557|FG000|Overall Study|Protocol Violation|4|||
41995869|NCT01085084|75803900|FG002|Overall Study|Lost to Follow-up|1|||
42133858|NCT00299104|75944772|FG001|Treatment Period|Refused treatment|2|||
42260915|NCT00946712|76088394|FG001|Overall Study|Ineligible|6|||
42260916|NCT00656669|76088401|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
42260917|NCT00656669|76088401|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
42260918|NCT00656669|76088401|FG000|AC (Cycles 6-9)|Adverse Event|1|||
42324995|NCT01627327|76162558|FG001|Overall Study|Protocol Violation|10|||
42324996|NCT01627327|76162557|FG000|Overall Study|Lost to Follow-up|1|||
42324997|NCT01627327|76162558|FG001|Overall Study|Lost to Follow-up|3|||
42260919|NCT00656669|76088401|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
42260920|NCT01338493|76088410|FG000|Enrolled|Withdrawal by Subject|1|||
42260921|NCT01338493|76088410|FG000|Enrolled|Patient not implanted|4|||
42324998|NCT01627327|76162557|FG000|Overall Study|Physician Decision|1|||
42324999|NCT01627327|76162558|FG001|Overall Study|Physician Decision|0|||
42325000|NCT01627327|76162557|FG000|Overall Study|Withdrawal by Subject|3|||
42325001|NCT01627327|76162558|FG001|Overall Study|Withdrawal by Subject|3|||
42325002|NCT01627249|76162567|FG000|Overall Study|Death|3|||
42325003|NCT01627249|76162568|FG001|Overall Study|Death|5|||
42325004|NCT01627249|76162569|FG002|Overall Study|Death|3|||
42325005|NCT01627249|76162567|FG000|Overall Study|Withdrawal by Subject|12|||
42325006|NCT01627249|76162568|FG001|Overall Study|Withdrawal by Subject|6|||
42325007|NCT01627249|76162569|FG002|Overall Study|Withdrawal by Subject|9|||
42325008|NCT01627249|76162567|FG000|Overall Study|Missed Visit|1|||
42325009|NCT01627249|76162568|FG001|Overall Study|Missed Visit|1|||
42325010|NCT01627249|76162569|FG002|Overall Study|Missed Visit|0|||
42325011|NCT01688830|76162598|FG000|Overall Study|Lost to Follow-up|0|||
42325012|NCT01688830|76162599|FG001|Overall Study|Lost to Follow-up|0|||
42325013|NCT01688830|76162600|FG002|Overall Study|Lost to Follow-up|0|||
42325014|NCT01688830|76162601|FG003|Overall Study|Lost to Follow-up|0|||
42325015|NCT01688830|76162602|FG004|Overall Study|Lost to Follow-up|0|||
42325016|NCT01688830|76162603|FG005|Overall Study|Lost to Follow-up|0|||
42325017|NCT01688830|76162604|FG006|Overall Study|Lost to Follow-up|0|||
42325018|NCT01688830|76162605|FG007|Overall Study|Lost to Follow-up|0|||
42325019|NCT01688830|76162606|FG008|Overall Study|Lost to Follow-up|0|||
42325020|NCT01688830|76162607|FG009|Overall Study|Lost to Follow-up|0|||
42325021|NCT01688830|76162608|FG010|Overall Study|Lost to Follow-up|1|||
42325022|NCT01688830|76162609|FG011|Overall Study|Lost to Follow-up|0|||
42325023|NCT01688830|76162610|FG012|Overall Study|Lost to Follow-up|0|||
42325024|NCT01688830|76162611|FG013|Overall Study|Lost to Follow-up|0|||
42325025|NCT01688830|76162612|FG014|Overall Study|Lost to Follow-up|0|||
42325026|NCT01688830|76162613|FG015|Overall Study|Lost to Follow-up|0|||
42325027|NCT01688830|76162614|FG016|Overall Study|Lost to Follow-up|0|||
42325028|NCT01688830|76162615|FG017|Overall Study|Lost to Follow-up|0|||
42325029|NCT01688830|76162616|FG018|Overall Study|Lost to Follow-up|0|||
42325030|NCT01688830|76162617|FG019|Overall Study|Lost to Follow-up|0|||
42325031|NCT01688830|76162618|FG020|Overall Study|Lost to Follow-up|0|||
42325032|NCT02178475|76162702|FG000|Overall Study|Withdrawal by Subject|7|||
42325033|NCT02178475|76162702|FG000|Overall Study|Lost to Follow-up|10|||
42325034|NCT02178475|76162702|FG000|Overall Study|Death|13|||
42325035|NCT02178475|76162702|FG000|Overall Study|Protocol-specified Criteria|99|||
42325036|NCT01569022|76162706|FG000|First Intervention|Lost to Follow-up|2|||
42325037|NCT01569022|76162707|FG001|First Intervention|Lost to Follow-up|1|||
42325038|NCT01569022|76162706|FG000|Second Intervention|Lost to Follow-up|2|||
42325039|NCT01569022|76162707|FG001|Second Intervention|Lost to Follow-up|2|||
42325040|NCT01629823|76162718|FG000|Trial Period|Missed visit|11|||
42325041|NCT01629823|76162719|FG001|Trial Period|Missed visit|9|||
42325042|NCT01629823|76162720|FG002|Trial Period|Missed visit|8|||
42325043|NCT01629823|76162718|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
42325044|NCT01629823|76162719|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
41995870|NCT01085084|75803898|FG000|Overall Study|Adverse Event|4|||
42260922|NCT01338493|76088410|FG000|Discharge|Death|1|||
42260923|NCT01338493|76088410|FG000|Discharge|Missed visit|1|||
42260924|NCT01338493|76088410|FG000|6 Months Follow up|Lost to Follow-up|11|||
42260925|NCT01338493|76088410|FG000|6 Months Follow up|Missed visit|8|||
42260926|NCT01338493|76088410|FG000|12 Months Follow up|Lost to Follow-up|9|||
42260927|NCT01362296|76088416|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
42260928|NCT01362296|76088417|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
42260929|NCT01362296|76088418|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
42260930|NCT01362296|76088419|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
42260931|NCT01362296|76088416|FG000|Randomized Phase (RP)|Physician Decision|1|||
42260932|NCT01362296|76088417|FG001|Randomized Phase (RP)|Physician Decision|9|||
42260933|NCT01362296|76088418|FG002|Randomized Phase (RP)|Physician Decision|0|||
42260934|NCT01362296|76088419|FG003|Randomized Phase (RP)|Physician Decision|0|||
42260935|NCT01362296|76088416|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
42260936|NCT01362296|76088417|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
42260937|NCT01362296|76088418|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
42260938|NCT01362296|76088419|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
42260939|NCT01362296|76088416|FG000|Randomized Phase (RP)|Adverse Event|20|||
42260940|NCT01362296|76088417|FG001|Randomized Phase (RP)|Adverse Event|4|||
42260941|NCT01362296|76088418|FG002|Randomized Phase (RP)|Adverse Event|0|||
42260942|NCT01362296|76088419|FG003|Randomized Phase (RP)|Adverse Event|0|||
42325045|NCT01629823|76162720|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
42325046|NCT01629823|76162718|FG000|Trial Period|Pregnancy|1|||
42325047|NCT01629823|76162719|FG001|Trial Period|Pregnancy|0|||
42325048|NCT01629823|76162720|FG002|Trial Period|Pregnancy|0|||
42325049|NCT01629823|76162718|FG000|Trial Period|Adverse Event|0|||
42325050|NCT01629823|76162719|FG001|Trial Period|Adverse Event|1|||
42325051|NCT01629823|76162720|FG002|Trial Period|Adverse Event|0|||
42325052|NCT01629823|76162718|FG000|Trial Period|Out-of-window visit|0|||
42325053|NCT01629823|76162719|FG001|Trial Period|Out-of-window visit|2|||
42325054|NCT01629823|76162720|FG002|Trial Period|Out-of-window visit|0|||
42325055|NCT01629823|76162718|FG000|Trial Period|Failed to hold medication|0|||
42325056|NCT01629823|76162719|FG001|Trial Period|Failed to hold medication|0|||
42325057|NCT01629823|76162720|FG002|Trial Period|Failed to hold medication|1|||
42325058|NCT01629823|76162718|FG000|Washout Period|Safety|2|||
42325059|NCT01629823|76162719|FG001|Washout Period|Safety|5|||
42325060|NCT01629823|76162720|FG002|Washout Period|Safety|0|||
42325061|NCT01629823|76162718|FG000|Washout Period|Pregnancy|1|||
42325062|NCT01629823|76162719|FG001|Washout Period|Pregnancy|0|||
42325063|NCT01629823|76162720|FG002|Washout Period|Pregnancy|0|||
42325064|NCT01629823|76162718|FG000|Washout Period|Protocol Violation|0|||
42325065|NCT01629823|76162719|FG001|Washout Period|Protocol Violation|1|||
42325066|NCT01629823|76162720|FG002|Washout Period|Protocol Violation|0|||
42325067|NCT01688050|76162728|FG000|Overall Study|Death|7|||
42325068|NCT01688050|76162728|FG000|Overall Study|Conversion to open repair|1|||
42325069|NCT01688050|76162728|FG000|Overall Study|Lost to Follow-up|13|||
42325070|NCT01688050|76162728|FG000|Overall Study|Withdrawal by Subject|10|||
42325071|NCT01604278|76162734|FG000|Overall Study|Lack of Efficacy|0|||
42325072|NCT01604278|76162735|FG001|Overall Study|Lack of Efficacy|1|||
42325073|NCT01604278|76162734|FG000|Overall Study|Lost to Follow-up|1|||
42325074|NCT01604278|76162735|FG001|Overall Study|Lost to Follow-up|0|||
42325075|NCT01604278|76162734|FG000|Overall Study|Administrative problems|2|||
42325076|NCT01604278|76162735|FG001|Overall Study|Administrative problems|1|||
42325077|NCT01604278|76162734|FG000|Overall Study|Withdrawal by Subject|3|||
42325078|NCT01604278|76162735|FG001|Overall Study|Withdrawal by Subject|3|||
41995871|NCT01085084|75803899|FG001|Overall Study|Adverse Event|3|||
41995872|NCT01085084|75803900|FG002|Overall Study|Adverse Event|6|||
42260943|NCT01362296|76088416|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
42260944|NCT01362296|76088417|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
42260945|NCT01362296|76088418|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
42260946|NCT01362296|76088419|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
42260947|NCT01362296|76088416|FG000|Crossover Phase|PD including Death due to PD|0|||
42260948|NCT01362296|76088417|FG001|Crossover Phase|PD including Death due to PD|0|||
42260949|NCT01362296|76088418|FG002|Crossover Phase|PD including Death due to PD|16|||
42260950|NCT01362296|76088419|FG003|Crossover Phase|PD including Death due to PD|1|||
42260951|NCT01362296|76088416|FG000|Crossover Phase|Withdrawal by Subject|0|||
42260952|NCT01362296|76088417|FG001|Crossover Phase|Withdrawal by Subject|0|||
42260953|NCT01362296|76088418|FG002|Crossover Phase|Withdrawal by Subject|2|||
42260954|NCT01362296|76088419|FG003|Crossover Phase|Withdrawal by Subject|1|||
42260955|NCT01362296|76088416|FG000|Crossover Phase|Adverse Event|0|||
42260956|NCT01362296|76088417|FG001|Crossover Phase|Adverse Event|0|||
42260957|NCT01362296|76088418|FG002|Crossover Phase|Adverse Event|4|||
42260958|NCT01362296|76088419|FG003|Crossover Phase|Adverse Event|0|||
42260959|NCT01362296|76088416|FG000|Crossover Phase|Study Closed/Terminated|0|||
41995873|NCT01085084|75803898|FG000|Overall Study|Treatment Failure|0|||
41995874|NCT01085084|75803899|FG001|Overall Study|Treatment Failure|1|||
41995875|NCT01085084|75803900|FG002|Overall Study|Treatment Failure|2|||
42260960|NCT01362296|76088417|FG001|Crossover Phase|Study Closed/Terminated|0|||
42260961|NCT01362296|76088418|FG002|Crossover Phase|Study Closed/Terminated|1|||
42325079|NCT01604278|76162734|FG000|Overall Study|Adverse Event|3|||
42325080|NCT01604278|76162735|FG001|Overall Study|Adverse Event|5|||
42325081|NCT01604278|76162734|FG000|Overall Study|Protocol Deviation|5|||
42325082|NCT01604278|76162735|FG001|Overall Study|Protocol Deviation|3|||
42325083|NCT01687270|76162741|FG000|Overall Study|Lack of Efficacy|11|||
42325084|NCT01687270|76162741|FG000|Overall Study|Lost to Follow-up|1|||
42325085|NCT01589770|76162747|FG000|Overall Study|EGFR <60ml/min|6|||
42325086|NCT01589770|76162748|FG001|Overall Study|EGFR <60ml/min|4|||
42325087|NCT01589770|76162747|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
42325088|NCT01589770|76162748|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
42325089|NCT01588990|76162754|FG000|Phase A|Withdrawal by Subject|5|||
42325090|NCT01588990|76162754|FG000|Phase A|Physician Decision|11|||
42325091|NCT01588990|76162754|FG000|Phase A|Other|14|||
42325092|NCT01588990|76162754|FG000|Phase A|Lost to Follow-up|1|||
42325093|NCT01588990|76162754|FG000|Phase A|Death|5|||
42325094|NCT01588990|76162754|FG000|Phase A|Adverse Event|28|||
42325095|NCT01588990|76162754|FG000|Phase A|Still on therapy at end of study|6|||
42325096|NCT01588990|76162754|FG000|Phase B|Adverse Event|2|||
42325097|NCT01588990|76162754|FG000|Phase B|Still on therapy at end of study|5|||
42325098|NCT01588990|76162754|FG000|Phase B|Withdrawal by Subject|3|||
42325099|NCT01588990|76162754|FG000|Phase B|Physician Decision|4|||
42325100|NCT01588990|76162754|FG000|Phase B|Other|2|||
42325101|NCT02176525|76162770|FG000|Overall Study|Adverse Event|0|||
42325102|NCT02176525|76162771|FG001|Overall Study|Adverse Event|0|||
42325103|NCT02176525|76162772|FG002|Overall Study|Adverse Event|0|||
42325104|NCT02176525|76162773|FG003|Overall Study|Adverse Event|1|||
42325105|NCT02176525|76162774|FG004|Overall Study|Adverse Event|1|||
42325106|NCT02176525|76162775|FG005|Overall Study|Adverse Event|0|||
42325107|NCT02176525|76162776|FG006|Overall Study|Adverse Event|1|||
42325108|NCT02176525|76162777|FG007|Overall Study|Adverse Event|0|||
42325109|NCT02176525|76162770|FG000|Overall Study|not treated|1|||
42325110|NCT02176525|76162771|FG001|Overall Study|not treated|0|||
42325111|NCT02176525|76162772|FG002|Overall Study|not treated|0|||
42325112|NCT02176525|76162773|FG003|Overall Study|not treated|0|||
42325113|NCT02176525|76162774|FG004|Overall Study|not treated|0|||
42325114|NCT02176525|76162775|FG005|Overall Study|not treated|1|||
42325115|NCT02176525|76162776|FG006|Overall Study|not treated|0|||
42325116|NCT02176525|76162777|FG007|Overall Study|not treated|0|||
42325117|NCT02127931|76162803|FG000|Overall Study|Glitch in Game|1|||
42325118|NCT02127307|76162808|FG000|Overall Study|Protocol Violation|36|||
42325119|NCT02127307|76162808|FG000|Overall Study|Lost to Follow-up|2|||
42325120|NCT02127307|76162808|FG000|Overall Study|Death|101|||
42325121|NCT02127307|76162808|FG000|Overall Study|Other than specified above|169|||
42325122|NCT02126839|76162814|FG000|Overall Study|Adverse Event|0|||
42325123|NCT02126839|76162815|FG001|Overall Study|Adverse Event|1|||
42325124|NCT02126839|76162814|FG000|Overall Study|Withdrawal by Subject|1|||
42325125|NCT02126839|76162815|FG001|Overall Study|Withdrawal by Subject|0|||
42325126|NCT02126839|76162814|FG000|Overall Study|Withdrawal by parent/guardian|1|||
42325127|NCT02126839|76162815|FG001|Overall Study|Withdrawal by parent/guardian|0|||
42325128|NCT02126839|76162814|FG000|Overall Study|Protocol Violation|2|||
42325129|NCT02126839|76162815|FG001|Overall Study|Protocol Violation|3|||
42325130|NCT02126839|76162814|FG000|Overall Study|Sponsor request|0|||
42325131|NCT02126839|76162815|FG001|Overall Study|Sponsor request|1|||
42325132|NCT02126839|76162814|FG000|Overall Study|Lost to Follow-up|1|||
42325133|NCT02126839|76162815|FG001|Overall Study|Lost to Follow-up|4|||
42325134|NCT02126839|76162814|FG000|Overall Study|Other|5|||
42325135|NCT02126839|76162815|FG001|Overall Study|Other|5|||
42325136|NCT02125279|76162821|FG000|Overall Study|Lack of Efficacy|2|||
42325137|NCT02125279|76162821|FG000|Overall Study|Withdrawal by Subject|6|||
42325138|NCT02125279|76162821|FG000|Overall Study|Protocol Violation|1|||
42325139|NCT02125279|76162821|FG000|Overall Study|Lost to Follow-up|4|||
42325140|NCT02124811|76162829|FG000|Overall Study|Early termination|2|||
42325141|NCT02124811|76162830|FG001|Overall Study|Early termination|2|||
42325142|NCT02124811|76162829|FG000|Overall Study|Withdrawal by Subject|1|||
42325143|NCT02124811|76162830|FG001|Overall Study|Withdrawal by Subject|0|||
42325144|NCT02148445|76162838|FG000|Overall Study|Death|1|||
42325145|NCT02148445|76162839|FG001|Overall Study|Death|3|||
42325146|NCT02148211|76162847|FG000|Overall Study|Lost to Follow-up|352|||
42325147|NCT02147587|76162853|FG000|Overall Study|Adverse Event|9|||
42325148|NCT02147587|76162854|FG001|Overall Study|Adverse Event|4|||
42325149|NCT02147587|76162853|FG000|Overall Study|Lack of Efficacy|2|||
42325150|NCT02147587|76162854|FG001|Overall Study|Lack of Efficacy|1|||
42325151|NCT02147353|76162862|FG000|Overall Study|Lost to Follow-up|2|||
42325152|NCT02147353|76162863|FG001|Overall Study|Lost to Follow-up|0|||
42325153|NCT02147353|76162862|FG000|Overall Study|unable to make visits|4|||
42325154|NCT02147353|76162863|FG001|Overall Study|unable to make visits|0|||
42325155|NCT02147353|76162862|FG000|Overall Study|medication noncompliance|3|||
42325156|NCT02147353|76162863|FG001|Overall Study|medication noncompliance|0|||
42325157|NCT02147197|76162872|FG000|Overall Study|Adverse Event|1|||
42325158|NCT02147197|76162873|FG001|Overall Study|Adverse Event|0|||
42325159|NCT02147197|76162874|FG002|Overall Study|Adverse Event|0|||
42325160|NCT02147197|76162872|FG000|Overall Study|Withdrawal of Consent|4|||
42325161|NCT02147197|76162873|FG001|Overall Study|Withdrawal of Consent|3|||
41995876|NCT01085045|75803908|FG000|Part A|Withdrawal by Subject|4|||
42133859|NCT00299104|75944773|FG002|Treatment Period|Refused treatment|2|||
41995877|NCT01085045|75803908|FG000|Part A|Adverse Event|6|||
42133860|NCT00299104|75944771|FG000|Treatment Period|Withdrew consent|14|||
42133861|NCT00299104|75944772|FG001|Treatment Period|Withdrew consent|19|||
42133862|NCT00299104|75944773|FG002|Treatment Period|Withdrew consent|9|||
42325162|NCT02147197|76162874|FG002|Overall Study|Withdrawal of Consent|2|||
42325163|NCT02147197|76162872|FG000|Overall Study|Lost to Follow-up|2|||
42325164|NCT02147197|76162873|FG001|Overall Study|Lost to Follow-up|3|||
42325165|NCT02147197|76162874|FG002|Overall Study|Lost to Follow-up|1|||
42325166|NCT02147197|76162872|FG000|Overall Study|Protocol Violation|1|||
42325167|NCT02147197|76162873|FG001|Overall Study|Protocol Violation|0|||
42325168|NCT02147197|76162874|FG002|Overall Study|Protocol Violation|3|||
42325169|NCT02147197|76162872|FG000|Overall Study|Other Miscellaneous Reasons|1|||
42325170|NCT02147197|76162873|FG001|Overall Study|Other Miscellaneous Reasons|0|||
42325171|NCT02147197|76162874|FG002|Overall Study|Other Miscellaneous Reasons|3|||
42325172|NCT02176291|76162884|FG000|Overall Study|Death|1|||
42325173|NCT02176291|76162885|FG001|Overall Study|Death|0|||
42325174|NCT02176291|76162884|FG000|Overall Study|non compliance with protocol|2|||
42325175|NCT02176291|76162885|FG001|Overall Study|non compliance with protocol|0|||
42133863|NCT00299104|75944771|FG000|Treatment Period|Administrative reasons|106|||
42133864|NCT00299104|75944772|FG001|Treatment Period|Administrative reasons|120|||
42133865|NCT00299104|75944773|FG002|Treatment Period|Administrative reasons|137|||
42133866|NCT00299104|75944771|FG000|Safety Follow-Up (SFU) Period|Death|3|||
42133867|NCT00299104|75944772|FG001|Safety Follow-Up (SFU) Period|Death|2|||
42133868|NCT00299104|75944773|FG002|Safety Follow-Up (SFU) Period|Death|1|||
42133869|NCT00299104|75944771|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
42133870|NCT00299104|75944772|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
42325176|NCT02176291|76162884|FG000|Overall Study|Withdrawal by Subject|2|||
42325177|NCT02176291|76162885|FG001|Overall Study|Withdrawal by Subject|0|||
42325178|NCT02175745|76162891|FG000|Overall Study|Not Eligible|1|||
42325179|NCT02175277|76162895|FG000|Overall Study|Protocol-specified Criteria|1|||
42325180|NCT02124265|76162899|FG000|Overall Study|Adverse Event|1|||
42325181|NCT02146105|76162903|FG000|Overall Study|Adverse Event|1|||
42325182|NCT02146105|76162903|FG000|Overall Study|Withdrawal by Subject|5|||
42325183|NCT02175199|76162909|FG000|Overall Study|Withdrawal by Subject|1|||
42325184|NCT02175199|76162910|FG001|Overall Study|Withdrawal by Subject|5|||
42325185|NCT02175199|76162909|FG000|Overall Study|Randomized in Error|1|||
42325186|NCT02175199|76162910|FG001|Overall Study|Randomized in Error|0|||
42325187|NCT02175199|76162909|FG000|Overall Study|Sponsor Decision|1|||
42325188|NCT02175199|76162910|FG001|Overall Study|Sponsor Decision|0|||
42325189|NCT02123797|76162919|FG000|Baseline Intervention|Death|9|||
42325190|NCT02123797|76162920|FG001|Baseline Intervention|Death|16|||
42325191|NCT02123797|76162921|FG002|Baseline Intervention|Death|0|||
42325192|NCT02123797|76162922|FG003|Baseline Intervention|Death|0|||
42325193|NCT02123797|76162923|FG004|Baseline Intervention|Death|0|||
42325194|NCT02123797|76162919|FG000|Baseline Intervention|Withdrawal by Subject|2|||
42325195|NCT02123797|76162920|FG001|Baseline Intervention|Withdrawal by Subject|8|||
42325196|NCT02123797|76162921|FG002|Baseline Intervention|Withdrawal by Subject|0|||
42325197|NCT02123797|76162922|FG003|Baseline Intervention|Withdrawal by Subject|0|||
42325198|NCT02123797|76162923|FG004|Baseline Intervention|Withdrawal by Subject|0|||
42325199|NCT02123797|76162919|FG000|Baseline Intervention|Relocation|2|||
42325200|NCT02123797|76162920|FG001|Baseline Intervention|Relocation|0|||
42325201|NCT02123797|76162921|FG002|Baseline Intervention|Relocation|0|||
42325202|NCT02123797|76162922|FG003|Baseline Intervention|Relocation|0|||
42325203|NCT02123797|76162923|FG004|Baseline Intervention|Relocation|0|||
42325204|NCT02123797|76162919|FG000|Baseline Intervention|Out of window for initial survey|6|||
42325205|NCT02123797|76162920|FG001|Baseline Intervention|Out of window for initial survey|13|||
42325206|NCT02123797|76162921|FG002|Baseline Intervention|Out of window for initial survey|0|||
42325207|NCT02123797|76162922|FG003|Baseline Intervention|Out of window for initial survey|0|||
42325208|NCT02123797|76162923|FG004|Baseline Intervention|Out of window for initial survey|0|||
42325209|NCT02123797|76162919|FG000|Baseline Intervention|Lost to Follow-up|0|||
42325210|NCT02123797|76162920|FG001|Baseline Intervention|Lost to Follow-up|5|||
42325211|NCT02123797|76162921|FG002|Baseline Intervention|Lost to Follow-up|0|||
42325212|NCT02123797|76162922|FG003|Baseline Intervention|Lost to Follow-up|0|||
42325213|NCT02123797|76162923|FG004|Baseline Intervention|Lost to Follow-up|0|||
42325214|NCT02123797|76162919|FG000|Baseline Intervention|Other Disease|3|||
42325215|NCT02123797|76162920|FG001|Baseline Intervention|Other Disease|0|||
42325216|NCT02123797|76162921|FG002|Baseline Intervention|Other Disease|0|||
42325217|NCT02123797|76162922|FG003|Baseline Intervention|Other Disease|0|||
42325218|NCT02123797|76162923|FG004|Baseline Intervention|Other Disease|0|||
42325219|NCT02123797|76162919|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
42034405|NCT00833911|75842500|FG000|Maintenance Phase II|Physician Decision|2|||
42034406|NCT00833911|75842500|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
42034407|NCT00833911|75842500|FG000|Maintenance Phase II|Lack of Efficacy|1|||
42034408|NCT01125293|75842514|FG000|Overall Study|Disease Progression|1|||
42034409|NCT01125293|75842515|FG001|Overall Study|Disease Progression|3|||
42034410|NCT01125293|75842516|FG002|Overall Study|Disease Progression|4|||
42034411|NCT01125293|75842517|FG003|Overall Study|Disease Progression|3|||
42034412|NCT01125293|75842518|FG004|Overall Study|Disease Progression|5|||
42034413|NCT01125293|75842519|FG005|Overall Study|Disease Progression|12|||
42034414|NCT01125293|75842514|FG000|Overall Study|Adverse Event|1|||
42034415|NCT01125293|75842515|FG001|Overall Study|Adverse Event|0|||
42034416|NCT01125293|75842516|FG002|Overall Study|Adverse Event|0|||
42034417|NCT01125293|75842517|FG003|Overall Study|Adverse Event|0|||
42034418|NCT01125293|75842518|FG004|Overall Study|Adverse Event|2|||
42034419|NCT01125293|75842519|FG005|Overall Study|Adverse Event|8|||
42034420|NCT01125293|75842514|FG000|Overall Study|Symptomatic Deterioration|1|||
42034421|NCT01125293|75842515|FG001|Overall Study|Symptomatic Deterioration|0|||
42034422|NCT01125293|75842516|FG002|Overall Study|Symptomatic Deterioration|0|||
42133871|NCT00299104|75944773|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
42325220|NCT02123797|76162920|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
42325221|NCT02123797|76162921|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
42325222|NCT02123797|76162922|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
42325223|NCT02123797|76162923|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
42325224|NCT02123797|76162919|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
41995878|NCT01085045|75803908|FG000|Part A|Protocol Violation|1|||
41995879|NCT01085045|75803908|FG000|Part A|Protocol Specified Criteria|7|||
42133872|NCT00299104|75944771|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
42133873|NCT00299104|75944772|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
42133874|NCT00299104|75944773|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
42133875|NCT00299104|75944771|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
42133876|NCT00299104|75944772|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
42133877|NCT00299104|75944773|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
42133878|NCT00299104|75944771|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
42133879|NCT00299104|75944772|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
42133880|NCT00299104|75944773|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
42133881|NCT00299104|75944771|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
42133882|NCT00299104|75944772|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
42133883|NCT00299104|75944773|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
42133884|NCT00299104|75944771|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
42133885|NCT00299104|75944772|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
42133886|NCT00299104|75944773|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
42133887|NCT00299104|75944771|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
42133888|NCT00299104|75944772|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
42133889|NCT00299104|75944773|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
42133890|NCT00313612|75944783|FG000|Overall Study|Patient never received treatment|0|||
42260962|NCT01362296|76088419|FG003|Crossover Phase|Study Closed/Terminated|0|||
42260963|NCT01338415|76088431|FG000|Core + Extension|Adverse Event|8|||
42260964|NCT01338415|76088432|FG001|Core + Extension|Adverse Event|6|||
42260965|NCT01338415|76088433|FG002|Core + Extension|Adverse Event|0|||
42260966|NCT01338415|76088431|FG000|Core + Extension|Withdrawal by Subject|1|||
42260967|NCT01338415|76088432|FG001|Core + Extension|Withdrawal by Subject|1|||
42260968|NCT01338415|76088433|FG002|Core + Extension|Withdrawal by Subject|0|||
42260969|NCT01338415|76088431|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
42260970|NCT01338415|76088432|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
42260971|NCT01338415|76088433|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
42260972|NCT01338415|76088431|FG000|Core + Extension|Other (administrative reason)|1|||
42260973|NCT01338415|76088432|FG001|Core + Extension|Other (administrative reason)|0|||
42260974|NCT01338415|76088433|FG002|Core + Extension|Other (administrative reason)|0|||
42260975|NCT01338415|76088431|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
42260976|NCT01338415|76088432|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
42260977|NCT01338415|76088433|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
42260978|NCT01338415|76088431|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
42260979|NCT01338415|76088432|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
42260980|NCT01338415|76088433|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
42260981|NCT01338415|76088431|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
42260982|NCT01338415|76088432|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
42133891|NCT00313612|75944784|FG001|Overall Study|Patient never received treatment|1|||
42260983|NCT01338415|76088433|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
41995880|NCT01085045|75803908|FG000|Part B|Withdrawal by Subject|2|||
42133892|NCT00507416|75944793|FG000|Overall Study|Adverse Event|58|||
42260984|NCT01338415|76088431|FG000|Exceptional Use Treatment Period|Death|0|||
42260985|NCT01338415|76088432|FG001|Exceptional Use Treatment Period|Death|0|||
42133893|NCT00507416|75944794|FG001|Overall Study|Adverse Event|67|||
42133894|NCT00507416|75944795|FG002|Overall Study|Adverse Event|65|||
42133895|NCT00507416|75944793|FG000|Overall Study|Protocol Violation|1|||
42133896|NCT00507416|75944794|FG001|Overall Study|Protocol Violation|2|||
42133897|NCT00507416|75944795|FG002|Overall Study|Protocol Violation|0|||
42133898|NCT00507416|75944793|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
42133899|NCT00507416|75944794|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
42133900|NCT00507416|75944795|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
42260986|NCT01338415|76088433|FG002|Exceptional Use Treatment Period|Death|1|||
42260987|NCT05258149|76088443|FG000|Period 1|Protocol Deviation|1|||
42260988|NCT05258149|76088444|FG001|Period 1|Protocol Deviation|0|||
42260989|NCT05258149|76088443|FG000|Period 1|Adverse Event|0|||
42260990|NCT05258149|76088444|FG001|Period 1|Adverse Event|1|||
42260991|NCT05258149|76088443|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
42325225|NCT02123797|76162920|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
42325226|NCT02123797|76162921|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
42260992|NCT05258149|76088444|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
42260993|NCT05258149|76088443|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
42260994|NCT05258149|76088444|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
42260995|NCT05258149|76088443|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
42260996|NCT05258149|76088444|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
42260997|NCT01371643|76088452|FG000|Overall Study|Withdrawal by Subject|3|||
42260998|NCT01371643|76088453|FG001|Overall Study|Withdrawal by Subject|0|||
42260999|NCT01371565|76088459|FG000|Overall Study|Withdrawal by Subject|1|||
42261000|NCT01371565|76088459|FG000|Overall Study|Death|1|||
42261001|NCT01371565|76088459|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
42261002|NCT02821819|76088467|FG000|Overall Study|Protocol Violation|1|||
42261003|NCT03926611|76088478|FG000|Overall Study|Adverse Event|0|||
42261004|NCT03926611|76088479|FG001|Overall Study|Adverse Event|0|||
42261005|NCT03926611|76088480|FG002|Overall Study|Adverse Event|0|||
42261006|NCT03926611|76088481|FG003|Overall Study|Adverse Event|3|||
42261007|NCT03926611|76088482|FG004|Overall Study|Adverse Event|1|||
42261008|NCT03926611|76088483|FG005|Overall Study|Adverse Event|3|||
42261009|NCT03926611|76088484|FG006|Overall Study|Adverse Event|0|||
42261010|NCT03926611|76088478|FG000|Overall Study|Lack of Efficacy|1|||
42261011|NCT03926611|76088479|FG001|Overall Study|Lack of Efficacy|2|||
42261012|NCT03926611|76088480|FG002|Overall Study|Lack of Efficacy|0|||
42261013|NCT03926611|76088481|FG003|Overall Study|Lack of Efficacy|0|||
42261014|NCT03926611|76088482|FG004|Overall Study|Lack of Efficacy|1|||
42261015|NCT03926611|76088483|FG005|Overall Study|Lack of Efficacy|0|||
42261016|NCT03926611|76088484|FG006|Overall Study|Lack of Efficacy|1|||
42261017|NCT03926611|76088478|FG000|Overall Study|Physician Decision|0|||
42261018|NCT03926611|76088479|FG001|Overall Study|Physician Decision|0|||
42261019|NCT03926611|76088480|FG002|Overall Study|Physician Decision|0|||
42261020|NCT03926611|76088481|FG003|Overall Study|Physician Decision|0|||
42261021|NCT03926611|76088482|FG004|Overall Study|Physician Decision|0|||
42261022|NCT03926611|76088483|FG005|Overall Study|Physician Decision|1|||
42261023|NCT03926611|76088484|FG006|Overall Study|Physician Decision|0|||
42261024|NCT03926611|76088478|FG000|Overall Study|Protocol Violation|1|||
42261025|NCT03926611|76088479|FG001|Overall Study|Protocol Violation|0|||
42261026|NCT03926611|76088480|FG002|Overall Study|Protocol Violation|0|||
42261027|NCT03926611|76088481|FG003|Overall Study|Protocol Violation|1|||
42261028|NCT03926611|76088482|FG004|Overall Study|Protocol Violation|1|||
42261029|NCT03926611|76088483|FG005|Overall Study|Protocol Violation|1|||
42261030|NCT03926611|76088484|FG006|Overall Study|Protocol Violation|1|||
42325227|NCT02123797|76162922|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
42133901|NCT00507416|75944793|FG000|Overall Study|Progressive Disease|20|||
42261031|NCT03926611|76088478|FG000|Overall Study|Technical problems|0|||
42261032|NCT03926611|76088479|FG001|Overall Study|Technical problems|0|||
42261033|NCT03926611|76088480|FG002|Overall Study|Technical problems|0|||
42261034|NCT03926611|76088481|FG003|Overall Study|Technical problems|0|||
42325228|NCT02123797|76162923|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
42325229|NCT02123797|76162919|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
42133902|NCT00507416|75944794|FG001|Overall Study|Progressive Disease|10|||
42133903|NCT00507416|75944795|FG002|Overall Study|Progressive Disease|13|||
42261035|NCT03926611|76088482|FG004|Overall Study|Technical problems|0|||
42261036|NCT03926611|76088483|FG005|Overall Study|Technical problems|1|||
42261037|NCT03926611|76088484|FG006|Overall Study|Technical problems|0|||
42261038|NCT03926611|76088478|FG000|Overall Study|Withdrawal by Subject|1|||
42325230|NCT02123797|76162920|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
42325231|NCT02123797|76162921|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
42325232|NCT02123797|76162922|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
42325233|NCT02123797|76162923|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
42325234|NCT02123797|76162919|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
42325235|NCT02123797|76162920|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
42325236|NCT02123797|76162921|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
42325237|NCT02123797|76162922|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
42325238|NCT02123797|76162923|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
42325239|NCT02123797|76162919|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
42325240|NCT02123797|76162920|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
42325241|NCT02123797|76162921|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
42325242|NCT02123797|76162922|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
42325243|NCT02123797|76162923|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
42325244|NCT02123797|76162919|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
42325245|NCT02123797|76162920|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
42325246|NCT02123797|76162921|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
42325247|NCT02123797|76162922|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
42325248|NCT02123797|76162923|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
42325249|NCT02123797|76162919|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
42325250|NCT02123797|76162920|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
42325251|NCT02123797|76162921|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
42325252|NCT02123797|76162922|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
42325253|NCT02123797|76162923|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
42325254|NCT02123797|76162919|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
42325255|NCT02123797|76162920|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
42325256|NCT02123797|76162921|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
42325257|NCT02123797|76162922|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
42325258|NCT02123797|76162923|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
42325259|NCT02123797|76162919|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
42325260|NCT02123797|76162920|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
42325261|NCT02123797|76162921|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
42325262|NCT02123797|76162922|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
42325263|NCT02123797|76162923|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
42325264|NCT02175121|76162948|FG000|Overall Study|Lack of Efficacy|1|||
42325265|NCT02175121|76162949|FG001|Overall Study|Lack of Efficacy|0|||
42325266|NCT02175121|76162950|FG002|Overall Study|Lack of Efficacy|0|||
42325267|NCT02175121|76162951|FG003|Overall Study|Lack of Efficacy|0|||
42325268|NCT02175121|76162952|FG004|Overall Study|Lack of Efficacy|0|||
42325269|NCT02175121|76162948|FG000|Overall Study|Lost to Follow-up|0|||
42325270|NCT02175121|76162949|FG001|Overall Study|Lost to Follow-up|1|||
42325271|NCT02175121|76162950|FG002|Overall Study|Lost to Follow-up|0|||
42325272|NCT02175121|76162951|FG003|Overall Study|Lost to Follow-up|1|||
42325273|NCT02175121|76162952|FG004|Overall Study|Lost to Follow-up|0|||
42325274|NCT02175121|76162948|FG000|Overall Study|Personal emergency|0|||
42325275|NCT02175121|76162949|FG001|Overall Study|Personal emergency|0|||
42325276|NCT02175121|76162950|FG002|Overall Study|Personal emergency|0|||
42325277|NCT02175121|76162951|FG003|Overall Study|Personal emergency|0|||
42325278|NCT02175121|76162952|FG004|Overall Study|Personal emergency|1|||
42261039|NCT03926611|76088479|FG001|Overall Study|Withdrawal by Subject|1|||
42261040|NCT03926611|76088480|FG002|Overall Study|Withdrawal by Subject|1|||
42325279|NCT02175121|76162948|FG000|Overall Study|Schedule conflict|0|||
42325280|NCT02175121|76162949|FG001|Overall Study|Schedule conflict|0|||
42325281|NCT02175121|76162950|FG002|Overall Study|Schedule conflict|1|||
42325282|NCT02175121|76162951|FG003|Overall Study|Schedule conflict|0|||
42325283|NCT02175121|76162952|FG004|Overall Study|Schedule conflict|0|||
42325284|NCT02175121|76162948|FG000|Overall Study|Time issues|0|||
42325285|NCT02175121|76162949|FG001|Overall Study|Time issues|0|||
42325286|NCT02175121|76162950|FG002|Overall Study|Time issues|1|||
42325287|NCT02175121|76162951|FG003|Overall Study|Time issues|0|||
42325288|NCT02175121|76162952|FG004|Overall Study|Time issues|0|||
42261041|NCT03926611|76088481|FG003|Overall Study|Withdrawal by Subject|0|||
42261042|NCT03926611|76088482|FG004|Overall Study|Withdrawal by Subject|0|||
42261043|NCT03926611|76088483|FG005|Overall Study|Withdrawal by Subject|1|||
42261044|NCT03926611|76088484|FG006|Overall Study|Withdrawal by Subject|3|||
42261045|NCT03926611|76088478|FG000|Overall Study|Covid-19 pandemic|0|||
42261046|NCT03926611|76088479|FG001|Overall Study|Covid-19 pandemic|0|||
42261047|NCT03926611|76088480|FG002|Overall Study|Covid-19 pandemic|1|||
42325289|NCT01568866|76162970|FG000|Overall Study|Disease Progression|208|||
41995881|NCT01085045|75803908|FG000|Part B|Protocol Specified Criteria|6|||
42261048|NCT03926611|76088481|FG003|Overall Study|Covid-19 pandemic|0|||
42261049|NCT03926611|76088482|FG004|Overall Study|Covid-19 pandemic|1|||
42325290|NCT01568866|76162971|FG001|Overall Study|Disease Progression|183|||
42325291|NCT01568866|76162970|FG000|Overall Study|Adverse Event|94|||
42325292|NCT01568866|76162971|FG001|Overall Study|Adverse Event|96|||
42325293|NCT01568866|76162970|FG000|Overall Study|Patient Request|55|||
42325294|NCT01568866|76162971|FG001|Overall Study|Patient Request|71|||
42325295|NCT01568866|76162970|FG000|Overall Study|Physician Decision|40|||
42325296|NCT01568866|76162971|FG001|Overall Study|Physician Decision|32|||
42325297|NCT01568866|76162970|FG000|Overall Study|Withdrawal by Subject|19|||
42325298|NCT01568866|76162971|FG001|Overall Study|Withdrawal by Subject|11|||
42261050|NCT03926611|76088483|FG005|Overall Study|Covid-19 pandemic|2|||
42261051|NCT03926611|76088484|FG006|Overall Study|Covid-19 pandemic|0|||
42325299|NCT01568866|76162970|FG000|Overall Study|Death|10|||
42325300|NCT01568866|76162971|FG001|Overall Study|Death|18|||
42325301|NCT01568866|76162970|FG000|Overall Study|Protocol Non-compliance|2|||
42325302|NCT01568866|76162971|FG001|Overall Study|Protocol Non-compliance|4|||
42261052|NCT02818777|76088513|FG000|Overall Study|Adverse Event|3|||
42261053|NCT02817841|76088527|FG000|Overall Study|Lost to Follow-up|287|||
42261054|NCT02817841|76088527|FG000|Overall Study|Withdrawal by Subject|183|||
42261055|NCT02817841|76088527|FG000|Overall Study|Adverse event not related to bleeding|131|||
42261056|NCT02817841|76088527|FG000|Overall Study|Adverse event related to bleeding|51|||
42261057|NCT02817841|76088527|FG000|Overall Study|Pregnancy|32|||
42261058|NCT02817841|76088527|FG000|Overall Study|Pregnancy wish|17|||
42261059|NCT02817841|76088527|FG000|Overall Study|Other reasons|53|||
42261060|NCT02817841|76088527|FG000|Overall Study|Protocol Violation|94|||
42261061|NCT02814565|76088537|FG000|Overall Study|Lack of Efficacy|0|||
42261062|NCT02814565|76088538|FG001|Overall Study|Lack of Efficacy|1|||
42261063|NCT02814565|76088537|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
42261064|NCT02814565|76088538|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
42261065|NCT02650466|76088544|FG000|Overall Study|Physician Decision|1|||
42261066|NCT02650466|76088544|FG000|Overall Study|Withdrawal by Subject|5|||
42261067|NCT02650466|76088544|FG000|Overall Study|Lost to Follow-up|1|||
42261068|NCT02815735|76088550|FG000|First Intervention (4 Weeks)|Discomfort|1|||
42261069|NCT02815735|76088551|FG001|First Intervention (4 Weeks)|Discomfort|0|||
42261070|NCT02815735|76088550|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
42261071|NCT02815735|76088551|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
42261072|NCT02815735|76088550|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
42261073|NCT02815735|76088551|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
42261074|NCT02815735|76088550|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
42261075|NCT02815735|76088551|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
42261076|NCT02814643|76088568|FG000|Overall Study|Lost to Follow-up|0|||
42261077|NCT02814643|76088569|FG001|Overall Study|Lost to Follow-up|1|||
42261078|NCT02814643|76088568|FG000|Overall Study|Withdrawal by Subject|1|||
42261079|NCT02814643|76088569|FG001|Overall Study|Withdrawal by Subject|2|||
42261080|NCT02724111|76088577|FG000|Overall Study|Protocol Violation|2|||
42261081|NCT02724111|76088578|FG001|Overall Study|Protocol Violation|5|||
42261082|NCT02649218|76088584|FG000|Overall Study|Adverse Event|8|||
42261083|NCT02649218|76088584|FG000|Overall Study|Lack of Efficacy|8|||
42261084|NCT02649218|76088584|FG000|Overall Study|Pregnancy|3|||
42261085|NCT02649218|76088584|FG000|Overall Study|Protocol Violation|3|||
42261086|NCT02649218|76088584|FG000|Overall Study|Physician Decision|1|||
42261087|NCT02649218|76088584|FG000|Overall Study|Withdrawal by Subject|2|||
42261088|NCT02814175|76088591|FG000|Part 1|Adverse Event|2|||
42261089|NCT02814175|76088592|FG001|Part 1|Adverse Event|3|||
42261090|NCT02814175|76088593|FG002|Part 1|Adverse Event|0|||
42261091|NCT02814175|76088594|FG003|Part 1|Adverse Event|0|||
42261092|NCT02814175|76088595|FG004|Part 1|Adverse Event|0|||
42261093|NCT02814175|76088596|FG005|Part 1|Adverse Event|0|||
42261094|NCT02814175|76088591|FG000|Part 1|Withdrawal Consent|8|||
42261095|NCT02814175|76088592|FG001|Part 1|Withdrawal Consent|1|||
42261096|NCT02814175|76088593|FG002|Part 1|Withdrawal Consent|0|||
42261097|NCT02814175|76088594|FG003|Part 1|Withdrawal Consent|0|||
42261098|NCT02814175|76088595|FG004|Part 1|Withdrawal Consent|0|||
42261099|NCT02814175|76088596|FG005|Part 1|Withdrawal Consent|0|||
42325303|NCT01568866|76162970|FG000|Overall Study|Lost to Follow-up|1|||
42325304|NCT01568866|76162971|FG001|Overall Study|Lost to Follow-up|0|||
42325305|NCT01568866|76162970|FG000|Overall Study|Randomized but Not Dosed|9|||
42325306|NCT01568866|76162971|FG001|Overall Study|Randomized but Not Dosed|1|||
42325307|NCT01568320|76162977|FG000|Overall Study|Death|20|||
42261100|NCT02814175|76088591|FG000|Part 1|Lost to Follow-up|1|||
42325308|NCT01568320|76162977|FG000|Overall Study|Lost to Follow-up|9|||
42325309|NCT01568320|76162977|FG000|Overall Study|Withdrawal by Subject|10|||
42325310|NCT01568320|76162977|FG000|Overall Study|Conversion to open repair|1|||
42325311|NCT01568320|76162977|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
42325312|NCT01567852|76162983|FG000|Overall Study|Withdrawal by Subject|3|||
42261101|NCT02814175|76088592|FG001|Part 1|Lost to Follow-up|0|||
42261102|NCT02814175|76088593|FG002|Part 1|Lost to Follow-up|0|||
42261103|NCT02814175|76088594|FG003|Part 1|Lost to Follow-up|0|||
42261104|NCT02814175|76088595|FG004|Part 1|Lost to Follow-up|0|||
42261105|NCT02814175|76088596|FG005|Part 1|Lost to Follow-up|0|||
42133904|NCT00507416|75944793|FG000|Overall Study|Patient declined further treatment|18|||
42133905|NCT00507416|75944794|FG001|Overall Study|Patient declined further treatment|14|||
42133906|NCT00507416|75944795|FG002|Overall Study|Patient declined further treatment|11|||
42133907|NCT00507416|75944793|FG000|Overall Study|Other|11|||
42133908|NCT00507416|75944794|FG001|Overall Study|Other|16|||
42133909|NCT00507416|75944795|FG002|Overall Study|Other|13|||
42133910|NCT00507416|75944793|FG000|Overall Study|Did not Receive Study Treatment|3|||
42133911|NCT00507416|75944794|FG001|Overall Study|Did not Receive Study Treatment|9|||
42133912|NCT00507416|75944795|FG002|Overall Study|Did not Receive Study Treatment|4|||
42133913|NCT00489476|75944807|FG000|Overall Study|Lost to Follow-up|0|||
42133914|NCT00489476|75944808|FG001|Overall Study|Lost to Follow-up|1|||
42133915|NCT00489476|75944809|FG002|Overall Study|Lost to Follow-up|0|||
42133916|NCT00489476|75944810|FG003|Overall Study|Lost to Follow-up|0|||
42133917|NCT00550745|75944822|FG000|Overall Study|Death|20|||
42133918|NCT00550745|75944823|FG001|Overall Study|Death|16|||
42133919|NCT00550745|75944822|FG000|Overall Study|Lost to Follow-up|45|||
42133920|NCT00550745|75944823|FG001|Overall Study|Lost to Follow-up|30|||
42133921|NCT00550745|75944822|FG000|Overall Study|Physician Decision|0|||
42133922|NCT00550745|75944823|FG001|Overall Study|Physician Decision|2|||
42133923|NCT00550745|75944822|FG000|Overall Study|Protocol Violation|4|||
42133924|NCT00550745|75944823|FG001|Overall Study|Protocol Violation|2|||
42133925|NCT00550745|75944822|FG000|Overall Study|Withdrawal by Subject|17|||
42133926|NCT00550745|75944823|FG001|Overall Study|Withdrawal by Subject|10|||
42133927|NCT00550745|75944822|FG000|Overall Study|Screen failure|1|||
42133928|NCT00550745|75944823|FG001|Overall Study|Screen failure|0|||
42133929|NCT00452790|75944831|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
42133930|NCT00452790|75944832|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
42133931|NCT00452790|75944831|FG000|Infant Series|Parent/legal guardian request|8|||
42133932|NCT00452790|75944832|FG001|Infant Series|Parent/legal guardian request|6|||
42133933|NCT00452790|75944831|FG000|Infant Series|Failed to return|4|||
42133934|NCT00452790|75944832|FG001|Infant Series|Failed to return|1|||
42133935|NCT00452790|75944831|FG000|Infant Series|Protocol Violation|1|||
42133936|NCT00452790|75944832|FG001|Infant Series|Protocol Violation|3|||
42133937|NCT00452790|75944831|FG000|Infant Series|Lost to Follow-up|2|||
42133938|NCT00452790|75944832|FG001|Infant Series|Lost to Follow-up|2|||
42133939|NCT00452790|75944831|FG000|Infant Series|Adverse Event|1|||
42133940|NCT00452790|75944832|FG001|Infant Series|Adverse Event|2|||
42133941|NCT00452790|75944831|FG000|Infant Series|Other reasons|1|||
42133942|NCT00452790|75944832|FG001|Infant Series|Other reasons|2|||
42133943|NCT00452790|75944831|FG000|Infant Series|Investigator request|0|||
42133944|NCT00452790|75944832|FG001|Infant Series|Investigator request|1|||
42133945|NCT00452790|75944831|FG000|Infant Series|Death|0|||
42133946|NCT00452790|75944832|FG001|Infant Series|Death|1|||
42133947|NCT00452790|75944831|FG000|After Infant Series|Investigator request|10|||
42133948|NCT00452790|75944832|FG001|After Infant Series|Investigator request|10|||
42133949|NCT00452790|75944831|FG000|After Infant Series|Adverse Event|4|||
42261106|NCT02814175|76088591|FG000|Part 1|Lack of Efficacy|1|||
42261107|NCT02814175|76088592|FG001|Part 1|Lack of Efficacy|2|||
42261108|NCT02814175|76088593|FG002|Part 1|Lack of Efficacy|0|||
42261109|NCT02814175|76088594|FG003|Part 1|Lack of Efficacy|0|||
42261110|NCT02814175|76088595|FG004|Part 1|Lack of Efficacy|0|||
42133950|NCT00452790|75944832|FG001|After Infant Series|Adverse Event|1|||
42133951|NCT00452790|75944831|FG000|After Infant Series|Parent/legal guardian request|1|||
42133952|NCT00452790|75944832|FG001|After Infant Series|Parent/legal guardian request|3|||
42133953|NCT00452790|75944831|FG000|After Infant Series|Lost to Follow-up|4|||
42133954|NCT00452790|75944832|FG001|After Infant Series|Lost to Follow-up|0|||
42133955|NCT00452790|75944831|FG000|After Infant Series|Failed to return|1|||
42133956|NCT00452790|75944832|FG001|After Infant Series|Failed to return|0|||
42133957|NCT00452790|75944831|FG000|After Infant Series|Other reasons|1|||
42133958|NCT00452790|75944832|FG001|After Infant Series|Other reasons|0|||
42133959|NCT00452790|75944831|FG000|Toddler Dose|Failed to return|0|||
42133960|NCT00452790|75944832|FG001|Toddler Dose|Failed to return|1|||
42133961|NCT00452790|75944831|FG000|Toddler Dose|Parent/legal guardian request|0|||
42133962|NCT00452790|75944832|FG001|Toddler Dose|Parent/legal guardian request|1|||
41995882|NCT01085045|75803908|FG000|Part B|Lost to Follow-up|1|||
42133963|NCT00463788|75944844|FG000|Overall Study|Progressive Disease|86|||
42133964|NCT00463788|75944845|FG001|Overall Study|Progressive Disease|42|||
42133965|NCT00463788|75944844|FG000|Overall Study|Adverse Event|6|||
42261111|NCT02814175|76088596|FG005|Part 1|Lack of Efficacy|0|||
42261112|NCT02814175|76088591|FG000|Part 2|Adverse Event|0|||
42133966|NCT00463788|75944845|FG001|Overall Study|Adverse Event|2|||
42133967|NCT00463788|75944844|FG000|Overall Study|Withdrawal by Subject|6|||
42133968|NCT00463788|75944845|FG001|Overall Study|Withdrawal by Subject|2|||
42133969|NCT00463788|75944844|FG000|Overall Study|Death|4|||
42133970|NCT00463788|75944845|FG001|Overall Study|Death|3|||
42133971|NCT00463788|75944844|FG000|Overall Study|Symptomatic Deterioration|2|||
42133972|NCT00463788|75944845|FG001|Overall Study|Symptomatic Deterioration|3|||
42133973|NCT00463788|75944844|FG000|Overall Study|Lost to Follow-up|1|||
42261113|NCT02814175|76088592|FG001|Part 2|Adverse Event|0|||
42133974|NCT00463788|75944845|FG001|Overall Study|Lost to Follow-up|0|||
42133975|NCT00463788|75944844|FG000|Overall Study|Protocol Violation|0|||
42133976|NCT00463788|75944845|FG001|Overall Study|Protocol Violation|1|||
42133977|NCT00463788|75944844|FG000|Overall Study|Other|3|||
42133978|NCT00463788|75944845|FG001|Overall Study|Other|0|||
42133979|NCT00463788|75944844|FG000|Overall Study|Randomized but not treated|1|||
42133980|NCT00463788|75944845|FG001|Overall Study|Randomized but not treated|1|||
42133981|NCT00548249|75944857|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
42133982|NCT00548249|75944858|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
42133983|NCT00548249|75944859|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
42261114|NCT02814175|76088593|FG002|Part 2|Adverse Event|0|||
42261115|NCT02814175|76088594|FG003|Part 2|Adverse Event|1|||
42261116|NCT02814175|76088595|FG004|Part 2|Adverse Event|1|||
41995883|NCT01085045|75803908|FG000|Part B|Adverse Event|6|||
41995884|NCT01084772|75803930|FG000|Baseline|Withdrawal by Subject|7|||
41995885|NCT01084772|75803931|FG001|Baseline|Withdrawal by Subject|6|||
41995886|NCT01084772|75803930|FG000|3 Months|Death|1|||
41995887|NCT01084772|75803931|FG001|3 Months|Death|0|||
41995888|NCT01084772|75803930|FG000|3 Months|Study Termination|2|||
41995889|NCT01084772|75803931|FG001|3 Months|Study Termination|2|||
41995890|NCT01084772|75803930|FG000|1 Year|Withdrawal by Subject|0|||
41995891|NCT01084772|75803931|FG001|1 Year|Withdrawal by Subject|1|||
41995892|NCT01084772|75803930|FG000|1 Year|Lost to Follow-up|3|||
41995893|NCT01084772|75803931|FG001|1 Year|Lost to Follow-up|0|||
42325313|NCT01567852|76162984|FG001|Overall Study|Withdrawal by Subject|6|||
42325314|NCT01567852|76162983|FG000|Overall Study|ECT discontinued|1|||
42325315|NCT01567852|76162984|FG001|Overall Study|ECT discontinued|1|||
42325316|NCT01588366|76162995|FG000|Overall Study|Adverse Event|0|||
42325317|NCT01588366|76162996|FG001|Overall Study|Adverse Event|1|||
41995894|NCT01084772|75803930|FG000|1 Year|Study Termination|0|||
42325318|NCT01588366|76162997|FG002|Overall Study|Adverse Event|0|||
42325319|NCT01588366|76162998|FG003|Overall Study|Adverse Event|1|||
42325320|NCT01588366|76162999|FG004|Overall Study|Adverse Event|0|||
42325321|NCT01588366|76163000|FG005|Overall Study|Adverse Event|2|||
42325322|NCT01686958|76163016|FG000|Overall Study|Withdrawal by Subject|1|||
42325323|NCT01686568|76163023|FG000|Main Study|Withdrawal by Subject|1|||
42325324|NCT01686568|76163024|FG001|Main Study|Withdrawal by Subject|3|||
42325325|NCT01686568|76163023|FG000|Main Study|Noncompliance with protocol|0|||
42325326|NCT01686568|76163024|FG001|Main Study|Noncompliance with protocol|1|||
41995895|NCT01084772|75803931|FG001|1 Year|Study Termination|7|||
42034423|NCT01125293|75842517|FG003|Overall Study|Symptomatic Deterioration|0|||
42034424|NCT01125293|75842518|FG004|Overall Study|Symptomatic Deterioration|0|||
42133984|NCT00548249|75944860|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
42261117|NCT02814175|76088596|FG005|Part 2|Adverse Event|2|||
42261118|NCT02814175|76088591|FG000|Part 2|Withdrawal Consent|0|||
42261119|NCT02814175|76088592|FG001|Part 2|Withdrawal Consent|0|||
42261120|NCT02814175|76088593|FG002|Part 2|Withdrawal Consent|0|||
42261121|NCT02814175|76088594|FG003|Part 2|Withdrawal Consent|2|||
42261122|NCT02814175|76088595|FG004|Part 2|Withdrawal Consent|1|||
42261123|NCT02814175|76088596|FG005|Part 2|Withdrawal Consent|1|||
42261124|NCT02814175|76088591|FG000|Part 2|Lost to Follow-up|0|||
42261125|NCT02814175|76088592|FG001|Part 2|Lost to Follow-up|0|||
42261126|NCT02814175|76088593|FG002|Part 2|Lost to Follow-up|0|||
42261127|NCT02814175|76088594|FG003|Part 2|Lost to Follow-up|1|||
42261128|NCT02814175|76088595|FG004|Part 2|Lost to Follow-up|0|||
42261129|NCT02814175|76088596|FG005|Part 2|Lost to Follow-up|0|||
42261130|NCT02814175|76088591|FG000|Part 2|Lack of Efficacy|0|||
42261131|NCT02814175|76088592|FG001|Part 2|Lack of Efficacy|0|||
42325327|NCT01686568|76163023|FG000|Main Study|Liver enzymes above range of exclusion|1|||
42325328|NCT01686568|76163024|FG001|Main Study|Liver enzymes above range of exclusion|0|||
41995896|NCT01084772|75803930|FG000|2 Years|Withdrawal by Subject|1|||
42261132|NCT02814175|76088593|FG002|Part 2|Lack of Efficacy|0|||
42261133|NCT02814175|76088594|FG003|Part 2|Lack of Efficacy|0|||
41995897|NCT01084772|75803931|FG001|2 Years|Withdrawal by Subject|0|||
42261134|NCT02814175|76088595|FG004|Part 2|Lack of Efficacy|0|||
42261135|NCT02814175|76088596|FG005|Part 2|Lack of Efficacy|3|||
42261136|NCT01335997|76088612|FG000|Period I and II|Adverse Event|63|||
41995898|NCT01084772|75803930|FG000|2 Years|Lost to Follow-up|5|||
41995899|NCT01084772|75803931|FG001|2 Years|Lost to Follow-up|2|||
41995900|NCT01084772|75803930|FG000|2 Years|Study Termination|3|||
41995901|NCT01084772|75803931|FG001|2 Years|Study Termination|2|||
42133985|NCT00548249|75944861|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
42133986|NCT00548249|75944857|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
42261137|NCT01335997|76088613|FG001|Period I and II|Adverse Event|43|||
42261138|NCT01335997|76088612|FG000|Period I and II|Noncompliance with Study Drug|1|||
42261139|NCT01335997|76088613|FG001|Period I and II|Noncompliance with Study Drug|1|||
42325329|NCT01686568|76163023|FG000|Sub-Study|Not consented for sub-study|2|||
42325330|NCT01686568|76163024|FG001|Sub-Study|Not consented for sub-study|2|||
42325331|NCT01567462|76163032|FG000|Overall Study|Withdrawal by Subject|4|||
42325332|NCT01567462|76163033|FG001|Overall Study|Withdrawal by Subject|7|||
42325333|NCT01587898|76163043|FG000|Overall Study|Adverse Event|1|||
42325334|NCT01587898|76163044|FG001|Overall Study|Adverse Event|1|||
42325335|NCT01587898|76163045|FG002|Overall Study|Adverse Event|0|||
42325336|NCT01587898|76163046|FG003|Overall Study|Adverse Event|0|||
42325337|NCT01587898|76163043|FG000|Overall Study|Protocol Violation|0|||
42325338|NCT01587898|76163044|FG001|Overall Study|Protocol Violation|2|||
42325339|NCT01587898|76163045|FG002|Overall Study|Protocol Violation|1|||
42325340|NCT01587898|76163046|FG003|Overall Study|Protocol Violation|1|||
42325341|NCT01587898|76163043|FG000|Overall Study|Lost to Follow-up|0|||
42325342|NCT01587898|76163044|FG001|Overall Study|Lost to Follow-up|0|||
42325343|NCT01587898|76163045|FG002|Overall Study|Lost to Follow-up|0|||
42325344|NCT01587898|76163046|FG003|Overall Study|Lost to Follow-up|1|||
42325345|NCT01587898|76163043|FG000|Overall Study|Withdrawal by Subject|2|||
42325346|NCT01587898|76163044|FG001|Overall Study|Withdrawal by Subject|1|||
42325347|NCT01587898|76163045|FG002|Overall Study|Withdrawal by Subject|0|||
42325348|NCT01587898|76163046|FG003|Overall Study|Withdrawal by Subject|0|||
42325349|NCT01587898|76163043|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
42325350|NCT01587898|76163044|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
42325351|NCT01587898|76163045|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
42325352|NCT01587898|76163046|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
42325353|NCT01567306|76163065|FG000|Overall Study|Protocol Violation|2|||
42325354|NCT01567306|76163066|FG001|Overall Study|Protocol Violation|2|||
42325355|NCT01567306|76163067|FG002|Overall Study|Protocol Violation|0|||
42325356|NCT01567306|76163068|FG003|Overall Study|Protocol Violation|3|||
42325357|NCT01567306|76163069|FG004|Overall Study|Protocol Violation|1|||
42325358|NCT01567306|76163070|FG005|Overall Study|Protocol Violation|1|||
42325359|NCT01567306|76163065|FG000|Overall Study|Change site living|1|||
42325360|NCT01567306|76163066|FG001|Overall Study|Change site living|0|||
42325361|NCT01567306|76163067|FG002|Overall Study|Change site living|0|||
42325362|NCT01567306|76163068|FG003|Overall Study|Change site living|0|||
42325363|NCT01567306|76163069|FG004|Overall Study|Change site living|0|||
42325364|NCT01567306|76163070|FG005|Overall Study|Change site living|0|||
42325365|NCT01567306|76163065|FG000|Overall Study|Adverse Event|0|||
42325366|NCT01567306|76163066|FG001|Overall Study|Adverse Event|0|||
42325367|NCT01567306|76163067|FG002|Overall Study|Adverse Event|0|||
42325368|NCT01567306|76163068|FG003|Overall Study|Adverse Event|2|||
42325369|NCT01567306|76163069|FG004|Overall Study|Adverse Event|4|||
42325370|NCT01567306|76163070|FG005|Overall Study|Adverse Event|1|||
42325371|NCT01567306|76163065|FG000|Overall Study|Lost to Follow-up|0|||
42325372|NCT01567306|76163066|FG001|Overall Study|Lost to Follow-up|0|||
42325373|NCT01567306|76163067|FG002|Overall Study|Lost to Follow-up|0|||
42325374|NCT01567306|76163068|FG003|Overall Study|Lost to Follow-up|0|||
42325375|NCT01567306|76163069|FG004|Overall Study|Lost to Follow-up|2|||
42325376|NCT01567306|76163070|FG005|Overall Study|Lost to Follow-up|0|||
42325377|NCT01567306|76163065|FG000|Overall Study|Withdrawal by Subject|0|||
42325378|NCT01567306|76163066|FG001|Overall Study|Withdrawal by Subject|0|||
42325379|NCT01567306|76163067|FG002|Overall Study|Withdrawal by Subject|0|||
42325380|NCT01567306|76163068|FG003|Overall Study|Withdrawal by Subject|0|||
42325381|NCT01567306|76163069|FG004|Overall Study|Withdrawal by Subject|0|||
42325382|NCT01567306|76163070|FG005|Overall Study|Withdrawal by Subject|1|||
41995902|NCT00179673|75803937|FG000|Overall Study|Adverse Event|7|||
42325383|NCT01587274|76163087|FG000|Overall Study|Lost to Follow-up|4|||
42325384|NCT01587274|76163088|FG001|Overall Study|Lost to Follow-up|5|||
42325385|NCT01587274|76163089|FG002|Overall Study|Lost to Follow-up|3|||
42325386|NCT01587118|76163097|FG000|Overall Study|Adverse Event|3|||
41995903|NCT00179673|75803937|FG000|Overall Study|Lack of Efficacy|15|||
42325387|NCT01587118|76163097|FG000|Overall Study|Lost to Follow-up|2|||
42325388|NCT01587118|76163097|FG000|Overall Study|Relocation|1|||
42325389|NCT01587118|76163097|FG000|Overall Study|nonresponse|1|||
41995904|NCT00179673|75803937|FG000|Overall Study|Withdrawal by Subject|3|||
41995905|NCT00179673|75803937|FG000|Overall Study|Death|4|||
42325390|NCT01905657|76163104|FG000|Overall Study|Adverse Event|23|||
42325391|NCT01905657|76163105|FG001|Overall Study|Adverse Event|17|||
42325392|NCT01905657|76163106|FG002|Overall Study|Adverse Event|18|||
42325393|NCT01905657|76163104|FG000|Overall Study|Clinical Progression|103|||
42325394|NCT01905657|76163105|FG001|Overall Study|Clinical Progression|78|||
42325395|NCT01905657|76163106|FG002|Overall Study|Clinical Progression|59|||
42325396|NCT01905657|76163104|FG000|Overall Study|Death|40|||
42325397|NCT01905657|76163105|FG001|Overall Study|Death|43|||
42325398|NCT01905657|76163106|FG002|Overall Study|Death|47|||
42325399|NCT01905657|76163104|FG000|Overall Study|Excluded Medication|13|||
42325400|NCT01905657|76163105|FG001|Overall Study|Excluded Medication|16|||
42325401|NCT01905657|76163106|FG002|Overall Study|Excluded Medication|9|||
42325402|NCT01905657|76163104|FG000|Overall Study|Lost to Follow-up|1|||
42325403|NCT01905657|76163105|FG001|Overall Study|Lost to Follow-up|2|||
42325404|NCT01905657|76163106|FG002|Overall Study|Lost to Follow-up|1|||
42325405|NCT01905657|76163104|FG000|Overall Study|Physician Decision|5|||
42325406|NCT01905657|76163105|FG001|Overall Study|Physician Decision|8|||
42325407|NCT01905657|76163106|FG002|Overall Study|Physician Decision|12|||
42325408|NCT01905657|76163104|FG000|Overall Study|Protocol Violation|2|||
42325409|NCT01905657|76163105|FG001|Overall Study|Protocol Violation|1|||
42325410|NCT01905657|76163106|FG002|Overall Study|Protocol Violation|1|||
42325411|NCT01905657|76163104|FG000|Overall Study|Screen Failure|0|||
42325412|NCT01905657|76163105|FG001|Overall Study|Screen Failure|1|||
42325413|NCT01905657|76163106|FG002|Overall Study|Screen Failure|0|||
42325414|NCT01905657|76163104|FG000|Overall Study|Withdrawal by Subject|15|||
42325415|NCT01905657|76163105|FG001|Overall Study|Withdrawal by Subject|21|||
42325416|NCT01905657|76163106|FG002|Overall Study|Withdrawal by Subject|53|||
42325417|NCT01905657|76163104|FG000|Overall Study|Sponsor Decision|1|||
42325418|NCT01905657|76163105|FG001|Overall Study|Sponsor Decision|0|||
42325419|NCT01905657|76163106|FG002|Overall Study|Sponsor Decision|0|||
42325420|NCT02202980|76163131|FG000|Overall Study|Lack of Efficacy|1|||
42325421|NCT02202980|76163132|FG001|Overall Study|Lack of Efficacy|0|||
42325422|NCT02202980|76163133|FG002|Overall Study|Lack of Efficacy|7|||
42325423|NCT02202980|76163134|FG003|Overall Study|Lack of Efficacy|0|||
42325424|NCT02202980|76163135|FG004|Overall Study|Lack of Efficacy|3|||
42325425|NCT02202980|76163136|FG005|Overall Study|Lack of Efficacy|1|||
42325426|NCT02202980|76163137|FG006|Overall Study|Lack of Efficacy|11|||
42325427|NCT02202980|76163138|FG007|Overall Study|Lack of Efficacy|2|||
42325428|NCT02202980|76163139|FG008|Overall Study|Lack of Efficacy|2|||
42325429|NCT02202980|76163140|FG009|Overall Study|Lack of Efficacy|0|||
42325430|NCT02202980|76163141|FG010|Overall Study|Lack of Efficacy|0|||
42325431|NCT02202980|76163142|FG011|Overall Study|Lack of Efficacy|3|||
42325432|NCT02202980|76163143|FG012|Overall Study|Lack of Efficacy|10|||
42325433|NCT02202980|76163144|FG013|Overall Study|Lack of Efficacy|0|||
42325434|NCT02202980|76163131|FG000|Overall Study|Protocol Violation|0|||
42325435|NCT02202980|76163132|FG001|Overall Study|Protocol Violation|0|||
42325436|NCT02202980|76163133|FG002|Overall Study|Protocol Violation|0|||
42325437|NCT02202980|76163134|FG003|Overall Study|Protocol Violation|3|||
42325438|NCT02202980|76163135|FG004|Overall Study|Protocol Violation|3|||
42325439|NCT02202980|76163136|FG005|Overall Study|Protocol Violation|0|||
42325440|NCT02202980|76163137|FG006|Overall Study|Protocol Violation|0|||
42325441|NCT02202980|76163138|FG007|Overall Study|Protocol Violation|0|||
41995906|NCT00179673|75803937|FG000|Overall Study|Other Observations and options|14|||
41995907|NCT01084655|75803944|FG000|Overall Study|Radiographic disease progression|3|||
41995908|NCT01084655|75803945|FG001|Overall Study|Radiographic disease progression|2|||
42133987|NCT00548249|75944858|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
42325442|NCT02202980|76163139|FG008|Overall Study|Protocol Violation|0|||
42325443|NCT02202980|76163140|FG009|Overall Study|Protocol Violation|0|||
42261140|NCT01335997|76088612|FG000|Period I and II|Lost to Follow-up|3|||
42261141|NCT01335997|76088613|FG001|Period I and II|Lost to Follow-up|5|||
42261142|NCT01335997|76088612|FG000|Period I and II|Withdrawal by Subject|9|||
42261143|NCT01335997|76088613|FG001|Period I and II|Withdrawal by Subject|4|||
42261144|NCT01335997|76088612|FG000|Period I and II|Study Terminated by Sponsor|406|||
42261145|NCT01335997|76088613|FG001|Period I and II|Study Terminated by Sponsor|415|||
42261146|NCT01335997|76088612|FG000|Period I and II|Protocol Violation|9|||
42261147|NCT01335997|76088613|FG001|Period I and II|Protocol Violation|10|||
42261148|NCT01335997|76088612|FG000|Period I and II|Physician Decision|2|||
42325444|NCT02202980|76163141|FG010|Overall Study|Protocol Violation|0|||
42325445|NCT02202980|76163142|FG011|Overall Study|Protocol Violation|0|||
42325446|NCT02202980|76163143|FG012|Overall Study|Protocol Violation|0|||
42325447|NCT02202980|76163144|FG013|Overall Study|Protocol Violation|0|||
42325448|NCT02202980|76163131|FG000|Overall Study|Lost to Follow-up|0|||
42325449|NCT02202980|76163132|FG001|Overall Study|Lost to Follow-up|1|||
42325450|NCT02202980|76163133|FG002|Overall Study|Lost to Follow-up|1|||
42325451|NCT02202980|76163134|FG003|Overall Study|Lost to Follow-up|1|||
42325452|NCT02202980|76163135|FG004|Overall Study|Lost to Follow-up|0|||
42325453|NCT02202980|76163136|FG005|Overall Study|Lost to Follow-up|0|||
42325454|NCT02202980|76163137|FG006|Overall Study|Lost to Follow-up|0|||
42325455|NCT02202980|76163138|FG007|Overall Study|Lost to Follow-up|1|||
42325456|NCT02202980|76163139|FG008|Overall Study|Lost to Follow-up|1|||
42325457|NCT02202980|76163140|FG009|Overall Study|Lost to Follow-up|0|||
42325458|NCT02202980|76163141|FG010|Overall Study|Lost to Follow-up|0|||
42325459|NCT02202980|76163142|FG011|Overall Study|Lost to Follow-up|0|||
42325460|NCT02202980|76163143|FG012|Overall Study|Lost to Follow-up|1|||
42325461|NCT02202980|76163144|FG013|Overall Study|Lost to Follow-up|0|||
42325462|NCT02202980|76163131|FG000|Overall Study|Withdrew Consent|0|||
42325463|NCT02202980|76163132|FG001|Overall Study|Withdrew Consent|1|||
42325464|NCT02202980|76163133|FG002|Overall Study|Withdrew Consent|2|||
42325465|NCT02202980|76163134|FG003|Overall Study|Withdrew Consent|0|||
42325466|NCT02202980|76163135|FG004|Overall Study|Withdrew Consent|0|||
42325467|NCT02202980|76163136|FG005|Overall Study|Withdrew Consent|0|||
42325468|NCT02202980|76163137|FG006|Overall Study|Withdrew Consent|0|||
42325469|NCT02202980|76163138|FG007|Overall Study|Withdrew Consent|0|||
42325470|NCT02202980|76163139|FG008|Overall Study|Withdrew Consent|1|||
42325471|NCT02202980|76163140|FG009|Overall Study|Withdrew Consent|0|||
42325472|NCT02202980|76163141|FG010|Overall Study|Withdrew Consent|0|||
42325473|NCT02202980|76163142|FG011|Overall Study|Withdrew Consent|0|||
42325474|NCT02202980|76163143|FG012|Overall Study|Withdrew Consent|0|||
42325475|NCT02202980|76163144|FG013|Overall Study|Withdrew Consent|0|||
42325476|NCT01952145|76163176|FG000|Overall Study|Protocol Violation|2|||
42325477|NCT01952145|76163177|FG001|Overall Study|Protocol Violation|1|||
42325478|NCT01952145|76163176|FG000|Overall Study|Death|0|||
42325479|NCT01952145|76163177|FG001|Overall Study|Death|1|||
42325480|NCT01952145|76163176|FG000|Overall Study|Adverse Event|9|||
42325481|NCT01952145|76163177|FG001|Overall Study|Adverse Event|0|||
42325482|NCT01952145|76163176|FG000|Overall Study|Withdrawal Criteria|16|||
42325483|NCT01952145|76163177|FG001|Overall Study|Withdrawal Criteria|11|||
42325484|NCT01952145|76163176|FG000|Overall Study|Unclassified|1|||
42325485|NCT01952145|76163177|FG001|Overall Study|Unclassified|1|||
42325486|NCT01923363|76163183|FG000|Overall Study|Protocol Violation|1|||
42325487|NCT01905267|76163189|FG000|Overall Study|Physician Decision|2|||
42325488|NCT01905267|76163190|FG001|Overall Study|Physician Decision|2|||
42325489|NCT01923285|76163198|FG000|Overall Study|Withdrawal by Subject|7|||
42325490|NCT01923285|76163199|FG001|Overall Study|Withdrawal by Subject|6|||
42325491|NCT01904721|76163212|FG000|Overall Study|Other Reasons|0|||
42325492|NCT01904721|76163213|FG001|Overall Study|Other Reasons|0|||
42325493|NCT01904721|76163214|FG002|Overall Study|Other Reasons|1|||
42325494|NCT01904721|76163215|FG003|Overall Study|Other Reasons|1|||
42325495|NCT01904721|76163216|FG004|Overall Study|Other Reasons|2|||
42325496|NCT01904721|76163217|FG005|Overall Study|Other Reasons|2|||
42325497|NCT01904721|76163218|FG006|Overall Study|Other Reasons|2|||
42325498|NCT01904721|76163212|FG000|Overall Study|Personal Reasons|0|||
42325499|NCT01904721|76163213|FG001|Overall Study|Personal Reasons|0|||
42325500|NCT01904721|76163214|FG002|Overall Study|Personal Reasons|0|||
42325501|NCT01904721|76163215|FG003|Overall Study|Personal Reasons|0|||
42325502|NCT01904721|76163216|FG004|Overall Study|Personal Reasons|2|||
42325503|NCT01904721|76163217|FG005|Overall Study|Personal Reasons|3|||
42325504|NCT01904721|76163218|FG006|Overall Study|Personal Reasons|3|||
42325505|NCT01904721|76163212|FG000|Overall Study|Lost to Follow-up|0|||
42325506|NCT01904721|76163213|FG001|Overall Study|Lost to Follow-up|0|||
42325507|NCT01904721|76163214|FG002|Overall Study|Lost to Follow-up|0|||
42325508|NCT01904721|76163215|FG003|Overall Study|Lost to Follow-up|0|||
42325509|NCT01904721|76163216|FG004|Overall Study|Lost to Follow-up|1|||
42325510|NCT01904721|76163217|FG005|Overall Study|Lost to Follow-up|3|||
42325511|NCT01904721|76163218|FG006|Overall Study|Lost to Follow-up|1|||
42325512|NCT01904721|76163212|FG000|Overall Study|Lack of Efficacy|0|||
42325513|NCT01904721|76163213|FG001|Overall Study|Lack of Efficacy|0|||
42325514|NCT01904721|76163214|FG002|Overall Study|Lack of Efficacy|0|||
42325515|NCT01904721|76163215|FG003|Overall Study|Lack of Efficacy|0|||
42325516|NCT01904721|76163216|FG004|Overall Study|Lack of Efficacy|0|||
42325517|NCT01904721|76163217|FG005|Overall Study|Lack of Efficacy|0|||
42325518|NCT01904721|76163218|FG006|Overall Study|Lack of Efficacy|1|||
42325519|NCT01904721|76163212|FG000|Overall Study|Adverse Event|0|||
42325520|NCT01904721|76163213|FG001|Overall Study|Adverse Event|0|||
42325521|NCT01904721|76163214|FG002|Overall Study|Adverse Event|0|||
42325522|NCT01904721|76163215|FG003|Overall Study|Adverse Event|0|||
42325523|NCT01904721|76163216|FG004|Overall Study|Adverse Event|3|||
42325524|NCT01904721|76163217|FG005|Overall Study|Adverse Event|1|||
42325525|NCT01904721|76163218|FG006|Overall Study|Adverse Event|0|||
42325526|NCT01904019|76163230|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
42325527|NCT01904019|76163230|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
42325528|NCT01904019|76163230|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
42325529|NCT01904019|76163230|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
42325530|NCT01904019|76163230|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
42325531|NCT01904019|76163230|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
42325532|NCT01922895|76163236|FG000|Overall Study|Death|0|||
42325533|NCT01922895|76163237|FG001|Overall Study|Death|1|||
42325534|NCT01922895|76163236|FG000|Overall Study|Withdrawal by Subject|1|||
42325535|NCT01922895|76163237|FG001|Overall Study|Withdrawal by Subject|2|||
42325536|NCT01922895|76163236|FG000|Overall Study|Lost to Follow-up|5|||
42325537|NCT01922895|76163237|FG001|Overall Study|Lost to Follow-up|11|||
42325538|NCT01922739|76163245|FG000|Titration/Adjustment Period|Adverse Event|3|||
42325539|NCT01922739|76163245|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
42325540|NCT01922739|76163245|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
42325541|NCT01922739|76163245|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
42325542|NCT01922739|76163245|FG000|Open-label Treatment Period|Adverse Event|6|||
42325543|NCT01922739|76163245|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
42325544|NCT01922739|76163245|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
42325545|NCT01922739|76163245|FG000|Open-label Treatment Period|Protocol Violation|5|||
42325546|NCT01922739|76163245|FG000|Open-label Treatment Period|Pregnancy|1|||
42325547|NCT01922739|76163245|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
42325548|NCT01922739|76163245|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
42325549|NCT01922739|76163245|FG000|Open-label Treatment Period|Physician Decision|1|||
42325550|NCT01922739|76163245|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
42325551|NCT02236988|76163265|FG000|Overall Study|Lost to Follow-up|0|||
42325552|NCT02236988|76163266|FG001|Overall Study|Lost to Follow-up|0|||
42325553|NCT02236988|76163267|FG002|Overall Study|Lost to Follow-up|0|||
42325554|NCT02236988|76163268|FG003|Overall Study|Lost to Follow-up|1|||
42325555|NCT02236988|76163265|FG000|Overall Study|Unable to Comply with Study Visits|0|||
42325556|NCT02236988|76163266|FG001|Overall Study|Unable to Comply with Study Visits|0|||
42325557|NCT02236988|76163267|FG002|Overall Study|Unable to Comply with Study Visits|0|||
42325558|NCT02236988|76163268|FG003|Overall Study|Unable to Comply with Study Visits|2|||
42325559|NCT02236598|76163321|FG000|Overall Study|Adverse Event|0|||
42325560|NCT02236598|76163322|FG001|Overall Study|Adverse Event|1|||
42325561|NCT02236598|76163321|FG000|Overall Study|Withdrawal by Subject|0|||
42325562|NCT02236598|76163322|FG001|Overall Study|Withdrawal by Subject|1|||
42325563|NCT01922349|76163332|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
42325564|NCT01922349|76163333|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
42325565|NCT01922349|76163334|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
42325566|NCT01922349|76163335|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
42325567|NCT02236520|76163373|FG000|Overall Study|Physician Decision|0|||
42325568|NCT02236520|76163374|FG001|Overall Study|Physician Decision|5|||
42325569|NCT02236520|76163375|FG002|Overall Study|Physician Decision|0|||
42325570|NCT02236520|76163376|FG003|Overall Study|Physician Decision|0|||
42325571|NCT02236520|76163373|FG000|Overall Study|Withdrawal by Subject|1|||
42325572|NCT02236520|76163374|FG001|Overall Study|Withdrawal by Subject|0|||
42325573|NCT02236520|76163375|FG002|Overall Study|Withdrawal by Subject|0|||
42325574|NCT02236520|76163376|FG003|Overall Study|Withdrawal by Subject|1|||
42325575|NCT02236520|76163373|FG000|Overall Study|Pregnancy|1|||
42325576|NCT02236520|76163374|FG001|Overall Study|Pregnancy|0|||
42325577|NCT02236520|76163375|FG002|Overall Study|Pregnancy|0|||
42325578|NCT02236520|76163376|FG003|Overall Study|Pregnancy|0|||
42325579|NCT01922271|76163388|FG000|WASHOUT Period|Withdrawal by Subject|1|||
42325580|NCT01922271|76163389|FG001|WASHOUT Period|Withdrawal by Subject|0|||
42325581|NCT02236130|76163397|FG000|Overall Study|Lost to Follow-up|7|||
42325582|NCT02236130|76163398|FG001|Overall Study|Lost to Follow-up|12|||
42325583|NCT02233946|76163406|FG000|Baseline|Withdrawal by Subject|2|||
41995909|NCT01084655|75803946|FG002|Overall Study|Radiographic disease progression|8|||
41995910|NCT01084655|75803944|FG000|Overall Study|Withdrawal by Subject|1|||
42325584|NCT02233946|76163407|FG001|Baseline|Withdrawal by Subject|0|||
42325585|NCT02233946|76163406|FG000|3-months Follow-up|Lost to Follow-up|53|||
42325586|NCT02233946|76163407|FG001|3-months Follow-up|Lost to Follow-up|29|||
42325587|NCT02233946|76163406|FG000|6-months Follow-up|Lost to Follow-up|21|||
42325588|NCT02233946|76163407|FG001|6-months Follow-up|Lost to Follow-up|2|||
41995911|NCT01084655|75803945|FG001|Overall Study|Withdrawal by Subject|0|||
42325589|NCT02233946|76163406|FG000|9-month Follow-up|Lost to Follow-up|20|||
42325590|NCT02233946|76163407|FG001|9-month Follow-up|Lost to Follow-up|11|||
42325591|NCT02233946|76163406|FG000|12-month Follow-up|Lost to Follow-up|28|||
42325592|NCT02233946|76163407|FG001|12-month Follow-up|Lost to Follow-up|11|||
42325593|NCT02232698|76163415|FG000|Overall Study|Pregnancy|1|||
42325594|NCT02232698|76163416|FG001|Overall Study|Pregnancy|1|||
42325595|NCT02232698|76163415|FG000|Overall Study|Met exclusion criteria|1|||
42325596|NCT02232698|76163416|FG001|Overall Study|Met exclusion criteria|1|||
42325597|NCT02232698|76163415|FG000|Overall Study|Had device-associated symptoms|7|||
42325598|NCT02232698|76163416|FG001|Overall Study|Had device-associated symptoms|0|||
42325599|NCT02232698|76163415|FG000|Overall Study|Non-compliance with study device|1|||
41995912|NCT01084655|75803946|FG002|Overall Study|Withdrawal by Subject|4|||
41995913|NCT01084655|75803944|FG000|Overall Study|Adverse Event|2|||
41995914|NCT01084655|75803945|FG001|Overall Study|Adverse Event|1|||
42325600|NCT02232698|76163416|FG001|Overall Study|Non-compliance with study device|4|||
42325601|NCT02232698|76163415|FG000|Overall Study|Allocated to control group|0|||
42325602|NCT02232698|76163416|FG001|Overall Study|Allocated to control group|3|||
42325603|NCT02232698|76163415|FG000|Overall Study|Withdrawal by Subject|0|||
42325604|NCT02232698|76163416|FG001|Overall Study|Withdrawal by Subject|11|||
42325605|NCT01632878|76163424|FG000|Screening|Physician Decision|268|||
42325606|NCT01632878|76163424|FG000|Treatment|Lost to Follow-up|41|||
41995915|NCT01084655|75803946|FG002|Overall Study|Adverse Event|2|||
41995916|NCT01084655|75803944|FG000|Overall Study|Other|0|||
42325607|NCT01632878|76163424|FG000|Treatment|Withdrawal by Subject|36|||
42325608|NCT01632878|76163424|FG000|Treatment|Physician Decision|34|||
42325609|NCT01632878|76163424|FG000|Treatment|missing information|4|||
42325610|NCT01632878|76163424|FG000|Treatment|no information on study completion|43|||
42325611|NCT01632800|76163428|FG000|Overall Study|Subject did not fit in apparatus|1|||
42325612|NCT01641809|76163436|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
42325613|NCT01641809|76163437|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
42325614|NCT01641809|76163438|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
42325615|NCT01641809|76163439|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
41995917|NCT01084655|75803945|FG001|Overall Study|Other|3|||
41995918|NCT01084655|75803946|FG002|Overall Study|Other|2|||
41995919|NCT01084655|75803944|FG000|Overall Study|Symptomatic deterioration|0|||
41995920|NCT01084655|75803945|FG001|Overall Study|Symptomatic deterioration|0|||
41995921|NCT01084655|75803946|FG002|Overall Study|Symptomatic deterioration|2|||
41995922|NCT01084655|75803944|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
41995923|NCT01084655|75803945|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
42325616|NCT01641809|76163436|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
42325617|NCT01641809|76163437|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
42325618|NCT01641809|76163438|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
42325619|NCT01641809|76163439|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
42325620|NCT01641809|76163436|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
42325621|NCT01641809|76163437|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
42325622|NCT01641809|76163438|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
42325623|NCT01641809|76163439|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
42325624|NCT01641809|76163436|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
42325625|NCT01641809|76163437|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
42325626|NCT01641809|76163438|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
41995924|NCT01084655|75803946|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
41995925|NCT01084538|75803958|FG000|Overall Study|Drug not available|30|||
41995926|NCT01084538|75803958|FG000|Overall Study|Adverse Event|9|||
42034425|NCT01125293|75842519|FG005|Overall Study|Symptomatic Deterioration|0|||
42034426|NCT01125293|75842514|FG000|Overall Study|Death|0|||
42034427|NCT01125293|75842515|FG001|Overall Study|Death|0|||
42034428|NCT01125293|75842516|FG002|Overall Study|Death|0|||
42325627|NCT01641809|76163439|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
42325628|NCT01641809|76163436|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
42325629|NCT01641809|76163437|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
42325630|NCT01641809|76163438|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
42325631|NCT01641809|76163439|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
42325632|NCT01641809|76163436|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
42325633|NCT01641809|76163437|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
42325634|NCT01641809|76163438|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
42325635|NCT01641809|76163439|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
42325636|NCT01641809|76163436|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
42325637|NCT01641809|76163437|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
42325638|NCT01641809|76163438|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
42325639|NCT01641809|76163439|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
41995927|NCT01084538|75803958|FG000|Overall Study|Kidney transplant|6|||
41995928|NCT01084538|75803958|FG000|Overall Study|Serious Adverse Event|3|||
41995929|NCT01084538|75803958|FG000|Overall Study|Lack of effectiveness|2|||
42034429|NCT01125293|75842517|FG003|Overall Study|Death|0|||
41995930|NCT01084538|75803958|FG000|Overall Study|Patient noncompliance|2|||
42034430|NCT01125293|75842518|FG004|Overall Study|Death|1|||
42034431|NCT01125293|75842519|FG005|Overall Study|Death|0|||
41995931|NCT01084538|75803958|FG000|Overall Study|Hyperphosphatemia|2|||
41995932|NCT01084538|75803958|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
41995933|NCT01084538|75803958|FG000|Overall Study|Change of residence|2|||
41995934|NCT01084538|75803958|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
41995935|NCT01084538|75803958|FG000|Overall Study|Reason unknown|8|||
41995936|NCT01083680|75803962|FG000|Overall Study|Lost to Follow-up|2758|||
41995937|NCT01083680|75803962|FG000|Overall Study|Withdrawal by Subject|1086|||
41995938|NCT00179517|75803968|FG000|Overall Study|Withdrawal by Subject|2|||
41995939|NCT00179517|75803969|FG001|Overall Study|Withdrawal by Subject|1|||
41995940|NCT01083641|75803975|FG000|Overall Study|Withdrawal by Subject|2|||
42261149|NCT01335997|76088613|FG001|Period I and II|Physician Decision|1|||
42261150|NCT01335997|76088612|FG000|Period III|Adverse Event|0|||
42325640|NCT01641809|76163436|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
42325641|NCT01641809|76163437|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
42325642|NCT01641809|76163438|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
42325643|NCT01641809|76163439|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
42325644|NCT01641809|76163436|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
42325645|NCT01641809|76163437|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
42325646|NCT01641809|76163438|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
42325647|NCT01641809|76163439|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
42325648|NCT01641809|76163436|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
42325649|NCT01641809|76163437|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
42325650|NCT01641809|76163438|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
42325651|NCT01641809|76163439|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
42325652|NCT01641809|76163436|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
42325653|NCT01641809|76163437|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
42325654|NCT01641809|76163438|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
42325655|NCT01641809|76163439|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
42325656|NCT01641809|76163436|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
42325657|NCT01641809|76163437|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
42325658|NCT01641809|76163438|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
42325659|NCT01641809|76163439|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
42325660|NCT01641809|76163436|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
42325661|NCT01641809|76163437|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
42325662|NCT01641809|76163438|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
42325663|NCT01641809|76163439|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
42325664|NCT01641809|76163436|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
42325665|NCT01641809|76163437|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
42325666|NCT01641809|76163438|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
42325667|NCT01641809|76163439|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
42325668|NCT01641809|76163436|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
42325669|NCT01641809|76163437|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
42325670|NCT01641809|76163438|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
42325671|NCT01641809|76163439|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
42325672|NCT01641809|76163436|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
42261151|NCT01335997|76088613|FG001|Period III|Adverse Event|2|||
42261152|NCT01335997|76088612|FG000|Period III|Study Terminated by Sponsor|77|||
42261153|NCT01335997|76088613|FG001|Period III|Study Terminated by Sponsor|76|||
42261154|NCT01335997|76088612|FG000|Period III|Protocol Violation|0|||
42261155|NCT01335997|76088613|FG001|Period III|Protocol Violation|1|||
42261156|NCT01335997|76088612|FG000|Period III|Lost to Follow-up|1|||
42261157|NCT01335997|76088613|FG001|Period III|Lost to Follow-up|0|||
41995941|NCT00179010|75803981|FG000|Overall Study|Muscle probe defective|1|||
41995942|NCT00179010|75803982|FG001|Overall Study|Muscle probe defective|1|||
41995943|NCT00179010|75803981|FG000|Overall Study|Failure to place arterial line|0|||
41995944|NCT00179010|75803982|FG001|Overall Study|Failure to place arterial line|1|||
41995945|NCT01083602|75803989|FG000|Overall Study|Adverse Event|11|||
41995946|NCT01083602|75803989|FG000|Overall Study|New Cancer Therapy|2|||
41995947|NCT01083602|75803989|FG000|Overall Study|Death|1|||
42261158|NCT02725671|76088621|FG000|Overall Study|Lost to Follow-up|1|||
42261159|NCT02446990|76088629|FG000|Overall Study|Death|485|||
42325673|NCT01641809|76163437|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
42325674|NCT01641809|76163438|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
42325675|NCT01641809|76163439|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
42325676|NCT01641809|76163436|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
42325677|NCT01641809|76163437|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
42325678|NCT01641809|76163438|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
42325679|NCT01641809|76163439|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
41995948|NCT01083602|75803989|FG000|Overall Study|Withdrawal by Subject|5|||
42325680|NCT01641809|76163436|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
42325681|NCT01641809|76163437|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
42325682|NCT01641809|76163438|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
42325683|NCT01641809|76163439|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
42325684|NCT01632566|76163462|FG000|Overall Study|Withdrawal by Subject|0|||
42325685|NCT01632566|76163463|FG001|Overall Study|Withdrawal by Subject|1|||
42325686|NCT01632566|76163464|FG002|Overall Study|Withdrawal by Subject|0|||
42325687|NCT01632566|76163465|FG003|Overall Study|Withdrawal by Subject|0|||
42325688|NCT01632566|76163466|FG004|Overall Study|Withdrawal by Subject|0|||
42325689|NCT01632566|76163462|FG000|Overall Study|Sponsor Decision|0|||
42325690|NCT01632566|76163463|FG001|Overall Study|Sponsor Decision|2|||
41995949|NCT01083602|75803989|FG000|Overall Study|Lack of Efficacy|36|||
41995950|NCT00178464|75803993|FG000|Overall Study|Withdrawal by Subject|1|||
41995951|NCT00178464|75803993|FG000|Overall Study|Physician Decision|1|||
42325691|NCT01632566|76163464|FG002|Overall Study|Sponsor Decision|9|||
42325692|NCT01632566|76163465|FG003|Overall Study|Sponsor Decision|2|||
42325693|NCT01632566|76163466|FG004|Overall Study|Sponsor Decision|2|||
42325694|NCT02254304|76163484|FG000|Overall Study|Adverse Event|2|||
42325695|NCT02254304|76163485|FG001|Overall Study|Adverse Event|1|||
42325696|NCT02254304|76163484|FG000|Overall Study|Lost to Follow-up|2|||
42325697|NCT02254304|76163485|FG001|Overall Study|Lost to Follow-up|2|||
42325698|NCT02254304|76163484|FG000|Overall Study|Protocol Violation|1|||
41995952|NCT01083485|75803999|FG000|Overall Study|Adverse Event|0|||
41995953|NCT01083485|75804000|FG001|Overall Study|Adverse Event|1|||
41995954|NCT01083485|75803999|FG000|Overall Study|Protocol Violation|1|||
41995955|NCT01083485|75804000|FG001|Overall Study|Protocol Violation|0|||
41995956|NCT01083485|75803999|FG000|Overall Study|Withdrawal by Subject|5|||
41995957|NCT01083485|75804000|FG001|Overall Study|Withdrawal by Subject|2|||
41995958|NCT01083485|75803999|FG000|Overall Study|Other|1|||
41995959|NCT01083485|75804000|FG001|Overall Study|Other|0|||
41995960|NCT01083173|75804008|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
41995961|NCT01083173|75804009|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
41995962|NCT01083173|75804008|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
41995963|NCT01083173|75804009|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
41995964|NCT01083173|75804008|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
41995965|NCT01083173|75804009|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
41995966|NCT01083173|75804008|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
41995967|NCT01083173|75804009|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
41995968|NCT01083173|75804008|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
41995969|NCT01083173|75804009|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
41995970|NCT01083173|75804008|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
41995971|NCT01083173|75804009|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
41995972|NCT01083173|75804008|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
41995973|NCT01083173|75804009|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
41995974|NCT01083173|75804008|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
41995975|NCT01083173|75804009|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
41995976|NCT01083173|75804008|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
41995977|NCT01083173|75804009|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
41995978|NCT01083173|75804008|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
42010571|NCT00993421|75817694|FG000|Overall Study|Withdrawal by Subject|3|||
42261160|NCT02446990|76088630|FG001|Overall Study|Death|458|||
42261161|NCT02446990|76088629|FG000|Overall Study|Lost to Follow-up|3|||
42261162|NCT02446990|76088630|FG001|Overall Study|Lost to Follow-up|1|||
42261163|NCT02446990|76088629|FG000|Overall Study|Physician Decision|1|||
42261164|NCT02446990|76088630|FG001|Overall Study|Physician Decision|0|||
42261165|NCT02446990|76088629|FG000|Overall Study|Withdrawal by Subject|231|||
42261166|NCT02446990|76088630|FG001|Overall Study|Withdrawal by Subject|199|||
42261167|NCT02725515|76088638|FG000|Overall Study|Refused infusion (no study treatment)|1|||
42261168|NCT02725515|76088639|FG001|Overall Study|Refused infusion (no study treatment)|0|||
42325699|NCT02254304|76163485|FG001|Overall Study|Protocol Violation|0|||
42325700|NCT02254304|76163484|FG000|Overall Study|Withdrawal by Subject|3|||
42325701|NCT02254304|76163485|FG001|Overall Study|Withdrawal by Subject|0|||
42325702|NCT02254304|76163484|FG000|Overall Study|Injection site pain and Injection fear|1|||
41995979|NCT01083173|75804009|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
41995980|NCT01083173|75804008|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
41995981|NCT01083173|75804009|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
41995982|NCT00177294|75804020|FG000|Overall Study|Withdrawal by Subject|7|||
41995983|NCT00177294|75804021|FG001|Overall Study|Withdrawal by Subject|5|||
42133988|NCT00548249|75944859|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
42325703|NCT02254304|76163485|FG001|Overall Study|Injection site pain and Injection fear|0|||
42325704|NCT02254304|76163484|FG000|Overall Study|Personal causes|4|||
42325705|NCT02254304|76163485|FG001|Overall Study|Personal causes|1|||
42325706|NCT02254304|76163484|FG000|Overall Study|Personal decision|1|||
42325707|NCT02254304|76163485|FG001|Overall Study|Personal decision|0|||
42261169|NCT02725515|76088638|FG000|Overall Study|Loss of Improvement per Protocol|14|||
42261170|NCT02725515|76088639|FG001|Overall Study|Loss of Improvement per Protocol|25|||
42325708|NCT02174731|76163495|FG000|Overall Study|Participant decision|67|||
42325709|NCT02174731|76163496|FG001|Overall Study|Participant decision|64|||
42261171|NCT02725515|76088638|FG000|Overall Study|Withdrawal by Subject|2|||
42261172|NCT02725515|76088639|FG001|Overall Study|Withdrawal by Subject|1|||
42261173|NCT02725515|76088638|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42261174|NCT02725515|76088639|FG001|Overall Study|Non-Compliance With Study Drug|3|||
42261175|NCT02725515|76088638|FG000|Overall Study|Lost to Follow-up|1|||
42325710|NCT02174731|76163495|FG000|Overall Study|Incorrect enrolment before randomization|0|||
42325711|NCT02174731|76163496|FG001|Overall Study|Incorrect enrolment before randomization|1|||
42325712|NCT02174731|76163495|FG000|Overall Study|Missing|2|||
42325713|NCT02174731|76163496|FG001|Overall Study|Missing|0|||
42325714|NCT01922037|76163504|FG000|Overall Study|Withdrawal by Subject|2|||
42325715|NCT01922037|76163505|FG001|Overall Study|Withdrawal by Subject|44|||
42325716|NCT01922037|76163504|FG000|Overall Study|Adverse Event|1|||
42325717|NCT01922037|76163505|FG001|Overall Study|Adverse Event|7|||
42325718|NCT01922037|76163504|FG000|Overall Study|Death|0|||
42325719|NCT01922037|76163505|FG001|Overall Study|Death|5|||
42261176|NCT02725515|76088639|FG001|Overall Study|Lost to Follow-up|1|||
42261177|NCT02725515|76088638|FG000|Overall Study|Adverse Event|7|||
42261178|NCT02725515|76088639|FG001|Overall Study|Adverse Event|2|||
42261179|NCT02725515|76088638|FG000|Overall Study|No Documented Disease Improvement|0|||
42261180|NCT02725515|76088639|FG001|Overall Study|No Documented Disease Improvement|1|||
42261181|NCT02725515|76088638|FG000|Overall Study|Completed Study Under Original Protocol|0|||
42261182|NCT02725515|76088639|FG001|Overall Study|Completed Study Under Original Protocol|1|||
42261183|NCT02725515|76088638|FG000|Overall Study|Lack of Response|0|||
42261184|NCT02725515|76088639|FG001|Overall Study|Lack of Response|1|||
42261185|NCT02416180|76088645|FG000|Overall Study|Withdrawal by Subject|1|||
42261186|NCT02473510|76088651|FG000|Overall Study|Lost to Follow-up|1|||
42261187|NCT02473510|76088652|FG001|Overall Study|Lost to Follow-up|2|||
42261188|NCT02445586|76088658|FG000|Overall Study|Death|14|||
42261189|NCT02445586|76088658|FG000|Overall Study|Withdrawal by Subject|13|||
42261190|NCT02445586|76088658|FG000|Overall Study|Disease Progression|10|||
42261191|NCT02445586|76088658|FG000|Overall Study|Protocol Violation|1|||
42261192|NCT02445586|76088658|FG000|Overall Study|Medical Condition|1|||
42261193|NCT01674062|76088664|FG000|Overall Study|Insufficient Therapeutic Response|56|||
42261194|NCT01674062|76088665|FG001|Overall Study|Insufficient Therapeutic Response|26|||
42261195|NCT01674062|76088664|FG000|Overall Study|Other|8|||
42261196|NCT01674062|76088665|FG001|Overall Study|Other|1|||
42261197|NCT01674062|76088664|FG000|Overall Study|Adverse Event|1|||
42261198|NCT01674062|76088665|FG001|Overall Study|Adverse Event|1|||
42261199|NCT01674062|76088664|FG000|Overall Study|Death|0|||
42261200|NCT01674062|76088665|FG001|Overall Study|Death|1|||
42261201|NCT01674062|76088664|FG000|Overall Study|Programming Error|1|||
42261202|NCT01674062|76088665|FG001|Overall Study|Programming Error|0|||
42261203|NCT02472886|76088674|FG000|Overall Study|Lack of Efficacy|0|||
42261204|NCT02472886|76088675|FG001|Overall Study|Lack of Efficacy|2|||
42261205|NCT02472886|76088676|FG002|Overall Study|Lack of Efficacy|1|||
42261206|NCT02472652|76088689|FG000|Overall Study|Lost to Follow-up|1|||
42325720|NCT01922037|76163504|FG000|Overall Study|Pregnancy|0|||
42325721|NCT01922037|76163505|FG001|Overall Study|Pregnancy|2|||
42325722|NCT01922037|76163504|FG000|Overall Study|Participant non-compliance|4|||
42325723|NCT01922037|76163505|FG001|Overall Study|Participant non-compliance|46|||
42325724|NCT01922037|76163504|FG000|Overall Study|Investigator/Sponsor decision|1|||
42325725|NCT01922037|76163505|FG001|Overall Study|Investigator/Sponsor decision|4|||
42325726|NCT01922037|76163504|FG000|Overall Study|Other unspecified|2|||
42325727|NCT01922037|76163505|FG001|Overall Study|Other unspecified|66|||
42325728|NCT02282813|76163516|FG000|Overall Study|Withdrawal by Subject|4|||
42325729|NCT02282813|76163517|FG001|Overall Study|Withdrawal by Subject|5|||
42325730|NCT02282813|76163518|FG002|Overall Study|Withdrawal by Subject|0|||
42325731|NCT02282813|76163516|FG000|Overall Study|Adverse Event|3|||
42325732|NCT02282813|76163517|FG001|Overall Study|Adverse Event|10|||
42325733|NCT02282813|76163518|FG002|Overall Study|Adverse Event|1|||
42325734|NCT02282813|76163516|FG000|Overall Study|Subject non-compliance|1|||
42325735|NCT02282813|76163517|FG001|Overall Study|Subject non-compliance|4|||
42325736|NCT02282813|76163518|FG002|Overall Study|Subject non-compliance|0|||
42325737|NCT02282813|76163516|FG000|Overall Study|Physician Decision|0|||
42325738|NCT02282813|76163517|FG001|Overall Study|Physician Decision|3|||
42325739|NCT02282813|76163518|FG002|Overall Study|Physician Decision|1|||
42325740|NCT02282813|76163516|FG000|Overall Study|Lost to Follow-up|2|||
42325741|NCT02282813|76163517|FG001|Overall Study|Lost to Follow-up|0|||
42325742|NCT02282813|76163518|FG002|Overall Study|Lost to Follow-up|1|||
42325743|NCT02282813|76163516|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
42325744|NCT02282813|76163517|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
42325745|NCT02282813|76163518|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
42325746|NCT02282813|76163516|FG000|Overall Study|Lack of Efficacy|1|||
42133989|NCT00548249|75944860|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
42133990|NCT00548249|75944861|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
42261207|NCT02807857|76088693|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
42261208|NCT02807857|76088693|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
42325747|NCT02282813|76163517|FG001|Overall Study|Lack of Efficacy|0|||
42325748|NCT02282813|76163518|FG002|Overall Study|Lack of Efficacy|0|||
42325749|NCT02282813|76163516|FG000|Overall Study|Administrative reasons|0|||
42133991|NCT00548249|75944857|FG000|Overall Study|Protocol Violation|1|||
42261209|NCT02807857|76088693|FG000|Follow-Up Set|Withdrawal by Subject|8|||
42261210|NCT02807857|76088693|FG000|Follow-Up Set|Lost to Follow-up|7|||
42261211|NCT02807857|76088693|FG000|Follow-Up Set|Physician Decision|6|||
42261212|NCT02807857|76088693|FG000|Follow-Up Set|Adverse Event|3|||
42261213|NCT02807857|76088693|FG000|Follow-Up Set|Death|27|||
42261214|NCT02807857|76088693|FG000|Follow-Up Set|Relocation|2|||
42261215|NCT02648438|76088706|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42261216|NCT02648438|76088707|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
42261217|NCT02648438|76088708|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
42261218|NCT02648438|76088706|FG000|Overall Study|Protocol Violation|2|||
42261219|NCT02648438|76088707|FG001|Overall Study|Protocol Violation|0|||
42261220|NCT02648438|76088708|FG002|Overall Study|Protocol Violation|0|||
42261221|NCT02648438|76088706|FG000|Overall Study|Withdrawal by Subject|1|||
42261222|NCT02648438|76088707|FG001|Overall Study|Withdrawal by Subject|1|||
42261223|NCT02648438|76088708|FG002|Overall Study|Withdrawal by Subject|0|||
42261224|NCT02415556|76088728|FG000|Overall Study|Adverse Event|3|||
42261225|NCT02415556|76088729|FG001|Overall Study|Adverse Event|4|||
42261226|NCT02415556|76088730|FG002|Overall Study|Adverse Event|2|||
42261227|NCT02415556|76088731|FG003|Overall Study|Adverse Event|4|||
42261228|NCT02415556|76088728|FG000|Overall Study|Lost to Follow-up|4|||
42261229|NCT02415556|76088729|FG001|Overall Study|Lost to Follow-up|5|||
42261230|NCT02415556|76088730|FG002|Overall Study|Lost to Follow-up|4|||
42261231|NCT02415556|76088731|FG003|Overall Study|Lost to Follow-up|1|||
42261232|NCT02415556|76088728|FG000|Overall Study|Withdrawal by Subject|13|||
42261233|NCT02415556|76088729|FG001|Overall Study|Withdrawal by Subject|4|||
42261234|NCT02415556|76088730|FG002|Overall Study|Withdrawal by Subject|14|||
42261235|NCT02415556|76088731|FG003|Overall Study|Withdrawal by Subject|12|||
42261236|NCT02415556|76088728|FG000|Overall Study|Physician Decision|1|||
42133992|NCT00548249|75944858|FG001|Overall Study|Protocol Violation|1|||
42261237|NCT02415556|76088729|FG001|Overall Study|Physician Decision|3|||
42261238|NCT02415556|76088730|FG002|Overall Study|Physician Decision|1|||
42261239|NCT02415556|76088731|FG003|Overall Study|Physician Decision|2|||
42261240|NCT02415556|76088728|FG000|Overall Study|Censored - study completion|4|||
42325750|NCT02282813|76163517|FG001|Overall Study|Administrative reasons|1|||
42325751|NCT02282813|76163518|FG002|Overall Study|Administrative reasons|0|||
42325752|NCT01903863|76163530|FG000|Overall Study|Physician Decision|2|||
42325753|NCT01903863|76163531|FG001|Overall Study|Physician Decision|0|||
42325754|NCT02123251|76163539|FG000|Overall Study|Death|1|||
42325755|NCT02123251|76163540|FG001|Overall Study|Death|1|||
42325756|NCT02123251|76163539|FG000|Overall Study|Withdrawal by Subject|0|||
42325757|NCT02123251|76163540|FG001|Overall Study|Withdrawal by Subject|3|||
42325758|NCT02123251|76163539|FG000|Overall Study|Lost Medicaid eligibility|29|||
42325759|NCT02123251|76163540|FG001|Overall Study|Lost Medicaid eligibility|22|||
42325760|NCT02123251|76163539|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
42325761|NCT02123251|76163540|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
42325762|NCT01902303|76163549|FG000|Overall Study|Adverse Event|0|||
41995984|NCT01082081|75804030|FG000|Overall Study|Lost to Follow-up|0|||
41995985|NCT01082081|75804031|FG001|Overall Study|Lost to Follow-up|0|||
41995986|NCT01082081|75804032|FG002|Overall Study|Lost to Follow-up|1|||
41995987|NCT01082081|75804030|FG000|Overall Study|Withdrawal by Subject|0|||
41995988|NCT01082081|75804031|FG001|Overall Study|Withdrawal by Subject|0|||
42133993|NCT00548249|75944859|FG002|Overall Study|Protocol Violation|4|||
42133994|NCT00548249|75944860|FG003|Overall Study|Protocol Violation|0|||
42133995|NCT00548249|75944861|FG004|Overall Study|Protocol Violation|3|||
42133996|NCT00548249|75944857|FG000|Overall Study|Miscellaneous|2|||
42325763|NCT01902303|76163550|FG001|Overall Study|Adverse Event|1|||
42325764|NCT01902303|76163549|FG000|Overall Study|Lost to Follow-up|0|||
42325765|NCT01902303|76163550|FG001|Overall Study|Lost to Follow-up|1|||
42325766|NCT01902303|76163549|FG000|Overall Study|Protocol Violation|2|||
42325767|NCT01902303|76163550|FG001|Overall Study|Protocol Violation|2|||
42133997|NCT00548249|75944858|FG001|Overall Study|Miscellaneous|3|||
42133998|NCT00548249|75944859|FG002|Overall Study|Miscellaneous|2|||
42325768|NCT01902303|76163549|FG000|Overall Study|subject lost investigational product|0|||
42325769|NCT01902303|76163550|FG001|Overall Study|subject lost investigational product|1|||
42325770|NCT01902303|76163549|FG000|Overall Study|Did not develop a cold sore|21|||
42325771|NCT01902303|76163550|FG001|Overall Study|Did not develop a cold sore|19|||
42325772|NCT02122783|76163560|FG000|Overall Study|Adverse Event|0|||
42325773|NCT02122783|76163561|FG001|Overall Study|Adverse Event|1|||
42325774|NCT01921257|76163570|FG000|Overall Study|Adverse Event|1|||
42325775|NCT01921257|76163570|FG000|Overall Study|Protocol Violation|1|||
41995989|NCT01082081|75804032|FG002|Overall Study|Withdrawal by Subject|1|||
41995990|NCT01082081|75804030|FG000|Overall Study|Other Reason|0|||
42261241|NCT02415556|76088729|FG001|Overall Study|Censored - study completion|5|||
41995991|NCT01082081|75804031|FG001|Overall Study|Other Reason|1|||
42261242|NCT02415556|76088730|FG002|Overall Study|Censored - study completion|1|||
41995992|NCT01082081|75804032|FG002|Overall Study|Other Reason|0|||
41995993|NCT00177216|75804043|FG000|Overall Study|Withdrawal by Subject|6|||
41995994|NCT00177216|75804044|FG001|Overall Study|Withdrawal by Subject|3|||
41995995|NCT00177216|75804045|FG002|Overall Study|Withdrawal by Subject|1|||
41995996|NCT01081886|75804059|FG000|Overall Study|Study termination|11|||
41995997|NCT01081886|75804060|FG001|Overall Study|Study termination|13|||
41995998|NCT01081769|75804068|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
41995999|NCT01081769|75804069|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
41996000|NCT01081769|75804068|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
41996001|NCT01081769|75804069|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
42325776|NCT01921257|76163570|FG000|Overall Study|Withdrawal by Subject|1|||
42325777|NCT02121847|76163575|FG000|Overall Study|Administrative Reasons|1|||
42325778|NCT02121847|76163575|FG000|Overall Study|Adverse Event|2|||
42325779|NCT01921179|76163581|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
42325780|NCT01921179|76163582|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
42325781|NCT01921179|76163581|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
42325782|NCT01921179|76163582|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
42325783|NCT01587040|76163593|FG000|Overall Study|Protocol Violation|0|||
42325784|NCT01587040|76163594|FG001|Overall Study|Protocol Violation|0|||
42325785|NCT01587040|76163595|FG002|Overall Study|Protocol Violation|1|||
42325786|NCT01587040|76163596|FG003|Overall Study|Protocol Violation|0|||
42325787|NCT01587040|76163593|FG000|Overall Study|Adverse Event|0|||
42325788|NCT01587040|76163594|FG001|Overall Study|Adverse Event|1|||
42325789|NCT01587040|76163595|FG002|Overall Study|Adverse Event|10|||
41996002|NCT01081769|75804068|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
41996003|NCT01081769|75804069|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
41996004|NCT01081769|75804068|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
41996005|NCT01081769|75804069|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
41996006|NCT01081769|75804068|FG000|CORE Intent-To-Treat|Adverse Event|14|||
41996007|NCT01081769|75804069|FG001|CORE Intent-To-Treat|Adverse Event|11|||
42261243|NCT02415556|76088731|FG003|Overall Study|Censored - study completion|0|||
42261244|NCT02415556|76088728|FG000|Overall Study|Family-related issues|0|||
42261245|NCT02415556|76088729|FG001|Overall Study|Family-related issues|0|||
42261246|NCT02415556|76088730|FG002|Overall Study|Family-related issues|0|||
42261247|NCT02415556|76088731|FG003|Overall Study|Family-related issues|1|||
42261248|NCT02807623|76088744|FG000|Overall Study|Lost to Follow-up|23|||
42261249|NCT02807623|76088745|FG001|Overall Study|Lost to Follow-up|18|||
42261250|NCT02807623|76088746|FG002|Overall Study|Lost to Follow-up|22|||
42261251|NCT02807623|76088744|FG000|Overall Study|Drug intolerance|0|||
42261252|NCT02807623|76088745|FG001|Overall Study|Drug intolerance|1|||
42261253|NCT02807623|76088746|FG002|Overall Study|Drug intolerance|0|||
42261254|NCT02807623|76088744|FG000|Overall Study|incomplete blood draw|0|||
42261255|NCT02807623|76088745|FG001|Overall Study|incomplete blood draw|2|||
42261256|NCT02807623|76088746|FG002|Overall Study|incomplete blood draw|1|||
42261257|NCT02805907|76088765|FG000|Overall Study|Lost to Follow-up|3|||
42261258|NCT02805907|76088766|FG001|Overall Study|Lost to Follow-up|3|||
42261259|NCT02723175|76088774|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
42261260|NCT02723175|76088775|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
42325790|NCT01587040|76163596|FG003|Overall Study|Adverse Event|0|||
42325791|NCT01587040|76163593|FG000|Overall Study|Disease progression|12|||
42325792|NCT01587040|76163594|FG001|Overall Study|Disease progression|1|||
42325793|NCT01587040|76163595|FG002|Overall Study|Disease progression|15|||
42325794|NCT01587040|76163596|FG003|Overall Study|Disease progression|3|||
42325795|NCT01587040|76163593|FG000|Overall Study|Other than specified|5|||
42325796|NCT01587040|76163594|FG001|Overall Study|Other than specified|1|||
42325797|NCT01587040|76163595|FG002|Overall Study|Other than specified|11|||
42325798|NCT01587040|76163596|FG003|Overall Study|Other than specified|1|||
42325799|NCT02144701|76163608|FG000|Overall Study|development of relapse, GVHD or death|9|||
42325800|NCT02144701|76163609|FG001|Overall Study|development of relapse, GVHD or death|3|||
42325801|NCT01921101|76163617|FG000|Overall Study|Death|16|||
42325802|NCT01921101|76163618|FG001|Overall Study|Death|6|||
42325803|NCT01586806|76163627|FG000|Overall Study|Protocol Violation|0|||
42325804|NCT01586806|76163628|FG001|Overall Study|Protocol Violation|1|||
42325805|NCT01586806|76163629|FG002|Overall Study|Protocol Violation|0|||
42261261|NCT02723175|76088774|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
42325806|NCT01586806|76163627|FG000|Overall Study|Withdrawal by Subject|1|||
42325807|NCT01586806|76163628|FG001|Overall Study|Withdrawal by Subject|0|||
41996008|NCT01081769|75804068|FG000|CORE Intent-To-Treat|Death|1|||
41996009|NCT01081769|75804069|FG001|CORE Intent-To-Treat|Death|1|||
41996010|NCT01081769|75804068|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
42261262|NCT02723175|76088775|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
42261263|NCT02801617|76088783|FG000|Overall Study|Protocol Violation|2|||
41996011|NCT01081769|75804069|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
41996012|NCT01081769|75804068|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
41996013|NCT01081769|75804069|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
41996014|NCT01081769|75804068|FG000|CORE Intent-To-Treat|Pregnancy|1|||
41996015|NCT01081769|75804069|FG001|CORE Intent-To-Treat|Pregnancy|0|||
41996016|NCT01081769|75804068|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
41996017|NCT01081769|75804069|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
41996018|NCT01081769|75804068|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
41996019|NCT01081769|75804069|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
41996020|NCT01081769|75804068|FG000|CORE Intent-To-Treat|Other|0|||
41996021|NCT01081769|75804069|FG001|CORE Intent-To-Treat|Other|1|||
42325808|NCT01586806|76163629|FG002|Overall Study|Withdrawal by Subject|0|||
42325809|NCT01586806|76163627|FG000|Overall Study|Lost to Follow-up|2|||
42325810|NCT01586806|76163628|FG001|Overall Study|Lost to Follow-up|3|||
42325811|NCT01586806|76163629|FG002|Overall Study|Lost to Follow-up|2|||
42325812|NCT02144077|76163639|FG000|Overall Study|Withdrawal by Subject|3|||
42325813|NCT02144077|76163640|FG001|Overall Study|Withdrawal by Subject|3|||
42325814|NCT02144077|76163639|FG000|Overall Study|Adverse Event|2|||
42325815|NCT02144077|76163640|FG001|Overall Study|Adverse Event|3|||
42325816|NCT02144077|76163639|FG000|Overall Study|Lost to Follow-up|2|||
42325817|NCT02144077|76163640|FG001|Overall Study|Lost to Follow-up|2|||
42325818|NCT02144077|76163639|FG000|Overall Study|Protocol Violation|1|||
42325819|NCT02144077|76163640|FG001|Overall Study|Protocol Violation|2|||
42325820|NCT02144077|76163639|FG000|Overall Study|Death|0|||
42325821|NCT02144077|76163640|FG001|Overall Study|Death|1|||
42325822|NCT02144077|76163639|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
42325823|NCT02144077|76163640|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
42325824|NCT02172625|76163648|FG000|Overall Study|Adverse Event|0|||
42325825|NCT02172625|76163649|FG001|Overall Study|Adverse Event|1|||
42325826|NCT02172625|76163648|FG000|Overall Study|Pregnancy|0|||
42325827|NCT02172625|76163649|FG001|Overall Study|Pregnancy|1|||
42325828|NCT02172625|76163648|FG000|Overall Study|car accident|0|||
42325829|NCT02172625|76163649|FG001|Overall Study|car accident|1|||
42325830|NCT02143843|76163659|FG000|Overall Study|Adverse Event|8|||
42325831|NCT02143843|76163659|FG000|Overall Study|Lack of Efficacy|2|||
42325832|NCT02143843|76163659|FG000|Overall Study|Withdrawal by Subject|2|||
42325833|NCT02121535|76163665|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
41996022|NCT01081769|75804068|FG000|CORE Intent-To-Treat|Ineligibility|3|||
41996023|NCT01081769|75804069|FG001|CORE Intent-To-Treat|Ineligibility|4|||
41996024|NCT01081769|75804068|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
41996025|NCT01081769|75804069|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
41996026|NCT01081769|75804068|FG000|CORE Intent-To-Treat|Patient Moved|2|||
41996027|NCT01081769|75804069|FG001|CORE Intent-To-Treat|Patient Moved|2|||
41996028|NCT01081301|75804075|FG000|Overall Study|Bereaved|3|||
41996029|NCT01081301|75804075|FG000|Overall Study|Too busy|5|||
41996030|NCT01081301|75804075|FG000|Overall Study|Patient too ill|2|||
41996031|NCT01081301|75804075|FG000|Overall Study|Lost to Follow-up|4|||
41996032|NCT00174954|75804096|FG000|Overall Study|Adverse Event|2|||
41996033|NCT00174954|75804096|FG000|Overall Study|No tophi found in MRI|1|||
41996034|NCT00174954|75804096|FG000|Overall Study|Physician Decision|1|||
41996035|NCT01081145|75804100|FG000|Open-Label Phase|Lack of Efficacy|56|||
41996036|NCT01081145|75804101|FG001|Open-Label Phase|Lack of Efficacy|0|||
41996037|NCT01081145|75804100|FG000|Open-Label Phase|Response criteria not met|46|||
41996038|NCT01081145|75804101|FG001|Open-Label Phase|Response criteria not met|0|||
41996039|NCT01081145|75804100|FG000|Open-Label Phase|Adverse Event|42|||
41996040|NCT01081145|75804101|FG001|Open-Label Phase|Adverse Event|0|||
42133999|NCT00548249|75944860|FG003|Overall Study|Miscellaneous|0|||
42134000|NCT00548249|75944861|FG004|Overall Study|Miscellaneous|2|||
42134001|NCT00548249|75944857|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
42134002|NCT00548249|75944858|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
42134003|NCT00548249|75944859|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
42261264|NCT02801617|76088784|FG001|Overall Study|Protocol Violation|6|||
42261265|NCT01334515|76088796|FG000|Overall Study|Adverse Event|1|||
42261266|NCT01334515|76088797|FG001|Overall Study|Adverse Event|6|||
42261267|NCT01334515|76088796|FG000|Overall Study|Death|1|||
42261268|NCT01334515|76088797|FG001|Overall Study|Death|0|||
42261269|NCT01334515|76088796|FG000|Overall Study|Lack of Efficacy|8|||
42261270|NCT01334515|76088797|FG001|Overall Study|Lack of Efficacy|21|||
42261271|NCT01334515|76088796|FG000|Overall Study|Physician Decision|1|||
42261272|NCT01334515|76088797|FG001|Overall Study|Physician Decision|1|||
42261273|NCT01334515|76088796|FG000|Overall Study|Withdrawal by Subject|1|||
41996041|NCT01081145|75804100|FG000|Open-Label Phase|Withdrawal by Subject|41|||
41996042|NCT01081145|75804101|FG001|Open-Label Phase|Withdrawal by Subject|0|||
41996043|NCT01081145|75804100|FG000|Open-Label Phase|Other|12|||
41996044|NCT01081145|75804101|FG001|Open-Label Phase|Other|0|||
42325834|NCT02121535|76163666|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
41996045|NCT01081145|75804100|FG000|Open-Label Phase|Lost to Follow-up|11|||
41996046|NCT01081145|75804101|FG001|Open-Label Phase|Lost to Follow-up|0|||
41996047|NCT01081145|75804100|FG000|Open-Label Phase|Protocol Violation|4|||
41996048|NCT01081145|75804101|FG001|Open-Label Phase|Protocol Violation|0|||
41996049|NCT01081145|75804100|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
41996050|NCT01081145|75804101|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
41996051|NCT01081145|75804100|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
42261274|NCT01334515|76088797|FG001|Overall Study|Withdrawal by Subject|1|||
42325835|NCT02121535|76163665|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
42325836|NCT02121535|76163666|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
42325837|NCT01586338|76163673|FG000|Overall Study|Adverse Event|3|||
42325838|NCT01586338|76163673|FG000|Overall Study|Lost to Follow-up|1|||
42325839|NCT01586338|76163673|FG000|Overall Study|Withdrawal by participant|3|||
42325840|NCT01586338|76163673|FG000|Overall Study|Other|1|||
42325841|NCT02143141|76163679|FG000|Overall Study|pain scores at 24 hours not collected|1|||
42325842|NCT02143141|76163680|FG001|Overall Study|pain scores at 24 hours not collected|0|||
42325843|NCT02171065|76163689|FG000|Overall Study|Withdrawal by Subject|1|||
42325844|NCT02171065|76163690|FG001|Overall Study|Withdrawal by Subject|0|||
42325845|NCT02171065|76163691|FG002|Overall Study|Withdrawal by Subject|0|||
41996052|NCT01081145|75804101|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
42261275|NCT02802319|76088805|FG000|Overall Study|Physician Decision|2|||
42325846|NCT02171065|76163689|FG000|Overall Study|Lost to Follow-up|0|||
42325847|NCT02171065|76163690|FG001|Overall Study|Lost to Follow-up|0|||
42325848|NCT02171065|76163691|FG002|Overall Study|Lost to Follow-up|1|||
42325849|NCT01566604|76163703|FG000|Overall Study|Patient's inability to use the device|1|||
42325850|NCT01566604|76163704|FG001|Overall Study|Patient's inability to use the device|0|||
42325851|NCT01566604|76163703|FG000|Overall Study|Administrative problems|1|||
42325852|NCT01566604|76163704|FG001|Overall Study|Administrative problems|0|||
42325853|NCT01566604|76163703|FG000|Overall Study|Lack of Efficacy|1|||
42325854|NCT01566604|76163704|FG001|Overall Study|Lack of Efficacy|2|||
42325855|NCT01566604|76163703|FG000|Overall Study|Protocol deviation|2|||
42325856|NCT01566604|76163704|FG001|Overall Study|Protocol deviation|0|||
42325857|NCT01566604|76163703|FG000|Overall Study|Abnormal laboratory value|2|||
42325858|NCT01566604|76163704|FG001|Overall Study|Abnormal laboratory value|0|||
42325859|NCT01566604|76163703|FG000|Overall Study|Death|4|||
42325860|NCT01566604|76163704|FG001|Overall Study|Death|1|||
42325861|NCT01566604|76163703|FG000|Overall Study|Adverse Event|4|||
42325862|NCT01566604|76163704|FG001|Overall Study|Adverse Event|2|||
42325863|NCT01566604|76163703|FG000|Overall Study|Withdrawal by Subject|9|||
42325864|NCT01566604|76163704|FG001|Overall Study|Withdrawal by Subject|6|||
42325865|NCT01684930|76163712|FG000|Overall Study|Withdrawal by Subject|3|||
42325866|NCT01684930|76163713|FG001|Overall Study|Withdrawal by Subject|1|||
42325867|NCT01566214|76163721|FG000|Overall Study|Lost to Follow-up|3|||
42325868|NCT01566214|76163722|FG001|Overall Study|Lost to Follow-up|0|||
42325869|NCT02253992|76163731|FG000|Overall Study|Study drug toxicity|1|||
42261276|NCT02802319|76088806|FG001|Overall Study|Physician Decision|1|||
42261277|NCT02802319|76088805|FG000|Overall Study|Lost to Follow-up|0|||
42261278|NCT02802319|76088806|FG001|Overall Study|Lost to Follow-up|4|||
42261279|NCT02415400|76088816|FG000|Overall Study|Adverse Event|0|||
42261280|NCT02415400|76088817|FG001|Overall Study|Adverse Event|1|||
42261281|NCT02415400|76088818|FG002|Overall Study|Adverse Event|1|||
42261282|NCT02415400|76088819|FG003|Overall Study|Adverse Event|2|||
42261283|NCT02415400|76088816|FG000|Overall Study|Participant request to stop therapy|4|||
42261284|NCT02415400|76088817|FG001|Overall Study|Participant request to stop therapy|3|||
42261285|NCT02415400|76088818|FG002|Overall Study|Participant request to stop therapy|8|||
42261286|NCT02415400|76088819|FG003|Overall Study|Participant request to stop therapy|6|||
42261287|NCT02415400|76088816|FG000|Overall Study|Participant withdrew consent|14|||
42261288|NCT02415400|76088817|FG001|Overall Study|Participant withdrew consent|12|||
42325870|NCT02253992|76163732|FG001|Overall Study|Study drug toxicity|0|||
42325871|NCT02253992|76163733|FG002|Overall Study|Study drug toxicity|10|||
42325872|NCT02253992|76163731|FG000|Overall Study|Disease progression|4|||
42325873|NCT02253992|76163732|FG001|Overall Study|Disease progression|3|||
42325874|NCT02253992|76163733|FG002|Overall Study|Disease progression|98|||
42325875|NCT02253992|76163731|FG000|Overall Study|Withdrawal by Subject|0|||
42325876|NCT02253992|76163732|FG001|Overall Study|Withdrawal by Subject|0|||
42325877|NCT02253992|76163733|FG002|Overall Study|Withdrawal by Subject|3|||
42325878|NCT02253992|76163731|FG000|Overall Study|Adverse Event|0|||
42261289|NCT02415400|76088818|FG002|Overall Study|Participant withdrew consent|30|||
42261290|NCT02415400|76088819|FG003|Overall Study|Participant withdrew consent|21|||
42261291|NCT02415400|76088816|FG000|Overall Study|Death|39|||
42325879|NCT02253992|76163732|FG001|Overall Study|Adverse Event|0|||
42325880|NCT02253992|76163733|FG002|Overall Study|Adverse Event|8|||
42325881|NCT02253992|76163731|FG000|Overall Study|Death|0|||
42325882|NCT02253992|76163732|FG001|Overall Study|Death|0|||
42261292|NCT02415400|76088817|FG001|Overall Study|Death|41|||
42261293|NCT02415400|76088818|FG002|Overall Study|Death|35|||
42261294|NCT02415400|76088819|FG003|Overall Study|Death|42|||
42325883|NCT02253992|76163733|FG002|Overall Study|Death|1|||
42325884|NCT02253992|76163731|FG000|Overall Study|Subject discontinued study drug|1|||
42325885|NCT02253992|76163732|FG001|Overall Study|Subject discontinued study drug|0|||
42325886|NCT02253992|76163733|FG002|Overall Study|Subject discontinued study drug|1|||
42325887|NCT02253992|76163731|FG000|Overall Study|Completed treatment as per protocol|0|||
42325888|NCT02253992|76163732|FG001|Overall Study|Completed treatment as per protocol|1|||
42325889|NCT02253992|76163733|FG002|Overall Study|Completed treatment as per protocol|22|||
42325890|NCT02253992|76163731|FG000|Overall Study|Other|0|||
42134004|NCT00548249|75944860|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
42134005|NCT00548249|75944861|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
42134006|NCT00548249|75944857|FG000|Overall Study|Adverse Event|2|||
42134007|NCT00548249|75944858|FG001|Overall Study|Adverse Event|2|||
42134008|NCT00548249|75944859|FG002|Overall Study|Adverse Event|0|||
42261295|NCT02415400|76088816|FG000|Overall Study|Lost to Follow-up|3|||
41996053|NCT01081145|75804100|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
41996054|NCT01081145|75804101|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
41996055|NCT01081145|75804100|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
41996056|NCT01081145|75804101|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
41996057|NCT01081145|75804100|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
42325891|NCT02253992|76163732|FG001|Overall Study|Other|0|||
42325892|NCT02253992|76163733|FG002|Overall Study|Other|1|||
41996058|NCT01081145|75804101|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
41996059|NCT01081145|75804100|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
42325893|NCT02252588|76163757|FG000|Overall Study|Withdrawal by Subject|4|||
41996060|NCT01081145|75804101|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
41996061|NCT01081145|75804100|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
41996062|NCT01081145|75804101|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
41996063|NCT00174915|75804114|FG000|Overall Study|Lost to Follow-up|19|||
41996064|NCT00174915|75804115|FG001|Overall Study|Lost to Follow-up|17|||
41996065|NCT00174915|75804116|FG002|Overall Study|Lost to Follow-up|9|||
41996066|NCT00174915|75804117|FG003|Overall Study|Lost to Follow-up|17|||
42261296|NCT02415400|76088817|FG001|Overall Study|Lost to Follow-up|3|||
42261297|NCT02415400|76088818|FG002|Overall Study|Lost to Follow-up|2|||
42261298|NCT02415400|76088819|FG003|Overall Study|Lost to Follow-up|5|||
42261299|NCT02415400|76088816|FG000|Overall Study|Poor/Non-Compliance|0|||
42261300|NCT02415400|76088817|FG001|Overall Study|Poor/Non-Compliance|1|||
42261301|NCT02415400|76088818|FG002|Overall Study|Poor/Non-Compliance|3|||
42261302|NCT02415400|76088819|FG003|Overall Study|Poor/Non-Compliance|4|||
42261303|NCT02415400|76088816|FG000|Overall Study|Participant no longer meets criteria|2|||
42261304|NCT02415400|76088817|FG001|Overall Study|Participant no longer meets criteria|0|||
42261305|NCT02415400|76088818|FG002|Overall Study|Participant no longer meets criteria|0|||
42261306|NCT02415400|76088819|FG003|Overall Study|Participant no longer meets criteria|1|||
42261307|NCT02415400|76088816|FG000|Overall Study|Participant doesn't answer phone|1|||
42261308|NCT02415400|76088817|FG001|Overall Study|Participant doesn't answer phone|0|||
42261309|NCT02415400|76088818|FG002|Overall Study|Participant doesn't answer phone|0|||
42261310|NCT02415400|76088819|FG003|Overall Study|Participant doesn't answer phone|0|||
42261311|NCT02415400|76088816|FG000|Overall Study|Participant wanted home visits|1|||
41996067|NCT00174915|75804118|FG004|Overall Study|Lost to Follow-up|10|||
41996068|NCT00174915|75804114|FG000|Overall Study|Adverse Event|18|||
42261312|NCT02415400|76088817|FG001|Overall Study|Participant wanted home visits|0|||
42261313|NCT02415400|76088818|FG002|Overall Study|Participant wanted home visits|0|||
42325894|NCT02252588|76163758|FG001|Overall Study|Withdrawal by Subject|0|||
42325895|NCT01585558|76163767|FG000|Overall Study|Withdrawal by Subject|4|||
41996069|NCT00174915|75804115|FG001|Overall Study|Adverse Event|16|||
42261314|NCT02415400|76088819|FG003|Overall Study|Participant wanted home visits|0|||
42261315|NCT02415400|76088816|FG000|Overall Study|Randomized in error|2|||
42261316|NCT02415400|76088817|FG001|Overall Study|Randomized in error|0|||
41996070|NCT00174915|75804116|FG002|Overall Study|Adverse Event|11|||
41996071|NCT00174915|75804117|FG003|Overall Study|Adverse Event|18|||
41996072|NCT00174915|75804118|FG004|Overall Study|Adverse Event|5|||
41996073|NCT00174915|75804114|FG000|Overall Study|Personal Reason(s)|16|||
41996074|NCT00174915|75804115|FG001|Overall Study|Personal Reason(s)|16|||
42325896|NCT01585558|76163768|FG001|Overall Study|Withdrawal by Subject|5|||
42325897|NCT01585558|76163769|FG002|Overall Study|Withdrawal by Subject|8|||
42325898|NCT01585558|76163767|FG000|Overall Study|Lost to Follow-up|2|||
42325899|NCT01585558|76163768|FG001|Overall Study|Lost to Follow-up|0|||
42325900|NCT01585558|76163769|FG002|Overall Study|Lost to Follow-up|3|||
42325901|NCT01585558|76163767|FG000|Overall Study|Adverse Event|3|||
42325902|NCT01585558|76163768|FG001|Overall Study|Adverse Event|4|||
42325903|NCT01585558|76163769|FG002|Overall Study|Adverse Event|1|||
42325904|NCT01585558|76163767|FG000|Overall Study|Protocol Violation|4|||
42325905|NCT01585558|76163768|FG001|Overall Study|Protocol Violation|3|||
42325906|NCT01585558|76163769|FG002|Overall Study|Protocol Violation|2|||
42325907|NCT01585558|76163767|FG000|Overall Study|Lack of Efficacy|0|||
42325908|NCT01585558|76163768|FG001|Overall Study|Lack of Efficacy|0|||
42325909|NCT01585558|76163769|FG002|Overall Study|Lack of Efficacy|1|||
41996075|NCT00174915|75804116|FG002|Overall Study|Personal Reason(s)|9|||
41996076|NCT00174915|75804117|FG003|Overall Study|Personal Reason(s)|9|||
42261317|NCT02415400|76088818|FG002|Overall Study|Randomized in error|0|||
42261318|NCT02415400|76088819|FG003|Overall Study|Randomized in error|0|||
42261319|NCT02415400|76088816|FG000|Overall Study|No study drug on site|0|||
42261320|NCT02415400|76088817|FG001|Overall Study|No study drug on site|1|||
42261321|NCT02415400|76088818|FG002|Overall Study|No study drug on site|0|||
42261322|NCT02415400|76088819|FG003|Overall Study|No study drug on site|0|||
42261323|NCT02415400|76088816|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
42261324|NCT02415400|76088817|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
42261325|NCT02415400|76088818|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
42261326|NCT02415400|76088819|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
42261327|NCT02415400|76088816|FG000|Overall Study|Coagulation values cannot be set|0|||
42261328|NCT02415400|76088817|FG001|Overall Study|Coagulation values cannot be set|0|||
42261329|NCT02415400|76088818|FG002|Overall Study|Coagulation values cannot be set|1|||
42261330|NCT02415400|76088819|FG003|Overall Study|Coagulation values cannot be set|0|||
42261331|NCT02415400|76088816|FG000|Overall Study|State regulations prevent participation|0|||
42261332|NCT02415400|76088817|FG001|Overall Study|State regulations prevent participation|0|||
42261333|NCT02415400|76088818|FG002|Overall Study|State regulations prevent participation|1|||
42261334|NCT02415400|76088819|FG003|Overall Study|State regulations prevent participation|0|||
42261335|NCT02415400|76088816|FG000|Overall Study|Poor treatment monitoring|0|||
42261336|NCT02415400|76088817|FG001|Overall Study|Poor treatment monitoring|0|||
42261337|NCT02415400|76088818|FG002|Overall Study|Poor treatment monitoring|1|||
42261338|NCT02415400|76088819|FG003|Overall Study|Poor treatment monitoring|0|||
42261339|NCT02415400|76088816|FG000|Overall Study|Participant in jail|0|||
42261340|NCT02415400|76088817|FG001|Overall Study|Participant in jail|0|||
42261341|NCT02415400|76088818|FG002|Overall Study|Participant in jail|1|||
42261342|NCT02415400|76088819|FG003|Overall Study|Participant in jail|0|||
42261343|NCT02415400|76088816|FG000|Overall Study|Investigator decision|0|||
42261344|NCT02415400|76088817|FG001|Overall Study|Investigator decision|0|||
42261345|NCT02415400|76088818|FG002|Overall Study|Investigator decision|1|||
42261346|NCT02415400|76088819|FG003|Overall Study|Investigator decision|1|||
42261347|NCT02415400|76088816|FG000|Overall Study|Site closure; participant won't transfer|0|||
42261348|NCT02415400|76088817|FG001|Overall Study|Site closure; participant won't transfer|0|||
42261349|NCT02415400|76088818|FG002|Overall Study|Site closure; participant won't transfer|0|||
42261350|NCT02415400|76088819|FG003|Overall Study|Site closure; participant won't transfer|1|||
42261351|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
42325910|NCT01565980|76163779|FG000|Overall Study|Death|1|||
42325911|NCT01565980|76163780|FG001|Overall Study|Death|0|||
42261352|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
42261353|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
42261354|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
42325912|NCT01565980|76163779|FG000|Overall Study|Lost to Follow-up|1|||
42325913|NCT01565980|76163780|FG001|Overall Study|Lost to Follow-up|0|||
42325914|NCT01565980|76163779|FG000|Overall Study|health complications|1|||
42325915|NCT01565980|76163780|FG001|Overall Study|health complications|1|||
42325916|NCT01565980|76163779|FG000|Overall Study|stopped medical treatment|1|||
42325917|NCT01565980|76163780|FG001|Overall Study|stopped medical treatment|0|||
42325918|NCT01565980|76163779|FG000|Overall Study|Withdrawal by Subject|0|||
41996077|NCT00174915|75804118|FG004|Overall Study|Personal Reason(s)|9|||
41996078|NCT00174915|75804114|FG000|Overall Study|Other|15|||
42325919|NCT01565980|76163780|FG001|Overall Study|Withdrawal by Subject|3|||
42325920|NCT01585246|76163795|FG000|Overall Study|Lost to Follow-up|0|||
42325921|NCT01585246|76163796|FG001|Overall Study|Lost to Follow-up|0|||
42325922|NCT01585246|76163797|FG002|Overall Study|Lost to Follow-up|2|||
42325923|NCT01585246|76163798|FG003|Overall Study|Lost to Follow-up|1|||
42325924|NCT01585246|76163799|FG004|Overall Study|Lost to Follow-up|0|||
42325925|NCT01585246|76163795|FG000|Overall Study|Protocol Violation|0|||
41996079|NCT00174915|75804115|FG001|Overall Study|Other|8|||
41996080|NCT00174915|75804116|FG002|Overall Study|Other|6|||
41996081|NCT00174915|75804117|FG003|Overall Study|Other|5|||
41996082|NCT00174915|75804118|FG004|Overall Study|Other|3|||
41996083|NCT00174915|75804114|FG000|Overall Study|Gout Flare|13|||
41996084|NCT00174915|75804115|FG001|Overall Study|Gout Flare|6|||
41996085|NCT00174915|75804116|FG002|Overall Study|Gout Flare|8|||
41996086|NCT00174915|75804117|FG003|Overall Study|Gout Flare|1|||
41996087|NCT00174915|75804118|FG004|Overall Study|Gout Flare|0|||
42325926|NCT01585246|76163796|FG001|Overall Study|Protocol Violation|0|||
42325927|NCT01585246|76163797|FG002|Overall Study|Protocol Violation|0|||
42261355|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
42261356|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
42261357|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
42261358|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
42261359|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
42261360|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
42261361|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
42261362|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
42261363|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
42261364|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
42261365|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
42261366|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
42261367|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
42261368|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
42261369|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
42261370|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
42261371|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
42261372|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
42261373|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
42261374|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
42261375|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
42261376|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
42261377|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
42261378|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
42261379|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
42261380|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
42261381|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
42261382|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
42325928|NCT01585246|76163798|FG003|Overall Study|Protocol Violation|0|||
42325929|NCT01585246|76163799|FG004|Overall Study|Protocol Violation|1|||
41996088|NCT00174915|75804114|FG000|Overall Study|Protocol Violation|6|||
41996089|NCT00174915|75804115|FG001|Overall Study|Protocol Violation|3|||
41996090|NCT00174915|75804116|FG002|Overall Study|Protocol Violation|3|||
42134009|NCT00548249|75944860|FG003|Overall Study|Adverse Event|1|||
41996091|NCT00174915|75804117|FG003|Overall Study|Protocol Violation|6|||
41996092|NCT00174915|75804118|FG004|Overall Study|Protocol Violation|3|||
41996093|NCT00174915|75804114|FG000|Overall Study|Therapeutic Failure|6|||
41996094|NCT00174915|75804115|FG001|Overall Study|Therapeutic Failure|3|||
41996095|NCT00174915|75804116|FG002|Overall Study|Therapeutic Failure|2|||
41996096|NCT00174915|75804117|FG003|Overall Study|Therapeutic Failure|1|||
42325930|NCT01585246|76163795|FG000|Overall Study|Withdrawal by Subject|0|||
42325931|NCT01585246|76163796|FG001|Overall Study|Withdrawal by Subject|0|||
42325932|NCT01585246|76163797|FG002|Overall Study|Withdrawal by Subject|1|||
42325933|NCT01585246|76163798|FG003|Overall Study|Withdrawal by Subject|2|||
42325934|NCT01585246|76163799|FG004|Overall Study|Withdrawal by Subject|1|||
42325935|NCT01585246|76163795|FG000|Overall Study|Other|0|||
42325936|NCT01585246|76163796|FG001|Overall Study|Other|1|||
42325937|NCT01585246|76163797|FG002|Overall Study|Other|1|||
42325938|NCT01585246|76163798|FG003|Overall Study|Other|1|||
42325939|NCT01585246|76163799|FG004|Overall Study|Other|0|||
42325940|NCT01585168|76163816|FG000|Overall Study|Lost to Follow-up|3|||
42325941|NCT01585168|76163817|FG001|Overall Study|Lost to Follow-up|1|||
42325942|NCT01585168|76163818|FG002|Overall Study|Lost to Follow-up|1|||
42325943|NCT01585168|76163819|FG003|Overall Study|Lost to Follow-up|1|||
42325944|NCT02232074|76163829|FG000|Overall Study|Withdrawal by Subject|5|||
42325945|NCT02232074|76163830|FG001|Overall Study|Withdrawal by Subject|3|||
42325946|NCT02232074|76163829|FG000|Overall Study|No legal concerns at baseline|36|||
42325947|NCT02232074|76163830|FG001|Overall Study|No legal concerns at baseline|41|||
42325948|NCT02232074|76163829|FG000|Overall Study|deemed ineligible|0|||
42325949|NCT02232074|76163830|FG001|Overall Study|deemed ineligible|1|||
42325950|NCT02142283|76163844|FG000|Overall Study|Death|20|||
42325951|NCT02142283|76163845|FG001|Overall Study|Death|18|||
42325952|NCT02142283|76163844|FG000|Overall Study|Withdrawal by Subject|1|||
42325953|NCT02142283|76163845|FG001|Overall Study|Withdrawal by Subject|3|||
42325954|NCT02231918|76163854|FG000|Overall Study|Withdrawal by Subject|0|||
42325955|NCT02231918|76163855|FG001|Overall Study|Withdrawal by Subject|1|||
42325956|NCT02231918|76163856|FG002|Overall Study|Withdrawal by Subject|0|||
41996097|NCT00174915|75804118|FG004|Overall Study|Therapeutic Failure|3|||
41996098|NCT01080716|75804134|FG000|Part 1|Physician Decision|1|||
41996099|NCT01080716|75804135|FG001|Part 1|Physician Decision|0|||
41996100|NCT01080716|75804136|FG002|Part 1|Physician Decision|0|||
41996101|NCT01080716|75804137|FG003|Part 1|Physician Decision|0|||
41996102|NCT00172185|75804155|FG000|Overall Study|Adverse Event|0|||
41996103|NCT00172185|75804156|FG001|Overall Study|Adverse Event|1|||
41996104|NCT00172185|75804157|FG002|Overall Study|Adverse Event|3|||
41996105|NCT00172185|75804158|FG003|Overall Study|Adverse Event|4|||
41996106|NCT00172185|75804155|FG000|Overall Study|Physician Decision|0|||
41996107|NCT00172185|75804156|FG001|Overall Study|Physician Decision|0|||
41996108|NCT00172185|75804157|FG002|Overall Study|Physician Decision|1|||
41996109|NCT00172185|75804158|FG003|Overall Study|Physician Decision|0|||
41996110|NCT00172185|75804155|FG000|Overall Study|SPONSOR Decision|0|||
41996111|NCT00172185|75804156|FG001|Overall Study|SPONSOR Decision|1|||
41996112|NCT00172185|75804157|FG002|Overall Study|SPONSOR Decision|0|||
41996113|NCT00172185|75804158|FG003|Overall Study|SPONSOR Decision|0|||
41996114|NCT00172185|75804155|FG000|Overall Study|Withdrawal by Subject|0|||
41996115|NCT00172185|75804156|FG001|Overall Study|Withdrawal by Subject|0|||
41996116|NCT00172185|75804157|FG002|Overall Study|Withdrawal by Subject|1|||
41996117|NCT00172185|75804158|FG003|Overall Study|Withdrawal by Subject|0|||
41996118|NCT01080326|75804172|FG000|Overall Study|Patient deterioration prior to procedure|3|||
41996119|NCT01080326|75804172|FG000|Overall Study|Surgeon decision|1|||
41996120|NCT00171951|75804176|FG000|Overall Study|Adverse Event|1|||
41996121|NCT00171951|75804176|FG000|Overall Study|Abnormal Laboratory Values|2|||
41996122|NCT00171951|75804176|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
41996123|NCT00171951|75804176|FG000|Overall Study|Participants Withdrew Consent|3|||
42261383|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
42261384|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
42261385|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
42261386|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
42261387|NCT04194801|76088836|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
42261388|NCT04194801|76088837|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
42261389|NCT04194801|76088838|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
42261390|NCT04194801|76088836|FG000|Part Ib/II End of Study|Death|2|||
42261391|NCT04194801|76088837|FG001|Part Ib/II End of Study|Death|3|||
42261392|NCT04194801|76088838|FG002|Part Ib/II End of Study|Death|3|||
42261393|NCT04194801|76088836|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
42261394|NCT04194801|76088837|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
42261395|NCT04194801|76088838|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
42325957|NCT02231918|76163854|FG000|Overall Study|Adverse Event|0|||
42325958|NCT02231918|76163855|FG001|Overall Study|Adverse Event|0|||
42325959|NCT02231918|76163856|FG002|Overall Study|Adverse Event|1|||
42325960|NCT02199314|76163864|FG000|Overall Study|Withdrawal by Subject|6|||
42325961|NCT02199314|76163864|FG000|Overall Study|Physician Decision|10|||
42325962|NCT02251652|76163868|FG000|Overall Study|Withdrawal by Subject|1|||
41996124|NCT00171951|75804176|FG000|Overall Study|New Cancer Therapy|5|||
41996125|NCT00171951|75804176|FG000|Overall Study|Reason not Specified|2|||
41996126|NCT01080131|75804185|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
41996127|NCT01080131|75804186|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
41996128|NCT01080131|75804185|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
42261396|NCT04194801|76088836|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
42261397|NCT04194801|76088837|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
42261398|NCT04194801|76088838|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
42261399|NCT04194801|76088836|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
42261400|NCT04194801|76088837|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
42261401|NCT04194801|76088838|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
42261402|NCT04194801|76088836|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
42261403|NCT04194801|76088837|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
42261404|NCT04194801|76088838|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
42261405|NCT02802865|76088862|FG000|Overall Study|Pregnancy|1|||
41996129|NCT01080131|75804186|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
41996130|NCT01080131|75804185|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
42261406|NCT02802865|76088863|FG001|Overall Study|Pregnancy|1|||
42261407|NCT02802865|76088862|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
42261408|NCT02802865|76088863|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
41996131|NCT01080131|75804186|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
42325963|NCT02197520|76163874|FG000|Period 1|Withdrawal by Subject|1|||
42325964|NCT02197520|76163875|FG001|Period 1|Withdrawal by Subject|0|||
42325965|NCT02197520|76163874|FG000|Period 2|Adverse Event|0|||
42325966|NCT02197520|76163875|FG001|Period 2|Adverse Event|2|||
42325967|NCT02197520|76163874|FG000|Period 2|Withdrawal by Subject|1|||
42325968|NCT02197520|76163875|FG001|Period 2|Withdrawal by Subject|0|||
41996132|NCT01080131|75804185|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
41996133|NCT01080131|75804186|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
41996134|NCT01080131|75804185|FG000|Core Study (0- 12 Weeks)|Death|1|||
41996135|NCT01080131|75804186|FG001|Core Study (0- 12 Weeks)|Death|0|||
41996136|NCT01080131|75804185|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
41996137|NCT01080131|75804186|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
41996138|NCT01080131|75804185|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
41996139|NCT01080131|75804186|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
41996140|NCT01080131|75804185|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
41996141|NCT01080131|75804186|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
41996142|NCT01080131|75804185|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
41996143|NCT01080131|75804186|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
41996144|NCT01080131|75804185|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
41996145|NCT01080131|75804186|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
41996146|NCT01080131|75804185|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
42134010|NCT00548249|75944861|FG004|Overall Study|Adverse Event|1|||
42134011|NCT00548249|75944857|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
42134012|NCT00548249|75944858|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
42134013|NCT00548249|75944859|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
42134014|NCT00548249|75944860|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
42134015|NCT00548249|75944861|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
42134016|NCT00548249|75944857|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
42134017|NCT00548249|75944858|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
41996147|NCT01080131|75804186|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
42325969|NCT02230904|76163885|FG000|Overall Study|Safety follow up could not take place|0|||
42325970|NCT02230904|76163886|FG001|Overall Study|Safety follow up could not take place|1|||
42325971|NCT02230670|76163896|FG000|Overall Study|Adverse Event|1|||
42325972|NCT02230670|76163897|FG001|Overall Study|Adverse Event|2|||
42325973|NCT02230670|76163896|FG000|Overall Study|Withdrawal by Subject|2|||
42325974|NCT02230670|76163897|FG001|Overall Study|Withdrawal by Subject|2|||
42325975|NCT02230670|76163896|FG000|Overall Study|Physician Decision|0|||
42325976|NCT02230670|76163897|FG001|Overall Study|Physician Decision|1|||
42325977|NCT02230670|76163896|FG000|Overall Study|Protocol Violation|0|||
42325978|NCT02230670|76163897|FG001|Overall Study|Protocol Violation|1|||
42325979|NCT02230670|76163896|FG000|Overall Study|Progression to Child-Pugh C|1|||
42325980|NCT02230670|76163897|FG001|Overall Study|Progression to Child-Pugh C|2|||
42325981|NCT02197130|76163906|FG000|Overall Study|Adverse Event|13|||
42325982|NCT02197130|76163907|FG001|Overall Study|Adverse Event|4|||
42325983|NCT02197130|76163908|FG002|Overall Study|Adverse Event|23|||
42325984|NCT02197130|76163906|FG000|Overall Study|Death|0|||
42325985|NCT02197130|76163907|FG001|Overall Study|Death|1|||
42325986|NCT02197130|76163908|FG002|Overall Study|Death|0|||
42325987|NCT02197130|76163906|FG000|Overall Study|Lost to Follow-up|2|||
42325988|NCT02197130|76163907|FG001|Overall Study|Lost to Follow-up|0|||
42325989|NCT02197130|76163908|FG002|Overall Study|Lost to Follow-up|1|||
42325990|NCT02197130|76163906|FG000|Overall Study|Does not meet entrance criteria|0|||
42325991|NCT02197130|76163907|FG001|Overall Study|Does not meet entrance criteria|0|||
42325992|NCT02197130|76163908|FG002|Overall Study|Does not meet entrance criteria|1|||
42325993|NCT02197130|76163906|FG000|Overall Study|Withdrawal by Subject|0|||
42325994|NCT02197130|76163907|FG001|Overall Study|Withdrawal by Subject|3|||
42325995|NCT02197130|76163908|FG002|Overall Study|Withdrawal by Subject|4|||
42325996|NCT02197130|76163906|FG000|Overall Study|Other|1|||
42325997|NCT02197130|76163907|FG001|Overall Study|Other|0|||
42325998|NCT02197130|76163908|FG002|Overall Study|Other|3|||
42325999|NCT02196506|76163918|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
42326000|NCT02196506|76163919|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
42326001|NCT02196506|76163920|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
42326002|NCT02196506|76163921|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
42326003|NCT02196506|76163918|FG000|Phase A|Withdrawal by Subject|34|||
42326004|NCT02196506|76163919|FG001|Phase A|Withdrawal by Subject|0|||
42326005|NCT02196506|76163920|FG002|Phase A|Withdrawal by Subject|0|||
42261409|NCT02414932|76088871|FG000|Overall Study|Withdrawal by Subject|2|||
42261410|NCT02414932|76088872|FG001|Overall Study|Withdrawal by Subject|3|||
42261411|NCT02414932|76088871|FG000|Overall Study|Adverse Event|1|||
42261412|NCT02414932|76088872|FG001|Overall Study|Adverse Event|0|||
42261413|NCT00704535|76088878|FG000|Overall Study|Adverse Event|2|||
42261414|NCT00704535|76088878|FG000|Overall Study|Death|2|||
42261415|NCT00704535|76088878|FG000|Overall Study|Lost to Follow-up|8|||
42261416|NCT00704535|76088878|FG000|Overall Study|Protocol Violation|10|||
42261417|NCT00704535|76088878|FG000|Overall Study|Completed status not on Case Report Form|124|||
42261418|NCT01740687|76088882|FG000|Overall Study|Lost to Follow-up|11|||
42261419|NCT01740687|76088882|FG000|Overall Study|Withdrawal by Subject|2|||
42261420|NCT01740687|76088882|FG000|Overall Study|other reason|22|||
42261421|NCT01740687|76088882|FG000|Overall Study|treatment not received|2|||
42261422|NCT02648204|76088890|FG000|Overall Study|Withdrawal by Subject|12|||
42261423|NCT02648204|76088891|FG001|Overall Study|Withdrawal by Subject|8|||
42261424|NCT02648204|76088892|FG002|Overall Study|Withdrawal by Subject|2|||
42261425|NCT02648204|76088893|FG003|Overall Study|Withdrawal by Subject|6|||
42261426|NCT02648204|76088890|FG000|Overall Study|Lost to Follow-up|5|||
42261427|NCT02648204|76088891|FG001|Overall Study|Lost to Follow-up|8|||
42261428|NCT02648204|76088892|FG002|Overall Study|Lost to Follow-up|4|||
42261429|NCT02648204|76088893|FG003|Overall Study|Lost to Follow-up|6|||
42261430|NCT02648204|76088890|FG000|Overall Study|Missing follow-up information|4|||
42261431|NCT02648204|76088891|FG001|Overall Study|Missing follow-up information|4|||
42326006|NCT02196506|76163921|FG003|Phase A|Withdrawal by Subject|0|||
42326007|NCT02196506|76163918|FG000|Phase A|Adverse Event|22|||
42326008|NCT02196506|76163919|FG001|Phase A|Adverse Event|0|||
42326009|NCT02196506|76163920|FG002|Phase A|Adverse Event|0|||
42326010|NCT02196506|76163921|FG003|Phase A|Adverse Event|0|||
42326011|NCT02196506|76163918|FG000|Phase A|Lost to Follow-up|9|||
42326012|NCT02196506|76163919|FG001|Phase A|Lost to Follow-up|0|||
42326013|NCT02196506|76163920|FG002|Phase A|Lost to Follow-up|0|||
42326014|NCT02196506|76163921|FG003|Phase A|Lost to Follow-up|0|||
42326015|NCT02196506|76163918|FG000|Phase A|Protocol deviation|12|||
42326016|NCT02196506|76163919|FG001|Phase A|Protocol deviation|0|||
42134018|NCT00548249|75944859|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
42134019|NCT00548249|75944860|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
42134020|NCT00548249|75944861|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
42134021|NCT00548249|75944857|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
42134022|NCT00548249|75944858|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
42134023|NCT00548249|75944859|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
42134024|NCT00548249|75944860|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
42134025|NCT00548249|75944861|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
42134026|NCT00548249|75944857|FG000|Overall Study|Prolonged hospitalization|0|||
42134027|NCT00548249|75944858|FG001|Overall Study|Prolonged hospitalization|0|||
42261432|NCT02648204|76088892|FG002|Overall Study|Missing follow-up information|4|||
42261433|NCT02648204|76088893|FG003|Overall Study|Missing follow-up information|2|||
42261434|NCT02648204|76088890|FG000|Overall Study|Death|1|||
42261435|NCT02648204|76088891|FG001|Overall Study|Death|1|||
42261436|NCT02648204|76088892|FG002|Overall Study|Death|2|||
42261437|NCT02648204|76088893|FG003|Overall Study|Death|2|||
41996148|NCT01080131|75804185|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
41996149|NCT01080131|75804186|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
41996150|NCT01080131|75804185|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
41996151|NCT01080131|75804186|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
41996152|NCT00171873|75804212|FG000|Overall Study|Withdrawal by Subject|4|||
41996153|NCT00171873|75804213|FG001|Overall Study|Withdrawal by Subject|2|||
41996154|NCT00171873|75804212|FG000|Overall Study|Adverse Event|5|||
41996155|NCT00171873|75804213|FG001|Overall Study|Adverse Event|0|||
41996156|NCT00171873|75804212|FG000|Overall Study|Switched to Octreotide|0|||
41996157|NCT00171873|75804213|FG001|Overall Study|Switched to Octreotide|1|||
42261438|NCT02648204|76088890|FG000|Overall Study|Adverse Event|0|||
41996158|NCT00171834|75804226|FG000|Overall Study|Adverse Event|2|||
42134028|NCT00548249|75944859|FG002|Overall Study|Prolonged hospitalization|2|||
42134029|NCT00548249|75944860|FG003|Overall Study|Prolonged hospitalization|1|||
42261439|NCT02648204|76088891|FG001|Overall Study|Adverse Event|0|||
42134030|NCT00548249|75944861|FG004|Overall Study|Prolonged hospitalization|0|||
42134031|NCT00548249|75944857|FG000|Overall Study|Withdrawal by Subject|2|||
42261440|NCT02648204|76088892|FG002|Overall Study|Adverse Event|1|||
41996159|NCT00171834|75804227|FG001|Overall Study|Adverse Event|1|||
41996160|NCT00171834|75804228|FG002|Overall Study|Adverse Event|3|||
42326017|NCT02196506|76163920|FG002|Phase A|Protocol deviation|0|||
42326018|NCT02196506|76163921|FG003|Phase A|Protocol deviation|0|||
42326019|NCT02196506|76163918|FG000|Phase A|Participant withdrawn by investigator|10|||
42326020|NCT02196506|76163919|FG001|Phase A|Participant withdrawn by investigator|0|||
42326021|NCT02196506|76163920|FG002|Phase A|Participant withdrawn by investigator|0|||
42326022|NCT02196506|76163921|FG003|Phase A|Participant withdrawn by investigator|0|||
42326023|NCT02196506|76163918|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
41996161|NCT00171834|75804229|FG003|Overall Study|Adverse Event|2|||
41996162|NCT00171834|75804230|FG004|Overall Study|Adverse Event|2|||
41996163|NCT00171834|75804231|FG005|Overall Study|Adverse Event|15|||
41996164|NCT00171834|75804232|FG006|Overall Study|Adverse Event|1|||
41996165|NCT00171834|75804226|FG000|Overall Study|Withdrawal by Subject|0|||
41996166|NCT00171834|75804227|FG001|Overall Study|Withdrawal by Subject|2|||
41996167|NCT00171834|75804228|FG002|Overall Study|Withdrawal by Subject|0|||
41996168|NCT00171834|75804229|FG003|Overall Study|Withdrawal by Subject|1|||
41996169|NCT00171834|75804230|FG004|Overall Study|Withdrawal by Subject|1|||
41996170|NCT00171834|75804231|FG005|Overall Study|Withdrawal by Subject|1|||
41996171|NCT00171834|75804232|FG006|Overall Study|Withdrawal by Subject|0|||
41996172|NCT00171834|75804226|FG000|Overall Study|Death from study indication|0|||
41996173|NCT00171834|75804227|FG001|Overall Study|Death from study indication|1|||
41996174|NCT00171834|75804228|FG002|Overall Study|Death from study indication|0|||
41996175|NCT00171834|75804229|FG003|Overall Study|Death from study indication|0|||
41996176|NCT00171834|75804230|FG004|Overall Study|Death from study indication|1|||
41996177|NCT00171834|75804231|FG005|Overall Study|Death from study indication|0|||
41996178|NCT00171834|75804232|FG006|Overall Study|Death from study indication|0|||
41996179|NCT00171834|75804226|FG000|Overall Study|Disease Progression|4|||
41996180|NCT00171834|75804227|FG001|Overall Study|Disease Progression|8|||
41996181|NCT00171834|75804228|FG002|Overall Study|Disease Progression|8|||
41996182|NCT00171834|75804229|FG003|Overall Study|Disease Progression|9|||
41996183|NCT00171834|75804230|FG004|Overall Study|Disease Progression|2|||
41996184|NCT00171834|75804231|FG005|Overall Study|Disease Progression|18|||
42261441|NCT02648204|76088893|FG003|Overall Study|Adverse Event|0|||
42261442|NCT02799745|76088905|FG000|Overall Study|Participant moved out of state|1|||
42261443|NCT02799745|76088906|FG001|Overall Study|Participant moved out of state|0|||
42261444|NCT02799745|76088905|FG000|Overall Study|Discontinued due to planned surgery|1|||
42261445|NCT02799745|76088906|FG001|Overall Study|Discontinued due to planned surgery|0|||
42261446|NCT02799745|76088905|FG000|Overall Study|Withdrawal by Subject|16|||
42261447|NCT02799745|76088906|FG001|Overall Study|Withdrawal by Subject|25|||
42261448|NCT02799745|76088905|FG000|Overall Study|Protocol Deviation|4|||
42261449|NCT02799745|76088906|FG001|Overall Study|Protocol Deviation|5|||
42261450|NCT02799745|76088905|FG000|Overall Study|Progressive Disease|28|||
42261451|NCT02799745|76088906|FG001|Overall Study|Progressive Disease|38|||
42261452|NCT02799745|76088905|FG000|Overall Study|Lost to Follow-up|3|||
42261453|NCT02799745|76088906|FG001|Overall Study|Lost to Follow-up|2|||
42261454|NCT02799745|76088905|FG000|Overall Study|Death|3|||
42326024|NCT02196506|76163919|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
42326025|NCT02196506|76163920|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
42326026|NCT02196506|76163921|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
42326027|NCT02196506|76163918|FG000|Phase B|Lack of Efficacy|0|||
41996185|NCT00171834|75804232|FG006|Overall Study|Disease Progression|3|||
41996186|NCT00171834|75804226|FG000|Overall Study|Treatment Duration Completed|0|||
41996187|NCT00171834|75804227|FG001|Overall Study|Treatment Duration Completed|0|||
41996188|NCT00171834|75804228|FG002|Overall Study|Treatment Duration Completed|1|||
42261455|NCT02799745|76088906|FG001|Overall Study|Death|0|||
42261456|NCT02799745|76088905|FG000|Overall Study|Adverse Event|0|||
42326028|NCT02196506|76163919|FG001|Phase B|Lack of Efficacy|1|||
42326029|NCT02196506|76163920|FG002|Phase B|Lack of Efficacy|2|||
42326030|NCT02196506|76163921|FG003|Phase B|Lack of Efficacy|0|||
42326031|NCT02196506|76163918|FG000|Phase B|Withdrawal by Participant|0|||
42326032|NCT02196506|76163919|FG001|Phase B|Withdrawal by Participant|8|||
42326033|NCT02196506|76163920|FG002|Phase B|Withdrawal by Participant|1|||
42326034|NCT02196506|76163921|FG003|Phase B|Withdrawal by Participant|0|||
42326035|NCT02196506|76163918|FG000|Phase B|Adverse Event|0|||
42326036|NCT02196506|76163919|FG001|Phase B|Adverse Event|4|||
42326037|NCT02196506|76163920|FG002|Phase B|Adverse Event|1|||
42326038|NCT02196506|76163921|FG003|Phase B|Adverse Event|0|||
42326039|NCT02196506|76163918|FG000|Phase B|Lost to Follow-up|0|||
42326040|NCT02196506|76163919|FG001|Phase B|Lost to Follow-up|2|||
42326041|NCT02196506|76163920|FG002|Phase B|Lost to Follow-up|1|||
42326042|NCT02196506|76163921|FG003|Phase B|Lost to Follow-up|0|||
42326043|NCT02196506|76163918|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
42326044|NCT02196506|76163919|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
42326045|NCT02196506|76163920|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
42326046|NCT02196506|76163921|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
42326047|NCT02196506|76163918|FG000|Phase A+|Withdrawal by Participant|0|||
42326048|NCT02196506|76163919|FG001|Phase A+|Withdrawal by Participant|0|||
42326049|NCT02196506|76163920|FG002|Phase A+|Withdrawal by Participant|0|||
42134032|NCT00548249|75944858|FG001|Overall Study|Withdrawal by Subject|0|||
42261457|NCT02799745|76088906|FG001|Overall Study|Adverse Event|1|||
42261458|NCT00705159|76088916|FG000|Overall Study|Withdrawal by Subject|0|||
42261459|NCT00705159|76088917|FG001|Overall Study|Withdrawal by Subject|1|||
42261460|NCT00705159|76088918|FG002|Overall Study|Withdrawal by Subject|1|||
42261461|NCT00705159|76088919|FG003|Overall Study|Withdrawal by Subject|1|||
42261462|NCT00705159|76088916|FG000|Overall Study|Protocol Violation|0|||
42261463|NCT00705159|76088917|FG001|Overall Study|Protocol Violation|1|||
42261464|NCT00705159|76088918|FG002|Overall Study|Protocol Violation|0|||
42261465|NCT00705159|76088919|FG003|Overall Study|Protocol Violation|0|||
42261466|NCT00705159|76088916|FG000|Overall Study|Adverse Event|0|||
42261467|NCT00705159|76088917|FG001|Overall Study|Adverse Event|0|||
42326050|NCT02196506|76163921|FG003|Phase A+|Withdrawal by Participant|5|||
42326051|NCT02196506|76163918|FG000|Phase A+|Adverse Event|0|||
42326052|NCT02196506|76163919|FG001|Phase A+|Adverse Event|0|||
42326053|NCT02196506|76163920|FG002|Phase A+|Adverse Event|0|||
42326054|NCT02196506|76163921|FG003|Phase A+|Adverse Event|1|||
42326055|NCT02196506|76163918|FG000|Phase A+|Lost to Follow-up|0|||
42261468|NCT00705159|76088918|FG002|Overall Study|Adverse Event|1|||
42261469|NCT00705159|76088919|FG003|Overall Study|Adverse Event|0|||
42261470|NCT00705159|76088916|FG000|Overall Study|Lost to Follow-up|0|||
42261471|NCT00705159|76088917|FG001|Overall Study|Lost to Follow-up|0|||
42261472|NCT00705159|76088918|FG002|Overall Study|Lost to Follow-up|3|||
42261473|NCT00705159|76088919|FG003|Overall Study|Lost to Follow-up|2|||
42261474|NCT00705159|76088916|FG000|Overall Study|Screen Failure|0|||
42261475|NCT00705159|76088917|FG001|Overall Study|Screen Failure|0|||
42261476|NCT00705159|76088918|FG002|Overall Study|Screen Failure|0|||
42261477|NCT00705159|76088919|FG003|Overall Study|Screen Failure|1|||
42261478|NCT01673984|76088931|FG000|Overall Study|Adverse Event|1|||
42326056|NCT02196506|76163919|FG001|Phase A+|Lost to Follow-up|0|||
42326057|NCT02196506|76163920|FG002|Phase A+|Lost to Follow-up|0|||
42326058|NCT02196506|76163921|FG003|Phase A+|Lost to Follow-up|6|||
42326059|NCT02196506|76163918|FG000|Phase A+|Participant withdrawn by investigator|0|||
42326060|NCT02196506|76163919|FG001|Phase A+|Participant withdrawn by investigator|0|||
42326061|NCT02196506|76163920|FG002|Phase A+|Participant withdrawn by investigator|0|||
42326062|NCT02196506|76163921|FG003|Phase A+|Participant withdrawn by investigator|1|||
42326063|NCT02228720|76163927|FG000|Open Label - Day 30|Lost to Follow-up|1|||
42326064|NCT02228564|76163931|FG000|Overall Study|Withdrawal by Subject|10|||
42326065|NCT02228564|76163931|FG000|Overall Study|Death|11|||
42261479|NCT01673984|76088932|FG001|Overall Study|Adverse Event|0|||
42261480|NCT01673984|76088931|FG000|Overall Study|Study termination|9|||
42326066|NCT02228564|76163931|FG000|Overall Study|Physician Decision|5|||
41996189|NCT00171834|75804229|FG003|Overall Study|Treatment Duration Completed|0|||
41996190|NCT00171834|75804230|FG004|Overall Study|Treatment Duration Completed|2|||
41996191|NCT00171834|75804231|FG005|Overall Study|Treatment Duration Completed|1|||
41996192|NCT00171834|75804232|FG006|Overall Study|Treatment Duration Completed|0|||
41996193|NCT00171249|75804262|FG000|Overall Study|Withdrawal by Subject|2|||
41996194|NCT00171249|75804263|FG001|Overall Study|Withdrawal by Subject|0|||
41996195|NCT00171249|75804264|FG002|Overall Study|Withdrawal by Subject|0|||
41996196|NCT00171249|75804265|FG003|Overall Study|Withdrawal by Subject|6|||
41996197|NCT00171249|75804266|FG004|Overall Study|Withdrawal by Subject|0|||
41996198|NCT00171249|75804267|FG005|Overall Study|Withdrawal by Subject|0|||
41996199|NCT00171249|75804268|FG006|Overall Study|Withdrawal by Subject|0|||
41996200|NCT00171249|75804262|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
41996201|NCT00171249|75804263|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
41996202|NCT00171249|75804264|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
41996203|NCT00171249|75804265|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
41996204|NCT00171249|75804266|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
41996205|NCT00171249|75804267|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
41996206|NCT00171249|75804268|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
41996207|NCT00171249|75804262|FG000|Overall Study|Death|7|||
41996208|NCT00171249|75804263|FG001|Overall Study|Death|1|||
41996209|NCT00171249|75804264|FG002|Overall Study|Death|0|||
41996210|NCT00171249|75804265|FG003|Overall Study|Death|4|||
41996211|NCT00171249|75804266|FG004|Overall Study|Death|0|||
41996212|NCT00171249|75804267|FG005|Overall Study|Death|3|||
41996213|NCT00171249|75804268|FG006|Overall Study|Death|1|||
41996214|NCT00171249|75804262|FG000|Overall Study|Other|10|||
42261481|NCT01673984|76088932|FG001|Overall Study|Study termination|6|||
42261482|NCT02332928|76088951|FG000|Overall Study|Withdrawal by Subject|0|||
41996215|NCT00171249|75804263|FG001|Overall Study|Other|0|||
41996216|NCT00171249|75804264|FG002|Overall Study|Other|0|||
41996217|NCT00171249|75804265|FG003|Overall Study|Other|43|||
41996218|NCT00171249|75804266|FG004|Overall Study|Other|0|||
41996219|NCT00171249|75804267|FG005|Overall Study|Other|2|||
41996220|NCT00171249|75804268|FG006|Overall Study|Other|0|||
41996221|NCT00171249|75804262|FG000|Overall Study|No Longer Requires Study Drug|4|||
41996222|NCT00171249|75804263|FG001|Overall Study|No Longer Requires Study Drug|0|||
42261483|NCT02332928|76088952|FG001|Overall Study|Withdrawal by Subject|2|||
42261484|NCT02332928|76088951|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
42261485|NCT02332928|76088952|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
42261486|NCT02647658|76088960|FG000|Overall Study|Consent refusal|15|||
42261487|NCT02647658|76088961|FG001|Overall Study|Consent refusal|24|||
42261488|NCT00703677|76088967|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
42261489|NCT00703911|76088975|FG000|Overall Study|Death|1|||
42261490|NCT00703911|76088975|FG000|Overall Study|Physician Decision|6|||
42261491|NCT00703911|76088975|FG000|Overall Study|Lost to Follow-up|1|||
42261492|NCT00703911|76088975|FG000|Overall Study|Withdrawal by Subject|2|||
42261493|NCT02055547|76088979|FG000|Overall Study|Protocol Violation|0|||
42261494|NCT02055547|76088980|FG001|Overall Study|Protocol Violation|0|||
42261495|NCT02055547|76088981|FG002|Overall Study|Protocol Violation|1|||
42261496|NCT02055547|76088982|FG003|Overall Study|Protocol Violation|0|||
42261497|NCT02055547|76088983|FG004|Overall Study|Protocol Violation|0|||
42261498|NCT02055547|76088984|FG005|Overall Study|Protocol Violation|0|||
41996223|NCT00171249|75804264|FG002|Overall Study|No Longer Requires Study Drug|0|||
41996224|NCT00171249|75804265|FG003|Overall Study|No Longer Requires Study Drug|3|||
41996225|NCT00171249|75804266|FG004|Overall Study|No Longer Requires Study Drug|0|||
41996226|NCT00171249|75804267|FG005|Overall Study|No Longer Requires Study Drug|5|||
42326067|NCT02228564|76163931|FG000|Overall Study|Lost to Follow-up|17|||
42326068|NCT02228564|76163931|FG000|Overall Study|Other|6|||
42326069|NCT01640951|76163943|FG000|Overall Study|Adverse Event|8|||
42326070|NCT01640951|76163944|FG001|Overall Study|Adverse Event|3|||
42326071|NCT01640951|76163945|FG002|Overall Study|Adverse Event|10|||
42326072|NCT01640951|76163946|FG003|Overall Study|Adverse Event|6|||
42326073|NCT01640951|76163947|FG004|Overall Study|Adverse Event|1|||
42326074|NCT01640951|76163948|FG005|Overall Study|Adverse Event|11|||
42326075|NCT01640951|76163949|FG006|Overall Study|Adverse Event|1|||
42326076|NCT01640951|76163950|FG007|Overall Study|Adverse Event|3|||
42326077|NCT01640951|76163943|FG000|Overall Study|Lack of Efficacy|20|||
42326078|NCT01640951|76163944|FG001|Overall Study|Lack of Efficacy|1|||
42326079|NCT01640951|76163945|FG002|Overall Study|Lack of Efficacy|7|||
42326080|NCT01640951|76163946|FG003|Overall Study|Lack of Efficacy|14|||
42326081|NCT01640951|76163947|FG004|Overall Study|Lack of Efficacy|0|||
42326082|NCT01640951|76163948|FG005|Overall Study|Lack of Efficacy|6|||
42326083|NCT01640951|76163949|FG006|Overall Study|Lack of Efficacy|5|||
42326084|NCT01640951|76163950|FG007|Overall Study|Lack of Efficacy|6|||
42326085|NCT01640951|76163943|FG000|Overall Study|Lost to Follow-up|1|||
42326086|NCT01640951|76163944|FG001|Overall Study|Lost to Follow-up|0|||
42326087|NCT01640951|76163945|FG002|Overall Study|Lost to Follow-up|6|||
42326088|NCT01640951|76163946|FG003|Overall Study|Lost to Follow-up|2|||
42326089|NCT01640951|76163947|FG004|Overall Study|Lost to Follow-up|2|||
42326090|NCT01640951|76163948|FG005|Overall Study|Lost to Follow-up|3|||
42326091|NCT01640951|76163949|FG006|Overall Study|Lost to Follow-up|1|||
42326092|NCT01640951|76163950|FG007|Overall Study|Lost to Follow-up|1|||
42326093|NCT01640951|76163943|FG000|Overall Study|Non-compliance with study treatment|0|||
42326094|NCT01640951|76163944|FG001|Overall Study|Non-compliance with study treatment|0|||
42326095|NCT01640951|76163945|FG002|Overall Study|Non-compliance with study treatment|1|||
42326096|NCT01640951|76163946|FG003|Overall Study|Non-compliance with study treatment|1|||
42261499|NCT02055547|76088985|FG006|Overall Study|Protocol Violation|1|||
42261500|NCT02055547|76088986|FG007|Overall Study|Protocol Violation|0|||
42261501|NCT02055547|76088987|FG008|Overall Study|Protocol Violation|0|||
42261502|NCT02055547|76088988|FG009|Overall Study|Protocol Violation|0|||
42326097|NCT01640951|76163947|FG004|Overall Study|Non-compliance with study treatment|1|||
42261503|NCT02055547|76088989|FG010|Overall Study|Protocol Violation|0|||
42261504|NCT02055547|76088990|FG011|Overall Study|Protocol Violation|0|||
42261505|NCT02055547|76088991|FG012|Overall Study|Protocol Violation|0|||
42261506|NCT02055547|76088992|FG013|Overall Study|Protocol Violation|0|||
42261507|NCT02055547|76088993|FG014|Overall Study|Protocol Violation|0|||
42261508|NCT02055547|76088994|FG015|Overall Study|Protocol Violation|0|||
42261509|NCT02055547|76088995|FG016|Overall Study|Protocol Violation|0|||
42261510|NCT02055547|76088996|FG017|Overall Study|Protocol Violation|0|||
42261511|NCT02055547|76088997|FG018|Overall Study|Protocol Violation|0|||
42261512|NCT02055547|76088979|FG000|Overall Study|Physician Decision|0|||
42261513|NCT02055547|76088980|FG001|Overall Study|Physician Decision|1|||
42261514|NCT02055547|76088981|FG002|Overall Study|Physician Decision|1|||
42261515|NCT02055547|76088982|FG003|Overall Study|Physician Decision|0|||
42261516|NCT02055547|76088983|FG004|Overall Study|Physician Decision|1|||
42261517|NCT02055547|76088984|FG005|Overall Study|Physician Decision|0|||
42261518|NCT02055547|76088985|FG006|Overall Study|Physician Decision|0|||
42261519|NCT02055547|76088986|FG007|Overall Study|Physician Decision|0|||
42261520|NCT02055547|76088987|FG008|Overall Study|Physician Decision|0|||
42261521|NCT02055547|76088988|FG009|Overall Study|Physician Decision|1|||
42261522|NCT02055547|76088989|FG010|Overall Study|Physician Decision|1|||
42261523|NCT02055547|76088990|FG011|Overall Study|Physician Decision|0|||
42261524|NCT02055547|76088991|FG012|Overall Study|Physician Decision|0|||
42261525|NCT02055547|76088992|FG013|Overall Study|Physician Decision|0|||
42261526|NCT02055547|76088993|FG014|Overall Study|Physician Decision|0|||
42261527|NCT02055547|76088994|FG015|Overall Study|Physician Decision|0|||
42261528|NCT02055547|76088995|FG016|Overall Study|Physician Decision|0|||
42261529|NCT02055547|76088996|FG017|Overall Study|Physician Decision|0|||
42261530|NCT02055547|76088997|FG018|Overall Study|Physician Decision|0|||
42261531|NCT02055547|76088979|FG000|Overall Study|Adverse Event|0|||
42261532|NCT02055547|76088980|FG001|Overall Study|Adverse Event|0|||
42261533|NCT02055547|76088981|FG002|Overall Study|Adverse Event|0|||
42261534|NCT02055547|76088982|FG003|Overall Study|Adverse Event|0|||
42261535|NCT02055547|76088983|FG004|Overall Study|Adverse Event|0|||
42326098|NCT01640951|76163948|FG005|Overall Study|Non-compliance with study treatment|4|||
42326099|NCT01640951|76163949|FG006|Overall Study|Non-compliance with study treatment|1|||
42326100|NCT01640951|76163950|FG007|Overall Study|Non-compliance with study treatment|0|||
42326101|NCT01640951|76163943|FG000|Overall Study|Physician Decision|2|||
42326102|NCT01640951|76163944|FG001|Overall Study|Physician Decision|5|||
42326103|NCT01640951|76163945|FG002|Overall Study|Physician Decision|2|||
42326104|NCT01640951|76163946|FG003|Overall Study|Physician Decision|2|||
42326105|NCT01640951|76163947|FG004|Overall Study|Physician Decision|2|||
42326106|NCT01640951|76163948|FG005|Overall Study|Physician Decision|3|||
42326107|NCT01640951|76163949|FG006|Overall Study|Physician Decision|3|||
42326108|NCT01640951|76163950|FG007|Overall Study|Physician Decision|0|||
42326109|NCT01640951|76163943|FG000|Overall Study|Pregnancy|3|||
42326110|NCT01640951|76163944|FG001|Overall Study|Pregnancy|0|||
42326111|NCT01640951|76163945|FG002|Overall Study|Pregnancy|0|||
42326112|NCT01640951|76163946|FG003|Overall Study|Pregnancy|4|||
42326113|NCT01640951|76163947|FG004|Overall Study|Pregnancy|0|||
42326114|NCT01640951|76163948|FG005|Overall Study|Pregnancy|0|||
42326115|NCT01640951|76163949|FG006|Overall Study|Pregnancy|2|||
42326116|NCT01640951|76163950|FG007|Overall Study|Pregnancy|0|||
42326117|NCT01640951|76163943|FG000|Overall Study|Protocol Deviation|0|||
42326118|NCT01640951|76163944|FG001|Overall Study|Protocol Deviation|1|||
42326119|NCT01640951|76163945|FG002|Overall Study|Protocol Deviation|2|||
42326120|NCT01640951|76163946|FG003|Overall Study|Protocol Deviation|1|||
42326121|NCT01640951|76163947|FG004|Overall Study|Protocol Deviation|0|||
42326122|NCT01640951|76163948|FG005|Overall Study|Protocol Deviation|1|||
42326123|NCT01640951|76163949|FG006|Overall Study|Protocol Deviation|0|||
42326124|NCT01640951|76163950|FG007|Overall Study|Protocol Deviation|0|||
42326125|NCT01640951|76163943|FG000|Overall Study|Subject/Guardian decision|12|||
42326126|NCT01640951|76163944|FG001|Overall Study|Subject/Guardian decision|4|||
42326127|NCT01640951|76163945|FG002|Overall Study|Subject/Guardian decision|13|||
42326128|NCT01640951|76163946|FG003|Overall Study|Subject/Guardian decision|15|||
42326129|NCT01640951|76163947|FG004|Overall Study|Subject/Guardian decision|7|||
42326130|NCT01640951|76163948|FG005|Overall Study|Subject/Guardian decision|19|||
42326131|NCT01640951|76163949|FG006|Overall Study|Subject/Guardian decision|5|||
42326132|NCT01640951|76163950|FG007|Overall Study|Subject/Guardian decision|4|||
42326133|NCT01640951|76163943|FG000|Overall Study|Death|0|||
42326134|NCT01640951|76163944|FG001|Overall Study|Death|1|||
42326135|NCT01640951|76163945|FG002|Overall Study|Death|1|||
42326136|NCT01640951|76163946|FG003|Overall Study|Death|0|||
42326137|NCT01640951|76163947|FG004|Overall Study|Death|0|||
42326138|NCT01640951|76163948|FG005|Overall Study|Death|0|||
42326139|NCT01640951|76163949|FG006|Overall Study|Death|0|||
42326140|NCT01640951|76163950|FG007|Overall Study|Death|2|||
42326141|NCT02228096|76163972|FG000|Overall Study|Study terminated by Sponsor|24|||
42326142|NCT02228096|76163972|FG000|Overall Study|Lack of Efficacy|18|||
41996227|NCT00171249|75804268|FG006|Overall Study|No Longer Requires Study Drug|0|||
41996228|NCT00171249|75804262|FG000|Overall Study|Administrative Problems|1|||
41996229|NCT00171249|75804263|FG001|Overall Study|Administrative Problems|0|||
42326143|NCT02228096|76163972|FG000|Overall Study|Death|12|||
42326144|NCT02228096|76163972|FG000|Overall Study|Physician Decision|3|||
42326145|NCT02228096|76163972|FG000|Overall Study|Subject/guardian decision|2|||
42326146|NCT02228096|76163972|FG000|Overall Study|New therapy for study indication|1|||
41996230|NCT00171249|75804264|FG002|Overall Study|Administrative Problems|0|||
42326147|NCT02228096|76163972|FG000|Overall Study|Enrolled, not infused|11|||
42326148|NCT01640873|76163992|FG000|Overall Study|Protocol Violation|2|||
42326149|NCT01640873|76163993|FG001|Overall Study|Protocol Violation|1|||
42326150|NCT01683994|76164004|FG000|Overall Study|Withdrawal by Subject|1|||
42326151|NCT01683994|76164005|FG001|Overall Study|Withdrawal by Subject|0|||
42326152|NCT01683994|76164006|FG002|Overall Study|Withdrawal by Subject|0|||
42326153|NCT01683994|76164007|FG003|Overall Study|Withdrawal by Subject|1|||
42326154|NCT01683994|76164008|FG004|Overall Study|Withdrawal by Subject|0|||
42326155|NCT01683994|76164004|FG000|Overall Study|Intercurrent illness|0|||
42326156|NCT01683994|76164005|FG001|Overall Study|Intercurrent illness|0|||
42326157|NCT01683994|76164006|FG002|Overall Study|Intercurrent illness|0|||
42326158|NCT01683994|76164007|FG003|Overall Study|Intercurrent illness|2|||
42326159|NCT01683994|76164008|FG004|Overall Study|Intercurrent illness|1|||
42326160|NCT02247440|76164026|FG000|Overall Study|Withdrawal by Subject|1|||
42326161|NCT02247440|76164026|FG000|Overall Study|Lack of Efficacy|3|||
42326162|NCT01683838|76164032|FG000|Overall Study|Adverse Event|12|||
42326163|NCT01683838|76164033|FG001|Overall Study|Adverse Event|2|||
42326164|NCT01683838|76164032|FG000|Overall Study|Protocol Violation|3|||
42326165|NCT01683838|76164033|FG001|Overall Study|Protocol Violation|1|||
42326166|NCT01683838|76164032|FG000|Overall Study|Withdrawal by Subject|6|||
42326167|NCT01683838|76164033|FG001|Overall Study|Withdrawal by Subject|5|||
42326168|NCT01683838|76164032|FG000|Overall Study|Lost to Follow-up|1|||
42326169|NCT01683838|76164033|FG001|Overall Study|Lost to Follow-up|1|||
42326170|NCT01683838|76164032|FG000|Overall Study|Other|4|||
42326171|NCT01683838|76164033|FG001|Overall Study|Other|3|||
42326172|NCT01683604|76164039|FG000|Overall Study|Adverse Event|2|||
42326173|NCT01683604|76164039|FG000|Overall Study|Lack of Efficacy|1|||
42326174|NCT01683604|76164039|FG000|Overall Study|Other|2|||
42326175|NCT02196038|76164050|FG000|Overall Study|Death|16|||
42326176|NCT02196038|76164051|FG001|Overall Study|Death|21|||
42326177|NCT02196038|76164050|FG000|Overall Study|Withdrawal by Subject|0|||
42326178|NCT02196038|76164051|FG001|Overall Study|Withdrawal by Subject|1|||
42326179|NCT02196038|76164050|FG000|Overall Study|Lost to Follow-up|1|||
42326180|NCT02196038|76164051|FG001|Overall Study|Lost to Follow-up|0|||
42326181|NCT02141659|76164063|FG000|Overall Study|Major Protocol Deviation|0|||
42326182|NCT02141659|76164064|FG001|Overall Study|Major Protocol Deviation|1|||
42261536|NCT02055547|76088984|FG005|Overall Study|Adverse Event|0|||
42261537|NCT02055547|76088985|FG006|Overall Study|Adverse Event|1|||
42261538|NCT02055547|76088986|FG007|Overall Study|Adverse Event|0|||
42261539|NCT02055547|76088987|FG008|Overall Study|Adverse Event|1|||
42261540|NCT02055547|76088988|FG009|Overall Study|Adverse Event|0|||
42261541|NCT02055547|76088989|FG010|Overall Study|Adverse Event|0|||
42261542|NCT02055547|76088990|FG011|Overall Study|Adverse Event|0|||
42261543|NCT02055547|76088991|FG012|Overall Study|Adverse Event|0|||
42261544|NCT02055547|76088992|FG013|Overall Study|Adverse Event|0|||
42326183|NCT02141659|76164065|FG002|Overall Study|Major Protocol Deviation|0|||
42326184|NCT02141659|76164066|FG003|Overall Study|Major Protocol Deviation|0|||
42261545|NCT02055547|76088993|FG014|Overall Study|Adverse Event|0|||
42261546|NCT02055547|76088994|FG015|Overall Study|Adverse Event|0|||
42326185|NCT02141659|76164067|FG004|Overall Study|Major Protocol Deviation|0|||
42326186|NCT02141659|76164068|FG005|Overall Study|Major Protocol Deviation|0|||
42261547|NCT02055547|76088995|FG016|Overall Study|Adverse Event|0|||
42326187|NCT02141659|76164063|FG000|Overall Study|Lack of Efficacy|0|||
42326188|NCT02141659|76164064|FG001|Overall Study|Lack of Efficacy|0|||
42326189|NCT02141659|76164065|FG002|Overall Study|Lack of Efficacy|0|||
42326190|NCT02141659|76164066|FG003|Overall Study|Lack of Efficacy|0|||
42326191|NCT02141659|76164067|FG004|Overall Study|Lack of Efficacy|0|||
42326192|NCT02141659|76164068|FG005|Overall Study|Lack of Efficacy|1|||
42326193|NCT02141659|76164063|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
42326194|NCT02141659|76164064|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
42326195|NCT02141659|76164065|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
42326196|NCT02141659|76164066|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
42326197|NCT02141659|76164067|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
42326198|NCT02141659|76164068|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
42326199|NCT01640249|76164089|FG000|Period 1|Withdrawal by Subject|1|||
42326200|NCT01640249|76164090|FG001|Period 1|Withdrawal by Subject|0|||
42326201|NCT01640249|76164091|FG002|Period 1|Withdrawal by Subject|0|||
42326202|NCT01640249|76164092|FG003|Period 1|Withdrawal by Subject|0|||
42326203|NCT01640249|76164093|FG004|Period 1|Withdrawal by Subject|0|||
42326204|NCT01640249|76164094|FG005|Period 1|Withdrawal by Subject|1|||
42326205|NCT01640249|76164095|FG006|Period 1|Withdrawal by Subject|0|||
42326206|NCT02121301|76164117|FG000|Overall Study|Protocol Violation|1|||
42326207|NCT02121301|76164118|FG001|Overall Study|Protocol Violation|4|||
42326208|NCT02121301|76164119|FG002|Overall Study|Protocol Violation|1|||
42326209|NCT02227862|76164129|FG000|Overall Study|Protocol Violation|7|||
42326210|NCT02227862|76164130|FG001|Overall Study|Protocol Violation|9|||
42326211|NCT02227862|76164129|FG000|Overall Study|Other|0|||
42326212|NCT02227862|76164130|FG001|Overall Study|Other|2|||
42261548|NCT02055547|76088996|FG017|Overall Study|Adverse Event|0|||
42261549|NCT02055547|76088997|FG018|Overall Study|Adverse Event|0|||
42326213|NCT02227862|76164129|FG000|Overall Study|Adverse Event|4|||
42326214|NCT02227862|76164130|FG001|Overall Study|Adverse Event|3|||
42326215|NCT02227862|76164129|FG000|Overall Study|Withdrawal by Subject|7|||
42326216|NCT02227862|76164130|FG001|Overall Study|Withdrawal by Subject|6|||
42326217|NCT02227862|76164129|FG000|Overall Study|Lost to Follow-up|1|||
42326218|NCT02227862|76164130|FG001|Overall Study|Lost to Follow-up|2|||
42326219|NCT02120833|76164138|FG000|Overall Study|Adverse Event|1|||
42326220|NCT02120833|76164139|FG001|Overall Study|Adverse Event|0|||
42326221|NCT02120833|76164138|FG000|Overall Study|Withdrawal by Subject|2|||
42326222|NCT02120833|76164139|FG001|Overall Study|Withdrawal by Subject|0|||
42326223|NCT02120833|76164138|FG000|Overall Study|Lost to Follow-up|1|||
42326224|NCT02120833|76164139|FG001|Overall Study|Lost to Follow-up|1|||
42326225|NCT02170207|76164145|FG000|Overall Study|Case report forms unavailable|5|||
42326226|NCT02227784|76164153|FG000|Double-Blind Phase|Adverse Event|3|||
42326227|NCT02227784|76164154|FG001|Double-Blind Phase|Adverse Event|2|||
42326228|NCT02227784|76164155|FG002|Double-Blind Phase|Adverse Event|1|||
42326229|NCT02227784|76164156|FG003|Double-Blind Phase|Adverse Event|3|||
42326230|NCT02227784|76164157|FG004|Double-Blind Phase|Adverse Event|0|||
42326231|NCT02227784|76164153|FG000|Double-Blind Phase|Physician Decision|1|||
42326232|NCT02227784|76164154|FG001|Double-Blind Phase|Physician Decision|0|||
42326233|NCT02227784|76164155|FG002|Double-Blind Phase|Physician Decision|0|||
42261550|NCT02055547|76088979|FG000|Overall Study|Withdrawal by Subject|0|||
42261551|NCT02055547|76088980|FG001|Overall Study|Withdrawal by Subject|0|||
42261552|NCT02055547|76088981|FG002|Overall Study|Withdrawal by Subject|0|||
42261553|NCT02055547|76088982|FG003|Overall Study|Withdrawal by Subject|0|||
42261554|NCT02055547|76088983|FG004|Overall Study|Withdrawal by Subject|0|||
42326234|NCT02227784|76164156|FG003|Double-Blind Phase|Physician Decision|1|||
41996231|NCT00171249|75804265|FG003|Overall Study|Administrative Problems|2|||
42261555|NCT02055547|76088984|FG005|Overall Study|Withdrawal by Subject|1|||
42261556|NCT02055547|76088985|FG006|Overall Study|Withdrawal by Subject|0|||
42261557|NCT02055547|76088986|FG007|Overall Study|Withdrawal by Subject|0|||
42326235|NCT02227784|76164157|FG004|Double-Blind Phase|Physician Decision|0|||
42326236|NCT02227784|76164153|FG000|Double-Blind Phase|Protocol Violation|0|||
42326237|NCT02227784|76164154|FG001|Double-Blind Phase|Protocol Violation|0|||
42326238|NCT02227784|76164155|FG002|Double-Blind Phase|Protocol Violation|1|||
42326239|NCT02227784|76164156|FG003|Double-Blind Phase|Protocol Violation|1|||
42326240|NCT02227784|76164157|FG004|Double-Blind Phase|Protocol Violation|0|||
42326241|NCT02227784|76164153|FG000|Double-Blind Phase|Sponsor Decision|34|||
42326242|NCT02227784|76164154|FG001|Double-Blind Phase|Sponsor Decision|15|||
42326243|NCT02227784|76164155|FG002|Double-Blind Phase|Sponsor Decision|14|||
42326244|NCT02227784|76164156|FG003|Double-Blind Phase|Sponsor Decision|32|||
42326245|NCT02227784|76164157|FG004|Double-Blind Phase|Sponsor Decision|0|||
42326246|NCT02227784|76164153|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
42326247|NCT02227784|76164154|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
42326248|NCT02227784|76164155|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
42326249|NCT02227784|76164156|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
42326250|NCT02227784|76164157|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
42326251|NCT02227784|76164153|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
42326252|NCT02227784|76164154|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
42326253|NCT02227784|76164155|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
42326254|NCT02227784|76164156|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
42326255|NCT02227784|76164157|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
42326256|NCT02227784|76164153|FG000|Open-Label Extension Phase (OLE)|Death|0|||
41996232|NCT00171249|75804266|FG004|Overall Study|Administrative Problems|0|||
41996233|NCT00171249|75804267|FG005|Overall Study|Administrative Problems|0|||
41996234|NCT00171249|75804268|FG006|Overall Study|Administrative Problems|0|||
41996235|NCT00171249|75804262|FG000|Overall Study|Adverse Event|3|||
42326257|NCT02227784|76164154|FG001|Open-Label Extension Phase (OLE)|Death|0|||
42326258|NCT02227784|76164155|FG002|Open-Label Extension Phase (OLE)|Death|0|||
42326259|NCT02227784|76164156|FG003|Open-Label Extension Phase (OLE)|Death|0|||
42326260|NCT02227784|76164157|FG004|Open-Label Extension Phase (OLE)|Death|1|||
42326261|NCT02227784|76164153|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
42326262|NCT02227784|76164154|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
42326263|NCT02227784|76164155|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
42326264|NCT02227784|76164156|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
42326265|NCT02227784|76164157|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
42326266|NCT02227784|76164153|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
42326267|NCT02227784|76164154|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
42326268|NCT02227784|76164155|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
42326269|NCT02227784|76164156|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
42326270|NCT02227784|76164157|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
42326271|NCT01565668|76164172|FG000|Overall Study|Death|2|||
42326272|NCT01565668|76164173|FG001|Overall Study|Death|1|||
42326273|NCT01565668|76164172|FG000|Overall Study|Lack of Efficacy|4|||
42326274|NCT01565668|76164173|FG001|Overall Study|Lack of Efficacy|2|||
42326275|NCT01565668|76164172|FG000|Overall Study|Participant went on Hospice Care|1|||
42326276|NCT01565668|76164173|FG001|Overall Study|Participant went on Hospice Care|0|||
42326277|NCT01565668|76164172|FG000|Overall Study|Adverse Event|6|||
42326278|NCT01565668|76164173|FG001|Overall Study|Adverse Event|1|||
42326279|NCT01565668|76164172|FG000|Overall Study|Randomized, but never received drug|0|||
42326280|NCT01565668|76164173|FG001|Overall Study|Randomized, but never received drug|2|||
42326281|NCT01565668|76164172|FG000|Overall Study|Progressive disease|13|||
42326282|NCT01565668|76164173|FG001|Overall Study|Progressive disease|14|||
42326283|NCT01565668|76164172|FG000|Overall Study|Withdrawal by Subject|1|||
42326284|NCT01565668|76164173|FG001|Overall Study|Withdrawal by Subject|3|||
42326285|NCT01565668|76164172|FG000|Overall Study|HSCT Transplant|11|||
42326286|NCT01565668|76164173|FG001|Overall Study|HSCT Transplant|15|||
42326287|NCT01683058|76164179|FG000|Overall Study|Lost to Follow-up|9|||
42326288|NCT01683058|76164179|FG000|Overall Study|Adverse Event|6|||
42326289|NCT01683058|76164179|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
42326290|NCT01683058|76164179|FG000|Overall Study|Withdrawal by Subject|7|||
42326291|NCT01683058|76164179|FG000|Overall Study|Lack of Efficacy|2|||
42326292|NCT01626859|76164187|FG000|Overall Study|Adverse Event|1|||
42326293|NCT01626859|76164188|FG001|Overall Study|Adverse Event|3|||
42326294|NCT01626859|76164189|FG002|Overall Study|Adverse Event|2|||
41996236|NCT00171249|75804263|FG001|Overall Study|Adverse Event|1|||
41996237|NCT00171249|75804264|FG002|Overall Study|Adverse Event|0|||
42326295|NCT01626859|76164187|FG000|Overall Study|Physician Decision|0|||
42326296|NCT01626859|76164188|FG001|Overall Study|Physician Decision|1|||
41996238|NCT00171249|75804265|FG003|Overall Study|Adverse Event|15|||
41996239|NCT00171249|75804266|FG004|Overall Study|Adverse Event|0|||
41996240|NCT00171249|75804267|FG005|Overall Study|Adverse Event|2|||
42261558|NCT02055547|76088987|FG008|Overall Study|Withdrawal by Subject|1|||
42261559|NCT02055547|76088988|FG009|Overall Study|Withdrawal by Subject|0|||
42261560|NCT02055547|76088989|FG010|Overall Study|Withdrawal by Subject|0|||
42261561|NCT02055547|76088990|FG011|Overall Study|Withdrawal by Subject|0|||
42261562|NCT02055547|76088991|FG012|Overall Study|Withdrawal by Subject|0|||
42261563|NCT02055547|76088992|FG013|Overall Study|Withdrawal by Subject|1|||
42261564|NCT02055547|76088993|FG014|Overall Study|Withdrawal by Subject|0|||
42261565|NCT02055547|76088994|FG015|Overall Study|Withdrawal by Subject|1|||
42261566|NCT02055547|76088995|FG016|Overall Study|Withdrawal by Subject|0|||
42326297|NCT01626859|76164189|FG002|Overall Study|Physician Decision|0|||
42326298|NCT01626859|76164187|FG000|Overall Study|Withdrawal by Subject|1|||
42326299|NCT01626859|76164188|FG001|Overall Study|Withdrawal by Subject|4|||
42326300|NCT01626859|76164189|FG002|Overall Study|Withdrawal by Subject|2|||
42326301|NCT02193776|76164201|FG000|Overall Study|Consent withdrawn|1|||
42326302|NCT02193776|76164202|FG001|Overall Study|Consent withdrawn|0|||
42326303|NCT02193776|76164203|FG002|Overall Study|Consent withdrawn|0|||
42326304|NCT02193776|76164204|FG003|Overall Study|Consent withdrawn|0|||
42326305|NCT02193776|76164201|FG000|Overall Study|Failure to comply with protocol|0|||
42326306|NCT02193776|76164202|FG001|Overall Study|Failure to comply with protocol|1|||
42326307|NCT02193776|76164203|FG002|Overall Study|Failure to comply with protocol|0|||
42326308|NCT02193776|76164204|FG003|Overall Study|Failure to comply with protocol|0|||
42326309|NCT02193776|76164201|FG000|Overall Study|Investigator/Sponsor decision|1|||
42326310|NCT02193776|76164202|FG001|Overall Study|Investigator/Sponsor decision|1|||
42326311|NCT02193776|76164203|FG002|Overall Study|Investigator/Sponsor decision|0|||
42326312|NCT02193776|76164204|FG003|Overall Study|Investigator/Sponsor decision|0|||
42326313|NCT02193776|76164201|FG000|Overall Study|Death|1|||
42326314|NCT02193776|76164202|FG001|Overall Study|Death|0|||
42326315|NCT02193776|76164203|FG002|Overall Study|Death|0|||
42326316|NCT02193776|76164204|FG003|Overall Study|Death|0|||
42326317|NCT02193776|76164201|FG000|Overall Study|Adverse event/Specific toxicity|5|||
42326318|NCT02193776|76164202|FG001|Overall Study|Adverse event/Specific toxicity|5|||
42326319|NCT02193776|76164203|FG002|Overall Study|Adverse event/Specific toxicity|2|||
42326320|NCT02193776|76164204|FG003|Overall Study|Adverse event/Specific toxicity|2|||
42326321|NCT02170064|76164217|FG000|Overall Study|Withdrawal by Subject|5|||
42326322|NCT02170064|76164218|FG001|Overall Study|Withdrawal by Subject|1|||
42326323|NCT02170064|76164219|FG002|Overall Study|Withdrawal by Subject|1|||
42326324|NCT02170064|76164217|FG000|Overall Study|Physician Decision|1|||
42326325|NCT02170064|76164218|FG001|Overall Study|Physician Decision|1|||
42326326|NCT02170064|76164219|FG002|Overall Study|Physician Decision|0|||
42326327|NCT02169830|76164230|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
42326328|NCT02169830|76164231|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
42326329|NCT02169830|76164232|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
42326330|NCT02169830|76164230|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
42326331|NCT02169830|76164231|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
42326332|NCT02169830|76164232|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
42326333|NCT02169830|76164230|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
42326334|NCT02169830|76164231|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
42326335|NCT02169830|76164232|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
42326336|NCT02169830|76164230|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
42326337|NCT02169830|76164231|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
42326338|NCT02169830|76164232|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
42326339|NCT02169830|76164230|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
42326340|NCT02169830|76164231|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
42326341|NCT02169830|76164232|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
42326342|NCT02169674|76164242|FG000|Overall Study|Withdrawal by Subject|2|||
42326343|NCT02169674|76164243|FG001|Overall Study|Withdrawal by Subject|1|||
42326344|NCT02169674|76164242|FG000|Overall Study|Seroprotected|30|||
42326345|NCT02169674|76164243|FG001|Overall Study|Seroprotected|76|||
42326346|NCT02169674|76164242|FG000|Overall Study|Lost to Follow-up|0|||
42326347|NCT02169674|76164243|FG001|Overall Study|Lost to Follow-up|1|||
42326348|NCT02169284|76164251|FG000|Overall Study|Physician Decision|0|||
41996241|NCT00171249|75804268|FG006|Overall Study|Adverse Event|0|||
42326349|NCT02169284|76164252|FG001|Overall Study|Physician Decision|1|||
42326350|NCT02119819|76164266|FG000|Overall Study|Adverse Event|3|||
42326351|NCT02119819|76164267|FG001|Overall Study|Adverse Event|1|||
42326352|NCT02119819|76164268|FG002|Overall Study|Adverse Event|2|||
42326353|NCT02119819|76164269|FG003|Overall Study|Adverse Event|3|||
42326354|NCT02119819|76164270|FG004|Overall Study|Adverse Event|0|||
41996242|NCT00171249|75804262|FG000|Overall Study|Lost to Follow-up|5|||
41996243|NCT00171249|75804263|FG001|Overall Study|Lost to Follow-up|0|||
41996244|NCT00171249|75804264|FG002|Overall Study|Lost to Follow-up|0|||
41996245|NCT00171249|75804265|FG003|Overall Study|Lost to Follow-up|9|||
41996246|NCT00171249|75804266|FG004|Overall Study|Lost to Follow-up|0|||
42326355|NCT02119819|76164271|FG005|Overall Study|Adverse Event|1|||
42326356|NCT02119819|76164266|FG000|Overall Study|Lack of Efficacy|0|||
42326357|NCT02119819|76164267|FG001|Overall Study|Lack of Efficacy|0|||
42326358|NCT02119819|76164268|FG002|Overall Study|Lack of Efficacy|0|||
42326359|NCT02119819|76164269|FG003|Overall Study|Lack of Efficacy|0|||
41996247|NCT00171249|75804267|FG005|Overall Study|Lost to Follow-up|0|||
42134033|NCT00548249|75944859|FG002|Overall Study|Withdrawal by Subject|0|||
42326360|NCT02119819|76164270|FG004|Overall Study|Lack of Efficacy|0|||
42326361|NCT02119819|76164271|FG005|Overall Study|Lack of Efficacy|1|||
42326362|NCT02119819|76164266|FG000|Overall Study|Lost to Follow-up|0|||
42326363|NCT02119819|76164267|FG001|Overall Study|Lost to Follow-up|0|||
42326364|NCT02119819|76164268|FG002|Overall Study|Lost to Follow-up|1|||
42326365|NCT02119819|76164269|FG003|Overall Study|Lost to Follow-up|2|||
42326366|NCT02119819|76164270|FG004|Overall Study|Lost to Follow-up|1|||
42326367|NCT02119819|76164271|FG005|Overall Study|Lost to Follow-up|2|||
42326368|NCT02119819|76164266|FG000|Overall Study|Physician Decision|1|||
42326369|NCT02119819|76164267|FG001|Overall Study|Physician Decision|1|||
42326370|NCT02119819|76164268|FG002|Overall Study|Physician Decision|0|||
42326371|NCT02119819|76164269|FG003|Overall Study|Physician Decision|0|||
42326372|NCT02119819|76164270|FG004|Overall Study|Physician Decision|0|||
42326373|NCT02119819|76164271|FG005|Overall Study|Physician Decision|1|||
42326374|NCT02119819|76164266|FG000|Overall Study|Withdrawal by Subject|5|||
42326375|NCT02119819|76164267|FG001|Overall Study|Withdrawal by Subject|3|||
42326376|NCT02119819|76164268|FG002|Overall Study|Withdrawal by Subject|0|||
42326377|NCT02119819|76164269|FG003|Overall Study|Withdrawal by Subject|0|||
42326378|NCT02119819|76164270|FG004|Overall Study|Withdrawal by Subject|6|||
42326379|NCT02119819|76164271|FG005|Overall Study|Withdrawal by Subject|10|||
42326380|NCT02119819|76164266|FG000|Overall Study|Jury Duty|0|||
42326381|NCT02119819|76164267|FG001|Overall Study|Jury Duty|0|||
42326382|NCT02119819|76164268|FG002|Overall Study|Jury Duty|1|||
42326383|NCT02119819|76164269|FG003|Overall Study|Jury Duty|0|||
42326384|NCT02119819|76164270|FG004|Overall Study|Jury Duty|0|||
42326385|NCT02119819|76164271|FG005|Overall Study|Jury Duty|0|||
42326386|NCT02119819|76164266|FG000|Overall Study|Protocol Violation|0|||
42326387|NCT02119819|76164267|FG001|Overall Study|Protocol Violation|0|||
42326388|NCT02119819|76164268|FG002|Overall Study|Protocol Violation|0|||
42326389|NCT02119819|76164269|FG003|Overall Study|Protocol Violation|1|||
42326390|NCT02119819|76164270|FG004|Overall Study|Protocol Violation|0|||
42326391|NCT02119819|76164271|FG005|Overall Study|Protocol Violation|0|||
42326392|NCT02119819|76164266|FG000|Overall Study|Left the city to get a job|0|||
42326393|NCT02119819|76164267|FG001|Overall Study|Left the city to get a job|0|||
42326394|NCT02119819|76164268|FG002|Overall Study|Left the city to get a job|0|||
42326395|NCT02119819|76164269|FG003|Overall Study|Left the city to get a job|1|||
42326396|NCT02119819|76164270|FG004|Overall Study|Left the city to get a job|0|||
42326397|NCT02119819|76164271|FG005|Overall Study|Left the city to get a job|0|||
42326398|NCT02168816|76164287|FG000|Overall Study|Lost to Follow-up|2|||
42326399|NCT02168816|76164288|FG001|Overall Study|Lost to Follow-up|2|||
42326400|NCT01584232|76164296|FG000|Overall Study|Adverse Event|3|||
42326401|NCT01584232|76164297|FG001|Overall Study|Adverse Event|1|||
42326402|NCT01584232|76164296|FG000|Overall Study|Withdrawal by Subject|2|||
42326403|NCT01584232|76164297|FG001|Overall Study|Withdrawal by Subject|1|||
42326404|NCT01584232|76164296|FG000|Overall Study|Physician Decision|2|||
42326405|NCT01584232|76164297|FG001|Overall Study|Physician Decision|1|||
42326406|NCT01584232|76164296|FG000|Overall Study|Lost to Follow-up|1|||
42326407|NCT01584232|76164297|FG001|Overall Study|Lost to Follow-up|0|||
42326408|NCT01639703|76164303|FG000|Overall Study|Withdrawal by Subject|5|||
42326409|NCT01639703|76164303|FG000|Overall Study|Other reason|7|||
42326410|NCT02119663|76164321|FG000|Overall Study|Disease progression|26|||
42326411|NCT02119663|76164322|FG001|Overall Study|Disease progression|27|||
42326412|NCT02119663|76164321|FG000|Overall Study|Adverse Event|5|||
42326413|NCT02119663|76164322|FG001|Overall Study|Adverse Event|5|||
42326414|NCT02119663|76164321|FG000|Overall Study|Death|3|||
42326415|NCT02119663|76164322|FG001|Overall Study|Death|2|||
42326416|NCT02119663|76164321|FG000|Overall Study|Physician Decision|1|||
41996248|NCT00171249|75804268|FG006|Overall Study|Lost to Follow-up|0|||
41996249|NCT01085630|75804279|FG000|Overall Study|Insufficient data|1|||
41996250|NCT01085630|75804280|FG001|Overall Study|Insufficient data|0|||
42326417|NCT02119663|76164322|FG001|Overall Study|Physician Decision|2|||
42326418|NCT02119663|76164321|FG000|Overall Study|Other unspecified|2|||
42326419|NCT02119663|76164322|FG001|Overall Study|Other unspecified|0|||
41996251|NCT01085630|75804279|FG000|Overall Study|Ineligible|3|||
42326420|NCT02119663|76164321|FG000|Overall Study|Subject decision|0|||
42326421|NCT02119663|76164322|FG001|Overall Study|Subject decision|1|||
42326422|NCT02119663|76164321|FG000|Overall Study|Study Terminated by the Sponsor|3|||
42326423|NCT02119663|76164322|FG001|Overall Study|Study Terminated by the Sponsor|4|||
42326424|NCT01639469|76164330|FG000|Overall Study|Death|4|||
42326425|NCT01639469|76164331|FG001|Overall Study|Death|2|||
42326426|NCT01639469|76164330|FG000|Overall Study|Lost to Follow-up|1|||
42326427|NCT01639469|76164331|FG001|Overall Study|Lost to Follow-up|1|||
41996252|NCT01085630|75804280|FG001|Overall Study|Ineligible|0|||
42326428|NCT02193074|76164339|FG000|Overall Study|Withdrawal by Subject|1|||
42326429|NCT02193074|76164340|FG001|Overall Study|Withdrawal by Subject|2|||
42326430|NCT02193074|76164339|FG000|Overall Study|Adverse Event|16|||
42326431|NCT02193074|76164340|FG001|Overall Study|Adverse Event|13|||
42326432|NCT02192606|76164348|FG000|Overall Study|surgery type was changed|1|||
42326433|NCT02192606|76164349|FG001|Overall Study|surgery type was changed|1|||
42326434|NCT02192606|76164348|FG000|Overall Study|Physician Decision|1|||
42326435|NCT02192606|76164349|FG001|Overall Study|Physician Decision|2|||
42326436|NCT02192606|76164348|FG000|Overall Study|3D equipment rep unable to join|0|||
42326437|NCT02192606|76164349|FG001|Overall Study|3D equipment rep unable to join|1|||
42326438|NCT01628107|76164355|FG000|Overall Study|Withdrawal by Subject|17|||
42326439|NCT01628107|76164355|FG000|Overall Study|Lost to Follow-up|4|||
42326440|NCT01628107|76164355|FG000|Overall Study|Adverse Event|33|||
42326441|NCT01628107|76164355|FG000|Overall Study|Physician Decision|2|||
42326442|NCT01628107|76164355|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
42326443|NCT01628107|76164355|FG000|Overall Study|Non-compliant with Study Procedures|10|||
42326444|NCT01628107|76164355|FG000|Overall Study|Not Treated|8|||
42326445|NCT01628107|76164355|FG000|Overall Study|Sponsor Decision|11|||
42326446|NCT01628107|76164355|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
42326447|NCT01628107|76164355|FG000|Overall Study|Relocated|8|||
42326448|NCT01628107|76164355|FG000|Overall Study|Kidney Transplant|9|||
42326449|NCT01628107|76164355|FG000|Overall Study|Use of Standard of Care|9|||
41996253|NCT00171210|75804288|FG000|Overall Study|Adverse Event|16|||
41996254|NCT00171210|75804289|FG001|Overall Study|Adverse Event|27|||
41996255|NCT00171210|75804288|FG000|Overall Study|Abnormal laboratory value(s)|6|||
41996256|NCT00171210|75804289|FG001|Overall Study|Abnormal laboratory value(s)|3|||
41996257|NCT00171210|75804288|FG000|Overall Study|Abnormal test procedure result(s)|0|||
41996258|NCT00171210|75804289|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42326450|NCT01583530|76164365|FG000|Overall Study|Adverse Event|0|||
41996259|NCT00171210|75804288|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
41996260|NCT00171210|75804289|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
41996261|NCT00171210|75804288|FG000|Overall Study|Protocol Violation|0|||
41996262|NCT00171210|75804289|FG001|Overall Study|Protocol Violation|2|||
41996263|NCT00171210|75804288|FG000|Overall Study|Withdrawal by Subject|32|||
41996264|NCT00171210|75804289|FG001|Overall Study|Withdrawal by Subject|30|||
41996265|NCT00171210|75804288|FG000|Overall Study|Lost to Follow-up|1|||
41996266|NCT00171210|75804289|FG001|Overall Study|Lost to Follow-up|0|||
41996267|NCT00171210|75804288|FG000|Overall Study|Administrative problems|1|||
41996268|NCT00171210|75804289|FG001|Overall Study|Administrative problems|1|||
41996269|NCT00171210|75804288|FG000|Overall Study|Death|2|||
41996270|NCT00171210|75804289|FG001|Overall Study|Death|3|||
41996271|NCT00171210|75804288|FG000|Overall Study|Stopped at end of core|0|||
41996272|NCT00171210|75804289|FG001|Overall Study|Stopped at end of core|32|||
41996273|NCT00171210|75804288|FG000|Overall Study|Stopped at end of extension 1|0|||
41996274|NCT00171210|75804289|FG001|Overall Study|Stopped at end of extension 1|1|||
41996275|NCT00171054|75804297|FG000|Overall Study|Protocol Violation|1|||
41996276|NCT00171054|75804298|FG001|Overall Study|Protocol Violation|2|||
41996277|NCT00171054|75804297|FG000|Overall Study|Patient withdrew consent|1|||
41996278|NCT00171054|75804298|FG001|Overall Study|Patient withdrew consent|0|||
41996279|NCT00171054|75804297|FG000|Overall Study|Lost to Follow-up|0|||
41996280|NCT00171054|75804298|FG001|Overall Study|Lost to Follow-up|1|||
41996281|NCT00171054|75804297|FG000|Overall Study|Adverse Event|8|||
41996282|NCT00171054|75804298|FG001|Overall Study|Adverse Event|8|||
41996283|NCT00171054|75804297|FG000|Overall Study|Condition no longer required study drug|0|||
41996284|NCT00171054|75804298|FG001|Overall Study|Condition no longer required study drug|1|||
41996285|NCT01084694|75804306|FG000|Overall Study|Withdrawal by Subject|2|||
41996286|NCT01084694|75804307|FG001|Overall Study|Withdrawal by Subject|1|||
41996287|NCT01084694|75804306|FG000|Overall Study|Death|2|||
42326451|NCT01583530|76164366|FG001|Overall Study|Adverse Event|0|||
42326452|NCT01583530|76164367|FG002|Overall Study|Adverse Event|0|||
42326453|NCT01583530|76164368|FG003|Overall Study|Adverse Event|0|||
42326454|NCT01583530|76164369|FG004|Overall Study|Adverse Event|0|||
42326455|NCT01583530|76164370|FG005|Overall Study|Adverse Event|1|||
41996288|NCT01084694|75804307|FG001|Overall Study|Death|12|||
41996289|NCT01084694|75804306|FG000|Overall Study|eligibility not maintained|2|||
42326456|NCT01583530|76164365|FG000|Overall Study|Withdrawal by Subject|0|||
41996290|NCT01084694|75804307|FG001|Overall Study|eligibility not maintained|7|||
41996291|NCT00479856|75804321|FG000|Overall Study|Adverse Event|1|||
41996292|NCT00479856|75804321|FG000|Overall Study|Withdrawal by Subject|1|||
41996293|NCT00479856|75804321|FG000|Overall Study|Physician Decision|1|||
41996294|NCT00479466|75804331|FG000|Overall Study|Adverse Event|5|||
41996295|NCT00479466|75804332|FG001|Overall Study|Adverse Event|1|||
41996296|NCT00479466|75804333|FG002|Overall Study|Adverse Event|0|||
41996297|NCT00479466|75804334|FG003|Overall Study|Adverse Event|1|||
42326457|NCT01583530|76164366|FG001|Overall Study|Withdrawal by Subject|3|||
42326458|NCT01583530|76164367|FG002|Overall Study|Withdrawal by Subject|0|||
42326459|NCT01583530|76164368|FG003|Overall Study|Withdrawal by Subject|1|||
42326460|NCT01583530|76164369|FG004|Overall Study|Withdrawal by Subject|1|||
42326461|NCT01583530|76164370|FG005|Overall Study|Withdrawal by Subject|2|||
42326462|NCT01583530|76164365|FG000|Overall Study|Lost to Follow-up|0|||
42326463|NCT01583530|76164366|FG001|Overall Study|Lost to Follow-up|0|||
42326464|NCT01583530|76164367|FG002|Overall Study|Lost to Follow-up|0|||
41996298|NCT00479466|75804335|FG004|Overall Study|Adverse Event|2|||
41996299|NCT00479466|75804336|FG005|Overall Study|Adverse Event|0|||
41996300|NCT00479466|75804331|FG000|Overall Study|Hyperglycemia|0|||
41996301|NCT00479466|75804332|FG001|Overall Study|Hyperglycemia|0|||
41996302|NCT00479466|75804333|FG002|Overall Study|Hyperglycemia|0|||
41996303|NCT00479466|75804334|FG003|Overall Study|Hyperglycemia|0|||
41996304|NCT00479466|75804335|FG004|Overall Study|Hyperglycemia|0|||
41996305|NCT00479466|75804336|FG005|Overall Study|Hyperglycemia|1|||
41996306|NCT00479466|75804331|FG000|Overall Study|Lack of Efficacy|2|||
42261567|NCT02055547|76088996|FG017|Overall Study|Withdrawal by Subject|0|||
42261568|NCT02055547|76088997|FG018|Overall Study|Withdrawal by Subject|0|||
42261569|NCT02055547|76088979|FG000|Overall Study|Lost to Follow-up|0|||
42261570|NCT02055547|76088980|FG001|Overall Study|Lost to Follow-up|0|||
42261571|NCT02055547|76088981|FG002|Overall Study|Lost to Follow-up|1|||
42261572|NCT02055547|76088982|FG003|Overall Study|Lost to Follow-up|0|||
42261573|NCT02055547|76088983|FG004|Overall Study|Lost to Follow-up|0|||
42261574|NCT02055547|76088984|FG005|Overall Study|Lost to Follow-up|0|||
42261575|NCT02055547|76088985|FG006|Overall Study|Lost to Follow-up|0|||
42261576|NCT02055547|76088986|FG007|Overall Study|Lost to Follow-up|0|||
42261577|NCT02055547|76088987|FG008|Overall Study|Lost to Follow-up|0|||
42261578|NCT02055547|76088988|FG009|Overall Study|Lost to Follow-up|0|||
42261579|NCT02055547|76088989|FG010|Overall Study|Lost to Follow-up|0|||
41996307|NCT00479466|75804332|FG001|Overall Study|Lack of Efficacy|0|||
41996308|NCT00479466|75804333|FG002|Overall Study|Lack of Efficacy|1|||
41996309|NCT00479466|75804334|FG003|Overall Study|Lack of Efficacy|0|||
42326465|NCT01583530|76164368|FG003|Overall Study|Lost to Follow-up|0|||
42261580|NCT02055547|76088990|FG011|Overall Study|Lost to Follow-up|0|||
42326466|NCT01583530|76164369|FG004|Overall Study|Lost to Follow-up|3|||
42326467|NCT01583530|76164370|FG005|Overall Study|Lost to Follow-up|0|||
42326468|NCT01583530|76164365|FG000|Overall Study|Lack of compliance|0|||
42326469|NCT01583530|76164366|FG001|Overall Study|Lack of compliance|0|||
42326470|NCT01583530|76164367|FG002|Overall Study|Lack of compliance|0|||
42326471|NCT01583530|76164368|FG003|Overall Study|Lack of compliance|0|||
42326472|NCT01583530|76164369|FG004|Overall Study|Lack of compliance|1|||
42326473|NCT01583530|76164370|FG005|Overall Study|Lack of compliance|0|||
42326474|NCT01639001|76164389|FG000|Overall Study|Refused further follow-up|9|||
42326475|NCT01639001|76164390|FG001|Overall Study|Refused further follow-up|12|||
42326476|NCT01639001|76164389|FG000|Overall Study|Lost to Follow-up|3|||
42326477|NCT01639001|76164390|FG001|Overall Study|Lost to Follow-up|0|||
42326478|NCT01639001|76164389|FG000|Overall Study|Death|62|||
42326479|NCT01639001|76164390|FG001|Overall Study|Death|61|||
42326480|NCT01639001|76164389|FG000|Overall Study|Randomized but not treated|0|||
42326481|NCT01639001|76164390|FG001|Overall Study|Randomized but not treated|2|||
42326482|NCT01639001|76164389|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
42326483|NCT01639001|76164390|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
42326484|NCT02224664|76164398|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
42326485|NCT02224664|76164399|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
42326486|NCT02224664|76164400|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
41996310|NCT00479466|75804335|FG004|Overall Study|Lack of Efficacy|0|||
41996311|NCT00479466|75804336|FG005|Overall Study|Lack of Efficacy|0|||
42326487|NCT02224664|76164401|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
42326488|NCT02224664|76164402|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
42326489|NCT02224664|76164398|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
42326490|NCT02224664|76164399|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
42326491|NCT02224664|76164400|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
42326492|NCT02224664|76164401|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
42326493|NCT02224664|76164402|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
42326494|NCT02224664|76164398|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
42326495|NCT02224664|76164399|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
42326496|NCT02224664|76164400|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
42326497|NCT02224664|76164401|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
42326498|NCT02224664|76164402|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
42326499|NCT02167256|76164420|FG000|Overall Study|Adverse Event|13|||
42326500|NCT02167256|76164421|FG001|Overall Study|Adverse Event|6|||
42326501|NCT02167256|76164420|FG000|Overall Study|Withdrawal by Subject|4|||
42326502|NCT02167256|76164421|FG001|Overall Study|Withdrawal by Subject|4|||
42326503|NCT02167256|76164420|FG000|Overall Study|non-compliance|3|||
42326504|NCT02167256|76164421|FG001|Overall Study|non-compliance|0|||
42326505|NCT02167256|76164420|FG000|Overall Study|Study partner unable to participate|1|||
42326506|NCT02167256|76164421|FG001|Overall Study|Study partner unable to participate|0|||
42326507|NCT02191046|76164429|FG000|Overall Study|low compliance|5|||
42326508|NCT02191046|76164430|FG001|Overall Study|low compliance|1|||
42326509|NCT02166476|76164438|FG000|Overall Study|Withdrawal by Subject|5|||
41996312|NCT00479466|75804331|FG000|Overall Study|Lost to Follow-up|0|||
42326510|NCT02166476|76164439|FG001|Overall Study|Withdrawal by Subject|7|||
42326511|NCT02166476|76164438|FG000|Overall Study|Adverse Event|3|||
42326512|NCT02166476|76164439|FG001|Overall Study|Adverse Event|3|||
42326513|NCT02166476|76164438|FG000|Overall Study|Lost to Follow-up|5|||
42326514|NCT02166476|76164439|FG001|Overall Study|Lost to Follow-up|10|||
42326515|NCT02166476|76164438|FG000|Overall Study|Physician Decision|1|||
42326516|NCT02166476|76164439|FG001|Overall Study|Physician Decision|0|||
42326517|NCT02166476|76164438|FG000|Overall Study|Unable to Come for Visit|0|||
42326518|NCT02166476|76164439|FG001|Overall Study|Unable to Come for Visit|3|||
42326519|NCT02224274|76164450|FG000|Overall Study|Death|1|||
42326520|NCT02224274|76164451|FG001|Overall Study|Death|0|||
42326521|NCT02189252|76164465|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
42326522|NCT02189252|76164466|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
42326523|NCT02189252|76164467|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
42326524|NCT02189252|76164468|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
42326525|NCT02189252|76164465|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
42326526|NCT02189252|76164466|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
42326527|NCT02189252|76164467|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
42326528|NCT02189252|76164468|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
42326529|NCT01583374|76164482|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
42326530|NCT01583374|76164483|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
42326531|NCT01583374|76164484|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
42326532|NCT01583374|76164485|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42326533|NCT01583374|76164486|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42326534|NCT01583374|76164487|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42326535|NCT01583374|76164488|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42326536|NCT01583374|76164489|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42326537|NCT01583374|76164490|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42326538|NCT01583374|76164482|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
42326539|NCT01583374|76164483|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
42326540|NCT01583374|76164484|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
42326541|NCT01583374|76164485|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42326542|NCT01583374|76164486|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42326543|NCT01583374|76164487|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42326544|NCT01583374|76164488|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42326545|NCT01583374|76164489|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42326546|NCT01583374|76164490|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42326547|NCT01583374|76164482|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
42326548|NCT01583374|76164483|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
42326549|NCT01583374|76164484|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42326550|NCT01583374|76164485|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42326551|NCT01583374|76164486|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42326552|NCT01583374|76164487|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42326553|NCT01583374|76164488|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42326554|NCT01583374|76164489|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42326555|NCT01583374|76164490|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42326556|NCT01583374|76164482|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
42326557|NCT01583374|76164483|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
42326558|NCT01583374|76164484|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
42326559|NCT01583374|76164485|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42326560|NCT01583374|76164486|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42326561|NCT01583374|76164487|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42326562|NCT01583374|76164488|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42326563|NCT01583374|76164489|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42326564|NCT01583374|76164490|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42326565|NCT01583374|76164482|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
42326566|NCT01583374|76164483|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
42326567|NCT01583374|76164484|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
42326568|NCT01583374|76164485|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
41996313|NCT00479466|75804332|FG001|Overall Study|Lost to Follow-up|1|||
42326569|NCT01583374|76164486|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
42326570|NCT01583374|76164487|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
42326571|NCT01583374|76164488|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
42326572|NCT01583374|76164489|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
42326573|NCT01583374|76164490|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
42326574|NCT01583374|76164482|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42326575|NCT01583374|76164483|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42326576|NCT01583374|76164484|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
42326577|NCT01583374|76164485|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42326578|NCT01583374|76164486|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42326579|NCT01583374|76164487|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42326580|NCT01583374|76164488|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42326581|NCT01583374|76164489|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42326582|NCT01583374|76164490|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42326583|NCT01583374|76164482|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
42326584|NCT01583374|76164483|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
42326585|NCT01583374|76164484|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
42326586|NCT01583374|76164485|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
42326587|NCT01583374|76164486|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
42326588|NCT01583374|76164487|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
42326589|NCT01583374|76164488|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
42326590|NCT01583374|76164489|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
42326591|NCT01583374|76164490|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
42326592|NCT01583374|76164482|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
42326593|NCT01583374|76164483|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
42326594|NCT01583374|76164484|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
42326595|NCT01583374|76164485|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
42326596|NCT01583374|76164486|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
42326597|NCT01583374|76164487|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
42326598|NCT01583374|76164488|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
42326599|NCT01583374|76164489|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
42326600|NCT01583374|76164490|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
42326601|NCT01583374|76164482|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
42326602|NCT01583374|76164483|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
42326603|NCT01583374|76164484|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
42326604|NCT01583374|76164485|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
42326605|NCT01583374|76164486|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
42326606|NCT01583374|76164487|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
42326607|NCT01583374|76164488|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
42326608|NCT01583374|76164489|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
42326609|NCT01583374|76164490|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
42326610|NCT01583374|76164482|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
42326611|NCT01583374|76164483|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
42326612|NCT01583374|76164484|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
42326613|NCT01583374|76164485|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
42326614|NCT01583374|76164486|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
42326615|NCT01583374|76164487|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
42326616|NCT01583374|76164488|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
42326617|NCT01583374|76164489|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
42326618|NCT01583374|76164490|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
42326619|NCT01583374|76164482|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
42326620|NCT01583374|76164483|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
42326621|NCT01583374|76164484|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
42326622|NCT01583374|76164485|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
42326623|NCT01583374|76164486|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
42326624|NCT01583374|76164487|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
42326625|NCT01583374|76164488|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
42326626|NCT01583374|76164489|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
42326627|NCT01583374|76164490|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
41996314|NCT00479466|75804333|FG002|Overall Study|Lost to Follow-up|1|||
41996315|NCT00479466|75804334|FG003|Overall Study|Lost to Follow-up|0|||
41996316|NCT00479466|75804335|FG004|Overall Study|Lost to Follow-up|2|||
41996317|NCT00479466|75804336|FG005|Overall Study|Lost to Follow-up|2|||
41996318|NCT00479466|75804331|FG000|Overall Study|Physician Decision|2|||
42326628|NCT01583374|76164482|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
42326629|NCT01583374|76164483|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
41996319|NCT00479466|75804332|FG001|Overall Study|Physician Decision|1|||
41996320|NCT00479466|75804333|FG002|Overall Study|Physician Decision|1|||
41996321|NCT00479466|75804334|FG003|Overall Study|Physician Decision|0|||
41996322|NCT00479466|75804335|FG004|Overall Study|Physician Decision|0|||
42326630|NCT01583374|76164484|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
42326631|NCT01583374|76164485|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
42326632|NCT01583374|76164486|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
42326633|NCT01583374|76164487|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
42326634|NCT01583374|76164488|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
42326635|NCT01583374|76164489|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
41996323|NCT00479466|75804336|FG005|Overall Study|Physician Decision|0|||
41996324|NCT00479466|75804331|FG000|Overall Study|Pregnancy|0|||
41996325|NCT00479466|75804332|FG001|Overall Study|Pregnancy|0|||
41996326|NCT00479466|75804333|FG002|Overall Study|Pregnancy|0|||
41996327|NCT00479466|75804334|FG003|Overall Study|Pregnancy|0|||
41996328|NCT00479466|75804335|FG004|Overall Study|Pregnancy|1|||
41996329|NCT00479466|75804336|FG005|Overall Study|Pregnancy|0|||
42134034|NCT00548249|75944860|FG003|Overall Study|Withdrawal by Subject|0|||
42134035|NCT00548249|75944861|FG004|Overall Study|Withdrawal by Subject|0|||
42134036|NCT00548249|75944857|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
42134037|NCT00548249|75944858|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
42134038|NCT00548249|75944859|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
42134039|NCT00548249|75944860|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
42134040|NCT00548249|75944861|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
42134041|NCT00548249|75944857|FG000|Overall Study|Sponsor's request|0|||
42261581|NCT02055547|76088991|FG012|Overall Study|Lost to Follow-up|0|||
42261582|NCT02055547|76088992|FG013|Overall Study|Lost to Follow-up|0|||
42261583|NCT02055547|76088993|FG014|Overall Study|Lost to Follow-up|0|||
42261584|NCT02055547|76088994|FG015|Overall Study|Lost to Follow-up|0|||
42261585|NCT02055547|76088995|FG016|Overall Study|Lost to Follow-up|0|||
42261586|NCT02055547|76088996|FG017|Overall Study|Lost to Follow-up|0|||
42261587|NCT02055547|76088997|FG018|Overall Study|Lost to Follow-up|0|||
42261588|NCT02414854|76089035|FG000|Overall Study|Adverse Event|9|||
42261589|NCT02414854|76089036|FG001|Overall Study|Adverse Event|7|||
42261590|NCT02414854|76089037|FG002|Overall Study|Adverse Event|1|||
42261591|NCT02414854|76089038|FG003|Overall Study|Adverse Event|12|||
42261592|NCT02414854|76089035|FG000|Overall Study|Poor compliance to protocol|1|||
42261593|NCT02414854|76089036|FG001|Overall Study|Poor compliance to protocol|1|||
42261594|NCT02414854|76089037|FG002|Overall Study|Poor compliance to protocol|2|||
42261595|NCT02414854|76089038|FG003|Overall Study|Poor compliance to protocol|2|||
42261596|NCT02414854|76089035|FG000|Overall Study|Other than specified above|12|||
42261597|NCT02414854|76089036|FG001|Overall Study|Other than specified above|37|||
42261598|NCT02414854|76089037|FG002|Overall Study|Other than specified above|17|||
42261599|NCT02414854|76089038|FG003|Overall Study|Other than specified above|37|||
42261600|NCT03332498|76089051|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
42261601|NCT03332498|76089052|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
42261602|NCT03332498|76089053|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
42261603|NCT01334125|76089062|FG000|Overall Study|Lost to Follow-up|3|||
42261604|NCT01334125|76089063|FG001|Overall Study|Lost to Follow-up|3|||
42261605|NCT02414152|76089070|FG000|Overall Study|Withdrawal by Subject|1|||
42261606|NCT02414152|76089070|FG000|Overall Study|Lack of Efficacy|1|||
42261607|NCT02413996|76089076|FG000|Overall Study|not comfortable with the intervention|9|||
42261608|NCT02413996|76089077|FG001|Overall Study|not comfortable with the intervention|2|||
42261609|NCT01333501|76089085|FG000|Overall Study|Adverse Event|3|||
42261610|NCT01333501|76089086|FG001|Overall Study|Adverse Event|1|||
42261611|NCT01333501|76089085|FG000|Overall Study|Abnormal laboratory value|2|||
42261612|NCT01333501|76089086|FG001|Overall Study|Abnormal laboratory value|1|||
42261613|NCT01333501|76089085|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42261614|NCT01333501|76089086|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
42261615|NCT01333501|76089085|FG000|Overall Study|Withdrawn consent|3|||
42261616|NCT01333501|76089086|FG001|Overall Study|Withdrawn consent|12|||
42261617|NCT01362140|76089094|FG000|Overall Study|Noncompliance|1|||
42261618|NCT01362140|76089095|FG001|Overall Study|Noncompliance|0|||
42261619|NCT01362140|76089094|FG000|Overall Study|Adverse Event|2|||
42261620|NCT01362140|76089095|FG001|Overall Study|Adverse Event|2|||
42261621|NCT01362140|76089094|FG000|Overall Study|Withdrawal by Subject|3|||
42261622|NCT01362140|76089095|FG001|Overall Study|Withdrawal by Subject|3|||
42261623|NCT01362140|76089094|FG000|Overall Study|Administrative Decision|0|||
42261624|NCT01362140|76089095|FG001|Overall Study|Administrative Decision|1|||
42326636|NCT01583374|76164490|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
42326637|NCT01583374|76164482|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
42261625|NCT01362140|76089094|FG000|Overall Study|Death|2|||
42261626|NCT01362140|76089095|FG001|Overall Study|Death|1|||
41996330|NCT00479466|75804331|FG000|Overall Study|Protocol Violation|1|||
42134042|NCT00548249|75944858|FG001|Overall Study|Sponsor's request|0|||
42134043|NCT00548249|75944859|FG002|Overall Study|Sponsor's request|0|||
42261627|NCT01362140|76089094|FG000|Overall Study|Other|1|||
42261628|NCT01362140|76089095|FG001|Overall Study|Other|1|||
42261629|NCT01362140|76089094|FG000|Overall Study|Protocol-specified Criteria|1|||
41996331|NCT00479466|75804332|FG001|Overall Study|Protocol Violation|0|||
42326638|NCT01583374|76164483|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
42326639|NCT01583374|76164484|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
42326640|NCT01583374|76164485|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
42326641|NCT01583374|76164486|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
42326642|NCT01583374|76164487|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
42326643|NCT01583374|76164488|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
42326644|NCT01583374|76164489|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
42326645|NCT01583374|76164490|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
42326646|NCT01583374|76164482|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
42326647|NCT01583374|76164483|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
42326648|NCT01583374|76164484|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
42326649|NCT01583374|76164485|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
42326650|NCT01583374|76164486|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
42326651|NCT01583374|76164487|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
42326652|NCT01583374|76164488|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
42326653|NCT01583374|76164489|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
42326654|NCT01583374|76164490|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
42326655|NCT01583374|76164482|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
42326656|NCT01583374|76164483|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
42326657|NCT01583374|76164484|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
42326658|NCT01583374|76164485|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
42326659|NCT01583374|76164486|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
42326660|NCT01583374|76164487|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
42326661|NCT01583374|76164488|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
42326662|NCT01583374|76164489|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
42326663|NCT01583374|76164490|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
42326664|NCT01583374|76164482|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
42326665|NCT01583374|76164483|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
42326666|NCT01583374|76164484|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
42326667|NCT01583374|76164485|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
42326668|NCT01583374|76164486|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
42326669|NCT01583374|76164487|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
42326670|NCT01583374|76164488|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
42326671|NCT01583374|76164489|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
42326672|NCT01583374|76164490|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
42326673|NCT01583374|76164482|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
42326674|NCT01583374|76164483|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
42326675|NCT01583374|76164484|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
42326676|NCT01583374|76164485|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
42326677|NCT01583374|76164486|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
42326678|NCT01583374|76164487|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
42326679|NCT01583374|76164488|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
42326680|NCT01583374|76164489|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
42326681|NCT01583374|76164490|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
42326682|NCT01583374|76164482|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
42326683|NCT01583374|76164483|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
41996332|NCT00479466|75804333|FG002|Overall Study|Protocol Violation|0|||
42326684|NCT01583374|76164484|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
42326685|NCT01583374|76164485|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
42326686|NCT01583374|76164486|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
42326687|NCT01583374|76164487|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
42326688|NCT01583374|76164488|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
42326689|NCT01583374|76164489|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
42326690|NCT01583374|76164490|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
42326691|NCT01583374|76164482|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
42326692|NCT01583374|76164483|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
42326693|NCT01583374|76164484|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
42326694|NCT01583374|76164485|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
42326695|NCT01583374|76164486|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
42326696|NCT01583374|76164487|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
42326697|NCT01583374|76164488|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
42326698|NCT01583374|76164489|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
42326699|NCT01583374|76164490|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
42326700|NCT01583296|76164511|FG000|Overall Study|Withdrawal by Subject|11|||
42326701|NCT01583296|76164512|FG001|Overall Study|Withdrawal by Subject|10|||
42326702|NCT02222714|76164523|FG000|Overall Study|Death|0|||
42326703|NCT02222714|76164524|FG001|Overall Study|Death|2|||
42326704|NCT02222714|76164525|FG002|Overall Study|Death|3|||
42326705|NCT02222714|76164526|FG003|Overall Study|Death|4|||
42326706|NCT02222714|76164527|FG004|Overall Study|Death|6|||
42326707|NCT02222714|76164523|FG000|Overall Study|Withdrawal by Subject|0|||
42326708|NCT02222714|76164524|FG001|Overall Study|Withdrawal by Subject|0|||
42326709|NCT02222714|76164525|FG002|Overall Study|Withdrawal by Subject|1|||
42326710|NCT02222714|76164526|FG003|Overall Study|Withdrawal by Subject|0|||
42326711|NCT02222714|76164527|FG004|Overall Study|Withdrawal by Subject|1|||
42326712|NCT02164916|76164544|FG000|Overall Study|Adverse Event|3|||
42326713|NCT02164916|76164545|FG001|Overall Study|Adverse Event|8|||
42326714|NCT02164916|76164544|FG000|Overall Study|Death|1|||
42326715|NCT02164916|76164545|FG001|Overall Study|Death|1|||
42326716|NCT02164916|76164544|FG000|Overall Study|Refusal unrelated to adverse event|3|||
42326717|NCT02164916|76164545|FG001|Overall Study|Refusal unrelated to adverse event|7|||
42326718|NCT02164916|76164544|FG000|Overall Study|Progression|37|||
42326719|NCT02164916|76164545|FG001|Overall Study|Progression|26|||
42326720|NCT02164916|76164544|FG000|Overall Study|Not protocol specified|5|||
42326721|NCT02164916|76164545|FG001|Overall Study|Not protocol specified|1|||
42326722|NCT02164916|76164544|FG000|Overall Study|Reason under review|1|||
42326723|NCT02164916|76164545|FG001|Overall Study|Reason under review|6|||
42326724|NCT02164916|76164544|FG000|Overall Study|Not eligible|2|||
42326725|NCT02164916|76164545|FG001|Overall Study|Not eligible|5|||
42326726|NCT02222558|76164556|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
42326727|NCT02222558|76164557|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
42326728|NCT02222558|76164558|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
42326729|NCT02222558|76164559|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
42326730|NCT02222558|76164560|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
41996333|NCT00479466|75804334|FG003|Overall Study|Protocol Violation|0|||
41996334|NCT00479466|75804335|FG004|Overall Study|Protocol Violation|0|||
42261630|NCT01362140|76089095|FG001|Overall Study|Protocol-specified Criteria|2|||
42261631|NCT01362140|76089094|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
42261632|NCT01362140|76089095|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
42261633|NCT01333189|76089103|FG000|Overall Study|Time constraints|1|||
42261634|NCT01333189|76089104|FG001|Overall Study|Time constraints|0|||
42261635|NCT01333189|76089103|FG000|Overall Study|Adverse Event|1|||
42261636|NCT01333189|76089104|FG001|Overall Study|Adverse Event|0|||
42261637|NCT01333189|76089103|FG000|Overall Study|Transportation difficulties|0|||
42261638|NCT01333189|76089104|FG001|Overall Study|Transportation difficulties|1|||
42261639|NCT01333189|76089103|FG000|Overall Study|Moved from region|0|||
42261640|NCT01333189|76089104|FG001|Overall Study|Moved from region|1|||
42261641|NCT01333111|76089113|FG000|Overall Study|patient undergoing major surgery|0|||
42261642|NCT01333111|76089114|FG001|Overall Study|patient undergoing major surgery|2|||
42261643|NCT01333111|76089115|FG002|Overall Study|patient undergoing major surgery|0|||
42261644|NCT01333111|76089113|FG000|Overall Study|personal reasons|0|||
42261645|NCT01333111|76089114|FG001|Overall Study|personal reasons|0|||
42261646|NCT01333111|76089115|FG002|Overall Study|personal reasons|1|||
42261647|NCT01333111|76089113|FG000|Overall Study|unclassified|1|||
42261648|NCT01333111|76089114|FG001|Overall Study|unclassified|0|||
42261649|NCT01333111|76089115|FG002|Overall Study|unclassified|0|||
42261650|NCT01333111|76089113|FG000|Overall Study|withdrawal criteria|0|||
42261651|NCT01333111|76089114|FG001|Overall Study|withdrawal criteria|1|||
42261652|NCT01333111|76089115|FG002|Overall Study|withdrawal criteria|0|||
42261653|NCT01333111|76089113|FG000|Overall Study|Non-compliance|1|||
42261654|NCT01333111|76089114|FG001|Overall Study|Non-compliance|0|||
41996335|NCT00479466|75804336|FG005|Overall Study|Protocol Violation|0|||
42326731|NCT02222558|76164561|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
42326732|NCT02222558|76164556|FG000|Period 3|Withdrawal by Subject|0|||
42326733|NCT02222558|76164557|FG001|Period 3|Withdrawal by Subject|0|||
42326734|NCT02222558|76164558|FG002|Period 3|Withdrawal by Subject|0|||
42326735|NCT02222558|76164559|FG003|Period 3|Withdrawal by Subject|0|||
42326736|NCT02222558|76164560|FG004|Period 3|Withdrawal by Subject|0|||
42326737|NCT02222558|76164561|FG005|Period 3|Withdrawal by Subject|1|||
42326738|NCT02188784|76164577|FG000|Overall Study|Death|3|||
42326739|NCT02188784|76164578|FG001|Overall Study|Death|1|||
42326740|NCT02188784|76164577|FG000|Overall Study|Lost to Follow-up|1|||
42326741|NCT02188784|76164578|FG001|Overall Study|Lost to Follow-up|0|||
42326742|NCT02188784|76164577|FG000|Overall Study|Withdrawal by Subject|3|||
42326743|NCT02188784|76164578|FG001|Overall Study|Withdrawal by Subject|9|||
42326744|NCT02188784|76164577|FG000|Overall Study|Physician Decision|2|||
42326745|NCT02188784|76164578|FG001|Overall Study|Physician Decision|3|||
42326746|NCT02222246|76164601|FG000|Overall Study|No Emergency Department Visits|27|||
42326747|NCT02222246|76164602|FG001|Overall Study|No Emergency Department Visits|26|||
42326748|NCT02222246|76164601|FG000|Overall Study|Physician Decision|0|||
42326749|NCT02222246|76164602|FG001|Overall Study|Physician Decision|1|||
42326750|NCT02188160|76164612|FG000|Overall Study|Adverse Event|1|||
42326751|NCT02188160|76164613|FG001|Overall Study|Adverse Event|0|||
42326752|NCT02188160|76164612|FG000|Overall Study|Use of an excluded medication|0|||
42326753|NCT02188160|76164613|FG001|Overall Study|Use of an excluded medication|1|||
42326754|NCT02220998|76164621|FG000|Overall Study|Randomized but Never Treated|1|||
42326755|NCT02220998|76164622|FG001|Overall Study|Randomized but Never Treated|2|||
42326756|NCT02220998|76164621|FG000|Overall Study|Death|2|||
42326757|NCT02220998|76164622|FG001|Overall Study|Death|0|||
42326758|NCT02220998|76164621|FG000|Overall Study|Lack of Efficacy|0|||
42326759|NCT02220998|76164622|FG001|Overall Study|Lack of Efficacy|5|||
42326760|NCT02220998|76164621|FG000|Overall Study|Lost to Follow-up|4|||
42326761|NCT02220998|76164622|FG001|Overall Study|Lost to Follow-up|4|||
42326762|NCT02220920|76164630|FG000|Overall Study|Adverse Event|1|||
42326763|NCT02220920|76164631|FG001|Overall Study|Adverse Event|0|||
42326764|NCT02220920|76164630|FG000|Overall Study|Lack of Efficacy|0|||
42326765|NCT02220920|76164631|FG001|Overall Study|Lack of Efficacy|1|||
42326766|NCT02220920|76164630|FG000|Overall Study|Withdrawal by Subject|1|||
42326767|NCT02220920|76164631|FG001|Overall Study|Withdrawal by Subject|0|||
42326768|NCT02220920|76164630|FG000|Overall Study|Conflict with the stopping criteria|1|||
42326769|NCT02220920|76164631|FG001|Overall Study|Conflict with the stopping criteria|2|||
42326770|NCT03966053|76164637|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
42326771|NCT01634555|76164650|FG000|Overall Study|Adverse Event|3|||
42326772|NCT01634555|76164650|FG000|Overall Study|Physician Decision|1|||
42326773|NCT01634243|76164657|FG000|Overall Study|Adverse Event|5|||
42326774|NCT01634243|76164658|FG001|Overall Study|Adverse Event|5|||
42326775|NCT01634243|76164657|FG000|Overall Study|Lack of Efficacy|1|||
42326776|NCT01634243|76164658|FG001|Overall Study|Lack of Efficacy|0|||
42326777|NCT01542034|76164675|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
42326778|NCT01542034|76164676|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
42326779|NCT01542034|76164675|FG000|Overall Study|Administrative decision|0|||
42326780|NCT01542034|76164676|FG001|Overall Study|Administrative decision|3|||
41996336|NCT00479466|75804331|FG000|Overall Study|Withdrawal by Subject|3|||
41996337|NCT00479466|75804332|FG001|Overall Study|Withdrawal by Subject|5|||
42261655|NCT01333111|76089115|FG002|Overall Study|Non-compliance|0|||
42261656|NCT01333111|76089113|FG000|Overall Study|Ineffective therapy|0|||
42261657|NCT01333111|76089114|FG001|Overall Study|Ineffective therapy|0|||
42261658|NCT01333111|76089115|FG002|Overall Study|Ineffective therapy|1|||
42261659|NCT00702507|76089123|FG000|Initial Treatment Phase|Adverse Event|2|||
42261660|NCT00702507|76089123|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
42261661|NCT00702507|76089123|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
42326781|NCT01542034|76164675|FG000|Overall Study|Subject Noncompliance|1|||
42326782|NCT01542034|76164676|FG001|Overall Study|Subject Noncompliance|0|||
42326783|NCT01542034|76164675|FG000|Overall Study|Adverse Event|2|||
42326784|NCT01542034|76164676|FG001|Overall Study|Adverse Event|2|||
42261662|NCT00702507|76089123|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
42326785|NCT01542034|76164675|FG000|Overall Study|Lost to Follow-up|7|||
42326786|NCT01542034|76164676|FG001|Overall Study|Lost to Follow-up|6|||
42326787|NCT01564732|76164684|FG000|Overall Study|Early termination by the study sponsor|6|||
42326788|NCT01564732|76164685|FG001|Overall Study|Early termination by the study sponsor|5|||
42326789|NCT01541644|76164691|FG000|Overall Study|Withdrawal by Subject|3|||
42326790|NCT01582282|76164698|FG000|Overall Study|Adverse Event|1|||
42326791|NCT01582282|76164699|FG001|Overall Study|Adverse Event|1|||
42326792|NCT01582282|76164700|FG002|Overall Study|Adverse Event|0|||
42326793|NCT01582282|76164698|FG000|Overall Study|Lost to Follow-up|1|||
42326794|NCT01582282|76164699|FG001|Overall Study|Lost to Follow-up|0|||
42326795|NCT01582282|76164700|FG002|Overall Study|Lost to Follow-up|0|||
42326796|NCT01582282|76164698|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
42326797|NCT01582282|76164699|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
42326798|NCT01582282|76164700|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
42326799|NCT01599650|76164711|FG000|Overall Study|Administrative issue|1|||
42326800|NCT01599650|76164712|FG001|Overall Study|Administrative issue|0|||
42326801|NCT01599650|76164713|FG002|Overall Study|Administrative issue|1|||
42326802|NCT01599650|76164711|FG000|Overall Study|Physician Decision|2|||
42326803|NCT01599650|76164712|FG001|Overall Study|Physician Decision|0|||
42326804|NCT01599650|76164713|FG002|Overall Study|Physician Decision|7|||
42326805|NCT01599650|76164711|FG000|Overall Study|Protocol Violation|0|||
42326806|NCT01599650|76164712|FG001|Overall Study|Protocol Violation|3|||
42326807|NCT01599650|76164713|FG002|Overall Study|Protocol Violation|0|||
42326808|NCT01599650|76164711|FG000|Overall Study|Death|2|||
42326809|NCT01599650|76164712|FG001|Overall Study|Death|1|||
42326810|NCT01599650|76164713|FG002|Overall Study|Death|2|||
42326811|NCT01599650|76164711|FG000|Overall Study|Lost to Follow-up|3|||
42326812|NCT01599650|76164712|FG001|Overall Study|Lost to Follow-up|3|||
42326813|NCT01599650|76164713|FG002|Overall Study|Lost to Follow-up|3|||
42326814|NCT01599650|76164711|FG000|Overall Study|Withdrawal by Subject|11|||
42326815|NCT01599650|76164712|FG001|Overall Study|Withdrawal by Subject|11|||
42326816|NCT01599650|76164713|FG002|Overall Study|Withdrawal by Subject|10|||
42326817|NCT01599650|76164711|FG000|Overall Study|Adverse Event|3|||
42326818|NCT01599650|76164712|FG001|Overall Study|Adverse Event|8|||
42326819|NCT01599650|76164713|FG002|Overall Study|Adverse Event|4|||
42326820|NCT01541254|76164723|FG000|Overall Study|Withdrawal by Subject|1|||
42326821|NCT01541254|76164723|FG000|Overall Study|excluded - metal allergy|1|||
42326822|NCT01541254|76164723|FG000|Overall Study|enrolled after study closed|1|||
42326823|NCT01541254|76164723|FG000|Overall Study|GI bleed prior to procedure|1|||
42326824|NCT01541254|76164723|FG000|Overall Study|stent not required|1|||
42326825|NCT01541254|76164723|FG000|Overall Study|alternate stent used|1|||
42326826|NCT02163902|76164729|FG000|Overall Study|Subject's Request|3|||
42326827|NCT02163902|76164730|FG001|Overall Study|Subject's Request|4|||
42326828|NCT02163902|76164729|FG000|Overall Study|Lost to Follow-up|6|||
42326829|NCT02163902|76164730|FG001|Overall Study|Lost to Follow-up|7|||
42326830|NCT02163902|76164729|FG000|Overall Study|Administrative Decision|2|||
42326831|NCT02163902|76164730|FG001|Overall Study|Administrative Decision|2|||
42326832|NCT01630616|76164742|FG000|Overall Study|Adverse Event|0|||
42326833|NCT01630616|76164743|FG001|Overall Study|Adverse Event|0|||
42326834|NCT01630616|76164744|FG002|Overall Study|Adverse Event|0|||
42326835|NCT01630616|76164745|FG003|Overall Study|Adverse Event|1|||
42326836|NCT01630616|76164746|FG004|Overall Study|Adverse Event|0|||
42326837|NCT01630616|76164747|FG005|Overall Study|Adverse Event|0|||
42326838|NCT01630616|76164742|FG000|Overall Study|Withdrawal by Subject|0|||
42326839|NCT01630616|76164743|FG001|Overall Study|Withdrawal by Subject|0|||
42326840|NCT01630616|76164744|FG002|Overall Study|Withdrawal by Subject|0|||
42326841|NCT01630616|76164745|FG003|Overall Study|Withdrawal by Subject|2|||
42326842|NCT01630616|76164746|FG004|Overall Study|Withdrawal by Subject|0|||
42326843|NCT01630616|76164747|FG005|Overall Study|Withdrawal by Subject|0|||
42326844|NCT03774875|76164766|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
42326845|NCT03774875|76164767|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
42326846|NCT03774875|76164766|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
42326847|NCT03774875|76164767|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
42326848|NCT03774875|76164766|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
42326849|NCT03774875|76164767|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
42326850|NCT03774875|76164766|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
41996338|NCT00479466|75804333|FG002|Overall Study|Withdrawal by Subject|0|||
42326851|NCT03774875|76164767|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
42326852|NCT03774875|76164766|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
42326853|NCT03774875|76164767|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
42326854|NCT03774875|76164766|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
42326855|NCT03774875|76164767|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
42326856|NCT03774875|76164766|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
42326857|NCT03774875|76164767|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
42326858|NCT03774875|76164766|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
42326859|NCT03774875|76164767|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
42326860|NCT03774875|76164766|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
42326861|NCT03774875|76164767|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
42326862|NCT03774875|76164766|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
42326863|NCT03774875|76164767|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
42326864|NCT03774875|76164766|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
42326865|NCT03774875|76164767|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
42326866|NCT03774875|76164766|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
42326867|NCT03774875|76164767|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
42326868|NCT03774875|76164766|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
42326869|NCT03774875|76164767|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
42326870|NCT02220764|76164780|FG000|Overall Study|Lost to Follow-up|3|||
42326871|NCT02220764|76164781|FG001|Overall Study|Lost to Follow-up|1|||
42326872|NCT02220764|76164780|FG000|Overall Study|Death|1|||
42326873|NCT02220764|76164781|FG001|Overall Study|Death|0|||
42326874|NCT01563172|76164787|FG000|Overall Study|Adverse Event|5|||
42326875|NCT01563172|76164787|FG000|Overall Study|Lost to Follow-up|2|||
42326876|NCT01563172|76164787|FG000|Overall Study|Other (Protocol deviation)|5|||
42326877|NCT01563172|76164787|FG000|Overall Study|Other (Not specified)|1|||
42326878|NCT02161718|76164804|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
42326879|NCT02161718|76164805|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
42326880|NCT02161718|76164806|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
42326881|NCT02161718|76164804|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
42326882|NCT02161718|76164805|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
42326883|NCT02161718|76164806|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
42326884|NCT02161718|76164804|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
42326885|NCT02161718|76164805|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
42326886|NCT02161718|76164806|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
42326887|NCT02161718|76164804|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
42326888|NCT02161718|76164805|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
42326889|NCT02161718|76164806|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
42326890|NCT02161718|76164804|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
42326891|NCT02161718|76164805|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
42326892|NCT02161718|76164806|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
42326893|NCT02161718|76164804|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
42326894|NCT02161718|76164805|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
42326895|NCT02161718|76164806|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
42326896|NCT02161718|76164804|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
42326897|NCT02161718|76164805|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
42326898|NCT02161718|76164806|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
42326899|NCT02161718|76164804|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
42326900|NCT02161718|76164805|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
42326901|NCT02161718|76164806|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
42326902|NCT02161718|76164804|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
42326903|NCT02161718|76164805|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
42326904|NCT02161718|76164806|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
42326905|NCT02161718|76164804|FG000|Post- Randomization Period|Lost to Follow-up|0|||
42326906|NCT02161718|76164805|FG001|Post- Randomization Period|Lost to Follow-up|9|||
42326907|NCT02161718|76164806|FG002|Post- Randomization Period|Lost to Follow-up|15|||
42326908|NCT02161718|76164804|FG000|Post- Randomization Period|Adverse Event|0|||
42326909|NCT02161718|76164805|FG001|Post- Randomization Period|Adverse Event|9|||
42326910|NCT02161718|76164806|FG002|Post- Randomization Period|Adverse Event|10|||
42326911|NCT02161718|76164804|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
42326912|NCT02161718|76164805|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
42326913|NCT02161718|76164806|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
42326914|NCT02161718|76164804|FG000|Post- Randomization Period|Physician Decision|0|||
42326915|NCT02161718|76164805|FG001|Post- Randomization Period|Physician Decision|2|||
42326916|NCT02161718|76164806|FG002|Post- Randomization Period|Physician Decision|4|||
42326917|NCT02161718|76164804|FG000|Post- Randomization Period|Protocol Violation|0|||
42326918|NCT02161718|76164805|FG001|Post- Randomization Period|Protocol Violation|2|||
42326919|NCT02161718|76164806|FG002|Post- Randomization Period|Protocol Violation|3|||
42326920|NCT02161718|76164804|FG000|Post- Randomization Period|Lack of Efficacy|0|||
42326921|NCT02161718|76164805|FG001|Post- Randomization Period|Lack of Efficacy|0|||
42326922|NCT02161718|76164806|FG002|Post- Randomization Period|Lack of Efficacy|1|||
42326923|NCT02161718|76164804|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
42326924|NCT02161718|76164805|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
42326925|NCT02161718|76164806|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
42326926|NCT02161718|76164804|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
42326927|NCT02161718|76164805|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
42326928|NCT02161718|76164806|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
42326929|NCT02161718|76164804|FG000|Post- Randomization Period|Relocation|0|||
42326930|NCT02161718|76164805|FG001|Post- Randomization Period|Relocation|3|||
42326931|NCT02161718|76164806|FG002|Post- Randomization Period|Relocation|0|||
42326932|NCT02219048|76164815|FG000|Overall Study|Adverse Event|2|||
42326933|NCT02219048|76164816|FG001|Overall Study|Adverse Event|5|||
42326934|NCT02219048|76164815|FG000|Overall Study|No longer meets eligibility criteria|1|||
42326935|NCT02219048|76164816|FG001|Overall Study|No longer meets eligibility criteria|0|||
42326936|NCT02219048|76164815|FG000|Overall Study|Study terminated by sponsor|16|||
42326937|NCT02219048|76164816|FG001|Overall Study|Study terminated by sponsor|15|||
42326938|NCT02219048|76164815|FG000|Overall Study|Withdrawal by Subject|2|||
42326939|NCT02219048|76164816|FG001|Overall Study|Withdrawal by Subject|0|||
42326940|NCT02219048|76164815|FG000|Overall Study|Other|0|||
42326941|NCT02219048|76164816|FG001|Overall Study|Other|1|||
42326942|NCT02218736|76164824|FG000|Overall Study|Withdrawal by Subject|10|||
42326943|NCT02218736|76164825|FG001|Overall Study|Withdrawal by Subject|9|||
42326944|NCT02218736|76164824|FG000|Overall Study|Protocol Violation|2|||
42326945|NCT02218736|76164825|FG001|Overall Study|Protocol Violation|0|||
42326946|NCT01540474|76164835|FG000|Vaccination Period|Lost to Follow-up|0|||
42326947|NCT01540474|76164836|FG001|Vaccination Period|Lost to Follow-up|1|||
42326948|NCT01540474|76164837|FG002|Vaccination Period|Lost to Follow-up|0|||
42326949|NCT01540474|76164838|FG003|Vaccination Period|Lost to Follow-up|0|||
42326950|NCT01580488|76164849|FG000|Overall Study|Withdrawal by Subject|1|||
42326951|NCT01580020|76164865|FG000|Overall Study|Lack of Efficacy|0|||
42326952|NCT01580020|76164866|FG001|Overall Study|Lack of Efficacy|5|||
42326953|NCT01580020|76164867|FG002|Overall Study|Lack of Efficacy|0|||
42326954|NCT01580020|76164868|FG003|Overall Study|Lack of Efficacy|1|||
42326955|NCT01580020|76164865|FG000|Overall Study|Withdrawal by Subject|0|||
42326956|NCT01580020|76164866|FG001|Overall Study|Withdrawal by Subject|1|||
42326957|NCT01580020|76164867|FG002|Overall Study|Withdrawal by Subject|1|||
42326958|NCT01580020|76164868|FG003|Overall Study|Withdrawal by Subject|0|||
42326959|NCT01580020|76164865|FG000|Overall Study|Adverse Event|1|||
42326960|NCT01580020|76164866|FG001|Overall Study|Adverse Event|1|||
42326961|NCT01580020|76164867|FG002|Overall Study|Adverse Event|1|||
42326962|NCT01580020|76164868|FG003|Overall Study|Adverse Event|1|||
42326963|NCT01580020|76164865|FG000|Overall Study|Administrative Problems|0|||
42326964|NCT01580020|76164866|FG001|Overall Study|Administrative Problems|0|||
42326965|NCT01580020|76164867|FG002|Overall Study|Administrative Problems|1|||
42326966|NCT01580020|76164868|FG003|Overall Study|Administrative Problems|0|||
42326967|NCT01580020|76164865|FG000|Overall Study|Lost to Follow-up|0|||
42326968|NCT01580020|76164866|FG001|Overall Study|Lost to Follow-up|0|||
42326969|NCT01580020|76164867|FG002|Overall Study|Lost to Follow-up|1|||
42326970|NCT01580020|76164868|FG003|Overall Study|Lost to Follow-up|0|||
42134044|NCT00548249|75944860|FG003|Overall Study|Sponsor's request|1|||
42326971|NCT01579474|76164884|FG000|Overall Study|Adverse Event|1|||
42134045|NCT00548249|75944861|FG004|Overall Study|Sponsor's request|0|||
42326972|NCT01579474|76164885|FG001|Overall Study|Adverse Event|13|||
42326973|NCT01579474|76164886|FG002|Overall Study|Adverse Event|2|||
42326974|NCT01579474|76164887|FG003|Overall Study|Adverse Event|0|||
42326975|NCT01579474|76164888|FG004|Overall Study|Adverse Event|0|||
42326976|NCT01579474|76164889|FG005|Overall Study|Adverse Event|1|||
42326977|NCT01579474|76164884|FG000|Overall Study|Lack of Efficacy|1|||
42326978|NCT01579474|76164885|FG001|Overall Study|Lack of Efficacy|0|||
42326979|NCT01579474|76164886|FG002|Overall Study|Lack of Efficacy|0|||
42326980|NCT01579474|76164887|FG003|Overall Study|Lack of Efficacy|0|||
42326981|NCT01579474|76164888|FG004|Overall Study|Lack of Efficacy|1|||
42326982|NCT01579474|76164889|FG005|Overall Study|Lack of Efficacy|0|||
42326983|NCT01579474|76164884|FG000|Overall Study|Withdrawal by Subject|1|||
41996339|NCT00479466|75804334|FG003|Overall Study|Withdrawal by Subject|2|||
42326984|NCT01579474|76164885|FG001|Overall Study|Withdrawal by Subject|0|||
42326985|NCT01579474|76164886|FG002|Overall Study|Withdrawal by Subject|0|||
42326986|NCT01579474|76164887|FG003|Overall Study|Withdrawal by Subject|0|||
42326987|NCT01579474|76164888|FG004|Overall Study|Withdrawal by Subject|0|||
42326988|NCT01579474|76164889|FG005|Overall Study|Withdrawal by Subject|0|||
41996340|NCT00479466|75804335|FG004|Overall Study|Withdrawal by Subject|3|||
42326989|NCT01579318|76164902|FG000|Overall Study|Disease Progression|1|||
42326990|NCT01562782|76164908|FG000|Overall Study|Withdrawal by Subject|3|||
42326991|NCT01562782|76164909|FG001|Overall Study|Withdrawal by Subject|3|||
42326992|NCT01562782|76164908|FG000|Overall Study|screen failure|1|||
42326993|NCT01562782|76164909|FG001|Overall Study|screen failure|2|||
42326994|NCT01579006|76164915|FG000|Overall Study|Lack of Efficacy|10|||
42326995|NCT01579006|76164915|FG000|Overall Study|Adverse Event|13|||
42326996|NCT01579006|76164915|FG000|Overall Study|Withdrawal by Subject|5|||
42326997|NCT01579006|76164915|FG000|Overall Study|Non-compliance|3|||
42326998|NCT01579006|76164915|FG000|Overall Study|Due to participant's health fund|1|||
42326999|NCT01579006|76164915|FG000|Overall Study|Scheduled surgery|1|||
42327000|NCT01578850|76164921|FG000|Period 1|Insufficient Clinical Response|1|||
42327001|NCT01578850|76164922|FG001|Period 1|Insufficient Clinical Response|0|||
42327002|NCT01578850|76164923|FG002|Period 1|Insufficient Clinical Response|0|||
42327003|NCT01578850|76164921|FG000|Period 1|Adverse Event|11|||
42327004|NCT01578850|76164922|FG001|Period 1|Adverse Event|0|||
42327005|NCT01578850|76164923|FG002|Period 1|Adverse Event|0|||
42327006|NCT01578850|76164921|FG000|Period 1|Death|1|||
42327007|NCT01578850|76164922|FG001|Period 1|Death|0|||
42327008|NCT01578850|76164923|FG002|Period 1|Death|0|||
42327009|NCT01578850|76164921|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
42327010|NCT01578850|76164922|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
42327011|NCT01578850|76164923|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
42327012|NCT01578850|76164921|FG000|Period 1|Withdrawal by Subject|9|||
42327013|NCT01578850|76164922|FG001|Period 1|Withdrawal by Subject|0|||
42327014|NCT01578850|76164923|FG002|Period 1|Withdrawal by Subject|0|||
42327015|NCT01578850|76164921|FG000|Period 1|Study Terminated by Sponsor|3|||
42327016|NCT01578850|76164922|FG001|Period 1|Study Terminated by Sponsor|0|||
42327017|NCT01578850|76164923|FG002|Period 1|Study Terminated by Sponsor|0|||
42327018|NCT01578850|76164921|FG000|Period 2|Insufficient Clinical Response|0|||
42327019|NCT01578850|76164922|FG001|Period 2|Insufficient Clinical Response|1|||
42327020|NCT01578850|76164923|FG002|Period 2|Insufficient Clinical Response|0|||
42327021|NCT01578850|76164921|FG000|Period 2|Adverse Event|0|||
42327022|NCT01578850|76164922|FG001|Period 2|Adverse Event|3|||
42327023|NCT01578850|76164923|FG002|Period 2|Adverse Event|6|||
42327024|NCT01578850|76164921|FG000|Period 2|Lost to Follow-up|0|||
42327025|NCT01578850|76164922|FG001|Period 2|Lost to Follow-up|1|||
42327026|NCT01578850|76164923|FG002|Period 2|Lost to Follow-up|2|||
42327027|NCT01578850|76164921|FG000|Period 2|Withdrawal by Subject|0|||
42327028|NCT01578850|76164922|FG001|Period 2|Withdrawal by Subject|2|||
42327029|NCT01578850|76164923|FG002|Period 2|Withdrawal by Subject|2|||
42327030|NCT01578850|76164921|FG000|Period 2|Study Terminated by Sponsor|0|||
42327031|NCT01578850|76164922|FG001|Period 2|Study Terminated by Sponsor|5|||
42327032|NCT01578850|76164923|FG002|Period 2|Study Terminated by Sponsor|4|||
42327033|NCT01578850|76164921|FG000|Period 2|Unspecified Reasons|0|||
42327034|NCT01578850|76164922|FG001|Period 2|Unspecified Reasons|1|||
42327035|NCT01578850|76164923|FG002|Period 2|Unspecified Reasons|0|||
42327036|NCT01539538|76164933|FG000|Overall Study|Adverse Event|13|||
42327037|NCT01539538|76164934|FG001|Overall Study|Adverse Event|18|||
42327038|NCT01539538|76164933|FG000|Overall Study|Lack of Efficacy|13|||
41996341|NCT00479466|75804336|FG005|Overall Study|Withdrawal by Subject|1|||
42327039|NCT01539538|76164934|FG001|Overall Study|Lack of Efficacy|16|||
42327040|NCT01539538|76164933|FG000|Overall Study|Withdrawal by Subject|2|||
42327041|NCT01539538|76164934|FG001|Overall Study|Withdrawal by Subject|3|||
42327042|NCT01539538|76164933|FG000|Overall Study|PCA no longer required or PCA problem|3|||
42327043|NCT01539538|76164934|FG001|Overall Study|PCA no longer required or PCA problem|7|||
42327044|NCT01562548|76164944|FG000|Overall Study|Lost to Follow-up|0|||
42327045|NCT01562548|76164945|FG001|Overall Study|Lost to Follow-up|0|||
42327046|NCT01562548|76164946|FG002|Overall Study|Lost to Follow-up|1|||
42327047|NCT01562548|76164947|FG003|Overall Study|Lost to Follow-up|0|||
41996342|NCT00479388|75804352|FG000|Overall Study|Adverse Event|90|||
42327048|NCT01562314|76164961|FG000|Overall Study|Adverse Event|10|||
42327049|NCT01562314|76164962|FG001|Overall Study|Adverse Event|5|||
42327050|NCT01562314|76164961|FG000|Overall Study|Met Withdrawal Criteria|3|||
42327051|NCT01562314|76164962|FG001|Overall Study|Met Withdrawal Criteria|2|||
42327052|NCT01562314|76164961|FG000|Overall Study|Withdrawal by Subject|0|||
42327053|NCT01562314|76164962|FG001|Overall Study|Withdrawal by Subject|1|||
42327054|NCT01539226|76164970|FG000|Overall Study|Withdrawal by Subject|24|||
42327055|NCT01539226|76164971|FG001|Overall Study|Withdrawal by Subject|54|||
42327056|NCT01539226|76164970|FG000|Overall Study|Lost to Follow-up|20|||
42327057|NCT01539226|76164971|FG001|Overall Study|Lost to Follow-up|54|||
42327058|NCT01539226|76164970|FG000|Overall Study|Death|1|||
42327059|NCT01539226|76164971|FG001|Overall Study|Death|2|||
42327060|NCT01539226|76164970|FG000|Overall Study|Adverse Event|2|||
42327061|NCT01539226|76164971|FG001|Overall Study|Adverse Event|0|||
42327062|NCT01539226|76164970|FG000|Overall Study|Pregnancy|13|||
42327063|NCT01539226|76164971|FG001|Overall Study|Pregnancy|29|||
42327064|NCT01539226|76164970|FG000|Overall Study|inappropriate enrollment|0|||
42327065|NCT01539226|76164971|FG001|Overall Study|inappropriate enrollment|1|||
42327066|NCT01539226|76164970|FG000|Overall Study|Multiple Reasons|3|||
42327067|NCT01539226|76164971|FG001|Overall Study|Multiple Reasons|1|||
42327068|NCT01539226|76164970|FG000|Overall Study|not HIV seroconversion-related|93|||
42327069|NCT01539226|76164971|FG001|Overall Study|not HIV seroconversion-related|176|||
42327070|NCT01539226|76164970|FG000|Overall Study|HIV seroconversion-related|55|||
42327071|NCT01539226|76164971|FG001|Overall Study|HIV seroconversion-related|80|||
42327072|NCT01539226|76164970|FG000|Overall Study|Non-compliance|6|||
42327073|NCT01539226|76164971|FG001|Overall Study|Non-compliance|8|||
42327074|NCT01577758|76164977|FG000|Dose Escalation Phase|Adverse Event|0|||
42327075|NCT01577758|76164978|FG001|Dose Escalation Phase|Adverse Event|0|||
42327076|NCT01577758|76164979|FG002|Dose Escalation Phase|Adverse Event|0|||
42327077|NCT01577758|76164980|FG003|Dose Escalation Phase|Adverse Event|0|||
42327078|NCT01577758|76164981|FG004|Dose Escalation Phase|Adverse Event|0|||
42327079|NCT01577758|76164982|FG005|Dose Escalation Phase|Adverse Event|2|||
42327080|NCT01577758|76164983|FG006|Dose Escalation Phase|Adverse Event|1|||
42327081|NCT01577758|76164984|FG007|Dose Escalation Phase|Adverse Event|0|||
42327082|NCT01577758|76164977|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
42327083|NCT01577758|76164978|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
42261663|NCT00702507|76089123|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
42261664|NCT00702507|76089123|FG000|Follow-up Phase|Protocol Violation|2|||
42261665|NCT00702507|76089123|FG000|Follow-up Phase|Lost to Follow-up|23|||
42327084|NCT01577758|76164979|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
42327085|NCT01577758|76164980|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
42327086|NCT01577758|76164981|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
42327087|NCT01577758|76164982|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
42327088|NCT01577758|76164983|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
42327089|NCT01577758|76164984|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
42327090|NCT01577758|76164977|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
42327091|NCT01577758|76164978|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
42327092|NCT01577758|76164979|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
42327093|NCT01577758|76164980|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
42327094|NCT01577758|76164981|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
42327095|NCT01577758|76164982|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
42327096|NCT01577758|76164983|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
42327097|NCT01577758|76164984|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
41996343|NCT00479388|75804353|FG001|Overall Study|Adverse Event|45|||
41996344|NCT00479388|75804352|FG000|Overall Study|Lost to Follow-up|0|||
41996345|NCT00479388|75804353|FG001|Overall Study|Lost to Follow-up|2|||
41996346|NCT00479388|75804352|FG000|Overall Study|Protocol Violation|10|||
42327098|NCT01577758|76164977|FG000|Dose Escalation Phase|Progression Disease|2|||
41996347|NCT00479388|75804353|FG001|Overall Study|Protocol Violation|9|||
41996348|NCT00479388|75804352|FG000|Overall Study|Withdrawal by Subject|32|||
41996349|NCT00479388|75804353|FG001|Overall Study|Withdrawal by Subject|17|||
41996350|NCT00479232|75804361|FG000|Overall Study|Adverse Event|0|||
41996351|NCT00479232|75804362|FG001|Overall Study|Adverse Event|0|||
41996352|NCT00479232|75804363|FG002|Overall Study|Adverse Event|5|||
41996353|NCT00479232|75804364|FG003|Overall Study|Adverse Event|0|||
42261666|NCT00702507|76089123|FG000|Follow-up Phase|Late Enrollment|1|||
42261667|NCT01673594|76089139|FG000|Overall Study|Adverse Event|3|||
42261668|NCT01673594|76089140|FG001|Overall Study|Adverse Event|1|||
42261669|NCT01673594|76089139|FG000|Overall Study|Lost to Follow-up|1|||
42261670|NCT01673594|76089140|FG001|Overall Study|Lost to Follow-up|0|||
42261671|NCT01673594|76089139|FG000|Overall Study|Physician Decision|2|||
42261672|NCT01673594|76089140|FG001|Overall Study|Physician Decision|4|||
42327099|NCT01577758|76164978|FG001|Dose Escalation Phase|Progression Disease|2|||
42327100|NCT01577758|76164979|FG002|Dose Escalation Phase|Progression Disease|1|||
41996354|NCT00479232|75804365|FG004|Overall Study|Adverse Event|0|||
41996355|NCT00479232|75804366|FG005|Overall Study|Adverse Event|10|||
41996356|NCT00479232|75804361|FG000|Overall Study|Deviation from Protocol|0|||
42261673|NCT01673594|76089139|FG000|Overall Study|Withdrawal by Subject|0|||
42261674|NCT01673594|76089140|FG001|Overall Study|Withdrawal by Subject|1|||
42261675|NCT02721147|76089149|FG000|Overall Study|Lost to Follow-up|2|||
41996357|NCT00479232|75804362|FG001|Overall Study|Deviation from Protocol|0|||
41996358|NCT00479232|75804363|FG002|Overall Study|Deviation from Protocol|1|||
41996359|NCT00479232|75804364|FG003|Overall Study|Deviation from Protocol|0|||
41996360|NCT00479232|75804365|FG004|Overall Study|Deviation from Protocol|0|||
41996361|NCT00479232|75804366|FG005|Overall Study|Deviation from Protocol|0|||
42327101|NCT01577758|76164980|FG003|Dose Escalation Phase|Progression Disease|2|||
42327102|NCT01577758|76164981|FG004|Dose Escalation Phase|Progression Disease|5|||
42327103|NCT01577758|76164982|FG005|Dose Escalation Phase|Progression Disease|0|||
42327104|NCT01577758|76164983|FG006|Dose Escalation Phase|Progression Disease|0|||
42327105|NCT01577758|76164984|FG007|Dose Escalation Phase|Progression Disease|0|||
42327106|NCT01577758|76164977|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
42327107|NCT01577758|76164978|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
42327108|NCT01577758|76164979|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
42327109|NCT01577758|76164980|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
42327110|NCT01577758|76164981|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
42327111|NCT01577758|76164982|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
42327112|NCT01577758|76164983|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
42327113|NCT01577758|76164984|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
42327114|NCT01577758|76164977|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
42327115|NCT01577758|76164978|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
42327116|NCT01577758|76164979|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
42327117|NCT01577758|76164980|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
42327118|NCT01577758|76164981|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
42327119|NCT01577758|76164982|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
42327120|NCT01577758|76164983|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
42327121|NCT01577758|76164984|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
42327122|NCT01577758|76164977|FG000|mCRC Expansion Phase|Progression Disease|0|||
42327123|NCT01577758|76164978|FG001|mCRC Expansion Phase|Progression Disease|0|||
42327124|NCT01577758|76164979|FG002|mCRC Expansion Phase|Progression Disease|0|||
42327125|NCT01577758|76164980|FG003|mCRC Expansion Phase|Progression Disease|0|||
42327126|NCT01577758|76164981|FG004|mCRC Expansion Phase|Progression Disease|0|||
42327127|NCT01577758|76164982|FG005|mCRC Expansion Phase|Progression Disease|0|||
42327128|NCT01577758|76164983|FG006|mCRC Expansion Phase|Progression Disease|0|||
42327129|NCT01577758|76164984|FG007|mCRC Expansion Phase|Progression Disease|19|||
42327130|NCT01537432|76165006|FG000|Overall Study|Lost to Follow-up|3|||
42327131|NCT01537432|76165007|FG001|Overall Study|Lost to Follow-up|1|||
42327132|NCT01537432|76165006|FG000|Overall Study|Withdrawal by Subject|0|||
42327133|NCT01537432|76165007|FG001|Overall Study|Withdrawal by Subject|1|||
42327134|NCT01537432|76165006|FG000|Overall Study|Administrative problems|1|||
42327135|NCT01537432|76165007|FG001|Overall Study|Administrative problems|0|||
42327136|NCT01537432|76165006|FG000|Overall Study|Adverse Event|1|||
42327137|NCT01537432|76165007|FG001|Overall Study|Adverse Event|0|||
42327138|NCT01537432|76165006|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42327139|NCT01537432|76165007|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42327140|NCT01537198|76165013|FG000|Overall Study|RSV infection|2|||
42327141|NCT01537198|76165013|FG000|Overall Study|Adverse Event|4|||
42327142|NCT01537198|76165013|FG000|Overall Study|No Further Visits to the Clinic|37|||
42327143|NCT01537198|76165013|FG000|Overall Study|Other|111|||
42327144|NCT01537120|76165017|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
42327145|NCT01537120|76165017|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
42327146|NCT01537042|76165025|FG000|Overall Study|Adverse Event|0|||
42327147|NCT01537042|76165026|FG001|Overall Study|Adverse Event|2|||
42327148|NCT01537042|76165025|FG000|Overall Study|Lack of Efficacy|0|||
42327149|NCT01537042|76165026|FG001|Overall Study|Lack of Efficacy|1|||
42327150|NCT01537042|76165025|FG000|Overall Study|Protocol Violation|0|||
42327151|NCT01537042|76165026|FG001|Overall Study|Protocol Violation|1|||
42327152|NCT01537042|76165025|FG000|Overall Study|Other|0|||
42327153|NCT01537042|76165026|FG001|Overall Study|Other|1|||
42327154|NCT01536574|76165047|FG000|Overall Study|Adverse Event|4|||
42327155|NCT01536574|76165048|FG001|Overall Study|Adverse Event|5|||
42327156|NCT01536574|76165047|FG000|Overall Study|Withdrawal by Subject|1|||
42327157|NCT01536574|76165048|FG001|Overall Study|Withdrawal by Subject|2|||
42327158|NCT01536574|76165047|FG000|Overall Study|Lack of Efficacy|1|||
42327159|NCT01536574|76165048|FG001|Overall Study|Lack of Efficacy|0|||
41996362|NCT00479232|75804361|FG000|Overall Study|Lack of Efficacy|0|||
41996363|NCT00479232|75804362|FG001|Overall Study|Lack of Efficacy|0|||
41996364|NCT00479232|75804363|FG002|Overall Study|Lack of Efficacy|2|||
41996365|NCT00479232|75804364|FG003|Overall Study|Lack of Efficacy|0|||
42327160|NCT01536418|76165056|FG000|Overall Study|Protocol Violation|2|||
41996366|NCT00479232|75804365|FG004|Overall Study|Lack of Efficacy|0|||
41996367|NCT00479232|75804366|FG005|Overall Study|Lack of Efficacy|4|||
42327161|NCT01536418|76165057|FG001|Overall Study|Protocol Violation|3|||
41996368|NCT00479232|75804361|FG000|Overall Study|Physician Decision|0|||
41996369|NCT00479232|75804362|FG001|Overall Study|Physician Decision|0|||
42327162|NCT01536418|76165056|FG000|Overall Study|Physician Decision|1|||
42327163|NCT01536418|76165057|FG001|Overall Study|Physician Decision|3|||
41996370|NCT00479232|75804363|FG002|Overall Study|Physician Decision|2|||
42327164|NCT01536418|76165056|FG000|Overall Study|Study closed/terminated|41|||
42327165|NCT01536418|76165057|FG001|Overall Study|Study closed/terminated|37|||
42327166|NCT01536418|76165056|FG000|Overall Study|Lack of Efficacy|10|||
42327167|NCT01536418|76165057|FG001|Overall Study|Lack of Efficacy|16|||
42327168|NCT01536418|76165056|FG000|Overall Study|Adverse Event|9|||
42327169|NCT01536418|76165057|FG001|Overall Study|Adverse Event|4|||
42327170|NCT01536418|76165056|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
42327171|NCT01536418|76165057|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
42327172|NCT01536418|76165056|FG000|Overall Study|Withdrawal by Subject|5|||
42327173|NCT01536418|76165057|FG001|Overall Study|Withdrawal by Subject|3|||
42327174|NCT01576042|76165066|FG000|Overall Study|Physician Decision|2|||
42327175|NCT01576042|76165067|FG001|Overall Study|Physician Decision|0|||
42327176|NCT01561300|76165073|FG000|Run in on Placebo|Adverse Event|1|||
42327177|NCT01561300|76165074|FG001|Run in on Placebo|Adverse Event|0|||
42327178|NCT01536262|76165084|FG000|Overall Study|Adverse Event|6|||
42327179|NCT01536262|76165085|FG001|Overall Study|Adverse Event|1|||
42327180|NCT01536262|76165086|FG002|Overall Study|Adverse Event|2|||
42327181|NCT01536262|76165084|FG000|Overall Study|Withdrawal by Subject|1|||
42327182|NCT01536262|76165085|FG001|Overall Study|Withdrawal by Subject|1|||
42327183|NCT01536262|76165086|FG002|Overall Study|Withdrawal by Subject|0|||
42327184|NCT01536262|76165084|FG000|Overall Study|Other than stated above|1|||
42327185|NCT01536262|76165085|FG001|Overall Study|Other than stated above|0|||
42327186|NCT01536262|76165086|FG002|Overall Study|Other than stated above|0|||
42327187|NCT01560988|76165095|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
42327188|NCT01560988|76165096|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
42327189|NCT01560988|76165095|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
42327190|NCT01560988|76165096|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
42327191|NCT01560988|76165095|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
42327192|NCT01560988|76165096|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
42327193|NCT01535638|76165107|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
42327194|NCT01535638|76165108|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
42327195|NCT01535638|76165109|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
42327196|NCT01535638|76165110|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
42327197|NCT01535638|76165111|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
42327198|NCT01535638|76165112|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
42327199|NCT01535638|76165107|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
42327200|NCT01535638|76165108|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
42327201|NCT01535638|76165109|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
42327202|NCT01535638|76165110|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
42327203|NCT01535638|76165111|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
42327204|NCT01535638|76165112|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
42327205|NCT01535560|76165123|FG000|Overall Study|Adverse Event|12|||
42327206|NCT01535560|76165124|FG001|Overall Study|Adverse Event|7|||
42327207|NCT01535560|76165123|FG000|Overall Study|Lost to Follow-up|1|||
42327208|NCT01535560|76165124|FG001|Overall Study|Lost to Follow-up|3|||
42327209|NCT01535560|76165123|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
42327210|NCT01535560|76165124|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
42327211|NCT01535560|76165123|FG000|Overall Study|Treatment Failure|21|||
42327212|NCT01535560|76165124|FG001|Overall Study|Treatment Failure|83|||
42327213|NCT01535560|76165123|FG000|Overall Study|Other|0|||
42327214|NCT01535560|76165124|FG001|Overall Study|Other|1|||
42327215|NCT01535560|76165123|FG000|Overall Study|Randomized in Error|0|||
42327216|NCT01535560|76165124|FG001|Overall Study|Randomized in Error|1|||
42327217|NCT01575028|76165132|FG000|Overall Study|Physician Decision|0|||
42327218|NCT01575028|76165133|FG001|Overall Study|Physician Decision|1|||
41996371|NCT00479232|75804364|FG003|Overall Study|Physician Decision|0|||
41996372|NCT00479232|75804365|FG004|Overall Study|Physician Decision|0|||
41996373|NCT00479232|75804366|FG005|Overall Study|Physician Decision|1|||
42327219|NCT01574716|76165158|FG000|Part 1|Death|3|||
42327220|NCT01574716|76165159|FG001|Part 1|Death|1|||
42327221|NCT01574716|76165160|FG002|Part 1|Death|8|||
42327222|NCT01574716|76165161|FG003|Part 1|Death|0|||
42327223|NCT01574716|76165162|FG004|Part 1|Death|0|||
42327224|NCT01574716|76165158|FG000|Part 1|Discontinuation of study by sponsor|0|||
42327225|NCT01574716|76165159|FG001|Part 1|Discontinuation of study by sponsor|0|||
42327226|NCT01574716|76165160|FG002|Part 1|Discontinuation of study by sponsor|1|||
42327227|NCT01574716|76165161|FG003|Part 1|Discontinuation of study by sponsor|0|||
42327228|NCT01574716|76165162|FG004|Part 1|Discontinuation of study by sponsor|0|||
41996374|NCT00479232|75804361|FG000|Overall Study|Progressive Disease|3|||
41996375|NCT00479232|75804362|FG001|Overall Study|Progressive Disease|1|||
42327229|NCT01574716|76165158|FG000|Part 1|Withdrawal by Subject|0|||
42327230|NCT01574716|76165159|FG001|Part 1|Withdrawal by Subject|2|||
42327231|NCT01574716|76165160|FG002|Part 1|Withdrawal by Subject|0|||
42327232|NCT01574716|76165161|FG003|Part 1|Withdrawal by Subject|0|||
42327233|NCT01574716|76165162|FG004|Part 1|Withdrawal by Subject|0|||
42327234|NCT01574716|76165158|FG000|Part 1|Lost to Follow-up|0|||
42327235|NCT01574716|76165159|FG001|Part 1|Lost to Follow-up|1|||
42327236|NCT01574716|76165160|FG002|Part 1|Lost to Follow-up|0|||
42327237|NCT01574716|76165161|FG003|Part 1|Lost to Follow-up|0|||
42327238|NCT01574716|76165162|FG004|Part 1|Lost to Follow-up|0|||
42327239|NCT01574716|76165158|FG000|Part 2|Progressive disease|0|||
42327240|NCT01574716|76165159|FG001|Part 2|Progressive disease|0|||
42327241|NCT01574716|76165160|FG002|Part 2|Progressive disease|0|||
42327242|NCT01574716|76165161|FG003|Part 2|Progressive disease|1|||
42327243|NCT01574716|76165162|FG004|Part 2|Progressive disease|0|||
42327244|NCT01574716|76165158|FG000|Part 2|Death|0|||
42327245|NCT01574716|76165159|FG001|Part 2|Death|0|||
42327246|NCT01574716|76165160|FG002|Part 2|Death|0|||
42327247|NCT01574716|76165161|FG003|Part 2|Death|76|||
42327248|NCT01574716|76165162|FG004|Part 2|Death|35|||
42327249|NCT01574716|76165158|FG000|Part 2|Discontinuation of study by sponsor|0|||
42327250|NCT01574716|76165159|FG001|Part 2|Discontinuation of study by sponsor|0|||
42327251|NCT01574716|76165160|FG002|Part 2|Discontinuation of study by sponsor|0|||
42327252|NCT01574716|76165161|FG003|Part 2|Discontinuation of study by sponsor|51|||
42327253|NCT01574716|76165162|FG004|Part 2|Discontinuation of study by sponsor|31|||
42327254|NCT01574716|76165158|FG000|Part 2|Withdrawal by Subject|0|||
42327255|NCT01574716|76165159|FG001|Part 2|Withdrawal by Subject|0|||
42327256|NCT01574716|76165160|FG002|Part 2|Withdrawal by Subject|0|||
42327257|NCT01574716|76165161|FG003|Part 2|Withdrawal by Subject|5|||
42327258|NCT01574716|76165162|FG004|Part 2|Withdrawal by Subject|4|||
42327259|NCT01574716|76165158|FG000|Part 2|Brain metastases|0|||
42327260|NCT01574716|76165159|FG001|Part 2|Brain metastases|0|||
42327261|NCT01574716|76165160|FG002|Part 2|Brain metastases|0|||
42327262|NCT01574716|76165161|FG003|Part 2|Brain metastases|1|||
42327263|NCT01574716|76165162|FG004|Part 2|Brain metastases|0|||
42327264|NCT01574716|76165158|FG000|Part 2|Lost to Follow-up|0|||
42327265|NCT01574716|76165159|FG001|Part 2|Lost to Follow-up|0|||
42327266|NCT01574716|76165160|FG002|Part 2|Lost to Follow-up|0|||
42327267|NCT01574716|76165161|FG003|Part 2|Lost to Follow-up|3|||
42327268|NCT01574716|76165162|FG004|Part 2|Lost to Follow-up|0|||
42327269|NCT02161562|76165173|FG000|Overall Study|Withdrawal by Subject|5|||
42327270|NCT02161562|76165174|FG001|Overall Study|Withdrawal by Subject|8|||
42327271|NCT02161562|76165173|FG000|Overall Study|Protocol Violation|9|||
42327272|NCT02161562|76165174|FG001|Overall Study|Protocol Violation|4|||
42327273|NCT02161562|76165173|FG000|Overall Study|Pregnancy|1|||
42327274|NCT02161562|76165174|FG001|Overall Study|Pregnancy|2|||
42327275|NCT02161562|76165173|FG000|Overall Study|Lost to Follow-up|3|||
42327276|NCT02161562|76165174|FG001|Overall Study|Lost to Follow-up|1|||
42327277|NCT02161562|76165173|FG000|Overall Study|Lack of Efficacy|4|||
42327278|NCT02161562|76165174|FG001|Overall Study|Lack of Efficacy|1|||
42327279|NCT02161562|76165173|FG000|Overall Study|Adverse Event|1|||
42327280|NCT02161562|76165174|FG001|Overall Study|Adverse Event|1|||
42327281|NCT02161562|76165173|FG000|Overall Study|Participant moved back to home country|1|||
42327282|NCT02161562|76165174|FG001|Overall Study|Participant moved back to home country|0|||
42327283|NCT02161562|76165173|FG000|Overall Study|Withdrew due to being out of the country|1|||
42327284|NCT02161562|76165174|FG001|Overall Study|Withdrew due to being out of the country|0|||
42327285|NCT02161562|76165173|FG000|Overall Study|Participant moved out of province|1|||
42327286|NCT02161562|76165174|FG001|Overall Study|Participant moved out of province|0|||
42327287|NCT01559116|76165193|FG000|Overall Study|Adverse Event|10|||
41996376|NCT00479232|75804363|FG002|Overall Study|Progressive Disease|12|||
41996377|NCT00479232|75804364|FG003|Overall Study|Progressive Disease|3|||
41996378|NCT00479232|75804365|FG004|Overall Study|Progressive Disease|3|||
42327288|NCT01559116|76165193|FG000|Overall Study|Lack of Efficacy|1|||
42327289|NCT01559116|76165193|FG000|Overall Study|Lost to Follow-up|1|||
42327290|NCT01559116|76165193|FG000|Overall Study|Protocol Violation|1|||
41996379|NCT00479232|75804366|FG005|Overall Study|Progressive Disease|12|||
42327291|NCT01559116|76165193|FG000|Overall Study|Withdrawal by Subject|4|||
42327292|NCT01559116|76165193|FG000|Overall Study|other than stated above|9|||
42327293|NCT01574326|76165212|FG000|Overall Study|Randomized but not treated|0|||
42327294|NCT01574326|76165213|FG001|Overall Study|Randomized but not treated|1|||
42327295|NCT01574326|76165212|FG000|Overall Study|Withdrawal by Participant|2|||
42327296|NCT01574326|76165213|FG001|Overall Study|Withdrawal by Participant|4|||
41996380|NCT00479232|75804361|FG000|Overall Study|Withdrew Consent|0|||
41996381|NCT00479232|75804362|FG001|Overall Study|Withdrew Consent|2|||
41996382|NCT00479232|75804363|FG002|Overall Study|Withdrew Consent|6|||
42327297|NCT01574326|76165212|FG000|Overall Study|Physician Decision|5|||
42327298|NCT01574326|76165213|FG001|Overall Study|Physician Decision|3|||
42327299|NCT01574326|76165212|FG000|Overall Study|Adverse Event|1|||
42327300|NCT01574326|76165213|FG001|Overall Study|Adverse Event|3|||
42327301|NCT01574326|76165212|FG000|Overall Study|Other: Mainly kidney transplant|8|||
42327302|NCT01574326|76165213|FG001|Overall Study|Other: Mainly kidney transplant|8|||
42327303|NCT01574248|76165226|FG000|Overall Study|Withdrawal by Subject|2|||
42327304|NCT01574248|76165227|FG001|Overall Study|Withdrawal by Subject|0|||
42327305|NCT01574248|76165226|FG000|Overall Study|Missing primary endpoint data|1|||
42327306|NCT01574248|76165227|FG001|Overall Study|Missing primary endpoint data|0|||
42327307|NCT01573624|76165233|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
42327308|NCT01573624|76165234|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
42327309|NCT01573624|76165235|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
42327310|NCT01573624|76165236|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
42327311|NCT01573624|76165237|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
42327312|NCT01573624|76165238|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
42327313|NCT01573624|76165239|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
42327314|NCT01573624|76165233|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
42327315|NCT01573624|76165234|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
42327316|NCT01573624|76165235|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
42327317|NCT01573624|76165236|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
42327318|NCT01573624|76165237|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
42327319|NCT01573624|76165238|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
42327320|NCT01573624|76165239|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
42327321|NCT01573624|76165233|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
42327322|NCT01573624|76165234|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
42327323|NCT01573624|76165235|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
42327324|NCT01573624|76165236|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
42327325|NCT01573624|76165237|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
42327326|NCT01573624|76165238|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
42327327|NCT01573624|76165239|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
42327328|NCT01573624|76165233|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
42327329|NCT01573624|76165234|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42327330|NCT01573624|76165235|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
42327331|NCT01573624|76165236|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42327332|NCT01573624|76165237|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42327333|NCT01573624|76165238|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
42327334|NCT01573624|76165239|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42327335|NCT01573624|76165233|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
42327336|NCT01573624|76165234|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
42327337|NCT01573624|76165235|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
42327338|NCT01573624|76165236|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
42327339|NCT01573624|76165237|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
42327340|NCT01573624|76165238|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
42327341|NCT01573624|76165239|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
42327342|NCT01573624|76165233|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
42327343|NCT01573624|76165234|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
42327344|NCT01573624|76165235|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
42327345|NCT01573624|76165236|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
42327346|NCT01573624|76165237|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
42327347|NCT01573624|76165238|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
42327348|NCT01573624|76165239|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
42327349|NCT01573624|76165233|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
42327350|NCT01573624|76165234|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
42327351|NCT01573624|76165235|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
42327352|NCT01573624|76165236|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
42327353|NCT01573624|76165237|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
42327354|NCT01573624|76165238|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
42327355|NCT01573624|76165239|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
42327356|NCT01573624|76165233|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
42327357|NCT01573624|76165234|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
42327358|NCT01573624|76165235|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
42327359|NCT01573624|76165236|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
42327360|NCT01573624|76165237|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
42327361|NCT01573624|76165238|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
42327362|NCT01573624|76165239|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
42327363|NCT01573624|76165233|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
42327364|NCT01573624|76165234|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
42327365|NCT01573624|76165235|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
41996383|NCT00479232|75804364|FG003|Overall Study|Withdrew Consent|0|||
41996384|NCT00479232|75804365|FG004|Overall Study|Withdrew Consent|1|||
42261676|NCT02721147|76089150|FG001|Overall Study|Lost to Follow-up|0|||
42261677|NCT02721147|76089151|FG002|Overall Study|Lost to Follow-up|0|||
42261678|NCT02720757|76089159|FG000|Overall Study|Other reason|5|||
41996385|NCT00479232|75804366|FG005|Overall Study|Withdrew Consent|3|||
41996386|NCT00478881|75804386|FG000|Overall Study|Adverse Event|31|||
41996387|NCT00478881|75804387|FG001|Overall Study|Adverse Event|12|||
41996388|NCT00478881|75804386|FG000|Overall Study|Lack of Efficacy|0|||
41996389|NCT00478881|75804387|FG001|Overall Study|Lack of Efficacy|3|||
41996390|NCT00478881|75804386|FG000|Overall Study|Lost to Follow-up|0|||
41996391|NCT00478881|75804387|FG001|Overall Study|Lost to Follow-up|1|||
41996392|NCT00478881|75804386|FG000|Overall Study|Protocol Violation|2|||
41996393|NCT00478881|75804387|FG001|Overall Study|Protocol Violation|2|||
41996394|NCT00478881|75804386|FG000|Overall Study|Withdrawal by Subject|6|||
41996395|NCT00478881|75804387|FG001|Overall Study|Withdrawal by Subject|2|||
41996396|NCT00478881|75804386|FG000|Overall Study|Non-Compliance with Study Medication|0|||
41996397|NCT00478881|75804387|FG001|Overall Study|Non-Compliance with Study Medication|2|||
41996398|NCT00478647|75804393|FG000|Overall Study|Adverse Event|1|||
41996399|NCT00478647|75804393|FG000|Overall Study|Withdrawal by Subject|1|||
41996400|NCT00478608|75804397|FG000|Overall Study|Adverse Event|1|||
41996401|NCT00478608|75804397|FG000|Overall Study|Serious Adverse Event|14|||
41996402|NCT00478608|75804397|FG000|Overall Study|Withdrawal by Subject|2|||
41996403|NCT00478608|75804397|FG000|Overall Study|Protocol Violation|3|||
41996404|NCT00478257|75804403|FG000|Overall Study|Withdrawal by Subject|8|||
41996405|NCT00478257|75804404|FG001|Overall Study|Withdrawal by Subject|3|||
41996406|NCT00478140|75804410|FG000|Overall Study|Clinical Disease Progression|1|||
41996407|NCT00478023|75804419|FG000|Overall Study|Adverse Event|11|||
41996408|NCT00478023|75804420|FG001|Overall Study|Adverse Event|7|||
41996409|NCT00478023|75804421|FG002|Overall Study|Adverse Event|8|||
41996410|NCT00478023|75804422|FG003|Overall Study|Adverse Event|14|||
41996411|NCT00478023|75804423|FG004|Overall Study|Adverse Event|6|||
41996412|NCT00478023|75804419|FG000|Overall Study|Death|1|||
41996413|NCT00478023|75804420|FG001|Overall Study|Death|0|||
41996414|NCT00478023|75804421|FG002|Overall Study|Death|0|||
41996415|NCT00478023|75804422|FG003|Overall Study|Death|0|||
41996416|NCT00478023|75804423|FG004|Overall Study|Death|0|||
41996417|NCT00478023|75804419|FG000|Overall Study|Lack of Efficacy|11|||
41996418|NCT00478023|75804420|FG001|Overall Study|Lack of Efficacy|10|||
41996419|NCT00478023|75804421|FG002|Overall Study|Lack of Efficacy|4|||
41996420|NCT00478023|75804422|FG003|Overall Study|Lack of Efficacy|5|||
41996421|NCT00478023|75804423|FG004|Overall Study|Lack of Efficacy|41|||
41996422|NCT00478023|75804419|FG000|Overall Study|Lost to Follow-up|3|||
41996423|NCT00478023|75804420|FG001|Overall Study|Lost to Follow-up|1|||
41996424|NCT00478023|75804421|FG002|Overall Study|Lost to Follow-up|1|||
41996425|NCT00478023|75804422|FG003|Overall Study|Lost to Follow-up|1|||
41996426|NCT00478023|75804423|FG004|Overall Study|Lost to Follow-up|0|||
41996427|NCT00478023|75804419|FG000|Overall Study|Withdrawal by Subject|2|||
41996428|NCT00478023|75804420|FG001|Overall Study|Withdrawal by Subject|3|||
41996429|NCT00478023|75804421|FG002|Overall Study|Withdrawal by Subject|2|||
41996430|NCT00478023|75804422|FG003|Overall Study|Withdrawal by Subject|4|||
41996431|NCT00478023|75804423|FG004|Overall Study|Withdrawal by Subject|5|||
41996432|NCT00478023|75804419|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
41996433|NCT00478023|75804420|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
41996434|NCT00478023|75804421|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
41996435|NCT00478023|75804422|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
41996436|NCT00478023|75804423|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
41996437|NCT00477750|75804435|FG000|Overall Study|Currently Receiving Treatment|11|||
42261679|NCT02720757|76089159|FG000|Overall Study|Loss of contact|4|||
42261680|NCT02720757|76089159|FG000|Overall Study|Informed consent withdrawal|1|||
42261681|NCT02720757|76089159|FG000|Overall Study|Patients wish to withdraw|2|||
41996438|NCT00477672|75804444|FG000|Overall Study|Adverse Event|3|||
41996439|NCT00477672|75804445|FG001|Overall Study|Adverse Event|5|||
41996440|NCT00477672|75804446|FG002|Overall Study|Adverse Event|6|||
41996441|NCT00477672|75804444|FG000|Overall Study|Death|0|||
41996442|NCT00477672|75804445|FG001|Overall Study|Death|1|||
41996443|NCT00477672|75804446|FG002|Overall Study|Death|0|||
41996444|NCT00477672|75804444|FG000|Overall Study|Disease progression|0|||
41996445|NCT00477672|75804445|FG001|Overall Study|Disease progression|1|||
41996446|NCT00477672|75804446|FG002|Overall Study|Disease progression|0|||
41996447|NCT00477672|75804444|FG000|Overall Study|Physician Decision|1|||
41996448|NCT00477672|75804445|FG001|Overall Study|Physician Decision|0|||
42261682|NCT02720757|76089159|FG000|Overall Study|Missing|3|||
42261683|NCT02720757|76089159|FG000|Overall Study|General exclusion|3|||
42261684|NCT02646566|76089189|FG000|Overall Study|Lost to Follow-up|5|||
41996449|NCT00477672|75804446|FG002|Overall Study|Physician Decision|0|||
41996450|NCT00477672|75804444|FG000|Overall Study|Protocol noncompliance|0|||
42327366|NCT01573624|76165236|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
42327367|NCT01573624|76165237|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
42327368|NCT01573624|76165238|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
42327369|NCT01573624|76165239|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
42327370|NCT01573624|76165233|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
42327371|NCT01573624|76165234|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
42327372|NCT01573624|76165235|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
42327373|NCT01573624|76165236|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
42327374|NCT01573624|76165237|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
42327375|NCT01573624|76165238|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
42327376|NCT01573624|76165239|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
41996451|NCT00477672|75804445|FG001|Overall Study|Protocol noncompliance|2|||
41996452|NCT00477672|75804446|FG002|Overall Study|Protocol noncompliance|0|||
41996453|NCT00477672|75804444|FG000|Overall Study|Consent withdrawn|2|||
41996454|NCT00477672|75804445|FG001|Overall Study|Consent withdrawn|5|||
41996455|NCT00477672|75804446|FG002|Overall Study|Consent withdrawn|10|||
41996456|NCT00477672|75804444|FG000|Overall Study|Discretion of Sponsor|1|||
41996457|NCT00477672|75804445|FG001|Overall Study|Discretion of Sponsor|2|||
41996458|NCT00477672|75804446|FG002|Overall Study|Discretion of Sponsor|0|||
41996459|NCT00477633|75804454|FG000|Overall Study|Did not receive treatment|23|||
41996460|NCT00477633|75804454|FG000|Overall Study|Adverse Event|143|||
41996461|NCT00477633|75804454|FG000|Overall Study|Pregnancy|23|||
41996462|NCT00477633|75804454|FG000|Overall Study|Lost to Follow-up|271|||
41996463|NCT00477633|75804454|FG000|Overall Study|Withdrawal by Subject|149|||
41996464|NCT00477633|75804454|FG000|Overall Study|Protocol Violation|25|||
41996465|NCT00477633|75804454|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
41996466|NCT01131676|75804470|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
41996467|NCT01131676|75804471|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
41996468|NCT01131676|75804472|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
41996469|NCT01131676|75804470|FG000|Discontinuation From Treatment|Not treated|4|||
41996470|NCT01131676|75804471|FG001|Discontinuation From Treatment|Not treated|2|||
41996471|NCT01131676|75804472|FG002|Discontinuation From Treatment|Not treated|2|||
42034432|NCT01125293|75842514|FG000|Overall Study|Withdrawal by Subject|0|||
42034433|NCT01125293|75842515|FG001|Overall Study|Withdrawal by Subject|0|||
42261685|NCT02646566|76089190|FG001|Overall Study|Lost to Follow-up|4|||
42261686|NCT02646566|76089191|FG002|Overall Study|Lost to Follow-up|5|||
42261687|NCT02646566|76089189|FG000|Overall Study|Treatment failure|1|||
42261688|NCT02646566|76089190|FG001|Overall Study|Treatment failure|0|||
42261689|NCT02646566|76089191|FG002|Overall Study|Treatment failure|0|||
42261690|NCT02720523|76089207|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
42261691|NCT02720523|76089208|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
42261692|NCT02720523|76089209|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
42261693|NCT02720523|76089210|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
42261694|NCT02720523|76089211|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
42261695|NCT02720523|76089212|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
42261696|NCT02720523|76089213|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
42261697|NCT02720523|76089207|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
42261698|NCT02720523|76089208|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
42261699|NCT02720523|76089209|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
42261700|NCT02720523|76089210|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
42261701|NCT02720523|76089211|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
42034434|NCT01125293|75842516|FG002|Overall Study|Withdrawal by Subject|0|||
42034435|NCT01125293|75842517|FG003|Overall Study|Withdrawal by Subject|0|||
42261702|NCT02720523|76089212|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
42261703|NCT02720523|76089213|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
41996472|NCT01131676|75804470|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
41996473|NCT01131676|75804471|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
41996474|NCT01131676|75804472|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
42034436|NCT01125293|75842518|FG004|Overall Study|Withdrawal by Subject|2|||
42261704|NCT02720523|76089207|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
42261705|NCT02720523|76089208|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
42327377|NCT01573624|76165233|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
42327378|NCT01573624|76165234|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
42327379|NCT01573624|76165235|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
42327380|NCT01573624|76165236|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
42327381|NCT01573624|76165237|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
42327382|NCT01573624|76165238|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
42327383|NCT01573624|76165239|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
42327384|NCT01573624|76165233|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
42327385|NCT01573624|76165234|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
42327386|NCT01573624|76165235|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
42327387|NCT01573624|76165236|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
42327388|NCT01573624|76165237|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
42327389|NCT01573624|76165238|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
42327390|NCT01573624|76165239|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
42327391|NCT01573624|76165233|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
42327392|NCT01573624|76165234|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
42327393|NCT01573624|76165235|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
42327394|NCT01573624|76165236|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
42327395|NCT01573624|76165237|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
42327396|NCT01573624|76165238|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
42327397|NCT01573624|76165239|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
42327398|NCT01573624|76165233|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
42327399|NCT01573624|76165234|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
42327400|NCT01573624|76165235|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
42327401|NCT01573624|76165236|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
42327402|NCT01573624|76165237|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
42327403|NCT01573624|76165238|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
42327404|NCT01573624|76165239|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
42327405|NCT01573624|76165233|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
42327406|NCT01573624|76165234|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
41996475|NCT01131676|75804470|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
41996476|NCT01131676|75804471|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
42327407|NCT01573624|76165235|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
42327408|NCT01573624|76165236|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
42327409|NCT01573624|76165237|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
42327410|NCT01573624|76165238|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
42327411|NCT01573624|76165239|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
42327412|NCT01573624|76165233|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
42327413|NCT01573624|76165234|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
42327414|NCT01573624|76165235|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
42327415|NCT01573624|76165236|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
42327416|NCT01573624|76165237|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
41996477|NCT01131676|75804472|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
41996478|NCT01131676|75804470|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
41996479|NCT01131676|75804471|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
41996480|NCT01131676|75804472|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
41996481|NCT01131676|75804470|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
41996482|NCT01131676|75804471|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
41996483|NCT01131676|75804472|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
41996484|NCT01131676|75804470|FG000|Discontinuation From Treatment|Other than those specified|162|||
41996485|NCT01131676|75804471|FG001|Discontinuation From Treatment|Other than those specified|142|||
42261706|NCT02720523|76089209|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
42261707|NCT02720523|76089210|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
42261708|NCT02720523|76089211|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
42261709|NCT02720523|76089212|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
42261710|NCT02720523|76089213|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
42261711|NCT02720523|76089207|FG000|Period 1: Placebo-controlled Period|Other|0|||
42261712|NCT02720523|76089208|FG001|Period 1: Placebo-controlled Period|Other|0|||
42261713|NCT02720523|76089209|FG002|Period 1: Placebo-controlled Period|Other|1|||
42261714|NCT02720523|76089210|FG003|Period 1: Placebo-controlled Period|Other|1|||
42261715|NCT02720523|76089211|FG004|Period 1: Placebo-controlled Period|Other|0|||
42261716|NCT02720523|76089212|FG005|Period 1: Placebo-controlled Period|Other|0|||
41996486|NCT01131676|75804472|FG002|Discontinuation From Treatment|Other than those specified|125|||
41996487|NCT01131676|75804470|FG000|Discontinuation From Treatment|Adverse Event|303|||
41996488|NCT01131676|75804471|FG001|Discontinuation From Treatment|Adverse Event|267|||
41996489|NCT01131676|75804472|FG002|Discontinuation From Treatment|Adverse Event|273|||
42034437|NCT01125293|75842519|FG005|Overall Study|Withdrawal by Subject|1|||
42034438|NCT01125293|75842514|FG000|Overall Study|Physician Decision|0|||
42034439|NCT01125293|75842515|FG001|Overall Study|Physician Decision|0|||
42327417|NCT01573624|76165238|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
42034440|NCT01125293|75842516|FG002|Overall Study|Physician Decision|0|||
42327418|NCT01573624|76165239|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
42327419|NCT01573624|76165233|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
42327420|NCT01573624|76165234|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
42327421|NCT01573624|76165235|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
42327422|NCT01573624|76165236|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
42327423|NCT01573624|76165237|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
42327424|NCT01573624|76165238|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
42327425|NCT01573624|76165239|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
42327426|NCT01573624|76165233|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
42327427|NCT01573624|76165234|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
42327428|NCT01573624|76165235|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
42327429|NCT01573624|76165236|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
42327430|NCT01573624|76165237|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
42327431|NCT01573624|76165238|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
42327432|NCT01573624|76165239|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
41996490|NCT01131676|75804470|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
42327433|NCT01573624|76165233|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
42327434|NCT01573624|76165234|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
42327435|NCT01573624|76165235|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
42327436|NCT01573624|76165236|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
42327437|NCT01573624|76165237|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
42327438|NCT01573624|76165238|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
42327439|NCT01573624|76165239|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
42327440|NCT01573624|76165233|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
42327441|NCT01573624|76165234|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
42327442|NCT01573624|76165235|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
42327443|NCT01573624|76165236|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
42327444|NCT01573624|76165237|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
42327445|NCT01573624|76165238|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
42327446|NCT01573624|76165239|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
42327447|NCT01573624|76165233|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
42327448|NCT01573624|76165234|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
42327449|NCT01573624|76165235|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
42327450|NCT01573624|76165236|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
42327451|NCT01573624|76165237|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
42327452|NCT01573624|76165238|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
42327453|NCT01573624|76165239|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
42327454|NCT01573624|76165233|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
42327455|NCT01573624|76165234|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
42327456|NCT01573624|76165235|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
42327457|NCT01573624|76165236|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
42327458|NCT01573624|76165237|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
41996491|NCT01131676|75804471|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
41996492|NCT01131676|75804472|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
42327459|NCT01573624|76165238|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
41996493|NCT01131676|75804470|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
41996494|NCT01131676|75804471|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
41996495|NCT01131676|75804472|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
41996496|NCT01131676|75804470|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
41996497|NCT01131676|75804471|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
41996498|NCT01131676|75804472|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
41996499|NCT01131676|75804470|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
42034441|NCT01125293|75842517|FG003|Overall Study|Physician Decision|0|||
41996500|NCT01131676|75804471|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
41996501|NCT01131676|75804472|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
41996502|NCT01131676|75804470|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
41996503|NCT01131676|75804471|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
41996504|NCT01131676|75804472|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
41996505|NCT01131676|75804470|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
41996506|NCT01131676|75804471|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
41996507|NCT01131676|75804472|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
41996508|NCT01131520|75804494|FG000|Overall Study|Computer problem|1|||
41996509|NCT01131520|75804495|FG001|Overall Study|Computer problem|0|||
41996510|NCT01131520|75804494|FG000|Overall Study|Counselor not available|0|||
41996511|NCT01131520|75804495|FG001|Overall Study|Counselor not available|3|||
41996512|NCT01131520|75804494|FG000|Overall Study|Subject changed history after enrollment|0|||
41996513|NCT01131520|75804495|FG001|Overall Study|Subject changed history after enrollment|1|||
41996514|NCT01131325|75804501|FG000|Overall Study|Adverse Event|1|||
41996515|NCT01131325|75804501|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
41996516|NCT01131130|75804505|FG000|Period 1 - Baseline|Pregnancy|1|||
41996517|NCT01131130|75804505|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
41996518|NCT01130974|75804515|FG000|Overall Study|Protocol Violation|10|||
41996519|NCT01130974|75804516|FG001|Overall Study|Protocol Violation|10|||
41996520|NCT01130974|75804515|FG000|Overall Study|Withdrawal by Subject|0|||
41996521|NCT01130974|75804516|FG001|Overall Study|Withdrawal by Subject|1|||
41996522|NCT01130974|75804515|FG000|Overall Study|Ineligibility criteria|5|||
41996523|NCT01130974|75804516|FG001|Overall Study|Ineligibility criteria|2|||
41996524|NCT01130272|75804528|FG000|Overall Study|Adverse Event|2|||
41996525|NCT01130272|75804529|FG001|Overall Study|Adverse Event|5|||
41996526|NCT01130272|75804530|FG002|Overall Study|Adverse Event|6|||
41996527|NCT01130272|75804531|FG003|Overall Study|Adverse Event|22|||
41996528|NCT01130272|75804532|FG004|Overall Study|Adverse Event|7|||
41996529|NCT01130272|75804528|FG000|Overall Study|IVRS-confirmed constipation|0|||
41996530|NCT01130272|75804529|FG001|Overall Study|IVRS-confirmed constipation|1|||
41996531|NCT01130272|75804530|FG002|Overall Study|IVRS-confirmed constipation|1|||
41996532|NCT01130272|75804531|FG003|Overall Study|IVRS-confirmed constipation|2|||
41996533|NCT01130272|75804532|FG004|Overall Study|IVRS-confirmed constipation|0|||
41996534|NCT01130272|75804528|FG000|Overall Study|Rescue medications due to diarrhea|3|||
41996535|NCT01130272|75804529|FG001|Overall Study|Rescue medications due to diarrhea|5|||
41996536|NCT01130272|75804530|FG002|Overall Study|Rescue medications due to diarrhea|8|||
41996537|NCT01130272|75804531|FG003|Overall Study|Rescue medications due to diarrhea|8|||
41996538|NCT01130272|75804532|FG004|Overall Study|Rescue medications due to diarrhea|6|||
41996539|NCT01130272|75804528|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
42327460|NCT01573624|76165239|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
42327461|NCT01573624|76165233|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
42327462|NCT01573624|76165234|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42327463|NCT01573624|76165235|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
41996540|NCT01130272|75804529|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
41996541|NCT01130272|75804530|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
41996542|NCT01130272|75804531|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
41996543|NCT01130272|75804532|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
41996544|NCT01130272|75804528|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
41996545|NCT01130272|75804529|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
41996546|NCT01130272|75804530|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
41996547|NCT01130272|75804531|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
41996548|NCT01130272|75804532|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
41996549|NCT01130272|75804528|FG000|Overall Study|Protocol Violation|0|||
41996550|NCT01130272|75804529|FG001|Overall Study|Protocol Violation|0|||
41996551|NCT01130272|75804530|FG002|Overall Study|Protocol Violation|3|||
41996552|NCT01130272|75804531|FG003|Overall Study|Protocol Violation|5|||
41996553|NCT01130272|75804532|FG004|Overall Study|Protocol Violation|5|||
42034442|NCT01125293|75842518|FG004|Overall Study|Physician Decision|0|||
42327464|NCT01573624|76165236|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42327465|NCT01573624|76165237|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
41996554|NCT01130272|75804528|FG000|Overall Study|Lost to Follow-up|4|||
41996555|NCT01130272|75804529|FG001|Overall Study|Lost to Follow-up|3|||
41996556|NCT01130272|75804530|FG002|Overall Study|Lost to Follow-up|4|||
41996557|NCT01130272|75804531|FG003|Overall Study|Lost to Follow-up|7|||
41996558|NCT01130272|75804532|FG004|Overall Study|Lost to Follow-up|6|||
41996559|NCT01130272|75804528|FG000|Overall Study|Withdrawal by Subject|4|||
42034443|NCT01125293|75842519|FG005|Overall Study|Physician Decision|2|||
41996560|NCT01130272|75804529|FG001|Overall Study|Withdrawal by Subject|11|||
42261717|NCT02720523|76089213|FG006|Period 1: Placebo-controlled Period|Other|0|||
42261718|NCT02720523|76089207|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
42261719|NCT02720523|76089208|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
42327466|NCT01573624|76165238|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
42327467|NCT01573624|76165239|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
42327468|NCT01573624|76165233|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
42327469|NCT01573624|76165234|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
42327470|NCT01573624|76165235|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
42327471|NCT01573624|76165236|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
42261720|NCT02720523|76089209|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
42261721|NCT02720523|76089210|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
42261722|NCT02720523|76089211|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
42261723|NCT02720523|76089212|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
42261724|NCT02720523|76089213|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
42261725|NCT02720523|76089207|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
42261726|NCT02720523|76089208|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
42261727|NCT02720523|76089209|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
42261728|NCT02720523|76089210|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
42261729|NCT02720523|76089211|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
42261730|NCT02720523|76089212|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
42261731|NCT02720523|76089213|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
42261732|NCT02720523|76089207|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
42261733|NCT02720523|76089208|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
42327472|NCT01573624|76165237|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
42327473|NCT01573624|76165238|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
42327474|NCT01573624|76165239|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
42327475|NCT01573624|76165233|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
42327476|NCT01573624|76165234|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
42327477|NCT01573624|76165235|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
42327478|NCT01573624|76165236|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
42327479|NCT01573624|76165237|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
42327480|NCT01573624|76165238|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
42327481|NCT01573624|76165239|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
42327482|NCT01573624|76165233|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
42327483|NCT01573624|76165234|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
42327484|NCT01573624|76165235|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
42327485|NCT01573624|76165236|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
42327486|NCT01573624|76165237|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
42327487|NCT01573624|76165238|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
42327488|NCT01573624|76165239|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
42327489|NCT01573624|76165233|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
42327490|NCT01573624|76165234|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
42327491|NCT01573624|76165235|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
41996561|NCT01130272|75804530|FG002|Overall Study|Withdrawal by Subject|10|||
41996562|NCT01130272|75804531|FG003|Overall Study|Withdrawal by Subject|9|||
42261734|NCT02720523|76089209|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
41996563|NCT01130272|75804532|FG004|Overall Study|Withdrawal by Subject|8|||
41996564|NCT01130272|75804528|FG000|Overall Study|Physician Decision|1|||
41996565|NCT01130272|75804529|FG001|Overall Study|Physician Decision|1|||
41996566|NCT01130272|75804530|FG002|Overall Study|Physician Decision|0|||
41996567|NCT01130272|75804531|FG003|Overall Study|Physician Decision|1|||
41996568|NCT01130272|75804532|FG004|Overall Study|Physician Decision|2|||
41996569|NCT01130272|75804528|FG000|Overall Study|Sponsor decision|6|||
42327492|NCT01573624|76165236|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
42327493|NCT01573624|76165237|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
42327494|NCT01573624|76165238|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
42327495|NCT01573624|76165239|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
42327496|NCT01557946|76165263|FG000|Overall Study|Adverse Event|3|||
42327497|NCT01557946|76165264|FG001|Overall Study|Adverse Event|0|||
42327498|NCT01534078|76165269|FG000|Overall Study|Death|1|||
42327499|NCT01534078|76165269|FG000|Overall Study|Withdrawal by Subject|1|||
42327500|NCT02185040|76165278|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
42327501|NCT02185040|76165279|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
42327502|NCT02185040|76165280|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
42327503|NCT02185040|76165281|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
42327504|NCT02185040|76165282|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
42327505|NCT02185040|76165283|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
42327506|NCT02185040|76165284|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
42327507|NCT02185040|76165278|FG000|Part 1 Treatment Phase|Adverse Event|1|||
42327508|NCT02185040|76165279|FG001|Part 1 Treatment Phase|Adverse Event|0|||
42327509|NCT02185040|76165280|FG002|Part 1 Treatment Phase|Adverse Event|0|||
42327510|NCT02185040|76165281|FG003|Part 1 Treatment Phase|Adverse Event|2|||
42327511|NCT02185040|76165282|FG004|Part 1 Treatment Phase|Adverse Event|3|||
42327512|NCT02185040|76165283|FG005|Part 1 Treatment Phase|Adverse Event|0|||
42327513|NCT02185040|76165284|FG006|Part 1 Treatment Phase|Adverse Event|0|||
42327514|NCT02185040|76165278|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
42327515|NCT02185040|76165279|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
42327516|NCT02185040|76165280|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
42327517|NCT02185040|76165281|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
42327518|NCT02185040|76165282|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
42327519|NCT02185040|76165283|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
42327520|NCT02185040|76165284|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
41996570|NCT01130272|75804529|FG001|Overall Study|Sponsor decision|15|||
41996571|NCT01130272|75804530|FG002|Overall Study|Sponsor decision|16|||
42261735|NCT02720523|76089210|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
42261736|NCT02720523|76089211|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
42261737|NCT02720523|76089212|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
42261738|NCT02720523|76089213|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
42261739|NCT02720523|76089207|FG000|Period 2: Long-term Extension Period|Other|0|||
42261740|NCT02720523|76089208|FG001|Period 2: Long-term Extension Period|Other|0|||
42261741|NCT02720523|76089209|FG002|Period 2: Long-term Extension Period|Other|0|||
42261742|NCT02720523|76089210|FG003|Period 2: Long-term Extension Period|Other|0|||
42261743|NCT02720523|76089211|FG004|Period 2: Long-term Extension Period|Other|2|||
42261744|NCT02720523|76089212|FG005|Period 2: Long-term Extension Period|Other|0|||
42261745|NCT02720523|76089213|FG006|Period 2: Long-term Extension Period|Other|3|||
42261746|NCT02646332|76089228|FG000|Overall Study|Lost to Follow-up|0|||
42261747|NCT02646332|76089229|FG001|Overall Study|Lost to Follow-up|3|||
42261748|NCT02471716|76089240|FG000|Overall Study|Withdrawal by Subject|0|||
42261749|NCT02471716|76089241|FG001|Overall Study|Withdrawal by Subject|1|||
42261750|NCT02471716|76089242|FG002|Overall Study|Withdrawal by Subject|0|||
42261751|NCT02471716|76089243|FG003|Overall Study|Withdrawal by Subject|2|||
42327521|NCT02185040|76165278|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
42327522|NCT02185040|76165279|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
42327523|NCT02185040|76165280|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
41996572|NCT01130272|75804531|FG003|Overall Study|Sponsor decision|13|||
41996573|NCT01130272|75804532|FG004|Overall Study|Sponsor decision|16|||
41996574|NCT01130272|75804528|FG000|Overall Study|Study arm discontinued|38|||
41996575|NCT01130272|75804529|FG001|Overall Study|Study arm discontinued|0|||
42261752|NCT02471716|76089244|FG004|Overall Study|Withdrawal by Subject|5|||
42327524|NCT02185040|76165281|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
42327525|NCT02185040|76165282|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
42327526|NCT02185040|76165283|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
42327527|NCT02185040|76165284|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
42327528|NCT02185040|76165278|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
42327529|NCT02185040|76165279|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
41996576|NCT01130272|75804530|FG002|Overall Study|Study arm discontinued|0|||
41996577|NCT01130272|75804531|FG003|Overall Study|Study arm discontinued|0|||
42261753|NCT02471716|76089240|FG000|Overall Study|Study Terminiated by sponsor|0|||
42261754|NCT02471716|76089241|FG001|Overall Study|Study Terminiated by sponsor|0|||
41996578|NCT01130272|75804532|FG004|Overall Study|Study arm discontinued|0|||
41996579|NCT01129960|75804548|FG000|Overall Study|Withdrawal by Subject|3|||
41996580|NCT01129960|75804549|FG001|Overall Study|Withdrawal by Subject|0|||
41996581|NCT01129960|75804550|FG002|Overall Study|Withdrawal by Subject|3|||
41996582|NCT01129960|75804551|FG003|Overall Study|Withdrawal by Subject|2|||
41996583|NCT01129960|75804548|FG000|Overall Study|Lack of Efficacy|1|||
41996584|NCT01129960|75804549|FG001|Overall Study|Lack of Efficacy|1|||
41996585|NCT01129960|75804550|FG002|Overall Study|Lack of Efficacy|1|||
41996586|NCT01129960|75804551|FG003|Overall Study|Lack of Efficacy|1|||
41996587|NCT01129960|75804548|FG000|Overall Study|Adverse Event|23|||
41996588|NCT01129960|75804549|FG001|Overall Study|Adverse Event|16|||
41996589|NCT01129960|75804550|FG002|Overall Study|Adverse Event|16|||
41996590|NCT01129960|75804551|FG003|Overall Study|Adverse Event|7|||
41996591|NCT01129960|75804548|FG000|Overall Study|Protocol Violation|1|||
41996592|NCT01129960|75804549|FG001|Overall Study|Protocol Violation|2|||
41996593|NCT01129960|75804550|FG002|Overall Study|Protocol Violation|3|||
41996594|NCT01129960|75804551|FG003|Overall Study|Protocol Violation|0|||
41996595|NCT01129960|75804548|FG000|Overall Study|Lost to Follow-up|0|||
41996596|NCT01129960|75804549|FG001|Overall Study|Lost to Follow-up|2|||
41996597|NCT01129960|75804550|FG002|Overall Study|Lost to Follow-up|3|||
41996598|NCT01129960|75804551|FG003|Overall Study|Lost to Follow-up|3|||
41996599|NCT01129960|75804548|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
41996600|NCT01129960|75804549|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
42261755|NCT02471716|76089242|FG002|Overall Study|Study Terminiated by sponsor|0|||
42261756|NCT02471716|76089243|FG003|Overall Study|Study Terminiated by sponsor|1|||
42261757|NCT02471716|76089244|FG004|Overall Study|Study Terminiated by sponsor|0|||
42261758|NCT02471716|76089240|FG000|Overall Study|Lost to Follow-up|0|||
42034444|NCT01121393|75842538|FG000|Overall Study|Progressive disease|201|||
42034445|NCT01121393|75842539|FG001|Overall Study|Progressive disease|20|||
42034446|NCT01121393|75842538|FG000|Overall Study|Other Adverse events|24|||
42034447|NCT01121393|75842539|FG001|Overall Study|Other Adverse events|45|||
42034448|NCT01121393|75842538|FG000|Overall Study|Non-compliant with protocol|0|||
42034449|NCT01121393|75842539|FG001|Overall Study|Non-compliant with protocol|3|||
42261759|NCT02471716|76089241|FG001|Overall Study|Lost to Follow-up|0|||
42261760|NCT02471716|76089242|FG002|Overall Study|Lost to Follow-up|0|||
42261761|NCT02471716|76089243|FG003|Overall Study|Lost to Follow-up|3|||
42327530|NCT02185040|76165280|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
42327531|NCT02185040|76165281|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
42327532|NCT02185040|76165282|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
42327533|NCT02185040|76165283|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
42327534|NCT02185040|76165284|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
42327535|NCT02185040|76165278|FG000|Active Treatment Extension Phase|Adverse Event|0|||
42327536|NCT02185040|76165279|FG001|Active Treatment Extension Phase|Adverse Event|0|||
42327537|NCT02185040|76165280|FG002|Active Treatment Extension Phase|Adverse Event|0|||
42327538|NCT02185040|76165281|FG003|Active Treatment Extension Phase|Adverse Event|0|||
42327539|NCT02185040|76165282|FG004|Active Treatment Extension Phase|Adverse Event|0|||
42327540|NCT02185040|76165283|FG005|Active Treatment Extension Phase|Adverse Event|1|||
42327541|NCT02185040|76165284|FG006|Active Treatment Extension Phase|Adverse Event|4|||
42327542|NCT02185040|76165278|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
42327543|NCT02185040|76165279|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
42327544|NCT02185040|76165280|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
42327545|NCT02185040|76165281|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
42327546|NCT02185040|76165282|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
42327547|NCT02185040|76165283|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
42327548|NCT02185040|76165284|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
42327549|NCT02185040|76165278|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
42327550|NCT02185040|76165279|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
42327551|NCT02185040|76165280|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
42327552|NCT02185040|76165281|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
42261762|NCT02471716|76089244|FG004|Overall Study|Lost to Follow-up|2|||
42261763|NCT02471716|76089240|FG000|Overall Study|Death|0|||
42261764|NCT02471716|76089241|FG001|Overall Study|Death|0|||
42261765|NCT02471716|76089242|FG002|Overall Study|Death|0|||
42261766|NCT02471716|76089243|FG003|Overall Study|Death|1|||
42261767|NCT02471716|76089244|FG004|Overall Study|Death|0|||
42327553|NCT02185040|76165282|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
41996601|NCT01129960|75804550|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
41996602|NCT01129960|75804551|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
41996603|NCT01129960|75804548|FG000|Overall Study|Physician Decision|1|||
41996604|NCT01129960|75804549|FG001|Overall Study|Physician Decision|0|||
42034450|NCT01121393|75842538|FG000|Overall Study|Lost to Follow-up|1|||
42034451|NCT01121393|75842539|FG001|Overall Study|Lost to Follow-up|0|||
42261768|NCT02471716|76089240|FG000|Overall Study|Other|0|||
41996605|NCT01129960|75804550|FG002|Overall Study|Physician Decision|0|||
41996606|NCT01129960|75804551|FG003|Overall Study|Physician Decision|0|||
41996607|NCT01129960|75804548|FG000|Overall Study|Pregnancy|1|||
41996608|NCT01129960|75804549|FG001|Overall Study|Pregnancy|0|||
41996609|NCT01129960|75804550|FG002|Overall Study|Pregnancy|0|||
41996610|NCT01129960|75804551|FG003|Overall Study|Pregnancy|0|||
41996611|NCT01129921|75804563|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
41996612|NCT01129921|75804564|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
42034452|NCT01121393|75842538|FG000|Overall Study|Refused cont. medication|7|||
42034453|NCT01121393|75842539|FG001|Overall Study|Refused cont. medication|7|||
42034454|NCT01121393|75842538|FG000|Overall Study|Not treated|3|||
42034455|NCT01121393|75842539|FG001|Overall Study|Not treated|9|||
42034456|NCT01121393|75842538|FG000|Overall Study|Other than listed|6|||
42034457|NCT01121393|75842539|FG001|Overall Study|Other than listed|0|||
42261769|NCT02471716|76089241|FG001|Overall Study|Other|0|||
42261770|NCT02471716|76089242|FG002|Overall Study|Other|0|||
42261771|NCT02471716|76089243|FG003|Overall Study|Other|8|||
42261772|NCT02471716|76089244|FG004|Overall Study|Other|9|||
42261773|NCT01370863|76089260|FG000|Overall Study|Adverse Event|1|||
42261774|NCT01370863|76089261|FG001|Overall Study|Adverse Event|1|||
42261775|NCT01370863|76089260|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
42261776|NCT01370863|76089261|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
42261777|NCT01370863|76089260|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
42034458|NCT00937521|75842586|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
41996613|NCT01129921|75804563|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
41996614|NCT01129921|75804564|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
41996615|NCT01129921|75804563|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
41996616|NCT01129921|75804564|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
41996617|NCT01129921|75804563|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
41996618|NCT01129921|75804564|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
41996619|NCT01129882|75804583|FG000|Overall Study|Adverse Event|39|||
41996620|NCT01129882|75804583|FG000|Overall Study|Death|6|||
41996621|NCT01129882|75804583|FG000|Overall Study|Lack of Efficacy|5|||
41996622|NCT01129882|75804583|FG000|Overall Study|Lost to Follow-up|13|||
41996623|NCT01129882|75804583|FG000|Overall Study|Physician Decision|27|||
41996624|NCT01129882|75804583|FG000|Overall Study|Protocol Deviation|3|||
41996625|NCT01129882|75804583|FG000|Overall Study|Withdrawal Criteria Met|19|||
41996626|NCT01129882|75804583|FG000|Overall Study|Trial Termination by Sponsor|6|||
41996627|NCT01129882|75804583|FG000|Overall Study|Withdrawal by Subject|160|||
41996628|NCT01129102|75804590|FG000|Overall Study|No study drug treatment|2|||
41996629|NCT01129102|75804591|FG001|Overall Study|No study drug treatment|3|||
42327554|NCT02185040|76165283|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
42327555|NCT02185040|76165284|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
42327556|NCT02161406|76165306|FG000|Overall Study|Death|2|||
42327557|NCT02161406|76165307|FG001|Overall Study|Death|1|||
42034459|NCT00937521|75842587|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
42034460|NCT00937521|75842588|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
42034461|NCT00937521|75842589|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
42034462|NCT00937521|75842590|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
42034463|NCT00937521|75842591|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
42034464|NCT00937521|75842592|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
42034465|NCT00937521|75842593|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
41996630|NCT01129102|75804592|FG002|Overall Study|No study drug treatment|1|||
41996631|NCT01129102|75804590|FG000|Overall Study|Withdrawal by Subject|2|||
41996632|NCT01129102|75804591|FG001|Overall Study|Withdrawal by Subject|0|||
41996633|NCT01129102|75804592|FG002|Overall Study|Withdrawal by Subject|3|||
41996634|NCT01129102|75804590|FG000|Overall Study|Protocol Violation|0|||
41996635|NCT01129102|75804591|FG001|Overall Study|Protocol Violation|1|||
41996636|NCT01129102|75804592|FG002|Overall Study|Protocol Violation|1|||
41996637|NCT01129102|75804590|FG000|Overall Study|Pregnancy|0|||
41996638|NCT01129102|75804591|FG001|Overall Study|Pregnancy|0|||
41996639|NCT01129102|75804592|FG002|Overall Study|Pregnancy|1|||
41996640|NCT01129102|75804590|FG000|Overall Study|Adverse Event|2|||
41996641|NCT01129102|75804591|FG001|Overall Study|Adverse Event|2|||
41996642|NCT01129102|75804592|FG002|Overall Study|Adverse Event|1|||
41996643|NCT01129102|75804590|FG000|Overall Study|Lost to Follow-up|2|||
41996644|NCT01129102|75804591|FG001|Overall Study|Lost to Follow-up|0|||
41996645|NCT01129102|75804592|FG002|Overall Study|Lost to Follow-up|0|||
41996646|NCT01129024|75804599|FG000|Overall Study|Physician Decision|5|||
41996647|NCT01129024|75804599|FG000|Overall Study|Study Terminated by Sponsor|8|||
41996648|NCT01129024|75804599|FG000|Overall Study|Withdrawal by Subject|2|||
41996649|NCT01129024|75804599|FG000|Overall Study|Lack of Efficacy|3|||
41996650|NCT01129024|75804599|FG000|Overall Study|Needed a Platelet Transfusion|1|||
41996651|NCT01128946|75804603|FG000|Period I|Protocol Violation|0|||
41996652|NCT01128946|75804604|FG001|Period I|Protocol Violation|1|||
41996653|NCT01128946|75804605|FG002|Period I|Protocol Violation|0|||
41996654|NCT01128946|75804606|FG003|Period I|Protocol Violation|0|||
41996655|NCT01128946|75804603|FG000|Period I|Withdrawal by Subject|0|||
41996656|NCT01128946|75804604|FG001|Period I|Withdrawal by Subject|0|||
41996657|NCT01128946|75804605|FG002|Period I|Withdrawal by Subject|1|||
41996658|NCT01128946|75804606|FG003|Period I|Withdrawal by Subject|1|||
41996659|NCT01128946|75804603|FG000|Period II|Protocol Violation|0|||
41996660|NCT01128946|75804604|FG001|Period II|Protocol Violation|1|||
42034466|NCT00937521|75842586|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
42034467|NCT00937521|75842587|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
42327558|NCT02161406|76165306|FG000|Overall Study|Lost to Follow-up|2|||
41996661|NCT01128946|75804605|FG002|Period II|Protocol Violation|0|||
41996662|NCT01128946|75804606|FG003|Period II|Protocol Violation|0|||
41996663|NCT01128946|75804603|FG000|Period II|Withdrawal by Subject|0|||
41996664|NCT01128946|75804604|FG001|Period II|Withdrawal by Subject|0|||
41996665|NCT01128946|75804605|FG002|Period II|Withdrawal by Subject|0|||
41996666|NCT01128946|75804606|FG003|Period II|Withdrawal by Subject|1|||
41996667|NCT01128946|75804603|FG000|Period III|Protocol Violation|1|||
41996668|NCT01128946|75804604|FG001|Period III|Protocol Violation|0|||
41996669|NCT01128946|75804605|FG002|Period III|Protocol Violation|0|||
41996670|NCT01128946|75804606|FG003|Period III|Protocol Violation|0|||
41996671|NCT01128595|75804617|FG000|Treatment Period 3|Withdrawal by Subject|0|||
41996672|NCT01128595|75804618|FG001|Treatment Period 3|Withdrawal by Subject|1|||
41996673|NCT01128595|75804619|FG002|Treatment Period 3|Withdrawal by Subject|0|||
41996674|NCT01128595|75804620|FG003|Treatment Period 3|Withdrawal by Subject|0|||
41996675|NCT01129336|75804633|FG000|Overall Study|Protocol Violation|1|||
41996676|NCT01129336|75804634|FG001|Overall Study|Protocol Violation|0|||
41996677|NCT01129336|75804633|FG000|Overall Study|Disease Progression|1|||
41996678|NCT01129336|75804634|FG001|Overall Study|Disease Progression|4|||
41996679|NCT01129336|75804633|FG000|Overall Study|Lost to Follow-up|1|||
41996680|NCT01129336|75804634|FG001|Overall Study|Lost to Follow-up|0|||
41996681|NCT01129336|75804633|FG000|Overall Study|Withdrawal by Subject|7|||
41996682|NCT01129336|75804634|FG001|Overall Study|Withdrawal by Subject|4|||
41996683|NCT01129336|75804633|FG000|Overall Study|Adverse Event|0|||
41996684|NCT01129336|75804634|FG001|Overall Study|Adverse Event|1|||
41996685|NCT01129336|75804633|FG000|Overall Study|Missing Study Completion Status|2|||
41996686|NCT01129336|75804634|FG001|Overall Study|Missing Study Completion Status|3|||
41996687|NCT01129336|75804633|FG000|Overall Study|Death|0|||
42327559|NCT02161406|76165307|FG001|Overall Study|Lost to Follow-up|1|||
42327560|NCT02161406|76165306|FG000|Overall Study|Withdrawal by Subject|2|||
42327561|NCT02161406|76165307|FG001|Overall Study|Withdrawal by Subject|4|||
42327562|NCT02161406|76165306|FG000|Overall Study|investigator withdrew subject|3|||
42327563|NCT02161406|76165307|FG001|Overall Study|investigator withdrew subject|1|||
42327564|NCT02161406|76165306|FG000|Overall Study|Lack of Efficacy|1|||
42327565|NCT02161406|76165307|FG001|Overall Study|Lack of Efficacy|1|||
42327566|NCT02161406|76165306|FG000|Overall Study|relocation|0|||
42327567|NCT02161406|76165307|FG001|Overall Study|relocation|1|||
41996688|NCT01129336|75804634|FG001|Overall Study|Death|4|||
41996689|NCT01128400|75804643|FG000|Overall Study|Lost to Follow-up|1|||
41996690|NCT01128400|75804644|FG001|Overall Study|Lost to Follow-up|0|||
41996691|NCT01128400|75804645|FG002|Overall Study|Lost to Follow-up|1|||
41996692|NCT01128400|75804643|FG000|Overall Study|Screening failure|1|||
41996693|NCT01128400|75804644|FG001|Overall Study|Screening failure|0|||
41996694|NCT01128400|75804645|FG002|Overall Study|Screening failure|0|||
41996695|NCT01128400|75804643|FG000|Overall Study|were not invited to participate on taste|0|||
41996696|NCT01128400|75804644|FG001|Overall Study|were not invited to participate on taste|0|||
41996697|NCT01128400|75804645|FG002|Overall Study|were not invited to participate on taste|15|||
41996698|NCT01128400|75804643|FG000|Overall Study|Excluded due to sinus problems|0|||
41996699|NCT01128400|75804644|FG001|Overall Study|Excluded due to sinus problems|1|||
41996700|NCT01128400|75804645|FG002|Overall Study|Excluded due to sinus problems|0|||
41996701|NCT01128361|75804655|FG000|Overall Study|Lost to Follow-up|0|||
41996702|NCT01128361|75804656|FG001|Overall Study|Lost to Follow-up|1|||
41996703|NCT01128361|75804655|FG000|Overall Study|Withdrawal by Subject|5|||
41996704|NCT01128361|75804656|FG001|Overall Study|Withdrawal by Subject|2|||
41996705|NCT01128244|75804662|FG000|Overall Study|Adverse Event|1|||
41996706|NCT01128244|75804662|FG000|Overall Study|Scheduling conflict|2|||
41996707|NCT01127893|75804670|FG000|Overall Study|Study Termination by the Sponsor|1|||
41996708|NCT01126879|75804676|FG000|Overall Study|Progressive Disease|3|||
41996709|NCT01126879|75804677|FG001|Overall Study|Progressive Disease|1|||
41996710|NCT01126879|75804676|FG000|Overall Study|Withdrawal by Subject|1|||
41996711|NCT01126879|75804677|FG001|Overall Study|Withdrawal by Subject|0|||
41996712|NCT01126879|75804676|FG000|Overall Study|Adverse Event|0|||
41996713|NCT01126879|75804677|FG001|Overall Study|Adverse Event|1|||
41996714|NCT01126879|75804676|FG000|Overall Study|Physician Decision|1|||
41996715|NCT01126879|75804677|FG001|Overall Study|Physician Decision|0|||
41996716|NCT01126060|75804685|FG000|Overall Study|Protocol Violation|0|||
42327568|NCT02161016|76165313|FG000|Overall Study|withdrawn by IRB|1|||
42327569|NCT01573000|76165319|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
42327570|NCT01573000|76165320|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
42327571|NCT01573000|76165319|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
42327572|NCT01573000|76165320|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
41996717|NCT01126060|75804686|FG001|Overall Study|Protocol Violation|2|||
41996718|NCT01125748|75804694|FG000|Overall Study|Adverse Event|0|||
41996719|NCT01125748|75804695|FG001|Overall Study|Adverse Event|2|||
41996720|NCT01125748|75804694|FG000|Overall Study|Lost to Follow-up|0|||
41996721|NCT01125748|75804695|FG001|Overall Study|Lost to Follow-up|1|||
41996722|NCT01125748|75804694|FG000|Overall Study|Physician Decision|8|||
41996723|NCT01125748|75804695|FG001|Overall Study|Physician Decision|7|||
42327573|NCT01573000|76165319|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
42327574|NCT01573000|76165320|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
42327575|NCT01573000|76165319|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
41996724|NCT01125748|75804694|FG000|Overall Study|Patient Decision to Withdraw|2|||
41996725|NCT01125748|75804695|FG001|Overall Study|Patient Decision to Withdraw|4|||
41996726|NCT01125514|75804701|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
41996727|NCT01125514|75804701|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
41996728|NCT01125514|75804701|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
41996729|NCT01125514|75804701|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
41996730|NCT01125514|75804701|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
41996731|NCT01125514|75804701|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
41996732|NCT01125358|75804719|FG000|Overall Study|Adverse Event|3|||
42327576|NCT01573000|76165320|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
42327577|NCT01573000|76165319|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
42327578|NCT01573000|76165320|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
42327579|NCT01573000|76165319|FG000|Crossover Phase|Lack of Efficacy|0|||
42327580|NCT01573000|76165320|FG001|Crossover Phase|Lack of Efficacy|13|||
42327581|NCT01573000|76165319|FG000|Crossover Phase|Lost to Follow-up|0|||
42327582|NCT01573000|76165320|FG001|Crossover Phase|Lost to Follow-up|2|||
42327583|NCT01573000|76165319|FG000|Crossover Phase|Death|0|||
42327584|NCT01573000|76165320|FG001|Crossover Phase|Death|3|||
41996733|NCT01125358|75804720|FG001|Overall Study|Adverse Event|0|||
41996734|NCT01125358|75804721|FG002|Overall Study|Adverse Event|0|||
41996735|NCT01125358|75804722|FG003|Overall Study|Adverse Event|2|||
41996736|NCT01125358|75804719|FG000|Overall Study|Perceived Lack of Efficacy|6|||
41996737|NCT01125358|75804720|FG001|Overall Study|Perceived Lack of Efficacy|3|||
41996738|NCT01125358|75804721|FG002|Overall Study|Perceived Lack of Efficacy|7|||
41996739|NCT01125358|75804722|FG003|Overall Study|Perceived Lack of Efficacy|4|||
41996740|NCT01125358|75804719|FG000|Overall Study|Protocol Violation|1|||
41996741|NCT01125358|75804720|FG001|Overall Study|Protocol Violation|0|||
41996742|NCT01125358|75804721|FG002|Overall Study|Protocol Violation|0|||
41996743|NCT01125358|75804722|FG003|Overall Study|Protocol Violation|0|||
42327585|NCT01573000|76165319|FG000|Long-Term Follow-Up|Death|3|||
42327586|NCT01573000|76165320|FG001|Long-Term Follow-Up|Death|0|||
42327587|NCT01573000|76165319|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
42327588|NCT01573000|76165320|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
42327589|NCT01572922|76165330|FG000|Overall Study|Adverse Event|1|||
42327590|NCT01572922|76165330|FG000|Overall Study|Protocol Violation|1|||
42327591|NCT01572922|76165330|FG000|Overall Study|Death|1|||
42327592|NCT01572844|76165339|FG000|Overall Study|Physician Decision|1|||
42327593|NCT01572844|76165340|FG001|Overall Study|Physician Decision|1|||
42327594|NCT01557400|76165349|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
42327595|NCT01557400|76165349|FG000|Overall Study|Adverse Event|3|||
42327596|NCT01557400|76165349|FG000|Overall Study|Lost to Follow-up|5|||
42327597|NCT01557400|76165349|FG000|Overall Study|Withdrawal by Subject|9|||
42327598|NCT01533922|76165353|FG000|Overall Study|Adverse Event|5|||
42327599|NCT01533922|76165354|FG001|Overall Study|Adverse Event|8|||
42327600|NCT01533922|76165355|FG002|Overall Study|Adverse Event|6|||
42327601|NCT01533922|76165356|FG003|Overall Study|Adverse Event|3|||
42327602|NCT01533922|76165357|FG004|Overall Study|Adverse Event|4|||
42327603|NCT01533922|76165353|FG000|Overall Study|Lack of Efficacy|0|||
42327604|NCT01533922|76165354|FG001|Overall Study|Lack of Efficacy|0|||
42327605|NCT01533922|76165355|FG002|Overall Study|Lack of Efficacy|1|||
42327606|NCT01533922|76165356|FG003|Overall Study|Lack of Efficacy|0|||
41996744|NCT01125358|75804719|FG000|Overall Study|Sponsor Decision|0|||
41996745|NCT01125358|75804720|FG001|Overall Study|Sponsor Decision|0|||
41996746|NCT01125358|75804721|FG002|Overall Study|Sponsor Decision|1|||
42327607|NCT01533922|76165357|FG004|Overall Study|Lack of Efficacy|0|||
42327608|NCT01533922|76165353|FG000|Overall Study|Protocol Violation|0|||
42327609|NCT01533922|76165354|FG001|Overall Study|Protocol Violation|3|||
41996747|NCT01125358|75804722|FG003|Overall Study|Sponsor Decision|1|||
41996748|NCT01125358|75804719|FG000|Overall Study|Withdrawal by Subject|2|||
41996749|NCT01125358|75804720|FG001|Overall Study|Withdrawal by Subject|1|||
41996750|NCT01125358|75804721|FG002|Overall Study|Withdrawal by Subject|1|||
41996751|NCT01125358|75804722|FG003|Overall Study|Withdrawal by Subject|1|||
41996752|NCT01125046|75804732|FG000|First 6 Months of Treatment|Death|1|||
41996753|NCT01125046|75804732|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
42327610|NCT01533922|76165355|FG002|Overall Study|Protocol Violation|0|||
42327611|NCT01533922|76165356|FG003|Overall Study|Protocol Violation|0|||
42327612|NCT01533922|76165357|FG004|Overall Study|Protocol Violation|1|||
41996754|NCT01125046|75804732|FG000|First 6 Months of Treatment|Non-compliance|1|||
41996755|NCT01125046|75804732|FG000|First 6 Months of Treatment|Surgery|1|||
41996756|NCT01125046|75804732|FG000|First 6 Months of Treatment|Progressive Disease|7|||
42327613|NCT01533922|76165353|FG000|Overall Study|Withdrawal by Subject|3|||
42327614|NCT01533922|76165354|FG001|Overall Study|Withdrawal by Subject|1|||
42327615|NCT01533922|76165355|FG002|Overall Study|Withdrawal by Subject|2|||
42327616|NCT01533922|76165356|FG003|Overall Study|Withdrawal by Subject|2|||
42327617|NCT01533922|76165357|FG004|Overall Study|Withdrawal by Subject|1|||
42327618|NCT01533922|76165353|FG000|Overall Study|Other reason not defined above|2|||
42327619|NCT01533922|76165354|FG001|Overall Study|Other reason not defined above|0|||
42327620|NCT01533922|76165355|FG002|Overall Study|Other reason not defined above|1|||
42327621|NCT01533922|76165356|FG003|Overall Study|Other reason not defined above|0|||
41996757|NCT01125046|75804732|FG000|First 6 Months of Treatment|Adverse Event|2|||
41996758|NCT01125046|75804732|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
41996759|NCT01125046|75804732|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
41996760|NCT01125046|75804732|FG000|Follow-up/Data Cut Off Point|Death|29|||
41996761|NCT01125046|75804732|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
41996762|NCT01124734|75804736|FG000|Overall Study|Disease progression|13|||
41996763|NCT01124734|75804736|FG000|Overall Study|Adverse Event|1|||
41996764|NCT01124734|75804736|FG000|Overall Study|Withdrawal by Subject|1|||
41996765|NCT01124734|75804736|FG000|Overall Study|Elected for alternative treatment|2|||
41996766|NCT01124617|75804747|FG000|Overall Study|Adverse Event|5|||
41996767|NCT01124617|75804748|FG001|Overall Study|Adverse Event|2|||
41996768|NCT01124617|75804747|FG000|Overall Study|Lack of Efficacy|2|||
41996769|NCT01124617|75804748|FG001|Overall Study|Lack of Efficacy|1|||
41996770|NCT01124617|75804747|FG000|Overall Study|Protocol Violation|1|||
42327622|NCT01533922|76165357|FG004|Overall Study|Other reason not defined above|0|||
42327623|NCT01533688|76165372|FG000|Overall Study|Withdrawal by Subject|5|||
42327624|NCT01533688|76165373|FG001|Overall Study|Withdrawal by Subject|4|||
42327625|NCT01533688|76165374|FG002|Overall Study|Withdrawal by Subject|3|||
42327626|NCT01533688|76165372|FG000|Overall Study|Medically unstable|1|||
42327627|NCT01533688|76165373|FG001|Overall Study|Medically unstable|3|||
42327628|NCT01533688|76165374|FG002|Overall Study|Medically unstable|3|||
42327629|NCT01533688|76165372|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
42327630|NCT01533688|76165373|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
42327631|NCT01533688|76165374|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
42327632|NCT01532986|76165386|FG000|Overall Study|Death|9|||
42327633|NCT01532986|76165387|FG001|Overall Study|Death|9|||
42327634|NCT01532986|76165386|FG000|Overall Study|Withdrawal by Subject|7|||
42327635|NCT01532986|76165387|FG001|Overall Study|Withdrawal by Subject|10|||
42327636|NCT01532986|76165386|FG000|Overall Study|Physician Decision|7|||
42327637|NCT01532986|76165387|FG001|Overall Study|Physician Decision|5|||
42327638|NCT01532908|76165396|FG000|Overall Study|Not Transplanted|1|||
42327639|NCT01532908|76165397|FG001|Overall Study|Not Transplanted|0|||
42327640|NCT02160782|76165403|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
42327641|NCT02160782|76165404|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
42327642|NCT02160782|76165405|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
42327643|NCT02160782|76165406|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
42327644|NCT02160782|76165407|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
42327645|NCT02160782|76165403|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
42327646|NCT02160782|76165404|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
42327647|NCT02160782|76165405|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
42327648|NCT02160782|76165406|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
42327649|NCT02160782|76165407|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
42327650|NCT02160782|76165403|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
42327651|NCT02160782|76165404|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
41996771|NCT01124617|75804748|FG001|Overall Study|Protocol Violation|1|||
41996772|NCT01124617|75804747|FG000|Overall Study|Withdrawal by Subject|9|||
41996773|NCT01124617|75804748|FG001|Overall Study|Withdrawal by Subject|1|||
42327652|NCT02160782|76165405|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
42327653|NCT02160782|76165406|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
42327654|NCT02160782|76165407|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
42327655|NCT02160782|76165403|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
42327656|NCT02160782|76165404|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
42327657|NCT02160782|76165405|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
41996774|NCT01124617|75804747|FG000|Overall Study|Other|2|||
41996775|NCT01124617|75804748|FG001|Overall Study|Other|1|||
41996776|NCT01124422|75804756|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
41996777|NCT01124422|75804757|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
41996778|NCT01124422|75804758|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
41996779|NCT01124422|75804756|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
41996780|NCT01124422|75804757|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
41996781|NCT01124422|75804758|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
41996782|NCT01124422|75804756|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
41996783|NCT01124422|75804757|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
41996784|NCT01124422|75804758|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
41996785|NCT01124422|75804756|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
41996786|NCT01124422|75804757|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
41996787|NCT01124422|75804758|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
41996788|NCT01124422|75804756|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
41996789|NCT01124422|75804757|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
41996790|NCT01124422|75804758|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
42261778|NCT01370863|76089261|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
42261779|NCT02444182|76089269|FG000|Overall Study|non-compliance|2|||
42261780|NCT02444182|76089270|FG001|Overall Study|non-compliance|1|||
42261781|NCT02444182|76089269|FG000|Overall Study|Lost to Follow-up|0|||
42327658|NCT02160782|76165406|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
42261782|NCT02444182|76089270|FG001|Overall Study|Lost to Follow-up|4|||
42261783|NCT02471404|76089279|FG000|Overall Study|Adverse Event|7|||
42261784|NCT02471404|76089280|FG001|Overall Study|Adverse Event|1|||
42261785|NCT02471404|76089281|FG002|Overall Study|Adverse Event|2|||
42261786|NCT02471404|76089279|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
42261787|NCT02471404|76089280|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
42261788|NCT02471404|76089281|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
42261789|NCT02471404|76089279|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
42261790|NCT02471404|76089280|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
42261791|NCT02471404|76089281|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
42261792|NCT02471404|76089279|FG000|Overall Study|Lost to Follow-up|1|||
42261793|NCT02471404|76089280|FG001|Overall Study|Lost to Follow-up|1|||
42261794|NCT02471404|76089281|FG002|Overall Study|Lost to Follow-up|3|||
42261795|NCT02471404|76089279|FG000|Overall Study|Protocol Violation|1|||
42261796|NCT02471404|76089280|FG001|Overall Study|Protocol Violation|0|||
42261797|NCT02471404|76089281|FG002|Overall Study|Protocol Violation|0|||
42261798|NCT02471404|76089279|FG000|Overall Study|Withdrawal by Subject|8|||
42261799|NCT02471404|76089280|FG001|Overall Study|Withdrawal by Subject|4|||
42261800|NCT02471404|76089281|FG002|Overall Study|Withdrawal by Subject|5|||
42261801|NCT02471404|76089279|FG000|Overall Study|Other reasons not specified|10|||
42261802|NCT02471404|76089280|FG001|Overall Study|Other reasons not specified|7|||
42261803|NCT02471404|76089281|FG002|Overall Study|Other reasons not specified|12|||
42261804|NCT02471014|76089291|FG000|Overall Study|Lost to Follow-up|2|||
42261805|NCT02471014|76089292|FG001|Overall Study|Lost to Follow-up|2|||
42261806|NCT02413372|76089301|FG000|Treatment|Lost to Follow-up|0|||
42261807|NCT02413372|76089302|FG001|Treatment|Lost to Follow-up|2|||
42261808|NCT02413372|76089303|FG002|Treatment|Lost to Follow-up|1|||
42261809|NCT02413372|76089301|FG000|Treatment|Withdrawal by Subject|1|||
42261810|NCT02413372|76089302|FG001|Treatment|Withdrawal by Subject|0|||
42261811|NCT02413372|76089303|FG002|Treatment|Withdrawal by Subject|0|||
42261812|NCT02413372|76089301|FG000|Follow-up|Lost to Follow-up|1|||
42261813|NCT02413372|76089302|FG001|Follow-up|Lost to Follow-up|1|||
42261814|NCT02413372|76089303|FG002|Follow-up|Lost to Follow-up|0|||
42261815|NCT02413372|76089301|FG000|Follow-up|Subject Withdrew Consent|1|||
42261816|NCT02413372|76089302|FG001|Follow-up|Subject Withdrew Consent|0|||
42261817|NCT02413372|76089303|FG002|Follow-up|Subject Withdrew Consent|1|||
42261818|NCT02413372|76089301|FG000|Follow-up|Subject unable to return for visit|0|||
42261819|NCT02413372|76089302|FG001|Follow-up|Subject unable to return for visit|0|||
42261820|NCT02413372|76089303|FG002|Follow-up|Subject unable to return for visit|1|||
42261821|NCT02413294|76089311|FG000|Overall Study|Withdrawal by Subject|1|||
42261822|NCT02719353|76089324|FG000|First Intervention|Physician Decision|0|||
42261823|NCT02719353|76089325|FG001|First Intervention|Physician Decision|1|||
42261824|NCT01362062|76089334|FG000|Overall Study|Adverse Event|1|||
42261825|NCT01362062|76089335|FG001|Overall Study|Adverse Event|0|||
42261826|NCT01362062|76089334|FG000|Overall Study|Lost to Follow-up|11|||
42261827|NCT01362062|76089335|FG001|Overall Study|Lost to Follow-up|0|||
42261828|NCT01362062|76089334|FG000|Overall Study|Withdrawal by Subject|2|||
42261829|NCT01362062|76089335|FG001|Overall Study|Withdrawal by Subject|0|||
42327659|NCT02160782|76165407|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
42327660|NCT02160782|76165403|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
42327661|NCT02160782|76165404|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
42327662|NCT02160782|76165405|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
42261830|NCT01362062|76089334|FG000|Overall Study|Non-compliant participant|2|||
42261831|NCT01362062|76089335|FG001|Overall Study|Non-compliant participant|0|||
42261832|NCT01362062|76089334|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
42261833|NCT01362062|76089335|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
42261834|NCT01362062|76089334|FG000|Overall Study|Had significant improvement|9|||
42261835|NCT01362062|76089335|FG001|Overall Study|Had significant improvement|0|||
42261836|NCT01361594|76089342|FG000|Overall Study|Withdrawal by Subject|1|||
42261837|NCT01361594|76089343|FG001|Overall Study|Withdrawal by Subject|2|||
42261838|NCT02642432|76089349|FG000|Overall Study|Adverse Event|2|||
42261839|NCT02642432|76089349|FG000|Overall Study|Withdrew Consent|1|||
42261840|NCT02642432|76089349|FG000|Overall Study|Lost to Follow-up|2|||
41996791|NCT01124422|75804756|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
41996792|NCT01124422|75804757|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
41996793|NCT01124422|75804758|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
41996794|NCT01124422|75804756|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
41996795|NCT01124422|75804757|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
41996796|NCT01124422|75804758|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
41996797|NCT01124422|75804756|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
41996798|NCT01124422|75804757|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
41996799|NCT01124422|75804758|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
41996800|NCT01124422|75804756|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
41996801|NCT01124422|75804757|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
41996802|NCT01124422|75804758|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
41996803|NCT01124422|75804756|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
41996804|NCT01124422|75804757|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
41996805|NCT01124422|75804758|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
41996806|NCT01124149|75804765|FG000|Acute Phase|Withdrawal by Subject|22|||
41996807|NCT01124149|75804765|FG000|Acute Phase|Adverse Event|21|||
41996808|NCT01124149|75804765|FG000|Acute Phase|Lack of Efficacy|17|||
41996809|NCT01124149|75804765|FG000|Acute Phase|Protocol Violation|14|||
41996810|NCT01124149|75804765|FG000|Acute Phase|Lost to Follow-up|2|||
41996811|NCT01124149|75804765|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
41996812|NCT01124149|75804765|FG000|Acute Phase|Sponsor request|1|||
41996813|NCT01124149|75804765|FG000|Acute Phase|UC symptoms not ameliorated|1|||
41996814|NCT01124149|75804765|FG000|Acute Phase|Non-compliance|1|||
41996815|NCT01124149|75804765|FG000|Acute Phase|Low hemoglobin|1|||
41996816|NCT01124149|75804765|FG000|Acute Phase|Travelling to another country|1|||
41996817|NCT01124149|75804765|FG000|Acute Phase|Sponsor decision|1|||
41996818|NCT01124149|75804765|FG000|Maintenance Phase|Lack of Efficacy|40|||
41996819|NCT01124149|75804765|FG000|Maintenance Phase|Adverse Event|24|||
41996820|NCT01124149|75804765|FG000|Maintenance Phase|Lost to Follow-up|15|||
41996821|NCT01124149|75804765|FG000|Maintenance Phase|Withdrawal by Subject|10|||
41996822|NCT01124149|75804765|FG000|Maintenance Phase|Protocol Violation|5|||
41996823|NCT01124149|75804765|FG000|Maintenance Phase|Coordinator error|1|||
41996824|NCT01124149|75804765|FG000|Maintenance Phase|Non-compliance|1|||
41996825|NCT01123642|75804772|FG000|Overall Study|Lost to Follow-up|23|||
41996826|NCT01123642|75804772|FG000|Overall Study|Withdrawal by Subject|9|||
41996827|NCT01123642|75804772|FG000|Overall Study|ineligible at baseline assessment|36|||
41996828|NCT01122862|75804777|FG000|Period 1|Protocol Violation|0|||
41996829|NCT01122862|75804778|FG001|Period 1|Protocol Violation|1|||
41996830|NCT01122862|75804779|FG002|Period 1|Protocol Violation|0|||
41996831|NCT01122862|75804777|FG000|Period 2|Adverse Event|0|||
41996832|NCT01122862|75804778|FG001|Period 2|Adverse Event|0|||
41996833|NCT01122862|75804779|FG002|Period 2|Adverse Event|1|||
41996834|NCT01122394|75804790|FG000|Overall Study|Withdrawal by Subject|1|||
41996835|NCT01122394|75804791|FG001|Overall Study|Withdrawal by Subject|1|||
41996836|NCT01122394|75804790|FG000|Overall Study|Lost to Follow-up|2|||
41996837|NCT01122394|75804791|FG001|Overall Study|Lost to Follow-up|2|||
41996838|NCT01122394|75804790|FG000|Overall Study|Adverse Event|0|||
41996839|NCT01122394|75804791|FG001|Overall Study|Adverse Event|1|||
41996840|NCT01121926|75804799|FG000|First Intervention Period|Adverse Event|1|||
41996841|NCT01121926|75804800|FG001|First Intervention Period|Adverse Event|0|||
41996842|NCT01121926|75804799|FG000|Washout Period|Adverse Event|0|||
41996843|NCT01121926|75804800|FG001|Washout Period|Adverse Event|1|||
41996844|NCT01121926|75804799|FG000|Washout Period|Positive pregnancy test|0|||
41996845|NCT01121926|75804800|FG001|Washout Period|Positive pregnancy test|1|||
41996846|NCT01121575|75804821|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
41996847|NCT01121575|75804822|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
41996848|NCT01121575|75804823|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
42261841|NCT02642432|76089349|FG000|Overall Study|Other|3|||
42261842|NCT02640482|76089355|FG000|Overall Study|Lost to Follow-up|3|||
42261843|NCT02640482|76089356|FG001|Overall Study|Lost to Follow-up|0|||
41996849|NCT01121575|75804824|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
41996850|NCT01121575|75804825|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
41996851|NCT01121575|75804826|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
41996852|NCT01121575|75804821|FG000|Overall Study|Unspecified Reasons|8|||
41996853|NCT01121575|75804822|FG001|Overall Study|Unspecified Reasons|6|||
42261844|NCT02719743|76089367|FG000|Overall Study|Consent withdrawal|0|||
42261845|NCT02719743|76089368|FG001|Overall Study|Consent withdrawal|2|||
41996854|NCT01121575|75804823|FG002|Overall Study|Unspecified Reasons|7|||
41996855|NCT01121575|75804824|FG003|Overall Study|Unspecified Reasons|5|||
41996856|NCT01121575|75804825|FG004|Overall Study|Unspecified Reasons|13|||
41996857|NCT01121575|75804826|FG005|Overall Study|Unspecified Reasons|10|||
41996858|NCT01121575|75804821|FG000|Overall Study|Death|6|||
41996859|NCT01121575|75804822|FG001|Overall Study|Death|0|||
41996860|NCT01121575|75804823|FG002|Overall Study|Death|0|||
42261846|NCT02719743|76089369|FG002|Overall Study|Consent withdrawal|0|||
41996861|NCT01121575|75804824|FG003|Overall Study|Death|1|||
41996862|NCT01121575|75804825|FG004|Overall Study|Death|7|||
41996863|NCT01121575|75804826|FG005|Overall Study|Death|1|||
41996864|NCT01121536|75804849|FG000|Overall Study|Adverse Event|63|||
41996865|NCT01121536|75804849|FG000|Overall Study|Lack of Efficacy|35|||
41996866|NCT01121536|75804849|FG000|Overall Study|Withdrawal by Subject|65|||
41996867|NCT01121536|75804849|FG000|Overall Study|Protocol Violation|20|||
41996868|NCT01121536|75804849|FG000|Overall Study|Noncompliance with study medication|12|||
41996869|NCT01121536|75804849|FG000|Overall Study|Noncompliance with study procedures|9|||
41996870|NCT01121536|75804849|FG000|Overall Study|Lost to Follow-up|39|||
41996871|NCT01121536|75804849|FG000|Overall Study|Other|118|||
41996872|NCT01121263|75804855|FG000|Overall Study|Death|3|||
41996873|NCT01121263|75804856|FG001|Overall Study|Death|2|||
42327663|NCT02160782|76165406|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
42327664|NCT02160782|76165407|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
42327665|NCT02160782|76165403|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
42327666|NCT02160782|76165404|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
42327667|NCT02160782|76165405|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
42327668|NCT02160782|76165406|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
42327669|NCT02160782|76165407|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
42327670|NCT02160782|76165403|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
42327671|NCT02160782|76165404|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
42327672|NCT02160782|76165405|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
42327673|NCT02160782|76165406|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
42327674|NCT02160782|76165407|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
42327675|NCT02160626|76165434|FG000|Overall Study|Adverse Event|1|||
42327676|NCT02160626|76165435|FG001|Overall Study|Adverse Event|0|||
42327677|NCT02160626|76165436|FG002|Overall Study|Adverse Event|0|||
42327678|NCT02160626|76165434|FG000|Overall Study|Schedule not conducive to study visits|0|||
42327679|NCT02160626|76165435|FG001|Overall Study|Schedule not conducive to study visits|0|||
42327680|NCT02160626|76165436|FG002|Overall Study|Schedule not conducive to study visits|1|||
42327681|NCT02160626|76165434|FG000|Overall Study|Withdrawal by Subject|0|||
42327682|NCT02160626|76165435|FG001|Overall Study|Withdrawal by Subject|1|||
42327683|NCT02160626|76165436|FG002|Overall Study|Withdrawal by Subject|0|||
42327684|NCT02160314|76165448|FG000|Overall Study|Adverse Event|0|||
42327685|NCT02160314|76165449|FG001|Overall Study|Adverse Event|6|||
42327686|NCT02160314|76165448|FG000|Overall Study|Protocol Violation|0|||
42327687|NCT02160314|76165449|FG001|Overall Study|Protocol Violation|4|||
42327688|NCT02160314|76165448|FG000|Overall Study|Withdrawal by Subject|1|||
42327689|NCT02160314|76165449|FG001|Overall Study|Withdrawal by Subject|2|||
42327690|NCT02160314|76165448|FG000|Overall Study|Lost to Follow-up|0|||
42327691|NCT02160314|76165449|FG001|Overall Study|Lost to Follow-up|1|||
42327692|NCT02160002|76165457|FG000|Overall Study|Withdrawal by Subject|2|||
42327693|NCT02160002|76165458|FG001|Overall Study|Withdrawal by Subject|1|||
42327694|NCT02218268|76165464|FG000|24 Hour Washout|Physician Decision|11|||
42327695|NCT02218268|76165465|FG001|24 Hour Washout|Physician Decision|9|||
42327696|NCT02217878|76165473|FG000|Overall Study|required morphine due to chest pain|1|||
42327697|NCT02217878|76165474|FG001|Overall Study|required morphine due to chest pain|2|||
41996874|NCT01121263|75804855|FG000|Overall Study|Lost to Follow-up|22|||
41996875|NCT01121263|75804856|FG001|Overall Study|Lost to Follow-up|12|||
41996876|NCT01121263|75804855|FG000|Overall Study|Withdrawal by Subject|0|||
41996877|NCT01121263|75804856|FG001|Overall Study|Withdrawal by Subject|1|||
41996878|NCT01121185|75804866|FG000|Overall Study|Not infused|0|||
41996879|NCT01121185|75804867|FG001|Overall Study|Not infused|1|||
41996880|NCT01121185|75804866|FG000|Overall Study|Not transplanted|1|||
41996881|NCT01121185|75804867|FG001|Overall Study|Not transplanted|0|||
41996882|NCT01121146|75804875|FG000|Overall Study|Death|17|||
41996883|NCT01121146|75804876|FG001|Overall Study|Death|15|||
42261847|NCT02719743|76089370|FG003|Overall Study|Consent withdrawal|1|||
42261848|NCT02719743|76089371|FG004|Overall Study|Consent withdrawal|0|||
42261849|NCT02719743|76089367|FG000|Overall Study|Migrated/moved from study area|0|||
42261850|NCT02719743|76089368|FG001|Overall Study|Migrated/moved from study area|0|||
42261851|NCT02719743|76089369|FG002|Overall Study|Migrated/moved from study area|0|||
42261852|NCT02719743|76089370|FG003|Overall Study|Migrated/moved from study area|0|||
42261853|NCT02719743|76089371|FG004|Overall Study|Migrated/moved from study area|2|||
42261854|NCT02719743|76089367|FG000|Overall Study|Lost to Follow-up|1|||
42261855|NCT02719743|76089368|FG001|Overall Study|Lost to Follow-up|1|||
42261856|NCT02719743|76089369|FG002|Overall Study|Lost to Follow-up|0|||
42261857|NCT02719743|76089370|FG003|Overall Study|Lost to Follow-up|0|||
42261858|NCT02719743|76089371|FG004|Overall Study|Lost to Follow-up|0|||
41996884|NCT01121146|75804875|FG000|Overall Study|Adverse Event|2|||
41996885|NCT01121146|75804876|FG001|Overall Study|Adverse Event|11|||
41996886|NCT01121146|75804875|FG000|Overall Study|Lost to Follow-up|7|||
41996887|NCT01121146|75804876|FG001|Overall Study|Lost to Follow-up|16|||
42261859|NCT02641730|76089386|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
41996888|NCT01120756|75804885|FG000|Overall Study|Withdrawal by Subject|1|||
41996889|NCT01120756|75804886|FG001|Overall Study|Withdrawal by Subject|1|||
41996890|NCT01120717|75804894|FG000|Overall Study|Withdrawal by Subject|11|||
41996891|NCT01120717|75804895|FG001|Overall Study|Withdrawal by Subject|6|||
41996892|NCT01120717|75804894|FG000|Overall Study|Adverse Event|10|||
42327698|NCT02217878|76165473|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
42327699|NCT02217878|76165474|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
42327700|NCT02217566|76165480|FG000|Overall Study|Lost to Follow-up|2|||
42327701|NCT02217566|76165480|FG000|Overall Study|Death|3|||
42327702|NCT02217566|76165480|FG000|Overall Study|Early study termination|6|||
42327703|NCT02217410|76165487|FG000|Overall Study|Graft Loss|0|||
42327704|NCT02217410|76165488|FG001|Overall Study|Graft Loss|0|||
42327705|NCT02217410|76165489|FG002|Overall Study|Graft Loss|2|||
42327706|NCT02217410|76165487|FG000|Overall Study|Withdrawal by Subject|0|||
42327707|NCT02217410|76165488|FG001|Overall Study|Withdrawal by Subject|0|||
42327708|NCT02217410|76165489|FG002|Overall Study|Withdrawal by Subject|2|||
42327709|NCT02217410|76165487|FG000|Overall Study|Lost to Follow-up|0|||
42327710|NCT02217410|76165488|FG001|Overall Study|Lost to Follow-up|0|||
42327711|NCT02217410|76165489|FG002|Overall Study|Lost to Follow-up|1|||
42327712|NCT02217410|76165487|FG000|Overall Study|Lack of Efficacy|0|||
42327713|NCT02217410|76165488|FG001|Overall Study|Lack of Efficacy|1|||
42327714|NCT02217410|76165489|FG002|Overall Study|Lack of Efficacy|0|||
42034468|NCT00937521|75842588|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
42034469|NCT00937521|75842589|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
42034470|NCT00937521|75842590|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
42034471|NCT00937521|75842591|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
42327715|NCT02217410|76165487|FG000|Overall Study|Physician Decision|1|||
42327716|NCT02217410|76165488|FG001|Overall Study|Physician Decision|3|||
42327717|NCT02217410|76165489|FG002|Overall Study|Physician Decision|0|||
42327718|NCT02217332|76165502|FG000|Overall Study|Adverse Event|3|||
42327719|NCT02217332|76165502|FG000|Overall Study|Dose interruption >1 month|1|||
42327720|NCT02217332|76165502|FG000|Overall Study|Protocol Violation (eligibility)|1|||
42261860|NCT02641730|76089387|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
42261861|NCT02641730|76089388|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
42261862|NCT02641730|76089389|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
42261863|NCT02641730|76089390|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
42261864|NCT02641730|76089386|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
42261865|NCT02641730|76089387|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
42261866|NCT02641730|76089388|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
42261867|NCT02641730|76089389|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
42261868|NCT02641730|76089390|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
42261869|NCT02641730|76089386|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
42261870|NCT02641730|76089387|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
42261871|NCT02641730|76089388|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
42327721|NCT02217332|76165502|FG000|Overall Study|Withdrawal by Subject|1|||
42327722|NCT02217332|76165502|FG000|Overall Study|Lost to Follow-up|1|||
41996893|NCT01120717|75804895|FG001|Overall Study|Adverse Event|6|||
42034472|NCT00937521|75842592|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
42034473|NCT00937521|75842593|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
42034474|NCT00937521|75842586|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
42034475|NCT00937521|75842587|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
42034476|NCT00937521|75842588|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
42034477|NCT00937521|75842589|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
42034478|NCT00937521|75842590|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
42034479|NCT00937521|75842591|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
42034480|NCT00937521|75842592|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
42034481|NCT00937521|75842593|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
42261872|NCT02641730|76089389|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
42261873|NCT02641730|76089390|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
42327723|NCT02184572|76165508|FG000|Overall Study|Lost to Follow-up|29|||
42327724|NCT02184572|76165509|FG001|Overall Study|Lost to Follow-up|21|||
42327725|NCT02184572|76165508|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
42327726|NCT02184572|76165509|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
42327727|NCT02184572|76165508|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
42327728|NCT02184572|76165509|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
42327729|NCT02184572|76165508|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
42327730|NCT02184572|76165509|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
41996894|NCT01120717|75804894|FG000|Overall Study|Protocol Deviation|2|||
41996895|NCT01120717|75804895|FG001|Overall Study|Protocol Deviation|5|||
41996896|NCT01120717|75804894|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
41996897|NCT01120717|75804895|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
41996898|NCT01120717|75804894|FG000|Overall Study|Lost to Follow-up|2|||
41996899|NCT01120717|75804895|FG001|Overall Study|Lost to Follow-up|3|||
41996900|NCT01120717|75804894|FG000|Overall Study|Death|3|||
41996901|NCT01120717|75804895|FG001|Overall Study|Death|1|||
41996902|NCT01120717|75804894|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
41996903|NCT01120717|75804895|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
41996904|NCT01120600|75804903|FG000|Overall Study|Adverse Event|7|||
42034482|NCT00937521|75842586|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
42034483|NCT00937521|75842587|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
42261874|NCT02641730|76089386|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
42261875|NCT02641730|76089387|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
42261876|NCT02641730|76089388|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
42261877|NCT02641730|76089389|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
42261878|NCT02641730|76089390|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
42261879|NCT02641730|76089386|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
42261880|NCT02641730|76089387|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
42261881|NCT02641730|76089388|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
42261882|NCT02641730|76089389|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
42261883|NCT02641730|76089390|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
42261884|NCT02641730|76089386|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
42261885|NCT02641730|76089387|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
42261886|NCT02641730|76089388|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
42261887|NCT02641730|76089389|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
42261888|NCT02641730|76089390|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
42261889|NCT02797171|76089410|FG000|Overall Study|Lost to Follow-up|2|||
42261890|NCT02797171|76089411|FG001|Overall Study|Lost to Follow-up|0|||
42261891|NCT02797171|76089412|FG002|Overall Study|Lost to Follow-up|2|||
42261892|NCT02797171|76089413|FG003|Overall Study|Lost to Follow-up|1|||
42261893|NCT02797171|76089414|FG004|Overall Study|Lost to Follow-up|2|||
42261894|NCT02797171|76089415|FG005|Overall Study|Lost to Follow-up|0|||
42261895|NCT02797171|76089410|FG000|Overall Study|Withdrawal by Subject|1|||
42261896|NCT02797171|76089411|FG001|Overall Study|Withdrawal by Subject|1|||
42261897|NCT02797171|76089412|FG002|Overall Study|Withdrawal by Subject|0|||
42261898|NCT02797171|76089413|FG003|Overall Study|Withdrawal by Subject|0|||
42261899|NCT02797171|76089414|FG004|Overall Study|Withdrawal by Subject|0|||
42261900|NCT02797171|76089415|FG005|Overall Study|Withdrawal by Subject|0|||
42261901|NCT02797171|76089410|FG000|Overall Study|Protocol Violation|1|||
42261902|NCT02797171|76089411|FG001|Overall Study|Protocol Violation|0|||
42261903|NCT02797171|76089412|FG002|Overall Study|Protocol Violation|0|||
42261904|NCT02797171|76089413|FG003|Overall Study|Protocol Violation|0|||
42261905|NCT02797171|76089414|FG004|Overall Study|Protocol Violation|0|||
42261906|NCT02797171|76089415|FG005|Overall Study|Protocol Violation|0|||
42261907|NCT02797171|76089410|FG000|Overall Study|Participant unable to adhere|0|||
41996905|NCT01120600|75804904|FG001|Overall Study|Adverse Event|7|||
41996906|NCT01120600|75804903|FG000|Overall Study|Excessive Bone Loss|0|||
42327731|NCT02184572|76165508|FG000|Overall Study|Traveling Outside The Country|1|||
42327732|NCT02184572|76165509|FG001|Overall Study|Traveling Outside The Country|0|||
42327733|NCT02184572|76165508|FG000|Overall Study|Withdrawal by Subject|14|||
42327734|NCT02184572|76165509|FG001|Overall Study|Withdrawal by Subject|9|||
42327735|NCT02181842|76165517|FG000|Overall Study|Case Report Forms Uncollected|2|||
42327736|NCT01632020|76165523|FG000|Overall Study|Withdrawal by Subject|1|||
42327737|NCT01632020|76165524|FG001|Overall Study|Withdrawal by Subject|0|||
42327738|NCT01632020|76165523|FG000|Overall Study|Adverse Event|1|||
42327739|NCT01632020|76165524|FG001|Overall Study|Adverse Event|0|||
42327740|NCT02181296|76165532|FG000|Overall Study|Lost to Follow-up|7|||
42327741|NCT02181296|76165533|FG001|Overall Study|Lost to Follow-up|6|||
42327742|NCT02215616|76165543|FG000|Overall Study|Sponsor requested to stop study drug|0|||
42327743|NCT02215616|76165544|FG001|Overall Study|Sponsor requested to stop study drug|0|||
42327744|NCT02215616|76165545|FG002|Overall Study|Sponsor requested to stop study drug|1|||
41996907|NCT01120600|75804904|FG001|Overall Study|Excessive Bone Loss|4|||
41996908|NCT01120600|75804903|FG000|Overall Study|Lost to Follow-up|1|||
41996909|NCT01120600|75804904|FG001|Overall Study|Lost to Follow-up|3|||
41996910|NCT01120600|75804903|FG000|Overall Study|Physician Decision|1|||
41996911|NCT01120600|75804904|FG001|Overall Study|Physician Decision|3|||
42327745|NCT02215616|76165546|FG003|Overall Study|Sponsor requested to stop study drug|4|||
42327746|NCT02215616|76165543|FG000|Overall Study|Death|1|||
42327747|NCT02215616|76165544|FG001|Overall Study|Death|0|||
42327748|NCT02215616|76165545|FG002|Overall Study|Death|0|||
42327749|NCT02215616|76165546|FG003|Overall Study|Death|0|||
42327750|NCT02215616|76165543|FG000|Overall Study|Adverse Event|7|||
42327751|NCT02215616|76165544|FG001|Overall Study|Adverse Event|4|||
42327752|NCT02215616|76165545|FG002|Overall Study|Adverse Event|9|||
42327753|NCT02215616|76165546|FG003|Overall Study|Adverse Event|2|||
41996912|NCT01120600|75804903|FG000|Overall Study|Protocol Violation|0|||
41996913|NCT01120600|75804904|FG001|Overall Study|Protocol Violation|4|||
41996914|NCT01120600|75804903|FG000|Overall Study|Withdrawal by Subject|10|||
41996915|NCT01120600|75804904|FG001|Overall Study|Withdrawal by Subject|11|||
41996916|NCT01120210|75804912|FG000|MAIN INFUSION|Adverse Event|1|||
41996917|NCT01120210|75804913|FG001|MAIN INFUSION|Adverse Event|0|||
41996918|NCT01120210|75804912|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
41996919|NCT01120210|75804913|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
41996920|NCT01120093|75804919|FG000|Treatment Period 1|Adverse Event|0|||
41996921|NCT01120093|75804920|FG001|Treatment Period 1|Adverse Event|0|||
41996922|NCT01120093|75804921|FG002|Treatment Period 1|Adverse Event|1|||
41996923|NCT01120093|75804922|FG003|Treatment Period 1|Adverse Event|0|||
41996924|NCT01120093|75804923|FG004|Treatment Period 1|Adverse Event|1|||
41996925|NCT01120093|75804919|FG000|Treatment Period 1|Withdrawal by Subject|0|||
41996926|NCT01120093|75804920|FG001|Treatment Period 1|Withdrawal by Subject|1|||
42261908|NCT02797171|76089411|FG001|Overall Study|Participant unable to adhere|1|||
42261909|NCT02797171|76089412|FG002|Overall Study|Participant unable to adhere|0|||
42261910|NCT02797171|76089413|FG003|Overall Study|Participant unable to adhere|0|||
42261911|NCT02797171|76089414|FG004|Overall Study|Participant unable to adhere|0|||
42261912|NCT02797171|76089415|FG005|Overall Study|Participant unable to adhere|0|||
42261913|NCT02797171|76089410|FG000|Overall Study|Not Randomized|0|||
42261914|NCT02797171|76089411|FG001|Overall Study|Not Randomized|0|||
42261915|NCT02797171|76089412|FG002|Overall Study|Not Randomized|0|||
42261916|NCT02797171|76089413|FG003|Overall Study|Not Randomized|0|||
42261917|NCT02797171|76089414|FG004|Overall Study|Not Randomized|0|||
42261918|NCT02797171|76089415|FG005|Overall Study|Not Randomized|1|||
41996927|NCT01120093|75804921|FG002|Treatment Period 1|Withdrawal by Subject|0|||
41996928|NCT01120093|75804922|FG003|Treatment Period 1|Withdrawal by Subject|0|||
41996929|NCT01120093|75804923|FG004|Treatment Period 1|Withdrawal by Subject|0|||
41996930|NCT01120093|75804919|FG000|Treatment Period 2|Adverse Event|0|||
41996931|NCT01120093|75804920|FG001|Treatment Period 2|Adverse Event|0|||
41996932|NCT01120093|75804921|FG002|Treatment Period 2|Adverse Event|0|||
41996933|NCT01120093|75804922|FG003|Treatment Period 2|Adverse Event|1|||
41996934|NCT01120093|75804923|FG004|Treatment Period 2|Adverse Event|0|||
41996935|NCT01120093|75804919|FG000|Treatment Period 2|Withdrawal by Subject|0|||
41996936|NCT01120093|75804920|FG001|Treatment Period 2|Withdrawal by Subject|0|||
41996937|NCT01120093|75804921|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42327754|NCT02215616|76165543|FG000|Overall Study|Withdrawal by Subject|1|||
42327755|NCT02215616|76165544|FG001|Overall Study|Withdrawal by Subject|8|||
42327756|NCT02215616|76165545|FG002|Overall Study|Withdrawal by Subject|2|||
42327757|NCT02215616|76165546|FG003|Overall Study|Withdrawal by Subject|5|||
42327758|NCT02215616|76165543|FG000|Overall Study|Non-compliance|0|||
42327759|NCT02215616|76165544|FG001|Overall Study|Non-compliance|2|||
42327760|NCT02215616|76165545|FG002|Overall Study|Non-compliance|1|||
42327761|NCT02215616|76165546|FG003|Overall Study|Non-compliance|0|||
41996938|NCT01120093|75804922|FG003|Treatment Period 2|Withdrawal by Subject|0|||
41996939|NCT01120093|75804923|FG004|Treatment Period 2|Withdrawal by Subject|1|||
41996940|NCT01120093|75804919|FG000|Treatment Period 3|Lack of Efficacy|0|||
41996941|NCT01120093|75804920|FG001|Treatment Period 3|Lack of Efficacy|0|||
41996942|NCT01120093|75804921|FG002|Treatment Period 3|Lack of Efficacy|0|||
41996943|NCT01120093|75804922|FG003|Treatment Period 3|Lack of Efficacy|1|||
41996944|NCT01120093|75804923|FG004|Treatment Period 3|Lack of Efficacy|0|||
41996945|NCT01120093|75804919|FG000|Treatment Period 3|Adverse Event|0|||
41996946|NCT01120093|75804920|FG001|Treatment Period 3|Adverse Event|0|||
41996947|NCT01120093|75804921|FG002|Treatment Period 3|Adverse Event|0|||
41996948|NCT01120093|75804922|FG003|Treatment Period 3|Adverse Event|0|||
41996949|NCT01120093|75804923|FG004|Treatment Period 3|Adverse Event|1|||
41996950|NCT01120093|75804919|FG000|Treatment Period 3|Withdrawal by Subject|0|||
41996951|NCT01120093|75804920|FG001|Treatment Period 3|Withdrawal by Subject|0|||
42034484|NCT00937521|75842588|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
42034485|NCT00937521|75842589|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
42034486|NCT00937521|75842590|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
42261919|NCT02797951|76089429|FG000|Overall Study|Adverse Event|4|||
42261920|NCT02797951|76089429|FG000|Overall Study|Death|1|||
42261921|NCT02797951|76089429|FG000|Overall Study|Lack of Efficacy|19|||
42261922|NCT02797951|76089429|FG000|Overall Study|Lost to Follow-up|4|||
42261923|NCT02797951|76089429|FG000|Overall Study|Physician Decision|6|||
42261924|NCT02797951|76089429|FG000|Overall Study|Withdrawal by Subject|15|||
42261925|NCT00701805|76089437|FG000|Overall Study|Withdrawal by Subject|3|||
42261926|NCT00701805|76089438|FG001|Overall Study|Withdrawal by Subject|1|||
42261927|NCT00701805|76089439|FG002|Overall Study|Withdrawal by Subject|4|||
42261928|NCT00701805|76089440|FG003|Overall Study|Withdrawal by Subject|3|||
42261929|NCT00701805|76089437|FG000|Overall Study|Adverse Event|0|||
42261930|NCT00701805|76089438|FG001|Overall Study|Adverse Event|1|||
42261931|NCT00701805|76089439|FG002|Overall Study|Adverse Event|1|||
42261932|NCT00701805|76089440|FG003|Overall Study|Adverse Event|0|||
42261933|NCT00701805|76089437|FG000|Overall Study|Missed 7 consecutive doses|0|||
42261934|NCT00701805|76089438|FG001|Overall Study|Missed 7 consecutive doses|1|||
42261935|NCT00701805|76089439|FG002|Overall Study|Missed 7 consecutive doses|0|||
42261936|NCT00701805|76089440|FG003|Overall Study|Missed 7 consecutive doses|0|||
42261937|NCT00701805|76089437|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
42261938|NCT00701805|76089438|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
42261939|NCT00701805|76089439|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
41996952|NCT01120093|75804921|FG002|Treatment Period 3|Withdrawal by Subject|1|||
42327762|NCT02215616|76165543|FG000|Overall Study|Protocol Violation|0|||
41996953|NCT01120093|75804922|FG003|Treatment Period 3|Withdrawal by Subject|0|||
41996954|NCT01120093|75804923|FG004|Treatment Period 3|Withdrawal by Subject|0|||
41996955|NCT01120093|75804919|FG000|Treatment Period 4|Adverse Event|1|||
41996956|NCT01120093|75804920|FG001|Treatment Period 4|Adverse Event|0|||
42261940|NCT00701805|76089440|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
42261941|NCT00701805|76089437|FG000|Overall Study|Physician decision, change of therapy|0|||
42261942|NCT00701805|76089438|FG001|Overall Study|Physician decision, change of therapy|0|||
41996957|NCT01120093|75804921|FG002|Treatment Period 4|Adverse Event|0|||
41996958|NCT01120093|75804922|FG003|Treatment Period 4|Adverse Event|0|||
41996959|NCT01120093|75804923|FG004|Treatment Period 4|Adverse Event|0|||
42327763|NCT02215616|76165544|FG001|Overall Study|Protocol Violation|2|||
42327764|NCT02215616|76165545|FG002|Overall Study|Protocol Violation|0|||
42327765|NCT02215616|76165546|FG003|Overall Study|Protocol Violation|0|||
42327766|NCT02215616|76165543|FG000|Overall Study|Lost to Follow-up|1|||
42327767|NCT02215616|76165544|FG001|Overall Study|Lost to Follow-up|1|||
42327768|NCT02215616|76165545|FG002|Overall Study|Lost to Follow-up|0|||
42327769|NCT02215616|76165546|FG003|Overall Study|Lost to Follow-up|1|||
42327770|NCT02215616|76165543|FG000|Overall Study|Other than specified|1|||
42327771|NCT02215616|76165544|FG001|Overall Study|Other than specified|0|||
42327772|NCT02215616|76165545|FG002|Overall Study|Other than specified|1|||
42327773|NCT02215616|76165546|FG003|Overall Study|Other than specified|1|||
42327774|NCT02213666|76165556|FG000|Overall Study|Withdrawal by Subject|1|||
42327775|NCT02213510|76165562|FG000|Overall Study|Death|0|||
42327776|NCT02213510|76165563|FG001|Overall Study|Death|1|||
41996960|NCT01120093|75804919|FG000|Treatment Period 5|Adverse Event|0|||
41996961|NCT01120093|75804920|FG001|Treatment Period 5|Adverse Event|1|||
41996962|NCT01120093|75804921|FG002|Treatment Period 5|Adverse Event|0|||
41996963|NCT01120093|75804922|FG003|Treatment Period 5|Adverse Event|1|||
41996964|NCT01120093|75804923|FG004|Treatment Period 5|Adverse Event|0|||
41996965|NCT01119937|75804937|FG000|Overall Study|Adverse Event|11|||
41996966|NCT01119937|75804938|FG001|Overall Study|Adverse Event|5|||
41996967|NCT01119937|75804937|FG000|Overall Study|Protocol deviation|3|||
41996968|NCT01119937|75804938|FG001|Overall Study|Protocol deviation|1|||
41996969|NCT01119937|75804937|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
41996970|NCT01119937|75804938|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
41996971|NCT01119937|75804937|FG000|Overall Study|Withdrawal by Subject|2|||
41996972|NCT01119937|75804938|FG001|Overall Study|Withdrawal by Subject|1|||
41996973|NCT01119898|75804946|FG000|Overall Study|Adverse Event|4|||
41996974|NCT01119898|75804947|FG001|Overall Study|Adverse Event|5|||
41996975|NCT01119898|75804946|FG000|Overall Study|Withdrawal by Subject|1|||
41996976|NCT01119898|75804947|FG001|Overall Study|Withdrawal by Subject|4|||
41996977|NCT01119898|75804946|FG000|Overall Study|Lack of Efficacy|0|||
41996978|NCT01119898|75804947|FG001|Overall Study|Lack of Efficacy|2|||
41996979|NCT01119898|75804946|FG000|Overall Study|Protocol Violation|1|||
41996980|NCT01119898|75804947|FG001|Overall Study|Protocol Violation|1|||
41996981|NCT01119898|75804946|FG000|Overall Study|Medical procedure|1|||
41996982|NCT01119898|75804947|FG001|Overall Study|Medical procedure|0|||
41996983|NCT01119898|75804946|FG000|Overall Study|Randomized in error did not participate|1|||
41996984|NCT01119898|75804947|FG001|Overall Study|Randomized in error did not participate|0|||
41996985|NCT01119859|75804955|FG000|Overall Study|Adverse Event|9|||
41996986|NCT01119859|75804956|FG001|Overall Study|Adverse Event|10|||
41996987|NCT01119859|75804955|FG000|Overall Study|Death|2|||
41996988|NCT01119859|75804956|FG001|Overall Study|Death|0|||
41996989|NCT01119859|75804955|FG000|Overall Study|Insufficient therapeutic response|7|||
41996990|NCT01119859|75804956|FG001|Overall Study|Insufficient therapeutic response|14|||
42327777|NCT02213510|76165562|FG000|Overall Study|Lost to Follow-up|1|||
42327778|NCT02213510|76165563|FG001|Overall Study|Lost to Follow-up|0|||
42327779|NCT02158442|76165571|FG000|Overall Study|Withdrawal by Subject|1|||
42327780|NCT02158442|76165572|FG001|Overall Study|Withdrawal by Subject|0|||
42327781|NCT02158442|76165571|FG000|Overall Study|Perfusion staff not available|1|||
42327782|NCT02158442|76165572|FG001|Overall Study|Perfusion staff not available|0|||
42327783|NCT02158364|76165578|FG000|Overall Study|Case report forms uncollected|10|||
42327784|NCT02158364|76165578|FG000|Overall Study|Protocol Deviation|50|||
42327785|NCT02180672|76165584|FG000|Overall Study|Lost to Follow-up|5|||
42327786|NCT02180672|76165585|FG001|Overall Study|Lost to Follow-up|7|||
42327787|NCT02213198|76165593|FG000|Baseline|No show for intake|7|||
42327788|NCT02213198|76165594|FG001|Baseline|No show for intake|9|||
42327789|NCT02213198|76165593|FG000|Baseline|Withdrawal by Subject|34|||
41996991|NCT01119859|75804955|FG000|Overall Study|Refused treatment|3|||
41996992|NCT01119859|75804956|FG001|Overall Study|Refused treatment|6|||
41996993|NCT01119859|75804955|FG000|Overall Study|Failure to return|3|||
42034487|NCT00937521|75842591|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
42327790|NCT02213198|76165594|FG001|Baseline|Withdrawal by Subject|11|||
42327791|NCT02213198|76165593|FG000|Baseline|transferred out of clinic|7|||
42327792|NCT02213198|76165594|FG001|Baseline|transferred out of clinic|9|||
42327793|NCT02213198|76165593|FG000|Baseline|Lost to Follow-up|40|||
41996994|NCT01119859|75804956|FG001|Overall Study|Failure to return|0|||
41996995|NCT01119703|75804964|FG000|Overall Study|Adverse Event|0|||
41996996|NCT01119703|75804965|FG001|Overall Study|Adverse Event|1|||
42327794|NCT02213198|76165594|FG001|Baseline|Lost to Follow-up|21|||
42327795|NCT02213198|76165593|FG000|Baseline|incarcerated,violent|0|||
42327796|NCT02213198|76165594|FG001|Baseline|incarcerated,violent|1|||
42327797|NCT02213198|76165593|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
42327798|NCT02213198|76165594|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
42327799|NCT02213198|76165593|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
42327800|NCT02213198|76165594|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
42327801|NCT02213198|76165593|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
42327802|NCT02213198|76165594|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
42327803|NCT02213198|76165593|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
42327804|NCT02213198|76165594|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
42327805|NCT02213198|76165593|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
42327806|NCT02213198|76165594|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
42327807|NCT02213198|76165593|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
42327808|NCT02213198|76165594|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
42327809|NCT02157506|76165605|FG000|Overall Study|Adverse Event|0|||
42327810|NCT02157506|76165606|FG001|Overall Study|Adverse Event|1|||
42327811|NCT02157506|76165607|FG002|Overall Study|Adverse Event|0|||
42327812|NCT02157506|76165608|FG003|Overall Study|Adverse Event|0|||
41996997|NCT01119625|75804972|FG000|Overall Study|Lost to Follow-up|1|||
41996998|NCT01119625|75804973|FG001|Overall Study|Lost to Follow-up|2|||
41996999|NCT01119625|75804972|FG000|Overall Study|Withdrawal by Subject|2|||
41997000|NCT01119625|75804973|FG001|Overall Study|Withdrawal by Subject|1|||
41997001|NCT01119625|75804972|FG000|Overall Study|Other|0|||
41997002|NCT01119625|75804973|FG001|Overall Study|Other|1|||
41997003|NCT01119118|75804979|FG000|Overall Study|Adverse Event|1|||
41997004|NCT01119001|75804983|FG000|Overall Study|Withdrawal by Subject|2|||
41997005|NCT01118962|75804989|FG000|Overall Study|Adverse Event|2|||
41997006|NCT01118962|75804989|FG000|Overall Study|Lack of Efficacy|1|||
41997007|NCT01118962|75804989|FG000|Overall Study|Protocol Violation|1|||
41997008|NCT01118962|75804989|FG000|Overall Study|Withdrawal by Subject|4|||
41997009|NCT01118962|75804989|FG000|Overall Study|Pregnancy|1|||
41997010|NCT01118962|75804989|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
42261943|NCT00701805|76089439|FG002|Overall Study|Physician decision, change of therapy|0|||
42261944|NCT00701805|76089440|FG003|Overall Study|Physician decision, change of therapy|1|||
42261945|NCT00701805|76089437|FG000|Overall Study|Difficult to travel to dialysis site|0|||
42261946|NCT00701805|76089438|FG001|Overall Study|Difficult to travel to dialysis site|0|||
42261947|NCT00701805|76089439|FG002|Overall Study|Difficult to travel to dialysis site|1|||
42261948|NCT00701805|76089440|FG003|Overall Study|Difficult to travel to dialysis site|0|||
42261949|NCT00701805|76089437|FG000|Overall Study|Resumption criteria were not met|0|||
42261950|NCT00701805|76089438|FG001|Overall Study|Resumption criteria were not met|1|||
42261951|NCT00701805|76089439|FG002|Overall Study|Resumption criteria were not met|0|||
42261952|NCT00701805|76089440|FG003|Overall Study|Resumption criteria were not met|0|||
42261953|NCT02715765|76089453|FG000|Overall Study|Study Termination|3|||
42261954|NCT02715765|76089454|FG001|Overall Study|Study Termination|0|||
42261955|NCT02715765|76089455|FG002|Overall Study|Study Termination|0|||
42261956|NCT04542291|76089463|FG000|Overall Study|Adverse Event|1|||
42327813|NCT02157506|76165609|FG004|Overall Study|Adverse Event|0|||
42327814|NCT02157506|76165605|FG000|Overall Study|Lost to Follow-up|0|||
42327815|NCT02157506|76165606|FG001|Overall Study|Lost to Follow-up|0|||
41997011|NCT01118728|75804993|FG000|Overall Study|Adverse Event|17|||
41997012|NCT01118728|75804993|FG000|Overall Study|Lack of Efficacy|27|||
41997013|NCT01118728|75804993|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
41997014|NCT01118728|75804993|FG000|Overall Study|Withdrawal by Subject|3|||
41997015|NCT01118728|75804993|FG000|Overall Study|Lost to Follow-up|4|||
42261957|NCT04542291|76089463|FG000|Overall Study|Physician Decision|2|||
41997016|NCT01118455|75804999|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
41997017|NCT01118455|75805000|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
41997018|NCT01118377|75805014|FG000|Overall Study|Did Not Receive Study Medication|1|||
41997019|NCT01118377|75805014|FG000|Overall Study|Death|38|||
41997020|NCT01118377|75805014|FG000|Overall Study|Failure to Return|3|||
41997021|NCT01118299|75805020|FG000|Overall Study|Death|7|||
41997022|NCT01118299|75805021|FG001|Overall Study|Death|5|||
41997023|NCT01118299|75805020|FG000|Overall Study|Withdrawal by Subject|8|||
41997024|NCT01118299|75805021|FG001|Overall Study|Withdrawal by Subject|8|||
41997025|NCT01118299|75805020|FG000|Overall Study|Lost to Follow-up|2|||
41997026|NCT01118299|75805021|FG001|Overall Study|Lost to Follow-up|1|||
41997027|NCT01118299|75805020|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
41997028|NCT01118299|75805021|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
41997029|NCT01118143|75805028|FG000|Overall Study|Withdrawal by Subject|2|||
41997030|NCT01118143|75805029|FG001|Overall Study|Withdrawal by Subject|5|||
41997031|NCT01117987|75805039|FG000|Overall Study|Protocol deviation|0|||
41997032|NCT01117987|75805040|FG001|Overall Study|Protocol deviation|1|||
41997033|NCT01117987|75805039|FG000|Overall Study|Subject no longer requires study drug|1|||
41997034|NCT01117987|75805040|FG001|Overall Study|Subject no longer requires study drug|0|||
41997035|NCT01117987|75805039|FG000|Overall Study|Lost to Follow-up|1|||
41997036|NCT01117987|75805040|FG001|Overall Study|Lost to Follow-up|1|||
41997037|NCT01117987|75805039|FG000|Overall Study|Abnormal test procedure result|2|||
41997038|NCT01117987|75805040|FG001|Overall Study|Abnormal test procedure result|0|||
41997039|NCT01117987|75805039|FG000|Overall Study|Lack of Efficacy|3|||
41997040|NCT01117987|75805040|FG001|Overall Study|Lack of Efficacy|4|||
41997041|NCT01117987|75805039|FG000|Overall Study|Death|5|||
41997042|NCT01117987|75805040|FG001|Overall Study|Death|10|||
41997043|NCT01117987|75805039|FG000|Overall Study|Withdrawal by Subject|5|||
42261958|NCT02795767|76089470|FG000|Overall Study|Received Commercial Emicizumab|1|||
42261959|NCT02795767|76089471|FG001|Overall Study|Received Commercial Emicizumab|0|||
42261960|NCT02795767|76089472|FG002|Overall Study|Received Commercial Emicizumab|0|||
42261961|NCT02796391|76089499|FG000|Overall Study|Lost to Follow-up|2|||
42261962|NCT02796391|76089500|FG001|Overall Study|Lost to Follow-up|2|||
42261963|NCT02796391|76089501|FG002|Overall Study|Lost to Follow-up|13|||
42261964|NCT02796391|76089502|FG003|Overall Study|Lost to Follow-up|8|||
42261965|NCT02796391|76089503|FG004|Overall Study|Lost to Follow-up|14|||
42261966|NCT02796391|76089504|FG005|Overall Study|Lost to Follow-up|13|||
41997044|NCT01117987|75805040|FG001|Overall Study|Withdrawal by Subject|10|||
41997045|NCT01117987|75805039|FG000|Overall Study|Adverse Event|19|||
41997046|NCT01117987|75805040|FG001|Overall Study|Adverse Event|26|||
41997047|NCT01117987|75805039|FG000|Overall Study|Administrative problems|25|||
42034488|NCT00937521|75842592|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
42034489|NCT00937521|75842593|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
42034490|NCT00937521|75842586|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
42034491|NCT00937521|75842587|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
42034492|NCT00937521|75842588|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
42034493|NCT00937521|75842589|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
42034494|NCT00937521|75842590|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
42034495|NCT00937521|75842591|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
42034496|NCT00937521|75842592|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
42034497|NCT00937521|75842593|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
42034498|NCT00937521|75842586|FG000|Booster Phase|Adverse Event|0|||
42034499|NCT00937521|75842587|FG001|Booster Phase|Adverse Event|0|||
42034500|NCT00937521|75842588|FG002|Booster Phase|Adverse Event|0|||
42034501|NCT00937521|75842589|FG003|Booster Phase|Adverse Event|0|||
42034502|NCT00937521|75842590|FG004|Booster Phase|Adverse Event|0|||
42034503|NCT00937521|75842591|FG005|Booster Phase|Adverse Event|0|||
42034504|NCT00937521|75842592|FG006|Booster Phase|Adverse Event|1|||
42034505|NCT00937521|75842593|FG007|Booster Phase|Adverse Event|0|||
42034506|NCT00937521|75842586|FG000|Booster Phase|Withdrawal by Subject|1|||
42034507|NCT00937521|75842587|FG001|Booster Phase|Withdrawal by Subject|0|||
42034508|NCT00937521|75842588|FG002|Booster Phase|Withdrawal by Subject|0|||
42034509|NCT00937521|75842589|FG003|Booster Phase|Withdrawal by Subject|1|||
42034510|NCT00937521|75842590|FG004|Booster Phase|Withdrawal by Subject|0|||
42034511|NCT00937521|75842591|FG005|Booster Phase|Withdrawal by Subject|0|||
42034512|NCT00937521|75842592|FG006|Booster Phase|Withdrawal by Subject|0|||
41997048|NCT01117987|75805040|FG001|Overall Study|Administrative problems|22|||
42261967|NCT02796391|76089499|FG000|Overall Study|COVID|0|||
42261968|NCT02796391|76089500|FG001|Overall Study|COVID|0|||
42327816|NCT02157506|76165607|FG002|Overall Study|Lost to Follow-up|1|||
41997049|NCT01117870|75805048|FG000|Overall Study|Inability to place needle|1|||
42034513|NCT00937521|75842593|FG007|Booster Phase|Withdrawal by Subject|2|||
42034514|NCT00937521|75842586|FG000|Booster Phase|Lost to Follow-up|2|||
42034515|NCT00937521|75842587|FG001|Booster Phase|Lost to Follow-up|2|||
42034516|NCT00937521|75842588|FG002|Booster Phase|Lost to Follow-up|4|||
42261969|NCT02796391|76089501|FG002|Overall Study|COVID|5|||
41997050|NCT01117870|75805049|FG001|Overall Study|Inability to place needle|0|||
41997051|NCT01117792|75805059|FG000|Overall Study|Death|1|||
41997052|NCT01117792|75805059|FG000|Overall Study|Adverse Event|3|||
41997053|NCT02219490|75805063|FG000|Overall Study|Adverse Event|24|||
41997054|NCT02219490|75805063|FG000|Overall Study|Withdrew consent|96|||
41997055|NCT02219490|75805063|FG000|Overall Study|Lost to Follow-up|126|||
41997056|NCT02219490|75805063|FG000|Overall Study|COVID-19 infection|2|||
41997057|NCT02219490|75805063|FG000|Overall Study|COVID-19 logistical restrictions|33|||
41997058|NCT02219490|75805063|FG000|Overall Study|Other, not specified|57|||
41997059|NCT01117480|75805071|FG000|Overall Study|Protocol Violation|8|||
41997060|NCT01117480|75805071|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
41997061|NCT01117051|75805077|FG000|Overall Study|Withdrawal by Subject|5|||
41997062|NCT01117051|75805078|FG001|Overall Study|Withdrawal by Subject|3|||
41997063|NCT01117051|75805077|FG000|Overall Study|Adverse Event|4|||
41997064|NCT01117051|75805078|FG001|Overall Study|Adverse Event|3|||
41997065|NCT01117051|75805077|FG000|Overall Study|Lost to Follow-up|0|||
41997066|NCT01117051|75805078|FG001|Overall Study|Lost to Follow-up|1|||
41997067|NCT01117051|75805077|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
41997068|NCT01117051|75805078|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
41997069|NCT01117051|75805077|FG000|Overall Study|Sponsor's decision|3|||
41997070|NCT01117051|75805078|FG001|Overall Study|Sponsor's decision|1|||
41997071|NCT01117051|75805077|FG000|Overall Study|Surgical procedure|0|||
41997072|NCT01117051|75805078|FG001|Overall Study|Surgical procedure|1|||
41997073|NCT01117051|75805077|FG000|Overall Study|Randomized by mistake|0|||
41997074|NCT01117051|75805078|FG001|Overall Study|Randomized by mistake|1|||
41997075|NCT01117051|75805077|FG000|Overall Study|Convenience issue|1|||
41997076|NCT01117051|75805078|FG001|Overall Study|Convenience issue|0|||
41997077|NCT02211417|75805087|FG000|Overall Study|Withdrawal by Subject|11|||
41997078|NCT02211417|75805088|FG001|Overall Study|Withdrawal by Subject|8|||
41997079|NCT02211417|75805087|FG000|Overall Study|Protocol Violation|1|||
41997080|NCT02211417|75805088|FG001|Overall Study|Protocol Violation|0|||
41997081|NCT02211417|75805087|FG000|Overall Study|Pregnancy|0|||
41997082|NCT02211417|75805088|FG001|Overall Study|Pregnancy|1|||
41997083|NCT02211417|75805087|FG000|Overall Study|Lost to Follow-up|2|||
41997084|NCT02211417|75805088|FG001|Overall Study|Lost to Follow-up|3|||
41997085|NCT02211417|75805087|FG000|Overall Study|Adverse Event|1|||
41997086|NCT02211417|75805088|FG001|Overall Study|Adverse Event|4|||
41997087|NCT01117012|75805101|FG000|Overall Study|Adverse Event|0|||
41997088|NCT01117012|75805102|FG001|Overall Study|Adverse Event|1|||
41997089|NCT01117012|75805101|FG000|Overall Study|Death|1|||
41997090|NCT01117012|75805102|FG001|Overall Study|Death|1|||
41997091|NCT01117012|75805101|FG000|Overall Study|Withdrawal by Subject|3|||
41997092|NCT01117012|75805102|FG001|Overall Study|Withdrawal by Subject|0|||
41997093|NCT01117012|75805101|FG000|Overall Study|Undefined|4|||
41997094|NCT01117012|75805102|FG001|Overall Study|Undefined|3|||
42034517|NCT00937521|75842589|FG003|Booster Phase|Lost to Follow-up|2|||
42034518|NCT00937521|75842590|FG004|Booster Phase|Lost to Follow-up|4|||
42261970|NCT02796391|76089502|FG003|Overall Study|COVID|5|||
42261971|NCT02796391|76089503|FG004|Overall Study|COVID|2|||
42261972|NCT02796391|76089504|FG005|Overall Study|COVID|4|||
42261973|NCT02796391|76089499|FG000|Overall Study|Participant did not like study cigarettes|0|||
42261974|NCT02796391|76089500|FG001|Overall Study|Participant did not like study cigarettes|0|||
42261975|NCT02796391|76089501|FG002|Overall Study|Participant did not like study cigarettes|3|||
42327817|NCT02157506|76165608|FG003|Overall Study|Lost to Follow-up|0|||
42327818|NCT02157506|76165609|FG004|Overall Study|Lost to Follow-up|0|||
42327819|NCT01920711|76165623|FG000|Overall Study|Death|347|||
42327820|NCT01920711|76165624|FG001|Overall Study|Death|356|||
42327821|NCT01920711|76165623|FG000|Overall Study|Lost to Follow-up|13|||
41997095|NCT01116739|75805110|FG000|Overall Study|Child had 2 years of HS|110|||
41997096|NCT01116739|75805111|FG001|Overall Study|Child had 2 years of HS|128|||
41997097|NCT01116739|75805110|FG000|Overall Study|Withdrawal by Subject|6|||
41997098|NCT01116739|75805111|FG001|Overall Study|Withdrawal by Subject|0|||
41997099|NCT01116739|75805110|FG000|Overall Study|child too young|2|||
42327822|NCT01920711|76165624|FG001|Overall Study|Lost to Follow-up|14|||
41997100|NCT01116739|75805111|FG001|Overall Study|child too young|6|||
41997101|NCT01116739|75805110|FG000|Overall Study|child not enrolled in head start|10|||
41997102|NCT01116739|75805111|FG001|Overall Study|child not enrolled in head start|2|||
41997103|NCT01116739|75805110|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
41997104|NCT01116739|75805111|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
41997105|NCT01116544|75805119|FG000|Overall Study|Protocol Violation|1|||
41997106|NCT01116544|75805120|FG001|Overall Study|Protocol Violation|0|||
41997107|NCT01116544|75805119|FG000|Overall Study|Withdrawal by Subject|1|||
41997108|NCT01116544|75805120|FG001|Overall Study|Withdrawal by Subject|1|||
42034519|NCT00937521|75842591|FG005|Booster Phase|Lost to Follow-up|4|||
41997109|NCT01116427|75805128|FG000|Core Phase|Adverse Event|0|||
41997110|NCT01116427|75805129|FG001|Core Phase|Adverse Event|1|||
41997111|NCT01116427|75805128|FG000|Core Phase|Lost to Follow-up|1|||
41997112|NCT01116427|75805129|FG001|Core Phase|Lost to Follow-up|0|||
41997113|NCT01116427|75805128|FG000|Core Phase|Withdrawal by Subject|3|||
41997114|NCT01116427|75805129|FG001|Core Phase|Withdrawal by Subject|0|||
41997115|NCT01116427|75805128|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
41997116|NCT01116427|75805129|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
41997117|NCT01116427|75805128|FG000|Extension Phase|Adverse Event|1|||
41997118|NCT01116427|75805129|FG001|Extension Phase|Adverse Event|1|||
41997119|NCT01116427|75805128|FG000|Extension Phase|Lost to Follow-up|2|||
41997120|NCT01116427|75805129|FG001|Extension Phase|Lost to Follow-up|0|||
41997121|NCT01116427|75805128|FG000|Extension Phase|Withdrawal by Subject|5|||
41997122|NCT01116427|75805129|FG001|Extension Phase|Withdrawal by Subject|1|||
41997123|NCT01116427|75805128|FG000|Extension Phase|Not using appropriate birth control|1|||
41997124|NCT01116427|75805129|FG001|Extension Phase|Not using appropriate birth control|0|||
41997125|NCT01116232|75805139|FG000|Overall Study|Progressive diease|4|||
41997126|NCT01115998|75805148|FG000|Overall Study|Lost to Follow-up|6|||
41997127|NCT01115998|75805149|FG001|Overall Study|Lost to Follow-up|6|||
41997128|NCT01205230|75805157|FG000|Overall Study|Adverse Event|4|||
41997129|NCT01205230|75805158|FG001|Overall Study|Adverse Event|0|||
41997130|NCT01205230|75805157|FG000|Overall Study|Physician Decision|1|||
41997131|NCT01205230|75805158|FG001|Overall Study|Physician Decision|0|||
41997132|NCT01205152|75805169|FG000|Overall Study|Death|1|||
41997133|NCT01205035|75805177|FG000|Overall Study|Withdrawal by Subject|1|||
41997134|NCT01205035|75805178|FG001|Overall Study|Withdrawal by Subject|0|||
41997135|NCT01205035|75805177|FG000|Overall Study|Physician Decision|1|||
41997136|NCT01205035|75805178|FG001|Overall Study|Physician Decision|0|||
41997137|NCT01204918|75805187|FG000|Overall Study|Withdrawal by Subject|4|||
41997138|NCT01204918|75805188|FG001|Overall Study|Withdrawal by Subject|10|||
41997139|NCT01204918|75805189|FG002|Overall Study|Withdrawal by Subject|5|||
41997140|NCT01204294|75805204|FG000|Overall Study|Adverse Event|2|||
41997141|NCT01204294|75805205|FG001|Overall Study|Adverse Event|6|||
41997142|NCT01204294|75805206|FG002|Overall Study|Adverse Event|0|||
41997143|NCT01204294|75805207|FG003|Overall Study|Adverse Event|7|||
41997144|NCT01204294|75805208|FG004|Overall Study|Adverse Event|1|||
41997145|NCT01204294|75805209|FG005|Overall Study|Adverse Event|4|||
41997146|NCT01204294|75805210|FG006|Overall Study|Adverse Event|0|||
41997147|NCT01204294|75805204|FG000|Overall Study|Protocol Violation|1|||
41997148|NCT01204294|75805205|FG001|Overall Study|Protocol Violation|0|||
41997149|NCT01204294|75805206|FG002|Overall Study|Protocol Violation|2|||
41997150|NCT01204294|75805207|FG003|Overall Study|Protocol Violation|1|||
41997151|NCT01204294|75805208|FG004|Overall Study|Protocol Violation|0|||
41997152|NCT01204294|75805209|FG005|Overall Study|Protocol Violation|0|||
41997153|NCT01204294|75805210|FG006|Overall Study|Protocol Violation|0|||
41997154|NCT01204294|75805204|FG000|Overall Study|Withdrawal by Subject|0|||
41997155|NCT01204294|75805205|FG001|Overall Study|Withdrawal by Subject|2|||
41997156|NCT01204294|75805206|FG002|Overall Study|Withdrawal by Subject|2|||
41997157|NCT01204294|75805207|FG003|Overall Study|Withdrawal by Subject|1|||
41997158|NCT01204294|75805208|FG004|Overall Study|Withdrawal by Subject|1|||
41997159|NCT01204294|75805209|FG005|Overall Study|Withdrawal by Subject|1|||
41997160|NCT01204294|75805210|FG006|Overall Study|Withdrawal by Subject|2|||
41997161|NCT01204294|75805204|FG000|Overall Study|Lack of Efficacy|0|||
41997162|NCT01204294|75805205|FG001|Overall Study|Lack of Efficacy|0|||
41997163|NCT01204294|75805206|FG002|Overall Study|Lack of Efficacy|0|||
41997164|NCT01204294|75805207|FG003|Overall Study|Lack of Efficacy|2|||
41997165|NCT01204294|75805208|FG004|Overall Study|Lack of Efficacy|0|||
41997166|NCT01204294|75805209|FG005|Overall Study|Lack of Efficacy|0|||
41997167|NCT01204294|75805210|FG006|Overall Study|Lack of Efficacy|0|||
41997168|NCT01204294|75805204|FG000|Overall Study|Other (house moving)|0|||
41997169|NCT01204294|75805205|FG001|Overall Study|Other (house moving)|0|||
41997170|NCT01204294|75805206|FG002|Overall Study|Other (house moving)|1|||
41997171|NCT01204294|75805207|FG003|Overall Study|Other (house moving)|0|||
41997172|NCT01204294|75805208|FG004|Overall Study|Other (house moving)|0|||
41997173|NCT01204294|75805209|FG005|Overall Study|Other (house moving)|0|||
41997174|NCT01204294|75805210|FG006|Overall Study|Other (house moving)|0|||
41997175|NCT01182181|75805228|FG000|First Intervention|Adverse Event|1|||
42134046|NCT00463476|75944875|FG000|Overall Study|Withdrawal by Subject|1|||
41997176|NCT01182181|75805229|FG001|First Intervention|Adverse Event|0|||
41997177|NCT01182181|75805228|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
41997178|NCT01182181|75805229|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
41997179|NCT01181986|75805237|FG000|Phase 1|Lost to Follow-up|0|||
41997180|NCT01181986|75805238|FG001|Phase 1|Lost to Follow-up|1|||
41997181|NCT01181986|75805239|FG002|Phase 1|Lost to Follow-up|1|||
41997182|NCT01181986|75805237|FG000|Phase 1|Adverse Event|0|||
41997183|NCT01181986|75805238|FG001|Phase 1|Adverse Event|0|||
41997184|NCT01181986|75805239|FG002|Phase 1|Adverse Event|1|||
41997185|NCT01181986|75805237|FG000|Phase 1|Protocol Violation|1|||
41997186|NCT01181986|75805238|FG001|Phase 1|Protocol Violation|0|||
41997187|NCT01181986|75805239|FG002|Phase 1|Protocol Violation|0|||
41997188|NCT01181986|75805237|FG000|Phase 2|Adverse Event|0|||
41997189|NCT01181986|75805238|FG001|Phase 2|Adverse Event|3|||
42134047|NCT00463476|75944876|FG001|Overall Study|Withdrawal by Subject|2|||
42134048|NCT00463476|75944875|FG000|Overall Study|Lost to Follow-up|1|||
42134049|NCT00463476|75944876|FG001|Overall Study|Lost to Follow-up|1|||
42134050|NCT03839940|75944884|FG000|Overall Study|Withdrawal by Subject|3|||
42261976|NCT02796391|76089502|FG003|Overall Study|Participant did not like study cigarettes|0|||
42261977|NCT02796391|76089503|FG004|Overall Study|Participant did not like study cigarettes|0|||
41997190|NCT01181986|75805239|FG002|Phase 2|Adverse Event|0|||
41997191|NCT01181986|75805237|FG000|Phase 2|Medical condition|0|||
42261978|NCT02796391|76089504|FG005|Overall Study|Participant did not like study cigarettes|0|||
42261979|NCT02796391|76089499|FG000|Overall Study|Withdrawal by Subject|1|||
42261980|NCT02796391|76089500|FG001|Overall Study|Withdrawal by Subject|1|||
42261981|NCT02796391|76089501|FG002|Overall Study|Withdrawal by Subject|4|||
42261982|NCT02796391|76089502|FG003|Overall Study|Withdrawal by Subject|3|||
42261983|NCT02796391|76089503|FG004|Overall Study|Withdrawal by Subject|4|||
42261984|NCT02796391|76089504|FG005|Overall Study|Withdrawal by Subject|3|||
42261985|NCT02796391|76089499|FG000|Overall Study|Adverse Event|0|||
42261986|NCT02796391|76089500|FG001|Overall Study|Adverse Event|0|||
42261987|NCT02796391|76089501|FG002|Overall Study|Adverse Event|0|||
42327823|NCT01920711|76165623|FG000|Overall Study|Withdrawal by Subject|4|||
42327824|NCT01920711|76165624|FG001|Overall Study|Withdrawal by Subject|3|||
42327825|NCT02180438|76165631|FG000|Overall Study|Lost to Follow-up|1|||
42327826|NCT02179190|76165635|FG000|Enrollment|Exit Prior to Device Attempt|11|||
42327827|NCT02179190|76165635|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
42327828|NCT02179190|76165635|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
42327829|NCT02179190|76165635|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
41997192|NCT01181986|75805238|FG001|Phase 2|Medical condition|1|||
41997193|NCT01181986|75805239|FG002|Phase 2|Medical condition|0|||
41997194|NCT01181167|75805255|FG000|Overall Study|Adverse Event|11|||
41997195|NCT01181167|75805256|FG001|Overall Study|Adverse Event|21|||
42261988|NCT02796391|76089502|FG003|Overall Study|Adverse Event|1|||
42261989|NCT02796391|76089503|FG004|Overall Study|Adverse Event|0|||
42261990|NCT02796391|76089504|FG005|Overall Study|Adverse Event|0|||
42261991|NCT02796391|76089499|FG000|Overall Study|Protocol Violation|0|||
42261992|NCT02796391|76089500|FG001|Overall Study|Protocol Violation|0|||
42261993|NCT02796391|76089501|FG002|Overall Study|Protocol Violation|0|||
42261994|NCT02796391|76089502|FG003|Overall Study|Protocol Violation|1|||
42327830|NCT02179190|76165635|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
42327831|NCT02179190|76165635|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
42327832|NCT02157116|76165639|FG000|Overall Study|Withdrawal by Subject|4|||
42261995|NCT02796391|76089503|FG004|Overall Study|Protocol Violation|0|||
42327833|NCT02157116|76165639|FG000|Overall Study|Physician Decision|3|||
42327834|NCT02157116|76165639|FG000|Overall Study|Failed Screening|2|||
42327835|NCT01920555|76165648|FG000|Overall Study|Physician Decision|1|||
42327836|NCT01920555|76165649|FG001|Overall Study|Physician Decision|2|||
42327837|NCT01920555|76165650|FG002|Overall Study|Physician Decision|1|||
42327838|NCT01920555|76165651|FG003|Overall Study|Physician Decision|2|||
42327839|NCT01920555|76165652|FG004|Overall Study|Physician Decision|0|||
42327840|NCT01920555|76165648|FG000|Overall Study|Lack of Efficacy|2|||
42327841|NCT01920555|76165649|FG001|Overall Study|Lack of Efficacy|0|||
42327842|NCT01920555|76165650|FG002|Overall Study|Lack of Efficacy|0|||
41997196|NCT01181167|75805255|FG000|Overall Study|Lost to Follow-up|1|||
41997197|NCT01181167|75805256|FG001|Overall Study|Lost to Follow-up|0|||
41997198|NCT01181167|75805255|FG000|Overall Study|Physician Decision|2|||
41997199|NCT01181167|75805256|FG001|Overall Study|Physician Decision|3|||
41997200|NCT01181167|75805255|FG000|Overall Study|Protocol Violation|3|||
41997201|NCT01181167|75805256|FG001|Overall Study|Protocol Violation|0|||
41997202|NCT01181167|75805255|FG000|Overall Study|Withdrawal by Subject|6|||
41997203|NCT01181167|75805256|FG001|Overall Study|Withdrawal by Subject|8|||
41997204|NCT01181128|75805265|FG000|Overall Study|Withdrawal by Subject|2|||
42134051|NCT03839940|75944885|FG001|Overall Study|Withdrawal by Subject|0|||
41997205|NCT01181128|75805266|FG001|Overall Study|Withdrawal by Subject|2|||
42134052|NCT03839940|75944884|FG000|Overall Study|Protocol Violation|0|||
41997206|NCT01181128|75805267|FG002|Overall Study|Withdrawal by Subject|0|||
41997207|NCT01181128|75805265|FG000|Overall Study|Death|1|||
41997208|NCT01181128|75805266|FG001|Overall Study|Death|0|||
41997209|NCT01181128|75805267|FG002|Overall Study|Death|0|||
41997210|NCT01181128|75805265|FG000|Overall Study|Physician Decision|2|||
41997211|NCT01181128|75805266|FG001|Overall Study|Physician Decision|0|||
41997212|NCT01181128|75805267|FG002|Overall Study|Physician Decision|0|||
41997213|NCT01181128|75805265|FG000|Overall Study|Adverse Event|0|||
41997214|NCT01181128|75805266|FG001|Overall Study|Adverse Event|2|||
41997215|NCT01181128|75805267|FG002|Overall Study|Adverse Event|0|||
41997216|NCT01181128|75805265|FG000|Overall Study|Other|1|||
41997217|NCT01181128|75805266|FG001|Overall Study|Other|1|||
41997218|NCT01181128|75805267|FG002|Overall Study|Other|1|||
41997219|NCT01203787|75805289|FG000|Overall Study|Death|12|||
41997220|NCT01203787|75805290|FG001|Overall Study|Death|10|||
41997221|NCT01203787|75805289|FG000|Overall Study|Withdrawal by Subject|6|||
41997222|NCT01203787|75805290|FG001|Overall Study|Withdrawal by Subject|2|||
41997223|NCT01203787|75805289|FG000|Overall Study|Lost to Follow-up|2|||
41997224|NCT01203787|75805290|FG001|Overall Study|Lost to Follow-up|0|||
41997225|NCT01203787|75805289|FG000|Overall Study|Adverse Event|11|||
41997226|NCT01203787|75805290|FG001|Overall Study|Adverse Event|15|||
41997227|NCT01181011|75805298|FG000|Overall Study|Adverse Event|2|||
41997228|NCT01181011|75805298|FG000|Overall Study|Lost to Follow-up|1|||
41997229|NCT01180777|75805307|FG000|Overall Study|Protocol Violation|6|||
41997230|NCT01180777|75805307|FG000|Overall Study|Poor lens fit|4|||
41997231|NCT01180777|75805307|FG000|Overall Study|Lost to Follow-up|1|||
41997232|NCT01180777|75805307|FG000|Overall Study|Adverse Event|1|||
41997233|NCT01648023|75805315|FG000|Overall Study|Screen Fail Post Randomization|1|||
41997234|NCT01648023|75805316|FG001|Overall Study|Screen Fail Post Randomization|2|||
41997235|NCT02756208|75805330|FG000|Overall Study|Withdrawal by Subject|1|||
41997236|NCT02756208|75805331|FG001|Overall Study|Withdrawal by Subject|0|||
41997237|NCT02756208|75805332|FG002|Overall Study|Withdrawal by Subject|1|||
41997238|NCT02756208|75805333|FG003|Overall Study|Withdrawal by Subject|3|||
41997239|NCT02756208|75805330|FG000|Overall Study|Lost to Follow-up|3|||
41997240|NCT02756208|75805331|FG001|Overall Study|Lost to Follow-up|1|||
41997241|NCT02756208|75805332|FG002|Overall Study|Lost to Follow-up|1|||
41997242|NCT02756208|75805333|FG003|Overall Study|Lost to Follow-up|1|||
41997243|NCT02756208|75805330|FG000|Overall Study|Physician Decision|1|||
41997244|NCT02756208|75805331|FG001|Overall Study|Physician Decision|0|||
41997245|NCT02756208|75805332|FG002|Overall Study|Physician Decision|0|||
41997246|NCT02756208|75805333|FG003|Overall Study|Physician Decision|0|||
41997247|NCT02756208|75805330|FG000|Overall Study|Protocol Violation|0|||
41997248|NCT02756208|75805331|FG001|Overall Study|Protocol Violation|1|||
41997249|NCT02756208|75805332|FG002|Overall Study|Protocol Violation|0|||
41997250|NCT02756208|75805333|FG003|Overall Study|Protocol Violation|0|||
41997251|NCT02756013|75805343|FG000|Overall Study|Adverse Event|1|||
41997252|NCT02756013|75805343|FG000|Overall Study|Hypersensitivity|1|||
41997253|NCT01202773|75805350|FG000|Overall Study|Adverse Event|4|||
41997254|NCT01202773|75805351|FG001|Overall Study|Adverse Event|5|||
42261996|NCT02796391|76089504|FG005|Overall Study|Protocol Violation|0|||
42327843|NCT01920555|76165651|FG003|Overall Study|Lack of Efficacy|0|||
42327844|NCT01920555|76165652|FG004|Overall Study|Lack of Efficacy|0|||
42261997|NCT01370317|76089520|FG000|Overall Study|Participant withdrew consent|1|||
42261998|NCT01370317|76089521|FG001|Overall Study|Participant withdrew consent|0|||
42261999|NCT01370317|76089520|FG000|Overall Study|Protocol deviation|0|||
42262000|NCT01370317|76089521|FG001|Overall Study|Protocol deviation|1|||
42262001|NCT01370083|76089529|FG000|Overall Study|Lost to Follow-up|2|||
42262002|NCT01370083|76089530|FG001|Overall Study|Lost to Follow-up|0|||
42327845|NCT01920555|76165648|FG000|Overall Study|Travel Difficulties|1|||
42327846|NCT01920555|76165649|FG001|Overall Study|Travel Difficulties|1|||
41997255|NCT01202773|75805352|FG002|Overall Study|Adverse Event|5|||
42262003|NCT01370083|76089529|FG000|Overall Study|Adverse Event|0|||
42262004|NCT01370083|76089530|FG001|Overall Study|Adverse Event|1|||
42262005|NCT03350815|76089536|FG000|Period 1|Adverse Event|10|||
41997256|NCT01202773|75805350|FG000|Overall Study|Lack of Efficacy|5|||
41997257|NCT01202773|75805351|FG001|Overall Study|Lack of Efficacy|4|||
41997258|NCT01202773|75805352|FG002|Overall Study|Lack of Efficacy|9|||
41997259|NCT01202773|75805350|FG000|Overall Study|Entry Criteria Not Met|2|||
41997260|NCT01202773|75805351|FG001|Overall Study|Entry Criteria Not Met|0|||
41997261|NCT01202773|75805352|FG002|Overall Study|Entry Criteria Not Met|1|||
41997262|NCT01202773|75805350|FG000|Overall Study|Lost to Follow-up|1|||
41997263|NCT01202773|75805351|FG001|Overall Study|Lost to Follow-up|2|||
42262006|NCT03350815|76089537|FG001|Period 1|Adverse Event|0|||
42262007|NCT03350815|76089538|FG002|Period 1|Adverse Event|0|||
41997264|NCT01202773|75805352|FG002|Overall Study|Lost to Follow-up|2|||
41997265|NCT01202773|75805350|FG000|Overall Study|Withdrawal by Subject|13|||
42262008|NCT03350815|76089539|FG003|Period 1|Adverse Event|0|||
41997266|NCT01202773|75805351|FG001|Overall Study|Withdrawal by Subject|6|||
41997267|NCT01202773|75805352|FG002|Overall Study|Withdrawal by Subject|5|||
41997268|NCT01202773|75805350|FG000|Overall Study|Physician Decision|2|||
41997269|NCT01202773|75805351|FG001|Overall Study|Physician Decision|0|||
41997270|NCT01202773|75805352|FG002|Overall Study|Physician Decision|0|||
41997271|NCT01202773|75805350|FG000|Overall Study|Protocol Violation|11|||
41997272|NCT01202773|75805351|FG001|Overall Study|Protocol Violation|6|||
41997273|NCT01202773|75805352|FG002|Overall Study|Protocol Violation|10|||
41997274|NCT01202773|75805350|FG000|Overall Study|Sponsor Decision|19|||
41997275|NCT01202773|75805351|FG001|Overall Study|Sponsor Decision|20|||
41997276|NCT01202773|75805352|FG002|Overall Study|Sponsor Decision|23|||
41997277|NCT01180660|75805372|FG000|Overall Study|Changed to open surgery|1|||
41997278|NCT01180660|75805373|FG001|Overall Study|Changed to open surgery|0|||
41997279|NCT01202227|75805379|FG000|Overall Study|Adverse Event|16|||
41997280|NCT01202227|75805379|FG000|Overall Study|Withdrawal by Subject|2|||
41997281|NCT01202227|75805379|FG000|Overall Study|Lack of Efficacy|1|||
41997282|NCT01202188|75805388|FG000|Overall Study|Protocol deviation|14|||
41997283|NCT01202188|75805389|FG001|Overall Study|Protocol deviation|8|||
41997284|NCT01202188|75805390|FG002|Overall Study|Protocol deviation|12|||
41997285|NCT01202188|75805391|FG003|Overall Study|Protocol deviation|10|||
41997286|NCT01202188|75805392|FG004|Overall Study|Protocol deviation|11|||
41997287|NCT01202188|75805388|FG000|Overall Study|Subject withdrew consent|12|||
41997288|NCT01202188|75805389|FG001|Overall Study|Subject withdrew consent|13|||
41997289|NCT01202188|75805390|FG002|Overall Study|Subject withdrew consent|22|||
41997290|NCT01202188|75805391|FG003|Overall Study|Subject withdrew consent|11|||
41997291|NCT01202188|75805392|FG004|Overall Study|Subject withdrew consent|13|||
41997292|NCT01202188|75805388|FG000|Overall Study|Adverse Event|5|||
41997293|NCT01202188|75805389|FG001|Overall Study|Adverse Event|23|||
41997294|NCT01202188|75805390|FG002|Overall Study|Adverse Event|13|||
41997295|NCT01202188|75805391|FG003|Overall Study|Adverse Event|10|||
41997296|NCT01202188|75805392|FG004|Overall Study|Adverse Event|10|||
41997297|NCT01202188|75805388|FG000|Overall Study|Administrative problems|3|||
41997298|NCT01202188|75805389|FG001|Overall Study|Administrative problems|2|||
41997299|NCT01202188|75805390|FG002|Overall Study|Administrative problems|1|||
41997300|NCT01202188|75805391|FG003|Overall Study|Administrative problems|1|||
41997301|NCT01202188|75805392|FG004|Overall Study|Administrative problems|2|||
41997302|NCT01202188|75805388|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
41997303|NCT01202188|75805389|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
41997304|NCT01202188|75805390|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
41997305|NCT01202188|75805391|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
41997306|NCT01202188|75805392|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
41997307|NCT01202188|75805388|FG000|Overall Study|Lost to Follow-up|1|||
41997308|NCT01202188|75805389|FG001|Overall Study|Lost to Follow-up|1|||
41997309|NCT01202188|75805390|FG002|Overall Study|Lost to Follow-up|0|||
41997310|NCT01202188|75805391|FG003|Overall Study|Lost to Follow-up|4|||
41997311|NCT01202188|75805392|FG004|Overall Study|Lost to Follow-up|1|||
41997312|NCT01202188|75805388|FG000|Overall Study|Death|1|||
41997313|NCT01202188|75805389|FG001|Overall Study|Death|1|||
41997314|NCT01202188|75805390|FG002|Overall Study|Death|1|||
41997315|NCT01202188|75805391|FG003|Overall Study|Death|1|||
41997316|NCT01202188|75805392|FG004|Overall Study|Death|0|||
41997317|NCT01202188|75805388|FG000|Overall Study|Abnormal test procedure result (s)|0|||
41997318|NCT01202188|75805389|FG001|Overall Study|Abnormal test procedure result (s)|0|||
41997319|NCT01202188|75805390|FG002|Overall Study|Abnormal test procedure result (s)|2|||
41997320|NCT01202188|75805391|FG003|Overall Study|Abnormal test procedure result (s)|0|||
41997321|NCT01202188|75805392|FG004|Overall Study|Abnormal test procedure result (s)|0|||
41997322|NCT01201915|75805413|FG000|Overall Study|Adverse Event|2|||
41997323|NCT01201915|75805414|FG001|Overall Study|Adverse Event|1|||
41997324|NCT01201915|75805415|FG002|Overall Study|Adverse Event|1|||
41997325|NCT01201915|75805413|FG000|Overall Study|Lost to Follow-up|0|||
41997326|NCT01201915|75805414|FG001|Overall Study|Lost to Follow-up|4|||
41997327|NCT01201915|75805415|FG002|Overall Study|Lost to Follow-up|0|||
41997328|NCT01201915|75805413|FG000|Overall Study|Physician Decision|3|||
41997329|NCT01201915|75805414|FG001|Overall Study|Physician Decision|0|||
41997330|NCT01201915|75805415|FG002|Overall Study|Physician Decision|0|||
41997331|NCT01201915|75805413|FG000|Overall Study|Subject Decision|3|||
41997332|NCT01201915|75805414|FG001|Overall Study|Subject Decision|3|||
41997333|NCT01201915|75805415|FG002|Overall Study|Subject Decision|5|||
41997334|NCT01201915|75805413|FG000|Overall Study|Target Lesion Progression|0|||
41997335|NCT01201915|75805414|FG001|Overall Study|Target Lesion Progression|3|||
41997336|NCT01201915|75805415|FG002|Overall Study|Target Lesion Progression|0|||
41997337|NCT01179919|75805423|FG000|Overall Study|Protocol Violation|1|||
41997338|NCT01179919|75805423|FG000|Overall Study|Adverse Event|1|||
41997339|NCT01201798|75805429|FG000|Overall Study|Adverse Event|2|||
41997340|NCT01201798|75805430|FG001|Overall Study|Adverse Event|0|||
41997341|NCT01201798|75805429|FG000|Overall Study|Lost to Follow-up|3|||
41997342|NCT01201798|75805430|FG001|Overall Study|Lost to Follow-up|5|||
42327847|NCT01920555|76165650|FG002|Overall Study|Travel Difficulties|0|||
42327848|NCT01920555|76165651|FG003|Overall Study|Travel Difficulties|0|||
42327849|NCT01920555|76165652|FG004|Overall Study|Travel Difficulties|1|||
42327850|NCT01920555|76165648|FG000|Overall Study|Lost to Follow-up|0|||
42327851|NCT01920555|76165649|FG001|Overall Study|Lost to Follow-up|1|||
42327852|NCT01920555|76165650|FG002|Overall Study|Lost to Follow-up|0|||
42327853|NCT01920555|76165651|FG003|Overall Study|Lost to Follow-up|1|||
42327854|NCT01920555|76165652|FG004|Overall Study|Lost to Follow-up|0|||
42327855|NCT02156804|76165664|FG000|Overall Study|Withdrawal by Subject|1|||
42327856|NCT02156492|76165671|FG000|Period 1|No Reason Given|0|||
42327857|NCT02156492|76165672|FG001|Period 1|No Reason Given|1|||
42327858|NCT02156492|76165673|FG002|Period 1|No Reason Given|0|||
42327859|NCT02156492|76165671|FG000|Period 3|Adverse Event|0|||
42327860|NCT02156492|76165672|FG001|Period 3|Adverse Event|1|||
42327861|NCT02156492|76165673|FG002|Period 3|Adverse Event|0|||
42327862|NCT01920477|76165693|FG000|Overall Study|Adverse Event|0|||
42327863|NCT01920477|76165694|FG001|Overall Study|Adverse Event|1|||
42327864|NCT01920477|76165693|FG000|Overall Study|Lack of Efficacy|1|||
42327865|NCT01920477|76165694|FG001|Overall Study|Lack of Efficacy|0|||
42327866|NCT01920477|76165693|FG000|Overall Study|Study closed/terminated|14|||
42327867|NCT01920477|76165694|FG001|Overall Study|Study closed/terminated|15|||
42327868|NCT01920477|76165693|FG000|Overall Study|Withdrawal by Subject|0|||
42327869|NCT01920477|76165694|FG001|Overall Study|Withdrawal by Subject|1|||
42327870|NCT02213042|76165703|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
42327871|NCT02213042|76165704|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
42327872|NCT02213042|76165705|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
42327873|NCT02213042|76165703|FG000|Overall Study|Adverse Event|2|||
41997343|NCT01201798|75805429|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
41997344|NCT01201798|75805430|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
41997345|NCT01201798|75805429|FG000|Overall Study|Noncompliance|1|||
41997346|NCT01201798|75805430|FG001|Overall Study|Noncompliance|0|||
41997347|NCT01201798|75805429|FG000|Overall Study|Protocol Violation|1|||
41997348|NCT01201798|75805430|FG001|Overall Study|Protocol Violation|1|||
41997349|NCT01201798|75805429|FG000|Overall Study|Treatment Failure|1|||
41997350|NCT01201798|75805430|FG001|Overall Study|Treatment Failure|8|||
41997351|NCT01201759|75805438|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
41997352|NCT01201759|75805439|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
41997353|NCT01201759|75805438|FG000|Visit 3 - Washout|Adverse Event|0|||
41997354|NCT01201759|75805439|FG001|Visit 3 - Washout|Adverse Event|3|||
41997355|NCT01201759|75805438|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
41997356|NCT01201759|75805439|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
41997357|NCT01201759|75805438|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
41997358|NCT01201759|75805439|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
41997359|NCT01200589|75805449|FG000|Overall Study|Withdrawal by Subject|13|||
42134053|NCT03839940|75944885|FG001|Overall Study|Protocol Violation|1|||
42262009|NCT03350815|76089536|FG000|Period 1|Technical problems|1|||
42262010|NCT03350815|76089537|FG001|Period 1|Technical problems|0|||
42262011|NCT03350815|76089538|FG002|Period 1|Technical problems|0|||
42262012|NCT03350815|76089539|FG003|Period 1|Technical problems|0|||
42262013|NCT03350815|76089536|FG000|Period 1|Lost to Follow-up|3|||
42262014|NCT03350815|76089537|FG001|Period 1|Lost to Follow-up|0|||
42262015|NCT03350815|76089538|FG002|Period 1|Lost to Follow-up|0|||
42262016|NCT03350815|76089539|FG003|Period 1|Lost to Follow-up|0|||
42262017|NCT03350815|76089536|FG000|Period 1|Physician Decision|1|||
42262018|NCT03350815|76089537|FG001|Period 1|Physician Decision|0|||
42262019|NCT03350815|76089538|FG002|Period 1|Physician Decision|0|||
42262020|NCT03350815|76089539|FG003|Period 1|Physician Decision|0|||
42327874|NCT02213042|76165704|FG001|Overall Study|Adverse Event|1|||
42134054|NCT03839940|75944884|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
42262021|NCT03350815|76089536|FG000|Period 1|Withdrawal by Subject|8|||
42262022|NCT03350815|76089537|FG001|Period 1|Withdrawal by Subject|0|||
42262023|NCT03350815|76089538|FG002|Period 1|Withdrawal by Subject|0|||
42327875|NCT02213042|76165705|FG002|Overall Study|Adverse Event|0|||
42327876|NCT02213042|76165703|FG000|Overall Study|Withdrawal by Subject|0|||
41997360|NCT01200589|75805450|FG001|Overall Study|Withdrawal by Subject|11|||
41997361|NCT01200589|75805449|FG000|Overall Study|Physician Decision|2|||
41997362|NCT01200589|75805450|FG001|Overall Study|Physician Decision|2|||
41997363|NCT01200589|75805449|FG000|Overall Study|Lost to Follow-up|5|||
41997364|NCT01200589|75805450|FG001|Overall Study|Lost to Follow-up|4|||
41997365|NCT01200589|75805449|FG000|Overall Study|Study terminated|170|||
41997366|NCT01200589|75805450|FG001|Overall Study|Study terminated|172|||
41997367|NCT01200511|75805456|FG000|Overall Study|Lost to Follow-up|3|||
41997368|NCT01200511|75805456|FG000|Overall Study|Withdrawal by Subject|1|||
42262024|NCT03350815|76089539|FG003|Period 1|Withdrawal by Subject|0|||
42262025|NCT03350815|76089536|FG000|Period 1|Lack of Efficacy|15|||
42262026|NCT03350815|76089537|FG001|Period 1|Lack of Efficacy|0|||
42262027|NCT03350815|76089538|FG002|Period 1|Lack of Efficacy|0|||
42262028|NCT03350815|76089539|FG003|Period 1|Lack of Efficacy|0|||
42262029|NCT03350815|76089536|FG000|Period 1|Non-compliance with study treatment|2|||
42327877|NCT02213042|76165704|FG001|Overall Study|Withdrawal by Subject|1|||
42327878|NCT02213042|76165705|FG002|Overall Study|Withdrawal by Subject|1|||
42327879|NCT02213042|76165703|FG000|Overall Study|Protocol Violation|1|||
42327880|NCT02213042|76165704|FG001|Overall Study|Protocol Violation|0|||
42327881|NCT02213042|76165705|FG002|Overall Study|Protocol Violation|0|||
42327882|NCT02213042|76165703|FG000|Overall Study|Investigator discretion|0|||
42327883|NCT02213042|76165704|FG001|Overall Study|Investigator discretion|0|||
42327884|NCT02213042|76165705|FG002|Overall Study|Investigator discretion|1|||
42327885|NCT02212730|76165717|FG000|Overall Study|Tumor not of the required cell histology|1|||
42327886|NCT02212730|76165718|FG001|Overall Study|Tumor not of the required cell histology|0|||
42327887|NCT02212730|76165717|FG000|Overall Study|Withdrawal by Subject|1|||
42327888|NCT02212730|76165718|FG001|Overall Study|Withdrawal by Subject|0|||
42327889|NCT02212730|76165717|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
42327890|NCT02212730|76165718|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
42327891|NCT02178956|76165728|FG000|Overall Study|Lost to Follow-up|4|||
42327892|NCT02178956|76165729|FG001|Overall Study|Lost to Follow-up|4|||
42327893|NCT02178956|76165728|FG000|Overall Study|Sponsor terminated study|49|||
42327894|NCT02178956|76165729|FG001|Overall Study|Sponsor terminated study|58|||
42327895|NCT02178956|76165728|FG000|Overall Study|Withdrawal by Subject|15|||
42327896|NCT02178956|76165729|FG001|Overall Study|Withdrawal by Subject|11|||
42327897|NCT02178956|76165728|FG000|Overall Study|Various Reasons|3|||
42327898|NCT02178956|76165729|FG001|Overall Study|Various Reasons|5|||
42327899|NCT02211638|76165739|FG000|Overall Study|Case Report Forms Uncollected|291|||
42327900|NCT02211638|76165739|FG000|Overall Study|Protocol Violation|692|||
42327901|NCT02178566|76165745|FG000|Overall Study|patient did not complete due to noncompliance|0|||
42327902|NCT02178566|76165746|FG001|Overall Study|patient did not complete due to noncompliance|1|||
42327903|NCT02211014|76165754|FG000|Overall Study|Adverse Event|0|||
42327904|NCT02211014|76165755|FG001|Overall Study|Adverse Event|2|||
42327905|NCT02211014|76165754|FG000|Overall Study|Physician Decision|1|||
42327906|NCT02211014|76165755|FG001|Overall Study|Physician Decision|2|||
42134055|NCT03839940|75944885|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
42262030|NCT03350815|76089537|FG001|Period 1|Non-compliance with study treatment|0|||
42327907|NCT02211014|76165754|FG000|Overall Study|Started another cancer therapy|1|||
42327908|NCT02211014|76165755|FG001|Overall Study|Started another cancer therapy|0|||
42327909|NCT02211014|76165754|FG000|Overall Study|Withdrawal by Subject|0|||
42327910|NCT02211014|76165755|FG001|Overall Study|Withdrawal by Subject|1|||
42327911|NCT02211014|76165754|FG000|Overall Study|In agreement with patient, no benefit|0|||
42327912|NCT02211014|76165755|FG001|Overall Study|In agreement with patient, no benefit|1|||
42327913|NCT01631864|76165779|FG000|Overall Study|Withdrawal by Subject|0|||
42327914|NCT01631864|76165780|FG001|Overall Study|Withdrawal by Subject|1|||
42327915|NCT01631864|76165779|FG000|Overall Study|Adverse Event|2|||
42327916|NCT01631864|76165780|FG001|Overall Study|Adverse Event|3|||
42327917|NCT02210780|76165788|FG000|Overall Study|Adverse Event|0|||
41997369|NCT01200511|75805456|FG000|Overall Study|Adverse Event|1|||
41997370|NCT01179334|75805464|FG000|Treatment Period|Adverse Event|1|||
41997371|NCT01179334|75805465|FG001|Treatment Period|Adverse Event|0|||
42262031|NCT03350815|76089538|FG002|Period 1|Non-compliance with study treatment|0|||
42327918|NCT02210780|76165789|FG001|Overall Study|Adverse Event|5|||
42327919|NCT02210780|76165788|FG000|Overall Study|Lost to Follow-up|2|||
42327920|NCT02210780|76165789|FG001|Overall Study|Lost to Follow-up|1|||
42327921|NCT02210780|76165788|FG000|Overall Study|Withdrawal by Subject|1|||
42327922|NCT02210780|76165789|FG001|Overall Study|Withdrawal by Subject|1|||
42327923|NCT02210780|76165788|FG000|Overall Study|Physician Decision|1|||
42327924|NCT02210780|76165789|FG001|Overall Study|Physician Decision|0|||
42327925|NCT02210780|76165788|FG000|Overall Study|Protocol Violation|1|||
42327926|NCT02210780|76165789|FG001|Overall Study|Protocol Violation|0|||
42327927|NCT02210780|76165788|FG000|Overall Study|Other than specified above|0|||
42327928|NCT02210780|76165789|FG001|Overall Study|Other than specified above|1|||
42327929|NCT01557244|76165800|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
42327930|NCT01557244|76165801|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
42327931|NCT01557244|76165802|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
42327932|NCT01557244|76165803|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
41997372|NCT01179334|75805464|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
41997373|NCT01179334|75805465|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
41997374|NCT01179334|75805464|FG000|Long-term Extension (LTE) Period|Death|3|||
41997375|NCT01179334|75805465|FG001|Long-term Extension (LTE) Period|Death|0|||
41997376|NCT01179334|75805464|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
41997377|NCT01179334|75805465|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
41997378|NCT01178671|75805473|FG000|Overall Study|Adverse Event|4|||
41997379|NCT01178671|75805474|FG001|Overall Study|Adverse Event|6|||
41997380|NCT01178671|75805473|FG000|Overall Study|Protocol Violation|1|||
41997381|NCT01178671|75805474|FG001|Overall Study|Protocol Violation|1|||
41997382|NCT01178671|75805473|FG000|Overall Study|Lack of Efficacy|0|||
41997383|NCT01178671|75805474|FG001|Overall Study|Lack of Efficacy|1|||
41997384|NCT01178671|75805473|FG000|Overall Study|Lost to Follow-up|3|||
41997385|NCT01178671|75805474|FG001|Overall Study|Lost to Follow-up|1|||
41997386|NCT01178671|75805473|FG000|Overall Study|Physician Decision|4|||
41997387|NCT01178671|75805474|FG001|Overall Study|Physician Decision|6|||
42327933|NCT01557244|76165804|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
42327934|NCT01557244|76165805|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
42327935|NCT01557244|76165806|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
42327936|NCT01557244|76165800|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
42327937|NCT01557244|76165801|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
42327938|NCT01557244|76165802|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
42327939|NCT01557244|76165803|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
42327940|NCT01557244|76165804|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
42327941|NCT01557244|76165805|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
42327942|NCT01557244|76165806|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
42327943|NCT01557244|76165800|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
42327944|NCT01557244|76165801|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
41997388|NCT01178125|75805480|FG000|Overall Study|Lost to Follow-up|397|||
41997389|NCT01178125|75805480|FG000|Overall Study|Adverse Event|244|||
41997390|NCT01178125|75805480|FG000|Overall Study|Withdrawal by Subject|209|||
41997391|NCT01178125|75805480|FG000|Overall Study|Noncompliance|184|||
42262032|NCT03350815|76089539|FG003|Period 1|Non-compliance with study treatment|0|||
42262033|NCT03350815|76089536|FG000|Period 1|Protocol Violation|3|||
42262034|NCT03350815|76089537|FG001|Period 1|Protocol Violation|0|||
42262035|NCT03350815|76089538|FG002|Period 1|Protocol Violation|0|||
42262036|NCT03350815|76089539|FG003|Period 1|Protocol Violation|0|||
42262037|NCT03350815|76089536|FG000|Period 2|Adverse Event|0|||
42262038|NCT03350815|76089537|FG001|Period 2|Adverse Event|3|||
42262039|NCT03350815|76089538|FG002|Period 2|Adverse Event|5|||
42262040|NCT03350815|76089539|FG003|Period 2|Adverse Event|0|||
42262041|NCT03350815|76089536|FG000|Period 2|Technical problem|0|||
42262042|NCT03350815|76089537|FG001|Period 2|Technical problem|1|||
42327945|NCT01557244|76165802|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
41997392|NCT01178125|75805480|FG000|Overall Study|Pregnancy|55|||
41997393|NCT01178125|75805480|FG000|Overall Study|Other Reason|39|||
41997394|NCT01178125|75805480|FG000|Overall Study|Sponsor Decision|28|||
41997395|NCT01178125|75805480|FG000|Overall Study|Protocol Violation|17|||
41997396|NCT01178125|75805480|FG000|Overall Study|Investigator Decision|5|||
41997397|NCT01178086|75805502|FG000|Overall Study|Participant refusal|7|||
41997398|NCT01178086|75805502|FG000|Overall Study|Physician Decision|44|||
42262043|NCT03350815|76089538|FG002|Period 2|Technical problem|0|||
42262044|NCT03350815|76089539|FG003|Period 2|Technical problem|0|||
42327946|NCT01557244|76165803|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
41997399|NCT01178086|75805502|FG000|Overall Study|Switch to other CLL therapy|113|||
41997400|NCT01178086|75805502|FG000|Overall Study|Death|59|||
41997401|NCT01178086|75805502|FG000|Overall Study|Other unspecified|89|||
41997402|NCT01178086|75805502|FG000|Overall Study|Excluded from EAS|20|||
41997403|NCT01177969|75805510|FG000|Overall Study|Protocol Violation|2|||
41997404|NCT01177969|75805511|FG001|Overall Study|Protocol Violation|1|||
42327947|NCT01557244|76165804|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
42327948|NCT01557244|76165805|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
42327949|NCT01557244|76165806|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
42327950|NCT01557244|76165800|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
42327951|NCT01557244|76165801|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
42327952|NCT01557244|76165802|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
42327953|NCT01557244|76165803|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
42327954|NCT01557244|76165804|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
42327955|NCT01557244|76165805|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
42327956|NCT01557244|76165806|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
42327957|NCT01557244|76165800|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
42327958|NCT01557244|76165801|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
42327959|NCT01557244|76165802|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
42327960|NCT01557244|76165803|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
42327961|NCT01557244|76165804|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
42327962|NCT01557244|76165805|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
42327963|NCT01557244|76165806|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
42327964|NCT01557244|76165800|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
42327965|NCT01557244|76165801|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
42327966|NCT01557244|76165802|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
42327967|NCT01557244|76165803|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
42327968|NCT01557244|76165804|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
42327969|NCT01557244|76165805|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
42327970|NCT01557244|76165806|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
42327971|NCT01557244|76165800|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
42327972|NCT01557244|76165801|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
42327973|NCT01557244|76165802|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
42327974|NCT01557244|76165803|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
42327975|NCT01557244|76165804|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
42262045|NCT03350815|76089536|FG000|Period 2|Lost to Follow-up|0|||
42262046|NCT03350815|76089537|FG001|Period 2|Lost to Follow-up|3|||
42262047|NCT03350815|76089538|FG002|Period 2|Lost to Follow-up|3|||
42262048|NCT03350815|76089539|FG003|Period 2|Lost to Follow-up|0|||
42262049|NCT03350815|76089536|FG000|Period 2|Physician Decision|0|||
42262050|NCT03350815|76089537|FG001|Period 2|Physician Decision|0|||
42262051|NCT03350815|76089538|FG002|Period 2|Physician Decision|1|||
42262052|NCT03350815|76089539|FG003|Period 2|Physician Decision|0|||
42262053|NCT03350815|76089536|FG000|Period 2|Withdrawal by Subject|0|||
42262054|NCT03350815|76089537|FG001|Period 2|Withdrawal by Subject|3|||
42262055|NCT03350815|76089538|FG002|Period 2|Withdrawal by Subject|4|||
41997405|NCT01177969|75805510|FG000|Overall Study|Withdrawal by Subject|1|||
42262056|NCT03350815|76089539|FG003|Period 2|Withdrawal by Subject|0|||
42262057|NCT03350815|76089536|FG000|Period 2|Lack of Efficacy|0|||
42262058|NCT03350815|76089537|FG001|Period 2|Lack of Efficacy|6|||
42134056|NCT03839628|75944893|FG000|Overall Study|Withdrawal by Subject|1|||
42262059|NCT03350815|76089538|FG002|Period 2|Lack of Efficacy|2|||
41997406|NCT01177969|75805511|FG001|Overall Study|Withdrawal by Subject|2|||
42262060|NCT03350815|76089539|FG003|Period 2|Lack of Efficacy|0|||
42262061|NCT03350815|76089536|FG000|Period 2|Protocol Violation|0|||
42262062|NCT03350815|76089537|FG001|Period 2|Protocol Violation|0|||
42262063|NCT03350815|76089538|FG002|Period 2|Protocol Violation|1|||
42262064|NCT03350815|76089539|FG003|Period 2|Protocol Violation|0|||
42262065|NCT03350815|76089536|FG000|Period 2|New therapy for study indication|0|||
42327976|NCT01557244|76165805|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
42327977|NCT01557244|76165806|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
42262066|NCT03350815|76089537|FG001|Period 2|New therapy for study indication|0|||
42262067|NCT03350815|76089538|FG002|Period 2|New therapy for study indication|1|||
42262068|NCT03350815|76089539|FG003|Period 2|New therapy for study indication|0|||
42262069|NCT00854295|76089554|FG000|Overall Study|Death|7|||
42262070|NCT00854295|76089555|FG001|Overall Study|Death|0|||
42262071|NCT00854295|76089556|FG002|Overall Study|Death|1|||
42262072|NCT00854295|76089557|FG003|Overall Study|Death|1|||
42327978|NCT01557244|76165800|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
42327979|NCT01557244|76165801|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
42327980|NCT01557244|76165802|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
42327981|NCT01557244|76165803|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
42327982|NCT01557244|76165804|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
42327983|NCT01557244|76165805|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
42327984|NCT01557244|76165806|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
42327985|NCT01557244|76165800|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
42327986|NCT01557244|76165801|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
42327987|NCT01557244|76165802|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
42327988|NCT01557244|76165803|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
42327989|NCT01557244|76165804|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
42327990|NCT01557244|76165805|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
42327991|NCT01557244|76165806|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
42327992|NCT01557244|76165800|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
42327993|NCT01557244|76165801|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
42327994|NCT01557244|76165802|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
42327995|NCT01557244|76165803|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
42327996|NCT01557244|76165804|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
42327997|NCT01557244|76165805|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
42327998|NCT01557244|76165806|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
42327999|NCT01557244|76165800|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
42328000|NCT01557244|76165801|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
42328001|NCT01557244|76165802|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
42328002|NCT01557244|76165803|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
42328003|NCT01557244|76165804|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
42328004|NCT01557244|76165805|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
42328005|NCT01557244|76165806|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
42328006|NCT01557244|76165800|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
42328007|NCT01557244|76165801|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
42328008|NCT01557244|76165802|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
42328009|NCT01557244|76165803|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
42328010|NCT01557244|76165804|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
42328011|NCT01557244|76165805|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
42262073|NCT00854295|76089554|FG000|Overall Study|Adverse Event|6|||
42262074|NCT00854295|76089555|FG001|Overall Study|Adverse Event|1|||
42262075|NCT00854295|76089556|FG002|Overall Study|Adverse Event|1|||
42262076|NCT00854295|76089557|FG003|Overall Study|Adverse Event|3|||
42262077|NCT00854295|76089554|FG000|Overall Study|Lost to Follow-up|18|||
42262078|NCT00854295|76089555|FG001|Overall Study|Lost to Follow-up|5|||
42328012|NCT01557244|76165806|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
42328013|NCT02177942|76165836|FG000|Overall Study|Adverse Event|1|||
42328014|NCT02177942|76165837|FG001|Overall Study|Adverse Event|0|||
42328015|NCT02177942|76165836|FG000|Overall Study|Lost to Follow-up|1|||
42328016|NCT02177942|76165837|FG001|Overall Study|Lost to Follow-up|1|||
42328017|NCT02177942|76165836|FG000|Overall Study|Protocol Violation|4|||
42328018|NCT02177942|76165837|FG001|Overall Study|Protocol Violation|6|||
42328019|NCT02177942|76165836|FG000|Overall Study|Withdrawal by Subject|71|||
42328020|NCT02177942|76165837|FG001|Overall Study|Withdrawal by Subject|81|||
42328021|NCT02155322|76165847|FG000|Overall Study|Adverse Event|1|||
42328022|NCT02155322|76165847|FG000|Overall Study|Physician Decision|1|||
42328023|NCT02155322|76165847|FG000|Overall Study|Relapse/Recurrence|8|||
42328024|NCT02155322|76165847|FG000|Overall Study|Withdrawal by Subject|4|||
42328025|NCT02210000|76165853|FG000|Overall Study|Study Terminated|11|||
42328026|NCT02210000|76165854|FG001|Overall Study|Study Terminated|12|||
42328027|NCT02210000|76165853|FG000|Overall Study|Withdrawal by Subject|7|||
42328028|NCT02210000|76165854|FG001|Overall Study|Withdrawal by Subject|1|||
42328029|NCT02210000|76165853|FG000|Overall Study|Adverse Event|1|||
42328030|NCT02210000|76165854|FG001|Overall Study|Adverse Event|5|||
42328031|NCT02210000|76165853|FG000|Overall Study|Lost to Follow-up|0|||
42328032|NCT02210000|76165854|FG001|Overall Study|Lost to Follow-up|2|||
42328033|NCT02210000|76165853|FG000|Overall Study|Physician Decision|0|||
42328034|NCT02210000|76165854|FG001|Overall Study|Physician Decision|1|||
42328035|NCT01531894|76165860|FG000|Overall Study|Physician Decision|8|||
42328036|NCT01531894|76165860|FG000|Overall Study|Death|1|||
42328037|NCT02209766|76165868|FG000|Overall Study|Withdrawal by Subject|0|||
42328038|NCT02209766|76165869|FG001|Overall Study|Withdrawal by Subject|0|||
42328039|NCT02209766|76165870|FG002|Overall Study|Withdrawal by Subject|0|||
42328040|NCT02209766|76165871|FG003|Overall Study|Withdrawal by Subject|1|||
42328041|NCT02209766|76165872|FG004|Overall Study|Withdrawal by Subject|0|||
42328042|NCT02209454|76165882|FG000|Second Period|Adverse Event|1|||
42328043|NCT02209454|76165883|FG001|Second Period|Adverse Event|0|||
42328044|NCT01571596|76165892|FG000|Overall Study|Adverse Event|2|||
42328045|NCT01571596|76165893|FG001|Overall Study|Adverse Event|0|||
42328046|NCT01571596|76165894|FG002|Overall Study|Adverse Event|0|||
42328047|NCT01571596|76165892|FG000|Overall Study|Study Terminated by the Sponsor|0|||
42328048|NCT01571596|76165893|FG001|Overall Study|Study Terminated by the Sponsor|1|||
42328049|NCT01571596|76165894|FG002|Overall Study|Study Terminated by the Sponsor|1|||
42328050|NCT01557166|76165906|FG000|Overall Study|Adverse Event|20|||
42328051|NCT01557166|76165907|FG001|Overall Study|Adverse Event|6|||
42328052|NCT01557166|76165906|FG000|Overall Study|Lack of Efficacy|2|||
41997407|NCT01177813|75805522|FG000|Overall Study|Adverse Event|8|||
41997408|NCT01177813|75805523|FG001|Overall Study|Adverse Event|2|||
41997409|NCT01177813|75805524|FG002|Overall Study|Adverse Event|4|||
41997410|NCT01177813|75805525|FG003|Overall Study|Adverse Event|6|||
41997411|NCT01177813|75805526|FG004|Overall Study|Adverse Event|3|||
41997412|NCT01177813|75805522|FG000|Overall Study|Lack of Efficacy|1|||
41997413|NCT01177813|75805523|FG001|Overall Study|Lack of Efficacy|0|||
41997414|NCT01177813|75805524|FG002|Overall Study|Lack of Efficacy|0|||
41997415|NCT01177813|75805525|FG003|Overall Study|Lack of Efficacy|0|||
41997416|NCT01177813|75805526|FG004|Overall Study|Lack of Efficacy|0|||
41997417|NCT01177813|75805522|FG000|Overall Study|Protocol Violation|3|||
41997418|NCT01177813|75805523|FG001|Overall Study|Protocol Violation|2|||
42328053|NCT01557166|76165907|FG001|Overall Study|Lack of Efficacy|1|||
42328054|NCT01557166|76165906|FG000|Overall Study|Protocol Violation|8|||
42328055|NCT01557166|76165907|FG001|Overall Study|Protocol Violation|5|||
42328056|NCT01557166|76165906|FG000|Overall Study|Withdrawn consent|12|||
42328057|NCT01557166|76165907|FG001|Overall Study|Withdrawn consent|20|||
42328058|NCT01557166|76165906|FG000|Overall Study|Target dose not tolerated|1|||
41997419|NCT01177813|75805524|FG002|Overall Study|Protocol Violation|2|||
42328059|NCT01557166|76165907|FG001|Overall Study|Target dose not tolerated|0|||
42328060|NCT01557166|76165906|FG000|Overall Study|Psychiatric disorder|1|||
42328061|NCT01557166|76165907|FG001|Overall Study|Psychiatric disorder|0|||
42328062|NCT01557166|76165906|FG000|Overall Study|Unclassified|2|||
42328063|NCT01557166|76165907|FG001|Overall Study|Unclassified|5|||
42328064|NCT01556932|76165913|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
41997420|NCT01177813|75805525|FG003|Overall Study|Protocol Violation|0|||
41997421|NCT01177813|75805526|FG004|Overall Study|Protocol Violation|1|||
41997422|NCT01177813|75805522|FG000|Overall Study|Lost to Follow-up|12|||
41997423|NCT01177813|75805523|FG001|Overall Study|Lost to Follow-up|5|||
42328065|NCT01556932|76165914|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
42328066|NCT02177786|76165923|FG000|Overall Study|Withdrew Consent|2|||
42328067|NCT02177786|76165924|FG001|Overall Study|Withdrew Consent|6|||
42328068|NCT02177786|76165925|FG002|Overall Study|Withdrew Consent|9|||
42328069|NCT02177786|76165926|FG003|Overall Study|Withdrew Consent|5|||
42328070|NCT02177786|76165923|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
42328071|NCT02177786|76165924|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
42328072|NCT02177786|76165925|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
42328073|NCT02177786|76165926|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
42328074|NCT02177786|76165923|FG000|Overall Study|Adverse Event|1|||
42328075|NCT02177786|76165924|FG001|Overall Study|Adverse Event|1|||
42328076|NCT02177786|76165925|FG002|Overall Study|Adverse Event|2|||
42328077|NCT02177786|76165926|FG003|Overall Study|Adverse Event|3|||
42328078|NCT02177786|76165923|FG000|Overall Study|Death|1|||
42328079|NCT02177786|76165924|FG001|Overall Study|Death|1|||
42328080|NCT02177786|76165925|FG002|Overall Study|Death|1|||
42328081|NCT02177786|76165926|FG003|Overall Study|Death|1|||
42328082|NCT02177786|76165923|FG000|Overall Study|Lost to Follow-up|0|||
42328083|NCT02177786|76165924|FG001|Overall Study|Lost to Follow-up|0|||
42328084|NCT02177786|76165925|FG002|Overall Study|Lost to Follow-up|2|||
42328085|NCT02177786|76165926|FG003|Overall Study|Lost to Follow-up|2|||
42328086|NCT02177786|76165923|FG000|Overall Study|Non-Compliance with Study Drug|0|||
42328087|NCT02177786|76165924|FG001|Overall Study|Non-Compliance with Study Drug|1|||
42328088|NCT02177786|76165925|FG002|Overall Study|Non-Compliance with Study Drug|0|||
42328089|NCT02177786|76165926|FG003|Overall Study|Non-Compliance with Study Drug|1|||
42328090|NCT02177786|76165923|FG000|Overall Study|Protocol Violation|0|||
42328091|NCT02177786|76165924|FG001|Overall Study|Protocol Violation|0|||
42328092|NCT02177786|76165925|FG002|Overall Study|Protocol Violation|2|||
42328093|NCT02177786|76165926|FG003|Overall Study|Protocol Violation|0|||
42328094|NCT02177786|76165923|FG000|Overall Study|Progressive Disease|0|||
42328095|NCT02177786|76165924|FG001|Overall Study|Progressive Disease|1|||
42328096|NCT02177786|76165925|FG002|Overall Study|Progressive Disease|0|||
42328097|NCT02177786|76165926|FG003|Overall Study|Progressive Disease|0|||
42328098|NCT02177786|76165923|FG000|Overall Study|Missing study completion status|0|||
42328099|NCT02177786|76165924|FG001|Overall Study|Missing study completion status|1|||
42328100|NCT02177786|76165925|FG002|Overall Study|Missing study completion status|0|||
42328101|NCT02177786|76165926|FG003|Overall Study|Missing study completion status|0|||
42328102|NCT01555762|76165936|FG000|Overall Study|No information on Bevacizumab intake|11|||
42328103|NCT01555762|76165936|FG000|Overall Study|Missing start date of infusion|8|||
42328104|NCT01555762|76165936|FG000|Overall Study|75 years old or more ticked No|1|||
42328105|NCT01555762|76165936|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
42328106|NCT01555762|76165936|FG000|Overall Study|Death linked to progression of disease|165|||
42328107|NCT01555762|76165936|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
42328108|NCT01555762|76165936|FG000|Overall Study|Investigator's decision|10|||
42328109|NCT01555762|76165936|FG000|Overall Study|Participant not wishing to continue|5|||
42328110|NCT01555762|76165936|FG000|Overall Study|Missing data|1|||
42328111|NCT01555762|76165936|FG000|Overall Study|Death linked to an adverse event|14|||
42328112|NCT02153918|76165940|FG000|Overall Study|Refused further treatment|1|||
42328113|NCT02176928|76165946|FG000|Overall Study|Lost to Follow-up|2|||
42328114|NCT02176928|76165947|FG001|Overall Study|Lost to Follow-up|4|||
42328115|NCT01628510|76165955|FG000|Overall Study|Withdrawal by Subject|0|||
42328116|NCT01628510|76165956|FG001|Overall Study|Withdrawal by Subject|4|||
41997424|NCT01177813|75805524|FG002|Overall Study|Lost to Follow-up|6|||
42328117|NCT01628510|76165955|FG000|Overall Study|Death|3|||
42328118|NCT01628510|76165956|FG001|Overall Study|Death|1|||
42328119|NCT01571362|76165964|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
42328120|NCT01571362|76165965|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
42328121|NCT01571362|76165966|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
42328122|NCT01571362|76165964|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
42328123|NCT01571362|76165965|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
41997425|NCT01177813|75805525|FG003|Overall Study|Lost to Follow-up|3|||
42328124|NCT01571362|76165966|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
42328125|NCT01571362|76165964|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
42328126|NCT01571362|76165965|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
42328127|NCT01571362|76165966|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
42328128|NCT01571362|76165964|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
42328129|NCT01571362|76165965|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
42328130|NCT01571362|76165966|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
42328131|NCT01571362|76165964|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
42328132|NCT01571362|76165965|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
42328133|NCT01571362|76165966|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
42328134|NCT01571362|76165964|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
42328135|NCT01571362|76165965|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
42328136|NCT01571362|76165966|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
42328137|NCT01571362|76165964|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42328138|NCT01571362|76165965|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
42328139|NCT01571362|76165966|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
42328140|NCT01571362|76165964|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
42328141|NCT01571362|76165965|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
42328142|NCT01571362|76165966|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
42328143|NCT01571362|76165964|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42328144|NCT01571362|76165965|FG001|Double-Blind Treatment Period|Adverse Event|9|||
42328145|NCT01571362|76165966|FG002|Double-Blind Treatment Period|Adverse Event|14|||
42328146|NCT01571362|76165964|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
42328147|NCT01571362|76165965|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
42328148|NCT01571362|76165966|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
42328149|NCT01571362|76165964|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
42328150|NCT01571362|76165965|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
42328151|NCT01571362|76165966|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
42328152|NCT01571362|76165964|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
42328153|NCT01571362|76165965|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
42328154|NCT01571362|76165966|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
42328155|NCT01571284|76165974|FG000|Overall Study|Participant's decision|84|||
42328156|NCT01571284|76165974|FG000|Overall Study|Lost to Follow-up|3|||
42328157|NCT01571284|76165974|FG000|Overall Study|Enrolled but not treated|2|||
41997426|NCT01177813|75805526|FG004|Overall Study|Lost to Follow-up|0|||
42328158|NCT01571284|76165974|FG000|Overall Study|Other than specified above|80|||
42328159|NCT02137772|76165980|FG000|Overall Study|Adverse Event|6|||
42328160|NCT02137772|76165981|FG001|Overall Study|Adverse Event|3|||
42328161|NCT02137772|76165980|FG000|Overall Study|Death|71|||
42328162|NCT02137772|76165981|FG001|Overall Study|Death|44|||
42328163|NCT02137772|76165980|FG000|Overall Study|Lost to Follow-up|8|||
42328164|NCT02137772|76165981|FG001|Overall Study|Lost to Follow-up|4|||
42328165|NCT02137772|76165980|FG000|Overall Study|Physician Decision|15|||
42328166|NCT02137772|76165981|FG001|Overall Study|Physician Decision|5|||
41997427|NCT01177813|75805522|FG000|Overall Study|Withdrawal by Subject|12|||
41997428|NCT01177813|75805523|FG001|Overall Study|Withdrawal by Subject|7|||
41997429|NCT01177813|75805524|FG002|Overall Study|Withdrawal by Subject|6|||
42262079|NCT00854295|76089556|FG002|Overall Study|Lost to Follow-up|21|||
42262080|NCT00854295|76089557|FG003|Overall Study|Lost to Follow-up|21|||
42262081|NCT00854295|76089554|FG000|Overall Study|Physician Decision|10|||
42262082|NCT00854295|76089555|FG001|Overall Study|Physician Decision|0|||
42262083|NCT00854295|76089556|FG002|Overall Study|Physician Decision|0|||
42262084|NCT00854295|76089557|FG003|Overall Study|Physician Decision|0|||
42262085|NCT02792959|76089568|FG000|Overall Study|Protocol Violation|1|||
42262086|NCT01652872|76089574|FG000|Overall Study|Death|36|||
42262087|NCT01652872|76089575|FG001|Overall Study|Death|39|||
41997430|NCT01177813|75805525|FG003|Overall Study|Withdrawal by Subject|5|||
42262088|NCT01652872|76089574|FG000|Overall Study|Lost to Follow-up|28|||
42262089|NCT01652872|76089575|FG001|Overall Study|Lost to Follow-up|23|||
42262090|NCT01652872|76089574|FG000|Overall Study|Decision by sponsor|5|||
42262091|NCT01652872|76089575|FG001|Overall Study|Decision by sponsor|7|||
42262092|NCT01652872|76089574|FG000|Overall Study|Withdrawal by Subject|76|||
42328167|NCT02137772|76165980|FG000|Overall Study|Withdrawal by Subject|28|||
42328168|NCT02137772|76165981|FG001|Overall Study|Withdrawal by Subject|17|||
42262093|NCT01652872|76089575|FG001|Overall Study|Withdrawal by Subject|84|||
42262094|NCT04251273|76089583|FG000|Overall Study|Lost to Follow-up|331|||
42328169|NCT02137772|76165980|FG000|Overall Study|Non-compliance with study drug|1|||
42328170|NCT02137772|76165981|FG001|Overall Study|Non-compliance with study drug|0|||
42328171|NCT02137772|76165980|FG000|Overall Study|Not treated|3|||
42328172|NCT02137772|76165981|FG001|Overall Study|Not treated|2|||
42328173|NCT01555138|76165989|FG000|Overall Study|Death|0|||
42328174|NCT01555138|76165990|FG001|Overall Study|Death|1|||
42328175|NCT01555138|76165989|FG000|Overall Study|Lost to Follow-up|1|||
42328176|NCT01555138|76165990|FG001|Overall Study|Lost to Follow-up|0|||
42328177|NCT01555138|76165989|FG000|Overall Study|Abnormal Lab reults|1|||
41997431|NCT01177813|75805526|FG004|Overall Study|Withdrawal by Subject|3|||
41997432|NCT01177813|75805522|FG000|Overall Study|Other reason not defined above|5|||
41997433|NCT01177813|75805523|FG001|Overall Study|Other reason not defined above|2|||
41997434|NCT01177813|75805524|FG002|Overall Study|Other reason not defined above|2|||
41997435|NCT01177813|75805525|FG003|Overall Study|Other reason not defined above|3|||
41997436|NCT01177813|75805526|FG004|Overall Study|Other reason not defined above|2|||
42328178|NCT01555138|76165990|FG001|Overall Study|Abnormal Lab reults|3|||
42328179|NCT01555138|76165989|FG000|Overall Study|Lack of Efficacy|2|||
42328180|NCT01555138|76165990|FG001|Overall Study|Lack of Efficacy|2|||
42328181|NCT01555138|76165989|FG000|Overall Study|Protocol Violation|5|||
42328182|NCT01555138|76165990|FG001|Overall Study|Protocol Violation|3|||
42328183|NCT01555138|76165989|FG000|Overall Study|Administrative problems|8|||
42328184|NCT01555138|76165990|FG001|Overall Study|Administrative problems|0|||
42328185|NCT01555138|76165989|FG000|Overall Study|Withdrawal by Subject|16|||
42328186|NCT01555138|76165990|FG001|Overall Study|Withdrawal by Subject|15|||
42328187|NCT01555138|76165989|FG000|Overall Study|Adverse Event|14|||
42328188|NCT01555138|76165990|FG001|Overall Study|Adverse Event|14|||
42328189|NCT02137226|76165998|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
42328190|NCT02137226|76165999|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
42328191|NCT02137226|76166000|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
42328192|NCT02137226|76166001|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
42328193|NCT02137226|76166002|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
42328194|NCT02137226|76165998|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
42328195|NCT02137226|76165999|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
42328196|NCT02137226|76166000|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
42328197|NCT02137226|76166001|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
42328198|NCT02137226|76166002|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
42328199|NCT02137226|76165998|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
42328200|NCT02137226|76165999|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
42328201|NCT02137226|76166000|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
42262095|NCT04251273|76089584|FG001|Overall Study|Lost to Follow-up|290|||
42262096|NCT02443402|76089592|FG000|Overall Study|Withdrawal by Subject|3|||
42262097|NCT02443402|76089593|FG001|Overall Study|Withdrawal by Subject|1|||
42262098|NCT02443402|76089592|FG000|Overall Study|Screen Failure|1|||
42262099|NCT02443402|76089593|FG001|Overall Study|Screen Failure|2|||
42262100|NCT01370005|76089602|FG000|Overall Study|Not treated|1|||
42262101|NCT01370005|76089603|FG001|Overall Study|Not treated|0|||
42262102|NCT01370005|76089604|FG002|Overall Study|Not treated|0|||
42262103|NCT01370005|76089602|FG000|Overall Study|Adverse Event|5|||
42262104|NCT01370005|76089603|FG001|Overall Study|Adverse Event|5|||
42262105|NCT01370005|76089604|FG002|Overall Study|Adverse Event|6|||
42262106|NCT01370005|76089602|FG000|Overall Study|Lack of Efficacy|1|||
42262107|NCT01370005|76089603|FG001|Overall Study|Lack of Efficacy|0|||
42262108|NCT01370005|76089604|FG002|Overall Study|Lack of Efficacy|0|||
42262109|NCT01370005|76089602|FG000|Overall Study|Non compliant with protocol|0|||
42262110|NCT01370005|76089603|FG001|Overall Study|Non compliant with protocol|1|||
42262111|NCT01370005|76089604|FG002|Overall Study|Non compliant with protocol|2|||
42262112|NCT01370005|76089602|FG000|Overall Study|Lost to Follow-up|1|||
42262113|NCT01370005|76089603|FG001|Overall Study|Lost to Follow-up|1|||
42262114|NCT01370005|76089604|FG002|Overall Study|Lost to Follow-up|1|||
42262115|NCT01370005|76089602|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
42262116|NCT01370005|76089603|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
42262117|NCT01370005|76089604|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
42262118|NCT01370005|76089602|FG000|Overall Study|Other reason not defined above|3|||
42262119|NCT01370005|76089603|FG001|Overall Study|Other reason not defined above|0|||
42262120|NCT01370005|76089604|FG002|Overall Study|Other reason not defined above|2|||
42262121|NCT02442778|76089615|FG000|Overall Study|Adverse Event|2|||
42328202|NCT02137226|76166001|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
42328203|NCT02137226|76166002|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
42262122|NCT02442778|76089616|FG001|Overall Study|Adverse Event|6|||
42262123|NCT02442778|76089617|FG002|Overall Study|Adverse Event|6|||
42328204|NCT02137226|76165998|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
42262124|NCT02442778|76089615|FG000|Overall Study|Death|0|||
42262125|NCT02442778|76089616|FG001|Overall Study|Death|2|||
42262126|NCT02442778|76089617|FG002|Overall Study|Death|0|||
42262127|NCT02442778|76089615|FG000|Overall Study|Lack of Efficacy|1|||
42328205|NCT02137226|76165999|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
42328206|NCT02137226|76166000|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
42328207|NCT02137226|76166001|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
42328208|NCT02137226|76166002|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
42328209|NCT02137226|76165998|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
42328210|NCT02137226|76165999|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
42328211|NCT02137226|76166000|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
42328212|NCT02137226|76166001|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
42328213|NCT02137226|76166002|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
42328214|NCT02137226|76165998|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
42328215|NCT02137226|76165999|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
42328216|NCT02137226|76166000|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
42328217|NCT02137226|76166001|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
42328218|NCT02137226|76166002|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
42328219|NCT02137226|76165998|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
42328220|NCT02137226|76165999|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
42134057|NCT00462462|75944899|FG000|Overall Study|Physician Decision|0|||
42134058|NCT00462462|75944900|FG001|Overall Study|Physician Decision|1|||
42262128|NCT02442778|76089616|FG001|Overall Study|Lack of Efficacy|0|||
42328221|NCT02137226|76166000|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
42328222|NCT02137226|76166001|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
42328223|NCT02137226|76166002|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
42328224|NCT02137226|76165998|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
42328225|NCT02137226|76165999|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
42328226|NCT02137226|76166000|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
42328227|NCT02137226|76166001|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
42328228|NCT02137226|76166002|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
42328229|NCT02137226|76165998|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
42328230|NCT02137226|76165999|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
42328231|NCT02137226|76166000|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
42328232|NCT02137226|76166001|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
42328233|NCT02137226|76166002|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
42328234|NCT02137226|76165998|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
41997437|NCT01200394|75805540|FG000|Overall Study|Adverse Event|0|||
41997438|NCT01200394|75805541|FG001|Overall Study|Adverse Event|14|||
41997439|NCT01200394|75805540|FG000|Overall Study|Death|1|||
41997440|NCT01200394|75805541|FG001|Overall Study|Death|0|||
41997441|NCT01200394|75805540|FG000|Overall Study|Lost to Follow-up|0|||
41997442|NCT01200394|75805541|FG001|Overall Study|Lost to Follow-up|1|||
41997443|NCT01200394|75805540|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
41997444|NCT01200394|75805541|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
41997445|NCT01200394|75805540|FG000|Overall Study|Protocol Violation|0|||
41997446|NCT01200394|75805541|FG001|Overall Study|Protocol Violation|3|||
41997447|NCT01200394|75805540|FG000|Overall Study|Withdrawal by Subject|0|||
42262129|NCT02442778|76089617|FG002|Overall Study|Lack of Efficacy|0|||
42262130|NCT02442778|76089615|FG000|Overall Study|Lost to Follow-up|1|||
42262131|NCT02442778|76089616|FG001|Overall Study|Lost to Follow-up|1|||
42262132|NCT02442778|76089617|FG002|Overall Study|Lost to Follow-up|1|||
42262133|NCT02442778|76089615|FG000|Overall Study|Non-compliance with study drug|2|||
42262134|NCT02442778|76089616|FG001|Overall Study|Non-compliance with study drug|0|||
41997448|NCT01200394|75805541|FG001|Overall Study|Withdrawal by Subject|5|||
42262135|NCT02442778|76089617|FG002|Overall Study|Non-compliance with study drug|1|||
42262136|NCT02442778|76089615|FG000|Overall Study|Physician Decision|1|||
42328235|NCT02137226|76165999|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
42328236|NCT02137226|76166000|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
42328237|NCT02137226|76166001|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
42328238|NCT02137226|76166002|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
42328239|NCT02137226|76165998|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
42328240|NCT02137226|76165999|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
42328241|NCT02137226|76166000|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
42328242|NCT02137226|76166001|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
42328243|NCT02137226|76166002|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
42328244|NCT02137226|76165998|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
42328245|NCT02137226|76165999|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
42328246|NCT02137226|76166000|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
42328247|NCT02137226|76166001|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
42328248|NCT02137226|76166002|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
42328249|NCT01530334|76166010|FG000|Overall Study|Adverse Event|3|||
42328250|NCT01530334|76166010|FG000|Overall Study|unknown reason|1|||
42328251|NCT01530334|76166010|FG000|Overall Study|Progressive disease|47|||
42328252|NCT01570192|76166016|FG000|Overall Study|no qualifying organism|6|||
42328253|NCT01570192|76166017|FG001|Overall Study|no qualifying organism|12|||
42328254|NCT01570192|76166016|FG000|Overall Study|changed to palliative care|1|||
42328255|NCT01570192|76166017|FG001|Overall Study|changed to palliative care|0|||
42328256|NCT01570192|76166016|FG000|Overall Study|Physician Decision|0|||
42328257|NCT01570192|76166017|FG001|Overall Study|Physician Decision|1|||
42328258|NCT02136914|76166030|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
42328259|NCT02136914|76166031|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
42328260|NCT02136914|76166030|FG000|Overall Study|Withdrawal by Subject|3|||
42328261|NCT02136914|76166031|FG001|Overall Study|Withdrawal by Subject|10|||
42328262|NCT02136914|76166030|FG000|Overall Study|Subject Unwilling to Proceed|7|||
42328263|NCT02136914|76166031|FG001|Overall Study|Subject Unwilling to Proceed|2|||
42328264|NCT02136914|76166030|FG000|Overall Study|Lost to Follow-up|1|||
42328265|NCT02136914|76166031|FG001|Overall Study|Lost to Follow-up|1|||
42328266|NCT02136914|76166030|FG000|Overall Study|Did Not Receive Study Drug|2|||
42134059|NCT00462384|75944908|FG000|Overall Study|Adverse Event|2|||
42134060|NCT00462384|75944908|FG000|Overall Study|Death|2|||
41997449|NCT01200394|75805540|FG000|Overall Study|Other|0|||
41997450|NCT01200394|75805541|FG001|Overall Study|Other|1|||
41997451|NCT01200355|75805550|FG000|Overall Study|Death|7|||
41997452|NCT01200355|75805551|FG001|Overall Study|Death|2|||
42134061|NCT00462384|75944908|FG000|Overall Study|Withdrawal by Subject|1|||
42328267|NCT02136914|76166031|FG001|Overall Study|Did Not Receive Study Drug|0|||
42328268|NCT02136914|76166030|FG000|Overall Study|Lack of Efficacy|1|||
42328269|NCT02136914|76166031|FG001|Overall Study|Lack of Efficacy|0|||
42328270|NCT02136914|76166030|FG000|Overall Study|Death|0|||
42328271|NCT02136914|76166031|FG001|Overall Study|Death|1|||
42328272|NCT01530256|76166037|FG000|Overall Study|Death|2|||
41997453|NCT01200238|75805559|FG000|Overall Study|Adverse Event|2|||
42328273|NCT01554904|76166041|FG000|Overall Study|Withdrawal by Subject|3|||
42328274|NCT01554904|76166041|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
42328275|NCT01529632|76166047|FG000|Overall Study|Administrative problem|2|||
42328276|NCT01529632|76166048|FG001|Overall Study|Administrative problem|1|||
42328277|NCT01529632|76166047|FG000|Overall Study|Protocol Violation|0|||
42328278|NCT01529632|76166048|FG001|Overall Study|Protocol Violation|1|||
42328279|NCT01529632|76166047|FG000|Overall Study|Adverse Event|1|||
42328280|NCT01529632|76166048|FG001|Overall Study|Adverse Event|1|||
42328281|NCT01554514|76166054|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
42328282|NCT01554514|76166054|FG000|Overall Study|Physician Decision|1|||
42328283|NCT01553188|76166062|FG000|Overall Study|Patient choice|1|||
42328284|NCT01553188|76166063|FG001|Overall Study|Patient choice|0|||
42328285|NCT01553188|76166064|FG002|Overall Study|Patient choice|0|||
42328286|NCT01553188|76166065|FG003|Overall Study|Patient choice|0|||
42328287|NCT01553188|76166062|FG000|Overall Study|Intercurrent illness and adverse event|0|||
41997454|NCT01200238|75805560|FG001|Overall Study|Adverse Event|1|||
42328288|NCT01553188|76166063|FG001|Overall Study|Intercurrent illness and adverse event|1|||
42328289|NCT01553188|76166064|FG002|Overall Study|Intercurrent illness and adverse event|2|||
42134062|NCT00462384|75944908|FG000|Overall Study|Other|4|||
42328290|NCT01553188|76166065|FG003|Overall Study|Intercurrent illness and adverse event|0|||
42328291|NCT02175758|76166084|FG000|Treatment Phase|Lost to Follow-up|0|||
42134063|NCT00452400|75944917|FG000|Overall Study|Adverse Event|1|||
42134064|NCT00452400|75944918|FG001|Overall Study|Adverse Event|1|||
42328292|NCT02175758|76166085|FG001|Treatment Phase|Lost to Follow-up|1|||
42328293|NCT02175758|76166086|FG002|Treatment Phase|Lost to Follow-up|0|||
42328294|NCT02175758|76166087|FG003|Treatment Phase|Lost to Follow-up|0|||
41997455|NCT01200238|75805559|FG000|Overall Study|Progressive Disease|5|||
41997456|NCT01200238|75805560|FG001|Overall Study|Progressive Disease|8|||
41997457|NCT01200238|75805559|FG000|Overall Study|Withdrawal by Subject|0|||
42134065|NCT00452400|75944919|FG002|Overall Study|Adverse Event|5|||
42328295|NCT02175758|76166088|FG004|Treatment Phase|Lost to Follow-up|0|||
42328296|NCT02175758|76166089|FG005|Treatment Phase|Lost to Follow-up|0|||
42328297|NCT02175758|76166084|FG000|Treatment Phase|Adverse Event|0|||
42328298|NCT02175758|76166085|FG001|Treatment Phase|Adverse Event|0|||
42328299|NCT02175758|76166086|FG002|Treatment Phase|Adverse Event|0|||
42328300|NCT02175758|76166087|FG003|Treatment Phase|Adverse Event|0|||
42328301|NCT02175758|76166088|FG004|Treatment Phase|Adverse Event|1|||
42328302|NCT02175758|76166089|FG005|Treatment Phase|Adverse Event|0|||
42328303|NCT01529008|76166131|FG000|Bone Marrow Harvesting|Physician Decision|1|||
42328304|NCT01529008|76166132|FG001|Bone Marrow Harvesting|Physician Decision|1|||
42328305|NCT01529008|76166131|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
42328306|NCT01529008|76166132|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
42328307|NCT01529008|76166131|FG000|Treatment|Adverse Event|6|||
42328308|NCT01529008|76166132|FG001|Treatment|Adverse Event|0|||
42328309|NCT01529008|76166131|FG000|Treatment|Other|3|||
42328310|NCT01529008|76166132|FG001|Treatment|Other|1|||
42328311|NCT01529008|76166131|FG000|Efficacy Analysis|Protocol Violation|2|||
42328312|NCT01529008|76166132|FG001|Efficacy Analysis|Protocol Violation|0|||
42328313|NCT01529008|76166131|FG000|Efficacy Analysis|Physician Decision|0|||
42328314|NCT01529008|76166132|FG001|Efficacy Analysis|Physician Decision|1|||
42328315|NCT01529008|76166131|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
42328316|NCT01529008|76166132|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
42328317|NCT01599104|76166141|FG000|Overall Study|Withdrawal by Subject|1|||
42328318|NCT01599104|76166142|FG001|Overall Study|Withdrawal by Subject|1|||
42328319|NCT01599104|76166143|FG002|Overall Study|Withdrawal by Subject|2|||
42328320|NCT01599104|76166141|FG000|Overall Study|Technical Problems|1|||
42328321|NCT01599104|76166142|FG001|Overall Study|Technical Problems|0|||
42328322|NCT01599104|76166143|FG002|Overall Study|Technical Problems|0|||
42262137|NCT02442778|76089616|FG001|Overall Study|Physician Decision|1|||
42262138|NCT02442778|76089617|FG002|Overall Study|Physician Decision|1|||
42262139|NCT02442778|76089615|FG000|Overall Study|Protocol Deviation|3|||
42262140|NCT02442778|76089616|FG001|Overall Study|Protocol Deviation|0|||
42262141|NCT02442778|76089617|FG002|Overall Study|Protocol Deviation|1|||
42262142|NCT02442778|76089615|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
42262143|NCT02442778|76089616|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
42262144|NCT02442778|76089617|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
42262145|NCT02442778|76089615|FG000|Overall Study|Withdrawal by Subject|4|||
42262146|NCT02442778|76089616|FG001|Overall Study|Withdrawal by Subject|4|||
42262147|NCT02442778|76089617|FG002|Overall Study|Withdrawal by Subject|3|||
42262148|NCT02442778|76089615|FG000|Overall Study|Reason not specified|1|||
42262149|NCT02442778|76089616|FG001|Overall Study|Reason not specified|4|||
42262150|NCT02442778|76089617|FG002|Overall Study|Reason not specified|0|||
42262151|NCT02412436|76089625|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
42262152|NCT02412436|76089625|FG000|Overall Study|Lost to Follow-up|6|||
42262153|NCT02412436|76089625|FG000|Overall Study|Unable to get to clinic|3|||
42262154|NCT02412436|76089625|FG000|Overall Study|Death|1|||
42262155|NCT02412436|76089625|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
42262156|NCT01651000|76089631|FG000|Overall Study|Adverse Event|2|||
42262157|NCT01651000|76089632|FG001|Overall Study|Adverse Event|8|||
42262158|NCT01651000|76089631|FG000|Overall Study|Lost to Follow-up|3|||
42262159|NCT01651000|76089632|FG001|Overall Study|Lost to Follow-up|2|||
42262160|NCT01651000|76089631|FG000|Overall Study|Protocol Violation|0|||
42262161|NCT01651000|76089632|FG001|Overall Study|Protocol Violation|3|||
42328323|NCT01599104|76166141|FG000|Overall Study|Physician Decision|3|||
42328324|NCT01599104|76166142|FG001|Overall Study|Physician Decision|2|||
42262162|NCT01651000|76089631|FG000|Overall Study|Withdrawal by Subject|2|||
42262163|NCT01651000|76089632|FG001|Overall Study|Withdrawal by Subject|10|||
42262164|NCT01651000|76089631|FG000|Overall Study|Subject noncompliance|0|||
42262165|NCT01651000|76089632|FG001|Overall Study|Subject noncompliance|3|||
42262166|NCT01651000|76089631|FG000|Overall Study|Lack of Efficacy|1|||
42262167|NCT01651000|76089632|FG001|Overall Study|Lack of Efficacy|1|||
42262168|NCT01651000|76089631|FG000|Overall Study|Physician Decision|1|||
42328325|NCT01599104|76166143|FG002|Overall Study|Physician Decision|2|||
42034520|NCT00937521|75842592|FG006|Booster Phase|Lost to Follow-up|3|||
42328326|NCT01599104|76166141|FG000|Overall Study|Non-compliance with study treatment|0|||
42328327|NCT01599104|76166142|FG001|Overall Study|Non-compliance with study treatment|1|||
41997458|NCT01200238|75805560|FG001|Overall Study|Withdrawal by Subject|1|||
41997459|NCT01199731|75805569|FG000|Overall Study|Adverse Event|0|||
41997460|NCT01199731|75805570|FG001|Overall Study|Adverse Event|1|||
41997461|NCT01199731|75805571|FG002|Overall Study|Adverse Event|0|||
41997462|NCT01199731|75805569|FG000|Overall Study|Study closed/terminated|7|||
41997463|NCT01199731|75805570|FG001|Overall Study|Study closed/terminated|9|||
41997464|NCT01199731|75805571|FG002|Overall Study|Study closed/terminated|7|||
41997465|NCT01199731|75805569|FG000|Overall Study|Lost to Follow-up|0|||
41997466|NCT01199731|75805570|FG001|Overall Study|Lost to Follow-up|0|||
41997467|NCT01199731|75805571|FG002|Overall Study|Lost to Follow-up|2|||
41997468|NCT01199731|75805569|FG000|Overall Study|Physician Decision|0|||
41997469|NCT01199731|75805570|FG001|Overall Study|Physician Decision|1|||
41997470|NCT01199731|75805571|FG002|Overall Study|Physician Decision|1|||
41997471|NCT01199731|75805569|FG000|Overall Study|Withdrawal by Subject|2|||
41997472|NCT01199731|75805570|FG001|Overall Study|Withdrawal by Subject|0|||
41997473|NCT01199731|75805571|FG002|Overall Study|Withdrawal by Subject|0|||
41997474|NCT01199263|75805581|FG000|Overall Study|Ineligible|0|||
41997475|NCT01199263|75805582|FG001|Overall Study|Ineligible|2|||
41997476|NCT01199263|75805581|FG000|Overall Study|Never Treated|6|||
41997477|NCT01199263|75805582|FG001|Overall Study|Never Treated|0|||
41997478|NCT01199068|75805593|FG000|Overall Study|Unacceptable toxicity|0|||
41997479|NCT01199068|75805594|FG001|Overall Study|Unacceptable toxicity|0|||
41997480|NCT01199068|75805595|FG002|Overall Study|Unacceptable toxicity|2|||
41997481|NCT01199068|75805593|FG000|Overall Study|Progressive disease|3|||
41997482|NCT01199068|75805594|FG001|Overall Study|Progressive disease|3|||
42328328|NCT01599104|76166143|FG002|Overall Study|Non-compliance with study treatment|0|||
42328329|NCT01599104|76166141|FG000|Overall Study|Lack of Efficacy|4|||
42328330|NCT01599104|76166142|FG001|Overall Study|Lack of Efficacy|4|||
42328331|NCT01599104|76166143|FG002|Overall Study|Lack of Efficacy|10|||
42328332|NCT01599104|76166141|FG000|Overall Study|Adverse Event|7|||
42328333|NCT01599104|76166142|FG001|Overall Study|Adverse Event|6|||
42328334|NCT01599104|76166143|FG002|Overall Study|Adverse Event|12|||
42328335|NCT01569568|76166153|FG000|Overall Study|Physician Decision|0|||
42328336|NCT01569568|76166154|FG001|Overall Study|Physician Decision|2|||
42328337|NCT02136680|76166162|FG000|Overall Study|No Longer Interested|1|||
42328338|NCT02136680|76166163|FG001|Overall Study|No Longer Interested|1|||
42328339|NCT02136680|76166162|FG000|Overall Study|No longer receiving care at clinic|3|||
42328340|NCT02136680|76166163|FG001|Overall Study|No longer receiving care at clinic|5|||
42328341|NCT02136680|76166162|FG000|Overall Study|Moved away|5|||
42328342|NCT02136680|76166163|FG001|Overall Study|Moved away|4|||
42328343|NCT02136680|76166162|FG000|Overall Study|Unable to schedule|17|||
42328344|NCT02136680|76166163|FG001|Overall Study|Unable to schedule|16|||
42328345|NCT02136680|76166162|FG000|Overall Study|Study ended before interview due|6|||
42328346|NCT02136680|76166163|FG001|Overall Study|Study ended before interview due|3|||
42328347|NCT01552954|76166171|FG000|Overall Study|Adverse Event|1|||
42328348|NCT01552954|76166172|FG001|Overall Study|Adverse Event|2|||
42328349|NCT01552954|76166171|FG000|Overall Study|Lost to Follow-up|1|||
42328350|NCT01552954|76166172|FG001|Overall Study|Lost to Follow-up|1|||
42328351|NCT01552954|76166171|FG000|Overall Study|Withdrawal by Subject|1|||
42328352|NCT01552954|76166172|FG001|Overall Study|Withdrawal by Subject|1|||
42328353|NCT01552954|76166171|FG000|Overall Study|Protocol Violation|1|||
42328354|NCT01552954|76166172|FG001|Overall Study|Protocol Violation|2|||
42328355|NCT01552954|76166171|FG000|Overall Study|diagnosed DM|1|||
42328356|NCT01552954|76166172|FG001|Overall Study|diagnosed DM|0|||
42328357|NCT02175368|76166178|FG000|Overall Study|Lost to Follow-up|1|||
42328358|NCT01518244|76166182|FG000|Overall Study|Adverse Event|3|||
41997483|NCT01199068|75805595|FG002|Overall Study|Progressive disease|6|||
42262169|NCT01651000|76089632|FG001|Overall Study|Physician Decision|0|||
42262170|NCT01651000|76089631|FG000|Overall Study|Administrative reason|1|||
42262171|NCT01651000|76089632|FG001|Overall Study|Administrative reason|0|||
42262172|NCT01651000|76089631|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
42262173|NCT01651000|76089632|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
42262174|NCT02469610|76089640|FG000|Overall Study|Death|1|||
42262175|NCT02469610|76089641|FG001|Overall Study|Death|0|||
42262176|NCT02469610|76089640|FG000|Overall Study|Lost to Follow-up|1|||
42262177|NCT02469610|76089641|FG001|Overall Study|Lost to Follow-up|0|||
42262178|NCT02469610|76089640|FG000|Overall Study|exclusion criteria|2|||
42262179|NCT02469610|76089641|FG001|Overall Study|exclusion criteria|1|||
42262180|NCT02469298|76089651|FG000|Overall Study|Protocol Violation|0|||
42262181|NCT02469298|76089652|FG001|Overall Study|Protocol Violation|1|||
42262182|NCT02469298|76089653|FG002|Overall Study|Protocol Violation|1|||
42262183|NCT02469298|76089654|FG003|Overall Study|Protocol Violation|0|||
42328359|NCT01552408|76166188|FG000|Overall Study|Lost to Follow-up|2|||
42328360|NCT01552408|76166189|FG001|Overall Study|Lost to Follow-up|0|||
42328361|NCT01552408|76166188|FG000|Overall Study|Relocation|0|||
41997484|NCT01199068|75805593|FG000|Overall Study|Withdrawal by Subject|0|||
41997485|NCT01199068|75805594|FG001|Overall Study|Withdrawal by Subject|0|||
41997486|NCT01199068|75805595|FG002|Overall Study|Withdrawal by Subject|1|||
42262184|NCT02469298|76089651|FG000|Overall Study|Lost to Follow-up|1|||
42262185|NCT02469298|76089652|FG001|Overall Study|Lost to Follow-up|0|||
42262186|NCT02469298|76089653|FG002|Overall Study|Lost to Follow-up|1|||
41997487|NCT01198873|75805612|FG000|Overall Study|Adverse Event|4|||
41997488|NCT01198873|75805613|FG001|Overall Study|Adverse Event|7|||
42328362|NCT01552408|76166189|FG001|Overall Study|Relocation|1|||
42328363|NCT01552408|76166188|FG000|Overall Study|Withdrawal by Subject|2|||
42328364|NCT01552408|76166189|FG001|Overall Study|Withdrawal by Subject|1|||
42328365|NCT01528696|76166198|FG000|Overall Study|See detailed description|18|||
42328366|NCT01528696|76166199|FG001|Overall Study|See detailed description|19|||
42328367|NCT02174276|76166209|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
42328368|NCT02174276|76166210|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
42328369|NCT02174276|76166211|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
42328370|NCT02174276|76166212|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
42328371|NCT02174276|76166209|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
42328372|NCT02174276|76166210|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
42328373|NCT02174276|76166211|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
42328374|NCT02174276|76166212|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
42328375|NCT02174276|76166209|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
42328376|NCT02174276|76166210|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
42328377|NCT02174276|76166211|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
42328378|NCT02174276|76166212|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
42328379|NCT02174276|76166209|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
42328380|NCT02174276|76166210|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
41997489|NCT01198873|75805612|FG000|Overall Study|Study closure|29|||
41997490|NCT01198873|75805613|FG001|Overall Study|Study closure|23|||
41997491|NCT01198873|75805612|FG000|Overall Study|Other than above|4|||
42262187|NCT02469298|76089654|FG003|Overall Study|Lost to Follow-up|0|||
42262188|NCT02469298|76089651|FG000|Overall Study|Physician Decision|0|||
42262189|NCT02469298|76089652|FG001|Overall Study|Physician Decision|0|||
42262190|NCT02469298|76089653|FG002|Overall Study|Physician Decision|0|||
42262191|NCT02469298|76089654|FG003|Overall Study|Physician Decision|1|||
42262192|NCT02469298|76089651|FG000|Overall Study|Withdrawal by Subject|0|||
42262193|NCT02469298|76089652|FG001|Overall Study|Withdrawal by Subject|0|||
42262194|NCT02469298|76089653|FG002|Overall Study|Withdrawal by Subject|0|||
42262195|NCT02469298|76089654|FG003|Overall Study|Withdrawal by Subject|1|||
42262196|NCT04163991|76089676|FG000|Overall Study|Adverse Event|0|||
42262197|NCT04163991|76089677|FG001|Overall Study|Adverse Event|0|||
42262198|NCT04163991|76089678|FG002|Overall Study|Adverse Event|0|||
42262199|NCT04163991|76089679|FG003|Overall Study|Adverse Event|1|||
42262200|NCT04163991|76089680|FG004|Overall Study|Adverse Event|0|||
42262201|NCT04163991|76089676|FG000|Overall Study|Death|0|||
42262202|NCT04163991|76089677|FG001|Overall Study|Death|0|||
42262203|NCT04163991|76089678|FG002|Overall Study|Death|1|||
42262204|NCT04163991|76089679|FG003|Overall Study|Death|0|||
42262205|NCT04163991|76089680|FG004|Overall Study|Death|0|||
42262206|NCT04163991|76089676|FG000|Overall Study|Lost to Follow-up|0|||
42262207|NCT04163991|76089677|FG001|Overall Study|Lost to Follow-up|1|||
42262208|NCT04163991|76089678|FG002|Overall Study|Lost to Follow-up|0|||
42262209|NCT04163991|76089679|FG003|Overall Study|Lost to Follow-up|0|||
42262210|NCT04163991|76089680|FG004|Overall Study|Lost to Follow-up|0|||
42262211|NCT04163991|76089676|FG000|Overall Study|Withdrawal by Subject|1|||
42262212|NCT04163991|76089677|FG001|Overall Study|Withdrawal by Subject|1|||
42262213|NCT04163991|76089678|FG002|Overall Study|Withdrawal by Subject|3|||
42262214|NCT04163991|76089679|FG003|Overall Study|Withdrawal by Subject|1|||
42262215|NCT04163991|76089680|FG004|Overall Study|Withdrawal by Subject|1|||
42262216|NCT04163991|76089676|FG000|Overall Study|Other, Not Specified|0|||
42262217|NCT04163991|76089677|FG001|Overall Study|Other, Not Specified|1|||
42262218|NCT04163991|76089678|FG002|Overall Study|Other, Not Specified|1|||
42262219|NCT04163991|76089679|FG003|Overall Study|Other, Not Specified|1|||
42262220|NCT04163991|76089680|FG004|Overall Study|Other, Not Specified|0|||
42262221|NCT02442622|76089698|FG000|Overall Study|Withdrawal by Subject|3|||
42262222|NCT02442622|76089699|FG001|Overall Study|Withdrawal by Subject|1|||
42262223|NCT02411578|76089707|FG000|Crossover Trial Phase|Pregnancy|0|||
42262224|NCT02411578|76089708|FG001|Crossover Trial Phase|Pregnancy|1|||
42262225|NCT02442310|76089716|FG000|Overall Study|Adverse Event|2|||
42262226|NCT02442310|76089716|FG000|Overall Study|Withdrawal by Subject|1|||
42262227|NCT02411110|76089728|FG000|Treatment Period 1|Adverse Event|4|||
42262228|NCT02411110|76089729|FG001|Treatment Period 1|Adverse Event|2|||
42262229|NCT02411110|76089728|FG000|Treatment Period 1|Lost to Follow-up|1|||
42262230|NCT02411110|76089729|FG001|Treatment Period 1|Lost to Follow-up|0|||
42262231|NCT02411110|76089728|FG000|Treatment Period 1|Personal Reasons|2|||
42262232|NCT02411110|76089729|FG001|Treatment Period 1|Personal Reasons|5|||
42262233|NCT02411110|76089728|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
42262234|NCT02411110|76089729|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
42262235|NCT02411110|76089728|FG000|Treatment Period 2|Adverse Event|1|||
42262236|NCT02411110|76089729|FG001|Treatment Period 2|Adverse Event|0|||
42328381|NCT02174276|76166211|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
42262237|NCT02411110|76089728|FG000|Treatment Period 2|Lost to Follow-up|0|||
42262238|NCT02411110|76089729|FG001|Treatment Period 2|Lost to Follow-up|2|||
42262239|NCT02411110|76089728|FG000|Treatment Period 2|Personal Reasons|0|||
41997492|NCT01198873|75805613|FG001|Overall Study|Other than above|2|||
41997493|NCT01198795|75805619|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
41997494|NCT01198795|75805619|FG000|Overall Study|Withdrawal by Subject|17|||
41997495|NCT01198795|75805619|FG000|Overall Study|Lost to Follow-up|15|||
41997496|NCT01198795|75805619|FG000|Overall Study|Adverse Event|9|||
41997497|NCT01198795|75805619|FG000|Overall Study|Lack of Efficacy|5|||
41997498|NCT01198795|75805619|FG000|Overall Study|Protocol Violation|2|||
41997499|NCT01198795|75805619|FG000|Overall Study|Other Reason|4|||
41997500|NCT01198756|75805627|FG000|Overall Study|Adverse Event|0|||
41997501|NCT01198756|75805628|FG001|Overall Study|Adverse Event|0|||
41997502|NCT01198756|75805629|FG002|Overall Study|Adverse Event|0|||
41997503|NCT01198756|75805630|FG003|Overall Study|Adverse Event|1|||
41997504|NCT01198756|75805627|FG000|Overall Study|Protocol Violation|0|||
41997505|NCT01198756|75805628|FG001|Overall Study|Protocol Violation|0|||
42328382|NCT02174276|76166212|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
42328383|NCT02174276|76166209|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
42328384|NCT02174276|76166210|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
42328385|NCT02174276|76166211|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
42328386|NCT02174276|76166212|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
42328387|NCT02174276|76166209|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
42328388|NCT02174276|76166210|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
42328389|NCT02174276|76166211|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
42328390|NCT02174276|76166212|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
42328391|NCT01528072|76166222|FG000|Overall Study|Withdrawal by Subject|5|||
42328392|NCT01528072|76166222|FG000|Overall Study|Physician Decision|1|||
42328393|NCT01528072|76166222|FG000|Overall Study|Determined not eligible by AEAC|1|||
42328394|NCT01528072|76166222|FG000|Overall Study|Missed Visit|2|||
42328395|NCT01528072|76166222|FG000|Overall Study|Lost to Follow-up|5|||
42328396|NCT01528072|76166222|FG000|Overall Study|Explanted|2|||
42328397|NCT01528072|76166222|FG000|Overall Study|Site Closure|4|||
42328398|NCT01528072|76166222|FG000|Overall Study|Death|2|||
42328399|NCT01528072|76166222|FG000|Overall Study|Early Termination of Study|52|||
42328400|NCT01527682|76166226|FG000|Overall Study|Protocol Violation|8|||
42328401|NCT01527370|76166230|FG000|Overall Study|Withdrawal by Subject|4|||
42328402|NCT01527370|76166230|FG000|Overall Study|Physician Decision|1|||
42328403|NCT01527370|76166230|FG000|Overall Study|Death|1|||
42328404|NCT01527292|76166236|FG000|Overall Study|Physician Decision|0|||
42328405|NCT01527292|76166237|FG001|Overall Study|Physician Decision|3|||
42328406|NCT01516216|76166245|FG000|Overall Study|Adverse Event|2|||
42328407|NCT01516216|76166246|FG001|Overall Study|Adverse Event|4|||
42328408|NCT01516216|76166245|FG000|Overall Study|Disease Progression|38|||
42328409|NCT01516216|76166246|FG001|Overall Study|Disease Progression|34|||
42328410|NCT01516216|76166245|FG000|Overall Study|Withdrawal by Subject|9|||
42328411|NCT01516216|76166246|FG001|Overall Study|Withdrawal by Subject|11|||
42328412|NCT01516216|76166245|FG000|Overall Study|Potentially Curative Resection|6|||
41997506|NCT01198756|75805629|FG002|Overall Study|Protocol Violation|0|||
41997507|NCT01198756|75805630|FG003|Overall Study|Protocol Violation|2|||
41997508|NCT01198756|75805627|FG000|Overall Study|Withdrawal by Subject|9|||
41997509|NCT01198756|75805628|FG001|Overall Study|Withdrawal by Subject|4|||
41997510|NCT01198756|75805629|FG002|Overall Study|Withdrawal by Subject|7|||
41997511|NCT01198756|75805630|FG003|Overall Study|Withdrawal by Subject|5|||
42328413|NCT01516216|76166246|FG001|Overall Study|Potentially Curative Resection|12|||
42328414|NCT01516216|76166245|FG000|Overall Study|Nonadherence|2|||
42328415|NCT01516216|76166246|FG001|Overall Study|Nonadherence|3|||
42328416|NCT01516216|76166245|FG000|Overall Study|Physician Decision|6|||
42328417|NCT01516216|76166246|FG001|Overall Study|Physician Decision|3|||
42328418|NCT01516216|76166245|FG000|Overall Study|Prolonged Treatment Delay|5|||
42328419|NCT01516216|76166246|FG001|Overall Study|Prolonged Treatment Delay|1|||
42328420|NCT01516216|76166245|FG000|Overall Study|Intercurrent Illness|1|||
42328421|NCT01516216|76166246|FG001|Overall Study|Intercurrent Illness|0|||
42328422|NCT01516216|76166245|FG000|Overall Study|Death|1|||
42328423|NCT01516216|76166246|FG001|Overall Study|Death|1|||
42328424|NCT01950819|76166256|FG000|Overall Study|Graft Loss|35|||
42328425|NCT01950819|76166257|FG001|Overall Study|Graft Loss|30|||
41997512|NCT01198756|75805627|FG000|Overall Study|Lost to Follow-up|29|||
42328426|NCT01950819|76166256|FG000|Overall Study|Death|29|||
42328427|NCT01950819|76166257|FG001|Overall Study|Death|34|||
41997513|NCT01198756|75805628|FG001|Overall Study|Lost to Follow-up|36|||
41997514|NCT01198756|75805629|FG002|Overall Study|Lost to Follow-up|23|||
41997515|NCT01198756|75805630|FG003|Overall Study|Lost to Follow-up|18|||
41997516|NCT01198600|75805647|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
42328428|NCT01950819|76166256|FG000|Overall Study|Subject / Gardian decision|54|||
41997517|NCT01198600|75805648|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
42328429|NCT01950819|76166257|FG001|Overall Study|Subject / Gardian decision|51|||
42328430|NCT01950819|76166256|FG000|Overall Study|technical problems|2|||
42328431|NCT01950819|76166257|FG001|Overall Study|technical problems|0|||
42328432|NCT01950819|76166256|FG000|Overall Study|Pregnancy|0|||
42328433|NCT01950819|76166257|FG001|Overall Study|Pregnancy|2|||
42328434|NCT01950819|76166256|FG000|Overall Study|Lost to Follow-up|9|||
42328435|NCT01950819|76166257|FG001|Overall Study|Lost to Follow-up|17|||
42328436|NCT01514422|76166263|FG000|Overall Study|Lost to Follow-up|1|||
41997518|NCT01198600|75805649|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
41997519|NCT01198600|75805650|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
41997520|NCT01198600|75805647|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
41997521|NCT01198600|75805648|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
41997522|NCT01198600|75805649|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
41997523|NCT01198600|75805650|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
41997524|NCT01198600|75805647|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
41997525|NCT01198600|75805648|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
41997526|NCT01198600|75805649|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
41997527|NCT01198600|75805650|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
42328437|NCT01513330|76166267|FG000|SenSura Mio First,|Adverse Event|2|||
42328438|NCT01513330|76166268|FG001|SenSura Mio First,|Adverse Event|0|||
42328439|NCT01513330|76166267|FG000|SenSura Mio First,|Lack of Efficacy|0|||
41997528|NCT01198600|75805647|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
41997529|NCT01198600|75805648|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
41997530|NCT01198600|75805649|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
41997531|NCT01198600|75805650|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
42262240|NCT02411110|76089729|FG001|Treatment Period 2|Personal Reasons|2|||
42262241|NCT01369849|76089740|FG000|Overall Study|Ineligible prior to treatment|0|||
42262242|NCT01369849|76089741|FG001|Overall Study|Ineligible prior to treatment|0|||
42262243|NCT01369849|76089742|FG002|Overall Study|Ineligible prior to treatment|1|||
42262244|NCT01369849|76089740|FG000|Overall Study|Ineligible after receiving treatment|0|||
42262245|NCT01369849|76089741|FG001|Overall Study|Ineligible after receiving treatment|1|||
42262246|NCT01369849|76089742|FG002|Overall Study|Ineligible after receiving treatment|0|||
42262247|NCT02716779|76089755|FG000|Monotherapy|Adverse Event|0|||
42328440|NCT01513330|76166268|FG001|SenSura Mio First,|Lack of Efficacy|1|||
41997532|NCT01198600|75805647|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
41997533|NCT01198600|75805648|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
41997534|NCT01198600|75805649|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
42328441|NCT01513330|76166267|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
42328442|NCT01513330|76166268|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
42262248|NCT02716779|76089756|FG001|Monotherapy|Adverse Event|1|||
42328443|NCT01513330|76166267|FG000|SenSura Mio First,|Other|1|||
42328444|NCT01513330|76166268|FG001|SenSura Mio First,|Other|0|||
42328445|NCT01513330|76166267|FG000|Standard Care First,|Lack of Efficacy|2|||
42328446|NCT01513330|76166268|FG001|Standard Care First,|Lack of Efficacy|2|||
42328447|NCT01513330|76166267|FG000|Standard Care First,|Withdrawal by Subject|1|||
42328448|NCT01513330|76166268|FG001|Standard Care First,|Withdrawal by Subject|2|||
42328449|NCT01513330|76166267|FG000|Standard Care First,|Other|1|||
42328450|NCT01513330|76166268|FG001|Standard Care First,|Other|0|||
42328451|NCT01524796|76166274|FG000|Overall Study|Adverse Event|13|||
42328452|NCT01524796|76166274|FG000|Overall Study|Lack of Efficacy|3|||
42328453|NCT01524796|76166274|FG000|Overall Study|Lost to Follow-up|1|||
42328454|NCT01524796|76166274|FG000|Overall Study|The price|1|||
42328455|NCT01524796|76166274|FG000|Overall Study|Withdrawal by Subject|4|||
42328456|NCT01524796|76166274|FG000|Overall Study|Move|1|||
42328457|NCT01524796|76166274|FG000|Overall Study|Deterioration of pains|1|||
42328458|NCT01524796|76166274|FG000|Overall Study|Gall stone surgery|1|||
42328459|NCT01524796|76166274|FG000|Overall Study|Nervous about confidentiality|1|||
42262249|NCT02716779|76089757|FG002|Monotherapy|Adverse Event|1|||
42262250|NCT02716779|76089755|FG000|Combination Therapy|Adverse Event|0|||
42262251|NCT02716779|76089756|FG001|Combination Therapy|Adverse Event|2|||
42262252|NCT02716779|76089757|FG002|Combination Therapy|Adverse Event|1|||
42262253|NCT01369615|76089773|FG000|Overall Study|Withdrawal by Subject|0|||
42262254|NCT01369615|76089774|FG001|Overall Study|Withdrawal by Subject|1|||
42262255|NCT01369615|76089773|FG000|Overall Study|Lost to Follow-up|0|||
42262256|NCT01369615|76089774|FG001|Overall Study|Lost to Follow-up|1|||
42262257|NCT02468674|76089798|FG000|Overall Study|Adverse Event|0|||
42262258|NCT02468674|76089799|FG001|Overall Study|Adverse Event|0|||
42262259|NCT02468674|76089800|FG002|Overall Study|Adverse Event|0|||
42262260|NCT02468674|76089801|FG003|Overall Study|Adverse Event|1|||
42262261|NCT02468674|76089802|FG004|Overall Study|Adverse Event|0|||
42328460|NCT01524796|76166274|FG000|Overall Study|Switch to carbamazapine|1|||
42328461|NCT01524796|76166274|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
42328462|NCT01547728|76166278|FG000|Overall Study|Change in procedure and equipment|1|||
42328463|NCT01547728|76166278|FG000|Overall Study|Drug not ready for subject|1|||
42328464|NCT01547728|76166278|FG000|Overall Study|Screen failure|39|||
42328465|NCT01523392|76166284|FG000|Treatment Period 1|Withdrawal by Subject|2|||
42262262|NCT02468674|76089803|FG005|Overall Study|Adverse Event|1|||
42262263|NCT02468674|76089804|FG006|Overall Study|Adverse Event|0|||
42328466|NCT01523392|76166285|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42328467|NCT01523392|76166284|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
42328468|NCT01523392|76166285|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
42328469|NCT01523392|76166284|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
42328470|NCT01523392|76166285|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
42328471|NCT01512160|76166297|FG000|Overall Study|Lost to Follow-up|1|||
42328472|NCT01512160|76166298|FG001|Overall Study|Lost to Follow-up|0|||
42328473|NCT01512160|76166299|FG002|Overall Study|Lost to Follow-up|0|||
42328474|NCT01512160|76166300|FG003|Overall Study|Lost to Follow-up|0|||
42328475|NCT01512160|76166297|FG000|Overall Study|Withdrawal by Subject|1|||
42328476|NCT01512160|76166298|FG001|Overall Study|Withdrawal by Subject|0|||
42328477|NCT01512160|76166299|FG002|Overall Study|Withdrawal by Subject|0|||
42328478|NCT01512160|76166300|FG003|Overall Study|Withdrawal by Subject|1|||
42328479|NCT01546168|76166313|FG000|Overall Study|Lost to Follow-up|1|||
42328480|NCT01546168|76166314|FG001|Overall Study|Lost to Follow-up|0|||
42328481|NCT01546168|76166313|FG000|Overall Study|Withdrawal by Subject|1|||
42328482|NCT01546168|76166314|FG001|Overall Study|Withdrawal by Subject|0|||
42328483|NCT01546168|76166313|FG000|Overall Study|ineligible after signing consent|2|||
42328484|NCT01546168|76166314|FG001|Overall Study|ineligible after signing consent|0|||
42328485|NCT01901289|76166320|FG000|Overall Study|Death|32|||
42328486|NCT01901289|76166320|FG000|Overall Study|Lost to Follow-up|16|||
42328487|NCT01901289|76166320|FG000|Overall Study|Withdrawal by Subject|35|||
42328488|NCT01901289|76166320|FG000|Overall Study|Other type of endpoint met|2|||
42328489|NCT01950741|76166324|FG000|Overall Study|Lost to Follow-up|1|||
41997535|NCT01198600|75805650|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
41997536|NCT01198600|75805647|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
41997537|NCT01198600|75805648|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
41997538|NCT01198600|75805649|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
41997539|NCT01198600|75805650|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
42328490|NCT01950741|76166324|FG000|Overall Study|Death|1|||
42328491|NCT01950741|76166324|FG000|Overall Study|Withdrawal by Subject|1|||
41997540|NCT01198600|75805647|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
41997541|NCT01198600|75805648|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
41997542|NCT01198600|75805649|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
41997543|NCT01198600|75805650|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
41997544|NCT01198132|75805660|FG000|Overall Study|Withdrawal by Subject|4|||
41997545|NCT01198132|75805661|FG001|Overall Study|Withdrawal by Subject|5|||
41997546|NCT01198132|75805660|FG000|Overall Study|Physician Decision|5|||
42328492|NCT01950273|76166330|FG000|Overall Study|Protocol Violation|1|||
42328493|NCT01950273|76166331|FG001|Overall Study|Protocol Violation|0|||
42328494|NCT01950273|76166330|FG000|Overall Study|Withdrawal by Subject|2|||
42328495|NCT01950273|76166331|FG001|Overall Study|Withdrawal by Subject|0|||
41997547|NCT01198132|75805661|FG001|Overall Study|Physician Decision|4|||
41997548|NCT01198132|75805660|FG000|Overall Study|Other Unspecified|3|||
41997549|NCT01198132|75805661|FG001|Overall Study|Other Unspecified|6|||
41997550|NCT01198132|75805660|FG000|Overall Study|Lack of Efficacy|2|||
41997551|NCT01198132|75805661|FG001|Overall Study|Lack of Efficacy|3|||
41997552|NCT01198132|75805660|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
41997553|NCT01198132|75805661|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
41997554|NCT01198132|75805660|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
41997555|NCT01198132|75805661|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
42262264|NCT02468674|76089805|FG007|Overall Study|Adverse Event|0|||
42262265|NCT02468674|76089806|FG008|Overall Study|Adverse Event|0|||
42262266|NCT02468674|76089798|FG000|Overall Study|Lost to Follow-up|1|||
42262267|NCT02468674|76089799|FG001|Overall Study|Lost to Follow-up|0|||
42262268|NCT02468674|76089800|FG002|Overall Study|Lost to Follow-up|0|||
42262269|NCT02468674|76089801|FG003|Overall Study|Lost to Follow-up|0|||
42262270|NCT02468674|76089802|FG004|Overall Study|Lost to Follow-up|0|||
42262271|NCT02468674|76089803|FG005|Overall Study|Lost to Follow-up|0|||
42262272|NCT02468674|76089804|FG006|Overall Study|Lost to Follow-up|0|||
42262273|NCT02468674|76089805|FG007|Overall Study|Lost to Follow-up|1|||
42262274|NCT02468674|76089806|FG008|Overall Study|Lost to Follow-up|1|||
42262275|NCT02468674|76089798|FG000|Overall Study|Physician Decision|0|||
42328496|NCT01950273|76166330|FG000|Overall Study|Other not defined above|1|||
42328497|NCT01950273|76166331|FG001|Overall Study|Other not defined above|0|||
41997556|NCT01198132|75805660|FG000|Overall Study|Adverse Event|0|||
41997557|NCT01198132|75805661|FG001|Overall Study|Adverse Event|1|||
41997558|NCT01198132|75805660|FG000|Overall Study|Protocol Violation|1|||
41997559|NCT01198132|75805661|FG001|Overall Study|Protocol Violation|0|||
41997560|NCT01197508|75805673|FG000|Overall Study|Withdrawal by Subject|8|||
41997561|NCT01197508|75805674|FG001|Overall Study|Withdrawal by Subject|7|||
41997562|NCT01197508|75805675|FG002|Overall Study|Withdrawal by Subject|15|||
42262276|NCT02468674|76089799|FG001|Overall Study|Physician Decision|0|||
42262277|NCT02468674|76089800|FG002|Overall Study|Physician Decision|0|||
42262278|NCT02468674|76089801|FG003|Overall Study|Physician Decision|0|||
42328498|NCT01919307|76166337|FG000|Overall Study|Withdrawal by Subject|9|||
41997563|NCT01197508|75805676|FG003|Overall Study|Withdrawal by Subject|4|||
41997564|NCT01197508|75805673|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
41997565|NCT01197508|75805674|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
41997566|NCT01197508|75805675|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
41997567|NCT01197508|75805676|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
41997568|NCT01197508|75805673|FG000|Overall Study|Adverse Event|10|||
41997569|NCT01197508|75805674|FG001|Overall Study|Adverse Event|13|||
41997570|NCT01197508|75805675|FG002|Overall Study|Adverse Event|23|||
41997571|NCT01197508|75805676|FG003|Overall Study|Adverse Event|3|||
41997572|NCT01197508|75805673|FG000|Overall Study|Severe non-compliance to protocol|0|||
41997573|NCT01197508|75805674|FG001|Overall Study|Severe non-compliance to protocol|3|||
41997574|NCT01197508|75805675|FG002|Overall Study|Severe non-compliance to protocol|1|||
41997575|NCT01197508|75805676|FG003|Overall Study|Severe non-compliance to protocol|3|||
41997576|NCT01197508|75805673|FG000|Overall Study|Condition under investigation worsened|1|||
41997577|NCT01197508|75805674|FG001|Overall Study|Condition under investigation worsened|1|||
41997578|NCT01197508|75805675|FG002|Overall Study|Condition under investigation worsened|1|||
41997579|NCT01197508|75805676|FG003|Overall Study|Condition under investigation worsened|1|||
41997580|NCT01197508|75805673|FG000|Overall Study|Lack of Efficacy|1|||
41997581|NCT01197508|75805674|FG001|Overall Study|Lack of Efficacy|2|||
41997582|NCT01197508|75805675|FG002|Overall Study|Lack of Efficacy|2|||
41997583|NCT01197508|75805676|FG003|Overall Study|Lack of Efficacy|1|||
41997584|NCT01197508|75805673|FG000|Overall Study|Study-specific withdrawal criteria|0|||
41997585|NCT01197508|75805674|FG001|Overall Study|Study-specific withdrawal criteria|0|||
42328499|NCT01919229|76166344|FG000|Overall Study|Subject/guardian decision|0|||
42328500|NCT01919229|76166345|FG001|Overall Study|Subject/guardian decision|0|||
42328501|NCT01919229|76166346|FG002|Overall Study|Subject/guardian decision|1|||
42328502|NCT01901055|76166356|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
42328503|NCT01901055|76166357|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
42328504|NCT01901055|76166356|FG000|Randomization But Not Titrated|Physician Decision|0|||
41997586|NCT01197508|75805675|FG002|Overall Study|Study-specific withdrawal criteria|1|||
41997587|NCT01197508|75805676|FG003|Overall Study|Study-specific withdrawal criteria|2|||
41997588|NCT01197508|75805673|FG000|Overall Study|Lost to Follow-up|1|||
41997589|NCT01197508|75805674|FG001|Overall Study|Lost to Follow-up|1|||
42328505|NCT01901055|76166357|FG001|Randomization But Not Titrated|Physician Decision|1|||
42328506|NCT01901055|76166356|FG000|Started Protocol to Week 6|Physician Decision|2|||
42328507|NCT01901055|76166357|FG001|Started Protocol to Week 6|Physician Decision|1|||
42328508|NCT01901055|76166356|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
42328509|NCT01901055|76166357|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
42328510|NCT01901055|76166356|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
42328511|NCT01901055|76166357|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
42328512|NCT01901055|76166356|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
42328513|NCT01901055|76166357|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
42328514|NCT01901055|76166356|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
42328515|NCT01901055|76166357|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
42328516|NCT01901055|76166356|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
42328517|NCT01901055|76166357|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
42328518|NCT01901055|76166356|FG000|Week 24|Withdrawal by Subject|13|||
42328519|NCT01901055|76166357|FG001|Week 24|Withdrawal by Subject|19|||
41997590|NCT01197508|75805675|FG002|Overall Study|Lost to Follow-up|2|||
41997591|NCT01197508|75805676|FG003|Overall Study|Lost to Follow-up|0|||
41997592|NCT01197508|75805673|FG000|Overall Study|Other|2|||
41997593|NCT01197508|75805674|FG001|Overall Study|Other|3|||
41997594|NCT01197508|75805675|FG002|Overall Study|Other|2|||
41997595|NCT01197508|75805676|FG003|Overall Study|Other|2|||
41997596|NCT01196416|75805693|FG000|Overall Study|Withdrawal by Subject|2|||
41997597|NCT01196104|75805699|FG000|Overall Study|Lost to Follow-up|1|||
41997598|NCT01196104|75805700|FG001|Overall Study|Lost to Follow-up|0|||
41997599|NCT01196104|75805699|FG000|Overall Study|Physician Decision|0|||
41997600|NCT01196104|75805700|FG001|Overall Study|Physician Decision|1|||
41997601|NCT01196104|75805699|FG000|Overall Study|Withdrawal by Subject|3|||
41997602|NCT01196104|75805700|FG001|Overall Study|Withdrawal by Subject|3|||
41997603|NCT01196104|75805699|FG000|Overall Study|Various|0|||
41997604|NCT01196104|75805700|FG001|Overall Study|Various|1|||
41997605|NCT01196026|75805718|FG000|Overall Study|Withdrawal by Subject|1|||
41997606|NCT01196026|75805719|FG001|Overall Study|Withdrawal by Subject|4|||
41997607|NCT01196026|75805720|FG002|Overall Study|Withdrawal by Subject|0|||
41997608|NCT01196026|75805721|FG003|Overall Study|Withdrawal by Subject|0|||
41997609|NCT01196026|75805722|FG004|Overall Study|Withdrawal by Subject|0|||
41997610|NCT01196026|75805723|FG005|Overall Study|Withdrawal by Subject|0|||
41997611|NCT01196026|75805718|FG000|Overall Study|Lost to Follow-up|0|||
41997612|NCT01196026|75805719|FG001|Overall Study|Lost to Follow-up|3|||
41997613|NCT01196026|75805720|FG002|Overall Study|Lost to Follow-up|0|||
41997614|NCT01196026|75805721|FG003|Overall Study|Lost to Follow-up|0|||
41997615|NCT01196026|75805722|FG004|Overall Study|Lost to Follow-up|1|||
41997616|NCT01196026|75805723|FG005|Overall Study|Lost to Follow-up|0|||
41997617|NCT01196026|75805718|FG000|Overall Study|Other|0|||
41997618|NCT01196026|75805719|FG001|Overall Study|Other|1|||
41997619|NCT01196026|75805720|FG002|Overall Study|Other|0|||
42262279|NCT02468674|76089802|FG004|Overall Study|Physician Decision|0|||
41997620|NCT01196026|75805721|FG003|Overall Study|Other|0|||
41997621|NCT01196026|75805722|FG004|Overall Study|Other|0|||
41997622|NCT01196026|75805723|FG005|Overall Study|Other|0|||
41997623|NCT01195948|75805742|FG000|Overall Study|Lost to Follow-up|0|||
41997624|NCT01195948|75805743|FG001|Overall Study|Lost to Follow-up|1|||
41997625|NCT01195948|75805744|FG002|Overall Study|Lost to Follow-up|2|||
41997626|NCT01195831|75805757|FG000|Overall Study|Lost to Follow-up|2|||
41997627|NCT01195831|75805758|FG001|Overall Study|Lost to Follow-up|4|||
42328520|NCT01901055|76166356|FG000|Week 24|Physician Decision|1|||
42328521|NCT01901055|76166357|FG001|Week 24|Physician Decision|0|||
42328522|NCT01901055|76166356|FG000|Week 36|Withdrawal by Subject|0|||
42328523|NCT01901055|76166357|FG001|Week 36|Withdrawal by Subject|5|||
42328524|NCT01511536|76166369|FG000|Phase 1|Other|0|||
42328525|NCT01511536|76166370|FG001|Phase 1|Other|1|||
42328526|NCT01511536|76166371|FG002|Phase 1|Other|0|||
42328527|NCT01511536|76166369|FG000|Phase 2|Other|0|||
42328528|NCT01511536|76166370|FG001|Phase 2|Other|0|||
42328529|NCT01511536|76166371|FG002|Phase 2|Other|9|||
42328530|NCT01890759|76166381|FG000|Overall Study|Protocol Violation|0|||
42328531|NCT01890759|76166382|FG001|Overall Study|Protocol Violation|2|||
42328532|NCT01890759|76166381|FG000|Overall Study|Lost to Follow-up|0|||
42328533|NCT01890759|76166382|FG001|Overall Study|Lost to Follow-up|2|||
42328534|NCT01890759|76166381|FG000|Overall Study|Withdrawal by Subject|2|||
42328535|NCT01890759|76166382|FG001|Overall Study|Withdrawal by Subject|8|||
42328536|NCT01900899|76166390|FG000|Overall Study|Withdrawal by Subject|7|||
42328537|NCT01900899|76166391|FG001|Overall Study|Withdrawal by Subject|1|||
42328538|NCT01900899|76166390|FG000|Overall Study|Migrated from study area|2|||
42328539|NCT01900899|76166391|FG001|Overall Study|Migrated from study area|0|||
42328540|NCT01510912|76166397|FG000|Overall Study|Adverse Event|99|||
42328541|NCT01510912|76166397|FG000|Overall Study|Lack of Efficacy|12|||
42328542|NCT01510912|76166397|FG000|Overall Study|Non-compliance with trial drug|23|||
42328543|NCT01510912|76166397|FG000|Overall Study|Withdrawal by Subject|49|||
42328544|NCT01510912|76166397|FG000|Overall Study|Physician Decision|1|||
42328545|NCT01510912|76166397|FG000|Overall Study|Protocol Violation|27|||
42328546|NCT01510912|76166397|FG000|Overall Study|Lost to Follow-up|26|||
42328547|NCT01510912|76166397|FG000|Overall Study|Other, including joint replacement|5|||
42328548|NCT01510756|76166401|FG000|Overall Study|Death|1|||
42328549|NCT01510756|76166401|FG000|Overall Study|Lack of Efficacy|2|||
42328550|NCT01510756|76166401|FG000|Overall Study|Physician Decision|1|||
41997628|NCT01195831|75805757|FG000|Overall Study|Withdrawal by Subject|2|||
42328551|NCT01522456|76166405|FG000|Overall Study|Adverse Event|2|||
42328552|NCT01522456|76166405|FG000|Overall Study|Lost to Follow-up|2|||
42328553|NCT01522456|76166405|FG000|Overall Study|Withdrawal by Subject|2|||
42328554|NCT01522456|76166405|FG000|Overall Study|Pregnancy|1|||
42328555|NCT01522456|76166405|FG000|Overall Study|Tolerability Assessment|1|||
42328556|NCT01545934|76166418|FG000|Overall Study|Withdrawal by Subject|4|||
42328557|NCT01545934|76166419|FG001|Overall Study|Withdrawal by Subject|3|||
42328558|NCT01545934|76166418|FG000|Overall Study|Lost to Follow-up|1|||
42328559|NCT01545934|76166419|FG001|Overall Study|Lost to Follow-up|0|||
42328560|NCT01521364|76166426|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
42328561|NCT01521364|76166426|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
42328562|NCT01545388|76166440|FG000|Overall Study|Adverse Event|2|||
42328563|NCT01545388|76166441|FG001|Overall Study|Adverse Event|4|||
41997629|NCT01195831|75805758|FG001|Overall Study|Withdrawal by Subject|2|||
41997630|NCT01195831|75805757|FG000|Overall Study|Adverse Event|4|||
41997631|NCT01195831|75805758|FG001|Overall Study|Adverse Event|2|||
41997632|NCT01195831|75805757|FG000|Overall Study|Protocol Violation|0|||
41997633|NCT01195831|75805758|FG001|Overall Study|Protocol Violation|2|||
41997634|NCT01195675|75805764|FG000|Overall Study|Adverse Event|1|||
41997635|NCT01195675|75805764|FG000|Overall Study|Withdrawal by Subject|2|||
41997636|NCT01195636|75805781|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
42328564|NCT01545388|76166442|FG002|Overall Study|Adverse Event|1|||
42328565|NCT01545388|76166440|FG000|Overall Study|Lack of Efficacy|3|||
42328566|NCT01545388|76166441|FG001|Overall Study|Lack of Efficacy|2|||
42328567|NCT01545388|76166442|FG002|Overall Study|Lack of Efficacy|5|||
42328568|NCT01545388|76166440|FG000|Overall Study|Participant moved or relocated|1|||
41997637|NCT01195636|75805782|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
42034521|NCT00937521|75842593|FG007|Booster Phase|Lost to Follow-up|0|||
42328569|NCT01545388|76166441|FG001|Overall Study|Participant moved or relocated|0|||
42328570|NCT01545388|76166442|FG002|Overall Study|Participant moved or relocated|0|||
42328571|NCT01545388|76166440|FG000|Overall Study|Withdrawal by Subject|1|||
42328572|NCT01545388|76166441|FG001|Overall Study|Withdrawal by Subject|4|||
42328573|NCT01545388|76166442|FG002|Overall Study|Withdrawal by Subject|2|||
42328574|NCT01545388|76166440|FG000|Overall Study|Other|1|||
42328575|NCT01545388|76166441|FG001|Overall Study|Other|1|||
42328576|NCT01545388|76166442|FG002|Overall Study|Other|0|||
42328577|NCT01545076|76166450|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
41997638|NCT01195636|75805781|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
41997639|NCT01195636|75805782|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
41997640|NCT01195636|75805781|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
42034522|NCT00937521|75842586|FG000|Booster Phase|Administrative Reason|0|||
42034523|NCT00937521|75842587|FG001|Booster Phase|Administrative Reason|0|||
42034524|NCT00937521|75842588|FG002|Booster Phase|Administrative Reason|1|||
42262280|NCT02468674|76089803|FG005|Overall Study|Physician Decision|0|||
42262281|NCT02468674|76089804|FG006|Overall Study|Physician Decision|1|||
42262282|NCT02468674|76089805|FG007|Overall Study|Physician Decision|0|||
42262283|NCT02468674|76089806|FG008|Overall Study|Physician Decision|0|||
42262284|NCT02468674|76089798|FG000|Overall Study|Patient/Guardian Decision|0|||
42262285|NCT02468674|76089799|FG001|Overall Study|Patient/Guardian Decision|0|||
42262286|NCT02468674|76089800|FG002|Overall Study|Patient/Guardian Decision|0|||
42262287|NCT02468674|76089801|FG003|Overall Study|Patient/Guardian Decision|0|||
42262288|NCT02468674|76089802|FG004|Overall Study|Patient/Guardian Decision|1|||
42262289|NCT02468674|76089803|FG005|Overall Study|Patient/Guardian Decision|0|||
42262290|NCT02468674|76089804|FG006|Overall Study|Patient/Guardian Decision|0|||
42328578|NCT01545076|76166451|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
42328579|NCT01545076|76166452|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
42328580|NCT01545076|76166453|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
42328581|NCT01545076|76166454|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
42328582|NCT01545076|76166450|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
42328583|NCT01545076|76166451|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
42328584|NCT01545076|76166452|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
41997641|NCT01195636|75805782|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
41997642|NCT01195636|75805781|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
42262291|NCT02468674|76089805|FG007|Overall Study|Patient/Guardian Decision|2|||
42262292|NCT02468674|76089806|FG008|Overall Study|Patient/Guardian Decision|1|||
42262293|NCT02468674|76089798|FG000|Overall Study|Protocol Deviation|0|||
42262294|NCT02468674|76089799|FG001|Overall Study|Protocol Deviation|0|||
42262295|NCT02468674|76089800|FG002|Overall Study|Protocol Deviation|0|||
41997643|NCT01195636|75805782|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
41997644|NCT01195636|75805781|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
42328585|NCT01545076|76166453|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
42328586|NCT01545076|76166454|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
42328587|NCT01545076|76166450|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
41997645|NCT01195636|75805782|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
41997646|NCT01195636|75805781|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
41997647|NCT01195636|75805782|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
41997648|NCT01195636|75805781|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
41997649|NCT01195636|75805782|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
41997650|NCT01195636|75805781|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
41997651|NCT01195636|75805782|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
41997652|NCT01195363|75805790|FG000|Overall Study|Lost to Follow-up|7|||
41997653|NCT01195363|75805791|FG001|Overall Study|Lost to Follow-up|4|||
41997654|NCT01195363|75805790|FG000|Overall Study|Adverse Event|3|||
41997655|NCT01195363|75805791|FG001|Overall Study|Adverse Event|1|||
41997656|NCT01195363|75805790|FG000|Overall Study|Lack of Efficacy|0|||
41997657|NCT01195363|75805791|FG001|Overall Study|Lack of Efficacy|4|||
41997658|NCT01195363|75805790|FG000|Overall Study|incarceration|1|||
41997659|NCT01195363|75805791|FG001|Overall Study|incarceration|0|||
41997660|NCT01195090|75805799|FG000|Overall Study|Adverse Event|1|||
41997661|NCT01195090|75805800|FG001|Overall Study|Adverse Event|2|||
41997662|NCT01195090|75805799|FG000|Overall Study|Lost to Follow-up|2|||
41997663|NCT01195090|75805800|FG001|Overall Study|Lost to Follow-up|2|||
41997664|NCT01195090|75805799|FG000|Overall Study|Protocol Violation|3|||
41997665|NCT01195090|75805800|FG001|Overall Study|Protocol Violation|4|||
41997666|NCT01194973|75805806|FG000|Screening Period|Screen Failure|3|||
41997667|NCT01194973|75805806|FG000|26 Week Treatment Period|Adverse Event|1|||
41997668|NCT01194973|75805806|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
41997669|NCT01194973|75805806|FG000|26 Week Treatment Period|Pregnancy|1|||
41997670|NCT02218697|75805812|FG000|Overall Study|Adverse Event|0|||
41997671|NCT02218697|75805813|FG001|Overall Study|Adverse Event|2|||
41997672|NCT02218697|75805812|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
41997673|NCT02218697|75805813|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
41997674|NCT02218697|75805812|FG000|Overall Study|Withdrawal by Subject|2|||
41997675|NCT02218697|75805813|FG001|Overall Study|Withdrawal by Subject|3|||
41997676|NCT01177540|75805821|FG000|Overall Study|Adverse Event|1|||
41997677|NCT01177540|75805822|FG001|Overall Study|Adverse Event|0|||
41997678|NCT01177384|75805830|FG000|Overall Study|Adverse Event|6|||
41997679|NCT01177384|75805831|FG001|Overall Study|Adverse Event|4|||
41997680|NCT01177384|75805830|FG000|Overall Study|Lack of Efficacy|0|||
41997681|NCT01177384|75805831|FG001|Overall Study|Lack of Efficacy|1|||
41997682|NCT01177384|75805830|FG000|Overall Study|Lost to Follow-up|3|||
41997683|NCT01177384|75805831|FG001|Overall Study|Lost to Follow-up|4|||
41997684|NCT01177384|75805830|FG000|Overall Study|Physician Decision|0|||
41997685|NCT01177384|75805831|FG001|Overall Study|Physician Decision|3|||
41997686|NCT01177384|75805830|FG000|Overall Study|Protocol Violation|0|||
41997687|NCT01177384|75805831|FG001|Overall Study|Protocol Violation|2|||
41997688|NCT01177384|75805830|FG000|Overall Study|Withdrawal by Subject|5|||
41997689|NCT01177384|75805831|FG001|Overall Study|Withdrawal by Subject|12|||
41997690|NCT01194154|75805839|FG000|Overall Study|Adverse Event|12|||
41997691|NCT01194154|75805840|FG001|Overall Study|Adverse Event|7|||
41997692|NCT01194154|75805839|FG000|Overall Study|Lost to Follow-up|2|||
41997693|NCT01194154|75805840|FG001|Overall Study|Lost to Follow-up|3|||
41997694|NCT01194154|75805839|FG000|Overall Study|Protocol Violation|0|||
41997695|NCT01194154|75805840|FG001|Overall Study|Protocol Violation|1|||
41997696|NCT01194154|75805839|FG000|Overall Study|Withdrawal by Subject|5|||
42034525|NCT00937521|75842589|FG003|Booster Phase|Administrative Reason|0|||
42034526|NCT00937521|75842590|FG004|Booster Phase|Administrative Reason|1|||
42034527|NCT00937521|75842591|FG005|Booster Phase|Administrative Reason|1|||
42328588|NCT01545076|76166451|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
42328589|NCT01545076|76166452|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
42328590|NCT01545076|76166453|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
42328591|NCT01545076|76166454|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
42328592|NCT01545076|76166450|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
42034528|NCT00937521|75842592|FG006|Booster Phase|Administrative Reason|0|||
41997697|NCT01194154|75805840|FG001|Overall Study|Withdrawal by Subject|6|||
41997698|NCT01194154|75805839|FG000|Overall Study|Blood pressure increase|5|||
41997699|NCT01194154|75805840|FG001|Overall Study|Blood pressure increase|3|||
41997700|NCT01194154|75805839|FG000|Overall Study|Hemoglobin decrease|0|||
41997701|NCT01194154|75805840|FG001|Overall Study|Hemoglobin decrease|1|||
41997702|NCT01194154|75805839|FG000|Overall Study|Hemoglobin increase|12|||
41997703|NCT01194154|75805840|FG001|Overall Study|Hemoglobin increase|3|||
41997704|NCT01194154|75805839|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
42328593|NCT01545076|76166451|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
42328594|NCT01545076|76166452|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
42328595|NCT01545076|76166453|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
42328596|NCT01545076|76166454|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
42328597|NCT01545076|76166450|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
42328598|NCT01545076|76166451|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
42328599|NCT01545076|76166452|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
42328600|NCT01545076|76166453|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
42328601|NCT01545076|76166454|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
42328602|NCT01545076|76166450|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
41997705|NCT01194154|75805840|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
42328603|NCT01545076|76166451|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
42328604|NCT01545076|76166452|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
42328605|NCT01545076|76166453|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
42328606|NCT01545076|76166454|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
42328607|NCT01545076|76166450|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
42328608|NCT01545076|76166451|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
42328609|NCT01545076|76166452|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
42328610|NCT01545076|76166453|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
42328611|NCT01545076|76166454|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
42328612|NCT01545076|76166450|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
42328613|NCT01545076|76166451|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
41997706|NCT01194154|75805839|FG000|Overall Study|Treatment with prohibited medication|4|||
41997707|NCT01194154|75805840|FG001|Overall Study|Treatment with prohibited medication|5|||
41997708|NCT01194154|75805839|FG000|Overall Study|Other|4|||
41997709|NCT01194154|75805840|FG001|Overall Study|Other|0|||
41997710|NCT01194154|75805839|FG000|Overall Study|Did not receive study medication|2|||
41997711|NCT01194154|75805840|FG001|Overall Study|Did not receive study medication|4|||
41997712|NCT05034731|75805862|FG000|Overall Study|Screen fail|1|||
41997713|NCT05034731|75805863|FG001|Overall Study|Screen fail|1|||
41997714|NCT04984993|75805873|FG000|Overall Study|Withdrawal by Subject|8|||
41997715|NCT04984993|75805874|FG001|Overall Study|Withdrawal by Subject|2|||
41997716|NCT04984993|75805873|FG000|Overall Study|Lost to Follow-up|2|||
41997717|NCT04984993|75805874|FG001|Overall Study|Lost to Follow-up|2|||
41997718|NCT04984993|75805873|FG000|Overall Study|Both patients moved to another country|4|||
41997719|NCT04984993|75805874|FG001|Overall Study|Both patients moved to another country|0|||
41997720|NCT04880161|75805881|FG000|Overall Study|Withdrawal by Subject|1|||
41997721|NCT04880161|75805882|FG001|Overall Study|Withdrawal by Subject|0|||
41997722|NCT04880161|75805881|FG000|Overall Study|Lack of Compliance|1|||
41997723|NCT04880161|75805882|FG001|Overall Study|Lack of Compliance|1|||
41997724|NCT04880161|75805881|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
41997725|NCT04880161|75805882|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
41997726|NCT04880161|75805881|FG000|Overall Study|Screen Failure|0|||
41997727|NCT04880161|75805882|FG001|Overall Study|Screen Failure|1|||
41997728|NCT04809220|75805890|FG000|Overall Study|Adverse Event|4|||
41997729|NCT04809220|75805891|FG001|Overall Study|Adverse Event|0|||
41997730|NCT04809220|75805890|FG000|Overall Study|Death|1|||
41997731|NCT04809220|75805891|FG001|Overall Study|Death|0|||
41997732|NCT04809220|75805890|FG000|Overall Study|Lost to Follow-up|3|||
41997733|NCT04809220|75805891|FG001|Overall Study|Lost to Follow-up|0|||
41997734|NCT04809220|75805890|FG000|Overall Study|Physician Decision|0|||
41997735|NCT04809220|75805891|FG001|Overall Study|Physician Decision|1|||
41997736|NCT04809220|75805890|FG000|Overall Study|Withdrawal by Subject|9|||
41997737|NCT04809220|75805891|FG001|Overall Study|Withdrawal by Subject|5|||
41997738|NCT04809220|75805890|FG000|Overall Study|Due to long-term overseas business trips|1|||
41997739|NCT04809220|75805891|FG001|Overall Study|Due to long-term overseas business trips|0|||
41997740|NCT04740827|75805900|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
41997741|NCT04740827|75805901|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
41997742|NCT04740827|75805900|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
42262296|NCT02468674|76089801|FG003|Overall Study|Protocol Deviation|0|||
42262297|NCT02468674|76089802|FG004|Overall Study|Protocol Deviation|0|||
42262298|NCT02468674|76089803|FG005|Overall Study|Protocol Deviation|0|||
42262299|NCT02468674|76089804|FG006|Overall Study|Protocol Deviation|0|||
42262300|NCT02468674|76089805|FG007|Overall Study|Protocol Deviation|1|||
42262301|NCT02468674|76089806|FG008|Overall Study|Protocol Deviation|1|||
42262302|NCT02467192|76089826|FG000|Overall Study|Death|1|||
42262303|NCT02467192|76089826|FG000|Overall Study|revealed to have pneumonia before|2|||
41997743|NCT04740827|75805901|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
41997744|NCT04740827|75805900|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
41997745|NCT04740827|75805901|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
42328614|NCT01545076|76166452|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
42328615|NCT01545076|76166453|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
42328616|NCT01545076|76166454|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
42328617|NCT01545076|76166450|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
42328618|NCT01545076|76166451|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
42328619|NCT01545076|76166452|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
42328620|NCT01545076|76166453|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
42328621|NCT01545076|76166454|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
41997746|NCT04740827|75805900|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
42328622|NCT01544920|76166469|FG000|Overall Study|Adverse Event|0|||
42328623|NCT01544920|76166470|FG001|Overall Study|Adverse Event|3|||
42328624|NCT01544920|76166469|FG000|Overall Study|Death|0|||
42328625|NCT01544920|76166470|FG001|Overall Study|Death|1|||
42328626|NCT01544920|76166469|FG000|Overall Study|Lost to Follow-up|11|||
42328627|NCT01544920|76166470|FG001|Overall Study|Lost to Follow-up|12|||
42328628|NCT01544920|76166469|FG000|Overall Study|Protocol Violation|0|||
42328629|NCT01544920|76166470|FG001|Overall Study|Protocol Violation|2|||
42328630|NCT01544920|76166469|FG000|Overall Study|Physician Decision|4|||
42328631|NCT01544920|76166470|FG001|Overall Study|Physician Decision|1|||
42328632|NCT01544920|76166469|FG000|Overall Study|Withdrawal by Subject|4|||
42328633|NCT01544920|76166470|FG001|Overall Study|Withdrawal by Subject|4|||
42328634|NCT01509664|76166480|FG000|Overall Study|Lost to Follow-up|15|||
42328635|NCT01509664|76166481|FG001|Overall Study|Lost to Follow-up|21|||
42328636|NCT01543828|76166489|FG000|Treatment 2|Lost to Follow-up|1|||
42328637|NCT01543828|76166490|FG001|Treatment 2|Lost to Follow-up|0|||
42328638|NCT01520506|76166498|FG000|Overall Study|Missed Visit|4|||
42328639|NCT01520506|76166498|FG000|Overall Study|Lost to Follow-up|1|||
42328640|NCT01520506|76166498|FG000|Overall Study|Withdrawal by Subject|1|||
42328641|NCT01519960|76166505|FG000|Overall Study|Withdrawal from the study|26|||
42328642|NCT01519960|76166506|FG001|Overall Study|Withdrawal from the study|22|||
41997747|NCT04740827|75805901|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
41997748|NCT04740827|75805900|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
41997749|NCT04740827|75805901|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
42328643|NCT01519960|76166507|FG002|Overall Study|Withdrawal from the study|5|||
42328644|NCT01543204|76166523|FG000|Overall Study|Non-compliance|1|||
42328645|NCT01543204|76166523|FG000|Overall Study|Adverse Event|1|||
42328646|NCT01543204|76166523|FG000|Overall Study|Withdrawal by Subject|4|||
42328647|NCT01543204|76166523|FG000|Overall Study|Requirement for Alternative Therapy|1|||
42328648|NCT01543204|76166523|FG000|Overall Study|Lost to Follow-up|1|||
41997750|NCT04740827|75805900|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
41997751|NCT04740827|75805901|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
41997752|NCT04725240|75805907|FG000|Overall Study|Adverse Event|2|||
42328649|NCT01488994|76166533|FG000|Overall Study|Withdrawal by Subject|0|||
42328650|NCT01488994|76166534|FG001|Overall Study|Withdrawal by Subject|1|||
42328651|NCT01508650|76166547|FG000|Overall Study|Lost to Follow-up|0|||
42328652|NCT01508650|76166548|FG001|Overall Study|Lost to Follow-up|3|||
42328653|NCT01488448|76166556|FG000|Overall Study|Withdrawal by Subject|3|||
42328654|NCT01488448|76166557|FG001|Overall Study|Withdrawal by Subject|1|||
42328655|NCT01488448|76166556|FG000|Overall Study|Adverse Event|9|||
42328656|NCT01488448|76166557|FG001|Overall Study|Adverse Event|4|||
42328657|NCT01488448|76166556|FG000|Overall Study|Physician Decision|4|||
42328658|NCT01488448|76166557|FG001|Overall Study|Physician Decision|9|||
42328659|NCT01488448|76166556|FG000|Overall Study|Protocol Violation|4|||
42328660|NCT01488448|76166557|FG001|Overall Study|Protocol Violation|3|||
42328661|NCT01518946|76166567|FG000|Open-label Phase|Other|4|||
42328662|NCT01518946|76166568|FG001|Open-label Phase|Other|0|||
42328663|NCT01518946|76166569|FG002|Open-label Phase|Other|0|||
42328664|NCT01518946|76166567|FG000|Randomized Phase (First Intervention)|Other|0|||
42328665|NCT01518946|76166568|FG001|Randomized Phase (First Intervention)|Other|1|||
42328666|NCT01518946|76166569|FG002|Randomized Phase (First Intervention)|Other|0|||
42328667|NCT01488370|76166579|FG000|Overall Study|Protocol Violation|0|||
42328668|NCT01488370|76166580|FG001|Overall Study|Protocol Violation|1|||
42328669|NCT01488370|76166581|FG002|Overall Study|Protocol Violation|1|||
42328670|NCT01518322|76166589|FG000|Overall Study|FeNO measurement was missing|13|||
42328671|NCT01507246|76166600|FG000|Overall Study|Required different surgical procedures|2|||
42328672|NCT01507246|76166601|FG001|Overall Study|Required different surgical procedures|1|||
42328673|NCT01507090|76166610|FG000|Overall Study|incomplete dataset|18|||
42328674|NCT01464346|76166624|FG000|Overall Study|Withdrawal by Subject|0|||
42328675|NCT01464346|76166625|FG001|Overall Study|Withdrawal by Subject|0|||
42328676|NCT01464346|76166626|FG002|Overall Study|Withdrawal by Subject|1|||
42328677|NCT01487200|76166653|FG000|Overall Study|Withdrawal by Subject|0|||
42328678|NCT01487200|76166654|FG001|Overall Study|Withdrawal by Subject|1|||
42328679|NCT01487200|76166655|FG002|Overall Study|Withdrawal by Subject|0|||
42328680|NCT01487200|76166656|FG003|Overall Study|Withdrawal by Subject|0|||
42328681|NCT01463878|76166669|FG000|Overall Study|no longer met criteria for tube feed|2|||
42328682|NCT01463878|76166670|FG001|Overall Study|no longer met criteria for tube feed|2|||
42328683|NCT01486966|76166678|FG000|Overall Study|Adverse Event|0|||
41997753|NCT04620746|75805922|FG000|Overall Study|Adverse Event|2|||
42262304|NCT02410954|76089836|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
42262305|NCT02410954|76089837|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
42262306|NCT02410954|76089836|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
42262307|NCT02410954|76089837|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
42262308|NCT05153499|76089858|FG000|Overall Study|Withdrawal by Subject|1|||
42262309|NCT05153499|76089859|FG001|Overall Study|Withdrawal by Subject|0|||
42262310|NCT05153499|76089858|FG000|Overall Study|Clinical Hold|1|||
42262311|NCT05153499|76089859|FG001|Overall Study|Clinical Hold|0|||
42262312|NCT05153499|76089858|FG000|Overall Study|Study Termination|6|||
42262313|NCT05153499|76089859|FG001|Overall Study|Study Termination|5|||
42262314|NCT05047770|76089869|FG000|Overall Study|Withdrawal by Subject|15|||
42262315|NCT05047770|76089870|FG001|Overall Study|Withdrawal by Subject|10|||
42262316|NCT05047770|76089871|FG002|Overall Study|Withdrawal by Subject|6|||
42262317|NCT05047770|76089872|FG003|Overall Study|Withdrawal by Subject|12|||
42262318|NCT05047770|76089869|FG000|Overall Study|Lost to Follow-up|7|||
42262319|NCT05047770|76089870|FG001|Overall Study|Lost to Follow-up|5|||
42262320|NCT05047770|76089871|FG002|Overall Study|Lost to Follow-up|12|||
42262321|NCT05047770|76089872|FG003|Overall Study|Lost to Follow-up|13|||
42262322|NCT05047770|76089869|FG000|Overall Study|Other|1|||
42262323|NCT05047770|76089870|FG001|Overall Study|Other|0|||
42262324|NCT05047770|76089871|FG002|Overall Study|Other|1|||
42262325|NCT05047770|76089872|FG003|Overall Study|Other|0|||
42262326|NCT04740814|76089912|FG000|Overall Study|Adverse Event|3|||
42262327|NCT04740814|76089912|FG000|Overall Study|Protocol Violation|2|||
42262328|NCT04740814|76089912|FG000|Overall Study|Lost to Follow-up|2|||
42262329|NCT04740814|76089912|FG000|Overall Study|Withdrawal by Subject|3|||
42262330|NCT04652453|76089923|FG000|Overall Study|Death|8|||
42262331|NCT04652453|76089924|FG001|Overall Study|Death|2|||
42262332|NCT04652453|76089925|FG002|Overall Study|Death|0|||
42262333|NCT04652453|76089923|FG000|Overall Study|Hospice|5|||
42262334|NCT04652453|76089924|FG001|Overall Study|Hospice|5|||
42262335|NCT04652453|76089925|FG002|Overall Study|Hospice|0|||
42262336|NCT04652453|76089923|FG000|Overall Study|Withdrawal by Subject|2|||
42262337|NCT04652453|76089924|FG001|Overall Study|Withdrawal by Subject|0|||
42262338|NCT04652453|76089925|FG002|Overall Study|Withdrawal by Subject|0|||
42262339|NCT04624672|76089933|FG000|Overall Study|Early Study Closure|2|||
42262340|NCT04624672|76089934|FG001|Overall Study|Early Study Closure|1|||
42262341|NCT04476108|76089971|FG000|Overall Study|Adverse Event|4|||
42328684|NCT01486966|76166679|FG001|Overall Study|Adverse Event|1|||
41997754|NCT04620746|75805923|FG001|Overall Study|Adverse Event|0|||
42262342|NCT04476108|76089972|FG001|Overall Study|Adverse Event|1|||
42262343|NCT04476108|76089971|FG000|Overall Study|Lost to Follow-up|1|||
42262344|NCT04476108|76089972|FG001|Overall Study|Lost to Follow-up|0|||
42262345|NCT04476108|76089971|FG000|Overall Study|Inadvertent Enrollment|1|||
42262346|NCT04476108|76089972|FG001|Overall Study|Inadvertent Enrollment|0|||
42262347|NCT04476108|76089971|FG000|Overall Study|Protocol Violation|1|||
42262348|NCT04476108|76089972|FG001|Overall Study|Protocol Violation|1|||
42262349|NCT04476108|76089971|FG000|Overall Study|Withdrawal by Subject|1|||
42328685|NCT01486966|76166678|FG000|Overall Study|Withdrawal by Subject|0|||
42328686|NCT01486966|76166679|FG001|Overall Study|Withdrawal by Subject|1|||
42328687|NCT01900665|76166687|FG000|Placebo Controlled Period|Death|9|||
42328688|NCT01900665|76166688|FG001|Placebo Controlled Period|Death|16|||
42328689|NCT01900665|76166687|FG000|Placebo Controlled Period|Adverse Event|48|||
42328690|NCT01900665|76166688|FG001|Placebo Controlled Period|Adverse Event|39|||
42328691|NCT01900665|76166687|FG000|Placebo Controlled Period|Protocol Violation|1|||
42328692|NCT01900665|76166688|FG001|Placebo Controlled Period|Protocol Violation|7|||
42328693|NCT01900665|76166687|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
42328694|NCT01900665|76166688|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
42328695|NCT01900665|76166687|FG000|Placebo Controlled Period|Physician Decision|11|||
42328696|NCT01900665|76166688|FG001|Placebo Controlled Period|Physician Decision|7|||
42328697|NCT01900665|76166687|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
42328698|NCT01900665|76166688|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
42328699|NCT01900665|76166687|FG000|Placebo Controlled Period|Caregiver Decision|33|||
42328700|NCT01900665|76166688|FG001|Placebo Controlled Period|Caregiver Decision|41|||
42328701|NCT01900665|76166687|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
42328702|NCT01900665|76166688|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
42328703|NCT01900665|76166687|FG000|Open Label Period|Adverse Event|16|||
42328704|NCT01900665|76166688|FG001|Open Label Period|Adverse Event|20|||
42328705|NCT01900665|76166687|FG000|Open Label Period|Death|5|||
42328706|NCT01900665|76166688|FG001|Open Label Period|Death|6|||
42328707|NCT01900665|76166687|FG000|Open Label Period|Lost to Follow-up|1|||
42328708|NCT01900665|76166688|FG001|Open Label Period|Lost to Follow-up|1|||
42328709|NCT01900665|76166687|FG000|Open Label Period|Parent/Caregiver Decision|33|||
42328710|NCT01900665|76166688|FG001|Open Label Period|Parent/Caregiver Decision|34|||
42328711|NCT01900665|76166687|FG000|Open Label Period|Physician Decision|4|||
42328712|NCT01900665|76166688|FG001|Open Label Period|Physician Decision|4|||
42328713|NCT01900665|76166687|FG000|Open Label Period|Protocol Violation|0|||
42328714|NCT01900665|76166688|FG001|Open Label Period|Protocol Violation|1|||
42328715|NCT01900665|76166687|FG000|Open Label Period|Sponsor Decision|802|||
42328716|NCT01900665|76166688|FG001|Open Label Period|Sponsor Decision|765|||
42328717|NCT01900665|76166687|FG000|Open Label Period|Withdrawal by Subject|20|||
42328718|NCT01900665|76166688|FG001|Open Label Period|Withdrawal by Subject|28|||
42328719|NCT01900431|76166699|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
42328720|NCT01900431|76166700|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
42328721|NCT01900431|76166701|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
42328722|NCT01900431|76166699|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
42328723|NCT01900431|76166700|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
42328724|NCT01900431|76166701|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
42328725|NCT01900431|76166699|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
42328726|NCT01900431|76166700|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
42328727|NCT01900431|76166701|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
42328728|NCT01900431|76166699|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
42328729|NCT01900431|76166700|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
42328730|NCT01900431|76166701|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
42328731|NCT01900431|76166699|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
42328732|NCT01900431|76166700|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
42328733|NCT01900431|76166701|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
42328734|NCT01900431|76166699|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
42328735|NCT01900431|76166700|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
42328736|NCT01900431|76166701|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
42328737|NCT01900431|76166699|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
42328738|NCT01900431|76166700|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
42328739|NCT01900431|76166701|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
42328740|NCT01900431|76166699|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
42328741|NCT01900431|76166700|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
42328742|NCT01900431|76166701|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
42328743|NCT01900431|76166699|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
42328744|NCT01900431|76166700|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
42328745|NCT01900431|76166701|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
42328746|NCT01948791|76166709|FG000|Overall Study|Adverse Event|12|||
42328747|NCT01948791|76166709|FG000|Overall Study|Lack of Efficacy|3|||
42328748|NCT01948791|76166709|FG000|Overall Study|Protocol Violation|2|||
42328749|NCT01948791|76166709|FG000|Overall Study|Withdrawal by Subject|5|||
42328750|NCT01948791|76166709|FG000|Overall Study|Lost to Follow-up|6|||
42328751|NCT01948791|76166709|FG000|Overall Study|Management issues|1|||
42328752|NCT01948791|76166709|FG000|Overall Study|Others|7|||
42328753|NCT01948791|76166709|FG000|Overall Study|Screening failure|35|||
42328754|NCT01899729|76166718|FG000|Overall Study|Adverse Event|1|||
42328755|NCT01899729|76166719|FG001|Overall Study|Adverse Event|0|||
42328756|NCT01899729|76166720|FG002|Overall Study|Adverse Event|0|||
42328757|NCT01899729|76166721|FG003|Overall Study|Adverse Event|0|||
42328758|NCT01899729|76166722|FG004|Overall Study|Adverse Event|1|||
42328759|NCT01899729|76166718|FG000|Overall Study|Withdrawal by Subject|1|||
42328760|NCT01899729|76166719|FG001|Overall Study|Withdrawal by Subject|2|||
42328761|NCT01899729|76166720|FG002|Overall Study|Withdrawal by Subject|0|||
42328762|NCT01899729|76166721|FG003|Overall Study|Withdrawal by Subject|0|||
42328763|NCT01899729|76166722|FG004|Overall Study|Withdrawal by Subject|0|||
42328764|NCT01899729|76166718|FG000|Overall Study|Lack of Efficacy|0|||
42328765|NCT01899729|76166719|FG001|Overall Study|Lack of Efficacy|0|||
42328766|NCT01899729|76166720|FG002|Overall Study|Lack of Efficacy|2|||
42328767|NCT01899729|76166721|FG003|Overall Study|Lack of Efficacy|0|||
42328768|NCT01899729|76166722|FG004|Overall Study|Lack of Efficacy|1|||
42328769|NCT01898091|76166736|FG000|Overall Study|Lost to Follow-up|1|||
42328770|NCT01898091|76166737|FG001|Overall Study|Lost to Follow-up|1|||
42328771|NCT01898091|76166736|FG000|Overall Study|Withdrawal by Subject|1|||
42328772|NCT01898091|76166737|FG001|Overall Study|Withdrawal by Subject|5|||
42328773|NCT01947855|76166746|FG000|Overall Study|Withdrawal by Subject|1|||
42328774|NCT01947855|76166747|FG001|Overall Study|Withdrawal by Subject|0|||
42328775|NCT01947855|76166748|FG002|Overall Study|Withdrawal by Subject|0|||
42328776|NCT01888965|76166756|FG000|Overall Study|Adverse Event|5|||
42328777|NCT01888965|76166756|FG000|Overall Study|Lack of Efficacy|4|||
42328778|NCT01888497|76166760|FG000|Washout Period 1|Withdrawal by Subject|0|||
42328779|NCT01888497|76166761|FG001|Washout Period 1|Withdrawal by Subject|0|||
42328780|NCT01888497|76166762|FG002|Washout Period 1|Withdrawal by Subject|1|||
42328781|NCT01888497|76166763|FG003|Washout Period 1|Withdrawal by Subject|1|||
42262350|NCT04476108|76089972|FG001|Overall Study|Withdrawal by Subject|1|||
42328782|NCT01888497|76166760|FG000|Washout Period 2|Adverse Event|0|||
42328783|NCT01888497|76166761|FG001|Washout Period 2|Adverse Event|0|||
42328784|NCT01888497|76166762|FG002|Washout Period 2|Adverse Event|0|||
42328785|NCT01888497|76166763|FG003|Washout Period 2|Adverse Event|1|||
42328786|NCT01888497|76166760|FG000|Washout Period 2|Withdrawal by Subject|0|||
42328787|NCT01888497|76166761|FG001|Washout Period 2|Withdrawal by Subject|0|||
42328788|NCT01888497|76166762|FG002|Washout Period 2|Withdrawal by Subject|0|||
42328789|NCT01888497|76166763|FG003|Washout Period 2|Withdrawal by Subject|1|||
42328790|NCT01505530|76166776|FG000|Overall Study|Progressive Disease|19|||
42328791|NCT01505530|76166777|FG001|Overall Study|Progressive Disease|17|||
42328792|NCT01505530|76166778|FG002|Overall Study|Progressive Disease|18|||
42328793|NCT01505530|76166776|FG000|Overall Study|Adverse Event|1|||
42328794|NCT01505530|76166777|FG001|Overall Study|Adverse Event|1|||
42328795|NCT01505530|76166778|FG002|Overall Study|Adverse Event|0|||
41997755|NCT04620746|75805922|FG000|Overall Study|Uniterpretable skin test|1|||
41997756|NCT04620746|75805923|FG001|Overall Study|Uniterpretable skin test|0|||
41997757|NCT04620746|75805922|FG000|Overall Study|Withdrawal by Subject|0|||
41997758|NCT04620746|75805923|FG001|Overall Study|Withdrawal by Subject|1|||
41997759|NCT04524858|75805954|FG000|Overall Study|Adverse Event|1|||
41997760|NCT04464265|75805958|FG000|Overall Study|Physician Decision|2|||
41997761|NCT04326231|75805971|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
41997762|NCT04275336|75805978|FG000|Overall Study|First venipuncture failed|4|||
41997763|NCT04275336|75805979|FG001|Overall Study|First venipuncture failed|6|||
41997764|NCT04275336|75805980|FG002|Overall Study|First venipuncture failed|5|||
42262351|NCT04456686|76089980|FG000|Overall Study|Adverse Event|2|||
42262352|NCT04456686|76089981|FG001|Overall Study|Adverse Event|1|||
42262353|NCT04456686|76089980|FG000|Overall Study|Lack of Efficacy|3|||
42262354|NCT04456686|76089981|FG001|Overall Study|Lack of Efficacy|1|||
42262355|NCT04456686|76089980|FG000|Overall Study|Withdrew consent|3|||
42262356|NCT04456686|76089981|FG001|Overall Study|Withdrew consent|1|||
42262357|NCT04456686|76089980|FG000|Overall Study|Physician Decision|2|||
42262358|NCT04456686|76089981|FG001|Overall Study|Physician Decision|2|||
42328796|NCT01505530|76166776|FG000|Overall Study|Withdrawal by Subject|7|||
42328797|NCT01505530|76166777|FG001|Overall Study|Withdrawal by Subject|8|||
42328798|NCT01505530|76166778|FG002|Overall Study|Withdrawal by Subject|6|||
42328799|NCT01505530|76166776|FG000|Overall Study|Physician Decision|6|||
42328800|NCT01505530|76166777|FG001|Overall Study|Physician Decision|2|||
42328801|NCT01505530|76166778|FG002|Overall Study|Physician Decision|5|||
42328802|NCT01505530|76166776|FG000|Overall Study|Sponsor Decision|1|||
42328803|NCT01505530|76166777|FG001|Overall Study|Sponsor Decision|8|||
42328804|NCT01505530|76166778|FG002|Overall Study|Sponsor Decision|7|||
42328805|NCT01505530|76166776|FG000|Overall Study|Death|7|||
41997765|NCT04275336|75805978|FG000|Overall Study|Unscheduled venipuncture|9|||
41997766|NCT04275336|75805979|FG001|Overall Study|Unscheduled venipuncture|13|||
42262359|NCT04456686|76089980|FG000|Overall Study|Withdrawal by Subject|5|||
42262360|NCT04456686|76089981|FG001|Overall Study|Withdrawal by Subject|1|||
41997767|NCT04275336|75805980|FG002|Overall Study|Unscheduled venipuncture|7|||
41997768|NCT04275336|75805978|FG000|Overall Study|Failed specimen of saliva|4|||
41997769|NCT04275336|75805979|FG001|Overall Study|Failed specimen of saliva|3|||
41997770|NCT04275336|75805980|FG002|Overall Study|Failed specimen of saliva|4|||
41997771|NCT04251910|75806006|FG000|Overall Study|Covid 19 lockdown|0|||
41997772|NCT04251910|75806007|FG001|Overall Study|Covid 19 lockdown|5|||
41997773|NCT04251910|75806008|FG002|Overall Study|Covid 19 lockdown|0|||
41997774|NCT04251910|75806009|FG003|Overall Study|Covid 19 lockdown|4|||
41997775|NCT04251910|75806010|FG004|Overall Study|Covid 19 lockdown|0|||
41997776|NCT04251910|75806011|FG005|Overall Study|Covid 19 lockdown|0|||
41997777|NCT04251910|75806006|FG000|Overall Study|Assisted living facility was closed|0|||
41997778|NCT04251910|75806007|FG001|Overall Study|Assisted living facility was closed|0|||
41997779|NCT04251910|75806008|FG002|Overall Study|Assisted living facility was closed|0|||
41997780|NCT04251910|75806009|FG003|Overall Study|Assisted living facility was closed|0|||
41997781|NCT04251910|75806010|FG004|Overall Study|Assisted living facility was closed|1|||
41997782|NCT04251910|75806011|FG005|Overall Study|Assisted living facility was closed|0|||
41997783|NCT04248491|75806030|FG000|Overall Study|Lost to Follow-up|1|||
41997784|NCT04248491|75806031|FG001|Overall Study|Lost to Follow-up|0|||
42134066|NCT00452400|75944920|FG003|Overall Study|Adverse Event|0|||
41997785|NCT04101318|75806045|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
41997786|NCT04101318|75806046|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
41997787|NCT04101318|75806045|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
41997788|NCT04101318|75806046|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
41997789|NCT04101318|75806045|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
41997790|NCT04101318|75806046|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
41997791|NCT04091672|75806054|FG000|Overall Study|Death|6|||
41997792|NCT04091672|75806055|FG001|Overall Study|Death|6|||
41997793|NCT04091672|75806054|FG000|Overall Study|Lost to Follow-up|7|||
41997794|NCT04091672|75806055|FG001|Overall Study|Lost to Follow-up|7|||
41997795|NCT04091672|75806054|FG000|Overall Study|Withdrawal by Subject|3|||
42134067|NCT00452400|75944921|FG004|Overall Study|Adverse Event|2|||
42134068|NCT00452400|75944917|FG000|Overall Study|Protocol Violation|0|||
42134069|NCT00452400|75944918|FG001|Overall Study|Protocol Violation|0|||
42134070|NCT00452400|75944919|FG002|Overall Study|Protocol Violation|1|||
42134071|NCT00452400|75944920|FG003|Overall Study|Protocol Violation|0|||
42134072|NCT00452400|75944921|FG004|Overall Study|Protocol Violation|0|||
42134073|NCT00452400|75944917|FG000|Overall Study|Lost to Follow-up|1|||
42134074|NCT00452400|75944918|FG001|Overall Study|Lost to Follow-up|0|||
42134075|NCT00452400|75944919|FG002|Overall Study|Lost to Follow-up|0|||
42134076|NCT00452400|75944920|FG003|Overall Study|Lost to Follow-up|0|||
42134077|NCT00452400|75944921|FG004|Overall Study|Lost to Follow-up|0|||
42134078|NCT00452400|75944917|FG000|Overall Study|Withdrawal by Subject|1|||
42134079|NCT00452400|75944918|FG001|Overall Study|Withdrawal by Subject|0|||
42134080|NCT00452400|75944919|FG002|Overall Study|Withdrawal by Subject|1|||
42134081|NCT00452400|75944920|FG003|Overall Study|Withdrawal by Subject|0|||
42134082|NCT00452400|75944921|FG004|Overall Study|Withdrawal by Subject|0|||
42134083|NCT00452400|75944917|FG000|Overall Study|Lack of Efficacy|2|||
42134084|NCT00452400|75944918|FG001|Overall Study|Lack of Efficacy|0|||
42134085|NCT00452400|75944919|FG002|Overall Study|Lack of Efficacy|0|||
42134086|NCT00452400|75944920|FG003|Overall Study|Lack of Efficacy|0|||
42134087|NCT00452400|75944921|FG004|Overall Study|Lack of Efficacy|0|||
42134088|NCT00452400|75944917|FG000|Overall Study|Other reasons not listed above|0|||
42134089|NCT00452400|75944918|FG001|Overall Study|Other reasons not listed above|0|||
42262361|NCT04456686|76089980|FG000|Overall Study|Protocol Violation|0|||
42262362|NCT04456686|76089981|FG001|Overall Study|Protocol Violation|1|||
41997796|NCT04091672|75806055|FG001|Overall Study|Withdrawal by Subject|3|||
41997797|NCT04091672|75806054|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
41997798|NCT04091672|75806055|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
42262363|NCT04269889|76090020|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
42262364|NCT04269889|76090020|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
42262365|NCT04099251|76090042|FG000|Pre-Treatment|Other reasons|1|||
42262366|NCT04099251|76090043|FG001|Pre-Treatment|Other reasons|0|||
42262367|NCT04099251|76090042|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
42262368|NCT04099251|76090043|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
42262369|NCT04099251|76090042|FG000|Blinded Treatment Phase|Other reasons|16|||
42262370|NCT04099251|76090043|FG001|Blinded Treatment Phase|Other reasons|7|||
41997799|NCT04003389|75806071|FG000|Overall Study|Adverse Event|27|||
41997800|NCT04003389|75806072|FG001|Overall Study|Adverse Event|34|||
42134090|NCT00452400|75944919|FG002|Overall Study|Other reasons not listed above|0|||
42134091|NCT00452400|75944920|FG003|Overall Study|Other reasons not listed above|1|||
42134092|NCT00452400|75944921|FG004|Overall Study|Other reasons not listed above|1|||
41997801|NCT04003389|75806073|FG002|Overall Study|Adverse Event|28|||
41997802|NCT04003389|75806071|FG000|Overall Study|Lost to Follow-up|39|||
41997803|NCT04003389|75806072|FG001|Overall Study|Lost to Follow-up|30|||
42262371|NCT04099251|76090042|FG000|Blinded Treatment Phase|Disease recurrence|26|||
42134093|NCT00462306|75944935|FG000|Overall Study|insufficient data|0|||
42134094|NCT00462306|75944936|FG001|Overall Study|insufficient data|13|||
42134095|NCT00461682|75944944|FG000|Overall Study|Protocol Violation|1|||
42134096|NCT00443430|75944952|FG000|Overall Study|Lack of Efficacy|3|||
42134097|NCT00443430|75944953|FG001|Overall Study|Lack of Efficacy|3|||
42134098|NCT00443430|75944952|FG000|Overall Study|Adverse Event|1|||
42134099|NCT00443430|75944953|FG001|Overall Study|Adverse Event|1|||
41997804|NCT04003389|75806073|FG002|Overall Study|Lost to Follow-up|33|||
41997805|NCT04003389|75806071|FG000|Overall Study|Protocol Violation|1|||
41997806|NCT04003389|75806072|FG001|Overall Study|Protocol Violation|6|||
41997807|NCT04003389|75806073|FG002|Overall Study|Protocol Violation|5|||
41997808|NCT04003389|75806071|FG000|Overall Study|Withdrawal by Subject|119|||
41997809|NCT04003389|75806072|FG001|Overall Study|Withdrawal by Subject|79|||
41997810|NCT04003389|75806073|FG002|Overall Study|Withdrawal by Subject|85|||
41997811|NCT04003389|75806071|FG000|Overall Study|Miscellaneous|14|||
41997812|NCT04003389|75806072|FG001|Overall Study|Miscellaneous|11|||
41997813|NCT04003389|75806073|FG002|Overall Study|Miscellaneous|14|||
41997814|NCT04003389|75806071|FG000|Overall Study|Participant did not receive study drug|1|||
41997815|NCT04003389|75806072|FG001|Overall Study|Participant did not receive study drug|0|||
41997816|NCT04003389|75806073|FG002|Overall Study|Participant did not receive study drug|0|||
42262372|NCT04099251|76090043|FG001|Blinded Treatment Phase|Disease recurrence|41|||
42328806|NCT01505530|76166777|FG001|Overall Study|Death|6|||
42328807|NCT01505530|76166778|FG002|Overall Study|Death|5|||
42328808|NCT01505530|76166776|FG000|Overall Study|entry criteria not met|0|||
42328809|NCT01505530|76166777|FG001|Overall Study|entry criteria not met|1|||
41997817|NCT03960437|75806081|FG000|Overall Study|Removed by PI|4|||
41997818|NCT03960437|75806081|FG000|Overall Study|Lost to Follow-up|2|||
41997819|NCT03960437|75806081|FG000|Overall Study|Withdrawal by Subject|1|||
41997820|NCT03960437|75806081|FG000|Overall Study|Death|2|||
41997821|NCT03959488|75806090|FG000|Season 1|Other|6|||
42134100|NCT00460746|75944959|FG000|Overall Study|Adverse Event|1|||
42328810|NCT01505530|76166778|FG002|Overall Study|entry criteria not met|0|||
42262373|NCT04099251|76090042|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
42262374|NCT04099251|76090043|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
42262375|NCT04099251|76090042|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
42262376|NCT04099251|76090043|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
42262377|NCT04099251|76090042|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
42262378|NCT04099251|76090043|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
42262379|NCT04099251|76090042|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
42262380|NCT04099251|76090043|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
42262381|NCT04099251|76090042|FG000|Blinded Treatment Phase|Death|6|||
42262382|NCT04099251|76090043|FG001|Blinded Treatment Phase|Death|2|||
42262383|NCT04099251|76090042|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
42262384|NCT04099251|76090043|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
42262385|NCT04099251|76090042|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
42262386|NCT04099251|76090043|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
42262387|NCT04099251|76090042|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
41997822|NCT03959488|75806091|FG001|Season 1|Other|7|||
42134101|NCT00460746|75944959|FG000|Overall Study|Lost to Follow-up|1|||
42262388|NCT04099251|76090043|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
42328811|NCT01485796|76166786|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
41997823|NCT03959488|75806092|FG002|Season 1|Other|0|||
41997824|NCT03959488|75806093|FG003|Season 1|Other|0|||
41997825|NCT03959488|75806094|FG004|Season 1|Other|0|||
42328812|NCT01485796|76166786|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
42328813|NCT01485796|76166786|FG000|Period 2: Epoch 2|Adverse Event|3|||
42328814|NCT01485796|76166786|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
42328815|NCT01485796|76166786|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
42328816|NCT01485796|76166786|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
42328817|NCT01485796|76166786|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
42328818|NCT01485796|76166786|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
42328819|NCT01505374|76166794|FG000|Overall Study|Lost to Follow-up|1|||
42328820|NCT01505374|76166795|FG001|Overall Study|Lost to Follow-up|0|||
42328821|NCT01897233|76166802|FG000|Part B (24 Weeks)|Adverse Event|1|||
42328822|NCT01897233|76166802|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
42328823|NCT01897233|76166802|FG000|Part B (24 Weeks)|Physician Decision|1|||
42328824|NCT01887717|76166812|FG000|Overall Study|Withdrawal by Subject|1|||
42328825|NCT01887717|76166813|FG001|Overall Study|Withdrawal by Subject|7|||
42328826|NCT01887717|76166812|FG000|Overall Study|Physician Decision|0|||
42328827|NCT01887717|76166813|FG001|Overall Study|Physician Decision|2|||
42328828|NCT01887717|76166812|FG000|Overall Study|Administrative reasons|5|||
42328829|NCT01887717|76166813|FG001|Overall Study|Administrative reasons|2|||
42328830|NCT01886781|76166821|FG000|Overall Study|Protocol Violation|5|||
42328831|NCT01886781|76166822|FG001|Overall Study|Protocol Violation|0|||
42328832|NCT01886781|76166821|FG000|Overall Study|Adverse Event|1|||
42328833|NCT01886781|76166822|FG001|Overall Study|Adverse Event|0|||
42328834|NCT01886781|76166821|FG000|Overall Study|Lost to Follow-up|5|||
42328835|NCT01886781|76166822|FG001|Overall Study|Lost to Follow-up|0|||
42328836|NCT01886781|76166821|FG000|Overall Study|Withdrawal by Subject|2|||
42328837|NCT01886781|76166822|FG001|Overall Study|Withdrawal by Subject|1|||
42328838|NCT01886781|76166821|FG000|Overall Study|Worsening of symptoms|1|||
42328839|NCT01886781|76166822|FG001|Overall Study|Worsening of symptoms|1|||
42328840|NCT01463098|76166842|FG000|Part A (11 Days)|Participant Choice|2|||
42328841|NCT01463098|76166843|FG001|Part A (11 Days)|Participant Choice|0|||
42328842|NCT01463098|76166844|FG002|Part A (11 Days)|Participant Choice|0|||
42328843|NCT01463098|76166845|FG003|Part A (11 Days)|Participant Choice|0|||
42328844|NCT01463098|76166846|FG004|Part A (11 Days)|Participant Choice|0|||
42328845|NCT01463098|76166847|FG005|Part A (11 Days)|Participant Choice|0|||
42328846|NCT01463098|76166848|FG006|Part A (11 Days)|Participant Choice|0|||
42328847|NCT01463098|76166849|FG007|Part A (11 Days)|Participant Choice|0|||
42328848|NCT01463098|76166850|FG008|Part A (11 Days)|Participant Choice|1|||
42328849|NCT01463098|76166851|FG009|Part A (11 Days)|Participant Choice|0|||
42328850|NCT01463098|76166852|FG010|Part A (11 Days)|Participant Choice|0|||
42328851|NCT01463098|76166853|FG011|Part A (11 Days)|Participant Choice|0|||
42328852|NCT01463098|76166854|FG012|Part A (11 Days)|Participant Choice|0|||
42328853|NCT01463098|76166855|FG013|Part A (11 Days)|Participant Choice|0|||
42328854|NCT01463098|76166842|FG000|Part A (11 Days)|Lost to Follow-up|0|||
42328855|NCT01463098|76166843|FG001|Part A (11 Days)|Lost to Follow-up|0|||
42328856|NCT01463098|76166844|FG002|Part A (11 Days)|Lost to Follow-up|0|||
42328857|NCT01463098|76166845|FG003|Part A (11 Days)|Lost to Follow-up|0|||
42328858|NCT01463098|76166846|FG004|Part A (11 Days)|Lost to Follow-up|1|||
42328859|NCT01463098|76166847|FG005|Part A (11 Days)|Lost to Follow-up|0|||
42328860|NCT01463098|76166848|FG006|Part A (11 Days)|Lost to Follow-up|0|||
42328861|NCT01463098|76166849|FG007|Part A (11 Days)|Lost to Follow-up|0|||
42262389|NCT04099251|76090042|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
42262390|NCT04099251|76090043|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
42262391|NCT04099251|76090042|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
42262392|NCT04099251|76090043|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
42262393|NCT04099251|76090042|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
42262394|NCT04099251|76090043|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
42262395|NCT04099251|76090042|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
42262396|NCT04099251|76090043|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
42262397|NCT04099251|76090042|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
42262398|NCT04099251|76090043|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
42262399|NCT04099251|76090042|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
42262400|NCT04099251|76090043|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
42262401|NCT04066491|76090053|FG000|Overall Study|Randomized, not treated|0|||
42328862|NCT01463098|76166850|FG008|Part A (11 Days)|Lost to Follow-up|0|||
42328863|NCT01463098|76166851|FG009|Part A (11 Days)|Lost to Follow-up|0|||
42328864|NCT01463098|76166852|FG010|Part A (11 Days)|Lost to Follow-up|0|||
42328865|NCT01463098|76166853|FG011|Part A (11 Days)|Lost to Follow-up|0|||
42328866|NCT01463098|76166854|FG012|Part A (11 Days)|Lost to Follow-up|0|||
42328867|NCT01463098|76166855|FG013|Part A (11 Days)|Lost to Follow-up|0|||
42328868|NCT01463098|76166842|FG000|Part B (11 Days)|Participant Choice|0|||
42328869|NCT01463098|76166843|FG001|Part B (11 Days)|Participant Choice|0|||
42328870|NCT01463098|76166844|FG002|Part B (11 Days)|Participant Choice|0|||
42328871|NCT01463098|76166845|FG003|Part B (11 Days)|Participant Choice|0|||
42328872|NCT01463098|76166846|FG004|Part B (11 Days)|Participant Choice|0|||
42328873|NCT01463098|76166847|FG005|Part B (11 Days)|Participant Choice|0|||
42328874|NCT01463098|76166848|FG006|Part B (11 Days)|Participant Choice|0|||
42328875|NCT01463098|76166849|FG007|Part B (11 Days)|Participant Choice|0|||
42328876|NCT01463098|76166850|FG008|Part B (11 Days)|Participant Choice|0|||
42328877|NCT01463098|76166851|FG009|Part B (11 Days)|Participant Choice|0|||
42328878|NCT01463098|76166852|FG010|Part B (11 Days)|Participant Choice|0|||
42328879|NCT01463098|76166853|FG011|Part B (11 Days)|Participant Choice|1|||
42328880|NCT01463098|76166854|FG012|Part B (11 Days)|Participant Choice|0|||
41997826|NCT03959488|75806090|FG000|Season 1|Withdrawal by parent/guardian|43|||
41997827|NCT03959488|75806091|FG001|Season 1|Withdrawal by parent/guardian|28|||
41997828|NCT03959488|75806092|FG002|Season 1|Withdrawal by parent/guardian|0|||
41997829|NCT03959488|75806093|FG003|Season 1|Withdrawal by parent/guardian|0|||
41997830|NCT03959488|75806094|FG004|Season 1|Withdrawal by parent/guardian|0|||
41997831|NCT03959488|75806090|FG000|Season 1|Due to COVID-19 pandemic|2|||
41997832|NCT03959488|75806091|FG001|Season 1|Due to COVID-19 pandemic|3|||
42328881|NCT01463098|76166855|FG013|Part B (11 Days)|Participant Choice|0|||
42328882|NCT01462942|76166909|FG000|Overall Study|Adverse Event|7|||
42328883|NCT01462942|76166910|FG001|Overall Study|Adverse Event|12|||
41997833|NCT03959488|75806092|FG002|Season 1|Due to COVID-19 pandemic|0|||
41997834|NCT03959488|75806093|FG003|Season 1|Due to COVID-19 pandemic|0|||
41997835|NCT03959488|75806094|FG004|Season 1|Due to COVID-19 pandemic|0|||
41997836|NCT03959488|75806090|FG000|Season 1|Lost to Follow-up|17|||
41997837|NCT03959488|75806091|FG001|Season 1|Lost to Follow-up|7|||
42328884|NCT01462942|76166911|FG002|Overall Study|Adverse Event|10|||
42328885|NCT01462942|76166912|FG003|Overall Study|Adverse Event|11|||
42328886|NCT01462942|76166913|FG004|Overall Study|Adverse Event|11|||
42328887|NCT01462942|76166909|FG000|Overall Study|Other, including COPD exacerbation|3|||
42328888|NCT01462942|76166910|FG001|Overall Study|Other, including COPD exacerbation|5|||
42328889|NCT01462942|76166911|FG002|Overall Study|Other, including COPD exacerbation|2|||
42328890|NCT01462942|76166912|FG003|Overall Study|Other, including COPD exacerbation|8|||
42328891|NCT01462942|76166913|FG004|Overall Study|Other, including COPD exacerbation|5|||
41997838|NCT03959488|75806092|FG002|Season 1|Lost to Follow-up|0|||
41997839|NCT03959488|75806093|FG003|Season 1|Lost to Follow-up|0|||
42034529|NCT00937521|75842593|FG007|Booster Phase|Administrative Reason|0|||
42262402|NCT04066491|76090054|FG001|Overall Study|Randomized, not treated|0|||
42262403|NCT04066491|76090055|FG002|Overall Study|Randomized, not treated|2|||
42262404|NCT03883828|76090070|FG000|Overall Study|Did not start radiotherapy|1|||
42262405|NCT03883828|76090071|FG001|Overall Study|Did not start radiotherapy|2|||
42262406|NCT03844269|76090077|FG000|Overall Study|Withdrawal pre-intervention|1|||
42262407|NCT03844269|76090077|FG000|Overall Study|Did not complete the intervention|2|||
42262408|NCT03777917|76090094|FG000|Overall Study|Withdrawal by Subject|1|||
42262409|NCT03777917|76090095|FG001|Overall Study|Withdrawal by Subject|0|||
42262410|NCT03777917|76090094|FG000|Overall Study|Physician Decision|1|||
42262411|NCT03777917|76090095|FG001|Overall Study|Physician Decision|0|||
42262412|NCT03777917|76090094|FG000|Overall Study|Lost to Follow-up|6|||
42262413|NCT03777917|76090095|FG001|Overall Study|Lost to Follow-up|2|||
42262414|NCT03777917|76090094|FG000|Overall Study|Other|1|||
42262415|NCT03777917|76090095|FG001|Overall Study|Other|0|||
42262416|NCT03594123|76090104|FG000|Overall Study|Lost to Follow-up|0|||
42262417|NCT03594123|76090105|FG001|Overall Study|Lost to Follow-up|1|||
42262418|NCT03594123|76090104|FG000|Overall Study|Adverse Event|8|||
42262419|NCT03594123|76090105|FG001|Overall Study|Adverse Event|5|||
42262420|NCT03594123|76090104|FG000|Overall Study|Site Terminated by Sponsor|4|||
42262421|NCT03594123|76090105|FG001|Overall Study|Site Terminated by Sponsor|1|||
42328892|NCT01462942|76166909|FG000|Overall Study|Withdrawal by Subject|14|||
42328893|NCT01462942|76166910|FG001|Overall Study|Withdrawal by Subject|10|||
42328894|NCT01462942|76166911|FG002|Overall Study|Withdrawal by Subject|14|||
41997840|NCT03959488|75806094|FG004|Season 1|Lost to Follow-up|0|||
41997841|NCT03959488|75806090|FG000|Season 1|Death|5|||
41997842|NCT03959488|75806091|FG001|Season 1|Death|1|||
41997843|NCT03959488|75806092|FG002|Season 1|Death|0|||
41997844|NCT03959488|75806093|FG003|Season 1|Death|0|||
42328895|NCT01462942|76166912|FG003|Overall Study|Withdrawal by Subject|16|||
42328896|NCT01462942|76166913|FG004|Overall Study|Withdrawal by Subject|19|||
42328897|NCT01462942|76166909|FG000|Overall Study|Lack of Efficacy|6|||
42328898|NCT01462942|76166910|FG001|Overall Study|Lack of Efficacy|0|||
42328899|NCT01462942|76166911|FG002|Overall Study|Lack of Efficacy|4|||
42328900|NCT01462942|76166912|FG003|Overall Study|Lack of Efficacy|5|||
42328901|NCT01462942|76166913|FG004|Overall Study|Lack of Efficacy|3|||
42328902|NCT01462942|76166909|FG000|Overall Study|Lost to Follow-up|0|||
42328903|NCT01462942|76166910|FG001|Overall Study|Lost to Follow-up|1|||
42328904|NCT01462942|76166911|FG002|Overall Study|Lost to Follow-up|1|||
42328905|NCT01462942|76166912|FG003|Overall Study|Lost to Follow-up|1|||
42328906|NCT01462942|76166913|FG004|Overall Study|Lost to Follow-up|1|||
42328907|NCT01462942|76166909|FG000|Overall Study|Protocol Violation|4|||
42328908|NCT01462942|76166910|FG001|Overall Study|Protocol Violation|6|||
42328909|NCT01462942|76166911|FG002|Overall Study|Protocol Violation|9|||
42328910|NCT01462942|76166912|FG003|Overall Study|Protocol Violation|9|||
42328911|NCT01462942|76166913|FG004|Overall Study|Protocol Violation|6|||
42328912|NCT01462630|76166925|FG000|Overall Study|Did not initiate therapy|3|||
41997845|NCT03959488|75806094|FG004|Season 1|Death|0|||
42262422|NCT03594123|76090104|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
42328913|NCT01462630|76166925|FG000|Overall Study|Death|1|||
42328914|NCT01462630|76166925|FG000|Overall Study|Protocol Violation|2|||
42328915|NCT01462630|76166925|FG000|Overall Study|Adverse Event|1|||
42328916|NCT01504204|76166931|FG000|Overall Study|Lost to Follow-up|1|||
42328917|NCT01504204|76166932|FG001|Overall Study|Lost to Follow-up|1|||
42328918|NCT01485640|76166938|FG000|Overall Study|Adverse Event|10|||
42328919|NCT01485640|76166938|FG000|Overall Study|Lack of Efficacy|2|||
42328920|NCT01485640|76166938|FG000|Overall Study|Protocol Violation|1|||
42328921|NCT01485640|76166938|FG000|Overall Study|Withdrawal by Subject|14|||
42328922|NCT01485640|76166938|FG000|Overall Study|Terminated by Sponsor|95|||
42328923|NCT02118961|76166944|FG000|Overall Study|Withdrawal by Subject|1|||
42328924|NCT02118961|76166945|FG001|Overall Study|Withdrawal by Subject|0|||
42328925|NCT02140645|76166957|FG000|Overall Study|Not linked|5489|||
42328926|NCT02140645|76166958|FG001|Overall Study|Not linked|61654|||
42328927|NCT02140645|76166959|FG002|Overall Study|Not linked|4236|||
42328928|NCT02140645|76166960|FG003|Overall Study|Not linked|13833|||
42328929|NCT02140645|76166961|FG004|Overall Study|Not linked|3286|||
42328930|NCT02140645|76166962|FG005|Overall Study|Not linked|70896|||
42328931|NCT02140567|76166971|FG000|Overall Study|Problems with recording equipment|6|||
42328932|NCT02140411|76166976|FG000|Overall Study|Adverse Event|1|||
42262423|NCT03594123|76090105|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
42262424|NCT03594123|76090104|FG000|Overall Study|Lack of Efficacy|1|||
42262425|NCT03594123|76090105|FG001|Overall Study|Lack of Efficacy|0|||
42262426|NCT03594123|76090104|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
42328933|NCT02139943|76166983|FG000|Overall Study|Adverse Event|0|||
42328934|NCT02139943|76166984|FG001|Overall Study|Adverse Event|1|||
42328935|NCT02139943|76166985|FG002|Overall Study|Adverse Event|2|||
42328936|NCT02139943|76166983|FG000|Overall Study|Lost to Follow-up|3|||
42328937|NCT02139943|76166984|FG001|Overall Study|Lost to Follow-up|2|||
42328938|NCT02139943|76166985|FG002|Overall Study|Lost to Follow-up|2|||
42328939|NCT02139943|76166983|FG000|Overall Study|Withdrawal by Subject|4|||
42328940|NCT02139943|76166984|FG001|Overall Study|Withdrawal by Subject|3|||
42328941|NCT02139943|76166985|FG002|Overall Study|Withdrawal by Subject|0|||
42328942|NCT02139943|76166983|FG000|Overall Study|Other|0|||
42328943|NCT02139943|76166984|FG001|Overall Study|Other|0|||
42328944|NCT02139943|76166985|FG002|Overall Study|Other|1|||
42328945|NCT02139943|76166983|FG000|Overall Study|Participant wishes to discontinue|2|||
42328946|NCT02139943|76166984|FG001|Overall Study|Participant wishes to discontinue|0|||
42328947|NCT02139943|76166985|FG002|Overall Study|Participant wishes to discontinue|0|||
42328948|NCT02139943|76166983|FG000|Overall Study|Participant in Poor Compliance|1|||
42262427|NCT03594123|76090105|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
42262428|NCT03583359|76090113|FG000|Overall Study|Withdrawal by Subject|15|||
42262429|NCT03583359|76090114|FG001|Overall Study|Withdrawal by Subject|6|||
42262430|NCT03583359|76090113|FG000|Overall Study|Lost to Follow-up|12|||
42262431|NCT03583359|76090114|FG001|Overall Study|Lost to Follow-up|3|||
42262432|NCT03583359|76090113|FG000|Overall Study|Adverse Event|0|||
42262433|NCT03583359|76090114|FG001|Overall Study|Adverse Event|1|||
42328949|NCT02139943|76166984|FG001|Overall Study|Participant in Poor Compliance|0|||
42328950|NCT02139943|76166985|FG002|Overall Study|Participant in Poor Compliance|1|||
42328951|NCT02139943|76166983|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
42328952|NCT02139943|76166984|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
42328953|NCT02139943|76166985|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
42328954|NCT01485172|76166999|FG000|Overall Study|Adverse Event|2|||
42262434|NCT03583359|76090113|FG000|Overall Study|Protocol Violation|0|||
42328955|NCT01485172|76167000|FG001|Overall Study|Adverse Event|1|||
42328956|NCT01485172|76167001|FG002|Overall Study|Adverse Event|2|||
42328957|NCT01485172|76167002|FG003|Overall Study|Adverse Event|2|||
42328958|NCT01485172|76167003|FG004|Overall Study|Adverse Event|1|||
42328959|NCT01485172|76167004|FG005|Overall Study|Adverse Event|2|||
42328960|NCT01485172|76166999|FG000|Overall Study|Lack of Efficacy|2|||
42328961|NCT01485172|76167000|FG001|Overall Study|Lack of Efficacy|0|||
42328962|NCT01485172|76167001|FG002|Overall Study|Lack of Efficacy|0|||
42328963|NCT01485172|76167002|FG003|Overall Study|Lack of Efficacy|0|||
42328964|NCT01485172|76167003|FG004|Overall Study|Lack of Efficacy|0|||
42262435|NCT03583359|76090114|FG001|Overall Study|Protocol Violation|1|||
42328965|NCT01485172|76167004|FG005|Overall Study|Lack of Efficacy|0|||
42328966|NCT01485172|76166999|FG000|Overall Study|Protocol Violation|0|||
42328967|NCT01485172|76167000|FG001|Overall Study|Protocol Violation|0|||
42328968|NCT01485172|76167001|FG002|Overall Study|Protocol Violation|4|||
42328969|NCT01485172|76167002|FG003|Overall Study|Protocol Violation|5|||
42328970|NCT01485172|76167003|FG004|Overall Study|Protocol Violation|1|||
42328971|NCT01485172|76167004|FG005|Overall Study|Protocol Violation|0|||
42328972|NCT01485172|76166999|FG000|Overall Study|Protocol defined stopping criteria|1|||
42328973|NCT01485172|76167000|FG001|Overall Study|Protocol defined stopping criteria|0|||
42328974|NCT01485172|76167001|FG002|Overall Study|Protocol defined stopping criteria|0|||
42328975|NCT01485172|76167002|FG003|Overall Study|Protocol defined stopping criteria|0|||
42328976|NCT01485172|76167003|FG004|Overall Study|Protocol defined stopping criteria|1|||
42328977|NCT01485172|76167004|FG005|Overall Study|Protocol defined stopping criteria|0|||
42328978|NCT01485172|76166999|FG000|Overall Study|Lost to Follow-up|0|||
42328979|NCT01485172|76167000|FG001|Overall Study|Lost to Follow-up|0|||
42328980|NCT01485172|76167001|FG002|Overall Study|Lost to Follow-up|1|||
42328981|NCT01485172|76167002|FG003|Overall Study|Lost to Follow-up|0|||
42328982|NCT01485172|76167003|FG004|Overall Study|Lost to Follow-up|0|||
42328983|NCT01485172|76167004|FG005|Overall Study|Lost to Follow-up|1|||
42328984|NCT01485172|76166999|FG000|Overall Study|Physician Decision|0|||
42328985|NCT01485172|76167000|FG001|Overall Study|Physician Decision|0|||
42328986|NCT01485172|76167001|FG002|Overall Study|Physician Decision|0|||
42328987|NCT01485172|76167002|FG003|Overall Study|Physician Decision|0|||
42328988|NCT01485172|76167003|FG004|Overall Study|Physician Decision|1|||
42328989|NCT01485172|76167004|FG005|Overall Study|Physician Decision|0|||
42328990|NCT01485172|76166999|FG000|Overall Study|Withdrawal by Subject|2|||
42328991|NCT01485172|76167000|FG001|Overall Study|Withdrawal by Subject|0|||
42328992|NCT01485172|76167001|FG002|Overall Study|Withdrawal by Subject|0|||
42328993|NCT01485172|76167002|FG003|Overall Study|Withdrawal by Subject|1|||
42328994|NCT01485172|76167003|FG004|Overall Study|Withdrawal by Subject|1|||
42328995|NCT01485172|76167004|FG005|Overall Study|Withdrawal by Subject|1|||
42328996|NCT02105701|76167022|FG000|Overall Study|Lost to Follow-up|1|||
42328997|NCT02105701|76167023|FG001|Overall Study|Lost to Follow-up|0|||
42134102|NCT00443118|75944966|FG000|Overall Study|unknown primary outcome|3|||
42262436|NCT03583359|76090113|FG000|Overall Study|Other|2|||
42262437|NCT03583359|76090114|FG001|Overall Study|Other|1|||
42262438|NCT03537651|76090120|FG000|Overall Study|Adverse Event|2|||
42262439|NCT03537651|76090120|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
42262440|NCT03537651|76090120|FG000|Overall Study|Commercial Drug is Available for Participant|56|||
42262441|NCT03537651|76090120|FG000|Overall Study|Other|1|||
42262442|NCT03506438|76090133|FG000|Overall Study|Lost to Follow-up|8|||
42262443|NCT03506438|76090134|FG001|Overall Study|Lost to Follow-up|7|||
42262444|NCT03506438|76090135|FG002|Overall Study|Lost to Follow-up|8|||
42262445|NCT03506438|76090136|FG003|Overall Study|Lost to Follow-up|7|||
42328998|NCT02105701|76167024|FG002|Overall Study|Lost to Follow-up|2|||
42328999|NCT02105701|76167025|FG003|Overall Study|Lost to Follow-up|1|||
42329000|NCT02105701|76167022|FG000|Overall Study|Protocol Violation|0|||
42329001|NCT02105701|76167023|FG001|Overall Study|Protocol Violation|0|||
42134103|NCT00443118|75944967|FG001|Overall Study|unknown primary outcome|1|||
42134104|NCT00443118|75944968|FG002|Overall Study|unknown primary outcome|0|||
42134105|NCT00443118|75944966|FG000|Overall Study|Withdrawal by Subject|1|||
42262446|NCT03506438|76090137|FG004|Overall Study|Lost to Follow-up|0|||
42329002|NCT02105701|76167024|FG002|Overall Study|Protocol Violation|1|||
42329003|NCT02105701|76167025|FG003|Overall Study|Protocol Violation|0|||
42329004|NCT02105701|76167022|FG000|Overall Study|Withdrawal by Subject|2|||
42329005|NCT02105701|76167023|FG001|Overall Study|Withdrawal by Subject|1|||
42329006|NCT02105701|76167024|FG002|Overall Study|Withdrawal by Subject|0|||
42262447|NCT03506438|76090138|FG005|Overall Study|Lost to Follow-up|0|||
42262448|NCT03493542|76090151|FG000|Overall Study|Ongoing|2|||
42329007|NCT02105701|76167025|FG003|Overall Study|Withdrawal by Subject|1|||
42329008|NCT02105701|76167022|FG000|Overall Study|Death|1|||
42329009|NCT02105701|76167023|FG001|Overall Study|Death|0|||
42329010|NCT02105701|76167024|FG002|Overall Study|Death|0|||
42329011|NCT02105701|76167025|FG003|Overall Study|Death|0|||
42329012|NCT01502956|76167037|FG000|Overall Study|Death|0|||
42329013|NCT01502956|76167038|FG001|Overall Study|Death|2|||
42329014|NCT01502956|76167037|FG000|Overall Study|Lost to Follow-up|14|||
42329015|NCT01502956|76167038|FG001|Overall Study|Lost to Follow-up|11|||
42329016|NCT01502956|76167037|FG000|Overall Study|Physician Decision|2|||
42329017|NCT01502956|76167038|FG001|Overall Study|Physician Decision|3|||
42329018|NCT01502956|76167037|FG000|Overall Study|Withdrawal by Subject|8|||
42329019|NCT01502956|76167038|FG001|Overall Study|Withdrawal by Subject|10|||
42329020|NCT01502644|76167047|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
42329021|NCT01502644|76167048|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
41997846|NCT03959488|75806090|FG000|Season 2|Other|0|||
41997847|NCT03959488|75806091|FG001|Season 2|Other|0|||
41997848|NCT03959488|75806092|FG002|Season 2|Other|2|||
41997849|NCT03959488|75806093|FG003|Season 2|Other|0|||
41997850|NCT03959488|75806094|FG004|Season 2|Other|0|||
41997851|NCT03959488|75806090|FG000|Season 2|Withdrawal by parent/guardian|0|||
41997852|NCT03959488|75806091|FG001|Season 2|Withdrawal by parent/guardian|0|||
41997853|NCT03959488|75806092|FG002|Season 2|Withdrawal by parent/guardian|3|||
41997854|NCT03959488|75806093|FG003|Season 2|Withdrawal by parent/guardian|1|||
41997855|NCT03959488|75806094|FG004|Season 2|Withdrawal by parent/guardian|1|||
41997856|NCT03959488|75806090|FG000|Season 2|Lost to Follow-up|0|||
41997857|NCT03959488|75806091|FG001|Season 2|Lost to Follow-up|0|||
41997858|NCT03959488|75806092|FG002|Season 2|Lost to Follow-up|1|||
41997859|NCT03959488|75806093|FG003|Season 2|Lost to Follow-up|0|||
41997860|NCT03959488|75806094|FG004|Season 2|Lost to Follow-up|1|||
41997861|NCT03847194|75806115|FG000|Overall Study|Lost to Follow-up|2|||
41997862|NCT03847194|75806116|FG001|Overall Study|Lost to Follow-up|5|||
41997863|NCT03847194|75806115|FG000|Overall Study|Withdrawal by Subject|1|||
41997864|NCT03847194|75806116|FG001|Overall Study|Withdrawal by Subject|2|||
41997865|NCT03847194|75806115|FG000|Overall Study|Death|0|||
41997866|NCT03847194|75806116|FG001|Overall Study|Death|1|||
42034530|NCT00937521|75842586|FG000|Booster Phase|Protocol Deviation|0|||
42329022|NCT01502644|76167049|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
42329023|NCT01502644|76167050|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
42329024|NCT01502644|76167047|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
42329025|NCT01502644|76167048|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
42034531|NCT00937521|75842587|FG001|Booster Phase|Protocol Deviation|0|||
42034532|NCT00937521|75842588|FG002|Booster Phase|Protocol Deviation|0|||
42329026|NCT01502644|76167049|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
42329027|NCT01502644|76167050|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
42329028|NCT01502644|76167047|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
42329029|NCT01502644|76167048|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
42329030|NCT01502644|76167049|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
42329031|NCT01502644|76167050|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
42329032|NCT01502644|76167047|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
42329033|NCT01502644|76167048|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
42329034|NCT01502644|76167049|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
42329035|NCT01502644|76167050|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
42329036|NCT01502644|76167047|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
42329037|NCT01502644|76167048|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
42262449|NCT03493542|76090152|FG001|Overall Study|Ongoing|3|||
42262450|NCT03493542|76090151|FG000|Overall Study|Withdrawal by parent or guardian|3|||
42262451|NCT03493542|76090152|FG001|Overall Study|Withdrawal by parent or guardian|0|||
42262452|NCT03493542|76090151|FG000|Overall Study|Withdrawal by Subject|2|||
42262453|NCT03493542|76090152|FG001|Overall Study|Withdrawal by Subject|6|||
42262454|NCT03476798|76090158|FG000|Overall Study|Death|1|||
42262455|NCT03476798|76090158|FG000|Overall Study|Withdrawal by Subject|2|||
42262456|NCT03476798|76090158|FG000|Overall Study|Protocol Violation|2|||
42262457|NCT03366337|76090189|FG000|Overall Study|Lost to Follow-up|1|||
42262458|NCT03366337|76090190|FG001|Overall Study|Lost to Follow-up|0|||
42262459|NCT03366337|76090191|FG002|Overall Study|Lost to Follow-up|1|||
42262460|NCT03366337|76090192|FG003|Overall Study|Lost to Follow-up|0|||
42262461|NCT03366337|76090189|FG000|Overall Study|Withdrawal by Subject|2|||
42262462|NCT03366337|76090190|FG001|Overall Study|Withdrawal by Subject|0|||
41997867|NCT03828747|75806124|FG000|Double-Blind Treatment Period|Adverse Event|6|||
41997868|NCT03828747|75806125|FG001|Double-Blind Treatment Period|Adverse Event|6|||
41997869|NCT03828747|75806124|FG000|Double-Blind Treatment Period|Death|1|||
41997870|NCT03828747|75806125|FG001|Double-Blind Treatment Period|Death|2|||
41997871|NCT03828747|75806124|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
41997872|NCT03828747|75806125|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
42034533|NCT00937521|75842589|FG003|Booster Phase|Protocol Deviation|0|||
42329038|NCT01502644|76167049|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
42329039|NCT01502644|76167050|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
42329040|NCT01462318|76167060|FG000|Main Study / TP-DI Study|Other|2|||
42329041|NCT01462318|76167061|FG001|Main Study / TP-DI Study|Other|0|||
42329042|NCT01462318|76167062|FG002|Main Study / TP-DI Study|Other|0|||
41997873|NCT03828747|75806124|FG000|Double-Blind Treatment Period|Withdrawal by Subject|19|||
41997874|NCT03828747|75806125|FG001|Double-Blind Treatment Period|Withdrawal by Subject|21|||
41997875|NCT03828747|75806124|FG000|Double-Blind Treatment Period|Physician Decision|0|||
41997876|NCT03828747|75806125|FG001|Double-Blind Treatment Period|Physician Decision|3|||
41997877|NCT03828747|75806124|FG000|Double-Blind Treatment Period|Various reasons|5|||
41997878|NCT03828747|75806125|FG001|Double-Blind Treatment Period|Various reasons|3|||
41997879|NCT03828747|75806124|FG000|Open-Label Extension|Continuing on Study|77|||
41997880|NCT03828747|75806125|FG001|Open-Label Extension|Continuing on Study|72|||
41997881|NCT03828747|75806124|FG000|Open-Label Extension|Adverse Event|3|||
41997882|NCT03828747|75806125|FG001|Open-Label Extension|Adverse Event|4|||
41997883|NCT03828747|75806124|FG000|Open-Label Extension|Death|0|||
41997884|NCT03828747|75806125|FG001|Open-Label Extension|Death|2|||
41997885|NCT03828747|75806124|FG000|Open-Label Extension|Lost to Follow-up|4|||
41997886|NCT03828747|75806125|FG001|Open-Label Extension|Lost to Follow-up|0|||
41997887|NCT03828747|75806124|FG000|Open-Label Extension|Withdrawal by Subject|19|||
41997888|NCT03828747|75806125|FG001|Open-Label Extension|Withdrawal by Subject|16|||
41997889|NCT03828747|75806124|FG000|Open-Label Extension|Various reasons|1|||
41997890|NCT03828747|75806125|FG001|Open-Label Extension|Various reasons|1|||
41997891|NCT03816176|75806163|FG000|Overall Study|Miscellaneous|5|||
41997892|NCT03816176|75806163|FG000|Overall Study|Lack of Efficacy|4|||
41997893|NCT03816176|75806163|FG000|Overall Study|Adverse Event|3|||
41997894|NCT03712098|75806175|FG000|Overall Study|Lost to Follow-up|3|||
41997895|NCT03712098|75806176|FG001|Overall Study|Lost to Follow-up|7|||
41997896|NCT03712098|75806175|FG000|Overall Study|Withdrawal by Subject|9|||
41997897|NCT03712098|75806176|FG001|Overall Study|Withdrawal by Subject|4|||
41997898|NCT03712098|75806175|FG000|Overall Study|Protocol Violation|2|||
41997899|NCT03712098|75806176|FG001|Overall Study|Protocol Violation|1|||
41997900|NCT03704688|75806188|FG000|Overall Study|Adverse Event|0|||
41997901|NCT03704688|75806189|FG001|Overall Study|Adverse Event|0|||
41997902|NCT03704688|75806190|FG002|Overall Study|Adverse Event|0|||
41997903|NCT03704688|75806191|FG003|Overall Study|Adverse Event|4|||
41997904|NCT03704688|75806192|FG004|Overall Study|Adverse Event|1|||
41997905|NCT03704688|75806193|FG005|Overall Study|Adverse Event|0|||
42262463|NCT03366337|76090191|FG002|Overall Study|Withdrawal by Subject|1|||
42262464|NCT03366337|76090192|FG003|Overall Study|Withdrawal by Subject|1|||
42262465|NCT03253744|76090215|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
42262466|NCT03253744|76090216|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
42262467|NCT03253744|76090217|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
42262468|NCT03253744|76090218|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
42262469|NCT03104400|76090247|FG000|Overall Study|Adverse Event|5|||
42262470|NCT03104400|76090248|FG001|Overall Study|Adverse Event|7|||
42262471|NCT03104400|76090249|FG002|Overall Study|Adverse Event|11|||
42262472|NCT03104400|76090250|FG003|Overall Study|Adverse Event|9|||
42262473|NCT03104400|76090251|FG004|Overall Study|Adverse Event|21|||
42262474|NCT03104400|76090247|FG000|Overall Study|Withdrawal by Subject|17|||
42262475|NCT03104400|76090248|FG001|Overall Study|Withdrawal by Subject|19|||
42262476|NCT03104400|76090249|FG002|Overall Study|Withdrawal by Subject|29|||
42262477|NCT03104400|76090250|FG003|Overall Study|Withdrawal by Subject|25|||
42262478|NCT03104400|76090251|FG004|Overall Study|Withdrawal by Subject|24|||
42262479|NCT03104400|76090247|FG000|Overall Study|Lost to Follow-up|4|||
42262480|NCT03104400|76090248|FG001|Overall Study|Lost to Follow-up|1|||
42329043|NCT01462318|76167060|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
41997906|NCT03704688|75806188|FG000|Overall Study|Disease Progression|0|||
41997907|NCT03704688|75806189|FG001|Overall Study|Disease Progression|0|||
41997908|NCT03704688|75806190|FG002|Overall Study|Disease Progression|0|||
41997909|NCT03704688|75806191|FG003|Overall Study|Disease Progression|3|||
41997910|NCT03704688|75806192|FG004|Overall Study|Disease Progression|1|||
42262481|NCT03104400|76090249|FG002|Overall Study|Lost to Follow-up|4|||
41997911|NCT03704688|75806193|FG005|Overall Study|Disease Progression|0|||
42329044|NCT01462318|76167061|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
41997912|NCT03704688|75806188|FG000|Overall Study|Death|0|||
41997913|NCT03704688|75806189|FG001|Overall Study|Death|0|||
41997914|NCT03704688|75806190|FG002|Overall Study|Death|0|||
41997915|NCT03704688|75806191|FG003|Overall Study|Death|0|||
42262482|NCT03104400|76090250|FG003|Overall Study|Lost to Follow-up|8|||
42329045|NCT01462318|76167062|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
42329046|NCT01462318|76167060|FG000|Main Study / TP-DI Study|Adverse Event|4|||
42329047|NCT01462318|76167061|FG001|Main Study / TP-DI Study|Adverse Event|0|||
42329048|NCT01462318|76167062|FG002|Main Study / TP-DI Study|Adverse Event|0|||
42329049|NCT01462318|76167060|FG000|Extension Phase|Lost to Follow-up|0|||
42329050|NCT01462318|76167061|FG001|Extension Phase|Lost to Follow-up|0|||
42329051|NCT01462318|76167062|FG002|Extension Phase|Lost to Follow-up|1|||
42329052|NCT01462318|76167060|FG000|Extension Phase|Other|0|||
42329053|NCT01462318|76167061|FG001|Extension Phase|Other|0|||
42329054|NCT01462318|76167062|FG002|Extension Phase|Other|1|||
42329055|NCT01462318|76167060|FG000|Extension Phase|Disease Progression|0|||
42329056|NCT01462318|76167061|FG001|Extension Phase|Disease Progression|0|||
42329057|NCT01462318|76167062|FG002|Extension Phase|Disease Progression|1|||
42329058|NCT01462318|76167060|FG000|Extension Phase|Withdrawal by Subject|0|||
42329059|NCT01462318|76167061|FG001|Extension Phase|Withdrawal by Subject|0|||
42329060|NCT01462318|76167062|FG002|Extension Phase|Withdrawal by Subject|15|||
42329061|NCT01462318|76167060|FG000|Extension Phase|Investigator Decision|0|||
42329062|NCT01462318|76167061|FG001|Extension Phase|Investigator Decision|0|||
42329063|NCT01462318|76167062|FG002|Extension Phase|Investigator Decision|5|||
41997916|NCT03704688|75806192|FG004|Overall Study|Death|3|||
41997917|NCT03704688|75806193|FG005|Overall Study|Death|0|||
41997918|NCT03683394|75806210|FG000|Overall Study|Withdrawal by Subject|4|||
41997919|NCT03683394|75806211|FG001|Overall Study|Withdrawal by Subject|8|||
41997920|NCT03683394|75806210|FG000|Overall Study|Lost to Follow-up|7|||
41997921|NCT03683394|75806211|FG001|Overall Study|Lost to Follow-up|0|||
41997922|NCT03683394|75806210|FG000|Overall Study|Death|3|||
41997923|NCT03683394|75806211|FG001|Overall Study|Death|1|||
41997924|NCT03656510|75806223|FG000|Overall Study|Lost to Follow-up|1|||
41997925|NCT03656510|75806224|FG001|Overall Study|Lost to Follow-up|0|||
41997926|NCT03656510|75806225|FG002|Overall Study|Lost to Follow-up|0|||
41997927|NCT03656510|75806226|FG003|Overall Study|Lost to Follow-up|0|||
41997928|NCT03656510|75806227|FG004|Overall Study|Lost to Follow-up|0|||
41997929|NCT03656510|75806228|FG005|Overall Study|Lost to Follow-up|0|||
41997930|NCT03656510|75806223|FG000|Overall Study|Withdrawal by Subject|1|||
41997931|NCT03656510|75806224|FG001|Overall Study|Withdrawal by Subject|1|||
41997932|NCT03656510|75806225|FG002|Overall Study|Withdrawal by Subject|0|||
42262483|NCT03104400|76090251|FG004|Overall Study|Lost to Follow-up|7|||
42262484|NCT03104400|76090247|FG000|Overall Study|Lack of Efficacy|6|||
41997933|NCT03656510|75806226|FG003|Overall Study|Withdrawal by Subject|1|||
41997934|NCT03656510|75806227|FG004|Overall Study|Withdrawal by Subject|0|||
41997935|NCT03656510|75806228|FG005|Overall Study|Withdrawal by Subject|0|||
41997936|NCT03539081|75806257|FG000|Overall Study|Withdrawal by Subject|2|||
41997937|NCT03539081|75806258|FG001|Overall Study|Withdrawal by Subject|3|||
41997938|NCT03539081|75806259|FG002|Overall Study|Withdrawal by Subject|0|||
41997939|NCT03539081|75806257|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
41997940|NCT03539081|75806258|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
41997941|NCT03539081|75806259|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
41997942|NCT03538626|75806278|FG000|Overall Study|Withdrawal by Subject|0|||
41997943|NCT03538626|75806279|FG001|Overall Study|Withdrawal by Subject|1|||
41997944|NCT03538626|75806280|FG002|Overall Study|Withdrawal by Subject|0|||
42034534|NCT00937521|75842590|FG004|Booster Phase|Protocol Deviation|0|||
42034535|NCT00937521|75842591|FG005|Booster Phase|Protocol Deviation|0|||
42262485|NCT03104400|76090248|FG001|Overall Study|Lack of Efficacy|3|||
42262486|NCT03104400|76090249|FG002|Overall Study|Lack of Efficacy|8|||
42262487|NCT03104400|76090250|FG003|Overall Study|Lack of Efficacy|2|||
42262488|NCT03104400|76090251|FG004|Overall Study|Lack of Efficacy|1|||
42262489|NCT03104400|76090247|FG000|Overall Study|COVID Logistical Restrictions|0|||
42262490|NCT03104400|76090248|FG001|Overall Study|COVID Logistical Restrictions|0|||
42262491|NCT03104400|76090249|FG002|Overall Study|COVID Logistical Restrictions|0|||
42262492|NCT03104400|76090250|FG003|Overall Study|COVID Logistical Restrictions|1|||
42262493|NCT03104400|76090251|FG004|Overall Study|COVID Logistical Restrictions|0|||
42262494|NCT03104400|76090247|FG000|Overall Study|Other|2|||
42329064|NCT01462318|76167060|FG000|Extension Phase|Adverse Event|0|||
42329065|NCT01462318|76167061|FG001|Extension Phase|Adverse Event|0|||
42262495|NCT03104400|76090248|FG001|Overall Study|Other|3|||
42262496|NCT03104400|76090249|FG002|Overall Study|Other|7|||
42262497|NCT03104400|76090250|FG003|Overall Study|Other|6|||
42262498|NCT03104400|76090251|FG004|Overall Study|Other|4|||
42329066|NCT01462318|76167062|FG002|Extension Phase|Adverse Event|22|||
42329067|NCT01485094|76167070|FG000|Overall Study|Adverse Event|1|||
42329068|NCT01485094|76167071|FG001|Overall Study|Adverse Event|1|||
42329069|NCT01485094|76167072|FG002|Overall Study|Adverse Event|1|||
42329070|NCT01485094|76167070|FG000|Overall Study|Lost to Follow-up|1|||
42034536|NCT00937521|75842592|FG006|Booster Phase|Protocol Deviation|1|||
42262499|NCT03104400|76090247|FG000|Overall Study|Other|0|||
42329071|NCT01485094|76167071|FG001|Overall Study|Lost to Follow-up|0|||
42329072|NCT01485094|76167072|FG002|Overall Study|Lost to Follow-up|0|||
42329073|NCT01485094|76167070|FG000|Overall Study|Withdrawal by Subject|1|||
41997945|NCT03538626|75806281|FG003|Overall Study|Withdrawal by Subject|0|||
41997946|NCT03538626|75806282|FG004|Overall Study|Withdrawal by Subject|0|||
41997947|NCT03538626|75806283|FG005|Overall Study|Withdrawal by Subject|0|||
41997948|NCT03538626|75806284|FG006|Overall Study|Withdrawal by Subject|0|||
41997949|NCT03538626|75806285|FG007|Overall Study|Withdrawal by Subject|0|||
41997950|NCT03538626|75806278|FG000|Overall Study|Lost to Follow-up|0|||
41997951|NCT03538626|75806279|FG001|Overall Study|Lost to Follow-up|0|||
41997952|NCT03538626|75806280|FG002|Overall Study|Lost to Follow-up|0|||
41997953|NCT03538626|75806281|FG003|Overall Study|Lost to Follow-up|0|||
41997954|NCT03538626|75806282|FG004|Overall Study|Lost to Follow-up|0|||
41997955|NCT03538626|75806283|FG005|Overall Study|Lost to Follow-up|0|||
42329074|NCT01485094|76167071|FG001|Overall Study|Withdrawal by Subject|1|||
42329075|NCT01485094|76167072|FG002|Overall Study|Withdrawal by Subject|0|||
42329076|NCT01484938|76167080|FG000|Overall Study|Adverse Event|2|||
42329077|NCT01484938|76167080|FG000|Overall Study|Lost to Follow-up|1|||
42329078|NCT01484938|76167080|FG000|Overall Study|Noncompliance|1|||
42329079|NCT01502410|76167088|FG000|Overall Study|Adverse Event|1|||
42329080|NCT01502410|76167089|FG001|Overall Study|Adverse Event|2|||
41997956|NCT03538626|75806284|FG006|Overall Study|Lost to Follow-up|1|||
41997957|NCT03538626|75806285|FG007|Overall Study|Lost to Follow-up|0|||
42262500|NCT03104400|76090248|FG001|Overall Study|Other|1|||
42262501|NCT03104400|76090249|FG002|Overall Study|Other|0|||
42329081|NCT01502410|76167090|FG002|Overall Study|Adverse Event|0|||
42262502|NCT03104400|76090250|FG003|Overall Study|Other|0|||
42262503|NCT03104400|76090251|FG004|Overall Study|Other|0|||
42262504|NCT03034044|76090274|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
42262505|NCT02878798|76090280|FG000|Overall Study|Withdrawal by Subject|5|||
42262506|NCT02878798|76090281|FG001|Overall Study|Withdrawal by Subject|4|||
42262507|NCT02878798|76090280|FG000|Overall Study|Lost to Follow-up|2|||
42329082|NCT01502410|76167091|FG003|Overall Study|Adverse Event|0|||
42262508|NCT02878798|76090281|FG001|Overall Study|Lost to Follow-up|2|||
42262509|NCT02878798|76090280|FG000|Overall Study|Protocol Violation|0|||
42262510|NCT02878798|76090281|FG001|Overall Study|Protocol Violation|1|||
42262511|NCT02854436|76090287|FG000|Overall Study|Adverse Event|1|||
42262512|NCT02854436|76090287|FG000|Overall Study|Death|208|||
42329083|NCT01502410|76167088|FG000|Overall Study|Lack of Efficacy|7|||
42329084|NCT01502410|76167089|FG001|Overall Study|Lack of Efficacy|7|||
42329085|NCT01502410|76167090|FG002|Overall Study|Lack of Efficacy|0|||
42329086|NCT01502410|76167091|FG003|Overall Study|Lack of Efficacy|0|||
42329087|NCT01502410|76167088|FG000|Overall Study|Physician Decision|0|||
42329088|NCT01502410|76167089|FG001|Overall Study|Physician Decision|1|||
42329089|NCT01502410|76167090|FG002|Overall Study|Physician Decision|0|||
42329090|NCT01502410|76167091|FG003|Overall Study|Physician Decision|0|||
42329091|NCT01502410|76167088|FG000|Overall Study|Withdrawal by Subject|2|||
42329092|NCT01502410|76167089|FG001|Overall Study|Withdrawal by Subject|0|||
42329093|NCT01502410|76167090|FG002|Overall Study|Withdrawal by Subject|0|||
42329094|NCT01502410|76167091|FG003|Overall Study|Withdrawal by Subject|0|||
42329095|NCT01462162|76167100|FG000|Overall Study|Adverse Event|5|||
42329096|NCT01462162|76167100|FG000|Overall Study|Lack of Efficacy|4|||
42329097|NCT01462162|76167100|FG000|Overall Study|Abnormal laboratory parameters|1|||
42329098|NCT01462162|76167100|FG000|Overall Study|Other|2|||
42329099|NCT01483924|76167110|FG000|Overall Study|Withdrawal by Subject|2|||
42329100|NCT01483924|76167111|FG001|Overall Study|Withdrawal by Subject|0|||
42329101|NCT01483924|76167112|FG002|Overall Study|Withdrawal by Subject|0|||
42329102|NCT01483924|76167113|FG003|Overall Study|Withdrawal by Subject|1|||
42329103|NCT01483924|76167114|FG004|Overall Study|Withdrawal by Subject|1|||
42329104|NCT01483924|76167110|FG000|Overall Study|Adverse Event|0|||
42329105|NCT01483924|76167111|FG001|Overall Study|Adverse Event|0|||
41997958|NCT03518203|75806303|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
41997959|NCT03518203|75806303|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
41997960|NCT03500172|75806317|FG000|Period 1: Baseline Randomization|Death|0|||
42329106|NCT01483924|76167112|FG002|Overall Study|Adverse Event|1|||
42329107|NCT01483924|76167113|FG003|Overall Study|Adverse Event|1|||
41997961|NCT03500172|75806318|FG001|Period 1: Baseline Randomization|Death|0|||
41997962|NCT03500172|75806319|FG002|Period 1: Baseline Randomization|Death|0|||
42262513|NCT02854436|76090287|FG000|Overall Study|Lost to Follow-up|5|||
42262514|NCT02854436|76090287|FG000|Overall Study|Withdrawal by Subject|12|||
42262515|NCT02854436|76090287|FG000|Overall Study|Other|45|||
42262516|NCT02854436|76090287|FG000|Overall Study|Ongoing|18|||
42262517|NCT02741193|76090291|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
42262518|NCT02741193|76090291|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
42262519|NCT02725177|76090295|FG000|Overall Study|Physician Decision|4|||
42329108|NCT01483924|76167114|FG004|Overall Study|Adverse Event|0|||
42329109|NCT01483924|76167110|FG000|Overall Study|Non-compliance|0|||
42329110|NCT01483924|76167111|FG001|Overall Study|Non-compliance|0|||
42329111|NCT01483924|76167112|FG002|Overall Study|Non-compliance|0|||
41997963|NCT03500172|75806320|FG003|Period 1: Baseline Randomization|Death|0|||
41997964|NCT03500172|75806321|FG004|Period 1: Baseline Randomization|Death|0|||
41997965|NCT03500172|75806322|FG005|Period 1: Baseline Randomization|Death|0|||
41997966|NCT03500172|75806323|FG006|Period 1: Baseline Randomization|Death|0|||
41997967|NCT03500172|75806324|FG007|Period 1: Baseline Randomization|Death|0|||
41997968|NCT03500172|75806325|FG008|Period 1: Baseline Randomization|Death|0|||
41997969|NCT03500172|75806326|FG009|Period 1: Baseline Randomization|Death|2|||
41997970|NCT03500172|75806327|FG010|Period 1: Baseline Randomization|Death|0|||
41997971|NCT03500172|75806317|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
41997972|NCT03500172|75806318|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
41997973|NCT03500172|75806319|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
41997974|NCT03500172|75806320|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
41997975|NCT03500172|75806321|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
42329112|NCT01483924|76167113|FG003|Overall Study|Non-compliance|1|||
42329113|NCT01483924|76167114|FG004|Overall Study|Non-compliance|1|||
42329114|NCT01483924|76167110|FG000|Overall Study|Sponsor concern over ECG result|0|||
42329115|NCT01483924|76167111|FG001|Overall Study|Sponsor concern over ECG result|0|||
42329116|NCT01483924|76167112|FG002|Overall Study|Sponsor concern over ECG result|0|||
42329117|NCT01483924|76167113|FG003|Overall Study|Sponsor concern over ECG result|1|||
42329118|NCT01483924|76167114|FG004|Overall Study|Sponsor concern over ECG result|0|||
42329119|NCT01462084|76167135|FG000|Overall Study|Withdrawal by Subject|1|||
42329120|NCT01462084|76167136|FG001|Overall Study|Withdrawal by Subject|0|||
42329121|NCT01462084|76167135|FG000|Overall Study|Protocol Violation|1|||
42329122|NCT01462084|76167136|FG001|Overall Study|Protocol Violation|1|||
42329123|NCT02134028|76167151|FG000|Overall Study|Lack of Efficacy|1|||
41997976|NCT03500172|75806322|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
41997977|NCT03500172|75806323|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
41997978|NCT03500172|75806324|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
41997979|NCT03500172|75806325|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
41997980|NCT03500172|75806326|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
41997981|NCT03500172|75806327|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
41997982|NCT03500172|75806317|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
41997983|NCT03500172|75806318|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
41997984|NCT03500172|75806319|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
41997985|NCT03500172|75806320|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
41997986|NCT03500172|75806321|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
42262520|NCT02725177|76090295|FG000|Overall Study|Adverse Event|1|||
42262521|NCT02488759|76090305|FG000|Overall Study|Disease progression|73|||
42262522|NCT02488759|76090306|FG001|Overall Study|Disease progression|111|||
42262523|NCT02488759|76090307|FG002|Overall Study|Disease progression|62|||
42262524|NCT02488759|76090308|FG003|Overall Study|Disease progression|7|||
42262525|NCT02488759|76090309|FG004|Overall Study|Disease progression|4|||
42262526|NCT02488759|76090310|FG005|Overall Study|Disease progression|2|||
42262527|NCT02488759|76090305|FG000|Overall Study|Study drug toxicity|11|||
42262528|NCT02488759|76090306|FG001|Overall Study|Study drug toxicity|33|||
42329124|NCT02134028|76167152|FG001|Overall Study|Lack of Efficacy|0|||
42329125|NCT02134028|76167153|FG002|Overall Study|Lack of Efficacy|3|||
42329126|NCT02134028|76167154|FG003|Overall Study|Lack of Efficacy|2|||
42262529|NCT02488759|76090307|FG002|Overall Study|Study drug toxicity|31|||
42262530|NCT02488759|76090308|FG003|Overall Study|Study drug toxicity|0|||
42262531|NCT02488759|76090309|FG004|Overall Study|Study drug toxicity|0|||
42262532|NCT02488759|76090310|FG005|Overall Study|Study drug toxicity|2|||
42262533|NCT02488759|76090305|FG000|Overall Study|Adverse event unrelated to study drug|9|||
42262534|NCT02488759|76090306|FG001|Overall Study|Adverse event unrelated to study drug|11|||
42262535|NCT02488759|76090307|FG002|Overall Study|Adverse event unrelated to study drug|7|||
42262536|NCT02488759|76090308|FG003|Overall Study|Adverse event unrelated to study drug|0|||
42262537|NCT02488759|76090309|FG004|Overall Study|Adverse event unrelated to study drug|1|||
42329127|NCT02134028|76167155|FG004|Overall Study|Lack of Efficacy|1|||
42329128|NCT02134028|76167156|FG005|Overall Study|Lack of Efficacy|2|||
42329129|NCT02134028|76167157|FG006|Overall Study|Lack of Efficacy|1|||
42329130|NCT02134028|76167158|FG007|Overall Study|Lack of Efficacy|0|||
42329131|NCT02134028|76167151|FG000|Overall Study|Poor compliance to protocol|1|||
42329132|NCT02134028|76167152|FG001|Overall Study|Poor compliance to protocol|1|||
42329133|NCT02134028|76167153|FG002|Overall Study|Poor compliance to protocol|3|||
42329134|NCT02134028|76167154|FG003|Overall Study|Poor compliance to protocol|7|||
41997987|NCT03500172|75806322|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
42262538|NCT02488759|76090310|FG005|Overall Study|Adverse event unrelated to study drug|0|||
42262539|NCT02488759|76090305|FG000|Overall Study|Participant request to discontinue study treatment|6|||
42262540|NCT02488759|76090306|FG001|Overall Study|Participant request to discontinue study treatment|8|||
42262541|NCT02488759|76090307|FG002|Overall Study|Participant request to discontinue study treatment|4|||
42329135|NCT02134028|76167155|FG004|Overall Study|Poor compliance to protocol|1|||
42329136|NCT02134028|76167156|FG005|Overall Study|Poor compliance to protocol|1|||
42329137|NCT02134028|76167157|FG006|Overall Study|Poor compliance to protocol|0|||
42329138|NCT02134028|76167158|FG007|Overall Study|Poor compliance to protocol|0|||
42329139|NCT02134028|76167151|FG000|Overall Study|Other unspecified|4|||
42329140|NCT02134028|76167152|FG001|Overall Study|Other unspecified|22|||
42329141|NCT02134028|76167153|FG002|Overall Study|Other unspecified|33|||
42329142|NCT02134028|76167154|FG003|Overall Study|Other unspecified|64|||
42329143|NCT02134028|76167155|FG004|Overall Study|Other unspecified|8|||
42329144|NCT02134028|76167156|FG005|Overall Study|Other unspecified|6|||
42329145|NCT02134028|76167157|FG006|Overall Study|Other unspecified|2|||
42329146|NCT02134028|76167158|FG007|Overall Study|Other unspecified|1|||
42329147|NCT02134028|76167151|FG000|Overall Study|Adverse Event|3|||
42329148|NCT02134028|76167152|FG001|Overall Study|Adverse Event|19|||
42329149|NCT02134028|76167153|FG002|Overall Study|Adverse Event|13|||
42329150|NCT02134028|76167154|FG003|Overall Study|Adverse Event|32|||
42329151|NCT02134028|76167155|FG004|Overall Study|Adverse Event|4|||
42329152|NCT02134028|76167156|FG005|Overall Study|Adverse Event|5|||
42329153|NCT02134028|76167157|FG006|Overall Study|Adverse Event|1|||
42329154|NCT02134028|76167158|FG007|Overall Study|Adverse Event|2|||
42329155|NCT02172950|76167180|FG000|Overall Study|Physician Decision|3|||
42329156|NCT02172950|76167181|FG001|Overall Study|Physician Decision|3|||
42329157|NCT02172950|76167180|FG000|Overall Study|Lack of Efficacy|1|||
42329158|NCT02172950|76167181|FG001|Overall Study|Lack of Efficacy|0|||
42329159|NCT02172950|76167180|FG000|Overall Study|Adverse Event|4|||
41997988|NCT03500172|75806323|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
41997989|NCT03500172|75806324|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
41997990|NCT03500172|75806325|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
41997991|NCT03500172|75806326|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
41997992|NCT03500172|75806327|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
41997993|NCT03500172|75806317|FG000|Period 2: Re-Randomization|Death|0|||
41997994|NCT03500172|75806318|FG001|Period 2: Re-Randomization|Death|0|||
41997995|NCT03500172|75806319|FG002|Period 2: Re-Randomization|Death|0|||
41997996|NCT03500172|75806320|FG003|Period 2: Re-Randomization|Death|4|||
42034537|NCT00937521|75842593|FG007|Booster Phase|Protocol Deviation|0|||
42034538|NCT00935883|75842628|FG000|Treatment Period|Physician Decision|1|||
42262542|NCT02488759|76090308|FG003|Overall Study|Participant request to discontinue study treatment|0|||
42262543|NCT02488759|76090309|FG004|Overall Study|Participant request to discontinue study treatment|0|||
42262544|NCT02488759|76090310|FG005|Overall Study|Participant request to discontinue study treatment|0|||
42262545|NCT02488759|76090305|FG000|Overall Study|Withdrawal by Subject|4|||
42262546|NCT02488759|76090306|FG001|Overall Study|Withdrawal by Subject|0|||
42262547|NCT02488759|76090307|FG002|Overall Study|Withdrawal by Subject|3|||
42262548|NCT02488759|76090308|FG003|Overall Study|Withdrawal by Subject|0|||
42329160|NCT02172950|76167181|FG001|Overall Study|Adverse Event|1|||
42262549|NCT02488759|76090309|FG004|Overall Study|Withdrawal by Subject|0|||
42262550|NCT02488759|76090310|FG005|Overall Study|Withdrawal by Subject|2|||
42262551|NCT02488759|76090305|FG000|Overall Study|Lost to Follow-up|0|||
42262552|NCT02488759|76090306|FG001|Overall Study|Lost to Follow-up|0|||
42262553|NCT02488759|76090307|FG002|Overall Study|Lost to Follow-up|2|||
42262554|NCT02488759|76090308|FG003|Overall Study|Lost to Follow-up|0|||
42262555|NCT02488759|76090309|FG004|Overall Study|Lost to Follow-up|0|||
42262556|NCT02488759|76090310|FG005|Overall Study|Lost to Follow-up|0|||
42329161|NCT02172950|76167180|FG000|Overall Study|Withdrawal by Subject|10|||
42329162|NCT02172950|76167181|FG001|Overall Study|Withdrawal by Subject|0|||
42329163|NCT02172950|76167180|FG000|Overall Study|Protocol Violation|1|||
42329164|NCT02172950|76167181|FG001|Overall Study|Protocol Violation|0|||
42329165|NCT02172950|76167180|FG000|Overall Study|Lost to Follow-up|1|||
42329166|NCT02172950|76167181|FG001|Overall Study|Lost to Follow-up|0|||
42329167|NCT02172950|76167180|FG000|Overall Study|Death|1|||
41997997|NCT03500172|75806321|FG004|Period 2: Re-Randomization|Death|2|||
41997998|NCT03500172|75806322|FG005|Period 2: Re-Randomization|Death|0|||
41997999|NCT03500172|75806323|FG006|Period 2: Re-Randomization|Death|5|||
41998000|NCT03500172|75806324|FG007|Period 2: Re-Randomization|Death|2|||
42329168|NCT02172950|76167181|FG001|Overall Study|Death|0|||
42329169|NCT02172950|76167180|FG000|Overall Study|Patient traveling|1|||
41998001|NCT03500172|75806325|FG008|Period 2: Re-Randomization|Death|0|||
42034539|NCT00935883|75842629|FG001|Treatment Period|Physician Decision|0|||
42329170|NCT02172950|76167181|FG001|Overall Study|Patient traveling|0|||
42329171|NCT02172950|76167180|FG000|Overall Study|Patient went to other country|1|||
42329172|NCT02172950|76167181|FG001|Overall Study|Patient went to other country|0|||
42262557|NCT02488759|76090305|FG000|Overall Study|Maximum clinical benefit|3|||
42262558|NCT02488759|76090306|FG001|Overall Study|Maximum clinical benefit|0|||
42329173|NCT02172950|76167180|FG000|Overall Study|Patient relocated overseas|1|||
42329174|NCT02172950|76167181|FG001|Overall Study|Patient relocated overseas|1|||
42329175|NCT02172950|76167180|FG000|Overall Study|Patient moving|1|||
42329176|NCT02172950|76167181|FG001|Overall Study|Patient moving|0|||
42329177|NCT02151266|76167191|FG000|Overall Study|Lost to Follow-up|1|||
42329178|NCT02151266|76167192|FG001|Overall Study|Lost to Follow-up|4|||
42329179|NCT02151266|76167193|FG002|Overall Study|Lost to Follow-up|1|||
42329180|NCT02151266|76167191|FG000|Overall Study|Did NOT receive intervention|3|||
42329181|NCT02151266|76167192|FG001|Overall Study|Did NOT receive intervention|6|||
42329182|NCT02151266|76167193|FG002|Overall Study|Did NOT receive intervention|2|||
42329183|NCT02151266|76167191|FG000|Overall Study|Not able to exercise|4|||
42329184|NCT02151266|76167192|FG001|Overall Study|Not able to exercise|5|||
42329185|NCT02151266|76167193|FG002|Overall Study|Not able to exercise|4|||
42329186|NCT02151110|76167209|FG000|Overall Study|Withdrawal by Subject|0|||
42329187|NCT02151110|76167210|FG001|Overall Study|Withdrawal by Subject|0|||
42329188|NCT02151110|76167211|FG002|Overall Study|Withdrawal by Subject|0|||
42329189|NCT02151110|76167212|FG003|Overall Study|Withdrawal by Subject|0|||
42329190|NCT02151110|76167213|FG004|Overall Study|Withdrawal by Subject|0|||
42329191|NCT02151110|76167214|FG005|Overall Study|Withdrawal by Subject|0|||
42034540|NCT00935883|75842628|FG000|Treatment Period|Withdrawal by Subject|0|||
42329192|NCT02151110|76167215|FG006|Overall Study|Withdrawal by Subject|0|||
42329193|NCT02151110|76167216|FG007|Overall Study|Withdrawal by Subject|1|||
42329194|NCT02151110|76167209|FG000|Overall Study|Lost to Follow-up|0|||
42329195|NCT02151110|76167210|FG001|Overall Study|Lost to Follow-up|0|||
42034541|NCT00935883|75842629|FG001|Treatment Period|Withdrawal by Subject|2|||
42034542|NCT00936975|75842635|FG000|Overall Study|Withdrawal by Subject|1|||
42034543|NCT00936975|75842635|FG000|Overall Study|Disease progression|3|||
42329196|NCT02151110|76167211|FG002|Overall Study|Lost to Follow-up|0|||
42329197|NCT02151110|76167212|FG003|Overall Study|Lost to Follow-up|0|||
42329198|NCT02151110|76167213|FG004|Overall Study|Lost to Follow-up|0|||
42329199|NCT02151110|76167214|FG005|Overall Study|Lost to Follow-up|0|||
42329200|NCT02151110|76167215|FG006|Overall Study|Lost to Follow-up|0|||
42329201|NCT02151110|76167216|FG007|Overall Study|Lost to Follow-up|2|||
42329202|NCT02132312|76167243|FG000|Overall Study|Adverse Event|2|||
42034544|NCT00936975|75842635|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
42034545|NCT00936897|75842642|FG000|Overall Study|Withdrawal by Subject|9|||
42034546|NCT00936897|75842643|FG001|Overall Study|Withdrawal by Subject|19|||
41998002|NCT03500172|75806326|FG009|Period 2: Re-Randomization|Death|0|||
41998003|NCT03500172|75806327|FG010|Period 2: Re-Randomization|Death|0|||
41998004|NCT03470922|75806345|FG000|Overall Study|Death|107|||
41998005|NCT03470922|75806346|FG001|Overall Study|Death|118|||
41998006|NCT03470922|75806345|FG000|Overall Study|Lost to Follow-up|5|||
41998007|NCT03470922|75806346|FG001|Overall Study|Lost to Follow-up|5|||
41998008|NCT03470922|75806345|FG000|Overall Study|Participant Withdrew Consent|4|||
41998009|NCT03470922|75806346|FG001|Overall Study|Participant Withdrew Consent|9|||
41998010|NCT03470922|75806345|FG000|Overall Study|Other reasons|1|||
41998011|NCT03470922|75806346|FG001|Overall Study|Other reasons|0|||
42262559|NCT02488759|76090307|FG002|Overall Study|Maximum clinical benefit|1|||
42262560|NCT02488759|76090308|FG003|Overall Study|Maximum clinical benefit|0|||
42262561|NCT02488759|76090309|FG004|Overall Study|Maximum clinical benefit|0|||
42262562|NCT02488759|76090310|FG005|Overall Study|Maximum clinical benefit|0|||
42262563|NCT02488759|76090305|FG000|Overall Study|Other reasons|7|||
42262564|NCT02488759|76090306|FG001|Overall Study|Other reasons|32|||
42262565|NCT02488759|76090307|FG002|Overall Study|Other reasons|23|||
42262566|NCT02488759|76090308|FG003|Overall Study|Other reasons|1|||
42262567|NCT02488759|76090309|FG004|Overall Study|Other reasons|1|||
42262568|NCT02488759|76090310|FG005|Overall Study|Other reasons|1|||
42262569|NCT02466685|76090326|FG000|Overall Study|Adverse Event|5|||
42262570|NCT02466685|76090327|FG001|Overall Study|Adverse Event|2|||
42262571|NCT02466685|76090326|FG000|Overall Study|Lost to Follow-up|1|||
42262572|NCT02466685|76090327|FG001|Overall Study|Lost to Follow-up|1|||
41998012|NCT03470922|75806345|FG000|Overall Study|Not reported|1|||
42262573|NCT02466685|76090326|FG000|Overall Study|Withdrawal by Subject|1|||
42329203|NCT02132312|76167244|FG001|Overall Study|Adverse Event|0|||
42329204|NCT02132312|76167243|FG000|Overall Study|Physician Decision|1|||
42329205|NCT02132312|76167244|FG001|Overall Study|Physician Decision|1|||
42329206|NCT02132312|76167243|FG000|Overall Study|Protocol Violation|0|||
42329207|NCT02132312|76167244|FG001|Overall Study|Protocol Violation|1|||
42034547|NCT00936897|75842642|FG000|Overall Study|Adverse Event|4|||
42034548|NCT00936897|75842643|FG001|Overall Study|Adverse Event|13|||
42329208|NCT02132312|76167243|FG000|Overall Study|Withdrawal by Subject|1|||
42329209|NCT02132312|76167244|FG001|Overall Study|Withdrawal by Subject|0|||
42329210|NCT02132312|76167243|FG000|Overall Study|Lost to Follow-up|2|||
42329211|NCT02132312|76167244|FG001|Overall Study|Lost to Follow-up|1|||
42329212|NCT02131766|76167250|FG000|Overall Study|Withdrawal by Subject|4|||
42329213|NCT02150954|76167259|FG000|Overall Study|Protocol Violation|1|||
42329214|NCT02150954|76167260|FG001|Overall Study|Protocol Violation|0|||
42329215|NCT02131532|76167266|FG000|Overall Study|Withdrawal by Subject|1|||
41998013|NCT03470922|75806346|FG001|Overall Study|Not reported|0|||
41998014|NCT03440814|75806354|FG000|Overall Study|Adverse Event|2|||
41998015|NCT03440814|75806355|FG001|Overall Study|Adverse Event|1|||
42262574|NCT02466685|76090327|FG001|Overall Study|Withdrawal by Subject|0|||
42262575|NCT02466685|76090326|FG000|Overall Study|Physician Decision|1|||
42329216|NCT02131532|76167266|FG000|Overall Study|Physician Decision|1|||
42329217|NCT02131532|76167266|FG000|Overall Study|Other health conditions|2|||
42262576|NCT02466685|76090327|FG001|Overall Study|Physician Decision|1|||
42329218|NCT02170688|76167280|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
42329219|NCT02170688|76167281|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
42329220|NCT02170688|76167282|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
42329221|NCT02170688|76167283|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
42329222|NCT02170688|76167284|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
42329223|NCT02170688|76167280|FG000|Overall Study|Full dose not received|0|||
42329224|NCT02170688|76167281|FG001|Overall Study|Full dose not received|1|||
42329225|NCT02170688|76167282|FG002|Overall Study|Full dose not received|0|||
42329226|NCT02170688|76167283|FG003|Overall Study|Full dose not received|0|||
42329227|NCT02170688|76167284|FG004|Overall Study|Full dose not received|0|||
42329228|NCT02170688|76167280|FG000|Overall Study|Physician Decision|0|||
42329229|NCT02170688|76167281|FG001|Overall Study|Physician Decision|0|||
42329230|NCT02170688|76167282|FG002|Overall Study|Physician Decision|1|||
42329231|NCT02170688|76167283|FG003|Overall Study|Physician Decision|0|||
42329232|NCT02170688|76167284|FG004|Overall Study|Physician Decision|0|||
42329233|NCT02170298|76167298|FG000|Overall Study|Withdrawal by Subject|0|||
42329234|NCT02170298|76167299|FG001|Overall Study|Withdrawal by Subject|1|||
42262577|NCT02312206|76090338|FG000|Overall Study|Adverse Event|3|||
42262578|NCT02312206|76090339|FG001|Overall Study|Adverse Event|6|||
42262579|NCT02312206|76090338|FG000|Overall Study|Withdrawal by Subject|6|||
42262580|NCT02312206|76090339|FG001|Overall Study|Withdrawal by Subject|6|||
42262581|NCT02312206|76090338|FG000|Overall Study|Physician Decision|7|||
42262582|NCT02312206|76090339|FG001|Overall Study|Physician Decision|6|||
42262583|NCT02312206|76090338|FG000|Overall Study|Death|31|||
42262584|NCT02312206|76090339|FG001|Overall Study|Death|36|||
42262585|NCT02312206|76090338|FG000|Overall Study|Study Terminated by Sponsor|81|||
42262586|NCT02312206|76090339|FG001|Overall Study|Study Terminated by Sponsor|74|||
42262587|NCT02312206|76090338|FG000|Overall Study|Patient transferred to hospice|0|||
42262588|NCT02312206|76090339|FG001|Overall Study|Patient transferred to hospice|1|||
42262589|NCT02312206|76090338|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
42262590|NCT02312206|76090339|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
42262591|NCT02312206|76090338|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
42262592|NCT02312206|76090339|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
42262593|NCT02312206|76090338|FG000|Overall Study|Disease Progression|1|||
42262594|NCT02312206|76090339|FG001|Overall Study|Disease Progression|0|||
42262595|NCT02264665|76090350|FG000|Overall Study|Other|0|||
42262596|NCT02264665|76090351|FG001|Overall Study|Other|0|||
42262597|NCT02264665|76090352|FG002|Overall Study|Other|3|||
42262598|NCT02264665|76090353|FG003|Overall Study|Other|0|||
42262599|NCT02264665|76090354|FG004|Overall Study|Other|0|||
42262600|NCT02264665|76090355|FG005|Overall Study|Other|0|||
42262601|NCT02264665|76090356|FG006|Overall Study|Other|0|||
42262602|NCT02264665|76090350|FG000|Overall Study|Death|9|||
41998016|NCT03440814|75806354|FG000|Overall Study|Lost to Follow-up|2|||
41998017|NCT03440814|75806355|FG001|Overall Study|Lost to Follow-up|0|||
42262603|NCT02264665|76090351|FG001|Overall Study|Death|8|||
42262604|NCT02264665|76090352|FG002|Overall Study|Death|13|||
42262605|NCT02264665|76090353|FG003|Overall Study|Death|5|||
42262606|NCT02264665|76090354|FG004|Overall Study|Death|0|||
42329235|NCT02170298|76167298|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
42262607|NCT02264665|76090355|FG005|Overall Study|Death|0|||
42262608|NCT02264665|76090356|FG006|Overall Study|Death|1|||
42262609|NCT02264665|76090350|FG000|Overall Study|Lost to Follow-up|1|||
42329236|NCT02170298|76167299|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
42329237|NCT02131064|76167307|FG000|Overall Study|Death|5|||
42329238|NCT02131064|76167308|FG001|Overall Study|Death|6|||
42329239|NCT02131064|76167307|FG000|Overall Study|Lost to Follow-up|4|||
42329240|NCT02131064|76167308|FG001|Overall Study|Lost to Follow-up|8|||
42329241|NCT02131064|76167307|FG000|Overall Study|Withdrawal by Subject|14|||
42329242|NCT02131064|76167308|FG001|Overall Study|Withdrawal by Subject|18|||
42329243|NCT02131064|76167307|FG000|Overall Study|Other|2|||
42329244|NCT02131064|76167308|FG001|Overall Study|Other|2|||
42329245|NCT02130986|76167317|FG000|Overall Study|Withdrawal by Subject|4|||
42329246|NCT02130986|76167318|FG001|Overall Study|Withdrawal by Subject|4|||
42329247|NCT02130986|76167317|FG000|Overall Study|Lost to Follow-up|151|||
41998018|NCT03440814|75806354|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
42034549|NCT00936897|75842642|FG000|Overall Study|Other|3|||
42329248|NCT02130986|76167318|FG001|Overall Study|Lost to Follow-up|160|||
42329249|NCT02130284|76167326|FG000|Overall Study|Withdrawal by Subject|3|||
42329250|NCT02130284|76167326|FG000|Overall Study|Subject Withdrew Consent|1|||
42329251|NCT02130284|76167326|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
42329252|NCT02130284|76167326|FG000|Overall Study|Subject was screened as backup for study|3|||
42329253|NCT02130284|76167326|FG000|Overall Study|Screen Failure|1|||
42329254|NCT02147288|76167332|FG000|Overall Study|post-operative hematoma|1|||
42329255|NCT02147288|76167333|FG001|Overall Study|post-operative hematoma|1|||
42329256|NCT02147288|76167334|FG002|Overall Study|post-operative hematoma|0|||
42329257|NCT02147288|76167335|FG003|Overall Study|post-operative hematoma|0|||
42329258|NCT02147288|76167336|FG004|Overall Study|post-operative hematoma|0|||
42329259|NCT02147288|76167337|FG005|Overall Study|post-operative hematoma|0|||
42329260|NCT02147288|76167338|FG006|Overall Study|post-operative hematoma|0|||
42329261|NCT02147288|76167339|FG007|Overall Study|post-operative hematoma|0|||
42329262|NCT02147288|76167340|FG008|Overall Study|post-operative hematoma|0|||
42329263|NCT02147288|76167341|FG009|Overall Study|post-operative hematoma|0|||
42329264|NCT02147288|76167332|FG000|Overall Study|complications from concurrent hernia rep|0|||
42329265|NCT02147288|76167333|FG001|Overall Study|complications from concurrent hernia rep|1|||
42329266|NCT02147288|76167334|FG002|Overall Study|complications from concurrent hernia rep|0|||
42329267|NCT02147288|76167335|FG003|Overall Study|complications from concurrent hernia rep|0|||
42329268|NCT02147288|76167336|FG004|Overall Study|complications from concurrent hernia rep|0|||
42329269|NCT02147288|76167337|FG005|Overall Study|complications from concurrent hernia rep|0|||
42329270|NCT02147288|76167338|FG006|Overall Study|complications from concurrent hernia rep|0|||
42329271|NCT02147288|76167339|FG007|Overall Study|complications from concurrent hernia rep|0|||
42329272|NCT02147288|76167340|FG008|Overall Study|complications from concurrent hernia rep|0|||
42329273|NCT02147288|76167341|FG009|Overall Study|complications from concurrent hernia rep|0|||
42329274|NCT02147132|76167347|FG000|Overall Study|Lost to Follow-up|1|||
42329275|NCT02147132|76167348|FG001|Overall Study|Lost to Follow-up|0|||
42329276|NCT02147132|76167349|FG002|Overall Study|Lost to Follow-up|0|||
42329277|NCT02147132|76167350|FG003|Overall Study|Lost to Follow-up|0|||
42329278|NCT02146430|76167364|FG000|Overall Study|Protocol Violation|5|||
42329279|NCT02146430|76167365|FG001|Overall Study|Protocol Violation|4|||
42329280|NCT02146430|76167366|FG002|Overall Study|Protocol Violation|8|||
42329281|NCT02146430|76167367|FG003|Overall Study|Protocol Violation|6|||
42329282|NCT02146430|76167364|FG000|Overall Study|Lack of Efficacy|13|||
42329283|NCT02146430|76167365|FG001|Overall Study|Lack of Efficacy|11|||
42329284|NCT02146430|76167366|FG002|Overall Study|Lack of Efficacy|8|||
42329285|NCT02146430|76167367|FG003|Overall Study|Lack of Efficacy|5|||
42329286|NCT02146430|76167364|FG000|Overall Study|Adverse Event|20|||
42262610|NCT02264665|76090351|FG001|Overall Study|Lost to Follow-up|0|||
42262611|NCT02264665|76090352|FG002|Overall Study|Lost to Follow-up|2|||
42262612|NCT02264665|76090353|FG003|Overall Study|Lost to Follow-up|1|||
42262613|NCT02264665|76090354|FG004|Overall Study|Lost to Follow-up|0|||
42262614|NCT02264665|76090355|FG005|Overall Study|Lost to Follow-up|0|||
42262615|NCT02264665|76090356|FG006|Overall Study|Lost to Follow-up|0|||
42262616|NCT02264665|76090350|FG000|Overall Study|Participant decision|0|||
42262617|NCT02264665|76090351|FG001|Overall Study|Participant decision|0|||
42262618|NCT02264665|76090352|FG002|Overall Study|Participant decision|0|||
42262619|NCT02264665|76090353|FG003|Overall Study|Participant decision|1|||
42262620|NCT02264665|76090354|FG004|Overall Study|Participant decision|0|||
42262621|NCT02264665|76090355|FG005|Overall Study|Participant decision|0|||
42262622|NCT02264665|76090356|FG006|Overall Study|Participant decision|0|||
42262623|NCT02264665|76090350|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
42262624|NCT02264665|76090351|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
42262625|NCT02264665|76090352|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
42329287|NCT02146430|76167365|FG001|Overall Study|Adverse Event|40|||
42329288|NCT02146430|76167366|FG002|Overall Study|Adverse Event|32|||
42329289|NCT02146430|76167367|FG003|Overall Study|Adverse Event|49|||
42329290|NCT02146430|76167364|FG000|Overall Study|Reason missing or not reported|2|||
42329291|NCT02146430|76167365|FG001|Overall Study|Reason missing or not reported|3|||
42329292|NCT02146430|76167366|FG002|Overall Study|Reason missing or not reported|4|||
42329293|NCT02146430|76167367|FG003|Overall Study|Reason missing or not reported|5|||
42329294|NCT02146430|76167364|FG000|Overall Study|Withdrawal by Subject|27|||
42329295|NCT02146430|76167365|FG001|Overall Study|Withdrawal by Subject|29|||
41998019|NCT03440814|75806355|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
41998020|NCT03427814|75806363|FG000|Overall Study|Withdrawal by Subject|4|||
41998021|NCT03427814|75806364|FG001|Overall Study|Withdrawal by Subject|4|||
41998022|NCT03427814|75806363|FG000|Overall Study|Lost to Follow-up|0|||
41998023|NCT03427814|75806364|FG001|Overall Study|Lost to Follow-up|2|||
41998024|NCT03427814|75806363|FG000|Overall Study|Death|42|||
41998025|NCT03427814|75806364|FG001|Overall Study|Death|31|||
41998026|NCT03427814|75806363|FG000|Overall Study|Sponsor's Decision|1|||
42034550|NCT00936897|75842643|FG001|Overall Study|Other|9|||
42329296|NCT02146430|76167366|FG002|Overall Study|Withdrawal by Subject|30|||
42329297|NCT02146430|76167367|FG003|Overall Study|Withdrawal by Subject|34|||
42329298|NCT02129192|76167383|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
42329299|NCT02129192|76167384|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
42329300|NCT02105948|76167397|FG000|Overall Study|Adverse Event|10|||
42329301|NCT02105948|76167398|FG001|Overall Study|Adverse Event|7|||
42329302|NCT02105948|76167399|FG002|Overall Study|Adverse Event|11|||
42329303|NCT02105948|76167400|FG003|Overall Study|Adverse Event|11|||
41998027|NCT03427814|75806364|FG001|Overall Study|Sponsor's Decision|0|||
42034551|NCT00936897|75842642|FG000|Overall Study|Lost to Follow-up|1|||
42034552|NCT00936897|75842643|FG001|Overall Study|Lost to Follow-up|10|||
42034553|NCT00936897|75842642|FG000|Overall Study|Administrative Decision|1|||
42034554|NCT00936897|75842643|FG001|Overall Study|Administrative Decision|2|||
42034555|NCT00936897|75842642|FG000|Overall Study|Protocol Violation|1|||
42262626|NCT02264665|76090353|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
42262627|NCT02264665|76090354|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
42262628|NCT02264665|76090355|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
42262629|NCT02264665|76090356|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
42262630|NCT02264665|76090350|FG000|Overall Study|Data Missing|0|||
42262631|NCT02264665|76090351|FG001|Overall Study|Data Missing|0|||
42262632|NCT02264665|76090352|FG002|Overall Study|Data Missing|1|||
42262633|NCT02264665|76090353|FG003|Overall Study|Data Missing|0|||
42262634|NCT02264665|76090354|FG004|Overall Study|Data Missing|0|||
42262635|NCT02264665|76090355|FG005|Overall Study|Data Missing|0|||
42262636|NCT02264665|76090356|FG006|Overall Study|Data Missing|0|||
42262637|NCT02155712|76090383|FG000|Overall Study|Death|12|||
42262638|NCT02155712|76090384|FG001|Overall Study|Death|0|||
42262639|NCT02155712|76090383|FG000|Overall Study|Lost to Follow-up|37|||
42262640|NCT02155712|76090384|FG001|Overall Study|Lost to Follow-up|22|||
42262641|NCT02155712|76090383|FG000|Overall Study|Revision of device|4|||
42262642|NCT02155712|76090384|FG001|Overall Study|Revision of device|3|||
42262643|NCT02155712|76090383|FG000|Overall Study|Withdrawal by Subject|39|||
42262644|NCT02155712|76090384|FG001|Overall Study|Withdrawal by Subject|21|||
42262645|NCT02155712|76090383|FG000|Overall Study|Site termination|77|||
42262646|NCT02155712|76090384|FG001|Overall Study|Site termination|19|||
42262647|NCT02155712|76090383|FG000|Overall Study|Sponsor terminated study early|150|||
42262648|NCT02155712|76090384|FG001|Overall Study|Sponsor terminated study early|0|||
42262649|NCT02155712|76090383|FG000|Overall Study|Missed final 5-year protocol visit|0|||
42262650|NCT02155712|76090384|FG001|Overall Study|Missed final 5-year protocol visit|32|||
42262651|NCT02155712|76090383|FG000|Overall Study|Censored because surgery cancelled|6|||
42262652|NCT02155712|76090384|FG001|Overall Study|Censored because surgery cancelled|10|||
42262653|NCT02155712|76090383|FG000|Overall Study|Censored because study device was not implanted|61|||
42262654|NCT02155712|76090384|FG001|Overall Study|Censored because study device was not implanted|66|||
42034556|NCT00936897|75842643|FG001|Overall Study|Protocol Violation|1|||
42034557|NCT00936897|75842642|FG000|Overall Study|Ineligibility Determined|0|||
42034558|NCT00936897|75842643|FG001|Overall Study|Ineligibility Determined|3|||
42034559|NCT00936897|75842642|FG000|Overall Study|Noncompliance|0|||
42034560|NCT00936897|75842643|FG001|Overall Study|Noncompliance|2|||
42262655|NCT02155712|76090383|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
42329304|NCT02105948|76167397|FG000|Overall Study|Lack of Efficacy|0|||
42329305|NCT02105948|76167398|FG001|Overall Study|Lack of Efficacy|1|||
42329306|NCT02105948|76167399|FG002|Overall Study|Lack of Efficacy|3|||
41998028|NCT03427814|75806363|FG000|Overall Study|Investigator's Decision|1|||
42034561|NCT00936897|75842642|FG000|Overall Study|Death|0|||
42262656|NCT02155712|76090384|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
42262657|NCT01972217|76090398|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
42262658|NCT01972217|76090399|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
42034562|NCT00936897|75842643|FG001|Overall Study|Death|1|||
42034563|NCT01120691|75842652|FG000|Overall Study|Adverse Event|59|||
42034564|NCT01120691|75842653|FG001|Overall Study|Adverse Event|67|||
42329307|NCT02105948|76167400|FG003|Overall Study|Lack of Efficacy|2|||
42329308|NCT02105948|76167397|FG000|Overall Study|Lost to Follow-up|0|||
42329309|NCT02105948|76167398|FG001|Overall Study|Lost to Follow-up|0|||
42329310|NCT02105948|76167399|FG002|Overall Study|Lost to Follow-up|2|||
42329311|NCT02105948|76167400|FG003|Overall Study|Lost to Follow-up|1|||
42329312|NCT02105948|76167397|FG000|Overall Study|Physician Decision|2|||
42329313|NCT02105948|76167398|FG001|Overall Study|Physician Decision|2|||
42329314|NCT02105948|76167399|FG002|Overall Study|Physician Decision|2|||
42329315|NCT02105948|76167400|FG003|Overall Study|Physician Decision|2|||
42329316|NCT02105948|76167397|FG000|Overall Study|Withdrawal by Subject|15|||
42329317|NCT02105948|76167398|FG001|Overall Study|Withdrawal by Subject|10|||
42329318|NCT02105948|76167399|FG002|Overall Study|Withdrawal by Subject|10|||
42329319|NCT02105948|76167400|FG003|Overall Study|Withdrawal by Subject|11|||
42329320|NCT02128724|76167415|FG000|Overall Study|Death|1|||
42329321|NCT02128724|76167416|FG001|Overall Study|Death|0|||
42329322|NCT02128724|76167417|FG002|Overall Study|Death|0|||
42329323|NCT02128724|76167418|FG003|Overall Study|Death|0|||
42329324|NCT02128724|76167415|FG000|Overall Study|Adverse Event|0|||
42329325|NCT02128724|76167416|FG001|Overall Study|Adverse Event|1|||
42329326|NCT02128724|76167417|FG002|Overall Study|Adverse Event|0|||
42329327|NCT02128724|76167418|FG003|Overall Study|Adverse Event|0|||
42329328|NCT02128724|76167415|FG000|Overall Study|Physician Decision|0|||
42329329|NCT02128724|76167416|FG001|Overall Study|Physician Decision|0|||
42134106|NCT00443118|75944967|FG001|Overall Study|Withdrawal by Subject|0|||
42262659|NCT01972217|76090400|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
42262660|NCT01972217|76090401|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
42262661|NCT01972217|76090398|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
42262662|NCT01972217|76090399|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
42262663|NCT01972217|76090400|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
42262664|NCT01972217|76090401|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
42262665|NCT01972217|76090398|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
42262666|NCT01972217|76090399|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
42262667|NCT01972217|76090400|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
42262668|NCT01972217|76090401|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
42262669|NCT01972217|76090398|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
42262670|NCT01972217|76090399|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
42262671|NCT01972217|76090400|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
42262672|NCT01972217|76090401|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
42329330|NCT02128724|76167417|FG002|Overall Study|Physician Decision|0|||
42329331|NCT02128724|76167418|FG003|Overall Study|Physician Decision|2|||
42329332|NCT02128724|76167415|FG000|Overall Study|Withdrawal by Subject|0|||
42134107|NCT00443118|75944968|FG002|Overall Study|Withdrawal by Subject|0|||
42134108|NCT00460434|75944996|FG000|Overall Study|Lost to Follow-up|3|||
42134109|NCT00460434|75944997|FG001|Overall Study|Lost to Follow-up|7|||
42262673|NCT01972217|76090398|FG000|Part B Double-blind, Randomised Period|Death|0|||
42262674|NCT01972217|76090399|FG001|Part B Double-blind, Randomised Period|Death|0|||
42329333|NCT02128724|76167416|FG001|Overall Study|Withdrawal by Subject|0|||
42329334|NCT02128724|76167417|FG002|Overall Study|Withdrawal by Subject|0|||
42329335|NCT02128724|76167418|FG003|Overall Study|Withdrawal by Subject|1|||
42329336|NCT02128490|76167432|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
42329337|NCT02128490|76167433|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
42329338|NCT02128490|76167434|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
42329339|NCT02128490|76167435|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
42329340|NCT02128490|76167436|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
42329341|NCT02128490|76167432|FG000|Overall Study|Major Protocol Deviation|1|||
42329342|NCT02128490|76167433|FG001|Overall Study|Major Protocol Deviation|2|||
42329343|NCT02128490|76167434|FG002|Overall Study|Major Protocol Deviation|0|||
42329344|NCT02128490|76167435|FG003|Overall Study|Major Protocol Deviation|2|||
42329345|NCT02128490|76167436|FG004|Overall Study|Major Protocol Deviation|2|||
42329346|NCT02128490|76167432|FG000|Overall Study|Lost to Follow-up|0|||
42329347|NCT02128490|76167433|FG001|Overall Study|Lost to Follow-up|0|||
42329348|NCT02128490|76167434|FG002|Overall Study|Lost to Follow-up|1|||
42329349|NCT02128490|76167435|FG003|Overall Study|Lost to Follow-up|1|||
42329350|NCT02128490|76167436|FG004|Overall Study|Lost to Follow-up|1|||
42329351|NCT02128490|76167432|FG000|Overall Study|Voluntary Withdrawal|3|||
42329352|NCT02128490|76167433|FG001|Overall Study|Voluntary Withdrawal|3|||
42329353|NCT02128490|76167434|FG002|Overall Study|Voluntary Withdrawal|1|||
42329354|NCT02128490|76167435|FG003|Overall Study|Voluntary Withdrawal|1|||
42329355|NCT02128490|76167436|FG004|Overall Study|Voluntary Withdrawal|2|||
42329356|NCT02128490|76167432|FG000|Overall Study|Lack of Efficacy|0|||
42329357|NCT02128490|76167433|FG001|Overall Study|Lack of Efficacy|1|||
42329358|NCT02128490|76167434|FG002|Overall Study|Lack of Efficacy|0|||
42329359|NCT02128490|76167435|FG003|Overall Study|Lack of Efficacy|0|||
42329360|NCT02128490|76167436|FG004|Overall Study|Lack of Efficacy|0|||
42329361|NCT02128490|76167432|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
42329362|NCT02128490|76167433|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
42329363|NCT02128490|76167434|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
42329364|NCT02128490|76167435|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
42329365|NCT02128490|76167436|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
42329366|NCT02128490|76167432|FG000|Overall Study|Other Miscellaneous Reasons|0|||
42329367|NCT02128490|76167433|FG001|Overall Study|Other Miscellaneous Reasons|0|||
42329368|NCT02128490|76167434|FG002|Overall Study|Other Miscellaneous Reasons|2|||
42329369|NCT02128490|76167435|FG003|Overall Study|Other Miscellaneous Reasons|1|||
42329370|NCT02128490|76167436|FG004|Overall Study|Other Miscellaneous Reasons|1|||
42329371|NCT02146352|76167448|FG000|Overall Study|Death|1|||
42329372|NCT02146352|76167448|FG000|Overall Study|Patient entered hospice care|1|||
42329373|NCT02146274|76167452|FG000|Overall Study|Protocol Violation|73|||
42329374|NCT02105636|76167461|FG000|Pre-Treatment|Disease Progression|1|||
42329375|NCT02105636|76167462|FG001|Pre-Treatment|Disease Progression|0|||
42329376|NCT02105636|76167461|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
42329377|NCT02105636|76167462|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
42329378|NCT02105636|76167461|FG000|Pre-Treatment|Participant withdrew consent|0|||
42329379|NCT02105636|76167462|FG001|Pre-Treatment|Participant withdrew consent|6|||
42329380|NCT02105636|76167461|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
42329381|NCT02105636|76167462|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
42329382|NCT02105636|76167461|FG000|Treatment|Study Drug Toxicity|14|||
42329383|NCT02105636|76167462|FG001|Treatment|Study Drug Toxicity|10|||
42329384|NCT02105636|76167461|FG000|Treatment|Adverse event unrelated to study drug|19|||
42329385|NCT02105636|76167462|FG001|Treatment|Adverse event unrelated to study drug|3|||
42329386|NCT02105636|76167461|FG000|Treatment|Participant request to discontinue study treatment|8|||
42329387|NCT02105636|76167462|FG001|Treatment|Participant request to discontinue study treatment|6|||
42329388|NCT02105636|76167461|FG000|Treatment|Participant withdrew consent|5|||
42329389|NCT02105636|76167462|FG001|Treatment|Participant withdrew consent|1|||
42329390|NCT02105636|76167461|FG000|Treatment|Lost to Follow-up|1|||
42329391|NCT02105636|76167462|FG001|Treatment|Lost to Follow-up|0|||
42329392|NCT02105636|76167461|FG000|Treatment|Maximum Clinical Benefit|1|||
42329393|NCT02105636|76167462|FG001|Treatment|Maximum Clinical Benefit|3|||
42329394|NCT02105636|76167461|FG000|Treatment|Poor/Non-compliance|0|||
42329395|NCT02105636|76167462|FG001|Treatment|Poor/Non-compliance|1|||
42329396|NCT02105636|76167461|FG000|Treatment|Participant no longer meets study criteria|1|||
42329397|NCT02105636|76167462|FG001|Treatment|Participant no longer meets study criteria|0|||
42329398|NCT02105636|76167461|FG000|Treatment|Other reasons|1|||
42329399|NCT02105636|76167462|FG001|Treatment|Other reasons|0|||
42329400|NCT02105636|76167461|FG000|Treatment|Disease Progression|185|||
42329401|NCT02105636|76167462|FG001|Treatment|Disease Progression|87|||
42329402|NCT01626872|76167471|FG000|Overall Study|Physician Decision|13|||
42329403|NCT01626872|76167472|FG001|Overall Study|Physician Decision|9|||
42329404|NCT01626872|76167473|FG002|Overall Study|Physician Decision|6|||
42329405|NCT01626872|76167471|FG000|Overall Study|Withdrawal by Subject|19|||
42329406|NCT01626872|76167472|FG001|Overall Study|Withdrawal by Subject|27|||
42329407|NCT01626872|76167473|FG002|Overall Study|Withdrawal by Subject|8|||
42329408|NCT01626872|76167471|FG000|Overall Study|Adverse Event (including Death)|20|||
42329409|NCT01626872|76167472|FG001|Overall Study|Adverse Event (including Death)|28|||
42329410|NCT01626872|76167473|FG002|Overall Study|Adverse Event (including Death)|8|||
42329411|NCT01626872|76167471|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
42329412|NCT01626872|76167472|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
42329413|NCT01626872|76167473|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
42329414|NCT01598090|76167484|FG000|Treatment Period|Poor/non-compliance|0|||
42329415|NCT01598090|76167485|FG001|Treatment Period|Poor/non-compliance|2|||
42329416|NCT01598090|76167486|FG002|Treatment Period|Poor/non-compliance|0|||
42329417|NCT01598090|76167484|FG000|Treatment Period|No longer meet study criteria|0|||
42329418|NCT01598090|76167485|FG001|Treatment Period|No longer meet study criteria|1|||
42329419|NCT01598090|76167486|FG002|Treatment Period|No longer meet study criteria|0|||
42329420|NCT01598090|76167484|FG000|Treatment Period|Lack of Efficacy|5|||
42329421|NCT01598090|76167485|FG001|Treatment Period|Lack of Efficacy|14|||
42329422|NCT01598090|76167486|FG002|Treatment Period|Lack of Efficacy|6|||
42329423|NCT01598090|76167484|FG000|Treatment Period|Adverse Event|2|||
42329424|NCT01598090|76167485|FG001|Treatment Period|Adverse Event|33|||
42329425|NCT01598090|76167486|FG002|Treatment Period|Adverse Event|17|||
42329426|NCT01598090|76167484|FG000|Treatment Period|Other reasons|0|||
42329427|NCT01598090|76167485|FG001|Treatment Period|Other reasons|4|||
42329428|NCT01598090|76167486|FG002|Treatment Period|Other reasons|1|||
42329429|NCT01598090|76167484|FG000|Treatment Period|Withdrawal by Subject|3|||
42329430|NCT01598090|76167485|FG001|Treatment Period|Withdrawal by Subject|13|||
42329431|NCT01598090|76167486|FG002|Treatment Period|Withdrawal by Subject|10|||
42329432|NCT01598090|76167484|FG000|Treatment Period|Lost to Follow-up|1|||
41998029|NCT03427814|75806364|FG001|Overall Study|Investigator's Decision|2|||
41998030|NCT03427814|75806363|FG000|Overall Study|Disease progression|1|||
41998031|NCT03427814|75806364|FG001|Overall Study|Disease progression|0|||
42329433|NCT01598090|76167485|FG001|Treatment Period|Lost to Follow-up|5|||
42329434|NCT01598090|76167486|FG002|Treatment Period|Lost to Follow-up|1|||
42329435|NCT01598090|76167484|FG000|Follow-up Period|Death|0|||
41998032|NCT03427814|75806363|FG000|Overall Study|Treatment Completed|0|||
41998033|NCT03427814|75806364|FG001|Overall Study|Treatment Completed|1|||
41998034|NCT03427814|75806363|FG000|Overall Study|Sponsor's Decision to End study|21|||
41998035|NCT03427814|75806364|FG001|Overall Study|Sponsor's Decision to End study|25|||
41998036|NCT03427814|75806363|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
41998037|NCT03427814|75806364|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
41998038|NCT03418493|75806381|FG000|Overall Study|Adverse Event|1|||
41998039|NCT03418493|75806382|FG001|Overall Study|Adverse Event|0|||
41998040|NCT03418493|75806383|FG002|Overall Study|Adverse Event|0|||
41998041|NCT03418493|75806384|FG003|Overall Study|Adverse Event|0|||
41998042|NCT03418493|75806385|FG004|Overall Study|Adverse Event|0|||
41998043|NCT03418493|75806386|FG005|Overall Study|Adverse Event|0|||
41998044|NCT03418493|75806387|FG006|Overall Study|Adverse Event|0|||
41998045|NCT03418493|75806388|FG007|Overall Study|Adverse Event|0|||
42134110|NCT00373425|75945008|FG000|Overall Study|Relapse of NSCLC|116|||
42134111|NCT00373425|75945009|FG001|Overall Study|Relapse of NSCLC|104|||
42134112|NCT00373425|75945010|FG002|Overall Study|Relapse of NSCLC|19|||
42262675|NCT01972217|76090400|FG002|Part B Double-blind, Randomised Period|Death|43|||
42262676|NCT01972217|76090401|FG003|Part B Double-blind, Randomised Period|Death|44|||
42262677|NCT01972217|76090398|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
42262678|NCT01972217|76090399|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
42262679|NCT01972217|76090400|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
42262680|NCT01972217|76090401|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
42262681|NCT01972217|76090398|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
42262682|NCT01972217|76090399|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
42262683|NCT01972217|76090400|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
42262684|NCT01972217|76090401|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
42262685|NCT01972217|76090398|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
42262686|NCT01972217|76090399|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
42262687|NCT01972217|76090400|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
42262688|NCT01972217|76090401|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
41998046|NCT03418493|75806389|FG008|Overall Study|Adverse Event|0|||
41998047|NCT03418493|75806390|FG009|Overall Study|Adverse Event|0|||
41998048|NCT03418493|75806391|FG010|Overall Study|Adverse Event|0|||
41998049|NCT03418493|75806381|FG000|Overall Study|Protocol Violation|0|||
41998050|NCT03418493|75806382|FG001|Overall Study|Protocol Violation|0|||
42262689|NCT01972217|76090398|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
42262690|NCT01972217|76090399|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
42329436|NCT01598090|76167485|FG001|Follow-up Period|Death|1|||
42329437|NCT01598090|76167486|FG002|Follow-up Period|Death|0|||
42329438|NCT01598090|76167484|FG000|Follow-up Period|No longer required per protocol|1|||
42329439|NCT01598090|76167485|FG001|Follow-up Period|No longer required per protocol|3|||
42329440|NCT01598090|76167486|FG002|Follow-up Period|No longer required per protocol|2|||
42329441|NCT01598090|76167484|FG000|Follow-up Period|Not reported|0|||
42329442|NCT01598090|76167485|FG001|Follow-up Period|Not reported|10|||
42329443|NCT01598090|76167486|FG002|Follow-up Period|Not reported|4|||
42329444|NCT01598090|76167484|FG000|Follow-up Period|Withdrawal by Subject|0|||
42329445|NCT01598090|76167485|FG001|Follow-up Period|Withdrawal by Subject|3|||
42329446|NCT01598090|76167486|FG002|Follow-up Period|Withdrawal by Subject|2|||
42329447|NCT01598090|76167484|FG000|Follow-up Period|Other reasons|2|||
42329448|NCT01598090|76167485|FG001|Follow-up Period|Other reasons|8|||
42329449|NCT01598090|76167486|FG002|Follow-up Period|Other reasons|8|||
42329450|NCT01598090|76167484|FG000|Follow-up Period|Lost to Follow-up|2|||
41998051|NCT03418493|75806383|FG002|Overall Study|Protocol Violation|0|||
41998052|NCT03418493|75806384|FG003|Overall Study|Protocol Violation|0|||
41998053|NCT03418493|75806385|FG004|Overall Study|Protocol Violation|0|||
41998054|NCT03418493|75806386|FG005|Overall Study|Protocol Violation|0|||
42262691|NCT01972217|76090400|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
42329451|NCT01598090|76167485|FG001|Follow-up Period|Lost to Follow-up|10|||
42329452|NCT01598090|76167486|FG002|Follow-up Period|Lost to Follow-up|12|||
42329453|NCT02105012|76167497|FG000|Overall Study|Withdrawal by Subject|11|||
42329454|NCT02105012|76167497|FG000|Overall Study|Protocol Specified Criteria|9|||
42329455|NCT02105012|76167497|FG000|Overall Study|Lost to Follow-up|4|||
42329456|NCT02105012|76167497|FG000|Overall Study|Protocol Violation|4|||
42329457|NCT02105012|76167497|FG000|Overall Study|Physician Decision|3|||
42329458|NCT02105012|76167497|FG000|Overall Study|Adverse Event|1|||
42329459|NCT02105012|76167497|FG000|Overall Study|Lack of Efficacy|1|||
42329460|NCT02145182|76167511|FG000|Overall Study|Adverse Event|4|||
42329461|NCT02145182|76167512|FG001|Overall Study|Adverse Event|1|||
42329462|NCT02145182|76167511|FG000|Overall Study|Death|7|||
42329463|NCT02145182|76167512|FG001|Overall Study|Death|7|||
42329464|NCT02145182|76167511|FG000|Overall Study|Lost to Follow-up|2|||
42329465|NCT02145182|76167512|FG001|Overall Study|Lost to Follow-up|2|||
42329466|NCT02145182|76167511|FG000|Overall Study|Pre-transplant Withdrawal|0|||
42262692|NCT01972217|76090401|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
42329467|NCT02145182|76167512|FG001|Overall Study|Pre-transplant Withdrawal|2|||
42329468|NCT02145182|76167511|FG000|Overall Study|Withdrawal by Subject|5|||
42329469|NCT02145182|76167512|FG001|Overall Study|Withdrawal by Subject|4|||
42329470|NCT02145026|76167518|FG000|Overall Study|Adverse Event|2|||
42329471|NCT02145026|76167518|FG000|Overall Study|Death|4|||
42329472|NCT02145026|76167518|FG000|Overall Study|Withdrawal by Subject|2|||
42329473|NCT02145026|76167518|FG000|Overall Study|Physician Decision|4|||
42329474|NCT02144012|76167524|FG000|Overall Study|Adverse Event|1|||
42329475|NCT02144012|76167525|FG001|Overall Study|Adverse Event|0|||
42329476|NCT02144012|76167524|FG000|Overall Study|Death|1|||
42329477|NCT02144012|76167525|FG001|Overall Study|Death|0|||
42329478|NCT02144012|76167524|FG000|Overall Study|Withdrawal by Subject|11|||
42329479|NCT02144012|76167525|FG001|Overall Study|Withdrawal by Subject|3|||
42329480|NCT02144012|76167524|FG000|Overall Study|Study Terminated by Sponsor|18|||
42329481|NCT02144012|76167525|FG001|Overall Study|Study Terminated by Sponsor|12|||
42329482|NCT02144012|76167524|FG000|Overall Study|Other|3|||
42329483|NCT02144012|76167525|FG001|Overall Study|Other|0|||
42329484|NCT02103062|76167533|FG000|Overall Study|Adverse Event|1|||
42329485|NCT02103062|76167534|FG001|Overall Study|Adverse Event|2|||
42329486|NCT02103062|76167533|FG000|Overall Study|Progressive Disease|17|||
42329487|NCT02103062|76167534|FG001|Overall Study|Progressive Disease|20|||
42262693|NCT01918007|76090424|FG000|Overall Study|Baseline oximetry not acceptable|11|||
42262694|NCT01918007|76090425|FG001|Overall Study|Baseline oximetry not acceptable|7|||
42262695|NCT01918007|76090424|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
42262696|NCT01918007|76090425|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
42262697|NCT01918007|76090424|FG000|Overall Study|Lost to Follow-up|4|||
42262698|NCT01918007|76090425|FG001|Overall Study|Lost to Follow-up|7|||
42262699|NCT01863446|76090435|FG000|Overall Study|Withdrawal by Subject|1|||
42262700|NCT01863446|76090436|FG001|Overall Study|Withdrawal by Subject|0|||
42262701|NCT01863446|76090437|FG002|Overall Study|Withdrawal by Subject|1|||
42262702|NCT01863446|76090438|FG003|Overall Study|Withdrawal by Subject|2|||
42262703|NCT01863446|76090435|FG000|Overall Study|Physician Decision|0|||
42262704|NCT01863446|76090436|FG001|Overall Study|Physician Decision|0|||
42262705|NCT01863446|76090437|FG002|Overall Study|Physician Decision|1|||
41998055|NCT03418493|75806387|FG006|Overall Study|Protocol Violation|0|||
42262706|NCT01863446|76090438|FG003|Overall Study|Physician Decision|0|||
42262707|NCT01809691|76090450|FG000|Overall Study|Currently on Treatment|192|||
42329488|NCT02103062|76167533|FG000|Overall Study|Death|0|||
42329489|NCT02103062|76167534|FG001|Overall Study|Death|1|||
42329490|NCT02141984|76167542|FG000|Overall Study|Lack of Efficacy|2|||
42329491|NCT02141672|76167549|FG000|Overall Study|Adverse Event|0|||
42329492|NCT02141672|76167550|FG001|Overall Study|Adverse Event|1|||
42329493|NCT02141672|76167551|FG002|Overall Study|Adverse Event|0|||
42262708|NCT01809691|76090451|FG001|Overall Study|Currently on Treatment|100|||
42329494|NCT02141672|76167549|FG000|Overall Study|Death|10|||
42329495|NCT02141672|76167550|FG001|Overall Study|Death|2|||
42329496|NCT02141672|76167551|FG002|Overall Study|Death|1|||
42329497|NCT02141672|76167549|FG000|Overall Study|Lack of Efficacy|0|||
42329498|NCT02141672|76167550|FG001|Overall Study|Lack of Efficacy|0|||
42329499|NCT02141672|76167551|FG002|Overall Study|Lack of Efficacy|2|||
42329500|NCT02141672|76167549|FG000|Overall Study|Lost to Follow-up|1|||
42329501|NCT02141672|76167550|FG001|Overall Study|Lost to Follow-up|1|||
42329502|NCT02141672|76167551|FG002|Overall Study|Lost to Follow-up|3|||
42329503|NCT02141672|76167549|FG000|Overall Study|Physician Decision|1|||
42329504|NCT02141672|76167550|FG001|Overall Study|Physician Decision|2|||
42329505|NCT02141672|76167551|FG002|Overall Study|Physician Decision|5|||
42329506|NCT02141672|76167549|FG000|Overall Study|Protocol Violation|0|||
42329507|NCT02141672|76167550|FG001|Overall Study|Protocol Violation|0|||
42329508|NCT02141672|76167551|FG002|Overall Study|Protocol Violation|1|||
42329509|NCT02141672|76167549|FG000|Overall Study|Withdrawal by Subject|3|||
42329510|NCT02141672|76167550|FG001|Overall Study|Withdrawal by Subject|2|||
42329511|NCT02141672|76167551|FG002|Overall Study|Withdrawal by Subject|5|||
42329512|NCT02141672|76167549|FG000|Overall Study|refused to follow-up|1|||
42329513|NCT02141672|76167550|FG001|Overall Study|refused to follow-up|0|||
42329514|NCT02141672|76167551|FG002|Overall Study|refused to follow-up|1|||
42329515|NCT02141516|76167562|FG000|Overall Study|Adverse Event|0|||
42329516|NCT02141516|76167563|FG001|Overall Study|Adverse Event|1|||
42329517|NCT02141516|76167564|FG002|Overall Study|Adverse Event|0|||
42329518|NCT02141516|76167562|FG000|Overall Study|Lost to Follow-up|0|||
42329519|NCT02141516|76167563|FG001|Overall Study|Lost to Follow-up|1|||
42329520|NCT02141516|76167564|FG002|Overall Study|Lost to Follow-up|0|||
42329521|NCT02141516|76167562|FG000|Overall Study|Other|0|||
42329522|NCT02141516|76167563|FG001|Overall Study|Other|3|||
42329523|NCT02141516|76167564|FG002|Overall Study|Other|0|||
42329524|NCT02141360|76167578|FG000|Overall Study|Withdrawal by Subject|6|||
42329525|NCT02141360|76167579|FG001|Overall Study|Withdrawal by Subject|0|||
41998056|NCT03418493|75806388|FG007|Overall Study|Protocol Violation|0|||
41998057|NCT03418493|75806389|FG008|Overall Study|Protocol Violation|0|||
41998058|NCT03418493|75806390|FG009|Overall Study|Protocol Violation|1|||
41998059|NCT03418493|75806391|FG010|Overall Study|Protocol Violation|0|||
41998060|NCT03368664|75806424|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
42329526|NCT02141360|76167580|FG002|Overall Study|Withdrawal by Subject|0|||
42329527|NCT02141360|76167578|FG000|Overall Study|Study Terminated before Visit|1|||
42329528|NCT02141360|76167579|FG001|Overall Study|Study Terminated before Visit|0|||
42034565|NCT01120691|75842654|FG002|Overall Study|Adverse Event|47|||
42329529|NCT02141360|76167580|FG002|Overall Study|Study Terminated before Visit|0|||
42329530|NCT01628198|76167588|FG000|Overall Study|Lost to Follow-up|7|||
41998061|NCT03368664|75806424|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
42329531|NCT01628198|76167588|FG000|Overall Study|Withdrawal by Subject|10|||
42329532|NCT01628198|76167588|FG000|Overall Study|Screen failure|1|||
42329533|NCT01628120|76167592|FG000|Overall Study|Withdrawal by Subject|7|||
42329534|NCT01628120|76167592|FG000|Overall Study|Adverse Event|12|||
42329535|NCT01628120|76167592|FG000|Overall Study|Lost to Follow-up|1|||
42329536|NCT01628120|76167592|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
42329537|NCT01628120|76167592|FG000|Overall Study|Non-compliant with Study Procedures|1|||
42329538|NCT01628120|76167592|FG000|Overall Study|Not Treated|3|||
41998062|NCT03368664|75806424|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
41998063|NCT03368664|75806424|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
42329539|NCT01628120|76167592|FG000|Overall Study|Sponsor Decision|5|||
42329540|NCT01628120|76167592|FG000|Overall Study|Switched Dialysis Method|2|||
41998064|NCT03343054|75806435|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
41998065|NCT03343054|75806436|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
41998066|NCT03343054|75806437|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
41998067|NCT03343054|75806435|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
41998068|NCT03343054|75806436|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
41998069|NCT03343054|75806437|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
41998070|NCT03343054|75806435|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
41998071|NCT03343054|75806436|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
41998072|NCT03343054|75806437|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
41998073|NCT03343054|75806435|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
41998074|NCT03343054|75806436|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
41998075|NCT03343054|75806437|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
41998076|NCT03309878|75806475|FG000|Overall Study|Adverse Event|1|||
41998077|NCT03309878|75806476|FG001|Overall Study|Adverse Event|0|||
41998078|NCT03309878|75806477|FG002|Overall Study|Adverse Event|0|||
41998079|NCT03309878|75806478|FG003|Overall Study|Adverse Event|0|||
41998080|NCT03309878|75806475|FG000|Overall Study|Did not maintain eligibility|2|||
41998081|NCT03309878|75806476|FG001|Overall Study|Did not maintain eligibility|1|||
41998082|NCT03309878|75806477|FG002|Overall Study|Did not maintain eligibility|0|||
41998083|NCT03309878|75806478|FG003|Overall Study|Did not maintain eligibility|0|||
41998084|NCT03309878|75806475|FG000|Overall Study|Withdrawal by Subject|0|||
41998085|NCT03309878|75806476|FG001|Overall Study|Withdrawal by Subject|1|||
41998086|NCT03309878|75806477|FG002|Overall Study|Withdrawal by Subject|0|||
41998087|NCT03309878|75806478|FG003|Overall Study|Withdrawal by Subject|0|||
41998088|NCT03200704|75806496|FG000|Overall Study|Withdrawal by Subject|1|||
41998089|NCT03176472|75806502|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
41998090|NCT03176472|75806503|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
41998091|NCT03176472|75806502|FG000|Double Blind Treatment Period|Adverse Event|0|||
41998092|NCT03176472|75806503|FG001|Double Blind Treatment Period|Adverse Event|5|||
41998093|NCT03176472|75806502|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
41998094|NCT03176472|75806503|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
41998095|NCT03176472|75806502|FG000|Double Blind Treatment Period|Physician Decision|0|||
41998096|NCT03176472|75806503|FG001|Double Blind Treatment Period|Physician Decision|1|||
41998097|NCT03176472|75806502|FG000|Double Blind Treatment Period|Protocol Violation|1|||
42262709|NCT01809691|76090450|FG000|Overall Study|No Protocol Treatment|10|||
42262710|NCT01809691|76090451|FG001|Overall Study|No Protocol Treatment|11|||
42262711|NCT01809691|76090450|FG000|Overall Study|Adverse Event|80|||
42262712|NCT01809691|76090451|FG001|Overall Study|Adverse Event|21|||
42262713|NCT01809691|76090450|FG000|Overall Study|Disease Progression|226|||
42262714|NCT01809691|76090451|FG001|Overall Study|Disease Progression|372|||
42262715|NCT01809691|76090450|FG000|Overall Study|Death|26|||
42262716|NCT01809691|76090451|FG001|Overall Study|Death|13|||
42329541|NCT01628120|76167592|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
42329542|NCT01628120|76167592|FG000|Overall Study|Moved or Relocated|5|||
41998098|NCT03176472|75806503|FG001|Double Blind Treatment Period|Protocol Violation|0|||
41998099|NCT03176472|75806502|FG000|Double Blind Treatment Period|Not Provided|1|||
41998100|NCT03176472|75806503|FG001|Double Blind Treatment Period|Not Provided|0|||
41998101|NCT03176472|75806502|FG000|Open Label Extension|Withdrawal by Subject|3|||
42262717|NCT01809691|76090450|FG000|Overall Study|Participant Refusal|70|||
42262718|NCT01809691|76090451|FG001|Overall Study|Participant Refusal|72|||
42262719|NCT01809691|76090450|FG000|Overall Study|Other, Not Specified|34|||
42329543|NCT01628120|76167592|FG000|Overall Study|Kidney Transplant|2|||
42329544|NCT01628120|76167592|FG000|Overall Study|Use of Standard of Care|1|||
41998102|NCT03176472|75806503|FG001|Open Label Extension|Withdrawal by Subject|4|||
41998103|NCT03176472|75806502|FG000|Open Label Extension|Adverse Event|2|||
41998104|NCT03176472|75806503|FG001|Open Label Extension|Adverse Event|4|||
41998105|NCT03176472|75806502|FG000|Open Label Extension|Lost to Follow-up|1|||
41998106|NCT03176472|75806503|FG001|Open Label Extension|Lost to Follow-up|2|||
41998107|NCT03176472|75806502|FG000|Open Label Extension|Protocol Violation|0|||
41998108|NCT03176472|75806503|FG001|Open Label Extension|Protocol Violation|1|||
41998109|NCT03176472|75806502|FG000|Open Label Extension|Not Provided|2|||
41998110|NCT03176472|75806503|FG001|Open Label Extension|Not Provided|1|||
41998111|NCT04876599|75806554|FG000|Overall Study|Missed|2|||
41998112|NCT04876599|75806555|FG001|Overall Study|Missed|0|||
41998113|NCT04876599|75806554|FG000|Overall Study|Declined|2|||
41998114|NCT04876599|75806555|FG001|Overall Study|Declined|3|||
42329545|NCT01627340|76167598|FG000|Overall Study|Adverse Event|1|||
42329546|NCT01627340|76167599|FG001|Overall Study|Adverse Event|0|||
42329547|NCT01627340|76167598|FG000|Overall Study|Lost to Follow-up|8|||
42329548|NCT01627340|76167599|FG001|Overall Study|Lost to Follow-up|4|||
42329549|NCT01627340|76167598|FG000|Overall Study|Pregnancy|1|||
42329550|NCT01627340|76167599|FG001|Overall Study|Pregnancy|0|||
42329551|NCT01627340|76167598|FG000|Overall Study|Withdrawal by Subject|2|||
42329552|NCT01627340|76167599|FG001|Overall Study|Withdrawal by Subject|0|||
42329553|NCT02125838|76167609|FG000|Overall Study|Lost to Follow-up|4|||
42329554|NCT02125838|76167610|FG001|Overall Study|Lost to Follow-up|4|||
42329555|NCT02125604|76167616|FG000|Overall Study|Other|4|||
42329556|NCT02125604|76167616|FG000|Overall Study|Investigator Decision|1|||
42329557|NCT02125604|76167616|FG000|Overall Study|Lost to Follow-up|2|||
42329558|NCT02125604|76167616|FG000|Overall Study|Consent Withdrawn|4|||
42329559|NCT02125604|76167616|FG000|Overall Study|Adverse Event|20|||
42329560|NCT02124746|76167623|FG000|Overall Study|Adverse Event|2|||
42329561|NCT02124746|76167624|FG001|Overall Study|Adverse Event|1|||
42329562|NCT02124746|76167625|FG002|Overall Study|Adverse Event|2|||
42329563|NCT02124746|76167623|FG000|Overall Study|Death|2|||
42329564|NCT02124746|76167624|FG001|Overall Study|Death|1|||
42329565|NCT02124746|76167625|FG002|Overall Study|Death|3|||
42329566|NCT02124746|76167623|FG000|Overall Study|Lack of Efficacy|3|||
42329567|NCT02124746|76167624|FG001|Overall Study|Lack of Efficacy|2|||
42329568|NCT02124746|76167625|FG002|Overall Study|Lack of Efficacy|2|||
42329569|NCT02124746|76167623|FG000|Overall Study|Physician Decision|6|||
42329570|NCT02124746|76167624|FG001|Overall Study|Physician Decision|4|||
42329571|NCT02124746|76167625|FG002|Overall Study|Physician Decision|5|||
42329572|NCT02124746|76167623|FG000|Overall Study|Non-Compliance with Study Drug|0|||
41998115|NCT04730947|75806564|FG000|Overall Study|Withdrawal by Subject|0|||
41998116|NCT04730947|75806565|FG001|Overall Study|Withdrawal by Subject|1|||
41998117|NCT04660799|75806573|FG000|Overall Study|Progressive Disease|1|||
41998118|NCT04660799|75806574|FG001|Overall Study|Progressive Disease|1|||
41998119|NCT04660799|75806573|FG000|Overall Study|Death|2|||
42134113|NCT00373425|75945011|FG003|Overall Study|Relapse of NSCLC|2|||
41998120|NCT04660799|75806574|FG001|Overall Study|Death|1|||
42134114|NCT00373425|75945012|FG004|Overall Study|Relapse of NSCLC|26|||
42134115|NCT00373425|75945008|FG000|Overall Study|Adverse Event|191|||
42134116|NCT00373425|75945009|FG001|Overall Study|Adverse Event|22|||
42134117|NCT00373425|75945010|FG002|Overall Study|Adverse Event|59|||
42134118|NCT00373425|75945011|FG003|Overall Study|Adverse Event|0|||
42134119|NCT00373425|75945012|FG004|Overall Study|Adverse Event|34|||
42134120|NCT00373425|75945008|FG000|Overall Study|Patient request|35|||
42134121|NCT00373425|75945009|FG001|Overall Study|Patient request|18|||
42134122|NCT00373425|75945010|FG002|Overall Study|Patient request|43|||
42134123|NCT00373425|75945011|FG003|Overall Study|Patient request|6|||
42134124|NCT00373425|75945012|FG004|Overall Study|Patient request|7|||
42134125|NCT00373425|75945008|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
42134126|NCT00373425|75945009|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
42134127|NCT00373425|75945010|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
42134128|NCT00373425|75945011|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
42134129|NCT00373425|75945012|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
42134130|NCT00373425|75945008|FG000|Overall Study|Death|7|||
41998121|NCT04660799|75806573|FG000|Overall Study|Adverse Event|2|||
42134131|NCT00373425|75945009|FG001|Overall Study|Death|0|||
42134132|NCT00373425|75945010|FG002|Overall Study|Death|3|||
42134133|NCT00373425|75945011|FG003|Overall Study|Death|1|||
42134134|NCT00373425|75945012|FG004|Overall Study|Death|0|||
42134135|NCT00459342|75945021|FG000|Overall Study|Not eligible|1|||
42329573|NCT02124746|76167624|FG001|Overall Study|Non-Compliance with Study Drug|1|||
42329574|NCT02124746|76167625|FG002|Overall Study|Non-Compliance with Study Drug|0|||
42329575|NCT02124746|76167623|FG000|Overall Study|Withdrawal by Subject|3|||
42329576|NCT02124746|76167624|FG001|Overall Study|Withdrawal by Subject|3|||
42329577|NCT02124746|76167625|FG002|Overall Study|Withdrawal by Subject|0|||
42329578|NCT02124746|76167623|FG000|Overall Study|Study Terminated by Sponsor|0|||
42329579|NCT02124746|76167624|FG001|Overall Study|Study Terminated by Sponsor|0|||
42329580|NCT02124746|76167625|FG002|Overall Study|Study Terminated by Sponsor|6|||
42329581|NCT02124746|76167623|FG000|Overall Study|Disease Progression|3|||
42329582|NCT02124746|76167624|FG001|Overall Study|Disease Progression|6|||
42329583|NCT02124746|76167625|FG002|Overall Study|Disease Progression|4|||
42329584|NCT02123966|76167633|FG000|Overall Study|Intercurrent Illness|1|||
42329585|NCT02123576|76167639|FG000|Overall Study|Adverse Event|1|||
42329586|NCT02123576|76167640|FG001|Overall Study|Adverse Event|0|||
41998122|NCT04660799|75806574|FG001|Overall Study|Adverse Event|1|||
41998123|NCT04660799|75806573|FG000|Overall Study|Withdrawal by Subject|2|||
41998124|NCT04660799|75806574|FG001|Overall Study|Withdrawal by Subject|5|||
41998125|NCT04553471|75806589|FG000|Overall Study|Did not start treatment on protocol|3|||
41998126|NCT04553471|75806589|FG000|Overall Study|Death|1|||
41998127|NCT04484831|75806595|FG000|Overall Study|Withdrawal by Subject|1|||
42134136|NCT00443040|75945028|FG000|Overall Study|Withdrawal by Subject|1|||
42134137|NCT00443040|75945029|FG001|Overall Study|Withdrawal by Subject|0|||
42329587|NCT01177397|76167658|FG000|Overall Study|Protocol Violation|0|||
42329588|NCT01177397|76167659|FG001|Overall Study|Protocol Violation|0|||
42329589|NCT01177397|76167660|FG002|Overall Study|Protocol Violation|0|||
42329590|NCT01177397|76167661|FG003|Overall Study|Protocol Violation|0|||
42329591|NCT01177397|76167662|FG004|Overall Study|Protocol Violation|0|||
42329592|NCT01177397|76167663|FG005|Overall Study|Protocol Violation|1|||
42329593|NCT01177397|76167664|FG006|Overall Study|Protocol Violation|0|||
42329594|NCT01177397|76167665|FG007|Overall Study|Protocol Violation|0|||
42329595|NCT01177397|76167666|FG008|Overall Study|Protocol Violation|0|||
42329596|NCT01177397|76167667|FG009|Overall Study|Protocol Violation|0|||
42329597|NCT01177397|76167668|FG010|Overall Study|Protocol Violation|0|||
42329598|NCT01177397|76167669|FG011|Overall Study|Protocol Violation|0|||
42329599|NCT01177397|76167658|FG000|Overall Study|Lost to Follow-up|0|||
42329600|NCT01177397|76167659|FG001|Overall Study|Lost to Follow-up|0|||
42329601|NCT01177397|76167660|FG002|Overall Study|Lost to Follow-up|0|||
42329602|NCT01177397|76167661|FG003|Overall Study|Lost to Follow-up|0|||
42329603|NCT01177397|76167662|FG004|Overall Study|Lost to Follow-up|1|||
42329604|NCT01177397|76167663|FG005|Overall Study|Lost to Follow-up|0|||
42329605|NCT01177397|76167664|FG006|Overall Study|Lost to Follow-up|0|||
42329606|NCT01177397|76167665|FG007|Overall Study|Lost to Follow-up|2|||
42329607|NCT01177397|76167666|FG008|Overall Study|Lost to Follow-up|0|||
42329608|NCT01177397|76167667|FG009|Overall Study|Lost to Follow-up|0|||
42329609|NCT01177397|76167668|FG010|Overall Study|Lost to Follow-up|0|||
42329610|NCT01177397|76167669|FG011|Overall Study|Lost to Follow-up|0|||
42329611|NCT01177397|76167658|FG000|Overall Study|Death|0|||
42329612|NCT01177397|76167659|FG001|Overall Study|Death|0|||
42329613|NCT01177397|76167660|FG002|Overall Study|Death|1|||
42262720|NCT01809691|76090451|FG001|Overall Study|Other, Not Specified|52|||
42262721|NCT01772472|76090459|FG000|Overall Study|Death|56|||
42262722|NCT01772472|76090460|FG001|Overall Study|Death|42|||
42262723|NCT01772472|76090459|FG000|Overall Study|Physician Decision|1|||
42262724|NCT01772472|76090460|FG001|Overall Study|Physician Decision|3|||
42262725|NCT01772472|76090459|FG000|Overall Study|Other|5|||
42262726|NCT01772472|76090460|FG001|Overall Study|Other|5|||
42262727|NCT01772472|76090459|FG000|Overall Study|Lost to Follow-up|12|||
42262728|NCT01772472|76090460|FG001|Overall Study|Lost to Follow-up|8|||
42262729|NCT01772472|76090459|FG000|Overall Study|Withdrawal by Subject|72|||
42262730|NCT01772472|76090460|FG001|Overall Study|Withdrawal by Subject|50|||
42262731|NCT01772472|76090459|FG000|Overall Study|Ongoing|597|||
42262732|NCT01772472|76090460|FG001|Overall Study|Ongoing|635|||
42262733|NCT01532388|76090477|FG000|3-month Follow-up|Lost to Follow-up|68|||
42329614|NCT01177397|76167661|FG003|Overall Study|Death|1|||
42262734|NCT01532388|76090478|FG001|3-month Follow-up|Lost to Follow-up|68|||
42329615|NCT01177397|76167662|FG004|Overall Study|Death|0|||
42329616|NCT01177397|76167663|FG005|Overall Study|Death|0|||
42262735|NCT01532388|76090477|FG000|6-month Follow-up|Lost to Follow-up|74|||
42262736|NCT01532388|76090478|FG001|6-month Follow-up|Lost to Follow-up|66|||
42262737|NCT01532388|76090477|FG000|12-month Follow-up|Lost to Follow-up|69|||
42262738|NCT01532388|76090478|FG001|12-month Follow-up|Lost to Follow-up|67|||
42329617|NCT01177397|76167664|FG006|Overall Study|Death|0|||
42329618|NCT01177397|76167665|FG007|Overall Study|Death|5|||
42329619|NCT01177397|76167666|FG008|Overall Study|Death|2|||
42329620|NCT01177397|76167667|FG009|Overall Study|Death|1|||
42329621|NCT01177397|76167668|FG010|Overall Study|Death|0|||
42329622|NCT01177397|76167669|FG011|Overall Study|Death|0|||
42329623|NCT01177397|76167658|FG000|Overall Study|Withdrawal by Subject|0|||
42329624|NCT01177397|76167659|FG001|Overall Study|Withdrawal by Subject|0|||
42329625|NCT01177397|76167660|FG002|Overall Study|Withdrawal by Subject|1|||
42329626|NCT01177397|76167661|FG003|Overall Study|Withdrawal by Subject|1|||
42329627|NCT01177397|76167662|FG004|Overall Study|Withdrawal by Subject|1|||
42329628|NCT01177397|76167663|FG005|Overall Study|Withdrawal by Subject|2|||
42329629|NCT01177397|76167664|FG006|Overall Study|Withdrawal by Subject|0|||
42329630|NCT01177397|76167665|FG007|Overall Study|Withdrawal by Subject|5|||
42329631|NCT01177397|76167666|FG008|Overall Study|Withdrawal by Subject|9|||
42329632|NCT01177397|76167667|FG009|Overall Study|Withdrawal by Subject|1|||
42329633|NCT01177397|76167668|FG010|Overall Study|Withdrawal by Subject|1|||
42329634|NCT01177397|76167669|FG011|Overall Study|Withdrawal by Subject|0|||
42329635|NCT01177397|76167658|FG000|Overall Study|Adverse Event|0|||
41998128|NCT04484831|75806596|FG001|Overall Study|Withdrawal by Subject|0|||
41998129|NCT04063787|75806634|FG000|Overall Study|Inadequate Doppler data|4|||
41998130|NCT04063787|75806634|FG000|Overall Study|Lost to Follow-up|2|||
41998131|NCT04063787|75806634|FG000|Overall Study|Death|3|||
41998132|NCT03995316|75806648|FG000|Overall Study|Lost to Follow-up|10|||
41998133|NCT03995316|75806649|FG001|Overall Study|Lost to Follow-up|3|||
42329636|NCT01177397|76167659|FG001|Overall Study|Adverse Event|0|||
42329637|NCT01177397|76167660|FG002|Overall Study|Adverse Event|1|||
42329638|NCT01177397|76167661|FG003|Overall Study|Adverse Event|2|||
42329639|NCT01177397|76167662|FG004|Overall Study|Adverse Event|0|||
42329640|NCT01177397|76167663|FG005|Overall Study|Adverse Event|12|||
42329641|NCT01177397|76167664|FG006|Overall Study|Adverse Event|1|||
42329642|NCT01177397|76167665|FG007|Overall Study|Adverse Event|14|||
42329643|NCT01177397|76167666|FG008|Overall Study|Adverse Event|8|||
42329644|NCT01177397|76167667|FG009|Overall Study|Adverse Event|6|||
42329645|NCT01177397|76167668|FG010|Overall Study|Adverse Event|3|||
41998134|NCT03927690|75806658|FG000|Overall Study|Withdrawal by Subject|3|||
41998135|NCT03927690|75806659|FG001|Overall Study|Withdrawal by Subject|1|||
41998136|NCT03927690|75806660|FG002|Overall Study|Withdrawal by Subject|1|||
42329646|NCT01177397|76167669|FG011|Overall Study|Adverse Event|7|||
42329647|NCT01177397|76167658|FG000|Overall Study|Disease progression|1|||
42329648|NCT01177397|76167659|FG001|Overall Study|Disease progression|2|||
42329649|NCT01177397|76167660|FG002|Overall Study|Disease progression|5|||
42329650|NCT01177397|76167661|FG003|Overall Study|Disease progression|5|||
42329651|NCT01177397|76167662|FG004|Overall Study|Disease progression|4|||
42329652|NCT01177397|76167663|FG005|Overall Study|Disease progression|10|||
42329653|NCT01177397|76167664|FG006|Overall Study|Disease progression|10|||
42329654|NCT01177397|76167665|FG007|Overall Study|Disease progression|21|||
42329655|NCT01177397|76167666|FG008|Overall Study|Disease progression|18|||
42329656|NCT01177397|76167667|FG009|Overall Study|Disease progression|12|||
42329657|NCT01177397|76167668|FG010|Overall Study|Disease progression|10|||
42329658|NCT01177397|76167669|FG011|Overall Study|Disease progression|8|||
42329659|NCT01177397|76167658|FG000|Overall Study|Other reasons|0|||
42329660|NCT01177397|76167659|FG001|Overall Study|Other reasons|0|||
42329661|NCT01177397|76167660|FG002|Overall Study|Other reasons|1|||
42329662|NCT01177397|76167661|FG003|Overall Study|Other reasons|0|||
42329663|NCT01177397|76167662|FG004|Overall Study|Other reasons|1|||
42329664|NCT01177397|76167663|FG005|Overall Study|Other reasons|1|||
42329665|NCT01177397|76167664|FG006|Overall Study|Other reasons|2|||
42329666|NCT01177397|76167665|FG007|Overall Study|Other reasons|6|||
42329667|NCT01177397|76167666|FG008|Overall Study|Other reasons|10|||
42329668|NCT01177397|76167667|FG009|Overall Study|Other reasons|8|||
42329669|NCT01177397|76167668|FG010|Overall Study|Other reasons|0|||
42329670|NCT01177397|76167669|FG011|Overall Study|Other reasons|2|||
42329671|NCT00864227|76167710|FG000|Overall Study|Withdrawal by Subject|1|||
42329672|NCT00864227|76167710|FG000|Overall Study|Disease Relapse/Progression|3|||
42329673|NCT02102204|76167714|FG000|Overall Study|Withdrawal by Subject|137|||
42329674|NCT02102204|76167714|FG000|Overall Study|Death|92|||
42329675|NCT02102204|76167714|FG000|Overall Study|Lost to Follow-up|65|||
42329676|NCT02102204|76167714|FG000|Overall Study|Sponsor Decision|5|||
42329677|NCT02102204|76167714|FG000|Overall Study|Ongoing|5|||
42329678|NCT02141204|76167720|FG000|Overall Study|Lost to Follow-up|2|||
41998137|NCT03927690|75806658|FG000|Overall Study|Adverse Event|1|||
41998138|NCT03927690|75806659|FG001|Overall Study|Adverse Event|0|||
41998139|NCT03927690|75806660|FG002|Overall Study|Adverse Event|0|||
41998140|NCT03927690|75806658|FG000|Overall Study|Death|1|||
41998141|NCT03927690|75806659|FG001|Overall Study|Death|0|||
41998142|NCT03927690|75806660|FG002|Overall Study|Death|0|||
41998143|NCT03927690|75806658|FG000|Overall Study|Lost to Follow-up|2|||
42329679|NCT02141204|76167721|FG001|Overall Study|Lost to Follow-up|1|||
42329680|NCT02141204|76167720|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
42329681|NCT02141204|76167721|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
42329682|NCT02141204|76167720|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
42329683|NCT02141204|76167721|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
42329684|NCT02141204|76167720|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
42329685|NCT02141204|76167721|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
42329686|NCT02140970|76167729|FG000|Overall Study|Lost to Follow-up|1|||
42329687|NCT02140970|76167730|FG001|Overall Study|Lost to Follow-up|2|||
42329688|NCT02140970|76167729|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
42329689|NCT02140970|76167730|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
42329690|NCT02140970|76167729|FG000|Overall Study|Did not meet inclusion criteria|0|||
41998144|NCT03927690|75806659|FG001|Overall Study|Lost to Follow-up|2|||
42329691|NCT02140970|76167730|FG001|Overall Study|Did not meet inclusion criteria|1|||
42329692|NCT02101112|76167736|FG000|Overall Study|Adverse Event|0|||
42329693|NCT02101112|76167737|FG001|Overall Study|Adverse Event|0|||
42329694|NCT02101112|76167738|FG002|Overall Study|Adverse Event|1|||
42329695|NCT02101112|76167739|FG003|Overall Study|Adverse Event|0|||
42329696|NCT02101112|76167740|FG004|Overall Study|Adverse Event|0|||
42329697|NCT02101112|76167741|FG005|Overall Study|Adverse Event|0|||
42329698|NCT02101112|76167736|FG000|Overall Study|Withdrawal by Subject|0|||
42329699|NCT02101112|76167737|FG001|Overall Study|Withdrawal by Subject|0|||
41998145|NCT03927690|75806660|FG002|Overall Study|Lost to Follow-up|1|||
41998146|NCT03793842|75806672|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
41998147|NCT03793842|75806673|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
42329700|NCT02101112|76167738|FG002|Overall Study|Withdrawal by Subject|0|||
42329701|NCT02101112|76167739|FG003|Overall Study|Withdrawal by Subject|0|||
42329702|NCT02101112|76167740|FG004|Overall Study|Withdrawal by Subject|1|||
42329703|NCT02101112|76167741|FG005|Overall Study|Withdrawal by Subject|0|||
42329704|NCT02139644|76167756|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
42329705|NCT02139644|76167757|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42329706|NCT02139644|76167758|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42329707|NCT02139644|76167759|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42329708|NCT02139644|76167760|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42329709|NCT02139644|76167761|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
41998148|NCT03793842|75806672|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
42329710|NCT02139644|76167756|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
42329711|NCT02139644|76167757|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42329712|NCT02139644|76167758|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42329713|NCT02139644|76167759|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42329714|NCT02139644|76167760|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42329715|NCT02139644|76167761|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42329716|NCT02139644|76167756|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
42329717|NCT02139644|76167757|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42329718|NCT02139644|76167758|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42329719|NCT02139644|76167759|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42329720|NCT02139644|76167760|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42329721|NCT02139644|76167761|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42329722|NCT02139644|76167756|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
42329723|NCT02139644|76167757|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42329724|NCT02139644|76167758|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
41998149|NCT03793842|75806673|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
41998150|NCT03555695|75806683|FG000|Overall Study|Withdrawal by Subject|1|||
41998151|NCT03555695|75806683|FG000|Overall Study|Lost to Follow-up|1|||
41998152|NCT03555695|75806683|FG000|Overall Study|appendicitis (unrelated)|1|||
42329725|NCT02139644|76167759|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42329726|NCT02139644|76167760|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42329727|NCT02139644|76167761|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
41998153|NCT03555695|75806683|FG000|Overall Study|pre-existing sciatica|1|||
41998154|NCT03538691|75806687|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
41998155|NCT03538691|75806688|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
41998156|NCT03538691|75806689|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
41998157|NCT03538691|75806690|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
41998158|NCT03538691|75806687|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
41998159|NCT03538691|75806688|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
41998160|NCT03538691|75806689|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
42262739|NCT01106534|76090493|FG000|Overall Study|Withdrawal by Subject|18|||
42262740|NCT01106534|76090493|FG000|Overall Study|Lost to Follow-up|2|||
42262741|NCT01106534|76090493|FG000|Overall Study|Death|16|||
42262742|NCT01106534|76090493|FG000|Overall Study|Physician Decision|1|||
41998161|NCT03538691|75806690|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
41998162|NCT03538691|75806687|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
41998163|NCT03538691|75806688|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
41998164|NCT03538691|75806689|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
41998165|NCT03538691|75806690|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
41998166|NCT03538691|75806687|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
42262743|NCT00961064|76090498|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
42262744|NCT00961064|76090498|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
42262745|NCT00961064|76090498|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
42262746|NCT00961064|76090498|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
42262747|NCT00961064|76090498|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
42329728|NCT02139644|76167756|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
42329729|NCT02139644|76167757|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42329730|NCT02139644|76167758|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42329731|NCT02139644|76167759|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42329732|NCT02139644|76167760|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42329733|NCT02139644|76167761|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42262748|NCT00961064|76090498|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
42262749|NCT00961064|76090498|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
42262750|NCT00961064|76090498|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
42262751|NCT00321555|76090510|FG000|Overall Study|Developed antibodies|1|||
42262752|NCT00321555|76090510|FG000|Overall Study|Switched to alternative treatment|3|||
42262753|NCT00321555|76090510|FG000|Overall Study|Physician Decision|1|||
42262754|NCT00321555|76090510|FG000|Overall Study|Disease progression on study|1|||
42262755|NCT00099437|76090533|FG000|Overall Study|Lost to Follow-up|30|||
42262756|NCT00099437|76090534|FG001|Overall Study|Lost to Follow-up|33|||
42262757|NCT00099437|76090533|FG000|Overall Study|Death|293|||
42262758|NCT00099437|76090534|FG001|Overall Study|Death|261|||
42262759|NCT00099437|76090533|FG000|Overall Study|Withdrawal by Subject|6|||
42262760|NCT00099437|76090534|FG001|Overall Study|Withdrawal by Subject|10|||
42329734|NCT02139644|76167756|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
42329735|NCT02139644|76167757|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
41998167|NCT03538691|75806688|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
42034566|NCT01120691|75842652|FG000|Overall Study|Subject withdrew consent|33|||
42034567|NCT01120691|75842653|FG001|Overall Study|Subject withdrew consent|50|||
42034568|NCT01120691|75842654|FG002|Overall Study|Subject withdrew consent|44|||
42262761|NCT00099437|76090533|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
42262762|NCT00099437|76090534|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
42262763|NCT02689453|76090549|FG000|Overall Study|Progressive disease|0|||
42262764|NCT02689453|76090550|FG001|Overall Study|Progressive disease|1|||
42262765|NCT02689453|76090551|FG002|Overall Study|Progressive disease|1|||
42329736|NCT02139644|76167758|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
42262766|NCT00701103|76090586|FG000|Overall Study|Adverse Event|0|||
42262767|NCT00701103|76090587|FG001|Overall Study|Adverse Event|0|||
42262768|NCT00701103|76090588|FG002|Overall Study|Adverse Event|1|||
41998168|NCT03538691|75806689|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
41998169|NCT03538691|75806690|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
41998170|NCT03538691|75806687|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
41998171|NCT03538691|75806688|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
41998172|NCT03538691|75806689|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
42262769|NCT00701103|76090589|FG003|Overall Study|Adverse Event|1|||
41998173|NCT03538691|75806690|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
42262770|NCT00701103|76090590|FG004|Overall Study|Adverse Event|0|||
42262771|NCT00701103|76090591|FG005|Overall Study|Adverse Event|1|||
42262772|NCT00701103|76090592|FG006|Overall Study|Adverse Event|1|||
42262773|NCT00701103|76090593|FG007|Overall Study|Adverse Event|0|||
42262774|NCT00701103|76090594|FG008|Overall Study|Adverse Event|0|||
42262775|NCT00701103|76090595|FG009|Overall Study|Adverse Event|2|||
42262776|NCT00701103|76090596|FG010|Overall Study|Adverse Event|0|||
42262777|NCT00701103|76090586|FG000|Overall Study|Progressive Disease|5|||
42262778|NCT00701103|76090587|FG001|Overall Study|Progressive Disease|2|||
42262779|NCT00701103|76090588|FG002|Overall Study|Progressive Disease|6|||
42262780|NCT00701103|76090589|FG003|Overall Study|Progressive Disease|5|||
42262781|NCT00701103|76090590|FG004|Overall Study|Progressive Disease|6|||
42262782|NCT00701103|76090591|FG005|Overall Study|Progressive Disease|5|||
42262783|NCT00701103|76090592|FG006|Overall Study|Progressive Disease|7|||
42262784|NCT00701103|76090593|FG007|Overall Study|Progressive Disease|7|||
42262785|NCT00701103|76090594|FG008|Overall Study|Progressive Disease|8|||
42262786|NCT00701103|76090595|FG009|Overall Study|Progressive Disease|8|||
42262787|NCT00701103|76090596|FG010|Overall Study|Progressive Disease|11|||
42262788|NCT00701103|76090586|FG000|Overall Study|Withdrawal by Subject|0|||
42262789|NCT00701103|76090587|FG001|Overall Study|Withdrawal by Subject|1|||
42262790|NCT00701103|76090588|FG002|Overall Study|Withdrawal by Subject|1|||
42262791|NCT00701103|76090589|FG003|Overall Study|Withdrawal by Subject|0|||
42262792|NCT00701103|76090590|FG004|Overall Study|Withdrawal by Subject|0|||
42262793|NCT00701103|76090591|FG005|Overall Study|Withdrawal by Subject|0|||
42262794|NCT00701103|76090592|FG006|Overall Study|Withdrawal by Subject|0|||
42262795|NCT00701103|76090593|FG007|Overall Study|Withdrawal by Subject|0|||
42262796|NCT00701103|76090594|FG008|Overall Study|Withdrawal by Subject|0|||
42262797|NCT00701103|76090595|FG009|Overall Study|Withdrawal by Subject|0|||
42262798|NCT00701103|76090596|FG010|Overall Study|Withdrawal by Subject|0|||
42262799|NCT00701103|76090586|FG000|Overall Study|Other|0|||
42262800|NCT00701103|76090587|FG001|Overall Study|Other|0|||
42329737|NCT02139644|76167759|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
42329738|NCT02139644|76167760|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
42329739|NCT02139644|76167761|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
42329740|NCT02139644|76167756|FG000|Run-In Period (Pre-assignment)|Other|6|||
42329741|NCT02139644|76167757|FG001|Run-In Period (Pre-assignment)|Other|0|||
42329742|NCT02139644|76167758|FG002|Run-In Period (Pre-assignment)|Other|0|||
42329743|NCT02139644|76167759|FG003|Run-In Period (Pre-assignment)|Other|0|||
42329744|NCT02139644|76167760|FG004|Run-In Period (Pre-assignment)|Other|0|||
42329745|NCT02139644|76167761|FG005|Run-In Period (Pre-assignment)|Other|0|||
42329746|NCT02139644|76167756|FG000|Treatment Period|Adverse Event|0|||
42329747|NCT02139644|76167757|FG001|Treatment Period|Adverse Event|0|||
42329748|NCT02139644|76167758|FG002|Treatment Period|Adverse Event|3|||
42329749|NCT02139644|76167759|FG003|Treatment Period|Adverse Event|2|||
42329750|NCT02139644|76167760|FG004|Treatment Period|Adverse Event|1|||
42329751|NCT02139644|76167761|FG005|Treatment Period|Adverse Event|6|||
42329752|NCT02139644|76167756|FG000|Treatment Period|Withdrawal by Subject|0|||
42329753|NCT02139644|76167757|FG001|Treatment Period|Withdrawal by Subject|0|||
42329754|NCT02139644|76167758|FG002|Treatment Period|Withdrawal by Subject|2|||
42329755|NCT02139644|76167759|FG003|Treatment Period|Withdrawal by Subject|2|||
42329756|NCT02139644|76167760|FG004|Treatment Period|Withdrawal by Subject|3|||
42329757|NCT02139644|76167761|FG005|Treatment Period|Withdrawal by Subject|2|||
42329758|NCT02139644|76167756|FG000|Treatment Period|Non-compliance|0|||
42329759|NCT02139644|76167757|FG001|Treatment Period|Non-compliance|0|||
42329760|NCT02139644|76167758|FG002|Treatment Period|Non-compliance|0|||
42329761|NCT02139644|76167759|FG003|Treatment Period|Non-compliance|1|||
42329762|NCT02139644|76167760|FG004|Treatment Period|Non-compliance|0|||
42329763|NCT02139644|76167761|FG005|Treatment Period|Non-compliance|0|||
42329764|NCT02139644|76167756|FG000|Treatment Period|Protocol Violation|0|||
42329765|NCT02139644|76167757|FG001|Treatment Period|Protocol Violation|0|||
42329766|NCT02139644|76167758|FG002|Treatment Period|Protocol Violation|0|||
42329767|NCT02139644|76167759|FG003|Treatment Period|Protocol Violation|1|||
42329768|NCT02139644|76167760|FG004|Treatment Period|Protocol Violation|1|||
42329769|NCT02139644|76167761|FG005|Treatment Period|Protocol Violation|1|||
42329770|NCT02139644|76167756|FG000|Treatment Period|Disease progression|0|||
42329771|NCT02139644|76167757|FG001|Treatment Period|Disease progression|0|||
42329772|NCT02139644|76167758|FG002|Treatment Period|Disease progression|0|||
42329773|NCT02139644|76167759|FG003|Treatment Period|Disease progression|1|||
42329774|NCT02139644|76167760|FG004|Treatment Period|Disease progression|1|||
42329775|NCT02139644|76167761|FG005|Treatment Period|Disease progression|2|||
42329776|NCT02139644|76167756|FG000|Treatment Period|Lost to Follow-up|0|||
42329777|NCT02139644|76167757|FG001|Treatment Period|Lost to Follow-up|0|||
42329778|NCT02139644|76167758|FG002|Treatment Period|Lost to Follow-up|1|||
42329779|NCT02139644|76167759|FG003|Treatment Period|Lost to Follow-up|1|||
42329780|NCT02139644|76167760|FG004|Treatment Period|Lost to Follow-up|1|||
42329781|NCT02139644|76167761|FG005|Treatment Period|Lost to Follow-up|1|||
42329782|NCT02139644|76167756|FG000|Treatment Period|Lack of Efficacy|0|||
42329783|NCT02139644|76167757|FG001|Treatment Period|Lack of Efficacy|0|||
42329784|NCT02139644|76167758|FG002|Treatment Period|Lack of Efficacy|1|||
42329785|NCT02139644|76167759|FG003|Treatment Period|Lack of Efficacy|0|||
42329786|NCT02139644|76167760|FG004|Treatment Period|Lack of Efficacy|1|||
42329787|NCT02139644|76167761|FG005|Treatment Period|Lack of Efficacy|4|||
42329788|NCT02139644|76167756|FG000|Treatment Period|Other|0|||
42329789|NCT02139644|76167757|FG001|Treatment Period|Other|3|||
42329790|NCT02139644|76167758|FG002|Treatment Period|Other|1|||
42329791|NCT02139644|76167759|FG003|Treatment Period|Other|1|||
42329792|NCT02139644|76167760|FG004|Treatment Period|Other|0|||
42329793|NCT02139644|76167761|FG005|Treatment Period|Other|1|||
42329794|NCT02100644|76167773|FG000|LTG Escalation Phase|Adverse Event|9|||
41998174|NCT03538691|75806687|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
41998175|NCT03538691|75806688|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
42329795|NCT02100644|76167774|FG001|LTG Escalation Phase|Adverse Event|0|||
42329796|NCT02100644|76167775|FG002|LTG Escalation Phase|Adverse Event|0|||
42329797|NCT02100644|76167773|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
42329798|NCT02100644|76167774|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
42329799|NCT02100644|76167775|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
42329800|NCT02100644|76167773|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
42329801|NCT02100644|76167774|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
42329802|NCT02100644|76167775|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
42329803|NCT02074982|76167781|FG000|Overall Study|Adverse Event|15|||
42329804|NCT02074982|76167782|FG001|Overall Study|Adverse Event|7|||
42329805|NCT02074982|76167781|FG000|Overall Study|Lack of Efficacy|6|||
42329806|NCT02074982|76167782|FG001|Overall Study|Lack of Efficacy|1|||
42329807|NCT02074982|76167781|FG000|Overall Study|Lost to Follow-up|9|||
42329808|NCT02074982|76167782|FG001|Overall Study|Lost to Follow-up|10|||
41998176|NCT03538691|75806689|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
42329809|NCT02074982|76167781|FG000|Overall Study|Non-compliance with study treatment|0|||
42329810|NCT02074982|76167782|FG001|Overall Study|Non-compliance with study treatment|2|||
42329811|NCT02074982|76167781|FG000|Overall Study|Physician Decision|1|||
42329812|NCT02074982|76167782|FG001|Overall Study|Physician Decision|1|||
42329813|NCT02074982|76167781|FG000|Overall Study|Pregnancy|1|||
42329814|NCT02074982|76167782|FG001|Overall Study|Pregnancy|2|||
42329815|NCT02074982|76167781|FG000|Overall Study|Protocol deviation|4|||
42329816|NCT02074982|76167782|FG001|Overall Study|Protocol deviation|3|||
42329817|NCT02074982|76167781|FG000|Overall Study|Technical problems|0|||
42329818|NCT02074982|76167782|FG001|Overall Study|Technical problems|2|||
42329819|NCT02074982|76167781|FG000|Overall Study|Subject/guardian decision|15|||
42329820|NCT02074982|76167782|FG001|Overall Study|Subject/guardian decision|24|||
42329821|NCT02074982|76167781|FG000|Overall Study|Death|0|||
42329822|NCT02074982|76167782|FG001|Overall Study|Death|2|||
42329823|NCT02074514|76167792|FG000|Overall Study|Lack of Efficacy|3|||
42329824|NCT02074514|76167793|FG001|Overall Study|Lack of Efficacy|2|||
42329825|NCT02074514|76167792|FG000|Overall Study|Lost to Follow-up|0|||
42329826|NCT02074514|76167793|FG001|Overall Study|Lost to Follow-up|1|||
42329827|NCT02074514|76167792|FG000|Overall Study|Withdrew Consent|0|||
42329828|NCT02074514|76167793|FG001|Overall Study|Withdrew Consent|1|||
42329829|NCT02099708|76167803|FG000|Overall Study|Data Not Available|30|||
42329830|NCT02099708|76167803|FG000|Overall Study|Lost to Follow-up|141|||
42329831|NCT02099708|76167803|FG000|Overall Study|Other|29|||
42329832|NCT02073656|76167807|FG000|Primary Study|Lost to Follow-up|6|||
42329833|NCT02073656|76167807|FG000|Primary Study|Death|1|||
42329834|NCT02073656|76167807|FG000|Primary Study|Withdrew Consent|1|||
42329835|NCT02242643|76167815|FG000|Overall Study|Protocol Violation|1|||
42329836|NCT02242643|76167816|FG001|Overall Study|Protocol Violation|2|||
42329837|NCT02242643|76167815|FG000|Overall Study|Withdrawal by Subject|15|||
42329838|NCT02242643|76167816|FG001|Overall Study|Withdrawal by Subject|10|||
42329839|NCT02242643|76167815|FG000|Overall Study|Migrated/moved from study area|1|||
42329840|NCT02242643|76167816|FG001|Overall Study|Migrated/moved from study area|3|||
42329841|NCT02242643|76167815|FG000|Overall Study|Lost to Follow-up|54|||
42329842|NCT02242643|76167816|FG001|Overall Study|Lost to Follow-up|61|||
42329843|NCT02242643|76167815|FG000|Overall Study|Child placed in foster care by family|0|||
42329844|NCT02242643|76167816|FG001|Overall Study|Child placed in foster care by family|1|||
42329845|NCT02242643|76167815|FG000|Overall Study|Non-compliance|1|||
42329846|NCT02242643|76167816|FG001|Overall Study|Non-compliance|0|||
42329847|NCT02242643|76167815|FG000|Overall Study|Consent withdrawal by parent|1|||
42329848|NCT02242643|76167816|FG001|Overall Study|Consent withdrawal by parent|0|||
42329849|NCT02242643|76167815|FG000|Overall Study|Protocol requirements not followed|1|||
42329850|NCT02242643|76167816|FG001|Overall Study|Protocol requirements not followed|0|||
42329851|NCT02242643|76167815|FG000|Overall Study|Language barrier|1|||
42329852|NCT02242643|76167816|FG001|Overall Study|Language barrier|0|||
41998177|NCT03538691|75806690|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
42329853|NCT02242643|76167815|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
42329854|NCT02242643|76167816|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
42329855|NCT02097290|76167824|FG000|Overall Study|Death|6|||
42329856|NCT02097290|76167824|FG000|Overall Study|Total Withdrawals|3|||
42329857|NCT02097290|76167824|FG000|Overall Study|Attempt|8|||
42329858|NCT02072174|76167830|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
42329859|NCT02072174|76167831|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
42329860|NCT02072174|76167830|FG000|Overall Study|Protocol Violation|16|||
42329861|NCT02072174|76167831|FG001|Overall Study|Protocol Violation|23|||
42329862|NCT02072174|76167830|FG000|Overall Study|Physician Decision|0|||
42329863|NCT02072174|76167831|FG001|Overall Study|Physician Decision|1|||
42329864|NCT02072174|76167830|FG000|Overall Study|Non-compliance with protocol requirement|2|||
42329865|NCT02072174|76167831|FG001|Overall Study|Non-compliance with protocol requirement|0|||
42329866|NCT02209181|76167843|FG000|Overall Study|Adverse Event|1|||
42329867|NCT02209181|76167844|FG001|Overall Study|Adverse Event|0|||
42329868|NCT02209181|76167845|FG002|Overall Study|Adverse Event|1|||
42329869|NCT02209181|76167846|FG003|Overall Study|Adverse Event|0|||
42329870|NCT02209181|76167843|FG000|Overall Study|Withdrawal by Subject|0|||
42329871|NCT02209181|76167844|FG001|Overall Study|Withdrawal by Subject|1|||
42329872|NCT02209181|76167845|FG002|Overall Study|Withdrawal by Subject|0|||
42329873|NCT02209181|76167846|FG003|Overall Study|Withdrawal by Subject|0|||
42329874|NCT02208089|76167858|FG000|Overall Study|Withdrawal by Subject|1|||
42329875|NCT02208089|76167859|FG001|Overall Study|Withdrawal by Subject|0|||
42329876|NCT02208089|76167858|FG000|Overall Study|Lost to Follow-up|6|||
42329877|NCT02208089|76167859|FG001|Overall Study|Lost to Follow-up|0|||
42329878|NCT02242487|76167868|FG000|Overall Study|Adverse Event|13|||
42329879|NCT02242487|76167869|FG001|Overall Study|Adverse Event|15|||
42329880|NCT02242487|76167868|FG000|Overall Study|Lack of Efficacy|4|||
42329881|NCT02242487|76167869|FG001|Overall Study|Lack of Efficacy|6|||
42329882|NCT02242487|76167868|FG000|Overall Study|Protocol Violation|2|||
42329883|NCT02242487|76167869|FG001|Overall Study|Protocol Violation|0|||
42329884|NCT02242487|76167868|FG000|Overall Study|Lost to Follow-up|2|||
42329885|NCT02242487|76167869|FG001|Overall Study|Lost to Follow-up|1|||
42329886|NCT02242487|76167868|FG000|Overall Study|Other - Miscellaneous|4|||
42329887|NCT02242487|76167869|FG001|Overall Study|Other - Miscellaneous|6|||
42329888|NCT02242487|76167868|FG000|Overall Study|Withdrawal by Subject|37|||
42329889|NCT02242487|76167869|FG001|Overall Study|Withdrawal by Subject|19|||
42329890|NCT02241785|76167877|FG000|Overall Study|Sponsor Termination|43|||
42329891|NCT02241785|76167877|FG000|Overall Study|Withdrawal by Subject|1|||
42329892|NCT02241785|76167877|FG000|Overall Study|Lost to Follow-up|2|||
42329893|NCT02241785|76167877|FG000|Overall Study|Adverse Event|1|||
42329894|NCT02241551|76167883|FG000|Overall Study|Adverse Event|1|||
42329895|NCT02241551|76167884|FG001|Overall Study|Adverse Event|0|||
42329896|NCT02207621|76167895|FG000|Overall Study|Adverse Event|71|||
42329897|NCT02207621|76167896|FG001|Overall Study|Adverse Event|15|||
42329898|NCT02207621|76167897|FG002|Overall Study|Adverse Event|132|||
42329899|NCT02207621|76167895|FG000|Overall Study|Withdrawal by Subject|9|||
42329900|NCT02207621|76167896|FG001|Overall Study|Withdrawal by Subject|9|||
42329901|NCT02207621|76167897|FG002|Overall Study|Withdrawal by Subject|13|||
42329902|NCT02207621|76167895|FG000|Overall Study|Non-Compliant|3|||
42329903|NCT02207621|76167896|FG001|Overall Study|Non-Compliant|3|||
42329904|NCT02207621|76167897|FG002|Overall Study|Non-Compliant|1|||
42329905|NCT02207621|76167895|FG000|Overall Study|Lost to Follow-up|1|||
42329906|NCT02207621|76167896|FG001|Overall Study|Lost to Follow-up|0|||
42329907|NCT02207621|76167897|FG002|Overall Study|Lost to Follow-up|3|||
42329908|NCT02207621|76167895|FG000|Overall Study|Lack of Efficacy|10|||
42329909|NCT02207621|76167896|FG001|Overall Study|Lack of Efficacy|2|||
42329910|NCT02207621|76167897|FG002|Overall Study|Lack of Efficacy|4|||
42329911|NCT02207621|76167895|FG000|Overall Study|Disallowed Concurrent Medication|2|||
42329912|NCT02207621|76167896|FG001|Overall Study|Disallowed Concurrent Medication|5|||
42329913|NCT02207621|76167897|FG002|Overall Study|Disallowed Concurrent Medication|2|||
42329914|NCT02207621|76167895|FG000|Overall Study|Physician Decision|1|||
42329915|NCT02207621|76167896|FG001|Overall Study|Physician Decision|2|||
42329916|NCT02207621|76167897|FG002|Overall Study|Physician Decision|2|||
42262801|NCT00701103|76090588|FG002|Overall Study|Other|0|||
42262802|NCT00701103|76090589|FG003|Overall Study|Other|0|||
42262803|NCT00701103|76090590|FG004|Overall Study|Other|0|||
42262804|NCT00701103|76090591|FG005|Overall Study|Other|0|||
42262805|NCT00701103|76090592|FG006|Overall Study|Other|0|||
42262806|NCT00701103|76090593|FG007|Overall Study|Other|0|||
42262807|NCT00701103|76090594|FG008|Overall Study|Other|1|||
42262808|NCT00701103|76090595|FG009|Overall Study|Other|1|||
42262809|NCT00701103|76090596|FG010|Overall Study|Other|0|||
42262810|NCT01369225|76090630|FG000|Overall Study|Withdrawal by Subject|1|||
42329917|NCT02207621|76167895|FG000|Overall Study|Protocol Violation|4|||
42329918|NCT02207621|76167896|FG001|Overall Study|Protocol Violation|10|||
42329919|NCT02207621|76167897|FG002|Overall Study|Protocol Violation|6|||
42329920|NCT02207621|76167895|FG000|Overall Study|Death|2|||
42329921|NCT02207621|76167896|FG001|Overall Study|Death|0|||
42262811|NCT01369225|76090631|FG001|Overall Study|Withdrawal by Subject|0|||
42262812|NCT01369225|76090632|FG002|Overall Study|Withdrawal by Subject|2|||
42329922|NCT02207621|76167897|FG002|Overall Study|Death|0|||
42329923|NCT02207621|76167895|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
42329924|NCT02207621|76167896|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
42329925|NCT02207621|76167897|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
42329926|NCT02240693|76167911|FG000|Overall Study|Adverse Event|0|||
42329927|NCT02240693|76167912|FG001|Overall Study|Adverse Event|0|||
42329928|NCT02240693|76167913|FG002|Overall Study|Adverse Event|0|||
42329929|NCT02240693|76167914|FG003|Overall Study|Adverse Event|0|||
42329930|NCT02240693|76167915|FG004|Overall Study|Adverse Event|1|||
42329931|NCT02240693|76167911|FG000|Overall Study|Withdrawal by Subject|0|||
42329932|NCT02240693|76167912|FG001|Overall Study|Withdrawal by Subject|0|||
42329933|NCT02240693|76167913|FG002|Overall Study|Withdrawal by Subject|2|||
42329934|NCT02240693|76167914|FG003|Overall Study|Withdrawal by Subject|1|||
42329935|NCT02240693|76167915|FG004|Overall Study|Withdrawal by Subject|0|||
42329936|NCT02240693|76167911|FG000|Overall Study|Other than specified|0|||
42329937|NCT02240693|76167912|FG001|Overall Study|Other than specified|0|||
42329938|NCT02240693|76167913|FG002|Overall Study|Other than specified|2|||
42329939|NCT02240693|76167914|FG003|Overall Study|Other than specified|0|||
42329940|NCT02240693|76167915|FG004|Overall Study|Other than specified|0|||
42329941|NCT02239679|76167932|FG000|Overall Study|Lost to Follow-up|1|||
42329942|NCT02239679|76167933|FG001|Overall Study|Lost to Follow-up|0|||
42329943|NCT02239679|76167934|FG002|Overall Study|Lost to Follow-up|0|||
42329944|NCT02239679|76167932|FG000|Overall Study|Withdrawal by Subject|2|||
42329945|NCT02239679|76167933|FG001|Overall Study|Withdrawal by Subject|3|||
42329946|NCT02239679|76167934|FG002|Overall Study|Withdrawal by Subject|1|||
42329947|NCT02072096|76167944|FG000|Overall Study|Lack of Efficacy|18|||
42329948|NCT02072096|76167945|FG001|Overall Study|Lack of Efficacy|29|||
42329949|NCT02072096|76167944|FG000|Overall Study|Protocol Violation|7|||
42329950|NCT02072096|76167945|FG001|Overall Study|Protocol Violation|7|||
42329951|NCT02072096|76167944|FG000|Overall Study|Withdrawal by Subject|5|||
42329952|NCT02072096|76167945|FG001|Overall Study|Withdrawal by Subject|7|||
42329953|NCT02072096|76167944|FG000|Overall Study|Adverse Event|5|||
42329954|NCT02072096|76167945|FG001|Overall Study|Adverse Event|2|||
42329955|NCT02072096|76167944|FG000|Overall Study|No Reason Provided|4|||
42329956|NCT02072096|76167945|FG001|Overall Study|No Reason Provided|2|||
42329957|NCT02072096|76167944|FG000|Overall Study|Death|2|||
42329958|NCT02072096|76167945|FG001|Overall Study|Death|0|||
42329959|NCT02072096|76167944|FG000|Overall Study|Physician Decision|0|||
42329960|NCT02072096|76167945|FG001|Overall Study|Physician Decision|1|||
42329961|NCT02072096|76167944|FG000|Overall Study|Study Terminated by Sponsor|43|||
42329962|NCT02072096|76167945|FG001|Overall Study|Study Terminated by Sponsor|30|||
42329963|NCT02072096|76167944|FG000|Overall Study|Lost to Follow-up|1|||
42329964|NCT02072096|76167945|FG001|Overall Study|Lost to Follow-up|0|||
42329965|NCT02071706|76167952|FG000|Overall Study|Adverse Event|1|||
42329966|NCT02071706|76167952|FG000|Overall Study|Withdrawal by Subject|2|||
42329967|NCT01631825|76167956|FG000|Overall Study|Adverse Event|42|||
42329968|NCT01631825|76167956|FG000|Overall Study|Lack of Efficacy|7|||
42329969|NCT01631825|76167956|FG000|Overall Study|Withdrawal by Subject|9|||
42329970|NCT01631825|76167956|FG000|Overall Study|Protocol Violation|4|||
42329971|NCT01631825|76167956|FG000|Overall Study|Discontinuation criteria|1|||
42329972|NCT01631825|76167956|FG000|Overall Study|Physician Decision|2|||
42329973|NCT02071082|76167962|FG000|Overall Study|Enrolled and Never Treated|1|||
42329974|NCT02071082|76167963|FG001|Overall Study|Enrolled and Never Treated|1|||
42329975|NCT02071082|76167962|FG000|Overall Study|Adverse Event|0|||
42329976|NCT02071082|76167963|FG001|Overall Study|Adverse Event|1|||
42329977|NCT02071082|76167962|FG000|Overall Study|Withdrew Consent|0|||
42329978|NCT02071082|76167963|FG001|Overall Study|Withdrew Consent|4|||
42329979|NCT02071082|76167962|FG000|Overall Study|Lost to Follow-up|1|||
42329980|NCT02071082|76167963|FG001|Overall Study|Lost to Follow-up|1|||
42329981|NCT02123108|76167971|FG000|Overall Study|Death|2|||
42329982|NCT02123108|76167972|FG001|Overall Study|Death|3|||
42329983|NCT02121392|76167980|FG000|Prior to Intervention|Protocol Violation|40|||
42329984|NCT02121392|76167981|FG001|Prior to Intervention|Protocol Violation|35|||
42329985|NCT02121392|76167980|FG000|Prior to Intervention|Withdrawal by Subject|8|||
42134138|NCT00443040|75945030|FG002|Overall Study|Withdrawal by Subject|0|||
42329986|NCT02121392|76167981|FG001|Prior to Intervention|Withdrawal by Subject|6|||
42329987|NCT02121392|76167980|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
42329988|NCT02121392|76167981|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
42329989|NCT02121392|76167980|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
42329990|NCT02121392|76167981|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
42329991|NCT02097056|76167987|FG000|Overall Study|Protocol Violation|2|||
42329992|NCT02097056|76167987|FG000|Overall Study|Withdrawal by Subject|15|||
42329993|NCT02097056|76167987|FG000|Overall Study|Lost to Follow-up|2|||
42329994|NCT02097056|76167987|FG000|Overall Study|Adverse Event|37|||
42134139|NCT00443040|75945028|FG000|Overall Study|Converted to an open laparotomy|3|||
42329995|NCT02097056|76167987|FG000|Overall Study|Other|2|||
42329996|NCT02121002|76167994|FG000|Overall Study|Physician Decision|2|||
42329997|NCT02121002|76167995|FG001|Overall Study|Physician Decision|0|||
42329998|NCT02121002|76167996|FG002|Overall Study|Physician Decision|0|||
42329999|NCT02121002|76167994|FG000|Overall Study|Withdrawal by Subject|3|||
42330000|NCT02121002|76167995|FG001|Overall Study|Withdrawal by Subject|1|||
42330001|NCT02121002|76167996|FG002|Overall Study|Withdrawal by Subject|4|||
42330002|NCT02121002|76167994|FG000|Overall Study|Protocol Violation|1|||
42330003|NCT02121002|76167995|FG001|Overall Study|Protocol Violation|2|||
42330004|NCT02121002|76167996|FG002|Overall Study|Protocol Violation|4|||
42330005|NCT02121002|76167994|FG000|Overall Study|Concomitant therapy|0|||
42330006|NCT02121002|76167995|FG001|Overall Study|Concomitant therapy|1|||
42330007|NCT02121002|76167996|FG002|Overall Study|Concomitant therapy|1|||
42330008|NCT02121002|76167994|FG000|Overall Study|Others|1|||
42330009|NCT02121002|76167995|FG001|Overall Study|Others|0|||
42330010|NCT02121002|76167996|FG002|Overall Study|Others|1|||
42330011|NCT02096900|76168006|FG000|Overall Study|Did not receive medication|3|||
42330012|NCT02096900|76168007|FG001|Overall Study|Did not receive medication|1|||
42330013|NCT02096900|76168006|FG000|Overall Study|Surgery cancelled- medication received|1|||
42330014|NCT02096900|76168007|FG001|Overall Study|Surgery cancelled- medication received|1|||
42330015|NCT02120924|76168016|FG000|Overall Study|Lack of Efficacy|1|||
42330016|NCT02120924|76168017|FG001|Overall Study|Lack of Efficacy|2|||
42330017|NCT02120924|76168018|FG002|Overall Study|Lack of Efficacy|3|||
42330018|NCT02120924|76168016|FG000|Overall Study|Adverse Event|0|||
42330019|NCT02120924|76168017|FG001|Overall Study|Adverse Event|1|||
42330020|NCT02120924|76168018|FG002|Overall Study|Adverse Event|3|||
42330021|NCT02120924|76168016|FG000|Overall Study|Withdrawal by Subject|16|||
42330022|NCT02120924|76168017|FG001|Overall Study|Withdrawal by Subject|20|||
42330023|NCT02120924|76168018|FG002|Overall Study|Withdrawal by Subject|8|||
42330024|NCT02120924|76168016|FG000|Overall Study|Lost to Follow-up|14|||
42330025|NCT02120924|76168017|FG001|Overall Study|Lost to Follow-up|14|||
42330026|NCT02120924|76168018|FG002|Overall Study|Lost to Follow-up|11|||
42330027|NCT02120924|76168016|FG000|Overall Study|Pregnancy|2|||
42330028|NCT02120924|76168017|FG001|Overall Study|Pregnancy|0|||
42330029|NCT02120924|76168018|FG002|Overall Study|Pregnancy|0|||
42330030|NCT02120924|76168016|FG000|Overall Study|Protocol Violation|3|||
42330031|NCT02120924|76168017|FG001|Overall Study|Protocol Violation|7|||
42330032|NCT02120924|76168018|FG002|Overall Study|Protocol Violation|2|||
42330033|NCT02120924|76168016|FG000|Overall Study|Physician Decision|0|||
42330034|NCT02120924|76168017|FG001|Overall Study|Physician Decision|1|||
42330035|NCT02120924|76168018|FG002|Overall Study|Physician Decision|1|||
42330036|NCT02120924|76168016|FG000|Overall Study|Death|1|||
42330037|NCT02120924|76168017|FG001|Overall Study|Death|0|||
42330038|NCT02120924|76168018|FG002|Overall Study|Death|0|||
42330039|NCT02120924|76168016|FG000|Overall Study|Compliance with IP|5|||
42330040|NCT02120924|76168017|FG001|Overall Study|Compliance with IP|1|||
42330041|NCT02120924|76168018|FG002|Overall Study|Compliance with IP|1|||
42330042|NCT02096744|76168027|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
42330043|NCT02096744|76168028|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
42134140|NCT00443040|75945029|FG001|Overall Study|Converted to an open laparotomy|0|||
42134141|NCT00443040|75945030|FG002|Overall Study|Converted to an open laparotomy|1|||
42134142|NCT00442962|75945038|FG000|Overall Study|Pregnancy|1|||
42134143|NCT00442962|75945038|FG000|Overall Study|Lost to Follow-up|7|||
42134144|NCT00313300|75945047|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
42134145|NCT00313300|75945048|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
42134146|NCT00313300|75945049|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
42134147|NCT00313300|75945050|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
42134148|NCT00313300|75945051|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
42134149|NCT00313300|75945047|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
42134150|NCT00313300|75945048|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
42134151|NCT00313300|75945049|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
42134152|NCT00313300|75945050|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
42134153|NCT00313300|75945051|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
42134154|NCT00313300|75945047|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
42262813|NCT01369225|76090633|FG003|Overall Study|Withdrawal by Subject|1|||
42262814|NCT01369225|76090634|FG004|Overall Study|Withdrawal by Subject|0|||
42262815|NCT01369225|76090635|FG005|Overall Study|Withdrawal by Subject|0|||
42262816|NCT01369225|76090630|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
42262817|NCT01369225|76090631|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
42262818|NCT01369225|76090632|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
42262819|NCT01369225|76090633|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
42262820|NCT01369225|76090634|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
42330044|NCT02096744|76168027|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
42330045|NCT02096744|76168028|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
42330046|NCT02096744|76168027|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
42330047|NCT02096744|76168028|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
42330048|NCT02120456|76168045|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
42330049|NCT02120456|76168046|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
42330050|NCT02120456|76168047|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
42330051|NCT02120456|76168048|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
42330052|NCT02120456|76168049|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
42330053|NCT02120456|76168050|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
42330054|NCT02120456|76168051|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
42330055|NCT02120456|76168052|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
42330056|NCT02120456|76168053|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
42330057|NCT02120456|76168045|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
42330058|NCT02120456|76168046|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
42330059|NCT02120456|76168047|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
42330060|NCT02120456|76168048|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
42330061|NCT02120456|76168049|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
42330062|NCT02120456|76168050|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
42330063|NCT02120456|76168051|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
42330064|NCT02120456|76168052|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
42330065|NCT02120456|76168053|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
42330066|NCT02120456|76168045|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
42330067|NCT02120456|76168046|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
42330068|NCT02120456|76168047|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
42330069|NCT02120456|76168048|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
42330070|NCT02120456|76168049|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
42330071|NCT02120456|76168050|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
42330072|NCT02120456|76168051|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
42330073|NCT02120456|76168052|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
42330074|NCT02120456|76168053|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
42330075|NCT02120300|76168077|FG000|Overall Study|Enrolled but Never Treated|2|||
42330076|NCT02120300|76168078|FG001|Overall Study|Enrolled but Never Treated|0|||
42330077|NCT02120300|76168079|FG002|Overall Study|Enrolled but Never Treated|0|||
42330078|NCT02120300|76168080|FG003|Overall Study|Enrolled but Never Treated|0|||
42330079|NCT02120300|76168077|FG000|Overall Study|Lack of Efficacy|0|||
42330080|NCT02120300|76168078|FG001|Overall Study|Lack of Efficacy|0|||
42330081|NCT02120300|76168079|FG002|Overall Study|Lack of Efficacy|0|||
42330082|NCT02120300|76168080|FG003|Overall Study|Lack of Efficacy|1|||
42330083|NCT02120300|76168077|FG000|Overall Study|Lost to Follow-up|1|||
42330084|NCT02120300|76168078|FG001|Overall Study|Lost to Follow-up|0|||
42330085|NCT02120300|76168079|FG002|Overall Study|Lost to Follow-up|0|||
42330086|NCT02120300|76168080|FG003|Overall Study|Lost to Follow-up|0|||
42330087|NCT02070380|76168096|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
42330088|NCT02070380|76168097|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
42330089|NCT02070380|76168098|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
42330090|NCT02070380|76168099|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
42330091|NCT02070380|76168096|FG000|Second Injection|Image sets missing or technically inadeq|0|||
42330092|NCT02070380|76168097|FG001|Second Injection|Image sets missing or technically inadeq|1|||
42330093|NCT02070380|76168098|FG002|Second Injection|Image sets missing or technically inadeq|0|||
42330094|NCT02070380|76168099|FG003|Second Injection|Image sets missing or technically inadeq|0|||
42330095|NCT02070380|76168096|FG000|Second Injection|Protocol Violation|0|||
42330096|NCT02070380|76168097|FG001|Second Injection|Protocol Violation|1|||
42330097|NCT02070380|76168098|FG002|Second Injection|Protocol Violation|1|||
42330098|NCT02070380|76168099|FG003|Second Injection|Protocol Violation|5|||
42330099|NCT02069366|76168117|FG000|Overall Study|Lost to Follow-up|0|||
42330100|NCT02069366|76168118|FG001|Overall Study|Lost to Follow-up|0|||
42330101|NCT02069366|76168119|FG002|Overall Study|Lost to Follow-up|1|||
42330102|NCT02069366|76168120|FG003|Overall Study|Lost to Follow-up|0|||
42134155|NCT00313300|75945048|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
42134156|NCT00313300|75945049|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
42262821|NCT01369225|76090635|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
42262822|NCT01369225|76090630|FG000|Overall Study|Other|1|||
42262823|NCT01369225|76090631|FG001|Overall Study|Other|0|||
42262824|NCT01369225|76090632|FG002|Overall Study|Other|0|||
42262825|NCT01369225|76090633|FG003|Overall Study|Other|0|||
42262826|NCT01369225|76090634|FG004|Overall Study|Other|1|||
42262827|NCT01369225|76090635|FG005|Overall Study|Other|0|||
42330103|NCT02069366|76168121|FG004|Overall Study|Lost to Follow-up|0|||
42330104|NCT02069366|76168122|FG005|Overall Study|Lost to Follow-up|2|||
42330105|NCT02069366|76168117|FG000|Overall Study|Protocol Violation|0|||
42330106|NCT02069366|76168118|FG001|Overall Study|Protocol Violation|0|||
42330107|NCT02069366|76168119|FG002|Overall Study|Protocol Violation|1|||
42330108|NCT02069366|76168120|FG003|Overall Study|Protocol Violation|0|||
42262828|NCT01369225|76090630|FG000|Overall Study|Adverse Event|0|||
42330109|NCT02069366|76168121|FG004|Overall Study|Protocol Violation|0|||
42262829|NCT01369225|76090631|FG001|Overall Study|Adverse Event|0|||
42262830|NCT01369225|76090632|FG002|Overall Study|Adverse Event|0|||
42330110|NCT02069366|76168122|FG005|Overall Study|Protocol Violation|0|||
42330111|NCT02069366|76168117|FG000|Overall Study|Withdrawal by Subject|1|||
42330112|NCT02069366|76168118|FG001|Overall Study|Withdrawal by Subject|0|||
42330113|NCT02069366|76168119|FG002|Overall Study|Withdrawal by Subject|1|||
42330114|NCT02069366|76168120|FG003|Overall Study|Withdrawal by Subject|2|||
42330115|NCT02069366|76168121|FG004|Overall Study|Withdrawal by Subject|0|||
42330116|NCT02069366|76168122|FG005|Overall Study|Withdrawal by Subject|0|||
42330117|NCT02068508|76168137|FG000|Overall Study|Case report forms uncollected|27|||
42330118|NCT02068508|76168137|FG000|Overall Study|Patient did not visit the study site|1|||
42330119|NCT02068508|76168137|FG000|Overall Study|Protocol Violation|4|||
42330120|NCT02068352|76168144|FG000|Overall Study|Lost to Follow-up|0|||
42330121|NCT02068352|76168145|FG001|Overall Study|Lost to Follow-up|2|||
42330122|NCT02068352|76168146|FG002|Overall Study|Lost to Follow-up|0|||
42330123|NCT02068352|76168144|FG000|Overall Study|Adverse Event|4|||
42330124|NCT02068352|76168145|FG001|Overall Study|Adverse Event|2|||
42330125|NCT02068352|76168146|FG002|Overall Study|Adverse Event|7|||
42330126|NCT02068352|76168144|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
42330127|NCT02068352|76168145|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
42330128|NCT02068352|76168146|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
42330129|NCT02068352|76168144|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
42330130|NCT02068352|76168145|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
42330131|NCT02068352|76168146|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
42330132|NCT02068352|76168144|FG000|Overall Study|Protocol Deviation|0|||
42330133|NCT02068352|76168145|FG001|Overall Study|Protocol Deviation|0|||
42330134|NCT02068352|76168146|FG002|Overall Study|Protocol Deviation|1|||
42330135|NCT02207231|76168157|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
42330136|NCT02207231|76168158|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
42330137|NCT02207231|76168159|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
42330138|NCT02207231|76168160|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
42330139|NCT02207231|76168157|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
42330140|NCT02207231|76168158|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
42330141|NCT02207231|76168159|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
42330142|NCT02207231|76168160|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
42330143|NCT02207231|76168157|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
42330144|NCT02207231|76168158|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
42330145|NCT02207231|76168159|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
42330146|NCT02207231|76168160|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
42330147|NCT02207231|76168157|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
42134157|NCT00313300|75945050|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
42134158|NCT00313300|75945051|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
42134159|NCT00313300|75945047|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
42134160|NCT00313300|75945048|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
42134161|NCT00313300|75945049|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
42134162|NCT00313300|75945050|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
42134163|NCT00313300|75945051|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
42134164|NCT00313300|75945047|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
42262831|NCT01369225|76090633|FG003|Overall Study|Adverse Event|1|||
42262832|NCT01369225|76090634|FG004|Overall Study|Adverse Event|1|||
42262833|NCT01369225|76090635|FG005|Overall Study|Adverse Event|0|||
42262834|NCT02639546|76090657|FG000|Overall Study|Death|2|||
42262835|NCT02639546|76090658|FG001|Overall Study|Death|2|||
42262836|NCT02639546|76090659|FG002|Overall Study|Death|1|||
42262837|NCT02639546|76090660|FG003|Overall Study|Death|2|||
42262838|NCT02639546|76090661|FG004|Overall Study|Death|2|||
42134165|NCT00313300|75945048|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
42134166|NCT00313300|75945049|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
42134167|NCT00313300|75945050|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
42134168|NCT00313300|75945051|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
42134169|NCT00313300|75945047|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
42134170|NCT00313300|75945048|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
42262839|NCT02639546|76090662|FG005|Overall Study|Death|2|||
42262840|NCT02639546|76090663|FG006|Overall Study|Death|0|||
42262841|NCT02639546|76090664|FG007|Overall Study|Death|0|||
42330148|NCT02207231|76168158|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
42330149|NCT02207231|76168159|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
42330150|NCT02207231|76168160|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
42262842|NCT02639546|76090657|FG000|Overall Study|Lost to Follow-up|0|||
42262843|NCT02639546|76090658|FG001|Overall Study|Lost to Follow-up|0|||
42262844|NCT02639546|76090659|FG002|Overall Study|Lost to Follow-up|1|||
42262845|NCT02639546|76090660|FG003|Overall Study|Lost to Follow-up|0|||
42262846|NCT02639546|76090661|FG004|Overall Study|Lost to Follow-up|1|||
42262847|NCT02639546|76090662|FG005|Overall Study|Lost to Follow-up|1|||
42262848|NCT02639546|76090663|FG006|Overall Study|Lost to Follow-up|0|||
42262849|NCT02639546|76090664|FG007|Overall Study|Lost to Follow-up|1|||
42330151|NCT02207231|76168157|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
42330152|NCT02207231|76168158|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
42330153|NCT02207231|76168159|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
42330154|NCT02207231|76168160|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
42330155|NCT02207231|76168157|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
42330156|NCT02207231|76168158|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
42330157|NCT02207231|76168159|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
42330158|NCT02207231|76168160|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
42330159|NCT02207231|76168157|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
42330160|NCT02207231|76168158|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
42330161|NCT02207231|76168159|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
42330162|NCT02207231|76168160|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
42330163|NCT02207231|76168157|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
42330164|NCT02207231|76168158|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
42330165|NCT02207231|76168159|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
42330166|NCT02207231|76168160|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
42330167|NCT02207231|76168157|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
42262850|NCT02639546|76090657|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
42262851|NCT02639546|76090658|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
42262852|NCT02639546|76090659|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
42262853|NCT02639546|76090660|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
42262854|NCT02639546|76090661|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
42262855|NCT02639546|76090662|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
42262856|NCT02639546|76090663|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
42262857|NCT02639546|76090664|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
42262858|NCT02639546|76090657|FG000|Overall Study|Study Terminated By Sponsor|0|||
42330168|NCT02207231|76168158|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
42330169|NCT02207231|76168159|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
42330170|NCT02207231|76168160|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
42330171|NCT02207231|76168157|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
42330172|NCT02207231|76168158|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
42330173|NCT02207231|76168159|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
42330174|NCT02207231|76168160|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
42330175|NCT02207231|76168157|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
42330176|NCT02207231|76168158|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
42330177|NCT02207231|76168159|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
42330178|NCT02207231|76168160|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
42330179|NCT02207231|76168157|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
42330180|NCT02207231|76168158|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
42330181|NCT02207231|76168159|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
42330182|NCT02207231|76168160|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
42330183|NCT02207231|76168157|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
42330184|NCT02207231|76168158|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
42330185|NCT02207231|76168159|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
42330186|NCT02207231|76168160|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
42330187|NCT02207231|76168157|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
42330188|NCT02207231|76168158|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
42330189|NCT02207231|76168159|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
42330190|NCT02207231|76168160|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
42330191|NCT02207231|76168157|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
42330192|NCT02207231|76168158|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
42330193|NCT02207231|76168159|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
42330194|NCT02207231|76168160|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
42262859|NCT02639546|76090658|FG001|Overall Study|Study Terminated By Sponsor|2|||
42262860|NCT02639546|76090659|FG002|Overall Study|Study Terminated By Sponsor|3|||
42262861|NCT02639546|76090660|FG003|Overall Study|Study Terminated By Sponsor|4|||
42262862|NCT02639546|76090661|FG004|Overall Study|Study Terminated By Sponsor|4|||
42262863|NCT02639546|76090662|FG005|Overall Study|Study Terminated By Sponsor|3|||
42262864|NCT02639546|76090663|FG006|Overall Study|Study Terminated By Sponsor|3|||
42262865|NCT02639546|76090664|FG007|Overall Study|Study Terminated By Sponsor|9|||
42262866|NCT02639546|76090657|FG000|Overall Study|Withdrawal by Subject|2|||
42262867|NCT02639546|76090658|FG001|Overall Study|Withdrawal by Subject|2|||
42262868|NCT02639546|76090659|FG002|Overall Study|Withdrawal by Subject|1|||
42262869|NCT02639546|76090660|FG003|Overall Study|Withdrawal by Subject|0|||
42262870|NCT02639546|76090661|FG004|Overall Study|Withdrawal by Subject|0|||
42262871|NCT02639546|76090662|FG005|Overall Study|Withdrawal by Subject|1|||
42262872|NCT02639546|76090663|FG006|Overall Study|Withdrawal by Subject|2|||
42262873|NCT02639546|76090664|FG007|Overall Study|Withdrawal by Subject|1|||
42262874|NCT02639390|76090698|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
42262875|NCT02639390|76090699|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
42262876|NCT02718417|76090708|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
42262877|NCT02718417|76090709|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
42330195|NCT02207231|76168157|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
42330196|NCT02207231|76168158|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
42330197|NCT02207231|76168159|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
42262878|NCT02718417|76090710|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
42330198|NCT02207231|76168160|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
42330199|NCT02207231|76168157|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
42262879|NCT02718417|76090708|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
42262880|NCT02718417|76090709|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
42262881|NCT02718417|76090710|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
42262882|NCT02718417|76090708|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
42262883|NCT02718417|76090709|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
42262884|NCT02718417|76090710|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
42262885|NCT02718417|76090708|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
42262886|NCT02718417|76090709|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
42330200|NCT02207231|76168158|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
42330201|NCT02207231|76168159|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
42330202|NCT02207231|76168160|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
42330203|NCT02207231|76168157|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
42330204|NCT02207231|76168158|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
42330205|NCT02207231|76168159|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
42330206|NCT02207231|76168160|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
42330207|NCT02207231|76168157|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
42330208|NCT02207231|76168158|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
42330209|NCT02207231|76168159|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
42330210|NCT02207231|76168160|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
42330211|NCT02207231|76168157|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
42330212|NCT02207231|76168158|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
42330213|NCT02207231|76168159|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
42330214|NCT02207231|76168160|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
42330215|NCT02207231|76168157|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
42330216|NCT02207231|76168158|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
42330217|NCT02207231|76168159|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
42330218|NCT02207231|76168160|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
42330219|NCT02239601|76168180|FG000|Overall Study|Withdrawal by Subject|3|||
42330220|NCT02239601|76168181|FG001|Overall Study|Withdrawal by Subject|4|||
42330221|NCT02239601|76168180|FG000|Overall Study|Protocol Violation|4|||
42330222|NCT02239601|76168181|FG001|Overall Study|Protocol Violation|2|||
42330223|NCT02236559|76168194|FG000|Overall Study|Met Exclusion|3|||
42330224|NCT02236559|76168195|FG001|Overall Study|Met Exclusion|6|||
42330225|NCT02236559|76168194|FG000|Overall Study|Did not Meet Inclusion|3|||
42330226|NCT02236559|76168195|FG001|Overall Study|Did not Meet Inclusion|3|||
42330227|NCT02236559|76168194|FG000|Overall Study|Subject Did Not Consent|4|||
42330228|NCT02236559|76168195|FG001|Overall Study|Subject Did Not Consent|2|||
42330229|NCT02236559|76168194|FG000|Overall Study|Physician Decision|1|||
42330230|NCT02236559|76168195|FG001|Overall Study|Physician Decision|1|||
42330231|NCT02236559|76168194|FG000|Overall Study|Withdrawal by Subject|1|||
42330232|NCT02236559|76168195|FG001|Overall Study|Withdrawal by Subject|0|||
42330233|NCT02206685|76168203|FG000|Overall Study|Surgery cancelled/changed|2|||
42330234|NCT02206685|76168204|FG001|Overall Study|Surgery cancelled/changed|3|||
42330235|NCT02206685|76168203|FG000|Overall Study|Withdrawal by Subject|1|||
42330236|NCT02206685|76168204|FG001|Overall Study|Withdrawal by Subject|2|||
42330237|NCT02206685|76168203|FG000|Overall Study|Protocol Violation|2|||
42330238|NCT02206685|76168204|FG001|Overall Study|Protocol Violation|2|||
42330239|NCT02206607|76168210|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
42330240|NCT02206607|76168211|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
42330241|NCT02206607|76168212|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
42330242|NCT02206607|76168213|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
42330243|NCT02206607|76168214|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
42330244|NCT02206607|76168210|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
42330245|NCT02206607|76168211|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
42330246|NCT02206607|76168212|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
42330247|NCT02206607|76168213|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
42330248|NCT02206607|76168214|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
42330249|NCT02119676|76168234|FG000|Overall Study|Adverse Event|9|||
42330250|NCT02119676|76168235|FG001|Overall Study|Adverse Event|17|||
42330251|NCT02119676|76168236|FG002|Overall Study|Adverse Event|10|||
42330252|NCT02119676|76168237|FG003|Overall Study|Adverse Event|10|||
42330253|NCT02119676|76168234|FG000|Overall Study|Disease progression|53|||
42330254|NCT02119676|76168235|FG001|Overall Study|Disease progression|55|||
42330255|NCT02119676|76168236|FG002|Overall Study|Disease progression|68|||
42330256|NCT02119676|76168237|FG003|Overall Study|Disease progression|73|||
42330257|NCT02119676|76168234|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
42330258|NCT02119676|76168235|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
42330259|NCT02119676|76168236|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
42330260|NCT02119676|76168237|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
42330261|NCT02119676|76168234|FG000|Overall Study|Physician Decision|4|||
42330262|NCT02119676|76168235|FG001|Overall Study|Physician Decision|2|||
42330263|NCT02119676|76168236|FG002|Overall Study|Physician Decision|3|||
42330264|NCT02119676|76168237|FG003|Overall Study|Physician Decision|2|||
42330265|NCT02119676|76168234|FG000|Overall Study|Death|9|||
42330266|NCT02119676|76168235|FG001|Overall Study|Death|3|||
42330267|NCT02119676|76168236|FG002|Overall Study|Death|2|||
42330268|NCT02119676|76168237|FG003|Overall Study|Death|1|||
42330269|NCT02119676|76168234|FG000|Overall Study|Noncompliance|0|||
42330270|NCT02119676|76168235|FG001|Overall Study|Noncompliance|1|||
42330271|NCT02119676|76168236|FG002|Overall Study|Noncompliance|0|||
42330272|NCT02119676|76168237|FG003|Overall Study|Noncompliance|0|||
42330273|NCT02119676|76168234|FG000|Overall Study|Lost to Follow-up|0|||
42330274|NCT02119676|76168235|FG001|Overall Study|Lost to Follow-up|0|||
42330275|NCT02119676|76168236|FG002|Overall Study|Lost to Follow-up|1|||
42330276|NCT02119676|76168237|FG003|Overall Study|Lost to Follow-up|0|||
42330277|NCT02119676|76168234|FG000|Overall Study|Protocol deviation|0|||
42330278|NCT02119676|76168235|FG001|Overall Study|Protocol deviation|0|||
42330279|NCT02119676|76168236|FG002|Overall Study|Protocol deviation|1|||
42330280|NCT02119676|76168237|FG003|Overall Study|Protocol deviation|0|||
42330281|NCT02119676|76168234|FG000|Overall Study|Other, unspecified|2|||
42330282|NCT02119676|76168235|FG001|Overall Study|Other, unspecified|1|||
42330283|NCT02119676|76168236|FG002|Overall Study|Other, unspecified|3|||
42330284|NCT02119676|76168237|FG003|Overall Study|Other, unspecified|4|||
42330285|NCT02119676|76168234|FG000|Overall Study|Did not receive study med|2|||
42330286|NCT02119676|76168235|FG001|Overall Study|Did not receive study med|2|||
42330287|NCT02119676|76168236|FG002|Overall Study|Did not receive study med|4|||
42330288|NCT02119676|76168237|FG003|Overall Study|Did not receive study med|5|||
42330289|NCT02206061|76168250|FG000|Overall Study|Withdrawal by Subject|4|||
42330290|NCT02206061|76168251|FG001|Overall Study|Withdrawal by Subject|7|||
42330291|NCT02206061|76168252|FG002|Overall Study|Withdrawal by Subject|1|||
42330292|NCT02206061|76168250|FG000|Overall Study|Lost to Follow-up|14|||
42330293|NCT02206061|76168251|FG001|Overall Study|Lost to Follow-up|7|||
42330294|NCT02206061|76168252|FG002|Overall Study|Lost to Follow-up|20|||
42330295|NCT02095106|76168262|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
42330296|NCT02095106|76168263|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
42330297|NCT01631747|76168275|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
42330298|NCT01631747|76168276|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
42134171|NCT00313300|75945049|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
42134172|NCT00313300|75945050|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
42134173|NCT00313300|75945051|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
42262887|NCT02718417|76090710|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
42262888|NCT02718417|76090708|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
42262889|NCT02718417|76090709|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
42262890|NCT02718417|76090710|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
42262891|NCT02718417|76090708|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
42262892|NCT02718417|76090709|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
42262893|NCT02718417|76090710|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
42262894|NCT02718417|76090708|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
42262895|NCT02718417|76090709|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
42262896|NCT02718417|76090710|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
42262897|NCT02718417|76090708|FG000|Chemotherapy Phase (CP)|Other|2|||
42262898|NCT02718417|76090709|FG001|Chemotherapy Phase (CP)|Other|0|||
42262899|NCT02718417|76090710|FG002|Chemotherapy Phase (CP)|Other|1|||
42262900|NCT02718417|76090708|FG000|Maintenance Phase (MP)|Adverse Event|21|||
42262901|NCT02718417|76090709|FG001|Maintenance Phase (MP)|Adverse Event|26|||
42262902|NCT02718417|76090710|FG002|Maintenance Phase (MP)|Adverse Event|0|||
42262903|NCT02718417|76090708|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
42262904|NCT02718417|76090709|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
42262905|NCT02718417|76090710|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
42262906|NCT02718417|76090708|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
42262907|NCT02718417|76090709|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
42262908|NCT02718417|76090710|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
42262909|NCT02718417|76090708|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
42262910|NCT02718417|76090709|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
42262911|NCT02718417|76090710|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
42262912|NCT02718417|76090708|FG000|Maintenance Phase (MP)|Physician's decision|6|||
42262913|NCT02718417|76090709|FG001|Maintenance Phase (MP)|Physician's decision|7|||
42262914|NCT02718417|76090710|FG002|Maintenance Phase (MP)|Physician's decision|0|||
42262915|NCT02718417|76090708|FG000|Maintenance Phase (MP)|Progressive disease|100|||
42262916|NCT02718417|76090709|FG001|Maintenance Phase (MP)|Progressive disease|88|||
42262917|NCT02718417|76090710|FG002|Maintenance Phase (MP)|Progressive disease|0|||
42262918|NCT02718417|76090708|FG000|Maintenance Phase (MP)|Other|2|||
42330299|NCT01631747|76168275|FG000|Live Birth|Pregnancy Termination|1|||
42330300|NCT01631747|76168276|FG001|Live Birth|Pregnancy Termination|0|||
42330301|NCT01631747|76168275|FG000|Live Birth|MIscarriage|2|||
42330302|NCT01631747|76168276|FG001|Live Birth|MIscarriage|0|||
42330303|NCT01631747|76168275|FG000|Live Birth|Stillbirth|1|||
42330304|NCT01631747|76168276|FG001|Live Birth|Stillbirth|1|||
42330305|NCT01631747|76168275|FG000|One Year Infant Outcomes|Patient Refused|13|||
42330306|NCT01631747|76168276|FG001|One Year Infant Outcomes|Patient Refused|9|||
42330307|NCT02068118|76168285|FG000|18-month Comparative Study Period|Death|90|||
42330308|NCT02068118|76168286|FG001|18-month Comparative Study Period|Death|97|||
42330309|NCT02068118|76168285|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
42330310|NCT02068118|76168286|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
42330311|NCT02068118|76168285|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
42330312|NCT02068118|76168286|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
42330313|NCT02068118|76168285|FG000|18-month Comparative Study Period|Heart transplant|9|||
41998178|NCT03538691|75806687|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
41998179|NCT03538691|75806688|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
41998180|NCT03538691|75806689|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
41998181|NCT03538691|75806690|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
41998182|NCT03538691|75806687|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
41998183|NCT03538691|75806688|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
41998184|NCT03538691|75806689|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
41998185|NCT03538691|75806690|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
41998186|NCT03538691|75806687|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
41998187|NCT03538691|75806688|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
41998188|NCT03538691|75806689|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
41998189|NCT03538691|75806690|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
41998190|NCT03538691|75806687|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
41998191|NCT03538691|75806688|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
41998192|NCT03538691|75806689|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
41998193|NCT03538691|75806690|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
41998194|NCT03538691|75806687|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
41998195|NCT03538691|75806688|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
41998196|NCT03538691|75806689|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
41998197|NCT03538691|75806690|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
41998198|NCT03538691|75806687|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
41998199|NCT03538691|75806688|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
41998200|NCT03538691|75806689|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
41998201|NCT03538691|75806690|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
42262919|NCT02718417|76090709|FG001|Maintenance Phase (MP)|Other|1|||
42262920|NCT02718417|76090710|FG002|Maintenance Phase (MP)|Other|0|||
42262921|NCT02718417|76090708|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
42262922|NCT02718417|76090709|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
42262923|NCT02718417|76090710|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
42262924|NCT02718417|76090708|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
42262925|NCT02718417|76090709|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
42262926|NCT02718417|76090710|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
42262927|NCT02718417|76090708|FG000|Observation Phase (OP)|Adverse Event|0|||
42262928|NCT02718417|76090709|FG001|Observation Phase (OP)|Adverse Event|0|||
42262929|NCT02718417|76090710|FG002|Observation Phase (OP)|Adverse Event|1|||
42330314|NCT02068118|76168286|FG001|18-month Comparative Study Period|Heart transplant|15|||
42330315|NCT02068118|76168285|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
42330316|NCT02068118|76168286|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
42330317|NCT02068118|76168285|FG000|18-month Comparative Study Period|Hemiplegia|0|||
41998202|NCT03538691|75806687|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
41998203|NCT03538691|75806688|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
41998204|NCT03538691|75806689|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
41998205|NCT03538691|75806690|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
41998206|NCT03538691|75806687|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
41998207|NCT03538691|75806688|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
41998208|NCT03538691|75806689|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
41998209|NCT03538691|75806690|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
41998210|NCT03538691|75806687|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
41998211|NCT03538691|75806688|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
41998212|NCT03538691|75806689|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
41998213|NCT03538691|75806690|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
41998214|NCT03538691|75806687|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
41998215|NCT03538691|75806688|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
41998216|NCT03538691|75806689|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
41998217|NCT03538691|75806690|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
41998218|NCT03538691|75806687|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
41998219|NCT03538691|75806688|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
41998220|NCT03538691|75806689|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
41998221|NCT03538691|75806690|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
41998222|NCT03538691|75806687|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
41998223|NCT03538691|75806688|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
41998224|NCT03538691|75806689|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
41998225|NCT03538691|75806690|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
41998226|NCT03538691|75806687|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
41998227|NCT03538691|75806688|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
41998228|NCT03538691|75806689|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
42330318|NCT02068118|76168286|FG001|18-month Comparative Study Period|Hemiplegia|1|||
42330319|NCT02068118|76168285|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
42330320|NCT02068118|76168286|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
42330321|NCT02068118|76168285|FG000|18-month Comparative Study Period|Move|0|||
42330322|NCT02068118|76168286|FG001|18-month Comparative Study Period|Move|1|||
42330323|NCT02068118|76168285|FG000|18-month Comparative Study Period|Hearing loss|0|||
42330324|NCT02068118|76168286|FG001|18-month Comparative Study Period|Hearing loss|1|||
42330325|NCT02068118|76168285|FG000|Extension Period|Death|0|||
42330326|NCT02068118|76168286|FG001|Extension Period|Death|2|||
42330327|NCT02068118|76168285|FG000|Extension Period|Withdrawal by Subject|1|||
42330328|NCT02068118|76168286|FG001|Extension Period|Withdrawal by Subject|0|||
42330329|NCT02068118|76168285|FG000|Extension Period|Heart transplant|1|||
42330330|NCT02068118|76168286|FG001|Extension Period|Heart transplant|0|||
42330331|NCT02068118|76168285|FG000|Extension Period|Wrong device use|0|||
42330332|NCT02068118|76168286|FG001|Extension Period|Wrong device use|1|||
42330333|NCT01623830|76168296|FG000|Overall Study|Withdrawal by Subject|6|||
42330334|NCT01623830|76168297|FG001|Overall Study|Withdrawal by Subject|7|||
42330335|NCT01623830|76168296|FG000|Overall Study|Exclusion from Study|1|||
42330336|NCT01623830|76168297|FG001|Overall Study|Exclusion from Study|2|||
42330337|NCT01634165|76168303|FG000|Period 2|Adverse Event|0|||
42330338|NCT01634165|76168304|FG001|Period 2|Adverse Event|1|||
42330339|NCT01634165|76168305|FG002|Period 2|Adverse Event|0|||
42330340|NCT01634165|76168306|FG003|Period 2|Adverse Event|0|||
42330341|NCT02235311|76168318|FG000|Overall Study|Lost to Follow-up|0|||
42330342|NCT02235311|76168319|FG001|Overall Study|Lost to Follow-up|1|||
42330343|NCT02235311|76168318|FG000|Overall Study|Protocol Violation|0|||
42137802|NCT00416598|75948179|FG000|Induction & Intensification|Withdrawal by Subject|46|||
42262930|NCT02718417|76090708|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
42262931|NCT02718417|76090709|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
42262932|NCT02718417|76090710|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
42262933|NCT02718417|76090708|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
42262934|NCT02718417|76090709|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
42262935|NCT02718417|76090710|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
42262936|NCT02718417|76090708|FG000|Observation Phase (OP)|Physician Decision|0|||
42262937|NCT02718417|76090709|FG001|Observation Phase (OP)|Physician Decision|0|||
42262938|NCT02718417|76090710|FG002|Observation Phase (OP)|Physician Decision|9|||
42330344|NCT02235311|76168319|FG001|Overall Study|Protocol Violation|1|||
42330345|NCT02204579|76168325|FG000|Overall Study|Screen failures|2|||
42330346|NCT02235077|76168336|FG000|Overall Study|Death|5|||
42330347|NCT02235077|76168337|FG001|Overall Study|Death|7|||
42330348|NCT02235077|76168336|FG000|Overall Study|Lost to Follow-up|5|||
42330349|NCT02235077|76168337|FG001|Overall Study|Lost to Follow-up|6|||
42330350|NCT02235077|76168336|FG000|Overall Study|Withdrawal by Subject|8|||
42330351|NCT02235077|76168337|FG001|Overall Study|Withdrawal by Subject|5|||
42330352|NCT02235077|76168336|FG000|Overall Study|Physician Decision|0|||
42330353|NCT02235077|76168337|FG001|Overall Study|Physician Decision|1|||
42330354|NCT02234141|76168347|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
42330355|NCT02234141|76168348|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
42330356|NCT02234141|76168349|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
42330357|NCT02234141|76168350|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
42330358|NCT02234141|76168351|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
42330359|NCT02234141|76168352|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
42330360|NCT02234141|76168353|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
42330361|NCT02234141|76168347|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
42330362|NCT02234141|76168348|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
42330363|NCT02234141|76168349|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
42330364|NCT02234141|76168350|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
42330365|NCT02234141|76168351|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
42330366|NCT02234141|76168352|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
42330367|NCT02234141|76168353|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
42330368|NCT02234141|76168347|FG000|Treatment Period (24 Weeks)|Death|1|||
42330369|NCT02234141|76168348|FG001|Treatment Period (24 Weeks)|Death|2|||
42330370|NCT02234141|76168349|FG002|Treatment Period (24 Weeks)|Death|0|||
42330371|NCT02234141|76168350|FG003|Treatment Period (24 Weeks)|Death|1|||
42330372|NCT02234141|76168351|FG004|Treatment Period (24 Weeks)|Death|0|||
42330373|NCT02234141|76168352|FG005|Treatment Period (24 Weeks)|Death|0|||
42330374|NCT02234141|76168353|FG006|Treatment Period (24 Weeks)|Death|0|||
42330375|NCT02234141|76168347|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
42330376|NCT02234141|76168348|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
42330377|NCT02234141|76168349|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
42330378|NCT02234141|76168350|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
42330379|NCT02234141|76168351|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
42330380|NCT02234141|76168352|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
42330381|NCT02234141|76168353|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
42330382|NCT02234141|76168347|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
42330383|NCT02234141|76168348|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
42330384|NCT02234141|76168349|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
42330385|NCT02234141|76168350|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
42330386|NCT02234141|76168351|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
42330387|NCT02234141|76168352|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
42330388|NCT02234141|76168353|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
42330389|NCT02234141|76168347|FG000|Long-Term Treatment Period|Death|0|||
42330390|NCT02234141|76168348|FG001|Long-Term Treatment Period|Death|0|||
42330391|NCT02234141|76168349|FG002|Long-Term Treatment Period|Death|0|||
42330392|NCT02234141|76168350|FG003|Long-Term Treatment Period|Death|0|||
42330393|NCT02234141|76168351|FG004|Long-Term Treatment Period|Death|0|||
42330394|NCT02234141|76168352|FG005|Long-Term Treatment Period|Death|1|||
42330395|NCT02234141|76168353|FG006|Long-Term Treatment Period|Death|0|||
42330396|NCT02234141|76168347|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
42330397|NCT02234141|76168348|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
42330398|NCT02234141|76168349|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
42330399|NCT02234141|76168350|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
42330400|NCT02234141|76168351|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
42330401|NCT02234141|76168352|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
42330402|NCT02234141|76168353|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
42330403|NCT02234141|76168347|FG000|Long-Term Treatment Period|Adverse Event|4|||
42330404|NCT02234141|76168348|FG001|Long-Term Treatment Period|Adverse Event|0|||
42330405|NCT02234141|76168349|FG002|Long-Term Treatment Period|Adverse Event|5|||
42330406|NCT02234141|76168350|FG003|Long-Term Treatment Period|Adverse Event|0|||
42330407|NCT02234141|76168351|FG004|Long-Term Treatment Period|Adverse Event|1|||
42330408|NCT02234141|76168352|FG005|Long-Term Treatment Period|Adverse Event|1|||
42330409|NCT02234141|76168353|FG006|Long-Term Treatment Period|Adverse Event|1|||
41998229|NCT03538691|75806690|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
41998230|NCT03538691|75806687|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
41998231|NCT03538691|75806688|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
41998232|NCT03538691|75806689|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
42330410|NCT02234141|76168347|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
42330411|NCT02234141|76168348|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
42330412|NCT02234141|76168349|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
42330413|NCT02234141|76168350|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
42330414|NCT02234141|76168351|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
42330415|NCT02234141|76168352|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
42330416|NCT02234141|76168353|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
42330417|NCT02234141|76168347|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
42330418|NCT02234141|76168348|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
42330419|NCT02234141|76168349|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
42330420|NCT02234141|76168350|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
42330421|NCT02234141|76168351|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
42330422|NCT02234141|76168352|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
42330423|NCT02234141|76168353|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
42330424|NCT02234063|76168366|FG000|Overall Study|Lost to Follow-up|235|||
42330425|NCT02234063|76168367|FG001|Overall Study|Lost to Follow-up|42|||
42330426|NCT02234063|76168366|FG000|Overall Study|Withdrawal by Subject|20|||
42330427|NCT02234063|76168367|FG001|Overall Study|Withdrawal by Subject|1|||
41998233|NCT03538691|75806690|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
41998234|NCT03538691|75806687|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
41998235|NCT03538691|75806688|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
42330428|NCT02232893|76168380|FG000|Overall Study|Withdrawal by Subject|4|||
42330429|NCT02232893|76168381|FG001|Overall Study|Withdrawal by Subject|1|||
42330430|NCT02232893|76168380|FG000|Overall Study|Adverse Event|0|||
42330431|NCT02232893|76168381|FG001|Overall Study|Adverse Event|1|||
42330432|NCT02232893|76168380|FG000|Overall Study|Sponsor request early termination|0|||
42330433|NCT02232893|76168381|FG001|Overall Study|Sponsor request early termination|1|||
42330434|NCT02232893|76168380|FG000|Overall Study|Developed exclusion criteria|0|||
42330435|NCT02232893|76168381|FG001|Overall Study|Developed exclusion criteria|1|||
42330436|NCT02232893|76168380|FG000|Overall Study|Other|0|||
42330437|NCT02232893|76168381|FG001|Overall Study|Other|3|||
42330438|NCT02203721|76168389|FG000|Overall Study|Lost to Follow-up|1|||
42330439|NCT02203721|76168390|FG001|Overall Study|Lost to Follow-up|0|||
42330440|NCT02203721|76168389|FG000|Overall Study|Death|0|||
42330441|NCT02203721|76168390|FG001|Overall Study|Death|2|||
42330442|NCT02203721|76168389|FG000|Overall Study|Illness|0|||
42330443|NCT02203721|76168390|FG001|Overall Study|Illness|1|||
41998236|NCT03538691|75806689|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
41998237|NCT03538691|75806690|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
41998238|NCT03538691|75806687|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
41998239|NCT03538691|75806688|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
41998240|NCT03538691|75806689|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
41998241|NCT03538691|75806690|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
41998242|NCT03538691|75806687|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
41998243|NCT03538691|75806688|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
41998244|NCT03538691|75806689|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
41998245|NCT03538691|75806690|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
41998246|NCT03538691|75806687|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
41998247|NCT03538691|75806688|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
41998248|NCT03538691|75806689|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
41998249|NCT03538691|75806690|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
42034569|NCT01120691|75842652|FG000|Overall Study|Death|21|||
42034570|NCT01120691|75842653|FG001|Overall Study|Death|22|||
42034571|NCT01120691|75842654|FG002|Overall Study|Death|24|||
42262939|NCT02718417|76090708|FG000|Observation Phase (OP)|Progressive disease|0|||
42262940|NCT02718417|76090709|FG001|Observation Phase (OP)|Progressive disease|0|||
42262941|NCT02718417|76090710|FG002|Observation Phase (OP)|Progressive disease|92|||
42262942|NCT02718417|76090708|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
42262943|NCT02718417|76090709|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
42262944|NCT02718417|76090710|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
42262945|NCT02718417|76090708|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
42262946|NCT02718417|76090709|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
42262947|NCT02718417|76090710|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
42262948|NCT02718417|76090708|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
42262949|NCT02718417|76090709|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
42262950|NCT02718417|76090710|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
42262951|NCT02718417|76090708|FG000|Observation Phase (OP)|Other|0|||
42262952|NCT02718417|76090709|FG001|Observation Phase (OP)|Other|0|||
42262953|NCT02718417|76090710|FG002|Observation Phase (OP)|Other|7|||
42262954|NCT02718417|76090708|FG000|Follow-up Phase|Adverse Event|3|||
42262955|NCT02718417|76090709|FG001|Follow-up Phase|Adverse Event|1|||
42330444|NCT01618695|76168400|FG000|Core Phase|Adverse Event|4|||
42330445|NCT01618695|76168401|FG001|Core Phase|Adverse Event|5|||
42262956|NCT02718417|76090710|FG002|Follow-up Phase|Adverse Event|1|||
42330446|NCT01618695|76168402|FG002|Core Phase|Adverse Event|15|||
42330447|NCT01618695|76168403|FG003|Core Phase|Adverse Event|20|||
42330448|NCT01618695|76168400|FG000|Core Phase|Lost to Follow-up|0|||
42330449|NCT01618695|76168401|FG001|Core Phase|Lost to Follow-up|0|||
42330450|NCT01618695|76168402|FG002|Core Phase|Lost to Follow-up|1|||
42330451|NCT01618695|76168403|FG003|Core Phase|Lost to Follow-up|0|||
42330452|NCT01618695|76168400|FG000|Core Phase|Withdrawal by Subject|16|||
41998250|NCT03538691|75806687|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
41998251|NCT03538691|75806688|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
41998252|NCT03538691|75806689|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
41998253|NCT03538691|75806690|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
41998254|NCT03538691|75806687|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
41998255|NCT03538691|75806688|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
41998256|NCT03538691|75806689|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
41998257|NCT03538691|75806690|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
41998258|NCT03538691|75806687|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
41998259|NCT03538691|75806688|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
41998260|NCT03538691|75806689|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
41998261|NCT03538691|75806690|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
41998262|NCT03538691|75806687|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
41998263|NCT03538691|75806688|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
41998264|NCT03538691|75806689|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
41998265|NCT03538691|75806690|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
42330453|NCT01618695|76168401|FG001|Core Phase|Withdrawal by Subject|11|||
42330454|NCT01618695|76168402|FG002|Core Phase|Withdrawal by Subject|9|||
42330455|NCT01618695|76168403|FG003|Core Phase|Withdrawal by Subject|13|||
42330456|NCT01618695|76168400|FG000|Core Phase|Pregnancy|2|||
42330457|NCT01618695|76168401|FG001|Core Phase|Pregnancy|0|||
42330458|NCT01618695|76168402|FG002|Core Phase|Pregnancy|0|||
42330459|NCT01618695|76168403|FG003|Core Phase|Pregnancy|0|||
42330460|NCT01618695|76168400|FG000|Core Phase|Lack of Efficacy|1|||
42330461|NCT01618695|76168401|FG001|Core Phase|Lack of Efficacy|2|||
42330462|NCT01618695|76168402|FG002|Core Phase|Lack of Efficacy|1|||
42330463|NCT01618695|76168403|FG003|Core Phase|Lack of Efficacy|1|||
42330464|NCT01618695|76168400|FG000|Core Phase|Other than specified|1|||
42330465|NCT01618695|76168401|FG001|Core Phase|Other than specified|2|||
42330466|NCT01618695|76168402|FG002|Core Phase|Other than specified|2|||
42330467|NCT01618695|76168403|FG003|Core Phase|Other than specified|2|||
42330468|NCT01618695|76168400|FG000|Core Phase|Not treated|1|||
41998266|NCT03511664|75806700|FG000|Overall Study|Treatment ongoing|49|||
41998267|NCT03511664|75806701|FG001|Overall Study|Treatment ongoing|5|||
41998268|NCT03511664|75806700|FG000|Overall Study|Entered long-term follow-up|140|||
41998269|NCT03511664|75806701|FG001|Overall Study|Entered long-term follow-up|50|||
41998270|NCT03511664|75806700|FG000|Overall Study|Withdrawal by Subject|29|||
42330469|NCT01618695|76168401|FG001|Core Phase|Not treated|0|||
42330470|NCT01618695|76168402|FG002|Core Phase|Not treated|2|||
42330471|NCT01618695|76168403|FG003|Core Phase|Not treated|0|||
42262957|NCT02718417|76090708|FG000|Follow-up Phase|Other|4|||
42262958|NCT02718417|76090709|FG001|Follow-up Phase|Other|6|||
42262959|NCT02718417|76090710|FG002|Follow-up Phase|Other|4|||
42262960|NCT02718417|76090708|FG000|Follow-up Phase|Withdrawal by Subject|19|||
42262961|NCT02718417|76090709|FG001|Follow-up Phase|Withdrawal by Subject|17|||
42262962|NCT02718417|76090710|FG002|Follow-up Phase|Withdrawal by Subject|5|||
42262963|NCT02718417|76090708|FG000|Follow-up Phase|Study terminated by sponsor|100|||
42262964|NCT02718417|76090709|FG001|Follow-up Phase|Study terminated by sponsor|138|||
42262965|NCT02718417|76090710|FG002|Follow-up Phase|Study terminated by sponsor|6|||
42262966|NCT02718417|76090708|FG000|Follow-up Phase|Lost to Follow-up|2|||
42262967|NCT02718417|76090709|FG001|Follow-up Phase|Lost to Follow-up|3|||
42262968|NCT02718417|76090710|FG002|Follow-up Phase|Lost to Follow-up|0|||
42262969|NCT02718417|76090708|FG000|Follow-up Phase|Death leading to discontinuation|7|||
42262970|NCT02718417|76090709|FG001|Follow-up Phase|Death leading to discontinuation|7|||
42262971|NCT02718417|76090710|FG002|Follow-up Phase|Death leading to discontinuation|3|||
42262972|NCT02718417|76090708|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
42262973|NCT02718417|76090709|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
42262974|NCT02718417|76090710|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
42262975|NCT02718417|76090708|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
42330472|NCT01618695|76168400|FG000|Extension Phase|Lack of Efficacy|17|||
42330473|NCT01618695|76168401|FG001|Extension Phase|Lack of Efficacy|33|||
42330474|NCT01618695|76168402|FG002|Extension Phase|Lack of Efficacy|26|||
42262976|NCT02718417|76090709|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
42262977|NCT02718417|76090710|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
42330475|NCT01618695|76168403|FG003|Extension Phase|Lack of Efficacy|24|||
42330476|NCT01618695|76168400|FG000|Extension Phase|Pregnancy|2|||
42330477|NCT01618695|76168401|FG001|Extension Phase|Pregnancy|0|||
42330478|NCT01618695|76168402|FG002|Extension Phase|Pregnancy|1|||
42330479|NCT01618695|76168403|FG003|Extension Phase|Pregnancy|1|||
42330480|NCT01618695|76168400|FG000|Extension Phase|Withdrawal by Subject|43|||
42330481|NCT01618695|76168401|FG001|Extension Phase|Withdrawal by Subject|48|||
42330482|NCT01618695|76168402|FG002|Extension Phase|Withdrawal by Subject|42|||
42330483|NCT01618695|76168403|FG003|Extension Phase|Withdrawal by Subject|33|||
42330484|NCT01618695|76168400|FG000|Extension Phase|Adverse Event|18|||
42330485|NCT01618695|76168401|FG001|Extension Phase|Adverse Event|16|||
42330486|NCT01618695|76168402|FG002|Extension Phase|Adverse Event|9|||
42330487|NCT01618695|76168403|FG003|Extension Phase|Adverse Event|20|||
42330488|NCT01618695|76168400|FG000|Extension Phase|Lost to Follow-up|2|||
41998271|NCT03511664|75806701|FG001|Overall Study|Withdrawal by Subject|53|||
41998272|NCT03511664|75806700|FG000|Overall Study|Lost to Follow-up|4|||
41998273|NCT03511664|75806701|FG001|Overall Study|Lost to Follow-up|4|||
41998274|NCT03511664|75806700|FG000|Overall Study|Physician Decision|0|||
41998275|NCT03511664|75806701|FG001|Overall Study|Physician Decision|1|||
41998276|NCT03120949|75806718|FG000|Overall Study|randomized in error|1|||
41998277|NCT03120949|75806719|FG001|Overall Study|randomized in error|0|||
41998278|NCT03120949|75806718|FG000|Overall Study|Death|13|||
42330489|NCT01618695|76168401|FG001|Extension Phase|Lost to Follow-up|1|||
42330490|NCT01618695|76168402|FG002|Extension Phase|Lost to Follow-up|1|||
41998279|NCT03120949|75806719|FG001|Overall Study|Death|13|||
41998280|NCT03120949|75806718|FG000|Overall Study|Lost to Follow-up|23|||
41998281|NCT03120949|75806719|FG001|Overall Study|Lost to Follow-up|13|||
41998282|NCT03120949|75806718|FG000|Overall Study|Withdrawal by Subject|139|||
41998283|NCT03120949|75806719|FG001|Overall Study|Withdrawal by Subject|124|||
41998284|NCT03120949|75806718|FG000|Overall Study|Covid-19|43|||
41998285|NCT03120949|75806719|FG001|Overall Study|Covid-19|34|||
41998286|NCT03120949|75806718|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
41998287|NCT03120949|75806719|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
41998288|NCT03120949|75806718|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
41998289|NCT03120949|75806719|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
41998290|NCT03120949|75806718|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
41998291|NCT03120949|75806719|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
41998292|NCT03120949|75806718|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
41998293|NCT03120949|75806719|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
41998294|NCT03120949|75806718|FG000|Overall Study|Site was closed|2|||
41998295|NCT03120949|75806719|FG001|Overall Study|Site was closed|3|||
41998296|NCT03120949|75806718|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
41998297|NCT03120949|75806719|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
41998298|NCT03120949|75806718|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
42262978|NCT02718417|76090708|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
42262979|NCT02718417|76090709|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
42262980|NCT02718417|76090710|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
42262981|NCT02718417|76090708|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
42262982|NCT02718417|76090709|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
42262983|NCT02718417|76090710|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
42262984|NCT02718417|76090708|FG000|Long-term Follow-up Phase|Other|0|||
42262985|NCT02718417|76090709|FG001|Long-term Follow-up Phase|Other|2|||
42262986|NCT02718417|76090710|FG002|Long-term Follow-up Phase|Other|0|||
42262987|NCT02640404|76090727|FG000|Overall Study|Protocol Violation|1|||
42262988|NCT02640404|76090728|FG001|Overall Study|Protocol Violation|0|||
42262989|NCT02640404|76090727|FG000|Overall Study|Withdrawal by Subject|1|||
42262990|NCT02640404|76090728|FG001|Overall Study|Withdrawal by Subject|0|||
42262991|NCT00701727|76090734|FG000|First Treatment Period|Adverse Event|0|||
42262992|NCT00701727|76090735|FG001|First Treatment Period|Adverse Event|0|||
42262993|NCT00701727|76090734|FG000|First Treatment Period|Withdrawal by Subject|1|||
42262994|NCT00701727|76090735|FG001|First Treatment Period|Withdrawal by Subject|0|||
42262995|NCT00701727|76090734|FG000|First Treatment Period|sponsor decision|0|||
42262996|NCT00701727|76090735|FG001|First Treatment Period|sponsor decision|1|||
42262997|NCT00701727|76090734|FG000|First Treatment Period|Lost to Follow-up|0|||
42262998|NCT00701727|76090735|FG001|First Treatment Period|Lost to Follow-up|1|||
42262999|NCT00701727|76090734|FG000|Second Treatment Period|Withdrawal by Subject|2|||
42263000|NCT00701727|76090735|FG001|Second Treatment Period|Withdrawal by Subject|0|||
42263001|NCT01369069|76090752|FG000|Overall Study|Lost to Follow-up|8|||
42263002|NCT01369069|76090753|FG001|Overall Study|Lost to Follow-up|9|||
42263003|NCT01369069|76090752|FG000|Overall Study|Withdrawal by Subject|9|||
42263004|NCT01369069|76090753|FG001|Overall Study|Withdrawal by Subject|7|||
42263005|NCT02441218|76090761|FG000|Overall Study|Death|503|||
42330491|NCT01618695|76168403|FG003|Extension Phase|Lost to Follow-up|1|||
42263006|NCT02441218|76090762|FG001|Overall Study|Death|553|||
42263007|NCT02441218|76090761|FG000|Overall Study|Withdrawal by Subject|73|||
42330492|NCT01618695|76168400|FG000|Extension Phase|Other than specified|13|||
42330493|NCT01618695|76168401|FG001|Extension Phase|Other than specified|18|||
42330494|NCT01618695|76168402|FG002|Extension Phase|Other than specified|13|||
42330495|NCT01618695|76168403|FG003|Extension Phase|Other than specified|18|||
41998299|NCT03120949|75806719|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
41998300|NCT03120949|75806718|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
41998301|NCT03120949|75806719|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
41998302|NCT03120949|75806718|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
41998303|NCT03120949|75806719|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
41998304|NCT03120949|75806718|FG000|Overall Study|Other: Adverse Event|0|||
41998305|NCT03120949|75806719|FG001|Overall Study|Other: Adverse Event|1|||
41998306|NCT03120949|75806718|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
41998307|NCT03120949|75806719|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
41998308|NCT03120949|75806718|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
41998309|NCT03120949|75806719|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
41998310|NCT03120949|75806718|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
41998311|NCT03120949|75806719|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
41998312|NCT03120949|75806718|FG000|Overall Study|Personal Reasons|0|||
41998313|NCT03120949|75806719|FG001|Overall Study|Personal Reasons|1|||
41998314|NCT03120949|75806718|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
41998315|NCT03120949|75806719|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
41998316|NCT03120949|75806718|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
41998317|NCT03120949|75806719|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
41998318|NCT03120949|75806718|FG000|Overall Study|Compliance With Medication|0|||
41998319|NCT03120949|75806719|FG001|Overall Study|Compliance With Medication|1|||
41998320|NCT03120949|75806718|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
41998321|NCT03120949|75806719|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
41998322|NCT03120949|75806718|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
41998323|NCT03120949|75806719|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
41998324|NCT03120949|75806718|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
41998325|NCT03120949|75806719|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
41998326|NCT02921256|75806742|FG000|Arm 1a v. Arm II|Adverse Event|6|||
41998327|NCT02921256|75806743|FG001|Arm 1a v. Arm II|Adverse Event|15|||
41998328|NCT02921256|75806744|FG002|Arm 1a v. Arm II|Adverse Event|0|||
41998329|NCT02921256|75806742|FG000|Arm 1a v. Arm II|Death|0|||
41998330|NCT02921256|75806743|FG001|Arm 1a v. Arm II|Death|2|||
41998331|NCT02921256|75806744|FG002|Arm 1a v. Arm II|Death|0|||
41998332|NCT02921256|75806742|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
41998333|NCT02921256|75806743|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
41998334|NCT02921256|75806744|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
41998335|NCT02921256|75806742|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
41998336|NCT02921256|75806743|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
41998337|NCT02921256|75806744|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
41998338|NCT02921256|75806742|FG000|Arm 1a v. Arm II|Physician Decision|1|||
41998339|NCT02921256|75806743|FG001|Arm 1a v. Arm II|Physician Decision|1|||
41998340|NCT02921256|75806744|FG002|Arm 1a v. Arm II|Physician Decision|0|||
41998341|NCT02921256|75806742|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
41998342|NCT02921256|75806743|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
41998343|NCT02921256|75806744|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
41998344|NCT02921256|75806742|FG000|Arm Ib v Arm III|Adverse Event|9|||
41998345|NCT02921256|75806743|FG001|Arm Ib v Arm III|Adverse Event|0|||
41998346|NCT02921256|75806744|FG002|Arm Ib v Arm III|Adverse Event|4|||
41998347|NCT02921256|75806742|FG000|Arm Ib v Arm III|Death|1|||
41998348|NCT02921256|75806743|FG001|Arm Ib v Arm III|Death|0|||
41998349|NCT02921256|75806744|FG002|Arm Ib v Arm III|Death|1|||
41998350|NCT02921256|75806742|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
41998351|NCT02921256|75806743|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
41998352|NCT02921256|75806744|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
41998353|NCT02921256|75806742|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
41998354|NCT02921256|75806743|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
41998355|NCT02921256|75806744|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
41998356|NCT02921256|75806742|FG000|Arm Ib v Arm III|Physician Decision|4|||
41998357|NCT02921256|75806743|FG001|Arm Ib v Arm III|Physician Decision|0|||
41998358|NCT02921256|75806744|FG002|Arm Ib v Arm III|Physician Decision|1|||
41998359|NCT02921256|75806742|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
41998360|NCT02921256|75806743|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
41998361|NCT02921256|75806744|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
41998362|NCT02757885|75806758|FG000|Overall Study|Screen Failures|4|||
42330496|NCT01896531|76168416|FG000|Overall Study|Death|57|||
42330497|NCT01896531|76168417|FG001|Overall Study|Death|59|||
42330498|NCT01896531|76168416|FG000|Overall Study|Lost to Follow-up|3|||
42330499|NCT01896531|76168417|FG001|Overall Study|Lost to Follow-up|0|||
42330500|NCT01896531|76168416|FG000|Overall Study|Non-compliance|0|||
42330501|NCT01896531|76168417|FG001|Overall Study|Non-compliance|1|||
42330502|NCT01896531|76168416|FG000|Overall Study|Study Ended by Sponsor|7|||
42330503|NCT01896531|76168417|FG001|Overall Study|Study Ended by Sponsor|20|||
42330504|NCT01896531|76168416|FG000|Overall Study|Withdrawal by Subject|3|||
42330505|NCT01896531|76168417|FG001|Overall Study|Withdrawal by Subject|2|||
42330506|NCT01896531|76168416|FG000|Overall Study|Death Prior to Treatment|1|||
42330507|NCT01896531|76168417|FG001|Overall Study|Death Prior to Treatment|0|||
42330508|NCT01618305|76168425|FG000|Overall Study|Death|0|||
42330509|NCT01618305|76168426|FG001|Overall Study|Death|1|||
42330510|NCT01618305|76168425|FG000|Overall Study|Lost to Follow-up|11|||
42330511|NCT01618305|76168426|FG001|Overall Study|Lost to Follow-up|7|||
42330512|NCT01618305|76168425|FG000|Overall Study|Protocol Violation|1|||
42330513|NCT01618305|76168426|FG001|Overall Study|Protocol Violation|0|||
42330514|NCT01618305|76168425|FG000|Overall Study|Withdrawal by Subject|3|||
42330515|NCT01618305|76168426|FG001|Overall Study|Withdrawal by Subject|2|||
42330516|NCT01886313|76168438|FG000|Overall Study|Adverse Event|1|||
42330517|NCT01886313|76168439|FG001|Overall Study|Adverse Event|1|||
42330518|NCT01896297|76168445|FG000|Overall Study|Died in post treatment phase|1|||
42330519|NCT01884675|76168451|FG000|Overall Study|Study closed/terminated|3|||
42330520|NCT01884675|76168452|FG001|Overall Study|Study closed/terminated|2|||
42330521|NCT01884597|76168463|FG000|Overall Study|Adverse Event|0|||
42330522|NCT01884597|76168464|FG001|Overall Study|Adverse Event|0|||
42330523|NCT01884597|76168465|FG002|Overall Study|Adverse Event|1|||
42330524|NCT01884597|76168463|FG000|Overall Study|Lack of Efficacy|1|||
42330525|NCT01884597|76168464|FG001|Overall Study|Lack of Efficacy|0|||
42330526|NCT01884597|76168465|FG002|Overall Study|Lack of Efficacy|0|||
42330527|NCT01884597|76168463|FG000|Overall Study|Death|0|||
42330528|NCT01884597|76168464|FG001|Overall Study|Death|1|||
42330529|NCT01884597|76168465|FG002|Overall Study|Death|0|||
42330530|NCT01895361|76168482|FG000|Overall Study|Adverse Event|1|||
42330531|NCT01895361|76168483|FG001|Overall Study|Adverse Event|1|||
42330532|NCT01895361|76168484|FG002|Overall Study|Adverse Event|3|||
42330533|NCT01895361|76168482|FG000|Overall Study|Death|2|||
42330534|NCT01895361|76168483|FG001|Overall Study|Death|1|||
42330535|NCT01895361|76168484|FG002|Overall Study|Death|2|||
42330536|NCT01895361|76168482|FG000|Overall Study|Lost to Follow-up|4|||
42330537|NCT01895361|76168483|FG001|Overall Study|Lost to Follow-up|4|||
42330538|NCT01895361|76168484|FG002|Overall Study|Lost to Follow-up|6|||
42330539|NCT01895361|76168482|FG000|Overall Study|Non-compliance with study|1|||
42330540|NCT01895361|76168483|FG001|Overall Study|Non-compliance with study|3|||
42330541|NCT01895361|76168484|FG002|Overall Study|Non-compliance with study|1|||
42330542|NCT01895361|76168482|FG000|Overall Study|Physician Decision|2|||
42330543|NCT01895361|76168483|FG001|Overall Study|Physician Decision|2|||
42330544|NCT01895361|76168484|FG002|Overall Study|Physician Decision|2|||
42263008|NCT02441218|76090762|FG001|Overall Study|Withdrawal by Subject|58|||
42263009|NCT02441218|76090761|FG000|Overall Study|Lost to Follow-up|2|||
42263010|NCT02441218|76090762|FG001|Overall Study|Lost to Follow-up|1|||
42263011|NCT02410252|76090768|FG000|Overall Study|Withdrawal by Subject|4|||
42263012|NCT02410252|76090768|FG000|Overall Study|Physician Decision|2|||
42263013|NCT02440594|76090782|FG000|Overall Study|Lost to Follow-up|34|||
42263014|NCT02440594|76090783|FG001|Overall Study|Lost to Follow-up|33|||
42263015|NCT02440594|76090784|FG002|Overall Study|Lost to Follow-up|54|||
42263016|NCT02440594|76090785|FG003|Overall Study|Lost to Follow-up|47|||
42330545|NCT01895361|76168482|FG000|Overall Study|Withdrawal by Subject|7|||
42330546|NCT01895361|76168483|FG001|Overall Study|Withdrawal by Subject|6|||
42330547|NCT01895361|76168484|FG002|Overall Study|Withdrawal by Subject|6|||
42330548|NCT01895361|76168482|FG000|Overall Study|Lack of Efficacy|0|||
42330549|NCT01895361|76168483|FG001|Overall Study|Lack of Efficacy|1|||
41998363|NCT02635867|75806776|FG000|Overall Study|Lost to Follow-up|4|||
41998364|NCT02635867|75806777|FG001|Overall Study|Lost to Follow-up|3|||
41998365|NCT02635867|75806778|FG002|Overall Study|Lost to Follow-up|3|||
42263017|NCT02440594|76090786|FG004|Overall Study|Lost to Follow-up|5|||
42263018|NCT02440594|76090787|FG005|Overall Study|Lost to Follow-up|4|||
42263019|NCT02440594|76090788|FG006|Overall Study|Lost to Follow-up|28|||
42263020|NCT02440594|76090789|FG007|Overall Study|Lost to Follow-up|48|||
42330550|NCT01895361|76168484|FG002|Overall Study|Lack of Efficacy|0|||
42330551|NCT01895361|76168482|FG000|Overall Study|Reasons different from categories above|7|||
42330552|NCT01895361|76168483|FG001|Overall Study|Reasons different from categories above|3|||
42330553|NCT01895361|76168484|FG002|Overall Study|Reasons different from categories above|4|||
42330554|NCT01883895|76168492|FG000|Overall Study|Lost to Follow-up|2|||
42330555|NCT01864005|76168498|FG000|Overall Study|Protocol Violation|0|||
42330556|NCT01864005|76168499|FG001|Overall Study|Protocol Violation|1|||
42330557|NCT01864005|76168498|FG000|Overall Study|Withdrawal by Subject|0|||
42330558|NCT01864005|76168499|FG001|Overall Study|Withdrawal by Subject|1|||
42330559|NCT01864005|76168498|FG000|Overall Study|Incorrect enrolment|1|||
42330560|NCT01864005|76168499|FG001|Overall Study|Incorrect enrolment|0|||
41998366|NCT02635867|75806779|FG003|Overall Study|Lost to Follow-up|4|||
42330561|NCT01864005|76168498|FG000|Overall Study|Disease need|1|||
42330562|NCT01864005|76168499|FG001|Overall Study|Disease need|1|||
41998367|NCT02635867|75806780|FG004|Overall Study|Lost to Follow-up|1|||
41998368|NCT02426658|75806797|FG000|Overall Study|Withdrawal by Subject|1|||
41998369|NCT02426658|75806797|FG000|Overall Study|Patient expired before treatment|2|||
41998370|NCT02158091|75806804|FG000|Overall Study|DLT|2|||
41998371|NCT02158091|75806805|FG001|Overall Study|DLT|1|||
41998372|NCT02158091|75806806|FG002|Overall Study|DLT|0|||
41998373|NCT02903420|75806836|FG000|Overall Study|Death|3|||
41998374|NCT02831933|75806840|FG000|Overall Study|Physician Decision|11|||
41998375|NCT02813668|75806844|FG000|Overall Study|Death|4|||
41998376|NCT02813668|75806844|FG000|Overall Study|Lost to Follow-up|509|||
41998377|NCT02813668|75806844|FG000|Overall Study|Withdrawal by Subject|148|||
41998378|NCT02813668|75806844|FG000|Overall Study|No longer at worksite|85|||
41998379|NCT02813668|75806844|FG000|Overall Study|Medical reasons not related to the study|4|||
41998380|NCT02763566|75806852|FG000|Overall Study|Lost to Follow-up|1|||
41998381|NCT02763566|75806853|FG001|Overall Study|Lost to Follow-up|4|||
41998382|NCT02763566|75806854|FG002|Overall Study|Lost to Follow-up|0|||
41998383|NCT02763566|75806855|FG003|Overall Study|Lost to Follow-up|1|||
41998384|NCT02763566|75806852|FG000|Overall Study|On study treatment at study conclusion|114|||
41998385|NCT02763566|75806853|FG001|Overall Study|On study treatment at study conclusion|34|||
41998386|NCT02763566|75806854|FG002|Overall Study|On study treatment at study conclusion|54|||
41998387|NCT02763566|75806855|FG003|Overall Study|On study treatment at study conclusion|13|||
41998388|NCT02763566|75806852|FG000|Overall Study|Withdrawal by Subject|3|||
41998389|NCT02763566|75806853|FG001|Overall Study|Withdrawal by Subject|1|||
41998390|NCT02763566|75806854|FG002|Overall Study|Withdrawal by Subject|0|||
41998391|NCT02763566|75806855|FG003|Overall Study|Withdrawal by Subject|0|||
41998392|NCT02760433|75806874|FG000|Overall Study|Lost to Follow-up|1|||
41998393|NCT02760433|75806875|FG001|Overall Study|Lost to Follow-up|0|||
41998394|NCT02760433|75806876|FG002|Overall Study|Lost to Follow-up|1|||
41998395|NCT02760433|75806877|FG003|Overall Study|Lost to Follow-up|0|||
41998396|NCT02760433|75806878|FG004|Overall Study|Lost to Follow-up|0|||
41998397|NCT02760433|75806874|FG000|Overall Study|Withdrawal by Subject|23|||
41998398|NCT02760433|75806875|FG001|Overall Study|Withdrawal by Subject|9|||
41998399|NCT02760433|75806876|FG002|Overall Study|Withdrawal by Subject|0|||
41998400|NCT02760433|75806877|FG003|Overall Study|Withdrawal by Subject|2|||
41998401|NCT02760433|75806878|FG004|Overall Study|Withdrawal by Subject|9|||
41998402|NCT02760433|75806874|FG000|Overall Study|Lack of Response At Week 14|0|||
41998403|NCT02760433|75806875|FG001|Overall Study|Lack of Response At Week 14|0|||
41998404|NCT02760433|75806876|FG002|Overall Study|Lack of Response At Week 14|0|||
41998405|NCT02760433|75806877|FG003|Overall Study|Lack of Response At Week 14|0|||
41998406|NCT02760433|75806878|FG004|Overall Study|Lack of Response At Week 14|1|||
41998407|NCT02760433|75806874|FG000|Overall Study|Subject refused to continue the study|1|||
41998408|NCT02760433|75806875|FG001|Overall Study|Subject refused to continue the study|0|||
41998409|NCT02760433|75806876|FG002|Overall Study|Subject refused to continue the study|0|||
41998410|NCT02760433|75806877|FG003|Overall Study|Subject refused to continue the study|0|||
41998411|NCT02760433|75806878|FG004|Overall Study|Subject refused to continue the study|0|||
41998412|NCT02760433|75806874|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
42263021|NCT02440594|76090782|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
42263022|NCT02440594|76090783|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
42263023|NCT02440594|76090784|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
42263024|NCT02440594|76090785|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
42263025|NCT02440594|76090786|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
42263026|NCT02440594|76090787|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
42263027|NCT02440594|76090788|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
42263028|NCT02440594|76090789|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
42263029|NCT02440594|76090782|FG000|Overall Study|Withdrawal by Subject|81|||
42263030|NCT02440594|76090783|FG001|Overall Study|Withdrawal by Subject|67|||
42263031|NCT02440594|76090784|FG002|Overall Study|Withdrawal by Subject|59|||
42263032|NCT02440594|76090785|FG003|Overall Study|Withdrawal by Subject|38|||
42263033|NCT02440594|76090786|FG004|Overall Study|Withdrawal by Subject|2|||
42263034|NCT02440594|76090787|FG005|Overall Study|Withdrawal by Subject|2|||
42263035|NCT02440594|76090788|FG006|Overall Study|Withdrawal by Subject|7|||
42263036|NCT02440594|76090789|FG007|Overall Study|Withdrawal by Subject|7|||
42263037|NCT02440594|76090782|FG000|Overall Study|Administratively w/drawn|3|||
42263038|NCT02440594|76090783|FG001|Overall Study|Administratively w/drawn|2|||
42263039|NCT02440594|76090784|FG002|Overall Study|Administratively w/drawn|0|||
42263040|NCT02440594|76090785|FG003|Overall Study|Administratively w/drawn|0|||
42263041|NCT02440594|76090786|FG004|Overall Study|Administratively w/drawn|0|||
42263042|NCT02440594|76090787|FG005|Overall Study|Administratively w/drawn|0|||
42263043|NCT02440594|76090788|FG006|Overall Study|Administratively w/drawn|2|||
42263044|NCT02440594|76090789|FG007|Overall Study|Administratively w/drawn|1|||
42263045|NCT03836001|76090816|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
42263046|NCT03836001|76090817|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
42263047|NCT03836001|76090818|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
42263048|NCT03836001|76090816|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
41998413|NCT02760433|75806875|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
41998414|NCT02760433|75806876|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
41998415|NCT02760433|75806877|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
41998416|NCT02760433|75806878|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
41998417|NCT02760433|75806874|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
41998418|NCT02760433|75806875|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
41998419|NCT02760433|75806876|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
41998420|NCT02760433|75806877|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
41998421|NCT02760433|75806878|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
41998422|NCT02760407|75806898|FG000|Overall Study|Death|2|||
41998423|NCT02760407|75806899|FG001|Overall Study|Death|3|||
42330563|NCT01864005|76168498|FG000|Overall Study|Need GP IIb/IIIa|1|||
42330564|NCT01864005|76168499|FG001|Overall Study|Need GP IIb/IIIa|3|||
42330565|NCT01863849|76168507|FG000|Overall Study|Lost to Follow-up|1|||
42330566|NCT01863849|76168508|FG001|Overall Study|Lost to Follow-up|0|||
42330567|NCT01863771|76168515|FG000|Induction Phase|Adverse Event|9|||
42330568|NCT01863771|76168516|FG001|Induction Phase|Adverse Event|0|||
42330569|NCT01863771|76168517|FG002|Induction Phase|Adverse Event|0|||
42330570|NCT01863771|76168518|FG003|Induction Phase|Adverse Event|0|||
42330571|NCT01863771|76168515|FG000|Induction Phase|Lack of Efficacy|10|||
42330572|NCT01863771|76168516|FG001|Induction Phase|Lack of Efficacy|0|||
42330573|NCT01863771|76168517|FG002|Induction Phase|Lack of Efficacy|0|||
42330574|NCT01863771|76168518|FG003|Induction Phase|Lack of Efficacy|0|||
42330575|NCT01863771|76168515|FG000|Induction Phase|Withdrawal by Subject|2|||
42330576|NCT01863771|76168516|FG001|Induction Phase|Withdrawal by Subject|0|||
42330577|NCT01863771|76168517|FG002|Induction Phase|Withdrawal by Subject|0|||
42330578|NCT01863771|76168518|FG003|Induction Phase|Withdrawal by Subject|0|||
42330579|NCT01863771|76168515|FG000|Maintenance Phase|Adverse Event|0|||
42330580|NCT01863771|76168516|FG001|Maintenance Phase|Adverse Event|0|||
42330581|NCT01863771|76168517|FG002|Maintenance Phase|Adverse Event|1|||
42330582|NCT01863771|76168518|FG003|Maintenance Phase|Adverse Event|1|||
42330583|NCT01863771|76168515|FG000|Maintenance Phase|Lack of Efficacy|0|||
42330584|NCT01863771|76168516|FG001|Maintenance Phase|Lack of Efficacy|3|||
42330585|NCT01863771|76168517|FG002|Maintenance Phase|Lack of Efficacy|7|||
42330586|NCT01863771|76168518|FG003|Maintenance Phase|Lack of Efficacy|38|||
42330587|NCT01863771|76168515|FG000|Maintenance Phase|Physician Decision|0|||
42330588|NCT01863771|76168516|FG001|Maintenance Phase|Physician Decision|0|||
42330589|NCT01863771|76168517|FG002|Maintenance Phase|Physician Decision|2|||
42330590|NCT01863771|76168518|FG003|Maintenance Phase|Physician Decision|1|||
42330591|NCT01863771|76168515|FG000|Maintenance Phase|Pregnancy|0|||
42330592|NCT01863771|76168516|FG001|Maintenance Phase|Pregnancy|1|||
42330593|NCT01863771|76168517|FG002|Maintenance Phase|Pregnancy|0|||
42330594|NCT01863771|76168518|FG003|Maintenance Phase|Pregnancy|0|||
42330595|NCT01863771|76168515|FG000|Maintenance Phase|Withdrawal by Subject|0|||
42330596|NCT01863771|76168516|FG001|Maintenance Phase|Withdrawal by Subject|1|||
42330597|NCT01863771|76168517|FG002|Maintenance Phase|Withdrawal by Subject|2|||
42330598|NCT01863771|76168518|FG003|Maintenance Phase|Withdrawal by Subject|3|||
42330599|NCT01894581|76168528|FG000|Overall Study|Withdrawal by Subject|2|||
42330600|NCT01894581|76168529|FG001|Overall Study|Withdrawal by Subject|3|||
42330601|NCT01894581|76168528|FG000|Overall Study|Screen Failure|3|||
42330602|NCT01894581|76168529|FG001|Overall Study|Screen Failure|4|||
42330603|NCT01893411|76168538|FG000|Overall Study|Protocol Violation|1|||
42330604|NCT01893411|76168539|FG001|Overall Study|Protocol Violation|0|||
42330605|NCT01893411|76168540|FG002|Overall Study|Protocol Violation|0|||
42330606|NCT01893411|76168538|FG000|Overall Study|Physician Decision|1|||
42330607|NCT01893411|76168539|FG001|Overall Study|Physician Decision|1|||
42330608|NCT01893411|76168540|FG002|Overall Study|Physician Decision|2|||
42330609|NCT01893411|76168538|FG000|Overall Study|Lack of Efficacy|2|||
42330610|NCT01893411|76168539|FG001|Overall Study|Lack of Efficacy|1|||
42330611|NCT01893411|76168540|FG002|Overall Study|Lack of Efficacy|0|||
42330612|NCT01893411|76168538|FG000|Overall Study|Other|3|||
42330613|NCT01893411|76168539|FG001|Overall Study|Other|1|||
42330614|NCT01893411|76168540|FG002|Overall Study|Other|3|||
42330615|NCT01893411|76168538|FG000|Overall Study|Adverse Event|1|||
42330616|NCT01893411|76168539|FG001|Overall Study|Adverse Event|0|||
42330617|NCT01893411|76168540|FG002|Overall Study|Adverse Event|0|||
42330618|NCT01893411|76168538|FG000|Overall Study|Withdrawal by Subject|7|||
42330619|NCT01893411|76168539|FG001|Overall Study|Withdrawal by Subject|4|||
42330620|NCT01893411|76168540|FG002|Overall Study|Withdrawal by Subject|3|||
42330621|NCT01893411|76168538|FG000|Overall Study|Lost to Follow-up|2|||
42330622|NCT01893411|76168539|FG001|Overall Study|Lost to Follow-up|0|||
42330623|NCT01893411|76168540|FG002|Overall Study|Lost to Follow-up|1|||
42330624|NCT02232425|76168550|FG000|Overall Study|Lost to Follow-up|6|||
42330625|NCT02232425|76168551|FG001|Overall Study|Lost to Follow-up|2|||
42330626|NCT02232425|76168550|FG000|Overall Study|Adverse Event|2|||
42330627|NCT02232425|76168551|FG001|Overall Study|Adverse Event|0|||
42330628|NCT02232425|76168550|FG000|Overall Study|Withdrawal by Subject|5|||
42330629|NCT02232425|76168551|FG001|Overall Study|Withdrawal by Subject|6|||
42330630|NCT02232425|76168550|FG000|Overall Study|Lack of Efficacy|1|||
42330631|NCT02232425|76168551|FG001|Overall Study|Lack of Efficacy|0|||
42330632|NCT01631435|76168557|FG000|Overall Study|Adverse Event|2|||
42330633|NCT01631435|76168557|FG000|Overall Study|Withdrawal by Subject|2|||
42330634|NCT01631435|76168557|FG000|Overall Study|incomplete study procedure|5|||
42330635|NCT02230085|76168562|FG000|Overall Study|Physician Decision|1|||
42330636|NCT02230085|76168562|FG000|Overall Study|Withdrawal by Subject|3|||
42330637|NCT02202785|76168569|FG000|Overall Study|Study Terminated by Sponsor|1|||
42330638|NCT02202785|76168570|FG001|Overall Study|Study Terminated by Sponsor|6|||
42330639|NCT02202785|76168571|FG002|Overall Study|Study Terminated by Sponsor|4|||
42330640|NCT02202785|76168569|FG000|Overall Study|Withdrawal by Subject|0|||
42330641|NCT02202785|76168570|FG001|Overall Study|Withdrawal by Subject|1|||
42330642|NCT02202785|76168571|FG002|Overall Study|Withdrawal by Subject|0|||
42330643|NCT02202785|76168569|FG000|Overall Study|Lost to Follow-up|0|||
42330644|NCT02202785|76168570|FG001|Overall Study|Lost to Follow-up|1|||
42330645|NCT02202785|76168571|FG002|Overall Study|Lost to Follow-up|0|||
42330646|NCT02202785|76168569|FG000|Overall Study|Reason not Specified|10|||
42330647|NCT02202785|76168570|FG001|Overall Study|Reason not Specified|7|||
42330648|NCT02202785|76168571|FG002|Overall Study|Reason not Specified|13|||
42330649|NCT01882647|76168581|FG000|Overall Study|Lost to Follow-up|2|||
42330650|NCT01882647|76168582|FG001|Overall Study|Lost to Follow-up|2|||
42330651|NCT01882647|76168581|FG000|Overall Study|Withdrawal by Subject|0|||
42330652|NCT01882647|76168582|FG001|Overall Study|Withdrawal by Subject|4|||
42330653|NCT01882257|76168591|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
42330654|NCT01882257|76168592|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
42330655|NCT01882257|76168593|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
42330656|NCT01882257|76168591|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
42330657|NCT01882257|76168592|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
42330658|NCT01882257|76168593|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
42330659|NCT01862991|76168603|FG000|Overall Study|Lost to Follow-up|2|||
42330660|NCT01862991|76168604|FG001|Overall Study|Lost to Follow-up|1|||
42330661|NCT01862991|76168605|FG002|Overall Study|Lost to Follow-up|1|||
42330662|NCT01862991|76168603|FG000|Overall Study|Protocol Violation|1|||
42330663|NCT01862991|76168604|FG001|Overall Study|Protocol Violation|0|||
42330664|NCT01862991|76168605|FG002|Overall Study|Protocol Violation|0|||
42330665|NCT02202551|76168617|FG000|Overall Study|Adverse Event|8|||
42330666|NCT02202551|76168618|FG001|Overall Study|Adverse Event|19|||
42330667|NCT02202551|76168619|FG002|Overall Study|Adverse Event|5|||
42330668|NCT02202551|76168620|FG003|Overall Study|Adverse Event|9|||
42330669|NCT02202551|76168617|FG000|Overall Study|Death|3|||
42330670|NCT02202551|76168618|FG001|Overall Study|Death|2|||
42330671|NCT02202551|76168619|FG002|Overall Study|Death|1|||
42330672|NCT02202551|76168620|FG003|Overall Study|Death|1|||
42330673|NCT02202551|76168617|FG000|Overall Study|Lost to Follow-up|0|||
42330674|NCT02202551|76168618|FG001|Overall Study|Lost to Follow-up|1|||
42330675|NCT02202551|76168619|FG002|Overall Study|Lost to Follow-up|0|||
42330676|NCT02202551|76168620|FG003|Overall Study|Lost to Follow-up|1|||
42330677|NCT02202551|76168617|FG000|Overall Study|Needed to take excluded medication|0|||
42330678|NCT02202551|76168618|FG001|Overall Study|Needed to take excluded medication|2|||
42330679|NCT02202551|76168619|FG002|Overall Study|Needed to take excluded medication|0|||
42330680|NCT02202551|76168620|FG003|Overall Study|Needed to take excluded medication|1|||
42330681|NCT02202551|76168617|FG000|Overall Study|Subject moved away|0|||
42330682|NCT02202551|76168618|FG001|Overall Study|Subject moved away|1|||
42330683|NCT02202551|76168619|FG002|Overall Study|Subject moved away|0|||
42330684|NCT02202551|76168620|FG003|Overall Study|Subject moved away|0|||
42330685|NCT02202551|76168617|FG000|Overall Study|DBS surgery|3|||
42330686|NCT02202551|76168618|FG001|Overall Study|DBS surgery|0|||
42330687|NCT02202551|76168619|FG002|Overall Study|DBS surgery|0|||
42330688|NCT02202551|76168620|FG003|Overall Study|DBS surgery|0|||
42330689|NCT02202551|76168617|FG000|Overall Study|Dyskinesia upon taper|1|||
42330690|NCT02202551|76168618|FG001|Overall Study|Dyskinesia upon taper|0|||
41998424|NCT02760407|75806900|FG002|Overall Study|Death|1|||
41998425|NCT02760407|75806901|FG003|Overall Study|Death|1|||
42330691|NCT02202551|76168619|FG002|Overall Study|Dyskinesia upon taper|0|||
42330692|NCT02202551|76168620|FG003|Overall Study|Dyskinesia upon taper|0|||
42330693|NCT02202551|76168617|FG000|Overall Study|Lack of Efficacy|0|||
42330694|NCT02202551|76168618|FG001|Overall Study|Lack of Efficacy|1|||
42330695|NCT02202551|76168619|FG002|Overall Study|Lack of Efficacy|0|||
42330696|NCT02202551|76168620|FG003|Overall Study|Lack of Efficacy|0|||
42330697|NCT02202551|76168617|FG000|Overall Study|Physician Decision|1|||
42330698|NCT02202551|76168618|FG001|Overall Study|Physician Decision|0|||
42330699|NCT02202551|76168619|FG002|Overall Study|Physician Decision|0|||
42330700|NCT02202551|76168620|FG003|Overall Study|Physician Decision|0|||
42330701|NCT02202551|76168617|FG000|Overall Study|Site closure|3|||
42330702|NCT02202551|76168618|FG001|Overall Study|Site closure|0|||
42330703|NCT02202551|76168619|FG002|Overall Study|Site closure|0|||
42330704|NCT02202551|76168620|FG003|Overall Study|Site closure|1|||
42330705|NCT02202551|76168617|FG000|Overall Study|Unable to complete visits per protocol|1|||
42330706|NCT02202551|76168618|FG001|Overall Study|Unable to complete visits per protocol|0|||
42330707|NCT02202551|76168619|FG002|Overall Study|Unable to complete visits per protocol|0|||
42330708|NCT02202551|76168620|FG003|Overall Study|Unable to complete visits per protocol|0|||
42330709|NCT02202551|76168617|FG000|Overall Study|Worsening Dyskinesia|0|||
42330710|NCT02202551|76168618|FG001|Overall Study|Worsening Dyskinesia|0|||
42330711|NCT02202551|76168619|FG002|Overall Study|Worsening Dyskinesia|0|||
42330712|NCT02202551|76168620|FG003|Overall Study|Worsening Dyskinesia|1|||
42330713|NCT02202551|76168617|FG000|Overall Study|Protocol Violation|0|||
42330714|NCT02202551|76168618|FG001|Overall Study|Protocol Violation|1|||
42330715|NCT02202551|76168619|FG002|Overall Study|Protocol Violation|0|||
42330716|NCT02202551|76168620|FG003|Overall Study|Protocol Violation|0|||
42330717|NCT02202551|76168617|FG000|Overall Study|Sponsor's decision|2|||
42330718|NCT02202551|76168618|FG001|Overall Study|Sponsor's decision|0|||
42330719|NCT02202551|76168619|FG002|Overall Study|Sponsor's decision|0|||
42330720|NCT02202551|76168620|FG003|Overall Study|Sponsor's decision|0|||
42330721|NCT02202551|76168617|FG000|Overall Study|Subject unwilling to proceed|1|||
42330722|NCT02202551|76168618|FG001|Overall Study|Subject unwilling to proceed|5|||
42330723|NCT02202551|76168619|FG002|Overall Study|Subject unwilling to proceed|3|||
42330724|NCT02202551|76168620|FG003|Overall Study|Subject unwilling to proceed|5|||
42330725|NCT02202551|76168617|FG000|Overall Study|Subject consent withdrawn|0|||
42330726|NCT02202551|76168618|FG001|Overall Study|Subject consent withdrawn|3|||
42330727|NCT02202551|76168619|FG002|Overall Study|Subject consent withdrawn|1|||
42330728|NCT02202551|76168620|FG003|Overall Study|Subject consent withdrawn|2|||
42330729|NCT02202551|76168617|FG000|Overall Study|eGFR<50mL/min/m2|2|||
42330730|NCT02202551|76168618|FG001|Overall Study|eGFR<50mL/min/m2|2|||
41998426|NCT02760407|75806898|FG000|Overall Study|Lost to Follow-up|1|||
41998427|NCT02760407|75806899|FG001|Overall Study|Lost to Follow-up|7|||
41998428|NCT02760407|75806900|FG002|Overall Study|Lost to Follow-up|4|||
41998429|NCT02760407|75806901|FG003|Overall Study|Lost to Follow-up|6|||
41998430|NCT02760407|75806898|FG000|Overall Study|Withdrawal by Subject|25|||
41998431|NCT02760407|75806899|FG001|Overall Study|Withdrawal by Subject|31|||
41998432|NCT02760407|75806900|FG002|Overall Study|Withdrawal by Subject|37|||
41998433|NCT02760407|75806901|FG003|Overall Study|Withdrawal by Subject|25|||
41998434|NCT02760407|75806898|FG000|Overall Study|Violation of Eligibility criteria|0|||
41998435|NCT02760407|75806899|FG001|Overall Study|Violation of Eligibility criteria|0|||
41998436|NCT02760407|75806900|FG002|Overall Study|Violation of Eligibility criteria|1|||
41998437|NCT02760407|75806901|FG003|Overall Study|Violation of Eligibility criteria|1|||
41998438|NCT02760407|75806898|FG000|Overall Study|Personal reasons|0|||
41998439|NCT02760407|75806899|FG001|Overall Study|Personal reasons|0|||
41998440|NCT02760407|75806900|FG002|Overall Study|Personal reasons|0|||
41998441|NCT02760407|75806901|FG003|Overall Study|Personal reasons|1|||
41998442|NCT02760407|75806898|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
41998443|NCT02760407|75806899|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
41998444|NCT02760407|75806900|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
41998445|NCT02760407|75806901|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
41998446|NCT02760407|75806898|FG000|Overall Study|Use of prohibited Medication|0|||
41998447|NCT02760407|75806899|FG001|Overall Study|Use of prohibited Medication|0|||
41998448|NCT02760407|75806900|FG002|Overall Study|Use of prohibited Medication|1|||
41998449|NCT02760407|75806901|FG003|Overall Study|Use of prohibited Medication|0|||
42263049|NCT03836001|76090817|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
42263050|NCT03836001|76090818|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
42263051|NCT03836001|76090816|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
42263052|NCT03836001|76090817|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
42263053|NCT03836001|76090818|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
42263054|NCT03836001|76090816|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
42263055|NCT03836001|76090817|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
42263056|NCT03836001|76090818|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
42263057|NCT02465866|76090825|FG000|Period 3|Withdrawal by Subject|0|||
42263058|NCT02465866|76090826|FG001|Period 3|Withdrawal by Subject|1|||
42263059|NCT02465866|76090827|FG002|Period 3|Withdrawal by Subject|0|||
42330731|NCT02202551|76168619|FG002|Overall Study|eGFR<50mL/min/m2|0|||
42330732|NCT02202551|76168620|FG003|Overall Study|eGFR<50mL/min/m2|1|||
42330733|NCT02202317|76168634|FG000|Overall Study|Lost to Follow-up|1|||
42330734|NCT02118337|76168647|FG000|Overall Study|Other|1|||
42330735|NCT02118337|76168648|FG001|Overall Study|Other|0|||
42330736|NCT02118337|76168649|FG002|Overall Study|Other|0|||
42330737|NCT02118337|76168650|FG003|Overall Study|Other|0|||
42330738|NCT02118337|76168651|FG004|Overall Study|Other|2|||
42330739|NCT02118337|76168652|FG005|Overall Study|Other|3|||
42330740|NCT02118337|76168653|FG006|Overall Study|Other|1|||
42330741|NCT02118337|76168654|FG007|Overall Study|Other|28|||
42330742|NCT02118337|76168655|FG008|Overall Study|Other|15|||
42330743|NCT02118337|76168647|FG000|Overall Study|Lost to Follow-up|0|||
42330744|NCT02118337|76168648|FG001|Overall Study|Lost to Follow-up|0|||
42330745|NCT02118337|76168649|FG002|Overall Study|Lost to Follow-up|0|||
42330746|NCT02118337|76168650|FG003|Overall Study|Lost to Follow-up|0|||
42330747|NCT02118337|76168651|FG004|Overall Study|Lost to Follow-up|0|||
42330748|NCT02118337|76168652|FG005|Overall Study|Lost to Follow-up|0|||
42330749|NCT02118337|76168653|FG006|Overall Study|Lost to Follow-up|0|||
42330750|NCT02118337|76168654|FG007|Overall Study|Lost to Follow-up|1|||
42330751|NCT02118337|76168655|FG008|Overall Study|Lost to Follow-up|0|||
42330752|NCT02118337|76168647|FG000|Overall Study|Withdrawal by Subject|1|||
42330753|NCT02118337|76168648|FG001|Overall Study|Withdrawal by Subject|3|||
42330754|NCT02118337|76168649|FG002|Overall Study|Withdrawal by Subject|2|||
42330755|NCT02118337|76168650|FG003|Overall Study|Withdrawal by Subject|1|||
42330756|NCT02118337|76168651|FG004|Overall Study|Withdrawal by Subject|2|||
42330757|NCT02118337|76168652|FG005|Overall Study|Withdrawal by Subject|2|||
42330758|NCT02118337|76168653|FG006|Overall Study|Withdrawal by Subject|1|||
42330759|NCT02118337|76168654|FG007|Overall Study|Withdrawal by Subject|4|||
42330760|NCT02118337|76168655|FG008|Overall Study|Withdrawal by Subject|2|||
42330761|NCT02118337|76168647|FG000|Overall Study|Death|2|||
42330762|NCT02118337|76168648|FG001|Overall Study|Death|2|||
42330763|NCT02118337|76168649|FG002|Overall Study|Death|1|||
42330764|NCT02118337|76168650|FG003|Overall Study|Death|2|||
42330765|NCT02118337|76168651|FG004|Overall Study|Death|5|||
42330766|NCT02118337|76168652|FG005|Overall Study|Death|1|||
42330767|NCT02118337|76168653|FG006|Overall Study|Death|2|||
42330768|NCT02118337|76168654|FG007|Overall Study|Death|9|||
42330769|NCT02118337|76168655|FG008|Overall Study|Death|4|||
42330770|NCT02117713|76168679|FG000|Week 48|Adverse Event|4|||
42330771|NCT02117713|76168679|FG000|Week 48|Withdrawal by caregiver|2|||
42330772|NCT02117713|76168679|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
42330773|NCT02117713|76168679|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
42330774|NCT02117713|76168679|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
42330775|NCT02117713|76168679|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
42330776|NCT02105467|76168693|FG000|Period 1|Lost to Follow-up|1|||
42330777|NCT02105467|76168694|FG001|Period 1|Lost to Follow-up|0|||
42330778|NCT02105467|76168693|FG000|Period 1|Death|1|||
42330779|NCT02105467|76168694|FG001|Period 1|Death|0|||
42330780|NCT02105467|76168693|FG000|Period 2|Lost to Follow-up|1|||
42330781|NCT02105467|76168694|FG001|Period 2|Lost to Follow-up|0|||
42330782|NCT02105467|76168693|FG000|Period 2|Death|1|||
42330783|NCT02105467|76168694|FG001|Period 2|Death|0|||
42330784|NCT02105467|76168693|FG000|Period 2|Withdrawal by Subject|0|||
42330785|NCT02105467|76168694|FG001|Period 2|Withdrawal by Subject|2|||
42330786|NCT02105467|76168693|FG000|Period 3|Lost to Follow-up|0|||
42330787|NCT02105467|76168694|FG001|Period 3|Lost to Follow-up|1|||
42330788|NCT02202161|76168709|FG000|Overall Study|Adverse Event|1|||
42330789|NCT02202161|76168710|FG001|Overall Study|Adverse Event|1|||
42330790|NCT02202161|76168711|FG002|Overall Study|Adverse Event|0|||
42330791|NCT02202161|76168712|FG003|Overall Study|Adverse Event|0|||
42330792|NCT02202161|76168713|FG004|Overall Study|Adverse Event|0|||
42330793|NCT02202161|76168714|FG005|Overall Study|Adverse Event|1|||
42330794|NCT02202161|76168715|FG006|Overall Study|Adverse Event|0|||
42330795|NCT02202161|76168716|FG007|Overall Study|Adverse Event|0|||
42330796|NCT02202161|76168709|FG000|Overall Study|Did not meet continuation criteria|0|||
42330797|NCT02202161|76168710|FG001|Overall Study|Did not meet continuation criteria|0|||
42263060|NCT02465866|76090828|FG003|Period 3|Withdrawal by Subject|0|||
42263061|NCT02439970|76090840|FG000|Overall Study|Study Terminated|2|||
42330798|NCT02202161|76168711|FG002|Overall Study|Did not meet continuation criteria|0|||
42330799|NCT02202161|76168712|FG003|Overall Study|Did not meet continuation criteria|0|||
42330800|NCT02202161|76168713|FG004|Overall Study|Did not meet continuation criteria|0|||
41998450|NCT02760407|75806898|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
41998451|NCT02760407|75806899|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
42263062|NCT02439970|76090841|FG001|Overall Study|Study Terminated|3|||
42263063|NCT02437864|76090849|FG000|Overall Study|Protocol Violation|4|||
42263064|NCT02437864|76090850|FG001|Overall Study|Protocol Violation|0|||
42263065|NCT02408068|76090856|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
42263066|NCT02408068|76090857|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
42263067|NCT02408068|76090858|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
42263068|NCT02408068|76090859|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
42263069|NCT02408068|76090860|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
42263070|NCT02408068|76090861|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
42330801|NCT02202161|76168714|FG005|Overall Study|Did not meet continuation criteria|0|||
42330802|NCT02202161|76168715|FG006|Overall Study|Did not meet continuation criteria|0|||
42330803|NCT02202161|76168716|FG007|Overall Study|Did not meet continuation criteria|3|||
42330804|NCT02202161|76168709|FG000|Overall Study|Physician Decision|0|||
42330805|NCT02202161|76168710|FG001|Overall Study|Physician Decision|0|||
42330806|NCT02202161|76168711|FG002|Overall Study|Physician Decision|0|||
42330807|NCT02202161|76168712|FG003|Overall Study|Physician Decision|0|||
42330808|NCT02202161|76168713|FG004|Overall Study|Physician Decision|0|||
42330809|NCT02202161|76168714|FG005|Overall Study|Physician Decision|0|||
42330810|NCT02202161|76168715|FG006|Overall Study|Physician Decision|0|||
42330811|NCT02202161|76168716|FG007|Overall Study|Physician Decision|3|||
42330812|NCT02202161|76168709|FG000|Overall Study|Withdrawal by Subject|0|||
42330813|NCT02202161|76168710|FG001|Overall Study|Withdrawal by Subject|0|||
42330814|NCT02202161|76168711|FG002|Overall Study|Withdrawal by Subject|0|||
42330815|NCT02202161|76168712|FG003|Overall Study|Withdrawal by Subject|0|||
42330816|NCT02202161|76168713|FG004|Overall Study|Withdrawal by Subject|1|||
42330817|NCT02202161|76168714|FG005|Overall Study|Withdrawal by Subject|0|||
42330818|NCT02202161|76168715|FG006|Overall Study|Withdrawal by Subject|0|||
42330819|NCT02202161|76168716|FG007|Overall Study|Withdrawal by Subject|0|||
42330820|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Adverse Event|76|||
42330821|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Adverse Event|0|||
42330822|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Adverse Event|0|||
42330823|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Death|3|||
42330824|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Death|0|||
42330825|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Death|0|||
42330826|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
42330827|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
42330828|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
42330829|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Physician Decision|9|||
42330830|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Physician Decision|0|||
42330831|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Physician Decision|0|||
42330832|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
42330833|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
42330834|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
42330835|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Disease progression|45|||
42330836|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Disease progression|0|||
42330837|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Disease progression|0|||
42330838|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
42330839|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
42330840|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
42330841|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
42330842|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
42330843|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
42330844|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
42330845|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
42330846|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
42330847|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
42330848|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
42330849|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
42330850|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
42330851|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
42330852|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
42330853|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
42330854|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
42330855|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
42330856|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
42330857|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
42330858|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
42330859|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
42330860|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
42330861|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
42330862|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
42134174|NCT00313300|75945047|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
42134175|NCT00313300|75945048|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
42134176|NCT00313300|75945049|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
42330863|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
42330864|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
42134177|NCT00313300|75945050|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
42330865|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Promotor request|1|||
42330866|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Promotor request|0|||
42330867|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Promotor request|0|||
42330868|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
42330869|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
42330870|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
42330871|NCT01461928|76168735|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
42330872|NCT01461928|76168736|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
42330873|NCT01461928|76168737|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
42330874|NCT01461928|76168735|FG000|Maintenance I (24 Months)|Death|3|||
42330875|NCT01461928|76168736|FG001|Maintenance I (24 Months)|Death|0|||
42330876|NCT01461928|76168737|FG002|Maintenance I (24 Months)|Death|0|||
41998452|NCT02760407|75806900|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
41998453|NCT02760407|75806901|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
41998454|NCT02760407|75806898|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
41998455|NCT02760407|75806899|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
41998456|NCT02760407|75806900|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
41998457|NCT02760407|75806901|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
41998458|NCT02760407|75806898|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
41998459|NCT02760407|75806899|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
41998460|NCT02760407|75806900|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
41998461|NCT02760407|75806901|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
41998462|NCT02760407|75806898|FG000|Overall Study|Inadequately Enrolled|0|||
41998463|NCT02760407|75806899|FG001|Overall Study|Inadequately Enrolled|0|||
41998464|NCT02760407|75806900|FG002|Overall Study|Inadequately Enrolled|0|||
41998465|NCT02760407|75806901|FG003|Overall Study|Inadequately Enrolled|1|||
41998466|NCT02760407|75806898|FG000|Overall Study|Withdrawal By PI's Decision|0|||
41998467|NCT02760407|75806899|FG001|Overall Study|Withdrawal By PI's Decision|1|||
41998468|NCT02760407|75806900|FG002|Overall Study|Withdrawal By PI's Decision|0|||
41998469|NCT02760407|75806901|FG003|Overall Study|Withdrawal By PI's Decision|0|||
41998470|NCT02760407|75806898|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
41998471|NCT02760407|75806899|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
41998472|NCT02760407|75806900|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
41998473|NCT02760407|75806901|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
41998474|NCT02760407|75806898|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
41998475|NCT02760407|75806899|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
41998476|NCT02760407|75806900|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
41998477|NCT02760407|75806901|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
41998478|NCT02760407|75806898|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
41998479|NCT02760407|75806899|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
41998480|NCT02760407|75806900|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
41998481|NCT02760407|75806901|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
41998482|NCT02760407|75806898|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
42330877|NCT01461928|76168735|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
42330878|NCT01461928|76168736|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
42330879|NCT01461928|76168737|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
42330880|NCT01461928|76168735|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
42330881|NCT01461928|76168736|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
42330882|NCT01461928|76168737|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
42330883|NCT01461928|76168735|FG000|Maintenance I (24 Months)|Diseases progression|91|||
42330884|NCT01461928|76168736|FG001|Maintenance I (24 Months)|Diseases progression|0|||
42330885|NCT01461928|76168737|FG002|Maintenance I (24 Months)|Diseases progression|0|||
42330886|NCT01461928|76168735|FG000|Maintenance I (24 Months)|Adverse Event|70|||
42330887|NCT01461928|76168736|FG001|Maintenance I (24 Months)|Adverse Event|0|||
42330888|NCT01461928|76168737|FG002|Maintenance I (24 Months)|Adverse Event|0|||
42330889|NCT01461928|76168735|FG000|Maintenance I (24 Months)|Physician Decision|9|||
42330890|NCT01461928|76168736|FG001|Maintenance I (24 Months)|Physician Decision|0|||
41998483|NCT02760407|75806899|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
41998484|NCT02760407|75806900|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
41998485|NCT02760407|75806901|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
42134178|NCT00313300|75945051|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
42134179|NCT00313300|75945047|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
42330891|NCT01461928|76168737|FG002|Maintenance I (24 Months)|Physician Decision|0|||
42330892|NCT01461928|76168735|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
42330893|NCT01461928|76168736|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
42330894|NCT01461928|76168737|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
42330895|NCT01461928|76168735|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
42330896|NCT01461928|76168736|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
42330897|NCT01461928|76168737|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
42330898|NCT01461928|76168735|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
42330899|NCT01461928|76168736|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
42330900|NCT01461928|76168737|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
42330901|NCT01461928|76168735|FG000|Maintenance I (24 Months)|Not compliant|1|||
42330902|NCT01461928|76168736|FG001|Maintenance I (24 Months)|Not compliant|0|||
42330903|NCT01461928|76168737|FG002|Maintenance I (24 Months)|Not compliant|0|||
42330904|NCT01461928|76168735|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
42330905|NCT01461928|76168736|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
42330906|NCT01461928|76168737|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
42330907|NCT01461928|76168735|FG000|Maintenance II (15 Months)|Adverse Event|0|||
42330908|NCT01461928|76168736|FG001|Maintenance II (15 Months)|Adverse Event|2|||
41998486|NCT02760407|75806898|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
41998487|NCT02760407|75806899|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
41998488|NCT02760407|75806900|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
41998489|NCT02760407|75806901|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
41998490|NCT02760407|75806898|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
41998491|NCT02760407|75806899|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
41998492|NCT02760407|75806900|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
41998493|NCT02760407|75806901|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
41998494|NCT02760407|75806898|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
41998495|NCT02760407|75806899|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
41998496|NCT02760407|75806900|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
41998497|NCT02760407|75806901|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
41998498|NCT02760407|75806898|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
41998499|NCT02760407|75806899|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
41998500|NCT02760407|75806900|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
41998501|NCT02760407|75806901|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
41998502|NCT02760407|75806898|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
41998503|NCT02760407|75806899|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
41998504|NCT02760407|75806900|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
41998505|NCT02760407|75806901|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
41998506|NCT02760368|75806917|FG000|Overall Study|Withdrawal by Subject|8|||
41998507|NCT02760368|75806918|FG001|Overall Study|Withdrawal by Subject|12|||
42330909|NCT01461928|76168737|FG002|Maintenance II (15 Months)|Adverse Event|0|||
42330910|NCT01461928|76168735|FG000|Maintenance II (15 Months)|Death|0|||
42330911|NCT01461928|76168736|FG001|Maintenance II (15 Months)|Death|10|||
42330912|NCT01461928|76168737|FG002|Maintenance II (15 Months)|Death|8|||
42330913|NCT01461928|76168735|FG000|Maintenance II (15 Months)|Physician Decision|0|||
42330914|NCT01461928|76168736|FG001|Maintenance II (15 Months)|Physician Decision|0|||
42330915|NCT01461928|76168737|FG002|Maintenance II (15 Months)|Physician Decision|4|||
42330916|NCT01461928|76168735|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
42330917|NCT01461928|76168736|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
42330918|NCT01461928|76168737|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
42330919|NCT01461928|76168735|FG000|Maintenance II (15 Months)|Moved to another town|0|||
41998508|NCT02760368|75806919|FG002|Overall Study|Withdrawal by Subject|9|||
41998509|NCT02760368|75806917|FG000|Overall Study|Screen Failure|0|||
41998510|NCT02760368|75806918|FG001|Overall Study|Screen Failure|0|||
41998511|NCT02760368|75806919|FG002|Overall Study|Screen Failure|1|||
41998512|NCT02760368|75806917|FG000|Overall Study|Death|0|||
41998513|NCT02760368|75806918|FG001|Overall Study|Death|1|||
41998514|NCT02760368|75806919|FG002|Overall Study|Death|0|||
41998515|NCT02760368|75806917|FG000|Overall Study|Withdrawal by Sponsor|0|||
41998516|NCT02760368|75806918|FG001|Overall Study|Withdrawal by Sponsor|0|||
41998517|NCT02760368|75806919|FG002|Overall Study|Withdrawal by Sponsor|1|||
42263071|NCT01361126|76090874|FG000|Overall Study|Sponsor decision|0|||
42263072|NCT01361126|76090875|FG001|Overall Study|Sponsor decision|2|||
42263073|NCT04428645|76090882|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
42263074|NCT01368835|76090886|FG000|Overall Study|Inclusion criteria/photography quality|22|||
42263075|NCT01368835|76090886|FG000|Overall Study|Lost to Follow-up|11|||
42263076|NCT02407990|76090905|FG000|Overall Study|Death|2|||
42263077|NCT02407990|76090906|FG001|Overall Study|Death|22|||
42263078|NCT02407990|76090907|FG002|Overall Study|Death|23|||
42263079|NCT02407990|76090908|FG003|Overall Study|Death|7|||
42263080|NCT02407990|76090909|FG004|Overall Study|Death|17|||
42263081|NCT02407990|76090910|FG005|Overall Study|Death|16|||
41998518|NCT02747004|75806933|FG000|Overall Study|Withdrawal by Subject|8|||
41998519|NCT02747004|75806934|FG001|Overall Study|Withdrawal by Subject|5|||
41998520|NCT02747004|75806935|FG002|Overall Study|Withdrawal by Subject|4|||
41998521|NCT02747004|75806933|FG000|Overall Study|Lost to Follow-up|1|||
41998522|NCT02747004|75806934|FG001|Overall Study|Lost to Follow-up|2|||
41998523|NCT02747004|75806935|FG002|Overall Study|Lost to Follow-up|2|||
41998524|NCT02747004|75806933|FG000|Overall Study|on study treatment/follow-up|48|||
41998525|NCT02747004|75806934|FG001|Overall Study|on study treatment/follow-up|42|||
42330920|NCT01461928|76168736|FG001|Maintenance II (15 Months)|Moved to another town|1|||
42330921|NCT01461928|76168737|FG002|Maintenance II (15 Months)|Moved to another town|0|||
42330922|NCT01461928|76168735|FG000|Maintenance II (15 Months)|Disease progression|0|||
42330923|NCT01461928|76168736|FG001|Maintenance II (15 Months)|Disease progression|0|||
41998526|NCT02747004|75806935|FG002|Overall Study|on study treatment/follow-up|41|||
41998527|NCT02741570|75806945|FG000|Pre-Treatment Period|Other reasons|0|||
41998528|NCT02741570|75806946|FG001|Pre-Treatment Period|Other reasons|3|||
41998529|NCT02741570|75806945|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
41998530|NCT02741570|75806946|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
41998531|NCT02741570|75806945|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
41998532|NCT02741570|75806946|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
41998533|NCT02741570|75806945|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
41998534|NCT02741570|75806946|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
41998535|NCT02741570|75806945|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
41998536|NCT02741570|75806946|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
41998537|NCT02741570|75806945|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
41998538|NCT02741570|75806946|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
41998539|NCT02741570|75806945|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
41998540|NCT02741570|75806946|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
41998541|NCT02741570|75806945|FG000|Pre-Treatment Period|Death|0|||
41998542|NCT02741570|75806946|FG001|Pre-Treatment Period|Death|1|||
41998543|NCT02741570|75806945|FG000|Pre-Treatment Period|Disease progression|0|||
41998544|NCT02741570|75806946|FG001|Pre-Treatment Period|Disease progression|1|||
41998545|NCT02741570|75806945|FG000|Treatment Period|Other reasons|47|||
41998546|NCT02741570|75806946|FG001|Treatment Period|Other reasons|12|||
42330924|NCT01461928|76168737|FG002|Maintenance II (15 Months)|Disease progression|3|||
42330925|NCT01461928|76168735|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
42330926|NCT01461928|76168736|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
42330927|NCT01461928|76168737|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
42330928|NCT01461928|76168735|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
42330929|NCT01461928|76168736|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
42330930|NCT01461928|76168737|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
42330931|NCT01461928|76168735|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
42330932|NCT01461928|76168736|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
42330933|NCT01461928|76168737|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
42330934|NCT01461928|76168735|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
42330935|NCT01461928|76168736|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
42330936|NCT01461928|76168737|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
42330937|NCT01461928|76168735|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
42330938|NCT01461928|76168736|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
42330939|NCT01461928|76168737|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
41998547|NCT02741570|75806945|FG000|Treatment Period|Poor/non-compliance|0|||
41998548|NCT02741570|75806946|FG001|Treatment Period|Poor/non-compliance|2|||
41998549|NCT02741570|75806945|FG000|Treatment Period|Maximum clinical benefit|4|||
41998550|NCT02741570|75806946|FG001|Treatment Period|Maximum clinical benefit|6|||
41998551|NCT02741570|75806945|FG000|Treatment Period|Lost to Follow-up|1|||
41998552|NCT02741570|75806946|FG001|Treatment Period|Lost to Follow-up|3|||
41998553|NCT02741570|75806945|FG000|Treatment Period|Participant withdrew consent|9|||
41998554|NCT02741570|75806946|FG001|Treatment Period|Participant withdrew consent|13|||
41998555|NCT02741570|75806945|FG000|Treatment Period|Participant request to discontinue treatment|8|||
41998556|NCT02741570|75806946|FG001|Treatment Period|Participant request to discontinue treatment|23|||
41998557|NCT02741570|75806945|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
41998558|NCT02741570|75806946|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
41998559|NCT02741570|75806945|FG000|Treatment Period|Death|9|||
41998560|NCT02741570|75806946|FG001|Treatment Period|Death|7|||
41998561|NCT02741570|75806945|FG000|Treatment Period|Study drug toxicity|55|||
41998562|NCT02741570|75806946|FG001|Treatment Period|Study drug toxicity|47|||
41998563|NCT02741570|75806945|FG000|Treatment Period|Disease progression|294|||
41998564|NCT02741570|75806946|FG001|Treatment Period|Disease progression|301|||
42330940|NCT03097991|76168750|FG000|Overall Study|Didn't meet study criteria|8|||
42330941|NCT03097991|76168751|FG001|Overall Study|Didn't meet study criteria|0|||
42330942|NCT03097991|76168750|FG000|Overall Study|Withdrawal by Subject|12|||
41998565|NCT02741570|75806945|FG000|Treatment Period|Administrative reason by sponsor|0|||
41998566|NCT02741570|75806946|FG001|Treatment Period|Administrative reason by sponsor|1|||
41998567|NCT02675231|75806973|FG000|Overall Study|Withdrawal by Subject|1|||
41998568|NCT02675231|75806974|FG001|Overall Study|Withdrawal by Subject|3|||
41998569|NCT02675231|75806975|FG002|Overall Study|Withdrawal by Subject|1|||
41998570|NCT02675231|75806973|FG000|Overall Study|Lost to Follow-up|2|||
41998571|NCT02675231|75806974|FG001|Overall Study|Lost to Follow-up|2|||
41998572|NCT02675231|75806975|FG002|Overall Study|Lost to Follow-up|2|||
42330943|NCT03097991|76168751|FG001|Overall Study|Withdrawal by Subject|6|||
41998573|NCT02675231|75806973|FG000|Overall Study|On study treatment/follow up|23|||
41998574|NCT02675231|75806974|FG001|Overall Study|On study treatment/follow up|31|||
41998575|NCT02675231|75806975|FG002|Overall Study|On study treatment/follow up|23|||
42330944|NCT03097991|76168750|FG000|Overall Study|Death of Baby|3|||
42330945|NCT03097991|76168751|FG001|Overall Study|Death of Baby|1|||
42330946|NCT03097991|76168750|FG000|Overall Study|Lost to Follow-up|24|||
42330947|NCT03097991|76168751|FG001|Overall Study|Lost to Follow-up|38|||
42330948|NCT03097991|76168750|FG000|Overall Study|Adverse Event|3|||
42330949|NCT03097991|76168751|FG001|Overall Study|Adverse Event|5|||
42330950|NCT02623205|76168763|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
42330951|NCT02623205|76168764|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
42330952|NCT01500694|76168773|FG000|Overall Study|Adverse Event|4|||
42330953|NCT01500694|76168774|FG001|Overall Study|Adverse Event|3|||
42330954|NCT01500694|76168773|FG000|Overall Study|Protocol Violation|0|||
42330955|NCT01500694|76168774|FG001|Overall Study|Protocol Violation|1|||
42330956|NCT01500694|76168773|FG000|Overall Study|Withdrawal by Subject|23|||
42330957|NCT01500694|76168774|FG001|Overall Study|Withdrawal by Subject|14|||
42330958|NCT01500694|76168773|FG000|Overall Study|Lost to Follow-up|2|||
42330959|NCT01500694|76168774|FG001|Overall Study|Lost to Follow-up|3|||
42330960|NCT01500694|76168773|FG000|Overall Study|Lack of Efficacy|14|||
42330961|NCT01500694|76168774|FG001|Overall Study|Lack of Efficacy|5|||
42330962|NCT01500694|76168773|FG000|Overall Study|Other|9|||
42330963|NCT01500694|76168774|FG001|Overall Study|Other|3|||
42330964|NCT01500382|76168784|FG000|Washout Period|Study site went out of business|0|||
42330965|NCT01500382|76168785|FG001|Washout Period|Study site went out of business|0|||
42330966|NCT01500382|76168786|FG002|Washout Period|Study site went out of business|1|||
42330967|NCT01500382|76168787|FG003|Washout Period|Study site went out of business|0|||
42330968|NCT02137837|76168800|FG000|Overall Study|Adverse Event|0|||
42330969|NCT02137837|76168801|FG001|Overall Study|Adverse Event|2|||
42330970|NCT02137837|76168802|FG002|Overall Study|Adverse Event|1|||
42330971|NCT02137837|76168800|FG000|Overall Study|Refusal unrelated to adverse event|2|||
42330972|NCT02137837|76168801|FG001|Overall Study|Refusal unrelated to adverse event|2|||
42330973|NCT02137837|76168802|FG002|Overall Study|Refusal unrelated to adverse event|1|||
42330974|NCT02137837|76168800|FG000|Overall Study|Progression/relapse|9|||
42330975|NCT02137837|76168801|FG001|Overall Study|Progression/relapse|7|||
42330976|NCT02137837|76168802|FG002|Overall Study|Progression/relapse|7|||
42330977|NCT02137837|76168800|FG000|Overall Study|Not protocol specified|2|||
42330978|NCT02137837|76168801|FG001|Overall Study|Not protocol specified|1|||
42330979|NCT02137837|76168802|FG002|Overall Study|Not protocol specified|3|||
42330980|NCT01483690|76168817|FG000|Overall Study|Adverse Event|1|||
42330981|NCT01483690|76168818|FG001|Overall Study|Adverse Event|2|||
42330982|NCT01483690|76168817|FG000|Overall Study|clinical deterioration|1|||
41998576|NCT02603887|75806988|FG000|Stage 1|Adverse Event|4|||
41998577|NCT02603887|75806988|FG000|Stage 1|Disease progression|1|||
41998578|NCT02603887|75806988|FG000|Stage 2|FDA guidance|1|||
41998579|NCT02554279|75806994|FG000|Overall Study|Adverse Event|2|||
41998580|NCT02554279|75806995|FG001|Overall Study|Adverse Event|5|||
41998581|NCT02554279|75806994|FG000|Overall Study|Lost to Follow-up|3|||
41998582|NCT02554279|75806995|FG001|Overall Study|Lost to Follow-up|2|||
41998583|NCT02554279|75806994|FG000|Overall Study|Withdrawal by Subject|6|||
41998584|NCT02554279|75806995|FG001|Overall Study|Withdrawal by Subject|4|||
41998585|NCT02554279|75806994|FG000|Overall Study|Protocol Violation|2|||
41998586|NCT02554279|75806995|FG001|Overall Study|Protocol Violation|1|||
41998587|NCT02554279|75806994|FG000|Overall Study|Other reason|19|||
41998588|NCT02554279|75806995|FG001|Overall Study|Other reason|6|||
41998589|NCT02542293|75807010|FG000|Overall Study|Death|367|||
41998590|NCT02542293|75807011|FG001|Overall Study|Death|377|||
41998591|NCT02542293|75807010|FG000|Overall Study|Withdrawal by Subject|8|||
42330983|NCT01483690|76168818|FG001|Overall Study|clinical deterioration|0|||
42330984|NCT01483690|76168817|FG000|Overall Study|Physician Decision|0|||
42330985|NCT01483690|76168818|FG001|Overall Study|Physician Decision|2|||
42330986|NCT01483690|76168817|FG000|Overall Study|exclusionary procedure|0|||
41998592|NCT02542293|75807011|FG001|Overall Study|Withdrawal by Subject|19|||
42330987|NCT01483690|76168818|FG001|Overall Study|exclusionary procedure|1|||
42330988|NCT02104765|76168831|FG000|Overall Study|Lost to Follow-up|0|||
42330989|NCT02104765|76168832|FG001|Overall Study|Lost to Follow-up|0|||
42330990|NCT02104765|76168833|FG002|Overall Study|Lost to Follow-up|1|||
41998593|NCT02439450|75807039|FG000|Overall Study|Adverse Event|4|||
41998594|NCT02439450|75807040|FG001|Overall Study|Adverse Event|1|||
42330991|NCT02104765|76168834|FG003|Overall Study|Lost to Follow-up|0|||
42330992|NCT02104765|76168835|FG004|Overall Study|Lost to Follow-up|0|||
42330993|NCT02104765|76168836|FG005|Overall Study|Lost to Follow-up|0|||
42330994|NCT02104765|76168837|FG006|Overall Study|Lost to Follow-up|0|||
42330995|NCT02104765|76168831|FG000|Overall Study|Withdrawal by Subject|0|||
42330996|NCT02104765|76168832|FG001|Overall Study|Withdrawal by Subject|0|||
42330997|NCT02104765|76168833|FG002|Overall Study|Withdrawal by Subject|0|||
42330998|NCT02104765|76168834|FG003|Overall Study|Withdrawal by Subject|1|||
42330999|NCT02104765|76168835|FG004|Overall Study|Withdrawal by Subject|1|||
42331000|NCT02104765|76168836|FG005|Overall Study|Withdrawal by Subject|0|||
42331001|NCT02104765|76168837|FG006|Overall Study|Withdrawal by Subject|1|||
42331002|NCT01483144|76168862|FG000|Overall Study|Adverse Event|9|||
42331003|NCT01483144|76168863|FG001|Overall Study|Adverse Event|4|||
42331004|NCT01483144|76168864|FG002|Overall Study|Adverse Event|6|||
42331005|NCT01483144|76168862|FG000|Overall Study|Withdrawal by Subject|0|||
42331006|NCT01483144|76168863|FG001|Overall Study|Withdrawal by Subject|2|||
42331007|NCT01483144|76168864|FG002|Overall Study|Withdrawal by Subject|5|||
42331008|NCT01483144|76168862|FG000|Overall Study|Physician Decision|1|||
42331009|NCT01483144|76168863|FG001|Overall Study|Physician Decision|0|||
42331010|NCT01483144|76168864|FG002|Overall Study|Physician Decision|0|||
42331011|NCT01483144|76168862|FG000|Overall Study|Lost to Follow-up|2|||
42331012|NCT01483144|76168863|FG001|Overall Study|Lost to Follow-up|4|||
42331013|NCT01483144|76168864|FG002|Overall Study|Lost to Follow-up|1|||
42331014|NCT01483144|76168862|FG000|Overall Study|Protocol Violation|3|||
42331015|NCT01483144|76168863|FG001|Overall Study|Protocol Violation|3|||
42331016|NCT01483144|76168864|FG002|Overall Study|Protocol Violation|3|||
42331017|NCT01881789|76168878|FG000|Overall Study|Withdrawal by Subject|0|||
42331018|NCT01881789|76168879|FG001|Overall Study|Withdrawal by Subject|2|||
42331019|NCT01881789|76168880|FG002|Overall Study|Withdrawal by Subject|1|||
42331020|NCT01881789|76168881|FG003|Overall Study|Withdrawal by Subject|0|||
42331021|NCT01881789|76168882|FG004|Overall Study|Withdrawal by Subject|1|||
42331022|NCT01881789|76168883|FG005|Overall Study|Withdrawal by Subject|1|||
42331023|NCT01881789|76168878|FG000|Overall Study|Study Terminated by Sponsor|0|||
42331024|NCT01881789|76168879|FG001|Overall Study|Study Terminated by Sponsor|0|||
42331025|NCT01881789|76168880|FG002|Overall Study|Study Terminated by Sponsor|0|||
42331026|NCT01881789|76168881|FG003|Overall Study|Study Terminated by Sponsor|0|||
42331027|NCT01881789|76168882|FG004|Overall Study|Study Terminated by Sponsor|0|||
42331028|NCT01881789|76168883|FG005|Overall Study|Study Terminated by Sponsor|1|||
42331029|NCT01881789|76168878|FG000|Overall Study|Other|3|||
42331030|NCT01881789|76168879|FG001|Overall Study|Other|5|||
42331031|NCT01881789|76168880|FG002|Overall Study|Other|2|||
42331032|NCT01881789|76168881|FG003|Overall Study|Other|3|||
42331033|NCT01881789|76168882|FG004|Overall Study|Other|1|||
42331034|NCT01881789|76168883|FG005|Overall Study|Other|1|||
42331035|NCT02075203|76168901|FG000|Overall Study|Withdrawal by Subject|1|||
42331036|NCT02075203|76168902|FG001|Overall Study|Withdrawal by Subject|0|||
42331037|NCT02075203|76168903|FG002|Overall Study|Withdrawal by Subject|1|||
42331038|NCT02075203|76168901|FG000|Overall Study|Adverse Event|1|||
42331039|NCT02075203|76168902|FG001|Overall Study|Adverse Event|0|||
42331040|NCT02075203|76168903|FG002|Overall Study|Adverse Event|0|||
42331041|NCT02075203|76168901|FG000|Overall Study|participant refused to use contraception|1|||
42331042|NCT02075203|76168902|FG001|Overall Study|participant refused to use contraception|0|||
42331043|NCT02075203|76168903|FG002|Overall Study|participant refused to use contraception|0|||
42331044|NCT01892163|76168913|FG000|Overall Study|Death|1|||
42331045|NCT01892163|76168914|FG001|Overall Study|Death|1|||
42331046|NCT01892163|76168913|FG000|Overall Study|Lost to Follow-up|1|||
42331047|NCT01892163|76168914|FG001|Overall Study|Lost to Follow-up|0|||
41998595|NCT02439450|75807041|FG002|Overall Study|Adverse Event|0|||
41998596|NCT02439450|75807042|FG003|Overall Study|Adverse Event|0|||
41998597|NCT02439450|75807039|FG000|Overall Study|Withdrawal by Subject|1|||
41998598|NCT02439450|75807040|FG001|Overall Study|Withdrawal by Subject|2|||
42331048|NCT01881009|76168922|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
42331049|NCT01881009|76168923|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
42331050|NCT01500226|76168932|FG000|Overall Study|Adverse Event|31|||
42331051|NCT01500226|76168933|FG001|Overall Study|Adverse Event|38|||
42331052|NCT01500226|76168932|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
42331053|NCT01500226|76168933|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
42331054|NCT01500226|76168932|FG000|Overall Study|Withdrawal by Subject|93|||
42331055|NCT01500226|76168933|FG001|Overall Study|Withdrawal by Subject|96|||
42331056|NCT01500226|76168932|FG000|Overall Study|Death|12|||
42331057|NCT01500226|76168933|FG001|Overall Study|Death|4|||
42331058|NCT01500226|76168932|FG000|Overall Study|Disease Progression|16|||
42331059|NCT01500226|76168933|FG001|Overall Study|Disease Progression|14|||
42331060|NCT01500226|76168932|FG000|Overall Study|Protocol Violation|53|||
42331061|NCT01500226|76168933|FG001|Overall Study|Protocol Violation|39|||
42331062|NCT01500226|76168932|FG000|Overall Study|Physician Decision|17|||
42331063|NCT01500226|76168933|FG001|Overall Study|Physician Decision|15|||
42331064|NCT01500226|76168932|FG000|Overall Study|Lack of Efficacy|14|||
42331065|NCT01500226|76168933|FG001|Overall Study|Lack of Efficacy|30|||
42331066|NCT01500226|76168932|FG000|Overall Study|Lost to Follow-up|9|||
42331067|NCT01500226|76168933|FG001|Overall Study|Lost to Follow-up|5|||
42331068|NCT01500226|76168932|FG000|Overall Study|Other Reasons|19|||
42331069|NCT01500226|76168933|FG001|Overall Study|Other Reasons|16|||
42331070|NCT02075047|76168941|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
42331071|NCT02075047|76168942|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
42331072|NCT02075047|76168941|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
42331073|NCT02075047|76168942|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
42331074|NCT02075047|76168941|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
42331075|NCT02075047|76168942|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
42331076|NCT02075047|76168941|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
42331077|NCT02075047|76168942|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
42331078|NCT02075047|76168941|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
42331079|NCT02075047|76168942|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
42331080|NCT02075047|76168941|FG000|Treatment Phase (4 Weeks)|Other|1|||
42331081|NCT02075047|76168942|FG001|Treatment Phase (4 Weeks)|Other|1|||
42331082|NCT02075047|76168941|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
42331083|NCT02075047|76168942|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
42331084|NCT02075047|76168941|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
42331085|NCT02075047|76168942|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
42331086|NCT02075047|76168941|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
42331087|NCT02075047|76168942|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
42331088|NCT02075047|76168941|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
42331089|NCT02075047|76168942|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
42331090|NCT02075047|76168941|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
42331091|NCT02075047|76168942|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
42331092|NCT02075047|76168941|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
42331093|NCT02075047|76168942|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
42331094|NCT02075047|76168941|FG000|Follow up Phase (5 Weeks)|Other|1|||
42331095|NCT02075047|76168942|FG001|Follow up Phase (5 Weeks)|Other|2|||
42331096|NCT02075047|76168941|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
42331097|NCT02075047|76168942|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
42331098|NCT01859949|76168950|FG000|Overall Study|Family Matters|0|||
42331099|NCT01859949|76168951|FG001|Overall Study|Family Matters|1|||
42331100|NCT01859949|76168950|FG000|Overall Study|Physician Decision|2|||
42331101|NCT01859949|76168951|FG001|Overall Study|Physician Decision|4|||
42331102|NCT01859949|76168950|FG000|Overall Study|Withdrawal by Subject|11|||
42331103|NCT01859949|76168951|FG001|Overall Study|Withdrawal by Subject|10|||
42331104|NCT01859949|76168950|FG000|Overall Study|Protocol Violation|1|||
42331105|NCT01859949|76168951|FG001|Overall Study|Protocol Violation|1|||
42331106|NCT01859949|76168950|FG000|Overall Study|Adverse Event|0|||
42331107|NCT01859949|76168951|FG001|Overall Study|Adverse Event|1|||
42331108|NCT01859793|76168959|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
42331109|NCT01859793|76168960|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
42331110|NCT01859793|76168959|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
42331111|NCT01859793|76168960|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
42331112|NCT01859793|76168959|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
42331113|NCT01859793|76168960|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
42331114|NCT01859793|76168959|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
42331115|NCT01859793|76168960|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
41998599|NCT02439450|75807041|FG002|Overall Study|Withdrawal by Subject|0|||
41998600|NCT02439450|75807042|FG003|Overall Study|Withdrawal by Subject|0|||
41998601|NCT02439450|75807039|FG000|Overall Study|Death|3|||
41998602|NCT02439450|75807040|FG001|Overall Study|Death|0|||
41998603|NCT02439450|75807041|FG002|Overall Study|Death|0|||
41998604|NCT02439450|75807042|FG003|Overall Study|Death|1|||
41998605|NCT02439450|75807039|FG000|Overall Study|Progressive Disease|18|||
41998606|NCT02439450|75807040|FG001|Overall Study|Progressive Disease|41|||
41998607|NCT02439450|75807041|FG002|Overall Study|Progressive Disease|2|||
41998608|NCT02439450|75807042|FG003|Overall Study|Progressive Disease|3|||
41998609|NCT02312258|75807063|FG000|Overall Study|Lost to Follow-up|8|||
41998610|NCT02312258|75807064|FG001|Overall Study|Lost to Follow-up|8|||
41998611|NCT02312258|75807063|FG000|Overall Study|Withdrawal by Patient|49|||
41998612|NCT02312258|75807064|FG001|Overall Study|Withdrawal by Patient|76|||
41998613|NCT02312258|75807063|FG000|Overall Study|Reason not Specified|107|||
41998614|NCT02312258|75807064|FG001|Overall Study|Reason not Specified|159|||
42331116|NCT01859715|76168969|FG000|Overall Study|No 2nd VAS|16|||
42331117|NCT01859715|76168970|FG001|Overall Study|No 2nd VAS|8|||
42331118|NCT01859715|76168971|FG002|Overall Study|No 2nd VAS|23|||
42331119|NCT01890915|76168983|FG000|Overall Study|Adverse Event|1|||
42331120|NCT01890915|76168984|FG001|Overall Study|Adverse Event|0|||
42331121|NCT01890915|76168983|FG000|Overall Study|Protocol Violation|2|||
42331122|NCT01890915|76168984|FG001|Overall Study|Protocol Violation|0|||
41998615|NCT02312258|75807063|FG000|Overall Study|Missing|2|||
42331123|NCT01890915|76168983|FG000|Overall Study|Equipment Malfunction|0|||
42331124|NCT01890915|76168984|FG001|Overall Study|Equipment Malfunction|1|||
42331125|NCT01615263|76168992|FG000|Overall Study|Post-randomization exclusion|0|||
42331126|NCT01615263|76168993|FG001|Overall Study|Post-randomization exclusion|2|||
42331127|NCT01859403|76169010|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
42331128|NCT01859403|76169011|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
42331129|NCT01859403|76169010|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
42331130|NCT01859403|76169011|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
42331131|NCT01859403|76169010|FG000|Primary Endpoint Measure|Physician Decision|0|||
42331132|NCT01859403|76169011|FG001|Primary Endpoint Measure|Physician Decision|1|||
42331133|NCT01859403|76169010|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
42331134|NCT01859403|76169011|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
42331135|NCT01858701|76169017|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
42331136|NCT01858701|76169018|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
42331137|NCT01858701|76169017|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
42331138|NCT01858701|76169018|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
42331139|NCT01858701|76169017|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
42331140|NCT01858701|76169018|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
42331141|NCT01858701|76169017|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
42331142|NCT01858701|76169018|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
42331143|NCT01461538|76169027|FG000|Overall Study|Death|15|||
42331144|NCT01461538|76169028|FG001|Overall Study|Death|6|||
42331145|NCT01461538|76169029|FG002|Overall Study|Death|2|||
42331146|NCT01461538|76169027|FG000|Overall Study|Study Stopped by Sponsor|2|||
42331147|NCT01461538|76169028|FG001|Overall Study|Study Stopped by Sponsor|1|||
42331148|NCT01461538|76169029|FG002|Overall Study|Study Stopped by Sponsor|0|||
42331149|NCT01461538|76169027|FG000|Overall Study|Withdrawal by Subject|1|||
42331150|NCT01461538|76169028|FG001|Overall Study|Withdrawal by Subject|1|||
42331151|NCT01461538|76169029|FG002|Overall Study|Withdrawal by Subject|0|||
42331152|NCT02117479|76169041|FG000|Overall Study|Death|13|||
42331153|NCT02117479|76169042|FG001|Overall Study|Death|8|||
42331154|NCT02117479|76169041|FG000|Overall Study|Adverse Event|8|||
42331155|NCT02117479|76169042|FG001|Overall Study|Adverse Event|16|||
42331156|NCT02117479|76169041|FG000|Overall Study|Subject decision|8|||
42331157|NCT02117479|76169042|FG001|Overall Study|Subject decision|9|||
42331158|NCT02117479|76169041|FG000|Overall Study|Disease progression|104|||
42331159|NCT02117479|76169042|FG001|Overall Study|Disease progression|108|||
42331160|NCT02117479|76169041|FG000|Overall Study|Noncompliance with study treatment|1|||
42331161|NCT02117479|76169042|FG001|Overall Study|Noncompliance with study treatment|0|||
42331162|NCT02117479|76169041|FG000|Overall Study|Study terminated by the sponsor|4|||
42331163|NCT02117479|76169042|FG001|Overall Study|Study terminated by the sponsor|6|||
42331164|NCT02117479|76169041|FG000|Overall Study|Physician Decision|7|||
42331165|NCT02117479|76169042|FG001|Overall Study|Physician Decision|2|||
42331166|NCT02117479|76169041|FG000|Overall Study|Other unspecified|11|||
41998616|NCT02312258|75807064|FG001|Overall Study|Missing|1|||
41998617|NCT02312258|75807063|FG000|Overall Study|Death|115|||
42331167|NCT02117479|76169042|FG001|Overall Study|Other unspecified|7|||
42331168|NCT02229851|76169051|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
42331169|NCT02229851|76169052|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
42331170|NCT02229851|76169053|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
41998618|NCT02312258|75807064|FG001|Overall Study|Death|181|||
41998619|NCT02049515|75807101|FG000|Overall Study|Adverse Event|46|||
41998620|NCT02049515|75807102|FG001|Overall Study|Adverse Event|2|||
41998621|NCT02049515|75807101|FG000|Overall Study|Protocol-specified Disease Progression|23|||
41998622|NCT02049515|75807102|FG001|Overall Study|Protocol-specified Disease Progression|2|||
41998623|NCT02049515|75807101|FG000|Overall Study|Death|6|||
41998624|NCT02049515|75807102|FG001|Overall Study|Death|0|||
41998625|NCT02049515|75807101|FG000|Overall Study|Physician Decision|5|||
41998626|NCT02049515|75807102|FG001|Overall Study|Physician Decision|1|||
41998627|NCT02049515|75807101|FG000|Overall Study|Withdrawal by Subject|3|||
41998628|NCT02049515|75807102|FG001|Overall Study|Withdrawal by Subject|0|||
41998629|NCT02049515|75807101|FG000|Overall Study|Termination of the Study by Sponsor|2|||
41998630|NCT02049515|75807102|FG001|Overall Study|Termination of the Study by Sponsor|0|||
41998631|NCT02049515|75807101|FG000|Overall Study|Protocol Violation|1|||
42331171|NCT02229851|76169054|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
42331172|NCT02229851|76169055|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
41998632|NCT02049515|75807102|FG001|Overall Study|Protocol Violation|1|||
41998633|NCT02049515|75807101|FG000|Overall Study|Clinical Deterioration|1|||
41998634|NCT02049515|75807102|FG001|Overall Study|Clinical Deterioration|0|||
41998635|NCT02049515|75807101|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
41998636|NCT02049515|75807102|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
42331173|NCT02229851|76169056|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
42331174|NCT02229851|76169057|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
42331175|NCT02229851|76169051|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
41998637|NCT02049515|75807101|FG000|Overall Study|Treatment Interruption >42 Days|1|||
41998638|NCT02049515|75807102|FG001|Overall Study|Treatment Interruption >42 Days|0|||
41998639|NCT02049515|75807101|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
41998640|NCT02049515|75807102|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
41998641|NCT02039401|75807110|FG000|Overall Study|Adverse Event|0|||
41998642|NCT02039401|75807111|FG001|Overall Study|Adverse Event|1|||
41998643|NCT02004522|75807120|FG000|Overall Study|Adverse Event|55|||
41998644|NCT02004522|75807121|FG001|Overall Study|Adverse Event|6|||
41998645|NCT02004522|75807120|FG000|Overall Study|Withdrawal by Subject|13|||
41998646|NCT02004522|75807121|FG001|Overall Study|Withdrawal by Subject|7|||
41998647|NCT02004522|75807120|FG000|Overall Study|Death|12|||
41998648|NCT02004522|75807121|FG001|Overall Study|Death|3|||
42331176|NCT02229851|76169052|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
42331177|NCT02229851|76169053|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
42331178|NCT02229851|76169054|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
42331179|NCT02229851|76169055|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
42331180|NCT02229851|76169056|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
42331181|NCT02229851|76169057|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
42331182|NCT02229851|76169051|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
42331183|NCT02229851|76169052|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
42331184|NCT02229851|76169053|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
42331185|NCT02229851|76169054|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
42331186|NCT02229851|76169055|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
42331187|NCT02229851|76169056|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
42331188|NCT02229851|76169057|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
42331189|NCT02229851|76169051|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
42331190|NCT02229851|76169052|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
42331191|NCT02229851|76169053|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
42331192|NCT02229851|76169054|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
42331193|NCT02229851|76169055|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
42331194|NCT02229851|76169056|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
42331195|NCT02229851|76169057|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
42331196|NCT02229851|76169051|FG000|Main Phase (Double-blind Phase)|Death|1|||
42331197|NCT02229851|76169052|FG001|Main Phase (Double-blind Phase)|Death|1|||
42331198|NCT02229851|76169053|FG002|Main Phase (Double-blind Phase)|Death|0|||
42331199|NCT02229851|76169054|FG003|Main Phase (Double-blind Phase)|Death|0|||
42331200|NCT02229851|76169055|FG004|Main Phase (Double-blind Phase)|Death|0|||
42331201|NCT02229851|76169056|FG005|Main Phase (Double-blind Phase)|Death|0|||
42331202|NCT02229851|76169057|FG006|Main Phase (Double-blind Phase)|Death|0|||
42331203|NCT02229851|76169051|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
41998649|NCT02004522|75807120|FG000|Overall Study|Physician Decision|3|||
42034572|NCT01120691|75842652|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
42034573|NCT01120691|75842653|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
42034574|NCT01120691|75842654|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
42263082|NCT02407990|76090911|FG006|Overall Study|Death|10|||
42331204|NCT02229851|76169052|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
42331205|NCT02229851|76169053|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
42331206|NCT02229851|76169054|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
42331207|NCT02229851|76169055|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
42331208|NCT02229851|76169056|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
42331209|NCT02229851|76169057|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
42331210|NCT02229851|76169051|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
42331211|NCT02229851|76169052|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
42331212|NCT02229851|76169053|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
42331213|NCT02229851|76169054|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
42331214|NCT02229851|76169055|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
42331215|NCT02229851|76169056|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
42331216|NCT02229851|76169057|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
42331217|NCT02229851|76169051|FG000|Extension Phase (Open-label Phase)|Death|0|||
42331218|NCT02229851|76169052|FG001|Extension Phase (Open-label Phase)|Death|0|||
42331219|NCT02229851|76169053|FG002|Extension Phase (Open-label Phase)|Death|0|||
42331220|NCT02229851|76169054|FG003|Extension Phase (Open-label Phase)|Death|1|||
42331221|NCT02229851|76169055|FG004|Extension Phase (Open-label Phase)|Death|0|||
42331222|NCT02229851|76169056|FG005|Extension Phase (Open-label Phase)|Death|1|||
42331223|NCT02229851|76169057|FG006|Extension Phase (Open-label Phase)|Death|1|||
42331224|NCT01482910|76169074|FG000|Overall Study|Adverse Event|6|||
42331225|NCT01482910|76169075|FG001|Overall Study|Adverse Event|5|||
42331226|NCT01482910|76169074|FG000|Overall Study|Lost to Follow-up|0|||
42331227|NCT01482910|76169075|FG001|Overall Study|Lost to Follow-up|1|||
42331228|NCT01482910|76169074|FG000|Overall Study|Protocol Violation|1|||
42331229|NCT01482910|76169075|FG001|Overall Study|Protocol Violation|1|||
42331230|NCT01482910|76169074|FG000|Overall Study|Withdrawal by Subject|7|||
42331231|NCT01482910|76169075|FG001|Overall Study|Withdrawal by Subject|2|||
42331232|NCT01482910|76169074|FG000|Overall Study|Death|1|||
42331233|NCT01482910|76169075|FG001|Overall Study|Death|0|||
41998650|NCT02004522|75807121|FG001|Overall Study|Physician Decision|4|||
41998651|NCT02004522|75807120|FG000|Overall Study|Protocol Violation|1|||
42331234|NCT01626391|76169085|FG000|Overall Study|Physician Decision|1|||
41998652|NCT02004522|75807121|FG001|Overall Study|Protocol Violation|0|||
41998653|NCT02004522|75807120|FG000|Overall Study|Other is reason listed by PI|4|||
41998654|NCT02004522|75807121|FG001|Overall Study|Other is reason listed by PI|1|||
41998655|NCT02004522|75807120|FG000|Overall Study|Never Dosed|2|||
42331235|NCT01626391|76169086|FG001|Overall Study|Physician Decision|0|||
42331236|NCT01626391|76169085|FG000|Overall Study|Withdrawal by Subject|1|||
42331237|NCT01626391|76169086|FG001|Overall Study|Withdrawal by Subject|0|||
42331238|NCT02103439|76169094|FG000|Overall Study|Adverse Event|0|||
41998656|NCT02004522|75807121|FG001|Overall Study|Never Dosed|4|||
41998657|NCT02004522|75807120|FG000|Overall Study|Disease Progression|35|||
41998658|NCT02004522|75807121|FG001|Overall Study|Disease Progression|31|||
41998659|NCT02004522|75807120|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
41998660|NCT02004522|75807121|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
41998661|NCT01959139|75807131|FG000|Phase II|Disease progression|0|||
41998662|NCT01959139|75807132|FG001|Phase II|Disease progression|0|||
41998663|NCT01959139|75807133|FG002|Phase II|Disease progression|26|||
41998664|NCT01959139|75807134|FG003|Phase II|Disease progression|34|||
41998665|NCT01959139|75807131|FG000|Phase II|Adverse Event|0|||
41998666|NCT01959139|75807132|FG001|Phase II|Adverse Event|0|||
41998667|NCT01959139|75807133|FG002|Phase II|Adverse Event|10|||
41998668|NCT01959139|75807134|FG003|Phase II|Adverse Event|11|||
41998669|NCT01959139|75807131|FG000|Phase II|Patient Refusal|0|||
41998670|NCT01959139|75807132|FG001|Phase II|Patient Refusal|0|||
42263083|NCT02407990|76090912|FG007|Overall Study|Death|248|||
42263084|NCT02407990|76090905|FG000|Overall Study|Lost to Follow-up|0|||
42263085|NCT02407990|76090906|FG001|Overall Study|Lost to Follow-up|1|||
42263086|NCT02407990|76090907|FG002|Overall Study|Lost to Follow-up|0|||
42263087|NCT02407990|76090908|FG003|Overall Study|Lost to Follow-up|0|||
42263088|NCT02407990|76090909|FG004|Overall Study|Lost to Follow-up|0|||
42263089|NCT02407990|76090910|FG005|Overall Study|Lost to Follow-up|0|||
42263090|NCT02407990|76090911|FG006|Overall Study|Lost to Follow-up|0|||
42263091|NCT02407990|76090912|FG007|Overall Study|Lost to Follow-up|17|||
42263092|NCT02407990|76090905|FG000|Overall Study|Progressive Disease|0|||
42263093|NCT02407990|76090906|FG001|Overall Study|Progressive Disease|0|||
42263094|NCT02407990|76090907|FG002|Overall Study|Progressive Disease|0|||
42263095|NCT02407990|76090908|FG003|Overall Study|Progressive Disease|0|||
42263096|NCT02407990|76090909|FG004|Overall Study|Progressive Disease|0|||
42263097|NCT02407990|76090910|FG005|Overall Study|Progressive Disease|0|||
42263098|NCT02407990|76090911|FG006|Overall Study|Progressive Disease|0|||
42263099|NCT02407990|76090912|FG007|Overall Study|Progressive Disease|1|||
42263100|NCT02407990|76090905|FG000|Overall Study|Withdrawal by Subject|0|||
42263101|NCT02407990|76090906|FG001|Overall Study|Withdrawal by Subject|0|||
42263102|NCT02407990|76090907|FG002|Overall Study|Withdrawal by Subject|0|||
42263103|NCT02407990|76090908|FG003|Overall Study|Withdrawal by Subject|0|||
42263104|NCT02407990|76090909|FG004|Overall Study|Withdrawal by Subject|1|||
42263105|NCT02407990|76090910|FG005|Overall Study|Withdrawal by Subject|0|||
42263106|NCT02407990|76090911|FG006|Overall Study|Withdrawal by Subject|0|||
42263107|NCT02407990|76090912|FG007|Overall Study|Withdrawal by Subject|30|||
42263108|NCT02407990|76090905|FG000|Overall Study|Study Terminated by Sponsor|1|||
42263109|NCT02407990|76090906|FG001|Overall Study|Study Terminated by Sponsor|3|||
42263110|NCT02407990|76090907|FG002|Overall Study|Study Terminated by Sponsor|3|||
42263111|NCT02407990|76090908|FG003|Overall Study|Study Terminated by Sponsor|0|||
42263112|NCT02407990|76090909|FG004|Overall Study|Study Terminated by Sponsor|3|||
42263113|NCT02407990|76090910|FG005|Overall Study|Study Terminated by Sponsor|4|||
42263114|NCT02407990|76090911|FG006|Overall Study|Study Terminated by Sponsor|3|||
42263115|NCT02407990|76090912|FG007|Overall Study|Study Terminated by Sponsor|37|||
42263116|NCT02407990|76090905|FG000|Overall Study|Logistics|0|||
42263117|NCT02407990|76090906|FG001|Overall Study|Logistics|0|||
42263118|NCT02407990|76090907|FG002|Overall Study|Logistics|0|||
42263119|NCT02407990|76090908|FG003|Overall Study|Logistics|0|||
42263120|NCT02407990|76090909|FG004|Overall Study|Logistics|0|||
42263121|NCT02407990|76090910|FG005|Overall Study|Logistics|0|||
42263122|NCT02407990|76090911|FG006|Overall Study|Logistics|0|||
42263123|NCT02407990|76090912|FG007|Overall Study|Logistics|1|||
42263124|NCT02407990|76090905|FG000|Overall Study|Rolled into long-term extension study|0|||
42263125|NCT02407990|76090906|FG001|Overall Study|Rolled into long-term extension study|0|||
42263126|NCT02407990|76090907|FG002|Overall Study|Rolled into long-term extension study|0|||
42331239|NCT02103439|76169095|FG001|Overall Study|Adverse Event|2|||
42331240|NCT02103439|76169094|FG000|Overall Study|Withdrawal by Subject|3|||
42331241|NCT02103439|76169095|FG001|Overall Study|Withdrawal by Subject|1|||
41998671|NCT01959139|75807133|FG002|Phase II|Patient Refusal|5|||
41998672|NCT01959139|75807134|FG003|Phase II|Patient Refusal|4|||
42263127|NCT02407990|76090908|FG003|Overall Study|Rolled into long-term extension study|0|||
42263128|NCT02407990|76090909|FG004|Overall Study|Rolled into long-term extension study|0|||
42263129|NCT02407990|76090910|FG005|Overall Study|Rolled into long-term extension study|0|||
42263130|NCT02407990|76090911|FG006|Overall Study|Rolled into long-term extension study|0|||
42263131|NCT02407990|76090912|FG007|Overall Study|Rolled into long-term extension study|1|||
42263132|NCT03288129|76090936|FG000|Overall Study|Adverse Event|10|||
42263133|NCT03288129|76090936|FG000|Overall Study|Lost to Follow-up|3|||
42263134|NCT03288129|76090936|FG000|Overall Study|Withdrawal by Subject|3|||
41998673|NCT01959139|75807131|FG000|Phase II|Death|0|||
41998674|NCT01959139|75807132|FG001|Phase II|Death|0|||
41998675|NCT01959139|75807133|FG002|Phase II|Death|3|||
42263135|NCT03288129|76090936|FG000|Overall Study|Withdrawal of consent/assent|1|||
41998676|NCT01959139|75807134|FG003|Phase II|Death|1|||
41998677|NCT01959139|75807131|FG000|Phase II|Other/Unknown|0|||
42263136|NCT03288129|76090936|FG000|Overall Study|Other|5|||
42331242|NCT02229539|76169108|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
42134180|NCT00313300|75945048|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
42134181|NCT00313300|75945049|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
42134182|NCT00313300|75945050|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
42134183|NCT00313300|75945051|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
42263137|NCT01673282|76090942|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
42263138|NCT01673282|76090943|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
42263139|NCT01673282|76090942|FG000|Overall Study|Lack of Efficacy|9|||
42263140|NCT01673282|76090943|FG001|Overall Study|Lack of Efficacy|2|||
42263141|NCT01673282|76090942|FG000|Overall Study|Lost to Follow-up|11|||
42263142|NCT01673282|76090943|FG001|Overall Study|Lost to Follow-up|10|||
42263143|NCT01673282|76090942|FG000|Overall Study|Withdrawal by Subject|3|||
42331243|NCT02229539|76169109|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
42331244|NCT02229539|76169110|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
42331245|NCT02229539|76169108|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
42331246|NCT02229539|76169109|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
42331247|NCT02229539|76169110|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
42331248|NCT02229539|76169108|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
42331249|NCT02229539|76169109|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
42331250|NCT02229539|76169110|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
42331251|NCT02229539|76169108|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
42331252|NCT02229539|76169109|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
42331253|NCT02229539|76169110|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
42331254|NCT02229539|76169108|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
42331255|NCT02229539|76169109|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
42331256|NCT02229539|76169110|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
42331257|NCT02229539|76169108|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
42331258|NCT02229539|76169109|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
42331259|NCT02229539|76169110|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
42331260|NCT02229539|76169108|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
42331261|NCT02229539|76169109|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
42331262|NCT02229539|76169110|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
42331263|NCT02229539|76169108|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
42331264|NCT02229539|76169109|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
42331265|NCT02229539|76169110|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
42331266|NCT02229539|76169108|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
42331267|NCT02229539|76169109|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
42331268|NCT02229539|76169110|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
42331269|NCT01835223|76169120|FG000|Overall Study|Adverse Event|1|||
42331270|NCT01835223|76169121|FG001|Overall Study|Adverse Event|0|||
42331271|NCT01835223|76169120|FG000|Overall Study|Withdrawal by Subject|2|||
42331272|NCT01835223|76169121|FG001|Overall Study|Withdrawal by Subject|0|||
42331273|NCT01835223|76169120|FG000|Overall Study|Disease progression|2|||
42331274|NCT01835223|76169121|FG001|Overall Study|Disease progression|1|||
42331275|NCT01835223|76169120|FG000|Overall Study|Became Inelligible|4|||
42331276|NCT01835223|76169121|FG001|Overall Study|Became Inelligible|0|||
42331277|NCT01482598|76169131|FG000|Overall Study|Death|7|||
41998678|NCT01959139|75807132|FG001|Phase II|Other/Unknown|0|||
41998679|NCT01959139|75807133|FG002|Phase II|Other/Unknown|8|||
41998680|NCT01959139|75807134|FG003|Phase II|Other/Unknown|5|||
41998681|NCT01959139|75807131|FG000|Phase II|On treatment|0|||
42331278|NCT01482598|76169132|FG001|Overall Study|Death|10|||
41998682|NCT01959139|75807132|FG001|Phase II|On treatment|0|||
41998683|NCT01959139|75807133|FG002|Phase II|On treatment|4|||
41998684|NCT01959139|75807134|FG003|Phase II|On treatment|0|||
41998685|NCT01932697|75807151|FG000|Overall Study|Received a different amount of tx|1|||
41998686|NCT01932697|75807152|FG001|Overall Study|Received a different amount of tx|0|||
42263144|NCT01673282|76090943|FG001|Overall Study|Withdrawal by Subject|3|||
42263145|NCT01673282|76090942|FG000|Overall Study|Other|1|||
42263146|NCT01673282|76090943|FG001|Overall Study|Other|6|||
42263147|NCT04157751|76090951|FG000|Overall Study|Withdrawal by Subject|12|||
42331279|NCT01482598|76169131|FG000|Overall Study|Physician Decision|0|||
41998687|NCT01932697|75807151|FG000|Overall Study|Ineligible|1|||
41998688|NCT01932697|75807152|FG001|Overall Study|Ineligible|0|||
42263148|NCT04157751|76090952|FG001|Overall Study|Withdrawal by Subject|17|||
42331280|NCT01482598|76169132|FG001|Overall Study|Physician Decision|3|||
42331281|NCT01482598|76169131|FG000|Overall Study|Withdrawal by Subject|4|||
41998689|NCT01739309|75807198|FG000|Overall Study|Adverse Event|1|||
41998690|NCT01739309|75807198|FG000|Overall Study|Withdrawal by Subject|1|||
41998691|NCT01659658|75807209|FG000|Overall Study|Withdrawal by Patient|18|||
42263149|NCT04157751|76090951|FG000|Overall Study|Lost to Follow-up|6|||
42331282|NCT01482598|76169132|FG001|Overall Study|Withdrawal by Subject|5|||
42331283|NCT01482598|76169131|FG000|Overall Study|Lost to Follow-up|5|||
42134184|NCT00313300|75945047|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
42263150|NCT04157751|76090952|FG001|Overall Study|Lost to Follow-up|2|||
42263151|NCT04157751|76090951|FG000|Overall Study|Adverse Event|34|||
42263152|NCT04157751|76090952|FG001|Overall Study|Adverse Event|23|||
42263153|NCT04157751|76090951|FG000|Overall Study|Not treated|1|||
42263154|NCT04157751|76090952|FG001|Overall Study|Not treated|5|||
42263155|NCT04157751|76090951|FG000|Overall Study|Other reason not stated above|10|||
42263156|NCT04157751|76090952|FG001|Overall Study|Other reason not stated above|10|||
42263157|NCT01673126|76090960|FG000|Overall Study|change of diagnosis|4|||
42331284|NCT01482598|76169132|FG001|Overall Study|Lost to Follow-up|4|||
42331285|NCT01460446|76169140|FG000|Overall Study|Non-compliance|2|||
42331286|NCT01460446|76169141|FG001|Overall Study|Non-compliance|9|||
42331287|NCT01460446|76169140|FG000|Overall Study|Consent Withdrawn|0|||
42331288|NCT01460446|76169141|FG001|Overall Study|Consent Withdrawn|4|||
42331289|NCT01460446|76169140|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
42331290|NCT01460446|76169141|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
42331291|NCT01460446|76169140|FG000|Overall Study|Surgery/Illness|1|||
42331292|NCT01460446|76169141|FG001|Overall Study|Surgery/Illness|1|||
42331293|NCT01460446|76169140|FG000|Overall Study|Pregnancy|1|||
42331294|NCT01460446|76169141|FG001|Overall Study|Pregnancy|0|||
42331295|NCT01460446|76169140|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
42331296|NCT01460446|76169141|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
42331297|NCT02229383|76169150|FG000|Overall Study|Adverse Event|7|||
42331298|NCT02229383|76169151|FG001|Overall Study|Adverse Event|4|||
42331299|NCT02229383|76169150|FG000|Overall Study|Death|0|||
42331300|NCT02229383|76169151|FG001|Overall Study|Death|1|||
42331301|NCT02229383|76169150|FG000|Overall Study|Lost to Follow-up|5|||
42331302|NCT02229383|76169151|FG001|Overall Study|Lost to Follow-up|3|||
42331303|NCT02229383|76169150|FG000|Overall Study|Withdrawal by Subject|4|||
42331304|NCT02229383|76169151|FG001|Overall Study|Withdrawal by Subject|6|||
42331305|NCT02229383|76169150|FG000|Overall Study|Did not receive treatment|1|||
42331306|NCT02229383|76169151|FG001|Overall Study|Did not receive treatment|0|||
42331307|NCT02229383|76169150|FG000|Overall Study|Other|3|||
42331308|NCT02229383|76169151|FG001|Overall Study|Other|8|||
42331309|NCT01499368|76169160|FG000|Overall Study|Did not meet I/E criteria|8|||
42331310|NCT01499368|76169161|FG001|Overall Study|Did not meet I/E criteria|4|||
42331311|NCT01499368|76169162|FG002|Overall Study|Did not meet I/E criteria|4|||
42331312|NCT01499368|76169160|FG000|Overall Study|Prohibited Concomitant medication|1|||
42331313|NCT01499368|76169161|FG001|Overall Study|Prohibited Concomitant medication|1|||
42331314|NCT01499368|76169162|FG002|Overall Study|Prohibited Concomitant medication|0|||
42331315|NCT01499368|76169160|FG000|Overall Study|Withdrawal by Subject|11|||
42331316|NCT01499368|76169161|FG001|Overall Study|Withdrawal by Subject|10|||
42331317|NCT01499368|76169162|FG002|Overall Study|Withdrawal by Subject|8|||
42331318|NCT01499368|76169160|FG000|Overall Study|Lost to Follow-up|3|||
42331319|NCT01499368|76169161|FG001|Overall Study|Lost to Follow-up|2|||
42331320|NCT01499368|76169162|FG002|Overall Study|Lost to Follow-up|5|||
42331321|NCT01499368|76169160|FG000|Overall Study|Adverse Event|4|||
42331322|NCT01499368|76169161|FG001|Overall Study|Adverse Event|0|||
42331323|NCT01499368|76169162|FG002|Overall Study|Adverse Event|2|||
42331324|NCT01499368|76169160|FG000|Overall Study|Physician Decision|0|||
42331325|NCT01499368|76169161|FG001|Overall Study|Physician Decision|1|||
42331326|NCT01499368|76169162|FG002|Overall Study|Physician Decision|0|||
42331327|NCT01499368|76169160|FG000|Overall Study|Deviation from visit window|0|||
42331328|NCT01499368|76169161|FG001|Overall Study|Deviation from visit window|0|||
41998692|NCT01659658|75807210|FG001|Overall Study|Withdrawal by Patient|4|||
41998693|NCT01659658|75807211|FG002|Overall Study|Withdrawal by Patient|2|||
41998694|NCT01659658|75807212|FG003|Overall Study|Withdrawal by Patient|0|||
41998695|NCT01659658|75807213|FG004|Overall Study|Withdrawal by Patient|11|||
41998696|NCT01659658|75807209|FG000|Overall Study|Study Terminated by Sponsor|9|||
41998697|NCT01659658|75807210|FG001|Overall Study|Study Terminated by Sponsor|7|||
41998698|NCT01659658|75807211|FG002|Overall Study|Study Terminated by Sponsor|0|||
41998699|NCT01659658|75807212|FG003|Overall Study|Study Terminated by Sponsor|1|||
42263158|NCT01673126|76090961|FG001|Overall Study|change of diagnosis|3|||
42331329|NCT01499368|76169162|FG002|Overall Study|Deviation from visit window|1|||
42331330|NCT01499368|76169160|FG000|Overall Study|Error of Prescriptions|0|||
42331331|NCT01499368|76169161|FG001|Overall Study|Error of Prescriptions|0|||
42331332|NCT01499368|76169162|FG002|Overall Study|Error of Prescriptions|1|||
42331333|NCT01835145|76169172|FG000|Overall Study|Ineligible prior to treatment|1|||
41998700|NCT01659658|75807213|FG004|Overall Study|Study Terminated by Sponsor|4|||
41998701|NCT01659658|75807209|FG000|Overall Study|Reason not Specified|61|||
42331334|NCT01835145|76169173|FG001|Overall Study|Ineligible prior to treatment|0|||
42331335|NCT02229227|76169183|FG000|Overall Study|Adverse Event|14|||
42331336|NCT02229227|76169184|FG001|Overall Study|Adverse Event|9|||
41998702|NCT01659658|75807210|FG001|Overall Study|Reason not Specified|15|||
42263159|NCT02407054|76090970|FG000|Overall Study|Adverse Event|1|||
42331337|NCT02229227|76169183|FG000|Overall Study|Lack of Efficacy|3|||
42331338|NCT02229227|76169184|FG001|Overall Study|Lack of Efficacy|3|||
42331339|NCT02229227|76169183|FG000|Overall Study|Protocol Violation|6|||
42331340|NCT02229227|76169184|FG001|Overall Study|Protocol Violation|8|||
42331341|NCT02229227|76169183|FG000|Overall Study|Protocol defined stopping criteria|1|||
42331342|NCT02229227|76169184|FG001|Overall Study|Protocol defined stopping criteria|3|||
42331343|NCT02229227|76169183|FG000|Overall Study|Lost to Follow-up|3|||
42331344|NCT02229227|76169184|FG001|Overall Study|Lost to Follow-up|3|||
42331345|NCT02229227|76169183|FG000|Overall Study|Study terminated by sponsor|11|||
42331346|NCT02229227|76169184|FG001|Overall Study|Study terminated by sponsor|11|||
42331347|NCT02229227|76169183|FG000|Overall Study|Withdrawal by Subject|8|||
42331348|NCT02229227|76169184|FG001|Overall Study|Withdrawal by Subject|12|||
42331349|NCT02229227|76169183|FG000|Overall Study|Other|0|||
42331350|NCT02229227|76169184|FG001|Overall Study|Other|1|||
42331351|NCT02229227|76169183|FG000|Overall Study|Physician Decision|5|||
42331352|NCT02229227|76169184|FG001|Overall Study|Physician Decision|12|||
42331353|NCT01499290|76169192|FG000|Overall Study|Withdrawal by Subject|22|||
42331354|NCT01499290|76169193|FG001|Overall Study|Withdrawal by Subject|15|||
42331355|NCT01499290|76169192|FG000|Overall Study|Not specified in study report|11|||
42331356|NCT01499290|76169193|FG001|Overall Study|Not specified in study report|5|||
42331357|NCT01499290|76169192|FG000|Overall Study|Condition improved/subject recovered|1|||
42331358|NCT01499290|76169193|FG001|Overall Study|Condition improved/subject recovered|0|||
42331359|NCT01499290|76169192|FG000|Overall Study|Lack of Efficacy|7|||
42331360|NCT01499290|76169193|FG001|Overall Study|Lack of Efficacy|8|||
42331361|NCT01499290|76169192|FG000|Overall Study|Adverse Event|14|||
42331362|NCT01499290|76169193|FG001|Overall Study|Adverse Event|7|||
42331363|NCT01833897|76169218|FG000|Overall Study|Lack of Efficacy|1|||
42331364|NCT01481896|76169222|FG000|Overall Study|Lost to Follow-up|12|||
42331365|NCT02226653|76169238|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
42331366|NCT02226653|76169239|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
42331367|NCT02226653|76169238|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
42331368|NCT02226653|76169239|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
42331369|NCT02201771|76169255|FG000|Overall Study|Death|3|||
42331370|NCT02201771|76169256|FG001|Overall Study|Death|2|||
42331371|NCT02201771|76169257|FG002|Overall Study|Death|0|||
42331372|NCT02201771|76169255|FG000|Overall Study|Protocol Violation|10|||
42331373|NCT02201771|76169256|FG001|Overall Study|Protocol Violation|8|||
42331374|NCT02201771|76169257|FG002|Overall Study|Protocol Violation|10|||
42331375|NCT01460368|76169267|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
42331376|NCT01460368|76169268|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
42331377|NCT01460368|76169269|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
42331378|NCT01460368|76169270|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
42331379|NCT01460368|76169271|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
42331380|NCT01460368|76169272|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
42331381|NCT01460368|76169273|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
42263160|NCT02407054|76090971|FG001|Overall Study|Adverse Event|4|||
42263161|NCT02407054|76090972|FG002|Overall Study|Adverse Event|1|||
42263162|NCT02407054|76090970|FG000|Overall Study|Non-compliance with Study|0|||
42263163|NCT02407054|76090971|FG001|Overall Study|Non-compliance with Study|2|||
42263164|NCT02407054|76090972|FG002|Overall Study|Non-compliance with Study|1|||
42263165|NCT02407054|76090970|FG000|Overall Study|Physician Decision|1|||
42263166|NCT02407054|76090971|FG001|Overall Study|Physician Decision|3|||
42263167|NCT02407054|76090972|FG002|Overall Study|Physician Decision|3|||
42263168|NCT02407054|76090970|FG000|Overall Study|Withdrawal by Subject|5|||
42263169|NCT02407054|76090971|FG001|Overall Study|Withdrawal by Subject|9|||
42263170|NCT02407054|76090972|FG002|Overall Study|Withdrawal by Subject|2|||
42263171|NCT01652716|76090983|FG000|Overall Study|Loss of glucose control|1|||
42263172|NCT01652716|76090984|FG001|Overall Study|Loss of glucose control|0|||
42263173|NCT01652716|76090983|FG000|Overall Study|Administrative|0|||
42331382|NCT01460368|76169267|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
42331383|NCT01460368|76169268|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
42331384|NCT01460368|76169269|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
42331385|NCT01460368|76169270|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
42331386|NCT01460368|76169271|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
42331387|NCT01460368|76169272|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
42331388|NCT01460368|76169273|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
42331389|NCT01460368|76169267|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
42331390|NCT01460368|76169268|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
42331391|NCT01460368|76169269|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
42331392|NCT01460368|76169270|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
42263174|NCT01652716|76090984|FG001|Overall Study|Administrative|2|||
42263175|NCT01652716|76090983|FG000|Overall Study|Investigator decision|1|||
42331393|NCT01460368|76169271|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
42331394|NCT01460368|76169272|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
42331395|NCT01460368|76169273|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
42331396|NCT01460368|76169267|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
42331397|NCT01460368|76169268|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
42331398|NCT01460368|76169269|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
42331399|NCT01460368|76169270|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
42331400|NCT01460368|76169271|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
42331401|NCT01460368|76169272|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
42331402|NCT01460368|76169273|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
42331403|NCT01460368|76169267|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
42331404|NCT01460368|76169268|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
42331405|NCT01460368|76169269|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
42331406|NCT01460368|76169270|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
42331407|NCT01460368|76169271|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
42331408|NCT01460368|76169272|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
42331409|NCT01460368|76169273|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
42331410|NCT01460290|76169282|FG000|Overall Study|Adverse Event|3|||
42331411|NCT01460290|76169282|FG000|Overall Study|Elevated liver function|1|||
42331412|NCT02200211|76169291|FG000|Overall Study|Lost to Follow-up|7|||
42331413|NCT02200211|76169292|FG001|Overall Study|Lost to Follow-up|7|||
42331414|NCT02200211|76169293|FG002|Overall Study|Lost to Follow-up|1|||
42331415|NCT02200211|76169294|FG003|Overall Study|Lost to Follow-up|2|||
42331416|NCT02200211|76169291|FG000|Overall Study|Withdrawal by Subject|1|||
41998703|NCT01659658|75807211|FG002|Overall Study|Reason not Specified|8|||
41998704|NCT01659658|75807212|FG003|Overall Study|Reason not Specified|1|||
41998705|NCT01659658|75807213|FG004|Overall Study|Reason not Specified|34|||
41998706|NCT01659658|75807209|FG000|Overall Study|Lost to Follow-up|2|||
41998707|NCT01659658|75807210|FG001|Overall Study|Lost to Follow-up|0|||
41998708|NCT01659658|75807211|FG002|Overall Study|Lost to Follow-up|0|||
41998709|NCT01659658|75807212|FG003|Overall Study|Lost to Follow-up|0|||
41998710|NCT01659658|75807213|FG004|Overall Study|Lost to Follow-up|0|||
41998711|NCT01357161|75807233|FG000|Part 1 (Open Label Run-in)|Death|5|||
41998712|NCT01357161|75807234|FG001|Part 1 (Open Label Run-in)|Death|0|||
41998713|NCT01357161|75807235|FG002|Part 1 (Open Label Run-in)|Death|0|||
41998714|NCT01357161|75807233|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
41998715|NCT01357161|75807234|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
41998716|NCT01357161|75807235|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
41998717|NCT01357161|75807233|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
41998718|NCT01357161|75807234|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
41998719|NCT01357161|75807235|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
41998720|NCT01357161|75807233|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
41998721|NCT01357161|75807234|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
41998722|NCT01357161|75807235|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
41998723|NCT01357161|75807233|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
41998724|NCT01357161|75807234|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
41998725|NCT01357161|75807235|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
41998726|NCT01357161|75807233|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
41998727|NCT01357161|75807234|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
41998728|NCT01357161|75807235|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
41998729|NCT01357161|75807233|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
41998730|NCT01357161|75807234|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
41998731|NCT01357161|75807235|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
42134185|NCT00313300|75945048|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
42134186|NCT00313300|75945049|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
42134187|NCT00313300|75945050|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
42134188|NCT00313300|75945051|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
42134189|NCT00313300|75945047|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
42134190|NCT00313300|75945048|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
42331417|NCT02200211|76169292|FG001|Overall Study|Withdrawal by Subject|0|||
41998732|NCT01357161|75807233|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
41998733|NCT01357161|75807234|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
41998734|NCT01357161|75807235|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
41998735|NCT01357161|75807233|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
41998736|NCT01357161|75807234|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
41998737|NCT01357161|75807235|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
41998738|NCT01357161|75807233|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
41998739|NCT01357161|75807234|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
42134191|NCT00313300|75945049|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
42331418|NCT02200211|76169293|FG002|Overall Study|Withdrawal by Subject|0|||
42331419|NCT02200211|76169294|FG003|Overall Study|Withdrawal by Subject|0|||
41998740|NCT01357161|75807235|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
41998741|NCT01357161|75807233|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
42134192|NCT00313300|75945050|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
42134193|NCT00313300|75945051|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
42134194|NCT00313300|75945047|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
42134195|NCT00313300|75945048|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
42134196|NCT00313300|75945049|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
42134197|NCT00313300|75945050|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
42134198|NCT00313300|75945051|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
42134199|NCT00313300|75945047|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
42134200|NCT00313300|75945048|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
42134201|NCT00313300|75945049|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
42134202|NCT00313300|75945050|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
42263176|NCT01652716|76090984|FG001|Overall Study|Investigator decision|4|||
42263177|NCT01652716|76090983|FG000|Overall Study|Lost to Follow-up|12|||
42263178|NCT01652716|76090984|FG001|Overall Study|Lost to Follow-up|11|||
42263179|NCT01652716|76090983|FG000|Overall Study|Protocol Violation|2|||
42263180|NCT01652716|76090984|FG001|Overall Study|Protocol Violation|1|||
42263181|NCT01652716|76090983|FG000|Overall Study|Adverse Event|7|||
42263182|NCT01652716|76090984|FG001|Overall Study|Adverse Event|10|||
42331420|NCT01459666|76169314|FG000|Overall Study|PI left institution|5|||
42331421|NCT01459666|76169315|FG001|Overall Study|PI left institution|4|||
42263183|NCT01652716|76090983|FG000|Overall Study|Withdrawal by Subject|33|||
42263184|NCT01652716|76090984|FG001|Overall Study|Withdrawal by Subject|18|||
42263185|NCT02790073|76090990|FG000|Overall Study|Death|1|||
42263186|NCT02790073|76090990|FG000|Overall Study|Withdrawal from HD|1|||
42263187|NCT02790073|76090990|FG000|Overall Study|Withdrawal by Subject|1|||
42263188|NCT02789137|76090994|FG000|Overall Study|Dropped out/Died|58|||
42263189|NCT01672970|76090999|FG000|Overall Study|Lack of Efficacy|12|||
42263190|NCT01672970|76090999|FG000|Overall Study|Adverse Event|18|||
42263191|NCT01672970|76090999|FG000|Overall Study|Withdrawal by Subject|2|||
42331422|NCT01858389|76169323|FG000|Overall Study|Death|1|||
42331423|NCT01858389|76169324|FG001|Overall Study|Death|3|||
42331424|NCT01858389|76169323|FG000|Overall Study|Study terminated by sponsor|0|||
42331425|NCT01858389|76169324|FG001|Overall Study|Study terminated by sponsor|2|||
42331426|NCT01858389|76169323|FG000|Overall Study|Withdrawal by Subject|0|||
42331427|NCT01858389|76169324|FG001|Overall Study|Withdrawal by Subject|1|||
42331428|NCT01858389|76169323|FG000|Overall Study|Progressive disease|10|||
42331429|NCT01858389|76169324|FG001|Overall Study|Progressive disease|11|||
42331430|NCT01858389|76169323|FG000|Overall Study|Other|2|||
42331431|NCT01858389|76169324|FG001|Overall Study|Other|4|||
42331432|NCT01858389|76169323|FG000|Overall Study|Adverse Event|3|||
42331433|NCT01858389|76169324|FG001|Overall Study|Adverse Event|1|||
42331434|NCT01858389|76169323|FG000|Overall Study|Did not receive treatment|0|||
42331435|NCT01858389|76169324|FG001|Overall Study|Did not receive treatment|3|||
42331436|NCT02199509|76169332|FG000|Overall Study|Suicidal Ideation|0|||
42331437|NCT02199509|76169333|FG001|Overall Study|Suicidal Ideation|1|||
42331438|NCT02199509|76169332|FG000|Overall Study|Misunderstood titration schedule|1|||
42331439|NCT02199509|76169333|FG001|Overall Study|Misunderstood titration schedule|0|||
42331440|NCT01458574|76169346|FG000|Overall Study|Adverse Event|5|||
42331441|NCT01458574|76169347|FG001|Overall Study|Adverse Event|9|||
42331442|NCT01458574|76169348|FG002|Overall Study|Adverse Event|7|||
42331443|NCT01458574|76169346|FG000|Overall Study|Lack of Efficacy|70|||
42331444|NCT01458574|76169347|FG001|Overall Study|Lack of Efficacy|53|||
41998742|NCT01357161|75807234|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
42134203|NCT00313300|75945051|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
42134204|NCT00313300|75945047|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
42134205|NCT00313300|75945048|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
42331445|NCT01458574|76169348|FG002|Overall Study|Lack of Efficacy|132|||
42331446|NCT01458574|76169346|FG000|Overall Study|Lost to Follow-up|3|||
42331447|NCT01458574|76169347|FG001|Overall Study|Lost to Follow-up|2|||
42331448|NCT01458574|76169348|FG002|Overall Study|Lost to Follow-up|1|||
42331449|NCT01458574|76169346|FG000|Overall Study|Pregnancy|1|||
42331450|NCT01458574|76169347|FG001|Overall Study|Pregnancy|1|||
42331451|NCT01458574|76169348|FG002|Overall Study|Pregnancy|0|||
42331452|NCT01458574|76169346|FG000|Overall Study|Protocol Violation|0|||
42331453|NCT01458574|76169347|FG001|Overall Study|Protocol Violation|1|||
42331454|NCT01458574|76169348|FG002|Overall Study|Protocol Violation|0|||
42331455|NCT01458574|76169346|FG000|Overall Study|Withdrawal by Subject|6|||
42331456|NCT01458574|76169347|FG001|Overall Study|Withdrawal by Subject|3|||
42331457|NCT01458574|76169348|FG002|Overall Study|Withdrawal by Subject|5|||
42331458|NCT01458574|76169346|FG000|Overall Study|Other|2|||
42331459|NCT01458574|76169347|FG001|Overall Study|Other|1|||
42331460|NCT01458574|76169348|FG002|Overall Study|Other|0|||
42331461|NCT01458574|76169346|FG000|Overall Study|Randomized but not treated|0|||
42331462|NCT01458574|76169347|FG001|Overall Study|Randomized but not treated|1|||
42331463|NCT01458574|76169348|FG002|Overall Study|Randomized but not treated|0|||
42331464|NCT02224703|76169359|FG000|Overall Study|Adverse Event|0|||
42134206|NCT00313300|75945049|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
42263192|NCT01672970|76090999|FG000|Overall Study|Lost to Follow-up|5|||
42263193|NCT01672970|76090999|FG000|Overall Study|Other|9|||
42263194|NCT01672970|76090999|FG000|Overall Study|Enrolled but not treated|1|||
42263195|NCT02788747|76091006|FG000|Overall Study|Adverse Event|1|||
42263196|NCT02788747|76091007|FG001|Overall Study|Adverse Event|0|||
42263197|NCT02788747|76091008|FG002|Overall Study|Adverse Event|0|||
42263198|NCT02406742|76091022|FG000|Overall Study|Progression of Disease|5|||
42263199|NCT02406742|76091023|FG001|Overall Study|Progression of Disease|1|||
42263200|NCT02406742|76091024|FG002|Overall Study|Progression of Disease|6|||
42263201|NCT02406742|76091022|FG000|Overall Study|Adverse Event|3|||
42263202|NCT02406742|76091023|FG001|Overall Study|Adverse Event|0|||
42263203|NCT02406742|76091024|FG002|Overall Study|Adverse Event|2|||
42263204|NCT02406742|76091022|FG000|Overall Study|Death|1|||
42263205|NCT02406742|76091023|FG001|Overall Study|Death|0|||
42263206|NCT02406742|76091024|FG002|Overall Study|Death|0|||
42263207|NCT02406742|76091022|FG000|Overall Study|Lack of Efficacy|0|||
42263208|NCT02406742|76091023|FG001|Overall Study|Lack of Efficacy|0|||
42263209|NCT02406742|76091024|FG002|Overall Study|Lack of Efficacy|1|||
42331465|NCT02224703|76169360|FG001|Overall Study|Adverse Event|5|||
42331466|NCT02224703|76169361|FG002|Overall Study|Adverse Event|0|||
42331467|NCT02224703|76169359|FG000|Overall Study|Withdrawn by investigator|1|||
42263210|NCT02406742|76091022|FG000|Overall Study|Withdrawal by Participant|1|||
42331468|NCT02224703|76169360|FG001|Overall Study|Withdrawn by investigator|0|||
42331469|NCT02224703|76169361|FG002|Overall Study|Withdrawn by investigator|0|||
42331470|NCT02224703|76169359|FG000|Overall Study|Advised by medical monitor|1|||
42331471|NCT02224703|76169360|FG001|Overall Study|Advised by medical monitor|0|||
42331472|NCT02224703|76169361|FG002|Overall Study|Advised by medical monitor|0|||
42331473|NCT02224703|76169359|FG000|Overall Study|Withdrawn by parent/guardian|0|||
42331474|NCT02224703|76169360|FG001|Overall Study|Withdrawn by parent/guardian|1|||
42331475|NCT02224703|76169361|FG002|Overall Study|Withdrawn by parent/guardian|0|||
42331476|NCT02224703|76169359|FG000|Overall Study|Lack of Efficacy|1|||
42331477|NCT02224703|76169360|FG001|Overall Study|Lack of Efficacy|0|||
42331478|NCT02224703|76169361|FG002|Overall Study|Lack of Efficacy|0|||
42331479|NCT02198963|76169370|FG000|Overall Study|Adverse Event|1|||
42331480|NCT02198963|76169370|FG000|Overall Study|Withdrawal by Subject|6|||
42331481|NCT01458106|76169394|FG000|Overall Study|Withdrawal by Subject|2|||
42331482|NCT01458106|76169395|FG001|Overall Study|Withdrawal by Subject|0|||
42331483|NCT01458106|76169394|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
42331484|NCT01458106|76169395|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
42331485|NCT01458106|76169394|FG000|Overall Study|Withdrawn Per Protocol|0|||
42331486|NCT01458106|76169395|FG001|Overall Study|Withdrawn Per Protocol|1|||
41998743|NCT01357161|75807235|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
41998744|NCT01321073|75807243|FG000|Overall Study|Did not attempt implant|4|||
41998745|NCT01321073|75807243|FG000|Overall Study|Death|3|||
41998746|NCT01276704|75807249|FG000|Overall Study|Lost to Follow-up|2|||
41998747|NCT01276704|75807250|FG001|Overall Study|Lost to Follow-up|3|||
42331487|NCT01457950|76169406|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
42331488|NCT01457950|76169407|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
42331489|NCT01457950|76169408|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
42331490|NCT01457950|76169409|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
42331491|NCT01457950|76169406|FG000|Double-Blind Phase|Protocol Violation|2|||
42263211|NCT02406742|76091023|FG001|Overall Study|Withdrawal by Participant|2|||
42263212|NCT02406742|76091024|FG002|Overall Study|Withdrawal by Participant|0|||
42263213|NCT02406742|76091022|FG000|Overall Study|Physician Decision|1|||
42263214|NCT02406742|76091023|FG001|Overall Study|Physician Decision|2|||
42263215|NCT02406742|76091024|FG002|Overall Study|Physician Decision|1|||
42263216|NCT02406742|76091022|FG000|Overall Study|Transition to other treatment|2|||
42263217|NCT02406742|76091023|FG001|Overall Study|Transition to other treatment|0|||
42263218|NCT02406742|76091024|FG002|Overall Study|Transition to other treatment|1|||
42263219|NCT02406742|76091022|FG000|Overall Study|Other Reasons|1|||
42263220|NCT02406742|76091023|FG001|Overall Study|Other Reasons|11|||
42263221|NCT02406742|76091024|FG002|Overall Study|Other Reasons|5|||
42263222|NCT02714595|76091034|FG000|Overall Study|Lost to Follow-up|1|||
42263223|NCT02714595|76091035|FG001|Overall Study|Lost to Follow-up|0|||
42331492|NCT01457950|76169407|FG001|Double-Blind Phase|Protocol Violation|1|||
42331493|NCT01457950|76169408|FG002|Double-Blind Phase|Protocol Violation|0|||
42331494|NCT01457950|76169409|FG003|Double-Blind Phase|Protocol Violation|0|||
42331495|NCT01457950|76169406|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
42263224|NCT02714595|76091034|FG000|Overall Study|Withdrawal by Subject|1|||
42331496|NCT01457950|76169407|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
42263225|NCT02714595|76091035|FG001|Overall Study|Withdrawal by Subject|2|||
42263226|NCT02714595|76091034|FG000|Overall Study|Lack of Efficacy|0|||
42263227|NCT02714595|76091035|FG001|Overall Study|Lack of Efficacy|1|||
42331497|NCT01457950|76169408|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
42331498|NCT01457950|76169409|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
42331499|NCT01457950|76169406|FG000|Open-Label Phase|Adverse Event|0|||
42331500|NCT01457950|76169407|FG001|Open-Label Phase|Adverse Event|0|||
42331501|NCT01457950|76169408|FG002|Open-Label Phase|Adverse Event|0|||
42331502|NCT01457950|76169409|FG003|Open-Label Phase|Adverse Event|1|||
42263228|NCT02714595|76091034|FG000|Overall Study|Death|30|||
42263229|NCT02714595|76091035|FG001|Overall Study|Death|9|||
42263230|NCT02714595|76091034|FG000|Overall Study|Other-Miscellaneous|0|||
42263231|NCT02714595|76091035|FG001|Overall Study|Other-Miscellaneous|1|||
42263232|NCT02437162|76091062|FG000|Overall Study|Protocol Violation|0|||
42263233|NCT02437162|76091063|FG001|Overall Study|Protocol Violation|1|||
42263234|NCT02437162|76091064|FG002|Overall Study|Protocol Violation|0|||
42331503|NCT01457950|76169406|FG000|Open-Label Phase|Protocol Violation|0|||
42331504|NCT01457950|76169407|FG001|Open-Label Phase|Protocol Violation|0|||
42331505|NCT01457950|76169408|FG002|Open-Label Phase|Protocol Violation|0|||
42331506|NCT01457950|76169409|FG003|Open-Label Phase|Protocol Violation|1|||
42331507|NCT01457950|76169406|FG000|Open-Label Phase|Withdrawal by Subject|0|||
42331508|NCT01457950|76169407|FG001|Open-Label Phase|Withdrawal by Subject|0|||
42331509|NCT01457950|76169408|FG002|Open-Label Phase|Withdrawal by Subject|2|||
42331510|NCT01457950|76169409|FG003|Open-Label Phase|Withdrawal by Subject|0|||
42331511|NCT01499134|76169422|FG000|Overall Study|Withdrawal by Subject|0|||
42331512|NCT01499134|76169423|FG001|Overall Study|Withdrawal by Subject|1|||
42331513|NCT02198651|76169429|FG000|Lead-in Period|Withdrew consent|13|||
42331514|NCT02198651|76169430|FG001|Lead-in Period|Withdrew consent|0|||
42331515|NCT02198651|76169431|FG002|Lead-in Period|Withdrew consent|0|||
42331516|NCT02198651|76169432|FG003|Lead-in Period|Withdrew consent|0|||
42331517|NCT02198651|76169433|FG004|Lead-in Period|Withdrew consent|0|||
42331518|NCT02198651|76169429|FG000|Lead-in Period|Adverse Event|2|||
42331519|NCT02198651|76169430|FG001|Lead-in Period|Adverse Event|0|||
42331520|NCT02198651|76169431|FG002|Lead-in Period|Adverse Event|0|||
42331521|NCT02198651|76169432|FG003|Lead-in Period|Adverse Event|0|||
42331522|NCT02198651|76169433|FG004|Lead-in Period|Adverse Event|0|||
42331523|NCT02198651|76169429|FG000|Lead-in Period|Other, not specified|22|||
42331524|NCT02198651|76169430|FG001|Lead-in Period|Other, not specified|0|||
42331525|NCT02198651|76169431|FG002|Lead-in Period|Other, not specified|0|||
42331526|NCT02198651|76169432|FG003|Lead-in Period|Other, not specified|0|||
42331527|NCT02198651|76169433|FG004|Lead-in Period|Other, not specified|0|||
42331528|NCT02198651|76169429|FG000|Double-blind Period|Withdrew consent|0|||
42331529|NCT02198651|76169430|FG001|Double-blind Period|Withdrew consent|4|||
42331530|NCT02198651|76169431|FG002|Double-blind Period|Withdrew consent|0|||
42331531|NCT02198651|76169432|FG003|Double-blind Period|Withdrew consent|0|||
42331532|NCT02198651|76169433|FG004|Double-blind Period|Withdrew consent|0|||
42331533|NCT02198651|76169429|FG000|Double-blind Period|Adverse Event|0|||
42331534|NCT02198651|76169430|FG001|Double-blind Period|Adverse Event|1|||
42331535|NCT02198651|76169431|FG002|Double-blind Period|Adverse Event|0|||
42331536|NCT02198651|76169432|FG003|Double-blind Period|Adverse Event|0|||
42331537|NCT02198651|76169433|FG004|Double-blind Period|Adverse Event|0|||
42331538|NCT02198651|76169429|FG000|Double-blind Period|Other, not specified|0|||
42331539|NCT02198651|76169430|FG001|Double-blind Period|Other, not specified|4|||
42331540|NCT02198651|76169431|FG002|Double-blind Period|Other, not specified|1|||
42331541|NCT02198651|76169432|FG003|Double-blind Period|Other, not specified|0|||
42331542|NCT02198651|76169433|FG004|Double-blind Period|Other, not specified|0|||
41998748|NCT01276704|75807249|FG000|Overall Study|Non-compliant|2|||
41998749|NCT01276704|75807250|FG001|Overall Study|Non-compliant|2|||
42331543|NCT02198651|76169429|FG000|Open-label Rescue Period|Withdrew consent|0|||
42331544|NCT02198651|76169430|FG001|Open-label Rescue Period|Withdrew consent|0|||
41998750|NCT01276704|75807249|FG000|Overall Study|Withdrawal by Subject|7|||
41998751|NCT01276704|75807250|FG001|Overall Study|Withdrawal by Subject|1|||
41998752|NCT01276704|75807249|FG000|Overall Study|Physician Decision|3|||
41998753|NCT01276704|75807250|FG001|Overall Study|Physician Decision|5|||
42263235|NCT02437162|76091062|FG000|Overall Study|Randomized but not treated|0|||
42263236|NCT02437162|76091063|FG001|Overall Study|Randomized but not treated|0|||
42263237|NCT02437162|76091064|FG002|Overall Study|Randomized but not treated|1|||
42263238|NCT02437162|76091062|FG000|Overall Study|Study discontinued by Sponsor|93|||
42263239|NCT02437162|76091063|FG001|Overall Study|Study discontinued by Sponsor|98|||
42263240|NCT02437162|76091064|FG002|Overall Study|Study discontinued by Sponsor|97|||
42034575|NCT01120691|75842652|FG000|Overall Study|Administrative problems|15|||
42034576|NCT01120691|75842653|FG001|Overall Study|Administrative problems|8|||
42034577|NCT01120691|75842654|FG002|Overall Study|Administrative problems|9|||
42034578|NCT01120691|75842652|FG000|Overall Study|Protocol deviation|13|||
42034579|NCT01120691|75842653|FG001|Overall Study|Protocol deviation|12|||
42034580|NCT01120691|75842654|FG002|Overall Study|Protocol deviation|12|||
42034581|NCT01120691|75842652|FG000|Overall Study|Lost to Follow-up|5|||
42034582|NCT01120691|75842653|FG001|Overall Study|Lost to Follow-up|6|||
42331545|NCT02198651|76169431|FG002|Open-label Rescue Period|Withdrew consent|0|||
42331546|NCT02198651|76169432|FG003|Open-label Rescue Period|Withdrew consent|2|||
42331547|NCT02198651|76169433|FG004|Open-label Rescue Period|Withdrew consent|0|||
42331548|NCT02198651|76169429|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
41998754|NCT01190930|75807258|FG000|Induction|Adverse Event|17|||
41998755|NCT01190930|75807259|FG001|Induction|Adverse Event|0|||
41998756|NCT01190930|75807260|FG002|Induction|Adverse Event|0|||
41998757|NCT01190930|75807261|FG003|Induction|Adverse Event|0|||
41998758|NCT01190930|75807262|FG004|Induction|Adverse Event|0|||
41998759|NCT01190930|75807263|FG005|Induction|Adverse Event|0|||
41998760|NCT01190930|75807264|FG006|Induction|Adverse Event|0|||
41998761|NCT01190930|75807265|FG007|Induction|Adverse Event|0|||
41998762|NCT01190930|75807266|FG008|Induction|Adverse Event|0|||
41998763|NCT01190930|75807267|FG009|Induction|Adverse Event|0|||
41998764|NCT01190930|75807258|FG000|Induction|Death|34|||
41998765|NCT01190930|75807259|FG001|Induction|Death|0|||
41998766|NCT01190930|75807260|FG002|Induction|Death|0|||
41998767|NCT01190930|75807261|FG003|Induction|Death|0|||
41998768|NCT01190930|75807262|FG004|Induction|Death|0|||
41998769|NCT01190930|75807263|FG005|Induction|Death|0|||
41998770|NCT01190930|75807264|FG006|Induction|Death|0|||
41998771|NCT01190930|75807265|FG007|Induction|Death|0|||
41998772|NCT01190930|75807266|FG008|Induction|Death|0|||
41998773|NCT01190930|75807267|FG009|Induction|Death|0|||
41998774|NCT01190930|75807258|FG000|Induction|Lost to Follow-up|1|||
41998775|NCT01190930|75807259|FG001|Induction|Lost to Follow-up|0|||
41998776|NCT01190930|75807260|FG002|Induction|Lost to Follow-up|0|||
41998777|NCT01190930|75807261|FG003|Induction|Lost to Follow-up|0|||
41998778|NCT01190930|75807262|FG004|Induction|Lost to Follow-up|0|||
41998779|NCT01190930|75807263|FG005|Induction|Lost to Follow-up|0|||
41998780|NCT01190930|75807264|FG006|Induction|Lost to Follow-up|0|||
42134207|NCT00313300|75945050|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
42263241|NCT02437162|76091062|FG000|Overall Study|Withdrawal by Subject|13|||
42263242|NCT02437162|76091063|FG001|Overall Study|Withdrawal by Subject|7|||
42263243|NCT02437162|76091064|FG002|Overall Study|Withdrawal by Subject|9|||
42263244|NCT02437162|76091062|FG000|Overall Study|Adverse Event|0|||
42263245|NCT02437162|76091063|FG001|Overall Study|Adverse Event|1|||
42263246|NCT02437162|76091064|FG002|Overall Study|Adverse Event|0|||
42263247|NCT02437162|76091062|FG000|Overall Study|Lost to Follow-up|1|||
42263248|NCT02437162|76091063|FG001|Overall Study|Lost to Follow-up|0|||
42263249|NCT02437162|76091064|FG002|Overall Study|Lost to Follow-up|1|||
42263250|NCT02437162|76091062|FG000|Overall Study|Death|0|||
42263251|NCT02437162|76091063|FG001|Overall Study|Death|1|||
42263252|NCT02437162|76091064|FG002|Overall Study|Death|0|||
42263253|NCT02437162|76091062|FG000|Overall Study|Other|0|||
42263254|NCT02437162|76091063|FG001|Overall Study|Other|0|||
42263255|NCT02437162|76091064|FG002|Overall Study|Other|1|||
42263256|NCT01368211|76091079|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
42263257|NCT01368211|76091080|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
42263258|NCT02437084|76091086|FG000|Overall Study|Withdrawal by Subject|2|||
42263259|NCT02437084|76091086|FG000|Overall Study|Physician Decision|1|||
42263260|NCT02406586|76091093|FG000|Overall Study|Lost to Follow-up|0|||
42263261|NCT02406586|76091094|FG001|Overall Study|Lost to Follow-up|4|||
42263262|NCT02406586|76091095|FG002|Overall Study|Lost to Follow-up|2|||
42263263|NCT02406586|76091093|FG000|Overall Study|Withdrawal by Subject|1|||
42263264|NCT02406586|76091094|FG001|Overall Study|Withdrawal by Subject|0|||
42263265|NCT02406586|76091095|FG002|Overall Study|Withdrawal by Subject|0|||
42263266|NCT02460562|76091108|FG000|Overall Study|Lost to Follow-up|15|||
42263267|NCT02460562|76091109|FG001|Overall Study|Lost to Follow-up|16|||
42263268|NCT02788357|76091117|FG000|Overall Study|Lost to Follow-up|3|||
41998781|NCT01190930|75807265|FG007|Induction|Lost to Follow-up|0|||
41998782|NCT01190930|75807266|FG008|Induction|Lost to Follow-up|0|||
41998783|NCT01190930|75807267|FG009|Induction|Lost to Follow-up|0|||
41998784|NCT01190930|75807258|FG000|Induction|Physician Decision|125|||
41998785|NCT01190930|75807259|FG001|Induction|Physician Decision|3|||
41998786|NCT01190930|75807260|FG002|Induction|Physician Decision|0|||
41998787|NCT01190930|75807261|FG003|Induction|Physician Decision|0|||
41998788|NCT01190930|75807262|FG004|Induction|Physician Decision|0|||
41998789|NCT01190930|75807263|FG005|Induction|Physician Decision|0|||
41998790|NCT01190930|75807264|FG006|Induction|Physician Decision|0|||
41998791|NCT01190930|75807265|FG007|Induction|Physician Decision|0|||
42034583|NCT01120691|75842654|FG002|Overall Study|Lost to Follow-up|4|||
42263269|NCT02788357|76091118|FG001|Overall Study|Lost to Follow-up|0|||
41998792|NCT01190930|75807266|FG008|Induction|Physician Decision|0|||
42331549|NCT02198651|76169430|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
42331550|NCT02198651|76169431|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
42331551|NCT02198651|76169432|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
42331552|NCT02198651|76169433|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
42331553|NCT01498822|76169448|FG000|Overall Study|Protocol Violation|8|||
42331554|NCT01498822|76169449|FG001|Overall Study|Protocol Violation|4|||
42331555|NCT01498822|76169448|FG000|Overall Study|Other Reason|5|||
42331556|NCT01498822|76169449|FG001|Overall Study|Other Reason|2|||
42331557|NCT01498822|76169448|FG000|Overall Study|Lack of Efficacy|7|||
42331558|NCT01498822|76169449|FG001|Overall Study|Lack of Efficacy|2|||
42331559|NCT01498822|76169448|FG000|Overall Study|AE, non-serious non-fatal|8|||
42331560|NCT01498822|76169449|FG001|Overall Study|AE, non-serious non-fatal|17|||
42331561|NCT01498822|76169448|FG000|Overall Study|SAE, non-fatal|2|||
42331562|NCT01498822|76169449|FG001|Overall Study|SAE, non-fatal|2|||
42331563|NCT01498822|76169448|FG000|Overall Study|Adverse Event, serious fatal|1|||
42331564|NCT01498822|76169449|FG001|Overall Study|Adverse Event, serious fatal|1|||
42331565|NCT01498822|76169448|FG000|Overall Study|Withdrawal by Subject|15|||
42331566|NCT01498822|76169449|FG001|Overall Study|Withdrawal by Subject|25|||
42331567|NCT01498822|76169448|FG000|Overall Study|Lost to Follow-up|8|||
42331568|NCT01498822|76169449|FG001|Overall Study|Lost to Follow-up|3|||
42331569|NCT01498120|76169457|FG000|Overall Study|Lost to Follow-up|1|||
42331570|NCT01498120|76169457|FG000|Overall Study|Withdrawal by Subject|5|||
42331571|NCT01498120|76169457|FG000|Overall Study|AE, non-serious non-fatal|3|||
42331572|NCT01498120|76169457|FG000|Overall Study|Other|4|||
42331573|NCT01497262|76169461|FG000|Overall Study|Abnormal Lab Values|4|||
42331574|NCT01497262|76169461|FG000|Overall Study|Abnormal Test Procedure Result|1|||
42331575|NCT01497262|76169461|FG000|Overall Study|Physician Decision|1|||
42331576|NCT01497262|76169461|FG000|Overall Study|Withdrawal by Subject|2|||
42331577|NCT01497262|76169461|FG000|Overall Study|Adverse Event|2|||
42331578|NCT01497262|76169461|FG000|Overall Study|Protocol Violation|1|||
42331579|NCT02224625|76169465|FG000|Irritation|Adverse Event|6|||
42331580|NCT02224625|76169465|FG000|Sensitization|Adverse Event|55|||
42331581|NCT02197247|76169477|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
42331582|NCT02197247|76169477|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
42331583|NCT02197247|76169477|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
42331584|NCT02197247|76169477|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
42331585|NCT02197247|76169477|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
42331586|NCT02197247|76169477|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
42331587|NCT02197247|76169477|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
42331588|NCT02197247|76169477|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
42331589|NCT02224157|76169489|FG000|Overall Study|Severe non-compliance to protocol|2|||
42331590|NCT02224157|76169490|FG001|Overall Study|Severe non-compliance to protocol|2|||
42331591|NCT02224157|76169489|FG000|Overall Study|Other|13|||
42331592|NCT02224157|76169490|FG001|Overall Study|Other|10|||
42331593|NCT02224157|76169489|FG000|Overall Study|Subject decision|58|||
42331594|NCT02224157|76169490|FG001|Overall Study|Subject decision|50|||
42331595|NCT02224157|76169489|FG000|Overall Study|Prematurely closed site|4|||
42331596|NCT02224157|76169490|FG001|Overall Study|Prematurely closed site|2|||
41998793|NCT01190930|75807267|FG009|Induction|Physician Decision|0|||
41998794|NCT01190930|75807258|FG000|Induction|Withdrawal by Subject|9|||
42263270|NCT02457910|76091130|FG000|Overall Study|Withdrawal by Subject|0|||
42263271|NCT02457910|76091131|FG001|Overall Study|Withdrawal by Subject|0|||
42263272|NCT02457910|76091132|FG002|Overall Study|Withdrawal by Subject|0|||
42263273|NCT02457910|76091133|FG003|Overall Study|Withdrawal by Subject|0|||
42263274|NCT02457910|76091134|FG004|Overall Study|Withdrawal by Subject|0|||
42263275|NCT02457910|76091135|FG005|Overall Study|Withdrawal by Subject|1|||
42263276|NCT02457910|76091130|FG000|Overall Study|Adverse Event|0|||
42263277|NCT02457910|76091131|FG001|Overall Study|Adverse Event|2|||
42263278|NCT02457910|76091132|FG002|Overall Study|Adverse Event|1|||
42263279|NCT02457910|76091133|FG003|Overall Study|Adverse Event|1|||
42331597|NCT02224157|76169489|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
42331598|NCT02224157|76169490|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
42331599|NCT02224157|76169489|FG000|Overall Study|Lost to Follow-up|27|||
42331600|NCT02224157|76169490|FG001|Overall Study|Lost to Follow-up|35|||
42331601|NCT02224157|76169489|FG000|Overall Study|Death|1|||
41998795|NCT01190930|75807259|FG001|Induction|Withdrawal by Subject|0|||
42134208|NCT00313300|75945051|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
42331602|NCT02224157|76169490|FG001|Overall Study|Death|1|||
42331603|NCT02224157|76169489|FG000|Overall Study|Adverse Event|1|||
42331604|NCT02224157|76169490|FG001|Overall Study|Adverse Event|3|||
42331605|NCT02196701|76169498|FG000|Overall Study|Adverse Event|1|||
42331606|NCT02196701|76169498|FG000|Overall Study|Lost to Follow-up|1|||
42331607|NCT02196701|76169498|FG000|Overall Study|Non-adherence to Protocol|1|||
42331608|NCT01481116|76169508|FG000|Overall Study|Adverse Event|26|||
42331609|NCT01481116|76169509|FG001|Overall Study|Adverse Event|26|||
42331610|NCT01481116|76169510|FG002|Overall Study|Adverse Event|42|||
42331611|NCT01481116|76169508|FG000|Overall Study|Major Protocol Deviation|3|||
41998796|NCT01190930|75807260|FG002|Induction|Withdrawal by Subject|0|||
41998797|NCT01190930|75807261|FG003|Induction|Withdrawal by Subject|0|||
42134209|NCT00313300|75945047|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
42263280|NCT02457910|76091134|FG004|Overall Study|Adverse Event|1|||
42263281|NCT02457910|76091135|FG005|Overall Study|Adverse Event|3|||
42331612|NCT01481116|76169509|FG001|Overall Study|Major Protocol Deviation|7|||
42263282|NCT02457910|76091130|FG000|Overall Study|Disease progression|3|||
42263283|NCT02457910|76091131|FG001|Overall Study|Disease progression|3|||
42263284|NCT02457910|76091132|FG002|Overall Study|Disease progression|1|||
42263285|NCT02457910|76091133|FG003|Overall Study|Disease progression|1|||
42263286|NCT02457910|76091134|FG004|Overall Study|Disease progression|4|||
42263287|NCT02457910|76091135|FG005|Overall Study|Disease progression|6|||
42263288|NCT02457910|76091130|FG000|Overall Study|Other complicating illness|0|||
42263289|NCT02457910|76091131|FG001|Overall Study|Other complicating illness|0|||
42263290|NCT02457910|76091132|FG002|Overall Study|Other complicating illness|0|||
42263291|NCT02457910|76091133|FG003|Overall Study|Other complicating illness|0|||
42263292|NCT02457910|76091134|FG004|Overall Study|Other complicating illness|0|||
42263293|NCT02457910|76091135|FG005|Overall Study|Other complicating illness|1|||
42263294|NCT02457910|76091130|FG000|Overall Study|Death|0|||
42263295|NCT02457910|76091131|FG001|Overall Study|Death|0|||
42263296|NCT02457910|76091132|FG002|Overall Study|Death|1|||
42263297|NCT02457910|76091133|FG003|Overall Study|Death|0|||
42331613|NCT01481116|76169510|FG002|Overall Study|Major Protocol Deviation|1|||
42331614|NCT01481116|76169508|FG000|Overall Study|Lost to Follow-up|8|||
42263298|NCT02457910|76091134|FG004|Overall Study|Death|0|||
42263299|NCT02457910|76091135|FG005|Overall Study|Death|0|||
42331615|NCT01481116|76169509|FG001|Overall Study|Lost to Follow-up|12|||
42331616|NCT01481116|76169510|FG002|Overall Study|Lost to Follow-up|11|||
42331617|NCT01481116|76169508|FG000|Overall Study|Withdrawal by Subject|37|||
42331618|NCT01481116|76169509|FG001|Overall Study|Withdrawal by Subject|33|||
42331619|NCT01481116|76169510|FG002|Overall Study|Withdrawal by Subject|37|||
42331620|NCT01481116|76169508|FG000|Overall Study|Study Termination|730|||
42331621|NCT01481116|76169509|FG001|Overall Study|Study Termination|729|||
42331622|NCT01481116|76169510|FG002|Overall Study|Study Termination|713|||
42331623|NCT01481116|76169508|FG000|Overall Study|Pregnancy|0|||
42331624|NCT01481116|76169509|FG001|Overall Study|Pregnancy|0|||
42331625|NCT01481116|76169510|FG002|Overall Study|Pregnancy|1|||
42331626|NCT01481116|76169508|FG000|Overall Study|Lack of Efficacy|3|||
42331627|NCT01481116|76169509|FG001|Overall Study|Lack of Efficacy|3|||
42331628|NCT01481116|76169510|FG002|Overall Study|Lack of Efficacy|1|||
42331629|NCT01481116|76169508|FG000|Overall Study|Contraindications|1|||
42331630|NCT01481116|76169509|FG001|Overall Study|Contraindications|1|||
42331631|NCT01481116|76169510|FG002|Overall Study|Contraindications|0|||
42331632|NCT01481116|76169508|FG000|Overall Study|Other|1|||
42331633|NCT01481116|76169509|FG001|Overall Study|Other|1|||
42331634|NCT01481116|76169510|FG002|Overall Study|Other|0|||
42331635|NCT01481116|76169508|FG000|Overall Study|Participant Started Taking Glipizide|1|||
42331636|NCT01481116|76169509|FG001|Overall Study|Participant Started Taking Glipizide|0|||
42331637|NCT01481116|76169510|FG002|Overall Study|Participant Started Taking Glipizide|0|||
41998798|NCT01190930|75807262|FG004|Induction|Withdrawal by Subject|0|||
41998799|NCT01190930|75807263|FG005|Induction|Withdrawal by Subject|0|||
41998800|NCT01190930|75807264|FG006|Induction|Withdrawal by Subject|0|||
41998801|NCT01190930|75807265|FG007|Induction|Withdrawal by Subject|0|||
42134210|NCT00313300|75945048|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
42331638|NCT01481116|76169508|FG000|Overall Study|Participant Moved Out of Area|2|||
41998802|NCT01190930|75807266|FG008|Induction|Withdrawal by Subject|0|||
42331639|NCT01481116|76169509|FG001|Overall Study|Participant Moved Out of Area|0|||
42331640|NCT01481116|76169510|FG002|Overall Study|Participant Moved Out of Area|1|||
42331641|NCT01481116|76169508|FG000|Overall Study|Participant Moved Out of Country|1|||
42263300|NCT02405962|76091154|FG000|Overall Study|Lost to Follow-up|1|||
42263301|NCT02405962|76091155|FG001|Overall Study|Lost to Follow-up|4|||
42263302|NCT02405962|76091154|FG000|Overall Study|A participant has moved to another place|0|||
42263303|NCT02405962|76091155|FG001|Overall Study|A participant has moved to another place|1|||
42263304|NCT02436304|76091164|FG000|Overall Study|Lost to Follow-up|0|||
42263305|NCT02436304|76091165|FG001|Overall Study|Lost to Follow-up|1|||
42263306|NCT02436304|76091166|FG002|Overall Study|Lost to Follow-up|0|||
42263307|NCT02436304|76091164|FG000|Overall Study|Withdrawal by Subject|0|||
42263308|NCT02436304|76091165|FG001|Overall Study|Withdrawal by Subject|1|||
42263309|NCT02436304|76091166|FG002|Overall Study|Withdrawal by Subject|0|||
42263310|NCT02436304|76091164|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
42263311|NCT02436304|76091165|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
42263312|NCT02436304|76091166|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
42263313|NCT02402218|76091178|FG000|Overall Study|Did not pickup study medication|12|||
42263314|NCT02402218|76091179|FG001|Overall Study|Did not pickup study medication|9|||
42263315|NCT02402218|76091180|FG002|Overall Study|Did not pickup study medication|13|||
42263316|NCT02402218|76091178|FG000|Overall Study|Lack of Efficacy|0|||
42263317|NCT02402218|76091179|FG001|Overall Study|Lack of Efficacy|1|||
42263318|NCT02402218|76091180|FG002|Overall Study|Lack of Efficacy|1|||
42263319|NCT02402218|76091178|FG000|Overall Study|Death|1|||
42263320|NCT02402218|76091179|FG001|Overall Study|Death|0|||
42263321|NCT02402218|76091180|FG002|Overall Study|Death|0|||
42263322|NCT02402218|76091178|FG000|Overall Study|Reinfection|0|||
42263323|NCT02402218|76091179|FG001|Overall Study|Reinfection|0|||
42263324|NCT02402218|76091180|FG002|Overall Study|Reinfection|1|||
42263325|NCT02402218|76091178|FG000|Overall Study|Adverse Event|0|||
42263326|NCT02402218|76091179|FG001|Overall Study|Adverse Event|2|||
42263327|NCT02402218|76091180|FG002|Overall Study|Adverse Event|1|||
42263328|NCT02402218|76091178|FG000|Overall Study|Withdrawal by Subject|1|||
42263329|NCT02402218|76091179|FG001|Overall Study|Withdrawal by Subject|1|||
42263330|NCT02402218|76091180|FG002|Overall Study|Withdrawal by Subject|1|||
42263331|NCT02457520|76091188|FG000|Active Treatment Phase|Adverse Event|10|||
42263332|NCT02457520|76091188|FG000|Active Treatment Phase|Lost to Follow-up|8|||
42263333|NCT02457520|76091188|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
42263334|NCT02457520|76091188|FG000|Active Treatment Phase|other|4|||
42263335|NCT02457520|76091188|FG000|Active Treatment Phase|Physician Decision|1|||
42263336|NCT02457520|76091188|FG000|Active Treatment Phase|Protocol Violation|1|||
42263337|NCT02457520|76091188|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
42263338|NCT02457520|76091188|FG000|Post-treatment Period|Other: Retreatment Required|7|||
42263339|NCT02457520|76091188|FG000|Post-treatment Period|Lost to Follow-up|23|||
42263340|NCT02457520|76091188|FG000|Post-treatment Period|Other|3|||
42263341|NCT02457520|76091188|FG000|Post-treatment Period|Physician Decision|1|||
42263342|NCT02457520|76091188|FG000|Post-treatment Period|Withdrawal by Subject|14|||
42263343|NCT02788279|76091221|FG000|Overall Study|Death|62|||
42263344|NCT02788279|76091222|FG001|Overall Study|Death|136|||
42263345|NCT02788279|76091223|FG002|Overall Study|Death|72|||
42263346|NCT02788279|76091221|FG000|Overall Study|Withdrawal by Subject|10|||
42263347|NCT02788279|76091222|FG001|Overall Study|Withdrawal by Subject|15|||
42263348|NCT02788279|76091223|FG002|Overall Study|Withdrawal by Subject|5|||
42263349|NCT02788279|76091221|FG000|Overall Study|Lost to Follow-up|0|||
42263350|NCT02788279|76091222|FG001|Overall Study|Lost to Follow-up|3|||
42263351|NCT02788279|76091223|FG002|Overall Study|Lost to Follow-up|2|||
42263352|NCT02788279|76091221|FG000|Overall Study|Sponsor decision|18|||
42263353|NCT02788279|76091222|FG001|Overall Study|Sponsor decision|29|||
42263354|NCT02788279|76091223|FG002|Overall Study|Sponsor decision|11|||
42263355|NCT02435992|76091239|FG000|Overall Study|non compliance with protocol|2|||
42263356|NCT02435992|76091240|FG001|Overall Study|non compliance with protocol|0|||
42263357|NCT02435992|76091241|FG002|Overall Study|non compliance with protocol|1|||
42263358|NCT02435992|76091242|FG003|Overall Study|non compliance with protocol|0|||
42263359|NCT02435992|76091243|FG004|Overall Study|non compliance with protocol|0|||
42263360|NCT02435992|76091239|FG000|Overall Study|Adverse Event|11|||
42263361|NCT02435992|76091240|FG001|Overall Study|Adverse Event|6|||
42263362|NCT02435992|76091241|FG002|Overall Study|Adverse Event|12|||
42263363|NCT02435992|76091242|FG003|Overall Study|Adverse Event|0|||
42263364|NCT02435992|76091243|FG004|Overall Study|Adverse Event|0|||
42263365|NCT02435992|76091239|FG000|Overall Study|Lack of Efficacy|4|||
42263366|NCT02435992|76091240|FG001|Overall Study|Lack of Efficacy|10|||
42263367|NCT02435992|76091241|FG002|Overall Study|Lack of Efficacy|9|||
42263368|NCT02435992|76091242|FG003|Overall Study|Lack of Efficacy|0|||
42263369|NCT02435992|76091243|FG004|Overall Study|Lack of Efficacy|0|||
42263370|NCT02435992|76091239|FG000|Overall Study|Withdrawal by Subject|10|||
42263371|NCT02435992|76091240|FG001|Overall Study|Withdrawal by Subject|8|||
42263372|NCT02435992|76091241|FG002|Overall Study|Withdrawal by Subject|20|||
42263373|NCT02435992|76091242|FG003|Overall Study|Withdrawal by Subject|0|||
42263374|NCT02435992|76091243|FG004|Overall Study|Withdrawal by Subject|0|||
42263375|NCT02435992|76091239|FG000|Overall Study|Other Reason|1|||
42263376|NCT02435992|76091240|FG001|Overall Study|Other Reason|0|||
42263377|NCT02435992|76091241|FG002|Overall Study|Other Reason|0|||
42263378|NCT02435992|76091242|FG003|Overall Study|Other Reason|0|||
42263379|NCT02435992|76091243|FG004|Overall Study|Other Reason|0|||
42263380|NCT02435992|76091239|FG000|Overall Study|Physician Decision|0|||
42263381|NCT02435992|76091240|FG001|Overall Study|Physician Decision|0|||
42263382|NCT02435992|76091241|FG002|Overall Study|Physician Decision|1|||
42263383|NCT02435992|76091242|FG003|Overall Study|Physician Decision|0|||
42331642|NCT01481116|76169509|FG001|Overall Study|Participant Moved Out of Country|0|||
42331643|NCT01481116|76169510|FG002|Overall Study|Participant Moved Out of Country|1|||
42331644|NCT01481116|76169508|FG000|Overall Study|Investigator Decision|3|||
42331645|NCT01481116|76169509|FG001|Overall Study|Investigator Decision|2|||
42331646|NCT01481116|76169510|FG002|Overall Study|Investigator Decision|1|||
42331647|NCT01481116|76169508|FG000|Overall Study|Sponsor Decision|0|||
42263384|NCT02435992|76091243|FG004|Overall Study|Physician Decision|0|||
42331648|NCT01481116|76169509|FG001|Overall Study|Sponsor Decision|1|||
42263385|NCT02788513|76091260|FG000|Overall Study|Withdrawal by Subject|3|||
42263386|NCT02788513|76091261|FG001|Overall Study|Withdrawal by Subject|0|||
42263387|NCT02788513|76091262|FG002|Overall Study|Withdrawal by Subject|2|||
42263388|NCT02788513|76091263|FG003|Overall Study|Withdrawal by Subject|3|||
42263389|NCT02788513|76091264|FG004|Overall Study|Withdrawal by Subject|1|||
42263390|NCT02788513|76091260|FG000|Overall Study|Lost to Follow-up|1|||
42263391|NCT02788513|76091261|FG001|Overall Study|Lost to Follow-up|0|||
42263392|NCT02788513|76091262|FG002|Overall Study|Lost to Follow-up|0|||
42263393|NCT02788513|76091263|FG003|Overall Study|Lost to Follow-up|0|||
42263394|NCT02788513|76091264|FG004|Overall Study|Lost to Follow-up|1|||
42331649|NCT01481116|76169510|FG002|Overall Study|Sponsor Decision|3|||
42263395|NCT02788513|76091260|FG000|Overall Study|Adverse Event|5|||
42263396|NCT02788513|76091261|FG001|Overall Study|Adverse Event|8|||
42263397|NCT02788513|76091262|FG002|Overall Study|Adverse Event|4|||
42263398|NCT02788513|76091263|FG003|Overall Study|Adverse Event|2|||
42263399|NCT02788513|76091264|FG004|Overall Study|Adverse Event|2|||
42263400|NCT02788513|76091260|FG000|Overall Study|Protocol Violation|0|||
42263401|NCT02788513|76091261|FG001|Overall Study|Protocol Violation|0|||
42263402|NCT02788513|76091262|FG002|Overall Study|Protocol Violation|1|||
42263403|NCT02788513|76091263|FG003|Overall Study|Protocol Violation|1|||
42263404|NCT02788513|76091264|FG004|Overall Study|Protocol Violation|0|||
42263405|NCT02788513|76091260|FG000|Overall Study|Subject decided to stop taking treatment|0|||
42263406|NCT02788513|76091261|FG001|Overall Study|Subject decided to stop taking treatment|0|||
42263407|NCT02788513|76091262|FG002|Overall Study|Subject decided to stop taking treatment|1|||
42263408|NCT02788513|76091263|FG003|Overall Study|Subject decided to stop taking treatment|0|||
42263409|NCT02788513|76091264|FG004|Overall Study|Subject decided to stop taking treatment|0|||
42263410|NCT02788513|76091260|FG000|Overall Study|Decision by the study team|0|||
42263411|NCT02788513|76091261|FG001|Overall Study|Decision by the study team|0|||
42263412|NCT02788513|76091262|FG002|Overall Study|Decision by the study team|0|||
42263413|NCT02788513|76091263|FG003|Overall Study|Decision by the study team|0|||
42263414|NCT02788513|76091264|FG004|Overall Study|Decision by the study team|1|||
42263415|NCT03077828|76091276|FG000|Treatment Cycles|Death|1|||
42263416|NCT03077828|76091276|FG000|Treatment Cycles|Withdrawal by Subject|1|||
42263417|NCT03077828|76091276|FG000|Treatment Cycles|Screen Fail|2|||
42263418|NCT03077828|76091276|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
42263419|NCT03077828|76091276|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
42263420|NCT03077828|76091276|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
42134211|NCT00313300|75945049|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
42134212|NCT00313300|75945050|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
42134213|NCT00313300|75945051|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
42134214|NCT00313300|75945047|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
42134215|NCT00313300|75945048|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
42134216|NCT00313300|75945049|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
42134217|NCT00313300|75945050|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
42134218|NCT00313300|75945051|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
42134219|NCT00313300|75945047|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
42134220|NCT00313300|75945048|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
42134221|NCT00313300|75945049|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
42134222|NCT00313300|75945050|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
42134223|NCT00313300|75945051|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
42134224|NCT00313300|75945047|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
42134225|NCT00313300|75945048|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
42134226|NCT00313300|75945049|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
42134227|NCT00313300|75945050|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
42263421|NCT03077828|76091276|FG000|Follow-up|Patients still in follow-up|15|||
42263422|NCT02401672|76091282|FG000|Overall Study|Withdrawal by Subject|1|||
42263423|NCT02401672|76091283|FG001|Overall Study|Withdrawal by Subject|3|||
42263424|NCT02435914|76091293|FG000|Overall Study|Ocular Adverse Event|1|||
42263425|NCT02435914|76091294|FG001|Overall Study|Ocular Adverse Event|0|||
42263426|NCT02435914|76091295|FG002|Overall Study|Ocular Adverse Event|0|||
42263427|NCT02435914|76091296|FG003|Overall Study|Ocular Adverse Event|0|||
42263428|NCT02435914|76091293|FG000|Overall Study|Withdrawal by Subject|0|||
42263429|NCT02435914|76091294|FG001|Overall Study|Withdrawal by Subject|1|||
42263430|NCT02435914|76091295|FG002|Overall Study|Withdrawal by Subject|0|||
42263431|NCT02435914|76091296|FG003|Overall Study|Withdrawal by Subject|0|||
42263432|NCT02435914|76091293|FG000|Overall Study|Other Miscellaneous Reason|0|||
42263433|NCT02435914|76091294|FG001|Overall Study|Other Miscellaneous Reason|0|||
42263434|NCT02435914|76091295|FG002|Overall Study|Other Miscellaneous Reason|1|||
42263435|NCT02435914|76091296|FG003|Overall Study|Other Miscellaneous Reason|0|||
42263436|NCT02786953|76091308|FG000|Overall Study|Withdrawal by Subject|3|||
42263437|NCT02786953|76091309|FG001|Overall Study|Withdrawal by Subject|0|||
42263438|NCT02786953|76091308|FG000|Overall Study|Physician Decision|0|||
42263439|NCT02786953|76091309|FG001|Overall Study|Physician Decision|1|||
42134228|NCT00313300|75945051|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
42134229|NCT00313300|75945047|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
42331650|NCT01481116|76169508|FG000|Overall Study|Non-Compliant With Study Drug|0|||
42331651|NCT01481116|76169509|FG001|Overall Study|Non-Compliant With Study Drug|1|||
42331652|NCT01481116|76169510|FG002|Overall Study|Non-Compliant With Study Drug|1|||
42331653|NCT01481116|76169508|FG000|Overall Study|Investigator's Discretion|2|||
42331654|NCT01481116|76169509|FG001|Overall Study|Investigator's Discretion|0|||
42331655|NCT01481116|76169510|FG002|Overall Study|Investigator's Discretion|0|||
42134230|NCT00313300|75945048|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
42134231|NCT00313300|75945049|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
42134232|NCT00313300|75945050|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
42134233|NCT00313300|75945051|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
42134234|NCT00313300|75945047|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
42134235|NCT00313300|75945048|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
42134236|NCT00313300|75945049|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
42134237|NCT00313300|75945050|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
42134238|NCT00313300|75945051|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
42134239|NCT00313300|75945047|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
42134240|NCT00313300|75945048|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
42134241|NCT00313300|75945049|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
42134242|NCT00313300|75945050|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
42331656|NCT01481116|76169508|FG000|Overall Study|Death|2|||
42331657|NCT01481116|76169509|FG001|Overall Study|Death|1|||
42263440|NCT02435836|76091315|FG000|Overall Study|Lost to Follow-up|21|||
42331658|NCT01481116|76169510|FG002|Overall Study|Death|0|||
42263441|NCT02435836|76091315|FG000|Overall Study|Lack of Efficacy|1|||
42263442|NCT02435836|76091315|FG000|Overall Study|Withdrawal by Subject|236|||
42263443|NCT02435836|76091315|FG000|Overall Study|Insufficient Clinical Response|26|||
41998803|NCT01190930|75807267|FG009|Induction|Withdrawal by Subject|0|||
41998804|NCT01190930|75807258|FG000|Induction|Refusal|235|||
41998805|NCT01190930|75807259|FG001|Induction|Refusal|0|||
41998806|NCT01190930|75807260|FG002|Induction|Refusal|0|||
42134243|NCT00313300|75945051|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
42263444|NCT02435836|76091315|FG000|Overall Study|Adverse Event|44|||
42263445|NCT02435836|76091315|FG000|Overall Study|Sponsor discontinued trial|167|||
42263446|NCT02435836|76091315|FG000|Overall Study|Noncompliance|27|||
42331659|NCT01481116|76169508|FG000|Overall Study|Hypoglycemic Event|4|||
42134244|NCT00313300|75945047|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
42134245|NCT00313300|75945048|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
42263447|NCT02435836|76091315|FG000|Overall Study|Protocol Violation|6|||
42263448|NCT02435836|76091315|FG000|Overall Study|Met Withdrawal Criteria|7|||
41998807|NCT01190930|75807261|FG003|Induction|Refusal|0|||
41998808|NCT01190930|75807262|FG004|Induction|Refusal|0|||
42263449|NCT02435836|76091315|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
42331660|NCT01481116|76169509|FG001|Overall Study|Hypoglycemic Event|0|||
41998809|NCT01190930|75807263|FG005|Induction|Refusal|0|||
41998810|NCT01190930|75807264|FG006|Induction|Refusal|0|||
41998811|NCT01190930|75807265|FG007|Induction|Refusal|0|||
42331661|NCT01481116|76169510|FG002|Overall Study|Hypoglycemic Event|0|||
42331662|NCT02222207|76169518|FG000|Overall Study|Death|1|||
42331663|NCT02222207|76169518|FG000|Overall Study|Other reasons|2|||
42331664|NCT02222207|76169518|FG000|Overall Study|Adverse Event|1|||
42331665|NCT01457014|76169522|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
42331666|NCT01457014|76169523|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
42331667|NCT01457014|76169524|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
42331668|NCT01457014|76169525|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
42331669|NCT01457014|76169522|FG000|First Night|Withdrawal by Subject|3|||
42331670|NCT01457014|76169523|FG001|First Night|Withdrawal by Subject|0|||
42331671|NCT01457014|76169524|FG002|First Night|Withdrawal by Subject|0|||
42331672|NCT01457014|76169525|FG003|First Night|Withdrawal by Subject|0|||
42331673|NCT02254421|76169535|FG000|Overall Study|Randomized but Not Treated|1|||
42331674|NCT02254421|76169536|FG001|Overall Study|Randomized but Not Treated|0|||
42331675|NCT02254421|76169535|FG000|Overall Study|Death|0|||
42331676|NCT02254421|76169536|FG001|Overall Study|Death|2|||
42331677|NCT02254421|76169535|FG000|Overall Study|Withdrew Consent|1|||
42331678|NCT02254421|76169536|FG001|Overall Study|Withdrew Consent|1|||
42331679|NCT02252939|76169542|FG000|Overall Study|Lost to Follow-up|3|||
42331680|NCT02196077|76169551|FG000|Overall Study|Adverse Event|4|||
42331681|NCT02196077|76169551|FG000|Overall Study|Lack of Efficacy|1|||
42331682|NCT02196077|76169551|FG000|Overall Study|Withdrawal by Subject|14|||
42331683|NCT02196077|76169551|FG000|Overall Study|Physician Decision|1|||
42331684|NCT02196077|76169551|FG000|Overall Study|Lost to Follow-up|3|||
42331685|NCT02196077|76169551|FG000|Overall Study|Protocol Violation|24|||
42331686|NCT02195687|76169565|FG000|Overall Study|Personal Reasons|1|||
42331687|NCT02195687|76169566|FG001|Overall Study|Personal Reasons|1|||
42331688|NCT02195687|76169565|FG000|Overall Study|Lost to Follow-up|4|||
42331689|NCT02195687|76169566|FG001|Overall Study|Lost to Follow-up|1|||
42331690|NCT02195531|76169575|FG000|Overall Study|Withdrawal by Subject|1|||
42331691|NCT02195531|76169576|FG001|Overall Study|Withdrawal by Subject|1|||
42331692|NCT02195531|76169577|FG002|Overall Study|Withdrawal by Subject|1|||
42331693|NCT02252081|76169587|FG000|Overall Study|Withdrawal by Subject|2|||
42331694|NCT02252081|76169588|FG001|Overall Study|Withdrawal by Subject|1|||
41998812|NCT01190930|75807266|FG008|Induction|Refusal|0|||
42331695|NCT02252081|76169587|FG000|Overall Study|Adverse Event|4|||
41998813|NCT01190930|75807267|FG009|Induction|Refusal|0|||
42331696|NCT02252081|76169588|FG001|Overall Study|Adverse Event|1|||
42331697|NCT02252081|76169587|FG000|Overall Study|non compliance & others|0|||
42331698|NCT02252081|76169588|FG001|Overall Study|non compliance & others|2|||
42331699|NCT01623752|76169602|FG000|Phase 1 (78 Weeks)|No Data|249|||
42331700|NCT01623752|76169603|FG001|Phase 1 (78 Weeks)|No Data|66|||
42331701|NCT01623752|76169604|FG002|Phase 1 (78 Weeks)|No Data|2|||
41998814|NCT01190930|75807258|FG000|Induction|Inevaluable|23|||
42331702|NCT01623752|76169602|FG000|Phase 1 (78 Weeks)|Other|33|||
42331703|NCT01623752|76169603|FG001|Phase 1 (78 Weeks)|Other|20|||
42331704|NCT01623752|76169604|FG002|Phase 1 (78 Weeks)|Other|0|||
42331705|NCT01623752|76169602|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
42331706|NCT01623752|76169603|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
42331707|NCT01623752|76169604|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
42331708|NCT01623752|76169602|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
42331709|NCT01623752|76169603|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
42331710|NCT01623752|76169604|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
42331711|NCT01623752|76169602|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
42331712|NCT01623752|76169603|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
42331713|NCT01623752|76169604|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
42331714|NCT01623752|76169602|FG000|Phase 2 (78 Weeks)|Other|5|||
42331715|NCT01623752|76169603|FG001|Phase 2 (78 Weeks)|Other|1|||
42331716|NCT01623752|76169604|FG002|Phase 2 (78 Weeks)|Other|0|||
42331717|NCT01623752|76169602|FG000|Phase 2 (78 Weeks)|No Data|43|||
42331718|NCT01623752|76169603|FG001|Phase 2 (78 Weeks)|No Data|11|||
42331719|NCT01623752|76169604|FG002|Phase 2 (78 Weeks)|No Data|0|||
42331720|NCT01623752|76169602|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
42331721|NCT01623752|76169603|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
42331722|NCT01623752|76169604|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
42331723|NCT01623596|76169615|FG000|Overall Study|Abnormal laboratory values|2|||
42331724|NCT01623596|76169616|FG001|Overall Study|Abnormal laboratory values|0|||
42331725|NCT01623596|76169615|FG000|Overall Study|Administrative problems|9|||
42331726|NCT01623596|76169616|FG001|Overall Study|Administrative problems|13|||
42331727|NCT01623596|76169615|FG000|Overall Study|Adverse Event|20|||
42331728|NCT01623596|76169616|FG001|Overall Study|Adverse Event|29|||
42331729|NCT01623596|76169615|FG000|Overall Study|Death|0|||
42331730|NCT01623596|76169616|FG001|Overall Study|Death|2|||
42331731|NCT01623596|76169615|FG000|Overall Study|Lost to Follow-up|12|||
42331732|NCT01623596|76169616|FG001|Overall Study|Lost to Follow-up|16|||
42331733|NCT01623596|76169615|FG000|Overall Study|Withdrawal by Subject|13|||
42331734|NCT01623596|76169616|FG001|Overall Study|Withdrawal by Subject|31|||
42331735|NCT01623596|76169615|FG000|Overall Study|Patient no longer requires study drug|1|||
42331736|NCT01623596|76169616|FG001|Overall Study|Patient no longer requires study drug|0|||
42331737|NCT01623596|76169615|FG000|Overall Study|Protocol Violation|0|||
42331738|NCT01623596|76169616|FG001|Overall Study|Protocol Violation|6|||
42331739|NCT01623596|76169615|FG000|Overall Study|Lack of Efficacy|5|||
42331740|NCT01623596|76169616|FG001|Overall Study|Lack of Efficacy|3|||
42331741|NCT02219477|76169627|FG000|Overall Study|Adverse Event|0|||
42331742|NCT02219477|76169628|FG001|Overall Study|Adverse Event|1|||
42331743|NCT02219477|76169629|FG002|Overall Study|Adverse Event|1|||
42331744|NCT02219477|76169627|FG000|Overall Study|Withdrawal by Subject|0|||
42134246|NCT00313300|75945049|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
42331745|NCT02219477|76169628|FG001|Overall Study|Withdrawal by Subject|1|||
42331746|NCT02219477|76169629|FG002|Overall Study|Withdrawal by Subject|0|||
42331747|NCT02119286|76169641|FG000|Overall Study|Adverse Event|9|||
42331748|NCT02119286|76169642|FG001|Overall Study|Adverse Event|7|||
42331749|NCT02119286|76169643|FG002|Overall Study|Adverse Event|2|||
42331750|NCT02119286|76169641|FG000|Overall Study|Lack of Efficacy|11|||
42331751|NCT02119286|76169642|FG001|Overall Study|Lack of Efficacy|3|||
42331752|NCT02119286|76169643|FG002|Overall Study|Lack of Efficacy|4|||
42331753|NCT02119286|76169641|FG000|Overall Study|Lost to Follow-up|2|||
42331754|NCT02119286|76169642|FG001|Overall Study|Lost to Follow-up|0|||
42331755|NCT02119286|76169643|FG002|Overall Study|Lost to Follow-up|1|||
42331756|NCT02119286|76169641|FG000|Overall Study|Withdrawal by Subject|4|||
41998815|NCT01190930|75807259|FG001|Induction|Inevaluable|1|||
41998816|NCT01190930|75807260|FG002|Induction|Inevaluable|0|||
41998817|NCT01190930|75807261|FG003|Induction|Inevaluable|0|||
41998818|NCT01190930|75807262|FG004|Induction|Inevaluable|0|||
41998819|NCT01190930|75807263|FG005|Induction|Inevaluable|0|||
41998820|NCT01190930|75807264|FG006|Induction|Inevaluable|0|||
41998821|NCT01190930|75807265|FG007|Induction|Inevaluable|0|||
41998822|NCT01190930|75807266|FG008|Induction|Inevaluable|0|||
42263450|NCT02788201|76091325|FG000|Overall Study|Death|1|||
42263451|NCT02788201|76091326|FG001|Overall Study|Death|1|||
42263452|NCT02788201|76091327|FG002|Overall Study|Death|1|||
42263453|NCT02788201|76091328|FG003|Overall Study|Death|1|||
42263454|NCT02788201|76091329|FG004|Overall Study|Death|0|||
42263455|NCT02788201|76091330|FG005|Overall Study|Death|1|||
42263456|NCT02788201|76091325|FG000|Overall Study|Ineligible|0|||
42263457|NCT02788201|76091326|FG001|Overall Study|Ineligible|0|||
42263458|NCT02788201|76091327|FG002|Overall Study|Ineligible|0|||
42263459|NCT02788201|76091328|FG003|Overall Study|Ineligible|0|||
41998823|NCT01190930|75807267|FG009|Induction|Inevaluable|0|||
41998824|NCT01190930|75807258|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
41998825|NCT01190930|75807259|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
42263460|NCT02788201|76091329|FG004|Overall Study|Ineligible|0|||
42263461|NCT02788201|76091330|FG005|Overall Study|Ineligible|1|||
42263462|NCT02788201|76091325|FG000|Overall Study|Withdrawal by Subject|0|||
42263463|NCT02788201|76091326|FG001|Overall Study|Withdrawal by Subject|0|||
42263464|NCT02788201|76091327|FG002|Overall Study|Withdrawal by Subject|0|||
42263465|NCT02788201|76091328|FG003|Overall Study|Withdrawal by Subject|0|||
42331757|NCT02119286|76169642|FG001|Overall Study|Withdrawal by Subject|1|||
42331758|NCT02119286|76169643|FG002|Overall Study|Withdrawal by Subject|0|||
42331759|NCT02250443|76169651|FG000|Overall Study|Administrative problems|7|||
42331760|NCT02250443|76169651|FG000|Overall Study|Adverse Event|3|||
42331761|NCT02093390|76169657|FG000|Overall Study|Withdrawal by Subject|0|||
42331762|NCT02093390|76169658|FG001|Overall Study|Withdrawal by Subject|1|||
42331763|NCT02194985|76169665|FG000|Overall Study|Adverse Event|1|||
42331764|NCT02194985|76169665|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
42331765|NCT02194985|76169665|FG000|Overall Study|Physician Decision|4|||
42331766|NCT02194985|76169665|FG000|Overall Study|Lost to Follow-up|1|||
42331767|NCT02194985|76169665|FG000|Overall Study|Withdrawal by Subject|2|||
42331768|NCT02219087|76169671|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
42331769|NCT02219087|76169672|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
42331770|NCT02248961|76169680|FG000|Overall Study|Adverse Event|1|||
42331771|NCT02248961|76169681|FG001|Overall Study|Adverse Event|0|||
41998826|NCT01190930|75807260|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
42331772|NCT02248961|76169680|FG000|Overall Study|Withdrawal by Subject|1|||
42331773|NCT02248961|76169681|FG001|Overall Study|Withdrawal by Subject|2|||
42331774|NCT02248961|76169680|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
41998827|NCT01190930|75807261|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
42331775|NCT02248961|76169681|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
42331776|NCT02219009|76169689|FG000|Overall Study|Withdrawal by Subject|5|||
41998828|NCT01190930|75807262|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
42331777|NCT02219009|76169690|FG001|Overall Study|Withdrawal by Subject|1|||
42331778|NCT02219009|76169689|FG000|Overall Study|Adverse Event|2|||
42331779|NCT02219009|76169690|FG001|Overall Study|Adverse Event|4|||
42331780|NCT02219009|76169689|FG000|Overall Study|Lost to Follow-up|2|||
41998829|NCT01190930|75807263|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
41998830|NCT01190930|75807264|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
41998831|NCT01190930|75807265|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
41998832|NCT01190930|75807266|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
42263466|NCT02788201|76091329|FG004|Overall Study|Withdrawal by Subject|0|||
42263467|NCT02788201|76091330|FG005|Overall Study|Withdrawal by Subject|1|||
42263468|NCT02456740|76091349|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
42263469|NCT02456740|76091350|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
42263470|NCT02456740|76091351|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
42263471|NCT02456740|76091352|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
42263472|NCT02456740|76091353|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
42263473|NCT02456740|76091354|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
42263474|NCT02456740|76091355|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
42263475|NCT02456740|76091356|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
42263476|NCT02456740|76091357|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
42263477|NCT02456740|76091349|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
41998833|NCT01190930|75807267|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
41998834|NCT01190930|75807258|FG000|Induction|High Risk Downs|80|||
42134247|NCT00313300|75945050|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
42134248|NCT00313300|75945051|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
42134249|NCT00459186|75945069|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
42331781|NCT02219009|76169690|FG001|Overall Study|Lost to Follow-up|2|||
42331782|NCT02219009|76169689|FG000|Overall Study|Protocol deviation|1|||
42331783|NCT02219009|76169690|FG001|Overall Study|Protocol deviation|0|||
42331784|NCT02219009|76169689|FG000|Overall Study|Physician Decision|0|||
42331785|NCT02219009|76169690|FG001|Overall Study|Physician Decision|1|||
42331786|NCT02248649|76169698|FG000|Overall Study|Death|7|||
42331787|NCT02248649|76169699|FG001|Overall Study|Death|11|||
42331788|NCT02248649|76169698|FG000|Overall Study|Lost to Follow-up|14|||
42331789|NCT02248649|76169699|FG001|Overall Study|Lost to Follow-up|10|||
42331790|NCT02218541|76169707|FG000|Overall Study|Lost to Follow-up|2|||
42331791|NCT02218541|76169708|FG001|Overall Study|Lost to Follow-up|1|||
42331792|NCT02218541|76169707|FG000|Overall Study|Implant Failure|4|||
42331793|NCT02218541|76169708|FG001|Overall Study|Implant Failure|1|||
42331794|NCT02217527|76169717|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
42331795|NCT02217527|76169718|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
42331796|NCT02217527|76169717|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
42331797|NCT02217527|76169718|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
42331798|NCT01456936|76169728|FG000|Overall Study|Other reason|41|||
42331799|NCT01456936|76169729|FG001|Overall Study|Other reason|30|||
42331800|NCT01456936|76169730|FG002|Overall Study|Other reason|36|||
42331801|NCT01456936|76169731|FG003|Overall Study|Other reason|33|||
42331802|NCT01456936|76169728|FG000|Overall Study|No longer meets eligibility criteria|4|||
42331803|NCT01456936|76169729|FG001|Overall Study|No longer meets eligibility criteria|8|||
42331804|NCT01456936|76169730|FG002|Overall Study|No longer meets eligibility criteria|6|||
42331805|NCT01456936|76169731|FG003|Overall Study|No longer meets eligibility criteria|5|||
42331806|NCT01456936|76169728|FG000|Overall Study|Protocol Violation|4|||
42331807|NCT01456936|76169729|FG001|Overall Study|Protocol Violation|2|||
42331808|NCT01456936|76169730|FG002|Overall Study|Protocol Violation|5|||
42331809|NCT01456936|76169731|FG003|Overall Study|Protocol Violation|5|||
42331810|NCT01456936|76169728|FG000|Overall Study|Pregnancy|1|||
42331811|NCT01456936|76169729|FG001|Overall Study|Pregnancy|0|||
42331812|NCT01456936|76169730|FG002|Overall Study|Pregnancy|0|||
42331813|NCT01456936|76169731|FG003|Overall Study|Pregnancy|1|||
42331814|NCT01456936|76169728|FG000|Overall Study|Insufficient clinical response|4|||
42331815|NCT01456936|76169729|FG001|Overall Study|Insufficient clinical response|4|||
42331816|NCT01456936|76169730|FG002|Overall Study|Insufficient clinical response|14|||
42331817|NCT01456936|76169731|FG003|Overall Study|Insufficient clinical response|13|||
42331818|NCT01456936|76169728|FG000|Overall Study|No longer willing to participate|195|||
42331819|NCT01456936|76169729|FG001|Overall Study|No longer willing to participate|218|||
42331820|NCT01456936|76169730|FG002|Overall Study|No longer willing to participate|224|||
42331821|NCT01456936|76169731|FG003|Overall Study|No longer willing to participate|248|||
42331822|NCT01456936|76169728|FG000|Overall Study|Lost to Follow-up|135|||
42331823|NCT01456936|76169729|FG001|Overall Study|Lost to Follow-up|126|||
42331824|NCT01456936|76169730|FG002|Overall Study|Lost to Follow-up|144|||
42331825|NCT01456936|76169731|FG003|Overall Study|Lost to Follow-up|127|||
42331826|NCT01456936|76169728|FG000|Overall Study|Medication error|0|||
42331827|NCT01456936|76169729|FG001|Overall Study|Medication error|1|||
42331828|NCT01456936|76169730|FG002|Overall Study|Medication error|0|||
42331829|NCT01456936|76169731|FG003|Overall Study|Medication error|1|||
42331830|NCT01456936|76169728|FG000|Overall Study|Adverse event (study drug)|25|||
42331831|NCT01456936|76169729|FG001|Overall Study|Adverse event (study drug)|21|||
42331832|NCT01456936|76169730|FG002|Overall Study|Adverse event (study drug)|26|||
42331833|NCT01456936|76169731|FG003|Overall Study|Adverse event (study drug)|17|||
42331834|NCT01456936|76169728|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
42331835|NCT01456936|76169729|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
42331836|NCT01456936|76169730|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
42331837|NCT01456936|76169731|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
42331838|NCT01456936|76169728|FG000|Overall Study|Death|0|||
42331839|NCT01456936|76169729|FG001|Overall Study|Death|3|||
42331840|NCT01456936|76169730|FG002|Overall Study|Death|1|||
42331841|NCT01456936|76169731|FG003|Overall Study|Death|3|||
42331842|NCT01456936|76169728|FG000|Overall Study|Randomized but not treated|21|||
42331843|NCT01456936|76169729|FG001|Overall Study|Randomized but not treated|28|||
42331844|NCT01456936|76169730|FG002|Overall Study|Randomized but not treated|16|||
42331845|NCT01456936|76169731|FG003|Overall Study|Randomized but not treated|21|||
42263478|NCT02456740|76091350|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
42263479|NCT02456740|76091351|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
42263480|NCT02456740|76091352|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
42263481|NCT02456740|76091353|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
42263482|NCT02456740|76091354|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
42263483|NCT02456740|76091355|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
42331846|NCT01456780|76169744|FG000|Overall Study|Lost to Follow-up|3|||
42331847|NCT01456780|76169745|FG001|Overall Study|Lost to Follow-up|3|||
42331848|NCT01456780|76169746|FG002|Overall Study|Lost to Follow-up|0|||
42331849|NCT01480258|76169756|FG000|Infant Series|Protocol Violation|2|||
42331850|NCT01480258|76169757|FG001|Infant Series|Protocol Violation|0|||
41998835|NCT01190930|75807259|FG001|Induction|High Risk Downs|0|||
41998836|NCT01190930|75807260|FG002|Induction|High Risk Downs|0|||
41998837|NCT01190930|75807261|FG003|Induction|High Risk Downs|0|||
41998838|NCT01190930|75807262|FG004|Induction|High Risk Downs|0|||
41998839|NCT01190930|75807263|FG005|Induction|High Risk Downs|0|||
41998840|NCT01190930|75807264|FG006|Induction|High Risk Downs|0|||
41998841|NCT01190930|75807265|FG007|Induction|High Risk Downs|0|||
41998842|NCT01190930|75807266|FG008|Induction|High Risk Downs|0|||
41998843|NCT01190930|75807267|FG009|Induction|High Risk Downs|0|||
41998844|NCT01190930|75807258|FG000|Induction|Enrollment onto another COG Protocol|1|||
41998845|NCT01190930|75807259|FG001|Induction|Enrollment onto another COG Protocol|0|||
41998846|NCT01190930|75807260|FG002|Induction|Enrollment onto another COG Protocol|0|||
41998847|NCT01190930|75807261|FG003|Induction|Enrollment onto another COG Protocol|0|||
41998848|NCT01190930|75807262|FG004|Induction|Enrollment onto another COG Protocol|0|||
41998849|NCT01190930|75807263|FG005|Induction|Enrollment onto another COG Protocol|0|||
41998850|NCT01190930|75807264|FG006|Induction|Enrollment onto another COG Protocol|0|||
41998851|NCT01190930|75807265|FG007|Induction|Enrollment onto another COG Protocol|0|||
41998852|NCT01190930|75807266|FG008|Induction|Enrollment onto another COG Protocol|0|||
41998853|NCT01190930|75807267|FG009|Induction|Enrollment onto another COG Protocol|0|||
41998854|NCT01190930|75807258|FG000|Induction|Average Risk|1847|||
41998855|NCT01190930|75807259|FG001|Induction|Average Risk|0|||
41998856|NCT01190930|75807260|FG002|Induction|Average Risk|0|||
41998857|NCT01190930|75807261|FG003|Induction|Average Risk|0|||
41998858|NCT01190930|75807262|FG004|Induction|Average Risk|0|||
41998859|NCT01190930|75807263|FG005|Induction|Average Risk|0|||
41998860|NCT01190930|75807264|FG006|Induction|Average Risk|0|||
41998861|NCT01190930|75807265|FG007|Induction|Average Risk|0|||
41998862|NCT01190930|75807266|FG008|Induction|Average Risk|0|||
41998863|NCT01190930|75807267|FG009|Induction|Average Risk|0|||
41998864|NCT01190930|75807258|FG000|Induction|High Risk|1227|||
41998865|NCT01190930|75807259|FG001|Induction|High Risk|0|||
41998866|NCT01190930|75807260|FG002|Induction|High Risk|0|||
41998867|NCT01190930|75807261|FG003|Induction|High Risk|0|||
41998868|NCT01190930|75807262|FG004|Induction|High Risk|0|||
41998869|NCT01190930|75807263|FG005|Induction|High Risk|0|||
41998870|NCT01190930|75807264|FG006|Induction|High Risk|0|||
41998871|NCT01190930|75807265|FG007|Induction|High Risk|0|||
41998872|NCT01190930|75807266|FG008|Induction|High Risk|0|||
41998873|NCT01190930|75807267|FG009|Induction|High Risk|0|||
41998874|NCT01190930|75807258|FG000|Induction|Low Risk|443|||
41998875|NCT01190930|75807259|FG001|Induction|Low Risk|0|||
41998876|NCT01190930|75807260|FG002|Induction|Low Risk|0|||
41998877|NCT01190930|75807261|FG003|Induction|Low Risk|0|||
42263484|NCT02456740|76091356|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
42263485|NCT02456740|76091357|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
42263486|NCT02456740|76091349|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
42263487|NCT02456740|76091350|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
42263488|NCT02456740|76091351|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
42263489|NCT02456740|76091352|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
42263490|NCT02456740|76091353|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
42263491|NCT02456740|76091354|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
42331851|NCT01480258|76169756|FG000|Infant Series|Physician Decision|0|||
42331852|NCT01480258|76169757|FG001|Infant Series|Physician Decision|1|||
42331853|NCT01480258|76169756|FG000|Infant Series|Not Vaccinated|3|||
42331854|NCT01480258|76169757|FG001|Infant Series|Not Vaccinated|0|||
42331855|NCT01480258|76169756|FG000|Infant Series|Adverse Event|1|||
42331856|NCT01480258|76169757|FG001|Infant Series|Adverse Event|1|||
42331857|NCT01480258|76169756|FG000|Infant Series|Withdrawal by Subject|1|||
42331858|NCT01480258|76169757|FG001|Infant Series|Withdrawal by Subject|6|||
42331859|NCT01480258|76169756|FG000|Interim Period|Lost to Follow-up|0|||
42331860|NCT01480258|76169757|FG001|Interim Period|Lost to Follow-up|2|||
41998878|NCT01190930|75807262|FG004|Induction|Low Risk|0|||
41998879|NCT01190930|75807263|FG005|Induction|Low Risk|0|||
42331861|NCT01480258|76169756|FG000|Interim Period|Physician Decision|1|||
41998880|NCT01190930|75807264|FG006|Induction|Low Risk|0|||
41998881|NCT01190930|75807265|FG007|Induction|Low Risk|0|||
41998882|NCT01190930|75807266|FG008|Induction|Low Risk|0|||
41998883|NCT01190930|75807267|FG009|Induction|Low Risk|0|||
41998884|NCT01190930|75807258|FG000|Induction|Very High Risk|1012|||
41998885|NCT01190930|75807259|FG001|Induction|Very High Risk|0|||
42331862|NCT01480258|76169757|FG001|Interim Period|Physician Decision|0|||
41998886|NCT01190930|75807260|FG002|Induction|Very High Risk|0|||
41998887|NCT01190930|75807261|FG003|Induction|Very High Risk|0|||
41998888|NCT01190930|75807262|FG004|Induction|Very High Risk|0|||
41998889|NCT01190930|75807263|FG005|Induction|Very High Risk|0|||
41998890|NCT01190930|75807264|FG006|Induction|Very High Risk|0|||
41998891|NCT01190930|75807265|FG007|Induction|Very High Risk|0|||
41998892|NCT01190930|75807266|FG008|Induction|Very High Risk|0|||
41998893|NCT01190930|75807267|FG009|Induction|Very High Risk|0|||
41998894|NCT01190930|75807258|FG000|Induction|Philadelphia chromosome-positive|99|||
41998895|NCT01190930|75807259|FG001|Induction|Philadelphia chromosome-positive|0|||
42263492|NCT02456740|76091355|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
42263493|NCT02456740|76091356|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
42263494|NCT02456740|76091357|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
42263495|NCT02456740|76091349|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
42263496|NCT02456740|76091350|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
42263497|NCT02456740|76091351|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
42263498|NCT02456740|76091352|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
42331863|NCT01480258|76169756|FG000|Interim Period|Protocol Violation|0|||
42331864|NCT01480258|76169757|FG001|Interim Period|Protocol Violation|1|||
42331865|NCT01480258|76169756|FG000|Interim Period|Withdrawal by Subject|9|||
42331866|NCT01480258|76169757|FG001|Interim Period|Withdrawal by Subject|6|||
42331867|NCT01479868|76169763|FG000|Overall Study|Adverse Event|1|||
42331868|NCT01479868|76169763|FG000|Overall Study|Lost to Follow-up|4|||
42331869|NCT01479868|76169763|FG000|Overall Study|Protocol Violation|1|||
42331870|NCT01479868|76169763|FG000|Overall Study|Withdrawal by Subject|1|||
42331871|NCT01479868|76169763|FG000|Overall Study|Sponsor's Decision|1|||
42331872|NCT01479868|76169763|FG000|Overall Study|Initiation of new HCV Therapy|1|||
42331873|NCT01478620|76169767|FG000|Overall Study|Lost to Follow-up|6|||
42331874|NCT01455220|76169771|FG000|Overall Study|screen fail|30|||
42331875|NCT01454830|76169780|FG000|Overall Study|Withdrawal by Subject|4|||
42331876|NCT01454830|76169781|FG001|Overall Study|Withdrawal by Subject|4|||
42331877|NCT01454830|76169780|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
42331878|NCT01454830|76169781|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
42331879|NCT01454830|76169780|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
42331880|NCT01454830|76169781|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
42331881|NCT01454830|76169780|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
42331882|NCT01454830|76169781|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
42331883|NCT01454830|76169780|FG000|Overall Study|Withdrawal - no polysomnography|3|||
42331884|NCT01454830|76169781|FG001|Overall Study|Withdrawal - no polysomnography|2|||
42331885|NCT01454596|76169799|FG000|Overall Study|Death|0|||
42331886|NCT01454596|76169800|FG001|Overall Study|Death|0|||
42331887|NCT01454596|76169801|FG002|Overall Study|Death|0|||
42331888|NCT01454596|76169802|FG003|Overall Study|Death|0|||
42331889|NCT01454596|76169803|FG004|Overall Study|Death|0|||
42331890|NCT01454596|76169804|FG005|Overall Study|Death|0|||
42331891|NCT01454596|76169805|FG006|Overall Study|Death|0|||
42331892|NCT01454596|76169806|FG007|Overall Study|Death|0|||
42331893|NCT01454596|76169807|FG008|Overall Study|Death|0|||
42331894|NCT01454596|76169808|FG009|Overall Study|Death|1|||
42331895|NCT01454596|76169809|FG010|Overall Study|Death|1|||
42331896|NCT01454596|76169810|FG011|Overall Study|Death|0|||
42331897|NCT02247479|76169839|FG000|Overall Study|Adverse Event|8|||
42331898|NCT02247479|76169840|FG001|Overall Study|Adverse Event|9|||
42331899|NCT02247479|76169841|FG002|Overall Study|Adverse Event|8|||
42331900|NCT02247479|76169839|FG000|Overall Study|Death|5|||
42331901|NCT02247479|76169840|FG001|Overall Study|Death|4|||
42331902|NCT02247479|76169841|FG002|Overall Study|Death|6|||
42331903|NCT02247479|76169839|FG000|Overall Study|Lost to Follow-up|3|||
42331904|NCT02247479|76169840|FG001|Overall Study|Lost to Follow-up|3|||
42331905|NCT02247479|76169841|FG002|Overall Study|Lost to Follow-up|1|||
42331906|NCT02247479|76169839|FG000|Overall Study|Non-compliance|0|||
42331907|NCT02247479|76169840|FG001|Overall Study|Non-compliance|0|||
42331908|NCT02247479|76169841|FG002|Overall Study|Non-compliance|1|||
42331909|NCT02247479|76169839|FG000|Overall Study|Withdrawal by Subject|25|||
42331910|NCT02247479|76169840|FG001|Overall Study|Withdrawal by Subject|29|||
42331911|NCT02247479|76169841|FG002|Overall Study|Withdrawal by Subject|24|||
42331912|NCT02247479|76169839|FG000|Overall Study|Study Terminated by Sponsor|98|||
42331913|NCT02247479|76169840|FG001|Overall Study|Study Terminated by Sponsor|88|||
42331914|NCT02247479|76169841|FG002|Overall Study|Study Terminated by Sponsor|94|||
42331915|NCT02247479|76169839|FG000|Overall Study|Physician Decision|1|||
42331916|NCT02247479|76169840|FG001|Overall Study|Physician Decision|0|||
42331917|NCT02247479|76169841|FG002|Overall Study|Physician Decision|2|||
42331918|NCT02247479|76169839|FG000|Overall Study|Unspecified Reason|2|||
42331919|NCT02247479|76169840|FG001|Overall Study|Unspecified Reason|5|||
41998896|NCT01190930|75807260|FG002|Induction|Philadelphia chromosome-positive|0|||
41998897|NCT01190930|75807261|FG003|Induction|Philadelphia chromosome-positive|0|||
41998898|NCT01190930|75807262|FG004|Induction|Philadelphia chromosome-positive|0|||
41998899|NCT01190930|75807263|FG005|Induction|Philadelphia chromosome-positive|0|||
41998900|NCT01190930|75807264|FG006|Induction|Philadelphia chromosome-positive|0|||
41998901|NCT01190930|75807265|FG007|Induction|Philadelphia chromosome-positive|0|||
41998902|NCT01190930|75807266|FG008|Induction|Philadelphia chromosome-positive|0|||
41998903|NCT01190930|75807267|FG009|Induction|Philadelphia chromosome-positive|0|||
41998904|NCT01190930|75807258|FG000|Induction|Incomplete Induction data|63|||
41998905|NCT01190930|75807259|FG001|Induction|Incomplete Induction data|0|||
41998906|NCT01190930|75807260|FG002|Induction|Incomplete Induction data|0|||
42263499|NCT02456740|76091353|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
42263500|NCT02456740|76091354|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
42263501|NCT02456740|76091355|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
42263502|NCT02456740|76091356|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
42263503|NCT02456740|76091357|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
42263504|NCT02456740|76091349|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
42263505|NCT02456740|76091350|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
42263506|NCT02456740|76091351|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
42263507|NCT02456740|76091352|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
42263508|NCT02456740|76091353|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
41998907|NCT01190930|75807261|FG003|Induction|Incomplete Induction data|0|||
41998908|NCT01190930|75807262|FG004|Induction|Incomplete Induction data|0|||
41998909|NCT01190930|75807263|FG005|Induction|Incomplete Induction data|0|||
41998910|NCT01190930|75807264|FG006|Induction|Incomplete Induction data|0|||
41998911|NCT01190930|75807265|FG007|Induction|Incomplete Induction data|0|||
41998912|NCT01190930|75807266|FG008|Induction|Incomplete Induction data|0|||
42263509|NCT02456740|76091354|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
42263510|NCT02456740|76091355|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
42263511|NCT02456740|76091356|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
42331920|NCT02247479|76169841|FG002|Overall Study|Unspecified Reason|2|||
42331921|NCT01454284|76169851|FG000|Overall Study|Adverse Event|20|||
42331922|NCT01454284|76169852|FG001|Overall Study|Adverse Event|7|||
42331923|NCT01454284|76169851|FG000|Overall Study|Death|0|||
42331924|NCT01454284|76169852|FG001|Overall Study|Death|3|||
42331925|NCT01454284|76169851|FG000|Overall Study|Lost to Follow-up|13|||
42331926|NCT01454284|76169852|FG001|Overall Study|Lost to Follow-up|8|||
41998913|NCT01190930|75807267|FG009|Induction|Incomplete Induction data|0|||
41998914|NCT01190930|75807258|FG000|Induction|Progressive disease|0|||
41998915|NCT01190930|75807259|FG001|Induction|Progressive disease|1|||
42331927|NCT01454284|76169851|FG000|Overall Study|Protocol Violation|9|||
42331928|NCT01454284|76169852|FG001|Overall Study|Protocol Violation|6|||
42331929|NCT01454284|76169851|FG000|Overall Study|Withdrawal by Subject|58|||
42331930|NCT01454284|76169852|FG001|Overall Study|Withdrawal by Subject|36|||
42331931|NCT01454284|76169851|FG000|Overall Study|Physician Decision|16|||
42331932|NCT01454284|76169852|FG001|Overall Study|Physician Decision|11|||
42331933|NCT01454284|76169851|FG000|Overall Study|Sponsor Decision|0|||
42331934|NCT01454284|76169852|FG001|Overall Study|Sponsor Decision|2|||
42331935|NCT02247401|76169861|FG000|Overall Study|Adverse Event|1|||
42331936|NCT02247401|76169862|FG001|Overall Study|Adverse Event|0|||
41998916|NCT01190930|75807260|FG002|Induction|Progressive disease|0|||
41998917|NCT01190930|75807261|FG003|Induction|Progressive disease|0|||
42331937|NCT02247401|76169863|FG002|Overall Study|Adverse Event|0|||
42331938|NCT02247401|76169861|FG000|Overall Study|Withdrawal by Subject|4|||
42331939|NCT02247401|76169862|FG001|Overall Study|Withdrawal by Subject|1|||
42331940|NCT02247401|76169863|FG002|Overall Study|Withdrawal by Subject|1|||
42331941|NCT02247401|76169861|FG000|Overall Study|Lost to Follow-up|1|||
42331942|NCT02247401|76169862|FG001|Overall Study|Lost to Follow-up|1|||
42331943|NCT02247401|76169863|FG002|Overall Study|Lost to Follow-up|1|||
42331944|NCT02247011|76169874|FG000|Overall Study|Poor quality of radiological results|125|||
42331945|NCT02246777|76169881|FG000|Overall Study|Adverse Event|2|||
42331946|NCT02246777|76169881|FG000|Overall Study|Change of residence|1|||
42331947|NCT01495702|76169892|FG000|Randomized Phase|Randomized But Not Treated|1|||
42331948|NCT01495702|76169893|FG001|Randomized Phase|Randomized But Not Treated|4|||
42331949|NCT01495702|76169892|FG000|Randomized Phase|Adverse Event|2|||
42331950|NCT01495702|76169893|FG001|Randomized Phase|Adverse Event|2|||
42331951|NCT01495702|76169892|FG000|Randomized Phase|Death|1|||
42331952|NCT01495702|76169893|FG001|Randomized Phase|Death|0|||
42331953|NCT01495702|76169892|FG000|Randomized Phase|Lack of Efficacy|2|||
42331954|NCT01495702|76169893|FG001|Randomized Phase|Lack of Efficacy|0|||
42331955|NCT01495702|76169892|FG000|Randomized Phase|Investigators Discretion|2|||
42331956|NCT01495702|76169893|FG001|Randomized Phase|Investigators Discretion|0|||
42331957|NCT01495702|76169892|FG000|Randomized Phase|Withdrew Consent|10|||
42331958|NCT01495702|76169893|FG001|Randomized Phase|Withdrew Consent|18|||
42331959|NCT01495702|76169892|FG000|Randomized Phase|Lost to Follow-up|4|||
42331960|NCT01495702|76169893|FG001|Randomized Phase|Lost to Follow-up|3|||
42331961|NCT01495702|76169892|FG000|Randomized Phase|Participant Noncompliance|1|||
42331962|NCT01495702|76169893|FG001|Randomized Phase|Participant Noncompliance|0|||
42331963|NCT01495702|76169892|FG000|Randomized Phase|Protocol Violation|3|||
42331964|NCT01495702|76169893|FG001|Randomized Phase|Protocol Violation|1|||
42331965|NCT01630889|76169900|FG000|Overall Study|Death|2|||
42331966|NCT01630889|76169900|FG000|Overall Study|Withdrawal by Subject|1|||
42331967|NCT01630889|76169900|FG000|Overall Study|Other than Specified|2|||
42331968|NCT01630889|76169900|FG000|Overall Study|Lost to Follow-up|4|||
42331969|NCT01630889|76169900|FG000|Overall Study|Other|1|||
42331970|NCT01495000|76169906|FG000|Overall Study|Lost to Follow-up|2|||
42331971|NCT01495000|76169907|FG001|Overall Study|Lost to Follow-up|2|||
42331972|NCT01495000|76169906|FG000|Overall Study|Protocol Violation|1|||
42331973|NCT01495000|76169907|FG001|Overall Study|Protocol Violation|0|||
42331974|NCT01495000|76169906|FG000|Overall Study|Withdrawal by Subject|10|||
42331975|NCT01495000|76169907|FG001|Overall Study|Withdrawal by Subject|10|||
42331976|NCT01494922|76169913|FG000|Overall Study|Adverse Event|1|||
42331977|NCT02192099|76169917|FG000|Overall Study|Adverse Event|1|||
42331978|NCT02192099|76169917|FG000|Overall Study|Lost to Follow-up|2|||
42331979|NCT02192099|76169917|FG000|Overall Study|Physician Decision|1|||
42331980|NCT02192099|76169917|FG000|Overall Study|Pregnancy|1|||
42331981|NCT02192099|76169917|FG000|Overall Study|Protocol Violation|8|||
41998918|NCT01190930|75807262|FG004|Induction|Progressive disease|0|||
42331982|NCT02192099|76169917|FG000|Overall Study|Study Terminated by Sponsor|32|||
42331983|NCT02192099|76169917|FG000|Overall Study|Withdrawal by Subject|11|||
42331984|NCT02192099|76169917|FG000|Overall Study|Miscellaneous Reasons|5|||
42331985|NCT01494610|76169921|FG000|Period 1|Withdrawal by Subject|1|||
42331986|NCT01494610|76169922|FG001|Period 1|Withdrawal by Subject|1|||
42134250|NCT00459186|75945069|FG000|PET Imaging and Assessment|Adverse Event|3|||
42134251|NCT00328510|75945075|FG000|Overall Study|Gag disorder, could not use frame|4|||
42331987|NCT01494610|76169921|FG000|Period 3|Adverse Event|1|||
42331988|NCT01494610|76169922|FG001|Period 3|Adverse Event|0|||
42331989|NCT01494610|76169921|FG000|Period 3|Withdrawal by Subject|1|||
42331990|NCT01494610|76169922|FG001|Period 3|Withdrawal by Subject|0|||
42331991|NCT01494610|76169921|FG000|Period 4|Protocol Violation|1|||
42331992|NCT01494610|76169922|FG001|Period 4|Protocol Violation|0|||
42331993|NCT02116777|76169941|FG000|Overall Study|Adverse Event|0|||
42331994|NCT02116777|76169942|FG001|Overall Study|Adverse Event|0|||
42331995|NCT02116777|76169943|FG002|Overall Study|Adverse Event|0|||
42331996|NCT02116777|76169944|FG003|Overall Study|Adverse Event|0|||
42331997|NCT02116777|76169945|FG004|Overall Study|Adverse Event|2|||
42331998|NCT02116777|76169946|FG005|Overall Study|Adverse Event|2|||
42331999|NCT02116777|76169947|FG006|Overall Study|Adverse Event|0|||
42332000|NCT02116777|76169941|FG000|Overall Study|Death|0|||
42332001|NCT02116777|76169942|FG001|Overall Study|Death|0|||
42332002|NCT02116777|76169943|FG002|Overall Study|Death|0|||
42332003|NCT02116777|76169944|FG003|Overall Study|Death|1|||
42332004|NCT02116777|76169945|FG004|Overall Study|Death|0|||
42332005|NCT02116777|76169946|FG005|Overall Study|Death|0|||
42332006|NCT02116777|76169947|FG006|Overall Study|Death|0|||
42332007|NCT02116777|76169941|FG000|Overall Study|Lack of Efficacy|3|||
42332008|NCT02116777|76169942|FG001|Overall Study|Lack of Efficacy|3|||
42332009|NCT02116777|76169943|FG002|Overall Study|Lack of Efficacy|3|||
42332010|NCT02116777|76169944|FG003|Overall Study|Lack of Efficacy|8|||
42034584|NCT01120691|75842652|FG000|Overall Study|Abnormal test procedure result(s)|3|||
42034585|NCT01120691|75842653|FG001|Overall Study|Abnormal test procedure result(s)|2|||
42034586|NCT01120691|75842654|FG002|Overall Study|Abnormal test procedure result(s)|1|||
42034587|NCT01120691|75842652|FG000|Overall Study|Patient's inability to use the device|3|||
42034588|NCT01120691|75842653|FG001|Overall Study|Patient's inability to use the device|1|||
42034589|NCT01120691|75842654|FG002|Overall Study|Patient's inability to use the device|0|||
42034590|NCT01120691|75842652|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42034591|NCT01120691|75842653|FG001|Overall Study|Abnormal laboratory value(s)|3|||
42034592|NCT01120691|75842654|FG002|Overall Study|Abnormal laboratory value(s)|4|||
42034593|NCT00935493|75842669|FG000|Overall Study|Lost to Follow-up|1|||
42263512|NCT02456740|76091357|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
42263513|NCT02456740|76091349|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
42263514|NCT02456740|76091350|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
42263515|NCT02456740|76091351|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
42263516|NCT02456740|76091352|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
42263517|NCT02456740|76091353|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
42263518|NCT02456740|76091354|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
42263519|NCT02456740|76091355|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
42263520|NCT02456740|76091356|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
42263521|NCT02456740|76091357|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
42263522|NCT02456740|76091349|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
42332011|NCT02116777|76169945|FG004|Overall Study|Lack of Efficacy|4|||
42263523|NCT02456740|76091350|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
42332012|NCT02116777|76169946|FG005|Overall Study|Lack of Efficacy|1|||
42332013|NCT02116777|76169947|FG006|Overall Study|Lack of Efficacy|9|||
42332014|NCT02116777|76169941|FG000|Overall Study|Physician Decision|0|||
42332015|NCT02116777|76169942|FG001|Overall Study|Physician Decision|0|||
42332016|NCT02116777|76169943|FG002|Overall Study|Physician Decision|0|||
42134252|NCT00328510|75945076|FG001|Overall Study|Gag disorder, could not use frame|0|||
42134253|NCT00328510|75945075|FG000|Overall Study|Dentition problems, could not use frame|1|||
42134254|NCT00328510|75945076|FG001|Overall Study|Dentition problems, could not use frame|0|||
42134255|NCT00328510|75945075|FG000|Overall Study|Withdrawal by Subject|4|||
42263524|NCT02456740|76091351|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
42263525|NCT02456740|76091352|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
42263526|NCT02456740|76091353|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
42263527|NCT02456740|76091354|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
42263528|NCT02456740|76091355|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
42263529|NCT02456740|76091356|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
42263530|NCT02456740|76091357|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
42263531|NCT02400580|76091369|FG000|Overall Study|Withdrawal by Subject|1|||
42263532|NCT02400580|76091370|FG001|Overall Study|Withdrawal by Subject|1|||
42332017|NCT02116777|76169944|FG003|Overall Study|Physician Decision|2|||
42332018|NCT02116777|76169945|FG004|Overall Study|Physician Decision|0|||
42332019|NCT02116777|76169946|FG005|Overall Study|Physician Decision|0|||
42332020|NCT02116777|76169947|FG006|Overall Study|Physician Decision|0|||
42332021|NCT02116777|76169941|FG000|Overall Study|Protocol Violation|0|||
42332022|NCT02116777|76169942|FG001|Overall Study|Protocol Violation|0|||
42332023|NCT02116777|76169943|FG002|Overall Study|Protocol Violation|0|||
42332024|NCT02116777|76169944|FG003|Overall Study|Protocol Violation|1|||
42332025|NCT02116777|76169945|FG004|Overall Study|Protocol Violation|0|||
42332026|NCT02116777|76169946|FG005|Overall Study|Protocol Violation|0|||
42332027|NCT02116777|76169947|FG006|Overall Study|Protocol Violation|0|||
42332028|NCT02116777|76169941|FG000|Overall Study|Withdrawal by Subject|0|||
42332029|NCT02116777|76169942|FG001|Overall Study|Withdrawal by Subject|0|||
42332030|NCT02116777|76169943|FG002|Overall Study|Withdrawal by Subject|0|||
42332031|NCT02116777|76169944|FG003|Overall Study|Withdrawal by Subject|1|||
41998919|NCT01190930|75807263|FG005|Induction|Progressive disease|0|||
42134256|NCT00328510|75945076|FG001|Overall Study|Withdrawal by Subject|2|||
42263533|NCT02400580|76091369|FG000|Overall Study|Adverse Event|1|||
42332032|NCT02116777|76169945|FG004|Overall Study|Withdrawal by Subject|0|||
42332033|NCT02116777|76169946|FG005|Overall Study|Withdrawal by Subject|0|||
42332034|NCT02116777|76169947|FG006|Overall Study|Withdrawal by Subject|0|||
42332035|NCT01494532|76169972|FG000|Overall Study|Adverse Event|4|||
42332036|NCT01494532|76169973|FG001|Overall Study|Adverse Event|1|||
42332037|NCT01494532|76169974|FG002|Overall Study|Adverse Event|8|||
42332038|NCT01494532|76169975|FG003|Overall Study|Adverse Event|6|||
42332039|NCT01494532|76169976|FG004|Overall Study|Adverse Event|5|||
42332040|NCT01494532|76169977|FG005|Overall Study|Adverse Event|0|||
42332041|NCT01494532|76169972|FG000|Overall Study|Lack of Efficacy|0|||
42034594|NCT00935493|75842670|FG001|Overall Study|Lost to Follow-up|1|||
42332042|NCT01494532|76169973|FG001|Overall Study|Lack of Efficacy|0|||
42332043|NCT01494532|76169974|FG002|Overall Study|Lack of Efficacy|0|||
42332044|NCT01494532|76169975|FG003|Overall Study|Lack of Efficacy|0|||
42034595|NCT00935493|75842671|FG002|Overall Study|Lost to Follow-up|1|||
42263534|NCT02400580|76091370|FG001|Overall Study|Adverse Event|0|||
42263535|NCT01367119|76091378|FG000|Overall Study|Adverse Event|1|||
42263536|NCT01367119|76091379|FG001|Overall Study|Adverse Event|0|||
42263537|NCT01367119|76091378|FG000|Overall Study|Withdrawal by Subject|1|||
42263538|NCT01367119|76091379|FG001|Overall Study|Withdrawal by Subject|1|||
42263539|NCT02635724|76091388|FG000|Overall Study|Withdrawal by Subject|0|||
42263540|NCT02635724|76091389|FG001|Overall Study|Withdrawal by Subject|1|||
42263541|NCT02635724|76091390|FG002|Overall Study|Withdrawal by Subject|0|||
42263542|NCT02635646|76091400|FG000|Overall Study|Lost to Follow-up|24|||
42263543|NCT02635646|76091401|FG001|Overall Study|Lost to Follow-up|25|||
42263544|NCT02635646|76091400|FG000|Overall Study|Pregnancy|1|||
42263545|NCT02635646|76091401|FG001|Overall Study|Pregnancy|1|||
42263546|NCT02634788|76091417|FG000|Overall Study|Adverse Event|0|||
42263547|NCT02634788|76091418|FG001|Overall Study|Adverse Event|8|||
42263548|NCT02634788|76091419|FG002|Overall Study|Adverse Event|3|||
42332045|NCT01494532|76169976|FG004|Overall Study|Lack of Efficacy|2|||
42332046|NCT01494532|76169977|FG005|Overall Study|Lack of Efficacy|0|||
42332047|NCT01494532|76169972|FG000|Overall Study|Protocol deviation|2|||
42332048|NCT01494532|76169973|FG001|Overall Study|Protocol deviation|1|||
42332049|NCT01494532|76169974|FG002|Overall Study|Protocol deviation|3|||
42332050|NCT01494532|76169975|FG003|Overall Study|Protocol deviation|2|||
42263549|NCT02634788|76091420|FG003|Overall Study|Adverse Event|1|||
42332051|NCT01494532|76169976|FG004|Overall Study|Protocol deviation|3|||
41998920|NCT01190930|75807264|FG006|Induction|Progressive disease|0|||
41998921|NCT01190930|75807265|FG007|Induction|Progressive disease|0|||
41998922|NCT01190930|75807266|FG008|Induction|Progressive disease|0|||
41998923|NCT01190930|75807267|FG009|Induction|Progressive disease|0|||
41998924|NCT01190930|75807258|FG000|Induction|No treatment|3|||
42332052|NCT01494532|76169977|FG005|Overall Study|Protocol deviation|0|||
42332053|NCT01494532|76169972|FG000|Overall Study|Protocol-defined stopping criteria|0|||
42332054|NCT01494532|76169973|FG001|Overall Study|Protocol-defined stopping criteria|0|||
42332055|NCT01494532|76169974|FG002|Overall Study|Protocol-defined stopping criteria|1|||
42332056|NCT01494532|76169975|FG003|Overall Study|Protocol-defined stopping criteria|0|||
42332057|NCT01494532|76169976|FG004|Overall Study|Protocol-defined stopping criteria|0|||
41998925|NCT01190930|75807259|FG001|Induction|No treatment|0|||
41998926|NCT01190930|75807260|FG002|Induction|No treatment|0|||
41998927|NCT01190930|75807261|FG003|Induction|No treatment|0|||
41998928|NCT01190930|75807262|FG004|Induction|No treatment|0|||
41998929|NCT01190930|75807263|FG005|Induction|No treatment|0|||
41998930|NCT01190930|75807264|FG006|Induction|No treatment|0|||
42263550|NCT02634788|76091417|FG000|Overall Study|Lack of Efficacy|4|||
42263551|NCT02634788|76091418|FG001|Overall Study|Lack of Efficacy|0|||
42263552|NCT02634788|76091419|FG002|Overall Study|Lack of Efficacy|1|||
42263553|NCT02634788|76091420|FG003|Overall Study|Lack of Efficacy|4|||
42263554|NCT02634788|76091417|FG000|Overall Study|Lost to Follow-up|0|||
42263555|NCT02634788|76091418|FG001|Overall Study|Lost to Follow-up|1|||
42263556|NCT02634788|76091419|FG002|Overall Study|Lost to Follow-up|0|||
42263557|NCT02634788|76091420|FG003|Overall Study|Lost to Follow-up|0|||
42263558|NCT02634788|76091417|FG000|Overall Study|Withdrawal by Subject|0|||
42263559|NCT02634788|76091418|FG001|Overall Study|Withdrawal by Subject|1|||
42332058|NCT01494532|76169977|FG005|Overall Study|Protocol-defined stopping criteria|0|||
42332059|NCT01494532|76169972|FG000|Overall Study|Lost to Follow-up|1|||
42332060|NCT01494532|76169973|FG001|Overall Study|Lost to Follow-up|0|||
42332061|NCT01494532|76169974|FG002|Overall Study|Lost to Follow-up|0|||
42332062|NCT01494532|76169975|FG003|Overall Study|Lost to Follow-up|2|||
42332063|NCT01494532|76169976|FG004|Overall Study|Lost to Follow-up|0|||
42332064|NCT01494532|76169977|FG005|Overall Study|Lost to Follow-up|0|||
42332065|NCT01494532|76169972|FG000|Overall Study|Physician Decision|0|||
42332066|NCT01494532|76169973|FG001|Overall Study|Physician Decision|1|||
42332067|NCT01494532|76169974|FG002|Overall Study|Physician Decision|1|||
42332068|NCT01494532|76169975|FG003|Overall Study|Physician Decision|2|||
42332069|NCT01494532|76169976|FG004|Overall Study|Physician Decision|0|||
42332070|NCT01494532|76169977|FG005|Overall Study|Physician Decision|0|||
42332071|NCT01494532|76169972|FG000|Overall Study|Withdrawal by Subject|3|||
42332072|NCT01494532|76169973|FG001|Overall Study|Withdrawal by Subject|1|||
42332073|NCT01494532|76169974|FG002|Overall Study|Withdrawal by Subject|4|||
42332074|NCT01494532|76169975|FG003|Overall Study|Withdrawal by Subject|3|||
42332075|NCT01494532|76169976|FG004|Overall Study|Withdrawal by Subject|2|||
42332076|NCT01494532|76169977|FG005|Overall Study|Withdrawal by Subject|0|||
42332077|NCT02191397|76169994|FG000|Overall Study|Adverse Event|28|||
42332078|NCT02191397|76169995|FG001|Overall Study|Adverse Event|17|||
42332079|NCT02191397|76169994|FG000|Overall Study|Lack of Efficacy|10|||
42332080|NCT02191397|76169995|FG001|Overall Study|Lack of Efficacy|5|||
42332081|NCT02191397|76169994|FG000|Overall Study|Protocol Violation|0|||
42332082|NCT02191397|76169995|FG001|Overall Study|Protocol Violation|3|||
42332083|NCT02191397|76169994|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
42332084|NCT02191397|76169995|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
42332085|NCT02191397|76169994|FG000|Overall Study|Lost to Follow-up|10|||
42332086|NCT02191397|76169995|FG001|Overall Study|Lost to Follow-up|11|||
42332087|NCT02191397|76169994|FG000|Overall Study|Physician Decision|8|||
42332088|NCT02191397|76169995|FG001|Overall Study|Physician Decision|3|||
42332089|NCT02191397|76169994|FG000|Overall Study|Withdrawal by Subject|22|||
42332090|NCT02191397|76169995|FG001|Overall Study|Withdrawal by Subject|27|||
42332091|NCT01630811|76170001|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
42332092|NCT01630811|76170002|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
42332093|NCT01494298|76170012|FG000|Overall Study|Protocol Violation|2|||
42332094|NCT01494298|76170013|FG001|Overall Study|Protocol Violation|8|||
42332095|NCT02169791|76170021|FG000|Overall Study|Death|6|||
42332096|NCT02169791|76170021|FG000|Overall Study|patient withdrew consent|1|||
42332097|NCT02216591|76170027|FG000|Overall Study|Lost to Follow-up|0|||
42332098|NCT02216591|76170028|FG001|Overall Study|Lost to Follow-up|1|||
42332099|NCT02216357|76170036|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
42332100|NCT02216357|76170037|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
42332101|NCT01492426|76170045|FG000|Treatment|Death|0|||
42332102|NCT01492426|76170046|FG001|Treatment|Death|1|||
42332103|NCT01492426|76170045|FG000|Treatment|Other|1|||
42332104|NCT01492426|76170046|FG001|Treatment|Other|0|||
42332105|NCT01492426|76170045|FG000|Treatment|Adverse Event|25|||
42332106|NCT01492426|76170046|FG001|Treatment|Adverse Event|25|||
42332107|NCT01492426|76170045|FG000|Treatment|Lack of Efficacy|38|||
42332108|NCT01492426|76170046|FG001|Treatment|Lack of Efficacy|5|||
42332109|NCT01492426|76170045|FG000|Treatment|Participant withdrew consent|1|||
42332110|NCT01492426|76170046|FG001|Treatment|Participant withdrew consent|2|||
42332111|NCT01492426|76170045|FG000|Treatment|Poor compliance/noncompliance|1|||
42332112|NCT01492426|76170046|FG001|Treatment|Poor compliance/noncompliance|0|||
42332113|NCT01492426|76170045|FG000|Treatment|Subject requested discontinue study drug|7|||
42332114|NCT01492426|76170046|FG001|Treatment|Subject requested discontinue study drug|3|||
42332115|NCT01492426|76170045|FG000|Treatment|Lost to Follow-up|9|||
42332116|NCT01492426|76170046|FG001|Treatment|Lost to Follow-up|4|||
42332117|NCT01492426|76170045|FG000|Treatment|Participant does not meet study criteria|1|||
42332118|NCT01492426|76170046|FG001|Treatment|Participant does not meet study criteria|0|||
41998931|NCT01190930|75807265|FG007|Induction|No treatment|0|||
41998932|NCT01190930|75807266|FG008|Induction|No treatment|0|||
42332119|NCT01492426|76170045|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
42332120|NCT01492426|76170046|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
42332121|NCT01492426|76170045|FG000|Follow-Up|Death|1|||
42332122|NCT01492426|76170046|FG001|Follow-Up|Death|0|||
42332123|NCT01492426|76170045|FG000|Follow-Up|Other|4|||
42332124|NCT01492426|76170046|FG001|Follow-Up|Other|2|||
42332125|NCT01492426|76170045|FG000|Follow-Up|Participant Withdrew Consent|6|||
42332126|NCT01492426|76170046|FG001|Follow-Up|Participant Withdrew Consent|1|||
42332127|NCT01492426|76170045|FG000|Follow-Up|Lost to Follow-up|12|||
42332128|NCT01492426|76170046|FG001|Follow-Up|Lost to Follow-up|6|||
41998933|NCT01190930|75807267|FG009|Induction|No treatment|0|||
41998934|NCT01190930|75807258|FG000|Induction|Ineligible|69|||
42332129|NCT01453348|76170059|FG000|Overall Study|Death|0|||
42332130|NCT01453348|76170060|FG001|Overall Study|Death|0|||
42332131|NCT01453348|76170061|FG002|Overall Study|Death|1|||
42332132|NCT01453348|76170059|FG000|Overall Study|Withdrawal by Subject|0|||
42332133|NCT01453348|76170060|FG001|Overall Study|Withdrawal by Subject|1|||
42332134|NCT01453348|76170061|FG002|Overall Study|Withdrawal by Subject|0|||
42332135|NCT01453348|76170059|FG000|Overall Study|Protocol Violation|1|||
42332136|NCT01453348|76170060|FG001|Overall Study|Protocol Violation|0|||
42332137|NCT01453348|76170061|FG002|Overall Study|Protocol Violation|0|||
42332138|NCT01453036|76170075|FG000|Overall Study|Lost to Follow-up|26|||
42332139|NCT01453036|76170076|FG001|Overall Study|Lost to Follow-up|115|||
42332140|NCT01453036|76170077|FG002|Overall Study|Lost to Follow-up|31|||
42332141|NCT01475734|76170087|FG000|Overall Study|Withdrawal by Subject|1|||
42332142|NCT01475734|76170088|FG001|Overall Study|Withdrawal by Subject|0|||
42332143|NCT01475734|76170087|FG000|Overall Study|Protocol Violation|1|||
42332144|NCT01475734|76170088|FG001|Overall Study|Protocol Violation|0|||
42332145|NCT01475734|76170087|FG000|Overall Study|Physician Decision|0|||
42332146|NCT01475734|76170088|FG001|Overall Study|Physician Decision|1|||
42332147|NCT01452412|76170096|FG000|Overall Study|Withdrawal by Subject|15|||
42332148|NCT01452412|76170097|FG001|Overall Study|Withdrawal by Subject|11|||
42332149|NCT01452412|76170096|FG000|Overall Study|Adverse Event|4|||
42332150|NCT01452412|76170097|FG001|Overall Study|Adverse Event|3|||
42332151|NCT01452412|76170096|FG000|Overall Study|Lost to Follow-up|5|||
42332152|NCT01452412|76170097|FG001|Overall Study|Lost to Follow-up|3|||
42332153|NCT01452412|76170096|FG000|Overall Study|Death|1|||
42332154|NCT01452412|76170097|FG001|Overall Study|Death|0|||
42332155|NCT01452412|76170096|FG000|Overall Study|Initiated dialysis|1|||
42332156|NCT01452412|76170097|FG001|Overall Study|Initiated dialysis|0|||
42332157|NCT01452412|76170096|FG000|Overall Study|Other|2|||
42332158|NCT01452412|76170097|FG001|Overall Study|Other|0|||
42332159|NCT01474876|76170106|FG000|Overall Study|Adverse Event|11|||
42332160|NCT01474876|76170107|FG001|Overall Study|Adverse Event|5|||
42332161|NCT01474876|76170108|FG002|Overall Study|Adverse Event|0|||
42332162|NCT01474876|76170106|FG000|Overall Study|Serious Adverse Event|2|||
42332163|NCT01474876|76170107|FG001|Overall Study|Serious Adverse Event|3|||
42332164|NCT01474876|76170108|FG002|Overall Study|Serious Adverse Event|0|||
42332165|NCT01474876|76170106|FG000|Overall Study|Lost to Follow-up|5|||
42332166|NCT01474876|76170107|FG001|Overall Study|Lost to Follow-up|4|||
42332167|NCT01474876|76170108|FG002|Overall Study|Lost to Follow-up|0|||
41998935|NCT01190930|75807259|FG001|Induction|Ineligible|4|||
41998936|NCT01190930|75807260|FG002|Induction|Ineligible|0|||
41998937|NCT01190930|75807261|FG003|Induction|Ineligible|0|||
41998938|NCT01190930|75807262|FG004|Induction|Ineligible|0|||
41998939|NCT01190930|75807263|FG005|Induction|Ineligible|0|||
41998940|NCT01190930|75807264|FG006|Induction|Ineligible|0|||
42134257|NCT00328510|75945075|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
42332168|NCT01474876|76170106|FG000|Overall Study|Investigator's decision|28|||
42332169|NCT01474876|76170107|FG001|Overall Study|Investigator's decision|6|||
42332170|NCT01474876|76170108|FG002|Overall Study|Investigator's decision|0|||
42332171|NCT01474876|76170106|FG000|Overall Study|Patient's request|19|||
42332172|NCT01474876|76170107|FG001|Overall Study|Patient's request|5|||
42332173|NCT01474876|76170108|FG002|Overall Study|Patient's request|0|||
42332174|NCT01474876|76170106|FG000|Overall Study|Investigator's decision and pt request|1|||
42332175|NCT01474876|76170107|FG001|Overall Study|Investigator's decision and pt request|0|||
42332176|NCT01474876|76170108|FG002|Overall Study|Investigator's decision and pt request|0|||
41998941|NCT01190930|75807265|FG007|Induction|Ineligible|0|||
42332177|NCT01491802|76170114|FG000|Overall Study|Adverse Event|1|||
42332178|NCT01491802|76170115|FG001|Overall Study|Adverse Event|1|||
41998942|NCT01190930|75807266|FG008|Induction|Ineligible|0|||
41998943|NCT01190930|75807267|FG009|Induction|Ineligible|0|||
41998944|NCT01190930|75807258|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
41998945|NCT01190930|75807259|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
41998946|NCT01190930|75807260|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
41998947|NCT01190930|75807261|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
41998948|NCT01190930|75807262|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
41998949|NCT01190930|75807263|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
41998950|NCT01190930|75807264|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
41998951|NCT01190930|75807265|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
41998952|NCT01190930|75807266|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
41998953|NCT01190930|75807267|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
41998954|NCT01190930|75807258|FG000|Post Induction Pre-Maintenance|Death|0|||
42332179|NCT01491802|76170114|FG000|Overall Study|Withdrawal by Subject|0|||
42332180|NCT01491802|76170115|FG001|Overall Study|Withdrawal by Subject|1|||
42332181|NCT02168777|76170125|FG000|Overall Study|Withdrawal by Subject|1|||
42332182|NCT02168777|76170126|FG001|Overall Study|Withdrawal by Subject|0|||
42332183|NCT02168777|76170127|FG002|Overall Study|Withdrawal by Subject|2|||
42332184|NCT02168777|76170125|FG000|Overall Study|Adverse Event|1|||
42332185|NCT02168777|76170126|FG001|Overall Study|Adverse Event|0|||
42332186|NCT02168777|76170127|FG002|Overall Study|Adverse Event|1|||
42332187|NCT02168777|76170125|FG000|Overall Study|Disease recurrence|0|||
42332188|NCT02168777|76170126|FG001|Overall Study|Disease recurrence|0|||
42332189|NCT02168777|76170127|FG002|Overall Study|Disease recurrence|1|||
42332190|NCT02168777|76170125|FG000|Overall Study|Radiological disease progression|0|||
42332191|NCT02168777|76170126|FG001|Overall Study|Radiological disease progression|5|||
42332192|NCT02168777|76170127|FG002|Overall Study|Radiological disease progression|5|||
42332193|NCT02168777|76170125|FG000|Overall Study|Clinical disease progression|0|||
42332194|NCT02168777|76170126|FG001|Overall Study|Clinical disease progression|1|||
42332195|NCT02168777|76170127|FG002|Overall Study|Clinical disease progression|2|||
42332196|NCT02168777|76170125|FG000|Overall Study|Other reason|0|||
42332197|NCT02168777|76170126|FG001|Overall Study|Other reason|1|||
42332198|NCT02168777|76170127|FG002|Overall Study|Other reason|0|||
42332199|NCT01491178|76170138|FG000|Overall Study|Adverse Event|1016|||
42332200|NCT01491178|76170138|FG000|Overall Study|Improvement of NVAF|210|||
42332201|NCT01491178|76170138|FG000|Overall Study|To conduct invasive treatment|59|||
42332202|NCT01491178|76170138|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
42332203|NCT01491178|76170138|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
42332204|NCT01491178|76170138|FG000|Overall Study|To take a contraindication|20|||
42332205|NCT01491178|76170138|FG000|Overall Study|Other than specified above|657|||
42332206|NCT02189837|76170146|FG000|Overall Study|Withdrawal by Subject|2|||
42332207|NCT02189837|76170147|FG001|Overall Study|Withdrawal by Subject|1|||
42332208|NCT02189837|76170148|FG002|Overall Study|Withdrawal by Subject|3|||
42332209|NCT02189837|76170149|FG003|Overall Study|Withdrawal by Subject|1|||
41998955|NCT01190930|75807259|FG001|Post Induction Pre-Maintenance|Death|0|||
42332210|NCT02189837|76170146|FG000|Overall Study|Sponsor Decision|0|||
42332211|NCT02189837|76170147|FG001|Overall Study|Sponsor Decision|0|||
42332212|NCT02189837|76170148|FG002|Overall Study|Sponsor Decision|0|||
42332213|NCT02189837|76170149|FG003|Overall Study|Sponsor Decision|1|||
42332214|NCT02216123|76170161|FG000|Overall Study|Lost to Follow-up|4|||
42332215|NCT02216123|76170162|FG001|Overall Study|Lost to Follow-up|2|||
42332216|NCT02216123|76170161|FG000|Overall Study|Withdrawal by Subject|2|||
42332217|NCT02216123|76170162|FG001|Overall Study|Withdrawal by Subject|0|||
42332218|NCT02189759|76170176|FG000|Overall Study|Lost to Follow-up|0|||
42332219|NCT02189759|76170177|FG001|Overall Study|Lost to Follow-up|0|||
42332220|NCT02189759|76170178|FG002|Overall Study|Lost to Follow-up|2|||
42332221|NCT02189759|76170179|FG003|Overall Study|Lost to Follow-up|5|||
42332222|NCT01490866|76170191|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
42332223|NCT01490866|76170191|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
42332224|NCT01490866|76170191|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
42332225|NCT01490866|76170191|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
42332226|NCT01490866|76170191|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
42332227|NCT01490866|76170191|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
42332228|NCT01490866|76170191|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
42332229|NCT01490866|76170191|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
42332230|NCT01490866|76170191|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
42332231|NCT01490866|76170191|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
42332232|NCT01490866|76170191|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
41998956|NCT01190930|75807260|FG002|Post Induction Pre-Maintenance|Death|8|||
41998957|NCT01190930|75807261|FG003|Post Induction Pre-Maintenance|Death|4|||
41998958|NCT01190930|75807262|FG004|Post Induction Pre-Maintenance|Death|0|||
41998959|NCT01190930|75807263|FG005|Post Induction Pre-Maintenance|Death|0|||
41998960|NCT01190930|75807264|FG006|Post Induction Pre-Maintenance|Death|0|||
41998961|NCT01190930|75807265|FG007|Post Induction Pre-Maintenance|Death|0|||
41998962|NCT01190930|75807266|FG008|Post Induction Pre-Maintenance|Death|0|||
41998963|NCT01190930|75807267|FG009|Post Induction Pre-Maintenance|Death|0|||
42332233|NCT02215967|76170202|FG000|Overall Study|Patient became ineligible for treatment|0|||
42332234|NCT02215967|76170203|FG001|Overall Study|Patient became ineligible for treatment|0|||
42332235|NCT02215967|76170204|FG002|Overall Study|Patient became ineligible for treatment|0|||
42332236|NCT02215967|76170205|FG003|Overall Study|Patient became ineligible for treatment|3|||
42332237|NCT02215967|76170202|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
42332238|NCT02215967|76170203|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
42332239|NCT02215967|76170204|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
42332240|NCT02215967|76170205|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
42332241|NCT02168387|76170217|FG000|Overall Study|Planned exubation|6|||
42332242|NCT02168387|76170218|FG001|Overall Study|Planned exubation|3|||
42332243|NCT02168387|76170217|FG000|Overall Study|Death|1|||
42332244|NCT02168387|76170218|FG001|Overall Study|Death|0|||
42332245|NCT02188589|76170224|FG000|Overall Study|Withdrawal by Subject|5|||
42332246|NCT02167451|76170229|FG000|Overall Study|Withdrawal by Subject|1|||
42332247|NCT02167139|76170235|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
42332248|NCT02167139|76170236|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
42332249|NCT02167139|76170237|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
42332250|NCT02167139|76170238|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
42332251|NCT02167139|76170235|FG000|Randomised, Double-blind|Adverse Event|2|||
42332252|NCT02167139|76170236|FG001|Randomised, Double-blind|Adverse Event|9|||
42332253|NCT02167139|76170237|FG002|Randomised, Double-blind|Adverse Event|0|||
42332254|NCT02167139|76170238|FG003|Randomised, Double-blind|Adverse Event|0|||
42332255|NCT02167139|76170235|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
42332256|NCT02167139|76170236|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
42332257|NCT02167139|76170237|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
42332258|NCT02167139|76170238|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
42332259|NCT02167139|76170235|FG000|Randomised, Double-blind|Other|3|||
42332260|NCT02167139|76170236|FG001|Randomised, Double-blind|Other|0|||
42332261|NCT02167139|76170237|FG002|Randomised, Double-blind|Other|0|||
42332262|NCT02167139|76170238|FG003|Randomised, Double-blind|Other|0|||
42332263|NCT02167139|76170235|FG000|Transition-extension|Adverse Event|2|||
42332264|NCT02167139|76170236|FG001|Transition-extension|Adverse Event|0|||
41998964|NCT01190930|75807258|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
41998965|NCT01190930|75807259|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
42134258|NCT00328510|75945076|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
42332265|NCT02167139|76170237|FG002|Transition-extension|Adverse Event|2|||
42332266|NCT02167139|76170238|FG003|Transition-extension|Adverse Event|3|||
42332267|NCT02167139|76170235|FG000|Transition-extension|Withdrawal by Subject|2|||
42332268|NCT02167139|76170236|FG001|Transition-extension|Withdrawal by Subject|0|||
42332269|NCT02167139|76170237|FG002|Transition-extension|Withdrawal by Subject|4|||
42332270|NCT02167139|76170238|FG003|Transition-extension|Withdrawal by Subject|1|||
42332271|NCT02167139|76170235|FG000|Transition-extension|Lack of Efficacy|0|||
42332272|NCT02167139|76170236|FG001|Transition-extension|Lack of Efficacy|0|||
42332273|NCT02167139|76170237|FG002|Transition-extension|Lack of Efficacy|1|||
42332274|NCT02167139|76170238|FG003|Transition-extension|Lack of Efficacy|1|||
42332275|NCT02167139|76170235|FG000|Transition-extension|Other|1|||
42332276|NCT02167139|76170236|FG001|Transition-extension|Other|0|||
42332277|NCT02167139|76170237|FG002|Transition-extension|Other|1|||
42332278|NCT02167139|76170238|FG003|Transition-extension|Other|0|||
42332279|NCT02167139|76170235|FG000|Transition-extension|Lost to Follow-up|1|||
42332280|NCT02167139|76170236|FG001|Transition-extension|Lost to Follow-up|0|||
42332281|NCT02167139|76170237|FG002|Transition-extension|Lost to Follow-up|0|||
42332282|NCT02167139|76170238|FG003|Transition-extension|Lost to Follow-up|0|||
42332283|NCT02116621|76170254|FG000|Baseline|Withdrawal by Subject|0|||
42332284|NCT02116621|76170255|FG001|Baseline|Withdrawal by Subject|4|||
42332285|NCT02116621|76170254|FG000|Three Month Follow-up|Death|1|||
42332286|NCT02116621|76170255|FG001|Three Month Follow-up|Death|1|||
42332287|NCT02116621|76170254|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
42332288|NCT02116621|76170255|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
42332289|NCT02116621|76170254|FG000|Three Month Follow-up|Lost to Follow-up|0|||
42332290|NCT02116621|76170255|FG001|Three Month Follow-up|Lost to Follow-up|1|||
42332291|NCT02116621|76170254|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
42332292|NCT02116621|76170255|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
42332293|NCT02116621|76170254|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
42332294|NCT02116621|76170255|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
42332295|NCT02116621|76170254|FG000|Six Month Follow-up|Lost to Follow-up|2|||
42332296|NCT02116621|76170255|FG001|Six Month Follow-up|Lost to Follow-up|1|||
42332297|NCT02116621|76170254|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
42332298|NCT02116621|76170255|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
42332299|NCT02116621|76170254|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
42332300|NCT02116621|76170255|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
42332301|NCT02116621|76170254|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
42332302|NCT02116621|76170255|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
42332303|NCT02116621|76170254|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
42332304|NCT02116621|76170255|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
42332305|NCT02116621|76170254|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
42332306|NCT02116621|76170255|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
42034596|NCT00935493|75842669|FG000|Overall Study|Treatment Discontinued|0|||
42332307|NCT02116309|76170263|FG000|Overall Study|Lost to Follow-up|0|||
42332308|NCT02116309|76170264|FG001|Overall Study|Lost to Follow-up|1|||
42332309|NCT02115607|76170270|FG000|Overall Study|Withdrawal by Subject|1|||
42332310|NCT01490632|76170279|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
42332311|NCT01490632|76170280|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
42332312|NCT01490632|76170281|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
42332313|NCT01490632|76170282|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
42332314|NCT01490632|76170283|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
42332315|NCT01490632|76170284|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
42332316|NCT01490632|76170285|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
42332317|NCT01490632|76170286|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
42332318|NCT01490632|76170287|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
42332319|NCT01490632|76170288|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
42332320|NCT01490632|76170289|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
42332321|NCT01490632|76170290|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
42332322|NCT01490632|76170291|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
42332323|NCT01490632|76170292|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
42332324|NCT01490632|76170293|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
42332325|NCT01490632|76170294|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
42332326|NCT01490632|76170295|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
42332327|NCT01490632|76170296|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
42332328|NCT01490632|76170297|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
42332329|NCT01490632|76170298|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
42332330|NCT01490632|76170279|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
42332331|NCT01490632|76170280|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
42332332|NCT01490632|76170281|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
42332333|NCT01490632|76170282|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
42332334|NCT01490632|76170283|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332335|NCT01490632|76170284|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332336|NCT01490632|76170285|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332337|NCT01490632|76170286|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332338|NCT01490632|76170287|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332339|NCT01490632|76170288|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332340|NCT01490632|76170289|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332341|NCT01490632|76170290|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332342|NCT01490632|76170291|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332343|NCT01490632|76170292|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332344|NCT01490632|76170293|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332345|NCT01490632|76170294|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332346|NCT01490632|76170295|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332347|NCT01490632|76170296|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332348|NCT01490632|76170297|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332349|NCT01490632|76170298|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
42332350|NCT01490632|76170279|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332351|NCT01490632|76170280|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332352|NCT01490632|76170281|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
42332353|NCT01490632|76170282|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
42332354|NCT01490632|76170283|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
41998966|NCT01190930|75807260|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
41998967|NCT01190930|75807261|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
42332355|NCT01490632|76170284|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
41998968|NCT01190930|75807262|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
41998969|NCT01190930|75807263|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
41998970|NCT01190930|75807264|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
41998971|NCT01190930|75807265|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
41998972|NCT01190930|75807266|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
42332356|NCT01490632|76170285|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332357|NCT01490632|76170286|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332358|NCT01490632|76170287|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332359|NCT01490632|76170288|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332360|NCT01490632|76170289|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332361|NCT01490632|76170290|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332362|NCT01490632|76170291|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332363|NCT01490632|76170292|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332364|NCT01490632|76170293|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332365|NCT01490632|76170294|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332366|NCT01490632|76170295|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332367|NCT01490632|76170296|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332368|NCT01490632|76170297|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332369|NCT01490632|76170298|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
42332370|NCT01490632|76170279|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
42332371|NCT01490632|76170280|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
41998973|NCT01190930|75807267|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
42332372|NCT01490632|76170281|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
41998974|NCT01190930|75807258|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
42332373|NCT01490632|76170282|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
42332374|NCT01490632|76170283|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
42332375|NCT01490632|76170284|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
42332376|NCT01490632|76170285|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
42332377|NCT01490632|76170286|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
41998975|NCT01190930|75807259|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
41998976|NCT01190930|75807260|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
41998977|NCT01190930|75807261|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
41998978|NCT01190930|75807262|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
41998979|NCT01190930|75807263|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
41998980|NCT01190930|75807264|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
41998981|NCT01190930|75807265|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
41998982|NCT01190930|75807266|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
42332378|NCT01490632|76170287|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
42332379|NCT01490632|76170288|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
42332380|NCT01490632|76170289|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
42332381|NCT01490632|76170290|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
42332382|NCT01490632|76170291|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
42332383|NCT01490632|76170292|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
42332384|NCT01490632|76170293|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
42332385|NCT01490632|76170294|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
42332386|NCT01490632|76170295|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
42332387|NCT01490632|76170296|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
42332388|NCT01490632|76170297|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
42332389|NCT01490632|76170298|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
42332390|NCT01490632|76170279|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
42332391|NCT01490632|76170280|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332392|NCT01490632|76170281|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332393|NCT01490632|76170282|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332394|NCT01490632|76170283|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332395|NCT01490632|76170284|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332396|NCT01490632|76170285|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332397|NCT01490632|76170286|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332398|NCT01490632|76170287|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332399|NCT01490632|76170288|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332400|NCT01490632|76170289|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332401|NCT01490632|76170290|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332402|NCT01490632|76170291|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332403|NCT01490632|76170292|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332404|NCT01490632|76170293|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332405|NCT01490632|76170294|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332406|NCT01490632|76170295|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332407|NCT01490632|76170296|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332408|NCT01490632|76170297|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332409|NCT01490632|76170298|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
42332410|NCT01490632|76170279|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
42332411|NCT01490632|76170280|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
42332412|NCT01490632|76170281|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332413|NCT01490632|76170282|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
42332414|NCT01490632|76170283|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
42332415|NCT01490632|76170284|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332416|NCT01490632|76170285|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332417|NCT01490632|76170286|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332418|NCT01490632|76170287|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332419|NCT01490632|76170288|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332420|NCT01490632|76170289|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332421|NCT01490632|76170290|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332422|NCT01490632|76170291|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332423|NCT01490632|76170292|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332424|NCT01490632|76170293|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
41998983|NCT01190930|75807267|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
41998984|NCT01190930|75807258|FG000|Post Induction Pre-Maintenance|Refusal|0|||
42134259|NCT00328510|75945075|FG000|Overall Study|Treatment changed to a single fraction|1|||
42134260|NCT00328510|75945076|FG001|Overall Study|Treatment changed to a single fraction|1|||
42263560|NCT02634788|76091419|FG002|Overall Study|Withdrawal by Subject|1|||
42263561|NCT02634788|76091420|FG003|Overall Study|Withdrawal by Subject|0|||
42263562|NCT02785939|76091432|FG000|Overall Study|Progression|25|||
42332425|NCT01490632|76170294|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332426|NCT01490632|76170295|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332427|NCT01490632|76170296|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332428|NCT01490632|76170297|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332429|NCT01490632|76170298|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
42332430|NCT01490632|76170279|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332431|NCT01490632|76170280|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332432|NCT01490632|76170281|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332433|NCT01490632|76170282|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332434|NCT01490632|76170283|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
42332435|NCT01490632|76170284|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332436|NCT01490632|76170285|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332437|NCT01490632|76170286|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332438|NCT01490632|76170287|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332439|NCT01490632|76170288|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332440|NCT01490632|76170289|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332441|NCT01490632|76170290|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332442|NCT01490632|76170291|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332443|NCT01490632|76170292|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332444|NCT01490632|76170293|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332445|NCT01490632|76170294|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332446|NCT01490632|76170295|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332447|NCT01490632|76170296|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332448|NCT01490632|76170297|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332449|NCT01490632|76170298|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
42332450|NCT01490632|76170279|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332451|NCT01490632|76170280|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332452|NCT01490632|76170281|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332453|NCT01490632|76170282|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332454|NCT01490632|76170283|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332455|NCT01490632|76170284|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
42332456|NCT01490632|76170285|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
42332457|NCT01490632|76170286|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332458|NCT01490632|76170287|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332459|NCT01490632|76170288|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
42332460|NCT01490632|76170289|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
42263563|NCT02785939|76091433|FG001|Overall Study|Progression|8|||
42263564|NCT02785939|76091432|FG000|Overall Study|Adverse Event|3|||
42263565|NCT02785939|76091433|FG001|Overall Study|Adverse Event|1|||
42263566|NCT02785939|76091432|FG000|Overall Study|Death|1|||
42263567|NCT02785939|76091433|FG001|Overall Study|Death|0|||
42263568|NCT02785939|76091432|FG000|Overall Study|Refusal|1|||
42134261|NCT00313144|75945082|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
42263569|NCT02785939|76091433|FG001|Overall Study|Refusal|0|||
42263570|NCT02785939|76091432|FG000|Overall Study|Deteriorating health|1|||
42263571|NCT02785939|76091433|FG001|Overall Study|Deteriorating health|0|||
42332461|NCT01490632|76170290|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
42332462|NCT01490632|76170291|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332463|NCT01490632|76170292|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332464|NCT01490632|76170293|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332465|NCT01490632|76170294|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332466|NCT01490632|76170295|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332467|NCT01490632|76170296|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332468|NCT01490632|76170297|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332469|NCT01490632|76170298|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
42332470|NCT01490632|76170279|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332471|NCT01490632|76170280|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332472|NCT01490632|76170281|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332473|NCT01490632|76170282|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332474|NCT01490632|76170283|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332475|NCT01490632|76170284|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332476|NCT01490632|76170285|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
41998985|NCT01190930|75807259|FG001|Post Induction Pre-Maintenance|Refusal|2|||
41998986|NCT01190930|75807260|FG002|Post Induction Pre-Maintenance|Refusal|694|||
41998987|NCT01190930|75807261|FG003|Post Induction Pre-Maintenance|Refusal|4|||
41998988|NCT01190930|75807262|FG004|Post Induction Pre-Maintenance|Refusal|0|||
42332477|NCT01490632|76170286|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332478|NCT01490632|76170287|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
42332479|NCT01490632|76170288|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
42332480|NCT01490632|76170289|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
42332481|NCT01490632|76170290|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332482|NCT01490632|76170291|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332483|NCT01490632|76170292|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332484|NCT01490632|76170293|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332485|NCT01490632|76170294|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332486|NCT01490632|76170295|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332487|NCT01490632|76170296|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332488|NCT01490632|76170297|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332489|NCT01490632|76170298|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
42332490|NCT01490632|76170279|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332491|NCT01490632|76170280|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332492|NCT01490632|76170281|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332493|NCT01490632|76170282|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332494|NCT01490632|76170283|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332495|NCT01490632|76170284|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332496|NCT01490632|76170285|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
42332497|NCT01490632|76170286|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332498|NCT01490632|76170287|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332499|NCT01490632|76170288|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
42332500|NCT01490632|76170289|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332501|NCT01490632|76170290|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332502|NCT01490632|76170291|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332503|NCT01490632|76170292|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332504|NCT01490632|76170293|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332505|NCT01490632|76170294|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332506|NCT01490632|76170295|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332507|NCT01490632|76170296|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332508|NCT01490632|76170297|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332509|NCT01490632|76170298|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
42332510|NCT01490632|76170279|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332511|NCT01490632|76170280|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
41998989|NCT01190930|75807263|FG005|Post Induction Pre-Maintenance|Refusal|3|||
42134262|NCT00313144|75945082|FG000|Overall Study|Death|7|||
42332512|NCT01490632|76170281|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332513|NCT01490632|76170282|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332514|NCT01490632|76170283|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
42263572|NCT02785939|76091432|FG000|Overall Study|Not protocol specified|0|||
42263573|NCT02785939|76091433|FG001|Overall Study|Not protocol specified|1|||
42263574|NCT02634320|76091447|FG000|Overall Study|Adverse Event|2|||
42263575|NCT02634320|76091447|FG000|Overall Study|Lost to Follow-up|3|||
42263576|NCT02634320|76091447|FG000|Overall Study|Moved out of area|2|||
42263577|NCT02634320|76091447|FG000|Overall Study|Out of window for study visits|1|||
42263578|NCT02634320|76091447|FG000|Overall Study|Protocol Violation|1|||
42263579|NCT02634320|76091447|FG000|Overall Study|Withdrawal by Subject|5|||
42263580|NCT02634320|76091447|FG000|Overall Study|Lack of Efficacy|2|||
42332515|NCT01490632|76170284|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332516|NCT01490632|76170285|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
42332517|NCT01490632|76170286|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332518|NCT01490632|76170287|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332519|NCT01490632|76170288|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332520|NCT01490632|76170289|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332521|NCT01490632|76170290|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332522|NCT01490632|76170291|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332523|NCT01490632|76170292|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332524|NCT01490632|76170293|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332525|NCT01490632|76170294|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332526|NCT01490632|76170295|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332527|NCT01490632|76170296|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332528|NCT01490632|76170297|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332529|NCT01490632|76170298|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
42332530|NCT01490632|76170279|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332531|NCT01490632|76170280|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332532|NCT01490632|76170281|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332533|NCT01490632|76170282|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332534|NCT01490632|76170283|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332535|NCT01490632|76170284|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
42332536|NCT01490632|76170285|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332537|NCT01490632|76170286|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332538|NCT01490632|76170287|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42263581|NCT02435680|76091454|FG000|Overall Study|Physician Decision|3|||
42263582|NCT02435680|76091455|FG001|Overall Study|Physician Decision|0|||
42263583|NCT02435680|76091456|FG002|Overall Study|Physician Decision|0|||
42263584|NCT02435680|76091454|FG000|Overall Study|subject / guardian decision|0|||
42263585|NCT02435680|76091455|FG001|Overall Study|subject / guardian decision|3|||
42332539|NCT01490632|76170288|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332540|NCT01490632|76170289|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332541|NCT01490632|76170290|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332542|NCT01490632|76170291|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332543|NCT01490632|76170292|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332544|NCT01490632|76170293|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42263586|NCT02435680|76091456|FG002|Overall Study|subject / guardian decision|2|||
42263587|NCT02435680|76091454|FG000|Overall Study|Adverse Event|8|||
42263588|NCT02435680|76091455|FG001|Overall Study|Adverse Event|3|||
42263589|NCT02435680|76091456|FG002|Overall Study|Adverse Event|2|||
42263590|NCT02435680|76091454|FG000|Overall Study|progressive disease|10|||
42263591|NCT02435680|76091455|FG001|Overall Study|progressive disease|7|||
42332545|NCT01490632|76170294|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332546|NCT01490632|76170295|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332547|NCT01490632|76170296|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332548|NCT01490632|76170297|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332549|NCT01490632|76170298|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
42332550|NCT01490632|76170279|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332551|NCT01490632|76170280|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42263592|NCT02435680|76091456|FG002|Overall Study|progressive disease|11|||
42263593|NCT02435680|76091454|FG000|Overall Study|not treated|0|||
42263594|NCT02435680|76091455|FG001|Overall Study|not treated|0|||
42263595|NCT02435680|76091456|FG002|Overall Study|not treated|1|||
42263596|NCT03371732|76091470|FG000|Overall Study|Withdrawal by Subject|9|||
42263597|NCT03371732|76091471|FG001|Overall Study|Withdrawal by Subject|3|||
41998990|NCT01190930|75807264|FG006|Post Induction Pre-Maintenance|Refusal|0|||
41998991|NCT01190930|75807265|FG007|Post Induction Pre-Maintenance|Refusal|0|||
42134263|NCT00313144|75945082|FG000|Overall Study|Lost to Follow-up|5|||
42263598|NCT03371732|76091470|FG000|Overall Study|Refusal to continue|3|||
42263599|NCT03371732|76091471|FG001|Overall Study|Refusal to continue|4|||
42263600|NCT02745119|76091483|FG000|Overall Study|Adverse Event|1|||
42263601|NCT02745119|76091484|FG001|Overall Study|Adverse Event|0|||
42263602|NCT02745119|76091485|FG002|Overall Study|Adverse Event|1|||
41998992|NCT01190930|75807266|FG008|Post Induction Pre-Maintenance|Refusal|0|||
42263603|NCT02745119|76091486|FG003|Overall Study|Adverse Event|3|||
42263604|NCT02745119|76091483|FG000|Overall Study|Death|3|||
42332552|NCT01490632|76170281|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332553|NCT01490632|76170282|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332554|NCT01490632|76170283|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332555|NCT01490632|76170284|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332556|NCT01490632|76170285|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
42332557|NCT01490632|76170286|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332558|NCT01490632|76170287|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
42332559|NCT01490632|76170288|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332560|NCT01490632|76170289|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
42332561|NCT01490632|76170290|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
42332562|NCT01490632|76170291|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332563|NCT01490632|76170292|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332564|NCT01490632|76170293|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332565|NCT01490632|76170294|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332566|NCT01490632|76170295|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332567|NCT01490632|76170296|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332568|NCT01490632|76170297|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332569|NCT01490632|76170298|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
42332570|NCT01490632|76170279|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332571|NCT01490632|76170280|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332572|NCT01490632|76170281|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332573|NCT01490632|76170282|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332574|NCT01490632|76170283|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332575|NCT01490632|76170284|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
41998993|NCT01190930|75807267|FG009|Post Induction Pre-Maintenance|Refusal|0|||
42332576|NCT01490632|76170285|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
42332577|NCT01490632|76170286|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
42332578|NCT01490632|76170287|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
42332579|NCT01490632|76170288|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
42332580|NCT01490632|76170289|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
42332581|NCT01490632|76170290|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
42332582|NCT01490632|76170291|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332583|NCT01490632|76170292|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332584|NCT01490632|76170293|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332585|NCT01490632|76170294|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332586|NCT01490632|76170295|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332587|NCT01490632|76170296|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332588|NCT01490632|76170297|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332589|NCT01490632|76170298|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
42332590|NCT01490632|76170279|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332591|NCT01490632|76170280|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332592|NCT01490632|76170281|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332593|NCT01490632|76170282|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332594|NCT01490632|76170283|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332595|NCT01490632|76170284|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332596|NCT01490632|76170285|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332597|NCT01490632|76170286|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332598|NCT01490632|76170287|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332599|NCT01490632|76170288|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332600|NCT01490632|76170289|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332601|NCT01490632|76170290|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332602|NCT01490632|76170291|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332603|NCT01490632|76170292|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332604|NCT01490632|76170293|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
42332605|NCT01490632|76170294|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
42332606|NCT01490632|76170295|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332607|NCT01490632|76170296|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332608|NCT01490632|76170297|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332609|NCT01490632|76170298|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
42332610|NCT01490632|76170279|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332611|NCT01490632|76170280|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332612|NCT01490632|76170281|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332613|NCT01490632|76170282|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332614|NCT01490632|76170283|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332615|NCT01490632|76170284|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332616|NCT01490632|76170285|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332617|NCT01490632|76170286|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332618|NCT01490632|76170287|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332619|NCT01490632|76170288|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332620|NCT01490632|76170289|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332621|NCT01490632|76170290|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332622|NCT01490632|76170291|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
41998994|NCT01190930|75807258|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
41998995|NCT01190930|75807259|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
42263605|NCT02745119|76091484|FG001|Overall Study|Death|3|||
42263606|NCT02745119|76091485|FG002|Overall Study|Death|0|||
42263607|NCT02745119|76091486|FG003|Overall Study|Death|4|||
42263608|NCT02745119|76091483|FG000|Overall Study|Lost to Follow-up|0|||
42263609|NCT02745119|76091484|FG001|Overall Study|Lost to Follow-up|0|||
42263610|NCT02745119|76091485|FG002|Overall Study|Lost to Follow-up|0|||
42263611|NCT02745119|76091486|FG003|Overall Study|Lost to Follow-up|1|||
42263612|NCT02745119|76091483|FG000|Overall Study|Protocol Deviation|0|||
42263613|NCT02745119|76091484|FG001|Overall Study|Protocol Deviation|0|||
42263614|NCT02745119|76091485|FG002|Overall Study|Protocol Deviation|0|||
42332623|NCT01490632|76170292|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
42332624|NCT01490632|76170293|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332625|NCT01490632|76170294|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42263615|NCT02745119|76091486|FG003|Overall Study|Protocol Deviation|1|||
42263616|NCT02745119|76091483|FG000|Overall Study|Withdrawal by Subject|7|||
42263617|NCT02745119|76091484|FG001|Overall Study|Withdrawal by Subject|15|||
42263618|NCT02745119|76091485|FG002|Overall Study|Withdrawal by Subject|8|||
42263619|NCT02745119|76091486|FG003|Overall Study|Withdrawal by Subject|14|||
42332626|NCT01490632|76170295|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332627|NCT01490632|76170296|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332628|NCT01490632|76170297|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332629|NCT01490632|76170298|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
42332630|NCT01490632|76170279|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332631|NCT01490632|76170280|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332632|NCT01490632|76170281|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332633|NCT01490632|76170282|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332634|NCT01490632|76170283|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332635|NCT01490632|76170284|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332636|NCT01490632|76170285|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332637|NCT01490632|76170286|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332638|NCT01490632|76170287|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332639|NCT01490632|76170288|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332640|NCT01490632|76170289|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332641|NCT01490632|76170290|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332642|NCT01490632|76170291|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332643|NCT01490632|76170292|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332644|NCT01490632|76170293|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
42332645|NCT01490632|76170294|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
42332646|NCT01490632|76170295|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332647|NCT01490632|76170296|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332648|NCT01490632|76170297|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332649|NCT01490632|76170298|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
42332650|NCT01490632|76170279|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332651|NCT01490632|76170280|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332652|NCT01490632|76170281|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332653|NCT01490632|76170282|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332654|NCT01490632|76170283|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332655|NCT01490632|76170284|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332656|NCT01490632|76170285|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332657|NCT01490632|76170286|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332658|NCT01490632|76170287|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332659|NCT01490632|76170288|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332660|NCT01490632|76170289|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332661|NCT01490632|76170290|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332662|NCT01490632|76170291|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
42332663|NCT01490632|76170292|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
42332664|NCT01490632|76170293|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
42332665|NCT01490632|76170294|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
42332666|NCT01490632|76170295|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332667|NCT01490632|76170296|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332668|NCT01490632|76170297|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332669|NCT01490632|76170298|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
42332670|NCT01490632|76170279|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
42332671|NCT01490632|76170280|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
42332672|NCT01490632|76170281|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
42332673|NCT01490632|76170282|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
42332674|NCT01490632|76170283|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
42332675|NCT01490632|76170284|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
42332676|NCT01490632|76170285|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
42332677|NCT01490632|76170286|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
42332678|NCT01490632|76170287|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
42332679|NCT01490632|76170288|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
42332680|NCT01490632|76170289|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
42332681|NCT01490632|76170290|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
42332682|NCT01490632|76170291|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
42332683|NCT01490632|76170292|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
42332684|NCT01490632|76170293|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
42332685|NCT01490632|76170294|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
42332686|NCT01490632|76170295|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
42332687|NCT01490632|76170296|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
42332688|NCT01490632|76170297|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
42332689|NCT01490632|76170298|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
42332690|NCT01490632|76170279|FG000|Part D: Re-Treatment Period|Death|0|||
42332691|NCT01490632|76170280|FG001|Part D: Re-Treatment Period|Death|0|||
42332692|NCT01490632|76170281|FG002|Part D: Re-Treatment Period|Death|0|||
42332693|NCT01490632|76170282|FG003|Part D: Re-Treatment Period|Death|0|||
42332694|NCT01490632|76170283|FG004|Part D: Re-Treatment Period|Death|0|||
42332695|NCT01490632|76170284|FG005|Part D: Re-Treatment Period|Death|0|||
42332696|NCT01490632|76170285|FG006|Part D: Re-Treatment Period|Death|0|||
42332697|NCT01490632|76170286|FG007|Part D: Re-Treatment Period|Death|0|||
41998996|NCT01190930|75807260|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
42263620|NCT02745119|76091483|FG000|Overall Study|Study Terminated by Sponsor|134|||
42263621|NCT02745119|76091484|FG001|Overall Study|Study Terminated by Sponsor|252|||
42263622|NCT02745119|76091485|FG002|Overall Study|Study Terminated by Sponsor|135|||
42263623|NCT02745119|76091486|FG003|Overall Study|Study Terminated by Sponsor|251|||
42263624|NCT02745119|76091483|FG000|Overall Study|Physician Decision|0|||
42263625|NCT02745119|76091484|FG001|Overall Study|Physician Decision|2|||
42263626|NCT02745119|76091485|FG002|Overall Study|Physician Decision|2|||
42263627|NCT02745119|76091486|FG003|Overall Study|Physician Decision|2|||
42263628|NCT02745119|76091483|FG000|Overall Study|Reason Not Specified|0|||
42332698|NCT01490632|76170287|FG008|Part D: Re-Treatment Period|Death|0|||
42332699|NCT01490632|76170288|FG009|Part D: Re-Treatment Period|Death|0|||
42332700|NCT01490632|76170289|FG010|Part D: Re-Treatment Period|Death|0|||
42332701|NCT01490632|76170290|FG011|Part D: Re-Treatment Period|Death|0|||
42332702|NCT01490632|76170291|FG012|Part D: Re-Treatment Period|Death|0|||
42332703|NCT01490632|76170292|FG013|Part D: Re-Treatment Period|Death|0|||
42332704|NCT01490632|76170293|FG014|Part D: Re-Treatment Period|Death|0|||
42332705|NCT01490632|76170294|FG015|Part D: Re-Treatment Period|Death|0|||
42332706|NCT01490632|76170295|FG016|Part D: Re-Treatment Period|Death|0|||
42332707|NCT01490632|76170296|FG017|Part D: Re-Treatment Period|Death|0|||
42263629|NCT02745119|76091484|FG001|Overall Study|Reason Not Specified|2|||
42263630|NCT02745119|76091485|FG002|Overall Study|Reason Not Specified|0|||
42263631|NCT02745119|76091486|FG003|Overall Study|Reason Not Specified|1|||
42263632|NCT01367665|76091500|FG000|Overall Study|Death|102|||
42263633|NCT01367665|76091501|FG001|Overall Study|Death|19|||
42263634|NCT01367665|76091500|FG000|Overall Study|Lost to Follow-up|222|||
42263635|NCT01367665|76091501|FG001|Overall Study|Lost to Follow-up|22|||
42263636|NCT01367665|76091500|FG000|Overall Study|Not Done|118|||
42263637|NCT01367665|76091501|FG001|Overall Study|Not Done|14|||
41998997|NCT01190930|75807261|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
41998998|NCT01190930|75807262|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
41998999|NCT01190930|75807263|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
41999000|NCT01190930|75807264|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
41999001|NCT01190930|75807265|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
41999002|NCT01190930|75807266|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
42134264|NCT00313144|75945082|FG000|Overall Study|Withdrawal by Subject|4|||
42134265|NCT00313144|75945082|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
41999003|NCT01190930|75807267|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
41999004|NCT01190930|75807258|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
41999005|NCT01190930|75807259|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
42263638|NCT02576847|76091508|FG000|Overall Study|Adverse Event|27|||
42332708|NCT01490632|76170297|FG018|Part D: Re-Treatment Period|Death|1|||
42332709|NCT01490632|76170298|FG019|Part D: Re-Treatment Period|Death|0|||
42332710|NCT01490632|76170279|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332711|NCT01490632|76170280|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332712|NCT01490632|76170281|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332713|NCT01490632|76170282|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
41999006|NCT01190930|75807260|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
41999007|NCT01190930|75807261|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
42134266|NCT00313144|75945082|FG000|Overall Study|Physician Decision|4|||
42263639|NCT02576847|76091508|FG000|Overall Study|Lost to Follow-up|22|||
42263640|NCT02576847|76091508|FG000|Overall Study|Physician Decision|1|||
42263641|NCT02576847|76091508|FG000|Overall Study|Pregnancy|1|||
42263642|NCT02576847|76091508|FG000|Overall Study|Protocol Violation|3|||
42263643|NCT02576847|76091508|FG000|Overall Study|Withdrawal by Subject|78|||
42263644|NCT02576847|76091508|FG000|Overall Study|Other|5|||
42263645|NCT02135029|76091524|FG000|Overall Study|Adverse Event|2|||
42263646|NCT02135029|76091525|FG001|Overall Study|Adverse Event|2|||
42263647|NCT02135029|76091526|FG002|Overall Study|Adverse Event|2|||
42263648|NCT02135029|76091524|FG000|Overall Study|Lost to Follow-up|0|||
42263649|NCT02135029|76091525|FG001|Overall Study|Lost to Follow-up|1|||
42332714|NCT01490632|76170283|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42263650|NCT02135029|76091526|FG002|Overall Study|Lost to Follow-up|0|||
42263651|NCT02135029|76091524|FG000|Overall Study|Withdrawal by Subject|2|||
42263652|NCT02135029|76091525|FG001|Overall Study|Withdrawal by Subject|0|||
42263653|NCT02135029|76091526|FG002|Overall Study|Withdrawal by Subject|1|||
42263654|NCT02135029|76091524|FG000|Overall Study|Other|0|||
42263655|NCT02135029|76091525|FG001|Overall Study|Other|1|||
42263656|NCT02135029|76091526|FG002|Overall Study|Other|0|||
42263657|NCT02135029|76091524|FG000|Overall Study|Death|0|||
42263658|NCT02135029|76091525|FG001|Overall Study|Death|1|||
42263659|NCT02135029|76091526|FG002|Overall Study|Death|0|||
42263660|NCT02842151|76091535|FG000|Overall Study|Adverse Event|1|||
42263661|NCT02842151|76091535|FG000|Overall Study|Subject moved too far away|1|||
42263662|NCT02842073|76091541|FG000|Overall Study|Withdrawal by Subject|1|||
42263663|NCT01367275|76091545|FG000|Overall Study|Ineligible|1|||
42263664|NCT01367275|76091545|FG000|Overall Study|Disease Progression|2|||
42263665|NCT02842853|76091553|FG000|Overall Study|Non-compliance with the protocol|3|||
42263666|NCT02842853|76091554|FG001|Overall Study|Non-compliance with the protocol|7|||
42263667|NCT02842853|76091555|FG002|Overall Study|Non-compliance with the protocol|2|||
42263668|NCT02842853|76091556|FG003|Overall Study|Non-compliance with the protocol|5|||
42263669|NCT02842853|76091553|FG000|Overall Study|Subject met exclusion criteria|0|||
42263670|NCT02842853|76091554|FG001|Overall Study|Subject met exclusion criteria|1|||
42332715|NCT01490632|76170284|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332716|NCT01490632|76170285|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332717|NCT01490632|76170286|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332718|NCT01490632|76170287|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332719|NCT01490632|76170288|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332720|NCT01490632|76170289|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332721|NCT01490632|76170290|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42263671|NCT02842853|76091555|FG002|Overall Study|Subject met exclusion criteria|0|||
42263672|NCT02842853|76091556|FG003|Overall Study|Subject met exclusion criteria|0|||
42263673|NCT02842853|76091553|FG000|Overall Study|Withdrawal by Subject|11|||
42263674|NCT02842853|76091554|FG001|Overall Study|Withdrawal by Subject|13|||
42263675|NCT02842853|76091555|FG002|Overall Study|Withdrawal by Subject|9|||
42263676|NCT02842853|76091556|FG003|Overall Study|Withdrawal by Subject|8|||
42263677|NCT02842853|76091553|FG000|Overall Study|Lost to Follow-up|9|||
42332722|NCT01490632|76170291|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
41999008|NCT01190930|75807262|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
41999009|NCT01190930|75807263|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
42263678|NCT02842853|76091554|FG001|Overall Study|Lost to Follow-up|13|||
42263679|NCT02842853|76091555|FG002|Overall Study|Lost to Follow-up|10|||
42263680|NCT02842853|76091556|FG003|Overall Study|Lost to Follow-up|11|||
42263681|NCT02433340|76091572|FG000|Overall Study|Adverse Event|0|||
42263682|NCT02433340|76091573|FG001|Overall Study|Adverse Event|0|||
42263683|NCT02433340|76091574|FG002|Overall Study|Adverse Event|1|||
42263684|NCT02433340|76091575|FG003|Overall Study|Adverse Event|0|||
42263685|NCT02433340|76091572|FG000|Overall Study|Withdrawal by Subject|1|||
42263686|NCT02433340|76091573|FG001|Overall Study|Withdrawal by Subject|0|||
42263687|NCT02433340|76091574|FG002|Overall Study|Withdrawal by Subject|1|||
42263688|NCT02433340|76091575|FG003|Overall Study|Withdrawal by Subject|2|||
42263689|NCT02433340|76091572|FG000|Overall Study|Lost to Follow-up|0|||
42263690|NCT02433340|76091573|FG001|Overall Study|Lost to Follow-up|1|||
42263691|NCT02433340|76091574|FG002|Overall Study|Lost to Follow-up|0|||
42263692|NCT02433340|76091575|FG003|Overall Study|Lost to Follow-up|0|||
42263693|NCT02433340|76091572|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
42332723|NCT01490632|76170292|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332724|NCT01490632|76170293|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332725|NCT01490632|76170294|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332726|NCT01490632|76170295|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
42332727|NCT01490632|76170296|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
42332728|NCT01490632|76170297|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
42332729|NCT01490632|76170298|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
42332730|NCT01490632|76170279|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332731|NCT01490632|76170280|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332732|NCT01490632|76170281|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332733|NCT01490632|76170282|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
41999010|NCT01190930|75807264|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
41999011|NCT01190930|75807265|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
41999012|NCT01190930|75807266|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
41999013|NCT01190930|75807267|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
41999014|NCT01190930|75807258|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
42263694|NCT02433340|76091573|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
42263695|NCT02433340|76091574|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
42263696|NCT02433340|76091575|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
42263697|NCT02433340|76091572|FG000|Overall Study|Other|0|||
42263698|NCT02433340|76091573|FG001|Overall Study|Other|1|||
42263699|NCT02433340|76091574|FG002|Overall Study|Other|0|||
42263700|NCT02433340|76091575|FG003|Overall Study|Other|0|||
42263701|NCT02400346|76091587|FG000|Overall Study|Adverse Event|24|||
42263702|NCT02400346|76091587|FG000|Overall Study|Lack of Efficacy|9|||
42263703|NCT02400346|76091587|FG000|Overall Study|Non-compliance with IMP|1|||
42263704|NCT02400346|76091587|FG000|Overall Study|Withdrawal by Subject|7|||
42263705|NCT02400346|76091587|FG000|Overall Study|Administrative or other reason(s)|2|||
42263706|NCT02400346|76091587|FG000|Overall Study|Lost to Follow-up|1|||
42263707|NCT02399254|76091591|FG000|Overall Study|Physician Decision|2|||
42263708|NCT02456662|76091598|FG000|Overall Study|Lost to Follow-up|2|||
42263709|NCT02456662|76091599|FG001|Overall Study|Lost to Follow-up|1|||
42263710|NCT01653262|76091605|FG000|Overall Study|Lack of Efficacy|1|||
42263711|NCT01653262|76091605|FG000|Overall Study|SAE, non-fatal|1|||
42263712|NCT01653262|76091605|FG000|Overall Study|AE, non-serious non-fatal|1|||
42263713|NCT02455336|76091611|FG000|Overall Study|Withdrawal by Subject|0|||
42263714|NCT02455336|76091612|FG001|Overall Study|Withdrawal by Subject|2|||
42263715|NCT02455336|76091611|FG000|Overall Study|Adverse Event|3|||
42332734|NCT01490632|76170283|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42263716|NCT02455336|76091612|FG001|Overall Study|Adverse Event|0|||
42263717|NCT02455336|76091611|FG000|Overall Study|Non-responder to treatment|2|||
42263718|NCT02455336|76091612|FG001|Overall Study|Non-responder to treatment|0|||
41999015|NCT01190930|75807259|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
41999016|NCT01190930|75807260|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
41999017|NCT01190930|75807261|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
41999018|NCT01190930|75807262|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
41999019|NCT01190930|75807263|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
41999020|NCT01190930|75807264|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
41999021|NCT01190930|75807265|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
41999022|NCT01190930|75807266|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
41999023|NCT01190930|75807267|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
41999024|NCT01190930|75807258|FG000|Post Induction Pre-Maintenance|Relapse|0|||
42263719|NCT04525703|76091639|FG000|Overall Study|Lost to Follow-up|6|||
42263720|NCT04525703|76091640|FG001|Overall Study|Lost to Follow-up|15|||
42263721|NCT04525703|76091641|FG002|Overall Study|Lost to Follow-up|8|||
41999025|NCT01190930|75807259|FG001|Post Induction Pre-Maintenance|Relapse|0|||
42263722|NCT04509076|76091654|FG000|Overall Study|Withdrawal by Subject|1|||
42263723|NCT04509076|76091655|FG001|Overall Study|Withdrawal by Subject|2|||
42263724|NCT04509076|76091654|FG000|Overall Study|Lost to Follow-up|1|||
42263725|NCT04509076|76091655|FG001|Overall Study|Lost to Follow-up|2|||
42263726|NCT04267614|76091669|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
42263727|NCT04267614|76091669|FG000|Overall Study|Lost to Follow-up|115|||
42263728|NCT03735680|76091680|FG000|Overall Study|Withdrawal by Subject|0|||
42263729|NCT03735680|76091681|FG001|Overall Study|Withdrawal by Subject|1|||
42263730|NCT03735680|76091682|FG002|Overall Study|Withdrawal by Subject|0|||
42263731|NCT03735680|76091683|FG003|Overall Study|Withdrawal by Subject|0|||
42263732|NCT03735680|76091684|FG004|Overall Study|Withdrawal by Subject|0|||
42263733|NCT03735680|76091685|FG005|Overall Study|Withdrawal by Subject|1|||
42263734|NCT03735680|76091680|FG000|Overall Study|Patient unable or unwilling to continue|0|||
42263735|NCT03735680|76091681|FG001|Overall Study|Patient unable or unwilling to continue|0|||
42263736|NCT03735680|76091682|FG002|Overall Study|Patient unable or unwilling to continue|1|||
42263737|NCT03735680|76091683|FG003|Overall Study|Patient unable or unwilling to continue|0|||
42263738|NCT03735680|76091684|FG004|Overall Study|Patient unable or unwilling to continue|0|||
42263739|NCT03735680|76091685|FG005|Overall Study|Patient unable or unwilling to continue|0|||
42263740|NCT03726658|76091721|FG000|Overall Study|Lost to Follow-up|0|||
42263741|NCT03726658|76091722|FG001|Overall Study|Lost to Follow-up|0|||
42263742|NCT03726658|76091723|FG002|Overall Study|Lost to Follow-up|2|||
42263743|NCT03726658|76091724|FG003|Overall Study|Lost to Follow-up|0|||
41999026|NCT01190930|75807260|FG002|Post Induction Pre-Maintenance|Relapse|1|||
41999027|NCT01190930|75807261|FG003|Post Induction Pre-Maintenance|Relapse|0|||
41999028|NCT01190930|75807262|FG004|Post Induction Pre-Maintenance|Relapse|0|||
41999029|NCT01190930|75807263|FG005|Post Induction Pre-Maintenance|Relapse|0|||
41999030|NCT01190930|75807264|FG006|Post Induction Pre-Maintenance|Relapse|0|||
41999031|NCT01190930|75807265|FG007|Post Induction Pre-Maintenance|Relapse|0|||
41999032|NCT01190930|75807266|FG008|Post Induction Pre-Maintenance|Relapse|0|||
41999033|NCT01190930|75807267|FG009|Post Induction Pre-Maintenance|Relapse|0|||
41999034|NCT01190930|75807258|FG000|Maintenance|Adverse Event|0|||
41999035|NCT01190930|75807259|FG001|Maintenance|Adverse Event|0|||
41999036|NCT01190930|75807260|FG002|Maintenance|Adverse Event|0|||
41999037|NCT01190930|75807261|FG003|Maintenance|Adverse Event|0|||
41999038|NCT01190930|75807262|FG004|Maintenance|Adverse Event|0|||
41999039|NCT01190930|75807263|FG005|Maintenance|Adverse Event|1|||
41999040|NCT01190930|75807264|FG006|Maintenance|Adverse Event|1|||
41999041|NCT01190930|75807265|FG007|Maintenance|Adverse Event|3|||
41999042|NCT01190930|75807266|FG008|Maintenance|Adverse Event|3|||
41999043|NCT01190930|75807267|FG009|Maintenance|Adverse Event|0|||
41999044|NCT01190930|75807258|FG000|Maintenance|Death|0|||
41999045|NCT01190930|75807259|FG001|Maintenance|Death|0|||
41999046|NCT01190930|75807260|FG002|Maintenance|Death|0|||
41999047|NCT01190930|75807261|FG003|Maintenance|Death|1|||
41999048|NCT01190930|75807262|FG004|Maintenance|Death|0|||
41999049|NCT01190930|75807263|FG005|Maintenance|Death|0|||
41999050|NCT01190930|75807264|FG006|Maintenance|Death|2|||
41999051|NCT01190930|75807265|FG007|Maintenance|Death|2|||
41999052|NCT01190930|75807266|FG008|Maintenance|Death|2|||
41999053|NCT01190930|75807267|FG009|Maintenance|Death|2|||
41999054|NCT01190930|75807258|FG000|Maintenance|Lost to Follow-up|0|||
41999055|NCT01190930|75807259|FG001|Maintenance|Lost to Follow-up|0|||
41999056|NCT01190930|75807260|FG002|Maintenance|Lost to Follow-up|0|||
41999057|NCT01190930|75807261|FG003|Maintenance|Lost to Follow-up|0|||
41999058|NCT01190930|75807262|FG004|Maintenance|Lost to Follow-up|0|||
41999059|NCT01190930|75807263|FG005|Maintenance|Lost to Follow-up|0|||
41999060|NCT01190930|75807264|FG006|Maintenance|Lost to Follow-up|1|||
41999061|NCT01190930|75807265|FG007|Maintenance|Lost to Follow-up|1|||
41999062|NCT01190930|75807266|FG008|Maintenance|Lost to Follow-up|1|||
41999063|NCT01190930|75807267|FG009|Maintenance|Lost to Follow-up|0|||
41999064|NCT01190930|75807258|FG000|Maintenance|Physician Decision|0|||
41999065|NCT01190930|75807259|FG001|Maintenance|Physician Decision|1|||
41999066|NCT01190930|75807260|FG002|Maintenance|Physician Decision|0|||
41999067|NCT01190930|75807261|FG003|Maintenance|Physician Decision|5|||
41999068|NCT01190930|75807262|FG004|Maintenance|Physician Decision|9|||
41999069|NCT01190930|75807263|FG005|Maintenance|Physician Decision|4|||
41999070|NCT01190930|75807264|FG006|Maintenance|Physician Decision|8|||
41999071|NCT01190930|75807265|FG007|Maintenance|Physician Decision|8|||
41999072|NCT01190930|75807266|FG008|Maintenance|Physician Decision|10|||
41999073|NCT01190930|75807267|FG009|Maintenance|Physician Decision|17|||
41999074|NCT01190930|75807258|FG000|Maintenance|Withdrawal by Subject|0|||
41999075|NCT01190930|75807259|FG001|Maintenance|Withdrawal by Subject|0|||
41999076|NCT01190930|75807260|FG002|Maintenance|Withdrawal by Subject|0|||
41999077|NCT01190930|75807261|FG003|Maintenance|Withdrawal by Subject|0|||
41999078|NCT01190930|75807262|FG004|Maintenance|Withdrawal by Subject|0|||
41999079|NCT01190930|75807263|FG005|Maintenance|Withdrawal by Subject|0|||
41999080|NCT01190930|75807264|FG006|Maintenance|Withdrawal by Subject|2|||
41999081|NCT01190930|75807265|FG007|Maintenance|Withdrawal by Subject|1|||
41999082|NCT01190930|75807266|FG008|Maintenance|Withdrawal by Subject|4|||
41999083|NCT01190930|75807267|FG009|Maintenance|Withdrawal by Subject|1|||
41999084|NCT01190930|75807258|FG000|Maintenance|Refusal|0|||
41999085|NCT01190930|75807259|FG001|Maintenance|Refusal|1|||
41999086|NCT01190930|75807260|FG002|Maintenance|Refusal|0|||
41999087|NCT01190930|75807261|FG003|Maintenance|Refusal|2|||
41999088|NCT01190930|75807262|FG004|Maintenance|Refusal|0|||
41999089|NCT01190930|75807263|FG005|Maintenance|Refusal|4|||
41999090|NCT01190930|75807264|FG006|Maintenance|Refusal|5|||
41999091|NCT01190930|75807265|FG007|Maintenance|Refusal|17|||
41999092|NCT01190930|75807266|FG008|Maintenance|Refusal|13|||
42263744|NCT03726658|76091725|FG004|Overall Study|Lost to Follow-up|0|||
41999093|NCT01190930|75807267|FG009|Maintenance|Refusal|6|||
41999094|NCT01190930|75807258|FG000|Maintenance|second malignant neoplasm|0|||
42263745|NCT03726658|76091726|FG005|Overall Study|Lost to Follow-up|1|||
42263746|NCT03726658|76091727|FG006|Overall Study|Lost to Follow-up|1|||
42263747|NCT03726658|76091721|FG000|Overall Study|Withdrawal by Subject|1|||
42263748|NCT03726658|76091722|FG001|Overall Study|Withdrawal by Subject|0|||
42263749|NCT03726658|76091723|FG002|Overall Study|Withdrawal by Subject|0|||
42263750|NCT03726658|76091724|FG003|Overall Study|Withdrawal by Subject|0|||
42263751|NCT03726658|76091725|FG004|Overall Study|Withdrawal by Subject|6|||
42263752|NCT03726658|76091726|FG005|Overall Study|Withdrawal by Subject|4|||
42263753|NCT03726658|76091727|FG006|Overall Study|Withdrawal by Subject|2|||
42263754|NCT03726658|76091721|FG000|Overall Study|Pregnancy|0|||
42263755|NCT03726658|76091722|FG001|Overall Study|Pregnancy|0|||
42263756|NCT03726658|76091723|FG002|Overall Study|Pregnancy|0|||
42263757|NCT03726658|76091724|FG003|Overall Study|Pregnancy|0|||
42263758|NCT03726658|76091725|FG004|Overall Study|Pregnancy|0|||
42263759|NCT03726658|76091726|FG005|Overall Study|Pregnancy|0|||
42263760|NCT03726658|76091727|FG006|Overall Study|Pregnancy|1|||
42263761|NCT03726658|76091721|FG000|Overall Study|Not Reported|0|||
41999095|NCT01190930|75807259|FG001|Maintenance|second malignant neoplasm|0|||
41999096|NCT01190930|75807260|FG002|Maintenance|second malignant neoplasm|0|||
41999097|NCT01190930|75807261|FG003|Maintenance|second malignant neoplasm|1|||
41999098|NCT01190930|75807262|FG004|Maintenance|second malignant neoplasm|0|||
41999099|NCT01190930|75807263|FG005|Maintenance|second malignant neoplasm|1|||
41999100|NCT01190930|75807264|FG006|Maintenance|second malignant neoplasm|0|||
41999101|NCT01190930|75807265|FG007|Maintenance|second malignant neoplasm|0|||
42332735|NCT01490632|76170284|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332736|NCT01490632|76170285|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332737|NCT01490632|76170286|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332738|NCT01490632|76170287|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332739|NCT01490632|76170288|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332740|NCT01490632|76170289|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332741|NCT01490632|76170290|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332742|NCT01490632|76170291|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332743|NCT01490632|76170292|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332744|NCT01490632|76170293|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332745|NCT01490632|76170294|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332746|NCT01490632|76170295|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332747|NCT01490632|76170296|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332748|NCT01490632|76170297|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
42332749|NCT01490632|76170298|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
42332750|NCT01490632|76170279|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
42332751|NCT01490632|76170280|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
41999102|NCT01190930|75807266|FG008|Maintenance|second malignant neoplasm|1|||
41999103|NCT01190930|75807267|FG009|Maintenance|second malignant neoplasm|0|||
41999104|NCT01190930|75807258|FG000|Maintenance|Inevaluable|0|||
41999105|NCT01190930|75807259|FG001|Maintenance|Inevaluable|0|||
41999106|NCT01190930|75807260|FG002|Maintenance|Inevaluable|0|||
41999107|NCT01190930|75807261|FG003|Maintenance|Inevaluable|0|||
41999108|NCT01190930|75807262|FG004|Maintenance|Inevaluable|0|||
41999109|NCT01190930|75807263|FG005|Maintenance|Inevaluable|1|||
41999110|NCT01190930|75807264|FG006|Maintenance|Inevaluable|1|||
42332752|NCT01490632|76170281|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
41999111|NCT01190930|75807265|FG007|Maintenance|Inevaluable|1|||
41999112|NCT01190930|75807266|FG008|Maintenance|Inevaluable|0|||
41999113|NCT01190930|75807267|FG009|Maintenance|Inevaluable|0|||
42134267|NCT00313144|75945082|FG000|Overall Study|Adverse event - transient|5|||
42263762|NCT03726658|76091722|FG001|Overall Study|Not Reported|0|||
42263763|NCT03726658|76091723|FG002|Overall Study|Not Reported|0|||
42263764|NCT03726658|76091724|FG003|Overall Study|Not Reported|0|||
42263765|NCT03726658|76091725|FG004|Overall Study|Not Reported|0|||
42263766|NCT03726658|76091726|FG005|Overall Study|Not Reported|0|||
42263767|NCT03726658|76091727|FG006|Overall Study|Not Reported|1|||
42263768|NCT03062358|76091796|FG000|Overall Study|Death|220|||
42263769|NCT03062358|76091797|FG001|Overall Study|Death|127|||
42263770|NCT03062358|76091796|FG000|Overall Study|Withdrawal by Subject|2|||
42263771|NCT03062358|76091797|FG001|Overall Study|Withdrawal by Subject|1|||
42263772|NCT03062358|76091796|FG000|Overall Study|Ongoing in Trial|78|||
42263773|NCT03062358|76091797|FG001|Overall Study|Ongoing in Trial|25|||
42263774|NCT02706873|76091808|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
42263775|NCT02706873|76091809|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
42263776|NCT02706873|76091810|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
42263777|NCT02706873|76091811|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
42332753|NCT01490632|76170282|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
42134268|NCT00313144|75945082|FG000|Overall Study|Liver transplant|1|||
42263778|NCT02706873|76091808|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
41999114|NCT01190930|75807258|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
42263779|NCT02706873|76091809|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
42263780|NCT02706873|76091810|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
42332754|NCT01490632|76170283|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
41999115|NCT01190930|75807259|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
41999116|NCT01190930|75807260|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
41999117|NCT01190930|75807261|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
41999118|NCT01190930|75807262|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
41999119|NCT01190930|75807263|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
42332755|NCT01490632|76170284|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
42332756|NCT01490632|76170285|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
42332757|NCT01490632|76170286|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
42332758|NCT01490632|76170287|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
42332759|NCT01490632|76170288|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
42332760|NCT01490632|76170289|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
42332761|NCT01490632|76170290|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
42332762|NCT01490632|76170291|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
42332763|NCT01490632|76170292|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
42332764|NCT01490632|76170293|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
42332765|NCT01490632|76170294|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
42332766|NCT01490632|76170295|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
42332767|NCT01490632|76170296|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
42332768|NCT01490632|76170297|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
42332769|NCT01490632|76170298|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
42332770|NCT01490632|76170279|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
42332771|NCT01490632|76170280|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
41999120|NCT01190930|75807264|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
42332772|NCT01490632|76170281|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
42332773|NCT01490632|76170282|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
42332774|NCT01490632|76170283|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
42332775|NCT01490632|76170284|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
42332776|NCT01490632|76170285|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
42332777|NCT01490632|76170286|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
42332778|NCT01490632|76170287|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
42332779|NCT01490632|76170288|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
42332780|NCT01490632|76170289|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
42332781|NCT01490632|76170290|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
42332782|NCT01490632|76170291|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
42332783|NCT01490632|76170292|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
42332784|NCT01490632|76170293|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
42332785|NCT01490632|76170294|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
42332786|NCT01490632|76170295|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
42332787|NCT01490632|76170296|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
42332788|NCT01490632|76170297|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
42332789|NCT01490632|76170298|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
42332790|NCT01490632|76170279|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332791|NCT01490632|76170280|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332792|NCT01490632|76170281|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332793|NCT01490632|76170282|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42263781|NCT02706873|76091811|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
42263782|NCT02706873|76091808|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
42263783|NCT02706873|76091809|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
42263784|NCT02706873|76091810|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
42263785|NCT02706873|76091811|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
42263786|NCT02706873|76091808|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
42263787|NCT02706873|76091809|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
42263788|NCT02706873|76091810|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
42263789|NCT02706873|76091811|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
42263790|NCT02706873|76091808|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
42263791|NCT02706873|76091809|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
42263792|NCT02706873|76091810|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
42263793|NCT02706873|76091811|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
42332794|NCT01490632|76170283|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332795|NCT01490632|76170284|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332796|NCT01490632|76170285|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
41999121|NCT01190930|75807265|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
41999122|NCT01190930|75807266|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
42263794|NCT02706873|76091808|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
42263795|NCT02706873|76091809|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
42263796|NCT02706873|76091810|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
42263797|NCT02706873|76091811|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
42263798|NCT02706873|76091808|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
42263799|NCT02706873|76091809|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
42263800|NCT02706873|76091810|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
42263801|NCT02706873|76091811|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
42332797|NCT01490632|76170286|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332798|NCT01490632|76170287|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332799|NCT01490632|76170288|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332800|NCT01490632|76170289|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332801|NCT01490632|76170290|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332802|NCT01490632|76170291|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332803|NCT01490632|76170292|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332804|NCT01490632|76170293|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332805|NCT01490632|76170294|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332806|NCT01490632|76170295|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
42332807|NCT01490632|76170296|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
42332808|NCT01490632|76170297|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
42332809|NCT01490632|76170298|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
42332810|NCT02073643|76170341|FG000|Overall Study|Lost to Follow-up|24|||
42332811|NCT01451554|76170347|FG000|Overall Study|Withdrawal by Subject|14|||
42263802|NCT02706873|76091808|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
42263803|NCT02706873|76091809|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
41999123|NCT01190930|75807267|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
41999124|NCT01190930|75807258|FG000|Maintenance|Relapse|0|||
42263804|NCT02706873|76091810|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
42263805|NCT02706873|76091811|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
42332812|NCT01451554|76170348|FG001|Overall Study|Withdrawal by Subject|9|||
42332813|NCT01474486|76170354|FG000|Overall Study|Death|2|||
42332814|NCT01474486|76170354|FG000|Overall Study|Withdrawal by Subject|4|||
42332815|NCT01474486|76170354|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
42332816|NCT01451398|76170364|FG000|Overall Study|Adverse Event|7|||
42332817|NCT01451398|76170365|FG001|Overall Study|Adverse Event|9|||
42332818|NCT01451398|76170364|FG000|Overall Study|Protocol Violation|1|||
42332819|NCT01451398|76170365|FG001|Overall Study|Protocol Violation|2|||
42332820|NCT01451398|76170364|FG000|Overall Study|Physician Decision|1|||
42332821|NCT01451398|76170365|FG001|Overall Study|Physician Decision|1|||
42332822|NCT01451398|76170364|FG000|Overall Study|Withdrawal by Subject|10|||
42332823|NCT01451398|76170365|FG001|Overall Study|Withdrawal by Subject|14|||
42332824|NCT01451398|76170364|FG000|Overall Study|Lost to Follow-up|6|||
42332825|NCT01451398|76170365|FG001|Overall Study|Lost to Follow-up|4|||
42332826|NCT01451398|76170364|FG000|Overall Study|Non-compliance with study drug|1|||
42332827|NCT01451398|76170365|FG001|Overall Study|Non-compliance with study drug|3|||
42332828|NCT01451398|76170364|FG000|Overall Study|Non-compliance with protocol|1|||
42332829|NCT01451398|76170365|FG001|Overall Study|Non-compliance with protocol|1|||
42332830|NCT01451398|76170364|FG000|Overall Study|Moved out of country|0|||
42332831|NCT01451398|76170365|FG001|Overall Study|Moved out of country|1|||
42332832|NCT01451398|76170364|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
42332833|NCT01451398|76170365|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
42332834|NCT01451398|76170364|FG000|Overall Study|Lack of Efficacy|0|||
42332835|NCT01451398|76170365|FG001|Overall Study|Lack of Efficacy|1|||
42332836|NCT02073565|76170373|FG000|Cohort A|Withdrawal by Subject|1|||
42332837|NCT02073565|76170374|FG001|Cohort A|Withdrawal by Subject|0|||
42332838|NCT02073565|76170373|FG000|Cohort B|Withdrawal by Subject|1|||
42332839|NCT02073565|76170374|FG001|Cohort B|Withdrawal by Subject|2|||
42332840|NCT02073565|76170373|FG000|Cohort C|Withdrawal by Subject|0|||
42332841|NCT02073565|76170374|FG001|Cohort C|Withdrawal by Subject|2|||
42332842|NCT02073565|76170373|FG000|Cohort C|Lost to Follow-up|0|||
42332843|NCT02073565|76170374|FG001|Cohort C|Lost to Follow-up|2|||
42332844|NCT02072941|76170382|FG000|Overall Study|Withdrawal by Subject|29|||
42332845|NCT02072941|76170383|FG001|Overall Study|Withdrawal by Subject|21|||
42332846|NCT02072941|76170382|FG000|Overall Study|Lost to Follow-up|4|||
42332847|NCT02072941|76170383|FG001|Overall Study|Lost to Follow-up|4|||
42332848|NCT02072941|76170382|FG000|Overall Study|Death|3|||
42332849|NCT02072941|76170383|FG001|Overall Study|Death|2|||
42332850|NCT02072941|76170382|FG000|Overall Study|Removed by Study Staff|2|||
42332851|NCT02072941|76170383|FG001|Overall Study|Removed by Study Staff|2|||
42332852|NCT02100631|76170392|FG000|Overall Study|Withdrawal by Subject|1|||
42332853|NCT02100631|76170393|FG001|Overall Study|Withdrawal by Subject|0|||
42332854|NCT02100631|76170394|FG002|Overall Study|Withdrawal by Subject|0|||
41999125|NCT01190930|75807259|FG001|Maintenance|Relapse|0|||
42263806|NCT02706873|76091808|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
42263807|NCT02706873|76091809|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
42263808|NCT02706873|76091810|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
42263809|NCT02706873|76091811|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
42263810|NCT02706873|76091808|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
42263811|NCT02706873|76091809|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
42332855|NCT02100631|76170392|FG000|Overall Study|Lost to Follow-up|3|||
42332856|NCT02100631|76170393|FG001|Overall Study|Lost to Follow-up|4|||
42332857|NCT02100631|76170394|FG002|Overall Study|Lost to Follow-up|0|||
42332858|NCT02100631|76170392|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
42332859|NCT02100631|76170393|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
42332860|NCT02100631|76170394|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
42332861|NCT01451164|76170406|FG000|Overall Study|Adverse Event|19|||
42263812|NCT02706873|76091810|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
42332862|NCT01451164|76170407|FG001|Overall Study|Adverse Event|12|||
41999126|NCT01190930|75807260|FG002|Maintenance|Relapse|0|||
42263813|NCT02706873|76091811|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
42263814|NCT02706873|76091808|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
42332863|NCT01451164|76170408|FG002|Overall Study|Adverse Event|18|||
42332864|NCT01451164|76170409|FG003|Overall Study|Adverse Event|21|||
42332865|NCT01451164|76170406|FG000|Overall Study|Withdrawal Criteria|1|||
42332866|NCT01451164|76170407|FG001|Overall Study|Withdrawal Criteria|1|||
42332867|NCT01451164|76170408|FG002|Overall Study|Withdrawal Criteria|1|||
42332868|NCT01451164|76170409|FG003|Overall Study|Withdrawal Criteria|1|||
42332869|NCT01451164|76170406|FG000|Overall Study|Physician Decision|2|||
42332870|NCT01451164|76170407|FG001|Overall Study|Physician Decision|0|||
42332871|NCT01451164|76170408|FG002|Overall Study|Physician Decision|1|||
42332872|NCT01451164|76170409|FG003|Overall Study|Physician Decision|0|||
42332873|NCT01451164|76170406|FG000|Overall Study|Withdrawal by Subject|14|||
42332874|NCT01451164|76170407|FG001|Overall Study|Withdrawal by Subject|11|||
42332875|NCT01451164|76170408|FG002|Overall Study|Withdrawal by Subject|16|||
42332876|NCT01451164|76170409|FG003|Overall Study|Withdrawal by Subject|17|||
42332877|NCT01451164|76170406|FG000|Overall Study|Protocol Violation|0|||
42332878|NCT01451164|76170407|FG001|Overall Study|Protocol Violation|1|||
42332879|NCT01451164|76170408|FG002|Overall Study|Protocol Violation|0|||
42332880|NCT01451164|76170409|FG003|Overall Study|Protocol Violation|0|||
42332881|NCT01451164|76170406|FG000|Overall Study|Lack of Efficacy|7|||
42332882|NCT01451164|76170407|FG001|Overall Study|Lack of Efficacy|9|||
42332883|NCT01451164|76170408|FG002|Overall Study|Lack of Efficacy|9|||
42332884|NCT01451164|76170409|FG003|Overall Study|Lack of Efficacy|7|||
42332885|NCT02071849|76170419|FG000|6-month Primary Endpoint|Did not receive device|4|||
42332886|NCT02071849|76170419|FG000|6-month Primary Endpoint|Adverse Event|1|||
42332887|NCT02071849|76170419|FG000|2-year Extended Follow-up|Adverse Event|1|||
42332888|NCT02071771|76170423|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
42332889|NCT02071771|76170424|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
42332890|NCT02071771|76170423|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
42332891|NCT02071771|76170424|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
42332892|NCT02071225|76170430|FG000|Overall Study|Withdrawal of Consent|2|||
42332893|NCT02071225|76170430|FG000|Overall Study|Protocol Deviation|1|||
42332894|NCT02071225|76170430|FG000|Overall Study|Lost to Follow-up|2|||
42332895|NCT02071225|76170430|FG000|Overall Study|Death|25|||
42332896|NCT01450696|76170436|FG000|Overall Study|Never Treated|1|||
42263815|NCT02706873|76091809|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
42263816|NCT02706873|76091810|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
42263817|NCT02706873|76091811|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
42263818|NCT02706873|76091808|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
42263819|NCT02706873|76091809|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
42263820|NCT02706873|76091810|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
42263821|NCT02706873|76091811|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
42263822|NCT02706873|76091808|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
42332897|NCT01450696|76170437|FG001|Overall Study|Never Treated|1|||
42332898|NCT01450696|76170436|FG000|Overall Study|Death|77|||
42332899|NCT01450696|76170437|FG001|Overall Study|Death|84|||
42134269|NCT00313144|75945082|FG000|Overall Study|Insurance (homecare provider) change|1|||
42134270|NCT00313144|75945082|FG000|Overall Study|Change to different product|1|||
42263823|NCT02706873|76091809|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
42263824|NCT02706873|76091810|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
42263825|NCT02706873|76091811|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
42332900|NCT01450696|76170436|FG000|Overall Study|Lost to Follow-up|3|||
42332901|NCT01450696|76170437|FG001|Overall Study|Lost to Follow-up|3|||
42332902|NCT01450696|76170436|FG000|Overall Study|Non-Compliance|1|||
42332903|NCT01450696|76170437|FG001|Overall Study|Non-Compliance|0|||
42332904|NCT01450696|76170436|FG000|Overall Study|Withdrawal by Subject|13|||
42332905|NCT01450696|76170437|FG001|Overall Study|Withdrawal by Subject|2|||
42332906|NCT01450696|76170436|FG000|Overall Study|Study Terminated by Sponsor|53|||
42332907|NCT01450696|76170437|FG001|Overall Study|Study Terminated by Sponsor|58|||
41999127|NCT01190930|75807261|FG003|Maintenance|Relapse|2|||
42263826|NCT02584634|76091834|FG000|Overall Study|Adverse Event|3|||
42263827|NCT02584634|76091835|FG001|Overall Study|Adverse Event|5|||
42263828|NCT02584634|76091834|FG000|Overall Study|Death|0|||
42263829|NCT02584634|76091835|FG001|Overall Study|Death|1|||
42263830|NCT02584634|76091834|FG000|Overall Study|Lost to Follow-up|0|||
42263831|NCT02584634|76091835|FG001|Overall Study|Lost to Follow-up|1|||
42332908|NCT02070991|76170445|FG000|Overall Study|Death|2|||
42332909|NCT02070991|76170446|FG001|Overall Study|Death|0|||
42332910|NCT02070991|76170445|FG000|Overall Study|Withdrawal by Subject|1|||
42332911|NCT02070991|76170446|FG001|Overall Study|Withdrawal by Subject|0|||
42332912|NCT02114515|76170454|FG000|Overall Study|Lost to Follow-up|52|||
42332913|NCT02114515|76170455|FG001|Overall Study|Lost to Follow-up|55|||
42332914|NCT02114515|76170454|FG000|Overall Study|Death|12|||
42332915|NCT02114515|76170455|FG001|Overall Study|Death|12|||
42332916|NCT02114515|76170454|FG000|Overall Study|Withdrawal by Subject|4|||
42332917|NCT02114515|76170455|FG001|Overall Study|Withdrawal by Subject|22|||
42332918|NCT02114515|76170454|FG000|Overall Study|Other|65|||
42332919|NCT02114515|76170455|FG001|Overall Study|Other|61|||
42332920|NCT01490086|76170466|FG000|Overall Study|Consent withdrawn|4|||
42332921|NCT01490086|76170467|FG001|Overall Study|Consent withdrawn|4|||
42332922|NCT01490086|76170468|FG002|Overall Study|Consent withdrawn|3|||
42332923|NCT01490086|76170469|FG003|Overall Study|Consent withdrawn|0|||
42332924|NCT01490086|76170470|FG004|Overall Study|Consent withdrawn|1|||
42332925|NCT01490086|76170466|FG000|Overall Study|Non-compliance|0|||
42332926|NCT01490086|76170467|FG001|Overall Study|Non-compliance|1|||
42332927|NCT01490086|76170468|FG002|Overall Study|Non-compliance|0|||
42332928|NCT01490086|76170469|FG003|Overall Study|Non-compliance|0|||
42332929|NCT01490086|76170470|FG004|Overall Study|Non-compliance|0|||
42332930|NCT01490086|76170466|FG000|Overall Study|Abnormal laboratory findings|1|||
42332931|NCT01490086|76170467|FG001|Overall Study|Abnormal laboratory findings|0|||
42332932|NCT01490086|76170468|FG002|Overall Study|Abnormal laboratory findings|0|||
42332933|NCT01490086|76170469|FG003|Overall Study|Abnormal laboratory findings|0|||
42332934|NCT01490086|76170470|FG004|Overall Study|Abnormal laboratory findings|0|||
42332935|NCT01490086|76170466|FG000|Overall Study|Lost to Follow-up|0|||
42332936|NCT01490086|76170467|FG001|Overall Study|Lost to Follow-up|0|||
42332937|NCT01490086|76170468|FG002|Overall Study|Lost to Follow-up|0|||
42332938|NCT01490086|76170469|FG003|Overall Study|Lost to Follow-up|0|||
42332939|NCT01490086|76170470|FG004|Overall Study|Lost to Follow-up|1|||
42332940|NCT01490086|76170466|FG000|Overall Study|Physician Decision|3|||
42332941|NCT01490086|76170467|FG001|Overall Study|Physician Decision|4|||
42332942|NCT01490086|76170468|FG002|Overall Study|Physician Decision|2|||
42332943|NCT01490086|76170469|FG003|Overall Study|Physician Decision|3|||
42332944|NCT01490086|76170470|FG004|Overall Study|Physician Decision|1|||
42332945|NCT01490086|76170466|FG000|Overall Study|Adverse Event|0|||
42332946|NCT01490086|76170467|FG001|Overall Study|Adverse Event|0|||
42332947|NCT01490086|76170468|FG002|Overall Study|Adverse Event|1|||
42332948|NCT01490086|76170469|FG003|Overall Study|Adverse Event|2|||
42332949|NCT01490086|76170470|FG004|Overall Study|Adverse Event|0|||
42332950|NCT01490086|76170466|FG000|Overall Study|Lack of Efficacy|0|||
42332951|NCT01490086|76170467|FG001|Overall Study|Lack of Efficacy|3|||
42332952|NCT01490086|76170468|FG002|Overall Study|Lack of Efficacy|1|||
42332953|NCT01490086|76170469|FG003|Overall Study|Lack of Efficacy|0|||
42332954|NCT01490086|76170470|FG004|Overall Study|Lack of Efficacy|8|||
41999128|NCT01190930|75807262|FG004|Maintenance|Relapse|0|||
42263832|NCT02584634|76091834|FG000|Overall Study|Physician Decision|1|||
42263833|NCT02584634|76091835|FG001|Overall Study|Physician Decision|2|||
42263834|NCT02584634|76091834|FG000|Overall Study|Progressive disease|7|||
42263835|NCT02584634|76091835|FG001|Overall Study|Progressive disease|15|||
42332955|NCT01490086|76170466|FG000|Overall Study|Worsening of symptoms|0|||
42332956|NCT01490086|76170467|FG001|Overall Study|Worsening of symptoms|1|||
42332957|NCT01490086|76170468|FG002|Overall Study|Worsening of symptoms|0|||
42332958|NCT01490086|76170469|FG003|Overall Study|Worsening of symptoms|1|||
42332959|NCT01490086|76170470|FG004|Overall Study|Worsening of symptoms|0|||
42332960|NCT01490086|76170466|FG000|Overall Study|Subject uncontrollable and abusive|0|||
41999129|NCT01190930|75807263|FG005|Maintenance|Relapse|1|||
42263836|NCT02584634|76091834|FG000|Overall Study|Withdrawal by Subject|1|||
42332961|NCT01490086|76170467|FG001|Overall Study|Subject uncontrollable and abusive|1|||
42332962|NCT01490086|76170468|FG002|Overall Study|Subject uncontrollable and abusive|0|||
42332963|NCT01490086|76170469|FG003|Overall Study|Subject uncontrollable and abusive|0|||
42332964|NCT01490086|76170470|FG004|Overall Study|Subject uncontrollable and abusive|0|||
41999130|NCT01190930|75807264|FG006|Maintenance|Relapse|6|||
41999131|NCT01190930|75807265|FG007|Maintenance|Relapse|13|||
41999132|NCT01190930|75807266|FG008|Maintenance|Relapse|11|||
41999133|NCT01190930|75807267|FG009|Maintenance|Relapse|11|||
41999134|NCT01190930|75807258|FG000|Maintenance|Still on therapy|0|||
41999135|NCT01190930|75807259|FG001|Maintenance|Still on therapy|8|||
41999136|NCT01190930|75807260|FG002|Maintenance|Still on therapy|0|||
41999137|NCT01190930|75807261|FG003|Maintenance|Still on therapy|29|||
41999138|NCT01190930|75807262|FG004|Maintenance|Still on therapy|0|||
41999139|NCT01190930|75807263|FG005|Maintenance|Still on therapy|0|||
41999140|NCT01190930|75807264|FG006|Maintenance|Still on therapy|0|||
41999141|NCT01190930|75807265|FG007|Maintenance|Still on therapy|0|||
41999142|NCT01190930|75807266|FG008|Maintenance|Still on therapy|0|||
42332965|NCT01490086|76170466|FG000|Overall Study|Subject left hospital|0|||
42332966|NCT01490086|76170467|FG001|Overall Study|Subject left hospital|1|||
42332967|NCT01490086|76170468|FG002|Overall Study|Subject left hospital|0|||
42332968|NCT01490086|76170469|FG003|Overall Study|Subject left hospital|1|||
42332969|NCT01490086|76170470|FG004|Overall Study|Subject left hospital|0|||
42332970|NCT02114203|76170485|FG000|Overall Study|Adverse Event|0|||
42332971|NCT02114203|76170486|FG001|Overall Study|Adverse Event|1|||
42332972|NCT02114203|76170487|FG002|Overall Study|Adverse Event|0|||
42332973|NCT02114203|76170485|FG000|Overall Study|Withdrawal by Subject|0|||
42332974|NCT02114203|76170486|FG001|Overall Study|Withdrawal by Subject|1|||
42332975|NCT02114203|76170487|FG002|Overall Study|Withdrawal by Subject|0|||
42332976|NCT02113579|76170497|FG000|Overall Study|Adverse Event|1|||
42332977|NCT02113579|76170498|FG001|Overall Study|Adverse Event|0|||
42332978|NCT02113579|76170497|FG000|Overall Study|Withdrawal by Subject|3|||
42332979|NCT02113579|76170498|FG001|Overall Study|Withdrawal by Subject|2|||
42332980|NCT02113579|76170497|FG000|Overall Study|Lost to Follow-up|6|||
42332981|NCT02113579|76170498|FG001|Overall Study|Lost to Follow-up|2|||
41999143|NCT01190930|75807267|FG009|Maintenance|Still on therapy|0|||
41999144|NCT01163682|75807316|FG000|Overall Study|Lost to Follow-up|6|||
41999145|NCT01163682|75807317|FG001|Overall Study|Lost to Follow-up|9|||
42134271|NCT00313144|75945082|FG000|Overall Study|Due to termination of the study|66|||
42134272|NCT00459108|75945095|FG000|Overall Study|Withdrawal by Subject|5|||
42134273|NCT00459108|75945095|FG000|Overall Study|Adverse Event|3|||
42134274|NCT00459108|75945095|FG000|Overall Study|Death|2|||
42134275|NCT00459108|75945095|FG000|Overall Study|Progression|1|||
42134276|NCT00458484|75945107|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
42263837|NCT02584634|76091835|FG001|Overall Study|Withdrawal by Subject|1|||
42263838|NCT02584634|76091834|FG000|Overall Study|Other|0|||
42263839|NCT02584634|76091835|FG001|Overall Study|Other|6|||
42263840|NCT01275729|76091849|FG000|Overall Study|Death|3|||
42263841|NCT01275729|76091849|FG000|Overall Study|Withdrawal by Subject|1|||
42263842|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
42263843|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
42263844|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
42332982|NCT01474018|76170506|FG000|Overall Study|Lost to Follow-up|0|||
42332983|NCT01474018|76170507|FG001|Overall Study|Lost to Follow-up|1|||
42263845|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
42134277|NCT00458484|75945108|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
42263846|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Adverse Event|198|||
42332984|NCT01474018|76170506|FG000|Overall Study|Withdrawal by Subject|0|||
42332985|NCT01474018|76170507|FG001|Overall Study|Withdrawal by Subject|2|||
42332986|NCT02100475|76170515|FG000|Overall Study|Unclassified|1|||
42332987|NCT02100475|76170516|FG001|Overall Study|Unclassified|2|||
42332988|NCT02100475|76170515|FG000|Overall Study|Withdrawal criteria|1|||
42332989|NCT02100475|76170516|FG001|Overall Study|Withdrawal criteria|0|||
42332990|NCT02113189|76170525|FG000|Overall Study|Lost to follow up|2|||
42332991|NCT02113189|76170526|FG001|Overall Study|Lost to follow up|1|||
42332992|NCT02113189|76170527|FG002|Overall Study|Lost to follow up|3|||
42332993|NCT01440946|76170540|FG000|Overall Study|Lost to Follow-up|1|||
42332994|NCT01440946|76170541|FG001|Overall Study|Lost to Follow-up|1|||
42332995|NCT01440946|76170540|FG000|Overall Study|Physician Decision|1|||
42332996|NCT01440946|76170541|FG001|Overall Study|Physician Decision|0|||
42332997|NCT01450540|76170550|FG000|Overall Study|Withdrawal by Subject|19|||
42332998|NCT01450540|76170551|FG001|Overall Study|Withdrawal by Subject|13|||
42332999|NCT01450540|76170550|FG000|Overall Study|protocol deviation|3|||
42333000|NCT01450540|76170551|FG001|Overall Study|protocol deviation|23|||
42333001|NCT02070757|76170561|FG000|Overall Study|Adverse Event|107|||
42333002|NCT02070757|76170562|FG001|Overall Study|Adverse Event|99|||
42333003|NCT02070757|76170561|FG000|Overall Study|Lost to Follow-up|7|||
42333004|NCT02070757|76170562|FG001|Overall Study|Lost to Follow-up|4|||
42333005|NCT02070757|76170561|FG000|Overall Study|Protocol Violation|0|||
42333006|NCT02070757|76170562|FG001|Overall Study|Protocol Violation|4|||
42333007|NCT02070757|76170561|FG000|Overall Study|Withdrawal by Subject|1|||
42333008|NCT02070757|76170562|FG001|Overall Study|Withdrawal by Subject|3|||
42333009|NCT02070757|76170561|FG000|Overall Study|Investigator Decision|0|||
41999146|NCT01047007|75807327|FG000|Overall Study|Adverse Event|0|||
41999147|NCT01047007|75807328|FG001|Overall Study|Adverse Event|2|||
41999148|NCT01047007|75807329|FG002|Overall Study|Adverse Event|1|||
41999149|NCT01047007|75807330|FG003|Overall Study|Adverse Event|0|||
41999150|NCT01047007|75807327|FG000|Overall Study|Progressive Disease|2|||
42134278|NCT00458484|75945109|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
42134279|NCT00458484|75945110|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
42263847|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Adverse Event|0|||
42333010|NCT02070757|76170562|FG001|Overall Study|Investigator Decision|2|||
42333011|NCT02070757|76170561|FG000|Overall Study|Discharged from Study Hospital|2|||
42333012|NCT02070757|76170562|FG001|Overall Study|Discharged from Study Hospital|2|||
42333013|NCT02100319|76170568|FG000|Overall Study|Case Report Forms Uncollected|11|||
42333014|NCT02100319|76170568|FG000|Overall Study|Protocol Deviation|5|||
42333015|NCT01625845|76170574|FG000|Overall Study|Adverse Event|1|||
42333016|NCT01625845|76170575|FG001|Overall Study|Adverse Event|2|||
42333017|NCT01625845|76170574|FG000|Overall Study|Lost to Follow-up|2|||
41999151|NCT01047007|75807328|FG001|Overall Study|Progressive Disease|4|||
42134280|NCT00458484|75945111|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
42263848|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Adverse Event|0|||
42263849|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Adverse Event|0|||
42263850|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Death|62|||
42263851|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Death|0|||
42263852|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Death|0|||
42263853|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Death|0|||
42263854|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
42263855|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
42263856|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
42263857|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
42263858|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Complicating disease|13|||
42263859|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Complicating disease|0|||
42263860|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Complicating disease|0|||
42263861|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Complicating disease|0|||
42263862|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
42333018|NCT01625845|76170575|FG001|Overall Study|Lost to Follow-up|1|||
42333019|NCT01625845|76170574|FG000|Overall Study|Withdrawal by Subject|2|||
42333020|NCT01625845|76170575|FG001|Overall Study|Withdrawal by Subject|0|||
42333021|NCT01473940|76170585|FG000|Induction Therapy|Death|0|||
42333022|NCT01473940|76170586|FG001|Induction Therapy|Death|0|||
42333023|NCT01473940|76170587|FG002|Induction Therapy|Death|1|||
41999152|NCT01047007|75807329|FG002|Overall Study|Progressive Disease|1|||
42134281|NCT00458484|75945112|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
42134282|NCT00458484|75945113|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
42263863|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
42263864|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
42263865|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
42263866|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
42263867|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
42263868|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
42263869|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
42333024|NCT01473940|76170588|FG003|Induction Therapy|Death|1|||
42333025|NCT01473940|76170585|FG000|Induction Therapy|Progressive Disease|0|||
42134283|NCT00328198|75945138|FG000|Treatment|Adverse Event|21|||
41999153|NCT01047007|75807330|FG003|Overall Study|Progressive Disease|0|||
42333026|NCT01473940|76170586|FG001|Induction Therapy|Progressive Disease|1|||
42333027|NCT01473940|76170587|FG002|Induction Therapy|Progressive Disease|1|||
42333028|NCT01473940|76170588|FG003|Induction Therapy|Progressive Disease|0|||
42333029|NCT01473940|76170585|FG000|Maintenance Therapy|Progressive Disease|1|||
42333030|NCT01473940|76170586|FG001|Maintenance Therapy|Progressive Disease|2|||
42333031|NCT01473940|76170587|FG002|Maintenance Therapy|Progressive Disease|1|||
42333032|NCT01473940|76170588|FG003|Maintenance Therapy|Progressive Disease|4|||
42333033|NCT01832727|76170610|FG000|Overall Study|Adverse Event|4|||
42333034|NCT01832727|76170611|FG001|Overall Study|Adverse Event|6|||
42333035|NCT01832727|76170612|FG002|Overall Study|Adverse Event|1|||
42333036|NCT01832727|76170613|FG003|Overall Study|Adverse Event|0|||
42333037|NCT01832727|76170614|FG004|Overall Study|Adverse Event|1|||
42333038|NCT01832727|76170615|FG005|Overall Study|Adverse Event|1|||
42333039|NCT01832727|76170616|FG006|Overall Study|Adverse Event|2|||
42333040|NCT01832727|76170617|FG007|Overall Study|Adverse Event|1|||
42333041|NCT01832727|76170618|FG008|Overall Study|Adverse Event|9|||
42263870|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Non-compliance|4|||
42263871|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Non-compliance|0|||
42263872|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Non-compliance|0|||
42263873|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Non-compliance|0|||
42263874|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Pain|4|||
42263875|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Pain|0|||
42263876|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Pain|0|||
42263877|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Pain|0|||
42263878|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
42263879|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
42333042|NCT01832727|76170610|FG000|Overall Study|Disease progression|3|||
42333043|NCT01832727|76170611|FG001|Overall Study|Disease progression|0|||
42333044|NCT01832727|76170612|FG002|Overall Study|Disease progression|2|||
42333045|NCT01832727|76170613|FG003|Overall Study|Disease progression|1|||
42333046|NCT01832727|76170614|FG004|Overall Study|Disease progression|3|||
42333047|NCT01832727|76170615|FG005|Overall Study|Disease progression|3|||
41999154|NCT00546351|75807470|FG000|Overall Study|Adverse Event|76|||
41999155|NCT00546351|75807470|FG000|Overall Study|Lack of Efficacy|15|||
41999156|NCT00546351|75807470|FG000|Overall Study|Withdrawal by Subject|109|||
41999157|NCT00546351|75807470|FG000|Overall Study|Lost to Follow-up|9|||
41999158|NCT00546351|75807470|FG000|Overall Study|Protocol Deviation|1|||
41999159|NCT00546351|75807470|FG000|Overall Study|Unsatisfactory compliance|9|||
41999160|NCT00546351|75807470|FG000|Overall Study|Other reasons for premature termination|17|||
41999161|NCT00003838|75807486|FG000|Overall Study|Death|0|||
41999162|NCT00003838|75807487|FG001|Overall Study|Death|12|||
41999163|NCT00003838|75807488|FG002|Overall Study|Death|7|||
41999164|NCT00003838|75807486|FG000|Overall Study|Lost to Follow-up|0|||
41999165|NCT00003838|75807487|FG001|Overall Study|Lost to Follow-up|1|||
41999166|NCT00003838|75807488|FG002|Overall Study|Lost to Follow-up|1|||
41999167|NCT00003838|75807486|FG000|Overall Study|Disease Progression|0|||
41999168|NCT00003838|75807487|FG001|Overall Study|Disease Progression|12|||
41999169|NCT00003838|75807488|FG002|Overall Study|Disease Progression|0|||
41999170|NCT04276883|75807520|FG000|Overall Study|Withdrawal by Subject|2|||
41999171|NCT04276883|75807521|FG001|Overall Study|Withdrawal by Subject|3|||
41999172|NCT04276883|75807522|FG002|Overall Study|Withdrawal by Subject|6|||
41999173|NCT04276883|75807520|FG000|Overall Study|Lost to Follow-up|1|||
41999174|NCT04276883|75807521|FG001|Overall Study|Lost to Follow-up|3|||
41999175|NCT04276883|75807522|FG002|Overall Study|Lost to Follow-up|0|||
41999176|NCT04276883|75807520|FG000|Overall Study|Adverse Event|0|||
41999177|NCT04276883|75807521|FG001|Overall Study|Adverse Event|1|||
41999178|NCT04276883|75807522|FG002|Overall Study|Adverse Event|0|||
41999179|NCT04276883|75807520|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
41999180|NCT04276883|75807521|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
41999181|NCT04276883|75807522|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
41999182|NCT04099888|75807532|FG000|Overall Study|Study terminated by sponsor|9|||
41999183|NCT04099888|75807533|FG001|Overall Study|Study terminated by sponsor|11|||
41999184|NCT04099888|75807532|FG000|Overall Study|Lost to Follow-up|1|||
41999185|NCT04099888|75807533|FG001|Overall Study|Lost to Follow-up|1|||
41999186|NCT04099888|75807532|FG000|Overall Study|Withdrawal by Subject|5|||
41999187|NCT04099888|75807533|FG001|Overall Study|Withdrawal by Subject|6|||
41999188|NCT04099888|75807532|FG000|Overall Study|Death|5|||
41999189|NCT04099888|75807533|FG001|Overall Study|Death|2|||
41999190|NCT04099888|75807532|FG000|Overall Study|Other|1|||
41999191|NCT04099888|75807533|FG001|Overall Study|Other|0|||
41999192|NCT04081389|75807543|FG000|Overall Study|Withdrawal by Subject|0|||
41999193|NCT04081389|75807544|FG001|Overall Study|Withdrawal by Subject|0|||
41999194|NCT04081389|75807545|FG002|Overall Study|Withdrawal by Subject|1|||
41999195|NCT04081389|75807546|FG003|Overall Study|Withdrawal by Subject|0|||
41999196|NCT04032080|75807556|FG000|Overall Study|Death|6|||
41999197|NCT03781323|75807570|FG000|Overall Study|Withdrawal by Subject|1|||
41999198|NCT03729362|75807576|FG000|Overall Study|Withdrawal by Subject|2|||
41999199|NCT03729362|75807577|FG001|Overall Study|Withdrawal by Subject|0|||
41999200|NCT03729362|75807576|FG000|Overall Study|Physician Decision|1|||
41999201|NCT03729362|75807577|FG001|Overall Study|Physician Decision|0|||
41999202|NCT03729362|75807576|FG000|Overall Study|COVID-19 Pandemic|1|||
41999203|NCT03729362|75807577|FG001|Overall Study|COVID-19 Pandemic|0|||
41999204|NCT03729362|75807576|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
41999205|NCT03729362|75807577|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
41999206|NCT03729362|75807576|FG000|Overall Study|Adverse Event|0|||
41999207|NCT03729362|75807577|FG001|Overall Study|Adverse Event|1|||
41999208|NCT03729362|75807576|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
41999209|NCT03729362|75807577|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
41999210|NCT03340766|75807604|FG000|Overall Study|Death|6|||
41999211|NCT03340766|75807605|FG001|Overall Study|Death|6|||
41999212|NCT03340766|75807606|FG002|Overall Study|Death|2|||
41999213|NCT03340766|75807604|FG000|Overall Study|Withdrawal by Subject|2|||
42034597|NCT00935493|75842670|FG001|Overall Study|Treatment Discontinued|1|||
42034598|NCT00935493|75842671|FG002|Overall Study|Treatment Discontinued|0|||
42034599|NCT03856996|75842681|FG000|Overall Study|Withdrawal by Subject|1|||
42034600|NCT03856996|75842682|FG001|Overall Study|Withdrawal by Subject|0|||
42134284|NCT00328198|75945138|FG000|Treatment|Death|1|||
41999214|NCT03340766|75807605|FG001|Overall Study|Withdrawal by Subject|1|||
42134285|NCT00328198|75945138|FG000|Treatment|Physician Decision|5|||
42333048|NCT01832727|76170616|FG006|Overall Study|Disease progression|6|||
41999215|NCT03340766|75807606|FG002|Overall Study|Withdrawal by Subject|2|||
41999216|NCT03340766|75807604|FG000|Overall Study|Continuing Study|3|||
41999217|NCT03340766|75807605|FG001|Overall Study|Continuing Study|3|||
41999218|NCT03340766|75807606|FG002|Overall Study|Continuing Study|5|||
41999219|NCT02711852|75807642|FG000|Overall Study|Death|5|||
41999220|NCT02711852|75807642|FG000|Overall Study|Lost to Follow-up|1|||
41999221|NCT02711852|75807642|FG000|Overall Study|Completed follow-up|3|||
41999222|NCT02711852|75807642|FG000|Overall Study|Withdrawal by Subject|1|||
41999223|NCT01977417|75807680|FG000|Overall Study|Adverse Event|1|||
42134286|NCT00328198|75945138|FG000|Treatment|Withdrawal by Subject|5|||
42333049|NCT01832727|76170617|FG007|Overall Study|Disease progression|2|||
42333050|NCT01832727|76170618|FG008|Overall Study|Disease progression|7|||
42333051|NCT01832727|76170610|FG000|Overall Study|Lost to Follow-up|0|||
42333052|NCT01832727|76170611|FG001|Overall Study|Lost to Follow-up|0|||
42333053|NCT01832727|76170612|FG002|Overall Study|Lost to Follow-up|0|||
42333054|NCT01832727|76170613|FG003|Overall Study|Lost to Follow-up|1|||
42333055|NCT01832727|76170614|FG004|Overall Study|Lost to Follow-up|0|||
42333056|NCT01832727|76170615|FG005|Overall Study|Lost to Follow-up|0|||
42333057|NCT01832727|76170616|FG006|Overall Study|Lost to Follow-up|0|||
42333058|NCT01832727|76170617|FG007|Overall Study|Lost to Follow-up|0|||
42333059|NCT01832727|76170618|FG008|Overall Study|Lost to Follow-up|0|||
42333060|NCT01832727|76170610|FG000|Overall Study|Physician Decision|1|||
42333061|NCT01832727|76170611|FG001|Overall Study|Physician Decision|0|||
42333062|NCT01832727|76170612|FG002|Overall Study|Physician Decision|0|||
42333063|NCT01832727|76170613|FG003|Overall Study|Physician Decision|1|||
42333064|NCT01832727|76170614|FG004|Overall Study|Physician Decision|0|||
42333065|NCT01832727|76170615|FG005|Overall Study|Physician Decision|1|||
42333066|NCT01832727|76170616|FG006|Overall Study|Physician Decision|0|||
42333067|NCT01832727|76170617|FG007|Overall Study|Physician Decision|0|||
42333068|NCT01832727|76170618|FG008|Overall Study|Physician Decision|0|||
42333069|NCT01832727|76170610|FG000|Overall Study|Withdrawal by Subject|1|||
42333070|NCT01832727|76170611|FG001|Overall Study|Withdrawal by Subject|1|||
42333071|NCT01832727|76170612|FG002|Overall Study|Withdrawal by Subject|0|||
42333072|NCT01832727|76170613|FG003|Overall Study|Withdrawal by Subject|1|||
42333073|NCT01832727|76170614|FG004|Overall Study|Withdrawal by Subject|0|||
42333074|NCT01832727|76170615|FG005|Overall Study|Withdrawal by Subject|1|||
42333075|NCT01832727|76170616|FG006|Overall Study|Withdrawal by Subject|0|||
42333076|NCT01832727|76170617|FG007|Overall Study|Withdrawal by Subject|2|||
42333077|NCT01832727|76170618|FG008|Overall Study|Withdrawal by Subject|1|||
42333078|NCT01832727|76170610|FG000|Overall Study|Study terminated by sponsor|0|||
42333079|NCT01832727|76170611|FG001|Overall Study|Study terminated by sponsor|0|||
42333080|NCT01832727|76170612|FG002|Overall Study|Study terminated by sponsor|0|||
42333081|NCT01832727|76170613|FG003|Overall Study|Study terminated by sponsor|0|||
42333082|NCT01832727|76170614|FG004|Overall Study|Study terminated by sponsor|0|||
42333083|NCT01832727|76170615|FG005|Overall Study|Study terminated by sponsor|0|||
42333084|NCT01832727|76170616|FG006|Overall Study|Study terminated by sponsor|0|||
42333085|NCT01832727|76170617|FG007|Overall Study|Study terminated by sponsor|1|||
42333086|NCT01832727|76170618|FG008|Overall Study|Study terminated by sponsor|1|||
42333087|NCT01473394|76170649|FG000|Overall Study|Adverse Event|13|||
42333088|NCT01473394|76170650|FG001|Overall Study|Adverse Event|16|||
42333089|NCT01473394|76170649|FG000|Overall Study|Insufficient Therapeutic Response|4|||
42333090|NCT01473394|76170650|FG001|Overall Study|Insufficient Therapeutic Response|1|||
42333091|NCT01473394|76170649|FG000|Overall Study|Protocol Violation|7|||
42333092|NCT01473394|76170650|FG001|Overall Study|Protocol Violation|5|||
42333093|NCT01473394|76170649|FG000|Overall Study|Withdrew Consent|12|||
42333094|NCT01473394|76170650|FG001|Overall Study|Withdrew Consent|10|||
42333095|NCT01473394|76170649|FG000|Overall Study|Lost to Follow-up|9|||
42333096|NCT01473394|76170650|FG001|Overall Study|Lost to Follow-up|11|||
42333097|NCT01449682|76170658|FG000|Overall Study|Death|0|||
42333098|NCT01449682|76170659|FG001|Overall Study|Death|1|||
42333099|NCT01449682|76170658|FG000|Overall Study|Adverse Event|1|||
42134287|NCT00328198|75945138|FG000|Treatment|Evidence of disease progression|2|||
42263880|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
42263881|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
42263882|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Hospice care|1|||
42263883|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Hospice care|0|||
42263884|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Hospice care|0|||
42263885|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Hospice care|0|||
42263886|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Physician Decision|1|||
42263887|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Physician Decision|0|||
42263888|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Physician Decision|0|||
42263889|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Physician Decision|0|||
42263890|NCT01107626|76091857|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
42263891|NCT01107626|76091858|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
42263892|NCT01107626|76091859|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
42263893|NCT01107626|76091860|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
42263894|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
42263895|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
42333100|NCT01449682|76170659|FG001|Overall Study|Adverse Event|0|||
42333101|NCT01449526|76170667|FG000|Overall Study|Lost to Follow-up|1|||
42333102|NCT01449526|76170668|FG001|Overall Study|Lost to Follow-up|2|||
42333103|NCT01449526|76170667|FG000|Overall Study|Withdrawal by Subject|1|||
42333104|NCT01449526|76170668|FG001|Overall Study|Withdrawal by Subject|1|||
42333105|NCT01449526|76170667|FG000|Overall Study|Symptoms/complaints|0|||
42333106|NCT01449526|76170668|FG001|Overall Study|Symptoms/complaints|1|||
42333107|NCT01449526|76170667|FG000|Overall Study|Lack of Motivation|0|||
42333108|NCT01449526|76170668|FG001|Overall Study|Lack of Motivation|1|||
42333109|NCT01449526|76170667|FG000|Overall Study|Cannot maintain visits|0|||
42333110|NCT01449526|76170668|FG001|Overall Study|Cannot maintain visits|1|||
42333111|NCT01440322|76170676|FG000|Overall Study|Discomfort|2|||
42333112|NCT01440322|76170677|FG001|Overall Study|Discomfort|0|||
42333113|NCT01440322|76170676|FG000|Overall Study|Biomicroscopy|1|||
42333114|NCT01440322|76170677|FG001|Overall Study|Biomicroscopy|0|||
42333115|NCT01440322|76170676|FG000|Overall Study|Symptoms and Problems|1|||
42333116|NCT01440322|76170677|FG001|Overall Study|Symptoms and Problems|0|||
42333117|NCT01440322|76170676|FG000|Overall Study|Unacceptable Subjective Vision|1|||
42333118|NCT01440322|76170677|FG001|Overall Study|Unacceptable Subjective Vision|0|||
42333119|NCT01440322|76170676|FG000|Overall Study|Other Product Related|1|||
42333120|NCT01440322|76170677|FG001|Overall Study|Other Product Related|0|||
42333121|NCT01440322|76170676|FG000|Overall Study|Unrelated Medical Problem|0|||
42333122|NCT01440322|76170677|FG001|Overall Study|Unrelated Medical Problem|1|||
42333123|NCT01440322|76170676|FG000|Overall Study|Other Non-Product Related|1|||
42333124|NCT01440322|76170677|FG001|Overall Study|Other Non-Product Related|0|||
42333125|NCT01832493|76170683|FG000|Overall Study|Physician Decision|2|||
42333126|NCT01832493|76170683|FG000|Overall Study|Protocol Violation|4|||
42333127|NCT01832493|76170683|FG000|Overall Study|Unable to place LV lead|2|||
42333128|NCT01831791|76170687|FG000|Overall Study|Withdrawal by Subject|10|||
42333129|NCT01857531|76170691|FG000|Overall Study|Withdrawal by Subject|4|||
42333130|NCT02166047|76170707|FG000|Overall Study|Withdrawal by Participant|0|||
42333131|NCT02166047|76170708|FG001|Overall Study|Withdrawal by Participant|1|||
42333132|NCT02166047|76170709|FG002|Overall Study|Withdrawal by Participant|2|||
41999224|NCT01977417|75807681|FG001|Overall Study|Adverse Event|0|||
42333133|NCT02166047|76170710|FG003|Overall Study|Withdrawal by Participant|0|||
42333134|NCT02166047|76170711|FG004|Overall Study|Withdrawal by Participant|0|||
42333135|NCT02166047|76170712|FG005|Overall Study|Withdrawal by Participant|0|||
42333136|NCT02166047|76170713|FG006|Overall Study|Withdrawal by Participant|1|||
42333137|NCT02166047|76170714|FG007|Overall Study|Withdrawal by Participant|0|||
42333138|NCT02166047|76170715|FG008|Overall Study|Withdrawal by Participant|0|||
42333139|NCT02166047|76170716|FG009|Overall Study|Withdrawal by Participant|0|||
42333140|NCT02166047|76170717|FG010|Overall Study|Withdrawal by Participant|0|||
42333141|NCT02166047|76170718|FG011|Overall Study|Withdrawal by Participant|0|||
42333142|NCT02166047|76170707|FG000|Overall Study|Adverse Event|0|||
42333143|NCT02166047|76170708|FG001|Overall Study|Adverse Event|0|||
42333144|NCT02166047|76170709|FG002|Overall Study|Adverse Event|0|||
42333145|NCT02166047|76170710|FG003|Overall Study|Adverse Event|0|||
42333146|NCT02166047|76170711|FG004|Overall Study|Adverse Event|1|||
42333147|NCT02166047|76170712|FG005|Overall Study|Adverse Event|0|||
41999225|NCT01977417|75807680|FG000|Overall Study|Withdrawal by Subject|2|||
41999226|NCT01977417|75807681|FG001|Overall Study|Withdrawal by Subject|4|||
41999227|NCT01977417|75807680|FG000|Overall Study|Female enrollment goal met|0|||
41999228|NCT01977417|75807681|FG001|Overall Study|Female enrollment goal met|2|||
41999229|NCT01951885|75807689|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
42263896|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
42263897|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
42263898|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
42263899|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
42263900|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
42263901|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
42263902|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Death|0|||
42263903|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Death|8|||
42263904|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Death|2|||
42263905|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Death|13|||
42263906|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
42333148|NCT02166047|76170713|FG006|Overall Study|Adverse Event|1|||
42333149|NCT02166047|76170714|FG007|Overall Study|Adverse Event|0|||
42333150|NCT02166047|76170715|FG008|Overall Study|Adverse Event|0|||
42333151|NCT02166047|76170716|FG009|Overall Study|Adverse Event|0|||
42333152|NCT02166047|76170717|FG010|Overall Study|Adverse Event|2|||
42333153|NCT02166047|76170718|FG011|Overall Study|Adverse Event|0|||
42333154|NCT01493284|76170744|FG000|Overall Study|Death|29|||
42333155|NCT01493284|76170744|FG000|Overall Study|Withdrawal by Subject|32|||
42333156|NCT02165735|76170750|FG000|Overall Study|Lost to Follow-up|12|||
42333157|NCT02165735|76170751|FG001|Overall Study|Lost to Follow-up|10|||
42333158|NCT02165735|76170750|FG000|Overall Study|Withdrawal by Subject|3|||
42333159|NCT02165735|76170751|FG001|Overall Study|Withdrawal by Subject|0|||
42333160|NCT02165735|76170750|FG000|Overall Study|Participant indicated lack of time|1|||
42333161|NCT02165735|76170751|FG001|Overall Study|Participant indicated lack of time|3|||
42333162|NCT02165735|76170750|FG000|Overall Study|Protocol Violation|0|||
42333163|NCT02165735|76170751|FG001|Overall Study|Protocol Violation|1|||
42333164|NCT02069899|76170760|FG000|Overall Study|Adverse Event|6|||
42134288|NCT00328198|75945138|FG000|Treatment|Non-compliance|1|||
42333165|NCT02069899|76170761|FG001|Overall Study|Adverse Event|0|||
42333166|NCT02069899|76170762|FG002|Overall Study|Adverse Event|1|||
42333167|NCT02069899|76170760|FG000|Overall Study|Withdrawal by Participant|2|||
42333168|NCT02069899|76170761|FG001|Overall Study|Withdrawal by Participant|0|||
42333169|NCT02069899|76170762|FG002|Overall Study|Withdrawal by Participant|0|||
42333170|NCT02069899|76170760|FG000|Overall Study|Lost to Follow-up|1|||
42333171|NCT02069899|76170761|FG001|Overall Study|Lost to Follow-up|0|||
42333172|NCT02069899|76170762|FG002|Overall Study|Lost to Follow-up|1|||
42333173|NCT02069899|76170760|FG000|Overall Study|Other|4|||
42333174|NCT02069899|76170761|FG001|Overall Study|Other|0|||
42333175|NCT02069899|76170762|FG002|Overall Study|Other|0|||
42333176|NCT02069899|76170760|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
42333177|NCT02069899|76170761|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
42333178|NCT02069899|76170762|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
42333179|NCT02069899|76170760|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
42333180|NCT02069899|76170761|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
42333181|NCT02069899|76170762|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
42333182|NCT01831089|76170777|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
42263907|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
42263908|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
42263909|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
42263910|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
42263911|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
42263912|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
42263913|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
42263914|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
42263915|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
42263916|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
42263917|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
42263918|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
42263919|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
42263920|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
42263921|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
42263922|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
42263923|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
42263924|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
42134289|NCT00328198|75945138|FG000|Treatment|Confirmed complete response, MRD -|3|||
42333183|NCT01831089|76170778|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
42333184|NCT01831089|76170779|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
42333185|NCT01831089|76170780|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
42333186|NCT01831089|76170781|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
42333187|NCT01831089|76170782|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
42333188|NCT01831089|76170777|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
42333189|NCT01831089|76170778|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
42333190|NCT01831089|76170779|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
42333191|NCT01831089|76170780|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
42134290|NCT00328198|75945138|FG000|Follow-up|Lost to Follow-up|4|||
42134291|NCT00328198|75945138|FG000|Follow-up|Death|31|||
42134292|NCT00450450|75945144|FG000|Overall Study|Death|1|||
42263925|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
42263926|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
42263927|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
42263928|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
42263929|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
42263930|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
42263931|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
42263932|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
42263933|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
42263934|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
42263935|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
42263936|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
42263937|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
42263938|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
42263939|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
42263940|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
42263941|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
42263942|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
42263943|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
42263944|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
42263945|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
42263946|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Pain|0|||
42263947|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Pain|0|||
42263948|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Pain|0|||
42263949|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Pain|1|||
42134293|NCT00450450|75945145|FG001|Overall Study|Death|3|||
42134294|NCT00450450|75945144|FG000|Overall Study|Relapse|2|||
42333192|NCT01831089|76170781|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
42263950|NCT01107626|76091857|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
42263951|NCT01107626|76091858|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
42263952|NCT01107626|76091859|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
42263953|NCT01107626|76091860|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
42263954|NCT00828009|76091869|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
42263955|NCT00828009|76091869|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
42263956|NCT00828009|76091869|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
42263957|NCT00828009|76091869|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
42333193|NCT01831089|76170782|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
42263958|NCT00828009|76091869|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
42263959|NCT00828009|76091869|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
42263960|NCT00828009|76091869|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
42263961|NCT00828009|76091869|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
42263962|NCT00828009|76091869|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
42263963|NCT00828009|76091869|FG000|Step 2 - Maintenance Therapy|Death|1|||
42263964|NCT00828009|76091869|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
42263965|NCT00828009|76091869|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
42263966|NCT00828009|76091869|FG000|Step 2 - Maintenance Therapy|Other|1|||
42263967|NCT00068393|76091889|FG000|Overall Study|Adverse Event|2|||
42263968|NCT00068393|76091889|FG000|Overall Study|Death|3|||
42263969|NCT00068393|76091889|FG000|Overall Study|Withdrawal by Subject|3|||
42263970|NCT00068393|76091889|FG000|Overall Study|Alternative treatment|1|||
42263971|NCT00068393|76091889|FG000|Overall Study|Quality of life worsening|1|||
42263972|NCT00062010|76091893|FG000|Overall Study|Ineligible|3|||
42263973|NCT00047008|76091899|FG000|Overall Study|Withdrawn consent|2|||
42263974|NCT00047008|76091900|FG001|Overall Study|Withdrawn consent|3|||
42333194|NCT01831089|76170777|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
42333195|NCT01831089|76170778|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
42333196|NCT01831089|76170779|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
42333197|NCT01831089|76170780|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
42333198|NCT01831089|76170781|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
42333199|NCT01831089|76170782|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
42333200|NCT01831089|76170777|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
42333201|NCT01831089|76170778|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
42333202|NCT01831089|76170779|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
42333203|NCT01831089|76170780|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
42333204|NCT01831089|76170781|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
42333205|NCT01831089|76170782|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
42333206|NCT01831089|76170777|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
42333207|NCT01831089|76170778|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
42333208|NCT01831089|76170779|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
42333209|NCT01831089|76170780|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
42333210|NCT01831089|76170781|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
42333211|NCT01831089|76170782|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
42333212|NCT01831089|76170777|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
42333213|NCT01831089|76170778|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
42333214|NCT01831089|76170779|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
42333215|NCT01831089|76170780|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
42333216|NCT01831089|76170781|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
41999230|NCT01951885|75807690|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
41999231|NCT01951885|75807689|FG000|Overall Study|Adverse Event|1|||
41999232|NCT01951885|75807690|FG001|Overall Study|Adverse Event|0|||
41999233|NCT01951885|75807689|FG000|Overall Study|Withdrawal by Subject|0|||
41999234|NCT01951885|75807690|FG001|Overall Study|Withdrawal by Subject|1|||
41999235|NCT01951885|75807689|FG000|Overall Study|ineligible due to a change in donor|0|||
41999236|NCT01951885|75807690|FG001|Overall Study|ineligible due to a change in donor|1|||
41999237|NCT01951885|75807689|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
42134295|NCT00450450|75945145|FG001|Overall Study|Relapse|0|||
42134296|NCT00450450|75945144|FG000|Overall Study|Missing Data|2|||
42134297|NCT00450450|75945145|FG001|Overall Study|Missing Data|0|||
42134298|NCT00442572|75945153|FG000|Overall Study|Relapse|8|||
42134299|NCT00442572|75945154|FG001|Overall Study|Relapse|1|||
42134300|NCT00442572|75945153|FG000|Overall Study|Lost to Follow-up|0|||
42134301|NCT00442572|75945154|FG001|Overall Study|Lost to Follow-up|1|||
42134302|NCT00442572|75945153|FG000|Overall Study|Withdrawal by Subject|0|||
42134303|NCT00442572|75945154|FG001|Overall Study|Withdrawal by Subject|1|||
42134304|NCT00442416|75945163|FG000|Overall Study|Adverse Event|4|||
42134305|NCT00442416|75945164|FG001|Overall Study|Adverse Event|1|||
42134306|NCT00442416|75945163|FG000|Overall Study|Death|1|||
42134307|NCT00442416|75945164|FG001|Overall Study|Death|0|||
42134308|NCT00442416|75945163|FG000|Overall Study|Lack of Efficacy|2|||
42134309|NCT00442416|75945164|FG001|Overall Study|Lack of Efficacy|0|||
42134310|NCT00442416|75945163|FG000|Overall Study|Protocol Violation|2|||
42134311|NCT00442416|75945164|FG001|Overall Study|Protocol Violation|3|||
42134312|NCT00442416|75945163|FG000|Overall Study|Withdrew consent|1|||
42134313|NCT00442416|75945164|FG001|Overall Study|Withdrew consent|2|||
42134314|NCT00442416|75945163|FG000|Overall Study|Administrative/Other|27|||
42134315|NCT00442416|75945164|FG001|Overall Study|Administrative/Other|33|||
42134316|NCT00441792|75945172|FG000|Overall Study|Lost to Follow-up|0|||
42134317|NCT00441792|75945173|FG001|Overall Study|Lost to Follow-up|2|||
42134318|NCT00312208|75945181|FG000|Overall Study|Adverse Event|97|||
42134319|NCT00312208|75945182|FG001|Overall Study|Adverse Event|61|||
42134320|NCT00312208|75945181|FG000|Overall Study|Protocol Violation|5|||
42134321|NCT00312208|75945182|FG001|Overall Study|Protocol Violation|3|||
42263975|NCT00047008|76091899|FG000|Overall Study|Ineligible|9|||
42333217|NCT01831089|76170782|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
42333218|NCT01831089|76170777|FG000|Cohort III: Dose Level 3|Global end of study|0|||
42333219|NCT01831089|76170778|FG001|Cohort III: Dose Level 3|Global end of study|0|||
42333220|NCT01831089|76170779|FG002|Cohort III: Dose Level 3|Global end of study|1|||
42333221|NCT01831089|76170780|FG003|Cohort III: Dose Level 3|Global end of study|0|||
42333222|NCT01831089|76170781|FG004|Cohort III: Dose Level 3|Global end of study|0|||
42333223|NCT01831089|76170782|FG005|Cohort III: Dose Level 3|Global end of study|0|||
42333224|NCT01831089|76170777|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
42333225|NCT01831089|76170778|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
42333226|NCT01831089|76170779|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
41999238|NCT01951885|75807690|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
41999239|NCT00626990|75807700|FG000|Overall Study|Lack of Efficacy|6|||
42134322|NCT00312208|75945181|FG000|Overall Study|Death|2|||
42134323|NCT00312208|75945182|FG001|Overall Study|Death|1|||
42134324|NCT00312208|75945181|FG000|Overall Study|Lack of Efficacy|7|||
42134325|NCT00312208|75945182|FG001|Overall Study|Lack of Efficacy|4|||
42134326|NCT00312208|75945181|FG000|Overall Study|Lost to Follow-up|3|||
42134327|NCT00312208|75945182|FG001|Overall Study|Lost to Follow-up|5|||
42134328|NCT00312208|75945181|FG000|Overall Study|Withdrawal by Subject|53|||
42134329|NCT00312208|75945182|FG001|Overall Study|Withdrawal by Subject|42|||
42134330|NCT00312208|75945181|FG000|Overall Study|Other|5|||
42134331|NCT00312208|75945182|FG001|Overall Study|Other|7|||
42134332|NCT00297778|75945190|FG000|Overall Study|Adverse Event|16|||
42263976|NCT00047008|76091900|FG001|Overall Study|Ineligible|8|||
42134333|NCT00297778|75945191|FG001|Overall Study|Adverse Event|10|||
42134334|NCT00297778|75945190|FG000|Overall Study|Withdrawal by Subject|1|||
42134335|NCT00297778|75945191|FG001|Overall Study|Withdrawal by Subject|5|||
42134336|NCT00297778|75945190|FG000|Overall Study|Lack of Efficacy|2|||
42134337|NCT00297778|75945191|FG001|Overall Study|Lack of Efficacy|1|||
42134338|NCT00297778|75945190|FG000|Overall Study|Non-compliant with trial protocol|0|||
42134339|NCT00297778|75945191|FG001|Overall Study|Non-compliant with trial protocol|3|||
42134340|NCT00297778|75945190|FG000|Overall Study|Other|0|||
42134341|NCT00297778|75945191|FG001|Overall Study|Other|1|||
42134342|NCT03848832|75945200|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
42134343|NCT03848832|75945201|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
42134344|NCT03848832|75945202|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
42134345|NCT03848832|75945200|FG000|Overall Study|Withdrawal by Subject|0|||
42134346|NCT03848832|75945201|FG001|Overall Study|Withdrawal by Subject|0|||
42134347|NCT03848832|75945202|FG002|Overall Study|Withdrawal by Subject|1|||
42134348|NCT03848832|75945200|FG000|Overall Study|Withdrawal (Covid-19)|0|||
42263977|NCT02397694|76091908|FG000|Double-Blinded Phase|Adverse Event|1|||
42263978|NCT02397694|76091909|FG001|Double-Blinded Phase|Adverse Event|0|||
42263979|NCT02397694|76091908|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
42263980|NCT02397694|76091909|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
42263981|NCT02397694|76091908|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
42263982|NCT02397694|76091909|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
42263983|NCT02397694|76091908|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
42263984|NCT02397694|76091909|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
42263985|NCT02397694|76091908|FG000|Open Label Extension Phase|Protocol Violation|1|||
42263986|NCT02397694|76091909|FG001|Open Label Extension Phase|Protocol Violation|0|||
42263987|NCT02397694|76091908|FG000|Open Label Extension Phase|Withdrew Consent|3|||
42263988|NCT02397694|76091909|FG001|Open Label Extension Phase|Withdrew Consent|1|||
42263989|NCT02397694|76091908|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
42263990|NCT02397694|76091909|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
42034601|NCT03856996|75842681|FG000|Overall Study|Lost to Follow-up|0|||
42134349|NCT03848832|75945201|FG001|Overall Study|Withdrawal (Covid-19)|2|||
42263991|NCT02783599|76091919|FG000|Overall Study|Progressive disease|23|||
42134350|NCT03848832|75945202|FG002|Overall Study|Withdrawal (Covid-19)|0|||
42263992|NCT02783599|76091919|FG000|Overall Study|Surgical Resection|10|||
42134351|NCT03848832|75945200|FG000|Overall Study|Physician Decision|2|||
41999240|NCT00626990|75807701|FG001|Overall Study|Lack of Efficacy|7|||
42333227|NCT01831089|76170780|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
42333228|NCT01831089|76170781|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
42333229|NCT01831089|76170782|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
42333230|NCT01831089|76170777|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
42333231|NCT01831089|76170778|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
42333232|NCT01831089|76170779|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
42333233|NCT01831089|76170780|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
42333234|NCT01831089|76170781|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
42333235|NCT01831089|76170782|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
41999241|NCT00626990|75807702|FG002|Overall Study|Lack of Efficacy|49|||
41999242|NCT00626990|75807703|FG003|Overall Study|Lack of Efficacy|40|||
41999243|NCT00626990|75807700|FG000|Overall Study|Adverse Event|1|||
41999244|NCT00626990|75807701|FG001|Overall Study|Adverse Event|7|||
42333236|NCT01831089|76170777|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
42333237|NCT01831089|76170778|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
42333238|NCT01831089|76170779|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
42333239|NCT01831089|76170780|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
42333240|NCT01831089|76170781|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
42333241|NCT01831089|76170782|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
42333242|NCT01831089|76170777|FG000|Cohort V: Dose Level 5|Death|0|||
42333243|NCT01831089|76170778|FG001|Cohort V: Dose Level 5|Death|0|||
42333244|NCT01831089|76170779|FG002|Cohort V: Dose Level 5|Death|0|||
42134352|NCT03848832|75945201|FG001|Overall Study|Physician Decision|1|||
42333245|NCT01831089|76170780|FG003|Cohort V: Dose Level 5|Death|0|||
42333246|NCT01831089|76170781|FG004|Cohort V: Dose Level 5|Death|1|||
42333247|NCT01831089|76170782|FG005|Cohort V: Dose Level 5|Death|0|||
42333248|NCT01831089|76170777|FG000|Cohort V: Dose Level 5|Global end of study|0|||
42333249|NCT01831089|76170778|FG001|Cohort V: Dose Level 5|Global end of study|0|||
42333250|NCT01831089|76170779|FG002|Cohort V: Dose Level 5|Global end of study|0|||
42333251|NCT01831089|76170780|FG003|Cohort V: Dose Level 5|Global end of study|0|||
42333252|NCT01831089|76170781|FG004|Cohort V: Dose Level 5|Global end of study|2|||
42333253|NCT01831089|76170782|FG005|Cohort V: Dose Level 5|Global end of study|0|||
42333254|NCT01831089|76170777|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
42333255|NCT01831089|76170778|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
42333256|NCT01831089|76170779|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
42333257|NCT01831089|76170780|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
42333258|NCT01831089|76170781|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
42333259|NCT01831089|76170782|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
42333260|NCT01831089|76170777|FG000|Cohort B: Arm B|Progressive disease|0|||
42333261|NCT01831089|76170778|FG001|Cohort B: Arm B|Progressive disease|0|||
42333262|NCT01831089|76170779|FG002|Cohort B: Arm B|Progressive disease|0|||
42333263|NCT01831089|76170780|FG003|Cohort B: Arm B|Progressive disease|0|||
42333264|NCT01831089|76170781|FG004|Cohort B: Arm B|Progressive disease|0|||
42333265|NCT01831089|76170782|FG005|Cohort B: Arm B|Progressive disease|8|||
42333266|NCT01831089|76170777|FG000|Cohort B: Arm B|Physician Decision|0|||
42333267|NCT01831089|76170778|FG001|Cohort B: Arm B|Physician Decision|0|||
42333268|NCT01831089|76170779|FG002|Cohort B: Arm B|Physician Decision|0|||
42333269|NCT01831089|76170780|FG003|Cohort B: Arm B|Physician Decision|0|||
42333270|NCT01831089|76170781|FG004|Cohort B: Arm B|Physician Decision|0|||
42333271|NCT01831089|76170782|FG005|Cohort B: Arm B|Physician Decision|2|||
42333272|NCT01831089|76170777|FG000|Cohort B: Arm B|Never treated|0|||
42333273|NCT01831089|76170778|FG001|Cohort B: Arm B|Never treated|0|||
42333274|NCT01831089|76170779|FG002|Cohort B: Arm B|Never treated|0|||
42333275|NCT01831089|76170780|FG003|Cohort B: Arm B|Never treated|0|||
42333276|NCT01831089|76170781|FG004|Cohort B: Arm B|Never treated|0|||
42333277|NCT01831089|76170782|FG005|Cohort B: Arm B|Never treated|2|||
42333278|NCT01831089|76170777|FG000|Cohort B: Arm B|Adverse Event|0|||
42333279|NCT01831089|76170778|FG001|Cohort B: Arm B|Adverse Event|0|||
42333280|NCT01831089|76170779|FG002|Cohort B: Arm B|Adverse Event|0|||
42333281|NCT01831089|76170780|FG003|Cohort B: Arm B|Adverse Event|0|||
42333282|NCT01831089|76170781|FG004|Cohort B: Arm B|Adverse Event|0|||
42333283|NCT01831089|76170782|FG005|Cohort B: Arm B|Adverse Event|1|||
42333284|NCT01831089|76170777|FG000|Cohort B: Arm B|Global end of study|0|||
42333285|NCT01831089|76170778|FG001|Cohort B: Arm B|Global end of study|0|||
42333286|NCT01831089|76170779|FG002|Cohort B: Arm B|Global end of study|0|||
42333287|NCT01831089|76170780|FG003|Cohort B: Arm B|Global end of study|0|||
42333288|NCT01831089|76170781|FG004|Cohort B: Arm B|Global end of study|0|||
42333289|NCT01831089|76170782|FG005|Cohort B: Arm B|Global end of study|1|||
42333290|NCT02112877|76170799|FG000|Overall Study|Withdrawal by Subject|1|||
42333291|NCT02112877|76170800|FG001|Overall Study|Withdrawal by Subject|7|||
42333292|NCT02112877|76170799|FG000|Overall Study|Visit Missed|1|||
42333293|NCT02112877|76170800|FG001|Overall Study|Visit Missed|6|||
42333294|NCT02098369|76170811|FG000|Overall Study|Withdrawal by Subject|1|||
42333295|NCT02098369|76170812|FG001|Overall Study|Withdrawal by Subject|5|||
42333296|NCT02098369|76170813|FG002|Overall Study|Withdrawal by Subject|0|||
42333297|NCT02098369|76170811|FG000|Overall Study|Lost to Follow-up|5|||
42263993|NCT02783599|76091919|FG000|Overall Study|Adverse Event|4|||
42263994|NCT02783599|76091919|FG000|Overall Study|Physician Decision|2|||
42333298|NCT02098369|76170812|FG001|Overall Study|Lost to Follow-up|1|||
42333299|NCT02098369|76170813|FG002|Overall Study|Lost to Follow-up|3|||
42333300|NCT02098369|76170811|FG000|Overall Study|Death|1|||
42333301|NCT02098369|76170812|FG001|Overall Study|Death|1|||
42333302|NCT02098369|76170813|FG002|Overall Study|Death|1|||
42333303|NCT02098369|76170811|FG000|Overall Study|Other|0|||
42333304|NCT02098369|76170812|FG001|Overall Study|Other|2|||
42333305|NCT02098369|76170813|FG002|Overall Study|Other|1|||
42333306|NCT02111785|76170825|FG000|Overall Study|Death|0|||
42333307|NCT02111785|76170826|FG001|Overall Study|Death|1|||
42333308|NCT02111785|76170827|FG002|Overall Study|Death|0|||
42333309|NCT02111785|76170828|FG003|Overall Study|Death|0|||
42333310|NCT02068885|76170845|FG000|Overall Study|Withdrew|3|||
42333311|NCT02068885|76170846|FG001|Overall Study|Withdrew|5|||
42263995|NCT02783599|76091919|FG000|Overall Study|Death|1|||
42263996|NCT02838017|76091932|FG000|Overall Study|Lost to Follow-up|14|||
42263997|NCT02838017|76091933|FG001|Overall Study|Lost to Follow-up|11|||
42263998|NCT03188666|76091941|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
42263999|NCT03188666|76091942|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
42264000|NCT03188666|76091943|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
42034602|NCT03856996|75842682|FG001|Overall Study|Lost to Follow-up|1|||
42264001|NCT03188666|76091944|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
42264002|NCT03188666|76091941|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
42333312|NCT02068885|76170847|FG002|Overall Study|Withdrew|8|||
42333313|NCT02068495|76170856|FG000|Overall Study|Case Report Forms Uncollected|60|||
42333314|NCT02068495|76170856|FG000|Overall Study|Protocol Deviation|49|||
42333315|NCT02097823|76170862|FG000|Overall Study|Withdrawal by Subject|1|||
42333316|NCT02097823|76170863|FG001|Overall Study|Withdrawal by Subject|1|||
42333317|NCT01830855|76170874|FG000|Overall Study|Other|7|||
42264003|NCT03188666|76091942|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
42333318|NCT01830855|76170875|FG001|Overall Study|Other|1|||
42333319|NCT01830855|76170876|FG002|Overall Study|Other|4|||
42333320|NCT01830855|76170877|FG003|Overall Study|Other|4|||
42333321|NCT01830855|76170874|FG000|Overall Study|Medication error without associated AE|1|||
42333322|NCT01830855|76170875|FG001|Overall Study|Medication error without associated AE|0|||
42333323|NCT01830855|76170876|FG002|Overall Study|Medication error without associated AE|0|||
42333324|NCT01830855|76170877|FG003|Overall Study|Medication error without associated AE|1|||
42034603|NCT03856996|75842681|FG000|Overall Study|Adverse Event|1|||
42034604|NCT03856996|75842682|FG001|Overall Study|Adverse Event|1|||
42264004|NCT03188666|76091943|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
42264005|NCT03188666|76091944|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
42264006|NCT03188666|76091941|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
42264007|NCT03188666|76091942|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
41999245|NCT00626990|75807702|FG002|Overall Study|Adverse Event|14|||
42034605|NCT03856996|75842681|FG000|Overall Study|Other|1|||
42034606|NCT03856996|75842682|FG001|Overall Study|Other|0|||
42034607|NCT00935259|75842688|FG000|Period 1|Administrative (scheduling conflict)|1|||
42034608|NCT00935259|75842689|FG001|Period 1|Administrative (scheduling conflict)|1|||
42034609|NCT01120379|75842706|FG000|One Year Timepoint|Withdrawal by Subject|41|||
42034610|NCT01120379|75842706|FG000|One Year Timepoint|Lost to Follow-up|115|||
42034611|NCT01120379|75842706|FG000|One Year Timepoint|Death|108|||
42264008|NCT03188666|76091943|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
42264009|NCT03188666|76091944|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
42264010|NCT03188666|76091941|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
42264011|NCT03188666|76091942|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
42264012|NCT03188666|76091943|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
42264013|NCT03188666|76091944|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
42264014|NCT02836769|76091958|FG000|Overall Study|Lost to Follow-up|10|||
42264015|NCT02836769|76091958|FG000|Overall Study|Medical withdrawal|2|||
42264016|NCT02836769|76091958|FG000|Overall Study|Withdrawal by Subject|3|||
42333325|NCT01830855|76170874|FG000|Overall Study|Pregnancy|3|||
42333326|NCT01830855|76170875|FG001|Overall Study|Pregnancy|1|||
42333327|NCT01830855|76170876|FG002|Overall Study|Pregnancy|2|||
42333328|NCT01830855|76170877|FG003|Overall Study|Pregnancy|1|||
42333329|NCT01830855|76170874|FG000|Overall Study|No longer meets eligibility criteria|11|||
42333330|NCT01830855|76170875|FG001|Overall Study|No longer meets eligibility criteria|2|||
42333331|NCT01830855|76170876|FG002|Overall Study|No longer meets eligibility criteria|3|||
42333332|NCT01830855|76170877|FG003|Overall Study|No longer meets eligibility criteria|5|||
42333333|NCT01830855|76170874|FG000|Overall Study|Adverse Event|11|||
42333334|NCT01830855|76170875|FG001|Overall Study|Adverse Event|5|||
42333335|NCT01830855|76170876|FG002|Overall Study|Adverse Event|6|||
42333336|NCT01830855|76170877|FG003|Overall Study|Adverse Event|3|||
42333337|NCT01830855|76170874|FG000|Overall Study|Protocol deviation|10|||
42333338|NCT01830855|76170875|FG001|Overall Study|Protocol deviation|5|||
42333339|NCT01830855|76170876|FG002|Overall Study|Protocol deviation|6|||
41999246|NCT00626990|75807703|FG003|Overall Study|Adverse Event|28|||
41999247|NCT00626990|75807700|FG000|Overall Study|Death|0|||
41999248|NCT00626990|75807701|FG001|Overall Study|Death|1|||
41999249|NCT00626990|75807702|FG002|Overall Study|Death|0|||
41999250|NCT00626990|75807703|FG003|Overall Study|Death|0|||
41999251|NCT00626990|75807700|FG000|Overall Study|Withdrawal by Subject|3|||
41999252|NCT00626990|75807701|FG001|Overall Study|Withdrawal by Subject|1|||
41999253|NCT00626990|75807702|FG002|Overall Study|Withdrawal by Subject|5|||
41999254|NCT00626990|75807703|FG003|Overall Study|Withdrawal by Subject|11|||
41999255|NCT00626990|75807700|FG000|Overall Study|Protocol Violation|0|||
42034612|NCT01120379|75842706|FG000|One Year Timepoint|Physician Decision|9|||
42264017|NCT02836613|76091964|FG000|Overall Study|Accidental drowning|1|||
42264018|NCT02836613|76091965|FG001|Overall Study|Accidental drowning|0|||
42264019|NCT02836613|76091964|FG000|Overall Study|Lost to Follow-up|0|||
42264020|NCT02836613|76091965|FG001|Overall Study|Lost to Follow-up|1|||
42264021|NCT02836613|76091964|FG000|Overall Study|Withdrawal by Subject|0|||
42333340|NCT01830855|76170877|FG003|Overall Study|Protocol deviation|6|||
42333341|NCT01830855|76170874|FG000|Overall Study|Withdrawal by Subject|33|||
42333342|NCT01830855|76170875|FG001|Overall Study|Withdrawal by Subject|14|||
41999256|NCT00626990|75807701|FG001|Overall Study|Protocol Violation|1|||
42333343|NCT01830855|76170876|FG002|Overall Study|Withdrawal by Subject|10|||
41999257|NCT00626990|75807702|FG002|Overall Study|Protocol Violation|1|||
41999258|NCT00626990|75807703|FG003|Overall Study|Protocol Violation|0|||
41999259|NCT00626990|75807700|FG000|Overall Study|Various different reasons/missing|4|||
41999260|NCT00626990|75807701|FG001|Overall Study|Various different reasons/missing|8|||
42333344|NCT01830855|76170877|FG003|Overall Study|Withdrawal by Subject|12|||
42333345|NCT01830855|76170874|FG000|Overall Study|No longer willing to participate|32|||
42333346|NCT01830855|76170875|FG001|Overall Study|No longer willing to participate|13|||
42333347|NCT01830855|76170876|FG002|Overall Study|No longer willing to participate|12|||
42333348|NCT01830855|76170877|FG003|Overall Study|No longer willing to participate|17|||
42333349|NCT01830855|76170874|FG000|Overall Study|Lost to Follow-up|47|||
42333350|NCT01830855|76170875|FG001|Overall Study|Lost to Follow-up|20|||
42333351|NCT01830855|76170876|FG002|Overall Study|Lost to Follow-up|23|||
42333352|NCT01830855|76170877|FG003|Overall Study|Lost to Follow-up|33|||
42333353|NCT01857063|76170894|FG000|Period 1 (7 Days)|Adverse Event|0|||
42333354|NCT01857063|76170895|FG001|Period 1 (7 Days)|Adverse Event|1|||
42333355|NCT01857063|76170894|FG000|Period 1 (7 Days)|Physician Decision|1|||
41999261|NCT00626990|75807702|FG002|Overall Study|Various different reasons/missing|8|||
41999262|NCT00626990|75807703|FG003|Overall Study|Various different reasons/missing|16|||
41999263|NCT00107198|75807717|FG000|Overall Study|Lack of Efficacy|28|||
41999264|NCT00107198|75807717|FG000|Overall Study|Lost to Follow-up|12|||
41999265|NCT00107198|75807717|FG000|Overall Study|Protocol Violation|1|||
41999266|NCT00107198|75807717|FG000|Overall Study|Withdrawal by Subject|6|||
41999267|NCT00107198|75807717|FG000|Overall Study|Ineligible|5|||
41999268|NCT01193920|75807740|FG000|Overall Study|Withdrawal by Subject|1|||
41999269|NCT01193920|75807741|FG001|Overall Study|Withdrawal by Subject|0|||
41999270|NCT01193920|75807742|FG002|Overall Study|Withdrawal by Subject|5|||
41999271|NCT01193920|75807743|FG003|Overall Study|Withdrawal by Subject|1|||
41999272|NCT01193920|75807744|FG004|Overall Study|Withdrawal by Subject|3|||
41999273|NCT01193920|75807745|FG005|Overall Study|Withdrawal by Subject|1|||
41999274|NCT01193920|75807746|FG006|Overall Study|Withdrawal by Subject|3|||
41999275|NCT01193920|75807747|FG007|Overall Study|Withdrawal by Subject|0|||
41999276|NCT01193920|75807748|FG008|Overall Study|Withdrawal by Subject|1|||
41999277|NCT01193920|75807749|FG009|Overall Study|Withdrawal by Subject|0|||
41999278|NCT01193920|75807740|FG000|Overall Study|Lost to Follow-up|1|||
41999279|NCT01193920|75807741|FG001|Overall Study|Lost to Follow-up|0|||
41999280|NCT01193920|75807742|FG002|Overall Study|Lost to Follow-up|1|||
42264022|NCT02836613|76091965|FG001|Overall Study|Withdrawal by Subject|2|||
42264023|NCT02397460|76091979|FG000|Treatment Period 2|Adverse Event|0|||
42264024|NCT02397460|76091980|FG001|Treatment Period 2|Adverse Event|0|||
42264025|NCT02397460|76091981|FG002|Treatment Period 2|Adverse Event|0|||
42264026|NCT02397460|76091982|FG003|Treatment Period 2|Adverse Event|0|||
42264027|NCT02397460|76091983|FG004|Treatment Period 2|Adverse Event|0|||
42264028|NCT02397460|76091984|FG005|Treatment Period 2|Adverse Event|0|||
42264029|NCT02397460|76091985|FG006|Treatment Period 2|Adverse Event|0|||
42264030|NCT02397460|76091986|FG007|Treatment Period 2|Adverse Event|1|||
42264031|NCT02397460|76091979|FG000|Treatment Period 4|Adverse Event|0|||
42264032|NCT02397460|76091980|FG001|Treatment Period 4|Adverse Event|1|||
42264033|NCT02397460|76091981|FG002|Treatment Period 4|Adverse Event|0|||
42264034|NCT02397460|76091982|FG003|Treatment Period 4|Adverse Event|0|||
42264035|NCT02397460|76091983|FG004|Treatment Period 4|Adverse Event|0|||
42264036|NCT02397460|76091984|FG005|Treatment Period 4|Adverse Event|0|||
42264037|NCT02397460|76091985|FG006|Treatment Period 4|Adverse Event|0|||
42333356|NCT01857063|76170895|FG001|Period 1 (7 Days)|Physician Decision|0|||
42333357|NCT01857063|76170894|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
42333358|NCT01857063|76170895|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
42333359|NCT01857063|76170894|FG000|Period 2 (7 Days)|Adverse Event|2|||
41999281|NCT01193920|75807743|FG003|Overall Study|Lost to Follow-up|1|||
41999282|NCT01193920|75807744|FG004|Overall Study|Lost to Follow-up|3|||
41999283|NCT01193920|75807745|FG005|Overall Study|Lost to Follow-up|3|||
41999284|NCT01193920|75807746|FG006|Overall Study|Lost to Follow-up|1|||
41999285|NCT01193920|75807747|FG007|Overall Study|Lost to Follow-up|0|||
41999286|NCT01193920|75807748|FG008|Overall Study|Lost to Follow-up|2|||
41999287|NCT01193920|75807749|FG009|Overall Study|Lost to Follow-up|3|||
41999288|NCT01193920|75807740|FG000|Overall Study|Protocol Violation|1|||
41999289|NCT01193920|75807741|FG001|Overall Study|Protocol Violation|0|||
41999290|NCT01193920|75807742|FG002|Overall Study|Protocol Violation|0|||
41999291|NCT01193920|75807743|FG003|Overall Study|Protocol Violation|0|||
41999292|NCT01193920|75807744|FG004|Overall Study|Protocol Violation|0|||
41999293|NCT01193920|75807745|FG005|Overall Study|Protocol Violation|0|||
41999294|NCT01193920|75807746|FG006|Overall Study|Protocol Violation|0|||
41999295|NCT01193920|75807747|FG007|Overall Study|Protocol Violation|0|||
41999296|NCT01193920|75807748|FG008|Overall Study|Protocol Violation|0|||
41999297|NCT01193920|75807749|FG009|Overall Study|Protocol Violation|0|||
41999298|NCT01193920|75807740|FG000|Overall Study|Death|0|||
41999299|NCT01193920|75807741|FG001|Overall Study|Death|0|||
41999300|NCT01193920|75807742|FG002|Overall Study|Death|0|||
41999301|NCT01193920|75807743|FG003|Overall Study|Death|1|||
41999302|NCT01193920|75807744|FG004|Overall Study|Death|0|||
41999303|NCT01193920|75807745|FG005|Overall Study|Death|0|||
41999304|NCT01193920|75807746|FG006|Overall Study|Death|2|||
41999305|NCT01193920|75807747|FG007|Overall Study|Death|3|||
41999306|NCT01193920|75807748|FG008|Overall Study|Death|2|||
41999307|NCT01193920|75807749|FG009|Overall Study|Death|4|||
41999308|NCT01193920|75807740|FG000|Overall Study|Unable to classify|0|||
41999309|NCT01193920|75807741|FG001|Overall Study|Unable to classify|0|||
41999310|NCT01193920|75807742|FG002|Overall Study|Unable to classify|0|||
41999311|NCT01193920|75807743|FG003|Overall Study|Unable to classify|1|||
41999312|NCT01193920|75807744|FG004|Overall Study|Unable to classify|0|||
41999313|NCT01193920|75807745|FG005|Overall Study|Unable to classify|0|||
41999314|NCT01193920|75807746|FG006|Overall Study|Unable to classify|0|||
41999315|NCT01193920|75807747|FG007|Overall Study|Unable to classify|1|||
41999316|NCT01193920|75807748|FG008|Overall Study|Unable to classify|0|||
41999317|NCT01193920|75807749|FG009|Overall Study|Unable to classify|0|||
41999318|NCT01193686|75807774|FG000|Overall Study|Withdrawal by Subject|4|||
41999319|NCT01193686|75807775|FG001|Overall Study|Withdrawal by Subject|1|||
41999320|NCT01193686|75807774|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
41999321|NCT01193686|75807775|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
41999322|NCT01193608|75807788|FG000|Overall Study|Other|0|||
41999323|NCT01193608|75807789|FG001|Overall Study|Other|1|||
41999324|NCT01193608|75807790|FG002|Overall Study|Other|0|||
41999325|NCT01193608|75807791|FG003|Overall Study|Other|0|||
41999326|NCT01193608|75807792|FG004|Overall Study|Other|0|||
41999327|NCT01193608|75807793|FG005|Overall Study|Other|0|||
41999328|NCT01193608|75807788|FG000|Overall Study|Withdrawal by Subject|0|||
41999329|NCT01193608|75807789|FG001|Overall Study|Withdrawal by Subject|1|||
42264038|NCT02397460|76091986|FG007|Treatment Period 4|Adverse Event|0|||
41999330|NCT01193608|75807790|FG002|Overall Study|Withdrawal by Subject|2|||
41999331|NCT01193608|75807791|FG003|Overall Study|Withdrawal by Subject|3|||
41999332|NCT01193608|75807792|FG004|Overall Study|Withdrawal by Subject|3|||
41999333|NCT01193608|75807793|FG005|Overall Study|Withdrawal by Subject|0|||
41999334|NCT01193608|75807788|FG000|Overall Study|Lost to Follow-up|0|||
41999335|NCT01193608|75807789|FG001|Overall Study|Lost to Follow-up|0|||
41999336|NCT01193608|75807790|FG002|Overall Study|Lost to Follow-up|0|||
41999337|NCT01193608|75807791|FG003|Overall Study|Lost to Follow-up|0|||
41999338|NCT01193608|75807792|FG004|Overall Study|Lost to Follow-up|1|||
41999339|NCT01193608|75807793|FG005|Overall Study|Lost to Follow-up|2|||
41999340|NCT01193608|75807788|FG000|Overall Study|Adverse Event|0|||
41999341|NCT01193608|75807789|FG001|Overall Study|Adverse Event|0|||
41999342|NCT01193608|75807790|FG002|Overall Study|Adverse Event|0|||
41999343|NCT01193608|75807791|FG003|Overall Study|Adverse Event|0|||
42264039|NCT02397460|76091979|FG000|Treatment Period 4|Physician Decision|0|||
42264040|NCT02397460|76091980|FG001|Treatment Period 4|Physician Decision|0|||
42264041|NCT02397460|76091981|FG002|Treatment Period 4|Physician Decision|0|||
42264042|NCT02397460|76091982|FG003|Treatment Period 4|Physician Decision|0|||
42264043|NCT02397460|76091983|FG004|Treatment Period 4|Physician Decision|1|||
42264044|NCT02397460|76091984|FG005|Treatment Period 4|Physician Decision|0|||
42264045|NCT02397460|76091985|FG006|Treatment Period 4|Physician Decision|0|||
42264046|NCT02397460|76091986|FG007|Treatment Period 4|Physician Decision|0|||
42264047|NCT02834819|76092062|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
42264048|NCT02834819|76092063|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
42264049|NCT02454478|76092069|FG000|Overall Study|Incomplete DLT Evaluation|1|||
42264050|NCT01341587|76092075|FG000|Overall Study|Lost to Follow-up|2|||
42264051|NCT01341587|76092076|FG001|Overall Study|Lost to Follow-up|0|||
42264052|NCT01341587|76092075|FG000|Overall Study|stopped using the meters|2|||
42333360|NCT01857063|76170895|FG001|Period 2 (7 Days)|Adverse Event|1|||
42333361|NCT01857063|76170894|FG000|Period 2 (7 Days)|Physician Decision|1|||
42333362|NCT01857063|76170895|FG001|Period 2 (7 Days)|Physician Decision|1|||
42333363|NCT01857063|76170894|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
42333364|NCT01857063|76170895|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
42333365|NCT01856907|76170904|FG000|Overall Study|Pregnancy|0|||
42333366|NCT01856907|76170905|FG001|Overall Study|Pregnancy|1|||
42333367|NCT01856907|76170906|FG002|Overall Study|Pregnancy|0|||
42333368|NCT01856907|76170904|FG000|Overall Study|Pregnancy|0|||
42333369|NCT01856907|76170905|FG001|Overall Study|Pregnancy|1|||
42333370|NCT01856907|76170906|FG002|Overall Study|Pregnancy|0|||
42333371|NCT01856907|76170904|FG000|Overall Study|Withdrawal by Subject|0|||
42333372|NCT01856907|76170905|FG001|Overall Study|Withdrawal by Subject|1|||
42333373|NCT01856907|76170906|FG002|Overall Study|Withdrawal by Subject|0|||
42333374|NCT02212457|76170923|FG000|Overall Study|Adverse Event|1|||
42333375|NCT02212457|76170924|FG001|Overall Study|Adverse Event|2|||
42333376|NCT02212457|76170925|FG002|Overall Study|Adverse Event|2|||
42333377|NCT02212457|76170926|FG003|Overall Study|Adverse Event|2|||
42333378|NCT02212457|76170927|FG004|Overall Study|Adverse Event|0|||
42333379|NCT02212457|76170928|FG005|Overall Study|Adverse Event|1|||
42333380|NCT02212457|76170923|FG000|Overall Study|Withdrawal by Subject|8|||
42333381|NCT02212457|76170924|FG001|Overall Study|Withdrawal by Subject|10|||
42333382|NCT02212457|76170925|FG002|Overall Study|Withdrawal by Subject|8|||
42333383|NCT02212457|76170926|FG003|Overall Study|Withdrawal by Subject|6|||
42333384|NCT02212457|76170927|FG004|Overall Study|Withdrawal by Subject|5|||
42333385|NCT02212457|76170928|FG005|Overall Study|Withdrawal by Subject|4|||
42333386|NCT02212457|76170923|FG000|Overall Study|Lost to Follow-up|6|||
42333387|NCT02212457|76170924|FG001|Overall Study|Lost to Follow-up|7|||
42333388|NCT02212457|76170925|FG002|Overall Study|Lost to Follow-up|4|||
42333389|NCT02212457|76170926|FG003|Overall Study|Lost to Follow-up|1|||
42333390|NCT02212457|76170927|FG004|Overall Study|Lost to Follow-up|8|||
42333391|NCT02212457|76170928|FG005|Overall Study|Lost to Follow-up|4|||
42134353|NCT03848832|75945202|FG002|Overall Study|Physician Decision|3|||
42134354|NCT03848832|75945200|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
42134355|NCT03848832|75945201|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
42134356|NCT03848832|75945202|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
42134357|NCT03848832|75945200|FG000|Overall Study|Adverse Event|1|||
42134358|NCT03848832|75945201|FG001|Overall Study|Adverse Event|0|||
42134359|NCT03848832|75945202|FG002|Overall Study|Adverse Event|0|||
42333392|NCT02212457|76170923|FG000|Overall Study|Protocol Violation|2|||
42134360|NCT00450372|75945212|FG000|Overall Study|Physician Decision|1|||
42264053|NCT01341587|76092076|FG001|Overall Study|stopped using the meters|10|||
42264054|NCT01358825|76092084|FG000|Overall Study|Blood sample not drawn|0|||
42264055|NCT01358825|76092085|FG001|Overall Study|Blood sample not drawn|1|||
42264056|NCT02453386|76092094|FG000|Overall Study|Adverse Event|22|||
42264057|NCT02453386|76092095|FG001|Overall Study|Adverse Event|30|||
42264058|NCT02453386|76092096|FG002|Overall Study|Adverse Event|15|||
42264059|NCT02453386|76092094|FG000|Overall Study|Protocol Violation|1|||
42264060|NCT02453386|76092095|FG001|Overall Study|Protocol Violation|0|||
42264061|NCT02453386|76092096|FG002|Overall Study|Protocol Violation|1|||
42264062|NCT02453386|76092094|FG000|Overall Study|Withdrawal by Subject|10|||
42264063|NCT02453386|76092095|FG001|Overall Study|Withdrawal by Subject|9|||
42264064|NCT02453386|76092096|FG002|Overall Study|Withdrawal by Subject|9|||
42264065|NCT02453386|76092094|FG000|Overall Study|Sponsor Terminated Study|14|||
42264066|NCT02453386|76092095|FG001|Overall Study|Sponsor Terminated Study|8|||
42264067|NCT02453386|76092096|FG002|Overall Study|Sponsor Terminated Study|11|||
42264068|NCT02453386|76092094|FG000|Overall Study|Subject Terminated by Sponsor|1|||
42264069|NCT02453386|76092095|FG001|Overall Study|Subject Terminated by Sponsor|1|||
42264070|NCT02453386|76092096|FG002|Overall Study|Subject Terminated by Sponsor|1|||
42264071|NCT02453386|76092094|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
41999344|NCT01193608|75807792|FG004|Overall Study|Adverse Event|1|||
41999345|NCT01193608|75807793|FG005|Overall Study|Adverse Event|0|||
41999346|NCT01177228|75807816|FG000|Overall Study|Positive tuberculosis test|0|||
41999347|NCT01177228|75807817|FG001|Overall Study|Positive tuberculosis test|1|||
41999348|NCT01177228|75807818|FG002|Overall Study|Positive tuberculosis test|0|||
42264072|NCT02453386|76092095|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
42264073|NCT02453386|76092096|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
42264074|NCT02453386|76092094|FG000|Overall Study|Lost to Follow-up|0|||
42264075|NCT02453386|76092095|FG001|Overall Study|Lost to Follow-up|0|||
42264076|NCT02453386|76092096|FG002|Overall Study|Lost to Follow-up|1|||
42264077|NCT02453386|76092094|FG000|Overall Study|Other|1|||
41999349|NCT01177228|75807819|FG003|Overall Study|Positive tuberculosis test|0|||
42264078|NCT02453386|76092095|FG001|Overall Study|Other|0|||
42264079|NCT02453386|76092096|FG002|Overall Study|Other|1|||
41999350|NCT01177228|75807816|FG000|Overall Study|Worsening disease activity|1|||
42333393|NCT02212457|76170924|FG001|Overall Study|Protocol Violation|1|||
42333394|NCT02212457|76170925|FG002|Overall Study|Protocol Violation|0|||
42333395|NCT02212457|76170926|FG003|Overall Study|Protocol Violation|1|||
42333396|NCT02212457|76170927|FG004|Overall Study|Protocol Violation|2|||
42333397|NCT02212457|76170928|FG005|Overall Study|Protocol Violation|3|||
42333398|NCT02212457|76170923|FG000|Overall Study|Other|2|||
42333399|NCT02212457|76170924|FG001|Overall Study|Other|1|||
42333400|NCT02212457|76170925|FG002|Overall Study|Other|2|||
42333401|NCT02212457|76170926|FG003|Overall Study|Other|1|||
42333402|NCT02212457|76170927|FG004|Overall Study|Other|0|||
42333403|NCT02212457|76170928|FG005|Overall Study|Other|1|||
42333404|NCT02097745|76170949|FG000|Overall Study|Adverse Event|25|||
42333405|NCT02097745|76170949|FG000|Overall Study|Death|16|||
42333406|NCT02097745|76170949|FG000|Overall Study|Failure to Return|14|||
42333407|NCT02097745|76170949|FG000|Overall Study|Administrative/Other|27|||
42333408|NCT02097745|76170949|FG000|Overall Study|Reason Not Specified|96|||
42333409|NCT02111083|76170958|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
42333410|NCT02111083|76170959|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
42333411|NCT01629563|76170967|FG000|Overall Study|Adverse Event|16|||
42333412|NCT01629563|76170968|FG001|Overall Study|Adverse Event|16|||
42333413|NCT01629563|76170967|FG000|Overall Study|Death|2|||
42333414|NCT01629563|76170968|FG001|Overall Study|Death|0|||
42333415|NCT01629563|76170967|FG000|Overall Study|Lack of Efficacy|2|||
41999351|NCT01177228|75807817|FG001|Overall Study|Worsening disease activity|0|||
41999352|NCT01177228|75807818|FG002|Overall Study|Worsening disease activity|0|||
42333416|NCT01629563|76170968|FG001|Overall Study|Lack of Efficacy|3|||
41999353|NCT01177228|75807819|FG003|Overall Study|Worsening disease activity|0|||
42333417|NCT01629563|76170967|FG000|Overall Study|Lost to Follow-up|1|||
42333418|NCT01629563|76170968|FG001|Overall Study|Lost to Follow-up|0|||
41999354|NCT01177228|75807816|FG000|Overall Study|Withdrawal by Subject|0|||
42333419|NCT01629563|76170967|FG000|Overall Study|Pregnancy|1|||
42264080|NCT02431468|76092114|FG000|Overall Study|Adverse Event|2|||
42264081|NCT02431468|76092115|FG001|Overall Study|Adverse Event|4|||
42264082|NCT02431468|76092116|FG002|Overall Study|Adverse Event|5|||
42264083|NCT02431468|76092114|FG000|Overall Study|Withdrawal by Subject|4|||
42264084|NCT02431468|76092115|FG001|Overall Study|Withdrawal by Subject|12|||
42264085|NCT02431468|76092116|FG002|Overall Study|Withdrawal by Subject|2|||
42264086|NCT02431468|76092114|FG000|Overall Study|noncompliance, investigator termination,|2|||
42264087|NCT02431468|76092115|FG001|Overall Study|noncompliance, investigator termination,|2|||
42264088|NCT02431468|76092116|FG002|Overall Study|noncompliance, investigator termination,|2|||
42264089|NCT02452762|76092132|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
42264090|NCT02452762|76092133|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
42264091|NCT02452762|76092132|FG000|Overall Study|Withdrawal by Subject|1|||
42264092|NCT02452762|76092133|FG001|Overall Study|Withdrawal by Subject|0|||
42264093|NCT02633306|76092140|FG000|Overall Study|Withdrawal by Subject|3|||
42264094|NCT02396758|76092149|FG000|Overall Study|Withdrawal by Subject|2|||
42264095|NCT02396758|76092150|FG001|Overall Study|Withdrawal by Subject|0|||
42264096|NCT02396758|76092151|FG002|Overall Study|Withdrawal by Subject|0|||
42333420|NCT01629563|76170968|FG001|Overall Study|Pregnancy|2|||
42333421|NCT01629563|76170967|FG000|Overall Study|Protocol Violation|0|||
42333422|NCT01629563|76170968|FG001|Overall Study|Protocol Violation|1|||
42333423|NCT01629563|76170967|FG000|Overall Study|Withdrawal by Subject|27|||
42333424|NCT01629563|76170968|FG001|Overall Study|Withdrawal by Subject|20|||
42333425|NCT01629563|76170967|FG000|Overall Study|surgery|0|||
42333426|NCT01629563|76170968|FG001|Overall Study|surgery|3|||
42333427|NCT01629563|76170967|FG000|Overall Study|Lack of return of menses|12|||
42333428|NCT01629563|76170968|FG001|Overall Study|Lack of return of menses|7|||
42333429|NCT01629563|76170967|FG000|Overall Study|Protocol Violation|0|||
42333430|NCT01629563|76170968|FG001|Overall Study|Protocol Violation|1|||
42333431|NCT02097277|76170979|FG000|Overall Study|Subject no longer meets study criteria|0|||
42333432|NCT02097277|76170980|FG001|Overall Study|Subject no longer meets study criteria|1|||
42333433|NCT02097277|76170981|FG002|Overall Study|Subject no longer meets study criteria|0|||
42333434|NCT02097277|76170982|FG003|Overall Study|Subject no longer meets study criteria|1|||
42333435|NCT02097277|76170983|FG004|Overall Study|Subject no longer meets study criteria|0|||
42264097|NCT02396758|76092152|FG003|Overall Study|Withdrawal by Subject|1|||
42264098|NCT02396758|76092149|FG000|Overall Study|Lost to Follow-up|8|||
42264099|NCT02396758|76092150|FG001|Overall Study|Lost to Follow-up|5|||
42264100|NCT02396758|76092151|FG002|Overall Study|Lost to Follow-up|3|||
42264101|NCT02396758|76092152|FG003|Overall Study|Lost to Follow-up|3|||
42264102|NCT02396758|76092149|FG000|Overall Study|Death|1|||
42264103|NCT02396758|76092150|FG001|Overall Study|Death|1|||
42264104|NCT02396758|76092151|FG002|Overall Study|Death|0|||
42264105|NCT02396758|76092152|FG003|Overall Study|Death|1|||
42264106|NCT02396758|76092149|FG000|Overall Study|Randomized but not treated|1|||
42264107|NCT02396758|76092150|FG001|Overall Study|Randomized but not treated|0|||
42264108|NCT02396758|76092151|FG002|Overall Study|Randomized but not treated|1|||
42264109|NCT02396758|76092152|FG003|Overall Study|Randomized but not treated|0|||
42333436|NCT02097277|76170979|FG000|Overall Study|Subject request to discontinue treatment|0|||
42333437|NCT02097277|76170980|FG001|Overall Study|Subject request to discontinue treatment|0|||
42333438|NCT02097277|76170981|FG002|Overall Study|Subject request to discontinue treatment|0|||
42333439|NCT02097277|76170982|FG003|Overall Study|Subject request to discontinue treatment|0|||
42333440|NCT02097277|76170983|FG004|Overall Study|Subject request to discontinue treatment|1|||
42333441|NCT02097277|76170979|FG000|Overall Study|Lost to Follow-up|0|||
42333442|NCT02097277|76170980|FG001|Overall Study|Lost to Follow-up|1|||
42333443|NCT02097277|76170981|FG002|Overall Study|Lost to Follow-up|1|||
42333444|NCT02097277|76170982|FG003|Overall Study|Lost to Follow-up|0|||
42333445|NCT02097277|76170983|FG004|Overall Study|Lost to Follow-up|0|||
42333446|NCT02097277|76170979|FG000|Overall Study|Withdrawal by Subject|2|||
42333447|NCT02097277|76170980|FG001|Overall Study|Withdrawal by Subject|1|||
42333448|NCT02097277|76170981|FG002|Overall Study|Withdrawal by Subject|0|||
42333449|NCT02097277|76170982|FG003|Overall Study|Withdrawal by Subject|1|||
42333450|NCT02097277|76170983|FG004|Overall Study|Withdrawal by Subject|0|||
42333451|NCT02097277|76170979|FG000|Overall Study|Adverse Event|0|||
42333452|NCT02097277|76170980|FG001|Overall Study|Adverse Event|0|||
42333453|NCT02097277|76170981|FG002|Overall Study|Adverse Event|1|||
42333454|NCT02097277|76170982|FG003|Overall Study|Adverse Event|2|||
42333455|NCT02097277|76170983|FG004|Overall Study|Adverse Event|0|||
42333456|NCT02212379|76170999|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
42333457|NCT02212379|76170999|FG000|From Baseline to Week 48|Adverse Event|7|||
42333458|NCT02212379|76170999|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
42333459|NCT02212379|76170999|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
42333460|NCT02212379|76170999|FG000|From Week 48 to Week 96|Adverse Event|1|||
42333461|NCT02212379|76170999|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
42333462|NCT02110693|76171006|FG000|Overall Study|Withdrawal by Subject|6|||
42333463|NCT02110693|76171007|FG001|Overall Study|Withdrawal by Subject|7|||
42333464|NCT02110693|76171006|FG000|Overall Study|skipped assessment|15|||
42333465|NCT02110693|76171007|FG001|Overall Study|skipped assessment|18|||
42333466|NCT02110693|76171006|FG000|Overall Study|technical difficulties|6|||
42333467|NCT02110693|76171007|FG001|Overall Study|technical difficulties|4|||
42333468|NCT02110693|76171006|FG000|Overall Study|Other|1|||
42333469|NCT02110693|76171007|FG001|Overall Study|Other|0|||
42333470|NCT02212301|76171027|FG000|Period 1|Lost to Follow-up|0|||
42333471|NCT02212301|76171028|FG001|Period 1|Lost to Follow-up|1|||
42333472|NCT02211209|76171037|FG000|Overall Study|Investigator judgment|0|||
42333473|NCT02211209|76171038|FG001|Overall Study|Investigator judgment|1|||
42333474|NCT02211209|76171037|FG000|Overall Study|Voluntary withdrawal|1|||
42333475|NCT02211209|76171038|FG001|Overall Study|Voluntary withdrawal|4|||
42034613|NCT01120379|75842706|FG000|One Year Timepoint|Any other reason for early termination|5|||
42264110|NCT02632838|76092164|FG000|Overall Study|Withdrawal by Subject|3|||
42264111|NCT02632838|76092165|FG001|Overall Study|Withdrawal by Subject|0|||
42333476|NCT02211209|76171037|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
42333477|NCT02211209|76171038|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
42333478|NCT02211209|76171037|FG000|Overall Study|Reason Not Specified|1|||
42264112|NCT02632838|76092164|FG000|Overall Study|Lost to Follow-up|0|||
42264113|NCT02632838|76092165|FG001|Overall Study|Lost to Follow-up|2|||
42264114|NCT02396212|76092175|FG000|Overall Study|Adverse Event|1|||
42264115|NCT02396212|76092175|FG000|Overall Study|Lack of Efficacy|2|||
42333479|NCT02211209|76171038|FG001|Overall Study|Reason Not Specified|0|||
42264116|NCT02395822|76092179|FG000|Overall Study|Withdrawal by Subject|1|||
42264117|NCT02395822|76092179|FG000|Overall Study|Death|1|||
42264118|NCT01651936|76092185|FG000|Base Study|Adverse Event|3|||
42264119|NCT01651936|76092186|FG001|Base Study|Adverse Event|0|||
42264120|NCT01651936|76092187|FG002|Base Study|Adverse Event|0|||
42264121|NCT01651936|76092185|FG000|Base Study|Withdrawal by Subject|1|||
42264122|NCT01651936|76092186|FG001|Base Study|Withdrawal by Subject|1|||
42264123|NCT01651936|76092187|FG002|Base Study|Withdrawal by Subject|0|||
42264124|NCT01651936|76092185|FG000|Base Study|Early Escape|2|||
42264125|NCT01651936|76092186|FG001|Base Study|Early Escape|8|||
42264126|NCT01651936|76092187|FG002|Base Study|Early Escape|0|||
42264127|NCT01651936|76092185|FG000|Base Study|Study terminated by sponsor|21|||
42264128|NCT01651936|76092186|FG001|Base Study|Study terminated by sponsor|16|||
42264129|NCT01651936|76092187|FG002|Base Study|Study terminated by sponsor|0|||
42264130|NCT01651936|76092185|FG000|Extension Study|Lack of Efficacy|0|||
42264131|NCT01651936|76092186|FG001|Extension Study|Lack of Efficacy|0|||
41999355|NCT01177228|75807817|FG001|Overall Study|Withdrawal by Subject|1|||
42264132|NCT01651936|76092187|FG002|Extension Study|Lack of Efficacy|1|||
42264133|NCT01651936|76092185|FG000|Extension Study|Study terminated by sponsor|0|||
42264134|NCT01651936|76092186|FG001|Extension Study|Study terminated by sponsor|0|||
42264135|NCT01651936|76092187|FG002|Extension Study|Study terminated by sponsor|13|||
42264136|NCT02395042|76092197|FG000|Treatment 1 Period|Adverse Event|1|||
42264137|NCT02395042|76092198|FG001|Treatment 1 Period|Adverse Event|3|||
42264138|NCT02395042|76092199|FG002|Treatment 1 Period|Adverse Event|1|||
42264139|NCT02395042|76092197|FG000|Treatment 1 Period|Lack of Efficacy|1|||
42264140|NCT02395042|76092198|FG001|Treatment 1 Period|Lack of Efficacy|1|||
42264141|NCT02395042|76092199|FG002|Treatment 1 Period|Lack of Efficacy|0|||
42264142|NCT02395042|76092197|FG000|Treatment 1 Period|Lost to Follow-up|1|||
42264143|NCT02395042|76092198|FG001|Treatment 1 Period|Lost to Follow-up|0|||
42264144|NCT02395042|76092199|FG002|Treatment 1 Period|Lost to Follow-up|0|||
42264145|NCT02395042|76092197|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
42264146|NCT02395042|76092198|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
42264147|NCT02395042|76092199|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
42264148|NCT02395042|76092197|FG000|Treatment 2 Period|Lack of Efficacy|1|||
42264149|NCT02395042|76092198|FG001|Treatment 2 Period|Lack of Efficacy|1|||
42264150|NCT02395042|76092199|FG002|Treatment 2 Period|Lack of Efficacy|0|||
42264151|NCT02394808|76092210|FG000|Period 1|Unsatisfactory lens fitting|0|||
42264152|NCT02394808|76092211|FG001|Period 1|Unsatisfactory lens fitting|1|||
42264153|NCT02394808|76092210|FG000|Period 2|Lost to Follow-up|1|||
42333480|NCT02187809|76171044|FG000|Overall Study|The study was terminated|3|||
42333481|NCT02187029|76171052|FG000|Overall Study|Adverse Event|0|||
42333482|NCT02187029|76171053|FG001|Overall Study|Adverse Event|1|||
42333483|NCT02187029|76171054|FG002|Overall Study|Adverse Event|1|||
42333484|NCT02187029|76171055|FG003|Overall Study|Adverse Event|0|||
42333485|NCT02187029|76171052|FG000|Overall Study|Study Terminated by Sponsor|0|||
42333486|NCT02187029|76171053|FG001|Overall Study|Study Terminated by Sponsor|0|||
42333487|NCT02187029|76171054|FG002|Overall Study|Study Terminated by Sponsor|10|||
42333488|NCT02187029|76171055|FG003|Overall Study|Study Terminated by Sponsor|3|||
42333489|NCT02187029|76171052|FG000|Overall Study|Withdrawal by Subject|1|||
42333490|NCT02187029|76171053|FG001|Overall Study|Withdrawal by Subject|0|||
42333491|NCT02187029|76171054|FG002|Overall Study|Withdrawal by Subject|0|||
42333492|NCT02187029|76171055|FG003|Overall Study|Withdrawal by Subject|0|||
42333493|NCT02162771|76171067|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
42333494|NCT02162771|76171068|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
42333495|NCT02162771|76171067|FG000|Core Study Period (Part 2)|Adverse Event|4|||
42333496|NCT02162771|76171068|FG001|Core Study Period (Part 2)|Adverse Event|1|||
42333497|NCT02162771|76171067|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
42333498|NCT02162771|76171068|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
42333499|NCT02162771|76171067|FG000|Core Study Period (Part 2)|Physician Decision|0|||
42333500|NCT02162771|76171068|FG001|Core Study Period (Part 2)|Physician Decision|2|||
42333501|NCT02162771|76171067|FG000|Core Study Period (Part 2)|Death|1|||
42333502|NCT02162771|76171068|FG001|Core Study Period (Part 2)|Death|0|||
42333503|NCT02162771|76171067|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
42333504|NCT02162771|76171068|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
42333505|NCT02162771|76171067|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
42333506|NCT02162771|76171068|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
42333507|NCT02162771|76171067|FG000|Maintenance Study Period (Part 2)|Death|2|||
42333508|NCT02162771|76171068|FG001|Maintenance Study Period (Part 2)|Death|1|||
42333509|NCT02162771|76171067|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
42333510|NCT02162771|76171068|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
42333511|NCT02162771|76171067|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
42333512|NCT02162771|76171068|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
42333513|NCT02162771|76171067|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
42333514|NCT02162771|76171068|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
42333515|NCT02161757|76171077|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
42333516|NCT02161757|76171078|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
42333517|NCT02161757|76171079|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
41999356|NCT01177228|75807818|FG002|Overall Study|Withdrawal by Subject|0|||
42264154|NCT02394808|76092211|FG001|Period 2|Lost to Follow-up|0|||
42264155|NCT02630966|76092219|FG000|Overall Study|Adverse Event|1|||
42264156|NCT02630966|76092220|FG001|Overall Study|Adverse Event|3|||
42264157|NCT02630966|76092219|FG000|Overall Study|Significant Protocol Deviation|0|||
42264158|NCT02630966|76092220|FG001|Overall Study|Significant Protocol Deviation|2|||
42264159|NCT02630966|76092219|FG000|Overall Study|Voluntary Withdrawal|1|||
42264160|NCT02630966|76092220|FG001|Overall Study|Voluntary Withdrawal|1|||
42264161|NCT02630966|76092219|FG000|Overall Study|Lack of Efficacy|0|||
42264162|NCT02630966|76092220|FG001|Overall Study|Lack of Efficacy|2|||
42264163|NCT01651780|76092228|FG000|Overall Study|Physician decision: No 30-day visit|2|||
42264164|NCT01651780|76092229|FG001|Overall Study|Physician decision: No 30-day visit|1|||
42134361|NCT00327340|75945221|FG000|Overall Study|Withdrawal by Subject|1|||
42134362|NCT00327340|75945222|FG001|Overall Study|Withdrawal by Subject|5|||
42134363|NCT00327340|75945221|FG000|Overall Study|Physician Decision|1|||
42134364|NCT00327340|75945222|FG001|Overall Study|Physician Decision|1|||
42134365|NCT00327340|75945221|FG000|Overall Study|Disease Progression|10|||
42134366|NCT00327340|75945222|FG001|Overall Study|Disease Progression|19|||
42134367|NCT00327340|75945221|FG000|Overall Study|Symptomatic Disease|0|||
42264165|NCT01651780|76092228|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
42264166|NCT01651780|76092229|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
42264167|NCT01651780|76092228|FG000|Overall Study|Withdrawal by Subject|2|||
42264168|NCT01651780|76092229|FG001|Overall Study|Withdrawal by Subject|0|||
42264169|NCT01651780|76092228|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
42264170|NCT01651780|76092229|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42264171|NCT01651780|76092228|FG000|Overall Study|Lost to Follow-up|1|||
42264172|NCT01651780|76092229|FG001|Overall Study|Lost to Follow-up|2|||
42264173|NCT01651780|76092228|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
42264174|NCT01651780|76092229|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
42134368|NCT00327340|75945222|FG001|Overall Study|Symptomatic Disease|2|||
42134369|NCT00327340|75945221|FG000|Overall Study|Adverse Event|3|||
42134370|NCT00327340|75945222|FG001|Overall Study|Adverse Event|3|||
42134371|NCT00548093|75945232|FG000|Overall Study|Death|33|||
42264175|NCT02394730|76092241|FG000|Overall Study|Lost to Follow-up|1|||
42333518|NCT02161757|76171077|FG000|Treatment Through Study Completion|Adverse Event|1|||
42333519|NCT02161757|76171078|FG001|Treatment Through Study Completion|Adverse Event|1|||
42333520|NCT02161757|76171079|FG002|Treatment Through Study Completion|Adverse Event|0|||
42333521|NCT02161757|76171077|FG000|Treatment Through Study Completion|Protocol Violation|0|||
42333522|NCT02161757|76171078|FG001|Treatment Through Study Completion|Protocol Violation|1|||
42333523|NCT02161757|76171079|FG002|Treatment Through Study Completion|Protocol Violation|2|||
42333524|NCT02161757|76171077|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
42333525|NCT02161757|76171078|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
42333526|NCT02161757|76171079|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
42333527|NCT02161757|76171077|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
42333528|NCT02161757|76171078|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
42333529|NCT02161757|76171079|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
42333530|NCT02161757|76171077|FG000|Treatment Through Study Completion|Other|20|||
42333531|NCT02161757|76171078|FG001|Treatment Through Study Completion|Other|19|||
42333532|NCT02161757|76171079|FG002|Treatment Through Study Completion|Other|12|||
42333533|NCT02161757|76171077|FG000|Treatment Through Study Completion|Death|2|||
42333534|NCT02161757|76171078|FG001|Treatment Through Study Completion|Death|1|||
42333535|NCT02161757|76171079|FG002|Treatment Through Study Completion|Death|1|||
42333536|NCT02160977|76171089|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
42333537|NCT02160977|76171090|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
42333538|NCT02160977|76171089|FG000|Three Months After Surgery|Lost to Follow-up|0|||
42333539|NCT02160977|76171090|FG001|Three Months After Surgery|Lost to Follow-up|2|||
42333540|NCT02160977|76171089|FG000|Six Months After Surgery|Lost to Follow-up|2|||
42333541|NCT02160977|76171090|FG001|Six Months After Surgery|Lost to Follow-up|1|||
42333542|NCT02160899|76171102|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
42333543|NCT02160899|76171103|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
42333544|NCT02160899|76171104|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
42333545|NCT02160899|76171105|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
42333546|NCT02160899|76171106|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
42333547|NCT02160899|76171107|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
42333548|NCT02160041|76171121|FG000|Overall Study|Adverse Event|11|||
42333549|NCT02160041|76171121|FG000|Overall Study|Death|2|||
42333550|NCT02160041|76171121|FG000|Overall Study|disease progression|57|||
42333551|NCT02160041|76171121|FG000|Overall Study|Protocol Violation|1|||
41999357|NCT01177228|75807819|FG003|Overall Study|Withdrawal by Subject|0|||
41999358|NCT01193530|75807836|FG000|Overall Study|Withdrawal by Subject|2|||
41999359|NCT01193530|75807837|FG001|Overall Study|Withdrawal by Subject|2|||
41999360|NCT01193530|75807836|FG000|Overall Study|Began Contraindicated Therapy|1|||
41999361|NCT01193530|75807837|FG001|Overall Study|Began Contraindicated Therapy|0|||
41999362|NCT01193530|75807836|FG000|Overall Study|Lost Light Box|0|||
41999363|NCT01193530|75807837|FG001|Overall Study|Lost Light Box|1|||
41999364|NCT01193530|75807836|FG000|Overall Study|Returned home - out of state|0|||
41999365|NCT01193530|75807837|FG001|Overall Study|Returned home - out of state|1|||
41999366|NCT01193530|75807836|FG000|Overall Study|Non-Compliance|0|||
41999367|NCT01193530|75807837|FG001|Overall Study|Non-Compliance|1|||
41999368|NCT00107172|75807845|FG000|Overall Study|Withdrawal by Subject|1|||
41999369|NCT00107172|75807846|FG001|Overall Study|Withdrawal by Subject|0|||
41999370|NCT00107172|75807845|FG000|Overall Study|Death|0|||
41999371|NCT00107172|75807846|FG001|Overall Study|Death|2|||
41999372|NCT00107172|75807845|FG000|Overall Study|Other Reason|4|||
41999373|NCT00107172|75807846|FG001|Overall Study|Other Reason|3|||
41999374|NCT01680965|75807860|FG000|Overall Study|Death|0|||
41999375|NCT01680965|75807861|FG001|Overall Study|Death|0|||
41999376|NCT01680965|75807862|FG002|Overall Study|Death|0|||
41999377|NCT01680965|75807863|FG003|Overall Study|Death|6|||
41999378|NCT01339923|75807878|FG000|Overall Study|Adverse Event|1|||
41999379|NCT01339923|75807879|FG001|Overall Study|Adverse Event|1|||
41999380|NCT01339923|75807880|FG002|Overall Study|Adverse Event|1|||
42134372|NCT00548093|75945233|FG001|Overall Study|Death|13|||
41999381|NCT01339923|75807881|FG003|Overall Study|Adverse Event|0|||
41999382|NCT01339923|75807882|FG004|Overall Study|Adverse Event|0|||
41999383|NCT01339923|75807883|FG005|Overall Study|Adverse Event|0|||
41999384|NCT01339923|75807884|FG006|Overall Study|Adverse Event|1|||
42333552|NCT02160041|76171121|FG000|Overall Study|non-compliance with study|1|||
42333553|NCT02160041|76171121|FG000|Overall Study|Physician Decision|3|||
42333554|NCT02160041|76171121|FG000|Overall Study|Withdrawal by Subject|8|||
42333555|NCT02160041|76171121|FG000|Overall Study|study terminated by by sponsor|1|||
42333556|NCT02186873|76171127|FG000|Overall Study|Adverse Event|1|||
42333557|NCT02186873|76171128|FG001|Overall Study|Adverse Event|3|||
42333558|NCT02186873|76171127|FG000|Overall Study|Lack of Efficacy|0|||
41999385|NCT01339923|75807878|FG000|Overall Study|Inappropriate Enrollment|1|||
41999386|NCT01339923|75807879|FG001|Overall Study|Inappropriate Enrollment|0|||
41999387|NCT01339923|75807880|FG002|Overall Study|Inappropriate Enrollment|0|||
42264176|NCT02394730|76092242|FG001|Overall Study|Lost to Follow-up|0|||
42264177|NCT02394730|76092241|FG000|Overall Study|Withdrawal by Subject|0|||
42264178|NCT02394730|76092242|FG001|Overall Study|Withdrawal by Subject|1|||
42264179|NCT02430532|76092250|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
42264180|NCT02430532|76092251|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
42264181|NCT02430532|76092250|FG000|Overall Study|Consent Withdrawn|0|||
42264182|NCT02430532|76092251|FG001|Overall Study|Consent Withdrawn|2|||
42264183|NCT02430532|76092250|FG000|Overall Study|Adverse Event|0|||
42264184|NCT02430532|76092251|FG001|Overall Study|Adverse Event|1|||
42333559|NCT02186873|76171128|FG001|Overall Study|Lack of Efficacy|1|||
42333560|NCT02186873|76171127|FG000|Overall Study|Lost to Follow-up|1|||
41999388|NCT01339923|75807881|FG003|Overall Study|Inappropriate Enrollment|0|||
42333561|NCT02186873|76171128|FG001|Overall Study|Lost to Follow-up|2|||
41999389|NCT01339923|75807882|FG004|Overall Study|Inappropriate Enrollment|0|||
42264185|NCT02394340|76092259|FG000|Overall Study|Failed drug screen test|1|||
42333562|NCT02186873|76171127|FG000|Overall Study|Withdrawal by Subject|7|||
41999390|NCT01339923|75807883|FG005|Overall Study|Inappropriate Enrollment|1|||
41999391|NCT01339923|75807884|FG006|Overall Study|Inappropriate Enrollment|0|||
41999392|NCT01339923|75807878|FG000|Overall Study|Lost to Follow-up|4|||
41999393|NCT01339923|75807879|FG001|Overall Study|Lost to Follow-up|4|||
41999394|NCT01339923|75807880|FG002|Overall Study|Lost to Follow-up|0|||
41999395|NCT01339923|75807881|FG003|Overall Study|Lost to Follow-up|3|||
41999396|NCT01339923|75807882|FG004|Overall Study|Lost to Follow-up|1|||
41999397|NCT01339923|75807883|FG005|Overall Study|Lost to Follow-up|1|||
41999398|NCT01339923|75807884|FG006|Overall Study|Lost to Follow-up|5|||
41999399|NCT01339923|75807878|FG000|Overall Study|Protocol Violation|0|||
41999400|NCT01339923|75807879|FG001|Overall Study|Protocol Violation|0|||
41999401|NCT01339923|75807880|FG002|Overall Study|Protocol Violation|0|||
41999402|NCT01339923|75807881|FG003|Overall Study|Protocol Violation|0|||
42264186|NCT02394340|76092259|FG000|Overall Study|Adverse Event|1|||
42264187|NCT01672736|76092263|FG000|Overall Study|Available drug expired on 31 May 16|3|||
42264188|NCT01560637|76092267|FG000|Overall Study|Adverse Event|63|||
42264189|NCT01560637|76092267|FG000|Overall Study|Death|69|||
42264190|NCT01560637|76092267|FG000|Overall Study|Lost to Follow-up|8|||
42264191|NCT01560637|76092267|FG000|Overall Study|Protocol Violation|8|||
42264192|NCT01560637|76092267|FG000|Overall Study|Withdrawal by Subject|24|||
42333563|NCT02186873|76171128|FG001|Overall Study|Withdrawal by Subject|2|||
42333564|NCT02096263|76171138|FG000|Overall Study|Adverse Event|1|||
42333565|NCT02096263|76171139|FG001|Overall Study|Adverse Event|0|||
42333566|NCT02096263|76171140|FG002|Overall Study|Adverse Event|1|||
42333567|NCT02096263|76171138|FG000|Overall Study|Lost to Follow-up|14|||
42333568|NCT02096263|76171139|FG001|Overall Study|Lost to Follow-up|18|||
42333569|NCT02096263|76171140|FG002|Overall Study|Lost to Follow-up|15|||
42333570|NCT02096263|76171138|FG000|Overall Study|Other|7|||
42333571|NCT02096263|76171139|FG001|Overall Study|Other|9|||
41999403|NCT01339923|75807882|FG004|Overall Study|Protocol Violation|0|||
41999404|NCT01339923|75807883|FG005|Overall Study|Protocol Violation|3|||
41999405|NCT01339923|75807884|FG006|Overall Study|Protocol Violation|1|||
41999406|NCT01339923|75807878|FG000|Overall Study|Unable to Classify|1|||
41999407|NCT01339923|75807879|FG001|Overall Study|Unable to Classify|0|||
41999408|NCT01339923|75807880|FG002|Overall Study|Unable to Classify|1|||
41999409|NCT01339923|75807881|FG003|Overall Study|Unable to Classify|0|||
41999410|NCT01339923|75807882|FG004|Overall Study|Unable to Classify|0|||
41999411|NCT01339923|75807883|FG005|Overall Study|Unable to Classify|1|||
41999412|NCT01339923|75807884|FG006|Overall Study|Unable to Classify|5|||
41999413|NCT01339923|75807878|FG000|Overall Study|Withdrawal by Subject|7|||
41999414|NCT01339923|75807879|FG001|Overall Study|Withdrawal by Subject|11|||
41999415|NCT01339923|75807880|FG002|Overall Study|Withdrawal by Subject|6|||
41999416|NCT01339923|75807881|FG003|Overall Study|Withdrawal by Subject|1|||
41999417|NCT01339923|75807882|FG004|Overall Study|Withdrawal by Subject|4|||
41999418|NCT01339923|75807883|FG005|Overall Study|Withdrawal by Subject|3|||
41999419|NCT01339923|75807884|FG006|Overall Study|Withdrawal by Subject|2|||
41999420|NCT01380093|75807917|FG000|Naloxone Challenge Phase|Screen failures|21|||
41999421|NCT01380093|75807918|FG001|Naloxone Challenge Phase|Screen failures|0|||
41999422|NCT01380093|75807919|FG002|Naloxone Challenge Phase|Screen failures|0|||
42264193|NCT01560637|76092267|FG000|Overall Study|Progressive Disease|20|||
42264194|NCT01560637|76092267|FG000|Overall Study|Other Reason Not Specified|6|||
42333572|NCT02096263|76171140|FG002|Overall Study|Other|6|||
42333573|NCT02096263|76171138|FG000|Overall Study|Sponsor study termination|0|||
42333574|NCT02096263|76171139|FG001|Overall Study|Sponsor study termination|0|||
42034614|NCT01120379|75842706|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
42034615|NCT01120379|75842706|FG000|Two Year Timepoint|Lost to Follow-up|87|||
42034616|NCT01120379|75842706|FG000|Two Year Timepoint|Death|123|||
42034617|NCT01120379|75842706|FG000|Two Year Timepoint|Physician Decision|12|||
42264195|NCT01353911|76092279|FG000|Overall Study|Lost to Follow-up|2|||
42264196|NCT01353911|76092280|FG001|Overall Study|Lost to Follow-up|6|||
42264197|NCT01353911|76092281|FG002|Overall Study|Lost to Follow-up|4|||
42264198|NCT01353911|76092282|FG003|Overall Study|Lost to Follow-up|0|||
42264199|NCT01353911|76092283|FG004|Overall Study|Lost to Follow-up|4|||
42264200|NCT01353911|76092284|FG005|Overall Study|Lost to Follow-up|4|||
42333575|NCT02096263|76171140|FG002|Overall Study|Sponsor study termination|1|||
42333576|NCT02096263|76171138|FG000|Overall Study|Protocol Violation|7|||
42333577|NCT02096263|76171139|FG001|Overall Study|Protocol Violation|2|||
42333578|NCT02096263|76171140|FG002|Overall Study|Protocol Violation|8|||
42333579|NCT02096263|76171138|FG000|Overall Study|Withdrawal by Subject|5|||
42333580|NCT02096263|76171139|FG001|Overall Study|Withdrawal by Subject|7|||
42333581|NCT02096263|76171140|FG002|Overall Study|Withdrawal by Subject|8|||
42333582|NCT01830543|76171151|FG000|Overall Study|Subject Decision|19|||
42333583|NCT01830543|76171152|FG001|Overall Study|Subject Decision|21|||
42333584|NCT01830543|76171153|FG002|Overall Study|Subject Decision|57|||
42333585|NCT01830543|76171151|FG000|Overall Study|Adverse Event|91|||
42333586|NCT01830543|76171152|FG001|Overall Study|Adverse Event|77|||
42333587|NCT01830543|76171153|FG002|Overall Study|Adverse Event|76|||
42333588|NCT01830543|76171151|FG000|Overall Study|Death|20|||
42333589|NCT01830543|76171152|FG001|Overall Study|Death|22|||
42333590|NCT01830543|76171153|FG002|Overall Study|Death|22|||
42333591|NCT01830543|76171151|FG000|Overall Study|Protocol Violation|3|||
42333592|NCT01830543|76171152|FG001|Overall Study|Protocol Violation|7|||
42333593|NCT01830543|76171153|FG002|Overall Study|Protocol Violation|7|||
42333594|NCT01830543|76171151|FG000|Overall Study|Physician Decision|11|||
42333595|NCT01830543|76171152|FG001|Overall Study|Physician Decision|5|||
42333596|NCT01830543|76171153|FG002|Overall Study|Physician Decision|12|||
42333597|NCT01830543|76171151|FG000|Overall Study|Withdrawal by consent|3|||
42333598|NCT01830543|76171152|FG001|Overall Study|Withdrawal by consent|3|||
42333599|NCT01830543|76171153|FG002|Overall Study|Withdrawal by consent|3|||
42333600|NCT01830543|76171151|FG000|Overall Study|Other|12|||
42333601|NCT01830543|76171152|FG001|Overall Study|Other|17|||
42333602|NCT01830543|76171153|FG002|Overall Study|Other|37|||
42333603|NCT02109445|76171161|FG000|Overall Study|Symptomatic deterioration|2|||
42333604|NCT02109445|76171161|FG000|Overall Study|Adverse Event|1|||
42333605|NCT02109133|76171167|FG000|Overall Study|Lost to Follow-up|1|||
42333606|NCT02109133|76171168|FG001|Overall Study|Lost to Follow-up|0|||
42333607|NCT01623271|76171176|FG000|Overall Study|Withdrawal by Subject|2|||
42333608|NCT01856673|76171183|FG000|Overall Study|Withdrawal by Subject|44|||
42333609|NCT01856673|76171184|FG001|Overall Study|Withdrawal by Subject|50|||
42333610|NCT01856673|76171185|FG002|Overall Study|Withdrawal by Subject|33|||
42333611|NCT01856673|76171183|FG000|Overall Study|Lost to Follow-up|31|||
42333612|NCT01856673|76171184|FG001|Overall Study|Lost to Follow-up|34|||
42134373|NCT00548093|75945232|FG000|Overall Study|Lost to Follow-up|3|||
41999423|NCT01380093|75807920|FG003|Naloxone Challenge Phase|Screen failures|0|||
41999424|NCT01380093|75807921|FG004|Naloxone Challenge Phase|Screen failures|0|||
41999425|NCT01380093|75807922|FG005|Naloxone Challenge Phase|Screen failures|0|||
41999426|NCT01380093|75807923|FG006|Naloxone Challenge Phase|Screen failures|0|||
42134374|NCT00548093|75945233|FG001|Overall Study|Lost to Follow-up|1|||
42264201|NCT01353911|76092285|FG006|Overall Study|Lost to Follow-up|3|||
42264202|NCT01353911|76092286|FG007|Overall Study|Lost to Follow-up|6|||
42264203|NCT01353911|76092279|FG000|Overall Study|Withdrawal by Subject|2|||
42264204|NCT01353911|76092280|FG001|Overall Study|Withdrawal by Subject|3|||
42264205|NCT01353911|76092281|FG002|Overall Study|Withdrawal by Subject|4|||
42264206|NCT01353911|76092282|FG003|Overall Study|Withdrawal by Subject|2|||
42264207|NCT01353911|76092283|FG004|Overall Study|Withdrawal by Subject|2|||
42264208|NCT01353911|76092284|FG005|Overall Study|Withdrawal by Subject|3|||
41999427|NCT01380093|75807924|FG007|Naloxone Challenge Phase|Screen failures|0|||
41999428|NCT01380093|75807925|FG008|Naloxone Challenge Phase|Screen failures|0|||
41999429|NCT01380093|75807917|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
41999430|NCT01380093|75807918|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
41999431|NCT01380093|75807919|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
42134375|NCT00548093|75945232|FG000|Overall Study|Objective progression or relapse|1|||
42134376|NCT00548093|75945233|FG001|Overall Study|Objective progression or relapse|1|||
42134377|NCT00548093|75945232|FG000|Overall Study|Other|11|||
42134378|NCT00548093|75945233|FG001|Overall Study|Other|1|||
42134379|NCT00548093|75945232|FG000|Overall Study|Withdrawal by Subject|1|||
41999432|NCT01380093|75807920|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
42134380|NCT00548093|75945233|FG001|Overall Study|Withdrawal by Subject|0|||
42134381|NCT00548093|75945232|FG000|Overall Study|Completed post-treatment follow-up|1|||
42333613|NCT01856673|76171185|FG002|Overall Study|Lost to Follow-up|0|||
42333614|NCT01856673|76171183|FG000|Overall Study|Unknown reasons|9|||
42333615|NCT01856673|76171184|FG001|Overall Study|Unknown reasons|0|||
42333616|NCT01856673|76171185|FG002|Overall Study|Unknown reasons|0|||
42333617|NCT01856673|76171183|FG000|Overall Study|Psychologist decision|1|||
42333618|NCT01856673|76171184|FG001|Overall Study|Psychologist decision|0|||
42333619|NCT01856673|76171185|FG002|Overall Study|Psychologist decision|0|||
42333620|NCT01856673|76171183|FG000|Overall Study|Paperwork errors|8|||
42333621|NCT01856673|76171184|FG001|Overall Study|Paperwork errors|0|||
42333622|NCT01856673|76171185|FG002|Overall Study|Paperwork errors|0|||
42333623|NCT01856673|76171183|FG000|Overall Study|Death|1|||
42333624|NCT01856673|76171184|FG001|Overall Study|Death|1|||
42333625|NCT01856673|76171185|FG002|Overall Study|Death|0|||
42333626|NCT01856673|76171183|FG000|Overall Study|Protocol Violation|1|||
42333627|NCT01856673|76171184|FG001|Overall Study|Protocol Violation|0|||
42333628|NCT01856673|76171185|FG002|Overall Study|Protocol Violation|1|||
41999433|NCT01380093|75807921|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
42333629|NCT02095951|76171195|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
42333630|NCT02095951|76171196|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
42333631|NCT02095873|76171208|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
42333632|NCT02095873|76171209|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
42333633|NCT02095873|76171208|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
42333634|NCT02095873|76171209|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
42333635|NCT02095873|76171208|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
42333636|NCT02095873|76171209|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
42333637|NCT02094937|76171217|FG000|8 Weeks in Period 1|Adverse Event|9|||
42333638|NCT02094937|76171218|FG001|8 Weeks in Period 1|Adverse Event|0|||
42333639|NCT02094937|76171219|FG002|8 Weeks in Period 1|Adverse Event|0|||
42333640|NCT02094937|76171220|FG003|8 Weeks in Period 1|Adverse Event|0|||
42333641|NCT02094937|76171217|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
42333642|NCT02094937|76171218|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
42333643|NCT02094937|76171219|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
42333644|NCT02094937|76171220|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
42333645|NCT02094937|76171217|FG000|8 Weeks in Period 1|Protocol Violation|2|||
42333646|NCT02094937|76171218|FG001|8 Weeks in Period 1|Protocol Violation|0|||
42333647|NCT02094937|76171219|FG002|8 Weeks in Period 1|Protocol Violation|0|||
42333648|NCT02094937|76171220|FG003|8 Weeks in Period 1|Protocol Violation|0|||
42333649|NCT02094937|76171217|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
42333650|NCT02094937|76171218|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
42333651|NCT02094937|76171219|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
42333652|NCT02094937|76171220|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
42333653|NCT02094937|76171217|FG000|8 Weeks in Period 1|Physician Decision|1|||
42333654|NCT02094937|76171218|FG001|8 Weeks in Period 1|Physician Decision|0|||
42333655|NCT02094937|76171219|FG002|8 Weeks in Period 1|Physician Decision|0|||
42333656|NCT02094937|76171220|FG003|8 Weeks in Period 1|Physician Decision|0|||
42333657|NCT02094937|76171217|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
41999434|NCT01380093|75807922|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
41999435|NCT01380093|75807923|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
42333658|NCT02094937|76171218|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
42333659|NCT02094937|76171219|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
42333660|NCT02094937|76171220|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
42333661|NCT02094937|76171217|FG000|12 Weeks in Period 2|Adverse Event|0|||
42333662|NCT02094937|76171218|FG001|12 Weeks in Period 2|Adverse Event|2|||
42333663|NCT02094937|76171219|FG002|12 Weeks in Period 2|Adverse Event|4|||
42333664|NCT02094937|76171220|FG003|12 Weeks in Period 2|Adverse Event|1|||
42333665|NCT02094937|76171217|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
42333666|NCT02094937|76171218|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
42333667|NCT02094937|76171219|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
42333668|NCT02094937|76171220|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
42333669|NCT02094937|76171217|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
42333670|NCT02094937|76171218|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
42333671|NCT02094937|76171219|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
42333672|NCT02094937|76171220|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
42333673|NCT02094937|76171217|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
42333674|NCT02094937|76171218|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
42333675|NCT02094937|76171219|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
42333676|NCT02094937|76171220|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
42333677|NCT02094937|76171217|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
42333678|NCT02094937|76171218|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
42333679|NCT02094937|76171219|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
42333680|NCT02094937|76171220|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
42333681|NCT02093923|76171234|FG000|Overall Study|Lost to Follow-up|0|||
42333682|NCT02093923|76171235|FG001|Overall Study|Lost to Follow-up|0|||
42333683|NCT02093923|76171236|FG002|Overall Study|Lost to Follow-up|0|||
42333684|NCT02093923|76171237|FG003|Overall Study|Lost to Follow-up|1|||
42333685|NCT02093923|76171238|FG004|Overall Study|Lost to Follow-up|0|||
42333686|NCT02093923|76171234|FG000|Overall Study|Screen failure after randomization|0|||
42333687|NCT02093923|76171235|FG001|Overall Study|Screen failure after randomization|0|||
42333688|NCT02093923|76171236|FG002|Overall Study|Screen failure after randomization|0|||
42034618|NCT01120379|75842706|FG000|Two Year Timepoint|Any other reason for early termination|4|||
42333689|NCT02093923|76171237|FG003|Overall Study|Screen failure after randomization|1|||
42333690|NCT02093923|76171238|FG004|Overall Study|Screen failure after randomization|0|||
42333691|NCT02186561|76171254|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
42333692|NCT02186561|76171254|FG000|Enrollment|Enrollment Cap Reached|5|||
42134382|NCT00548093|75945233|FG001|Overall Study|Completed post-treatment follow-up|0|||
42134383|NCT00450216|75945244|FG000|Overall Study|Adverse Event|38|||
42134384|NCT00450216|75945245|FG001|Overall Study|Adverse Event|23|||
42134385|NCT00450216|75945244|FG000|Overall Study|Withdrawal by Subject|48|||
42134386|NCT00450216|75945245|FG001|Overall Study|Withdrawal by Subject|26|||
42134387|NCT00450216|75945244|FG000|Overall Study|Lost to Follow-up|16|||
42333693|NCT02186561|76171254|FG000|Enrollment|Insurance Denial|2|||
42333694|NCT02186561|76171254|FG000|Enrollment|Withdrawal by Subject|2|||
42333695|NCT02186561|76171254|FG000|Enrollment|Investigator Withdrew Consent|1|||
42333696|NCT02186561|76171254|FG000|30-Day Post Index Procedure Visit|Death|1|||
42134388|NCT00450216|75945245|FG001|Overall Study|Lost to Follow-up|9|||
42134389|NCT00450216|75945244|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
42134390|NCT00450216|75945245|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
42134391|NCT00450216|75945244|FG000|Overall Study|misc|21|||
42134392|NCT00450216|75945245|FG001|Overall Study|misc|20|||
42134393|NCT00441480|75945253|FG000|Overall Study|Protocol Violation|1|||
42134394|NCT00441480|75945254|FG001|Overall Study|Protocol Violation|1|||
42134395|NCT00441480|75945253|FG000|Overall Study|Withdrawal by Subject|2|||
42134396|NCT00441480|75945254|FG001|Overall Study|Withdrawal by Subject|3|||
42134397|NCT00547703|75945262|FG000|Overall Study|Lost to Follow-up|1|||
42333697|NCT02186561|76171254|FG000|1- Year Post Index Procedure Visit|Death|1|||
42333698|NCT02186561|76171254|FG000|1- Year Post Index Procedure Visit|Missed|1|||
42333699|NCT02066467|76171260|FG000|Overall Study|Did not undergo implant procedure|24|||
42333700|NCT02066467|76171260|FG000|Overall Study|Attempted to implant withoput success|43|||
42333701|NCT02066467|76171260|FG000|Overall Study|Consent ineligible|1|||
42333702|NCT02066467|76171260|FG000|Overall Study|Death|54|||
42333703|NCT02066467|76171260|FG000|Overall Study|Lost to Follow-up|51|||
42333704|NCT02066467|76171260|FG000|Overall Study|Adverse Event|20|||
42333705|NCT02066467|76171260|FG000|Overall Study|Withdrawal by Subject|16|||
42333706|NCT02066467|76171260|FG000|Overall Study|Physician Decision|2|||
42333707|NCT02066467|76171260|FG000|Overall Study|Not defined|4|||
42333708|NCT02186171|76171266|FG000|Overall Study|Withdrawal by Subject|1|||
42333709|NCT02186171|76171267|FG001|Overall Study|Withdrawal by Subject|9|||
42333710|NCT02186171|76171266|FG000|Overall Study|Lost to Follow-up|2|||
42134398|NCT00547703|75945263|FG001|Overall Study|Lost to Follow-up|0|||
42134399|NCT00297232|75945269|FG000|Overall Study|Lack of Efficacy|7|||
42134400|NCT00297232|75945269|FG000|Overall Study|Lost to Follow-up|10|||
42134401|NCT00297232|75945269|FG000|Overall Study|Adverse Event|63|||
42134402|NCT00297232|75945269|FG000|Overall Study|Voluntary Withdrawal|120|||
42134403|NCT00297232|75945269|FG000|Overall Study|Subject was Noncompliant|9|||
42134404|NCT00297232|75945269|FG000|Overall Study|Death|9|||
42134405|NCT00297232|75945269|FG000|Overall Study|Anti-natalizumab Positive|8|||
42134406|NCT00297232|75945269|FG000|Overall Study|Switched to Commercial Tysabri|22|||
42134407|NCT00297232|75945269|FG000|Overall Study|Disease Progression|8|||
42134408|NCT00297232|75945269|FG000|Overall Study|Fear of PML|10|||
42134409|NCT00297232|75945269|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
42134410|NCT00297232|75945269|FG000|Overall Study|Miscellaneous|5|||
42134411|NCT00297232|75945269|FG000|Overall Study|Sponsor Decision|34|||
42333711|NCT02186171|76171267|FG001|Overall Study|Lost to Follow-up|2|||
42333712|NCT02186171|76171266|FG000|Overall Study|Death|1|||
42333713|NCT02186171|76171267|FG001|Overall Study|Death|2|||
42333714|NCT02186171|76171266|FG000|Overall Study|Protocol-specified Criteria|0|||
42333715|NCT02186171|76171267|FG001|Overall Study|Protocol-specified Criteria|2|||
42333716|NCT02186015|76171275|FG000|Overall Study|Physician Decision|1|||
42333717|NCT02186015|76171276|FG001|Overall Study|Physician Decision|0|||
42333718|NCT02066389|76171289|FG000|Overall Study|Adverse Event|1|||
42333719|NCT02066389|76171290|FG001|Overall Study|Adverse Event|1|||
42333720|NCT02066389|76171291|FG002|Overall Study|Adverse Event|1|||
42333721|NCT02066389|76171292|FG003|Overall Study|Adverse Event|1|||
42333722|NCT02066389|76171293|FG004|Overall Study|Adverse Event|5|||
42333723|NCT02066389|76171294|FG005|Overall Study|Adverse Event|1|||
42134412|NCT00297232|75945269|FG000|Overall Study|Subject Relocated|7|||
42333724|NCT02066389|76171289|FG000|Overall Study|Withdrawal by Subject|4|||
42333725|NCT02066389|76171290|FG001|Overall Study|Withdrawal by Subject|0|||
42333726|NCT02066389|76171291|FG002|Overall Study|Withdrawal by Subject|5|||
42333727|NCT02066389|76171292|FG003|Overall Study|Withdrawal by Subject|1|||
42333728|NCT02066389|76171293|FG004|Overall Study|Withdrawal by Subject|1|||
42333729|NCT02066389|76171294|FG005|Overall Study|Withdrawal by Subject|2|||
42134413|NCT00297232|75945269|FG000|Overall Study|Subject Withdrew Consent|37|||
42134414|NCT00297232|75945269|FG000|Overall Study|Persistently Positive Antibodies|11|||
42134415|NCT00297232|75945269|FG000|Overall Study|Investigator Withdrew From Program|19|||
42134416|NCT00297232|75945269|FG000|Overall Study|Did Not Enroll to Week 264|34|||
42134417|NCT00297232|75945269|FG000|Overall Study|Did Not Enroll to Week 480|17|||
42134418|NCT00297232|75945269|FG000|Overall Study|No data available after Week 264|161|||
42333730|NCT02066389|76171289|FG000|Overall Study|Lost to Follow-up|0|||
42333731|NCT02066389|76171290|FG001|Overall Study|Lost to Follow-up|0|||
42134419|NCT00297232|75945269|FG000|Overall Study|Other|1|||
42333732|NCT02066389|76171291|FG002|Overall Study|Lost to Follow-up|0|||
42134420|NCT00449670|75945285|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
42134421|NCT00449670|75945286|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
42134422|NCT00449670|75945285|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
42134423|NCT00449670|75945286|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
42134424|NCT00449670|75945285|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
42134425|NCT00449670|75945286|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
42134426|NCT00449670|75945285|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
42134427|NCT00449670|75945286|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
42134428|NCT00449670|75945285|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
42134429|NCT00449670|75945286|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
42134430|NCT00449670|75945285|FG000|Booster Phase (Study no.109873)|Other|0|||
42134431|NCT00449670|75945286|FG001|Booster Phase (Study no.109873)|Other|2|||
42134432|NCT00296374|75945302|FG000|Overall Study|Adverse Event|14|||
42134433|NCT00296374|75945303|FG001|Overall Study|Adverse Event|10|||
42134434|NCT00296374|75945304|FG002|Overall Study|Adverse Event|7|||
42134435|NCT00296374|75945302|FG000|Overall Study|Withdrawal by Subject|3|||
42134436|NCT00296374|75945303|FG001|Overall Study|Withdrawal by Subject|5|||
42134437|NCT00296374|75945304|FG002|Overall Study|Withdrawal by Subject|11|||
42134438|NCT00296374|75945302|FG000|Overall Study|Incorrect enrollment|3|||
42134439|NCT00296374|75945303|FG001|Overall Study|Incorrect enrollment|3|||
42134440|NCT00296374|75945304|FG002|Overall Study|Incorrect enrollment|4|||
42134441|NCT00296374|75945302|FG000|Overall Study|Protocol Violation|1|||
42134442|NCT00296374|75945303|FG001|Overall Study|Protocol Violation|2|||
42134443|NCT00296374|75945304|FG002|Overall Study|Protocol Violation|3|||
42134444|NCT00296374|75945302|FG000|Overall Study|Lost to Follow-up|3|||
42134445|NCT00296374|75945303|FG001|Overall Study|Lost to Follow-up|1|||
42134446|NCT00296374|75945304|FG002|Overall Study|Lost to Follow-up|1|||
42134447|NCT00296374|75945302|FG000|Overall Study|Relocated to another state|1|||
42134448|NCT00296374|75945303|FG001|Overall Study|Relocated to another state|0|||
42134449|NCT00296374|75945304|FG002|Overall Study|Relocated to another state|0|||
42134450|NCT00296374|75945302|FG000|Overall Study|Stopped drug before end of study visit|0|||
42134451|NCT00296374|75945303|FG001|Overall Study|Stopped drug before end of study visit|1|||
42134452|NCT00296374|75945304|FG002|Overall Study|Stopped drug before end of study visit|0|||
42134453|NCT00296374|75945302|FG000|Overall Study|Nephrologist introduced ACE|0|||
42134454|NCT00296374|75945303|FG001|Overall Study|Nephrologist introduced ACE|1|||
42134455|NCT00296374|75945304|FG002|Overall Study|Nephrologist introduced ACE|0|||
42134456|NCT00296374|75945302|FG000|Overall Study|Pregnancy|0|||
42134457|NCT00296374|75945303|FG001|Overall Study|Pregnancy|0|||
42134458|NCT00296374|75945304|FG002|Overall Study|Pregnancy|2|||
42134459|NCT00296374|75945302|FG000|Overall Study|Other|0|||
42134460|NCT00296374|75945303|FG001|Overall Study|Other|0|||
42134461|NCT00296374|75945304|FG002|Overall Study|Other|1|||
42134462|NCT00326950|75945327|FG000|Overall Study|Progressive Disease|1|||
42134463|NCT00548717|75945333|FG000|Overall Study|Death|5|||
42134464|NCT00548717|75945334|FG001|Overall Study|Death|2|||
42134465|NCT00548717|75945333|FG000|Overall Study|Relapse|3|||
42134466|NCT00548717|75945334|FG001|Overall Study|Relapse|0|||
42134467|NCT00548717|75945333|FG000|Overall Study|Alternative treatment for GVHD|1|||
42134468|NCT00548717|75945334|FG001|Overall Study|Alternative treatment for GVHD|0|||
42134469|NCT00441168|75945345|FG000|Treatment Period|Death|3|||
42134470|NCT00441168|75945346|FG001|Treatment Period|Death|0|||
42134471|NCT00441168|75945345|FG000|Treatment Period|Adverse Event|1|||
42134472|NCT00441168|75945346|FG001|Treatment Period|Adverse Event|2|||
42134473|NCT00441168|75945345|FG000|Treatment Period|Progressive Disease|0|||
42134474|NCT00441168|75945346|FG001|Treatment Period|Progressive Disease|2|||
42134475|NCT00441168|75945345|FG000|Treatment Period|Protocol Violation|0|||
42134476|NCT00441168|75945346|FG001|Treatment Period|Protocol Violation|1|||
42134477|NCT00441168|75945345|FG000|Treatment Period|Lost to Follow-up|0|||
42134478|NCT00441168|75945346|FG001|Treatment Period|Lost to Follow-up|1|||
42134479|NCT00441168|75945345|FG000|Treatment Period|Withdrawal by Subject|3|||
42134480|NCT00441168|75945346|FG001|Treatment Period|Withdrawal by Subject|0|||
41999436|NCT01380093|75807924|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
41999437|NCT01380093|75807925|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
42134481|NCT00441168|75945345|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
42134482|NCT00441168|75945346|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
42134483|NCT00441168|75945345|FG000|Treatment Period|refractory disease|1|||
42134484|NCT00441168|75945346|FG001|Treatment Period|refractory disease|0|||
42134485|NCT00441168|75945345|FG000|Follow-up Period|Death|3|||
42134486|NCT00441168|75945346|FG001|Follow-up Period|Death|0|||
42134487|NCT00441168|75945345|FG000|Follow-up Period|Lost to Follow-up|5|||
42134488|NCT00441168|75945346|FG001|Follow-up Period|Lost to Follow-up|6|||
42134489|NCT00441168|75945345|FG000|Follow-up Period|Withdrawal by Subject|3|||
42134490|NCT00441168|75945346|FG001|Follow-up Period|Withdrawal by Subject|0|||
41999438|NCT01380093|75807917|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
42264209|NCT01353911|76092285|FG006|Overall Study|Withdrawal by Subject|3|||
42264210|NCT01353911|76092286|FG007|Overall Study|Withdrawal by Subject|9|||
42264211|NCT01353911|76092279|FG000|Overall Study|Status Not Recorded|4|||
42264212|NCT01353911|76092280|FG001|Overall Study|Status Not Recorded|0|||
42264213|NCT01353911|76092281|FG002|Overall Study|Status Not Recorded|1|||
42264214|NCT01353911|76092282|FG003|Overall Study|Status Not Recorded|0|||
42264215|NCT01353911|76092283|FG004|Overall Study|Status Not Recorded|0|||
42264216|NCT01353911|76092284|FG005|Overall Study|Status Not Recorded|0|||
42264217|NCT01353911|76092285|FG006|Overall Study|Status Not Recorded|0|||
42264218|NCT01353911|76092286|FG007|Overall Study|Status Not Recorded|0|||
42264219|NCT01671488|76092304|FG000|Overall Study|Withdrawal by Subject|1|||
42264220|NCT02783911|76092310|FG000|Overall Study|Lost to Follow-up|3|||
42264221|NCT02783911|76092311|FG001|Overall Study|Lost to Follow-up|32|||
42264222|NCT01358357|76092319|FG000|Open Label Phase|Adverse Event|0|||
42264223|NCT01358357|76092320|FG001|Open Label Phase|Adverse Event|0|||
42264224|NCT01358357|76092321|FG002|Open Label Phase|Adverse Event|59|||
42264225|NCT01358357|76092319|FG000|Open Label Phase|Lack of Efficacy|0|||
42264226|NCT01358357|76092320|FG001|Open Label Phase|Lack of Efficacy|0|||
42264227|NCT01358357|76092321|FG002|Open Label Phase|Lack of Efficacy|107|||
42264228|NCT01358357|76092319|FG000|Open Label Phase|Lost to Follow-up|0|||
42264229|NCT01358357|76092320|FG001|Open Label Phase|Lost to Follow-up|0|||
42264230|NCT01358357|76092321|FG002|Open Label Phase|Lost to Follow-up|76|||
42264231|NCT01358357|76092319|FG000|Open Label Phase|Protocol Violation|0|||
42264232|NCT01358357|76092320|FG001|Open Label Phase|Protocol Violation|0|||
42264233|NCT01358357|76092321|FG002|Open Label Phase|Protocol Violation|45|||
42264234|NCT01358357|76092319|FG000|Open Label Phase|Withdrawal by Subject|0|||
42264235|NCT01358357|76092320|FG001|Open Label Phase|Withdrawal by Subject|0|||
42264236|NCT01358357|76092321|FG002|Open Label Phase|Withdrawal by Subject|112|||
42264237|NCT01358357|76092319|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
42264238|NCT01358357|76092320|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
42264239|NCT01358357|76092321|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
42264240|NCT01358357|76092319|FG000|Open Label Phase|Terminated at study completion|0|||
42264241|NCT01358357|76092320|FG001|Open Label Phase|Terminated at study completion|0|||
42264242|NCT01358357|76092321|FG002|Open Label Phase|Terminated at study completion|5|||
42264243|NCT01358357|76092319|FG000|Open Label Phase|Mood episode|0|||
42333733|NCT02066389|76171292|FG003|Overall Study|Lost to Follow-up|1|||
42333734|NCT02066389|76171293|FG004|Overall Study|Lost to Follow-up|1|||
42264244|NCT01358357|76092320|FG001|Open Label Phase|Mood episode|0|||
42264245|NCT01358357|76092321|FG002|Open Label Phase|Mood episode|42|||
42264246|NCT01358357|76092319|FG000|Double-Blind Phase|Adverse Event|8|||
42264247|NCT01358357|76092320|FG001|Double-Blind Phase|Adverse Event|5|||
42264248|NCT01358357|76092321|FG002|Double-Blind Phase|Adverse Event|0|||
42264249|NCT01358357|76092319|FG000|Double-Blind Phase|Lost to Follow-up|5|||
42264250|NCT01358357|76092320|FG001|Double-Blind Phase|Lost to Follow-up|7|||
42264251|NCT01358357|76092321|FG002|Double-Blind Phase|Lost to Follow-up|0|||
42264252|NCT01358357|76092319|FG000|Double-Blind Phase|Protocol Violation|1|||
42264253|NCT01358357|76092320|FG001|Double-Blind Phase|Protocol Violation|11|||
42264254|NCT01358357|76092321|FG002|Double-Blind Phase|Protocol Violation|0|||
42264255|NCT01358357|76092319|FG000|Double-Blind Phase|Protocol Violation|16|||
42264256|NCT01358357|76092320|FG001|Double-Blind Phase|Protocol Violation|12|||
42264257|NCT01358357|76092321|FG002|Double-Blind Phase|Protocol Violation|0|||
42264258|NCT01358357|76092319|FG000|Double-Blind Phase|Terminated at study completion|2|||
42264259|NCT01358357|76092320|FG001|Double-Blind Phase|Terminated at study completion|0|||
42333735|NCT02066389|76171294|FG005|Overall Study|Lost to Follow-up|1|||
42333736|NCT02066389|76171289|FG000|Overall Study|Randomized in Error|0|||
42333737|NCT02066389|76171290|FG001|Overall Study|Randomized in Error|0|||
42333738|NCT02066389|76171291|FG002|Overall Study|Randomized in Error|0|||
42333739|NCT02066389|76171292|FG003|Overall Study|Randomized in Error|0|||
42333740|NCT02066389|76171293|FG004|Overall Study|Randomized in Error|0|||
42333741|NCT02066389|76171294|FG005|Overall Study|Randomized in Error|1|||
42333742|NCT02106403|76171308|FG000|Follow-Up Visit 3|Other Reason|0|||
42333743|NCT02106403|76171309|FG001|Follow-Up Visit 3|Other Reason|0|||
42333744|NCT02106403|76171310|FG002|Follow-Up Visit 3|Other Reason|0|||
42333745|NCT02106403|76171311|FG003|Follow-Up Visit 3|Other Reason|0|||
42333746|NCT02106403|76171312|FG004|Follow-Up Visit 3|Other Reason|0|||
42333747|NCT02106403|76171313|FG005|Follow-Up Visit 3|Other Reason|1|||
42333748|NCT02133131|76171330|FG000|Overall Study|Adverse Event|0|||
42333749|NCT02133131|76171331|FG001|Overall Study|Adverse Event|0|||
42333750|NCT02133131|76171332|FG002|Overall Study|Adverse Event|0|||
42333751|NCT02133131|76171333|FG003|Overall Study|Adverse Event|1|||
42333752|NCT02133131|76171334|FG004|Overall Study|Adverse Event|0|||
42333753|NCT02133131|76171335|FG005|Overall Study|Adverse Event|0|||
42333754|NCT02133131|76171336|FG006|Overall Study|Adverse Event|0|||
42333755|NCT02133131|76171330|FG000|Overall Study|Lost to Follow-up|1|||
42333756|NCT02133131|76171331|FG001|Overall Study|Lost to Follow-up|0|||
42333757|NCT02133131|76171332|FG002|Overall Study|Lost to Follow-up|0|||
42333758|NCT02133131|76171333|FG003|Overall Study|Lost to Follow-up|1|||
42333759|NCT02133131|76171334|FG004|Overall Study|Lost to Follow-up|0|||
42333760|NCT02133131|76171335|FG005|Overall Study|Lost to Follow-up|0|||
42333761|NCT02133131|76171336|FG006|Overall Study|Lost to Follow-up|0|||
42333762|NCT02133131|76171330|FG000|Overall Study|Status not recorded|4|||
42333763|NCT02133131|76171331|FG001|Overall Study|Status not recorded|5|||
42333764|NCT02133131|76171332|FG002|Overall Study|Status not recorded|1|||
42333765|NCT02133131|76171333|FG003|Overall Study|Status not recorded|4|||
42134491|NCT00441168|75945345|FG000|Follow-up Period|Other|1|||
42134492|NCT00441168|75945346|FG001|Follow-up Period|Other|3|||
42134493|NCT00296140|75945354|FG000|Overall Study|Lost to Follow-up|1|||
42134494|NCT00296140|75945355|FG001|Overall Study|Lost to Follow-up|0|||
42134495|NCT00296140|75945354|FG000|Overall Study|Withdrawal by Subject|1|||
42134496|NCT00296140|75945355|FG001|Overall Study|Withdrawal by Subject|0|||
42264260|NCT01358357|76092321|FG002|Double-Blind Phase|Terminated at study completion|0|||
42264261|NCT01358357|76092319|FG000|Double-Blind Phase|Recurrence of mood event|48|||
42264262|NCT01358357|76092320|FG001|Double-Blind Phase|Recurrence of mood event|64|||
42264263|NCT01358357|76092321|FG002|Double-Blind Phase|Recurrence of mood event|0|||
42264264|NCT01358357|76092319|FG000|Double-Blind Phase|Administrative|0|||
42264265|NCT01358357|76092320|FG001|Double-Blind Phase|Administrative|1|||
42264266|NCT01358357|76092321|FG002|Double-Blind Phase|Administrative|0|||
42264267|NCT02831387|76092330|FG000|Overall Study|Withdrawal by Subject|1|||
42264268|NCT02831387|76092331|FG001|Overall Study|Withdrawal by Subject|1|||
42264269|NCT02831387|76092330|FG000|Overall Study|Discontinued due to stock recovery|0|||
42264270|NCT02831387|76092331|FG001|Overall Study|Discontinued due to stock recovery|1|||
42264271|NCT02831855|76092337|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
42264272|NCT02831855|76092338|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
42333766|NCT02133131|76171334|FG004|Overall Study|Status not recorded|0|||
42333767|NCT02133131|76171335|FG005|Overall Study|Status not recorded|0|||
42333768|NCT02133131|76171336|FG006|Overall Study|Status not recorded|0|||
42333769|NCT02133131|76171330|FG000|Overall Study|Ongoing in study|0|||
42333770|NCT02133131|76171331|FG001|Overall Study|Ongoing in study|0|||
41999439|NCT01380093|75807918|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
41999440|NCT01380093|75807919|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
41999441|NCT01380093|75807920|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
41999442|NCT01380093|75807921|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
41999443|NCT01380093|75807922|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
41999444|NCT01380093|75807923|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
41999445|NCT01380093|75807924|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
41999446|NCT01380093|75807925|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
41999447|NCT01380093|75807917|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
41999448|NCT01380093|75807918|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
41999449|NCT01380093|75807919|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
41999450|NCT01380093|75807920|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
41999451|NCT01380093|75807921|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
42134497|NCT00296140|75945354|FG000|Overall Study|Discharge to Nursing Home|1|||
42134498|NCT00296140|75945355|FG001|Overall Study|Discharge to Nursing Home|0|||
42134499|NCT03958331|75945364|FG000|Overall Study|Withdrawal by Subject|3|||
42134500|NCT03958331|75945365|FG001|Overall Study|Withdrawal by Subject|1|||
42264273|NCT02831855|76092339|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
42264274|NCT02831855|76092337|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
41999452|NCT01380093|75807922|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
41999453|NCT01380093|75807923|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
41999454|NCT01380093|75807924|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
41999455|NCT01380093|75807925|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
41999456|NCT01380093|75807917|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
41999457|NCT01380093|75807918|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
41999458|NCT01380093|75807919|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
41999459|NCT01380093|75807920|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
41999460|NCT01380093|75807921|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
42264275|NCT02831855|76092338|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
42264276|NCT02831855|76092339|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
42264277|NCT02831855|76092337|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
42264278|NCT02831855|76092338|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
42264279|NCT02831855|76092339|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
42333771|NCT02133131|76171332|FG002|Overall Study|Ongoing in study|0|||
42333772|NCT02133131|76171333|FG003|Overall Study|Ongoing in study|0|||
42333773|NCT02133131|76171334|FG004|Overall Study|Ongoing in study|15|||
42333774|NCT02133131|76171335|FG005|Overall Study|Ongoing in study|14|||
42333775|NCT02133131|76171336|FG006|Overall Study|Ongoing in study|11|||
42333776|NCT02133131|76171330|FG000|Overall Study|Protocol Violation|0|||
42333777|NCT02133131|76171331|FG001|Overall Study|Protocol Violation|0|||
42333778|NCT02133131|76171332|FG002|Overall Study|Protocol Violation|0|||
42333779|NCT02133131|76171333|FG003|Overall Study|Protocol Violation|0|||
42333780|NCT02133131|76171334|FG004|Overall Study|Protocol Violation|0|||
42333781|NCT02133131|76171335|FG005|Overall Study|Protocol Violation|0|||
42333782|NCT02133131|76171336|FG006|Overall Study|Protocol Violation|1|||
42333783|NCT02106325|76171354|FG000|Phase 1|Lost to Follow-up|2|||
42333784|NCT02106325|76171355|FG001|Phase 1|Lost to Follow-up|2|||
41999461|NCT01380093|75807922|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
42264280|NCT02831855|76092337|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
42264281|NCT02831855|76092338|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
42333785|NCT02106325|76171354|FG000|Phase 2|Lost to Follow-up|2|||
42333786|NCT02106325|76171355|FG001|Phase 2|Lost to Follow-up|3|||
42333787|NCT02106325|76171354|FG000|Phase 3|Lost to Follow-up|2|||
42333788|NCT02106325|76171355|FG001|Phase 3|Lost to Follow-up|1|||
42333789|NCT01625689|76171363|FG000|Overall Study|Migration|2|||
42333790|NCT01625689|76171364|FG001|Overall Study|Migration|1|||
41999462|NCT01380093|75807923|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
41999463|NCT01380093|75807924|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
41999464|NCT01380093|75807925|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
42333791|NCT02184611|76171372|FG000|Overall Study|Lack of Efficacy|11|||
42333792|NCT02184611|76171373|FG001|Overall Study|Lack of Efficacy|15|||
42333793|NCT02184611|76171372|FG000|Overall Study|Withdrawal by Subject|5|||
42333794|NCT02184611|76171373|FG001|Overall Study|Withdrawal by Subject|6|||
42333795|NCT02184611|76171372|FG000|Overall Study|Adverse Event|4|||
42333796|NCT02184611|76171373|FG001|Overall Study|Adverse Event|5|||
41999465|NCT01380093|75807917|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
41999466|NCT01380093|75807918|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
41999467|NCT01380093|75807919|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
41999468|NCT01380093|75807920|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
42333797|NCT02184611|76171372|FG000|Overall Study|Protocol Violation|1|||
42134501|NCT03958331|75945366|FG002|Overall Study|Withdrawal by Subject|5|||
42134502|NCT03958331|75945364|FG000|Overall Study|Weaned from medicine|2|||
42134503|NCT03958331|75945365|FG001|Overall Study|Weaned from medicine|0|||
42134504|NCT03958331|75945366|FG002|Overall Study|Weaned from medicine|0|||
41999469|NCT01380093|75807921|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
41999470|NCT01380093|75807922|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
41999471|NCT01380093|75807923|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
41999472|NCT01380093|75807924|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
41999473|NCT01380093|75807925|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
41999474|NCT01380093|75807917|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
41999475|NCT01380093|75807918|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
42264282|NCT02831855|76092339|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
42264283|NCT02831855|76092337|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
42264284|NCT02831855|76092338|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
42264285|NCT02831855|76092339|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
42264286|NCT02831855|76092337|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
42264287|NCT02831855|76092338|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
42264288|NCT02831855|76092339|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
42264289|NCT02831855|76092337|FG000|Open Label Phase (24 Weeks)|Other|4|||
42264290|NCT02831855|76092338|FG001|Open Label Phase (24 Weeks)|Other|0|||
42264291|NCT02831855|76092339|FG002|Open Label Phase (24 Weeks)|Other|0|||
42333798|NCT02184611|76171373|FG001|Overall Study|Protocol Violation|1|||
42333799|NCT02184611|76171372|FG000|Overall Study|Protocol defined stopping criteria|0|||
42333800|NCT02184611|76171373|FG001|Overall Study|Protocol defined stopping criteria|1|||
42333801|NCT02066311|76171379|FG000|Overall Study|Adverse Event|4|||
42333802|NCT02066311|76171379|FG000|Overall Study|Withdrawal by Subject|1|||
42333803|NCT02184455|76171383|FG000|Overall Study|Lost to Follow-up|1|||
42333804|NCT02184143|76171389|FG000|Overall Study|Withdrawal by Subject|4|||
42333805|NCT02184143|76171390|FG001|Overall Study|Withdrawal by Subject|4|||
42333806|NCT02184143|76171389|FG000|Overall Study|Lost to Follow-up|5|||
42264292|NCT02831855|76092337|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
42264293|NCT02831855|76092338|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
42264294|NCT02831855|76092339|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
42264295|NCT02831855|76092337|FG000|Double Blind Phase (24 Weeks)|Death|0|||
42034619|NCT01120379|75842706|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
42034620|NCT01120379|75842706|FG000|Three Year Timepoint|Lost to Follow-up|43|||
42034621|NCT01120379|75842706|FG000|Three Year Timepoint|Death|120|||
42134505|NCT03958331|75945364|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
42264296|NCT02831855|76092338|FG001|Double Blind Phase (24 Weeks)|Death|0|||
42264297|NCT02831855|76092339|FG002|Double Blind Phase (24 Weeks)|Death|2|||
41999476|NCT01380093|75807919|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
42134506|NCT03958331|75945365|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
42264298|NCT02831855|76092337|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
42264299|NCT02831855|76092338|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
42264300|NCT02831855|76092339|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
42264301|NCT02831855|76092337|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
42264302|NCT02831855|76092338|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
42264303|NCT02831855|76092339|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
42264304|NCT02831855|76092337|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
42264305|NCT02831855|76092338|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
42333807|NCT02184143|76171390|FG001|Overall Study|Lost to Follow-up|3|||
41999477|NCT01380093|75807920|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
41999478|NCT01380093|75807921|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
41999479|NCT01380093|75807922|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
41999480|NCT01380093|75807923|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
41999481|NCT01380093|75807924|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
41999482|NCT01380093|75807925|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
41999483|NCT01380093|75807917|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
41999484|NCT01380093|75807918|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
41999485|NCT01380093|75807919|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
41999486|NCT01380093|75807920|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
41999487|NCT01380093|75807921|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
41999488|NCT01380093|75807922|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
41999489|NCT01380093|75807923|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
41999490|NCT01380093|75807924|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
42264306|NCT02831855|76092339|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
42264307|NCT02831855|76092337|FG000|Double Blind Phase (24 Weeks)|Other|0|||
42264308|NCT02831855|76092338|FG001|Double Blind Phase (24 Weeks)|Other|2|||
42264309|NCT02831855|76092339|FG002|Double Blind Phase (24 Weeks)|Other|5|||
42264310|NCT02831855|76092337|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
42264311|NCT02831855|76092338|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
41999491|NCT01380093|75807925|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
41999492|NCT01380093|75807917|FG000|Treatment Phase: Second Intervention|Other|0|||
41999493|NCT01380093|75807918|FG001|Treatment Phase: Second Intervention|Other|0|||
41999494|NCT01380093|75807919|FG002|Treatment Phase: Second Intervention|Other|0|||
41999495|NCT01380093|75807920|FG003|Treatment Phase: Second Intervention|Other|1|||
41999496|NCT01380093|75807921|FG004|Treatment Phase: Second Intervention|Other|0|||
41999497|NCT01380093|75807922|FG005|Treatment Phase: Second Intervention|Other|0|||
41999498|NCT01380093|75807923|FG006|Treatment Phase: Second Intervention|Other|0|||
41999499|NCT01380093|75807924|FG007|Treatment Phase: Second Intervention|Other|0|||
41999500|NCT01380093|75807925|FG008|Treatment Phase: Second Intervention|Other|0|||
41999501|NCT01380093|75807917|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
41999502|NCT01380093|75807918|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
41999503|NCT01380093|75807919|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
41999504|NCT01380093|75807920|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
41999505|NCT01380093|75807921|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
41999506|NCT01380093|75807922|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
41999507|NCT01380093|75807923|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
41999508|NCT01380093|75807924|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
41999509|NCT01380093|75807925|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
41999510|NCT01380093|75807917|FG000|Treatment Phase: Third Intervention|Other|0|||
41999511|NCT01380093|75807918|FG001|Treatment Phase: Third Intervention|Other|0|||
41999512|NCT01380093|75807919|FG002|Treatment Phase: Third Intervention|Other|0|||
41999513|NCT01380093|75807920|FG003|Treatment Phase: Third Intervention|Other|0|||
41999514|NCT01380093|75807921|FG004|Treatment Phase: Third Intervention|Other|0|||
41999515|NCT01380093|75807922|FG005|Treatment Phase: Third Intervention|Other|0|||
41999516|NCT01380093|75807923|FG006|Treatment Phase: Third Intervention|Other|0|||
41999517|NCT01380093|75807924|FG007|Treatment Phase: Third Intervention|Other|0|||
41999518|NCT01380093|75807925|FG008|Treatment Phase: Third Intervention|Other|1|||
41999519|NCT01379937|75807943|FG000|Overall Study|Protocol Violation|0|||
41999520|NCT01379937|75807944|FG001|Overall Study|Protocol Violation|0|||
41999521|NCT01379937|75807945|FG002|Overall Study|Protocol Violation|0|||
41999522|NCT01379937|75807946|FG003|Overall Study|Protocol Violation|1|||
41999523|NCT01379937|75807943|FG000|Overall Study|Consent withdrawal|0|||
41999524|NCT01379937|75807944|FG001|Overall Study|Consent withdrawal|1|||
41999525|NCT01379937|75807945|FG002|Overall Study|Consent withdrawal|0|||
41999526|NCT01379937|75807946|FG003|Overall Study|Consent withdrawal|0|||
41999527|NCT01379937|75807943|FG000|Overall Study|Lost to Follow-up|1|||
41999528|NCT01379937|75807944|FG001|Overall Study|Lost to Follow-up|2|||
41999529|NCT01379937|75807945|FG002|Overall Study|Lost to Follow-up|2|||
41999530|NCT01379937|75807946|FG003|Overall Study|Lost to Follow-up|0|||
41999531|NCT01379781|75807972|FG000|Overall Study|Lost to Follow-up|11|||
41999532|NCT01379781|75807973|FG001|Overall Study|Lost to Follow-up|8|||
41999533|NCT01379703|75807979|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
41999534|NCT01379703|75807980|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
41999535|NCT01379703|75807981|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
41999536|NCT01379703|75807979|FG000|Study Start Through 9 Months|Adverse Event|0|||
41999537|NCT01379703|75807980|FG001|Study Start Through 9 Months|Adverse Event|14|||
41999538|NCT01379703|75807981|FG002|Study Start Through 9 Months|Adverse Event|10|||
41999539|NCT01379703|75807979|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
41999540|NCT01379703|75807980|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
41999541|NCT01379703|75807981|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
41999542|NCT01379703|75807979|FG000|Study Start Through 9 Months|Treatment Failure|0|||
41999543|NCT01379703|75807980|FG001|Study Start Through 9 Months|Treatment Failure|2|||
41999544|NCT01379703|75807981|FG002|Study Start Through 9 Months|Treatment Failure|2|||
41999545|NCT01379703|75807979|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
41999546|NCT01379703|75807980|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
41999547|NCT01379703|75807981|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
41999548|NCT01379703|75807979|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
41999549|NCT01379703|75807980|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
41999550|NCT01379703|75807981|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
41999551|NCT01379703|75807979|FG000|Study Start Through 9 Months|Medication not available|0|||
41999552|NCT01379703|75807980|FG001|Study Start Through 9 Months|Medication not available|2|||
41999553|NCT01379703|75807981|FG002|Study Start Through 9 Months|Medication not available|1|||
41999554|NCT01379703|75807979|FG000|Study Start Through 9 Months|Poor general condition|0|||
41999555|NCT01379703|75807980|FG001|Study Start Through 9 Months|Poor general condition|1|||
41999556|NCT01379703|75807981|FG002|Study Start Through 9 Months|Poor general condition|0|||
41999557|NCT01379703|75807979|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
41999558|NCT01379703|75807980|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
41999559|NCT01379703|75807981|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
42264312|NCT02831855|76092339|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
42333808|NCT02184143|76171389|FG000|Overall Study|Death|1|||
41999560|NCT01379703|75807979|FG000|Study Start Through 9 Months|Reason unknown|2|||
41999561|NCT01379703|75807980|FG001|Study Start Through 9 Months|Reason unknown|31|||
41999562|NCT01379703|75807981|FG002|Study Start Through 9 Months|Reason unknown|24|||
41999563|NCT01379703|75807979|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
41999564|NCT01379703|75807980|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
41999565|NCT01379703|75807981|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
41999566|NCT01379703|75807979|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
41999567|NCT01379703|75807980|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
41999568|NCT01379703|75807981|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
41999569|NCT01379703|75807979|FG000|9 Months Through 18 Months|Adverse Event|0|||
41999570|NCT01379703|75807980|FG001|9 Months Through 18 Months|Adverse Event|6|||
41999571|NCT01379703|75807981|FG002|9 Months Through 18 Months|Adverse Event|0|||
41999572|NCT01379703|75807979|FG000|9 Months Through 18 Months|Treatment failure|0|||
41999573|NCT01379703|75807980|FG001|9 Months Through 18 Months|Treatment failure|5|||
41999574|NCT01379703|75807981|FG002|9 Months Through 18 Months|Treatment failure|0|||
41999575|NCT01379703|75807979|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
41999576|NCT01379703|75807980|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
41999577|NCT01379703|75807981|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
41999578|NCT01379703|75807979|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
41999579|NCT01379703|75807980|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
41999580|NCT01379703|75807981|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
41999581|NCT01379703|75807979|FG000|9 Months Through 18 Months|Fatigue|0|||
41999582|NCT01379703|75807980|FG001|9 Months Through 18 Months|Fatigue|1|||
41999583|NCT01379703|75807981|FG002|9 Months Through 18 Months|Fatigue|0|||
41999584|NCT01379703|75807979|FG000|9 Months Through 18 Months|Reason Unknown|0|||
41999585|NCT01379703|75807980|FG001|9 Months Through 18 Months|Reason Unknown|23|||
41999586|NCT01379703|75807981|FG002|9 Months Through 18 Months|Reason Unknown|0|||
41999587|NCT01335477|75807992|FG000|Overall Study|Adverse Event|30|||
41999588|NCT01335477|75807993|FG001|Overall Study|Adverse Event|42|||
41999589|NCT01335477|75807992|FG000|Overall Study|Non compliant with protocol|0|||
41999590|NCT01335477|75807993|FG001|Overall Study|Non compliant with protocol|2|||
41999591|NCT01335477|75807992|FG000|Overall Study|Lost to Follow-up|1|||
41999592|NCT01335477|75807993|FG001|Overall Study|Lost to Follow-up|2|||
42333809|NCT02184143|76171390|FG001|Overall Study|Death|0|||
42333810|NCT01625611|76171400|FG000|Overall Study|No adlib drinks Lab 1|3|||
42333811|NCT01625611|76171401|FG001|Overall Study|No adlib drinks Lab 1|0|||
42333812|NCT01625611|76171400|FG000|Overall Study|Technical issues with PET|1|||
42333813|NCT01625611|76171401|FG001|Overall Study|Technical issues with PET|0|||
42333814|NCT01625611|76171400|FG000|Overall Study|Unable to complete study procedures|1|||
42333815|NCT01625611|76171401|FG001|Overall Study|Unable to complete study procedures|0|||
42333816|NCT01625611|76171400|FG000|Overall Study|Withdrawal by Subject|3|||
42333817|NCT01625611|76171401|FG001|Overall Study|Withdrawal by Subject|0|||
42333818|NCT02159807|76171411|FG000|Overall Study|Adverse Event|0|||
42333819|NCT02159807|76171412|FG001|Overall Study|Adverse Event|0|||
42333820|NCT02159807|76171413|FG002|Overall Study|Adverse Event|1|||
42333821|NCT02159807|76171411|FG000|Overall Study|No CSF|1|||
42333822|NCT02159807|76171412|FG001|Overall Study|No CSF|1|||
42333823|NCT02159807|76171413|FG002|Overall Study|No CSF|1|||
42333824|NCT02159807|76171411|FG000|Overall Study|elevated blood pressure|0|||
42333825|NCT02159807|76171412|FG001|Overall Study|elevated blood pressure|0|||
42333826|NCT02159807|76171413|FG002|Overall Study|elevated blood pressure|1|||
42333827|NCT02066233|76171423|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
42333828|NCT02066233|76171424|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
42333829|NCT02159729|76171432|FG000|Overall Study|Adverse Event|0|||
42333830|NCT02159729|76171433|FG001|Overall Study|Adverse Event|1|||
42333831|NCT02159729|76171432|FG000|Overall Study|Subject's Request|13|||
42333832|NCT02159729|76171433|FG001|Overall Study|Subject's Request|10|||
42333833|NCT02159729|76171432|FG000|Overall Study|Lost to Follow-up|24|||
42333834|NCT02159729|76171433|FG001|Overall Study|Lost to Follow-up|9|||
42333835|NCT02159729|76171432|FG000|Overall Study|Non compliance|2|||
42333836|NCT02159729|76171433|FG001|Overall Study|Non compliance|0|||
42333837|NCT02159729|76171432|FG000|Overall Study|Other Unspecified|3|||
42333838|NCT02159729|76171433|FG001|Overall Study|Other Unspecified|1|||
41999593|NCT01335477|75807992|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
41999594|NCT01335477|75807993|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
41999595|NCT01335477|75807992|FG000|Overall Study|Not treated|1|||
42333839|NCT02159183|76171441|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
42333840|NCT02159183|76171442|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
42333841|NCT02159183|76171441|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
41999596|NCT01335477|75807993|FG001|Overall Study|Not treated|2|||
42333842|NCT02159183|76171442|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
42333843|NCT02159183|76171441|FG000|Analysis After the 36 Months Follow-up|Death|0|||
42333844|NCT02159183|76171442|FG001|Analysis After the 36 Months Follow-up|Death|1|||
42333845|NCT02159183|76171441|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
41999597|NCT01335477|75807992|FG000|Overall Study|Reason other than those stated above|2|||
41999598|NCT01335477|75807993|FG001|Overall Study|Reason other than those stated above|2|||
41999599|NCT01371825|75807999|FG000|Overall Study|Death|4|||
41999600|NCT01371747|75808009|FG000|Overall Study|Adverse Event|4|||
41999601|NCT01371747|75808010|FG001|Overall Study|Adverse Event|2|||
41999602|NCT01371747|75808011|FG002|Overall Study|Adverse Event|7|||
41999603|NCT01371747|75808012|FG003|Overall Study|Adverse Event|2|||
41999604|NCT01371747|75808013|FG004|Overall Study|Adverse Event|2|||
41999605|NCT01371747|75808014|FG005|Overall Study|Adverse Event|2|||
41999606|NCT01371747|75808009|FG000|Overall Study|Death|1|||
41999607|NCT01371747|75808010|FG001|Overall Study|Death|0|||
41999608|NCT01371747|75808011|FG002|Overall Study|Death|4|||
41999609|NCT01371747|75808012|FG003|Overall Study|Death|1|||
41999610|NCT01371747|75808013|FG004|Overall Study|Death|2|||
41999611|NCT01371747|75808014|FG005|Overall Study|Death|0|||
41999612|NCT01371747|75808009|FG000|Overall Study|Abnormal Renal Function|0|||
41999613|NCT01371747|75808010|FG001|Overall Study|Abnormal Renal Function|2|||
41999614|NCT01371747|75808011|FG002|Overall Study|Abnormal Renal Function|0|||
41999615|NCT01371747|75808012|FG003|Overall Study|Abnormal Renal Function|1|||
41999616|NCT01371747|75808013|FG004|Overall Study|Abnormal Renal Function|0|||
41999617|NCT01371747|75808014|FG005|Overall Study|Abnormal Renal Function|1|||
41999618|NCT01371747|75808009|FG000|Overall Study|High Serum Potassium Results|1|||
41999619|NCT01371747|75808010|FG001|Overall Study|High Serum Potassium Results|1|||
41999620|NCT01371747|75808011|FG002|Overall Study|High Serum Potassium Results|1|||
41999621|NCT01371747|75808012|FG003|Overall Study|High Serum Potassium Results|2|||
41999622|NCT01371747|75808013|FG004|Overall Study|High Serum Potassium Results|0|||
41999623|NCT01371747|75808014|FG005|Overall Study|High Serum Potassium Results|2|||
41999624|NCT01371747|75808009|FG000|Overall Study|Low Serum Potassium Results|1|||
41999625|NCT01371747|75808010|FG001|Overall Study|Low Serum Potassium Results|1|||
41999626|NCT01371747|75808011|FG002|Overall Study|Low Serum Potassium Results|1|||
41999627|NCT01371747|75808012|FG003|Overall Study|Low Serum Potassium Results|1|||
41999628|NCT01371747|75808013|FG004|Overall Study|Low Serum Potassium Results|0|||
41999629|NCT01371747|75808014|FG005|Overall Study|Low Serum Potassium Results|3|||
41999630|NCT01371747|75808009|FG000|Overall Study|Protocol Violation|0|||
41999631|NCT01371747|75808010|FG001|Overall Study|Protocol Violation|0|||
41999632|NCT01371747|75808011|FG002|Overall Study|Protocol Violation|1|||
41999633|NCT01371747|75808012|FG003|Overall Study|Protocol Violation|0|||
41999634|NCT01371747|75808013|FG004|Overall Study|Protocol Violation|0|||
41999635|NCT01371747|75808014|FG005|Overall Study|Protocol Violation|0|||
41999636|NCT01371747|75808009|FG000|Overall Study|Non-Compliance|3|||
41999637|NCT01371747|75808010|FG001|Overall Study|Non-Compliance|4|||
41999638|NCT01371747|75808011|FG002|Overall Study|Non-Compliance|3|||
41999639|NCT01371747|75808012|FG003|Overall Study|Non-Compliance|0|||
41999640|NCT01371747|75808013|FG004|Overall Study|Non-Compliance|0|||
41999641|NCT01371747|75808014|FG005|Overall Study|Non-Compliance|1|||
41999642|NCT01371747|75808009|FG000|Overall Study|Physician Decision|0|||
41999643|NCT01371747|75808010|FG001|Overall Study|Physician Decision|0|||
41999644|NCT01371747|75808011|FG002|Overall Study|Physician Decision|0|||
41999645|NCT01371747|75808012|FG003|Overall Study|Physician Decision|0|||
41999646|NCT01371747|75808013|FG004|Overall Study|Physician Decision|1|||
41999647|NCT01371747|75808014|FG005|Overall Study|Physician Decision|0|||
41999648|NCT01371747|75808009|FG000|Overall Study|Withdrawal by Subject|6|||
41999649|NCT01371747|75808010|FG001|Overall Study|Withdrawal by Subject|12|||
41999650|NCT01371747|75808011|FG002|Overall Study|Withdrawal by Subject|5|||
41999651|NCT01371747|75808012|FG003|Overall Study|Withdrawal by Subject|2|||
41999652|NCT01371747|75808013|FG004|Overall Study|Withdrawal by Subject|2|||
41999653|NCT01371747|75808014|FG005|Overall Study|Withdrawal by Subject|4|||
41999654|NCT01371747|75808009|FG000|Overall Study|Other Reasons|2|||
41999655|NCT01371747|75808010|FG001|Overall Study|Other Reasons|1|||
41999656|NCT01371747|75808011|FG002|Overall Study|Other Reasons|2|||
41999657|NCT01371747|75808012|FG003|Overall Study|Other Reasons|0|||
41999658|NCT01371747|75808013|FG004|Overall Study|Other Reasons|0|||
41999659|NCT01371747|75808014|FG005|Overall Study|Other Reasons|1|||
41999660|NCT01371708|75808049|FG000|Overall Study|Insufficient clinical response|3|||
41999661|NCT01371708|75808050|FG001|Overall Study|Insufficient clinical response|2|||
41999662|NCT01371708|75808051|FG002|Overall Study|Insufficient clinical response|0|||
41999663|NCT01371708|75808049|FG000|Overall Study|Lost to Follow-up|5|||
41999664|NCT01371708|75808050|FG001|Overall Study|Lost to Follow-up|9|||
41999665|NCT01371708|75808051|FG002|Overall Study|Lost to Follow-up|7|||
41999666|NCT01371708|75808049|FG000|Overall Study|Protocol Violation|2|||
41999667|NCT01371708|75808050|FG001|Overall Study|Protocol Violation|1|||
42134507|NCT03958331|75945366|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
42134508|NCT03956615|75945372|FG000|Overall Study|No multiple myeloma confirmed|2|||
42134509|NCT03956615|75945372|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
41999668|NCT01371708|75808051|FG002|Overall Study|Protocol Violation|2|||
41999669|NCT01371708|75808049|FG000|Overall Study|No longer willing to participate|7|||
41999670|NCT01371708|75808050|FG001|Overall Study|No longer willing to participate|7|||
41999671|NCT01371708|75808051|FG002|Overall Study|No longer willing to participate|13|||
41999672|NCT01371708|75808049|FG000|Overall Study|Medication error/not related to AE|0|||
41999673|NCT01371708|75808050|FG001|Overall Study|Medication error/not related to AE|1|||
41999674|NCT01371708|75808051|FG002|Overall Study|Medication error/not related to AE|0|||
41999675|NCT01371708|75808049|FG000|Overall Study|Other|3|||
41999676|NCT01371708|75808050|FG001|Overall Study|Other|2|||
41999677|NCT01371708|75808051|FG002|Overall Study|Other|4|||
41999678|NCT01371708|75808049|FG000|Overall Study|Adverse Event|5|||
41999679|NCT01371708|75808050|FG001|Overall Study|Adverse Event|8|||
41999680|NCT01371708|75808051|FG002|Overall Study|Adverse Event|12|||
41999681|NCT01371708|75808049|FG000|Overall Study|Started but did not receive treatment|1|||
41999682|NCT01371708|75808050|FG001|Overall Study|Started but did not receive treatment|0|||
41999683|NCT01371708|75808051|FG002|Overall Study|Started but did not receive treatment|1|||
41999684|NCT01335399|75808063|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
41999685|NCT01335399|75808064|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
41999686|NCT01335399|75808063|FG000|Pre-treatment Period|Participant request to discontinue|0|||
41999687|NCT01335399|75808064|FG001|Pre-treatment Period|Participant request to discontinue|1|||
41999688|NCT01335399|75808063|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
41999689|NCT01335399|75808064|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
42333846|NCT02159183|76171442|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
42333847|NCT02159183|76171441|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
42333848|NCT02159183|76171442|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
42333849|NCT02183675|76171454|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
42333850|NCT02183675|76171455|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
42333851|NCT02183675|76171456|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
42333852|NCT02183675|76171457|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
42333853|NCT02183675|76171458|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
42333854|NCT02183675|76171459|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
42333855|NCT02183519|76171471|FG000|Overall Study|computer error|3|||
42333856|NCT02183519|76171472|FG001|Overall Study|computer error|0|||
42333857|NCT02183519|76171471|FG000|Overall Study|Did not respond to cough inducter|0|||
42333858|NCT02183519|76171472|FG001|Overall Study|Did not respond to cough inducter|3|||
41999690|NCT01335399|75808063|FG000|Pre-treatment Period|Consent withdrawal|3|||
41999691|NCT01335399|75808064|FG001|Pre-treatment Period|Consent withdrawal|0|||
41999692|NCT01335399|75808063|FG000|Treatment Period|Disease progression|117|||
41999693|NCT01335399|75808064|FG001|Treatment Period|Disease progression|145|||
41999694|NCT01335399|75808063|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
41999695|NCT01335399|75808064|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
41999696|NCT01335399|75808063|FG000|Treatment Period|Study drug toxicity|52|||
42264313|NCT02831855|76092337|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
42264314|NCT02831855|76092338|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
42264315|NCT02831855|76092339|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
42264316|NCT02831855|76092337|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
42264317|NCT02831855|76092338|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
42264318|NCT02831855|76092339|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
42264319|NCT02628938|76092352|FG000|Overall Study|Did not attend the follow up recall|2|||
42264320|NCT02628938|76092353|FG001|Overall Study|Did not attend the follow up recall|2|||
42264321|NCT02628938|76092354|FG002|Overall Study|Did not attend the follow up recall|1|||
42264322|NCT02628938|76092352|FG000|Overall Study|Failure to comply with the instructions|3|||
42264323|NCT02628938|76092353|FG001|Overall Study|Failure to comply with the instructions|0|||
42264324|NCT02628938|76092354|FG002|Overall Study|Failure to comply with the instructions|3|||
42264325|NCT01356407|76092368|FG000|Overall Study|Lost to Follow-up|2|||
42264326|NCT01356407|76092369|FG001|Overall Study|Lost to Follow-up|0|||
42264327|NCT01356407|76092368|FG000|Overall Study|Patient Withdrew Consent|2|||
42264328|NCT01356407|76092369|FG001|Overall Study|Patient Withdrew Consent|1|||
42264329|NCT01356407|76092368|FG000|Overall Study|Could not afford IMP administration|0|||
42264330|NCT01356407|76092369|FG001|Overall Study|Could not afford IMP administration|1|||
42264331|NCT01356407|76092368|FG000|Overall Study|Not complete Endoscopy|2|||
42264332|NCT01356407|76092369|FG001|Overall Study|Not complete Endoscopy|2|||
42264333|NCT00109837|76092375|FG000|Overall Study|Adverse Event|2|||
42264334|NCT00109837|76092375|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
42264335|NCT00109837|76092375|FG000|Overall Study|Death|1|||
42264336|NCT00109837|76092375|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
42264337|NCT00109837|76092375|FG000|Overall Study|Not treated|1|||
42264338|NCT00109837|76092375|FG000|Overall Study|Ineligible|1|||
42264339|NCT02828111|76092388|FG000|Overall Study|Withdrawal by Subject|0|||
42333859|NCT02132195|76171481|FG000|Initial Assignment|Relapsed|14|||
41999697|NCT01335399|75808064|FG001|Treatment Period|Study drug toxicity|64|||
42264340|NCT02828111|76092389|FG001|Overall Study|Withdrawal by Subject|0|||
42264341|NCT02828111|76092390|FG002|Overall Study|Withdrawal by Subject|2|||
42264342|NCT02828111|76092391|FG003|Overall Study|Withdrawal by Subject|0|||
42264343|NCT02828111|76092392|FG004|Overall Study|Withdrawal by Subject|0|||
42333860|NCT02132195|76171482|FG001|Initial Assignment|Relapsed|0|||
42333861|NCT02132195|76171483|FG002|Initial Assignment|Relapsed|0|||
41999698|NCT01335399|75808063|FG000|Treatment Period|Participant request to discontinue|30|||
41999699|NCT01335399|75808064|FG001|Treatment Period|Participant request to discontinue|22|||
41999700|NCT01335399|75808063|FG000|Treatment Period|Other reasons|30|||
41999701|NCT01335399|75808064|FG001|Treatment Period|Other reasons|30|||
41999702|NCT01335399|75808063|FG000|Treatment Period|Consent withdrawal|10|||
41999703|NCT01335399|75808064|FG001|Treatment Period|Consent withdrawal|7|||
41999704|NCT01335399|75808063|FG000|Treatment Period|Death|7|||
41999705|NCT01335399|75808064|FG001|Treatment Period|Death|6|||
41999706|NCT01335399|75808063|FG000|Treatment Period|Poor/Non-compliance|3|||
42034622|NCT01120379|75842706|FG000|Three Year Timepoint|Physician Decision|9|||
42034623|NCT01120379|75842706|FG000|Three Year Timepoint|Any other reason for early termination|17|||
42034624|NCT01120379|75842706|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
41999707|NCT01335399|75808064|FG001|Treatment Period|Poor/Non-compliance|4|||
41999708|NCT01335399|75808063|FG000|Treatment Period|Lost to Follow-up|2|||
41999709|NCT01335399|75808064|FG001|Treatment Period|Lost to Follow-up|2|||
42034625|NCT01120379|75842706|FG000|Four Year Timepoint|Lost to Follow-up|10|||
42034626|NCT01120379|75842706|FG000|Four Year Timepoint|Death|131|||
42034627|NCT01120379|75842706|FG000|Four Year Timepoint|Physician Decision|5|||
42034628|NCT01120379|75842706|FG000|Four Year Timepoint|Any other reason for early termination|217|||
42264344|NCT02828111|76092388|FG000|Overall Study|Lost to Follow-up|0|||
42264345|NCT02828111|76092389|FG001|Overall Study|Lost to Follow-up|0|||
41999710|NCT01335399|75808063|FG000|Treatment Period|Maximum clinical benefit|1|||
41999711|NCT01335399|75808064|FG001|Treatment Period|Maximum clinical benefit|1|||
41999712|NCT01335399|75808063|FG000|Treatment Period|No longer meet study criteria|1|||
42264346|NCT02828111|76092390|FG002|Overall Study|Lost to Follow-up|0|||
42264347|NCT02828111|76092391|FG003|Overall Study|Lost to Follow-up|1|||
42264348|NCT02828111|76092392|FG004|Overall Study|Lost to Follow-up|1|||
42264349|NCT01671332|76092415|FG000|Overall Study|Withdrawal by Subject|1|||
42333862|NCT02132195|76171481|FG000|Rescue Therapy|Relapsed|0|||
42333863|NCT02132195|76171482|FG001|Rescue Therapy|Relapsed|0|||
42333864|NCT02132195|76171483|FG002|Rescue Therapy|Relapsed|7|||
42333865|NCT02132195|76171481|FG000|Rescue Therapy|Physician Decision|0|||
42333866|NCT02132195|76171482|FG001|Rescue Therapy|Physician Decision|0|||
42333867|NCT02132195|76171483|FG002|Rescue Therapy|Physician Decision|1|||
42333868|NCT02132195|76171481|FG000|Rescue Therapy|Withdrawal by Subject|0|||
42333869|NCT02132195|76171482|FG001|Rescue Therapy|Withdrawal by Subject|0|||
42333870|NCT02132195|76171483|FG002|Rescue Therapy|Withdrawal by Subject|1|||
42333871|NCT02132195|76171481|FG000|Rescue Therapy|Adverse Event|0|||
42333872|NCT02132195|76171482|FG001|Rescue Therapy|Adverse Event|0|||
42333873|NCT02132195|76171483|FG002|Rescue Therapy|Adverse Event|2|||
42333874|NCT02182973|76171493|FG000|Overall Study|Withdrawal by Subject|3|||
42333875|NCT02182973|76171494|FG001|Overall Study|Withdrawal by Subject|0|||
42333876|NCT02182895|76171503|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
42333877|NCT02182895|76171504|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
42333878|NCT01625377|76171512|FG000|Overall Study|Death|1|||
42333879|NCT01625377|76171513|FG001|Overall Study|Death|1|||
42333880|NCT01625377|76171512|FG000|Overall Study|Administrative Problem|1|||
41999713|NCT01335399|75808064|FG001|Treatment Period|No longer meet study criteria|1|||
41999714|NCT01335399|75808063|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
42034629|NCT01120067|75842712|FG000|Overall Study|Lost to Follow-up|3|||
42264350|NCT01671332|76092416|FG001|Overall Study|Withdrawal by Subject|1|||
42264351|NCT01355627|76092424|FG000|Overall Study|Request By the Patient to Discontinue|5|||
42264352|NCT01355627|76092425|FG001|Overall Study|Request By the Patient to Discontinue|7|||
42264353|NCT01355627|76092424|FG000|Overall Study|Lost to Follow-up|8|||
42264354|NCT01355627|76092425|FG001|Overall Study|Lost to Follow-up|7|||
42264355|NCT01355627|76092424|FG000|Overall Study|Fatal Adverse Event|19|||
42264356|NCT01355627|76092425|FG001|Overall Study|Fatal Adverse Event|23|||
42264357|NCT01355627|76092424|FG000|Overall Study|Other|1|||
42264358|NCT01355627|76092425|FG001|Overall Study|Other|1|||
42333881|NCT01625377|76171513|FG001|Overall Study|Administrative Problem|1|||
42333882|NCT01625377|76171512|FG000|Overall Study|Protocol Violation|0|||
42333883|NCT01625377|76171513|FG001|Overall Study|Protocol Violation|3|||
42333884|NCT01625377|76171512|FG000|Overall Study|Adverse Event|3|||
42333885|NCT01625377|76171513|FG001|Overall Study|Adverse Event|16|||
42333886|NCT01625377|76171512|FG000|Overall Study|Graft loss|1|||
42034630|NCT01120067|75842713|FG001|Overall Study|Lost to Follow-up|1|||
42034631|NCT01120067|75842712|FG000|Overall Study|fail to engage >3 sessions|2|||
42264359|NCT00100802|76092431|FG000|Overall Study|Adverse Event|9|||
42264360|NCT00100802|76092431|FG000|Overall Study|Death|1|||
42264361|NCT00100802|76092431|FG000|Overall Study|Lack of Efficacy|47|||
42264362|NCT00100802|76092431|FG000|Overall Study|Physician Decision|5|||
42264363|NCT00100802|76092431|FG000|Overall Study|Protocol Violation|1|||
42264364|NCT00100802|76092431|FG000|Overall Study|Withdrawal by Subject|5|||
42264365|NCT00100802|76092431|FG000|Overall Study|Ineligible|12|||
42264366|NCT01355159|76092437|FG000|Overall Study|Withdrew consent|39|||
42333887|NCT01625377|76171513|FG001|Overall Study|Graft loss|0|||
42264367|NCT01355159|76092438|FG001|Overall Study|Withdrew consent|47|||
42264368|NCT01355159|76092437|FG000|Overall Study|No primary outcome data|17|||
42264369|NCT01355159|76092438|FG001|Overall Study|No primary outcome data|11|||
42264370|NCT01355159|76092437|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
42264371|NCT01355159|76092438|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
41999715|NCT01335399|75808064|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
41999716|NCT01366521|75808074|FG000|Overall Study|Adverse Event|1|||
41999717|NCT01366521|75808075|FG001|Overall Study|Adverse Event|0|||
41999718|NCT01366521|75808076|FG002|Overall Study|Adverse Event|0|||
41999719|NCT01366521|75808077|FG003|Overall Study|Adverse Event|0|||
41999720|NCT01366521|75808074|FG000|Overall Study|Protocol Violation|0|||
41999721|NCT01366521|75808075|FG001|Overall Study|Protocol Violation|0|||
41999722|NCT01366521|75808076|FG002|Overall Study|Protocol Violation|1|||
41999723|NCT01366521|75808077|FG003|Overall Study|Protocol Violation|0|||
41999724|NCT01366521|75808074|FG000|Overall Study|Physician Decision|0|||
41999725|NCT01366521|75808075|FG001|Overall Study|Physician Decision|0|||
41999726|NCT01366521|75808076|FG002|Overall Study|Physician Decision|1|||
41999727|NCT01366521|75808077|FG003|Overall Study|Physician Decision|0|||
41999728|NCT01366521|75808074|FG000|Overall Study|Withdrawal by Subject|0|||
41999729|NCT01366521|75808075|FG001|Overall Study|Withdrawal by Subject|1|||
41999730|NCT01366521|75808076|FG002|Overall Study|Withdrawal by Subject|0|||
41999731|NCT01366521|75808077|FG003|Overall Study|Withdrawal by Subject|0|||
41999732|NCT01335009|75808091|FG000|Overall Study|Too ill to travel to study sites|1|||
41999733|NCT01335009|75808092|FG001|Overall Study|Too ill to travel to study sites|0|||
41999734|NCT01335009|75808091|FG000|Overall Study|Death|28|||
41999735|NCT01335009|75808092|FG001|Overall Study|Death|32|||
41999736|NCT01335009|75808091|FG000|Overall Study|Withdrawal by Subject|1|||
41999737|NCT01335009|75808092|FG001|Overall Study|Withdrawal by Subject|1|||
41999738|NCT01335009|75808091|FG000|Overall Study|Lost to Follow-up|1|||
41999739|NCT01335009|75808092|FG001|Overall Study|Lost to Follow-up|0|||
41999740|NCT01366443|75808107|FG000|Overall Study|Lost to Follow-up|2|||
41999741|NCT01366443|75808107|FG000|Overall Study|Under 18 yo|1|||
41999742|NCT01332630|75808112|FG000|Overall Study|Withdrawal by Subject|3|||
41999743|NCT01366209|75808118|FG000|Overall Study|Adverse Event|6|||
41999744|NCT01366209|75808119|FG001|Overall Study|Adverse Event|7|||
41999745|NCT01366209|75808118|FG000|Overall Study|Withdrawal by Subject|4|||
41999746|NCT01366209|75808119|FG001|Overall Study|Withdrawal by Subject|4|||
41999747|NCT01366209|75808118|FG000|Overall Study|Death|12|||
41999748|NCT01366209|75808119|FG001|Overall Study|Death|19|||
41999749|NCT01366209|75808118|FG000|Overall Study|Lung transplantation|6|||
41999750|NCT01366209|75808119|FG001|Overall Study|Lung transplantation|1|||
41999751|NCT01366209|75808118|FG000|Overall Study|Lost to Follow-up|2|||
41999752|NCT01366209|75808119|FG001|Overall Study|Lost to Follow-up|1|||
41999753|NCT01366209|75808118|FG000|Overall Study|Physician Decision|1|||
41999754|NCT01366209|75808119|FG001|Overall Study|Physician Decision|0|||
41999755|NCT01366209|75808118|FG000|Overall Study|Sponsors decision|0|||
41999756|NCT01366209|75808119|FG001|Overall Study|Sponsors decision|1|||
41999757|NCT01366209|75808118|FG000|Overall Study|Withdrew consent|4|||
41999758|NCT01366209|75808119|FG001|Overall Study|Withdrew consent|3|||
41999759|NCT01365546|75808125|FG000|Overall Study|Withdrawal by Subject|1|||
41999760|NCT01365546|75808125|FG000|Overall Study|Screen failure|9|||
41999761|NCT01365546|75808125|FG000|Overall Study|Study termination|1|||
41999762|NCT01365507|75808135|FG000|Overall Study|Withdrawal Criteria|8|||
41999763|NCT01365507|75808136|FG001|Overall Study|Withdrawal Criteria|5|||
41999764|NCT01365507|75808135|FG000|Overall Study|Unclassified|1|||
42264372|NCT01355159|76092437|FG000|Overall Study|Early intrauterine fetal death|6|||
42264373|NCT01355159|76092438|FG001|Overall Study|Early intrauterine fetal death|6|||
42264374|NCT02630186|76092444|FG000|Overall Study|Withdrawal by Subject|1|||
42264375|NCT01669928|76092450|FG000|First Intervention|Withdrawal by Subject|3|||
42264376|NCT01669928|76092451|FG001|First Intervention|Withdrawal by Subject|5|||
42264377|NCT01355081|76092462|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
42264378|NCT01355081|76092463|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
42264379|NCT01355081|76092464|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
42264380|NCT01355081|76092462|FG000|Overall Study|Major Protocol Deviation|0|||
42264381|NCT01355081|76092463|FG001|Overall Study|Major Protocol Deviation|1|||
41999765|NCT01365507|75808136|FG001|Overall Study|Unclassified|4|||
41999766|NCT01365468|75808160|FG000|Overall Study|Physician Decision|1|||
41999767|NCT01365468|75808161|FG001|Overall Study|Physician Decision|0|||
41999768|NCT01365468|75808160|FG000|Overall Study|Disease progression|1|||
41999769|NCT01365468|75808161|FG001|Overall Study|Disease progression|0|||
41999770|NCT01365468|75808160|FG000|Overall Study|Lost to Follow-up|2|||
41999771|NCT01365468|75808161|FG001|Overall Study|Lost to Follow-up|0|||
41999772|NCT01357980|75808172|FG000|Overall Study|Lack of Efficacy|0|||
41999773|NCT01357980|75808173|FG001|Overall Study|Lack of Efficacy|1|||
42034632|NCT01120067|75842713|FG001|Overall Study|fail to engage >3 sessions|0|||
41999774|NCT01357980|75808174|FG002|Overall Study|Lack of Efficacy|0|||
41999775|NCT01357980|75808175|FG003|Overall Study|Lack of Efficacy|0|||
41999776|NCT01357980|75808172|FG000|Overall Study|Consent withdrawn|0|||
41999777|NCT01357980|75808173|FG001|Overall Study|Consent withdrawn|0|||
41999778|NCT01357980|75808174|FG002|Overall Study|Consent withdrawn|1|||
41999779|NCT01357980|75808175|FG003|Overall Study|Consent withdrawn|0|||
41999780|NCT01332318|75808189|FG000|Overall Study|Adverse Event|0|||
41999781|NCT01332318|75808190|FG001|Overall Study|Adverse Event|3|||
41999782|NCT01332318|75808191|FG002|Overall Study|Adverse Event|0|||
41999783|NCT01332318|75808192|FG003|Overall Study|Adverse Event|0|||
41999784|NCT01332318|75808189|FG000|Overall Study|Withdrawal by Subject|1|||
41999785|NCT01332318|75808190|FG001|Overall Study|Withdrawal by Subject|1|||
41999786|NCT01332318|75808191|FG002|Overall Study|Withdrawal by Subject|0|||
41999787|NCT01332318|75808192|FG003|Overall Study|Withdrawal by Subject|1|||
42264382|NCT01355081|76092464|FG002|Overall Study|Major Protocol Deviation|0|||
42264383|NCT01355081|76092462|FG000|Overall Study|Lost to Follow-up|0|||
41999788|NCT01332318|75808189|FG000|Overall Study|Protocol Violation|1|||
41999789|NCT01332318|75808190|FG001|Overall Study|Protocol Violation|0|||
41999790|NCT01332318|75808191|FG002|Overall Study|Protocol Violation|1|||
41999791|NCT01332318|75808192|FG003|Overall Study|Protocol Violation|1|||
41999792|NCT01331109|75808207|FG000|Overall Study|Adverse Event|6|||
41999793|NCT01331109|75808207|FG000|Overall Study|Lack of Efficacy|2|||
41999794|NCT01331109|75808207|FG000|Overall Study|Protocol Violation|3|||
41999795|NCT01331109|75808207|FG000|Overall Study|Withdrawal by Subject|7|||
41999796|NCT01331109|75808207|FG000|Overall Study|Lost to Follow-up|1|||
41999797|NCT01331109|75808207|FG000|Overall Study|Study Terminated by Sponsor|38|||
41999798|NCT01357551|75808213|FG000|Overall Study|Withdrawal by Subject|6|||
41999799|NCT01357551|75808214|FG001|Overall Study|Withdrawal by Subject|4|||
42034633|NCT01124045|75842721|FG000|Overall Study|Lost to Follow-up|0|||
42264384|NCT01355081|76092463|FG001|Overall Study|Lost to Follow-up|0|||
42264385|NCT01355081|76092464|FG002|Overall Study|Lost to Follow-up|1|||
42264386|NCT01355081|76092462|FG000|Overall Study|Withdrawal of Consent|2|||
42264387|NCT01355081|76092463|FG001|Overall Study|Withdrawal of Consent|3|||
42264388|NCT01355081|76092464|FG002|Overall Study|Withdrawal of Consent|3|||
42264389|NCT01355081|76092462|FG000|Overall Study|Lack of Efficacy|2|||
42264390|NCT01355081|76092463|FG001|Overall Study|Lack of Efficacy|1|||
42264391|NCT01355081|76092464|FG002|Overall Study|Lack of Efficacy|1|||
42264392|NCT01355081|76092462|FG000|Overall Study|Non Compliance with Study Medication|0|||
42264393|NCT01355081|76092463|FG001|Overall Study|Non Compliance with Study Medication|1|||
42264394|NCT01355081|76092464|FG002|Overall Study|Non Compliance with Study Medication|0|||
42264395|NCT01354223|76092474|FG000|Overall Study|Withdrawal by Subject|3|||
42264396|NCT01354223|76092475|FG001|Overall Study|Withdrawal by Subject|1|||
42264397|NCT04043455|76092485|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
42264398|NCT04043455|76092486|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
42264399|NCT04043455|76092487|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
42264400|NCT04043455|76092488|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
42264401|NCT04043455|76092489|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
42264402|NCT04043455|76092490|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
42264403|NCT04043455|76092485|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
42264404|NCT04043455|76092486|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
42264405|NCT04043455|76092487|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
42333888|NCT01625377|76171512|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42333889|NCT01625377|76171513|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
42333890|NCT01625377|76171512|FG000|Overall Study|Abnormal laboratory values|1|||
42333891|NCT01625377|76171513|FG001|Overall Study|Abnormal laboratory values|0|||
42333892|NCT02158949|76171521|FG000|Overall Study|Withdrawal by Subject|1|||
42333893|NCT02158949|76171522|FG001|Overall Study|Withdrawal by Subject|0|||
42333894|NCT02158949|76171521|FG000|Overall Study|Lost to Follow-up|5|||
42333895|NCT02158949|76171522|FG001|Overall Study|Lost to Follow-up|11|||
42333896|NCT02132117|76171530|FG000|Overall Study|Adverse Event|6|||
42333897|NCT02132117|76171531|FG001|Overall Study|Adverse Event|1|||
42333898|NCT02132117|76171530|FG000|Overall Study|Lost to Follow-up|2|||
42333899|NCT02132117|76171531|FG001|Overall Study|Lost to Follow-up|2|||
42333900|NCT02132117|76171530|FG000|Overall Study|Personal Reasons|1|||
42333901|NCT02132117|76171531|FG001|Overall Study|Personal Reasons|2|||
42333902|NCT02132117|76171530|FG000|Overall Study|Other Miscellaneous Reasons|2|||
42333903|NCT02132117|76171531|FG001|Overall Study|Other Miscellaneous Reasons|0|||
42333904|NCT02093689|76171540|FG000|Overall Study|Physician Decision|4|||
41999800|NCT01357551|75808213|FG000|Overall Study|Death|0|||
41999801|NCT01357551|75808214|FG001|Overall Study|Death|1|||
41999802|NCT01357551|75808213|FG000|Overall Study|Lost to Follow-up|16|||
41999803|NCT01357551|75808214|FG001|Overall Study|Lost to Follow-up|6|||
41999804|NCT01357239|75808227|FG000|Stratum: All Patients|Adverse Event|0|||
41999805|NCT01357239|75808228|FG001|Stratum: All Patients|Adverse Event|0|||
41999806|NCT01357239|75808229|FG002|Stratum: All Patients|Adverse Event|1|||
41999807|NCT01357239|75808230|FG003|Stratum: All Patients|Adverse Event|1|||
41999808|NCT01357239|75808227|FG000|Stratum: All Patients|Subject withdrew consent|0|||
41999809|NCT01357239|75808228|FG001|Stratum: All Patients|Subject withdrew consent|0|||
41999810|NCT01357239|75808229|FG002|Stratum: All Patients|Subject withdrew consent|1|||
41999811|NCT01357239|75808230|FG003|Stratum: All Patients|Subject withdrew consent|1|||
41999812|NCT01357239|75808227|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
41999813|NCT01357239|75808228|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
41999814|NCT01357239|75808229|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
41999815|NCT01357239|75808230|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
41999816|NCT01357239|75808227|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
41999817|NCT01357239|75808228|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
41999818|NCT01357239|75808229|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
41999819|NCT01357239|75808230|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
41999820|NCT01357239|75808227|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
41999821|NCT01357239|75808228|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
41999822|NCT01357239|75808229|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
41999823|NCT01357239|75808230|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
41999824|NCT01351350|75808248|FG000|Overall Study|Disease Progression|5|||
41999825|NCT01351350|75808249|FG001|Overall Study|Disease Progression|13|||
41999826|NCT01351350|75808250|FG002|Overall Study|Disease Progression|6|||
41999827|NCT01351350|75808251|FG003|Overall Study|Disease Progression|8|||
41999828|NCT01351350|75808252|FG004|Overall Study|Disease Progression|5|||
41999829|NCT01351350|75808248|FG000|Overall Study|Adverse Event|1|||
41999830|NCT01351350|75808249|FG001|Overall Study|Adverse Event|10|||
41999831|NCT01351350|75808250|FG002|Overall Study|Adverse Event|1|||
41999832|NCT01351350|75808251|FG003|Overall Study|Adverse Event|2|||
41999833|NCT01351350|75808252|FG004|Overall Study|Adverse Event|0|||
41999834|NCT01351350|75808248|FG000|Overall Study|Participant Decision|2|||
41999835|NCT01351350|75808249|FG001|Overall Study|Participant Decision|6|||
41999836|NCT01351350|75808250|FG002|Overall Study|Participant Decision|3|||
41999837|NCT01351350|75808251|FG003|Overall Study|Participant Decision|3|||
41999838|NCT01351350|75808252|FG004|Overall Study|Participant Decision|2|||
41999839|NCT01351350|75808248|FG000|Overall Study|Enrolled but not Treated|0|||
41999840|NCT01351350|75808249|FG001|Overall Study|Enrolled but not Treated|0|||
41999841|NCT01351350|75808250|FG002|Overall Study|Enrolled but not Treated|1|||
41999842|NCT01351350|75808251|FG003|Overall Study|Enrolled but not Treated|0|||
41999843|NCT01351350|75808252|FG004|Overall Study|Enrolled but not Treated|0|||
41999844|NCT01350999|75808280|FG000|Overall Study|Adverse Event|4|||
41999845|NCT01350999|75808281|FG001|Overall Study|Adverse Event|9|||
41999846|NCT01350999|75808282|FG002|Overall Study|Adverse Event|10|||
41999847|NCT01350999|75808280|FG000|Overall Study|Voluntary withdrawal|3|||
41999848|NCT01350999|75808281|FG001|Overall Study|Voluntary withdrawal|4|||
41999849|NCT01350999|75808282|FG002|Overall Study|Voluntary withdrawal|6|||
41999850|NCT01350999|75808280|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
41999851|NCT01350999|75808281|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
41999852|NCT01350999|75808282|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
41999853|NCT01330914|75808301|FG000|Overall Study|Withdrawal by Subject|4|||
41999854|NCT01330914|75808301|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
41999855|NCT01350804|75808309|FG000|Core Study|Withdrawal by Subject|11|||
41999856|NCT01350804|75808310|FG001|Core Study|Withdrawal by Subject|17|||
41999857|NCT01350804|75808311|FG002|Core Study|Withdrawal by Subject|16|||
41999858|NCT01350804|75808312|FG003|Core Study|Withdrawal by Subject|7|||
41999859|NCT01350804|75808309|FG000|Core Study|Study terminated by Sponsor|0|||
41999860|NCT01350804|75808310|FG001|Core Study|Study terminated by Sponsor|0|||
41999861|NCT01350804|75808311|FG002|Core Study|Study terminated by Sponsor|0|||
41999862|NCT01350804|75808312|FG003|Core Study|Study terminated by Sponsor|2|||
41999863|NCT01350804|75808309|FG000|Core Study|Protocol deviation|1|||
41999864|NCT01350804|75808310|FG001|Core Study|Protocol deviation|0|||
41999865|NCT01350804|75808311|FG002|Core Study|Protocol deviation|1|||
41999866|NCT01350804|75808312|FG003|Core Study|Protocol deviation|0|||
41999867|NCT01350804|75808309|FG000|Core Study|Physician Decision|1|||
41999868|NCT01350804|75808310|FG001|Core Study|Physician Decision|0|||
41999869|NCT01350804|75808311|FG002|Core Study|Physician Decision|1|||
41999870|NCT01350804|75808312|FG003|Core Study|Physician Decision|3|||
41999871|NCT01350804|75808309|FG000|Core Study|Lost to Follow-up|3|||
41999872|NCT01350804|75808310|FG001|Core Study|Lost to Follow-up|0|||
41999873|NCT01350804|75808311|FG002|Core Study|Lost to Follow-up|2|||
41999874|NCT01350804|75808312|FG003|Core Study|Lost to Follow-up|1|||
41999875|NCT01350804|75808309|FG000|Core Study|Lack of Efficacy|16|||
41999876|NCT01350804|75808310|FG001|Core Study|Lack of Efficacy|19|||
41999877|NCT01350804|75808311|FG002|Core Study|Lack of Efficacy|18|||
42034634|NCT01124045|75842722|FG001|Overall Study|Lost to Follow-up|1|||
42034635|NCT01124045|75842721|FG000|Overall Study|Physician Decision|0|||
41999878|NCT01350804|75808312|FG003|Core Study|Lack of Efficacy|5|||
41999879|NCT01350804|75808309|FG000|Core Study|Death|1|||
41999880|NCT01350804|75808310|FG001|Core Study|Death|1|||
41999881|NCT01350804|75808311|FG002|Core Study|Death|1|||
41999882|NCT01350804|75808312|FG003|Core Study|Death|0|||
41999883|NCT01350804|75808309|FG000|Core Study|Adverse Event|8|||
41999884|NCT01350804|75808310|FG001|Core Study|Adverse Event|10|||
41999885|NCT01350804|75808311|FG002|Core Study|Adverse Event|8|||
41999886|NCT01350804|75808312|FG003|Core Study|Adverse Event|8|||
41999887|NCT01350804|75808309|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
41999888|NCT01350804|75808310|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
41999889|NCT01350804|75808311|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
41999890|NCT01350804|75808312|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
41999891|NCT01350804|75808309|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
41999892|NCT01350804|75808310|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
41999893|NCT01350804|75808311|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
41999894|NCT01350804|75808312|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
41999895|NCT01350804|75808309|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
41999896|NCT01350804|75808310|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
41999897|NCT01350804|75808311|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
41999898|NCT01350804|75808312|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
41999899|NCT01350804|75808309|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
41999900|NCT01350804|75808310|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
41999901|NCT01350804|75808311|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
42333905|NCT02093689|76171541|FG001|Overall Study|Physician Decision|0|||
42333906|NCT02093689|76171542|FG002|Overall Study|Physician Decision|0|||
42333907|NCT02047045|76171550|FG000|Baseline|Withdrawal by Subject|3|||
42333908|NCT02047045|76171551|FG001|Baseline|Withdrawal by Subject|2|||
42333909|NCT02047045|76171550|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
42333910|NCT02047045|76171551|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
42333911|NCT02047045|76171550|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
42333912|NCT02047045|76171551|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
42333913|NCT02047045|76171550|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
42333914|NCT02047045|76171551|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
42333915|NCT02047045|76171550|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
42333916|NCT02047045|76171551|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
42333917|NCT02047045|76171550|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
42333918|NCT02047045|76171551|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
42333919|NCT02047045|76171550|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
42333920|NCT02047045|76171551|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
42333921|NCT02047045|76171550|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
42333922|NCT02047045|76171551|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
42333923|NCT02047045|76171550|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
42333924|NCT02047045|76171551|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
42333925|NCT02131259|76171557|FG000|Overall Study|Progressive disease|751|||
42333926|NCT02131259|76171557|FG000|Overall Study|Adverse Event|341|||
42333927|NCT02131259|76171557|FG000|Overall Study|Lost to Follow-up|7|||
42333928|NCT02131259|76171557|FG000|Overall Study|Relocation|32|||
42333929|NCT02131259|76171557|FG000|Overall Study|Other|63|||
42333930|NCT02131259|76171557|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
41999902|NCT01350804|75808312|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
42264406|NCT04043455|76092488|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
42264407|NCT04043455|76092489|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
42264408|NCT04043455|76092490|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
42264409|NCT04043455|76092485|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
42264410|NCT04043455|76092486|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
42264411|NCT04043455|76092487|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
42264412|NCT04043455|76092488|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
42264413|NCT04043455|76092489|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
42264414|NCT04043455|76092490|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
42264415|NCT04043455|76092485|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
42264416|NCT04043455|76092486|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
42264417|NCT04043455|76092487|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
42333931|NCT02131259|76171557|FG000|Overall Study|Progressive disease/relocation|1|||
41999903|NCT01350804|75808309|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
41999904|NCT01350804|75808310|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
41999905|NCT01350804|75808311|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
41999906|NCT01350804|75808312|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
41999907|NCT01350804|75808309|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
41999908|NCT01350804|75808310|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
41999909|NCT01350804|75808311|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
41999910|NCT01350804|75808312|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
41999911|NCT01350492|75808334|FG000|Intervention|Lost to Follow-up|2|||
41999912|NCT01350492|75808335|FG001|Intervention|Lost to Follow-up|5|||
41999913|NCT01350492|75808334|FG000|Intervention|Withdrawal by Subject|3|||
41999914|NCT01350492|75808335|FG001|Intervention|Withdrawal by Subject|1|||
41999915|NCT01350492|75808334|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
41999916|NCT01350492|75808335|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
41999917|NCT01350492|75808334|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
41999918|NCT01350492|75808335|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
41999919|NCT02270957|75808343|FG000|Overall Study|Lack of Efficacy|2|||
41999920|NCT02270957|75808344|FG001|Overall Study|Lack of Efficacy|4|||
41999921|NCT02270957|75808343|FG000|Overall Study|Adverse Event|2|||
41999922|NCT02270957|75808344|FG001|Overall Study|Adverse Event|0|||
41999923|NCT01350414|75808351|FG000|Overall Study|Lost to Follow-up|13|||
41999924|NCT01350414|75808351|FG000|Overall Study|Withdrawal by Subject|4|||
41999925|NCT01350414|75808351|FG000|Overall Study|Physician Decision|2|||
41999926|NCT01350336|75808361|FG000|Overall Study|Lost to Follow-up|31|||
41999927|NCT01350336|75808361|FG000|Overall Study|Withdrawal by Subject|14|||
41999928|NCT01350336|75808361|FG000|Overall Study|Physician Decision|8|||
41999929|NCT01350336|75808361|FG000|Overall Study|Death|4|||
41999930|NCT01349049|75808419|FG000|Overall Study|Disease progression|3|||
41999931|NCT01349049|75808420|FG001|Overall Study|Disease progression|5|||
41999932|NCT01349049|75808421|FG002|Overall Study|Disease progression|3|||
41999933|NCT01349049|75808422|FG003|Overall Study|Disease progression|2|||
41999934|NCT01349049|75808423|FG004|Overall Study|Disease progression|2|||
41999935|NCT01349049|75808424|FG005|Overall Study|Disease progression|2|||
41999936|NCT01349049|75808425|FG006|Overall Study|Disease progression|3|||
41999937|NCT01349049|75808426|FG007|Overall Study|Disease progression|2|||
41999938|NCT01349049|75808427|FG008|Overall Study|Disease progression|33|||
41999939|NCT01349049|75808419|FG000|Overall Study|Adverse Event|0|||
41999940|NCT01349049|75808420|FG001|Overall Study|Adverse Event|1|||
41999941|NCT01349049|75808421|FG002|Overall Study|Adverse Event|0|||
41999942|NCT01349049|75808422|FG003|Overall Study|Adverse Event|0|||
41999943|NCT01349049|75808423|FG004|Overall Study|Adverse Event|0|||
41999944|NCT01349049|75808424|FG005|Overall Study|Adverse Event|3|||
41999945|NCT01349049|75808425|FG006|Overall Study|Adverse Event|1|||
41999946|NCT01349049|75808426|FG007|Overall Study|Adverse Event|0|||
42264418|NCT04043455|76092488|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
42264419|NCT04043455|76092489|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
42264420|NCT04043455|76092490|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
42264421|NCT04043455|76092485|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
42264422|NCT04043455|76092486|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
42264423|NCT04043455|76092487|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
42264424|NCT04043455|76092488|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
42264425|NCT04043455|76092489|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
42264426|NCT04043455|76092490|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
42264427|NCT04043455|76092485|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
42264428|NCT04043455|76092486|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
42264429|NCT04043455|76092487|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
42264430|NCT04043455|76092488|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
42264431|NCT04043455|76092489|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
42264432|NCT04043455|76092490|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
42264433|NCT04043455|76092485|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
42264434|NCT04043455|76092486|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
41999947|NCT01349049|75808427|FG008|Overall Study|Adverse Event|4|||
41999948|NCT01349049|75808419|FG000|Overall Study|Physician Decision|0|||
41999949|NCT01349049|75808420|FG001|Overall Study|Physician Decision|1|||
41999950|NCT01349049|75808421|FG002|Overall Study|Physician Decision|0|||
41999951|NCT01349049|75808422|FG003|Overall Study|Physician Decision|0|||
41999952|NCT01349049|75808423|FG004|Overall Study|Physician Decision|0|||
41999953|NCT01349049|75808424|FG005|Overall Study|Physician Decision|0|||
41999954|NCT01349049|75808425|FG006|Overall Study|Physician Decision|0|||
41999955|NCT01349049|75808426|FG007|Overall Study|Physician Decision|0|||
41999956|NCT01349049|75808427|FG008|Overall Study|Physician Decision|2|||
41999957|NCT01349049|75808419|FG000|Overall Study|Protocol Violation|0|||
41999958|NCT01349049|75808420|FG001|Overall Study|Protocol Violation|0|||
41999959|NCT01349049|75808421|FG002|Overall Study|Protocol Violation|0|||
41999960|NCT01349049|75808422|FG003|Overall Study|Protocol Violation|0|||
41999961|NCT01349049|75808423|FG004|Overall Study|Protocol Violation|0|||
41999962|NCT01349049|75808424|FG005|Overall Study|Protocol Violation|0|||
41999963|NCT01349049|75808425|FG006|Overall Study|Protocol Violation|0|||
41999964|NCT01349049|75808426|FG007|Overall Study|Protocol Violation|0|||
41999965|NCT01349049|75808427|FG008|Overall Study|Protocol Violation|1|||
42333932|NCT02131259|76171557|FG000|Overall Study|Progressive disease/other|2|||
42333933|NCT02131259|76171557|FG000|Overall Study|AE/lost to follow-up|1|||
42333934|NCT02131259|76171557|FG000|Overall Study|AE/other|1|||
42333935|NCT02131259|76171557|FG000|Overall Study|Progressive disease/AE/other|1|||
42333936|NCT02131259|76171557|FG000|Overall Study|Missing|3|||
42333937|NCT01856595|76171570|FG000|Overall Study|Withdrawal by Subject|0|||
42333938|NCT01856595|76171571|FG001|Overall Study|Withdrawal by Subject|1|||
42333939|NCT01856595|76171572|FG002|Overall Study|Withdrawal by Subject|0|||
42333940|NCT01856595|76171573|FG003|Overall Study|Withdrawal by Subject|0|||
42333941|NCT01856595|76171574|FG004|Overall Study|Withdrawal by Subject|0|||
42333942|NCT01856595|76171575|FG005|Overall Study|Withdrawal by Subject|0|||
42333943|NCT01856595|76171576|FG006|Overall Study|Withdrawal by Subject|1|||
42333944|NCT01856595|76171577|FG007|Overall Study|Withdrawal by Subject|0|||
42333945|NCT01856595|76171578|FG008|Overall Study|Withdrawal by Subject|0|||
42333946|NCT02158247|76171615|FG000|Overall Study|Invisible vocal cords|5|||
42333947|NCT01829295|76171637|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
42333948|NCT01829295|76171638|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
42333949|NCT01829295|76171639|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
42333950|NCT01829295|76171640|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
42333951|NCT01829295|76171637|FG000|6-12 Months|Adverse Event|0|||
42333952|NCT01829295|76171638|FG001|6-12 Months|Adverse Event|0|||
42333953|NCT01829295|76171639|FG002|6-12 Months|Adverse Event|3|||
42333954|NCT01829295|76171640|FG003|6-12 Months|Adverse Event|2|||
42333955|NCT01829295|76171637|FG000|6-12 Months|Lost to Follow-up|2|||
42333956|NCT01829295|76171638|FG001|6-12 Months|Lost to Follow-up|0|||
42333957|NCT01829295|76171639|FG002|6-12 Months|Lost to Follow-up|0|||
42333958|NCT01829295|76171640|FG003|6-12 Months|Lost to Follow-up|0|||
42333959|NCT01829295|76171637|FG000|6-12 Months|Withdrawal by Subject|2|||
42333960|NCT01829295|76171638|FG001|6-12 Months|Withdrawal by Subject|2|||
42333961|NCT01829295|76171639|FG002|6-12 Months|Withdrawal by Subject|0|||
42333962|NCT01829295|76171640|FG003|6-12 Months|Withdrawal by Subject|0|||
42333963|NCT02157935|76171652|FG000|Overall Study|Withdrawal by Subject|25|||
41999966|NCT01349049|75808419|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
41999967|NCT01349049|75808420|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
41999968|NCT01349049|75808421|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
41999969|NCT01349049|75808422|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
41999970|NCT01349049|75808423|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
41999971|NCT01349049|75808424|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
41999972|NCT01349049|75808425|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
42134510|NCT03956615|75945372|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
42333964|NCT02157935|76171653|FG001|Overall Study|Withdrawal by Subject|39|||
42333965|NCT02157935|76171652|FG000|Overall Study|Screen failure|1|||
42333966|NCT02157935|76171653|FG001|Overall Study|Screen failure|2|||
42333967|NCT02157935|76171652|FG000|Overall Study|Protocol Violation|1|||
42333968|NCT02157935|76171653|FG001|Overall Study|Protocol Violation|0|||
42333969|NCT02157935|76171652|FG000|Overall Study|Progressive disease|0|||
41999973|NCT01349049|75808426|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
41999974|NCT01349049|75808427|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
41999975|NCT01349049|75808419|FG000|Overall Study|Other|0|||
42137803|NCT00416598|75948179|FG000|Induction & Intensification|Alternative Treatment|135|||
42264435|NCT04043455|76092487|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
42264436|NCT04043455|76092488|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
42264437|NCT04043455|76092489|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
42264438|NCT04043455|76092490|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
42264439|NCT04043455|76092485|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
42264440|NCT04043455|76092486|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
42264441|NCT04043455|76092487|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
42264442|NCT04043455|76092488|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
42264443|NCT04043455|76092489|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
42264444|NCT04043455|76092490|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
42264445|NCT04043455|76092485|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
42264446|NCT04043455|76092486|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
42333970|NCT02157935|76171653|FG001|Overall Study|Progressive disease|2|||
41999976|NCT01349049|75808420|FG001|Overall Study|Other|0|||
41999977|NCT01349049|75808421|FG002|Overall Study|Other|0|||
41999978|NCT01349049|75808422|FG003|Overall Study|Other|0|||
41999979|NCT01349049|75808423|FG004|Overall Study|Other|0|||
42264447|NCT04043455|76092487|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
42264448|NCT04043455|76092488|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
42264449|NCT04043455|76092489|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
42264450|NCT04043455|76092490|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
42264451|NCT04043455|76092485|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
42264452|NCT04043455|76092486|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
42264453|NCT04043455|76092487|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
42264454|NCT04043455|76092488|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
42264455|NCT04043455|76092489|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
42264456|NCT04043455|76092490|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
42264457|NCT04043455|76092485|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
42264458|NCT04043455|76092486|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
42264459|NCT04043455|76092487|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
42264460|NCT04043455|76092488|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
42264461|NCT04043455|76092489|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
42264462|NCT04043455|76092490|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
42264463|NCT02627144|76092508|FG000|Overall Study|Serious adverse event|32|||
42264464|NCT02627144|76092508|FG000|Overall Study|Cancer progression|171|||
42264465|NCT02627144|76092508|FG000|Overall Study|Death from cancer|20|||
42264466|NCT02627144|76092508|FG000|Overall Study|Death from other cause|8|||
42264467|NCT02627144|76092508|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
42264468|NCT02627144|76092508|FG000|Overall Study|Administrative reasons|65|||
42264469|NCT02627144|76092508|FG000|Overall Study|Lost to Follow-up|8|||
42264470|NCT02627144|76092508|FG000|Overall Study|Enrolled, not treated|6|||
42264471|NCT02627144|76092508|FG000|Overall Study|Other|17|||
42264472|NCT02626520|76092514|FG000|Overall Study|Physician Decision|1|||
42264473|NCT02626520|76092515|FG001|Overall Study|Physician Decision|1|||
42264474|NCT02626520|76092514|FG000|Overall Study|Adverse Event|0|||
42264475|NCT02626520|76092515|FG001|Overall Study|Adverse Event|4|||
42264476|NCT02626520|76092514|FG000|Overall Study|Lack of Efficacy|0|||
42264477|NCT02626520|76092515|FG001|Overall Study|Lack of Efficacy|2|||
42264478|NCT02626520|76092514|FG000|Overall Study|Did not start protocol therapy|0|||
42264479|NCT02626520|76092515|FG001|Overall Study|Did not start protocol therapy|2|||
42264480|NCT02626520|76092514|FG000|Overall Study|Study terminated|0|||
42264481|NCT02626520|76092515|FG001|Overall Study|Study terminated|1|||
42264482|NCT04522141|76092523|FG000|Overall Study|Withdrawal by Subject|1|||
42264483|NCT04522141|76092524|FG001|Overall Study|Withdrawal by Subject|0|||
42264484|NCT01329029|76092547|FG000|Overall Study|Withdrawal by Subject|117|||
42264485|NCT01329029|76092548|FG001|Overall Study|Withdrawal by Subject|87|||
42264486|NCT01329029|76092547|FG000|Overall Study|Adverse Event|82|||
42264487|NCT01329029|76092548|FG001|Overall Study|Adverse Event|29|||
42264488|NCT01329029|76092547|FG000|Overall Study|Death|16|||
42264489|NCT01329029|76092548|FG001|Overall Study|Death|19|||
42264490|NCT01329029|76092547|FG000|Overall Study|Other|14|||
42264491|NCT01329029|76092548|FG001|Overall Study|Other|20|||
42264492|NCT01329029|76092547|FG000|Overall Study|COPD Exacerbation|11|||
42264493|NCT01329029|76092548|FG001|Overall Study|COPD Exacerbation|18|||
42264494|NCT01329029|76092547|FG000|Overall Study|Physician Decision|16|||
42264495|NCT01329029|76092548|FG001|Overall Study|Physician Decision|13|||
42264496|NCT01329029|76092547|FG000|Overall Study|Lost to Follow-up|8|||
42264497|NCT01329029|76092548|FG001|Overall Study|Lost to Follow-up|5|||
42264498|NCT01329029|76092547|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
42264499|NCT01329029|76092548|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
42264500|NCT01372085|76092564|FG000|Washout Period 2|Physician Decision|0|||
42264501|NCT01372085|76092565|FG001|Washout Period 2|Physician Decision|0|||
42264502|NCT01372085|76092566|FG002|Washout Period 2|Physician Decision|0|||
42264503|NCT01372085|76092567|FG003|Washout Period 2|Physician Decision|0|||
42264504|NCT01372085|76092568|FG004|Washout Period 2|Physician Decision|1|||
42264505|NCT01372085|76092569|FG005|Washout Period 2|Physician Decision|0|||
42264506|NCT01372085|76092570|FG006|Washout Period 2|Physician Decision|0|||
42264507|NCT01372085|76092571|FG007|Washout Period 2|Physician Decision|0|||
42264508|NCT01372085|76092572|FG008|Washout Period 2|Physician Decision|0|||
42264509|NCT01372085|76092573|FG009|Washout Period 2|Physician Decision|0|||
42264510|NCT01372085|76092564|FG000|Washout Period 3|Withdrawal by Subject|0|||
42264511|NCT01372085|76092565|FG001|Washout Period 3|Withdrawal by Subject|0|||
42264512|NCT01372085|76092566|FG002|Washout Period 3|Withdrawal by Subject|0|||
42264513|NCT01372085|76092567|FG003|Washout Period 3|Withdrawal by Subject|0|||
42264514|NCT01372085|76092568|FG004|Washout Period 3|Withdrawal by Subject|0|||
42264515|NCT01372085|76092569|FG005|Washout Period 3|Withdrawal by Subject|2|||
41999980|NCT01349049|75808424|FG005|Overall Study|Other|1|||
41999981|NCT01349049|75808425|FG006|Overall Study|Other|0|||
42264516|NCT01372085|76092570|FG006|Washout Period 3|Withdrawal by Subject|0|||
42333971|NCT02157935|76171652|FG000|Overall Study|Other|5|||
42264517|NCT01372085|76092571|FG007|Washout Period 3|Withdrawal by Subject|0|||
42264518|NCT01372085|76092572|FG008|Washout Period 3|Withdrawal by Subject|0|||
42264519|NCT01372085|76092573|FG009|Washout Period 3|Withdrawal by Subject|0|||
42264520|NCT04012853|76092599|FG000|Overall Study|Withdrawal by Subject|1|||
42264521|NCT04012853|76092600|FG001|Overall Study|Withdrawal by Subject|1|||
42264522|NCT04012853|76092599|FG000|Overall Study|Protocol Violation|1|||
42264523|NCT04012853|76092600|FG001|Overall Study|Protocol Violation|0|||
42264524|NCT04012853|76092599|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
42333972|NCT02157935|76171653|FG001|Overall Study|Other|12|||
42333973|NCT02157935|76171652|FG000|Overall Study|Lack of Efficacy|0|||
42333974|NCT02157935|76171653|FG001|Overall Study|Lack of Efficacy|1|||
42333975|NCT02157935|76171652|FG000|Overall Study|Death|4|||
42333976|NCT02157935|76171653|FG001|Overall Study|Death|4|||
42333977|NCT02157935|76171652|FG000|Overall Study|Adverse Event|3|||
42333978|NCT02157935|76171653|FG001|Overall Study|Adverse Event|5|||
42333979|NCT02157779|76171661|FG000|Overall Study|Logistical|9|||
42333980|NCT02157779|76171662|FG001|Overall Study|Logistical|3|||
42333981|NCT02157779|76171661|FG000|Overall Study|Stopped attending, reason unknown|11|||
42333982|NCT02157779|76171662|FG001|Overall Study|Stopped attending, reason unknown|7|||
42333983|NCT02157779|76171661|FG000|Overall Study|No response to outreach after Baseline|1|||
42333984|NCT02157779|76171662|FG001|Overall Study|No response to outreach after Baseline|1|||
42333985|NCT02157779|76171661|FG000|Overall Study|Moved|1|||
42333986|NCT02157779|76171662|FG001|Overall Study|Moved|0|||
42333987|NCT02157779|76171661|FG000|Overall Study|Medical|1|||
42333988|NCT02157779|76171662|FG001|Overall Study|Medical|0|||
42333989|NCT02157779|76171661|FG000|Overall Study|Legal issue|1|||
42333990|NCT02157779|76171662|FG001|Overall Study|Legal issue|0|||
42333991|NCT02093221|76171676|FG000|Overall Study|Adverse Event|1|||
42333992|NCT02093221|76171677|FG001|Overall Study|Adverse Event|0|||
42333993|NCT02093221|76171678|FG002|Overall Study|Adverse Event|0|||
42333994|NCT02093221|76171679|FG003|Overall Study|Adverse Event|0|||
42333995|NCT02093221|76171680|FG004|Overall Study|Adverse Event|0|||
42333996|NCT02093221|76171676|FG000|Overall Study|Withdrawal by Subject|1|||
42333997|NCT02093221|76171677|FG001|Overall Study|Withdrawal by Subject|1|||
42333998|NCT02093221|76171678|FG002|Overall Study|Withdrawal by Subject|4|||
42333999|NCT02093221|76171679|FG003|Overall Study|Withdrawal by Subject|1|||
42334000|NCT02093221|76171680|FG004|Overall Study|Withdrawal by Subject|1|||
42334001|NCT02093221|76171676|FG000|Overall Study|Lost to Follow-up|2|||
42334002|NCT02093221|76171677|FG001|Overall Study|Lost to Follow-up|0|||
42334003|NCT02093221|76171678|FG002|Overall Study|Lost to Follow-up|1|||
41999982|NCT01349049|75808426|FG007|Overall Study|Other|0|||
41999983|NCT01349049|75808427|FG008|Overall Study|Other|4|||
41999984|NCT01349049|75808419|FG000|Overall Study|Death|0|||
41999985|NCT01349049|75808420|FG001|Overall Study|Death|0|||
41999986|NCT01349049|75808421|FG002|Overall Study|Death|0|||
41999987|NCT01349049|75808422|FG003|Overall Study|Death|0|||
41999988|NCT01349049|75808423|FG004|Overall Study|Death|0|||
41999989|NCT01349049|75808424|FG005|Overall Study|Death|0|||
41999990|NCT01349049|75808425|FG006|Overall Study|Death|0|||
41999991|NCT01349049|75808426|FG007|Overall Study|Death|1|||
41999992|NCT01349049|75808427|FG008|Overall Study|Death|5|||
41999993|NCT01349049|75808419|FG000|Overall Study|Non-compliance|0|||
41999994|NCT01349049|75808420|FG001|Overall Study|Non-compliance|0|||
41999995|NCT01349049|75808421|FG002|Overall Study|Non-compliance|0|||
41999996|NCT01349049|75808422|FG003|Overall Study|Non-compliance|1|||
41999997|NCT01349049|75808423|FG004|Overall Study|Non-compliance|0|||
41999998|NCT01349049|75808424|FG005|Overall Study|Non-compliance|0|||
41999999|NCT01349049|75808425|FG006|Overall Study|Non-compliance|0|||
42134511|NCT03956615|75945372|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
42264525|NCT04012853|76092600|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
42264526|NCT02941549|76092609|FG000|Overall Study|Adverse Event|1|||
42264527|NCT02941549|76092610|FG001|Overall Study|Adverse Event|0|||
42264528|NCT02941549|76092611|FG002|Overall Study|Adverse Event|0|||
42334004|NCT02093221|76171679|FG003|Overall Study|Lost to Follow-up|1|||
42334005|NCT02093221|76171680|FG004|Overall Study|Lost to Follow-up|0|||
42334006|NCT02093221|76171676|FG000|Overall Study|Death|0|||
42334007|NCT02093221|76171677|FG001|Overall Study|Death|1|||
42334008|NCT02093221|76171678|FG002|Overall Study|Death|0|||
42334009|NCT02093221|76171679|FG003|Overall Study|Death|0|||
42334010|NCT02093221|76171680|FG004|Overall Study|Death|0|||
42000000|NCT01349049|75808426|FG007|Overall Study|Non-compliance|0|||
42000001|NCT01349049|75808427|FG008|Overall Study|Non-compliance|0|||
42000002|NCT01349049|75808419|FG000|Overall Study|Withdrawal by Subject|0|||
42000003|NCT01349049|75808420|FG001|Overall Study|Withdrawal by Subject|0|||
42000004|NCT01349049|75808421|FG002|Overall Study|Withdrawal by Subject|0|||
42000005|NCT01349049|75808422|FG003|Overall Study|Withdrawal by Subject|0|||
42000006|NCT01349049|75808423|FG004|Overall Study|Withdrawal by Subject|0|||
42264529|NCT02941549|76092609|FG000|Overall Study|Withdrawal by Subject|2|||
42334011|NCT02093221|76171676|FG000|Overall Study|Protocol Violation|0|||
42334012|NCT02093221|76171677|FG001|Overall Study|Protocol Violation|1|||
42334013|NCT02093221|76171678|FG002|Overall Study|Protocol Violation|0|||
42334014|NCT02093221|76171679|FG003|Overall Study|Protocol Violation|0|||
42334015|NCT02093221|76171680|FG004|Overall Study|Protocol Violation|0|||
42334016|NCT02093221|76171676|FG000|Overall Study|Study termination|6|||
42334017|NCT02093221|76171677|FG001|Overall Study|Study termination|5|||
42334018|NCT02093221|76171678|FG002|Overall Study|Study termination|4|||
42334019|NCT02093221|76171679|FG003|Overall Study|Study termination|6|||
42334020|NCT02093221|76171680|FG004|Overall Study|Study termination|7|||
42334021|NCT02092909|76171696|FG000|Overall Study|Adverse Event|0|||
42334022|NCT02092909|76171697|FG001|Overall Study|Adverse Event|0|||
42334023|NCT02092909|76171698|FG002|Overall Study|Adverse Event|4|||
42334024|NCT02092909|76171699|FG003|Overall Study|Adverse Event|2|||
42334025|NCT02092909|76171696|FG000|Overall Study|Lack of Efficacy|0|||
42334026|NCT02092909|76171697|FG001|Overall Study|Lack of Efficacy|2|||
42334027|NCT02092909|76171698|FG002|Overall Study|Lack of Efficacy|1|||
42334028|NCT02092909|76171699|FG003|Overall Study|Lack of Efficacy|0|||
42334029|NCT02092909|76171696|FG000|Overall Study|Withdrawal by Subject|0|||
42264530|NCT02941549|76092610|FG001|Overall Study|Withdrawal by Subject|1|||
42334030|NCT02092909|76171697|FG001|Overall Study|Withdrawal by Subject|0|||
42334031|NCT02092909|76171698|FG002|Overall Study|Withdrawal by Subject|2|||
42334032|NCT02092909|76171699|FG003|Overall Study|Withdrawal by Subject|1|||
42000007|NCT01349049|75808424|FG005|Overall Study|Withdrawal by Subject|0|||
42000008|NCT01349049|75808425|FG006|Overall Study|Withdrawal by Subject|0|||
42000009|NCT01349049|75808426|FG007|Overall Study|Withdrawal by Subject|0|||
42264531|NCT02941549|76092611|FG002|Overall Study|Withdrawal by Subject|2|||
42000010|NCT01349049|75808427|FG008|Overall Study|Withdrawal by Subject|6|||
42000011|NCT01348854|75808461|FG000|Overall Study|Lost to Follow-up|2|||
42000012|NCT01348854|75808462|FG001|Overall Study|Lost to Follow-up|1|||
42000013|NCT01348854|75808461|FG000|Overall Study|Withdrawal by Subject|1|||
42000014|NCT01348854|75808462|FG001|Overall Study|Withdrawal by Subject|0|||
42264532|NCT02394028|76092633|FG000|Induction Phase|Adverse Event|2|||
42264533|NCT02394028|76092634|FG001|Induction Phase|Adverse Event|4|||
42264534|NCT02394028|76092635|FG002|Induction Phase|Adverse Event|1|||
42264535|NCT02394028|76092636|FG003|Induction Phase|Adverse Event|2|||
42264536|NCT02394028|76092637|FG004|Induction Phase|Adverse Event|5|||
42264537|NCT02394028|76092638|FG005|Induction Phase|Adverse Event|2|||
42264538|NCT02394028|76092639|FG006|Induction Phase|Adverse Event|0|||
42264539|NCT02394028|76092640|FG007|Induction Phase|Adverse Event|0|||
42264540|NCT02394028|76092641|FG008|Induction Phase|Adverse Event|0|||
42264541|NCT02394028|76092642|FG009|Induction Phase|Adverse Event|0|||
42264542|NCT02394028|76092643|FG010|Induction Phase|Adverse Event|0|||
42264543|NCT02394028|76092633|FG000|Induction Phase|Lack of Efficacy|3|||
42264544|NCT02394028|76092634|FG001|Induction Phase|Lack of Efficacy|6|||
42264545|NCT02394028|76092635|FG002|Induction Phase|Lack of Efficacy|2|||
42264546|NCT02394028|76092636|FG003|Induction Phase|Lack of Efficacy|17|||
42264547|NCT02394028|76092637|FG004|Induction Phase|Lack of Efficacy|14|||
42264548|NCT02394028|76092638|FG005|Induction Phase|Lack of Efficacy|8|||
42264549|NCT02394028|76092639|FG006|Induction Phase|Lack of Efficacy|17|||
42264550|NCT02394028|76092640|FG007|Induction Phase|Lack of Efficacy|23|||
42264551|NCT02394028|76092641|FG008|Induction Phase|Lack of Efficacy|0|||
42264552|NCT02394028|76092642|FG009|Induction Phase|Lack of Efficacy|0|||
42264553|NCT02394028|76092643|FG010|Induction Phase|Lack of Efficacy|0|||
42264554|NCT02394028|76092633|FG000|Induction Phase|Lost to Follow-up|1|||
42264555|NCT02394028|76092634|FG001|Induction Phase|Lost to Follow-up|0|||
42264556|NCT02394028|76092635|FG002|Induction Phase|Lost to Follow-up|0|||
42264557|NCT02394028|76092636|FG003|Induction Phase|Lost to Follow-up|1|||
42264558|NCT02394028|76092637|FG004|Induction Phase|Lost to Follow-up|0|||
42264559|NCT02394028|76092638|FG005|Induction Phase|Lost to Follow-up|0|||
42264560|NCT02394028|76092639|FG006|Induction Phase|Lost to Follow-up|1|||
42264561|NCT02394028|76092640|FG007|Induction Phase|Lost to Follow-up|0|||
42264562|NCT02394028|76092641|FG008|Induction Phase|Lost to Follow-up|0|||
42264563|NCT02394028|76092642|FG009|Induction Phase|Lost to Follow-up|0|||
42264564|NCT02394028|76092643|FG010|Induction Phase|Lost to Follow-up|0|||
42264565|NCT02394028|76092633|FG000|Induction Phase|Non-compliance|0|||
42264566|NCT02394028|76092634|FG001|Induction Phase|Non-compliance|1|||
42264567|NCT02394028|76092635|FG002|Induction Phase|Non-compliance|3|||
42334033|NCT02092909|76171696|FG000|Overall Study|Study terminated by Sponsor|0|||
42334034|NCT02092909|76171697|FG001|Overall Study|Study terminated by Sponsor|0|||
42334035|NCT02092909|76171698|FG002|Overall Study|Study terminated by Sponsor|0|||
42000015|NCT01348776|75808468|FG000|Overall Study|Lost to Follow-up|3|||
42000016|NCT01348698|75808481|FG000|Overall Study|Does not meet lesion size criteria|1|||
42264568|NCT02394028|76092636|FG003|Induction Phase|Non-compliance|1|||
42264569|NCT02394028|76092637|FG004|Induction Phase|Non-compliance|3|||
42264570|NCT02394028|76092638|FG005|Induction Phase|Non-compliance|0|||
42264571|NCT02394028|76092639|FG006|Induction Phase|Non-compliance|1|||
42264572|NCT02394028|76092640|FG007|Induction Phase|Non-compliance|1|||
42264573|NCT02394028|76092641|FG008|Induction Phase|Non-compliance|0|||
42334036|NCT02092909|76171699|FG003|Overall Study|Study terminated by Sponsor|2|||
42264574|NCT02394028|76092642|FG009|Induction Phase|Non-compliance|0|||
42334037|NCT02092909|76171696|FG000|Overall Study|Miscellaneous|1|||
42264575|NCT02394028|76092643|FG010|Induction Phase|Non-compliance|0|||
42264576|NCT02394028|76092633|FG000|Induction Phase|Physician Decision|0|||
42264577|NCT02394028|76092634|FG001|Induction Phase|Physician Decision|0|||
42134512|NCT03956225|75945378|FG000|Overall Study|Lack of Efficacy|1|||
42134513|NCT03956225|75945379|FG001|Overall Study|Lack of Efficacy|1|||
42134514|NCT03956225|75945378|FG000|Overall Study|Lost to Follow-up|0|||
42134515|NCT03956225|75945379|FG001|Overall Study|Lost to Follow-up|1|||
42000017|NCT01348698|75808481|FG000|Overall Study|Death|3|||
42000018|NCT01348698|75808481|FG000|Overall Study|PI decision to close study|68|||
42000019|NCT01348542|75808487|FG000|Overall Study|Withdrawal by Subject|3|||
42000020|NCT01348542|75808488|FG001|Overall Study|Withdrawal by Subject|0|||
42000021|NCT01346709|75808494|FG000|Overall Study|Protocol Violation|35|||
42000022|NCT01346709|75808494|FG000|Overall Study|Lost to Follow-up|31|||
42000023|NCT01346709|75808494|FG000|Overall Study|Missing data in candidate risk factor|285|||
42000024|NCT01346592|75808501|FG000|Overall Study|Lost to Follow-up|62|||
42000025|NCT01346592|75808502|FG001|Overall Study|Lost to Follow-up|29|||
42000026|NCT01346592|75808503|FG002|Overall Study|Lost to Follow-up|29|||
42134516|NCT03956225|75945378|FG000|Overall Study|Withdrawal by Subject|2|||
42264578|NCT02394028|76092635|FG002|Induction Phase|Physician Decision|1|||
42264579|NCT02394028|76092636|FG003|Induction Phase|Physician Decision|4|||
42264580|NCT02394028|76092637|FG004|Induction Phase|Physician Decision|0|||
42264581|NCT02394028|76092638|FG005|Induction Phase|Physician Decision|2|||
42264582|NCT02394028|76092639|FG006|Induction Phase|Physician Decision|1|||
42264583|NCT02394028|76092640|FG007|Induction Phase|Physician Decision|0|||
42264584|NCT02394028|76092641|FG008|Induction Phase|Physician Decision|0|||
42264585|NCT02394028|76092642|FG009|Induction Phase|Physician Decision|0|||
42264586|NCT02394028|76092643|FG010|Induction Phase|Physician Decision|0|||
42264587|NCT02394028|76092633|FG000|Induction Phase|Protocol Violation|0|||
42264588|NCT02394028|76092634|FG001|Induction Phase|Protocol Violation|2|||
42264589|NCT02394028|76092635|FG002|Induction Phase|Protocol Violation|0|||
42264590|NCT02394028|76092636|FG003|Induction Phase|Protocol Violation|3|||
42264591|NCT02394028|76092637|FG004|Induction Phase|Protocol Violation|0|||
42034636|NCT01124045|75842722|FG001|Overall Study|Physician Decision|2|||
42334038|NCT02092909|76171697|FG001|Overall Study|Miscellaneous|1|||
42334039|NCT02092909|76171698|FG002|Overall Study|Miscellaneous|2|||
42334040|NCT02092909|76171699|FG003|Overall Study|Miscellaneous|1|||
42334041|NCT01623115|76171711|FG000|Overall Study|Randomized but not treated|0|||
42334042|NCT01623115|76171712|FG001|Overall Study|Randomized but not treated|1|||
42334043|NCT01623115|76171711|FG000|Overall Study|Physician Decision|1|||
42334044|NCT01623115|76171712|FG001|Overall Study|Physician Decision|0|||
42334045|NCT01623115|76171711|FG000|Overall Study|Participants moved|1|||
42334046|NCT01623115|76171712|FG001|Overall Study|Participants moved|5|||
42334047|NCT01623115|76171711|FG000|Overall Study|Adverse Event|10|||
42034637|NCT01123889|75842730|FG000|Overall Study|Lost to Follow-up|3|||
42034638|NCT01123889|75842731|FG001|Overall Study|Lost to Follow-up|1|||
42034639|NCT00934947|75842739|FG000|Overall Study|Adverse Event|0|||
42034640|NCT00934947|75842740|FG001|Overall Study|Adverse Event|2|||
42034641|NCT01123655|75842750|FG000|Overall Study|Medication for RA had to be changed|1|||
42264592|NCT02394028|76092638|FG005|Induction Phase|Protocol Violation|1|||
42264593|NCT02394028|76092639|FG006|Induction Phase|Protocol Violation|1|||
42334048|NCT01623115|76171712|FG001|Overall Study|Adverse Event|13|||
42334049|NCT01623115|76171711|FG000|Overall Study|Poor compliance to protocol|4|||
42334050|NCT01623115|76171712|FG001|Overall Study|Poor compliance to protocol|10|||
42334051|NCT01623115|76171711|FG000|Overall Study|Consent withdrawn by participant|2|||
42334052|NCT01623115|76171712|FG001|Overall Study|Consent withdrawn by participant|6|||
42334053|NCT01623115|76171711|FG000|Overall Study|Related to study drug administration|0|||
42334054|NCT01623115|76171712|FG001|Overall Study|Related to study drug administration|2|||
42334055|NCT01623115|76171711|FG000|Overall Study|Last visit outside protocol visit window|14|||
42334056|NCT01623115|76171712|FG001|Overall Study|Last visit outside protocol visit window|26|||
42334057|NCT01623115|76171711|FG000|Overall Study|Site closure|1|||
42334058|NCT01623115|76171712|FG001|Overall Study|Site closure|7|||
42134517|NCT03956225|75945379|FG001|Overall Study|Withdrawal by Subject|1|||
42134518|NCT03956225|75945378|FG000|Overall Study|Other Reasons|2|||
42264594|NCT02394028|76092640|FG007|Induction Phase|Protocol Violation|0|||
42264595|NCT02394028|76092641|FG008|Induction Phase|Protocol Violation|0|||
42334059|NCT01623115|76171711|FG000|Overall Study|Death|0|||
42334060|NCT01623115|76171712|FG001|Overall Study|Death|4|||
42334061|NCT01623115|76171711|FG000|Overall Study|Other than specified above|0|||
42134519|NCT03956225|75945379|FG001|Overall Study|Other Reasons|1|||
42134520|NCT00457626|75945388|FG000|Overall Study|Adverse Event|3|||
42264596|NCT02394028|76092642|FG009|Induction Phase|Protocol Violation|0|||
42264597|NCT02394028|76092643|FG010|Induction Phase|Protocol Violation|0|||
42334062|NCT01623115|76171712|FG001|Overall Study|Other than specified above|3|||
42334063|NCT02092285|76171718|FG000|Induction Phase|Adverse Event|7|||
42334064|NCT02092285|76171718|FG000|Induction Phase|Physician Decision|4|||
42000027|NCT01346592|75808501|FG000|Overall Study|Protocol Violation|2|||
42134521|NCT00457626|75945388|FG000|Overall Study|Administrative Problems|2|||
42334065|NCT02092285|76171718|FG000|Induction Phase|Pregnancy|1|||
42334066|NCT02092285|76171718|FG000|Induction Phase|Relapse/Recurrence|7|||
42334067|NCT02092285|76171718|FG000|Induction Phase|Withdrawal by Subject|2|||
42334068|NCT02092285|76171718|FG000|Induction Phase|Lack of Efficacy|14|||
42334069|NCT02092285|76171718|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
42334070|NCT02092285|76171718|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
42334071|NCT02092285|76171718|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
42334072|NCT02092285|76171718|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
42334073|NCT02092285|76171718|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
42334074|NCT02092285|76171718|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
42334075|NCT02092285|76171718|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
42334076|NCT02092285|76171718|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
42334077|NCT02092285|76171718|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
42334078|NCT02091739|76171725|FG000|MP: 16 Weeks|Adverse Event|1|||
42334079|NCT02091739|76171726|FG001|MP: 16 Weeks|Adverse Event|1|||
42334080|NCT02091739|76171727|FG002|MP: 16 Weeks|Adverse Event|1|||
42334081|NCT02091739|76171728|FG003|MP: 16 Weeks|Adverse Event|0|||
42334082|NCT02091739|76171729|FG004|MP: 16 Weeks|Adverse Event|0|||
42334083|NCT02091739|76171725|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
42334084|NCT02091739|76171726|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
42334085|NCT02091739|76171727|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
42334086|NCT02091739|76171728|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
42334087|NCT02091739|76171729|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
42334088|NCT02091739|76171725|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
42334089|NCT02091739|76171726|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
42334090|NCT02091739|76171727|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
42334091|NCT02091739|76171728|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
42334092|NCT02091739|76171729|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
42334093|NCT02091739|76171725|FG000|EP: 48 Weeks|Other|0|||
42334094|NCT02091739|76171726|FG001|EP: 48 Weeks|Other|0|||
42334095|NCT02091739|76171727|FG002|EP: 48 Weeks|Other|0|||
42334096|NCT02091739|76171728|FG003|EP: 48 Weeks|Other|1|||
42334097|NCT02091739|76171729|FG004|EP: 48 Weeks|Other|0|||
42334098|NCT02091739|76171725|FG000|EP: 48 Weeks|Death|0|||
42334099|NCT02091739|76171726|FG001|EP: 48 Weeks|Death|0|||
42334100|NCT02091739|76171727|FG002|EP: 48 Weeks|Death|0|||
42334101|NCT02091739|76171728|FG003|EP: 48 Weeks|Death|3|||
42334102|NCT02091739|76171729|FG004|EP: 48 Weeks|Death|2|||
42334103|NCT02091739|76171725|FG000|EP: 48 Weeks|Adverse Event|0|||
42334104|NCT02091739|76171726|FG001|EP: 48 Weeks|Adverse Event|0|||
42334105|NCT02091739|76171727|FG002|EP: 48 Weeks|Adverse Event|0|||
42334106|NCT02091739|76171728|FG003|EP: 48 Weeks|Adverse Event|2|||
42334107|NCT02091739|76171729|FG004|EP: 48 Weeks|Adverse Event|6|||
42334108|NCT02091739|76171725|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
42334109|NCT02091739|76171726|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
42334110|NCT02091739|76171727|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
42334111|NCT02091739|76171728|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
42334112|NCT02091739|76171729|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
42334113|NCT02045875|76171741|FG000|Overall Study|Lost to Follow-up|3|||
42334114|NCT02045875|76171742|FG001|Overall Study|Lost to Follow-up|0|||
42334115|NCT02045875|76171741|FG000|Overall Study|Withdrawal by Subject|4|||
42334116|NCT02045875|76171742|FG001|Overall Study|Withdrawal by Subject|3|||
42334117|NCT01597635|76171751|FG000|Part A|Adverse Event|3|||
42334118|NCT01597635|76171752|FG001|Part A|Adverse Event|0|||
42334119|NCT01597635|76171753|FG002|Part A|Adverse Event|0|||
42334120|NCT01597635|76171751|FG000|Part B|Adverse Event|0|||
42334121|NCT01597635|76171752|FG001|Part B|Adverse Event|0|||
42334122|NCT01597635|76171753|FG002|Part B|Adverse Event|1|||
42334123|NCT01597635|76171751|FG000|Part B|Protocol Violation|0|||
42334124|NCT01597635|76171752|FG001|Part B|Protocol Violation|1|||
42334125|NCT01597635|76171753|FG002|Part B|Protocol Violation|0|||
42334126|NCT01597635|76171751|FG000|Part B|Protocol-defined stopping criteria|0|||
42000028|NCT01346592|75808502|FG001|Overall Study|Protocol Violation|1|||
42000029|NCT01346592|75808503|FG002|Overall Study|Protocol Violation|0|||
42000030|NCT01346592|75808501|FG000|Overall Study|Death|1|||
42334127|NCT01597635|76171752|FG001|Part B|Protocol-defined stopping criteria|4|||
42334128|NCT01597635|76171753|FG002|Part B|Protocol-defined stopping criteria|3|||
42334129|NCT01597635|76171751|FG000|Part B|Withdrawal by Subject|0|||
42334130|NCT01597635|76171752|FG001|Part B|Withdrawal by Subject|1|||
42334131|NCT01597635|76171753|FG002|Part B|Withdrawal by Subject|0|||
42334132|NCT01828281|76171764|FG000|Overall Study|Withdrawal by Subject|1|||
42334133|NCT01828281|76171765|FG001|Overall Study|Withdrawal by Subject|0|||
42334134|NCT01827267|76171774|FG000|Overall Study|Did not receive study drug|1|||
42334135|NCT01827267|76171775|FG001|Overall Study|Did not receive study drug|1|||
42334136|NCT01827267|76171774|FG000|Overall Study|Physician Decision|1|||
42000031|NCT01346592|75808502|FG001|Overall Study|Death|3|||
42334137|NCT01827267|76171775|FG001|Overall Study|Physician Decision|0|||
42334138|NCT01827267|76171774|FG000|Overall Study|Disease Progression|1|||
42334139|NCT01827267|76171775|FG001|Overall Study|Disease Progression|1|||
42334140|NCT01827267|76171774|FG000|Overall Study|Sponsor Discontinued Study|2|||
42334141|NCT01827267|76171775|FG001|Overall Study|Sponsor Discontinued Study|8|||
42264598|NCT02394028|76092633|FG000|Induction Phase|Withdrawal by Subject|1|||
42264599|NCT02394028|76092634|FG001|Induction Phase|Withdrawal by Subject|2|||
42264600|NCT02394028|76092635|FG002|Induction Phase|Withdrawal by Subject|4|||
42334142|NCT01827267|76171774|FG000|Overall Study|Still on study|0|||
42334143|NCT01827267|76171775|FG001|Overall Study|Still on study|2|||
42334144|NCT01855425|76171782|FG000|Overall Study|Physician Decision|20|||
42334145|NCT01854879|76171786|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
42334146|NCT01854879|76171786|FG000|Overall Study|screen fail|3|||
42334147|NCT01854879|76171786|FG000|Overall Study|incomplete data set|1|||
42334148|NCT01827111|76171790|FG000|Overall Study|Disease Progression|1|||
42334149|NCT02045095|76171794|FG000|Overall Study|Other|0|||
42334150|NCT02045095|76171795|FG001|Overall Study|Other|0|||
42000032|NCT01346592|75808503|FG002|Overall Study|Death|4|||
42000033|NCT01346592|75808501|FG000|Overall Study|Adverse Event|0|||
42000034|NCT01346592|75808502|FG001|Overall Study|Adverse Event|1|||
42000035|NCT01346592|75808503|FG002|Overall Study|Adverse Event|0|||
42000036|NCT01346592|75808501|FG000|Overall Study|Withdrawal by Subject|77|||
42000037|NCT01346592|75808502|FG001|Overall Study|Withdrawal by Subject|51|||
42134522|NCT00457626|75945388|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
42264601|NCT02394028|76092636|FG003|Induction Phase|Withdrawal by Subject|6|||
42264602|NCT02394028|76092637|FG004|Induction Phase|Withdrawal by Subject|7|||
42264603|NCT02394028|76092638|FG005|Induction Phase|Withdrawal by Subject|4|||
42264604|NCT02394028|76092639|FG006|Induction Phase|Withdrawal by Subject|3|||
42264605|NCT02394028|76092640|FG007|Induction Phase|Withdrawal by Subject|6|||
42264606|NCT02394028|76092641|FG008|Induction Phase|Withdrawal by Subject|0|||
42264607|NCT02394028|76092642|FG009|Induction Phase|Withdrawal by Subject|0|||
42264608|NCT02394028|76092643|FG010|Induction Phase|Withdrawal by Subject|0|||
42264609|NCT02394028|76092633|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
42264610|NCT02394028|76092634|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
42264611|NCT02394028|76092635|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
42264612|NCT02394028|76092636|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
42264613|NCT02394028|76092637|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
42264614|NCT02394028|76092638|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
42334151|NCT02045095|76171796|FG002|Overall Study|Other|1|||
42334152|NCT02045095|76171797|FG003|Overall Study|Other|0|||
42264615|NCT02394028|76092639|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
42264616|NCT02394028|76092640|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
42264617|NCT02394028|76092641|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
42264618|NCT02394028|76092642|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
42334153|NCT02045095|76171798|FG004|Overall Study|Other|0|||
42334154|NCT02045095|76171799|FG005|Overall Study|Other|2|||
42334155|NCT02045095|76171800|FG006|Overall Study|Other|0|||
42334156|NCT02045095|76171794|FG000|Overall Study|Progressive Disease|3|||
42334157|NCT02045095|76171795|FG001|Overall Study|Progressive Disease|3|||
42334158|NCT02045095|76171796|FG002|Overall Study|Progressive Disease|2|||
42334159|NCT02045095|76171797|FG003|Overall Study|Progressive Disease|4|||
42334160|NCT02045095|76171798|FG004|Overall Study|Progressive Disease|2|||
42134523|NCT00373113|75945394|FG000|Overall Study|Death|1|||
42334161|NCT02045095|76171799|FG005|Overall Study|Progressive Disease|4|||
42334162|NCT02045095|76171800|FG006|Overall Study|Progressive Disease|1|||
42000038|NCT01346592|75808503|FG002|Overall Study|Withdrawal by Subject|38|||
42134524|NCT00373113|75945395|FG001|Overall Study|Death|7|||
42334163|NCT02045095|76171794|FG000|Overall Study|Withdrawal by Subject|0|||
42334164|NCT02045095|76171795|FG001|Overall Study|Withdrawal by Subject|0|||
42334165|NCT02045095|76171796|FG002|Overall Study|Withdrawal by Subject|0|||
42334166|NCT02045095|76171797|FG003|Overall Study|Withdrawal by Subject|0|||
42334167|NCT02045095|76171798|FG004|Overall Study|Withdrawal by Subject|3|||
42334168|NCT02045095|76171799|FG005|Overall Study|Withdrawal by Subject|0|||
42334169|NCT02045095|76171800|FG006|Overall Study|Withdrawal by Subject|0|||
42334170|NCT02045095|76171794|FG000|Overall Study|Adverse Event|0|||
42334171|NCT02045095|76171795|FG001|Overall Study|Adverse Event|1|||
42334172|NCT02045095|76171796|FG002|Overall Study|Adverse Event|1|||
42334173|NCT02045095|76171797|FG003|Overall Study|Adverse Event|0|||
42334174|NCT02045095|76171798|FG004|Overall Study|Adverse Event|0|||
42334175|NCT02045095|76171799|FG005|Overall Study|Adverse Event|2|||
42334176|NCT02045095|76171800|FG006|Overall Study|Adverse Event|0|||
42334177|NCT02181803|76171825|FG000|Overall Study|Withdrawal by Subject|0|||
42334178|NCT02181803|76171826|FG001|Overall Study|Withdrawal by Subject|2|||
42334179|NCT02181803|76171827|FG002|Overall Study|Withdrawal by Subject|0|||
42334180|NCT02181803|76171828|FG003|Overall Study|Withdrawal by Subject|0|||
42334181|NCT02181803|76171829|FG004|Overall Study|Withdrawal by Subject|0|||
42334182|NCT02181803|76171830|FG005|Overall Study|Withdrawal by Subject|0|||
42334183|NCT02181803|76171831|FG006|Overall Study|Withdrawal by Subject|0|||
42334184|NCT02181803|76171832|FG007|Overall Study|Withdrawal by Subject|0|||
42334185|NCT02181803|76171833|FG008|Overall Study|Withdrawal by Subject|0|||
42334186|NCT02181803|76171825|FG000|Overall Study|Physician Decision|0|||
42334187|NCT02181803|76171826|FG001|Overall Study|Physician Decision|0|||
42000039|NCT01346592|75808501|FG000|Overall Study|Inappropriate enrollment|3|||
42000040|NCT01346592|75808502|FG001|Overall Study|Inappropriate enrollment|1|||
42334188|NCT02181803|76171827|FG002|Overall Study|Physician Decision|0|||
42334189|NCT02181803|76171828|FG003|Overall Study|Physician Decision|1|||
42334190|NCT02181803|76171829|FG004|Overall Study|Physician Decision|0|||
42334191|NCT02181803|76171830|FG005|Overall Study|Physician Decision|0|||
42264619|NCT02394028|76092643|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
42000041|NCT01346592|75808503|FG002|Overall Study|Inappropriate enrollment|1|||
42000042|NCT01346592|75808501|FG000|Overall Study|Administrative reason|1|||
42000043|NCT01346592|75808502|FG001|Overall Study|Administrative reason|0|||
42000044|NCT01346592|75808503|FG002|Overall Study|Administrative reason|0|||
42000045|NCT01346592|75808501|FG000|Overall Study|Unable to Classify|7|||
42000046|NCT01346592|75808502|FG001|Overall Study|Unable to Classify|3|||
42000047|NCT01346592|75808503|FG002|Overall Study|Unable to Classify|6|||
42000048|NCT01346514|75808530|FG000|Overall Study|Lost to Follow-up|19|||
42000049|NCT01346514|75808531|FG001|Overall Study|Lost to Follow-up|30|||
42034642|NCT01123655|75842751|FG001|Overall Study|Medication for RA had to be changed|0|||
42034643|NCT01123655|75842752|FG002|Overall Study|Medication for RA had to be changed|0|||
42034644|NCT01123655|75842750|FG000|Overall Study|new illness|0|||
42264620|NCT02394028|76092633|FG000|Induction Phase|Sponsor decision|0|||
42264621|NCT02394028|76092634|FG001|Induction Phase|Sponsor decision|1|||
42034645|NCT01123655|75842751|FG001|Overall Study|new illness|1|||
42034646|NCT01123655|75842752|FG002|Overall Study|new illness|0|||
42034647|NCT01123655|75842750|FG000|Overall Study|began prohibitive drug|0|||
42034648|NCT01123655|75842751|FG001|Overall Study|began prohibitive drug|0|||
42034649|NCT01123655|75842752|FG002|Overall Study|began prohibitive drug|1|||
42034650|NCT00934791|75842760|FG000|Overall Study|Withdrawal by Subject|1|||
42034651|NCT00934791|75842761|FG001|Overall Study|Withdrawal by Subject|0|||
42264622|NCT02394028|76092635|FG002|Induction Phase|Sponsor decision|2|||
42034652|NCT01119443|75842769|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
42034653|NCT01119443|75842770|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
42034654|NCT01111019|75842779|FG000|Overall Study|Withdrew Prematurely|2|||
42264623|NCT02394028|76092636|FG003|Induction Phase|Sponsor decision|0|||
42264624|NCT02394028|76092637|FG004|Induction Phase|Sponsor decision|0|||
42264625|NCT02394028|76092638|FG005|Induction Phase|Sponsor decision|0|||
42034655|NCT01111019|75842779|FG000|Overall Study|Other|1|||
42034656|NCT01119287|75842798|FG000|Overall Study|Patient Decision, not related to AE|0|||
42034657|NCT01119287|75842799|FG001|Overall Study|Patient Decision, not related to AE|0|||
42034658|NCT01119287|75842800|FG002|Overall Study|Patient Decision, not related to AE|2|||
42034659|NCT01119287|75842801|FG003|Overall Study|Patient Decision, not related to AE|2|||
42034660|NCT01119287|75842802|FG004|Overall Study|Patient Decision, not related to AE|1|||
42034661|NCT01119287|75842803|FG005|Overall Study|Patient Decision, not related to AE|0|||
42264626|NCT02394028|76092639|FG006|Induction Phase|Sponsor decision|0|||
42334192|NCT02181803|76171831|FG006|Overall Study|Physician Decision|0|||
42334193|NCT02181803|76171832|FG007|Overall Study|Physician Decision|1|||
42334194|NCT02181803|76171833|FG008|Overall Study|Physician Decision|0|||
42000050|NCT01346514|75808530|FG000|Overall Study|Withdrawal by Subject|7|||
42034662|NCT01110707|75842817|FG000|Overall Study|Protocol Violation|0|||
42334195|NCT02181803|76171825|FG000|Overall Study|Adverse Event|0|||
42334196|NCT02181803|76171826|FG001|Overall Study|Adverse Event|2|||
42334197|NCT02181803|76171827|FG002|Overall Study|Adverse Event|0|||
42334198|NCT02181803|76171828|FG003|Overall Study|Adverse Event|1|||
42134525|NCT00373113|75945394|FG000|Overall Study|Adverse Event|38|||
42264627|NCT02394028|76092640|FG007|Induction Phase|Sponsor decision|0|||
42264628|NCT02394028|76092641|FG008|Induction Phase|Sponsor decision|0|||
42264629|NCT02394028|76092642|FG009|Induction Phase|Sponsor decision|0|||
42264630|NCT02394028|76092643|FG010|Induction Phase|Sponsor decision|0|||
42264631|NCT02394028|76092633|FG000|Induction Phase|Technical reason|0|||
42264632|NCT02394028|76092634|FG001|Induction Phase|Technical reason|0|||
42264633|NCT02394028|76092635|FG002|Induction Phase|Technical reason|0|||
42264634|NCT02394028|76092636|FG003|Induction Phase|Technical reason|1|||
42264635|NCT02394028|76092637|FG004|Induction Phase|Technical reason|0|||
42264636|NCT02394028|76092638|FG005|Induction Phase|Technical reason|0|||
42264637|NCT02394028|76092639|FG006|Induction Phase|Technical reason|0|||
42264638|NCT02394028|76092640|FG007|Induction Phase|Technical reason|0|||
42334199|NCT02181803|76171829|FG004|Overall Study|Adverse Event|0|||
42334200|NCT02181803|76171830|FG005|Overall Study|Adverse Event|0|||
42334201|NCT02181803|76171831|FG006|Overall Study|Adverse Event|1|||
42334202|NCT02181803|76171832|FG007|Overall Study|Adverse Event|0|||
42334203|NCT02181803|76171833|FG008|Overall Study|Adverse Event|0|||
42334204|NCT01826487|76171880|FG000|Overall Study|Adverse Event|1|||
42334205|NCT01826487|76171881|FG001|Overall Study|Adverse Event|1|||
42264639|NCT02394028|76092641|FG008|Induction Phase|Technical reason|0|||
42264640|NCT02394028|76092642|FG009|Induction Phase|Technical reason|0|||
42264641|NCT02394028|76092643|FG010|Induction Phase|Technical reason|0|||
42264642|NCT02394028|76092633|FG000|Induction Phase|:ack of calculation|0|||
42264643|NCT02394028|76092634|FG001|Induction Phase|:ack of calculation|0|||
42264644|NCT02394028|76092635|FG002|Induction Phase|:ack of calculation|0|||
42264645|NCT02394028|76092636|FG003|Induction Phase|:ack of calculation|0|||
42264646|NCT02394028|76092637|FG004|Induction Phase|:ack of calculation|0|||
42264647|NCT02394028|76092638|FG005|Induction Phase|:ack of calculation|0|||
42264648|NCT02394028|76092639|FG006|Induction Phase|:ack of calculation|0|||
42264649|NCT02394028|76092640|FG007|Induction Phase|:ack of calculation|1|||
42264650|NCT02394028|76092641|FG008|Induction Phase|:ack of calculation|0|||
42264651|NCT02394028|76092642|FG009|Induction Phase|:ack of calculation|0|||
42264652|NCT02394028|76092643|FG010|Induction Phase|:ack of calculation|0|||
42264653|NCT02394028|76092633|FG000|Maintenance Phase|Protocol Violation|0|||
42264654|NCT02394028|76092634|FG001|Maintenance Phase|Protocol Violation|0|||
42264655|NCT02394028|76092635|FG002|Maintenance Phase|Protocol Violation|0|||
42264656|NCT02394028|76092636|FG003|Maintenance Phase|Protocol Violation|0|||
42334206|NCT01826487|76171880|FG000|Overall Study|Lost to Follow-up|1|||
42000051|NCT01346514|75808531|FG001|Overall Study|Withdrawal by Subject|3|||
42000052|NCT01346514|75808530|FG000|Overall Study|Death|3|||
42000053|NCT01346514|75808531|FG001|Overall Study|Death|4|||
42000054|NCT01193335|75808541|FG000|After Infant Series|Lost to Follow-up|1|||
42000055|NCT01193335|75808542|FG001|After Infant Series|Lost to Follow-up|2|||
42000056|NCT01193335|75808541|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
42000057|NCT01193335|75808542|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
42000058|NCT01193335|75808541|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
42000059|NCT01193335|75808542|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
42000060|NCT01193335|75808541|FG000|1-Year Follow-up|Lost to Follow-up|4|||
42000061|NCT01193335|75808542|FG001|1-Year Follow-up|Lost to Follow-up|0|||
42000062|NCT01193335|75808541|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
42000063|NCT01193335|75808542|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
42000064|NCT01193335|75808541|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
42000065|NCT01193335|75808542|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
42000066|NCT01342887|75808564|FG000|Overall Study|Death|2|||
42000067|NCT01342341|75808570|FG000|Overall Study|Lost to Follow-up|4|||
42000068|NCT01342341|75808571|FG001|Overall Study|Lost to Follow-up|4|||
42264657|NCT02394028|76092637|FG004|Maintenance Phase|Protocol Violation|0|||
42334207|NCT01826487|76171881|FG001|Overall Study|Lost to Follow-up|0|||
42000069|NCT01340664|75808580|FG000|Overall Study|Adverse Event|0|||
42000070|NCT01340664|75808581|FG001|Overall Study|Adverse Event|1|||
42264658|NCT02394028|76092638|FG005|Maintenance Phase|Protocol Violation|0|||
42334208|NCT01826487|76171880|FG000|Overall Study|Withdrawal by Subject|1|||
42134526|NCT00373113|75945395|FG001|Overall Study|Adverse Event|24|||
42134527|NCT00373113|75945394|FG000|Overall Study|Study terminated by sponsor|9|||
42134528|NCT00373113|75945395|FG001|Overall Study|Study terminated by sponsor|1|||
42134529|NCT00373113|75945394|FG000|Overall Study|Global deterioration of health status|10|||
42134530|NCT00373113|75945395|FG001|Overall Study|Global deterioration of health status|7|||
42134531|NCT00373113|75945394|FG000|Overall Study|Lost to Follow-up|1|||
42134532|NCT00373113|75945395|FG001|Overall Study|Lost to Follow-up|3|||
42134533|NCT00373113|75945394|FG000|Overall Study|Objective progression or relapse|150|||
42134534|NCT00373113|75945395|FG001|Overall Study|Objective progression or relapse|169|||
42134535|NCT00373113|75945394|FG000|Overall Study|Other|14|||
42034663|NCT01110707|75842818|FG001|Overall Study|Protocol Violation|3|||
42034664|NCT01119131|75842828|FG000|Overall Study|Adverse Event|1|||
42034665|NCT01119131|75842829|FG001|Overall Study|Adverse Event|1|||
42034666|NCT01119131|75842830|FG002|Overall Study|Adverse Event|1|||
42034667|NCT01119131|75842828|FG000|Overall Study|Non-Compliance|1|||
42034668|NCT01119131|75842829|FG001|Overall Study|Non-Compliance|0|||
42034669|NCT01119131|75842830|FG002|Overall Study|Non-Compliance|4|||
42034670|NCT01119131|75842828|FG000|Overall Study|Physician Decision|0|||
42034671|NCT01119131|75842829|FG001|Overall Study|Physician Decision|0|||
42034672|NCT01119131|75842830|FG002|Overall Study|Physician Decision|1|||
42034673|NCT01118975|75842840|FG000|Overall Study|Adverse Event|0|||
42034674|NCT01118975|75842841|FG001|Overall Study|Adverse Event|1|||
42034675|NCT01110239|75842851|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
42034676|NCT01110239|75842852|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
42034677|NCT01110239|75842853|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
42034678|NCT01110239|75842854|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
42034679|NCT01110239|75842851|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
42034680|NCT01110239|75842852|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
42034681|NCT01110239|75842853|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
42034682|NCT01110239|75842854|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
42134536|NCT00373113|75945395|FG001|Overall Study|Other|17|||
42134537|NCT00373113|75945394|FG000|Overall Study|Protocol Violation|5|||
42134538|NCT00373113|75945395|FG001|Overall Study|Protocol Violation|1|||
42134539|NCT00373113|75945394|FG000|Overall Study|Withdrawal by Subject|10|||
42134540|NCT00373113|75945395|FG001|Overall Study|Withdrawal by Subject|15|||
42134541|NCT00407511|75945401|FG000|Overall Study|Adverse Event|9|||
42134542|NCT00407511|75945401|FG000|Overall Study|Lost to Follow-up|4|||
42134543|NCT00407511|75945401|FG000|Overall Study|Other|5|||
42264659|NCT02394028|76092639|FG006|Maintenance Phase|Protocol Violation|0|||
42264660|NCT02394028|76092640|FG007|Maintenance Phase|Protocol Violation|0|||
42264661|NCT02394028|76092641|FG008|Maintenance Phase|Protocol Violation|0|||
42264662|NCT02394028|76092642|FG009|Maintenance Phase|Protocol Violation|0|||
42264663|NCT02394028|76092643|FG010|Maintenance Phase|Protocol Violation|1|||
42264664|NCT02394028|76092633|FG000|Maintenance Phase|Physician Decision|0|||
42264665|NCT02394028|76092634|FG001|Maintenance Phase|Physician Decision|0|||
42264666|NCT02394028|76092635|FG002|Maintenance Phase|Physician Decision|0|||
42264667|NCT02394028|76092636|FG003|Maintenance Phase|Physician Decision|0|||
42264668|NCT02394028|76092637|FG004|Maintenance Phase|Physician Decision|0|||
42264669|NCT02394028|76092638|FG005|Maintenance Phase|Physician Decision|0|||
42264670|NCT02394028|76092639|FG006|Maintenance Phase|Physician Decision|0|||
42264671|NCT02394028|76092640|FG007|Maintenance Phase|Physician Decision|0|||
42264672|NCT02394028|76092641|FG008|Maintenance Phase|Physician Decision|1|||
42264673|NCT02394028|76092642|FG009|Maintenance Phase|Physician Decision|3|||
42264674|NCT02394028|76092643|FG010|Maintenance Phase|Physician Decision|2|||
42264675|NCT02394028|76092633|FG000|Maintenance Phase|Lack of Efficacy|0|||
42264676|NCT02394028|76092634|FG001|Maintenance Phase|Lack of Efficacy|0|||
42264677|NCT02394028|76092635|FG002|Maintenance Phase|Lack of Efficacy|0|||
42034683|NCT01118663|75842867|FG000|Overall Study|Adverse Event|2|||
42034684|NCT01118663|75842868|FG001|Overall Study|Adverse Event|1|||
42264678|NCT02394028|76092636|FG003|Maintenance Phase|Lack of Efficacy|0|||
42264679|NCT02394028|76092637|FG004|Maintenance Phase|Lack of Efficacy|0|||
42264680|NCT02394028|76092638|FG005|Maintenance Phase|Lack of Efficacy|0|||
42264681|NCT02394028|76092639|FG006|Maintenance Phase|Lack of Efficacy|0|||
42264682|NCT02394028|76092640|FG007|Maintenance Phase|Lack of Efficacy|0|||
42034685|NCT01118663|75842867|FG000|Overall Study|Withdrawal by Subject|0|||
42034686|NCT01118663|75842868|FG001|Overall Study|Withdrawal by Subject|1|||
42034687|NCT01118351|75842874|FG000|Overall Study|Adverse Event|3|||
42134544|NCT00407511|75945401|FG000|Overall Study|Withdrawal by Subject|4|||
42134545|NCT00384189|75945409|FG000|Overall Study|Reason Not Specified|50|||
42134546|NCT00384189|75945410|FG001|Overall Study|Reason Not Specified|57|||
42134547|NCT00384189|75945411|FG002|Overall Study|Reason Not Specified|58|||
42134548|NCT00384189|75945412|FG003|Overall Study|Reason Not Specified|40|||
42264683|NCT02394028|76092641|FG008|Maintenance Phase|Lack of Efficacy|7|||
42334209|NCT01826487|76171881|FG001|Overall Study|Withdrawal by Subject|3|||
42334210|NCT01826487|76171880|FG000|Overall Study|Protocol Violation|1|||
42034688|NCT01118351|75842874|FG000|Overall Study|Withdrawal by Subject|1|||
42264684|NCT02394028|76092642|FG009|Maintenance Phase|Lack of Efficacy|25|||
42334211|NCT01826487|76171881|FG001|Overall Study|Protocol Violation|1|||
42334212|NCT02064439|76171891|FG000|Overall Study|Adverse Event|51|||
42334213|NCT02064439|76171892|FG001|Overall Study|Adverse Event|47|||
42334214|NCT02064439|76171893|FG002|Overall Study|Adverse Event|46|||
42334215|NCT02064439|76171891|FG000|Overall Study|Death|0|||
42334216|NCT02064439|76171892|FG001|Overall Study|Death|2|||
42334217|NCT02064439|76171893|FG002|Overall Study|Death|3|||
42334218|NCT02064439|76171891|FG000|Overall Study|Withdrawal by Subject|29|||
42334219|NCT02064439|76171892|FG001|Overall Study|Withdrawal by Subject|18|||
42334220|NCT02064439|76171893|FG002|Overall Study|Withdrawal by Subject|26|||
42334221|NCT02064439|76171891|FG000|Overall Study|Protocol Violation|3|||
42334222|NCT02064439|76171892|FG001|Overall Study|Protocol Violation|5|||
42334223|NCT02064439|76171893|FG002|Overall Study|Protocol Violation|3|||
42334224|NCT02064439|76171891|FG000|Overall Study|Lost to Follow-up|1|||
42334225|NCT02064439|76171892|FG001|Overall Study|Lost to Follow-up|3|||
42334226|NCT02064439|76171893|FG002|Overall Study|Lost to Follow-up|4|||
42334227|NCT02064439|76171891|FG000|Overall Study|Non-compliance with study medication|21|||
42334228|NCT02064439|76171892|FG001|Overall Study|Non-compliance with study medication|19|||
42334229|NCT02064439|76171893|FG002|Overall Study|Non-compliance with study medication|23|||
42334230|NCT02064439|76171891|FG000|Overall Study|Physician Decision|0|||
42334231|NCT02064439|76171892|FG001|Overall Study|Physician Decision|1|||
42334232|NCT02064439|76171893|FG002|Overall Study|Physician Decision|1|||
42334233|NCT02064439|76171891|FG000|Overall Study|Logistical difficulties|6|||
42334234|NCT02064439|76171892|FG001|Overall Study|Logistical difficulties|5|||
42334235|NCT02064439|76171893|FG002|Overall Study|Logistical difficulties|2|||
42334236|NCT02064439|76171891|FG000|Overall Study|Efficacy outcome reached|18|||
42334237|NCT02064439|76171892|FG001|Overall Study|Efficacy outcome reached|16|||
42334238|NCT02064439|76171893|FG002|Overall Study|Efficacy outcome reached|57|||
42334239|NCT02064439|76171891|FG000|Overall Study|Safety outcome reached|12|||
42334240|NCT02064439|76171892|FG001|Overall Study|Safety outcome reached|20|||
42334241|NCT02064439|76171893|FG002|Overall Study|Safety outcome reached|10|||
42334242|NCT02064439|76171891|FG000|Overall Study|Other|2|||
42334243|NCT02064439|76171892|FG001|Overall Study|Other|2|||
42034689|NCT01118117|75842895|FG000|Overall Study|Death|8|||
42134549|NCT00326716|75945424|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
42264685|NCT02394028|76092643|FG010|Maintenance Phase|Lack of Efficacy|33|||
42264686|NCT02394028|76092633|FG000|Maintenance Phase|Death|0|||
42264687|NCT02394028|76092634|FG001|Maintenance Phase|Death|0|||
42264688|NCT02394028|76092635|FG002|Maintenance Phase|Death|0|||
42264689|NCT02394028|76092636|FG003|Maintenance Phase|Death|0|||
42264690|NCT02394028|76092637|FG004|Maintenance Phase|Death|0|||
42264691|NCT02394028|76092638|FG005|Maintenance Phase|Death|0|||
42264692|NCT02394028|76092639|FG006|Maintenance Phase|Death|0|||
42264693|NCT02394028|76092640|FG007|Maintenance Phase|Death|0|||
42264694|NCT02394028|76092641|FG008|Maintenance Phase|Death|0|||
42264695|NCT02394028|76092642|FG009|Maintenance Phase|Death|0|||
42264696|NCT02394028|76092643|FG010|Maintenance Phase|Death|1|||
42264697|NCT02394028|76092633|FG000|Maintenance Phase|Adverse Event|0|||
42264698|NCT02394028|76092634|FG001|Maintenance Phase|Adverse Event|0|||
42264699|NCT02394028|76092635|FG002|Maintenance Phase|Adverse Event|0|||
42264700|NCT02394028|76092636|FG003|Maintenance Phase|Adverse Event|0|||
42264701|NCT02394028|76092637|FG004|Maintenance Phase|Adverse Event|0|||
42264702|NCT02394028|76092638|FG005|Maintenance Phase|Adverse Event|0|||
42264703|NCT02394028|76092639|FG006|Maintenance Phase|Adverse Event|0|||
42264704|NCT02394028|76092640|FG007|Maintenance Phase|Adverse Event|0|||
42264705|NCT02394028|76092641|FG008|Maintenance Phase|Adverse Event|1|||
42264706|NCT02394028|76092642|FG009|Maintenance Phase|Adverse Event|1|||
42264707|NCT02394028|76092643|FG010|Maintenance Phase|Adverse Event|3|||
42264708|NCT02394028|76092633|FG000|Maintenance Phase|Site closure|0|||
42264709|NCT02394028|76092634|FG001|Maintenance Phase|Site closure|0|||
42264710|NCT02394028|76092635|FG002|Maintenance Phase|Site closure|0|||
42264711|NCT02394028|76092636|FG003|Maintenance Phase|Site closure|0|||
42264712|NCT02394028|76092637|FG004|Maintenance Phase|Site closure|0|||
42264713|NCT02394028|76092638|FG005|Maintenance Phase|Site closure|0|||
42264714|NCT02394028|76092639|FG006|Maintenance Phase|Site closure|0|||
42264715|NCT02394028|76092640|FG007|Maintenance Phase|Site closure|0|||
42264716|NCT02394028|76092641|FG008|Maintenance Phase|Site closure|0|||
42264717|NCT02394028|76092642|FG009|Maintenance Phase|Site closure|1|||
42264718|NCT02394028|76092643|FG010|Maintenance Phase|Site closure|0|||
42264719|NCT02394028|76092633|FG000|Maintenance Phase|Withdrawal by Subject|0|||
42334244|NCT02064439|76171893|FG002|Overall Study|Other|7|||
42334245|NCT02130557|76171903|FG000|Overall Study|Withdrawal by Subject|12|||
42334246|NCT02130557|76171904|FG001|Overall Study|Withdrawal by Subject|12|||
42334247|NCT02130557|76171903|FG000|Overall Study|Investigator Request|0|||
42334248|NCT02130557|76171904|FG001|Overall Study|Investigator Request|2|||
42334249|NCT02130557|76171903|FG000|Overall Study|Deceased|14|||
42334250|NCT02130557|76171904|FG001|Overall Study|Deceased|14|||
42334251|NCT02130557|76171903|FG000|Overall Study|Lost to Follow-up|6|||
42264720|NCT02394028|76092634|FG001|Maintenance Phase|Withdrawal by Subject|0|||
42334252|NCT02130557|76171904|FG001|Overall Study|Lost to Follow-up|7|||
42264721|NCT02394028|76092635|FG002|Maintenance Phase|Withdrawal by Subject|0|||
42264722|NCT02394028|76092636|FG003|Maintenance Phase|Withdrawal by Subject|0|||
42264723|NCT02394028|76092637|FG004|Maintenance Phase|Withdrawal by Subject|0|||
42264724|NCT02394028|76092638|FG005|Maintenance Phase|Withdrawal by Subject|0|||
42264725|NCT02394028|76092639|FG006|Maintenance Phase|Withdrawal by Subject|0|||
42264726|NCT02394028|76092640|FG007|Maintenance Phase|Withdrawal by Subject|0|||
42264727|NCT02394028|76092641|FG008|Maintenance Phase|Withdrawal by Subject|3|||
42264728|NCT02394028|76092642|FG009|Maintenance Phase|Withdrawal by Subject|12|||
42264729|NCT02394028|76092643|FG010|Maintenance Phase|Withdrawal by Subject|12|||
42272694|NCT00857285|76103028|FG000|Overall Study|Randomization criteria not met|1|||
42272695|NCT00857285|76103029|FG001|Overall Study|Randomization criteria not met|1|||
42272696|NCT02278354|76103035|FG000|Overall Study|Lost to Follow-up|2|||
42272697|NCT02278354|76103036|FG001|Overall Study|Lost to Follow-up|2|||
42272698|NCT02278354|76103035|FG000|Overall Study|Withdrawal by Subject|0|||
42334253|NCT02130557|76171903|FG000|Overall Study|Other|2|||
42334254|NCT02130557|76171904|FG001|Overall Study|Other|1|||
42334255|NCT02130557|76171903|FG000|Overall Study|Missing|2|||
42334256|NCT02130557|76171904|FG001|Overall Study|Missing|1|||
42272699|NCT02278354|76103036|FG001|Overall Study|Withdrawal by Subject|1|||
42272700|NCT02278354|76103035|FG000|Overall Study|<10 professional fights|2|||
42272701|NCT02278354|76103036|FG001|Overall Study|<10 professional fights|0|||
42272702|NCT01657370|76103055|FG000|Overall Study|Withdrawal by Subject|0|||
42272703|NCT01657370|76103056|FG001|Overall Study|Withdrawal by Subject|0|||
42272704|NCT01657370|76103057|FG002|Overall Study|Withdrawal by Subject|1|||
42272705|NCT01657370|76103058|FG003|Overall Study|Withdrawal by Subject|0|||
42272706|NCT01657370|76103059|FG004|Overall Study|Withdrawal by Subject|0|||
42272707|NCT01657370|76103060|FG005|Overall Study|Withdrawal by Subject|1|||
42272708|NCT01657370|76103055|FG000|Overall Study|Physician Decision|2|||
42272709|NCT01657370|76103056|FG001|Overall Study|Physician Decision|3|||
42272710|NCT01657370|76103057|FG002|Overall Study|Physician Decision|1|||
42334257|NCT01854645|76171915|FG000|Overall Study|Protocol-Specified Criteria|13|||
42334258|NCT01854645|76171916|FG001|Overall Study|Protocol-Specified Criteria|10|||
42334259|NCT01854645|76171917|FG002|Overall Study|Protocol-Specified Criteria|8|||
42334260|NCT01854645|76171918|FG003|Overall Study|Protocol-Specified Criteria|5|||
42334261|NCT01854645|76171919|FG004|Overall Study|Protocol-Specified Criteria|7|||
42334262|NCT01854645|76171915|FG000|Overall Study|Administrative Reasons / Missing|0|||
42334263|NCT01854645|76171916|FG001|Overall Study|Administrative Reasons / Missing|0|||
42334264|NCT01854645|76171917|FG002|Overall Study|Administrative Reasons / Missing|0|||
42334265|NCT01854645|76171918|FG003|Overall Study|Administrative Reasons / Missing|1|||
42334266|NCT01854645|76171919|FG004|Overall Study|Administrative Reasons / Missing|1|||
42334267|NCT01854645|76171915|FG000|Overall Study|Protocol Violation|3|||
42334268|NCT01854645|76171916|FG001|Overall Study|Protocol Violation|0|||
42334269|NCT01854645|76171917|FG002|Overall Study|Protocol Violation|5|||
42334270|NCT01854645|76171918|FG003|Overall Study|Protocol Violation|4|||
42334271|NCT01854645|76171919|FG004|Overall Study|Protocol Violation|1|||
42334272|NCT01854645|76171915|FG000|Overall Study|Lost to Follow-up|10|||
42134550|NCT00326716|75945425|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
42272711|NCT01657370|76103058|FG003|Overall Study|Physician Decision|2|||
42272712|NCT01657370|76103059|FG004|Overall Study|Physician Decision|5|||
42272713|NCT01657370|76103060|FG005|Overall Study|Physician Decision|0|||
42272714|NCT01657370|76103055|FG000|Overall Study|Lack of Qualifying Event|1|||
42272715|NCT01657370|76103056|FG001|Overall Study|Lack of Qualifying Event|0|||
42334273|NCT01854645|76171916|FG001|Overall Study|Lost to Follow-up|7|||
42272716|NCT01657370|76103057|FG002|Overall Study|Lack of Qualifying Event|3|||
42272717|NCT01657370|76103058|FG003|Overall Study|Lack of Qualifying Event|2|||
42272718|NCT01657370|76103059|FG004|Overall Study|Lack of Qualifying Event|1|||
42272719|NCT01657370|76103060|FG005|Overall Study|Lack of Qualifying Event|2|||
42334274|NCT01854645|76171917|FG002|Overall Study|Lost to Follow-up|8|||
42334275|NCT01854645|76171918|FG003|Overall Study|Lost to Follow-up|5|||
42334276|NCT01854645|76171919|FG004|Overall Study|Lost to Follow-up|0|||
42334277|NCT01854645|76171915|FG000|Overall Study|Physician Decision|1|||
42334278|NCT01854645|76171916|FG001|Overall Study|Physician Decision|5|||
42334279|NCT01854645|76171917|FG002|Overall Study|Physician Decision|3|||
42334280|NCT01854645|76171918|FG003|Overall Study|Physician Decision|3|||
42334281|NCT01854645|76171919|FG004|Overall Study|Physician Decision|7|||
42134551|NCT00326716|75945426|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
42134552|NCT00326716|75945427|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
42134553|NCT00548405|75945460|FG000|Overall Study|Adverse Event|6|||
42134554|NCT00548405|75945461|FG001|Overall Study|Adverse Event|2|||
42134555|NCT00548405|75945462|FG002|Overall Study|Adverse Event|0|||
42134556|NCT00548405|75945460|FG000|Overall Study|Lack of Efficacy|6|||
42000071|NCT01340664|75808582|FG002|Overall Study|Adverse Event|7|||
42334282|NCT01854645|76171915|FG000|Overall Study|Withdrawal by Subject|31|||
42334283|NCT01854645|76171916|FG001|Overall Study|Withdrawal by Subject|41|||
42334284|NCT01854645|76171917|FG002|Overall Study|Withdrawal by Subject|30|||
42334285|NCT01854645|76171918|FG003|Overall Study|Withdrawal by Subject|21|||
42334286|NCT01854645|76171919|FG004|Overall Study|Withdrawal by Subject|24|||
42334287|NCT01854645|76171915|FG000|Overall Study|Lack of Efficacy|7|||
42334288|NCT01854645|76171916|FG001|Overall Study|Lack of Efficacy|12|||
42334289|NCT01854645|76171917|FG002|Overall Study|Lack of Efficacy|9|||
42334290|NCT01854645|76171918|FG003|Overall Study|Lack of Efficacy|3|||
42334291|NCT01854645|76171919|FG004|Overall Study|Lack of Efficacy|9|||
42334292|NCT01854645|76171915|FG000|Overall Study|Adverse Event|33|||
42334293|NCT01854645|76171916|FG001|Overall Study|Adverse Event|31|||
42334294|NCT01854645|76171917|FG002|Overall Study|Adverse Event|19|||
42334295|NCT01854645|76171918|FG003|Overall Study|Adverse Event|20|||
42334296|NCT01854645|76171919|FG004|Overall Study|Adverse Event|11|||
42334297|NCT01825941|76171933|FG000|Overall Study|Lost to Follow-up|4|||
42334298|NCT01825941|76171934|FG001|Overall Study|Lost to Follow-up|1|||
42334299|NCT02064205|76171940|FG000|Overall Study|Withdrawal by Subject|1|||
42334300|NCT02090959|76171956|FG000|Overall Study|Withdrawal by Subject|10|||
42334301|NCT02090959|76171956|FG000|Overall Study|Adverse Event|1|||
42334302|NCT02090959|76171956|FG000|Overall Study|Investigator decision|2|||
42334303|NCT02090959|76171956|FG000|Overall Study|Study termination|6|||
42334304|NCT02090959|76171956|FG000|Overall Study|Enrolled but not treated|1|||
42334305|NCT02090959|76171956|FG000|Overall Study|Transfer for compassionate use medicine|4|||
42334306|NCT02090959|76171956|FG000|Overall Study|Move to medical need program|3|||
42334307|NCT02090959|76171956|FG000|Overall Study|Entered in to other study|34|||
42334308|NCT02090959|76171956|FG000|Overall Study|Switched to commercial supply|88|||
42334309|NCT02090959|76171956|FG000|Overall Study|Other than specified|2|||
42334310|NCT02044159|76171962|FG000|Overall Study|Consent declined (deferred consent)|2|||
42334311|NCT02044159|76171963|FG001|Overall Study|Consent declined (deferred consent)|4|||
42334312|NCT02044159|76171962|FG000|Overall Study|No longer eligible, drug not given|1|||
42334313|NCT02044159|76171963|FG001|Overall Study|No longer eligible, drug not given|0|||
42334314|NCT02044159|76171962|FG000|Overall Study|Nurse declined to give study drug|1|||
42334315|NCT02044159|76171963|FG001|Overall Study|Nurse declined to give study drug|0|||
42334316|NCT02090725|76171972|FG000|Overall Study|Withdrawal by Subject|1|||
42334317|NCT02090725|76171972|FG000|Overall Study|participants moved from area|3|||
42334318|NCT02180165|76171980|FG000|Overall Study|Not Treated|0|||
42334319|NCT02180165|76171981|FG001|Overall Study|Not Treated|0|||
42334320|NCT02180165|76171982|FG002|Overall Study|Not Treated|1|||
42334321|NCT02180165|76171983|FG003|Overall Study|Not Treated|0|||
42334322|NCT02180165|76171980|FG000|Overall Study|Adverse Event|7|||
42334323|NCT02180165|76171981|FG001|Overall Study|Adverse Event|0|||
42334324|NCT02180165|76171982|FG002|Overall Study|Adverse Event|18|||
42334325|NCT02180165|76171983|FG003|Overall Study|Adverse Event|3|||
42334326|NCT02180165|76171980|FG000|Overall Study|Lack of Efficacy|0|||
42334327|NCT02180165|76171981|FG001|Overall Study|Lack of Efficacy|1|||
42334328|NCT02180165|76171982|FG002|Overall Study|Lack of Efficacy|3|||
42334329|NCT02180165|76171983|FG003|Overall Study|Lack of Efficacy|2|||
42334330|NCT02180165|76171980|FG000|Overall Study|Physician Decision|1|||
42334331|NCT02180165|76171981|FG001|Overall Study|Physician Decision|0|||
42134557|NCT00548405|75945461|FG001|Overall Study|Lack of Efficacy|0|||
42134558|NCT00548405|75945462|FG002|Overall Study|Lack of Efficacy|0|||
42334332|NCT02180165|76171982|FG002|Overall Study|Physician Decision|5|||
42334333|NCT02180165|76171983|FG003|Overall Study|Physician Decision|0|||
42334334|NCT02180165|76171980|FG000|Overall Study|Withdrawal by Subject|3|||
42334335|NCT02180165|76171981|FG001|Overall Study|Withdrawal by Subject|0|||
42334336|NCT02180165|76171982|FG002|Overall Study|Withdrawal by Subject|2|||
42334337|NCT02180165|76171983|FG003|Overall Study|Withdrawal by Subject|1|||
42334338|NCT02155985|76171998|FG000|Overall Study|Withdrawal by Subject|0|||
42334339|NCT02155985|76171999|FG001|Overall Study|Withdrawal by Subject|0|||
42334340|NCT02155985|76172000|FG002|Overall Study|Withdrawal by Subject|1|||
42000072|NCT01340664|75808580|FG000|Overall Study|Lost to Follow-up|2|||
42334341|NCT02155985|76171998|FG000|Overall Study|Lost to Follow-up|1|||
42334342|NCT02155985|76171999|FG001|Overall Study|Lost to Follow-up|0|||
42334343|NCT02155985|76172000|FG002|Overall Study|Lost to Follow-up|0|||
42334344|NCT02155829|76172010|FG000|Overall Study|Adverse Event|1|||
42334345|NCT02155829|76172011|FG001|Overall Study|Adverse Event|0|||
42334346|NCT02155829|76172010|FG000|Overall Study|Withdrawal by Subject|3|||
42334347|NCT02155829|76172011|FG001|Overall Study|Withdrawal by Subject|3|||
42334348|NCT02155829|76172010|FG000|Overall Study|Protocol Violation|2|||
42334349|NCT02155829|76172011|FG001|Overall Study|Protocol Violation|0|||
42134559|NCT00548405|75945460|FG000|Overall Study|Physician Decision|3|||
42134560|NCT00548405|75945461|FG001|Overall Study|Physician Decision|4|||
42134561|NCT00548405|75945462|FG002|Overall Study|Physician Decision|1|||
42134562|NCT00548405|75945460|FG000|Overall Study|Pregnancy|1|||
42264730|NCT01371539|76092697|FG000|Period One: One Week|Lost to Follow-up|0|||
42264731|NCT01371539|76092698|FG001|Period One: One Week|Lost to Follow-up|1|||
42264732|NCT01371539|76092697|FG000|Period Two: One Week|Lost to Follow-up|0|||
42264733|NCT01371539|76092698|FG001|Period Two: One Week|Lost to Follow-up|1|||
42264734|NCT01371539|76092697|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
42264735|NCT01371539|76092698|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
42264736|NCT01371539|76092697|FG000|Period Two: One Week|Time/job conflict|0|||
42264737|NCT01371539|76092698|FG001|Period Two: One Week|Time/job conflict|1|||
42264738|NCT02819297|76092706|FG000|Overall Study|Withdrawal by Subject|25|||
42264739|NCT02819297|76092707|FG001|Overall Study|Withdrawal by Subject|13|||
42264740|NCT02819297|76092706|FG000|Overall Study|Lost to Follow-up|12|||
42264741|NCT02819297|76092707|FG001|Overall Study|Lost to Follow-up|14|||
42264742|NCT02819297|76092706|FG000|Overall Study|Adverse Event|12|||
42264743|NCT02819297|76092707|FG001|Overall Study|Adverse Event|10|||
42264744|NCT02819297|76092706|FG000|Overall Study|Physician Decision|5|||
42334350|NCT02129777|76172023|FG000|Double-Blind Period|Adverse Event|0|||
42334351|NCT02129777|76172024|FG001|Double-Blind Period|Adverse Event|0|||
42334352|NCT02129777|76172025|FG002|Double-Blind Period|Adverse Event|0|||
42334353|NCT02129777|76172026|FG003|Double-Blind Period|Adverse Event|0|||
42334354|NCT02129777|76172027|FG004|Double-Blind Period|Adverse Event|1|||
42334355|NCT02129777|76172028|FG005|Double-Blind Period|Adverse Event|0|||
42334356|NCT02129777|76172029|FG006|Double-Blind Period|Adverse Event|0|||
42134563|NCT00548405|75945461|FG001|Overall Study|Pregnancy|0|||
42134564|NCT00548405|75945462|FG002|Overall Study|Pregnancy|0|||
42264745|NCT02819297|76092707|FG001|Overall Study|Physician Decision|5|||
42334357|NCT02129777|76172023|FG000|Double-Blind Period|Lost to Follow-up|1|||
42134565|NCT00548405|75945460|FG000|Overall Study|Protocol Violation|1|||
42334358|NCT02129777|76172024|FG001|Double-Blind Period|Lost to Follow-up|1|||
42334359|NCT02129777|76172025|FG002|Double-Blind Period|Lost to Follow-up|1|||
42334360|NCT02129777|76172026|FG003|Double-Blind Period|Lost to Follow-up|2|||
42334361|NCT02129777|76172027|FG004|Double-Blind Period|Lost to Follow-up|0|||
42334362|NCT02129777|76172028|FG005|Double-Blind Period|Lost to Follow-up|0|||
42334363|NCT02129777|76172029|FG006|Double-Blind Period|Lost to Follow-up|0|||
42334364|NCT02129777|76172023|FG000|Double-Blind Period|Withdrawal by Subject|2|||
42334365|NCT02129777|76172024|FG001|Double-Blind Period|Withdrawal by Subject|4|||
42264746|NCT02819297|76092706|FG000|Overall Study|Lack of Efficacy|5|||
42264747|NCT02819297|76092707|FG001|Overall Study|Lack of Efficacy|8|||
42264748|NCT02819297|76092706|FG000|Overall Study|Protocol Violation|1|||
42264749|NCT02819297|76092707|FG001|Overall Study|Protocol Violation|2|||
42264750|NCT02429830|76092713|FG000|Overall Study|Lost to Follow-up|1|||
42264751|NCT02429830|76092713|FG000|Overall Study|Device Explant|2|||
42264752|NCT02821715|76092717|FG000|Overall Study|Protocol Violation|1|||
42264753|NCT02821715|76092718|FG001|Overall Study|Protocol Violation|0|||
42264754|NCT02821715|76092719|FG002|Overall Study|Protocol Violation|0|||
42264755|NCT02821715|76092720|FG003|Overall Study|Protocol Violation|0|||
42264756|NCT02821715|76092721|FG004|Overall Study|Protocol Violation|0|||
42264757|NCT02821715|76092722|FG005|Overall Study|Protocol Violation|0|||
42264758|NCT02813681|76092733|FG000|Overall Study|Physician Decision|5|||
42264759|NCT02813681|76092734|FG001|Overall Study|Physician Decision|5|||
42264760|NCT02813681|76092735|FG002|Overall Study|Physician Decision|0|||
42334366|NCT02129777|76172025|FG002|Double-Blind Period|Withdrawal by Subject|3|||
42334367|NCT02129777|76172026|FG003|Double-Blind Period|Withdrawal by Subject|2|||
42334368|NCT02129777|76172027|FG004|Double-Blind Period|Withdrawal by Subject|3|||
42334369|NCT02129777|76172028|FG005|Double-Blind Period|Withdrawal by Subject|0|||
42334370|NCT02129777|76172029|FG006|Double-Blind Period|Withdrawal by Subject|0|||
42334371|NCT02129777|76172023|FG000|Double-Blind Period|Pregnancy|0|||
42334372|NCT02129777|76172024|FG001|Double-Blind Period|Pregnancy|0|||
42334373|NCT02129777|76172025|FG002|Double-Blind Period|Pregnancy|0|||
42334374|NCT02129777|76172026|FG003|Double-Blind Period|Pregnancy|0|||
42334375|NCT02129777|76172027|FG004|Double-Blind Period|Pregnancy|1|||
42334376|NCT02129777|76172028|FG005|Double-Blind Period|Pregnancy|0|||
42334377|NCT02129777|76172029|FG006|Double-Blind Period|Pregnancy|0|||
42334378|NCT02129777|76172023|FG000|Double-Blind Period|Lack of Efficacy|3|||
42334379|NCT02129777|76172024|FG001|Double-Blind Period|Lack of Efficacy|1|||
42334380|NCT02129777|76172025|FG002|Double-Blind Period|Lack of Efficacy|0|||
42334381|NCT02129777|76172026|FG003|Double-Blind Period|Lack of Efficacy|3|||
42334382|NCT02129777|76172027|FG004|Double-Blind Period|Lack of Efficacy|2|||
42334383|NCT02129777|76172028|FG005|Double-Blind Period|Lack of Efficacy|0|||
42334384|NCT02129777|76172029|FG006|Double-Blind Period|Lack of Efficacy|0|||
42334385|NCT02129777|76172023|FG000|Double-Blind Period|Other|1|||
42334386|NCT02129777|76172024|FG001|Double-Blind Period|Other|2|||
42334387|NCT02129777|76172025|FG002|Double-Blind Period|Other|0|||
42334388|NCT02129777|76172026|FG003|Double-Blind Period|Other|0|||
42334389|NCT02129777|76172027|FG004|Double-Blind Period|Other|0|||
42334390|NCT02129777|76172028|FG005|Double-Blind Period|Other|0|||
42334391|NCT02129777|76172029|FG006|Double-Blind Period|Other|0|||
42334392|NCT02129777|76172023|FG000|Open-Label Period|Lack of Efficacy|0|||
42334393|NCT02129777|76172024|FG001|Open-Label Period|Lack of Efficacy|0|||
42334394|NCT02129777|76172025|FG002|Open-Label Period|Lack of Efficacy|0|||
42334395|NCT02129777|76172026|FG003|Open-Label Period|Lack of Efficacy|0|||
42334396|NCT02129777|76172027|FG004|Open-Label Period|Lack of Efficacy|0|||
42334397|NCT02129777|76172028|FG005|Open-Label Period|Lack of Efficacy|0|||
42334398|NCT02129777|76172029|FG006|Open-Label Period|Lack of Efficacy|5|||
42334399|NCT02129777|76172023|FG000|Open-Label Period|Lost to Follow-up|0|||
42334400|NCT02129777|76172024|FG001|Open-Label Period|Lost to Follow-up|0|||
42334401|NCT02129777|76172025|FG002|Open-Label Period|Lost to Follow-up|0|||
42334402|NCT02129777|76172026|FG003|Open-Label Period|Lost to Follow-up|0|||
42334403|NCT02129777|76172027|FG004|Open-Label Period|Lost to Follow-up|0|||
42334404|NCT02129777|76172028|FG005|Open-Label Period|Lost to Follow-up|1|||
42034690|NCT01118117|75842896|FG001|Overall Study|Death|0|||
42264761|NCT02813681|76092733|FG000|Overall Study|Lost to Follow-up|0|||
42334405|NCT02129777|76172029|FG006|Open-Label Period|Lost to Follow-up|1|||
42334406|NCT02129777|76172023|FG000|Open-Label Period|Withdrawal by Subject|0|||
42334407|NCT02129777|76172024|FG001|Open-Label Period|Withdrawal by Subject|0|||
42334408|NCT02129777|76172025|FG002|Open-Label Period|Withdrawal by Subject|0|||
42334409|NCT02129777|76172026|FG003|Open-Label Period|Withdrawal by Subject|0|||
42264762|NCT02813681|76092734|FG001|Overall Study|Lost to Follow-up|1|||
42264763|NCT02813681|76092735|FG002|Overall Study|Lost to Follow-up|0|||
42034691|NCT01118117|75842895|FG000|Overall Study|Lost to Follow-up|6|||
42264764|NCT02393950|76092747|FG000|Overall Study|Adverse Event|1|||
42334410|NCT02129777|76172027|FG004|Open-Label Period|Withdrawal by Subject|0|||
42334411|NCT02129777|76172028|FG005|Open-Label Period|Withdrawal by Subject|1|||
42334412|NCT02129777|76172029|FG006|Open-Label Period|Withdrawal by Subject|3|||
42334413|NCT02129777|76172023|FG000|Open-Label Period|Study Termination|0|||
42334414|NCT02129777|76172024|FG001|Open-Label Period|Study Termination|0|||
42334415|NCT02129777|76172025|FG002|Open-Label Period|Study Termination|0|||
42334416|NCT02129777|76172026|FG003|Open-Label Period|Study Termination|0|||
42334417|NCT02129777|76172027|FG004|Open-Label Period|Study Termination|0|||
42334418|NCT02129777|76172028|FG005|Open-Label Period|Study Termination|10|||
42334419|NCT02129777|76172029|FG006|Open-Label Period|Study Termination|39|||
42334420|NCT02178995|76172050|FG000|Double Blind|Adverse Event|0|||
42334421|NCT02178995|76172051|FG001|Double Blind|Adverse Event|0|||
42334422|NCT02178995|76172052|FG002|Double Blind|Adverse Event|0|||
42334423|NCT02178995|76172053|FG003|Double Blind|Adverse Event|0|||
42334424|NCT02178995|76172054|FG004|Double Blind|Adverse Event|0|||
42334425|NCT02178995|76172055|FG005|Double Blind|Adverse Event|1|||
42334426|NCT02178995|76172056|FG006|Double Blind|Adverse Event|0|||
42334427|NCT02178995|76172057|FG007|Double Blind|Adverse Event|1|||
42334428|NCT02178995|76172058|FG008|Double Blind|Adverse Event|1|||
42334429|NCT02178995|76172050|FG000|Double Blind|Lost to Follow-up|0|||
42334430|NCT02178995|76172051|FG001|Double Blind|Lost to Follow-up|1|||
42334431|NCT02178995|76172052|FG002|Double Blind|Lost to Follow-up|0|||
42334432|NCT02178995|76172053|FG003|Double Blind|Lost to Follow-up|0|||
42334433|NCT02178995|76172054|FG004|Double Blind|Lost to Follow-up|0|||
42334434|NCT02178995|76172055|FG005|Double Blind|Lost to Follow-up|0|||
42334435|NCT02178995|76172056|FG006|Double Blind|Lost to Follow-up|0|||
42334436|NCT02178995|76172057|FG007|Double Blind|Lost to Follow-up|1|||
42334437|NCT02178995|76172058|FG008|Double Blind|Lost to Follow-up|0|||
42334438|NCT02178995|76172050|FG000|Open Label|Adverse Event|2|||
42334439|NCT02178995|76172051|FG001|Open Label|Adverse Event|0|||
42334440|NCT02178995|76172052|FG002|Open Label|Adverse Event|0|||
42334441|NCT02178995|76172053|FG003|Open Label|Adverse Event|0|||
42334442|NCT02178995|76172054|FG004|Open Label|Adverse Event|0|||
42334443|NCT02178995|76172055|FG005|Open Label|Adverse Event|0|||
42334444|NCT02178995|76172056|FG006|Open Label|Adverse Event|0|||
42334445|NCT02178995|76172057|FG007|Open Label|Adverse Event|0|||
42334446|NCT02178995|76172058|FG008|Open Label|Adverse Event|0|||
42334447|NCT02128997|76172084|FG000|Overall Study|Lost to Follow-up|6|||
42334448|NCT02128997|76172085|FG001|Overall Study|Lost to Follow-up|11|||
42334449|NCT02155283|76172091|FG000|Overall Study|Lost to Follow-up|3|||
42334450|NCT02155283|76172091|FG000|Overall Study|Withdrawal by Subject|1|||
42334451|NCT02155283|76172091|FG000|Overall Study|Protocol Violation|3|||
42334452|NCT02154581|76172097|FG000|Overall Study|Lost to Follow-up|7|||
42334453|NCT02154581|76172098|FG001|Overall Study|Lost to Follow-up|8|||
42334454|NCT02154425|76172106|FG000|Screening Period|Adverse Event|1|||
42334455|NCT02154347|76172116|FG000|Double-blind Period|Adverse Event|1|||
42334456|NCT02154347|76172117|FG001|Double-blind Period|Adverse Event|2|||
42334457|NCT02154347|76172116|FG000|Double-blind Period|Lack of Efficacy|1|||
42334458|NCT02154347|76172117|FG001|Double-blind Period|Lack of Efficacy|0|||
42334459|NCT02154347|76172116|FG000|Double-blind Period|Physician Decision|0|||
42334460|NCT02154347|76172117|FG001|Double-blind Period|Physician Decision|1|||
42264765|NCT02393950|76092748|FG001|Overall Study|Adverse Event|0|||
42264766|NCT02393950|76092747|FG000|Overall Study|Withdrawal by Subject|0|||
42264767|NCT02393950|76092748|FG001|Overall Study|Withdrawal by Subject|1|||
42264768|NCT02815397|76092783|FG000|Overall Study|Physician Decision|2|||
42264769|NCT02427958|76092787|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
42264770|NCT02427958|76092787|FG000|Overall Study|Lost to Follow-up|6|||
42264771|NCT02427958|76092787|FG000|Overall Study|Withdrawal by Subject|14|||
42264772|NCT02427958|76092787|FG000|Overall Study|Lack of Efficacy|1|||
42264773|NCT02392624|76092794|FG000|Overall Study|Withdrawal by Subject|15|||
42264774|NCT02392624|76092795|FG001|Overall Study|Withdrawal by Subject|12|||
42264775|NCT02392624|76092796|FG002|Overall Study|Withdrawal by Subject|9|||
42334461|NCT02154347|76172116|FG000|Double-blind Period|Withdrawal by Subject|1|||
42334462|NCT02154347|76172117|FG001|Double-blind Period|Withdrawal by Subject|1|||
42334463|NCT02154347|76172116|FG000|Open-label Period|Adverse Event|3|||
42334464|NCT02154347|76172117|FG001|Open-label Period|Adverse Event|4|||
42334465|NCT02154347|76172116|FG000|Open-label Period|Lack of Efficacy|4|||
42334466|NCT02154347|76172117|FG001|Open-label Period|Lack of Efficacy|19|||
42334467|NCT02154347|76172116|FG000|Open-label Period|Protocol Violation|0|||
42334468|NCT02154347|76172117|FG001|Open-label Period|Protocol Violation|1|||
42334469|NCT02154347|76172116|FG000|Open-label Period|Withdrawal by Subject|0|||
42334470|NCT02154347|76172117|FG001|Open-label Period|Withdrawal by Subject|1|||
42334471|NCT01627067|76172124|FG000|Overall Study|Screen Failure|1|||
42334472|NCT02178059|76172130|FG000|Washout|Physician Decision|1|||
42334473|NCT02178059|76172131|FG001|Washout|Physician Decision|0|||
42264776|NCT02392624|76092794|FG000|Overall Study|Adverse Event|4|||
42264777|NCT02392624|76092795|FG001|Overall Study|Adverse Event|1|||
42334474|NCT01626989|76172137|FG000|Screening Period|Screen Failure|15|||
42334475|NCT01626989|76172138|FG001|Screening Period|Screen Failure|0|||
42334476|NCT01626989|76172139|FG002|Screening Period|Screen Failure|0|||
42334477|NCT01626989|76172137|FG000|Screening Period|Withdrawal by Subject|2|||
42334478|NCT01626989|76172138|FG001|Screening Period|Withdrawal by Subject|0|||
42334479|NCT01626989|76172139|FG002|Screening Period|Withdrawal by Subject|0|||
42334480|NCT02128217|76172150|FG000|Overall Study|Lost to Follow-up|0|||
42334481|NCT02128217|76172151|FG001|Overall Study|Lost to Follow-up|1|||
42334482|NCT01629953|76172164|FG000|Overall Study|Death|3|||
42334483|NCT01629953|76172165|FG001|Overall Study|Death|1|||
42334484|NCT01629953|76172164|FG000|Overall Study|Lost to Follow-up|10|||
42334485|NCT01629953|76172165|FG001|Overall Study|Lost to Follow-up|14|||
42334486|NCT02127281|76172173|FG000|Overall Study|Lost to Follow-up|1|||
42334487|NCT02127281|76172174|FG001|Overall Study|Lost to Follow-up|0|||
42334488|NCT01628549|76172184|FG000|Overall Study|Adverse Event|1|||
42334489|NCT01628549|76172185|FG001|Overall Study|Adverse Event|1|||
42334490|NCT01628549|76172186|FG002|Overall Study|Adverse Event|0|||
42334491|NCT01628549|76172187|FG003|Overall Study|Adverse Event|4|||
42334492|NCT01628549|76172184|FG000|Overall Study|Lost to Follow-up|3|||
42000073|NCT01340664|75808581|FG001|Overall Study|Lost to Follow-up|0|||
42000074|NCT01340664|75808582|FG002|Overall Study|Lost to Follow-up|2|||
42000075|NCT01340664|75808580|FG000|Overall Study|Withdrawal by Subject|2|||
42000076|NCT01340664|75808581|FG001|Overall Study|Withdrawal by Subject|4|||
42000077|NCT01340664|75808582|FG002|Overall Study|Withdrawal by Subject|0|||
42000078|NCT01340664|75808580|FG000|Overall Study|Glycemic withdrawal criteria|2|||
42000079|NCT01340664|75808581|FG001|Overall Study|Glycemic withdrawal criteria|0|||
42000080|NCT01340664|75808582|FG002|Overall Study|Glycemic withdrawal criteria|0|||
42000081|NCT01340664|75808580|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
42000082|NCT01340664|75808581|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
42000083|NCT01340664|75808582|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
42264778|NCT02392624|76092796|FG002|Overall Study|Adverse Event|2|||
42000084|NCT01340664|75808580|FG000|Overall Study|Other|1|||
42000085|NCT01340664|75808581|FG001|Overall Study|Other|2|||
42000086|NCT01340664|75808582|FG002|Overall Study|Other|2|||
42000087|NCT01340625|75808592|FG000|First Intervention|Adverse Event|1|||
42000088|NCT01340625|75808593|FG001|First Intervention|Adverse Event|0|||
42000089|NCT01340625|75808592|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
42000090|NCT01340625|75808593|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
42000091|NCT01340196|75808599|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
42000092|NCT01327599|75808608|FG000|Overall Study|Adverse Event|1|||
42034692|NCT01118117|75842896|FG001|Overall Study|Lost to Follow-up|0|||
42264779|NCT02392624|76092794|FG000|Overall Study|Pregnancy|1|||
42264780|NCT02392624|76092795|FG001|Overall Study|Pregnancy|0|||
42264781|NCT02392624|76092796|FG002|Overall Study|Pregnancy|0|||
42264782|NCT02392624|76092794|FG000|Overall Study|Protocol Violation|0|||
42264783|NCT02392624|76092795|FG001|Overall Study|Protocol Violation|0|||
42264784|NCT02392624|76092796|FG002|Overall Study|Protocol Violation|1|||
42264785|NCT02392624|76092794|FG000|Overall Study|Sponsor/Investigator Decision|2|||
42264786|NCT02392624|76092795|FG001|Overall Study|Sponsor/Investigator Decision|1|||
42264787|NCT02392624|76092796|FG002|Overall Study|Sponsor/Investigator Decision|0|||
42264788|NCT02392624|76092794|FG000|Overall Study|Other|49|||
42264789|NCT02392624|76092795|FG001|Overall Study|Other|1|||
42264790|NCT02392624|76092796|FG002|Overall Study|Other|1|||
42264791|NCT02387164|76092806|FG000|Overall Study|Lost to Follow-up|2|||
42264792|NCT02387164|76092807|FG001|Overall Study|Lost to Follow-up|0|||
42334493|NCT01628549|76172185|FG001|Overall Study|Lost to Follow-up|4|||
42334494|NCT01628549|76172186|FG002|Overall Study|Lost to Follow-up|3|||
42000093|NCT01327599|75808608|FG000|Overall Study|Could Not Attend Visit|1|||
42000094|NCT01327599|75808608|FG000|Overall Study|Withdrawal of Consent|1|||
42000095|NCT01193257|75808614|FG000|Overall Study|Death|202|||
42264793|NCT02387164|76092806|FG000|Overall Study|Diagnosed|1|||
42264794|NCT02387164|76092807|FG001|Overall Study|Diagnosed|2|||
42264795|NCT02392234|76092825|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
42334495|NCT01628549|76172187|FG003|Overall Study|Lost to Follow-up|3|||
42334496|NCT01628549|76172184|FG000|Overall Study|Withdrawal by Subject|3|||
42334497|NCT01628549|76172185|FG001|Overall Study|Withdrawal by Subject|4|||
42334498|NCT01628549|76172186|FG002|Overall Study|Withdrawal by Subject|4|||
42334499|NCT01628549|76172187|FG003|Overall Study|Withdrawal by Subject|1|||
42334500|NCT01628549|76172184|FG000|Overall Study|Protocol Violation|2|||
42264796|NCT02392234|76092826|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
42264797|NCT02392234|76092827|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
42264798|NCT02392234|76092828|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
42264799|NCT02392234|76092829|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
42264800|NCT02392234|76092830|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
42264801|NCT02392234|76092825|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
42134566|NCT00548405|75945461|FG001|Overall Study|Protocol Violation|0|||
42264802|NCT02392234|76092826|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
42264803|NCT02392234|76092827|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
42264804|NCT02392234|76092828|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
42264805|NCT02392234|76092829|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
42264806|NCT02392234|76092830|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
42264807|NCT02392234|76092825|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
42264808|NCT02392234|76092826|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
42264809|NCT02392234|76092827|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
42264810|NCT02392234|76092828|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
42264811|NCT02392234|76092829|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
42264812|NCT02392234|76092830|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
42264813|NCT02392234|76092825|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
42264814|NCT02392234|76092826|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
42264815|NCT02392234|76092827|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
42264816|NCT02392234|76092828|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
42264817|NCT02392234|76092829|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
42264818|NCT02392234|76092830|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
42264819|NCT02392234|76092825|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
42264820|NCT02392234|76092826|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
42264821|NCT02392234|76092827|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
42264822|NCT02392234|76092828|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
42264823|NCT02392234|76092829|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
42264824|NCT02392234|76092830|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
42264825|NCT02392234|76092825|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
42264826|NCT02392234|76092826|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
42264827|NCT02392234|76092827|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
42264828|NCT02392234|76092828|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
42264829|NCT02392234|76092829|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
42264830|NCT02392234|76092830|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
42264831|NCT02392234|76092825|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
42264832|NCT02392234|76092826|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
42264833|NCT02392234|76092827|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
42264834|NCT02392234|76092828|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
42264835|NCT02392234|76092829|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
42264836|NCT02392234|76092830|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
42264837|NCT02392234|76092825|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
42264838|NCT02392234|76092826|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
42264839|NCT02392234|76092827|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
42264840|NCT02392234|76092828|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
42264841|NCT02392234|76092829|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
42264842|NCT02392234|76092830|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
42264843|NCT02963090|76092844|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
42264844|NCT02963090|76092845|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
42264845|NCT02427802|76092857|FG000|Overall Study|Adverse Event|11|||
42264846|NCT02427802|76092858|FG001|Overall Study|Adverse Event|3|||
42264847|NCT02427802|76092859|FG002|Overall Study|Adverse Event|7|||
42264848|NCT02427802|76092857|FG000|Overall Study|Death|0|||
42264849|NCT02427802|76092858|FG001|Overall Study|Death|4|||
42264850|NCT02427802|76092859|FG002|Overall Study|Death|1|||
42264851|NCT02427802|76092857|FG000|Overall Study|Lost to Follow-up|13|||
42264852|NCT02427802|76092858|FG001|Overall Study|Lost to Follow-up|8|||
42264853|NCT02427802|76092859|FG002|Overall Study|Lost to Follow-up|8|||
42264854|NCT02427802|76092857|FG000|Overall Study|Physician Decision|4|||
42264855|NCT02427802|76092858|FG001|Overall Study|Physician Decision|2|||
42264856|NCT02427802|76092859|FG002|Overall Study|Physician Decision|4|||
42264857|NCT02427802|76092857|FG000|Overall Study|Withdrawal by Subject|10|||
42264858|NCT02427802|76092858|FG001|Overall Study|Withdrawal by Subject|5|||
42264859|NCT02427802|76092859|FG002|Overall Study|Withdrawal by Subject|11|||
42264860|NCT02427802|76092857|FG000|Overall Study|Protocol Violation|3|||
42264861|NCT02427802|76092858|FG001|Overall Study|Protocol Violation|1|||
42264862|NCT02427802|76092859|FG002|Overall Study|Protocol Violation|1|||
42264863|NCT02427802|76092857|FG000|Overall Study|protocol specific treatment unrelated|18|||
42264864|NCT02427802|76092858|FG001|Overall Study|protocol specific treatment unrelated|11|||
42334501|NCT01628549|76172185|FG001|Overall Study|Protocol Violation|1|||
42334502|NCT01628549|76172186|FG002|Overall Study|Protocol Violation|1|||
42334503|NCT01628549|76172187|FG003|Overall Study|Protocol Violation|0|||
42334504|NCT01628549|76172184|FG000|Overall Study|withdrawn for noncompliance|0|||
42334505|NCT01628549|76172185|FG001|Overall Study|withdrawn for noncompliance|2|||
42334506|NCT01628549|76172186|FG002|Overall Study|withdrawn for noncompliance|1|||
42334507|NCT01628549|76172187|FG003|Overall Study|withdrawn for noncompliance|0|||
42334508|NCT01628549|76172184|FG000|Overall Study|abnormal laboratory test results|0|||
42334509|NCT01628549|76172185|FG001|Overall Study|abnormal laboratory test results|0|||
42334510|NCT01628549|76172186|FG002|Overall Study|abnormal laboratory test results|1|||
42334511|NCT01628549|76172187|FG003|Overall Study|abnormal laboratory test results|0|||
42334512|NCT01628549|76172184|FG000|Overall Study|positive pregnancy test|0|||
42334513|NCT01628549|76172185|FG001|Overall Study|positive pregnancy test|0|||
42334514|NCT01628549|76172186|FG002|Overall Study|positive pregnancy test|0|||
42334515|NCT01628549|76172187|FG003|Overall Study|positive pregnancy test|1|||
42334516|NCT02127125|76172206|FG000|Overall Study|Lost to Follow-up|0|||
42334517|NCT02127125|76172207|FG001|Overall Study|Lost to Follow-up|0|||
42334518|NCT02127125|76172208|FG002|Overall Study|Lost to Follow-up|0|||
42334519|NCT02127125|76172209|FG003|Overall Study|Lost to Follow-up|0|||
42334520|NCT02127125|76172210|FG004|Overall Study|Lost to Follow-up|2|||
42334521|NCT02127125|76172211|FG005|Overall Study|Lost to Follow-up|1|||
42334522|NCT02127125|76172212|FG006|Overall Study|Lost to Follow-up|0|||
42334523|NCT02127125|76172213|FG007|Overall Study|Lost to Follow-up|0|||
42334524|NCT02127125|76172214|FG008|Overall Study|Lost to Follow-up|0|||
42334525|NCT02127125|76172206|FG000|Overall Study|Withdrawal by Subject|0|||
42334526|NCT02127125|76172207|FG001|Overall Study|Withdrawal by Subject|0|||
42334527|NCT02127125|76172208|FG002|Overall Study|Withdrawal by Subject|0|||
42334528|NCT02127125|76172209|FG003|Overall Study|Withdrawal by Subject|1|||
42334529|NCT02127125|76172210|FG004|Overall Study|Withdrawal by Subject|0|||
42334530|NCT02127125|76172211|FG005|Overall Study|Withdrawal by Subject|0|||
42334531|NCT02127125|76172212|FG006|Overall Study|Withdrawal by Subject|0|||
42334532|NCT02127125|76172213|FG007|Overall Study|Withdrawal by Subject|0|||
42334533|NCT02127125|76172214|FG008|Overall Study|Withdrawal by Subject|0|||
42334534|NCT02127125|76172206|FG000|Overall Study|Physician Decision|0|||
42334535|NCT02127125|76172207|FG001|Overall Study|Physician Decision|0|||
42334536|NCT02127125|76172208|FG002|Overall Study|Physician Decision|1|||
42334537|NCT02127125|76172209|FG003|Overall Study|Physician Decision|0|||
42334538|NCT02127125|76172210|FG004|Overall Study|Physician Decision|1|||
42334539|NCT02127125|76172211|FG005|Overall Study|Physician Decision|2|||
42334540|NCT02127125|76172212|FG006|Overall Study|Physician Decision|0|||
42334541|NCT02127125|76172213|FG007|Overall Study|Physician Decision|0|||
42334542|NCT02127125|76172214|FG008|Overall Study|Physician Decision|0|||
42334543|NCT02090413|76172237|FG000|Overall Study|Adverse Event|11|||
42334544|NCT02090413|76172238|FG001|Overall Study|Adverse Event|15|||
42264865|NCT02427802|76092859|FG002|Overall Study|protocol specific treatment unrelated|11|||
42264866|NCT02427646|76092869|FG000|Overall Study|Lack of Efficacy|2|||
42264867|NCT02427646|76092870|FG001|Overall Study|Lack of Efficacy|3|||
42264868|NCT02427646|76092869|FG000|Overall Study|Physician Decision|1|||
42264869|NCT02427646|76092870|FG001|Overall Study|Physician Decision|4|||
42264870|NCT02427646|76092869|FG000|Overall Study|Protocol Violation|3|||
42264871|NCT02427646|76092870|FG001|Overall Study|Protocol Violation|3|||
42264872|NCT02427646|76092869|FG000|Overall Study|Bothersome hand weakness|2|||
42264873|NCT02427646|76092870|FG001|Overall Study|Bothersome hand weakness|4|||
42264874|NCT02392000|76092878|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
42264875|NCT02392000|76092878|FG000|Overall Study|Withdrawal by Subject|1|||
42264876|NCT02392000|76092878|FG000|Overall Study|Lost to Follow-up|8|||
42264877|NCT02385526|76092886|FG000|Overall Study|Withdrawal by Subject|0|||
42264878|NCT02385526|76092887|FG001|Overall Study|Withdrawal by Subject|2|||
42334545|NCT02090413|76172239|FG002|Overall Study|Adverse Event|20|||
42334546|NCT02090413|76172237|FG000|Overall Study|Flushing event|2|||
42334547|NCT02090413|76172238|FG001|Overall Study|Flushing event|0|||
42334548|NCT02090413|76172239|FG002|Overall Study|Flushing event|1|||
42334549|NCT02090413|76172237|FG000|Overall Study|Withdrawal by Subject|2|||
42334550|NCT02090413|76172238|FG001|Overall Study|Withdrawal by Subject|2|||
42334551|NCT02090413|76172239|FG002|Overall Study|Withdrawal by Subject|2|||
42264879|NCT02385526|76092888|FG002|Overall Study|Withdrawal by Subject|0|||
42264880|NCT02385526|76092886|FG000|Overall Study|Lost to Follow-up|0|||
42264881|NCT02385526|76092887|FG001|Overall Study|Lost to Follow-up|1|||
42264882|NCT02385526|76092888|FG002|Overall Study|Lost to Follow-up|0|||
42264883|NCT02385526|76092886|FG000|Overall Study|Physician Decision|1|||
42264884|NCT02385526|76092887|FG001|Overall Study|Physician Decision|0|||
42334552|NCT02090413|76172237|FG000|Overall Study|Investigator Decision|1|||
42334553|NCT02090413|76172238|FG001|Overall Study|Investigator Decision|1|||
42334554|NCT02090413|76172239|FG002|Overall Study|Investigator Decision|0|||
42334555|NCT02090413|76172237|FG000|Overall Study|Other|2|||
42334556|NCT02090413|76172238|FG001|Overall Study|Other|1|||
42334557|NCT02090413|76172239|FG002|Overall Study|Other|0|||
42334558|NCT02090413|76172237|FG000|Overall Study|Lost to Follow-up|1|||
42264885|NCT02385526|76092888|FG002|Overall Study|Physician Decision|0|||
42264886|NCT02385526|76092886|FG000|Overall Study|Protocol Violation|1|||
42264887|NCT02385526|76092887|FG001|Overall Study|Protocol Violation|0|||
42264888|NCT02385526|76092888|FG002|Overall Study|Protocol Violation|0|||
42264889|NCT02808143|76092898|FG000|Maintenance Phase|Disease recurrence|1|||
42264890|NCT02808143|76092899|FG001|Maintenance Phase|Disease recurrence|3|||
42264891|NCT02808143|76092898|FG000|Maintenance Phase|Disease progression|1|||
42264892|NCT02808143|76092899|FG001|Maintenance Phase|Disease progression|2|||
42264893|NCT02808143|76092898|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
42334559|NCT02090413|76172238|FG001|Overall Study|Lost to Follow-up|1|||
42334560|NCT02090413|76172239|FG002|Overall Study|Lost to Follow-up|0|||
42334561|NCT02063737|76172250|FG000|Overall Study|Lost to Follow-up|11|||
42334562|NCT02063737|76172251|FG001|Overall Study|Lost to Follow-up|4|||
42334563|NCT02125877|76172259|FG000|Overall Study|Physician Decision|1|||
42334564|NCT02125877|76172260|FG001|Overall Study|Physician Decision|0|||
42334565|NCT02125877|76172259|FG000|Overall Study|Death|0|||
42334566|NCT02125877|76172260|FG001|Overall Study|Death|1|||
42334567|NCT02125877|76172259|FG000|Overall Study|Administrative problems|0|||
42334568|NCT02125877|76172260|FG001|Overall Study|Administrative problems|1|||
42334569|NCT02125877|76172259|FG000|Overall Study|Participant/guardian decision|0|||
42334570|NCT02125877|76172260|FG001|Overall Study|Participant/guardian decision|2|||
42334571|NCT02125877|76172259|FG000|Overall Study|Withdrawal by Subject|2|||
42334572|NCT02125877|76172260|FG001|Overall Study|Withdrawal by Subject|1|||
42334573|NCT02125877|76172259|FG000|Overall Study|Protocol deviation|4|||
42334574|NCT02125877|76172260|FG001|Overall Study|Protocol deviation|1|||
42334575|NCT02125877|76172259|FG000|Overall Study|Adverse Event|6|||
42334576|NCT02125877|76172260|FG001|Overall Study|Adverse Event|4|||
42334577|NCT01598987|76172266|FG000|Baseline to Month 12|Administrative problems|2|||
42334578|NCT01598987|76172266|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
42334579|NCT01598987|76172266|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
42334580|NCT01598987|76172266|FG000|Baseline to 24 Month|Administrative problems|2|||
42334581|NCT01598987|76172266|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
42334582|NCT02063659|76172280|FG000|Double-Blind Treatment Period|Adverse Event|1|||
42334583|NCT02063659|76172281|FG001|Double-Blind Treatment Period|Adverse Event|2|||
42334584|NCT02063659|76172282|FG002|Double-Blind Treatment Period|Adverse Event|0|||
42000096|NCT01193257|75808615|FG001|Overall Study|Death|391|||
42000097|NCT01193257|75808614|FG000|Overall Study|Study termination by sponsor|0|||
42000098|NCT01193257|75808615|FG001|Overall Study|Study termination by sponsor|3|||
42264894|NCT02808143|76092899|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
42264895|NCT02808143|76092898|FG000|Survival Follow-Up|Disease recurrence|0|||
42264896|NCT02808143|76092899|FG001|Survival Follow-Up|Disease recurrence|2|||
42334585|NCT02063659|76172283|FG003|Double-Blind Treatment Period|Adverse Event|0|||
42334586|NCT02063659|76172280|FG000|Double-Blind Treatment Period|Physician Decision|1|||
42334587|NCT02063659|76172281|FG001|Double-Blind Treatment Period|Physician Decision|0|||
42334588|NCT02063659|76172282|FG002|Double-Blind Treatment Period|Physician Decision|0|||
42000099|NCT01193257|75808614|FG000|Overall Study|Withdrawal by Subject|26|||
42000100|NCT01193257|75808615|FG001|Overall Study|Withdrawal by Subject|86|||
42334589|NCT02063659|76172283|FG003|Double-Blind Treatment Period|Physician Decision|0|||
42334590|NCT02063659|76172280|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
42334591|NCT02063659|76172281|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
42334592|NCT02063659|76172282|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
42334593|NCT02063659|76172283|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
42334594|NCT02063659|76172280|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
42334595|NCT02063659|76172281|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
42334596|NCT02063659|76172282|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
42334597|NCT02063659|76172283|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
42334598|NCT02063659|76172280|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
42334599|NCT02063659|76172281|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
42334600|NCT02063659|76172282|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
42334601|NCT02063659|76172283|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
42334602|NCT02063659|76172280|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
42334603|NCT02063659|76172281|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
42334604|NCT02063659|76172282|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
42334605|NCT02063659|76172283|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
42334606|NCT02063659|76172280|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
42334607|NCT02063659|76172281|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
42334608|NCT02063659|76172282|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
42334609|NCT02063659|76172283|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
42334610|NCT02063659|76172280|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
42334611|NCT02063659|76172281|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
42000101|NCT01193257|75808614|FG000|Overall Study|Lost to Follow-up|2|||
42264897|NCT02808143|76092898|FG000|Survival Follow-Up|Adverse Event|0|||
42264898|NCT02808143|76092899|FG001|Survival Follow-Up|Adverse Event|1|||
42000102|NCT01193257|75808615|FG001|Overall Study|Lost to Follow-up|3|||
42000103|NCT01193257|75808614|FG000|Overall Study|Unblinded due to futility|135|||
42000104|NCT01193257|75808615|FG001|Overall Study|Unblinded due to futility|251|||
42000105|NCT01193218|75808626|FG000|0-12 Weeks|Adverse Event|6|||
42000106|NCT01193218|75808627|FG001|0-12 Weeks|Adverse Event|0|||
42000107|NCT01193218|75808628|FG002|0-12 Weeks|Adverse Event|1|||
42000108|NCT01193218|75808629|FG003|0-12 Weeks|Adverse Event|0|||
42000109|NCT01193218|75808630|FG004|0-12 Weeks|Adverse Event|0|||
42000110|NCT01193218|75808631|FG005|0-12 Weeks|Adverse Event|2|||
42264899|NCT02808143|76092898|FG000|Survival Follow-Up|Death|1|||
42264900|NCT02808143|76092899|FG001|Survival Follow-Up|Death|0|||
42264901|NCT02427100|76092909|FG000|Overall Study|Lost to Follow-up|0|||
42264902|NCT02427100|76092910|FG001|Overall Study|Lost to Follow-up|2|||
42264903|NCT02806973|76092916|FG000|Period 1|Withdrawal by Subject|0|||
42264904|NCT02806973|76092917|FG001|Period 1|Withdrawal by Subject|2|||
42264905|NCT02806973|76092918|FG002|Period 1|Withdrawal by Subject|1|||
42264906|NCT02806973|76092919|FG003|Period 1|Withdrawal by Subject|1|||
42264907|NCT02806973|76092916|FG000|Period 1|Adverse Event|0|||
42264908|NCT02806973|76092917|FG001|Period 1|Adverse Event|0|||
42264909|NCT02806973|76092918|FG002|Period 1|Adverse Event|0|||
42264910|NCT02806973|76092919|FG003|Period 1|Adverse Event|1|||
42334612|NCT02063659|76172282|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
42334613|NCT02063659|76172283|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
42334614|NCT02062879|76172299|FG000|Overall Study|Withdrawal by Subject|4|||
42334615|NCT02062879|76172300|FG001|Overall Study|Withdrawal by Subject|1|||
42334616|NCT02062645|76172306|FG000|Overall Study|Adverse Event|2|||
42334617|NCT02062645|76172306|FG000|Overall Study|Protocol Violation|8|||
42334618|NCT02062645|76172306|FG000|Overall Study|Lost to Follow-up|5|||
42334619|NCT02088697|76172312|FG000|Period I|Physician Decision|1|||
42334620|NCT02088697|76172313|FG001|Period I|Physician Decision|4|||
42334621|NCT02088697|76172312|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
42334622|NCT02088697|76172313|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
42334623|NCT01825785|76172326|FG000|Overall Study|Adverse Event|0|||
42334624|NCT01825785|76172327|FG001|Overall Study|Adverse Event|0|||
42334625|NCT01825785|76172328|FG002|Overall Study|Adverse Event|0|||
42334626|NCT01825785|76172329|FG003|Overall Study|Adverse Event|0|||
42334627|NCT01825785|76172330|FG004|Overall Study|Adverse Event|1|||
42334628|NCT01825785|76172331|FG005|Overall Study|Adverse Event|0|||
42334629|NCT01825785|76172332|FG006|Overall Study|Adverse Event|0|||
42334630|NCT01825785|76172326|FG000|Overall Study|Withdrawal by Subject|0|||
42334631|NCT01825785|76172327|FG001|Overall Study|Withdrawal by Subject|0|||
42334632|NCT01825785|76172328|FG002|Overall Study|Withdrawal by Subject|0|||
42334633|NCT01825785|76172329|FG003|Overall Study|Withdrawal by Subject|0|||
42334634|NCT01825785|76172330|FG004|Overall Study|Withdrawal by Subject|1|||
42334635|NCT01825785|76172331|FG005|Overall Study|Withdrawal by Subject|1|||
42334636|NCT01825785|76172332|FG006|Overall Study|Withdrawal by Subject|0|||
42334637|NCT02043301|76172357|FG000|Overall Study|Discontinued|0|||
42334638|NCT02043301|76172358|FG001|Overall Study|Discontinued|1|||
42334639|NCT02043301|76172359|FG002|Overall Study|Discontinued|0|||
42334640|NCT01598753|76172371|FG000|Overall Study|Adverse Event|1|||
42334641|NCT01598753|76172372|FG001|Overall Study|Adverse Event|9|||
42134567|NCT00548405|75945462|FG002|Overall Study|Protocol Violation|0|||
42334642|NCT01598753|76172373|FG002|Overall Study|Adverse Event|1|||
42334643|NCT01598753|76172374|FG003|Overall Study|Adverse Event|7|||
42334644|NCT01598753|76172371|FG000|Overall Study|Lost to Follow-up|4|||
42334645|NCT01598753|76172372|FG001|Overall Study|Lost to Follow-up|3|||
42334646|NCT01598753|76172373|FG002|Overall Study|Lost to Follow-up|7|||
42334647|NCT01598753|76172374|FG003|Overall Study|Lost to Follow-up|5|||
42264911|NCT02806973|76092916|FG000|Period 3|Withdrawal by Subject|0|||
42264912|NCT02806973|76092917|FG001|Period 3|Withdrawal by Subject|0|||
42000111|NCT01193218|75808632|FG006|0-12 Weeks|Adverse Event|2|||
42000112|NCT01193218|75808633|FG007|0-12 Weeks|Adverse Event|0|||
42264913|NCT02806973|76092918|FG002|Period 3|Withdrawal by Subject|0|||
42334648|NCT01598753|76172371|FG000|Overall Study|Physician Decision|0|||
42334649|NCT01598753|76172372|FG001|Overall Study|Physician Decision|1|||
42334650|NCT01598753|76172373|FG002|Overall Study|Physician Decision|0|||
42000113|NCT01193218|75808626|FG000|0-12 Weeks|Protocol Violation|0|||
42000114|NCT01193218|75808627|FG001|0-12 Weeks|Protocol Violation|0|||
42264914|NCT02806973|76092919|FG003|Period 3|Withdrawal by Subject|3|||
42264915|NCT02806973|76092916|FG000|Period 3|Adverse Event|0|||
42334651|NCT01598753|76172374|FG003|Overall Study|Physician Decision|2|||
42334652|NCT01598753|76172371|FG000|Overall Study|Withdrawal by Subject|7|||
42334653|NCT01598753|76172372|FG001|Overall Study|Withdrawal by Subject|2|||
42334654|NCT01598753|76172373|FG002|Overall Study|Withdrawal by Subject|0|||
42334655|NCT01598753|76172374|FG003|Overall Study|Withdrawal by Subject|1|||
42334656|NCT02177123|76172384|FG000|Overall Study|Lost to Follow-up|6|||
42334657|NCT02177123|76172384|FG000|Overall Study|Withdrawal by Subject|4|||
42334658|NCT02177123|76172384|FG000|Overall Study|Adverse Event|4|||
42334659|NCT02177123|76172384|FG000|Overall Study|Physician Decision|3|||
42334660|NCT02177123|76172384|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
42334661|NCT02177123|76172384|FG000|Overall Study|Excluded for medical reasons|2|||
42334662|NCT02177123|76172384|FG000|Overall Study|Death|1|||
42334663|NCT02177123|76172384|FG000|Overall Study|Other|1|||
42334664|NCT02177123|76172384|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
42334665|NCT01824693|76172394|FG000|Overall Study|Death|0|||
42334666|NCT01824693|76172395|FG001|Overall Study|Death|1|||
42334667|NCT01824693|76172396|FG002|Overall Study|Death|0|||
42334668|NCT01824693|76172394|FG000|Overall Study|Physician Decision|1|||
42334669|NCT01824693|76172395|FG001|Overall Study|Physician Decision|1|||
42334670|NCT01824693|76172396|FG002|Overall Study|Physician Decision|1|||
42334671|NCT01824693|76172394|FG000|Overall Study|Withdrawal by Subject|0|||
42334672|NCT01824693|76172395|FG001|Overall Study|Withdrawal by Subject|0|||
42334673|NCT01824693|76172396|FG002|Overall Study|Withdrawal by Subject|1|||
42334674|NCT01824693|76172394|FG000|Overall Study|Progressive Disease|0|||
42334675|NCT01824693|76172395|FG001|Overall Study|Progressive Disease|5|||
42334676|NCT01824693|76172396|FG002|Overall Study|Progressive Disease|0|||
42334677|NCT01824693|76172394|FG000|Overall Study|Ineligible|0|||
42334678|NCT01824693|76172395|FG001|Overall Study|Ineligible|0|||
42334679|NCT01824693|76172396|FG002|Overall Study|Ineligible|3|||
42334680|NCT01824693|76172394|FG000|Overall Study|No Transplant Planned|0|||
42334681|NCT01824693|76172395|FG001|Overall Study|No Transplant Planned|0|||
42334682|NCT01824693|76172396|FG002|Overall Study|No Transplant Planned|10|||
42334683|NCT02176655|76172403|FG000|Overall Study|Subjects did not treat|6|||
42334684|NCT02125331|76172410|FG000|Overall Study|Protocol Violation|1|||
42334685|NCT02125331|76172411|FG001|Overall Study|Protocol Violation|0|||
42334686|NCT02125331|76172410|FG000|Overall Study|technical problem|2|||
42334687|NCT02125331|76172411|FG001|Overall Study|technical problem|0|||
42334688|NCT02125331|76172410|FG000|Overall Study|screen failure|2|||
42334689|NCT02125331|76172411|FG001|Overall Study|screen failure|0|||
42334690|NCT01622569|76172421|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
42334691|NCT01622569|76172422|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
42334692|NCT01622569|76172423|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
42334693|NCT01622569|76172424|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
42334694|NCT01622569|76172421|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
42334695|NCT01622569|76172422|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
42334696|NCT01622569|76172423|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
42334697|NCT01622569|76172424|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
42334698|NCT01622569|76172421|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
42334699|NCT01622569|76172422|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
42334700|NCT01622569|76172423|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
42334701|NCT01622569|76172424|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
42334702|NCT01622569|76172421|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
42334703|NCT01622569|76172422|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
42334704|NCT01622569|76172423|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
42334705|NCT01622569|76172424|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
42334706|NCT01622569|76172421|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
42334707|NCT01622569|76172422|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
42334708|NCT01622569|76172423|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
42334709|NCT01622569|76172424|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
42334710|NCT01622569|76172421|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
42334711|NCT01622569|76172422|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
42334712|NCT01622569|76172423|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
42334713|NCT01622569|76172424|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
42334714|NCT01622569|76172421|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
42334715|NCT01622569|76172422|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
42334716|NCT01622569|76172423|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
42334717|NCT01622569|76172424|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
42334718|NCT01622569|76172421|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
42334719|NCT01622569|76172422|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
42334720|NCT01622569|76172423|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
42334721|NCT01622569|76172424|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
42334722|NCT01824303|76172446|FG000|Randomized Study|Withdrawal by Subject|1|||
42334723|NCT01824303|76172447|FG001|Randomized Study|Withdrawal by Subject|1|||
42334724|NCT01824303|76172446|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
42334725|NCT01824303|76172447|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
42334726|NCT01853397|76172459|FG000|Overall Study|Withdrawal by Subject|0|||
42334727|NCT01853397|76172460|FG001|Overall Study|Withdrawal by Subject|0|||
42334728|NCT01853397|76172461|FG002|Overall Study|Withdrawal by Subject|0|||
42334729|NCT01853397|76172462|FG003|Overall Study|Withdrawal by Subject|1|||
42334730|NCT01853397|76172459|FG000|Overall Study|Subject Noncompliance|0|||
42334731|NCT01853397|76172460|FG001|Overall Study|Subject Noncompliance|0|||
42334732|NCT01853397|76172461|FG002|Overall Study|Subject Noncompliance|0|||
42334733|NCT01853397|76172462|FG003|Overall Study|Subject Noncompliance|1|||
42334734|NCT02088073|76172477|FG000|Acute Phase|Withdrawal by Subject|5|||
42334735|NCT02088073|76172478|FG001|Acute Phase|Withdrawal by Subject|0|||
42334736|NCT02088073|76172479|FG002|Acute Phase|Withdrawal by Subject|0|||
42334737|NCT02088073|76172480|FG003|Acute Phase|Withdrawal by Subject|0|||
42334738|NCT02088073|76172481|FG004|Acute Phase|Withdrawal by Subject|0|||
42334739|NCT02088073|76172477|FG000|Acute Phase|Hyperkalemia|2|||
42334740|NCT02088073|76172478|FG001|Acute Phase|Hyperkalemia|0|||
42334741|NCT02088073|76172479|FG002|Acute Phase|Hyperkalemia|0|||
42334742|NCT02088073|76172480|FG003|Acute Phase|Hyperkalemia|0|||
42334743|NCT02088073|76172481|FG004|Acute Phase|Hyperkalemia|0|||
42334744|NCT02088073|76172477|FG000|Maintanance Phase|Withdrawal by Subject|0|||
42264916|NCT02806973|76092917|FG001|Period 3|Adverse Event|0|||
42264917|NCT02806973|76092918|FG002|Period 3|Adverse Event|1|||
42264918|NCT02806973|76092919|FG003|Period 3|Adverse Event|0|||
42264919|NCT02806505|76092931|FG000|Overall Study|Adverse event/intercurrent illness|1|||
42334745|NCT02088073|76172478|FG001|Maintanance Phase|Withdrawal by Subject|2|||
42334746|NCT02088073|76172479|FG002|Maintanance Phase|Withdrawal by Subject|0|||
42334747|NCT02088073|76172480|FG003|Maintanance Phase|Withdrawal by Subject|0|||
42334748|NCT02088073|76172481|FG004|Maintanance Phase|Withdrawal by Subject|0|||
42334749|NCT02088073|76172477|FG000|Maintanance Phase|Adverse Event|0|||
42334750|NCT02088073|76172478|FG001|Maintanance Phase|Adverse Event|0|||
42334751|NCT02088073|76172479|FG002|Maintanance Phase|Adverse Event|3|||
42334752|NCT02088073|76172480|FG003|Maintanance Phase|Adverse Event|0|||
42334753|NCT02088073|76172481|FG004|Maintanance Phase|Adverse Event|1|||
42334754|NCT02088073|76172477|FG000|Maintanance Phase|Physician Decision|0|||
42334755|NCT02088073|76172478|FG001|Maintanance Phase|Physician Decision|0|||
42334756|NCT02088073|76172479|FG002|Maintanance Phase|Physician Decision|0|||
42334757|NCT02088073|76172480|FG003|Maintanance Phase|Physician Decision|0|||
42334758|NCT02088073|76172481|FG004|Maintanance Phase|Physician Decision|1|||
42334759|NCT02088073|76172477|FG000|Maintanance Phase|Sponsor's decision|0|||
42134568|NCT00548405|75945460|FG000|Overall Study|Withdrawal by Subject|36|||
42264920|NCT02806505|76092932|FG001|Overall Study|Adverse event/intercurrent illness|3|||
42264921|NCT02806505|76092931|FG000|Overall Study|Death|4|||
42264922|NCT02806505|76092932|FG001|Overall Study|Death|0|||
42264923|NCT02806505|76092931|FG000|Overall Study|Did not cooperate/refused treatment|3|||
42264924|NCT02806505|76092932|FG001|Overall Study|Did not cooperate/refused treatment|3|||
42264925|NCT02806505|76092931|FG000|Overall Study|Failure to return|0|||
42334760|NCT02088073|76172478|FG001|Maintanance Phase|Sponsor's decision|2|||
42334761|NCT02088073|76172479|FG002|Maintanance Phase|Sponsor's decision|0|||
42334762|NCT02088073|76172480|FG003|Maintanance Phase|Sponsor's decision|2|||
42334763|NCT02088073|76172481|FG004|Maintanance Phase|Sponsor's decision|1|||
42134569|NCT00548405|75945461|FG001|Overall Study|Withdrawal by Subject|12|||
42264926|NCT02806505|76092932|FG001|Overall Study|Failure to return|1|||
42264927|NCT02806505|76092931|FG000|Overall Study|Insufficient therapeutic response|2|||
42264928|NCT02806505|76092932|FG001|Overall Study|Insufficient therapeutic response|4|||
42264929|NCT02807363|76092942|FG000|Dosing Period|Adverse Event|0|||
42334764|NCT02088073|76172477|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
42334765|NCT02088073|76172478|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
42334766|NCT02088073|76172479|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
42264930|NCT02807363|76092943|FG001|Dosing Period|Adverse Event|1|||
42334767|NCT02088073|76172480|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
42334768|NCT02088073|76172481|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
42334769|NCT02088073|76172477|FG000|Maintanance Phase|Miscellaneous|0|||
42264931|NCT02807363|76092944|FG002|Dosing Period|Adverse Event|0|||
42264932|NCT02807363|76092945|FG003|Dosing Period|Adverse Event|0|||
42334770|NCT02088073|76172478|FG001|Maintanance Phase|Miscellaneous|2|||
42334771|NCT02088073|76172479|FG002|Maintanance Phase|Miscellaneous|1|||
42334772|NCT02088073|76172480|FG003|Maintanance Phase|Miscellaneous|2|||
42334773|NCT02088073|76172481|FG004|Maintanance Phase|Miscellaneous|1|||
42334774|NCT02088073|76172477|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
42334775|NCT02088073|76172478|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
42334776|NCT02088073|76172479|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
42334777|NCT02088073|76172480|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
42264933|NCT02383966|76092959|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
42264934|NCT02383966|76092960|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
42264935|NCT02383966|76092959|FG000|Overall Study|Randomized, but not treated|1|||
42264936|NCT02383966|76092960|FG001|Overall Study|Randomized, but not treated|3|||
42264937|NCT02383576|76092968|FG000|Overall Study|Death|53|||
42264938|NCT02383576|76092969|FG001|Overall Study|Death|33|||
42264939|NCT02383576|76092968|FG000|Overall Study|Lost to Follow-up|7|||
42264940|NCT02383576|76092969|FG001|Overall Study|Lost to Follow-up|1|||
42334778|NCT02088073|76172481|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
42334779|NCT02088073|76172477|FG000|Maintanance Phase|Subject compliance|0|||
42334780|NCT02088073|76172478|FG001|Maintanance Phase|Subject compliance|1|||
42334781|NCT02088073|76172479|FG002|Maintanance Phase|Subject compliance|0|||
42334782|NCT02088073|76172480|FG003|Maintanance Phase|Subject compliance|0|||
42264941|NCT02383576|76092968|FG000|Overall Study|Withdrew Consent|1|||
42264942|NCT02383576|76092969|FG001|Overall Study|Withdrew Consent|6|||
42264943|NCT02383576|76092968|FG000|Overall Study|Investigator's Decision|0|||
42334783|NCT02088073|76172481|FG004|Maintanance Phase|Subject compliance|0|||
42334784|NCT01823991|76172496|FG000|Overall Study|Withdrawal by Subject|8|||
42000115|NCT01193218|75808628|FG002|0-12 Weeks|Protocol Violation|0|||
42000116|NCT01193218|75808629|FG003|0-12 Weeks|Protocol Violation|0|||
42000117|NCT01193218|75808630|FG004|0-12 Weeks|Protocol Violation|1|||
42000118|NCT01193218|75808631|FG005|0-12 Weeks|Protocol Violation|1|||
42000119|NCT01193218|75808632|FG006|0-12 Weeks|Protocol Violation|0|||
42000120|NCT01193218|75808633|FG007|0-12 Weeks|Protocol Violation|0|||
42000121|NCT01193218|75808626|FG000|0-12 Weeks|Withdrawal by Subject|3|||
42000122|NCT01193218|75808627|FG001|0-12 Weeks|Withdrawal by Subject|0|||
42000123|NCT01193218|75808628|FG002|0-12 Weeks|Withdrawal by Subject|2|||
42264944|NCT02383576|76092969|FG001|Overall Study|Investigator's Decision|1|||
42334785|NCT01823991|76172497|FG001|Overall Study|Withdrawal by Subject|5|||
42334786|NCT02087059|76172507|FG000|Overall Study|Disease Progression|1|||
42334787|NCT02087059|76172507|FG000|Overall Study|Adverse Event|5|||
42000124|NCT01193218|75808629|FG003|0-12 Weeks|Withdrawal by Subject|0|||
42000125|NCT01193218|75808630|FG004|0-12 Weeks|Withdrawal by Subject|0|||
42000126|NCT01193218|75808631|FG005|0-12 Weeks|Withdrawal by Subject|0|||
42264945|NCT02383576|76092968|FG000|Overall Study|Administrative/Other|2|||
42334788|NCT02087059|76172507|FG000|Overall Study|Lost to Follow-up|1|||
42334789|NCT02152163|76172513|FG000|Overall Study|Physician Decision|12|||
42334790|NCT02152163|76172514|FG001|Overall Study|Physician Decision|13|||
42346932|NCT01707147|76185972|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
42346933|NCT01876251|76185979|FG000|Overall Study|Clinical progression|1|||
42346934|NCT01876251|76185980|FG001|Overall Study|Clinical progression|0|||
42346935|NCT01876251|76185981|FG002|Overall Study|Clinical progression|0|||
42346936|NCT01876251|76185979|FG000|Overall Study|Death|2|||
42346937|NCT01876251|76185980|FG001|Overall Study|Death|0|||
42346938|NCT01876251|76185981|FG002|Overall Study|Death|1|||
42346939|NCT01876251|76185979|FG000|Overall Study|Participant started new treatment|1|||
42346940|NCT01876251|76185980|FG001|Overall Study|Participant started new treatment|0|||
42346941|NCT01876251|76185981|FG002|Overall Study|Participant started new treatment|1|||
42346942|NCT01876251|76185979|FG000|Overall Study|Participant refused further follow-up|0|||
42346943|NCT01876251|76185980|FG001|Overall Study|Participant refused further follow-up|0|||
42346944|NCT01876251|76185981|FG002|Overall Study|Participant refused further follow-up|1|||
42346945|NCT01876251|76185979|FG000|Overall Study|Study terminated|1|||
42346946|NCT01876251|76185980|FG001|Overall Study|Study terminated|0|||
42346947|NCT01876251|76185981|FG002|Overall Study|Study terminated|0|||
42346948|NCT01876251|76185979|FG000|Overall Study|Objective progression or relapse|10|||
42346949|NCT01876251|76185980|FG001|Overall Study|Objective progression or relapse|3|||
42346950|NCT01876251|76185981|FG002|Overall Study|Objective progression or relapse|8|||
42346951|NCT01875471|76185992|FG000|Overall Study|Adverse Event|0|||
42346952|NCT01875471|76185993|FG001|Overall Study|Adverse Event|1|||
42346953|NCT01875471|76185992|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
42346954|NCT01875471|76185993|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
42346955|NCT01875237|76186001|FG000|Overall Study|GVDH before DLI|1|||
42346956|NCT01875237|76186002|FG001|Overall Study|GVDH before DLI|0|||
42346957|NCT01875237|76186001|FG000|Overall Study|DLI cells could not be produced|1|||
42346958|NCT01875237|76186002|FG001|Overall Study|DLI cells could not be produced|0|||
42346959|NCT01874535|76186012|FG000|Overall Study|Lost to Follow-up|10|||
42346960|NCT01874535|76186013|FG001|Overall Study|Lost to Follow-up|9|||
42346961|NCT01874535|76186012|FG000|Overall Study|incomplete symptom resolution|45|||
42346962|NCT01874535|76186013|FG001|Overall Study|incomplete symptom resolution|35|||
42346963|NCT01722045|76186019|FG000|Overall Study|Adverse Event|8|||
42346964|NCT01722045|76186019|FG000|Overall Study|Death|3|||
42346965|NCT01722045|76186019|FG000|Overall Study|Withdrawal by Subject|8|||
42346966|NCT01722045|76186019|FG000|Overall Study|Lost to Follow-up|4|||
42346967|NCT01722045|76186019|FG000|Overall Study|Protocol Deviation|1|||
42346968|NCT01722045|76186019|FG000|Overall Study|Physician Decision|3|||
42346969|NCT01722045|76186019|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
42346970|NCT01721109|76186023|FG000|Overall Study|Lack of Efficacy|1|||
42346971|NCT01721109|76186023|FG000|Overall Study|Non- Compliance with Study Drug|3|||
42346972|NCT01721109|76186023|FG000|Overall Study|Withdrew Consent|1|||
42346973|NCT01721109|76186023|FG000|Overall Study|Lost to Follow-up|2|||
42346974|NCT01874145|76186029|FG000|Core Period|Non-compliance|1|||
42000127|NCT01193218|75808632|FG006|0-12 Weeks|Withdrawal by Subject|1|||
42264946|NCT02383576|76092969|FG001|Overall Study|Administrative/Other|4|||
42264947|NCT02748317|76092975|FG000|Overall Study|Withdrawal by Subject|14|||
42264948|NCT02748317|76092975|FG000|Overall Study|Lost to Follow-up|8|||
42264949|NCT02748317|76092975|FG000|Overall Study|Death|1|||
42264950|NCT02426086|76092981|FG000|Overall Study|Death|33|||
42264951|NCT02426086|76092982|FG001|Overall Study|Death|36|||
42264952|NCT02426086|76092981|FG000|Overall Study|Lost to Follow-up|2|||
42264953|NCT02426086|76092982|FG001|Overall Study|Lost to Follow-up|0|||
42346975|NCT01874145|76186030|FG001|Core Period|Non-compliance|0|||
42000128|NCT01193218|75808633|FG007|0-12 Weeks|Withdrawal by Subject|0|||
42000129|NCT01193218|75808626|FG000|12-52 Weeks|Adverse Event|1|||
42134570|NCT00548405|75945462|FG002|Overall Study|Withdrawal by Subject|5|||
42346976|NCT01874145|76186029|FG000|Core Period|Protocol Violation|1|||
42346977|NCT01874145|76186030|FG001|Core Period|Protocol Violation|1|||
42346978|NCT01874145|76186029|FG000|Core Period|Physician Decision|1|||
42346979|NCT01874145|76186030|FG001|Core Period|Physician Decision|1|||
42346980|NCT01874145|76186029|FG000|Core Period|Adverse Event|0|||
42346981|NCT01874145|76186030|FG001|Core Period|Adverse Event|1|||
42346982|NCT01874145|76186029|FG000|Core Period|Withdrawal by Subject|0|||
42346983|NCT01874145|76186030|FG001|Core Period|Withdrawal by Subject|4|||
42346984|NCT01874145|76186029|FG000|Extension Period|Adverse Event|3|||
42346985|NCT01874145|76186030|FG001|Extension Period|Adverse Event|2|||
42134571|NCT00548405|75945460|FG000|Overall Study|Lost to Follow-up|1|||
42000130|NCT01193218|75808627|FG001|12-52 Weeks|Adverse Event|0|||
42264954|NCT02426086|76092981|FG000|Overall Study|Study Terminated by Sponsor|5|||
42334791|NCT02152007|76172520|FG000|Overall Study|Withdrawal by Subject|1|||
42334792|NCT02151851|76172527|FG000|Overall Study|Lack of Efficacy|67|||
42334793|NCT02151851|76172528|FG001|Overall Study|Lack of Efficacy|94|||
42334794|NCT02151851|76172527|FG000|Overall Study|Protocol Violation|0|||
42334795|NCT02151851|76172528|FG001|Overall Study|Protocol Violation|1|||
42334796|NCT02151851|76172527|FG000|Overall Study|Withdrawal by Subject|2|||
42334797|NCT02151851|76172528|FG001|Overall Study|Withdrawal by Subject|5|||
42334798|NCT02151851|76172527|FG000|Overall Study|Medical impairment|1|||
42334799|NCT02151851|76172528|FG001|Overall Study|Medical impairment|0|||
42334800|NCT02151851|76172527|FG000|Overall Study|Low compliance to study visits|0|||
42334801|NCT02151851|76172528|FG001|Overall Study|Low compliance to study visits|1|||
42334802|NCT02151851|76172527|FG000|Overall Study|Subject entered into study in error|0|||
42334803|NCT02151851|76172528|FG001|Overall Study|Subject entered into study in error|1|||
42334804|NCT02151851|76172527|FG000|Overall Study|Adverse Event|6|||
42334805|NCT02151851|76172528|FG001|Overall Study|Adverse Event|28|||
42334806|NCT02176421|76172534|FG000|Overall Study|Lost to Follow-up|4|||
42334807|NCT02176421|76172534|FG000|Overall Study|Adverse Event|1|||
42334808|NCT02042443|76172540|FG000|Overall Study|Adverse Event|2|||
42334809|NCT02042443|76172541|FG001|Overall Study|Adverse Event|1|||
42334810|NCT02042443|76172540|FG000|Overall Study|Withdrawal by Subject|0|||
42334811|NCT02042443|76172541|FG001|Overall Study|Withdrawal by Subject|1|||
42334812|NCT02042443|76172540|FG000|Overall Study|Progression|21|||
42334813|NCT02042443|76172541|FG001|Overall Study|Progression|17|||
42334814|NCT02042443|76172540|FG000|Overall Study|not protocol specified|1|||
42334815|NCT02042443|76172541|FG001|Overall Study|not protocol specified|1|||
42334816|NCT02042443|76172540|FG000|Overall Study|Not eligible/not analyzable|3|||
42334817|NCT02042443|76172541|FG001|Overall Study|Not eligible/not analyzable|6|||
42334818|NCT02118896|76172558|FG000|Overall Study|Death|4|||
42334819|NCT02118896|76172559|FG001|Overall Study|Death|0|||
42334820|NCT02118896|76172560|FG002|Overall Study|Death|4|||
42334821|NCT02118896|76172561|FG003|Overall Study|Death|6|||
42264955|NCT02426086|76092982|FG001|Overall Study|Study Terminated by Sponsor|14|||
42264956|NCT02426086|76092981|FG000|Overall Study|Withdrawal by Subject|8|||
42264957|NCT02426086|76092982|FG001|Overall Study|Withdrawal by Subject|9|||
42264958|NCT02422264|76092995|FG000|Overall Study|Serious Adverse Event|1|||
42264959|NCT02422264|76092996|FG001|Overall Study|Serious Adverse Event|0|||
42334822|NCT02118896|76172562|FG004|Overall Study|Death|3|||
42334823|NCT02118896|76172563|FG005|Overall Study|Death|1|||
42334824|NCT02118896|76172564|FG006|Overall Study|Death|0|||
42334825|NCT02118896|76172565|FG007|Overall Study|Death|0|||
42334826|NCT02118896|76172566|FG008|Overall Study|Death|0|||
42334827|NCT02118896|76172567|FG009|Overall Study|Death|0|||
42264960|NCT02422264|76092995|FG000|Overall Study|Withdrawal by Subject|1|||
42264961|NCT02422264|76092996|FG001|Overall Study|Withdrawal by Subject|2|||
42264962|NCT02422264|76092995|FG000|Overall Study|Migrated/moved from study area|3|||
42334828|NCT02118896|76172558|FG000|Overall Study|Adverse Event|5|||
42334829|NCT02118896|76172559|FG001|Overall Study|Adverse Event|4|||
42334830|NCT02118896|76172560|FG002|Overall Study|Adverse Event|4|||
42264963|NCT02422264|76092996|FG001|Overall Study|Migrated/moved from study area|1|||
42334831|NCT02118896|76172561|FG003|Overall Study|Adverse Event|5|||
42334832|NCT02118896|76172562|FG004|Overall Study|Adverse Event|5|||
42334833|NCT02118896|76172563|FG005|Overall Study|Adverse Event|9|||
42264964|NCT02422264|76092995|FG000|Overall Study|Subject vaccinated outside of the study|0|||
42334834|NCT02118896|76172564|FG006|Overall Study|Adverse Event|1|||
42334835|NCT02118896|76172565|FG007|Overall Study|Adverse Event|1|||
42334836|NCT02118896|76172566|FG008|Overall Study|Adverse Event|4|||
42334837|NCT02118896|76172567|FG009|Overall Study|Adverse Event|0|||
42334838|NCT02118896|76172558|FG000|Overall Study|Consent withdrawn|2|||
42334839|NCT02118896|76172559|FG001|Overall Study|Consent withdrawn|0|||
42334840|NCT02118896|76172560|FG002|Overall Study|Consent withdrawn|3|||
42334841|NCT02118896|76172561|FG003|Overall Study|Consent withdrawn|4|||
42334842|NCT02118896|76172562|FG004|Overall Study|Consent withdrawn|1|||
42334843|NCT02118896|76172563|FG005|Overall Study|Consent withdrawn|4|||
42334844|NCT02118896|76172564|FG006|Overall Study|Consent withdrawn|0|||
42334845|NCT02118896|76172565|FG007|Overall Study|Consent withdrawn|0|||
42334846|NCT02118896|76172566|FG008|Overall Study|Consent withdrawn|0|||
42334847|NCT02118896|76172567|FG009|Overall Study|Consent withdrawn|0|||
42334848|NCT02118896|76172558|FG000|Overall Study|Non-compliance|2|||
42334849|NCT02118896|76172559|FG001|Overall Study|Non-compliance|1|||
42334850|NCT02118896|76172560|FG002|Overall Study|Non-compliance|1|||
42334851|NCT02118896|76172561|FG003|Overall Study|Non-compliance|5|||
42334852|NCT02118896|76172562|FG004|Overall Study|Non-compliance|0|||
42334853|NCT02118896|76172563|FG005|Overall Study|Non-compliance|1|||
42334854|NCT02118896|76172564|FG006|Overall Study|Non-compliance|0|||
42334855|NCT02118896|76172565|FG007|Overall Study|Non-compliance|1|||
42334856|NCT02118896|76172566|FG008|Overall Study|Non-compliance|0|||
42334857|NCT02118896|76172567|FG009|Overall Study|Non-compliance|0|||
42334858|NCT02118896|76172558|FG000|Overall Study|Pregnancy|1|||
42264965|NCT02422264|76092996|FG001|Overall Study|Subject vaccinated outside of the study|1|||
42264966|NCT02390362|76093004|FG000|Overall Study|Withdrawal by Subject|0|||
42264967|NCT02390362|76093005|FG001|Overall Study|Withdrawal by Subject|1|||
42264968|NCT02389894|76093014|FG000|Overall Study|Death|4|||
42264969|NCT02389894|76093015|FG001|Overall Study|Death|5|||
42264970|NCT02389894|76093016|FG002|Overall Study|Death|3|||
42264971|NCT02389894|76093014|FG000|Overall Study|Withdrawal by Subject|2|||
42264972|NCT02389894|76093015|FG001|Overall Study|Withdrawal by Subject|4|||
42264973|NCT02389894|76093016|FG002|Overall Study|Withdrawal by Subject|5|||
42264974|NCT02389894|76093014|FG000|Overall Study|Lost to Follow-up|2|||
42264975|NCT02389894|76093015|FG001|Overall Study|Lost to Follow-up|1|||
42264976|NCT02389894|76093016|FG002|Overall Study|Lost to Follow-up|1|||
42264977|NCT02389816|76093027|FG000|Overall Study|Randomized but Not Treated|1|||
42264978|NCT02389816|76093028|FG001|Overall Study|Randomized but Not Treated|0|||
42264979|NCT02389816|76093029|FG002|Overall Study|Randomized but Not Treated|0|||
42264980|NCT02389816|76093027|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
42264981|NCT02389816|76093028|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
42264982|NCT02389816|76093029|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
42264983|NCT02389816|76093027|FG000|Overall Study|Major Protocol Deviation|1|||
42264984|NCT02389816|76093028|FG001|Overall Study|Major Protocol Deviation|0|||
42334859|NCT02118896|76172559|FG001|Overall Study|Pregnancy|1|||
42334860|NCT02118896|76172560|FG002|Overall Study|Pregnancy|0|||
42334861|NCT02118896|76172561|FG003|Overall Study|Pregnancy|0|||
42334862|NCT02118896|76172562|FG004|Overall Study|Pregnancy|1|||
42334863|NCT02118896|76172563|FG005|Overall Study|Pregnancy|3|||
42334864|NCT02118896|76172564|FG006|Overall Study|Pregnancy|1|||
42334865|NCT02118896|76172565|FG007|Overall Study|Pregnancy|0|||
42334866|NCT02118896|76172566|FG008|Overall Study|Pregnancy|0|||
42334867|NCT02118896|76172567|FG009|Overall Study|Pregnancy|0|||
42334868|NCT02118896|76172558|FG000|Overall Study|Lost to Follow-up|1|||
42334869|NCT02118896|76172559|FG001|Overall Study|Lost to Follow-up|2|||
42334870|NCT02118896|76172560|FG002|Overall Study|Lost to Follow-up|1|||
42334871|NCT02118896|76172561|FG003|Overall Study|Lost to Follow-up|0|||
42334872|NCT02118896|76172562|FG004|Overall Study|Lost to Follow-up|2|||
42334873|NCT02118896|76172563|FG005|Overall Study|Lost to Follow-up|1|||
42334874|NCT02118896|76172564|FG006|Overall Study|Lost to Follow-up|0|||
42334875|NCT02118896|76172565|FG007|Overall Study|Lost to Follow-up|0|||
42334876|NCT02118896|76172566|FG008|Overall Study|Lost to Follow-up|0|||
42334877|NCT02118896|76172567|FG009|Overall Study|Lost to Follow-up|0|||
42334878|NCT02118896|76172558|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
42264985|NCT02389816|76093029|FG002|Overall Study|Major Protocol Deviation|0|||
42264986|NCT02389816|76093027|FG000|Overall Study|Lost to Follow-up|1|||
42264987|NCT02389816|76093028|FG001|Overall Study|Lost to Follow-up|0|||
42334879|NCT02118896|76172559|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
42334880|NCT02118896|76172560|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
42334881|NCT02118896|76172561|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
42334882|NCT02118896|76172562|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
42264988|NCT02389816|76093029|FG002|Overall Study|Lost to Follow-up|0|||
42264989|NCT02389816|76093027|FG000|Overall Study|Withdrawal of Consent|6|||
42264990|NCT02389816|76093028|FG001|Overall Study|Withdrawal of Consent|4|||
42334883|NCT02118896|76172563|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
42334884|NCT02118896|76172564|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
42334885|NCT02118896|76172565|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
42334886|NCT02118896|76172566|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
42334887|NCT02118896|76172567|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
42334888|NCT02118896|76172558|FG000|Overall Study|Prohibited medication|0|||
42264991|NCT02389816|76093029|FG002|Overall Study|Withdrawal of Consent|4|||
42264992|NCT02389816|76093027|FG000|Overall Study|Lack of Efficacy|1|||
42264993|NCT02389816|76093028|FG001|Overall Study|Lack of Efficacy|0|||
42264994|NCT02389816|76093029|FG002|Overall Study|Lack of Efficacy|0|||
42264995|NCT02389816|76093027|FG000|Overall Study|Non Compliance with Study Drug|1|||
42264996|NCT02389816|76093028|FG001|Overall Study|Non Compliance with Study Drug|1|||
42264997|NCT02389816|76093029|FG002|Overall Study|Non Compliance with Study Drug|1|||
42264998|NCT02389816|76093027|FG000|Overall Study|Reason not Specified|0|||
42264999|NCT02389816|76093028|FG001|Overall Study|Reason not Specified|2|||
42265000|NCT02389816|76093029|FG002|Overall Study|Reason not Specified|0|||
42265001|NCT02388724|76093039|FG000|Overall Study|Reason not Specified|0|||
42265002|NCT02388724|76093040|FG001|Overall Study|Reason not Specified|1|||
42265003|NCT02388724|76093039|FG000|Overall Study|Major Protocol Deviation|3|||
42265004|NCT02388724|76093040|FG001|Overall Study|Major Protocol Deviation|3|||
42334889|NCT02118896|76172559|FG001|Overall Study|Prohibited medication|0|||
42134572|NCT00548405|75945461|FG001|Overall Study|Lost to Follow-up|1|||
42265005|NCT02388724|76093039|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
42334890|NCT02118896|76172560|FG002|Overall Study|Prohibited medication|0|||
42265006|NCT02388724|76093040|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
42334891|NCT02118896|76172561|FG003|Overall Study|Prohibited medication|0|||
42334892|NCT02118896|76172562|FG004|Overall Study|Prohibited medication|1|||
42334893|NCT02118896|76172563|FG005|Overall Study|Prohibited medication|3|||
42334894|NCT02118896|76172564|FG006|Overall Study|Prohibited medication|0|||
42334895|NCT02118896|76172565|FG007|Overall Study|Prohibited medication|0|||
42334896|NCT02118896|76172566|FG008|Overall Study|Prohibited medication|0|||
42334897|NCT02118896|76172567|FG009|Overall Study|Prohibited medication|0|||
42334898|NCT02118896|76172558|FG000|Overall Study|Miscellaneous|1|||
42334899|NCT02118896|76172559|FG001|Overall Study|Miscellaneous|2|||
42334900|NCT02118896|76172560|FG002|Overall Study|Miscellaneous|0|||
42334901|NCT02118896|76172561|FG003|Overall Study|Miscellaneous|2|||
42334902|NCT02118896|76172562|FG004|Overall Study|Miscellaneous|0|||
42265007|NCT02388724|76093039|FG000|Overall Study|Voluntary Withdrawal|6|||
42265008|NCT02388724|76093040|FG001|Overall Study|Voluntary Withdrawal|5|||
42265009|NCT02388724|76093039|FG000|Overall Study|Randomized but not Treated|0|||
42265010|NCT02388724|76093040|FG001|Overall Study|Randomized but not Treated|2|||
42265011|NCT02382796|76093046|FG000|Overall Study|Global deterioration of health status|1|||
42265012|NCT02382796|76093046|FG000|Overall Study|Objective progression or relapse|3|||
42265013|NCT02382796|76093046|FG000|Overall Study|Commercial dacomitinib became available|3|||
42265014|NCT02382640|76093054|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
42265015|NCT02382640|76093055|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
42265016|NCT02382640|76093056|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
42265017|NCT02382640|76093057|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
42265018|NCT02801669|76093069|FG000|Overall Study|Death|66|||
42265019|NCT02801669|76093070|FG001|Overall Study|Death|69|||
42265020|NCT02801669|76093069|FG000|Overall Study|Withdrawal by Subject|81|||
42265021|NCT02801669|76093070|FG001|Overall Study|Withdrawal by Subject|77|||
42265022|NCT02801669|76093069|FG000|Overall Study|Other|4|||
42265023|NCT02801669|76093070|FG001|Overall Study|Other|6|||
42265024|NCT02804399|76093076|FG000|Period 2|Adverse Event|0|||
42265025|NCT02804399|76093077|FG001|Period 2|Adverse Event|1|||
42265026|NCT01333943|76093088|FG000|Overall Study|Known neuropathy|1|||
42265027|NCT01333943|76093089|FG001|Overall Study|Known neuropathy|0|||
42265028|NCT01333865|76093095|FG000|Overall Study|Adverse Event|2|||
42265029|NCT01333475|76093101|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
42265030|NCT01333475|76093102|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
42265031|NCT01333475|76093101|FG000|Overall Study|Toxicity|1|||
42265032|NCT01333475|76093102|FG001|Overall Study|Toxicity|3|||
42265033|NCT01333397|76093114|FG000|Overall Study|Lost to Follow-up|1|||
42265034|NCT01333397|76093115|FG001|Overall Study|Lost to Follow-up|0|||
42265035|NCT01333397|76093116|FG002|Overall Study|Lost to Follow-up|0|||
42265036|NCT01333397|76093117|FG003|Overall Study|Lost to Follow-up|1|||
42265037|NCT01333397|76093118|FG004|Overall Study|Lost to Follow-up|0|||
42265038|NCT02798861|76093139|FG000|Overall Study|Lost to Follow-up|22|||
42265039|NCT02798861|76093139|FG000|Overall Study|Withdrawal by Subject|1|||
42265040|NCT02798315|76093143|FG000|Overall Study|Failure to return|1|||
42265041|NCT02796755|76093149|FG000|Overall Study|Adverse Event|2|||
42265042|NCT02796755|76093150|FG001|Overall Study|Adverse Event|0|||
42265043|NCT02382016|76093158|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
42265044|NCT02382016|76093159|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
42265045|NCT02382016|76093158|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
42265046|NCT02382016|76093159|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
42265047|NCT02382016|76093158|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
42265048|NCT02382016|76093159|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
42265049|NCT02382016|76093158|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
42265050|NCT02382016|76093159|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
42265051|NCT02382016|76093158|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
42265052|NCT02382016|76093159|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
42265053|NCT02382016|76093158|FG000|Open-label (OL) Treatment Period|Death|4|||
42265054|NCT02382016|76093159|FG001|Open-label (OL) Treatment Period|Death|0|||
42265055|NCT02382016|76093158|FG000|OL Extension Period|Physician Decision|3|||
42265056|NCT02382016|76093159|FG001|OL Extension Period|Physician Decision|0|||
42334903|NCT02118896|76172563|FG005|Overall Study|Miscellaneous|4|||
42334904|NCT02118896|76172564|FG006|Overall Study|Miscellaneous|0|||
42334905|NCT02118896|76172565|FG007|Overall Study|Miscellaneous|0|||
42000131|NCT01193218|75808628|FG002|12-52 Weeks|Adverse Event|1|||
42000132|NCT01193218|75808629|FG003|12-52 Weeks|Adverse Event|2|||
42265057|NCT02382016|76093158|FG000|OL Extension Period|Death|2|||
42265058|NCT02382016|76093159|FG001|OL Extension Period|Death|0|||
42265059|NCT02382016|76093158|FG000|OL Extension Period|Withdrawal by Subject|1|||
42265060|NCT02382016|76093159|FG001|OL Extension Period|Withdrawal by Subject|0|||
42334906|NCT02118896|76172566|FG008|Overall Study|Miscellaneous|0|||
42334907|NCT02118896|76172567|FG009|Overall Study|Miscellaneous|0|||
42265061|NCT02422186|76093169|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
42265062|NCT02422186|76093170|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
42265063|NCT02422186|76093169|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
42265064|NCT02422186|76093170|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
42265065|NCT02422186|76093169|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
42265066|NCT02422186|76093170|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
42265067|NCT02422186|76093169|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
42265068|NCT02422186|76093170|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
42265069|NCT02422186|76093169|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
42265070|NCT02422186|76093170|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
42265071|NCT02422186|76093169|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
42265072|NCT02422186|76093170|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
42265073|NCT02422186|76093169|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
42265074|NCT02422186|76093170|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
42265075|NCT02422186|76093169|FG000|Follow-up Phase (2 Weeks)|Other|3|||
42265076|NCT02422186|76093170|FG001|Follow-up Phase (2 Weeks)|Other|0|||
42265077|NCT02421952|76093178|FG000|Overall Study|Diary Not Returned|93|||
42265078|NCT02421952|76093178|FG000|Overall Study|Failed seriation task|13|||
42265079|NCT02421952|76093178|FG000|Overall Study|Subject uncooperative for baseline test|2|||
42265080|NCT02421952|76093178|FG000|Overall Study|Surgery cancelled|1|||
42265081|NCT02796677|76093189|FG000|Overall Study|Adverse Event|11|||
42265082|NCT02796677|76093190|FG001|Overall Study|Adverse Event|22|||
42334908|NCT02124707|76172590|FG000|Overall Study|Adverse Event|5|||
42000133|NCT01193218|75808630|FG004|12-52 Weeks|Adverse Event|3|||
42000134|NCT01193218|75808631|FG005|12-52 Weeks|Adverse Event|3|||
42334909|NCT02124707|76172590|FG000|Overall Study|Physician Decision|1|||
42334910|NCT02124707|76172590|FG000|Overall Study|Death|1|||
42334911|NCT02067728|76172597|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
42334912|NCT02067728|76172598|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
42334913|NCT02067728|76172597|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
42334914|NCT02067728|76172598|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
42334915|NCT02067728|76172597|FG000|6 Month Measurements|Unable to attend|114|||
42334916|NCT02067728|76172598|FG001|6 Month Measurements|Unable to attend|97|||
42334917|NCT02118428|76172606|FG000|Overall Study|Physician Decision|0|||
42334918|NCT02118428|76172607|FG001|Overall Study|Physician Decision|1|||
42334919|NCT02118428|76172608|FG002|Overall Study|Physician Decision|0|||
42334920|NCT02118428|76172606|FG000|Overall Study|Withdrawal by Subject|2|||
42334921|NCT02118428|76172607|FG001|Overall Study|Withdrawal by Subject|2|||
42334922|NCT02118428|76172608|FG002|Overall Study|Withdrawal by Subject|0|||
42334923|NCT02118428|76172606|FG000|Overall Study|Death|7|||
42334924|NCT02118428|76172607|FG001|Overall Study|Death|5|||
42334925|NCT02118428|76172608|FG002|Overall Study|Death|0|||
42334926|NCT02118428|76172606|FG000|Overall Study|Lost to Follow-up|3|||
42334927|NCT02118428|76172607|FG001|Overall Study|Lost to Follow-up|1|||
42334928|NCT02118428|76172608|FG002|Overall Study|Lost to Follow-up|0|||
42334929|NCT02118428|76172606|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
42334930|NCT02118428|76172607|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
42334931|NCT02118428|76172608|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
42000135|NCT01193218|75808632|FG006|12-52 Weeks|Adverse Event|1|||
42265083|NCT02796677|76093191|FG002|Overall Study|Adverse Event|14|||
42265084|NCT02796677|76093192|FG003|Overall Study|Adverse Event|14|||
42265085|NCT02796677|76093189|FG000|Overall Study|Protocol Violation|7|||
42334932|NCT02067104|76172616|FG000|Overall Study|Study termination due to low accrual|4|||
42334933|NCT02067104|76172617|FG001|Overall Study|Study termination due to low accrual|5|||
42334934|NCT02092220|76172623|FG000|Period 1|Unrelated Illness|0|||
42334935|NCT02092220|76172624|FG001|Period 1|Unrelated Illness|2|||
42334936|NCT02092220|76172623|FG000|Period 2|Severe Hypoglycaemia|1|||
42334937|NCT02092220|76172624|FG001|Period 2|Severe Hypoglycaemia|0|||
42334938|NCT02092220|76172623|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
42334939|NCT02092220|76172624|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
42334940|NCT02066402|76172634|FG000|Overall Study|Adverse Event|1|||
42334941|NCT02066402|76172635|FG001|Overall Study|Adverse Event|2|||
42334942|NCT02066402|76172634|FG000|Overall Study|Lost to Follow-up|11|||
42334943|NCT02066402|76172635|FG001|Overall Study|Lost to Follow-up|8|||
42134573|NCT00548405|75945462|FG002|Overall Study|Lost to Follow-up|2|||
42134574|NCT00548405|75945460|FG000|Overall Study|Death|0|||
42134575|NCT00548405|75945461|FG001|Overall Study|Death|1|||
42134576|NCT00548405|75945462|FG002|Overall Study|Death|1|||
42134577|NCT00548405|75945460|FG000|Overall Study|Sponsor decision|1|||
42265086|NCT02796677|76093190|FG001|Overall Study|Protocol Violation|5|||
42265087|NCT02796677|76093191|FG002|Overall Study|Protocol Violation|4|||
42265088|NCT02796677|76093192|FG003|Overall Study|Protocol Violation|8|||
42265089|NCT02796677|76093189|FG000|Overall Study|Lost to Follow-up|1|||
42265090|NCT02796677|76093190|FG001|Overall Study|Lost to Follow-up|5|||
42265091|NCT02796677|76093191|FG002|Overall Study|Lost to Follow-up|2|||
42265092|NCT02796677|76093192|FG003|Overall Study|Lost to Follow-up|2|||
42265093|NCT02796677|76093189|FG000|Overall Study|Lack of Efficacy|7|||
42265094|NCT02796677|76093190|FG001|Overall Study|Lack of Efficacy|9|||
42265095|NCT02796677|76093191|FG002|Overall Study|Lack of Efficacy|14|||
42265096|NCT02796677|76093192|FG003|Overall Study|Lack of Efficacy|20|||
42265097|NCT02796677|76093189|FG000|Overall Study|Withdrawal by Subject|4|||
42265098|NCT02796677|76093190|FG001|Overall Study|Withdrawal by Subject|14|||
42265099|NCT02796677|76093191|FG002|Overall Study|Withdrawal by Subject|6|||
42265100|NCT02796677|76093192|FG003|Overall Study|Withdrawal by Subject|7|||
42265101|NCT02796677|76093189|FG000|Overall Study|Progressive disease|6|||
42265102|NCT02796677|76093190|FG001|Overall Study|Progressive disease|15|||
42265103|NCT02796677|76093191|FG002|Overall Study|Progressive disease|13|||
42265104|NCT02796677|76093192|FG003|Overall Study|Progressive disease|18|||
42265105|NCT02796677|76093189|FG000|Overall Study|Reason not mentioned|2|||
42265106|NCT02796677|76093190|FG001|Overall Study|Reason not mentioned|3|||
42265107|NCT02796677|76093191|FG002|Overall Study|Reason not mentioned|0|||
42265108|NCT02796677|76093192|FG003|Overall Study|Reason not mentioned|5|||
42334944|NCT02066402|76172634|FG000|Overall Study|Withdrawal by Subject|14|||
42334945|NCT02066402|76172635|FG001|Overall Study|Withdrawal by Subject|11|||
42134578|NCT00548405|75945461|FG001|Overall Study|Sponsor decision|0|||
42134579|NCT00548405|75945462|FG002|Overall Study|Sponsor decision|0|||
42134580|NCT00548405|75945460|FG000|Overall Study|Randomized but not treated|1|||
42134581|NCT00548405|75945461|FG001|Overall Study|Randomized but not treated|0|||
42134582|NCT00548405|75945462|FG002|Overall Study|Randomized but not treated|0|||
42265109|NCT02421172|76093206|FG000|Period 1|Adverse Event|1|||
42265110|NCT02421172|76093207|FG001|Period 1|Adverse Event|0|||
42265111|NCT02421172|76093208|FG002|Period 1|Adverse Event|0|||
42265112|NCT02421172|76093209|FG003|Period 1|Adverse Event|0|||
42265113|NCT02421172|76093210|FG004|Period 1|Adverse Event|0|||
42265114|NCT02421172|76093206|FG000|Period 1|Lost to Follow-up|3|||
42265115|NCT02421172|76093207|FG001|Period 1|Lost to Follow-up|1|||
42265116|NCT02421172|76093208|FG002|Period 1|Lost to Follow-up|0|||
42265117|NCT02421172|76093209|FG003|Period 1|Lost to Follow-up|0|||
42134583|NCT00295750|75945474|FG000|Overall Study|Adverse Event|19|||
42134584|NCT00295750|75945475|FG001|Overall Study|Adverse Event|15|||
42265118|NCT02421172|76093210|FG004|Period 1|Lost to Follow-up|0|||
42334946|NCT02066402|76172634|FG000|Overall Study|Progressive disease-clinical progression|0|||
42334947|NCT02066402|76172635|FG001|Overall Study|Progressive disease-clinical progression|1|||
42134585|NCT00295750|75945476|FG002|Overall Study|Adverse Event|12|||
42134586|NCT00295750|75945474|FG000|Overall Study|Lack of Efficacy|1|||
42134587|NCT00295750|75945475|FG001|Overall Study|Lack of Efficacy|1|||
42134588|NCT00295750|75945476|FG002|Overall Study|Lack of Efficacy|0|||
42134589|NCT00295750|75945474|FG000|Overall Study|Lost to Follow-up|1|||
42134590|NCT00295750|75945475|FG001|Overall Study|Lost to Follow-up|4|||
42134591|NCT00295750|75945476|FG002|Overall Study|Lost to Follow-up|1|||
42134592|NCT00295750|75945474|FG000|Overall Study|Taking prohibited therapy|2|||
42134593|NCT00295750|75945475|FG001|Overall Study|Taking prohibited therapy|3|||
42134594|NCT00295750|75945476|FG002|Overall Study|Taking prohibited therapy|2|||
42134595|NCT00295750|75945474|FG000|Overall Study|Administrative errors|2|||
42134596|NCT00295750|75945475|FG001|Overall Study|Administrative errors|4|||
42134597|NCT00295750|75945476|FG002|Overall Study|Administrative errors|5|||
42334948|NCT02066402|76172634|FG000|Overall Study|Protocol driven decision point|0|||
42334949|NCT02066402|76172635|FG001|Overall Study|Protocol driven decision point|1|||
42000136|NCT01193218|75808633|FG007|12-52 Weeks|Adverse Event|2|||
42000137|NCT01193218|75808626|FG000|12-52 Weeks|Lack of Efficacy|0|||
42334950|NCT02060383|76172646|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
42334951|NCT02060383|76172647|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
42334952|NCT02060383|76172648|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
42334953|NCT02060383|76172649|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
42334954|NCT02060383|76172650|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
42334955|NCT02060383|76172646|FG000|Core Phase|Adverse Event|2|||
42334956|NCT02060383|76172647|FG001|Core Phase|Adverse Event|0|||
42334957|NCT02060383|76172648|FG002|Core Phase|Adverse Event|0|||
42134598|NCT00295750|75945474|FG000|Overall Study|Trial drug errors|1|||
42134599|NCT00295750|75945475|FG001|Overall Study|Trial drug errors|1|||
42000138|NCT01193218|75808627|FG001|12-52 Weeks|Lack of Efficacy|0|||
42000139|NCT01193218|75808628|FG002|12-52 Weeks|Lack of Efficacy|0|||
42000140|NCT01193218|75808629|FG003|12-52 Weeks|Lack of Efficacy|0|||
42000141|NCT01193218|75808630|FG004|12-52 Weeks|Lack of Efficacy|0|||
42000142|NCT01193218|75808631|FG005|12-52 Weeks|Lack of Efficacy|0|||
42000143|NCT01193218|75808632|FG006|12-52 Weeks|Lack of Efficacy|1|||
42000144|NCT01193218|75808633|FG007|12-52 Weeks|Lack of Efficacy|0|||
42000145|NCT01193218|75808626|FG000|12-52 Weeks|Withdrawal by Subject|3|||
42000146|NCT01193218|75808627|FG001|12-52 Weeks|Withdrawal by Subject|0|||
42000147|NCT01193218|75808628|FG002|12-52 Weeks|Withdrawal by Subject|3|||
42000148|NCT01193218|75808629|FG003|12-52 Weeks|Withdrawal by Subject|0|||
42000149|NCT01193218|75808630|FG004|12-52 Weeks|Withdrawal by Subject|0|||
42134600|NCT00295750|75945476|FG002|Overall Study|Trial drug errors|0|||
42134601|NCT00295750|75945474|FG000|Overall Study|Disease progression|2|||
42134602|NCT00295750|75945475|FG001|Overall Study|Disease progression|1|||
42134603|NCT00295750|75945476|FG002|Overall Study|Disease progression|0|||
42134604|NCT00295750|75945474|FG000|Overall Study|Personal reasons|0|||
42134605|NCT00295750|75945475|FG001|Overall Study|Personal reasons|1|||
42134606|NCT00295750|75945476|FG002|Overall Study|Personal reasons|0|||
42134607|NCT00295750|75945474|FG000|Overall Study|Randomized but never received trial drug|4|||
42134608|NCT00295750|75945475|FG001|Overall Study|Randomized but never received trial drug|3|||
42134609|NCT00295750|75945476|FG002|Overall Study|Randomized but never received trial drug|3|||
42265119|NCT02421172|76093206|FG000|Period 1|Patient/guardian decision|0|||
42265120|NCT02421172|76093207|FG001|Period 1|Patient/guardian decision|1|||
42265121|NCT02421172|76093208|FG002|Period 1|Patient/guardian decision|0|||
42265122|NCT02421172|76093209|FG003|Period 1|Patient/guardian decision|0|||
42265123|NCT02421172|76093210|FG004|Period 1|Patient/guardian decision|0|||
42265124|NCT02421172|76093206|FG000|Period 2|Adverse Event|0|||
42265125|NCT02421172|76093207|FG001|Period 2|Adverse Event|0|||
42265126|NCT02421172|76093208|FG002|Period 2|Adverse Event|4|||
42265127|NCT02421172|76093209|FG003|Period 2|Adverse Event|0|||
42265128|NCT02421172|76093210|FG004|Period 2|Adverse Event|0|||
42265129|NCT02421172|76093206|FG000|Period 2|Lost to Follow-up|0|||
42265130|NCT02421172|76093207|FG001|Period 2|Lost to Follow-up|0|||
42334958|NCT02060383|76172649|FG003|Core Phase|Adverse Event|2|||
42000150|NCT01193218|75808631|FG005|12-52 Weeks|Withdrawal by Subject|2|||
42034693|NCT01118117|75842895|FG000|Overall Study|Missed 12 Month Visit|7|||
42034694|NCT01118117|75842896|FG001|Overall Study|Missed 12 Month Visit|0|||
42034695|NCT01109849|75842904|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
42034696|NCT01109849|75842905|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
42034697|NCT01109849|75842906|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
42034698|NCT01109849|75842907|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
42034699|NCT01109849|75842908|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
42034700|NCT01109849|75842904|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
42034701|NCT01109849|75842905|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
42034702|NCT01109849|75842906|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
42034703|NCT01109849|75842907|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
42034704|NCT01109849|75842908|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
42034705|NCT01109849|75842904|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
42034706|NCT01109849|75842905|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
42034707|NCT01109849|75842906|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
42034708|NCT01109849|75842907|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
42000151|NCT01193218|75808632|FG006|12-52 Weeks|Withdrawal by Subject|1|||
42000152|NCT01193218|75808633|FG007|12-52 Weeks|Withdrawal by Subject|2|||
42034709|NCT01109849|75842908|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
42034710|NCT01109849|75842904|FG000|Initial Randomization: ADHD Treatment|move away|2|||
42034711|NCT01109849|75842905|FG001|Initial Randomization: ADHD Treatment|move away|7|||
42034712|NCT01109849|75842906|FG002|Initial Randomization: ADHD Treatment|move away|0|||
42034713|NCT01109849|75842907|FG003|Initial Randomization: ADHD Treatment|move away|0|||
42265131|NCT02421172|76093208|FG002|Period 2|Lost to Follow-up|0|||
42265132|NCT02421172|76093209|FG003|Period 2|Lost to Follow-up|1|||
42000153|NCT01193218|75808626|FG000|12-52 Weeks|Other reason than above|1|||
42000154|NCT01193218|75808627|FG001|12-52 Weeks|Other reason than above|0|||
42000155|NCT01193218|75808628|FG002|12-52 Weeks|Other reason than above|0|||
42000156|NCT01193218|75808629|FG003|12-52 Weeks|Other reason than above|1|||
42000157|NCT01193218|75808630|FG004|12-52 Weeks|Other reason than above|1|||
42000158|NCT01193218|75808631|FG005|12-52 Weeks|Other reason than above|0|||
42000159|NCT01193218|75808632|FG006|12-52 Weeks|Other reason than above|0|||
42000160|NCT01193218|75808633|FG007|12-52 Weeks|Other reason than above|0|||
42000161|NCT01193101|75808653|FG000|Overall Study|Adverse Event|0|||
42000162|NCT01193101|75808654|FG001|Overall Study|Adverse Event|1|||
42000163|NCT01193101|75808655|FG002|Overall Study|Adverse Event|1|||
42000164|NCT01193101|75808656|FG003|Overall Study|Adverse Event|3|||
42000165|NCT01193101|75808653|FG000|Overall Study|Lack of Efficacy|3|||
42000166|NCT01193101|75808654|FG001|Overall Study|Lack of Efficacy|1|||
42000167|NCT01193101|75808655|FG002|Overall Study|Lack of Efficacy|0|||
42000168|NCT01193101|75808656|FG003|Overall Study|Lack of Efficacy|8|||
42265133|NCT02421172|76093210|FG004|Period 2|Lost to Follow-up|0|||
42265134|NCT02421172|76093206|FG000|Period 2|Patient/guardian decision|0|||
42265135|NCT02421172|76093207|FG001|Period 2|Patient/guardian decision|0|||
42265136|NCT02421172|76093208|FG002|Period 2|Patient/guardian decision|3|||
42265137|NCT02421172|76093209|FG003|Period 2|Patient/guardian decision|2|||
42265138|NCT02421172|76093210|FG004|Period 2|Patient/guardian decision|1|||
42265139|NCT02379052|76093223|FG000|Overall Study|Protocol Violation|0|||
42265140|NCT02379052|76093224|FG001|Overall Study|Protocol Violation|1|||
42265141|NCT02379052|76093223|FG000|Overall Study|Adverse Event|0|||
42265142|NCT02379052|76093224|FG001|Overall Study|Adverse Event|1|||
42265143|NCT02379052|76093223|FG000|Overall Study|Physician Decision|1|||
42265144|NCT02379052|76093224|FG001|Overall Study|Physician Decision|1|||
42265145|NCT02379052|76093223|FG000|Overall Study|Withdrawal by Subject|2|||
42265146|NCT02379052|76093224|FG001|Overall Study|Withdrawal by Subject|0|||
42265147|NCT02379052|76093223|FG000|Overall Study|Lost to Follow-up|2|||
42000169|NCT01193101|75808653|FG000|Overall Study|Withdrawal by Subject|2|||
42034714|NCT01109849|75842908|FG004|Initial Randomization: ADHD Treatment|move away|0|||
42034715|NCT01109849|75842904|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
42034716|NCT01109849|75842905|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
42034717|NCT01109849|75842906|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
42134610|NCT00295750|75945474|FG000|Overall Study|Withdrawal by Subject|9|||
42265148|NCT02379052|76093224|FG001|Overall Study|Lost to Follow-up|1|||
42265149|NCT02379052|76093223|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
42265150|NCT02379052|76093224|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
42265151|NCT02379052|76093223|FG000|Overall Study|Subject was Incarcerated|0|||
42000170|NCT01193101|75808654|FG001|Overall Study|Withdrawal by Subject|4|||
42265152|NCT02379052|76093224|FG001|Overall Study|Subject was Incarcerated|1|||
42265153|NCT02378662|76093232|FG000|Overall Study|Early Discontinuation|2|||
42000171|NCT01193101|75808655|FG002|Overall Study|Withdrawal by Subject|1|||
42000172|NCT01193101|75808656|FG003|Overall Study|Withdrawal by Subject|1|||
42000173|NCT01193101|75808653|FG000|Overall Study|Administrative problems|0|||
42334959|NCT02060383|76172650|FG004|Core Phase|Adverse Event|6|||
42334960|NCT02060383|76172646|FG000|Core Phase|Administrative problems|0|||
42334961|NCT02060383|76172647|FG001|Core Phase|Administrative problems|1|||
42334962|NCT02060383|76172648|FG002|Core Phase|Administrative problems|0|||
42334963|NCT02060383|76172649|FG003|Core Phase|Administrative problems|0|||
42334964|NCT02060383|76172650|FG004|Core Phase|Administrative problems|0|||
42334965|NCT02060383|76172646|FG000|Core Phase|Protocol Violation|0|||
42334966|NCT02060383|76172647|FG001|Core Phase|Protocol Violation|0|||
42334967|NCT02060383|76172648|FG002|Core Phase|Protocol Violation|0|||
42334968|NCT02060383|76172649|FG003|Core Phase|Protocol Violation|1|||
42334969|NCT02060383|76172650|FG004|Core Phase|Protocol Violation|0|||
42334970|NCT02060383|76172646|FG000|Core Phase|Withdrawal by Subject|0|||
42334971|NCT02060383|76172647|FG001|Core Phase|Withdrawal by Subject|0|||
42334972|NCT02060383|76172648|FG002|Core Phase|Withdrawal by Subject|0|||
42334973|NCT02060383|76172649|FG003|Core Phase|Withdrawal by Subject|4|||
42334974|NCT02060383|76172650|FG004|Core Phase|Withdrawal by Subject|2|||
42334975|NCT02060383|76172646|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
42334976|NCT02060383|76172647|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
42334977|NCT02060383|76172648|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
42334978|NCT02060383|76172649|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
42334979|NCT02060383|76172650|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
42334980|NCT02060383|76172646|FG000|Extension Phase|Adverse Event|1|||
42334981|NCT02060383|76172647|FG001|Extension Phase|Adverse Event|1|||
42334982|NCT02060383|76172648|FG002|Extension Phase|Adverse Event|2|||
42334983|NCT02060383|76172649|FG003|Extension Phase|Adverse Event|0|||
42334984|NCT02060383|76172650|FG004|Extension Phase|Adverse Event|1|||
42334985|NCT02060383|76172646|FG000|Extension Phase|Withdrawal by Subject|0|||
42265154|NCT02378662|76093233|FG001|Overall Study|Early Discontinuation|0|||
42265155|NCT02378506|76093239|FG000|Overall Study|Lack of Efficacy|3|||
42265156|NCT02378506|76093239|FG000|Overall Study|Withdrawal by Subject|4|||
42265157|NCT02378506|76093239|FG000|Overall Study|Protocol Violation|2|||
42265158|NCT02378506|76093239|FG000|Overall Study|Death|1|||
42265159|NCT02378506|76093239|FG000|Overall Study|Adverse Event|14|||
42265160|NCT02378506|76093239|FG000|Overall Study|Randomized But Not Treated|1|||
42265161|NCT02347774|76093246|FG000|Study Participation|Lost to Follow-up|3|||
42265162|NCT02347774|76093247|FG001|Study Participation|Lost to Follow-up|6|||
42265163|NCT02347774|76093248|FG002|Study Participation|Lost to Follow-up|2|||
42265164|NCT02347774|76093246|FG000|Study Participation|Withdrawal by Subject|8|||
42265165|NCT02347774|76093247|FG001|Study Participation|Withdrawal by Subject|9|||
42265166|NCT02347774|76093248|FG002|Study Participation|Withdrawal by Subject|15|||
42265167|NCT02347774|76093246|FG000|Study Participation|Adverse Event|1|||
42265168|NCT02347774|76093247|FG001|Study Participation|Adverse Event|4|||
42265169|NCT02347774|76093248|FG002|Study Participation|Adverse Event|6|||
42265170|NCT02347774|76093246|FG000|Study Participation|withdrew consent|1|||
42265171|NCT02347774|76093247|FG001|Study Participation|withdrew consent|1|||
42265172|NCT02347774|76093248|FG002|Study Participation|withdrew consent|1|||
42265173|NCT02347774|76093246|FG000|Study Participation|Met Prolonged QT criteria|1|||
42265174|NCT02347774|76093247|FG001|Study Participation|Met Prolonged QT criteria|0|||
42265175|NCT02347774|76093248|FG002|Study Participation|Met Prolonged QT criteria|0|||
42265176|NCT02347774|76093246|FG000|Study Participation|non-compliance with study drug|0|||
42265177|NCT02347774|76093247|FG001|Study Participation|non-compliance with study drug|1|||
42265178|NCT02347774|76093248|FG002|Study Participation|non-compliance with study drug|0|||
42265179|NCT02347774|76093246|FG000|Study Participation|incarceration|1|||
42265180|NCT02347774|76093247|FG001|Study Participation|incarceration|0|||
42265181|NCT02347774|76093248|FG002|Study Participation|incarceration|0|||
42265182|NCT02347774|76093246|FG000|Study Participation|randomized in error|0|||
42265183|NCT02347774|76093247|FG001|Study Participation|randomized in error|0|||
42265184|NCT02347774|76093248|FG002|Study Participation|randomized in error|1|||
42265185|NCT02347774|76093246|FG000|On Study Treatment|Adverse Event|9|||
42265186|NCT02347774|76093247|FG001|On Study Treatment|Adverse Event|15|||
42265187|NCT02347774|76093248|FG002|On Study Treatment|Adverse Event|19|||
42334986|NCT02060383|76172647|FG001|Extension Phase|Withdrawal by Subject|1|||
42334987|NCT02060383|76172648|FG002|Extension Phase|Withdrawal by Subject|0|||
42334988|NCT02060383|76172649|FG003|Extension Phase|Withdrawal by Subject|0|||
42334989|NCT02060383|76172650|FG004|Extension Phase|Withdrawal by Subject|2|||
42334990|NCT02060383|76172646|FG000|Extension Phase|Administrative problems|1|||
42265188|NCT02347774|76093246|FG000|On Study Treatment|Lack of Efficacy|3|||
42265189|NCT02347774|76093247|FG001|On Study Treatment|Lack of Efficacy|0|||
42265190|NCT02347774|76093248|FG002|On Study Treatment|Lack of Efficacy|2|||
42334991|NCT02060383|76172647|FG001|Extension Phase|Administrative problems|0|||
42334992|NCT02060383|76172648|FG002|Extension Phase|Administrative problems|0|||
42334993|NCT02060383|76172649|FG003|Extension Phase|Administrative problems|0|||
42334994|NCT02060383|76172650|FG004|Extension Phase|Administrative problems|0|||
42265191|NCT02347774|76093246|FG000|On Study Treatment|non-complicance with study medication|0|||
42265192|NCT02347774|76093247|FG001|On Study Treatment|non-complicance with study medication|2|||
42272720|NCT01657370|76103055|FG000|Overall Study|Adverse Event|0|||
42334995|NCT02060383|76172646|FG000|Extension Phase|Death|0|||
42334996|NCT02060383|76172647|FG001|Extension Phase|Death|0|||
42334997|NCT02060383|76172648|FG002|Extension Phase|Death|1|||
42000174|NCT01193101|75808654|FG001|Overall Study|Administrative problems|0|||
42000175|NCT01193101|75808655|FG002|Overall Study|Administrative problems|1|||
42000176|NCT01193101|75808656|FG003|Overall Study|Administrative problems|0|||
42000177|NCT01193101|75808653|FG000|Overall Study|Abnormal test procedure results|0|||
42000178|NCT01193101|75808654|FG001|Overall Study|Abnormal test procedure results|1|||
42000179|NCT01193101|75808655|FG002|Overall Study|Abnormal test procedure results|0|||
42000180|NCT01193101|75808656|FG003|Overall Study|Abnormal test procedure results|0|||
42000181|NCT01192516|75808669|FG000|Overall Study|Lost to Follow-up|7|||
42000182|NCT01192516|75808670|FG001|Overall Study|Lost to Follow-up|10|||
42000183|NCT01192516|75808671|FG002|Overall Study|Lost to Follow-up|7|||
42000184|NCT01192516|75808669|FG000|Overall Study|Withdrawal by Subject|4|||
42000185|NCT01192516|75808670|FG001|Overall Study|Withdrawal by Subject|4|||
42000186|NCT01192516|75808671|FG002|Overall Study|Withdrawal by Subject|1|||
42000187|NCT01192516|75808669|FG000|Overall Study|started new treatment|5|||
42000188|NCT01192516|75808670|FG001|Overall Study|started new treatment|1|||
42000189|NCT01192516|75808671|FG002|Overall Study|started new treatment|0|||
42000190|NCT01192516|75808669|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
42000191|NCT01192516|75808670|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
42000192|NCT01192516|75808671|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
42000193|NCT01192399|75808683|FG000|Overall Study|Lack of Efficacy|2|||
42000194|NCT01176916|75808687|FG000|Overall Study|Adverse Event|61|||
42000195|NCT01176916|75808687|FG000|Overall Study|Death|1|||
42000196|NCT01176916|75808687|FG000|Overall Study|Lost to Follow-up|15|||
42000197|NCT01176916|75808687|FG000|Overall Study|Objective progression or relapse|17|||
42000198|NCT01176916|75808687|FG000|Overall Study|Protocol Violation|24|||
42000199|NCT01176916|75808687|FG000|Overall Study|Withdrawal by Subject|37|||
42000200|NCT01176916|75808687|FG000|Overall Study|Other|6|||
42000201|NCT01176916|75808687|FG000|Overall Study|Withdrawal prior to Treatment|6|||
42000202|NCT01192204|75808693|FG000|Overall Study|could not keep recall appointments|1|||
42000203|NCT01192204|75808694|FG001|Overall Study|could not keep recall appointments|0|||
42000204|NCT01192126|75808701|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
42000205|NCT01192126|75808702|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
42034718|NCT01109849|75842907|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
42034719|NCT01109849|75842908|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
42034720|NCT01109849|75842904|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
42034721|NCT01109849|75842905|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
42034722|NCT01109849|75842906|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
42265193|NCT02347774|76093248|FG002|On Study Treatment|non-complicance with study medication|0|||
42265194|NCT02347774|76093246|FG000|On Study Treatment|Protocol Violation|0|||
42265195|NCT02347774|76093247|FG001|On Study Treatment|Protocol Violation|0|||
42334998|NCT02060383|76172649|FG003|Extension Phase|Death|0|||
42334999|NCT02060383|76172650|FG004|Extension Phase|Death|1|||
42335000|NCT02060383|76172646|FG000|Extension Phase|Protocol Violation|0|||
42335001|NCT02060383|76172647|FG001|Extension Phase|Protocol Violation|0|||
42335002|NCT02060383|76172648|FG002|Extension Phase|Protocol Violation|0|||
42335003|NCT02060383|76172649|FG003|Extension Phase|Protocol Violation|0|||
42335004|NCT02060383|76172650|FG004|Extension Phase|Protocol Violation|1|||
42335005|NCT02086591|76172662|FG000|Overall Study|Adverse Event|1|||
42335006|NCT02086591|76172662|FG000|Overall Study|Withdrawal by Subject|1|||
42335007|NCT02086591|76172662|FG000|Overall Study|protocol terminated|3|||
42335008|NCT02065622|76172668|FG000|Induction Study|Adverse Event|13|||
42335009|NCT02065622|76172669|FG001|Induction Study|Adverse Event|19|||
42335010|NCT02065622|76172670|FG002|Induction Study|Adverse Event|0|||
42265196|NCT02347774|76093248|FG002|On Study Treatment|Protocol Violation|1|||
42265197|NCT02347774|76093246|FG000|On Study Treatment|withdrew consent|9|||
42265198|NCT02347774|76093247|FG001|On Study Treatment|withdrew consent|8|||
42265199|NCT02347774|76093248|FG002|On Study Treatment|withdrew consent|12|||
42265200|NCT02347774|76093246|FG000|On Study Treatment|Lost to Follow-up|2|||
42265201|NCT02347774|76093247|FG001|On Study Treatment|Lost to Follow-up|6|||
42265202|NCT02347774|76093248|FG002|On Study Treatment|Lost to Follow-up|1|||
42335011|NCT02065622|76172671|FG003|Induction Study|Adverse Event|0|||
42335012|NCT02065622|76172672|FG004|Induction Study|Adverse Event|0|||
42335013|NCT02065622|76172668|FG000|Induction Study|Withdrawal by Subject|3|||
42335014|NCT02065622|76172669|FG001|Induction Study|Withdrawal by Subject|5|||
42000206|NCT01192126|75808701|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
42000207|NCT01192126|75808702|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
42000208|NCT01327482|75808708|FG000|Overall Study|Adverse Event|1|||
42000209|NCT01176565|75808714|FG000|Overall Study|Lost to Follow-up|12|||
42000210|NCT01176565|75808715|FG001|Overall Study|Lost to Follow-up|16|||
42000211|NCT01176565|75808714|FG000|Overall Study|Withdrawal by Subject|7|||
42000212|NCT01176565|75808715|FG001|Overall Study|Withdrawal by Subject|1|||
42265203|NCT02347774|76093246|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
42335015|NCT02065622|76172670|FG002|Induction Study|Withdrawal by Subject|0|||
42335016|NCT02065622|76172671|FG003|Induction Study|Withdrawal by Subject|0|||
42335017|NCT02065622|76172672|FG004|Induction Study|Withdrawal by Subject|0|||
42335018|NCT02065622|76172668|FG000|Induction Study|Lost to Follow-up|1|||
42335019|NCT02065622|76172669|FG001|Induction Study|Lost to Follow-up|0|||
42335020|NCT02065622|76172670|FG002|Induction Study|Lost to Follow-up|0|||
42335021|NCT02065622|76172671|FG003|Induction Study|Lost to Follow-up|0|||
42335022|NCT02065622|76172672|FG004|Induction Study|Lost to Follow-up|0|||
42335023|NCT02065622|76172668|FG000|Induction Study|Lack of Efficacy|22|||
42335024|NCT02065622|76172669|FG001|Induction Study|Lack of Efficacy|27|||
42335025|NCT02065622|76172670|FG002|Induction Study|Lack of Efficacy|0|||
42335026|NCT02065622|76172671|FG003|Induction Study|Lack of Efficacy|0|||
42335027|NCT02065622|76172672|FG004|Induction Study|Lack of Efficacy|0|||
42335028|NCT02065622|76172668|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
42335029|NCT02065622|76172669|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
42335030|NCT02065622|76172670|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
42335031|NCT02065622|76172671|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
42335032|NCT02065622|76172672|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
42335033|NCT02065622|76172668|FG000|Induction Study|Subject Noncompliance|1|||
42335034|NCT02065622|76172669|FG001|Induction Study|Subject Noncompliance|1|||
42335035|NCT02065622|76172670|FG002|Induction Study|Subject Noncompliance|0|||
42335036|NCT02065622|76172671|FG003|Induction Study|Subject Noncompliance|0|||
42335037|NCT02065622|76172672|FG004|Induction Study|Subject Noncompliance|0|||
42335038|NCT02065622|76172668|FG000|Induction Study|Other, Not Specified|3|||
42335039|NCT02065622|76172669|FG001|Induction Study|Other, Not Specified|2|||
42335040|NCT02065622|76172670|FG002|Induction Study|Other, Not Specified|0|||
42335041|NCT02065622|76172671|FG003|Induction Study|Other, Not Specified|0|||
42335042|NCT02065622|76172672|FG004|Induction Study|Other, Not Specified|0|||
42335043|NCT02065622|76172668|FG000|Maintenance Study|Adverse Event|0|||
42335044|NCT02065622|76172669|FG001|Maintenance Study|Adverse Event|0|||
42335045|NCT02065622|76172670|FG002|Maintenance Study|Adverse Event|25|||
42335046|NCT02065622|76172671|FG003|Maintenance Study|Adverse Event|22|||
42335047|NCT02065622|76172672|FG004|Maintenance Study|Adverse Event|11|||
42335048|NCT02065622|76172668|FG000|Maintenance Study|Withdrawal by Subject|0|||
42335049|NCT02065622|76172669|FG001|Maintenance Study|Withdrawal by Subject|0|||
42335050|NCT02065622|76172670|FG002|Maintenance Study|Withdrawal by Subject|11|||
42335051|NCT02065622|76172671|FG003|Maintenance Study|Withdrawal by Subject|5|||
42335052|NCT02065622|76172672|FG004|Maintenance Study|Withdrawal by Subject|7|||
42335053|NCT02065622|76172668|FG000|Maintenance Study|Lost to Follow-up|0|||
42335054|NCT02065622|76172669|FG001|Maintenance Study|Lost to Follow-up|0|||
42335055|NCT02065622|76172670|FG002|Maintenance Study|Lost to Follow-up|4|||
42335056|NCT02065622|76172671|FG003|Maintenance Study|Lost to Follow-up|1|||
42335057|NCT02065622|76172672|FG004|Maintenance Study|Lost to Follow-up|1|||
42335058|NCT02065622|76172668|FG000|Maintenance Study|Lack of Efficacy|0|||
42335059|NCT02065622|76172669|FG001|Maintenance Study|Lack of Efficacy|0|||
42335060|NCT02065622|76172670|FG002|Maintenance Study|Lack of Efficacy|70|||
42335061|NCT02065622|76172671|FG003|Maintenance Study|Lack of Efficacy|55|||
42335062|NCT02065622|76172672|FG004|Maintenance Study|Lack of Efficacy|19|||
42335063|NCT02065622|76172668|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
42335064|NCT02065622|76172669|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
42335065|NCT02065622|76172670|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
42335066|NCT02065622|76172671|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
42335067|NCT02065622|76172672|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
42335068|NCT02065622|76172668|FG000|Maintenance Study|Subject Non-Compliance|0|||
42335069|NCT02065622|76172669|FG001|Maintenance Study|Subject Non-Compliance|0|||
42335070|NCT02065622|76172670|FG002|Maintenance Study|Subject Non-Compliance|1|||
42000213|NCT01176565|75808714|FG000|Overall Study|Not Analyzed (any other reason)|1|||
42000214|NCT01176565|75808715|FG001|Overall Study|Not Analyzed (any other reason)|2|||
42000215|NCT01176292|75808723|FG000|Overall Study|Lost to Follow-up|2|||
42335071|NCT02065622|76172671|FG003|Maintenance Study|Subject Non-Compliance|3|||
42335072|NCT02065622|76172672|FG004|Maintenance Study|Subject Non-Compliance|2|||
42335073|NCT02065622|76172668|FG000|Maintenance Study|Other, Not Specified|0|||
42000216|NCT01176292|75808724|FG001|Overall Study|Lost to Follow-up|4|||
42000217|NCT01176292|75808723|FG000|Overall Study|Adverse Event|1|||
42000218|NCT01176292|75808724|FG001|Overall Study|Adverse Event|1|||
42335074|NCT02065622|76172669|FG001|Maintenance Study|Other, Not Specified|0|||
42335075|NCT02065622|76172670|FG002|Maintenance Study|Other, Not Specified|6|||
42335076|NCT02065622|76172671|FG003|Maintenance Study|Other, Not Specified|14|||
42335077|NCT02065622|76172672|FG004|Maintenance Study|Other, Not Specified|2|||
42335078|NCT02065622|76172668|FG000|Maintenance Study|Unknown Reason|0|||
42000219|NCT01176292|75808723|FG000|Overall Study|Physician Decision|0|||
42335079|NCT02065622|76172669|FG001|Maintenance Study|Unknown Reason|0|||
42335080|NCT02065622|76172670|FG002|Maintenance Study|Unknown Reason|0|||
42000220|NCT01176292|75808724|FG001|Overall Study|Physician Decision|2|||
42000221|NCT01176292|75808723|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
42335081|NCT02065622|76172671|FG003|Maintenance Study|Unknown Reason|1|||
42335082|NCT02065622|76172672|FG004|Maintenance Study|Unknown Reason|0|||
42335083|NCT02117648|76172687|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
42335084|NCT02117648|76172687|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
42335085|NCT02117648|76172687|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
42335086|NCT02117648|76172687|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
42335087|NCT02117648|76172687|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
42335088|NCT02117648|76172687|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
42335089|NCT02117648|76172687|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
42335090|NCT02117648|76172687|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
42335091|NCT02117648|76172687|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
42134611|NCT00295750|75945475|FG001|Overall Study|Withdrawal by Subject|4|||
42134612|NCT00295750|75945476|FG002|Overall Study|Withdrawal by Subject|7|||
42134613|NCT00295750|75945474|FG000|Overall Study|Protocol Violation|2|||
42134614|NCT00295750|75945475|FG001|Overall Study|Protocol Violation|4|||
42134615|NCT00295750|75945476|FG002|Overall Study|Protocol Violation|2|||
42134616|NCT03948581|75945486|FG000|Overall Study|Lost to Follow-up|0|||
42134617|NCT03948581|75945487|FG001|Overall Study|Lost to Follow-up|1|||
42134618|NCT00548327|75945495|FG000|Overall Study|Adverse Event|0|||
42265204|NCT02347774|76093247|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
42034723|NCT01109849|75842907|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
42034724|NCT01109849|75842908|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
42265205|NCT02347774|76093248|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
42265206|NCT02347774|76093246|FG000|On Study Treatment|ranomized in error|0|||
42265207|NCT02347774|76093247|FG001|On Study Treatment|ranomized in error|0|||
42265208|NCT02347774|76093248|FG002|On Study Treatment|ranomized in error|1|||
42265209|NCT02794883|76093259|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
42265210|NCT02794883|76093260|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
42265211|NCT02794883|76093261|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
42265212|NCT02794883|76093259|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
42335092|NCT02117648|76172687|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
42335093|NCT02117648|76172687|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
42335094|NCT02124161|76172697|FG000|Overall Study|Other unspecified|0|||
42335095|NCT02124161|76172698|FG001|Overall Study|Other unspecified|1|||
42335096|NCT02124161|76172697|FG000|Overall Study|Death|1|||
42335097|NCT02124161|76172698|FG001|Overall Study|Death|0|||
42335098|NCT02124161|76172697|FG000|Overall Study|Protocol Violation|2|||
42335099|NCT02124161|76172698|FG001|Overall Study|Protocol Violation|1|||
42335100|NCT02124161|76172697|FG000|Overall Study|Withdrawal by Subject|1|||
42335101|NCT02124161|76172698|FG001|Overall Study|Withdrawal by Subject|2|||
42335102|NCT02124161|76172697|FG000|Overall Study|Adverse Event|2|||
42335103|NCT02124161|76172698|FG001|Overall Study|Adverse Event|0|||
42335104|NCT02124161|76172697|FG000|Overall Study|Does not meet entrance criteria|2|||
42335105|NCT02124161|76172698|FG001|Overall Study|Does not meet entrance criteria|3|||
42335106|NCT02124161|76172697|FG000|Overall Study|No longer meets eligibility criteria|5|||
42335107|NCT02124161|76172698|FG001|Overall Study|No longer meets eligibility criteria|4|||
42335108|NCT02124161|76172697|FG000|Overall Study|Lost to Follow-up|3|||
42335109|NCT02124161|76172698|FG001|Overall Study|Lost to Follow-up|4|||
42335110|NCT02175641|76172713|FG000|Overall Study|Death|3|||
42335111|NCT02175641|76172714|FG001|Overall Study|Death|4|||
42335112|NCT02175641|76172713|FG000|Overall Study|Lost to Follow-up|4|||
42335113|NCT02175641|76172714|FG001|Overall Study|Lost to Follow-up|4|||
42335114|NCT02175641|76172713|FG000|Overall Study|Withdrawal by Subject|7|||
42335115|NCT02175641|76172714|FG001|Overall Study|Withdrawal by Subject|4|||
42335116|NCT02175641|76172713|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
42335117|NCT02175641|76172714|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
42335118|NCT02175641|76172713|FG000|Overall Study|Developed Contraindicated Condition|8|||
42335119|NCT02175641|76172714|FG001|Overall Study|Developed Contraindicated Condition|0|||
42335120|NCT02117570|76172723|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
42335121|NCT02117570|76172724|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
42335122|NCT02117570|76172725|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
42335123|NCT02117570|76172723|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
42034725|NCT01061736|75842938|FG000|Overall Study|Dose regimen not selected|0|||
42134619|NCT00548327|75945496|FG001|Overall Study|Adverse Event|1|||
42134620|NCT03953183|75945518|FG000|Overall Study|Physician Decision|0|||
42134621|NCT03953183|75945519|FG001|Overall Study|Physician Decision|1|||
42335124|NCT02117570|76172724|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
42335125|NCT02117570|76172725|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
42335126|NCT02117570|76172723|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
42335127|NCT02117570|76172724|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
42335128|NCT02117570|76172725|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
42335129|NCT02117570|76172723|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
42335130|NCT02117570|76172724|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
42335131|NCT02117570|76172725|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
42335132|NCT02117570|76172723|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
42335133|NCT02117570|76172724|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
42335134|NCT02117570|76172725|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
42335135|NCT02117570|76172723|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
42335136|NCT02117570|76172724|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
42335137|NCT02117570|76172725|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
42335138|NCT02117570|76172723|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
42335139|NCT02117570|76172724|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
42335140|NCT02117570|76172725|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
42335141|NCT02123459|76172736|FG000|Washout Period (1 Day)|Adverse Event|1|||
42335142|NCT02123459|76172737|FG001|Washout Period (1 Day)|Adverse Event|0|||
42335143|NCT01853475|76172746|FG000|Overall Study|Withdrawal by Subject|0|||
42335144|NCT01853475|76172747|FG001|Overall Study|Withdrawal by Subject|1|||
42335145|NCT01853475|76172748|FG002|Overall Study|Withdrawal by Subject|0|||
42335146|NCT02151773|76172756|FG000|Overall Study|Protocol Deviation|64|||
42335147|NCT02151461|76172764|FG000|Overall Study|Adverse Event|5|||
42335148|NCT02151461|76172765|FG001|Overall Study|Adverse Event|1|||
42335149|NCT02151461|76172766|FG002|Overall Study|Adverse Event|0|||
42335150|NCT02151461|76172767|FG003|Overall Study|Adverse Event|2|||
42335151|NCT02151461|76172764|FG000|Overall Study|Lost to Follow-up|0|||
42335152|NCT02151461|76172765|FG001|Overall Study|Lost to Follow-up|0|||
42335153|NCT02151461|76172766|FG002|Overall Study|Lost to Follow-up|1|||
42335154|NCT02151461|76172767|FG003|Overall Study|Lost to Follow-up|1|||
42335155|NCT02151461|76172764|FG000|Overall Study|Withdrawal by Subject|1|||
42265213|NCT02794883|76093260|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
42265214|NCT02794883|76093261|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
42265215|NCT02794883|76093259|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
42265216|NCT02794883|76093260|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
42265217|NCT02794883|76093261|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
42265218|NCT02794883|76093259|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
42265219|NCT02794883|76093260|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
42265220|NCT02794883|76093261|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
42265221|NCT02794883|76093259|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
42265222|NCT02794883|76093260|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
42265223|NCT02794883|76093261|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
42265224|NCT02794883|76093259|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
42265225|NCT02794883|76093260|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
42265226|NCT02794883|76093261|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
42265227|NCT02794883|76093259|FG000|Follow-up Period (up to 2 Years)|Death|12|||
42265228|NCT02794883|76093260|FG001|Follow-up Period (up to 2 Years)|Death|10|||
42265229|NCT02794883|76093261|FG002|Follow-up Period (up to 2 Years)|Death|10|||
42265230|NCT01370603|76093271|FG000|Period 1|Adverse Event|5|||
42335156|NCT02151461|76172765|FG001|Overall Study|Withdrawal by Subject|0|||
42335157|NCT02151461|76172766|FG002|Overall Study|Withdrawal by Subject|1|||
42335158|NCT02151461|76172767|FG003|Overall Study|Withdrawal by Subject|1|||
42335159|NCT02151461|76172764|FG000|Overall Study|Treatment discontinuation|0|||
42335160|NCT02151461|76172765|FG001|Overall Study|Treatment discontinuation|0|||
42335161|NCT02151461|76172766|FG002|Overall Study|Treatment discontinuation|1|||
42335162|NCT02151461|76172767|FG003|Overall Study|Treatment discontinuation|0|||
42265231|NCT01370603|76093272|FG001|Period 1|Adverse Event|3|||
42265232|NCT01370603|76093271|FG000|Period 1|Lost to Follow-up|2|||
42265233|NCT01370603|76093272|FG001|Period 1|Lost to Follow-up|0|||
42265234|NCT01370603|76093271|FG000|Period 1|Protocol Violation|2|||
42265235|NCT01370603|76093272|FG001|Period 1|Protocol Violation|2|||
42265236|NCT01370603|76093271|FG000|Period 1|Withdrawal by Subject|5|||
42265237|NCT01370603|76093272|FG001|Period 1|Withdrawal by Subject|5|||
42265238|NCT01370603|76093271|FG000|Crossover Washout|Adverse Event|2|||
42265239|NCT01370603|76093272|FG001|Crossover Washout|Adverse Event|1|||
42265240|NCT01370603|76093271|FG000|Crossover Washout|Lost to Follow-up|2|||
42265241|NCT01370603|76093272|FG001|Crossover Washout|Lost to Follow-up|0|||
42335163|NCT02117414|76172779|FG000|Overall Study|Death|5|||
42335164|NCT02117414|76172780|FG001|Overall Study|Death|2|||
42335165|NCT02117414|76172779|FG000|Overall Study|Withdrawal by Subject|10|||
42335166|NCT02117414|76172780|FG001|Overall Study|Withdrawal by Subject|4|||
42335167|NCT02091986|76172791|FG000|Overall Study|7 rand in error 1 patient decision|2|||
42335168|NCT02091986|76172792|FG001|Overall Study|7 rand in error 1 patient decision|3|||
42335169|NCT02091986|76172793|FG002|Overall Study|7 rand in error 1 patient decision|3|||
42335170|NCT02091986|76172791|FG000|Overall Study|Lost to Follow-up|1|||
42335171|NCT02091986|76172792|FG001|Overall Study|Lost to Follow-up|0|||
42335172|NCT02091986|76172793|FG002|Overall Study|Lost to Follow-up|0|||
42335173|NCT02091986|76172791|FG000|Overall Study|Withdrawal by Subject|4|||
42335174|NCT02091986|76172792|FG001|Overall Study|Withdrawal by Subject|8|||
42335175|NCT02091986|76172793|FG002|Overall Study|Withdrawal by Subject|3|||
42335176|NCT02091986|76172791|FG000|Overall Study|Adverse Event|0|||
42335177|NCT02091986|76172792|FG001|Overall Study|Adverse Event|0|||
42335178|NCT02091986|76172793|FG002|Overall Study|Adverse Event|2|||
42335179|NCT02091752|76172801|FG000|Overall Study|Study terminated by Sponsor|2|||
42335180|NCT02091752|76172801|FG000|Overall Study|Adverse Event|1|||
42335181|NCT02117024|76172807|FG000|Overall Study|Progressive Disease|26|||
42335182|NCT02117024|76172808|FG001|Overall Study|Progressive Disease|9|||
42335183|NCT02117024|76172807|FG000|Overall Study|Significant Clinical Progression|7|||
42335184|NCT02117024|76172808|FG001|Overall Study|Significant Clinical Progression|4|||
42335185|NCT02117024|76172807|FG000|Overall Study|Death|5|||
42335186|NCT02117024|76172808|FG001|Overall Study|Death|0|||
42335187|NCT02117024|76172807|FG000|Overall Study|Withdrawal by Subject|3|||
42335188|NCT02117024|76172808|FG001|Overall Study|Withdrawal by Subject|1|||
42335189|NCT02117024|76172807|FG000|Overall Study|Protocol Violation|1|||
42335190|NCT02117024|76172808|FG001|Overall Study|Protocol Violation|0|||
42335191|NCT02117024|76172807|FG000|Overall Study|Adverse Event|1|||
42335192|NCT02117024|76172808|FG001|Overall Study|Adverse Event|2|||
42335193|NCT02117024|76172807|FG000|Overall Study|Randomized in Error|1|||
42335194|NCT02117024|76172808|FG001|Overall Study|Randomized in Error|0|||
42000222|NCT01176292|75808724|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
42000223|NCT01113541|75808730|FG000|Overall Study|Withdrawal by Subject|1|||
42000224|NCT01113541|75808730|FG000|Overall Study|Protocol Violation|1|||
42000225|NCT01113541|75808730|FG000|Overall Study|Study Terminated by Sponsor|7|||
42335195|NCT02117024|76172807|FG000|Overall Study|Patient returned to primary oncologist|0|||
42000226|NCT01113541|75808730|FG000|Overall Study|Adverse Event|4|||
42265242|NCT01370603|76093271|FG000|Crossover Washout|Protocol Violation|1|||
42335196|NCT02117024|76172808|FG001|Overall Study|Patient returned to primary oncologist|1|||
42335197|NCT02117024|76172807|FG000|Overall Study|Patient took treatment break|0|||
42335198|NCT02117024|76172808|FG001|Overall Study|Patient took treatment break|1|||
42335199|NCT02117024|76172807|FG000|Overall Study|Physician Decision|0|||
42265243|NCT01370603|76093272|FG001|Crossover Washout|Protocol Violation|0|||
42265244|NCT01370603|76093271|FG000|Crossover Washout|Withdrawal by Subject|4|||
42335200|NCT02117024|76172808|FG001|Overall Study|Physician Decision|2|||
42335201|NCT02091440|76172814|FG000|Overall Study|Death|2|||
42265245|NCT01370603|76093272|FG001|Crossover Washout|Withdrawal by Subject|1|||
42335202|NCT02064920|76172820|FG000|Overall Study|Adverse Event|0|||
42000227|NCT01113502|75808743|FG000|Overall Study|Withdrawal by Subject|1|||
42000228|NCT01113502|75808744|FG001|Overall Study|Withdrawal by Subject|0|||
42000229|NCT01113502|75808745|FG002|Overall Study|Withdrawal by Subject|1|||
42000230|NCT01113502|75808746|FG003|Overall Study|Withdrawal by Subject|1|||
42335203|NCT02064920|76172821|FG001|Overall Study|Adverse Event|4|||
42335204|NCT02064920|76172820|FG000|Overall Study|Physician Decision|0|||
42335205|NCT02064920|76172821|FG001|Overall Study|Physician Decision|1|||
42335206|NCT02064920|76172820|FG000|Overall Study|Technical Problems|0|||
42335207|NCT02064920|76172821|FG001|Overall Study|Technical Problems|1|||
42335208|NCT02064920|76172820|FG000|Overall Study|Withdrawal by Subject|1|||
42335209|NCT02064920|76172821|FG001|Overall Study|Withdrawal by Subject|3|||
42335210|NCT02151149|76172829|FG000|Treatment Period|Death|2|||
42335211|NCT02151149|76172830|FG001|Treatment Period|Death|3|||
42335212|NCT02151149|76172829|FG000|Treatment Period|Adverse Event|17|||
42335213|NCT02151149|76172830|FG001|Treatment Period|Adverse Event|14|||
42335214|NCT02151149|76172829|FG000|Treatment Period|Progressive Disease|25|||
42335215|NCT02151149|76172830|FG001|Treatment Period|Progressive Disease|24|||
42335216|NCT02151149|76172829|FG000|Treatment Period|Symptomatic Deterioration|2|||
42335217|NCT02151149|76172830|FG001|Treatment Period|Symptomatic Deterioration|10|||
42335218|NCT02151149|76172829|FG000|Treatment Period|Withdrawal by Subject|13|||
42335219|NCT02151149|76172830|FG001|Treatment Period|Withdrawal by Subject|11|||
42335220|NCT02151149|76172829|FG000|Treatment Period|Miscellaneous|8|||
42335221|NCT02151149|76172830|FG001|Treatment Period|Miscellaneous|7|||
42335222|NCT02151149|76172829|FG000|Treatment Period|Participants randomized but not treated|3|||
42335223|NCT02151149|76172830|FG001|Treatment Period|Participants randomized but not treated|2|||
42335224|NCT02151149|76172829|FG000|Follow-Up Period|Lost to Follow-up|2|||
42335225|NCT02151149|76172830|FG001|Follow-Up Period|Lost to Follow-up|3|||
42335226|NCT02151149|76172829|FG000|Follow-Up Period|Death|37|||
42335227|NCT02151149|76172830|FG001|Follow-Up Period|Death|34|||
42335228|NCT02150213|76172836|FG000|Overall Study|Lost to Follow-up|1|||
42335229|NCT02150213|76172836|FG000|Overall Study|Withdrawal by Subject|1|||
42335230|NCT02091362|76172842|FG000|Period 1|Protocol Violation|1|||
42335231|NCT02091362|76172843|FG001|Period 1|Protocol Violation|0|||
42335232|NCT02091362|76172842|FG000|Period 1|Withdrawal by Subject|2|||
42335233|NCT02091362|76172843|FG001|Period 1|Withdrawal by Subject|3|||
42335234|NCT02091362|76172842|FG000|Period 1|Lost to Follow-up|0|||
42335235|NCT02091362|76172843|FG001|Period 1|Lost to Follow-up|1|||
42335236|NCT02091362|76172842|FG000|Period 1|Adverse Event|2|||
42335237|NCT02091362|76172843|FG001|Period 1|Adverse Event|0|||
42335238|NCT02091362|76172842|FG000|Wash-out|Lost to Follow-up|1|||
42335239|NCT02091362|76172843|FG001|Wash-out|Lost to Follow-up|1|||
42335240|NCT02091362|76172842|FG000|Wash-out|Withdrawal by Subject|0|||
42335241|NCT02091362|76172843|FG001|Wash-out|Withdrawal by Subject|2|||
42335242|NCT02091362|76172842|FG000|Period 2|Adverse Event|1|||
42335243|NCT02091362|76172843|FG001|Period 2|Adverse Event|0|||
42335244|NCT02091362|76172842|FG000|Period 2|Lost to Follow-up|0|||
42335245|NCT02091362|76172843|FG001|Period 2|Lost to Follow-up|1|||
42335246|NCT02091362|76172842|FG000|Period 2|Withdrawal by Subject|1|||
42335247|NCT02091362|76172843|FG001|Period 2|Withdrawal by Subject|1|||
42000231|NCT01113502|75808747|FG004|Overall Study|Withdrawal by Subject|0|||
42000232|NCT01113502|75808743|FG000|Overall Study|Adverse Event|0|||
42000233|NCT01113502|75808744|FG001|Overall Study|Adverse Event|0|||
42000234|NCT01113502|75808745|FG002|Overall Study|Adverse Event|3|||
42272721|NCT01657370|76103056|FG001|Overall Study|Adverse Event|0|||
42335248|NCT02150057|76172855|FG000|Overall Study|Lost to Follow-up|6|||
42335249|NCT02150057|76172856|FG001|Overall Study|Lost to Follow-up|4|||
42335250|NCT02064296|76172865|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
42000235|NCT01113502|75808746|FG003|Overall Study|Adverse Event|2|||
42272722|NCT01657370|76103057|FG002|Overall Study|Adverse Event|0|||
42272723|NCT01657370|76103058|FG003|Overall Study|Adverse Event|0|||
42272724|NCT01657370|76103059|FG004|Overall Study|Adverse Event|1|||
42272725|NCT01657370|76103060|FG005|Overall Study|Adverse Event|0|||
42272726|NCT01657370|76103055|FG000|Overall Study|Protocol Violation|1|||
42272727|NCT01657370|76103056|FG001|Overall Study|Protocol Violation|1|||
42272728|NCT01657370|76103057|FG002|Overall Study|Protocol Violation|1|||
42272729|NCT01657370|76103058|FG003|Overall Study|Protocol Violation|1|||
42272730|NCT01657370|76103059|FG004|Overall Study|Protocol Violation|0|||
42272731|NCT01657370|76103060|FG005|Overall Study|Protocol Violation|0|||
42335251|NCT02064296|76172866|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
42335252|NCT02064296|76172867|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
42335253|NCT02064296|76172865|FG000|Intervention|Withdrawal by Subject|0|||
42335254|NCT02064296|76172866|FG001|Intervention|Withdrawal by Subject|1|||
42335255|NCT02064296|76172867|FG002|Intervention|Withdrawal by Subject|2|||
42335256|NCT02063984|76172879|FG000|Overall Study|Lost to Follow-up|6|||
42335257|NCT02063984|76172880|FG001|Overall Study|Lost to Follow-up|5|||
42335258|NCT02091284|76172892|FG000|Overall Study|Withdrawal by Subject|2|||
42335259|NCT02091284|76172893|FG001|Overall Study|Withdrawal by Subject|1|||
42335260|NCT02091284|76172892|FG000|Overall Study|unreliable data|1|||
42335261|NCT02091284|76172893|FG001|Overall Study|unreliable data|0|||
42335262|NCT02115386|76172901|FG000|Overall Study|Protocol Violation|1|||
42335263|NCT02115386|76172901|FG000|Overall Study|Administrative - trial was terminated|6|||
42335264|NCT02091206|76172909|FG000|Treatment Period|Adverse Event|0|||
42335265|NCT02091206|76172910|FG001|Treatment Period|Adverse Event|1|||
42335266|NCT02091206|76172911|FG002|Treatment Period|Adverse Event|0|||
42335267|NCT02091206|76172912|FG003|Treatment Period|Adverse Event|0|||
42335268|NCT02091206|76172909|FG000|Treatment Period|Met withdrawal criteria|0|||
42335269|NCT02091206|76172910|FG001|Treatment Period|Met withdrawal criteria|0|||
42134622|NCT03953183|75945518|FG000|Overall Study|Withdrawal by Subject|0|||
42134623|NCT03953183|75945519|FG001|Overall Study|Withdrawal by Subject|1|||
42134624|NCT00406653|75945529|FG000|Induction Period|Adverse Event|1|||
42265246|NCT01370603|76093271|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
42134625|NCT00406653|75945530|FG001|Induction Period|Adverse Event|10|||
42134626|NCT00406653|75945531|FG002|Induction Period|Adverse Event|4|||
42134627|NCT00406653|75945532|FG003|Induction Period|Adverse Event|11|||
42134628|NCT00406653|75945533|FG004|Induction Period|Adverse Event|0|||
42134629|NCT00406653|75945534|FG005|Induction Period|Adverse Event|0|||
42134630|NCT00406653|75945535|FG006|Induction Period|Adverse Event|0|||
42134631|NCT00406653|75945529|FG000|Induction Period|Lack of Efficacy|11|||
42265247|NCT01370603|76093272|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
42265248|NCT01370603|76093271|FG000|Period 2|Adverse Event|1|||
42265249|NCT01370603|76093272|FG001|Period 2|Adverse Event|4|||
42265250|NCT01370603|76093271|FG000|Period 2|Lost to Follow-up|1|||
42335270|NCT02091206|76172911|FG002|Treatment Period|Met withdrawal criteria|1|||
42335271|NCT02091206|76172912|FG003|Treatment Period|Met withdrawal criteria|0|||
42335272|NCT02091206|76172909|FG000|Taper Period|Participant refused study drug|1|||
42335273|NCT02091206|76172910|FG001|Taper Period|Participant refused study drug|0|||
42335274|NCT02091206|76172911|FG002|Taper Period|Participant refused study drug|0|||
42335275|NCT02091206|76172912|FG003|Taper Period|Participant refused study drug|1|||
42335276|NCT02091206|76172909|FG000|Taper Period|Lost to Follow-up|0|||
42335277|NCT02091206|76172910|FG001|Taper Period|Lost to Follow-up|0|||
42335278|NCT02091206|76172911|FG002|Taper Period|Lost to Follow-up|0|||
42335279|NCT02091206|76172912|FG003|Taper Period|Lost to Follow-up|1|||
42335280|NCT02090426|76172924|FG000|Overall Study|Lost to Follow-up|12|||
42335281|NCT02090426|76172925|FG001|Overall Study|Lost to Follow-up|6|||
42335282|NCT02063828|76172934|FG000|Overall Study|Withdrawal by Subject|4|||
42335283|NCT02063828|76172935|FG001|Overall Study|Withdrawal by Subject|6|||
42335284|NCT02063828|76172936|FG002|Overall Study|Withdrawal by Subject|3|||
42335285|NCT02063828|76172934|FG000|Overall Study|Death|0|||
42335286|NCT02063828|76172935|FG001|Overall Study|Death|0|||
42335287|NCT02063828|76172936|FG002|Overall Study|Death|1|||
42335288|NCT02063672|76172946|FG000|Overall Study|Ongoing Follow-up|27|||
42335289|NCT02063672|76172947|FG001|Overall Study|Ongoing Follow-up|14|||
42335290|NCT02063672|76172946|FG000|Overall Study|Death|5|||
42265251|NCT01370603|76093272|FG001|Period 2|Lost to Follow-up|0|||
42265252|NCT01370603|76093271|FG000|Period 2|Withdrawal by Subject|1|||
42265253|NCT01370603|76093272|FG001|Period 2|Withdrawal by Subject|0|||
42265254|NCT02347072|76093278|FG000|Overall Study|Adverse Event|2|||
42265255|NCT02347072|76093278|FG000|Overall Study|Withdrawal by Subject|6|||
42265256|NCT02347072|76093278|FG000|Overall Study|Physician Decision|1|||
42335291|NCT02063672|76172947|FG001|Overall Study|Death|3|||
42335292|NCT02063672|76172946|FG000|Overall Study|Lost to Follow-up|1|||
42335293|NCT02063672|76172947|FG001|Overall Study|Lost to Follow-up|3|||
42335294|NCT02063672|76172946|FG000|Overall Study|Withdrawal by Subject|2|||
42335295|NCT02063672|76172947|FG001|Overall Study|Withdrawal by Subject|2|||
42134632|NCT00406653|75945530|FG001|Induction Period|Lack of Efficacy|14|||
42134633|NCT00406653|75945531|FG002|Induction Period|Lack of Efficacy|8|||
42265257|NCT02347072|76093278|FG000|Overall Study|Lost to Follow-up|2|||
42134634|NCT00406653|75945532|FG003|Induction Period|Lack of Efficacy|10|||
42134635|NCT00406653|75945533|FG004|Induction Period|Lack of Efficacy|0|||
42134636|NCT00406653|75945534|FG005|Induction Period|Lack of Efficacy|0|||
42265258|NCT02347072|76093278|FG000|Overall Study|Protocol Violation|1|||
42335296|NCT02062658|76172953|FG000|Overall Study|Withdrawal by Subject|1|||
42335297|NCT02062658|76172953|FG000|Overall Study|Lack of Efficacy|1|||
42335298|NCT02115308|76172959|FG000|Overall Study|Safety Screening|2|||
42335299|NCT02115308|76172960|FG001|Overall Study|Safety Screening|2|||
42335300|NCT02114684|76172972|FG000|Overall Study|Death|6|||
42335301|NCT02114684|76172973|FG001|Overall Study|Death|4|||
42335302|NCT02114684|76172972|FG000|Overall Study|Lost to Follow-up|1|||
42335303|NCT02114684|76172973|FG001|Overall Study|Lost to Follow-up|2|||
42335304|NCT02114684|76172972|FG000|Overall Study|Withdrawal by Subject|1|||
42335305|NCT02114684|76172973|FG001|Overall Study|Withdrawal by Subject|2|||
42335306|NCT02114684|76172972|FG000|Overall Study|Relocation|3|||
42335307|NCT02114684|76172973|FG001|Overall Study|Relocation|1|||
42335308|NCT02114684|76172972|FG000|Overall Study|Rifampicin resistant on culture|0|||
42335309|NCT02114684|76172973|FG001|Overall Study|Rifampicin resistant on culture|1|||
42335310|NCT02114684|76172972|FG000|Overall Study|Patient Incarcerated|1|||
42335311|NCT02114684|76172973|FG001|Overall Study|Patient Incarcerated|0|||
42335312|NCT02090114|76172987|FG000|Overall Study|Withdrawal by Subject|3|||
42335313|NCT02090114|76172988|FG001|Overall Study|Withdrawal by Subject|6|||
42335314|NCT02090114|76172989|FG002|Overall Study|Withdrawal by Subject|2|||
42335315|NCT02090114|76172990|FG003|Overall Study|Withdrawal by Subject|1|||
42335316|NCT02090114|76172987|FG000|Overall Study|Physician Decision|5|||
42335317|NCT02090114|76172988|FG001|Overall Study|Physician Decision|0|||
42335318|NCT02090114|76172989|FG002|Overall Study|Physician Decision|1|||
42335319|NCT02090114|76172990|FG003|Overall Study|Physician Decision|1|||
42335320|NCT02090114|76172987|FG000|Overall Study|Adverse Event|1|||
42335321|NCT02090114|76172988|FG001|Overall Study|Adverse Event|2|||
42335322|NCT02090114|76172989|FG002|Overall Study|Adverse Event|2|||
42335323|NCT02090114|76172990|FG003|Overall Study|Adverse Event|0|||
42335324|NCT02090114|76172987|FG000|Overall Study|Progressive Disease|20|||
42335325|NCT02090114|76172988|FG001|Overall Study|Progressive Disease|21|||
42335326|NCT02090114|76172989|FG002|Overall Study|Progressive Disease|23|||
42335327|NCT02090114|76172990|FG003|Overall Study|Progressive Disease|6|||
42335328|NCT02090114|76172987|FG000|Overall Study|Death|1|||
42335329|NCT02090114|76172988|FG001|Overall Study|Death|0|||
42335330|NCT02090114|76172989|FG002|Overall Study|Death|1|||
42335331|NCT02090114|76172990|FG003|Overall Study|Death|0|||
42335332|NCT01623050|76173000|FG000|Overall Study|Lost to Follow-up|9|||
42335333|NCT02089334|76173008|FG000|Overall Study|Withdrawal by Subject|0|||
42335334|NCT02089334|76173009|FG001|Overall Study|Withdrawal by Subject|0|||
42335335|NCT02089334|76173010|FG002|Overall Study|Withdrawal by Subject|0|||
42335336|NCT02089334|76173011|FG003|Overall Study|Withdrawal by Subject|2|||
42335337|NCT02089334|76173008|FG000|Overall Study|Adverse Event|0|||
42335338|NCT02089334|76173009|FG001|Overall Study|Adverse Event|0|||
42335339|NCT02089334|76173010|FG002|Overall Study|Adverse Event|0|||
42335340|NCT02089334|76173011|FG003|Overall Study|Adverse Event|2|||
42335341|NCT02089334|76173008|FG000|Overall Study|Progressive disease|0|||
42335342|NCT02089334|76173009|FG001|Overall Study|Progressive disease|0|||
42335343|NCT02089334|76173010|FG002|Overall Study|Progressive disease|0|||
42335344|NCT02089334|76173011|FG003|Overall Study|Progressive disease|2|||
42000236|NCT01113502|75808747|FG004|Overall Study|Adverse Event|0|||
42000237|NCT01113463|75808760|FG000|Overall Study|Physician Decision|5|||
42000238|NCT01112917|75808764|FG000|Overall Study|Death|2|||
42335345|NCT02089334|76173008|FG000|Overall Study|Physician Decision|0|||
42335346|NCT02089334|76173009|FG001|Overall Study|Physician Decision|0|||
42335347|NCT02089334|76173010|FG002|Overall Study|Physician Decision|1|||
42000239|NCT01112917|75808765|FG001|Overall Study|Death|11|||
42000240|NCT01112917|75808764|FG000|Overall Study|Lost to Follow-up|1|||
42000241|NCT01112917|75808765|FG001|Overall Study|Lost to Follow-up|1|||
42335348|NCT02089334|76173011|FG003|Overall Study|Physician Decision|1|||
42335349|NCT02114606|76173024|FG000|Overall Study|Unable to swallow Cytosponge|6|||
42335350|NCT02113436|76173030|FG000|Period 1: 8 Weeks|Adverse Event|1|||
42335351|NCT02113436|76173031|FG001|Period 1: 8 Weeks|Adverse Event|0|||
42335352|NCT02113436|76173032|FG002|Period 1: 8 Weeks|Adverse Event|0|||
42335353|NCT02113436|76173033|FG003|Period 1: 8 Weeks|Adverse Event|0|||
42335354|NCT02113436|76173030|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
42335355|NCT02113436|76173031|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
42335356|NCT02113436|76173032|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
42335357|NCT02113436|76173033|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
42335358|NCT02113436|76173030|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
42335359|NCT02113436|76173031|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
42335360|NCT02113436|76173032|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
42335361|NCT02113436|76173033|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
42335362|NCT02113436|76173030|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
42335363|NCT02113436|76173031|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
42335364|NCT02113436|76173032|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
42335365|NCT02113436|76173033|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
42335366|NCT02113436|76173030|FG000|Period 2: 16 Weeks|Adverse Event|0|||
42335367|NCT02113436|76173031|FG001|Period 2: 16 Weeks|Adverse Event|0|||
42335368|NCT02113436|76173032|FG002|Period 2: 16 Weeks|Adverse Event|4|||
42335369|NCT02113436|76173033|FG003|Period 2: 16 Weeks|Adverse Event|5|||
42335370|NCT02113436|76173030|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
42335371|NCT02113436|76173031|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
42335372|NCT02113436|76173032|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
42335373|NCT02113436|76173033|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
42335374|NCT02113436|76173030|FG000|Period 2: 16 Weeks|Physician Decision|0|||
42335375|NCT02113436|76173031|FG001|Period 2: 16 Weeks|Physician Decision|0|||
42335376|NCT02113436|76173032|FG002|Period 2: 16 Weeks|Physician Decision|2|||
42335377|NCT02113436|76173033|FG003|Period 2: 16 Weeks|Physician Decision|0|||
42335378|NCT02113436|76173030|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
42335379|NCT02113436|76173031|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
42335380|NCT02113436|76173032|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
42335381|NCT02113436|76173033|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
42335382|NCT02113124|76173044|FG000|Overall Study|Unable to retrieve blood sample|1|||
42335383|NCT02113124|76173045|FG001|Overall Study|Unable to retrieve blood sample|1|||
42335384|NCT02087774|76173053|FG000|Overall Study|Were absent day of data collection|8|||
42335385|NCT02087774|76173054|FG001|Overall Study|Were absent day of data collection|20|||
42335386|NCT02111564|76173062|FG000|Overall Study|Death|109|||
42335387|NCT02111564|76173063|FG001|Overall Study|Death|120|||
42335388|NCT02111564|76173062|FG000|Overall Study|Lost to Follow-up|2|||
42335389|NCT02111564|76173063|FG001|Overall Study|Lost to Follow-up|3|||
42335390|NCT02111564|76173062|FG000|Overall Study|Withdrawal by Subject|20|||
42335391|NCT02111564|76173063|FG001|Overall Study|Withdrawal by Subject|20|||
42335392|NCT02087150|76173072|FG000|Overall Study|Death|0|||
42335393|NCT02087150|76173073|FG001|Overall Study|Death|1|||
42335394|NCT02087150|76173074|FG002|Overall Study|Death|0|||
42335395|NCT02087150|76173072|FG000|Overall Study|Lost to Follow-up|6|||
42335396|NCT02087150|76173073|FG001|Overall Study|Lost to Follow-up|13|||
42335397|NCT02087150|76173074|FG002|Overall Study|Lost to Follow-up|7|||
42335398|NCT02087150|76173072|FG000|Overall Study|Withdrawal by Subject|2|||
42335399|NCT02087150|76173073|FG001|Overall Study|Withdrawal by Subject|5|||
42335400|NCT02087150|76173074|FG002|Overall Study|Withdrawal by Subject|3|||
42335401|NCT02087150|76173072|FG000|Overall Study|Physician Decision|0|||
42335402|NCT02087150|76173073|FG001|Overall Study|Physician Decision|1|||
42335403|NCT02087150|76173074|FG002|Overall Study|Physician Decision|0|||
42335404|NCT02087150|76173072|FG000|Overall Study|Procedure not done|1|||
42335405|NCT02087150|76173073|FG001|Overall Study|Procedure not done|13|||
42335406|NCT02087150|76173074|FG002|Overall Study|Procedure not done|0|||
42034726|NCT01061736|75842939|FG001|Overall Study|Dose regimen not selected|0|||
42335407|NCT02087150|76173072|FG000|Overall Study|F/U not completed w/in study window|0|||
42134637|NCT00406653|75945535|FG006|Induction Period|Lack of Efficacy|0|||
42335408|NCT02087150|76173073|FG001|Overall Study|F/U not completed w/in study window|0|||
42335409|NCT02087150|76173074|FG002|Overall Study|F/U not completed w/in study window|1|||
42335410|NCT02087150|76173072|FG000|Overall Study|Other|1|||
42335411|NCT02087150|76173073|FG001|Overall Study|Other|0|||
42335412|NCT02087150|76173074|FG002|Overall Study|Other|0|||
42335413|NCT02087150|76173072|FG000|Overall Study|Pt moved out of town|0|||
42335414|NCT02087150|76173073|FG001|Overall Study|Pt moved out of town|1|||
42335415|NCT02087150|76173074|FG002|Overall Study|Pt moved out of town|0|||
42335416|NCT02111174|76173085|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
42335417|NCT02111174|76173086|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
42335418|NCT02111174|76173085|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
42335419|NCT02111174|76173086|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
42335420|NCT02111174|76173085|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
42335421|NCT02111174|76173086|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
42335422|NCT02111174|76173085|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
42335423|NCT02111174|76173086|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
42335424|NCT02111096|76173095|FG000|Overall Study|Adverse Event|4|||
42335425|NCT02111096|76173096|FG001|Overall Study|Adverse Event|1|||
42335426|NCT02111096|76173097|FG002|Overall Study|Adverse Event|2|||
42335427|NCT02111096|76173095|FG000|Overall Study|Non-Compliance with Study Drug|1|||
42335428|NCT02111096|76173096|FG001|Overall Study|Non-Compliance with Study Drug|1|||
42335429|NCT02111096|76173097|FG002|Overall Study|Non-Compliance with Study Drug|0|||
42335430|NCT02111096|76173095|FG000|Overall Study|Lost to Follow Up|1|||
42335431|NCT02111096|76173096|FG001|Overall Study|Lost to Follow Up|1|||
42335432|NCT02111096|76173097|FG002|Overall Study|Lost to Follow Up|1|||
42335433|NCT02111096|76173095|FG000|Overall Study|Physician Decision|0|||
42335434|NCT02111096|76173096|FG001|Overall Study|Physician Decision|1|||
42335435|NCT02111096|76173097|FG002|Overall Study|Physician Decision|0|||
42335436|NCT02111096|76173095|FG000|Overall Study|Protocol Violation|1|||
42335437|NCT02111096|76173096|FG001|Overall Study|Protocol Violation|0|||
42335438|NCT02111096|76173097|FG002|Overall Study|Protocol Violation|1|||
42335439|NCT02111096|76173095|FG000|Overall Study|Terminated by Sponsor|53|||
42335440|NCT02111096|76173096|FG001|Overall Study|Terminated by Sponsor|35|||
42335441|NCT02111096|76173097|FG002|Overall Study|Terminated by Sponsor|54|||
42335442|NCT02111096|76173095|FG000|Overall Study|Withdrawal by Subject|4|||
42335443|NCT02111096|76173096|FG001|Overall Study|Withdrawal by Subject|2|||
42335444|NCT02111096|76173097|FG002|Overall Study|Withdrawal by Subject|8|||
42335445|NCT02110706|76173110|FG000|Overall Study|Adverse Event|2|||
42335446|NCT02110706|76173111|FG001|Overall Study|Adverse Event|3|||
42335447|NCT02110706|76173110|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
42335448|NCT02110706|76173111|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
42335449|NCT02110238|76173121|FG000|12 Week Pivotal Phase|Adverse Event|3|||
42335450|NCT02110238|76173122|FG001|12 Week Pivotal Phase|Adverse Event|0|||
42335451|NCT02110238|76173121|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
42335452|NCT02110238|76173122|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
42335453|NCT02110238|76173121|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
42335454|NCT02110238|76173122|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
42335455|NCT02110238|76173121|FG000|12 Week Pivotal Phase|Physician Decision|0|||
42335456|NCT02110238|76173122|FG001|12 Week Pivotal Phase|Physician Decision|2|||
42335457|NCT02110238|76173121|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
42335458|NCT02110238|76173122|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
42335459|NCT02110238|76173121|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
42335460|NCT02110238|76173122|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
42335461|NCT02110238|76173121|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
42335462|NCT02110238|76173122|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
42335463|NCT02110238|76173121|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
42335464|NCT02110238|76173122|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
42335465|NCT02110238|76173121|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
42335466|NCT02110238|76173122|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
42335467|NCT02110238|76173121|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
42335468|NCT02110238|76173122|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
42335469|NCT02110238|76173121|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
42335470|NCT02110238|76173122|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
42335471|NCT02108912|76173130|FG000|Overall Study|Lost to Follow-up|1|||
42335472|NCT02108912|76173131|FG001|Overall Study|Lost to Follow-up|1|||
42000242|NCT01112917|75808764|FG000|Overall Study|Withdrawal by Subject|1|||
42335473|NCT02108912|76173130|FG000|Overall Study|lack of transportation|1|||
42000243|NCT01112917|75808765|FG001|Overall Study|Withdrawal by Subject|3|||
42000244|NCT01112917|75808764|FG000|Overall Study|Unable to Convert Filter|3|||
42335474|NCT02108912|76173131|FG001|Overall Study|lack of transportation|0|||
42335475|NCT02108912|76173130|FG000|Overall Study|high blood pressure|1|||
42335476|NCT02108912|76173131|FG001|Overall Study|high blood pressure|0|||
42335477|NCT02108600|76173139|FG000|Overall Study|Withdrawal by Subject|2|||
42335478|NCT02108600|76173140|FG001|Overall Study|Withdrawal by Subject|0|||
42335479|NCT02108600|76173139|FG000|Overall Study|Lost to Follow-up|1|||
42335480|NCT02108600|76173140|FG001|Overall Study|Lost to Follow-up|1|||
42335481|NCT02107898|76173148|FG000|Overall Study|Adverse Event|4|||
42335482|NCT02107898|76173149|FG001|Overall Study|Adverse Event|7|||
42335483|NCT02107898|76173148|FG000|Overall Study|Poor compliance to protocol|0|||
42335484|NCT02107898|76173149|FG001|Overall Study|Poor compliance to protocol|1|||
42335485|NCT02107898|76173148|FG000|Overall Study|Participant moved|0|||
42335486|NCT02107898|76173149|FG001|Overall Study|Participant moved|2|||
42335487|NCT02107898|76173148|FG000|Overall Study|Consent withdrawn by participant|2|||
42335488|NCT02107898|76173149|FG001|Overall Study|Consent withdrawn by participant|1|||
42335489|NCT02107898|76173148|FG000|Overall Study|Randomized but not treated|0|||
42335490|NCT02107898|76173149|FG001|Overall Study|Randomized but not treated|1|||
42335491|NCT02059148|76173155|FG000|Treatment 1|Protocol Violation|0|||
42335492|NCT02059148|76173156|FG001|Treatment 1|Protocol Violation|0|||
42335493|NCT02059148|76173157|FG002|Treatment 1|Protocol Violation|0|||
42335494|NCT02059148|76173158|FG003|Treatment 1|Protocol Violation|0|||
42000245|NCT01112917|75808765|FG001|Overall Study|Unable to Convert Filter|0|||
42134638|NCT00406653|75945529|FG000|Induction Period|Lost to Follow-up|0|||
42335495|NCT02059148|76173159|FG004|Treatment 1|Protocol Violation|0|||
42335496|NCT02059148|76173160|FG005|Treatment 1|Protocol Violation|1|||
42335497|NCT02058992|76173171|FG000|Overall Study|Lost to Follow-up|4|||
42335498|NCT02058992|76173171|FG000|Overall Study|Protocol Violation|92|||
42335499|NCT02058992|76173171|FG000|Overall Study|CRF Uncollected|20|||
42335500|NCT02058836|76173177|FG000|Overall Study|Withdrawal by Subject|1|||
42335501|NCT02058836|76173178|FG001|Overall Study|Withdrawal by Subject|1|||
42335502|NCT02107274|76173186|FG000|Treatment vs. Placebo|Adverse Event|3|||
42335503|NCT02107274|76173187|FG001|Treatment vs. Placebo|Adverse Event|0|||
42335504|NCT02107274|76173186|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
42335505|NCT02107274|76173187|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
42335506|NCT02107274|76173186|FG000|Control Phase|Lost to Follow-up|1|||
42335507|NCT02107274|76173187|FG001|Control Phase|Lost to Follow-up|1|||
42335508|NCT02107274|76173186|FG000|Control Phase|Death|2|||
42335509|NCT02107274|76173187|FG001|Control Phase|Death|0|||
42335510|NCT02107274|76173186|FG000|Control Phase|Adverse Event|0|||
42335511|NCT02107274|76173187|FG001|Control Phase|Adverse Event|1|||
42335512|NCT02174627|76173195|FG000|Overall Study|Missing|0|||
42335513|NCT02174627|76173196|FG001|Overall Study|Missing|1|||
42335514|NCT02174627|76173195|FG000|Overall Study|Incorrect enrolment before randomization|0|||
42335515|NCT02174627|76173196|FG001|Overall Study|Incorrect enrolment before randomization|1|||
42335516|NCT02174627|76173195|FG000|Overall Study|Participant decision|84|||
42335517|NCT02174627|76173196|FG001|Overall Study|Participant decision|128|||
42335518|NCT02173769|76173202|FG000|Overall Study|Protocol Violation|4|||
42335519|NCT02121509|76173209|FG000|Washout Period (35 Days)|Adverse Event|1|||
42335520|NCT02121509|76173210|FG001|Washout Period (35 Days)|Adverse Event|1|||
42335521|NCT02121509|76173211|FG002|Washout Period (35 Days)|Adverse Event|0|||
42335522|NCT02121509|76173212|FG003|Washout Period (35 Days)|Adverse Event|0|||
42335523|NCT02121509|76173209|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
42335524|NCT02121509|76173210|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
42335525|NCT02121509|76173211|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
42335526|NCT02121509|76173212|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
42335527|NCT02121509|76173209|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
42265259|NCT02347072|76093278|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
42265260|NCT02794103|76093286|FG000|Overall Study|Loss to follow up due to high sedation|3|||
42265261|NCT02346370|76093293|FG000|Overall Study|Not treated|1|||
42265262|NCT02346370|76093294|FG001|Overall Study|Not treated|0|||
42265263|NCT02346370|76093295|FG002|Overall Study|Not treated|0|||
42265264|NCT02346370|76093293|FG000|Overall Study|Withdrawal of consent|1|||
42265265|NCT02346370|76093294|FG001|Overall Study|Withdrawal of consent|0|||
42265266|NCT02346370|76093295|FG002|Overall Study|Withdrawal of consent|0|||
42265267|NCT02346370|76093293|FG000|Overall Study|Death|1|||
42000246|NCT01176058|75808771|FG000|Overall Study|Adverse Event|1|||
42000247|NCT01176058|75808772|FG001|Overall Study|Adverse Event|0|||
42000248|NCT01176058|75808771|FG000|Overall Study|Insufficient clinical response|2|||
42335528|NCT02121509|76173210|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
42335529|NCT02121509|76173211|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
42335530|NCT02121509|76173212|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
42335531|NCT02149199|76173225|FG000|Overall Study|Study specific withdrawal criteria|4|||
42335532|NCT02149199|76173226|FG001|Overall Study|Study specific withdrawal criteria|21|||
42335533|NCT02149199|76173227|FG002|Overall Study|Study specific withdrawal criteria|6|||
42335534|NCT02149199|76173225|FG000|Overall Study|Other|20|||
42335535|NCT02149199|76173226|FG001|Overall Study|Other|25|||
42335536|NCT02149199|76173227|FG002|Overall Study|Other|20|||
42335537|NCT02149199|76173225|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
42335538|NCT02149199|76173226|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
42265268|NCT02346370|76093294|FG001|Overall Study|Death|3|||
42265269|NCT02346370|76093295|FG002|Overall Study|Death|1|||
42335539|NCT02149199|76173227|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
42335540|NCT02149199|76173225|FG000|Overall Study|Withdrawal by Subject|75|||
42335541|NCT02149199|76173226|FG001|Overall Study|Withdrawal by Subject|93|||
42335542|NCT02149199|76173227|FG002|Overall Study|Withdrawal by Subject|77|||
42335543|NCT02149199|76173225|FG000|Overall Study|Protocol Violation|16|||
42265270|NCT02346370|76093293|FG000|Overall Study|Sponsor discontinued study|5|||
42265271|NCT02346370|76093294|FG001|Overall Study|Sponsor discontinued study|0|||
42265272|NCT02346370|76093295|FG002|Overall Study|Sponsor discontinued study|2|||
42265273|NCT02346370|76093293|FG000|Overall Study|Radiologic progression|0|||
42265274|NCT02346370|76093294|FG001|Overall Study|Radiologic progression|0|||
42265275|NCT02346370|76093295|FG002|Overall Study|Radiologic progression|1|||
42265276|NCT02346370|76093293|FG000|Overall Study|Physician Decision|0|||
42265277|NCT02346370|76093294|FG001|Overall Study|Physician Decision|1|||
42265278|NCT02346370|76093295|FG002|Overall Study|Physician Decision|0|||
42265279|NCT02346136|76093307|FG000|Overall Study|Withdrawal by Subject|7|||
42265280|NCT02346136|76093308|FG001|Overall Study|Withdrawal by Subject|5|||
42265281|NCT02346136|76093307|FG000|Overall Study|Death|1|||
42265282|NCT02346136|76093308|FG001|Overall Study|Death|0|||
42265283|NCT02346136|76093307|FG000|Overall Study|Study termination|14|||
42265284|NCT02346136|76093308|FG001|Overall Study|Study termination|18|||
42265285|NCT02793947|76093316|FG000|Overall Study|Death|1|||
42265286|NCT02793947|76093317|FG001|Overall Study|Death|0|||
42265287|NCT02793947|76093316|FG000|Overall Study|Physician Decision|1|||
42265288|NCT02793947|76093317|FG001|Overall Study|Physician Decision|5|||
42265289|NCT02345512|76093323|FG000|Overall Study|Adverse Event|1|||
42265290|NCT02345512|76093323|FG000|Overall Study|Withdrawal by Subject|1|||
42265291|NCT02345434|76093334|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
42265292|NCT02345434|76093335|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
42265293|NCT01370213|76093344|FG000|Overall Study|Early Death|1|||
42000249|NCT01176058|75808772|FG001|Overall Study|Insufficient clinical response|2|||
42265294|NCT01370213|76093345|FG001|Overall Study|Early Death|0|||
42265295|NCT01370213|76093346|FG002|Overall Study|Early Death|0|||
42265296|NCT01370213|76093344|FG000|Overall Study|Not evaluable|0|||
42265297|NCT01370213|76093345|FG001|Overall Study|Not evaluable|2|||
42265298|NCT01370213|76093346|FG002|Overall Study|Not evaluable|0|||
42265299|NCT01370525|76093355|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
42265300|NCT01370525|76093356|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
42265301|NCT01370525|76093355|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
42265302|NCT01370525|76093356|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
42265303|NCT01370525|76093355|FG000|Overall Study|Adverse Event|0|||
42265304|NCT01370525|76093356|FG001|Overall Study|Adverse Event|1|||
42265305|NCT01370525|76093355|FG000|Overall Study|Protocol Violation|2|||
42335544|NCT02149199|76173226|FG001|Overall Study|Protocol Violation|13|||
42335545|NCT02149199|76173227|FG002|Overall Study|Protocol Violation|15|||
42335546|NCT02149199|76173225|FG000|Overall Study|Lost to Follow-up|3|||
42335547|NCT02149199|76173226|FG001|Overall Study|Lost to Follow-up|12|||
42335548|NCT02149199|76173227|FG002|Overall Study|Lost to Follow-up|11|||
42335549|NCT02149199|76173225|FG000|Overall Study|Death|0|||
42335550|NCT02149199|76173226|FG001|Overall Study|Death|0|||
42335551|NCT02149199|76173227|FG002|Overall Study|Death|1|||
42335552|NCT02149199|76173225|FG000|Overall Study|Adverse Event|6|||
42335553|NCT02149199|76173226|FG001|Overall Study|Adverse Event|15|||
42335554|NCT02149199|76173227|FG002|Overall Study|Adverse Event|9|||
42335555|NCT02120417|76173237|FG000|Overall Study|Death|5|||
42335556|NCT02120417|76173238|FG001|Overall Study|Death|1|||
42335557|NCT02120417|76173237|FG000|Overall Study|Adverse Event|3|||
42335558|NCT02120417|76173238|FG001|Overall Study|Adverse Event|9|||
42335559|NCT02120417|76173237|FG000|Overall Study|Participant decision|4|||
42335560|NCT02120417|76173238|FG001|Overall Study|Participant decision|4|||
42335561|NCT02120417|76173237|FG000|Overall Study|Disease progression|41|||
42335562|NCT02120417|76173238|FG001|Overall Study|Disease progression|45|||
42335563|NCT02120417|76173237|FG000|Overall Study|Noncompliance with study treatment|0|||
42000250|NCT01176058|75808771|FG000|Overall Study|Insufficient mycological response|0|||
42000251|NCT01176058|75808772|FG001|Overall Study|Insufficient mycological response|1|||
42265306|NCT01370525|76093356|FG001|Overall Study|Protocol Violation|1|||
42265307|NCT01370525|76093355|FG000|Overall Study|Lost to follow up|2|||
42265308|NCT01370525|76093356|FG001|Overall Study|Lost to follow up|6|||
42265309|NCT02792777|76093364|FG000|Overall Study|Withdrawal by Subject|2|||
42265310|NCT02792777|76093365|FG001|Overall Study|Withdrawal by Subject|0|||
42265311|NCT02792777|76093364|FG000|Overall Study|Recording malfunction|2|||
42265312|NCT02792777|76093365|FG001|Overall Study|Recording malfunction|0|||
42265313|NCT02792777|76093364|FG000|Overall Study|Later determined to be ineligible|2|||
42265314|NCT02792777|76093365|FG001|Overall Study|Later determined to be ineligible|0|||
42265315|NCT02792777|76093364|FG000|Overall Study|Participant interviewed twice|1|||
42265316|NCT02792777|76093365|FG001|Overall Study|Participant interviewed twice|0|||
42265317|NCT02625974|76093374|FG000|Overall Study|Adverse Event|12|||
42265318|NCT02625974|76093375|FG001|Overall Study|Adverse Event|2|||
42265319|NCT02625974|76093374|FG000|Overall Study|Withdrawal by Subject|3|||
42265320|NCT02625974|76093375|FG001|Overall Study|Withdrawal by Subject|1|||
42265321|NCT02625974|76093374|FG000|Overall Study|positive parasitemia|1|||
42265322|NCT02625974|76093375|FG001|Overall Study|positive parasitemia|0|||
42265323|NCT02625974|76093374|FG000|Overall Study|non-compliance with study drug|0|||
42265324|NCT02625974|76093375|FG001|Overall Study|non-compliance with study drug|2|||
42265325|NCT02625974|76093374|FG000|Overall Study|Protocol Violation|0|||
42335564|NCT02120417|76173238|FG001|Overall Study|Noncompliance with study treatment|2|||
42335565|NCT02120417|76173237|FG000|Overall Study|Physician Decision|2|||
42335566|NCT02120417|76173238|FG001|Overall Study|Physician Decision|3|||
42335567|NCT02120417|76173237|FG000|Overall Study|Other unspecified|5|||
42265326|NCT02625974|76093375|FG001|Overall Study|Protocol Violation|1|||
42335568|NCT02120417|76173238|FG001|Overall Study|Other unspecified|4|||
42335569|NCT02148263|76173246|FG000|Overall Study|Withdrawal by Subject|3|||
42335570|NCT02148263|76173247|FG001|Overall Study|Withdrawal by Subject|2|||
42335571|NCT02147561|76173253|FG000|Overall Study|Lost to Follow-up|3|||
42335572|NCT02147561|76173253|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
42335573|NCT02058368|76173259|FG000|Overall Study|Adverse Event|15|||
42335574|NCT02058368|76173260|FG001|Overall Study|Adverse Event|20|||
42335575|NCT02058368|76173259|FG000|Overall Study|Lack of Efficacy|0|||
42335576|NCT02058368|76173260|FG001|Overall Study|Lack of Efficacy|1|||
42335577|NCT02058368|76173259|FG000|Overall Study|Protocol Violation|0|||
42335578|NCT02058368|76173260|FG001|Overall Study|Protocol Violation|4|||
42335579|NCT02058368|76173259|FG000|Overall Study|Lost to Follow-up|2|||
42335580|NCT02058368|76173260|FG001|Overall Study|Lost to Follow-up|0|||
42335581|NCT02058368|76173259|FG000|Overall Study|Physician Decision|2|||
42335582|NCT02058368|76173260|FG001|Overall Study|Physician Decision|3|||
42335583|NCT02058368|76173259|FG000|Overall Study|Withdrawal by Subject|22|||
42335584|NCT02058368|76173260|FG001|Overall Study|Withdrawal by Subject|26|||
42335585|NCT02107196|76173268|FG000|12-week Treatment Period|Adverse Event|6|||
42335586|NCT02107196|76173269|FG001|12-week Treatment Period|Adverse Event|3|||
42335587|NCT02107196|76173268|FG000|12-week Treatment Period|Lack of Efficacy|2|||
42335588|NCT02107196|76173269|FG001|12-week Treatment Period|Lack of Efficacy|1|||
42335589|NCT02107196|76173268|FG000|12-week Treatment Period|Lost to Follow-up|3|||
42335590|NCT02107196|76173269|FG001|12-week Treatment Period|Lost to Follow-up|6|||
42335591|NCT02107196|76173268|FG000|12-week Treatment Period|Physician Decision|0|||
42335592|NCT02107196|76173269|FG001|12-week Treatment Period|Physician Decision|1|||
42335593|NCT02107196|76173268|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
42335594|NCT02107196|76173269|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
42335595|NCT02107196|76173268|FG000|12-week Treatment Period|Protocol Violation|7|||
42335596|NCT02107196|76173269|FG001|12-week Treatment Period|Protocol Violation|8|||
42335597|NCT02107196|76173268|FG000|12-week Treatment Period|Reason Missing|11|||
42335598|NCT02107196|76173269|FG001|12-week Treatment Period|Reason Missing|8|||
42335599|NCT02107196|76173268|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
42335600|NCT02107196|76173269|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
42335601|NCT02107196|76173268|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
42335602|NCT02107196|76173269|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
42335603|NCT02107196|76173268|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
42265327|NCT02792699|76093420|FG000|Overall Study|Adverse Event|1|||
42335604|NCT02107196|76173269|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
42335605|NCT02107196|76173268|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
42335606|NCT02107196|76173269|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
42335607|NCT02058290|76173277|FG000|Overall Study|Protocol Violation|2|||
42335608|NCT02058290|76173278|FG001|Overall Study|Protocol Violation|1|||
42335609|NCT02058290|76173277|FG000|Overall Study|Physician Decision|1|||
42335610|NCT02058290|76173278|FG001|Overall Study|Physician Decision|0|||
42335611|NCT02058290|76173277|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
42335612|NCT02058290|76173278|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
42335613|NCT02058290|76173277|FG000|Overall Study|Withdrawal by Subject|0|||
42335614|NCT02058290|76173278|FG001|Overall Study|Withdrawal by Subject|1|||
42335615|NCT02082158|76173290|FG000|Overall Study|Withdrawal by Subject|0|||
42335616|NCT02082158|76173291|FG001|Overall Study|Withdrawal by Subject|0|||
42335617|NCT02082158|76173292|FG002|Overall Study|Withdrawal by Subject|0|||
42335618|NCT02082158|76173293|FG003|Overall Study|Withdrawal by Subject|0|||
42335619|NCT02082158|76173294|FG004|Overall Study|Withdrawal by Subject|1|||
42335620|NCT02082158|76173295|FG005|Overall Study|Withdrawal by Subject|0|||
42335621|NCT02082158|76173290|FG000|Overall Study|Failed Fit-testing|8|||
42335622|NCT02082158|76173291|FG001|Overall Study|Failed Fit-testing|8|||
42335623|NCT02082158|76173292|FG002|Overall Study|Failed Fit-testing|14|||
42335624|NCT02082158|76173293|FG003|Overall Study|Failed Fit-testing|4|||
42335625|NCT02082158|76173294|FG004|Overall Study|Failed Fit-testing|3|||
42335626|NCT02082158|76173295|FG005|Overall Study|Failed Fit-testing|7|||
42335627|NCT02106884|76173317|FG000|Overall Study|Change of diagnosis/exclusion|0|||
42335628|NCT02106884|76173318|FG001|Overall Study|Change of diagnosis/exclusion|1|||
42335629|NCT02081846|76173329|FG000|Overall Study|Withdrawal by Subject|1|||
42335630|NCT02081846|76173330|FG001|Overall Study|Withdrawal by Subject|0|||
42335631|NCT02081846|76173329|FG000|Overall Study|invalid consent|1|||
42335632|NCT02081846|76173330|FG001|Overall Study|invalid consent|0|||
42335633|NCT02081690|76173336|FG000|Overall Study|Death|3|||
42335634|NCT02081690|76173336|FG000|Overall Study|Physician Decision|3|||
42335635|NCT02081690|76173336|FG000|Overall Study|Withdrawal by Subject|1|||
42335636|NCT02057666|76173342|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
42335637|NCT02057666|76173343|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
42335638|NCT02057666|76173342|FG000|Double Blind Treatment Period|Poor tolerability|7|||
42335639|NCT02057666|76173343|FG001|Double Blind Treatment Period|Poor tolerability|2|||
42335640|NCT02057666|76173342|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
42335641|NCT02057666|76173343|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
42335642|NCT02057666|76173342|FG000|Double Blind Treatment Period|Physician Decision|1|||
42335643|NCT02057666|76173343|FG001|Double Blind Treatment Period|Physician Decision|0|||
42335644|NCT02057666|76173342|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
42335645|NCT02057666|76173343|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
42335646|NCT02057666|76173342|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
42335647|NCT02057666|76173343|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
42335648|NCT02057666|76173342|FG000|Double Blind Treatment Period|Sponsor's request|70|||
42335649|NCT02057666|76173343|FG001|Double Blind Treatment Period|Sponsor's request|34|||
42335650|NCT02057666|76173342|FG000|Open-Label Treatment Period|Poor tolerability|0|||
42335651|NCT02057666|76173343|FG001|Open-Label Treatment Period|Poor tolerability|1|||
42335652|NCT02057666|76173342|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
42335653|NCT02057666|76173343|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
42335654|NCT02057666|76173342|FG000|Open-Label Treatment Period|Sponsor's request|0|||
42335655|NCT02057666|76173343|FG001|Open-Label Treatment Period|Sponsor's request|4|||
42335656|NCT01625000|76173354|FG000|Overall Study|Physician Decision|15|||
42335657|NCT01625000|76173355|FG001|Overall Study|Physician Decision|7|||
42335658|NCT01625000|76173356|FG002|Overall Study|Physician Decision|7|||
42335659|NCT01625000|76173357|FG003|Overall Study|Physician Decision|2|||
42335660|NCT01625000|76173358|FG004|Overall Study|Physician Decision|15|||
42335661|NCT01625000|76173354|FG000|Overall Study|Protocol Violation|3|||
42335662|NCT01625000|76173355|FG001|Overall Study|Protocol Violation|10|||
42335663|NCT01625000|76173356|FG002|Overall Study|Protocol Violation|4|||
42335664|NCT01625000|76173357|FG003|Overall Study|Protocol Violation|1|||
42335665|NCT01625000|76173358|FG004|Overall Study|Protocol Violation|2|||
42335666|NCT01625000|76173354|FG000|Overall Study|Withdrawal by Subject|19|||
42335667|NCT01625000|76173355|FG001|Overall Study|Withdrawal by Subject|16|||
42335668|NCT01625000|76173356|FG002|Overall Study|Withdrawal by Subject|11|||
42000252|NCT01176058|75808771|FG000|Overall Study|Withdrawal by Subject|1|||
42000253|NCT01176058|75808772|FG001|Overall Study|Withdrawal by Subject|0|||
42000254|NCT01175824|75808780|FG000|Overall Study|Adverse Event|2|||
42335669|NCT01625000|76173357|FG003|Overall Study|Withdrawal by Subject|9|||
42335670|NCT01625000|76173358|FG004|Overall Study|Withdrawal by Subject|17|||
42335671|NCT01625000|76173354|FG000|Overall Study|Adverse Event (including Death)|15|||
42335672|NCT01625000|76173355|FG001|Overall Study|Adverse Event (including Death)|19|||
42335673|NCT01625000|76173356|FG002|Overall Study|Adverse Event (including Death)|11|||
42335674|NCT01625000|76173357|FG003|Overall Study|Adverse Event (including Death)|7|||
42335675|NCT01625000|76173358|FG004|Overall Study|Adverse Event (including Death)|21|||
42335676|NCT02081534|76173377|FG000|Overall Study|Adverse Event|5|||
42335677|NCT02081534|76173378|FG001|Overall Study|Adverse Event|4|||
42335678|NCT02081534|76173379|FG002|Overall Study|Adverse Event|3|||
42335679|NCT02081534|76173380|FG003|Overall Study|Adverse Event|10|||
42335680|NCT02081534|76173381|FG004|Overall Study|Adverse Event|2|||
42335681|NCT02081534|76173382|FG005|Overall Study|Adverse Event|8|||
42335682|NCT02081534|76173383|FG006|Overall Study|Adverse Event|2|||
42335683|NCT02081534|76173377|FG000|Overall Study|Withdrawal by Subject|0|||
42335684|NCT02081534|76173378|FG001|Overall Study|Withdrawal by Subject|1|||
42335685|NCT02081534|76173379|FG002|Overall Study|Withdrawal by Subject|1|||
42335686|NCT02081534|76173380|FG003|Overall Study|Withdrawal by Subject|1|||
42335687|NCT02081534|76173381|FG004|Overall Study|Withdrawal by Subject|1|||
42335688|NCT02081534|76173382|FG005|Overall Study|Withdrawal by Subject|0|||
42335689|NCT02081534|76173383|FG006|Overall Study|Withdrawal by Subject|1|||
42335690|NCT02081534|76173377|FG000|Overall Study|Protocol Violation|0|||
42335691|NCT02081534|76173378|FG001|Overall Study|Protocol Violation|3|||
42335692|NCT02081534|76173379|FG002|Overall Study|Protocol Violation|0|||
42335693|NCT02081534|76173380|FG003|Overall Study|Protocol Violation|0|||
42335694|NCT02081534|76173381|FG004|Overall Study|Protocol Violation|0|||
42335695|NCT02081534|76173382|FG005|Overall Study|Protocol Violation|0|||
42335696|NCT02081534|76173383|FG006|Overall Study|Protocol Violation|1|||
42335697|NCT02081534|76173377|FG000|Overall Study|Lost to Follow-up|0|||
42335698|NCT02081534|76173378|FG001|Overall Study|Lost to Follow-up|0|||
42335699|NCT02081534|76173379|FG002|Overall Study|Lost to Follow-up|0|||
42335700|NCT02081534|76173380|FG003|Overall Study|Lost to Follow-up|2|||
42335701|NCT02081534|76173381|FG004|Overall Study|Lost to Follow-up|1|||
42335702|NCT02081534|76173382|FG005|Overall Study|Lost to Follow-up|1|||
42335703|NCT02081534|76173383|FG006|Overall Study|Lost to Follow-up|0|||
42335704|NCT02057198|76173402|FG000|Overall Study|Death|0|||
42335705|NCT02057198|76173403|FG001|Overall Study|Death|0|||
42335706|NCT02057198|76173404|FG002|Overall Study|Death|1|||
42335707|NCT02057198|76173402|FG000|Overall Study|Discharged early; lost to followup|0|||
42335708|NCT02057198|76173403|FG001|Overall Study|Discharged early; lost to followup|1|||
42335709|NCT02057198|76173404|FG002|Overall Study|Discharged early; lost to followup|0|||
42335710|NCT02056652|76173414|FG000|Overall Study|Withdrawal by Subject|1|||
42335711|NCT02056652|76173415|FG001|Overall Study|Withdrawal by Subject|0|||
42335712|NCT02056652|76173414|FG000|Overall Study|Lost to Follow-up|0|||
42335713|NCT02056652|76173415|FG001|Overall Study|Lost to Follow-up|3|||
42335714|NCT02056340|76173423|FG000|Overall Study|Lost to Follow-up|5|||
42335715|NCT02056340|76173424|FG001|Overall Study|Lost to Follow-up|5|||
42335716|NCT02056340|76173423|FG000|Overall Study|Withdrawal by Subject|2|||
42335717|NCT02056340|76173424|FG001|Overall Study|Withdrawal by Subject|6|||
42335718|NCT02046122|76173430|FG000|Overall Study|Physician Decision|8|||
42335719|NCT02046122|76173430|FG000|Overall Study|Withdrawal by Subject|1|||
42335720|NCT02080832|76173437|FG000|Overall Study|Excluded from analysis by MRI|9|||
42335721|NCT02080832|76173438|FG001|Overall Study|Excluded from analysis by MRI|10|||
42335722|NCT02080832|76173439|FG002|Overall Study|Excluded from analysis by MRI|14|||
42335723|NCT02080832|76173437|FG000|Overall Study|Lost to Follow-up|0|||
42335724|NCT02080832|76173438|FG001|Overall Study|Lost to Follow-up|2|||
42335725|NCT02080832|76173439|FG002|Overall Study|Lost to Follow-up|2|||
42335726|NCT02080364|76173453|FG000|Baseline Period|Protocol Violation|2|||
42335727|NCT02080364|76173454|FG001|Baseline Period|Protocol Violation|1|||
42335728|NCT02080364|76173455|FG002|Baseline Period|Protocol Violation|0|||
42335729|NCT02080364|76173456|FG003|Baseline Period|Protocol Violation|0|||
42335730|NCT02080364|76173453|FG000|Baseline Period|Other|0|||
42335731|NCT02080364|76173454|FG001|Baseline Period|Other|1|||
42335732|NCT02080364|76173455|FG002|Baseline Period|Other|1|||
42335733|NCT02080364|76173456|FG003|Baseline Period|Other|0|||
42335734|NCT02080364|76173453|FG000|Treatment Period|Adverse Event|10|||
42335735|NCT02080364|76173454|FG001|Treatment Period|Adverse Event|15|||
42335736|NCT02080364|76173455|FG002|Treatment Period|Adverse Event|11|||
42335737|NCT02080364|76173456|FG003|Treatment Period|Adverse Event|14|||
42335738|NCT02080364|76173453|FG000|Treatment Period|Lost to Follow-up|2|||
42335739|NCT02080364|76173454|FG001|Treatment Period|Lost to Follow-up|3|||
42335740|NCT02080364|76173455|FG002|Treatment Period|Lost to Follow-up|5|||
42335741|NCT02080364|76173456|FG003|Treatment Period|Lost to Follow-up|0|||
42335742|NCT02080364|76173453|FG000|Treatment Period|Protocol Violation|5|||
42335743|NCT02080364|76173454|FG001|Treatment Period|Protocol Violation|3|||
42335744|NCT02080364|76173455|FG002|Treatment Period|Protocol Violation|5|||
42335745|NCT02080364|76173456|FG003|Treatment Period|Protocol Violation|1|||
42335746|NCT02080364|76173453|FG000|Treatment Period|Withdrawal by Subject|16|||
42335747|NCT02080364|76173454|FG001|Treatment Period|Withdrawal by Subject|16|||
42335748|NCT02080364|76173455|FG002|Treatment Period|Withdrawal by Subject|15|||
42335749|NCT02080364|76173456|FG003|Treatment Period|Withdrawal by Subject|10|||
42335750|NCT02080364|76173453|FG000|Treatment Period|Study Terminated by Sponsor|0|||
42335751|NCT02080364|76173454|FG001|Treatment Period|Study Terminated by Sponsor|0|||
42335752|NCT02080364|76173455|FG002|Treatment Period|Study Terminated by Sponsor|180|||
42335753|NCT02080364|76173456|FG003|Treatment Period|Study Terminated by Sponsor|183|||
42335754|NCT02080364|76173453|FG000|Treatment Period|Other|14|||
42335755|NCT02080364|76173454|FG001|Treatment Period|Other|12|||
42335756|NCT02080364|76173455|FG002|Treatment Period|Other|21|||
42335757|NCT02080364|76173456|FG003|Treatment Period|Other|16|||
42335758|NCT02079038|76173468|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
42335759|NCT02079038|76173469|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
42335760|NCT02079038|76173468|FG000|Modified Intent to Treat Population|Death|1|||
42335761|NCT02079038|76173469|FG001|Modified Intent to Treat Population|Death|0|||
42335762|NCT02079038|76173468|FG000|Completed 6 Months|Lost to Follow-up|2|||
42335763|NCT02079038|76173469|FG001|Completed 6 Months|Lost to Follow-up|1|||
42335764|NCT02045732|76173477|FG000|Overall Study|At the discretion of the investigator|1|||
42335765|NCT02045732|76173478|FG001|Overall Study|At the discretion of the investigator|1|||
42335766|NCT02044874|76173487|FG000|Overall Study|Adverse Event|5|||
42335767|NCT02044874|76173488|FG001|Overall Study|Adverse Event|6|||
42265328|NCT02792699|76093421|FG001|Overall Study|Adverse Event|2|||
42265329|NCT02792699|76093422|FG002|Overall Study|Adverse Event|4|||
42265330|NCT02792699|76093420|FG000|Overall Study|Withdrawal by Subject|4|||
42265331|NCT02792699|76093421|FG001|Overall Study|Withdrawal by Subject|4|||
42265332|NCT02792699|76093422|FG002|Overall Study|Withdrawal by Subject|3|||
42265333|NCT02792699|76093420|FG000|Overall Study|Lost to Follow-up|0|||
42265334|NCT02792699|76093421|FG001|Overall Study|Lost to Follow-up|1|||
42265335|NCT02792699|76093422|FG002|Overall Study|Lost to Follow-up|2|||
42265336|NCT02792699|76093420|FG000|Overall Study|Physician Decision|2|||
42265337|NCT02792699|76093421|FG001|Overall Study|Physician Decision|0|||
42265338|NCT02792699|76093422|FG002|Overall Study|Physician Decision|0|||
42335768|NCT02044874|76173489|FG002|Overall Study|Adverse Event|6|||
42335769|NCT02044874|76173487|FG000|Overall Study|Withdrawal by Subject|8|||
42335770|NCT02044874|76173488|FG001|Overall Study|Withdrawal by Subject|16|||
42265339|NCT02792699|76093420|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
42265340|NCT02792699|76093421|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
42265341|NCT02792699|76093422|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
42335771|NCT02044874|76173489|FG002|Overall Study|Withdrawal by Subject|23|||
42335772|NCT02044874|76173487|FG000|Overall Study|Physician Decision|0|||
42335773|NCT02044874|76173488|FG001|Overall Study|Physician Decision|2|||
42335774|NCT02044874|76173489|FG002|Overall Study|Physician Decision|1|||
42335775|NCT02044874|76173487|FG000|Overall Study|Lost to Follow-up|10|||
42335776|NCT02044874|76173488|FG001|Overall Study|Lost to Follow-up|27|||
42335777|NCT02044874|76173489|FG002|Overall Study|Lost to Follow-up|21|||
42335778|NCT02044874|76173487|FG000|Overall Study|Sponsor Decision|0|||
42335779|NCT02044874|76173488|FG001|Overall Study|Sponsor Decision|1|||
42335780|NCT02044874|76173489|FG002|Overall Study|Sponsor Decision|1|||
42335781|NCT02044874|76173487|FG000|Overall Study|Other|7|||
42335782|NCT02044874|76173488|FG001|Overall Study|Other|3|||
42335783|NCT02044874|76173489|FG002|Overall Study|Other|8|||
42335784|NCT02078960|76173502|FG000|Treatment Period|Other|0|||
42335785|NCT02078960|76173503|FG001|Treatment Period|Other|0|||
42335786|NCT02078960|76173504|FG002|Treatment Period|Other|1|||
42335787|NCT02078960|76173502|FG000|Treatment Period|Lack of Efficacy|0|||
42335788|NCT02078960|76173503|FG001|Treatment Period|Lack of Efficacy|1|||
42335789|NCT02078960|76173504|FG002|Treatment Period|Lack of Efficacy|0|||
42335790|NCT02078960|76173502|FG000|Treatment Period|Disease progression - accelerated phase|0|||
42335791|NCT02078960|76173503|FG001|Treatment Period|Disease progression - accelerated phase|1|||
42335792|NCT02078960|76173504|FG002|Treatment Period|Disease progression - accelerated phase|0|||
42335793|NCT02078960|76173502|FG000|Treatment Period|Disease progression - blast phase|1|||
42335794|NCT02078960|76173503|FG001|Treatment Period|Disease progression - blast phase|0|||
42335795|NCT02078960|76173504|FG002|Treatment Period|Disease progression - blast phase|0|||
42335796|NCT02078960|76173502|FG000|Treatment Period|Withdrawal by Subject|0|||
42335797|NCT02078960|76173503|FG001|Treatment Period|Withdrawal by Subject|1|||
42335798|NCT02078960|76173504|FG002|Treatment Period|Withdrawal by Subject|1|||
42335799|NCT02078960|76173502|FG000|Treatment Period|Adverse Event|1|||
42265342|NCT02792699|76093420|FG000|Overall Study|Other|1|||
42265343|NCT02792699|76093421|FG001|Overall Study|Other|0|||
42265344|NCT02792699|76093422|FG002|Overall Study|Other|0|||
42265345|NCT03010319|76093439|FG000|Overall Study|Adverse Event|15|||
42265346|NCT03010319|76093440|FG001|Overall Study|Adverse Event|9|||
42265347|NCT03010319|76093439|FG000|Overall Study|Withdrawal by Subject|1|||
42265348|NCT03010319|76093440|FG001|Overall Study|Withdrawal by Subject|6|||
42265349|NCT03010319|76093439|FG000|Overall Study|Physician Decision|2|||
42265350|NCT03010319|76093440|FG001|Overall Study|Physician Decision|4|||
42265351|NCT03010319|76093439|FG000|Overall Study|Sponsor requested withdrawal|2|||
42265352|NCT03010319|76093440|FG001|Overall Study|Sponsor requested withdrawal|2|||
42335800|NCT02078960|76173503|FG001|Treatment Period|Adverse Event|0|||
42265353|NCT03010319|76093439|FG000|Overall Study|Death|1|||
42335801|NCT02078960|76173504|FG002|Treatment Period|Adverse Event|0|||
42265354|NCT03010319|76093440|FG001|Overall Study|Death|0|||
42265355|NCT03010319|76093439|FG000|Overall Study|Lost to Follow-up|0|||
42335802|NCT02078960|76173502|FG000|Treatment Period|Death|0|||
42335803|NCT02078960|76173503|FG001|Treatment Period|Death|0|||
42335804|NCT02078960|76173504|FG002|Treatment Period|Death|1|||
42000255|NCT01175824|75808781|FG001|Overall Study|Adverse Event|1|||
42000256|NCT01175824|75808780|FG000|Overall Study|Lack of Efficacy|2|||
42335805|NCT02078960|76173502|FG000|Follow-up Period|Death|2|||
42335806|NCT02078960|76173503|FG001|Follow-up Period|Death|0|||
42335807|NCT02078960|76173504|FG002|Follow-up Period|Death|0|||
42335808|NCT02078960|76173502|FG000|Follow-up Period|Lost to Follow-up|0|||
42335809|NCT02078960|76173503|FG001|Follow-up Period|Lost to Follow-up|1|||
42335810|NCT02078960|76173504|FG002|Follow-up Period|Lost to Follow-up|0|||
42335811|NCT02078102|76173516|FG000|Overall Study|Adverse Event|1|||
42335812|NCT02078102|76173517|FG001|Overall Study|Adverse Event|0|||
42335813|NCT02078102|76173516|FG000|Overall Study|Withdrawal by Subject|1|||
42335814|NCT02078102|76173517|FG001|Overall Study|Withdrawal by Subject|0|||
42335815|NCT02078102|76173516|FG000|Overall Study|Physician Decision|0|||
42335816|NCT02078102|76173517|FG001|Overall Study|Physician Decision|1|||
42335817|NCT02054702|76173526|FG000|Overall Study|Lost to Follow-up|3|||
42335818|NCT02054702|76173527|FG001|Overall Study|Lost to Follow-up|5|||
42335819|NCT02054702|76173526|FG000|Overall Study|Adverse Event|3|||
42335820|NCT02054702|76173527|FG001|Overall Study|Adverse Event|1|||
42335821|NCT02054702|76173526|FG000|Overall Study|Met Withdrawal Criteria|4|||
42335822|NCT02054702|76173527|FG001|Overall Study|Met Withdrawal Criteria|1|||
42335823|NCT02054702|76173526|FG000|Overall Study|Physician Decision|0|||
42335824|NCT02054702|76173527|FG001|Overall Study|Physician Decision|1|||
42335825|NCT02054702|76173526|FG000|Overall Study|Withdrawal by Subject|14|||
42335826|NCT02054702|76173527|FG001|Overall Study|Withdrawal by Subject|4|||
42335827|NCT02044094|76173533|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
42335828|NCT02044094|76173533|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
42335829|NCT02044094|76173533|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
42335830|NCT02044094|76173533|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
42335831|NCT02044094|76173533|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
42335832|NCT02044094|76173533|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
42335833|NCT02044094|76173533|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
42335834|NCT02044094|76173533|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
42335835|NCT02043938|76173548|FG000|Overall Study|Withdrawal by Subject|7|||
42335836|NCT02043938|76173548|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
42335837|NCT02043938|76173548|FG000|Overall Study|No show by subject|1|||
42335838|NCT02043938|76173548|FG000|Overall Study|Investigator decision|1|||
42335839|NCT02053610|76173557|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
42335840|NCT02053610|76173558|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
42335841|NCT02053610|76173557|FG000|Overall Study|Withdrew Consent|2|||
42335842|NCT02053610|76173558|FG001|Overall Study|Withdrew Consent|9|||
42335843|NCT02053610|76173557|FG000|Overall Study|Death|5|||
42335844|NCT02053610|76173558|FG001|Overall Study|Death|5|||
42335845|NCT02053610|76173557|FG000|Overall Study|Administrative/Other|1|||
42335846|NCT02053610|76173558|FG001|Overall Study|Administrative/Other|1|||
42335847|NCT02053610|76173557|FG000|Overall Study|Disease Progression|2|||
42335848|NCT02053610|76173558|FG001|Overall Study|Disease Progression|3|||
42335849|NCT02053610|76173557|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
42335850|NCT02053610|76173558|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
42335851|NCT02053610|76173557|FG000|Overall Study|Did not Receive Treatment|4|||
42335852|NCT02053610|76173558|FG001|Overall Study|Did not Receive Treatment|2|||
42335853|NCT02053610|76173557|FG000|Overall Study|Insufficient Therapeutic Response|1|||
42335854|NCT02053610|76173558|FG001|Overall Study|Insufficient Therapeutic Response|1|||
42335855|NCT02053610|76173557|FG000|Overall Study|Violation of Selection Criteria|1|||
42335856|NCT02053610|76173558|FG001|Overall Study|Violation of Selection Criteria|0|||
42335857|NCT02075606|76173564|FG000|Overall Study|Adverse Event|5|||
42335858|NCT02075606|76173564|FG000|Overall Study|Withdrawal by Subject|1|||
42335859|NCT02075606|76173564|FG000|Overall Study|Death|1|||
42335860|NCT02075606|76173564|FG000|Overall Study|Investigator's decision|1|||
42335861|NCT02075606|76173564|FG000|Overall Study|Symptom management|1|||
42335862|NCT02075606|76173564|FG000|Overall Study|Increasing Symptoms|1|||
42335863|NCT02043782|76173573|FG000|Period 1|Adverse Event|0|||
42335864|NCT02043782|76173574|FG001|Period 1|Adverse Event|0|||
42335865|NCT02043782|76173575|FG002|Period 1|Adverse Event|1|||
42335866|NCT02043782|76173576|FG003|Period 1|Adverse Event|0|||
42335867|NCT02043782|76173577|FG004|Period 1|Adverse Event|0|||
42335868|NCT02043782|76173578|FG005|Period 1|Adverse Event|0|||
42335869|NCT02052596|76173588|FG000|Active Phase|Adverse Event|3|||
42000257|NCT01175824|75808781|FG001|Overall Study|Lack of Efficacy|0|||
42335870|NCT02052596|76173589|FG001|Active Phase|Adverse Event|2|||
42335871|NCT02052596|76173588|FG000|Active Phase|Lost to Follow-up|8|||
42335872|NCT02052596|76173589|FG001|Active Phase|Lost to Follow-up|11|||
42335873|NCT02052596|76173588|FG000|Active Phase|Protocol Violation|1|||
42335874|NCT02052596|76173589|FG001|Active Phase|Protocol Violation|2|||
42335875|NCT02052596|76173588|FG000|Active Phase|Withdrawal by Subject|3|||
42335876|NCT02052596|76173589|FG001|Active Phase|Withdrawal by Subject|4|||
42335877|NCT02052596|76173588|FG000|Active Phase|Enrolled in error|1|||
42335878|NCT02052596|76173589|FG001|Active Phase|Enrolled in error|0|||
42335879|NCT02052596|76173588|FG000|Active Phase|Lost due to Crohn's disease|0|||
42335880|NCT02052596|76173589|FG001|Active Phase|Lost due to Crohn's disease|1|||
42335881|NCT02052596|76173588|FG000|Safety Phase|Adverse Event|6|||
42335882|NCT02052596|76173589|FG001|Safety Phase|Adverse Event|3|||
42335883|NCT02052596|76173588|FG000|Safety Phase|Lost to Follow-up|11|||
42335884|NCT02052596|76173589|FG001|Safety Phase|Lost to Follow-up|18|||
42335885|NCT02052596|76173588|FG000|Safety Phase|Protocol Violation|1|||
42335886|NCT02052596|76173589|FG001|Safety Phase|Protocol Violation|2|||
42335887|NCT02052596|76173588|FG000|Safety Phase|Withdrawal by Subject|8|||
42335888|NCT02052596|76173589|FG001|Safety Phase|Withdrawal by Subject|11|||
42335889|NCT02052596|76173588|FG000|Safety Phase|Enrolled in error|1|||
42335890|NCT02052596|76173589|FG001|Safety Phase|Enrolled in error|0|||
42335891|NCT02052596|76173588|FG000|Safety Phase|Lost due to Crohn's disease|0|||
42335892|NCT02052596|76173589|FG001|Safety Phase|Lost due to Crohn's disease|1|||
42335893|NCT02052440|76173597|FG000|Overall Study|Withdrawal by Subject|0|||
42335894|NCT02052440|76173598|FG001|Overall Study|Withdrawal by Subject|1|||
42335895|NCT02049944|76173604|FG000|Overall Study|Protocol Violation|2|||
42335896|NCT02043548|76173610|FG000|Overall Study|Lack of Efficacy|1|||
42335897|NCT02043548|76173611|FG001|Overall Study|Lack of Efficacy|0|||
42335898|NCT02043548|76173610|FG000|Overall Study|Adverse Event|0|||
42335899|NCT02043548|76173611|FG001|Overall Study|Adverse Event|1|||
42335900|NCT01622348|76173620|FG000|Overall Study|Withdrawal by Subject|1|||
42335901|NCT01622348|76173621|FG001|Overall Study|Withdrawal by Subject|0|||
42335902|NCT01622348|76173622|FG002|Overall Study|Withdrawal by Subject|1|||
42335903|NCT01621880|76173632|FG000|Overall Study|Adverse Event|5|||
42335904|NCT01621880|76173633|FG001|Overall Study|Adverse Event|1|||
42335905|NCT01621880|76173632|FG000|Overall Study|Withdrawal by Subject|5|||
42335906|NCT01621880|76173633|FG001|Overall Study|Withdrawal by Subject|4|||
42335907|NCT01621802|76173646|FG000|Overall Study|Protocol Violation|0|||
42335908|NCT01621802|76173647|FG001|Overall Study|Protocol Violation|0|||
42335909|NCT01621802|76173648|FG002|Overall Study|Protocol Violation|0|||
42335910|NCT01621802|76173649|FG003|Overall Study|Protocol Violation|0|||
42335911|NCT01621802|76173650|FG004|Overall Study|Protocol Violation|0|||
42335912|NCT01621802|76173651|FG005|Overall Study|Protocol Violation|1|||
42335913|NCT01621802|76173646|FG000|Overall Study|Withdrawal by Subject|8|||
42335914|NCT01621802|76173647|FG001|Overall Study|Withdrawal by Subject|4|||
42335915|NCT01621802|76173648|FG002|Overall Study|Withdrawal by Subject|4|||
42335916|NCT01621802|76173649|FG003|Overall Study|Withdrawal by Subject|2|||
42335917|NCT01621802|76173650|FG004|Overall Study|Withdrawal by Subject|2|||
42335918|NCT01621802|76173651|FG005|Overall Study|Withdrawal by Subject|0|||
42335919|NCT01621802|76173646|FG000|Overall Study|Migrated/moved from study area|0|||
42335920|NCT01621802|76173647|FG001|Overall Study|Migrated/moved from study area|0|||
42335921|NCT01621802|76173648|FG002|Overall Study|Migrated/moved from study area|2|||
42335922|NCT01621802|76173649|FG003|Overall Study|Migrated/moved from study area|0|||
42335923|NCT01621802|76173650|FG004|Overall Study|Migrated/moved from study area|1|||
42335924|NCT01621802|76173651|FG005|Overall Study|Migrated/moved from study area|0|||
42335925|NCT01621802|76173646|FG000|Overall Study|Others|3|||
42335926|NCT01621802|76173647|FG001|Overall Study|Others|3|||
42335927|NCT01621802|76173648|FG002|Overall Study|Others|3|||
42335928|NCT01621802|76173649|FG003|Overall Study|Others|2|||
42335929|NCT01621802|76173650|FG004|Overall Study|Others|1|||
42335930|NCT01621802|76173651|FG005|Overall Study|Others|0|||
42134639|NCT00406653|75945530|FG001|Induction Period|Lost to Follow-up|2|||
42335931|NCT01621802|76173646|FG000|Overall Study|Lost to Follow-up|36|||
42335932|NCT01621802|76173647|FG001|Overall Study|Lost to Follow-up|16|||
42335933|NCT01621802|76173648|FG002|Overall Study|Lost to Follow-up|24|||
42335934|NCT01621802|76173649|FG003|Overall Study|Lost to Follow-up|7|||
42335935|NCT01621802|76173650|FG004|Overall Study|Lost to Follow-up|31|||
42335936|NCT01621802|76173651|FG005|Overall Study|Lost to Follow-up|11|||
42335937|NCT02059291|76173677|FG000|Epoch 2|Lack of Efficacy|0|||
42335938|NCT02059291|76173678|FG001|Epoch 2|Lack of Efficacy|0|||
42335939|NCT02059291|76173679|FG002|Epoch 2|Lack of Efficacy|0|||
42335940|NCT02059291|76173680|FG003|Epoch 2|Lack of Efficacy|1|||
42335941|NCT02059291|76173681|FG004|Epoch 2|Lack of Efficacy|0|||
42335942|NCT02059291|76173682|FG005|Epoch 2|Lack of Efficacy|1|||
42335943|NCT02059291|76173683|FG006|Epoch 2|Lack of Efficacy|0|||
42335944|NCT02059291|76173684|FG007|Epoch 2|Lack of Efficacy|0|||
42335945|NCT02059291|76173685|FG008|Epoch 2|Lack of Efficacy|0|||
42335946|NCT02059291|76173686|FG009|Epoch 2|Lack of Efficacy|0|||
42000258|NCT01175824|75808780|FG000|Overall Study|Lost to Follow-up|0|||
42000259|NCT01175824|75808781|FG001|Overall Study|Lost to Follow-up|1|||
42000260|NCT01175824|75808780|FG000|Overall Study|Physician Decision|0|||
42000261|NCT01175824|75808781|FG001|Overall Study|Physician Decision|4|||
42000262|NCT01175824|75808780|FG000|Overall Study|Protocol Violation|2|||
42000263|NCT01175824|75808781|FG001|Overall Study|Protocol Violation|5|||
42000264|NCT01175824|75808780|FG000|Overall Study|Withdrawal by Subject|3|||
42134640|NCT00406653|75945531|FG002|Induction Period|Lost to Follow-up|0|||
42134641|NCT00406653|75945532|FG003|Induction Period|Lost to Follow-up|0|||
42134642|NCT00406653|75945533|FG004|Induction Period|Lost to Follow-up|0|||
42134643|NCT00406653|75945534|FG005|Induction Period|Lost to Follow-up|0|||
42134644|NCT00406653|75945535|FG006|Induction Period|Lost to Follow-up|0|||
42134645|NCT00406653|75945529|FG000|Induction Period|Withdrawal of Consent|2|||
42134646|NCT00406653|75945530|FG001|Induction Period|Withdrawal of Consent|5|||
42134647|NCT00406653|75945531|FG002|Induction Period|Withdrawal of Consent|1|||
42134648|NCT00406653|75945532|FG003|Induction Period|Withdrawal of Consent|2|||
42134649|NCT00406653|75945533|FG004|Induction Period|Withdrawal of Consent|0|||
42134650|NCT00406653|75945534|FG005|Induction Period|Withdrawal of Consent|0|||
42265356|NCT03010319|76093440|FG001|Overall Study|Lost to Follow-up|1|||
42265357|NCT03010319|76093439|FG000|Overall Study|Other Reason|5|||
42000265|NCT01175824|75808781|FG001|Overall Study|Withdrawal by Subject|7|||
42000266|NCT01175824|75808780|FG000|Overall Study|Sponsor Decision|1|||
42000267|NCT01175824|75808781|FG001|Overall Study|Sponsor Decision|0|||
42134651|NCT00406653|75945535|FG006|Induction Period|Withdrawal of Consent|0|||
42134652|NCT00406653|75945529|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
42134653|NCT00406653|75945530|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
42134654|NCT00406653|75945531|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
42134655|NCT00406653|75945532|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
42134656|NCT00406653|75945533|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
42134657|NCT00406653|75945534|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
42335947|NCT02059291|76173687|FG010|Epoch 2|Lack of Efficacy|0|||
42335948|NCT02059291|76173688|FG011|Epoch 2|Lack of Efficacy|0|||
42335949|NCT02059291|76173689|FG012|Epoch 2|Lack of Efficacy|0|||
42335950|NCT02059291|76173690|FG013|Epoch 2|Lack of Efficacy|0|||
42335951|NCT02059291|76173691|FG014|Epoch 2|Lack of Efficacy|0|||
42335952|NCT02059291|76173692|FG015|Epoch 2|Lack of Efficacy|0|||
42335953|NCT02059291|76173693|FG016|Epoch 2|Lack of Efficacy|0|||
42335954|NCT02059291|76173694|FG017|Epoch 2|Lack of Efficacy|0|||
42335955|NCT02059291|76173695|FG018|Epoch 2|Lack of Efficacy|0|||
42335956|NCT02059291|76173696|FG019|Epoch 2|Lack of Efficacy|0|||
42335957|NCT02059291|76173697|FG020|Epoch 2|Lack of Efficacy|0|||
42335958|NCT02059291|76173698|FG021|Epoch 2|Lack of Efficacy|0|||
42335959|NCT02059291|76173699|FG022|Epoch 2|Lack of Efficacy|0|||
42335960|NCT02059291|76173700|FG023|Epoch 2|Lack of Efficacy|0|||
42335961|NCT02059291|76173701|FG024|Epoch 2|Lack of Efficacy|0|||
42335962|NCT02059291|76173677|FG000|Epoch 2|Adverse Event|0|||
42335963|NCT02059291|76173678|FG001|Epoch 2|Adverse Event|0|||
42335964|NCT02059291|76173679|FG002|Epoch 2|Adverse Event|1|||
42335965|NCT02059291|76173680|FG003|Epoch 2|Adverse Event|1|||
42335966|NCT02059291|76173681|FG004|Epoch 2|Adverse Event|0|||
42335967|NCT02059291|76173682|FG005|Epoch 2|Adverse Event|0|||
42335968|NCT02059291|76173683|FG006|Epoch 2|Adverse Event|0|||
42335969|NCT02059291|76173684|FG007|Epoch 2|Adverse Event|1|||
42335970|NCT02059291|76173685|FG008|Epoch 2|Adverse Event|1|||
42335971|NCT02059291|76173686|FG009|Epoch 2|Adverse Event|0|||
42335972|NCT02059291|76173687|FG010|Epoch 2|Adverse Event|0|||
42335973|NCT02059291|76173688|FG011|Epoch 2|Adverse Event|0|||
42335974|NCT02059291|76173689|FG012|Epoch 2|Adverse Event|0|||
42335975|NCT02059291|76173690|FG013|Epoch 2|Adverse Event|0|||
42335976|NCT02059291|76173691|FG014|Epoch 2|Adverse Event|0|||
42335977|NCT02059291|76173692|FG015|Epoch 2|Adverse Event|0|||
42335978|NCT02059291|76173693|FG016|Epoch 2|Adverse Event|0|||
42335979|NCT02059291|76173694|FG017|Epoch 2|Adverse Event|0|||
42335980|NCT02059291|76173695|FG018|Epoch 2|Adverse Event|0|||
42335981|NCT02059291|76173696|FG019|Epoch 2|Adverse Event|0|||
42335982|NCT02059291|76173697|FG020|Epoch 2|Adverse Event|0|||
42134658|NCT00406653|75945535|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
42134659|NCT00406653|75945529|FG000|Induction Period|Pregnancy|1|||
42134660|NCT00406653|75945530|FG001|Induction Period|Pregnancy|0|||
42134661|NCT00406653|75945531|FG002|Induction Period|Pregnancy|0|||
42134662|NCT00406653|75945532|FG003|Induction Period|Pregnancy|0|||
42134663|NCT00406653|75945533|FG004|Induction Period|Pregnancy|0|||
42134664|NCT00406653|75945534|FG005|Induction Period|Pregnancy|0|||
42134665|NCT00406653|75945535|FG006|Induction Period|Pregnancy|0|||
42335983|NCT02059291|76173698|FG021|Epoch 2|Adverse Event|0|||
42335984|NCT02059291|76173699|FG022|Epoch 2|Adverse Event|0|||
42335985|NCT02059291|76173700|FG023|Epoch 2|Adverse Event|0|||
42335986|NCT02059291|76173701|FG024|Epoch 2|Adverse Event|0|||
42335987|NCT02059291|76173677|FG000|Epoch 2|Withdrawal by Subject|0|||
42335988|NCT02059291|76173678|FG001|Epoch 2|Withdrawal by Subject|1|||
42335989|NCT02059291|76173679|FG002|Epoch 2|Withdrawal by Subject|0|||
42335990|NCT02059291|76173680|FG003|Epoch 2|Withdrawal by Subject|0|||
42335991|NCT02059291|76173681|FG004|Epoch 2|Withdrawal by Subject|0|||
42335992|NCT02059291|76173682|FG005|Epoch 2|Withdrawal by Subject|1|||
42335993|NCT02059291|76173683|FG006|Epoch 2|Withdrawal by Subject|0|||
42335994|NCT02059291|76173684|FG007|Epoch 2|Withdrawal by Subject|0|||
42000268|NCT01175824|75808780|FG000|Overall Study|Entry Criteria Not Met|6|||
42335995|NCT02059291|76173685|FG008|Epoch 2|Withdrawal by Subject|1|||
42335996|NCT02059291|76173686|FG009|Epoch 2|Withdrawal by Subject|0|||
42335997|NCT02059291|76173687|FG010|Epoch 2|Withdrawal by Subject|0|||
42335998|NCT02059291|76173688|FG011|Epoch 2|Withdrawal by Subject|0|||
42335999|NCT02059291|76173689|FG012|Epoch 2|Withdrawal by Subject|0|||
42336000|NCT02059291|76173690|FG013|Epoch 2|Withdrawal by Subject|0|||
42000269|NCT01175824|75808781|FG001|Overall Study|Entry Criteria Not Met|4|||
42336001|NCT02059291|76173691|FG014|Epoch 2|Withdrawal by Subject|0|||
42336002|NCT02059291|76173692|FG015|Epoch 2|Withdrawal by Subject|0|||
42336003|NCT02059291|76173693|FG016|Epoch 2|Withdrawal by Subject|0|||
42134666|NCT00406653|75945529|FG000|Induction Period|Declined participation but followup done|0|||
42134667|NCT00406653|75945530|FG001|Induction Period|Declined participation but followup done|2|||
42336004|NCT02059291|76173694|FG017|Epoch 2|Withdrawal by Subject|0|||
42336005|NCT02059291|76173695|FG018|Epoch 2|Withdrawal by Subject|0|||
42336006|NCT02059291|76173696|FG019|Epoch 2|Withdrawal by Subject|0|||
42336007|NCT02059291|76173697|FG020|Epoch 2|Withdrawal by Subject|0|||
42336008|NCT02059291|76173698|FG021|Epoch 2|Withdrawal by Subject|0|||
42336009|NCT02059291|76173699|FG022|Epoch 2|Withdrawal by Subject|0|||
42336010|NCT02059291|76173700|FG023|Epoch 2|Withdrawal by Subject|0|||
42336011|NCT02059291|76173701|FG024|Epoch 2|Withdrawal by Subject|0|||
42336012|NCT02059291|76173677|FG000|Epoch 3|Physician Decision|0|||
42336013|NCT02059291|76173678|FG001|Epoch 3|Physician Decision|0|||
42336014|NCT02059291|76173679|FG002|Epoch 3|Physician Decision|0|||
42336015|NCT02059291|76173680|FG003|Epoch 3|Physician Decision|0|||
42336016|NCT02059291|76173681|FG004|Epoch 3|Physician Decision|0|||
42336017|NCT02059291|76173682|FG005|Epoch 3|Physician Decision|0|||
42336018|NCT02059291|76173683|FG006|Epoch 3|Physician Decision|0|||
42336019|NCT02059291|76173684|FG007|Epoch 3|Physician Decision|0|||
42336020|NCT02059291|76173685|FG008|Epoch 3|Physician Decision|0|||
42336021|NCT02059291|76173686|FG009|Epoch 3|Physician Decision|0|||
42336022|NCT02059291|76173687|FG010|Epoch 3|Physician Decision|0|||
42336023|NCT02059291|76173688|FG011|Epoch 3|Physician Decision|0|||
42336024|NCT02059291|76173689|FG012|Epoch 3|Physician Decision|0|||
42336025|NCT02059291|76173690|FG013|Epoch 3|Physician Decision|1|||
42336026|NCT02059291|76173691|FG014|Epoch 3|Physician Decision|0|||
42336027|NCT02059291|76173692|FG015|Epoch 3|Physician Decision|1|||
42336028|NCT02059291|76173693|FG016|Epoch 3|Physician Decision|0|||
42336029|NCT02059291|76173694|FG017|Epoch 3|Physician Decision|0|||
42336030|NCT02059291|76173695|FG018|Epoch 3|Physician Decision|0|||
42336031|NCT02059291|76173696|FG019|Epoch 3|Physician Decision|0|||
42336032|NCT02059291|76173697|FG020|Epoch 3|Physician Decision|0|||
42134668|NCT00406653|75945531|FG002|Induction Period|Declined participation but followup done|1|||
42134669|NCT00406653|75945532|FG003|Induction Period|Declined participation but followup done|1|||
42134670|NCT00406653|75945533|FG004|Induction Period|Declined participation but followup done|0|||
42134671|NCT00406653|75945534|FG005|Induction Period|Declined participation but followup done|0|||
42134672|NCT00406653|75945535|FG006|Induction Period|Declined participation but followup done|0|||
42134673|NCT00406653|75945529|FG000|Induction Period|Given prohibited drug|0|||
42134674|NCT00406653|75945530|FG001|Induction Period|Given prohibited drug|1|||
42134675|NCT00406653|75945531|FG002|Induction Period|Given prohibited drug|2|||
42134676|NCT00406653|75945532|FG003|Induction Period|Given prohibited drug|0|||
42134677|NCT00406653|75945533|FG004|Induction Period|Given prohibited drug|0|||
42336033|NCT02059291|76173698|FG021|Epoch 3|Physician Decision|0|||
42336034|NCT02059291|76173699|FG022|Epoch 3|Physician Decision|0|||
42336035|NCT02059291|76173700|FG023|Epoch 3|Physician Decision|0|||
42336036|NCT02059291|76173701|FG024|Epoch 3|Physician Decision|0|||
42336037|NCT02059291|76173677|FG000|Epoch 3|Adverse Event|0|||
42336038|NCT02059291|76173678|FG001|Epoch 3|Adverse Event|0|||
42336039|NCT02059291|76173679|FG002|Epoch 3|Adverse Event|0|||
42336040|NCT02059291|76173680|FG003|Epoch 3|Adverse Event|0|||
42336041|NCT02059291|76173681|FG004|Epoch 3|Adverse Event|0|||
42336042|NCT02059291|76173682|FG005|Epoch 3|Adverse Event|0|||
42336043|NCT02059291|76173683|FG006|Epoch 3|Adverse Event|0|||
42336044|NCT02059291|76173684|FG007|Epoch 3|Adverse Event|0|||
42336045|NCT02059291|76173685|FG008|Epoch 3|Adverse Event|0|||
42336046|NCT02059291|76173686|FG009|Epoch 3|Adverse Event|0|||
42336047|NCT02059291|76173687|FG010|Epoch 3|Adverse Event|0|||
42336048|NCT02059291|76173688|FG011|Epoch 3|Adverse Event|0|||
42336049|NCT02059291|76173689|FG012|Epoch 3|Adverse Event|0|||
42336050|NCT02059291|76173690|FG013|Epoch 3|Adverse Event|0|||
42336051|NCT02059291|76173691|FG014|Epoch 3|Adverse Event|0|||
42336052|NCT02059291|76173692|FG015|Epoch 3|Adverse Event|1|||
42336053|NCT02059291|76173693|FG016|Epoch 3|Adverse Event|0|||
42336054|NCT02059291|76173694|FG017|Epoch 3|Adverse Event|0|||
42134678|NCT00406653|75945534|FG005|Induction Period|Given prohibited drug|0|||
42265358|NCT03010319|76093440|FG001|Overall Study|Other Reason|7|||
42265359|NCT01369511|76093450|FG000|Overall Study|Adverse Event|1|||
42265360|NCT01369511|76093451|FG001|Overall Study|Adverse Event|1|||
42265361|NCT01369511|76093452|FG002|Overall Study|Adverse Event|5|||
42265362|NCT01369511|76093453|FG003|Overall Study|Adverse Event|0|||
42265363|NCT01369511|76093450|FG000|Overall Study|Entry criteria not met|2|||
42265364|NCT01369511|76093451|FG001|Overall Study|Entry criteria not met|0|||
42265365|NCT01369511|76093452|FG002|Overall Study|Entry criteria not met|0|||
42265366|NCT01369511|76093453|FG003|Overall Study|Entry criteria not met|1|||
42265367|NCT01369511|76093450|FG000|Overall Study|Lost to Follow-up|0|||
42265368|NCT01369511|76093451|FG001|Overall Study|Lost to Follow-up|1|||
42265369|NCT01369511|76093452|FG002|Overall Study|Lost to Follow-up|1|||
42265370|NCT01369511|76093453|FG003|Overall Study|Lost to Follow-up|2|||
42265371|NCT01369511|76093450|FG000|Overall Study|Protocol Violation|0|||
42265372|NCT01369511|76093451|FG001|Overall Study|Protocol Violation|1|||
42265373|NCT01369511|76093452|FG002|Overall Study|Protocol Violation|0|||
42265374|NCT01369511|76093453|FG003|Overall Study|Protocol Violation|2|||
42265375|NCT01369511|76093450|FG000|Overall Study|Physician Decision|3|||
42265376|NCT01369511|76093451|FG001|Overall Study|Physician Decision|4|||
42265377|NCT01369511|76093452|FG002|Overall Study|Physician Decision|0|||
42265378|NCT01369511|76093453|FG003|Overall Study|Physician Decision|0|||
42265379|NCT01369511|76093450|FG000|Overall Study|Sponsor decision|2|||
42265380|NCT01369511|76093451|FG001|Overall Study|Sponsor decision|0|||
42336055|NCT02059291|76173695|FG018|Epoch 3|Adverse Event|0|||
42336056|NCT02059291|76173696|FG019|Epoch 3|Adverse Event|0|||
42336057|NCT02059291|76173697|FG020|Epoch 3|Adverse Event|0|||
42336058|NCT02059291|76173698|FG021|Epoch 3|Adverse Event|0|||
42336059|NCT02059291|76173699|FG022|Epoch 3|Adverse Event|0|||
42336060|NCT02059291|76173700|FG023|Epoch 3|Adverse Event|0|||
42336061|NCT02059291|76173701|FG024|Epoch 3|Adverse Event|0|||
42336062|NCT02059291|76173677|FG000|Epoch 3|Lack of Efficacy|0|||
42336063|NCT02059291|76173678|FG001|Epoch 3|Lack of Efficacy|0|||
42336064|NCT02059291|76173679|FG002|Epoch 3|Lack of Efficacy|0|||
42336065|NCT02059291|76173680|FG003|Epoch 3|Lack of Efficacy|0|||
42336066|NCT02059291|76173681|FG004|Epoch 3|Lack of Efficacy|0|||
42336067|NCT02059291|76173682|FG005|Epoch 3|Lack of Efficacy|0|||
42336068|NCT02059291|76173683|FG006|Epoch 3|Lack of Efficacy|0|||
42336069|NCT02059291|76173684|FG007|Epoch 3|Lack of Efficacy|0|||
42336070|NCT02059291|76173685|FG008|Epoch 3|Lack of Efficacy|0|||
42336071|NCT02059291|76173686|FG009|Epoch 3|Lack of Efficacy|0|||
42336072|NCT02059291|76173687|FG010|Epoch 3|Lack of Efficacy|0|||
42336073|NCT02059291|76173688|FG011|Epoch 3|Lack of Efficacy|0|||
42336074|NCT02059291|76173689|FG012|Epoch 3|Lack of Efficacy|0|||
42336075|NCT02059291|76173690|FG013|Epoch 3|Lack of Efficacy|0|||
42336076|NCT02059291|76173691|FG014|Epoch 3|Lack of Efficacy|0|||
42336077|NCT02059291|76173692|FG015|Epoch 3|Lack of Efficacy|3|||
42336078|NCT02059291|76173693|FG016|Epoch 3|Lack of Efficacy|0|||
42336079|NCT02059291|76173694|FG017|Epoch 3|Lack of Efficacy|0|||
42336080|NCT02059291|76173695|FG018|Epoch 3|Lack of Efficacy|0|||
42336081|NCT02059291|76173696|FG019|Epoch 3|Lack of Efficacy|0|||
42336082|NCT02059291|76173697|FG020|Epoch 3|Lack of Efficacy|0|||
42336083|NCT02059291|76173698|FG021|Epoch 3|Lack of Efficacy|0|||
42336084|NCT02059291|76173699|FG022|Epoch 3|Lack of Efficacy|0|||
42336085|NCT02059291|76173700|FG023|Epoch 3|Lack of Efficacy|0|||
42336086|NCT02059291|76173701|FG024|Epoch 3|Lack of Efficacy|0|||
42336087|NCT02059291|76173677|FG000|Epoch 3|Withdrawal by Subject|0|||
42336088|NCT02059291|76173678|FG001|Epoch 3|Withdrawal by Subject|0|||
42336089|NCT02059291|76173679|FG002|Epoch 3|Withdrawal by Subject|0|||
42336090|NCT02059291|76173680|FG003|Epoch 3|Withdrawal by Subject|0|||
42336091|NCT02059291|76173681|FG004|Epoch 3|Withdrawal by Subject|0|||
42336092|NCT02059291|76173682|FG005|Epoch 3|Withdrawal by Subject|0|||
42336093|NCT02059291|76173683|FG006|Epoch 3|Withdrawal by Subject|0|||
42336094|NCT02059291|76173684|FG007|Epoch 3|Withdrawal by Subject|0|||
42336095|NCT02059291|76173685|FG008|Epoch 3|Withdrawal by Subject|0|||
42336096|NCT02059291|76173686|FG009|Epoch 3|Withdrawal by Subject|0|||
42336097|NCT02059291|76173687|FG010|Epoch 3|Withdrawal by Subject|0|||
42336098|NCT02059291|76173688|FG011|Epoch 3|Withdrawal by Subject|0|||
42336099|NCT02059291|76173689|FG012|Epoch 3|Withdrawal by Subject|0|||
42336100|NCT02059291|76173690|FG013|Epoch 3|Withdrawal by Subject|0|||
42336101|NCT02059291|76173691|FG014|Epoch 3|Withdrawal by Subject|0|||
42336102|NCT02059291|76173692|FG015|Epoch 3|Withdrawal by Subject|1|||
42336103|NCT02059291|76173693|FG016|Epoch 3|Withdrawal by Subject|0|||
42336104|NCT02059291|76173694|FG017|Epoch 3|Withdrawal by Subject|0|||
42336105|NCT02059291|76173695|FG018|Epoch 3|Withdrawal by Subject|0|||
42336106|NCT02059291|76173696|FG019|Epoch 3|Withdrawal by Subject|0|||
42336107|NCT02059291|76173697|FG020|Epoch 3|Withdrawal by Subject|0|||
42336108|NCT02059291|76173698|FG021|Epoch 3|Withdrawal by Subject|0|||
42134679|NCT00406653|75945535|FG006|Induction Period|Given prohibited drug|0|||
42134680|NCT00406653|75945529|FG000|Induction Period|Incarcerated|0|||
42265381|NCT01369511|76093452|FG002|Overall Study|Sponsor decision|1|||
42265382|NCT01369511|76093453|FG003|Overall Study|Sponsor decision|0|||
42265383|NCT01369511|76093450|FG000|Overall Study|Withdrawal by Subject|5|||
42265384|NCT01369511|76093451|FG001|Overall Study|Withdrawal by Subject|6|||
42265385|NCT01369511|76093452|FG002|Overall Study|Withdrawal by Subject|4|||
42265386|NCT01369511|76093453|FG003|Overall Study|Withdrawal by Subject|6|||
42265387|NCT01369433|76093465|FG000|Overall Study|Adverse Event|31|||
42265388|NCT01369433|76093466|FG001|Overall Study|Adverse Event|1|||
42265389|NCT01369433|76093465|FG000|Overall Study|Required significant surgical procedure|1|||
42265390|NCT01369433|76093466|FG001|Overall Study|Required significant surgical procedure|0|||
42265391|NCT01369433|76093465|FG000|Overall Study|Non-compliance|1|||
42265392|NCT01369433|76093466|FG001|Overall Study|Non-compliance|0|||
42265393|NCT01369433|76093465|FG000|Overall Study|Withdrawal by Subject|5|||
42265394|NCT01369433|76093466|FG001|Overall Study|Withdrawal by Subject|2|||
42265395|NCT01369433|76093465|FG000|Overall Study|Study terminated by Sponsor|67|||
42265396|NCT01369433|76093466|FG001|Overall Study|Study terminated by Sponsor|0|||
42336109|NCT02059291|76173699|FG022|Epoch 3|Withdrawal by Subject|0|||
42336110|NCT02059291|76173700|FG023|Epoch 3|Withdrawal by Subject|0|||
42336111|NCT02059291|76173701|FG024|Epoch 3|Withdrawal by Subject|0|||
42336112|NCT02059291|76173677|FG000|Epoch 4|Adverse Event|0|||
42336113|NCT02059291|76173678|FG001|Epoch 4|Adverse Event|0|||
42134681|NCT00406653|75945530|FG001|Induction Period|Incarcerated|0|||
42336114|NCT02059291|76173679|FG002|Epoch 4|Adverse Event|0|||
42336115|NCT02059291|76173680|FG003|Epoch 4|Adverse Event|0|||
42336116|NCT02059291|76173681|FG004|Epoch 4|Adverse Event|0|||
42336117|NCT02059291|76173682|FG005|Epoch 4|Adverse Event|0|||
42336118|NCT02059291|76173683|FG006|Epoch 4|Adverse Event|0|||
42336119|NCT02059291|76173684|FG007|Epoch 4|Adverse Event|0|||
42336120|NCT02059291|76173685|FG008|Epoch 4|Adverse Event|0|||
42336121|NCT02059291|76173686|FG009|Epoch 4|Adverse Event|0|||
42336122|NCT02059291|76173687|FG010|Epoch 4|Adverse Event|0|||
42336123|NCT02059291|76173688|FG011|Epoch 4|Adverse Event|0|||
42336124|NCT02059291|76173689|FG012|Epoch 4|Adverse Event|0|||
42336125|NCT02059291|76173690|FG013|Epoch 4|Adverse Event|0|||
42336126|NCT02059291|76173691|FG014|Epoch 4|Adverse Event|0|||
42336127|NCT02059291|76173692|FG015|Epoch 4|Adverse Event|0|||
42336128|NCT02059291|76173693|FG016|Epoch 4|Adverse Event|1|||
42336129|NCT02059291|76173694|FG017|Epoch 4|Adverse Event|0|||
42336130|NCT02059291|76173695|FG018|Epoch 4|Adverse Event|0|||
42336131|NCT02059291|76173696|FG019|Epoch 4|Adverse Event|0|||
42336132|NCT02059291|76173697|FG020|Epoch 4|Adverse Event|0|||
42336133|NCT02059291|76173698|FG021|Epoch 4|Adverse Event|0|||
42336134|NCT02059291|76173699|FG022|Epoch 4|Adverse Event|1|||
42336135|NCT02059291|76173700|FG023|Epoch 4|Adverse Event|0|||
42336136|NCT02059291|76173701|FG024|Epoch 4|Adverse Event|0|||
42336137|NCT02059291|76173677|FG000|Epoch 4|Pregnancy|0|||
42336138|NCT02059291|76173678|FG001|Epoch 4|Pregnancy|0|||
42336139|NCT02059291|76173679|FG002|Epoch 4|Pregnancy|0|||
42034727|NCT01061736|75842940|FG002|Overall Study|Dose regimen not selected|0|||
42034728|NCT01061736|75842941|FG003|Overall Study|Dose regimen not selected|0|||
42034729|NCT01061736|75842942|FG004|Overall Study|Dose regimen not selected|0|||
42034730|NCT01061736|75842943|FG005|Overall Study|Dose regimen not selected|0|||
42034731|NCT01061736|75842944|FG006|Overall Study|Dose regimen not selected|79|||
42034732|NCT01061736|75842945|FG007|Overall Study|Dose regimen not selected|0|||
42134682|NCT00406653|75945531|FG002|Induction Period|Incarcerated|1|||
42134683|NCT00406653|75945532|FG003|Induction Period|Incarcerated|0|||
42134684|NCT00406653|75945533|FG004|Induction Period|Incarcerated|0|||
42134685|NCT00406653|75945534|FG005|Induction Period|Incarcerated|0|||
42134686|NCT00406653|75945535|FG006|Induction Period|Incarcerated|0|||
42134687|NCT00406653|75945529|FG000|Induction Period|Patient relocated|0|||
42134688|NCT00406653|75945530|FG001|Induction Period|Patient relocated|0|||
42134689|NCT00406653|75945531|FG002|Induction Period|Patient relocated|1|||
42134690|NCT00406653|75945532|FG003|Induction Period|Patient relocated|0|||
42134691|NCT00406653|75945533|FG004|Induction Period|Patient relocated|0|||
42134692|NCT00406653|75945534|FG005|Induction Period|Patient relocated|0|||
42265397|NCT01369433|76093465|FG000|Overall Study|Lost to Follow-up|1|||
42265398|NCT01369433|76093466|FG001|Overall Study|Lost to Follow-up|0|||
42265399|NCT01369433|76093465|FG000|Overall Study|Death|5|||
42265400|NCT01369433|76093466|FG001|Overall Study|Death|0|||
42265401|NCT01369433|76093465|FG000|Overall Study|Investigator discretion|6|||
42265402|NCT01369433|76093466|FG001|Overall Study|Investigator discretion|1|||
42265403|NCT01369433|76093465|FG000|Overall Study|Progressive Disease|92|||
42265404|NCT01369433|76093466|FG001|Overall Study|Progressive Disease|12|||
42265405|NCT02624492|76093475|FG000|Overall Study|Adverse Event|2|||
42265406|NCT02624492|76093476|FG001|Overall Study|Adverse Event|2|||
42265407|NCT02624492|76093477|FG002|Overall Study|Adverse Event|2|||
42265408|NCT02624492|76093475|FG000|Overall Study|Progressive disease|0|||
42265409|NCT02624492|76093476|FG001|Overall Study|Progressive disease|2|||
42265410|NCT02624492|76093477|FG002|Overall Study|Progressive disease|3|||
42265411|NCT01975831|76093494|FG000|Overall Study|Adverse Event|1|||
42265412|NCT01975831|76093495|FG001|Overall Study|Adverse Event|2|||
42265413|NCT01975831|76093496|FG002|Overall Study|Adverse Event|2|||
42265414|NCT01975831|76093497|FG003|Overall Study|Adverse Event|0|||
42265415|NCT01975831|76093498|FG004|Overall Study|Adverse Event|1|||
42265416|NCT01975831|76093499|FG005|Overall Study|Adverse Event|1|||
42265417|NCT01975831|76093500|FG006|Overall Study|Adverse Event|3|||
42265418|NCT01975831|76093501|FG007|Overall Study|Adverse Event|4|||
42265419|NCT01975831|76093502|FG008|Overall Study|Adverse Event|1|||
42336140|NCT02059291|76173680|FG003|Epoch 4|Pregnancy|0|||
42336141|NCT02059291|76173681|FG004|Epoch 4|Pregnancy|0|||
42336142|NCT02059291|76173682|FG005|Epoch 4|Pregnancy|0|||
42336143|NCT02059291|76173683|FG006|Epoch 4|Pregnancy|0|||
42034733|NCT01061736|75842946|FG008|Overall Study|Dose regimen not selected|0|||
42265420|NCT01975831|76093494|FG000|Overall Study|Death|1|||
42265421|NCT01975831|76093495|FG001|Overall Study|Death|1|||
42336144|NCT02059291|76173684|FG007|Epoch 4|Pregnancy|0|||
42265422|NCT01975831|76093496|FG002|Overall Study|Death|0|||
42265423|NCT01975831|76093497|FG003|Overall Study|Death|0|||
42336145|NCT02059291|76173685|FG008|Epoch 4|Pregnancy|0|||
42336146|NCT02059291|76173686|FG009|Epoch 4|Pregnancy|0|||
42034734|NCT01061736|75842947|FG009|Overall Study|Dose regimen not selected|0|||
42134693|NCT00406653|75945535|FG006|Induction Period|Patient relocated|0|||
42134694|NCT00406653|75945529|FG000|Maintenance Period|Adverse Event|0|||
42134695|NCT00406653|75945530|FG001|Maintenance Period|Adverse Event|0|||
42134696|NCT00406653|75945531|FG002|Maintenance Period|Adverse Event|0|||
42265424|NCT01975831|76093498|FG004|Overall Study|Death|1|||
42336147|NCT02059291|76173687|FG010|Epoch 4|Pregnancy|0|||
42336148|NCT02059291|76173688|FG011|Epoch 4|Pregnancy|0|||
42336149|NCT02059291|76173689|FG012|Epoch 4|Pregnancy|0|||
42336150|NCT02059291|76173690|FG013|Epoch 4|Pregnancy|0|||
42336151|NCT02059291|76173691|FG014|Epoch 4|Pregnancy|0|||
42134697|NCT00406653|75945532|FG003|Maintenance Period|Adverse Event|0|||
42134698|NCT00406653|75945533|FG004|Maintenance Period|Adverse Event|1|||
42134699|NCT00406653|75945534|FG005|Maintenance Period|Adverse Event|1|||
42134700|NCT00406653|75945535|FG006|Maintenance Period|Adverse Event|0|||
42134701|NCT00406653|75945529|FG000|Maintenance Period|Lack of Efficacy|0|||
42134702|NCT00406653|75945530|FG001|Maintenance Period|Lack of Efficacy|0|||
42134703|NCT00406653|75945531|FG002|Maintenance Period|Lack of Efficacy|0|||
42336152|NCT02059291|76173692|FG015|Epoch 4|Pregnancy|0|||
42336153|NCT02059291|76173693|FG016|Epoch 4|Pregnancy|1|||
42336154|NCT02059291|76173694|FG017|Epoch 4|Pregnancy|0|||
42336155|NCT02059291|76173695|FG018|Epoch 4|Pregnancy|0|||
42336156|NCT02059291|76173696|FG019|Epoch 4|Pregnancy|0|||
42336157|NCT02059291|76173697|FG020|Epoch 4|Pregnancy|0|||
42336158|NCT02059291|76173698|FG021|Epoch 4|Pregnancy|0|||
42336159|NCT02059291|76173699|FG022|Epoch 4|Pregnancy|0|||
42336160|NCT02059291|76173700|FG023|Epoch 4|Pregnancy|0|||
42336161|NCT02059291|76173701|FG024|Epoch 4|Pregnancy|0|||
42336162|NCT02059291|76173677|FG000|Epoch 4|Withdrawal by Subject|0|||
42336163|NCT02059291|76173678|FG001|Epoch 4|Withdrawal by Subject|0|||
42336164|NCT02059291|76173679|FG002|Epoch 4|Withdrawal by Subject|0|||
42336165|NCT02059291|76173680|FG003|Epoch 4|Withdrawal by Subject|0|||
42336166|NCT02059291|76173681|FG004|Epoch 4|Withdrawal by Subject|0|||
42336167|NCT02059291|76173682|FG005|Epoch 4|Withdrawal by Subject|0|||
42336168|NCT02059291|76173683|FG006|Epoch 4|Withdrawal by Subject|0|||
42336169|NCT02059291|76173684|FG007|Epoch 4|Withdrawal by Subject|0|||
42336170|NCT02059291|76173685|FG008|Epoch 4|Withdrawal by Subject|0|||
42336171|NCT02059291|76173686|FG009|Epoch 4|Withdrawal by Subject|0|||
42336172|NCT02059291|76173687|FG010|Epoch 4|Withdrawal by Subject|0|||
42336173|NCT02059291|76173688|FG011|Epoch 4|Withdrawal by Subject|0|||
42336174|NCT02059291|76173689|FG012|Epoch 4|Withdrawal by Subject|0|||
42336175|NCT02059291|76173690|FG013|Epoch 4|Withdrawal by Subject|0|||
42336176|NCT02059291|76173691|FG014|Epoch 4|Withdrawal by Subject|0|||
42336177|NCT02059291|76173692|FG015|Epoch 4|Withdrawal by Subject|0|||
42336178|NCT02059291|76173693|FG016|Epoch 4|Withdrawal by Subject|0|||
42336179|NCT02059291|76173694|FG017|Epoch 4|Withdrawal by Subject|0|||
42336180|NCT02059291|76173695|FG018|Epoch 4|Withdrawal by Subject|0|||
42336181|NCT02059291|76173696|FG019|Epoch 4|Withdrawal by Subject|0|||
42336182|NCT02059291|76173697|FG020|Epoch 4|Withdrawal by Subject|1|||
42336183|NCT02059291|76173698|FG021|Epoch 4|Withdrawal by Subject|0|||
42336184|NCT02059291|76173699|FG022|Epoch 4|Withdrawal by Subject|0|||
42336185|NCT02059291|76173700|FG023|Epoch 4|Withdrawal by Subject|0|||
42336186|NCT02059291|76173701|FG024|Epoch 4|Withdrawal by Subject|0|||
42336187|NCT02059291|76173677|FG000|Epoch 4|Lack of Efficacy|0|||
42336188|NCT02059291|76173678|FG001|Epoch 4|Lack of Efficacy|0|||
42336189|NCT02059291|76173679|FG002|Epoch 4|Lack of Efficacy|0|||
42336190|NCT02059291|76173680|FG003|Epoch 4|Lack of Efficacy|0|||
42336191|NCT02059291|76173681|FG004|Epoch 4|Lack of Efficacy|0|||
42336192|NCT02059291|76173682|FG005|Epoch 4|Lack of Efficacy|0|||
42336193|NCT02059291|76173683|FG006|Epoch 4|Lack of Efficacy|0|||
42336194|NCT02059291|76173684|FG007|Epoch 4|Lack of Efficacy|0|||
42336195|NCT02059291|76173685|FG008|Epoch 4|Lack of Efficacy|0|||
42336196|NCT02059291|76173686|FG009|Epoch 4|Lack of Efficacy|0|||
42336197|NCT02059291|76173687|FG010|Epoch 4|Lack of Efficacy|0|||
42336198|NCT02059291|76173688|FG011|Epoch 4|Lack of Efficacy|0|||
42265425|NCT01975831|76093499|FG005|Overall Study|Death|0|||
42265426|NCT01975831|76093500|FG006|Overall Study|Death|1|||
42265427|NCT01975831|76093501|FG007|Overall Study|Death|0|||
42265428|NCT01975831|76093502|FG008|Overall Study|Death|0|||
42265429|NCT01975831|76093494|FG000|Overall Study|Progressive Disease|1|||
42265430|NCT01975831|76093495|FG001|Overall Study|Progressive Disease|3|||
42265431|NCT01975831|76093496|FG002|Overall Study|Progressive Disease|2|||
42265432|NCT01975831|76093497|FG003|Overall Study|Progressive Disease|4|||
42265433|NCT01975831|76093498|FG004|Overall Study|Progressive Disease|13|||
42265434|NCT01975831|76093499|FG005|Overall Study|Progressive Disease|9|||
42265435|NCT01975831|76093500|FG006|Overall Study|Progressive Disease|10|||
42265436|NCT01975831|76093501|FG007|Overall Study|Progressive Disease|8|||
42265437|NCT01975831|76093502|FG008|Overall Study|Progressive Disease|10|||
42265438|NCT01975831|76093494|FG000|Overall Study|Withdrawal by Subject|0|||
42265439|NCT01975831|76093495|FG001|Overall Study|Withdrawal by Subject|3|||
42265440|NCT01975831|76093496|FG002|Overall Study|Withdrawal by Subject|0|||
42265441|NCT01975831|76093497|FG003|Overall Study|Withdrawal by Subject|0|||
42265442|NCT01975831|76093498|FG004|Overall Study|Withdrawal by Subject|3|||
42336199|NCT02059291|76173689|FG012|Epoch 4|Lack of Efficacy|0|||
42336200|NCT02059291|76173690|FG013|Epoch 4|Lack of Efficacy|0|||
42134704|NCT00406653|75945532|FG003|Maintenance Period|Lack of Efficacy|0|||
42134705|NCT00406653|75945533|FG004|Maintenance Period|Lack of Efficacy|20|||
42265443|NCT01975831|76093499|FG005|Overall Study|Withdrawal by Subject|1|||
42265444|NCT01975831|76093500|FG006|Overall Study|Withdrawal by Subject|1|||
42336201|NCT02059291|76173691|FG014|Epoch 4|Lack of Efficacy|0|||
42336202|NCT02059291|76173692|FG015|Epoch 4|Lack of Efficacy|0|||
42336203|NCT02059291|76173693|FG016|Epoch 4|Lack of Efficacy|0|||
42336204|NCT02059291|76173694|FG017|Epoch 4|Lack of Efficacy|0|||
42336205|NCT02059291|76173695|FG018|Epoch 4|Lack of Efficacy|0|||
42336206|NCT02059291|76173696|FG019|Epoch 4|Lack of Efficacy|0|||
42336207|NCT02059291|76173697|FG020|Epoch 4|Lack of Efficacy|0|||
42336208|NCT02059291|76173698|FG021|Epoch 4|Lack of Efficacy|0|||
42336209|NCT02059291|76173699|FG022|Epoch 4|Lack of Efficacy|0|||
42336210|NCT02059291|76173700|FG023|Epoch 4|Lack of Efficacy|1|||
42336211|NCT02059291|76173701|FG024|Epoch 4|Lack of Efficacy|0|||
42336212|NCT02042924|76173729|FG000|Overall Study|Early Death|1|||
42336213|NCT02041520|76173735|FG000|Overall Study|Adverse Event|2|||
42336214|NCT02041520|76173736|FG001|Overall Study|Adverse Event|1|||
42336215|NCT02041520|76173735|FG000|Overall Study|Withdrawal by Subject|3|||
42336216|NCT02041520|76173736|FG001|Overall Study|Withdrawal by Subject|4|||
42336217|NCT02041520|76173735|FG000|Overall Study|Protocol Violation|1|||
42336218|NCT02041520|76173736|FG001|Overall Study|Protocol Violation|0|||
42336219|NCT02041520|76173735|FG000|Overall Study|Lost to Follow-up|0|||
42336220|NCT02041520|76173736|FG001|Overall Study|Lost to Follow-up|1|||
42336221|NCT02041520|76173735|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
42336222|NCT02041520|76173736|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
42336223|NCT02041429|76173748|FG000|Overall Study|Progressive Disease|2|||
42336224|NCT02041429|76173749|FG001|Overall Study|Progressive Disease|2|||
42336225|NCT02041429|76173750|FG002|Overall Study|Progressive Disease|3|||
42336226|NCT02041429|76173751|FG003|Overall Study|Progressive Disease|2|||
42336227|NCT02041429|76173748|FG000|Overall Study|Toxicity|0|||
42336228|NCT02041429|76173749|FG001|Overall Study|Toxicity|1|||
42336229|NCT02041429|76173750|FG002|Overall Study|Toxicity|4|||
42336230|NCT02041429|76173751|FG003|Overall Study|Toxicity|2|||
42336231|NCT02041429|76173748|FG000|Overall Study|Withdrawal by Subject|0|||
42336232|NCT02041429|76173749|FG001|Overall Study|Withdrawal by Subject|1|||
42336233|NCT02041429|76173750|FG002|Overall Study|Withdrawal by Subject|0|||
42336234|NCT02041429|76173751|FG003|Overall Study|Withdrawal by Subject|0|||
42336235|NCT02041429|76173748|FG000|Overall Study|On Maintenance Therapy|1|||
42336236|NCT02041429|76173749|FG001|Overall Study|On Maintenance Therapy|0|||
42336237|NCT02041429|76173750|FG002|Overall Study|On Maintenance Therapy|0|||
42336238|NCT02041429|76173751|FG003|Overall Study|On Maintenance Therapy|2|||
42336239|NCT02083783|76173768|FG000|Overall Study|Withdrawal by Subject|1|||
42336240|NCT02083783|76173769|FG001|Overall Study|Withdrawal by Subject|0|||
42336241|NCT02083081|76173779|FG000|Overall Study|Lost to Follow-up|31|||
42336242|NCT02083081|76173780|FG001|Overall Study|Lost to Follow-up|9|||
42336243|NCT02040805|76173788|FG000|Overall Study|Lost to Follow-up|14|||
42336244|NCT02040805|76173789|FG001|Overall Study|Lost to Follow-up|9|||
42336245|NCT02040805|76173788|FG000|Overall Study|Withdrawal by Subject|28|||
42336246|NCT02040805|76173789|FG001|Overall Study|Withdrawal by Subject|41|||
42336247|NCT02040259|76173795|FG000|Overall Study|Death|280|||
42336248|NCT02040259|76173795|FG000|Overall Study|Lost to Follow-up|76|||
42336249|NCT02040259|76173795|FG000|Overall Study|Assessment not completed|3|||
42336250|NCT02040259|76173795|FG000|Overall Study|Withdrawal by Subject|4|||
42336251|NCT02059135|76173803|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
42336252|NCT02059135|76173804|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
42336253|NCT02059135|76173803|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
42336254|NCT02059135|76173804|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
42336255|NCT02059135|76173803|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
42336256|NCT02059135|76173804|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
42336257|NCT02059135|76173803|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
42336258|NCT02059135|76173804|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
42336259|NCT02059135|76173803|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
42336260|NCT02059135|76173804|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
42336261|NCT02059135|76173803|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
42336262|NCT02059135|76173804|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
42336263|NCT02059135|76173803|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
42336264|NCT02059135|76173804|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
42336265|NCT02059135|76173803|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
42336266|NCT02059135|76173804|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
42336267|NCT02081677|76173816|FG000|Overall Study|Adverse Event|0|||
42336268|NCT02081677|76173817|FG001|Overall Study|Adverse Event|0|||
42336269|NCT02081677|76173818|FG002|Overall Study|Adverse Event|1|||
42336270|NCT02081677|76173819|FG003|Overall Study|Adverse Event|0|||
42336271|NCT02081677|76173816|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
42000270|NCT01175707|75808789|FG000|Overall Study|Adverse Event|4|||
42336272|NCT02081677|76173817|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
42336273|NCT02081677|76173818|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
42336274|NCT02081677|76173819|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
42336275|NCT02081677|76173816|FG000|Overall Study|Not comfortable with lens care system|1|||
42336276|NCT02081677|76173817|FG001|Overall Study|Not comfortable with lens care system|0|||
42336277|NCT02081677|76173818|FG002|Overall Study|Not comfortable with lens care system|0|||
42336278|NCT02081677|76173819|FG003|Overall Study|Not comfortable with lens care system|0|||
42336279|NCT02081677|76173816|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
42336280|NCT02081677|76173817|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
42336281|NCT02081677|76173818|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
42336282|NCT02081677|76173819|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
42336283|NCT02038933|76173831|FG000|Overall Study|Disease progression|104|||
42336284|NCT02038933|76173831|FG000|Overall Study|Study drug toxicity|6|||
42336285|NCT02038933|76173831|FG000|Overall Study|Adverse event unrelated to study drug|6|||
42336286|NCT02038933|76173831|FG000|Overall Study|Participant request to discontinue treatment|2|||
42336287|NCT02038933|76173831|FG000|Overall Study|Lost to Follow-up|1|||
42336288|NCT02038933|76173831|FG000|Overall Study|Other reasons|2|||
42336289|NCT02081599|76173838|FG000|Period 1：Double-blind Period|Adverse Event|3|||
42336290|NCT02081599|76173839|FG001|Period 1：Double-blind Period|Adverse Event|0|||
42336291|NCT02081599|76173838|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
42336292|NCT02081599|76173839|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
42336293|NCT02081599|76173838|FG000|Period 1：Double-blind Period|Physician Decision|1|||
42336294|NCT02081599|76173839|FG001|Period 1：Double-blind Period|Physician Decision|0|||
42336295|NCT02081599|76173838|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
42336296|NCT02081599|76173839|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
42336297|NCT02081599|76173838|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
42336298|NCT02081599|76173839|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
42336299|NCT02081599|76173838|FG000|Period 1：Double-blind Period|stopping criteria|1|||
42336300|NCT02081599|76173839|FG001|Period 1：Double-blind Period|stopping criteria|0|||
42336301|NCT02081599|76173838|FG000|Period 2：Open-label Period|Adverse Event|1|||
42336302|NCT02081599|76173839|FG001|Period 2：Open-label Period|Adverse Event|0|||
42336303|NCT02081599|76173838|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
42336304|NCT02081599|76173839|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
42336305|NCT02081599|76173838|FG000|Period 2：Open-label Period|Physician Decision|1|||
42336306|NCT02081599|76173839|FG001|Period 2：Open-label Period|Physician Decision|0|||
42336307|NCT02081599|76173838|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
42336308|NCT02081599|76173839|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
42336309|NCT02038543|76173851|FG000|Overall Study|Screen Failure|0|||
42336310|NCT02038543|76173852|FG001|Overall Study|Screen Failure|0|||
42336311|NCT02038543|76173853|FG002|Overall Study|Screen Failure|0|||
42336312|NCT02038543|76173854|FG003|Overall Study|Screen Failure|1|||
42336313|NCT02038543|76173851|FG000|Overall Study|Withdrawal by Subject|0|||
42336314|NCT02038543|76173852|FG001|Overall Study|Withdrawal by Subject|0|||
42336315|NCT02038543|76173853|FG002|Overall Study|Withdrawal by Subject|0|||
42336316|NCT02038543|76173854|FG003|Overall Study|Withdrawal by Subject|1|||
42336317|NCT02038153|76173864|FG000|Overall Study|Withdrawal by Subject|1|||
42336318|NCT02058589|76173870|FG000|Overall Study|Serious Adverse Event|1|||
42336319|NCT02058589|76173871|FG001|Overall Study|Serious Adverse Event|1|||
42336320|NCT02058589|76173870|FG000|Overall Study|Non-Serious Adverse Event|1|||
42336321|NCT02058589|76173871|FG001|Overall Study|Non-Serious Adverse Event|0|||
42336322|NCT02058589|76173870|FG000|Overall Study|Withdrawal by Subject|0|||
42336323|NCT02058589|76173871|FG001|Overall Study|Withdrawal by Subject|1|||
42336324|NCT02079805|76173881|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
42336325|NCT02079805|76173882|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
42336326|NCT02079805|76173881|FG000|Overall Study|Voluntary Withdrawal|0|||
42336327|NCT02079805|76173882|FG001|Overall Study|Voluntary Withdrawal|1|||
42336328|NCT02037295|76173892|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
42336329|NCT02037295|76173893|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
42336330|NCT02037295|76173894|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
42336331|NCT02037295|76173895|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
42336332|NCT02079649|76173911|FG000|Overall Study|Lost to Follow-up|0|||
42336333|NCT02079649|76173912|FG001|Overall Study|Lost to Follow-up|0|||
42336334|NCT02079649|76173913|FG002|Overall Study|Lost to Follow-up|0|||
42336335|NCT02079649|76173914|FG003|Overall Study|Lost to Follow-up|1|||
42336336|NCT02079649|76173911|FG000|Overall Study|Withdrawal by Subject|0|||
42336337|NCT02079649|76173912|FG001|Overall Study|Withdrawal by Subject|0|||
42336338|NCT02079649|76173913|FG002|Overall Study|Withdrawal by Subject|0|||
42336339|NCT02079649|76173914|FG003|Overall Study|Withdrawal by Subject|1|||
42336340|NCT02079649|76173911|FG000|Overall Study|Randomization error (prior to treatment)|1|||
42336341|NCT02079649|76173912|FG001|Overall Study|Randomization error (prior to treatment)|0|||
42336342|NCT02079649|76173913|FG002|Overall Study|Randomization error (prior to treatment)|1|||
42336343|NCT02079649|76173914|FG003|Overall Study|Randomization error (prior to treatment)|0|||
42134706|NCT00406653|75945534|FG005|Maintenance Period|Lack of Efficacy|26|||
42134707|NCT00406653|75945535|FG006|Maintenance Period|Lack of Efficacy|0|||
42336344|NCT02036515|76173928|FG000|Overall Study|Adverse Event|1|||
42336345|NCT02036515|76173929|FG001|Overall Study|Adverse Event|1|||
42336346|NCT02036515|76173930|FG002|Overall Study|Adverse Event|2|||
42336347|NCT02036515|76173928|FG000|Overall Study|Lost to Follow-up|0|||
42336348|NCT02036515|76173929|FG001|Overall Study|Lost to Follow-up|2|||
42336349|NCT02036515|76173930|FG002|Overall Study|Lost to Follow-up|0|||
42336350|NCT02036515|76173928|FG000|Overall Study|Non-compliance with study drug|0|||
42336351|NCT02036515|76173929|FG001|Overall Study|Non-compliance with study drug|0|||
42336352|NCT02036515|76173930|FG002|Overall Study|Non-compliance with study drug|2|||
42336353|NCT02036515|76173928|FG000|Overall Study|Screen failure|0|||
42336354|NCT02036515|76173929|FG001|Overall Study|Screen failure|2|||
42134708|NCT00406653|75945529|FG000|Maintenance Period|Lost to Follow-up|0|||
42134709|NCT00406653|75945530|FG001|Maintenance Period|Lost to Follow-up|0|||
42000271|NCT01175707|75808790|FG001|Overall Study|Adverse Event|6|||
42000272|NCT01112059|75808799|FG000|Overall Study|Withdrawal by Subject|1|||
42336355|NCT02036515|76173930|FG002|Overall Study|Screen failure|0|||
42336356|NCT02036515|76173928|FG000|Overall Study|Withdrawal by Subject|4|||
42336357|NCT02036515|76173929|FG001|Overall Study|Withdrawal by Subject|7|||
42336358|NCT02036515|76173930|FG002|Overall Study|Withdrawal by Subject|9|||
42336359|NCT02036515|76173928|FG000|Overall Study|Hyperglycemia|0|||
42336360|NCT02036515|76173929|FG001|Overall Study|Hyperglycemia|0|||
42336361|NCT02036515|76173930|FG002|Overall Study|Hyperglycemia|1|||
42336362|NCT02078713|76173942|FG000|Overall Study|Lost to Follow-up|49|||
42336363|NCT02078713|76173943|FG001|Overall Study|Lost to Follow-up|55|||
42336364|NCT02078713|76173944|FG002|Overall Study|Lost to Follow-up|0|||
42336365|NCT02078713|76173945|FG003|Overall Study|Lost to Follow-up|0|||
42336366|NCT02078713|76173942|FG000|Overall Study|Pregnant at baseline|3|||
42336367|NCT02078713|76173943|FG001|Overall Study|Pregnant at baseline|5|||
42336368|NCT02078713|76173944|FG002|Overall Study|Pregnant at baseline|0|||
42336369|NCT02078713|76173945|FG003|Overall Study|Pregnant at baseline|0|||
42336370|NCT02078713|76173942|FG000|Overall Study|Enrolled twice|0|||
42336371|NCT02078713|76173943|FG001|Overall Study|Enrolled twice|1|||
42336372|NCT02078713|76173944|FG002|Overall Study|Enrolled twice|0|||
42336373|NCT02078713|76173945|FG003|Overall Study|Enrolled twice|0|||
42336374|NCT02035267|76173961|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
42336375|NCT02035267|76173962|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
42336376|NCT02035267|76173963|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
42336377|NCT02035267|76173964|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
42336378|NCT02035267|76173961|FG000|Overall Study|Adverse Event|0|||
42336379|NCT02035267|76173962|FG001|Overall Study|Adverse Event|0|||
42336380|NCT02035267|76173963|FG002|Overall Study|Adverse Event|1|||
42336381|NCT02035267|76173964|FG003|Overall Study|Adverse Event|0|||
42336382|NCT02035267|76173961|FG000|Overall Study|Lost to Follow-up|0|||
42336383|NCT02035267|76173962|FG001|Overall Study|Lost to Follow-up|0|||
42336384|NCT02035267|76173963|FG002|Overall Study|Lost to Follow-up|0|||
42336385|NCT02035267|76173964|FG003|Overall Study|Lost to Follow-up|1|||
42134710|NCT00406653|75945531|FG002|Maintenance Period|Lost to Follow-up|0|||
42134711|NCT00406653|75945532|FG003|Maintenance Period|Lost to Follow-up|0|||
42336386|NCT02035267|76173961|FG000|Overall Study|Other unspecified|0|||
42134712|NCT00406653|75945533|FG004|Maintenance Period|Lost to Follow-up|2|||
42336387|NCT02035267|76173962|FG001|Overall Study|Other unspecified|1|||
42336388|NCT02035267|76173963|FG002|Overall Study|Other unspecified|0|||
42336389|NCT02035267|76173964|FG003|Overall Study|Other unspecified|0|||
42000273|NCT01112059|75808800|FG001|Overall Study|Withdrawal by Subject|0|||
42000274|NCT01175668|75808811|FG000|Overall Study|Withdrawal by Subject|2|||
42336390|NCT04373460|76173998|FG000|Overall Study|Did not receive tranfusion|18|||
42336391|NCT04373460|76173999|FG001|Overall Study|Did not receive tranfusion|26|||
42336392|NCT04280081|76174009|FG000|Overall Study|Adverse Event|4|||
42336393|NCT04280081|76174009|FG000|Overall Study|Death|2|||
42336394|NCT04280081|76174009|FG000|Overall Study|Progressive Disease|6|||
42336395|NCT04159805|76174025|FG000|Overall Study|Withdrawal by Subject|0|||
42336396|NCT04159805|76174026|FG001|Overall Study|Withdrawal by Subject|2|||
42336397|NCT04159805|76174027|FG002|Overall Study|Withdrawal by Subject|2|||
42336398|NCT03901456|76174038|FG000|Overall Study|Withdrawal by Subject|0|||
42336399|NCT03901456|76174039|FG001|Overall Study|Withdrawal by Subject|0|||
42336400|NCT03901456|76174040|FG002|Overall Study|Withdrawal by Subject|1|||
42336401|NCT03901456|76174038|FG000|Overall Study|Lost to Follow-up|0|||
42336402|NCT03901456|76174039|FG001|Overall Study|Lost to Follow-up|1|||
42336403|NCT03901456|76174040|FG002|Overall Study|Lost to Follow-up|0|||
42336404|NCT03226249|76174091|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
42336405|NCT03226249|76174091|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
42336406|NCT03226249|76174091|FG000|Survival Follow-up|Patients still in follow-up.|30|||
42336407|NCT02849548|76174097|FG000|Overall Study|Lost to Follow-up|1|||
42336408|NCT02849548|76174098|FG001|Overall Study|Lost to Follow-up|2|||
42336409|NCT02849548|76174097|FG000|Overall Study|Protocol Violation|1|||
42336410|NCT02849548|76174098|FG001|Overall Study|Protocol Violation|0|||
42336411|NCT02411448|76174116|FG000|Overall Study|Withdrawal by Subject|1|||
42336412|NCT02411448|76174117|FG001|Overall Study|Withdrawal by Subject|14|||
42336413|NCT02411448|76174118|FG002|Overall Study|Withdrawal by Subject|9|||
42336414|NCT02411448|76174116|FG000|Overall Study|Other|0|||
42336415|NCT02411448|76174117|FG001|Overall Study|Other|2|||
42336416|NCT02411448|76174118|FG002|Overall Study|Other|0|||
42336417|NCT02411448|76174116|FG000|Overall Study|Did not receive study treatment|0|||
42336418|NCT02411448|76174117|FG001|Overall Study|Did not receive study treatment|3|||
42336419|NCT02411448|76174118|FG002|Overall Study|Did not receive study treatment|0|||
42336420|NCT02411448|76174116|FG000|Overall Study|Alive on study treatment|3|||
42336421|NCT02411448|76174117|FG001|Overall Study|Alive on study treatment|64|||
42336422|NCT02411448|76174118|FG002|Overall Study|Alive on study treatment|43|||
42336423|NCT02321514|76174130|FG000|Overall Study|Death|15|||
42336424|NCT02321514|76174130|FG000|Overall Study|Missed Visit|7|||
42336425|NCT02321514|76174130|FG000|Overall Study|Study Exit|3|||
42336426|NCT02266134|76174138|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
42336427|NCT02266134|76174139|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
42336428|NCT02266134|76174140|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
42336429|NCT02266134|76174141|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
42336430|NCT02266134|76174138|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
42336431|NCT02266134|76174139|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
42336432|NCT02266134|76174140|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
42336433|NCT02266134|76174141|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
42336434|NCT02266134|76174138|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
42336435|NCT02266134|76174139|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
42336436|NCT02266134|76174140|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
42336437|NCT02266134|76174141|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
42336438|NCT02266134|76174138|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
42336439|NCT02266134|76174139|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
42336440|NCT02266134|76174140|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
42336441|NCT02266134|76174141|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
42336442|NCT02266134|76174138|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
42336443|NCT02266134|76174139|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
42336444|NCT02266134|76174140|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
42336445|NCT02266134|76174141|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
42336446|NCT02266134|76174138|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
42034735|NCT01061736|75842938|FG000|Overall Study|Adverse Event|13|||
42336447|NCT02266134|76174139|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
42336448|NCT02266134|76174140|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
42265445|NCT01975831|76093501|FG007|Overall Study|Withdrawal by Subject|0|||
42265446|NCT01975831|76093502|FG008|Overall Study|Withdrawal by Subject|0|||
42265447|NCT01975831|76093494|FG000|Overall Study|Physician Decision|0|||
42265448|NCT01975831|76093495|FG001|Overall Study|Physician Decision|0|||
42265449|NCT01975831|76093496|FG002|Overall Study|Physician Decision|0|||
42265450|NCT01975831|76093497|FG003|Overall Study|Physician Decision|0|||
42265451|NCT01975831|76093498|FG004|Overall Study|Physician Decision|0|||
42265452|NCT01975831|76093499|FG005|Overall Study|Physician Decision|1|||
42265453|NCT01975831|76093500|FG006|Overall Study|Physician Decision|0|||
42265454|NCT01975831|76093501|FG007|Overall Study|Physician Decision|1|||
42265455|NCT01975831|76093502|FG008|Overall Study|Physician Decision|0|||
42265456|NCT01975831|76093494|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
42265457|NCT01975831|76093495|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
42265458|NCT01975831|76093496|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
42265459|NCT01975831|76093497|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
42265460|NCT01975831|76093498|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
42265461|NCT01975831|76093499|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
42265462|NCT01975831|76093500|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
42265463|NCT01975831|76093501|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
42265464|NCT01975831|76093502|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
42265465|NCT01975831|76093494|FG000|Overall Study|Entered Hospice|0|||
42134713|NCT00406653|75945534|FG005|Maintenance Period|Lost to Follow-up|1|||
42134714|NCT00406653|75945535|FG006|Maintenance Period|Lost to Follow-up|0|||
42265466|NCT01975831|76093495|FG001|Overall Study|Entered Hospice|0|||
42265467|NCT01975831|76093496|FG002|Overall Study|Entered Hospice|0|||
42134715|NCT00406653|75945529|FG000|Maintenance Period|Withdrawal of Consent|0|||
42134716|NCT00406653|75945530|FG001|Maintenance Period|Withdrawal of Consent|0|||
42134717|NCT00406653|75945531|FG002|Maintenance Period|Withdrawal of Consent|0|||
42265468|NCT01975831|76093497|FG003|Overall Study|Entered Hospice|0|||
42265469|NCT01975831|76093498|FG004|Overall Study|Entered Hospice|0|||
42265470|NCT01975831|76093499|FG005|Overall Study|Entered Hospice|1|||
42265471|NCT01975831|76093500|FG006|Overall Study|Entered Hospice|0|||
42265472|NCT01975831|76093501|FG007|Overall Study|Entered Hospice|0|||
42265473|NCT01975831|76093502|FG008|Overall Study|Entered Hospice|0|||
42265474|NCT01975831|76093494|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
42265475|NCT01975831|76093495|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
42265476|NCT01975831|76093496|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
42265477|NCT01975831|76093497|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
42265478|NCT01975831|76093498|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
42265479|NCT01975831|76093499|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
42265480|NCT01975831|76093500|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
42265481|NCT01975831|76093501|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
42265482|NCT01975831|76093502|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
42265483|NCT00700713|76093525|FG000|Overall Study|Protocol Violation|1|||
42265484|NCT00700713|76093526|FG001|Overall Study|Protocol Violation|0|||
42265485|NCT00700713|76093527|FG002|Overall Study|Protocol Violation|1|||
42265486|NCT00700713|76093525|FG000|Overall Study|Withdrawal by Subject|0|||
42265487|NCT00700713|76093526|FG001|Overall Study|Withdrawal by Subject|0|||
42265488|NCT00700713|76093527|FG002|Overall Study|Withdrawal by Subject|1|||
42265489|NCT02622386|76093535|FG000|First Assignment|Withdrawal by Subject|3|||
42265490|NCT02622386|76093536|FG001|First Assignment|Withdrawal by Subject|2|||
42265491|NCT02622386|76093535|FG000|Washout|Withdrawal by Subject|4|||
42265492|NCT02622386|76093536|FG001|Washout|Withdrawal by Subject|4|||
42265493|NCT02622386|76093535|FG000|Second Assignment|Withdrawal by Subject|0|||
42265494|NCT02622386|76093536|FG001|Second Assignment|Withdrawal by Subject|2|||
42265495|NCT02792231|76093544|FG000|Overall Study|Patient/guardian decision|32|||
42265496|NCT02792231|76093545|FG001|Overall Study|Patient/guardian decision|42|||
42265497|NCT02792231|76093544|FG000|Overall Study|Adverse Event|15|||
42265498|NCT02792231|76093545|FG001|Overall Study|Adverse Event|11|||
42265499|NCT02792231|76093544|FG000|Overall Study|Physician Decision|14|||
42265500|NCT02792231|76093545|FG001|Overall Study|Physician Decision|12|||
42265501|NCT02792231|76093544|FG000|Overall Study|Lack of Efficacy|7|||
42265502|NCT02792231|76093545|FG001|Overall Study|Lack of Efficacy|9|||
42265503|NCT02792231|76093544|FG000|Overall Study|Lost to Follow-up|9|||
42265504|NCT02792231|76093545|FG001|Overall Study|Lost to Follow-up|5|||
42265505|NCT02792231|76093544|FG000|Overall Study|Pregnancy|1|||
42265506|NCT02792231|76093545|FG001|Overall Study|Pregnancy|3|||
42265507|NCT02792231|76093544|FG000|Overall Study|Non-compliance with study treatment|2|||
42265508|NCT02792231|76093545|FG001|Overall Study|Non-compliance with study treatment|1|||
42336449|NCT02266134|76174141|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
42336450|NCT01847274|76174169|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
42336451|NCT01847274|76174170|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
42336452|NCT01847274|76174171|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
42336453|NCT01847274|76174172|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
42336454|NCT01847274|76174173|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
42336455|NCT01847274|76174174|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
42336456|NCT01847274|76174175|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
42336457|NCT01847274|76174176|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
42336458|NCT01847274|76174177|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
42336459|NCT01847274|76174178|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
42336460|NCT01847274|76174179|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
42336461|NCT01847274|76174169|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
42336462|NCT01847274|76174170|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
42336463|NCT01847274|76174171|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
42336464|NCT01847274|76174172|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
42336465|NCT01847274|76174173|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
42265509|NCT02792231|76093544|FG000|Overall Study|Protocol deviation|2|||
42265510|NCT02792231|76093545|FG001|Overall Study|Protocol deviation|0|||
42265511|NCT02792231|76093544|FG000|Overall Study|Technical problems|0|||
42265512|NCT02792231|76093545|FG001|Overall Study|Technical problems|1|||
42265513|NCT00700401|76093551|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
42134718|NCT00406653|75945532|FG003|Maintenance Period|Withdrawal of Consent|0|||
42265514|NCT00700401|76093551|FG000|Overall Study|Adverse Event|5|||
42265515|NCT00700401|76093551|FG000|Overall Study|Refused Treatment|2|||
42265516|NCT00700401|76093551|FG000|Overall Study|Lost to Follow-up|1|||
42265517|NCT00700401|76093551|FG000|Overall Study|Treatment never started|1|||
42265518|NCT00700401|76093551|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
42265519|NCT00700401|76093551|FG000|Overall Study|Withdrawal by Subject|2|||
42265520|NCT02621606|76093558|FG000|Overall Study|Withdrawal by Subject|0|||
42265521|NCT02621606|76093559|FG001|Overall Study|Withdrawal by Subject|1|||
42265522|NCT02621606|76093560|FG002|Overall Study|Withdrawal by Subject|0|||
42265523|NCT02871401|76093570|FG000|Overall Study|Adverse Event|1|||
42265524|NCT02871401|76093571|FG001|Overall Study|Adverse Event|0|||
42265525|NCT02619812|76093581|FG000|Overall Study|Withdrawal by Subject|0|||
42265526|NCT02619812|76093582|FG001|Overall Study|Withdrawal by Subject|0|||
42265527|NCT02619812|76093583|FG002|Overall Study|Withdrawal by Subject|1|||
42265528|NCT02619812|76093584|FG003|Overall Study|Withdrawal by Subject|2|||
42265529|NCT02623322|76093597|FG000|Overall Study|Lost to Follow-up|2|||
42265530|NCT02623322|76093598|FG001|Overall Study|Lost to Follow-up|1|||
42265531|NCT02623322|76093599|FG002|Overall Study|Lost to Follow-up|0|||
42265532|NCT00105157|76093613|FG000|Double-Blind (DB)|Never Treated|1|||
42265533|NCT00105157|76093614|FG001|Double-Blind (DB)|Never Treated|0|||
42265534|NCT00105157|76093615|FG002|Double-Blind (DB)|Never Treated|0|||
42265535|NCT00105157|76093616|FG003|Double-Blind (DB)|Never Treated|0|||
42265536|NCT00105157|76093613|FG000|Double-Blind (DB)|Adverse Event|2|||
42265537|NCT00105157|76093614|FG001|Double-Blind (DB)|Adverse Event|0|||
42265538|NCT00105157|76093615|FG002|Double-Blind (DB)|Adverse Event|1|||
42265539|NCT00105157|76093616|FG003|Double-Blind (DB)|Adverse Event|1|||
42265540|NCT00105157|76093613|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
42265541|NCT00105157|76093614|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
42265542|NCT00105157|76093615|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
42265543|NCT00105157|76093616|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
42265544|NCT00105157|76093613|FG000|Open-Label Continuation of DB|Adverse Event|3|||
42265545|NCT00105157|76093614|FG001|Open-Label Continuation of DB|Adverse Event|1|||
42265546|NCT00105157|76093615|FG002|Open-Label Continuation of DB|Adverse Event|0|||
42265547|NCT00105157|76093616|FG003|Open-Label Continuation of DB|Adverse Event|0|||
42265548|NCT00105157|76093613|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
42265549|NCT00105157|76093614|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
42265550|NCT00105157|76093615|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
42265551|NCT00105157|76093616|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
42265552|NCT00105157|76093613|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
42265553|NCT00105157|76093614|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
42265554|NCT00105157|76093615|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
42265555|NCT00105157|76093616|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
42265556|NCT00105157|76093613|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
42265557|NCT00105157|76093614|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
42265558|NCT00105157|76093615|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
42265559|NCT00105157|76093616|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
42134719|NCT00406653|75945533|FG004|Maintenance Period|Withdrawal of Consent|2|||
42265560|NCT00105157|76093613|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
42265561|NCT00105157|76093614|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
42265562|NCT00105157|76093615|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
42265563|NCT00105157|76093616|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
42265564|NCT00105157|76093613|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
42265565|NCT00105157|76093614|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
42265566|NCT00105157|76093615|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
42265567|NCT00105157|76093616|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
42265568|NCT00105157|76093613|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
42265569|NCT00105157|76093614|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
42265570|NCT00105157|76093615|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
42265571|NCT00105157|76093616|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
42265572|NCT00105157|76093613|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
42265573|NCT00105157|76093614|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
42265574|NCT00105157|76093615|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
42265575|NCT00105157|76093616|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
42134720|NCT00406653|75945534|FG005|Maintenance Period|Withdrawal of Consent|0|||
42265576|NCT00105157|76093613|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
42265577|NCT00105157|76093614|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
42265578|NCT00105157|76093615|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
42265579|NCT00105157|76093616|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
42265580|NCT00105157|76093613|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
42134721|NCT00406653|75945535|FG006|Maintenance Period|Withdrawal of Consent|0|||
42265581|NCT00105157|76093614|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
42265582|NCT00105157|76093615|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
42265583|NCT00105157|76093616|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
42265584|NCT00105157|76093613|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
42265585|NCT00105157|76093614|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
42265586|NCT00105157|76093615|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
42265587|NCT00105157|76093616|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
42265588|NCT02148133|76093637|FG000|Overall Study|Investigator discretion|1|||
42265589|NCT02148133|76093637|FG000|Overall Study|Lack of Efficacy|1|||
42265590|NCT02148133|76093637|FG000|Overall Study|Protocol deviation|1|||
42265591|NCT02148133|76093637|FG000|Overall Study|Protocol-defined stopping criteria|2|||
42265592|NCT00803569|76093641|FG000|Overall Study|Progressive Disease|3|||
42265593|NCT00803569|76093641|FG000|Overall Study|Noncompliance|1|||
42265594|NCT00112957|76093645|FG000|Overall Study|Progressive disease|18|||
42265595|NCT00112957|76093645|FG000|Overall Study|Physician Decision|1|||
42265596|NCT02376790|76093652|FG000|Overall Study|Withdrawal by Subject|43|||
42265597|NCT02376790|76093653|FG001|Overall Study|Withdrawal by Subject|36|||
42265598|NCT02376790|76093654|FG002|Overall Study|Withdrawal by Subject|37|||
42000275|NCT01175668|75808812|FG001|Overall Study|Withdrawal by Subject|0|||
42000276|NCT01111825|75808822|FG000|Overall Study|Withdrawal by Subject|0|||
42000277|NCT01111825|75808823|FG001|Overall Study|Withdrawal by Subject|0|||
42000278|NCT01111825|75808824|FG002|Overall Study|Withdrawal by Subject|1|||
42000279|NCT01111825|75808825|FG003|Overall Study|Withdrawal by Subject|0|||
42000280|NCT01111825|75808822|FG000|Overall Study|Lost to Follow-up|0|||
42000281|NCT01111825|75808823|FG001|Overall Study|Lost to Follow-up|0|||
42000282|NCT01111825|75808824|FG002|Overall Study|Lost to Follow-up|3|||
42000283|NCT01111825|75808825|FG003|Overall Study|Lost to Follow-up|1|||
42265599|NCT02376790|76093652|FG000|Overall Study|Decision by Sponsor|2|||
42265600|NCT02376790|76093653|FG001|Overall Study|Decision by Sponsor|1|||
42336466|NCT01847274|76174174|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
42336467|NCT01847274|76174175|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
42336468|NCT01847274|76174176|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
42336469|NCT01847274|76174177|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
42336470|NCT01847274|76174178|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
42336471|NCT01847274|76174179|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
42336472|NCT01847274|76174169|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
42336473|NCT01847274|76174170|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
42336474|NCT01847274|76174171|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
42336475|NCT01847274|76174172|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
42336476|NCT01847274|76174173|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
42336477|NCT01847274|76174174|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
42336478|NCT01847274|76174175|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
42336479|NCT01847274|76174176|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
42336480|NCT01847274|76174177|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
42336481|NCT01847274|76174178|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
42336482|NCT01847274|76174179|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
42336483|NCT01847274|76174169|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
42336484|NCT01847274|76174170|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
42336485|NCT01847274|76174171|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
42336486|NCT01847274|76174172|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
42336487|NCT01847274|76174173|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
42336488|NCT01847274|76174174|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
42336489|NCT01847274|76174175|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
42336490|NCT01847274|76174176|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
42336491|NCT01847274|76174177|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
42000284|NCT01111825|75808822|FG000|Overall Study|Adverse Event|2|||
42265601|NCT02376790|76093654|FG002|Overall Study|Decision by Sponsor|4|||
42265602|NCT02376790|76093652|FG000|Overall Study|Lost to Follow-up|15|||
42265603|NCT02376790|76093653|FG001|Overall Study|Lost to Follow-up|10|||
42265604|NCT02376790|76093654|FG002|Overall Study|Lost to Follow-up|12|||
42265605|NCT02376166|76093662|FG000|Overall Study|Adverse Event|1|||
42265606|NCT02376166|76093662|FG000|Overall Study|Discontinued metformin early|2|||
42265607|NCT02311894|76093666|FG000|Overall Study|Discontinued in error|1|||
42000285|NCT01111825|75808823|FG001|Overall Study|Adverse Event|1|||
42034736|NCT01061736|75842939|FG001|Overall Study|Adverse Event|1|||
42134722|NCT00406653|75945529|FG000|Maintenance Period|Pregnancy|0|||
42265608|NCT02311894|76093666|FG000|Overall Study|Lost to Follow-up|1|||
42265609|NCT02311894|76093666|FG000|Overall Study|Adverse Event|1|||
42265610|NCT02311894|76093666|FG000|Overall Study|Withdrawal by Subject|1|||
42272732|NCT01657370|76103055|FG000|Overall Study|Lost to Follow-up|2|||
42336492|NCT01847274|76174178|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
42336493|NCT01847274|76174179|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
42336494|NCT01847274|76174169|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
42336495|NCT01847274|76174170|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
42336496|NCT01847274|76174171|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
42336497|NCT01847274|76174172|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
42336498|NCT01847274|76174173|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
42336499|NCT01847274|76174174|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
42336500|NCT01847274|76174175|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
42336501|NCT01847274|76174176|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
42336502|NCT01847274|76174177|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
42336503|NCT01847274|76174178|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
42336504|NCT01847274|76174179|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
42336505|NCT01847274|76174169|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
42336506|NCT01847274|76174170|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
42336507|NCT01847274|76174171|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
42336508|NCT01847274|76174172|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
42336509|NCT01847274|76174173|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
42336510|NCT01847274|76174174|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
42336511|NCT01847274|76174175|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
42336512|NCT01847274|76174176|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
42336513|NCT01847274|76174177|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
42336514|NCT01847274|76174178|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
42336515|NCT01847274|76174179|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
42336516|NCT01847274|76174169|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
42336517|NCT01847274|76174170|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
42336518|NCT01847274|76174171|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
42336519|NCT01847274|76174172|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
42336520|NCT01847274|76174173|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
42336521|NCT01847274|76174174|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
42336522|NCT01847274|76174175|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
42336523|NCT01847274|76174176|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
42336524|NCT01847274|76174177|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
42336525|NCT01847274|76174178|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
42336526|NCT01847274|76174179|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
42336527|NCT01847274|76174169|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
42336528|NCT01847274|76174170|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
42336529|NCT01847274|76174171|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
42336530|NCT01847274|76174172|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
42336531|NCT01847274|76174173|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
42336532|NCT01847274|76174174|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
42336533|NCT01847274|76174175|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
42336534|NCT01847274|76174176|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
42336535|NCT01847274|76174177|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
42336536|NCT01847274|76174178|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
42336537|NCT01847274|76174179|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
42336538|NCT01847274|76174169|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
42336539|NCT01847274|76174170|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
42336540|NCT01847274|76174171|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
42336541|NCT01847274|76174172|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
42336542|NCT01847274|76174173|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
42336543|NCT01847274|76174174|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
42336544|NCT01847274|76174175|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
42336545|NCT01847274|76174176|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
42336546|NCT01847274|76174177|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
42336547|NCT01847274|76174178|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
42336548|NCT01847274|76174179|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
42336549|NCT01847274|76174169|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
42336550|NCT01847274|76174170|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
42336551|NCT01847274|76174171|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
42336552|NCT01847274|76174172|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
42336553|NCT01847274|76174173|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
42336554|NCT01847274|76174174|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
42336555|NCT01847274|76174175|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
42336556|NCT01847274|76174176|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
42336557|NCT01847274|76174177|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
42336558|NCT01847274|76174178|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
42336559|NCT01847274|76174179|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
42336560|NCT01847274|76174169|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
42336561|NCT01847274|76174170|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
42336562|NCT01847274|76174171|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
42336563|NCT01847274|76174172|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
42336564|NCT01847274|76174173|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
42336565|NCT01847274|76174174|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
42336566|NCT01847274|76174175|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
42336567|NCT01847274|76174176|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
42336568|NCT01847274|76174177|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
42336569|NCT01847274|76174178|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
42336570|NCT01847274|76174179|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
42336571|NCT01847274|76174169|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
42336572|NCT01847274|76174170|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
42265611|NCT02310646|76093672|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
42265612|NCT02310646|76093673|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
42265613|NCT02310646|76093672|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
42265614|NCT02310646|76093673|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
42265615|NCT02375698|76093697|FG000|Overall Study|Withdrawal by Subject|0|||
42265616|NCT02375698|76093698|FG001|Overall Study|Withdrawal by Subject|2|||
42265617|NCT02375698|76093697|FG000|Overall Study|Physician Decision|2|||
42265618|NCT02375698|76093698|FG001|Overall Study|Physician Decision|0|||
42265619|NCT02374918|76093708|FG000|Overall Study|Protocol Violation|2|||
42265620|NCT02374918|76093709|FG001|Overall Study|Protocol Violation|0|||
42265621|NCT02374918|76093710|FG002|Overall Study|Protocol Violation|2|||
42265622|NCT02374918|76093711|FG003|Overall Study|Protocol Violation|1|||
42265623|NCT02374918|76093708|FG000|Overall Study|Withdrawal by Subject|1|||
42265624|NCT02374918|76093709|FG001|Overall Study|Withdrawal by Subject|1|||
42265625|NCT02374918|76093710|FG002|Overall Study|Withdrawal by Subject|1|||
42265626|NCT02374918|76093711|FG003|Overall Study|Withdrawal by Subject|0|||
42265627|NCT02374918|76093708|FG000|Overall Study|Lack of Efficacy|0|||
42034737|NCT01061736|75842940|FG002|Overall Study|Adverse Event|3|||
42265628|NCT02374918|76093709|FG001|Overall Study|Lack of Efficacy|0|||
42265629|NCT02374918|76093710|FG002|Overall Study|Lack of Efficacy|1|||
42336573|NCT01847274|76174171|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
42336574|NCT01847274|76174172|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
42336575|NCT01847274|76174173|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
42336576|NCT01847274|76174174|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
42336577|NCT01847274|76174175|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
42336578|NCT01847274|76174176|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
42336579|NCT01847274|76174177|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
42336580|NCT01847274|76174178|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
42336581|NCT01847274|76174179|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
42336582|NCT01847274|76174169|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
42336583|NCT01847274|76174170|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
42336584|NCT01847274|76174171|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
42336585|NCT01847274|76174172|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
42336586|NCT01847274|76174173|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
42336587|NCT01847274|76174174|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
42336588|NCT01847274|76174175|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
42336589|NCT01847274|76174176|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
42336590|NCT01847274|76174177|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
42336591|NCT01847274|76174178|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
42336592|NCT01847274|76174179|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
42336593|NCT01847274|76174169|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
42336594|NCT01847274|76174170|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
42336595|NCT01847274|76174171|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
42336596|NCT01847274|76174172|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
42336597|NCT01847274|76174173|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
42336598|NCT01847274|76174174|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
42336599|NCT01847274|76174175|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
42336600|NCT01847274|76174176|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
42336601|NCT01847274|76174177|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
42336602|NCT01847274|76174178|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
42336603|NCT01847274|76174179|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
42336604|NCT01847274|76174169|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
42336605|NCT01847274|76174170|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
42336606|NCT01847274|76174171|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
42336607|NCT01847274|76174172|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
42336608|NCT01847274|76174173|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
42336609|NCT01847274|76174174|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
42336610|NCT01847274|76174175|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
42336611|NCT01847274|76174176|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
42336612|NCT01847274|76174177|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
42336613|NCT01847274|76174178|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
42336614|NCT01847274|76174179|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
42336615|NCT01847274|76174169|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
42336616|NCT01847274|76174170|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
42336617|NCT01847274|76174171|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
42336618|NCT01847274|76174172|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
42336619|NCT01847274|76174173|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
42336620|NCT01847274|76174174|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
42336621|NCT01847274|76174175|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
42336622|NCT01847274|76174176|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
42336623|NCT01847274|76174177|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
42336624|NCT01847274|76174178|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
42336625|NCT01847274|76174179|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
42336626|NCT01560819|76174218|FG000|Overall Study|Physician Decision|1|||
42336627|NCT01560819|76174219|FG001|Overall Study|Physician Decision|0|||
42336628|NCT01425528|76174225|FG000|Overall Study|Withdrawal by Subject|1|||
42336629|NCT01425528|76174226|FG001|Overall Study|Withdrawal by Subject|1|||
42336630|NCT00442104|76174232|FG000|Overall Study|Adverse Event|5|||
42336631|NCT00442104|76174232|FG000|Overall Study|Death|2|||
42336632|NCT00442104|76174232|FG000|Overall Study|Lost to Follow-up|3|||
42336633|NCT00442104|76174232|FG000|Overall Study|Withdrawal by Subject|5|||
42134723|NCT00406653|75945530|FG001|Maintenance Period|Pregnancy|0|||
42000286|NCT01111825|75808824|FG002|Overall Study|Adverse Event|4|||
42336634|NCT00442104|76174232|FG000|Overall Study|Insufficient Clinical Response|10|||
42336635|NCT00442104|76174232|FG000|Overall Study|Other|21|||
42336636|NCT00442104|76174232|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
42336637|NCT00441896|76174246|FG000|Overall Study|Withdrawal by Subject|0|||
42034738|NCT01061736|75842941|FG003|Overall Study|Adverse Event|2|||
42034739|NCT01061736|75842942|FG004|Overall Study|Adverse Event|4|||
42034740|NCT01061736|75842943|FG005|Overall Study|Adverse Event|1|||
42034741|NCT01061736|75842944|FG006|Overall Study|Adverse Event|4|||
42034742|NCT01061736|75842945|FG007|Overall Study|Adverse Event|63|||
42134724|NCT00406653|75945531|FG002|Maintenance Period|Pregnancy|0|||
42134725|NCT00406653|75945532|FG003|Maintenance Period|Pregnancy|0|||
42265630|NCT02374918|76093711|FG003|Overall Study|Lack of Efficacy|1|||
42265631|NCT02344576|76093723|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
42265632|NCT02344576|76093724|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
42265633|NCT02344576|76093725|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
42265634|NCT02344576|76093726|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
42265635|NCT02344576|76093723|FG000|1-Month Follow-Up|Death|13|||
42265636|NCT02344576|76093724|FG001|1-Month Follow-Up|Death|8|||
42265637|NCT02344576|76093725|FG002|1-Month Follow-Up|Death|0|||
42265638|NCT02344576|76093726|FG003|1-Month Follow-Up|Death|0|||
42265639|NCT02344576|76093723|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
42265640|NCT02344576|76093724|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
42265641|NCT02344576|76093725|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
42265642|NCT02344576|76093726|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
42265643|NCT02344576|76093723|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
42265644|NCT02344576|76093724|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
42265645|NCT02344576|76093725|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
42265646|NCT02344576|76093726|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
42265647|NCT02344576|76093723|FG000|6-Month Follow-Up|Death|14|||
42265648|NCT02344576|76093724|FG001|6-Month Follow-Up|Death|14|||
42265649|NCT02344576|76093725|FG002|6-Month Follow-Up|Death|0|||
42265650|NCT02344576|76093726|FG003|6-Month Follow-Up|Death|0|||
42265651|NCT02344576|76093723|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
42265652|NCT02344576|76093724|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
42265653|NCT02344576|76093725|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
42265654|NCT02344576|76093726|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
42265655|NCT02344576|76093723|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
42265656|NCT02344576|76093724|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
42265657|NCT02344576|76093725|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
42265658|NCT02344576|76093726|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
42265659|NCT02344342|76093742|FG000|Overall Study|Industry partner dropped out|11|||
42265660|NCT02344342|76093743|FG001|Overall Study|Industry partner dropped out|9|||
42265661|NCT02344342|76093744|FG002|Overall Study|Industry partner dropped out|14|||
42265662|NCT02344342|76093745|FG003|Overall Study|Industry partner dropped out|10|||
42265663|NCT02310568|76093764|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
42265664|NCT02310568|76093765|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
42265665|NCT02310568|76093766|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
42265666|NCT02310568|76093767|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
42265667|NCT02310568|76093768|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
42265668|NCT02310568|76093764|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
42265669|NCT02310568|76093765|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
42265670|NCT02310568|76093766|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
42265671|NCT02310568|76093767|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
42265672|NCT02310568|76093768|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
42265673|NCT02310568|76093764|FG000|Stage 1 ( 4 Weeks)|Other|1|||
42265674|NCT02310568|76093765|FG001|Stage 1 ( 4 Weeks)|Other|1|||
42265675|NCT02310568|76093766|FG002|Stage 1 ( 4 Weeks)|Other|0|||
42265676|NCT02310568|76093767|FG003|Stage 1 ( 4 Weeks)|Other|0|||
42265677|NCT02310568|76093768|FG004|Stage 1 ( 4 Weeks)|Other|0|||
42265678|NCT02310568|76093764|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
42336638|NCT00441896|76174247|FG001|Overall Study|Withdrawal by Subject|0|||
42336639|NCT00441896|76174248|FG002|Overall Study|Withdrawal by Subject|0|||
42336640|NCT00441896|76174249|FG003|Overall Study|Withdrawal by Subject|1|||
42336641|NCT00441896|76174250|FG004|Overall Study|Withdrawal by Subject|0|||
42265679|NCT02310568|76093765|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
42265680|NCT02310568|76093766|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
42034743|NCT01061736|75842946|FG008|Overall Study|Adverse Event|67|||
42134726|NCT00406653|75945533|FG004|Maintenance Period|Pregnancy|0|||
42265681|NCT02310568|76093767|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
42265682|NCT02310568|76093768|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
42265683|NCT02310568|76093764|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
42265684|NCT02310568|76093765|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
42265685|NCT02310568|76093766|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
42265686|NCT02310568|76093767|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
42265687|NCT02310568|76093768|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
42336642|NCT00441896|76174251|FG005|Overall Study|Withdrawal by Subject|0|||
42336643|NCT00441896|76174252|FG006|Overall Study|Withdrawal by Subject|0|||
42336644|NCT00441896|76174253|FG007|Overall Study|Withdrawal by Subject|0|||
42336645|NCT00441896|76174254|FG008|Overall Study|Withdrawal by Subject|0|||
42336646|NCT00441896|76174255|FG009|Overall Study|Withdrawal by Subject|0|||
42336647|NCT00441896|76174246|FG000|Overall Study|Other|0|||
42336648|NCT00441896|76174247|FG001|Overall Study|Other|0|||
42336649|NCT00441896|76174248|FG002|Overall Study|Other|0|||
42336650|NCT00441896|76174249|FG003|Overall Study|Other|0|||
42336651|NCT00441896|76174250|FG004|Overall Study|Other|1|||
42336652|NCT00441896|76174251|FG005|Overall Study|Other|0|||
42336653|NCT00441896|76174252|FG006|Overall Study|Other|0|||
42336654|NCT00441896|76174253|FG007|Overall Study|Other|0|||
42336655|NCT00441896|76174254|FG008|Overall Study|Other|0|||
42336656|NCT00441896|76174255|FG009|Overall Study|Other|0|||
42336657|NCT02034877|76174283|FG000|Overall Study|Lost to Follow-up|0|||
42336658|NCT02034877|76174284|FG001|Overall Study|Lost to Follow-up|3|||
42336659|NCT02034877|76174283|FG000|Overall Study|No Longer Willing to Participate|0|||
42336660|NCT02034877|76174284|FG001|Overall Study|No Longer Willing to Participate|3|||
42336661|NCT02034799|76174292|FG000|Overall Study|Withdrawal by Subject|0|||
42336662|NCT02034799|76174293|FG001|Overall Study|Withdrawal by Subject|2|||
42336663|NCT02034799|76174292|FG000|Overall Study|Lost to Follow-up|0|||
42336664|NCT02034799|76174293|FG001|Overall Study|Lost to Follow-up|1|||
42336665|NCT02034799|76174292|FG000|Overall Study|Death|2|||
42336666|NCT02034799|76174293|FG001|Overall Study|Death|1|||
42336667|NCT02057575|76174303|FG000|Overall Study|Adverse Event|0|||
42336668|NCT02057575|76174304|FG001|Overall Study|Adverse Event|2|||
42336669|NCT02057575|76174305|FG002|Overall Study|Adverse Event|0|||
42336670|NCT02057575|76174306|FG003|Overall Study|Adverse Event|1|||
42336671|NCT02057575|76174303|FG000|Overall Study|Withdrawal by Subject|1|||
42336672|NCT02057575|76174304|FG001|Overall Study|Withdrawal by Subject|0|||
42336673|NCT02057575|76174305|FG002|Overall Study|Withdrawal by Subject|0|||
42336674|NCT02057575|76174306|FG003|Overall Study|Withdrawal by Subject|0|||
42336675|NCT02057575|76174303|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
42336676|NCT02057575|76174304|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
42336677|NCT02057575|76174305|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
42336678|NCT02057575|76174306|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
42336679|NCT02057575|76174303|FG000|Overall Study|Protocol Violation|0|||
42336680|NCT02057575|76174304|FG001|Overall Study|Protocol Violation|1|||
42336681|NCT02057575|76174305|FG002|Overall Study|Protocol Violation|0|||
42336682|NCT02057575|76174306|FG003|Overall Study|Protocol Violation|0|||
42336683|NCT02077465|76174318|FG000|Overall Study|Withdrew Consent|0|||
42336684|NCT02077465|76174319|FG001|Overall Study|Withdrew Consent|1|||
42336685|NCT02077465|76174318|FG000|Overall Study|Lost to Follow-up|1|||
42336686|NCT02077465|76174319|FG001|Overall Study|Lost to Follow-up|0|||
42336687|NCT02034565|76174325|FG000|Overall Study|Adverse Event|1|||
42336688|NCT02034565|76174326|FG001|Overall Study|Adverse Event|0|||
42336689|NCT02075515|76174337|FG000|Overall Study|Serious Adverse Event|1|||
42134727|NCT00406653|75945534|FG005|Maintenance Period|Pregnancy|1|||
42336690|NCT02075515|76174338|FG001|Overall Study|Serious Adverse Event|1|||
42336691|NCT02075515|76174339|FG002|Overall Study|Serious Adverse Event|1|||
42336692|NCT02075515|76174337|FG000|Overall Study|Non-Serious Adverse Event|0|||
42336693|NCT02075515|76174338|FG001|Overall Study|Non-Serious Adverse Event|1|||
42336694|NCT02075515|76174339|FG002|Overall Study|Non-Serious Adverse Event|0|||
42336695|NCT02075515|76174337|FG000|Overall Study|Withdrawal by Subject|2|||
42134728|NCT00406653|75945535|FG006|Maintenance Period|Pregnancy|0|||
42336696|NCT02075515|76174338|FG001|Overall Study|Withdrawal by Subject|0|||
42336697|NCT02075515|76174339|FG002|Overall Study|Withdrawal by Subject|1|||
42336698|NCT02075515|76174337|FG000|Overall Study|Lost to Follow-up|1|||
42336699|NCT02075515|76174338|FG001|Overall Study|Lost to Follow-up|3|||
42336700|NCT02075515|76174339|FG002|Overall Study|Lost to Follow-up|6|||
42336701|NCT02034409|76174350|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
42336702|NCT02034409|76174351|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
42336703|NCT02034409|76174350|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
42336704|NCT02034409|76174351|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
42336705|NCT02034409|76174350|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
42265688|NCT02310568|76093764|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
42265689|NCT02310568|76093765|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
42265690|NCT02310568|76093766|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
42265691|NCT02310568|76093767|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
42265692|NCT02310568|76093768|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
42265693|NCT02310568|76093764|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
42265694|NCT02310568|76093765|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
42265695|NCT02310568|76093766|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
42265696|NCT02310568|76093767|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
42265697|NCT02310568|76093768|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
42265698|NCT02310568|76093764|FG000|Stage 2 (4 Weeks)|Other|0|||
42265699|NCT02310568|76093765|FG001|Stage 2 (4 Weeks)|Other|1|||
42265700|NCT02310568|76093766|FG002|Stage 2 (4 Weeks)|Other|1|||
42265701|NCT02310568|76093767|FG003|Stage 2 (4 Weeks)|Other|0|||
42265702|NCT02310568|76093768|FG004|Stage 2 (4 Weeks)|Other|0|||
42265703|NCT02310568|76093764|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
42265704|NCT02310568|76093765|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
42265705|NCT02310568|76093766|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
42265706|NCT02310568|76093767|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
42265707|NCT02310568|76093768|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
42265708|NCT02310568|76093764|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
42265709|NCT02310568|76093765|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
42265710|NCT02310568|76093766|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
42265711|NCT02310568|76093767|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
42265712|NCT02310568|76093768|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
42265713|NCT02310568|76093764|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
42265714|NCT02310568|76093765|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
42265715|NCT02310568|76093766|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
42265716|NCT02310568|76093767|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
42265717|NCT02310568|76093768|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
42265718|NCT02310100|76093786|FG000|Overall Study|Physician Decision|3|||
42265719|NCT02310100|76093786|FG000|Overall Study|Withdrawal by Subject|10|||
42265720|NCT02310100|76093786|FG000|Overall Study|Enrollment closure|1|||
42265721|NCT02310100|76093786|FG000|Overall Study|Unapproved ablation operator|1|||
42265722|NCT02310100|76093786|FG000|Overall Study|Visit compliance|1|||
42265723|NCT02310100|76093786|FG000|Overall Study|Lost to Follow-up|2|||
42265724|NCT02780167|76093796|FG000|Overall Study|Adverse Event|9|||
42265725|NCT02780167|76093797|FG001|Overall Study|Adverse Event|8|||
42265726|NCT02780167|76093798|FG002|Overall Study|Adverse Event|8|||
42265727|NCT02780167|76093799|FG003|Overall Study|Adverse Event|12|||
42265728|NCT02780167|76093800|FG004|Overall Study|Adverse Event|8|||
42265729|NCT02780167|76093796|FG000|Overall Study|Lack of Efficacy|6|||
42265730|NCT02780167|76093797|FG001|Overall Study|Lack of Efficacy|5|||
42265731|NCT02780167|76093798|FG002|Overall Study|Lack of Efficacy|6|||
42265732|NCT02780167|76093799|FG003|Overall Study|Lack of Efficacy|1|||
42265733|NCT02780167|76093800|FG004|Overall Study|Lack of Efficacy|0|||
42265734|NCT02780167|76093796|FG000|Overall Study|Lost to Follow-up|2|||
42265735|NCT02780167|76093797|FG001|Overall Study|Lost to Follow-up|0|||
42265736|NCT02780167|76093798|FG002|Overall Study|Lost to Follow-up|1|||
42265737|NCT02780167|76093799|FG003|Overall Study|Lost to Follow-up|0|||
42265738|NCT02780167|76093800|FG004|Overall Study|Lost to Follow-up|0|||
42265739|NCT02780167|76093796|FG000|Overall Study|Does not meet entrance criteria|0|||
42265740|NCT02780167|76093797|FG001|Overall Study|Does not meet entrance criteria|0|||
42265741|NCT02780167|76093798|FG002|Overall Study|Does not meet entrance criteria|1|||
42265742|NCT02780167|76093799|FG003|Overall Study|Does not meet entrance criteria|0|||
42265743|NCT02780167|76093800|FG004|Overall Study|Does not meet entrance criteria|0|||
42265744|NCT02780167|76093796|FG000|Overall Study|No longer meets eligibility criteria|0|||
42265745|NCT02780167|76093797|FG001|Overall Study|No longer meets eligibility criteria|0|||
42265746|NCT02780167|76093798|FG002|Overall Study|No longer meets eligibility criteria|0|||
42265747|NCT02780167|76093799|FG003|Overall Study|No longer meets eligibility criteria|1|||
42265748|NCT02780167|76093800|FG004|Overall Study|No longer meets eligibility criteria|1|||
42265749|NCT02780167|76093796|FG000|Overall Study|Protocol Violation|5|||
42265750|NCT02780167|76093797|FG001|Overall Study|Protocol Violation|5|||
42265751|NCT02780167|76093798|FG002|Overall Study|Protocol Violation|1|||
42265752|NCT02780167|76093799|FG003|Overall Study|Protocol Violation|1|||
42265753|NCT02780167|76093800|FG004|Overall Study|Protocol Violation|2|||
42336706|NCT02034409|76174351|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
42336707|NCT02034409|76174350|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
42336708|NCT02034409|76174351|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
42336709|NCT02034409|76174350|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
42336710|NCT02034409|76174351|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
42336711|NCT02034409|76174350|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
42336712|NCT02034409|76174351|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
42336713|NCT02021318|76174359|FG000|Overall Study|Adverse Event|2|||
42336714|NCT02021318|76174360|FG001|Overall Study|Adverse Event|1|||
42336715|NCT02021318|76174359|FG000|Overall Study|Death|33|||
42336716|NCT02021318|76174360|FG001|Overall Study|Death|34|||
42336717|NCT02021318|76174359|FG000|Overall Study|Lost to Follow-up|3|||
42336718|NCT02021318|76174360|FG001|Overall Study|Lost to Follow-up|3|||
42336719|NCT02021318|76174359|FG000|Overall Study|Progressive Disease|0|||
42336720|NCT02021318|76174360|FG001|Overall Study|Progressive Disease|1|||
42336721|NCT02021318|76174359|FG000|Overall Study|Withdrawal by Subject|30|||
42336722|NCT02021318|76174360|FG001|Overall Study|Withdrawal by Subject|18|||
42336723|NCT02021318|76174359|FG000|Overall Study|Physician Decision|3|||
42336724|NCT02021318|76174360|FG001|Overall Study|Physician Decision|3|||
42336725|NCT02021318|76174359|FG000|Overall Study|Miscellaneous|2|||
42336726|NCT02021318|76174360|FG001|Overall Study|Miscellaneous|3|||
42336727|NCT02041286|76174367|FG000|Overall Study|Adverse Event|1|||
42336728|NCT02020616|76174380|FG000|Overall Study|Adverse Event|0|||
42336729|NCT02020616|76174381|FG001|Overall Study|Adverse Event|0|||
42336730|NCT02020616|76174382|FG002|Overall Study|Adverse Event|0|||
42336731|NCT02020616|76174383|FG003|Overall Study|Adverse Event|0|||
42336732|NCT02020616|76174384|FG004|Overall Study|Adverse Event|0|||
42336733|NCT02020616|76174385|FG005|Overall Study|Adverse Event|1|||
42336734|NCT02020616|76174386|FG006|Overall Study|Adverse Event|1|||
42336735|NCT02020616|76174380|FG000|Overall Study|Physician Decision|0|||
42336736|NCT02020616|76174381|FG001|Overall Study|Physician Decision|0|||
42336737|NCT02020616|76174382|FG002|Overall Study|Physician Decision|0|||
42336738|NCT02020616|76174383|FG003|Overall Study|Physician Decision|0|||
42336739|NCT02020616|76174384|FG004|Overall Study|Physician Decision|0|||
42336740|NCT02020616|76174385|FG005|Overall Study|Physician Decision|1|||
42336741|NCT02020616|76174386|FG006|Overall Study|Physician Decision|2|||
42336742|NCT02020616|76174380|FG000|Overall Study|Withdrawal by Subject|0|||
42336743|NCT02020616|76174381|FG001|Overall Study|Withdrawal by Subject|0|||
42336744|NCT02020616|76174382|FG002|Overall Study|Withdrawal by Subject|1|||
42336745|NCT02020616|76174383|FG003|Overall Study|Withdrawal by Subject|0|||
42336746|NCT02020616|76174384|FG004|Overall Study|Withdrawal by Subject|0|||
42336747|NCT02020616|76174385|FG005|Overall Study|Withdrawal by Subject|1|||
42336748|NCT02020616|76174386|FG006|Overall Study|Withdrawal by Subject|1|||
42265754|NCT02780167|76093796|FG000|Overall Study|Withdrawal by Subject|6|||
42265755|NCT02780167|76093797|FG001|Overall Study|Withdrawal by Subject|4|||
42265756|NCT02780167|76093798|FG002|Overall Study|Withdrawal by Subject|4|||
42000287|NCT01111825|75808825|FG003|Overall Study|Adverse Event|0|||
42265757|NCT02780167|76093799|FG003|Overall Study|Withdrawal by Subject|3|||
42265758|NCT02780167|76093800|FG004|Overall Study|Withdrawal by Subject|4|||
42265759|NCT02780167|76093796|FG000|Overall Study|Other|0|||
42265760|NCT02780167|76093797|FG001|Overall Study|Other|0|||
42265761|NCT02780167|76093798|FG002|Overall Study|Other|3|||
42265762|NCT02780167|76093799|FG003|Overall Study|Other|1|||
42265763|NCT02780167|76093800|FG004|Overall Study|Other|2|||
42265764|NCT02779075|76093812|FG000|Overall Study|Withdrawal by Subject|1|||
42265765|NCT02779075|76093813|FG001|Overall Study|Withdrawal by Subject|3|||
42265766|NCT02779075|76093812|FG000|Overall Study|IV lost during 2nd study|1|||
42265767|NCT02779075|76093813|FG001|Overall Study|IV lost during 2nd study|0|||
42265768|NCT00105079|76093825|FG000|Overall Study|Adverse Event|5|||
42265769|NCT00105079|76093826|FG001|Overall Study|Adverse Event|12|||
42336749|NCT02020616|76174380|FG000|Overall Study|Lost to Follow-up|0|||
42336750|NCT02020616|76174381|FG001|Overall Study|Lost to Follow-up|1|||
42336751|NCT02020616|76174382|FG002|Overall Study|Lost to Follow-up|0|||
42336752|NCT02020616|76174383|FG003|Overall Study|Lost to Follow-up|1|||
42336753|NCT02020616|76174384|FG004|Overall Study|Lost to Follow-up|1|||
42336754|NCT02020616|76174385|FG005|Overall Study|Lost to Follow-up|1|||
42336755|NCT02020616|76174386|FG006|Overall Study|Lost to Follow-up|0|||
42336756|NCT02020616|76174380|FG000|Overall Study|Early Termination Criteria Met|0|||
42336757|NCT02020616|76174381|FG001|Overall Study|Early Termination Criteria Met|0|||
42336758|NCT02020616|76174382|FG002|Overall Study|Early Termination Criteria Met|1|||
42336759|NCT02020616|76174383|FG003|Overall Study|Early Termination Criteria Met|0|||
42265770|NCT00105079|76093825|FG000|Overall Study|Death|3|||
42265771|NCT00105079|76093826|FG001|Overall Study|Death|1|||
42336760|NCT02020616|76174384|FG004|Overall Study|Early Termination Criteria Met|0|||
42336761|NCT02020616|76174385|FG005|Overall Study|Early Termination Criteria Met|1|||
42336762|NCT02020616|76174386|FG006|Overall Study|Early Termination Criteria Met|0|||
42336763|NCT02020616|76174380|FG000|Overall Study|Randomized in Error|0|||
42336764|NCT02020616|76174381|FG001|Overall Study|Randomized in Error|0|||
42336765|NCT02020616|76174382|FG002|Overall Study|Randomized in Error|0|||
42336766|NCT02020616|76174383|FG003|Overall Study|Randomized in Error|1|||
42336767|NCT02020616|76174384|FG004|Overall Study|Randomized in Error|0|||
42336768|NCT02020616|76174385|FG005|Overall Study|Randomized in Error|0|||
42336769|NCT02020616|76174386|FG006|Overall Study|Randomized in Error|0|||
42336770|NCT02020616|76174380|FG000|Overall Study|Lack of Efficacy|0|||
42336771|NCT02020616|76174381|FG001|Overall Study|Lack of Efficacy|0|||
42336772|NCT02020616|76174382|FG002|Overall Study|Lack of Efficacy|0|||
42336773|NCT02020616|76174383|FG003|Overall Study|Lack of Efficacy|0|||
42336774|NCT02020616|76174384|FG004|Overall Study|Lack of Efficacy|1|||
42336775|NCT02020616|76174385|FG005|Overall Study|Lack of Efficacy|0|||
42336776|NCT02020616|76174386|FG006|Overall Study|Lack of Efficacy|0|||
42336777|NCT02048072|76174416|FG000|Overall Study|Adverse Event|3|||
42336778|NCT02048072|76174416|FG000|Overall Study|Lost to Follow-up|1|||
42336779|NCT02047604|76174426|FG000|Overall Study|Withdrawal by Subject|0|||
42336780|NCT02047604|76174427|FG001|Overall Study|Withdrawal by Subject|0|||
42336781|NCT02047604|76174428|FG002|Overall Study|Withdrawal by Subject|0|||
42336782|NCT02047604|76174429|FG003|Overall Study|Withdrawal by Subject|0|||
42336783|NCT02047604|76174430|FG004|Overall Study|Withdrawal by Subject|1|||
42336784|NCT02047604|76174431|FG005|Overall Study|Withdrawal by Subject|1|||
42336785|NCT01622660|76174445|FG000|Overall Study|Adverse Event|1|||
42336786|NCT02019602|76174451|FG000|Screening Period|Ineligibility|4|||
42336787|NCT02019602|76174452|FG001|Screening Period|Ineligibility|0|||
42336788|NCT02019602|76174451|FG000|Screening Period|Adverse Event|1|||
42336789|NCT02019602|76174452|FG001|Screening Period|Adverse Event|0|||
42336790|NCT01994876|76174459|FG000|Test Period 1|Withdrawal by Subject|0|||
42336791|NCT01994876|76174460|FG001|Test Period 1|Withdrawal by Subject|1|||
42336792|NCT01994876|76174459|FG000|Test Period 1|Adverse Event|0|||
42336793|NCT01994876|76174460|FG001|Test Period 1|Adverse Event|1|||
42336794|NCT01994876|76174459|FG000|Test Period 2|Adverse Event|1|||
42336795|NCT01994876|76174460|FG001|Test Period 2|Adverse Event|0|||
42336796|NCT01994876|76174459|FG000|Test Period 2|Protocol Violation|0|||
42336797|NCT01994876|76174460|FG001|Test Period 2|Protocol Violation|1|||
42336798|NCT02040428|76174470|FG000|Overall Study|Death|4|||
42336799|NCT02040428|76174471|FG001|Overall Study|Death|3|||
42336800|NCT02040428|76174470|FG000|Overall Study|Withdrawal by Subject|1|||
42336801|NCT02040428|76174471|FG001|Overall Study|Withdrawal by Subject|1|||
42336802|NCT02018822|76174479|FG000|Overall Study|filling replaced by crown|0|||
42336803|NCT02018822|76174480|FG001|Overall Study|filling replaced by crown|1|||
42336804|NCT02018822|76174481|FG002|Overall Study|filling replaced by crown|0|||
42336805|NCT02018822|76174479|FG000|Overall Study|Physician Decision|0|||
42336806|NCT02018822|76174480|FG001|Overall Study|Physician Decision|1|||
42336807|NCT02018822|76174481|FG002|Overall Study|Physician Decision|1|||
42000288|NCT01111825|75808822|FG000|Overall Study|Disease Progression|1|||
42336808|NCT02018822|76174479|FG000|Overall Study|Lost to Follow-up|6|||
42336809|NCT02018822|76174480|FG001|Overall Study|Lost to Follow-up|6|||
42336810|NCT02018822|76174481|FG002|Overall Study|Lost to Follow-up|5|||
42336811|NCT02055157|76174496|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
42336812|NCT02055157|76174497|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
42336813|NCT02055157|76174498|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
42336814|NCT02055157|76174499|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
42336815|NCT02055157|76174496|FG000|Initial 6 Months|Adverse Event|0|||
42000289|NCT01111825|75808823|FG001|Overall Study|Disease Progression|0|||
42000290|NCT01111825|75808824|FG002|Overall Study|Disease Progression|0|||
42000291|NCT01111825|75808825|FG003|Overall Study|Disease Progression|0|||
42265772|NCT00105079|76093825|FG000|Overall Study|Lost to Follow-up|12|||
42336816|NCT02055157|76174497|FG001|Initial 6 Months|Adverse Event|0|||
42336817|NCT02055157|76174498|FG002|Initial 6 Months|Adverse Event|0|||
42336818|NCT02055157|76174499|FG003|Initial 6 Months|Adverse Event|1|||
42336819|NCT02055157|76174496|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
42336820|NCT02055157|76174497|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
42336821|NCT02055157|76174498|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
42336822|NCT02055157|76174499|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
42336823|NCT02055157|76174496|FG000|18-month Extension|Investigator decision|0|||
42265773|NCT00105079|76093826|FG001|Overall Study|Lost to Follow-up|12|||
42265774|NCT00105079|76093825|FG000|Overall Study|Lack of Efficacy|9|||
42265775|NCT00105079|76093826|FG001|Overall Study|Lack of Efficacy|3|||
42336824|NCT02055157|76174497|FG001|18-month Extension|Investigator decision|1|||
42336825|NCT02055157|76174498|FG002|18-month Extension|Investigator decision|0|||
42336826|NCT02055157|76174499|FG003|18-month Extension|Investigator decision|0|||
42336827|NCT02055157|76174496|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
42336828|NCT02055157|76174497|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
42336829|NCT02055157|76174498|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
42336830|NCT02055157|76174499|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
42336831|NCT02022007|76174523|FG000|Overall Study|Withdrawal by Subject|1|||
42336832|NCT02022007|76174524|FG001|Overall Study|Withdrawal by Subject|1|||
42336833|NCT02022007|76174525|FG002|Overall Study|Withdrawal by Subject|1|||
42336834|NCT02022007|76174523|FG000|Overall Study|Noncompliant|0|||
42336835|NCT02022007|76174524|FG001|Overall Study|Noncompliant|0|||
42336836|NCT02022007|76174525|FG002|Overall Study|Noncompliant|1|||
42336837|NCT02031679|76174535|FG000|Overall Study|Protocol Violation|0|||
42336838|NCT02031679|76174536|FG001|Overall Study|Protocol Violation|1|||
42336839|NCT02031679|76174535|FG000|Overall Study|Lack of Efficacy|0|||
42336840|NCT02031679|76174536|FG001|Overall Study|Lack of Efficacy|1|||
42336841|NCT02053753|76174544|FG000|Overall Study|Withdrawal by Subject|2|||
42265776|NCT00105079|76093825|FG000|Overall Study|Refused treatment|6|||
42265777|NCT00105079|76093826|FG001|Overall Study|Refused treatment|4|||
42265778|NCT00105079|76093825|FG000|Overall Study|Violation of selection criteria at entry|0|||
42265779|NCT00105079|76093826|FG001|Overall Study|Violation of selection criteria at entry|2|||
42265780|NCT00105079|76093825|FG000|Overall Study|Protocol Violation|1|||
42265781|NCT00105079|76093826|FG001|Overall Study|Protocol Violation|0|||
42265782|NCT00105079|76093825|FG000|Overall Study|Other|3|||
42265783|NCT00105079|76093826|FG001|Overall Study|Other|1|||
42265784|NCT02777827|76093832|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
42265785|NCT02777827|76093833|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
42265786|NCT02777827|76093834|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
42265787|NCT02777827|76093835|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
42265788|NCT02777827|76093836|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
42265789|NCT02777827|76093837|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
42265790|NCT02712333|76093853|FG000|First Period|Withdrawal by Subject|3|||
42265791|NCT02712333|76093854|FG001|First Period|Withdrawal by Subject|2|||
42265792|NCT02343406|76093870|FG000|Overall Study|Progressive disease|72|||
42336842|NCT02053753|76174545|FG001|Overall Study|Withdrawal by Subject|4|||
42336843|NCT02053753|76174544|FG000|Overall Study|Decision by Sponsor|1|||
42336844|NCT02053753|76174545|FG001|Overall Study|Decision by Sponsor|1|||
42265793|NCT02343406|76093871|FG001|Overall Study|Progressive disease|70|||
42336845|NCT02053753|76174544|FG000|Overall Study|Lost to Follow-up|4|||
42336846|NCT02053753|76174545|FG001|Overall Study|Lost to Follow-up|3|||
42336847|NCT02019979|76174551|FG000|Overall Study|study terminated|14|||
42336848|NCT02019667|76174555|FG000|First Intervention (6 Months)|Adverse Event|0|||
42336849|NCT02019667|76174556|FG001|First Intervention (6 Months)|Adverse Event|1|||
42336850|NCT02019667|76174555|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
42336851|NCT02019667|76174556|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
42336852|NCT02019667|76174555|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
42336853|NCT02019667|76174556|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
42336854|NCT02030821|76174568|FG000|Overall Study|Physician Decision|2|||
42336855|NCT02030821|76174569|FG001|Overall Study|Physician Decision|2|||
42336856|NCT02030821|76174570|FG002|Overall Study|Physician Decision|5|||
42336857|NCT02030821|76174571|FG003|Overall Study|Physician Decision|2|||
42336858|NCT02052739|76174583|FG000|Overall Study|Withdrew due to Adverse Event|3|||
42336859|NCT02052739|76174584|FG001|Overall Study|Withdrew due to Adverse Event|0|||
42336860|NCT02052739|76174583|FG000|Overall Study|Participant Died|2|||
42336861|NCT02052739|76174584|FG001|Overall Study|Participant Died|1|||
42336862|NCT02019277|76174592|FG000|Overall Study|Withdrawal by Subject|3|||
42336863|NCT02019277|76174592|FG000|Overall Study|Death|7|||
42336864|NCT02019277|76174592|FG000|Overall Study|Did no Cooperate|1|||
42336865|NCT02019277|76174592|FG000|Overall Study|Adverse Event|1|||
42336866|NCT02030119|76174600|FG000|Overall Study|Withdrawal by Subject|3|||
42336867|NCT02030119|76174601|FG001|Overall Study|Withdrawal by Subject|1|||
42336868|NCT02030119|76174602|FG002|Overall Study|Withdrawal by Subject|5|||
42336869|NCT02030119|76174603|FG003|Overall Study|Withdrawal by Subject|3|||
42336870|NCT02030119|76174600|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
42336871|NCT02030119|76174601|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
42336872|NCT02030119|76174602|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
42336873|NCT02030119|76174603|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
42336874|NCT01823835|76174628|FG000|Overall Study|Adverse Event|0|||
42336875|NCT01823835|76174629|FG001|Overall Study|Adverse Event|0|||
42336876|NCT01823835|76174630|FG002|Overall Study|Adverse Event|0|||
42336877|NCT01823835|76174631|FG003|Overall Study|Adverse Event|0|||
42336878|NCT01823835|76174632|FG004|Overall Study|Adverse Event|1|||
42336879|NCT01823835|76174633|FG005|Overall Study|Adverse Event|0|||
42336880|NCT01823835|76174634|FG006|Overall Study|Adverse Event|1|||
42336881|NCT01823835|76174635|FG007|Overall Study|Adverse Event|0|||
42336882|NCT01823835|76174636|FG008|Overall Study|Adverse Event|0|||
42336883|NCT01823835|76174637|FG009|Overall Study|Adverse Event|0|||
42336884|NCT01823835|76174638|FG010|Overall Study|Adverse Event|1|||
42336885|NCT01823835|76174639|FG011|Overall Study|Adverse Event|2|||
42336886|NCT01823835|76174640|FG012|Overall Study|Adverse Event|0|||
42336887|NCT01823835|76174641|FG013|Overall Study|Adverse Event|0|||
42336888|NCT01823835|76174642|FG014|Overall Study|Adverse Event|0|||
42336889|NCT01823835|76174628|FG000|Overall Study|Physician Decision|0|||
42336890|NCT01823835|76174629|FG001|Overall Study|Physician Decision|0|||
42336891|NCT01823835|76174630|FG002|Overall Study|Physician Decision|0|||
42000292|NCT01111825|75808822|FG000|Overall Study|Discontinuation by Sponsor|0|||
42000293|NCT01111825|75808823|FG001|Overall Study|Discontinuation by Sponsor|0|||
42336892|NCT01823835|76174631|FG003|Overall Study|Physician Decision|0|||
42336893|NCT01823835|76174632|FG004|Overall Study|Physician Decision|0|||
42336894|NCT01823835|76174633|FG005|Overall Study|Physician Decision|0|||
42336895|NCT01823835|76174634|FG006|Overall Study|Physician Decision|0|||
42336896|NCT01823835|76174635|FG007|Overall Study|Physician Decision|0|||
42336897|NCT01823835|76174636|FG008|Overall Study|Physician Decision|0|||
42336898|NCT01823835|76174637|FG009|Overall Study|Physician Decision|0|||
42336899|NCT01823835|76174638|FG010|Overall Study|Physician Decision|0|||
42336900|NCT01823835|76174639|FG011|Overall Study|Physician Decision|2|||
42336901|NCT01823835|76174640|FG012|Overall Study|Physician Decision|0|||
42336902|NCT01823835|76174641|FG013|Overall Study|Physician Decision|0|||
42336903|NCT01823835|76174642|FG014|Overall Study|Physician Decision|0|||
42336904|NCT01823835|76174628|FG000|Overall Study|Progressive Disease|3|||
42336905|NCT01823835|76174629|FG001|Overall Study|Progressive Disease|4|||
42336906|NCT01823835|76174630|FG002|Overall Study|Progressive Disease|3|||
42336907|NCT01823835|76174631|FG003|Overall Study|Progressive Disease|6|||
42336908|NCT01823835|76174632|FG004|Overall Study|Progressive Disease|4|||
42336909|NCT01823835|76174633|FG005|Overall Study|Progressive Disease|6|||
42336910|NCT01823835|76174634|FG006|Overall Study|Progressive Disease|5|||
42336911|NCT01823835|76174635|FG007|Overall Study|Progressive Disease|3|||
42336912|NCT01823835|76174636|FG008|Overall Study|Progressive Disease|3|||
42336913|NCT01823835|76174637|FG009|Overall Study|Progressive Disease|18|||
42336914|NCT01823835|76174638|FG010|Overall Study|Progressive Disease|8|||
42336915|NCT01823835|76174639|FG011|Overall Study|Progressive Disease|46|||
42336916|NCT01823835|76174640|FG012|Overall Study|Progressive Disease|18|||
42336917|NCT01823835|76174641|FG013|Overall Study|Progressive Disease|4|||
42336918|NCT01823835|76174642|FG014|Overall Study|Progressive Disease|6|||
42336919|NCT01823835|76174628|FG000|Overall Study|Study Termination|0|||
42336920|NCT01823835|76174629|FG001|Overall Study|Study Termination|0|||
42336921|NCT01823835|76174630|FG002|Overall Study|Study Termination|0|||
42336922|NCT01823835|76174631|FG003|Overall Study|Study Termination|0|||
42336923|NCT01823835|76174632|FG004|Overall Study|Study Termination|1|||
42336924|NCT01823835|76174633|FG005|Overall Study|Study Termination|0|||
42336925|NCT01823835|76174634|FG006|Overall Study|Study Termination|0|||
42336926|NCT01823835|76174635|FG007|Overall Study|Study Termination|0|||
42336927|NCT01823835|76174636|FG008|Overall Study|Study Termination|0|||
42336928|NCT01823835|76174637|FG009|Overall Study|Study Termination|0|||
42336929|NCT01823835|76174638|FG010|Overall Study|Study Termination|0|||
42336930|NCT01823835|76174639|FG011|Overall Study|Study Termination|1|||
42336931|NCT01823835|76174640|FG012|Overall Study|Study Termination|0|||
42336932|NCT01823835|76174641|FG013|Overall Study|Study Termination|0|||
42000294|NCT01111825|75808824|FG002|Overall Study|Discontinuation by Sponsor|0|||
42000295|NCT01111825|75808825|FG003|Overall Study|Discontinuation by Sponsor|20|||
42000296|NCT01175590|75808837|FG000|Overall Study|Lost to Follow-up|1|||
42000297|NCT01175590|75808838|FG001|Overall Study|Lost to Follow-up|0|||
42000298|NCT01175590|75808837|FG000|Overall Study|Withdrawal by Subject|0|||
42336933|NCT01823835|76174642|FG014|Overall Study|Study Termination|0|||
42336934|NCT01823835|76174628|FG000|Overall Study|Withdrawal by Subject|0|||
42336935|NCT01823835|76174629|FG001|Overall Study|Withdrawal by Subject|0|||
42336936|NCT01823835|76174630|FG002|Overall Study|Withdrawal by Subject|1|||
42336937|NCT01823835|76174631|FG003|Overall Study|Withdrawal by Subject|0|||
42336938|NCT01823835|76174632|FG004|Overall Study|Withdrawal by Subject|0|||
42336939|NCT01823835|76174633|FG005|Overall Study|Withdrawal by Subject|0|||
42336940|NCT01823835|76174634|FG006|Overall Study|Withdrawal by Subject|0|||
42336941|NCT01823835|76174635|FG007|Overall Study|Withdrawal by Subject|0|||
42336942|NCT01823835|76174636|FG008|Overall Study|Withdrawal by Subject|0|||
42336943|NCT01823835|76174637|FG009|Overall Study|Withdrawal by Subject|1|||
42336944|NCT01823835|76174638|FG010|Overall Study|Withdrawal by Subject|1|||
42336945|NCT01823835|76174639|FG011|Overall Study|Withdrawal by Subject|2|||
42336946|NCT01823835|76174640|FG012|Overall Study|Withdrawal by Subject|1|||
42336947|NCT01823835|76174641|FG013|Overall Study|Withdrawal by Subject|0|||
42336948|NCT01823835|76174642|FG014|Overall Study|Withdrawal by Subject|0|||
42336949|NCT01823679|76174682|FG000|Overall Study|Death|1|||
42336950|NCT01823289|76174687|FG000|Overall Study|Lost to Follow-up|5|||
42336951|NCT01823289|76174687|FG000|Overall Study|Adverse Event|5|||
42336952|NCT01823289|76174687|FG000|Overall Study|Lack of Efficacy|1|||
42336953|NCT01823289|76174687|FG000|Overall Study|Physician Decision|9|||
42336954|NCT01823289|76174687|FG000|Overall Study|Administered contraindicated medicine|1|||
42336955|NCT01823289|76174687|FG000|Overall Study|Transaminase increased more than 3 times|1|||
42336956|NCT01823289|76174687|FG000|Overall Study|Drug affected efficacy and safety|1|||
42336957|NCT01823289|76174687|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
42336958|NCT01822899|76174693|FG000|Overall Study|Adverse Event|6|||
42336959|NCT01822899|76174694|FG001|Overall Study|Adverse Event|5|||
42336960|NCT01822899|76174693|FG000|Overall Study|Lack of Efficacy|6|||
42336961|NCT01822899|76174694|FG001|Overall Study|Lack of Efficacy|3|||
42336962|NCT01822899|76174693|FG000|Overall Study|Protocol Violation|6|||
42336963|NCT01822899|76174694|FG001|Overall Study|Protocol Violation|3|||
42336964|NCT01822899|76174693|FG000|Overall Study|Lost to Follow-up|1|||
42336965|NCT01822899|76174694|FG001|Overall Study|Lost to Follow-up|0|||
42336966|NCT01822899|76174693|FG000|Overall Study|Withdrawal by Subject|5|||
42336967|NCT01822899|76174694|FG001|Overall Study|Withdrawal by Subject|7|||
42000299|NCT01175590|75808838|FG001|Overall Study|Withdrawal by Subject|2|||
42336968|NCT01822821|76174702|FG000|Overall Study|Eligible surgery cancelled|1|||
42000300|NCT01175590|75808837|FG000|Overall Study|Adverse Event|4|||
42000301|NCT01175590|75808838|FG001|Overall Study|Adverse Event|0|||
42000302|NCT01175590|75808837|FG000|Overall Study|Physician Decision|1|||
42336969|NCT01822821|76174703|FG001|Overall Study|Eligible surgery cancelled|1|||
42336970|NCT01822821|76174702|FG000|Overall Study|Other reasons|1|||
42336971|NCT01822821|76174703|FG001|Overall Study|Other reasons|0|||
42336972|NCT01822665|76174709|FG000|Overall Study|Adverse Event|3|||
42336973|NCT01822665|76174709|FG000|Overall Study|Other Reason|5|||
42336974|NCT02173301|76174731|FG000|Overall Study|Adverse Event|7|||
42336975|NCT02173301|76174732|FG001|Overall Study|Adverse Event|8|||
42336976|NCT02173301|76174733|FG002|Overall Study|Adverse Event|13|||
42336977|NCT02173301|76174734|FG003|Overall Study|Adverse Event|5|||
42336978|NCT02173301|76174731|FG000|Overall Study|Withdrawal by Subject|8|||
42336979|NCT02173301|76174732|FG001|Overall Study|Withdrawal by Subject|10|||
42336980|NCT02173301|76174733|FG002|Overall Study|Withdrawal by Subject|4|||
42336981|NCT02173301|76174734|FG003|Overall Study|Withdrawal by Subject|8|||
42336982|NCT02173301|76174731|FG000|Overall Study|Lost to Follow-up|4|||
42336983|NCT02173301|76174732|FG001|Overall Study|Lost to Follow-up|4|||
42000303|NCT01175590|75808838|FG001|Overall Study|Physician Decision|4|||
42000304|NCT01175590|75808837|FG000|Overall Study|Lack of Efficacy|1|||
42265794|NCT02343406|76093872|FG002|Overall Study|Progressive disease|43|||
42265795|NCT02343406|76093873|FG003|Overall Study|Progressive disease|15|||
42336984|NCT02173301|76174733|FG002|Overall Study|Lost to Follow-up|2|||
42336985|NCT02173301|76174734|FG003|Overall Study|Lost to Follow-up|2|||
42336986|NCT02173301|76174731|FG000|Overall Study|Protocol Violation|0|||
42336987|NCT02173301|76174732|FG001|Overall Study|Protocol Violation|1|||
42336988|NCT02173301|76174733|FG002|Overall Study|Protocol Violation|0|||
42336989|NCT02173301|76174734|FG003|Overall Study|Protocol Violation|0|||
42336990|NCT02173301|76174731|FG000|Overall Study|Physician Decision|0|||
42336991|NCT02173301|76174732|FG001|Overall Study|Physician Decision|0|||
42336992|NCT02173301|76174733|FG002|Overall Study|Physician Decision|1|||
42336993|NCT02173301|76174734|FG003|Overall Study|Physician Decision|0|||
42336994|NCT02173301|76174731|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
42336995|NCT02173301|76174732|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
42336996|NCT02173301|76174733|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
42336997|NCT02173301|76174734|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
42336998|NCT01822587|76174747|FG000|Overall Study|Lost to Follow-up|7|||
42336999|NCT01822587|76174748|FG001|Overall Study|Lost to Follow-up|9|||
42337000|NCT01822587|76174749|FG002|Overall Study|Lost to Follow-up|12|||
42337001|NCT01822587|76174747|FG000|Overall Study|Physician Decision|9|||
42337002|NCT01822587|76174748|FG001|Overall Study|Physician Decision|6|||
42337003|NCT01822587|76174749|FG002|Overall Study|Physician Decision|6|||
42337004|NCT01822353|76174760|FG000|Overall Study|Adverse Event|1|||
42337005|NCT01822353|76174761|FG001|Overall Study|Adverse Event|3|||
42337006|NCT01822353|76174762|FG002|Overall Study|Adverse Event|1|||
42337007|NCT01822353|76174760|FG000|Overall Study|Pregnancy|0|||
42337008|NCT01822353|76174761|FG001|Overall Study|Pregnancy|1|||
42337009|NCT01822353|76174762|FG002|Overall Study|Pregnancy|0|||
42337010|NCT01822353|76174760|FG000|Overall Study|Withdrawal by Subject|3|||
42337011|NCT01822353|76174761|FG001|Overall Study|Withdrawal by Subject|1|||
42337012|NCT01822353|76174762|FG002|Overall Study|Withdrawal by Subject|0|||
42337013|NCT01821963|76174773|FG000|Overall Study|Adverse Event|1|||
42337014|NCT01821807|76174779|FG000|Overall Study|Lost to Follow-up|3|||
42337015|NCT01821807|76174780|FG001|Overall Study|Lost to Follow-up|1|||
42265796|NCT02343406|76093874|FG004|Overall Study|Progressive disease|5|||
42265797|NCT02343406|76093870|FG000|Overall Study|Adverse Event|6|||
42265798|NCT02343406|76093871|FG001|Overall Study|Adverse Event|8|||
42265799|NCT02343406|76093872|FG002|Overall Study|Adverse Event|6|||
42265800|NCT02343406|76093873|FG003|Overall Study|Adverse Event|3|||
42265801|NCT02343406|76093874|FG004|Overall Study|Adverse Event|0|||
42265802|NCT02343406|76093870|FG000|Overall Study|Withdrawal by Subject|6|||
42265803|NCT02343406|76093871|FG001|Overall Study|Withdrawal by Subject|4|||
42265804|NCT02343406|76093872|FG002|Overall Study|Withdrawal by Subject|8|||
42265805|NCT02343406|76093873|FG003|Overall Study|Withdrawal by Subject|3|||
42265806|NCT02343406|76093874|FG004|Overall Study|Withdrawal by Subject|0|||
42265807|NCT02343406|76093870|FG000|Overall Study|Death|2|||
42265808|NCT02343406|76093871|FG001|Overall Study|Death|1|||
42265809|NCT02343406|76093872|FG002|Overall Study|Death|0|||
42337016|NCT01821729|76174786|FG000|Overall Study|Withdrawal by Subject|1|||
42337017|NCT01820637|76174790|FG000|Overall Study|Death|2|||
42337018|NCT01820637|76174790|FG000|Overall Study|Withdrawal by Subject|1|||
42337019|NCT02172911|76174796|FG000|Overall Study|Serious Adverse Event|0|||
42000305|NCT01175590|75808838|FG001|Overall Study|Lack of Efficacy|1|||
42265810|NCT02343406|76093873|FG003|Overall Study|Death|0|||
42265811|NCT02343406|76093874|FG004|Overall Study|Death|0|||
42265812|NCT02343406|76093870|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
42265813|NCT02343406|76093871|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
42265814|NCT02343406|76093872|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
42337020|NCT02172911|76174797|FG001|Overall Study|Serious Adverse Event|1|||
42337021|NCT02172911|76174796|FG000|Overall Study|Progression of Disease|0|||
42337022|NCT02172911|76174797|FG001|Overall Study|Progression of Disease|1|||
42337023|NCT02172911|76174796|FG000|Overall Study|Loss of insurance coverage|1|||
42000306|NCT01175590|75808837|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
42337024|NCT02172911|76174797|FG001|Overall Study|Loss of insurance coverage|0|||
42337025|NCT02120027|76174805|FG000|Overall Study|Adverse Event|4|||
42337026|NCT02120027|76174806|FG001|Overall Study|Adverse Event|5|||
42337027|NCT02120027|76174805|FG000|Overall Study|Lack of Efficacy|3|||
42337028|NCT02120027|76174806|FG001|Overall Study|Lack of Efficacy|5|||
42337029|NCT02120027|76174805|FG000|Overall Study|Lost to Follow-up|5|||
42337030|NCT02120027|76174806|FG001|Overall Study|Lost to Follow-up|13|||
42337031|NCT02120027|76174805|FG000|Overall Study|Other|4|||
42337032|NCT02120027|76174806|FG001|Overall Study|Other|0|||
42337033|NCT02120027|76174805|FG000|Overall Study|Physician Decision|4|||
42337034|NCT02120027|76174806|FG001|Overall Study|Physician Decision|3|||
42337035|NCT02120027|76174805|FG000|Overall Study|Protocol Violation|18|||
42337036|NCT02120027|76174806|FG001|Overall Study|Protocol Violation|21|||
42337037|NCT02120027|76174805|FG000|Overall Study|Study terminated by Sponsor|45|||
42337038|NCT02120027|76174806|FG001|Overall Study|Study terminated by Sponsor|47|||
42337039|NCT02120027|76174805|FG000|Overall Study|Withdrawal by Subject|33|||
42337040|NCT02120027|76174806|FG001|Overall Study|Withdrawal by Subject|25|||
42337041|NCT01850823|76174815|FG000|Overall Study|Early Visit Window|0|||
42337042|NCT01850823|76174816|FG001|Overall Study|Early Visit Window|1|||
42337043|NCT01850823|76174817|FG002|Overall Study|Early Visit Window|4|||
42337044|NCT01850823|76174815|FG000|Overall Study|Enrolled in Error|0|||
42337045|NCT01850823|76174816|FG001|Overall Study|Enrolled in Error|1|||
42337046|NCT01850823|76174817|FG002|Overall Study|Enrolled in Error|2|||
42337047|NCT01850823|76174815|FG000|Overall Study|Lack of Efficacy|1|||
42337048|NCT01850823|76174816|FG001|Overall Study|Lack of Efficacy|0|||
42337049|NCT01850823|76174817|FG002|Overall Study|Lack of Efficacy|0|||
42337050|NCT01850823|76174815|FG000|Overall Study|Lost to Follow-up|0|||
42337051|NCT01850823|76174816|FG001|Overall Study|Lost to Follow-up|0|||
42337052|NCT01850823|76174817|FG002|Overall Study|Lost to Follow-up|1|||
42337053|NCT01850823|76174815|FG000|Overall Study|Restricted Medication|0|||
42337054|NCT01850823|76174816|FG001|Overall Study|Restricted Medication|0|||
42337055|NCT01850823|76174817|FG002|Overall Study|Restricted Medication|2|||
42337056|NCT01850823|76174815|FG000|Overall Study|Significant worstening of SAR|0|||
42337057|NCT01850823|76174816|FG001|Overall Study|Significant worstening of SAR|1|||
42337058|NCT01850823|76174817|FG002|Overall Study|Significant worstening of SAR|0|||
42337059|NCT01850823|76174815|FG000|Overall Study|Withdrawal by Subject|2|||
42337060|NCT01850823|76174816|FG001|Overall Study|Withdrawal by Subject|0|||
42337061|NCT01850823|76174817|FG002|Overall Study|Withdrawal by Subject|1|||
42337062|NCT01820559|76174830|FG000|Overall Study|Adverse Event|4|||
42337063|NCT01820559|76174831|FG001|Overall Study|Adverse Event|6|||
42337064|NCT01820559|76174832|FG002|Overall Study|Adverse Event|13|||
42337065|NCT01820559|76174830|FG000|Overall Study|Withdrawal by Subject|1|||
42337066|NCT01820559|76174831|FG001|Overall Study|Withdrawal by Subject|2|||
42337067|NCT01820559|76174832|FG002|Overall Study|Withdrawal by Subject|5|||
42337068|NCT01820559|76174830|FG000|Overall Study|Protocol Violation|2|||
42337069|NCT01820559|76174831|FG001|Overall Study|Protocol Violation|1|||
42337070|NCT01820559|76174832|FG002|Overall Study|Protocol Violation|3|||
42337071|NCT01820559|76174830|FG000|Overall Study|Subject's non-compliance|1|||
42337072|NCT01820559|76174831|FG001|Overall Study|Subject's non-compliance|0|||
42337073|NCT01820559|76174832|FG002|Overall Study|Subject's non-compliance|2|||
42337074|NCT01820559|76174830|FG000|Overall Study|Lost to Follow-up|3|||
42337075|NCT01820559|76174831|FG001|Overall Study|Lost to Follow-up|2|||
42337076|NCT01820559|76174832|FG002|Overall Study|Lost to Follow-up|2|||
42337077|NCT01820559|76174830|FG000|Overall Study|At sponsor request|0|||
42337078|NCT01820559|76174831|FG001|Overall Study|At sponsor request|0|||
42337079|NCT01820559|76174832|FG002|Overall Study|At sponsor request|1|||
42337080|NCT01820559|76174830|FG000|Overall Study|Lack of Efficacy|3|||
42337081|NCT01820559|76174831|FG001|Overall Study|Lack of Efficacy|2|||
42337082|NCT01820559|76174832|FG002|Overall Study|Lack of Efficacy|3|||
42337083|NCT01818765|76174840|FG000|Overall Study|Death|2|||
42034744|NCT01061736|75842947|FG009|Overall Study|Adverse Event|34|||
42337084|NCT01850589|76174847|FG000|Overall Study|Withdrawal by Subject|8|||
42337085|NCT01850589|76174848|FG001|Overall Study|Withdrawal by Subject|0|||
42337086|NCT01818531|76174856|FG000|Overall Study|Withdrawn for case delay after block|1|||
42337087|NCT01818531|76174857|FG001|Overall Study|Withdrawn for case delay after block|0|||
42337088|NCT01818531|76174856|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
42337089|NCT01818531|76174857|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
42337090|NCT01818531|76174856|FG000|Overall Study|Withdrawn for failure to place block|0|||
42034745|NCT01061736|75842938|FG000|Overall Study|Lack of Efficacy|0|||
42134729|NCT00406653|75945529|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
42337091|NCT01818531|76174857|FG001|Overall Study|Withdrawn for failure to place block|1|||
42337092|NCT02171429|76174866|FG000|Overall Study|Other|0|||
42337093|NCT02171429|76174867|FG001|Overall Study|Other|1|||
42337094|NCT02171429|76174868|FG002|Overall Study|Other|1|||
42337095|NCT02171429|76174866|FG000|Overall Study|Non-Compliance|0|||
42337096|NCT02171429|76174867|FG001|Overall Study|Non-Compliance|0|||
42337097|NCT02171429|76174868|FG002|Overall Study|Non-Compliance|1|||
42337098|NCT02171429|76174866|FG000|Overall Study|Physician Decision|0|||
42337099|NCT02171429|76174867|FG001|Overall Study|Physician Decision|0|||
42337100|NCT02171429|76174868|FG002|Overall Study|Physician Decision|1|||
42337101|NCT02171429|76174866|FG000|Overall Study|Withdrawal by Subject|1|||
42337102|NCT02171429|76174867|FG001|Overall Study|Withdrawal by Subject|1|||
42000307|NCT01175590|75808838|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
42000308|NCT01175590|75808837|FG000|Overall Study|Treated not as randomized|3|||
42265815|NCT02343406|76093873|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
42265816|NCT02343406|76093874|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
42265817|NCT02343406|76093870|FG000|Overall Study|Other primary malignancy|0|||
42265818|NCT02343406|76093871|FG001|Overall Study|Other primary malignancy|1|||
42265819|NCT02343406|76093872|FG002|Overall Study|Other primary malignancy|0|||
42265820|NCT02343406|76093873|FG003|Overall Study|Other primary malignancy|0|||
42265821|NCT02343406|76093874|FG004|Overall Study|Other primary malignancy|0|||
42265822|NCT02343406|76093870|FG000|Overall Study|Other, not specified|2|||
42265823|NCT02343406|76093871|FG001|Overall Study|Other, not specified|1|||
42265824|NCT02343406|76093872|FG002|Overall Study|Other, not specified|1|||
42265825|NCT02343406|76093873|FG003|Overall Study|Other, not specified|4|||
42265826|NCT02343406|76093874|FG004|Overall Study|Other, not specified|0|||
42265827|NCT02710071|76093887|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
42265828|NCT02710071|76093888|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
42265829|NCT02710071|76093887|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
42265830|NCT02710071|76093888|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
42265831|NCT02373202|76093899|FG000|Overall Study|Adverse Event|2|||
42265832|NCT02373202|76093900|FG001|Overall Study|Adverse Event|5|||
42265833|NCT02373202|76093901|FG002|Overall Study|Adverse Event|2|||
42265834|NCT02373202|76093902|FG003|Overall Study|Adverse Event|1|||
42265835|NCT02373202|76093899|FG000|Overall Study|Lack of Efficacy|0|||
42265836|NCT02373202|76093900|FG001|Overall Study|Lack of Efficacy|0|||
42265837|NCT02373202|76093901|FG002|Overall Study|Lack of Efficacy|1|||
42265838|NCT02373202|76093902|FG003|Overall Study|Lack of Efficacy|0|||
42265839|NCT02373202|76093899|FG000|Overall Study|Other|0|||
42265840|NCT02373202|76093900|FG001|Overall Study|Other|1|||
42265841|NCT02373202|76093901|FG002|Overall Study|Other|0|||
42265842|NCT02373202|76093902|FG003|Overall Study|Other|0|||
42265843|NCT02622074|76093918|FG000|Overall Study|Death|4|||
42265844|NCT02622074|76093919|FG001|Overall Study|Death|0|||
42265845|NCT02622074|76093920|FG002|Overall Study|Death|0|||
42265846|NCT02622074|76093921|FG003|Overall Study|Death|1|||
42265847|NCT02622074|76093922|FG004|Overall Study|Death|1|||
42337103|NCT02171429|76174868|FG002|Overall Study|Withdrawal by Subject|1|||
42000309|NCT01175590|75808838|FG001|Overall Study|Treated not as randomized|2|||
42000310|NCT01175590|75808837|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
42000311|NCT01175590|75808838|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
42000312|NCT01175590|75808837|FG000|Overall Study|Protocol Violation|0|||
42000313|NCT01175590|75808838|FG001|Overall Study|Protocol Violation|1|||
42000314|NCT01175473|75808847|FG000|Overall Study|Adverse Event|2|||
42000315|NCT01175473|75808848|FG001|Overall Study|Adverse Event|2|||
42000316|NCT01111552|75808854|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
42000317|NCT01111552|75808855|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
42000318|NCT01111552|75808856|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
42000319|NCT01111552|75808857|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
42000320|NCT01111552|75808858|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
42337104|NCT02171429|76174866|FG000|Overall Study|Lost to Follow-up|0|||
42000321|NCT01111552|75808854|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
42265848|NCT02622074|76093923|FG005|Overall Study|Death|0|||
42337105|NCT02171429|76174867|FG001|Overall Study|Lost to Follow-up|1|||
42337106|NCT02171429|76174868|FG002|Overall Study|Lost to Follow-up|0|||
42337107|NCT02171429|76174866|FG000|Overall Study|Death|0|||
42000322|NCT01111552|75808855|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
42000323|NCT01111552|75808856|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
42000324|NCT01111552|75808857|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
42000325|NCT01111552|75808858|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
42000326|NCT01111552|75808854|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
42000327|NCT01111552|75808855|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
42000328|NCT01111552|75808856|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
42000329|NCT01111552|75808857|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
42000330|NCT01111552|75808858|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
42000331|NCT01111552|75808854|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
42000332|NCT01111552|75808855|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
42000333|NCT01111552|75808856|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
42000334|NCT01111552|75808857|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
42000335|NCT01111552|75808858|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
42000336|NCT01111552|75808854|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
42000337|NCT01111552|75808855|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
42000338|NCT01111552|75808856|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
42000339|NCT01111552|75808857|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
42000340|NCT01111552|75808858|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
42000341|NCT01111552|75808854|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
42000342|NCT01111552|75808855|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
42000343|NCT01111552|75808856|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
42000344|NCT01111552|75808857|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
42000345|NCT01111552|75808858|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
42000346|NCT01111552|75808854|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
42000347|NCT01111552|75808855|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
42000348|NCT01111552|75808856|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
42000349|NCT01111552|75808857|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
42000350|NCT01111552|75808858|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
42000351|NCT01111552|75808854|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
42000352|NCT01111552|75808855|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
42000353|NCT01111552|75808856|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
42000354|NCT01111552|75808857|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
42000355|NCT01111552|75808858|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
42000356|NCT01111552|75808854|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
42000357|NCT01111552|75808855|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
42000358|NCT01111552|75808856|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
42000359|NCT01111552|75808857|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
42000360|NCT01111552|75808858|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
42000361|NCT01111552|75808854|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
42000362|NCT01111552|75808855|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
42000363|NCT01111552|75808856|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
42265849|NCT02622074|76093918|FG000|Overall Study|Withdrawal by Subject|0|||
42265850|NCT02622074|76093919|FG001|Overall Study|Withdrawal by Subject|1|||
42265851|NCT02622074|76093920|FG002|Overall Study|Withdrawal by Subject|0|||
42265852|NCT02622074|76093921|FG003|Overall Study|Withdrawal by Subject|0|||
42265853|NCT02622074|76093922|FG004|Overall Study|Withdrawal by Subject|0|||
42265854|NCT02622074|76093923|FG005|Overall Study|Withdrawal by Subject|0|||
42265855|NCT02308696|76093939|FG000|Overall Study|Lost to Follow-up|28|||
42265856|NCT02308696|76093940|FG001|Overall Study|Lost to Follow-up|21|||
42265857|NCT02308696|76093939|FG000|Overall Study|Death|8|||
42265858|NCT02308696|76093940|FG001|Overall Study|Death|4|||
42265859|NCT02308696|76093939|FG000|Overall Study|Moved to a Higher Level of Care|17|||
42265860|NCT02308696|76093940|FG001|Overall Study|Moved to a Higher Level of Care|6|||
42265861|NCT02342704|76093948|FG000|Overall Study|Physician Decision|0|||
42000364|NCT01111552|75808857|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
42000365|NCT01111552|75808858|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
42000366|NCT01111552|75808854|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
42000367|NCT01111552|75808855|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
42000368|NCT01111552|75808856|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
42000369|NCT01111552|75808857|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
42000370|NCT01111552|75808858|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
42337108|NCT02171429|76174867|FG001|Overall Study|Death|0|||
42337109|NCT02171429|76174868|FG002|Overall Study|Death|1|||
42337110|NCT01818297|76174881|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
42337111|NCT01818297|76174882|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
42337112|NCT01818297|76174881|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
42337113|NCT01818297|76174882|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
42000371|NCT01111552|75808854|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
42000372|NCT01111552|75808855|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
42337114|NCT01818297|76174881|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
42337115|NCT01818297|76174882|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
42337116|NCT01818141|76174890|FG000|Overall Study|Withdrawal by Subject|2|||
42337117|NCT01818141|76174891|FG001|Overall Study|Withdrawal by Subject|0|||
42337118|NCT01818141|76174890|FG000|Overall Study|No baseline C.diff colonies|1|||
42337119|NCT01818141|76174891|FG001|Overall Study|No baseline C.diff colonies|1|||
42337120|NCT01818141|76174890|FG000|Overall Study|Lost to Follow-up|0|||
42337121|NCT01818141|76174891|FG001|Overall Study|Lost to Follow-up|2|||
42337122|NCT01849497|76174899|FG000|Overall Study|Withdrawal by Subject|1|||
42337123|NCT01849497|76174900|FG001|Overall Study|Withdrawal by Subject|2|||
42337124|NCT01849497|76174899|FG000|Overall Study|Sponsor Decision|0|||
42337125|NCT01849497|76174900|FG001|Overall Study|Sponsor Decision|1|||
42337126|NCT01849497|76174899|FG000|Overall Study|Lost to Follow-up|0|||
42337127|NCT01849497|76174900|FG001|Overall Study|Lost to Follow-up|1|||
42337128|NCT02147093|76174908|FG000|Period 1|Lost to Follow-up|0|||
42337129|NCT02147093|76174909|FG001|Period 1|Lost to Follow-up|1|||
42337130|NCT02147093|76174908|FG000|Period 2|Protocol Violation|2|||
42337131|NCT02147093|76174909|FG001|Period 2|Protocol Violation|0|||
42337132|NCT02119325|76174915|FG000|Washout Period 1|Adverse Event|0|||
42337133|NCT02119325|76174916|FG001|Washout Period 1|Adverse Event|1|||
42337134|NCT01816893|76174926|FG000|Washout Period|Withdrawal by Subject|2|||
42337135|NCT01816893|76174927|FG001|Washout Period|Withdrawal by Subject|0|||
42337136|NCT01848483|76174935|FG000|Overall Study|Death|2|||
42337137|NCT01848483|76174936|FG001|Overall Study|Death|1|||
42134730|NCT00406653|75945530|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
42337138|NCT01848483|76174935|FG000|Overall Study|Lost to Follow-up|6|||
42337139|NCT01848483|76174936|FG001|Overall Study|Lost to Follow-up|8|||
42337140|NCT01848483|76174935|FG000|Overall Study|Withdrawal by Subject|1|||
42337141|NCT01848483|76174936|FG001|Overall Study|Withdrawal by Subject|0|||
42337142|NCT01848483|76174935|FG000|Overall Study|Incarceration|2|||
42337143|NCT01848483|76174936|FG001|Overall Study|Incarceration|2|||
42034746|NCT01061736|75842939|FG001|Overall Study|Lack of Efficacy|2|||
42034747|NCT01061736|75842940|FG002|Overall Study|Lack of Efficacy|1|||
42034748|NCT01061736|75842941|FG003|Overall Study|Lack of Efficacy|1|||
42034749|NCT01061736|75842942|FG004|Overall Study|Lack of Efficacy|1|||
42034750|NCT01061736|75842943|FG005|Overall Study|Lack of Efficacy|2|||
42034751|NCT01061736|75842944|FG006|Overall Study|Lack of Efficacy|1|||
42034752|NCT01061736|75842945|FG007|Overall Study|Lack of Efficacy|9|||
42034753|NCT01061736|75842946|FG008|Overall Study|Lack of Efficacy|9|||
42134731|NCT00406653|75945531|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
42337144|NCT01610271|76174945|FG000|Overall Study|Surgery not complete|0|||
42337145|NCT01610271|76174946|FG001|Overall Study|Surgery not complete|1|||
42337146|NCT01610271|76174945|FG000|Overall Study|Prosthesis not implanted|2|||
42337147|NCT01610271|76174946|FG001|Overall Study|Prosthesis not implanted|3|||
42337148|NCT02170727|76174956|FG000|Overall Study|Lost to Follow-up|1|||
42337149|NCT02170727|76174957|FG001|Overall Study|Lost to Follow-up|0|||
42337150|NCT02170727|76174956|FG000|Overall Study|Withdrawal by Subject|2|||
42337151|NCT02170727|76174957|FG001|Overall Study|Withdrawal by Subject|0|||
42337152|NCT01847313|76174968|FG000|Overall Study|Death|0|||
42337153|NCT01847313|76174969|FG001|Overall Study|Death|1|||
42337154|NCT01847313|76174968|FG000|Overall Study|Withdrawal by Subject|0|||
42337155|NCT01847313|76174969|FG001|Overall Study|Withdrawal by Subject|1|||
42337156|NCT02144285|76174985|FG000|Overall Study|Withdrawal by Subject|0|||
42337157|NCT02144285|76174986|FG001|Overall Study|Withdrawal by Subject|0|||
42337158|NCT02144285|76174987|FG002|Overall Study|Withdrawal by Subject|0|||
42337159|NCT02144285|76174988|FG003|Overall Study|Withdrawal by Subject|0|||
42337160|NCT02144285|76174989|FG004|Overall Study|Withdrawal by Subject|1|||
42337161|NCT02144285|76174990|FG005|Overall Study|Withdrawal by Subject|0|||
42337162|NCT02144285|76174991|FG006|Overall Study|Withdrawal by Subject|0|||
42337163|NCT02144285|76174992|FG007|Overall Study|Withdrawal by Subject|0|||
42337164|NCT02144285|76174993|FG008|Overall Study|Withdrawal by Subject|0|||
42337165|NCT02144285|76174994|FG009|Overall Study|Withdrawal by Subject|0|||
42337166|NCT02117687|76175032|FG000|Overall Study|Lost to Follow-up|0|||
42337167|NCT02117687|76175033|FG001|Overall Study|Lost to Follow-up|1|||
42337168|NCT02117687|76175032|FG000|Overall Study|Adverse Event|0|||
42337169|NCT02117687|76175033|FG001|Overall Study|Adverse Event|2|||
42337170|NCT02117687|76175032|FG000|Overall Study|Other Reasons|1|||
42337171|NCT02117687|76175033|FG001|Overall Study|Other Reasons|1|||
42337172|NCT02143583|76175042|FG000|Overall Study|Withdrawal by Subject|1|||
42337173|NCT02143583|76175043|FG001|Overall Study|Withdrawal by Subject|0|||
42337174|NCT02143583|76175044|FG002|Overall Study|Withdrawal by Subject|1|||
42337175|NCT02143583|76175042|FG000|Overall Study|husband illness|0|||
42337176|NCT02143583|76175043|FG001|Overall Study|husband illness|0|||
42337177|NCT02143583|76175044|FG002|Overall Study|husband illness|1|||
42337178|NCT02105987|76175054|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
42337179|NCT02105987|76175055|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
42337180|NCT02105987|76175056|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
42337181|NCT02105987|76175057|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
42337182|NCT02105987|76175058|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
42337183|NCT02105987|76175059|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
42337184|NCT02105987|76175054|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
42337185|NCT02105987|76175055|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
42337186|NCT02105987|76175056|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
42337187|NCT02105987|76175057|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
42337188|NCT02105987|76175058|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
42337189|NCT02105987|76175059|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
42337190|NCT02105987|76175054|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
42337191|NCT02105987|76175055|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
42337192|NCT02105987|76175056|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
42337193|NCT02105987|76175057|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
42337194|NCT02105987|76175058|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
42337195|NCT02105987|76175059|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
42337196|NCT02105987|76175054|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
42337197|NCT02105987|76175055|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
42337198|NCT02105987|76175056|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
42000373|NCT01111552|75808856|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
42000374|NCT01111552|75808857|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
42000375|NCT01111552|75808858|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
42000376|NCT01111552|75808854|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
42000377|NCT01111552|75808855|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
42000378|NCT01111552|75808856|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
42000379|NCT01111552|75808857|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
42000380|NCT01111552|75808858|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
42000381|NCT01111552|75808854|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
42337199|NCT02105987|76175057|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
42337200|NCT02105987|76175058|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
42337201|NCT02105987|76175059|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
42337202|NCT02105987|76175054|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
42337203|NCT02105987|76175055|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
42337204|NCT02105987|76175056|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
42337205|NCT02105987|76175057|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
42337206|NCT02105987|76175058|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
42337207|NCT02105987|76175059|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
42337208|NCT02105987|76175054|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
42337209|NCT02105987|76175055|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
42337210|NCT02105987|76175056|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
42337211|NCT02105987|76175057|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
42000382|NCT01111552|75808855|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
42000383|NCT01111552|75808856|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
42000384|NCT01111552|75808857|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
42000385|NCT01111552|75808858|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
42000386|NCT01175083|75808874|FG000|Primary Epoch|Withdrawal by Subject|0|||
42000387|NCT01175083|75808875|FG001|Primary Epoch|Withdrawal by Subject|0|||
42034754|NCT01061736|75842947|FG009|Overall Study|Lack of Efficacy|10|||
42034755|NCT01061736|75842938|FG000|Overall Study|Poor compliance to protocol|0|||
42034756|NCT01061736|75842939|FG001|Overall Study|Poor compliance to protocol|0|||
42034757|NCT01061736|75842940|FG002|Overall Study|Poor compliance to protocol|0|||
42034758|NCT01061736|75842941|FG003|Overall Study|Poor compliance to protocol|0|||
42034759|NCT01061736|75842942|FG004|Overall Study|Poor compliance to protocol|0|||
42034760|NCT01061736|75842943|FG005|Overall Study|Poor compliance to protocol|0|||
42034761|NCT01061736|75842944|FG006|Overall Study|Poor compliance to protocol|0|||
42034762|NCT01061736|75842945|FG007|Overall Study|Poor compliance to protocol|2|||
42034763|NCT01061736|75842946|FG008|Overall Study|Poor compliance to protocol|5|||
42034764|NCT01061736|75842947|FG009|Overall Study|Poor compliance to protocol|9|||
42034765|NCT01061736|75842938|FG000|Overall Study|Not treated|0|||
42034766|NCT01061736|75842939|FG001|Overall Study|Not treated|0|||
42034767|NCT01061736|75842940|FG002|Overall Study|Not treated|0|||
42034768|NCT01061736|75842941|FG003|Overall Study|Not treated|0|||
42034769|NCT01061736|75842942|FG004|Overall Study|Not treated|1|||
42034770|NCT01061736|75842943|FG005|Overall Study|Not treated|0|||
42034771|NCT01061736|75842944|FG006|Overall Study|Not treated|0|||
42034772|NCT01061736|75842945|FG007|Overall Study|Not treated|2|||
42034773|NCT01061736|75842946|FG008|Overall Study|Not treated|1|||
42034774|NCT01061736|75842947|FG009|Overall Study|Not treated|0|||
42034775|NCT01061736|75842938|FG000|Overall Study|Other than specified above|0|||
42034776|NCT01061736|75842939|FG001|Overall Study|Other than specified above|1|||
42034777|NCT01061736|75842940|FG002|Overall Study|Other than specified above|2|||
42034778|NCT01061736|75842941|FG003|Overall Study|Other than specified above|0|||
42034779|NCT01061736|75842942|FG004|Overall Study|Other than specified above|1|||
42337212|NCT02105987|76175058|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
42337213|NCT02105987|76175059|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
42000388|NCT01175083|75808876|FG002|Primary Epoch|Withdrawal by Subject|0|||
42034780|NCT01061736|75842943|FG005|Overall Study|Other than specified above|0|||
42000389|NCT01175083|75808877|FG003|Primary Epoch|Withdrawal by Subject|0|||
42034781|NCT01061736|75842944|FG006|Overall Study|Other than specified above|0|||
42034782|NCT01061736|75842945|FG007|Overall Study|Other than specified above|18|||
42034783|NCT01061736|75842946|FG008|Overall Study|Other than specified above|15|||
42034784|NCT01061736|75842947|FG009|Overall Study|Other than specified above|21|||
42034785|NCT01117337|75842974|FG000|Overall Study|Lost to Follow-up|4|||
42000390|NCT01175083|75808878|FG004|Primary Epoch|Withdrawal by Subject|0|||
42000391|NCT01175083|75808879|FG005|Primary Epoch|Withdrawal by Subject|2|||
42337214|NCT02105987|76175054|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
42337215|NCT02105987|76175055|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
42337216|NCT02105987|76175056|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
42337217|NCT02105987|76175057|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
42337218|NCT02105987|76175058|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
42337219|NCT02105987|76175059|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
42337220|NCT02105987|76175054|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
42337221|NCT02105987|76175055|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
42337222|NCT02105987|76175056|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
42337223|NCT02105987|76175057|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
42337224|NCT02105987|76175058|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
42337225|NCT02105987|76175059|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
42337226|NCT02105987|76175054|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
42337227|NCT02105987|76175055|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
42337228|NCT02105987|76175056|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
42337229|NCT02105987|76175057|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
42337230|NCT02105987|76175058|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
42337231|NCT02105987|76175059|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
42337232|NCT02105987|76175054|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
42337233|NCT02105987|76175055|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
42337234|NCT02105987|76175056|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
42337235|NCT02105987|76175057|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
42337236|NCT02105987|76175058|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
42337237|NCT02105987|76175059|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
42000392|NCT01175083|75808874|FG000|Primary Epoch|Lost to Follow-up|0|||
42000393|NCT01175083|75808875|FG001|Primary Epoch|Lost to Follow-up|0|||
42000394|NCT01175083|75808876|FG002|Primary Epoch|Lost to Follow-up|0|||
42000395|NCT01175083|75808877|FG003|Primary Epoch|Lost to Follow-up|0|||
42000396|NCT01175083|75808878|FG004|Primary Epoch|Lost to Follow-up|0|||
42337238|NCT02105987|76175054|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
42337239|NCT02105987|76175055|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
42337240|NCT02105987|76175056|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
42337241|NCT02105987|76175057|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
42337242|NCT02105987|76175058|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
42337243|NCT02105987|76175059|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
42265862|NCT02342704|76093949|FG001|Overall Study|Physician Decision|3|||
42265863|NCT02342704|76093948|FG000|Overall Study|Sponsor Termination|49|||
42265864|NCT02342704|76093949|FG001|Overall Study|Sponsor Termination|43|||
42265865|NCT02342704|76093948|FG000|Overall Study|Other|0|||
42265866|NCT02342704|76093949|FG001|Overall Study|Other|1|||
42265867|NCT02342704|76093948|FG000|Overall Study|Withdrawal by Subject|1|||
42265868|NCT02342704|76093949|FG001|Overall Study|Withdrawal by Subject|0|||
42265869|NCT02342704|76093948|FG000|Overall Study|Lost to Follow-up|2|||
42265870|NCT02342704|76093949|FG001|Overall Study|Lost to Follow-up|1|||
42265871|NCT02342704|76093948|FG000|Overall Study|Adverse Event|1|||
42265872|NCT02342704|76093949|FG001|Overall Study|Adverse Event|3|||
42265873|NCT02342548|76093958|FG000|Overall Study|Adverse Event|12|||
42265874|NCT02342548|76093959|FG001|Overall Study|Adverse Event|17|||
42265875|NCT02342548|76093960|FG002|Overall Study|Adverse Event|13|||
42265876|NCT02342548|76093958|FG000|Overall Study|Lost to Follow-up|0|||
42265877|NCT02342548|76093959|FG001|Overall Study|Lost to Follow-up|1|||
42265878|NCT02342548|76093960|FG002|Overall Study|Lost to Follow-up|0|||
42265879|NCT02342548|76093958|FG000|Overall Study|Study terminated by sponsor|20|||
42265880|NCT02342548|76093959|FG001|Overall Study|Study terminated by sponsor|39|||
42265881|NCT02342548|76093960|FG002|Overall Study|Study terminated by sponsor|25|||
42265882|NCT02342548|76093958|FG000|Overall Study|Protocol Violation|0|||
42265883|NCT02342548|76093959|FG001|Overall Study|Protocol Violation|1|||
42265884|NCT02342548|76093960|FG002|Overall Study|Protocol Violation|0|||
42265885|NCT02342548|76093958|FG000|Overall Study|Withdrawal by Subject|1|||
42265886|NCT02342548|76093959|FG001|Overall Study|Withdrawal by Subject|3|||
42265887|NCT02342548|76093960|FG002|Overall Study|Withdrawal by Subject|4|||
42265888|NCT02342548|76093958|FG000|Overall Study|Other|1|||
42265889|NCT02342548|76093959|FG001|Overall Study|Other|1|||
42265890|NCT02342548|76093960|FG002|Overall Study|Other|1|||
42265891|NCT03142191|76093973|FG000|Placebo Controlled Period|Death|0|||
42265892|NCT03142191|76093974|FG001|Placebo Controlled Period|Death|1|||
42265893|NCT03142191|76093975|FG002|Placebo Controlled Period|Death|1|||
42265894|NCT03142191|76093976|FG003|Placebo Controlled Period|Death|0|||
42265895|NCT03142191|76093977|FG004|Placebo Controlled Period|Death|0|||
42337244|NCT02105987|76175054|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
42337245|NCT02105987|76175055|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
42265896|NCT03142191|76093973|FG000|Placebo Controlled Period|Adverse Event|4|||
42265897|NCT03142191|76093974|FG001|Placebo Controlled Period|Adverse Event|5|||
42265898|NCT03142191|76093975|FG002|Placebo Controlled Period|Adverse Event|1|||
42337246|NCT02105987|76175056|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
42337247|NCT02105987|76175057|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
42337248|NCT02105987|76175058|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
42337249|NCT02105987|76175059|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
42337250|NCT02105987|76175054|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
42337251|NCT02105987|76175055|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
42337252|NCT02105987|76175056|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
42337253|NCT02105987|76175057|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
42337254|NCT02105987|76175058|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
42337255|NCT02105987|76175059|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
42337256|NCT02105987|76175054|FG000|Continuation Phase|Protocol Violation|0|||
42337257|NCT02105987|76175055|FG001|Continuation Phase|Protocol Violation|0|||
42337258|NCT02105987|76175056|FG002|Continuation Phase|Protocol Violation|0|||
42337259|NCT02105987|76175057|FG003|Continuation Phase|Protocol Violation|0|||
42337260|NCT02105987|76175058|FG004|Continuation Phase|Protocol Violation|1|||
42337261|NCT02105987|76175059|FG005|Continuation Phase|Protocol Violation|0|||
42337262|NCT02141633|76175067|FG000|Overall Study|Physician Decision|1|||
42337263|NCT02141633|76175068|FG001|Overall Study|Physician Decision|0|||
42337264|NCT01846611|76175076|FG000|Overall Study|Lost to Follow-up|4|||
42337265|NCT01846611|76175077|FG001|Overall Study|Lost to Follow-up|6|||
42337266|NCT01846611|76175076|FG000|Overall Study|Withdrawal by Subject|15|||
42337267|NCT01846611|76175077|FG001|Overall Study|Withdrawal by Subject|19|||
42337268|NCT01846611|76175076|FG000|Overall Study|Other|19|||
42337269|NCT01846611|76175077|FG001|Overall Study|Other|18|||
42337270|NCT02141399|76175083|FG000|Overall Study|Adverse Event|158|||
42337271|NCT02141399|76175083|FG000|Overall Study|Lack of Efficacy|62|||
42337272|NCT02141399|76175083|FG000|Overall Study|Lost to Follow-up|151|||
42337273|NCT02141399|76175083|FG000|Overall Study|Non-compliance with study drug|18|||
42337274|NCT02141399|76175083|FG000|Overall Study|Other|45|||
42337275|NCT02141399|76175083|FG000|Overall Study|Physician Decision|17|||
42337276|NCT02141399|76175083|FG000|Overall Study|Pregnancy|3|||
42337277|NCT02141399|76175083|FG000|Overall Study|Protocol Violation|38|||
42337278|NCT02141399|76175083|FG000|Overall Study|Withdrawal by Subject|238|||
42337279|NCT02141399|76175083|FG000|Overall Study|Failure to meet eligibility criteria|14|||
42337280|NCT01846299|76175089|FG000|Overall Study|Physician Decision|4|||
42337281|NCT01846299|76175090|FG001|Overall Study|Physician Decision|2|||
42337282|NCT01846299|76175089|FG000|Overall Study|Protocol deviation|1|||
42337283|NCT01846299|76175090|FG001|Overall Study|Protocol deviation|0|||
42337284|NCT01846299|76175089|FG000|Overall Study|Death|1|||
42337285|NCT01846299|76175090|FG001|Overall Study|Death|2|||
42000397|NCT01175083|75808879|FG005|Primary Epoch|Lost to Follow-up|1|||
42000398|NCT01175083|75808874|FG000|Booster Epoch|Death|0|||
42000399|NCT01175083|75808875|FG001|Booster Epoch|Death|0|||
42000400|NCT01175083|75808876|FG002|Booster Epoch|Death|1|||
42000401|NCT01175083|75808877|FG003|Booster Epoch|Death|0|||
42000402|NCT01175083|75808878|FG004|Booster Epoch|Death|0|||
42000403|NCT01175083|75808879|FG005|Booster Epoch|Death|0|||
42000404|NCT01175083|75808874|FG000|Booster Epoch|Withdrawal by Subject|0|||
42000405|NCT01175083|75808875|FG001|Booster Epoch|Withdrawal by Subject|0|||
42000406|NCT01175083|75808876|FG002|Booster Epoch|Withdrawal by Subject|0|||
42034786|NCT01117337|75842975|FG001|Overall Study|Lost to Follow-up|0|||
42000407|NCT01175083|75808877|FG003|Booster Epoch|Withdrawal by Subject|1|||
42000408|NCT01175083|75808878|FG004|Booster Epoch|Withdrawal by Subject|0|||
42000409|NCT01175083|75808879|FG005|Booster Epoch|Withdrawal by Subject|0|||
42000410|NCT01174459|75808897|FG000|Overall Study|case report form (CRF) not collected|5|||
42034787|NCT01108523|75842985|FG000|Overall Study|Protocol Violation|4|||
42034788|NCT01035606|75842992|FG000|Overall Study|change in health, job demands,family|3|||
42034789|NCT01035606|75842993|FG001|Overall Study|change in health, job demands,family|3|||
42034790|NCT01035606|75842994|FG002|Overall Study|change in health, job demands,family|4|||
42034791|NCT01117181|75843004|FG000|Overall Study|Lost to Follow-up|1|||
42034792|NCT01117181|75843005|FG001|Overall Study|Lost to Follow-up|0|||
42034793|NCT01117181|75843004|FG000|Overall Study|Withdrawal by Subject|0|||
42034794|NCT01117181|75843005|FG001|Overall Study|Withdrawal by Subject|2|||
42034795|NCT01040130|75843013|FG000|Overall Study|Adverse Event|1|||
42337286|NCT01846299|76175089|FG000|Overall Study|Lost to Follow-up|3|||
42337287|NCT01846299|76175090|FG001|Overall Study|Lost to Follow-up|0|||
42337288|NCT01846299|76175089|FG000|Overall Study|Withdrawal by Subject|1|||
42337289|NCT01846299|76175090|FG001|Overall Study|Withdrawal by Subject|6|||
42337290|NCT01846299|76175089|FG000|Overall Study|Adverse Event|2|||
42337291|NCT01846299|76175090|FG001|Overall Study|Adverse Event|0|||
42337292|NCT01628393|76175101|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
42000411|NCT01174342|75808901|FG000|Overall Study|Conversion to cesarean section|4|||
42000412|NCT01111474|75808905|FG000|Overall Study|Lost to Follow-up|12|||
42000413|NCT01174264|75808914|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
42000414|NCT01174264|75808915|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
42337293|NCT01628393|76175102|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
42337294|NCT01628393|76175103|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
42337295|NCT01628393|76175104|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
42337296|NCT01628393|76175105|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
42337297|NCT01628393|76175101|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
42337298|NCT01628393|76175102|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
42337299|NCT01628393|76175103|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
42337300|NCT01628393|76175104|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
42337301|NCT01628393|76175105|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
42337302|NCT01628393|76175101|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
42337303|NCT01628393|76175102|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
42337304|NCT01628393|76175103|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
42337305|NCT01628393|76175104|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
42337306|NCT01628393|76175105|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
42337307|NCT01628393|76175101|FG000|Blinded Active Extension Period|Adverse Event|0|||
42337308|NCT01628393|76175102|FG001|Blinded Active Extension Period|Adverse Event|1|||
42337309|NCT01628393|76175103|FG002|Blinded Active Extension Period|Adverse Event|0|||
42337310|NCT01628393|76175104|FG003|Blinded Active Extension Period|Adverse Event|2|||
42337311|NCT01628393|76175105|FG004|Blinded Active Extension Period|Adverse Event|2|||
42337312|NCT01628393|76175101|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
42337313|NCT01628393|76175102|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
42337314|NCT01628393|76175103|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
42337315|NCT01628393|76175104|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
42337316|NCT01628393|76175105|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
42337317|NCT01628393|76175101|FG000|Blinded Active Extension Period|Physician Decision|0|||
42337318|NCT01628393|76175102|FG001|Blinded Active Extension Period|Physician Decision|3|||
42337319|NCT01628393|76175103|FG002|Blinded Active Extension Period|Physician Decision|0|||
42337320|NCT01628393|76175104|FG003|Blinded Active Extension Period|Physician Decision|1|||
42337321|NCT01628393|76175105|FG004|Blinded Active Extension Period|Physician Decision|0|||
42337322|NCT01628393|76175101|FG000|Blinded Active Extension Period|Protocol Violation|0|||
42337323|NCT01628393|76175102|FG001|Blinded Active Extension Period|Protocol Violation|0|||
42337324|NCT01628393|76175103|FG002|Blinded Active Extension Period|Protocol Violation|2|||
42337325|NCT01628393|76175104|FG003|Blinded Active Extension Period|Protocol Violation|1|||
42337326|NCT01628393|76175105|FG004|Blinded Active Extension Period|Protocol Violation|0|||
42337327|NCT01628393|76175101|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
42337328|NCT01628393|76175102|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
42337329|NCT01628393|76175103|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
42337330|NCT01628393|76175104|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
42337331|NCT01628393|76175105|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
42337332|NCT01846221|76175121|FG000|Overall Study|Catheter Failure|2|||
42337333|NCT01846221|76175122|FG001|Overall Study|Catheter Failure|0|||
42337334|NCT01846221|76175121|FG000|Overall Study|Age Exclusion|1|||
42337335|NCT01846221|76175122|FG001|Overall Study|Age Exclusion|0|||
42337336|NCT01815099|76175128|FG000|Overall Study|Lack of Efficacy|1|||
42337337|NCT01815099|76175128|FG000|Overall Study|unable to attend study visits|1|||
42337338|NCT01845831|76175135|FG000|Inpatient Phase|Withdrawal by Subject|1|||
42337339|NCT01845831|76175136|FG001|Inpatient Phase|Withdrawal by Subject|1|||
42337340|NCT01845831|76175137|FG002|Inpatient Phase|Withdrawal by Subject|0|||
42337341|NCT01845831|76175138|FG003|Inpatient Phase|Withdrawal by Subject|0|||
42337342|NCT01845831|76175139|FG004|Inpatient Phase|Withdrawal by Subject|0|||
42337343|NCT01627691|76175150|FG000|Overall Study|Death|11|||
42337344|NCT01627691|76175150|FG000|Overall Study|Lost to Follow-up|3|||
42337345|NCT01627691|76175150|FG000|Overall Study|Withdrawal by Subject|1|||
42337346|NCT01627691|76175150|FG000|Overall Study|Missed the visit|3|||
42337347|NCT01844895|76175154|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
42034796|NCT01040130|75843014|FG001|Overall Study|Adverse Event|1|||
42337348|NCT01844895|76175154|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
42337349|NCT01844895|76175154|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
42337350|NCT01844895|76175154|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
42337351|NCT01844895|76175154|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
42337352|NCT01844895|76175154|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
42337353|NCT01844895|76175154|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
42337354|NCT02116361|76175171|FG000|Overall Study|Pregnancy|0|||
42337355|NCT02116361|76175172|FG001|Overall Study|Pregnancy|0|||
42337356|NCT02116361|76175173|FG002|Overall Study|Pregnancy|0|||
42337357|NCT02116361|76175174|FG003|Overall Study|Pregnancy|1|||
42337358|NCT02116361|76175171|FG000|Overall Study|Protocol Violation|1|||
42337359|NCT02116361|76175172|FG001|Overall Study|Protocol Violation|0|||
42337360|NCT02116361|76175173|FG002|Overall Study|Protocol Violation|0|||
42337361|NCT02116361|76175174|FG003|Overall Study|Protocol Violation|2|||
42337362|NCT02116361|76175171|FG000|Overall Study|Physician Decision|2|||
42337363|NCT02116361|76175172|FG001|Overall Study|Physician Decision|3|||
42337364|NCT02116361|76175173|FG002|Overall Study|Physician Decision|0|||
42337365|NCT02116361|76175174|FG003|Overall Study|Physician Decision|0|||
42337366|NCT02116361|76175171|FG000|Overall Study|Adverse Event|1|||
42337367|NCT02116361|76175172|FG001|Overall Study|Adverse Event|0|||
42337368|NCT02116361|76175173|FG002|Overall Study|Adverse Event|0|||
42337369|NCT02116361|76175174|FG003|Overall Study|Adverse Event|3|||
42337370|NCT02116361|76175171|FG000|Overall Study|Other Reasons|3|||
42337371|NCT02116361|76175172|FG001|Overall Study|Other Reasons|3|||
42337372|NCT02116361|76175173|FG002|Overall Study|Other Reasons|3|||
42265899|NCT03142191|76093976|FG003|Placebo Controlled Period|Adverse Event|0|||
42265900|NCT03142191|76093977|FG004|Placebo Controlled Period|Adverse Event|0|||
42265901|NCT03142191|76093973|FG000|Placebo Controlled Period|Progressive Disease|1|||
42265902|NCT03142191|76093974|FG001|Placebo Controlled Period|Progressive Disease|0|||
42265903|NCT03142191|76093975|FG002|Placebo Controlled Period|Progressive Disease|1|||
42265904|NCT03142191|76093976|FG003|Placebo Controlled Period|Progressive Disease|0|||
42265905|NCT03142191|76093977|FG004|Placebo Controlled Period|Progressive Disease|0|||
42265906|NCT03142191|76093973|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
42265907|NCT03142191|76093974|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
42265908|NCT03142191|76093975|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
42265909|NCT03142191|76093976|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
42265910|NCT03142191|76093977|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
42265911|NCT03142191|76093973|FG000|Placebo Controlled Period|Other Reasons|1|||
42337373|NCT02116361|76175174|FG003|Overall Study|Other Reasons|3|||
42337374|NCT02116361|76175171|FG000|Overall Study|Lack of Efficacy|5|||
42337375|NCT02116361|76175172|FG001|Overall Study|Lack of Efficacy|7|||
42337376|NCT02116361|76175173|FG002|Overall Study|Lack of Efficacy|4|||
42337377|NCT02116361|76175174|FG003|Overall Study|Lack of Efficacy|3|||
42337378|NCT02116361|76175171|FG000|Overall Study|Lost to Follow-up|4|||
42337379|NCT02116361|76175172|FG001|Overall Study|Lost to Follow-up|5|||
42337380|NCT02116361|76175173|FG002|Overall Study|Lost to Follow-up|7|||
42337381|NCT02116361|76175174|FG003|Overall Study|Lost to Follow-up|5|||
42337382|NCT02116361|76175171|FG000|Overall Study|Personal Reasons|6|||
42337383|NCT02116361|76175172|FG001|Overall Study|Personal Reasons|6|||
42337384|NCT02116361|76175173|FG002|Overall Study|Personal Reasons|4|||
42337385|NCT02116361|76175174|FG003|Overall Study|Personal Reasons|9|||
42337386|NCT02116361|76175171|FG000|Overall Study|Investigator Decision - Relapse|9|||
42337387|NCT02116361|76175172|FG001|Overall Study|Investigator Decision - Relapse|7|||
42337388|NCT02116361|76175173|FG002|Overall Study|Investigator Decision - Relapse|8|||
42337389|NCT02116361|76175174|FG003|Overall Study|Investigator Decision - Relapse|5|||
42337390|NCT02140775|76175186|FG000|Overall Study|Withdrawal by Subject|30|||
42337391|NCT02140775|76175187|FG001|Overall Study|Withdrawal by Subject|7|||
42134732|NCT00406653|75945532|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
42134733|NCT00406653|75945533|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
42134734|NCT00406653|75945534|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
42134735|NCT00406653|75945535|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
42134736|NCT00406653|75945529|FG000|Maintenance Period|Error in disease score evaluation|0|||
42272733|NCT01657370|76103056|FG001|Overall Study|Lost to Follow-up|0|||
42272734|NCT01657370|76103057|FG002|Overall Study|Lost to Follow-up|1|||
42272735|NCT01657370|76103058|FG003|Overall Study|Lost to Follow-up|0|||
42272736|NCT01657370|76103059|FG004|Overall Study|Lost to Follow-up|0|||
42272737|NCT01657370|76103060|FG005|Overall Study|Lost to Follow-up|1|||
42272738|NCT00849797|76103102|FG000|First Intervention|bad veins|1|||
42272739|NCT00849797|76103103|FG001|First Intervention|bad veins|0|||
42272740|NCT00849797|76103102|FG000|First Intervention|Adverse Event|0|||
42272741|NCT00849797|76103103|FG001|First Intervention|Adverse Event|1|||
42272742|NCT00849797|76103102|FG000|Washout: One Week|Withdrawal by Subject|0|||
42272743|NCT00849797|76103103|FG001|Washout: One Week|Withdrawal by Subject|2|||
42272744|NCT00840203|76103133|FG000|First Intervention|Protocol Violation|1|||
42272745|NCT00840203|76103134|FG001|First Intervention|Protocol Violation|1|||
42272746|NCT00840203|76103133|FG000|Washout|Protocol Violation|1|||
42272747|NCT00840203|76103134|FG001|Washout|Protocol Violation|0|||
42272748|NCT00835991|76103140|FG000|First Intervention|Adverse Event|0|||
42272749|NCT00835991|76103141|FG001|First Intervention|Adverse Event|1|||
42272750|NCT00835991|76103140|FG000|Washout|Protocol Violation|0|||
42272751|NCT00835991|76103141|FG001|Washout|Protocol Violation|2|||
42272752|NCT00835991|76103140|FG000|Washout|Withdrawal by Subject|3|||
42272753|NCT00835991|76103141|FG001|Washout|Withdrawal by Subject|1|||
42272754|NCT02276872|76103148|FG000|Overall Study|Adverse Event|1|||
42272755|NCT02276872|76103149|FG001|Overall Study|Adverse Event|0|||
42272756|NCT02276872|76103150|FG002|Overall Study|Adverse Event|0|||
42272757|NCT00835367|76103165|FG000|Washout|Adverse Event|2|||
42272758|NCT00835367|76103166|FG001|Washout|Adverse Event|0|||
42272759|NCT00835367|76103165|FG000|Washout|Withdrawal by Subject|1|||
42272760|NCT00835367|76103166|FG001|Washout|Withdrawal by Subject|0|||
42272761|NCT00835367|76103165|FG000|Second Intervention|Adverse Event|1|||
42272762|NCT00835367|76103166|FG001|Second Intervention|Adverse Event|1|||
42272763|NCT02276560|76103173|FG000|Overall Study|Adverse Event|1|||
42337392|NCT01844817|76175197|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
42337393|NCT01844817|76175198|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
42337394|NCT01844817|76175197|FG000|Treatment|Progressive Disease|27|||
42337395|NCT01844817|76175198|FG001|Treatment|Progressive Disease|36|||
42337396|NCT01844817|76175197|FG000|Treatment|Adverse Event|17|||
42337397|NCT01844817|76175198|FG001|Treatment|Adverse Event|9|||
42337398|NCT01844817|76175197|FG000|Treatment|Withdrawal by Subject|10|||
42337399|NCT01844817|76175198|FG001|Treatment|Withdrawal by Subject|6|||
42337400|NCT01844817|76175197|FG000|Treatment|Death|10|||
42337401|NCT01844817|76175198|FG001|Treatment|Death|8|||
42337402|NCT01844817|76175197|FG000|Treatment|Lost to Follow-up|0|||
42337403|NCT01844817|76175198|FG001|Treatment|Lost to Follow-up|1|||
42337404|NCT01844817|76175197|FG000|Treatment|Other|0|||
42337405|NCT01844817|76175198|FG001|Treatment|Other|3|||
42337406|NCT04594239|76175209|FG000|Overall Study|Withdrawal by Subject|3|||
42000415|NCT01174264|75808916|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
42000416|NCT01174264|75808914|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
42000417|NCT01174264|75808915|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
42000418|NCT01174264|75808916|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
42000419|NCT01174264|75808914|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
42000420|NCT01174264|75808915|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
42000421|NCT01174264|75808916|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
42000422|NCT01174186|75808926|FG000|Overall Study|Lost to Follow-up|0|||
42000423|NCT01174186|75808927|FG001|Overall Study|Lost to Follow-up|1|||
42000424|NCT01174186|75808926|FG000|Overall Study|Withdrawal by Subject|0|||
42337407|NCT04594239|76175210|FG001|Overall Study|Withdrawal by Subject|4|||
42337408|NCT04594239|76175211|FG002|Overall Study|Withdrawal by Subject|2|||
42337409|NCT04594239|76175212|FG003|Overall Study|Withdrawal by Subject|4|||
42337410|NCT04594239|76175209|FG000|Overall Study|Lost to Follow-up|8|||
42337411|NCT04594239|76175210|FG001|Overall Study|Lost to Follow-up|5|||
42337412|NCT04594239|76175211|FG002|Overall Study|Lost to Follow-up|4|||
42337413|NCT04594239|76175212|FG003|Overall Study|Lost to Follow-up|6|||
42337414|NCT04594239|76175209|FG000|Overall Study|Subject relocated|0|||
42337415|NCT04594239|76175210|FG001|Overall Study|Subject relocated|0|||
42337416|NCT04594239|76175211|FG002|Overall Study|Subject relocated|0|||
42337417|NCT04594239|76175212|FG003|Overall Study|Subject relocated|1|||
42337418|NCT01814553|76175230|FG000|Overall Study|PD per clinical progression|6|||
42337419|NCT01814553|76175231|FG001|Overall Study|PD per clinical progression|8|||
42337420|NCT01814553|76175230|FG000|Overall Study|Other Adverse Event|4|||
42337421|NCT01814553|76175231|FG001|Overall Study|Other Adverse Event|5|||
42337422|NCT01814553|76175230|FG000|Overall Study|Withdrawal by Subject|1|||
42337423|NCT01814553|76175231|FG001|Overall Study|Withdrawal by Subject|1|||
42337424|NCT01814553|76175230|FG000|Overall Study|Other than stated|7|||
42337425|NCT01814553|76175231|FG001|Overall Study|Other than stated|8|||
42000425|NCT01174186|75808927|FG001|Overall Study|Withdrawal by Subject|2|||
42000426|NCT01173718|75808933|FG000|Overall Study|Death|17|||
42000427|NCT01173718|75808933|FG000|Overall Study|Abandonment of study graft|27|||
42000428|NCT01111240|75808937|FG000|Overall Study|Adverse Event|190|||
42134737|NCT00406653|75945530|FG001|Maintenance Period|Error in disease score evaluation|0|||
42265912|NCT03142191|76093974|FG001|Placebo Controlled Period|Other Reasons|0|||
42265913|NCT03142191|76093975|FG002|Placebo Controlled Period|Other Reasons|0|||
42265914|NCT03142191|76093976|FG003|Placebo Controlled Period|Other Reasons|0|||
42265915|NCT03142191|76093977|FG004|Placebo Controlled Period|Other Reasons|0|||
42265916|NCT03142191|76093973|FG000|Active Treatment Extension Period|Death|2|||
42265917|NCT03142191|76093974|FG001|Active Treatment Extension Period|Death|1|||
42265918|NCT03142191|76093975|FG002|Active Treatment Extension Period|Death|1|||
42265919|NCT03142191|76093976|FG003|Active Treatment Extension Period|Death|1|||
42337426|NCT02116205|76175241|FG000|Overall Study|Withdrawal by Subject|2|||
42337427|NCT02116205|76175242|FG001|Overall Study|Withdrawal by Subject|4|||
42337428|NCT02116205|76175243|FG002|Overall Study|Withdrawal by Subject|1|||
42337429|NCT02116205|76175244|FG003|Overall Study|Withdrawal by Subject|3|||
42337430|NCT02116205|76175241|FG000|Overall Study|Lost to Follow-up|0|||
42337431|NCT02116205|76175242|FG001|Overall Study|Lost to Follow-up|2|||
42337432|NCT02116205|76175243|FG002|Overall Study|Lost to Follow-up|1|||
42337433|NCT02116205|76175244|FG003|Overall Study|Lost to Follow-up|2|||
42337434|NCT02116205|76175241|FG000|Overall Study|Physician Decision|0|||
42337435|NCT02116205|76175242|FG001|Overall Study|Physician Decision|1|||
42034797|NCT01040130|75843015|FG002|Overall Study|Adverse Event|0|||
42034798|NCT01040130|75843016|FG003|Overall Study|Adverse Event|5|||
42034799|NCT01040130|75843017|FG004|Overall Study|Adverse Event|0|||
42034800|NCT01040130|75843018|FG005|Overall Study|Adverse Event|3|||
42034801|NCT01040130|75843013|FG000|Overall Study|Protocol Violation|0|||
42034802|NCT01040130|75843014|FG001|Overall Study|Protocol Violation|0|||
42034803|NCT01040130|75843015|FG002|Overall Study|Protocol Violation|2|||
42034804|NCT01040130|75843016|FG003|Overall Study|Protocol Violation|0|||
42034805|NCT01040130|75843017|FG004|Overall Study|Protocol Violation|0|||
42034806|NCT01040130|75843018|FG005|Overall Study|Protocol Violation|0|||
42034807|NCT01040130|75843013|FG000|Overall Study|Withdrawal by Subject|0|||
42134738|NCT00406653|75945531|FG002|Maintenance Period|Error in disease score evaluation|0|||
42134739|NCT00406653|75945532|FG003|Maintenance Period|Error in disease score evaluation|0|||
42134740|NCT00406653|75945533|FG004|Maintenance Period|Error in disease score evaluation|1|||
42134741|NCT00406653|75945534|FG005|Maintenance Period|Error in disease score evaluation|0|||
42134742|NCT00406653|75945535|FG006|Maintenance Period|Error in disease score evaluation|0|||
42265920|NCT03142191|76093977|FG004|Active Treatment Extension Period|Death|0|||
42265921|NCT03142191|76093973|FG000|Active Treatment Extension Period|Adverse Event|6|||
42265922|NCT03142191|76093974|FG001|Active Treatment Extension Period|Adverse Event|5|||
42265923|NCT03142191|76093975|FG002|Active Treatment Extension Period|Adverse Event|4|||
42265924|NCT03142191|76093976|FG003|Active Treatment Extension Period|Adverse Event|1|||
42265925|NCT03142191|76093977|FG004|Active Treatment Extension Period|Adverse Event|0|||
42265926|NCT03142191|76093973|FG000|Active Treatment Extension Period|Progressive Disease|10|||
42265927|NCT03142191|76093974|FG001|Active Treatment Extension Period|Progressive Disease|5|||
42265928|NCT03142191|76093975|FG002|Active Treatment Extension Period|Progressive Disease|4|||
42265929|NCT03142191|76093976|FG003|Active Treatment Extension Period|Progressive Disease|1|||
42265930|NCT03142191|76093977|FG004|Active Treatment Extension Period|Progressive Disease|2|||
42265931|NCT03142191|76093973|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
42265932|NCT03142191|76093974|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
42265933|NCT03142191|76093975|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
42265934|NCT03142191|76093976|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
42265935|NCT03142191|76093977|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
42265936|NCT03142191|76093973|FG000|Active Treatment Extension Period|Physician Decision|2|||
42265937|NCT03142191|76093974|FG001|Active Treatment Extension Period|Physician Decision|0|||
42265938|NCT03142191|76093975|FG002|Active Treatment Extension Period|Physician Decision|0|||
42265939|NCT03142191|76093976|FG003|Active Treatment Extension Period|Physician Decision|0|||
42265940|NCT03142191|76093977|FG004|Active Treatment Extension Period|Physician Decision|0|||
42265941|NCT03142191|76093973|FG000|Active Treatment Extension Period|Other Reasons|3|||
42265942|NCT03142191|76093974|FG001|Active Treatment Extension Period|Other Reasons|3|||
42265943|NCT03142191|76093975|FG002|Active Treatment Extension Period|Other Reasons|3|||
42265944|NCT03142191|76093976|FG003|Active Treatment Extension Period|Other Reasons|8|||
42265945|NCT03142191|76093977|FG004|Active Treatment Extension Period|Other Reasons|3|||
42265946|NCT03142191|76093973|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
42265947|NCT03142191|76093974|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
42265948|NCT03142191|76093975|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
42265949|NCT03142191|76093976|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
42265950|NCT03142191|76093977|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
42265951|NCT02617628|76094006|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
42265952|NCT02617628|76094007|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
42265953|NCT02308540|76094023|FG000|Overall Study|Lost to Follow-up|0|||
42265954|NCT02308540|76094024|FG001|Overall Study|Lost to Follow-up|0|||
42265955|NCT02308540|76094025|FG002|Overall Study|Lost to Follow-up|0|||
42265956|NCT02308540|76094026|FG003|Overall Study|Lost to Follow-up|0|||
42265957|NCT02308540|76094027|FG004|Overall Study|Lost to Follow-up|0|||
42265958|NCT02308540|76094028|FG005|Overall Study|Lost to Follow-up|1|||
42265959|NCT02308228|76094079|FG000|Overall Study|Adverse Event|3|||
42265960|NCT02308228|76094080|FG001|Overall Study|Adverse Event|4|||
42265961|NCT02308228|76094079|FG000|Overall Study|Withdrawal by Subject|5|||
42265962|NCT02308228|76094080|FG001|Overall Study|Withdrawal by Subject|3|||
42265963|NCT02616614|76094098|FG000|Overall Study|Withdrawal by Subject|10|||
42337436|NCT02116205|76175243|FG002|Overall Study|Physician Decision|1|||
42337437|NCT02116205|76175244|FG003|Overall Study|Physician Decision|1|||
42034808|NCT01040130|75843014|FG001|Overall Study|Withdrawal by Subject|2|||
42337438|NCT02116205|76175241|FG000|Overall Study|Exclusion criteria|0|||
42337439|NCT02116205|76175242|FG001|Overall Study|Exclusion criteria|0|||
42337440|NCT02116205|76175243|FG002|Overall Study|Exclusion criteria|1|||
42337441|NCT02116205|76175244|FG003|Overall Study|Exclusion criteria|0|||
42337442|NCT01844583|76175256|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
42000429|NCT01111240|75808937|FG000|Overall Study|Lack of Efficacy|545|||
42337443|NCT01844583|76175257|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
42337444|NCT02115815|76175275|FG000|Overall Study|Withdrawal by Subject|2|||
42000430|NCT01111240|75808937|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
42337445|NCT02115815|76175276|FG001|Overall Study|Withdrawal by Subject|0|||
42000431|NCT01111240|75808937|FG000|Overall Study|Other|312|||
42000432|NCT01111123|75808943|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
42134743|NCT00406653|75945529|FG000|Open-Label Period|Death|0|||
42134744|NCT00406653|75945530|FG001|Open-Label Period|Death|0|||
42134745|NCT00406653|75945531|FG002|Open-Label Period|Death|0|||
42134746|NCT00406653|75945532|FG003|Open-Label Period|Death|0|||
42134747|NCT00406653|75945533|FG004|Open-Label Period|Death|0|||
42134748|NCT00406653|75945534|FG005|Open-Label Period|Death|0|||
42134749|NCT00406653|75945535|FG006|Open-Label Period|Death|1|||
42134750|NCT00406653|75945529|FG000|Open-Label Period|Adverse Event|0|||
42134751|NCT00406653|75945530|FG001|Open-Label Period|Adverse Event|0|||
42134752|NCT00406653|75945531|FG002|Open-Label Period|Adverse Event|0|||
42134753|NCT00406653|75945532|FG003|Open-Label Period|Adverse Event|0|||
42134754|NCT00406653|75945533|FG004|Open-Label Period|Adverse Event|0|||
42134755|NCT00406653|75945534|FG005|Open-Label Period|Adverse Event|0|||
42134756|NCT00406653|75945535|FG006|Open-Label Period|Adverse Event|18|||
42134757|NCT00406653|75945529|FG000|Open-Label Period|Lack of Efficacy|0|||
42134758|NCT00406653|75945530|FG001|Open-Label Period|Lack of Efficacy|0|||
42134759|NCT00406653|75945531|FG002|Open-Label Period|Lack of Efficacy|0|||
42134760|NCT00406653|75945532|FG003|Open-Label Period|Lack of Efficacy|0|||
42134761|NCT00406653|75945533|FG004|Open-Label Period|Lack of Efficacy|0|||
42134762|NCT00406653|75945534|FG005|Open-Label Period|Lack of Efficacy|0|||
42134763|NCT00406653|75945535|FG006|Open-Label Period|Lack of Efficacy|160|||
42134764|NCT00406653|75945529|FG000|Open-Label Period|Lost to Follow-up|0|||
42134765|NCT00406653|75945530|FG001|Open-Label Period|Lost to Follow-up|0|||
42134766|NCT00406653|75945531|FG002|Open-Label Period|Lost to Follow-up|0|||
42134767|NCT00406653|75945532|FG003|Open-Label Period|Lost to Follow-up|0|||
42134768|NCT00406653|75945533|FG004|Open-Label Period|Lost to Follow-up|0|||
42134769|NCT00406653|75945534|FG005|Open-Label Period|Lost to Follow-up|0|||
42134770|NCT00406653|75945535|FG006|Open-Label Period|Lost to Follow-up|6|||
42134771|NCT00406653|75945529|FG000|Open-Label Period|Withdrawal of Consent|0|||
42134772|NCT00406653|75945530|FG001|Open-Label Period|Withdrawal of Consent|0|||
42134773|NCT00406653|75945531|FG002|Open-Label Period|Withdrawal of Consent|0|||
42134774|NCT00406653|75945532|FG003|Open-Label Period|Withdrawal of Consent|0|||
42134775|NCT00406653|75945533|FG004|Open-Label Period|Withdrawal of Consent|0|||
42337446|NCT02115815|76175277|FG002|Overall Study|Withdrawal by Subject|0|||
42337447|NCT02115815|76175278|FG003|Overall Study|Withdrawal by Subject|0|||
42337448|NCT02115815|76175279|FG004|Overall Study|Withdrawal by Subject|0|||
42337449|NCT02115815|76175280|FG005|Overall Study|Withdrawal by Subject|0|||
42337450|NCT02115815|76175281|FG006|Overall Study|Withdrawal by Subject|0|||
42337451|NCT02115815|76175275|FG000|Overall Study|Not enough drug to dose participant|0|||
42337452|NCT02115815|76175276|FG001|Overall Study|Not enough drug to dose participant|0|||
42337453|NCT02115815|76175277|FG002|Overall Study|Not enough drug to dose participant|0|||
42337454|NCT02115815|76175278|FG003|Overall Study|Not enough drug to dose participant|0|||
42000433|NCT01111123|75808944|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
42000434|NCT01111123|75808943|FG000|Maintenance Phase|Lost to Follow-up|0|||
42000435|NCT01111123|75808944|FG001|Maintenance Phase|Lost to Follow-up|2|||
42000436|NCT01173679|75808952|FG000|Overall Study|Death|1|||
42000437|NCT01110382|75808959|FG000|Overall Study|Withdrawal by Subject|0|||
42000438|NCT01110382|75808960|FG001|Overall Study|Withdrawal by Subject|1|||
42000439|NCT01110382|75808959|FG000|Overall Study|Protocol Violation|0|||
42000440|NCT01110382|75808960|FG001|Overall Study|Protocol Violation|1|||
42000441|NCT01173601|75808970|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
42000442|NCT01173601|75808971|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
42000443|NCT01173601|75808972|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
42000444|NCT01173601|75808973|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
42000445|NCT01173601|75808974|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
42000446|NCT01173601|75808970|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
42000447|NCT01173601|75808971|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
42034809|NCT01040130|75843015|FG002|Overall Study|Withdrawal by Subject|0|||
42134776|NCT00406653|75945534|FG005|Open-Label Period|Withdrawal of Consent|0|||
42134777|NCT00406653|75945535|FG006|Open-Label Period|Withdrawal of Consent|11|||
42134778|NCT00406653|75945529|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
42000448|NCT01173601|75808972|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
42000449|NCT01173601|75808973|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
42134779|NCT00406653|75945530|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
42134780|NCT00406653|75945531|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
42134781|NCT00406653|75945532|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
42134782|NCT00406653|75945533|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
42134783|NCT00406653|75945534|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
42134784|NCT00406653|75945535|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
42134785|NCT00406653|75945529|FG000|Open-Label Period|Pregnancy|0|||
42134786|NCT00406653|75945530|FG001|Open-Label Period|Pregnancy|0|||
42134787|NCT00406653|75945531|FG002|Open-Label Period|Pregnancy|0|||
42134788|NCT00406653|75945532|FG003|Open-Label Period|Pregnancy|0|||
42134789|NCT00406653|75945533|FG004|Open-Label Period|Pregnancy|0|||
42134790|NCT00406653|75945534|FG005|Open-Label Period|Pregnancy|0|||
42134791|NCT00406653|75945535|FG006|Open-Label Period|Pregnancy|2|||
42134792|NCT00406653|75945529|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
42134793|NCT00406653|75945530|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
42134794|NCT00406653|75945531|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
42134795|NCT00406653|75945532|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
42134796|NCT00406653|75945533|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
42134797|NCT00406653|75945534|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
42134798|NCT00406653|75945535|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
42134799|NCT00406653|75945529|FG000|Open-Label Period|Declined participation but followup done|0|||
42134800|NCT00406653|75945530|FG001|Open-Label Period|Declined participation but followup done|0|||
42134801|NCT00406653|75945531|FG002|Open-Label Period|Declined participation but followup done|0|||
42134802|NCT00406653|75945532|FG003|Open-Label Period|Declined participation but followup done|0|||
42134803|NCT00406653|75945533|FG004|Open-Label Period|Declined participation but followup done|0|||
42134804|NCT00406653|75945534|FG005|Open-Label Period|Declined participation but followup done|0|||
42134805|NCT00406653|75945535|FG006|Open-Label Period|Declined participation but followup done|8|||
42134806|NCT00406653|75945529|FG000|Open-Label Period|Discontinued by Sponsor|0|||
42134807|NCT00406653|75945530|FG001|Open-Label Period|Discontinued by Sponsor|0|||
42134808|NCT00406653|75945531|FG002|Open-Label Period|Discontinued by Sponsor|0|||
42134809|NCT00406653|75945532|FG003|Open-Label Period|Discontinued by Sponsor|0|||
42134810|NCT00406653|75945533|FG004|Open-Label Period|Discontinued by Sponsor|0|||
42134811|NCT00406653|75945534|FG005|Open-Label Period|Discontinued by Sponsor|0|||
42134812|NCT00406653|75945535|FG006|Open-Label Period|Discontinued by Sponsor|1|||
42134813|NCT00406653|75945529|FG000|Open-Label Period|Refused followup|0|||
42134814|NCT00406653|75945530|FG001|Open-Label Period|Refused followup|0|||
42134815|NCT00406653|75945531|FG002|Open-Label Period|Refused followup|0|||
42134816|NCT00406653|75945532|FG003|Open-Label Period|Refused followup|0|||
42134817|NCT00406653|75945533|FG004|Open-Label Period|Refused followup|0|||
42134818|NCT00406653|75945534|FG005|Open-Label Period|Refused followup|0|||
42134819|NCT00406653|75945535|FG006|Open-Label Period|Refused followup|1|||
42134820|NCT00547157|75945557|FG000|Overall Study|Other|1|||
42134821|NCT00547157|75945558|FG001|Overall Study|Other|0|||
42134822|NCT00547157|75945557|FG000|Overall Study|Death|38|||
42034810|NCT01040130|75843016|FG003|Overall Study|Withdrawal by Subject|0|||
42034811|NCT01040130|75843017|FG004|Overall Study|Withdrawal by Subject|0|||
42337455|NCT02115815|76175279|FG004|Overall Study|Not enough drug to dose participant|0|||
42134823|NCT00547157|75945558|FG001|Overall Study|Death|18|||
42134824|NCT00547157|75945557|FG000|Overall Study|Withdrawal by Subject|3|||
42134825|NCT00547157|75945558|FG001|Overall Study|Withdrawal by Subject|1|||
42134826|NCT00547157|75945557|FG000|Overall Study|Administrative decision|3|||
42265964|NCT02616614|76094099|FG001|Overall Study|Withdrawal by Subject|5|||
42265965|NCT02616614|76094100|FG002|Overall Study|Withdrawal by Subject|6|||
42265966|NCT02616614|76094098|FG000|Overall Study|Physician Decision|2|||
42265967|NCT02616614|76094099|FG001|Overall Study|Physician Decision|1|||
42265968|NCT02616614|76094100|FG002|Overall Study|Physician Decision|0|||
42265969|NCT02616614|76094098|FG000|Overall Study|Adverse Event|1|||
42265970|NCT02616614|76094099|FG001|Overall Study|Adverse Event|4|||
42265971|NCT02616614|76094100|FG002|Overall Study|Adverse Event|1|||
42265972|NCT02616614|76094098|FG000|Overall Study|Protocol Violation|0|||
42265973|NCT02616614|76094099|FG001|Overall Study|Protocol Violation|3|||
42265974|NCT02616614|76094100|FG002|Overall Study|Protocol Violation|1|||
42265975|NCT02616614|76094098|FG000|Overall Study|Prohibited Medication|12|||
42265976|NCT02616614|76094099|FG001|Overall Study|Prohibited Medication|9|||
42265977|NCT02616614|76094100|FG002|Overall Study|Prohibited Medication|5|||
42265978|NCT02616614|76094098|FG000|Overall Study|More than 3 applications missed|6|||
42337456|NCT02115815|76175280|FG005|Overall Study|Not enough drug to dose participant|1|||
42337457|NCT02115815|76175281|FG006|Overall Study|Not enough drug to dose participant|0|||
42337458|NCT02115815|76175275|FG000|Overall Study|Missed appointment, randomized in error|0|||
42134827|NCT00547157|75945558|FG001|Overall Study|Administrative decision|2|||
42134828|NCT00547157|75945557|FG000|Overall Study|Lost to Follow-up|4|||
42265979|NCT02616614|76094099|FG001|Overall Study|More than 3 applications missed|8|||
42265980|NCT02616614|76094100|FG002|Overall Study|More than 3 applications missed|1|||
42265981|NCT02616614|76094098|FG000|Overall Study|Lost to Follow-up|31|||
42134829|NCT00547157|75945558|FG001|Overall Study|Lost to Follow-up|2|||
42134830|NCT00384033|75945568|FG000|Overall Study|Adverse Event|10|||
42134831|NCT00384033|75945569|FG001|Overall Study|Adverse Event|8|||
42134832|NCT00384033|75945570|FG002|Overall Study|Adverse Event|11|||
42134833|NCT00384033|75945571|FG003|Overall Study|Adverse Event|20|||
42134834|NCT00384033|75945568|FG000|Overall Study|Failed to return|1|||
42134835|NCT00384033|75945569|FG001|Overall Study|Failed to return|3|||
42134836|NCT00384033|75945570|FG002|Overall Study|Failed to return|2|||
42134837|NCT00384033|75945571|FG003|Overall Study|Failed to return|2|||
42134838|NCT00384033|75945568|FG000|Overall Study|Physician Decision|1|||
42134839|NCT00384033|75945569|FG001|Overall Study|Physician Decision|0|||
42134840|NCT00384033|75945570|FG002|Overall Study|Physician Decision|0|||
42134841|NCT00384033|75945571|FG003|Overall Study|Physician Decision|0|||
42134842|NCT00384033|75945568|FG000|Overall Study|Lost to Follow-up|6|||
42134843|NCT00384033|75945569|FG001|Overall Study|Lost to Follow-up|12|||
42134844|NCT00384033|75945570|FG002|Overall Study|Lost to Follow-up|7|||
42134845|NCT00384033|75945571|FG003|Overall Study|Lost to Follow-up|7|||
42134846|NCT00384033|75945568|FG000|Overall Study|Other|2|||
42134847|NCT00384033|75945569|FG001|Overall Study|Other|0|||
42134848|NCT00384033|75945570|FG002|Overall Study|Other|0|||
42134849|NCT00384033|75945571|FG003|Overall Study|Other|0|||
42134850|NCT00384033|75945568|FG000|Overall Study|Protocol Violation|5|||
42134851|NCT00384033|75945569|FG001|Overall Study|Protocol Violation|0|||
42134852|NCT00384033|75945570|FG002|Overall Study|Protocol Violation|5|||
42134853|NCT00384033|75945571|FG003|Overall Study|Protocol Violation|6|||
42134854|NCT00384033|75945568|FG000|Overall Study|Withdrawal by Subject|6|||
42134855|NCT00384033|75945569|FG001|Overall Study|Withdrawal by Subject|2|||
42134856|NCT00384033|75945570|FG002|Overall Study|Withdrawal by Subject|5|||
42134857|NCT00384033|75945571|FG003|Overall Study|Withdrawal by Subject|2|||
42134858|NCT00384033|75945568|FG000|Overall Study|Lack of Efficacy|7|||
42134859|NCT00384033|75945569|FG001|Overall Study|Lack of Efficacy|3|||
42134860|NCT00384033|75945570|FG002|Overall Study|Lack of Efficacy|3|||
42134861|NCT00384033|75945571|FG003|Overall Study|Lack of Efficacy|1|||
42134862|NCT00384033|75945568|FG000|Overall Study|Randomized but not treated|3|||
42134863|NCT00384033|75945569|FG001|Overall Study|Randomized but not treated|7|||
42134864|NCT00384033|75945570|FG002|Overall Study|Randomized but not treated|10|||
42134865|NCT00384033|75945571|FG003|Overall Study|Randomized but not treated|2|||
42134866|NCT00546377|75945581|FG000|Overall Study|Deemed ineligible|1|||
42134867|NCT00546377|75945581|FG000|Overall Study|Adverse Event|6|||
42134868|NCT00545753|75945588|FG000|Overall Study|Withdrawal by Subject|0|||
42134869|NCT00545753|75945589|FG001|Overall Study|Withdrawal by Subject|1|||
42134870|NCT00545753|75945590|FG002|Overall Study|Withdrawal by Subject|10|||
42134871|NCT00545753|75945588|FG000|Overall Study|Lost to Follow-up|13|||
42134872|NCT00545753|75945589|FG001|Overall Study|Lost to Follow-up|3|||
42134873|NCT00545753|75945590|FG002|Overall Study|Lost to Follow-up|12|||
42134874|NCT00545753|75945588|FG000|Overall Study|Protocol Violation|3|||
42134875|NCT00545753|75945589|FG001|Overall Study|Protocol Violation|1|||
42134876|NCT00545753|75945590|FG002|Overall Study|Protocol Violation|4|||
42134877|NCT00406419|75945602|FG000|Overall Study|Death|3|||
42134878|NCT00406419|75945603|FG001|Overall Study|Death|1|||
42134879|NCT00406419|75945604|FG002|Overall Study|Death|4|||
42134880|NCT00406419|75945602|FG000|Overall Study|Protocol Violation|6|||
42134881|NCT00406419|75945603|FG001|Overall Study|Protocol Violation|2|||
42134882|NCT00406419|75945604|FG002|Overall Study|Protocol Violation|5|||
42134883|NCT00406419|75945602|FG000|Overall Study|Study Terminated by Sponsor|260|||
42134884|NCT00406419|75945603|FG001|Overall Study|Study Terminated by Sponsor|288|||
42134885|NCT00406419|75945604|FG002|Overall Study|Study Terminated by Sponsor|282|||
42134886|NCT00406419|75945602|FG000|Overall Study|Withdrawal by Subject|17|||
42134887|NCT00406419|75945603|FG001|Overall Study|Withdrawal by Subject|24|||
42134888|NCT00406419|75945604|FG002|Overall Study|Withdrawal by Subject|26|||
42134889|NCT00406419|75945602|FG000|Overall Study|Lack of Efficacy|12|||
42134890|NCT00406419|75945603|FG001|Overall Study|Lack of Efficacy|1|||
42134891|NCT00406419|75945604|FG002|Overall Study|Lack of Efficacy|6|||
42134892|NCT00406419|75945602|FG000|Overall Study|Non-Compliance with Study Drug|5|||
42337459|NCT02115815|76175276|FG001|Overall Study|Missed appointment, randomized in error|0|||
42134893|NCT00406419|75945603|FG001|Overall Study|Non-Compliance with Study Drug|6|||
42134894|NCT00406419|75945604|FG002|Overall Study|Non-Compliance with Study Drug|3|||
42134895|NCT00406419|75945602|FG000|Overall Study|Adverse Event|10|||
42134896|NCT00406419|75945603|FG001|Overall Study|Adverse Event|12|||
42134897|NCT00406419|75945604|FG002|Overall Study|Adverse Event|16|||
42134898|NCT00406419|75945602|FG000|Overall Study|Lost to Follow-up|11|||
42134899|NCT00406419|75945603|FG001|Overall Study|Lost to Follow-up|10|||
42134900|NCT00406419|75945604|FG002|Overall Study|Lost to Follow-up|5|||
42134901|NCT00325468|75945617|FG000|Overall Study|Adverse Event|1|||
42134902|NCT00325468|75945618|FG001|Overall Study|Adverse Event|1|||
42134903|NCT00325468|75945619|FG002|Overall Study|Adverse Event|0|||
42134904|NCT00325468|75945620|FG003|Overall Study|Adverse Event|5|||
42134905|NCT00325468|75945621|FG004|Overall Study|Adverse Event|1|||
42134906|NCT00325468|75945617|FG000|Overall Study|Death|2|||
42134907|NCT00325468|75945618|FG001|Overall Study|Death|0|||
42134908|NCT00325468|75945619|FG002|Overall Study|Death|2|||
42134909|NCT00325468|75945620|FG003|Overall Study|Death|4|||
42134910|NCT00325468|75945621|FG004|Overall Study|Death|0|||
42134911|NCT00325468|75945617|FG000|Overall Study|Lost to Follow-up|0|||
42134912|NCT00325468|75945618|FG001|Overall Study|Lost to Follow-up|0|||
42134913|NCT00325468|75945619|FG002|Overall Study|Lost to Follow-up|1|||
42134914|NCT00325468|75945620|FG003|Overall Study|Lost to Follow-up|2|||
42134915|NCT00325468|75945621|FG004|Overall Study|Lost to Follow-up|2|||
42134916|NCT00325468|75945617|FG000|Overall Study|Physician Decision|1|||
42134917|NCT00325468|75945618|FG001|Overall Study|Physician Decision|1|||
42134918|NCT00325468|75945619|FG002|Overall Study|Physician Decision|0|||
42134919|NCT00325468|75945620|FG003|Overall Study|Physician Decision|1|||
42134920|NCT00325468|75945621|FG004|Overall Study|Physician Decision|0|||
42134921|NCT00325468|75945617|FG000|Overall Study|Withdrawal by Subject|3|||
42134922|NCT00325468|75945618|FG001|Overall Study|Withdrawal by Subject|1|||
42134923|NCT00325468|75945619|FG002|Overall Study|Withdrawal by Subject|0|||
42134924|NCT00325468|75945620|FG003|Overall Study|Withdrawal by Subject|14|||
42134925|NCT00325468|75945621|FG004|Overall Study|Withdrawal by Subject|4|||
42134926|NCT00325468|75945617|FG000|Overall Study|site closure etc|4|||
42134927|NCT00325468|75945618|FG001|Overall Study|site closure etc|2|||
42134928|NCT00325468|75945619|FG002|Overall Study|site closure etc|1|||
42134929|NCT00325468|75945620|FG003|Overall Study|site closure etc|8|||
42134930|NCT00325468|75945621|FG004|Overall Study|site closure etc|1|||
42134931|NCT00311584|75945636|FG000|Overall Study|Death|1|||
42134932|NCT00311584|75945637|FG001|Overall Study|Death|0|||
42134933|NCT00311584|75945636|FG000|Overall Study|Lack of Efficacy|12|||
42134934|NCT00311584|75945637|FG001|Overall Study|Lack of Efficacy|15|||
42134935|NCT00311584|75945636|FG000|Overall Study|Physician Decision|4|||
42134936|NCT00311584|75945637|FG001|Overall Study|Physician Decision|5|||
42134937|NCT00311584|75945636|FG000|Overall Study|Withdrawal by Subject|1|||
42134938|NCT00311584|75945637|FG001|Overall Study|Withdrawal by Subject|1|||
42134939|NCT00311584|75945636|FG000|Overall Study|ineligible|2|||
42134940|NCT00311584|75945637|FG001|Overall Study|ineligible|2|||
42134941|NCT00383331|75945645|FG000|Overall Study|Protocol Violation|0|||
42134942|NCT00383331|75945646|FG001|Overall Study|Protocol Violation|1|||
42134943|NCT03934541|75945656|FG000|Overall Study|Study Terminated by Sponsor|0|||
42134944|NCT03934541|75945657|FG001|Overall Study|Study Terminated by Sponsor|1|||
42134945|NCT03934541|75945658|FG002|Overall Study|Study Terminated by Sponsor|0|||
42134946|NCT03934541|75945659|FG003|Overall Study|Study Terminated by Sponsor|0|||
42134947|NCT00325234|75945671|FG000|Overall Study|Adverse Event|10|||
42134948|NCT00325234|75945672|FG001|Overall Study|Adverse Event|7|||
42134949|NCT00325234|75945671|FG000|Overall Study|Death due to Study Disease|1|||
42134950|NCT00325234|75945672|FG001|Overall Study|Death due to Study Disease|0|||
42134951|NCT00325234|75945671|FG000|Overall Study|Entry Criteria Not Met|1|||
42134952|NCT00325234|75945672|FG001|Overall Study|Entry Criteria Not Met|2|||
42134953|NCT00325234|75945671|FG000|Overall Study|Subject Decision|6|||
42134954|NCT00325234|75945672|FG001|Overall Study|Subject Decision|8|||
42134955|NCT00325234|75945671|FG000|Overall Study|Physician Decision|17|||
42134956|NCT00325234|75945672|FG001|Overall Study|Physician Decision|12|||
42134957|NCT00325234|75945671|FG000|Overall Study|Progressive Disease|34|||
42134958|NCT00325234|75945672|FG001|Overall Study|Progressive Disease|37|||
42134959|NCT00366249|75945682|FG000|Overall Study|Adverse Event|53|||
42134960|NCT00366249|75945683|FG001|Overall Study|Adverse Event|28|||
42134961|NCT00366249|75945682|FG000|Overall Study|Death|0|||
42134962|NCT00366249|75945683|FG001|Overall Study|Death|1|||
42134963|NCT00366249|75945682|FG000|Overall Study|Physician Decision|5|||
42134964|NCT00366249|75945683|FG001|Overall Study|Physician Decision|2|||
42134965|NCT00366249|75945682|FG000|Overall Study|Lost to Follow-up|2|||
42134966|NCT00366249|75945683|FG001|Overall Study|Lost to Follow-up|0|||
42134967|NCT00366249|75945682|FG000|Overall Study|Protocol Violation|1|||
42265982|NCT02616614|76094099|FG001|Overall Study|Lost to Follow-up|28|||
42265983|NCT02616614|76094100|FG002|Overall Study|Lost to Follow-up|13|||
42265984|NCT02616614|76094098|FG000|Overall Study|Pregnancy|2|||
42265985|NCT02616614|76094099|FG001|Overall Study|Pregnancy|0|||
42265986|NCT02616614|76094100|FG002|Overall Study|Pregnancy|1|||
42134968|NCT00366249|75945683|FG001|Overall Study|Protocol Violation|2|||
42265987|NCT02616614|76094098|FG000|Overall Study|Other|1|||
42134969|NCT00366249|75945682|FG000|Overall Study|Withdrawal by Subject|18|||
42134970|NCT00366249|75945683|FG001|Overall Study|Withdrawal by Subject|4|||
42134971|NCT00366249|75945682|FG000|Overall Study|Lack of Efficacy|21|||
42134972|NCT00366249|75945683|FG001|Overall Study|Lack of Efficacy|21|||
42134973|NCT00366249|75945682|FG000|Overall Study|Most due to osteomylitis status|31|||
42134974|NCT00366249|75945683|FG001|Overall Study|Most due to osteomylitis status|20|||
42134975|NCT00325156|75945689|FG000|Overall Study|Protocol Violation|8|||
42134976|NCT00325156|75945689|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
42134977|NCT00325156|75945689|FG000|Overall Study|Migrated/moved from study area|12|||
42134978|NCT00325156|75945689|FG000|Overall Study|Adverse event, non-fatal|3|||
42134979|NCT00325156|75945689|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
42134980|NCT00325156|75945689|FG000|Overall Study|Other|1|||
42265988|NCT02616614|76094099|FG001|Overall Study|Other|2|||
42134981|NCT00325156|75945689|FG000|Overall Study|Withdrawal by Subject|31|||
42134982|NCT03927911|75945699|FG000|Overall Study|problems with eDiary|0|||
42134983|NCT03927911|75945700|FG001|Overall Study|problems with eDiary|1|||
42134984|NCT03927911|75945701|FG002|Overall Study|problems with eDiary|0|||
42134985|NCT03927911|75945702|FG003|Overall Study|problems with eDiary|1|||
42134986|NCT03927911|75945703|FG004|Overall Study|problems with eDiary|0|||
42134987|NCT03927911|75945704|FG005|Overall Study|problems with eDiary|4|||
42134988|NCT03927911|75945699|FG000|Overall Study|Adverse Event|0|||
42134989|NCT03927911|75945700|FG001|Overall Study|Adverse Event|0|||
42134990|NCT03927911|75945701|FG002|Overall Study|Adverse Event|0|||
42134991|NCT03927911|75945702|FG003|Overall Study|Adverse Event|0|||
42134992|NCT03927911|75945703|FG004|Overall Study|Adverse Event|0|||
42134993|NCT03927911|75945704|FG005|Overall Study|Adverse Event|1|||
42134994|NCT03927911|75945699|FG000|Overall Study|not treated -study terminated by sponsor|0|||
42134995|NCT03927911|75945700|FG001|Overall Study|not treated -study terminated by sponsor|1|||
42134996|NCT03927911|75945701|FG002|Overall Study|not treated -study terminated by sponsor|0|||
42134997|NCT03927911|75945702|FG003|Overall Study|not treated -study terminated by sponsor|0|||
42134998|NCT03927911|75945703|FG004|Overall Study|not treated -study terminated by sponsor|0|||
42134999|NCT03927911|75945704|FG005|Overall Study|not treated -study terminated by sponsor|0|||
42135000|NCT03927911|75945699|FG000|Overall Study|Surgery cancelled|0|||
42135001|NCT03927911|75945700|FG001|Overall Study|Surgery cancelled|0|||
42135002|NCT03927911|75945701|FG002|Overall Study|Surgery cancelled|0|||
42135003|NCT03927911|75945702|FG003|Overall Study|Surgery cancelled|1|||
42135004|NCT03927911|75945703|FG004|Overall Study|Surgery cancelled|0|||
42135005|NCT03927911|75945704|FG005|Overall Study|Surgery cancelled|1|||
42135006|NCT03927911|75945699|FG000|Overall Study|Protocol Violation|0|||
42135007|NCT03927911|75945700|FG001|Overall Study|Protocol Violation|0|||
42135008|NCT03927911|75945701|FG002|Overall Study|Protocol Violation|0|||
42135009|NCT03927911|75945702|FG003|Overall Study|Protocol Violation|0|||
42135010|NCT03927911|75945703|FG004|Overall Study|Protocol Violation|0|||
42135011|NCT03927911|75945704|FG005|Overall Study|Protocol Violation|1|||
42135012|NCT00383019|75945720|FG000|Overall Study|Adverse Event|5|||
42135013|NCT00383019|75945721|FG001|Overall Study|Adverse Event|1|||
42135014|NCT00383019|75945720|FG000|Overall Study|Withdrawal by Subject|0|||
42135015|NCT00383019|75945721|FG001|Overall Study|Withdrawal by Subject|1|||
42135016|NCT00310804|75945729|FG000|Overall Study|Lost to Follow-up|2|||
42135017|NCT00310804|75945730|FG001|Overall Study|Lost to Follow-up|0|||
42135018|NCT00310804|75945729|FG000|Overall Study|Withdrawal by Subject|3|||
42135019|NCT00310804|75945730|FG001|Overall Study|Withdrawal by Subject|0|||
42135020|NCT03826186|75945752|FG000|Overall Study|Protocol Violation|2|||
42135021|NCT03826186|75945753|FG001|Overall Study|Protocol Violation|0|||
42135022|NCT03826186|75945752|FG000|Overall Study|Withdrawal by Subject|1|||
42135023|NCT03826186|75945753|FG001|Overall Study|Withdrawal by Subject|0|||
42135024|NCT00382863|75945761|FG000|Overall Study|Death|9|||
42135025|NCT00382863|75945762|FG001|Overall Study|Death|9|||
42135026|NCT00382863|75945761|FG000|Overall Study|Lost to Follow-up|1|||
42265989|NCT02616614|76094100|FG002|Overall Study|Other|1|||
42265990|NCT02616380|76094126|FG000|Overall Study|Lost to Follow-up|1|||
42265991|NCT02616380|76094126|FG000|Overall Study|Other|2|||
42265992|NCT04436822|76094136|FG000|Overall Study|Physician Decision|2|||
42265993|NCT04436822|76094137|FG001|Overall Study|Physician Decision|0|||
42265994|NCT04436822|76094136|FG000|Overall Study|Sponsor request|1|||
42265995|NCT04436822|76094137|FG001|Overall Study|Sponsor request|0|||
42265996|NCT04436822|76094136|FG000|Overall Study|Withdrawal by parent/guardian|0|||
42000450|NCT01173601|75808974|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
42000451|NCT01173601|75808970|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
42000452|NCT01173601|75808971|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
42000453|NCT01173601|75808972|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
42000454|NCT01173601|75808973|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
42000455|NCT01173601|75808974|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
42000456|NCT01173601|75808970|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
42265997|NCT04436822|76094137|FG001|Overall Study|Withdrawal by parent/guardian|3|||
42265998|NCT04436822|76094136|FG000|Overall Study|Unsuccessful procedure|0|||
42000457|NCT01173601|75808971|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
42000458|NCT01173601|75808972|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
42000459|NCT01173601|75808973|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
42135027|NCT00382863|75945762|FG001|Overall Study|Lost to Follow-up|2|||
42135028|NCT00382863|75945761|FG000|Overall Study|Withdrawal by Subject|5|||
42135029|NCT00382863|75945762|FG001|Overall Study|Withdrawal by Subject|25|||
42135030|NCT03933449|75945770|FG000|Overall Study|Adverse Event|6|||
42135031|NCT03933449|75945771|FG001|Overall Study|Adverse Event|4|||
42135032|NCT03933449|75945770|FG000|Overall Study|Death|55|||
42135033|NCT03933449|75945771|FG001|Overall Study|Death|57|||
42135034|NCT03933449|75945770|FG000|Overall Study|Sponsor Decision|1|||
42000460|NCT01173601|75808974|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
42135035|NCT03933449|75945771|FG001|Overall Study|Sponsor Decision|0|||
42000461|NCT01173601|75808970|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
42000462|NCT01173601|75808971|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
42000463|NCT01173601|75808972|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
42135036|NCT00290758|75945794|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
42265999|NCT04436822|76094137|FG001|Overall Study|Unsuccessful procedure|1|||
42135037|NCT00290758|75945795|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
42135038|NCT00290758|75945794|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
42135039|NCT00290758|75945795|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
42135040|NCT00290758|75945794|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
42135041|NCT00290758|75945795|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
42135042|NCT00290758|75945794|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
42135043|NCT00290758|75945795|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
42135044|NCT00290758|75945794|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
42135045|NCT00290758|75945795|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
42135046|NCT00290758|75945794|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
42266000|NCT04436822|76094136|FG000|Overall Study|Withdrawal due to Covid-19|8|||
42266001|NCT04436822|76094137|FG001|Overall Study|Withdrawal due to Covid-19|1|||
42266002|NCT04436822|76094136|FG000|Overall Study|Withdrawal by Subject|1|||
42266003|NCT04436822|76094137|FG001|Overall Study|Withdrawal by Subject|0|||
42266004|NCT04436822|76094136|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
42337460|NCT02115815|76175277|FG002|Overall Study|Missed appointment, randomized in error|0|||
42337461|NCT02115815|76175278|FG003|Overall Study|Missed appointment, randomized in error|0|||
42337462|NCT02115815|76175279|FG004|Overall Study|Missed appointment, randomized in error|0|||
42337463|NCT02115815|76175280|FG005|Overall Study|Missed appointment, randomized in error|1|||
42337464|NCT02115815|76175281|FG006|Overall Study|Missed appointment, randomized in error|0|||
42337465|NCT02115269|76175297|FG000|Overall Study|Lost to Follow-up|43|||
42337466|NCT02115269|76175297|FG000|Overall Study|Did not complete patient diary|3|||
42337467|NCT02115269|76175297|FG000|Overall Study|Moved to another city|7|||
42337468|NCT02115269|76175297|FG000|Overall Study|Withdrawal by Subject|2|||
42337469|NCT02115269|76175297|FG000|Overall Study|Didn't take study drug|2|||
42266005|NCT04436822|76094137|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
42000464|NCT01173601|75808973|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
42266006|NCT01596062|76094147|FG000|Overall Study|Adverse Event|1|||
42266007|NCT01596062|76094148|FG001|Overall Study|Adverse Event|0|||
42266008|NCT01596062|76094149|FG002|Overall Study|Adverse Event|2|||
42266009|NCT01596062|76094147|FG000|Overall Study|Lack of Efficacy|0|||
42266010|NCT01596062|76094148|FG001|Overall Study|Lack of Efficacy|0|||
42337470|NCT02115113|76175312|FG000|Participants in Run-in Period|Death|0|||
42337471|NCT02115113|76175313|FG001|Participants in Run-in Period|Death|0|||
42337472|NCT02115113|76175314|FG002|Participants in Run-in Period|Death|1|||
42000465|NCT01173601|75808974|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
42000466|NCT01173601|75808970|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
42266011|NCT01596062|76094149|FG002|Overall Study|Lack of Efficacy|1|||
42266012|NCT02614898|76094168|FG000|Overall Study|Participated until study termination|10|||
42337473|NCT02115113|76175312|FG000|Participants in Run-in Period|Administrative problems|0|||
42337474|NCT02115113|76175313|FG001|Participants in Run-in Period|Administrative problems|0|||
42337475|NCT02115113|76175314|FG002|Participants in Run-in Period|Administrative problems|1|||
42337476|NCT02115113|76175312|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
42337477|NCT02115113|76175313|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
42337478|NCT02115113|76175314|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
42337479|NCT02115113|76175312|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
42337480|NCT02115113|76175313|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
42337481|NCT02115113|76175314|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
42337482|NCT02115113|76175312|FG000|Participants Randomized|Lost to Follow-up|1|||
42337483|NCT02115113|76175313|FG001|Participants Randomized|Lost to Follow-up|0|||
42337484|NCT02115113|76175314|FG002|Participants Randomized|Lost to Follow-up|0|||
42337485|NCT02115113|76175312|FG000|Participants Randomized|Death|1|||
42337486|NCT02115113|76175313|FG001|Participants Randomized|Death|0|||
42337487|NCT02115113|76175314|FG002|Participants Randomized|Death|0|||
42337488|NCT02114879|76175325|FG000|Overall Study|Withdrawal by Subject|9|||
42337489|NCT02114879|76175326|FG001|Overall Study|Withdrawal by Subject|5|||
42337490|NCT02114879|76175325|FG000|Overall Study|Death|6|||
42337491|NCT02114879|76175326|FG001|Overall Study|Death|11|||
42337492|NCT02114879|76175325|FG000|Overall Study|Lost to Follow-up|4|||
42337493|NCT02114879|76175326|FG001|Overall Study|Lost to Follow-up|6|||
42337494|NCT02114879|76175325|FG000|Overall Study|Physician Decision|0|||
42337495|NCT02114879|76175326|FG001|Overall Study|Physician Decision|2|||
42337496|NCT02114177|76175334|FG000|Overall Study|Lost to Follow-up|1|||
42337497|NCT02114177|76175335|FG001|Overall Study|Lost to Follow-up|2|||
42337498|NCT02114177|76175334|FG000|Overall Study|Withdrawal by Subject|6|||
42337499|NCT02114177|76175335|FG001|Overall Study|Withdrawal by Subject|1|||
42000467|NCT01173601|75808971|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
42000468|NCT01173601|75808972|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
42000469|NCT01173601|75808973|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
42000470|NCT01173601|75808974|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
42000471|NCT01173601|75808970|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
42266013|NCT02614898|76094169|FG001|Overall Study|Participated until study termination|26|||
42266014|NCT02614898|76094168|FG000|Overall Study|Lost to Follow-up|0|||
42266015|NCT02614898|76094169|FG001|Overall Study|Lost to Follow-up|2|||
42266016|NCT02614898|76094168|FG000|Overall Study|Physician Decision|1|||
42266017|NCT02614898|76094169|FG001|Overall Study|Physician Decision|8|||
42266018|NCT02614898|76094168|FG000|Overall Study|Study Terminated by Sponsor|3|||
42266019|NCT02614898|76094169|FG001|Overall Study|Study Terminated by Sponsor|0|||
42266020|NCT02614898|76094168|FG000|Overall Study|Withdrawal by Subject|0|||
42266021|NCT02614898|76094169|FG001|Overall Study|Withdrawal by Subject|2|||
42337500|NCT02114177|76175334|FG000|Overall Study|Other|2|||
42337501|NCT02114177|76175335|FG001|Overall Study|Other|1|||
42337502|NCT02138825|76175343|FG000|Main Study Treatment|Adverse Event|11|||
42337503|NCT02138825|76175344|FG001|Main Study Treatment|Adverse Event|3|||
42337504|NCT02138825|76175343|FG000|Main Study Treatment|Death|1|||
42337505|NCT02138825|76175344|FG001|Main Study Treatment|Death|2|||
42337506|NCT02138825|76175343|FG000|Main Study Treatment|Protocol Violation|2|||
42337507|NCT02138825|76175344|FG001|Main Study Treatment|Protocol Violation|2|||
42337508|NCT02138825|76175343|FG000|Main Study Treatment|Sponsor decision|12|||
42337509|NCT02138825|76175344|FG001|Main Study Treatment|Sponsor decision|18|||
42337510|NCT02138825|76175343|FG000|Main Study Treatment|Study terminated by sponsor|10|||
42000472|NCT01173601|75808971|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
42266022|NCT02614898|76094168|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
42337511|NCT02138825|76175344|FG001|Main Study Treatment|Study terminated by sponsor|9|||
42337512|NCT02138825|76175343|FG000|Main Study Treatment|Withdrawal by Subject|3|||
42337513|NCT02138825|76175344|FG001|Main Study Treatment|Withdrawal by Subject|1|||
42337514|NCT02138825|76175343|FG000|Main Study Treatment|Medical decision|1|||
42337515|NCT02138825|76175344|FG001|Main Study Treatment|Medical decision|0|||
42337516|NCT02138825|76175343|FG000|Long-term Extension|Study termination by sponsor|32|||
42337517|NCT02138825|76175344|FG001|Long-term Extension|Study termination by sponsor|38|||
42337518|NCT02138825|76175343|FG000|Safety Follow-up|Adverse Event|4|||
42337519|NCT02138825|76175344|FG001|Safety Follow-up|Adverse Event|3|||
42337520|NCT02138825|76175343|FG000|Safety Follow-up|Death|11|||
42337521|NCT02138825|76175344|FG001|Safety Follow-up|Death|5|||
42337522|NCT02138825|76175343|FG000|Safety Follow-up|Withdrawal by Subject|5|||
42337523|NCT02138825|76175344|FG001|Safety Follow-up|Withdrawal by Subject|3|||
42337524|NCT02138825|76175343|FG000|Safety Follow-up|clinic worsening|1|||
42337525|NCT02138825|76175344|FG001|Safety Follow-up|clinic worsening|0|||
42337526|NCT02138825|76175343|FG000|Safety Follow-up|withdrawal by PI|1|||
42337527|NCT02138825|76175344|FG001|Safety Follow-up|withdrawal by PI|0|||
42337528|NCT02138825|76175343|FG000|Safety Follow-up|logistical difficulties|0|||
42337529|NCT02138825|76175344|FG001|Safety Follow-up|logistical difficulties|1|||
42337530|NCT02138825|76175343|FG000|Safety Follow-up|progressive disease|0|||
42337531|NCT02138825|76175344|FG001|Safety Follow-up|progressive disease|2|||
42337532|NCT02138825|76175343|FG000|Safety Follow-up|too unwell to attend the visit|0|||
42337533|NCT02138825|76175344|FG001|Safety Follow-up|too unwell to attend the visit|1|||
42337534|NCT02138825|76175343|FG000|Safety Follow-up|treatment unblinded|0|||
42337535|NCT02138825|76175344|FG001|Safety Follow-up|treatment unblinded|1|||
42337536|NCT02138825|76175343|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
42337537|NCT02138825|76175344|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
42000473|NCT01173601|75808972|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
42266023|NCT02614898|76094169|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
42266024|NCT02614898|76094168|FG000|Overall Study|Other-Additional Information Unavailable|0|||
42266025|NCT02614898|76094169|FG001|Overall Study|Other-Additional Information Unavailable|11|||
42266026|NCT02614898|76094168|FG000|Overall Study|Missing|0|||
42266027|NCT02614898|76094169|FG001|Overall Study|Missing|1|||
42266028|NCT02776033|76094189|FG000|Overall Study|Withdrawal by Subject|0|||
42266029|NCT02776033|76094190|FG001|Overall Study|Withdrawal by Subject|0|||
42266030|NCT02776033|76094191|FG002|Overall Study|Withdrawal by Subject|2|||
42266031|NCT02776033|76094189|FG000|Overall Study|Physician Decision|2|||
42266032|NCT02776033|76094190|FG001|Overall Study|Physician Decision|0|||
42266033|NCT02776033|76094191|FG002|Overall Study|Physician Decision|0|||
42266034|NCT02776033|76094189|FG000|Overall Study|Lost to Follow-up|1|||
42266035|NCT02776033|76094190|FG001|Overall Study|Lost to Follow-up|0|||
42266036|NCT02776033|76094191|FG002|Overall Study|Lost to Follow-up|0|||
42266037|NCT02776033|76094189|FG000|Overall Study|Adverse Event|1|||
42266038|NCT02776033|76094190|FG001|Overall Study|Adverse Event|2|||
42266039|NCT02776033|76094191|FG002|Overall Study|Adverse Event|0|||
42266040|NCT02777125|76094207|FG000|Overall Study|Consent form violation|14|||
42266041|NCT02777125|76094208|FG001|Overall Study|Consent form violation|12|||
42266042|NCT02777125|76094207|FG000|Overall Study|Assent form violation|21|||
42266043|NCT02777125|76094208|FG001|Overall Study|Assent form violation|23|||
42266044|NCT02777125|76094207|FG000|Overall Study|Protocol Violation|8|||
42266045|NCT02777125|76094208|FG001|Overall Study|Protocol Violation|12|||
42266046|NCT02769481|76094233|FG000|Overall Study|Protocol Violation|1|||
42266047|NCT02769481|76094234|FG001|Overall Study|Protocol Violation|0|||
42266048|NCT02769481|76094233|FG000|Overall Study|Adverse Event|3|||
42266049|NCT02769481|76094234|FG001|Overall Study|Adverse Event|6|||
42266050|NCT02769481|76094233|FG000|Overall Study|Entry Criteria Not Met|1|||
42266051|NCT02769481|76094234|FG001|Overall Study|Entry Criteria Not Met|2|||
42266052|NCT02769481|76094233|FG000|Overall Study|Withdrawal by Subject|14|||
42266053|NCT02769481|76094234|FG001|Overall Study|Withdrawal by Subject|16|||
42266054|NCT02769481|76094233|FG000|Overall Study|Lost to Follow-up|9|||
42266055|NCT02769481|76094234|FG001|Overall Study|Lost to Follow-up|9|||
42266056|NCT02769481|76094233|FG000|Overall Study|Physician Decision|0|||
42266057|NCT02769481|76094234|FG001|Overall Study|Physician Decision|1|||
42266058|NCT02769481|76094233|FG000|Overall Study|Terminated by Sponsor|1|||
42266059|NCT02769481|76094234|FG001|Overall Study|Terminated by Sponsor|0|||
42337538|NCT02138747|76175359|FG000|Treatment Period 1|Adverse Event|10|||
42337539|NCT02138747|76175360|FG001|Treatment Period 1|Adverse Event|14|||
42000474|NCT01173601|75808973|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
42000475|NCT01173601|75808974|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
42266060|NCT02769481|76094233|FG000|Overall Study|Death|0|||
42337540|NCT02138747|76175361|FG002|Treatment Period 1|Adverse Event|2|||
42337541|NCT02138747|76175362|FG003|Treatment Period 1|Adverse Event|1|||
42337542|NCT02138747|76175359|FG000|Treatment Period 1|Lost to Follow-up|0|||
42337543|NCT02138747|76175360|FG001|Treatment Period 1|Lost to Follow-up|1|||
42337544|NCT02138747|76175361|FG002|Treatment Period 1|Lost to Follow-up|1|||
42266061|NCT02769481|76094234|FG001|Overall Study|Death|1|||
42266062|NCT02769481|76094233|FG000|Overall Study|Undefined|4|||
42337545|NCT02138747|76175362|FG003|Treatment Period 1|Lost to Follow-up|0|||
42337546|NCT02138747|76175359|FG000|Treatment Period 1|Protocol Violation|0|||
42337547|NCT02138747|76175360|FG001|Treatment Period 1|Protocol Violation|2|||
42337548|NCT02138747|76175361|FG002|Treatment Period 1|Protocol Violation|0|||
42337549|NCT02138747|76175362|FG003|Treatment Period 1|Protocol Violation|0|||
42337550|NCT02138747|76175359|FG000|Treatment Period 1|Withdrawal by Subject|8|||
42337551|NCT02138747|76175360|FG001|Treatment Period 1|Withdrawal by Subject|4|||
42337552|NCT02138747|76175361|FG002|Treatment Period 1|Withdrawal by Subject|1|||
42337553|NCT02138747|76175362|FG003|Treatment Period 1|Withdrawal by Subject|3|||
42337554|NCT02138747|76175359|FG000|Treatment Period 1|Other - Miscellaneous|2|||
42337555|NCT02138747|76175360|FG001|Treatment Period 1|Other - Miscellaneous|4|||
42337556|NCT02138747|76175361|FG002|Treatment Period 1|Other - Miscellaneous|0|||
42337557|NCT02138747|76175362|FG003|Treatment Period 1|Other - Miscellaneous|0|||
42337558|NCT02138747|76175359|FG000|Treatment Period 2|Adverse Event|6|||
42337559|NCT02138747|76175360|FG001|Treatment Period 2|Adverse Event|3|||
42337560|NCT02138747|76175361|FG002|Treatment Period 2|Adverse Event|1|||
42337561|NCT02138747|76175362|FG003|Treatment Period 2|Adverse Event|1|||
42337562|NCT02138747|76175359|FG000|Treatment Period 2|Lost to Follow-up|2|||
42337563|NCT02138747|76175360|FG001|Treatment Period 2|Lost to Follow-up|0|||
42337564|NCT02138747|76175361|FG002|Treatment Period 2|Lost to Follow-up|0|||
42337565|NCT02138747|76175362|FG003|Treatment Period 2|Lost to Follow-up|0|||
42337566|NCT02138747|76175359|FG000|Treatment Period 2|Protocol Violation|1|||
42337567|NCT02138747|76175360|FG001|Treatment Period 2|Protocol Violation|0|||
42337568|NCT02138747|76175361|FG002|Treatment Period 2|Protocol Violation|0|||
42337569|NCT02138747|76175362|FG003|Treatment Period 2|Protocol Violation|0|||
42337570|NCT02138747|76175359|FG000|Treatment Period 2|Withdrawal by Subject|5|||
42337571|NCT02138747|76175360|FG001|Treatment Period 2|Withdrawal by Subject|4|||
42337572|NCT02138747|76175361|FG002|Treatment Period 2|Withdrawal by Subject|1|||
42337573|NCT02138747|76175362|FG003|Treatment Period 2|Withdrawal by Subject|2|||
42337574|NCT02138747|76175359|FG000|Treatment Period 2|Other - Miscellaneous|3|||
42337575|NCT02138747|76175360|FG001|Treatment Period 2|Other - Miscellaneous|0|||
42337576|NCT02138747|76175361|FG002|Treatment Period 2|Other - Miscellaneous|0|||
42000476|NCT01173601|75808970|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
42000477|NCT01173601|75808971|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
42000478|NCT01173601|75808972|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
42000479|NCT01173601|75808973|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
42337577|NCT02138747|76175362|FG003|Treatment Period 2|Other - Miscellaneous|0|||
42337578|NCT02105285|76175375|FG000|Overall Study|Adverse Event|1|||
42337579|NCT02105285|76175376|FG001|Overall Study|Adverse Event|1|||
42337580|NCT02105285|76175377|FG002|Overall Study|Adverse Event|0|||
42337581|NCT02105285|76175375|FG000|Overall Study|Protocol Violation|0|||
42337582|NCT02105285|76175376|FG001|Overall Study|Protocol Violation|1|||
42337583|NCT02105285|76175377|FG002|Overall Study|Protocol Violation|0|||
42337584|NCT02105285|76175375|FG000|Overall Study|Withdrawal by Subject|1|||
42337585|NCT02105285|76175376|FG001|Overall Study|Withdrawal by Subject|0|||
42337586|NCT02105285|76175377|FG002|Overall Study|Withdrawal by Subject|0|||
42337587|NCT02104895|76175386|FG000|Overall Study|Withdrawal by Subject|0|||
42337588|NCT02104895|76175387|FG001|Overall Study|Withdrawal by Subject|14|||
42266063|NCT02769481|76094234|FG001|Overall Study|Undefined|1|||
42266064|NCT02769247|76094244|FG000|Overall Study|Withdrawal by Subject|1|||
42266065|NCT02769247|76094245|FG001|Overall Study|Withdrawal by Subject|0|||
42266066|NCT02769247|76094246|FG002|Overall Study|Withdrawal by Subject|0|||
42266067|NCT02769247|76094247|FG003|Overall Study|Withdrawal by Subject|1|||
42266068|NCT02769247|76094244|FG000|Overall Study|Protocol Violation|0|||
42266069|NCT02769247|76094245|FG001|Overall Study|Protocol Violation|0|||
42266070|NCT02769247|76094246|FG002|Overall Study|Protocol Violation|1|||
42266071|NCT02769247|76094247|FG003|Overall Study|Protocol Violation|0|||
42337589|NCT01621490|76175402|FG000|Overall Study|Participant completed treatment|4|||
42337590|NCT01621490|76175403|FG001|Overall Study|Participant completed treatment|4|||
42337591|NCT01621490|76175404|FG002|Overall Study|Participant completed treatment|1|||
42337592|NCT01621490|76175405|FG003|Overall Study|Participant completed treatment|0|||
42337593|NCT01621490|76175406|FG004|Overall Study|Participant completed treatment|0|||
42337594|NCT01621490|76175407|FG005|Overall Study|Participant completed treatment|0|||
42337595|NCT01621490|76175408|FG006|Overall Study|Participant completed treatment|0|||
42337596|NCT01621490|76175409|FG007|Overall Study|Participant completed treatment|1|||
42337597|NCT01621490|76175410|FG008|Overall Study|Participant completed treatment|0|||
42337598|NCT01621490|76175402|FG000|Overall Study|Patient could not travel|1|||
42337599|NCT01621490|76175403|FG001|Overall Study|Patient could not travel|0|||
42337600|NCT01621490|76175404|FG002|Overall Study|Patient could not travel|0|||
42337601|NCT01621490|76175405|FG003|Overall Study|Patient could not travel|0|||
42266072|NCT02769247|76094244|FG000|Overall Study|Physician Decision|1|||
42337602|NCT01621490|76175406|FG004|Overall Study|Patient could not travel|0|||
42337603|NCT01621490|76175407|FG005|Overall Study|Patient could not travel|0|||
42337604|NCT01621490|76175408|FG006|Overall Study|Patient could not travel|0|||
42337605|NCT01621490|76175409|FG007|Overall Study|Patient could not travel|0|||
42034812|NCT01040130|75843018|FG005|Overall Study|Withdrawal by Subject|1|||
42034813|NCT01040130|75843013|FG000|Overall Study|Other reasons not listed above|2|||
42266073|NCT02769247|76094245|FG001|Overall Study|Physician Decision|0|||
42266074|NCT02769247|76094246|FG002|Overall Study|Physician Decision|0|||
42266075|NCT02769247|76094247|FG003|Overall Study|Physician Decision|0|||
42266076|NCT02773537|76094264|FG000|Overall Study|Lost to Follow-up|0|||
42266077|NCT02773537|76094265|FG001|Overall Study|Lost to Follow-up|1|||
42266078|NCT02773537|76094266|FG002|Overall Study|Lost to Follow-up|4|||
42266079|NCT02780713|76094274|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
42266080|NCT02780713|76094275|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
42266081|NCT02780713|76094276|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
42266082|NCT02780713|76094277|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
42034814|NCT01040130|75843014|FG001|Overall Study|Other reasons not listed above|0|||
42034815|NCT01040130|75843015|FG002|Overall Study|Other reasons not listed above|0|||
42266083|NCT02780713|76094278|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
42337606|NCT01621490|76175410|FG008|Overall Study|Patient could not travel|0|||
42337607|NCT01621490|76175402|FG000|Overall Study|Subject no longer meets study criteria|0|||
42337608|NCT01621490|76175403|FG001|Overall Study|Subject no longer meets study criteria|0|||
42337609|NCT01621490|76175404|FG002|Overall Study|Subject no longer meets study criteria|0|||
42034816|NCT01040130|75843016|FG003|Overall Study|Other reasons not listed above|0|||
42034817|NCT01040130|75843017|FG004|Overall Study|Other reasons not listed above|0|||
42266084|NCT02767765|76094297|FG000|Overall Study|Adverse Event|4|||
42034818|NCT01040130|75843018|FG005|Overall Study|Other reasons not listed above|0|||
42034819|NCT00932451|75843028|FG000|Overall Study|Withdrawal by Subject|69|||
42034820|NCT00932451|75843028|FG000|Overall Study|Lost to Follow-up|22|||
42034821|NCT00932451|75843028|FG000|Overall Study|Death|726|||
42034822|NCT00932451|75843028|FG000|Overall Study|Other reasons|5|||
42034823|NCT01108055|75843036|FG000|Overall Study|Ineligible|11|||
42034824|NCT01108055|75843036|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
42034825|NCT01107899|75843043|FG000|Overall Study|Physician Decision|5|||
42034826|NCT01107899|75843044|FG001|Overall Study|Physician Decision|0|||
42034827|NCT01107899|75843045|FG002|Overall Study|Physician Decision|3|||
42034828|NCT01107899|75843043|FG000|Overall Study|Withdrawal by Subject|0|||
42034829|NCT01107899|75843044|FG001|Overall Study|Withdrawal by Subject|0|||
42034830|NCT01107899|75843045|FG002|Overall Study|Withdrawal by Subject|1|||
42034831|NCT01115933|75843056|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
42034832|NCT01107743|75843113|FG000|Overall Study|Protocol Violation|46|||
42034833|NCT01059864|75843162|FG000|Open-Label Run-In Phase|Adverse Event|7|||
42034834|NCT01059864|75843163|FG001|Open-Label Run-In Phase|Adverse Event|0|||
42034835|NCT01059864|75843164|FG002|Open-Label Run-In Phase|Adverse Event|0|||
42337610|NCT01621490|76175405|FG003|Overall Study|Subject no longer meets study criteria|0|||
42337611|NCT01621490|76175406|FG004|Overall Study|Subject no longer meets study criteria|1|||
42337612|NCT01621490|76175407|FG005|Overall Study|Subject no longer meets study criteria|0|||
42337613|NCT01621490|76175408|FG006|Overall Study|Subject no longer meets study criteria|0|||
42337614|NCT01621490|76175409|FG007|Overall Study|Subject no longer meets study criteria|0|||
42337615|NCT01621490|76175410|FG008|Overall Study|Subject no longer meets study criteria|0|||
42337616|NCT01621490|76175402|FG000|Overall Study|Maximum clinical benefit|3|||
42337617|NCT01621490|76175403|FG001|Overall Study|Maximum clinical benefit|2|||
42337618|NCT01621490|76175404|FG002|Overall Study|Maximum clinical benefit|0|||
42337619|NCT01621490|76175405|FG003|Overall Study|Maximum clinical benefit|0|||
42337620|NCT01621490|76175406|FG004|Overall Study|Maximum clinical benefit|0|||
42337621|NCT01621490|76175407|FG005|Overall Study|Maximum clinical benefit|0|||
42337622|NCT01621490|76175408|FG006|Overall Study|Maximum clinical benefit|1|||
42337623|NCT01621490|76175409|FG007|Overall Study|Maximum clinical benefit|2|||
42337624|NCT01621490|76175410|FG008|Overall Study|Maximum clinical benefit|0|||
42337625|NCT01621490|76175402|FG000|Overall Study|Withdrawal by Subject|1|||
42337626|NCT01621490|76175403|FG001|Overall Study|Withdrawal by Subject|0|||
42337627|NCT01621490|76175404|FG002|Overall Study|Withdrawal by Subject|0|||
42337628|NCT01621490|76175405|FG003|Overall Study|Withdrawal by Subject|0|||
42337629|NCT01621490|76175406|FG004|Overall Study|Withdrawal by Subject|0|||
42337630|NCT01621490|76175407|FG005|Overall Study|Withdrawal by Subject|3|||
42337631|NCT01621490|76175408|FG006|Overall Study|Withdrawal by Subject|0|||
42337632|NCT01621490|76175409|FG007|Overall Study|Withdrawal by Subject|0|||
42034836|NCT01059864|75843162|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
42034837|NCT01059864|75843163|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
42034838|NCT01059864|75843164|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
42034839|NCT01059864|75843162|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
42266085|NCT02767765|76094297|FG000|Overall Study|Death|1|||
42266086|NCT02767765|76094297|FG000|Overall Study|Insufficient response|1|||
42266087|NCT02767765|76094297|FG000|Overall Study|Lost to Follow-up|2|||
42266088|NCT02767765|76094297|FG000|Overall Study|Investigator decision|1|||
42266089|NCT02767765|76094297|FG000|Overall Study|Non-Compliance|1|||
42266090|NCT02767765|76094297|FG000|Overall Study|Withdrawal by Subject|1|||
42266091|NCT02772757|76094304|FG000|Overall Study|Withdrawal by Subject|1|||
42266092|NCT02772757|76094305|FG001|Overall Study|Withdrawal by Subject|0|||
42266093|NCT02772757|76094306|FG002|Overall Study|Withdrawal by Subject|1|||
42266094|NCT02772757|76094304|FG000|Overall Study|Protocol Violation|0|||
42266095|NCT02772757|76094305|FG001|Overall Study|Protocol Violation|0|||
42266096|NCT02772757|76094306|FG002|Overall Study|Protocol Violation|1|||
42266097|NCT02772757|76094304|FG000|Overall Study|Physician Decision|0|||
42266098|NCT02772757|76094305|FG001|Overall Study|Physician Decision|3|||
42266099|NCT02772757|76094306|FG002|Overall Study|Physician Decision|3|||
42266100|NCT00103207|76094315|FG000|Overall Study|Adverse Event|3|||
42266101|NCT00103207|76094315|FG000|Overall Study|Death|1|||
42266102|NCT00103207|76094315|FG000|Overall Study|Withdrawal by Subject|2|||
42266103|NCT00103207|76094315|FG000|Overall Study|Other complicating disease|1|||
42266104|NCT00103207|76094315|FG000|Overall Study|Ineligible|4|||
42266105|NCT00103207|76094315|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
42266106|NCT01369355|76094327|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
42266107|NCT01369355|76094328|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
42266108|NCT01369355|76094329|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
42266109|NCT01369355|76094330|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
42266110|NCT01369355|76094331|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
42266111|NCT01369355|76094332|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
42266112|NCT01369355|76094333|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
42337633|NCT01621490|76175410|FG008|Overall Study|Withdrawal by Subject|0|||
42337634|NCT01621490|76175402|FG000|Overall Study|Subject request to discontinue study|1|||
42337635|NCT01621490|76175403|FG001|Overall Study|Subject request to discontinue study|3|||
42337636|NCT01621490|76175404|FG002|Overall Study|Subject request to discontinue study|1|||
42337637|NCT01621490|76175405|FG003|Overall Study|Subject request to discontinue study|1|||
42337638|NCT01621490|76175406|FG004|Overall Study|Subject request to discontinue study|0|||
42337639|NCT01621490|76175407|FG005|Overall Study|Subject request to discontinue study|2|||
42000480|NCT01173601|75808974|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
42000481|NCT01173601|75808970|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
42337640|NCT01621490|76175408|FG006|Overall Study|Subject request to discontinue study|1|||
42337641|NCT01621490|76175409|FG007|Overall Study|Subject request to discontinue study|0|||
42337642|NCT01621490|76175410|FG008|Overall Study|Subject request to discontinue study|1|||
42337643|NCT01621490|76175402|FG000|Overall Study|Adverse event unrelated to study drug|2|||
42337644|NCT01621490|76175403|FG001|Overall Study|Adverse event unrelated to study drug|1|||
42337645|NCT01621490|76175404|FG002|Overall Study|Adverse event unrelated to study drug|0|||
42337646|NCT01621490|76175405|FG003|Overall Study|Adverse event unrelated to study drug|0|||
42337647|NCT01621490|76175406|FG004|Overall Study|Adverse event unrelated to study drug|0|||
42337648|NCT01621490|76175407|FG005|Overall Study|Adverse event unrelated to study drug|0|||
42337649|NCT01621490|76175408|FG006|Overall Study|Adverse event unrelated to study drug|0|||
42337650|NCT01621490|76175409|FG007|Overall Study|Adverse event unrelated to study drug|2|||
42337651|NCT01621490|76175410|FG008|Overall Study|Adverse event unrelated to study drug|1|||
42337652|NCT01621490|76175402|FG000|Overall Study|Disease progression|27|||
42337653|NCT01621490|76175403|FG001|Overall Study|Disease progression|28|||
42337654|NCT01621490|76175404|FG002|Overall Study|Disease progression|1|||
42337655|NCT01621490|76175405|FG003|Overall Study|Disease progression|5|||
42337656|NCT01621490|76175406|FG004|Overall Study|Disease progression|3|||
42337657|NCT01621490|76175407|FG005|Overall Study|Disease progression|8|||
42337658|NCT01621490|76175408|FG006|Overall Study|Disease progression|7|||
42337659|NCT01621490|76175409|FG007|Overall Study|Disease progression|0|||
42337660|NCT01621490|76175410|FG008|Overall Study|Disease progression|4|||
42337661|NCT01621490|76175402|FG000|Overall Study|Study drug toxicity|1|||
42337662|NCT01621490|76175403|FG001|Overall Study|Study drug toxicity|4|||
42337663|NCT01621490|76175404|FG002|Overall Study|Study drug toxicity|5|||
42337664|NCT01621490|76175405|FG003|Overall Study|Study drug toxicity|3|||
42337665|NCT01621490|76175406|FG004|Overall Study|Study drug toxicity|1|||
42337666|NCT01621490|76175407|FG005|Overall Study|Study drug toxicity|10|||
42337667|NCT01621490|76175408|FG006|Overall Study|Study drug toxicity|1|||
42337668|NCT01621490|76175409|FG007|Overall Study|Study drug toxicity|4|||
42337669|NCT01621490|76175410|FG008|Overall Study|Study drug toxicity|1|||
42337670|NCT01621490|76175402|FG000|Overall Study|Death|0|||
42337671|NCT01621490|76175403|FG001|Overall Study|Death|0|||
42337672|NCT01621490|76175404|FG002|Overall Study|Death|0|||
42337673|NCT01621490|76175405|FG003|Overall Study|Death|0|||
42337674|NCT01621490|76175406|FG004|Overall Study|Death|0|||
42337675|NCT01621490|76175407|FG005|Overall Study|Death|0|||
42337676|NCT01621490|76175408|FG006|Overall Study|Death|0|||
42337677|NCT01621490|76175409|FG007|Overall Study|Death|1|||
42337678|NCT01621490|76175410|FG008|Overall Study|Death|0|||
42337679|NCT01621490|76175402|FG000|Overall Study|Grade 4 Lipase elevation|1|||
42337680|NCT01621490|76175403|FG001|Overall Study|Grade 4 Lipase elevation|0|||
42337681|NCT01621490|76175404|FG002|Overall Study|Grade 4 Lipase elevation|0|||
42337682|NCT01621490|76175405|FG003|Overall Study|Grade 4 Lipase elevation|0|||
42337683|NCT01621490|76175406|FG004|Overall Study|Grade 4 Lipase elevation|0|||
42337684|NCT01621490|76175407|FG005|Overall Study|Grade 4 Lipase elevation|0|||
42337685|NCT01621490|76175408|FG006|Overall Study|Grade 4 Lipase elevation|0|||
42337686|NCT01621490|76175409|FG007|Overall Study|Grade 4 Lipase elevation|0|||
42337687|NCT01621490|76175410|FG008|Overall Study|Grade 4 Lipase elevation|0|||
42000482|NCT01173601|75808971|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
42000483|NCT01173601|75808972|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
42000484|NCT01173601|75808973|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
42000485|NCT01173601|75808974|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
42000486|NCT01173601|75808970|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
42000487|NCT01173601|75808971|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
42000488|NCT01173601|75808972|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
42000489|NCT01173601|75808973|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
42337688|NCT01621490|76175402|FG000|Overall Study|BMS informed of patient status|0|||
42337689|NCT01621490|76175403|FG001|Overall Study|BMS informed of patient status|0|||
42337690|NCT01621490|76175404|FG002|Overall Study|BMS informed of patient status|1|||
42337691|NCT01621490|76175405|FG003|Overall Study|BMS informed of patient status|0|||
42337692|NCT01621490|76175406|FG004|Overall Study|BMS informed of patient status|0|||
42337693|NCT01621490|76175407|FG005|Overall Study|BMS informed of patient status|0|||
42337694|NCT01621490|76175408|FG006|Overall Study|BMS informed of patient status|0|||
42337695|NCT01621490|76175409|FG007|Overall Study|BMS informed of patient status|0|||
42337696|NCT01621490|76175410|FG008|Overall Study|BMS informed of patient status|0|||
42337697|NCT01621490|76175402|FG000|Overall Study|Investigator decision|0|||
42337698|NCT01621490|76175403|FG001|Overall Study|Investigator decision|0|||
42337699|NCT01621490|76175404|FG002|Overall Study|Investigator decision|1|||
42337700|NCT01621490|76175405|FG003|Overall Study|Investigator decision|0|||
42337701|NCT01621490|76175406|FG004|Overall Study|Investigator decision|1|||
42337702|NCT01621490|76175407|FG005|Overall Study|Investigator decision|0|||
42337703|NCT01621490|76175408|FG006|Overall Study|Investigator decision|1|||
42337704|NCT01621490|76175409|FG007|Overall Study|Investigator decision|0|||
42337705|NCT01621490|76175410|FG008|Overall Study|Investigator decision|0|||
42337706|NCT01621490|76175402|FG000|Overall Study|Documented disease progression|0|||
42337707|NCT01621490|76175403|FG001|Overall Study|Documented disease progression|0|||
42337708|NCT01621490|76175404|FG002|Overall Study|Documented disease progression|1|||
42337709|NCT01621490|76175405|FG003|Overall Study|Documented disease progression|0|||
42337710|NCT01621490|76175406|FG004|Overall Study|Documented disease progression|0|||
42337711|NCT01621490|76175407|FG005|Overall Study|Documented disease progression|0|||
42337712|NCT01621490|76175408|FG006|Overall Study|Documented disease progression|0|||
42337713|NCT01621490|76175409|FG007|Overall Study|Documented disease progression|0|||
42337714|NCT01621490|76175410|FG008|Overall Study|Documented disease progression|0|||
42337715|NCT01621490|76175402|FG000|Overall Study|Patient reached treatment 2 yr limit|0|||
42337716|NCT01621490|76175403|FG001|Overall Study|Patient reached treatment 2 yr limit|1|||
42337717|NCT01621490|76175404|FG002|Overall Study|Patient reached treatment 2 yr limit|0|||
42337718|NCT01621490|76175405|FG003|Overall Study|Patient reached treatment 2 yr limit|0|||
42337719|NCT01621490|76175406|FG004|Overall Study|Patient reached treatment 2 yr limit|0|||
42337720|NCT01621490|76175407|FG005|Overall Study|Patient reached treatment 2 yr limit|0|||
42337721|NCT01621490|76175408|FG006|Overall Study|Patient reached treatment 2 yr limit|0|||
42337722|NCT01621490|76175409|FG007|Overall Study|Patient reached treatment 2 yr limit|0|||
42337723|NCT01621490|76175410|FG008|Overall Study|Patient reached treatment 2 yr limit|0|||
42337724|NCT01621490|76175402|FG000|Overall Study|Clinical deterioration|0|||
42337725|NCT01621490|76175403|FG001|Overall Study|Clinical deterioration|1|||
42337726|NCT01621490|76175404|FG002|Overall Study|Clinical deterioration|0|||
42337727|NCT01621490|76175405|FG003|Overall Study|Clinical deterioration|0|||
42337728|NCT01621490|76175406|FG004|Overall Study|Clinical deterioration|0|||
42337729|NCT01621490|76175407|FG005|Overall Study|Clinical deterioration|0|||
42337730|NCT01621490|76175408|FG006|Overall Study|Clinical deterioration|0|||
42337731|NCT01621490|76175409|FG007|Overall Study|Clinical deterioration|0|||
42337732|NCT01621490|76175410|FG008|Overall Study|Clinical deterioration|0|||
42337733|NCT01621490|76175402|FG000|Overall Study|Complete response|0|||
42337734|NCT01621490|76175403|FG001|Overall Study|Complete response|0|||
42337735|NCT01621490|76175404|FG002|Overall Study|Complete response|0|||
42000490|NCT01173601|75808974|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
42000491|NCT01173601|75808970|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
42135047|NCT00290758|75945795|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
42337736|NCT01621490|76175405|FG003|Overall Study|Complete response|0|||
42337737|NCT01621490|76175406|FG004|Overall Study|Complete response|0|||
42337738|NCT01621490|76175407|FG005|Overall Study|Complete response|0|||
42337739|NCT01621490|76175408|FG006|Overall Study|Complete response|0|||
42337740|NCT01621490|76175409|FG007|Overall Study|Complete response|0|||
42337741|NCT01621490|76175410|FG008|Overall Study|Complete response|1|||
42337742|NCT01621490|76175402|FG000|Overall Study|Patient delayed due to toxicity|0|||
42337743|NCT01621490|76175403|FG001|Overall Study|Patient delayed due to toxicity|0|||
42337744|NCT01621490|76175404|FG002|Overall Study|Patient delayed due to toxicity|0|||
42337745|NCT01621490|76175405|FG003|Overall Study|Patient delayed due to toxicity|0|||
42337746|NCT01621490|76175406|FG004|Overall Study|Patient delayed due to toxicity|0|||
42337747|NCT01621490|76175407|FG005|Overall Study|Patient delayed due to toxicity|1|||
42337748|NCT01621490|76175408|FG006|Overall Study|Patient delayed due to toxicity|0|||
42337749|NCT01621490|76175409|FG007|Overall Study|Patient delayed due to toxicity|0|||
42337750|NCT01621490|76175410|FG008|Overall Study|Patient delayed due to toxicity|0|||
42337751|NCT02018887|76175531|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
42000492|NCT01173601|75808971|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
42000493|NCT01173601|75808972|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
42000494|NCT01173601|75808973|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
42000495|NCT01173601|75808974|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
42000496|NCT01173601|75808970|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
42000497|NCT01173601|75808971|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
42000498|NCT01173601|75808972|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
42000499|NCT01173601|75808973|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
42000500|NCT01173601|75808974|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
42000501|NCT01173601|75808970|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
42135048|NCT00290758|75945794|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
42337752|NCT02018887|76175532|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
42337753|NCT02018887|76175533|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
42337754|NCT02018887|76175534|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
42337755|NCT02018887|76175535|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
42337756|NCT02018887|76175536|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
42337757|NCT02018887|76175537|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
42337758|NCT02018887|76175538|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
42337759|NCT02018887|76175539|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
42337760|NCT02018887|76175540|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
42337761|NCT02018887|76175541|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
42337762|NCT02018887|76175531|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
42337763|NCT02018887|76175532|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
42337764|NCT02018887|76175533|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
42337765|NCT02018887|76175534|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
42337766|NCT02018887|76175535|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
42337767|NCT02018887|76175536|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
42266113|NCT01369355|76094334|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
42266114|NCT01369355|76094335|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
42266115|NCT01369355|76094327|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
42266116|NCT01369355|76094328|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
42266117|NCT01369355|76094329|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
42266118|NCT01369355|76094330|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
42266119|NCT01369355|76094331|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
42266120|NCT01369355|76094332|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
42266121|NCT01369355|76094333|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
42266122|NCT01369355|76094334|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
42266123|NCT01369355|76094335|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
42266124|NCT01369355|76094327|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
42266125|NCT01369355|76094328|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
42266126|NCT01369355|76094329|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
42266127|NCT01369355|76094330|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
42337768|NCT02018887|76175537|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
42337769|NCT02018887|76175538|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
42337770|NCT02018887|76175539|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
42337771|NCT02018887|76175540|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
42337772|NCT02018887|76175541|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
42337773|NCT02018887|76175531|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
42337774|NCT02018887|76175532|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
42337775|NCT02018887|76175533|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
42337776|NCT02018887|76175534|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
42337777|NCT02018887|76175535|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
42337778|NCT02018887|76175536|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
42337779|NCT02018887|76175537|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
42337780|NCT02018887|76175538|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
42337781|NCT02018887|76175539|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
42337782|NCT02018887|76175540|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
42337783|NCT02018887|76175541|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
42337784|NCT02018887|76175531|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
42337785|NCT02018887|76175532|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
42337786|NCT02018887|76175533|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
42337787|NCT02018887|76175534|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
42337788|NCT02018887|76175535|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
42337789|NCT02018887|76175536|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
42337790|NCT02018887|76175537|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
42337791|NCT02018887|76175538|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
42337792|NCT02018887|76175539|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
42337793|NCT02018887|76175540|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
42337794|NCT02018887|76175541|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
42337795|NCT02030041|76175610|FG000|Overall Study|Withdrawal by Subject|2|||
42337796|NCT02030041|76175611|FG001|Overall Study|Withdrawal by Subject|2|||
42337797|NCT02030041|76175612|FG002|Overall Study|Withdrawal by Subject|1|||
42337798|NCT01994720|76175622|FG000|Overall Study|Withdrawal by Subject|46|||
42337799|NCT01994720|76175623|FG001|Overall Study|Withdrawal by Subject|56|||
42337800|NCT01814397|76175629|FG000|Overall Study|Adverse Event|7|||
42337801|NCT01814397|76175629|FG000|Overall Study|Withdrawal by Subject|7|||
42337802|NCT01814007|76175633|FG000|Overall Study|Withdrawal by Subject|1|||
42337803|NCT01844115|76175640|FG000|Overall Study|Adverse Event|4|||
42337804|NCT01844115|76175641|FG001|Overall Study|Adverse Event|22|||
42337805|NCT01844115|76175640|FG000|Overall Study|Lack of Efficacy|1|||
42337806|NCT01844115|76175641|FG001|Overall Study|Lack of Efficacy|4|||
42337807|NCT01844115|76175640|FG000|Overall Study|Protocol Violation|12|||
42337808|NCT01844115|76175641|FG001|Overall Study|Protocol Violation|10|||
42337809|NCT01844115|76175640|FG000|Overall Study|Withdrawal by Subject|11|||
42337810|NCT01844115|76175641|FG001|Overall Study|Withdrawal by Subject|11|||
42337811|NCT01844115|76175640|FG000|Overall Study|Lost to Follow-up|11|||
42337812|NCT01844115|76175641|FG001|Overall Study|Lost to Follow-up|10|||
42337813|NCT01844115|76175640|FG000|Overall Study|Pregnancy|0|||
42337814|NCT01844115|76175641|FG001|Overall Study|Pregnancy|1|||
42337815|NCT02018042|76175647|FG000|Overall Study|Withdrawal by Subject|1|||
42337816|NCT01813305|76175653|FG000|Overall Study|Withdrawal by Subject|12|||
42337817|NCT01813305|76175654|FG001|Overall Study|Withdrawal by Subject|5|||
42337818|NCT01813305|76175653|FG000|Overall Study|Safety Concern|4|||
42337819|NCT01813305|76175654|FG001|Overall Study|Safety Concern|0|||
42337820|NCT01813305|76175653|FG000|Overall Study|Ulcer became worse|4|||
42337821|NCT01813305|76175654|FG001|Overall Study|Ulcer became worse|0|||
42337822|NCT01813305|76175653|FG000|Overall Study|Physician Decision|4|||
42337823|NCT01813305|76175654|FG001|Overall Study|Physician Decision|0|||
42337824|NCT01813305|76175653|FG000|Overall Study|Lost to Follow-up|3|||
42337825|NCT01813305|76175654|FG001|Overall Study|Lost to Follow-up|1|||
42337826|NCT01813305|76175653|FG000|Overall Study|Protocol Violation|1|||
42337827|NCT01813305|76175654|FG001|Overall Study|Protocol Violation|0|||
42337828|NCT01813305|76175653|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
42337829|NCT01813305|76175654|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
42337830|NCT01993940|76175664|FG000|Overall Study|Adverse Event|16|||
42337831|NCT01993940|76175665|FG001|Overall Study|Adverse Event|11|||
42337832|NCT01993940|76175664|FG000|Overall Study|Withdrawal by Subject|15|||
42337833|NCT01993940|76175665|FG001|Overall Study|Withdrawal by Subject|19|||
42337834|NCT01993940|76175664|FG000|Overall Study|Lost to Follow-up|2|||
42337835|NCT01993940|76175665|FG001|Overall Study|Lost to Follow-up|5|||
42337836|NCT01993940|76175664|FG000|Overall Study|Protocol Violation|5|||
42337837|NCT01993940|76175665|FG001|Overall Study|Protocol Violation|8|||
42337838|NCT01993940|76175664|FG000|Overall Study|Death|1|||
42337839|NCT01993940|76175665|FG001|Overall Study|Death|0|||
42337840|NCT01993940|76175664|FG000|Overall Study|Other - Miscellaneous|1|||
42337841|NCT01993940|76175665|FG001|Overall Study|Other - Miscellaneous|1|||
42337842|NCT01843803|76175673|FG000|Overall Study|not a Veteran, did not see provider|1|||
42337843|NCT01843803|76175674|FG001|Overall Study|not a Veteran, did not see provider|3|||
42337844|NCT02017171|76175682|FG000|Overall Study|Death|10|||
42337845|NCT02017171|76175683|FG001|Overall Study|Death|4|||
42337846|NCT02017171|76175682|FG000|Overall Study|Withdrawal by Subject|23|||
42337847|NCT02017171|76175683|FG001|Overall Study|Withdrawal by Subject|17|||
42337848|NCT02017171|76175682|FG000|Overall Study|Lost to Follow-up|21|||
42337849|NCT02017171|76175683|FG001|Overall Study|Lost to Follow-up|20|||
42337850|NCT02017171|76175682|FG000|Overall Study|ESKD|6|||
42337851|NCT02017171|76175683|FG001|Overall Study|ESKD|2|||
42337852|NCT02017171|76175682|FG000|Overall Study|Miscellaneous|2|||
42000502|NCT01173601|75808971|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
42000503|NCT01173601|75808972|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
42000504|NCT01173601|75808973|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
42337853|NCT02017171|76175683|FG001|Overall Study|Miscellaneous|3|||
42337854|NCT02029417|76175690|FG000|Overall Study|Death|1|||
42337855|NCT02029417|76175690|FG000|Overall Study|Adverse Event|1|||
42337856|NCT02016716|76175697|FG000|Overall Study|Withdrawal by Subject|5|||
42337857|NCT02016716|76175698|FG001|Overall Study|Withdrawal by Subject|5|||
42337858|NCT02016716|76175699|FG002|Overall Study|Withdrawal by Subject|5|||
42135049|NCT00290758|75945795|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
42337859|NCT02016716|76175697|FG000|Overall Study|Protocol-specified Criteria|0|||
42337860|NCT02016716|76175698|FG001|Overall Study|Protocol-specified Criteria|1|||
42337861|NCT02016716|76175699|FG002|Overall Study|Protocol-specified Criteria|0|||
42337862|NCT02016716|76175697|FG000|Overall Study|Lost to Follow-up|1|||
42337863|NCT02016716|76175698|FG001|Overall Study|Lost to Follow-up|2|||
42337864|NCT02016716|76175699|FG002|Overall Study|Lost to Follow-up|1|||
42337865|NCT02050321|76175708|FG000|Overall Study|Withdrawal by Subject|1|||
42337866|NCT02050321|76175708|FG000|Overall Study|Adverse Event|1|||
42337867|NCT02039414|76175714|FG000|Overall Study|Delivered|1|||
42337868|NCT02039414|76175715|FG001|Overall Study|Delivered|1|||
42337869|NCT02039414|76175714|FG000|Overall Study|Lost to Follow-up|2|||
42337870|NCT02039414|76175715|FG001|Overall Study|Lost to Follow-up|0|||
42337871|NCT02039414|76175714|FG000|Overall Study|Protocol Violation|3|||
42337872|NCT02039414|76175715|FG001|Overall Study|Protocol Violation|1|||
42337873|NCT02017015|76175721|FG000|Overall Study|Adverse Event|9|||
42337874|NCT02017015|76175721|FG000|Overall Study|Withdrawal by Subject|21|||
42337875|NCT02017015|76175721|FG000|Overall Study|Death|4|||
42337876|NCT02017015|76175721|FG000|Overall Study|Progressive Disease|31|||
42034840|NCT01059864|75843163|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
42034841|NCT01059864|75843164|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
42034842|NCT01059864|75843162|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
42034843|NCT01059864|75843163|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
42034844|NCT01059864|75843164|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
42034845|NCT01059864|75843162|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
42034846|NCT01059864|75843163|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
42034847|NCT01059864|75843164|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
42034848|NCT01059864|75843162|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
42034849|NCT01059864|75843163|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
42135050|NCT00290758|75945794|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
42135051|NCT00290758|75945795|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
42266128|NCT01369355|76094331|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
42266129|NCT01369355|76094332|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
42266130|NCT01369355|76094333|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
42266131|NCT01369355|76094334|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
42266132|NCT01369355|76094335|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
42266133|NCT01369355|76094327|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
42266134|NCT01369355|76094328|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
42266135|NCT01369355|76094329|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
42266136|NCT01369355|76094330|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
42266137|NCT01369355|76094331|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
42266138|NCT01369355|76094332|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
42337877|NCT02017015|76175721|FG000|Overall Study|Non-compliance with study drug|2|||
42337878|NCT02017015|76175721|FG000|Overall Study|Physician Decision|2|||
42337879|NCT02016625|76175728|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
42337880|NCT02016625|76175729|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
42337881|NCT02016625|76175728|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
42337882|NCT02016625|76175729|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
42337883|NCT02016625|76175728|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
42337884|NCT02016625|76175729|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
42337885|NCT02016482|76175747|FG000|Period A|Adverse Event|3|||
42337886|NCT02016482|76175748|FG001|Period A|Adverse Event|5|||
42337887|NCT02016482|76175747|FG000|Period A|Withdrawal by Subject|3|||
42337888|NCT02016482|76175748|FG001|Period A|Withdrawal by Subject|4|||
42337889|NCT02016482|76175747|FG000|Period A|Lost to Follow-up|3|||
42337890|NCT02016482|76175748|FG001|Period A|Lost to Follow-up|3|||
42337891|NCT02016482|76175747|FG000|Period A|Lack of Efficacy|2|||
42337892|NCT02016482|76175748|FG001|Period A|Lack of Efficacy|1|||
42337893|NCT02016482|76175747|FG000|Period A|Other|3|||
42337894|NCT02016482|76175748|FG001|Period A|Other|0|||
42337895|NCT02016482|76175747|FG000|Period A|Protocol Violation|0|||
42337896|NCT02016482|76175748|FG001|Period A|Protocol Violation|1|||
42337897|NCT02016482|76175747|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
42337898|NCT02016482|76175748|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
42337899|NCT02016482|76175747|FG000|Period B|Withdrawal by Subject|1|||
42337900|NCT02016482|76175748|FG001|Period B|Withdrawal by Subject|1|||
42337901|NCT02016482|76175747|FG000|Period B|Lost to Follow-up|2|||
42337902|NCT02016482|76175748|FG001|Period B|Lost to Follow-up|0|||
42337903|NCT02016482|76175747|FG000|Period B|Lack of Efficacy|6|||
42135052|NCT00372567|75945808|FG000|Phase 3 Study|Adverse Event|5|||
42337904|NCT02016482|76175748|FG001|Period B|Lack of Efficacy|4|||
42337905|NCT02016482|76175747|FG000|Period B|Other|4|||
42337906|NCT02016482|76175748|FG001|Period B|Other|0|||
42337907|NCT02016482|76175747|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
42337908|NCT02016482|76175748|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
42337909|NCT02028871|76175758|FG000|Overall Study|Positive urine drug screen|1|||
42337910|NCT02028871|76175759|FG001|Overall Study|Positive urine drug screen|1|||
42337911|NCT02028871|76175758|FG000|Overall Study|Withdrawal by Subject|1|||
42337912|NCT02028871|76175759|FG001|Overall Study|Withdrawal by Subject|2|||
42337913|NCT02028871|76175758|FG000|Overall Study|IV placement difficulty|1|||
42337914|NCT02028871|76175759|FG001|Overall Study|IV placement difficulty|0|||
42337915|NCT02028871|76175758|FG000|Overall Study|Current Illness|1|||
42337916|NCT02028871|76175759|FG001|Overall Study|Current Illness|0|||
42337917|NCT02028715|76175770|FG000|Overall Study|Adverse Event|2|||
42337918|NCT02028715|76175771|FG001|Overall Study|Adverse Event|2|||
42337919|NCT02028715|76175770|FG000|Overall Study|Physician Decision|1|||
42337920|NCT02028715|76175771|FG001|Overall Study|Physician Decision|0|||
42337921|NCT02028715|76175770|FG000|Overall Study|Did not complete satisfaction surveys|2|||
42337922|NCT02028715|76175771|FG001|Overall Study|Did not complete satisfaction surveys|2|||
42337923|NCT02016170|76175780|FG000|Overall Study|Adverse Event|1|||
42337924|NCT02016170|76175781|FG001|Overall Study|Adverse Event|1|||
42337925|NCT02016170|76175782|FG002|Overall Study|Adverse Event|0|||
42337926|NCT02016170|76175780|FG000|Overall Study|Protocol Violation|1|||
42337927|NCT02016170|76175781|FG001|Overall Study|Protocol Violation|0|||
42266139|NCT01369355|76094333|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
42266140|NCT01369355|76094334|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
42266141|NCT01369355|76094335|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
42266142|NCT01369355|76094327|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
42266143|NCT01369355|76094328|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
42266144|NCT01369355|76094329|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
42337928|NCT02016170|76175782|FG002|Overall Study|Protocol Violation|0|||
42337929|NCT02028169|76175789|FG000|Overall Study|Lost to Follow-up|21|||
42337930|NCT02028169|76175789|FG000|Overall Study|Lack of Efficacy|2|||
42266145|NCT01369355|76094330|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
42266146|NCT01369355|76094331|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
42266147|NCT01369355|76094332|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
42266148|NCT01369355|76094333|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
42266149|NCT01369355|76094334|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
42266150|NCT01369355|76094335|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
42266151|NCT01369355|76094327|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
42266152|NCT01369355|76094328|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
42266153|NCT01369355|76094329|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
42266154|NCT01369355|76094330|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
42266155|NCT01369355|76094331|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
42266156|NCT01369355|76094332|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
42266157|NCT01369355|76094333|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
42266158|NCT01369355|76094334|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
42266159|NCT01369355|76094335|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
42337931|NCT02028169|76175789|FG000|Overall Study|Withdrawal by Subject|2|||
42337932|NCT02028169|76175789|FG000|Overall Study|Adverse Event|1|||
42337933|NCT02028169|76175789|FG000|Overall Study|Cessation of Drug|1|||
42337934|NCT02028169|76175789|FG000|Overall Study|Concomitant Medication Usage|1|||
42266160|NCT01369355|76094327|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
42266161|NCT01369355|76094328|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
42266162|NCT01369355|76094329|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
42337935|NCT02015546|76175796|FG000|Overall Study|Withdrawal by Subject|1|||
42337936|NCT02015546|76175797|FG001|Overall Study|Withdrawal by Subject|1|||
42337937|NCT02015546|76175798|FG002|Overall Study|Withdrawal by Subject|1|||
42337938|NCT02015546|76175796|FG000|Overall Study|Screem Failure|2|||
42337939|NCT02015546|76175797|FG001|Overall Study|Screem Failure|1|||
42337940|NCT02015546|76175798|FG002|Overall Study|Screem Failure|3|||
42337941|NCT02027701|76175806|FG000|Overall Study|Adverse Event|3|||
42337942|NCT02027701|76175806|FG000|Overall Study|Lack of Efficacy|8|||
42337943|NCT02027701|76175806|FG000|Overall Study|Physician Decision|2|||
42337944|NCT02027701|76175806|FG000|Overall Study|Withdrawal by Subject|3|||
42337945|NCT02038790|76175812|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
42337946|NCT02038790|76175813|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
42337947|NCT02027623|76175822|FG000|Overall Study|Lost to Follow-up|3|||
42337948|NCT02027623|76175823|FG001|Overall Study|Lost to Follow-up|3|||
42337949|NCT02027623|76175822|FG000|Overall Study|Withdrawal by Subject|6|||
42337950|NCT02027623|76175823|FG001|Overall Study|Withdrawal by Subject|9|||
42337951|NCT02015221|76175832|FG000|Overall Study|Withdrawal by Subject|8|||
42034850|NCT01059864|75843164|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
42266163|NCT01369355|76094330|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
42266164|NCT01369355|76094331|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
42266165|NCT01369355|76094332|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
42337952|NCT02015221|76175833|FG001|Overall Study|Withdrawal by Subject|6|||
42337953|NCT02015221|76175832|FG000|Overall Study|Lost to Follow-up|1|||
42337954|NCT02015221|76175833|FG001|Overall Study|Lost to Follow-up|0|||
42337955|NCT02027311|76175841|FG000|Overall Study|Protocol Violation|3|||
42337956|NCT02027311|76175842|FG001|Overall Study|Protocol Violation|2|||
42337957|NCT02047903|76175850|FG000|Overall Study|Adverse Event|14|||
42337958|NCT02047903|76175850|FG000|Overall Study|Serious adverse event|10|||
42337959|NCT02047903|76175850|FG000|Overall Study|Withdrawal by Subject|16|||
42337960|NCT02047903|76175850|FG000|Overall Study|Lost to Follow-up|4|||
42034851|NCT01035138|75843174|FG000|Overall Study|Adverse Event|4|||
42337961|NCT02047903|76175850|FG000|Overall Study|Reason not listed|6|||
42337962|NCT02047903|76175850|FG000|Overall Study|Not Treated|9|||
42337963|NCT02015065|76175857|FG000|Overall Study|Death on study|1|||
42337964|NCT02015065|76175858|FG001|Overall Study|Death on study|2|||
42337965|NCT02015065|76175859|FG002|Overall Study|Death on study|1|||
42337966|NCT02026141|76175869|FG000|Overall Study|Protocol Violation|0|||
42337967|NCT02026141|76175870|FG001|Overall Study|Protocol Violation|1|||
42337968|NCT02026063|76175878|FG000|Overall Study|Physician Decision|0|||
42337969|NCT02026063|76175879|FG001|Overall Study|Physician Decision|10|||
42266166|NCT01369355|76094333|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
42266167|NCT01369355|76094334|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
42266168|NCT01369355|76094335|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
42266169|NCT01369355|76094327|FG000|Long-term Extension (Week 44-272)|Death|0|||
42266170|NCT01369355|76094328|FG001|Long-term Extension (Week 44-272)|Death|0|||
42266171|NCT01369355|76094329|FG002|Long-term Extension (Week 44-272)|Death|0|||
42266172|NCT01369355|76094330|FG003|Long-term Extension (Week 44-272)|Death|0|||
42266173|NCT01369355|76094331|FG004|Long-term Extension (Week 44-272)|Death|0|||
42266174|NCT01369355|76094332|FG005|Long-term Extension (Week 44-272)|Death|0|||
42266175|NCT01369355|76094333|FG006|Long-term Extension (Week 44-272)|Death|0|||
42266176|NCT01369355|76094334|FG007|Long-term Extension (Week 44-272)|Death|1|||
42266177|NCT01369355|76094335|FG008|Long-term Extension (Week 44-272)|Death|3|||
42266178|NCT01369355|76094327|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
42266179|NCT01369355|76094328|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
42266180|NCT01369355|76094329|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
42266181|NCT01369355|76094330|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
42266182|NCT01369355|76094331|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
42266183|NCT01369355|76094332|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
42266184|NCT01369355|76094333|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
42266185|NCT01369355|76094334|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
42266186|NCT01369355|76094335|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
42266187|NCT01369355|76094327|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
42266188|NCT01369355|76094328|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
42266189|NCT01369355|76094329|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
42266190|NCT01369355|76094330|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
42337970|NCT02026063|76175878|FG000|Overall Study|Noncompliance with Study Drug|1|||
42337971|NCT02026063|76175879|FG001|Overall Study|Noncompliance with Study Drug|1|||
42337972|NCT02026063|76175878|FG000|Overall Study|Withdrawal of Consent|1|||
42337973|NCT02026063|76175879|FG001|Overall Study|Withdrawal of Consent|6|||
42337974|NCT02026063|76175878|FG000|Overall Study|Adverse Event|5|||
42337975|NCT02026063|76175879|FG001|Overall Study|Adverse Event|20|||
42266191|NCT01369355|76094331|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
42266192|NCT01369355|76094332|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
42266193|NCT01369355|76094333|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
42266194|NCT01369355|76094334|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
42266195|NCT01369355|76094335|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
42266196|NCT01369355|76094327|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
42000505|NCT01173601|75808974|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
42000506|NCT01173601|75808970|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
42000507|NCT01173601|75808971|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
42337976|NCT02026063|76175878|FG000|Overall Study|Lack of Efficacy|0|||
42337977|NCT02026063|76175879|FG001|Overall Study|Lack of Efficacy|4|||
42337978|NCT02026063|76175878|FG000|Overall Study|Lost to Follow-up|0|||
42337979|NCT02026063|76175879|FG001|Overall Study|Lost to Follow-up|1|||
42337980|NCT02026063|76175878|FG000|Overall Study|Reason not Specified|2|||
42337981|NCT02026063|76175879|FG001|Overall Study|Reason not Specified|7|||
42337982|NCT02025907|76175888|FG000|Overall Study|Lack of Efficacy|1|||
42337983|NCT02025907|76175889|FG001|Overall Study|Lack of Efficacy|0|||
42337984|NCT02025907|76175888|FG000|Overall Study|Withdrawal by Subject|15|||
42337985|NCT02025907|76175889|FG001|Overall Study|Withdrawal by Subject|8|||
42337986|NCT02025907|76175888|FG000|Overall Study|Protocol Violation|2|||
42337987|NCT02025907|76175889|FG001|Overall Study|Protocol Violation|0|||
42337988|NCT02025907|76175888|FG000|Overall Study|Physician Decision|2|||
42337989|NCT02025907|76175889|FG001|Overall Study|Physician Decision|0|||
42337990|NCT02025907|76175888|FG000|Overall Study|Lost to Follow-up|2|||
42337991|NCT02025907|76175889|FG001|Overall Study|Lost to Follow-up|2|||
42337992|NCT02025907|76175888|FG000|Overall Study|Adverse Event|3|||
42337993|NCT02025907|76175889|FG001|Overall Study|Adverse Event|1|||
42337994|NCT02025907|76175888|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
42337995|NCT02025907|76175889|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
42337996|NCT01813071|76175904|FG000|Overall Study|Protocol Violation|0|||
42337997|NCT01813071|76175905|FG001|Overall Study|Protocol Violation|0|||
42337998|NCT01813071|76175906|FG002|Overall Study|Protocol Violation|0|||
42337999|NCT01813071|76175907|FG003|Overall Study|Protocol Violation|0|||
42338000|NCT01813071|76175908|FG004|Overall Study|Protocol Violation|1|||
42338001|NCT01813071|76175909|FG005|Overall Study|Protocol Violation|4|||
42338002|NCT01813071|76175910|FG006|Overall Study|Protocol Violation|2|||
42338003|NCT01813071|76175911|FG007|Overall Study|Protocol Violation|4|||
42338004|NCT01813071|76175912|FG008|Overall Study|Protocol Violation|2|||
42338005|NCT01813071|76175904|FG000|Overall Study|Withdrawal by Subject|0|||
42338006|NCT01813071|76175905|FG001|Overall Study|Withdrawal by Subject|0|||
42338007|NCT01813071|76175906|FG002|Overall Study|Withdrawal by Subject|0|||
42338008|NCT01813071|76175907|FG003|Overall Study|Withdrawal by Subject|0|||
42338009|NCT01813071|76175908|FG004|Overall Study|Withdrawal by Subject|0|||
42338010|NCT01813071|76175909|FG005|Overall Study|Withdrawal by Subject|1|||
42338011|NCT01813071|76175910|FG006|Overall Study|Withdrawal by Subject|0|||
42338012|NCT01813071|76175911|FG007|Overall Study|Withdrawal by Subject|0|||
42338013|NCT01813071|76175912|FG008|Overall Study|Withdrawal by Subject|0|||
42338014|NCT01813071|76175904|FG000|Overall Study|Adverse Event|0|||
42338015|NCT01813071|76175905|FG001|Overall Study|Adverse Event|0|||
42338016|NCT01813071|76175906|FG002|Overall Study|Adverse Event|0|||
42338017|NCT01813071|76175907|FG003|Overall Study|Adverse Event|0|||
42338018|NCT01813071|76175908|FG004|Overall Study|Adverse Event|0|||
42338019|NCT01813071|76175909|FG005|Overall Study|Adverse Event|1|||
42338020|NCT01813071|76175910|FG006|Overall Study|Adverse Event|0|||
42266197|NCT01369355|76094328|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
42266198|NCT01369355|76094329|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
42338021|NCT01813071|76175911|FG007|Overall Study|Adverse Event|0|||
42338022|NCT01813071|76175912|FG008|Overall Study|Adverse Event|0|||
42338023|NCT01813071|76175904|FG000|Overall Study|Physician Decision|0|||
42338024|NCT01813071|76175905|FG001|Overall Study|Physician Decision|0|||
42338025|NCT01813071|76175906|FG002|Overall Study|Physician Decision|0|||
42338026|NCT01813071|76175907|FG003|Overall Study|Physician Decision|0|||
42338027|NCT01813071|76175908|FG004|Overall Study|Physician Decision|0|||
42338028|NCT01813071|76175909|FG005|Overall Study|Physician Decision|0|||
42338029|NCT01813071|76175910|FG006|Overall Study|Physician Decision|1|||
42266199|NCT01369355|76094330|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
42266200|NCT01369355|76094331|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
42266201|NCT01369355|76094332|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
42266202|NCT01369355|76094333|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
42266203|NCT01369355|76094334|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
42266204|NCT01369355|76094335|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
42266205|NCT01369355|76094327|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
42338030|NCT01813071|76175911|FG007|Overall Study|Physician Decision|0|||
42338031|NCT01813071|76175912|FG008|Overall Study|Physician Decision|0|||
42338032|NCT01813071|76175904|FG000|Overall Study|Met inc/exc criteria|0|||
42338033|NCT01813071|76175905|FG001|Overall Study|Met inc/exc criteria|0|||
42338034|NCT01813071|76175906|FG002|Overall Study|Met inc/exc criteria|0|||
42338035|NCT01813071|76175907|FG003|Overall Study|Met inc/exc criteria|0|||
42338036|NCT01813071|76175908|FG004|Overall Study|Met inc/exc criteria|0|||
42338037|NCT01813071|76175909|FG005|Overall Study|Met inc/exc criteria|1|||
42338038|NCT01813071|76175910|FG006|Overall Study|Met inc/exc criteria|0|||
42338039|NCT01813071|76175911|FG007|Overall Study|Met inc/exc criteria|1|||
42338040|NCT01813071|76175912|FG008|Overall Study|Met inc/exc criteria|1|||
42338041|NCT02025751|76175948|FG000|Overall Study|Lost to Follow-up|1|||
42338042|NCT02025751|76175949|FG001|Overall Study|Lost to Follow-up|0|||
42338043|NCT02025751|76175948|FG000|Overall Study|Adverse Event|0|||
42338044|NCT02025751|76175949|FG001|Overall Study|Adverse Event|1|||
42338045|NCT02025751|76175948|FG000|Overall Study|Physician Decision|0|||
42338046|NCT02025751|76175949|FG001|Overall Study|Physician Decision|1|||
42338047|NCT02025751|76175948|FG000|Overall Study|Withdrawal by Subject|0|||
42338048|NCT02025751|76175949|FG001|Overall Study|Withdrawal by Subject|1|||
42338049|NCT02025205|76175957|FG000|Overall Study|Withdrawal by Subject|1|||
42338050|NCT02025205|76175958|FG001|Overall Study|Withdrawal by Subject|1|||
42338051|NCT02025205|76175957|FG000|Overall Study|Protocol Violation|2|||
42338052|NCT02025205|76175958|FG001|Overall Study|Protocol Violation|1|||
42338053|NCT02025205|76175957|FG000|Overall Study|Death|0|||
42338054|NCT02025205|76175958|FG001|Overall Study|Death|1|||
42338055|NCT01812837|76175967|FG000|Overall Study|Lost to Follow-up|1|||
42338056|NCT01812837|76175968|FG001|Overall Study|Lost to Follow-up|1|||
42338057|NCT01812837|76175969|FG002|Overall Study|Lost to Follow-up|0|||
42338058|NCT01812837|76175967|FG000|Overall Study|Protocol Violation|1|||
42338059|NCT01812837|76175968|FG001|Overall Study|Protocol Violation|0|||
42338060|NCT01812837|76175969|FG002|Overall Study|Protocol Violation|0|||
42338061|NCT02024971|76175977|FG000|Overall Study|Data Not Available|30|||
42338062|NCT02024971|76175977|FG000|Overall Study|Lost to Follow-up|6|||
42338063|NCT01843023|76175983|FG000|Overall Study|Death|1|||
42338064|NCT01843023|76175984|FG001|Overall Study|Death|0|||
42338065|NCT01843023|76175983|FG000|Overall Study|Lost to Follow-up|24|||
42338066|NCT01843023|76175984|FG001|Overall Study|Lost to Follow-up|29|||
42338067|NCT01843023|76175983|FG000|Overall Study|Withdrawal by Subject|8|||
42338068|NCT01843023|76175984|FG001|Overall Study|Withdrawal by Subject|6|||
42338069|NCT01812759|76175993|FG000|Overall Study|Physician Decision|0|||
42338070|NCT01812759|76175994|FG001|Overall Study|Physician Decision|0|||
42338071|NCT01812759|76175995|FG002|Overall Study|Physician Decision|1|||
42338072|NCT01812057|76176005|FG000|Overall Study|Protocol Violation|1|||
42338073|NCT01812057|76176006|FG001|Overall Study|Protocol Violation|0|||
42338074|NCT01812057|76176005|FG000|Overall Study|Physician Decision|1|||
42338075|NCT01812057|76176006|FG001|Overall Study|Physician Decision|0|||
42338076|NCT01842633|76176019|FG000|Overall Study|Screen Failure|1|||
42338077|NCT01842633|76176020|FG001|Overall Study|Screen Failure|0|||
42338078|NCT01842633|76176021|FG002|Overall Study|Screen Failure|0|||
42338079|NCT01842633|76176019|FG000|Overall Study|Adverse Event|1|||
42338080|NCT01842633|76176020|FG001|Overall Study|Adverse Event|1|||
42338081|NCT01842633|76176021|FG002|Overall Study|Adverse Event|0|||
42338082|NCT01842633|76176019|FG000|Overall Study|Withdrawal by Subject|0|||
42338083|NCT01842633|76176020|FG001|Overall Study|Withdrawal by Subject|1|||
42338084|NCT01842633|76176021|FG002|Overall Study|Withdrawal by Subject|0|||
42338085|NCT01842633|76176019|FG000|Overall Study|Technical issues|1|||
42338086|NCT01842633|76176020|FG001|Overall Study|Technical issues|0|||
42338087|NCT01842633|76176021|FG002|Overall Study|Technical issues|0|||
42338088|NCT01810263|76176033|FG000|Overall Study|Lost to Follow-up|8|||
42338089|NCT01810263|76176034|FG001|Overall Study|Lost to Follow-up|7|||
42266206|NCT01369355|76094328|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
42266207|NCT01369355|76094329|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
42266208|NCT01369355|76094330|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
42266209|NCT01369355|76094331|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
42266210|NCT01369355|76094332|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
42266211|NCT01369355|76094333|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
42266212|NCT01369355|76094334|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
42266213|NCT01369355|76094335|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
42266214|NCT01369355|76094327|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
42338090|NCT01841697|76176042|FG000|Overall Study|Death|0|||
42338091|NCT01841697|76176043|FG001|Overall Study|Death|1|||
42338092|NCT01841697|76176042|FG000|Overall Study|Lost to Follow-up|4|||
42338093|NCT01841697|76176043|FG001|Overall Study|Lost to Follow-up|1|||
42338094|NCT01841697|76176042|FG000|Overall Study|Withdrawal by Subject|16|||
42338095|NCT01841697|76176043|FG001|Overall Study|Withdrawal by Subject|16|||
42338096|NCT01841073|76176051|FG000|Overall Study|Adverse Event|1|||
42338097|NCT01841073|76176052|FG001|Overall Study|Adverse Event|1|||
42338098|NCT01841073|76176051|FG000|Overall Study|Physician Decision|1|||
42338099|NCT01841073|76176052|FG001|Overall Study|Physician Decision|0|||
42338100|NCT01841073|76176051|FG000|Overall Study|Lost to Follow-up|0|||
42338101|NCT01841073|76176052|FG001|Overall Study|Lost to Follow-up|2|||
42338102|NCT01809327|76176065|FG000|Overall Study|Lost to Follow-up|5|||
42338103|NCT01809327|76176066|FG001|Overall Study|Lost to Follow-up|2|||
42338104|NCT01809327|76176067|FG002|Overall Study|Lost to Follow-up|4|||
42338105|NCT01809327|76176068|FG003|Overall Study|Lost to Follow-up|2|||
42338106|NCT01809327|76176069|FG004|Overall Study|Lost to Follow-up|3|||
42338107|NCT01809327|76176065|FG000|Overall Study|Withdrawal by Subject|6|||
42338108|NCT01809327|76176066|FG001|Overall Study|Withdrawal by Subject|4|||
42338109|NCT01809327|76176067|FG002|Overall Study|Withdrawal by Subject|4|||
42338110|NCT01809327|76176068|FG003|Overall Study|Withdrawal by Subject|2|||
42338111|NCT01809327|76176069|FG004|Overall Study|Withdrawal by Subject|5|||
42338112|NCT01809327|76176065|FG000|Overall Study|Adverse Event|4|||
42338113|NCT01809327|76176066|FG001|Overall Study|Adverse Event|3|||
42338114|NCT01809327|76176067|FG002|Overall Study|Adverse Event|7|||
42338115|NCT01809327|76176068|FG003|Overall Study|Adverse Event|4|||
42338116|NCT01809327|76176069|FG004|Overall Study|Adverse Event|8|||
42338117|NCT01809327|76176065|FG000|Overall Study|Death|1|||
42338118|NCT01809327|76176066|FG001|Overall Study|Death|0|||
42338119|NCT01809327|76176067|FG002|Overall Study|Death|0|||
42338120|NCT01809327|76176068|FG003|Overall Study|Death|0|||
42338121|NCT01809327|76176069|FG004|Overall Study|Death|0|||
42338122|NCT01809327|76176065|FG000|Overall Study|Protocol Violation|0|||
42338123|NCT01809327|76176066|FG001|Overall Study|Protocol Violation|1|||
42338124|NCT01809327|76176067|FG002|Overall Study|Protocol Violation|0|||
42338125|NCT01809327|76176068|FG003|Overall Study|Protocol Violation|0|||
42338126|NCT01809327|76176069|FG004|Overall Study|Protocol Violation|0|||
42338127|NCT01809327|76176065|FG000|Overall Study|Physician Decision|1|||
42338128|NCT01809327|76176066|FG001|Overall Study|Physician Decision|1|||
42338129|NCT01809327|76176067|FG002|Overall Study|Physician Decision|0|||
42338130|NCT01809327|76176068|FG003|Overall Study|Physician Decision|0|||
42338131|NCT01809327|76176069|FG004|Overall Study|Physician Decision|0|||
42338132|NCT01809327|76176065|FG000|Overall Study|Pregnancy|1|||
42338133|NCT01809327|76176066|FG001|Overall Study|Pregnancy|0|||
42338134|NCT01809327|76176067|FG002|Overall Study|Pregnancy|0|||
42338135|NCT01809327|76176068|FG003|Overall Study|Pregnancy|0|||
42338136|NCT01809327|76176069|FG004|Overall Study|Pregnancy|0|||
42338137|NCT01809327|76176065|FG000|Overall Study|Other|14|||
42338138|NCT01809327|76176066|FG001|Overall Study|Other|15|||
42338139|NCT01809327|76176067|FG002|Overall Study|Other|7|||
42338140|NCT01809327|76176068|FG003|Overall Study|Other|4|||
42338141|NCT01809327|76176069|FG004|Overall Study|Other|9|||
42338142|NCT01808313|76176090|FG000|Overall Study|Adverse Event|5|||
42338143|NCT01808313|76176090|FG000|Overall Study|Protocol Violation|2|||
42338144|NCT01808313|76176090|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
42338145|NCT01808313|76176090|FG000|Overall Study|Lost to Follow-up|1|||
42338146|NCT01808313|76176090|FG000|Overall Study|Physician Decision|1|||
42338147|NCT01840605|76176096|FG000|Overall Study|Adverse Event|0|||
42338148|NCT01840605|76176097|FG001|Overall Study|Adverse Event|1|||
42338149|NCT01840605|76176096|FG000|Overall Study|Physician Decision|2|||
42338150|NCT01840605|76176097|FG001|Overall Study|Physician Decision|1|||
42338151|NCT02023879|76176106|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
42338152|NCT02023879|76176107|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
42338153|NCT02023879|76176108|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
42338154|NCT02023879|76176106|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
42338155|NCT02023879|76176107|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
42338156|NCT02023879|76176108|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
42338157|NCT02023879|76176106|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
42338158|NCT02023879|76176107|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
42338159|NCT02023879|76176108|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
42338160|NCT02023879|76176106|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
42338161|NCT02023879|76176107|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
42338162|NCT02023879|76176108|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
42338163|NCT02023879|76176106|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
42338164|NCT02023879|76176107|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
42338165|NCT02023879|76176108|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
42266215|NCT01369355|76094328|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
42338166|NCT02023879|76176106|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
42338167|NCT02023879|76176107|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
42338168|NCT02023879|76176108|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
42338169|NCT02023879|76176106|FG000|Extension Open Label Treatment|Adverse Event|1|||
42338170|NCT02023879|76176107|FG001|Extension Open Label Treatment|Adverse Event|7|||
42338171|NCT02023879|76176108|FG002|Extension Open Label Treatment|Adverse Event|3|||
42338172|NCT02023879|76176106|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
42338173|NCT02023879|76176107|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
42338174|NCT02023879|76176108|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
42338175|NCT02023879|76176106|FG000|Extension Open Label Treatment|Participant moved|1|||
42338176|NCT02023879|76176107|FG001|Extension Open Label Treatment|Participant moved|2|||
42338177|NCT02023879|76176108|FG002|Extension Open Label Treatment|Participant moved|0|||
42338178|NCT02023879|76176106|FG000|Extension Open Label Treatment|Other than specified above|2|||
42338179|NCT02023879|76176107|FG001|Extension Open Label Treatment|Other than specified above|7|||
42338180|NCT02023879|76176108|FG002|Extension Open Label Treatment|Other than specified above|2|||
42338181|NCT02014441|76176123|FG000|Overall Study|Withdrawal by Subject|12|||
42338182|NCT02013817|76176129|FG000|Overall Study|Adverse Event|12|||
42338183|NCT02013817|76176129|FG000|Overall Study|Withdrawal by Subject|4|||
42338184|NCT02013817|76176129|FG000|Overall Study|Death|2|||
42338185|NCT02013817|76176129|FG000|Overall Study|Other|9|||
42338186|NCT01994863|76176133|FG000|Period 1|Adverse Event|4|||
42338187|NCT01994863|76176134|FG001|Period 1|Adverse Event|0|||
42338188|NCT01994863|76176133|FG000|Period 1|Withdrawal by Subject|1|||
42338189|NCT01994863|76176134|FG001|Period 1|Withdrawal by Subject|0|||
42338190|NCT01994863|76176133|FG000|Period 1|Trial stopped by sponsor|1|||
42338191|NCT01994863|76176134|FG001|Period 1|Trial stopped by sponsor|3|||
42338192|NCT01994863|76176133|FG000|Period 1|Lack of Efficacy|1|||
42338193|NCT01994863|76176134|FG001|Period 1|Lack of Efficacy|0|||
42338194|NCT01994863|76176133|FG000|Period 2|Adverse Event|0|||
42338195|NCT01994863|76176134|FG001|Period 2|Adverse Event|1|||
42338196|NCT01994863|76176133|FG000|Period 2|Lack of Efficacy|0|||
42338197|NCT01994863|76176134|FG001|Period 2|Lack of Efficacy|2|||
42338198|NCT01994863|76176133|FG000|Period 2|Withdrawal by Subject|1|||
42338199|NCT01994863|76176134|FG001|Period 2|Withdrawal by Subject|1|||
42266216|NCT01369355|76094329|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
42266217|NCT01369355|76094330|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
42266218|NCT01369355|76094331|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
42266219|NCT01369355|76094332|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
42266220|NCT01369355|76094333|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
42266221|NCT01369355|76094334|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
42266222|NCT01369355|76094335|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
42266223|NCT01369355|76094327|FG000|Long-term Extension (Week 44-272)|Other|0|||
42266224|NCT01369355|76094328|FG001|Long-term Extension (Week 44-272)|Other|0|||
42266225|NCT01369355|76094329|FG002|Long-term Extension (Week 44-272)|Other|0|||
42266226|NCT01369355|76094330|FG003|Long-term Extension (Week 44-272)|Other|0|||
42266227|NCT01369355|76094331|FG004|Long-term Extension (Week 44-272)|Other|0|||
42266228|NCT01369355|76094332|FG005|Long-term Extension (Week 44-272)|Other|0|||
42266229|NCT01369355|76094333|FG006|Long-term Extension (Week 44-272)|Other|110|||
42266230|NCT01369355|76094334|FG007|Long-term Extension (Week 44-272)|Other|9|||
42338200|NCT02023099|76176143|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
42338201|NCT02023099|76176144|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
42338202|NCT02023099|76176145|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
42338203|NCT02023099|76176143|FG000|Overall Study|Withdrawn Consent|3|||
42338204|NCT02023099|76176144|FG001|Overall Study|Withdrawn Consent|0|||
42338205|NCT02023099|76176145|FG002|Overall Study|Withdrawn Consent|1|||
42338206|NCT02023099|76176143|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
42338207|NCT02023099|76176144|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
42338208|NCT02023099|76176145|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
42338209|NCT02013037|76176153|FG000|Overall Study|Death|6|||
42338210|NCT02013037|76176153|FG000|Overall Study|Withdrawal by Subject|1|||
42338211|NCT02013037|76176153|FG000|Overall Study|Awaiting Transplantation|7|||
42338212|NCT02013037|76176153|FG000|Overall Study|Transplanted without DSA|2|||
42338213|NCT01967719|76176160|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
42338214|NCT01967719|76176161|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
42338215|NCT01967719|76176162|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
42338216|NCT01967719|76176163|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
42338217|NCT01967719|76176160|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
42338218|NCT01967719|76176161|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
42338219|NCT01967719|76176162|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
42338220|NCT01967719|76176163|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
42338221|NCT01967173|76176181|FG000|Overall Study|Lost to Follow-up|5|||
42338222|NCT01967173|76176182|FG001|Overall Study|Lost to Follow-up|3|||
42338223|NCT01967173|76176183|FG002|Overall Study|Lost to Follow-up|2|||
42338224|NCT01967173|76176184|FG003|Overall Study|Lost to Follow-up|4|||
42338225|NCT01967173|76176185|FG004|Overall Study|Lost to Follow-up|8|||
42338226|NCT01967173|76176186|FG005|Overall Study|Lost to Follow-up|12|||
42338227|NCT01967173|76176187|FG006|Overall Study|Lost to Follow-up|6|||
42338228|NCT01967173|76176188|FG007|Overall Study|Lost to Follow-up|8|||
42338229|NCT01967173|76176181|FG000|Overall Study|Physician Decision|2|||
42338230|NCT01967173|76176182|FG001|Overall Study|Physician Decision|0|||
42338231|NCT01967173|76176183|FG002|Overall Study|Physician Decision|2|||
42338232|NCT01967173|76176184|FG003|Overall Study|Physician Decision|1|||
42338233|NCT01967173|76176185|FG004|Overall Study|Physician Decision|1|||
42338234|NCT01967173|76176186|FG005|Overall Study|Physician Decision|1|||
42338235|NCT01967173|76176187|FG006|Overall Study|Physician Decision|1|||
42338236|NCT01967173|76176188|FG007|Overall Study|Physician Decision|0|||
42338237|NCT01967173|76176181|FG000|Overall Study|Lack of Efficacy|2|||
42338238|NCT01967173|76176182|FG001|Overall Study|Lack of Efficacy|0|||
42338239|NCT01967173|76176183|FG002|Overall Study|Lack of Efficacy|2|||
42338240|NCT01967173|76176184|FG003|Overall Study|Lack of Efficacy|2|||
42338241|NCT01967173|76176185|FG004|Overall Study|Lack of Efficacy|0|||
42338242|NCT01967173|76176186|FG005|Overall Study|Lack of Efficacy|1|||
42338243|NCT01967173|76176187|FG006|Overall Study|Lack of Efficacy|0|||
42000508|NCT01173601|75808972|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
42000509|NCT01173601|75808973|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
42000510|NCT01173601|75808974|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
42000511|NCT01173523|75808994|FG000|Overall Study|Clinical Progression|1|||
42000512|NCT01173523|75808995|FG001|Overall Study|Clinical Progression|1|||
42000513|NCT01173523|75808994|FG000|Overall Study|Progressive Disease|10|||
42000514|NCT01173523|75808995|FG001|Overall Study|Progressive Disease|8|||
42135053|NCT00372567|75945809|FG001|Phase 3 Study|Adverse Event|1|||
42266231|NCT01369355|76094335|FG008|Long-term Extension (Week 44-272)|Other|17|||
42266232|NCT02614196|76094358|FG000|Double Blind Treatment Phase|Adverse Event|8|||
42266233|NCT02614196|76094359|FG001|Double Blind Treatment Phase|Adverse Event|5|||
42266234|NCT02614196|76094360|FG002|Double Blind Treatment Phase|Adverse Event|9|||
42266235|NCT02614196|76094361|FG003|Double Blind Treatment Phase|Adverse Event|0|||
42266236|NCT02614196|76094362|FG004|Double Blind Treatment Phase|Adverse Event|0|||
42266237|NCT02614196|76094363|FG005|Double Blind Treatment Phase|Adverse Event|0|||
42266238|NCT02614196|76094358|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
42266239|NCT02614196|76094359|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
42266240|NCT02614196|76094360|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
42266241|NCT02614196|76094361|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
42266242|NCT02614196|76094362|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
42266243|NCT02614196|76094363|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
42338244|NCT01967173|76176188|FG007|Overall Study|Lack of Efficacy|2|||
42338245|NCT01967173|76176181|FG000|Overall Study|Pregnancy|0|||
42266244|NCT02614196|76094358|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
42338246|NCT01967173|76176182|FG001|Overall Study|Pregnancy|0|||
42338247|NCT01967173|76176183|FG002|Overall Study|Pregnancy|0|||
42338248|NCT01967173|76176184|FG003|Overall Study|Pregnancy|0|||
42338249|NCT01967173|76176185|FG004|Overall Study|Pregnancy|0|||
42338250|NCT01967173|76176186|FG005|Overall Study|Pregnancy|0|||
42000515|NCT01173523|75808994|FG000|Overall Study|Other|2|||
42000516|NCT01173523|75808995|FG001|Overall Study|Other|3|||
42000517|NCT01173055|75809003|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
42000518|NCT01173055|75809004|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
42000519|NCT01173055|75809003|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
42000520|NCT01173055|75809004|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
42000521|NCT01172938|75809013|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
42000522|NCT01172938|75809014|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
42000523|NCT01172938|75809015|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
42000524|NCT01172938|75809016|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42000525|NCT01172938|75809017|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42000526|NCT01172938|75809018|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42000527|NCT01172938|75809019|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42000528|NCT01172938|75809020|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42000529|NCT01172938|75809021|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
42000530|NCT01172938|75809013|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
42000531|NCT01172938|75809014|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
42000532|NCT01172938|75809015|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
42000533|NCT01172938|75809016|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42000534|NCT01172938|75809017|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42000535|NCT01172938|75809018|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42000536|NCT01172938|75809019|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42000537|NCT01172938|75809020|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42000538|NCT01172938|75809021|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
42000539|NCT01172938|75809013|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42000540|NCT01172938|75809014|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
42338251|NCT01967173|76176187|FG006|Overall Study|Pregnancy|1|||
42338252|NCT01967173|76176188|FG007|Overall Study|Pregnancy|1|||
42338253|NCT01967173|76176181|FG000|Overall Study|Adverse Event|0|||
42338254|NCT01967173|76176182|FG001|Overall Study|Adverse Event|0|||
42338255|NCT01967173|76176183|FG002|Overall Study|Adverse Event|0|||
42338256|NCT01967173|76176184|FG003|Overall Study|Adverse Event|0|||
42338257|NCT01967173|76176185|FG004|Overall Study|Adverse Event|0|||
42338258|NCT01967173|76176186|FG005|Overall Study|Adverse Event|0|||
42338259|NCT01967173|76176187|FG006|Overall Study|Adverse Event|0|||
42338260|NCT01967173|76176188|FG007|Overall Study|Adverse Event|1|||
42338261|NCT01967173|76176181|FG000|Overall Study|Withdrawal by Subject|15|||
42338262|NCT01967173|76176182|FG001|Overall Study|Withdrawal by Subject|14|||
42338263|NCT01967173|76176183|FG002|Overall Study|Withdrawal by Subject|10|||
42338264|NCT01967173|76176184|FG003|Overall Study|Withdrawal by Subject|7|||
42338265|NCT01967173|76176185|FG004|Overall Study|Withdrawal by Subject|8|||
42338266|NCT01967173|76176186|FG005|Overall Study|Withdrawal by Subject|9|||
42338267|NCT01967173|76176187|FG006|Overall Study|Withdrawal by Subject|10|||
42338268|NCT01967173|76176188|FG007|Overall Study|Withdrawal by Subject|12|||
42338269|NCT01994629|76176202|FG000|Overall Study|Withdrawal by Subject|1|||
42338270|NCT01994629|76176203|FG001|Overall Study|Withdrawal by Subject|0|||
42338271|NCT01994629|76176202|FG000|Overall Study|Lost to Follow-up|0|||
42338272|NCT01994629|76176203|FG001|Overall Study|Lost to Follow-up|3|||
42338273|NCT01994395|76176211|FG000|Overall Study|Withdrawal by Subject|1|||
42338274|NCT01994395|76176212|FG001|Overall Study|Withdrawal by Subject|2|||
42338275|NCT01992536|76176228|FG000|Overall Study|Administrative Reason|0|||
42338276|NCT01992536|76176229|FG001|Overall Study|Administrative Reason|0|||
42338277|NCT01992536|76176230|FG002|Overall Study|Administrative Reason|0|||
42338278|NCT01992536|76176231|FG003|Overall Study|Administrative Reason|0|||
42338279|NCT01992536|76176232|FG004|Overall Study|Administrative Reason|0|||
42338280|NCT01992536|76176233|FG005|Overall Study|Administrative Reason|0|||
42338281|NCT01992536|76176234|FG006|Overall Study|Administrative Reason|7|||
42338282|NCT01992536|76176235|FG007|Overall Study|Administrative Reason|0|||
42338283|NCT01992536|76176236|FG008|Overall Study|Administrative Reason|0|||
42338284|NCT01992536|76176237|FG009|Overall Study|Administrative Reason|0|||
42338285|NCT01992536|76176228|FG000|Overall Study|Lost to Follow-up|4|||
42338286|NCT01992536|76176229|FG001|Overall Study|Lost to Follow-up|2|||
42338287|NCT01992536|76176230|FG002|Overall Study|Lost to Follow-up|1|||
42338288|NCT01992536|76176231|FG003|Overall Study|Lost to Follow-up|0|||
42135054|NCT00372567|75945810|FG002|Phase 3 Study|Adverse Event|1|||
42135055|NCT00372567|75945808|FG000|Phase 3 Study|Death|1|||
42135056|NCT00372567|75945809|FG001|Phase 3 Study|Death|1|||
42135057|NCT00372567|75945810|FG002|Phase 3 Study|Death|0|||
42000541|NCT01172938|75809015|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
42000542|NCT01172938|75809016|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42000543|NCT01172938|75809017|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42000544|NCT01172938|75809018|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42000545|NCT01172938|75809019|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42000546|NCT01172938|75809020|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42000547|NCT01172938|75809021|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
42000548|NCT01172938|75809013|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
42000549|NCT01172938|75809014|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
42000550|NCT01172938|75809015|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
42000551|NCT01172938|75809016|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42000552|NCT01172938|75809017|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42000553|NCT01172938|75809018|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42000554|NCT01172938|75809019|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42000555|NCT01172938|75809020|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42000556|NCT01172938|75809021|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
42000557|NCT01172938|75809013|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
42000558|NCT01172938|75809014|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
42000559|NCT01172938|75809015|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
42000560|NCT01172938|75809016|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
42000561|NCT01172938|75809017|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
42000562|NCT01172938|75809018|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
42000563|NCT01172938|75809019|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
42000564|NCT01172938|75809020|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
42000565|NCT01172938|75809021|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
42000566|NCT01172938|75809013|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
42135058|NCT00372567|75945808|FG000|Phase 3 Study|Protocol Violation|0|||
42338289|NCT01992536|76176232|FG004|Overall Study|Lost to Follow-up|0|||
42338290|NCT01992536|76176233|FG005|Overall Study|Lost to Follow-up|1|||
42338291|NCT01992536|76176234|FG006|Overall Study|Lost to Follow-up|0|||
42338292|NCT01992536|76176235|FG007|Overall Study|Lost to Follow-up|0|||
42338293|NCT01992536|76176236|FG008|Overall Study|Lost to Follow-up|1|||
42338294|NCT01992536|76176237|FG009|Overall Study|Lost to Follow-up|1|||
42338295|NCT01992536|76176228|FG000|Overall Study|Withdrawal by Subject|0|||
42135059|NCT00372567|75945809|FG001|Phase 3 Study|Protocol Violation|0|||
42338296|NCT01992536|76176229|FG001|Overall Study|Withdrawal by Subject|1|||
42338297|NCT01992536|76176230|FG002|Overall Study|Withdrawal by Subject|0|||
42338298|NCT01992536|76176231|FG003|Overall Study|Withdrawal by Subject|2|||
42338299|NCT01992536|76176232|FG004|Overall Study|Withdrawal by Subject|0|||
42338300|NCT01992536|76176233|FG005|Overall Study|Withdrawal by Subject|0|||
42338301|NCT01992536|76176234|FG006|Overall Study|Withdrawal by Subject|0|||
42338302|NCT01992536|76176235|FG007|Overall Study|Withdrawal by Subject|0|||
42338303|NCT01992536|76176236|FG008|Overall Study|Withdrawal by Subject|0|||
42338304|NCT01992536|76176237|FG009|Overall Study|Withdrawal by Subject|0|||
42338305|NCT01993927|76176279|FG000|Overall Study|Case Report Forms Uncollected|18|||
42338306|NCT01993927|76176279|FG000|Overall Study|Protocol Violation|11|||
42338307|NCT02015390|76176285|FG000|Overall Study|Lost to Follow-up|1|||
42338308|NCT02015390|76176286|FG001|Overall Study|Lost to Follow-up|0|||
42338309|NCT02015390|76176285|FG000|Overall Study|Adverse Event|0|||
42338310|NCT02015390|76176286|FG001|Overall Study|Adverse Event|3|||
42338311|NCT02015390|76176285|FG000|Overall Study|Physician Decision|0|||
42338312|NCT02015390|76176286|FG001|Overall Study|Physician Decision|1|||
42338313|NCT02012959|76176293|FG000|Treatment Phase A|Adverse Event|2|||
42338314|NCT02012959|76176294|FG001|Treatment Phase A|Adverse Event|0|||
42338315|NCT02012959|76176295|FG002|Treatment Phase A|Adverse Event|0|||
42338316|NCT02012959|76176296|FG003|Treatment Phase A|Adverse Event|0|||
42338317|NCT02012959|76176297|FG004|Treatment Phase A|Adverse Event|0|||
42338318|NCT01990742|76176309|FG000|Overall Study|Withdrawal by facility|407|||
42000567|NCT01172938|75809014|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42000568|NCT01172938|75809015|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42338319|NCT01990742|76176310|FG001|Overall Study|Withdrawal by facility|1083|||
42338320|NCT01990742|76176309|FG000|Overall Study|Facility closed|0|||
42338321|NCT01990742|76176310|FG001|Overall Study|Facility closed|270|||
42338322|NCT02012491|76176318|FG000|Overall Study|Lost to Follow-up|1|||
42338323|NCT02012491|76176319|FG001|Overall Study|Lost to Follow-up|0|||
42000569|NCT01172938|75809016|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42338324|NCT02012491|76176318|FG000|Overall Study|Protocol Violation|0|||
42338325|NCT02012491|76176319|FG001|Overall Study|Protocol Violation|1|||
42338326|NCT02012491|76176318|FG000|Overall Study|Withdrawal by Subject|1|||
42338327|NCT02012491|76176319|FG001|Overall Study|Withdrawal by Subject|0|||
42000570|NCT01172938|75809017|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42000571|NCT01172938|75809018|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42000572|NCT01172938|75809019|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42000573|NCT01172938|75809020|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42000574|NCT01172938|75809021|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
42000575|NCT01172938|75809013|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
42000576|NCT01172938|75809014|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
42000577|NCT01172938|75809015|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
42338328|NCT01990664|76176327|FG000|Overall Study|Lost to Follow-up|2|||
42338329|NCT01990664|76176328|FG001|Overall Study|Lost to Follow-up|6|||
42338330|NCT01990664|76176327|FG000|Overall Study|Withdrawal by Subject|2|||
42034852|NCT01035138|75843175|FG001|Overall Study|Adverse Event|0|||
42338331|NCT01990664|76176328|FG001|Overall Study|Withdrawal by Subject|3|||
42338332|NCT01990664|76176327|FG000|Overall Study|Protocol Violation|1|||
42338333|NCT01990664|76176328|FG001|Overall Study|Protocol Violation|0|||
42338334|NCT01990664|76176327|FG000|Overall Study|Lens Discomfort|1|||
42338335|NCT01990664|76176328|FG001|Overall Study|Lens Discomfort|1|||
42338336|NCT01990664|76176327|FG000|Overall Study|Lens Handling Difficulties|1|||
42338337|NCT01990664|76176328|FG001|Overall Study|Lens Handling Difficulties|0|||
42338338|NCT01990664|76176327|FG000|Overall Study|Unsatisfactory Visual Response|0|||
42338339|NCT01990664|76176328|FG001|Overall Study|Unsatisfactory Visual Response|1|||
42338340|NCT02038010|76176334|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
42338341|NCT02038010|76176335|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
42338342|NCT02038010|76176336|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
42338343|NCT02038010|76176337|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
42338344|NCT02038010|76176334|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
42338345|NCT02038010|76176335|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
42338346|NCT02038010|76176336|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
42338347|NCT02038010|76176337|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
42338348|NCT02038010|76176334|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
42338349|NCT02038010|76176335|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
42338350|NCT02038010|76176336|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
42338351|NCT02038010|76176337|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
42338352|NCT02038010|76176334|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
42338353|NCT02038010|76176335|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
42338354|NCT02038010|76176336|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
42338355|NCT02038010|76176337|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
42338356|NCT02038010|76176334|FG000|Follow Up|Death|4|||
42338357|NCT02038010|76176335|FG001|Follow Up|Death|3|||
42338358|NCT02038010|76176336|FG002|Follow Up|Death|0|||
42338359|NCT02038010|76176337|FG003|Follow Up|Death|0|||
42338360|NCT02038010|76176334|FG000|Follow Up|Other|3|||
42338361|NCT02038010|76176335|FG001|Follow Up|Other|0|||
42338362|NCT02038010|76176336|FG002|Follow Up|Other|0|||
42338363|NCT02038010|76176337|FG003|Follow Up|Other|0|||
42338364|NCT01989572|76176351|FG000|Overall Study|Lack of Efficacy|35|||
42338365|NCT01989572|76176352|FG001|Overall Study|Lack of Efficacy|48|||
42338366|NCT01989572|76176353|FG002|Overall Study|Lack of Efficacy|48|||
42338367|NCT01989572|76176354|FG003|Overall Study|Lack of Efficacy|43|||
42338368|NCT01989572|76176355|FG004|Overall Study|Lack of Efficacy|71|||
42338369|NCT01989572|76176356|FG005|Overall Study|Lack of Efficacy|79|||
42338370|NCT01989572|76176351|FG000|Overall Study|Adverse Event|2|||
42338371|NCT01989572|76176352|FG001|Overall Study|Adverse Event|1|||
42338372|NCT01989572|76176353|FG002|Overall Study|Adverse Event|3|||
42338373|NCT01989572|76176354|FG003|Overall Study|Adverse Event|0|||
42338374|NCT01989572|76176355|FG004|Overall Study|Adverse Event|3|||
42338375|NCT01989572|76176356|FG005|Overall Study|Adverse Event|0|||
42338376|NCT01989572|76176351|FG000|Overall Study|Death|0|||
42338377|NCT01989572|76176352|FG001|Overall Study|Death|0|||
42338378|NCT01989572|76176353|FG002|Overall Study|Death|0|||
42338379|NCT01989572|76176354|FG003|Overall Study|Death|0|||
42338380|NCT01989572|76176355|FG004|Overall Study|Death|1|||
42338381|NCT01989572|76176356|FG005|Overall Study|Death|0|||
42338382|NCT01989572|76176351|FG000|Overall Study|Withdrawal by Subject|4|||
42338383|NCT01989572|76176352|FG001|Overall Study|Withdrawal by Subject|1|||
42338384|NCT01989572|76176353|FG002|Overall Study|Withdrawal by Subject|5|||
42338385|NCT01989572|76176354|FG003|Overall Study|Withdrawal by Subject|1|||
42338386|NCT01989572|76176355|FG004|Overall Study|Withdrawal by Subject|12|||
42338387|NCT01989572|76176356|FG005|Overall Study|Withdrawal by Subject|4|||
42338388|NCT01989572|76176351|FG000|Overall Study|complicating disease|1|||
42338389|NCT01989572|76176352|FG001|Overall Study|complicating disease|1|||
42338390|NCT01989572|76176353|FG002|Overall Study|complicating disease|2|||
42338391|NCT01989572|76176354|FG003|Overall Study|complicating disease|0|||
42338392|NCT01989572|76176355|FG004|Overall Study|complicating disease|1|||
42338393|NCT01989572|76176356|FG005|Overall Study|complicating disease|0|||
42338394|NCT01989572|76176351|FG000|Overall Study|error|2|||
42338395|NCT01989572|76176352|FG001|Overall Study|error|1|||
42338396|NCT01989572|76176353|FG002|Overall Study|error|1|||
42338397|NCT01989572|76176354|FG003|Overall Study|error|1|||
42338398|NCT01989572|76176355|FG004|Overall Study|error|1|||
42338399|NCT01989572|76176356|FG005|Overall Study|error|1|||
42338400|NCT01989572|76176351|FG000|Overall Study|maximum dose reached|0|||
42338401|NCT01989572|76176352|FG001|Overall Study|maximum dose reached|1|||
42338402|NCT01989572|76176353|FG002|Overall Study|maximum dose reached|0|||
42338403|NCT01989572|76176354|FG003|Overall Study|maximum dose reached|0|||
42338404|NCT01989572|76176355|FG004|Overall Study|maximum dose reached|1|||
42338405|NCT01989572|76176356|FG005|Overall Study|maximum dose reached|0|||
42338406|NCT01989572|76176351|FG000|Overall Study|unknown/not specify|3|||
42338407|NCT01989572|76176352|FG001|Overall Study|unknown/not specify|4|||
42338408|NCT01989572|76176353|FG002|Overall Study|unknown/not specify|1|||
42338409|NCT01989572|76176354|FG003|Overall Study|unknown/not specify|3|||
42135060|NCT00372567|75945810|FG002|Phase 3 Study|Protocol Violation|1|||
42000578|NCT01172938|75809016|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
42000579|NCT01172938|75809017|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
42000580|NCT01172938|75809018|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
42000581|NCT01172938|75809019|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
42000582|NCT01172938|75809020|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
42000583|NCT01172938|75809021|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
42000584|NCT01172938|75809013|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
42000585|NCT01172938|75809014|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
42034853|NCT01035138|75843176|FG002|Overall Study|Adverse Event|2|||
42135061|NCT00372567|75945808|FG000|Phase 3 Study|Objective progression or relapse|10|||
42135062|NCT00372567|75945809|FG001|Phase 3 Study|Objective progression or relapse|13|||
42338410|NCT01989572|76176355|FG004|Overall Study|unknown/not specify|3|||
42338411|NCT01989572|76176356|FG005|Overall Study|unknown/not specify|5|||
42338412|NCT01989572|76176351|FG000|Overall Study|not start protocol therapy|5|||
42338413|NCT01989572|76176352|FG001|Overall Study|not start protocol therapy|1|||
42338414|NCT01989572|76176353|FG002|Overall Study|not start protocol therapy|2|||
42338415|NCT01989572|76176354|FG003|Overall Study|not start protocol therapy|3|||
42338416|NCT01989572|76176355|FG004|Overall Study|not start protocol therapy|4|||
42338417|NCT01989572|76176356|FG005|Overall Study|not start protocol therapy|18|||
42338418|NCT01989572|76176351|FG000|Overall Study|alternative therapy|3|||
42338419|NCT01989572|76176352|FG001|Overall Study|alternative therapy|0|||
42338420|NCT01989572|76176353|FG002|Overall Study|alternative therapy|0|||
42338421|NCT01989572|76176354|FG003|Overall Study|alternative therapy|0|||
42338422|NCT01989572|76176355|FG004|Overall Study|alternative therapy|1|||
42338423|NCT01989572|76176356|FG005|Overall Study|alternative therapy|3|||
42338424|NCT02036294|76176376|FG000|Overall Study|Death|7|||
42338425|NCT02036294|76176377|FG001|Overall Study|Death|8|||
42338426|NCT02036294|76176376|FG000|Overall Study|Withdrawal by Subject|2|||
42338427|NCT02036294|76176377|FG001|Overall Study|Withdrawal by Subject|3|||
42338428|NCT02035748|76176383|FG000|Overall Study|Adverse Event|5|||
42000586|NCT01172938|75809015|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
42000587|NCT01172938|75809016|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
42266245|NCT02614196|76094359|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
42266246|NCT02614196|76094360|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
42266247|NCT02614196|76094361|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
42266248|NCT02614196|76094362|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
42266249|NCT02614196|76094363|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
42266250|NCT02614196|76094358|FG000|Double Blind Treatment Phase|Physician Decision|4|||
42266251|NCT02614196|76094359|FG001|Double Blind Treatment Phase|Physician Decision|0|||
42266252|NCT02614196|76094360|FG002|Double Blind Treatment Phase|Physician Decision|2|||
42266253|NCT02614196|76094361|FG003|Double Blind Treatment Phase|Physician Decision|0|||
42266254|NCT02614196|76094362|FG004|Double Blind Treatment Phase|Physician Decision|0|||
42266255|NCT02614196|76094363|FG005|Double Blind Treatment Phase|Physician Decision|0|||
42266256|NCT02614196|76094358|FG000|Double Blind Treatment Phase|Pregnancy|1|||
42266257|NCT02614196|76094359|FG001|Double Blind Treatment Phase|Pregnancy|2|||
42266258|NCT02614196|76094360|FG002|Double Blind Treatment Phase|Pregnancy|0|||
42266259|NCT02614196|76094361|FG003|Double Blind Treatment Phase|Pregnancy|0|||
42266260|NCT02614196|76094362|FG004|Double Blind Treatment Phase|Pregnancy|0|||
42266261|NCT02614196|76094363|FG005|Double Blind Treatment Phase|Pregnancy|0|||
42266262|NCT02614196|76094358|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
42266263|NCT02614196|76094359|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
42266264|NCT02614196|76094360|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
42338429|NCT02035748|76176383|FG000|Overall Study|Death|3|||
42338430|NCT02035748|76176383|FG000|Overall Study|Lost to Follow-up|2|||
42338431|NCT02035748|76176383|FG000|Overall Study|Physician Decision|3|||
42338432|NCT02035748|76176383|FG000|Overall Study|Withdrawal by Subject|6|||
42338433|NCT02035748|76176383|FG000|Overall Study|Progressive Disease|1|||
42000588|NCT01172938|75809017|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
42266265|NCT02614196|76094361|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
42266266|NCT02614196|76094362|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
42338434|NCT02014376|76176391|FG000|Overall Study|Adverse Event|1|||
42338435|NCT02014376|76176392|FG001|Overall Study|Adverse Event|1|||
42338436|NCT02014376|76176393|FG002|Overall Study|Adverse Event|0|||
42338437|NCT02014376|76176391|FG000|Overall Study|Lost to Follow-up|2|||
42338438|NCT02014376|76176392|FG001|Overall Study|Lost to Follow-up|0|||
42338439|NCT02014376|76176393|FG002|Overall Study|Lost to Follow-up|0|||
42338440|NCT02035202|76176404|FG000|Overall Study|Lost to Follow-up|8|||
42338441|NCT02035202|76176405|FG001|Overall Study|Lost to Follow-up|16|||
42338442|NCT02035202|76176406|FG002|Overall Study|Lost to Follow-up|2|||
42338443|NCT01988402|76176416|FG000|Overall Study|Adverse Event|1|||
42338444|NCT01988402|76176417|FG001|Overall Study|Adverse Event|2|||
42338445|NCT01988402|76176416|FG000|Overall Study|Withdrawal by Subject|1|||
42338446|NCT01988402|76176417|FG001|Overall Study|Withdrawal by Subject|0|||
42338447|NCT01988090|76176425|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
42338448|NCT01988090|76176426|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
42338449|NCT01988090|76176425|FG000|Start Treament After Randomization|Protocol Violation|0|||
42338450|NCT01988090|76176426|FG001|Start Treament After Randomization|Protocol Violation|1|||
42338451|NCT01988090|76176425|FG000|Complete Study After Start|Withdrawal by Subject|2|||
42338452|NCT01988090|76176426|FG001|Complete Study After Start|Withdrawal by Subject|0|||
42338453|NCT01988090|76176425|FG000|Complete Study After Start|Protocol Violation|1|||
42338454|NCT01988090|76176426|FG001|Complete Study After Start|Protocol Violation|1|||
42338455|NCT01988012|76176432|FG000|Overall Study|Adverse Event|5|||
42338456|NCT01988012|76176432|FG000|Overall Study|Insufficient Therapeutic Response|3|||
42338457|NCT01988012|76176432|FG000|Overall Study|Patient Withdrawal of Consent|4|||
42338458|NCT01988012|76176432|FG000|Overall Study|Lost to Follow-up|1|||
42338459|NCT01988012|76176432|FG000|Overall Study|Physician Decision|1|||
42338460|NCT01988012|76176432|FG000|Overall Study|Protocol Violation|1|||
42338461|NCT02011945|76176439|FG000|Overall Study|Participant requested to Discontinue|0|||
42338462|NCT02011945|76176440|FG001|Overall Study|Participant requested to Discontinue|1|||
42266267|NCT02614196|76094363|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
42266268|NCT02614196|76094358|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
42338463|NCT02011945|76176441|FG002|Overall Study|Participant requested to Discontinue|1|||
42266269|NCT02614196|76094359|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
42266270|NCT02614196|76094360|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
42266271|NCT02614196|76094361|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
42266272|NCT02614196|76094362|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
42266273|NCT02614196|76094363|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
42338464|NCT02011945|76176439|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
42338465|NCT02011945|76176440|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
42338466|NCT02011945|76176441|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
42338467|NCT02011945|76176439|FG000|Overall Study|Study Drug Toxicity|0|||
42338468|NCT02011945|76176440|FG001|Overall Study|Study Drug Toxicity|0|||
42338469|NCT02011945|76176441|FG002|Overall Study|Study Drug Toxicity|1|||
42338470|NCT02011945|76176439|FG000|Overall Study|Treatment Failure|0|||
42338471|NCT02011945|76176440|FG001|Overall Study|Treatment Failure|7|||
42338472|NCT02011945|76176441|FG002|Overall Study|Treatment Failure|6|||
42338473|NCT02011945|76176439|FG000|Overall Study|No Longer Meets Study Criteria|1|||
42338474|NCT02011945|76176440|FG001|Overall Study|No Longer Meets Study Criteria|0|||
42338475|NCT02011945|76176441|FG002|Overall Study|No Longer Meets Study Criteria|0|||
42338476|NCT02011945|76176439|FG000|Overall Study|Proceeded to stem cell transplant|0|||
42338477|NCT02011945|76176440|FG001|Overall Study|Proceeded to stem cell transplant|0|||
42338478|NCT02011945|76176441|FG002|Overall Study|Proceeded to stem cell transplant|1|||
42338479|NCT02011945|76176439|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
42338480|NCT02011945|76176440|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
42338481|NCT02011945|76176441|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
42338482|NCT02013830|76176449|FG000|Overall Study|Adverse Event|3|||
42338483|NCT02013830|76176449|FG000|Overall Study|Death|1|||
42338484|NCT02013830|76176449|FG000|Overall Study|Insufficient therapeutic response|25|||
42338485|NCT02013830|76176449|FG000|Overall Study|Refused treatment|1|||
42338486|NCT02010775|76176458|FG000|Overall Study|Adverse Event|0|||
42338487|NCT02010775|76176459|FG001|Overall Study|Adverse Event|0|||
42338488|NCT02010775|76176460|FG002|Overall Study|Adverse Event|0|||
42338489|NCT02010775|76176461|FG003|Overall Study|Adverse Event|0|||
42338490|NCT02010775|76176462|FG004|Overall Study|Adverse Event|1|||
42338491|NCT02010775|76176458|FG000|Overall Study|Pregnancy|0|||
42338492|NCT02010775|76176459|FG001|Overall Study|Pregnancy|0|||
42338493|NCT02010775|76176460|FG002|Overall Study|Pregnancy|2|||
42338494|NCT02010775|76176461|FG003|Overall Study|Pregnancy|0|||
42338495|NCT02010775|76176462|FG004|Overall Study|Pregnancy|0|||
42338496|NCT02010775|76176458|FG000|Overall Study|Lost to Follow-up|2|||
42338497|NCT02010775|76176459|FG001|Overall Study|Lost to Follow-up|0|||
42338498|NCT02010775|76176460|FG002|Overall Study|Lost to Follow-up|0|||
42338499|NCT02010775|76176461|FG003|Overall Study|Lost to Follow-up|1|||
42338500|NCT02010775|76176462|FG004|Overall Study|Lost to Follow-up|1|||
42338501|NCT02010775|76176458|FG000|Overall Study|Personal Reasons|3|||
42338502|NCT02010775|76176459|FG001|Overall Study|Personal Reasons|3|||
42338503|NCT02010775|76176460|FG002|Overall Study|Personal Reasons|1|||
42338504|NCT02010775|76176461|FG003|Overall Study|Personal Reasons|2|||
42338505|NCT02010775|76176462|FG004|Overall Study|Personal Reasons|4|||
42338506|NCT01993615|76176476|FG000|Overall Study|Death|1|||
42338507|NCT01993615|76176477|FG001|Overall Study|Death|0|||
42338508|NCT01619059|76176485|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
42338509|NCT01619059|76176486|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
42338510|NCT01619059|76176485|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
42338511|NCT01619059|76176486|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
42338512|NCT01619059|76176485|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
42338513|NCT01619059|76176486|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
42338514|NCT01619059|76176485|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
42338515|NCT01619059|76176486|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
42338516|NCT01619059|76176485|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
42338517|NCT01619059|76176486|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
42338518|NCT01619059|76176485|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
42338519|NCT01619059|76176486|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
42338520|NCT01619059|76176485|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
42338521|NCT01619059|76176486|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
42338522|NCT01619059|76176485|FG000|Long-Term (LT) Treatment Period|Death|1|||
42338523|NCT01619059|76176486|FG001|Long-Term (LT) Treatment Period|Death|0|||
42338524|NCT01619059|76176485|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
42338525|NCT01619059|76176486|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
42338526|NCT01619059|76176485|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
42338527|NCT01619059|76176486|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
42338528|NCT02013206|76176494|FG000|Overall Study|Progressive disease (PD)|14|||
42338529|NCT02013206|76176495|FG001|Overall Study|Progressive disease (PD)|17|||
42338530|NCT02013206|76176494|FG000|Overall Study|Symptomatic deterioration|3|||
42338531|NCT02013206|76176495|FG001|Overall Study|Symptomatic deterioration|1|||
42338532|NCT02013206|76176494|FG000|Overall Study|Adverse Event|1|||
42338533|NCT02013206|76176495|FG001|Overall Study|Adverse Event|0|||
42338534|NCT02013206|76176494|FG000|Overall Study|Patient refusal|2|||
42338535|NCT02013206|76176495|FG001|Overall Study|Patient refusal|0|||
42338536|NCT02013206|76176494|FG000|Overall Study|Patient non-compliance|1|||
42338537|NCT02013206|76176495|FG001|Overall Study|Patient non-compliance|0|||
42338538|NCT02013206|76176494|FG000|Overall Study|Death|1|||
42338539|NCT02013206|76176495|FG001|Overall Study|Death|2|||
42338540|NCT02013206|76176494|FG000|Overall Study|Other reasons off treatment|5|||
42034854|NCT01035138|75843174|FG000|Overall Study|Caregiver Decision|2|||
42338541|NCT02013206|76176495|FG001|Overall Study|Other reasons off treatment|2|||
42338542|NCT01807923|76176504|FG000|Overall Study|Adverse Event|2|||
42338543|NCT01807923|76176505|FG001|Overall Study|Adverse Event|1|||
42338544|NCT01807923|76176506|FG002|Overall Study|Adverse Event|2|||
42338545|NCT01807923|76176504|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
42338546|NCT01807923|76176505|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
42338547|NCT01807923|76176506|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
42338548|NCT01807923|76176504|FG000|Overall Study|Physician Decision|0|||
42338549|NCT01807923|76176505|FG001|Overall Study|Physician Decision|0|||
42338550|NCT01807923|76176506|FG002|Overall Study|Physician Decision|1|||
42338551|NCT01807923|76176504|FG000|Overall Study|Not Eligible (Genotype)|0|||
42338552|NCT01807923|76176505|FG001|Overall Study|Not Eligible (Genotype)|0|||
42338553|NCT01807923|76176506|FG002|Overall Study|Not Eligible (Genotype)|1|||
42338554|NCT01807923|76176504|FG000|Overall Study|Randomized But Not Treated|3|||
42338555|NCT01807923|76176505|FG001|Overall Study|Randomized But Not Treated|2|||
42338556|NCT01807923|76176506|FG002|Overall Study|Randomized But Not Treated|5|||
42338557|NCT01966003|76176518|FG000|Overall Study|Death|43|||
42338558|NCT01966003|76176519|FG001|Overall Study|Death|36|||
42338559|NCT01966003|76176518|FG000|Overall Study|Protocol Violation|6|||
42338560|NCT01966003|76176519|FG001|Overall Study|Protocol Violation|4|||
42338561|NCT01966003|76176518|FG000|Overall Study|Lost to Follow-up|4|||
42266274|NCT02614196|76094358|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
42338562|NCT01966003|76176519|FG001|Overall Study|Lost to Follow-up|3|||
42338563|NCT01966003|76176518|FG000|Overall Study|Physician Decision|12|||
42338564|NCT01966003|76176519|FG001|Overall Study|Physician Decision|13|||
42338565|NCT01966003|76176518|FG000|Overall Study|Withdrawal by Subject|29|||
42338566|NCT01966003|76176519|FG001|Overall Study|Withdrawal by Subject|19|||
42338567|NCT01966003|76176518|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
42338568|NCT01966003|76176519|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
42338569|NCT01966003|76176518|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
42338570|NCT01966003|76176519|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
42338571|NCT01966003|76176518|FG000|Overall Study|Other|1|||
42338572|NCT01966003|76176519|FG001|Overall Study|Other|1|||
42338573|NCT01839279|76176528|FG000|Overall Study|Adverse Event|4|||
42338574|NCT01839279|76176529|FG001|Overall Study|Adverse Event|1|||
42338575|NCT01839279|76176530|FG002|Overall Study|Adverse Event|1|||
42338576|NCT01839279|76176528|FG000|Overall Study|Withdrawal by Subject|4|||
42338577|NCT01839279|76176529|FG001|Overall Study|Withdrawal by Subject|1|||
42338578|NCT01839279|76176530|FG002|Overall Study|Withdrawal by Subject|1|||
42338579|NCT01839279|76176528|FG000|Overall Study|Classified as 'Other'|5|||
42266275|NCT02614196|76094359|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
42266276|NCT02614196|76094360|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
42338580|NCT01839279|76176529|FG001|Overall Study|Classified as 'Other'|0|||
42338581|NCT01839279|76176530|FG002|Overall Study|Classified as 'Other'|0|||
42338582|NCT01807299|76176549|FG000|Overall Study|Protocol Violation|3|||
42338583|NCT01807299|76176550|FG001|Overall Study|Protocol Violation|1|||
42338584|NCT01807299|76176551|FG002|Overall Study|Protocol Violation|0|||
42338585|NCT01807299|76176552|FG003|Overall Study|Protocol Violation|2|||
42338586|NCT01965535|76176564|FG000|Overall Study|Lack of Efficacy|2|||
42338587|NCT01965535|76176565|FG001|Overall Study|Lack of Efficacy|1|||
42338588|NCT01964755|76176571|FG000|Overall Study|Death|2|||
42338589|NCT01964521|76176575|FG000|Overall Study|Lost to Follow-up|4|||
42338590|NCT01992757|76176580|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
42338591|NCT01991743|76176589|FG000|Overall Study|external cephalic version not performed|0|||
42338592|NCT01991743|76176590|FG001|Overall Study|external cephalic version not performed|0|||
42338593|NCT01991743|76176591|FG002|Overall Study|external cephalic version not performed|1|||
42338594|NCT01991743|76176592|FG003|Overall Study|external cephalic version not performed|0|||
42338595|NCT01991197|76176604|FG000|Overall Study|Lost to Follow-up|1|||
42338596|NCT01991197|76176605|FG001|Overall Study|Lost to Follow-up|1|||
42338597|NCT01991197|76176604|FG000|Overall Study|Physician Decision|0|||
42338598|NCT01991197|76176605|FG001|Overall Study|Physician Decision|2|||
42338599|NCT01991197|76176604|FG000|Overall Study|Withdrawal by Subject|2|||
42338600|NCT01991197|76176605|FG001|Overall Study|Withdrawal by Subject|0|||
42338601|NCT01990573|76176619|FG000|Overall Study|Physician Decision|0|||
42338602|NCT01990573|76176620|FG001|Overall Study|Physician Decision|0|||
42338603|NCT01990573|76176621|FG002|Overall Study|Physician Decision|1|||
42338604|NCT01990495|76176631|FG000|Overall Study|Physician Decision|5|||
42338605|NCT01990495|76176632|FG001|Overall Study|Physician Decision|4|||
42266277|NCT02614196|76094361|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
42266278|NCT02614196|76094362|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
42266279|NCT02614196|76094363|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
42266280|NCT02614196|76094358|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
42266281|NCT02614196|76094359|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
42266282|NCT02614196|76094360|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
42266283|NCT02614196|76094361|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
42266284|NCT02614196|76094362|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
42266285|NCT02614196|76094363|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
42266286|NCT02614196|76094358|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
42266287|NCT02614196|76094359|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
42266288|NCT02614196|76094360|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
42266289|NCT02614196|76094361|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
42266290|NCT02614196|76094362|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
42338606|NCT01990339|76176640|FG000|Overall Study|Data Not Available|49|||
42338607|NCT01990339|76176640|FG000|Overall Study|Voluntary Withdrawal|1402|||
42338608|NCT01990339|76176640|FG000|Overall Study|Lost to Follow-up|861|||
42338609|NCT02007577|76176646|FG000|Overall Study|Adverse Event|1|||
42338610|NCT02007577|76176647|FG001|Overall Study|Adverse Event|0|||
42338611|NCT02007577|76176646|FG000|Overall Study|Withdrawal by Subject|0|||
42338612|NCT02007577|76176647|FG001|Overall Study|Withdrawal by Subject|1|||
42338613|NCT01990261|76176653|FG000|Overall Study|Death Before Treatment Start|2|||
42338614|NCT01990261|76176653|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
42338615|NCT01990261|76176653|FG000|Overall Study|Death From other Causes|1|||
42338616|NCT01990261|76176653|FG000|Overall Study|Disease Progression (PD)|8|||
42338617|NCT01990261|76176653|FG000|Overall Study|PD Before Treatment Start|1|||
42135063|NCT00372567|75945810|FG002|Phase 3 Study|Objective progression or relapse|4|||
42338618|NCT01990261|76176653|FG000|Overall Study|Dossier not Approved|1|||
42338619|NCT01990261|76176653|FG000|Overall Study|Lost to Follow-up|2|||
42338620|NCT01963117|76176657|FG000|Overall Study|Death|1|||
42338621|NCT02007109|76176661|FG000|Overall Study|Diary not returned or excluded|102|||
42338622|NCT02007109|76176661|FG000|Overall Study|Excluded - Age<7yo|9|||
42338623|NCT02006719|76176670|FG000|Overall Study|Withdrawal by Subject|10|||
42338624|NCT02006719|76176671|FG001|Overall Study|Withdrawal by Subject|2|||
42338625|NCT02006719|76176670|FG000|Overall Study|Lost to Follow-up|5|||
42338626|NCT02006719|76176671|FG001|Overall Study|Lost to Follow-up|1|||
42338627|NCT02006719|76176670|FG000|Overall Study|Protocol Violation|2|||
42338628|NCT02006719|76176671|FG001|Overall Study|Protocol Violation|0|||
42338629|NCT02006719|76176670|FG000|Overall Study|Adverse Event|1|||
42338630|NCT02006719|76176671|FG001|Overall Study|Adverse Event|1|||
42338631|NCT02006719|76176670|FG000|Overall Study|Other/Unknown|0|||
42338632|NCT02006719|76176671|FG001|Overall Study|Other/Unknown|1|||
42338633|NCT01962493|76176679|FG000|Overall Study|Adverse Event|1|||
42338634|NCT01962493|76176680|FG001|Overall Study|Adverse Event|2|||
42338635|NCT01962493|76176679|FG000|Overall Study|Protocol Violation|0|||
42338636|NCT01962493|76176680|FG001|Overall Study|Protocol Violation|1|||
42338637|NCT01962493|76176679|FG000|Overall Study|Withdrawal by Subject|4|||
42338638|NCT01962493|76176680|FG001|Overall Study|Withdrawal by Subject|2|||
42338639|NCT01989169|76176688|FG000|Period 2|Adverse Event|0|||
42266291|NCT02614196|76094363|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
42266292|NCT02614196|76094358|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
42266293|NCT02614196|76094359|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
42266294|NCT02614196|76094360|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
42266295|NCT02614196|76094361|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
42266296|NCT02614196|76094362|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
42266297|NCT02614196|76094363|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
42266298|NCT02614196|76094358|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
42266299|NCT02614196|76094359|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
42266300|NCT02614196|76094360|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
42338640|NCT01989169|76176689|FG001|Period 2|Adverse Event|1|||
42338641|NCT01988779|76176697|FG000|Overall Study|Withdrawal by Subject|2|||
42338642|NCT01988779|76176698|FG001|Overall Study|Withdrawal by Subject|2|||
42266301|NCT02614196|76094361|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
42266302|NCT02614196|76094362|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
42338643|NCT01988779|76176697|FG000|Overall Study|Protocol Violation|1|||
42338644|NCT01988779|76176698|FG001|Overall Study|Protocol Violation|0|||
42338645|NCT01988233|76176706|FG000|Overall Study|Lost to Follow-up|64|||
42338646|NCT01988233|76176707|FG001|Overall Study|Lost to Follow-up|51|||
42338647|NCT01987765|76176713|FG000|Overall Study|Protocol Violation|65|||
42338648|NCT01987765|76176713|FG000|Overall Study|Lost to Follow-up|37|||
42338649|NCT01987609|76176717|FG000|Overall Study|Adverse Event|1|||
42338650|NCT02013674|76176733|FG000|Overall Study|Death|0|||
42338651|NCT02013674|76176734|FG001|Overall Study|Death|1|||
42338652|NCT02013674|76176733|FG000|Overall Study|Lost to Follow-up|1|||
42338653|NCT02013674|76176734|FG001|Overall Study|Lost to Follow-up|0|||
42338654|NCT01987232|76176745|FG000|Overall Study|Ongoing in Study|0|||
42338655|NCT01987232|76176746|FG001|Overall Study|Ongoing in Study|0|||
42338656|NCT01987232|76176747|FG002|Overall Study|Ongoing in Study|0|||
42338657|NCT01987232|76176748|FG003|Overall Study|Ongoing in Study|1|||
42338658|NCT01987232|76176749|FG004|Overall Study|Ongoing in Study|0|||
42338659|NCT01986920|76176763|FG000|A- 101 25%|Withdrawal by Subject|1|||
42338660|NCT01986920|76176764|FG001|A- 101 25%|Withdrawal by Subject|0|||
42338661|NCT01986920|76176765|FG002|A- 101 25%|Withdrawal by Subject|0|||
42338662|NCT01986920|76176766|FG003|A- 101 25%|Withdrawal by Subject|0|||
42338663|NCT01986920|76176763|FG000|A-101 32.5%|Withdrawal by Subject|0|||
42338664|NCT01986920|76176764|FG001|A-101 32.5%|Withdrawal by Subject|1|||
42338665|NCT01986920|76176765|FG002|A-101 32.5%|Withdrawal by Subject|0|||
42338666|NCT01986920|76176766|FG003|A-101 32.5%|Withdrawal by Subject|0|||
42338667|NCT01986920|76176763|FG000|A-101 40%|Withdrawal by Subject|0|||
42338668|NCT01986920|76176764|FG001|A-101 40%|Withdrawal by Subject|0|||
42338669|NCT01986920|76176765|FG002|A-101 40%|Withdrawal by Subject|1|||
42338670|NCT01986920|76176766|FG003|A-101 40%|Withdrawal by Subject|0|||
42338671|NCT01986920|76176763|FG000|Placebo|Withdrawal by Subject|0|||
42338672|NCT01986920|76176764|FG001|Placebo|Withdrawal by Subject|0|||
42338673|NCT01986920|76176765|FG002|Placebo|Withdrawal by Subject|0|||
42338674|NCT01986920|76176766|FG003|Placebo|Withdrawal by Subject|1|||
42272764|NCT02276560|76103174|FG001|Overall Study|Adverse Event|0|||
42338675|NCT02010632|76176776|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
42272765|NCT02276560|76103175|FG002|Overall Study|Adverse Event|0|||
42272766|NCT02276482|76103185|FG000|Overall Study|Adverse Event|1|||
42272767|NCT02276482|76103186|FG001|Overall Study|Adverse Event|0|||
42272768|NCT02276482|76103185|FG000|Overall Study|Withdrawal by Subject|1|||
42272769|NCT02276482|76103186|FG001|Overall Study|Withdrawal by Subject|0|||
42272770|NCT02276482|76103185|FG000|Overall Study|Gram-negative infection|1|||
42272771|NCT02276482|76103186|FG001|Overall Study|Gram-negative infection|0|||
42272772|NCT02276482|76103185|FG000|Overall Study|Reason not specified|0|||
42338676|NCT02010632|76176777|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
42338677|NCT01986140|76176785|FG000|Overall Study|Withdrawal by Subject|31|||
42338678|NCT01986140|76176786|FG001|Overall Study|Withdrawal by Subject|25|||
42338679|NCT01986140|76176785|FG000|Overall Study|alternative treatment|1|||
42338680|NCT01986140|76176786|FG001|Overall Study|alternative treatment|1|||
42338681|NCT01986140|76176785|FG000|Overall Study|found not eligible|3|||
42338682|NCT01986140|76176786|FG001|Overall Study|found not eligible|0|||
42338683|NCT01986140|76176785|FG000|Overall Study|Adverse Event|0|||
42338684|NCT01986140|76176786|FG001|Overall Study|Adverse Event|1|||
42266303|NCT02614196|76094363|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
42266304|NCT02614196|76094358|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
42266305|NCT02614196|76094359|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
42266306|NCT02614196|76094360|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
42266307|NCT02614196|76094361|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
42266308|NCT02614196|76094362|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
42266309|NCT02614196|76094363|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
42266310|NCT02765035|76094393|FG000|First Intervention (90 Days)|Adverse Event|1|||
42266311|NCT02765035|76094394|FG001|First Intervention (90 Days)|Adverse Event|1|||
42266312|NCT02765035|76094393|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
42266313|NCT02765035|76094394|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
42338685|NCT01986140|76176785|FG000|Overall Study|progression disease|0|||
42338686|NCT01986140|76176786|FG001|Overall Study|progression disease|1|||
42338687|NCT01986062|76176794|FG000|Overall Study|Lost to Follow-up|1|||
42338688|NCT01986062|76176795|FG001|Overall Study|Lost to Follow-up|0|||
42338689|NCT01986062|76176794|FG000|Overall Study|Withdrawal by Subject|0|||
42338690|NCT01986062|76176795|FG001|Overall Study|Withdrawal by Subject|1|||
42034855|NCT01035138|75843175|FG001|Overall Study|Caregiver Decision|0|||
42338691|NCT01985360|76176803|FG000|Overall Study|Withdrawal by Subject|4|||
42338692|NCT01985360|76176804|FG001|Overall Study|Withdrawal by Subject|0|||
42338693|NCT01985360|76176803|FG000|Overall Study|Lost to Follow-up|5|||
42338694|NCT01985360|76176804|FG001|Overall Study|Lost to Follow-up|3|||
42338695|NCT02032706|76176810|FG000|Overall Study|Did not qualify|5|||
42338696|NCT02032706|76176810|FG000|Overall Study|Protocol Violation|1|||
42338697|NCT02032238|76176816|FG000|Overall Study|Lost to Follow-up|2|||
42338698|NCT02032238|76176817|FG001|Overall Study|Lost to Follow-up|0|||
42338699|NCT02009930|76176823|FG000|Overall Study|withdrawn|5|||
42338700|NCT01985126|76176836|FG000|Overall Study|Death|15|||
42338701|NCT01985126|76176837|FG001|Overall Study|Death|69|||
42338702|NCT01985126|76176836|FG000|Overall Study|Lost to Follow-up|0|||
42338703|NCT01985126|76176837|FG001|Overall Study|Lost to Follow-up|8|||
42338704|NCT01985126|76176836|FG000|Overall Study|Study Terminated By Sponsor|1|||
42338705|NCT01985126|76176837|FG001|Overall Study|Study Terminated By Sponsor|22|||
42338706|NCT01985126|76176836|FG000|Overall Study|Withdrawal by Subject|2|||
42338707|NCT01985126|76176837|FG001|Overall Study|Withdrawal by Subject|7|||
42338708|NCT01984892|76176843|FG000|Overall Study|Progressive disease|7|||
42338709|NCT01807221|76176853|FG000|Overall Study|Progressive disease|1|||
42338710|NCT01807221|76176854|FG001|Overall Study|Progressive disease|0|||
42338711|NCT01807221|76176855|FG002|Overall Study|Progressive disease|1|||
42338712|NCT01807221|76176856|FG003|Overall Study|Progressive disease|0|||
42338713|NCT01807221|76176857|FG004|Overall Study|Progressive disease|0|||
42338714|NCT01807221|76176858|FG005|Overall Study|Progressive disease|0|||
42338715|NCT01807221|76176853|FG000|Overall Study|Death|7|||
42338716|NCT01807221|76176854|FG001|Overall Study|Death|9|||
42338717|NCT01807221|76176855|FG002|Overall Study|Death|4|||
42338718|NCT01807221|76176856|FG003|Overall Study|Death|2|||
42338719|NCT01807221|76176857|FG004|Overall Study|Death|1|||
42338720|NCT01807221|76176858|FG005|Overall Study|Death|6|||
42338721|NCT01807221|76176853|FG000|Overall Study|Physician Decision|2|||
42338722|NCT01807221|76176854|FG001|Overall Study|Physician Decision|1|||
42338723|NCT01807221|76176855|FG002|Overall Study|Physician Decision|0|||
42338724|NCT01807221|76176856|FG003|Overall Study|Physician Decision|0|||
42338725|NCT01807221|76176857|FG004|Overall Study|Physician Decision|0|||
42338726|NCT01807221|76176858|FG005|Overall Study|Physician Decision|0|||
42338727|NCT01807221|76176853|FG000|Overall Study|Adverse Event|33|||
42338728|NCT01807221|76176854|FG001|Overall Study|Adverse Event|22|||
42338729|NCT01807221|76176855|FG002|Overall Study|Adverse Event|26|||
42338730|NCT01807221|76176856|FG003|Overall Study|Adverse Event|25|||
42338731|NCT01807221|76176857|FG004|Overall Study|Adverse Event|18|||
42338732|NCT01807221|76176858|FG005|Overall Study|Adverse Event|21|||
42338733|NCT01807221|76176853|FG000|Overall Study|Protocol Violation|0|||
42338734|NCT01807221|76176854|FG001|Overall Study|Protocol Violation|2|||
42338735|NCT01807221|76176855|FG002|Overall Study|Protocol Violation|1|||
42338736|NCT01807221|76176856|FG003|Overall Study|Protocol Violation|2|||
42338737|NCT01807221|76176857|FG004|Overall Study|Protocol Violation|0|||
42338738|NCT01807221|76176858|FG005|Overall Study|Protocol Violation|1|||
42338739|NCT01807221|76176853|FG000|Overall Study|Non-compliance|1|||
42338740|NCT01807221|76176854|FG001|Overall Study|Non-compliance|2|||
42338741|NCT01807221|76176855|FG002|Overall Study|Non-compliance|0|||
42338742|NCT01807221|76176856|FG003|Overall Study|Non-compliance|1|||
42338743|NCT01807221|76176857|FG004|Overall Study|Non-compliance|0|||
42338744|NCT01807221|76176858|FG005|Overall Study|Non-compliance|0|||
42338745|NCT01807221|76176853|FG000|Overall Study|Logistical difficulties|0|||
42338746|NCT01807221|76176854|FG001|Overall Study|Logistical difficulties|1|||
42338747|NCT01807221|76176855|FG002|Overall Study|Logistical difficulties|0|||
42338748|NCT01807221|76176856|FG003|Overall Study|Logistical difficulties|0|||
42338749|NCT01807221|76176857|FG004|Overall Study|Logistical difficulties|1|||
42338750|NCT01807221|76176858|FG005|Overall Study|Logistical difficulties|0|||
42338751|NCT01807221|76176853|FG000|Overall Study|Withdrawal by Subject|33|||
42338752|NCT01807221|76176854|FG001|Overall Study|Withdrawal by Subject|15|||
42338753|NCT01807221|76176855|FG002|Overall Study|Withdrawal by Subject|8|||
42338754|NCT01807221|76176856|FG003|Overall Study|Withdrawal by Subject|14|||
42338755|NCT01807221|76176857|FG004|Overall Study|Withdrawal by Subject|16|||
42338756|NCT01807221|76176858|FG005|Overall Study|Withdrawal by Subject|13|||
42338757|NCT01807221|76176853|FG000|Overall Study|Sponsor decision|2|||
42338758|NCT01807221|76176854|FG001|Overall Study|Sponsor decision|0|||
42000589|NCT01172938|75809018|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
42338759|NCT01807221|76176855|FG002|Overall Study|Sponsor decision|1|||
42338760|NCT01807221|76176856|FG003|Overall Study|Sponsor decision|1|||
42338761|NCT01807221|76176857|FG004|Overall Study|Sponsor decision|0|||
42338762|NCT01807221|76176858|FG005|Overall Study|Sponsor decision|0|||
42338763|NCT01807221|76176853|FG000|Overall Study|Lost to Follow-up|1|||
42338764|NCT01807221|76176854|FG001|Overall Study|Lost to Follow-up|0|||
42338765|NCT01807221|76176855|FG002|Overall Study|Lost to Follow-up|2|||
42338766|NCT01807221|76176856|FG003|Overall Study|Lost to Follow-up|1|||
42338767|NCT01807221|76176857|FG004|Overall Study|Lost to Follow-up|0|||
42338768|NCT01807221|76176858|FG005|Overall Study|Lost to Follow-up|0|||
42338769|NCT01838499|76176874|FG000|Overall Study|Protocol Violation|0|||
42338770|NCT01838499|76176875|FG001|Overall Study|Protocol Violation|1|||
42338771|NCT01838499|76176874|FG000|Overall Study|Lost to Follow-up|2|||
42338772|NCT01838499|76176875|FG001|Overall Study|Lost to Follow-up|4|||
42338773|NCT01838499|76176874|FG000|Overall Study|Lack of Efficacy|1|||
42338774|NCT01838499|76176875|FG001|Overall Study|Lack of Efficacy|2|||
42338775|NCT01838499|76176874|FG000|Overall Study|Adverse Event|2|||
42338776|NCT01838499|76176875|FG001|Overall Study|Adverse Event|1|||
42338777|NCT01838499|76176874|FG000|Overall Study|Withdrawal by Subject|19|||
42338778|NCT01838499|76176875|FG001|Overall Study|Withdrawal by Subject|9|||
42338779|NCT01807065|76176883|FG000|Overall Study|Receive no sip-T due to IV access|1|||
42338780|NCT01807065|76176884|FG001|Overall Study|Receive no sip-T due to IV access|1|||
42338781|NCT02031458|76176897|FG000|May 8, 2015 to January 11, 2019|Death|89|||
42338782|NCT02031458|76176898|FG001|May 8, 2015 to January 11, 2019|Death|193|||
42338783|NCT02031458|76176899|FG002|May 8, 2015 to January 11, 2019|Death|198|||
42338784|NCT02031458|76176897|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
42338785|NCT02031458|76176898|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
42338786|NCT02031458|76176899|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
42338787|NCT02031458|76176897|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
42338788|NCT02031458|76176898|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
42338789|NCT02031458|76176899|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
42338790|NCT02031458|76176897|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
42338791|NCT02031458|76176898|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
42338792|NCT02031458|76176899|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
42338793|NCT02031458|76176897|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
42338794|NCT02031458|76176898|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
42338795|NCT02031458|76176899|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
42338796|NCT02031458|76176897|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
42338797|NCT02031458|76176898|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
42338798|NCT02031458|76176899|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
42338799|NCT02031458|76176897|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
42338800|NCT02031458|76176898|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
42338801|NCT02031458|76176899|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
42338802|NCT02031458|76176897|FG000|Baseline to May 8, 2015|Death|36|||
42338803|NCT02031458|76176898|FG001|Baseline to May 8, 2015|Death|87|||
42338804|NCT02031458|76176899|FG002|Baseline to May 8, 2015|Death|100|||
42338805|NCT02031458|76176897|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
42338806|NCT02031458|76176898|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
42338807|NCT02031458|76176899|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
42338808|NCT02031458|76176897|FG000|Baseline to May 8, 2015|Physician Decision|0|||
42338809|NCT02031458|76176898|FG001|Baseline to May 8, 2015|Physician Decision|1|||
42338810|NCT02031458|76176899|FG002|Baseline to May 8, 2015|Physician Decision|0|||
42338811|NCT02031458|76176897|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
42338812|NCT02031458|76176898|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
42338813|NCT02031458|76176899|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
42338814|NCT02031458|76176897|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
42338815|NCT02031458|76176898|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
42338816|NCT02031458|76176899|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
42338817|NCT02031458|76176897|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
42338818|NCT02031458|76176898|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
42338819|NCT02031458|76176899|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
42338820|NCT02031458|76176897|FG000|Baseline to May 8, 2015|On Treatment|43|||
42338821|NCT02031458|76176898|FG001|Baseline to May 8, 2015|On Treatment|81|||
42338822|NCT02031458|76176899|FG002|Baseline to May 8, 2015|On Treatment|73|||
42338823|NCT02031458|76176897|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
42338824|NCT02031458|76176898|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
42338825|NCT02031458|76176899|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
42338826|NCT02009696|76176909|FG000|Overall Study|Withdrawal by Subject|2|||
42338827|NCT01806597|76176916|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
42338828|NCT01806597|76176917|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
42338829|NCT01806597|76176918|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
42000590|NCT01172938|75809019|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
42266314|NCT02307682|76094404|FG000|Overall Study|Adverse Event|9|||
42266315|NCT02307682|76094405|FG001|Overall Study|Adverse Event|8|||
42266316|NCT02307682|76094406|FG002|Overall Study|Adverse Event|12|||
42266317|NCT02307682|76094404|FG000|Overall Study|Lack of Efficacy|1|||
42338830|NCT01806597|76176919|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
42338831|NCT01806597|76176920|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
42338832|NCT01806597|76176921|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
42338833|NCT01806597|76176916|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
42338834|NCT01806597|76176917|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
42338835|NCT01806597|76176918|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
42338836|NCT01806597|76176919|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
42338837|NCT01806597|76176920|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
42338838|NCT01806597|76176921|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
42338839|NCT01806597|76176916|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
42338840|NCT01806597|76176917|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
42338841|NCT01806597|76176918|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
42338842|NCT01806597|76176919|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
42338843|NCT01806597|76176920|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
42338844|NCT01806597|76176921|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
42338845|NCT01806597|76176916|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
42338846|NCT01806597|76176917|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
42338847|NCT01806597|76176918|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
42338848|NCT01806597|76176919|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
42338849|NCT01806597|76176920|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
42338850|NCT01806597|76176921|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
42338851|NCT01806597|76176916|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
42338852|NCT01806597|76176917|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
42338853|NCT01806597|76176918|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
42338854|NCT01806597|76176919|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
42338855|NCT01806597|76176920|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
42338856|NCT01806597|76176921|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
42338857|NCT01806597|76176916|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
42338858|NCT01806597|76176917|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
42338859|NCT01806597|76176918|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
42338860|NCT01806597|76176919|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
42266318|NCT02307682|76094405|FG001|Overall Study|Lack of Efficacy|0|||
42266319|NCT02307682|76094406|FG002|Overall Study|Lack of Efficacy|1|||
42266320|NCT02307682|76094404|FG000|Overall Study|Physician Decision|2|||
42266321|NCT02307682|76094405|FG001|Overall Study|Physician Decision|2|||
42266322|NCT02307682|76094406|FG002|Overall Study|Physician Decision|8|||
42266323|NCT02307682|76094404|FG000|Overall Study|Progressive Disease|1|||
42266324|NCT02307682|76094405|FG001|Overall Study|Progressive Disease|0|||
42266325|NCT02307682|76094406|FG002|Overall Study|Progressive Disease|0|||
42266326|NCT02307682|76094404|FG000|Overall Study|Withdrawal by Subject|26|||
42000591|NCT01172938|75809020|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
42338861|NCT01806597|76176920|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
42338862|NCT01806597|76176921|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
42338863|NCT01806597|76176916|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
42338864|NCT01806597|76176917|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
42338865|NCT01806597|76176918|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
42338866|NCT01806597|76176919|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
42338867|NCT01806597|76176920|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
42338868|NCT01806597|76176921|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
42338869|NCT01806597|76176916|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
42338870|NCT01806597|76176917|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
42338871|NCT01806597|76176918|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
42338872|NCT01806597|76176919|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
42338873|NCT01806597|76176920|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
42338874|NCT01806597|76176921|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
42338875|NCT01806597|76176916|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
42338876|NCT01806597|76176917|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
42338877|NCT01806597|76176918|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
42338878|NCT01806597|76176919|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
42338879|NCT01806597|76176920|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
42338880|NCT01806597|76176921|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
42338881|NCT01806597|76176916|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
42338882|NCT01806597|76176917|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
42338883|NCT01806597|76176918|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
42338884|NCT01806597|76176919|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
42338885|NCT01806597|76176920|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
42338886|NCT01806597|76176921|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
42338887|NCT01806597|76176916|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
42338888|NCT01806597|76176917|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
42338889|NCT01806597|76176918|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
42338890|NCT01806597|76176919|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
42338891|NCT01806597|76176920|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
42338892|NCT01806597|76176921|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
42338893|NCT01806597|76176916|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
42338894|NCT01806597|76176917|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
42338895|NCT01806597|76176918|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
42338896|NCT01806597|76176919|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
42338897|NCT01806597|76176920|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
42338898|NCT01806597|76176921|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
42338899|NCT01806597|76176916|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
42338900|NCT01806597|76176917|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
42338901|NCT01806597|76176918|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
42338902|NCT01806597|76176919|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
42338903|NCT01806597|76176920|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
42338904|NCT01806597|76176921|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
42338905|NCT01806597|76176916|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
42338906|NCT01806597|76176917|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
42338907|NCT01806597|76176918|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
42338908|NCT01806597|76176919|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
42338909|NCT01806597|76176920|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
42338910|NCT01806597|76176921|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
42338911|NCT01806597|76176916|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
42338912|NCT01806597|76176917|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
42338913|NCT01806597|76176918|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
42338914|NCT01806597|76176919|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
42338915|NCT01806597|76176920|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
42338916|NCT01806597|76176921|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
42338917|NCT01806597|76176916|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
42338918|NCT01806597|76176917|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
42338919|NCT01806597|76176918|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
42338920|NCT01806597|76176919|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
42266327|NCT02307682|76094405|FG001|Overall Study|Withdrawal by Subject|34|||
42266328|NCT02307682|76094406|FG002|Overall Study|Withdrawal by Subject|23|||
42266329|NCT02307682|76094404|FG000|Overall Study|Death|9|||
42266330|NCT02307682|76094405|FG001|Overall Study|Death|7|||
42266331|NCT02307682|76094406|FG002|Overall Study|Death|12|||
42266332|NCT02307682|76094404|FG000|Overall Study|Lost to Follow-up|1|||
42266333|NCT02307682|76094405|FG001|Overall Study|Lost to Follow-up|5|||
42266334|NCT02307682|76094406|FG002|Overall Study|Lost to Follow-up|6|||
42266335|NCT02307682|76094404|FG000|Overall Study|Protocol Deviation|0|||
42266336|NCT02307682|76094405|FG001|Overall Study|Protocol Deviation|0|||
42266337|NCT02307682|76094406|FG002|Overall Study|Protocol Deviation|2|||
42266338|NCT02307682|76094404|FG000|Overall Study|Other|1|||
42266339|NCT02307682|76094405|FG001|Overall Study|Other|1|||
42266340|NCT02307682|76094406|FG002|Overall Study|Other|0|||
42266341|NCT02615990|76094416|FG000|Overall Study|study terminated|1|||
42266342|NCT02615990|76094417|FG001|Overall Study|study terminated|1|||
42266343|NCT02613884|76094423|FG000|Overall Study|Death|1|||
42266344|NCT02613884|76094423|FG000|Overall Study|Lost to Follow-up|1|||
42266345|NCT02791763|76094431|FG000|Overall Study|Protocol Violation|0|||
42266346|NCT02791763|76094432|FG001|Overall Study|Protocol Violation|0|||
42266347|NCT02791763|76094433|FG002|Overall Study|Protocol Violation|1|||
42266348|NCT02791763|76094431|FG000|Overall Study|Withdrawal by Subject|5|||
42266349|NCT02791763|76094432|FG001|Overall Study|Withdrawal by Subject|1|||
42266350|NCT02791763|76094433|FG002|Overall Study|Withdrawal by Subject|0|||
42338921|NCT01806597|76176920|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
42338922|NCT01806597|76176921|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
42338923|NCT01806597|76176916|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
42338924|NCT01806597|76176917|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
42338925|NCT01806597|76176918|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
42338926|NCT01806597|76176919|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
42338927|NCT01806597|76176920|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
42338928|NCT01806597|76176921|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
42266351|NCT02791763|76094431|FG000|Overall Study|Physician Decision|0|||
42266352|NCT02791763|76094432|FG001|Overall Study|Physician Decision|1|||
42266353|NCT02791763|76094433|FG002|Overall Study|Physician Decision|0|||
42266354|NCT02791763|76094431|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
42266355|NCT02791763|76094432|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
42266356|NCT02791763|76094433|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
42266357|NCT02791763|76094431|FG000|Overall Study|Cancer event|1|||
42266358|NCT02791763|76094432|FG001|Overall Study|Cancer event|3|||
42338929|NCT01806597|76176916|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
42338930|NCT01806597|76176917|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
42338931|NCT01806597|76176918|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
42338932|NCT01806597|76176919|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
42338933|NCT01806597|76176920|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
42338934|NCT01806597|76176921|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
42338935|NCT01806597|76176916|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
42338936|NCT01806597|76176917|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
42338937|NCT01806597|76176918|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
42338938|NCT01806597|76176919|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
42338939|NCT01806597|76176920|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
42338940|NCT01806597|76176921|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
42338941|NCT02031302|76176937|FG000|Overall Study|Death|115|||
42266359|NCT02791763|76094433|FG002|Overall Study|Cancer event|0|||
42266360|NCT02791763|76094431|FG000|Overall Study|Participant had renal transplant|3|||
42266361|NCT02791763|76094432|FG001|Overall Study|Participant had renal transplant|0|||
42266362|NCT02791763|76094433|FG002|Overall Study|Participant had renal transplant|0|||
42266363|NCT02791763|76094431|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
42266364|NCT02791763|76094432|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
42266365|NCT02791763|76094433|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
42266366|NCT02791763|76094431|FG000|Overall Study|Adverse Event|12|||
42266367|NCT02791763|76094432|FG001|Overall Study|Adverse Event|13|||
42266368|NCT02791763|76094433|FG002|Overall Study|Adverse Event|7|||
42266369|NCT02613572|76094453|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
42266370|NCT02613572|76094454|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
42266371|NCT02613572|76094455|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
42266372|NCT02613572|76094453|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
42266373|NCT02613572|76094454|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
42266374|NCT02613572|76094455|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
42266375|NCT02087189|76094467|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
42266376|NCT02341456|76094474|FG000|Overall Study|Disease progression|2|||
42266377|NCT02341456|76094475|FG001|Overall Study|Disease progression|3|||
42266378|NCT02341456|76094476|FG002|Overall Study|Disease progression|1|||
42266379|NCT02341456|76094474|FG000|Overall Study|Death|1|||
42266380|NCT02341456|76094475|FG001|Overall Study|Death|1|||
42266381|NCT02341456|76094476|FG002|Overall Study|Death|1|||
42266382|NCT02341456|76094474|FG000|Overall Study|Withdrawal by Subject|0|||
42266383|NCT02341456|76094475|FG001|Overall Study|Withdrawal by Subject|1|||
42266384|NCT02341456|76094476|FG002|Overall Study|Withdrawal by Subject|1|||
42266385|NCT02341456|76094474|FG000|Overall Study|Moved to local access programme.|0|||
42266386|NCT02341456|76094475|FG001|Overall Study|Moved to local access programme.|1|||
42338942|NCT02031302|76176938|FG001|Overall Study|Death|0|||
42338943|NCT02031302|76176937|FG000|Overall Study|Not treated with study valve system|18|||
42338944|NCT02031302|76176938|FG001|Overall Study|Not treated with study valve system|0|||
42338945|NCT02031302|76176937|FG000|Overall Study|Missed Follow Up|27|||
42338946|NCT02031302|76176938|FG001|Overall Study|Missed Follow Up|0|||
42338947|NCT02031302|76176937|FG000|Overall Study|Lost to Follow-up|4|||
42338948|NCT02031302|76176938|FG001|Overall Study|Lost to Follow-up|0|||
42338949|NCT01610037|76176948|FG000|All Patients|Adverse Event|27|||
42338950|NCT01610037|76176949|FG001|All Patients|Adverse Event|22|||
42338951|NCT01610037|76176950|FG002|All Patients|Adverse Event|26|||
42338952|NCT01610037|76176948|FG000|All Patients|Withdrawal by Subject|12|||
42338953|NCT01610037|76176949|FG001|All Patients|Withdrawal by Subject|10|||
42338954|NCT01610037|76176950|FG002|All Patients|Withdrawal by Subject|20|||
42338955|NCT01610037|76176948|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
42338956|NCT01610037|76176949|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
42338957|NCT01610037|76176950|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
42338958|NCT01610037|76176948|FG000|All Patients|Death|4|||
42338959|NCT01610037|76176949|FG001|All Patients|Death|2|||
42338960|NCT01610037|76176950|FG002|All Patients|Death|1|||
42338961|NCT01610037|76176948|FG000|All Patients|Protocol deviation|4|||
42338962|NCT01610037|76176949|FG001|All Patients|Protocol deviation|3|||
42338963|NCT01610037|76176950|FG002|All Patients|Protocol deviation|3|||
42338964|NCT01610037|76176948|FG000|All Patients|Abnormal laboratory value|1|||
42338965|NCT01610037|76176949|FG001|All Patients|Abnormal laboratory value|1|||
42338966|NCT01610037|76176950|FG002|All Patients|Abnormal laboratory value|0|||
42338967|NCT01610037|76176948|FG000|All Patients|Administrative problems|1|||
42338968|NCT01610037|76176949|FG001|All Patients|Administrative problems|4|||
42338969|NCT01610037|76176950|FG002|All Patients|Administrative problems|4|||
42338970|NCT01610037|76176948|FG000|All Patients|Lost to Follow-up|1|||
42338971|NCT01610037|76176949|FG001|All Patients|Lost to Follow-up|0|||
42338972|NCT01610037|76176950|FG002|All Patients|Lost to Follow-up|0|||
42338973|NCT01610037|76176948|FG000|All Patients|Abnormal test procedure result(s)|0|||
42338974|NCT01610037|76176949|FG001|All Patients|Abnormal test procedure result(s)|1|||
42338975|NCT01610037|76176950|FG002|All Patients|Abnormal test procedure result(s)|3|||
42266387|NCT02341456|76094476|FG002|Overall Study|Moved to local access programme.|1|||
42266388|NCT02341456|76094474|FG000|Overall Study|Physician Decision|1|||
42338976|NCT01610037|76176948|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
42338977|NCT01610037|76176949|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
42338978|NCT01610037|76176950|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
42338979|NCT01610037|76176948|FG000|Treatment and Follow up Period|Death|10|||
42338980|NCT01610037|76176949|FG001|Treatment and Follow up Period|Death|5|||
42338981|NCT01610037|76176950|FG002|Treatment and Follow up Period|Death|4|||
42338982|NCT01610037|76176948|FG000|Treatment and Follow up Period|Administrative problems|1|||
42338983|NCT01610037|76176949|FG001|Treatment and Follow up Period|Administrative problems|3|||
42338984|NCT01610037|76176950|FG002|Treatment and Follow up Period|Administrative problems|2|||
42338985|NCT01610037|76176948|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
42338986|NCT01610037|76176949|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
42338987|NCT01610037|76176950|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
42338988|NCT01806051|76176958|FG000|Overall Study|Withdrawal by Subject|6|||
42338989|NCT01837797|76176967|FG000|Period 1|Adverse Event|9|||
42338990|NCT01837797|76176968|FG001|Period 1|Adverse Event|0|||
42338991|NCT01837797|76176969|FG002|Period 1|Adverse Event|0|||
42338992|NCT01837797|76176970|FG003|Period 1|Adverse Event|0|||
42338993|NCT01837797|76176971|FG004|Period 1|Adverse Event|0|||
42266389|NCT02341456|76094475|FG001|Overall Study|Physician Decision|0|||
42266390|NCT02341456|76094476|FG002|Overall Study|Physician Decision|0|||
42266391|NCT02370784|76094486|FG000|Overall Study|Patient started prohibited medication|0|||
42266392|NCT02370784|76094487|FG001|Overall Study|Patient started prohibited medication|1|||
42266393|NCT02307370|76094495|FG000|Overall Study|Death|5|||
42266394|NCT02307370|76094495|FG000|Overall Study|Lost to Follow-up|1|||
42266395|NCT02307370|76094495|FG000|Overall Study|Withdrawal by Subject|1|||
42266396|NCT02307370|76094495|FG000|Overall Study|Declined Addendum ICF|6|||
42338994|NCT01837797|76176967|FG000|Period 1|Withdrawal by Subject|6|||
42266397|NCT02307370|76094495|FG000|Overall Study|No response during telephone contact|5|||
42266398|NCT02307370|76094495|FG000|Overall Study|Protocol Violation|1|||
42266399|NCT02370394|76094503|FG000|Overall Study|Lost to Follow-up|2|||
42266400|NCT02370394|76094504|FG001|Overall Study|Lost to Follow-up|1|||
42266401|NCT02370394|76094503|FG000|Overall Study|Withdrawal by Subject|0|||
42266402|NCT02370394|76094504|FG001|Overall Study|Withdrawal by Subject|1|||
42266403|NCT01595438|76094513|FG000|Overall Study|Lost to Follow-up|20|||
42266404|NCT01595438|76094514|FG001|Overall Study|Lost to Follow-up|20|||
42266405|NCT01595438|76094513|FG000|Overall Study|Withdrawal by Subject|12|||
42266406|NCT01595438|76094514|FG001|Overall Study|Withdrawal by Subject|12|||
42266407|NCT01595438|76094513|FG000|Overall Study|Other Eligibility criteria|11|||
42266408|NCT01595438|76094514|FG001|Overall Study|Other Eligibility criteria|9|||
42266409|NCT02340520|76094520|FG000|Overall Study|Lost to Follow-up|1|||
42266410|NCT02340520|76094520|FG000|Overall Study|Patient did not take drug as specified|1|||
42338995|NCT01837797|76176968|FG001|Period 1|Withdrawal by Subject|0|||
42338996|NCT01837797|76176969|FG002|Period 1|Withdrawal by Subject|0|||
42338997|NCT01837797|76176970|FG003|Period 1|Withdrawal by Subject|0|||
42338998|NCT01837797|76176971|FG004|Period 1|Withdrawal by Subject|0|||
42338999|NCT01837797|76176967|FG000|Period 1|Administrative reasons|76|||
42339000|NCT01837797|76176968|FG001|Period 1|Administrative reasons|0|||
42339001|NCT01837797|76176969|FG002|Period 1|Administrative reasons|0|||
42339002|NCT01837797|76176970|FG003|Period 1|Administrative reasons|0|||
42339003|NCT01837797|76176971|FG004|Period 1|Administrative reasons|0|||
42339004|NCT01837797|76176967|FG000|Period 1|Withdrawal of consent before treatment|1|||
42339005|NCT01837797|76176968|FG001|Period 1|Withdrawal of consent before treatment|0|||
42339006|NCT01837797|76176969|FG002|Period 1|Withdrawal of consent before treatment|0|||
42339007|NCT01837797|76176970|FG003|Period 1|Withdrawal of consent before treatment|0|||
42339008|NCT01837797|76176971|FG004|Period 1|Withdrawal of consent before treatment|0|||
42339009|NCT01837797|76176967|FG000|Period 1|Other|10|||
42339010|NCT01837797|76176968|FG001|Period 1|Other|0|||
42339011|NCT01837797|76176969|FG002|Period 1|Other|0|||
42339012|NCT01837797|76176970|FG003|Period 1|Other|0|||
42339013|NCT01837797|76176971|FG004|Period 1|Other|0|||
42339014|NCT01837797|76176967|FG000|Period 2|Administrative or other reasons|0|||
42339015|NCT01837797|76176968|FG001|Period 2|Administrative or other reasons|5|||
42339016|NCT01837797|76176969|FG002|Period 2|Administrative or other reasons|2|||
42339017|NCT01837797|76176970|FG003|Period 2|Administrative or other reasons|4|||
42266411|NCT02340520|76094520|FG000|Overall Study|Withdrawal by Subject|1|||
42339018|NCT01837797|76176971|FG004|Period 2|Administrative or other reasons|0|||
42339019|NCT01837797|76176967|FG000|Period 2|Adverse Event|0|||
42266412|NCT02339584|76094526|FG000|Overall Study|Adverse Event|11|||
42266413|NCT02339584|76094527|FG001|Overall Study|Adverse Event|7|||
42266414|NCT02339584|76094526|FG000|Overall Study|Lack of Efficacy|0|||
42339020|NCT01837797|76176968|FG001|Period 2|Adverse Event|0|||
42339021|NCT01837797|76176969|FG002|Period 2|Adverse Event|0|||
42339022|NCT01837797|76176970|FG003|Period 2|Adverse Event|1|||
42339023|NCT01837797|76176971|FG004|Period 2|Adverse Event|0|||
42339024|NCT01837797|76176967|FG000|Period 3|Adverse Event|0|||
42339025|NCT01837797|76176968|FG001|Period 3|Adverse Event|0|||
42339026|NCT01837797|76176969|FG002|Period 3|Adverse Event|0|||
42339027|NCT01837797|76176970|FG003|Period 3|Adverse Event|0|||
42339028|NCT01837797|76176971|FG004|Period 3|Adverse Event|1|||
42339029|NCT01837797|76176967|FG000|Period 3|Administrative reasons|0|||
42339030|NCT01837797|76176968|FG001|Period 3|Administrative reasons|0|||
42339031|NCT01837797|76176969|FG002|Period 3|Administrative reasons|0|||
42339032|NCT01837797|76176970|FG003|Period 3|Administrative reasons|0|||
42339033|NCT01837797|76176971|FG004|Period 3|Administrative reasons|20|||
42339034|NCT01837797|76176967|FG000|Period 3|Other|0|||
42339035|NCT01837797|76176968|FG001|Period 3|Other|0|||
42339036|NCT01837797|76176969|FG002|Period 3|Other|0|||
42339037|NCT01837797|76176970|FG003|Period 3|Other|0|||
42339038|NCT01837797|76176971|FG004|Period 3|Other|2|||
42339039|NCT01984424|76176981|FG000|Overall Study|Withdrawal by Subject|3|||
42339040|NCT01984424|76176982|FG001|Overall Study|Withdrawal by Subject|5|||
42339041|NCT01984424|76176981|FG000|Overall Study|Sponsor Decision|0|||
42339042|NCT01984424|76176982|FG001|Overall Study|Sponsor Decision|1|||
42339043|NCT01984424|76176981|FG000|Overall Study|Lost to Follow-up|0|||
42339044|NCT01984424|76176982|FG001|Overall Study|Lost to Follow-up|1|||
42339045|NCT01837719|76176988|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
42339046|NCT01837719|76176988|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
42339047|NCT01984268|76177003|FG000|Overall Study|Study Terminated|15|||
42339048|NCT02031146|76177009|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
42339049|NCT02031146|76177010|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
42000592|NCT01172938|75809021|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
42339050|NCT02031146|76177011|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
42339051|NCT02031146|76177012|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
42000593|NCT01172938|75809013|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
42000594|NCT01172938|75809014|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
42000595|NCT01172938|75809015|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
42339052|NCT02031146|76177013|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
42339053|NCT02031146|76177014|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
42339054|NCT02031146|76177015|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
42339055|NCT02009384|76177025|FG000|Overall Study|Death|2|||
42339056|NCT01805037|76177029|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
42339057|NCT01805037|76177030|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
42339058|NCT01805037|76177029|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
42339059|NCT01805037|76177030|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
42339060|NCT01805037|76177029|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
42339061|NCT01805037|76177030|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
42339062|NCT01805037|76177029|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
42339063|NCT01805037|76177030|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
42339064|NCT01805037|76177029|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
42339065|NCT01805037|76177030|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
42339066|NCT01805037|76177029|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
42339067|NCT01805037|76177030|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
42339068|NCT01805037|76177029|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
42339069|NCT01805037|76177030|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
42339070|NCT01805037|76177029|FG000|Follow Up (up to 3 Years)|Death|0|||
42339071|NCT01805037|76177030|FG001|Follow Up (up to 3 Years)|Death|2|||
42339072|NCT01805037|76177029|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
42339073|NCT01805037|76177030|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
42339074|NCT01805037|76177029|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
42339075|NCT01805037|76177030|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
42339076|NCT01803711|76177036|FG000|Overall Study|Adverse Event|1|||
42339077|NCT01803711|76177037|FG001|Overall Study|Adverse Event|1|||
42339078|NCT01836549|76177051|FG000|Overall Study|Did not receive study drug|0|||
42339079|NCT01836549|76177052|FG001|Overall Study|Did not receive study drug|0|||
42339080|NCT01836549|76177053|FG002|Overall Study|Did not receive study drug|1|||
42339081|NCT01836549|76177054|FG003|Overall Study|Did not receive study drug|0|||
42034856|NCT01035138|75843176|FG002|Overall Study|Caregiver Decision|1|||
42034857|NCT01035138|75843174|FG000|Overall Study|Withdrawal by Subject|1|||
42034858|NCT01035138|75843175|FG001|Overall Study|Withdrawal by Subject|0|||
42339082|NCT01836549|76177055|FG004|Overall Study|Did not receive study drug|0|||
42339083|NCT01836549|76177056|FG005|Overall Study|Did not receive study drug|0|||
42339084|NCT01836549|76177057|FG006|Overall Study|Did not receive study drug|0|||
42339085|NCT01836549|76177051|FG000|Overall Study|Patient declared ineligible|0|||
42266415|NCT02339584|76094527|FG001|Overall Study|Lack of Efficacy|1|||
42266416|NCT02339584|76094526|FG000|Overall Study|Physician Decision|1|||
42266417|NCT02339584|76094527|FG001|Overall Study|Physician Decision|2|||
42266418|NCT02339584|76094526|FG000|Overall Study|Protocol Violation|1|||
42266419|NCT02339584|76094527|FG001|Overall Study|Protocol Violation|1|||
42266420|NCT02339584|76094526|FG000|Overall Study|Withdrawal by Subject|2|||
42266421|NCT02339584|76094527|FG001|Overall Study|Withdrawal by Subject|4|||
42266422|NCT02339506|76094533|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
42266423|NCT02339506|76094534|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
42266424|NCT02339506|76094533|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
42266425|NCT02339506|76094534|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
42266426|NCT02305888|76094543|FG000|Overall Study|Lost to Follow-up|0|||
42266427|NCT02305888|76094544|FG001|Overall Study|Lost to Follow-up|0|||
42266428|NCT02305888|76094545|FG002|Overall Study|Lost to Follow-up|1|||
42266429|NCT02305888|76094543|FG000|Overall Study|Adverse Event|0|||
42266430|NCT02305888|76094544|FG001|Overall Study|Adverse Event|1|||
42266431|NCT02305888|76094545|FG002|Overall Study|Adverse Event|0|||
42266432|NCT02338882|76094555|FG000|Overall Study|Death|1|||
42266433|NCT02338882|76094556|FG001|Overall Study|Death|0|||
42266434|NCT02338882|76094555|FG000|Overall Study|Lost to Follow-up|6|||
42266435|NCT02338882|76094556|FG001|Overall Study|Lost to Follow-up|3|||
42266436|NCT01594970|76094568|FG000|Overall Study|Non-Adverse Event Related|4|||
42266437|NCT01594970|76094569|FG001|Overall Study|Non-Adverse Event Related|5|||
42266438|NCT01594970|76094570|FG002|Overall Study|Non-Adverse Event Related|6|||
42339086|NCT01836549|76177052|FG001|Overall Study|Patient declared ineligible|0|||
42135064|NCT00372567|75945808|FG000|Phase 3 Study|Global deterioration of health status|0|||
42266439|NCT01594970|76094568|FG000|Overall Study|Adverse Event|17|||
42266440|NCT01594970|76094569|FG001|Overall Study|Adverse Event|23|||
42266441|NCT01594970|76094570|FG002|Overall Study|Adverse Event|23|||
42266442|NCT01594970|76094568|FG000|Overall Study|Lost to Follow-up|54|||
42266443|NCT01594970|76094569|FG001|Overall Study|Lost to Follow-up|54|||
42266444|NCT01594970|76094570|FG002|Overall Study|Lost to Follow-up|37|||
42339087|NCT01836549|76177053|FG002|Overall Study|Patient declared ineligible|0|||
42339088|NCT01836549|76177054|FG003|Overall Study|Patient declared ineligible|1|||
42339089|NCT01836549|76177055|FG004|Overall Study|Patient declared ineligible|0|||
42339090|NCT01836549|76177056|FG005|Overall Study|Patient declared ineligible|0|||
42034859|NCT01035138|75843176|FG002|Overall Study|Withdrawal by Subject|0|||
42266445|NCT02338492|76094578|FG000|Overall Study|Death|32|||
42339091|NCT01836549|76177057|FG006|Overall Study|Patient declared ineligible|0|||
42135065|NCT00372567|75945809|FG001|Phase 3 Study|Global deterioration of health status|1|||
42266446|NCT02338492|76094578|FG000|Overall Study|Adverse Event|3|||
42266447|NCT02338492|76094578|FG000|Overall Study|Lost to Follow-up|4|||
42266448|NCT02338492|76094578|FG000|Overall Study|Reason not captured above|6|||
42266449|NCT02337946|76094582|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
42266450|NCT02337946|76094583|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
42266451|NCT02337946|76094584|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
42266452|NCT02337946|76094582|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
42266453|NCT02337946|76094583|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
42266454|NCT02337946|76094584|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
42266455|NCT02337946|76094582|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
42266456|NCT02337946|76094583|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
42266457|NCT02337946|76094584|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
42266458|NCT02337946|76094582|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
42266459|NCT02337946|76094583|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
42266460|NCT02337946|76094584|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
42266461|NCT02337946|76094582|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
42266462|NCT02337946|76094583|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
42266463|NCT02337946|76094584|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
42266464|NCT02337946|76094582|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
42266465|NCT02337946|76094583|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
42266466|NCT02337946|76094584|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
42266467|NCT02337946|76094582|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
42266468|NCT02337946|76094583|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
42266469|NCT02337946|76094584|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
42266470|NCT02337946|76094582|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
42266471|NCT02337946|76094583|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
42266472|NCT02337946|76094584|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
42266473|NCT02337946|76094582|FG000|In-between Period|Without Informed Consent|1|||
42266474|NCT02337946|76094583|FG001|In-between Period|Without Informed Consent|0|||
42266475|NCT02337946|76094584|FG002|In-between Period|Without Informed Consent|0|||
42266476|NCT02337946|76094582|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
42266477|NCT02337946|76094583|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
42266478|NCT02337946|76094584|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
42339092|NCT01836549|76177051|FG000|Overall Study|Patient inevaluable to start therapy|0|||
42339093|NCT01836549|76177052|FG001|Overall Study|Patient inevaluable to start therapy|0|||
42339094|NCT01836549|76177053|FG002|Overall Study|Patient inevaluable to start therapy|0|||
42339095|NCT01836549|76177054|FG003|Overall Study|Patient inevaluable to start therapy|0|||
42339096|NCT01836549|76177055|FG004|Overall Study|Patient inevaluable to start therapy|0|||
42339097|NCT01836549|76177056|FG005|Overall Study|Patient inevaluable to start therapy|0|||
42339098|NCT01836549|76177057|FG006|Overall Study|Patient inevaluable to start therapy|1|||
42339099|NCT01836471|76177078|FG000|Overall Study|Pregnancy|1|||
42339100|NCT01836471|76177079|FG001|Overall Study|Pregnancy|0|||
42339101|NCT01836471|76177080|FG002|Overall Study|Pregnancy|0|||
42339102|NCT01836471|76177081|FG003|Overall Study|Pregnancy|0|||
42000596|NCT01172938|75809016|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
42266479|NCT02337946|76094582|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
42266480|NCT02337946|76094583|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
42266481|NCT02337946|76094584|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
42266482|NCT02337946|76094582|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
42266483|NCT02337946|76094583|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
42266484|NCT02337946|76094584|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
42266485|NCT02337946|76094582|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
42266486|NCT02337946|76094583|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
42339103|NCT01836471|76177082|FG004|Overall Study|Pregnancy|0|||
42339104|NCT01836471|76177078|FG000|Overall Study|Withdrawal by Subject|3|||
42339105|NCT01836471|76177079|FG001|Overall Study|Withdrawal by Subject|4|||
42339106|NCT01836471|76177080|FG002|Overall Study|Withdrawal by Subject|1|||
42339107|NCT01836471|76177081|FG003|Overall Study|Withdrawal by Subject|0|||
42339108|NCT01836471|76177082|FG004|Overall Study|Withdrawal by Subject|2|||
42339109|NCT01836471|76177078|FG000|Overall Study|Physician Decision|0|||
42339110|NCT01836471|76177079|FG001|Overall Study|Physician Decision|1|||
42339111|NCT01836471|76177080|FG002|Overall Study|Physician Decision|0|||
42339112|NCT01836471|76177081|FG003|Overall Study|Physician Decision|0|||
42339113|NCT01836471|76177082|FG004|Overall Study|Physician Decision|0|||
42339114|NCT01836471|76177078|FG000|Overall Study|Lost to Follow-up|0|||
42339115|NCT01836471|76177079|FG001|Overall Study|Lost to Follow-up|0|||
42339116|NCT01836471|76177080|FG002|Overall Study|Lost to Follow-up|0|||
42339117|NCT01836471|76177081|FG003|Overall Study|Lost to Follow-up|1|||
42135066|NCT00372567|75945810|FG002|Phase 3 Study|Global deterioration of health status|0|||
42339118|NCT01836471|76177082|FG004|Overall Study|Lost to Follow-up|1|||
42339119|NCT01836471|76177078|FG000|Overall Study|Adverse Event|6|||
42339120|NCT01836471|76177079|FG001|Overall Study|Adverse Event|3|||
42339121|NCT01836471|76177080|FG002|Overall Study|Adverse Event|1|||
42339122|NCT01836471|76177081|FG003|Overall Study|Adverse Event|1|||
42339123|NCT01836471|76177082|FG004|Overall Study|Adverse Event|2|||
42339124|NCT01836471|76177078|FG000|Overall Study|Non compliance with tx|1|||
42135067|NCT00372567|75945808|FG000|Phase 3 Study|Other|2|||
42339125|NCT01836471|76177079|FG001|Overall Study|Non compliance with tx|1|||
42339126|NCT01836471|76177080|FG002|Overall Study|Non compliance with tx|0|||
42339127|NCT01836471|76177081|FG003|Overall Study|Non compliance with tx|0|||
42339128|NCT01836471|76177082|FG004|Overall Study|Non compliance with tx|0|||
42339129|NCT02030600|76177097|FG000|Treatment Period 1|Adverse Event|5|||
42339130|NCT02030600|76177098|FG001|Treatment Period 1|Adverse Event|7|||
42339131|NCT02030600|76177097|FG000|Treatment Period 1|Lack of Efficacy|0|||
42339132|NCT02030600|76177098|FG001|Treatment Period 1|Lack of Efficacy|1|||
42339133|NCT02030600|76177097|FG000|Treatment Period 1|Lost to Follow-up|11|||
42339134|NCT02030600|76177098|FG001|Treatment Period 1|Lost to Follow-up|3|||
42339135|NCT02030600|76177097|FG000|Treatment Period 1|Protocol Violation|22|||
42339136|NCT02030600|76177098|FG001|Treatment Period 1|Protocol Violation|17|||
42339137|NCT02030600|76177097|FG000|Treatment Period 1|Withdrawal by Subject|13|||
42339138|NCT02030600|76177098|FG001|Treatment Period 1|Withdrawal by Subject|17|||
42339139|NCT02030600|76177097|FG000|Treatment Period 1|Casebook Unsigned|1|||
42339140|NCT02030600|76177098|FG001|Treatment Period 1|Casebook Unsigned|0|||
42339141|NCT02030600|76177097|FG000|Treatment Period 1|Unclassified|1|||
42339142|NCT02030600|76177098|FG001|Treatment Period 1|Unclassified|0|||
42339143|NCT02030600|76177097|FG000|Treatment Period 2|Adverse Event|4|||
42339144|NCT02030600|76177098|FG001|Treatment Period 2|Adverse Event|4|||
42339145|NCT02030600|76177097|FG000|Treatment Period 2|Lack of Efficacy|2|||
42339146|NCT02030600|76177098|FG001|Treatment Period 2|Lack of Efficacy|1|||
42339147|NCT02030600|76177097|FG000|Treatment Period 2|Lost to Follow-up|4|||
42339148|NCT02030600|76177098|FG001|Treatment Period 2|Lost to Follow-up|2|||
42339149|NCT02030600|76177097|FG000|Treatment Period 2|Protocol Violation|1|||
42135068|NCT00372567|75945809|FG001|Phase 3 Study|Other|2|||
42135069|NCT00372567|75945810|FG002|Phase 3 Study|Other|1|||
42135070|NCT00372567|75945808|FG000|Phase 3 Study|study terminated by sponsor|13|||
42135071|NCT00372567|75945809|FG001|Phase 3 Study|study terminated by sponsor|8|||
42135072|NCT00372567|75945810|FG002|Phase 3 Study|study terminated by sponsor|5|||
42135073|NCT00365547|75945818|FG000|Overall Study|Insurance did not cover Avastin|1|||
42135074|NCT00365547|75945818|FG000|Overall Study|Screen failure|1|||
42135075|NCT00365547|75945818|FG000|Overall Study|Withdrawal by Subject|1|||
42135076|NCT00545441|75945827|FG000|Overall Study|Fistula draining at 6 months|2|||
42135077|NCT00545441|75945828|FG001|Overall Study|Fistula draining at 6 months|4|||
42266487|NCT02337946|76094584|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
42266488|NCT02337946|76094582|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
42000597|NCT01172938|75809017|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
42135078|NCT00545441|75945827|FG000|Overall Study|Lost to Follow-up|9|||
42000598|NCT01172938|75809018|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
42000599|NCT01172938|75809019|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
42000600|NCT01172938|75809020|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
42339150|NCT02030600|76177098|FG001|Treatment Period 2|Protocol Violation|2|||
42339151|NCT02030600|76177097|FG000|Treatment Period 2|Withdrawal by Subject|13|||
42339152|NCT02030600|76177098|FG001|Treatment Period 2|Withdrawal by Subject|9|||
42339153|NCT02030600|76177097|FG000|Treatment Period 2|Unclassified|1|||
42339154|NCT02030600|76177098|FG001|Treatment Period 2|Unclassified|0|||
42339155|NCT01802775|76177108|FG000|Overall Study|Death|0|||
42339156|NCT01802775|76177109|FG001|Overall Study|Death|3|||
42339157|NCT01802775|76177108|FG000|Overall Study|Reason not provided|0|||
42339158|NCT01802775|76177109|FG001|Overall Study|Reason not provided|1|||
42339159|NCT01802775|76177108|FG000|Overall Study|Physician Decision|1|||
42339160|NCT01802775|76177109|FG001|Overall Study|Physician Decision|0|||
42339161|NCT01802775|76177108|FG000|Overall Study|Adverse Event|1|||
42339162|NCT01802775|76177109|FG001|Overall Study|Adverse Event|1|||
42339163|NCT01802775|76177108|FG000|Overall Study|Withdrawal by Subject|3|||
42339164|NCT01802775|76177109|FG001|Overall Study|Withdrawal by Subject|5|||
42339165|NCT01802775|76177108|FG000|Overall Study|Lost to Follow-up|1|||
42339166|NCT01802775|76177109|FG001|Overall Study|Lost to Follow-up|2|||
42000601|NCT01172938|75809021|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
42339167|NCT01802385|76177117|FG000|Overall Study|Death|106|||
42339168|NCT01802385|76177118|FG001|Overall Study|Death|120|||
42339169|NCT01773993|76177124|FG000|Overall Study|No Visit After Treatment|35|||
42339170|NCT01802073|76177130|FG000|Overall Study|Lost to Follow-up|0|||
42266489|NCT02337946|76094583|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
42266490|NCT02337946|76094584|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
42266491|NCT02337946|76094582|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
42266492|NCT02337946|76094583|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
42339171|NCT01802073|76177131|FG001|Overall Study|Lost to Follow-up|1|||
42339172|NCT01802073|76177130|FG000|Overall Study|Non-compliant|4|||
42339173|NCT01802073|76177131|FG001|Overall Study|Non-compliant|2|||
42339174|NCT01802073|76177130|FG000|Overall Study|Withdrawal by Subject|1|||
42339175|NCT01802073|76177131|FG001|Overall Study|Withdrawal by Subject|1|||
42339176|NCT01802073|76177130|FG000|Overall Study|Physician Decision|0|||
42339177|NCT01802073|76177131|FG001|Overall Study|Physician Decision|7|||
42339178|NCT01607073|76177137|FG000|Overall Study|Adverse Event|1|||
42339179|NCT01773291|76177147|FG000|Overall Study|Protocol Violation|1|||
42339180|NCT01773291|76177148|FG001|Overall Study|Protocol Violation|0|||
42339181|NCT01773291|76177149|FG002|Overall Study|Protocol Violation|0|||
42339182|NCT01773291|76177147|FG000|Overall Study|Withdrawal by Subject|0|||
42339183|NCT01773291|76177148|FG001|Overall Study|Withdrawal by Subject|0|||
42339184|NCT01773291|76177149|FG002|Overall Study|Withdrawal by Subject|1|||
42339185|NCT01801917|76177162|FG000|Period 1 - Randomized|Adverse Event|1|||
42339186|NCT01801917|76177163|FG001|Period 1 - Randomized|Adverse Event|0|||
42339187|NCT01801917|76177164|FG002|Period 1 - Randomized|Adverse Event|1|||
42266493|NCT02337946|76094584|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
42266494|NCT01369199|76094590|FG000|Overall Study|Withdrawal by Subject|1|||
42266495|NCT01369199|76094590|FG000|Overall Study|Lost to Follow-up|2|||
42266496|NCT01368965|76094594|FG000|Overall Study|Lost to Follow-up|12|||
42266497|NCT02610140|76094602|FG000|Randomization and Treatment Period|Radiological progression|23|||
42266498|NCT02610140|76094603|FG001|Randomization and Treatment Period|Radiological progression|15|||
42266499|NCT02610140|76094602|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
42266500|NCT02610140|76094603|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
42266501|NCT02610140|76094602|FG000|Randomization and Treatment Period|Protocol Violation|1|||
42339188|NCT01801917|76177165|FG003|Period 1 - Randomized|Adverse Event|0|||
42034860|NCT01035138|75843174|FG000|Overall Study|Physician Decision|0|||
42135079|NCT00545441|75945828|FG001|Overall Study|Lost to Follow-up|5|||
42266502|NCT02610140|76094603|FG001|Randomization and Treatment Period|Protocol Violation|0|||
42266503|NCT02610140|76094602|FG000|Randomization and Treatment Period|Physician Decision|0|||
42339189|NCT02008916|76177179|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
42339190|NCT02008916|76177180|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
42339191|NCT02008916|76177181|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
42339192|NCT02008916|76177179|FG000|Week 16 - 156|Adverse Event|4|||
42266504|NCT02610140|76094603|FG001|Randomization and Treatment Period|Physician Decision|1|||
42266505|NCT02610140|76094602|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
42266506|NCT02610140|76094603|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
42266507|NCT02610140|76094602|FG000|Randomization and Treatment Period|Death|7|||
42339193|NCT02008916|76177180|FG001|Week 16 - 156|Adverse Event|2|||
42339194|NCT02008916|76177181|FG002|Week 16 - 156|Adverse Event|3|||
42339195|NCT02008916|76177179|FG000|Week 16 - 156|Withdrawal by Subject|7|||
42339196|NCT02008916|76177180|FG001|Week 16 - 156|Withdrawal by Subject|3|||
42266508|NCT02610140|76094603|FG001|Randomization and Treatment Period|Death|1|||
42266509|NCT02610140|76094602|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
42339197|NCT02008916|76177181|FG002|Week 16 - 156|Withdrawal by Subject|5|||
42339198|NCT02008916|76177179|FG000|Week 16 - 156|No longer requires treatment|0|||
42339199|NCT02008916|76177180|FG001|Week 16 - 156|No longer requires treatment|1|||
42339200|NCT02008916|76177181|FG002|Week 16 - 156|No longer requires treatment|0|||
42339201|NCT02008916|76177179|FG000|Week 16 - 156|Lost to Follow-up|5|||
42339202|NCT02008916|76177180|FG001|Week 16 - 156|Lost to Follow-up|0|||
42339203|NCT02008916|76177181|FG002|Week 16 - 156|Lost to Follow-up|0|||
42339204|NCT02008916|76177179|FG000|Week 16 - 156|Lack of Efficacy|3|||
42339205|NCT02008916|76177180|FG001|Week 16 - 156|Lack of Efficacy|5|||
42339206|NCT02008916|76177181|FG002|Week 16 - 156|Lack of Efficacy|2|||
42339207|NCT02008916|76177179|FG000|Week 16 - 156|Pregnancy|0|||
42339208|NCT02008916|76177180|FG001|Week 16 - 156|Pregnancy|1|||
42266510|NCT02610140|76094603|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
42339209|NCT02008916|76177181|FG002|Week 16 - 156|Pregnancy|0|||
42339210|NCT02008916|76177179|FG000|Week 16 - 156|Physician Decision|0|||
42339211|NCT02008916|76177180|FG001|Week 16 - 156|Physician Decision|1|||
42339212|NCT02008916|76177181|FG002|Week 16 - 156|Physician Decision|0|||
42339213|NCT01772823|76177192|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
42339214|NCT01772823|76177193|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
42339215|NCT01772823|76177192|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
42339216|NCT01772823|76177193|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
42339217|NCT01772823|76177192|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
42339218|NCT01772823|76177193|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
42339219|NCT01772823|76177192|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
42339220|NCT01772823|76177193|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
42339221|NCT01772823|76177192|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
42339222|NCT01772823|76177193|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
42339223|NCT01772823|76177192|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
42339224|NCT01772823|76177193|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
42339225|NCT01772823|76177192|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
42339226|NCT01772823|76177193|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
42339227|NCT01772823|76177192|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
42339228|NCT01772823|76177193|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
42339229|NCT01772823|76177192|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
42339230|NCT01772823|76177193|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
42339231|NCT01772823|76177192|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
42339232|NCT01772823|76177193|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
42339233|NCT01772823|76177192|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
42339234|NCT01772823|76177193|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
42339235|NCT01772823|76177192|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
42339236|NCT01772823|76177193|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
42339237|NCT01772823|76177192|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
42339238|NCT01772823|76177193|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
42339239|NCT01772823|76177192|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
42339240|NCT01772823|76177193|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
42339241|NCT01772823|76177192|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
42339242|NCT01772823|76177193|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
42339243|NCT01772823|76177192|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
42339244|NCT01772823|76177193|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
42339245|NCT02029976|76177206|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
42339246|NCT02029976|76177207|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
42339247|NCT02029976|76177206|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
42339248|NCT02029976|76177207|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
42339249|NCT02029976|76177206|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
42339250|NCT02029976|76177207|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
42339251|NCT02029976|76177206|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
42339252|NCT02029976|76177207|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
42266511|NCT02610140|76094602|FG000|Randomization and Treatment Period|Adverse Event|44|||
42266512|NCT02610140|76094603|FG001|Randomization and Treatment Period|Adverse Event|13|||
42266513|NCT02610140|76094602|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
42266514|NCT02610140|76094603|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
42266515|NCT02610140|76094602|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
42266516|NCT02610140|76094603|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
42266517|NCT02610140|76094602|FG000|Randomization and Treatment Period|Not treated|3|||
42266518|NCT02610140|76094603|FG001|Randomization and Treatment Period|Not treated|10|||
42266519|NCT02610140|76094602|FG000|Safety Follow-up|Other|0|||
42266520|NCT02610140|76094603|FG001|Safety Follow-up|Other|2|||
42266521|NCT02610140|76094602|FG000|Safety Follow-up|Lost to Follow-up|1|||
42339253|NCT01983254|76177215|FG000|Overall Study|Death|6|||
42266522|NCT02610140|76094603|FG001|Safety Follow-up|Lost to Follow-up|0|||
42339254|NCT01983254|76177216|FG001|Overall Study|Death|6|||
42266523|NCT02610140|76094602|FG000|Safety Follow-up|No follow-up|5|||
42339255|NCT01983254|76177215|FG000|Overall Study|Lost to Follow-up|17|||
42339256|NCT01983254|76177216|FG001|Overall Study|Lost to Follow-up|16|||
42339257|NCT01983254|76177215|FG000|Overall Study|too ill|11|||
42339258|NCT01983254|76177216|FG001|Overall Study|too ill|8|||
42339259|NCT01771809|76177224|FG000|Overall Study|Adverse Event|4|||
42339260|NCT01771809|76177225|FG001|Overall Study|Adverse Event|12|||
42339261|NCT01771809|76177224|FG000|Overall Study|Protocol Violation|0|||
42339262|NCT01771809|76177225|FG001|Overall Study|Protocol Violation|1|||
42339263|NCT01771809|76177224|FG000|Overall Study|Withdrawal by Subject|34|||
42339264|NCT01771809|76177225|FG001|Overall Study|Withdrawal by Subject|42|||
42339265|NCT01771809|76177224|FG000|Overall Study|Lost to Follow-up|1|||
42339266|NCT01771809|76177225|FG001|Overall Study|Lost to Follow-up|3|||
42339267|NCT01771809|76177224|FG000|Overall Study|Other (Insufficient clinical response)|22|||
42339268|NCT01771809|76177225|FG001|Overall Study|Other (Insufficient clinical response)|20|||
42339269|NCT01771809|76177224|FG000|Overall Study|Death|1|||
42339270|NCT01771809|76177225|FG001|Overall Study|Death|0|||
42339271|NCT01771809|76177224|FG000|Overall Study|Other (other)|9|||
42339272|NCT01771809|76177225|FG001|Overall Study|Other (other)|5|||
42339273|NCT01771731|76177233|FG000|Overall Study|Physician Decision|1|||
42339274|NCT01771731|76177234|FG001|Overall Study|Physician Decision|0|||
42339275|NCT01771731|76177233|FG000|Overall Study|Protocol Violation|0|||
42339276|NCT01771731|76177234|FG001|Overall Study|Protocol Violation|1|||
42339277|NCT01771731|76177233|FG000|Overall Study|Adverse event: Pain Crisis|1|||
42339278|NCT01771731|76177234|FG001|Overall Study|Adverse event: Pain Crisis|1|||
42339279|NCT01982942|76177242|FG000|Overall Study|Adverse Event|10|||
42339280|NCT01982942|76177243|FG001|Overall Study|Adverse Event|5|||
42339281|NCT01982942|76177242|FG000|Overall Study|Lost to Follow-up|4|||
42339282|NCT01982942|76177243|FG001|Overall Study|Lost to Follow-up|3|||
42339283|NCT01982942|76177242|FG000|Overall Study|Multiple sclerosis progression|3|||
42339284|NCT01982942|76177243|FG001|Overall Study|Multiple sclerosis progression|2|||
42339285|NCT01982942|76177242|FG000|Overall Study|Wanted to try therapy not permitted|1|||
42339286|NCT01982942|76177243|FG001|Overall Study|Wanted to try therapy not permitted|0|||
42339287|NCT01982942|76177242|FG000|Overall Study|Subject declined future visits|0|||
42339288|NCT01982942|76177243|FG001|Overall Study|Subject declined future visits|1|||
42339289|NCT01982942|76177242|FG000|Overall Study|Left geographical area|2|||
42339290|NCT01982942|76177243|FG001|Overall Study|Left geographical area|0|||
42266524|NCT02610140|76094603|FG001|Safety Follow-up|No follow-up|3|||
42339291|NCT01982942|76177242|FG000|Overall Study|Too many pills|1|||
42339292|NCT01982942|76177243|FG001|Overall Study|Too many pills|0|||
42339293|NCT01982942|76177242|FG000|Overall Study|MS Relapse|0|||
42339294|NCT01982942|76177243|FG001|Overall Study|MS Relapse|1|||
42339295|NCT01982942|76177242|FG000|Overall Study|Chose to join a stem cell trial|0|||
42339296|NCT01982942|76177243|FG001|Overall Study|Chose to join a stem cell trial|1|||
42339297|NCT01982942|76177242|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
42339298|NCT01982942|76177243|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
42339299|NCT01769469|76177249|FG000|Overall Study|Consent Withdrawn|5|||
42339300|NCT01769469|76177249|FG000|Overall Study|Moved Out Of Area|3|||
42339301|NCT01769469|76177249|FG000|Overall Study|Lost to Follow-up|17|||
42339302|NCT01769469|76177249|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
42339303|NCT01769469|76177249|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
42339304|NCT02008526|76177258|FG000|Overall Study|Death|0|||
42339305|NCT02008526|76177259|FG001|Overall Study|Death|2|||
42339306|NCT02008526|76177260|FG002|Overall Study|Death|1|||
42339307|NCT02008526|76177258|FG000|Overall Study|Withdrawal by Subject|3|||
42339308|NCT02008526|76177259|FG001|Overall Study|Withdrawal by Subject|3|||
42339309|NCT02008526|76177260|FG002|Overall Study|Withdrawal by Subject|2|||
42339310|NCT02008526|76177258|FG000|Overall Study|Lost to Follow-up|5|||
42266525|NCT02610140|76094602|FG000|Safety Follow-up|Death|12|||
42266526|NCT02610140|76094603|FG001|Safety Follow-up|Death|2|||
42266527|NCT02610140|76094602|FG000|Safety Follow-up|Deterioration of general conditions|15|||
42266528|NCT02610140|76094603|FG001|Safety Follow-up|Deterioration of general conditions|5|||
42266529|NCT02610140|76094602|FG000|Safety Follow-up|Withdrawal by Subject|12|||
42266530|NCT02610140|76094603|FG001|Safety Follow-up|Withdrawal by Subject|12|||
42339311|NCT02008526|76177259|FG001|Overall Study|Lost to Follow-up|9|||
42339312|NCT02008526|76177260|FG002|Overall Study|Lost to Follow-up|6|||
42339313|NCT01769391|76177270|FG000|Overall Study|Death|10|||
42339314|NCT01769391|76177271|FG001|Overall Study|Death|1|||
42339315|NCT01769391|76177270|FG000|Overall Study|Adverse Event|0|||
42339316|NCT01769391|76177271|FG001|Overall Study|Adverse Event|3|||
42339317|NCT01769391|76177270|FG000|Overall Study|Progressive Disease|1|||
42339318|NCT01769391|76177271|FG001|Overall Study|Progressive Disease|2|||
42339319|NCT01769391|76177270|FG000|Overall Study|Withdrawal by Subject|4|||
42339320|NCT01769391|76177271|FG001|Overall Study|Withdrawal by Subject|3|||
42339321|NCT01769391|76177270|FG000|Overall Study|Investigator Decision|2|||
42339322|NCT01769391|76177271|FG001|Overall Study|Investigator Decision|0|||
42339323|NCT01800903|76177283|FG000|Second Test Period|unable to catheterise|1|||
42339324|NCT01800903|76177284|FG001|Second Test Period|unable to catheterise|0|||
42339325|NCT01800903|76177285|FG002|Second Test Period|unable to catheterise|0|||
42339326|NCT01800903|76177286|FG003|Second Test Period|unable to catheterise|0|||
42339327|NCT01800903|76177287|FG004|Second Test Period|unable to catheterise|0|||
42339328|NCT01800903|76177288|FG005|Second Test Period|unable to catheterise|0|||
42339329|NCT01767987|76177296|FG000|Overall Study|Physician Decision|4|||
42339330|NCT01767987|76177297|FG001|Overall Study|Physician Decision|1|||
42339331|NCT01800201|76177305|FG000|Overall Study|Withdrawal by Subject|2|||
42339332|NCT01800201|76177306|FG001|Overall Study|Withdrawal by Subject|0|||
42339333|NCT01800201|76177305|FG000|Overall Study|patient privacy concerns|1|||
42339334|NCT01800201|76177306|FG001|Overall Study|patient privacy concerns|1|||
42339335|NCT01800201|76177305|FG000|Overall Study|did not want to use device|0|||
42339336|NCT01800201|76177306|FG001|Overall Study|did not want to use device|1|||
42339337|NCT01800201|76177305|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
42339338|NCT01800201|76177306|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
42339339|NCT01767909|76177315|FG000|Overall Study|Withdrawal by Subject|4|||
42339340|NCT01767909|76177316|FG001|Overall Study|Withdrawal by Subject|7|||
42339341|NCT01767909|76177315|FG000|Overall Study|Adverse Event|3|||
42339342|NCT01767909|76177316|FG001|Overall Study|Adverse Event|1|||
42339343|NCT01767909|76177315|FG000|Overall Study|Withdrawal by Study Partner|3|||
42339344|NCT01767909|76177316|FG001|Overall Study|Withdrawal by Study Partner|1|||
42339345|NCT01767909|76177315|FG000|Overall Study|Non-Compliance|2|||
42339346|NCT01767909|76177316|FG001|Overall Study|Non-Compliance|0|||
42339347|NCT01767909|76177315|FG000|Overall Study|Perceived Lack of Efficacy|1|||
42000602|NCT01172938|75809013|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
42000603|NCT01172938|75809014|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
42034861|NCT01035138|75843175|FG001|Overall Study|Physician Decision|0|||
42266531|NCT02610140|76094602|FG000|Active Follow-up|Progressive disease - radiological|30|||
42266532|NCT02610140|76094603|FG001|Active Follow-up|Progressive disease - radiological|22|||
42266533|NCT02610140|76094602|FG000|Active Follow-up|Death|8|||
42266534|NCT02610140|76094603|FG001|Active Follow-up|Death|1|||
42266535|NCT02610140|76094602|FG000|Active Follow-up|Withdrawal by Subject|4|||
42266536|NCT02610140|76094603|FG001|Active Follow-up|Withdrawal by Subject|0|||
42266537|NCT02610140|76094602|FG000|Active Follow-up|Progressive disease - clinical|1|||
42266538|NCT02610140|76094603|FG001|Active Follow-up|Progressive disease - clinical|2|||
42266539|NCT02610140|76094602|FG000|Active Follow-up|Deterioration of general conditions|1|||
42266540|NCT02610140|76094603|FG001|Active Follow-up|Deterioration of general conditions|0|||
42339348|NCT01767909|76177316|FG001|Overall Study|Perceived Lack of Efficacy|0|||
42339349|NCT01767909|76177315|FG000|Overall Study|Investigator Recommendation|0|||
42339350|NCT01767909|76177316|FG001|Overall Study|Investigator Recommendation|1|||
42339351|NCT01767909|76177315|FG000|Overall Study|Lost to Follow-up|0|||
42339352|NCT01767909|76177316|FG001|Overall Study|Lost to Follow-up|1|||
42135080|NCT00545441|75945827|FG000|Overall Study|Technical failure|0|||
42135081|NCT00545441|75945828|FG001|Overall Study|Technical failure|1|||
42135082|NCT00545441|75945827|FG000|Overall Study|Withdrawal by Subject|1|||
42135083|NCT00545441|75945828|FG001|Overall Study|Withdrawal by Subject|1|||
42135084|NCT00545441|75945827|FG000|Overall Study|Persistence or recurrence of fistula|5|||
42135085|NCT00545441|75945828|FG001|Overall Study|Persistence or recurrence of fistula|2|||
42135086|NCT00545441|75945827|FG000|Overall Study|Patients were not treated|1|||
42135087|NCT00545441|75945828|FG001|Overall Study|Patients were not treated|3|||
42135088|NCT00294658|75945836|FG000|Overall Study|Death|0|||
42135089|NCT00294658|75945837|FG001|Overall Study|Death|1|||
42135090|NCT00294658|75945836|FG000|Overall Study|Lost to Follow-up|4|||
42135091|NCT00294658|75945837|FG001|Overall Study|Lost to Follow-up|0|||
42135092|NCT00294658|75945836|FG000|Overall Study|Physician Decision|1|||
42135093|NCT00294658|75945837|FG001|Overall Study|Physician Decision|2|||
42135094|NCT00294658|75945836|FG000|Overall Study|Pregnancy|0|||
42266541|NCT02610140|76094602|FG000|Active Follow-up|Ongoing but not completed|4|||
42266542|NCT02610140|76094603|FG001|Active Follow-up|Ongoing but not completed|1|||
42266543|NCT02610140|76094602|FG000|Long-term Follow-up|Death|86|||
42266544|NCT02610140|76094603|FG001|Long-term Follow-up|Death|44|||
42266545|NCT02610140|76094602|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
42266546|NCT02610140|76094603|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
42266547|NCT02610140|76094602|FG000|Long-term Follow-up|Lost to Follow-up|1|||
42266548|NCT02610140|76094603|FG001|Long-term Follow-up|Lost to Follow-up|2|||
42266549|NCT02610140|76094602|FG000|Long-term Follow-up|Ongoing but not completed|30|||
42266550|NCT02610140|76094603|FG001|Long-term Follow-up|Ongoing but not completed|17|||
42266551|NCT02789657|76094613|FG000|Overall Study|Withdrawal by Subject|2|||
42266552|NCT02789657|76094614|FG001|Overall Study|Withdrawal by Subject|0|||
42266553|NCT02789657|76094615|FG002|Overall Study|Withdrawal by Subject|0|||
42266554|NCT02789657|76094616|FG003|Overall Study|Withdrawal by Subject|0|||
42339353|NCT01767909|76177315|FG000|Overall Study|LP uncessessful|0|||
42339354|NCT01767909|76177316|FG001|Overall Study|LP uncessessful|1|||
42000604|NCT01172938|75809015|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
42135095|NCT00294658|75945837|FG001|Overall Study|Pregnancy|1|||
42135096|NCT00294658|75945836|FG000|Overall Study|Withdrawal by Subject|0|||
42266555|NCT02609984|76094627|FG000|Overall Study|Death|29|||
42135097|NCT00294658|75945837|FG001|Overall Study|Withdrawal by Subject|4|||
42135098|NCT00294658|75945836|FG000|Overall Study|Found to have invasive thymoma|1|||
42135099|NCT00294658|75945837|FG001|Overall Study|Found to have invasive thymoma|0|||
42135100|NCT00294658|75945836|FG000|Overall Study|Patient and family were not satisfied|0|||
42135101|NCT00294658|75945837|FG001|Overall Study|Patient and family were not satisfied|1|||
42135102|NCT03923933|75945845|FG000|Overall Study|Lost to Follow-up|1|||
42135103|NCT03923933|75945846|FG001|Overall Study|Lost to Follow-up|0|||
42135104|NCT03923933|75945845|FG000|Overall Study|Withdrawal by Subject|0|||
42135105|NCT03923933|75945846|FG001|Overall Study|Withdrawal by Subject|1|||
42135106|NCT00372489|75945852|FG000|Overall Study|Adverse Event|18|||
42135107|NCT00372489|75945852|FG000|Overall Study|Lack of Efficacy|1|||
42135108|NCT00372489|75945852|FG000|Overall Study|Lost to Follow-up|3|||
42135109|NCT00372489|75945852|FG000|Overall Study|Physician Decision|3|||
42266556|NCT02609984|76094628|FG001|Overall Study|Death|26|||
42266557|NCT02609984|76094627|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
42000605|NCT01172938|75809016|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
42000606|NCT01172938|75809017|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
42000607|NCT01172938|75809018|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
42000608|NCT01172938|75809019|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
42000609|NCT01172938|75809020|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
42000610|NCT01172938|75809021|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
42000611|NCT01172938|75809013|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
42000612|NCT01172938|75809014|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
42000613|NCT01172938|75809015|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
42000614|NCT01172938|75809016|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
42000615|NCT01172938|75809017|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
42000616|NCT01172938|75809018|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
42000617|NCT01172938|75809019|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
42000618|NCT01172938|75809020|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
42000619|NCT01172938|75809021|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
42000620|NCT01172938|75809013|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
42000621|NCT01172938|75809014|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
42000622|NCT01172938|75809015|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
42000623|NCT01172938|75809016|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
42000624|NCT01172938|75809017|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
42000625|NCT01172938|75809018|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
42000626|NCT01172938|75809019|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
42000627|NCT01172938|75809020|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
42000628|NCT01172938|75809021|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
42000629|NCT01172938|75809013|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
42000630|NCT01172938|75809014|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
42000631|NCT01172938|75809015|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
42000632|NCT01172938|75809016|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
42000633|NCT01172938|75809017|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
42000634|NCT01172938|75809018|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
42000635|NCT01172938|75809019|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
42000636|NCT01172938|75809020|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
42000637|NCT01172938|75809021|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
42135110|NCT00372489|75945852|FG000|Overall Study|Withdrawal by Subject|5|||
42266558|NCT02609984|76094628|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
42266559|NCT02609984|76094627|FG000|Overall Study|Lost to Follow-up|1|||
42266560|NCT02609984|76094628|FG001|Overall Study|Lost to Follow-up|2|||
42266561|NCT02609984|76094627|FG000|Overall Study|Withdrawal by Subject|0|||
42266562|NCT02609984|76094628|FG001|Overall Study|Withdrawal by Subject|1|||
42266563|NCT02609984|76094627|FG000|Overall Study|Disease Progression|2|||
42266564|NCT02609984|76094628|FG001|Overall Study|Disease Progression|0|||
42266565|NCT02609672|76094636|FG000|Overall Study|Lost to Follow-up|3|||
42266566|NCT02609672|76094637|FG001|Overall Study|Lost to Follow-up|1|||
42266567|NCT02611778|76094645|FG000|Overall Study|Withdrawal by Subject|2|||
42266568|NCT02611778|76094646|FG001|Overall Study|Withdrawal by Subject|8|||
42266569|NCT02611778|76094645|FG000|Overall Study|Adverse Event|1|||
42266570|NCT02611778|76094646|FG001|Overall Study|Adverse Event|2|||
42266571|NCT02611778|76094645|FG000|Overall Study|Death|2|||
42266572|NCT02611778|76094646|FG001|Overall Study|Death|1|||
42266573|NCT02611778|76094645|FG000|Overall Study|Protocol Violation|1|||
42000638|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
42000639|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
42000640|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
42000641|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
42000642|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
42000643|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
42000644|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
42000645|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
42000646|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
42000647|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
42000648|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
42000649|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
42000650|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
42000651|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
42000652|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
42000653|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
42000654|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
42000655|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
42000656|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
42000657|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
42000658|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
42000659|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
42000660|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
42000661|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
42000662|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
42000663|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
42000664|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
42000665|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
42000666|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
42000667|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
42000668|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
42000669|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
42000670|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
42000671|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
42135111|NCT00372489|75945852|FG000|Overall Study|Patient Relocation|2|||
42135112|NCT00372489|75945852|FG000|Overall Study|Renal transplant|6|||
42339355|NCT02029274|76177328|FG000|Overall Study|Adverse Event|1|||
42339356|NCT02029274|76177329|FG001|Overall Study|Adverse Event|0|||
42339357|NCT02029274|76177330|FG002|Overall Study|Adverse Event|2|||
42339358|NCT02029274|76177331|FG003|Overall Study|Adverse Event|2|||
42000672|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
42000673|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
42000674|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
42000675|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
42000676|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
42000677|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
42000678|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
42000679|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
42000680|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
42000681|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
42000682|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
42000683|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
42000684|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
42000685|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
42000686|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
42000687|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
42000688|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
42000689|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
42135113|NCT00372489|75945852|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
42135114|NCT00372411|75945859|FG000|Overall Study|Withdrawal by Subject|3|||
42339359|NCT02008370|76177345|FG000|Overall Study|Lost to Follow-up|7|||
42339360|NCT01981616|76177351|FG000|Overall Study|Adverse Event|0|||
42339361|NCT01981616|76177352|FG001|Overall Study|Adverse Event|1|||
42000690|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
42000691|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
42000692|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
42000693|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
42000694|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
42000695|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
42000696|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
42000697|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
42000698|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
42000699|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
42000700|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
42000701|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
42339362|NCT01981616|76177351|FG000|Overall Study|Protocol Violation|1|||
42339363|NCT01981616|76177352|FG001|Overall Study|Protocol Violation|0|||
42000702|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
42000703|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
42000704|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
42000705|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
42000706|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
42000707|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
42000708|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
42000709|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
42266574|NCT02611778|76094646|FG001|Overall Study|Protocol Violation|0|||
42266575|NCT02611778|76094645|FG000|Overall Study|Lost to Follow-up|3|||
42266576|NCT02611778|76094646|FG001|Overall Study|Lost to Follow-up|1|||
42266577|NCT02611778|76094645|FG000|Overall Study|Need for alternative treatment|1|||
42266578|NCT02611778|76094646|FG001|Overall Study|Need for alternative treatment|0|||
42266579|NCT02611778|76094645|FG000|Overall Study|Other Reason|2|||
42266580|NCT02611778|76094646|FG001|Overall Study|Other Reason|1|||
42266581|NCT02709369|76094653|FG000|Overall Study|Lost to Follow-up|15|||
42266582|NCT02709369|76094653|FG000|Overall Study|Withdrawal by Subject|10|||
42266583|NCT02709369|76094653|FG000|Overall Study|Did not received intervention|2|||
42266584|NCT02613182|76094657|FG000|Overall Study|Death|6|||
42266585|NCT02613182|76094657|FG000|Overall Study|Physician Decision|1|||
42266586|NCT02613182|76094657|FG000|Overall Study|Study Terminated by Sponsor|21|||
42266587|NCT02613182|76094657|FG000|Overall Study|Withdrawal by Subject|6|||
42000710|NCT01172938|75809013|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
42266588|NCT04843579|76094683|FG000|Overall Study|Adverse Event|1|||
42266589|NCT04843579|76094683|FG000|Overall Study|Disease Progression|1|||
42266590|NCT04649359|76094689|FG000|Overall Study|Withdrawal by Subject|7|||
42339364|NCT02104817|76177360|FG000|Overall Study|Death|363|||
42000711|NCT01172938|75809014|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
42000712|NCT01172938|75809015|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
42000713|NCT01172938|75809016|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
42000714|NCT01172938|75809017|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
42000715|NCT01172938|75809018|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
42000716|NCT01172938|75809019|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
42266591|NCT04649359|76094690|FG001|Overall Study|Withdrawal by Subject|7|||
42266592|NCT04649359|76094689|FG000|Overall Study|Death|41|||
42266593|NCT04649359|76094690|FG001|Overall Study|Death|26|||
42266594|NCT04649359|76094689|FG000|Overall Study|Ongoing in the study|75|||
42266595|NCT04649359|76094690|FG001|Overall Study|Ongoing in the study|31|||
42266596|NCT04567693|76094712|FG000|Overall Study|Death|0|||
42266597|NCT04567693|76094713|FG001|Overall Study|Death|0|||
42266598|NCT04567693|76094714|FG002|Overall Study|Death|2|||
42266599|NCT04567693|76094712|FG000|Overall Study|Lost to Follow-up|1|||
42266600|NCT04567693|76094713|FG001|Overall Study|Lost to Follow-up|0|||
42266601|NCT04567693|76094714|FG002|Overall Study|Lost to Follow-up|2|||
42266602|NCT04567693|76094712|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
42000717|NCT01172938|75809020|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
42000718|NCT01172938|75809021|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
42000719|NCT01172938|75809013|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
42000720|NCT01172938|75809014|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
42000721|NCT01172938|75809015|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
42000722|NCT01172938|75809016|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
42000723|NCT01172938|75809017|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
42000724|NCT01172938|75809018|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
42000725|NCT01172938|75809019|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
42266603|NCT04567693|76094713|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
42266604|NCT04567693|76094714|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
42266605|NCT04238663|76094725|FG000|Overall Study|Lost to Follow-up|0|||
42266606|NCT04238663|76094726|FG001|Overall Study|Lost to Follow-up|1|||
42266607|NCT04238663|76094727|FG002|Overall Study|Lost to Follow-up|0|||
42266608|NCT04139642|76094747|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
42266609|NCT04139642|76094748|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
42266610|NCT03980483|76094791|FG000|Overall Study|Adverse Event|13|||
42266611|NCT03980483|76094792|FG001|Overall Study|Adverse Event|29|||
42266612|NCT03980483|76094793|FG002|Overall Study|Adverse Event|11|||
42266613|NCT03980483|76094794|FG003|Overall Study|Adverse Event|2|||
42266614|NCT03980483|76094795|FG004|Overall Study|Adverse Event|2|||
42266615|NCT03980483|76094796|FG005|Overall Study|Adverse Event|2|||
42266616|NCT03980483|76094791|FG000|Overall Study|Lack of Efficacy|7|||
42266617|NCT03980483|76094792|FG001|Overall Study|Lack of Efficacy|6|||
42266618|NCT03980483|76094793|FG002|Overall Study|Lack of Efficacy|0|||
42266619|NCT03980483|76094794|FG003|Overall Study|Lack of Efficacy|3|||
42266620|NCT03980483|76094795|FG004|Overall Study|Lack of Efficacy|1|||
42266621|NCT03980483|76094796|FG005|Overall Study|Lack of Efficacy|1|||
42266622|NCT03980483|76094791|FG000|Overall Study|Lost to Follow-up|2|||
42266623|NCT03980483|76094792|FG001|Overall Study|Lost to Follow-up|4|||
42266624|NCT03980483|76094793|FG002|Overall Study|Lost to Follow-up|2|||
42000726|NCT01172938|75809020|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
42000727|NCT01172938|75809021|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
42000728|NCT01172938|75809013|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
42266625|NCT03980483|76094794|FG003|Overall Study|Lost to Follow-up|1|||
42266626|NCT03980483|76094795|FG004|Overall Study|Lost to Follow-up|2|||
42000729|NCT01172938|75809014|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
42000730|NCT01172938|75809015|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
42000731|NCT01172938|75809016|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
42000732|NCT01172938|75809017|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
42000733|NCT01172938|75809018|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
42000734|NCT01172938|75809019|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
42000735|NCT01172938|75809020|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
42000736|NCT01172938|75809021|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
42000737|NCT01172938|75809013|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
42000738|NCT01172938|75809014|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
42000739|NCT01172938|75809015|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
42000740|NCT01172938|75809016|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
42000741|NCT01172938|75809017|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
42000742|NCT01172938|75809018|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
42000743|NCT01172938|75809019|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
42000744|NCT01172938|75809020|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
42000745|NCT01172938|75809021|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
42000746|NCT01172938|75809013|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
42000747|NCT01172938|75809014|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
42000748|NCT01172938|75809015|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
42000749|NCT01172938|75809016|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
42000750|NCT01172938|75809017|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
42000751|NCT01172938|75809018|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
42000752|NCT01172938|75809019|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
42000753|NCT01172938|75809020|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
42000754|NCT01172938|75809021|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
42000755|NCT01172938|75809013|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
42000756|NCT01172938|75809014|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
42000757|NCT01172938|75809015|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
42000758|NCT01172938|75809016|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
42000759|NCT01172938|75809017|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
42000760|NCT01172938|75809018|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
42000761|NCT01172938|75809019|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
42034862|NCT01035138|75843176|FG002|Overall Study|Physician Decision|1|||
42034863|NCT01035138|75843174|FG000|Overall Study|Sponsor Decision|66|||
42034864|NCT01035138|75843175|FG001|Overall Study|Sponsor Decision|60|||
42034865|NCT01035138|75843176|FG002|Overall Study|Sponsor Decision|42|||
42034866|NCT01035138|75843174|FG000|Overall Study|Lost to Follow-up|0|||
42034867|NCT01035138|75843175|FG001|Overall Study|Lost to Follow-up|0|||
42034868|NCT01035138|75843176|FG002|Overall Study|Lost to Follow-up|1|||
42034869|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
42034870|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
42034871|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
42034872|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
42000762|NCT01172938|75809020|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
42000763|NCT01172938|75809021|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
42034873|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
42034874|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
42034875|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
42034876|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
42034877|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
42034878|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
42034879|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
42034880|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
42034881|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
42266627|NCT03980483|76094796|FG005|Overall Study|Lost to Follow-up|0|||
42266628|NCT03980483|76094791|FG000|Overall Study|Protocol Violation|4|||
42266629|NCT03980483|76094792|FG001|Overall Study|Protocol Violation|2|||
42266630|NCT03980483|76094793|FG002|Overall Study|Protocol Violation|1|||
42266631|NCT03980483|76094794|FG003|Overall Study|Protocol Violation|1|||
42266632|NCT03980483|76094795|FG004|Overall Study|Protocol Violation|0|||
42000764|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
42266633|NCT03980483|76094796|FG005|Overall Study|Protocol Violation|0|||
42266634|NCT03980483|76094791|FG000|Overall Study|Physician Decision|14|||
42266635|NCT03980483|76094792|FG001|Overall Study|Physician Decision|10|||
42266636|NCT03980483|76094793|FG002|Overall Study|Physician Decision|7|||
42000765|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
42266637|NCT03980483|76094794|FG003|Overall Study|Physician Decision|4|||
42034882|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
42034883|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
42034884|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
42034885|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Program Termination|3|||
42034886|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Program Termination|0|||
42266638|NCT03980483|76094795|FG004|Overall Study|Physician Decision|4|||
42000766|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
42000767|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
42000768|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
42000769|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
42000770|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
42000771|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
42000772|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
42000773|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
42000774|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
42000775|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
42000776|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
42000777|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
42000778|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
42000779|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
42000780|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
42000781|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
42000782|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
42000783|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
42000784|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
42000785|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
42000786|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
42000787|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
42034887|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Program Termination|1|||
42266639|NCT03980483|76094796|FG005|Overall Study|Physician Decision|2|||
42266640|NCT03980483|76094791|FG000|Overall Study|Withdrawal by Subject|38|||
42266641|NCT03980483|76094792|FG001|Overall Study|Withdrawal by Subject|21|||
42266642|NCT03980483|76094793|FG002|Overall Study|Withdrawal by Subject|15|||
42266643|NCT03980483|76094794|FG003|Overall Study|Withdrawal by Subject|5|||
42266644|NCT03980483|76094795|FG004|Overall Study|Withdrawal by Subject|3|||
42266645|NCT03980483|76094796|FG005|Overall Study|Withdrawal by Subject|4|||
42266646|NCT03980483|76094791|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
42266647|NCT03980483|76094792|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
42266648|NCT03980483|76094793|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
42266649|NCT03980483|76094794|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
42266650|NCT03980483|76094795|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
42266651|NCT03980483|76094796|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
42266652|NCT03980483|76094791|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
42266653|NCT03980483|76094792|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
42266654|NCT03980483|76094793|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
42266655|NCT03980483|76094794|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
42266656|NCT03980483|76094795|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
42266657|NCT03980483|76094796|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
42266658|NCT03980483|76094791|FG000|Overall Study|Other|0|||
42266659|NCT03980483|76094792|FG001|Overall Study|Other|1|||
42266660|NCT03980483|76094793|FG002|Overall Study|Other|0|||
42266661|NCT03980483|76094794|FG003|Overall Study|Other|0|||
42266662|NCT03980483|76094795|FG004|Overall Study|Other|0|||
42266663|NCT03980483|76094796|FG005|Overall Study|Other|0|||
42266664|NCT03510468|76094837|FG000|Overall Study|Lost to Follow-up|1|||
42000788|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
42000789|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
42034888|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Program Termination|1|||
42266665|NCT03510468|76094837|FG000|Overall Study|Adverse Event|5|||
42266666|NCT03510468|76094837|FG000|Overall Study|Physician Decision|1|||
42266667|NCT03510468|76094837|FG000|Overall Study|non-compliant with treatment|2|||
42266668|NCT03510468|76094837|FG000|Overall Study|Missed visit|1|||
42266669|NCT03374202|76094844|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
42266670|NCT03374202|76094845|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
42266671|NCT03374202|76094846|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
42266672|NCT03374202|76094844|FG000|Five Year Long Term Follow Up|Death|0|||
42339365|NCT02104817|76177361|FG001|Overall Study|Death|330|||
42000790|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
42266673|NCT03374202|76094845|FG001|Five Year Long Term Follow Up|Death|1|||
42266674|NCT03374202|76094846|FG002|Five Year Long Term Follow Up|Death|0|||
42266675|NCT03218826|76094868|FG000|Overall Study|Non-compliance with protocol|1|||
42266676|NCT03218826|76094869|FG001|Overall Study|Non-compliance with protocol|0|||
42000791|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
42000792|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
42000793|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
42000794|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
42000795|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
42000796|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
42000797|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
42000798|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
42000799|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
42000800|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
42000801|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
42000802|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
42000803|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
42000804|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
42000805|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
42000806|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
42000807|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
42000808|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
42000809|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
42000810|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
42000811|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
42000812|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
42000813|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
42000814|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
42000815|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
42000816|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
42034889|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
42034890|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
42034891|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
42034892|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
42034893|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
42034894|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
42000817|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
42000818|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
42000819|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
42000820|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
42000821|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
42000822|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
42000823|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
42000824|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
42000825|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
42000826|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
42000827|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
42000828|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
42000829|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
42034895|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
42266677|NCT03218826|76094870|FG002|Overall Study|Non-compliance with protocol|2|||
42266678|NCT03218826|76094871|FG003|Overall Study|Non-compliance with protocol|1|||
42266679|NCT03218826|76094872|FG004|Overall Study|Non-compliance with protocol|1|||
42266680|NCT03075215|76094884|FG000|12-Month Primary Endpoint|Death|152|||
42266681|NCT03075215|76094884|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
42266682|NCT03075215|76094884|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
42266683|NCT03075215|76094884|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
42266684|NCT03063632|76094890|FG000|Overall Study|Death|4|||
42266685|NCT03063632|76094891|FG001|Overall Study|Death|6|||
42266686|NCT03063632|76094890|FG000|Overall Study|Lost to Follow-up|0|||
42266687|NCT03063632|76094891|FG001|Overall Study|Lost to Follow-up|1|||
42266688|NCT03063632|76094890|FG000|Overall Study|Withdrawal by Subject|0|||
42266689|NCT03063632|76094891|FG001|Overall Study|Withdrawal by Subject|2|||
42266690|NCT03063632|76094890|FG000|Overall Study|Physician Decision|2|||
42266691|NCT03063632|76094891|FG001|Overall Study|Physician Decision|0|||
42266692|NCT03063632|76094890|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
42266693|NCT03063632|76094891|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
42034896|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
42266694|NCT02759731|76094911|FG000|Overall Study|Did not complete treatment.|8|||
42266695|NCT02665117|76094919|FG000|Overall Study|Physician Decision|1|||
42266696|NCT02665117|76094920|FG001|Overall Study|Physician Decision|0|||
42034897|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
42034898|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
42034899|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
42034900|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
42034901|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
42034902|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
42034903|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
42034904|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
42034905|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
42000830|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
42000831|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
42000832|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
42000833|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
42000834|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
42000835|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
42000836|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
42000837|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
42000838|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
42000839|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
42000840|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
42000841|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
42000842|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
42000843|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
42000844|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
42000845|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
42000846|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
42000847|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
42000848|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
42000849|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
42000850|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
42000851|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
42000852|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
42000853|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
42000854|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
42000855|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
42000856|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
42000857|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
42000858|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
42000859|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
42000860|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
42000861|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
42000862|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
42000863|NCT01172938|75809013|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
42000864|NCT01172938|75809014|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
42000865|NCT01172938|75809015|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
42000866|NCT01172938|75809016|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
42000867|NCT01172938|75809017|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
42000868|NCT01172938|75809018|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
42000869|NCT01172938|75809019|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
42000870|NCT01172938|75809020|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
42000871|NCT01172938|75809021|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
42000872|NCT01109992|75809041|FG000|Overall Study|Withdrawal by Subject|0|||
42000873|NCT01109992|75809042|FG001|Overall Study|Withdrawal by Subject|1|||
42000874|NCT01109992|75809041|FG000|Overall Study|Movement during rest scan.|0|||
42000875|NCT01109992|75809042|FG001|Overall Study|Movement during rest scan.|1|||
42034906|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
42034907|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
42034908|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
42034909|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
42034910|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
42034911|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
42034912|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
42034913|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
42034914|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
42034915|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
42034916|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
42034917|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
42034918|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
42034919|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
42034920|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
42034921|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
42034922|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
42034923|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
42034924|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
42034925|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
42034926|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
42034927|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
42266697|NCT02617485|76094928|FG000|Treatment and Observation Period|Adverse Event|9|||
42266698|NCT02617485|76094929|FG001|Treatment and Observation Period|Adverse Event|1|||
42000876|NCT01109524|75809051|FG000|Overall Study|Disease Progression|29|||
42000877|NCT01109524|75809051|FG000|Overall Study|Study Drug toxicity|6|||
42000878|NCT01109524|75809051|FG000|Overall Study|Adverse Event|4|||
42000879|NCT01109524|75809051|FG000|Overall Study|Withdrawal by Subject|2|||
42000880|NCT01109524|75809051|FG000|Overall Study|Maximum clinical benefit|3|||
42000881|NCT01109524|75809051|FG000|Overall Study|Death|2|||
42000882|NCT01109524|75809051|FG000|Overall Study|No longer meets criteria|2|||
42000883|NCT01109524|75809051|FG000|Overall Study|Participant requested to end treatment|4|||
42000884|NCT01109524|75809051|FG000|Overall Study|Other|5|||
42000885|NCT01109173|75809066|FG000|Overall Study|Adverse Event|15|||
42000886|NCT01109173|75809067|FG001|Overall Study|Adverse Event|17|||
42000887|NCT01109173|75809068|FG002|Overall Study|Adverse Event|9|||
42000888|NCT01109173|75809069|FG003|Overall Study|Adverse Event|6|||
42000889|NCT01109173|75809066|FG000|Overall Study|Lost to Follow-up|0|||
42000890|NCT01109173|75809067|FG001|Overall Study|Lost to Follow-up|1|||
42000891|NCT01109173|75809068|FG002|Overall Study|Lost to Follow-up|0|||
42000892|NCT01109173|75809069|FG003|Overall Study|Lost to Follow-up|0|||
42000893|NCT01109173|75809066|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
42000894|NCT01109173|75809067|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
42000895|NCT01109173|75809068|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
42000896|NCT01109173|75809069|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
42000897|NCT01109173|75809066|FG000|Overall Study|Noncompliance|0|||
42000898|NCT01109173|75809067|FG001|Overall Study|Noncompliance|1|||
42000899|NCT01109173|75809068|FG002|Overall Study|Noncompliance|0|||
42000900|NCT01109173|75809069|FG003|Overall Study|Noncompliance|0|||
42000901|NCT01109173|75809066|FG000|Overall Study|Treatment Failure|25|||
42000902|NCT01109173|75809067|FG001|Overall Study|Treatment Failure|32|||
42000903|NCT01109173|75809068|FG002|Overall Study|Treatment Failure|69|||
42000904|NCT01109173|75809069|FG003|Overall Study|Treatment Failure|64|||
42034928|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
42266699|NCT02617485|76094928|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
42266700|NCT02617485|76094929|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
42266701|NCT02617485|76094928|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
42266702|NCT02617485|76094929|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
42266703|NCT02617485|76094928|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
42266704|NCT02617485|76094929|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
42266705|NCT02617485|76094928|FG000|Treatment and Observation Period|Physician Decision|0|||
42266706|NCT02617485|76094929|FG001|Treatment and Observation Period|Physician Decision|1|||
42266707|NCT02617485|76094928|FG000|Follow-up Period|Adverse Event|1|||
42135115|NCT00372411|75945860|FG001|Overall Study|Withdrawal by Subject|4|||
42266708|NCT02617485|76094929|FG001|Follow-up Period|Adverse Event|0|||
42266709|NCT02617485|76094928|FG000|Follow-up Period|Withdrawal by Subject|1|||
42000905|NCT01109173|75809066|FG000|Overall Study|Protocol Violation|4|||
42000906|NCT01109173|75809067|FG001|Overall Study|Protocol Violation|5|||
42000907|NCT01109173|75809068|FG002|Overall Study|Protocol Violation|1|||
42135116|NCT00372411|75945861|FG002|Overall Study|Withdrawal by Subject|1|||
42135117|NCT00372411|75945859|FG000|Overall Study|Death|0|||
42135118|NCT00372411|75945860|FG001|Overall Study|Death|2|||
42135119|NCT00372411|75945861|FG002|Overall Study|Death|1|||
42135120|NCT00372411|75945859|FG000|Overall Study|Lost to Follow-up|1|||
42135121|NCT00372411|75945860|FG001|Overall Study|Lost to Follow-up|1|||
42135122|NCT00372411|75945861|FG002|Overall Study|Lost to Follow-up|1|||
42135123|NCT00372411|75945859|FG000|Overall Study|Adverse Event|1|||
42135124|NCT00372411|75945860|FG001|Overall Study|Adverse Event|1|||
42135125|NCT00372411|75945861|FG002|Overall Study|Adverse Event|0|||
42135126|NCT00372255|75945871|FG000|Overall Study|Withdrawn for other reasons|2|||
42135127|NCT00372255|75945872|FG001|Overall Study|Withdrawn for other reasons|1|||
42135128|NCT00274456|75945883|FG000|Overall Study|Still on treatment|2|||
42135129|NCT00274456|75945884|FG001|Overall Study|Still on treatment|3|||
42135130|NCT00274456|75945885|FG002|Overall Study|Still on treatment|5|||
42135131|NCT00274456|75945886|FG003|Overall Study|Still on treatment|1|||
42000908|NCT01109173|75809069|FG003|Overall Study|Protocol Violation|2|||
42000909|NCT01109173|75809066|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
42000910|NCT01109173|75809067|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
42000911|NCT01109173|75809068|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
42000912|NCT01109173|75809069|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
42000913|NCT01109173|75809066|FG000|Overall Study|Not Specifiied|5|||
42000914|NCT01109173|75809067|FG001|Overall Study|Not Specifiied|4|||
42000915|NCT01109173|75809068|FG002|Overall Study|Not Specifiied|9|||
42000916|NCT01109173|75809069|FG003|Overall Study|Not Specifiied|14|||
42000917|NCT01172821|75809083|FG000|Overall Study|Adverse Event|5|||
42000918|NCT01172821|75809084|FG001|Overall Study|Adverse Event|2|||
42000919|NCT01172821|75809085|FG002|Overall Study|Adverse Event|2|||
42000920|NCT01172821|75809086|FG003|Overall Study|Adverse Event|7|||
42000921|NCT01172821|75809083|FG000|Overall Study|Protocol Violation|0|||
42000922|NCT01172821|75809084|FG001|Overall Study|Protocol Violation|2|||
42000923|NCT01172821|75809085|FG002|Overall Study|Protocol Violation|1|||
42000924|NCT01172821|75809086|FG003|Overall Study|Protocol Violation|2|||
42000925|NCT01172821|75809083|FG000|Overall Study|Lost to Follow-up|4|||
42000926|NCT01172821|75809084|FG001|Overall Study|Lost to Follow-up|1|||
42000927|NCT01172821|75809085|FG002|Overall Study|Lost to Follow-up|2|||
42000928|NCT01172821|75809086|FG003|Overall Study|Lost to Follow-up|2|||
42000929|NCT01172821|75809083|FG000|Overall Study|Withdrawal by Subject|2|||
42000930|NCT01172821|75809084|FG001|Overall Study|Withdrawal by Subject|3|||
42000931|NCT01172821|75809085|FG002|Overall Study|Withdrawal by Subject|3|||
42000932|NCT01172821|75809086|FG003|Overall Study|Withdrawal by Subject|3|||
42000933|NCT01172821|75809083|FG000|Overall Study|Other|3|||
42135132|NCT00274456|75945883|FG000|Overall Study|Unacceptable toxicity|10|||
42135133|NCT00274456|75945884|FG001|Overall Study|Unacceptable toxicity|5|||
42135134|NCT00274456|75945885|FG002|Overall Study|Unacceptable toxicity|12|||
42135135|NCT00274456|75945886|FG003|Overall Study|Unacceptable toxicity|16|||
42135136|NCT00274456|75945883|FG000|Overall Study|Adverse Event|0|||
42135137|NCT00274456|75945884|FG001|Overall Study|Adverse Event|1|||
42135138|NCT00274456|75945885|FG002|Overall Study|Adverse Event|2|||
42000934|NCT01172821|75809084|FG001|Overall Study|Other|4|||
42000935|NCT01172821|75809085|FG002|Overall Study|Other|5|||
42000936|NCT01172821|75809086|FG003|Overall Study|Other|3|||
42000937|NCT01172275|75809098|FG000|Overall Study|Lost to Follow-up|1|||
42000938|NCT01172275|75809099|FG001|Overall Study|Lost to Follow-up|0|||
42000939|NCT01172275|75809098|FG000|Overall Study|Protocol Violation|1|||
42135139|NCT00274456|75945886|FG003|Overall Study|Adverse Event|2|||
42135140|NCT00274456|75945883|FG000|Overall Study|Physician Decision|7|||
42034929|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
42034930|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
42000940|NCT01172275|75809099|FG001|Overall Study|Protocol Violation|0|||
42000941|NCT01108510|75809107|FG000|Overall Study|Randomized but Not Treated|5|||
42000942|NCT01108510|75809108|FG001|Overall Study|Randomized but Not Treated|1|||
42000943|NCT01108510|75809107|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
42000944|NCT01108510|75809108|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
42034931|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
42034932|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
42034933|NCT03739840|75843190|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
42034934|NCT03739840|75843191|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
42034935|NCT03739840|75843192|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
42034936|NCT03739840|75843193|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
42034937|NCT03739840|75843190|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
42034938|NCT03739840|75843191|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
42034939|NCT03739840|75843192|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
42034940|NCT03739840|75843193|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
42034941|NCT03739840|75843190|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
42034942|NCT03739840|75843191|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
42034943|NCT03739840|75843192|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
42266710|NCT02617485|76094929|FG001|Follow-up Period|Withdrawal by Subject|0|||
42266711|NCT02617485|76094928|FG000|Follow-up Period|Disease progression|2|||
42266712|NCT02617485|76094929|FG001|Follow-up Period|Disease progression|1|||
42266713|NCT02617485|76094928|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
42266714|NCT02617485|76094929|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
42266715|NCT02617485|76094928|FG000|Follow-up Period|Patient needed radiotherapy|9|||
42000945|NCT01108510|75809107|FG000|Overall Study|Adverse Event|26|||
42000946|NCT01108510|75809108|FG001|Overall Study|Adverse Event|19|||
42000947|NCT01108510|75809107|FG000|Overall Study|Lost to Follow-up|20|||
42000948|NCT01108510|75809108|FG001|Overall Study|Lost to Follow-up|17|||
42000949|NCT01108510|75809107|FG000|Overall Study|Withdrew Consent|21|||
42000950|NCT01108510|75809108|FG001|Overall Study|Withdrew Consent|15|||
42000951|NCT01108510|75809107|FG000|Overall Study|Investigator's Discretion|12|||
42000952|NCT01108510|75809108|FG001|Overall Study|Investigator's Discretion|10|||
42000953|NCT01108510|75809107|FG000|Overall Study|Participant Noncompliance|5|||
42000954|NCT01108510|75809108|FG001|Overall Study|Participant Noncompliance|7|||
42000955|NCT01108510|75809107|FG000|Overall Study|Lack of Efficacy|3|||
42000956|NCT01108510|75809108|FG001|Overall Study|Lack of Efficacy|0|||
42000957|NCT01108510|75809107|FG000|Overall Study|Pregnancy|0|||
42000958|NCT01108510|75809108|FG001|Overall Study|Pregnancy|3|||
42000959|NCT01108510|75809107|FG000|Overall Study|Death|1|||
42000960|NCT01108510|75809108|FG001|Overall Study|Death|1|||
42000961|NCT01340027|75809126|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
42000962|NCT01340027|75809127|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
42000963|NCT01340027|75809128|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
42266716|NCT02617485|76094929|FG001|Follow-up Period|Patient needed radiotherapy|5|||
42000964|NCT01340027|75809129|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
42000965|NCT01340027|75809130|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
42034944|NCT03739840|75843193|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
42000966|NCT01340027|75809131|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
42000967|NCT01340027|75809132|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
42000968|NCT01340027|75809133|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
42000969|NCT01340027|75809134|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
42000970|NCT01340027|75809135|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
42000971|NCT01340027|75809136|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
42000972|NCT01340027|75809137|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
42000973|NCT01340027|75809126|FG000|Overall Study|Adverse Event|0|||
42000974|NCT01340027|75809127|FG001|Overall Study|Adverse Event|1|||
42000975|NCT01340027|75809128|FG002|Overall Study|Adverse Event|2|||
42000976|NCT01340027|75809129|FG003|Overall Study|Adverse Event|0|||
42034945|NCT03739840|75843190|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
42034946|NCT03739840|75843191|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
42034947|NCT03739840|75843192|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
42034948|NCT03739840|75843193|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
42034949|NCT03739840|75843190|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
42034950|NCT03739840|75843191|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
42034951|NCT03739840|75843192|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
42034952|NCT03739840|75843193|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
42000977|NCT01340027|75809130|FG004|Overall Study|Adverse Event|1|||
42000978|NCT01340027|75809131|FG005|Overall Study|Adverse Event|2|||
42000979|NCT01340027|75809132|FG006|Overall Study|Adverse Event|2|||
42000980|NCT01340027|75809133|FG007|Overall Study|Adverse Event|1|||
42000981|NCT01340027|75809134|FG008|Overall Study|Adverse Event|4|||
42000982|NCT01340027|75809135|FG009|Overall Study|Adverse Event|1|||
42000983|NCT01340027|75809136|FG010|Overall Study|Adverse Event|1|||
42000984|NCT01340027|75809137|FG011|Overall Study|Adverse Event|3|||
42034953|NCT03739840|75843190|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
42034954|NCT03739840|75843191|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
42034955|NCT03739840|75843192|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
42034956|NCT03739840|75843193|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
42034957|NCT03739840|75843190|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
42034958|NCT03739840|75843191|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
42034959|NCT03739840|75843192|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
42000985|NCT01340027|75809126|FG000|Overall Study|Lack of Efficacy|0|||
42000986|NCT01340027|75809127|FG001|Overall Study|Lack of Efficacy|0|||
42000987|NCT01340027|75809128|FG002|Overall Study|Lack of Efficacy|0|||
42034960|NCT03739840|75843193|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
42034961|NCT03739840|75843190|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
42034962|NCT03739840|75843191|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
42034963|NCT03739840|75843192|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
42034964|NCT03739840|75843193|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
42034965|NCT03739840|75843190|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
42034966|NCT03739840|75843191|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
42034967|NCT03739840|75843192|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
42034968|NCT03739840|75843193|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
42266717|NCT02617485|76094928|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
42000988|NCT01340027|75809129|FG003|Overall Study|Lack of Efficacy|0|||
42000989|NCT01340027|75809130|FG004|Overall Study|Lack of Efficacy|0|||
42000990|NCT01340027|75809131|FG005|Overall Study|Lack of Efficacy|0|||
42266718|NCT02617485|76094929|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
42266719|NCT02589522|76094938|FG000|Overall Study|Physician Decision|1|||
42266720|NCT02589522|76094939|FG001|Overall Study|Physician Decision|2|||
42266721|NCT02589522|76094940|FG002|Overall Study|Physician Decision|0|||
42266722|NCT02589522|76094938|FG000|Overall Study|Did not start treatment|1|||
42266723|NCT02589522|76094939|FG001|Overall Study|Did not start treatment|0|||
42266724|NCT02589522|76094940|FG002|Overall Study|Did not start treatment|0|||
42266725|NCT02485860|76094950|FG000|Overall Study|Lost to Follow-up|4|||
42266726|NCT02485860|76094951|FG001|Overall Study|Lost to Follow-up|1|||
42266727|NCT02485860|76094950|FG000|Overall Study|Physician Decision|1|||
42266728|NCT02485860|76094951|FG001|Overall Study|Physician Decision|2|||
42266729|NCT02485860|76094950|FG000|Overall Study|Health context (COVID-19)|1|||
42266730|NCT02485860|76094951|FG001|Overall Study|Health context (COVID-19)|0|||
42266731|NCT02385123|76094957|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
42266732|NCT02337686|76094961|FG000|Overall Study|Adverse Event|1|||
42266733|NCT02097420|76094965|FG000|Overall Study|Death|6|||
42000991|NCT01340027|75809132|FG006|Overall Study|Lack of Efficacy|1|||
42266734|NCT02097420|76094965|FG000|Overall Study|Valve explanted|13|||
42000992|NCT01340027|75809133|FG007|Overall Study|Lack of Efficacy|1|||
42000993|NCT01340027|75809134|FG008|Overall Study|Lack of Efficacy|1|||
42000994|NCT01340027|75809135|FG009|Overall Study|Lack of Efficacy|0|||
42000995|NCT01340027|75809136|FG010|Overall Study|Lack of Efficacy|0|||
42000996|NCT01340027|75809137|FG011|Overall Study|Lack of Efficacy|0|||
42000997|NCT01340027|75809126|FG000|Overall Study|Lost to Follow-up|0|||
42000998|NCT01340027|75809127|FG001|Overall Study|Lost to Follow-up|1|||
42000999|NCT01340027|75809128|FG002|Overall Study|Lost to Follow-up|0|||
42001000|NCT01340027|75809129|FG003|Overall Study|Lost to Follow-up|0|||
42001001|NCT01340027|75809130|FG004|Overall Study|Lost to Follow-up|0|||
42001002|NCT01340027|75809131|FG005|Overall Study|Lost to Follow-up|0|||
42001003|NCT01340027|75809132|FG006|Overall Study|Lost to Follow-up|1|||
42001004|NCT01340027|75809133|FG007|Overall Study|Lost to Follow-up|0|||
42001005|NCT01340027|75809134|FG008|Overall Study|Lost to Follow-up|0|||
42001006|NCT01340027|75809135|FG009|Overall Study|Lost to Follow-up|1|||
42001007|NCT01340027|75809136|FG010|Overall Study|Lost to Follow-up|0|||
42001008|NCT01340027|75809137|FG011|Overall Study|Lost to Follow-up|0|||
42001009|NCT01340027|75809126|FG000|Overall Study|Protocol Violation|1|||
42001010|NCT01340027|75809127|FG001|Overall Study|Protocol Violation|2|||
42001011|NCT01340027|75809128|FG002|Overall Study|Protocol Violation|0|||
42001012|NCT01340027|75809129|FG003|Overall Study|Protocol Violation|0|||
42001013|NCT01340027|75809130|FG004|Overall Study|Protocol Violation|6|||
42001014|NCT01340027|75809131|FG005|Overall Study|Protocol Violation|0|||
42001015|NCT01340027|75809132|FG006|Overall Study|Protocol Violation|0|||
42001016|NCT01340027|75809133|FG007|Overall Study|Protocol Violation|1|||
42001017|NCT01340027|75809134|FG008|Overall Study|Protocol Violation|2|||
42001018|NCT01340027|75809135|FG009|Overall Study|Protocol Violation|2|||
42001019|NCT01340027|75809136|FG010|Overall Study|Protocol Violation|0|||
42001020|NCT01340027|75809137|FG011|Overall Study|Protocol Violation|0|||
42001021|NCT01340027|75809126|FG000|Overall Study|Withdrawal by Subject|4|||
42001022|NCT01340027|75809127|FG001|Overall Study|Withdrawal by Subject|3|||
42001023|NCT01340027|75809128|FG002|Overall Study|Withdrawal by Subject|1|||
42001024|NCT01340027|75809129|FG003|Overall Study|Withdrawal by Subject|3|||
42001025|NCT01340027|75809130|FG004|Overall Study|Withdrawal by Subject|3|||
42001026|NCT01340027|75809131|FG005|Overall Study|Withdrawal by Subject|2|||
42001027|NCT01340027|75809132|FG006|Overall Study|Withdrawal by Subject|3|||
42001028|NCT01340027|75809133|FG007|Overall Study|Withdrawal by Subject|4|||
42001029|NCT01340027|75809134|FG008|Overall Study|Withdrawal by Subject|1|||
42001030|NCT01340027|75809135|FG009|Overall Study|Withdrawal by Subject|2|||
42001031|NCT01340027|75809136|FG010|Overall Study|Withdrawal by Subject|0|||
42001032|NCT01340027|75809137|FG011|Overall Study|Withdrawal by Subject|1|||
42001033|NCT01340027|75809126|FG000|Overall Study|Miscellaneous|0|||
42001034|NCT01340027|75809127|FG001|Overall Study|Miscellaneous|0|||
42001035|NCT01340027|75809128|FG002|Overall Study|Miscellaneous|0|||
42001036|NCT01340027|75809129|FG003|Overall Study|Miscellaneous|1|||
42001037|NCT01340027|75809130|FG004|Overall Study|Miscellaneous|0|||
42001038|NCT01340027|75809131|FG005|Overall Study|Miscellaneous|0|||
42001039|NCT01340027|75809132|FG006|Overall Study|Miscellaneous|0|||
42001040|NCT01340027|75809133|FG007|Overall Study|Miscellaneous|0|||
42001041|NCT01340027|75809134|FG008|Overall Study|Miscellaneous|0|||
42001042|NCT01340027|75809135|FG009|Overall Study|Miscellaneous|0|||
42001043|NCT01340027|75809136|FG010|Overall Study|Miscellaneous|1|||
42001044|NCT01340027|75809137|FG011|Overall Study|Miscellaneous|0|||
42001045|NCT01327053|75809165|FG000|Overall Study|Adverse Event|23|||
42001046|NCT01327053|75809166|FG001|Overall Study|Adverse Event|57|||
42001047|NCT01327053|75809165|FG000|Overall Study|Patient/guardian decision|11|||
42001048|NCT01327053|75809166|FG001|Overall Study|Patient/guardian decision|35|||
42001049|NCT01327053|75809165|FG000|Overall Study|Physician Decision|10|||
42001050|NCT01327053|75809166|FG001|Overall Study|Physician Decision|14|||
42001051|NCT01327053|75809165|FG000|Overall Study|Death|1|||
42001052|NCT01327053|75809166|FG001|Overall Study|Death|5|||
42001053|NCT01327053|75809165|FG000|Overall Study|Lost to Follow-up|2|||
42001054|NCT01327053|75809166|FG001|Overall Study|Lost to Follow-up|4|||
42001055|NCT01327053|75809165|FG000|Overall Study|Non-compliance with study treatment|0|||
42001056|NCT01327053|75809166|FG001|Overall Study|Non-compliance with study treatment|5|||
42001057|NCT01327053|75809165|FG000|Overall Study|Study terminated by Sponsor|1|||
42001058|NCT01327053|75809166|FG001|Overall Study|Study terminated by Sponsor|3|||
42001059|NCT01327053|75809165|FG000|Overall Study|Progressive disease|31|||
42001060|NCT01327053|75809166|FG001|Overall Study|Progressive disease|26|||
42001061|NCT01327053|75809165|FG000|Overall Study|Protocol Violation|0|||
42001062|NCT01327053|75809166|FG001|Overall Study|Protocol Violation|1|||
42001063|NCT01327053|75809165|FG000|Overall Study|Untreated|0|||
42001064|NCT01327053|75809166|FG001|Overall Study|Untreated|1|||
42001065|NCT01107925|75809180|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
42001066|NCT01107925|75809181|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
42001067|NCT01107925|75809182|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
42001068|NCT01107925|75809183|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
42001069|NCT01107925|75809184|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
42001070|NCT01107925|75809185|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
42001071|NCT01107925|75809180|FG000|Period 2|Withdrawal by Subject|0|||
42001072|NCT01107925|75809181|FG001|Period 2|Withdrawal by Subject|1|||
42001073|NCT01107925|75809182|FG002|Period 2|Withdrawal by Subject|0|||
42001074|NCT01107925|75809183|FG003|Period 2|Withdrawal by Subject|0|||
42266735|NCT02097420|76094965|FG000|Overall Study|Other Reason|1|||
42339366|NCT02104817|76177360|FG000|Overall Study|Lost to Follow-up|3|||
42339367|NCT02104817|76177361|FG001|Overall Study|Lost to Follow-up|2|||
42339368|NCT02104817|76177360|FG000|Overall Study|Protocol Violation|0|||
42339369|NCT02104817|76177361|FG001|Overall Study|Protocol Violation|1|||
42339370|NCT02104817|76177360|FG000|Overall Study|Study terminated by sponsor|5854|||
42339371|NCT02104817|76177361|FG001|Overall Study|Study terminated by sponsor|5901|||
42339372|NCT02104817|76177360|FG000|Overall Study|Withdrawal by Subject|111|||
42339373|NCT02104817|76177361|FG001|Overall Study|Withdrawal by Subject|78|||
42339374|NCT02104817|76177360|FG000|Overall Study|Other reasons|128|||
42339375|NCT02104817|76177361|FG001|Overall Study|Other reasons|135|||
42339376|NCT01962103|76177376|FG000|Phase 1|Adverse Event|4|||
42339377|NCT01962103|76177377|FG001|Phase 1|Adverse Event|0|||
42339378|NCT01962103|76177378|FG002|Phase 1|Adverse Event|2|||
42339379|NCT01962103|76177379|FG003|Phase 1|Adverse Event|1|||
42339380|NCT01962103|76177380|FG004|Phase 1|Adverse Event|2|||
42339381|NCT01962103|76177381|FG005|Phase 1|Adverse Event|2|||
42339382|NCT01962103|76177382|FG006|Phase 1|Adverse Event|0|||
42339383|NCT01962103|76177383|FG007|Phase 1|Adverse Event|0|||
42339384|NCT01962103|76177384|FG008|Phase 1|Adverse Event|0|||
42339385|NCT01962103|76177376|FG000|Phase 1|Progressive Disease|8|||
42339386|NCT01962103|76177377|FG001|Phase 1|Progressive Disease|6|||
42339387|NCT01962103|76177378|FG002|Phase 1|Progressive Disease|8|||
42339388|NCT01962103|76177379|FG003|Phase 1|Progressive Disease|4|||
42339389|NCT01962103|76177380|FG004|Phase 1|Progressive Disease|5|||
42339390|NCT01962103|76177381|FG005|Phase 1|Progressive Disease|4|||
42339391|NCT01962103|76177382|FG006|Phase 1|Progressive Disease|0|||
42339392|NCT01962103|76177383|FG007|Phase 1|Progressive Disease|0|||
42339393|NCT01962103|76177384|FG008|Phase 1|Progressive Disease|0|||
42339394|NCT01962103|76177376|FG000|Phase 1|Withdrawal by Subject|0|||
42339395|NCT01962103|76177377|FG001|Phase 1|Withdrawal by Subject|0|||
42339396|NCT01962103|76177378|FG002|Phase 1|Withdrawal by Subject|0|||
42339397|NCT01962103|76177379|FG003|Phase 1|Withdrawal by Subject|2|||
42339398|NCT01962103|76177380|FG004|Phase 1|Withdrawal by Subject|0|||
42339399|NCT01962103|76177381|FG005|Phase 1|Withdrawal by Subject|0|||
42339400|NCT01962103|76177382|FG006|Phase 1|Withdrawal by Subject|0|||
42339401|NCT01962103|76177383|FG007|Phase 1|Withdrawal by Subject|0|||
42339402|NCT01962103|76177384|FG008|Phase 1|Withdrawal by Subject|0|||
42339403|NCT01962103|76177376|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
42339404|NCT01962103|76177377|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
42339405|NCT01962103|76177378|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
42339406|NCT01962103|76177379|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
42339407|NCT01962103|76177380|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
42339408|NCT01962103|76177381|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
42339409|NCT01962103|76177382|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
42339410|NCT01962103|76177383|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
42339411|NCT01962103|76177384|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
42339412|NCT01962103|76177376|FG000|Phase 1|Physician Decision|0|||
42339413|NCT01962103|76177377|FG001|Phase 1|Physician Decision|0|||
42339414|NCT01962103|76177378|FG002|Phase 1|Physician Decision|0|||
42339415|NCT01962103|76177379|FG003|Phase 1|Physician Decision|1|||
42266736|NCT02000115|76094972|FG000|Overall Study|Death|56|||
42266737|NCT02000115|76094973|FG001|Overall Study|Death|45|||
42266738|NCT02000115|76094974|FG002|Overall Study|Death|0|||
42266739|NCT02000115|76094975|FG003|Overall Study|Death|0|||
42266740|NCT02000115|76094972|FG000|Overall Study|Missed Visit|6|||
42266741|NCT02000115|76094973|FG001|Overall Study|Missed Visit|8|||
42266742|NCT02000115|76094974|FG002|Overall Study|Missed Visit|1|||
42266743|NCT02000115|76094975|FG003|Overall Study|Missed Visit|0|||
42266744|NCT02000115|76094972|FG000|Overall Study|Protocol Violation|2|||
42266745|NCT02000115|76094973|FG001|Overall Study|Protocol Violation|1|||
42339416|NCT01962103|76177380|FG004|Phase 1|Physician Decision|0|||
42339417|NCT01962103|76177381|FG005|Phase 1|Physician Decision|0|||
42339418|NCT01962103|76177382|FG006|Phase 1|Physician Decision|0|||
42339419|NCT01962103|76177383|FG007|Phase 1|Physician Decision|0|||
42266746|NCT02000115|76094974|FG002|Overall Study|Protocol Violation|0|||
42266747|NCT02000115|76094975|FG003|Overall Study|Protocol Violation|0|||
42339420|NCT01962103|76177384|FG008|Phase 1|Physician Decision|0|||
42339421|NCT01962103|76177376|FG000|Phase 1|Symptomatic Deterioration|3|||
42339422|NCT01962103|76177377|FG001|Phase 1|Symptomatic Deterioration|2|||
42339423|NCT01962103|76177378|FG002|Phase 1|Symptomatic Deterioration|2|||
42339424|NCT01962103|76177379|FG003|Phase 1|Symptomatic Deterioration|2|||
42339425|NCT01962103|76177380|FG004|Phase 1|Symptomatic Deterioration|1|||
42339426|NCT01962103|76177381|FG005|Phase 1|Symptomatic Deterioration|1|||
42339427|NCT01962103|76177382|FG006|Phase 1|Symptomatic Deterioration|0|||
42339428|NCT01962103|76177383|FG007|Phase 1|Symptomatic Deterioration|0|||
42339429|NCT01962103|76177384|FG008|Phase 1|Symptomatic Deterioration|0|||
42339430|NCT01962103|76177376|FG000|Phase 1|Miscellaneous|1|||
42339431|NCT01962103|76177377|FG001|Phase 1|Miscellaneous|0|||
42339432|NCT01962103|76177378|FG002|Phase 1|Miscellaneous|0|||
42339433|NCT01962103|76177379|FG003|Phase 1|Miscellaneous|0|||
42339434|NCT01962103|76177380|FG004|Phase 1|Miscellaneous|0|||
42339435|NCT01962103|76177381|FG005|Phase 1|Miscellaneous|0|||
42339436|NCT01962103|76177382|FG006|Phase 1|Miscellaneous|0|||
42339437|NCT01962103|76177383|FG007|Phase 1|Miscellaneous|0|||
42339438|NCT01962103|76177384|FG008|Phase 1|Miscellaneous|0|||
42339439|NCT01962103|76177376|FG000|Phase 2|Adverse Event|0|||
42339440|NCT01962103|76177377|FG001|Phase 2|Adverse Event|0|||
42339441|NCT01962103|76177378|FG002|Phase 2|Adverse Event|0|||
42339442|NCT01962103|76177379|FG003|Phase 2|Adverse Event|0|||
42339443|NCT01962103|76177380|FG004|Phase 2|Adverse Event|0|||
42339444|NCT01962103|76177381|FG005|Phase 2|Adverse Event|0|||
42339445|NCT01962103|76177382|FG006|Phase 2|Adverse Event|1|||
42339446|NCT01962103|76177383|FG007|Phase 2|Adverse Event|0|||
42339447|NCT01962103|76177384|FG008|Phase 2|Adverse Event|3|||
42339448|NCT01962103|76177376|FG000|Phase 2|Progressive Disease|0|||
42339449|NCT01962103|76177377|FG001|Phase 2|Progressive Disease|0|||
42339450|NCT01962103|76177378|FG002|Phase 2|Progressive Disease|0|||
42339451|NCT01962103|76177379|FG003|Phase 2|Progressive Disease|0|||
42339452|NCT01962103|76177380|FG004|Phase 2|Progressive Disease|0|||
42339453|NCT01962103|76177381|FG005|Phase 2|Progressive Disease|0|||
42339454|NCT01962103|76177382|FG006|Phase 2|Progressive Disease|11|||
42339455|NCT01962103|76177383|FG007|Phase 2|Progressive Disease|12|||
42339456|NCT01962103|76177384|FG008|Phase 2|Progressive Disease|11|||
42339457|NCT01962103|76177376|FG000|Phase 2|Symptomatic Deterioration|0|||
42339458|NCT01962103|76177377|FG001|Phase 2|Symptomatic Deterioration|0|||
42339459|NCT01962103|76177378|FG002|Phase 2|Symptomatic Deterioration|0|||
42339460|NCT01962103|76177379|FG003|Phase 2|Symptomatic Deterioration|0|||
42339461|NCT01962103|76177380|FG004|Phase 2|Symptomatic Deterioration|0|||
42339462|NCT01962103|76177381|FG005|Phase 2|Symptomatic Deterioration|0|||
42339463|NCT01962103|76177382|FG006|Phase 2|Symptomatic Deterioration|2|||
42339464|NCT01962103|76177383|FG007|Phase 2|Symptomatic Deterioration|2|||
42339465|NCT01962103|76177384|FG008|Phase 2|Symptomatic Deterioration|0|||
42339466|NCT01961323|76177404|FG000|Overall Study|Withdrawal by Subject|7|||
42339467|NCT01961323|76177404|FG000|Overall Study|Lost to Follow-up|8|||
42339468|NCT01961323|76177404|FG000|Overall Study|screen failure|34|||
42339469|NCT01960855|76177413|FG000|Overall Study|Subject noncompliant|1|||
42339470|NCT01960855|76177414|FG001|Overall Study|Subject noncompliant|0|||
42339471|NCT01960855|76177415|FG002|Overall Study|Subject noncompliant|0|||
42339472|NCT01960855|76177416|FG003|Overall Study|Subject noncompliant|0|||
42339473|NCT01960855|76177417|FG004|Overall Study|Subject noncompliant|0|||
42339474|NCT01960855|76177413|FG000|Overall Study|Adverse Event|2|||
42339475|NCT01960855|76177414|FG001|Overall Study|Adverse Event|0|||
42339476|NCT01960855|76177415|FG002|Overall Study|Adverse Event|6|||
42339477|NCT01960855|76177416|FG003|Overall Study|Adverse Event|2|||
42339478|NCT01960855|76177417|FG004|Overall Study|Adverse Event|2|||
42266748|NCT02000115|76094972|FG000|Overall Study|Physician Decision|2|||
42266749|NCT02000115|76094973|FG001|Overall Study|Physician Decision|0|||
42266750|NCT02000115|76094974|FG002|Overall Study|Physician Decision|0|||
42266751|NCT02000115|76094975|FG003|Overall Study|Physician Decision|0|||
42266752|NCT02000115|76094972|FG000|Overall Study|Withdrawal by Subject|11|||
42266753|NCT02000115|76094973|FG001|Overall Study|Withdrawal by Subject|11|||
42266754|NCT02000115|76094974|FG002|Overall Study|Withdrawal by Subject|0|||
42266755|NCT02000115|76094975|FG003|Overall Study|Withdrawal by Subject|0|||
42266756|NCT02000115|76094972|FG000|Overall Study|Lost to Follow-up|0|||
42266757|NCT02000115|76094973|FG001|Overall Study|Lost to Follow-up|1|||
42266758|NCT02000115|76094974|FG002|Overall Study|Lost to Follow-up|0|||
42266759|NCT02000115|76094975|FG003|Overall Study|Lost to Follow-up|0|||
42266760|NCT02000115|76094972|FG000|Overall Study|Non-compliance|2|||
42266761|NCT02000115|76094973|FG001|Overall Study|Non-compliance|1|||
42266762|NCT02000115|76094974|FG002|Overall Study|Non-compliance|0|||
42266763|NCT02000115|76094975|FG003|Overall Study|Non-compliance|0|||
42339479|NCT01960855|76177413|FG000|Overall Study|Lack of Efficacy|1|||
42339480|NCT01960855|76177414|FG001|Overall Study|Lack of Efficacy|1|||
42339481|NCT01960855|76177415|FG002|Overall Study|Lack of Efficacy|0|||
42266764|NCT02000115|76094972|FG000|Overall Study|Withdrawn on day of randomization|0|||
42266765|NCT02000115|76094973|FG001|Overall Study|Withdrawn on day of randomization|1|||
42266766|NCT02000115|76094974|FG002|Overall Study|Withdrawn on day of randomization|0|||
42266767|NCT02000115|76094975|FG003|Overall Study|Withdrawn on day of randomization|0|||
42266768|NCT02000115|76094972|FG000|Overall Study|Still on Study|0|||
42339482|NCT01960855|76177416|FG003|Overall Study|Lack of Efficacy|0|||
42339483|NCT01960855|76177417|FG004|Overall Study|Lack of Efficacy|0|||
42339484|NCT01960855|76177413|FG000|Overall Study|Other|2|||
42339485|NCT01960855|76177414|FG001|Overall Study|Other|1|||
42339486|NCT01960855|76177415|FG002|Overall Study|Other|1|||
42339487|NCT01960855|76177416|FG003|Overall Study|Other|1|||
42339488|NCT01960855|76177417|FG004|Overall Study|Other|0|||
42339489|NCT01960855|76177413|FG000|Overall Study|Consent withdrawn by subject|3|||
42339490|NCT01960855|76177414|FG001|Overall Study|Consent withdrawn by subject|1|||
42339491|NCT01960855|76177415|FG002|Overall Study|Consent withdrawn by subject|2|||
42339492|NCT01960855|76177416|FG003|Overall Study|Consent withdrawn by subject|1|||
42339493|NCT01960855|76177417|FG004|Overall Study|Consent withdrawn by subject|1|||
42339494|NCT01960855|76177413|FG000|Overall Study|Lost to Follow-up|2|||
42339495|NCT01960855|76177414|FG001|Overall Study|Lost to Follow-up|1|||
42339496|NCT01960855|76177415|FG002|Overall Study|Lost to Follow-up|0|||
42339497|NCT01960855|76177416|FG003|Overall Study|Lost to Follow-up|0|||
42339498|NCT01960855|76177417|FG004|Overall Study|Lost to Follow-up|2|||
42339499|NCT02007434|76177437|FG000|Overall Study|Lost to Follow-up|0|||
42339500|NCT02007434|76177438|FG001|Overall Study|Lost to Follow-up|1|||
42339501|NCT02007434|76177439|FG002|Overall Study|Lost to Follow-up|0|||
42339502|NCT02007434|76177440|FG003|Overall Study|Lost to Follow-up|0|||
42339503|NCT02007434|76177441|FG004|Overall Study|Lost to Follow-up|0|||
42339504|NCT02007434|76177442|FG005|Overall Study|Lost to Follow-up|0|||
42339505|NCT02007434|76177443|FG006|Overall Study|Lost to Follow-up|0|||
42339506|NCT02007434|76177444|FG007|Overall Study|Lost to Follow-up|0|||
42339507|NCT02007434|76177437|FG000|Overall Study|Non-compliance|1|||
42339508|NCT02007434|76177438|FG001|Overall Study|Non-compliance|0|||
42339509|NCT02007434|76177439|FG002|Overall Study|Non-compliance|1|||
42339510|NCT02007434|76177440|FG003|Overall Study|Non-compliance|0|||
42339511|NCT02007434|76177441|FG004|Overall Study|Non-compliance|0|||
42339512|NCT02007434|76177442|FG005|Overall Study|Non-compliance|0|||
42339513|NCT02007434|76177443|FG006|Overall Study|Non-compliance|0|||
42339514|NCT02007434|76177444|FG007|Overall Study|Non-compliance|0|||
42339515|NCT01987453|76177466|FG000|Overall Study|Death|0|||
42339516|NCT01987453|76177467|FG001|Overall Study|Death|0|||
42339517|NCT01987453|76177468|FG002|Overall Study|Death|1|||
42339518|NCT01987453|76177466|FG000|Overall Study|Lack of Efficacy|1|||
42339519|NCT01987453|76177467|FG001|Overall Study|Lack of Efficacy|12|||
42339520|NCT01987453|76177468|FG002|Overall Study|Lack of Efficacy|0|||
42339521|NCT02006641|76177483|FG000|Overall Study|Withdrawal before treatment|2|||
42339522|NCT02006641|76177484|FG001|Overall Study|Withdrawal before treatment|5|||
42001075|NCT01107925|75809184|FG004|Period 2|Withdrawal by Subject|0|||
42001076|NCT01107925|75809185|FG005|Period 2|Withdrawal by Subject|1|||
42001077|NCT01339832|75809213|FG000|Overall Study|Lost to Follow-up|3|||
42001078|NCT01339832|75809213|FG000|Overall Study|Death|11|||
42001079|NCT01339559|75809217|FG000|Overall Study|Adverse Event|92|||
42001080|NCT01339559|75809217|FG000|Overall Study|Death|5|||
42001081|NCT01339559|75809217|FG000|Overall Study|Lack of Efficacy|164|||
42001082|NCT01339559|75809217|FG000|Overall Study|Lost to Follow-up|22|||
42001083|NCT01339559|75809217|FG000|Overall Study|Subject choice|89|||
42001084|NCT01339559|75809217|FG000|Overall Study|Protocol Violation|15|||
42001085|NCT01339559|75809217|FG000|Overall Study|Study closure at site|1|||
42266769|NCT02000115|76094973|FG001|Overall Study|Still on Study|0|||
42266770|NCT02000115|76094974|FG002|Overall Study|Still on Study|0|||
42266771|NCT02000115|76094975|FG003|Overall Study|Still on Study|53|||
42339523|NCT02006641|76177485|FG002|Overall Study|Withdrawal before treatment|3|||
42339524|NCT02006641|76177483|FG000|Overall Study|Adverse Event|15|||
42266772|NCT00113360|76095011|FG000|Overall Study|Adverse Event|3|||
42266773|NCT00113360|76095011|FG000|Overall Study|Subject required surgery|1|||
42266774|NCT00113360|76095011|FG000|Overall Study|Did not meet eligibility criteria|3|||
42266775|NCT00087685|76095015|FG000|Overall Study|Adverse Event|5|||
42266776|NCT00087685|76095015|FG000|Overall Study|Non-Compliance|1|||
42266777|NCT00087685|76095015|FG000|Overall Study|Progressive Disease|5|||
42266778|NCT00087685|76095015|FG000|Overall Study|Withdrawal by Subject|3|||
42266779|NCT02610842|76095019|FG000|Overall Study|Lost to Follow-up|5|||
42266780|NCT01648582|76095028|FG000|Overall Study|Adverse Event|6|||
42266781|NCT01648582|76095029|FG001|Overall Study|Adverse Event|11|||
42339525|NCT02006641|76177484|FG001|Overall Study|Adverse Event|11|||
42339526|NCT02006641|76177485|FG002|Overall Study|Adverse Event|15|||
42339527|NCT02006641|76177483|FG000|Overall Study|Protocol Violation|0|||
42339528|NCT02006641|76177484|FG001|Overall Study|Protocol Violation|2|||
42339529|NCT02006641|76177485|FG002|Overall Study|Protocol Violation|2|||
42339530|NCT02006641|76177483|FG000|Overall Study|Lost to Follow-up|0|||
42001086|NCT01339559|75809217|FG000|Overall Study|Incarcerated|2|||
42034969|NCT01035060|75843217|FG000|Overall Study|Lost to Follow-up|0|||
42266782|NCT01648582|76095030|FG002|Overall Study|Adverse Event|2|||
42266783|NCT01648582|76095028|FG000|Overall Study|Lost to Follow-up|9|||
42339531|NCT02006641|76177484|FG001|Overall Study|Lost to Follow-up|1|||
42266784|NCT01648582|76095029|FG001|Overall Study|Lost to Follow-up|6|||
42266785|NCT01648582|76095030|FG002|Overall Study|Lost to Follow-up|8|||
42266786|NCT01648582|76095028|FG000|Overall Study|Protocol Violation|1|||
42339532|NCT02006641|76177485|FG002|Overall Study|Lost to Follow-up|0|||
42001087|NCT01339559|75809217|FG000|Overall Study|Epilepsy surgery|1|||
42339533|NCT02006641|76177483|FG000|Overall Study|Withdrawal by Subject|7|||
42339534|NCT02006641|76177484|FG001|Overall Study|Withdrawal by Subject|12|||
42339535|NCT02006641|76177485|FG002|Overall Study|Withdrawal by Subject|11|||
42339536|NCT02006641|76177483|FG000|Overall Study|Other reason: patient didn't show up|1|||
42339537|NCT02006641|76177484|FG001|Overall Study|Other reason: patient didn't show up|0|||
42339538|NCT02006641|76177485|FG002|Overall Study|Other reason: patient didn't show up|0|||
42339539|NCT02006641|76177483|FG000|Overall Study|Other reason:patient didn't want to come|0|||
42339540|NCT02006641|76177484|FG001|Overall Study|Other reason:patient didn't want to come|0|||
42339541|NCT02006641|76177485|FG002|Overall Study|Other reason:patient didn't want to come|1|||
42339542|NCT02006641|76177483|FG000|Overall Study|Other reason: patient has moved|1|||
42339543|NCT02006641|76177484|FG001|Overall Study|Other reason: patient has moved|0|||
42339544|NCT02006641|76177485|FG002|Overall Study|Other reason: patient has moved|1|||
42339545|NCT02006641|76177483|FG000|Overall Study|Other reason: caregiver in hospital|0|||
42339546|NCT02006641|76177484|FG001|Overall Study|Other reason: caregiver in hospital|1|||
42339547|NCT02006641|76177485|FG002|Overall Study|Other reason: caregiver in hospital|0|||
42339548|NCT02006641|76177483|FG000|Overall Study|Other reason: patient's wife has died|0|||
42339549|NCT02006641|76177484|FG001|Overall Study|Other reason: patient's wife has died|0|||
42339550|NCT02006641|76177485|FG002|Overall Study|Other reason: patient's wife has died|1|||
42339551|NCT02006641|76177483|FG000|Overall Study|Other reason: hospitalisation|0|||
42339552|NCT02006641|76177484|FG001|Overall Study|Other reason: hospitalisation|1|||
42339553|NCT02006641|76177485|FG002|Overall Study|Other reason: hospitalisation|0|||
42339554|NCT02006641|76177483|FG000|Overall Study|Other reason: caregiver impossibility|0|||
42339555|NCT02006641|76177484|FG001|Overall Study|Other reason: caregiver impossibility|0|||
42339556|NCT02006641|76177485|FG002|Overall Study|Other reason: caregiver impossibility|1|||
42339557|NCT02006641|76177483|FG000|Overall Study|Other reason: protocol non-compliance|0|||
42339558|NCT02006641|76177484|FG001|Overall Study|Other reason: protocol non-compliance|0|||
42339559|NCT02006641|76177485|FG002|Overall Study|Other reason: protocol non-compliance|1|||
42339560|NCT01959919|76177493|FG000|Overall Study|Did not meet the eligibility criteria|2|||
42339561|NCT01986985|76177501|FG000|Overall Study|Withdrawal by Subject|4|||
42339562|NCT01986985|76177501|FG000|Overall Study|Scan not completed due to malfunction|3|||
42339563|NCT01986907|76177505|FG000|Overall Study|Adverse Event|11|||
42339564|NCT01986907|76177505|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
42339565|NCT01986907|76177505|FG000|Overall Study|Protocol Violation|4|||
42339566|NCT01986907|76177505|FG000|Overall Study|Withdrawal by Subject|76|||
42339567|NCT01986907|76177505|FG000|Overall Study|Lost to Follow-up|38|||
42339568|NCT01986907|76177505|FG000|Overall Study|Death|9|||
42339569|NCT01959841|76177515|FG000|Overall Study|Adverse Event|1|||
42339570|NCT01959841|76177516|FG001|Overall Study|Adverse Event|3|||
42339571|NCT01959841|76177517|FG002|Overall Study|Adverse Event|2|||
42339572|NCT01959841|76177515|FG000|Overall Study|Lack of Efficacy|5|||
42339573|NCT01959841|76177516|FG001|Overall Study|Lack of Efficacy|0|||
42339574|NCT01959841|76177517|FG002|Overall Study|Lack of Efficacy|0|||
42339575|NCT01959841|76177515|FG000|Overall Study|Lost to Follow-up|1|||
42339576|NCT01959841|76177516|FG001|Overall Study|Lost to Follow-up|1|||
42339577|NCT01959841|76177517|FG002|Overall Study|Lost to Follow-up|0|||
42001088|NCT01339559|75809217|FG000|Overall Study|Pregnancy planned|2|||
42001089|NCT01339559|75809217|FG000|Overall Study|Left the country|1|||
42001090|NCT01339559|75809217|FG000|Overall Study|Investigator decision|2|||
42001091|NCT01339559|75809217|FG000|Overall Study|Patient didn't wish to continue|1|||
42001092|NCT01339559|75809217|FG000|Overall Study|PI decision|1|||
42001093|NCT00107900|75809228|FG000|Overall Study|Adverse Event|3|||
42001094|NCT00107900|75809229|FG001|Overall Study|Adverse Event|2|||
42001095|NCT00107900|75809230|FG002|Overall Study|Adverse Event|10|||
42001096|NCT00107900|75809231|FG003|Overall Study|Adverse Event|3|||
42001097|NCT00107900|75809232|FG004|Overall Study|Adverse Event|5|||
42001098|NCT00107900|75809233|FG005|Overall Study|Adverse Event|3|||
42001099|NCT00107900|75809228|FG000|Overall Study|Death|0|||
42001100|NCT00107900|75809229|FG001|Overall Study|Death|0|||
42001101|NCT00107900|75809230|FG002|Overall Study|Death|0|||
42001102|NCT00107900|75809231|FG003|Overall Study|Death|0|||
42001103|NCT00107900|75809232|FG004|Overall Study|Death|1|||
42001104|NCT00107900|75809233|FG005|Overall Study|Death|0|||
42001105|NCT00107900|75809228|FG000|Overall Study|Lost to Follow-up|4|||
42001106|NCT00107900|75809229|FG001|Overall Study|Lost to Follow-up|1|||
42001107|NCT00107900|75809230|FG002|Overall Study|Lost to Follow-up|3|||
42001108|NCT00107900|75809231|FG003|Overall Study|Lost to Follow-up|2|||
42001109|NCT00107900|75809232|FG004|Overall Study|Lost to Follow-up|5|||
42001110|NCT00107900|75809233|FG005|Overall Study|Lost to Follow-up|5|||
42001111|NCT00107900|75809228|FG000|Overall Study|Protocol Violation|1|||
42001112|NCT00107900|75809229|FG001|Overall Study|Protocol Violation|0|||
42001113|NCT00107900|75809230|FG002|Overall Study|Protocol Violation|5|||
42339578|NCT01959841|76177515|FG000|Overall Study|Physician Decision|0|||
42339579|NCT01959841|76177516|FG001|Overall Study|Physician Decision|2|||
42339580|NCT01959841|76177517|FG002|Overall Study|Physician Decision|3|||
42339581|NCT01959841|76177515|FG000|Overall Study|Protocol Violation|16|||
42339582|NCT01959841|76177516|FG001|Overall Study|Protocol Violation|23|||
42339583|NCT01959841|76177517|FG002|Overall Study|Protocol Violation|16|||
42339584|NCT01959841|76177515|FG000|Overall Study|Withdrawal by Subject|7|||
42339585|NCT01959841|76177516|FG001|Overall Study|Withdrawal by Subject|7|||
42339586|NCT01959841|76177517|FG002|Overall Study|Withdrawal by Subject|5|||
42001114|NCT00107900|75809231|FG003|Overall Study|Protocol Violation|5|||
42001115|NCT00107900|75809232|FG004|Overall Study|Protocol Violation|7|||
42001116|NCT00107900|75809233|FG005|Overall Study|Protocol Violation|0|||
42001117|NCT00107900|75809228|FG000|Overall Study|Withdrawal by Subject|1|||
42001118|NCT00107900|75809229|FG001|Overall Study|Withdrawal by Subject|0|||
42001119|NCT00107900|75809230|FG002|Overall Study|Withdrawal by Subject|5|||
42001120|NCT00107900|75809231|FG003|Overall Study|Withdrawal by Subject|0|||
42266787|NCT01648582|76095029|FG001|Overall Study|Protocol Violation|2|||
42339587|NCT01959841|76177515|FG000|Overall Study|Clinical laboratory value|2|||
42339588|NCT01959841|76177516|FG001|Overall Study|Clinical laboratory value|6|||
42339589|NCT01959841|76177517|FG002|Overall Study|Clinical laboratory value|6|||
42339590|NCT01959841|76177515|FG000|Overall Study|Platelet count below on day1 or 4|11|||
42339591|NCT01959841|76177516|FG001|Overall Study|Platelet count below on day1 or 4|15|||
42339592|NCT01959841|76177517|FG002|Overall Study|Platelet count below on day1 or 4|11|||
42339593|NCT02005627|76177527|FG000|Overall Study|Lost to Follow-up|1|||
42001121|NCT00107900|75809232|FG004|Overall Study|Withdrawal by Subject|1|||
42001122|NCT00107900|75809233|FG005|Overall Study|Withdrawal by Subject|1|||
42001123|NCT00107900|75809228|FG000|Overall Study|Administrative Reasons|1|||
42001124|NCT00107900|75809229|FG001|Overall Study|Administrative Reasons|0|||
42001125|NCT00107900|75809230|FG002|Overall Study|Administrative Reasons|2|||
42001126|NCT00107900|75809231|FG003|Overall Study|Administrative Reasons|2|||
42001127|NCT00107900|75809232|FG004|Overall Study|Administrative Reasons|2|||
42001128|NCT00107900|75809233|FG005|Overall Study|Administrative Reasons|0|||
42001129|NCT01339052|75809249|FG000|Overall Study|Disease progression|13|||
42001130|NCT01339052|75809250|FG001|Overall Study|Disease progression|46|||
42001131|NCT01339052|75809249|FG000|Overall Study|Adverse Event|1|||
42001132|NCT01339052|75809250|FG001|Overall Study|Adverse Event|1|||
42001133|NCT01339052|75809249|FG000|Overall Study|Withdrawal by Subject|0|||
42001134|NCT01339052|75809250|FG001|Overall Study|Withdrawal by Subject|3|||
42001135|NCT01339052|75809249|FG000|Overall Study|Physician Decision|1|||
42001136|NCT01339052|75809250|FG001|Overall Study|Physician Decision|0|||
42001137|NCT00107315|75809259|FG000|Overall Study|Disease Progression|9|||
42001138|NCT00107315|75809259|FG000|Overall Study|Adverse Event|4|||
42001139|NCT00107315|75809259|FG000|Overall Study|Withdrawal by Subject|2|||
42001140|NCT01335971|75809266|FG000|Overall Study|Withdrawal by Subject|1|||
42266788|NCT01648582|76095030|FG002|Overall Study|Protocol Violation|1|||
42266789|NCT01648582|76095028|FG000|Overall Study|Withdrawal by Subject|15|||
42266790|NCT01648582|76095029|FG001|Overall Study|Withdrawal by Subject|17|||
42266791|NCT01648582|76095030|FG002|Overall Study|Withdrawal by Subject|17|||
42266792|NCT01648582|76095028|FG000|Overall Study|Physician Decision|0|||
42266793|NCT01648582|76095029|FG001|Overall Study|Physician Decision|1|||
42266794|NCT01648582|76095030|FG002|Overall Study|Physician Decision|3|||
42266795|NCT01648582|76095028|FG000|Overall Study|Death|1|||
42266796|NCT01648582|76095029|FG001|Overall Study|Death|0|||
42266797|NCT01648582|76095030|FG002|Overall Study|Death|0|||
42266798|NCT01648582|76095028|FG000|Overall Study|Sponsor Decision|0|||
42266799|NCT01648582|76095029|FG001|Overall Study|Sponsor Decision|1|||
42266800|NCT01648582|76095030|FG002|Overall Study|Sponsor Decision|1|||
42339594|NCT02005627|76177528|FG001|Overall Study|Lost to Follow-up|2|||
42339595|NCT02005627|76177527|FG000|Overall Study|Withdrawal by Subject|1|||
42266801|NCT02607800|76095043|FG000|Overall Study|Lost to Follow-up|7|||
42001141|NCT01335971|75809267|FG001|Overall Study|Withdrawal by Subject|0|||
42001142|NCT01335971|75809268|FG002|Overall Study|Withdrawal by Subject|0|||
42266802|NCT02607800|76095044|FG001|Overall Study|Lost to Follow-up|10|||
42266803|NCT02607800|76095043|FG000|Overall Study|Withdrew Consent|2|||
42266804|NCT02607800|76095044|FG001|Overall Study|Withdrew Consent|0|||
42339596|NCT02005627|76177528|FG001|Overall Study|Withdrawal by Subject|2|||
42339597|NCT02104583|76177540|FG000|Overall Study|New ICD or CRT-D implanted|2|||
42001143|NCT01335971|75809266|FG000|Overall Study|Did not complete bronchoscopy|1|||
42266805|NCT02607800|76095043|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
42266806|NCT02607800|76095044|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
42266807|NCT02304484|76095051|FG000|Overall Study|Death|9|||
42266808|NCT02304484|76095051|FG000|Overall Study|Withdrawal by Subject|14|||
42266809|NCT02304484|76095051|FG000|Overall Study|Lost to Follow-up|2|||
42266810|NCT02708355|76095058|FG000|Overall Study|Adverse Event|1|||
42266811|NCT02708355|76095059|FG001|Overall Study|Adverse Event|0|||
42266812|NCT02708355|76095060|FG002|Overall Study|Adverse Event|0|||
42266813|NCT02708277|76095070|FG000|Overall Study|Lost to Follow-up|7|||
42266814|NCT02708277|76095071|FG001|Overall Study|Lost to Follow-up|4|||
42266815|NCT02337478|76095077|FG000|Overall Study|Lack of Efficacy|5|||
42266816|NCT02303704|76095083|FG000|Overall Study|Protocol Violation|5|||
42266817|NCT02303704|76095084|FG001|Overall Study|Protocol Violation|9|||
42266818|NCT02608892|76095092|FG000|Overall Study|Lost to Follow-up|1|||
42266819|NCT02608892|76095093|FG001|Overall Study|Lost to Follow-up|0|||
42266832|NCT02708121|76095115|FG000|Overall Study|Withdrawn by Study Team|1|||
42266833|NCT02708121|76095116|FG001|Overall Study|Withdrawn by Study Team|1|||
42266834|NCT02708121|76095115|FG000|Overall Study|Withdrawal by Subject|0|||
42266835|NCT02708121|76095116|FG001|Overall Study|Withdrawal by Subject|4|||
42266836|NCT02707965|76095131|FG000|Overall Study|Withdrawal by Subject|0|||
42266837|NCT02707965|76095132|FG001|Overall Study|Withdrawal by Subject|0|||
42266838|NCT02707965|76095133|FG002|Overall Study|Withdrawal by Subject|1|||
42266839|NCT02707965|76095134|FG003|Overall Study|Withdrawal by Subject|0|||
42266840|NCT02707965|76095135|FG004|Overall Study|Withdrawal by Subject|0|||
42135141|NCT00274456|75945884|FG001|Overall Study|Physician Decision|5|||
42135142|NCT00274456|75945885|FG002|Overall Study|Physician Decision|6|||
42135143|NCT00274456|75945886|FG003|Overall Study|Physician Decision|13|||
42135144|NCT00274456|75945883|FG000|Overall Study|Lost to Follow-up|0|||
42135145|NCT00274456|75945884|FG001|Overall Study|Lost to Follow-up|0|||
42135146|NCT00274456|75945885|FG002|Overall Study|Lost to Follow-up|1|||
42135147|NCT00274456|75945886|FG003|Overall Study|Lost to Follow-up|0|||
42135148|NCT00274456|75945883|FG000|Overall Study|Withdrawal by Subject|18|||
42266841|NCT02707965|76095136|FG005|Overall Study|Withdrawal by Subject|0|||
42266842|NCT02707965|76095137|FG006|Overall Study|Withdrawal by Subject|0|||
42266843|NCT02707965|76095138|FG007|Overall Study|Withdrawal by Subject|2|||
42266844|NCT02707965|76095139|FG008|Overall Study|Withdrawal by Subject|0|||
42266845|NCT02707965|76095140|FG009|Overall Study|Withdrawal by Subject|0|||
42266846|NCT02707965|76095141|FG010|Overall Study|Withdrawal by Subject|0|||
42266847|NCT02707965|76095142|FG011|Overall Study|Withdrawal by Subject|0|||
42001144|NCT01335971|75809267|FG001|Overall Study|Did not complete bronchoscopy|1|||
42001145|NCT01335971|75809268|FG002|Overall Study|Did not complete bronchoscopy|1|||
42001146|NCT00107276|75809276|FG000|Overall Study|Progression|46|||
42001147|NCT00107276|75809276|FG000|Overall Study|Adverse Event|6|||
42001148|NCT00107276|75809276|FG000|Overall Study|M.D. decision|2|||
42135149|NCT00274456|75945884|FG001|Overall Study|Withdrawal by Subject|13|||
42135150|NCT00274456|75945885|FG002|Overall Study|Withdrawal by Subject|9|||
42266848|NCT02707965|76095143|FG012|Overall Study|Withdrawal by Subject|0|||
42266849|NCT02707965|76095144|FG013|Overall Study|Withdrawal by Subject|0|||
42266850|NCT02707965|76095145|FG014|Overall Study|Withdrawal by Subject|0|||
42266851|NCT02707965|76095146|FG015|Overall Study|Withdrawal by Subject|0|||
42266852|NCT02707965|76095131|FG000|Overall Study|PI decisions|0|||
42266853|NCT02707965|76095132|FG001|Overall Study|PI decisions|0|||
42266854|NCT02707965|76095133|FG002|Overall Study|PI decisions|0|||
42266855|NCT02707965|76095134|FG003|Overall Study|PI decisions|0|||
42266856|NCT02707965|76095135|FG004|Overall Study|PI decisions|0|||
42266857|NCT02707965|76095136|FG005|Overall Study|PI decisions|0|||
42266858|NCT02707965|76095137|FG006|Overall Study|PI decisions|0|||
42266859|NCT02707965|76095138|FG007|Overall Study|PI decisions|0|||
42266860|NCT02707965|76095139|FG008|Overall Study|PI decisions|0|||
42266861|NCT02707965|76095140|FG009|Overall Study|PI decisions|0|||
42339598|NCT02104583|76177541|FG001|Overall Study|New ICD or CRT-D implanted|0|||
42266862|NCT02707965|76095141|FG010|Overall Study|PI decisions|0|||
42266863|NCT02707965|76095142|FG011|Overall Study|PI decisions|0|||
42135151|NCT00274456|75945886|FG003|Overall Study|Withdrawal by Subject|13|||
42266864|NCT02707965|76095143|FG012|Overall Study|PI decisions|0|||
42001149|NCT00107276|75809276|FG000|Overall Study|Patient refusal|1|||
42001150|NCT00107276|75809276|FG000|Overall Study|Death|1|||
42001151|NCT00107276|75809276|FG000|Overall Study|Ineligible|16|||
42001152|NCT01335698|75809286|FG000|Treatment Stage 1|Lack of Efficacy|3|||
42001153|NCT01335698|75809287|FG001|Treatment Stage 1|Lack of Efficacy|1|||
42001154|NCT01335698|75809288|FG002|Treatment Stage 1|Lack of Efficacy|3|||
42001155|NCT01335698|75809289|FG003|Treatment Stage 1|Lack of Efficacy|3|||
42001156|NCT01335698|75809290|FG004|Treatment Stage 1|Lack of Efficacy|1|||
42001157|NCT01335698|75809286|FG000|Treatment Stage 1|Adverse Event|1|||
42001158|NCT01335698|75809287|FG001|Treatment Stage 1|Adverse Event|2|||
42001159|NCT01335698|75809288|FG002|Treatment Stage 1|Adverse Event|2|||
42001160|NCT01335698|75809289|FG003|Treatment Stage 1|Adverse Event|1|||
42001161|NCT01335698|75809290|FG004|Treatment Stage 1|Adverse Event|1|||
42001162|NCT01335698|75809286|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
42001163|NCT01335698|75809287|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
42001164|NCT01335698|75809288|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
42001165|NCT01335698|75809289|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
42001166|NCT01335698|75809290|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
42001167|NCT01335698|75809286|FG000|Treatment Stage 1|Lost to Follow-up|1|||
42001168|NCT01335698|75809287|FG001|Treatment Stage 1|Lost to Follow-up|1|||
42001169|NCT01335698|75809288|FG002|Treatment Stage 1|Lost to Follow-up|0|||
42001170|NCT01335698|75809289|FG003|Treatment Stage 1|Lost to Follow-up|0|||
42001171|NCT01335698|75809290|FG004|Treatment Stage 1|Lost to Follow-up|0|||
42001172|NCT01335698|75809286|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
42001173|NCT01335698|75809287|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
42001174|NCT01335698|75809288|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
42001175|NCT01335698|75809289|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
42001176|NCT01335698|75809290|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
42339599|NCT02104583|76177542|FG002|Overall Study|New ICD or CRT-D implanted|1|||
42339600|NCT02104583|76177543|FG003|Overall Study|New ICD or CRT-D implanted|0|||
42339601|NCT02104583|76177544|FG004|Overall Study|New ICD or CRT-D implanted|0|||
42339602|NCT02104583|76177540|FG000|Overall Study|Death|2|||
42339603|NCT02104583|76177541|FG001|Overall Study|Death|1|||
42339604|NCT02104583|76177542|FG002|Overall Study|Death|3|||
42339605|NCT02104583|76177543|FG003|Overall Study|Death|3|||
42339606|NCT02104583|76177544|FG004|Overall Study|Death|5|||
42339607|NCT02104583|76177540|FG000|Overall Study|Subject required cardiac ablation|6|||
42339608|NCT02104583|76177541|FG001|Overall Study|Subject required cardiac ablation|4|||
42339609|NCT02104583|76177542|FG002|Overall Study|Subject required cardiac ablation|4|||
42339610|NCT02104583|76177543|FG003|Overall Study|Subject required cardiac ablation|5|||
42339611|NCT02104583|76177544|FG004|Overall Study|Subject required cardiac ablation|4|||
42339612|NCT02104583|76177540|FG000|Overall Study|Subject required prohibited medication|0|||
42339613|NCT02104583|76177541|FG001|Overall Study|Subject required prohibited medication|1|||
42266865|NCT02707965|76095144|FG013|Overall Study|PI decisions|0|||
42266866|NCT02707965|76095145|FG014|Overall Study|PI decisions|2|||
42266867|NCT02707965|76095146|FG015|Overall Study|PI decisions|0|||
42266868|NCT02707965|76095131|FG000|Overall Study|Protocol deviation|1|||
42339614|NCT02104583|76177542|FG002|Overall Study|Subject required prohibited medication|1|||
42339615|NCT02104583|76177543|FG003|Overall Study|Subject required prohibited medication|0|||
42339616|NCT02104583|76177544|FG004|Overall Study|Subject required prohibited medication|1|||
42001177|NCT01335698|75809286|FG000|Treatment Stage 1|No longer meets study criteria|1|||
42001178|NCT01335698|75809287|FG001|Treatment Stage 1|No longer meets study criteria|1|||
42001179|NCT01335698|75809288|FG002|Treatment Stage 1|No longer meets study criteria|0|||
42001180|NCT01335698|75809289|FG003|Treatment Stage 1|No longer meets study criteria|1|||
42001181|NCT01335698|75809290|FG004|Treatment Stage 1|No longer meets study criteria|0|||
42001182|NCT01335698|75809286|FG000|Treatment Stage 1|Other|1|||
42001183|NCT01335698|75809287|FG001|Treatment Stage 1|Other|0|||
42266869|NCT02707965|76095132|FG001|Overall Study|Protocol deviation|1|||
42266870|NCT02707965|76095133|FG002|Overall Study|Protocol deviation|0|||
42266871|NCT02707965|76095134|FG003|Overall Study|Protocol deviation|0|||
42001184|NCT01335698|75809288|FG002|Treatment Stage 1|Other|0|||
42001185|NCT01335698|75809289|FG003|Treatment Stage 1|Other|1|||
42001186|NCT01335698|75809290|FG004|Treatment Stage 1|Other|0|||
42266872|NCT02707965|76095135|FG004|Overall Study|Protocol deviation|0|||
42001187|NCT01335698|75809286|FG000|Treatment Stage 2|Lack of Efficacy|2|||
42339617|NCT02104583|76177540|FG000|Overall Study|Withdrew Consent|3|||
42001188|NCT01335698|75809287|FG001|Treatment Stage 2|Lack of Efficacy|1|||
42001189|NCT01335698|75809288|FG002|Treatment Stage 2|Lack of Efficacy|3|||
42266873|NCT02707965|76095136|FG005|Overall Study|Protocol deviation|0|||
42339618|NCT02104583|76177541|FG001|Overall Study|Withdrew Consent|2|||
42339619|NCT02104583|76177542|FG002|Overall Study|Withdrew Consent|0|||
42001190|NCT01335698|75809289|FG003|Treatment Stage 2|Lack of Efficacy|1|||
42034970|NCT01035060|75843218|FG001|Overall Study|Lost to Follow-up|7|||
42266874|NCT02707965|76095137|FG006|Overall Study|Protocol deviation|0|||
42001191|NCT01335698|75809290|FG004|Treatment Stage 2|Lack of Efficacy|0|||
42001192|NCT01335698|75809286|FG000|Treatment Stage 2|Adverse Event|2|||
42001193|NCT01335698|75809287|FG001|Treatment Stage 2|Adverse Event|0|||
42001194|NCT01335698|75809288|FG002|Treatment Stage 2|Adverse Event|0|||
42001195|NCT01335698|75809289|FG003|Treatment Stage 2|Adverse Event|3|||
42001196|NCT01335698|75809290|FG004|Treatment Stage 2|Adverse Event|0|||
42266875|NCT02707965|76095138|FG007|Overall Study|Protocol deviation|1|||
42001197|NCT01335698|75809286|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
42001198|NCT01335698|75809287|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
42001199|NCT01335698|75809288|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
42001200|NCT01335698|75809289|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
42001201|NCT01335698|75809290|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
42001202|NCT01335698|75809286|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
42001203|NCT01335698|75809287|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
42001204|NCT01335698|75809288|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
42001205|NCT01335698|75809289|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
42001206|NCT01335698|75809290|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
42001207|NCT01335698|75809286|FG000|Treatment Stage 2|Lost to Follow-up|1|||
42001208|NCT01335698|75809287|FG001|Treatment Stage 2|Lost to Follow-up|0|||
42001209|NCT01335698|75809288|FG002|Treatment Stage 2|Lost to Follow-up|0|||
42001210|NCT01335698|75809289|FG003|Treatment Stage 2|Lost to Follow-up|0|||
42001211|NCT01335698|75809290|FG004|Treatment Stage 2|Lost to Follow-up|0|||
42001212|NCT01335698|75809286|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
42001213|NCT01335698|75809287|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
42001214|NCT01335698|75809288|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
42001215|NCT01335698|75809289|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
42001216|NCT01335698|75809290|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
42001217|NCT01335698|75809286|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
42001218|NCT01335698|75809287|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
42001219|NCT01335698|75809288|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
42001220|NCT01335698|75809289|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
42001221|NCT01335698|75809290|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
42001222|NCT01335698|75809286|FG000|Treatment Stage 2|Switched to another formulation|1|||
42001223|NCT01335698|75809287|FG001|Treatment Stage 2|Switched to another formulation|1|||
42001224|NCT01335698|75809288|FG002|Treatment Stage 2|Switched to another formulation|0|||
42001225|NCT01335698|75809289|FG003|Treatment Stage 2|Switched to another formulation|0|||
42001226|NCT01335698|75809290|FG004|Treatment Stage 2|Switched to another formulation|0|||
42001227|NCT00107120|75809306|FG000|Overall Study|Adverse Event|4|||
42001228|NCT00107120|75809307|FG001|Overall Study|Adverse Event|1|||
42001229|NCT00107120|75809306|FG000|Overall Study|Lack of Efficacy|5|||
42001230|NCT00107120|75809307|FG001|Overall Study|Lack of Efficacy|5|||
42001231|NCT00107120|75809306|FG000|Overall Study|Protocol Violation|3|||
42001232|NCT00107120|75809307|FG001|Overall Study|Protocol Violation|0|||
42001233|NCT00107120|75809306|FG000|Overall Study|Withdrawal by Subject|8|||
42001234|NCT00107120|75809307|FG001|Overall Study|Withdrawal by Subject|9|||
42001235|NCT00107120|75809306|FG000|Overall Study|Lost to Follow-up|8|||
42001236|NCT00107120|75809307|FG001|Overall Study|Lost to Follow-up|6|||
42001237|NCT00107120|75809306|FG000|Overall Study|Pregnancy|0|||
42001238|NCT00107120|75809307|FG001|Overall Study|Pregnancy|1|||
42001239|NCT00107120|75809306|FG000|Overall Study|moving away from site|1|||
42001240|NCT00107120|75809307|FG001|Overall Study|moving away from site|1|||
42001241|NCT00107120|75809306|FG000|Overall Study|death of parent|0|||
42001242|NCT00107120|75809307|FG001|Overall Study|death of parent|1|||
42001243|NCT01335464|75809315|FG000|Overall Study|Adverse Event|15|||
42001244|NCT01335464|75809316|FG001|Overall Study|Adverse Event|25|||
42001245|NCT01335464|75809315|FG000|Overall Study|Non compliant with protocol|2|||
42001246|NCT01335464|75809316|FG001|Overall Study|Non compliant with protocol|0|||
42266876|NCT02707965|76095139|FG008|Overall Study|Protocol deviation|0|||
42266877|NCT02707965|76095140|FG009|Overall Study|Protocol deviation|0|||
42266878|NCT02707965|76095141|FG010|Overall Study|Protocol deviation|0|||
42266879|NCT02707965|76095142|FG011|Overall Study|Protocol deviation|0|||
42266880|NCT02707965|76095143|FG012|Overall Study|Protocol deviation|0|||
42266881|NCT02707965|76095144|FG013|Overall Study|Protocol deviation|0|||
42266882|NCT02707965|76095145|FG014|Overall Study|Protocol deviation|0|||
42266883|NCT02707965|76095146|FG015|Overall Study|Protocol deviation|0|||
42266884|NCT01667900|76095184|FG000|Part B|Death|0|||
42266885|NCT01667900|76095185|FG001|Part B|Death|0|||
42266886|NCT01667900|76095186|FG002|Part B|Death|0|||
42266887|NCT01667900|76095187|FG003|Part B|Death|0|||
42266888|NCT01667900|76095188|FG004|Part B|Death|0|||
42266889|NCT01667900|76095189|FG005|Part B|Death|0|||
42266890|NCT01667900|76095190|FG006|Part B|Death|0|||
42266891|NCT01667900|76095191|FG007|Part B|Death|0|||
42266892|NCT01667900|76095192|FG008|Part B|Death|0|||
42266893|NCT01667900|76095193|FG009|Part B|Death|0|||
42266894|NCT01667900|76095194|FG010|Part B|Death|0|||
42266895|NCT01667900|76095195|FG011|Part B|Death|0|||
42266896|NCT01667900|76095196|FG012|Part B|Death|0|||
42266897|NCT01667900|76095197|FG013|Part B|Death|0|||
42001247|NCT01335464|75809315|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
42001248|NCT01335464|75809316|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
42266898|NCT01667900|76095198|FG014|Part B|Death|0|||
42266899|NCT01667900|76095199|FG015|Part B|Death|0|||
42266900|NCT01667900|76095200|FG016|Part B|Death|1|||
42266901|NCT01667900|76095201|FG017|Part B|Death|0|||
42001249|NCT01335464|75809315|FG000|Overall Study|Not treated|2|||
42001250|NCT01335464|75809316|FG001|Overall Study|Not treated|0|||
42001251|NCT01335464|75809315|FG000|Overall Study|Reason other than those stated above|1|||
42266902|NCT01667900|76095202|FG018|Part B|Death|0|||
42001252|NCT01335464|75809316|FG001|Overall Study|Reason other than those stated above|1|||
42266903|NCT01667900|76095203|FG019|Part B|Death|0|||
42266904|NCT02605928|76095232|FG000|Overall Study|Model tuning phase|28|||
42266905|NCT02605928|76095232|FG000|Overall Study|Lack of Efficacy|5|||
42266906|NCT02706717|76095238|FG000|Overall Study|Withdrawal by Subject|1|||
42266907|NCT02706717|76095239|FG001|Overall Study|Withdrawal by Subject|8|||
42266908|NCT02706717|76095238|FG000|Overall Study|Lost to Follow-up|0|||
42266909|NCT02706717|76095239|FG001|Overall Study|Lost to Follow-up|1|||
42266910|NCT02706717|76095238|FG000|Overall Study|Physician Decision|0|||
42001253|NCT00107042|75809324|FG000|Overall Study|Lost to Follow-up|9|||
42001254|NCT00107042|75809325|FG001|Overall Study|Lost to Follow-up|7|||
42001255|NCT00107042|75809324|FG000|Overall Study|Withdrawal by Subject|6|||
42001256|NCT00107042|75809325|FG001|Overall Study|Withdrawal by Subject|1|||
42001257|NCT00107042|75809324|FG000|Overall Study|Moved out of area|5|||
42001258|NCT00107042|75809325|FG001|Overall Study|Moved out of area|3|||
42266911|NCT02706717|76095239|FG001|Overall Study|Physician Decision|1|||
42266912|NCT02706717|76095238|FG000|Overall Study|Death|0|||
42266913|NCT02706717|76095239|FG001|Overall Study|Death|1|||
42001259|NCT00107042|75809324|FG000|Overall Study|Pregnancy|1|||
42001260|NCT00107042|75809325|FG001|Overall Study|Pregnancy|1|||
42001261|NCT00107042|75809324|FG000|Overall Study|Inadvertent enrollment|0|||
42001262|NCT00107042|75809325|FG001|Overall Study|Inadvertent enrollment|1|||
42001263|NCT00107042|75809324|FG000|Overall Study|vaccinated outside window|1|||
42001264|NCT00107042|75809325|FG001|Overall Study|vaccinated outside window|1|||
42266914|NCT01331837|76095247|FG000|Overall Study|Death|30|||
42266915|NCT01331837|76095248|FG001|Overall Study|Death|34|||
42266916|NCT01331837|76095247|FG000|Overall Study|Lost to Follow-up|3|||
42001265|NCT00107042|75809324|FG000|Overall Study|Disallowed medications|0|||
42001266|NCT00107042|75809325|FG001|Overall Study|Disallowed medications|2|||
42001267|NCT00106964|75809376|FG000|Overall Study|Lost to Follow-up|8|||
42266917|NCT01331837|76095248|FG001|Overall Study|Lost to Follow-up|1|||
42266918|NCT01331837|76095247|FG000|Overall Study|Info not recorded|10|||
42001268|NCT00106964|75809377|FG001|Overall Study|Lost to Follow-up|6|||
42001269|NCT00106964|75809378|FG002|Overall Study|Lost to Follow-up|2|||
42001270|NCT00106964|75809376|FG000|Overall Study|Pregnancy|2|||
42034971|NCT01035060|75843217|FG000|Overall Study|Did not quality after 2nd screening|14|||
42034972|NCT01035060|75843218|FG001|Overall Study|Did not quality after 2nd screening|1|||
42034973|NCT01035060|75843217|FG000|Overall Study|Withdrawal by Subject|8|||
42034974|NCT01035060|75843218|FG001|Overall Study|Withdrawal by Subject|6|||
42034975|NCT01035060|75843217|FG000|Overall Study|Physician Decision|2|||
42034976|NCT01035060|75843218|FG001|Overall Study|Physician Decision|0|||
42034977|NCT01039428|75843226|FG000|Overall Study|Protocol Violation|1|||
42034978|NCT01039428|75843227|FG001|Overall Study|Protocol Violation|0|||
42034979|NCT01039428|75843226|FG000|Overall Study|Withdrawal by Subject|1|||
42034980|NCT01039428|75843227|FG001|Overall Study|Withdrawal by Subject|0|||
42034981|NCT01034358|75843233|FG000|Overall Study|Withdrawal by Subject|1|||
42034982|NCT01034358|75843233|FG000|Overall Study|Protocol Violation|1|||
42034983|NCT01033734|75843241|FG000|Overall Study|Withdrawal by Subject|1|||
42034984|NCT01115855|75843256|FG000|Overall Study|Adverse Event|16|||
42034985|NCT01115855|75843257|FG001|Overall Study|Adverse Event|18|||
42034986|NCT01115855|75843256|FG000|Overall Study|Death|6|||
42034987|NCT01115855|75843257|FG001|Overall Study|Death|5|||
42034988|NCT01115855|75843256|FG000|Overall Study|Lab Abnormality|1|||
42034989|NCT01115855|75843257|FG001|Overall Study|Lab Abnormality|1|||
42001271|NCT00106964|75809377|FG001|Overall Study|Pregnancy|3|||
42001272|NCT00106964|75809378|FG002|Overall Study|Pregnancy|2|||
42001273|NCT00106964|75809376|FG000|Overall Study|Death|1|||
42001274|NCT00106964|75809377|FG001|Overall Study|Death|1|||
42001275|NCT00106964|75809378|FG002|Overall Study|Death|0|||
42001276|NCT00106964|75809376|FG000|Overall Study|Incarceration|0|||
42001277|NCT00106964|75809377|FG001|Overall Study|Incarceration|1|||
42001278|NCT00106964|75809378|FG002|Overall Study|Incarceration|0|||
42001279|NCT00106964|75809376|FG000|Overall Study|Site Funding Terminated|0|||
42001280|NCT00106964|75809377|FG001|Overall Study|Site Funding Terminated|1|||
42001281|NCT00106964|75809378|FG002|Overall Study|Site Funding Terminated|1|||
42001282|NCT00106964|75809376|FG000|Overall Study|Failure to adhere|2|||
42034990|NCT01115855|75843256|FG000|Overall Study|Protocol Violation|0|||
42034991|NCT01115855|75843257|FG001|Overall Study|Protocol Violation|1|||
42034992|NCT01115855|75843256|FG000|Overall Study|Withdrawal by Subject|5|||
42034993|NCT01115855|75843257|FG001|Overall Study|Withdrawal by Subject|5|||
42001283|NCT00106964|75809377|FG001|Overall Study|Failure to adhere|0|||
42266919|NCT01331837|76095248|FG001|Overall Study|Info not recorded|16|||
42266920|NCT01331837|76095247|FG000|Overall Study|Withdrawal by Subject|13|||
42266921|NCT01331837|76095248|FG001|Overall Study|Withdrawal by Subject|16|||
42266922|NCT02706483|76095254|FG000|Overall Study|Adverse Event|97|||
42266923|NCT02706483|76095254|FG000|Overall Study|Death|1|||
42266924|NCT02706483|76095254|FG000|Overall Study|Lack of Efficacy|39|||
42266925|NCT02706483|76095254|FG000|Overall Study|Lost to Follow-up|101|||
42266926|NCT02706483|76095254|FG000|Overall Study|Non-compliance with study drug|15|||
42266927|NCT02706483|76095254|FG000|Overall Study|Physician Decision|6|||
42266928|NCT02706483|76095254|FG000|Overall Study|Pregnancy|6|||
42266929|NCT02706483|76095254|FG000|Overall Study|Protocol Violation|18|||
42266930|NCT02706483|76095254|FG000|Overall Study|Withdrawal by Subject|136|||
42266931|NCT02706483|76095254|FG000|Overall Study|Non-compliance with visits|6|||
42266932|NCT02706483|76095254|FG000|Overall Study|Site closure|4|||
42001284|NCT00106964|75809378|FG002|Overall Study|Failure to adhere|0|||
42001285|NCT00106964|75809376|FG000|Overall Study|Did not meet eligibility criteria|0|||
42001286|NCT00106964|75809377|FG001|Overall Study|Did not meet eligibility criteria|2|||
42001287|NCT00106964|75809378|FG002|Overall Study|Did not meet eligibility criteria|2|||
42001288|NCT00106964|75809376|FG000|Overall Study|Required disallowed medication|0|||
42001289|NCT00106964|75809377|FG001|Overall Study|Required disallowed medication|1|||
42034994|NCT01115855|75843256|FG000|Overall Study|Other|8|||
42001290|NCT00106964|75809378|FG002|Overall Study|Required disallowed medication|0|||
42001291|NCT00106184|75809397|FG000|Overall Study|Withdrawal by Subject|3|||
42001292|NCT00106184|75809398|FG001|Overall Study|Withdrawal by Subject|2|||
42001293|NCT01334918|75809408|FG000|Overall Study|Did not receive study drug|6|||
42001294|NCT01334918|75809409|FG001|Overall Study|Did not receive study drug|0|||
42001295|NCT01334918|75809408|FG000|Overall Study|Adverse Event|2|||
42001296|NCT01334918|75809409|FG001|Overall Study|Adverse Event|0|||
42001297|NCT01334918|75809408|FG000|Overall Study|Withdrawal by Subject|0|||
42001298|NCT01334918|75809409|FG001|Overall Study|Withdrawal by Subject|1|||
42001299|NCT01332968|75809428|FG000|Induction Period|Adverse Event|23|||
42001300|NCT01332968|75809429|FG001|Induction Period|Adverse Event|26|||
42001301|NCT01332968|75809430|FG002|Induction Period|Adverse Event|0|||
42001302|NCT01332968|75809431|FG003|Induction Period|Adverse Event|0|||
42001303|NCT01332968|75809432|FG004|Induction Period|Adverse Event|0|||
42001304|NCT01332968|75809433|FG005|Induction Period|Adverse Event|0|||
42001305|NCT01332968|75809434|FG006|Induction Period|Adverse Event|0|||
42001306|NCT01332968|75809435|FG007|Induction Period|Adverse Event|0|||
42001307|NCT01332968|75809428|FG000|Induction Period|Death|1|||
42001308|NCT01332968|75809429|FG001|Induction Period|Death|4|||
42034995|NCT01115855|75843257|FG001|Overall Study|Other|6|||
42266933|NCT02706483|76095254|FG000|Overall Study|Subject moved|1|||
42339620|NCT02104583|76177543|FG003|Overall Study|Withdrew Consent|2|||
42339621|NCT02104583|76177544|FG004|Overall Study|Withdrew Consent|1|||
42339622|NCT02104583|76177540|FG000|Overall Study|Investigator's Discretion|1|||
42339623|NCT02104583|76177541|FG001|Overall Study|Investigator's Discretion|0|||
42339624|NCT02104583|76177542|FG002|Overall Study|Investigator's Discretion|0|||
42339625|NCT02104583|76177543|FG003|Overall Study|Investigator's Discretion|0|||
42339626|NCT02104583|76177544|FG004|Overall Study|Investigator's Discretion|0|||
42339627|NCT02104583|76177540|FG000|Overall Study|Protocol Violation|0|||
42339628|NCT02104583|76177541|FG001|Overall Study|Protocol Violation|0|||
42339629|NCT02104583|76177542|FG002|Overall Study|Protocol Violation|1|||
42339630|NCT02104583|76177543|FG003|Overall Study|Protocol Violation|0|||
42339631|NCT02104583|76177544|FG004|Overall Study|Protocol Violation|0|||
42339632|NCT02104583|76177540|FG000|Overall Study|Adverse Event|3|||
42339633|NCT02104583|76177541|FG001|Overall Study|Adverse Event|3|||
42339634|NCT02104583|76177542|FG002|Overall Study|Adverse Event|6|||
42339635|NCT02104583|76177543|FG003|Overall Study|Adverse Event|6|||
42001309|NCT01332968|75809430|FG002|Induction Period|Death|0|||
42001310|NCT01332968|75809431|FG003|Induction Period|Death|0|||
42266934|NCT01648348|76095261|FG000|Overall Study|Cancel|1|||
42266935|NCT01648348|76095262|FG001|Overall Study|Cancel|0|||
42266936|NCT01648348|76095263|FG002|Overall Study|Cancel|0|||
42266937|NCT01648348|76095264|FG003|Overall Study|Cancel|0|||
42266938|NCT01648348|76095265|FG004|Overall Study|Cancel|3|||
42266939|NCT01648348|76095266|FG005|Overall Study|Cancel|6|||
42266940|NCT01648348|76095261|FG000|Overall Study|Replaced for MTD analysis|1|||
42266941|NCT01648348|76095262|FG001|Overall Study|Replaced for MTD analysis|0|||
42266942|NCT01648348|76095263|FG002|Overall Study|Replaced for MTD analysis|1|||
42339636|NCT02104583|76177544|FG004|Overall Study|Adverse Event|1|||
42001311|NCT01332968|75809432|FG004|Induction Period|Death|0|||
42001312|NCT01332968|75809433|FG005|Induction Period|Death|0|||
42034996|NCT01115309|75843267|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
42339637|NCT02104583|76177540|FG000|Overall Study|Lost to Follow-up|1|||
42339638|NCT02104583|76177541|FG001|Overall Study|Lost to Follow-up|0|||
42266943|NCT01648348|76095264|FG003|Overall Study|Replaced for MTD analysis|0|||
42339639|NCT02104583|76177542|FG002|Overall Study|Lost to Follow-up|0|||
42339640|NCT02104583|76177543|FG003|Overall Study|Lost to Follow-up|0|||
42339641|NCT02104583|76177544|FG004|Overall Study|Lost to Follow-up|0|||
42339642|NCT02104583|76177540|FG000|Overall Study|Randomized but Never Treated|0|||
42339643|NCT02104583|76177541|FG001|Overall Study|Randomized but Never Treated|0|||
42266944|NCT01648348|76095265|FG004|Overall Study|Replaced for MTD analysis|0|||
42266945|NCT01648348|76095266|FG005|Overall Study|Replaced for MTD analysis|0|||
42266946|NCT01648270|76095279|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
42266947|NCT02302846|76095289|FG000|Overall Study|Withdrawal by Subject|1|||
42266948|NCT02336230|76095293|FG000|Overall Study|Adverse Event|1|||
42266949|NCT02336230|76095293|FG000|Overall Study|Withdrawal of consent|1|||
42266950|NCT02336230|76095293|FG000|Overall Study|Death|9|||
42266951|NCT02336230|76095293|FG000|Overall Study|Dose not received due to shipping delay|1|||
42266952|NCT02336230|76095293|FG000|Overall Study|Discontinuation of MSC infusion|1|||
42266953|NCT02302222|76095299|FG000|Overall Study|Physician Decision|0|||
42266954|NCT02302222|76095300|FG001|Overall Study|Physician Decision|4|||
42266955|NCT02302222|76095299|FG000|Overall Study|Lost to Follow-up|1|||
42266956|NCT02302222|76095300|FG001|Overall Study|Lost to Follow-up|0|||
42339644|NCT02104583|76177542|FG002|Overall Study|Randomized but Never Treated|0|||
42339645|NCT02104583|76177543|FG003|Overall Study|Randomized but Never Treated|1|||
42339646|NCT02104583|76177544|FG004|Overall Study|Randomized but Never Treated|0|||
42339647|NCT02073929|76177567|FG000|Overall Study|Lost to Follow-up|2|||
42339648|NCT02073929|76177568|FG001|Overall Study|Lost to Follow-up|1|||
42339649|NCT02073929|76177567|FG000|Overall Study|Adverse Event|2|||
42339650|NCT02073929|76177568|FG001|Overall Study|Adverse Event|1|||
42339651|NCT02073929|76177567|FG000|Overall Study|Withdrawal by Subject|0|||
42339652|NCT02073929|76177568|FG001|Overall Study|Withdrawal by Subject|1|||
42339653|NCT02113007|76177574|FG000|Overall Study|Progressive disease|2|||
42266957|NCT02302222|76095299|FG000|Overall Study|Treatment discontinued before day 5|0|||
42339654|NCT02104505|76177580|FG000|First Intervention (14 Days)|Adverse Event|2|||
42339655|NCT02104505|76177581|FG001|First Intervention (14 Days)|Adverse Event|0|||
42339656|NCT02104505|76177580|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
42135152|NCT00364923|75945896|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
42001313|NCT01332968|75809434|FG006|Induction Period|Death|0|||
42001314|NCT01332968|75809435|FG007|Induction Period|Death|0|||
42001315|NCT01332968|75809428|FG000|Induction Period|Non-compliance|1|||
42001316|NCT01332968|75809429|FG001|Induction Period|Non-compliance|0|||
42001317|NCT01332968|75809430|FG002|Induction Period|Non-compliance|0|||
42001318|NCT01332968|75809431|FG003|Induction Period|Non-compliance|0|||
42001319|NCT01332968|75809432|FG004|Induction Period|Non-compliance|0|||
42001320|NCT01332968|75809433|FG005|Induction Period|Non-compliance|0|||
42001321|NCT01332968|75809434|FG006|Induction Period|Non-compliance|0|||
42001322|NCT01332968|75809435|FG007|Induction Period|Non-compliance|0|||
42001323|NCT01332968|75809428|FG000|Induction Period|Other|2|||
42001324|NCT01332968|75809429|FG001|Induction Period|Other|2|||
42001325|NCT01332968|75809430|FG002|Induction Period|Other|0|||
42001326|NCT01332968|75809431|FG003|Induction Period|Other|0|||
42001327|NCT01332968|75809432|FG004|Induction Period|Other|0|||
42001328|NCT01332968|75809433|FG005|Induction Period|Other|0|||
42001329|NCT01332968|75809434|FG006|Induction Period|Other|0|||
42001330|NCT01332968|75809435|FG007|Induction Period|Other|0|||
42001331|NCT01332968|75809428|FG000|Induction Period|Physician Decision|6|||
42001332|NCT01332968|75809429|FG001|Induction Period|Physician Decision|1|||
42001333|NCT01332968|75809430|FG002|Induction Period|Physician Decision|0|||
42001334|NCT01332968|75809431|FG003|Induction Period|Physician Decision|0|||
42001335|NCT01332968|75809432|FG004|Induction Period|Physician Decision|0|||
42001336|NCT01332968|75809433|FG005|Induction Period|Physician Decision|0|||
42001337|NCT01332968|75809434|FG006|Induction Period|Physician Decision|0|||
42001338|NCT01332968|75809435|FG007|Induction Period|Physician Decision|0|||
42001339|NCT01332968|75809428|FG000|Induction Period|Progressive Disease|15|||
42001340|NCT01332968|75809429|FG001|Induction Period|Progressive Disease|7|||
42266958|NCT02302222|76095300|FG001|Overall Study|Treatment discontinued before day 5|1|||
42266959|NCT02302222|76095299|FG000|Overall Study|Withdrawn prior to any treatment|0|||
42266960|NCT02302222|76095300|FG001|Overall Study|Withdrawn prior to any treatment|1|||
42266961|NCT02335450|76095306|FG000|Overall Study|Pregnancy|1|||
42266962|NCT02302066|76095320|FG000|Overall Study|Adverse Event|1|||
42266963|NCT02302066|76095321|FG001|Overall Study|Adverse Event|1|||
42266964|NCT02302066|76095322|FG002|Overall Study|Adverse Event|3|||
42266965|NCT02302066|76095323|FG003|Overall Study|Adverse Event|0|||
42266966|NCT02302066|76095320|FG000|Overall Study|Lost to Follow-up|4|||
42266967|NCT02302066|76095321|FG001|Overall Study|Lost to Follow-up|5|||
42266968|NCT02302066|76095322|FG002|Overall Study|Lost to Follow-up|24|||
42266969|NCT02302066|76095323|FG003|Overall Study|Lost to Follow-up|7|||
42266970|NCT02302066|76095320|FG000|Overall Study|Withdrawal by Subject|25|||
42266971|NCT02302066|76095321|FG001|Overall Study|Withdrawal by Subject|58|||
42266972|NCT02302066|76095322|FG002|Overall Study|Withdrawal by Subject|124|||
42266973|NCT02302066|76095323|FG003|Overall Study|Withdrawal by Subject|33|||
42266974|NCT02302066|76095320|FG000|Overall Study|Pregnancy|2|||
42266975|NCT02302066|76095321|FG001|Overall Study|Pregnancy|10|||
42266976|NCT02302066|76095322|FG002|Overall Study|Pregnancy|12|||
42266977|NCT02302066|76095323|FG003|Overall Study|Pregnancy|0|||
42266978|NCT02302066|76095320|FG000|Overall Study|Reason Not Specified|1|||
42266979|NCT02302066|76095321|FG001|Overall Study|Reason Not Specified|1|||
42266980|NCT02302066|76095322|FG002|Overall Study|Reason Not Specified|9|||
42266981|NCT02302066|76095323|FG003|Overall Study|Reason Not Specified|1|||
42266982|NCT02301988|76095345|FG000|Overall Study|Withdrawal by Subject|2|||
42266983|NCT02301988|76095346|FG001|Overall Study|Withdrawal by Subject|1|||
42266984|NCT02301988|76095345|FG000|Overall Study|Physician Decision|2|||
42266985|NCT02301988|76095346|FG001|Overall Study|Physician Decision|2|||
42266986|NCT02301988|76095345|FG000|Overall Study|Unknown Reason|1|||
42266987|NCT02301988|76095346|FG001|Overall Study|Unknown Reason|3|||
42266988|NCT02301988|76095345|FG000|Overall Study|Lack of Efficacy|3|||
42266989|NCT02301988|76095346|FG001|Overall Study|Lack of Efficacy|2|||
42266990|NCT02301988|76095345|FG000|Overall Study|Death|1|||
42266991|NCT02301988|76095346|FG001|Overall Study|Death|0|||
42266992|NCT02301988|76095345|FG000|Overall Study|Adverse Event|1|||
42001341|NCT01332968|75809430|FG002|Induction Period|Progressive Disease|0|||
42001342|NCT01332968|75809431|FG003|Induction Period|Progressive Disease|0|||
42001343|NCT01332968|75809432|FG004|Induction Period|Progressive Disease|0|||
42266993|NCT02301988|76095346|FG001|Overall Study|Adverse Event|1|||
42266994|NCT02334748|76095361|FG000|Overall Study|Adverse Event|1|||
42266995|NCT02334748|76095361|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
42266996|NCT02334748|76095361|FG000|Overall Study|Patient no longer required study drug|2|||
42266997|NCT02334748|76095361|FG000|Overall Study|Lack of Efficacy|4|||
42266998|NCT02332876|76095367|FG000|Overall Study|Lost to Follow-up|1|||
42266999|NCT02332876|76095368|FG001|Overall Study|Lost to Follow-up|1|||
42001344|NCT01332968|75809433|FG005|Induction Period|Progressive Disease|0|||
42001345|NCT01332968|75809434|FG006|Induction Period|Progressive Disease|0|||
42001346|NCT01332968|75809435|FG007|Induction Period|Progressive Disease|0|||
42001347|NCT01332968|75809428|FG000|Induction Period|Protocol Violation|3|||
42267000|NCT02332798|76095377|FG000|Overall Study|Unwilling to Participate in Study|0|||
42267001|NCT02332798|76095378|FG001|Overall Study|Unwilling to Participate in Study|1|||
42267002|NCT02332798|76095379|FG002|Overall Study|Unwilling to Participate in Study|1|||
42267003|NCT02332798|76095377|FG000|Overall Study|Positive Urine Drug Test|0|||
42267004|NCT02332798|76095378|FG001|Overall Study|Positive Urine Drug Test|1|||
42001348|NCT01332968|75809429|FG001|Induction Period|Protocol Violation|4|||
42001349|NCT01332968|75809430|FG002|Induction Period|Protocol Violation|0|||
42001350|NCT01332968|75809431|FG003|Induction Period|Protocol Violation|0|||
42267005|NCT02332798|76095379|FG002|Overall Study|Positive Urine Drug Test|0|||
42267006|NCT02332798|76095377|FG000|Overall Study|Abnormal Laboratory Findings|1|||
42267007|NCT02332798|76095378|FG001|Overall Study|Abnormal Laboratory Findings|0|||
42267008|NCT02332798|76095379|FG002|Overall Study|Abnormal Laboratory Findings|0|||
42267009|NCT02790437|76095389|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
42267010|NCT02790437|76095390|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
42267011|NCT02790437|76095389|FG000|Overall Study|Adverse Event|1|||
42267012|NCT02790437|76095390|FG001|Overall Study|Adverse Event|0|||
42267013|NCT02790437|76095389|FG000|Overall Study|Withdrawal by Subject|1|||
42339657|NCT02104505|76177581|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
42339658|NCT02104505|76177580|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
42339659|NCT02104505|76177581|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
42339660|NCT02104505|76177580|FG000|First Intervention (14 Days)|exclusionary condition|0|||
42339661|NCT02104505|76177581|FG001|First Intervention (14 Days)|exclusionary condition|1|||
42339662|NCT02104505|76177580|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
42339663|NCT02104505|76177581|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
42339664|NCT02104505|76177580|FG000|Second Intervention (14 Days)|Adverse Event|2|||
42267014|NCT02790437|76095390|FG001|Overall Study|Withdrawal by Subject|0|||
42267015|NCT02604212|76095407|FG000|Overall Study|Study Terminated by Sponsor|2|||
42001351|NCT01332968|75809432|FG004|Induction Period|Protocol Violation|0|||
42339665|NCT02104505|76177581|FG001|Second Intervention (14 Days)|Adverse Event|0|||
42339666|NCT02111993|76177590|FG000|Overall Study|Physician Decision|5|||
42339667|NCT02111993|76177591|FG001|Overall Study|Physician Decision|4|||
42339668|NCT01959607|76177601|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
42339669|NCT01959607|76177602|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
42339670|NCT01959607|76177603|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
42339671|NCT01959607|76177604|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
42001352|NCT01332968|75809433|FG005|Induction Period|Protocol Violation|0|||
42001353|NCT01332968|75809434|FG006|Induction Period|Protocol Violation|0|||
42001354|NCT01332968|75809435|FG007|Induction Period|Protocol Violation|0|||
42001355|NCT01332968|75809428|FG000|Induction Period|Withdrawal by Subject|3|||
42001356|NCT01332968|75809429|FG001|Induction Period|Withdrawal by Subject|5|||
42339672|NCT02111603|76177613|FG000|Overall Study|Withdrawal by Subject|1|||
42339673|NCT02102399|76177619|FG000|Overall Study|Withdrawal by Subject|6|||
42339674|NCT02102399|76177620|FG001|Overall Study|Withdrawal by Subject|4|||
42339675|NCT02111369|76177631|FG000|Overall Study|Lost to Follow-up|2|||
42339676|NCT02111369|76177631|FG000|Overall Study|Withdrawal by Subject|1|||
42339677|NCT02111213|76177637|FG000|Overall Study|Withdrawal by Subject|3|||
42339678|NCT02111213|76177638|FG001|Overall Study|Withdrawal by Subject|2|||
42339679|NCT02111213|76177637|FG000|Overall Study|Lost to Follow-up|3|||
42001357|NCT01332968|75809430|FG002|Induction Period|Withdrawal by Subject|0|||
42001358|NCT01332968|75809431|FG003|Induction Period|Withdrawal by Subject|0|||
42001359|NCT01332968|75809432|FG004|Induction Period|Withdrawal by Subject|0|||
42001360|NCT01332968|75809433|FG005|Induction Period|Withdrawal by Subject|0|||
42001361|NCT01332968|75809434|FG006|Induction Period|Withdrawal by Subject|0|||
42001362|NCT01332968|75809435|FG007|Induction Period|Withdrawal by Subject|0|||
42001363|NCT01332968|75809428|FG000|Induction Period|Randomised but not treated|4|||
42001364|NCT01332968|75809429|FG001|Induction Period|Randomised but not treated|7|||
42001365|NCT01332968|75809430|FG002|Induction Period|Randomised but not treated|0|||
42001366|NCT01332968|75809431|FG003|Induction Period|Randomised but not treated|0|||
42001367|NCT01332968|75809432|FG004|Induction Period|Randomised but not treated|0|||
42001368|NCT01332968|75809433|FG005|Induction Period|Randomised but not treated|0|||
42001369|NCT01332968|75809434|FG006|Induction Period|Randomised but not treated|0|||
42034997|NCT01115309|75843267|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
42001370|NCT01332968|75809435|FG007|Induction Period|Randomised but not treated|0|||
42001371|NCT01332968|75809428|FG000|Maintenance/Observation Period|Adverse Event|0|||
42001372|NCT01332968|75809429|FG001|Maintenance/Observation Period|Adverse Event|0|||
42001373|NCT01332968|75809430|FG002|Maintenance/Observation Period|Adverse Event|53|||
42001374|NCT01332968|75809431|FG003|Maintenance/Observation Period|Adverse Event|66|||
42001375|NCT01332968|75809432|FG004|Maintenance/Observation Period|Adverse Event|0|||
42001376|NCT01332968|75809433|FG005|Maintenance/Observation Period|Adverse Event|0|||
42001377|NCT01332968|75809434|FG006|Maintenance/Observation Period|Adverse Event|0|||
42001378|NCT01332968|75809435|FG007|Maintenance/Observation Period|Adverse Event|0|||
42001379|NCT01332968|75809428|FG000|Maintenance/Observation Period|Death|0|||
42001380|NCT01332968|75809429|FG001|Maintenance/Observation Period|Death|0|||
42001381|NCT01332968|75809430|FG002|Maintenance/Observation Period|Death|5|||
42001382|NCT01332968|75809431|FG003|Maintenance/Observation Period|Death|6|||
42001383|NCT01332968|75809432|FG004|Maintenance/Observation Period|Death|0|||
42001384|NCT01332968|75809433|FG005|Maintenance/Observation Period|Death|0|||
42001385|NCT01332968|75809434|FG006|Maintenance/Observation Period|Death|0|||
42001386|NCT01332968|75809435|FG007|Maintenance/Observation Period|Death|0|||
42001387|NCT01332968|75809428|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
42001388|NCT01332968|75809429|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
42001389|NCT01332968|75809430|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
42001390|NCT01332968|75809431|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
42001391|NCT01332968|75809432|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
42001392|NCT01332968|75809433|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
42001393|NCT01332968|75809434|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
42001394|NCT01332968|75809435|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
42001395|NCT01332968|75809428|FG000|Maintenance/Observation Period|Non-compliance|0|||
42001396|NCT01332968|75809429|FG001|Maintenance/Observation Period|Non-compliance|0|||
42001397|NCT01332968|75809430|FG002|Maintenance/Observation Period|Non-compliance|4|||
42001398|NCT01332968|75809431|FG003|Maintenance/Observation Period|Non-compliance|3|||
42001399|NCT01332968|75809432|FG004|Maintenance/Observation Period|Non-compliance|0|||
42001400|NCT01332968|75809433|FG005|Maintenance/Observation Period|Non-compliance|0|||
42001401|NCT01332968|75809434|FG006|Maintenance/Observation Period|Non-compliance|0|||
42001402|NCT01332968|75809435|FG007|Maintenance/Observation Period|Non-compliance|0|||
42001403|NCT01332968|75809428|FG000|Maintenance/Observation Period|Other|0|||
42001404|NCT01332968|75809429|FG001|Maintenance/Observation Period|Other|0|||
42001405|NCT01332968|75809430|FG002|Maintenance/Observation Period|Other|4|||
42001406|NCT01332968|75809431|FG003|Maintenance/Observation Period|Other|7|||
42001407|NCT01332968|75809432|FG004|Maintenance/Observation Period|Other|0|||
42001408|NCT01332968|75809433|FG005|Maintenance/Observation Period|Other|0|||
42001409|NCT01332968|75809434|FG006|Maintenance/Observation Period|Other|0|||
42001410|NCT01332968|75809435|FG007|Maintenance/Observation Period|Other|0|||
42001411|NCT01332968|75809428|FG000|Maintenance/Observation Period|Physician Decision|0|||
42001412|NCT01332968|75809429|FG001|Maintenance/Observation Period|Physician Decision|0|||
42267016|NCT02604212|76095408|FG001|Overall Study|Study Terminated by Sponsor|1|||
42267017|NCT02604212|76095409|FG002|Overall Study|Study Terminated by Sponsor|3|||
42267018|NCT02604212|76095410|FG003|Overall Study|Study Terminated by Sponsor|3|||
42267019|NCT02604212|76095407|FG000|Overall Study|Withdrawal by Subject|0|||
42267020|NCT02604212|76095408|FG001|Overall Study|Withdrawal by Subject|0|||
42267021|NCT02604212|76095409|FG002|Overall Study|Withdrawal by Subject|1|||
42267022|NCT02604212|76095410|FG003|Overall Study|Withdrawal by Subject|0|||
42267023|NCT02789111|76095427|FG000|Overall Study|Withdrawal by Subject|1|||
42267024|NCT02789111|76095428|FG001|Overall Study|Withdrawal by Subject|4|||
42267025|NCT01359644|76095446|FG000|Treatment Period|Lack of Efficacy|0|||
42339680|NCT02111213|76177638|FG001|Overall Study|Lost to Follow-up|4|||
42339681|NCT02110901|76177646|FG000|Overall Study|Death|6|||
42001413|NCT01332968|75809430|FG002|Maintenance/Observation Period|Physician Decision|14|||
42001414|NCT01332968|75809431|FG003|Maintenance/Observation Period|Physician Decision|19|||
42034998|NCT01115309|75843267|FG000|Long-term Follow-up|Lost to Follow-up|6|||
42267026|NCT01359644|76095447|FG001|Treatment Period|Lack of Efficacy|1|||
42267027|NCT01359644|76095448|FG002|Treatment Period|Lack of Efficacy|0|||
42339682|NCT02110901|76177647|FG001|Overall Study|Death|3|||
42339683|NCT02110901|76177646|FG000|Overall Study|Lost to Follow-up|12|||
42001415|NCT01332968|75809432|FG004|Maintenance/Observation Period|Physician Decision|0|||
42001416|NCT01332968|75809433|FG005|Maintenance/Observation Period|Physician Decision|1|||
42001417|NCT01332968|75809434|FG006|Maintenance/Observation Period|Physician Decision|0|||
42001418|NCT01332968|75809435|FG007|Maintenance/Observation Period|Physician Decision|0|||
42001419|NCT01332968|75809428|FG000|Maintenance/Observation Period|Progressive Disease|0|||
42001420|NCT01332968|75809429|FG001|Maintenance/Observation Period|Progressive Disease|0|||
42267028|NCT01359644|76095449|FG003|Treatment Period|Lack of Efficacy|0|||
42267029|NCT01359644|76095450|FG004|Treatment Period|Lack of Efficacy|0|||
42267030|NCT01359644|76095451|FG005|Treatment Period|Lack of Efficacy|0|||
42267031|NCT01359644|76095452|FG006|Treatment Period|Lack of Efficacy|0|||
42267032|NCT01359644|76095453|FG007|Treatment Period|Lack of Efficacy|0|||
42267033|NCT01359644|76095454|FG008|Treatment Period|Lack of Efficacy|0|||
42267034|NCT01359644|76095455|FG009|Treatment Period|Lack of Efficacy|0|||
42267035|NCT01359644|76095446|FG000|Treatment Period|Adverse Event|0|||
42267036|NCT01359644|76095447|FG001|Treatment Period|Adverse Event|0|||
42267037|NCT01359644|76095448|FG002|Treatment Period|Adverse Event|1|||
42267038|NCT01359644|76095449|FG003|Treatment Period|Adverse Event|0|||
42267039|NCT01359644|76095450|FG004|Treatment Period|Adverse Event|0|||
42267040|NCT01359644|76095451|FG005|Treatment Period|Adverse Event|1|||
42267041|NCT01359644|76095452|FG006|Treatment Period|Adverse Event|0|||
42267042|NCT01359644|76095453|FG007|Treatment Period|Adverse Event|0|||
42267043|NCT01359644|76095454|FG008|Treatment Period|Adverse Event|0|||
42267044|NCT01359644|76095455|FG009|Treatment Period|Adverse Event|0|||
42267045|NCT01359644|76095446|FG000|Treatment Period|Lost to Follow-up|0|||
42267046|NCT01359644|76095447|FG001|Treatment Period|Lost to Follow-up|0|||
42267047|NCT01359644|76095448|FG002|Treatment Period|Lost to Follow-up|0|||
42339684|NCT02110901|76177647|FG001|Overall Study|Lost to Follow-up|8|||
42339685|NCT02110901|76177646|FG000|Overall Study|Withdrawal by Subject|7|||
42339686|NCT02110901|76177647|FG001|Overall Study|Withdrawal by Subject|3|||
42339687|NCT02110901|76177646|FG000|Overall Study|received a kidney transplant|5|||
42339688|NCT02110901|76177647|FG001|Overall Study|received a kidney transplant|0|||
42339689|NCT02070965|76177657|FG000|Overall Study|Lost to Follow-up|0|||
42339690|NCT02070965|76177658|FG001|Overall Study|Lost to Follow-up|1|||
42339691|NCT02070965|76177659|FG002|Overall Study|Lost to Follow-up|0|||
42339692|NCT02070965|76177657|FG000|Overall Study|Withdrawal by Subject|1|||
42339693|NCT02070965|76177658|FG001|Overall Study|Withdrawal by Subject|1|||
42339694|NCT02070965|76177659|FG002|Overall Study|Withdrawal by Subject|1|||
42339695|NCT02070965|76177657|FG000|Overall Study|Subject moved|1|||
42339696|NCT02070965|76177658|FG001|Overall Study|Subject moved|0|||
42339697|NCT02070965|76177659|FG002|Overall Study|Subject moved|0|||
42339698|NCT02109107|76177667|FG000|Overall Study|Lost to Follow-up|2|||
42339699|NCT02100839|76177673|FG000|Multiple Ascending Dose|Adverse Event|2|||
42339700|NCT02100839|76177674|FG001|Multiple Ascending Dose|Adverse Event|0|||
42339701|NCT02100839|76177673|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
42001421|NCT01332968|75809430|FG002|Maintenance/Observation Period|Progressive Disease|72|||
42001422|NCT01332968|75809431|FG003|Maintenance/Observation Period|Progressive Disease|40|||
42001423|NCT01332968|75809432|FG004|Maintenance/Observation Period|Progressive Disease|0|||
42001424|NCT01332968|75809433|FG005|Maintenance/Observation Period|Progressive Disease|0|||
42001425|NCT01332968|75809434|FG006|Maintenance/Observation Period|Progressive Disease|0|||
42001426|NCT01332968|75809435|FG007|Maintenance/Observation Period|Progressive Disease|0|||
42001427|NCT01332968|75809428|FG000|Maintenance/Observation Period|Protocol Violation|0|||
42001428|NCT01332968|75809429|FG001|Maintenance/Observation Period|Protocol Violation|0|||
42001429|NCT01332968|75809430|FG002|Maintenance/Observation Period|Protocol Violation|1|||
42001430|NCT01332968|75809431|FG003|Maintenance/Observation Period|Protocol Violation|1|||
42001431|NCT01332968|75809432|FG004|Maintenance/Observation Period|Protocol Violation|0|||
42001432|NCT01332968|75809433|FG005|Maintenance/Observation Period|Protocol Violation|0|||
42001433|NCT01332968|75809434|FG006|Maintenance/Observation Period|Protocol Violation|0|||
42001434|NCT01332968|75809435|FG007|Maintenance/Observation Period|Protocol Violation|0|||
42001435|NCT01332968|75809428|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
42001436|NCT01332968|75809429|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
42001437|NCT01332968|75809430|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
42001438|NCT01332968|75809431|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
42001439|NCT01332968|75809432|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
42267048|NCT01359644|76095449|FG003|Treatment Period|Lost to Follow-up|0|||
42267049|NCT01359644|76095450|FG004|Treatment Period|Lost to Follow-up|0|||
42001440|NCT01332968|75809433|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
42001441|NCT01332968|75809434|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
42267050|NCT01359644|76095451|FG005|Treatment Period|Lost to Follow-up|1|||
42001442|NCT01332968|75809435|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
42267051|NCT01359644|76095452|FG006|Treatment Period|Lost to Follow-up|0|||
42267052|NCT01359644|76095453|FG007|Treatment Period|Lost to Follow-up|0|||
42339702|NCT02100839|76177674|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
42339703|NCT02069093|76177680|FG000|Overall Study|Disease progression|14|||
42339704|NCT02069093|76177680|FG000|Overall Study|New cancer therapy|1|||
42339705|NCT02069093|76177680|FG000|Overall Study|Death|1|||
42339706|NCT02069093|76177680|FG000|Overall Study|Administrative problems|1|||
42339707|NCT02069093|76177680|FG000|Overall Study|Withdrawal by Subject|2|||
42339708|NCT02069093|76177680|FG000|Overall Study|Abnormal laboratory values|1|||
42339709|NCT02069093|76177680|FG000|Overall Study|Adverse Event|10|||
42339710|NCT02109029|76177687|FG000|Part B|Adverse Event|0|||
42339711|NCT02109029|76177688|FG001|Part B|Adverse Event|0|||
42339712|NCT02109029|76177689|FG002|Part B|Adverse Event|0|||
42267053|NCT01359644|76095454|FG008|Treatment Period|Lost to Follow-up|0|||
42339713|NCT02109029|76177690|FG003|Part B|Adverse Event|0|||
42339714|NCT02109029|76177691|FG004|Part B|Adverse Event|1|||
42339715|NCT02109029|76177692|FG005|Part B|Adverse Event|1|||
42339716|NCT02069015|76177705|FG000|Overall Study|Lost to Follow-up|39|||
42339717|NCT02069015|76177706|FG001|Overall Study|Lost to Follow-up|32|||
42339718|NCT02069015|76177705|FG000|Overall Study|Withdrawal by Subject|1|||
42267054|NCT01359644|76095455|FG009|Treatment Period|Lost to Follow-up|0|||
42267055|NCT01359644|76095446|FG000|Follow-up Period|Withdrawal by Subject|0|||
42267056|NCT01359644|76095447|FG001|Follow-up Period|Withdrawal by Subject|0|||
42267057|NCT01359644|76095448|FG002|Follow-up Period|Withdrawal by Subject|0|||
42267058|NCT01359644|76095449|FG003|Follow-up Period|Withdrawal by Subject|0|||
42267059|NCT01359644|76095450|FG004|Follow-up Period|Withdrawal by Subject|0|||
42034999|NCT03638128|75843275|FG000|Overall Study|Withdrawal by Subject|1|||
42035000|NCT03638128|75843276|FG001|Overall Study|Withdrawal by Subject|7|||
42035001|NCT03638128|75843277|FG002|Overall Study|Withdrawal by Subject|6|||
42035002|NCT03638128|75843275|FG000|Overall Study|Sponsor Decision|15|||
42267060|NCT01359644|76095451|FG005|Follow-up Period|Withdrawal by Subject|1|||
42267061|NCT01359644|76095452|FG006|Follow-up Period|Withdrawal by Subject|0|||
42035003|NCT03638128|75843276|FG001|Overall Study|Sponsor Decision|12|||
42339719|NCT02069015|76177706|FG001|Overall Study|Withdrawal by Subject|1|||
42339720|NCT01598129|76177713|FG000|Overall Study|Disease progression|6|||
42339721|NCT01598129|76177713|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
42339722|NCT01598129|76177713|FG000|Overall Study|Withdrawal by Subject|1|||
42339723|NCT02068547|76177720|FG000|Overall Study|Lost to Follow-up|3|||
42339724|NCT02068547|76177721|FG001|Overall Study|Lost to Follow-up|3|||
42001443|NCT01332968|75809428|FG000|Follow-Up Period|Adverse Event|0|||
42001444|NCT01332968|75809429|FG001|Follow-Up Period|Adverse Event|0|||
42001445|NCT01332968|75809430|FG002|Follow-Up Period|Adverse Event|0|||
42001446|NCT01332968|75809431|FG003|Follow-Up Period|Adverse Event|0|||
42267062|NCT01359644|76095453|FG007|Follow-up Period|Withdrawal by Subject|0|||
42267063|NCT01359644|76095454|FG008|Follow-up Period|Withdrawal by Subject|0|||
42267064|NCT01359644|76095455|FG009|Follow-up Period|Withdrawal by Subject|0|||
42267065|NCT01359644|76095446|FG000|Follow-up Period|Lost to Follow-up|0|||
42267066|NCT01359644|76095447|FG001|Follow-up Period|Lost to Follow-up|0|||
42267067|NCT01359644|76095448|FG002|Follow-up Period|Lost to Follow-up|0|||
42267068|NCT01359644|76095449|FG003|Follow-up Period|Lost to Follow-up|0|||
42267069|NCT01359644|76095450|FG004|Follow-up Period|Lost to Follow-up|0|||
42267070|NCT01359644|76095451|FG005|Follow-up Period|Lost to Follow-up|0|||
42339725|NCT02068547|76177720|FG000|Overall Study|Physician Decision|1|||
42001447|NCT01332968|75809432|FG004|Follow-Up Period|Adverse Event|0|||
42001448|NCT01332968|75809433|FG005|Follow-Up Period|Adverse Event|0|||
42001449|NCT01332968|75809434|FG006|Follow-Up Period|Adverse Event|0|||
42001450|NCT01332968|75809435|FG007|Follow-Up Period|Adverse Event|4|||
42001451|NCT01332968|75809428|FG000|Follow-Up Period|Death|0|||
42001452|NCT01332968|75809429|FG001|Follow-Up Period|Death|0|||
42001453|NCT01332968|75809430|FG002|Follow-Up Period|Death|0|||
42267071|NCT01359644|76095452|FG006|Follow-up Period|Lost to Follow-up|1|||
42339726|NCT02068547|76177721|FG001|Overall Study|Physician Decision|0|||
42339727|NCT02108951|76177727|FG000|Overall Study|Lost to Follow-up|1|||
42339728|NCT02108951|76177727|FG000|Overall Study|Patient's/guardian's decision|1|||
42339729|NCT02108951|76177727|FG000|Overall Study|Study Terminated by Sponsor|14|||
42339730|NCT02107859|76177731|FG000|Overall Study|Withdrawal by Subject|14|||
42339731|NCT02107859|76177731|FG000|Overall Study|Adverse Event|3|||
42339732|NCT02107859|76177731|FG000|Overall Study|Study closure|41|||
42339733|NCT02107859|76177731|FG000|Overall Study|Other than specified|3|||
42001454|NCT01332968|75809431|FG003|Follow-Up Period|Death|0|||
42001455|NCT01332968|75809432|FG004|Follow-Up Period|Death|0|||
42001456|NCT01332968|75809433|FG005|Follow-Up Period|Death|0|||
42267072|NCT01359644|76095453|FG007|Follow-up Period|Lost to Follow-up|2|||
42001457|NCT01332968|75809434|FG006|Follow-Up Period|Death|27|||
42339734|NCT02007278|76177737|FG000|Overall Study|Failure to comply with an eligibility|0|||
42339735|NCT02007278|76177738|FG001|Overall Study|Failure to comply with an eligibility|1|||
42339736|NCT02007278|76177737|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
42267073|NCT01359644|76095454|FG008|Follow-up Period|Lost to Follow-up|0|||
42267074|NCT01359644|76095455|FG009|Follow-up Period|Lost to Follow-up|0|||
42267075|NCT02603120|76095490|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
42267076|NCT02603120|76095491|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
42267077|NCT02603120|76095490|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
42267078|NCT02603120|76095491|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
42267079|NCT02603120|76095490|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
42267080|NCT02603120|76095491|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
42267081|NCT02603120|76095490|FG000|Double-Blind Treatment Phase|Death|2|||
42267082|NCT02603120|76095491|FG001|Double-Blind Treatment Phase|Death|0|||
42267083|NCT02603120|76095490|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
42267084|NCT02603120|76095491|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
42267085|NCT02603120|76095490|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
42267086|NCT02603120|76095491|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
42267087|NCT02603120|76095490|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
42267088|NCT02603120|76095491|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
42267089|NCT02603120|76095490|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
42267090|NCT02603120|76095491|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
42267091|NCT02603120|76095490|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
42267092|NCT02603120|76095491|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
42267093|NCT02603120|76095490|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
42267094|NCT02603120|76095491|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
42267095|NCT02603120|76095490|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
42267096|NCT02603120|76095491|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
42267097|NCT02603120|76095490|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
42267098|NCT02603120|76095491|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
42267099|NCT02603120|76095490|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
42267100|NCT02603120|76095491|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
42267101|NCT02603120|76095490|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
42267102|NCT02603120|76095491|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
42267103|NCT02599688|76095499|FG000|Overall Study|Lack of Efficacy|1|||
42267104|NCT02599688|76095499|FG000|Overall Study|Withdrawal by Subject|1|||
42267105|NCT02599688|76095499|FG000|Overall Study|Termination by Sponsor|2|||
42267106|NCT01331291|76095505|FG000|Overall Study|Lack of Efficacy|2|||
42267107|NCT01331291|76095506|FG001|Overall Study|Lack of Efficacy|8|||
42267108|NCT01331291|76095505|FG000|Overall Study|Death|0|||
42267109|NCT01331291|76095506|FG001|Overall Study|Death|1|||
42267110|NCT02601560|76095519|FG000|Overall Study|Other|0|||
42267111|NCT02601560|76095520|FG001|Overall Study|Other|0|||
42267112|NCT02601560|76095521|FG002|Overall Study|Other|0|||
42267113|NCT02601560|76095522|FG003|Overall Study|Other|0|||
42267114|NCT02601560|76095523|FG004|Overall Study|Other|0|||
42267115|NCT02601560|76095524|FG005|Overall Study|Other|0|||
42267116|NCT02601560|76095525|FG006|Overall Study|Other|1|||
42267117|NCT02601560|76095526|FG007|Overall Study|Other|0|||
42267118|NCT02595398|76095557|FG000|Overall Study|Non-compliance|1|||
42267119|NCT02595398|76095558|FG001|Overall Study|Non-compliance|0|||
42267120|NCT02595398|76095557|FG000|Overall Study|Withdrawal by Subject|2|||
42267121|NCT02595398|76095558|FG001|Overall Study|Withdrawal by Subject|1|||
42267122|NCT02595398|76095557|FG000|Overall Study|Lost to Follow-up|1|||
42267123|NCT02595398|76095558|FG001|Overall Study|Lost to Follow-up|0|||
42267124|NCT01368497|76095564|FG000|Overall Study|Lost to Follow-up|2|||
42267125|NCT02595008|76095570|FG000|Overall Study|Enrolled In Error|1|||
42267126|NCT02595008|76095571|FG001|Overall Study|Enrolled In Error|0|||
42267127|NCT02598128|76095577|FG000|Period A: Days -7 to -1|Adverse Event|1|||
42267128|NCT02598128|76095578|FG001|Period A: Days -7 to -1|Adverse Event|0|||
42267129|NCT02598128|76095579|FG002|Period A: Days -7 to -1|Adverse Event|0|||
42339737|NCT02007278|76177738|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
42339738|NCT02007278|76177737|FG000|Overall Study|Incorrect medication administration|1|||
42339739|NCT02007278|76177738|FG001|Overall Study|Incorrect medication administration|0|||
42339740|NCT02007278|76177737|FG000|Overall Study|Mis-randomization|1|||
42339741|NCT02007278|76177738|FG001|Overall Study|Mis-randomization|1|||
42001458|NCT01332968|75809435|FG007|Follow-Up Period|Death|30|||
42001459|NCT01332968|75809428|FG000|Follow-Up Period|Lost to Follow-up|0|||
42267130|NCT02598128|76095580|FG003|Period A: Days -7 to -1|Adverse Event|0|||
42267131|NCT05041439|76095624|FG000|Overall Study|Withdrawal by Subject|1|||
42339742|NCT02107313|76177744|FG000|Overall Study|One participant did not do the FED cohor|0|||
42267132|NCT05041439|76095625|FG001|Overall Study|Withdrawal by Subject|1|||
42267133|NCT05041439|76095624|FG000|Overall Study|Death|1|||
42267134|NCT05041439|76095625|FG001|Overall Study|Death|0|||
42267135|NCT05037409|76095634|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
42267136|NCT05037409|76095635|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
42267137|NCT05037409|76095636|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
42267138|NCT04999111|76095650|FG000|Overall Study|Lost to Follow-up|21|||
42267139|NCT04999111|76095651|FG001|Overall Study|Lost to Follow-up|16|||
42267140|NCT04999111|76095652|FG002|Overall Study|Lost to Follow-up|2|||
42267141|NCT04999111|76095653|FG003|Overall Study|Lost to Follow-up|26|||
42267142|NCT04999111|76095654|FG004|Overall Study|Lost to Follow-up|30|||
42267143|NCT04999111|76095655|FG005|Overall Study|Lost to Follow-up|6|||
42267144|NCT04999111|76095650|FG000|Overall Study|Physician Decision|1|||
42267145|NCT04999111|76095651|FG001|Overall Study|Physician Decision|3|||
42267146|NCT04999111|76095652|FG002|Overall Study|Physician Decision|0|||
42267147|NCT04999111|76095653|FG003|Overall Study|Physician Decision|1|||
42267148|NCT04999111|76095654|FG004|Overall Study|Physician Decision|2|||
42267149|NCT04999111|76095655|FG005|Overall Study|Physician Decision|0|||
42267150|NCT04999111|76095650|FG000|Overall Study|Withdrawal by Subject|23|||
42267151|NCT04999111|76095651|FG001|Overall Study|Withdrawal by Subject|29|||
42267152|NCT04999111|76095652|FG002|Overall Study|Withdrawal by Subject|15|||
42267153|NCT04999111|76095653|FG003|Overall Study|Withdrawal by Subject|30|||
42267154|NCT04999111|76095654|FG004|Overall Study|Withdrawal by Subject|35|||
42267155|NCT04999111|76095655|FG005|Overall Study|Withdrawal by Subject|10|||
42267156|NCT04999111|76095650|FG000|Overall Study|Other|6|||
42267157|NCT04999111|76095651|FG001|Overall Study|Other|6|||
42267158|NCT04999111|76095652|FG002|Overall Study|Other|3|||
42267159|NCT04999111|76095653|FG003|Overall Study|Other|8|||
42267160|NCT04999111|76095654|FG004|Overall Study|Other|8|||
42267161|NCT04999111|76095655|FG005|Overall Study|Other|5|||
42267162|NCT04999111|76095650|FG000|Overall Study|Non-compliance with study schedule|1|||
42267163|NCT04999111|76095651|FG001|Overall Study|Non-compliance with study schedule|0|||
42267164|NCT04999111|76095652|FG002|Overall Study|Non-compliance with study schedule|0|||
42267165|NCT04999111|76095653|FG003|Overall Study|Non-compliance with study schedule|1|||
42267166|NCT04999111|76095654|FG004|Overall Study|Non-compliance with study schedule|1|||
42267167|NCT04999111|76095655|FG005|Overall Study|Non-compliance with study schedule|1|||
42267168|NCT04999111|76095650|FG000|Overall Study|Randomized but not vaccinated|1|||
42267169|NCT04999111|76095651|FG001|Overall Study|Randomized but not vaccinated|2|||
42001460|NCT01332968|75809429|FG001|Follow-Up Period|Lost to Follow-up|0|||
42267170|NCT04999111|76095652|FG002|Overall Study|Randomized but not vaccinated|0|||
42267171|NCT04999111|76095653|FG003|Overall Study|Randomized but not vaccinated|3|||
42001461|NCT01332968|75809430|FG002|Follow-Up Period|Lost to Follow-up|0|||
42001462|NCT01332968|75809431|FG003|Follow-Up Period|Lost to Follow-up|0|||
42001463|NCT01332968|75809432|FG004|Follow-Up Period|Lost to Follow-up|0|||
42001464|NCT01332968|75809433|FG005|Follow-Up Period|Lost to Follow-up|0|||
42001465|NCT01332968|75809434|FG006|Follow-Up Period|Lost to Follow-up|11|||
42001466|NCT01332968|75809435|FG007|Follow-Up Period|Lost to Follow-up|15|||
42001467|NCT01332968|75809428|FG000|Follow-Up Period|Non-compliance|0|||
42001468|NCT01332968|75809429|FG001|Follow-Up Period|Non-compliance|0|||
42001469|NCT01332968|75809430|FG002|Follow-Up Period|Non-compliance|0|||
42001470|NCT01332968|75809431|FG003|Follow-Up Period|Non-compliance|0|||
42001471|NCT01332968|75809432|FG004|Follow-Up Period|Non-compliance|0|||
42001472|NCT01332968|75809433|FG005|Follow-Up Period|Non-compliance|0|||
42001473|NCT01332968|75809434|FG006|Follow-Up Period|Non-compliance|4|||
42001474|NCT01332968|75809435|FG007|Follow-Up Period|Non-compliance|9|||
42001475|NCT01332968|75809428|FG000|Follow-Up Period|Other|0|||
42001476|NCT01332968|75809429|FG001|Follow-Up Period|Other|0|||
42001477|NCT01332968|75809430|FG002|Follow-Up Period|Other|0|||
42001478|NCT01332968|75809431|FG003|Follow-Up Period|Other|0|||
42001479|NCT01332968|75809432|FG004|Follow-Up Period|Other|0|||
42001480|NCT01332968|75809433|FG005|Follow-Up Period|Other|0|||
42001481|NCT01332968|75809434|FG006|Follow-Up Period|Other|18|||
42001482|NCT01332968|75809435|FG007|Follow-Up Period|Other|21|||
42001483|NCT01332968|75809428|FG000|Follow-Up Period|Physician Decision|0|||
42267172|NCT04999111|76095654|FG004|Overall Study|Randomized but not vaccinated|3|||
42267173|NCT04999111|76095655|FG005|Overall Study|Randomized but not vaccinated|0|||
42035004|NCT03638128|75843277|FG002|Overall Study|Sponsor Decision|19|||
42035005|NCT03638128|75843275|FG000|Overall Study|Lost to Follow-up|0|||
42035006|NCT03638128|75843276|FG001|Overall Study|Lost to Follow-up|0|||
42267174|NCT04999111|76095650|FG000|Overall Study|Adverse Event|1|||
42001484|NCT01332968|75809429|FG001|Follow-Up Period|Physician Decision|0|||
42001485|NCT01332968|75809430|FG002|Follow-Up Period|Physician Decision|0|||
42001486|NCT01332968|75809431|FG003|Follow-Up Period|Physician Decision|0|||
42001487|NCT01332968|75809432|FG004|Follow-Up Period|Physician Decision|0|||
42001488|NCT01332968|75809433|FG005|Follow-Up Period|Physician Decision|0|||
42267175|NCT04999111|76095651|FG001|Overall Study|Adverse Event|1|||
42267176|NCT04999111|76095652|FG002|Overall Study|Adverse Event|0|||
42267177|NCT04999111|76095653|FG003|Overall Study|Adverse Event|0|||
42001489|NCT01332968|75809434|FG006|Follow-Up Period|Physician Decision|12|||
42001490|NCT01332968|75809435|FG007|Follow-Up Period|Physician Decision|15|||
42001491|NCT01332968|75809428|FG000|Follow-Up Period|Progressive Disease|0|||
42001492|NCT01332968|75809429|FG001|Follow-Up Period|Progressive Disease|0|||
42001493|NCT01332968|75809430|FG002|Follow-Up Period|Progressive Disease|0|||
42001494|NCT01332968|75809431|FG003|Follow-Up Period|Progressive Disease|0|||
42001495|NCT01332968|75809432|FG004|Follow-Up Period|Progressive Disease|0|||
42001496|NCT01332968|75809433|FG005|Follow-Up Period|Progressive Disease|0|||
42001497|NCT01332968|75809434|FG006|Follow-Up Period|Progressive Disease|126|||
42001498|NCT01332968|75809435|FG007|Follow-Up Period|Progressive Disease|106|||
42001499|NCT01332968|75809428|FG000|Follow-Up Period|Protocol Violation|0|||
42001500|NCT01332968|75809429|FG001|Follow-Up Period|Protocol Violation|0|||
42001501|NCT01332968|75809430|FG002|Follow-Up Period|Protocol Violation|0|||
42001502|NCT01332968|75809431|FG003|Follow-Up Period|Protocol Violation|0|||
42001503|NCT01332968|75809432|FG004|Follow-Up Period|Protocol Violation|0|||
42001504|NCT01332968|75809433|FG005|Follow-Up Period|Protocol Violation|0|||
42001505|NCT01332968|75809434|FG006|Follow-Up Period|Protocol Violation|1|||
42001506|NCT01332968|75809435|FG007|Follow-Up Period|Protocol Violation|0|||
42001507|NCT01332968|75809428|FG000|Follow-Up Period|Withdrawal by Subject|0|||
42001508|NCT01332968|75809429|FG001|Follow-Up Period|Withdrawal by Subject|0|||
42001509|NCT01332968|75809430|FG002|Follow-Up Period|Withdrawal by Subject|0|||
42001510|NCT01332968|75809431|FG003|Follow-Up Period|Withdrawal by Subject|0|||
42001511|NCT01332968|75809432|FG004|Follow-Up Period|Withdrawal by Subject|0|||
42001512|NCT01332968|75809433|FG005|Follow-Up Period|Withdrawal by Subject|0|||
42001513|NCT01332968|75809434|FG006|Follow-Up Period|Withdrawal by Subject|29|||
42001514|NCT01332968|75809435|FG007|Follow-Up Period|Withdrawal by Subject|32|||
42001515|NCT01332968|75809428|FG000|Follow-Up Period|No reason provided|0|||
42001516|NCT01332968|75809429|FG001|Follow-Up Period|No reason provided|0|||
42001517|NCT01332968|75809430|FG002|Follow-Up Period|No reason provided|0|||
42001518|NCT01332968|75809431|FG003|Follow-Up Period|No reason provided|0|||
42001519|NCT01332968|75809432|FG004|Follow-Up Period|No reason provided|0|||
42001520|NCT01332968|75809433|FG005|Follow-Up Period|No reason provided|0|||
42001521|NCT01332968|75809434|FG006|Follow-Up Period|No reason provided|2|||
42001522|NCT01332968|75809435|FG007|Follow-Up Period|No reason provided|3|||
42001523|NCT01332851|75809445|FG000|Overall Study|Withdrawal by Subject|4|||
42001524|NCT01332851|75809446|FG001|Overall Study|Withdrawal by Subject|2|||
42001525|NCT01332851|75809445|FG000|Overall Study|Lost to Follow-up|7|||
42001526|NCT01332851|75809446|FG001|Overall Study|Lost to Follow-up|11|||
42001527|NCT01332305|75809461|FG000|Overall Study|Adverse Event|1|||
42001528|NCT01332305|75809462|FG001|Overall Study|Adverse Event|4|||
42001529|NCT01332305|75809463|FG002|Overall Study|Adverse Event|6|||
42001530|NCT01332305|75809464|FG003|Overall Study|Adverse Event|3|||
42001531|NCT01332305|75809465|FG004|Overall Study|Adverse Event|5|||
42001532|NCT01332305|75809461|FG000|Overall Study|Withdrawal by Subject|6|||
42001533|NCT01332305|75809462|FG001|Overall Study|Withdrawal by Subject|5|||
42001534|NCT01332305|75809463|FG002|Overall Study|Withdrawal by Subject|4|||
42001535|NCT01332305|75809464|FG003|Overall Study|Withdrawal by Subject|1|||
42001536|NCT01332305|75809465|FG004|Overall Study|Withdrawal by Subject|0|||
42001537|NCT01332305|75809461|FG000|Overall Study|Lost to Follow-up|0|||
42001538|NCT01332305|75809462|FG001|Overall Study|Lost to Follow-up|2|||
42001539|NCT01332305|75809463|FG002|Overall Study|Lost to Follow-up|3|||
42001540|NCT01332305|75809464|FG003|Overall Study|Lost to Follow-up|2|||
42001541|NCT01332305|75809465|FG004|Overall Study|Lost to Follow-up|3|||
42001542|NCT01332305|75809461|FG000|Overall Study|Protocol Violation|1|||
42001543|NCT01332305|75809462|FG001|Overall Study|Protocol Violation|2|||
42001544|NCT01332305|75809463|FG002|Overall Study|Protocol Violation|1|||
42001545|NCT01332305|75809464|FG003|Overall Study|Protocol Violation|0|||
42001546|NCT01332305|75809465|FG004|Overall Study|Protocol Violation|3|||
42001547|NCT01332305|75809461|FG000|Overall Study|Withdrawal by Sponsor|1|||
42001548|NCT01332305|75809462|FG001|Overall Study|Withdrawal by Sponsor|0|||
42001549|NCT01332305|75809463|FG002|Overall Study|Withdrawal by Sponsor|0|||
42001550|NCT01332305|75809464|FG003|Overall Study|Withdrawal by Sponsor|1|||
42001551|NCT01332305|75809465|FG004|Overall Study|Withdrawal by Sponsor|1|||
42001552|NCT01332305|75809461|FG000|Overall Study|Treatment Failure|1|||
42001553|NCT01332305|75809462|FG001|Overall Study|Treatment Failure|1|||
42001554|NCT01332305|75809463|FG002|Overall Study|Treatment Failure|0|||
42001555|NCT01332305|75809464|FG003|Overall Study|Treatment Failure|0|||
42001556|NCT01332305|75809465|FG004|Overall Study|Treatment Failure|0|||
42001557|NCT01332305|75809461|FG000|Overall Study|Physician Decision|0|||
42001558|NCT01332305|75809462|FG001|Overall Study|Physician Decision|0|||
42001559|NCT01332305|75809463|FG002|Overall Study|Physician Decision|0|||
42001560|NCT01332305|75809464|FG003|Overall Study|Physician Decision|1|||
42001561|NCT01332305|75809465|FG004|Overall Study|Physician Decision|0|||
42001562|NCT01332227|75809479|FG000|Overall Study|Adverse Event|4|||
42001563|NCT01332227|75809480|FG001|Overall Study|Adverse Event|1|||
42001564|NCT01332227|75809479|FG000|Overall Study|Withdrawal by Subject|5|||
42001565|NCT01332227|75809480|FG001|Overall Study|Withdrawal by Subject|1|||
42001566|NCT01332227|75809479|FG000|Overall Study|Lost to Follow-up|2|||
42001567|NCT01332227|75809480|FG001|Overall Study|Lost to Follow-up|0|||
42001568|NCT01332227|75809479|FG000|Overall Study|Lack of Efficacy|3|||
42001569|NCT01332227|75809480|FG001|Overall Study|Lack of Efficacy|1|||
42001570|NCT01332227|75809479|FG000|Overall Study|Poor compliance/noncompliance|1|||
42001571|NCT01332227|75809480|FG001|Overall Study|Poor compliance/noncompliance|1|||
42001572|NCT01332227|75809479|FG000|Overall Study|Patient moved from area|1|||
42001573|NCT01332227|75809480|FG001|Overall Study|Patient moved from area|0|||
42001574|NCT01332227|75809479|FG000|Overall Study|Patient began prohibited medication|0|||
42001575|NCT01332227|75809480|FG001|Overall Study|Patient began prohibited medication|1|||
42001576|NCT01332149|75809488|FG000|Overall Study|Adverse Event|11|||
42001577|NCT01332149|75809489|FG001|Overall Study|Adverse Event|9|||
42001578|NCT01332149|75809488|FG000|Overall Study|Other unspecified|5|||
42001579|NCT01332149|75809489|FG001|Overall Study|Other unspecified|7|||
42001580|NCT01332149|75809488|FG000|Overall Study|Protocol Violation|1|||
42001581|NCT01332149|75809489|FG001|Overall Study|Protocol Violation|3|||
42001582|NCT01332149|75809488|FG000|Overall Study|Withdrawal by Subject|4|||
42001583|NCT01332149|75809489|FG001|Overall Study|Withdrawal by Subject|5|||
42001584|NCT01332149|75809488|FG000|Overall Study|Lost to Follow-up|1|||
42001585|NCT01332149|75809489|FG001|Overall Study|Lost to Follow-up|1|||
42001586|NCT01332149|75809488|FG000|Overall Study|Insufficient clinical response|4|||
42001587|NCT01332149|75809489|FG001|Overall Study|Insufficient clinical response|7|||
42001588|NCT01332149|75809488|FG000|Overall Study|Did not meet entrance criteria|3|||
42001589|NCT01332149|75809489|FG001|Overall Study|Did not meet entrance criteria|4|||
42001590|NCT01332149|75809488|FG000|Overall Study|Randomized but not treated|1|||
42001591|NCT01332149|75809489|FG001|Overall Study|Randomized but not treated|2|||
42001592|NCT01330628|75809497|FG000|Overall Study|Death|2|||
42001593|NCT01330628|75809498|FG001|Overall Study|Death|3|||
42001594|NCT01330628|75809497|FG000|Overall Study|Lost to Follow-up|5|||
42001595|NCT01330628|75809498|FG001|Overall Study|Lost to Follow-up|6|||
42001596|NCT01330628|75809497|FG000|Overall Study|Adverse Event|44|||
42001597|NCT01330628|75809498|FG001|Overall Study|Adverse Event|25|||
42001598|NCT01330628|75809497|FG000|Overall Study|Withdrawn|18|||
42001599|NCT01330628|75809498|FG001|Overall Study|Withdrawn|6|||
42001600|NCT01330628|75809497|FG000|Overall Study|Didn't receive study treatment|1|||
42001601|NCT01330628|75809498|FG001|Overall Study|Didn't receive study treatment|0|||
42001602|NCT01330433|75809506|FG000|Overall Study|Death|1|||
42001603|NCT01330433|75809507|FG001|Overall Study|Death|3|||
42001604|NCT01330433|75809506|FG000|Overall Study|Lost to Follow-up|1|||
42001605|NCT01330433|75809507|FG001|Overall Study|Lost to Follow-up|0|||
42001606|NCT01330316|75809515|FG000|Overall Study|Adverse Event|2|||
42001607|NCT01330316|75809516|FG001|Overall Study|Adverse Event|2|||
42001608|NCT01330316|75809515|FG000|Overall Study|Lack of Efficacy|0|||
42001609|NCT01330316|75809516|FG001|Overall Study|Lack of Efficacy|10|||
42001610|NCT01330316|75809515|FG000|Overall Study|Lost to Follow-up|0|||
42001611|NCT01330316|75809516|FG001|Overall Study|Lost to Follow-up|1|||
42001612|NCT01330316|75809515|FG000|Overall Study|Withdrawal by Subject|0|||
42001613|NCT01330316|75809516|FG001|Overall Study|Withdrawal by Subject|1|||
42001614|NCT01330316|75809515|FG000|Overall Study|other than above|0|||
42001615|NCT01330316|75809516|FG001|Overall Study|other than above|1|||
42001616|NCT01326702|75809529|FG000|Overall Study|Other|1|||
42001617|NCT01326702|75809530|FG001|Overall Study|Other|0|||
42035007|NCT03638128|75843277|FG002|Overall Study|Lost to Follow-up|1|||
42001618|NCT01326702|75809531|FG002|Overall Study|Other|0|||
42001619|NCT01326702|75809532|FG003|Overall Study|Other|0|||
42001620|NCT01326702|75809533|FG004|Overall Study|Other|0|||
42001621|NCT01326702|75809534|FG005|Overall Study|Other|1|||
42001622|NCT01326702|75809535|FG006|Overall Study|Other|0|||
42001623|NCT01326702|75809529|FG000|Overall Study|progressive disease|1|||
42001624|NCT01326702|75809530|FG001|Overall Study|progressive disease|1|||
42001625|NCT01326702|75809531|FG002|Overall Study|progressive disease|3|||
42001626|NCT01326702|75809532|FG003|Overall Study|progressive disease|1|||
42001627|NCT01326702|75809533|FG004|Overall Study|progressive disease|3|||
42001628|NCT01326702|75809534|FG005|Overall Study|progressive disease|2|||
42001629|NCT01326702|75809535|FG006|Overall Study|progressive disease|3|||
42001630|NCT01326702|75809529|FG000|Overall Study|Death|0|||
42001631|NCT01326702|75809530|FG001|Overall Study|Death|1|||
42001632|NCT01326702|75809531|FG002|Overall Study|Death|0|||
42001633|NCT01326702|75809532|FG003|Overall Study|Death|0|||
42001634|NCT01326702|75809533|FG004|Overall Study|Death|0|||
42001635|NCT01326702|75809534|FG005|Overall Study|Death|0|||
42001636|NCT01326702|75809535|FG006|Overall Study|Death|0|||
42001637|NCT01326702|75809529|FG000|Overall Study|Adverse Event|0|||
42001638|NCT01326702|75809530|FG001|Overall Study|Adverse Event|0|||
42001639|NCT01326702|75809531|FG002|Overall Study|Adverse Event|1|||
42001640|NCT01326702|75809532|FG003|Overall Study|Adverse Event|1|||
42001641|NCT01326702|75809533|FG004|Overall Study|Adverse Event|0|||
42001642|NCT01326702|75809534|FG005|Overall Study|Adverse Event|3|||
42001643|NCT01326702|75809535|FG006|Overall Study|Adverse Event|1|||
42001644|NCT01326702|75809529|FG000|Overall Study|Withdrawal by Subject|0|||
42001645|NCT01326702|75809530|FG001|Overall Study|Withdrawal by Subject|0|||
42001646|NCT01326702|75809531|FG002|Overall Study|Withdrawal by Subject|1|||
42001647|NCT01326702|75809532|FG003|Overall Study|Withdrawal by Subject|0|||
42001648|NCT01326702|75809533|FG004|Overall Study|Withdrawal by Subject|1|||
42001649|NCT01326702|75809534|FG005|Overall Study|Withdrawal by Subject|1|||
42001650|NCT01326702|75809535|FG006|Overall Study|Withdrawal by Subject|3|||
42001651|NCT01326702|75809529|FG000|Overall Study|Not Treated|0|||
42001652|NCT01326702|75809530|FG001|Overall Study|Not Treated|0|||
42001653|NCT01326702|75809531|FG002|Overall Study|Not Treated|0|||
42001654|NCT01326702|75809532|FG003|Overall Study|Not Treated|1|||
42001655|NCT01326702|75809533|FG004|Overall Study|Not Treated|0|||
42001656|NCT01326702|75809534|FG005|Overall Study|Not Treated|1|||
42001657|NCT01326702|75809535|FG006|Overall Study|Not Treated|0|||
42001658|NCT01327703|75809554|FG000|Second Treatment Period|Adverse Event|1|||
42001659|NCT01327703|75809555|FG001|Second Treatment Period|Adverse Event|1|||
42001660|NCT01327703|75809554|FG000|Second Treatment Period|Protocol Violation|0|||
42001661|NCT01327703|75809555|FG001|Second Treatment Period|Protocol Violation|1|||
42001662|NCT01380080|75809566|FG000|Overall Study|Death|36|||
42001663|NCT01380080|75809567|FG001|Overall Study|Death|44|||
42001664|NCT01380080|75809566|FG000|Overall Study|Site is closing|28|||
42001665|NCT01380080|75809567|FG001|Overall Study|Site is closing|31|||
42001666|NCT01380080|75809566|FG000|Overall Study|Not able to get to clinic|7|||
42001667|NCT01380080|75809567|FG001|Overall Study|Not able to get to clinic|1|||
42001668|NCT01380080|75809566|FG000|Overall Study|Not willing to adhere to requirements|6|||
42001669|NCT01380080|75809567|FG001|Overall Study|Not willing to adhere to requirements|2|||
42001670|NCT01380080|75809566|FG000|Overall Study|Withdrawal by Subject|5|||
42001671|NCT01380080|75809567|FG001|Overall Study|Withdrawal by Subject|2|||
42001672|NCT01380080|75809566|FG000|Overall Study|Lost to Follow-up|3|||
42001673|NCT01380080|75809567|FG001|Overall Study|Lost to Follow-up|3|||
42001674|NCT01379768|75809576|FG000|Overall Study|Adverse Event|1|||
42001675|NCT01379768|75809577|FG001|Overall Study|Adverse Event|1|||
42001676|NCT01379768|75809578|FG002|Overall Study|Adverse Event|0|||
42001677|NCT01379768|75809576|FG000|Overall Study|Lost to Follow-up|2|||
42001678|NCT01379768|75809577|FG001|Overall Study|Lost to Follow-up|0|||
42001679|NCT01379768|75809578|FG002|Overall Study|Lost to Follow-up|0|||
42001680|NCT01379573|75809586|FG000|Overall Study|Lost to Follow-up|1|||
42001681|NCT01379573|75809586|FG000|Overall Study|Screen Failure|10|||
42001682|NCT01379534|75809592|FG000|Treatment Phase|Withdrawal by Subject|2|||
42001683|NCT01379534|75809593|FG001|Treatment Phase|Withdrawal by Subject|2|||
42267178|NCT04999111|76095654|FG004|Overall Study|Adverse Event|0|||
42267179|NCT04999111|76095655|FG005|Overall Study|Adverse Event|0|||
42267180|NCT04999111|76095650|FG000|Overall Study|Initiated prohibited medication|0|||
42267181|NCT04999111|76095651|FG001|Overall Study|Initiated prohibited medication|0|||
42267182|NCT04999111|76095652|FG002|Overall Study|Initiated prohibited medication|0|||
42267183|NCT04999111|76095653|FG003|Overall Study|Initiated prohibited medication|0|||
42267184|NCT04999111|76095654|FG004|Overall Study|Initiated prohibited medication|1|||
42267185|NCT04999111|76095655|FG005|Overall Study|Initiated prohibited medication|0|||
42001684|NCT01379534|75809592|FG000|Treatment Phase|Progressive disease|13|||
42001685|NCT01379534|75809593|FG001|Treatment Phase|Progressive disease|22|||
42001686|NCT01379534|75809592|FG000|Treatment Phase|Adverse Event|7|||
42001687|NCT01379534|75809593|FG001|Treatment Phase|Adverse Event|7|||
42001688|NCT01379534|75809592|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
42135153|NCT00364923|75945896|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
42267186|NCT04964557|76095675|FG000|Overall Study|Withdrawal by Subject|3|||
42001689|NCT01379534|75809593|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
42001690|NCT01379534|75809592|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
42001691|NCT01379534|75809593|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
42001692|NCT01379534|75809592|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
42001693|NCT01379534|75809593|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
42001694|NCT01379534|75809592|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
42001695|NCT01379534|75809593|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
42001696|NCT01371851|75809601|FG000|Overall Study|Lost to Follow-up|5|||
42001697|NCT01371851|75809602|FG001|Overall Study|Lost to Follow-up|8|||
42001698|NCT01371851|75809601|FG000|Overall Study|was arrested and put in jail|0|||
42001699|NCT01371851|75809602|FG001|Overall Study|was arrested and put in jail|1|||
42001700|NCT01371851|75809601|FG000|Overall Study|non study related adverse event|1|||
42001701|NCT01371851|75809602|FG001|Overall Study|non study related adverse event|0|||
42001702|NCT01371851|75809601|FG000|Overall Study|Blood Pressure outside study parameters|2|||
42001703|NCT01371851|75809602|FG001|Overall Study|Blood Pressure outside study parameters|0|||
42001704|NCT01371734|75809611|FG000|Overall Study|Other|2|||
42001705|NCT01371734|75809612|FG001|Overall Study|Other|1|||
42001706|NCT01371734|75809613|FG002|Overall Study|Other|2|||
42001707|NCT01371734|75809611|FG000|Overall Study|Withdrawal by Subject|3|||
42001708|NCT01371734|75809612|FG001|Overall Study|Withdrawal by Subject|4|||
42001709|NCT01371734|75809613|FG002|Overall Study|Withdrawal by Subject|9|||
42001710|NCT01371734|75809611|FG000|Overall Study|Lost to Follow-up|5|||
42001711|NCT01371734|75809612|FG001|Overall Study|Lost to Follow-up|3|||
42001712|NCT01371734|75809613|FG002|Overall Study|Lost to Follow-up|1|||
42001713|NCT01371734|75809611|FG000|Overall Study|Protocol Violation|3|||
42001714|NCT01371734|75809612|FG001|Overall Study|Protocol Violation|1|||
42001715|NCT01371734|75809613|FG002|Overall Study|Protocol Violation|2|||
42001716|NCT01371734|75809611|FG000|Overall Study|Adverse Event|8|||
42001717|NCT01371734|75809612|FG001|Overall Study|Adverse Event|8|||
42001718|NCT01371734|75809613|FG002|Overall Study|Adverse Event|3|||
42001719|NCT01371734|75809611|FG000|Overall Study|Lack of Efficacy|2|||
42001720|NCT01371734|75809612|FG001|Overall Study|Lack of Efficacy|2|||
42001721|NCT01371734|75809613|FG002|Overall Study|Lack of Efficacy|0|||
42001722|NCT01365494|75809623|FG000|Overall Study|Adverse Event|1|||
42001723|NCT01365494|75809624|FG001|Overall Study|Adverse Event|0|||
42267187|NCT04964557|76095676|FG001|Overall Study|Withdrawal by Subject|2|||
42267188|NCT04964557|76095675|FG000|Overall Study|Lost to Follow-up|1|||
42267189|NCT04964557|76095676|FG001|Overall Study|Lost to Follow-up|2|||
42267190|NCT04964557|76095675|FG000|Overall Study|Physician Decision|2|||
42267191|NCT04964557|76095676|FG001|Overall Study|Physician Decision|0|||
42267192|NCT04964557|76095675|FG000|Overall Study|Death|3|||
42267193|NCT04964557|76095676|FG001|Overall Study|Death|0|||
42267194|NCT04964557|76095675|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
42267195|NCT04964557|76095676|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
42267196|NCT04798027|76095689|FG000|Overall Study|Protocol Violation|0|||
42267197|NCT04798027|76095690|FG001|Overall Study|Protocol Violation|0|||
42267198|NCT04798027|76095691|FG002|Overall Study|Protocol Violation|0|||
42267199|NCT04798027|76095692|FG003|Overall Study|Protocol Violation|0|||
42267200|NCT04798027|76095693|FG004|Overall Study|Protocol Violation|1|||
42267201|NCT04798027|76095694|FG005|Overall Study|Protocol Violation|0|||
42267202|NCT04798027|76095695|FG006|Overall Study|Protocol Violation|0|||
42267203|NCT04798027|76095696|FG007|Overall Study|Protocol Violation|1|||
42267204|NCT04798027|76095697|FG008|Overall Study|Protocol Violation|0|||
42267205|NCT04798027|76095689|FG000|Overall Study|Withdrawal by Subject|1|||
42267206|NCT04798027|76095690|FG001|Overall Study|Withdrawal by Subject|0|||
42267207|NCT04798027|76095691|FG002|Overall Study|Withdrawal by Subject|1|||
42267208|NCT04798027|76095692|FG003|Overall Study|Withdrawal by Subject|1|||
42267209|NCT04798027|76095693|FG004|Overall Study|Withdrawal by Subject|1|||
42267210|NCT04798027|76095694|FG005|Overall Study|Withdrawal by Subject|1|||
42267211|NCT04798027|76095695|FG006|Overall Study|Withdrawal by Subject|3|||
42267212|NCT04798027|76095696|FG007|Overall Study|Withdrawal by Subject|2|||
42267213|NCT04798027|76095697|FG008|Overall Study|Withdrawal by Subject|2|||
42267214|NCT04798027|76095689|FG000|Overall Study|Lost to Follow-up|1|||
42267215|NCT04798027|76095690|FG001|Overall Study|Lost to Follow-up|3|||
42267216|NCT04798027|76095691|FG002|Overall Study|Lost to Follow-up|0|||
42267217|NCT04798027|76095692|FG003|Overall Study|Lost to Follow-up|0|||
42267218|NCT04798027|76095693|FG004|Overall Study|Lost to Follow-up|0|||
42267219|NCT04798027|76095694|FG005|Overall Study|Lost to Follow-up|1|||
42267220|NCT04798027|76095695|FG006|Overall Study|Lost to Follow-up|0|||
42267221|NCT04798027|76095696|FG007|Overall Study|Lost to Follow-up|0|||
42267222|NCT04798027|76095697|FG008|Overall Study|Lost to Follow-up|1|||
42001724|NCT01365494|75809623|FG000|Overall Study|Withdrawal by Subject|0|||
42001725|NCT01365494|75809624|FG001|Overall Study|Withdrawal by Subject|1|||
42001726|NCT01365494|75809623|FG000|Overall Study|Lost to Follow-up|1|||
42001727|NCT01365494|75809624|FG001|Overall Study|Lost to Follow-up|2|||
42001728|NCT01357889|75809633|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
42267223|NCT04798027|76095689|FG000|Overall Study|Withdrawal by Sponsor|8|||
42267224|NCT04798027|76095690|FG001|Overall Study|Withdrawal by Sponsor|22|||
42001729|NCT01357889|75809634|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
42001730|NCT01357889|75809633|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
42267225|NCT04798027|76095691|FG002|Overall Study|Withdrawal by Sponsor|9|||
42267226|NCT04798027|76095692|FG003|Overall Study|Withdrawal by Sponsor|26|||
42267227|NCT04798027|76095693|FG004|Overall Study|Withdrawal by Sponsor|24|||
42001731|NCT01357889|75809634|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
42001732|NCT01357889|75809633|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
42001733|NCT01357889|75809634|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
42001734|NCT01357889|75809633|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
42001735|NCT01357889|75809634|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
42001736|NCT01357889|75809633|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
42001737|NCT01357889|75809634|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
42001738|NCT01357889|75809633|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
42001739|NCT01357889|75809634|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
42001740|NCT01357889|75809633|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
42267228|NCT04798027|76095694|FG005|Overall Study|Withdrawal by Sponsor|11|||
42267229|NCT04798027|76095695|FG006|Overall Study|Withdrawal by Sponsor|25|||
42267230|NCT04798027|76095696|FG007|Overall Study|Withdrawal by Sponsor|26|||
42267231|NCT04798027|76095697|FG008|Overall Study|Withdrawal by Sponsor|11|||
42267232|NCT04682405|76095724|FG000|Overall Study|Adverse Event|0|||
42267233|NCT04682405|76095725|FG001|Overall Study|Adverse Event|1|||
42267234|NCT04607980|76095737|FG000|Overall Study|Adverse Event|3|||
42267235|NCT04607980|76095738|FG001|Overall Study|Adverse Event|4|||
42267236|NCT04607980|76095737|FG000|Overall Study|Death|0|||
42001741|NCT01357889|75809634|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
42001742|NCT01357889|75809633|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
42001743|NCT01357889|75809634|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
42001744|NCT01357889|75809633|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
42001745|NCT01357889|75809634|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
42001746|NCT01357889|75809633|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
42001747|NCT01357889|75809634|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
42001748|NCT01357889|75809633|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
42001749|NCT01357889|75809634|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
42001750|NCT01357889|75809633|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
42001751|NCT01357889|75809634|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
42001752|NCT01357889|75809633|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
42001753|NCT01357889|75809634|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
42001754|NCT01357850|75809646|FG000|Overall Study|Lost to Follow-up|1|||
42001755|NCT01357850|75809647|FG001|Overall Study|Lost to Follow-up|0|||
42001756|NCT01357850|75809648|FG002|Overall Study|Lost to Follow-up|0|||
42001757|NCT01357850|75809649|FG003|Overall Study|Lost to Follow-up|0|||
42001758|NCT01357655|75809662|FG000|Overall Study|Administrative Reason by Sponsor|45|||
42267237|NCT04607980|76095738|FG001|Overall Study|Death|1|||
42267238|NCT04607980|76095737|FG000|Overall Study|Withdrawal by Subject|2|||
42267239|NCT04607980|76095738|FG001|Overall Study|Withdrawal by Subject|5|||
42267240|NCT04607980|76095737|FG000|Overall Study|Lost to Follow-up|4|||
42267241|NCT04607980|76095738|FG001|Overall Study|Lost to Follow-up|8|||
42267242|NCT04607980|76095737|FG000|Overall Study|Protocol Violation|0|||
42267243|NCT04607980|76095738|FG001|Overall Study|Protocol Violation|3|||
42267244|NCT04607980|76095737|FG000|Overall Study|Other|3|||
42267245|NCT04607980|76095738|FG001|Overall Study|Other|0|||
42267246|NCT04543279|76095758|FG000|Overall Study|Withdrawal by Subject|1|||
42267247|NCT04543279|76095759|FG001|Overall Study|Withdrawal by Subject|0|||
42267248|NCT04543279|76095758|FG000|Overall Study|Adverse Event|1|||
42001759|NCT01357655|75809663|FG001|Overall Study|Administrative Reason by Sponsor|0|||
42001760|NCT01357655|75809662|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
42135154|NCT00381849|75945902|FG000|Wash Out|Withdrawal by Subject|0|||
42267249|NCT04543279|76095759|FG001|Overall Study|Adverse Event|0|||
42267250|NCT04543279|76095758|FG000|Overall Study|Physician Decision|1|||
42267251|NCT04543279|76095759|FG001|Overall Study|Physician Decision|0|||
42267252|NCT04540913|76095767|FG000|Overall Study|Withdrawal by Subject|14|||
42267253|NCT04540913|76095768|FG001|Overall Study|Withdrawal by Subject|3|||
42267254|NCT04540133|76095779|FG000|Overall Study|Lost to Follow-up|1|||
42267255|NCT04540133|76095780|FG001|Overall Study|Lost to Follow-up|0|||
42267256|NCT04494633|76095788|FG000|Overall Study|Lost to Follow-up|5|||
42267257|NCT04494633|76095789|FG001|Overall Study|Lost to Follow-up|3|||
42267258|NCT04494633|76095788|FG000|Overall Study|Protocol Violation|1|||
42267259|NCT04494633|76095789|FG001|Overall Study|Protocol Violation|1|||
42267260|NCT04233801|76095799|FG000|Overall Study|Other than listed|0|||
42267261|NCT04233801|76095800|FG001|Overall Study|Other than listed|0|||
42267262|NCT04233801|76095801|FG002|Overall Study|Other than listed|1|||
42267263|NCT04233801|76095799|FG000|Overall Study|Withdrawal by Subject|0|||
42267264|NCT04233801|76095800|FG001|Overall Study|Withdrawal by Subject|2|||
42267265|NCT04233801|76095801|FG002|Overall Study|Withdrawal by Subject|3|||
42267266|NCT04225039|76095814|FG000|Overall Study|Withdrawal by Subject|1|||
42267267|NCT04225039|76095815|FG001|Overall Study|Withdrawal by Subject|0|||
42267268|NCT04225039|76095816|FG002|Overall Study|Withdrawal by Subject|0|||
42267269|NCT04225039|76095817|FG003|Overall Study|Withdrawal by Subject|1|||
42267270|NCT04225039|76095814|FG000|Overall Study|Currently active on study treatment|0|||
42267271|NCT04225039|76095815|FG001|Overall Study|Currently active on study treatment|1|||
42267272|NCT04225039|76095816|FG002|Overall Study|Currently active on study treatment|0|||
42267273|NCT04225039|76095817|FG003|Overall Study|Currently active on study treatment|0|||
42267274|NCT04225039|76095814|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
42267275|NCT04225039|76095815|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
42001761|NCT01357655|75809663|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
42001762|NCT01357655|75809662|FG000|Overall Study|Disease Progression|1|||
42001763|NCT01357655|75809663|FG001|Overall Study|Disease Progression|0|||
42001764|NCT01357655|75809662|FG000|Overall Study|Lost to Follow-up|2|||
42001765|NCT01357655|75809663|FG001|Overall Study|Lost to Follow-up|0|||
42001766|NCT01357655|75809662|FG000|Overall Study|Maximum Clinical Benefit|2|||
42001767|NCT01357655|75809663|FG001|Overall Study|Maximum Clinical Benefit|0|||
42001768|NCT01357655|75809662|FG000|Overall Study|Reason Unspecified|1|||
42267276|NCT04225039|76095816|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
42267277|NCT04225039|76095817|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
42267278|NCT04225039|76095814|FG000|Overall Study|Ineligible for treatment|0|||
42267279|NCT04225039|76095815|FG001|Overall Study|Ineligible for treatment|0|||
42267280|NCT04225039|76095816|FG002|Overall Study|Ineligible for treatment|0|||
42267281|NCT04225039|76095817|FG003|Overall Study|Ineligible for treatment|4|||
42267282|NCT04059484|76095826|FG000|Overall Study|Adverse Event|2|||
42267283|NCT04059484|76095827|FG001|Overall Study|Adverse Event|5|||
42267284|NCT04059484|76095826|FG000|Overall Study|Withdrawal by Subject|5|||
42267285|NCT04059484|76095827|FG001|Overall Study|Withdrawal by Subject|3|||
42267286|NCT04059484|76095826|FG000|Overall Study|Progressive disease|112|||
42267287|NCT04059484|76095827|FG001|Overall Study|Progressive disease|112|||
42001769|NCT01357655|75809663|FG001|Overall Study|Reason Unspecified|0|||
42001770|NCT01357655|75809662|FG000|Overall Study|Study Drug Toxicity|11|||
42001771|NCT01357655|75809663|FG001|Overall Study|Study Drug Toxicity|0|||
42001772|NCT01357655|75809662|FG000|Overall Study|Subject Withdrew Consent|1|||
42001773|NCT01357655|75809663|FG001|Overall Study|Subject Withdrew Consent|0|||
42001774|NCT01357616|75809670|FG000|Overall Study|Adverse Event|1|||
42001775|NCT01357616|75809671|FG001|Overall Study|Adverse Event|1|||
42001776|NCT01357616|75809670|FG000|Overall Study|Lost to Follow-up|4|||
42001777|NCT01357616|75809671|FG001|Overall Study|Lost to Follow-up|3|||
42001778|NCT01357616|75809670|FG000|Overall Study|Protocol Violation|0|||
42001779|NCT01357616|75809671|FG001|Overall Study|Protocol Violation|2|||
42001780|NCT01357616|75809670|FG000|Overall Study|Inadequate Control of IOP|1|||
42001781|NCT01357616|75809671|FG001|Overall Study|Inadequate Control of IOP|2|||
42001782|NCT01357616|75809670|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
42001783|NCT01357616|75809671|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
42001784|NCT01357616|75809670|FG000|Overall Study|Withdrawal by Subject|1|||
42001785|NCT01357616|75809671|FG001|Overall Study|Withdrawal by Subject|0|||
42001786|NCT01357577|75809679|FG000|Overall Study|Lost to Follow-up|20|||
42001787|NCT01357577|75809680|FG001|Overall Study|Lost to Follow-up|16|||
42001788|NCT01357577|75809679|FG000|Overall Study|Withdrawal by Subject|16|||
42001789|NCT01357577|75809680|FG001|Overall Study|Withdrawal by Subject|8|||
42001790|NCT01357577|75809679|FG000|Overall Study|look at data in database?|1|||
42001791|NCT01357577|75809680|FG001|Overall Study|look at data in database?|2|||
42001792|NCT01351025|75809689|FG000|Week 0 - 20|Lost to Follow-up|2|||
42001793|NCT01351025|75809690|FG001|Week 0 - 20|Lost to Follow-up|1|||
42001794|NCT01351025|75809689|FG000|Week 0 - 20|Withdrawal by Subject|1|||
42001795|NCT01351025|75809690|FG001|Week 0 - 20|Withdrawal by Subject|0|||
42001796|NCT01351025|75809689|FG000|Week 24 - 44|Lost to Follow-up|0|||
42001797|NCT01351025|75809690|FG001|Week 24 - 44|Lost to Follow-up|2|||
42001798|NCT01351025|75809689|FG000|Week 24 - 44|Site closed|0|||
42001799|NCT01351025|75809690|FG001|Week 24 - 44|Site closed|1|||
42001800|NCT01351025|75809689|FG000|Week 24 - 44|unable to get to clinic|1|||
42001801|NCT01351025|75809690|FG001|Week 24 - 44|unable to get to clinic|1|||
42001802|NCT01349036|75809704|FG000|Overall Study|Disease progression|13|||
42001803|NCT01349036|75809705|FG001|Overall Study|Disease progression|22|||
42001804|NCT01349036|75809704|FG000|Overall Study|Other|1|||
42001805|NCT01349036|75809705|FG001|Overall Study|Other|0|||
42001806|NCT01349036|75809704|FG000|Overall Study|Withdrawal by Subject|0|||
42001807|NCT01349036|75809705|FG001|Overall Study|Withdrawal by Subject|2|||
42001808|NCT01348763|75809715|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
42001809|NCT01348763|75809715|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
42001810|NCT01346969|75809723|FG000|Overall Study|Withdrawal by Subject|0|||
42001811|NCT01346969|75809724|FG001|Overall Study|Withdrawal by Subject|0|||
42001812|NCT01346969|75809725|FG002|Overall Study|Withdrawal by Subject|1|||
42001813|NCT01346969|75809726|FG003|Overall Study|Withdrawal by Subject|0|||
42001814|NCT01346969|75809723|FG000|Overall Study|Lost to Follow-up|1|||
42001815|NCT01346969|75809724|FG001|Overall Study|Lost to Follow-up|0|||
42001816|NCT01346969|75809725|FG002|Overall Study|Lost to Follow-up|2|||
42267288|NCT04059484|76095826|FG000|Overall Study|Other|8|||
42001817|NCT01346969|75809726|FG003|Overall Study|Lost to Follow-up|0|||
42267289|NCT04059484|76095827|FG001|Overall Study|Other|3|||
42267290|NCT04059484|76095826|FG000|Overall Study|Ongoing|20|||
42267291|NCT04059484|76095827|FG001|Overall Study|Ongoing|20|||
42001818|NCT01346969|75809723|FG000|Overall Study|Physician Decision|0|||
42001819|NCT01346969|75809724|FG001|Overall Study|Physician Decision|0|||
42001820|NCT01346969|75809725|FG002|Overall Study|Physician Decision|0|||
42001821|NCT01346969|75809726|FG003|Overall Study|Physician Decision|1|||
42001822|NCT01346969|75809723|FG000|Overall Study|Randomized but not treated|1|||
42001823|NCT01346969|75809724|FG001|Overall Study|Randomized but not treated|0|||
42001824|NCT01346969|75809725|FG002|Overall Study|Randomized but not treated|0|||
42001825|NCT01346969|75809726|FG003|Overall Study|Randomized but not treated|0|||
42001826|NCT01346774|75809738|FG000|Overall Study|Did not take a single dose|6|||
42267292|NCT04033003|76095847|FG000|T1 3rd Trimester|Lost to Follow-up|113|||
42339743|NCT02107313|76177745|FG001|Overall Study|One participant did not do the FED cohor|1|||
42339744|NCT02028338|76177753|FG000|Overall Study|Withdrawal by Subject|3|||
42339745|NCT02028338|76177754|FG001|Overall Study|Withdrawal by Subject|1|||
42001827|NCT01346774|75809739|FG001|Overall Study|Did not take a single dose|4|||
42001828|NCT01346774|75809738|FG000|Overall Study|Lost to Follow-up|3|||
42001829|NCT01346774|75809739|FG001|Overall Study|Lost to Follow-up|4|||
42339746|NCT02028338|76177753|FG000|Overall Study|Unable to contact participant|1|||
42339747|NCT02028338|76177754|FG001|Overall Study|Unable to contact participant|0|||
42339748|NCT01625897|76177762|FG000|Overall Study|Adverse Event|27|||
42339749|NCT01625897|76177763|FG001|Overall Study|Adverse Event|10|||
42339750|NCT01625897|76177762|FG000|Overall Study|Physician Decision|0|||
42339751|NCT01625897|76177763|FG001|Overall Study|Physician Decision|1|||
42339752|NCT01625897|76177762|FG000|Overall Study|Withdrawal by Subject|25|||
42339753|NCT01625897|76177763|FG001|Overall Study|Withdrawal by Subject|3|||
42339754|NCT02106923|76177772|FG000|Overall Study|Protocol Violation|0|||
42339755|NCT02106923|76177773|FG001|Overall Study|Protocol Violation|0|||
42339756|NCT02106923|76177774|FG002|Overall Study|Protocol Violation|0|||
42339757|NCT02106923|76177775|FG003|Overall Study|Protocol Violation|0|||
42339758|NCT02106923|76177776|FG004|Overall Study|Protocol Violation|0|||
42339759|NCT02106923|76177777|FG005|Overall Study|Protocol Violation|1|||
42339760|NCT02006732|76177795|FG000|Overall Study|Adverse Event|10|||
42339761|NCT02006732|76177796|FG001|Overall Study|Adverse Event|7|||
42339762|NCT02006732|76177797|FG002|Overall Study|Adverse Event|4|||
42339763|NCT02006732|76177798|FG003|Overall Study|Adverse Event|2|||
42339764|NCT02006732|76177795|FG000|Overall Study|Lack of Efficacy|6|||
42339765|NCT02006732|76177796|FG001|Overall Study|Lack of Efficacy|3|||
42339766|NCT02006732|76177797|FG002|Overall Study|Lack of Efficacy|1|||
42339767|NCT02006732|76177798|FG003|Overall Study|Lack of Efficacy|1|||
42339768|NCT02006732|76177795|FG000|Overall Study|Protocol Violation|1|||
42339769|NCT02006732|76177796|FG001|Overall Study|Protocol Violation|1|||
42339770|NCT02006732|76177797|FG002|Overall Study|Protocol Violation|0|||
42339771|NCT02006732|76177798|FG003|Overall Study|Protocol Violation|0|||
42339772|NCT02006732|76177795|FG000|Overall Study|Lost to Follow-up|0|||
42339773|NCT02006732|76177796|FG001|Overall Study|Lost to Follow-up|1|||
42339774|NCT02006732|76177797|FG002|Overall Study|Lost to Follow-up|0|||
42339775|NCT02006732|76177798|FG003|Overall Study|Lost to Follow-up|0|||
42339776|NCT02006732|76177795|FG000|Overall Study|Withdrawal by Subject|3|||
42339777|NCT02006732|76177796|FG001|Overall Study|Withdrawal by Subject|0|||
42001830|NCT01346774|75809738|FG000|Overall Study|Withdrawal by Subject|1|||
42001831|NCT01346774|75809739|FG001|Overall Study|Withdrawal by Subject|4|||
42001832|NCT01346774|75809738|FG000|Overall Study|Protocol Violation|2|||
42135155|NCT00381849|75945903|FG001|Wash Out|Withdrawal by Subject|1|||
42135156|NCT00273052|75945911|FG000|Overall Study|Withdrawal by Subject|16|||
42135157|NCT00273052|75945912|FG001|Overall Study|Withdrawal by Subject|19|||
42135158|NCT00273052|75945911|FG000|Overall Study|Adverse Event|21|||
42135159|NCT00273052|75945912|FG001|Overall Study|Adverse Event|19|||
42135160|NCT00273052|75945911|FG000|Overall Study|Protocol Violation|14|||
42135161|NCT00273052|75945912|FG001|Overall Study|Protocol Violation|18|||
42135162|NCT00273052|75945911|FG000|Overall Study|Lost to Follow-up|7|||
42135163|NCT00273052|75945912|FG001|Overall Study|Lost to Follow-up|25|||
42135164|NCT00273052|75945911|FG000|Overall Study|Lack of Efficacy|6|||
42135165|NCT00273052|75945912|FG001|Overall Study|Lack of Efficacy|4|||
42135166|NCT00273052|75945911|FG000|Overall Study|Non-Compliance|3|||
42135167|NCT00273052|75945912|FG001|Overall Study|Non-Compliance|1|||
42135168|NCT00273052|75945911|FG000|Overall Study|Other|2|||
42135169|NCT00273052|75945912|FG001|Overall Study|Other|0|||
42339778|NCT02006732|76177797|FG002|Overall Study|Withdrawal by Subject|4|||
42339779|NCT02006732|76177798|FG003|Overall Study|Withdrawal by Subject|1|||
42339780|NCT02098733|76177808|FG000|Overall Study|Data Not Available|5|||
42339781|NCT02098733|76177808|FG000|Overall Study|Lost to Follow-up|5|||
42339782|NCT02028182|76177812|FG000|Overall Study|Protocol Violation|2|||
42339783|NCT02098109|76177819|FG000|Overall Study|Protocol Violation|3|||
42339784|NCT02098109|76177820|FG001|Overall Study|Protocol Violation|0|||
42339785|NCT02097719|76177828|FG000|Overall Study|Subject Withdrew Consent|1|||
42339786|NCT02097719|76177829|FG001|Overall Study|Subject Withdrew Consent|0|||
42001833|NCT01346774|75809739|FG001|Overall Study|Protocol Violation|3|||
42339787|NCT02097719|76177828|FG000|Overall Study|Lost to Follow-up|0|||
42339788|NCT02097719|76177829|FG001|Overall Study|Lost to Follow-up|1|||
42339789|NCT02097719|76177828|FG000|Overall Study|Adverse Event|2|||
42339790|NCT02097719|76177829|FG001|Overall Study|Adverse Event|0|||
42339791|NCT01449370|76177860|FG000|Overall Study|Disease Progression|5|||
42339792|NCT01449370|76177861|FG001|Overall Study|Disease Progression|4|||
42339793|NCT01449370|76177862|FG002|Overall Study|Disease Progression|8|||
42267293|NCT04033003|76095848|FG001|T1 3rd Trimester|Lost to Follow-up|190|||
42339794|NCT01449370|76177863|FG003|Overall Study|Disease Progression|3|||
42339795|NCT01449370|76177864|FG004|Overall Study|Disease Progression|3|||
42339796|NCT01449370|76177865|FG005|Overall Study|Disease Progression|3|||
42339797|NCT01449370|76177866|FG006|Overall Study|Disease Progression|3|||
42339798|NCT01449370|76177867|FG007|Overall Study|Disease Progression|2|||
42339799|NCT01449370|76177868|FG008|Overall Study|Disease Progression|9|||
42339800|NCT01449370|76177869|FG009|Overall Study|Disease Progression|1|||
42339801|NCT01449370|76177870|FG010|Overall Study|Disease Progression|3|||
42339802|NCT01449370|76177871|FG011|Overall Study|Disease Progression|3|||
42339803|NCT01449370|76177872|FG012|Overall Study|Disease Progression|2|||
42339804|NCT01449370|76177873|FG013|Overall Study|Disease Progression|8|||
42339805|NCT01449370|76177874|FG014|Overall Study|Disease Progression|3|||
42339806|NCT01449370|76177875|FG015|Overall Study|Disease Progression|1|||
42339807|NCT01449370|76177876|FG016|Overall Study|Disease Progression|4|||
42339808|NCT01449370|76177877|FG017|Overall Study|Disease Progression|3|||
42339809|NCT01449370|76177878|FG018|Overall Study|Disease Progression|1|||
42339810|NCT01449370|76177879|FG019|Overall Study|Disease Progression|2|||
42339811|NCT01449370|76177880|FG020|Overall Study|Disease Progression|5|||
42339812|NCT01449370|76177881|FG021|Overall Study|Disease Progression|2|||
42339813|NCT01449370|76177882|FG022|Overall Study|Disease Progression|3|||
42339814|NCT01449370|76177883|FG023|Overall Study|Disease Progression|7|||
42339815|NCT01449370|76177884|FG024|Overall Study|Disease Progression|3|||
42339816|NCT01449370|76177860|FG000|Overall Study|Adverse Event|1|||
42339817|NCT01449370|76177861|FG001|Overall Study|Adverse Event|2|||
42339818|NCT01449370|76177862|FG002|Overall Study|Adverse Event|0|||
42339819|NCT01449370|76177863|FG003|Overall Study|Adverse Event|1|||
42339820|NCT01449370|76177864|FG004|Overall Study|Adverse Event|0|||
42001834|NCT01346774|75809738|FG000|Overall Study|Adverse Event|1|||
42267294|NCT04033003|76095847|FG000|T1 3rd Trimester|Protocol Violation|115|||
42267295|NCT04033003|76095848|FG001|T1 3rd Trimester|Protocol Violation|0|||
42267296|NCT04033003|76095847|FG000|T1 3rd Trimester|Withdrawal by Subject|2|||
42267297|NCT04033003|76095848|FG001|T1 3rd Trimester|Withdrawal by Subject|6|||
42267298|NCT04033003|76095847|FG000|T1 3rd Trimester|No longer meets criteria|30|||
42267299|NCT04033003|76095848|FG001|T1 3rd Trimester|No longer meets criteria|19|||
42267300|NCT04033003|76095847|FG000|T1 3rd Trimester|Death|0|||
42267301|NCT04033003|76095848|FG001|T1 3rd Trimester|Death|1|||
42267302|NCT04033003|76095847|FG000|T2 Post Delivery|Lost to Follow-up|133|||
42339821|NCT01449370|76177865|FG005|Overall Study|Adverse Event|0|||
42339822|NCT01449370|76177866|FG006|Overall Study|Adverse Event|0|||
42339823|NCT01449370|76177867|FG007|Overall Study|Adverse Event|0|||
42339824|NCT01449370|76177868|FG008|Overall Study|Adverse Event|1|||
42339825|NCT01449370|76177869|FG009|Overall Study|Adverse Event|1|||
42339826|NCT01449370|76177870|FG010|Overall Study|Adverse Event|0|||
42339827|NCT01449370|76177871|FG011|Overall Study|Adverse Event|0|||
42339828|NCT01449370|76177872|FG012|Overall Study|Adverse Event|0|||
42339829|NCT01449370|76177873|FG013|Overall Study|Adverse Event|2|||
42339830|NCT01449370|76177874|FG014|Overall Study|Adverse Event|0|||
42339831|NCT01449370|76177875|FG015|Overall Study|Adverse Event|1|||
42339832|NCT01449370|76177876|FG016|Overall Study|Adverse Event|0|||
42339833|NCT01449370|76177877|FG017|Overall Study|Adverse Event|0|||
42339834|NCT01449370|76177878|FG018|Overall Study|Adverse Event|1|||
42339835|NCT01449370|76177879|FG019|Overall Study|Adverse Event|1|||
42339836|NCT01449370|76177880|FG020|Overall Study|Adverse Event|0|||
42339837|NCT01449370|76177881|FG021|Overall Study|Adverse Event|1|||
42339838|NCT01449370|76177882|FG022|Overall Study|Adverse Event|0|||
42339839|NCT01449370|76177883|FG023|Overall Study|Adverse Event|1|||
42339840|NCT01449370|76177884|FG024|Overall Study|Adverse Event|3|||
42339841|NCT01449370|76177860|FG000|Overall Study|Participant Decision|0|||
42339842|NCT01449370|76177861|FG001|Overall Study|Participant Decision|0|||
42339843|NCT01449370|76177862|FG002|Overall Study|Participant Decision|0|||
42339844|NCT01449370|76177863|FG003|Overall Study|Participant Decision|0|||
42001835|NCT01346774|75809739|FG001|Overall Study|Adverse Event|2|||
42001836|NCT01346696|75809745|FG000|Overall Study|Death|1|||
42001837|NCT01346540|75809751|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
42001838|NCT01346540|75809752|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
42339845|NCT01449370|76177864|FG004|Overall Study|Participant Decision|0|||
42339846|NCT01449370|76177865|FG005|Overall Study|Participant Decision|0|||
42339847|NCT01449370|76177866|FG006|Overall Study|Participant Decision|0|||
42339848|NCT01449370|76177867|FG007|Overall Study|Participant Decision|1|||
42339849|NCT01449370|76177868|FG008|Overall Study|Participant Decision|1|||
42339850|NCT01449370|76177869|FG009|Overall Study|Participant Decision|0|||
42339851|NCT01449370|76177870|FG010|Overall Study|Participant Decision|0|||
42339852|NCT01449370|76177871|FG011|Overall Study|Participant Decision|0|||
42339853|NCT01449370|76177872|FG012|Overall Study|Participant Decision|1|||
42339854|NCT01449370|76177873|FG013|Overall Study|Participant Decision|1|||
42339855|NCT01449370|76177874|FG014|Overall Study|Participant Decision|0|||
42339856|NCT01449370|76177875|FG015|Overall Study|Participant Decision|1|||
42339857|NCT01449370|76177876|FG016|Overall Study|Participant Decision|3|||
42339858|NCT01449370|76177877|FG017|Overall Study|Participant Decision|0|||
42339859|NCT01449370|76177878|FG018|Overall Study|Participant Decision|1|||
42001839|NCT01346540|75809751|FG000|Overall Study|Adverse Event|0|||
42001840|NCT01346540|75809752|FG001|Overall Study|Adverse Event|4|||
42001841|NCT01342913|75809761|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
42001842|NCT01342913|75809762|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
42001843|NCT01342913|75809763|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
42001844|NCT01342913|75809761|FG000|2-week Run-in Period|Physician Decision|6|||
42001845|NCT01342913|75809762|FG001|2-week Run-in Period|Physician Decision|0|||
42135170|NCT00273052|75945911|FG000|Overall Study|Worsening serum lipid levels|0|||
42135171|NCT00273052|75945912|FG001|Overall Study|Worsening serum lipid levels|2|||
42001846|NCT01342913|75809763|FG002|2-week Run-in Period|Physician Decision|0|||
42339860|NCT01449370|76177879|FG019|Overall Study|Participant Decision|0|||
42339861|NCT01449370|76177880|FG020|Overall Study|Participant Decision|0|||
42339862|NCT01449370|76177881|FG021|Overall Study|Participant Decision|1|||
42339863|NCT01449370|76177882|FG022|Overall Study|Participant Decision|0|||
42339864|NCT01449370|76177883|FG023|Overall Study|Participant Decision|0|||
42339865|NCT01449370|76177884|FG024|Overall Study|Participant Decision|1|||
42339866|NCT01449370|76177860|FG000|Overall Study|Lost to Follow-up|0|||
42339867|NCT01449370|76177861|FG001|Overall Study|Lost to Follow-up|0|||
42339868|NCT01449370|76177862|FG002|Overall Study|Lost to Follow-up|0|||
42339869|NCT01449370|76177863|FG003|Overall Study|Lost to Follow-up|0|||
42001847|NCT01342913|75809761|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
42267303|NCT04033003|76095848|FG001|T2 Post Delivery|Lost to Follow-up|247|||
42001848|NCT01342913|75809762|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
42001849|NCT01342913|75809763|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
42001850|NCT01342913|75809761|FG000|2-week Run-in Period|Adverse Event|2|||
42001851|NCT01342913|75809762|FG001|2-week Run-in Period|Adverse Event|0|||
42001852|NCT01342913|75809763|FG002|2-week Run-in Period|Adverse Event|0|||
42001853|NCT01342913|75809761|FG000|2-week Run-in Period|Protocol Violation|5|||
42001854|NCT01342913|75809762|FG001|2-week Run-in Period|Protocol Violation|0|||
42001855|NCT01342913|75809763|FG002|2-week Run-in Period|Protocol Violation|0|||
42001856|NCT01342913|75809761|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
42001857|NCT01342913|75809762|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
42001858|NCT01342913|75809763|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
42001859|NCT01342913|75809761|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42001860|NCT01342913|75809762|FG001|Double-Blind Treatment Period|Adverse Event|3|||
42001861|NCT01342913|75809763|FG002|Double-Blind Treatment Period|Adverse Event|6|||
42001862|NCT01342913|75809761|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
42001863|NCT01342913|75809762|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
42001864|NCT01342913|75809763|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
42001865|NCT01342913|75809761|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
42001866|NCT01342913|75809762|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
42001867|NCT01342913|75809763|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
42001868|NCT01342913|75809761|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
42001869|NCT01342913|75809762|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
42001870|NCT01342913|75809763|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
42001871|NCT01342913|75809761|FG000|Double-Blind Treatment Period|Physician Decision|0|||
42001872|NCT01342913|75809762|FG001|Double-Blind Treatment Period|Physician Decision|2|||
42001873|NCT01342913|75809763|FG002|Double-Blind Treatment Period|Physician Decision|0|||
42001874|NCT01342913|75809761|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42001875|NCT01342913|75809762|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
42001876|NCT01342913|75809763|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
42001877|NCT01342796|75809771|FG000|Overall Study|Withdrawal by Subject|2|||
42001878|NCT01342796|75809772|FG001|Overall Study|Withdrawal by Subject|0|||
42001879|NCT01342796|75809771|FG000|Overall Study|Lost to Follow-up|0|||
42001880|NCT01342796|75809772|FG001|Overall Study|Lost to Follow-up|3|||
42267304|NCT04033003|76095847|FG000|T2 Post Delivery|Protocol Violation|4|||
42267305|NCT04033003|76095848|FG001|T2 Post Delivery|Protocol Violation|0|||
42267306|NCT04033003|76095847|FG000|T2 Post Delivery|Withdrawal by Subject|5|||
42267307|NCT04033003|76095848|FG001|T2 Post Delivery|Withdrawal by Subject|3|||
42267308|NCT04033003|76095847|FG000|T2 Post Delivery|No longer meets criteria|1|||
42339870|NCT01449370|76177864|FG004|Overall Study|Lost to Follow-up|0|||
42339871|NCT01449370|76177865|FG005|Overall Study|Lost to Follow-up|0|||
42339872|NCT01449370|76177866|FG006|Overall Study|Lost to Follow-up|0|||
42339873|NCT01449370|76177867|FG007|Overall Study|Lost to Follow-up|0|||
42267309|NCT04033003|76095848|FG001|T2 Post Delivery|No longer meets criteria|10|||
42267310|NCT04033003|76095847|FG000|T2 Post Delivery|Death|2|||
42267311|NCT04033003|76095848|FG001|T2 Post Delivery|Death|2|||
42267312|NCT03872128|76095857|FG000|Overall Study|Dropped out before treatment|1|||
42267313|NCT03872128|76095858|FG001|Overall Study|Dropped out before treatment|0|||
42267314|NCT03872128|76095859|FG002|Overall Study|Dropped out before treatment|4|||
42267315|NCT03872128|76095857|FG000|Overall Study|Lost to Follow-up|2|||
42267316|NCT03872128|76095858|FG001|Overall Study|Lost to Follow-up|5|||
42267317|NCT03872128|76095859|FG002|Overall Study|Lost to Follow-up|8|||
42339874|NCT01449370|76177868|FG008|Overall Study|Lost to Follow-up|0|||
42339875|NCT01449370|76177869|FG009|Overall Study|Lost to Follow-up|0|||
42339876|NCT01449370|76177870|FG010|Overall Study|Lost to Follow-up|0|||
42339877|NCT01449370|76177871|FG011|Overall Study|Lost to Follow-up|0|||
42339878|NCT01449370|76177872|FG012|Overall Study|Lost to Follow-up|0|||
42339879|NCT01449370|76177873|FG013|Overall Study|Lost to Follow-up|0|||
42339880|NCT01449370|76177874|FG014|Overall Study|Lost to Follow-up|0|||
42001881|NCT01342796|75809771|FG000|Overall Study|Inappropriate enrollment|1|||
42001882|NCT01342796|75809772|FG001|Overall Study|Inappropriate enrollment|0|||
42001883|NCT01342640|75809778|FG000|Overall Study|Adverse Event|3|||
42001884|NCT01342640|75809778|FG000|Overall Study|Protocol Violation|16|||
42001885|NCT01342640|75809778|FG000|Overall Study|Lost to Follow-up|21|||
42267318|NCT03221257|76095888|FG000|Overall Study|Lost to Follow-up|0|||
42267319|NCT03221257|76095889|FG001|Overall Study|Lost to Follow-up|1|||
42267320|NCT03221257|76095888|FG000|Overall Study|Withdrawal by Subject|1|||
42267321|NCT03221257|76095889|FG001|Overall Study|Withdrawal by Subject|1|||
42339881|NCT01449370|76177875|FG015|Overall Study|Lost to Follow-up|0|||
42339882|NCT01449370|76177876|FG016|Overall Study|Lost to Follow-up|0|||
42339883|NCT01449370|76177877|FG017|Overall Study|Lost to Follow-up|0|||
42339884|NCT01449370|76177878|FG018|Overall Study|Lost to Follow-up|0|||
42339885|NCT01449370|76177879|FG019|Overall Study|Lost to Follow-up|0|||
42339886|NCT01449370|76177880|FG020|Overall Study|Lost to Follow-up|1|||
42339887|NCT01449370|76177881|FG021|Overall Study|Lost to Follow-up|0|||
42339888|NCT01449370|76177882|FG022|Overall Study|Lost to Follow-up|0|||
42339889|NCT01449370|76177883|FG023|Overall Study|Lost to Follow-up|0|||
42339890|NCT01449370|76177884|FG024|Overall Study|Lost to Follow-up|0|||
42339891|NCT01449370|76177860|FG000|Overall Study|Other|0|||
42339892|NCT01449370|76177861|FG001|Overall Study|Other|0|||
42339893|NCT01449370|76177862|FG002|Overall Study|Other|0|||
42339894|NCT01449370|76177863|FG003|Overall Study|Other|0|||
42339895|NCT01449370|76177864|FG004|Overall Study|Other|0|||
42339896|NCT01449370|76177865|FG005|Overall Study|Other|0|||
42339897|NCT01449370|76177866|FG006|Overall Study|Other|0|||
42267322|NCT02978326|76095898|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
42267323|NCT02978326|76095899|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
42267324|NCT02978326|76095900|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
42267325|NCT02978326|76095898|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
42267326|NCT02978326|76095899|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
42267327|NCT02978326|76095900|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
42267328|NCT02978326|76095898|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
42267329|NCT02978326|76095899|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
42267330|NCT02978326|76095900|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
42267331|NCT02978326|76095898|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
42267332|NCT02978326|76095899|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
42267333|NCT02978326|76095900|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
42267334|NCT02834403|76095926|FG000|Overall Study|Physician Decision|2|||
42267335|NCT02834403|76095927|FG001|Overall Study|Physician Decision|1|||
42267336|NCT02834403|76095928|FG002|Overall Study|Physician Decision|2|||
42267337|NCT02834403|76095929|FG003|Overall Study|Physician Decision|1|||
42267338|NCT02834403|76095930|FG004|Overall Study|Physician Decision|1|||
42267339|NCT02834403|76095931|FG005|Overall Study|Physician Decision|2|||
42267340|NCT02834403|76095932|FG006|Overall Study|Physician Decision|12|||
42267341|NCT02834403|76095926|FG000|Overall Study|Adverse Event|0|||
42267342|NCT02834403|76095927|FG001|Overall Study|Adverse Event|0|||
42339898|NCT01449370|76177867|FG007|Overall Study|Other|0|||
42339899|NCT01449370|76177868|FG008|Overall Study|Other|1|||
42339900|NCT01449370|76177869|FG009|Overall Study|Other|1|||
42339901|NCT01449370|76177870|FG010|Overall Study|Other|0|||
42339902|NCT01449370|76177871|FG011|Overall Study|Other|0|||
42339903|NCT01449370|76177872|FG012|Overall Study|Other|0|||
42339904|NCT01449370|76177873|FG013|Overall Study|Other|0|||
42339905|NCT01449370|76177874|FG014|Overall Study|Other|0|||
42339906|NCT01449370|76177875|FG015|Overall Study|Other|0|||
42339907|NCT01449370|76177876|FG016|Overall Study|Other|0|||
42339908|NCT01449370|76177877|FG017|Overall Study|Other|0|||
42339909|NCT01449370|76177878|FG018|Overall Study|Other|0|||
42339910|NCT01449370|76177879|FG019|Overall Study|Other|0|||
42339911|NCT01449370|76177880|FG020|Overall Study|Other|0|||
42339912|NCT01449370|76177881|FG021|Overall Study|Other|0|||
42339913|NCT01449370|76177882|FG022|Overall Study|Other|1|||
42339914|NCT01449370|76177883|FG023|Overall Study|Other|1|||
42339915|NCT01449370|76177884|FG024|Overall Study|Other|0|||
42339916|NCT01449370|76177860|FG000|Overall Study|Medication Prohibited by Protocol|0|||
42339917|NCT01449370|76177861|FG001|Overall Study|Medication Prohibited by Protocol|0|||
42339918|NCT01449370|76177862|FG002|Overall Study|Medication Prohibited by Protocol|0|||
42339919|NCT01449370|76177863|FG003|Overall Study|Medication Prohibited by Protocol|0|||
42339920|NCT01449370|76177864|FG004|Overall Study|Medication Prohibited by Protocol|0|||
42339921|NCT01449370|76177865|FG005|Overall Study|Medication Prohibited by Protocol|0|||
42339922|NCT01449370|76177866|FG006|Overall Study|Medication Prohibited by Protocol|0|||
42339923|NCT01449370|76177867|FG007|Overall Study|Medication Prohibited by Protocol|0|||
42339924|NCT01449370|76177868|FG008|Overall Study|Medication Prohibited by Protocol|0|||
42339925|NCT01449370|76177869|FG009|Overall Study|Medication Prohibited by Protocol|0|||
42267343|NCT02834403|76095928|FG002|Overall Study|Adverse Event|0|||
42267344|NCT02834403|76095929|FG003|Overall Study|Adverse Event|0|||
42267345|NCT02834403|76095930|FG004|Overall Study|Adverse Event|1|||
42267346|NCT02834403|76095931|FG005|Overall Study|Adverse Event|1|||
42267347|NCT02834403|76095932|FG006|Overall Study|Adverse Event|3|||
42339926|NCT01449370|76177870|FG010|Overall Study|Medication Prohibited by Protocol|0|||
42339927|NCT01449370|76177871|FG011|Overall Study|Medication Prohibited by Protocol|0|||
42339928|NCT01449370|76177872|FG012|Overall Study|Medication Prohibited by Protocol|0|||
42339929|NCT01449370|76177873|FG013|Overall Study|Medication Prohibited by Protocol|0|||
42267348|NCT02834403|76095926|FG000|Overall Study|Withdrawal by Subject|0|||
42267349|NCT02834403|76095927|FG001|Overall Study|Withdrawal by Subject|1|||
42267350|NCT02834403|76095928|FG002|Overall Study|Withdrawal by Subject|0|||
42267351|NCT02834403|76095929|FG003|Overall Study|Withdrawal by Subject|0|||
42267352|NCT02834403|76095930|FG004|Overall Study|Withdrawal by Subject|1|||
42267353|NCT02834403|76095931|FG005|Overall Study|Withdrawal by Subject|0|||
42267354|NCT02834403|76095932|FG006|Overall Study|Withdrawal by Subject|0|||
42267355|NCT02834403|76095926|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
42267356|NCT02834403|76095927|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
42267357|NCT02834403|76095928|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
42267358|NCT02834403|76095929|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
42267359|NCT02834403|76095930|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
42267360|NCT02834403|76095931|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
42267361|NCT02834403|76095932|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
42339930|NCT01449370|76177874|FG014|Overall Study|Medication Prohibited by Protocol|0|||
42339931|NCT01449370|76177875|FG015|Overall Study|Medication Prohibited by Protocol|0|||
42339932|NCT01449370|76177876|FG016|Overall Study|Medication Prohibited by Protocol|0|||
42339933|NCT01449370|76177877|FG017|Overall Study|Medication Prohibited by Protocol|0|||
42339934|NCT01449370|76177878|FG018|Overall Study|Medication Prohibited by Protocol|0|||
42339935|NCT01449370|76177879|FG019|Overall Study|Medication Prohibited by Protocol|0|||
42339936|NCT01449370|76177880|FG020|Overall Study|Medication Prohibited by Protocol|0|||
42339937|NCT01449370|76177881|FG021|Overall Study|Medication Prohibited by Protocol|0|||
42339938|NCT01449370|76177882|FG022|Overall Study|Medication Prohibited by Protocol|0|||
42339939|NCT01449370|76177883|FG023|Overall Study|Medication Prohibited by Protocol|1|||
42339940|NCT01449370|76177884|FG024|Overall Study|Medication Prohibited by Protocol|0|||
42339941|NCT01449370|76177860|FG000|Overall Study|Death|0|||
42339942|NCT01449370|76177861|FG001|Overall Study|Death|0|||
42339943|NCT01449370|76177862|FG002|Overall Study|Death|0|||
42339944|NCT01449370|76177863|FG003|Overall Study|Death|0|||
42339945|NCT01449370|76177864|FG004|Overall Study|Death|0|||
42339946|NCT01449370|76177865|FG005|Overall Study|Death|0|||
42339947|NCT01449370|76177866|FG006|Overall Study|Death|0|||
42339948|NCT01449370|76177867|FG007|Overall Study|Death|0|||
42339949|NCT01449370|76177868|FG008|Overall Study|Death|0|||
42339950|NCT01449370|76177869|FG009|Overall Study|Death|0|||
42339951|NCT01449370|76177870|FG010|Overall Study|Death|0|||
42339952|NCT01449370|76177871|FG011|Overall Study|Death|0|||
42339953|NCT01449370|76177872|FG012|Overall Study|Death|0|||
42339954|NCT01449370|76177873|FG013|Overall Study|Death|0|||
42339955|NCT01449370|76177874|FG014|Overall Study|Death|0|||
42339956|NCT01449370|76177875|FG015|Overall Study|Death|0|||
42339957|NCT01449370|76177876|FG016|Overall Study|Death|0|||
42339958|NCT01449370|76177877|FG017|Overall Study|Death|0|||
42339959|NCT01449370|76177878|FG018|Overall Study|Death|0|||
42339960|NCT01449370|76177879|FG019|Overall Study|Death|0|||
42135172|NCT00290290|75945920|FG000|Overall Study|Death|3|||
42339961|NCT01449370|76177880|FG020|Overall Study|Death|0|||
42339962|NCT01449370|76177881|FG021|Overall Study|Death|0|||
42339963|NCT01449370|76177882|FG022|Overall Study|Death|0|||
42339964|NCT01449370|76177883|FG023|Overall Study|Death|0|||
42339965|NCT01449370|76177884|FG024|Overall Study|Death|1|||
42339966|NCT02067533|76177959|FG000|Overall Study|Lost to Follow-up|4|||
42339967|NCT02067533|76177960|FG001|Overall Study|Lost to Follow-up|2|||
42339968|NCT02066129|76177968|FG000|Overall Study|Lost to Follow-up|13|||
42339969|NCT02066129|76177969|FG001|Overall Study|Lost to Follow-up|12|||
42339970|NCT02066129|76177968|FG000|Overall Study|Withdrawal by Subject|7|||
42339971|NCT02066129|76177969|FG001|Overall Study|Withdrawal by Subject|10|||
42339972|NCT02066129|76177968|FG000|Overall Study|Lack of Efficacy|8|||
42339973|NCT02066129|76177969|FG001|Overall Study|Lack of Efficacy|10|||
42339974|NCT02066129|76177968|FG000|Overall Study|Physician Decision|1|||
42339975|NCT02066129|76177969|FG001|Overall Study|Physician Decision|1|||
42339976|NCT02066051|76177975|FG000|Overall Study|Subject developed active GVHD|1|||
42339977|NCT01980992|76177981|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
42339978|NCT01980992|76177982|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
42339979|NCT01980992|76177981|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
42339980|NCT01980992|76177982|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
42339981|NCT01980992|76177981|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
42339982|NCT01980992|76177982|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
42339983|NCT01980992|76177981|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
42339984|NCT01980992|76177982|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
42339985|NCT01980992|76177981|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
42035008|NCT01059630|75843290|FG000|Overall Study|Death|100|||
42001886|NCT01342640|75809778|FG000|Overall Study|Other|1|||
42001887|NCT01342484|75809785|FG000|Overall Study|Other Reasons|1|||
42001888|NCT01342484|75809786|FG001|Overall Study|Other Reasons|0|||
42001889|NCT01342484|75809787|FG002|Overall Study|Other Reasons|0|||
42001890|NCT01342484|75809785|FG000|Overall Study|Protocol Violation|0|||
42001891|NCT01342484|75809786|FG001|Overall Study|Protocol Violation|0|||
42001892|NCT01342484|75809787|FG002|Overall Study|Protocol Violation|1|||
42001893|NCT01342484|75809785|FG000|Overall Study|Withdrawal by Subject|1|||
42001894|NCT01342484|75809786|FG001|Overall Study|Withdrawal by Subject|0|||
42001895|NCT01342484|75809787|FG002|Overall Study|Withdrawal by Subject|0|||
42001896|NCT01342445|75809797|FG000|Overall Study|Experienced side effects|0|||
42001897|NCT01342445|75809798|FG001|Overall Study|Experienced side effects|2|||
42001898|NCT01342211|75809813|FG000|Overall Study|Lost to Follow-up|0|||
42001899|NCT01342211|75809814|FG001|Overall Study|Lost to Follow-up|0|||
42001900|NCT01342211|75809815|FG002|Overall Study|Lost to Follow-up|0|||
42135173|NCT00290290|75945921|FG001|Overall Study|Death|4|||
42001901|NCT01342211|75809816|FG003|Overall Study|Lost to Follow-up|1|||
42001902|NCT01342211|75809817|FG004|Overall Study|Lost to Follow-up|0|||
42135174|NCT00290290|75945920|FG000|Overall Study|Withdrawal by Subject|2|||
42135175|NCT00290290|75945921|FG001|Overall Study|Withdrawal by Subject|2|||
42001903|NCT01342211|75809813|FG000|Overall Study|Adverse Event|0|||
42001904|NCT01342211|75809814|FG001|Overall Study|Adverse Event|0|||
42001905|NCT01342211|75809815|FG002|Overall Study|Adverse Event|0|||
42001906|NCT01342211|75809816|FG003|Overall Study|Adverse Event|0|||
42001907|NCT01342211|75809817|FG004|Overall Study|Adverse Event|1|||
42339986|NCT01980992|76177982|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
42339987|NCT01980992|76177981|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
42001908|NCT01342211|75809813|FG000|Overall Study|Withdrawal by Subject|0|||
42339988|NCT01980992|76177982|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
42339989|NCT02065895|76177995|FG000|Overall Study|Protocol Violation|1|||
42339990|NCT02065895|76177996|FG001|Overall Study|Protocol Violation|0|||
42339991|NCT02065895|76177997|FG002|Overall Study|Protocol Violation|0|||
42339992|NCT02065895|76177998|FG003|Overall Study|Protocol Violation|1|||
42339993|NCT02065895|76177999|FG004|Overall Study|Protocol Violation|0|||
42339994|NCT02065895|76178000|FG005|Overall Study|Protocol Violation|0|||
42339995|NCT02065895|76177995|FG000|Overall Study|Scheduling conflicts|0|||
42339996|NCT02065895|76177996|FG001|Overall Study|Scheduling conflicts|1|||
42339997|NCT02065895|76177997|FG002|Overall Study|Scheduling conflicts|0|||
42339998|NCT02065895|76177998|FG003|Overall Study|Scheduling conflicts|0|||
42339999|NCT02065895|76177999|FG004|Overall Study|Scheduling conflicts|0|||
42340000|NCT02065895|76178000|FG005|Overall Study|Scheduling conflicts|0|||
42340001|NCT02106455|76178017|FG000|Overall Study|Case Report Form Uncollected|6|||
42340002|NCT02106455|76178017|FG000|Overall Study|Protocol Deviation|2|||
42340003|NCT02006654|76178023|FG000|Overall Study|Withdrawal before treatment|4|||
42340004|NCT02006654|76178024|FG001|Overall Study|Withdrawal before treatment|2|||
42340005|NCT02006654|76178023|FG000|Overall Study|Adverse Event|16|||
42340006|NCT02006654|76178024|FG001|Overall Study|Adverse Event|17|||
42340007|NCT02006654|76178023|FG000|Overall Study|Death|1|||
42340008|NCT02006654|76178024|FG001|Overall Study|Death|0|||
42340009|NCT02006654|76178023|FG000|Overall Study|Withdrawal by Subject|14|||
42340010|NCT02006654|76178024|FG001|Overall Study|Withdrawal by Subject|12|||
42340011|NCT02006654|76178023|FG000|Overall Study|Protocol Violation|5|||
42340012|NCT02006654|76178024|FG001|Overall Study|Protocol Violation|8|||
42340013|NCT02006654|76178023|FG000|Overall Study|Lost to Follow-up|1|||
42340014|NCT02006654|76178024|FG001|Overall Study|Lost to Follow-up|0|||
42340015|NCT02006654|76178023|FG000|Overall Study|patient's will|2|||
42340016|NCT02006654|76178024|FG001|Overall Study|patient's will|1|||
42340017|NCT02006654|76178023|FG000|Overall Study|insufficient compliance|1|||
42340018|NCT02006654|76178024|FG001|Overall Study|insufficient compliance|0|||
42340019|NCT02006654|76178023|FG000|Overall Study|worsening cognitive condition|0|||
42340020|NCT02006654|76178024|FG001|Overall Study|worsening cognitive condition|1|||
42340021|NCT02006654|76178023|FG000|Overall Study|faecal incontinence|0|||
42001909|NCT01342211|75809814|FG001|Overall Study|Withdrawal by Subject|0|||
42001910|NCT01342211|75809815|FG002|Overall Study|Withdrawal by Subject|0|||
42001911|NCT01342211|75809816|FG003|Overall Study|Withdrawal by Subject|1|||
42001912|NCT01342211|75809817|FG004|Overall Study|Withdrawal by Subject|0|||
42001913|NCT01342211|75809813|FG000|Overall Study|Randomized, but not Treated|0|||
42001914|NCT01342211|75809814|FG001|Overall Study|Randomized, but not Treated|2|||
42001915|NCT01342211|75809815|FG002|Overall Study|Randomized, but not Treated|0|||
42001916|NCT01342211|75809816|FG003|Overall Study|Randomized, but not Treated|0|||
42135176|NCT00290290|75945920|FG000|Overall Study|Underwent clean surgical procedure|13|||
42135177|NCT00290290|75945921|FG001|Overall Study|Underwent clean surgical procedure|12|||
42267404|NCT01966731|76095970|FG000|Overall Study|Death|2|||
42267405|NCT01966731|76095970|FG000|Overall Study|Lost to Follow-up|1|||
42267406|NCT01966731|76095970|FG000|Overall Study|Physician Decision|2|||
42267407|NCT01966731|76095970|FG000|Overall Study|Follow up is not complete|600|||
42267408|NCT01966731|76095970|FG000|Overall Study|Screening Failure|29|||
42267409|NCT01966731|76095970|FG000|Overall Study|Found to be ineligible|1|||
42267410|NCT02788175|76095983|FG000|Overall Study|Protocol Violation|3|||
42267411|NCT02788175|76095983|FG000|Overall Study|Withdrawal by Subject|4|||
42267412|NCT02788175|76095983|FG000|Overall Study|Ineligible prior to study agent|6|||
42340022|NCT02006654|76178024|FG001|Overall Study|faecal incontinence|1|||
42340023|NCT02006654|76178023|FG000|Overall Study|mood disorder|0|||
42340024|NCT02006654|76178024|FG001|Overall Study|mood disorder|1|||
42340025|NCT02006654|76178023|FG000|Overall Study|disallowed medication|1|||
42001917|NCT01342211|75809817|FG004|Overall Study|Randomized, but not Treated|1|||
42001918|NCT01342094|75809835|FG000|Overall Study|Adverse Event|5|||
42267413|NCT02787083|76095989|FG000|Overall Study|Adverse Event|1|||
42267414|NCT02787083|76095990|FG001|Overall Study|Adverse Event|0|||
42340026|NCT02006654|76178024|FG001|Overall Study|disallowed medication|0|||
42340027|NCT02006654|76178023|FG000|Overall Study|moving out of state|0|||
42340028|NCT02006654|76178024|FG001|Overall Study|moving out of state|1|||
42340029|NCT01980056|76178034|FG000|Overall Study|Death|1|||
42340030|NCT01980056|76178035|FG001|Overall Study|Death|1|||
42340031|NCT01980056|76178036|FG002|Overall Study|Death|0|||
42340032|NCT02027558|76178050|FG000|Overall Study|Death|0|||
42340033|NCT02027558|76178051|FG001|Overall Study|Death|1|||
42340034|NCT02027558|76178050|FG000|Overall Study|Withdrawal by Subject|2|||
42340035|NCT02027558|76178051|FG001|Overall Study|Withdrawal by Subject|0|||
42340036|NCT02027558|76178050|FG000|Overall Study|Lost to Follow-up|4|||
42340037|NCT02027558|76178051|FG001|Overall Study|Lost to Follow-up|1|||
42340038|NCT02027558|76178050|FG000|Overall Study|Refused assessment|3|||
42340039|NCT02027558|76178051|FG001|Overall Study|Refused assessment|0|||
42135178|NCT00272038|75945927|FG000|Overall Study|withdrew before they received 2 cycles|7|||
42135179|NCT00271024|75945936|FG000|Overall Study|Lost Interest|3|||
42135180|NCT00271024|75945937|FG001|Overall Study|Lost Interest|4|||
42135181|NCT00271024|75945938|FG002|Overall Study|Lost Interest|2|||
42135182|NCT00271024|75945939|FG003|Overall Study|Lost Interest|3|||
42135183|NCT00271024|75945936|FG000|Overall Study|Unknown/Unspecified|11|||
42135184|NCT00271024|75945937|FG001|Overall Study|Unknown/Unspecified|11|||
42135185|NCT00271024|75945938|FG002|Overall Study|Unknown/Unspecified|8|||
42135186|NCT00271024|75945939|FG003|Overall Study|Unknown/Unspecified|4|||
42135187|NCT00271024|75945936|FG000|Overall Study|Protocol Violation|1|||
42135188|NCT00271024|75945937|FG001|Overall Study|Protocol Violation|6|||
42135189|NCT00271024|75945938|FG002|Overall Study|Protocol Violation|5|||
42135190|NCT00271024|75945939|FG003|Overall Study|Protocol Violation|11|||
42135191|NCT00271024|75945936|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
42001919|NCT01342094|75809836|FG001|Overall Study|Adverse Event|0|||
42001920|NCT01342094|75809835|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
42267415|NCT02787083|76095989|FG000|Overall Study|Withdrawal by Subject|2|||
42267416|NCT02787083|76095990|FG001|Overall Study|Withdrawal by Subject|2|||
42267417|NCT02787863|76096004|FG000|Overall Study|Death|1|||
42267418|NCT02787863|76096005|FG001|Overall Study|Death|0|||
42001921|NCT01342094|75809836|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
42267419|NCT02787863|76096006|FG002|Overall Study|Death|1|||
42267420|NCT02787863|76096007|FG003|Overall Study|Death|0|||
42267421|NCT02787863|76096008|FG004|Overall Study|Death|0|||
42267422|NCT02787863|76096009|FG005|Overall Study|Death|0|||
42267423|NCT02787863|76096010|FG006|Overall Study|Death|0|||
42267424|NCT02787863|76096011|FG007|Overall Study|Death|0|||
42267425|NCT02787863|76096004|FG000|Overall Study|Withdrawal by Subject|0|||
42267426|NCT02787863|76096005|FG001|Overall Study|Withdrawal by Subject|1|||
42267427|NCT02787863|76096006|FG002|Overall Study|Withdrawal by Subject|1|||
42267428|NCT02787863|76096007|FG003|Overall Study|Withdrawal by Subject|0|||
42267429|NCT02787863|76096008|FG004|Overall Study|Withdrawal by Subject|0|||
42267430|NCT02787863|76096009|FG005|Overall Study|Withdrawal by Subject|0|||
42267431|NCT02787863|76096010|FG006|Overall Study|Withdrawal by Subject|0|||
42267432|NCT02787863|76096011|FG007|Overall Study|Withdrawal by Subject|0|||
42267433|NCT02596958|76096052|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
42267434|NCT02596958|76096052|FG000|Overall Study|Cancer Progression|441|||
42267435|NCT02596958|76096052|FG000|Overall Study|Death From Cancer|112|||
42001922|NCT01342094|75809835|FG000|Overall Study|Withdrawal by Subject|0|||
42001923|NCT01342094|75809836|FG001|Overall Study|Withdrawal by Subject|2|||
42135192|NCT00271024|75945937|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
42135193|NCT00271024|75945938|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
42267436|NCT02596958|76096052|FG000|Overall Study|Death From Other Cause|33|||
42267437|NCT02596958|76096052|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
42267438|NCT02596958|76096052|FG000|Overall Study|Administrative Reasons/Other|231|||
42340040|NCT02027402|76178061|FG000|Overall Study|Withdrawal by Subject|4|||
42340041|NCT02027402|76178062|FG001|Overall Study|Withdrawal by Subject|1|||
42001924|NCT01340768|75809844|FG000|Overall Study|Lost to Follow-up|10|||
42001925|NCT01340768|75809845|FG001|Overall Study|Lost to Follow-up|4|||
42340042|NCT01448824|76178078|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
42340043|NCT01448824|76178079|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
42001926|NCT01340768|75809844|FG000|Overall Study|Withdrawal by Subject|5|||
42340044|NCT01448824|76178080|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
42340045|NCT01448824|76178081|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
42340046|NCT01448824|76178082|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
42267439|NCT02596958|76096052|FG000|Overall Study|Lost to Follow-up|33|||
42267440|NCT02596958|76096052|FG000|Overall Study|Missing|32|||
42267441|NCT02596958|76096052|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
42267442|NCT01367249|76096058|FG000|Overall Study|Withdrawal by Subject|6|||
42267443|NCT01367249|76096059|FG001|Overall Study|Withdrawal by Subject|6|||
42267444|NCT01367249|76096058|FG000|Overall Study|Other|3|||
42340047|NCT01448824|76178083|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
42340048|NCT01448824|76178084|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
42340049|NCT01448824|76178085|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
42340050|NCT01448824|76178078|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
42340051|NCT01448824|76178079|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
42340052|NCT01448824|76178080|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
42340053|NCT01448824|76178081|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
42340054|NCT01448824|76178082|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
42340055|NCT01448824|76178083|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
42340056|NCT01448824|76178084|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
42340057|NCT01448824|76178085|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
42340058|NCT01448824|76178078|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
42340059|NCT01448824|76178079|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
42340060|NCT01448824|76178080|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
42340061|NCT01448824|76178081|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
42340062|NCT01448824|76178082|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
42340063|NCT01448824|76178083|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
42340064|NCT01448824|76178084|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
42340065|NCT01448824|76178085|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
42340066|NCT01448824|76178078|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
42340067|NCT01448824|76178079|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
42340068|NCT01448824|76178080|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
42340069|NCT01448824|76178081|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
42340070|NCT01448824|76178082|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
42340071|NCT01448824|76178083|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
42340072|NCT01448824|76178084|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
42340073|NCT01448824|76178085|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
42340074|NCT01448824|76178078|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
42340075|NCT01448824|76178079|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
42340076|NCT01448824|76178080|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
42001927|NCT01340768|75809845|FG001|Overall Study|Withdrawal by Subject|1|||
42267445|NCT01367249|76096059|FG001|Overall Study|Other|10|||
42267446|NCT02786927|76096065|FG000|Overall Study|Adverse Event|1|||
42267447|NCT02786927|76096065|FG000|Overall Study|Protocol Violation|4|||
42267448|NCT02592434|76096070|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
42267449|NCT02592434|76096071|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
42267450|NCT02592434|76096072|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
42001928|NCT01340768|75809844|FG000|Overall Study|Other|2|||
42001929|NCT01340768|75809845|FG001|Overall Study|Other|0|||
42001930|NCT01340651|75809851|FG000|Overall Study|Adverse Event|3|||
42267451|NCT02592434|76096070|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
42001931|NCT01340651|75809851|FG000|Overall Study|Consent Withdrawn|2|||
42001932|NCT01340651|75809851|FG000|Overall Study|Commercial Supply per Sponsor|12|||
42001933|NCT01340495|75809857|FG000|Overall Study|Withdrawal by Subject|1|||
42001934|NCT01340300|75809865|FG000|Overall Study|Lost to Follow-up|3|||
42001935|NCT01340300|75809866|FG001|Overall Study|Lost to Follow-up|0|||
42001936|NCT01340300|75809867|FG002|Overall Study|Lost to Follow-up|5|||
42001937|NCT01340300|75809868|FG003|Overall Study|Lost to Follow-up|10|||
42001938|NCT01340300|75809865|FG000|Overall Study|Withdrawal by Subject|5|||
42001939|NCT01340300|75809866|FG001|Overall Study|Withdrawal by Subject|6|||
42001940|NCT01340300|75809867|FG002|Overall Study|Withdrawal by Subject|6|||
42001941|NCT01340300|75809868|FG003|Overall Study|Withdrawal by Subject|3|||
42001942|NCT01340300|75809865|FG000|Overall Study|Adverse Event|1|||
42001943|NCT01340300|75809866|FG001|Overall Study|Adverse Event|0|||
42001944|NCT01340300|75809867|FG002|Overall Study|Adverse Event|4|||
42001945|NCT01340300|75809868|FG003|Overall Study|Adverse Event|0|||
42001946|NCT01340300|75809865|FG000|Overall Study|Physician Decision|0|||
42001947|NCT01340300|75809866|FG001|Overall Study|Physician Decision|1|||
42001948|NCT01340300|75809867|FG002|Overall Study|Physician Decision|0|||
42001949|NCT01340300|75809868|FG003|Overall Study|Physician Decision|0|||
42001950|NCT01340300|75809865|FG000|Overall Study|Unrelated sickness|0|||
42001951|NCT01340300|75809866|FG001|Overall Study|Unrelated sickness|2|||
42001952|NCT01340300|75809867|FG002|Overall Study|Unrelated sickness|0|||
42001953|NCT01340300|75809868|FG003|Overall Study|Unrelated sickness|1|||
42001954|NCT01340066|75809880|FG000|Placebo Run in Period|Screen Failures|27|||
42001955|NCT01340066|75809881|FG001|Placebo Run in Period|Screen Failures|0|||
42001956|NCT01340066|75809882|FG002|Placebo Run in Period|Screen Failures|0|||
42001957|NCT01340066|75809880|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
42001958|NCT01340066|75809881|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
42001959|NCT01340066|75809882|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
42001960|NCT01340066|75809880|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
42001961|NCT01340066|75809881|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
42001962|NCT01340066|75809882|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
42001963|NCT01340066|75809880|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
42001964|NCT01340066|75809881|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
42001965|NCT01340066|75809882|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
42001966|NCT01107535|75809889|FG000|Overall Study|Death|5|||
42001967|NCT01326546|75809895|FG000|Overall Study|Lost to Follow-up|8|||
42001968|NCT01326546|75809896|FG001|Overall Study|Lost to Follow-up|7|||
42001969|NCT01326546|75809895|FG000|Overall Study|Protocol Violation|3|||
42267452|NCT02592434|76096071|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
42267453|NCT02592434|76096072|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
42267454|NCT02592434|76096070|FG000|Open-Label Phase (18 Weeks)|Other|3|||
42267455|NCT02592434|76096071|FG001|Open-Label Phase (18 Weeks)|Other|0|||
42267456|NCT02592434|76096072|FG002|Open-Label Phase (18 Weeks)|Other|0|||
42267457|NCT02592434|76096070|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
42267458|NCT02592434|76096071|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
42267459|NCT02592434|76096072|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
42267460|NCT02592434|76096070|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
42267461|NCT02592434|76096071|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
42267462|NCT02592434|76096072|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
42267463|NCT02592434|76096070|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
42267464|NCT02592434|76096071|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
42267465|NCT02592434|76096072|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
42267466|NCT02592434|76096070|FG000|Double Blind Phase (26 Weeks)|Other|0|||
42267467|NCT02592434|76096071|FG001|Double Blind Phase (26 Weeks)|Other|1|||
42267468|NCT02592434|76096072|FG002|Double Blind Phase (26 Weeks)|Other|0|||
42001970|NCT01326546|75809896|FG001|Overall Study|Protocol Violation|4|||
42001971|NCT01326546|75809895|FG000|Overall Study|Pregnancy|0|||
42267469|NCT02592434|76096070|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
42267470|NCT02592434|76096071|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
42001972|NCT01326546|75809896|FG001|Overall Study|Pregnancy|1|||
42001973|NCT01326546|75809895|FG000|Overall Study|Adverse Event|1|||
42267471|NCT02592434|76096072|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
42001974|NCT01326546|75809896|FG001|Overall Study|Adverse Event|0|||
42001975|NCT01326546|75809895|FG000|Overall Study|Withdrawal by Subject|5|||
42001976|NCT01326546|75809896|FG001|Overall Study|Withdrawal by Subject|1|||
42001977|NCT01325532|75809904|FG000|Overall Study|Withdrawal by Subject|2|||
42001978|NCT01325532|75809905|FG001|Overall Study|Withdrawal by Subject|0|||
42001979|NCT01171963|75809913|FG000|Overall Study|Adverse Event|10|||
42001980|NCT01171963|75809914|FG001|Overall Study|Adverse Event|15|||
42001981|NCT01171963|75809913|FG000|Overall Study|Lost to Follow-up|23|||
42267472|NCT02592434|76096070|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
42267473|NCT02592434|76096071|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
42267474|NCT02592434|76096072|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
42267475|NCT02592434|76096070|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
42267476|NCT02592434|76096071|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
42267477|NCT02592434|76096072|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
42267478|NCT02785913|76096080|FG000|Overall Study|Adverse Event|5|||
42267479|NCT02785913|76096080|FG000|Overall Study|Death|2|||
42267480|NCT02785913|76096080|FG000|Overall Study|Progression|18|||
42267481|NCT02785913|76096080|FG000|Overall Study|Not protocol specified|1|||
42267482|NCT02590562|76096089|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
42267483|NCT02783729|76096116|FG000|Overall Study|Lack of Efficacy|1|||
42267484|NCT02783729|76096117|FG001|Overall Study|Lack of Efficacy|0|||
42267485|NCT02783729|76096118|FG002|Overall Study|Lack of Efficacy|0|||
42340077|NCT01448824|76178081|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
42001982|NCT01171963|75809914|FG001|Overall Study|Lost to Follow-up|24|||
42001983|NCT01171963|75809913|FG000|Overall Study|Other - diarrhoea|1|||
42001984|NCT01171963|75809914|FG001|Overall Study|Other - diarrhoea|0|||
42001985|NCT01171963|75809913|FG000|Overall Study|Withdrawal by Subject|114|||
42001986|NCT01171963|75809914|FG001|Overall Study|Withdrawal by Subject|129|||
42340078|NCT01448824|76178082|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
42340079|NCT01448824|76178083|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
42340080|NCT01448824|76178084|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
42340081|NCT01448824|76178085|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
42340082|NCT01448824|76178078|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
42340083|NCT01448824|76178079|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
42340084|NCT01448824|76178080|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
42340085|NCT01448824|76178081|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
42340086|NCT01448824|76178082|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
42001987|NCT01171183|75809925|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
42001988|NCT01171183|75809926|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
42001989|NCT01171183|75809925|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
42001990|NCT01171183|75809926|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
42135194|NCT00271024|75945939|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
42135195|NCT00271024|75945936|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
42340087|NCT01448824|76178083|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
42340088|NCT01448824|76178084|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
42340089|NCT01448824|76178085|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
42340090|NCT01448824|76178078|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
42340091|NCT01448824|76178079|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
42340092|NCT01448824|76178080|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
42340093|NCT01448824|76178081|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
42135196|NCT00271024|75945937|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
42135197|NCT00271024|75945938|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
42267486|NCT02783729|76096119|FG003|Overall Study|Lack of Efficacy|0|||
42267487|NCT02783729|76096116|FG000|Overall Study|Adverse Event|2|||
42267488|NCT02783729|76096117|FG001|Overall Study|Adverse Event|6|||
42267489|NCT02783729|76096118|FG002|Overall Study|Adverse Event|2|||
42267490|NCT02783729|76096119|FG003|Overall Study|Adverse Event|3|||
42267491|NCT02783729|76096116|FG000|Overall Study|Other|1|||
42267492|NCT02783729|76096117|FG001|Overall Study|Other|6|||
42340094|NCT01448824|76178082|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
42340095|NCT01448824|76178083|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
42340096|NCT01448824|76178084|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
42267493|NCT02783729|76096118|FG002|Overall Study|Other|2|||
42340097|NCT01448824|76178085|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
42340098|NCT01448824|76178078|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
42135198|NCT00271024|75945939|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
42001991|NCT01171183|75809925|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
42135199|NCT00381693|75945949|FG000|Overall Study|Death|1|||
42340099|NCT01448824|76178079|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
42340100|NCT01448824|76178080|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
42135200|NCT00381693|75945949|FG000|Overall Study|Adverse Event|4|||
42267494|NCT02783729|76096119|FG003|Overall Study|Other|3|||
42267495|NCT02783729|76096116|FG000|Overall Study|Withdrawal by Subject|2|||
42340101|NCT01448824|76178081|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
42001992|NCT01171183|75809926|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
42001993|NCT01171183|75809925|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
42001994|NCT01171183|75809926|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
42001995|NCT01171183|75809925|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
42001996|NCT01171183|75809926|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
42001997|NCT01171183|75809925|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
42001998|NCT01171183|75809926|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
42001999|NCT01170091|75809932|FG000|Overall Study|Missing efficacy evaluation|3|||
42002000|NCT01170091|75809932|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
42002001|NCT01169779|75809938|FG000|Overall Study|Adverse Event|3|||
42002002|NCT01169779|75809939|FG001|Overall Study|Adverse Event|11|||
42002003|NCT01169779|75809938|FG000|Overall Study|Lack of Efficacy|1|||
42002004|NCT01169779|75809939|FG001|Overall Study|Lack of Efficacy|0|||
42002005|NCT01169779|75809938|FG000|Overall Study|Protocol Violation|1|||
42002006|NCT01169779|75809939|FG001|Overall Study|Protocol Violation|1|||
42002007|NCT01169779|75809938|FG000|Overall Study|Withdrawal by Subject|3|||
42340102|NCT01448824|76178082|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
42340103|NCT01448824|76178083|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
42340104|NCT01448824|76178084|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
42340105|NCT01448824|76178085|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
42340106|NCT02005562|76178115|FG000|Overall Study|Death|2|||
42340107|NCT02005562|76178116|FG001|Overall Study|Death|2|||
42340108|NCT02005562|76178115|FG000|Overall Study|Graft loss|7|||
42340109|NCT02005562|76178116|FG001|Overall Study|Graft loss|6|||
42340110|NCT02005562|76178115|FG000|Overall Study|Withdrawal by Subject|2|||
42340111|NCT02005562|76178116|FG001|Overall Study|Withdrawal by Subject|2|||
42340112|NCT02005562|76178115|FG000|Overall Study|No transplant|1|||
42340113|NCT02005562|76178116|FG001|Overall Study|No transplant|4|||
42340114|NCT02005562|76178115|FG000|Overall Study|Physician Decision|0|||
42002008|NCT01169779|75809939|FG001|Overall Study|Withdrawal by Subject|2|||
42340115|NCT02005562|76178116|FG001|Overall Study|Physician Decision|1|||
42340116|NCT01448044|76178124|FG000|Treatment Period|Adverse Event|4|||
42340117|NCT01448044|76178125|FG001|Treatment Period|Adverse Event|3|||
42340118|NCT01448044|76178124|FG000|Treatment Period|Lack of Efficacy|5|||
42340119|NCT01448044|76178125|FG001|Treatment Period|Lack of Efficacy|12|||
42340120|NCT01448044|76178124|FG000|Treatment Period|Subject requested discontinue study drug|1|||
42340121|NCT01448044|76178125|FG001|Treatment Period|Subject requested discontinue study drug|0|||
42035009|NCT01059630|75843291|FG001|Overall Study|Death|84|||
42035010|NCT01059630|75843290|FG000|Overall Study|Lost to Follow-up|4|||
42340122|NCT01448044|76178124|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
42340123|NCT01448044|76178125|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
42340124|NCT01448044|76178124|FG000|Treatment Period|Participant does not meet study criteria|1|||
42340125|NCT01448044|76178125|FG001|Treatment Period|Participant does not meet study criteria|0|||
42340126|NCT01448044|76178124|FG000|Treatment Period|Lost to Follow-up|2|||
42340127|NCT01448044|76178125|FG001|Treatment Period|Lost to Follow-up|1|||
42340128|NCT01448044|76178124|FG000|Treatment Period|Other reason|2|||
42035011|NCT01059630|75843291|FG001|Overall Study|Lost to Follow-up|1|||
42035012|NCT01059630|75843290|FG000|Overall Study|Physician Decision|2|||
42340129|NCT01448044|76178125|FG001|Treatment Period|Other reason|0|||
42340130|NCT01448044|76178124|FG000|Follow Up Period|Withdrawal by Subject|1|||
42340131|NCT01448044|76178125|FG001|Follow Up Period|Withdrawal by Subject|1|||
42340132|NCT01448044|76178124|FG000|Follow Up Period|Lost to Follow-up|6|||
42340133|NCT01448044|76178125|FG001|Follow Up Period|Lost to Follow-up|2|||
42340134|NCT01448044|76178124|FG000|Follow Up Period|Other|5|||
42340135|NCT01448044|76178125|FG001|Follow Up Period|Other|11|||
42340136|NCT02025530|76178133|FG000|Overall Study|No longer met elligibility criteria|5|||
42340137|NCT02025530|76178134|FG001|Overall Study|No longer met elligibility criteria|1|||
42340138|NCT01472380|76178140|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
42002009|NCT01169779|75809938|FG000|Overall Study|Familial and personal reasons|3|||
42035013|NCT01059630|75843291|FG001|Overall Study|Physician Decision|4|||
42035014|NCT01059630|75843290|FG000|Overall Study|Withdrawal by Subject|21|||
42035015|NCT01059630|75843291|FG001|Overall Study|Withdrawal by Subject|14|||
42135201|NCT00381693|75945949|FG000|Overall Study|Patient Choice|1|||
42135202|NCT00381693|75945949|FG000|Overall Study|Progression|2|||
42002010|NCT01169779|75809939|FG001|Overall Study|Familial and personal reasons|3|||
42135203|NCT00545363|75945955|FG000|Overall Study|Adverse Event|6|||
42135204|NCT00545363|75945956|FG001|Overall Study|Adverse Event|7|||
42135205|NCT00545363|75945955|FG000|Overall Study|Withdrawal by Subject|6|||
42002011|NCT01169701|75809947|FG000|Overall Study|Lost to Follow-up|1|||
42002012|NCT01169701|75809948|FG001|Overall Study|Lost to Follow-up|1|||
42002013|NCT01169701|75809947|FG000|Overall Study|Withdrawal by Subject|1|||
42002014|NCT01169701|75809948|FG001|Overall Study|Withdrawal by Subject|3|||
42135206|NCT00545363|75945956|FG001|Overall Study|Withdrawal by Subject|5|||
42135207|NCT00545363|75945955|FG000|Overall Study|Non-compliance|3|||
42135208|NCT00545363|75945956|FG001|Overall Study|Non-compliance|1|||
42267496|NCT02783729|76096117|FG001|Overall Study|Withdrawal by Subject|3|||
42267497|NCT02783729|76096118|FG002|Overall Study|Withdrawal by Subject|1|||
42267498|NCT02783729|76096119|FG003|Overall Study|Withdrawal by Subject|2|||
42267499|NCT02783729|76096116|FG000|Overall Study|Participant's choice|2|||
42267500|NCT02783729|76096117|FG001|Overall Study|Participant's choice|1|||
42267501|NCT02783729|76096118|FG002|Overall Study|Participant's choice|2|||
42267502|NCT02783729|76096119|FG003|Overall Study|Participant's choice|1|||
42267503|NCT02783729|76096116|FG000|Overall Study|Lost to Follow-up|2|||
42267504|NCT02783729|76096117|FG001|Overall Study|Lost to Follow-up|1|||
42267505|NCT02783729|76096118|FG002|Overall Study|Lost to Follow-up|1|||
42267506|NCT02783729|76096119|FG003|Overall Study|Lost to Follow-up|0|||
42267507|NCT02784431|76096158|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
42267508|NCT02784431|76096158|FG000|Overall Study|Early Study Termination|19|||
42267509|NCT02590406|76096164|FG000|Overall Study|Adverse Event|1|||
42267510|NCT02590406|76096165|FG001|Overall Study|Adverse Event|0|||
42267511|NCT02590406|76096164|FG000|Overall Study|Saturometer malfunction|0|||
42135209|NCT00545363|75945955|FG000|Overall Study|Did not meet entry criteria|1|||
42135210|NCT00545363|75945956|FG001|Overall Study|Did not meet entry criteria|1|||
42267512|NCT02590406|76096165|FG001|Overall Study|Saturometer malfunction|1|||
42267513|NCT01359254|76096173|FG000|Overall Study|Death|1|||
42267514|NCT01359254|76096174|FG001|Overall Study|Death|0|||
42002015|NCT01169701|75809947|FG000|Overall Study|Adverse Event|1|||
42340139|NCT01472380|76178140|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
42340140|NCT01978262|76178147|FG000|Overall Study|Withdrawal by Subject|9|||
42340141|NCT01978262|76178147|FG000|Overall Study|Lost to Follow-up|2|||
42340142|NCT01447576|76178152|FG000|Overall Study|Lost to Follow-up|52|||
42340143|NCT01447576|76178152|FG000|Overall Study|Adverse Event|127|||
42340144|NCT01447576|76178152|FG000|Overall Study|Participant met withdrawal criteria|40|||
42340145|NCT01447576|76178152|FG000|Overall Study|Withdrawal by Subject|100|||
42340146|NCT01447576|76178152|FG000|Overall Study|Protocol deviation|83|||
42340147|NCT01447576|76178152|FG000|Overall Study|Lack of Efficacy|68|||
42340148|NCT01447576|76178152|FG000|Overall Study|Physician Decision|6|||
42340149|NCT01447420|76178159|FG000|Overall Study|Adverse Event|2|||
42340150|NCT01447420|76178160|FG001|Overall Study|Adverse Event|4|||
42340151|NCT01447420|76178161|FG002|Overall Study|Adverse Event|2|||
42340152|NCT01447420|76178159|FG000|Overall Study|Protocol Violation|3|||
42340153|NCT01447420|76178160|FG001|Overall Study|Protocol Violation|3|||
42340154|NCT01447420|76178161|FG002|Overall Study|Protocol Violation|0|||
42135211|NCT00545363|75945955|FG000|Overall Study|Lost to Follow-up|2|||
42340155|NCT01447420|76178159|FG000|Overall Study|Withdrawal by Subject|4|||
42340156|NCT01447420|76178160|FG001|Overall Study|Withdrawal by Subject|1|||
42340157|NCT01447420|76178161|FG002|Overall Study|Withdrawal by Subject|0|||
42340158|NCT01447420|76178159|FG000|Overall Study|Lack of Efficacy|1|||
42340159|NCT01447420|76178160|FG001|Overall Study|Lack of Efficacy|19|||
42340160|NCT01447420|76178161|FG002|Overall Study|Lack of Efficacy|8|||
42340161|NCT01446874|76178171|FG000|Overall Study|Not eligible|1|||
42340162|NCT01446874|76178172|FG001|Overall Study|Not eligible|0|||
42340163|NCT01446874|76178173|FG002|Overall Study|Not eligible|0|||
42340164|NCT01446874|76178171|FG000|Overall Study|No surgery/No qualifying surgery|1|||
42340165|NCT01446874|76178172|FG001|Overall Study|No surgery/No qualifying surgery|0|||
42340166|NCT01446874|76178173|FG002|Overall Study|No surgery/No qualifying surgery|12|||
42340167|NCT01446874|76178171|FG000|Overall Study|Non-compliance|0|||
42340168|NCT01446874|76178172|FG001|Overall Study|Non-compliance|4|||
42340169|NCT01446874|76178173|FG002|Overall Study|Non-compliance|0|||
42340170|NCT01446874|76178171|FG000|Overall Study|Antibiotics for pre-op infection|0|||
42002016|NCT01169701|75809948|FG001|Overall Study|Adverse Event|2|||
42135212|NCT00545363|75945956|FG001|Overall Study|Lost to Follow-up|0|||
42135213|NCT00545363|75945955|FG000|Overall Study|Other|1|||
42267515|NCT01667432|76096180|FG000|Overall Study|Premature Study Termination|26|||
42267516|NCT01667432|76096180|FG000|Overall Study|Failure to Return|10|||
42267517|NCT01667432|76096180|FG000|Overall Study|Moved to Another Center|3|||
42267518|NCT01667432|76096180|FG000|Overall Study|Lost to Follow-up|3|||
42267519|NCT01667432|76096180|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
42267520|NCT01667432|76096180|FG000|Overall Study|Insufficient Therapeutic Response|4|||
42267521|NCT01667432|76096180|FG000|Overall Study|Adverse Event|1|||
42267522|NCT01667432|76096180|FG000|Overall Study|Protocol Deviation|2|||
42267523|NCT01667432|76096180|FG000|Overall Study|Principal Investigator Decision|1|||
42267524|NCT01667432|76096180|FG000|Overall Study|Reason Not Specified|2|||
42267525|NCT01667432|76096180|FG000|Overall Study|Missing Information|4|||
42340171|NCT01446874|76178172|FG001|Overall Study|Antibiotics for pre-op infection|0|||
42340172|NCT01446874|76178173|FG002|Overall Study|Antibiotics for pre-op infection|2|||
42340173|NCT01446874|76178171|FG000|Overall Study|Withdrawal by Subject|0|||
42340174|NCT01446874|76178172|FG001|Overall Study|Withdrawal by Subject|0|||
42340175|NCT01446874|76178173|FG002|Overall Study|Withdrawal by Subject|4|||
42340176|NCT01446796|76178181|FG000|Overall Study|Withdrawal by Subject|1|||
42340177|NCT01446796|76178182|FG001|Overall Study|Withdrawal by Subject|0|||
42340178|NCT01439074|76178192|FG000|Overall Study|Lost to Follow-up|3|||
42340179|NCT01439074|76178193|FG001|Overall Study|Lost to Follow-up|4|||
42340180|NCT01439074|76178192|FG000|Overall Study|Subject shedding|1|||
42002017|NCT01169701|75809947|FG000|Overall Study|Exclusion criteria|2|||
42135214|NCT00545363|75945956|FG001|Overall Study|Other|1|||
42267526|NCT01563107|76096188|FG000|Overall Study|Physician Decision|0|||
42267527|NCT01563107|76096189|FG001|Overall Study|Physician Decision|1|||
42002018|NCT01169701|75809948|FG001|Overall Study|Exclusion criteria|0|||
42002019|NCT01169701|75809947|FG000|Overall Study|Death|0|||
42002020|NCT01169701|75809948|FG001|Overall Study|Death|1|||
42002021|NCT01169701|75809947|FG000|Overall Study|Administrative problems|0|||
42002022|NCT01169701|75809948|FG001|Overall Study|Administrative problems|1|||
42002023|NCT01169701|75809947|FG000|Overall Study|Serious adverse event|0|||
42002024|NCT01169701|75809948|FG001|Overall Study|Serious adverse event|1|||
42002025|NCT01169701|75809947|FG000|Overall Study|Sponsor decision|0|||
42340181|NCT01439074|76178193|FG001|Overall Study|Subject shedding|0|||
42340182|NCT01439074|76178192|FG000|Overall Study|Withdrawal by Subject|1|||
42340183|NCT01439074|76178193|FG001|Overall Study|Withdrawal by Subject|5|||
42340184|NCT01439074|76178192|FG000|Overall Study|Other|4|||
42135215|NCT00457392|75945964|FG000|Overall Study|Objective Progression or Relapse|229|||
42135216|NCT00457392|75945965|FG001|Overall Study|Objective Progression or Relapse|296|||
42135217|NCT00457392|75945964|FG000|Overall Study|Death|106|||
42135218|NCT00457392|75945965|FG001|Overall Study|Death|106|||
42002026|NCT01169701|75809948|FG001|Overall Study|Sponsor decision|1|||
42002027|NCT01168999|75809958|FG000|Overall Study|Lost to Follow-up|2|||
42002028|NCT01168999|75809959|FG001|Overall Study|Lost to Follow-up|1|||
42002029|NCT01168999|75809960|FG002|Overall Study|Lost to Follow-up|0|||
42002030|NCT01168999|75809961|FG003|Overall Study|Lost to Follow-up|0|||
42002031|NCT01167907|75809973|FG000|Overall Study|Protocol Violation|1|||
42002032|NCT01167907|75809974|FG001|Overall Study|Protocol Violation|0|||
42002033|NCT01167907|75809973|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
42002034|NCT01167907|75809974|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
42002035|NCT01166659|75809980|FG000|Overall Study|Subject Decision|8|||
42002036|NCT01166659|75809980|FG000|Overall Study|Investigator Decision|2|||
42002037|NCT01166659|75809980|FG000|Overall Study|Death|1|||
42002038|NCT01166659|75809980|FG000|Overall Study|Lost to Follow-up|1|||
42002039|NCT01166659|75809980|FG000|Overall Study|Study Closed at Site|1|||
42002040|NCT01115491|75809985|FG000|Overall Study|Death|22|||
42002041|NCT01115491|75809985|FG000|Overall Study|Adverse Event|3|||
42002042|NCT01115491|75809985|FG000|Overall Study|Lost to Follow-up|3|||
42002043|NCT01115491|75809985|FG000|Overall Study|Withdrawal by Subject|1|||
42002044|NCT01115491|75809985|FG000|Overall Study|Physician Decision|1|||
42002045|NCT01113931|75809991|FG000|Overall Study|Adverse Event|2|||
42267528|NCT01563107|76096190|FG002|Overall Study|Physician Decision|1|||
42267529|NCT01563107|76096191|FG003|Overall Study|Physician Decision|3|||
42267530|NCT01563107|76096188|FG000|Overall Study|Withdrawal by Subject|1|||
42267531|NCT01563107|76096189|FG001|Overall Study|Withdrawal by Subject|2|||
42267532|NCT01563107|76096190|FG002|Overall Study|Withdrawal by Subject|1|||
42267533|NCT01563107|76096191|FG003|Overall Study|Withdrawal by Subject|2|||
42267534|NCT02589626|76096253|FG000|Overall Study|Other than the reason specified|1|||
42267535|NCT02589626|76096254|FG001|Overall Study|Other than the reason specified|0|||
42267536|NCT02589626|76096253|FG000|Overall Study|Withdrawal by Subject|1|||
42267537|NCT02589626|76096254|FG001|Overall Study|Withdrawal by Subject|1|||
42267538|NCT02589626|76096253|FG000|Overall Study|Adverse Event|1|||
42267539|NCT02589626|76096254|FG001|Overall Study|Adverse Event|1|||
42267540|NCT01666730|76096269|FG000|Overall Study|Adverse Event|16|||
42267541|NCT01666730|76096269|FG000|Overall Study|Death|2|||
42267542|NCT01666730|76096269|FG000|Overall Study|Physician Decision|5|||
42267543|NCT01666730|76096269|FG000|Overall Study|Withdrawal by Subject|9|||
42267544|NCT01666730|76096269|FG000|Overall Study|Disease progression/relapse|18|||
42267545|NCT00103285|76096282|FG000|Induction|Adverse Event|14|||
42267546|NCT00103285|76096283|FG001|Induction|Adverse Event|0|||
42267547|NCT00103285|76096284|FG002|Induction|Adverse Event|0|||
42267548|NCT00103285|76096285|FG003|Induction|Adverse Event|0|||
42267549|NCT00103285|76096286|FG004|Induction|Adverse Event|0|||
42267550|NCT00103285|76096287|FG005|Induction|Adverse Event|0|||
42267551|NCT00103285|76096288|FG006|Induction|Adverse Event|0|||
42267552|NCT00103285|76096289|FG007|Induction|Adverse Event|0|||
42267553|NCT00103285|76096282|FG000|Induction|Death|24|||
42267554|NCT00103285|76096283|FG001|Induction|Death|0|||
42135219|NCT00457392|75945964|FG000|Overall Study|Adverse Event|84|||
42267555|NCT00103285|76096284|FG002|Induction|Death|0|||
42002046|NCT01113931|75809992|FG001|Overall Study|Adverse Event|2|||
42002047|NCT01113931|75809991|FG000|Overall Study|Physician Decision|0|||
42135220|NCT00457392|75945965|FG001|Overall Study|Adverse Event|41|||
42267556|NCT00103285|76096285|FG003|Induction|Death|0|||
42267557|NCT00103285|76096286|FG004|Induction|Death|0|||
42267558|NCT00103285|76096287|FG005|Induction|Death|0|||
42267559|NCT00103285|76096288|FG006|Induction|Death|0|||
42002048|NCT01113931|75809992|FG001|Overall Study|Physician Decision|2|||
42002049|NCT01113931|75809991|FG000|Overall Study|Lost to Follow-up|12|||
42002050|NCT01113931|75809992|FG001|Overall Study|Lost to Follow-up|9|||
42002051|NCT01113931|75809991|FG000|Overall Study|Various|2|||
42002052|NCT01113931|75809992|FG001|Overall Study|Various|4|||
42267560|NCT00103285|76096289|FG007|Induction|Death|0|||
42267561|NCT00103285|76096282|FG000|Induction|Physician Decision|103|||
42267562|NCT00103285|76096283|FG001|Induction|Physician Decision|0|||
42267563|NCT00103285|76096284|FG002|Induction|Physician Decision|0|||
42267564|NCT00103285|76096285|FG003|Induction|Physician Decision|0|||
42267565|NCT00103285|76096286|FG004|Induction|Physician Decision|0|||
42267566|NCT00103285|76096287|FG005|Induction|Physician Decision|0|||
42267567|NCT00103285|76096288|FG006|Induction|Physician Decision|0|||
42267568|NCT00103285|76096289|FG007|Induction|Physician Decision|0|||
42267569|NCT00103285|76096282|FG000|Induction|Withdrawal by Subject|1|||
42267570|NCT00103285|76096283|FG001|Induction|Withdrawal by Subject|0|||
42267571|NCT00103285|76096284|FG002|Induction|Withdrawal by Subject|0|||
42267572|NCT00103285|76096285|FG003|Induction|Withdrawal by Subject|0|||
42340185|NCT01439074|76178193|FG001|Overall Study|Other|4|||
42340186|NCT01438996|76178202|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
42340187|NCT01438996|76178203|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
42340188|NCT01438996|76178204|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
42002053|NCT01113931|75809991|FG000|Overall Study|Withdrawal by Subject|3|||
42002054|NCT01113931|75809992|FG001|Overall Study|Withdrawal by Subject|0|||
42002055|NCT01107379|75809998|FG000|Overall Study|Withdrawal by Subject|18|||
42002056|NCT01107379|75809998|FG000|Overall Study|Lost to Follow-up|3|||
42002057|NCT01106911|75810002|FG000|Overall Study|Physician Decision|2|||
42002058|NCT01106911|75810002|FG000|Overall Study|deemed ineligible after screening|3|||
42002059|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
42002060|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
42002061|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
42002062|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
42002063|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Death|0|||
42002064|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Death|0|||
42002065|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Death|1|||
42002066|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Death|0|||
42002067|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
42002068|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
42002069|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
42002070|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
42002071|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
42002072|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
42002073|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
42002074|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
42002075|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
42002076|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
42002077|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
42002078|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
42002079|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
42002080|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
42002081|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
42002082|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
42002083|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
42002084|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
42002085|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
42002086|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
42002087|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
42002088|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
42002089|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
42002090|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
42002091|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
42002092|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
42002093|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
42002094|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
42002095|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
42002096|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
42002097|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
42267573|NCT00103285|76096286|FG004|Induction|Withdrawal by Subject|0|||
42267574|NCT00103285|76096287|FG005|Induction|Withdrawal by Subject|0|||
42340189|NCT01438840|76178214|FG000|Core Study|Adverse Event|0|||
42340190|NCT01438840|76178215|FG001|Core Study|Adverse Event|3|||
42340191|NCT01438840|76178216|FG002|Core Study|Adverse Event|0|||
42340192|NCT01438840|76178214|FG000|Core Study|Lack of Efficacy|15|||
42035016|NCT00932373|75843308|FG000|Overall Study|Progressive disease|3|||
42035017|NCT00932373|75843309|FG001|Overall Study|Progressive disease|1|||
42267575|NCT00103285|76096288|FG006|Induction|Withdrawal by Subject|0|||
42267576|NCT00103285|76096289|FG007|Induction|Withdrawal by Subject|0|||
42267577|NCT00103285|76096282|FG000|Induction|Ineligible|43|||
42267578|NCT00103285|76096283|FG001|Induction|Ineligible|0|||
42267579|NCT00103285|76096284|FG002|Induction|Ineligible|0|||
42267580|NCT00103285|76096285|FG003|Induction|Ineligible|0|||
42267581|NCT00103285|76096286|FG004|Induction|Ineligible|0|||
42267582|NCT00103285|76096287|FG005|Induction|Ineligible|0|||
42267583|NCT00103285|76096288|FG006|Induction|Ineligible|0|||
42267584|NCT00103285|76096289|FG007|Induction|Ineligible|0|||
42267585|NCT00103285|76096282|FG000|Induction|Refusal|906|||
42267586|NCT00103285|76096283|FG001|Induction|Refusal|0|||
42267587|NCT00103285|76096284|FG002|Induction|Refusal|0|||
42267588|NCT00103285|76096285|FG003|Induction|Refusal|0|||
42267589|NCT00103285|76096286|FG004|Induction|Refusal|0|||
42267590|NCT00103285|76096287|FG005|Induction|Refusal|0|||
42267591|NCT00103285|76096288|FG006|Induction|Refusal|0|||
42267592|NCT00103285|76096289|FG007|Induction|Refusal|0|||
42267593|NCT00103285|76096282|FG000|Induction|Other|258|||
42002098|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
42002099|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
42002100|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
42002101|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
42002102|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
42002103|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Other|8|||
42002104|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Other|14|||
42002105|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Other|8|||
42002106|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Other|23|||
42002107|NCT01106677|75810010|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
42267594|NCT00103285|76096283|FG001|Induction|Other|0|||
42267595|NCT00103285|76096284|FG002|Induction|Other|0|||
42267596|NCT00103285|76096285|FG003|Induction|Other|0|||
42267597|NCT00103285|76096286|FG004|Induction|Other|0|||
42267598|NCT00103285|76096287|FG005|Induction|Other|0|||
42267599|NCT00103285|76096288|FG006|Induction|Other|0|||
42267600|NCT00103285|76096289|FG007|Induction|Other|0|||
42267601|NCT00103285|76096282|FG000|Response Assignment|Adverse Event|0|||
42267602|NCT00103285|76096283|FG001|Response Assignment|Adverse Event|8|||
42267603|NCT00103285|76096284|FG002|Response Assignment|Adverse Event|3|||
42267604|NCT00103285|76096285|FG003|Response Assignment|Adverse Event|2|||
42267605|NCT00103285|76096286|FG004|Response Assignment|Adverse Event|3|||
42267606|NCT00103285|76096287|FG005|Response Assignment|Adverse Event|1|||
42267607|NCT00103285|76096288|FG006|Response Assignment|Adverse Event|1|||
42267608|NCT00103285|76096289|FG007|Response Assignment|Adverse Event|2|||
42267609|NCT00103285|76096282|FG000|Response Assignment|Death|0|||
42267610|NCT00103285|76096283|FG001|Response Assignment|Death|5|||
42267611|NCT00103285|76096284|FG002|Response Assignment|Death|2|||
42267612|NCT00103285|76096285|FG003|Response Assignment|Death|2|||
42267613|NCT00103285|76096286|FG004|Response Assignment|Death|3|||
42267614|NCT00103285|76096287|FG005|Response Assignment|Death|1|||
42267615|NCT00103285|76096288|FG006|Response Assignment|Death|0|||
42267616|NCT00103285|76096289|FG007|Response Assignment|Death|8|||
42267617|NCT00103285|76096282|FG000|Response Assignment|Lost to Follow-up|0|||
42267618|NCT00103285|76096283|FG001|Response Assignment|Lost to Follow-up|9|||
42267619|NCT00103285|76096284|FG002|Response Assignment|Lost to Follow-up|5|||
42267620|NCT00103285|76096285|FG003|Response Assignment|Lost to Follow-up|5|||
42267621|NCT00103285|76096286|FG004|Response Assignment|Lost to Follow-up|1|||
42267622|NCT00103285|76096287|FG005|Response Assignment|Lost to Follow-up|2|||
42267623|NCT00103285|76096288|FG006|Response Assignment|Lost to Follow-up|2|||
42267624|NCT00103285|76096289|FG007|Response Assignment|Lost to Follow-up|5|||
42267625|NCT00103285|76096282|FG000|Response Assignment|Physician Decision|0|||
42267626|NCT00103285|76096283|FG001|Response Assignment|Physician Decision|13|||
42267627|NCT00103285|76096284|FG002|Response Assignment|Physician Decision|14|||
42267628|NCT00103285|76096285|FG003|Response Assignment|Physician Decision|9|||
42267629|NCT00103285|76096286|FG004|Response Assignment|Physician Decision|13|||
42267630|NCT00103285|76096287|FG005|Response Assignment|Physician Decision|7|||
42267631|NCT00103285|76096288|FG006|Response Assignment|Physician Decision|4|||
42267632|NCT00103285|76096289|FG007|Response Assignment|Physician Decision|35|||
42267633|NCT00103285|76096282|FG000|Response Assignment|Protocol Violation|0|||
42267634|NCT00103285|76096283|FG001|Response Assignment|Protocol Violation|2|||
42267635|NCT00103285|76096284|FG002|Response Assignment|Protocol Violation|0|||
42267636|NCT00103285|76096285|FG003|Response Assignment|Protocol Violation|0|||
42267637|NCT00103285|76096286|FG004|Response Assignment|Protocol Violation|0|||
42267638|NCT00103285|76096287|FG005|Response Assignment|Protocol Violation|0|||
42340193|NCT01438840|76178215|FG001|Core Study|Lack of Efficacy|7|||
42340194|NCT01438840|76178216|FG002|Core Study|Lack of Efficacy|0|||
42340195|NCT01438840|76178214|FG000|Core Study|Withdrawal of consent|1|||
42340196|NCT01438840|76178215|FG001|Core Study|Withdrawal of consent|0|||
42340197|NCT01438840|76178216|FG002|Core Study|Withdrawal of consent|0|||
42340198|NCT01438840|76178214|FG000|Extension Phase|Adverse Event|0|||
42340199|NCT01438840|76178215|FG001|Extension Phase|Adverse Event|0|||
42340200|NCT01438840|76178216|FG002|Extension Phase|Adverse Event|3|||
42340201|NCT01438840|76178214|FG000|Extension Phase|Lost to Follow-up|0|||
42340202|NCT01438840|76178215|FG001|Extension Phase|Lost to Follow-up|0|||
42135221|NCT00457392|75945964|FG000|Overall Study|Global Deterioration of Health Status|22|||
42135222|NCT00457392|75945965|FG001|Overall Study|Global Deterioration of Health Status|8|||
42135223|NCT00457392|75945964|FG000|Overall Study|Withdrawal by Subject|14|||
42135224|NCT00457392|75945965|FG001|Overall Study|Withdrawal by Subject|8|||
42135225|NCT00457392|75945964|FG000|Overall Study|Lost to Follow-up|6|||
42002108|NCT01106677|75810011|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
42002109|NCT01106677|75810012|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
42002110|NCT01106677|75810013|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
42002111|NCT01106677|75810010|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
42002112|NCT01106677|75810011|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
42002113|NCT01106677|75810012|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
42340203|NCT01438840|76178216|FG002|Extension Phase|Lost to Follow-up|1|||
42340204|NCT01438840|76178214|FG000|Extension Phase|Withdrawal by Subject|0|||
42340205|NCT01438840|76178215|FG001|Extension Phase|Withdrawal by Subject|0|||
42340206|NCT01438840|76178216|FG002|Extension Phase|Withdrawal by Subject|3|||
42340207|NCT01438840|76178214|FG000|Extension Phase|Lack of Efficacy|0|||
42340208|NCT01438840|76178215|FG001|Extension Phase|Lack of Efficacy|0|||
42340209|NCT01438840|76178216|FG002|Extension Phase|Lack of Efficacy|2|||
42340210|NCT01438840|76178214|FG000|Extension Phase|Other|0|||
42340211|NCT01438840|76178215|FG001|Extension Phase|Other|0|||
42340212|NCT01438840|76178216|FG002|Extension Phase|Other|1|||
42340213|NCT01471054|76178225|FG000|Overall Study|Study terminated prematurely|4|||
42340214|NCT01471054|76178226|FG001|Overall Study|Study terminated prematurely|0|||
42340215|NCT01978184|76178244|FG000|Overall Study|Progressive disease|5|||
42340216|NCT01978184|76178245|FG001|Overall Study|Progressive disease|5|||
42340217|NCT01978184|76178244|FG000|Overall Study|Other than PDA|2|||
42340218|NCT01978184|76178245|FG001|Overall Study|Other than PDA|2|||
42340219|NCT01978184|76178244|FG000|Overall Study|Physician Decision|0|||
42340220|NCT01978184|76178245|FG001|Overall Study|Physician Decision|3|||
42340221|NCT01978184|76178244|FG000|Overall Study|Noncompliance|1|||
42340222|NCT01978184|76178245|FG001|Overall Study|Noncompliance|2|||
42340223|NCT01978184|76178244|FG000|Overall Study|Death|1|||
42340224|NCT01978184|76178245|FG001|Overall Study|Death|0|||
42340225|NCT01978184|76178244|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
42340226|NCT01978184|76178245|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
42340227|NCT01445548|76178251|FG000|Overall Study|Adverse Event|1|||
42340228|NCT01977794|76178257|FG000|Overall Study|Adverse Event|2|||
42002114|NCT01106677|75810013|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
42002115|NCT01106677|75810010|FG000|Extension Period: Week 26 to Week 52|Death|0|||
42002116|NCT01106677|75810011|FG001|Extension Period: Week 26 to Week 52|Death|0|||
42340229|NCT01977794|76178258|FG001|Overall Study|Adverse Event|2|||
42340230|NCT01977794|76178257|FG000|Overall Study|Lost to Follow-up|2|||
42340231|NCT01977794|76178258|FG001|Overall Study|Lost to Follow-up|1|||
42340232|NCT01977794|76178257|FG000|Overall Study|Protocol Violation|1|||
42135226|NCT00457392|75945965|FG001|Overall Study|Lost to Follow-up|7|||
42340233|NCT01977794|76178258|FG001|Overall Study|Protocol Violation|0|||
42340234|NCT01977794|76178257|FG000|Overall Study|Death|1|||
42340235|NCT01977794|76178258|FG001|Overall Study|Death|1|||
42340236|NCT01977794|76178257|FG000|Overall Study|Withdrew consent|2|||
42340237|NCT01977794|76178258|FG001|Overall Study|Withdrew consent|1|||
42002117|NCT01106677|75810012|FG002|Extension Period: Week 26 to Week 52|Death|0|||
42340238|NCT01977794|76178257|FG000|Overall Study|Other|0|||
42340239|NCT01977794|76178258|FG001|Overall Study|Other|1|||
42340240|NCT02005484|76178264|FG000|Overall Study|Death|1|||
42340241|NCT02005484|76178264|FG000|Overall Study|Disease progression|1|||
42340242|NCT02005484|76178264|FG000|Overall Study|Changed to a Different Study|1|||
42340243|NCT02005484|76178264|FG000|Overall Study|Sponsor decision|1|||
42340244|NCT02005250|76178270|FG000|Overall Study|Lost to Follow-up|15|||
42340245|NCT02005250|76178271|FG001|Overall Study|Lost to Follow-up|5|||
42340246|NCT02024750|76178279|FG000|Overall Study|Withdrawal by Subject|2|||
42340247|NCT02024750|76178280|FG001|Overall Study|Withdrawal by Subject|1|||
42340248|NCT01597973|76178288|FG000|Overall Study|Found ineligible before study medication started|4|||
42340249|NCT01597973|76178289|FG001|Overall Study|Found ineligible before study medication started|2|||
42340250|NCT01597973|76178288|FG000|Overall Study|Eligible pathogen not confirmed|14|||
42340251|NCT01597973|76178289|FG001|Overall Study|Eligible pathogen not confirmed|15|||
42340252|NCT01597973|76178288|FG000|Overall Study|LAR not authorized to consent|0|||
42340253|NCT01597973|76178289|FG001|Overall Study|LAR not authorized to consent|1|||
42340254|NCT01597973|76178288|FG000|Overall Study|Ineligible due to early seizures|1|||
42002118|NCT01106677|75810013|FG003|Extension Period: Week 26 to Week 52|Death|1|||
42002119|NCT01106677|75810010|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
42340255|NCT01597973|76178289|FG001|Overall Study|Ineligible due to early seizures|0|||
42340256|NCT01597973|76178288|FG000|Overall Study|Ineligible due to non-target infection|1|||
42340257|NCT01597973|76178289|FG001|Overall Study|Ineligible due to non-target infection|1|||
42340258|NCT02023268|76178299|FG000|Overall Study|Lack of Efficacy|0|||
42340259|NCT02023268|76178300|FG001|Overall Study|Lack of Efficacy|1|||
42340260|NCT02023268|76178299|FG000|Overall Study|Adverse Event|0|||
42340261|NCT02023268|76178300|FG001|Overall Study|Adverse Event|2|||
42340262|NCT02023268|76178299|FG000|Overall Study|Withdrawal by Subject|0|||
42340263|NCT02023268|76178300|FG001|Overall Study|Withdrawal by Subject|1|||
42340264|NCT02047253|76178306|FG000|Overall Study|Lost to Follow-up|8|||
42340265|NCT02096705|76178312|FG000|Treatment|Adverse Event|6|||
42340266|NCT02096705|76178313|FG001|Treatment|Adverse Event|3|||
42002120|NCT01106677|75810011|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
42002121|NCT01106677|75810012|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
42002122|NCT01106677|75810013|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
42002123|NCT01106677|75810010|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
42002124|NCT01106677|75810011|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
42002125|NCT01106677|75810012|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
42002126|NCT01106677|75810013|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
42002127|NCT01106677|75810010|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
42002128|NCT01106677|75810011|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
42002129|NCT01106677|75810012|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
42002130|NCT01106677|75810013|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
42002131|NCT01106677|75810010|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
42002132|NCT01106677|75810011|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
42002133|NCT01106677|75810012|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
42002134|NCT01106677|75810013|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
42002135|NCT01106677|75810010|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
42340267|NCT02096705|76178312|FG000|Treatment|Subject request to discontinue treatment|1|||
42340268|NCT02096705|76178313|FG001|Treatment|Subject request to discontinue treatment|1|||
42340269|NCT02096705|76178312|FG000|Treatment|Withdrawal by Subject|1|||
42340270|NCT02096705|76178313|FG001|Treatment|Withdrawal by Subject|0|||
42340271|NCT02096705|76178312|FG000|Treatment|Other|1|||
42340272|NCT02096705|76178313|FG001|Treatment|Other|1|||
42340273|NCT02096705|76178312|FG000|Follow-up|Withdrawal by Subject|1|||
42340274|NCT02096705|76178313|FG001|Follow-up|Withdrawal by Subject|0|||
42340275|NCT02096705|76178312|FG000|Follow-up|Adverse Event|2|||
42340276|NCT02096705|76178313|FG001|Follow-up|Adverse Event|2|||
42340277|NCT02096705|76178312|FG000|Follow-up|Subjects not reporting status|1|||
42340278|NCT02096705|76178313|FG001|Follow-up|Subjects not reporting status|2|||
42340279|NCT02096471|76178319|FG000|Overall Study|Adverse Event|1|||
42340280|NCT02096471|76178319|FG000|Overall Study|Lack of Efficacy|7|||
42340281|NCT02096471|76178319|FG000|Overall Study|Withdrawal by Subject|3|||
42340282|NCT02096471|76178319|FG000|Overall Study|Non-Compliant|2|||
42340283|NCT02096003|76178325|FG000|Overall Study|Protocol Violation|0|||
42340284|NCT02096003|76178326|FG001|Overall Study|Protocol Violation|2|||
42002136|NCT01106677|75810011|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
42002137|NCT01106677|75810012|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
42002138|NCT01106677|75810013|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
42002139|NCT01106677|75810010|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
42267639|NCT00103285|76096288|FG006|Response Assignment|Protocol Violation|0|||
42340285|NCT02096003|76178325|FG000|Overall Study|additional surgery|2|||
42340286|NCT02096003|76178326|FG001|Overall Study|additional surgery|1|||
42340287|NCT02062385|76178336|FG000|Overall Study|Adverse Event|19|||
42340288|NCT02062385|76178337|FG001|Overall Study|Adverse Event|13|||
42340289|NCT02062385|76178338|FG002|Overall Study|Adverse Event|1|||
42340290|NCT02062385|76178339|FG003|Overall Study|Adverse Event|0|||
42340291|NCT02062385|76178336|FG000|Overall Study|Protocol Violation|1|||
42340292|NCT02062385|76178337|FG001|Overall Study|Protocol Violation|0|||
42340293|NCT02062385|76178338|FG002|Overall Study|Protocol Violation|0|||
42340294|NCT02062385|76178339|FG003|Overall Study|Protocol Violation|0|||
42340295|NCT02062385|76178336|FG000|Overall Study|Incomplete EPI by database lock|2|||
42340296|NCT02062385|76178337|FG001|Overall Study|Incomplete EPI by database lock|0|||
42340297|NCT02062385|76178338|FG002|Overall Study|Incomplete EPI by database lock|0|||
42340298|NCT02062385|76178339|FG003|Overall Study|Incomplete EPI by database lock|0|||
42002140|NCT01106677|75810011|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
42002141|NCT01106677|75810012|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
42010572|NCT00993421|75817695|FG001|Overall Study|Withdrawal by Subject|2|||
42267640|NCT00103285|76096289|FG007|Response Assignment|Protocol Violation|0|||
42267641|NCT00103285|76096282|FG000|Response Assignment|Withdrawal by Subject|0|||
42267642|NCT00103285|76096283|FG001|Response Assignment|Withdrawal by Subject|4|||
42267643|NCT00103285|76096284|FG002|Response Assignment|Withdrawal by Subject|1|||
42267644|NCT00103285|76096285|FG003|Response Assignment|Withdrawal by Subject|1|||
42267645|NCT00103285|76096286|FG004|Response Assignment|Withdrawal by Subject|2|||
42267646|NCT00103285|76096287|FG005|Response Assignment|Withdrawal by Subject|2|||
42267647|NCT00103285|76096288|FG006|Response Assignment|Withdrawal by Subject|0|||
42267648|NCT00103285|76096289|FG007|Response Assignment|Withdrawal by Subject|2|||
42267649|NCT00103285|76096282|FG000|Response Assignment|Ineligible|0|||
42267650|NCT00103285|76096283|FG001|Response Assignment|Ineligible|8|||
42267651|NCT00103285|76096284|FG002|Response Assignment|Ineligible|6|||
42267652|NCT00103285|76096285|FG003|Response Assignment|Ineligible|2|||
42267653|NCT00103285|76096286|FG004|Response Assignment|Ineligible|0|||
42267654|NCT00103285|76096287|FG005|Response Assignment|Ineligible|3|||
42267655|NCT00103285|76096288|FG006|Response Assignment|Ineligible|1|||
42267656|NCT00103285|76096289|FG007|Response Assignment|Ineligible|5|||
42267657|NCT00103285|76096282|FG000|Response Assignment|Refusal|0|||
42340299|NCT02062385|76178336|FG000|Overall Study|Moved|10|||
42340300|NCT02062385|76178337|FG001|Overall Study|Moved|11|||
42340301|NCT02062385|76178338|FG002|Overall Study|Moved|1|||
42267658|NCT00103285|76096283|FG001|Response Assignment|Refusal|53|||
42340302|NCT02062385|76178339|FG003|Overall Study|Moved|0|||
42340303|NCT02062385|76178336|FG000|Overall Study|Withdrawn by parent/guardian|46|||
42340304|NCT02062385|76178337|FG001|Overall Study|Withdrawn by parent/guardian|41|||
42340305|NCT02062385|76178338|FG002|Overall Study|Withdrawn by parent/guardian|9|||
42267659|NCT00103285|76096284|FG002|Response Assignment|Refusal|5|||
42267660|NCT00103285|76096285|FG003|Response Assignment|Refusal|3|||
42267661|NCT00103285|76096286|FG004|Response Assignment|Refusal|25|||
42267662|NCT00103285|76096287|FG005|Response Assignment|Refusal|15|||
42267663|NCT00103285|76096288|FG006|Response Assignment|Refusal|30|||
42267664|NCT00103285|76096289|FG007|Response Assignment|Refusal|10|||
42340306|NCT02062385|76178339|FG003|Overall Study|Withdrawn by parent/guardian|8|||
42340307|NCT02062385|76178336|FG000|Overall Study|Death|0|||
42340308|NCT02062385|76178337|FG001|Overall Study|Death|0|||
42340309|NCT02062385|76178338|FG002|Overall Study|Death|0|||
42340310|NCT02062385|76178339|FG003|Overall Study|Death|1|||
42340311|NCT02062385|76178336|FG000|Overall Study|Lost to Follow-up|0|||
42340312|NCT02062385|76178337|FG001|Overall Study|Lost to Follow-up|0|||
42340313|NCT02062385|76178338|FG002|Overall Study|Lost to Follow-up|1|||
42340314|NCT02062385|76178339|FG003|Overall Study|Lost to Follow-up|0|||
42340315|NCT02062151|76178347|FG000|Overall Study|screen failure|1|||
42340316|NCT02060903|76178353|FG000|Overall Study|Lost to Follow-up|4|||
42340317|NCT02060903|76178354|FG001|Overall Study|Lost to Follow-up|0|||
42340318|NCT02060903|76178353|FG000|Overall Study|Withdrawal by Subject|0|||
42340319|NCT02060903|76178354|FG001|Overall Study|Withdrawal by Subject|7|||
42340320|NCT02095691|76178360|FG000|Overall Study|Physician Decision|1|||
42340321|NCT02095535|76178376|FG000|Recruitment|Protocol Violation|2|||
42340322|NCT02095223|76178382|FG000|Overall Study|Withdrawal by Subject|1|||
42340323|NCT02095223|76178383|FG001|Overall Study|Withdrawal by Subject|0|||
42340324|NCT02095145|76178391|FG000|Overall Study|Withdrawal by Subject|1|||
42135227|NCT00457392|75945964|FG000|Overall Study|Protocol Violation|4|||
42135228|NCT00457392|75945965|FG001|Overall Study|Protocol Violation|3|||
42135229|NCT00457392|75945964|FG000|Overall Study|Other|7|||
42135230|NCT00457392|75945965|FG001|Overall Study|Other|4|||
42135231|NCT00457392|75945964|FG000|Overall Study|Study Terminated by Sponsor|1|||
42135232|NCT00457392|75945965|FG001|Overall Study|Study Terminated by Sponsor|4|||
42135233|NCT00457392|75945964|FG000|Overall Study|Randomized, Not Treated|7|||
42135234|NCT00457392|75945965|FG001|Overall Study|Randomized, Not Treated|3|||
42135235|NCT00545051|75945973|FG000|Overall Study|Adverse Event|7|||
42135236|NCT00545051|75945974|FG001|Overall Study|Adverse Event|3|||
42135237|NCT00545051|75945973|FG000|Overall Study|Death|1|||
42340325|NCT02095145|76178392|FG001|Overall Study|Withdrawal by Subject|0|||
42340326|NCT02059187|76178402|FG000|Overall Study|Adverse Event|0|||
42340327|NCT02059187|76178403|FG001|Overall Study|Adverse Event|3|||
42340328|NCT02059187|76178402|FG000|Overall Study|Death|1|||
42340329|NCT02059187|76178403|FG001|Overall Study|Death|1|||
42135238|NCT00545051|75945974|FG001|Overall Study|Death|0|||
42135239|NCT00545051|75945973|FG000|Overall Study|Violation of inclusion/exclusion|0|||
42267665|NCT00103285|76096282|FG000|Response Assignment|Other|0|||
42267666|NCT00103285|76096283|FG001|Response Assignment|Other|30|||
42267667|NCT00103285|76096284|FG002|Response Assignment|Other|48|||
42267668|NCT00103285|76096285|FG003|Response Assignment|Other|38|||
42267669|NCT00103285|76096286|FG004|Response Assignment|Other|37|||
42267670|NCT00103285|76096287|FG005|Response Assignment|Other|17|||
42267671|NCT00103285|76096288|FG006|Response Assignment|Other|11|||
42267672|NCT00103285|76096289|FG007|Response Assignment|Other|53|||
42267673|NCT02783573|76096317|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
42267674|NCT02783573|76096318|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
42267675|NCT02783573|76096319|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
42340330|NCT02059187|76178402|FG000|Overall Study|Lost to Follow-up|9|||
42340331|NCT02059187|76178403|FG001|Overall Study|Lost to Follow-up|8|||
42135240|NCT00545051|75945974|FG001|Overall Study|Violation of inclusion/exclusion|2|||
42135241|NCT00545051|75945973|FG000|Overall Study|Protocol Violation|1|||
42135242|NCT00545051|75945974|FG001|Overall Study|Protocol Violation|0|||
42267676|NCT02783573|76096317|FG000|Placebo-Controlled Treatment Period|Death|4|||
42267677|NCT02783573|76096318|FG001|Placebo-Controlled Treatment Period|Death|2|||
42267678|NCT02783573|76096319|FG002|Placebo-Controlled Treatment Period|Death|3|||
42340332|NCT02059187|76178402|FG000|Overall Study|Non-compliance with study drug|1|||
42340333|NCT02059187|76178403|FG001|Overall Study|Non-compliance with study drug|0|||
42340334|NCT02059187|76178402|FG000|Overall Study|Physician Decision|1|||
42340335|NCT02059187|76178403|FG001|Overall Study|Physician Decision|2|||
42135243|NCT00545051|75945973|FG000|Overall Study|Withdrawal by Subject|0|||
42340336|NCT02059187|76178402|FG000|Overall Study|Protocol Violation|1|||
42340337|NCT02059187|76178403|FG001|Overall Study|Protocol Violation|0|||
42340338|NCT02059187|76178402|FG000|Overall Study|Withdrawal by Subject|12|||
42340339|NCT02059187|76178403|FG001|Overall Study|Withdrawal by Subject|8|||
42340340|NCT02043899|76178409|FG000|Overall Study|Adverse Event|3|||
42340341|NCT02043899|76178409|FG000|Overall Study|Physician Decision|1|||
42340342|NCT02043899|76178409|FG000|Overall Study|Withdrawal by Subject|2|||
42340343|NCT02043899|76178409|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
42002142|NCT01106677|75810013|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
42002143|NCT01106677|75810010|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
42002144|NCT01106677|75810011|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
42002145|NCT01106677|75810012|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
42002146|NCT01106677|75810013|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
42002147|NCT01106677|75810010|FG000|Extension Period: Week 26 to Week 52|Other|6|||
42002148|NCT01106677|75810011|FG001|Extension Period: Week 26 to Week 52|Other|5|||
42002149|NCT01106677|75810012|FG002|Extension Period: Week 26 to Week 52|Other|8|||
42135244|NCT00545051|75945974|FG001|Overall Study|Withdrawal by Subject|1|||
42135245|NCT00545051|75945973|FG000|Overall Study|Administrative reasons|0|||
42267679|NCT02783573|76096317|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
42267680|NCT02783573|76096318|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
42267681|NCT02783573|76096319|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
42267682|NCT02783573|76096317|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
42267683|NCT02783573|76096318|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
42267684|NCT02783573|76096319|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
42267685|NCT02783573|76096317|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
42267686|NCT02783573|76096318|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
42267687|NCT02783573|76096319|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
42267688|NCT02783573|76096317|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
42340344|NCT02043899|76178409|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
42340345|NCT02043899|76178409|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
42340346|NCT02043899|76178409|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
42340347|NCT02043899|76178409|FG000|Overall Study|Treatment delayed|1|||
42340348|NCT02043509|76178415|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
42340349|NCT02043509|76178416|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
42340350|NCT02043509|76178415|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
42340351|NCT02043509|76178416|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
42340352|NCT02043509|76178415|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
42340353|NCT02043509|76178416|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
42340354|NCT02043509|76178415|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
42340355|NCT02043509|76178416|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
42340356|NCT02058563|76178424|FG000|Overall Study|Lost to Follow-up|26|||
42340357|NCT02058563|76178425|FG001|Overall Study|Lost to Follow-up|22|||
42340358|NCT02058563|76178424|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
42002150|NCT01106677|75810013|FG003|Extension Period: Week 26 to Week 52|Other|5|||
42002151|NCT01106287|75810034|FG000|Overall Study|Adverse Event|1|||
42002152|NCT01106287|75810035|FG001|Overall Study|Adverse Event|0|||
42002153|NCT01106287|75810036|FG002|Overall Study|Adverse Event|0|||
42002154|NCT01106287|75810037|FG003|Overall Study|Adverse Event|0|||
42002155|NCT01104493|75810053|FG000|Overall Study|Lost to Follow-up|0|||
42002156|NCT01104493|75810054|FG001|Overall Study|Lost to Follow-up|2|||
42002157|NCT01104415|75810060|FG000|Core Phase|Consent withdrawn by subjects|1|||
42002158|NCT01104415|75810061|FG001|Core Phase|Consent withdrawn by subjects|0|||
42002159|NCT01104415|75810060|FG000|Extension Period|Progressive disease|0|||
42002160|NCT01104415|75810061|FG001|Extension Period|Progressive disease|4|||
42340359|NCT02058563|76178425|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
42340360|NCT02058563|76178424|FG000|Overall Study|Consent Withdrawal|1|||
42340361|NCT02058563|76178425|FG001|Overall Study|Consent Withdrawal|1|||
42340362|NCT02058563|76178424|FG000|Overall Study|Other (patient incarcerated)|0|||
42340363|NCT02058563|76178425|FG001|Overall Study|Other (patient incarcerated)|1|||
42340364|NCT01622231|76178431|FG000|Overall Study|Physician Decision|1|||
42340365|NCT01622231|76178431|FG000|Overall Study|Withdrawal by Subject|1|||
42340366|NCT02042183|76178437|FG000|Overall Study|Physician Decision|7|||
42340367|NCT02042183|76178438|FG001|Overall Study|Physician Decision|2|||
42340368|NCT02042183|76178437|FG000|Overall Study|Lack of Efficacy|4|||
42340369|NCT02042183|76178438|FG001|Overall Study|Lack of Efficacy|3|||
42340370|NCT02042183|76178437|FG000|Overall Study|Non-compliance with Study Drug|2|||
42340371|NCT02042183|76178438|FG001|Overall Study|Non-compliance with Study Drug|3|||
42340372|NCT02042183|76178437|FG000|Overall Study|Adverse Event|17|||
42340373|NCT02042183|76178438|FG001|Overall Study|Adverse Event|6|||
42340374|NCT02042183|76178437|FG000|Overall Study|Other|3|||
42340375|NCT02042183|76178438|FG001|Overall Study|Other|3|||
42340376|NCT02042183|76178437|FG000|Overall Study|Withdrawal by Subject|21|||
42340377|NCT02042183|76178438|FG001|Overall Study|Withdrawal by Subject|16|||
42340378|NCT02042183|76178437|FG000|Overall Study|Site Terminated by Sponsor|2|||
42340379|NCT02042183|76178438|FG001|Overall Study|Site Terminated by Sponsor|1|||
42340380|NCT02042183|76178437|FG000|Overall Study|Lost to Follow-up|9|||
42340381|NCT02042183|76178438|FG001|Overall Study|Lost to Follow-up|2|||
42340382|NCT01977482|76178452|FG000|Overall Study|Adverse Event|0|||
42340383|NCT01977482|76178453|FG001|Overall Study|Adverse Event|1|||
42340384|NCT01977482|76178454|FG002|Overall Study|Adverse Event|1|||
42340385|NCT01977482|76178455|FG003|Overall Study|Adverse Event|0|||
42340386|NCT01977482|76178456|FG004|Overall Study|Adverse Event|2|||
42340387|NCT01977482|76178457|FG005|Overall Study|Adverse Event|0|||
42340388|NCT01977482|76178452|FG000|Overall Study|Lost to Follow-up|1|||
42340389|NCT01977482|76178453|FG001|Overall Study|Lost to Follow-up|0|||
42340390|NCT01977482|76178454|FG002|Overall Study|Lost to Follow-up|0|||
42340391|NCT01977482|76178455|FG003|Overall Study|Lost to Follow-up|0|||
42340392|NCT01977482|76178456|FG004|Overall Study|Lost to Follow-up|0|||
42340393|NCT01977482|76178457|FG005|Overall Study|Lost to Follow-up|0|||
42340394|NCT01977482|76178452|FG000|Overall Study|Physician Decision|0|||
42340395|NCT01977482|76178453|FG001|Overall Study|Physician Decision|1|||
42340396|NCT01977482|76178454|FG002|Overall Study|Physician Decision|0|||
42340397|NCT01977482|76178455|FG003|Overall Study|Physician Decision|0|||
42340398|NCT01977482|76178456|FG004|Overall Study|Physician Decision|0|||
42340399|NCT01977482|76178457|FG005|Overall Study|Physician Decision|0|||
42340400|NCT01977482|76178452|FG000|Overall Study|Protocol Violation|0|||
42002161|NCT01104415|75810060|FG000|Extension Period|Death|0|||
42002162|NCT01104415|75810061|FG001|Extension Period|Death|1|||
42002163|NCT01104415|75810060|FG000|Extension Period|Physician Decision|0|||
42002164|NCT01104415|75810061|FG001|Extension Period|Physician Decision|1|||
42002165|NCT01104415|75810060|FG000|Extension Period|Transition to Study LX1606.302|0|||
42002166|NCT01104415|75810061|FG001|Extension Period|Transition to Study LX1606.302|4|||
42002167|NCT01104415|75810060|FG000|Extension Period|Heart surgery/feeling miserable|0|||
42002168|NCT01104415|75810061|FG001|Extension Period|Heart surgery/feeling miserable|1|||
42340401|NCT01977482|76178453|FG001|Overall Study|Protocol Violation|0|||
42002169|NCT01099579|75810071|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
42002170|NCT01099579|75810072|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
42002171|NCT01099579|75810073|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
42002172|NCT01099579|75810071|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
42002173|NCT01099579|75810072|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
42002174|NCT01099579|75810073|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
42340402|NCT01977482|76178454|FG002|Overall Study|Protocol Violation|1|||
42340403|NCT01977482|76178455|FG003|Overall Study|Protocol Violation|0|||
42340404|NCT01977482|76178456|FG004|Overall Study|Protocol Violation|0|||
42340405|NCT01977482|76178457|FG005|Overall Study|Protocol Violation|0|||
42002175|NCT01099579|75810071|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
42002176|NCT01099579|75810072|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
42002177|NCT01099579|75810073|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
42002178|NCT01099579|75810071|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
42002179|NCT01099579|75810072|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
42002180|NCT01099579|75810073|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
42267689|NCT02783573|76096318|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
42267690|NCT02783573|76096319|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
42267691|NCT02783573|76096317|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
42267692|NCT02783573|76096318|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
42267693|NCT02783573|76096319|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
42267694|NCT02783573|76096317|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
42267695|NCT02783573|76096318|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
42267696|NCT02783573|76096319|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
42267697|NCT02783573|76096317|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
42267698|NCT02783573|76096318|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
42267699|NCT02783573|76096319|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
42267700|NCT02783573|76096317|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
42267701|NCT02783573|76096318|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
42267702|NCT02783573|76096319|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
42267703|NCT02783573|76096317|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
42267704|NCT02783573|76096318|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
42267705|NCT02783573|76096319|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
42267706|NCT02783573|76096317|FG000|Delayed-Start Period|Sponsor Decision|0|||
42267707|NCT02783573|76096318|FG001|Delayed-Start Period|Sponsor Decision|17|||
42267708|NCT02783573|76096319|FG002|Delayed-Start Period|Sponsor Decision|12|||
42267709|NCT01666652|76096335|FG000|Overall Study|Serious Adverse Event|0|||
42267710|NCT01666652|76096336|FG001|Overall Study|Serious Adverse Event|0|||
42267711|NCT01666652|76096337|FG002|Overall Study|Serious Adverse Event|0|||
42267712|NCT01666652|76096338|FG003|Overall Study|Serious Adverse Event|1|||
42340406|NCT01977482|76178452|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
42340407|NCT01977482|76178453|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
42340408|NCT01977482|76178454|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
42340409|NCT01977482|76178455|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
42340410|NCT01977482|76178456|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
42340411|NCT01977482|76178457|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
42340412|NCT01977482|76178452|FG000|Overall Study|Withdrawal by Subject|2|||
42340413|NCT01977482|76178453|FG001|Overall Study|Withdrawal by Subject|4|||
42340414|NCT01977482|76178454|FG002|Overall Study|Withdrawal by Subject|1|||
42340415|NCT01977482|76178455|FG003|Overall Study|Withdrawal by Subject|3|||
42340416|NCT01977482|76178456|FG004|Overall Study|Withdrawal by Subject|1|||
42340417|NCT01977482|76178457|FG005|Overall Study|Withdrawal by Subject|5|||
42340418|NCT02058095|76178478|FG000|Overall Study|Adverse Event|1|||
42340419|NCT02058095|76178479|FG001|Overall Study|Adverse Event|0|||
42340420|NCT02023112|76178487|FG000|Overall Study|Withdrawal by Subject|2|||
42340421|NCT02023112|76178488|FG001|Overall Study|Withdrawal by Subject|1|||
42340422|NCT01977092|76178498|FG000|Overall Study|Death|3|||
42340423|NCT01977092|76178499|FG001|Overall Study|Death|4|||
42340424|NCT01977092|76178498|FG000|Overall Study|Lost to Follow-up|23|||
42340425|NCT01977092|76178499|FG001|Overall Study|Lost to Follow-up|14|||
42267713|NCT01666652|76096339|FG004|Overall Study|Serious Adverse Event|0|||
42267714|NCT01666652|76096335|FG000|Overall Study|Withdrawal by Subject|0|||
42267715|NCT01666652|76096336|FG001|Overall Study|Withdrawal by Subject|0|||
42267716|NCT01666652|76096337|FG002|Overall Study|Withdrawal by Subject|0|||
42267717|NCT01666652|76096338|FG003|Overall Study|Withdrawal by Subject|0|||
42267718|NCT01666652|76096339|FG004|Overall Study|Withdrawal by Subject|1|||
42267719|NCT01666652|76096335|FG000|Overall Study|Moved from study area|1|||
42267720|NCT01666652|76096336|FG001|Overall Study|Moved from study area|0|||
42267721|NCT01666652|76096337|FG002|Overall Study|Moved from study area|0|||
42267722|NCT01666652|76096338|FG003|Overall Study|Moved from study area|2|||
42267723|NCT01666652|76096339|FG004|Overall Study|Moved from study area|0|||
42340426|NCT01977092|76178498|FG000|Overall Study|Withdrawal by Subject|2|||
42267724|NCT01666652|76096335|FG000|Overall Study|Lost to Follow-up|1|||
42267725|NCT01666652|76096336|FG001|Overall Study|Lost to Follow-up|1|||
42340427|NCT01977092|76178499|FG001|Overall Study|Withdrawal by Subject|1|||
42267726|NCT01666652|76096337|FG002|Overall Study|Lost to Follow-up|1|||
42267727|NCT01666652|76096338|FG003|Overall Study|Lost to Follow-up|1|||
42340428|NCT01977092|76178498|FG000|Overall Study|In prison|3|||
42340429|NCT01977092|76178499|FG001|Overall Study|In prison|11|||
42340430|NCT01976624|76178505|FG000|Overall Study|Participants contraindicated|2|||
42340431|NCT01976624|76178505|FG000|Overall Study|Participants age less than 19 years|12|||
42002181|NCT01099579|75810071|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
42002182|NCT01099579|75810072|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
42002183|NCT01099579|75810073|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
42267728|NCT01666652|76096339|FG004|Overall Study|Lost to Follow-up|0|||
42267729|NCT00109733|76096353|FG000|Overall Study|Protocol Violation|0|||
42267730|NCT00109733|76096354|FG001|Overall Study|Protocol Violation|1|||
42267731|NCT00109733|76096353|FG000|Overall Study|Stopped taking study drug|1|||
42267732|NCT00109733|76096354|FG001|Overall Study|Stopped taking study drug|1|||
42267733|NCT00109733|76096353|FG000|Overall Study|Non-compliant|0|||
42267734|NCT00109733|76096354|FG001|Overall Study|Non-compliant|1|||
42267735|NCT00109733|76096353|FG000|Overall Study|Could not commit time for study|1|||
42267736|NCT00109733|76096354|FG001|Overall Study|Could not commit time for study|1|||
42267737|NCT02706405|76096368|FG000|Overall Study|Death|3|||
42267738|NCT02706405|76096369|FG001|Overall Study|Death|2|||
42267739|NCT02706405|76096370|FG002|Overall Study|Death|0|||
42267740|NCT02706405|76096371|FG003|Overall Study|Death|1|||
42267741|NCT02706405|76096372|FG004|Overall Study|Death|0|||
42267742|NCT02706405|76096373|FG005|Overall Study|Death|0|||
42267743|NCT02706405|76096374|FG006|Overall Study|Death|3|||
42340432|NCT02041091|76178511|FG000|Treatment|Adverse Event|3|||
42340433|NCT02041091|76178512|FG001|Treatment|Adverse Event|3|||
42340434|NCT02041091|76178511|FG000|Treatment|Withdrawal by Subject|2|||
42340435|NCT02041091|76178512|FG001|Treatment|Withdrawal by Subject|4|||
42340436|NCT02041091|76178511|FG000|Treatment|Physician Decision|1|||
42340437|NCT02041091|76178512|FG001|Treatment|Physician Decision|0|||
42267744|NCT02706405|76096375|FG007|Overall Study|Death|4|||
42267745|NCT02706405|76096368|FG000|Overall Study|Disease progression|0|||
42340438|NCT02041091|76178511|FG000|Treatment|Sponsor Decision|15|||
42340439|NCT02041091|76178512|FG001|Treatment|Sponsor Decision|16|||
42340440|NCT02041091|76178511|FG000|Treatment|Lost to Follow-up|1|||
42340441|NCT02041091|76178512|FG001|Treatment|Lost to Follow-up|0|||
42340442|NCT02041091|76178511|FG000|Optional Safety Extension Period|Adverse Event|4|||
42340443|NCT02041091|76178512|FG001|Optional Safety Extension Period|Adverse Event|2|||
42267746|NCT02706405|76096369|FG001|Overall Study|Disease progression|0|||
42267747|NCT02706405|76096370|FG002|Overall Study|Disease progression|0|||
42267748|NCT02706405|76096371|FG003|Overall Study|Disease progression|0|||
42267749|NCT02706405|76096372|FG004|Overall Study|Disease progression|0|||
42267750|NCT02706405|76096373|FG005|Overall Study|Disease progression|0|||
42340444|NCT02041091|76178511|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
42340445|NCT02041091|76178512|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
42340446|NCT02041091|76178511|FG000|Optional Safety Extension Period|Protocol Violation|2|||
42340447|NCT02041091|76178512|FG001|Optional Safety Extension Period|Protocol Violation|0|||
42340448|NCT02041091|76178511|FG000|Optional Safety Extension Period|Physician Decision|2|||
42340449|NCT02041091|76178512|FG001|Optional Safety Extension Period|Physician Decision|1|||
42340450|NCT02041091|76178511|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
42340451|NCT02041091|76178512|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
42340452|NCT02041091|76178511|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
42340453|NCT02041091|76178512|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
42340454|NCT02057549|76178526|FG000|Overall Study|Lost to Follow-up|1|||
42340455|NCT02057549|76178527|FG001|Overall Study|Lost to Follow-up|0|||
42340456|NCT02057549|76178526|FG000|Overall Study|Physician Decision|1|||
42340457|NCT02057549|76178527|FG001|Overall Study|Physician Decision|0|||
42340458|NCT02057549|76178526|FG000|Overall Study|Withdrawal by Subject|1|||
42340459|NCT02057549|76178527|FG001|Overall Study|Withdrawal by Subject|0|||
42002184|NCT01099579|75810071|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
42267751|NCT02706405|76096374|FG006|Overall Study|Disease progression|0|||
42002185|NCT01099579|75810072|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
42002186|NCT01099579|75810073|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
42002187|NCT01099579|75810071|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
42002188|NCT01099579|75810072|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
42267752|NCT02706405|76096375|FG007|Overall Study|Disease progression|1|||
42267753|NCT02706405|76096368|FG000|Overall Study|Pt moved to new therapy|0|||
42267754|NCT02706405|76096369|FG001|Overall Study|Pt moved to new therapy|0|||
42267755|NCT02706405|76096370|FG002|Overall Study|Pt moved to new therapy|0|||
42267756|NCT02706405|76096371|FG003|Overall Study|Pt moved to new therapy|0|||
42340460|NCT02057393|76178533|FG000|Overall Study|Withdrawal by Subject|1|||
42340461|NCT02057393|76178533|FG000|Overall Study|Patient did not meet criteria|1|||
42340462|NCT02040779|76178540|FG000|Overall Study|Adverse Event|1|||
42340463|NCT02040779|76178541|FG001|Overall Study|Adverse Event|0|||
42340464|NCT02040779|76178542|FG002|Overall Study|Adverse Event|0|||
42340465|NCT02040779|76178540|FG000|Overall Study|Withdrawal by Subject|4|||
42340466|NCT02040779|76178541|FG001|Overall Study|Withdrawal by Subject|1|||
42340467|NCT02040779|76178542|FG002|Overall Study|Withdrawal by Subject|3|||
42340468|NCT02040779|76178540|FG000|Overall Study|Non-compliance|0|||
42340469|NCT02040779|76178541|FG001|Overall Study|Non-compliance|1|||
42002189|NCT01099579|75810073|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
42002190|NCT01099579|75810071|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
42002191|NCT01099579|75810072|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
42002192|NCT01099579|75810073|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
42002193|NCT01099579|75810071|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
42135246|NCT00545051|75945974|FG001|Overall Study|Administrative reasons|1|||
42135247|NCT00381615|75945984|FG000|Overall Study|Withdrawal by Subject|1|||
42135248|NCT00381615|75945985|FG001|Overall Study|Withdrawal by Subject|3|||
42135249|NCT00381615|75945986|FG002|Overall Study|Withdrawal by Subject|0|||
42135250|NCT00381615|75945987|FG003|Overall Study|Withdrawal by Subject|1|||
42135251|NCT00381615|75945984|FG000|Overall Study|Lost to Follow-up|3|||
42135252|NCT00381615|75945985|FG001|Overall Study|Lost to Follow-up|2|||
42135253|NCT00381615|75945986|FG002|Overall Study|Lost to Follow-up|0|||
42135254|NCT00381615|75945987|FG003|Overall Study|Lost to Follow-up|1|||
42135255|NCT00381615|75945984|FG000|Overall Study|Protocol Violation|0|||
42135256|NCT00381615|75945985|FG001|Overall Study|Protocol Violation|0|||
42135257|NCT00381615|75945986|FG002|Overall Study|Protocol Violation|1|||
42135258|NCT00381615|75945987|FG003|Overall Study|Protocol Violation|0|||
42135259|NCT00371865|75946001|FG000|Overall Study|Lack of Efficacy|0|||
42135260|NCT00371865|75946002|FG001|Overall Study|Lack of Efficacy|2|||
42135261|NCT00371865|75946001|FG000|Overall Study|Protocol Violation|3|||
42135262|NCT00371865|75946002|FG001|Overall Study|Protocol Violation|2|||
42135263|NCT00371865|75946001|FG000|Overall Study|Withdrawal by Subject|12|||
42135264|NCT00371865|75946002|FG001|Overall Study|Withdrawal by Subject|10|||
42135265|NCT00364845|75946010|FG000|Overall Study|Adverse Event|1|||
42135266|NCT00364845|75946011|FG001|Overall Study|Adverse Event|0|||
42135267|NCT00364845|75946010|FG000|Overall Study|Withdrawal by Subject|2|||
42135268|NCT00364845|75946011|FG001|Overall Study|Withdrawal by Subject|1|||
42135269|NCT00364845|75946010|FG000|Overall Study|Physician Decision|8|||
42002194|NCT01099579|75810072|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
42002195|NCT01099579|75810073|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
42002196|NCT01099579|75810071|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
42002197|NCT01099579|75810072|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
42002198|NCT01099579|75810073|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
42002199|NCT01103713|75810083|FG000|Overall Study|Lost to Follow-up|2|||
42002200|NCT01103713|75810083|FG000|Overall Study|Withdrawal by Subject|8|||
42002201|NCT01103713|75810083|FG000|Overall Study|Study terminated by sponsor|2|||
42002202|NCT01103713|75810083|FG000|Overall Study|Other|1|||
42002203|NCT01103479|75810093|FG000|Overall Study|Up to date with CRC screening|1|||
42002204|NCT01103479|75810094|FG001|Overall Study|Up to date with CRC screening|9|||
42002205|NCT01103479|75810095|FG002|Overall Study|Up to date with CRC screening|12|||
42002206|NCT01103479|75810093|FG000|Overall Study|Family history of CRC|1|||
42002207|NCT01103479|75810094|FG001|Overall Study|Family history of CRC|0|||
42002208|NCT01103479|75810095|FG002|Overall Study|Family history of CRC|2|||
42002209|NCT01103479|75810093|FG000|Overall Study|Active cancer|1|||
42002210|NCT01103479|75810094|FG001|Overall Study|Active cancer|0|||
42002211|NCT01103479|75810095|FG002|Overall Study|Active cancer|0|||
42002212|NCT01103479|75810093|FG000|Overall Study|Saw non-study physician|2|||
42002213|NCT01103479|75810094|FG001|Overall Study|Saw non-study physician|0|||
42002214|NCT01103479|75810095|FG002|Overall Study|Saw non-study physician|0|||
42002215|NCT01103323|75810106|FG000|Without/Before Drug Switch|Adverse Event|50|||
42002216|NCT01103323|75810107|FG001|Without/Before Drug Switch|Adverse Event|7|||
42002217|NCT01103323|75810106|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
42002218|NCT01103323|75810107|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
42002219|NCT01103323|75810106|FG000|Without/Before Drug Switch|Protocol Violation|2|||
42002220|NCT01103323|75810107|FG001|Without/Before Drug Switch|Protocol Violation|0|||
42002221|NCT01103323|75810106|FG000|Without/Before Drug Switch|Physician Decision|2|||
42002222|NCT01103323|75810107|FG001|Without/Before Drug Switch|Physician Decision|0|||
42002223|NCT01103323|75810106|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
42002224|NCT01103323|75810107|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
42035018|NCT00932373|75843310|FG002|Overall Study|Progressive disease|0|||
42135270|NCT00364845|75946011|FG001|Overall Study|Physician Decision|8|||
42135271|NCT00364845|75946010|FG000|Overall Study|Lost to Follow-up|0|||
42267757|NCT02706405|76096372|FG004|Overall Study|Pt moved to new therapy|0|||
42002225|NCT01103323|75810106|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
42135272|NCT00364845|75946011|FG001|Overall Study|Lost to Follow-up|1|||
42135273|NCT00364845|75946010|FG000|Overall Study|Death|0|||
42135274|NCT00364845|75946011|FG001|Overall Study|Death|1|||
42135275|NCT00293722|75946017|FG000|Overall Study|Other|427|||
42135276|NCT00381303|75946023|FG000|Overall Study|Lost to Follow-up|25|||
42267758|NCT02706405|76096373|FG005|Overall Study|Pt moved to new therapy|1|||
42002226|NCT01103323|75810107|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
42002227|NCT01103323|75810106|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
42002228|NCT01103323|75810107|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
42002229|NCT01103245|75810118|FG000|Overall Study|Withdrawal by Subject|1|||
42035019|NCT00932373|75843311|FG003|Overall Study|Progressive disease|0|||
42267759|NCT02706405|76096374|FG006|Overall Study|Pt moved to new therapy|0|||
42135277|NCT00381303|75946024|FG001|Overall Study|Lost to Follow-up|9|||
42135278|NCT00381303|75946023|FG000|Overall Study|AE/HIV-related event|22|||
42135279|NCT00381303|75946024|FG001|Overall Study|AE/HIV-related event|6|||
42135280|NCT00381303|75946023|FG000|Overall Study|Non-Adherence|13|||
42135281|NCT00381303|75946024|FG001|Overall Study|Non-Adherence|6|||
42135282|NCT00381303|75946023|FG000|Overall Study|Withdrawal by Subject|13|||
42135283|NCT00381303|75946024|FG001|Overall Study|Withdrawal by Subject|6|||
42135284|NCT00381303|75946023|FG000|Overall Study|Virologic failure|6|||
42135285|NCT00381303|75946024|FG001|Overall Study|Virologic failure|4|||
42135286|NCT00381303|75946023|FG000|Overall Study|Ineligible to continue the trial|2|||
42135287|NCT00381303|75946024|FG001|Overall Study|Ineligible to continue the trial|1|||
42135288|NCT00381303|75946023|FG000|Overall Study|Pregnancy|2|||
42135289|NCT00381303|75946024|FG001|Overall Study|Pregnancy|0|||
42267760|NCT02706405|76096375|FG007|Overall Study|Pt moved to new therapy|1|||
42267761|NCT02706405|76096368|FG000|Overall Study|Physician Decision|1|||
42267762|NCT02706405|76096369|FG001|Overall Study|Physician Decision|0|||
42267763|NCT02706405|76096370|FG002|Overall Study|Physician Decision|0|||
42267764|NCT02706405|76096371|FG003|Overall Study|Physician Decision|0|||
42267765|NCT02706405|76096372|FG004|Overall Study|Physician Decision|0|||
42267766|NCT02706405|76096373|FG005|Overall Study|Physician Decision|0|||
42267767|NCT02706405|76096374|FG006|Overall Study|Physician Decision|0|||
42267768|NCT02706405|76096375|FG007|Overall Study|Physician Decision|0|||
42267769|NCT02761993|76096404|FG000|Overall Study|Adverse Event|0|||
42267770|NCT02761993|76096405|FG001|Overall Study|Adverse Event|2|||
42267771|NCT02761993|76096406|FG002|Overall Study|Adverse Event|0|||
42267772|NCT02761993|76096404|FG000|Overall Study|Lost to Follow-up|1|||
42267773|NCT02761993|76096405|FG001|Overall Study|Lost to Follow-up|3|||
42267774|NCT02761993|76096406|FG002|Overall Study|Lost to Follow-up|2|||
42267775|NCT02761993|76096404|FG000|Overall Study|Withdrawal by Subject|1|||
42267776|NCT02761993|76096405|FG001|Overall Study|Withdrawal by Subject|1|||
42267777|NCT02761993|76096406|FG002|Overall Study|Withdrawal by Subject|2|||
42267778|NCT02766283|76096414|FG000|Overall Study|Lost to Follow-up|27|||
42267779|NCT02761915|76096448|FG000|Overall Study|Death|3|||
42267780|NCT02761915|76096449|FG001|Overall Study|Death|1|||
42267781|NCT02761915|76096450|FG002|Overall Study|Death|1|||
42267782|NCT02761915|76096451|FG003|Overall Study|Death|1|||
42267783|NCT02761915|76096452|FG004|Overall Study|Death|0|||
42267784|NCT02761915|76096453|FG005|Overall Study|Death|1|||
42267785|NCT02761915|76096448|FG000|Overall Study|Withdrawal by Subject|1|||
42267786|NCT02761915|76096449|FG001|Overall Study|Withdrawal by Subject|0|||
42267787|NCT02761915|76096450|FG002|Overall Study|Withdrawal by Subject|0|||
42267788|NCT02761915|76096451|FG003|Overall Study|Withdrawal by Subject|0|||
42267789|NCT02761915|76096452|FG004|Overall Study|Withdrawal by Subject|1|||
42267790|NCT02761915|76096453|FG005|Overall Study|Withdrawal by Subject|2|||
42267791|NCT02761915|76096448|FG000|Overall Study|Disease Progression|0|||
42267792|NCT02761915|76096449|FG001|Overall Study|Disease Progression|0|||
42267793|NCT02761915|76096450|FG002|Overall Study|Disease Progression|0|||
42267794|NCT02761915|76096451|FG003|Overall Study|Disease Progression|2|||
42267795|NCT02761915|76096452|FG004|Overall Study|Disease Progression|2|||
42267796|NCT02761915|76096453|FG005|Overall Study|Disease Progression|2|||
42267797|NCT02706327|76096474|FG000|Overall Study|Lost to Follow-up|1|||
42267798|NCT02706327|76096475|FG001|Overall Study|Lost to Follow-up|1|||
42267799|NCT02706327|76096476|FG002|Overall Study|Lost to Follow-up|2|||
42267800|NCT02764333|76096484|FG000|Overall Study|Ineligible|1|||
42267801|NCT02705625|76096491|FG000|Overall Study|Protocol Violation|1|||
42267802|NCT02705625|76096492|FG001|Overall Study|Protocol Violation|0|||
42267803|NCT02705625|76096493|FG002|Overall Study|Protocol Violation|0|||
42267804|NCT02705625|76096491|FG000|Overall Study|Adverse Event|6|||
42267805|NCT02705625|76096492|FG001|Overall Study|Adverse Event|5|||
42267806|NCT02705625|76096493|FG002|Overall Study|Adverse Event|2|||
42267807|NCT02705625|76096491|FG000|Overall Study|Death|0|||
42267808|NCT02705625|76096492|FG001|Overall Study|Death|0|||
42267809|NCT02705625|76096493|FG002|Overall Study|Death|1|||
42035020|NCT00932373|75843312|FG004|Overall Study|Progressive disease|10|||
42135290|NCT00381303|75946023|FG000|Overall Study|Physician Decision|1|||
42135291|NCT00381303|75946024|FG001|Overall Study|Physician Decision|0|||
42135292|NCT00381303|75946023|FG000|Overall Study|Physician's decision to close the site|3|||
42135293|NCT00381303|75946024|FG001|Overall Study|Physician's decision to close the site|1|||
42135294|NCT00381303|75946023|FG000|Overall Study|Subject moved out of state|2|||
42267810|NCT02705625|76096491|FG000|Overall Study|Withdrawal by Subject|1|||
42267811|NCT02705625|76096492|FG001|Overall Study|Withdrawal by Subject|4|||
42267812|NCT02705625|76096493|FG002|Overall Study|Withdrawal by Subject|5|||
42267813|NCT02705625|76096491|FG000|Overall Study|Lost to Follow-up|0|||
42267814|NCT02705625|76096492|FG001|Overall Study|Lost to Follow-up|0|||
42267815|NCT02705625|76096493|FG002|Overall Study|Lost to Follow-up|1|||
42267816|NCT02705625|76096491|FG000|Overall Study|Non-compliance|0|||
42267817|NCT02705625|76096492|FG001|Overall Study|Non-compliance|1|||
42267818|NCT02705625|76096493|FG002|Overall Study|Non-compliance|1|||
42267819|NCT02705625|76096491|FG000|Overall Study|Overdosing|0|||
42002230|NCT01103245|75810119|FG001|Overall Study|Withdrawal by Subject|0|||
42002231|NCT01103245|75810120|FG002|Overall Study|Withdrawal by Subject|3|||
42002232|NCT01103245|75810121|FG003|Overall Study|Withdrawal by Subject|0|||
42002233|NCT01103245|75810118|FG000|Overall Study|Inadequate IV access|1|||
42002234|NCT01103245|75810119|FG001|Overall Study|Inadequate IV access|0|||
42002235|NCT01103245|75810120|FG002|Overall Study|Inadequate IV access|0|||
42002236|NCT01103245|75810121|FG003|Overall Study|Inadequate IV access|0|||
42135295|NCT00381303|75946024|FG001|Overall Study|Subject moved out of state|0|||
42135296|NCT00381303|75946023|FG000|Overall Study|Subject taking too many different meds|1|||
42135297|NCT00381303|75946024|FG001|Overall Study|Subject taking too many different meds|0|||
42267820|NCT02705625|76096492|FG001|Overall Study|Overdosing|0|||
42267821|NCT02705625|76096493|FG002|Overall Study|Overdosing|1|||
42267822|NCT02588612|76096501|FG000|Overall Study|Physician Decision|1|||
42002237|NCT01103245|75810118|FG000|Overall Study|Adverse Event|0|||
42002238|NCT01103245|75810119|FG001|Overall Study|Adverse Event|2|||
42002239|NCT01103245|75810120|FG002|Overall Study|Adverse Event|1|||
42002240|NCT01103245|75810121|FG003|Overall Study|Adverse Event|0|||
42002241|NCT01103245|75810118|FG000|Overall Study|Physician Decision|1|||
42002242|NCT01103245|75810119|FG001|Overall Study|Physician Decision|0|||
42002243|NCT01103245|75810120|FG002|Overall Study|Physician Decision|0|||
42002244|NCT01103245|75810121|FG003|Overall Study|Physician Decision|0|||
42002245|NCT01099267|75810131|FG000|MDS-003 Study|Adverse Event|37|||
42002246|NCT01099267|75810131|FG000|MDS-003 Study|Lack of Efficacy|52|||
42002247|NCT01099267|75810131|FG000|MDS-003 Study|Withdrawal by Subject|8|||
42267823|NCT02588612|76096501|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
42340470|NCT02040779|76178542|FG002|Overall Study|Non-compliance|0|||
42340471|NCT02040779|76178540|FG000|Overall Study|Protocol Violation|2|||
42340472|NCT02040779|76178541|FG001|Overall Study|Protocol Violation|1|||
42340473|NCT02040779|76178542|FG002|Overall Study|Protocol Violation|0|||
42340474|NCT02040779|76178540|FG000|Overall Study|Lost to Follow-up|1|||
42340475|NCT02040779|76178541|FG001|Overall Study|Lost to Follow-up|2|||
42340476|NCT02040779|76178542|FG002|Overall Study|Lost to Follow-up|1|||
42340477|NCT02040779|76178540|FG000|Overall Study|Lack of Efficacy|4|||
42340478|NCT02040779|76178541|FG001|Overall Study|Lack of Efficacy|2|||
42340479|NCT02040779|76178542|FG002|Overall Study|Lack of Efficacy|0|||
42340480|NCT02056301|76178552|FG000|Overall Study|Protocol Violation|1|||
42340481|NCT02056301|76178553|FG001|Overall Study|Protocol Violation|2|||
42340482|NCT02056301|76178552|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
42340483|NCT02056301|76178553|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
42340484|NCT02056301|76178552|FG000|Overall Study|Withdrawal by Subject|0|||
42340485|NCT02056301|76178553|FG001|Overall Study|Withdrawal by Subject|1|||
42340486|NCT02056301|76178552|FG000|Overall Study|Issues with epidural|0|||
42340487|NCT02056301|76178553|FG001|Overall Study|Issues with epidural|3|||
42340488|NCT01967732|76178561|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
42002248|NCT01099267|75810131|FG000|MDS-003 Study|Lost to Follow-up|1|||
42002249|NCT01099267|75810131|FG000|MDS-003 Study|Death|11|||
42002250|NCT01099267|75810131|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
42002251|NCT01099267|75810131|FG000|MDS-003 Study|Disease Progression|7|||
42002252|NCT01099267|75810131|FG000|MDS-003 Study|Investigator Decision|2|||
42002253|NCT01099267|75810131|FG000|MDS-003 Study|Non-Compliance|2|||
42002254|NCT01099267|75810131|FG000|MDS-003 Study|Loss of Response|1|||
42002255|NCT01099267|75810131|FG000|MDS-003 Study|Secondary Malign Disease|1|||
42002256|NCT01098487|75810135|FG000|Overall Study|Adverse Event|22|||
42002257|NCT01098487|75810135|FG000|Overall Study|Lack of Efficacy|11|||
42002258|NCT01098487|75810135|FG000|Overall Study|Withdrawal by Subject|7|||
42267824|NCT02588612|76096501|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
42267825|NCT02588612|76096501|FG000|Overall Study|Death prior to T-cell infusion|1|||
42267826|NCT02704689|76096514|FG000|Overall Study|Physician Decision|1|||
42267827|NCT02704689|76096514|FG000|Overall Study|Study device not implanted|2|||
42340489|NCT01967732|76178562|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
42340490|NCT01967732|76178563|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
42340491|NCT01967732|76178564|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
42340492|NCT01967732|76178561|FG000|First Intervention (Day 1)|Poor venous access|0|||
42002259|NCT01098487|75810135|FG000|Overall Study|Lost to Follow-up|3|||
42002260|NCT01098487|75810135|FG000|Overall Study|Physician Decision|1|||
42002261|NCT01098097|75810139|FG000|Overall Study|Adverse Event|17|||
42002262|NCT01098097|75810139|FG000|Overall Study|Lost to Follow-up|18|||
42267828|NCT02704143|76096518|FG000|Overall Study|disease progression|10|||
42002263|NCT01098097|75810139|FG000|Overall Study|Status unknown|16|||
42002264|NCT01098097|75810139|FG000|Overall Study|No reason reported|31|||
42002265|NCT01097863|75810146|FG000|Overall Study|Discomfort|1|||
42340493|NCT01967732|76178562|FG001|First Intervention (Day 1)|Poor venous access|1|||
42340494|NCT01967732|76178563|FG002|First Intervention (Day 1)|Poor venous access|0|||
42340495|NCT01967732|76178564|FG003|First Intervention (Day 1)|Poor venous access|0|||
42340496|NCT01967576|76178572|FG000|Overall Study|Withdrawal by Subject|3|||
42135298|NCT00381303|75946023|FG000|Overall Study|No virologic response by week 12|1|||
42135299|NCT00381303|75946024|FG001|Overall Study|No virologic response by week 12|0|||
42135300|NCT00381303|75946023|FG000|Overall Study|Subject was too busy for appointments|1|||
42340497|NCT01967576|76178572|FG000|Overall Study|Progressed/Removed from treatment|1|||
42002266|NCT01097863|75810147|FG001|Overall Study|Discomfort|0|||
42002267|NCT01097863|75810148|FG002|Overall Study|Discomfort|1|||
42002268|NCT01097863|75810146|FG000|Overall Study|Did not return for final visit|0|||
42002269|NCT01097863|75810147|FG001|Overall Study|Did not return for final visit|0|||
42002270|NCT01097863|75810148|FG002|Overall Study|Did not return for final visit|1|||
42002271|NCT01326962|75810156|FG000|Overall Study|Adverse Event|1|||
42002272|NCT01326962|75810156|FG000|Overall Study|Withdrawal by Subject|1|||
42002273|NCT01326962|75810156|FG000|Overall Study|Lost to Follow-up|3|||
42002274|NCT01326962|75810156|FG000|Overall Study|Other|2|||
42002275|NCT01326728|75810162|FG000|Overall Study|Death|13|||
42002276|NCT01326728|75810163|FG001|Overall Study|Death|0|||
42002277|NCT01326728|75810162|FG000|Overall Study|Early closure of study|34|||
42002278|NCT01326728|75810163|FG001|Overall Study|Early closure of study|9|||
42002279|NCT01097707|75810173|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
42002280|NCT01097707|75810174|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
42002281|NCT01097707|75810175|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
42002282|NCT01097707|75810176|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
42002283|NCT01097707|75810177|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
42002284|NCT01097707|75810173|FG000|Overall Study|Adverse Event|4|||
42002285|NCT01097707|75810174|FG001|Overall Study|Adverse Event|2|||
42002286|NCT01097707|75810175|FG002|Overall Study|Adverse Event|3|||
42002287|NCT01097707|75810176|FG003|Overall Study|Adverse Event|1|||
42002288|NCT01097707|75810177|FG004|Overall Study|Adverse Event|3|||
42002289|NCT01097707|75810173|FG000|Overall Study|Entry Criteria Not Met|2|||
42135301|NCT00381303|75946024|FG001|Overall Study|Subject was too busy for appointments|0|||
42267829|NCT02586506|76096522|FG000|Overall Study|Protocol Violation|6|||
42267830|NCT02586506|76096522|FG000|Overall Study|Lost to Follow-up|1|||
42267831|NCT02586506|76096522|FG000|Overall Study|Other Reason|2|||
42267832|NCT00109031|76096530|FG000|Overall Study|Adverse Event|0|||
42340498|NCT01967576|76178572|FG000|Overall Study|Study closing at site|1|||
42340499|NCT01967576|76178572|FG000|Overall Study|Adverse Event|1|||
42340500|NCT01967576|76178572|FG000|Overall Study|Refused further treatment|1|||
42340501|NCT02039687|76178580|FG000|Overall Study|Adverse Event|0|||
42340502|NCT02039687|76178581|FG001|Overall Study|Adverse Event|0|||
42340503|NCT02039687|76178582|FG002|Overall Study|Adverse Event|1|||
42340504|NCT02039687|76178583|FG003|Overall Study|Adverse Event|0|||
42340505|NCT02039687|76178580|FG000|Overall Study|Withdrawal by Subject|0|||
42340506|NCT02039687|76178581|FG001|Overall Study|Withdrawal by Subject|1|||
42340507|NCT02039687|76178582|FG002|Overall Study|Withdrawal by Subject|0|||
42267833|NCT00109031|76096531|FG001|Overall Study|Adverse Event|0|||
42267834|NCT00109031|76096532|FG002|Overall Study|Adverse Event|1|||
42267835|NCT00109031|76096533|FG003|Overall Study|Adverse Event|0|||
42267836|NCT00109031|76096530|FG000|Overall Study|Withdrawal by Subject|0|||
42267837|NCT00109031|76096531|FG001|Overall Study|Withdrawal by Subject|1|||
42267838|NCT00109031|76096532|FG002|Overall Study|Withdrawal by Subject|0|||
42267839|NCT00109031|76096533|FG003|Overall Study|Withdrawal by Subject|0|||
42267840|NCT00109031|76096530|FG000|Overall Study|Physician Decision|0|||
42340508|NCT02039687|76178583|FG003|Overall Study|Withdrawal by Subject|0|||
42340509|NCT02039687|76178580|FG000|Overall Study|treatment assignment could not be confir|0|||
42340510|NCT02039687|76178581|FG001|Overall Study|treatment assignment could not be confir|0|||
42340511|NCT02039687|76178582|FG002|Overall Study|treatment assignment could not be confir|2|||
42002290|NCT01097707|75810174|FG001|Overall Study|Entry Criteria Not Met|1|||
42135302|NCT00381303|75946023|FG000|Overall Study|Subject did not continue visits|1|||
42267841|NCT00109031|76096531|FG001|Overall Study|Physician Decision|1|||
42267842|NCT00109031|76096532|FG002|Overall Study|Physician Decision|0|||
42267843|NCT00109031|76096533|FG003|Overall Study|Physician Decision|0|||
42340512|NCT02039687|76178583|FG003|Overall Study|treatment assignment could not be confir|0|||
42002291|NCT01097707|75810175|FG002|Overall Study|Entry Criteria Not Met|1|||
42002292|NCT01097707|75810176|FG003|Overall Study|Entry Criteria Not Met|0|||
42002293|NCT01097707|75810177|FG004|Overall Study|Entry Criteria Not Met|1|||
42002294|NCT01097707|75810173|FG000|Overall Study|Lack of Efficacy|1|||
42002295|NCT01097707|75810174|FG001|Overall Study|Lack of Efficacy|0|||
42002296|NCT01097707|75810175|FG002|Overall Study|Lack of Efficacy|0|||
42002297|NCT01097707|75810176|FG003|Overall Study|Lack of Efficacy|1|||
42002298|NCT01097707|75810177|FG004|Overall Study|Lack of Efficacy|0|||
42002299|NCT01097707|75810173|FG000|Overall Study|Lost to Follow-up|1|||
42135303|NCT00381303|75946024|FG001|Overall Study|Subject did not continue visits|0|||
42135304|NCT00381303|75946023|FG000|Overall Study|Subject primary physician's decision|1|||
42267844|NCT00109031|76096530|FG000|Overall Study|Protocol Violation|0|||
42267845|NCT00109031|76096531|FG001|Overall Study|Protocol Violation|0|||
42267846|NCT00109031|76096532|FG002|Overall Study|Protocol Violation|1|||
42267847|NCT00109031|76096533|FG003|Overall Study|Protocol Violation|0|||
42267848|NCT01664624|76096547|FG000|Overall Study|Adverse Event|0|||
42267849|NCT01664624|76096548|FG001|Overall Study|Adverse Event|1|||
42267850|NCT01664624|76096549|FG002|Overall Study|Adverse Event|0|||
42267851|NCT01664624|76096550|FG003|Overall Study|Adverse Event|0|||
42267852|NCT02702193|76096562|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
42267853|NCT02702193|76096563|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
42267854|NCT02702193|76096562|FG000|4 Month Follow up|Withdrawal by Subject|1|||
42267855|NCT02702193|76096563|FG001|4 Month Follow up|Withdrawal by Subject|0|||
42267856|NCT02702193|76096562|FG000|4 Month Follow up|Lost to Follow-up|17|||
42267857|NCT02702193|76096563|FG001|4 Month Follow up|Lost to Follow-up|18|||
42267858|NCT02702193|76096562|FG000|8 Month Follow up|Withdrawal by Subject|1|||
42267859|NCT02702193|76096563|FG001|8 Month Follow up|Withdrawal by Subject|0|||
42002300|NCT01097707|75810174|FG001|Overall Study|Lost to Follow-up|1|||
42002301|NCT01097707|75810175|FG002|Overall Study|Lost to Follow-up|2|||
42002302|NCT01097707|75810176|FG003|Overall Study|Lost to Follow-up|0|||
42002303|NCT01097707|75810177|FG004|Overall Study|Lost to Follow-up|3|||
42002304|NCT01097707|75810173|FG000|Overall Study|Protocol Violation|2|||
42002305|NCT01097707|75810174|FG001|Overall Study|Protocol Violation|2|||
42002306|NCT01097707|75810175|FG002|Overall Study|Protocol Violation|3|||
42002307|NCT01097707|75810176|FG003|Overall Study|Protocol Violation|2|||
42002308|NCT01097707|75810177|FG004|Overall Study|Protocol Violation|2|||
42002309|NCT01097707|75810173|FG000|Overall Study|Sponsor Decision|31|||
42002310|NCT01097707|75810174|FG001|Overall Study|Sponsor Decision|31|||
42002311|NCT01097707|75810175|FG002|Overall Study|Sponsor Decision|34|||
42002312|NCT01097707|75810176|FG003|Overall Study|Sponsor Decision|35|||
42002313|NCT01097707|75810177|FG004|Overall Study|Sponsor Decision|36|||
42002314|NCT01097707|75810173|FG000|Overall Study|Withdrawal by Subject|3|||
42002315|NCT01097707|75810174|FG001|Overall Study|Withdrawal by Subject|6|||
42002316|NCT01097707|75810175|FG002|Overall Study|Withdrawal by Subject|1|||
42002317|NCT01097707|75810176|FG003|Overall Study|Withdrawal by Subject|4|||
42002318|NCT01097707|75810177|FG004|Overall Study|Withdrawal by Subject|3|||
42267860|NCT02702193|76096562|FG000|8 Month Follow up|Lost to Follow-up|14|||
42267861|NCT02702193|76096563|FG001|8 Month Follow up|Lost to Follow-up|18|||
42267862|NCT02702193|76096562|FG000|12 Month Follow up|Withdrawal by Subject|1|||
42267863|NCT02702193|76096563|FG001|12 Month Follow up|Withdrawal by Subject|0|||
42267864|NCT02702193|76096562|FG000|12 Month Follow up|Lost to Follow-up|16|||
42267865|NCT02702193|76096563|FG001|12 Month Follow up|Lost to Follow-up|18|||
42267866|NCT02761057|76096573|FG000|Overall Study|Currently On Study Treatment|0|||
42267867|NCT02761057|76096574|FG001|Overall Study|Currently On Study Treatment|3|||
42267868|NCT02761057|76096575|FG002|Overall Study|Currently On Study Treatment|0|||
42267869|NCT02761057|76096576|FG003|Overall Study|Currently On Study Treatment|0|||
42340513|NCT02003534|76178593|FG000|Overall Study|Lost to Follow-up|47|||
42340514|NCT02055365|76178597|FG000|Overall Study|Prematurely Withdrawn|1|||
42002319|NCT01097707|75810173|FG000|Overall Study|Reason unknown|0|||
42002320|NCT01097707|75810174|FG001|Overall Study|Reason unknown|0|||
42002321|NCT01097707|75810175|FG002|Overall Study|Reason unknown|0|||
42267870|NCT02761057|76096573|FG000|Overall Study|Adverse Event|11|||
42267871|NCT02761057|76096574|FG001|Overall Study|Adverse Event|9|||
42267872|NCT02761057|76096575|FG002|Overall Study|Adverse Event|5|||
42267873|NCT02761057|76096576|FG003|Overall Study|Adverse Event|3|||
42267874|NCT02761057|76096573|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
42267875|NCT02761057|76096574|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
42267876|NCT02761057|76096575|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
42267877|NCT02761057|76096576|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
42267878|NCT02761057|76096573|FG000|Overall Study|Progression/Relapse|29|||
42267879|NCT02761057|76096574|FG001|Overall Study|Progression/Relapse|27|||
42267880|NCT02761057|76096575|FG002|Overall Study|Progression/Relapse|20|||
42267881|NCT02761057|76096576|FG003|Overall Study|Progression/Relapse|23|||
42267882|NCT02761057|76096573|FG000|Overall Study|Death|2|||
42267883|NCT02761057|76096574|FG001|Overall Study|Death|2|||
42267884|NCT02761057|76096575|FG002|Overall Study|Death|1|||
42267885|NCT02761057|76096576|FG003|Overall Study|Death|1|||
42267886|NCT02761057|76096573|FG000|Overall Study|Other - Not Protocol Specified|2|||
42267887|NCT02761057|76096574|FG001|Overall Study|Other - Not Protocol Specified|1|||
42267888|NCT02761057|76096575|FG002|Overall Study|Other - Not Protocol Specified|2|||
42267889|NCT02761057|76096576|FG003|Overall Study|Other - Not Protocol Specified|0|||
42267890|NCT05085730|76096586|FG000|Overall Study|Withdrawal by Subject|4|||
42267891|NCT05085730|76096586|FG000|Overall Study|Physician Decision|1|||
42267892|NCT04886596|76096598|FG000|Overall Study|Adverse Event|73|||
42267893|NCT04886596|76096599|FG001|Overall Study|Adverse Event|78|||
42267894|NCT04886596|76096598|FG000|Overall Study|Lost to Follow-up|104|||
42267895|NCT04886596|76096599|FG001|Overall Study|Lost to Follow-up|104|||
42267896|NCT04886596|76096598|FG000|Overall Study|Ongoing|12095|||
42267897|NCT04886596|76096599|FG001|Overall Study|Ongoing|12107|||
42267898|NCT04886596|76096598|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
42267899|NCT04886596|76096599|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
42002322|NCT01097707|75810176|FG003|Overall Study|Reason unknown|0|||
42002323|NCT01097707|75810177|FG004|Overall Study|Reason unknown|1|||
42035021|NCT00932373|75843313|FG005|Overall Study|Progressive disease|1|||
42267900|NCT04886596|76096598|FG000|Overall Study|Migrated / Moved from the study area|17|||
42267901|NCT04886596|76096599|FG001|Overall Study|Migrated / Moved from the study area|14|||
42267902|NCT04886596|76096598|FG000|Overall Study|Unknown reason|16|||
42002324|NCT01326104|75810191|FG000|Overall Study|progressed prior to vaccine|0|||
42002325|NCT01326104|75810192|FG001|Overall Study|progressed prior to vaccine|2|||
42002326|NCT01326104|75810191|FG000|Overall Study|unable to make vaccine|0|||
42002327|NCT01326104|75810192|FG001|Overall Study|unable to make vaccine|2|||
42002328|NCT01326026|75810200|FG000|Overall Study|Adverse Event|4|||
42267903|NCT04886596|76096599|FG001|Overall Study|Unknown reason|23|||
42267904|NCT04839380|76096605|FG000|Overall Study|Withdrawal by Subject|2|||
42267905|NCT04839380|76096605|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
42267906|NCT04788147|76096611|FG000|Overall Study|Screen Failure|3|||
42002329|NCT01326026|75810201|FG001|Overall Study|Adverse Event|3|||
42002330|NCT01326026|75810200|FG000|Overall Study|Withdrawal Criteria|5|||
42002331|NCT01326026|75810201|FG001|Overall Study|Withdrawal Criteria|7|||
42002332|NCT01326026|75810200|FG000|Overall Study|Other|3|||
42002333|NCT01326026|75810201|FG001|Overall Study|Other|3|||
42135305|NCT00381303|75946024|FG001|Overall Study|Subject primary physician's decision|0|||
42135306|NCT00448812|75946044|FG000|Year 2|Missed visit but remained in study|4|||
42135307|NCT00448812|75946045|FG001|Year 2|Missed visit but remained in study|1|||
42135308|NCT00448812|75946044|FG000|Year 3|Withdrawal by Subject|1|||
42135309|NCT00448812|75946045|FG001|Year 3|Withdrawal by Subject|3|||
42135310|NCT00448812|75946044|FG000|Year 3|Lost to Follow-up|1|||
42340515|NCT02039375|76178608|FG000|Overall Study|Lost to Follow-up|2|||
42340516|NCT02054897|76178615|FG000|Overall Study|Withdrawal by Subject|2|||
42340517|NCT02054897|76178616|FG001|Overall Study|Withdrawal by Subject|0|||
42340518|NCT02054897|76178617|FG002|Overall Study|Withdrawal by Subject|2|||
42340519|NCT02054897|76178615|FG000|Overall Study|Missing follow-up information|3|||
42340520|NCT02054897|76178616|FG001|Overall Study|Missing follow-up information|5|||
42135311|NCT00448812|75946045|FG001|Year 3|Lost to Follow-up|0|||
42135312|NCT00448812|75946044|FG000|Year 3|Missed visit but remained in study|2|||
42002334|NCT01097629|75810210|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
42002335|NCT01097629|75810211|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
42002336|NCT01097629|75810212|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
42002337|NCT01097629|75810213|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
42002338|NCT01097629|75810214|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
42035022|NCT00932373|75843314|FG006|Overall Study|Progressive disease|0|||
42135313|NCT00448812|75946045|FG001|Year 3|Missed visit but remained in study|0|||
42135314|NCT00448812|75946044|FG000|Year 5|Missed visit but remained in study|1|||
42135315|NCT00448812|75946045|FG001|Year 5|Missed visit but remained in study|0|||
42340521|NCT02054897|76178617|FG002|Overall Study|Missing follow-up information|3|||
42340522|NCT02054897|76178615|FG000|Overall Study|Lost to Follow-up|4|||
42340523|NCT02054897|76178616|FG001|Overall Study|Lost to Follow-up|2|||
42002339|NCT01097629|75810215|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
42135316|NCT00364689|75946066|FG000|Overall Study|Lost to Follow-up|1|||
42135317|NCT00545129|75946074|FG000|Overall Study|Lack of Efficacy|2|||
42135318|NCT00545129|75946075|FG001|Overall Study|Lack of Efficacy|5|||
42135319|NCT00545129|75946074|FG000|Overall Study|Death|2|||
42135320|NCT00545129|75946075|FG001|Overall Study|Death|1|||
42135321|NCT00545129|75946074|FG000|Overall Study|Adverse Event|1|||
42135322|NCT00545129|75946075|FG001|Overall Study|Adverse Event|1|||
42135323|NCT00545129|75946074|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
42135324|NCT00545129|75946075|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
42340524|NCT02054897|76178617|FG002|Overall Study|Lost to Follow-up|7|||
42340525|NCT02054897|76178615|FG000|Overall Study|Randomized but not exposed|1|||
42340526|NCT02054897|76178616|FG001|Overall Study|Randomized but not exposed|0|||
42002340|NCT01097629|75810216|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
42002341|NCT01097629|75810217|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
42002342|NCT01097629|75810210|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
42002343|NCT01097629|75810211|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
42002344|NCT01097629|75810212|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
42002345|NCT01097629|75810213|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
42002346|NCT01097629|75810214|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
42002347|NCT01097629|75810215|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
42002348|NCT01097629|75810216|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
42002349|NCT01097629|75810217|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
42002350|NCT01097629|75810210|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
42002351|NCT01097629|75810211|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
42002352|NCT01097629|75810212|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
42002353|NCT01097629|75810213|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
42002354|NCT01097629|75810214|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
42002355|NCT01097629|75810215|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
42002356|NCT01097629|75810216|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
42002357|NCT01097629|75810217|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
42002358|NCT01097629|75810210|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
42002359|NCT01097629|75810211|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
42002360|NCT01097629|75810212|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
42002361|NCT01097629|75810213|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
42002362|NCT01097629|75810214|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
42002363|NCT01097629|75810215|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
42002364|NCT01097629|75810216|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
42135325|NCT00545129|75946074|FG000|Overall Study|Other|3|||
42135326|NCT00545129|75946075|FG001|Overall Study|Other|3|||
42135327|NCT00364611|75946083|FG000|Overall Study|Did not receive study medication|0|||
42135328|NCT00364611|75946084|FG001|Overall Study|Did not receive study medication|1|||
42135329|NCT00364611|75946083|FG000|Overall Study|Adverse Event|7|||
42135330|NCT00364611|75946084|FG001|Overall Study|Adverse Event|4|||
42135331|NCT00364611|75946083|FG000|Overall Study|Participant's Request|3|||
42267907|NCT04788147|76096612|FG001|Overall Study|Screen Failure|10|||
42267908|NCT04788147|76096611|FG000|Overall Study|Incomplete RMRS image session|2|||
42267909|NCT04788147|76096612|FG001|Overall Study|Incomplete RMRS image session|0|||
42267910|NCT04770155|76096633|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
42267911|NCT04770155|76096634|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
42267912|NCT04770155|76096635|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
42267913|NCT04770155|76096636|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
42267914|NCT04770155|76096637|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
42267915|NCT04770155|76096638|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
42267916|NCT04770155|76096639|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
42267917|NCT04770155|76096640|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
42267918|NCT04576988|76096660|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
42267919|NCT04576988|76096661|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
42267920|NCT04576988|76096660|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
42267921|NCT04576988|76096661|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
42267922|NCT04576988|76096660|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
42267923|NCT04576988|76096661|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
42267924|NCT04576988|76096660|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
42267925|NCT04576988|76096661|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
42267926|NCT04576988|76096660|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
42267927|NCT04576988|76096661|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
42267928|NCT04576988|76096660|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
42267929|NCT04576988|76096661|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
42267930|NCT04576988|76096660|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
42267931|NCT04576988|76096661|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
42267932|NCT04576988|76096660|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
42267933|NCT04576988|76096661|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
42267934|NCT04576988|76096660|FG000|Long Term Double Blind (LTDB)|Death|2|||
42267935|NCT04576988|76096661|FG001|Long Term Double Blind (LTDB)|Death|1|||
42002365|NCT01097629|75810217|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
42002366|NCT01097629|75810210|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
42002367|NCT01097629|75810211|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
42002368|NCT01097629|75810212|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
42002369|NCT01097629|75810213|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
42002370|NCT01097629|75810214|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
42002371|NCT01097629|75810215|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
42002372|NCT01097629|75810216|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
42002373|NCT01097629|75810217|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
42002374|NCT01097629|75810210|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
42002375|NCT01097629|75810211|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
42002376|NCT01097629|75810212|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42002377|NCT01097629|75810213|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42002378|NCT01097629|75810214|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42002379|NCT01097629|75810215|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42002380|NCT01097629|75810216|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42002381|NCT01097629|75810217|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
42002382|NCT01097629|75810210|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
42002383|NCT01097629|75810211|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
42002384|NCT01097629|75810212|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
42002385|NCT01097629|75810213|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42002386|NCT01097629|75810214|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42002387|NCT01097629|75810215|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42002388|NCT01097629|75810216|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42002389|NCT01097629|75810217|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
42002390|NCT01097629|75810210|FG000|DB RO Phase|Withdrawal by Subject|0|||
42002391|NCT01097629|75810211|FG001|DB RO Phase|Withdrawal by Subject|0|||
42002392|NCT01097629|75810212|FG002|DB RO Phase|Withdrawal by Subject|0|||
42002393|NCT01097629|75810213|FG003|DB RO Phase|Withdrawal by Subject|0|||
42002394|NCT01097629|75810214|FG004|DB RO Phase|Withdrawal by Subject|0|||
42002395|NCT01097629|75810215|FG005|DB RO Phase|Withdrawal by Subject|0|||
42002396|NCT01097629|75810216|FG006|DB RO Phase|Withdrawal by Subject|0|||
42002397|NCT01097629|75810217|FG007|DB RO Phase|Withdrawal by Subject|1|||
42002398|NCT01097629|75810210|FG000|DB RO Phase|Protocol Violation|0|||
42002399|NCT01097629|75810211|FG001|DB RO Phase|Protocol Violation|0|||
42002400|NCT01097629|75810212|FG002|DB RO Phase|Protocol Violation|0|||
42002401|NCT01097629|75810213|FG003|DB RO Phase|Protocol Violation|1|||
42002402|NCT01097629|75810214|FG004|DB RO Phase|Protocol Violation|0|||
42002403|NCT01097629|75810215|FG005|DB RO Phase|Protocol Violation|1|||
42002404|NCT01097629|75810216|FG006|DB RO Phase|Protocol Violation|1|||
42002405|NCT01097629|75810217|FG007|DB RO Phase|Protocol Violation|0|||
42002406|NCT01097629|75810210|FG000|DB RO Phase|Lost to Follow-up|0|||
42002407|NCT01097629|75810211|FG001|DB RO Phase|Lost to Follow-up|0|||
42002408|NCT01097629|75810212|FG002|DB RO Phase|Lost to Follow-up|0|||
42002409|NCT01097629|75810213|FG003|DB RO Phase|Lost to Follow-up|0|||
42002410|NCT01097629|75810214|FG004|DB RO Phase|Lost to Follow-up|0|||
42002411|NCT01097629|75810215|FG005|DB RO Phase|Lost to Follow-up|0|||
42002412|NCT01097629|75810216|FG006|DB RO Phase|Lost to Follow-up|2|||
42002413|NCT01097629|75810217|FG007|DB RO Phase|Lost to Follow-up|0|||
42002414|NCT01324622|75810242|FG000|Overall Study|Lost to Follow-up|7|||
42002415|NCT01324622|75810243|FG001|Overall Study|Lost to Follow-up|7|||
42002416|NCT01324622|75810242|FG000|Overall Study|Death|1|||
42002417|NCT01324622|75810243|FG001|Overall Study|Death|0|||
42002418|NCT01324622|75810242|FG000|Overall Study|Lack of Efficacy|1|||
42002419|NCT01324622|75810243|FG001|Overall Study|Lack of Efficacy|0|||
42267936|NCT04576988|76096660|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
42267937|NCT04576988|76096661|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
42267938|NCT04471207|76096675|FG000|Overall Study|Lost to Follow-up|4|||
42267939|NCT04471207|76096676|FG001|Overall Study|Lost to Follow-up|1|||
42267940|NCT04471207|76096675|FG000|Overall Study|Medication Contraindication|0|||
42267941|NCT04471207|76096676|FG001|Overall Study|Medication Contraindication|1|||
42267942|NCT04471207|76096675|FG000|Overall Study|Loss of Interest|2|||
42267943|NCT04471207|76096676|FG001|Overall Study|Loss of Interest|1|||
42267944|NCT04471207|76096675|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
42267945|NCT04471207|76096676|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
42267946|NCT04471207|76096675|FG000|Overall Study|Scheduling Conflicts|3|||
42002420|NCT01097005|75810250|FG000|Overall Study|Case Report Form not collected|18|||
42002421|NCT01097005|75810250|FG000|Overall Study|Subjects cannot visit the hospital|1|||
42002422|NCT01097005|75810250|FG000|Overall Study|Poor medication compliance|1|||
42002423|NCT01097005|75810250|FG000|Overall Study|No examination data available|244|||
42002424|NCT01097005|75810250|FG000|Overall Study|Deviation from exclusion criteria|37|||
42002425|NCT01097005|75810250|FG000|Overall Study|Adverse Event|14|||
42267947|NCT04471207|76096676|FG001|Overall Study|Scheduling Conflicts|1|||
42267948|NCT04471207|76096675|FG000|Overall Study|Physician Decision|1|||
42002426|NCT01097005|75810250|FG000|Overall Study|Discontinuance by complication|50|||
42002427|NCT01096849|75810259|FG000|Overall Study|Consent Withdrawn|1|||
42002428|NCT01096849|75810260|FG001|Overall Study|Consent Withdrawn|4|||
42002429|NCT01096849|75810261|FG002|Overall Study|Consent Withdrawn|2|||
42002430|NCT01096849|75810259|FG000|Overall Study|Lack of Efficacy|0|||
42002431|NCT01096849|75810260|FG001|Overall Study|Lack of Efficacy|2|||
42002432|NCT01096849|75810261|FG002|Overall Study|Lack of Efficacy|0|||
42002433|NCT01096849|75810259|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
42002434|NCT01096849|75810260|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
42002435|NCT01096849|75810261|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
42002436|NCT01096849|75810259|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
42002437|NCT01096849|75810260|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
42002438|NCT01096849|75810261|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
42002439|NCT01096849|75810259|FG000|Overall Study|Administrative Reasons|0|||
42002440|NCT01096849|75810260|FG001|Overall Study|Administrative Reasons|1|||
42002441|NCT01096849|75810261|FG002|Overall Study|Administrative Reasons|2|||
42002442|NCT01096849|75810259|FG000|Overall Study|Lost to Follow-up|1|||
42002443|NCT01096849|75810260|FG001|Overall Study|Lost to Follow-up|3|||
42002444|NCT01096849|75810261|FG002|Overall Study|Lost to Follow-up|1|||
42002445|NCT01324388|75810272|FG000|Part 1 of Study|Adverse Event|2|||
42340527|NCT02054897|76178617|FG002|Overall Study|Randomized but not exposed|0|||
42002446|NCT01324388|75810273|FG001|Part 1 of Study|Adverse Event|0|||
42002447|NCT01324388|75810274|FG002|Part 1 of Study|Adverse Event|0|||
42002448|NCT01324388|75810275|FG003|Part 1 of Study|Adverse Event|0|||
42002449|NCT01324388|75810272|FG000|Part 1 of Study|Protocol Violation|1|||
42002450|NCT01324388|75810273|FG001|Part 1 of Study|Protocol Violation|2|||
42002451|NCT01324388|75810274|FG002|Part 1 of Study|Protocol Violation|0|||
42002452|NCT01324388|75810275|FG003|Part 1 of Study|Protocol Violation|0|||
42267949|NCT04471207|76096676|FG001|Overall Study|Physician Decision|0|||
42267950|NCT04471207|76096675|FG000|Overall Study|Unwilling to Use System|0|||
42267951|NCT04471207|76096676|FG001|Overall Study|Unwilling to Use System|1|||
42340528|NCT01976312|76178627|FG000|Overall Study|Pregnancy|0|||
42340529|NCT01976312|76178628|FG001|Overall Study|Pregnancy|1|||
42340530|NCT01976312|76178627|FG000|Overall Study|Lost to Follow-up|2|||
42135332|NCT00364611|75946084|FG001|Overall Study|Participant's Request|4|||
42135333|NCT00364611|75946083|FG000|Overall Study|Disease Progression|38|||
42135334|NCT00364611|75946084|FG001|Overall Study|Disease Progression|8|||
42135335|NCT00364611|75946083|FG000|Overall Study|Investigator decision|2|||
42135336|NCT00364611|75946084|FG001|Overall Study|Investigator decision|2|||
42135337|NCT00364611|75946083|FG000|Overall Study|Found Ineligible|1|||
42135338|NCT00364611|75946084|FG001|Overall Study|Found Ineligible|0|||
42267952|NCT04356040|76096688|FG000|Overall Study|Death|2|||
42267953|NCT04356040|76096689|FG001|Overall Study|Death|0|||
42267954|NCT04356040|76096688|FG000|Overall Study|Lost to Follow-up|1|||
42002453|NCT01324388|75810272|FG000|Part 1 of Study|Physician Decision|1|||
42002454|NCT01324388|75810273|FG001|Part 1 of Study|Physician Decision|0|||
42267955|NCT04356040|76096689|FG001|Overall Study|Lost to Follow-up|0|||
42267956|NCT04356040|76096688|FG000|Overall Study|Physician Decision|0|||
42267957|NCT04356040|76096689|FG001|Overall Study|Physician Decision|1|||
42267958|NCT04356040|76096688|FG000|Overall Study|Withdrawal by Subject|13|||
42340531|NCT01976312|76178628|FG001|Overall Study|Lost to Follow-up|0|||
42340532|NCT01976312|76178627|FG000|Overall Study|Withdrawal by Subject|7|||
42340533|NCT01976312|76178628|FG001|Overall Study|Withdrawal by Subject|2|||
42340534|NCT01976312|76178627|FG000|Overall Study|Adverse Event|6|||
42340535|NCT01976312|76178628|FG001|Overall Study|Adverse Event|6|||
42340536|NCT01976312|76178627|FG000|Overall Study|Protocol Violation|2|||
42340537|NCT01976312|76178628|FG001|Overall Study|Protocol Violation|0|||
42340538|NCT02039219|76178637|FG000|Treatment|Withdrawal by Subject|1|||
42340539|NCT02039219|76178638|FG001|Treatment|Withdrawal by Subject|0|||
42340540|NCT02039219|76178637|FG000|Treatment|Adverse Event|0|||
42340541|NCT02039219|76178638|FG001|Treatment|Adverse Event|1|||
42340542|NCT02039219|76178637|FG000|Treatment|Physician Decision|1|||
42267959|NCT04356040|76096689|FG001|Overall Study|Withdrawal by Subject|1|||
42002455|NCT01324388|75810274|FG002|Part 1 of Study|Physician Decision|0|||
42002456|NCT01324388|75810275|FG003|Part 1 of Study|Physician Decision|0|||
42135339|NCT00364611|75946083|FG000|Overall Study|Presumed CR on Study|0|||
42267960|NCT04356040|76096688|FG000|Overall Study|Enrollment Pause|10|||
42340543|NCT02039219|76178638|FG001|Treatment|Physician Decision|0|||
42267961|NCT04356040|76096689|FG001|Overall Study|Enrollment Pause|0|||
42267962|NCT04356040|76096688|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
42340544|NCT02039219|76178637|FG000|Treatment|Lost to Follow-up|0|||
42002457|NCT01324388|75810272|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
42267963|NCT04356040|76096689|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
42002458|NCT01324388|75810273|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
42340545|NCT02039219|76178638|FG001|Treatment|Lost to Follow-up|1|||
42002459|NCT01324388|75810274|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
42340546|NCT02039219|76178637|FG000|Treatment|Protocol Violation|1|||
42002460|NCT01324388|75810275|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
42002461|NCT01324388|75810272|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
42002462|NCT01324388|75810273|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
42002463|NCT01324388|75810274|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
42002464|NCT01324388|75810275|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
42002465|NCT01102777|75810289|FG000|Overall Study|Death|2|||
42002466|NCT01102777|75810290|FG001|Overall Study|Death|6|||
42002467|NCT01102777|75810289|FG000|Overall Study|Lost to Follow-up|7|||
42002468|NCT01102777|75810290|FG001|Overall Study|Lost to Follow-up|10|||
42002469|NCT01324310|75810297|FG000|Overall Study|Adverse Event|1|||
42002470|NCT01324310|75810297|FG000|Overall Study|Disease Progression|1|||
42002471|NCT01102231|75810303|FG000|Overall Study|Protocol Violation|3|||
42002472|NCT01102231|75810303|FG000|Overall Study|Lack of Efficacy|2|||
42002473|NCT01102231|75810303|FG000|Overall Study|Death|2|||
42002474|NCT01102231|75810303|FG000|Overall Study|Adverse Event|3|||
42002475|NCT01102231|75810303|FG000|Overall Study|Withdrawal by Subject|1|||
42002476|NCT01102231|75810303|FG000|Overall Study|Did not received the treatment|4|||
42002477|NCT01094743|75810308|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
42002478|NCT01095835|75810316|FG000|Overall Study|Adverse Event|8|||
42002479|NCT01095835|75810317|FG001|Overall Study|Adverse Event|6|||
42002480|NCT01095835|75810318|FG002|Overall Study|Adverse Event|6|||
42002481|NCT01095835|75810316|FG000|Overall Study|Lack of Efficacy|0|||
42002482|NCT01095835|75810317|FG001|Overall Study|Lack of Efficacy|1|||
42002483|NCT01095835|75810318|FG002|Overall Study|Lack of Efficacy|0|||
42002484|NCT01095835|75810316|FG000|Overall Study|Physician Decision|0|||
42002485|NCT01095835|75810317|FG001|Overall Study|Physician Decision|0|||
42002486|NCT01095835|75810318|FG002|Overall Study|Physician Decision|1|||
42002487|NCT01095835|75810316|FG000|Overall Study|Withdrawal by Subject|1|||
42002488|NCT01095835|75810317|FG001|Overall Study|Withdrawal by Subject|3|||
42002489|NCT01095835|75810318|FG002|Overall Study|Withdrawal by Subject|0|||
42002490|NCT01095835|75810316|FG000|Overall Study|Non study compliance|0|||
42002491|NCT01095835|75810317|FG001|Overall Study|Non study compliance|0|||
42002492|NCT01095835|75810318|FG002|Overall Study|Non study compliance|1|||
42002493|NCT01095835|75810316|FG000|Overall Study|Protocol Violation|1|||
42267964|NCT04356040|76096688|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
42267965|NCT04356040|76096689|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
42267966|NCT04356040|76096688|FG000|Overall Study|PI left institution|3|||
42267967|NCT04356040|76096689|FG001|Overall Study|PI left institution|0|||
42267968|NCT04349631|76096695|FG000|Overall Study|Lost to Follow-up|3|||
42267969|NCT04349631|76096695|FG000|Overall Study|Withdrawal by Subject|7|||
42267970|NCT03961204|76096699|FG000|Overall Study|Withdrawal by Subject|2|||
42267971|NCT03961204|76096699|FG000|Overall Study|Lost to Follow-up|3|||
42267972|NCT03961204|76096699|FG000|Overall Study|Other|1|||
42267973|NCT03961204|76096699|FG000|Overall Study|Missing|1|||
42267974|NCT03898180|76096705|FG000|Overall Study|Ongoing in Study|133|||
42267975|NCT03898180|76096706|FG001|Overall Study|Ongoing in Study|134|||
42340547|NCT02039219|76178638|FG001|Treatment|Protocol Violation|0|||
42340548|NCT02039219|76178637|FG000|Treatment|Death|1|||
42340549|NCT02039219|76178638|FG001|Treatment|Death|0|||
42340550|NCT02039219|76178637|FG000|Follow up|Adverse Event|0|||
42340551|NCT02039219|76178638|FG001|Follow up|Adverse Event|1|||
42340552|NCT02053493|76178646|FG000|Overall Study|Withdrawal by Subject|1|||
42340553|NCT02053493|76178647|FG001|Overall Study|Withdrawal by Subject|1|||
42135340|NCT00364611|75946084|FG001|Overall Study|Presumed CR on Study|1|||
42002494|NCT01095835|75810317|FG001|Overall Study|Protocol Violation|2|||
42135341|NCT00364611|75946083|FG000|Overall Study|Receiving Liver Ablation|0|||
42340554|NCT02003144|76178655|FG000|Open Label Maintenance Phase|Other than specified|2|||
42340555|NCT02003144|76178656|FG001|Open Label Maintenance Phase|Other than specified|4|||
42340556|NCT02003144|76178655|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
42340557|NCT02003144|76178656|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
42340558|NCT02003144|76178655|FG000|Open Label Maintenance Phase|Pregnancy|0|||
42340559|NCT02003144|76178656|FG001|Open Label Maintenance Phase|Pregnancy|2|||
42340560|NCT02003144|76178655|FG000|Open Label Maintenance Phase|Physician Decision|1|||
42340561|NCT02003144|76178656|FG001|Open Label Maintenance Phase|Physician Decision|1|||
42340562|NCT02003144|76178655|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
42340563|NCT02003144|76178656|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
42340564|NCT02003144|76178655|FG000|Open Label Maintenance Phase|Adverse Event|2|||
42340565|NCT02003144|76178656|FG001|Open Label Maintenance Phase|Adverse Event|1|||
42340566|NCT02001194|76178667|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
42340567|NCT02001194|76178668|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
42002495|NCT01095835|75810318|FG002|Overall Study|Protocol Violation|0|||
42002496|NCT01324232|75810331|FG000|Overall Study|Protocol Violation|0|||
42002497|NCT01324232|75810332|FG001|Overall Study|Protocol Violation|0|||
42002498|NCT01324232|75810333|FG002|Overall Study|Protocol Violation|0|||
42267976|NCT03898180|76096705|FG000|Overall Study|Withdrawal by Subject|3|||
42002499|NCT01324232|75810334|FG003|Overall Study|Protocol Violation|2|||
42002500|NCT01324232|75810331|FG000|Overall Study|Missing|0|||
42002501|NCT01324232|75810332|FG001|Overall Study|Missing|0|||
42002502|NCT01324232|75810333|FG002|Overall Study|Missing|1|||
42135342|NCT00364611|75946084|FG001|Overall Study|Receiving Liver Ablation|1|||
42135343|NCT00364533|75946095|FG000|Overall Study|Adverse Event|8|||
42135344|NCT00364533|75946096|FG001|Overall Study|Adverse Event|7|||
42135345|NCT00364533|75946097|FG002|Overall Study|Adverse Event|15|||
42135346|NCT00364533|75946098|FG003|Overall Study|Adverse Event|5|||
42135347|NCT00364533|75946099|FG004|Overall Study|Adverse Event|2|||
42135348|NCT00364533|75946095|FG000|Overall Study|Withdrawal by Subject|4|||
42135349|NCT00364533|75946096|FG001|Overall Study|Withdrawal by Subject|8|||
42135350|NCT00364533|75946097|FG002|Overall Study|Withdrawal by Subject|6|||
42135351|NCT00364533|75946098|FG003|Overall Study|Withdrawal by Subject|6|||
42135352|NCT00364533|75946099|FG004|Overall Study|Withdrawal by Subject|6|||
42135353|NCT00364533|75946095|FG000|Overall Study|Lack of Efficacy|22|||
42002503|NCT01324232|75810334|FG003|Overall Study|Missing|0|||
42002504|NCT01324232|75810331|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
42002505|NCT01324232|75810332|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
42002506|NCT01324232|75810333|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
42002507|NCT01324232|75810334|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
42002508|NCT01324232|75810331|FG000|Overall Study|Lack of Efficacy|2|||
42002509|NCT01324232|75810332|FG001|Overall Study|Lack of Efficacy|1|||
42002510|NCT01324232|75810333|FG002|Overall Study|Lack of Efficacy|2|||
42002511|NCT01324232|75810334|FG003|Overall Study|Lack of Efficacy|2|||
42135354|NCT00364533|75946096|FG001|Overall Study|Lack of Efficacy|22|||
42135355|NCT00364533|75946097|FG002|Overall Study|Lack of Efficacy|21|||
42135356|NCT00364533|75946098|FG003|Overall Study|Lack of Efficacy|17|||
42135357|NCT00364533|75946099|FG004|Overall Study|Lack of Efficacy|42|||
42340568|NCT02001194|76178669|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
42340569|NCT02001194|76178670|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
42340570|NCT02001194|76178667|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
42340571|NCT02001194|76178668|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
42340572|NCT02001194|76178669|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
42340573|NCT02001194|76178670|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
42340574|NCT02038907|76178694|FG000|Overall Study|Protocol Violation|0|||
42340575|NCT02038907|76178695|FG001|Overall Study|Protocol Violation|0|||
42002512|NCT01324232|75810331|FG000|Overall Study|Participant Refused Medication|0|||
42002513|NCT01324232|75810332|FG001|Overall Study|Participant Refused Medication|1|||
42002514|NCT01324232|75810333|FG002|Overall Study|Participant Refused Medication|0|||
42002515|NCT01324232|75810334|FG003|Overall Study|Participant Refused Medication|0|||
42002516|NCT01324232|75810331|FG000|Overall Study|Intercurrent illness|0|||
42002517|NCT01324232|75810332|FG001|Overall Study|Intercurrent illness|0|||
42002518|NCT01324232|75810333|FG002|Overall Study|Intercurrent illness|0|||
42002519|NCT01324232|75810334|FG003|Overall Study|Intercurrent illness|1|||
42002520|NCT01324232|75810331|FG000|Overall Study|Adverse Event|2|||
42002521|NCT01324232|75810332|FG001|Overall Study|Adverse Event|5|||
42002522|NCT01324232|75810333|FG002|Overall Study|Adverse Event|6|||
42002523|NCT01324232|75810334|FG003|Overall Study|Adverse Event|6|||
42002524|NCT01324232|75810331|FG000|Overall Study|Withdrawal by Subject|0|||
42340576|NCT02038907|76178696|FG002|Overall Study|Protocol Violation|0|||
42340577|NCT02038907|76178697|FG003|Overall Study|Protocol Violation|0|||
42340578|NCT02038907|76178698|FG004|Overall Study|Protocol Violation|0|||
42340579|NCT02038907|76178699|FG005|Overall Study|Protocol Violation|0|||
42340580|NCT02038907|76178700|FG006|Overall Study|Protocol Violation|0|||
42340581|NCT02038907|76178701|FG007|Overall Study|Protocol Violation|0|||
42340582|NCT02038907|76178702|FG008|Overall Study|Protocol Violation|0|||
42002525|NCT01324232|75810332|FG001|Overall Study|Withdrawal by Subject|3|||
42340583|NCT02038907|76178703|FG009|Overall Study|Protocol Violation|0|||
42340584|NCT02038907|76178704|FG010|Overall Study|Protocol Violation|1|||
42340585|NCT02038907|76178705|FG011|Overall Study|Protocol Violation|0|||
42340586|NCT02038907|76178706|FG012|Overall Study|Protocol Violation|0|||
42002526|NCT01324232|75810333|FG002|Overall Study|Withdrawal by Subject|4|||
42340587|NCT02038907|76178707|FG013|Overall Study|Protocol Violation|0|||
42340588|NCT02038907|76178694|FG000|Overall Study|Withdrawal by Subject|0|||
42002527|NCT01324232|75810334|FG003|Overall Study|Withdrawal by Subject|0|||
42002528|NCT01324232|75810331|FG000|Overall Study|Lost to Follow-up|1|||
42002529|NCT01324232|75810332|FG001|Overall Study|Lost to Follow-up|0|||
42267977|NCT03898180|76096706|FG001|Overall Study|Withdrawal by Subject|2|||
42002530|NCT01324232|75810333|FG002|Overall Study|Lost to Follow-up|0|||
42002531|NCT01324232|75810334|FG003|Overall Study|Lost to Follow-up|0|||
42267978|NCT03898180|76096705|FG000|Overall Study|Death|109|||
42267979|NCT03898180|76096706|FG001|Overall Study|Death|106|||
42340589|NCT02038907|76178695|FG001|Overall Study|Withdrawal by Subject|0|||
42340590|NCT02038907|76178696|FG002|Overall Study|Withdrawal by Subject|0|||
42340591|NCT02038907|76178697|FG003|Overall Study|Withdrawal by Subject|0|||
42340592|NCT02038907|76178698|FG004|Overall Study|Withdrawal by Subject|0|||
42340593|NCT02038907|76178699|FG005|Overall Study|Withdrawal by Subject|0|||
42340594|NCT02038907|76178700|FG006|Overall Study|Withdrawal by Subject|0|||
42340595|NCT02038907|76178701|FG007|Overall Study|Withdrawal by Subject|0|||
42340596|NCT02038907|76178702|FG008|Overall Study|Withdrawal by Subject|0|||
42340597|NCT02038907|76178703|FG009|Overall Study|Withdrawal by Subject|0|||
42340598|NCT02038907|76178704|FG010|Overall Study|Withdrawal by Subject|1|||
42340599|NCT02038907|76178705|FG011|Overall Study|Withdrawal by Subject|0|||
42340600|NCT02038907|76178706|FG012|Overall Study|Withdrawal by Subject|0|||
42002532|NCT01094119|75810351|FG000|Overall Study|Lack of Efficacy|2|||
42340601|NCT02038907|76178707|FG013|Overall Study|Withdrawal by Subject|0|||
42002533|NCT01094119|75810352|FG001|Overall Study|Lack of Efficacy|4|||
42002534|NCT01323920|75810358|FG000|Overall Study|Death|5|||
42340602|NCT02038829|76178739|FG000|Washout Period 1|Death|0|||
42340603|NCT02038829|76178740|FG001|Washout Period 1|Death|0|||
42002535|NCT01323920|75810358|FG000|Overall Study|Withdrawal by Subject|1|||
42002536|NCT01093885|75810362|FG000|Overall Study|Adverse Event|4|||
42340604|NCT02038829|76178741|FG002|Washout Period 1|Death|0|||
42340605|NCT02038829|76178742|FG003|Washout Period 1|Death|0|||
42340606|NCT02038829|76178743|FG004|Washout Period 1|Death|1|||
42340607|NCT02038829|76178744|FG005|Washout Period 1|Death|0|||
42340608|NCT02038829|76178745|FG006|Washout Period 1|Death|0|||
42340609|NCT02038829|76178746|FG007|Washout Period 1|Death|0|||
42340610|NCT02038829|76178747|FG008|Washout Period 1|Death|0|||
42340611|NCT02038829|76178748|FG009|Washout Period 1|Death|0|||
42340612|NCT02038829|76178749|FG010|Washout Period 1|Death|0|||
42340613|NCT02038829|76178750|FG011|Washout Period 1|Death|0|||
42340614|NCT02038829|76178739|FG000|Treatment Period 2|Adverse Event|0|||
42340615|NCT02038829|76178740|FG001|Treatment Period 2|Adverse Event|0|||
42340616|NCT02038829|76178741|FG002|Treatment Period 2|Adverse Event|0|||
42340617|NCT02038829|76178742|FG003|Treatment Period 2|Adverse Event|0|||
42340618|NCT02038829|76178743|FG004|Treatment Period 2|Adverse Event|0|||
42340619|NCT02038829|76178744|FG005|Treatment Period 2|Adverse Event|0|||
42340620|NCT02038829|76178745|FG006|Treatment Period 2|Adverse Event|0|||
42340621|NCT02038829|76178746|FG007|Treatment Period 2|Adverse Event|0|||
42340622|NCT02038829|76178747|FG008|Treatment Period 2|Adverse Event|0|||
42340623|NCT02038829|76178748|FG009|Treatment Period 2|Adverse Event|0|||
42340624|NCT02038829|76178749|FG010|Treatment Period 2|Adverse Event|1|||
42340625|NCT02038829|76178750|FG011|Treatment Period 2|Adverse Event|0|||
42340626|NCT02038829|76178739|FG000|Treatment Period 2|Withdrawal by Subject|1|||
42340627|NCT02038829|76178740|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42340628|NCT02038829|76178741|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42340629|NCT02038829|76178742|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42340630|NCT02038829|76178743|FG004|Treatment Period 2|Withdrawal by Subject|0|||
42340631|NCT02038829|76178744|FG005|Treatment Period 2|Withdrawal by Subject|0|||
42340632|NCT02038829|76178745|FG006|Treatment Period 2|Withdrawal by Subject|0|||
42340633|NCT02038829|76178746|FG007|Treatment Period 2|Withdrawal by Subject|0|||
42340634|NCT02038829|76178747|FG008|Treatment Period 2|Withdrawal by Subject|0|||
42340635|NCT02038829|76178748|FG009|Treatment Period 2|Withdrawal by Subject|0|||
42340636|NCT02038829|76178749|FG010|Treatment Period 2|Withdrawal by Subject|0|||
42340637|NCT02038829|76178750|FG011|Treatment Period 2|Withdrawal by Subject|0|||
42340638|NCT02038829|76178739|FG000|Washout Period 2|Adverse Event|0|||
42002537|NCT01093885|75810362|FG000|Overall Study|Lost to Follow-up|1|||
42002538|NCT01101997|75810367|FG000|Overall Study|Withdrawal by Subject|2|||
42002539|NCT01324830|75810397|FG000|Overall Study|Progressive Disease|3|||
42002540|NCT01324830|75810398|FG001|Overall Study|Progressive Disease|2|||
42002541|NCT01324830|75810399|FG002|Overall Study|Progressive Disease|3|||
42002542|NCT01324830|75810400|FG003|Overall Study|Progressive Disease|3|||
42002543|NCT01324830|75810401|FG004|Overall Study|Progressive Disease|6|||
42002544|NCT01324830|75810402|FG005|Overall Study|Progressive Disease|6|||
42002545|NCT01324830|75810403|FG006|Overall Study|Progressive Disease|3|||
42002546|NCT01324830|75810404|FG007|Overall Study|Progressive Disease|3|||
42002547|NCT01324830|75810405|FG008|Overall Study|Progressive Disease|3|||
42002548|NCT01324830|75810406|FG009|Overall Study|Progressive Disease|6|||
42002549|NCT01324830|75810407|FG010|Overall Study|Progressive Disease|2|||
42002550|NCT01324830|75810408|FG011|Overall Study|Progressive Disease|1|||
42002551|NCT01324830|75810409|FG012|Overall Study|Progressive Disease|1|||
42002552|NCT01324830|75810410|FG013|Overall Study|Progressive Disease|1|||
42002553|NCT01324830|75810411|FG014|Overall Study|Progressive Disease|1|||
42002554|NCT01324830|75810412|FG015|Overall Study|Progressive Disease|3|||
42002555|NCT01324830|75810413|FG016|Overall Study|Progressive Disease|2|||
42002556|NCT01324830|75810414|FG017|Overall Study|Progressive Disease|3|||
42002557|NCT01324830|75810415|FG018|Overall Study|Progressive Disease|4|||
42002558|NCT01324830|75810397|FG000|Overall Study|Dose limiting toxicity|0|||
42002559|NCT01324830|75810398|FG001|Overall Study|Dose limiting toxicity|0|||
42002560|NCT01324830|75810399|FG002|Overall Study|Dose limiting toxicity|0|||
42002561|NCT01324830|75810400|FG003|Overall Study|Dose limiting toxicity|0|||
42002562|NCT01324830|75810401|FG004|Overall Study|Dose limiting toxicity|1|||
42002563|NCT01324830|75810402|FG005|Overall Study|Dose limiting toxicity|0|||
42002564|NCT01324830|75810403|FG006|Overall Study|Dose limiting toxicity|0|||
42002565|NCT01324830|75810404|FG007|Overall Study|Dose limiting toxicity|0|||
42002566|NCT01324830|75810405|FG008|Overall Study|Dose limiting toxicity|0|||
42002567|NCT01324830|75810406|FG009|Overall Study|Dose limiting toxicity|0|||
42002568|NCT01324830|75810407|FG010|Overall Study|Dose limiting toxicity|0|||
42002569|NCT01324830|75810408|FG011|Overall Study|Dose limiting toxicity|0|||
42002570|NCT01324830|75810409|FG012|Overall Study|Dose limiting toxicity|0|||
42002571|NCT01324830|75810410|FG013|Overall Study|Dose limiting toxicity|0|||
42002572|NCT01324830|75810411|FG014|Overall Study|Dose limiting toxicity|0|||
42002573|NCT01324830|75810412|FG015|Overall Study|Dose limiting toxicity|0|||
42002574|NCT01324830|75810413|FG016|Overall Study|Dose limiting toxicity|1|||
42002575|NCT01324830|75810414|FG017|Overall Study|Dose limiting toxicity|1|||
42002576|NCT01324830|75810415|FG018|Overall Study|Dose limiting toxicity|1|||
42002577|NCT01324830|75810397|FG000|Overall Study|Reason not mentioned above|0|||
42035023|NCT00932373|75843315|FG007|Overall Study|Progressive disease|2|||
42267980|NCT03816007|76096714|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
42267981|NCT03816007|76096715|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
42267982|NCT03816007|76096714|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
42002578|NCT01324830|75810398|FG001|Overall Study|Reason not mentioned above|0|||
42002579|NCT01324830|75810399|FG002|Overall Study|Reason not mentioned above|0|||
42002580|NCT01324830|75810400|FG003|Overall Study|Reason not mentioned above|0|||
42002581|NCT01324830|75810401|FG004|Overall Study|Reason not mentioned above|0|||
42002582|NCT01324830|75810402|FG005|Overall Study|Reason not mentioned above|0|||
42035024|NCT00932373|75843316|FG008|Overall Study|Progressive disease|1|||
42035025|NCT00932373|75843317|FG009|Overall Study|Progressive disease|9|||
42035026|NCT00932373|75843318|FG010|Overall Study|Progressive disease|2|||
42267983|NCT03816007|76096715|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
42267984|NCT03816007|76096714|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
42267985|NCT03816007|76096715|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
42267986|NCT03712449|76096723|FG000|Overall Study|Withdraw Consent|0|||
42267987|NCT03712449|76096724|FG001|Overall Study|Withdraw Consent|1|||
42267988|NCT03530124|76096732|FG000|Overall Study|Withdrawal by Subject|0|||
42267989|NCT03530124|76096733|FG001|Overall Study|Withdrawal by Subject|1|||
42267990|NCT03530124|76096732|FG000|Overall Study|Protocol Violation|1|||
42267991|NCT03530124|76096733|FG001|Overall Study|Protocol Violation|0|||
42267992|NCT03530124|76096732|FG000|Overall Study|Discharged prior to study completion|1|||
42267993|NCT03530124|76096733|FG001|Overall Study|Discharged prior to study completion|0|||
42002583|NCT01324830|75810403|FG006|Overall Study|Reason not mentioned above|0|||
42002584|NCT01324830|75810404|FG007|Overall Study|Reason not mentioned above|0|||
42002585|NCT01324830|75810405|FG008|Overall Study|Reason not mentioned above|0|||
42002586|NCT01324830|75810406|FG009|Overall Study|Reason not mentioned above|0|||
42002587|NCT01324830|75810407|FG010|Overall Study|Reason not mentioned above|0|||
42002588|NCT01324830|75810408|FG011|Overall Study|Reason not mentioned above|0|||
42035027|NCT00932373|75843308|FG000|Overall Study|Adverse Event|0|||
42267994|NCT03343483|76096741|FG000|Overall Study|Death|0|||
42002589|NCT01324830|75810409|FG012|Overall Study|Reason not mentioned above|0|||
42002590|NCT01324830|75810410|FG013|Overall Study|Reason not mentioned above|0|||
42002591|NCT01324830|75810411|FG014|Overall Study|Reason not mentioned above|0|||
42002592|NCT01324830|75810412|FG015|Overall Study|Reason not mentioned above|0|||
42002593|NCT01324830|75810413|FG016|Overall Study|Reason not mentioned above|0|||
42002594|NCT01324830|75810414|FG017|Overall Study|Reason not mentioned above|1|||
42002595|NCT01324830|75810415|FG018|Overall Study|Reason not mentioned above|0|||
42002596|NCT01324830|75810397|FG000|Overall Study|Adverse Event, serious fatal|0|||
42002597|NCT01324830|75810398|FG001|Overall Study|Adverse Event, serious fatal|1|||
42002598|NCT01324830|75810399|FG002|Overall Study|Adverse Event, serious fatal|0|||
42002599|NCT01324830|75810400|FG003|Overall Study|Adverse Event, serious fatal|0|||
42002600|NCT01324830|75810401|FG004|Overall Study|Adverse Event, serious fatal|0|||
42002601|NCT01324830|75810402|FG005|Overall Study|Adverse Event, serious fatal|0|||
42002602|NCT01324830|75810403|FG006|Overall Study|Adverse Event, serious fatal|0|||
42002603|NCT01324830|75810404|FG007|Overall Study|Adverse Event, serious fatal|0|||
42002604|NCT01324830|75810405|FG008|Overall Study|Adverse Event, serious fatal|0|||
42002605|NCT01324830|75810406|FG009|Overall Study|Adverse Event, serious fatal|0|||
42002606|NCT01324830|75810407|FG010|Overall Study|Adverse Event, serious fatal|0|||
42002607|NCT01324830|75810408|FG011|Overall Study|Adverse Event, serious fatal|0|||
42002608|NCT01324830|75810409|FG012|Overall Study|Adverse Event, serious fatal|0|||
42002609|NCT01324830|75810410|FG013|Overall Study|Adverse Event, serious fatal|0|||
42002610|NCT01324830|75810411|FG014|Overall Study|Adverse Event, serious fatal|0|||
42002611|NCT01324830|75810412|FG015|Overall Study|Adverse Event, serious fatal|0|||
42002612|NCT01324830|75810413|FG016|Overall Study|Adverse Event, serious fatal|0|||
42002613|NCT01324830|75810414|FG017|Overall Study|Adverse Event, serious fatal|0|||
42002614|NCT01324830|75810415|FG018|Overall Study|Adverse Event, serious fatal|0|||
42002615|NCT01324830|75810397|FG000|Overall Study|Adverse Event, non-fatal|0|||
42002616|NCT01324830|75810398|FG001|Overall Study|Adverse Event, non-fatal|0|||
42002617|NCT01324830|75810399|FG002|Overall Study|Adverse Event, non-fatal|0|||
42002618|NCT01324830|75810400|FG003|Overall Study|Adverse Event, non-fatal|0|||
42002619|NCT01324830|75810401|FG004|Overall Study|Adverse Event, non-fatal|0|||
42002620|NCT01324830|75810402|FG005|Overall Study|Adverse Event, non-fatal|0|||
42002621|NCT01324830|75810403|FG006|Overall Study|Adverse Event, non-fatal|0|||
42002622|NCT01324830|75810404|FG007|Overall Study|Adverse Event, non-fatal|0|||
42002623|NCT01324830|75810405|FG008|Overall Study|Adverse Event, non-fatal|2|||
42002624|NCT01324830|75810406|FG009|Overall Study|Adverse Event, non-fatal|0|||
42002625|NCT01324830|75810407|FG010|Overall Study|Adverse Event, non-fatal|1|||
42002626|NCT01324830|75810408|FG011|Overall Study|Adverse Event, non-fatal|0|||
42002627|NCT01324830|75810409|FG012|Overall Study|Adverse Event, non-fatal|0|||
42002628|NCT01324830|75810410|FG013|Overall Study|Adverse Event, non-fatal|0|||
42002629|NCT01324830|75810411|FG014|Overall Study|Adverse Event, non-fatal|0|||
42340639|NCT02038829|76178740|FG001|Washout Period 2|Adverse Event|0|||
42340640|NCT02038829|76178741|FG002|Washout Period 2|Adverse Event|0|||
42340641|NCT02038829|76178742|FG003|Washout Period 2|Adverse Event|0|||
42340642|NCT02038829|76178743|FG004|Washout Period 2|Adverse Event|0|||
42340643|NCT02038829|76178744|FG005|Washout Period 2|Adverse Event|0|||
42340644|NCT02038829|76178745|FG006|Washout Period 2|Adverse Event|0|||
42002630|NCT01324830|75810412|FG015|Overall Study|Adverse Event, non-fatal|0|||
42002631|NCT01324830|75810413|FG016|Overall Study|Adverse Event, non-fatal|0|||
42002632|NCT01324830|75810414|FG017|Overall Study|Adverse Event, non-fatal|1|||
42002633|NCT01324830|75810415|FG018|Overall Study|Adverse Event, non-fatal|0|||
42002634|NCT01324830|75810397|FG000|Overall Study|Withdrawal by Subject|0|||
42002635|NCT01324830|75810398|FG001|Overall Study|Withdrawal by Subject|0|||
42002636|NCT01324830|75810399|FG002|Overall Study|Withdrawal by Subject|0|||
42002637|NCT01324830|75810400|FG003|Overall Study|Withdrawal by Subject|0|||
42002638|NCT01324830|75810401|FG004|Overall Study|Withdrawal by Subject|0|||
42002639|NCT01324830|75810402|FG005|Overall Study|Withdrawal by Subject|1|||
42002640|NCT01324830|75810403|FG006|Overall Study|Withdrawal by Subject|0|||
42002641|NCT01324830|75810404|FG007|Overall Study|Withdrawal by Subject|0|||
42002642|NCT01324830|75810405|FG008|Overall Study|Withdrawal by Subject|0|||
42002643|NCT01324830|75810406|FG009|Overall Study|Withdrawal by Subject|0|||
42002644|NCT01324830|75810407|FG010|Overall Study|Withdrawal by Subject|1|||
42002645|NCT01324830|75810408|FG011|Overall Study|Withdrawal by Subject|0|||
42002646|NCT01324830|75810409|FG012|Overall Study|Withdrawal by Subject|0|||
42002647|NCT01324830|75810410|FG013|Overall Study|Withdrawal by Subject|0|||
42002648|NCT01324830|75810411|FG014|Overall Study|Withdrawal by Subject|0|||
42002649|NCT01324830|75810412|FG015|Overall Study|Withdrawal by Subject|0|||
42002650|NCT01324830|75810413|FG016|Overall Study|Withdrawal by Subject|0|||
42002651|NCT01324830|75810414|FG017|Overall Study|Withdrawal by Subject|0|||
42002652|NCT01324830|75810415|FG018|Overall Study|Withdrawal by Subject|1|||
42002653|NCT01324440|75810463|FG000|Overall Study|Subject moved|0|||
42002654|NCT01324440|75810464|FG001|Overall Study|Subject moved|1|||
42002655|NCT01325493|75810472|FG000|Overall Study|Protocol Violation|0|||
42002656|NCT01325493|75810473|FG001|Overall Study|Protocol Violation|1|||
42002657|NCT01325493|75810472|FG000|Overall Study|loss of neuromonitoring signals|0|||
42002658|NCT01325493|75810473|FG001|Overall Study|loss of neuromonitoring signals|2|||
42002659|NCT01325493|75810472|FG000|Overall Study|Allergy|1|||
42002660|NCT01325493|75810473|FG001|Overall Study|Allergy|0|||
42002661|NCT01323972|75810483|FG000|Overall Study|Withdrawal by Subject|1|||
42002662|NCT01323972|75810484|FG001|Overall Study|Withdrawal by Subject|0|||
42002663|NCT01323972|75810485|FG002|Overall Study|Withdrawal by Subject|1|||
42002664|NCT01323972|75810486|FG003|Overall Study|Withdrawal by Subject|0|||
42002665|NCT01323972|75810483|FG000|Overall Study|Migrated/moved from study area|1|||
42002666|NCT01323972|75810484|FG001|Overall Study|Migrated/moved from study area|2|||
42002667|NCT01323972|75810485|FG002|Overall Study|Migrated/moved from study area|0|||
42002668|NCT01323972|75810486|FG003|Overall Study|Migrated/moved from study area|0|||
42002669|NCT01323972|75810483|FG000|Overall Study|Lost to Follow-up|0|||
42002670|NCT01323972|75810484|FG001|Overall Study|Lost to Follow-up|1|||
42002671|NCT01323972|75810485|FG002|Overall Study|Lost to Follow-up|1|||
42002672|NCT01323972|75810486|FG003|Overall Study|Lost to Follow-up|1|||
42002673|NCT01325337|75810503|FG000|Overall Study|Adverse Event|0|||
42002674|NCT01325337|75810504|FG001|Overall Study|Adverse Event|2|||
42002675|NCT01325337|75810505|FG002|Overall Study|Adverse Event|2|||
42002676|NCT01325337|75810506|FG003|Overall Study|Adverse Event|1|||
42002677|NCT01325337|75810507|FG004|Overall Study|Adverse Event|2|||
42002678|NCT01325337|75810503|FG000|Overall Study|Lost to Follow-up|2|||
42002679|NCT01325337|75810504|FG001|Overall Study|Lost to Follow-up|2|||
42002680|NCT01325337|75810505|FG002|Overall Study|Lost to Follow-up|2|||
42002681|NCT01325337|75810506|FG003|Overall Study|Lost to Follow-up|1|||
42340645|NCT02038829|76178746|FG007|Washout Period 2|Adverse Event|0|||
42267995|NCT03343483|76096742|FG001|Overall Study|Death|3|||
42267996|NCT03343483|76096741|FG000|Overall Study|Lost to Follow-up|9|||
42267997|NCT03343483|76096742|FG001|Overall Study|Lost to Follow-up|13|||
42267998|NCT03343483|76096741|FG000|Overall Study|Withdrawal by Subject|8|||
42267999|NCT03343483|76096742|FG001|Overall Study|Withdrawal by Subject|17|||
42268000|NCT03035409|76096748|FG000|Overall Study|Adverse Event|5|||
42268001|NCT03035409|76096748|FG000|Overall Study|Death|2|||
42268002|NCT03035409|76096748|FG000|Overall Study|Withdrawal by Subject|2|||
42268003|NCT03035409|76096748|FG000|Overall Study|Non compliance|4|||
42340646|NCT02038829|76178747|FG008|Washout Period 2|Adverse Event|1|||
42340647|NCT02038829|76178748|FG009|Washout Period 2|Adverse Event|0|||
42340648|NCT02038829|76178749|FG010|Washout Period 2|Adverse Event|0|||
42340649|NCT02038829|76178750|FG011|Washout Period 2|Adverse Event|0|||
42340650|NCT02038829|76178739|FG000|Washout Period 2|Withdrawal by Subject|0|||
42340651|NCT02038829|76178740|FG001|Washout Period 2|Withdrawal by Subject|0|||
42268004|NCT03035409|76096748|FG000|Overall Study|Patient was jittery|1|||
42268005|NCT03035409|76096748|FG000|Overall Study|Did not like Questionnaire|1|||
42268006|NCT03035409|76096748|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
42340652|NCT02038829|76178741|FG002|Washout Period 2|Withdrawal by Subject|0|||
42002682|NCT01325337|75810507|FG004|Overall Study|Lost to Follow-up|2|||
42002683|NCT01325337|75810503|FG000|Overall Study|Personal Reasons|2|||
42002684|NCT01325337|75810504|FG001|Overall Study|Personal Reasons|5|||
42002685|NCT01325337|75810505|FG002|Overall Study|Personal Reasons|4|||
42002686|NCT01325337|75810506|FG003|Overall Study|Personal Reasons|8|||
42002687|NCT01325337|75810507|FG004|Overall Study|Personal Reasons|3|||
42002688|NCT01325337|75810503|FG000|Overall Study|Withdrawal by Subject|1|||
42340653|NCT02038829|76178742|FG003|Washout Period 2|Withdrawal by Subject|0|||
42002689|NCT01325337|75810504|FG001|Overall Study|Withdrawal by Subject|0|||
42002690|NCT01325337|75810505|FG002|Overall Study|Withdrawal by Subject|1|||
42002691|NCT01325337|75810506|FG003|Overall Study|Withdrawal by Subject|0|||
42002692|NCT01325337|75810507|FG004|Overall Study|Withdrawal by Subject|1|||
42002693|NCT01324947|75810519|FG000|Overall Study|Adverse Event|7|||
42002694|NCT01324947|75810519|FG000|Overall Study|Death|10|||
42002695|NCT01324947|75810519|FG000|Overall Study|Other|3|||
42002696|NCT01324947|75810519|FG000|Overall Study|Progressive Disease|50|||
42002697|NCT01324947|75810519|FG000|Overall Study|Withdrawal by Subject|3|||
42002698|NCT01324947|75810519|FG000|Overall Study|1 discontinued before starting drug|1|||
42002699|NCT01101841|75810527|FG000|Overall Study|Adverse Event|15|||
42002700|NCT01101841|75810528|FG001|Overall Study|Adverse Event|15|||
42002701|NCT01101841|75810527|FG000|Overall Study|Lost to Follow-up|9|||
42002702|NCT01101841|75810528|FG001|Overall Study|Lost to Follow-up|3|||
42002703|NCT01101841|75810527|FG000|Overall Study|Withdrawal by Subject|21|||
42002704|NCT01101841|75810528|FG001|Overall Study|Withdrawal by Subject|40|||
42002705|NCT01101841|75810527|FG000|Overall Study|Protocol Violation|1|||
42002706|NCT01101841|75810528|FG001|Overall Study|Protocol Violation|1|||
42002707|NCT01101841|75810527|FG000|Overall Study|Physician Decision|0|||
42002708|NCT01101841|75810528|FG001|Overall Study|Physician Decision|2|||
42002709|NCT01101841|75810527|FG000|Overall Study|Lack of Efficacy|0|||
42002710|NCT01101841|75810528|FG001|Overall Study|Lack of Efficacy|2|||
42002711|NCT01101841|75810527|FG000|Overall Study|Other|0|||
42002712|NCT01101841|75810528|FG001|Overall Study|Other|1|||
42002713|NCT01101841|75810527|FG000|Overall Study|Suicidality Tracking Scale|3|||
42002714|NCT01101841|75810528|FG001|Overall Study|Suicidality Tracking Scale|1|||
42002715|NCT01101841|75810527|FG000|Overall Study|Eligibility Criteria|1|||
42002716|NCT01101841|75810528|FG001|Overall Study|Eligibility Criteria|2|||
42002717|NCT01324401|75810537|FG000|Overall Study|Withdrawn before any treatment|0|||
42002718|NCT01324401|75810538|FG001|Overall Study|Withdrawn before any treatment|3|||
42002719|NCT01324401|75810537|FG000|Overall Study|Adverse Event|1|||
42002720|NCT01324401|75810538|FG001|Overall Study|Adverse Event|3|||
42002721|NCT01323660|75810544|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
42002722|NCT01323660|75810545|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
42002723|NCT01323660|75810546|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
42002724|NCT01323660|75810547|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
42002725|NCT01323660|75810548|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
42002726|NCT01323660|75810549|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
42002727|NCT01323660|75810544|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
42002728|NCT01323660|75810545|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
42002729|NCT01323660|75810546|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
42002730|NCT01323660|75810547|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
42002731|NCT01323660|75810548|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
42002732|NCT01323660|75810549|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
42002733|NCT01323660|75810544|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
42002734|NCT01323660|75810545|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
42002735|NCT01323660|75810546|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
42002736|NCT01323660|75810547|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
42002737|NCT01323660|75810548|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
42002738|NCT01323660|75810549|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
42002739|NCT01323660|75810544|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
42002740|NCT01323660|75810545|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
42002741|NCT01323660|75810546|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
42002742|NCT01323660|75810547|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
42002743|NCT01323660|75810548|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
42002744|NCT01323660|75810549|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
42002745|NCT01323660|75810544|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42002746|NCT01323660|75810545|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42002747|NCT01323660|75810546|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42002748|NCT01323660|75810547|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42002749|NCT01323660|75810548|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
42002750|NCT01323660|75810549|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42002751|NCT01323660|75810544|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
42002752|NCT01323660|75810545|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
42002753|NCT01323660|75810546|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
42002754|NCT01323660|75810547|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
42002755|NCT01323660|75810548|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
42002756|NCT01323660|75810549|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
42002757|NCT01323660|75810544|FG000|Washout Period (14 Days)|Adverse Event|0|||
42002758|NCT01323660|75810545|FG001|Washout Period (14 Days)|Adverse Event|0|||
42002759|NCT01323660|75810546|FG002|Washout Period (14 Days)|Adverse Event|0|||
42002760|NCT01323660|75810547|FG003|Washout Period (14 Days)|Adverse Event|0|||
42002761|NCT01323660|75810548|FG004|Washout Period (14 Days)|Adverse Event|1|||
42002762|NCT01323660|75810549|FG005|Washout Period (14 Days)|Adverse Event|0|||
42135358|NCT00364533|75946095|FG000|Overall Study|Subject discharged from hospital|4|||
42268007|NCT03035409|76096748|FG000|Overall Study|Did not like taking drugs|1|||
42268008|NCT02948088|76096752|FG000|Overall Study|Lost to Follow-up|8|||
42268009|NCT02948088|76096752|FG000|Overall Study|Death|1|||
42035028|NCT00932373|75843309|FG001|Overall Study|Adverse Event|0|||
42035029|NCT00932373|75843310|FG002|Overall Study|Adverse Event|0|||
42035030|NCT00932373|75843311|FG003|Overall Study|Adverse Event|0|||
42035031|NCT00932373|75843312|FG004|Overall Study|Adverse Event|2|||
42035032|NCT00932373|75843313|FG005|Overall Study|Adverse Event|1|||
42268010|NCT02948088|76096752|FG000|Overall Study|Withdrawal by Subject|4|||
42268011|NCT02948088|76096752|FG000|Overall Study|Other|2|||
42268012|NCT02943915|76096791|FG000|Overall Study|Withdrawal by Subject|2|||
42268013|NCT02943915|76096792|FG001|Overall Study|Withdrawal by Subject|1|||
42268014|NCT02943915|76096793|FG002|Overall Study|Withdrawal by Subject|0|||
42268015|NCT02943915|76096794|FG003|Overall Study|Withdrawal by Subject|0|||
42268016|NCT02943915|76096791|FG000|Overall Study|Lost to Follow-up|3|||
42268017|NCT02943915|76096792|FG001|Overall Study|Lost to Follow-up|1|||
42268018|NCT02943915|76096793|FG002|Overall Study|Lost to Follow-up|0|||
42035033|NCT00932373|75843314|FG006|Overall Study|Adverse Event|0|||
42268019|NCT02943915|76096794|FG003|Overall Study|Lost to Follow-up|0|||
42002763|NCT01323660|75810544|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
42268020|NCT02943915|76096791|FG000|Overall Study|excluded|0|||
42002764|NCT01323660|75810545|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
42035034|NCT00932373|75843315|FG007|Overall Study|Adverse Event|1|||
42035035|NCT00932373|75843316|FG008|Overall Study|Adverse Event|0|||
42002765|NCT01323660|75810546|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
42002766|NCT01323660|75810547|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
42002767|NCT01323660|75810548|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
42002768|NCT01323660|75810549|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
42002769|NCT01323660|75810544|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
42002770|NCT01323660|75810545|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
42002771|NCT01323660|75810546|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
42002772|NCT01323660|75810547|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
42002773|NCT01323660|75810548|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
42002774|NCT01323660|75810549|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
42002775|NCT01323660|75810544|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
42002776|NCT01323660|75810545|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
42002777|NCT01323660|75810546|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
42002778|NCT01323660|75810547|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
42002779|NCT01323660|75810548|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
42002780|NCT01323660|75810549|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
42002781|NCT01323660|75810544|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
42002782|NCT01323660|75810545|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
42002783|NCT01323660|75810546|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
42002784|NCT01323660|75810547|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
42002785|NCT01323660|75810548|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
42002786|NCT01323660|75810549|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
42002787|NCT01323660|75810544|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
42035036|NCT00932373|75843317|FG009|Overall Study|Adverse Event|2|||
42035037|NCT00932373|75843318|FG010|Overall Study|Adverse Event|1|||
42035038|NCT00932373|75843308|FG000|Overall Study|Physician Decision|0|||
42135359|NCT00364533|75946096|FG001|Overall Study|Subject discharged from hospital|1|||
42135360|NCT00364533|75946097|FG002|Overall Study|Subject discharged from hospital|2|||
42002788|NCT01323660|75810545|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
42002789|NCT01323660|75810546|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
42135361|NCT00364533|75946098|FG003|Overall Study|Subject discharged from hospital|3|||
42135362|NCT00364533|75946099|FG004|Overall Study|Subject discharged from hospital|1|||
42135363|NCT00364533|75946095|FG000|Overall Study|Variations in drug compliance|2|||
42135364|NCT00364533|75946096|FG001|Overall Study|Variations in drug compliance|1|||
42135365|NCT00364533|75946097|FG002|Overall Study|Variations in drug compliance|1|||
42135366|NCT00364533|75946098|FG003|Overall Study|Variations in drug compliance|0|||
42135367|NCT00364533|75946099|FG004|Overall Study|Variations in drug compliance|0|||
42135368|NCT00364533|75946095|FG000|Overall Study|Non-compliance|1|||
42135369|NCT00364533|75946096|FG001|Overall Study|Non-compliance|0|||
42135370|NCT00364533|75946097|FG002|Overall Study|Non-compliance|0|||
42135371|NCT00364533|75946098|FG003|Overall Study|Non-compliance|0|||
42135372|NCT00364533|75946099|FG004|Overall Study|Non-compliance|0|||
42135373|NCT00364533|75946095|FG000|Overall Study|Protocol Violation|1|||
42135374|NCT00364533|75946096|FG001|Overall Study|Protocol Violation|1|||
42002790|NCT01323660|75810547|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
42002791|NCT01323660|75810548|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
42002792|NCT01323660|75810549|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
42002793|NCT01323660|75810544|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
42002794|NCT01323660|75810545|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
42002795|NCT01323660|75810546|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
42002796|NCT01323660|75810547|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42135375|NCT00364533|75946097|FG002|Overall Study|Protocol Violation|0|||
42002797|NCT01323660|75810548|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
42135376|NCT00364533|75946098|FG003|Overall Study|Protocol Violation|0|||
42135377|NCT00364533|75946099|FG004|Overall Study|Protocol Violation|0|||
42135378|NCT04006847|75946111|FG000|Overall Study|Product issue|1|||
42135379|NCT00544817|75946115|FG000|Combined Modality|Lack of Efficacy|2|||
42135380|NCT00544817|75946115|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
42135381|NCT00544817|75946115|FG000|Combined Modality|Adverse Event|2|||
42135382|NCT00544817|75946115|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
42135383|NCT00544817|75946115|FG000|No Treatment Interval|Lack of Efficacy|8|||
42135384|NCT00544817|75946115|FG000|No Treatment Interval|Physician Decision|3|||
42035039|NCT00932373|75843309|FG001|Overall Study|Physician Decision|0|||
42035040|NCT00932373|75843310|FG002|Overall Study|Physician Decision|1|||
42035041|NCT00932373|75843311|FG003|Overall Study|Physician Decision|0|||
42035042|NCT00932373|75843312|FG004|Overall Study|Physician Decision|2|||
42035043|NCT00932373|75843313|FG005|Overall Study|Physician Decision|0|||
42035044|NCT00932373|75843314|FG006|Overall Study|Physician Decision|0|||
42035045|NCT00932373|75843315|FG007|Overall Study|Physician Decision|0|||
42035046|NCT00932373|75843316|FG008|Overall Study|Physician Decision|0|||
42035047|NCT00932373|75843317|FG009|Overall Study|Physician Decision|1|||
42135385|NCT00544817|75946115|FG000|No Treatment Interval|Adverse Event|1|||
42135386|NCT00544817|75946115|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
42135387|NCT00544817|75946115|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
42135388|NCT00544817|75946115|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
42135389|NCT00289978|75946122|FG000|Overall Study|Withdrawal by Subject|31|||
42135390|NCT00289978|75946123|FG001|Overall Study|Withdrawal by Subject|17|||
42135391|NCT00289978|75946124|FG002|Overall Study|Withdrawal by Subject|28|||
42135392|NCT00289978|75946122|FG000|Overall Study|Adverse Event|22|||
42002798|NCT01323660|75810549|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42002799|NCT01092637|75810565|FG000|Overall Study|Death|47|||
42002800|NCT01092637|75810566|FG001|Overall Study|Death|49|||
42002801|NCT01324323|75810573|FG000|Overall Study|Withdrawal by Subject|1|||
42002802|NCT01323582|75810587|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
42002803|NCT01323582|75810588|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
42002804|NCT01323582|75810587|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
42002805|NCT01323582|75810588|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
42002806|NCT01323582|75810587|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
42002807|NCT01323582|75810588|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
42002808|NCT01323621|75810598|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
42002809|NCT01323621|75810599|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
42002810|NCT01323621|75810600|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
42035048|NCT00932373|75843318|FG010|Overall Study|Physician Decision|0|||
42035049|NCT00932373|75843308|FG000|Overall Study|Dose limiting toxicity|0|||
42135393|NCT00289978|75946123|FG001|Overall Study|Adverse Event|13|||
42135394|NCT00289978|75946124|FG002|Overall Study|Adverse Event|18|||
42135395|NCT00289978|75946122|FG000|Overall Study|Lack of Efficacy|13|||
42135396|NCT00289978|75946123|FG001|Overall Study|Lack of Efficacy|6|||
42268021|NCT02943915|76096792|FG001|Overall Study|excluded|1|||
42268022|NCT02943915|76096793|FG002|Overall Study|excluded|0|||
42268023|NCT02943915|76096794|FG003|Overall Study|excluded|0|||
42268024|NCT02763384|76096803|FG000|Overall Study|Physician Decision|1|||
42268025|NCT02763384|76096803|FG000|Overall Study|Rapid decline - went on hospice|1|||
42268026|NCT02649855|76096810|FG000|Overall Study|Refused further treatment|2|||
42268027|NCT02649855|76096811|FG001|Overall Study|Refused further treatment|1|||
42268028|NCT02649855|76096812|FG002|Overall Study|Refused further treatment|1|||
42268029|NCT02649855|76096810|FG000|Overall Study|Withdrew consent|0|||
42268030|NCT02649855|76096811|FG001|Overall Study|Withdrew consent|1|||
42268031|NCT02649855|76096812|FG002|Overall Study|Withdrew consent|0|||
42268032|NCT02649855|76096810|FG000|Overall Study|Switched to alternative treatment|0|||
42268033|NCT02649855|76096811|FG001|Overall Study|Switched to alternative treatment|1|||
42268034|NCT02649855|76096812|FG002|Overall Study|Switched to alternative treatment|1|||
42268035|NCT02649855|76096810|FG000|Overall Study|Principal investigator discretion|0|||
42268036|NCT02649855|76096811|FG001|Overall Study|Principal investigator discretion|1|||
42002811|NCT01323621|75810598|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
42002812|NCT01323621|75810599|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
42268037|NCT02649855|76096812|FG002|Overall Study|Principal investigator discretion|1|||
42002813|NCT01323621|75810600|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
42035050|NCT00932373|75843309|FG001|Overall Study|Dose limiting toxicity|0|||
42035051|NCT00932373|75843310|FG002|Overall Study|Dose limiting toxicity|0|||
42035052|NCT00932373|75843311|FG003|Overall Study|Dose limiting toxicity|0|||
42035053|NCT00932373|75843312|FG004|Overall Study|Dose limiting toxicity|0|||
42135397|NCT00289978|75946124|FG002|Overall Study|Lack of Efficacy|25|||
42135398|NCT00289978|75946122|FG000|Overall Study|Abnormal laboratory value(s)|20|||
42135399|NCT00289978|75946123|FG001|Overall Study|Abnormal laboratory value(s)|9|||
42135400|NCT00289978|75946124|FG002|Overall Study|Abnormal laboratory value(s)|1|||
42135401|NCT00289978|75946122|FG000|Overall Study|Lost to Follow-up|3|||
42135402|NCT00289978|75946123|FG001|Overall Study|Lost to Follow-up|5|||
42135403|NCT00289978|75946124|FG002|Overall Study|Lost to Follow-up|7|||
42135404|NCT00289978|75946122|FG000|Overall Study|Protocol Violation|5|||
42135405|NCT00289978|75946123|FG001|Overall Study|Protocol Violation|5|||
42135406|NCT00289978|75946124|FG002|Overall Study|Protocol Violation|4|||
42135407|NCT00289978|75946122|FG000|Overall Study|Abnormal test procedure result(s)|2|||
42135408|NCT00289978|75946123|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42135409|NCT00289978|75946124|FG002|Overall Study|Abnormal test procedure result(s)|1|||
42135410|NCT00289978|75946122|FG000|Overall Study|Death|1|||
42135411|NCT00289978|75946123|FG001|Overall Study|Death|0|||
42135412|NCT00289978|75946124|FG002|Overall Study|Death|2|||
42135413|NCT00543803|75946132|FG000|Overall Study|Adverse Event|14|||
42135414|NCT00543803|75946132|FG000|Overall Study|Lack of Efficacy|22|||
42135415|NCT00543803|75946132|FG000|Overall Study|Lost to Follow-up|20|||
42135416|NCT00543803|75946132|FG000|Overall Study|Other|86|||
42035054|NCT00932373|75843313|FG005|Overall Study|Dose limiting toxicity|1|||
42035055|NCT00932373|75843314|FG006|Overall Study|Dose limiting toxicity|0|||
42035056|NCT00932373|75843315|FG007|Overall Study|Dose limiting toxicity|0|||
42035057|NCT00932373|75843316|FG008|Overall Study|Dose limiting toxicity|0|||
42035058|NCT00932373|75843317|FG009|Overall Study|Dose limiting toxicity|0|||
42035059|NCT00932373|75843318|FG010|Overall Study|Dose limiting toxicity|0|||
42035060|NCT00932373|75843308|FG000|Overall Study|Withdrawal by Subject|0|||
42035061|NCT00932373|75843309|FG001|Overall Study|Withdrawal by Subject|0|||
42035062|NCT00932373|75843310|FG002|Overall Study|Withdrawal by Subject|0|||
42035063|NCT00932373|75843311|FG003|Overall Study|Withdrawal by Subject|0|||
42035064|NCT00932373|75843312|FG004|Overall Study|Withdrawal by Subject|0|||
42035065|NCT00932373|75843313|FG005|Overall Study|Withdrawal by Subject|0|||
42268038|NCT02649855|76096810|FG000|Overall Study|No treatment, per protocol|1|||
42268039|NCT02649855|76096811|FG001|Overall Study|No treatment, per protocol|0|||
42268040|NCT02649855|76096812|FG002|Overall Study|No treatment, per protocol|0|||
42002814|NCT01323621|75810598|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
42002815|NCT01323621|75810599|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
42002816|NCT01323621|75810600|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
42002817|NCT01323621|75810598|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
42002818|NCT01323621|75810599|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
42002819|NCT01323621|75810600|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
42002820|NCT01323621|75810598|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
42002821|NCT01323621|75810599|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
42002822|NCT01323621|75810600|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
42002823|NCT01323621|75810598|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
42002824|NCT01323621|75810599|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
42002825|NCT01323621|75810600|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
42002826|NCT01323621|75810598|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
42268041|NCT02649855|76096810|FG000|Overall Study|Initiate new treatment|1|||
42002827|NCT01323621|75810599|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
42002828|NCT01323621|75810600|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
42002829|NCT01323621|75810598|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
42002830|NCT01323621|75810599|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
42002831|NCT01323621|75810600|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
42035066|NCT00932373|75843314|FG006|Overall Study|Withdrawal by Subject|0|||
42035067|NCT00932373|75843315|FG007|Overall Study|Withdrawal by Subject|0|||
42035068|NCT00932373|75843316|FG008|Overall Study|Withdrawal by Subject|1|||
42002832|NCT01323621|75810598|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
42002833|NCT01323621|75810599|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
42002834|NCT01323621|75810600|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
42002835|NCT01323621|75810598|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
42002836|NCT01323621|75810599|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
42002837|NCT01323621|75810600|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
42002838|NCT01323621|75810598|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
42002839|NCT01323621|75810599|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
42002840|NCT01323621|75810600|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
42002841|NCT01323621|75810598|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
42002842|NCT01323621|75810599|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
42002843|NCT01323621|75810600|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
42002844|NCT01323192|75810608|FG000|Overall Study|Adverse Event|6|||
42002845|NCT01323192|75810609|FG001|Overall Study|Adverse Event|1|||
42002846|NCT01323192|75810608|FG000|Overall Study|Withdrawal by Subject|3|||
42002847|NCT01323192|75810609|FG001|Overall Study|Withdrawal by Subject|1|||
42002848|NCT01323192|75810608|FG000|Overall Study|Noncompliance with study medication|0|||
42135417|NCT00542321|75946140|FG000|Overall Study|Death|0|||
42340654|NCT02038829|76178743|FG004|Washout Period 2|Withdrawal by Subject|0|||
42002849|NCT01323192|75810609|FG001|Overall Study|Noncompliance with study medication|3|||
42002850|NCT01323192|75810608|FG000|Overall Study|Nonmedical reasons|0|||
42002851|NCT01323192|75810609|FG001|Overall Study|Nonmedical reasons|1|||
42002852|NCT01323387|75810615|FG000|Overall Study|Withdrawal by Subject|41|||
42002853|NCT01323387|75810615|FG000|Overall Study|Radiographic Data Unavailable|1|||
42002854|NCT01323387|75810615|FG000|Overall Study|Revision|14|||
42002855|NCT01323387|75810615|FG000|Overall Study|Protocol Violation|12|||
42002856|NCT01323387|75810615|FG000|Overall Study|Randomized but Never Treated|16|||
42002857|NCT01321749|75810623|FG000|Overall Study|Lost to Follow-up|4|||
42002858|NCT01321749|75810624|FG001|Overall Study|Lost to Follow-up|11|||
42002859|NCT01321749|75810623|FG000|Overall Study|Protocol Violation|4|||
42002860|NCT01321749|75810624|FG001|Overall Study|Protocol Violation|7|||
42002861|NCT01321749|75810623|FG000|Overall Study|Withdrawal by Subject|5|||
42002862|NCT01321749|75810624|FG001|Overall Study|Withdrawal by Subject|4|||
42002863|NCT01320735|75810630|FG000|Overall Study|Adverse Event|3|||
42002864|NCT01320735|75810630|FG000|Overall Study|Withdrawal by Subject|3|||
42002865|NCT01320735|75810630|FG000|Overall Study|Lost to Follow-up|13|||
42002866|NCT01320735|75810630|FG000|Overall Study|Administrative Reason|6|||
42002867|NCT01320735|75810630|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
42002868|NCT01320735|75810630|FG000|Overall Study|Protocol Violation|1|||
42002869|NCT01320735|75810630|FG000|Overall Study|Other|1|||
42002870|NCT01320735|75810630|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
42002871|NCT01320735|75810630|FG000|Overall Study|Investigator Unable to be Contacted|17|||
42002872|NCT01320033|75810637|FG000|Overall Study|Lack of Efficacy|0|||
42002873|NCT01320033|75810638|FG001|Overall Study|Lack of Efficacy|0|||
42002874|NCT01320033|75810639|FG002|Overall Study|Lack of Efficacy|1|||
42002875|NCT01320033|75810637|FG000|Overall Study|Adverse Event|9|||
42002876|NCT01320033|75810638|FG001|Overall Study|Adverse Event|7|||
42002877|NCT01320033|75810639|FG002|Overall Study|Adverse Event|8|||
42002878|NCT01320033|75810637|FG000|Overall Study|Withdrawal by Subject|22|||
42340655|NCT02038829|76178744|FG005|Washout Period 2|Withdrawal by Subject|1|||
42340656|NCT02038829|76178745|FG006|Washout Period 2|Withdrawal by Subject|0|||
42340657|NCT02038829|76178746|FG007|Washout Period 2|Withdrawal by Subject|0|||
42340658|NCT02038829|76178747|FG008|Washout Period 2|Withdrawal by Subject|0|||
42340659|NCT02038829|76178748|FG009|Washout Period 2|Withdrawal by Subject|0|||
42340660|NCT02038829|76178749|FG010|Washout Period 2|Withdrawal by Subject|0|||
42002879|NCT01320033|75810638|FG001|Overall Study|Withdrawal by Subject|23|||
42002880|NCT01320033|75810639|FG002|Overall Study|Withdrawal by Subject|23|||
42002881|NCT01320033|75810637|FG000|Overall Study|Protocol Violation|3|||
42002882|NCT01320033|75810638|FG001|Overall Study|Protocol Violation|5|||
42002883|NCT01320033|75810639|FG002|Overall Study|Protocol Violation|3|||
42002884|NCT01320033|75810637|FG000|Overall Study|Lost to Follow-up|22|||
42002885|NCT01320033|75810638|FG001|Overall Study|Lost to Follow-up|26|||
42002886|NCT01320033|75810639|FG002|Overall Study|Lost to Follow-up|17|||
42002887|NCT01320033|75810637|FG000|Overall Study|Other|2|||
42002888|NCT01320033|75810638|FG001|Overall Study|Other|3|||
42340661|NCT02038829|76178750|FG011|Washout Period 2|Withdrawal by Subject|0|||
42002889|NCT01320033|75810639|FG002|Overall Study|Other|1|||
42002890|NCT01101061|75810653|FG000|Overall Study|Adverse Event|0|||
42002891|NCT01101061|75810654|FG001|Overall Study|Adverse Event|0|||
42002892|NCT01101061|75810655|FG002|Overall Study|Adverse Event|1|||
42002893|NCT01101061|75810656|FG003|Overall Study|Adverse Event|0|||
42002894|NCT01101061|75810657|FG004|Overall Study|Adverse Event|0|||
42002895|NCT01101061|75810658|FG005|Overall Study|Adverse Event|0|||
42002896|NCT01317615|75810676|FG000|Overall Study|Disease progression|25|||
42002897|NCT01317615|75810676|FG000|Overall Study|New cancer therapy|5|||
42002898|NCT01317615|75810676|FG000|Overall Study|Death|6|||
42002899|NCT01317615|75810676|FG000|Overall Study|Withdrawal by Subject|5|||
42002900|NCT01317615|75810676|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42002901|NCT01317615|75810676|FG000|Overall Study|Adverse Event|7|||
42002902|NCT01078675|75810682|FG000|Overall Study|Withdrawal by Subject|7|||
42002903|NCT01078675|75810683|FG001|Overall Study|Withdrawal by Subject|3|||
42002904|NCT01078675|75810682|FG000|Overall Study|Protocol Violation|56|||
42002905|NCT01078675|75810683|FG001|Overall Study|Protocol Violation|0|||
42002906|NCT01078675|75810682|FG000|Overall Study|Provided in CRF for specific reasons|2|||
42002907|NCT01078675|75810683|FG001|Overall Study|Provided in CRF for specific reasons|3|||
42002908|NCT01078675|75810682|FG000|Overall Study|Adverse Event|3|||
42002909|NCT01078675|75810683|FG001|Overall Study|Adverse Event|0|||
42002910|NCT01100437|75810689|FG000|Titration/Stabilization|Adverse Event|0|||
42002911|NCT01100437|75810690|FG001|Titration/Stabilization|Adverse Event|0|||
42002912|NCT01100437|75810691|FG002|Titration/Stabilization|Adverse Event|4|||
42002913|NCT01100437|75810689|FG000|Titration/Stabilization|Non-compliance|0|||
42002914|NCT01100437|75810690|FG001|Titration/Stabilization|Non-compliance|0|||
42002915|NCT01100437|75810691|FG002|Titration/Stabilization|Non-compliance|1|||
42002916|NCT01100437|75810689|FG000|Titration/Stabilization|Sponsor canceled study|0|||
42002917|NCT01100437|75810690|FG001|Titration/Stabilization|Sponsor canceled study|0|||
42002918|NCT01100437|75810691|FG002|Titration/Stabilization|Sponsor canceled study|1|||
42002919|NCT01100437|75810689|FG000|Maintenance|Withdrawal by Subject|0|||
42002920|NCT01100437|75810690|FG001|Maintenance|Withdrawal by Subject|0|||
42002921|NCT01100437|75810691|FG002|Maintenance|Withdrawal by Subject|1|||
42002922|NCT01100437|75810689|FG000|Maintenance|Sponsor termination of study|0|||
42002923|NCT01100437|75810690|FG001|Maintenance|Sponsor termination of study|0|||
42002924|NCT01100437|75810691|FG002|Maintenance|Sponsor termination of study|1|||
42002925|NCT01322490|75810703|FG000|Treatment Period|Adverse Event|12|||
42002926|NCT01322490|75810704|FG001|Treatment Period|Adverse Event|18|||
42002927|NCT01322490|75810705|FG002|Treatment Period|Adverse Event|15|||
42002928|NCT01322490|75810703|FG000|Treatment Period|Death|5|||
42002929|NCT01322490|75810704|FG001|Treatment Period|Death|7|||
42002930|NCT01322490|75810705|FG002|Treatment Period|Death|3|||
42002931|NCT01322490|75810703|FG000|Treatment Period|Lack of Efficacy|89|||
42002932|NCT01322490|75810704|FG001|Treatment Period|Lack of Efficacy|100|||
42135418|NCT00542321|75946141|FG001|Overall Study|Death|1|||
42135419|NCT00289900|75946153|FG000|Overall Study|Adverse Event|28|||
42135420|NCT00289900|75946154|FG001|Overall Study|Adverse Event|40|||
42135421|NCT00289900|75946155|FG002|Overall Study|Adverse Event|13|||
42268042|NCT02649855|76096811|FG001|Overall Study|Initiate new treatment|0|||
42268043|NCT02649855|76096812|FG002|Overall Study|Initiate new treatment|0|||
42002933|NCT01322490|75810705|FG002|Treatment Period|Lack of Efficacy|112|||
42002934|NCT01322490|75810703|FG000|Treatment Period|Physician Decision|0|||
42002935|NCT01322490|75810704|FG001|Treatment Period|Physician Decision|2|||
42002936|NCT01322490|75810705|FG002|Treatment Period|Physician Decision|1|||
42002937|NCT01322490|75810703|FG000|Treatment Period|Protocol Violation|7|||
42002938|NCT01322490|75810704|FG001|Treatment Period|Protocol Violation|5|||
42002939|NCT01322490|75810705|FG002|Treatment Period|Protocol Violation|4|||
42002940|NCT01322490|75810703|FG000|Treatment Period|Withdrawal by Subject|14|||
42002941|NCT01322490|75810704|FG001|Treatment Period|Withdrawal by Subject|16|||
42002942|NCT01322490|75810705|FG002|Treatment Period|Withdrawal by Subject|11|||
42002943|NCT01322490|75810703|FG000|Treatment Period|Non-compliance with study drug|0|||
42002944|NCT01322490|75810704|FG001|Treatment Period|Non-compliance with study drug|0|||
42002945|NCT01322490|75810705|FG002|Treatment Period|Non-compliance with study drug|1|||
42002946|NCT01322490|75810703|FG000|Treatment Period|Other per report|2|||
42002947|NCT01322490|75810704|FG001|Treatment Period|Other per report|2|||
42002948|NCT01322490|75810705|FG002|Treatment Period|Other per report|1|||
42002949|NCT01322490|75810703|FG000|Treatment Period|Randomized but Not Treated|3|||
42002950|NCT01322490|75810704|FG001|Treatment Period|Randomized but Not Treated|3|||
42002951|NCT01322490|75810705|FG002|Treatment Period|Randomized but Not Treated|5|||
42002952|NCT01322490|75810703|FG000|Long Term Follow-up Period|Death|235|||
42002953|NCT01322490|75810704|FG001|Long Term Follow-up Period|Death|239|||
42002954|NCT01322490|75810705|FG002|Long Term Follow-up Period|Death|236|||
42002955|NCT01322490|75810703|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
42002956|NCT01322490|75810704|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
42002957|NCT01322490|75810705|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
42002958|NCT01322490|75810703|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
42002959|NCT01322490|75810704|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
42002960|NCT01322490|75810705|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
42002961|NCT01322490|75810703|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
42002962|NCT01322490|75810704|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
42002963|NCT01322490|75810705|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
42002964|NCT01322490|75810703|FG000|Long Term Follow-up Period|Other per report|3|||
42002965|NCT01322490|75810704|FG001|Long Term Follow-up Period|Other per report|2|||
42002966|NCT01322490|75810705|FG002|Long Term Follow-up Period|Other per report|2|||
42002967|NCT01322490|75810703|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
42002968|NCT01322490|75810704|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
42002969|NCT01322490|75810705|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
42002970|NCT01314261|75810717|FG000|Overall Study|Adverse Event|1|||
42002971|NCT01314261|75810718|FG001|Overall Study|Adverse Event|0|||
42002972|NCT01314261|75810719|FG002|Overall Study|Adverse Event|0|||
42002973|NCT01314261|75810720|FG003|Overall Study|Adverse Event|0|||
42002974|NCT01314261|75810717|FG000|Overall Study|Withdrawal by Subject|0|||
42002975|NCT01314261|75810718|FG001|Overall Study|Withdrawal by Subject|3|||
42002976|NCT01314261|75810719|FG002|Overall Study|Withdrawal by Subject|1|||
42002977|NCT01314261|75810720|FG003|Overall Study|Withdrawal by Subject|0|||
42002978|NCT01314261|75810717|FG000|Overall Study|Lost to Follow-up|1|||
42002979|NCT01314261|75810718|FG001|Overall Study|Lost to Follow-up|0|||
42002980|NCT01314261|75810719|FG002|Overall Study|Lost to Follow-up|2|||
42002981|NCT01314261|75810720|FG003|Overall Study|Lost to Follow-up|2|||
42002982|NCT01314261|75810717|FG000|Overall Study|Virologic Failure|0|||
42002983|NCT01314261|75810718|FG001|Overall Study|Virologic Failure|1|||
42002984|NCT01314261|75810719|FG002|Overall Study|Virologic Failure|0|||
42002985|NCT01314261|75810720|FG003|Overall Study|Virologic Failure|1|||
42002986|NCT01321710|75810733|FG000|Overall Study|Lost to Follow-up|4|||
42002987|NCT01321710|75810734|FG001|Overall Study|Lost to Follow-up|5|||
42002988|NCT01321710|75810735|FG002|Overall Study|Lost to Follow-up|0|||
42002989|NCT01321008|75810745|FG000|Overall Study|Early Study Termination|1|||
42002990|NCT01320150|75810751|FG000|Overall Study|Protocol Violation|15|||
42002991|NCT01320150|75810751|FG000|Overall Study|Withdrawal by Subject|5|||
42002992|NCT01320150|75810751|FG000|Overall Study|Death|2|||
42002993|NCT01320150|75810751|FG000|Overall Study|Lost to Follow-up|44|||
42002994|NCT01323530|75810762|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
42002995|NCT01323530|75810763|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
42002996|NCT01323530|75810764|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
42002997|NCT01323530|75810765|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
42002998|NCT01323530|75810766|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
42002999|NCT01323530|75810767|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
42003000|NCT01323530|75810768|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
42003001|NCT01323530|75810762|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
42003002|NCT01323530|75810763|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
42268044|NCT02619682|76096820|FG000|Overall Study|Withdrawal by Subject|3|||
42268045|NCT02619682|76096820|FG000|Overall Study|Lack of Efficacy|8|||
42268046|NCT02619682|76096820|FG000|Overall Study|new secondary cancer|1|||
42268047|NCT02619682|76096820|FG000|Overall Study|post surgery complications|2|||
42268048|NCT02613507|76096827|FG000|Overall Study|Disease Progression|237|||
42268049|NCT02613507|76096828|FG001|Overall Study|Disease Progression|109|||
42268050|NCT02613507|76096827|FG000|Overall Study|Study Drug Toxicity|15|||
42003003|NCT01323530|75810764|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
42003004|NCT01323530|75810765|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
42003005|NCT01323530|75810766|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
42003006|NCT01323530|75810767|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
42003007|NCT01323530|75810768|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
42003008|NCT01323530|75810762|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
42268051|NCT02613507|76096828|FG001|Overall Study|Study Drug Toxicity|14|||
42003009|NCT01323530|75810763|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
42003010|NCT01323530|75810764|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
42003011|NCT01323530|75810765|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
42003012|NCT01323530|75810766|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
42003013|NCT01323530|75810767|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
42003014|NCT01323530|75810768|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
42003015|NCT01323530|75810762|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
42003016|NCT01323530|75810763|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
42003017|NCT01323530|75810764|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
42003018|NCT01323530|75810765|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
42003019|NCT01323530|75810766|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
42003020|NCT01323530|75810767|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
42003021|NCT01323530|75810768|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
42003022|NCT01323530|75810762|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
42003023|NCT01323530|75810763|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
42003024|NCT01323530|75810764|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
42003025|NCT01323530|75810765|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
42003026|NCT01323530|75810766|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
42003027|NCT01323530|75810767|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
42003028|NCT01323530|75810768|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
42003029|NCT01323530|75810762|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
42003030|NCT01323530|75810763|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
42003031|NCT01323530|75810764|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
42003032|NCT01323530|75810765|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
42003033|NCT01323530|75810766|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
42003034|NCT01323530|75810767|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
42003035|NCT01323530|75810768|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
42003036|NCT01323530|75810762|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
42003037|NCT01323530|75810763|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
42003038|NCT01323530|75810764|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
42003039|NCT01323530|75810765|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
42003040|NCT01323530|75810766|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
42003041|NCT01323530|75810767|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
42003042|NCT01323530|75810768|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
42003043|NCT01323530|75810762|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
42003044|NCT01323530|75810763|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
42003045|NCT01323530|75810764|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
42003046|NCT01323530|75810765|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
42003047|NCT01323530|75810766|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
42003048|NCT01323530|75810767|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
42003049|NCT01323530|75810768|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
42003050|NCT01313637|75810789|FG000|Overall Study|Adverse Event|17|||
42003051|NCT01313637|75810790|FG001|Overall Study|Adverse Event|24|||
42003052|NCT01313637|75810791|FG002|Overall Study|Adverse Event|25|||
42003053|NCT01313637|75810792|FG003|Overall Study|Adverse Event|18|||
42003054|NCT01313637|75810789|FG000|Overall Study|Lack of Efficacy|44|||
42003055|NCT01313637|75810790|FG001|Overall Study|Lack of Efficacy|38|||
42003056|NCT01313637|75810791|FG002|Overall Study|Lack of Efficacy|37|||
42003057|NCT01313637|75810792|FG003|Overall Study|Lack of Efficacy|24|||
42003058|NCT01313637|75810789|FG000|Overall Study|Protocol Violation|4|||
42003059|NCT01313637|75810790|FG001|Overall Study|Protocol Violation|3|||
42003060|NCT01313637|75810791|FG002|Overall Study|Protocol Violation|11|||
42003061|NCT01313637|75810792|FG003|Overall Study|Protocol Violation|5|||
42003062|NCT01313637|75810789|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
42003063|NCT01313637|75810790|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
42003064|NCT01313637|75810791|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
42003065|NCT01313637|75810792|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
42003066|NCT01313637|75810789|FG000|Overall Study|Lost to Follow-up|0|||
42003067|NCT01313637|75810790|FG001|Overall Study|Lost to Follow-up|2|||
42035069|NCT00932373|75843317|FG009|Overall Study|Withdrawal by Subject|0|||
42035070|NCT00932373|75843318|FG010|Overall Study|Withdrawal by Subject|0|||
42135422|NCT00289900|75946156|FG003|Overall Study|Adverse Event|19|||
42003068|NCT01313637|75810791|FG002|Overall Study|Lost to Follow-up|1|||
42003069|NCT01313637|75810792|FG003|Overall Study|Lost to Follow-up|3|||
42003070|NCT01313637|75810789|FG000|Overall Study|Withdrawal by Subject|11|||
42003071|NCT01313637|75810790|FG001|Overall Study|Withdrawal by Subject|13|||
42003072|NCT01313637|75810791|FG002|Overall Study|Withdrawal by Subject|18|||
42003073|NCT01313637|75810792|FG003|Overall Study|Withdrawal by Subject|15|||
42003074|NCT01320722|75810807|FG000|Overall Study|Did not Receive Intervention|3|||
42003075|NCT01320722|75810808|FG001|Overall Study|Did not Receive Intervention|2|||
42003076|NCT01320722|75810809|FG002|Overall Study|Did not Receive Intervention|1|||
42003077|NCT01320722|75810810|FG003|Overall Study|Did not Receive Intervention|1|||
42003078|NCT01320722|75810811|FG004|Overall Study|Did not Receive Intervention|2|||
42003079|NCT01320722|75810807|FG000|Overall Study|Lost to Follow-up|0|||
42003080|NCT01320722|75810808|FG001|Overall Study|Lost to Follow-up|1|||
42003081|NCT01320722|75810809|FG002|Overall Study|Lost to Follow-up|0|||
42003082|NCT01320722|75810810|FG003|Overall Study|Lost to Follow-up|1|||
42003083|NCT01320722|75810811|FG004|Overall Study|Lost to Follow-up|3|||
42003084|NCT01320722|75810807|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
42003085|NCT01320722|75810808|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
42003086|NCT01320722|75810809|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
42003087|NCT01320722|75810810|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
42003088|NCT01320722|75810811|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
42003089|NCT01320722|75810807|FG000|Overall Study|Participant Developed a Rash|0|||
42003090|NCT01320722|75810808|FG001|Overall Study|Participant Developed a Rash|0|||
42003091|NCT01320722|75810809|FG002|Overall Study|Participant Developed a Rash|2|||
42003092|NCT01320722|75810810|FG003|Overall Study|Participant Developed a Rash|1|||
42003093|NCT01320722|75810811|FG004|Overall Study|Participant Developed a Rash|1|||
42003094|NCT01320722|75810807|FG000|Overall Study|Non-compliant with Medication|0|||
42003095|NCT01320722|75810808|FG001|Overall Study|Non-compliant with Medication|0|||
42003096|NCT01320722|75810809|FG002|Overall Study|Non-compliant with Medication|1|||
42003097|NCT01320722|75810810|FG003|Overall Study|Non-compliant with Medication|0|||
42003098|NCT01320722|75810811|FG004|Overall Study|Non-compliant with Medication|0|||
42003099|NCT01320722|75810807|FG000|Overall Study|Adverse Event|0|||
42003100|NCT01320722|75810808|FG001|Overall Study|Adverse Event|0|||
42003101|NCT01320722|75810809|FG002|Overall Study|Adverse Event|3|||
42003102|NCT01320722|75810810|FG003|Overall Study|Adverse Event|6|||
42003103|NCT01320722|75810811|FG004|Overall Study|Adverse Event|0|||
42003104|NCT01320722|75810807|FG000|Overall Study|Not Compliant with Study Procedures|0|||
42003105|NCT01320722|75810808|FG001|Overall Study|Not Compliant with Study Procedures|0|||
42003106|NCT01320722|75810809|FG002|Overall Study|Not Compliant with Study Procedures|0|||
42003107|NCT01320722|75810810|FG003|Overall Study|Not Compliant with Study Procedures|4|||
42003108|NCT01320722|75810811|FG004|Overall Study|Not Compliant with Study Procedures|0|||
42003109|NCT01320722|75810807|FG000|Overall Study|Pregnancy|0|||
42003110|NCT01320722|75810808|FG001|Overall Study|Pregnancy|0|||
42003111|NCT01320722|75810809|FG002|Overall Study|Pregnancy|0|||
42003112|NCT01320722|75810810|FG003|Overall Study|Pregnancy|1|||
42003113|NCT01320722|75810811|FG004|Overall Study|Pregnancy|0|||
42003114|NCT01320722|75810807|FG000|Overall Study|Started an Exclusionary Medication|0|||
42003115|NCT01320722|75810808|FG001|Overall Study|Started an Exclusionary Medication|0|||
42003116|NCT01320722|75810809|FG002|Overall Study|Started an Exclusionary Medication|0|||
42003117|NCT01320722|75810810|FG003|Overall Study|Started an Exclusionary Medication|0|||
42003118|NCT01320722|75810811|FG004|Overall Study|Started an Exclusionary Medication|1|||
42003119|NCT01320722|75810807|FG000|Overall Study|Withdrew due to Health Condition|0|||
42003120|NCT01320722|75810808|FG001|Overall Study|Withdrew due to Health Condition|0|||
42003121|NCT01320722|75810809|FG002|Overall Study|Withdrew due to Health Condition|0|||
42003122|NCT01320722|75810810|FG003|Overall Study|Withdrew due to Health Condition|0|||
42003123|NCT01320722|75810811|FG004|Overall Study|Withdrew due to Health Condition|1|||
42003124|NCT01313559|75810828|FG000|Overall Study|Withdrawal by Subject|1|||
42003125|NCT01313559|75810829|FG001|Overall Study|Withdrawal by Subject|2|||
42003126|NCT01313559|75810828|FG000|Overall Study|Disease progression|1|||
42003127|NCT01313559|75810829|FG001|Overall Study|Disease progression|0|||
42003128|NCT01313559|75810828|FG000|Overall Study|Rising PSA|2|||
42003129|NCT01313559|75810829|FG001|Overall Study|Rising PSA|0|||
42003130|NCT01312779|75810835|FG000|Overall Study|Withdrawal by Subject|2|||
42003131|NCT01312779|75810835|FG000|Overall Study|Death|3|||
42003132|NCT01312779|75810835|FG000|Overall Study|Not Implanted with Device|27|||
42003133|NCT01312467|75810848|FG000|Overall Study|Adverse Event|4|||
42340662|NCT02038829|76178739|FG000|Treatment Period 4|Adverse Event|0|||
42340663|NCT02038829|76178740|FG001|Treatment Period 4|Adverse Event|1|||
42003134|NCT01312467|75810848|FG000|Overall Study|Lost to Follow-up|1|||
42003135|NCT01312467|75810848|FG000|Overall Study|Withdrawal by Subject|2|||
42003136|NCT01312467|75810848|FG000|Overall Study|Deported to country of origin|1|||
42003137|NCT01312467|75810848|FG000|Overall Study|Another medical condition|1|||
42003138|NCT01312467|75810848|FG000|Overall Study|Ineligible|4|||
42003139|NCT01310127|75810855|FG000|Overall Study|Protocol Violation|1|||
42003140|NCT01310127|75810856|FG001|Overall Study|Protocol Violation|1|||
42003141|NCT01310127|75810855|FG000|Overall Study|advanced psc cataract outlier|1|||
42003142|NCT01310127|75810856|FG001|Overall Study|advanced psc cataract outlier|0|||
42135423|NCT00289900|75946157|FG004|Overall Study|Adverse Event|20|||
42003143|NCT01309893|75810862|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
42003144|NCT01309893|75810863|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
42003145|NCT01309893|75810862|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
42003146|NCT01309893|75810863|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
42003147|NCT01318902|75810873|FG000|Overall Study|Symptomatic Deterioration|0|||
42003148|NCT01318902|75810874|FG001|Overall Study|Symptomatic Deterioration|1|||
42003149|NCT01318902|75810875|FG002|Overall Study|Symptomatic Deterioration|1|||
42003150|NCT01318902|75810876|FG003|Overall Study|Symptomatic Deterioration|2|||
42003151|NCT01318902|75810873|FG000|Overall Study|Withdrawal by Patient|0|||
42003152|NCT01318902|75810874|FG001|Overall Study|Withdrawal by Patient|1|||
42003153|NCT01318902|75810875|FG002|Overall Study|Withdrawal by Patient|0|||
42003154|NCT01318902|75810876|FG003|Overall Study|Withdrawal by Patient|3|||
42003155|NCT01318902|75810873|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
42003156|NCT01318902|75810874|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
42003157|NCT01318902|75810875|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
42003158|NCT01318902|75810876|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
42003159|NCT01318902|75810873|FG000|Overall Study|Adverse Event|0|||
42003160|NCT01318902|75810874|FG001|Overall Study|Adverse Event|1|||
42003161|NCT01318902|75810875|FG002|Overall Study|Adverse Event|0|||
42003162|NCT01318902|75810876|FG003|Overall Study|Adverse Event|0|||
42003163|NCT01318902|75810873|FG000|Overall Study|Terminated by Sponsor|0|||
42003164|NCT01318902|75810874|FG001|Overall Study|Terminated by Sponsor|0|||
42003165|NCT01318902|75810875|FG002|Overall Study|Terminated by Sponsor|1|||
42003166|NCT01318902|75810876|FG003|Overall Study|Terminated by Sponsor|0|||
42003167|NCT01313858|75810891|FG000|Overall Study|Premature Treatment Termination|251|||
42003168|NCT01313858|75810892|FG001|Overall Study|Premature Treatment Termination|219|||
42003169|NCT01313858|75810893|FG002|Overall Study|Premature Treatment Termination|191|||
42268052|NCT02613507|76096827|FG000|Overall Study|Death|3|||
42268053|NCT02613507|76096828|FG001|Overall Study|Death|0|||
42268054|NCT02613507|76096827|FG000|Overall Study|Adverse Event Unrelated to Study Drug|17|||
42268055|NCT02613507|76096828|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
42340664|NCT02038829|76178741|FG002|Treatment Period 4|Adverse Event|0|||
42340665|NCT02038829|76178742|FG003|Treatment Period 4|Adverse Event|0|||
42340666|NCT02038829|76178743|FG004|Treatment Period 4|Adverse Event|0|||
42340667|NCT02038829|76178744|FG005|Treatment Period 4|Adverse Event|0|||
42340668|NCT02038829|76178745|FG006|Treatment Period 4|Adverse Event|0|||
42340669|NCT02038829|76178746|FG007|Treatment Period 4|Adverse Event|0|||
42340670|NCT02038829|76178747|FG008|Treatment Period 4|Adverse Event|0|||
42340671|NCT02038829|76178748|FG009|Treatment Period 4|Adverse Event|0|||
42340672|NCT02038829|76178749|FG010|Treatment Period 4|Adverse Event|0|||
42340673|NCT02038829|76178750|FG011|Treatment Period 4|Adverse Event|0|||
42340674|NCT02038829|76178739|FG000|Washout Period 4|Adverse Event|0|||
42340675|NCT02038829|76178740|FG001|Washout Period 4|Adverse Event|0|||
42340676|NCT02038829|76178741|FG002|Washout Period 4|Adverse Event|0|||
42340677|NCT02038829|76178742|FG003|Washout Period 4|Adverse Event|0|||
42340678|NCT02038829|76178743|FG004|Washout Period 4|Adverse Event|0|||
42268056|NCT02613507|76096827|FG000|Overall Study|Request to Discontinue Study Treatment|8|||
42268057|NCT02613507|76096828|FG001|Overall Study|Request to Discontinue Study Treatment|17|||
42268058|NCT02613507|76096827|FG000|Overall Study|Participant Withdrew Consent|0|||
42268059|NCT02613507|76096828|FG001|Overall Study|Participant Withdrew Consent|2|||
42268060|NCT02613507|76096827|FG000|Overall Study|Lost to Follow-up|1|||
42340679|NCT02038829|76178744|FG005|Washout Period 4|Adverse Event|0|||
42003170|NCT01313858|75810891|FG000|Overall Study|Lost to Follow-up|35|||
42003171|NCT01313858|75810892|FG001|Overall Study|Lost to Follow-up|51|||
42003172|NCT01313858|75810893|FG002|Overall Study|Lost to Follow-up|47|||
42003173|NCT01090765|75810905|FG000|Overall Study|Patient withdrew consent|0|||
42003174|NCT01090765|75810906|FG001|Overall Study|Patient withdrew consent|0|||
42003175|NCT01090765|75810907|FG002|Overall Study|Patient withdrew consent|0|||
42268061|NCT02613507|76096828|FG001|Overall Study|Lost to Follow-up|0|||
42340680|NCT02038829|76178745|FG006|Washout Period 4|Adverse Event|1|||
42340681|NCT02038829|76178746|FG007|Washout Period 4|Adverse Event|0|||
42340682|NCT02038829|76178747|FG008|Washout Period 4|Adverse Event|0|||
42340683|NCT02038829|76178748|FG009|Washout Period 4|Adverse Event|0|||
42003176|NCT01090765|75810908|FG003|Overall Study|Patient withdrew consent|0|||
42003177|NCT01090765|75810909|FG004|Overall Study|Patient withdrew consent|1|||
42003178|NCT01090765|75810910|FG005|Overall Study|Patient withdrew consent|1|||
42003179|NCT01090765|75810905|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
42135424|NCT00289900|75946158|FG005|Overall Study|Adverse Event|33|||
42135425|NCT00289900|75946153|FG000|Overall Study|Lost to Follow-up|7|||
42135426|NCT00289900|75946154|FG001|Overall Study|Lost to Follow-up|7|||
42135427|NCT00289900|75946155|FG002|Overall Study|Lost to Follow-up|8|||
42003180|NCT01090765|75810906|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
42003181|NCT01090765|75810907|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
42003182|NCT01090765|75810908|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
42003183|NCT01090765|75810909|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
42003184|NCT01090765|75810910|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
42003185|NCT01090765|75810905|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
42003186|NCT01090765|75810906|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
42003187|NCT01090765|75810907|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
42003188|NCT01090765|75810908|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
42003189|NCT01090765|75810909|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
42003190|NCT01090765|75810910|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
42003191|NCT01313780|75810927|FG000|Overall Study|Lack of Efficacy|4|||
42003192|NCT01313780|75810928|FG001|Overall Study|Lack of Efficacy|2|||
42003193|NCT01313780|75810927|FG000|Overall Study|Adverse Event|6|||
42003194|NCT01313780|75810928|FG001|Overall Study|Adverse Event|11|||
42003195|NCT01313780|75810927|FG000|Overall Study|Withdrawal by Subject|2|||
42003196|NCT01313780|75810928|FG001|Overall Study|Withdrawal by Subject|8|||
42003197|NCT01313780|75810927|FG000|Overall Study|Protocol Violation|10|||
42003198|NCT01313780|75810928|FG001|Overall Study|Protocol Violation|4|||
42003199|NCT01313780|75810927|FG000|Overall Study|missing data|3|||
42003200|NCT01313780|75810928|FG001|Overall Study|missing data|3|||
42003201|NCT01090453|75810936|FG000|Overall Study|Withdrawal by Subject|1|||
42003202|NCT01090453|75810937|FG001|Overall Study|Withdrawal by Subject|2|||
42003203|NCT01090453|75810936|FG000|Overall Study|Lost to Follow-up|7|||
42003204|NCT01090453|75810937|FG001|Overall Study|Lost to Follow-up|7|||
42003205|NCT01090453|75810936|FG000|Overall Study|Non serious AEs|1|||
42003206|NCT01090453|75810937|FG001|Overall Study|Non serious AEs|0|||
42003207|NCT01090453|75810936|FG000|Overall Study|Protocol Violation|2|||
42003208|NCT01090453|75810937|FG001|Overall Study|Protocol Violation|0|||
42003209|NCT01090453|75810936|FG000|Overall Study|Other|2|||
42003210|NCT01090453|75810937|FG001|Overall Study|Other|4|||
42003211|NCT01090453|75810936|FG000|Overall Study|Eligibility Criteria|0|||
42003212|NCT01090453|75810937|FG001|Overall Study|Eligibility Criteria|1|||
42003213|NCT01171612|75810943|FG000|Overall Study|Lost to Follow-up|51|||
42003214|NCT01171534|75810952|FG000|Overall Study|Lost to Follow-up|0|||
42003215|NCT01171534|75810953|FG001|Overall Study|Lost to Follow-up|2|||
42135428|NCT00289900|75946156|FG003|Overall Study|Lost to Follow-up|8|||
42135429|NCT00289900|75946157|FG004|Overall Study|Lost to Follow-up|4|||
42135430|NCT00289900|75946158|FG005|Overall Study|Lost to Follow-up|8|||
42135431|NCT00289900|75946153|FG000|Overall Study|Participant had flushing|18|||
42135432|NCT00289900|75946154|FG001|Overall Study|Participant had flushing|42|||
42135433|NCT00289900|75946155|FG002|Overall Study|Participant had flushing|1|||
42268062|NCT02613507|76096827|FG000|Overall Study|Maximum Clinical Benefit|4|||
42268063|NCT02613507|76096828|FG001|Overall Study|Maximum Clinical Benefit|10|||
42268064|NCT02613507|76096827|FG000|Overall Study|Brain Radiotherapy Activity Limited|1|||
42268065|NCT02613507|76096828|FG001|Overall Study|Brain Radiotherapy Activity Limited|0|||
42268066|NCT02613507|76096827|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
42268067|NCT02613507|76096828|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
42268068|NCT02613507|76096827|FG000|Overall Study|Randomized but not Treated|1|||
42268069|NCT02613507|76096828|FG001|Overall Study|Randomized but not Treated|10|||
42268070|NCT02521285|76096849|FG000|Overall Study|Lost to Follow-up|1|||
42003216|NCT01171534|75810952|FG000|Overall Study|screen failure|0|||
42003217|NCT01171534|75810953|FG001|Overall Study|screen failure|1|||
42003218|NCT01170598|75810959|FG000|Overall Study|Withdrawal by Subject|1|||
42003219|NCT01170598|75810959|FG000|Overall Study|Death|3|||
42003220|NCT01170598|75810959|FG000|Overall Study|Lost to Follow-up|1|||
42003221|NCT01170598|75810959|FG000|Overall Study|Refused|1|||
42003222|NCT01170364|75810965|FG000|Overall Study|Protocol Violation|4|||
42003223|NCT01170364|75810966|FG001|Overall Study|Protocol Violation|1|||
42003224|NCT01076179|75810972|FG000|Overall Study|Withdrawal by Subject|1|||
42135434|NCT00289900|75946156|FG003|Overall Study|Participant had flushing|2|||
42268071|NCT02521285|76096850|FG001|Overall Study|Lost to Follow-up|1|||
42003225|NCT01170208|75810980|FG000|Overall Study|Withdrawal by Subject|5|||
42003226|NCT01170208|75810981|FG001|Overall Study|Withdrawal by Subject|0|||
42003227|NCT01170208|75810982|FG002|Overall Study|Withdrawal by Subject|1|||
42003228|NCT01170208|75810980|FG000|Overall Study|Protocol Violation|1|||
42003229|NCT01170208|75810981|FG001|Overall Study|Protocol Violation|0|||
42003230|NCT01170208|75810982|FG002|Overall Study|Protocol Violation|1|||
42003231|NCT01313624|75810995|FG000|Double-Blind Phase|Adverse Event|27|||
42003232|NCT01313624|75810996|FG001|Double-Blind Phase|Adverse Event|4|||
42003233|NCT01313624|75810995|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
42003234|NCT01313624|75810996|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
42003235|NCT01313624|75810995|FG000|Double-Blind Phase|Lost to Follow-up|0|||
42268072|NCT02521285|76096849|FG000|Overall Study|Withdrawal by Subject|1|||
42268073|NCT02521285|76096850|FG001|Overall Study|Withdrawal by Subject|1|||
42268074|NCT02521285|76096849|FG000|Overall Study|Adverse Event|0|||
42268075|NCT02521285|76096850|FG001|Overall Study|Adverse Event|1|||
42268076|NCT02331134|76096883|FG000|Overall Study|Withdrawal by Subject|1|||
42268077|NCT02243605|76096889|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
42268078|NCT02243605|76096890|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
42268079|NCT02243605|76096889|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
42268080|NCT02243605|76096890|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
42340684|NCT02038829|76178749|FG010|Washout Period 4|Adverse Event|0|||
42340685|NCT02038829|76178750|FG011|Washout Period 4|Adverse Event|0|||
42340686|NCT02038829|76178739|FG000|Treatment Period 6|Adverse Event|0|||
42340687|NCT02038829|76178740|FG001|Treatment Period 6|Adverse Event|0|||
42340688|NCT02038829|76178741|FG002|Treatment Period 6|Adverse Event|1|||
42340689|NCT02038829|76178742|FG003|Treatment Period 6|Adverse Event|0|||
42340690|NCT02038829|76178743|FG004|Treatment Period 6|Adverse Event|0|||
42340691|NCT02038829|76178744|FG005|Treatment Period 6|Adverse Event|0|||
42340692|NCT02038829|76178745|FG006|Treatment Period 6|Adverse Event|0|||
42340693|NCT02038829|76178746|FG007|Treatment Period 6|Adverse Event|0|||
42340694|NCT02038829|76178747|FG008|Treatment Period 6|Adverse Event|0|||
42340695|NCT02038829|76178748|FG009|Treatment Period 6|Adverse Event|0|||
42340696|NCT02038829|76178749|FG010|Treatment Period 6|Adverse Event|0|||
42340697|NCT02038829|76178750|FG011|Treatment Period 6|Adverse Event|0|||
42340698|NCT02038049|76178767|FG000|Overall Study|Lost to Follow-up|1|||
42003236|NCT01313624|75810996|FG001|Double-Blind Phase|Lost to Follow-up|2|||
42340699|NCT02038049|76178768|FG001|Overall Study|Lost to Follow-up|0|||
42003237|NCT01313624|75810995|FG000|Double-Blind Phase|Physician Decision|1|||
42003238|NCT01313624|75810996|FG001|Double-Blind Phase|Physician Decision|0|||
42340700|NCT02052011|76178780|FG000|Overall Study|Lost to Follow-up|3|||
42340701|NCT02052011|76178781|FG001|Overall Study|Lost to Follow-up|0|||
42340702|NCT02052011|76178780|FG000|Overall Study|Withdrawal by Subject|1|||
42340703|NCT02052011|76178781|FG001|Overall Study|Withdrawal by Subject|2|||
42003239|NCT01313624|75810995|FG000|Double-Blind Phase|Lack of Efficacy|1|||
42003240|NCT01313624|75810996|FG001|Double-Blind Phase|Lack of Efficacy|0|||
42003241|NCT01313624|75810995|FG000|Open-Label Phase|Adverse Event|1|||
42340704|NCT02036645|76178799|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
42340705|NCT02036645|76178800|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
42340706|NCT02036645|76178801|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
42340707|NCT02036645|76178802|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
42340708|NCT02036645|76178803|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
42003242|NCT01313624|75810996|FG001|Open-Label Phase|Adverse Event|10|||
42268081|NCT02243605|76096889|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
42268082|NCT02243605|76096890|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
42268083|NCT02243605|76096889|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
42268084|NCT02243605|76096890|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
42268085|NCT02243605|76096889|FG000|Stage 2 - Final Analysis Population|Progression|0|||
42268086|NCT02243605|76096890|FG001|Stage 2 - Final Analysis Population|Progression|1|||
42268087|NCT01284348|76096917|FG000|Overall Study|Death|1|||
42268088|NCT01284348|76096918|FG001|Overall Study|Death|1|||
42268089|NCT01284348|76096917|FG000|Overall Study|Withdrew consent|0|||
42268090|NCT01284348|76096918|FG001|Overall Study|Withdrew consent|1|||
42268091|NCT01284348|76096917|FG000|Overall Study|Status not recorded|9|||
42268092|NCT01284348|76096918|FG001|Overall Study|Status not recorded|10|||
42268093|NCT00727025|76096924|FG000|Overall Study|Physician Decision|23|||
42268094|NCT02701413|76096934|FG000|Overall Study|Withdrawal by Subject|7|||
42268095|NCT02701413|76096935|FG001|Overall Study|Withdrawal by Subject|11|||
42268096|NCT02582684|76096941|FG000|Overall Study|Unable to contact subject/parent|4|||
42268097|NCT02582684|76096941|FG000|Overall Study|Subject not able to get to clinic|10|||
42268098|NCT02582684|76096941|FG000|Overall Study|Subject withdrew consent|1|||
42268099|NCT02582684|76096941|FG000|Overall Study|Found to be ineligible after enrollment|2|||
42268100|NCT02585960|76096948|FG000|PK/Safety Assessment Period|Physician Decision|0|||
42340709|NCT02036645|76178804|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
42340710|NCT02036645|76178805|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
42003243|NCT01313624|75810995|FG000|Open-Label Phase|Withdrawal by Subject|2|||
42268101|NCT02585960|76096949|FG001|PK/Safety Assessment Period|Physician Decision|1|||
42268102|NCT02585960|76096950|FG002|PK/Safety Assessment Period|Physician Decision|0|||
42268103|NCT02585960|76096948|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
42268104|NCT02585960|76096949|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
42268105|NCT02585960|76096950|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
42003244|NCT01313624|75810996|FG001|Open-Label Phase|Withdrawal by Subject|2|||
42003245|NCT01313624|75810995|FG000|Open-Label Phase|Lost to Follow-up|1|||
42003246|NCT01313624|75810996|FG001|Open-Label Phase|Lost to Follow-up|1|||
42003247|NCT01169350|75811004|FG000|Overall Study|Physician Decision|3|||
42003248|NCT01169350|75811004|FG000|Overall Study|Lost to Follow-up|2|||
42003249|NCT01169038|75811008|FG000|Overall Study|Death|1|||
42003250|NCT01169038|75811008|FG000|Overall Study|Adverse Event|5|||
42003251|NCT01169038|75811008|FG000|Overall Study|Required antibiotic administration|1|||
42003252|NCT01167634|75811016|FG000|Overall Study|Lost to Follow-up|1|||
42003253|NCT01167634|75811017|FG001|Overall Study|Lost to Follow-up|3|||
42003254|NCT01167634|75811018|FG002|Overall Study|Lost to Follow-up|3|||
42003255|NCT01167634|75811019|FG003|Overall Study|Lost to Follow-up|4|||
42003256|NCT01167634|75811016|FG000|Overall Study|Withdrawal by Subject|1|||
42003257|NCT01167634|75811017|FG001|Overall Study|Withdrawal by Subject|1|||
42003258|NCT01167634|75811018|FG002|Overall Study|Withdrawal by Subject|0|||
42003259|NCT01167634|75811019|FG003|Overall Study|Withdrawal by Subject|0|||
42003260|NCT01166386|75811031|FG000|Overall Study|Withdrawal by Subject|3|||
42003261|NCT01166386|75811032|FG001|Overall Study|Withdrawal by Subject|5|||
42003262|NCT01114828|75811040|FG000|Overall Study|Adverse Event|1|||
42003263|NCT01114828|75811041|FG001|Overall Study|Adverse Event|1|||
42003264|NCT01114828|75811040|FG000|Overall Study|Lack of Efficacy|0|||
42003265|NCT01114828|75811041|FG001|Overall Study|Lack of Efficacy|2|||
42003266|NCT01114828|75811040|FG000|Overall Study|Protocol Violation|2|||
42003267|NCT01114828|75811041|FG001|Overall Study|Protocol Violation|0|||
42003268|NCT01114828|75811040|FG000|Overall Study|Withdrawal by Subject|0|||
42003269|NCT01114828|75811041|FG001|Overall Study|Withdrawal by Subject|1|||
42003270|NCT01313312|75811047|FG000|Overall Study|Adverse Event|5|||
42003271|NCT01313312|75811047|FG000|Overall Study|Withdrawal by Subject|18|||
42003272|NCT01313312|75811047|FG000|Overall Study|Lack of Efficacy|3|||
42003273|NCT01313312|75811047|FG000|Overall Study|Investigator Decision|1|||
42003274|NCT01313312|75811047|FG000|Overall Study|Observational Phase|1|||
42003275|NCT01313312|75811047|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
42003276|NCT01313312|75811047|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
42003277|NCT01114672|75811053|FG000|Overall Study|Death|0|||
42003278|NCT01114672|75811054|FG001|Overall Study|Death|1|||
42003279|NCT01114672|75811053|FG000|Overall Study|Withdrawal by Subject|2|||
42003280|NCT01114672|75811054|FG001|Overall Study|Withdrawal by Subject|1|||
42035071|NCT00932373|75843308|FG000|Overall Study|Clinical progression|0|||
42003281|NCT01114672|75811053|FG000|Overall Study|Lost to Follow-up|1|||
42003282|NCT01114672|75811054|FG001|Overall Study|Lost to Follow-up|0|||
42003283|NCT01114672|75811053|FG000|Overall Study|transplanted|1|||
42035072|NCT00932373|75843309|FG001|Overall Study|Clinical progression|0|||
42035073|NCT00932373|75843310|FG002|Overall Study|Clinical progression|0|||
42268106|NCT02585960|76096948|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
42268107|NCT02585960|76096949|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
42268108|NCT02585960|76096950|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
42268109|NCT02585960|76096948|FG000|PK/Safety Assessment Period|Other|4|||
42003284|NCT01114672|75811054|FG001|Overall Study|transplanted|0|||
42003285|NCT01114516|75811062|FG000|Overall Study|Lost to Follow-up|2|||
42003286|NCT01114516|75811063|FG001|Overall Study|Lost to Follow-up|1|||
42035074|NCT00932373|75843311|FG003|Overall Study|Clinical progression|0|||
42003287|NCT01114438|75811069|FG000|Overall Study|Adverse Event|10|||
42268110|NCT02585960|76096949|FG001|PK/Safety Assessment Period|Other|4|||
42003288|NCT01114438|75811069|FG000|Overall Study|concomitant medication|1|||
42003289|NCT01114438|75811069|FG000|Overall Study|Physician Decision|1|||
42003290|NCT01114438|75811069|FG000|Overall Study|Withdrawal by Subject|2|||
42003291|NCT01313078|75811078|FG000|Overall Study|Death|1|||
42003292|NCT01313078|75811078|FG000|Overall Study|Discontinued study drug|1|||
42003293|NCT01313078|75811078|FG000|Overall Study|Withdrawal by Subject|1|||
42003294|NCT01114360|75811082|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
42003295|NCT01114360|75811083|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
42003296|NCT01310036|75811103|FG000|Overall Study|Administrative/other|10|||
42003297|NCT01310036|75811103|FG000|Overall Study|Withdrew Consent|11|||
42003298|NCT01310036|75811103|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
42003299|NCT01310036|75811103|FG000|Overall Study|Progression of Disease|164|||
42003300|NCT01310036|75811103|FG000|Overall Study|Death|1|||
42003301|NCT01310036|75811103|FG000|Overall Study|Adverse event or intercurrent illness|12|||
42003302|NCT01309100|75811107|FG000|Overall Study|Protocol Violation|1|||
42003303|NCT01309100|75811107|FG000|Overall Study|Positive Slit lamp finding|1|||
42003304|NCT01308788|75811116|FG000|2-year Treatment|medication change by treating physician|4|||
42268111|NCT02585960|76096950|FG002|PK/Safety Assessment Period|Other|0|||
42268112|NCT02585960|76096948|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
42268113|NCT02585960|76096949|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
42268114|NCT02585960|76096950|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
42268115|NCT02585960|76096948|FG000|PK/Safety Assessment Period|Screen Failure|0|||
42340711|NCT02036645|76178806|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
42340712|NCT02036645|76178807|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
42340713|NCT02036645|76178808|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
42340714|NCT02036645|76178809|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
42340715|NCT02036645|76178810|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
42340716|NCT02036645|76178799|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
42340717|NCT02036645|76178800|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
42340718|NCT02036645|76178801|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
42340719|NCT02036645|76178802|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
42340720|NCT02036645|76178803|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
42340721|NCT02036645|76178804|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
42340722|NCT02036645|76178805|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
42340723|NCT02036645|76178806|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
42340724|NCT02036645|76178807|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
42340725|NCT02036645|76178808|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
42340726|NCT02036645|76178809|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
42268116|NCT02585960|76096949|FG001|PK/Safety Assessment Period|Screen Failure|0|||
42268117|NCT02585960|76096950|FG002|PK/Safety Assessment Period|Screen Failure|1|||
42268118|NCT02585960|76096948|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
42268119|NCT02585960|76096949|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
42268120|NCT02585960|76096950|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
42268121|NCT02585960|76096948|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
42268122|NCT02585960|76096949|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
42268123|NCT02585960|76096950|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
42268124|NCT02699463|76096963|FG000|Overall Study|Lost to Follow-up|11|||
42268125|NCT02699463|76096964|FG001|Overall Study|Lost to Follow-up|8|||
42268126|NCT02699463|76096963|FG000|Overall Study|Withdrawal by Subject|4|||
42268127|NCT02699463|76096964|FG001|Overall Study|Withdrawal by Subject|1|||
42268128|NCT00100789|76096970|FG000|Overall Study|Adverse Event|10|||
42268129|NCT00100789|76096970|FG000|Overall Study|Withdrawal by Subject|1|||
42268130|NCT00100789|76096970|FG000|Overall Study|Progression/relapse|42|||
42268131|NCT00100789|76096970|FG000|Overall Study|Death|2|||
42268132|NCT00100789|76096970|FG000|Overall Study|Not protocol specified|5|||
42268133|NCT00100789|76096970|FG000|Overall Study|Ineligible|3|||
42268134|NCT00100789|76096970|FG000|Overall Study|Never received treatment|1|||
42268135|NCT00708123|76096975|FG000|Period 1|Protocol Violation|0|||
42268136|NCT00708123|76096976|FG001|Period 1|Protocol Violation|1|||
42268137|NCT00708123|76096977|FG002|Period 1|Protocol Violation|0|||
42268138|NCT00708123|76096978|FG003|Period 1|Protocol Violation|1|||
42340727|NCT02036645|76178810|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
42340728|NCT02051933|76178850|FG000|Overall Study|Physician Decision|0|||
42340729|NCT02051933|76178851|FG001|Overall Study|Physician Decision|1|||
42268139|NCT00708123|76096979|FG004|Period 1|Protocol Violation|0|||
42003305|NCT01308788|75811117|FG001|2-year Treatment|medication change by treating physician|11|||
42003306|NCT01075321|75811123|FG000|Overall Study|Withdrawal by Subject|0|||
42003307|NCT01075321|75811124|FG001|Overall Study|Withdrawal by Subject|0|||
42003308|NCT01075321|75811125|FG002|Overall Study|Withdrawal by Subject|1|||
42268140|NCT00708123|76096975|FG000|Period 1|Adverse Event|0|||
42268141|NCT00708123|76096976|FG001|Period 1|Adverse Event|0|||
42268142|NCT00708123|76096977|FG002|Period 1|Adverse Event|1|||
42268143|NCT00708123|76096978|FG003|Period 1|Adverse Event|0|||
42268144|NCT00708123|76096979|FG004|Period 1|Adverse Event|0|||
42003309|NCT01075321|75811126|FG003|Overall Study|Withdrawal by Subject|1|||
42003310|NCT01075321|75811123|FG000|Overall Study|Protocol Violation|0|||
42003311|NCT01075321|75811124|FG001|Overall Study|Protocol Violation|0|||
42003312|NCT01075321|75811125|FG002|Overall Study|Protocol Violation|1|||
42003313|NCT01075321|75811126|FG003|Overall Study|Protocol Violation|0|||
42003314|NCT01075321|75811123|FG000|Overall Study|Treatment Incomplete due to progression|1|||
42003315|NCT01075321|75811124|FG001|Overall Study|Treatment Incomplete due to progression|0|||
42003316|NCT01075321|75811125|FG002|Overall Study|Treatment Incomplete due to progression|0|||
42003317|NCT01075321|75811126|FG003|Overall Study|Treatment Incomplete due to progression|0|||
42003318|NCT01075321|75811123|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
42003319|NCT01075321|75811124|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
42003320|NCT01075321|75811125|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
42003321|NCT01075321|75811126|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
42003322|NCT01114204|75811140|FG000|Overall Study|Adverse Event|3|||
42003323|NCT01114204|75811141|FG001|Overall Study|Adverse Event|2|||
42003324|NCT01114204|75811140|FG000|Overall Study|Lost to Follow-up|1|||
42340730|NCT02050373|76178864|FG000|Overall Study|Adverse Event|4|||
42340731|NCT02050373|76178865|FG001|Overall Study|Adverse Event|7|||
42340732|NCT02050373|76178864|FG000|Overall Study|Death|3|||
42340733|NCT02050373|76178865|FG001|Overall Study|Death|3|||
42003325|NCT01114204|75811141|FG001|Overall Study|Lost to Follow-up|0|||
42003326|NCT01114204|75811140|FG000|Overall Study|Withdrawal by Subject|10|||
42003327|NCT01114204|75811141|FG001|Overall Study|Withdrawal by Subject|6|||
42003328|NCT01114204|75811140|FG000|Overall Study|Death|1|||
42003329|NCT01114204|75811141|FG001|Overall Study|Death|0|||
42003330|NCT01114204|75811140|FG000|Overall Study|Other-Personal reasons|2|||
42003331|NCT01114204|75811141|FG001|Overall Study|Other-Personal reasons|0|||
42003332|NCT01114204|75811140|FG000|Overall Study|Other-Medical monitor request|1|||
42003333|NCT01114204|75811141|FG001|Overall Study|Other-Medical monitor request|0|||
42340734|NCT02049437|76178874|FG000|Period 1|Adverse Event|1|||
42340735|NCT02049437|76178875|FG001|Period 1|Adverse Event|1|||
42003334|NCT01114204|75811140|FG000|Overall Study|Other-Participant request|2|||
42003335|NCT01114204|75811141|FG001|Overall Study|Other-Participant request|0|||
42003336|NCT01114204|75811140|FG000|Overall Study|Other-Protocol Violation|1|||
42003337|NCT01114204|75811141|FG001|Overall Study|Other-Protocol Violation|0|||
42340736|NCT02049437|76178874|FG000|Period 1|Adverse Event|1|||
42340737|NCT02049437|76178875|FG001|Period 1|Adverse Event|0|||
42003338|NCT01075243|75811150|FG000|Overall Study|Lost to Follow-up|5|||
42003339|NCT01075243|75811151|FG001|Overall Study|Lost to Follow-up|2|||
42003340|NCT01075243|75811152|FG002|Overall Study|Lost to Follow-up|0|||
42268145|NCT00708123|76096975|FG000|Period 2|Protocol Violation|0|||
42268146|NCT00708123|76096976|FG001|Period 2|Protocol Violation|0|||
42340738|NCT02035553|76178883|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
42340739|NCT02035553|76178884|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
42340740|NCT02035553|76178883|FG000|Overall Study|Adverse Event|10|||
42340741|NCT02035553|76178884|FG001|Overall Study|Adverse Event|6|||
42340742|NCT02035553|76178883|FG000|Overall Study|Physician Decision|3|||
42340743|NCT02035553|76178884|FG001|Overall Study|Physician Decision|2|||
42340744|NCT02035553|76178883|FG000|Overall Study|Lack of Efficacy|1|||
42340745|NCT02035553|76178884|FG001|Overall Study|Lack of Efficacy|1|||
42340746|NCT02035553|76178883|FG000|Overall Study|Withdrawal by Subject|4|||
42268147|NCT00708123|76096977|FG002|Period 2|Protocol Violation|0|||
42268148|NCT00708123|76096978|FG003|Period 2|Protocol Violation|1|||
42268149|NCT00708123|76096979|FG004|Period 2|Protocol Violation|0|||
42268150|NCT00708123|76096975|FG000|Period 2|Other Reason|1|||
42268151|NCT00708123|76096976|FG001|Period 2|Other Reason|0|||
42340747|NCT02035553|76178884|FG001|Overall Study|Withdrawal by Subject|7|||
42340748|NCT02035553|76178883|FG000|Overall Study|Non-compliance with Study Drug|0|||
42003341|NCT01075243|75811150|FG000|Overall Study|Withdrawal by Subject|1|||
42003342|NCT01075243|75811151|FG001|Overall Study|Withdrawal by Subject|1|||
42003343|NCT01075243|75811152|FG002|Overall Study|Withdrawal by Subject|0|||
42003344|NCT01308476|75811164|FG000|Overall Study|Lost to Follow-up|2|||
42268152|NCT00708123|76096977|FG002|Period 2|Other Reason|0|||
42268153|NCT00708123|76096978|FG003|Period 2|Other Reason|0|||
42340749|NCT02035553|76178884|FG001|Overall Study|Non-compliance with Study Drug|1|||
42003345|NCT01308476|75811165|FG001|Overall Study|Lost to Follow-up|2|||
42003346|NCT01308476|75811164|FG000|Overall Study|Other|1|||
42003347|NCT01308476|75811165|FG001|Overall Study|Other|0|||
42003348|NCT01078441|75811171|FG000|Overall Study|Withdrawal by Subject|1|||
42003349|NCT01308008|75811177|FG000|4 Weeks|Illness, disinterest, time|9|||
42003350|NCT01308008|75811178|FG001|4 Weeks|Illness, disinterest, time|2|||
42003351|NCT01113892|75811186|FG000|Overall Study|Lost to Follow-up|2|||
42003352|NCT01113892|75811187|FG001|Overall Study|Lost to Follow-up|2|||
42003353|NCT01113892|75811186|FG000|Overall Study|Withdrawal by Subject|1|||
42003354|NCT01113892|75811187|FG001|Overall Study|Withdrawal by Subject|1|||
42003355|NCT01113892|75811186|FG000|Overall Study|Death|2|||
42003356|NCT01113892|75811187|FG001|Overall Study|Death|4|||
42003357|NCT01113892|75811186|FG000|Overall Study|Graft no longer evaluable|9|||
42003358|NCT01113892|75811187|FG001|Overall Study|Graft no longer evaluable|9|||
42003359|NCT01090063|75811193|FG000|Screen|Screen Failed|4|||
42003360|NCT01090063|75811193|FG000|Treatment|Withdrawal by Subject|4|||
42003361|NCT01113580|75811209|FG000|Overall Study|Protocol Violation|1|||
42003362|NCT01113580|75811210|FG001|Overall Study|Protocol Violation|0|||
42003363|NCT01306214|75811219|FG000|Overall Study|Death|0|||
42003364|NCT01306214|75811220|FG001|Overall Study|Death|0|||
42003365|NCT01306214|75811221|FG002|Overall Study|Death|1|||
42003366|NCT01306214|75811219|FG000|Overall Study|Lost to Follow-up|3|||
42003367|NCT01306214|75811220|FG001|Overall Study|Lost to Follow-up|5|||
42003368|NCT01306214|75811221|FG002|Overall Study|Lost to Follow-up|4|||
42003369|NCT01306214|75811219|FG000|Overall Study|Withdrawal by Subject|24|||
42003370|NCT01306214|75811220|FG001|Overall Study|Withdrawal by Subject|22|||
42003371|NCT01306214|75811221|FG002|Overall Study|Withdrawal by Subject|16|||
42003372|NCT01306214|75811219|FG000|Overall Study|Not treated|1|||
42003373|NCT01306214|75811220|FG001|Overall Study|Not treated|1|||
42003374|NCT01306214|75811221|FG002|Overall Study|Not treated|1|||
42003375|NCT01077739|75811231|FG000|Overall Study|Premature withdrawal|1|||
42003376|NCT01077739|75811232|FG001|Overall Study|Premature withdrawal|3|||
42003377|NCT01077739|75811231|FG000|Overall Study|Withdrawal by Subject|1|||
42003378|NCT01077739|75811232|FG001|Overall Study|Withdrawal by Subject|0|||
42003379|NCT01077739|75811231|FG000|Overall Study|Death|0|||
42003380|NCT01077739|75811232|FG001|Overall Study|Death|3|||
42003381|NCT01077739|75811231|FG000|Overall Study|Unacceptable toxicity|1|||
42003382|NCT01077739|75811232|FG001|Overall Study|Unacceptable toxicity|2|||
42003383|NCT01077739|75811231|FG000|Overall Study|Other|2|||
42003384|NCT01077739|75811232|FG001|Overall Study|Other|2|||
42003385|NCT01306058|75811238|FG000|Overall Study|Death|1|||
42003386|NCT01306058|75811238|FG000|Overall Study|Enrolled but did not get treatment|1|||
42268154|NCT00708123|76096979|FG004|Period 2|Other Reason|0|||
42268155|NCT00708123|76096975|FG000|Period 3|Lost to Follow-up|0|||
42268156|NCT00708123|76096976|FG001|Period 3|Lost to Follow-up|0|||
42268157|NCT00708123|76096977|FG002|Period 3|Lost to Follow-up|1|||
42268158|NCT00708123|76096978|FG003|Period 3|Lost to Follow-up|1|||
42268159|NCT00708123|76096979|FG004|Period 3|Lost to Follow-up|0|||
42003387|NCT01305200|75811245|FG000|Overall Study|Physician Decision|4|||
42003388|NCT01305200|75811246|FG001|Overall Study|Physician Decision|6|||
42003389|NCT01305200|75811247|FG002|Overall Study|Physician Decision|1|||
42003390|NCT01305200|75811245|FG000|Overall Study|Withdrawal by Subject|24|||
42003391|NCT01305200|75811246|FG001|Overall Study|Withdrawal by Subject|21|||
42003392|NCT01305200|75811247|FG002|Overall Study|Withdrawal by Subject|1|||
42003393|NCT01305200|75811245|FG000|Overall Study|Ineligible|1|||
42003394|NCT01305200|75811246|FG001|Overall Study|Ineligible|2|||
42003395|NCT01305200|75811247|FG002|Overall Study|Ineligible|1|||
42003396|NCT01305200|75811245|FG000|Overall Study|Death|0|||
42003397|NCT01305200|75811246|FG001|Overall Study|Death|2|||
42003398|NCT01305200|75811247|FG002|Overall Study|Death|0|||
42003399|NCT01077271|75811257|FG000|Overall Study|Parental desire|8|||
42268160|NCT00708123|76096975|FG000|Period 4|Protocol Violation|0|||
42268161|NCT00708123|76096976|FG001|Period 4|Protocol Violation|1|||
42003400|NCT01077271|75811257|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
42003401|NCT01077271|75811257|FG000|Overall Study|Noncompliance|2|||
42003402|NCT01077271|75811257|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
42003403|NCT01077271|75811257|FG000|Overall Study|Changed doctors|2|||
42003404|NCT01077271|75811257|FG000|Overall Study|Parents thought too many injections|2|||
42003405|NCT01077271|75811257|FG000|Overall Study|End of RSV season nearly reached|1|||
42003406|NCT01077271|75811257|FG000|Overall Study|Mother unconvinced of the necessity|1|||
42003407|NCT01305044|75811271|FG000|Overall Study|Withdrawal by Subject|3|||
42003408|NCT01305044|75811272|FG001|Overall Study|Withdrawal by Subject|6|||
42003409|NCT01304498|75811280|FG000|Overall Study|Adverse Event|1|||
42003410|NCT01304498|75811281|FG001|Overall Study|Adverse Event|1|||
42003411|NCT01304498|75811280|FG000|Overall Study|Withdrawal by Subject|2|||
42003412|NCT01304498|75811281|FG001|Overall Study|Withdrawal by Subject|3|||
42003413|NCT01304498|75811280|FG000|Overall Study|Protocol Violation|1|||
42003414|NCT01304498|75811281|FG001|Overall Study|Protocol Violation|0|||
42003415|NCT01304498|75811280|FG000|Overall Study|Lost to Follow-up|2|||
42003416|NCT01304498|75811281|FG001|Overall Study|Lost to Follow-up|1|||
42003417|NCT01077193|75811287|FG000|Overall Study|Lost to Follow-up|1|||
42003418|NCT01077193|75811287|FG000|Overall Study|Withdrawal by Subject|2|||
42003419|NCT01077193|75811287|FG000|Overall Study|Lack of Efficacy|1|||
42003420|NCT01077193|75811287|FG000|Overall Study|Study Terminated by Sponsor|40|||
42003421|NCT01074931|75811291|FG000|Overall Study|Economic reasons|1|||
42003422|NCT01074931|75811291|FG000|Overall Study|Death|5|||
42003423|NCT01303172|75811301|FG000|Overall Study|Physician Decision|9|||
42003424|NCT01303172|75811302|FG001|Overall Study|Physician Decision|6|||
42003425|NCT01303172|75811301|FG000|Overall Study|Adverse Event|5|||
42003426|NCT01303172|75811302|FG001|Overall Study|Adverse Event|2|||
42003427|NCT01303172|75811301|FG000|Overall Study|Withdrawal by Subject|4|||
42003428|NCT01303172|75811302|FG001|Overall Study|Withdrawal by Subject|2|||
42003429|NCT01303172|75811301|FG000|Overall Study|Death|20|||
42003430|NCT01303172|75811302|FG001|Overall Study|Death|7|||
42003431|NCT01303172|75811301|FG000|Overall Study|Lack of Efficacy|25|||
42003432|NCT01303172|75811302|FG001|Overall Study|Lack of Efficacy|17|||
42003433|NCT01302938|75811311|FG000|Overall Study|Withdrawal by Subject|1|||
42003434|NCT01302938|75811312|FG001|Overall Study|Withdrawal by Subject|0|||
42003435|NCT01302938|75811311|FG000|Overall Study|Adverse Event|1|||
42003436|NCT01302938|75811312|FG001|Overall Study|Adverse Event|0|||
42003437|NCT01302548|75811321|FG000|Overall Study|Lost to Follow-up|2|||
42003438|NCT01302548|75811322|FG001|Overall Study|Lost to Follow-up|1|||
42003439|NCT01076959|75811328|FG000|Overall Study|Adverse Event|767|||
42003440|NCT01076959|75811328|FG000|Overall Study|Lack of Efficacy|849|||
42003441|NCT01076959|75811328|FG000|Overall Study|Non-compliance|274|||
42003442|NCT01076959|75811328|FG000|Overall Study|Lost to Follow-up|241|||
42003443|NCT01076959|75811328|FG000|Overall Study|Other|119|||
42003444|NCT01302392|75811347|FG000|Overall Study|Lost to Follow-up|1|||
42003445|NCT01302392|75811348|FG001|Overall Study|Lost to Follow-up|0|||
42003446|NCT01302392|75811347|FG000|Overall Study|Withdrawal by Subject|6|||
42003447|NCT01302392|75811348|FG001|Overall Study|Withdrawal by Subject|1|||
42003448|NCT01076647|75811356|FG000|Overall Study|Adverse Event|4|||
42003449|NCT01076647|75811357|FG001|Overall Study|Adverse Event|1|||
42003450|NCT01076647|75811356|FG000|Overall Study|Lack of Efficacy|0|||
42003451|NCT01076647|75811357|FG001|Overall Study|Lack of Efficacy|1|||
42003452|NCT01076647|75811356|FG000|Overall Study|Protocol Violation|7|||
42003453|NCT01076647|75811357|FG001|Overall Study|Protocol Violation|9|||
42003454|NCT01076647|75811356|FG000|Overall Study|Withdrawal criteria|2|||
42003455|NCT01076647|75811357|FG001|Overall Study|Withdrawal criteria|2|||
42003456|NCT01076647|75811356|FG000|Overall Study|Unclassified|12|||
42003457|NCT01076647|75811357|FG001|Overall Study|Unclassified|12|||
42268162|NCT00708123|76096977|FG002|Period 4|Protocol Violation|0|||
42268163|NCT00708123|76096978|FG003|Period 4|Protocol Violation|0|||
42268164|NCT00708123|76096979|FG004|Period 4|Protocol Violation|0|||
42003458|NCT01074307|75811365|FG000|Overall Study|No primary endpoint evaluation|14|||
42003459|NCT01074307|75811366|FG001|Overall Study|No primary endpoint evaluation|6|||
42003460|NCT01074307|75811365|FG000|Overall Study|Exclusion criterion|0|||
42003461|NCT01074307|75811366|FG001|Overall Study|Exclusion criterion|1|||
42003462|NCT01074307|75811365|FG000|Overall Study|Protocol Violation|8|||
42003463|NCT01074307|75811366|FG001|Overall Study|Protocol Violation|5|||
42003464|NCT01076335|75811372|FG000|Overall Study|Withdrawal by Subject|3|||
42003465|NCT01076335|75811372|FG000|Overall Study|Withdrawal without treatment|1|||
42003466|NCT01309737|75811379|FG000|Week 0 to 16|Death|1|||
42003467|NCT01309737|75811380|FG001|Week 0 to 16|Death|0|||
42003468|NCT01309737|75811381|FG002|Week 0 to 16|Death|1|||
42003469|NCT01309737|75811382|FG003|Week 0 to 16|Death|0|||
42003470|NCT01309737|75811383|FG004|Week 0 to 16|Death|0|||
42003471|NCT01309737|75811379|FG000|Week 0 to 16|Adverse Event|11|||
42003472|NCT01309737|75811380|FG001|Week 0 to 16|Adverse Event|10|||
42003473|NCT01309737|75811381|FG002|Week 0 to 16|Adverse Event|5|||
42003474|NCT01309737|75811382|FG003|Week 0 to 16|Adverse Event|0|||
42268165|NCT02165215|76096998|FG000|Induction Phase|Adverse Event|1|||
42003475|NCT01309737|75811383|FG004|Week 0 to 16|Adverse Event|0|||
42003476|NCT01309737|75811379|FG000|Week 0 to 16|Lack of Efficacy|15|||
42003477|NCT01309737|75811380|FG001|Week 0 to 16|Lack of Efficacy|2|||
42003478|NCT01309737|75811381|FG002|Week 0 to 16|Lack of Efficacy|24|||
42003479|NCT01309737|75811382|FG003|Week 0 to 16|Lack of Efficacy|0|||
42003480|NCT01309737|75811383|FG004|Week 0 to 16|Lack of Efficacy|0|||
42003481|NCT01309737|75811379|FG000|Week 0 to 16|Lost to Follow-up|7|||
42003482|NCT01309737|75811380|FG001|Week 0 to 16|Lost to Follow-up|8|||
42003483|NCT01309737|75811381|FG002|Week 0 to 16|Lost to Follow-up|3|||
42003484|NCT01309737|75811382|FG003|Week 0 to 16|Lost to Follow-up|0|||
42003485|NCT01309737|75811383|FG004|Week 0 to 16|Lost to Follow-up|0|||
42003486|NCT01309737|75811379|FG000|Week 0 to 16|Withdrawal by Subject|7|||
42003487|NCT01309737|75811380|FG001|Week 0 to 16|Withdrawal by Subject|6|||
42003488|NCT01309737|75811381|FG002|Week 0 to 16|Withdrawal by Subject|7|||
42003489|NCT01309737|75811382|FG003|Week 0 to 16|Withdrawal by Subject|0|||
42003490|NCT01309737|75811383|FG004|Week 0 to 16|Withdrawal by Subject|0|||
42003491|NCT01309737|75811379|FG000|Week 0 to 16|Other|10|||
42003492|NCT01309737|75811380|FG001|Week 0 to 16|Other|14|||
42003493|NCT01309737|75811381|FG002|Week 0 to 16|Other|4|||
42003494|NCT01309737|75811382|FG003|Week 0 to 16|Other|0|||
42003495|NCT01309737|75811383|FG004|Week 0 to 16|Other|0|||
42003496|NCT01309737|75811379|FG000|Week 0 to 16|Randomized, but not treated|1|||
42135435|NCT00289900|75946157|FG004|Overall Study|Participant had flushing|0|||
42135436|NCT00289900|75946158|FG005|Overall Study|Participant had flushing|4|||
42135437|NCT00289900|75946153|FG000|Overall Study|Other|0|||
42268166|NCT02165215|76096999|FG001|Induction Phase|Adverse Event|0|||
42268167|NCT02165215|76097000|FG002|Induction Phase|Adverse Event|0|||
42268168|NCT02165215|76096998|FG000|Induction Phase|Withdrawal by Subject|10|||
42268169|NCT02165215|76096999|FG001|Induction Phase|Withdrawal by Subject|0|||
42268170|NCT02165215|76097000|FG002|Induction Phase|Withdrawal by Subject|0|||
42268171|NCT02165215|76096998|FG000|Induction Phase|Protocol Violation|1|||
42268172|NCT02165215|76096999|FG001|Induction Phase|Protocol Violation|0|||
42268173|NCT02165215|76097000|FG002|Induction Phase|Protocol Violation|0|||
42268174|NCT02165215|76096998|FG000|Induction Phase|Physician Decision|1|||
42268175|NCT02165215|76096999|FG001|Induction Phase|Physician Decision|0|||
42268176|NCT02165215|76097000|FG002|Induction Phase|Physician Decision|0|||
42268177|NCT02165215|76096998|FG000|Induction Phase|Lack of Efficacy|2|||
42268178|NCT02165215|76096999|FG001|Induction Phase|Lack of Efficacy|0|||
42268179|NCT02165215|76097000|FG002|Induction Phase|Lack of Efficacy|0|||
42268180|NCT02165215|76096998|FG000|Induction Phase|Non-Compliance|2|||
42268181|NCT02165215|76096999|FG001|Induction Phase|Non-Compliance|0|||
42268182|NCT02165215|76097000|FG002|Induction Phase|Non-Compliance|0|||
42340750|NCT02035553|76178883|FG000|Overall Study|Lost to Follow-up|0|||
42340751|NCT02035553|76178884|FG001|Overall Study|Lost to Follow-up|1|||
42340752|NCT02035553|76178883|FG000|Overall Study|Other Reason|0|||
42340753|NCT02035553|76178884|FG001|Overall Study|Other Reason|4|||
42340754|NCT01445080|76178899|FG000|Overall Study|Adverse Event|5|||
42340755|NCT01445080|76178900|FG001|Overall Study|Adverse Event|3|||
42340756|NCT01445080|76178901|FG002|Overall Study|Adverse Event|11|||
42340757|NCT01445080|76178902|FG003|Overall Study|Adverse Event|6|||
42340758|NCT01445080|76178903|FG004|Overall Study|Adverse Event|2|||
42340759|NCT01445080|76178904|FG005|Overall Study|Adverse Event|3|||
42340760|NCT01445080|76178905|FG006|Overall Study|Adverse Event|0|||
42340761|NCT01445080|76178906|FG007|Overall Study|Adverse Event|3|||
42340762|NCT01445080|76178907|FG008|Overall Study|Adverse Event|10|||
42340763|NCT01445080|76178899|FG000|Overall Study|Physician Decision|0|||
42340764|NCT01445080|76178900|FG001|Overall Study|Physician Decision|0|||
42340765|NCT01445080|76178901|FG002|Overall Study|Physician Decision|1|||
42003497|NCT01309737|75811380|FG001|Week 0 to 16|Randomized, but not treated|0|||
42003498|NCT01309737|75811381|FG002|Week 0 to 16|Randomized, but not treated|0|||
42003499|NCT01309737|75811382|FG003|Week 0 to 16|Randomized, but not treated|0|||
42003500|NCT01309737|75811383|FG004|Week 0 to 16|Randomized, but not treated|0|||
42003501|NCT01309737|75811379|FG000|Week 16 to 52|Death|0|||
42003502|NCT01309737|75811380|FG001|Week 16 to 52|Death|0|||
42003503|NCT01309737|75811381|FG002|Week 16 to 52|Death|0|||
42003504|NCT01309737|75811382|FG003|Week 16 to 52|Death|0|||
42135438|NCT00289900|75946154|FG001|Overall Study|Other|0|||
42268183|NCT02165215|76096998|FG000|Induction Phase|Lost to Follow-up|6|||
42268184|NCT02165215|76096999|FG001|Induction Phase|Lost to Follow-up|0|||
42268185|NCT02165215|76097000|FG002|Induction Phase|Lost to Follow-up|0|||
42268186|NCT02165215|76096998|FG000|Maintenance Phase|Withdrawal by Subject|0|||
42340766|NCT01445080|76178902|FG003|Overall Study|Physician Decision|0|||
42340767|NCT01445080|76178903|FG004|Overall Study|Physician Decision|0|||
42340768|NCT01445080|76178904|FG005|Overall Study|Physician Decision|3|||
42268187|NCT02165215|76096999|FG001|Maintenance Phase|Withdrawal by Subject|7|||
42268188|NCT02165215|76097000|FG002|Maintenance Phase|Withdrawal by Subject|3|||
42268189|NCT02165215|76096998|FG000|Maintenance Phase|Multiple reasons|0|||
42268190|NCT02165215|76096999|FG001|Maintenance Phase|Multiple reasons|2|||
42268191|NCT02165215|76097000|FG002|Maintenance Phase|Multiple reasons|1|||
42268192|NCT02165215|76096998|FG000|Maintenance Phase|Lost to Follow-up|0|||
42268193|NCT02165215|76096999|FG001|Maintenance Phase|Lost to Follow-up|2|||
42268194|NCT02165215|76097000|FG002|Maintenance Phase|Lost to Follow-up|0|||
42268195|NCT02165215|76096998|FG000|Maintenance Phase|Adverse Event|0|||
42268196|NCT02165215|76096999|FG001|Maintenance Phase|Adverse Event|1|||
42268197|NCT02165215|76097000|FG002|Maintenance Phase|Adverse Event|1|||
42268198|NCT02757625|76097015|FG000|Overall Study|Investigator's discretion|0|||
42268199|NCT02757625|76097016|FG001|Overall Study|Investigator's discretion|0|||
42268200|NCT02757625|76097017|FG002|Overall Study|Investigator's discretion|1|||
42268201|NCT02757625|76097018|FG003|Overall Study|Investigator's discretion|0|||
42268202|NCT02757625|76097015|FG000|Overall Study|Adverse Event|0|||
42268203|NCT02757625|76097016|FG001|Overall Study|Adverse Event|0|||
42003505|NCT01309737|75811383|FG004|Week 16 to 52|Death|1|||
42003506|NCT01309737|75811379|FG000|Week 16 to 52|Adverse Event|7|||
42003507|NCT01309737|75811380|FG001|Week 16 to 52|Adverse Event|7|||
42003508|NCT01309737|75811381|FG002|Week 16 to 52|Adverse Event|0|||
42003509|NCT01309737|75811382|FG003|Week 16 to 52|Adverse Event|6|||
42003510|NCT01309737|75811383|FG004|Week 16 to 52|Adverse Event|5|||
42003511|NCT01309737|75811379|FG000|Week 16 to 52|Lack of Efficacy|107|||
42003512|NCT01309737|75811380|FG001|Week 16 to 52|Lack of Efficacy|76|||
42003513|NCT01309737|75811381|FG002|Week 16 to 52|Lack of Efficacy|0|||
42003514|NCT01309737|75811382|FG003|Week 16 to 52|Lack of Efficacy|25|||
42003515|NCT01309737|75811383|FG004|Week 16 to 52|Lack of Efficacy|21|||
42003516|NCT01309737|75811379|FG000|Week 16 to 52|Lost to Follow-up|4|||
42003517|NCT01309737|75811380|FG001|Week 16 to 52|Lost to Follow-up|2|||
42003518|NCT01309737|75811381|FG002|Week 16 to 52|Lost to Follow-up|0|||
42003519|NCT01309737|75811382|FG003|Week 16 to 52|Lost to Follow-up|1|||
42003520|NCT01309737|75811383|FG004|Week 16 to 52|Lost to Follow-up|4|||
42003521|NCT01309737|75811379|FG000|Week 16 to 52|Withdrawal by Subject|5|||
42003522|NCT01309737|75811380|FG001|Week 16 to 52|Withdrawal by Subject|6|||
42003523|NCT01309737|75811381|FG002|Week 16 to 52|Withdrawal by Subject|0|||
42003524|NCT01309737|75811382|FG003|Week 16 to 52|Withdrawal by Subject|0|||
42003525|NCT01309737|75811383|FG004|Week 16 to 52|Withdrawal by Subject|2|||
42003526|NCT01309737|75811379|FG000|Week 16 to 52|Other|10|||
42003527|NCT01309737|75811380|FG001|Week 16 to 52|Other|12|||
42003528|NCT01309737|75811381|FG002|Week 16 to 52|Other|0|||
42003529|NCT01309737|75811382|FG003|Week 16 to 52|Other|2|||
42268204|NCT02757625|76097017|FG002|Overall Study|Adverse Event|1|||
42268205|NCT02757625|76097018|FG003|Overall Study|Adverse Event|0|||
42268206|NCT02581202|76097030|FG000|Overall Study|Lack of Efficacy|2|||
42268207|NCT02581202|76097030|FG000|Overall Study|Withdrawal by Subject|4|||
42268208|NCT02581202|76097030|FG000|Overall Study|Lost to Follow-up|5|||
42268209|NCT02581202|76097030|FG000|Overall Study|Pregnancy|3|||
42268210|NCT02758171|76097037|FG000|Wash-out|Withdrawal by Subject|1|||
42268211|NCT02758171|76097038|FG001|Wash-out|Withdrawal by Subject|0|||
42268212|NCT02758171|76097037|FG000|Wash-out|Other reason|1|||
42268213|NCT02758171|76097038|FG001|Wash-out|Other reason|0|||
42268214|NCT01664078|76097053|FG000|Overall Study|Death|9|||
42268215|NCT01664078|76097053|FG000|Overall Study|Withdrawal by Subject|4|||
42268216|NCT01664078|76097053|FG000|Overall Study|Lost to Follow-up|2|||
42268217|NCT01664078|76097053|FG000|Overall Study|missed 5 year visit|1|||
42268218|NCT01664078|76097053|FG000|Overall Study|Other|53|||
42268219|NCT03367403|76097106|FG000|Overall Study|Adverse Event|20|||
42268220|NCT03367403|76097107|FG001|Overall Study|Adverse Event|6|||
42268221|NCT03367403|76097108|FG002|Overall Study|Adverse Event|2|||
42268222|NCT03367403|76097106|FG000|Overall Study|Withdrawal by Subject|12|||
42268223|NCT03367403|76097107|FG001|Overall Study|Withdrawal by Subject|13|||
42003530|NCT01309737|75811383|FG004|Week 16 to 52|Other|0|||
42003531|NCT01074229|75811409|FG000|Overall Study|Lost to Follow-up|1|||
42003532|NCT01074229|75811410|FG001|Overall Study|Lost to Follow-up|0|||
42003533|NCT01074229|75811411|FG002|Overall Study|Lost to Follow-up|0|||
42003534|NCT01074229|75811409|FG000|Overall Study|Change to open surgical procedure|1|||
42003535|NCT01074229|75811410|FG001|Overall Study|Change to open surgical procedure|3|||
42003536|NCT01074229|75811411|FG002|Overall Study|Change to open surgical procedure|4|||
42003537|NCT01106014|75811423|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
42003538|NCT01106014|75811424|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
42268224|NCT03367403|76097108|FG002|Overall Study|Withdrawal by Subject|1|||
42268225|NCT03367403|76097106|FG000|Overall Study|Death|1|||
42268226|NCT03367403|76097107|FG001|Overall Study|Death|2|||
42268227|NCT03367403|76097108|FG002|Overall Study|Death|0|||
42268228|NCT03367403|76097106|FG000|Overall Study|Physician Decision|0|||
42268229|NCT03367403|76097107|FG001|Overall Study|Physician Decision|1|||
42268230|NCT03367403|76097108|FG002|Overall Study|Physician Decision|0|||
42268231|NCT03367403|76097106|FG000|Overall Study|Protocol Violation|1|||
42268232|NCT03367403|76097107|FG001|Overall Study|Protocol Violation|1|||
42003539|NCT01106014|75811423|FG000|Overall Study|Adverse Event|78|||
42003540|NCT01106014|75811424|FG001|Overall Study|Adverse Event|42|||
42003541|NCT01106014|75811423|FG000|Overall Study|Withdrawal by Subject|43|||
42003542|NCT01106014|75811424|FG001|Overall Study|Withdrawal by Subject|37|||
42003543|NCT01106014|75811423|FG000|Overall Study|Administrative reason|7|||
42003544|NCT01106014|75811424|FG001|Overall Study|Administrative reason|6|||
42003545|NCT01106014|75811423|FG000|Overall Study|Lost to Follow-up|2|||
42003546|NCT01106014|75811424|FG001|Overall Study|Lost to Follow-up|3|||
42003547|NCT01073605|75811433|FG000|Overall Study|Ongoing at Cutoff Date|1|||
42003548|NCT01073605|75811434|FG001|Overall Study|Ongoing at Cutoff Date|1|||
42003549|NCT01073605|75811435|FG002|Overall Study|Ongoing at Cutoff Date|0|||
42003550|NCT01073605|75811433|FG000|Overall Study|Adverse Event|2|||
42003551|NCT01073605|75811434|FG001|Overall Study|Adverse Event|1|||
42003552|NCT01073605|75811435|FG002|Overall Study|Adverse Event|0|||
42003553|NCT01073605|75811433|FG000|Overall Study|Lost to Follow-up|3|||
42003554|NCT01073605|75811434|FG001|Overall Study|Lost to Follow-up|4|||
42003555|NCT01073605|75811435|FG002|Overall Study|Lost to Follow-up|9|||
42003556|NCT01073605|75811433|FG000|Overall Study|Other|25|||
42003557|NCT01073605|75811434|FG001|Overall Study|Other|21|||
42003558|NCT01073605|75811435|FG002|Overall Study|Other|29|||
42003559|NCT01073605|75811433|FG000|Overall Study|Withdrawal by Subject|31|||
42003560|NCT01073605|75811434|FG001|Overall Study|Withdrawal by Subject|39|||
42003561|NCT01073605|75811435|FG002|Overall Study|Withdrawal by Subject|22|||
42003562|NCT01073605|75811433|FG000|Overall Study|Randomized But Not Treated|0|||
42003563|NCT01073605|75811434|FG001|Overall Study|Randomized But Not Treated|1|||
42003564|NCT01073605|75811435|FG002|Overall Study|Randomized But Not Treated|1|||
42003565|NCT01073293|75811445|FG000|Overall Study|Lost to Follow-up|0|||
42003566|NCT01073293|75811446|FG001|Overall Study|Lost to Follow-up|1|||
42003567|NCT01073293|75811445|FG000|Overall Study|Withdrawal by Subject|5|||
42003568|NCT01073293|75811446|FG001|Overall Study|Withdrawal by Subject|10|||
42003569|NCT01105936|75811452|FG000|Period 1|Adverse Event|0|||
42135439|NCT00289900|75946155|FG002|Overall Study|Other|0|||
42268233|NCT03367403|76097108|FG002|Overall Study|Protocol Violation|0|||
42268234|NCT03367403|76097106|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
42268235|NCT03367403|76097107|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
42268236|NCT03367403|76097108|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
42268237|NCT03367403|76097106|FG000|Overall Study|COVID-19|3|||
42268238|NCT03367403|76097107|FG001|Overall Study|COVID-19|6|||
42268239|NCT03367403|76097108|FG002|Overall Study|COVID-19|0|||
42268240|NCT03367403|76097106|FG000|Overall Study|Abuse of Alcohol Intake|0|||
42268241|NCT03367403|76097107|FG001|Overall Study|Abuse of Alcohol Intake|1|||
42268242|NCT03367403|76097108|FG002|Overall Study|Abuse of Alcohol Intake|0|||
42268243|NCT03367403|76097106|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
42340769|NCT01445080|76178905|FG006|Overall Study|Physician Decision|2|||
42340770|NCT01445080|76178906|FG007|Overall Study|Physician Decision|2|||
42340771|NCT01445080|76178907|FG008|Overall Study|Physician Decision|0|||
42340772|NCT01445080|76178899|FG000|Overall Study|Withdrawal by Subject|1|||
42340773|NCT01445080|76178900|FG001|Overall Study|Withdrawal by Subject|0|||
42340774|NCT01445080|76178901|FG002|Overall Study|Withdrawal by Subject|0|||
42340775|NCT01445080|76178902|FG003|Overall Study|Withdrawal by Subject|1|||
42340776|NCT01445080|76178903|FG004|Overall Study|Withdrawal by Subject|0|||
42340777|NCT01445080|76178904|FG005|Overall Study|Withdrawal by Subject|0|||
42340778|NCT01445080|76178905|FG006|Overall Study|Withdrawal by Subject|0|||
42340779|NCT01445080|76178906|FG007|Overall Study|Withdrawal by Subject|0|||
42340780|NCT01445080|76178907|FG008|Overall Study|Withdrawal by Subject|2|||
42340781|NCT01445080|76178899|FG000|Overall Study|Ineligible/Inevaluable|1|||
42340782|NCT01445080|76178900|FG001|Overall Study|Ineligible/Inevaluable|2|||
42003570|NCT01105936|75811453|FG001|Period 1|Adverse Event|0|||
42003571|NCT01105936|75811454|FG002|Period 1|Adverse Event|0|||
42003572|NCT01105936|75811455|FG003|Period 1|Adverse Event|1|||
42003573|NCT01105936|75811452|FG000|Period 2|Adverse Event|1|||
42003574|NCT01105936|75811453|FG001|Period 2|Adverse Event|0|||
42003575|NCT01105936|75811454|FG002|Period 2|Adverse Event|0|||
42003576|NCT01105936|75811455|FG003|Period 2|Adverse Event|0|||
42003577|NCT01105936|75811452|FG000|Period 3|Protocol Violation|0|||
42003578|NCT01105936|75811453|FG001|Period 3|Protocol Violation|2|||
42135440|NCT00289900|75946156|FG003|Overall Study|Other|5|||
42268244|NCT03367403|76097107|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
42340783|NCT01445080|76178901|FG002|Overall Study|Ineligible/Inevaluable|0|||
42003579|NCT01105936|75811454|FG002|Period 3|Protocol Violation|0|||
42003580|NCT01105936|75811455|FG003|Period 3|Protocol Violation|0|||
42003581|NCT01309659|75811466|FG000|Overall Study|Protocol Violation|0|||
42003582|NCT01309659|75811467|FG001|Overall Study|Protocol Violation|1|||
42003583|NCT01104766|75811477|FG000|Overall Study|Did not meet inc/exc criteria|1|||
42003584|NCT01104766|75811478|FG001|Overall Study|Did not meet inc/exc criteria|0|||
42003585|NCT01104766|75811479|FG002|Overall Study|Did not meet inc/exc criteria|0|||
42003586|NCT01104766|75811480|FG003|Overall Study|Did not meet inc/exc criteria|0|||
42003587|NCT01104766|75811477|FG000|Overall Study|Adverse Event|17|||
42003588|NCT01104766|75811478|FG001|Overall Study|Adverse Event|15|||
42003589|NCT01104766|75811479|FG002|Overall Study|Adverse Event|20|||
42035075|NCT00932373|75843312|FG004|Overall Study|Clinical progression|0|||
42035076|NCT00932373|75843313|FG005|Overall Study|Clinical progression|0|||
42268245|NCT03367403|76097108|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
42268246|NCT02577146|76097116|FG000|Overall Study|Lost to Follow-up|8|||
42268247|NCT02577146|76097116|FG000|Overall Study|Physician Decision|3|||
42268248|NCT02577146|76097116|FG000|Overall Study|Screen Failure|17|||
42268249|NCT00109967|76097122|FG000|Overall Study|Cancel Prior to Treatment|2|||
42268250|NCT00109967|76097123|FG001|Overall Study|Cancel Prior to Treatment|0|||
42268251|NCT00109967|76097122|FG000|Overall Study|Adverse Event|12|||
42268252|NCT00109967|76097123|FG001|Overall Study|Adverse Event|1|||
42268253|NCT00109967|76097122|FG000|Overall Study|Withdrawal by Subject|5|||
42268254|NCT00109967|76097123|FG001|Overall Study|Withdrawal by Subject|0|||
42268255|NCT00109967|76097122|FG000|Overall Study|Physician Decision|1|||
42268256|NCT00109967|76097123|FG001|Overall Study|Physician Decision|3|||
42268257|NCT00109967|76097122|FG000|Overall Study|Death|0|||
42268258|NCT00109967|76097123|FG001|Overall Study|Death|2|||
42268259|NCT02579096|76097131|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
42268260|NCT02579096|76097132|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
42268261|NCT02579096|76097131|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
42268262|NCT02579096|76097132|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
42268263|NCT02579096|76097131|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
42268264|NCT02579096|76097132|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
42268265|NCT02579096|76097131|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
42268266|NCT02579096|76097132|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
42268267|NCT02579096|76097131|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
42268268|NCT02579096|76097132|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
42268269|NCT02579096|76097131|FG000|Phase 2, Weeks 25 - 48|Death|2|||
42268270|NCT02579096|76097132|FG001|Phase 2, Weeks 25 - 48|Death|4|||
42268271|NCT02579096|76097131|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
42268272|NCT02579096|76097132|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
42268273|NCT02579096|76097131|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
42268274|NCT02579096|76097132|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
42268275|NCT02579096|76097131|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
42268276|NCT02579096|76097132|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
42268277|NCT02579096|76097131|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
42268278|NCT02579096|76097132|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
42003590|NCT01104766|75811480|FG003|Overall Study|Adverse Event|14|||
42003591|NCT01104766|75811477|FG000|Overall Study|Lack of Efficacy|20|||
42003592|NCT01104766|75811478|FG001|Overall Study|Lack of Efficacy|15|||
42268279|NCT02579096|76097131|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
42268280|NCT02579096|76097132|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
42268281|NCT02579096|76097131|FG000|Phase 3, Weeks 49 - 72|Death|3|||
42268282|NCT02579096|76097132|FG001|Phase 3, Weeks 49 - 72|Death|2|||
42268283|NCT02579096|76097131|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
42268284|NCT02579096|76097132|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
42268285|NCT02579096|76097131|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
42268286|NCT02579096|76097132|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
42003593|NCT01104766|75811479|FG002|Overall Study|Lack of Efficacy|14|||
42035077|NCT00932373|75843314|FG006|Overall Study|Clinical progression|1|||
42035078|NCT00932373|75843315|FG007|Overall Study|Clinical progression|0|||
42268287|NCT02579096|76097131|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
42268288|NCT02579096|76097132|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
42268289|NCT02579096|76097131|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
42003594|NCT01104766|75811480|FG003|Overall Study|Lack of Efficacy|8|||
42003595|NCT01104766|75811477|FG000|Overall Study|Protocol Violation|2|||
42268290|NCT02579096|76097132|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
42003596|NCT01104766|75811478|FG001|Overall Study|Protocol Violation|0|||
42003597|NCT01104766|75811479|FG002|Overall Study|Protocol Violation|0|||
42003598|NCT01104766|75811480|FG003|Overall Study|Protocol Violation|0|||
42003599|NCT01104766|75811477|FG000|Overall Study|Withdrawal by Subject|17|||
42003600|NCT01104766|75811478|FG001|Overall Study|Withdrawal by Subject|19|||
42003601|NCT01104766|75811479|FG002|Overall Study|Withdrawal by Subject|25|||
42003602|NCT01104766|75811480|FG003|Overall Study|Withdrawal by Subject|15|||
42003603|NCT01104766|75811477|FG000|Overall Study|Lost to Follow-up|1|||
42003604|NCT01104766|75811478|FG001|Overall Study|Lost to Follow-up|2|||
42003605|NCT01104766|75811479|FG002|Overall Study|Lost to Follow-up|1|||
42003606|NCT01104766|75811480|FG003|Overall Study|Lost to Follow-up|1|||
42003607|NCT01104376|75811490|FG000|Overall Study|Withdrawal by Subject|15|||
42003608|NCT01104376|75811490|FG000|Overall Study|Consented but excluded after labs|13|||
42003609|NCT01072357|75811496|FG000|Overall Study|Lost to Follow-up|0|||
42003610|NCT01072357|75811497|FG001|Overall Study|Lost to Follow-up|1|||
42003611|NCT01072201|75811505|FG000|Overall Study|Lost to Follow-up|0|||
42003612|NCT01072201|75811506|FG001|Overall Study|Lost to Follow-up|1|||
42003613|NCT01103362|75811512|FG000|Overall Study|study terminated|596|||
42003614|NCT01103284|75811518|FG000|Overall Study|Death|2|||
42003615|NCT01103284|75811519|FG001|Overall Study|Death|0|||
42003616|NCT01103284|75811518|FG000|Overall Study|Lost to Follow-up|9|||
42003617|NCT01103284|75811519|FG001|Overall Study|Lost to Follow-up|10|||
42003618|NCT01103284|75811518|FG000|Overall Study|Pregnancy|3|||
42003619|NCT01103284|75811519|FG001|Overall Study|Pregnancy|1|||
42003620|NCT01103284|75811518|FG000|Overall Study|Protocol Violation|12|||
42003621|NCT01103284|75811519|FG001|Overall Study|Protocol Violation|5|||
42003622|NCT01103284|75811518|FG000|Overall Study|Adverse Event|0|||
42003623|NCT01103284|75811519|FG001|Overall Study|Adverse Event|5|||
42003624|NCT01103284|75811518|FG000|Overall Study|Withdrawal by Subject|14|||
42003625|NCT01103284|75811519|FG001|Overall Study|Withdrawal by Subject|18|||
42003626|NCT01103284|75811518|FG000|Overall Study|Dermal Hypersensitivity|0|||
42003627|NCT01103284|75811519|FG001|Overall Study|Dermal Hypersensitivity|1|||
42003628|NCT01103284|75811518|FG000|Overall Study|Termination by the Sponsor|0|||
42003629|NCT01103284|75811519|FG001|Overall Study|Termination by the Sponsor|1|||
42003630|NCT01103284|75811518|FG000|Overall Study|Not described|2|||
42003631|NCT01103284|75811519|FG001|Overall Study|Not described|1|||
42003632|NCT01103284|75811518|FG000|Overall Study|Missing CRF entries for study completion|0|||
42003633|NCT01103284|75811519|FG001|Overall Study|Missing CRF entries for study completion|2|||
42003634|NCT01070953|75811525|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
42003635|NCT01070953|75811525|FG000|Participants for Safety Evaluation|Off-label use|283|||
42003636|NCT01070953|75811525|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
42003637|NCT01070953|75811525|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
42003638|NCT01070953|75811525|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
42003639|NCT01070953|75811525|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
42003640|NCT01070953|75811525|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
42003641|NCT01070953|75811525|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
42003642|NCT01070953|75811525|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
42340784|NCT01445080|76178902|FG003|Overall Study|Ineligible/Inevaluable|1|||
42340785|NCT01445080|76178903|FG004|Overall Study|Ineligible/Inevaluable|2|||
42340786|NCT01445080|76178904|FG005|Overall Study|Ineligible/Inevaluable|3|||
42340787|NCT01445080|76178905|FG006|Overall Study|Ineligible/Inevaluable|0|||
42340788|NCT01445080|76178906|FG007|Overall Study|Ineligible/Inevaluable|0|||
42340789|NCT01445080|76178907|FG008|Overall Study|Ineligible/Inevaluable|6|||
42340790|NCT02035475|76178942|FG000|Overall Study|Withdrawal by Subject|4|||
42340791|NCT02035475|76178942|FG000|Overall Study|Physician Decision|1|||
42340792|NCT02035475|76178942|FG000|Overall Study|Equipment Error|1|||
42340793|NCT01444456|76178948|FG000|Overall Study|Withdrawal by Subject|21|||
42340794|NCT01444456|76178948|FG000|Overall Study|Physician Decision|9|||
42003643|NCT01070953|75811525|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
42003644|NCT01089361|75811537|FG000|Overall Study|Death|1|||
42003645|NCT01089361|75811538|FG001|Overall Study|Death|0|||
42003646|NCT01102972|75811548|FG000|Overall Study|Adverse Event|8|||
42003647|NCT01102972|75811549|FG001|Overall Study|Adverse Event|2|||
42003648|NCT01102972|75811548|FG000|Overall Study|Lack of Efficacy|2|||
42003649|NCT01102972|75811549|FG001|Overall Study|Lack of Efficacy|1|||
42003650|NCT01102972|75811548|FG000|Overall Study|Protocol Violation|1|||
42003651|NCT01102972|75811549|FG001|Overall Study|Protocol Violation|0|||
42340795|NCT01444456|76178948|FG000|Overall Study|Lost to Follow-up|37|||
42003652|NCT01102972|75811548|FG000|Overall Study|Lost to Follow-up|10|||
42003653|NCT01102972|75811549|FG001|Overall Study|Lost to Follow-up|5|||
42003654|NCT01102972|75811548|FG000|Overall Study|Investigator Discretion|2|||
42003655|NCT01102972|75811549|FG001|Overall Study|Investigator Discretion|0|||
42003656|NCT01102972|75811548|FG000|Overall Study|Withdrawal by Subject|6|||
42003657|NCT01102972|75811549|FG001|Overall Study|Withdrawal by Subject|6|||
42003658|NCT01309269|75811555|FG000|Overall Study|Adverse Event|56|||
42003659|NCT01309269|75811555|FG000|Overall Study|Withdrawal by Subject|25|||
42003660|NCT01309269|75811555|FG000|Overall Study|Lack of Acceptance|15|||
42003661|NCT01309269|75811555|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
42003662|NCT01309269|75811555|FG000|Overall Study|Kidney Transplant|25|||
42003663|NCT01309269|75811555|FG000|Overall Study|Administrative Problems|141|||
42003664|NCT01309269|75811555|FG000|Overall Study|Other|256|||
42003665|NCT01309269|75811555|FG000|Overall Study|Other|1|||
42003666|NCT01309269|75811555|FG000|Overall Study|Study Completion Data Not Recorded|95|||
42003667|NCT01309269|75811555|FG000|Overall Study|Enrolled but not Treated|107|||
42003668|NCT01088503|75811562|FG000|Overall Study|Withdrawal by Subject|118|||
42003669|NCT01088503|75811563|FG001|Overall Study|Withdrawal by Subject|327|||
42003670|NCT01088503|75811564|FG002|Overall Study|Withdrawal by Subject|10|||
42003671|NCT01088503|75811562|FG000|Overall Study|Death|64|||
42003672|NCT01088503|75811563|FG001|Overall Study|Death|358|||
42003673|NCT01088503|75811564|FG002|Overall Study|Death|7|||
42003674|NCT01087489|75811570|FG000|Overall Study|enrolled in another VA study|0|||
42003675|NCT01087489|75811571|FG001|Overall Study|enrolled in another VA study|1|||
42003676|NCT01087489|75811570|FG000|Overall Study|Death|0|||
42003677|NCT01087489|75811571|FG001|Overall Study|Death|1|||
42003678|NCT01087489|75811570|FG000|Overall Study|unable to survey by telephone|0|||
42003679|NCT01087489|75811571|FG001|Overall Study|unable to survey by telephone|1|||
42003680|NCT01082965|75811579|FG000|Overall Study|Protocol Violation|0|||
42003681|NCT01082965|75811580|FG001|Overall Study|Protocol Violation|1|||
42003682|NCT01082965|75811579|FG000|Overall Study|Other|1|||
42003683|NCT01082965|75811580|FG001|Overall Study|Other|1|||
42003684|NCT01102426|75811588|FG000|Overall Study|Randomized but not treated|4|||
42003685|NCT01102426|75811589|FG001|Overall Study|Randomized but not treated|1|||
42003686|NCT01102426|75811588|FG000|Overall Study|Adverse Events (treatment-related)|15|||
42003687|NCT01102426|75811589|FG001|Overall Study|Adverse Events (treatment-related)|8|||
42003688|NCT01102426|75811588|FG000|Overall Study|Physician Decision|9|||
42003689|NCT01102426|75811589|FG001|Overall Study|Physician Decision|6|||
42268291|NCT02579096|76097131|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
42268292|NCT02579096|76097132|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
42268293|NCT02579096|76097131|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
42268294|NCT02579096|76097132|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
42268295|NCT02578940|76097138|FG000|Overall Study|Screening failure|5|||
42268296|NCT02578940|76097138|FG000|Overall Study|Lost to Follow-up|1|||
42268297|NCT02578862|76097146|FG000|Overall Study|Withdrawal by Subject|0|||
42268298|NCT02578862|76097147|FG001|Overall Study|Withdrawal by Subject|1|||
42268299|NCT02578862|76097146|FG000|Overall Study|Unplanned unilateral procedure|0|||
42268300|NCT02578862|76097147|FG001|Overall Study|Unplanned unilateral procedure|1|||
42268301|NCT02578706|76097156|FG000|Overall Study|Withdrawal by Subject|1|||
42268302|NCT02578706|76097157|FG001|Overall Study|Withdrawal by Subject|0|||
42268303|NCT02578706|76097158|FG002|Overall Study|Withdrawal by Subject|0|||
42268304|NCT02578706|76097156|FG000|Overall Study|Lost to Follow-up|0|||
42268305|NCT02578706|76097157|FG001|Overall Study|Lost to Follow-up|4|||
42268306|NCT02578706|76097158|FG002|Overall Study|Lost to Follow-up|0|||
42268307|NCT02578706|76097156|FG000|Overall Study|Physician Decision|0|||
42268308|NCT02578706|76097157|FG001|Overall Study|Physician Decision|1|||
42268309|NCT02578706|76097158|FG002|Overall Study|Physician Decision|0|||
42268310|NCT00108953|76097168|FG000|Follow-up|Death|18|||
42268311|NCT00108953|76097169|FG001|Follow-up|Death|26|||
42268312|NCT00108953|76097168|FG000|Follow-up|Lost to Follow-up|1|||
42268313|NCT00108953|76097169|FG001|Follow-up|Lost to Follow-up|1|||
42268314|NCT00108953|76097168|FG000|Follow-up|Study terminated by sponsor|10|||
42268315|NCT00108953|76097169|FG001|Follow-up|Study terminated by sponsor|6|||
42003690|NCT01102426|75811588|FG000|Overall Study|Progressive Disease|85|||
42003691|NCT01102426|75811589|FG001|Overall Study|Progressive Disease|44|||
42003692|NCT01102426|75811588|FG000|Overall Study|Adverse Events (unrelated to|9|||
42003693|NCT01102426|75811589|FG001|Overall Study|Adverse Events (unrelated to|1|||
42003694|NCT01102426|75811588|FG000|Overall Study|Patient Refusal|24|||
42003695|NCT01102426|75811589|FG001|Overall Study|Patient Refusal|12|||
42003696|NCT01102426|75811588|FG000|Overall Study|Death (due to adverse events|0|||
42003697|NCT01102426|75811589|FG001|Overall Study|Death (due to adverse events|1|||
42003698|NCT01102426|75811588|FG000|Overall Study|Death (non-related to the study|19|||
42003699|NCT01102426|75811589|FG001|Overall Study|Death (non-related to the study|8|||
42003700|NCT01101334|75811597|FG000|Overall Study|Adverse Event|9|||
42268316|NCT02578316|76097177|FG000|Extension Phase|Progression of disease|6|||
42003701|NCT01101334|75811598|FG001|Overall Study|Adverse Event|4|||
42340796|NCT01444456|76178948|FG000|Overall Study|Death|73|||
42340797|NCT01444456|76178948|FG000|Overall Study|Ineligibility determined|23|||
42340798|NCT01444456|76178948|FG000|Overall Study|Other|18|||
42340799|NCT01444456|76178948|FG000|Overall Study|Not treated|104|||
42340800|NCT01438294|76178954|FG000|Overall Study|Lost to Follow-up|3|||
42340801|NCT01438294|76178955|FG001|Overall Study|Lost to Follow-up|7|||
42003702|NCT01101334|75811597|FG000|Overall Study|Death|7|||
42003703|NCT01101334|75811598|FG001|Overall Study|Death|1|||
42003704|NCT01101334|75811597|FG000|Overall Study|Withdrawal by Subject|4|||
42003705|NCT01101334|75811598|FG001|Overall Study|Withdrawal by Subject|3|||
42003706|NCT01101334|75811597|FG000|Overall Study|Withdrawal by Sponsor|1|||
42003707|NCT01101334|75811598|FG001|Overall Study|Withdrawal by Sponsor|1|||
42003708|NCT01101334|75811597|FG000|Overall Study|Progressive Disease|22|||
42003709|NCT01101334|75811598|FG001|Overall Study|Progressive Disease|35|||
42003710|NCT01101334|75811597|FG000|Overall Study|Other|2|||
42003711|NCT01101334|75811598|FG001|Overall Study|Other|1|||
42003712|NCT01327547|75811606|FG000|Overall Study|Adverse Event|4|||
42003713|NCT01327547|75811607|FG001|Overall Study|Adverse Event|1|||
42003714|NCT01327547|75811606|FG000|Overall Study|Death|1|||
42003715|NCT01327547|75811607|FG001|Overall Study|Death|2|||
42003716|NCT01327547|75811606|FG000|Overall Study|Lost to Follow-up|6|||
42003717|NCT01327547|75811607|FG001|Overall Study|Lost to Follow-up|6|||
42003718|NCT01327547|75811606|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
42003719|NCT01327547|75811607|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
42003720|NCT01327547|75811606|FG000|Overall Study|Withdrawal by Subject|3|||
42003721|NCT01327547|75811607|FG001|Overall Study|Withdrawal by Subject|7|||
42003722|NCT01327547|75811606|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
42003723|NCT01327547|75811607|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
42003724|NCT01327547|75811606|FG000|Overall Study|Protocol Violation|1|||
42003725|NCT01327547|75811607|FG001|Overall Study|Protocol Violation|0|||
42003726|NCT01327547|75811606|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
42003727|NCT01327547|75811607|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
42003728|NCT01327547|75811606|FG000|Overall Study|Required prohibited medication|2|||
42003729|NCT01327547|75811607|FG001|Overall Study|Required prohibited medication|0|||
42003730|NCT01327547|75811606|FG000|Overall Study|Non-compliance with study procedures|1|||
42003731|NCT01327547|75811607|FG001|Overall Study|Non-compliance with study procedures|0|||
42003732|NCT01327547|75811606|FG000|Overall Study|By investigator in subject's interest|0|||
42003733|NCT01327547|75811607|FG001|Overall Study|By investigator in subject's interest|1|||
42003734|NCT01308567|75811629|FG000|Overall Study|Lost to Follow-up|2|||
42003735|NCT01308567|75811630|FG001|Overall Study|Lost to Follow-up|4|||
42003736|NCT01308567|75811631|FG002|Overall Study|Lost to Follow-up|4|||
42003737|NCT01307319|75811642|FG000|Overall Study|Adverse Event|2|||
42003738|NCT01307319|75811643|FG001|Overall Study|Adverse Event|2|||
42003739|NCT01307319|75811644|FG002|Overall Study|Adverse Event|1|||
42003740|NCT01307319|75811642|FG000|Overall Study|Lost to Follow-up|1|||
42003741|NCT01307319|75811643|FG001|Overall Study|Lost to Follow-up|0|||
42340802|NCT02033759|76178963|FG000|Overall Study|Withdrawal by Subject|2|||
42340803|NCT02033759|76178964|FG001|Overall Study|Withdrawal by Subject|1|||
42340804|NCT02033759|76178963|FG000|Overall Study|Protocol Violation|1|||
42340805|NCT02033759|76178964|FG001|Overall Study|Protocol Violation|1|||
42340806|NCT01959529|76178972|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
42340807|NCT01959529|76178973|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
42340808|NCT01959529|76178972|FG000|Overall Study|Lost to Follow-up|4|||
42340809|NCT01959529|76178973|FG001|Overall Study|Lost to Follow-up|1|||
42340810|NCT01959529|76178972|FG000|Overall Study|Other|70|||
42340811|NCT01959529|76178973|FG001|Overall Study|Other|68|||
42340812|NCT01959529|76178972|FG000|Overall Study|Hypoglycaemia|1|||
42340813|NCT01959529|76178973|FG001|Overall Study|Hypoglycaemia|1|||
42340814|NCT01959529|76178972|FG000|Overall Study|Lack of glycaemic control|1|||
42340815|NCT01959529|76178973|FG001|Overall Study|Lack of glycaemic control|1|||
42340816|NCT02033369|76178981|FG000|Overall Study|Physician Decision|1|||
42340817|NCT02033369|76178982|FG001|Overall Study|Physician Decision|2|||
42003742|NCT01307319|75811644|FG002|Overall Study|Lost to Follow-up|1|||
42340818|NCT02033369|76178981|FG000|Overall Study|Not a good demographic match|0|||
42340819|NCT02033369|76178982|FG001|Overall Study|Not a good demographic match|2|||
42003743|NCT01307319|75811642|FG000|Overall Study|Protocol Violation|1|||
42003744|NCT01307319|75811643|FG001|Overall Study|Protocol Violation|1|||
42003745|NCT01307319|75811644|FG002|Overall Study|Protocol Violation|0|||
42003746|NCT01307319|75811642|FG000|Overall Study|Withdrawal by Subject|0|||
42003747|NCT01307319|75811643|FG001|Overall Study|Withdrawal by Subject|1|||
42003748|NCT01307319|75811644|FG002|Overall Study|Withdrawal by Subject|2|||
42003749|NCT01307319|75811642|FG000|Overall Study|Other|0|||
42003750|NCT01307319|75811643|FG001|Overall Study|Other|4|||
42340820|NCT02033369|76178981|FG000|Overall Study|Withdrawal by Subject|1|||
42340821|NCT02033369|76178982|FG001|Overall Study|Withdrawal by Subject|1|||
42340822|NCT02033369|76178981|FG000|Overall Study|Lost to Follow-up|1|||
42340823|NCT02033369|76178982|FG001|Overall Study|Lost to Follow-up|0|||
42340824|NCT02033369|76178981|FG000|Overall Study|Protocol Violation|2|||
42003751|NCT01307319|75811644|FG002|Overall Study|Other|3|||
42003752|NCT01080391|75811654|FG000|Overall Study|Randomized but not treated|7|||
42003753|NCT01080391|75811655|FG001|Overall Study|Randomized but not treated|4|||
42003754|NCT01070329|75811663|FG000|Overall Study|Adverse Event|13|||
42003755|NCT01070329|75811664|FG001|Overall Study|Adverse Event|10|||
42003756|NCT01070329|75811663|FG000|Overall Study|Lost to Follow-up|22|||
42003757|NCT01070329|75811664|FG001|Overall Study|Lost to Follow-up|12|||
42003758|NCT01070329|75811663|FG000|Overall Study|Withdrawal by Subject|9|||
42003759|NCT01070329|75811664|FG001|Overall Study|Withdrawal by Subject|11|||
42003760|NCT01070329|75811663|FG000|Overall Study|Protocol Violation|3|||
42003761|NCT01070329|75811664|FG001|Overall Study|Protocol Violation|8|||
42268317|NCT02576678|76097188|FG000|Overall Study|Adverse Event|0|||
42268318|NCT02576678|76097189|FG001|Overall Study|Adverse Event|0|||
42268319|NCT02576678|76097190|FG002|Overall Study|Adverse Event|2|||
42268320|NCT02576678|76097188|FG000|Overall Study|Withdrawal by Subject|3|||
42268321|NCT02576678|76097189|FG001|Overall Study|Withdrawal by Subject|1|||
42268322|NCT02576678|76097190|FG002|Overall Study|Withdrawal by Subject|2|||
42268323|NCT02576678|76097188|FG000|Overall Study|Lost to Follow-up|0|||
42268324|NCT02576678|76097189|FG001|Overall Study|Lost to Follow-up|0|||
42268325|NCT02576678|76097190|FG002|Overall Study|Lost to Follow-up|1|||
42268326|NCT02576678|76097188|FG000|Overall Study|Miscellaneous|2|||
42268327|NCT02576678|76097189|FG001|Overall Study|Miscellaneous|0|||
42268328|NCT02576678|76097190|FG002|Overall Study|Miscellaneous|0|||
42268329|NCT00108745|76097201|FG000|Overall Study|Withdrawal by Subject|19|||
42268330|NCT00108745|76097202|FG001|Overall Study|Withdrawal by Subject|12|||
42268331|NCT00108745|76097203|FG002|Overall Study|Withdrawal by Subject|12|||
42268332|NCT00108745|76097201|FG000|Overall Study|Never Treated|8|||
42268333|NCT00108745|76097202|FG001|Overall Study|Never Treated|10|||
42268334|NCT00108745|76097203|FG002|Overall Study|Never Treated|12|||
42268335|NCT00108745|76097201|FG000|Overall Study|Ineligible|7|||
42268336|NCT00108745|76097202|FG001|Overall Study|Ineligible|13|||
42268337|NCT00108745|76097203|FG002|Overall Study|Ineligible|13|||
42268338|NCT02716805|76097233|FG000|Overall Study|Progressive disease|2|||
42268339|NCT02716805|76097234|FG001|Overall Study|Progressive disease|0|||
42268340|NCT02716805|76097235|FG002|Overall Study|Progressive disease|0|||
42268341|NCT02716805|76097236|FG003|Overall Study|Progressive disease|0|||
42268342|NCT02581982|76097240|FG000|Overall Study|Lack of Efficacy|12|||
42268343|NCT02581982|76097240|FG000|Overall Study|Adverse Event|3|||
42268344|NCT02581982|76097240|FG000|Overall Study|Physician Decision|1|||
42268345|NCT04318132|76097294|FG000|Overall Study|Protocol Violation|0|||
42268346|NCT04318132|76097295|FG001|Overall Study|Protocol Violation|0|||
42268347|NCT04318132|76097296|FG002|Overall Study|Protocol Violation|3|||
42268348|NCT04318132|76097297|FG003|Overall Study|Protocol Violation|0|||
42268349|NCT04271254|76097313|FG000|Overall Study|Withdrawal by Subject|3|||
42268350|NCT03970837|76097333|FG000|Overall Study|Adverse Event|23|||
42268351|NCT03970837|76097334|FG001|Overall Study|Adverse Event|20|||
42268352|NCT03970837|76097335|FG002|Overall Study|Adverse Event|16|||
42268353|NCT03970837|76097336|FG003|Overall Study|Adverse Event|6|||
42268354|NCT03970837|76097337|FG004|Overall Study|Adverse Event|4|||
42268355|NCT03970837|76097338|FG005|Overall Study|Adverse Event|5|||
42268356|NCT03970837|76097339|FG006|Overall Study|Adverse Event|1|||
42268357|NCT03970837|76097340|FG007|Overall Study|Adverse Event|5|||
42268358|NCT03970837|76097341|FG008|Overall Study|Adverse Event|0|||
42268359|NCT03970837|76097342|FG009|Overall Study|Adverse Event|0|||
42268360|NCT03970837|76097343|FG010|Overall Study|Adverse Event|1|||
42268361|NCT03970837|76097344|FG011|Overall Study|Adverse Event|1|||
42268362|NCT03970837|76097333|FG000|Overall Study|Lack of Efficacy|14|||
42268363|NCT03970837|76097334|FG001|Overall Study|Lack of Efficacy|12|||
42340825|NCT02033369|76178982|FG001|Overall Study|Protocol Violation|0|||
42340826|NCT02032901|76178988|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
42340827|NCT02032901|76178989|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
42268364|NCT03970837|76097335|FG002|Overall Study|Lack of Efficacy|1|||
42003762|NCT01070329|75811663|FG000|Overall Study|Lack of Efficacy|2|||
42268365|NCT03970837|76097336|FG003|Overall Study|Lack of Efficacy|2|||
42340828|NCT02032901|76178988|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
42268366|NCT03970837|76097337|FG004|Overall Study|Lack of Efficacy|3|||
42268367|NCT03970837|76097338|FG005|Overall Study|Lack of Efficacy|4|||
42003763|NCT01070329|75811664|FG001|Overall Study|Lack of Efficacy|6|||
42003764|NCT01070329|75811663|FG000|Overall Study|Physician Decision|2|||
42268368|NCT03970837|76097339|FG006|Overall Study|Lack of Efficacy|6|||
42268369|NCT03970837|76097340|FG007|Overall Study|Lack of Efficacy|1|||
42268370|NCT03970837|76097341|FG008|Overall Study|Lack of Efficacy|1|||
42268371|NCT03970837|76097342|FG009|Overall Study|Lack of Efficacy|0|||
42003765|NCT01070329|75811664|FG001|Overall Study|Physician Decision|1|||
42268372|NCT03970837|76097343|FG010|Overall Study|Lack of Efficacy|0|||
42268373|NCT03970837|76097344|FG011|Overall Study|Lack of Efficacy|0|||
42340829|NCT02032901|76178989|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
42003766|NCT01070329|75811663|FG000|Overall Study|Entry Criteria Not Met|1|||
42003767|NCT01070329|75811664|FG001|Overall Study|Entry Criteria Not Met|0|||
42268374|NCT03970837|76097333|FG000|Overall Study|Lost to Follow-up|6|||
42003768|NCT01070329|75811663|FG000|Overall Study|Sponsor Decision|0|||
42003769|NCT01070329|75811664|FG001|Overall Study|Sponsor Decision|1|||
42003770|NCT01069861|75811670|FG000|Overall Study|Death|1|||
42003771|NCT01069861|75811670|FG000|Overall Study|Adverse Event|1|||
42003772|NCT01069861|75811670|FG000|Overall Study|Did not meet entrance criteria|1|||
42003773|NCT01306929|75811674|FG000|Overall Study|Withdrawal by Subject|23|||
42003774|NCT01306929|75811674|FG000|Overall Study|Adverse Event|21|||
42003775|NCT01306929|75811674|FG000|Overall Study|Physician Decision|13|||
42003776|NCT01306929|75811674|FG000|Overall Study|Death|8|||
42003777|NCT01306929|75811674|FG000|Overall Study|Withdrawal by parent/guardian|5|||
42003778|NCT01306929|75811674|FG000|Overall Study|Protocol Violation|3|||
42003779|NCT01306929|75811674|FG000|Overall Study|Non-compliance with study drug|2|||
42003780|NCT01306929|75811674|FG000|Overall Study|Lost to Follow-up|2|||
42003781|NCT01306929|75811674|FG000|Overall Study|Various|17|||
42003782|NCT01064401|75811680|FG000|Overall Study|Adverse Event|47|||
42003783|NCT01064401|75811681|FG001|Overall Study|Adverse Event|56|||
42003784|NCT01064401|75811680|FG000|Overall Study|Lack of Efficacy|46|||
42003785|NCT01064401|75811681|FG001|Overall Study|Lack of Efficacy|23|||
42003786|NCT01064401|75811680|FG000|Overall Study|Lost to Follow-up|12|||
42003787|NCT01064401|75811681|FG001|Overall Study|Lost to Follow-up|9|||
42003788|NCT01064401|75811680|FG000|Overall Study|Consent Withdrawn|98|||
42003789|NCT01064401|75811681|FG001|Overall Study|Consent Withdrawn|80|||
42003790|NCT01064401|75811680|FG000|Overall Study|Investigator Decision|4|||
42003791|NCT01064401|75811681|FG001|Overall Study|Investigator Decision|6|||
42003792|NCT01064401|75811680|FG000|Overall Study|Death|4|||
42003793|NCT01064401|75811681|FG001|Overall Study|Death|0|||
42003794|NCT01064401|75811680|FG000|Overall Study|Pregnancy|4|||
42003795|NCT01064401|75811681|FG001|Overall Study|Pregnancy|7|||
42003796|NCT01064401|75811680|FG000|Overall Study|Noncompliance|7|||
42003797|NCT01064401|75811681|FG001|Overall Study|Noncompliance|8|||
42003798|NCT01064401|75811680|FG000|Overall Study|Site Closure|4|||
42003799|NCT01064401|75811681|FG001|Overall Study|Site Closure|5|||
42003800|NCT01064401|75811680|FG000|Overall Study|Other|2|||
42003801|NCT01064401|75811681|FG001|Overall Study|Other|1|||
42003802|NCT01306617|75811691|FG000|Overall Study|Adverse Event|1|||
42003803|NCT01306617|75811692|FG001|Overall Study|Adverse Event|0|||
42003804|NCT01306617|75811693|FG002|Overall Study|Adverse Event|0|||
42003805|NCT01306617|75811691|FG000|Overall Study|Virologic Failure|0|||
42003806|NCT01306617|75811692|FG001|Overall Study|Virologic Failure|0|||
42340830|NCT02020967|76178999|FG000|Overall Study|Withdrawal by Subject|51|||
42340831|NCT01986829|76179005|FG000|Overall Study|Death|1|||
42340832|NCT01986751|76179014|FG000|Overall Study|improperly consented|10|||
42340833|NCT01986751|76179015|FG001|Overall Study|improperly consented|2|||
42340834|NCT02004847|76179027|FG000|Overall Study|Protocol Violation|1|||
42340835|NCT02004847|76179028|FG001|Overall Study|Protocol Violation|1|||
42340836|NCT01438060|76179045|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
42340837|NCT01438060|76179046|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
42340838|NCT01438060|76179045|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
42340839|NCT01438060|76179046|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
42340840|NCT01438060|76179045|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
42340841|NCT01438060|76179046|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
42003807|NCT01306617|75811693|FG002|Overall Study|Virologic Failure|5|||
42003808|NCT01306617|75811691|FG000|Overall Study|Non-compliance|0|||
42003809|NCT01306617|75811692|FG001|Overall Study|Non-compliance|1|||
42003810|NCT01306617|75811693|FG002|Overall Study|Non-compliance|0|||
42340842|NCT01438060|76179045|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
42340843|NCT01438060|76179046|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
42340844|NCT01438060|76179045|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
42003811|NCT01306305|75811703|FG000|Overall Study|Lost to Follow-up|1|||
42003812|NCT01306305|75811704|FG001|Overall Study|Lost to Follow-up|0|||
42003813|NCT01306305|75811703|FG000|Overall Study|Withdrew consent|1|||
42003814|NCT01306305|75811704|FG001|Overall Study|Withdrew consent|0|||
42003815|NCT01038427|75811713|FG000|Overall Study|Lost to follow up|1|||
42003816|NCT01038427|75811714|FG001|Overall Study|Lost to follow up|1|||
42003817|NCT01038427|75811715|FG002|Overall Study|Lost to follow up|0|||
42135441|NCT00289900|75946157|FG004|Overall Study|Other|1|||
42340845|NCT01438060|76179046|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
42003818|NCT01038427|75811713|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
42003819|NCT01038427|75811714|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
42003820|NCT01038427|75811715|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
42003821|NCT01038427|75811713|FG000|Overall Study|Withdrew consent|0|||
42003822|NCT01038427|75811714|FG001|Overall Study|Withdrew consent|0|||
42003823|NCT01038427|75811715|FG002|Overall Study|Withdrew consent|1|||
42003824|NCT01038427|75811713|FG000|Overall Study|Adverse Event|2|||
42003825|NCT01038427|75811714|FG001|Overall Study|Adverse Event|2|||
42003826|NCT01038427|75811715|FG002|Overall Study|Adverse Event|1|||
42003827|NCT01038427|75811713|FG000|Overall Study|Enrolled in error|0|||
42003828|NCT01038427|75811714|FG001|Overall Study|Enrolled in error|1|||
42003829|NCT01038427|75811715|FG002|Overall Study|Enrolled in error|1|||
42003830|NCT01038427|75811713|FG000|Overall Study|Other|0|||
42003831|NCT01038427|75811714|FG001|Overall Study|Other|2|||
42003832|NCT01038427|75811715|FG002|Overall Study|Other|0|||
42003833|NCT01037413|75811723|FG000|Part A: Skin Testing|Adverse Event|1|||
42003834|NCT01037413|75811724|FG001|Part A: Skin Testing|Adverse Event|0|||
42003835|NCT01037413|75811723|FG000|Part A: Skin Testing|Protocol Violation|1|||
42003836|NCT01037413|75811724|FG001|Part A: Skin Testing|Protocol Violation|0|||
42003837|NCT01037413|75811723|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
42035079|NCT00932373|75843316|FG008|Overall Study|Clinical progression|0|||
42035080|NCT00932373|75843317|FG009|Overall Study|Clinical progression|0|||
42268375|NCT03970837|76097334|FG001|Overall Study|Lost to Follow-up|5|||
42268376|NCT03970837|76097335|FG002|Overall Study|Lost to Follow-up|5|||
42268377|NCT03970837|76097336|FG003|Overall Study|Lost to Follow-up|1|||
42268378|NCT03970837|76097337|FG004|Overall Study|Lost to Follow-up|0|||
42268379|NCT03970837|76097338|FG005|Overall Study|Lost to Follow-up|2|||
42268380|NCT03970837|76097339|FG006|Overall Study|Lost to Follow-up|0|||
42268381|NCT03970837|76097340|FG007|Overall Study|Lost to Follow-up|0|||
42268382|NCT03970837|76097341|FG008|Overall Study|Lost to Follow-up|0|||
42268383|NCT03970837|76097342|FG009|Overall Study|Lost to Follow-up|0|||
42268384|NCT03970837|76097343|FG010|Overall Study|Lost to Follow-up|0|||
42268385|NCT03970837|76097344|FG011|Overall Study|Lost to Follow-up|0|||
42268386|NCT03970837|76097333|FG000|Overall Study|Protocol Violation|1|||
42268387|NCT03970837|76097334|FG001|Overall Study|Protocol Violation|0|||
42340846|NCT01438060|76179045|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
42340847|NCT01438060|76179046|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
42340848|NCT01438060|76179045|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
42340849|NCT01438060|76179046|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
42340850|NCT01438060|76179045|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
42340851|NCT01438060|76179046|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
42340852|NCT01438060|76179045|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
42340853|NCT01438060|76179046|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
42340854|NCT01438060|76179045|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
42340855|NCT01438060|76179046|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
42340856|NCT01438060|76179045|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
42340857|NCT01438060|76179046|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
42340858|NCT01438060|76179045|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
42340859|NCT01438060|76179046|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
42340860|NCT01438060|76179045|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
42340861|NCT01438060|76179046|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
42340862|NCT01438060|76179045|FG000|On Study Beyond Week 140|Adverse Event|0|||
42340863|NCT01438060|76179046|FG001|On Study Beyond Week 140|Adverse Event|2|||
42003838|NCT01037413|75811724|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
42003839|NCT01037413|75811723|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
42003840|NCT01037413|75811724|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
42003841|NCT01326845|75811739|FG000|Overall Study|Administrative Problems|5|||
42003842|NCT01326845|75811740|FG001|Overall Study|Administrative Problems|2|||
42135442|NCT00289900|75946158|FG005|Overall Study|Other|0|||
42268388|NCT03970837|76097335|FG002|Overall Study|Protocol Violation|0|||
42003843|NCT01326845|75811739|FG000|Overall Study|Adverse Event|1|||
42268389|NCT03970837|76097336|FG003|Overall Study|Protocol Violation|0|||
42003844|NCT01326845|75811740|FG001|Overall Study|Adverse Event|0|||
42003845|NCT01326845|75811739|FG000|Overall Study|Misisng|1|||
42003846|NCT01326845|75811740|FG001|Overall Study|Misisng|3|||
42003847|NCT01062763|75811748|FG000|Overall Study|Adverse Event|3|||
42003848|NCT01062763|75811749|FG001|Overall Study|Adverse Event|4|||
42003849|NCT01048099|75811755|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
42003850|NCT01048099|75811755|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
42003851|NCT01303965|75811763|FG000|Overall Study|Adverse Event|1|||
42003852|NCT01303965|75811764|FG001|Overall Study|Adverse Event|1|||
42003853|NCT01303965|75811763|FG000|Overall Study|Death|0|||
42003854|NCT01303965|75811764|FG001|Overall Study|Death|3|||
42003855|NCT01303965|75811763|FG000|Overall Study|Withdrawal by Subject|1|||
42003856|NCT01303965|75811764|FG001|Overall Study|Withdrawal by Subject|0|||
42003857|NCT01303965|75811763|FG000|Overall Study|Disease Progression|1|||
42003858|NCT01303965|75811764|FG001|Overall Study|Disease Progression|6|||
42003859|NCT01045993|75811774|FG000|Overall Study|Treated-later found eligibility not met|0|||
42003860|NCT01045993|75811775|FG001|Overall Study|Treated-later found eligibility not met|1|||
42003861|NCT01045993|75811776|FG002|Overall Study|Treated-later found eligibility not met|0|||
42003862|NCT01045993|75811777|FG003|Overall Study|Treated-later found eligibility not met|0|||
42003863|NCT01303419|75811787|FG000|Overall Study|Discontinuation of study|60|||
42003864|NCT01303419|75811787|FG000|Overall Study|Did not complete both imaging methods|5|||
42003865|NCT01303419|75811787|FG000|Overall Study|Did not meet all I/E after screening|31|||
42003866|NCT01326533|75811793|FG000|Overall Study|Lost to Follow-up|2|||
42003867|NCT01326533|75811794|FG001|Overall Study|Lost to Follow-up|0|||
42003868|NCT01326533|75811793|FG000|Overall Study|Withdrawal by Subject|1|||
42003869|NCT01326533|75811794|FG001|Overall Study|Withdrawal by Subject|0|||
42003870|NCT01326533|75811793|FG000|Overall Study|Adverse Event|1|||
42003871|NCT01326533|75811794|FG001|Overall Study|Adverse Event|0|||
42003872|NCT01045447|75811802|FG000|Overall Study|Adverse Event|0|||
42003873|NCT01045447|75811803|FG001|Overall Study|Adverse Event|1|||
42003874|NCT01045447|75811802|FG000|Overall Study|Lack of Efficacy|3|||
42003875|NCT01045447|75811803|FG001|Overall Study|Lack of Efficacy|1|||
42003876|NCT01045447|75811802|FG000|Overall Study|Protocol Violation|6|||
42003877|NCT01045447|75811803|FG001|Overall Study|Protocol Violation|3|||
42003878|NCT01045447|75811802|FG000|Overall Study|Withdrawal Criteria|10|||
42003879|NCT01045447|75811803|FG001|Overall Study|Withdrawal Criteria|10|||
42003880|NCT01045447|75811802|FG000|Overall Study|Unclassified|17|||
42003881|NCT01045447|75811803|FG001|Overall Study|Unclassified|13|||
42003882|NCT01301625|75811809|FG000|Overall Study|Death|5|||
42003883|NCT01301625|75811809|FG000|Overall Study|Not Due|21|||
42003884|NCT01301625|75811809|FG000|Overall Study|Expected|8|||
42003885|NCT01301625|75811809|FG000|Overall Study|Lost to Follow-up|1|||
42135443|NCT00289900|75946153|FG000|Overall Study|Participant moved|1|||
42135444|NCT00289900|75946154|FG001|Overall Study|Participant moved|0|||
42340864|NCT01438060|76179045|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
42340865|NCT01438060|76179046|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
42340866|NCT01438060|76179045|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
42340867|NCT01438060|76179046|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
42340868|NCT01438060|76179045|FG000|On Study Beyond Week 140|Death|0|||
42340869|NCT01438060|76179046|FG001|On Study Beyond Week 140|Death|1|||
42340870|NCT01438060|76179045|FG000|On Study Beyond Week 140|Other Reason|0|||
42340871|NCT01438060|76179046|FG001|On Study Beyond Week 140|Other Reason|3|||
42003886|NCT01301391|75811813|FG000|Overall Study|Death|13|||
42003887|NCT01301391|75811813|FG000|Overall Study|Lost to Follow-up|3|||
42003888|NCT01301391|75811813|FG000|Overall Study|Physician Decision|2|||
42003889|NCT01301391|75811813|FG000|Overall Study|Sponsor's decision|8|||
42003890|NCT01036321|75811819|FG000|Overall Study|Ineligible after randomization|0|||
42003891|NCT01036321|75811820|FG001|Overall Study|Ineligible after randomization|1|||
42003892|NCT01036321|75811819|FG000|Overall Study|Withdrawal by Subject|3|||
42003893|NCT01036321|75811820|FG001|Overall Study|Withdrawal by Subject|2|||
42003894|NCT01036321|75811819|FG000|Overall Study|Adverse Event|2|||
42003895|NCT01036321|75811820|FG001|Overall Study|Adverse Event|1|||
42003896|NCT01061359|75811826|FG000|Overall Study|Death|32|||
42003897|NCT01061359|75811826|FG000|Overall Study|Lost to Follow-up|1072|||
42003898|NCT01061359|75811826|FG000|Overall Study|Relapse|187|||
42003899|NCT01061359|75811826|FG000|Overall Study|Secondary neoplasm|11|||
42003900|NCT01301079|75811832|FG000|Overall Study|Lost to Follow-up|2|||
42003901|NCT01301079|75811833|FG001|Overall Study|Lost to Follow-up|2|||
42003902|NCT01036165|75811843|FG000|Overall Study|Adverse Event|6|||
42003903|NCT01036165|75811843|FG000|Overall Study|Lost to Follow-up|2|||
42003904|NCT01036165|75811843|FG000|Overall Study|Withdrawal by Subject|3|||
42003905|NCT01036165|75811843|FG000|Overall Study|Device Related Issues|3|||
42003906|NCT01036165|75811843|FG000|Overall Study|Problems finding proper area to inject|1|||
42003907|NCT01301001|75811847|FG000|First Intervention|Lost to Follow-up|4|||
42268390|NCT03970837|76097337|FG004|Overall Study|Protocol Violation|0|||
42003908|NCT01301001|75811848|FG001|First Intervention|Lost to Follow-up|4|||
42340872|NCT01469182|76179059|FG000|Overall Study|Adverse Event|21|||
42340873|NCT01469182|76179060|FG001|Overall Study|Adverse Event|3|||
42003909|NCT01301001|75811847|FG000|First Intervention|Withdrawal by Subject|1|||
42003910|NCT01301001|75811848|FG001|First Intervention|Withdrawal by Subject|4|||
42003911|NCT01301001|75811847|FG000|First Intervention|Adverse Event|5|||
42003912|NCT01301001|75811848|FG001|First Intervention|Adverse Event|0|||
42003913|NCT01301001|75811847|FG000|First Intervention|Protocol Violation|0|||
42003914|NCT01301001|75811848|FG001|First Intervention|Protocol Violation|1|||
42003915|NCT01301001|75811847|FG000|Second Intervention|Adverse Event|2|||
42003916|NCT01301001|75811848|FG001|Second Intervention|Adverse Event|0|||
42003917|NCT01301001|75811847|FG000|Second Intervention|Withdrawal by Subject|2|||
42003918|NCT01301001|75811848|FG001|Second Intervention|Withdrawal by Subject|0|||
42003919|NCT01300923|75811855|FG000|Overall Study|Physician Decision|0|||
42003920|NCT01300923|75811856|FG001|Overall Study|Physician Decision|2|||
42003921|NCT01300767|75811861|FG000|Overall Study|Discomfort|2|||
42003922|NCT01300767|75811861|FG000|Overall Study|Biomicroscopy|1|||
42003923|NCT01300767|75811861|FG000|Overall Study|Unacceptable fit|1|||
42003924|NCT01300455|75811869|FG000|Washout|Withdrawal by Subject|1|||
42003925|NCT01300455|75811870|FG001|Washout|Withdrawal by Subject|0|||
42003926|NCT01107418|75811880|FG000|Overall Study|Disease Progression|45|||
42003927|NCT01107418|75811880|FG000|Overall Study|Adverse Event|3|||
42003928|NCT01107418|75811880|FG000|Overall Study|Withdrawal by Subject|1|||
42003929|NCT01107418|75811880|FG000|Overall Study|Study Closing|1|||
42003930|NCT01107418|75811880|FG000|Overall Study|Started Other Therapy|1|||
42003931|NCT01107418|75811880|FG000|Overall Study|Entered Extension Study|1|||
42003932|NCT01101178|75811895|FG000|Period 1|Withdrawal by Subject|1|||
42003933|NCT01101178|75811896|FG001|Period 1|Withdrawal by Subject|2|||
42003934|NCT01101178|75811895|FG000|Period 1|Positive drug screen|1|||
42003935|NCT01101178|75811896|FG001|Period 1|Positive drug screen|1|||
42003936|NCT01101178|75811895|FG000|Period 1|Adverse Event|2|||
42340874|NCT01469182|76179059|FG000|Overall Study|Lost to Follow-up|3|||
42340875|NCT01469182|76179060|FG001|Overall Study|Lost to Follow-up|0|||
42340876|NCT01469182|76179059|FG000|Overall Study|Withdrawal by Subject|4|||
42340877|NCT01469182|76179060|FG001|Overall Study|Withdrawal by Subject|1|||
42340878|NCT01469182|76179059|FG000|Overall Study|Protocol Violation|4|||
42340879|NCT01469182|76179060|FG001|Overall Study|Protocol Violation|2|||
42340880|NCT01469182|76179059|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
42340881|NCT01469182|76179060|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
42340882|NCT01444378|76179066|FG000|Overall Study|Lost to Follow-up|1|||
42003937|NCT01101178|75811896|FG001|Period 1|Adverse Event|1|||
42003938|NCT01101178|75811895|FG000|Period 2|Withdrawal by Subject|0|||
42003939|NCT01101178|75811896|FG001|Period 2|Withdrawal by Subject|1|||
42003940|NCT01101022|75811905|FG000|Overall Study|Adverse Event|6|||
42003941|NCT01101022|75811906|FG001|Overall Study|Adverse Event|2|||
42003942|NCT01101022|75811905|FG000|Overall Study|Protocol Violation|4|||
42003943|NCT01101022|75811906|FG001|Overall Study|Protocol Violation|3|||
42003944|NCT01101022|75811905|FG000|Overall Study|Withdrawal by Subject|3|||
42003945|NCT01101022|75811906|FG001|Overall Study|Withdrawal by Subject|8|||
42003946|NCT01101022|75811905|FG000|Overall Study|Lost to Follow-up|1|||
42003947|NCT01101022|75811906|FG001|Overall Study|Lost to Follow-up|4|||
42340883|NCT01444378|76179066|FG000|Overall Study|Withdrawal by Subject|1|||
42340884|NCT01444378|76179066|FG000|Overall Study|Death|3|||
42003948|NCT01101022|75811905|FG000|Overall Study|Lack of Efficacy|0|||
42003949|NCT01101022|75811906|FG001|Overall Study|Lack of Efficacy|7|||
42003950|NCT01101022|75811905|FG000|Overall Study|Sponsor decision|1|||
42003951|NCT01101022|75811906|FG001|Overall Study|Sponsor decision|1|||
42003952|NCT01101022|75811905|FG000|Overall Study|Non-compliance|1|||
42003953|NCT01101022|75811906|FG001|Overall Study|Non-compliance|0|||
42035081|NCT00932373|75843318|FG010|Overall Study|Clinical progression|0|||
42268391|NCT03970837|76097338|FG005|Overall Study|Protocol Violation|0|||
42268392|NCT03970837|76097339|FG006|Overall Study|Protocol Violation|0|||
42268393|NCT03970837|76097340|FG007|Overall Study|Protocol Violation|0|||
42268394|NCT03970837|76097341|FG008|Overall Study|Protocol Violation|0|||
42268395|NCT03970837|76097342|FG009|Overall Study|Protocol Violation|0|||
42268396|NCT03970837|76097343|FG010|Overall Study|Protocol Violation|0|||
42268397|NCT03970837|76097344|FG011|Overall Study|Protocol Violation|0|||
42268398|NCT03970837|76097333|FG000|Overall Study|Physician Decision|5|||
42268399|NCT03970837|76097334|FG001|Overall Study|Physician Decision|8|||
42268400|NCT03970837|76097335|FG002|Overall Study|Physician Decision|4|||
42268401|NCT03970837|76097336|FG003|Overall Study|Physician Decision|1|||
42268402|NCT03970837|76097337|FG004|Overall Study|Physician Decision|5|||
42268403|NCT03970837|76097338|FG005|Overall Study|Physician Decision|2|||
42268404|NCT03970837|76097339|FG006|Overall Study|Physician Decision|4|||
42268405|NCT03970837|76097340|FG007|Overall Study|Physician Decision|5|||
42268406|NCT03970837|76097341|FG008|Overall Study|Physician Decision|0|||
42268407|NCT03970837|76097342|FG009|Overall Study|Physician Decision|1|||
42268408|NCT03970837|76097343|FG010|Overall Study|Physician Decision|0|||
42003954|NCT01101022|75811905|FG000|Overall Study|Work schedule|1|||
42003955|NCT01101022|75811906|FG001|Overall Study|Work schedule|1|||
42035082|NCT00932373|75843308|FG000|Overall Study|Lack of Efficacy|0|||
42268409|NCT03970837|76097344|FG011|Overall Study|Physician Decision|0|||
42268410|NCT03970837|76097333|FG000|Overall Study|Withdrawal by Subject|32|||
42268411|NCT03970837|76097334|FG001|Overall Study|Withdrawal by Subject|35|||
42003956|NCT01101022|75811905|FG000|Overall Study|Vacation|0|||
42003957|NCT01101022|75811906|FG001|Overall Study|Vacation|1|||
42003958|NCT01299909|75811915|FG000|Overall Study|Lost to Follow-up|22|||
42003959|NCT01299909|75811916|FG001|Overall Study|Lost to Follow-up|18|||
42003960|NCT01299909|75811917|FG002|Overall Study|Lost to Follow-up|17|||
42003961|NCT01298661|75811927|FG000|Overall Study|Withdrawal by Subject|2|||
42135445|NCT00289900|75946155|FG002|Overall Study|Participant moved|0|||
42135446|NCT00289900|75946156|FG003|Overall Study|Participant moved|1|||
42135447|NCT00289900|75946157|FG004|Overall Study|Participant moved|1|||
42268412|NCT03970837|76097335|FG002|Overall Study|Withdrawal by Subject|12|||
42268413|NCT03970837|76097336|FG003|Overall Study|Withdrawal by Subject|8|||
42268414|NCT03970837|76097337|FG004|Overall Study|Withdrawal by Subject|6|||
42268415|NCT03970837|76097338|FG005|Overall Study|Withdrawal by Subject|8|||
42268416|NCT03970837|76097339|FG006|Overall Study|Withdrawal by Subject|2|||
42268417|NCT03970837|76097340|FG007|Overall Study|Withdrawal by Subject|3|||
42268418|NCT03970837|76097341|FG008|Overall Study|Withdrawal by Subject|0|||
42268419|NCT03970837|76097342|FG009|Overall Study|Withdrawal by Subject|0|||
42268420|NCT03970837|76097343|FG010|Overall Study|Withdrawal by Subject|0|||
42268421|NCT03970837|76097344|FG011|Overall Study|Withdrawal by Subject|1|||
42268422|NCT03970837|76097333|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
42268423|NCT03970837|76097334|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
42268424|NCT03970837|76097335|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
42268425|NCT03970837|76097336|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
42268426|NCT03970837|76097337|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
42268427|NCT03970837|76097338|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
42268428|NCT03970837|76097339|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
42268429|NCT03970837|76097340|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
42340885|NCT01444378|76179066|FG000|Overall Study|Administrative Closure Of The Study|2|||
42340886|NCT01444378|76179066|FG000|Overall Study|Missed Visits|10|||
42340887|NCT02020889|76179075|FG000|Overall Study|Adverse Event|0|||
42340888|NCT02020889|76179076|FG001|Overall Study|Adverse Event|1|||
42340889|NCT02020889|76179075|FG000|Overall Study|Lack of Efficacy|1|||
42340890|NCT02020889|76179076|FG001|Overall Study|Lack of Efficacy|0|||
42340891|NCT02020889|76179075|FG000|Overall Study|Lost to Follow-up|1|||
42340892|NCT02020889|76179076|FG001|Overall Study|Lost to Follow-up|0|||
42340893|NCT02020889|76179075|FG000|Overall Study|Physician Decision|2|||
42340894|NCT02020889|76179076|FG001|Overall Study|Physician Decision|0|||
42003962|NCT01298661|75811928|FG001|Overall Study|Withdrawal by Subject|0|||
42135448|NCT00289900|75946158|FG005|Overall Study|Participant moved|1|||
42268430|NCT03970837|76097341|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
42268431|NCT03970837|76097342|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
42003963|NCT01298661|75811929|FG002|Overall Study|Withdrawal by Subject|2|||
42135449|NCT00289900|75946153|FG000|Overall Study|Withdrawal by Subject|10|||
42340895|NCT02020889|76179075|FG000|Overall Study|Withdrawal by Subject|3|||
42340896|NCT02020889|76179076|FG001|Overall Study|Withdrawal by Subject|2|||
42340897|NCT01444300|76179084|FG000|Overall Study|Adverse Event|4|||
42003964|NCT01100944|75811938|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
42003965|NCT01100944|75811939|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
42003966|NCT01100944|75811940|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
42003967|NCT01100944|75811938|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
42003968|NCT01100944|75811939|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
42003969|NCT01100944|75811940|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
42003970|NCT01100944|75811938|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
42003971|NCT01100944|75811939|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
42003972|NCT01100944|75811940|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
42003973|NCT01100944|75811938|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
42003974|NCT01100944|75811939|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
42003975|NCT01100944|75811940|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
42003976|NCT01100320|75811961|FG000|Period 1|Withdrawal by Subject|2|||
42003977|NCT01100320|75811962|FG001|Period 1|Withdrawal by Subject|4|||
42003978|NCT01100320|75811961|FG000|Period 1|Positive Drug Screen|1|||
42003979|NCT01100320|75811962|FG001|Period 1|Positive Drug Screen|1|||
42003980|NCT01100320|75811961|FG000|Period 1|Adverse Event|2|||
42003981|NCT01100320|75811962|FG001|Period 1|Adverse Event|2|||
42003982|NCT01100320|75811961|FG000|Period 2|Withdrawal by Subject|1|||
42003983|NCT01100320|75811962|FG001|Period 2|Withdrawal by Subject|1|||
42003984|NCT01100086|75811968|FG000|Period 1|Withdrawal by Subject|1|||
42003985|NCT01100086|75811969|FG001|Period 1|Withdrawal by Subject|0|||
42003986|NCT01297959|75811977|FG000|Overall Study|Adverse Event|0|||
42003987|NCT01297959|75811978|FG001|Overall Study|Adverse Event|1|||
42135450|NCT00289900|75946154|FG001|Overall Study|Withdrawal by Subject|21|||
42135451|NCT00289900|75946155|FG002|Overall Study|Withdrawal by Subject|8|||
42135452|NCT00289900|75946156|FG003|Overall Study|Withdrawal by Subject|18|||
42135453|NCT00289900|75946157|FG004|Overall Study|Withdrawal by Subject|12|||
42135454|NCT00289900|75946158|FG005|Overall Study|Withdrawal by Subject|11|||
42135455|NCT00289900|75946153|FG000|Overall Study|Protocol Violation|3|||
42135456|NCT00289900|75946154|FG001|Overall Study|Protocol Violation|9|||
42003988|NCT01297959|75811977|FG000|Overall Study|Protocol Violation|2|||
42135457|NCT00289900|75946155|FG002|Overall Study|Protocol Violation|2|||
42268432|NCT03970837|76097343|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
42268433|NCT03970837|76097344|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
42268434|NCT03970837|76097333|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
42268435|NCT03970837|76097334|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
42268436|NCT03970837|76097335|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
42268437|NCT03970837|76097336|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
42268438|NCT03970837|76097337|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
42268439|NCT03970837|76097338|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
42340898|NCT01444300|76179085|FG001|Overall Study|Adverse Event|0|||
42268440|NCT03970837|76097339|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
42340899|NCT01443364|76179092|FG000|Overall Study|Lack of Efficacy|14|||
42340900|NCT01443364|76179092|FG000|Overall Study|Lost to Follow-up|3|||
42340901|NCT01443364|76179092|FG000|Overall Study|Withdrawal by Subject|5|||
42340902|NCT01443364|76179092|FG000|Overall Study|Other Reason|4|||
42340903|NCT01443364|76179092|FG000|Overall Study|SAE, non-fatal|6|||
42003989|NCT01297959|75811978|FG001|Overall Study|Protocol Violation|1|||
42003990|NCT01297959|75811977|FG000|Overall Study|Withdrawal by Subject|5|||
42340904|NCT01443364|76179092|FG000|Overall Study|AE, non-serious non-fatal|8|||
42003991|NCT01297959|75811978|FG001|Overall Study|Withdrawal by Subject|4|||
42003992|NCT01297959|75811977|FG000|Overall Study|Physician Decision|0|||
42135458|NCT00289900|75946156|FG003|Overall Study|Protocol Violation|6|||
42135459|NCT00289900|75946157|FG004|Overall Study|Protocol Violation|7|||
42340905|NCT01443364|76179092|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
42340906|NCT02020577|76179098|FG000|Overall Study|Progressive disease|3|||
42340907|NCT02020577|76179099|FG001|Overall Study|Progressive disease|38|||
42340908|NCT02020577|76179098|FG000|Overall Study|Other AE or clinical progression|0|||
42340909|NCT02020577|76179099|FG001|Overall Study|Other AE or clinical progression|15|||
42340910|NCT02020577|76179098|FG000|Overall Study|Withdrawal by Subject|0|||
42340911|NCT02020577|76179099|FG001|Overall Study|Withdrawal by Subject|1|||
42340912|NCT02020577|76179098|FG000|Overall Study|Other than stated above|0|||
42340913|NCT02020577|76179099|FG001|Overall Study|Other than stated above|1|||
42340914|NCT02020031|76179109|FG000|Overall Study|Physician Decision|1|||
42340915|NCT02020031|76179110|FG001|Overall Study|Physician Decision|1|||
42340916|NCT04179305|76179120|FG000|Overall Study|Death|1|||
42003993|NCT01297959|75811978|FG001|Overall Study|Physician Decision|1|||
42003994|NCT01297959|75811977|FG000|Overall Study|Unrelated medical illness / complication|0|||
42003995|NCT01297959|75811978|FG001|Overall Study|Unrelated medical illness / complication|2|||
42003996|NCT01297959|75811977|FG000|Overall Study|Other|13|||
42340917|NCT04179305|76179121|FG001|Overall Study|Death|1|||
42340918|NCT04179305|76179122|FG002|Overall Study|Death|0|||
42340919|NCT04179305|76179123|FG003|Overall Study|Death|0|||
42340920|NCT04179305|76179120|FG000|Overall Study|Lost to Follow-up|1|||
42340921|NCT04179305|76179121|FG001|Overall Study|Lost to Follow-up|1|||
42340922|NCT04179305|76179122|FG002|Overall Study|Lost to Follow-up|0|||
42340923|NCT04179305|76179123|FG003|Overall Study|Lost to Follow-up|0|||
42340924|NCT04179305|76179120|FG000|Overall Study|Withdrawal by Subject|0|||
42340925|NCT04179305|76179121|FG001|Overall Study|Withdrawal by Subject|1|||
42340926|NCT04179305|76179122|FG002|Overall Study|Withdrawal by Subject|0|||
42340927|NCT04179305|76179123|FG003|Overall Study|Withdrawal by Subject|0|||
42340928|NCT04179305|76179120|FG000|Overall Study|Did not have scan|1|||
42340929|NCT04179305|76179121|FG001|Overall Study|Did not have scan|0|||
42340930|NCT04179305|76179122|FG002|Overall Study|Did not have scan|0|||
42340931|NCT04179305|76179123|FG003|Overall Study|Did not have scan|0|||
42340932|NCT04179305|76179120|FG000|Overall Study|In hospice care|3|||
42340933|NCT04179305|76179121|FG001|Overall Study|In hospice care|0|||
42340934|NCT04179305|76179122|FG002|Overall Study|In hospice care|0|||
42340935|NCT04179305|76179123|FG003|Overall Study|In hospice care|0|||
42340936|NCT02019719|76179139|FG000|Overall Study|Adverse Event|1|||
42340937|NCT02019719|76179140|FG001|Overall Study|Adverse Event|0|||
42340938|NCT02019719|76179141|FG002|Overall Study|Adverse Event|0|||
42340939|NCT02019719|76179142|FG003|Overall Study|Adverse Event|1|||
42340940|NCT02019719|76179143|FG004|Overall Study|Adverse Event|1|||
42340941|NCT02019719|76179139|FG000|Overall Study|Protocol Violation|1|||
42340942|NCT02019719|76179140|FG001|Overall Study|Protocol Violation|1|||
42340943|NCT02019719|76179141|FG002|Overall Study|Protocol Violation|0|||
42340944|NCT02019719|76179142|FG003|Overall Study|Protocol Violation|0|||
42340945|NCT02019719|76179143|FG004|Overall Study|Protocol Violation|0|||
42340946|NCT02019719|76179139|FG000|Overall Study|Protocol defined stopping criteria|2|||
42340947|NCT02019719|76179140|FG001|Overall Study|Protocol defined stopping criteria|0|||
42340948|NCT02019719|76179141|FG002|Overall Study|Protocol defined stopping criteria|0|||
42340949|NCT02019719|76179142|FG003|Overall Study|Protocol defined stopping criteria|1|||
42340950|NCT02019719|76179143|FG004|Overall Study|Protocol defined stopping criteria|1|||
42035083|NCT00932373|75843309|FG001|Overall Study|Lack of Efficacy|0|||
42268441|NCT03970837|76097340|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
42268442|NCT03970837|76097341|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
42268443|NCT03970837|76097342|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
42268444|NCT03970837|76097343|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
42268445|NCT03970837|76097344|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
42268446|NCT03938636|76097399|FG000|Overall Study|Protocol Violation|0|||
42268447|NCT03938636|76097400|FG001|Overall Study|Protocol Violation|1|||
42268448|NCT03938636|76097401|FG002|Overall Study|Protocol Violation|1|||
42268449|NCT03938636|76097399|FG000|Overall Study|Subject withdrew due to death in family|0|||
42268450|NCT03938636|76097400|FG001|Overall Study|Subject withdrew due to death in family|1|||
42268451|NCT03938636|76097401|FG002|Overall Study|Subject withdrew due to death in family|0|||
42268452|NCT03938636|76097399|FG000|Overall Study|Missed visit|0|||
42268453|NCT03938636|76097400|FG001|Overall Study|Missed visit|1|||
42268454|NCT03938636|76097401|FG002|Overall Study|Missed visit|0|||
42268455|NCT03938636|76097399|FG000|Overall Study|Adverse Event|0|||
42268456|NCT03938636|76097400|FG001|Overall Study|Adverse Event|0|||
42340951|NCT02019719|76179139|FG000|Overall Study|Physician Decision|2|||
42340952|NCT02019719|76179140|FG001|Overall Study|Physician Decision|0|||
42340953|NCT02019719|76179141|FG002|Overall Study|Physician Decision|0|||
42268457|NCT03938636|76097401|FG002|Overall Study|Adverse Event|1|||
42268458|NCT03938636|76097399|FG000|Overall Study|Lost to Follow-up|0|||
42268459|NCT03938636|76097400|FG001|Overall Study|Lost to Follow-up|0|||
42340954|NCT02019719|76179142|FG003|Overall Study|Physician Decision|0|||
42340955|NCT02019719|76179143|FG004|Overall Study|Physician Decision|0|||
42340956|NCT02030405|76179162|FG000|Overall Study|Withdrawal by Subject|1|||
42340957|NCT02030405|76179162|FG000|Overall Study|Lost to Follow-up|1|||
42340958|NCT01975376|76179169|FG000|Overall Study|Adverse Event|5|||
42340959|NCT01975376|76179170|FG001|Overall Study|Adverse Event|5|||
42340960|NCT01975376|76179169|FG000|Overall Study|Death|65|||
42340961|NCT01975376|76179170|FG001|Overall Study|Death|72|||
42340962|NCT01975376|76179169|FG000|Overall Study|Lost to Follow-up|70|||
42340963|NCT01975376|76179170|FG001|Overall Study|Lost to Follow-up|66|||
42340964|NCT01975376|76179169|FG000|Overall Study|Withdrew consent|68|||
42340965|NCT01975376|76179170|FG001|Overall Study|Withdrew consent|62|||
42340966|NCT01975376|76179169|FG000|Overall Study|Other|2|||
42340967|NCT01975376|76179170|FG001|Overall Study|Other|4|||
42340968|NCT01975376|76179169|FG000|Overall Study|Randomized, Not Treated|16|||
42340969|NCT01975376|76179170|FG001|Overall Study|Randomized, Not Treated|8|||
42340970|NCT01443130|76179182|FG000|Overall Study|Lost to Follow-up|44|||
42340971|NCT01443130|76179183|FG001|Overall Study|Lost to Follow-up|42|||
42340972|NCT01443130|76179184|FG002|Overall Study|Lost to Follow-up|50|||
42340973|NCT01443130|76179185|FG003|Overall Study|Lost to Follow-up|23|||
42340974|NCT01443130|76179186|FG004|Overall Study|Lost to Follow-up|25|||
42340975|NCT01443130|76179187|FG005|Overall Study|Lost to Follow-up|21|||
42340976|NCT01443130|76179182|FG000|Overall Study|Death|0|||
42340977|NCT01443130|76179183|FG001|Overall Study|Death|1|||
42340978|NCT01443130|76179184|FG002|Overall Study|Death|0|||
42340979|NCT01443130|76179185|FG003|Overall Study|Death|7|||
42340980|NCT01443130|76179186|FG004|Overall Study|Death|10|||
42340981|NCT01443130|76179187|FG005|Overall Study|Death|8|||
42340982|NCT01443130|76179182|FG000|Overall Study|Adverse Event|2|||
42340983|NCT01443130|76179183|FG001|Overall Study|Adverse Event|1|||
42340984|NCT01443130|76179184|FG002|Overall Study|Adverse Event|1|||
42340985|NCT01443130|76179185|FG003|Overall Study|Adverse Event|0|||
42340986|NCT01443130|76179186|FG004|Overall Study|Adverse Event|0|||
42340987|NCT01443130|76179187|FG005|Overall Study|Adverse Event|0|||
42340988|NCT01443130|76179182|FG000|Overall Study|Protocol Violation|2|||
42340989|NCT01443130|76179183|FG001|Overall Study|Protocol Violation|1|||
42340990|NCT01443130|76179184|FG002|Overall Study|Protocol Violation|3|||
42340991|NCT01443130|76179185|FG003|Overall Study|Protocol Violation|2|||
42340992|NCT01443130|76179186|FG004|Overall Study|Protocol Violation|2|||
42340993|NCT01443130|76179187|FG005|Overall Study|Protocol Violation|3|||
42340994|NCT01443130|76179182|FG000|Overall Study|Withdrawal by Subject|15|||
42268460|NCT03938636|76097401|FG002|Overall Study|Lost to Follow-up|1|||
42268461|NCT03836716|76097426|FG000|Overall Study|Adverse Event|3|||
42268462|NCT03836716|76097426|FG000|Overall Study|Death|22|||
42268463|NCT03836716|76097426|FG000|Overall Study|Withdrawal by Subject|8|||
42268464|NCT03836716|76097426|FG000|Overall Study|Study terminated by sponsor|87|||
42268465|NCT03686215|76097433|FG000|Overall Study|Adverse Event|0|||
42268466|NCT03686215|76097434|FG001|Overall Study|Adverse Event|0|||
42268467|NCT03686215|76097435|FG002|Overall Study|Adverse Event|7|||
42268468|NCT03686215|76097433|FG000|Overall Study|Physician Decision|0|||
42268469|NCT03686215|76097434|FG001|Overall Study|Physician Decision|0|||
42340995|NCT01443130|76179183|FG001|Overall Study|Withdrawal by Subject|14|||
42340996|NCT01443130|76179184|FG002|Overall Study|Withdrawal by Subject|12|||
42340997|NCT01443130|76179185|FG003|Overall Study|Withdrawal by Subject|7|||
42340998|NCT01443130|76179186|FG004|Overall Study|Withdrawal by Subject|7|||
42340999|NCT01443130|76179187|FG005|Overall Study|Withdrawal by Subject|2|||
42341000|NCT01443130|76179182|FG000|Overall Study|Death of Subject's Infant|5|||
42341001|NCT01443130|76179183|FG001|Overall Study|Death of Subject's Infant|10|||
42341002|NCT01443130|76179184|FG002|Overall Study|Death of Subject's Infant|11|||
42341003|NCT01443130|76179185|FG003|Overall Study|Death of Subject's Infant|0|||
42341004|NCT01443130|76179186|FG004|Overall Study|Death of Subject's Infant|0|||
42268470|NCT03686215|76097435|FG002|Overall Study|Physician Decision|1|||
42268471|NCT03686215|76097433|FG000|Overall Study|Protocol Violation|0|||
42341005|NCT01443130|76179187|FG005|Overall Study|Death of Subject's Infant|0|||
42341006|NCT01436500|76179203|FG000|Overall Study|Death|1|||
42341007|NCT01436500|76179204|FG001|Overall Study|Death|0|||
42341008|NCT01436500|76179205|FG002|Overall Study|Death|0|||
42341009|NCT01436500|76179206|FG003|Overall Study|Death|0|||
42341010|NCT01436500|76179207|FG004|Overall Study|Death|0|||
42341011|NCT01436500|76179203|FG000|Overall Study|Adverse Event|0|||
42341012|NCT01436500|76179204|FG001|Overall Study|Adverse Event|2|||
42341013|NCT01436500|76179205|FG002|Overall Study|Adverse Event|2|||
42341014|NCT01436500|76179206|FG003|Overall Study|Adverse Event|0|||
42341015|NCT01436500|76179207|FG004|Overall Study|Adverse Event|1|||
42268472|NCT03686215|76097434|FG001|Overall Study|Protocol Violation|0|||
42268473|NCT03686215|76097435|FG002|Overall Study|Protocol Violation|4|||
42268474|NCT03686215|76097433|FG000|Overall Study|Device issue|1|||
42268475|NCT03686215|76097434|FG001|Overall Study|Device issue|0|||
42268476|NCT03686215|76097435|FG002|Overall Study|Device issue|2|||
42268477|NCT03665077|76097443|FG000|Overall Study|Lost to Follow-up|2|||
42268478|NCT03665077|76097443|FG000|Overall Study|Physician Decision|2|||
42268479|NCT03606174|76097458|FG000|Overall Study|Death|37|||
42268480|NCT03606174|76097459|FG001|Overall Study|Death|15|||
42268481|NCT03606174|76097460|FG002|Overall Study|Death|15|||
42268482|NCT03606174|76097461|FG003|Overall Study|Death|7|||
42268483|NCT03606174|76097462|FG004|Overall Study|Death|35|||
42268484|NCT03606174|76097463|FG005|Overall Study|Death|12|||
42268485|NCT03606174|76097464|FG006|Overall Study|Death|35|||
42268486|NCT03606174|76097465|FG007|Overall Study|Death|8|||
42268487|NCT03606174|76097466|FG008|Overall Study|Death|5|||
42268488|NCT03606174|76097467|FG009|Overall Study|Death|3|||
42268489|NCT03606174|76097468|FG010|Overall Study|Death|0|||
42268490|NCT03606174|76097458|FG000|Overall Study|Lost to Follow-up|0|||
42268491|NCT03606174|76097459|FG001|Overall Study|Lost to Follow-up|0|||
42268492|NCT03606174|76097460|FG002|Overall Study|Lost to Follow-up|0|||
42268493|NCT03606174|76097461|FG003|Overall Study|Lost to Follow-up|0|||
42268494|NCT03606174|76097462|FG004|Overall Study|Lost to Follow-up|1|||
42268495|NCT03606174|76097463|FG005|Overall Study|Lost to Follow-up|1|||
42268496|NCT03606174|76097464|FG006|Overall Study|Lost to Follow-up|0|||
42268497|NCT03606174|76097465|FG007|Overall Study|Lost to Follow-up|0|||
42268498|NCT03606174|76097466|FG008|Overall Study|Lost to Follow-up|0|||
42268499|NCT03606174|76097467|FG009|Overall Study|Lost to Follow-up|0|||
42341016|NCT01436500|76179203|FG000|Overall Study|Withdrawal by Subject|0|||
42268500|NCT03606174|76097468|FG010|Overall Study|Lost to Follow-up|0|||
42268501|NCT03606174|76097458|FG000|Overall Study|Withdrawal by Subject|6|||
42268502|NCT03606174|76097459|FG001|Overall Study|Withdrawal by Subject|0|||
42268503|NCT03606174|76097460|FG002|Overall Study|Withdrawal by Subject|0|||
42268504|NCT03606174|76097461|FG003|Overall Study|Withdrawal by Subject|1|||
42268505|NCT03606174|76097462|FG004|Overall Study|Withdrawal by Subject|2|||
42268506|NCT03606174|76097463|FG005|Overall Study|Withdrawal by Subject|1|||
42341017|NCT01436500|76179204|FG001|Overall Study|Withdrawal by Subject|0|||
42341018|NCT01436500|76179205|FG002|Overall Study|Withdrawal by Subject|2|||
42135460|NCT00289900|75946158|FG005|Overall Study|Protocol Violation|4|||
42268507|NCT03606174|76097464|FG006|Overall Study|Withdrawal by Subject|4|||
42268508|NCT03606174|76097465|FG007|Overall Study|Withdrawal by Subject|0|||
42268509|NCT03606174|76097466|FG008|Overall Study|Withdrawal by Subject|0|||
42268510|NCT03606174|76097467|FG009|Overall Study|Withdrawal by Subject|0|||
42268511|NCT03606174|76097468|FG010|Overall Study|Withdrawal by Subject|1|||
42268512|NCT03606174|76097458|FG000|Overall Study|Study Terminated by Sponsor|5|||
42268513|NCT03606174|76097459|FG001|Overall Study|Study Terminated by Sponsor|7|||
42268514|NCT03606174|76097460|FG002|Overall Study|Study Terminated by Sponsor|3|||
42268515|NCT03606174|76097461|FG003|Overall Study|Study Terminated by Sponsor|0|||
42268516|NCT03606174|76097462|FG004|Overall Study|Study Terminated by Sponsor|11|||
42268517|NCT03606174|76097463|FG005|Overall Study|Study Terminated by Sponsor|6|||
42268518|NCT03606174|76097464|FG006|Overall Study|Study Terminated by Sponsor|12|||
42341019|NCT01436500|76179206|FG003|Overall Study|Withdrawal by Subject|0|||
42341020|NCT01436500|76179207|FG004|Overall Study|Withdrawal by Subject|2|||
42341021|NCT01436500|76179203|FG000|Overall Study|Physician Decision|0|||
42341022|NCT01436500|76179204|FG001|Overall Study|Physician Decision|0|||
42268519|NCT03606174|76097465|FG007|Overall Study|Study Terminated by Sponsor|1|||
42268520|NCT03606174|76097466|FG008|Overall Study|Study Terminated by Sponsor|3|||
42268521|NCT03606174|76097467|FG009|Overall Study|Study Terminated by Sponsor|1|||
42268522|NCT03606174|76097468|FG010|Overall Study|Study Terminated by Sponsor|2|||
42268523|NCT03606174|76097458|FG000|Overall Study|Miscellaneous|1|||
42341023|NCT01436500|76179205|FG002|Overall Study|Physician Decision|1|||
42341024|NCT01436500|76179206|FG003|Overall Study|Physician Decision|0|||
42341025|NCT01436500|76179207|FG004|Overall Study|Physician Decision|0|||
42135461|NCT00289900|75946153|FG000|Overall Study|site terminated|1|||
42135462|NCT00289900|75946154|FG001|Overall Study|site terminated|0|||
42135463|NCT00289900|75946155|FG002|Overall Study|site terminated|1|||
42135464|NCT00289900|75946156|FG003|Overall Study|site terminated|0|||
42135465|NCT00289900|75946157|FG004|Overall Study|site terminated|0|||
42135466|NCT00289900|75946158|FG005|Overall Study|site terminated|0|||
42341026|NCT01436500|76179203|FG000|Overall Study|liver transplant|1|||
42341027|NCT01436500|76179204|FG001|Overall Study|liver transplant|0|||
42341028|NCT01436500|76179205|FG002|Overall Study|liver transplant|0|||
42341029|NCT01436500|76179206|FG003|Overall Study|liver transplant|0|||
42341030|NCT01436500|76179207|FG004|Overall Study|liver transplant|0|||
42341031|NCT01436500|76179203|FG000|Overall Study|initiation of dialysis|0|||
42341032|NCT01436500|76179204|FG001|Overall Study|initiation of dialysis|0|||
42341033|NCT01436500|76179205|FG002|Overall Study|initiation of dialysis|0|||
42341034|NCT01436500|76179206|FG003|Overall Study|initiation of dialysis|0|||
42341035|NCT01436500|76179207|FG004|Overall Study|initiation of dialysis|1|||
42341036|NCT01436500|76179203|FG000|Overall Study|discontinued study drug|1|||
42341037|NCT01436500|76179204|FG001|Overall Study|discontinued study drug|0|||
42341038|NCT01436500|76179205|FG002|Overall Study|discontinued study drug|0|||
42341039|NCT01436500|76179206|FG003|Overall Study|discontinued study drug|0|||
42341040|NCT01436500|76179207|FG004|Overall Study|discontinued study drug|0|||
42341041|NCT01436500|76179203|FG000|Overall Study|Other|0|||
42341042|NCT01436500|76179204|FG001|Overall Study|Other|1|||
42341043|NCT01436500|76179205|FG002|Overall Study|Other|0|||
42341044|NCT01436500|76179206|FG003|Overall Study|Other|1|||
42341045|NCT01436500|76179207|FG004|Overall Study|Other|0|||
42341046|NCT01958827|76179220|FG000|Overall Study|Adverse Event|3|||
42341047|NCT01958827|76179220|FG000|Overall Study|Lack of Efficacy|6|||
42341048|NCT01958827|76179220|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
42341049|NCT01620086|76179226|FG000|Overall Study|Withdrawal by Subject|3|||
42341050|NCT01620086|76179227|FG001|Overall Study|Withdrawal by Subject|3|||
42341051|NCT01620086|76179228|FG002|Overall Study|Withdrawal by Subject|0|||
42341052|NCT01620086|76179226|FG000|Overall Study|failed study criteria|1|||
42341053|NCT01620086|76179227|FG001|Overall Study|failed study criteria|4|||
42341054|NCT01620086|76179228|FG002|Overall Study|failed study criteria|0|||
42341055|NCT01620086|76179226|FG000|Overall Study|Physician Decision|1|||
42341056|NCT01620086|76179227|FG001|Overall Study|Physician Decision|0|||
42341057|NCT01620086|76179228|FG002|Overall Study|Physician Decision|0|||
42341058|NCT01436110|76179240|FG000|Overall Study|Lack of Efficacy|23|||
42341059|NCT01436110|76179241|FG001|Overall Study|Lack of Efficacy|14|||
42341060|NCT01436110|76179242|FG002|Overall Study|Lack of Efficacy|9|||
42341061|NCT01436110|76179240|FG000|Overall Study|Withdrawal by Subject|6|||
42135467|NCT00289900|75946153|FG000|Overall Study|Not treated|0|||
42135468|NCT00289900|75946154|FG001|Overall Study|Not treated|1|||
42135469|NCT00289900|75946155|FG002|Overall Study|Not treated|0|||
42268524|NCT03606174|76097459|FG001|Overall Study|Miscellaneous|1|||
42268525|NCT03606174|76097460|FG002|Overall Study|Miscellaneous|0|||
42268526|NCT03606174|76097461|FG003|Overall Study|Miscellaneous|1|||
42341062|NCT01436110|76179241|FG001|Overall Study|Withdrawal by Subject|8|||
42341063|NCT01436110|76179242|FG002|Overall Study|Withdrawal by Subject|4|||
42341064|NCT01436110|76179240|FG000|Overall Study|Adverse Event|2|||
42341065|NCT01436110|76179241|FG001|Overall Study|Adverse Event|1|||
42341066|NCT01436110|76179242|FG002|Overall Study|Adverse Event|2|||
42341067|NCT01436110|76179240|FG000|Overall Study|Physician Decision|3|||
42341068|NCT01436110|76179241|FG001|Overall Study|Physician Decision|1|||
42341069|NCT01436110|76179242|FG002|Overall Study|Physician Decision|1|||
42135470|NCT00289900|75946156|FG003|Overall Study|Not treated|0|||
42135471|NCT00289900|75946157|FG004|Overall Study|Not treated|0|||
42135472|NCT00289900|75946158|FG005|Overall Study|Not treated|0|||
42135473|NCT00543725|75946177|FG000|Overall Study|Adverse Event|18|||
42135474|NCT00543725|75946178|FG001|Overall Study|Adverse Event|27|||
42135475|NCT00543725|75946177|FG000|Overall Study|Sponsor's Decision|0|||
42135476|NCT00543725|75946178|FG001|Overall Study|Sponsor's Decision|1|||
42135477|NCT00543725|75946177|FG000|Overall Study|Subject Non-Compliant|4|||
42135478|NCT00543725|75946178|FG001|Overall Study|Subject Non-Compliant|4|||
42268527|NCT03606174|76097462|FG004|Overall Study|Miscellaneous|4|||
42268528|NCT03606174|76097463|FG005|Overall Study|Miscellaneous|7|||
42268529|NCT03606174|76097464|FG006|Overall Study|Miscellaneous|5|||
42268530|NCT03606174|76097465|FG007|Overall Study|Miscellaneous|0|||
42268531|NCT03606174|76097466|FG008|Overall Study|Miscellaneous|0|||
42268532|NCT03606174|76097467|FG009|Overall Study|Miscellaneous|0|||
42268533|NCT03606174|76097468|FG010|Overall Study|Miscellaneous|1|||
42268534|NCT03450707|76097498|FG000|Overall Study|Outside enrollment window|4|||
42341070|NCT01436110|76179240|FG000|Overall Study|Lost to Follow-up|1|||
42341071|NCT01436110|76179241|FG001|Overall Study|Lost to Follow-up|1|||
42341072|NCT01436110|76179242|FG002|Overall Study|Lost to Follow-up|3|||
42341073|NCT01436110|76179240|FG000|Overall Study|Protocol Violation|3|||
42341074|NCT01436110|76179241|FG001|Overall Study|Protocol Violation|1|||
42341075|NCT01436110|76179242|FG002|Overall Study|Protocol Violation|1|||
42341076|NCT01436110|76179240|FG000|Overall Study|Did Not Receive Trial Medication|1|||
42341077|NCT01436110|76179241|FG001|Overall Study|Did Not Receive Trial Medication|0|||
42341078|NCT01436110|76179242|FG002|Overall Study|Did Not Receive Trial Medication|3|||
42341079|NCT01619852|76179252|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
42341080|NCT01619852|76179253|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
42341081|NCT01619852|76179252|FG000|3 Month Follow up|Lost to Follow-up|31|||
42341082|NCT01619852|76179253|FG001|3 Month Follow up|Lost to Follow-up|34|||
42341083|NCT02000882|76179260|FG000|Overall Study|Adverse Event|3|||
42341084|NCT02000882|76179260|FG000|Overall Study|Physician Decision|2|||
42341085|NCT02000882|76179260|FG000|Overall Study|Withdrawal by Subject|1|||
42341086|NCT01965938|76179266|FG000|Overall Study|Withdrawal by Subject|1|||
42341087|NCT01965938|76179267|FG001|Overall Study|Withdrawal by Subject|0|||
42341088|NCT01965860|76179278|FG000|Overall Study|Pregnancy|1|||
42341089|NCT01965860|76179279|FG001|Overall Study|Pregnancy|0|||
42341090|NCT01965860|76179280|FG002|Overall Study|Pregnancy|1|||
42341091|NCT01965860|76179278|FG000|Overall Study|Logistics|1|||
42341092|NCT01965860|76179279|FG001|Overall Study|Logistics|0|||
42341093|NCT01965860|76179280|FG002|Overall Study|Logistics|0|||
42341094|NCT01965704|76179301|FG000|Overall Study|Withdrawal by Subject|2|||
42341095|NCT01965704|76179302|FG001|Overall Study|Withdrawal by Subject|2|||
42268535|NCT03450707|76097499|FG001|Overall Study|Outside enrollment window|1|||
42268536|NCT03450707|76097498|FG000|Overall Study|Death|1|||
42268537|NCT03450707|76097499|FG001|Overall Study|Death|0|||
42341096|NCT01965704|76179303|FG002|Overall Study|Withdrawal by Subject|1|||
42135479|NCT00543725|75946177|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
42341097|NCT01965704|76179304|FG003|Overall Study|Withdrawal by Subject|1|||
42341098|NCT01965704|76179301|FG000|Overall Study|Delivered at home|1|||
42341099|NCT01965704|76179302|FG001|Overall Study|Delivered at home|1|||
42341100|NCT01965704|76179303|FG002|Overall Study|Delivered at home|0|||
42268538|NCT03450707|76097498|FG000|Overall Study|Indication for thiamine|1|||
42341101|NCT01965704|76179304|FG003|Overall Study|Delivered at home|0|||
42341102|NCT01965704|76179301|FG000|Overall Study|Experienced complications|0|||
42341103|NCT01965704|76179302|FG001|Overall Study|Experienced complications|0|||
42341104|NCT01965704|76179303|FG002|Overall Study|Experienced complications|2|||
42341105|NCT01965704|76179304|FG003|Overall Study|Experienced complications|2|||
42341106|NCT01965704|76179301|FG000|Overall Study|Adverse Event|0|||
42341107|NCT01965704|76179302|FG001|Overall Study|Adverse Event|0|||
42341108|NCT01965704|76179303|FG002|Overall Study|Adverse Event|1|||
42341109|NCT01965704|76179304|FG003|Overall Study|Adverse Event|1|||
42341110|NCT01965704|76179301|FG000|Overall Study|Did not meet inclusion criteria|0|||
42341111|NCT01965704|76179302|FG001|Overall Study|Did not meet inclusion criteria|0|||
42341112|NCT01965704|76179303|FG002|Overall Study|Did not meet inclusion criteria|1|||
42341113|NCT01965704|76179304|FG003|Overall Study|Did not meet inclusion criteria|1|||
42341114|NCT02003365|76179315|FG000|Overall Study|Lost to Follow-up|0|||
42341115|NCT02003365|76179316|FG001|Overall Study|Lost to Follow-up|0|||
42341116|NCT02003365|76179317|FG002|Overall Study|Lost to Follow-up|1|||
42341117|NCT01975220|76179328|FG000|Test Period 1|Not treated|0|||
42341118|NCT01975220|76179329|FG001|Test Period 1|Not treated|1|||
42341119|NCT01975220|76179330|FG002|Test Period 1|Not treated|0|||
42341120|NCT01975220|76179331|FG003|Test Period 1|Not treated|0|||
42341121|NCT01975220|76179332|FG004|Test Period 1|Not treated|0|||
42341122|NCT01975220|76179333|FG005|Test Period 1|Not treated|0|||
42341123|NCT01958437|76179350|FG000|Overall Study|Incidental MRI findings|0|||
42341124|NCT01958437|76179351|FG001|Overall Study|Incidental MRI findings|0|||
42341125|NCT01958437|76179352|FG002|Overall Study|Incidental MRI findings|1|||
42341126|NCT01958437|76179353|FG003|Overall Study|Incidental MRI findings|1|||
42341127|NCT01974752|76179372|FG000|Overall Study|Death|33|||
42341128|NCT01974752|76179373|FG001|Overall Study|Death|11|||
42341129|NCT01974752|76179372|FG000|Overall Study|Lost to Follow-up|2|||
42341130|NCT01974752|76179373|FG001|Overall Study|Lost to Follow-up|0|||
42341131|NCT01974752|76179372|FG000|Overall Study|Withdrawal by Subject|2|||
42341132|NCT01974752|76179373|FG001|Overall Study|Withdrawal by Subject|3|||
42341133|NCT01974752|76179372|FG000|Overall Study|Other Eligibility Criteria|0|||
42341134|NCT01974752|76179373|FG001|Overall Study|Other Eligibility Criteria|1|||
42341135|NCT01999946|76179382|FG000|Overall Study|Participant not released from jail|2|||
42341136|NCT01999946|76179383|FG001|Overall Study|Participant not released from jail|2|||
42341137|NCT01999946|76179384|FG002|Overall Study|Participant not released from jail|0|||
42341138|NCT01999946|76179382|FG000|Overall Study|Not included in primary outcome analysis|0|||
42341139|NCT01999946|76179383|FG001|Overall Study|Not included in primary outcome analysis|0|||
42341140|NCT01999946|76179384|FG002|Overall Study|Not included in primary outcome analysis|79|||
42341141|NCT01958281|76179394|FG000|Overall Study|Lack of Efficacy|5|||
42341142|NCT01958281|76179395|FG001|Overall Study|Lack of Efficacy|2|||
42341143|NCT01958281|76179396|FG002|Overall Study|Lack of Efficacy|0|||
42341144|NCT01958281|76179394|FG000|Overall Study|Adverse Event|0|||
42341145|NCT01958281|76179395|FG001|Overall Study|Adverse Event|2|||
42341146|NCT01958281|76179396|FG002|Overall Study|Adverse Event|0|||
42341147|NCT01958281|76179394|FG000|Overall Study|Withdrew Consent|1|||
42341148|NCT01958281|76179395|FG001|Overall Study|Withdrew Consent|0|||
42341149|NCT01958281|76179396|FG002|Overall Study|Withdrew Consent|0|||
42341150|NCT01958125|76179407|FG000|Overall Study|Missing diary data|2|||
42341151|NCT01958125|76179408|FG001|Overall Study|Missing diary data|6|||
42341152|NCT01958125|76179407|FG000|Overall Study|No headache attacks|0|||
42341153|NCT01958125|76179408|FG001|Overall Study|No headache attacks|2|||
42341154|NCT02002975|76179414|FG000|Overall Study|Case Report Forms Uncollected|135|||
42341155|NCT02002975|76179414|FG000|Overall Study|Protocol Deviation|437|||
42341156|NCT02001181|76179420|FG000|Overall Study|Adverse Event|0|||
42341157|NCT02001181|76179421|FG001|Overall Study|Adverse Event|2|||
42341158|NCT02001181|76179420|FG000|Overall Study|Lost to Follow-up|1|||
42341159|NCT02001181|76179421|FG001|Overall Study|Lost to Follow-up|0|||
42341160|NCT02001181|76179420|FG000|Overall Study|Withdrawal by Subject|0|||
42341161|NCT02001181|76179421|FG001|Overall Study|Withdrawal by Subject|1|||
42341162|NCT01999465|76179429|FG000|Overall Study|Lost to Follow-up|0|||
42341163|NCT01999465|76179430|FG001|Overall Study|Lost to Follow-up|2|||
42341164|NCT01999465|76179429|FG000|Overall Study|Protocol Violation|0|||
42341165|NCT01999465|76179430|FG001|Overall Study|Protocol Violation|1|||
42341166|NCT01982773|76179438|FG000|Overall Study|Withdrawal by Subject|1|||
42341167|NCT01982773|76179439|FG001|Overall Study|Withdrawal by Subject|3|||
42341168|NCT01982773|76179438|FG000|Overall Study|Lost to Follow-up|7|||
42341169|NCT01982773|76179439|FG001|Overall Study|Lost to Follow-up|1|||
42341170|NCT01974206|76179447|FG000|Overall Study|Did Not Take Study Drug|0|||
42341171|NCT01974206|76179448|FG001|Overall Study|Did Not Take Study Drug|1|||
42341172|NCT01974206|76179447|FG000|Overall Study|Physician Decision|1|||
42341173|NCT01974206|76179448|FG001|Overall Study|Physician Decision|0|||
42341174|NCT01974206|76179447|FG000|Overall Study|Withdrawal by Subject|3|||
42341175|NCT01974206|76179448|FG001|Overall Study|Withdrawal by Subject|0|||
42341176|NCT01974206|76179447|FG000|Overall Study|Lost to Follow-up|1|||
42341177|NCT01974206|76179448|FG001|Overall Study|Lost to Follow-up|0|||
42003997|NCT01297959|75811978|FG001|Overall Study|Other|7|||
42003998|NCT01035229|75811986|FG000|Overall Study|Adverse Event|61|||
42003999|NCT01035229|75811987|FG001|Overall Study|Adverse Event|14|||
42004000|NCT01035229|75811986|FG000|Overall Study|Withdrawal by Subject|20|||
42004001|NCT01035229|75811987|FG001|Overall Study|Withdrawal by Subject|7|||
42004002|NCT01035229|75811986|FG000|Overall Study|Lost to Follow-up|1|||
42004003|NCT01035229|75811987|FG001|Overall Study|Lost to Follow-up|0|||
42004004|NCT01035229|75811986|FG000|Overall Study|Administrative problems|1|||
42004005|NCT01035229|75811987|FG001|Overall Study|Administrative problems|1|||
42135480|NCT00543725|75946178|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
42135481|NCT00543725|75946177|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
42341178|NCT01974206|76179447|FG000|Overall Study|Death|1|||
42341179|NCT01974206|76179448|FG001|Overall Study|Death|0|||
42341180|NCT01999868|76179457|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
42341181|NCT01999868|76179458|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
42341182|NCT01999868|76179459|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
42341183|NCT01999868|76179457|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
42341184|NCT01999868|76179458|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
42341185|NCT01999868|76179459|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
42341186|NCT01999868|76179457|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
42341187|NCT01999868|76179458|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
42341188|NCT01999868|76179459|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
42341189|NCT01999868|76179457|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
42341190|NCT01999868|76179458|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
42341191|NCT01999868|76179459|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
42341192|NCT01999868|76179457|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
42341193|NCT01999868|76179458|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
42341194|NCT01999868|76179459|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
42341195|NCT01999868|76179457|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
42341196|NCT01999868|76179458|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
42341197|NCT01999868|76179459|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
42341198|NCT01999868|76179457|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
42341199|NCT01999868|76179458|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
42341200|NCT01999868|76179459|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
42341201|NCT01999868|76179457|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
42341202|NCT01999868|76179458|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
42341203|NCT01999868|76179459|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
42268539|NCT03450707|76097499|FG001|Overall Study|Indication for thiamine|1|||
42268540|NCT03450707|76097498|FG000|Overall Study|Evidence of traumatic brain injury|1|||
42268541|NCT03450707|76097499|FG001|Overall Study|Evidence of traumatic brain injury|0|||
42268542|NCT03450707|76097498|FG000|Overall Study|Following commands|0|||
42268543|NCT03450707|76097499|FG001|Overall Study|Following commands|3|||
42268544|NCT03450707|76097498|FG000|Overall Study|Lactate < 3.5|0|||
42341204|NCT01999868|76179457|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
42341205|NCT01999868|76179458|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
42341206|NCT01999868|76179459|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
42341207|NCT01999868|76179457|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
42341208|NCT01999868|76179458|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
42341209|NCT01999868|76179459|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
42341210|NCT01999868|76179457|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
42341211|NCT01999868|76179458|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
42341212|NCT01999868|76179459|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
42341213|NCT01999868|76179457|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
42341214|NCT01999868|76179458|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
42341215|NCT01999868|76179459|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
42341216|NCT01999868|76179457|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
42341217|NCT01999868|76179458|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
42341218|NCT01999868|76179459|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
42341219|NCT01999868|76179457|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
42341220|NCT01999868|76179458|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
42341221|NCT01999868|76179459|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
42341222|NCT01999868|76179457|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
42341223|NCT01999868|76179458|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
42341224|NCT01999868|76179459|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
42341225|NCT01957579|76179471|FG000|Overall Study|Withdrawal of concent|0|||
42341226|NCT01957579|76179472|FG001|Overall Study|Withdrawal of concent|1|||
42341227|NCT01957579|76179473|FG002|Overall Study|Withdrawal of concent|0|||
42341228|NCT01957579|76179474|FG003|Overall Study|Withdrawal of concent|0|||
42341229|NCT01957579|76179471|FG000|Overall Study|Death|0|||
42341230|NCT01957579|76179472|FG001|Overall Study|Death|0|||
42341231|NCT01957579|76179473|FG002|Overall Study|Death|2|||
42341232|NCT01957579|76179474|FG003|Overall Study|Death|0|||
42341233|NCT01999322|76179503|FG000|Overall Study|Adverse Event|1|||
42341234|NCT01999322|76179504|FG001|Overall Study|Adverse Event|0|||
42341235|NCT01996982|76179510|FG000|Overall Study|PI/team left institution|7|||
42268545|NCT03450707|76097499|FG001|Overall Study|Lactate < 3.5|2|||
42268546|NCT03450707|76097498|FG000|Overall Study|Rearrest with ECMO|0|||
42268547|NCT03450707|76097499|FG001|Overall Study|Rearrest with ECMO|1|||
42268548|NCT03450707|76097498|FG000|Overall Study|Indication for thiamine + head CT results|0|||
42268549|NCT03450707|76097499|FG001|Overall Study|Indication for thiamine + head CT results|1|||
42268550|NCT03450707|76097498|FG000|Overall Study|Family/patient goals of care|0|||
42341236|NCT01965158|76179516|FG000|Overall Study|Adverse Event|14|||
42341237|NCT01965158|76179517|FG001|Overall Study|Adverse Event|5|||
42341238|NCT01965158|76179516|FG000|Overall Study|Withdrawal by Subject|16|||
42341239|NCT01965158|76179517|FG001|Overall Study|Withdrawal by Subject|24|||
42341240|NCT01965158|76179516|FG000|Overall Study|Lost to Follow-up|7|||
42341241|NCT01965158|76179517|FG001|Overall Study|Lost to Follow-up|5|||
42341242|NCT01965158|76179516|FG000|Overall Study|Protocol Violation|1|||
42341243|NCT01965158|76179517|FG001|Overall Study|Protocol Violation|1|||
42341244|NCT01965158|76179516|FG000|Overall Study|Other - Miscellaneous|3|||
42341245|NCT01965158|76179517|FG001|Overall Study|Other - Miscellaneous|0|||
42341246|NCT01964924|76179523|FG000|Trametinib Monotherapy|Progression|19|||
42341247|NCT01964924|76179524|FG001|Trametinib Monotherapy|Progression|0|||
42341248|NCT01964378|76179535|FG000|Overall Study|Disc. due to death before first dosing|0|||
42341249|NCT01964378|76179536|FG001|Overall Study|Disc. due to death before first dosing|1|||
42004006|NCT01035229|75811986|FG000|Overall Study|Death|13|||
42004007|NCT01035229|75811987|FG001|Overall Study|Death|5|||
42004008|NCT01035229|75811986|FG000|Overall Study|New cancer therapy|2|||
42004009|NCT01035229|75811987|FG001|Overall Study|New cancer therapy|0|||
42004010|NCT01035229|75811986|FG000|Overall Study|Protocol Violation|0|||
42004011|NCT01035229|75811987|FG001|Overall Study|Protocol Violation|2|||
42004012|NCT01035229|75811986|FG000|Overall Study|Sponsor's decision to end study|3|||
42004013|NCT01035229|75811987|FG001|Overall Study|Sponsor's decision to end study|3|||
42004014|NCT01035229|75811986|FG000|Overall Study|Disease Progression|261|||
42004015|NCT01035229|75811987|FG001|Overall Study|Disease Progression|152|||
42004016|NCT01106404|75811997|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
42004017|NCT01106404|75811998|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
42004018|NCT01106404|75811997|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
42004019|NCT01106404|75811998|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
42004020|NCT01106404|75811997|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
42004021|NCT01106404|75811998|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
42341250|NCT01964378|76179535|FG000|Overall Study|Disc. due to AE before first dosing|1|||
42341251|NCT01964378|76179536|FG001|Overall Study|Disc. due to AE before first dosing|0|||
42341252|NCT01964378|76179535|FG000|Overall Study|Death|3|||
42341253|NCT01964378|76179536|FG001|Overall Study|Death|2|||
42341254|NCT01964378|76179535|FG000|Overall Study|Adverse Event|12|||
42341255|NCT01964378|76179536|FG001|Overall Study|Adverse Event|5|||
42341256|NCT01964378|76179535|FG000|Overall Study|Lack of Efficacy|0|||
42268551|NCT03450707|76097499|FG001|Overall Study|Family/patient goals of care|1|||
42268552|NCT03296527|76097507|FG000|Overall Study|Adverse Event|15|||
42268553|NCT03296527|76097508|FG001|Overall Study|Adverse Event|33|||
42268554|NCT03296527|76097507|FG000|Overall Study|Protocol Deviation|4|||
42268555|NCT03296527|76097508|FG001|Overall Study|Protocol Deviation|0|||
42268556|NCT03296527|76097507|FG000|Overall Study|Participant withdrew consent|3|||
42268557|NCT03296527|76097508|FG001|Overall Study|Participant withdrew consent|1|||
42268558|NCT03296527|76097507|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
42268559|NCT03296527|76097508|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
42341257|NCT01964378|76179536|FG001|Overall Study|Lack of Efficacy|1|||
42341258|NCT01964378|76179535|FG000|Overall Study|Protocol Violation|0|||
42004022|NCT01106404|75811997|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
42004023|NCT01106404|75811998|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
42341259|NCT01964378|76179536|FG001|Overall Study|Protocol Violation|1|||
42004024|NCT01059799|75812012|FG000|Overall Study|Adverse Event|2|||
42004025|NCT01059799|75812013|FG001|Overall Study|Adverse Event|3|||
42004026|NCT01059799|75812012|FG000|Overall Study|Lack of Efficacy|1|||
42004027|NCT01059799|75812013|FG001|Overall Study|Lack of Efficacy|0|||
42135482|NCT00543725|75946178|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
42268560|NCT03296527|76097507|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
42268561|NCT03296527|76097508|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
42268562|NCT03296527|76097507|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
42268563|NCT03296527|76097508|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
42268564|NCT03296527|76097507|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
42268565|NCT03296527|76097508|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
42268566|NCT03296527|76097507|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
42268567|NCT03296527|76097508|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
42268568|NCT03228680|76097517|FG000|Overall Study|Adverse Event|13|||
42268569|NCT03228680|76097518|FG001|Overall Study|Adverse Event|18|||
42268570|NCT03228680|76097517|FG000|Overall Study|Randomization failure|0|||
42268571|NCT03228680|76097518|FG001|Overall Study|Randomization failure|1|||
42268572|NCT03228680|76097517|FG000|Overall Study|Withdrawal by Subject|1|||
42341260|NCT01964378|76179535|FG000|Overall Study|Lost to Follow-up|0|||
42341261|NCT01964378|76179536|FG001|Overall Study|Lost to Follow-up|1|||
42341262|NCT01964378|76179535|FG000|Overall Study|Withdrawal by Subject|7|||
42341263|NCT01964378|76179536|FG001|Overall Study|Withdrawal by Subject|5|||
42341264|NCT01964378|76179535|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
42341265|NCT01964378|76179536|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
42341266|NCT01964378|76179535|FG000|Overall Study|Other|1|||
42341267|NCT01964378|76179536|FG001|Overall Study|Other|2|||
42341268|NCT01442038|76179544|FG000|Overall Study|Death|35|||
42341269|NCT01442038|76179545|FG001|Overall Study|Death|29|||
42341270|NCT01442038|76179544|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
42341271|NCT01442038|76179545|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
42341272|NCT01442038|76179544|FG000|Overall Study|Participant Withdrew Consent|137|||
42004028|NCT01059799|75812012|FG000|Overall Study|Protocol Violation|3|||
42341273|NCT01442038|76179545|FG001|Overall Study|Participant Withdrew Consent|102|||
42341274|NCT01442038|76179544|FG000|Overall Study|Lost to Follow-up|37|||
42341275|NCT01442038|76179545|FG001|Overall Study|Lost to Follow-up|51|||
42004029|NCT01059799|75812013|FG001|Overall Study|Protocol Violation|2|||
42135483|NCT00543725|75946177|FG000|Overall Study|Protocol Violation|0|||
42135484|NCT00543725|75946178|FG001|Overall Study|Protocol Violation|1|||
42341276|NCT01442038|76179544|FG000|Overall Study|Adverse Event|26|||
42341277|NCT01442038|76179545|FG001|Overall Study|Adverse Event|15|||
42341278|NCT01442038|76179544|FG000|Overall Study|Protocol Deviation|9|||
42341279|NCT01442038|76179545|FG001|Overall Study|Protocol Deviation|20|||
42341280|NCT01442038|76179544|FG000|Overall Study|Investigator's Discretion|13|||
42341281|NCT01442038|76179545|FG001|Overall Study|Investigator's Discretion|16|||
42341282|NCT01442038|76179544|FG000|Overall Study|Study Terminated By Sponsor|2|||
42004030|NCT01059799|75812012|FG000|Overall Study|Withdrawal criteria|13|||
42004031|NCT01059799|75812013|FG001|Overall Study|Withdrawal criteria|2|||
42004032|NCT01059799|75812012|FG000|Overall Study|Other|12|||
42004033|NCT01059799|75812013|FG001|Overall Study|Other|3|||
42004034|NCT01106248|75812019|FG000|Overall Study|Adverse Event|1|||
42004035|NCT01106248|75812019|FG000|Overall Study|Administrative|2|||
42004036|NCT01059175|75812025|FG000|Overall Study|Death|17|||
42004037|NCT01059175|75812026|FG001|Overall Study|Death|17|||
42004038|NCT01059175|75812025|FG000|Overall Study|Adverse Event|4|||
42004039|NCT01059175|75812026|FG001|Overall Study|Adverse Event|2|||
42135485|NCT00543725|75946177|FG000|Overall Study|Withdrawal by Subject|4|||
42135486|NCT00543725|75946178|FG001|Overall Study|Withdrawal by Subject|13|||
42268573|NCT03228680|76097518|FG001|Overall Study|Withdrawal by Subject|0|||
42268574|NCT03228680|76097517|FG000|Overall Study|Other|9|||
42268575|NCT03228680|76097518|FG001|Overall Study|Other|16|||
42268576|NCT03194542|76097529|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
42268577|NCT03194542|76097530|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
42268578|NCT03194542|76097531|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
42268579|NCT03194542|76097532|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
42268580|NCT03194542|76097529|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
42268581|NCT03194542|76097530|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
42268582|NCT03194542|76097531|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
42268583|NCT03194542|76097532|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
42268584|NCT03194542|76097529|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
42268585|NCT03194542|76097530|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
42341283|NCT01442038|76179545|FG001|Overall Study|Study Terminated By Sponsor|3|||
42341284|NCT01998919|76179553|FG000|Overall Study|Death|2|||
42004040|NCT01059175|75812025|FG000|Overall Study|Lost to Follow-up|0|||
42004041|NCT01059175|75812026|FG001|Overall Study|Lost to Follow-up|1|||
42341285|NCT01998919|76179554|FG001|Overall Study|Death|2|||
42004042|NCT01297491|75812034|FG000|Overall Study|Adverse Event|11|||
42004043|NCT01297491|75812035|FG001|Overall Study|Adverse Event|6|||
42004044|NCT01297491|75812034|FG000|Overall Study|Physician Decision|3|||
42135487|NCT00543725|75946177|FG000|Overall Study|Lost to Follow-up|15|||
42035084|NCT00932373|75843310|FG002|Overall Study|Lack of Efficacy|0|||
42035085|NCT00932373|75843311|FG003|Overall Study|Lack of Efficacy|0|||
42035086|NCT00932373|75843312|FG004|Overall Study|Lack of Efficacy|0|||
42035087|NCT00932373|75843313|FG005|Overall Study|Lack of Efficacy|0|||
42035088|NCT00932373|75843314|FG006|Overall Study|Lack of Efficacy|0|||
42035089|NCT00932373|75843315|FG007|Overall Study|Lack of Efficacy|0|||
42035090|NCT00932373|75843316|FG008|Overall Study|Lack of Efficacy|0|||
42035091|NCT00932373|75843317|FG009|Overall Study|Lack of Efficacy|1|||
42341286|NCT01998919|76179553|FG000|Overall Study|Adverse Event|0|||
42341287|NCT01998919|76179554|FG001|Overall Study|Adverse Event|5|||
42341288|NCT01998919|76179553|FG000|Overall Study|Disease progression|31|||
42341289|NCT01998919|76179554|FG001|Overall Study|Disease progression|22|||
42341290|NCT01998919|76179553|FG000|Overall Study|Withdrawal by Subject|2|||
42341291|NCT01998919|76179554|FG001|Overall Study|Withdrawal by Subject|4|||
42341292|NCT01998919|76179553|FG000|Overall Study|Lost to Follow-up|2|||
42341293|NCT01998919|76179554|FG001|Overall Study|Lost to Follow-up|0|||
42341294|NCT01998919|76179553|FG000|Overall Study|Other|5|||
42341295|NCT01998919|76179554|FG001|Overall Study|Other|2|||
42341296|NCT01957111|76179562|FG000|Overall Study|Withdrawal by Subject|1|||
42341297|NCT01957111|76179563|FG001|Overall Study|Withdrawal by Subject|1|||
42341298|NCT01964300|76179571|FG000|Overall Study|Ineligible after enrollment|0|||
42341299|NCT01964300|76179572|FG001|Overall Study|Ineligible after enrollment|1|||
42341300|NCT01964300|76179571|FG000|Overall Study|Adverse Event|1|||
42341301|NCT01964300|76179572|FG001|Overall Study|Adverse Event|1|||
42341302|NCT01964300|76179571|FG000|Overall Study|Lack of Efficacy|3|||
42341303|NCT01964300|76179572|FG001|Overall Study|Lack of Efficacy|5|||
42341304|NCT01964300|76179571|FG000|Overall Study|Withdrawal by Subject|0|||
42341305|NCT01964300|76179572|FG001|Overall Study|Withdrawal by Subject|1|||
42341306|NCT01964300|76179571|FG000|Overall Study|To receive alternative therapy|1|||
42341307|NCT01964300|76179572|FG001|Overall Study|To receive alternative therapy|2|||
42341308|NCT01964300|76179571|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
42341309|NCT01964300|76179572|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
42341310|NCT01964300|76179571|FG000|Overall Study|Weight criteria not met|0|||
42341311|NCT01964300|76179572|FG001|Overall Study|Weight criteria not met|1|||
42341312|NCT01964222|76179580|FG000|Overall Study|Lost to Follow-up|7|||
42341313|NCT01964222|76179581|FG001|Overall Study|Lost to Follow-up|5|||
42341314|NCT01964222|76179580|FG000|Overall Study|Withdrawal by Subject|6|||
42341315|NCT01964222|76179581|FG001|Overall Study|Withdrawal by Subject|6|||
42004045|NCT01297491|75812035|FG001|Overall Study|Physician Decision|2|||
42004046|NCT01297491|75812034|FG000|Overall Study|Progressive disease|11|||
42004047|NCT01297491|75812035|FG001|Overall Study|Progressive disease|20|||
42004048|NCT01297491|75812034|FG000|Overall Study|Patient/Guardian decision|3|||
42004049|NCT01297491|75812035|FG001|Overall Study|Patient/Guardian decision|4|||
42004050|NCT01297491|75812034|FG000|Overall Study|Death|2|||
42004051|NCT01297491|75812035|FG001|Overall Study|Death|1|||
42004052|NCT01106092|75812045|FG000|Overall Study|Withdrawal by Subject|0|||
42004053|NCT01106092|75812046|FG001|Overall Study|Withdrawal by Subject|0|||
42004054|NCT01106092|75812047|FG002|Overall Study|Withdrawal by Subject|0|||
42004055|NCT01106092|75812048|FG003|Overall Study|Withdrawal by Subject|1|||
42004056|NCT01097668|75812060|FG000|Overall Study|Withdrawal by Subject|1|||
42004057|NCT01097668|75812061|FG001|Overall Study|Withdrawal by Subject|2|||
42004058|NCT01097668|75812060|FG000|Overall Study|Lost to Follow-up|1|||
42004059|NCT01097668|75812061|FG001|Overall Study|Lost to Follow-up|0|||
42035092|NCT00932373|75843318|FG010|Overall Study|Lack of Efficacy|0|||
42035093|NCT01055496|75843352|FG000|Overall Study|Withdrawal by Subject|2|||
42341316|NCT01964222|76179580|FG000|Overall Study|Screening Failure|2|||
42004060|NCT01325207|75812077|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
42035094|NCT01055496|75843353|FG001|Overall Study|Withdrawal by Subject|4|||
42341317|NCT01964222|76179581|FG001|Overall Study|Screening Failure|0|||
42268586|NCT03194542|76097531|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
42268587|NCT03194542|76097532|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
42268588|NCT03194542|76097529|FG000|Overall Study|Loss of Response|4|||
42268589|NCT03194542|76097530|FG001|Overall Study|Loss of Response|2|||
42268590|NCT03194542|76097531|FG002|Overall Study|Loss of Response|3|||
42268591|NCT03194542|76097532|FG003|Overall Study|Loss of Response|4|||
42268592|NCT03194542|76097529|FG000|Overall Study|Physician Decision|0|||
42268593|NCT03194542|76097530|FG001|Overall Study|Physician Decision|1|||
42268594|NCT03194542|76097531|FG002|Overall Study|Physician Decision|0|||
42268595|NCT03194542|76097532|FG003|Overall Study|Physician Decision|0|||
42268596|NCT03194542|76097529|FG000|Overall Study|Lack of Efficacy|2|||
42268597|NCT03194542|76097530|FG001|Overall Study|Lack of Efficacy|2|||
42268598|NCT03194542|76097531|FG002|Overall Study|Lack of Efficacy|2|||
42268599|NCT03194542|76097532|FG003|Overall Study|Lack of Efficacy|6|||
42268600|NCT03194542|76097529|FG000|Overall Study|Withdrawal by Subject|2|||
42268601|NCT03194542|76097530|FG001|Overall Study|Withdrawal by Subject|1|||
42341318|NCT01467700|76179591|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
42341319|NCT01467700|76179592|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
42341320|NCT01467700|76179593|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
42341321|NCT01467700|76179594|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
42341322|NCT01467700|76179591|FG000|Overall Study|Major Protocol Deviation|3|||
42341323|NCT01467700|76179592|FG001|Overall Study|Major Protocol Deviation|3|||
42341324|NCT01467700|76179593|FG002|Overall Study|Major Protocol Deviation|2|||
42341325|NCT01467700|76179594|FG003|Overall Study|Major Protocol Deviation|3|||
42004061|NCT01325207|75812078|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
42004062|NCT01325207|75812079|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
42268602|NCT03194542|76097531|FG002|Overall Study|Withdrawal by Subject|5|||
42268603|NCT03194542|76097532|FG003|Overall Study|Withdrawal by Subject|4|||
42268604|NCT03194542|76097529|FG000|Overall Study|Progressive Disease|1|||
42268605|NCT03194542|76097530|FG001|Overall Study|Progressive Disease|0|||
42341326|NCT01467700|76179591|FG000|Overall Study|Lost to Follow-up|6|||
42341327|NCT01467700|76179592|FG001|Overall Study|Lost to Follow-up|5|||
42341328|NCT01467700|76179593|FG002|Overall Study|Lost to Follow-up|2|||
42268606|NCT03194542|76097531|FG002|Overall Study|Progressive Disease|1|||
42341329|NCT01467700|76179594|FG003|Overall Study|Lost to Follow-up|3|||
42004063|NCT01325207|75812080|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
42004064|NCT01325207|75812081|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
42004065|NCT01325207|75812082|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
42004066|NCT01325207|75812077|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
42035095|NCT01055496|75843352|FG000|Overall Study|Death|13|||
42035096|NCT01055496|75843353|FG001|Overall Study|Death|23|||
42035097|NCT01055496|75843352|FG000|Overall Study|Lost to Follow-up|0|||
42035098|NCT01055496|75843353|FG001|Overall Study|Lost to Follow-up|2|||
42035099|NCT01055496|75843352|FG000|Overall Study|Other - Unspecified|0|||
42035100|NCT01055496|75843353|FG001|Overall Study|Other - Unspecified|1|||
42035101|NCT01055262|75843380|FG000|Overall Study|Adverse Event|5|||
42035102|NCT01055262|75843380|FG000|Overall Study|Protocol Violation|3|||
42035103|NCT01055262|75843380|FG000|Overall Study|Uncooperativeness|1|||
42035104|NCT01052844|75843386|FG000|Overall Study|Adverse Event|0|||
42035105|NCT01052844|75843387|FG001|Overall Study|Adverse Event|1|||
42035106|NCT01049412|75843395|FG000|Period I|Withdrawal by Subject|4|||
42341330|NCT01467700|76179591|FG000|Overall Study|Voluntary Withdrawal|5|||
42341331|NCT01467700|76179592|FG001|Overall Study|Voluntary Withdrawal|7|||
42341332|NCT01467700|76179593|FG002|Overall Study|Voluntary Withdrawal|6|||
42341333|NCT01467700|76179594|FG003|Overall Study|Voluntary Withdrawal|2|||
42341334|NCT01467700|76179591|FG000|Overall Study|Study Termination|6|||
42341335|NCT01467700|76179592|FG001|Overall Study|Study Termination|5|||
42341336|NCT01467700|76179593|FG002|Overall Study|Study Termination|10|||
42341337|NCT01467700|76179594|FG003|Overall Study|Study Termination|7|||
42341338|NCT01467700|76179591|FG000|Overall Study|Pregnancy|0|||
42341339|NCT01467700|76179592|FG001|Overall Study|Pregnancy|1|||
42341340|NCT01467700|76179593|FG002|Overall Study|Pregnancy|1|||
42341341|NCT01467700|76179594|FG003|Overall Study|Pregnancy|0|||
42341342|NCT01467700|76179591|FG000|Overall Study|Lack of Efficacy|2|||
42341343|NCT01467700|76179592|FG001|Overall Study|Lack of Efficacy|0|||
42341344|NCT01467700|76179593|FG002|Overall Study|Lack of Efficacy|2|||
42341345|NCT01467700|76179594|FG003|Overall Study|Lack of Efficacy|1|||
42341346|NCT01467700|76179591|FG000|Overall Study|Reason not Specified|1|||
42341347|NCT01467700|76179592|FG001|Overall Study|Reason not Specified|3|||
42341348|NCT01467700|76179593|FG002|Overall Study|Reason not Specified|2|||
42341349|NCT01467700|76179594|FG003|Overall Study|Reason not Specified|8|||
42341350|NCT01972724|76179607|FG000|Double-Blind|Rescue Criteria Met|1|||
42341351|NCT01972724|76179608|FG001|Double-Blind|Rescue Criteria Met|0|||
42341352|NCT01972724|76179609|FG002|Double-Blind|Rescue Criteria Met|0|||
42341353|NCT01972724|76179607|FG000|Double-Blind|Adverse Event|1|||
42341354|NCT01972724|76179608|FG001|Double-Blind|Adverse Event|0|||
42341355|NCT01972724|76179609|FG002|Double-Blind|Adverse Event|0|||
42341356|NCT01972724|76179607|FG000|Double-Blind|Withdrawal of Consent|2|||
42341357|NCT01972724|76179608|FG001|Double-Blind|Withdrawal of Consent|1|||
42341358|NCT01972724|76179609|FG002|Double-Blind|Withdrawal of Consent|0|||
42341359|NCT01972724|76179607|FG000|Double-Blind|Significant Protocol Deviation|5|||
42341360|NCT01972724|76179608|FG001|Double-Blind|Significant Protocol Deviation|8|||
42341361|NCT01972724|76179609|FG002|Double-Blind|Significant Protocol Deviation|0|||
42341362|NCT01972724|76179607|FG000|Open-Label|Withdrew Consent|0|||
42341363|NCT01972724|76179608|FG001|Open-Label|Withdrew Consent|0|||
42341364|NCT01972724|76179609|FG002|Open-Label|Withdrew Consent|3|||
42341365|NCT01972724|76179607|FG000|Open-Label|Significant Protocol Deviation|0|||
42341366|NCT01972724|76179608|FG001|Open-Label|Significant Protocol Deviation|0|||
42341367|NCT01972724|76179609|FG002|Open-Label|Significant Protocol Deviation|2|||
42341368|NCT01441960|76179617|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
42341369|NCT01441960|76179618|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
42341370|NCT01441960|76179617|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
42341371|NCT01441960|76179618|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
42341372|NCT01441960|76179617|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
42341373|NCT01441960|76179618|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
42341374|NCT01955707|76179630|FG000|Overall Study|Adverse Event|1|||
42341375|NCT01955707|76179631|FG001|Overall Study|Adverse Event|2|||
42341376|NCT01955707|76179630|FG000|Overall Study|Lost to Follow-up|2|||
42341377|NCT01955707|76179631|FG001|Overall Study|Lost to Follow-up|1|||
42035107|NCT01049412|75843396|FG001|Period I|Withdrawal by Subject|6|||
42341378|NCT01955707|76179630|FG000|Overall Study|Withdrawal by Subject|0|||
42004067|NCT01325207|75812078|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
42341379|NCT01955707|76179631|FG001|Overall Study|Withdrawal by Subject|3|||
42341380|NCT01955707|76179630|FG000|Overall Study|Death|13|||
42341381|NCT01955707|76179631|FG001|Overall Study|Death|14|||
42341382|NCT01955707|76179630|FG000|Overall Study|Other|4|||
42341383|NCT01955707|76179631|FG001|Overall Study|Other|2|||
42341384|NCT01435798|76179637|FG000|Overall Study|Withdrawal by Subject|1|||
42341385|NCT01972568|76179650|FG000|Overall Study|Other events|3|||
42341386|NCT01972568|76179651|FG001|Overall Study|Other events|0|||
42341387|NCT01972568|76179652|FG002|Overall Study|Other events|0|||
42341388|NCT01972568|76179650|FG000|Overall Study|Lack of Efficacy|0|||
42341389|NCT01972568|76179651|FG001|Overall Study|Lack of Efficacy|1|||
42341390|NCT01972568|76179652|FG002|Overall Study|Lack of Efficacy|2|||
42341391|NCT01972568|76179650|FG000|Overall Study|Protocol Violation|1|||
42341392|NCT01972568|76179651|FG001|Overall Study|Protocol Violation|2|||
42341393|NCT01972568|76179652|FG002|Overall Study|Protocol Violation|2|||
42341394|NCT01972568|76179650|FG000|Overall Study|Withdrawal by Subject|6|||
42341395|NCT01972568|76179651|FG001|Overall Study|Withdrawal by Subject|3|||
42341396|NCT01972568|76179652|FG002|Overall Study|Withdrawal by Subject|7|||
42341397|NCT01972568|76179650|FG000|Overall Study|Lost to Follow-up|1|||
42341398|NCT01972568|76179651|FG001|Overall Study|Lost to Follow-up|0|||
42341399|NCT01972568|76179652|FG002|Overall Study|Lost to Follow-up|0|||
42341400|NCT01972568|76179650|FG000|Overall Study|Adverse Event|5|||
42341401|NCT01972568|76179651|FG001|Overall Study|Adverse Event|6|||
42341402|NCT01972568|76179652|FG002|Overall Study|Adverse Event|5|||
42004068|NCT01325207|75812079|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
42341403|NCT01955161|76179663|FG000|Overall Study|Withdrawal before treatment|2|||
42341404|NCT01955161|76179664|FG001|Overall Study|Withdrawal before treatment|0|||
42341405|NCT01955161|76179665|FG002|Overall Study|Withdrawal before treatment|1|||
42341406|NCT01955161|76179663|FG000|Overall Study|Adverse Event|10|||
42341407|NCT01955161|76179664|FG001|Overall Study|Adverse Event|14|||
42341408|NCT01955161|76179665|FG002|Overall Study|Adverse Event|15|||
42341409|NCT01955161|76179663|FG000|Overall Study|Death|1|||
42341410|NCT01955161|76179664|FG001|Overall Study|Death|1|||
42341411|NCT01955161|76179665|FG002|Overall Study|Death|3|||
42341412|NCT01955161|76179663|FG000|Overall Study|Withdrawal by Subject|9|||
42341413|NCT01955161|76179664|FG001|Overall Study|Withdrawal by Subject|8|||
42341414|NCT01955161|76179665|FG002|Overall Study|Withdrawal by Subject|12|||
42341415|NCT01955161|76179663|FG000|Overall Study|Protocol Violation|2|||
42341416|NCT01955161|76179664|FG001|Overall Study|Protocol Violation|0|||
42341417|NCT01955161|76179665|FG002|Overall Study|Protocol Violation|0|||
42341418|NCT01955161|76179663|FG000|Overall Study|Other reason: physician decision|0|||
42341419|NCT01955161|76179664|FG001|Overall Study|Other reason: physician decision|1|||
42341420|NCT01955161|76179665|FG002|Overall Study|Other reason: physician decision|1|||
42341421|NCT01955161|76179663|FG000|Overall Study|Other reason: disallowed medication|1|||
42341422|NCT01955161|76179664|FG001|Overall Study|Other reason: disallowed medication|0|||
42341423|NCT01955161|76179665|FG002|Overall Study|Other reason: disallowed medication|1|||
42341424|NCT01955161|76179663|FG000|Overall Study|Other reason: caregiver unavailable|1|||
42341425|NCT01955161|76179664|FG001|Overall Study|Other reason: caregiver unavailable|0|||
42341426|NCT01955161|76179665|FG002|Overall Study|Other reason: caregiver unavailable|0|||
42341427|NCT01955161|76179663|FG000|Overall Study|Other reason: moved to nursing home|0|||
42341428|NCT01955161|76179664|FG001|Overall Study|Other reason: moved to nursing home|1|||
42341429|NCT01955161|76179665|FG002|Overall Study|Other reason: moved to nursing home|0|||
42341430|NCT01955161|76179663|FG000|Overall Study|Other reason: insufficient compliance|0|||
42341431|NCT01955161|76179664|FG001|Overall Study|Other reason: insufficient compliance|0|||
42341432|NCT01955161|76179665|FG002|Overall Study|Other reason: insufficient compliance|1|||
42341433|NCT01955161|76179663|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
42341434|NCT01955161|76179664|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
42341435|NCT01955161|76179665|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
42341436|NCT01955161|76179663|FG000|Overall Study|Other reason: patient's will|0|||
42341437|NCT01955161|76179664|FG001|Overall Study|Other reason: patient's will|0|||
42341438|NCT01955161|76179665|FG002|Overall Study|Other reason: patient's will|1|||
42341439|NCT01441414|76179673|FG000|Overall Study|Participant died|9|||
42341440|NCT01441414|76179673|FG000|Overall Study|Other reasons|3|||
42341441|NCT01441414|76179673|FG000|Overall Study|Study terminated by sponsor|2|||
42341442|NCT01441414|76179673|FG000|Overall Study|Subject refused further follow-up|1|||
42341443|NCT01971554|76179693|FG000|Overall Study|Lost to Follow-up|1|||
42341444|NCT01971554|76179694|FG001|Overall Study|Lost to Follow-up|0|||
42341445|NCT01971554|76179695|FG002|Overall Study|Lost to Follow-up|0|||
42341446|NCT01971554|76179696|FG003|Overall Study|Lost to Follow-up|0|||
42341447|NCT01955083|76179708|FG000|Overall Study|Lost to Follow-up|1|||
42341448|NCT01955083|76179709|FG001|Overall Study|Lost to Follow-up|1|||
42341449|NCT01955005|76179741|FG000|Overall Study|Withdrawal by Subject|3|||
42341450|NCT01955005|76179742|FG001|Overall Study|Withdrawal by Subject|5|||
42341451|NCT01954927|76179750|FG000|Overall Study|Withdrawal by Subject|3|||
42341452|NCT01954927|76179751|FG001|Overall Study|Withdrawal by Subject|1|||
42341453|NCT01954771|76179760|FG000|Overall Study|Missing HbA1c of end-point|1|||
42341454|NCT01954771|76179761|FG001|Overall Study|Missing HbA1c of end-point|1|||
42341455|NCT01954771|76179762|FG002|Overall Study|Missing HbA1c of end-point|0|||
42341456|NCT01954771|76179760|FG000|Overall Study|Missing CGMS of end-point|1|||
42341457|NCT01954771|76179761|FG001|Overall Study|Missing CGMS of end-point|1|||
42341458|NCT01954771|76179762|FG002|Overall Study|Missing CGMS of end-point|0|||
42341459|NCT01954771|76179760|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
42341460|NCT01954771|76179761|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
42341461|NCT01954771|76179762|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
42341462|NCT01997281|76179775|FG000|Overall Study|Withdrawal by Subject|1|||
42341463|NCT01997281|76179776|FG001|Overall Study|Withdrawal by Subject|0|||
42341464|NCT01996033|76179782|FG000|Overall Study|Death|1|||
42341465|NCT01996033|76179782|FG000|Overall Study|Physician Decision|1|||
42341466|NCT01996033|76179782|FG000|Overall Study|Withdrawal by Subject|4|||
42341467|NCT01996033|76179782|FG000|Overall Study|Lost to Follow-up|3|||
42341468|NCT01953913|76179786|FG000|Overall Study|Disease Progression|349|||
42135488|NCT00543725|75946178|FG001|Overall Study|Lost to Follow-up|11|||
42341469|NCT01953913|76179786|FG000|Overall Study|Worsening of underlying cancer|22|||
42341470|NCT01953913|76179786|FG000|Overall Study|Adverse Event|20|||
42341471|NCT01953913|76179786|FG000|Overall Study|Protocol Violation|6|||
42341472|NCT01953913|76179786|FG000|Overall Study|Lost to Follow-up|4|||
42135489|NCT00543725|75946177|FG000|Overall Study|Other|3|||
42341473|NCT01953913|76179786|FG000|Overall Study|Withdrawal by Subject|32|||
42341474|NCT01953913|76179786|FG000|Overall Study|Other than listed|108|||
42341475|NCT01953913|76179786|FG000|Overall Study|Not Treated|1|||
42341476|NCT01971476|76179793|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
42341477|NCT01971476|76179794|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
42341478|NCT01971476|76179795|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
42135490|NCT00543725|75946178|FG001|Overall Study|Other|3|||
42004069|NCT01325207|75812080|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
42004070|NCT01325207|75812081|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
42004071|NCT01325207|75812082|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
42341479|NCT01971476|76179793|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
42341480|NCT01971476|76179794|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
42341481|NCT01971476|76179795|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
42341482|NCT01971476|76179793|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
42341483|NCT01971476|76179794|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
42341484|NCT01971476|76179795|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
42341485|NCT01996904|76179814|FG000|Overall Study|Lost to Follow-up|38|||
42341486|NCT01996904|76179815|FG001|Overall Study|Lost to Follow-up|27|||
42341487|NCT01970540|76179824|FG000|Overall Study|Non-treatment-related AE|0|||
42341488|NCT01970540|76179825|FG001|Overall Study|Non-treatment-related AE|0|||
42135491|NCT00269152|75946186|FG000|Overall Study|Adverse Event|9|||
42268607|NCT03194542|76097532|FG003|Overall Study|Progressive Disease|1|||
42268608|NCT03194542|76097529|FG000|Overall Study|Adverse Event|1|||
42268609|NCT03194542|76097530|FG001|Overall Study|Adverse Event|2|||
42268610|NCT03194542|76097531|FG002|Overall Study|Adverse Event|0|||
42341489|NCT01970540|76179826|FG002|Overall Study|Non-treatment-related AE|1|||
42341490|NCT01970540|76179824|FG000|Overall Study|Progressive disease|55|||
42341491|NCT01970540|76179825|FG001|Overall Study|Progressive disease|23|||
42341492|NCT01970540|76179826|FG002|Overall Study|Progressive disease|10|||
42341493|NCT01970540|76179824|FG000|Overall Study|Treatment delay over protocol|0|||
42341494|NCT01970540|76179825|FG001|Overall Study|Treatment delay over protocol|0|||
42341495|NCT01970540|76179826|FG002|Overall Study|Treatment delay over protocol|1|||
42341496|NCT01970540|76179824|FG000|Overall Study|Physician Decision|7|||
42341497|NCT01970540|76179825|FG001|Overall Study|Physician Decision|2|||
42341498|NCT01970540|76179826|FG002|Overall Study|Physician Decision|0|||
42341499|NCT01970540|76179824|FG000|Overall Study|Clinical progression|0|||
42341500|NCT01970540|76179825|FG001|Overall Study|Clinical progression|1|||
42341501|NCT01970540|76179826|FG002|Overall Study|Clinical progression|1|||
42341502|NCT01970540|76179824|FG000|Overall Study|End of study|2|||
42341503|NCT01970540|76179825|FG001|Overall Study|End of study|0|||
42341504|NCT01970540|76179826|FG002|Overall Study|End of study|2|||
42341505|NCT01970540|76179824|FG000|Overall Study|Adverse Event|0|||
42341506|NCT01970540|76179825|FG001|Overall Study|Adverse Event|2|||
42341507|NCT01970540|76179826|FG002|Overall Study|Adverse Event|1|||
42341508|NCT01970540|76179824|FG000|Overall Study|Treatment-related AE|4|||
42341509|NCT01970540|76179825|FG001|Overall Study|Treatment-related AE|0|||
42341510|NCT01970540|76179826|FG002|Overall Study|Treatment-related AE|2|||
42341511|NCT01970540|76179824|FG000|Overall Study|Withdrawal by Subject|4|||
42341512|NCT01970540|76179825|FG001|Overall Study|Withdrawal by Subject|0|||
42341513|NCT01970540|76179826|FG002|Overall Study|Withdrawal by Subject|1|||
42341514|NCT01970540|76179824|FG000|Overall Study|Clinical deterioration|1|||
42341515|NCT01970540|76179825|FG001|Overall Study|Clinical deterioration|0|||
42341516|NCT01970540|76179826|FG002|Overall Study|Clinical deterioration|0|||
42341517|NCT01963676|76179847|FG000|Overall Study|Withdrawal by Subject|1|||
42341518|NCT01963676|76179848|FG001|Overall Study|Withdrawal by Subject|0|||
42341519|NCT01996826|76179856|FG000|Overall Study|Lost to Follow-up|6|||
42268611|NCT03194542|76097532|FG003|Overall Study|Adverse Event|5|||
42268612|NCT03194542|76097529|FG000|Overall Study|Death|1|||
42268613|NCT03194542|76097530|FG001|Overall Study|Death|2|||
42268614|NCT03194542|76097531|FG002|Overall Study|Death|0|||
42135492|NCT00269152|75946187|FG001|Overall Study|Adverse Event|3|||
42268615|NCT03194542|76097532|FG003|Overall Study|Death|5|||
42268616|NCT03194542|76097529|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
42341520|NCT01996826|76179857|FG001|Overall Study|Lost to Follow-up|2|||
42341521|NCT01996826|76179856|FG000|Overall Study|Physician Decision|1|||
42341522|NCT01996826|76179857|FG001|Overall Study|Physician Decision|1|||
42341523|NCT01996748|76179865|FG000|Overall Study|Personal reason|1|||
42341524|NCT01996748|76179866|FG001|Overall Study|Personal reason|0|||
42341525|NCT01996748|76179865|FG000|Overall Study|Physician Decision|2|||
42341526|NCT01996748|76179866|FG001|Overall Study|Physician Decision|0|||
42341527|NCT01996748|76179865|FG000|Overall Study|Adverse Event|1|||
42004072|NCT01325207|75812077|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
42135493|NCT00269152|75946186|FG000|Overall Study|Withdrawal by Subject|7|||
42268617|NCT03194542|76097530|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
42268618|NCT03194542|76097531|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
42341528|NCT01996748|76179866|FG001|Overall Study|Adverse Event|4|||
42341529|NCT01996748|76179865|FG000|Overall Study|Withdrawal by Subject|0|||
42341530|NCT01996748|76179866|FG001|Overall Study|Withdrawal by Subject|1|||
42341531|NCT01996748|76179865|FG000|Overall Study|Lost to Follow-up|4|||
42341532|NCT01996748|76179866|FG001|Overall Study|Lost to Follow-up|1|||
42341533|NCT01621178|76179877|FG000|Overall Study|Adverse Event|5|||
42341534|NCT01621178|76179878|FG001|Overall Study|Adverse Event|2|||
42341535|NCT01621178|76179879|FG002|Overall Study|Adverse Event|8|||
42341536|NCT01621178|76179877|FG000|Overall Study|Death|6|||
42341537|NCT01621178|76179878|FG001|Overall Study|Death|7|||
42341538|NCT01621178|76179879|FG002|Overall Study|Death|2|||
42341539|NCT01621178|76179877|FG000|Overall Study|Lost to Follow-up|1|||
42341540|NCT01621178|76179878|FG001|Overall Study|Lost to Follow-up|2|||
42341541|NCT01621178|76179879|FG002|Overall Study|Lost to Follow-up|1|||
42341542|NCT01621178|76179877|FG000|Overall Study|Withdrawal by Subject|14|||
42341543|NCT01621178|76179878|FG001|Overall Study|Withdrawal by Subject|17|||
42341544|NCT01621178|76179879|FG002|Overall Study|Withdrawal by Subject|18|||
42341545|NCT01621178|76179877|FG000|Overall Study|Physician Decision|5|||
42341546|NCT01621178|76179878|FG001|Overall Study|Physician Decision|2|||
42341547|NCT01621178|76179879|FG002|Overall Study|Physician Decision|7|||
42268619|NCT03194542|76097532|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
42268620|NCT02362035|76097549|FG000|Overall Study|Death|67|||
42268621|NCT02362035|76097549|FG000|Overall Study|Lost to Follow-up|3|||
42268622|NCT02362035|76097549|FG000|Overall Study|Adverse Event|1|||
42268623|NCT02362035|76097549|FG000|Overall Study|Physician Decision|1|||
42268624|NCT02362035|76097549|FG000|Overall Study|Subject started another cancer therapy|10|||
42268625|NCT02362035|76097549|FG000|Overall Study|Study terminated by sponsor|45|||
42268626|NCT02362035|76097549|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
42268627|NCT02362035|76097549|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
42268628|NCT02362035|76097549|FG000|Overall Study|Disease progression|11|||
42268629|NCT02362035|76097549|FG000|Overall Study|Withdrawal by Subject|20|||
42268630|NCT02328014|76097557|FG000|Overall Study|Adverse Event|1|||
42268631|NCT02328014|76097558|FG001|Overall Study|Adverse Event|0|||
42268632|NCT02328014|76097559|FG002|Overall Study|Adverse Event|0|||
42268633|NCT02328014|76097560|FG003|Overall Study|Adverse Event|1|||
42268634|NCT02328014|76097557|FG000|Overall Study|Death|0|||
42268635|NCT02328014|76097558|FG001|Overall Study|Death|0|||
42268636|NCT02328014|76097559|FG002|Overall Study|Death|0|||
42268637|NCT02328014|76097560|FG003|Overall Study|Death|4|||
42268638|NCT02328014|76097557|FG000|Overall Study|Physician Decision|0|||
42268639|NCT02328014|76097558|FG001|Overall Study|Physician Decision|0|||
42268640|NCT02328014|76097559|FG002|Overall Study|Physician Decision|0|||
42268641|NCT02328014|76097560|FG003|Overall Study|Physician Decision|1|||
42341548|NCT01962974|76179891|FG000|Overall Study|Study termination|7|||
42341549|NCT01996592|76179895|FG000|Overall Study|no response to text/no diary entry|32|||
42004073|NCT01325207|75812078|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
42004074|NCT01325207|75812079|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
42004075|NCT01325207|75812080|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
42004076|NCT01325207|75812081|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
42004077|NCT01325207|75812082|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
42268642|NCT02328014|76097557|FG000|Overall Study|Disease Progression|1|||
42268643|NCT02328014|76097558|FG001|Overall Study|Disease Progression|0|||
42268644|NCT02328014|76097559|FG002|Overall Study|Disease Progression|1|||
42268645|NCT02328014|76097560|FG003|Overall Study|Disease Progression|3|||
42268646|NCT02328014|76097557|FG000|Overall Study|Study Terminated by Sponsor|4|||
42341550|NCT01996592|76179895|FG000|Overall Study|change in surgical date|4|||
42341551|NCT01996592|76179895|FG000|Overall Study|Withdrawal by Subject|5|||
42341552|NCT01996592|76179895|FG000|Overall Study|change in mode of delivery|4|||
42341553|NCT01962896|76179904|FG000|Overall Study|Lack of Efficacy|4|||
42341554|NCT01970462|76179911|FG000|Overall Study|Lost to Follow-up|0|||
42341555|NCT01970462|76179912|FG001|Overall Study|Lost to Follow-up|2|||
42341556|NCT01958671|76179921|FG000|Overall Study|Adverse Event|1|||
42341557|NCT01958671|76179922|FG001|Overall Study|Adverse Event|1|||
42341558|NCT01958671|76179923|FG002|Overall Study|Adverse Event|5|||
42341559|NCT01958671|76179921|FG000|Overall Study|Death|1|||
42341560|NCT01958671|76179922|FG001|Overall Study|Death|0|||
42341561|NCT01958671|76179923|FG002|Overall Study|Death|0|||
42341562|NCT01958671|76179921|FG000|Overall Study|Excluded medication|0|||
42004078|NCT01325207|75812077|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
42004079|NCT01325207|75812078|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
42268647|NCT02328014|76097558|FG001|Overall Study|Study Terminated by Sponsor|1|||
42268648|NCT02328014|76097559|FG002|Overall Study|Study Terminated by Sponsor|1|||
42268649|NCT02328014|76097560|FG003|Overall Study|Study Terminated by Sponsor|0|||
42268650|NCT02328014|76097557|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
42268651|NCT02328014|76097558|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
42268652|NCT02328014|76097559|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
42268653|NCT02328014|76097560|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
42268654|NCT02328014|76097557|FG000|Overall Study|Withdrawal by Subject|0|||
42341563|NCT01958671|76179922|FG001|Overall Study|Excluded medication|0|||
42035108|NCT01049412|75843395|FG000|Period I|Lost to Follow-up|2|||
42341564|NCT01958671|76179923|FG002|Overall Study|Excluded medication|1|||
42341565|NCT01958671|76179921|FG000|Overall Study|Hyperglycemia|0|||
42341566|NCT01958671|76179922|FG001|Overall Study|Hyperglycemia|0|||
42341567|NCT01958671|76179923|FG002|Overall Study|Hyperglycemia|2|||
42341568|NCT01958671|76179921|FG000|Overall Study|Lost to Follow-up|7|||
42341569|NCT01958671|76179922|FG001|Overall Study|Lost to Follow-up|11|||
42341570|NCT01958671|76179923|FG002|Overall Study|Lost to Follow-up|7|||
42341571|NCT01958671|76179921|FG000|Overall Study|Non-compliance with study drug|1|||
42341572|NCT01958671|76179922|FG001|Overall Study|Non-compliance with study drug|1|||
42341573|NCT01958671|76179923|FG002|Overall Study|Non-compliance with study drug|1|||
42341574|NCT01958671|76179921|FG000|Overall Study|Pregnancy|0|||
42341575|NCT01958671|76179922|FG001|Overall Study|Pregnancy|0|||
42341576|NCT01958671|76179923|FG002|Overall Study|Pregnancy|1|||
42341577|NCT01958671|76179921|FG000|Overall Study|Protocol Violation|0|||
42341578|NCT01958671|76179922|FG001|Overall Study|Protocol Violation|1|||
42341579|NCT01958671|76179923|FG002|Overall Study|Protocol Violation|0|||
42341580|NCT01958671|76179921|FG000|Overall Study|Study site terminated by sponsor|1|||
42341581|NCT01958671|76179922|FG001|Overall Study|Study site terminated by sponsor|0|||
42341582|NCT01958671|76179923|FG002|Overall Study|Study site terminated by sponsor|1|||
42341583|NCT01958671|76179921|FG000|Overall Study|Participant moved|0|||
42341584|NCT01958671|76179922|FG001|Overall Study|Participant moved|0|||
42341585|NCT01958671|76179923|FG002|Overall Study|Participant moved|1|||
42341586|NCT01958671|76179921|FG000|Overall Study|Withdrawal by Subject|8|||
42341587|NCT01958671|76179922|FG001|Overall Study|Withdrawal by Subject|10|||
42341588|NCT01958671|76179923|FG002|Overall Study|Withdrawal by Subject|13|||
42341589|NCT01995266|76179935|FG000|Overall Study|Death|1|||
42341590|NCT01995266|76179935|FG000|Overall Study|Lack of Efficacy|6|||
42341591|NCT01995266|76179935|FG000|Overall Study|Adverse Event|2|||
42341592|NCT01969058|76179941|FG000|Overall Study|Withdrawal by Subject|2|||
42341593|NCT01969058|76179942|FG001|Overall Study|Withdrawal by Subject|0|||
42341594|NCT01969058|76179941|FG000|Overall Study|Adverse Event|1|||
42341595|NCT01969058|76179942|FG001|Overall Study|Adverse Event|0|||
42341596|NCT01968980|76179950|FG000|Overall Study|Death|0|||
42341597|NCT01968980|76179951|FG001|Overall Study|Death|1|||
42341598|NCT01968980|76179950|FG000|Overall Study|Adverse Event|1|||
42341599|NCT01968980|76179951|FG001|Overall Study|Adverse Event|3|||
42341600|NCT01968980|76179950|FG000|Overall Study|Does not meet entry criteria|1|||
42341601|NCT01968980|76179951|FG001|Overall Study|Does not meet entry criteria|3|||
42341602|NCT01968980|76179950|FG000|Overall Study|Withdrawal by Subject|13|||
42341603|NCT01968980|76179951|FG001|Overall Study|Withdrawal by Subject|5|||
42341604|NCT01968980|76179950|FG000|Overall Study|Other unspecified|1|||
42341605|NCT01968980|76179951|FG001|Overall Study|Other unspecified|2|||
42341606|NCT01961882|76179960|FG000|Overall Study|Adverse Event|3|||
42341607|NCT01961882|76179961|FG001|Overall Study|Adverse Event|2|||
42341608|NCT01961882|76179960|FG000|Overall Study|Physician Decision|1|||
42341609|NCT01961882|76179961|FG001|Overall Study|Physician Decision|0|||
42341610|NCT01961882|76179960|FG000|Overall Study|Withdrawal by Subject|4|||
42341611|NCT01961882|76179961|FG001|Overall Study|Withdrawal by Subject|1|||
42341612|NCT01961882|76179960|FG000|Overall Study|Relapse of AML|39|||
42341613|NCT01961882|76179961|FG001|Overall Study|Relapse of AML|37|||
42341614|NCT01961882|76179960|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
42341615|NCT01961882|76179961|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
42341616|NCT01961882|76179960|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
42341617|NCT01961882|76179961|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
42341618|NCT01968434|76179969|FG000|Overall Study|Lost to Follow-up|3|||
42341619|NCT01968434|76179970|FG001|Overall Study|Lost to Follow-up|6|||
42341620|NCT01946438|76179980|FG000|Overall Study|Adverse Event|0|||
42341621|NCT01946438|76179981|FG001|Overall Study|Adverse Event|0|||
42341622|NCT01946438|76179982|FG002|Overall Study|Adverse Event|0|||
42341623|NCT01946438|76179983|FG003|Overall Study|Adverse Event|1|||
42341624|NCT01946438|76179980|FG000|Overall Study|Serious Adverse event|1|||
42341625|NCT01946438|76179981|FG001|Overall Study|Serious Adverse event|0|||
42341626|NCT01946438|76179982|FG002|Overall Study|Serious Adverse event|0|||
42341627|NCT01946438|76179983|FG003|Overall Study|Serious Adverse event|0|||
42341628|NCT01946438|76179980|FG000|Overall Study|Protocol Violation|0|||
42341629|NCT01946438|76179981|FG001|Overall Study|Protocol Violation|0|||
42341630|NCT01946438|76179982|FG002|Overall Study|Protocol Violation|1|||
42341631|NCT01946438|76179983|FG003|Overall Study|Protocol Violation|0|||
42341632|NCT01946438|76179980|FG000|Overall Study|Withdrawal by Subject|1|||
42341633|NCT01946438|76179981|FG001|Overall Study|Withdrawal by Subject|0|||
42341634|NCT01946438|76179982|FG002|Overall Study|Withdrawal by Subject|0|||
42341635|NCT01946438|76179983|FG003|Overall Study|Withdrawal by Subject|0|||
42341636|NCT01946282|76180002|FG000|Year 1|Did not return FIT kit|4186|||
42341637|NCT01946282|76180003|FG001|Year 1|Did not return FIT kit|608|||
42341638|NCT01946282|76180004|FG002|Year 1|Did not return FIT kit|654|||
42341639|NCT01946282|76180002|FG000|Year 2|Did not return FIT kit|803|||
42341640|NCT01946282|76180003|FG001|Year 2|Did not return FIT kit|131|||
42341641|NCT01946282|76180004|FG002|Year 2|Did not return FIT kit|115|||
42341642|NCT01946282|76180002|FG000|Year 3|Did not return FIT kit|288|||
42135494|NCT00269152|75946187|FG001|Overall Study|Withdrawal by Subject|3|||
42268655|NCT02328014|76097558|FG001|Overall Study|Withdrawal by Subject|0|||
42268656|NCT02328014|76097559|FG002|Overall Study|Withdrawal by Subject|0|||
42268657|NCT02328014|76097560|FG003|Overall Study|Withdrawal by Subject|1|||
42268658|NCT02213926|76097570|FG000|Overall Study|Death|59|||
42268659|NCT02213926|76097570|FG000|Overall Study|Withdrawal by Subject|10|||
42268660|NCT02213926|76097570|FG000|Overall Study|study terminated by sponsor|51|||
42268661|NCT02213926|76097570|FG000|Overall Study|Lost to Follow-up|3|||
42268662|NCT02213926|76097570|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
42268663|NCT01892085|76097577|FG000|Overall Study|Death|4|||
42268664|NCT01892085|76097578|FG001|Overall Study|Death|1|||
42341643|NCT01946282|76180003|FG001|Year 3|Did not return FIT kit|43|||
42341644|NCT01946282|76180004|FG002|Year 3|Did not return FIT kit|30|||
42341645|NCT01945580|76180016|FG000|Overall Study|Withdrawal by Subject|13|||
42341646|NCT01945580|76180017|FG001|Overall Study|Withdrawal by Subject|35|||
42341647|NCT01945580|76180016|FG000|Overall Study|Physician Decision|3|||
42341648|NCT01945580|76180017|FG001|Overall Study|Physician Decision|2|||
42341649|NCT01945580|76180016|FG000|Overall Study|Lost to Follow-up|26|||
42268665|NCT01892085|76097579|FG002|Overall Study|Death|3|||
42268666|NCT01892085|76097577|FG000|Overall Study|Withdrawal by Subject|2|||
42268667|NCT01892085|76097578|FG001|Overall Study|Withdrawal by Subject|0|||
42004080|NCT01325207|75812079|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
42341650|NCT01945580|76180017|FG001|Overall Study|Lost to Follow-up|39|||
42341651|NCT01945580|76180016|FG000|Overall Study|Death|7|||
42341652|NCT01945580|76180017|FG001|Overall Study|Death|2|||
42004081|NCT01325207|75812080|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
42004082|NCT01325207|75812081|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
42135495|NCT00269152|75946186|FG000|Overall Study|Physician Decision|2|||
42268668|NCT01892085|76097579|FG002|Overall Study|Withdrawal by Subject|2|||
42268669|NCT04510285|76097609|FG000|Overall Study|Death|1|||
42268670|NCT02576054|76097613|FG000|Overall Study|Withdrawal by Subject|1|||
42268671|NCT01606202|76097621|FG000|Overall Study|Adverse Event|5|||
42268672|NCT01606202|76097622|FG001|Overall Study|Adverse Event|0|||
42268673|NCT01606202|76097621|FG000|Overall Study|Withdrawal by Subject|2|||
42268674|NCT01606202|76097622|FG001|Overall Study|Withdrawal by Subject|1|||
42268675|NCT01606202|76097621|FG000|Overall Study|Personal problems|0|||
42268676|NCT01606202|76097622|FG001|Overall Study|Personal problems|1|||
42268677|NCT01606202|76097621|FG000|Overall Study|Problems with administration|0|||
42268678|NCT01606202|76097622|FG001|Overall Study|Problems with administration|1|||
42268679|NCT01493960|76097630|FG000|Overall Study|Adverse Event|0|||
42341653|NCT01945580|76180016|FG000|Overall Study|Patient moved out of state|0|||
42341654|NCT01945580|76180017|FG001|Overall Study|Patient moved out of state|1|||
42341655|NCT01945580|76180016|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
42341656|NCT01945580|76180017|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
42341657|NCT01945580|76180016|FG000|Overall Study|Family illness - unable to return|0|||
42341658|NCT01945580|76180017|FG001|Overall Study|Family illness - unable to return|1|||
42341659|NCT01945580|76180016|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
42341660|NCT01945580|76180017|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
42341661|NCT01945580|76180016|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
42341662|NCT01945580|76180017|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
42341663|NCT01945580|76180016|FG000|Overall Study|Noncompliance with 36 month visit|1|||
42341664|NCT01945580|76180017|FG001|Overall Study|Noncompliance with 36 month visit|0|||
42341665|NCT01945580|76180016|FG000|Overall Study|The patient moved.|1|||
42341666|NCT01945580|76180017|FG001|Overall Study|The patient moved.|0|||
42341667|NCT01945580|76180016|FG000|Overall Study|No data available|0|||
42341668|NCT01945580|76180017|FG001|Overall Study|No data available|2|||
42341669|NCT01945034|76180030|FG000|Overall Study|Medication Error|0|||
42341670|NCT01945034|76180031|FG001|Overall Study|Medication Error|1|||
42341671|NCT01945034|76180032|FG002|Overall Study|Medication Error|0|||
42341672|NCT01945034|76180030|FG000|Overall Study|Withdrawal by Subject|0|||
42341673|NCT01945034|76180031|FG001|Overall Study|Withdrawal by Subject|3|||
42341674|NCT01945034|76180032|FG002|Overall Study|Withdrawal by Subject|1|||
42341675|NCT01945034|76180030|FG000|Overall Study|Other|0|||
42341676|NCT01945034|76180031|FG001|Overall Study|Other|1|||
42341677|NCT01945034|76180032|FG002|Overall Study|Other|3|||
42341678|NCT01945034|76180030|FG000|Overall Study|Lost to Follow-up|0|||
42341679|NCT01945034|76180031|FG001|Overall Study|Lost to Follow-up|0|||
42341680|NCT01945034|76180032|FG002|Overall Study|Lost to Follow-up|2|||
42341681|NCT01945034|76180030|FG000|Overall Study|Protocol Violation|1|||
42341682|NCT01945034|76180031|FG001|Overall Study|Protocol Violation|0|||
42341683|NCT01945034|76180032|FG002|Overall Study|Protocol Violation|1|||
42341684|NCT01960790|76180040|FG000|Overall Study|Survey forms could not be recovered|3|||
42341685|NCT01960790|76180040|FG000|Overall Study|Treat with Humira outside survey period|3|||
42341686|NCT01960790|76180040|FG000|Overall Study|Transferred to another hospital|4|||
42341687|NCT01960790|76180040|FG000|Overall Study|Unevaluable for safety|1|||
42341688|NCT01618214|76180046|FG000|Overall Study|Adverse Event|3|||
42341689|NCT01618214|76180047|FG001|Overall Study|Adverse Event|1|||
42341690|NCT01618214|76180046|FG000|Overall Study|Lack of Efficacy|1|||
42341691|NCT01618214|76180047|FG001|Overall Study|Lack of Efficacy|1|||
42341692|NCT01618214|76180046|FG000|Overall Study|Protocol Violation|1|||
42341693|NCT01618214|76180047|FG001|Overall Study|Protocol Violation|4|||
42341694|NCT01618214|76180046|FG000|Overall Study|Withdrawal Criteria|1|||
42341695|NCT01618214|76180047|FG001|Overall Study|Withdrawal Criteria|2|||
42341696|NCT01618214|76180046|FG000|Overall Study|Unclassified|4|||
42341697|NCT01618214|76180047|FG001|Overall Study|Unclassified|5|||
42341698|NCT01917968|76180055|FG000|Overall Study|Death|3|||
42341699|NCT01917968|76180056|FG001|Overall Study|Death|2|||
42341700|NCT01917968|76180055|FG000|Overall Study|Lost to Follow-up|21|||
42135496|NCT00269152|75946187|FG001|Overall Study|Physician Decision|3|||
42341701|NCT01917968|76180056|FG001|Overall Study|Lost to Follow-up|39|||
42341702|NCT01917968|76180055|FG000|Overall Study|Physician Decision|1|||
42341703|NCT01917968|76180056|FG001|Overall Study|Physician Decision|2|||
42341704|NCT01917968|76180055|FG000|Overall Study|Withdrawal by Subject|20|||
42341705|NCT01917968|76180056|FG001|Overall Study|Withdrawal by Subject|35|||
42341706|NCT01917968|76180055|FG000|Overall Study|Subject Relocation|5|||
42268680|NCT01493960|76097631|FG001|Overall Study|Adverse Event|1|||
42135497|NCT00269152|75946186|FG000|Overall Study|Protocol Violation|0|||
42268681|NCT01493960|76097630|FG000|Overall Study|Lack of Efficacy|15|||
42268682|NCT01493960|76097631|FG001|Overall Study|Lack of Efficacy|9|||
42268683|NCT01493960|76097630|FG000|Overall Study|Protocol Violation|3|||
42268684|NCT01493960|76097631|FG001|Overall Study|Protocol Violation|0|||
42268685|NCT01493960|76097630|FG000|Overall Study|Withdrawal by Subject|10|||
42268686|NCT01493960|76097631|FG001|Overall Study|Withdrawal by Subject|4|||
42268687|NCT01493960|76097630|FG000|Overall Study|Non-specified|4|||
42268688|NCT01493960|76097631|FG001|Overall Study|Non-specified|4|||
42268689|NCT02630459|76097641|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
42268690|NCT02630459|76097642|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
42268691|NCT02630459|76097643|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
42268692|NCT02630459|76097644|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
42268693|NCT02630459|76097645|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
42268694|NCT02630459|76097646|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
42268695|NCT02630459|76097647|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
42268696|NCT02630459|76097648|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
42268697|NCT02630459|76097641|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
42268698|NCT02630459|76097642|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
42268699|NCT02630459|76097643|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
42268700|NCT02630459|76097644|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
42268701|NCT02630459|76097645|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
42268702|NCT02630459|76097646|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
42268703|NCT02630459|76097647|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
42268704|NCT02630459|76097648|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
42268705|NCT02630459|76097641|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
42268706|NCT02630459|76097642|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
42268707|NCT02630459|76097643|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
42268708|NCT02630459|76097644|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
42268709|NCT02630459|76097645|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
42268710|NCT02630459|76097646|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
42268711|NCT02630459|76097647|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
42268712|NCT02630459|76097648|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
42268713|NCT02630459|76097641|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
42268714|NCT02630459|76097642|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
42268715|NCT02630459|76097643|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
42268716|NCT02630459|76097644|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
42268717|NCT02630459|76097645|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
42268718|NCT02630459|76097646|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
42268719|NCT02630459|76097647|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
42268720|NCT02630459|76097648|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
42268721|NCT02630459|76097641|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
42268722|NCT02630459|76097642|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
42268723|NCT02630459|76097643|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
42268724|NCT02630459|76097644|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
42268725|NCT02630459|76097645|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
42268726|NCT02630459|76097646|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
42268727|NCT02630459|76097647|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
42268728|NCT02630459|76097648|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
42268729|NCT02630459|76097641|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
42268730|NCT02630459|76097642|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
42268731|NCT02630459|76097643|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
42268732|NCT02630459|76097644|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
42268733|NCT02630459|76097645|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
42268734|NCT02630459|76097646|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
42268735|NCT02630459|76097647|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
42268736|NCT02630459|76097648|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
42341707|NCT01917968|76180056|FG001|Overall Study|Subject Relocation|1|||
42341708|NCT01917968|76180055|FG000|Overall Study|36M Missed Visit|3|||
42341709|NCT01917968|76180056|FG001|Overall Study|36M Missed Visit|2|||
42341710|NCT01917968|76180055|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
42341711|NCT01917968|76180056|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
42341712|NCT01917968|76180055|FG000|Overall Study|Change in Family Circumstances|0|||
42341713|NCT01917968|76180056|FG001|Overall Study|Change in Family Circumstances|1|||
42341714|NCT01917968|76180055|FG000|Overall Study|No Data Available|0|||
42341715|NCT01917968|76180056|FG001|Overall Study|No Data Available|2|||
42341716|NCT01917656|76180071|FG000|Overall Study|Adverse Event|11|||
42341717|NCT01917656|76180072|FG001|Overall Study|Adverse Event|0|||
42341718|NCT01917656|76180071|FG000|Overall Study|Withdrawal criteria|8|||
42341719|NCT01917656|76180072|FG001|Overall Study|Withdrawal criteria|14|||
42341720|NCT01917656|76180071|FG000|Overall Study|Unclassified|0|||
42341721|NCT01917656|76180072|FG001|Overall Study|Unclassified|3|||
42341722|NCT01917656|76180071|FG000|Overall Study|Withdrawal by Subject|4|||
42341723|NCT01917656|76180072|FG001|Overall Study|Withdrawal by Subject|3|||
42341724|NCT01917656|76180071|FG000|Overall Study|Lost to Follow-up|3|||
42341725|NCT01917656|76180072|FG001|Overall Study|Lost to Follow-up|4|||
42341726|NCT01944722|76180080|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
42341727|NCT01944722|76180080|FG000|Overall Study|Specimen Shipping Issues|34|||
42341728|NCT01944722|76180080|FG000|Overall Study|Improper Storage/Transport|5|||
42341729|NCT01944722|76180080|FG000|Overall Study|Insufficient Volume for Test|1|||
42341730|NCT01944722|76180080|FG000|Overall Study|Missing Specimens|3|||
42341731|NCT01944722|76180080|FG000|Overall Study|Specimens Mislabeled|2|||
42341732|NCT01944722|76180080|FG000|Overall Study|Withdrawal by Subject|8|||
42341733|NCT01944722|76180080|FG000|Overall Study|NILM Subjects <30 years old|8106|||
42341734|NCT01944722|76180080|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
42341735|NCT01944722|76180080|FG000|Overall Study|>ASCUS Cytology|1122|||
42341736|NCT01917344|76180089|FG000|Overall Study|Withdrawal by Subject|1|||
42341737|NCT02017535|76180097|FG000|Overall Study|Withdrawal by Subject|1|||
42341738|NCT02017535|76180098|FG001|Overall Study|Withdrawal by Subject|0|||
42341739|NCT02017535|76180099|FG002|Overall Study|Withdrawal by Subject|0|||
42341740|NCT02017535|76180100|FG003|Overall Study|Withdrawal by Subject|0|||
42341741|NCT01944098|76180112|FG000|Overall Study|Physician Decision|1|||
42341742|NCT01944098|76180113|FG001|Overall Study|Physician Decision|0|||
42341743|NCT02017223|76180119|FG000|Overall Study|Algorithm problems|2|||
42341744|NCT01944020|76180125|FG000|Overall Study|Withdrawal by Subject|5|||
42341745|NCT01944020|76180126|FG001|Overall Study|Withdrawal by Subject|0|||
42341746|NCT01943552|76180134|FG000|Overall Study|Adverse Event|3|||
42341747|NCT01943552|76180135|FG001|Overall Study|Adverse Event|2|||
42341748|NCT01943552|76180134|FG000|Overall Study|Withdrawal by Subject|6|||
42341749|NCT01943552|76180135|FG001|Overall Study|Withdrawal by Subject|6|||
42341750|NCT01943552|76180134|FG000|Overall Study|Other Reasons|16|||
42341751|NCT01943552|76180135|FG001|Overall Study|Other Reasons|17|||
42341752|NCT01915940|76180143|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
42341753|NCT01915940|76180144|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
42341754|NCT01915940|76180145|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
42341755|NCT01915940|76180143|FG000|Treatment Period|Decision of Participant|0|||
42341756|NCT01915940|76180144|FG001|Treatment Period|Decision of Participant|1|||
42341757|NCT01915940|76180145|FG002|Treatment Period|Decision of Participant|3|||
42341758|NCT01915940|76180143|FG000|Treatment Period|Adverse Event|0|||
42341759|NCT01915940|76180144|FG001|Treatment Period|Adverse Event|9|||
42341760|NCT01915940|76180145|FG002|Treatment Period|Adverse Event|1|||
42341761|NCT01915940|76180143|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
42341762|NCT01915940|76180144|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
42341763|NCT01915940|76180145|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
42341764|NCT01914926|76180153|FG000|Overall Study|Adverse Event|1|||
42341765|NCT01914926|76180154|FG001|Overall Study|Adverse Event|0|||
42341766|NCT01914926|76180153|FG000|Overall Study|uncooperative, agitated and removed|0|||
42341767|NCT01914926|76180154|FG001|Overall Study|uncooperative, agitated and removed|1|||
42341768|NCT02016755|76180160|FG000|Overall Study|Major amputation of index limb|2|||
42341769|NCT02016755|76180160|FG000|Overall Study|Adverse Event|2|||
42341770|NCT02016755|76180160|FG000|Overall Study|Physician Decision|1|||
42341771|NCT02016755|76180160|FG000|Overall Study|Death|2|||
42341772|NCT01942148|76180164|FG000|Overall Study|Adverse Event|4|||
42341773|NCT01942148|76180164|FG000|Overall Study|Lack of Efficacy|2|||
42341774|NCT01942148|76180164|FG000|Overall Study|Physician Decision|11|||
42035109|NCT01049412|75843396|FG001|Period I|Lost to Follow-up|2|||
42035110|NCT01049412|75843395|FG000|Period I|Physician Decision|0|||
42341775|NCT01942148|76180164|FG000|Overall Study|Protocol Violation|1|||
42341776|NCT01942148|76180164|FG000|Overall Study|Withdrawal by Subject|8|||
42341777|NCT01942148|76180164|FG000|Overall Study|Use of the prohibition medicine|1|||
42341778|NCT02030015|76180168|FG000|Overall Study|Withdrawal by Subject|3|||
42341779|NCT02030015|76180168|FG000|Overall Study|Death|13|||
42341780|NCT02029235|76180174|FG000|Overall Study|Non-compliance with study meds or diary|4|||
42341781|NCT02029235|76180175|FG001|Overall Study|Non-compliance with study meds or diary|1|||
42341782|NCT01617434|76180183|FG000|Overall Study|Adverse Event|12|||
42341783|NCT01617434|76180184|FG001|Overall Study|Adverse Event|3|||
42341784|NCT01617434|76180183|FG000|Overall Study|Protocol Violation|8|||
42341785|NCT01617434|76180184|FG001|Overall Study|Protocol Violation|7|||
42341786|NCT01617434|76180183|FG000|Overall Study|Withdrawal Criteria|12|||
42341787|NCT01617434|76180184|FG001|Overall Study|Withdrawal Criteria|37|||
42341788|NCT01617434|76180183|FG000|Overall Study|Unclassified|3|||
42341789|NCT01617434|76180184|FG001|Overall Study|Unclassified|4|||
42341790|NCT01940900|76180192|FG000|Overall Study|Physician Decision|4|||
42341791|NCT01940900|76180193|FG001|Overall Study|Physician Decision|0|||
42341792|NCT01940900|76180192|FG000|Overall Study|Adverse Event|10|||
42341793|NCT01940900|76180193|FG001|Overall Study|Adverse Event|15|||
42341794|NCT01940900|76180192|FG000|Overall Study|Withdrawal by Subject|11|||
42341795|NCT01940900|76180193|FG001|Overall Study|Withdrawal by Subject|15|||
42341796|NCT01940900|76180192|FG000|Overall Study|Lost to Follow-up|1|||
42341797|NCT01940900|76180193|FG001|Overall Study|Lost to Follow-up|0|||
42341798|NCT01940900|76180192|FG000|Overall Study|Sponsor Decision|1|||
42341799|NCT01940900|76180193|FG001|Overall Study|Sponsor Decision|0|||
42341800|NCT01940900|76180192|FG000|Overall Study|subject non-compliance|1|||
42341801|NCT01940900|76180193|FG001|Overall Study|subject non-compliance|1|||
42341802|NCT01940900|76180192|FG000|Overall Study|other|1|||
42341803|NCT01940900|76180193|FG001|Overall Study|other|0|||
42341804|NCT01940354|76180201|FG000|Overall Study|Withdrawal by Subject|4|||
42341805|NCT01940354|76180202|FG001|Overall Study|Withdrawal by Subject|2|||
42341806|NCT01940120|76180208|FG000|Overall Study|Death|40|||
42341807|NCT01940120|76180208|FG000|Overall Study|Withdrawal by Subject|8|||
42341808|NCT01911260|76180217|FG000|Supplementation Period|transference or evasion of school|7|||
42341809|NCT01911260|76180218|FG001|Supplementation Period|transference or evasion of school|9|||
42341810|NCT01911260|76180219|FG002|Supplementation Period|transference or evasion of school|7|||
42341811|NCT01911260|76180220|FG003|Supplementation Period|transference or evasion of school|6|||
42341812|NCT01911260|76180217|FG000|Supplementation Period|Adverse Event|2|||
42341813|NCT01911260|76180218|FG001|Supplementation Period|Adverse Event|0|||
42341814|NCT01911260|76180219|FG002|Supplementation Period|Adverse Event|1|||
42035111|NCT01049412|75843396|FG001|Period I|Physician Decision|3|||
42035112|NCT01049412|75843395|FG000|Period I|Protocol Violation|1|||
42035113|NCT01049412|75843396|FG001|Period I|Protocol Violation|2|||
42035114|NCT01049412|75843395|FG000|Period I|Adverse Event|1|||
42035115|NCT01049412|75843396|FG001|Period I|Adverse Event|0|||
42035116|NCT01049412|75843395|FG000|Period II|Withdrawal by Subject|2|||
42035117|NCT01049412|75843396|FG001|Period II|Withdrawal by Subject|3|||
42341815|NCT01911260|76180220|FG003|Supplementation Period|Adverse Event|0|||
42341816|NCT01911260|76180217|FG000|Supplementation Period|refused to receive supplement|1|||
42341817|NCT01911260|76180218|FG001|Supplementation Period|refused to receive supplement|0|||
42341818|NCT01911260|76180219|FG002|Supplementation Period|refused to receive supplement|1|||
42341819|NCT01911260|76180220|FG003|Supplementation Period|refused to receive supplement|0|||
42341820|NCT01911260|76180217|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
42341821|NCT01911260|76180218|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
42341822|NCT01911260|76180219|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
42341823|NCT01911260|76180220|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
42341824|NCT01911260|76180217|FG000|Follow-up Period|transference or evasion of school|13|||
42341825|NCT01911260|76180218|FG001|Follow-up Period|transference or evasion of school|20|||
42341826|NCT01911260|76180219|FG002|Follow-up Period|transference or evasion of school|15|||
42341827|NCT01911260|76180220|FG003|Follow-up Period|transference or evasion of school|12|||
42341828|NCT02015819|76180234|FG000|Overall Study|Rickham catheter was misaligned|0|||
42268737|NCT02630459|76097641|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
42268738|NCT02630459|76097642|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
42268739|NCT02630459|76097643|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
42268740|NCT02630459|76097644|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
42268741|NCT02630459|76097645|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
42268742|NCT02630459|76097646|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
42268743|NCT02630459|76097647|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
42268744|NCT02630459|76097648|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
42268745|NCT02573948|76097673|FG000|Longitudinal Cohort|Death|9|||
42268746|NCT02573948|76097673|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
42268747|NCT02573948|76097673|FG000|Longitudinal Cohort|Incarcerated|25|||
42268748|NCT01464593|76097680|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
42268749|NCT05279131|76097684|FG000|Overall Study|Lost to Follow-up|1|||
42268750|NCT05279131|76097684|FG000|Overall Study|Death|1|||
42268751|NCT05279131|76097684|FG000|Overall Study|Physician Decision|1|||
42268752|NCT05028517|76097695|FG000|Overall Study|Lost to Follow-up|13|||
42268753|NCT05028517|76097696|FG001|Overall Study|Lost to Follow-up|20|||
42268754|NCT05028517|76097697|FG002|Overall Study|Lost to Follow-up|12|||
42268755|NCT05028517|76097695|FG000|Overall Study|Withdrawal by Subject|0|||
42268756|NCT05028517|76097696|FG001|Overall Study|Withdrawal by Subject|0|||
42268757|NCT05028517|76097697|FG002|Overall Study|Withdrawal by Subject|1|||
42268758|NCT04390243|76097718|FG000|Overall Study|Death|1|||
42268759|NCT04390243|76097718|FG000|Overall Study|Disease Progression|4|||
42268760|NCT04390243|76097718|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
42268761|NCT04363944|76097724|FG000|Overall Study|Withdrawal by Subject|2|||
42268762|NCT04363944|76097725|FG001|Overall Study|Withdrawal by Subject|0|||
42268763|NCT04335110|76097738|FG000|Overall Study|Withdrawal by Subject|1|||
42268764|NCT04335110|76097739|FG001|Overall Study|Withdrawal by Subject|1|||
42268765|NCT04335110|76097738|FG000|Overall Study|Death|0|||
42268766|NCT04335110|76097739|FG001|Overall Study|Death|1|||
42268767|NCT04156620|76097755|FG000|Overall Study|Adverse event - TP 1|5|||
42268768|NCT04156620|76097756|FG001|Overall Study|Adverse event - TP 1|2|||
42268769|NCT04156620|76097755|FG000|Overall Study|Lost to follow-up TP 1|1|||
42268770|NCT04156620|76097756|FG001|Overall Study|Lost to follow-up TP 1|1|||
42268771|NCT04156620|76097755|FG000|Overall Study|Progressive disease - TP 1|0|||
42268772|NCT04156620|76097756|FG001|Overall Study|Progressive disease - TP 1|1|||
42268773|NCT04156620|76097755|FG000|Overall Study|Subject decision - TP 1|3|||
42268774|NCT04156620|76097756|FG001|Overall Study|Subject decision - TP 1|5|||
42268775|NCT04156620|76097755|FG000|Overall Study|Adverse event - TP 2|5|||
42268776|NCT04156620|76097756|FG001|Overall Study|Adverse event - TP 2|6|||
42268777|NCT04156620|76097755|FG000|Overall Study|Death - TP 2|1|||
42268778|NCT04156620|76097756|FG001|Overall Study|Death - TP 2|0|||
42268779|NCT04156620|76097755|FG000|Overall Study|Lost to follow-up - TP 2|5|||
42268780|NCT04156620|76097756|FG001|Overall Study|Lost to follow-up - TP 2|2|||
42268781|NCT04156620|76097755|FG000|Overall Study|Physician decision - TP 2|4|||
42268782|NCT04156620|76097756|FG001|Overall Study|Physician decision - TP 2|2|||
42268783|NCT04156620|76097755|FG000|Overall Study|Pregnancy - TP 2|1|||
42268784|NCT04156620|76097756|FG001|Overall Study|Pregnancy - TP 2|1|||
42268785|NCT04156620|76097755|FG000|Overall Study|Subject decision - TP 2|11|||
42268786|NCT04156620|76097756|FG001|Overall Study|Subject decision - TP 2|9|||
42268787|NCT04156620|76097755|FG000|Overall Study|New therapy for study indication - TP 2|1|||
42268788|NCT04156620|76097756|FG001|Overall Study|New therapy for study indication - TP 2|0|||
42268789|NCT03816332|76097766|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
42268790|NCT03816332|76097766|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
42004083|NCT01325207|75812082|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
42341829|NCT02015819|76180235|FG001|Overall Study|Rickham catheter was misaligned|0|||
42341830|NCT02015819|76180236|FG002|Overall Study|Rickham catheter was misaligned|0|||
42341831|NCT02015819|76180237|FG003|Overall Study|Rickham catheter was misaligned|1|||
42341832|NCT01939496|76180254|FG000|Overall Study|Adverse Event|2|||
42341833|NCT01939496|76180255|FG001|Overall Study|Adverse Event|0|||
42341834|NCT01939496|76180256|FG002|Overall Study|Adverse Event|0|||
42341835|NCT01939496|76180254|FG000|Overall Study|Lost to Follow-up|1|||
42341836|NCT01939496|76180255|FG001|Overall Study|Lost to Follow-up|1|||
42341837|NCT01939496|76180256|FG002|Overall Study|Lost to Follow-up|0|||
42341838|NCT01939496|76180254|FG000|Overall Study|Physician Decision|1|||
42341839|NCT01939496|76180255|FG001|Overall Study|Physician Decision|0|||
42341840|NCT01939496|76180256|FG002|Overall Study|Physician Decision|0|||
42341841|NCT01939496|76180254|FG000|Overall Study|Protocol Violation|3|||
42341842|NCT01939496|76180255|FG001|Overall Study|Protocol Violation|0|||
42341843|NCT01939496|76180256|FG002|Overall Study|Protocol Violation|0|||
42341844|NCT01939496|76180254|FG000|Overall Study|Withdrawal by Subject|0|||
42341845|NCT01939496|76180255|FG001|Overall Study|Withdrawal by Subject|1|||
42004084|NCT01325207|75812077|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
42341846|NCT01939496|76180256|FG002|Overall Study|Withdrawal by Subject|1|||
42341847|NCT01939496|76180254|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
42341848|NCT01939496|76180255|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
42341849|NCT01939496|76180256|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
42135498|NCT00269152|75946187|FG001|Overall Study|Protocol Violation|1|||
42341850|NCT01939496|76180254|FG000|Overall Study|Other|2|||
42341851|NCT01939496|76180255|FG001|Overall Study|Other|0|||
42341852|NCT01939496|76180256|FG002|Overall Study|Other|1|||
42341853|NCT01939028|76180264|FG000|Overall Study|Withdrawal by Subject|5|||
42341854|NCT01939028|76180264|FG000|Overall Study|Physician Decision|7|||
42341855|NCT01938716|76180268|FG000|Overall Study|Physician Decision|2|||
42341856|NCT01938716|76180268|FG000|Overall Study|Withdrawal by Subject|2|||
42341857|NCT01937390|76180272|FG000|Overall Study|Death|2|||
42341858|NCT01937390|76180272|FG000|Overall Study|Lost to Follow-up|7|||
42341859|NCT01937390|76180272|FG000|Overall Study|Withdrawal by Subject|5|||
42341860|NCT01937390|76180272|FG000|Overall Study|Fail to return|21|||
42341861|NCT02028767|76180276|FG000|Treatment Period 2|Non compliant with protocol|1|||
42341862|NCT02028767|76180277|FG001|Treatment Period 2|Non compliant with protocol|0|||
42341863|NCT02028767|76180276|FG000|Treatment Period 2|Reason other than those specified above|1|||
42341864|NCT02028767|76180277|FG001|Treatment Period 2|Reason other than those specified above|0|||
42341865|NCT01959932|76180286|FG000|Overall Study|Withdrawal by Subject|1|||
42341866|NCT01959932|76180287|FG001|Overall Study|Withdrawal by Subject|0|||
42341867|NCT01959932|76180288|FG002|Overall Study|Withdrawal by Subject|0|||
42135499|NCT00379899|75946195|FG000|Overall Study|Adverse Event|7|||
42135500|NCT00379899|75946196|FG001|Overall Study|Adverse Event|3|||
42135501|NCT00379899|75946195|FG000|Overall Study|Death|10|||
42135502|NCT00379899|75946196|FG001|Overall Study|Death|10|||
42341868|NCT02028065|76180300|FG000|Randomization Through Start Treatment|Not treated|1|||
42004085|NCT01325207|75812078|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
42135503|NCT00379899|75946195|FG000|Overall Study|Lost to Follow-up|2|||
42135504|NCT00379899|75946196|FG001|Overall Study|Lost to Follow-up|4|||
42341869|NCT02028065|76180301|FG001|Randomization Through Start Treatment|Not treated|3|||
42004086|NCT01325207|75812079|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
42135505|NCT00379899|75946195|FG000|Overall Study|Physician Decision|3|||
42004087|NCT01325207|75812080|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
42135506|NCT00379899|75946196|FG001|Overall Study|Physician Decision|4|||
42135507|NCT00379899|75946195|FG000|Overall Study|Withdrawal by Subject|5|||
42341870|NCT02028065|76180302|FG002|Randomization Through Start Treatment|Not treated|3|||
42341871|NCT02028065|76180300|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
42341872|NCT02028065|76180301|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
42341873|NCT02028065|76180302|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
42341874|NCT02028065|76180300|FG000|Treatment Through Study Completion|Physician Decision|1|||
42341875|NCT02028065|76180301|FG001|Treatment Through Study Completion|Physician Decision|0|||
42341876|NCT02028065|76180302|FG002|Treatment Through Study Completion|Physician Decision|0|||
42341877|NCT02028065|76180300|FG000|Treatment Through Study Completion|Protocol Violation|1|||
42341878|NCT02028065|76180301|FG001|Treatment Through Study Completion|Protocol Violation|4|||
42341879|NCT02028065|76180302|FG002|Treatment Through Study Completion|Protocol Violation|0|||
42135508|NCT00379899|75946196|FG001|Overall Study|Withdrawal by Subject|5|||
42341880|NCT02028065|76180300|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
42341881|NCT02028065|76180301|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
42341882|NCT02028065|76180302|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
42341883|NCT02028065|76180300|FG000|Treatment Through Study Completion|Adverse Event|3|||
42341884|NCT02028065|76180301|FG001|Treatment Through Study Completion|Adverse Event|3|||
42341885|NCT02028065|76180302|FG002|Treatment Through Study Completion|Adverse Event|5|||
42341886|NCT02015195|76180317|FG000|Overall Study|Adverse Event|0|||
42341887|NCT02015195|76180318|FG001|Overall Study|Adverse Event|0|||
42341888|NCT02015195|76180319|FG002|Overall Study|Adverse Event|0|||
42341889|NCT02015195|76180320|FG003|Overall Study|Adverse Event|1|||
42341890|NCT02015195|76180321|FG004|Overall Study|Adverse Event|0|||
42341891|NCT02015195|76180322|FG005|Overall Study|Adverse Event|0|||
42341892|NCT02015195|76180323|FG006|Overall Study|Adverse Event|0|||
42341893|NCT02015039|76180340|FG000|Overall Study|Not eligible|0|||
42341894|NCT02015039|76180341|FG001|Overall Study|Not eligible|1|||
42341895|NCT02025725|76180349|FG000|Overall Study|Adverse Event|5|||
42341896|NCT02025725|76180350|FG001|Overall Study|Adverse Event|0|||
42341897|NCT02025725|76180349|FG000|Overall Study|Lost to Follow-up|2|||
42341898|NCT02025725|76180350|FG001|Overall Study|Lost to Follow-up|0|||
42341899|NCT02025725|76180349|FG000|Overall Study|Protocol Violation|1|||
42341900|NCT02025725|76180350|FG001|Overall Study|Protocol Violation|1|||
42341901|NCT02025725|76180349|FG000|Overall Study|Withdrawal by Subject|3|||
42341902|NCT02025725|76180350|FG001|Overall Study|Withdrawal by Subject|2|||
42341903|NCT02025725|76180349|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
42341904|NCT02025725|76180350|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
42341905|NCT02025179|76180361|FG000|Overall Study|Lost to Follow-up|0|||
42341906|NCT02025179|76180362|FG001|Overall Study|Lost to Follow-up|0|||
42341907|NCT02025179|76180363|FG002|Overall Study|Lost to Follow-up|1|||
42341908|NCT02013791|76180380|FG000|Period 1|Lost to Follow-up|0|||
42341909|NCT02013791|76180381|FG001|Period 1|Lost to Follow-up|0|||
42341910|NCT02013791|76180382|FG002|Period 1|Lost to Follow-up|0|||
42341911|NCT02013791|76180383|FG003|Period 1|Lost to Follow-up|1|||
42341912|NCT02013791|76180384|FG004|Period 1|Lost to Follow-up|0|||
42341913|NCT02013791|76180385|FG005|Period 1|Lost to Follow-up|0|||
42341914|NCT02013791|76180386|FG006|Period 1|Lost to Follow-up|1|||
42341915|NCT02013791|76180387|FG007|Period 1|Lost to Follow-up|1|||
42341916|NCT02013791|76180388|FG008|Period 1|Lost to Follow-up|0|||
42341917|NCT02013791|76180380|FG000|Period 1|Other Miscellaneous Reasons|0|||
42341918|NCT02013791|76180381|FG001|Period 1|Other Miscellaneous Reasons|2|||
42341919|NCT02013791|76180382|FG002|Period 1|Other Miscellaneous Reasons|0|||
42341920|NCT02013791|76180383|FG003|Period 1|Other Miscellaneous Reasons|0|||
42341921|NCT02013791|76180384|FG004|Period 1|Other Miscellaneous Reasons|0|||
42341922|NCT02013791|76180385|FG005|Period 1|Other Miscellaneous Reasons|0|||
42341923|NCT02013791|76180386|FG006|Period 1|Other Miscellaneous Reasons|0|||
42341924|NCT02013791|76180387|FG007|Period 1|Other Miscellaneous Reasons|0|||
42341925|NCT02013791|76180388|FG008|Period 1|Other Miscellaneous Reasons|0|||
42341926|NCT02024867|76180411|FG000|Overall Study|Protocol Violation|3|||
42341927|NCT02024867|76180412|FG001|Overall Study|Protocol Violation|3|||
42341928|NCT02024867|76180411|FG000|Overall Study|Lost to Follow-up|6|||
42341929|NCT02024867|76180412|FG001|Overall Study|Lost to Follow-up|4|||
42341930|NCT01953601|76180421|FG000|Part 1 (Base Study)|Adverse Event|24|||
42341931|NCT01953601|76180422|FG001|Part 1 (Base Study)|Adverse Event|37|||
42341932|NCT01953601|76180423|FG002|Part 1 (Base Study)|Adverse Event|15|||
42341933|NCT01953601|76180421|FG000|Part 1 (Base Study)|Death|2|||
42341934|NCT01953601|76180422|FG001|Part 1 (Base Study)|Death|0|||
42341935|NCT01953601|76180423|FG002|Part 1 (Base Study)|Death|3|||
42341936|NCT01953601|76180421|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
42341937|NCT01953601|76180422|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
42341938|NCT01953601|76180423|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
42341939|NCT01953601|76180421|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
42341940|NCT01953601|76180422|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
42341941|NCT01953601|76180423|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
42341942|NCT01953601|76180421|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
42341943|NCT01953601|76180422|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
42341944|NCT01953601|76180423|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
42341945|NCT01953601|76180421|FG000|Part 1 (Base Study)|Physician Decision|3|||
42035118|NCT01049412|75843395|FG000|Period II|Adverse Event|1|||
42135509|NCT00379899|75946195|FG000|Overall Study|Ineligibility determined|0|||
42135510|NCT00379899|75946196|FG001|Overall Study|Ineligibility determined|1|||
42135511|NCT00379899|75946195|FG000|Overall Study|Noncompliance|1|||
42135512|NCT00379899|75946196|FG001|Overall Study|Noncompliance|1|||
42135513|NCT00379899|75946195|FG000|Overall Study|Parathyroidectomy|0|||
42135514|NCT00379899|75946196|FG001|Overall Study|Parathyroidectomy|2|||
42135515|NCT00379899|75946195|FG000|Overall Study|Renal transplantation|5|||
42135516|NCT00379899|75946196|FG001|Overall Study|Renal transplantation|4|||
42135517|NCT00379899|75946195|FG000|Overall Study|Coronary artery bypass graft|1|||
42341946|NCT01953601|76180422|FG001|Part 1 (Base Study)|Physician Decision|7|||
42341947|NCT01953601|76180423|FG002|Part 1 (Base Study)|Physician Decision|4|||
42035119|NCT01049412|75843396|FG001|Period II|Adverse Event|0|||
42035120|NCT01049412|75843395|FG000|Period II|Lost to Follow-up|1|||
42268791|NCT03621189|76097783|FG000|Overall Study|Withdrawal by Subject|0|||
42268792|NCT03621189|76097784|FG001|Overall Study|Withdrawal by Subject|3|||
42268793|NCT03621189|76097783|FG000|Overall Study|Physician Decision|0|||
42268794|NCT03621189|76097784|FG001|Overall Study|Physician Decision|2|||
42268795|NCT03486834|76097794|FG000|Overall Study|Withdrawal by Subject|46|||
42268796|NCT03486834|76097795|FG001|Overall Study|Withdrawal by Subject|46|||
42268797|NCT03486834|76097796|FG002|Overall Study|Withdrawal by Subject|52|||
42268798|NCT03486834|76097794|FG000|Overall Study|Adverse Event|8|||
42268799|NCT03486834|76097795|FG001|Overall Study|Adverse Event|7|||
42268800|NCT03486834|76097796|FG002|Overall Study|Adverse Event|0|||
42268801|NCT03486834|76097794|FG000|Overall Study|Lost to Follow-up|41|||
42341948|NCT01953601|76180421|FG000|Part 1 (Base Study)|Screen failure|1|||
42341949|NCT01953601|76180422|FG001|Part 1 (Base Study)|Screen failure|0|||
42341950|NCT01953601|76180423|FG002|Part 1 (Base Study)|Screen failure|1|||
42035121|NCT01049412|75843396|FG001|Period II|Lost to Follow-up|0|||
42035122|NCT00934089|75843406|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
42035123|NCT00934089|75843407|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
42035124|NCT00934089|75843406|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
42035125|NCT00934089|75843407|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
42035126|NCT01032174|75843415|FG000|Overall Study|Adverse Event|0|||
42035127|NCT01032174|75843416|FG001|Overall Study|Adverse Event|1|||
42035128|NCT00933933|75843427|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
42035129|NCT00933933|75843428|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
42035130|NCT00933933|75843429|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
42135518|NCT00379899|75946196|FG001|Overall Study|Coronary artery bypass graft|1|||
42135519|NCT00379899|75946195|FG000|Overall Study|Other protocol-specified criteria|3|||
42135520|NCT00379899|75946196|FG001|Overall Study|Other protocol-specified criteria|4|||
42268802|NCT03486834|76097795|FG001|Overall Study|Lost to Follow-up|24|||
42341951|NCT01953601|76180421|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
42341952|NCT01953601|76180422|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
42341953|NCT01953601|76180423|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
42341954|NCT01953601|76180421|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
42341955|NCT01953601|76180422|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
42341956|NCT01953601|76180423|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
42341957|NCT01953601|76180421|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
42341958|NCT01953601|76180422|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
42341959|NCT01953601|76180423|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
42341960|NCT01953601|76180421|FG000|Part 1 (Base Study)|Subject moved|2|||
42341961|NCT01953601|76180422|FG001|Part 1 (Base Study)|Subject moved|2|||
42341962|NCT01953601|76180423|FG002|Part 1 (Base Study)|Subject moved|1|||
42341963|NCT01953601|76180421|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
42341964|NCT01953601|76180422|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
42341965|NCT01953601|76180423|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
42341966|NCT01953601|76180421|FG000|Part 2 (Extension Study)|Adverse Event|1|||
42341967|NCT01953601|76180422|FG001|Part 2 (Extension Study)|Adverse Event|1|||
42341968|NCT01953601|76180423|FG002|Part 2 (Extension Study)|Adverse Event|10|||
42341969|NCT01953601|76180421|FG000|Part 2 (Extension Study)|Death|0|||
42341970|NCT01953601|76180422|FG001|Part 2 (Extension Study)|Death|3|||
42341971|NCT01953601|76180423|FG002|Part 2 (Extension Study)|Death|0|||
42341972|NCT01953601|76180421|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
42341973|NCT01953601|76180422|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
42341974|NCT01953601|76180423|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
42341975|NCT01953601|76180421|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
42341976|NCT01953601|76180422|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
42341977|NCT01953601|76180423|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
42341978|NCT01953601|76180421|FG000|Part 2 (Extension Study)|Physician Decision|2|||
42268803|NCT03486834|76097796|FG002|Overall Study|Lost to Follow-up|39|||
42268804|NCT03486834|76097794|FG000|Overall Study|Non-compliance with Study Drug|2|||
42268805|NCT03486834|76097795|FG001|Overall Study|Non-compliance with Study Drug|2|||
42341979|NCT01953601|76180422|FG001|Part 2 (Extension Study)|Physician Decision|0|||
42341980|NCT01953601|76180423|FG002|Part 2 (Extension Study)|Physician Decision|2|||
42341981|NCT01953601|76180421|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
42341982|NCT01953601|76180422|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
42341983|NCT01953601|76180423|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
42341984|NCT01953601|76180421|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
42341985|NCT01953601|76180422|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
42341986|NCT01953601|76180423|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
42341987|NCT01953601|76180421|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
42135521|NCT00379899|75946195|FG000|Overall Study|Other|3|||
42268806|NCT03486834|76097796|FG002|Overall Study|Non-compliance with Study Drug|0|||
42268807|NCT03486834|76097794|FG000|Overall Study|Physician Decision|5|||
42268808|NCT03486834|76097795|FG001|Overall Study|Physician Decision|2|||
42268809|NCT03486834|76097796|FG002|Overall Study|Physician Decision|3|||
42268810|NCT03486834|76097794|FG000|Overall Study|Pregnancy|10|||
42268811|NCT03486834|76097795|FG001|Overall Study|Pregnancy|12|||
42268812|NCT03486834|76097796|FG002|Overall Study|Pregnancy|12|||
42268813|NCT03486834|76097794|FG000|Overall Study|Protocol Deviation|2|||
42341988|NCT01953601|76180422|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
42341989|NCT01953601|76180423|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
42341990|NCT01953601|76180421|FG000|Part 2 (Extension Study)|Subject moved|0|||
42341991|NCT01953601|76180422|FG001|Part 2 (Extension Study)|Subject moved|0|||
42341992|NCT01953601|76180423|FG002|Part 2 (Extension Study)|Subject moved|1|||
42341993|NCT01953601|76180421|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
42341994|NCT01953601|76180422|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
42341995|NCT01953601|76180423|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
42341996|NCT01952665|76180436|FG000|Overall Study|Physician Decision|3|||
42341997|NCT01952665|76180437|FG001|Overall Study|Physician Decision|2|||
42341998|NCT01952665|76180436|FG000|Overall Study|Lost to Follow-up|1|||
42341999|NCT01952665|76180437|FG001|Overall Study|Lost to Follow-up|2|||
42342000|NCT01952665|76180436|FG000|Overall Study|Adverse Event|2|||
42342001|NCT01952665|76180437|FG001|Overall Study|Adverse Event|1|||
42342002|NCT01952665|76180436|FG000|Overall Study|Protocol Violation|0|||
42342003|NCT01952665|76180437|FG001|Overall Study|Protocol Violation|1|||
42342004|NCT01952041|76180448|FG000|Overall Study|Lost to Follow-up|9|||
42342005|NCT01952041|76180449|FG001|Overall Study|Lost to Follow-up|16|||
42342006|NCT01952041|76180448|FG000|Overall Study|Withdrawal by Subject|7|||
42342007|NCT01952041|76180449|FG001|Overall Study|Withdrawal by Subject|5|||
42342008|NCT01952041|76180448|FG000|Overall Study|Death|1|||
42342009|NCT01952041|76180449|FG001|Overall Study|Death|0|||
42342010|NCT01951573|76180455|FG000|Washout Period|Adverse Event|0|||
42342011|NCT01951573|76180456|FG001|Washout Period|Adverse Event|1|||
42342012|NCT02023697|76180465|FG000|Treatment Period|Radiological progression|13|||
42342013|NCT02023697|76180466|FG001|Treatment Period|Radiological progression|17|||
42342014|NCT02023697|76180467|FG002|Treatment Period|Radiological progression|26|||
42342015|NCT02023697|76180465|FG000|Treatment Period|Never Treated|5|||
42342016|NCT02023697|76180466|FG001|Treatment Period|Never Treated|6|||
42342017|NCT02023697|76180467|FG002|Treatment Period|Never Treated|10|||
42342018|NCT02023697|76180465|FG000|Treatment Period|Adverse Event|13|||
42342019|NCT02023697|76180466|FG001|Treatment Period|Adverse Event|25|||
42342020|NCT02023697|76180467|FG002|Treatment Period|Adverse Event|23|||
42342021|NCT02023697|76180465|FG000|Treatment Period|Logistical difficulties|1|||
42342022|NCT02023697|76180466|FG001|Treatment Period|Logistical difficulties|1|||
42342023|NCT02023697|76180467|FG002|Treatment Period|Logistical difficulties|1|||
42342024|NCT02023697|76180465|FG000|Treatment Period|Clinical progression|10|||
42342025|NCT02023697|76180466|FG001|Treatment Period|Clinical progression|8|||
42342026|NCT02023697|76180467|FG002|Treatment Period|Clinical progression|28|||
42342027|NCT02023697|76180465|FG000|Treatment Period|Withdrawal by Subject|4|||
42342028|NCT02023697|76180466|FG001|Treatment Period|Withdrawal by Subject|5|||
42342029|NCT02023697|76180467|FG002|Treatment Period|Withdrawal by Subject|13|||
42342030|NCT02023697|76180465|FG000|Treatment Period|Safety outcome reached|0|||
42342031|NCT02023697|76180466|FG001|Treatment Period|Safety outcome reached|1|||
42342032|NCT02023697|76180467|FG002|Treatment Period|Safety outcome reached|0|||
42342033|NCT02023697|76180465|FG000|Treatment Period|Physician Decision|0|||
42342034|NCT02023697|76180466|FG001|Treatment Period|Physician Decision|0|||
42135522|NCT00379899|75946196|FG001|Overall Study|Other|1|||
42342035|NCT02023697|76180467|FG002|Treatment Period|Physician Decision|1|||
42342036|NCT02023697|76180465|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
42342037|NCT02023697|76180466|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
42135523|NCT00371787|75946204|FG000|Overall Study|Withdrawal by Subject|3|||
42135524|NCT00371787|75946205|FG001|Overall Study|Withdrawal by Subject|1|||
42268814|NCT03486834|76097795|FG001|Overall Study|Protocol Deviation|3|||
42342038|NCT02023697|76180467|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
42342039|NCT02023697|76180465|FG000|Active Follow-up Period|Lost to Follow-up|1|||
42342040|NCT02023697|76180466|FG001|Active Follow-up Period|Lost to Follow-up|1|||
42342041|NCT02023697|76180467|FG002|Active Follow-up Period|Lost to Follow-up|1|||
42004088|NCT01325207|75812081|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
42004089|NCT01325207|75812082|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
42004090|NCT01325207|75812077|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
42004091|NCT01325207|75812078|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
42004092|NCT01325207|75812079|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
42004093|NCT01325207|75812080|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
42004094|NCT01325207|75812081|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
42342042|NCT02023697|76180465|FG000|Active Follow-up Period|Deterioration of general condition|1|||
42342043|NCT02023697|76180466|FG001|Active Follow-up Period|Deterioration of general condition|1|||
42342044|NCT02023697|76180467|FG002|Active Follow-up Period|Deterioration of general condition|1|||
42342045|NCT02023697|76180465|FG000|Active Follow-up Period|Other unspecified|2|||
42342046|NCT02023697|76180466|FG001|Active Follow-up Period|Other unspecified|0|||
42342047|NCT02023697|76180467|FG002|Active Follow-up Period|Other unspecified|1|||
42342048|NCT02023697|76180465|FG000|Active Follow-up Period|Clinical progression|0|||
42342049|NCT02023697|76180466|FG001|Active Follow-up Period|Clinical progression|2|||
42342050|NCT02023697|76180467|FG002|Active Follow-up Period|Clinical progression|1|||
42342051|NCT02023697|76180465|FG000|Active Follow-up Period|Radiological progression|0|||
42342052|NCT02023697|76180466|FG001|Active Follow-up Period|Radiological progression|0|||
42342053|NCT02023697|76180467|FG002|Active Follow-up Period|Radiological progression|1|||
42342054|NCT02023697|76180465|FG000|Active Follow-up Period|Death|83|||
42004095|NCT01325207|75812082|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
42342055|NCT02023697|76180466|FG001|Active Follow-up Period|Death|82|||
42004096|NCT01325207|75812077|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
42268815|NCT03486834|76097796|FG002|Overall Study|Protocol Deviation|3|||
42268816|NCT03486834|76097794|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
42268817|NCT03486834|76097795|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
42268818|NCT03486834|76097796|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
42268819|NCT03486834|76097794|FG000|Overall Study|Randomized but not treated|4|||
42342056|NCT02023697|76180467|FG002|Active Follow-up Period|Death|87|||
42342057|NCT02023697|76180465|FG000|Long-term Follow-up Period|Death|9|||
42342058|NCT02023697|76180466|FG001|Long-term Follow-up Period|Death|6|||
42342059|NCT02023697|76180467|FG002|Long-term Follow-up Period|Death|4|||
42342060|NCT02023697|76180465|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
42342061|NCT02023697|76180466|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
42342062|NCT02023697|76180467|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
42342063|NCT02023697|76180465|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
42342064|NCT02023697|76180466|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
42268820|NCT03486834|76097795|FG001|Overall Study|Randomized but not treated|4|||
42268821|NCT03486834|76097796|FG002|Overall Study|Randomized but not treated|1|||
42268822|NCT03356145|76097812|FG000|Overall Study|Withdrawal by Subject|2|||
42268823|NCT03356145|76097813|FG001|Overall Study|Withdrawal by Subject|1|||
42342065|NCT02023697|76180467|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
42342066|NCT02023697|76180465|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
42342067|NCT02023697|76180466|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
42342068|NCT02023697|76180467|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
42342069|NCT02023697|76180465|FG000|Long-term Follow-up Period|Technical problems|0|||
42342070|NCT02023697|76180466|FG001|Long-term Follow-up Period|Technical problems|0|||
42342071|NCT02023697|76180467|FG002|Long-term Follow-up Period|Technical problems|1|||
42342072|NCT02023697|76180465|FG000|Long-term Follow-up Period|Other unspecified|6|||
42342073|NCT02023697|76180466|FG001|Long-term Follow-up Period|Other unspecified|3|||
42342074|NCT02023697|76180467|FG002|Long-term Follow-up Period|Other unspecified|5|||
42342075|NCT01951417|76180482|FG000|Overall Study|Withdrawal by Subject|1|||
42342076|NCT01951417|76180482|FG000|Overall Study|Protocol Violation|2|||
42342077|NCT01951417|76180482|FG000|Overall Study|Lost to Follow-up|6|||
42342078|NCT01951261|76180492|FG000|Overall Study|Death|1|||
42342079|NCT01951261|76180493|FG001|Overall Study|Death|0|||
42342080|NCT01951261|76180492|FG000|Overall Study|Lost to Follow-up|4|||
42342081|NCT01951261|76180493|FG001|Overall Study|Lost to Follow-up|3|||
42342082|NCT01951261|76180492|FG000|Overall Study|Protocol Violation|4|||
42342083|NCT01951261|76180493|FG001|Overall Study|Protocol Violation|3|||
42342084|NCT02023151|76180499|FG000|Overall Study|Lost to Follow-up|4|||
42342085|NCT01979185|76180505|FG000|Period 2|Other|0|||
42342086|NCT01979185|76180506|FG001|Period 2|Other|1|||
42342087|NCT01946425|76180514|FG000|Overall Study|Protocol Violation|1|||
42342088|NCT01946425|76180515|FG001|Overall Study|Protocol Violation|0|||
42342089|NCT01946425|76180514|FG000|Overall Study|Withdrawal by Subject|1|||
42342090|NCT01946425|76180515|FG001|Overall Study|Withdrawal by Subject|0|||
42342091|NCT01946191|76180524|FG000|Allocation|Did not complete orientation|1|||
42342092|NCT01946191|76180525|FG001|Allocation|Did not complete orientation|1|||
42268824|NCT03356145|76097812|FG000|Overall Study|Did not meet inclusion criteria|1|||
42342093|NCT01946191|76180524|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
42342094|NCT01946191|76180525|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
42342095|NCT01946191|76180524|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
42342096|NCT01946191|76180525|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
42342097|NCT01946191|76180524|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
42135525|NCT00363129|75946213|FG000|Overall Study|Withdrawal by Subject|11|||
42342098|NCT01946191|76180525|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
42342099|NCT01937312|76180534|FG000|Overall Study|Adverse Event|10|||
42342100|NCT01937312|76180535|FG001|Overall Study|Adverse Event|1|||
42342101|NCT01937312|76180534|FG000|Overall Study|Lack of Efficacy|0|||
42342102|NCT01937312|76180535|FG001|Overall Study|Lack of Efficacy|1|||
42342103|NCT01937312|76180534|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
42342104|NCT01937312|76180535|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
42342105|NCT01935128|76180542|FG000|Overall Study|Death|1|||
42342106|NCT01935128|76180542|FG000|Overall Study|Adverse Event|6|||
42342107|NCT01934972|76180548|FG000|Overall Study|Withdrawal by Subject|9|||
42342108|NCT01934972|76180549|FG001|Overall Study|Withdrawal by Subject|6|||
42342109|NCT01959230|76180557|FG000|Overall Study|Failure to follow study procedures|0|||
42342110|NCT01959230|76180558|FG001|Overall Study|Failure to follow study procedures|1|||
42342111|NCT01959230|76180557|FG000|Overall Study|Administrative reasons|2|||
42342112|NCT01959230|76180558|FG001|Overall Study|Administrative reasons|0|||
42342113|NCT01959230|76180557|FG000|Overall Study|Withdrawal by Subject|2|||
42342114|NCT01959230|76180558|FG001|Overall Study|Withdrawal by Subject|0|||
42342115|NCT01909778|76180564|FG000|Overall Study|failed screening|1|||
42342116|NCT01977937|76180572|FG000|Overall Study|Withdrawal by Subject|2|||
42342117|NCT01977937|76180573|FG001|Overall Study|Withdrawal by Subject|1|||
42342118|NCT01977937|76180572|FG000|Overall Study|Adverse Event|1|||
42342119|NCT01977937|76180573|FG001|Overall Study|Adverse Event|0|||
42342120|NCT01977937|76180572|FG000|Overall Study|Physician Decision|0|||
42342121|NCT01977937|76180573|FG001|Overall Study|Physician Decision|1|||
42342122|NCT02015663|76180581|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
42342123|NCT02015663|76180582|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
42342124|NCT02015663|76180581|FG000|Overall Study|Withdrawal by Subject|1|||
42342125|NCT02015663|76180582|FG001|Overall Study|Withdrawal by Subject|0|||
42342126|NCT02015663|76180581|FG000|Overall Study|Protocol Violation|0|||
42342127|NCT02015663|76180582|FG001|Overall Study|Protocol Violation|1|||
42342128|NCT02015663|76180581|FG000|Overall Study|Adverse Event|3|||
42342129|NCT02015663|76180582|FG001|Overall Study|Adverse Event|0|||
42342130|NCT02015663|76180581|FG000|Overall Study|Administrative problems|10|||
42342131|NCT02015663|76180582|FG001|Overall Study|Administrative problems|11|||
42342132|NCT01978093|76180591|FG000|Overall Study|Death|1|||
42342133|NCT01978093|76180592|FG001|Overall Study|Death|0|||
42342134|NCT01978093|76180591|FG000|Overall Study|Adverse Event|0|||
42342135|NCT01978093|76180592|FG001|Overall Study|Adverse Event|5|||
42342136|NCT01978093|76180591|FG000|Overall Study|Protocol Violation|8|||
42342137|NCT01978093|76180592|FG001|Overall Study|Protocol Violation|2|||
42342138|NCT01978093|76180591|FG000|Overall Study|Withdrawal by Subject|29|||
42342139|NCT01978093|76180592|FG001|Overall Study|Withdrawal by Subject|25|||
42342140|NCT01978093|76180591|FG000|Overall Study|Lost to Follow-up|11|||
42342141|NCT01978093|76180592|FG001|Overall Study|Lost to Follow-up|15|||
42342142|NCT01978093|76180591|FG000|Overall Study|Migrated/moved from study area|11|||
42342143|NCT01978093|76180592|FG001|Overall Study|Migrated/moved from study area|13|||
42342144|NCT01978093|76180591|FG000|Overall Study|Loss of kaiser coverage|4|||
42342145|NCT01978093|76180592|FG001|Overall Study|Loss of kaiser coverage|10|||
42342146|NCT01978093|76180591|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
42342147|NCT01978093|76180592|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
42342148|NCT01978093|76180591|FG000|Overall Study|Mother lost custody of child|0|||
42342149|NCT01978093|76180592|FG001|Overall Study|Mother lost custody of child|1|||
42342150|NCT01978093|76180591|FG000|Overall Study|Child was in care of grandmother|0|||
42342151|NCT01978093|76180592|FG001|Overall Study|Child was in care of grandmother|1|||
42342152|NCT01978093|76180591|FG000|Overall Study|N/A for vaccine administration|0|||
42342153|NCT01978093|76180592|FG001|Overall Study|N/A for vaccine administration|1|||
42342154|NCT01951105|76180604|FG000|Overall Study|Adverse Event|0|||
42342155|NCT01951105|76180605|FG001|Overall Study|Adverse Event|5|||
42342156|NCT01951105|76180606|FG002|Overall Study|Adverse Event|0|||
42342157|NCT01951105|76180604|FG000|Overall Study|Lost to Follow-up|0|||
42036449|NCT01017120|75844852|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
42268825|NCT03356145|76097813|FG001|Overall Study|Did not meet inclusion criteria|0|||
42268826|NCT03312738|76097821|FG000|Overall Study|Progressive disease|58|||
42268827|NCT03312738|76097822|FG001|Overall Study|Progressive disease|67|||
42268828|NCT03312738|76097821|FG000|Overall Study|Patient/guardian decision|13|||
42268829|NCT03312738|76097822|FG001|Overall Study|Patient/guardian decision|5|||
42268830|NCT03312738|76097821|FG000|Overall Study|Adverse Event|5|||
42268831|NCT03312738|76097822|FG001|Overall Study|Adverse Event|3|||
42268832|NCT03312738|76097821|FG000|Overall Study|Protocol deviation|2|||
42268833|NCT03312738|76097822|FG001|Overall Study|Protocol deviation|0|||
42268834|NCT03312738|76097821|FG000|Overall Study|Technical problems|0|||
42135526|NCT00363129|75946214|FG001|Overall Study|Withdrawal by Subject|18|||
42135527|NCT00363129|75946213|FG000|Overall Study|Adverse Event|8|||
42135528|NCT00363129|75946214|FG001|Overall Study|Adverse Event|3|||
42135529|NCT00363129|75946213|FG000|Overall Study|Alternate Treatment|2|||
42135530|NCT00363129|75946214|FG001|Overall Study|Alternate Treatment|4|||
42135531|NCT00363129|75946213|FG000|Overall Study|Other Medical Problems|2|||
42135532|NCT00363129|75946214|FG001|Overall Study|Other Medical Problems|4|||
42135533|NCT00363129|75946213|FG000|Overall Study|Death|0|||
42135534|NCT00363129|75946214|FG001|Overall Study|Death|1|||
42135535|NCT00363129|75946213|FG000|Overall Study|Other Reasons|6|||
42135536|NCT00363129|75946214|FG001|Overall Study|Other Reasons|3|||
42135537|NCT00268996|75946222|FG000|Overall Study|Adverse Event|11|||
42268835|NCT03312738|76097822|FG001|Overall Study|Technical problems|1|||
42268836|NCT03312738|76097821|FG000|Overall Study|Physician Decision|2|||
42268837|NCT03312738|76097822|FG001|Overall Study|Physician Decision|3|||
42268838|NCT03268954|76097832|FG000|Overall Study|Ongoing|23|||
42268839|NCT03268954|76097833|FG001|Overall Study|Ongoing|31|||
42268840|NCT03268954|76097832|FG000|Overall Study|Adverse Event|53|||
42268841|NCT03268954|76097833|FG001|Overall Study|Adverse Event|62|||
42268842|NCT03268954|76097832|FG000|Overall Study|Withdrawal by Subject|25|||
42268843|NCT03268954|76097833|FG001|Overall Study|Withdrawal by Subject|16|||
42268844|NCT03268954|76097832|FG000|Overall Study|Progressive Disease|61|||
42135538|NCT00268996|75946223|FG001|Overall Study|Adverse Event|7|||
42135539|NCT00268996|75946222|FG000|Overall Study|Lost to Follow-up|3|||
42135540|NCT00268996|75946223|FG001|Overall Study|Lost to Follow-up|1|||
42135541|NCT00268996|75946222|FG000|Overall Study|Withdrawal by Subject|5|||
42342158|NCT01951105|76180605|FG001|Overall Study|Lost to Follow-up|1|||
42342159|NCT01951105|76180606|FG002|Overall Study|Lost to Follow-up|0|||
42342160|NCT01951105|76180604|FG000|Overall Study|Protocol Violation|1|||
42342161|NCT01951105|76180605|FG001|Overall Study|Protocol Violation|1|||
42342162|NCT01951105|76180606|FG002|Overall Study|Protocol Violation|1|||
42342163|NCT01951105|76180604|FG000|Overall Study|Withdrawal by Subject|0|||
42342164|NCT01951105|76180605|FG001|Overall Study|Withdrawal by Subject|3|||
42342165|NCT01951105|76180606|FG002|Overall Study|Withdrawal by Subject|1|||
42342166|NCT01958918|76180622|FG000|Overall Study|Death|1|||
42342167|NCT01958918|76180623|FG001|Overall Study|Death|3|||
42342168|NCT01958918|76180622|FG000|Overall Study|Lost to Follow-up|4|||
42342169|NCT01958918|76180623|FG001|Overall Study|Lost to Follow-up|7|||
42342170|NCT01958918|76180622|FG000|Overall Study|Withdrawal by Subject|13|||
42342171|NCT01958918|76180623|FG001|Overall Study|Withdrawal by Subject|8|||
42342172|NCT01958918|76180622|FG000|Overall Study|Lack of Efficacy|13|||
42342173|NCT01958918|76180623|FG001|Overall Study|Lack of Efficacy|10|||
42342174|NCT01958918|76180622|FG000|Overall Study|Adverse Event|12|||
42342175|NCT01958918|76180623|FG001|Overall Study|Adverse Event|12|||
42342176|NCT01958918|76180622|FG000|Overall Study|administrative problems|0|||
42342177|NCT01958918|76180623|FG001|Overall Study|administrative problems|2|||
42342178|NCT01945489|76180631|FG000|Cycle 1|Adverse Event|2|||
42342179|NCT01945489|76180632|FG001|Cycle 1|Adverse Event|0|||
42342180|NCT01945489|76180631|FG000|Cycle 1|Lost to Follow-up|4|||
42342181|NCT01945489|76180632|FG001|Cycle 1|Lost to Follow-up|0|||
42342182|NCT01945489|76180631|FG000|Cycle 1|Personal Reasons|4|||
42342183|NCT01945489|76180632|FG001|Cycle 1|Personal Reasons|2|||
42342184|NCT01945489|76180631|FG000|Cycle 1|Protocol Violation|0|||
42342185|NCT01945489|76180632|FG001|Cycle 1|Protocol Violation|1|||
42342186|NCT01945489|76180631|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
42342187|NCT01945489|76180632|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
42342188|NCT01945489|76180631|FG000|Cycle 2|Adverse Event|1|||
42342189|NCT01945489|76180632|FG001|Cycle 2|Adverse Event|0|||
42342190|NCT01945489|76180631|FG000|Cycle 2|Lost to Follow-up|0|||
42342191|NCT01945489|76180632|FG001|Cycle 2|Lost to Follow-up|1|||
42342192|NCT01934894|76180641|FG000|Overall Study|Adverse Event|1|||
42342193|NCT01934894|76180642|FG001|Overall Study|Adverse Event|2|||
42342194|NCT01934894|76180641|FG000|Overall Study|Death|2|||
42342195|NCT01934894|76180642|FG001|Overall Study|Death|0|||
42342196|NCT01934894|76180641|FG000|Overall Study|Withdrawal by Subject|0|||
42342197|NCT01934894|76180642|FG001|Overall Study|Withdrawal by Subject|1|||
42342198|NCT01934894|76180641|FG000|Overall Study|Progressive Disease|3|||
42342199|NCT01934894|76180642|FG001|Overall Study|Progressive Disease|2|||
42342200|NCT01950169|76180654|FG000|Overall Study|Withdrawal by Subject|2|||
42342201|NCT01950169|76180655|FG001|Overall Study|Withdrawal by Subject|8|||
42342202|NCT01950169|76180656|FG002|Overall Study|Withdrawal by Subject|1|||
42342203|NCT01950169|76180654|FG000|Overall Study|Death|1|||
42342204|NCT01950169|76180655|FG001|Overall Study|Death|0|||
42342205|NCT01950169|76180656|FG002|Overall Study|Death|0|||
42342206|NCT01934504|76180669|FG000|Overall Study|Protocol Deviation|0|||
42342207|NCT01934504|76180670|FG001|Overall Study|Protocol Deviation|0|||
42342208|NCT01934504|76180671|FG002|Overall Study|Protocol Deviation|0|||
42342209|NCT01934504|76180672|FG003|Overall Study|Protocol Deviation|2|||
42342210|NCT01934504|76180669|FG000|Overall Study|Study Terminated by Sponsor|1|||
42342211|NCT01934504|76180670|FG001|Overall Study|Study Terminated by Sponsor|0|||
42342212|NCT01934504|76180671|FG002|Overall Study|Study Terminated by Sponsor|5|||
42135542|NCT00268996|75946223|FG001|Overall Study|Withdrawal by Subject|11|||
42135543|NCT00268996|75946222|FG000|Overall Study|Non-compliance|1|||
42135544|NCT00268996|75946223|FG001|Overall Study|Non-compliance|0|||
42342213|NCT01934504|76180672|FG003|Overall Study|Study Terminated by Sponsor|5|||
42342214|NCT01950013|76180685|FG000|Overall Study|Withdrawal by Subject|0|||
42342215|NCT01950013|76180686|FG001|Overall Study|Withdrawal by Subject|2|||
42342216|NCT01950013|76180687|FG002|Overall Study|Withdrawal by Subject|0|||
42342217|NCT01949155|76180697|FG000|Overall Study|Lost to Follow-up|1|||
42342218|NCT01949155|76180698|FG001|Overall Study|Lost to Follow-up|0|||
42342219|NCT01949155|76180697|FG000|Overall Study|Protocol Violation|1|||
42342220|NCT01949155|76180698|FG001|Overall Study|Protocol Violation|0|||
42342221|NCT01909466|76180705|FG000|Overall Study|Lost to Follow-up|5|||
42342222|NCT01909466|76180706|FG001|Overall Study|Lost to Follow-up|7|||
42342223|NCT01909466|76180705|FG000|Overall Study|Adverse Event|3|||
42342224|NCT01909466|76180706|FG001|Overall Study|Adverse Event|4|||
42342225|NCT01909466|76180705|FG000|Overall Study|Met Withdrawal Criteria|0|||
42342226|NCT01909466|76180706|FG001|Overall Study|Met Withdrawal Criteria|3|||
42342227|NCT01909466|76180705|FG000|Overall Study|Physician Decision|2|||
42342228|NCT01909466|76180706|FG001|Overall Study|Physician Decision|0|||
42342229|NCT01909466|76180705|FG000|Overall Study|Withdrawal by Subject|11|||
42342230|NCT01909466|76180706|FG001|Overall Study|Withdrawal by Subject|9|||
42342231|NCT01909466|76180705|FG000|Overall Study|Lack of Efficacy|1|||
42342232|NCT01909466|76180706|FG001|Overall Study|Lack of Efficacy|0|||
42342233|NCT01977625|76180710|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
42342234|NCT01977625|76180711|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
42342235|NCT01977625|76180710|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
42342236|NCT01977625|76180711|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
42342237|NCT01944631|76180721|FG000|Overall Study|Adverse Event|1|||
42342238|NCT01944631|76180722|FG001|Overall Study|Adverse Event|0|||
42342239|NCT01944631|76180721|FG000|Overall Study|Lost to Follow-up|3|||
42004097|NCT01325207|75812078|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
42004098|NCT01325207|75812079|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
42004099|NCT01325207|75812080|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
42004100|NCT01325207|75812081|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
42342240|NCT01944631|76180722|FG001|Overall Study|Lost to Follow-up|1|||
42342241|NCT01944631|76180721|FG000|Overall Study|Withdrawal by Subject|0|||
42004101|NCT01325207|75812082|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
42004102|NCT01324349|75812099|FG000|Overall Study|Death|1|||
42004103|NCT01324349|75812100|FG001|Overall Study|Death|1|||
42004104|NCT01324349|75812099|FG000|Overall Study|Withdrawal by Subject|0|||
42004105|NCT01324349|75812100|FG001|Overall Study|Withdrawal by Subject|1|||
42004106|NCT01095250|75812110|FG000|Overall Study|administrative reasons|8|||
42135545|NCT00268996|75946222|FG000|Overall Study|Other|1|||
42135546|NCT00268996|75946223|FG001|Overall Study|Other|1|||
42135547|NCT00371397|75946231|FG000|Session 1|Withdrawal by Subject|1|||
42135548|NCT00371397|75946232|FG001|Session 1|Withdrawal by Subject|0|||
42135549|NCT00371397|75946233|FG002|Session 1|Withdrawal by Subject|0|||
42135550|NCT00371397|75946234|FG003|Session 1|Withdrawal by Subject|0|||
42135551|NCT00371397|75946235|FG004|Session 1|Withdrawal by Subject|0|||
42135552|NCT00371397|75946236|FG005|Session 1|Withdrawal by Subject|0|||
42135553|NCT00371397|75946237|FG006|Session 1|Withdrawal by Subject|0|||
42135554|NCT00371397|75946238|FG007|Session 1|Withdrawal by Subject|1|||
42135555|NCT00371397|75946239|FG008|Session 1|Withdrawal by Subject|0|||
42135556|NCT00371397|75946240|FG009|Session 1|Withdrawal by Subject|0|||
42135557|NCT00371397|75946241|FG010|Session 1|Withdrawal by Subject|0|||
42135558|NCT00371397|75946242|FG011|Session 1|Withdrawal by Subject|0|||
42135559|NCT00379587|75946248|FG000|Overall Study|Lost to Follow-up|2|||
42135560|NCT00289276|75946254|FG000|Second Part of FAST Study (Expansion)|Death|0|||
42135561|NCT00289276|75946255|FG001|Second Part of FAST Study (Expansion)|Death|2|||
42135562|NCT00289276|75946254|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
42135563|NCT00289276|75946255|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
42135564|NCT00289198|75946263|FG000|Overall Study|Adverse Event|0|||
42135565|NCT00289198|75946264|FG001|Overall Study|Adverse Event|2|||
42135566|NCT00289198|75946263|FG000|Overall Study|Protocol Violation|2|||
42135567|NCT00289198|75946264|FG001|Overall Study|Protocol Violation|1|||
42135568|NCT00289198|75946263|FG000|Overall Study|Withdrawal by Subject|4|||
42004107|NCT01095250|75812111|FG001|Overall Study|administrative reasons|10|||
42004108|NCT01095250|75812112|FG002|Overall Study|administrative reasons|7|||
42035131|NCT00933933|75843427|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
42035132|NCT00933933|75843428|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
42035133|NCT00933933|75843429|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
42035134|NCT01032018|75843447|FG000|Overall Study|Lost to Follow-up|6|||
42035135|NCT01032018|75843448|FG001|Overall Study|Lost to Follow-up|5|||
42035136|NCT01032018|75843447|FG000|Overall Study|Death|0|||
42035137|NCT01032018|75843448|FG001|Overall Study|Death|1|||
42035138|NCT01031706|75843456|FG000|Overall Study|Adverse Event|1|||
42004109|NCT01095250|75812113|FG003|Overall Study|administrative reasons|5|||
42004110|NCT01095250|75812110|FG000|Overall Study|Withdrawal by Subject|0|||
42004111|NCT01095250|75812111|FG001|Overall Study|Withdrawal by Subject|0|||
42004112|NCT01095250|75812112|FG002|Overall Study|Withdrawal by Subject|1|||
42035139|NCT01031706|75843457|FG001|Overall Study|Adverse Event|0|||
42035140|NCT01031706|75843456|FG000|Overall Study|Withdrawal by Subject|1|||
42004113|NCT01095250|75812113|FG003|Overall Study|Withdrawal by Subject|0|||
42135569|NCT00289198|75946264|FG001|Overall Study|Withdrawal by Subject|1|||
42268845|NCT03268954|76097833|FG001|Overall Study|Progressive Disease|48|||
42004114|NCT01324271|75812123|FG000|Overall Study|Lost to Follow-up|3|||
42004115|NCT01324271|75812124|FG001|Overall Study|Lost to Follow-up|0|||
42035141|NCT01031706|75843457|FG001|Overall Study|Withdrawal by Subject|1|||
42035142|NCT00927069|75843465|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
42135570|NCT00289198|75946263|FG000|Overall Study|Lack of Efficacy|2|||
42135571|NCT00289198|75946264|FG001|Overall Study|Lack of Efficacy|0|||
42135572|NCT00289198|75946263|FG000|Overall Study|Other: Low compliance|0|||
42135573|NCT00289198|75946264|FG001|Overall Study|Other: Low compliance|1|||
42135574|NCT00289198|75946263|FG000|Overall Study|Other: Physician's decision|0|||
42135575|NCT00289198|75946264|FG001|Overall Study|Other: Physician's decision|1|||
42135576|NCT00289198|75946263|FG000|Overall Study|Other: Unable to attend on schedule|2|||
42135577|NCT00289198|75946264|FG001|Overall Study|Other: Unable to attend on schedule|1|||
42135578|NCT00289198|75946263|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
42135579|NCT00289198|75946264|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
42135580|NCT00289198|75946263|FG000|Overall Study|Other: Impossible to come on visit|0|||
42135581|NCT00289198|75946264|FG001|Overall Study|Other: Impossible to come on visit|1|||
42135582|NCT00363051|75946273|FG000|Overall Study|Adminstrative problems|1|||
42135583|NCT00363051|75946274|FG001|Overall Study|Adminstrative problems|1|||
42135584|NCT00363051|75946273|FG000|Overall Study|Adverse Event|21|||
42135585|NCT00363051|75946274|FG001|Overall Study|Adverse Event|12|||
42135586|NCT00363051|75946273|FG000|Overall Study|New Cancer Therapy|2|||
42135587|NCT00363051|75946274|FG001|Overall Study|New Cancer Therapy|1|||
42135588|NCT00363051|75946273|FG000|Overall Study|Withdrawal by Subject|11|||
42135589|NCT00363051|75946274|FG001|Overall Study|Withdrawal by Subject|3|||
42135590|NCT00363051|75946273|FG000|Overall Study|Lost to Follow-up|0|||
42135591|NCT00363051|75946274|FG001|Overall Study|Lost to Follow-up|1|||
42135592|NCT00363051|75946273|FG000|Overall Study|Protocol Violation|0|||
42135593|NCT00363051|75946274|FG001|Overall Study|Protocol Violation|2|||
42135594|NCT00363051|75946273|FG000|Overall Study|Death|3|||
42135595|NCT00363051|75946274|FG001|Overall Study|Death|2|||
42135596|NCT00379353|75946284|FG000|Overall Study|Hospitalization|3|||
42135597|NCT00379353|75946285|FG001|Overall Study|Hospitalization|3|||
42135598|NCT00379353|75946284|FG000|Overall Study|Withdrawal by Subject|5|||
42268846|NCT03268954|76097832|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
42268847|NCT03268954|76097833|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
42342242|NCT01944631|76180722|FG001|Overall Study|Withdrawal by Subject|1|||
42342243|NCT01948063|76180730|FG000|Overall Study|Boston MCI halted research protocol|0|||
42004116|NCT01324271|75812123|FG000|Overall Study|Physician Decision|1|||
42004117|NCT01324271|75812124|FG001|Overall Study|Physician Decision|0|||
42004118|NCT01095094|75812130|FG000|Overall Study|Withdrawal by Subject|1|||
42268848|NCT03268954|76097832|FG000|Overall Study|Reason not Specified|40|||
42268849|NCT03268954|76097833|FG001|Overall Study|Reason not Specified|40|||
42268850|NCT03194646|76097847|FG000|Overall Study|Adverse Event|24|||
42268851|NCT03194646|76097848|FG001|Overall Study|Adverse Event|25|||
42268852|NCT03194646|76097849|FG002|Overall Study|Adverse Event|14|||
42268853|NCT03194646|76097850|FG003|Overall Study|Adverse Event|17|||
42268854|NCT03194646|76097847|FG000|Overall Study|Lack of Efficacy|4|||
42268855|NCT03194646|76097848|FG001|Overall Study|Lack of Efficacy|2|||
42268856|NCT03194646|76097849|FG002|Overall Study|Lack of Efficacy|2|||
42268857|NCT03194646|76097850|FG003|Overall Study|Lack of Efficacy|12|||
42268858|NCT03194646|76097847|FG000|Overall Study|Lost to Follow-up|30|||
42268859|NCT03194646|76097848|FG001|Overall Study|Lost to Follow-up|22|||
42268860|NCT03194646|76097849|FG002|Overall Study|Lost to Follow-up|12|||
42268861|NCT03194646|76097850|FG003|Overall Study|Lost to Follow-up|35|||
42342244|NCT01948063|76180731|FG001|Overall Study|Boston MCI halted research protocol|1|||
42342245|NCT01948063|76180730|FG000|Overall Study|Discovered an enrollment in other study|0|||
42342246|NCT01948063|76180731|FG001|Overall Study|Discovered an enrollment in other study|1|||
42342247|NCT01948063|76180730|FG000|Overall Study|Blood samples were accidentally thawed|1|||
42342248|NCT01948063|76180731|FG001|Overall Study|Blood samples were accidentally thawed|0|||
42342249|NCT01995071|76180749|FG000|Overall Study|Adverse Event|0|||
42342250|NCT01995071|76180750|FG001|Overall Study|Adverse Event|0|||
42342251|NCT01995071|76180751|FG002|Overall Study|Adverse Event|0|||
42342252|NCT01995071|76180752|FG003|Overall Study|Adverse Event|0|||
42342253|NCT01995071|76180753|FG004|Overall Study|Adverse Event|0|||
42342254|NCT01995071|76180754|FG005|Overall Study|Adverse Event|0|||
42268862|NCT03194646|76097847|FG000|Overall Study|Non-compliance with study drug|4|||
42268863|NCT03194646|76097848|FG001|Overall Study|Non-compliance with study drug|0|||
42004119|NCT01095094|75812130|FG000|Overall Study|Death|1|||
42268864|NCT03194646|76097849|FG002|Overall Study|Non-compliance with study drug|1|||
42342255|NCT01995071|76180755|FG006|Overall Study|Adverse Event|1|||
42342256|NCT01995071|76180756|FG007|Overall Study|Adverse Event|0|||
42004120|NCT01095094|75812130|FG000|Overall Study|Physician Decision|1|||
42135599|NCT00379353|75946285|FG001|Overall Study|Withdrawal by Subject|2|||
42135600|NCT00379353|75946284|FG000|Overall Study|Death|1|||
42135601|NCT00379353|75946285|FG001|Overall Study|Death|0|||
42135602|NCT00379353|75946284|FG000|Overall Study|Cardiac Tamponade|1|||
42135603|NCT00379353|75946285|FG001|Overall Study|Cardiac Tamponade|0|||
42135604|NCT00379353|75946284|FG000|Overall Study|Non-compliance|1|||
42268865|NCT03194646|76097850|FG003|Overall Study|Non-compliance with study drug|1|||
42268866|NCT03194646|76097847|FG000|Overall Study|Other|89|||
42268867|NCT03194646|76097848|FG001|Overall Study|Other|68|||
42268868|NCT03194646|76097849|FG002|Overall Study|Other|34|||
42268869|NCT03194646|76097850|FG003|Overall Study|Other|31|||
42268870|NCT03194646|76097847|FG000|Overall Study|Physician Decision|7|||
42268871|NCT03194646|76097848|FG001|Overall Study|Physician Decision|9|||
42268872|NCT03194646|76097849|FG002|Overall Study|Physician Decision|5|||
42268873|NCT03194646|76097850|FG003|Overall Study|Physician Decision|4|||
42268874|NCT03194646|76097847|FG000|Overall Study|Pregnancy|4|||
42268875|NCT03194646|76097848|FG001|Overall Study|Pregnancy|5|||
42268876|NCT03194646|76097849|FG002|Overall Study|Pregnancy|1|||
42268877|NCT03194646|76097850|FG003|Overall Study|Pregnancy|2|||
42268878|NCT03194646|76097847|FG000|Overall Study|Protocol Violation|4|||
42268879|NCT03194646|76097848|FG001|Overall Study|Protocol Violation|2|||
42268880|NCT03194646|76097849|FG002|Overall Study|Protocol Violation|1|||
42268881|NCT03194646|76097850|FG003|Overall Study|Protocol Violation|1|||
42268882|NCT03194646|76097847|FG000|Overall Study|Site terminated by sponsor|0|||
42268883|NCT03194646|76097848|FG001|Overall Study|Site terminated by sponsor|0|||
42268884|NCT03194646|76097849|FG002|Overall Study|Site terminated by sponsor|2|||
42268885|NCT03194646|76097850|FG003|Overall Study|Site terminated by sponsor|0|||
42268886|NCT03194646|76097847|FG000|Overall Study|Study terminated by sponsor|62|||
42268887|NCT03194646|76097848|FG001|Overall Study|Study terminated by sponsor|61|||
42268888|NCT03194646|76097849|FG002|Overall Study|Study terminated by sponsor|30|||
42268889|NCT03194646|76097850|FG003|Overall Study|Study terminated by sponsor|34|||
42268890|NCT03194646|76097847|FG000|Overall Study|Withdrawal by Subject|75|||
42268891|NCT03194646|76097848|FG001|Overall Study|Withdrawal by Subject|74|||
42268892|NCT03194646|76097849|FG002|Overall Study|Withdrawal by Subject|36|||
42268893|NCT03194646|76097850|FG003|Overall Study|Withdrawal by Subject|131|||
42268894|NCT03194646|76097847|FG000|Overall Study|Missing|1|||
42268895|NCT03194646|76097848|FG001|Overall Study|Missing|0|||
42268896|NCT03194646|76097849|FG002|Overall Study|Missing|1|||
42268897|NCT03194646|76097850|FG003|Overall Study|Missing|12|||
42268898|NCT02979522|76097898|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
42268899|NCT02979522|76097899|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
42268900|NCT02979522|76097898|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
42268901|NCT02979522|76097899|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
42268902|NCT02927262|76097913|FG000|Overall Study|Adverse Event|7|||
42268903|NCT02927262|76097914|FG001|Overall Study|Adverse Event|1|||
42268904|NCT02927262|76097913|FG000|Overall Study|Death|1|||
42268905|NCT02927262|76097914|FG001|Overall Study|Death|0|||
42268906|NCT02927262|76097913|FG000|Overall Study|Withdrawal by Subject|3|||
42268907|NCT02927262|76097914|FG001|Overall Study|Withdrawal by Subject|0|||
42268908|NCT02927262|76097913|FG000|Overall Study|Disease Relapse|23|||
42268909|NCT02927262|76097914|FG001|Overall Study|Disease Relapse|18|||
42268910|NCT02927262|76097913|FG000|Overall Study|Miscellaneous|5|||
42268911|NCT02927262|76097914|FG001|Overall Study|Miscellaneous|4|||
42268912|NCT02927262|76097913|FG000|Overall Study|Ongoing|4|||
42268913|NCT02927262|76097914|FG001|Overall Study|Ongoing|0|||
42268914|NCT02663622|76097924|FG000|Overall Study|Death|3|||
42268915|NCT02663622|76097925|FG001|Overall Study|Death|1|||
42268916|NCT02663622|76097926|FG002|Overall Study|Death|1|||
42268917|NCT02663622|76097927|FG003|Overall Study|Death|8|||
42268918|NCT02663622|76097924|FG000|Overall Study|Protocol Violation|0|||
42268919|NCT02663622|76097925|FG001|Overall Study|Protocol Violation|0|||
42268920|NCT02663622|76097926|FG002|Overall Study|Protocol Violation|0|||
42268921|NCT02663622|76097927|FG003|Overall Study|Protocol Violation|1|||
42342257|NCT01995071|76180757|FG008|Overall Study|Adverse Event|0|||
42342258|NCT01995071|76180758|FG009|Overall Study|Adverse Event|0|||
42342259|NCT01995071|76180759|FG010|Overall Study|Adverse Event|0|||
42342260|NCT01995071|76180760|FG011|Overall Study|Adverse Event|0|||
42342261|NCT01995071|76180749|FG000|Overall Study|Moved|0|||
42342262|NCT01995071|76180750|FG001|Overall Study|Moved|0|||
42342263|NCT01995071|76180751|FG002|Overall Study|Moved|1|||
42342264|NCT01995071|76180752|FG003|Overall Study|Moved|0|||
42342265|NCT01995071|76180753|FG004|Overall Study|Moved|1|||
42342266|NCT01995071|76180754|FG005|Overall Study|Moved|0|||
42342267|NCT01995071|76180755|FG006|Overall Study|Moved|0|||
42268922|NCT02637713|76097938|FG000|Overall Study|Screen Failure|2|||
42268923|NCT02421939|76097953|FG000|Overall Study|Progressive disease|70|||
42268924|NCT02421939|76097954|FG001|Overall Study|Progressive disease|16|||
42268925|NCT02421939|76097953|FG000|Overall Study|Lack of Efficacy|21|||
42268926|NCT02421939|76097954|FG001|Overall Study|Lack of Efficacy|31|||
42268927|NCT02421939|76097953|FG000|Overall Study|Death|36|||
42268928|NCT02421939|76097954|FG001|Overall Study|Death|10|||
42268929|NCT02421939|76097953|FG000|Overall Study|Disease relapse|33|||
42268930|NCT02421939|76097954|FG001|Overall Study|Disease relapse|2|||
42268931|NCT02421939|76097953|FG000|Overall Study|Adverse Event|28|||
42268932|NCT02421939|76097954|FG001|Overall Study|Adverse Event|5|||
42268933|NCT02421939|76097953|FG000|Overall Study|Withdrawal by Subject|5|||
42342268|NCT01995071|76180756|FG007|Overall Study|Moved|0|||
42342269|NCT01995071|76180757|FG008|Overall Study|Moved|0|||
42004121|NCT01323647|75812136|FG000|Overall Study|Migrated/moved from study area|2|||
42004122|NCT01323647|75812137|FG001|Overall Study|Migrated/moved from study area|0|||
42135605|NCT00379353|75946285|FG001|Overall Study|Non-compliance|0|||
42135606|NCT00379353|75946284|FG000|Overall Study|Conflicting drug treatment|0|||
42342270|NCT01995071|76180758|FG009|Overall Study|Moved|0|||
42342271|NCT01995071|76180759|FG010|Overall Study|Moved|1|||
42342272|NCT01995071|76180760|FG011|Overall Study|Moved|0|||
42342273|NCT01995071|76180749|FG000|Overall Study|Lost to Follow-up|1|||
42342274|NCT01995071|76180750|FG001|Overall Study|Lost to Follow-up|0|||
42342275|NCT01995071|76180751|FG002|Overall Study|Lost to Follow-up|0|||
42342276|NCT01995071|76180752|FG003|Overall Study|Lost to Follow-up|0|||
42342277|NCT01995071|76180753|FG004|Overall Study|Lost to Follow-up|0|||
42342278|NCT01995071|76180754|FG005|Overall Study|Lost to Follow-up|0|||
42342279|NCT01995071|76180755|FG006|Overall Study|Lost to Follow-up|0|||
42342280|NCT01995071|76180756|FG007|Overall Study|Lost to Follow-up|1|||
42342281|NCT01995071|76180757|FG008|Overall Study|Lost to Follow-up|1|||
42342282|NCT01995071|76180758|FG009|Overall Study|Lost to Follow-up|0|||
42342283|NCT01995071|76180759|FG010|Overall Study|Lost to Follow-up|0|||
42342284|NCT01995071|76180760|FG011|Overall Study|Lost to Follow-up|0|||
42342285|NCT01995071|76180749|FG000|Overall Study|Incarcerated|0|||
42342286|NCT01995071|76180750|FG001|Overall Study|Incarcerated|0|||
42342287|NCT01995071|76180751|FG002|Overall Study|Incarcerated|0|||
42342288|NCT01995071|76180752|FG003|Overall Study|Incarcerated|0|||
42342289|NCT01995071|76180753|FG004|Overall Study|Incarcerated|0|||
42342290|NCT01995071|76180754|FG005|Overall Study|Incarcerated|0|||
42342291|NCT01995071|76180755|FG006|Overall Study|Incarcerated|0|||
42342292|NCT01995071|76180756|FG007|Overall Study|Incarcerated|1|||
42342293|NCT01995071|76180757|FG008|Overall Study|Incarcerated|0|||
42342294|NCT01995071|76180758|FG009|Overall Study|Incarcerated|0|||
42342295|NCT01995071|76180759|FG010|Overall Study|Incarcerated|0|||
42342296|NCT01995071|76180760|FG011|Overall Study|Incarcerated|0|||
42342297|NCT01994837|76180792|FG000|Overall Study|Progressive disease per protocol|23|||
42342298|NCT01994837|76180792|FG000|Overall Study|Adv event related to progressive disease|3|||
42342299|NCT01994837|76180792|FG000|Overall Study|Fatal progressive disease|2|||
42342300|NCT01994837|76180792|FG000|Overall Study|Adverse event not related to progression|1|||
42135607|NCT00379353|75946285|FG001|Overall Study|Conflicting drug treatment|1|||
42135608|NCT00378573|75946301|FG000|Treatment Period|Adverse Event|9|||
42135609|NCT00378573|75946301|FG000|Treatment Period|Physician Decision|1|||
42135610|NCT00378573|75946301|FG000|Treatment Period|Withdrawal by Subject|2|||
42135611|NCT00378573|75946301|FG000|Treatment Period|Disease Progression|4|||
42135612|NCT00378573|75946301|FG000|Treatment Period|Sponsor decision to close study|1|||
42268934|NCT02421939|76097954|FG001|Overall Study|Withdrawal by Subject|24|||
42268935|NCT02421939|76097953|FG000|Overall Study|Physician Decision|11|||
42268936|NCT02421939|76097954|FG001|Overall Study|Physician Decision|11|||
42268937|NCT02421939|76097953|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
42268938|NCT02421939|76097954|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
42268939|NCT02421939|76097953|FG000|Overall Study|Miscellaneous|4|||
42268940|NCT02421939|76097954|FG001|Overall Study|Miscellaneous|5|||
42268941|NCT02421939|76097953|FG000|Overall Study|Protocol deviation|1|||
42342301|NCT01994837|76180792|FG000|Overall Study|Chose palliative care|1|||
42342302|NCT01994837|76180792|FG000|Overall Study|Proceeded to transplant|1|||
42342303|NCT01994837|76180792|FG000|Overall Study|Removed from study due to no response|1|||
42342304|NCT02010593|76180798|FG000|Overall Study|Lost to Follow-up|1|||
42342305|NCT02010593|76180799|FG001|Overall Study|Lost to Follow-up|0|||
42342306|NCT02010593|76180798|FG000|Overall Study|Physician Decision|1|||
42342307|NCT02010593|76180799|FG001|Overall Study|Physician Decision|0|||
42135613|NCT00378573|75946301|FG000|Follow-up|Death|12|||
42342308|NCT02010593|76180798|FG000|Overall Study|Unable to adhere to visit schedule|0|||
42004123|NCT01323647|75812136|FG000|Overall Study|Withdrawal by Subject|5|||
42268942|NCT02421939|76097954|FG001|Overall Study|Protocol deviation|1|||
42268943|NCT02294461|76097962|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
42268944|NCT02294461|76097963|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
42004124|NCT01323647|75812137|FG001|Overall Study|Withdrawal by Subject|0|||
42004125|NCT01323647|75812136|FG000|Overall Study|Lost to Follow-up|2|||
42268945|NCT02294461|76097962|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
42268946|NCT02294461|76097963|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
42268947|NCT02294461|76097962|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
42268948|NCT02294461|76097963|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
42268949|NCT02294461|76097962|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
42268950|NCT02294461|76097963|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
42268951|NCT02294461|76097962|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
42268952|NCT02294461|76097963|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
42342309|NCT02010593|76180799|FG001|Overall Study|Unable to adhere to visit schedule|2|||
42342310|NCT01994291|76180808|FG000|Overall Study|Adverse Event|4|||
42342311|NCT01994291|76180809|FG001|Overall Study|Adverse Event|1|||
42342312|NCT01994291|76180810|FG002|Overall Study|Adverse Event|3|||
42342313|NCT01994291|76180808|FG000|Overall Study|Lost to Follow-up|1|||
42342314|NCT01994291|76180809|FG001|Overall Study|Lost to Follow-up|1|||
42342315|NCT01994291|76180810|FG002|Overall Study|Lost to Follow-up|0|||
42342316|NCT01994291|76180808|FG000|Overall Study|Does not meet entrance criteria|1|||
42268953|NCT02294461|76097962|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
42268954|NCT02294461|76097963|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
42268955|NCT02294461|76097962|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
42268956|NCT02294461|76097963|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
42268957|NCT02294461|76097962|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
42268958|NCT02294461|76097963|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
42004126|NCT01323647|75812137|FG001|Overall Study|Lost to Follow-up|0|||
42342317|NCT01994291|76180809|FG001|Overall Study|Does not meet entrance criteria|0|||
42342318|NCT01994291|76180810|FG002|Overall Study|Does not meet entrance criteria|0|||
42342319|NCT01994291|76180808|FG000|Overall Study|Medication error without associated AE|1|||
42342320|NCT01994291|76180809|FG001|Overall Study|Medication error without associated AE|0|||
42342321|NCT01994291|76180810|FG002|Overall Study|Medication error without associated AE|1|||
42342322|NCT01994291|76180808|FG000|Overall Study|Protocol Violation|1|||
42135614|NCT00378573|75946301|FG000|Follow-up|Lost to Follow-up|1|||
42342323|NCT01994291|76180809|FG001|Overall Study|Protocol Violation|0|||
42342324|NCT01994291|76180810|FG002|Overall Study|Protocol Violation|0|||
42342325|NCT01994291|76180808|FG000|Overall Study|Withdrawal by Subject|6|||
42342326|NCT01994291|76180809|FG001|Overall Study|Withdrawal by Subject|3|||
42135615|NCT00378573|75946301|FG000|Follow-up|Withdrawal by Subject|1|||
42135616|NCT03831945|75946307|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
42342327|NCT01994291|76180810|FG002|Overall Study|Withdrawal by Subject|5|||
42342328|NCT01994291|76180808|FG000|Overall Study|Other|1|||
42342329|NCT01994291|76180809|FG001|Overall Study|Other|2|||
42342330|NCT01994291|76180810|FG002|Overall Study|Other|0|||
42342331|NCT02094677|76180821|FG000|Overall Study|Screening|3|||
42004127|NCT01094782|75812149|FG000|Overall Study|Withdrawal by Subject|5|||
42004128|NCT01094782|75812150|FG001|Overall Study|Withdrawal by Subject|5|||
42004129|NCT01094782|75812151|FG002|Overall Study|Withdrawal by Subject|1|||
42135617|NCT03831945|75946308|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
42135618|NCT03831945|75946307|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
42135619|NCT03831945|75946308|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
42135620|NCT03831945|75946307|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
42135621|NCT03831945|75946308|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
42268959|NCT02294461|76097962|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
42268960|NCT02294461|76097963|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
42268961|NCT02294461|76097962|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
42268962|NCT02294461|76097963|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
42268963|NCT02294461|76097962|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
42268964|NCT02294461|76097963|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
42342332|NCT02094677|76180822|FG001|Overall Study|Screening|1|||
42342333|NCT01993823|76180837|FG000|Overall Study|Requested by the patient|6|||
42342334|NCT01993823|76180838|FG001|Overall Study|Requested by the patient|11|||
42342335|NCT01993823|76180837|FG000|Overall Study|Protocol Violation|0|||
42342336|NCT01993823|76180838|FG001|Overall Study|Protocol Violation|1|||
42342337|NCT01993823|76180837|FG000|Overall Study|Lost to Follow-up|1|||
42342338|NCT01993823|76180838|FG001|Overall Study|Lost to Follow-up|4|||
42342339|NCT01993667|76180846|FG000|Overall Study|Insufficient data to analyze|16|||
42342340|NCT01993667|76180847|FG001|Overall Study|Insufficient data to analyze|16|||
42342341|NCT01993667|76180846|FG000|Overall Study|Insufficient altitude reached|3|||
42342342|NCT01993667|76180847|FG001|Overall Study|Insufficient altitude reached|1|||
42342343|NCT01993667|76180846|FG000|Overall Study|Lost to Follow-up|2|||
42342344|NCT01993667|76180847|FG001|Overall Study|Lost to Follow-up|2|||
42342345|NCT01992107|76180856|FG000|Overall Study|Administrative reasons|2|||
42342346|NCT01992107|76180857|FG001|Overall Study|Administrative reasons|0|||
42342347|NCT01992107|76180858|FG002|Overall Study|Administrative reasons|0|||
42342348|NCT01992107|76180856|FG000|Overall Study|Adverse Event|0|||
42342349|NCT01992107|76180857|FG001|Overall Study|Adverse Event|1|||
42342350|NCT01992107|76180858|FG002|Overall Study|Adverse Event|0|||
42342351|NCT01992107|76180856|FG000|Overall Study|Lost to Follow-up|46|||
42342352|NCT01992107|76180857|FG001|Overall Study|Lost to Follow-up|22|||
42342353|NCT01992107|76180858|FG002|Overall Study|Lost to Follow-up|26|||
42342354|NCT01992107|76180856|FG000|Overall Study|noncompliance and were unavailable|7|||
42342355|NCT01992107|76180857|FG001|Overall Study|noncompliance and were unavailable|3|||
42004130|NCT01094782|75812152|FG003|Overall Study|Withdrawal by Subject|5|||
42268965|NCT02294461|76097962|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
42342356|NCT01992107|76180858|FG002|Overall Study|noncompliance and were unavailable|2|||
42342357|NCT01992107|76180856|FG000|Overall Study|Withdrawal by Subject|13|||
42342358|NCT01992107|76180857|FG001|Overall Study|Withdrawal by Subject|7|||
42342359|NCT01992107|76180858|FG002|Overall Study|Withdrawal by Subject|8|||
42342360|NCT01934192|76180887|FG000|Overall Study|Protocol Violation|0|||
42342361|NCT01934192|76180888|FG001|Overall Study|Protocol Violation|0|||
42135622|NCT00457002|75946316|FG000|Overall Study|Death|40|||
42135623|NCT00457002|75946317|FG001|Overall Study|Death|47|||
42135624|NCT00457002|75946316|FG000|Overall Study|Adverse Event|284|||
42342362|NCT01934192|76180889|FG002|Overall Study|Protocol Violation|0|||
42342363|NCT01934192|76180890|FG003|Overall Study|Protocol Violation|1|||
42342364|NCT01934192|76180887|FG000|Overall Study|Other: reached stopping criteria|6|||
42342365|NCT01934192|76180888|FG001|Overall Study|Other: reached stopping criteria|5|||
42342366|NCT01934192|76180889|FG002|Overall Study|Other: reached stopping criteria|1|||
42342367|NCT01934192|76180890|FG003|Overall Study|Other: reached stopping criteria|0|||
42342368|NCT01934192|76180887|FG000|Overall Study|Physician Decision|3|||
42342369|NCT01934192|76180888|FG001|Overall Study|Physician Decision|2|||
42342370|NCT01934192|76180889|FG002|Overall Study|Physician Decision|0|||
42342371|NCT01934192|76180890|FG003|Overall Study|Physician Decision|0|||
42342372|NCT01933880|76180913|FG000|Overall Study|Withdrawal by Subject|5|||
42342373|NCT01933880|76180914|FG001|Overall Study|Withdrawal by Subject|0|||
42342374|NCT01933880|76180913|FG000|Overall Study|Lack of Efficacy|1|||
42342375|NCT01933880|76180914|FG001|Overall Study|Lack of Efficacy|0|||
42342376|NCT01933880|76180913|FG000|Overall Study|Concomitant medication Interference|0|||
42342377|NCT01933880|76180914|FG001|Overall Study|Concomitant medication Interference|1|||
42342378|NCT01933880|76180913|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
42342379|NCT01933880|76180914|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
42342380|NCT01933880|76180913|FG000|Overall Study|Other|4|||
42342381|NCT01933880|76180914|FG001|Overall Study|Other|0|||
42342382|NCT01933880|76180913|FG000|Overall Study|Protocol Violation|1|||
42342383|NCT01933880|76180914|FG001|Overall Study|Protocol Violation|0|||
42342384|NCT02008877|76180925|FG000|Overall Study|Inevaluable|0|||
42342385|NCT02008877|76180926|FG001|Overall Study|Inevaluable|1|||
42342386|NCT02008877|76180927|FG002|Overall Study|Inevaluable|0|||
42342387|NCT01933334|76180938|FG000|Overall Study|Adverse Event|5|||
42342388|NCT01933334|76180939|FG001|Overall Study|Adverse Event|1|||
42342389|NCT01933334|76180938|FG000|Overall Study|Withdrawal by Subject|0|||
42342390|NCT01933334|76180939|FG001|Overall Study|Withdrawal by Subject|1|||
42342391|NCT01908140|76180947|FG000|Overall Study|Other or Progressive Disease|5|||
42342392|NCT01908140|76180948|FG001|Overall Study|Other or Progressive Disease|12|||
42342393|NCT01908140|76180947|FG000|Overall Study|Lack of Efficacy|7|||
42342394|NCT01908140|76180948|FG001|Overall Study|Lack of Efficacy|5|||
42342395|NCT01908140|76180947|FG000|Overall Study|Withdrawal by Subject|23|||
42342396|NCT01908140|76180948|FG001|Overall Study|Withdrawal by Subject|24|||
42342397|NCT01908140|76180947|FG000|Overall Study|Lost to Follow-up|1|||
42342398|NCT01908140|76180948|FG001|Overall Study|Lost to Follow-up|6|||
42342399|NCT01908140|76180947|FG000|Overall Study|Protocol Violation|8|||
42342400|NCT01908140|76180948|FG001|Overall Study|Protocol Violation|9|||
42342401|NCT01908140|76180947|FG000|Overall Study|Adverse Event|22|||
42342402|NCT01908140|76180948|FG001|Overall Study|Adverse Event|23|||
42342403|NCT02008565|76180958|FG000|Overall Study|Protocol Violation|1|||
42342404|NCT02008565|76180959|FG001|Overall Study|Protocol Violation|1|||
42342405|NCT02008565|76180960|FG002|Overall Study|Protocol Violation|2|||
42342406|NCT02008565|76180961|FG003|Overall Study|Protocol Violation|0|||
42342407|NCT01907906|76180975|FG000|Overall Study|Withdrawal by Subject|1|||
42342408|NCT01907906|76180976|FG001|Overall Study|Withdrawal by Subject|0|||
42342409|NCT01907906|76180975|FG000|Overall Study|Physician Decision|3|||
42342410|NCT01907906|76180976|FG001|Overall Study|Physician Decision|1|||
42342411|NCT01907828|76180986|FG000|Overall Study|Exclusion criteria not met|0|||
42342412|NCT01907828|76180987|FG001|Overall Study|Exclusion criteria not met|1|||
42342413|NCT01907828|76180986|FG000|Overall Study|Withdrawal by Subject|3|||
42342414|NCT01907828|76180987|FG001|Overall Study|Withdrawal by Subject|4|||
42342415|NCT01907828|76180986|FG000|Overall Study|Lost to Follow-up|3|||
42342416|NCT01907828|76180987|FG001|Overall Study|Lost to Follow-up|0|||
42342417|NCT01907828|76180986|FG000|Overall Study|Participant refused 24-month follow-up|1|||
42342418|NCT01907828|76180987|FG001|Overall Study|Participant refused 24-month follow-up|0|||
42342419|NCT01907828|76180986|FG000|Overall Study|Participant met exclusion criteria|0|||
42342420|NCT01907828|76180987|FG001|Overall Study|Participant met exclusion criteria|1|||
42342421|NCT01907516|76180995|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
42342422|NCT01907516|76180996|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
42342423|NCT01907516|76180995|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
42342424|NCT01907516|76180996|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
42342425|NCT01907516|76180995|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
42342426|NCT01907516|76180996|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
42342427|NCT01907516|76180995|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
42342428|NCT01907516|76180996|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
42342429|NCT01931462|76181003|FG000|Overall Study|Withdrawal by Subject|1|||
42342430|NCT01931150|76181009|FG000|Overall Study|Withdrawal by Subject|1|||
42342431|NCT01931150|76181010|FG001|Overall Study|Withdrawal by Subject|2|||
42342432|NCT01930214|76181019|FG000|Overall Study|Death|4|||
42342433|NCT01930214|76181020|FG001|Overall Study|Death|4|||
42342434|NCT01930214|76181021|FG002|Overall Study|Death|11|||
42342435|NCT01930214|76181019|FG000|Overall Study|Lost to Follow-up|12|||
42342436|NCT01930214|76181020|FG001|Overall Study|Lost to Follow-up|13|||
42342437|NCT01930214|76181021|FG002|Overall Study|Lost to Follow-up|12|||
42342438|NCT01930214|76181019|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
42342439|NCT01930214|76181020|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
42342440|NCT01930214|76181021|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
42342441|NCT01930214|76181019|FG000|Overall Study|Physician Decision|2|||
42342442|NCT01930214|76181020|FG001|Overall Study|Physician Decision|0|||
42342443|NCT01930214|76181021|FG002|Overall Study|Physician Decision|0|||
42342444|NCT01958294|76181029|FG000|Overall Study|Clinical Circumstances|2|||
42342445|NCT01906346|76181033|FG000|Overall Study|AEs|1|||
42342446|NCT01958060|76181045|FG000|Overall Study|Not treated|2|||
42342447|NCT01958060|76181046|FG001|Overall Study|Not treated|0|||
42342448|NCT01958060|76181047|FG002|Overall Study|Not treated|0|||
42342449|NCT01958060|76181048|FG003|Overall Study|Not treated|0|||
42342450|NCT01958060|76181049|FG004|Overall Study|Not treated|1|||
42342451|NCT01958060|76181050|FG005|Overall Study|Not treated|0|||
42342452|NCT01929980|76181069|FG000|Overall Study|Physician Decision|1|||
42342453|NCT01363076|76181075|FG000|Overall Study|Withdrawal by Subject|0|||
42342454|NCT01363076|76181076|FG001|Overall Study|Withdrawal by Subject|1|||
42342455|NCT01929044|76181084|FG000|Overall Study|Adverse Event|1|||
42342456|NCT01929044|76181085|FG001|Overall Study|Adverse Event|0|||
42342457|NCT01929044|76181084|FG000|Overall Study|Protocol Violation|9|||
42342458|NCT01929044|76181085|FG001|Overall Study|Protocol Violation|14|||
42342459|NCT01929044|76181084|FG000|Overall Study|Not Treated|1|||
42342460|NCT01929044|76181085|FG001|Overall Study|Not Treated|3|||
42342461|NCT01903460|76181095|FG000|Overall Study|Adverse Event|0|||
42342462|NCT01903460|76181096|FG001|Overall Study|Adverse Event|0|||
42268966|NCT02294461|76097963|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
42268967|NCT02294461|76097962|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
42268968|NCT02294461|76097963|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
42268969|NCT02294461|76097962|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
42268970|NCT02294461|76097963|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
42268971|NCT02294461|76097962|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
42268972|NCT02294461|76097963|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
42268973|NCT01651208|76098005|FG000|Overall Study|Lost to Follow-up|14|||
42268974|NCT01651208|76098006|FG001|Overall Study|Lost to Follow-up|16|||
42268975|NCT01361711|76098013|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
42268976|NCT01361711|76098013|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
42268977|NCT01361711|76098013|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
42268978|NCT01361711|76098013|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
42268979|NCT01361711|76098013|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
42342463|NCT01903460|76181097|FG002|Overall Study|Adverse Event|0|||
42268980|NCT01361711|76098013|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
42268981|NCT01361711|76098013|FG000|Completed Week 18 of Treatment|Other|9|||
42268982|NCT01361711|76098013|FG000|10 Year Follow-up|Still in follow-up|22|||
42135625|NCT00457002|75946317|FG001|Overall Study|Adverse Event|260|||
42268983|NCT01361711|76098013|FG000|10 Year Follow-up|Death|7|||
42268984|NCT01361711|76098013|FG000|10 Year Follow-up|Developed new cancer|1|||
42268985|NCT01361711|76098013|FG000|10 Year Follow-up|Lost to Follow-up|2|||
42268986|NCT01361711|76098013|FG000|10 Year Follow-up|New treatment started|6|||
42268987|NCT01361711|76098013|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
42268988|NCT01361711|76098013|FG000|10 Year Follow-up|Progressive Disease|1|||
42268989|NCT02572388|76098021|FG000|Overall Study|Withdrawal by Subject|1|||
42268990|NCT02572388|76098022|FG001|Overall Study|Withdrawal by Subject|1|||
42268991|NCT02572388|76098023|FG002|Overall Study|Withdrawal by Subject|2|||
42035143|NCT00927069|75843466|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
42268992|NCT02572388|76098024|FG003|Overall Study|Withdrawal by Subject|2|||
42268993|NCT02573870|76098036|FG000|Overall Study|Adverse Event|0|||
42268994|NCT02573870|76098037|FG001|Overall Study|Adverse Event|2|||
42268995|NCT02573870|76098036|FG000|Overall Study|Lack of Efficacy|0|||
42268996|NCT02573870|76098037|FG001|Overall Study|Lack of Efficacy|1|||
42268997|NCT02573870|76098036|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
42268998|NCT02573870|76098037|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
42268999|NCT02573870|76098036|FG000|Overall Study|Lost to Follow-up|0|||
42269000|NCT02573870|76098037|FG001|Overall Study|Lost to Follow-up|1|||
42035144|NCT00927069|75843467|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
42269001|NCT02573870|76098036|FG000|Overall Study|Other: Fail to Meet Visit|0|||
42269002|NCT02573870|76098037|FG001|Overall Study|Other: Fail to Meet Visit|2|||
42269003|NCT02572076|76098043|FG000|Overall Study|Protocol Violation|1|||
42269004|NCT02571452|76098049|FG000|Overall Study Treatment|Protocol Violation|0|||
42035145|NCT00927069|75843468|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
42035146|NCT00927069|75843465|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
42135626|NCT00457002|75946316|FG000|Overall Study|Withdrawal by Subject|299|||
42135627|NCT00457002|75946317|FG001|Overall Study|Withdrawal by Subject|271|||
42135628|NCT00457002|75946316|FG000|Overall Study|Lost to Follow-up|72|||
42135629|NCT00457002|75946317|FG001|Overall Study|Lost to Follow-up|71|||
42135630|NCT00457002|75946316|FG000|Overall Study|Poor/Non-compliance|46|||
42269005|NCT02571452|76098050|FG001|Overall Study Treatment|Protocol Violation|1|||
42269006|NCT02571452|76098049|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
42269007|NCT02571452|76098050|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
42269008|NCT02571452|76098049|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
42269009|NCT02571452|76098050|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
42269010|NCT02574260|76098056|FG000|Overall Study|Disease Progression|1|||
42269011|NCT02570126|76098062|FG000|Overall Study|Lost to Follow-up|2|||
42269012|NCT02570126|76098063|FG001|Overall Study|Lost to Follow-up|0|||
42269013|NCT02570126|76098062|FG000|Overall Study|Unable To Arrange Visit 3|1|||
42269014|NCT02570126|76098063|FG001|Overall Study|Unable To Arrange Visit 3|0|||
42269015|NCT02570126|76098062|FG000|Overall Study|Violation Of Procedures GSK|0|||
42269016|NCT02570126|76098063|FG001|Overall Study|Violation Of Procedures GSK|1|||
42269017|NCT02570126|76098062|FG000|Overall Study|Protocol Violation|0|||
42135631|NCT00457002|75946317|FG001|Overall Study|Poor/Non-compliance|33|||
42269018|NCT02570126|76098063|FG001|Overall Study|Protocol Violation|1|||
42269019|NCT02570126|76098062|FG000|Overall Study|Withdrawal by Subject|3|||
42269020|NCT02570126|76098063|FG001|Overall Study|Withdrawal by Subject|7|||
42269021|NCT02755831|76098071|FG000|Overall Study|Lost to Follow-up|3|||
42269022|NCT02755831|76098072|FG001|Overall Study|Lost to Follow-up|3|||
42269023|NCT02573246|76098083|FG000|Overall Study|Lost to Follow-up|2|||
42269024|NCT02573246|76098084|FG001|Overall Study|Lost to Follow-up|0|||
42035147|NCT00927069|75843466|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
42269025|NCT02573246|76098085|FG002|Overall Study|Lost to Follow-up|0|||
42269026|NCT02573246|76098086|FG003|Overall Study|Lost to Follow-up|0|||
42269027|NCT02573246|76098087|FG004|Overall Study|Lost to Follow-up|1|||
42269028|NCT02573246|76098083|FG000|Overall Study|Withdrawal by Subject|0|||
42269029|NCT02573246|76098084|FG001|Overall Study|Withdrawal by Subject|0|||
42269030|NCT02573246|76098085|FG002|Overall Study|Withdrawal by Subject|0|||
42269031|NCT02573246|76098086|FG003|Overall Study|Withdrawal by Subject|0|||
42269032|NCT02573246|76098087|FG004|Overall Study|Withdrawal by Subject|1|||
42269033|NCT02573246|76098083|FG000|Overall Study|Physician Decision|1|||
42269034|NCT02573246|76098084|FG001|Overall Study|Physician Decision|1|||
42269035|NCT02573246|76098085|FG002|Overall Study|Physician Decision|3|||
42269036|NCT02573246|76098086|FG003|Overall Study|Physician Decision|2|||
42269037|NCT02573246|76098087|FG004|Overall Study|Physician Decision|2|||
42035148|NCT00927069|75843467|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
42269038|NCT02570750|76098106|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
42269039|NCT02570750|76098107|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
42269040|NCT02570750|76098106|FG000|Overall Study|Protocol deviation|4|||
42269041|NCT02570750|76098107|FG001|Overall Study|Protocol deviation|2|||
42269042|NCT02570750|76098106|FG000|Overall Study|Withdrawal by Subject|5|||
42269043|NCT02570750|76098107|FG001|Overall Study|Withdrawal by Subject|0|||
42269044|NCT02570750|76098106|FG000|Overall Study|Lost to Follow-up|2|||
42269045|NCT02570750|76098107|FG001|Overall Study|Lost to Follow-up|2|||
42269046|NCT02570750|76098106|FG000|Overall Study|Adverse Event|2|||
42269047|NCT02570750|76098107|FG001|Overall Study|Adverse Event|1|||
42269048|NCT02573012|76098115|FG000|Overall Study|Adverse Event|5|||
42269049|NCT02573012|76098116|FG001|Overall Study|Adverse Event|5|||
42269050|NCT02573012|76098115|FG000|Overall Study|Lack of Efficacy|5|||
42269051|NCT02573012|76098116|FG001|Overall Study|Lack of Efficacy|4|||
42269052|NCT02573012|76098115|FG000|Overall Study|Non-compliance|1|||
42269053|NCT02573012|76098116|FG001|Overall Study|Non-compliance|2|||
42269054|NCT02573012|76098115|FG000|Overall Study|Withdrawal by Subject|2|||
42269055|NCT02573012|76098116|FG001|Overall Study|Withdrawal by Subject|2|||
42269056|NCT02573012|76098115|FG000|Overall Study|Study Ended per Protocol|1|||
42269057|NCT02573012|76098116|FG001|Overall Study|Study Ended per Protocol|0|||
42269058|NCT02573012|76098115|FG000|Overall Study|Physician Decision|1|||
42269059|NCT02573012|76098116|FG001|Overall Study|Physician Decision|2|||
42269060|NCT02752633|76098122|FG000|Overall Study|Withdrawal by Subject|1|||
42269061|NCT02752087|76098126|FG000|Washout|Physician Decision|1|||
42269062|NCT02752087|76098127|FG001|Washout|Physician Decision|0|||
42269063|NCT04766996|76098136|FG000|Overall Study|Withdrawal by Subject|1|||
42269064|NCT04766996|76098137|FG001|Overall Study|Withdrawal by Subject|0|||
42269065|NCT04766996|76098138|FG002|Overall Study|Withdrawal by Subject|13|||
42269066|NCT02563028|76098144|FG000|Overall Study|Lack of equipment|1|||
42269067|NCT02563028|76098144|FG000|Overall Study|Unable to elicit VEP post induction|1|||
42269068|NCT02192827|76098150|FG000|Overall Study|Lost to Follow-up|25|||
42269069|NCT02192827|76098151|FG001|Overall Study|Lost to Follow-up|27|||
42269070|NCT02192827|76098150|FG000|Overall Study|Given additional steroids with admission|13|||
42269071|NCT02192827|76098151|FG001|Overall Study|Given additional steroids with admission|11|||
42269072|NCT02562482|76098159|FG000|Overall Study|Enrolled, but did not receive product|4|||
42269073|NCT02562482|76098160|FG001|Overall Study|Enrolled, but did not receive product|0|||
42269074|NCT02562482|76098159|FG000|Overall Study|Lost to Follow-up|9|||
42269075|NCT02562482|76098160|FG001|Overall Study|Lost to Follow-up|6|||
42269076|NCT02562482|76098159|FG000|Overall Study|Moved from area|2|||
42269077|NCT02562482|76098160|FG001|Overall Study|Moved from area|3|||
42269078|NCT02562482|76098159|FG000|Overall Study|Withdrawal by Subject|5|||
42269079|NCT02562482|76098160|FG001|Overall Study|Withdrawal by Subject|3|||
42269080|NCT02562482|76098159|FG000|Overall Study|Physician Decision|1|||
42269081|NCT02562482|76098160|FG001|Overall Study|Physician Decision|3|||
42269082|NCT02562482|76098159|FG000|Overall Study|Illness/Injury unrelated to product|0|||
42269083|NCT02562482|76098160|FG001|Overall Study|Illness/Injury unrelated to product|1|||
42269084|NCT02568254|76098175|FG000|Period 2|Adverse Event|0|||
42269085|NCT02568254|76098176|FG001|Period 2|Adverse Event|0|||
42269086|NCT02568254|76098177|FG002|Period 2|Adverse Event|1|||
42269087|NCT02568254|76098178|FG003|Period 2|Adverse Event|0|||
42269088|NCT02568254|76098179|FG004|Period 2|Adverse Event|0|||
42269089|NCT02568254|76098180|FG005|Period 2|Adverse Event|0|||
42269090|NCT02568254|76098175|FG000|Period 3|Unstatisfactory Lens fitting|0|||
42269091|NCT02568254|76098176|FG001|Period 3|Unstatisfactory Lens fitting|0|||
42269092|NCT02568254|76098177|FG002|Period 3|Unstatisfactory Lens fitting|0|||
42269093|NCT02568254|76098178|FG003|Period 3|Unstatisfactory Lens fitting|0|||
42269094|NCT02568254|76098179|FG004|Period 3|Unstatisfactory Lens fitting|1|||
42269095|NCT02568254|76098180|FG005|Period 3|Unstatisfactory Lens fitting|0|||
42269096|NCT02567708|76098188|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
42269097|NCT02567708|76098189|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
42269098|NCT02567708|76098188|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
42035149|NCT00927069|75843468|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
42269099|NCT02567708|76098189|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
42269100|NCT02567708|76098188|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
42269101|NCT02567708|76098189|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
42342464|NCT01903460|76181098|FG003|Overall Study|Adverse Event|1|||
42269102|NCT02567708|76098188|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
42269103|NCT02567708|76098189|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
42269104|NCT02562716|76098198|FG000|Overall Study|Adverse Event|7|||
42269105|NCT02562716|76098199|FG001|Overall Study|Adverse Event|14|||
42269106|NCT02562716|76098198|FG000|Overall Study|Withdrawal unrelated to AE|7|||
42269107|NCT02562716|76098199|FG001|Overall Study|Withdrawal unrelated to AE|1|||
42269108|NCT02562716|76098198|FG000|Overall Study|Progression|8|||
42269109|NCT02562716|76098199|FG001|Overall Study|Progression|10|||
42269110|NCT02562716|76098198|FG000|Overall Study|Death|2|||
42269111|NCT02562716|76098199|FG001|Overall Study|Death|1|||
42269112|NCT02562716|76098198|FG000|Overall Study|Not protocol specified|4|||
42269113|NCT02562716|76098199|FG001|Overall Study|Not protocol specified|2|||
42269114|NCT02751931|76098209|FG000|Overall Study|Adverse Event|3|||
42269115|NCT02751931|76098210|FG001|Overall Study|Adverse Event|0|||
42269116|NCT02751931|76098209|FG000|Overall Study|Other: Miscelleneous|10|||
42269117|NCT02751931|76098210|FG001|Overall Study|Other: Miscelleneous|8|||
42269118|NCT02561156|76098235|FG000|Part 2|Adverse Event|0|||
42269119|NCT02561156|76098236|FG001|Part 2|Adverse Event|0|||
42269120|NCT02561156|76098237|FG002|Part 2|Adverse Event|0|||
42269121|NCT02561156|76098238|FG003|Part 2|Adverse Event|0|||
42269122|NCT02561156|76098239|FG004|Part 2|Adverse Event|0|||
42269123|NCT02561156|76098240|FG005|Part 2|Adverse Event|0|||
42269124|NCT02561156|76098241|FG006|Part 2|Adverse Event|0|||
42269125|NCT02561156|76098242|FG007|Part 2|Adverse Event|0|||
42269126|NCT02561156|76098243|FG008|Part 2|Adverse Event|0|||
42269127|NCT02561156|76098244|FG009|Part 2|Adverse Event|0|||
42269128|NCT02561156|76098245|FG010|Part 2|Adverse Event|0|||
42269129|NCT02561156|76098246|FG011|Part 2|Adverse Event|1|||
42269130|NCT02561156|76098247|FG012|Part 2|Adverse Event|0|||
42269131|NCT02561078|76098293|FG000|Overall Study|Adverse Event|5|||
42269132|NCT02561078|76098294|FG001|Overall Study|Adverse Event|2|||
42269133|NCT02561078|76098293|FG000|Overall Study|Death|2|||
42269134|NCT02561078|76098294|FG001|Overall Study|Death|1|||
42269135|NCT02561078|76098293|FG000|Overall Study|Lost to Follow-up|2|||
42269136|NCT02561078|76098294|FG001|Overall Study|Lost to Follow-up|6|||
42269137|NCT02561078|76098293|FG000|Overall Study|Non-Compliance with Study Drug|6|||
42269138|NCT02561078|76098294|FG001|Overall Study|Non-Compliance with Study Drug|3|||
42269139|NCT02561078|76098293|FG000|Overall Study|Physician Decision|2|||
42269140|NCT02561078|76098294|FG001|Overall Study|Physician Decision|3|||
42269141|NCT02561078|76098293|FG000|Overall Study|Withdrawal by Subject|13|||
42269142|NCT02561078|76098294|FG001|Overall Study|Withdrawal by Subject|10|||
42004131|NCT01094782|75812153|FG004|Overall Study|Withdrawal by Subject|5|||
42135632|NCT00457002|75946316|FG000|Overall Study|No longer met criteria|41|||
42135633|NCT00457002|75946317|FG001|Overall Study|No longer met criteria|37|||
42269143|NCT04907227|76098302|FG000|Overall Study|Death|10|||
42269144|NCT04907227|76098303|FG001|Overall Study|Death|7|||
42269145|NCT04907227|76098302|FG000|Overall Study|Withdrawal by Subject|1|||
42269146|NCT04907227|76098303|FG001|Overall Study|Withdrawal by Subject|0|||
42269147|NCT04907227|76098302|FG000|Overall Study|Participants ongoing in the study|30|||
42004132|NCT01094782|75812154|FG005|Overall Study|Withdrawal by Subject|0|||
42135634|NCT00457002|75946316|FG000|Overall Study|Administrative reason by Sponsor|1|||
42135635|NCT00457002|75946317|FG001|Overall Study|Administrative reason by Sponsor|0|||
42269148|NCT04907227|76098303|FG001|Overall Study|Participants ongoing in the study|33|||
42135636|NCT00457002|75946316|FG000|Overall Study|non-specified|29|||
42004133|NCT01094782|75812149|FG000|Overall Study|Lost to Follow-up|1|||
42004134|NCT01094782|75812150|FG001|Overall Study|Lost to Follow-up|0|||
42004135|NCT01094782|75812151|FG002|Overall Study|Lost to Follow-up|0|||
42004136|NCT01094782|75812152|FG003|Overall Study|Lost to Follow-up|2|||
42004137|NCT01094782|75812153|FG004|Overall Study|Lost to Follow-up|1|||
42004138|NCT01094782|75812154|FG005|Overall Study|Lost to Follow-up|4|||
42269149|NCT04881448|76098309|FG000|Overall Study|Study cancelled by sponsor|220|||
42269150|NCT04881448|76098309|FG000|Overall Study|Withdrawal by Subject|2|||
42269151|NCT04881448|76098309|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
42135637|NCT00457002|75946317|FG001|Overall Study|non-specified|38|||
42004139|NCT01094782|75812149|FG000|Overall Study|Positive Drug Screen|2|||
42004140|NCT01094782|75812150|FG001|Overall Study|Positive Drug Screen|2|||
42269152|NCT04275310|76098340|FG000|Overall Study|Non-randomized due to running out of funding|4|||
42269153|NCT04275310|76098341|FG001|Overall Study|Non-randomized due to running out of funding|0|||
42269154|NCT04157088|76098347|FG000|Overall Study|Study terminated by sponsor|23|||
42269155|NCT04157088|76098347|FG000|Overall Study|Withdrawal by Subject|4|||
42269156|NCT04157088|76098347|FG000|Overall Study|Lost to Follow-up|2|||
42269157|NCT04157088|76098347|FG000|Overall Study|Death|1|||
42269158|NCT04140266|76098355|FG000|Overall Study|Physician Decision|2|||
42269159|NCT04140266|76098356|FG001|Overall Study|Physician Decision|0|||
42269160|NCT04140266|76098355|FG000|Overall Study|Withdrawal by Subject|4|||
42269161|NCT04140266|76098356|FG001|Overall Study|Withdrawal by Subject|2|||
42269162|NCT03926143|76098379|FG000|Overall Study|Physician Decision|3|||
42269163|NCT03926143|76098379|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
42269164|NCT03926143|76098379|FG000|Overall Study|Adverse Event|2|||
42269165|NCT03926143|76098379|FG000|Overall Study|Progressive disease|3|||
42269166|NCT03018080|76098396|FG000|Overall Study|Death|12|||
42269167|NCT03018080|76098397|FG001|Overall Study|Death|19|||
42269168|NCT02781090|76098405|FG000|3-Month Follow-Up|Missed Visit|20|||
42004141|NCT01094782|75812151|FG002|Overall Study|Positive Drug Screen|1|||
42269169|NCT02781090|76098406|FG001|3-Month Follow-Up|Missed Visit|20|||
42269170|NCT02781090|76098405|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
42269171|NCT02781090|76098406|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
42269172|NCT02781090|76098405|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
42269173|NCT02781090|76098406|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
42269174|NCT02781090|76098405|FG000|3-Month Follow-Up|Death|1|||
42269175|NCT02781090|76098406|FG001|3-Month Follow-Up|Death|0|||
42269176|NCT02781090|76098405|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
42269177|NCT02781090|76098406|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
42269178|NCT02781090|76098405|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
42269179|NCT02781090|76098406|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
42269180|NCT02781090|76098405|FG000|6-Month Follow-Up|Death|0|||
42269181|NCT02781090|76098406|FG001|6-Month Follow-Up|Death|1|||
42269182|NCT02774291|76098414|FG000|Overall Study|Lost to Follow-up|1|||
42342465|NCT01957202|76181107|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42269183|NCT01897571|76098430|FG000|Overall Study|Lost to Follow-up|3|||
42269184|NCT01897571|76098431|FG001|Overall Study|Lost to Follow-up|0|||
42269185|NCT01897571|76098432|FG002|Overall Study|Lost to Follow-up|0|||
42269186|NCT01897571|76098433|FG003|Overall Study|Lost to Follow-up|0|||
42269187|NCT01897571|76098434|FG004|Overall Study|Lost to Follow-up|2|||
42269188|NCT01897571|76098435|FG005|Overall Study|Lost to Follow-up|0|||
42269189|NCT01897571|76098436|FG006|Overall Study|Lost to Follow-up|0|||
42269190|NCT01897571|76098437|FG007|Overall Study|Lost to Follow-up|0|||
42269191|NCT01897571|76098438|FG008|Overall Study|Lost to Follow-up|1|||
42269192|NCT01897571|76098439|FG009|Overall Study|Lost to Follow-up|2|||
42269193|NCT01897571|76098440|FG010|Overall Study|Lost to Follow-up|4|||
42269194|NCT01897571|76098430|FG000|Overall Study|Withdrawal by Subject|0|||
42269195|NCT01897571|76098431|FG001|Overall Study|Withdrawal by Subject|0|||
42269196|NCT01897571|76098432|FG002|Overall Study|Withdrawal by Subject|0|||
42269197|NCT01897571|76098433|FG003|Overall Study|Withdrawal by Subject|0|||
42269198|NCT01897571|76098434|FG004|Overall Study|Withdrawal by Subject|0|||
42269199|NCT01897571|76098435|FG005|Overall Study|Withdrawal by Subject|0|||
42269200|NCT01897571|76098436|FG006|Overall Study|Withdrawal by Subject|0|||
42269201|NCT01897571|76098437|FG007|Overall Study|Withdrawal by Subject|1|||
42269202|NCT01897571|76098438|FG008|Overall Study|Withdrawal by Subject|4|||
42269203|NCT01897571|76098439|FG009|Overall Study|Withdrawal by Subject|3|||
42269204|NCT01897571|76098440|FG010|Overall Study|Withdrawal by Subject|1|||
42269205|NCT01897571|76098430|FG000|Overall Study|Other|1|||
42269206|NCT01897571|76098431|FG001|Overall Study|Other|0|||
42269207|NCT01897571|76098432|FG002|Overall Study|Other|0|||
42269208|NCT01897571|76098433|FG003|Overall Study|Other|3|||
42269209|NCT01897571|76098434|FG004|Overall Study|Other|3|||
42269210|NCT01897571|76098435|FG005|Overall Study|Other|4|||
42269211|NCT01897571|76098436|FG006|Overall Study|Other|7|||
42269212|NCT01897571|76098437|FG007|Overall Study|Other|0|||
42004142|NCT01094782|75812152|FG003|Overall Study|Positive Drug Screen|1|||
42269213|NCT01897571|76098438|FG008|Overall Study|Other|0|||
42269214|NCT01897571|76098439|FG009|Overall Study|Other|0|||
42269215|NCT01897571|76098440|FG010|Overall Study|Other|0|||
42269216|NCT01897571|76098430|FG000|Overall Study|Enrolled in rollover study|0|||
42269217|NCT01897571|76098431|FG001|Overall Study|Enrolled in rollover study|0|||
42269218|NCT01897571|76098432|FG002|Overall Study|Enrolled in rollover study|0|||
42269219|NCT01897571|76098433|FG003|Overall Study|Enrolled in rollover study|0|||
42269220|NCT01897571|76098434|FG004|Overall Study|Enrolled in rollover study|0|||
42004143|NCT01094782|75812153|FG004|Overall Study|Positive Drug Screen|3|||
42004144|NCT01094782|75812154|FG005|Overall Study|Positive Drug Screen|2|||
42004145|NCT01094782|75812149|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
42269221|NCT01897571|76098435|FG005|Overall Study|Enrolled in rollover study|0|||
42269222|NCT01897571|76098436|FG006|Overall Study|Enrolled in rollover study|0|||
42269223|NCT01897571|76098437|FG007|Overall Study|Enrolled in rollover study|9|||
42269224|NCT01897571|76098438|FG008|Overall Study|Enrolled in rollover study|7|||
42269225|NCT01897571|76098439|FG009|Overall Study|Enrolled in rollover study|9|||
42269226|NCT01897571|76098440|FG010|Overall Study|Enrolled in rollover study|1|||
42269227|NCT01897571|76098430|FG000|Overall Study|Death|2|||
42269228|NCT01897571|76098431|FG001|Overall Study|Death|2|||
42269229|NCT01897571|76098432|FG002|Overall Study|Death|3|||
42269230|NCT01897571|76098433|FG003|Overall Study|Death|6|||
42035150|NCT00927069|75843465|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
42035151|NCT00927069|75843466|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
42035152|NCT00927069|75843467|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
42035153|NCT00927069|75843468|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
42269231|NCT01897571|76098434|FG004|Overall Study|Death|7|||
42269232|NCT01897571|76098435|FG005|Overall Study|Death|9|||
42269233|NCT01897571|76098436|FG006|Overall Study|Death|5|||
42269234|NCT01897571|76098437|FG007|Overall Study|Death|22|||
42269235|NCT01897571|76098438|FG008|Overall Study|Death|23|||
42269236|NCT01897571|76098439|FG009|Overall Study|Death|129|||
42269237|NCT01897571|76098440|FG010|Overall Study|Death|59|||
42269238|NCT01207778|76098462|FG000|Overall Study|Lost to Follow-up|0|||
42269239|NCT01207778|76098463|FG001|Overall Study|Lost to Follow-up|3|||
42269240|NCT01207778|76098464|FG002|Overall Study|Lost to Follow-up|3|||
42269241|NCT02567552|76098474|FG000|Overall Study|Adverse Event|0|||
42269242|NCT02567552|76098475|FG001|Overall Study|Adverse Event|1|||
42269243|NCT02561000|76098489|FG000|Overall Study|Withdrawal by Subject|2|||
42269244|NCT02561000|76098490|FG001|Overall Study|Withdrawal by Subject|3|||
42269245|NCT02561000|76098491|FG002|Overall Study|Withdrawal by Subject|0|||
42269246|NCT02561000|76098489|FG000|Overall Study|Adverse Event|0|||
42269247|NCT02561000|76098490|FG001|Overall Study|Adverse Event|1|||
42269248|NCT02561000|76098491|FG002|Overall Study|Adverse Event|0|||
42269249|NCT01663532|76098501|FG000|Overall Study|Lost to Follow-up|9|||
42269250|NCT01663532|76098502|FG001|Overall Study|Lost to Follow-up|10|||
42269251|NCT01663532|76098501|FG000|Overall Study|Adverse Event|7|||
42269252|NCT01663532|76098502|FG001|Overall Study|Adverse Event|13|||
42269253|NCT01663532|76098501|FG000|Overall Study|Met Withdrawal Criteria|7|||
42269254|NCT01663532|76098502|FG001|Overall Study|Met Withdrawal Criteria|6|||
42269255|NCT01663532|76098501|FG000|Overall Study|Physician Decision|1|||
42269256|NCT01663532|76098502|FG001|Overall Study|Physician Decision|1|||
42269257|NCT01663532|76098501|FG000|Overall Study|Withdrawal by Subject|35|||
42269258|NCT01663532|76098502|FG001|Overall Study|Withdrawal by Subject|17|||
42269259|NCT01663532|76098501|FG000|Overall Study|Lack of Efficacy|15|||
42269260|NCT01663532|76098502|FG001|Overall Study|Lack of Efficacy|60|||
42269261|NCT02525939|76098510|FG000|Overall Study|Lost to Follow-up|27|||
42269262|NCT02525939|76098511|FG001|Overall Study|Lost to Follow-up|24|||
42269263|NCT02525939|76098510|FG000|Overall Study|Physician Decision|0|||
42269264|NCT02525939|76098511|FG001|Overall Study|Physician Decision|1|||
42269265|NCT02525939|76098510|FG000|Overall Study|Withdrawal by Subject|24|||
42269266|NCT02525939|76098511|FG001|Overall Study|Withdrawal by Subject|39|||
42269267|NCT02525939|76098510|FG000|Overall Study|Death|180|||
42269268|NCT02525939|76098511|FG001|Overall Study|Death|179|||
42004146|NCT01094782|75812150|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
42269269|NCT02697591|76098548|FG000|Overall Study|Lost to Follow-up|0|||
42269270|NCT02697591|76098549|FG001|Overall Study|Lost to Follow-up|0|||
42269271|NCT02697591|76098550|FG002|Overall Study|Lost to Follow-up|0|||
42269272|NCT02697591|76098551|FG003|Overall Study|Lost to Follow-up|0|||
42269273|NCT02697591|76098552|FG004|Overall Study|Lost to Follow-up|0|||
42269274|NCT02697591|76098553|FG005|Overall Study|Lost to Follow-up|1|||
42269275|NCT02697591|76098554|FG006|Overall Study|Lost to Follow-up|1|||
42269276|NCT02697591|76098555|FG007|Overall Study|Lost to Follow-up|0|||
42269277|NCT02697591|76098556|FG008|Overall Study|Lost to Follow-up|0|||
42269278|NCT02697591|76098557|FG009|Overall Study|Lost to Follow-up|1|||
42269279|NCT02697591|76098548|FG000|Overall Study|Withdrawal by Subject|1|||
42269280|NCT02697591|76098549|FG001|Overall Study|Withdrawal by Subject|1|||
42269281|NCT02697591|76098550|FG002|Overall Study|Withdrawal by Subject|2|||
42004147|NCT01094782|75812151|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
42342466|NCT01957202|76181108|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
42342467|NCT01957202|76181109|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342468|NCT01957202|76181110|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342469|NCT01957202|76181111|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342470|NCT01957202|76181112|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342471|NCT01957202|76181113|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342472|NCT01957202|76181114|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342473|NCT01957202|76181115|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342474|NCT01957202|76181116|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342475|NCT01957202|76181117|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342476|NCT01957202|76181118|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342477|NCT01957202|76181119|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342478|NCT01957202|76181120|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342479|NCT01957202|76181121|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342480|NCT01957202|76181122|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342481|NCT01957202|76181123|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
42342482|NCT01957202|76181124|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
42342483|NCT01957202|76181107|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342484|NCT01957202|76181108|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342485|NCT01957202|76181109|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342486|NCT01957202|76181110|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342487|NCT01957202|76181111|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
42269282|NCT02697591|76098551|FG003|Overall Study|Withdrawal by Subject|1|||
42342488|NCT01957202|76181112|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342489|NCT01957202|76181113|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342490|NCT01957202|76181114|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342491|NCT01957202|76181115|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342492|NCT01957202|76181116|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342493|NCT01957202|76181117|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
42269283|NCT02697591|76098552|FG004|Overall Study|Withdrawal by Subject|7|||
42269284|NCT02697591|76098553|FG005|Overall Study|Withdrawal by Subject|6|||
42269285|NCT02697591|76098554|FG006|Overall Study|Withdrawal by Subject|9|||
42269286|NCT02697591|76098555|FG007|Overall Study|Withdrawal by Subject|1|||
42269287|NCT02697591|76098556|FG008|Overall Study|Withdrawal by Subject|6|||
42269288|NCT02697591|76098557|FG009|Overall Study|Withdrawal by Subject|10|||
42269289|NCT02697591|76098548|FG000|Overall Study|Physician Decision|1|||
42269290|NCT02697591|76098549|FG001|Overall Study|Physician Decision|0|||
42269291|NCT02697591|76098550|FG002|Overall Study|Physician Decision|0|||
42269292|NCT02697591|76098551|FG003|Overall Study|Physician Decision|0|||
42269293|NCT02697591|76098552|FG004|Overall Study|Physician Decision|1|||
42269294|NCT02697591|76098553|FG005|Overall Study|Physician Decision|2|||
42269295|NCT02697591|76098554|FG006|Overall Study|Physician Decision|0|||
42269296|NCT02697591|76098555|FG007|Overall Study|Physician Decision|0|||
42269297|NCT02697591|76098556|FG008|Overall Study|Physician Decision|1|||
42269298|NCT02697591|76098557|FG009|Overall Study|Physician Decision|1|||
42269299|NCT02697591|76098548|FG000|Overall Study|Death|2|||
42269300|NCT02697591|76098549|FG001|Overall Study|Death|3|||
42269301|NCT02697591|76098550|FG002|Overall Study|Death|1|||
42269302|NCT02697591|76098551|FG003|Overall Study|Death|1|||
42269303|NCT02697591|76098552|FG004|Overall Study|Death|4|||
42269304|NCT02697591|76098553|FG005|Overall Study|Death|5|||
42269305|NCT02697591|76098554|FG006|Overall Study|Death|3|||
42269306|NCT02697591|76098555|FG007|Overall Study|Death|1|||
42004148|NCT01094782|75812152|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
42004149|NCT01094782|75812153|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
42004150|NCT01094782|75812154|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
42004151|NCT01094782|75812149|FG000|Overall Study|Unable to Complete Questionnaires|0|||
42342494|NCT01957202|76181118|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342495|NCT01957202|76181119|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342496|NCT01957202|76181120|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342497|NCT01957202|76181121|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
42342498|NCT01957202|76181122|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
42004152|NCT01094782|75812150|FG001|Overall Study|Unable to Complete Questionnaires|1|||
42004153|NCT01094782|75812151|FG002|Overall Study|Unable to Complete Questionnaires|0|||
42004154|NCT01094782|75812152|FG003|Overall Study|Unable to Complete Questionnaires|0|||
42004155|NCT01094782|75812153|FG004|Overall Study|Unable to Complete Questionnaires|0|||
42269307|NCT02697591|76098556|FG008|Overall Study|Death|1|||
42269308|NCT02697591|76098557|FG009|Overall Study|Death|5|||
42269309|NCT02697591|76098548|FG000|Overall Study|Reason not Specified|0|||
42269310|NCT02697591|76098549|FG001|Overall Study|Reason not Specified|0|||
42269311|NCT02697591|76098550|FG002|Overall Study|Reason not Specified|0|||
42269312|NCT02697591|76098551|FG003|Overall Study|Reason not Specified|1|||
42269313|NCT02697591|76098552|FG004|Overall Study|Reason not Specified|1|||
42269314|NCT02697591|76098553|FG005|Overall Study|Reason not Specified|2|||
42269315|NCT02697591|76098554|FG006|Overall Study|Reason not Specified|3|||
42269316|NCT02697591|76098555|FG007|Overall Study|Reason not Specified|1|||
42269317|NCT02697591|76098556|FG008|Overall Study|Reason not Specified|1|||
42269318|NCT02697591|76098557|FG009|Overall Study|Reason not Specified|3|||
42269319|NCT02697435|76098582|FG000|Overall Study|Withdrawal by Subject|1|||
42269320|NCT02697435|76098583|FG001|Overall Study|Withdrawal by Subject|0|||
42269321|NCT02697435|76098582|FG000|Overall Study|Physician Decision|0|||
42269322|NCT02697435|76098583|FG001|Overall Study|Physician Decision|4|||
42269323|NCT02174861|76098590|FG000|Overall Study|Decision by sponsor|8|||
42269324|NCT02174861|76098590|FG000|Overall Study|Withdrawal by Subject|124|||
42269325|NCT02174861|76098590|FG000|Overall Study|Lost to Follow-up|26|||
42269326|NCT00140855|76098596|FG000|Overall Study|Progressive disease|2|||
42269327|NCT00700635|76098603|FG000|Overall Study|Adverse Event|1|||
42269328|NCT00700635|76098604|FG001|Overall Study|Adverse Event|0|||
42269329|NCT00700635|76098605|FG002|Overall Study|Adverse Event|0|||
42269330|NCT00700635|76098603|FG000|Overall Study|Lost to Follow-up|1|||
42269331|NCT00700635|76098604|FG001|Overall Study|Lost to Follow-up|3|||
42269332|NCT00700635|76098605|FG002|Overall Study|Lost to Follow-up|0|||
42269333|NCT00700635|76098603|FG000|Overall Study|Protocol Violation|2|||
42269334|NCT00700635|76098604|FG001|Overall Study|Protocol Violation|2|||
42269335|NCT00700635|76098605|FG002|Overall Study|Protocol Violation|0|||
42269336|NCT00700635|76098603|FG000|Overall Study|Withdrawal by Subject|7|||
42342499|NCT01957202|76181123|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
42342500|NCT01957202|76181124|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
42269337|NCT00700635|76098604|FG001|Overall Study|Withdrawal by Subject|3|||
42269338|NCT00700635|76098605|FG002|Overall Study|Withdrawal by Subject|1|||
42269339|NCT02780687|76098615|FG000|Overall Study|Adverse Event|1|||
42342501|NCT01616654|76181139|FG000|Overall Study|Lack of Efficacy|1|||
42342502|NCT01616654|76181140|FG001|Overall Study|Lack of Efficacy|0|||
42269340|NCT02780687|76098616|FG001|Overall Study|Adverse Event|1|||
42269341|NCT02780687|76098615|FG000|Overall Study|Withdrawal by Subject|2|||
42342503|NCT01616654|76181141|FG002|Overall Study|Lack of Efficacy|0|||
42135638|NCT00457002|75946316|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
42135639|NCT00457002|75946317|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
42135640|NCT00362115|75946330|FG000|Overall Study|Adverse Event|0|||
42135641|NCT00362115|75946331|FG001|Overall Study|Adverse Event|1|||
42135642|NCT00362115|75946332|FG002|Overall Study|Adverse Event|1|||
42135643|NCT00362115|75946333|FG003|Overall Study|Adverse Event|1|||
42135644|NCT00362115|75946334|FG004|Overall Study|Adverse Event|2|||
42135645|NCT00362115|75946335|FG005|Overall Study|Adverse Event|2|||
42135646|NCT00362115|75946336|FG006|Overall Study|Adverse Event|1|||
42135647|NCT00362115|75946330|FG000|Overall Study|Protocol Violation|0|||
42135648|NCT00362115|75946331|FG001|Overall Study|Protocol Violation|0|||
42135649|NCT00362115|75946332|FG002|Overall Study|Protocol Violation|0|||
42135650|NCT00362115|75946333|FG003|Overall Study|Protocol Violation|0|||
42135651|NCT00362115|75946334|FG004|Overall Study|Protocol Violation|0|||
42269342|NCT02780687|76098616|FG001|Overall Study|Withdrawal by Subject|1|||
42269343|NCT02780687|76098615|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
42269344|NCT02780687|76098616|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
42269345|NCT02780687|76098615|FG000|Overall Study|progressive disease|29|||
42004156|NCT01094782|75812154|FG005|Overall Study|Unable to Complete Questionnaires|0|||
42269346|NCT02780687|76098616|FG001|Overall Study|progressive disease|6|||
42269347|NCT02698371|76098621|FG000|All Participants Flow|Lost to Follow-up|3|||
42269348|NCT02698371|76098621|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
42269349|NCT02698371|76098621|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
42269350|NCT02698371|76098621|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
42269351|NCT02698371|76098621|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
42004157|NCT01094782|75812149|FG000|Overall Study|Healthy Subject Had Pain|0|||
42004158|NCT01094782|75812150|FG001|Overall Study|Healthy Subject Had Pain|1|||
42004159|NCT01094782|75812151|FG002|Overall Study|Healthy Subject Had Pain|0|||
42135652|NCT00362115|75946335|FG005|Overall Study|Protocol Violation|1|||
42135653|NCT00362115|75946336|FG006|Overall Study|Protocol Violation|0|||
42135654|NCT00362115|75946330|FG000|Overall Study|Lost to Follow-up|0|||
42269352|NCT02698371|76098621|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
42269353|NCT02698371|76098621|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
42269354|NCT02781311|76098640|FG000|Overall Study|Adverse Event|2|||
42269355|NCT02781311|76098641|FG001|Overall Study|Adverse Event|6|||
42269356|NCT02781311|76098642|FG002|Overall Study|Adverse Event|1|||
42269357|NCT02781311|76098640|FG000|Overall Study|Withdrawal of Consent|11|||
42269358|NCT02781311|76098641|FG001|Overall Study|Withdrawal of Consent|12|||
42342504|NCT01616654|76181142|FG003|Overall Study|Lack of Efficacy|0|||
42342505|NCT01616654|76181143|FG004|Overall Study|Lack of Efficacy|1|||
42342506|NCT01616654|76181139|FG000|Overall Study|Adverse Event|0|||
42342507|NCT01616654|76181140|FG001|Overall Study|Adverse Event|1|||
42342508|NCT01616654|76181141|FG002|Overall Study|Adverse Event|2|||
42342509|NCT01616654|76181142|FG003|Overall Study|Adverse Event|1|||
42342510|NCT01616654|76181143|FG004|Overall Study|Adverse Event|0|||
42342511|NCT01616654|76181139|FG000|Overall Study|Withdrawal by Subject|2|||
42342512|NCT01616654|76181140|FG001|Overall Study|Withdrawal by Subject|2|||
42342513|NCT01616654|76181141|FG002|Overall Study|Withdrawal by Subject|3|||
42342514|NCT01616654|76181142|FG003|Overall Study|Withdrawal by Subject|1|||
42342515|NCT01616654|76181143|FG004|Overall Study|Withdrawal by Subject|5|||
42135655|NCT00362115|75946331|FG001|Overall Study|Lost to Follow-up|1|||
42269359|NCT02781311|76098642|FG002|Overall Study|Withdrawal of Consent|2|||
42269360|NCT02781311|76098640|FG000|Overall Study|Lost to Follow-up|11|||
42269361|NCT02781311|76098641|FG001|Overall Study|Lost to Follow-up|8|||
42269362|NCT02781311|76098642|FG002|Overall Study|Lost to Follow-up|1|||
42269363|NCT02781311|76098640|FG000|Overall Study|Non-Compliance with Study Drug|2|||
42269364|NCT02781311|76098641|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42269365|NCT02781311|76098642|FG002|Overall Study|Non-Compliance with Study Drug|0|||
42269366|NCT02564198|76098652|FG000|Overall Study|Withdrawal by Subject|2|||
42269367|NCT02564198|76098653|FG001|Overall Study|Withdrawal by Subject|4|||
42269368|NCT02564198|76098654|FG002|Overall Study|Withdrawal by Subject|0|||
42269369|NCT02564198|76098652|FG000|Overall Study|Adverse Event|0|||
42269370|NCT02564198|76098653|FG001|Overall Study|Adverse Event|1|||
42342516|NCT01616654|76181139|FG000|Overall Study|Protocol Violation|0|||
42342517|NCT01616654|76181140|FG001|Overall Study|Protocol Violation|5|||
42342518|NCT01616654|76181141|FG002|Overall Study|Protocol Violation|2|||
42342519|NCT01616654|76181142|FG003|Overall Study|Protocol Violation|4|||
42269371|NCT02564198|76098654|FG002|Overall Study|Adverse Event|0|||
42269372|NCT02564120|76098669|FG000|Overall Study|Did not return release forms|160|||
42269373|NCT02564120|76098669|FG000|Overall Study|Death|58|||
42342520|NCT01616654|76181143|FG004|Overall Study|Protocol Violation|4|||
42342521|NCT01616654|76181139|FG000|Overall Study|Lost to Follow-up|1|||
42342522|NCT01616654|76181140|FG001|Overall Study|Lost to Follow-up|0|||
42342523|NCT01616654|76181141|FG002|Overall Study|Lost to Follow-up|3|||
42342524|NCT01616654|76181142|FG003|Overall Study|Lost to Follow-up|2|||
42342525|NCT01616654|76181143|FG004|Overall Study|Lost to Follow-up|1|||
42342526|NCT01616654|76181139|FG000|Overall Study|Pregnancy|1|||
42342527|NCT01616654|76181140|FG001|Overall Study|Pregnancy|0|||
42342528|NCT01616654|76181141|FG002|Overall Study|Pregnancy|0|||
42342529|NCT01616654|76181142|FG003|Overall Study|Pregnancy|0|||
42342530|NCT01616654|76181143|FG004|Overall Study|Pregnancy|1|||
42342531|NCT01902290|76181158|FG000|Overall Study|Withdrawal by Subject|19|||
42342532|NCT01902290|76181159|FG001|Overall Study|Withdrawal by Subject|27|||
42342533|NCT01902290|76181158|FG000|Overall Study|Lost to Follow-up|2|||
42342534|NCT01902290|76181159|FG001|Overall Study|Lost to Follow-up|2|||
42342535|NCT01902290|76181158|FG000|Overall Study|Death|1|||
42342536|NCT01902290|76181159|FG001|Overall Study|Death|0|||
42342537|NCT01902290|76181158|FG000|Overall Study|Sponsor Decision|26|||
42342538|NCT01902290|76181159|FG001|Overall Study|Sponsor Decision|24|||
42342539|NCT01927562|76181166|FG000|Overall Study|Lost to Follow-up|30|||
42342540|NCT01927562|76181166|FG000|Overall Study|Withdrawal by Subject|3|||
42342541|NCT01927562|76181166|FG000|Overall Study|Physician Decision|5|||
42342542|NCT01467466|76181174|FG000|Overall Study|Withdrawal by Subject|15|||
42342543|NCT01467466|76181175|FG001|Overall Study|Withdrawal by Subject|18|||
42342544|NCT01467466|76181176|FG002|Overall Study|Withdrawal by Subject|13|||
42342545|NCT01467466|76181177|FG003|Overall Study|Withdrawal by Subject|11|||
42342546|NCT01467466|76181174|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
42342547|NCT01467466|76181175|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
42342548|NCT01467466|76181176|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
42342549|NCT01467466|76181177|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
42342550|NCT01467466|76181174|FG000|Overall Study|Procedure Cancelled|46|||
42342551|NCT01467466|76181175|FG001|Overall Study|Procedure Cancelled|45|||
42342552|NCT01467466|76181176|FG002|Overall Study|Procedure Cancelled|25|||
42342553|NCT01467466|76181177|FG003|Overall Study|Procedure Cancelled|29|||
42342554|NCT01467466|76181174|FG000|Overall Study|No Endpoint Blood Draw|38|||
42342555|NCT01467466|76181175|FG001|Overall Study|No Endpoint Blood Draw|32|||
42342556|NCT01467466|76181176|FG002|Overall Study|No Endpoint Blood Draw|51|||
42342557|NCT01467466|76181177|FG003|Overall Study|No Endpoint Blood Draw|43|||
42342558|NCT01441180|76181190|FG000|Overall Study|Lost to Follow-up|1|||
42342559|NCT01441180|76181191|FG001|Overall Study|Lost to Follow-up|1|||
42004160|NCT01094782|75812152|FG003|Overall Study|Healthy Subject Had Pain|0|||
42004161|NCT01094782|75812153|FG004|Overall Study|Healthy Subject Had Pain|0|||
42004162|NCT01094782|75812154|FG005|Overall Study|Healthy Subject Had Pain|0|||
42004163|NCT01094782|75812149|FG000|Overall Study|Hypertension|0|||
42004164|NCT01094782|75812150|FG001|Overall Study|Hypertension|0|||
42342560|NCT01441180|76181192|FG002|Overall Study|Lost to Follow-up|1|||
42342561|NCT01441180|76181190|FG000|Overall Study|Discontinued|0|||
42342562|NCT01441180|76181191|FG001|Overall Study|Discontinued|0|||
42342563|NCT01441180|76181192|FG002|Overall Study|Discontinued|2|||
42342564|NCT01441102|76181203|FG000|Overall Study|Adverse Event|1|||
42342565|NCT01441102|76181203|FG000|Overall Study|Withdrawal by Subject|2|||
42342566|NCT01467076|76181210|FG000|Overall Study|Lost to Follow-up|1|||
42342567|NCT01467076|76181211|FG001|Overall Study|Lost to Follow-up|0|||
42342568|NCT01467076|76181212|FG002|Overall Study|Lost to Follow-up|0|||
42342569|NCT01466062|76181220|FG000|Overall Study|Adverse Event|1|||
42342570|NCT01466062|76181220|FG000|Overall Study|Withdrawal by Subject|1|||
42342571|NCT01435018|76181227|FG000|Overall Study|Death|37|||
42342572|NCT01435018|76181228|FG001|Overall Study|Death|18|||
42342573|NCT01435018|76181229|FG002|Overall Study|Death|25|||
42342574|NCT01435018|76181227|FG000|Overall Study|Site is closing|4|||
42342575|NCT01435018|76181228|FG001|Overall Study|Site is closing|9|||
42342576|NCT01435018|76181229|FG002|Overall Study|Site is closing|7|||
42342577|NCT01435018|76181227|FG000|Overall Study|Withdrew consent|0|||
42342578|NCT01435018|76181228|FG001|Overall Study|Withdrew consent|3|||
42342579|NCT01435018|76181229|FG002|Overall Study|Withdrew consent|1|||
42342580|NCT01435018|76181227|FG000|Overall Study|Not willing to adhere to requirements|0|||
42342581|NCT01435018|76181228|FG001|Overall Study|Not willing to adhere to requirements|2|||
42342582|NCT01435018|76181229|FG002|Overall Study|Not willing to adhere to requirements|3|||
42342583|NCT01435018|76181227|FG000|Overall Study|Not able to get to clinic|2|||
42342584|NCT01435018|76181228|FG001|Overall Study|Not able to get to clinic|0|||
42342585|NCT01435018|76181229|FG002|Overall Study|Not able to get to clinic|2|||
42342586|NCT01435018|76181227|FG000|Overall Study|Severe debilitation, unable to continue|0|||
42342587|NCT01435018|76181228|FG001|Overall Study|Severe debilitation, unable to continue|0|||
42342588|NCT01435018|76181229|FG002|Overall Study|Severe debilitation, unable to continue|1|||
42342589|NCT01435018|76181227|FG000|Overall Study|Unable to contact participant/parent|1|||
42342590|NCT01435018|76181228|FG001|Overall Study|Unable to contact participant/parent|1|||
42342591|NCT01435018|76181229|FG002|Overall Study|Unable to contact participant/parent|1|||
42342592|NCT01435018|76181227|FG000|Overall Study|Enrollment Violation|0|||
42342593|NCT01435018|76181228|FG001|Overall Study|Enrollment Violation|1|||
42342594|NCT01435018|76181229|FG002|Overall Study|Enrollment Violation|0|||
42342595|NCT01435018|76181227|FG000|Overall Study|Never started chemotherapy|3|||
42342596|NCT01435018|76181228|FG001|Overall Study|Never started chemotherapy|0|||
42342597|NCT01435018|76181229|FG002|Overall Study|Never started chemotherapy|1|||
42342598|NCT01419184|76181241|FG000|Overall Study|Site data not available|3|||
42342599|NCT01419184|76181242|FG001|Overall Study|Site data not available|2|||
42342600|NCT01419184|76181241|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
42342601|NCT01419184|76181242|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
42342602|NCT01419184|76181241|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
42342603|NCT01419184|76181242|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
42342604|NCT01419184|76181241|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
42342605|NCT01419184|76181242|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
42342606|NCT01419184|76181241|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
42342607|NCT01419184|76181242|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
42004165|NCT01094782|75812151|FG002|Overall Study|Hypertension|1|||
42004166|NCT01094782|75812152|FG003|Overall Study|Hypertension|0|||
42269374|NCT02564120|76098669|FG000|Overall Study|Withdrawal by Subject|204|||
42269375|NCT02564120|76098669|FG000|Overall Study|Other medical condition|24|||
42269376|NCT00705783|76098685|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
42004167|NCT01094782|75812153|FG004|Overall Study|Hypertension|0|||
42342608|NCT01419184|76181241|FG000|Overall Study|Participant randomized, not treated|1|||
42342609|NCT01419184|76181242|FG001|Overall Study|Participant randomized, not treated|0|||
42269377|NCT00705783|76098686|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
42269378|NCT00705783|76098687|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
42269379|NCT00705783|76098685|FG000|Conversion Phase|Lost to Follow-up|13|||
42269380|NCT00705783|76098686|FG001|Conversion Phase|Lost to Follow-up|0|||
42269381|NCT00705783|76098687|FG002|Conversion Phase|Lost to Follow-up|0|||
42269382|NCT00705783|76098685|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
42269383|NCT00705783|76098686|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
42269384|NCT00705783|76098687|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
42342610|NCT01417234|76181248|FG000|Overall Study|Subject non-compliant|3|||
42342611|NCT01417156|76181252|FG000|Overall Study|Adverse Event|12|||
42342612|NCT01417156|76181252|FG000|Overall Study|Protocol Violation|2|||
42269385|NCT00705783|76098685|FG000|Conversion Phase|Withdrawn by Investigator|4|||
42342613|NCT01417078|76181256|FG000|Overall Study|Withdrawal by Subject|1|||
42342614|NCT01954394|76181264|FG000|Overall Study|Enrolled but not treated|1|||
42342615|NCT01954394|76181265|FG001|Overall Study|Enrolled but not treated|0|||
42342616|NCT01954394|76181264|FG000|Overall Study|Adverse Event|10|||
42342617|NCT01954394|76181265|FG001|Overall Study|Adverse Event|23|||
42135656|NCT00362115|75946332|FG002|Overall Study|Lost to Follow-up|0|||
42342618|NCT01954394|76181264|FG000|Overall Study|Poor compliance to protocol|7|||
42342619|NCT01954394|76181265|FG001|Overall Study|Poor compliance to protocol|7|||
42342620|NCT01954394|76181264|FG000|Overall Study|Participant Moved|0|||
42342621|NCT01954394|76181265|FG001|Overall Study|Participant Moved|4|||
42035154|NCT00927069|75843465|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
42269386|NCT00705783|76098686|FG001|Conversion Phase|Withdrawn by Investigator|0|||
42269387|NCT00705783|76098687|FG002|Conversion Phase|Withdrawn by Investigator|0|||
42269388|NCT00705783|76098685|FG000|Conversion Phase|Withdrew Consent|24|||
42269389|NCT00705783|76098686|FG001|Conversion Phase|Withdrew Consent|0|||
42269390|NCT00705783|76098687|FG002|Conversion Phase|Withdrew Consent|0|||
42269391|NCT00705783|76098685|FG000|Conversion Phase|Protocol Deviation|2|||
42269392|NCT00705783|76098686|FG001|Conversion Phase|Protocol Deviation|0|||
42269393|NCT00705783|76098687|FG002|Conversion Phase|Protocol Deviation|0|||
42269394|NCT00705783|76098685|FG000|Conversion Phase|Adverse Event|11|||
42269395|NCT00705783|76098686|FG001|Conversion Phase|Adverse Event|0|||
42269396|NCT00705783|76098687|FG002|Conversion Phase|Adverse Event|0|||
42269397|NCT00705783|76098685|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
42269398|NCT00705783|76098686|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
42269399|NCT00705783|76098687|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
42269400|NCT00705783|76098685|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
42269401|NCT00705783|76098686|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
42269402|NCT00705783|76098687|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
42269403|NCT00705783|76098685|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
42269404|NCT00705783|76098686|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
42342622|NCT01954394|76181264|FG000|Overall Study|Related to Study Drug administration|2|||
42342623|NCT01954394|76181265|FG001|Overall Study|Related to Study Drug administration|2|||
42135657|NCT00362115|75946333|FG003|Overall Study|Lost to Follow-up|0|||
42135658|NCT00362115|75946334|FG004|Overall Study|Lost to Follow-up|2|||
42135659|NCT00362115|75946335|FG005|Overall Study|Lost to Follow-up|0|||
42135660|NCT00362115|75946336|FG006|Overall Study|Lost to Follow-up|1|||
42135661|NCT00362115|75946330|FG000|Overall Study|Withdrawal by Subject|1|||
42135662|NCT00362115|75946331|FG001|Overall Study|Withdrawal by Subject|3|||
42135663|NCT00362115|75946332|FG002|Overall Study|Withdrawal by Subject|1|||
42135664|NCT00362115|75946333|FG003|Overall Study|Withdrawal by Subject|0|||
42135665|NCT00362115|75946334|FG004|Overall Study|Withdrawal by Subject|1|||
42342624|NCT01954394|76181264|FG000|Overall Study|Other than specified above|10|||
42342625|NCT01954394|76181265|FG001|Overall Study|Other than specified above|21|||
42342626|NCT01464424|76181273|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
42135666|NCT00362115|75946335|FG005|Overall Study|Withdrawal by Subject|3|||
42269405|NCT00705783|76098687|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
42269406|NCT00705783|76098685|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
42269407|NCT00705783|76098686|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
42269408|NCT00705783|76098687|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
42269409|NCT00705783|76098685|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
42269410|NCT00705783|76098686|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
42269411|NCT00705783|76098687|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
42135667|NCT00362115|75946336|FG006|Overall Study|Withdrawal by Subject|4|||
42135668|NCT00362115|75946330|FG000|Overall Study|Lack of Efficacy|1|||
42269412|NCT00705783|76098685|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
42342627|NCT01464424|76181274|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
42342628|NCT01902134|76181286|FG000|Overall Study|Adverse Event|3|||
42342629|NCT01902134|76181287|FG001|Overall Study|Adverse Event|1|||
42342630|NCT01902134|76181288|FG002|Overall Study|Adverse Event|2|||
42342631|NCT01902134|76181289|FG003|Overall Study|Adverse Event|1|||
42342632|NCT01902134|76181290|FG004|Overall Study|Adverse Event|1|||
42342633|NCT01902134|76181291|FG005|Overall Study|Adverse Event|3|||
42342634|NCT01902134|76181286|FG000|Overall Study|Lack of Efficacy|0|||
42342635|NCT01902134|76181287|FG001|Overall Study|Lack of Efficacy|0|||
42342636|NCT01902134|76181288|FG002|Overall Study|Lack of Efficacy|2|||
42342637|NCT01902134|76181289|FG003|Overall Study|Lack of Efficacy|0|||
42342638|NCT01902134|76181290|FG004|Overall Study|Lack of Efficacy|0|||
42342639|NCT01902134|76181291|FG005|Overall Study|Lack of Efficacy|1|||
42342640|NCT01902134|76181286|FG000|Overall Study|Physician Decision|0|||
42342641|NCT01902134|76181287|FG001|Overall Study|Physician Decision|1|||
42342642|NCT01902134|76181288|FG002|Overall Study|Physician Decision|0|||
42342643|NCT01902134|76181289|FG003|Overall Study|Physician Decision|0|||
42342644|NCT01902134|76181290|FG004|Overall Study|Physician Decision|0|||
42342645|NCT01902134|76181291|FG005|Overall Study|Physician Decision|0|||
42342646|NCT01902134|76181286|FG000|Overall Study|Protocol Violation|0|||
42342647|NCT01902134|76181287|FG001|Overall Study|Protocol Violation|0|||
42342648|NCT01902134|76181288|FG002|Overall Study|Protocol Violation|0|||
42342649|NCT01902134|76181289|FG003|Overall Study|Protocol Violation|0|||
42342650|NCT01902134|76181290|FG004|Overall Study|Protocol Violation|0|||
42342651|NCT01902134|76181291|FG005|Overall Study|Protocol Violation|1|||
42342652|NCT01902134|76181286|FG000|Overall Study|Withdrawal by Subject|4|||
42342653|NCT01902134|76181287|FG001|Overall Study|Withdrawal by Subject|8|||
42342654|NCT01902134|76181288|FG002|Overall Study|Withdrawal by Subject|9|||
42342655|NCT01902134|76181289|FG003|Overall Study|Withdrawal by Subject|1|||
42342656|NCT01902134|76181290|FG004|Overall Study|Withdrawal by Subject|5|||
42342657|NCT01902134|76181291|FG005|Overall Study|Withdrawal by Subject|4|||
42342658|NCT01902134|76181286|FG000|Overall Study|no compliance|1|||
42342659|NCT01902134|76181287|FG001|Overall Study|no compliance|0|||
42342660|NCT01902134|76181288|FG002|Overall Study|no compliance|0|||
42342661|NCT01902134|76181289|FG003|Overall Study|no compliance|0|||
42342662|NCT01902134|76181290|FG004|Overall Study|no compliance|0|||
42342663|NCT01902134|76181291|FG005|Overall Study|no compliance|0|||
42342664|NCT01902134|76181286|FG000|Overall Study|Other|0|||
42342665|NCT01902134|76181287|FG001|Overall Study|Other|1|||
42342666|NCT01902134|76181288|FG002|Overall Study|Other|2|||
42342667|NCT01902134|76181289|FG003|Overall Study|Other|0|||
42342668|NCT01902134|76181290|FG004|Overall Study|Other|1|||
42342669|NCT01902134|76181291|FG005|Overall Study|Other|0|||
42342670|NCT01954082|76181309|FG000|Overall Study|Study Suspension|42|||
42342671|NCT01954082|76181310|FG001|Overall Study|Study Suspension|36|||
42342672|NCT01954082|76181309|FG000|Overall Study|Adverse Event|10|||
42342673|NCT01954082|76181310|FG001|Overall Study|Adverse Event|4|||
42342674|NCT01954082|76181309|FG000|Overall Study|Intolerance|0|||
42342675|NCT01954082|76181310|FG001|Overall Study|Intolerance|1|||
42342676|NCT01954082|76181309|FG000|Overall Study|Non-compliance|6|||
42342677|NCT01954082|76181310|FG001|Overall Study|Non-compliance|4|||
42342678|NCT01954082|76181309|FG000|Overall Study|Physician Decision|2|||
42342679|NCT01954082|76181310|FG001|Overall Study|Physician Decision|0|||
42342680|NCT01954082|76181309|FG000|Overall Study|Parent Decision|1|||
42342681|NCT01954082|76181310|FG001|Overall Study|Parent Decision|0|||
42342682|NCT01954082|76181309|FG000|Overall Study|Withdrawal by Subject|0|||
42342683|NCT01954082|76181310|FG001|Overall Study|Withdrawal by Subject|1|||
42342684|NCT01954082|76181309|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
42342685|NCT01954082|76181310|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
42342686|NCT01954082|76181309|FG000|Overall Study|Redirection of Care|0|||
42342687|NCT01954082|76181310|FG001|Overall Study|Redirection of Care|2|||
42342688|NCT01954082|76181309|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
42342689|NCT01954082|76181310|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
42135669|NCT00362115|75946331|FG001|Overall Study|Lack of Efficacy|0|||
42342690|NCT01954082|76181309|FG000|Overall Study|Comfort Care|0|||
42342691|NCT01954082|76181310|FG001|Overall Study|Comfort Care|1|||
42342692|NCT01954082|76181309|FG000|Overall Study|Infant Moved|0|||
42342693|NCT01954082|76181310|FG001|Overall Study|Infant Moved|1|||
42342694|NCT01954082|76181309|FG000|Overall Study|Randomized not Treated|4|||
42342695|NCT01954082|76181310|FG001|Overall Study|Randomized not Treated|2|||
42342696|NCT01417000|76181318|FG000|Overall Study|Death|59|||
42342697|NCT01417000|76181319|FG001|Overall Study|Death|28|||
42342698|NCT01417000|76181318|FG000|Overall Study|Lost to Follow-up|1|||
42342699|NCT01417000|76181319|FG001|Overall Study|Lost to Follow-up|0|||
42342700|NCT01417000|76181318|FG000|Overall Study|Study Terminated by Sponsor|1|||
42342701|NCT01417000|76181319|FG001|Overall Study|Study Terminated by Sponsor|1|||
42342702|NCT01416610|76181325|FG000|Overall Study|Adverse Event|4|||
42342703|NCT01416610|76181325|FG000|Overall Study|Adverse Event -Patient decision|3|||
42342704|NCT01416610|76181325|FG000|Overall Study|Lack of Efficacy|4|||
42342705|NCT01416610|76181325|FG000|Overall Study|No reason given|5|||
42342706|NCT01416610|76181325|FG000|Overall Study|Withdrawal by Subject|13|||
42342707|NCT01416610|76181325|FG000|Overall Study|Lost to Follow-up|7|||
42342708|NCT01416610|76181325|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
42342709|NCT01416142|76181333|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
42342710|NCT01416142|76181334|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
42342711|NCT01416142|76181335|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
42342712|NCT01415986|76181343|FG000|Overall Study|Lost to Follow-up|1|||
42342713|NCT01415908|76181350|FG000|Overall Study|Withdrawal by Subject|1|||
42342714|NCT01415908|76181351|FG001|Overall Study|Withdrawal by Subject|0|||
42342715|NCT01415518|76181359|FG000|Overall Study|Withdrawal by Subject|2|||
42342716|NCT01415518|76181360|FG001|Overall Study|Withdrawal by Subject|12|||
42342717|NCT01415518|76181359|FG000|Overall Study|Protocol Violation|6|||
42342718|NCT01415518|76181360|FG001|Overall Study|Protocol Violation|8|||
42342719|NCT01415518|76181359|FG000|Overall Study|Lost to Follow-up|3|||
42342720|NCT01415518|76181360|FG001|Overall Study|Lost to Follow-up|5|||
42342721|NCT01415518|76181359|FG000|Overall Study|Adverse Event|3|||
42342722|NCT01415518|76181360|FG001|Overall Study|Adverse Event|4|||
42342723|NCT01415518|76181359|FG000|Overall Study|Death|1|||
42342724|NCT01415518|76181360|FG001|Overall Study|Death|1|||
42342725|NCT01415518|76181359|FG000|Overall Study|Condition under Investigation Worsened|1|||
42342726|NCT01415518|76181360|FG001|Overall Study|Condition under Investigation Worsened|1|||
42342727|NCT01393600|76181366|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
42342728|NCT01393600|76181367|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
42342729|NCT01393600|76181368|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
42342730|NCT01393600|76181369|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
42342731|NCT01393600|76181366|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
42342732|NCT01393600|76181367|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
42342733|NCT01393600|76181368|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
42342734|NCT01393600|76181369|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
42342735|NCT01393600|76181366|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
42342736|NCT01393600|76181367|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
42342737|NCT01393600|76181368|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
42269413|NCT00705783|76098686|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
42269414|NCT00705783|76098687|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
42269415|NCT00705783|76098685|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
42269416|NCT00705783|76098686|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
42269417|NCT00705783|76098687|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
42269418|NCT00705783|76098685|FG000|Oral Stabilization Phase|Adverse Event|14|||
42269419|NCT00705783|76098686|FG001|Oral Stabilization Phase|Adverse Event|0|||
42269420|NCT00705783|76098687|FG002|Oral Stabilization Phase|Adverse Event|0|||
42269421|NCT00705783|76098685|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
42269422|NCT00705783|76098686|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
42269423|NCT00705783|76098687|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
42269424|NCT00705783|76098685|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
42269425|NCT00705783|76098686|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
42269426|NCT00705783|76098687|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
42269427|NCT00705783|76098685|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
42269428|NCT00705783|76098686|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
42269429|NCT00705783|76098687|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
42269430|NCT00705783|76098685|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
42269431|NCT00705783|76098686|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
42269432|NCT00705783|76098687|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
42269433|NCT00705783|76098685|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
42269434|NCT00705783|76098686|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
42035155|NCT00927069|75843466|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
42269435|NCT00705783|76098687|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
42269436|NCT00705783|76098685|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
42269437|NCT00705783|76098686|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
42269438|NCT00705783|76098687|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
42342738|NCT01393600|76181369|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
42342739|NCT01393600|76181366|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
42342740|NCT01393600|76181367|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
42342741|NCT01393600|76181368|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
42342742|NCT01393600|76181369|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
42342743|NCT01393600|76181366|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
42342744|NCT01393600|76181367|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
42342745|NCT01393600|76181368|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
42342746|NCT01393600|76181369|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
42342747|NCT01393600|76181366|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
42342748|NCT01393600|76181367|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
42342749|NCT01393600|76181368|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
42342750|NCT01393600|76181369|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
42342751|NCT01393600|76181366|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
42342752|NCT01393600|76181367|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
42342753|NCT01393600|76181368|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
42342754|NCT01393600|76181369|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
42342755|NCT01432756|76181385|FG000|Overall Study|Lost to Follow-up|1|||
42342756|NCT01432756|76181386|FG001|Overall Study|Lost to Follow-up|0|||
42342757|NCT01432756|76181387|FG002|Overall Study|Lost to Follow-up|2|||
42342758|NCT01432756|76181388|FG003|Overall Study|Lost to Follow-up|1|||
42342759|NCT01432600|76181399|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
42342760|NCT01432600|76181400|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
42342761|NCT01432600|76181401|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
42342762|NCT01432444|76181411|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
42342763|NCT01432444|76181412|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
42342764|NCT01432444|76181413|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
42342765|NCT01432444|76181411|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
42342766|NCT01432444|76181412|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
42342767|NCT01432444|76181413|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
42342768|NCT01432444|76181411|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
42342769|NCT01432444|76181412|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
42342770|NCT01432444|76181413|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
42342771|NCT01432444|76181411|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
42342772|NCT01432444|76181412|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
42342773|NCT01432444|76181413|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
42342774|NCT01432444|76181411|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
42342775|NCT01432444|76181412|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
42342776|NCT01432444|76181413|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
42342777|NCT01432444|76181411|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
42342778|NCT01432444|76181412|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
42342779|NCT01432444|76181413|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
42342780|NCT01432444|76181411|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
42342781|NCT01432444|76181412|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
42342782|NCT01432444|76181413|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
42342783|NCT01432444|76181411|FG000|Treatment Phase|Lost to Follow-up|0|||
42342784|NCT01432444|76181412|FG001|Treatment Phase|Lost to Follow-up|33|||
42342785|NCT01432444|76181413|FG002|Treatment Phase|Lost to Follow-up|0|||
42342786|NCT01432444|76181411|FG000|Treatment Phase|Adverse Event|0|||
42035156|NCT00927069|75843467|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
42035157|NCT00927069|75843468|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
42035158|NCT00927069|75843465|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
42035159|NCT00927069|75843466|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
42035160|NCT00927069|75843467|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
42035161|NCT00927069|75843468|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
42035162|NCT01031628|75843482|FG000|Overall Study|Study terminated early|0|||
42035163|NCT01031628|75843483|FG001|Overall Study|Study terminated early|1|||
42035164|NCT01031628|75843484|FG002|Overall Study|Study terminated early|3|||
42035165|NCT01031628|75843485|FG003|Overall Study|Study terminated early|0|||
42035166|NCT01031004|75843497|FG000|Overall Study|Protocol Violation|0|||
42035167|NCT01031004|75843498|FG001|Overall Study|Protocol Violation|1|||
42035168|NCT01031004|75843497|FG000|Overall Study|Lost to Follow-up|1|||
42035169|NCT01031004|75843498|FG001|Overall Study|Lost to Follow-up|0|||
42035170|NCT00931515|75843506|FG000|Overall Study|Lost to Follow-up|2|||
42035171|NCT00931515|75843507|FG001|Overall Study|Lost to Follow-up|5|||
42269439|NCT00705783|76098685|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
42035172|NCT01028352|75843513|FG000|Overall Study|Ineligible due to baseline average pain|5|||
42035173|NCT01028352|75843513|FG000|Overall Study|Withdrawal by Subject|1|||
42035174|NCT00929643|75843530|FG000|Overall Study|Protocol Violation|2|||
42269440|NCT00705783|76098686|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
42269441|NCT00705783|76098687|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
42269442|NCT00705783|76098685|FG000|Depot Stabilization Phase|Adverse Event|17|||
42269443|NCT00705783|76098686|FG001|Depot Stabilization Phase|Adverse Event|0|||
42269444|NCT00705783|76098687|FG002|Depot Stabilization Phase|Adverse Event|0|||
42269445|NCT00705783|76098685|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
42342787|NCT01432444|76181412|FG001|Treatment Phase|Adverse Event|37|||
42342788|NCT01432444|76181413|FG002|Treatment Phase|Adverse Event|0|||
42342789|NCT01432444|76181411|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
42342790|NCT01432444|76181412|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
42342791|NCT01432444|76181413|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
42342792|NCT01432444|76181411|FG000|Treatment Phase|Physician Decision|0|||
42342793|NCT01432444|76181412|FG001|Treatment Phase|Physician Decision|5|||
42342794|NCT01432444|76181413|FG002|Treatment Phase|Physician Decision|0|||
42342795|NCT01432444|76181411|FG000|Treatment Phase|Withdrawal by Subject|0|||
42342796|NCT01432444|76181412|FG001|Treatment Phase|Withdrawal by Subject|41|||
42342797|NCT01432444|76181413|FG002|Treatment Phase|Withdrawal by Subject|0|||
42342798|NCT01432444|76181411|FG000|Treatment Phase|Protocol Deviation|0|||
42342799|NCT01432444|76181412|FG001|Treatment Phase|Protocol Deviation|3|||
42342800|NCT01432444|76181413|FG002|Treatment Phase|Protocol Deviation|0|||
42342801|NCT01432444|76181411|FG000|Treatment Phase|Lack of Efficacy|0|||
42342802|NCT01432444|76181412|FG001|Treatment Phase|Lack of Efficacy|10|||
42342803|NCT01432444|76181413|FG002|Treatment Phase|Lack of Efficacy|0|||
42342804|NCT01432444|76181411|FG000|Extension Phase|Lost to Follow-up|0|||
42342805|NCT01432444|76181412|FG001|Extension Phase|Lost to Follow-up|0|||
42342806|NCT01432444|76181413|FG002|Extension Phase|Lost to Follow-up|17|||
42342807|NCT01432444|76181411|FG000|Extension Phase|Adverse Event|0|||
42342808|NCT01432444|76181412|FG001|Extension Phase|Adverse Event|0|||
42342809|NCT01432444|76181413|FG002|Extension Phase|Adverse Event|10|||
42342810|NCT01432444|76181411|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
42342811|NCT01432444|76181412|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
42342812|NCT01432444|76181413|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
42342813|NCT01432444|76181411|FG000|Extension Phase|Met Withdrawal Criteria|0|||
42342814|NCT01432444|76181412|FG001|Extension Phase|Met Withdrawal Criteria|0|||
42342815|NCT01432444|76181413|FG002|Extension Phase|Met Withdrawal Criteria|144|||
42342816|NCT01432444|76181411|FG000|Extension Phase|Physician Decision|0|||
42342817|NCT01432444|76181412|FG001|Extension Phase|Physician Decision|0|||
42342818|NCT01432444|76181413|FG002|Extension Phase|Physician Decision|1|||
42342819|NCT01432444|76181411|FG000|Extension Phase|Withdrawal by Subject|0|||
42342820|NCT01432444|76181412|FG001|Extension Phase|Withdrawal by Subject|0|||
42342821|NCT01432444|76181413|FG002|Extension Phase|Withdrawal by Subject|13|||
42342822|NCT01432366|76181418|FG000|Overall Study|Non-Responder|7|||
42342823|NCT01432366|76181418|FG000|Overall Study|Adverse Event|8|||
42342824|NCT01432366|76181418|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
42342825|NCT01432366|76181418|FG000|Overall Study|Pregnancy|1|||
42342826|NCT01432366|76181418|FG000|Overall Study|Lost to Follow-up|13|||
42342827|NCT01432366|76181418|FG000|Overall Study|Lack of Efficacy|1|||
42342828|NCT01432366|76181418|FG000|Overall Study|Site Closed|20|||
42342829|NCT01432366|76181418|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
42342830|NCT01432366|76181418|FG000|Overall Study|Other|14|||
42342831|NCT01415440|76181425|FG000|Overall Study|Lost to Follow-up|0|||
42342832|NCT01415440|76181426|FG001|Overall Study|Lost to Follow-up|1|||
42342833|NCT01415440|76181427|FG002|Overall Study|Lost to Follow-up|2|||
42342834|NCT01415440|76181425|FG000|Overall Study|Physician Decision|3|||
42342835|NCT01415440|76181426|FG001|Overall Study|Physician Decision|0|||
42342836|NCT01415440|76181427|FG002|Overall Study|Physician Decision|0|||
42342837|NCT01415440|76181425|FG000|Overall Study|Withdrawal by Subject|1|||
42342838|NCT01415440|76181426|FG001|Overall Study|Withdrawal by Subject|0|||
42342839|NCT01415440|76181427|FG002|Overall Study|Withdrawal by Subject|0|||
42342840|NCT01932788|76181445|FG000|Overall Study|Protocol Violation|18|||
42342841|NCT01932788|76181446|FG001|Overall Study|Protocol Violation|0|||
42342842|NCT01932788|76181445|FG000|Overall Study|Lost to Follow-up|18|||
42342843|NCT01932788|76181446|FG001|Overall Study|Lost to Follow-up|46|||
42342844|NCT01932788|76181445|FG000|Overall Study|Lack of Efficacy|2|||
42342845|NCT01932788|76181446|FG001|Overall Study|Lack of Efficacy|0|||
42342846|NCT01932788|76181445|FG000|Overall Study|Withdrawal by Subject|0|||
42342847|NCT01932788|76181446|FG001|Overall Study|Withdrawal by Subject|5|||
42342848|NCT01414738|76181452|FG000|Overall Study|Death|26|||
42342849|NCT01414738|76181452|FG000|Overall Study|Refused testing|5|||
42342850|NCT01414738|76181452|FG000|Overall Study|Lost to Follow-up|2|||
42342851|NCT01414738|76181452|FG000|Overall Study|Refused, disease progression|8|||
42342852|NCT01414738|76181452|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
42342853|NCT01414114|76181456|FG000|Overall Study|Adverse Event|2|||
42342854|NCT01414114|76181456|FG000|Overall Study|Withdrawal by Subject|1|||
42342855|NCT01414114|76181456|FG000|Overall Study|Other|2|||
42342856|NCT01393444|76181462|FG000|Overall Study|Withdrawal by Subject|1|||
42342857|NCT01393444|76181462|FG000|Overall Study|Determined ineligible during screening.|2|||
42342858|NCT01431976|76181466|FG000|Overall Study|Adverse Event|6|||
42342859|NCT01431976|76181466|FG000|Overall Study|Lack of Efficacy|2|||
42342860|NCT01431976|76181466|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
42135670|NCT00362115|75946332|FG002|Overall Study|Lack of Efficacy|5|||
42342861|NCT01431976|76181466|FG000|Overall Study|Physician Decision|1|||
42342862|NCT01431976|76181466|FG000|Overall Study|Withdrawal by Subject|1|||
42342863|NCT01392742|76181470|FG000|Overall Study|Premature study termination|42|||
42342864|NCT01392742|76181470|FG000|Overall Study|Failure to return|35|||
42342865|NCT01392742|76181470|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
42342866|NCT01392742|76181470|FG000|Overall Study|Lost to Follow-up|34|||
42342867|NCT01392742|76181470|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
42342868|NCT01392742|76181470|FG000|Overall Study|ITR and Protocol deviation|1|||
42342869|NCT01392742|76181470|FG000|Overall Study|Adverse event/intercurrent illness|17|||
42342870|NCT01392742|76181470|FG000|Overall Study|Protocol Violation|14|||
42342871|NCT01392742|76181470|FG000|Overall Study|Other|3|||
42342872|NCT01392742|76181470|FG000|Overall Study|Missing information|13|||
42342873|NCT01413958|76181476|FG000|Overall Study|Lost to Follow-up|0|||
42342874|NCT01413958|76181477|FG001|Overall Study|Lost to Follow-up|1|||
42342875|NCT01413178|76181486|FG000|Overall Study|Toxicity|1|||
42342876|NCT01413178|76181487|FG001|Overall Study|Toxicity|0|||
42342877|NCT01413178|76181486|FG000|Overall Study|Ineligible|0|||
42342878|NCT01413178|76181487|FG001|Overall Study|Ineligible|2|||
42342879|NCT01799889|76181505|FG000|Overall Study|Adverse Event|4|||
42342880|NCT01799889|76181506|FG001|Overall Study|Adverse Event|4|||
42342881|NCT01799889|76181507|FG002|Overall Study|Adverse Event|5|||
42342882|NCT01799889|76181508|FG003|Overall Study|Adverse Event|1|||
42342883|NCT01799889|76181509|FG004|Overall Study|Adverse Event|11|||
42342884|NCT01799889|76181510|FG005|Overall Study|Adverse Event|1|||
42342885|NCT01799889|76181511|FG006|Overall Study|Adverse Event|5|||
42342886|NCT01799889|76181512|FG007|Overall Study|Adverse Event|2|||
42342887|NCT01799889|76181513|FG008|Overall Study|Adverse Event|3|||
42342888|NCT01799889|76181514|FG009|Overall Study|Adverse Event|1|||
42342889|NCT01799889|76181515|FG010|Overall Study|Adverse Event|1|||
42342890|NCT01799889|76181516|FG011|Overall Study|Adverse Event|0|||
42342891|NCT01799889|76181505|FG000|Overall Study|Death|1|||
42342892|NCT01799889|76181506|FG001|Overall Study|Death|0|||
42342893|NCT01799889|76181507|FG002|Overall Study|Death|5|||
42342894|NCT01799889|76181508|FG003|Overall Study|Death|3|||
42342895|NCT01799889|76181509|FG004|Overall Study|Death|1|||
42342896|NCT01799889|76181510|FG005|Overall Study|Death|0|||
42342897|NCT01799889|76181511|FG006|Overall Study|Death|0|||
42342898|NCT01799889|76181512|FG007|Overall Study|Death|0|||
42342899|NCT01799889|76181513|FG008|Overall Study|Death|1|||
42342900|NCT01799889|76181514|FG009|Overall Study|Death|0|||
42342901|NCT01799889|76181515|FG010|Overall Study|Death|1|||
42342902|NCT01799889|76181516|FG011|Overall Study|Death|0|||
42342903|NCT01799889|76181505|FG000|Overall Study|Lack of Efficacy|1|||
42342904|NCT01799889|76181506|FG001|Overall Study|Lack of Efficacy|1|||
42342905|NCT01799889|76181507|FG002|Overall Study|Lack of Efficacy|0|||
42342906|NCT01799889|76181508|FG003|Overall Study|Lack of Efficacy|1|||
42342907|NCT01799889|76181509|FG004|Overall Study|Lack of Efficacy|2|||
42342908|NCT01799889|76181510|FG005|Overall Study|Lack of Efficacy|2|||
42342909|NCT01799889|76181511|FG006|Overall Study|Lack of Efficacy|0|||
42342910|NCT01799889|76181512|FG007|Overall Study|Lack of Efficacy|0|||
42342911|NCT01799889|76181513|FG008|Overall Study|Lack of Efficacy|2|||
42342912|NCT01799889|76181514|FG009|Overall Study|Lack of Efficacy|0|||
42342913|NCT01799889|76181515|FG010|Overall Study|Lack of Efficacy|1|||
42342914|NCT01799889|76181516|FG011|Overall Study|Lack of Efficacy|0|||
42342915|NCT01799889|76181505|FG000|Overall Study|Lost to Follow-up|0|||
42342916|NCT01799889|76181506|FG001|Overall Study|Lost to Follow-up|1|||
42342917|NCT01799889|76181507|FG002|Overall Study|Lost to Follow-up|0|||
42342918|NCT01799889|76181508|FG003|Overall Study|Lost to Follow-up|0|||
42342919|NCT01799889|76181509|FG004|Overall Study|Lost to Follow-up|0|||
42342920|NCT01799889|76181510|FG005|Overall Study|Lost to Follow-up|0|||
42342921|NCT01799889|76181511|FG006|Overall Study|Lost to Follow-up|0|||
42342922|NCT01799889|76181512|FG007|Overall Study|Lost to Follow-up|0|||
42342923|NCT01799889|76181513|FG008|Overall Study|Lost to Follow-up|0|||
42342924|NCT01799889|76181514|FG009|Overall Study|Lost to Follow-up|0|||
42342925|NCT01799889|76181515|FG010|Overall Study|Lost to Follow-up|0|||
42342926|NCT01799889|76181516|FG011|Overall Study|Lost to Follow-up|0|||
42342927|NCT01799889|76181505|FG000|Overall Study|Physician Decision|3|||
42342928|NCT01799889|76181506|FG001|Overall Study|Physician Decision|2|||
42342929|NCT01799889|76181507|FG002|Overall Study|Physician Decision|4|||
42342930|NCT01799889|76181508|FG003|Overall Study|Physician Decision|4|||
42342931|NCT01799889|76181509|FG004|Overall Study|Physician Decision|5|||
42342932|NCT01799889|76181510|FG005|Overall Study|Physician Decision|5|||
42342933|NCT01799889|76181511|FG006|Overall Study|Physician Decision|5|||
42342934|NCT01799889|76181512|FG007|Overall Study|Physician Decision|2|||
42342935|NCT01799889|76181513|FG008|Overall Study|Physician Decision|6|||
42342936|NCT01799889|76181514|FG009|Overall Study|Physician Decision|0|||
42342937|NCT01799889|76181515|FG010|Overall Study|Physician Decision|0|||
42342938|NCT01799889|76181516|FG011|Overall Study|Physician Decision|1|||
42342939|NCT01799889|76181505|FG000|Overall Study|Progressive Disease|30|||
42342940|NCT01799889|76181506|FG001|Overall Study|Progressive Disease|26|||
42342941|NCT01799889|76181507|FG002|Overall Study|Progressive Disease|25|||
42342942|NCT01799889|76181508|FG003|Overall Study|Progressive Disease|30|||
42342943|NCT01799889|76181509|FG004|Overall Study|Progressive Disease|23|||
42342944|NCT01799889|76181510|FG005|Overall Study|Progressive Disease|9|||
42342945|NCT01799889|76181511|FG006|Overall Study|Progressive Disease|8|||
42342946|NCT01799889|76181512|FG007|Overall Study|Progressive Disease|13|||
42342947|NCT01799889|76181513|FG008|Overall Study|Progressive Disease|18|||
42342948|NCT01799889|76181514|FG009|Overall Study|Progressive Disease|5|||
42342949|NCT01799889|76181515|FG010|Overall Study|Progressive Disease|3|||
42342950|NCT01799889|76181516|FG011|Overall Study|Progressive Disease|1|||
42342951|NCT01799889|76181505|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
42342952|NCT01799889|76181506|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
42342953|NCT01799889|76181507|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
42342954|NCT01799889|76181508|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
42342955|NCT01799889|76181509|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
42342956|NCT01799889|76181510|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
42342957|NCT01799889|76181511|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
42342958|NCT01799889|76181512|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
42342959|NCT01799889|76181513|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
42342960|NCT01799889|76181514|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
42342961|NCT01799889|76181515|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
42342962|NCT01799889|76181516|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
42342963|NCT01799889|76181505|FG000|Overall Study|Study Terminated By Sponsor|1|||
42342964|NCT01799889|76181506|FG001|Overall Study|Study Terminated By Sponsor|0|||
42342965|NCT01799889|76181507|FG002|Overall Study|Study Terminated By Sponsor|0|||
42342966|NCT01799889|76181508|FG003|Overall Study|Study Terminated By Sponsor|0|||
42342967|NCT01799889|76181509|FG004|Overall Study|Study Terminated By Sponsor|2|||
42342968|NCT01799889|76181510|FG005|Overall Study|Study Terminated By Sponsor|1|||
42342969|NCT01799889|76181511|FG006|Overall Study|Study Terminated By Sponsor|0|||
42342970|NCT01799889|76181512|FG007|Overall Study|Study Terminated By Sponsor|2|||
42342971|NCT01799889|76181513|FG008|Overall Study|Study Terminated By Sponsor|1|||
42342972|NCT01799889|76181514|FG009|Overall Study|Study Terminated By Sponsor|1|||
42342973|NCT01799889|76181515|FG010|Overall Study|Study Terminated By Sponsor|0|||
42342974|NCT01799889|76181516|FG011|Overall Study|Study Terminated By Sponsor|0|||
42342975|NCT01799889|76181505|FG000|Overall Study|Withdrawal by Subject|1|||
42342976|NCT01799889|76181506|FG001|Overall Study|Withdrawal by Subject|6|||
42342977|NCT01799889|76181507|FG002|Overall Study|Withdrawal by Subject|4|||
42342978|NCT01799889|76181508|FG003|Overall Study|Withdrawal by Subject|0|||
42342979|NCT01799889|76181509|FG004|Overall Study|Withdrawal by Subject|5|||
42342980|NCT01799889|76181510|FG005|Overall Study|Withdrawal by Subject|1|||
42342981|NCT01799889|76181511|FG006|Overall Study|Withdrawal by Subject|3|||
42342982|NCT01799889|76181512|FG007|Overall Study|Withdrawal by Subject|1|||
42342983|NCT01799889|76181513|FG008|Overall Study|Withdrawal by Subject|2|||
42342984|NCT01799889|76181514|FG009|Overall Study|Withdrawal by Subject|1|||
42342985|NCT01799889|76181515|FG010|Overall Study|Withdrawal by Subject|1|||
42342986|NCT01799889|76181516|FG011|Overall Study|Withdrawal by Subject|1|||
42342987|NCT01799889|76181505|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42342988|NCT01799889|76181506|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42342989|NCT01799889|76181507|FG002|Overall Study|Non-Compliance With Study Drug|0|||
42342990|NCT01799889|76181508|FG003|Overall Study|Non-Compliance With Study Drug|0|||
42342991|NCT01799889|76181509|FG004|Overall Study|Non-Compliance With Study Drug|0|||
42342992|NCT01799889|76181510|FG005|Overall Study|Non-Compliance With Study Drug|1|||
42342993|NCT01799889|76181511|FG006|Overall Study|Non-Compliance With Study Drug|0|||
42342994|NCT01799889|76181512|FG007|Overall Study|Non-Compliance With Study Drug|0|||
42342995|NCT01799889|76181513|FG008|Overall Study|Non-Compliance With Study Drug|0|||
42004168|NCT01094782|75812154|FG005|Overall Study|Hypertension|0|||
42004169|NCT01094782|75812149|FG000|Overall Study|Wrong Pain Condition|0|||
42269446|NCT00705783|76098686|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
42269447|NCT00705783|76098687|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
42269448|NCT00705783|76098685|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
42269449|NCT00705783|76098686|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
42269450|NCT00705783|76098687|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
42269451|NCT00705783|76098685|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
42269452|NCT00705783|76098686|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
42269453|NCT00705783|76098687|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
42269454|NCT00705783|76098685|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
42269455|NCT00705783|76098686|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
42342996|NCT01799889|76181514|FG009|Overall Study|Non-Compliance With Study Drug|0|||
42004170|NCT01094782|75812150|FG001|Overall Study|Wrong Pain Condition|0|||
42342997|NCT01799889|76181515|FG010|Overall Study|Non-Compliance With Study Drug|0|||
42342998|NCT01799889|76181516|FG011|Overall Study|Non-Compliance With Study Drug|0|||
42342999|NCT01412944|76181555|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
42343000|NCT01412944|76181556|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
42269456|NCT00705783|76098687|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
42343001|NCT01412944|76181557|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
42343002|NCT01412944|76181558|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
42343003|NCT01412944|76181559|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
42343004|NCT01412944|76181560|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
42343005|NCT01412944|76181555|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
42343006|NCT01412944|76181556|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
42343007|NCT01412944|76181557|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
42343008|NCT01412944|76181558|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
42343009|NCT01412944|76181559|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
42343010|NCT01412944|76181560|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
42343011|NCT01412944|76181555|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
42343012|NCT01412944|76181556|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
42343013|NCT01412944|76181557|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
42343014|NCT01412944|76181558|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
42343015|NCT01412944|76181559|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
42343016|NCT01412944|76181560|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
42343017|NCT01412944|76181555|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
42343018|NCT01412944|76181556|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
42343019|NCT01412944|76181557|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
42343020|NCT01412944|76181558|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
42343021|NCT01412944|76181559|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
42343022|NCT01412944|76181560|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
42343023|NCT01412944|76181555|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
42343024|NCT01412944|76181556|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
42343025|NCT01412944|76181557|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
42343026|NCT01412944|76181558|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
42343027|NCT01412944|76181559|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
42343028|NCT01412944|76181560|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
42343029|NCT01412944|76181555|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
42343030|NCT01412944|76181556|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
42343031|NCT01412944|76181557|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
42343032|NCT01412944|76181558|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
42343033|NCT01412944|76181559|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
42343034|NCT01412944|76181560|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
42343035|NCT01412944|76181555|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
42343036|NCT01412944|76181556|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
42343037|NCT01412944|76181557|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
42343038|NCT01412944|76181558|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
42343039|NCT01412944|76181559|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
42343040|NCT01412944|76181560|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
42343041|NCT01412944|76181555|FG000|Entire: IV + Maintenance|Adverse Event|0|||
42343042|NCT01412944|76181556|FG001|Entire: IV + Maintenance|Adverse Event|0|||
42343043|NCT01412944|76181557|FG002|Entire: IV + Maintenance|Adverse Event|0|||
42343044|NCT01412944|76181558|FG003|Entire: IV + Maintenance|Adverse Event|0|||
42343045|NCT01412944|76181559|FG004|Entire: IV + Maintenance|Adverse Event|1|||
42343046|NCT01412944|76181560|FG005|Entire: IV + Maintenance|Adverse Event|0|||
42343047|NCT01412944|76181555|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
42343048|NCT01412944|76181556|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
42343049|NCT01412944|76181557|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
42343050|NCT01412944|76181558|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
42343051|NCT01412944|76181559|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
42343052|NCT01412944|76181560|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
42343053|NCT01412944|76181555|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
42343054|NCT01412944|76181556|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
42343055|NCT01412944|76181557|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
42343056|NCT01412944|76181558|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
42269457|NCT00705783|76098685|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
42269458|NCT00705783|76098686|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
42269459|NCT00705783|76098687|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
42269460|NCT00705783|76098685|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
42269461|NCT00705783|76098686|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
42269462|NCT00705783|76098687|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
42269463|NCT00705783|76098685|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
42343057|NCT01412944|76181559|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
42343058|NCT01412944|76181560|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
42343059|NCT01412944|76181555|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
42269464|NCT00705783|76098686|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
42269465|NCT00705783|76098687|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
42004171|NCT01094782|75812151|FG002|Overall Study|Wrong Pain Condition|0|||
42269466|NCT00705783|76098685|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
42343060|NCT01412944|76181556|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
42343061|NCT01412944|76181557|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
42343062|NCT01412944|76181558|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
42343063|NCT01412944|76181559|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
42343064|NCT01412944|76181560|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
42343065|NCT01412944|76181555|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
42343066|NCT01412944|76181556|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
42343067|NCT01412944|76181557|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
42343068|NCT01412944|76181558|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
42343069|NCT01412944|76181559|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
42343070|NCT01412944|76181560|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
42343071|NCT01412944|76181555|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
42343072|NCT01412944|76181556|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
42343073|NCT01412944|76181557|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
42343074|NCT01412944|76181558|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
42343075|NCT01412944|76181559|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
42343076|NCT01412944|76181560|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
42343077|NCT01412944|76181555|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
42343078|NCT01412944|76181556|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
42343079|NCT01412944|76181557|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
42343080|NCT01412944|76181558|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
42343081|NCT01412944|76181559|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
42343082|NCT01412944|76181560|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
42343083|NCT01412944|76181555|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
42343084|NCT01412944|76181556|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
42343085|NCT01412944|76181557|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
42343086|NCT01412944|76181558|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
42343087|NCT01412944|76181559|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
42343088|NCT01412944|76181560|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
42135671|NCT00362115|75946333|FG003|Overall Study|Lack of Efficacy|2|||
42269467|NCT00705783|76098686|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
42269468|NCT00705783|76098687|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
42269469|NCT00705783|76098685|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
42269470|NCT00705783|76098686|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
42269471|NCT00705783|76098687|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
42269472|NCT00705783|76098685|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
42269473|NCT00705783|76098686|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
42343089|NCT01412944|76181555|FG000|Entire: IV + Maintenance|Adverse Event|0|||
42343090|NCT01412944|76181556|FG001|Entire: IV + Maintenance|Adverse Event|1|||
42343091|NCT01412944|76181557|FG002|Entire: IV + Maintenance|Adverse Event|0|||
42343092|NCT01412944|76181558|FG003|Entire: IV + Maintenance|Adverse Event|0|||
42343093|NCT01412944|76181559|FG004|Entire: IV + Maintenance|Adverse Event|0|||
42343094|NCT01412944|76181560|FG005|Entire: IV + Maintenance|Adverse Event|0|||
42343095|NCT01798485|76181578|FG000|Overall Study|Adverse Event|32|||
42269474|NCT00705783|76098687|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
42269475|NCT00705783|76098685|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
42269476|NCT00705783|76098686|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
42269477|NCT00705783|76098687|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
42269478|NCT02694549|76098696|FG000|Overall Study|screen failures|2|||
42343096|NCT01798485|76181579|FG001|Overall Study|Adverse Event|40|||
42343097|NCT01798485|76181578|FG000|Overall Study|Withdrawal by Subject|27|||
42343098|NCT01798485|76181579|FG001|Overall Study|Withdrawal by Subject|31|||
42343099|NCT01798485|76181578|FG000|Overall Study|Lost to Follow-up|0|||
42343100|NCT01798485|76181579|FG001|Overall Study|Lost to Follow-up|3|||
42343101|NCT01798485|76181578|FG000|Overall Study|Physician Decision|14|||
42343102|NCT01798485|76181579|FG001|Overall Study|Physician Decision|10|||
42343103|NCT01798485|76181578|FG000|Overall Study|Objective Disease Progression|152|||
42343104|NCT01798485|76181579|FG001|Overall Study|Objective Disease Progression|106|||
42343105|NCT01798485|76181578|FG000|Overall Study|Death|25|||
42343106|NCT01798485|76181579|FG001|Overall Study|Death|22|||
42343107|NCT01798485|76181578|FG000|Overall Study|Sponsor Decision|61|||
42343108|NCT01798485|76181579|FG001|Overall Study|Sponsor Decision|54|||
42343109|NCT01798485|76181578|FG000|Overall Study|Clinical Progression|35|||
42343110|NCT01798485|76181579|FG001|Overall Study|Clinical Progression|24|||
42343111|NCT01767597|76181587|FG000|Overall Study|Incomplete intervention|3|||
42343112|NCT01767597|76181588|FG001|Overall Study|Incomplete intervention|1|||
42343113|NCT01767597|76181587|FG000|Overall Study|Withdrawal by Subject|1|||
42343114|NCT01767597|76181588|FG001|Overall Study|Withdrawal by Subject|0|||
42343115|NCT01767519|76181597|FG000|Overall Study|Other Reasons|4|||
42343116|NCT01767519|76181598|FG001|Overall Study|Other Reasons|4|||
42343117|NCT01767519|76181599|FG002|Overall Study|Other Reasons|2|||
42343118|NCT01767519|76181597|FG000|Overall Study|Protocol Violation|0|||
42343119|NCT01767519|76181598|FG001|Overall Study|Protocol Violation|3|||
42343120|NCT01767519|76181599|FG002|Overall Study|Protocol Violation|0|||
42343121|NCT01767519|76181597|FG000|Overall Study|Personal Reasons|1|||
42343122|NCT01767519|76181598|FG001|Overall Study|Personal Reasons|0|||
42343123|NCT01767519|76181599|FG002|Overall Study|Personal Reasons|0|||
42343124|NCT01767519|76181597|FG000|Overall Study|Lost to Follow-up|3|||
42343125|NCT01767519|76181598|FG001|Overall Study|Lost to Follow-up|1|||
42343126|NCT01767519|76181599|FG002|Overall Study|Lost to Follow-up|2|||
42343127|NCT01767519|76181597|FG000|Overall Study|Lack of Efficacy|1|||
42343128|NCT01767519|76181598|FG001|Overall Study|Lack of Efficacy|0|||
42343129|NCT01767519|76181599|FG002|Overall Study|Lack of Efficacy|0|||
42269479|NCT02782325|76098702|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
42269480|NCT02782325|76098703|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
42269481|NCT02782325|76098704|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
42269482|NCT02782325|76098702|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
42269483|NCT02782325|76098703|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
42269484|NCT02782325|76098704|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
42343130|NCT01767519|76181597|FG000|Overall Study|Adverse Event|5|||
42343131|NCT01767519|76181598|FG001|Overall Study|Adverse Event|5|||
42343132|NCT01767519|76181599|FG002|Overall Study|Adverse Event|1|||
42343133|NCT01797783|76181609|FG000|Overall Study|Adverse Event|1|||
42343134|NCT01797783|76181610|FG001|Overall Study|Adverse Event|1|||
42343135|NCT01797783|76181609|FG000|Overall Study|Withdrawal by Subject|1|||
42343136|NCT01797783|76181610|FG001|Overall Study|Withdrawal by Subject|0|||
42343137|NCT01766817|76181627|FG000|Overall Study|Drug-related adverse event|1|||
42343138|NCT01766817|76181628|FG001|Overall Study|Drug-related adverse event|2|||
42343139|NCT01766817|76181629|FG002|Overall Study|Drug-related adverse event|1|||
42343140|NCT01766817|76181627|FG000|Overall Study|Drug-unrelated adverse event|3|||
42343141|NCT01766817|76181628|FG001|Overall Study|Drug-unrelated adverse event|3|||
42343142|NCT01766817|76181629|FG002|Overall Study|Drug-unrelated adverse event|3|||
42343143|NCT01766817|76181627|FG000|Overall Study|Death|1|||
42343144|NCT01766817|76181628|FG001|Overall Study|Death|1|||
42343145|NCT01766817|76181629|FG002|Overall Study|Death|0|||
42343146|NCT01766817|76181627|FG000|Overall Study|Unable to take study drug|0|||
42343147|NCT01766817|76181628|FG001|Overall Study|Unable to take study drug|1|||
42343148|NCT01766817|76181629|FG002|Overall Study|Unable to take study drug|0|||
42343149|NCT01766817|76181627|FG000|Overall Study|Withdrawal by Subject|2|||
42343150|NCT01766817|76181628|FG001|Overall Study|Withdrawal by Subject|0|||
42343151|NCT01766817|76181629|FG002|Overall Study|Withdrawal by Subject|3|||
42343152|NCT01766817|76181627|FG000|Overall Study|Subject non-compliance|0|||
42343153|NCT01766817|76181628|FG001|Overall Study|Subject non-compliance|1|||
42343154|NCT01766817|76181629|FG002|Overall Study|Subject non-compliance|2|||
42343155|NCT01766817|76181627|FG000|Overall Study|Physician Decision|3|||
42343156|NCT01766817|76181628|FG001|Overall Study|Physician Decision|3|||
42343157|NCT01766817|76181629|FG002|Overall Study|Physician Decision|4|||
42343158|NCT01766817|76181627|FG000|Overall Study|Other|1|||
42343159|NCT01766817|76181628|FG001|Overall Study|Other|0|||
42343160|NCT01766817|76181629|FG002|Overall Study|Other|0|||
42343161|NCT01797705|76181637|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
42343162|NCT01797705|76181637|FG000|Overall Study|Withdrawal by Subject|1|||
42343163|NCT01797081|76181645|FG000|Overall Study|Adverse Event|1|||
42343164|NCT01797081|76181646|FG001|Overall Study|Adverse Event|0|||
42343165|NCT01797081|76181647|FG002|Overall Study|Adverse Event|1|||
42343166|NCT01797081|76181648|FG003|Overall Study|Adverse Event|0|||
42343167|NCT01797081|76181645|FG000|Overall Study|Pregnancy|1|||
42343168|NCT01797081|76181646|FG001|Overall Study|Pregnancy|0|||
42343169|NCT01797081|76181647|FG002|Overall Study|Pregnancy|0|||
42343170|NCT01797081|76181648|FG003|Overall Study|Pregnancy|0|||
42135672|NCT00362115|75946334|FG004|Overall Study|Lack of Efficacy|2|||
42135673|NCT00362115|75946335|FG005|Overall Study|Lack of Efficacy|0|||
42343171|NCT01797081|76181645|FG000|Overall Study|Personal Reasons|12|||
42343172|NCT01797081|76181646|FG001|Overall Study|Personal Reasons|4|||
42343173|NCT01797081|76181647|FG002|Overall Study|Personal Reasons|4|||
42343174|NCT01797081|76181648|FG003|Overall Study|Personal Reasons|8|||
42135674|NCT00362115|75946336|FG006|Overall Study|Lack of Efficacy|3|||
42343175|NCT01797081|76181645|FG000|Overall Study|Protocol Violation|0|||
42343176|NCT01797081|76181646|FG001|Overall Study|Protocol Violation|0|||
42343177|NCT01797081|76181647|FG002|Overall Study|Protocol Violation|0|||
42004172|NCT01094782|75812152|FG003|Overall Study|Wrong Pain Condition|2|||
42004173|NCT01094782|75812153|FG004|Overall Study|Wrong Pain Condition|1|||
42004174|NCT01094782|75812154|FG005|Overall Study|Wrong Pain Condition|1|||
42004175|NCT01094782|75812149|FG000|Overall Study|Recent Interventional Injection|0|||
42004176|NCT01094782|75812150|FG001|Overall Study|Recent Interventional Injection|0|||
42004177|NCT01094782|75812151|FG002|Overall Study|Recent Interventional Injection|0|||
42004178|NCT01094782|75812152|FG003|Overall Study|Recent Interventional Injection|0|||
42004179|NCT01094782|75812153|FG004|Overall Study|Recent Interventional Injection|0|||
42004180|NCT01094782|75812154|FG005|Overall Study|Recent Interventional Injection|1|||
42004181|NCT01094782|75812149|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
42004182|NCT01094782|75812150|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
42004183|NCT01094782|75812151|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
42004184|NCT01094782|75812152|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
42004185|NCT01094782|75812153|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
42004186|NCT01094782|75812154|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
42004187|NCT01094782|75812149|FG000|Overall Study|Noncompliance With Study Schedule|0|||
42004188|NCT01094782|75812150|FG001|Overall Study|Noncompliance With Study Schedule|0|||
42004189|NCT01094782|75812151|FG002|Overall Study|Noncompliance With Study Schedule|0|||
42004190|NCT01094782|75812152|FG003|Overall Study|Noncompliance With Study Schedule|1|||
42135675|NCT00362115|75946330|FG000|Overall Study|Physician Decision|0|||
42269485|NCT02693691|76098712|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
42269486|NCT02693691|76098712|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
42269487|NCT02693691|76098712|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
42269488|NCT02693691|76098712|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
42269489|NCT02693691|76098712|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
42004191|NCT01094782|75812153|FG004|Overall Study|Noncompliance With Study Schedule|0|||
42004192|NCT01094782|75812154|FG005|Overall Study|Noncompliance With Study Schedule|0|||
42004193|NCT01097044|75812170|FG000|Overall Study|Withdrawal by Subject|4|||
42004194|NCT01097044|75812171|FG001|Overall Study|Withdrawal by Subject|4|||
42004195|NCT01097044|75812170|FG000|Overall Study|Lost to Follow-up|1|||
42004196|NCT01097044|75812171|FG001|Overall Study|Lost to Follow-up|0|||
42135676|NCT00362115|75946331|FG001|Overall Study|Physician Decision|0|||
42135677|NCT00362115|75946332|FG002|Overall Study|Physician Decision|0|||
42269490|NCT02693691|76098712|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
42269491|NCT02693691|76098712|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
42269492|NCT04203667|76098716|FG000|Overall Study|Withdrawal by Subject|1|||
42269493|NCT04203667|76098716|FG000|Overall Study|Lost to Follow-up|1|||
42269494|NCT04203667|76098716|FG000|Overall Study|Death|1|||
42343178|NCT01797081|76181648|FG003|Overall Study|Protocol Violation|1|||
42343179|NCT01794117|76181660|FG000|Overall Study|Adverse Event|1|||
42269495|NCT04203667|76098716|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
42269496|NCT02782169|76098723|FG000|Overall Study|Lost to Follow-up|1|||
42269497|NCT02782169|76098724|FG001|Overall Study|Lost to Follow-up|2|||
42269498|NCT02564042|76098736|FG000|Overall Study|Adverse Event|4|||
42343180|NCT01794117|76181661|FG001|Overall Study|Adverse Event|0|||
42343181|NCT01794117|76181662|FG002|Overall Study|Adverse Event|0|||
42343182|NCT01794117|76181663|FG003|Overall Study|Adverse Event|0|||
42343183|NCT01794117|76181660|FG000|Overall Study|Participant noncompliance|0|||
42343184|NCT01794117|76181661|FG001|Overall Study|Participant noncompliance|1|||
42269499|NCT02564042|76098737|FG001|Overall Study|Adverse Event|4|||
42269500|NCT02564042|76098738|FG002|Overall Study|Adverse Event|3|||
42269501|NCT02564042|76098739|FG003|Overall Study|Adverse Event|0|||
42269502|NCT02564042|76098740|FG004|Overall Study|Adverse Event|0|||
42343185|NCT01794117|76181662|FG002|Overall Study|Participant noncompliance|0|||
42343186|NCT01794117|76181663|FG003|Overall Study|Participant noncompliance|0|||
42343187|NCT01794117|76181660|FG000|Overall Study|Refused further treatment|0|||
42343188|NCT01794117|76181661|FG001|Overall Study|Refused further treatment|2|||
42343189|NCT01794117|76181662|FG002|Overall Study|Refused further treatment|0|||
42343190|NCT01794117|76181663|FG003|Overall Study|Refused further treatment|0|||
42343191|NCT01766037|76181676|FG000|Overall Study|Adverse Event|1|||
42135678|NCT00362115|75946333|FG003|Overall Study|Physician Decision|0|||
42343192|NCT01766037|76181677|FG001|Overall Study|Adverse Event|0|||
42343193|NCT01766037|76181676|FG000|Overall Study|Lack of Efficacy|1|||
42343194|NCT01766037|76181677|FG001|Overall Study|Lack of Efficacy|0|||
42343195|NCT01766037|76181676|FG000|Overall Study|Lost to Follow-up|0|||
42343196|NCT01766037|76181677|FG001|Overall Study|Lost to Follow-up|10|||
42343197|NCT01766037|76181676|FG000|Overall Study|Physician Decision|0|||
42343198|NCT01766037|76181677|FG001|Overall Study|Physician Decision|1|||
42343199|NCT01766037|76181676|FG000|Overall Study|Withdrawal by Subject|18|||
42343200|NCT01766037|76181677|FG001|Overall Study|Withdrawal by Subject|16|||
42343201|NCT01766037|76181676|FG000|Overall Study|Moved from area|5|||
42343202|NCT01766037|76181677|FG001|Overall Study|Moved from area|0|||
42343203|NCT01766037|76181676|FG000|Overall Study|medical - unrelated|1|||
42004197|NCT01097044|75812170|FG000|Overall Study|Withdrawal by Sponsor|0|||
42004198|NCT01097044|75812171|FG001|Overall Study|Withdrawal by Sponsor|1|||
42004199|NCT01322009|75812181|FG000|Overall Study|Death|0|||
42004200|NCT01322009|75812182|FG001|Overall Study|Death|1|||
42343204|NCT01766037|76181677|FG001|Overall Study|medical - unrelated|2|||
42343205|NCT01766037|76181676|FG000|Overall Study|nausea / discomfort|3|||
42343206|NCT01766037|76181677|FG001|Overall Study|nausea / discomfort|0|||
42343207|NCT01765569|76181683|FG000|Period B|Withdrawal by Subject|1|||
42343208|NCT01765569|76181683|FG000|Period C|Death|1|||
42343209|NCT01609257|76181692|FG000|Overall Study|Lost to Follow-up|2|||
42343210|NCT01609257|76181693|FG001|Overall Study|Lost to Follow-up|1|||
42343211|NCT01609257|76181692|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
42343212|NCT01609257|76181693|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
42343213|NCT01609257|76181692|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
42343214|NCT01609257|76181693|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
42343215|NCT01609023|76181702|FG000|Overall Study|Lack of Efficacy|3|||
42343216|NCT01609023|76181702|FG000|Overall Study|Withdrawal by Subject|4|||
42343217|NCT01609023|76181702|FG000|Overall Study|Lost to Follow-up|8|||
42343218|NCT01609023|76181702|FG000|Overall Study|Toxicity|3|||
42343219|NCT01609023|76181702|FG000|Overall Study|Disease progression|10|||
42343220|NCT01609023|76181702|FG000|Overall Study|Physician Decision|2|||
42343221|NCT01609023|76181702|FG000|Overall Study|Death|2|||
42343222|NCT01609023|76181702|FG000|Overall Study|Personal reasons|1|||
42343223|NCT01765179|76181706|FG000|Overall Study|Adverse Event|3|||
42343224|NCT01765179|76181706|FG000|Overall Study|Lost to Follow-up|5|||
42343225|NCT01765179|76181706|FG000|Overall Study|Non-compliance with study drug|2|||
42343226|NCT01765179|76181706|FG000|Overall Study|Protocol Violation|1|||
42343227|NCT01765179|76181706|FG000|Overall Study|Withdrawal by Subject|8|||
42343228|NCT01765179|76181706|FG000|Overall Study|Hematocrit >54%|3|||
42343229|NCT01765179|76181706|FG000|Overall Study|prohibited med|1|||
42343230|NCT01765179|76181706|FG000|Overall Study|Out of country unable to finish study|1|||
42343231|NCT01765179|76181706|FG000|Overall Study|lack of venous access|1|||
42343232|NCT01765179|76181706|FG000|Overall Study|work conflict|1|||
42343233|NCT01765179|76181706|FG000|Overall Study|Ca elevated 10.6|1|||
42343234|NCT01764945|76181718|FG000|Overall Study|Adverse Event|0|||
42269503|NCT02564042|76098741|FG005|Overall Study|Adverse Event|1|||
42269504|NCT02564042|76098736|FG000|Overall Study|Lost to Follow-up|1|||
42269505|NCT02564042|76098737|FG001|Overall Study|Lost to Follow-up|1|||
42269506|NCT02564042|76098738|FG002|Overall Study|Lost to Follow-up|1|||
42269507|NCT02564042|76098739|FG003|Overall Study|Lost to Follow-up|0|||
42269508|NCT02564042|76098740|FG004|Overall Study|Lost to Follow-up|1|||
42269509|NCT02564042|76098741|FG005|Overall Study|Lost to Follow-up|1|||
42269510|NCT02564042|76098736|FG000|Overall Study|Physician Decision|1|||
42269511|NCT02564042|76098737|FG001|Overall Study|Physician Decision|0|||
42269512|NCT02564042|76098738|FG002|Overall Study|Physician Decision|0|||
42269513|NCT02564042|76098739|FG003|Overall Study|Physician Decision|1|||
42269514|NCT02564042|76098740|FG004|Overall Study|Physician Decision|0|||
42269515|NCT02564042|76098741|FG005|Overall Study|Physician Decision|0|||
42269516|NCT02564042|76098736|FG000|Overall Study|Withdrawal by Subject|5|||
42269517|NCT02564042|76098737|FG001|Overall Study|Withdrawal by Subject|3|||
42343235|NCT01764945|76181719|FG001|Overall Study|Adverse Event|1|||
42343236|NCT01764945|76181720|FG002|Overall Study|Adverse Event|0|||
42343237|NCT01764945|76181721|FG003|Overall Study|Adverse Event|0|||
42343238|NCT01764945|76181722|FG004|Overall Study|Adverse Event|0|||
42343239|NCT01764945|76181723|FG005|Overall Study|Adverse Event|0|||
42343240|NCT01764945|76181724|FG006|Overall Study|Adverse Event|1|||
42343241|NCT01764945|76181725|FG007|Overall Study|Adverse Event|0|||
42343242|NCT01793883|76181746|FG000|Overall Study|Withdrawal by Subject|3|||
42269518|NCT02564042|76098738|FG002|Overall Study|Withdrawal by Subject|2|||
42269519|NCT02564042|76098739|FG003|Overall Study|Withdrawal by Subject|2|||
42269520|NCT02564042|76098740|FG004|Overall Study|Withdrawal by Subject|10|||
42269521|NCT02564042|76098741|FG005|Overall Study|Withdrawal by Subject|12|||
42269522|NCT02695719|76098774|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
42269523|NCT02695719|76098775|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
42269524|NCT02695719|76098774|FG000|Overall Study|Significant Protocol Deviation|0|||
42269525|NCT02695719|76098775|FG001|Overall Study|Significant Protocol Deviation|1|||
42269526|NCT02695719|76098774|FG000|Overall Study|Voluntary Withdrawal|1|||
42269527|NCT02695719|76098775|FG001|Overall Study|Voluntary Withdrawal|0|||
42269528|NCT02563106|76098792|FG000|Overall Study|Withdrawal by Subject|7|||
42269529|NCT02563106|76098793|FG001|Overall Study|Withdrawal by Subject|8|||
42269530|NCT02563106|76098792|FG000|Overall Study|Adverse Event|17|||
42269531|NCT02563106|76098793|FG001|Overall Study|Adverse Event|15|||
42135679|NCT00362115|75946334|FG004|Overall Study|Physician Decision|0|||
42343243|NCT01793883|76181747|FG001|Overall Study|Withdrawal by Subject|7|||
42343244|NCT01793883|76181748|FG002|Overall Study|Withdrawal by Subject|3|||
42343245|NCT01793883|76181746|FG000|Overall Study|Subject noncompliance|0|||
42343246|NCT01793883|76181747|FG001|Overall Study|Subject noncompliance|1|||
42343247|NCT01793883|76181748|FG002|Overall Study|Subject noncompliance|1|||
42343248|NCT01793883|76181746|FG000|Overall Study|Lost to Follow-up|5|||
42343249|NCT01793883|76181747|FG001|Overall Study|Lost to Follow-up|1|||
42343250|NCT01793883|76181748|FG002|Overall Study|Lost to Follow-up|3|||
42343251|NCT01793883|76181746|FG000|Overall Study|Randomized in error|1|||
42343252|NCT01793883|76181747|FG001|Overall Study|Randomized in error|0|||
42343253|NCT01793883|76181748|FG002|Overall Study|Randomized in error|0|||
42343254|NCT01793883|76181746|FG000|Overall Study|Unable to complete spriometry|1|||
42343255|NCT01793883|76181747|FG001|Overall Study|Unable to complete spriometry|0|||
42343256|NCT01793883|76181748|FG002|Overall Study|Unable to complete spriometry|0|||
42343257|NCT01793883|76181746|FG000|Overall Study|Unable to complete measurements|1|||
42343258|NCT01793883|76181747|FG001|Overall Study|Unable to complete measurements|0|||
42343259|NCT01793883|76181748|FG002|Overall Study|Unable to complete measurements|0|||
42343260|NCT01793883|76181746|FG000|Overall Study|Met exclusion criteria|1|||
42343261|NCT01793883|76181747|FG001|Overall Study|Met exclusion criteria|0|||
42343262|NCT01793883|76181748|FG002|Overall Study|Met exclusion criteria|0|||
42343263|NCT01793883|76181746|FG000|Overall Study|Dosing error|0|||
42343264|NCT01793883|76181747|FG001|Overall Study|Dosing error|1|||
42343265|NCT01793883|76181748|FG002|Overall Study|Dosing error|0|||
42343266|NCT01793883|76181746|FG000|Overall Study|Respiratory distress during spirometry|0|||
42343267|NCT01793883|76181747|FG001|Overall Study|Respiratory distress during spirometry|0|||
42343268|NCT01793883|76181748|FG002|Overall Study|Respiratory distress during spirometry|1|||
42343269|NCT01792635|76181759|FG000|Part B|Adverse Event|0|||
42343270|NCT01792635|76181760|FG001|Part B|Adverse Event|0|||
42343271|NCT01792635|76181761|FG002|Part B|Adverse Event|1|||
42343272|NCT01792635|76181759|FG000|Part B|Study terminated|0|||
42343273|NCT01792635|76181760|FG001|Part B|Study terminated|4|||
42343274|NCT01792635|76181761|FG002|Part B|Study terminated|3|||
42343275|NCT01953692|76181779|FG000|Overall Study|Adverse Event|5|||
42343276|NCT01953692|76181780|FG001|Overall Study|Adverse Event|2|||
42343277|NCT01953692|76181781|FG002|Overall Study|Adverse Event|4|||
42343278|NCT01953692|76181782|FG003|Overall Study|Adverse Event|2|||
42343279|NCT01953692|76181783|FG004|Overall Study|Adverse Event|1|||
42343280|NCT01953692|76181784|FG005|Overall Study|Adverse Event|2|||
42343281|NCT01953692|76181785|FG006|Overall Study|Adverse Event|0|||
42343282|NCT01953692|76181786|FG007|Overall Study|Adverse Event|0|||
42343283|NCT01953692|76181787|FG008|Overall Study|Adverse Event|0|||
42343284|NCT01953692|76181779|FG000|Overall Study|Clinical Progression|0|||
42343285|NCT01953692|76181780|FG001|Overall Study|Clinical Progression|15|||
42343286|NCT01953692|76181781|FG002|Overall Study|Clinical Progression|7|||
42343287|NCT01953692|76181782|FG003|Overall Study|Clinical Progression|5|||
42343288|NCT01953692|76181783|FG004|Overall Study|Clinical Progression|0|||
42343289|NCT01953692|76181784|FG005|Overall Study|Clinical Progression|7|||
42343290|NCT01953692|76181785|FG006|Overall Study|Clinical Progression|20|||
42343291|NCT01953692|76181786|FG007|Overall Study|Clinical Progression|3|||
42343292|NCT01953692|76181787|FG008|Overall Study|Clinical Progression|3|||
42343293|NCT01953692|76181779|FG000|Overall Study|Death|5|||
42343294|NCT01953692|76181780|FG001|Overall Study|Death|0|||
42343295|NCT01953692|76181781|FG002|Overall Study|Death|2|||
42343296|NCT01953692|76181782|FG003|Overall Study|Death|2|||
42343297|NCT01953692|76181783|FG004|Overall Study|Death|1|||
42343298|NCT01953692|76181784|FG005|Overall Study|Death|3|||
42004201|NCT01322009|75812181|FG000|Overall Study|Adverse Event|0|||
42004202|NCT01322009|75812182|FG001|Overall Study|Adverse Event|1|||
42004203|NCT01322009|75812181|FG000|Overall Study|ng tube discontinued|0|||
42004204|NCT01322009|75812182|FG001|Overall Study|ng tube discontinued|1|||
42269532|NCT02563106|76098792|FG000|Overall Study|Protocol Violation|1|||
42269533|NCT02563106|76098793|FG001|Overall Study|Protocol Violation|0|||
42269534|NCT02563106|76098792|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
42269535|NCT02563106|76098793|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
42269536|NCT02563106|76098792|FG000|Overall Study|Lost to Follow-up|3|||
42269537|NCT02563106|76098793|FG001|Overall Study|Lost to Follow-up|2|||
42269538|NCT02563106|76098792|FG000|Overall Study|Physician Decision|3|||
42269539|NCT02563106|76098793|FG001|Overall Study|Physician Decision|1|||
42269540|NCT02563106|76098792|FG000|Overall Study|Other reason - not specified|2|||
42269541|NCT02563106|76098793|FG001|Overall Study|Other reason - not specified|1|||
42269542|NCT02691741|76098801|FG000|Overall Study|Adverse Event|0|||
42269543|NCT02691741|76098802|FG001|Overall Study|Adverse Event|2|||
42269544|NCT02691741|76098801|FG000|Overall Study|Lost to Follow-up|1|||
42269545|NCT02691741|76098802|FG001|Overall Study|Lost to Follow-up|0|||
42269546|NCT02691741|76098801|FG000|Overall Study|Physician Decision|0|||
42269547|NCT02691741|76098802|FG001|Overall Study|Physician Decision|1|||
42269548|NCT02691741|76098801|FG000|Overall Study|Withdrawal by Subject|0|||
42269549|NCT02691741|76098802|FG001|Overall Study|Withdrawal by Subject|4|||
42269550|NCT02691507|76098815|FG000|Overall Study|Missed Visit 3|0|||
42269551|NCT02691507|76098816|FG001|Overall Study|Missed Visit 3|1|||
42269552|NCT04579393|76098824|FG000|Overall Study|Withdrawal by Subject|2|||
42269553|NCT04579393|76098825|FG001|Overall Study|Withdrawal by Subject|2|||
42269554|NCT04579393|76098824|FG000|Overall Study|Death|1|||
42269555|NCT04579393|76098825|FG001|Overall Study|Death|3|||
42269556|NCT02776553|76098834|FG000|Overall Study|Lost to Follow-up|1|||
42343299|NCT01953692|76181785|FG006|Overall Study|Death|6|||
42343300|NCT01953692|76181786|FG007|Overall Study|Death|2|||
42343301|NCT01953692|76181787|FG008|Overall Study|Death|1|||
42343302|NCT01953692|76181779|FG000|Overall Study|Excluded Medication|1|||
42343303|NCT01953692|76181780|FG001|Overall Study|Excluded Medication|0|||
42343304|NCT01953692|76181781|FG002|Overall Study|Excluded Medication|0|||
42343305|NCT01953692|76181782|FG003|Overall Study|Excluded Medication|0|||
42343306|NCT01953692|76181783|FG004|Overall Study|Excluded Medication|0|||
42343307|NCT01953692|76181784|FG005|Overall Study|Excluded Medication|0|||
42343308|NCT01953692|76181785|FG006|Overall Study|Excluded Medication|0|||
42343309|NCT01953692|76181786|FG007|Overall Study|Excluded Medication|0|||
42004205|NCT01321697|75812188|FG000|Overall Study|Study Terminated|7|||
42269557|NCT02776553|76098835|FG001|Overall Study|Lost to Follow-up|0|||
42269558|NCT02776553|76098834|FG000|Overall Study|got liver transplant|1|||
42269559|NCT02776553|76098835|FG001|Overall Study|got liver transplant|2|||
42269560|NCT02776553|76098834|FG000|Overall Study|had other surgery|1|||
42269561|NCT02776553|76098835|FG001|Overall Study|had other surgery|0|||
42269562|NCT02776553|76098834|FG000|Overall Study|Protocol Violation|0|||
42269563|NCT02776553|76098835|FG001|Overall Study|Protocol Violation|1|||
42269564|NCT02690727|76098841|FG000|Overall Study|Adverse Event|2|||
42269565|NCT02690727|76098842|FG001|Overall Study|Adverse Event|2|||
42343310|NCT01953692|76181787|FG008|Overall Study|Excluded Medication|0|||
42343311|NCT01953692|76181779|FG000|Overall Study|Lost to Follow-up|1|||
42343312|NCT01953692|76181780|FG001|Overall Study|Lost to Follow-up|0|||
42343313|NCT01953692|76181781|FG002|Overall Study|Lost to Follow-up|3|||
42343314|NCT01953692|76181782|FG003|Overall Study|Lost to Follow-up|1|||
42269566|NCT02777333|76098852|FG000|Overall Study|Withdrawal by Subject|0|||
42269567|NCT02777333|76098853|FG001|Overall Study|Withdrawal by Subject|1|||
42343315|NCT01953692|76181783|FG004|Overall Study|Lost to Follow-up|0|||
42135680|NCT00362115|75946335|FG005|Overall Study|Physician Decision|0|||
42135681|NCT00362115|75946336|FG006|Overall Study|Physician Decision|3|||
42135682|NCT00362115|75946330|FG000|Overall Study|Other|0|||
42135683|NCT00362115|75946331|FG001|Overall Study|Other|1|||
42135684|NCT00362115|75946332|FG002|Overall Study|Other|0|||
42135685|NCT00362115|75946333|FG003|Overall Study|Other|1|||
42269568|NCT02777333|76098852|FG000|Overall Study|Lost to Follow-up|0|||
42269569|NCT02777333|76098853|FG001|Overall Study|Lost to Follow-up|1|||
42269570|NCT02695329|76098861|FG000|Overall Study|Adverse Event|1|||
42269571|NCT02695329|76098862|FG001|Overall Study|Adverse Event|0|||
42269572|NCT02695329|76098861|FG000|Overall Study|Poor X-ray quality for measurement|4|||
42269573|NCT02695329|76098862|FG001|Overall Study|Poor X-ray quality for measurement|5|||
42269574|NCT02690649|76098870|FG000|Overall Study|Withdrawal by Subject|1|||
42269575|NCT02690649|76098871|FG001|Overall Study|Withdrawal by Subject|1|||
42269576|NCT02690649|76098870|FG000|Overall Study|Protocol Violation|0|||
42269577|NCT02690649|76098871|FG001|Overall Study|Protocol Violation|3|||
42269578|NCT01358864|76098887|FG000|Overall Study|Adverse Event|0|||
42269579|NCT01358864|76098888|FG001|Overall Study|Adverse Event|6|||
42269580|NCT01358864|76098889|FG002|Overall Study|Adverse Event|9|||
42269581|NCT01358864|76098890|FG003|Overall Study|Adverse Event|0|||
42269582|NCT01358864|76098891|FG004|Overall Study|Adverse Event|4|||
42269583|NCT01358864|76098892|FG005|Overall Study|Adverse Event|8|||
42269584|NCT01358864|76098893|FG006|Overall Study|Adverse Event|12|||
42343316|NCT01953692|76181784|FG005|Overall Study|Lost to Follow-up|1|||
42135686|NCT00362115|75946334|FG004|Overall Study|Other|0|||
42135687|NCT00362115|75946335|FG005|Overall Study|Other|1|||
42135688|NCT00362115|75946336|FG006|Overall Study|Other|0|||
42343317|NCT01953692|76181785|FG006|Overall Study|Lost to Follow-up|0|||
42343318|NCT01953692|76181786|FG007|Overall Study|Lost to Follow-up|0|||
42343319|NCT01953692|76181787|FG008|Overall Study|Lost to Follow-up|0|||
42343320|NCT01953692|76181779|FG000|Overall Study|Physician Decision|11|||
42343321|NCT01953692|76181780|FG001|Overall Study|Physician Decision|4|||
42343322|NCT01953692|76181781|FG002|Overall Study|Physician Decision|2|||
42343323|NCT01953692|76181782|FG003|Overall Study|Physician Decision|2|||
42343324|NCT01953692|76181783|FG004|Overall Study|Physician Decision|1|||
42343325|NCT01953692|76181784|FG005|Overall Study|Physician Decision|2|||
42343326|NCT01953692|76181785|FG006|Overall Study|Physician Decision|4|||
42343327|NCT01953692|76181786|FG007|Overall Study|Physician Decision|1|||
42343328|NCT01953692|76181787|FG008|Overall Study|Physician Decision|0|||
42343329|NCT01953692|76181779|FG000|Overall Study|Protocol Violation|0|||
42343330|NCT01953692|76181780|FG001|Overall Study|Protocol Violation|2|||
42343331|NCT01953692|76181781|FG002|Overall Study|Protocol Violation|1|||
42343332|NCT01953692|76181782|FG003|Overall Study|Protocol Violation|0|||
42343333|NCT01953692|76181783|FG004|Overall Study|Protocol Violation|0|||
42343334|NCT01953692|76181784|FG005|Overall Study|Protocol Violation|0|||
42343335|NCT01953692|76181785|FG006|Overall Study|Protocol Violation|0|||
42343336|NCT01953692|76181786|FG007|Overall Study|Protocol Violation|1|||
42004206|NCT01320683|75812192|FG000|Overall Study|Positive antibody response|1|||
42269585|NCT01358864|76098894|FG007|Overall Study|Adverse Event|7|||
42269586|NCT01358864|76098887|FG000|Overall Study|Lack of Efficacy|26|||
42269587|NCT01358864|76098888|FG001|Overall Study|Lack of Efficacy|3|||
42269588|NCT01358864|76098889|FG002|Overall Study|Lack of Efficacy|4|||
42269589|NCT01358864|76098890|FG003|Overall Study|Lack of Efficacy|19|||
42269590|NCT01358864|76098891|FG004|Overall Study|Lack of Efficacy|7|||
42269591|NCT01358864|76098892|FG005|Overall Study|Lack of Efficacy|4|||
42343337|NCT01953692|76181787|FG008|Overall Study|Protocol Violation|0|||
42343338|NCT01953692|76181779|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
42135689|NCT00485264|75946358|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
42343339|NCT01953692|76181780|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
42269592|NCT01358864|76098893|FG006|Overall Study|Lack of Efficacy|49|||
42269593|NCT01358864|76098894|FG007|Overall Study|Lack of Efficacy|44|||
42343340|NCT01953692|76181781|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
42343341|NCT01953692|76181782|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
42343342|NCT01953692|76181783|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
42343343|NCT01953692|76181784|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
42343344|NCT01953692|76181785|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
42343345|NCT01953692|76181786|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
42343346|NCT01953692|76181787|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
42343347|NCT01953692|76181779|FG000|Overall Study|Withdrawal by Subject|4|||
42343348|NCT01953692|76181780|FG001|Overall Study|Withdrawal by Subject|2|||
42343349|NCT01953692|76181781|FG002|Overall Study|Withdrawal by Subject|1|||
42343350|NCT01953692|76181782|FG003|Overall Study|Withdrawal by Subject|2|||
42343351|NCT01953692|76181783|FG004|Overall Study|Withdrawal by Subject|0|||
42343352|NCT01953692|76181784|FG005|Overall Study|Withdrawal by Subject|3|||
42343353|NCT01953692|76181785|FG006|Overall Study|Withdrawal by Subject|2|||
42343354|NCT01953692|76181786|FG007|Overall Study|Withdrawal by Subject|1|||
42343355|NCT01953692|76181787|FG008|Overall Study|Withdrawal by Subject|1|||
42343356|NCT01791153|76181821|FG000|Part 1: Blinded Period|Adverse Event|7|||
42343357|NCT01791153|76181822|FG001|Part 1: Blinded Period|Adverse Event|3|||
42343358|NCT01791153|76181823|FG002|Part 1: Blinded Period|Adverse Event|2|||
42343359|NCT01791153|76181824|FG003|Part 1: Blinded Period|Adverse Event|0|||
42343360|NCT01791153|76181825|FG004|Part 1: Blinded Period|Adverse Event|0|||
42343361|NCT01791153|76181826|FG005|Part 1: Blinded Period|Adverse Event|0|||
42343362|NCT01791153|76181827|FG006|Part 1: Blinded Period|Adverse Event|0|||
42343363|NCT01791153|76181828|FG007|Part 1: Blinded Period|Adverse Event|0|||
42343364|NCT01791153|76181821|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
42343365|NCT01791153|76181822|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
42343366|NCT01791153|76181823|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
42343367|NCT01791153|76181824|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
42135690|NCT00485264|75946359|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
42135691|NCT00485264|75946360|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
42135692|NCT00485264|75946361|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
42343368|NCT01791153|76181825|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
42343369|NCT01791153|76181826|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
42343370|NCT01791153|76181827|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
42343371|NCT01791153|76181828|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
42343372|NCT01791153|76181821|FG000|Part 1: Blinded Period|Non-Compliance|1|||
42343373|NCT01791153|76181822|FG001|Part 1: Blinded Period|Non-Compliance|0|||
42004207|NCT01320293|75812196|FG000|Overall Study|Lack of Efficacy|1|||
42004208|NCT01320293|75812196|FG000|Overall Study|Adverse Event|1|||
42343374|NCT01791153|76181823|FG002|Part 1: Blinded Period|Non-Compliance|0|||
42343375|NCT01791153|76181824|FG003|Part 1: Blinded Period|Non-Compliance|0|||
42343376|NCT01791153|76181825|FG004|Part 1: Blinded Period|Non-Compliance|0|||
42343377|NCT01791153|76181826|FG005|Part 1: Blinded Period|Non-Compliance|0|||
42343378|NCT01791153|76181827|FG006|Part 1: Blinded Period|Non-Compliance|0|||
42343379|NCT01791153|76181828|FG007|Part 1: Blinded Period|Non-Compliance|0|||
42343380|NCT01791153|76181821|FG000|Part 1: Blinded Period|Physician Decision|0|||
42343381|NCT01791153|76181822|FG001|Part 1: Blinded Period|Physician Decision|0|||
42343382|NCT01791153|76181823|FG002|Part 1: Blinded Period|Physician Decision|0|||
42343383|NCT01791153|76181824|FG003|Part 1: Blinded Period|Physician Decision|1|||
42343384|NCT01791153|76181825|FG004|Part 1: Blinded Period|Physician Decision|0|||
42343385|NCT01791153|76181826|FG005|Part 1: Blinded Period|Physician Decision|0|||
42343386|NCT01791153|76181827|FG006|Part 1: Blinded Period|Physician Decision|0|||
42343387|NCT01791153|76181828|FG007|Part 1: Blinded Period|Physician Decision|0|||
42343388|NCT01791153|76181821|FG000|Part 1: Blinded Period|Protocol Violation|0|||
42343389|NCT01791153|76181822|FG001|Part 1: Blinded Period|Protocol Violation|0|||
42343390|NCT01791153|76181823|FG002|Part 1: Blinded Period|Protocol Violation|0|||
42269594|NCT01358864|76098887|FG000|Overall Study|Lost to Follow-up|0|||
42269595|NCT01358864|76098888|FG001|Overall Study|Lost to Follow-up|0|||
42269596|NCT01358864|76098889|FG002|Overall Study|Lost to Follow-up|1|||
42269597|NCT01358864|76098890|FG003|Overall Study|Lost to Follow-up|0|||
42269598|NCT01358864|76098891|FG004|Overall Study|Lost to Follow-up|0|||
42269599|NCT01358864|76098892|FG005|Overall Study|Lost to Follow-up|0|||
42269600|NCT01358864|76098893|FG006|Overall Study|Lost to Follow-up|0|||
42269601|NCT01358864|76098894|FG007|Overall Study|Lost to Follow-up|1|||
42269602|NCT01358864|76098887|FG000|Overall Study|Withdrawal by Subject|3|||
42269603|NCT01358864|76098888|FG001|Overall Study|Withdrawal by Subject|4|||
42269604|NCT01358864|76098889|FG002|Overall Study|Withdrawal by Subject|2|||
42269605|NCT01358864|76098890|FG003|Overall Study|Withdrawal by Subject|0|||
42269606|NCT01358864|76098891|FG004|Overall Study|Withdrawal by Subject|0|||
42269607|NCT01358864|76098892|FG005|Overall Study|Withdrawal by Subject|1|||
42269608|NCT01358864|76098893|FG006|Overall Study|Withdrawal by Subject|1|||
42269609|NCT01358864|76098894|FG007|Overall Study|Withdrawal by Subject|3|||
42269610|NCT01358864|76098887|FG000|Overall Study|Other reason not defined above|2|||
42269611|NCT01358864|76098888|FG001|Overall Study|Other reason not defined above|0|||
42269612|NCT01358864|76098889|FG002|Overall Study|Other reason not defined above|0|||
42004209|NCT01318811|75812202|FG000|Overall Study|Physician Decision|1|||
42004210|NCT01318811|75812203|FG001|Overall Study|Physician Decision|1|||
42004211|NCT01318811|75812202|FG000|Overall Study|CRRT stopped for head CT|0|||
42004212|NCT01318811|75812203|FG001|Overall Study|CRRT stopped for head CT|1|||
42004213|NCT01318811|75812202|FG000|Overall Study|Death|0|||
42135693|NCT00485264|75946362|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
42135694|NCT00485264|75946363|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
42269613|NCT01358864|76098890|FG003|Overall Study|Other reason not defined above|0|||
42269614|NCT01358864|76098891|FG004|Overall Study|Other reason not defined above|0|||
42269615|NCT01358864|76098892|FG005|Overall Study|Other reason not defined above|0|||
42269616|NCT01358864|76098893|FG006|Overall Study|Other reason not defined above|2|||
42269617|NCT01358864|76098894|FG007|Overall Study|Other reason not defined above|0|||
42269618|NCT01358864|76098887|FG000|Overall Study|Not treated|0|||
42269619|NCT01358864|76098888|FG001|Overall Study|Not treated|0|||
42269620|NCT01358864|76098889|FG002|Overall Study|Not treated|0|||
42269621|NCT01358864|76098890|FG003|Overall Study|Not treated|0|||
42269622|NCT01358864|76098891|FG004|Overall Study|Not treated|0|||
42269623|NCT01358864|76098892|FG005|Overall Study|Not treated|0|||
42269624|NCT01358864|76098893|FG006|Overall Study|Not treated|1|||
42269625|NCT01358864|76098894|FG007|Overall Study|Not treated|0|||
42269626|NCT02750761|76098920|FG000|Overall Study|Lost to Follow-up|0|||
42004214|NCT01318811|75812203|FG001|Overall Study|Death|1|||
42269627|NCT02750761|76098921|FG001|Overall Study|Lost to Follow-up|0|||
42269628|NCT02750761|76098922|FG002|Overall Study|Lost to Follow-up|1|||
42343391|NCT01791153|76181824|FG003|Part 1: Blinded Period|Protocol Violation|1|||
42269629|NCT02750761|76098923|FG003|Overall Study|Lost to Follow-up|0|||
42269630|NCT02750761|76098924|FG004|Overall Study|Lost to Follow-up|0|||
42343392|NCT01791153|76181825|FG004|Part 1: Blinded Period|Protocol Violation|0|||
42269631|NCT02750761|76098925|FG005|Overall Study|Lost to Follow-up|0|||
42269632|NCT02688933|76098968|FG000|Overall Study|Adverse Event|3|||
42269633|NCT02688933|76098969|FG001|Overall Study|Adverse Event|1|||
42269634|NCT02688933|76098968|FG000|Overall Study|Lack of Efficacy|2|||
42269635|NCT02688933|76098969|FG001|Overall Study|Lack of Efficacy|2|||
42269636|NCT02688933|76098968|FG000|Overall Study|Poor compliance to protocol|7|||
42269637|NCT02688933|76098969|FG001|Overall Study|Poor compliance to protocol|4|||
42269638|NCT02688933|76098968|FG000|Overall Study|Hypoglycemia|2|||
42269639|NCT02688933|76098969|FG001|Overall Study|Hypoglycemia|0|||
42343393|NCT01791153|76181826|FG005|Part 1: Blinded Period|Protocol Violation|0|||
42269640|NCT02688933|76098968|FG000|Overall Study|Other than Specified|14|||
42269641|NCT02688933|76098969|FG001|Overall Study|Other than Specified|25|||
42269642|NCT02688933|76098968|FG000|Overall Study|Lost to Follow-up|1|||
42269643|NCT02688933|76098969|FG001|Overall Study|Lost to Follow-up|5|||
42269644|NCT02688621|76098989|FG000|Overall Study|Pregnancy|1|||
42269645|NCT02688621|76098990|FG001|Overall Study|Pregnancy|3|||
42269646|NCT02688621|76098989|FG000|Overall Study|Lost to Follow-up|38|||
42269647|NCT02688621|76098990|FG001|Overall Study|Lost to Follow-up|15|||
42269648|NCT02688621|76098989|FG000|Overall Study|Withdrawal by Subject|1|||
42269649|NCT02688621|76098990|FG001|Overall Study|Withdrawal by Subject|0|||
42269650|NCT04227704|76099002|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
42269651|NCT04227704|76099003|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
42269652|NCT04227704|76099004|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
42269653|NCT04227704|76099002|FG000|Overall Study|due to C/S being cancelled|1|||
42269654|NCT04227704|76099003|FG001|Overall Study|due to C/S being cancelled|0|||
42269655|NCT04227704|76099004|FG002|Overall Study|due to C/S being cancelled|0|||
42269656|NCT03530293|76099025|FG000|Pre-randomization|Adverse Event|12|||
42269657|NCT03530293|76099026|FG001|Pre-randomization|Adverse Event|0|||
42269658|NCT03530293|76099027|FG002|Pre-randomization|Adverse Event|0|||
42269659|NCT03530293|76099025|FG000|Pre-randomization|Protocol Violation|2|||
42269660|NCT03530293|76099026|FG001|Pre-randomization|Protocol Violation|0|||
42269661|NCT03530293|76099027|FG002|Pre-randomization|Protocol Violation|0|||
42269662|NCT03530293|76099025|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
42343394|NCT01791153|76181827|FG006|Part 1: Blinded Period|Protocol Violation|0|||
42343395|NCT01791153|76181828|FG007|Part 1: Blinded Period|Protocol Violation|0|||
42343396|NCT01791153|76181821|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
42343397|NCT01791153|76181822|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
42343398|NCT01791153|76181823|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
42343399|NCT01791153|76181824|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
42269663|NCT03530293|76099026|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
42269664|NCT03530293|76099027|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
42269665|NCT03530293|76099025|FG000|Pre-randomization|Withdrawal by Subject|5|||
42269666|NCT03530293|76099026|FG001|Pre-randomization|Withdrawal by Subject|0|||
42269667|NCT03530293|76099027|FG002|Pre-randomization|Withdrawal by Subject|0|||
42343400|NCT01791153|76181825|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
42343401|NCT01791153|76181826|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
42343402|NCT01791153|76181827|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
42343403|NCT01791153|76181828|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
42343404|NCT01791153|76181821|FG000|Part 2: Open-label Period|Adverse Event|0|||
42343405|NCT01791153|76181822|FG001|Part 2: Open-label Period|Adverse Event|0|||
42343406|NCT01791153|76181823|FG002|Part 2: Open-label Period|Adverse Event|0|||
42343407|NCT01791153|76181824|FG003|Part 2: Open-label Period|Adverse Event|0|||
42343408|NCT01791153|76181825|FG004|Part 2: Open-label Period|Adverse Event|0|||
42343409|NCT01791153|76181826|FG005|Part 2: Open-label Period|Adverse Event|1|||
42343410|NCT01791153|76181827|FG006|Part 2: Open-label Period|Adverse Event|1|||
42343411|NCT01791153|76181828|FG007|Part 2: Open-label Period|Adverse Event|2|||
42343412|NCT01791153|76181821|FG000|Part 2: Open-label Period|Death|0|||
42343413|NCT01791153|76181822|FG001|Part 2: Open-label Period|Death|0|||
42343414|NCT01791153|76181823|FG002|Part 2: Open-label Period|Death|0|||
42343415|NCT01791153|76181824|FG003|Part 2: Open-label Period|Death|0|||
42343416|NCT01791153|76181825|FG004|Part 2: Open-label Period|Death|0|||
42343417|NCT01791153|76181826|FG005|Part 2: Open-label Period|Death|1|||
42343418|NCT01791153|76181827|FG006|Part 2: Open-label Period|Death|1|||
42343419|NCT01791153|76181828|FG007|Part 2: Open-label Period|Death|1|||
42343420|NCT01791153|76181821|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
42343421|NCT01791153|76181822|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
42343422|NCT01791153|76181823|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
42343423|NCT01791153|76181824|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
42343424|NCT01791153|76181825|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
42343425|NCT01791153|76181826|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
42343426|NCT01791153|76181827|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
42343427|NCT01791153|76181828|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
42343428|NCT01791153|76181821|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
42343429|NCT01791153|76181822|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
42343430|NCT01791153|76181823|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
42343431|NCT01791153|76181824|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
42343432|NCT01791153|76181825|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
42343433|NCT01791153|76181826|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
42343434|NCT01791153|76181827|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
42343435|NCT01791153|76181828|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
42343436|NCT01791153|76181821|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
42343437|NCT01791153|76181822|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
42343438|NCT01791153|76181823|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
42343439|NCT01791153|76181824|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
42343440|NCT01791153|76181825|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
42343441|NCT01791153|76181826|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
42343442|NCT01791153|76181827|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
42343443|NCT01791153|76181828|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
42343444|NCT01791153|76181821|FG000|Part 2: Open-label Period|Physician Decision|0|||
42343445|NCT01791153|76181822|FG001|Part 2: Open-label Period|Physician Decision|0|||
42343446|NCT01791153|76181823|FG002|Part 2: Open-label Period|Physician Decision|0|||
42343447|NCT01791153|76181824|FG003|Part 2: Open-label Period|Physician Decision|0|||
42343448|NCT01791153|76181825|FG004|Part 2: Open-label Period|Physician Decision|1|||
42343449|NCT01791153|76181826|FG005|Part 2: Open-label Period|Physician Decision|1|||
42343450|NCT01791153|76181827|FG006|Part 2: Open-label Period|Physician Decision|0|||
42343451|NCT01791153|76181828|FG007|Part 2: Open-label Period|Physician Decision|0|||
42343452|NCT01926782|76181849|FG000|Overall Study|Participant moved|2|||
42343453|NCT01926782|76181850|FG001|Overall Study|Participant moved|0|||
42343454|NCT01926782|76181851|FG002|Overall Study|Participant moved|1|||
42343455|NCT01926782|76181852|FG003|Overall Study|Participant moved|1|||
42343456|NCT01926782|76181853|FG004|Overall Study|Participant moved|0|||
42343457|NCT01926782|76181854|FG005|Overall Study|Participant moved|3|||
42343458|NCT01926782|76181849|FG000|Overall Study|Physician Decision|0|||
42343459|NCT01926782|76181850|FG001|Overall Study|Physician Decision|2|||
42343460|NCT01926782|76181851|FG002|Overall Study|Physician Decision|1|||
42343461|NCT01926782|76181852|FG003|Overall Study|Physician Decision|1|||
42343462|NCT01926782|76181853|FG004|Overall Study|Physician Decision|0|||
42343463|NCT01926782|76181854|FG005|Overall Study|Physician Decision|0|||
42343464|NCT01926782|76181849|FG000|Overall Study|Other than specified|2|||
42343465|NCT01926782|76181850|FG001|Overall Study|Other than specified|3|||
42343466|NCT01926782|76181851|FG002|Overall Study|Other than specified|5|||
42004215|NCT01318811|75812202|FG000|Overall Study|CRRT stopped for head MRI|0|||
42135695|NCT00485264|75946358|FG000|Overall Study|Death|1|||
42135696|NCT00485264|75946359|FG001|Overall Study|Death|0|||
42269668|NCT03530293|76099025|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
42269669|NCT03530293|76099026|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
42269670|NCT03530293|76099027|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
42269671|NCT03530293|76099025|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
42269672|NCT03530293|76099026|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
42269673|NCT03530293|76099027|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
42269674|NCT03530293|76099025|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
42269675|NCT03530293|76099026|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
42269676|NCT03530293|76099027|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
42269677|NCT03530293|76099025|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
42269678|NCT03530293|76099026|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
42269679|NCT03530293|76099027|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
42269680|NCT03530293|76099025|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
42269681|NCT03530293|76099026|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
42269682|NCT03530293|76099027|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
42269683|NCT03335371|76099056|FG000|Overall Study|Lost to Follow-up|0|||
42269684|NCT03335371|76099057|FG001|Overall Study|Lost to Follow-up|0|||
42269685|NCT03335371|76099058|FG002|Overall Study|Lost to Follow-up|0|||
42269686|NCT03335371|76099059|FG003|Overall Study|Lost to Follow-up|0|||
42269687|NCT03335371|76099060|FG004|Overall Study|Lost to Follow-up|1|||
42269688|NCT03335371|76099056|FG000|Overall Study|Withdrawal by Subject|0|||
42269689|NCT03335371|76099057|FG001|Overall Study|Withdrawal by Subject|0|||
42135697|NCT00485264|75946360|FG002|Overall Study|Death|0|||
42343467|NCT01926782|76181852|FG003|Overall Study|Other than specified|12|||
42343468|NCT01926782|76181853|FG004|Overall Study|Other than specified|4|||
42343469|NCT01926782|76181854|FG005|Overall Study|Other than specified|11|||
42343470|NCT01926782|76181849|FG000|Overall Study|Adverse Event|13|||
42343471|NCT01926782|76181850|FG001|Overall Study|Adverse Event|4|||
42343472|NCT01926782|76181851|FG002|Overall Study|Adverse Event|17|||
42343473|NCT01926782|76181852|FG003|Overall Study|Adverse Event|4|||
42135698|NCT00485264|75946361|FG003|Overall Study|Death|0|||
42343474|NCT01926782|76181853|FG004|Overall Study|Adverse Event|3|||
42343475|NCT01926782|76181854|FG005|Overall Study|Adverse Event|14|||
42343476|NCT01926782|76181849|FG000|Overall Study|Poor compliance to protocol|5|||
42343477|NCT01926782|76181850|FG001|Overall Study|Poor compliance to protocol|3|||
42343478|NCT01926782|76181851|FG002|Overall Study|Poor compliance to protocol|8|||
42343479|NCT01926782|76181852|FG003|Overall Study|Poor compliance to protocol|0|||
42343480|NCT01926782|76181853|FG004|Overall Study|Poor compliance to protocol|1|||
42343481|NCT01926782|76181854|FG005|Overall Study|Poor compliance to protocol|6|||
42343482|NCT01926782|76181849|FG000|Overall Study|Randomized and not treated|0|||
42343483|NCT01926782|76181850|FG001|Overall Study|Randomized and not treated|0|||
42343484|NCT01926782|76181851|FG002|Overall Study|Randomized and not treated|0|||
42343485|NCT01926782|76181852|FG003|Overall Study|Randomized and not treated|1|||
42343486|NCT01926782|76181853|FG004|Overall Study|Randomized and not treated|0|||
42343487|NCT01926782|76181854|FG005|Overall Study|Randomized and not treated|0|||
42343488|NCT01926782|76181849|FG000|Overall Study|Withdrawal by Subject|6|||
42343489|NCT01926782|76181850|FG001|Overall Study|Withdrawal by Subject|1|||
42343490|NCT01926782|76181851|FG002|Overall Study|Withdrawal by Subject|8|||
42343491|NCT01926782|76181852|FG003|Overall Study|Withdrawal by Subject|1|||
42269690|NCT03335371|76099058|FG002|Overall Study|Withdrawal by Subject|0|||
42269691|NCT03335371|76099059|FG003|Overall Study|Withdrawal by Subject|0|||
42269692|NCT03335371|76099060|FG004|Overall Study|Withdrawal by Subject|1|||
42269693|NCT03335371|76099056|FG000|Overall Study|Randomization Error|0|||
42343492|NCT01926782|76181853|FG004|Overall Study|Withdrawal by Subject|0|||
42343493|NCT01926782|76181854|FG005|Overall Study|Withdrawal by Subject|5|||
42343494|NCT01926782|76181849|FG000|Overall Study|Related to study drug administration|0|||
42343495|NCT01926782|76181850|FG001|Overall Study|Related to study drug administration|0|||
42343496|NCT01926782|76181851|FG002|Overall Study|Related to study drug administration|0|||
42343497|NCT01926782|76181852|FG003|Overall Study|Related to study drug administration|0|||
42343498|NCT01926782|76181853|FG004|Overall Study|Related to study drug administration|0|||
42343499|NCT01926782|76181854|FG005|Overall Study|Related to study drug administration|2|||
42343500|NCT01926626|76181869|FG000|Overall Study|Withdrawal by Subject|15|||
42343501|NCT01926626|76181869|FG000|Overall Study|Lost to Follow-up|7|||
42343502|NCT01953224|76181875|FG000|Overall Study|Lost to Follow-up|1|||
42343503|NCT01953224|76181876|FG001|Overall Study|Lost to Follow-up|1|||
42343504|NCT01953224|76181875|FG000|Overall Study|Withdrawal by Subject|1|||
42269694|NCT03335371|76099057|FG001|Overall Study|Randomization Error|0|||
42269695|NCT03335371|76099058|FG002|Overall Study|Randomization Error|1|||
42269696|NCT03335371|76099059|FG003|Overall Study|Randomization Error|0|||
42269697|NCT03335371|76099060|FG004|Overall Study|Randomization Error|0|||
42269698|NCT02762929|76099092|FG000|Overall Study|Adverse Event|0|||
42269699|NCT02762929|76099093|FG001|Overall Study|Adverse Event|0|||
42269700|NCT02762929|76099094|FG002|Overall Study|Adverse Event|0|||
42269701|NCT02762929|76099095|FG003|Overall Study|Adverse Event|1|||
42269702|NCT02762929|76099096|FG004|Overall Study|Adverse Event|0|||
42343505|NCT01953224|76181876|FG001|Overall Study|Withdrawal by Subject|2|||
42343506|NCT01900730|76181884|FG000|Overall Study|Withdrawal by Subject|1|||
42343507|NCT01900730|76181885|FG001|Overall Study|Withdrawal by Subject|0|||
42343508|NCT01900730|76181884|FG000|Overall Study|Screen Failure|1|||
42269703|NCT02762929|76099097|FG005|Overall Study|Adverse Event|0|||
42343509|NCT01900730|76181885|FG001|Overall Study|Screen Failure|0|||
42343510|NCT01952834|76181891|FG000|Overall Study|Adverse Event|1|||
42343511|NCT01952054|76181896|FG000|Overall Study|Physician Decision|1|||
42343512|NCT01925768|76181902|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
42343513|NCT01925768|76181903|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
42343514|NCT01925768|76181902|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
42343515|NCT01925768|76181903|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
42135699|NCT00485264|75946362|FG004|Overall Study|Death|1|||
42135700|NCT00485264|75946363|FG005|Overall Study|Death|0|||
42135701|NCT00485264|75946358|FG000|Overall Study|Adverse Event|1|||
42269704|NCT02762929|76099092|FG000|Overall Study|Lost to Follow-up|1|||
42269705|NCT02762929|76099093|FG001|Overall Study|Lost to Follow-up|2|||
42269706|NCT02762929|76099094|FG002|Overall Study|Lost to Follow-up|0|||
42269707|NCT02762929|76099095|FG003|Overall Study|Lost to Follow-up|1|||
42269708|NCT02762929|76099096|FG004|Overall Study|Lost to Follow-up|0|||
42269709|NCT02762929|76099097|FG005|Overall Study|Lost to Follow-up|0|||
42269710|NCT02762929|76099092|FG000|Overall Study|Withdrawal by Subject|0|||
42269711|NCT02762929|76099093|FG001|Overall Study|Withdrawal by Subject|1|||
42269712|NCT02762929|76099094|FG002|Overall Study|Withdrawal by Subject|0|||
42269713|NCT02762929|76099095|FG003|Overall Study|Withdrawal by Subject|0|||
42269714|NCT02762929|76099096|FG004|Overall Study|Withdrawal by Subject|0|||
42269715|NCT02762929|76099097|FG005|Overall Study|Withdrawal by Subject|0|||
42135702|NCT00485264|75946359|FG001|Overall Study|Adverse Event|0|||
42269716|NCT02762929|76099092|FG000|Overall Study|exclusionary medication disclosed late|0|||
42343516|NCT01925768|76181902|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
42343517|NCT01925768|76181903|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
42269717|NCT02762929|76099093|FG001|Overall Study|exclusionary medication disclosed late|0|||
42269718|NCT02762929|76099094|FG002|Overall Study|exclusionary medication disclosed late|0|||
42269719|NCT02762929|76099095|FG003|Overall Study|exclusionary medication disclosed late|1|||
42269720|NCT02762929|76099096|FG004|Overall Study|exclusionary medication disclosed late|0|||
42269721|NCT02762929|76099097|FG005|Overall Study|exclusionary medication disclosed late|0|||
42135703|NCT00485264|75946360|FG002|Overall Study|Adverse Event|2|||
42135704|NCT00485264|75946361|FG003|Overall Study|Adverse Event|3|||
42269722|NCT03301051|76099118|FG000|Overall Study|Adverse Event|0|||
42269723|NCT03301051|76099119|FG001|Overall Study|Adverse Event|4|||
42269724|NCT03301051|76099118|FG000|Overall Study|Withdrawal by Subject|59|||
42269725|NCT03301051|76099119|FG001|Overall Study|Withdrawal by Subject|65|||
42269726|NCT03301051|76099118|FG000|Overall Study|Lost to Follow-up|263|||
42269727|NCT03301051|76099119|FG001|Overall Study|Lost to Follow-up|282|||
42269728|NCT03301051|76099118|FG000|Overall Study|Protocol Violation|1|||
42269729|NCT03301051|76099119|FG001|Overall Study|Protocol Violation|3|||
42269730|NCT03301051|76099118|FG000|Overall Study|Physician Decision|1|||
42269731|NCT03301051|76099119|FG001|Overall Study|Physician Decision|3|||
42269732|NCT03301051|76099118|FG000|Overall Study|Death|1|||
42269733|NCT03301051|76099119|FG001|Overall Study|Death|1|||
42269734|NCT03301051|76099118|FG000|Overall Study|Miscellaneous|8|||
42269735|NCT03301051|76099119|FG001|Overall Study|Miscellaneous|4|||
42269736|NCT03301051|76099118|FG000|Overall Study|Randomized, not vaccinated|13|||
42269737|NCT03301051|76099119|FG001|Overall Study|Randomized, not vaccinated|10|||
42269738|NCT01662986|76099127|FG000|Overall Study|Adverse Event|5|||
42269739|NCT01662986|76099128|FG001|Overall Study|Adverse Event|4|||
42269740|NCT01662986|76099127|FG000|Overall Study|Protocol Violation|2|||
42269741|NCT01662986|76099128|FG001|Overall Study|Protocol Violation|3|||
42269742|NCT01662986|76099127|FG000|Overall Study|Lost to Follow-up|5|||
42269743|NCT01662986|76099128|FG001|Overall Study|Lost to Follow-up|4|||
42269744|NCT01662986|76099127|FG000|Overall Study|Withdrawal by Subject|2|||
42135705|NCT00485264|75946362|FG004|Overall Study|Adverse Event|1|||
42135706|NCT00485264|75946363|FG005|Overall Study|Adverse Event|3|||
42135707|NCT00485264|75946358|FG000|Overall Study|Pregnancy|4|||
42135708|NCT00485264|75946359|FG001|Overall Study|Pregnancy|0|||
42004216|NCT01318811|75812203|FG001|Overall Study|CRRT stopped for head MRI|1|||
42004217|NCT01093846|75812212|FG000|Overall Study|Adverse Event|0|||
42004218|NCT01093846|75812213|FG001|Overall Study|Adverse Event|0|||
42004219|NCT01093846|75812214|FG002|Overall Study|Adverse Event|1|||
42269745|NCT01662986|76099128|FG001|Overall Study|Withdrawal by Subject|2|||
42269746|NCT01662986|76099127|FG000|Overall Study|Not Treated|1|||
42269747|NCT01662986|76099128|FG001|Overall Study|Not Treated|0|||
42269748|NCT01662986|76099127|FG000|Overall Study|Other than stated above|3|||
42269749|NCT01662986|76099128|FG001|Overall Study|Other than stated above|0|||
42269750|NCT01337167|76099136|FG000|Infant Series|Adverse Event|1|||
42269751|NCT01337167|76099137|FG001|Infant Series|Adverse Event|1|||
42269752|NCT01337167|76099136|FG000|Infant Series|Death|1|||
42269753|NCT01337167|76099137|FG001|Infant Series|Death|1|||
42269754|NCT01337167|76099136|FG000|Infant Series|Lost to Follow-up|13|||
42269755|NCT01337167|76099137|FG001|Infant Series|Lost to Follow-up|7|||
42343518|NCT01925768|76181902|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
42343519|NCT01925768|76181903|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
42004220|NCT01093846|75812212|FG000|Overall Study|Lack of Efficacy|0|||
42269756|NCT01337167|76099136|FG000|Infant Series|Non-compliance with study drug|2|||
42269757|NCT01337167|76099137|FG001|Infant Series|Non-compliance with study drug|1|||
42004221|NCT01093846|75812213|FG001|Overall Study|Lack of Efficacy|0|||
42269758|NCT01337167|76099136|FG000|Infant Series|Physician Decision|3|||
42269759|NCT01337167|76099137|FG001|Infant Series|Physician Decision|1|||
42269760|NCT01337167|76099136|FG000|Infant Series|Protocol Violation|22|||
42269761|NCT01337167|76099137|FG001|Infant Series|Protocol Violation|9|||
42269762|NCT01337167|76099136|FG000|Infant Series|Withdrawal by Subject|15|||
42269763|NCT01337167|76099137|FG001|Infant Series|Withdrawal by Subject|4|||
42269764|NCT01337167|76099136|FG000|Infant Series|Randomized but not vaccinated|5|||
42004222|NCT01093846|75812214|FG002|Overall Study|Lack of Efficacy|4|||
42004223|NCT01093846|75812212|FG000|Overall Study|Condition no longer required study drug|1|||
42004224|NCT01093846|75812213|FG001|Overall Study|Condition no longer required study drug|1|||
42004225|NCT01093846|75812214|FG002|Overall Study|Condition no longer required study drug|1|||
42135709|NCT00485264|75946360|FG002|Overall Study|Pregnancy|0|||
42135710|NCT00485264|75946361|FG003|Overall Study|Pregnancy|0|||
42269765|NCT01337167|76099137|FG001|Infant Series|Randomized but not vaccinated|3|||
42135711|NCT00485264|75946362|FG004|Overall Study|Pregnancy|0|||
42135712|NCT00485264|75946363|FG005|Overall Study|Pregnancy|0|||
42269766|NCT01337167|76099136|FG000|Interim Period|Lost to Follow-up|51|||
42269767|NCT01337167|76099137|FG001|Interim Period|Lost to Follow-up|23|||
42269768|NCT01337167|76099136|FG000|Interim Period|Non-compliance with study drug|1|||
42269769|NCT01337167|76099137|FG001|Interim Period|Non-compliance with study drug|0|||
42269770|NCT01337167|76099136|FG000|Interim Period|Physician Decision|6|||
42269771|NCT01337167|76099137|FG001|Interim Period|Physician Decision|3|||
42269772|NCT01337167|76099136|FG000|Interim Period|Protocol Violation|5|||
42269773|NCT01337167|76099137|FG001|Interim Period|Protocol Violation|3|||
42269774|NCT01337167|76099136|FG000|Interim Period|Withdrawal by Subject|18|||
42269775|NCT01337167|76099137|FG001|Interim Period|Withdrawal by Subject|10|||
42269776|NCT01337167|76099136|FG000|Interim Period|Other protocol criterion not met|0|||
42269777|NCT01337167|76099137|FG001|Interim Period|Other protocol criterion not met|1|||
42135713|NCT00485264|75946358|FG000|Overall Study|Disallowed Medication|0|||
42269778|NCT01337167|76099136|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
42343520|NCT01925768|76181902|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
42135714|NCT00485264|75946359|FG001|Overall Study|Disallowed Medication|0|||
42135715|NCT00485264|75946360|FG002|Overall Study|Disallowed Medication|0|||
42135716|NCT00485264|75946361|FG003|Overall Study|Disallowed Medication|0|||
42135717|NCT00485264|75946362|FG004|Overall Study|Disallowed Medication|0|||
42135718|NCT00485264|75946363|FG005|Overall Study|Disallowed Medication|1|||
42269779|NCT01337167|76099137|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
42343521|NCT01925768|76181903|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
42343522|NCT01925768|76181902|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
42343523|NCT01925768|76181903|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
42343524|NCT01925768|76181902|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
42269780|NCT01337167|76099136|FG000|Toddler Vaccinations|Protocol Violation|0|||
42269781|NCT01337167|76099137|FG001|Toddler Vaccinations|Protocol Violation|1|||
42269782|NCT01337167|76099136|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
42269783|NCT01337167|76099137|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
42269784|NCT01338025|76099145|FG000|Overall Study|Unexpected closure of study|10|||
42269785|NCT01338025|76099146|FG001|Overall Study|Unexpected closure of study|9|||
42269786|NCT01338025|76099145|FG000|Overall Study|Withdrawal by Subject|0|||
42269787|NCT01338025|76099146|FG001|Overall Study|Withdrawal by Subject|2|||
42269788|NCT01338025|76099145|FG000|Overall Study|Found ineligible after starting|1|||
42269789|NCT01338025|76099146|FG001|Overall Study|Found ineligible after starting|0|||
42269790|NCT02559206|76099190|FG000|Overall Study|Adverse Event|0|||
42269791|NCT02559206|76099191|FG001|Overall Study|Adverse Event|4|||
42269792|NCT02559206|76099192|FG002|Overall Study|Adverse Event|1|||
42135719|NCT00485264|75946358|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
42135720|NCT00485264|75946359|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
42135721|NCT00485264|75946360|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
42135722|NCT00485264|75946361|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
42135723|NCT00485264|75946362|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
42135724|NCT00485264|75946363|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
42135725|NCT00485264|75946358|FG000|Overall Study|Lack of Efficacy|0|||
42135726|NCT00485264|75946359|FG001|Overall Study|Lack of Efficacy|1|||
42135727|NCT00485264|75946360|FG002|Overall Study|Lack of Efficacy|0|||
42135728|NCT00485264|75946361|FG003|Overall Study|Lack of Efficacy|0|||
42135729|NCT00485264|75946362|FG004|Overall Study|Lack of Efficacy|0|||
42135730|NCT00485264|75946363|FG005|Overall Study|Lack of Efficacy|0|||
42135731|NCT00485264|75946358|FG000|Overall Study|Guardian Consent Withdrawn|1|||
42135732|NCT00485264|75946359|FG001|Overall Study|Guardian Consent Withdrawn|0|||
42135733|NCT00485264|75946360|FG002|Overall Study|Guardian Consent Withdrawn|0|||
42135734|NCT00485264|75946361|FG003|Overall Study|Guardian Consent Withdrawn|0|||
42135735|NCT00485264|75946362|FG004|Overall Study|Guardian Consent Withdrawn|1|||
42135736|NCT00485264|75946363|FG005|Overall Study|Guardian Consent Withdrawn|0|||
42135737|NCT00485264|75946358|FG000|Overall Study|Physician Decision|0|||
42135738|NCT00485264|75946359|FG001|Overall Study|Physician Decision|2|||
42135739|NCT00485264|75946360|FG002|Overall Study|Physician Decision|0|||
42135740|NCT00485264|75946361|FG003|Overall Study|Physician Decision|0|||
42135741|NCT00485264|75946362|FG004|Overall Study|Physician Decision|0|||
42135742|NCT00485264|75946363|FG005|Overall Study|Physician Decision|0|||
42135743|NCT00485264|75946358|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
42135744|NCT00485264|75946359|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
42135745|NCT00485264|75946360|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
42135746|NCT00485264|75946361|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
42135747|NCT00485264|75946362|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
42135748|NCT00485264|75946363|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
42135749|NCT00485264|75946358|FG000|Overall Study|Not Able to Attend Clinic|5|||
42135750|NCT00485264|75946359|FG001|Overall Study|Not Able to Attend Clinic|0|||
42135751|NCT00485264|75946360|FG002|Overall Study|Not Able to Attend Clinic|0|||
42135752|NCT00485264|75946361|FG003|Overall Study|Not Able to Attend Clinic|1|||
42135753|NCT00485264|75946362|FG004|Overall Study|Not Able to Attend Clinic|1|||
42135754|NCT00485264|75946363|FG005|Overall Study|Not Able to Attend Clinic|2|||
42135755|NCT00485264|75946358|FG000|Overall Study|Non-Compliant|17|||
42135756|NCT00485264|75946359|FG001|Overall Study|Non-Compliant|2|||
42135757|NCT00485264|75946360|FG002|Overall Study|Non-Compliant|1|||
42135758|NCT00485264|75946361|FG003|Overall Study|Non-Compliant|0|||
42135759|NCT00485264|75946362|FG004|Overall Study|Non-Compliant|1|||
42135760|NCT00485264|75946363|FG005|Overall Study|Non-Compliant|0|||
42135761|NCT00485264|75946358|FG000|Overall Study|Lost to Follow-up|2|||
42135762|NCT00485264|75946359|FG001|Overall Study|Lost to Follow-up|1|||
42135763|NCT00485264|75946360|FG002|Overall Study|Lost to Follow-up|1|||
42135764|NCT00485264|75946361|FG003|Overall Study|Lost to Follow-up|0|||
42135765|NCT00485264|75946362|FG004|Overall Study|Lost to Follow-up|0|||
42343525|NCT01925768|76181903|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
42343526|NCT01925768|76181902|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
42135766|NCT00485264|75946363|FG005|Overall Study|Lost to Follow-up|1|||
42135767|NCT00485264|75946358|FG000|Overall Study|Other Reason|3|||
42135768|NCT00485264|75946359|FG001|Overall Study|Other Reason|0|||
42343527|NCT01925768|76181903|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
42135769|NCT00485264|75946360|FG002|Overall Study|Other Reason|0|||
42135770|NCT00485264|75946361|FG003|Overall Study|Other Reason|0|||
42135771|NCT00485264|75946362|FG004|Overall Study|Other Reason|0|||
42135772|NCT00485264|75946363|FG005|Overall Study|Other Reason|0|||
42343528|NCT01925768|76181902|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
42343529|NCT01925768|76181903|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
42343530|NCT01925768|76181902|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
42343531|NCT01925768|76181903|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
42343532|NCT01925768|76181902|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
42343533|NCT01925768|76181903|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
42343534|NCT01431274|76181918|FG000|Overall Study|Adverse Event|51|||
42343535|NCT01431274|76181919|FG001|Overall Study|Adverse Event|37|||
42004226|NCT01093846|75812212|FG000|Overall Study|Administrative Problems|18|||
42004227|NCT01093846|75812213|FG001|Overall Study|Administrative Problems|17|||
42343536|NCT01431274|76181920|FG002|Overall Study|Adverse Event|43|||
42343537|NCT01431274|76181921|FG003|Overall Study|Adverse Event|30|||
42343538|NCT01431274|76181922|FG004|Overall Study|Adverse Event|37|||
42343539|NCT01431274|76181918|FG000|Overall Study|Consent withdrawn not due to AE|29|||
42135773|NCT00293254|75946384|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
42343540|NCT01431274|76181919|FG001|Overall Study|Consent withdrawn not due to AE|20|||
42343541|NCT01431274|76181920|FG002|Overall Study|Consent withdrawn not due to AE|17|||
42343542|NCT01431274|76181921|FG003|Overall Study|Consent withdrawn not due to AE|20|||
42343543|NCT01431274|76181922|FG004|Overall Study|Consent withdrawn not due to AE|11|||
42343544|NCT01431274|76181918|FG000|Overall Study|Non compliant with protocol|5|||
42343545|NCT01431274|76181919|FG001|Overall Study|Non compliant with protocol|8|||
42343546|NCT01431274|76181920|FG002|Overall Study|Non compliant with protocol|4|||
42004228|NCT01093846|75812214|FG002|Overall Study|Administrative Problems|15|||
42004229|NCT01315847|75812222|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
42004230|NCT01315847|75812223|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
42004231|NCT01315847|75812222|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
42343547|NCT01431274|76181921|FG003|Overall Study|Non compliant with protocol|4|||
42343548|NCT01431274|76181922|FG004|Overall Study|Non compliant with protocol|4|||
42343549|NCT01431274|76181918|FG000|Overall Study|Lost to Follow-up|6|||
42343550|NCT01431274|76181919|FG001|Overall Study|Lost to Follow-up|7|||
42343551|NCT01431274|76181920|FG002|Overall Study|Lost to Follow-up|1|||
42343552|NCT01431274|76181921|FG003|Overall Study|Lost to Follow-up|4|||
42343553|NCT01431274|76181922|FG004|Overall Study|Lost to Follow-up|0|||
42343554|NCT01431274|76181918|FG000|Overall Study|Other reason not stated above|6|||
42343555|NCT01431274|76181919|FG001|Overall Study|Other reason not stated above|5|||
42343556|NCT01431274|76181920|FG002|Overall Study|Other reason not stated above|7|||
42343557|NCT01431274|76181921|FG003|Overall Study|Other reason not stated above|2|||
42343558|NCT01431274|76181922|FG004|Overall Study|Other reason not stated above|4|||
42343559|NCT01991795|76181936|FG000|Overall Study|Lost to Follow-up|6|||
42343560|NCT01991795|76181937|FG001|Overall Study|Lost to Follow-up|4|||
42343561|NCT01991795|76181936|FG000|Overall Study|Withdrawal by Subject|117|||
42343562|NCT01991795|76181937|FG001|Overall Study|Withdrawal by Subject|94|||
42343563|NCT01991795|76181936|FG000|Overall Study|Site prematurely closed by sponsor|26|||
42343564|NCT01991795|76181937|FG001|Overall Study|Site prematurely closed by sponsor|25|||
42343565|NCT01411852|76181978|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
42343566|NCT01411852|76181979|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
42343567|NCT01411852|76181978|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
42343568|NCT01411852|76181979|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
42343569|NCT01411852|76181978|FG000|Prehospital Intervention Phase|Found to be under age|0|||
42135774|NCT00293254|75946385|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
42343570|NCT01411852|76181979|FG001|Prehospital Intervention Phase|Found to be under age|1|||
42343571|NCT01411852|76181978|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
42343572|NCT01411852|76181979|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
42343573|NCT01411852|76181978|FG000|Hospital Intervention Phase|Severe head injury|5|||
42343574|NCT01411852|76181979|FG001|Hospital Intervention Phase|Severe head injury|4|||
42135775|NCT00293254|75946384|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
42135776|NCT00293254|75946385|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
42343575|NCT01411852|76181978|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
42343576|NCT01411852|76181979|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
42343577|NCT01411852|76181978|FG000|Hospital Intervention Phase|Miscommunication error|1|||
42343578|NCT01411852|76181979|FG001|Hospital Intervention Phase|Miscommunication error|2|||
42343579|NCT01411852|76181978|FG000|Hospital Intervention Phase|CPR administered|3|||
42135777|NCT00293254|75946384|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
42135778|NCT00293254|75946385|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
42343580|NCT01411852|76181979|FG001|Hospital Intervention Phase|CPR administered|1|||
42343581|NCT01411852|76181978|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
42343582|NCT01411852|76181979|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
42343583|NCT01411852|76181978|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
42343584|NCT01411852|76181979|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
42343585|NCT01411852|76181978|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
42343586|NCT01411852|76181979|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
42343587|NCT01411852|76181978|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
42343588|NCT01411852|76181979|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
42343589|NCT01411852|76181978|FG000|Hospital Intervention Phase|Other ineligible|2|||
42343590|NCT01411852|76181979|FG001|Hospital Intervention Phase|Other ineligible|2|||
42343591|NCT01411852|76181978|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
42343592|NCT01411852|76181979|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
42343593|NCT01411852|76181978|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
42343594|NCT01411852|76181979|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
42135779|NCT00293254|75946384|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
42269793|NCT02559206|76099193|FG003|Overall Study|Adverse Event|5|||
42269794|NCT02559206|76099194|FG004|Overall Study|Adverse Event|3|||
42269795|NCT02559206|76099195|FG005|Overall Study|Adverse Event|0|||
42269796|NCT02559206|76099196|FG006|Overall Study|Adverse Event|1|||
42269797|NCT02559206|76099197|FG007|Overall Study|Adverse Event|0|||
42269798|NCT02559206|76099190|FG000|Overall Study|Protocol Violation|1|||
42269799|NCT02559206|76099191|FG001|Overall Study|Protocol Violation|0|||
42269800|NCT02559206|76099192|FG002|Overall Study|Protocol Violation|1|||
42269801|NCT02559206|76099193|FG003|Overall Study|Protocol Violation|0|||
42269802|NCT02559206|76099194|FG004|Overall Study|Protocol Violation|0|||
42269803|NCT02559206|76099195|FG005|Overall Study|Protocol Violation|2|||
42269804|NCT02559206|76099196|FG006|Overall Study|Protocol Violation|0|||
42269805|NCT02559206|76099197|FG007|Overall Study|Protocol Violation|0|||
42135780|NCT00293254|75946385|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
42135781|NCT00293254|75946384|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
42004232|NCT01315847|75812223|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
42269806|NCT02559206|76099190|FG000|Overall Study|Withdrawal by Subject|3|||
42343595|NCT01411852|76181978|FG000|Hospital Intervention Phase|Vascular access failed|1|||
42343596|NCT01411852|76181979|FG001|Hospital Intervention Phase|Vascular access failed|0|||
42269807|NCT02559206|76099191|FG001|Overall Study|Withdrawal by Subject|3|||
42269808|NCT02559206|76099192|FG002|Overall Study|Withdrawal by Subject|1|||
42269809|NCT02559206|76099193|FG003|Overall Study|Withdrawal by Subject|3|||
42269810|NCT02559206|76099194|FG004|Overall Study|Withdrawal by Subject|5|||
42269811|NCT02559206|76099195|FG005|Overall Study|Withdrawal by Subject|4|||
42269812|NCT02559206|76099196|FG006|Overall Study|Withdrawal by Subject|1|||
42269813|NCT02559206|76099197|FG007|Overall Study|Withdrawal by Subject|2|||
42004233|NCT01093534|75812232|FG000|Overall Study|Adverse Event|2|||
42004234|NCT01093534|75812233|FG001|Overall Study|Adverse Event|5|||
42269814|NCT02559206|76099190|FG000|Overall Study|Lost to Follow-up|3|||
42269815|NCT02559206|76099191|FG001|Overall Study|Lost to Follow-up|5|||
42343597|NCT01411774|76181989|FG000|Overall Study|Withdrawal by Subject|0|||
42343598|NCT01411774|76181990|FG001|Overall Study|Withdrawal by Subject|3|||
42343599|NCT01411228|76181999|FG000|Overall Study|Lost to Follow-up|0|||
42004235|NCT01093534|75812234|FG002|Overall Study|Adverse Event|2|||
42135782|NCT00293254|75946385|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
42343600|NCT01411228|76182000|FG001|Overall Study|Lost to Follow-up|0|||
42343601|NCT01411228|76182001|FG002|Overall Study|Lost to Follow-up|1|||
42269816|NCT02559206|76099192|FG002|Overall Study|Lost to Follow-up|3|||
42269817|NCT02559206|76099193|FG003|Overall Study|Lost to Follow-up|3|||
42269818|NCT02559206|76099194|FG004|Overall Study|Lost to Follow-up|2|||
42269819|NCT02559206|76099195|FG005|Overall Study|Lost to Follow-up|5|||
42269820|NCT02559206|76099196|FG006|Overall Study|Lost to Follow-up|1|||
42269821|NCT02559206|76099197|FG007|Overall Study|Lost to Follow-up|4|||
42343602|NCT01411228|76181999|FG000|Overall Study|Withdrawal by Subject|1|||
42343603|NCT01411228|76182000|FG001|Overall Study|Withdrawal by Subject|0|||
42343604|NCT01411228|76182001|FG002|Overall Study|Withdrawal by Subject|0|||
42343605|NCT01410604|76182011|FG000|Overall Study|Adverse Event|2|||
42343606|NCT01410604|76182012|FG001|Overall Study|Adverse Event|1|||
42343607|NCT01410604|76182011|FG000|Overall Study|Lost to Follow-up|1|||
42343608|NCT01410604|76182012|FG001|Overall Study|Lost to Follow-up|0|||
42343609|NCT01410604|76182011|FG000|Overall Study|Physician Decision|0|||
42343610|NCT01410604|76182012|FG001|Overall Study|Physician Decision|1|||
42343611|NCT01991483|76182022|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
42343612|NCT01991483|76182023|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
42343613|NCT01991483|76182024|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
42343614|NCT01991483|76182025|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
42269822|NCT02559206|76099190|FG000|Overall Study|Lack of Efficacy|1|||
42343615|NCT01991483|76182022|FG000|Dose Level 600 mg|Physician Decision|0|||
42343616|NCT01991483|76182023|FG001|Dose Level 600 mg|Physician Decision|0|||
42343617|NCT01991483|76182024|FG002|Dose Level 600 mg|Physician Decision|1|||
42343618|NCT01991483|76182025|FG003|Dose Level 600 mg|Physician Decision|0|||
42343619|NCT01991483|76182022|FG000|Dose Level 1000 mg|Protocol Violation|0|||
42269823|NCT02559206|76099191|FG001|Overall Study|Lack of Efficacy|0|||
42343620|NCT01991483|76182023|FG001|Dose Level 1000 mg|Protocol Violation|0|||
42343621|NCT01991483|76182024|FG002|Dose Level 1000 mg|Protocol Violation|0|||
42343622|NCT01991483|76182025|FG003|Dose Level 1000 mg|Protocol Violation|1|||
42343623|NCT01410448|76182040|FG000|Overall Study|No conversion to everolimus|0|||
42343624|NCT01410448|76182041|FG001|Overall Study|No conversion to everolimus|24|||
42343625|NCT01410448|76182040|FG000|Overall Study|Graft loss|4|||
42343626|NCT01410448|76182041|FG001|Overall Study|Graft loss|1|||
42343627|NCT01410448|76182040|FG000|Overall Study|Administrative issues|2|||
42343628|NCT01410448|76182041|FG001|Overall Study|Administrative issues|1|||
42343629|NCT01410448|76182040|FG000|Overall Study|Lost to Follow-up|1|||
42269824|NCT02559206|76099192|FG002|Overall Study|Lack of Efficacy|3|||
42269825|NCT02559206|76099193|FG003|Overall Study|Lack of Efficacy|2|||
42269826|NCT02559206|76099194|FG004|Overall Study|Lack of Efficacy|2|||
42269827|NCT02559206|76099195|FG005|Overall Study|Lack of Efficacy|3|||
42343630|NCT01410448|76182041|FG001|Overall Study|Lost to Follow-up|0|||
42343631|NCT01410448|76182040|FG000|Overall Study|Withdrawal by Subject|3|||
42343632|NCT01410448|76182041|FG001|Overall Study|Withdrawal by Subject|2|||
42269828|NCT02559206|76099196|FG006|Overall Study|Lack of Efficacy|3|||
42269829|NCT02559206|76099197|FG007|Overall Study|Lack of Efficacy|3|||
42269830|NCT02559206|76099190|FG000|Overall Study|Other Not Specified|0|||
42269831|NCT02559206|76099191|FG001|Overall Study|Other Not Specified|0|||
42269832|NCT02559206|76099192|FG002|Overall Study|Other Not Specified|0|||
42269833|NCT02559206|76099193|FG003|Overall Study|Other Not Specified|1|||
42269834|NCT02559206|76099194|FG004|Overall Study|Other Not Specified|0|||
42269835|NCT02559206|76099195|FG005|Overall Study|Other Not Specified|0|||
42269836|NCT02559206|76099196|FG006|Overall Study|Other Not Specified|0|||
42269837|NCT02559206|76099197|FG007|Overall Study|Other Not Specified|0|||
42269838|NCT02558894|76099217|FG000|Overall Study|Death; any cause, entire study duration|28|||
42269839|NCT02558894|76099218|FG001|Overall Study|Death; any cause, entire study duration|31|||
42269840|NCT02558894|76099217|FG000|Overall Study|Withdrawal by Subject|2|||
42269841|NCT02558894|76099218|FG001|Overall Study|Withdrawal by Subject|1|||
42343633|NCT01410448|76182040|FG000|Overall Study|Protocol Violation|0|||
42343634|NCT01410448|76182041|FG001|Overall Study|Protocol Violation|4|||
42343635|NCT01410448|76182040|FG000|Overall Study|Death|2|||
42343636|NCT01410448|76182041|FG001|Overall Study|Death|3|||
42343637|NCT01943851|76182065|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42269842|NCT02558894|76099217|FG000|Overall Study|Closure of Part A|2|||
42343638|NCT01943851|76182066|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42269843|NCT02558894|76099218|FG001|Overall Study|Closure of Part A|1|||
42343639|NCT01943851|76182067|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42269844|NCT02688387|76099228|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42343640|NCT01943851|76182068|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
42343641|NCT01943851|76182069|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42343642|NCT01943851|76182070|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42343643|NCT01943851|76182071|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
42343644|NCT01943851|76182072|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
42343645|NCT01943851|76182073|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
42343646|NCT01943851|76182074|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42004236|NCT01093534|75812232|FG000|Overall Study|Lack of Efficacy|2|||
42004237|NCT01093534|75812233|FG001|Overall Study|Lack of Efficacy|1|||
42004238|NCT01093534|75812234|FG002|Overall Study|Lack of Efficacy|1|||
42004239|NCT01093534|75812232|FG000|Overall Study|Withdrawal by Subject|5|||
42004240|NCT01093534|75812233|FG001|Overall Study|Withdrawal by Subject|7|||
42004241|NCT01093534|75812234|FG002|Overall Study|Withdrawal by Subject|2|||
42343647|NCT01943851|76182075|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42004242|NCT01093534|75812232|FG000|Overall Study|Other|1|||
42004243|NCT01093534|75812233|FG001|Overall Study|Other|3|||
42004244|NCT01093534|75812234|FG002|Overall Study|Other|4|||
42004245|NCT01314911|75812245|FG000|Overall Study|Lost to Follow-up|3|||
42004246|NCT01314911|75812246|FG001|Overall Study|Lost to Follow-up|2|||
42004247|NCT01314911|75812245|FG000|Overall Study|Withdrawal by Subject|1|||
42004248|NCT01314911|75812246|FG001|Overall Study|Withdrawal by Subject|3|||
42004249|NCT01314911|75812245|FG000|Overall Study|Received Non-randomized Study Drug|0|||
42004250|NCT01314911|75812246|FG001|Overall Study|Received Non-randomized Study Drug|1|||
42269845|NCT02688387|76099229|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269846|NCT02688387|76099230|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
42269847|NCT02688387|76099231|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269848|NCT02688387|76099232|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269849|NCT02688387|76099233|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42343648|NCT01943851|76182076|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42343649|NCT01943851|76182077|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42343650|NCT01943851|76182078|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42343651|NCT01943851|76182079|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42343652|NCT01943851|76182080|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42343653|NCT01943851|76182081|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42343654|NCT01943851|76182082|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
42343655|NCT01943851|76182065|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343656|NCT01943851|76182066|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343657|NCT01943851|76182067|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343658|NCT01943851|76182068|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343659|NCT01943851|76182069|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
42343660|NCT01943851|76182070|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343661|NCT01943851|76182071|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343662|NCT01943851|76182072|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
42343663|NCT01943851|76182073|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343664|NCT01943851|76182074|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343665|NCT01943851|76182075|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343666|NCT01943851|76182076|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343667|NCT01943851|76182077|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343668|NCT01943851|76182078|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343669|NCT01943851|76182079|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343670|NCT01943851|76182080|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343671|NCT01943851|76182081|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42343672|NCT01943851|76182082|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
42004251|NCT01314911|75812245|FG000|Overall Study|Never Started Treatment|1|||
42343673|NCT01943851|76182065|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42004252|NCT01314911|75812246|FG001|Overall Study|Never Started Treatment|0|||
42343674|NCT01943851|76182066|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42004253|NCT01093222|75812252|FG000|Overall Study|Ineligible|6|||
42269850|NCT02688387|76099234|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269851|NCT02688387|76099235|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269852|NCT02688387|76099236|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269853|NCT02688387|76099237|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269854|NCT02688387|76099238|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269855|NCT02688387|76099239|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269856|NCT02688387|76099240|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269857|NCT02688387|76099241|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269858|NCT02688387|76099242|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269859|NCT02688387|76099243|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269860|NCT02688387|76099244|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269861|NCT02688387|76099245|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269862|NCT02688387|76099246|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269863|NCT02688387|76099247|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269864|NCT02688387|76099248|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269865|NCT02688387|76099249|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
42269866|NCT02688387|76099228|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269867|NCT02688387|76099229|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269868|NCT02688387|76099230|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269869|NCT02688387|76099231|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
42269870|NCT02688387|76099232|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269871|NCT02688387|76099233|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269872|NCT02688387|76099234|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269873|NCT02688387|76099235|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269874|NCT02688387|76099236|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269875|NCT02688387|76099237|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269876|NCT02688387|76099238|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269877|NCT02688387|76099239|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269878|NCT02688387|76099240|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269879|NCT02688387|76099241|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269880|NCT02688387|76099242|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269881|NCT02688387|76099243|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269882|NCT02688387|76099244|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269883|NCT02688387|76099245|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269884|NCT02688387|76099246|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269885|NCT02688387|76099247|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269886|NCT02688387|76099248|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269887|NCT02688387|76099249|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269888|NCT02688387|76099228|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269889|NCT02688387|76099229|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
42343675|NCT01943851|76182067|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343676|NCT01943851|76182068|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343677|NCT01943851|76182069|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343678|NCT01943851|76182070|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343679|NCT01943851|76182071|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42004254|NCT01093222|75812252|FG000|Overall Study|Adverse Event|7|||
42343680|NCT01943851|76182072|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343681|NCT01943851|76182073|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343682|NCT01943851|76182074|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343683|NCT01943851|76182075|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343684|NCT01943851|76182076|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343685|NCT01943851|76182077|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343686|NCT01943851|76182078|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
42343687|NCT01943851|76182079|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343688|NCT01943851|76182080|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42004255|NCT01093222|75812252|FG000|Overall Study|Progression/relapse|24|||
42004256|NCT01093222|75812252|FG000|Overall Study|Death|2|||
42004257|NCT01093222|75812252|FG000|Overall Study|Not protocol specified|1|||
42004258|NCT01313663|75812258|FG000|Overall Study|Study Closed/Terminated|2|||
42004259|NCT01313663|75812259|FG001|Overall Study|Study Closed/Terminated|4|||
42004260|NCT01313663|75812258|FG000|Overall Study|Lost to Follow-up|0|||
42004261|NCT01313663|75812259|FG001|Overall Study|Lost to Follow-up|1|||
42269890|NCT02688387|76099230|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269891|NCT02688387|76099231|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269892|NCT02688387|76099232|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269893|NCT02688387|76099233|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269894|NCT02688387|76099234|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269895|NCT02688387|76099235|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269896|NCT02688387|76099236|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269897|NCT02688387|76099237|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269898|NCT02688387|76099238|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269899|NCT02688387|76099239|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42343689|NCT01943851|76182081|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343690|NCT01943851|76182082|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
42343691|NCT01943851|76182065|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343692|NCT01943851|76182066|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343693|NCT01943851|76182067|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343694|NCT01943851|76182068|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343695|NCT01943851|76182069|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343696|NCT01943851|76182070|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343697|NCT01943851|76182071|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343698|NCT01943851|76182072|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343699|NCT01943851|76182073|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343700|NCT01943851|76182074|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343701|NCT01943851|76182075|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343702|NCT01943851|76182076|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343703|NCT01943851|76182077|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343704|NCT01943851|76182078|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343705|NCT01943851|76182079|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343706|NCT01943851|76182080|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
42343707|NCT01943851|76182081|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343708|NCT01943851|76182082|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
42343709|NCT01943851|76182065|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42343710|NCT01943851|76182066|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42343711|NCT01943851|76182067|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42343712|NCT01943851|76182068|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42343713|NCT01943851|76182069|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42343714|NCT01943851|76182070|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42004262|NCT01313663|75812258|FG000|Overall Study|Physician Decision|0|||
42004263|NCT01313663|75812259|FG001|Overall Study|Physician Decision|2|||
42004264|NCT01313663|75812258|FG000|Overall Study|Withdrawal by Subject|2|||
42004265|NCT01313663|75812259|FG001|Overall Study|Withdrawal by Subject|1|||
42004266|NCT01092832|75812267|FG000|Overall Study|Other|1|||
42004267|NCT01092832|75812268|FG001|Overall Study|Other|0|||
42004268|NCT01313273|75812276|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
42004269|NCT01313273|75812277|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
42004270|NCT01313273|75812276|FG000|Overall Study|Withdrawal by Subject|1|||
42004271|NCT01313273|75812277|FG001|Overall Study|Withdrawal by Subject|0|||
42004272|NCT01313273|75812276|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
42004273|NCT01313273|75812277|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
42004274|NCT01091974|75812287|FG000|Overall Study|Did not start intervention|3|||
42269900|NCT02688387|76099240|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269901|NCT02688387|76099241|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269902|NCT02688387|76099242|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269903|NCT02688387|76099243|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269904|NCT02688387|76099244|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269905|NCT02688387|76099245|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269906|NCT02688387|76099246|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269907|NCT02688387|76099247|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269908|NCT02688387|76099248|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269909|NCT02688387|76099249|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
42269910|NCT02688387|76099228|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269911|NCT02688387|76099229|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269912|NCT02688387|76099230|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
42269913|NCT02688387|76099231|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269914|NCT02688387|76099232|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
42269915|NCT02688387|76099233|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269916|NCT02688387|76099234|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269917|NCT02688387|76099235|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269918|NCT02688387|76099236|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269919|NCT02688387|76099237|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269920|NCT02688387|76099238|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269921|NCT02688387|76099239|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269922|NCT02688387|76099240|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269923|NCT02688387|76099241|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269924|NCT02688387|76099242|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269925|NCT02688387|76099243|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269926|NCT02688387|76099244|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269927|NCT02688387|76099245|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269928|NCT02688387|76099246|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42004275|NCT01091974|75812288|FG001|Overall Study|Did not start intervention|1|||
42004276|NCT01091974|75812289|FG002|Overall Study|Did not start intervention|3|||
42004277|NCT01091974|75812290|FG003|Overall Study|Did not start intervention|1|||
42004278|NCT01091974|75812287|FG000|Overall Study|resumed sleep medication|0|||
42035175|NCT00926367|75843536|FG000|Overall Study|Withdrawal by Subject|0|||
42035176|NCT00926367|75843537|FG001|Overall Study|Withdrawal by Subject|1|||
42135783|NCT00293254|75946384|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
42343715|NCT01943851|76182071|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42343716|NCT01943851|76182072|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42343717|NCT01943851|76182073|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42343718|NCT01943851|76182074|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42343719|NCT01943851|76182075|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42343720|NCT01943851|76182076|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42135784|NCT00293254|75946385|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
42135785|NCT00293254|75946384|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
42135786|NCT00293254|75946385|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
42269929|NCT02688387|76099247|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269930|NCT02688387|76099248|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269931|NCT02688387|76099249|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
42269932|NCT02688387|76099228|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
42269933|NCT02688387|76099229|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269934|NCT02688387|76099230|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269935|NCT02688387|76099231|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42135787|NCT00293254|75946384|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
42135788|NCT00293254|75946385|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
42135789|NCT00293254|75946384|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
42135790|NCT00293254|75946385|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
42135791|NCT00293254|75946384|FG000|Extension - Double-Blind Week 49-156|Death|4|||
42135792|NCT00293254|75946385|FG001|Extension - Double-Blind Week 49-156|Death|1|||
42135793|NCT00293254|75946384|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
42135794|NCT00293254|75946385|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
42135795|NCT00293254|75946384|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
42135796|NCT00293254|75946385|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
42135797|NCT00293254|75946384|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
42135798|NCT00293254|75946385|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
42135799|NCT00293254|75946384|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
42135800|NCT00293254|75946385|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
42135801|NCT00293254|75946384|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
42135802|NCT00293254|75946385|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
42135803|NCT00293254|75946384|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
42135804|NCT00293254|75946385|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
42135805|NCT00293254|75946384|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
42135806|NCT00293254|75946385|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
42135807|NCT00293254|75946384|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
42135808|NCT00293254|75946385|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
42135809|NCT00293254|75946384|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
42135810|NCT00293254|75946385|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
42135811|NCT00293254|75946384|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
42135812|NCT00293254|75946385|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
42135813|NCT00293254|75946384|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
42135814|NCT00293254|75946385|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
42269936|NCT02688387|76099232|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269937|NCT02688387|76099233|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269938|NCT02688387|76099234|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269939|NCT02688387|76099235|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269940|NCT02688387|76099236|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269941|NCT02688387|76099237|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269942|NCT02688387|76099238|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269943|NCT02688387|76099239|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269944|NCT02688387|76099240|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269945|NCT02688387|76099241|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269946|NCT02688387|76099242|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269947|NCT02688387|76099243|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269948|NCT02688387|76099244|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269949|NCT02688387|76099245|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42343721|NCT01943851|76182077|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42004279|NCT01091974|75812288|FG001|Overall Study|resumed sleep medication|0|||
42004280|NCT01091974|75812289|FG002|Overall Study|resumed sleep medication|1|||
42004281|NCT01091974|75812290|FG003|Overall Study|resumed sleep medication|2|||
42004282|NCT01091974|75812287|FG000|Overall Study|Withdrawal by Subject|1|||
42004283|NCT01091974|75812288|FG001|Overall Study|Withdrawal by Subject|3|||
42004284|NCT01091974|75812289|FG002|Overall Study|Withdrawal by Subject|2|||
42004285|NCT01091974|75812290|FG003|Overall Study|Withdrawal by Subject|2|||
42004286|NCT01091974|75812287|FG000|Overall Study|side-effects|1|||
42035177|NCT00926367|75843536|FG000|Overall Study|Lost to Follow-up|1|||
42269950|NCT02688387|76099246|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42343722|NCT01943851|76182078|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42269951|NCT02688387|76099247|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269952|NCT02688387|76099248|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269953|NCT02688387|76099249|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
42269954|NCT02688387|76099228|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269955|NCT02688387|76099229|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269956|NCT02688387|76099230|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269957|NCT02688387|76099231|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269958|NCT02688387|76099232|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269959|NCT02688387|76099233|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269960|NCT02688387|76099234|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269961|NCT02688387|76099235|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269962|NCT02688387|76099236|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269963|NCT02688387|76099237|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269964|NCT02688387|76099238|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
42269965|NCT02688387|76099239|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269966|NCT02688387|76099240|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269967|NCT02688387|76099241|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269968|NCT02688387|76099242|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269969|NCT02688387|76099243|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269970|NCT02688387|76099244|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269971|NCT02688387|76099245|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269972|NCT02688387|76099246|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269973|NCT02688387|76099247|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269974|NCT02688387|76099248|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269975|NCT02688387|76099249|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
42269976|NCT02688387|76099228|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269977|NCT02688387|76099229|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269978|NCT02688387|76099230|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269979|NCT02688387|76099231|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269980|NCT02688387|76099232|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269981|NCT02688387|76099233|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269982|NCT02688387|76099234|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42343723|NCT01943851|76182079|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
42269983|NCT02688387|76099235|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269984|NCT02688387|76099236|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42343724|NCT01943851|76182080|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
42343725|NCT01943851|76182081|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
42343726|NCT01943851|76182082|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
42343727|NCT01430104|76182123|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
42343728|NCT01990859|76182130|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
42343729|NCT01990859|76182130|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
42343730|NCT02093897|76182135|FG000|Overall Study|Physician Decision|1|||
42004287|NCT01091974|75812288|FG001|Overall Study|side-effects|1|||
42004288|NCT01091974|75812289|FG002|Overall Study|side-effects|0|||
42004289|NCT01091974|75812290|FG003|Overall Study|side-effects|2|||
42004290|NCT01313117|75812300|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
42004291|NCT01313117|75812300|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
42343731|NCT02093897|76182135|FG000|Overall Study|Planned age group closure - no's reached|17|||
42343732|NCT02093897|76182135|FG000|Overall Study|Adverse event, non-fatal|1|||
42343733|NCT01990313|76182146|FG000|Overall Study|Lost to Follow-up|1|||
42343734|NCT01947517|76182152|FG000|Overall Study|Withdrawal by Subject|1|||
42343735|NCT01947517|76182153|FG001|Overall Study|Withdrawal by Subject|1|||
42343736|NCT02006927|76182159|FG000|Overall Study|Adverse Event|2|||
42343737|NCT02006927|76182159|FG000|Overall Study|Withdrawal by Subject|1|||
42343738|NCT01947283|76182170|FG000|Overall Study|Death|1|||
42004292|NCT01313039|75812305|FG000|Overall Study|Physician Decision|1|||
42004293|NCT01313039|75812305|FG000|Overall Study|Adverse Event|1|||
42343739|NCT01947283|76182171|FG001|Overall Study|Death|1|||
42343740|NCT01947283|76182172|FG002|Overall Study|Death|1|||
42343741|NCT01947283|76182173|FG003|Overall Study|Death|0|||
42343742|NCT01947283|76182174|FG004|Overall Study|Death|0|||
42135815|NCT00293254|75946384|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
42135816|NCT00293254|75946385|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
42135817|NCT00293254|75946384|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
42135818|NCT00293254|75946385|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
42135819|NCT00293254|75946384|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
42135820|NCT00293254|75946385|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
42135821|NCT00293254|75946384|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
42135822|NCT00293254|75946385|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
42135823|NCT00293254|75946384|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
42135824|NCT00293254|75946385|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
42135825|NCT00293254|75946384|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
42343743|NCT01947283|76182175|FG005|Overall Study|Death|0|||
42343744|NCT01947283|76182176|FG006|Overall Study|Death|0|||
42343745|NCT01947283|76182170|FG000|Overall Study|Lost to Follow-up|4|||
42343746|NCT01947283|76182171|FG001|Overall Study|Lost to Follow-up|6|||
42343747|NCT01947283|76182172|FG002|Overall Study|Lost to Follow-up|5|||
42343748|NCT01947283|76182173|FG003|Overall Study|Lost to Follow-up|5|||
42343749|NCT01947283|76182174|FG004|Overall Study|Lost to Follow-up|0|||
42343750|NCT01947283|76182175|FG005|Overall Study|Lost to Follow-up|2|||
42343751|NCT01947283|76182176|FG006|Overall Study|Lost to Follow-up|5|||
42343752|NCT01947283|76182170|FG000|Overall Study|Withdrawal by Subject|10|||
42343753|NCT01947283|76182171|FG001|Overall Study|Withdrawal by Subject|8|||
42343754|NCT01947283|76182172|FG002|Overall Study|Withdrawal by Subject|4|||
42343755|NCT01947283|76182173|FG003|Overall Study|Withdrawal by Subject|1|||
42343756|NCT01947283|76182174|FG004|Overall Study|Withdrawal by Subject|0|||
42343757|NCT01947283|76182175|FG005|Overall Study|Withdrawal by Subject|0|||
42343758|NCT01947283|76182176|FG006|Overall Study|Withdrawal by Subject|2|||
42343759|NCT01947283|76182170|FG000|Overall Study|No Clinical Recording|12|||
42343760|NCT01947283|76182171|FG001|Overall Study|No Clinical Recording|6|||
42343761|NCT01947283|76182172|FG002|Overall Study|No Clinical Recording|8|||
42343762|NCT01947283|76182173|FG003|Overall Study|No Clinical Recording|10|||
42343763|NCT01947283|76182174|FG004|Overall Study|No Clinical Recording|0|||
42343764|NCT01947283|76182175|FG005|Overall Study|No Clinical Recording|0|||
42343765|NCT01947283|76182176|FG006|Overall Study|No Clinical Recording|0|||
42343766|NCT01947283|76182170|FG000|Overall Study|Non-coding Clinical Recording language|0|||
42343767|NCT01947283|76182171|FG001|Overall Study|Non-coding Clinical Recording language|0|||
42343768|NCT01947283|76182172|FG002|Overall Study|Non-coding Clinical Recording language|0|||
42343769|NCT01947283|76182173|FG003|Overall Study|Non-coding Clinical Recording language|1|||
42343770|NCT01947283|76182174|FG004|Overall Study|Non-coding Clinical Recording language|0|||
42343771|NCT01947283|76182175|FG005|Overall Study|Non-coding Clinical Recording language|0|||
42343772|NCT01947283|76182176|FG006|Overall Study|Non-coding Clinical Recording language|0|||
42343773|NCT01947283|76182170|FG000|Overall Study|Missing Follow-up Assessment|2|||
42343774|NCT01947283|76182171|FG001|Overall Study|Missing Follow-up Assessment|2|||
42343775|NCT01947283|76182172|FG002|Overall Study|Missing Follow-up Assessment|3|||
42343776|NCT01947283|76182173|FG003|Overall Study|Missing Follow-up Assessment|0|||
42135826|NCT00293254|75946385|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
42135827|NCT00456846|75946399|FG000|Overall Study|Adverse Event|2|||
42135828|NCT00456846|75946400|FG001|Overall Study|Adverse Event|15|||
42135829|NCT00456846|75946399|FG000|Overall Study|Physician Decision|11|||
42135830|NCT00456846|75946400|FG001|Overall Study|Physician Decision|6|||
42135831|NCT00456846|75946399|FG000|Overall Study|Protocol Deviation|2|||
42135832|NCT00456846|75946400|FG001|Overall Study|Protocol Deviation|0|||
42269985|NCT02688387|76099237|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269986|NCT02688387|76099238|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269987|NCT02688387|76099239|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269988|NCT02688387|76099240|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269989|NCT02688387|76099241|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269990|NCT02688387|76099242|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
42269991|NCT02688387|76099243|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42343777|NCT01947283|76182174|FG004|Overall Study|Missing Follow-up Assessment|0|||
42343778|NCT01947283|76182175|FG005|Overall Study|Missing Follow-up Assessment|2|||
42343779|NCT01947283|76182176|FG006|Overall Study|Missing Follow-up Assessment|0|||
42343780|NCT01947283|76182170|FG000|Overall Study|No patients were enrolled in study|0|||
42343781|NCT01947283|76182171|FG001|Overall Study|No patients were enrolled in study|0|||
42343782|NCT01947283|76182172|FG002|Overall Study|No patients were enrolled in study|0|||
42343783|NCT01947283|76182173|FG003|Overall Study|No patients were enrolled in study|0|||
42343784|NCT01947283|76182174|FG004|Overall Study|No patients were enrolled in study|0|||
42343785|NCT01947283|76182175|FG005|Overall Study|No patients were enrolled in study|3|||
42343786|NCT01947283|76182176|FG006|Overall Study|No patients were enrolled in study|1|||
42343787|NCT02006693|76182195|FG000|Overall Study|No Reason Specified|6|||
42343788|NCT02006693|76182196|FG001|Overall Study|No Reason Specified|8|||
42343789|NCT02006693|76182195|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
42343790|NCT02006693|76182196|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
42343791|NCT02006693|76182195|FG000|Overall Study|XEN Implant Explantation|0|||
42343792|NCT02006693|76182196|FG001|Overall Study|XEN Implant Explantation|1|||
42343793|NCT02006693|76182195|FG000|Overall Study|Death|2|||
42343794|NCT02006693|76182196|FG001|Overall Study|Death|2|||
42343795|NCT02006693|76182195|FG000|Overall Study|Lost to Follow-up|4|||
42135833|NCT00456846|75946399|FG000|Overall Study|Participant Discretion|1|||
42135834|NCT00456846|75946400|FG001|Overall Study|Participant Discretion|5|||
42135835|NCT00456846|75946399|FG000|Overall Study|Other|0|||
42135836|NCT00456846|75946400|FG001|Overall Study|Other|2|||
42343796|NCT02006693|76182196|FG001|Overall Study|Lost to Follow-up|1|||
42343797|NCT02006693|76182195|FG000|Overall Study|Patient Decision|4|||
42343798|NCT02006693|76182196|FG001|Overall Study|Patient Decision|0|||
42343799|NCT01947127|76182204|FG000|Overall Study|Protocol Violation|18|||
42004294|NCT01091662|75812311|FG000|Overall Study|Adverse Event|1|||
42135837|NCT00448344|75946408|FG000|Overall Study|Lost to Follow-up|20|||
42135838|NCT00448344|75946409|FG001|Overall Study|Lost to Follow-up|22|||
42343800|NCT01947127|76182205|FG001|Overall Study|Protocol Violation|38|||
42343801|NCT01947127|76182204|FG000|Overall Study|Withdrawal by Subject|1|||
42343802|NCT01947127|76182205|FG001|Overall Study|Withdrawal by Subject|1|||
42343803|NCT01947127|76182204|FG000|Overall Study|Data loss|4|||
42343804|NCT01947127|76182205|FG001|Overall Study|Data loss|4|||
42343805|NCT01976845|76182214|FG000|Overall Study|Physician Decision|8|||
42343806|NCT01976845|76182215|FG001|Overall Study|Physician Decision|8|||
42343807|NCT01976845|76182216|FG002|Overall Study|Physician Decision|3|||
42343808|NCT01989689|76182226|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
42343809|NCT01989689|76182227|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
42343810|NCT01989689|76182226|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
42343811|NCT01989689|76182227|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
42343812|NCT01943539|76182235|FG000|Overall Study|Non-compliance with at-home intervention|4|||
42343813|NCT01943539|76182236|FG001|Overall Study|Non-compliance with at-home intervention|0|||
42343814|NCT01942993|76182243|FG000|Overall Study|Lost to Follow-up|1|||
42343815|NCT01942993|76182243|FG000|Overall Study|Physician Decision|1|||
42004295|NCT01091662|75812312|FG001|Overall Study|Adverse Event|9|||
42004296|NCT01091662|75812311|FG000|Overall Study|Physician Decision|1|||
42269992|NCT02688387|76099244|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269993|NCT02688387|76099245|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269994|NCT02688387|76099246|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269995|NCT02688387|76099247|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269996|NCT02688387|76099248|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269997|NCT02688387|76099249|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
42269998|NCT02688387|76099228|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42269999|NCT02688387|76099229|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270000|NCT02688387|76099230|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270001|NCT02688387|76099231|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270002|NCT02688387|76099232|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270003|NCT02688387|76099233|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270004|NCT02688387|76099234|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270005|NCT02688387|76099235|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270006|NCT02688387|76099236|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270007|NCT02688387|76099237|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42343816|NCT01989455|76182252|FG000|Overall Study|Adverse Event|0|||
42343817|NCT01989455|76182253|FG001|Overall Study|Adverse Event|1|||
42343818|NCT01989455|76182254|FG002|Overall Study|Adverse Event|0|||
42343819|NCT01989455|76182255|FG003|Overall Study|Adverse Event|0|||
42343820|NCT01989455|76182256|FG004|Overall Study|Adverse Event|0|||
42343821|NCT01989455|76182252|FG000|Overall Study|Withdrawal by Subject|0|||
42343822|NCT01989455|76182253|FG001|Overall Study|Withdrawal by Subject|1|||
42343823|NCT01989455|76182254|FG002|Overall Study|Withdrawal by Subject|0|||
42343824|NCT01989455|76182255|FG003|Overall Study|Withdrawal by Subject|0|||
42343825|NCT01989455|76182256|FG004|Overall Study|Withdrawal by Subject|0|||
42343826|NCT01989455|76182252|FG000|Overall Study|Technical problems with infusion|0|||
42343827|NCT01989455|76182253|FG001|Overall Study|Technical problems with infusion|0|||
42270008|NCT02688387|76099238|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270009|NCT02688387|76099239|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270010|NCT02688387|76099240|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270011|NCT02688387|76099241|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270012|NCT02688387|76099242|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270013|NCT02688387|76099243|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270014|NCT02688387|76099244|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270015|NCT02688387|76099245|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270016|NCT02688387|76099246|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270017|NCT02688387|76099247|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270018|NCT02688387|76099248|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
42270019|NCT02688387|76099249|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
42270020|NCT02688387|76099228|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270021|NCT02688387|76099229|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270022|NCT02688387|76099230|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270023|NCT02688387|76099231|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270024|NCT02688387|76099232|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42343828|NCT01989455|76182254|FG002|Overall Study|Technical problems with infusion|1|||
42270025|NCT02688387|76099233|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42343829|NCT01989455|76182255|FG003|Overall Study|Technical problems with infusion|0|||
42270026|NCT02688387|76099234|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270027|NCT02688387|76099235|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270028|NCT02688387|76099236|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270029|NCT02688387|76099237|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270030|NCT02688387|76099238|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270031|NCT02688387|76099239|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270032|NCT02688387|76099240|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270033|NCT02688387|76099241|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270034|NCT02688387|76099242|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270035|NCT02688387|76099243|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270036|NCT02688387|76099244|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270037|NCT02688387|76099245|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270038|NCT02688387|76099246|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
42270039|NCT02688387|76099247|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270040|NCT02688387|76099248|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
42270041|NCT02688387|76099249|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
42270042|NCT02688387|76099228|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270043|NCT02688387|76099229|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270044|NCT02688387|76099230|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270045|NCT02688387|76099231|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270046|NCT02688387|76099232|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270047|NCT02688387|76099233|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42343830|NCT01989455|76182256|FG004|Overall Study|Technical problems with infusion|1|||
42343831|NCT01942837|76182272|FG000|Overall Study|Death|1|||
42343832|NCT01942837|76182272|FG000|Overall Study|Symptomatic or radiographic progression|49|||
42343833|NCT01942837|76182272|FG000|Overall Study|Adverse Event|6|||
42343834|NCT01942837|76182272|FG000|Overall Study|Physician Decision|3|||
42343835|NCT01942837|76182272|FG000|Overall Study|Withdrawal by Subject|2|||
42343836|NCT01942837|76182272|FG000|Overall Study|Intercurrent Illness|1|||
42343837|NCT01942837|76182272|FG000|Overall Study|On treatment|3|||
42343838|NCT01942837|76182272|FG000|Overall Study|Never initiate the treatment|2|||
42343839|NCT01987895|76182279|FG000|Overall Study|Withdrawal by Subject|12|||
42343840|NCT01987895|76182280|FG001|Overall Study|Withdrawal by Subject|7|||
42343841|NCT01987895|76182279|FG000|Overall Study|Physician Decision|8|||
42343842|NCT01987895|76182280|FG001|Overall Study|Physician Decision|10|||
42343843|NCT01987895|76182279|FG000|Overall Study|Death|7|||
42343844|NCT01987895|76182280|FG001|Overall Study|Death|7|||
42343845|NCT01987895|76182279|FG000|Overall Study|Lost to Follow-up|3|||
42343846|NCT01987895|76182280|FG001|Overall Study|Lost to Follow-up|5|||
42343847|NCT01987895|76182279|FG000|Overall Study|randomized before giving IC|0|||
42343848|NCT01987895|76182280|FG001|Overall Study|randomized before giving IC|1|||
42343849|NCT02005445|76182288|FG000|Overall Study|Dual study enrollment|0|||
42343850|NCT02005445|76182289|FG001|Overall Study|Dual study enrollment|1|||
42343851|NCT01618669|76182297|FG000|Overall Study|Lost to Follow-up|1|||
42343852|NCT01618669|76182298|FG001|Overall Study|Lost to Follow-up|1|||
42343853|NCT01618669|76182297|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
42343854|NCT01618669|76182298|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
42343855|NCT01618669|76182297|FG000|Overall Study|Adverse Event|16|||
42343856|NCT01618669|76182298|FG001|Overall Study|Adverse Event|7|||
42343857|NCT01618669|76182297|FG000|Overall Study|Protocol Violation|5|||
42343858|NCT01618669|76182298|FG001|Overall Study|Protocol Violation|3|||
42343859|NCT01618669|76182297|FG000|Overall Study|Withdrawal by Subject|9|||
42343860|NCT01618669|76182298|FG001|Overall Study|Withdrawal by Subject|9|||
42270048|NCT02688387|76099234|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270049|NCT02688387|76099235|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270050|NCT02688387|76099236|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42343861|NCT01618669|76182297|FG000|Overall Study|Miscellaneous Reason|0|||
42343862|NCT01618669|76182298|FG001|Overall Study|Miscellaneous Reason|1|||
42343863|NCT01390948|76182319|FG000|Overall Study|End of Study|1|||
42343864|NCT01390948|76182320|FG001|Overall Study|End of Study|0|||
42004297|NCT01091662|75812312|FG001|Overall Study|Physician Decision|1|||
42004298|NCT01091662|75812311|FG000|Overall Study|Withdrawal by Subject|7|||
42004299|NCT01091662|75812312|FG001|Overall Study|Withdrawal by Subject|6|||
42004300|NCT01091662|75812311|FG000|Overall Study|met exit criteria|7|||
42004301|NCT01091662|75812312|FG001|Overall Study|met exit criteria|13|||
42004302|NCT01091662|75812311|FG000|Overall Study|met exclusion criteria|1|||
42004303|NCT01091662|75812312|FG001|Overall Study|met exclusion criteria|0|||
42004304|NCT01091662|75812311|FG000|Overall Study|Lost to Follow-up|0|||
42270051|NCT02688387|76099237|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42343865|NCT01390948|76182321|FG002|Overall Study|End of Study|0|||
42343866|NCT01390948|76182319|FG000|Overall Study|Withdrew consent|2|||
42343867|NCT01390948|76182320|FG001|Overall Study|Withdrew consent|2|||
42343868|NCT01390948|76182321|FG002|Overall Study|Withdrew consent|0|||
42343869|NCT01390948|76182319|FG000|Overall Study|Progressive Disease|2|||
42343870|NCT01390948|76182320|FG001|Overall Study|Progressive Disease|5|||
42343871|NCT01390948|76182321|FG002|Overall Study|Progressive Disease|0|||
42343872|NCT01390948|76182319|FG000|Overall Study|Death during follow-up|10|||
42343873|NCT01390948|76182320|FG001|Overall Study|Death during follow-up|11|||
42343874|NCT01390948|76182321|FG002|Overall Study|Death during follow-up|1|||
42343875|NCT02005211|76182335|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
42343876|NCT02005211|76182336|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
42343877|NCT02005211|76182337|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
42004305|NCT01091662|75812312|FG001|Overall Study|Lost to Follow-up|1|||
42004306|NCT01091662|75812311|FG000|Overall Study|Pregnancy|0|||
42270052|NCT02688387|76099238|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270053|NCT02688387|76099239|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270054|NCT02688387|76099240|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270055|NCT02688387|76099241|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270056|NCT02688387|76099242|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270057|NCT02688387|76099243|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270058|NCT02688387|76099244|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270059|NCT02688387|76099245|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270060|NCT02688387|76099246|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270061|NCT02688387|76099247|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
42270062|NCT02688387|76099248|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270063|NCT02688387|76099249|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
42270064|NCT02476201|76099295|FG000|Overall Study|Unable to program MPP|9|||
42270065|NCT02476201|76099295|FG000|Overall Study|Study echo not performed|5|||
42270066|NCT02476201|76099295|FG000|Overall Study|Adverse Event|4|||
42270067|NCT02476201|76099295|FG000|Overall Study|Death|2|||
42270068|NCT02476201|76099295|FG000|Overall Study|Lost to Follow-up|2|||
42270069|NCT02476201|76099295|FG000|Overall Study|MPP programmed to OFF|2|||
42270070|NCT02476201|76099295|FG000|Overall Study|Withdrawal by Subject|1|||
42270071|NCT02476201|76099295|FG000|Overall Study|Unsuccessful implant|1|||
42343878|NCT02005211|76182338|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
42004307|NCT01091662|75812312|FG001|Overall Study|Pregnancy|1|||
42270072|NCT02688153|76099302|FG000|Overall Study|Death|7|||
42004308|NCT01091662|75812311|FG000|Overall Study|Protocol Violation|0|||
42270073|NCT02688153|76099303|FG001|Overall Study|Death|5|||
42270074|NCT02688153|76099302|FG000|Overall Study|Withdrawal by Subject|4|||
42270075|NCT02688153|76099303|FG001|Overall Study|Withdrawal by Subject|2|||
42004309|NCT01091662|75812312|FG001|Overall Study|Protocol Violation|2|||
42004310|NCT01091662|75812311|FG000|Overall Study|unable to swallow capsule|0|||
42004311|NCT01091662|75812312|FG001|Overall Study|unable to swallow capsule|1|||
42004312|NCT01312961|75812325|FG000|Overall Study|Adverse Event|3|||
42004313|NCT01312961|75812326|FG001|Overall Study|Adverse Event|3|||
42270076|NCT02688153|76099302|FG000|Overall Study|Valve Explant|1|||
42270077|NCT02688153|76099303|FG001|Overall Study|Valve Explant|0|||
42270078|NCT02688153|76099302|FG000|Overall Study|Conversion to Commercial Valve|3|||
42270079|NCT02688153|76099303|FG001|Overall Study|Conversion to Commercial Valve|0|||
42343879|NCT02005211|76182339|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
42004314|NCT01312961|75812325|FG000|Overall Study|Lack of Efficacy|11|||
42270080|NCT02687919|76099312|FG000|Overall Study|Withdrawal by Subject|6|||
42270081|NCT02687919|76099313|FG001|Overall Study|Withdrawal by Subject|6|||
42270082|NCT02687919|76099312|FG000|Overall Study|Protocol Violation|2|||
42270083|NCT02687919|76099313|FG001|Overall Study|Protocol Violation|0|||
42270084|NCT02687451|76099325|FG000|Overall Study|Withdrawal by Subject|1|||
42270085|NCT02687451|76099326|FG001|Overall Study|Withdrawal by Subject|0|||
42270086|NCT02687451|76099327|FG002|Overall Study|Withdrawal by Subject|0|||
42343880|NCT02005211|76182340|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
42343881|NCT02005211|76182341|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
42343882|NCT01429792|76182364|FG000|Overall Study|Other Reasons|67|||
42270087|NCT02687451|76099328|FG003|Overall Study|Withdrawal by Subject|0|||
42343883|NCT01429792|76182364|FG000|Overall Study|Unknown Disposition|94|||
42343884|NCT01429792|76182364|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
42343885|NCT01429792|76182364|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
42343886|NCT01429792|76182364|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
42343887|NCT01429792|76182364|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
42343888|NCT01429792|76182364|FG000|Overall Study|Withdrawal by Subject|70|||
42343889|NCT01429792|76182364|FG000|Overall Study|Lost to Follow-up|88|||
42343890|NCT01409434|76182368|FG000|Overall Study|Protocol Violation|4|||
42343891|NCT01940887|76182374|FG000|Year 1|Protocol Violation|0|||
42343892|NCT01940887|76182375|FG001|Year 1|Protocol Violation|1|||
42343893|NCT01940887|76182374|FG000|Year 1|Physician Decision|7|||
42343894|NCT01940887|76182375|FG001|Year 1|Physician Decision|3|||
42343895|NCT01940887|76182374|FG000|Year 1|Death|5|||
42343896|NCT01940887|76182375|FG001|Year 1|Death|3|||
42343897|NCT01940887|76182374|FG000|Year 1|Adverse Event|7|||
42343898|NCT01940887|76182375|FG001|Year 1|Adverse Event|6|||
42343899|NCT01940887|76182374|FG000|Year 1|Withdrawal by Subject|18|||
42343900|NCT01940887|76182375|FG001|Year 1|Withdrawal by Subject|9|||
42004315|NCT01312961|75812326|FG001|Overall Study|Lack of Efficacy|1|||
42270088|NCT02687451|76099329|FG004|Overall Study|Withdrawal by Subject|0|||
42270089|NCT02687451|76099330|FG005|Overall Study|Withdrawal by Subject|1|||
42004316|NCT01312961|75812325|FG000|Overall Study|Poor compliance to protocol|1|||
42343901|NCT01940887|76182374|FG000|Year 1|Lost to Follow-up|2|||
42343902|NCT01940887|76182375|FG001|Year 1|Lost to Follow-up|1|||
42343903|NCT01940887|76182374|FG000|Year 2|Physician Decision|8|||
42343904|NCT01940887|76182375|FG001|Year 2|Physician Decision|1|||
42343905|NCT01940887|76182374|FG000|Year 2|Death|0|||
42343906|NCT01940887|76182375|FG001|Year 2|Death|2|||
42343907|NCT01940887|76182374|FG000|Year 2|Sponsor Decision, early termination|192|||
42343908|NCT01940887|76182375|FG001|Year 2|Sponsor Decision, early termination|203|||
42343909|NCT01940887|76182374|FG000|Year 2|Adverse Event|8|||
42343910|NCT01940887|76182375|FG001|Year 2|Adverse Event|2|||
42343911|NCT01940887|76182374|FG000|Year 2|Withdrawal by Subject|8|||
42343912|NCT01940887|76182375|FG001|Year 2|Withdrawal by Subject|8|||
42343913|NCT01940887|76182374|FG000|Year 2|Lost to Follow-up|1|||
42343914|NCT01940887|76182375|FG001|Year 2|Lost to Follow-up|6|||
42343915|NCT01925612|76182386|FG000|Overall Study|Progressive Disease|1|||
42343916|NCT01925612|76182387|FG001|Overall Study|Progressive Disease|1|||
42343917|NCT01925612|76182388|FG002|Overall Study|Progressive Disease|1|||
42343918|NCT01925612|76182389|FG003|Overall Study|Progressive Disease|0|||
42343919|NCT01925612|76182390|FG004|Overall Study|Progressive Disease|0|||
42343920|NCT01925612|76182386|FG000|Overall Study|Adverse Event|3|||
42343921|NCT01925612|76182387|FG001|Overall Study|Adverse Event|3|||
42343922|NCT01925612|76182388|FG002|Overall Study|Adverse Event|0|||
42343923|NCT01925612|76182389|FG003|Overall Study|Adverse Event|1|||
42343924|NCT01925612|76182390|FG004|Overall Study|Adverse Event|2|||
42343925|NCT02093663|76182402|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
42343926|NCT02093663|76182403|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
42343927|NCT02093663|76182404|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
42343928|NCT02093663|76182405|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
42343929|NCT02093663|76182406|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
42343930|NCT02093663|76182402|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
42343931|NCT02093663|76182403|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
42343932|NCT02093663|76182404|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
42343933|NCT02093663|76182405|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
42343934|NCT02093663|76182406|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
42343935|NCT02093663|76182402|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
42343936|NCT02093663|76182403|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
42343937|NCT02093663|76182404|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
42343938|NCT02093663|76182405|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
42135839|NCT00448344|75946408|FG000|Overall Study|Withdrawal by Subject|6|||
42135840|NCT00448344|75946409|FG001|Overall Study|Withdrawal by Subject|8|||
42270090|NCT02557646|76099346|FG000|Overall Study|Adverse Event|40|||
42270091|NCT02557646|76099346|FG000|Overall Study|Death|1|||
42270092|NCT02557646|76099346|FG000|Overall Study|Lack of Efficacy|186|||
42270093|NCT02557646|76099346|FG000|Overall Study|Withdrawal by Subject|18|||
42270094|NCT02557646|76099346|FG000|Overall Study|Lost to Follow-up|17|||
42270095|NCT02557646|76099346|FG000|Overall Study|Other|14|||
42270096|NCT02679573|76099352|FG000|Overall Study|Adverse Event|13|||
42270097|NCT02679573|76099353|FG001|Overall Study|Adverse Event|6|||
42270098|NCT02679573|76099352|FG000|Overall Study|Lack of Efficacy|12|||
42270099|NCT02679573|76099353|FG001|Overall Study|Lack of Efficacy|15|||
42270100|NCT02679573|76099352|FG000|Overall Study|Could not complete required study visits|6|||
42270101|NCT02679573|76099353|FG001|Overall Study|Could not complete required study visits|2|||
42270102|NCT02679573|76099352|FG000|Overall Study|Withdrawal by Subject|2|||
42270103|NCT02679573|76099353|FG001|Overall Study|Withdrawal by Subject|9|||
42270104|NCT02679573|76099352|FG000|Overall Study|Death|2|||
42343939|NCT02093663|76182406|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
42343940|NCT02093663|76182402|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
42343941|NCT02093663|76182403|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
42343942|NCT02093663|76182404|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
42343943|NCT02093663|76182405|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
42343944|NCT02093663|76182406|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
42343945|NCT02093663|76182402|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
42343946|NCT02093663|76182403|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
42343947|NCT02093663|76182404|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
42343948|NCT02093663|76182405|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
42343949|NCT02093663|76182406|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
42343950|NCT02093663|76182402|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
42343951|NCT02093663|76182403|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
42343952|NCT02093663|76182404|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
42343953|NCT02093663|76182405|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
42343954|NCT02093663|76182406|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
42343955|NCT02093663|76182402|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
42343956|NCT02093663|76182403|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
42343957|NCT02093663|76182404|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
42343958|NCT02093663|76182405|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
42343959|NCT02093663|76182406|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
42343960|NCT02093663|76182402|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
42343961|NCT02093663|76182403|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
42343962|NCT02093663|76182404|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
42343963|NCT02093663|76182405|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
42343964|NCT02093663|76182406|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
42270105|NCT02679573|76099353|FG001|Overall Study|Death|0|||
42270106|NCT02679573|76099352|FG000|Overall Study|Physician Decision|2|||
42270107|NCT02679573|76099353|FG001|Overall Study|Physician Decision|4|||
42270108|NCT02679573|76099352|FG000|Overall Study|Lost to Follow-up|0|||
42270109|NCT02679573|76099353|FG001|Overall Study|Lost to Follow-up|3|||
42270110|NCT02685033|76099361|FG000|Overall Study|Withdrawal of Consent|0|||
42270111|NCT02685033|76099362|FG001|Overall Study|Withdrawal of Consent|1|||
42270112|NCT02685033|76099361|FG000|Overall Study|Lost to Follow-up|2|||
42270113|NCT02685033|76099362|FG001|Overall Study|Lost to Follow-up|1|||
42270114|NCT02685033|76099361|FG000|Overall Study|Adverse Event|1|||
42270115|NCT02685033|76099362|FG001|Overall Study|Adverse Event|0|||
42270116|NCT02684097|76099370|FG000|Overall Study|Lack of Efficacy|13|||
42270117|NCT02684097|76099371|FG001|Overall Study|Lack of Efficacy|6|||
42270118|NCT02555618|76099379|FG000|Overall Study|Sponsor's Circumstances|1|||
42343965|NCT02093663|76182402|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
42343966|NCT02093663|76182403|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
42343967|NCT02093663|76182404|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
42343968|NCT02093663|76182405|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
42343969|NCT02093663|76182406|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
42343970|NCT01408888|76182423|FG000|First Intervention|Adverse Event|0|||
42343971|NCT01408888|76182424|FG001|First Intervention|Adverse Event|1|||
42343972|NCT01408888|76182423|FG000|First Intervention|Withdrawal by Subject|0|||
42343973|NCT01408888|76182424|FG001|First Intervention|Withdrawal by Subject|2|||
42343974|NCT01408888|76182423|FG000|Second Intervention|Withdrawal by Subject|1|||
42343975|NCT01408888|76182424|FG001|Second Intervention|Withdrawal by Subject|0|||
42343976|NCT01408888|76182423|FG000|Second Intervention|Adverse Event|1|||
42343977|NCT01408888|76182424|FG001|Second Intervention|Adverse Event|0|||
42343978|NCT01918033|76182443|FG000|Overall Study|Adverse Event|1|||
42343979|NCT01918033|76182444|FG001|Overall Study|Adverse Event|0|||
42343980|NCT01918033|76182445|FG002|Overall Study|Adverse Event|2|||
42343981|NCT01918033|76182443|FG000|Overall Study|Lost to Follow-up|0|||
42343982|NCT01918033|76182444|FG001|Overall Study|Lost to Follow-up|1|||
42343983|NCT01918033|76182445|FG002|Overall Study|Lost to Follow-up|0|||
42343984|NCT01918033|76182443|FG000|Overall Study|Protocol Violation|2|||
42343985|NCT01918033|76182444|FG001|Overall Study|Protocol Violation|0|||
42343986|NCT01918033|76182445|FG002|Overall Study|Protocol Violation|1|||
42270119|NCT02555618|76099380|FG001|Overall Study|Sponsor's Circumstances|0|||
42270120|NCT02557100|76099406|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
42270121|NCT02557100|76099407|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
42270122|NCT02557100|76099408|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
42270123|NCT02557100|76099406|FG000|Single Blind Treatment Period|Death|0|||
42270124|NCT02557100|76099407|FG001|Single Blind Treatment Period|Death|1|||
42270125|NCT02557100|76099408|FG002|Single Blind Treatment Period|Death|0|||
42343987|NCT01918033|76182443|FG000|Overall Study|Withdrawal by Subject|2|||
42343988|NCT01918033|76182444|FG001|Overall Study|Withdrawal by Subject|1|||
42343989|NCT01918033|76182445|FG002|Overall Study|Withdrawal by Subject|0|||
42343990|NCT01408732|76182453|FG000|Overall Study|Withdrawal by Subject|2|||
42343991|NCT01408732|76182454|FG001|Overall Study|Withdrawal by Subject|2|||
42343992|NCT01390402|76182460|FG000|Overall Study|Death|1|||
42343993|NCT01390402|76182460|FG000|Overall Study|Disease Progression|4|||
42343994|NCT01976299|76182466|FG000|Overall Study|Withdrawal by Subject|3|||
42343995|NCT01976299|76182467|FG001|Overall Study|Withdrawal by Subject|1|||
42343996|NCT01976299|76182466|FG000|Overall Study|Death|4|||
42343997|NCT01976299|76182467|FG001|Overall Study|Death|2|||
42343998|NCT01976299|76182466|FG000|Overall Study|Lost to Follow-up|7|||
42343999|NCT01976299|76182467|FG001|Overall Study|Lost to Follow-up|1|||
42344000|NCT01976299|76182466|FG000|Overall Study|See clarification above in comments|9|||
42344001|NCT01976299|76182467|FG001|Overall Study|See clarification above in comments|2|||
42344002|NCT01428076|76182475|FG000|Overall Study|Adverse Event|0|||
42344003|NCT01428076|76182476|FG001|Overall Study|Adverse Event|1|||
42344004|NCT01900652|76182486|FG000|Overall Study|Progressive Disease|1|||
42344005|NCT01900652|76182487|FG001|Overall Study|Progressive Disease|0|||
42344006|NCT01900652|76182486|FG000|Overall Study|Consent withdrawn by subject|1|||
42344007|NCT01900652|76182487|FG001|Overall Study|Consent withdrawn by subject|1|||
42344008|NCT01900652|76182486|FG000|Overall Study|Death|3|||
42344009|NCT01900652|76182487|FG001|Overall Study|Death|0|||
42344010|NCT01900652|76182486|FG000|Overall Study|Adverse Event|2|||
42344011|NCT01900652|76182487|FG001|Overall Study|Adverse Event|1|||
42344012|NCT01900652|76182486|FG000|Overall Study|Physician Decision|1|||
42344013|NCT01900652|76182487|FG001|Overall Study|Physician Decision|1|||
42344014|NCT02093351|76182501|FG000|Part A|Adverse Event|0|||
42035178|NCT00926367|75843537|FG001|Overall Study|Lost to Follow-up|0|||
42270126|NCT02557100|76099406|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
42270127|NCT02557100|76099407|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
42270128|NCT02557100|76099408|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
42270129|NCT02557100|76099406|FG000|Single Blind Treatment Period|Adverse Event|0|||
42270130|NCT02557100|76099407|FG001|Single Blind Treatment Period|Adverse Event|1|||
42270131|NCT02557100|76099408|FG002|Single Blind Treatment Period|Adverse Event|0|||
42270132|NCT02557100|76099406|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
42344015|NCT02093351|76182502|FG001|Part A|Adverse Event|1|||
42344016|NCT02093351|76182503|FG002|Part A|Adverse Event|1|||
42344017|NCT02093351|76182504|FG003|Part A|Adverse Event|0|||
42344018|NCT02093351|76182501|FG000|Part A|Condition under investigation worsened|2|||
42344019|NCT02093351|76182502|FG001|Part A|Condition under investigation worsened|0|||
42344020|NCT02093351|76182503|FG002|Part A|Condition under investigation worsened|2|||
42344021|NCT02093351|76182504|FG003|Part A|Condition under investigation worsened|0|||
42344022|NCT02093351|76182501|FG000|Part A|Death|0|||
42344023|NCT02093351|76182502|FG001|Part A|Death|1|||
42344024|NCT02093351|76182503|FG002|Part A|Death|0|||
42344025|NCT02093351|76182504|FG003|Part A|Death|0|||
42270133|NCT02557100|76099407|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
42270134|NCT02557100|76099408|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
42270135|NCT02557100|76099406|FG000|Cumulative Abatacept Period|Other Reasons|0|||
42344026|NCT02093351|76182501|FG000|Part B|Patient decision|0|||
42344027|NCT02093351|76182502|FG001|Part B|Patient decision|0|||
42344028|NCT02093351|76182503|FG002|Part B|Patient decision|0|||
42344029|NCT02093351|76182504|FG003|Part B|Patient decision|3|||
42344030|NCT02093351|76182501|FG000|Part B|Disease progression|0|||
42344031|NCT02093351|76182502|FG001|Part B|Disease progression|0|||
42270136|NCT02557100|76099407|FG001|Cumulative Abatacept Period|Other Reasons|0|||
42270137|NCT02557100|76099408|FG002|Cumulative Abatacept Period|Other Reasons|1|||
42270138|NCT02557100|76099406|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
42270139|NCT02557100|76099407|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
42270140|NCT02557100|76099408|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
42270141|NCT02557100|76099406|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
42270142|NCT02557100|76099407|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
42270143|NCT02557100|76099408|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
42270144|NCT01337635|76099418|FG000|Overall Study|Lost to Follow-up|0|||
42270145|NCT01337635|76099419|FG001|Overall Study|Lost to Follow-up|1|||
42270146|NCT02556710|76099427|FG000|Overall Study|Surgical treatment|3|||
42270147|NCT02556710|76099428|FG001|Overall Study|Surgical treatment|0|||
42035179|NCT00926367|75843536|FG000|Overall Study|Skin Irritation|1|||
42344032|NCT02093351|76182503|FG002|Part B|Disease progression|0|||
42344033|NCT02093351|76182504|FG003|Part B|Disease progression|4|||
42344034|NCT02093351|76182501|FG000|Part B|Complete response|0|||
42344035|NCT02093351|76182502|FG001|Part B|Complete response|0|||
42344036|NCT02093351|76182503|FG002|Part B|Complete response|0|||
42344037|NCT02093351|76182504|FG003|Part B|Complete response|1|||
42344038|NCT02093351|76182501|FG000|Part B|Adverse event + disease progression|0|||
42344039|NCT02093351|76182502|FG001|Part B|Adverse event + disease progression|0|||
42344040|NCT02093351|76182503|FG002|Part B|Adverse event + disease progression|0|||
42344041|NCT02093351|76182504|FG003|Part B|Adverse event + disease progression|1|||
42344042|NCT02093351|76182501|FG000|Part B|Lack of therapeutic response|0|||
42344043|NCT02093351|76182502|FG001|Part B|Lack of therapeutic response|0|||
42344044|NCT02093351|76182503|FG002|Part B|Lack of therapeutic response|0|||
42344045|NCT02093351|76182504|FG003|Part B|Lack of therapeutic response|12|||
42344046|NCT02093351|76182501|FG000|Part B|Condition under investigation worsened|0|||
42344047|NCT02093351|76182502|FG001|Part B|Condition under investigation worsened|0|||
42344048|NCT02093351|76182503|FG002|Part B|Condition under investigation worsened|0|||
42344049|NCT02093351|76182504|FG003|Part B|Condition under investigation worsened|39|||
42344050|NCT02093351|76182501|FG000|Part B|Adverse Event|0|||
42344051|NCT02093351|76182502|FG001|Part B|Adverse Event|0|||
42344052|NCT02093351|76182503|FG002|Part B|Adverse Event|0|||
42344053|NCT02093351|76182504|FG003|Part B|Adverse Event|2|||
42344054|NCT02093351|76182501|FG000|Part B|Death|0|||
42344055|NCT02093351|76182502|FG001|Part B|Death|0|||
42344056|NCT02093351|76182503|FG002|Part B|Death|0|||
42344057|NCT02093351|76182504|FG003|Part B|Death|1|||
42344058|NCT02092961|76182543|FG000|Overall Study|Not reported|1|||
42344059|NCT02092961|76182544|FG001|Overall Study|Not reported|0|||
42344060|NCT02092961|76182545|FG002|Overall Study|Not reported|1|||
42344061|NCT02092961|76182543|FG000|Overall Study|Study stopped|13|||
42344062|NCT02092961|76182544|FG001|Overall Study|Study stopped|9|||
42344063|NCT02092961|76182545|FG002|Overall Study|Study stopped|12|||
42344064|NCT02092961|76182543|FG000|Overall Study|Lack of therapeutic response|2|||
42344065|NCT02092961|76182544|FG001|Overall Study|Lack of therapeutic response|1|||
42344066|NCT02092961|76182545|FG002|Overall Study|Lack of therapeutic response|3|||
42344067|NCT02092961|76182543|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
42344068|NCT02092961|76182544|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
42344069|NCT02092961|76182545|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
42004317|NCT01312961|75812326|FG001|Overall Study|Poor compliance to protocol|0|||
42135841|NCT00448344|75946408|FG000|Overall Study|Death|3|||
42135842|NCT00448344|75946409|FG001|Overall Study|Death|4|||
42135843|NCT00448344|75946408|FG000|Overall Study|Physician Decision|1|||
42135844|NCT00448344|75946409|FG001|Overall Study|Physician Decision|2|||
42135845|NCT00484094|75946415|FG000|Overall Study|Discontinued|39|||
42135846|NCT00484094|75946415|FG000|Overall Study|Other|3|||
42344070|NCT02092961|76182543|FG000|Overall Study|Adverse Event|2|||
42344071|NCT02092961|76182544|FG001|Overall Study|Adverse Event|4|||
42344072|NCT02092961|76182545|FG002|Overall Study|Adverse Event|0|||
42344073|NCT01898078|76182556|FG000|Overall Study|Progressive Disease|1|||
42344074|NCT01898078|76182557|FG001|Overall Study|Progressive Disease|5|||
42344075|NCT01898078|76182556|FG000|Overall Study|Adverse Event|2|||
42344076|NCT01898078|76182557|FG001|Overall Study|Adverse Event|1|||
42344077|NCT01898078|76182556|FG000|Overall Study|Withdrawal by Subject|1|||
42344078|NCT01898078|76182557|FG001|Overall Study|Withdrawal by Subject|1|||
42344079|NCT01898078|76182556|FG000|Overall Study|Symptomatic Deterioration|2|||
42344080|NCT01898078|76182557|FG001|Overall Study|Symptomatic Deterioration|0|||
42344081|NCT01898078|76182556|FG000|Overall Study|Reason not Specified|0|||
42344082|NCT01898078|76182557|FG001|Overall Study|Reason not Specified|1|||
42344083|NCT01987817|76182567|FG000|Overall Study|Adverse Event|4|||
42344084|NCT01987817|76182568|FG001|Overall Study|Adverse Event|0|||
42004318|NCT01312961|75812325|FG000|Overall Study|Other than specified above|2|||
42004319|NCT01312961|75812326|FG001|Overall Study|Other than specified above|3|||
42004320|NCT01311557|75812335|FG000|Overall Study|Serious adverse event|0|||
42004321|NCT01311557|75812336|FG001|Overall Study|Serious adverse event|1|||
42004322|NCT01311557|75812335|FG000|Overall Study|Protocol Violation|4|||
42004323|NCT01311557|75812336|FG001|Overall Study|Protocol Violation|2|||
42004324|NCT01311557|75812335|FG000|Overall Study|Lost to Follow-up|0|||
42004325|NCT01311557|75812336|FG001|Overall Study|Lost to Follow-up|1|||
42004326|NCT01311557|75812335|FG000|Overall Study|Withdrawal by Subject|1|||
42004327|NCT01311557|75812336|FG001|Overall Study|Withdrawal by Subject|2|||
42270148|NCT02556710|76099427|FG000|Overall Study|Required proscribed pain medication|2|||
42270149|NCT02556710|76099428|FG001|Overall Study|Required proscribed pain medication|1|||
42270150|NCT02556710|76099427|FG000|Overall Study|Lack of Efficacy|1|||
42270151|NCT02556710|76099428|FG001|Overall Study|Lack of Efficacy|0|||
42270152|NCT02556710|76099427|FG000|Overall Study|Worsening osteoarthritis|1|||
42270153|NCT02556710|76099428|FG001|Overall Study|Worsening osteoarthritis|0|||
42270154|NCT02556710|76099427|FG000|Overall Study|Moved out of state|1|||
42344085|NCT01987817|76182567|FG000|Overall Study|Withdrawal by Subject|1|||
42344086|NCT01987817|76182568|FG001|Overall Study|Withdrawal by Subject|1|||
42344087|NCT01987817|76182567|FG000|Overall Study|Physician Decision|1|||
42344088|NCT01987817|76182568|FG001|Overall Study|Physician Decision|0|||
42344089|NCT01940497|76182577|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
42344090|NCT01940497|76182578|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
42344091|NCT01940497|76182577|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
42135847|NCT00447876|75946421|FG000|Overall Study|Withdrawal by Subject|1|||
42135848|NCT00447876|75946422|FG001|Overall Study|Withdrawal by Subject|4|||
42135849|NCT00447876|75946421|FG000|Overall Study|Lost to Follow-up|1|||
42270155|NCT02556710|76099428|FG001|Overall Study|Moved out of state|0|||
42344092|NCT01940497|76182578|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
42344093|NCT01940497|76182577|FG000|Overall Study|Violation of Entry Criteria|1|||
42270156|NCT02556710|76099427|FG000|Overall Study|Missing reason|3|||
42004328|NCT01310777|75812345|FG000|Overall Study|Adverse Event|23|||
42004329|NCT01310777|75812346|FG001|Overall Study|Adverse Event|1|||
42004330|NCT01310777|75812347|FG002|Overall Study|Adverse Event|15|||
42135850|NCT00447876|75946422|FG001|Overall Study|Lost to Follow-up|0|||
42344094|NCT01940497|76182578|FG001|Overall Study|Violation of Entry Criteria|1|||
42344095|NCT01940497|76182577|FG000|Overall Study|Refused Treatment|1|||
42344096|NCT01940497|76182578|FG001|Overall Study|Refused Treatment|3|||
42344097|NCT01940497|76182577|FG000|Overall Study|Withdrew Consent|6|||
42004331|NCT01310777|75812345|FG000|Overall Study|Lost to Follow-up|0|||
42135851|NCT00447876|75946421|FG000|Overall Study|Deterioration of symptomology|1|||
42344098|NCT01940497|76182578|FG001|Overall Study|Withdrew Consent|2|||
42344099|NCT01940497|76182577|FG000|Overall Study|Administrative/Other|1|||
42344100|NCT01940497|76182578|FG001|Overall Study|Administrative/Other|1|||
42344101|NCT01924754|76182598|FG000|Overall Study|Lost to Follow-up|1|||
42344102|NCT01924754|76182599|FG001|Overall Study|Lost to Follow-up|2|||
42344103|NCT01924754|76182600|FG002|Overall Study|Lost to Follow-up|1|||
42344104|NCT01924754|76182598|FG000|Overall Study|Pregnancy|0|||
42344105|NCT01924754|76182599|FG001|Overall Study|Pregnancy|1|||
42344106|NCT01924754|76182600|FG002|Overall Study|Pregnancy|2|||
42344107|NCT01924364|76182611|FG000|Overall Study|Physician Decision|3|||
42344108|NCT01987505|76182628|FG000|Overall Study|Other|9|||
42344109|NCT01987505|76182628|FG000|Overall Study|Withdrawal by Subject|2|||
42344110|NCT01987505|76182628|FG000|Overall Study|Other Reason|2|||
42344111|NCT01987505|76182628|FG000|Overall Study|Lost to Follow-up|15|||
42344112|NCT01987505|76182628|FG000|Overall Study|Investigator Decision|2|||
42344113|NCT01987505|76182628|FG000|Overall Study|Death|4|||
42344114|NCT01923896|76182636|FG000|Overall Study|Adverse Event|1|||
42344115|NCT01923896|76182637|FG001|Overall Study|Adverse Event|0|||
42344116|NCT02004353|76182643|FG000|Overall Study|Voluntary participation|1334|||
42344117|NCT01938625|76182649|FG000|Overall Study|Withdrawal by Subject|0|||
42344118|NCT01938625|76182650|FG001|Overall Study|Withdrawal by Subject|1|||
42344119|NCT01938625|76182649|FG000|Overall Study|Adverse Event|0|||
42344120|NCT01938625|76182650|FG001|Overall Study|Adverse Event|1|||
42344121|NCT01975675|76182660|FG000|Overall Study|Death|0|||
42344122|NCT01975675|76182661|FG001|Overall Study|Death|1|||
42344123|NCT01975675|76182662|FG002|Overall Study|Death|0|||
42344124|NCT01975675|76182663|FG003|Overall Study|Death|0|||
42344125|NCT01975285|76182675|FG000|Overall Study|Failed Block and follow up|2|||
42344126|NCT01975285|76182676|FG001|Overall Study|Failed Block and follow up|2|||
42344127|NCT01974895|76182684|FG000|Overall Study|Protocol Violation|1|||
42344128|NCT01974895|76182685|FG001|Overall Study|Protocol Violation|0|||
42344129|NCT01974895|76182684|FG000|Overall Study|Lost to Follow-up|4|||
42344130|NCT01974895|76182685|FG001|Overall Study|Lost to Follow-up|6|||
42344131|NCT01974895|76182684|FG000|Overall Study|Withdrawal by Subject|0|||
42344132|NCT01974895|76182685|FG001|Overall Study|Withdrawal by Subject|1|||
42344133|NCT01974895|76182684|FG000|Overall Study|Other (Missed Visit)|1|||
42344134|NCT01974895|76182685|FG001|Overall Study|Other (Missed Visit)|0|||
42344135|NCT01974895|76182684|FG000|Overall Study|Other (Reason unknown)|9|||
42344136|NCT01974895|76182685|FG001|Overall Study|Other (Reason unknown)|8|||
42344137|NCT01974817|76182691|FG000|Overall Study|Death|4|||
42344138|NCT01974817|76182691|FG000|Overall Study|Lost to Follow-up|2|||
42344139|NCT01974817|76182691|FG000|Overall Study|Protocol Violation|2|||
42344140|NCT01915849|76182699|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
42344141|NCT01915849|76182700|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
42004332|NCT01310777|75812346|FG001|Overall Study|Lost to Follow-up|4|||
42344142|NCT01915849|76182701|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
42344143|NCT01915849|76182702|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
42344144|NCT01915849|76182699|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
42344145|NCT01915849|76182700|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
42344146|NCT01915849|76182701|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
42344147|NCT01915849|76182702|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
42344148|NCT01915771|76182712|FG000|Day 1|Withdrawal by Subject|1|||
42004333|NCT01310777|75812347|FG002|Overall Study|Lost to Follow-up|1|||
42135852|NCT00447876|75946422|FG001|Overall Study|Deterioration of symptomology|0|||
42344149|NCT01915771|76182712|FG000|Day 15|Withdrawal by Subject|1|||
42344150|NCT01938391|76182720|FG000|6 Month Follow up|Withdrawal by Subject|1|||
42344151|NCT01938391|76182720|FG000|12 Month Follow up|Physician Decision|1|||
42344152|NCT01938391|76182720|FG000|12 Month Follow up|Withdrawal by Subject|1|||
42344153|NCT01915303|76182724|FG000|Core Phase|Adverse Event|7|||
42344154|NCT01915303|76182724|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
42270157|NCT02556710|76099428|FG001|Overall Study|Missing reason|1|||
42035180|NCT00926367|75843537|FG001|Overall Study|Skin Irritation|2|||
42035181|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
42035182|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
42035183|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
42035184|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
42035185|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
42036450|NCT01017120|75844853|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
42270158|NCT02556710|76099427|FG000|Overall Study|Pain as lack of efficacy|0|||
42270159|NCT02556710|76099428|FG001|Overall Study|Pain as lack of efficacy|4|||
42270160|NCT02556632|76099439|FG000|Overall Study|Lost to Follow-up|1|||
42270161|NCT02556632|76099440|FG001|Overall Study|Lost to Follow-up|0|||
42270162|NCT02556632|76099441|FG002|Overall Study|Lost to Follow-up|0|||
42270163|NCT02556632|76099439|FG000|Overall Study|Disliked Intervention|1|||
42270164|NCT02556632|76099440|FG001|Overall Study|Disliked Intervention|1|||
42270165|NCT02556632|76099441|FG002|Overall Study|Disliked Intervention|1|||
42270166|NCT02556632|76099439|FG000|Overall Study|No Reason|1|||
42270167|NCT02556632|76099440|FG001|Overall Study|No Reason|0|||
42270168|NCT02556632|76099441|FG002|Overall Study|No Reason|1|||
42270169|NCT02556632|76099439|FG000|Overall Study|Personal Issues|0|||
42270170|NCT02556632|76099440|FG001|Overall Study|Personal Issues|1|||
42270171|NCT02556632|76099441|FG002|Overall Study|Personal Issues|1|||
42270172|NCT02556632|76099439|FG000|Overall Study|Changed Mind|0|||
42270173|NCT02556632|76099440|FG001|Overall Study|Changed Mind|1|||
42270174|NCT02556632|76099441|FG002|Overall Study|Changed Mind|0|||
42004334|NCT01310777|75812345|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
42270175|NCT02556632|76099439|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
42270176|NCT02556632|76099440|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
42344155|NCT01915303|76182724|FG000|Core Phase|Death|2|||
42344156|NCT01915303|76182724|FG000|Core Phase|Protocol Violation|2|||
42344157|NCT01915303|76182724|FG000|Core Phase|Abnormal lab value|1|||
42344158|NCT01915303|76182724|FG000|Core Phase|Withdrawal by Subject|1|||
42344159|NCT01915303|76182724|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
42344160|NCT01915303|76182724|FG000|Extension Phase|Withdrawal by Subject|4|||
42344161|NCT01915303|76182724|FG000|Extension Phase|Adverse Event|3|||
42344162|NCT01915303|76182724|FG000|Extension Phase|Death|1|||
42344163|NCT01915303|76182724|FG000|Extension Phase|Protocol Violation|1|||
42344164|NCT01987427|76182731|FG000|Overall Study|Adverse Event|4|||
42344165|NCT01987427|76182732|FG001|Overall Study|Adverse Event|2|||
42344166|NCT01987427|76182733|FG002|Overall Study|Adverse Event|8|||
42344167|NCT01987427|76182731|FG000|Overall Study|Lost to Follow-up|6|||
42344168|NCT01987427|76182732|FG001|Overall Study|Lost to Follow-up|6|||
42344169|NCT01987427|76182733|FG002|Overall Study|Lost to Follow-up|9|||
42344170|NCT01987427|76182731|FG000|Overall Study|Withdrawal by Subject|2|||
42344171|NCT01987427|76182732|FG001|Overall Study|Withdrawal by Subject|1|||
42344172|NCT01987427|76182733|FG002|Overall Study|Withdrawal by Subject|3|||
42344173|NCT01987427|76182731|FG000|Overall Study|Lack of Efficacy|1|||
42344174|NCT01987427|76182732|FG001|Overall Study|Lack of Efficacy|0|||
42344175|NCT01987427|76182733|FG002|Overall Study|Lack of Efficacy|0|||
42344176|NCT01987427|76182731|FG000|Overall Study|Other|1|||
42344177|NCT01987427|76182732|FG001|Overall Study|Other|1|||
42344178|NCT01987427|76182733|FG002|Overall Study|Other|0|||
42344179|NCT01937299|76182743|FG000|Overall Study|Adverse Event|13|||
42344180|NCT01937299|76182744|FG001|Overall Study|Adverse Event|0|||
42344181|NCT01937299|76182743|FG000|Overall Study|Lack of Efficacy|0|||
42344182|NCT01937299|76182744|FG001|Overall Study|Lack of Efficacy|4|||
42344183|NCT01937299|76182743|FG000|Overall Study|Withdrawal by Subject|1|||
42344184|NCT01937299|76182744|FG001|Overall Study|Withdrawal by Subject|0|||
42344185|NCT02003963|76182753|FG000|Overall Study|Lost to Follow-up|2|||
42004335|NCT01310777|75812346|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
42004336|NCT01310777|75812347|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
42004337|NCT01310777|75812345|FG000|Overall Study|Inadequate Control of IOP|5|||
42004338|NCT01310777|75812346|FG001|Overall Study|Inadequate Control of IOP|7|||
42004339|NCT01310777|75812347|FG002|Overall Study|Inadequate Control of IOP|10|||
42004340|NCT01310777|75812345|FG000|Overall Study|Other|4|||
42004341|NCT01310777|75812346|FG001|Overall Study|Other|1|||
42004342|NCT01310777|75812347|FG002|Overall Study|Other|2|||
42004343|NCT01310699|75812357|FG000|Overall Study|Patients did not complete tandem.|4|||
42004344|NCT01310699|75812358|FG001|Overall Study|Patients did not complete tandem.|6|||
42004345|NCT01310075|75812368|FG000|Overall Study|Lost to Follow-up|1|||
42004346|NCT01310075|75812369|FG001|Overall Study|Lost to Follow-up|0|||
42270177|NCT02556632|76099441|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
42270178|NCT02556632|76099439|FG000|Overall Study|Unrelated Adverse Event|1|||
42270179|NCT02556632|76099440|FG001|Overall Study|Unrelated Adverse Event|0|||
42270180|NCT02556632|76099441|FG002|Overall Study|Unrelated Adverse Event|3|||
42270181|NCT02556632|76099439|FG000|Overall Study|Related Adverse Event|0|||
42270182|NCT02556632|76099440|FG001|Overall Study|Related Adverse Event|1|||
42270183|NCT02556632|76099441|FG002|Overall Study|Related Adverse Event|0|||
42270184|NCT02556632|76099439|FG000|Overall Study|Possibly Related Adverse Event|0|||
42270185|NCT02556632|76099440|FG001|Overall Study|Possibly Related Adverse Event|0|||
42270186|NCT02556632|76099441|FG002|Overall Study|Possibly Related Adverse Event|1|||
42270187|NCT02556632|76099439|FG000|Overall Study|Did Not Start RT|0|||
42270188|NCT02556632|76099440|FG001|Overall Study|Did Not Start RT|1|||
42270189|NCT02556632|76099441|FG002|Overall Study|Did Not Start RT|0|||
42270190|NCT02556632|76099439|FG000|Overall Study|Ineligible|0|||
42270191|NCT02556632|76099440|FG001|Overall Study|Ineligible|1|||
42270192|NCT02556632|76099441|FG002|Overall Study|Ineligible|0|||
42344186|NCT02003963|76182754|FG001|Overall Study|Lost to Follow-up|1|||
42270193|NCT02556632|76099439|FG000|Overall Study|Disliked Study Procedures|0|||
42270194|NCT02556632|76099440|FG001|Overall Study|Disliked Study Procedures|0|||
42270195|NCT02556632|76099441|FG002|Overall Study|Disliked Study Procedures|1|||
42344187|NCT01606761|76182765|FG000|Prior to Week 24|Lost to Follow-up|0|||
42344188|NCT01606761|76182766|FG001|Prior to Week 24|Lost to Follow-up|3|||
42004347|NCT01310075|75812368|FG000|Overall Study|Physician Decision|10|||
42004348|NCT01310075|75812369|FG001|Overall Study|Physician Decision|7|||
42004349|NCT01310075|75812368|FG000|Overall Study|Protocol Violation|2|||
42344189|NCT01606761|76182767|FG002|Prior to Week 24|Lost to Follow-up|2|||
42344190|NCT01606761|76182768|FG003|Prior to Week 24|Lost to Follow-up|0|||
42344191|NCT01606761|76182769|FG004|Prior to Week 24|Lost to Follow-up|0|||
42344192|NCT01606761|76182765|FG000|Prior to Week 24|Withdrawal by Subject|12|||
42344193|NCT01606761|76182766|FG001|Prior to Week 24|Withdrawal by Subject|10|||
42344194|NCT01606761|76182767|FG002|Prior to Week 24|Withdrawal by Subject|9|||
42344195|NCT01606761|76182768|FG003|Prior to Week 24|Withdrawal by Subject|0|||
42270196|NCT02556632|76099439|FG000|Overall Study|Treatment or Change Delay|0|||
42270197|NCT02556632|76099440|FG001|Overall Study|Treatment or Change Delay|0|||
42270198|NCT02556632|76099441|FG002|Overall Study|Treatment or Change Delay|1|||
42270199|NCT01662440|76099453|FG000|Overall Study|Adverse Event|1|||
42270200|NCT01662440|76099454|FG001|Overall Study|Adverse Event|0|||
42270201|NCT01662440|76099455|FG002|Overall Study|Adverse Event|0|||
42135853|NCT00456612|75946428|FG000|Overall Study|Withdrawal by Subject|3|||
42135854|NCT00456300|75946433|FG000|Overall Study|Adverse Event|1|||
42344196|NCT01606761|76182769|FG004|Prior to Week 24|Withdrawal by Subject|0|||
42135855|NCT00456300|75946434|FG001|Overall Study|Adverse Event|0|||
42270202|NCT01662440|76099456|FG003|Overall Study|Adverse Event|1|||
42344197|NCT01606761|76182765|FG000|Prior to Week 24|Adverse Event|11|||
42344198|NCT01606761|76182766|FG001|Prior to Week 24|Adverse Event|18|||
42135856|NCT00267748|75946445|FG000|Non-randomized Period|Progressive disease|10|||
42270203|NCT01662440|76099453|FG000|Overall Study|Death|0|||
42270204|NCT01662440|76099454|FG001|Overall Study|Death|1|||
42270205|NCT01662440|76099455|FG002|Overall Study|Death|0|||
42135857|NCT00267748|75946446|FG001|Non-randomized Period|Progressive disease|0|||
42135858|NCT00267748|75946447|FG002|Non-randomized Period|Progressive disease|0|||
42135859|NCT00267748|75946445|FG000|Non-randomized Period|Adverse Event|8|||
42135860|NCT00267748|75946446|FG001|Non-randomized Period|Adverse Event|0|||
42135861|NCT00267748|75946447|FG002|Non-randomized Period|Adverse Event|0|||
42135862|NCT00267748|75946445|FG000|Non-randomized Period|Death|1|||
42135863|NCT00267748|75946446|FG001|Non-randomized Period|Death|0|||
42135864|NCT00267748|75946447|FG002|Non-randomized Period|Death|0|||
42135865|NCT00267748|75946445|FG000|Non-randomized Period|Participant not willing to participate|1|||
42135866|NCT00267748|75946446|FG001|Non-randomized Period|Participant not willing to participate|0|||
42135867|NCT00267748|75946447|FG002|Non-randomized Period|Participant not willing to participate|0|||
42135868|NCT00267748|75946445|FG000|Non-randomized Period|Other|3|||
42135869|NCT00267748|75946446|FG001|Non-randomized Period|Other|0|||
42135870|NCT00267748|75946447|FG002|Non-randomized Period|Other|0|||
42135871|NCT00267748|75946445|FG000|Randomized Period|Death|0|||
42135872|NCT00267748|75946446|FG001|Randomized Period|Death|2|||
42135873|NCT00267748|75946447|FG002|Randomized Period|Death|3|||
42135874|NCT00267748|75946445|FG000|Randomized Period|Adverse Event|0|||
42135875|NCT00267748|75946446|FG001|Randomized Period|Adverse Event|23|||
42135876|NCT00267748|75946447|FG002|Randomized Period|Adverse Event|25|||
42135877|NCT00267748|75946445|FG000|Randomized Period|Global deterioration of health status|0|||
42135878|NCT00267748|75946446|FG001|Randomized Period|Global deterioration of health status|6|||
42135879|NCT00267748|75946447|FG002|Randomized Period|Global deterioration of health status|7|||
42135880|NCT00267748|75946445|FG000|Randomized Period|Lost to Follow-up|0|||
42135881|NCT00267748|75946446|FG001|Randomized Period|Lost to Follow-up|1|||
42135882|NCT00267748|75946447|FG002|Randomized Period|Lost to Follow-up|0|||
42135883|NCT00267748|75946445|FG000|Randomized Period|Objective progression or relapse|0|||
42135884|NCT00267748|75946446|FG001|Randomized Period|Objective progression or relapse|77|||
42135885|NCT00267748|75946447|FG002|Randomized Period|Objective progression or relapse|86|||
42135886|NCT00267748|75946445|FG000|Randomized Period|Withdrawal by Subject|0|||
42270206|NCT01662440|76099456|FG003|Overall Study|Death|0|||
42270207|NCT01662440|76099453|FG000|Overall Study|Lost to Follow-up|2|||
42270208|NCT01662440|76099454|FG001|Overall Study|Lost to Follow-up|2|||
42270209|NCT01662440|76099455|FG002|Overall Study|Lost to Follow-up|4|||
42270210|NCT01662440|76099456|FG003|Overall Study|Lost to Follow-up|1|||
42270211|NCT01662440|76099453|FG000|Overall Study|Subject moved to another country.|0|||
42270212|NCT01662440|76099454|FG001|Overall Study|Subject moved to another country.|1|||
42270213|NCT01662440|76099455|FG002|Overall Study|Subject moved to another country.|0|||
42270214|NCT01662440|76099456|FG003|Overall Study|Subject moved to another country.|0|||
42270215|NCT01662440|76099453|FG000|Overall Study|Protocol Violation|1|||
42344199|NCT01606761|76182767|FG002|Prior to Week 24|Adverse Event|22|||
42344200|NCT01606761|76182768|FG003|Prior to Week 24|Adverse Event|0|||
42344201|NCT01606761|76182769|FG004|Prior to Week 24|Adverse Event|0|||
42344202|NCT01606761|76182765|FG000|Prior to Week 24|Lack of Efficacy|15|||
42004350|NCT01310075|75812369|FG001|Overall Study|Protocol Violation|2|||
42135887|NCT00267748|75946446|FG001|Randomized Period|Withdrawal by Subject|9|||
42135888|NCT00267748|75946447|FG002|Randomized Period|Withdrawal by Subject|2|||
42135889|NCT00267748|75946445|FG000|Randomized Period|Other|0|||
42135890|NCT00267748|75946446|FG001|Randomized Period|Other|9|||
42270216|NCT01662440|76099454|FG001|Overall Study|Protocol Violation|0|||
42344203|NCT01606761|76182766|FG001|Prior to Week 24|Lack of Efficacy|14|||
42004351|NCT01310075|75812368|FG000|Overall Study|Withdrawal by Subject|1|||
42004352|NCT01310075|75812369|FG001|Overall Study|Withdrawal by Subject|1|||
42004353|NCT01309997|75812377|FG000|Overall Study|Adverse Event|1|||
42270217|NCT01662440|76099455|FG002|Overall Study|Protocol Violation|0|||
42270218|NCT01662440|76099456|FG003|Overall Study|Protocol Violation|0|||
42270219|NCT01662440|76099453|FG000|Overall Study|Withdrawal by Subject|5|||
42270220|NCT01662440|76099454|FG001|Overall Study|Withdrawal by Subject|2|||
42270221|NCT01662440|76099455|FG002|Overall Study|Withdrawal by Subject|2|||
42344204|NCT01606761|76182767|FG002|Prior to Week 24|Lack of Efficacy|8|||
42004354|NCT01309997|75812378|FG001|Overall Study|Adverse Event|0|||
42004355|NCT01309997|75812377|FG000|Overall Study|Death|1|||
42135891|NCT00267748|75946447|FG002|Randomized Period|Other|6|||
42270222|NCT01662440|76099456|FG003|Overall Study|Withdrawal by Subject|2|||
42270223|NCT01662362|76099476|FG000|Overall Study|Lost to Follow-up|38|||
42270224|NCT02554682|76099491|FG000|Overall Study|Lost to Follow-up|11|||
42270225|NCT02554682|76099492|FG001|Overall Study|Lost to Follow-up|9|||
42270226|NCT02554682|76099493|FG002|Overall Study|Lost to Follow-up|4|||
42270227|NCT02554682|76099494|FG003|Overall Study|Lost to Follow-up|3|||
42270228|NCT02554682|76099495|FG004|Overall Study|Lost to Follow-up|2|||
42270229|NCT02554682|76099496|FG005|Overall Study|Lost to Follow-up|1|||
42270230|NCT02554682|76099497|FG006|Overall Study|Lost to Follow-up|6|||
42270231|NCT02554682|76099498|FG007|Overall Study|Lost to Follow-up|6|||
42270232|NCT02554682|76099499|FG008|Overall Study|Lost to Follow-up|2|||
42270233|NCT02554682|76099500|FG009|Overall Study|Lost to Follow-up|2|||
42270234|NCT02554682|76099491|FG000|Overall Study|Withdrawal by Subject|2|||
42270235|NCT02554682|76099492|FG001|Overall Study|Withdrawal by Subject|1|||
42270236|NCT02554682|76099493|FG002|Overall Study|Withdrawal by Subject|0|||
42270237|NCT02554682|76099494|FG003|Overall Study|Withdrawal by Subject|0|||
42270238|NCT02554682|76099495|FG004|Overall Study|Withdrawal by Subject|0|||
42004356|NCT01309997|75812378|FG001|Overall Study|Death|3|||
42004357|NCT01309997|75812377|FG000|Overall Study|Lack of Efficacy|2|||
42270239|NCT02554682|76099496|FG005|Overall Study|Withdrawal by Subject|0|||
42270240|NCT02554682|76099497|FG006|Overall Study|Withdrawal by Subject|0|||
42004358|NCT01309997|75812378|FG001|Overall Study|Lack of Efficacy|2|||
42004359|NCT01309997|75812377|FG000|Overall Study|Withdrawal by Subject|1|||
42344205|NCT01606761|76182768|FG003|Prior to Week 24|Lack of Efficacy|0|||
42344206|NCT01606761|76182769|FG004|Prior to Week 24|Lack of Efficacy|0|||
42004360|NCT01309997|75812378|FG001|Overall Study|Withdrawal by Subject|1|||
42004361|NCT01309919|75812397|FG000|Overall Study|Did not receive a postpartum IUD|17|||
42004362|NCT01309919|75812398|FG001|Overall Study|Did not receive a postpartum IUD|48|||
42004363|NCT01309841|75812407|FG000|Overall Study|Other|0|||
42004364|NCT01309841|75812408|FG001|Overall Study|Other|1|||
42270241|NCT02554682|76099498|FG007|Overall Study|Withdrawal by Subject|0|||
42270242|NCT02554682|76099499|FG008|Overall Study|Withdrawal by Subject|0|||
42270243|NCT02554682|76099500|FG009|Overall Study|Withdrawal by Subject|0|||
42270244|NCT02554682|76099491|FG000|Overall Study|Physician Decision|2|||
42270245|NCT02554682|76099492|FG001|Overall Study|Physician Decision|2|||
42270246|NCT02554682|76099493|FG002|Overall Study|Physician Decision|0|||
42270247|NCT02554682|76099494|FG003|Overall Study|Physician Decision|0|||
42270248|NCT02554682|76099495|FG004|Overall Study|Physician Decision|0|||
42270249|NCT02554682|76099496|FG005|Overall Study|Physician Decision|0|||
42270250|NCT02554682|76099497|FG006|Overall Study|Physician Decision|0|||
42270251|NCT02554682|76099498|FG007|Overall Study|Physician Decision|0|||
42004365|NCT01309841|75812409|FG002|Overall Study|Other|1|||
42270252|NCT02554682|76099499|FG008|Overall Study|Physician Decision|0|||
42004366|NCT01309841|75812407|FG000|Overall Study|Lost to Follow-up|7|||
42004367|NCT01309841|75812408|FG001|Overall Study|Lost to Follow-up|6|||
42004368|NCT01309841|75812409|FG002|Overall Study|Lost to Follow-up|4|||
42004369|NCT01309841|75812407|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
42004370|NCT01309841|75812408|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
42004371|NCT01309841|75812409|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
42004372|NCT01309841|75812407|FG000|Overall Study|Lack of Efficacy|0|||
42004373|NCT01309841|75812408|FG001|Overall Study|Lack of Efficacy|0|||
42004374|NCT01309841|75812409|FG002|Overall Study|Lack of Efficacy|2|||
42004375|NCT01309841|75812407|FG000|Overall Study|Adverse Event|9|||
42004376|NCT01309841|75812408|FG001|Overall Study|Adverse Event|22|||
42004377|NCT01309841|75812409|FG002|Overall Study|Adverse Event|11|||
42004378|NCT01309841|75812407|FG000|Overall Study|Death|1|||
42004379|NCT01309841|75812408|FG001|Overall Study|Death|0|||
42004380|NCT01309841|75812409|FG002|Overall Study|Death|0|||
42004381|NCT01309841|75812407|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
42004382|NCT01309841|75812408|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
42004383|NCT01309841|75812409|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
42004384|NCT01309841|75812407|FG000|Overall Study|Withdrawal by Subject|17|||
42004385|NCT01309841|75812408|FG001|Overall Study|Withdrawal by Subject|6|||
42004386|NCT01309841|75812409|FG002|Overall Study|Withdrawal by Subject|13|||
42004387|NCT01309841|75812407|FG000|Overall Study|Did Not Receive Treatment|2|||
42004388|NCT01309841|75812408|FG001|Overall Study|Did Not Receive Treatment|0|||
42004389|NCT01309841|75812409|FG002|Overall Study|Did Not Receive Treatment|1|||
42004390|NCT01309841|75812407|FG000|Overall Study|Severe non-compliance with protocol|0|||
42004391|NCT01309841|75812408|FG001|Overall Study|Severe non-compliance with protocol|5|||
42004392|NCT01309841|75812409|FG002|Overall Study|Severe non-compliance with protocol|2|||
42004393|NCT01308749|75812419|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
42270253|NCT02554682|76099500|FG009|Overall Study|Physician Decision|0|||
42004394|NCT01308749|75812420|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
42270254|NCT00154063|76099536|FG000|Overall Study|Adverse Event|4|||
42270255|NCT00154063|76099537|FG001|Overall Study|Adverse Event|8|||
42270256|NCT00154063|76099536|FG000|Overall Study|Protocol Violation|1|||
42270257|NCT00154063|76099537|FG001|Overall Study|Protocol Violation|1|||
42270258|NCT00154063|76099536|FG000|Overall Study|Investigator or Sponsor Request|0|||
42270259|NCT00154063|76099537|FG001|Overall Study|Investigator or Sponsor Request|1|||
42270260|NCT00154063|76099536|FG000|Overall Study|Withdrawal by Subject|4|||
42270261|NCT00154063|76099537|FG001|Overall Study|Withdrawal by Subject|9|||
42270262|NCT00154063|76099536|FG000|Overall Study|Other|3|||
42270263|NCT00154063|76099537|FG001|Overall Study|Other|3|||
42270264|NCT02683941|76099549|FG000|Double-blind Phase|Adverse Event|0|||
42270265|NCT02683941|76099550|FG001|Double-blind Phase|Adverse Event|1|||
42270266|NCT02683941|76099549|FG000|Double-blind Phase|Withdrawal by Subject|4|||
42270267|NCT02683941|76099550|FG001|Double-blind Phase|Withdrawal by Subject|2|||
42004395|NCT01308749|75812419|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
42004396|NCT01308749|75812420|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
42004397|NCT01308749|75812419|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
42270268|NCT02683941|76099549|FG000|Double-blind Phase|Lost to Follow-up|1|||
42270269|NCT02683941|76099550|FG001|Double-blind Phase|Lost to Follow-up|0|||
42270270|NCT02683941|76099549|FG000|Double-blind Phase|Disease Progression|5|||
42270271|NCT02683941|76099550|FG001|Double-blind Phase|Disease Progression|2|||
42270272|NCT02683941|76099549|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
42270273|NCT02683941|76099550|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
42270274|NCT02683941|76099549|FG000|Open-label Treatment Phase|Disease Progression|1|||
42270275|NCT02683941|76099550|FG001|Open-label Treatment Phase|Disease Progression|2|||
42270276|NCT02683941|76099549|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
42270277|NCT02683941|76099550|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
42344207|NCT01606761|76182765|FG000|Prior to Week 24|Physician Decision|0|||
42004398|NCT01308749|75812420|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
42004399|NCT01307891|75812442|FG000|Overall Study|Progressive Disease|3|||
42004400|NCT01307891|75812443|FG001|Overall Study|Progressive Disease|1|||
42004401|NCT01307579|75812451|FG000|Overall Study|Death|3|||
42004402|NCT01307579|75812452|FG001|Overall Study|Death|6|||
42004403|NCT01307579|75812451|FG000|Overall Study|Physician Decision|26|||
42004404|NCT01307579|75812452|FG001|Overall Study|Physician Decision|29|||
42004405|NCT01307579|75812451|FG000|Overall Study|Withdrawal by Subject|7|||
42004406|NCT01307579|75812452|FG001|Overall Study|Withdrawal by Subject|3|||
42004407|NCT01307579|75812451|FG000|Overall Study|Institutional diagnosis of IFD|21|||
42004408|NCT01307579|75812452|FG001|Overall Study|Institutional diagnosis of IFD|36|||
42344208|NCT01606761|76182766|FG001|Prior to Week 24|Physician Decision|3|||
42004409|NCT01307579|75812451|FG000|Overall Study|Begin conditioning for HSCT|42|||
42004410|NCT01307579|75812452|FG001|Overall Study|Begin conditioning for HSCT|44|||
42004411|NCT01307579|75812451|FG000|Overall Study|Refractory or relapsed AML|38|||
42004412|NCT01307579|75812452|FG001|Overall Study|Refractory or relapsed AML|23|||
42270278|NCT02683941|76099549|FG000|Open-label Treatment Phase|Other|1|||
42270279|NCT02683941|76099550|FG001|Open-label Treatment Phase|Other|0|||
42270280|NCT02683941|76099549|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
42035186|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
42035187|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
42035188|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
42035189|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
42035190|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
42270281|NCT02683941|76099550|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
42270282|NCT02683941|76099549|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
42270283|NCT02683941|76099550|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
42270284|NCT02683941|76099549|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
42270285|NCT02683941|76099550|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
42270286|NCT02683941|76099549|FG000|Open-label Follow-up Phase|Other|8|||
42270287|NCT02683941|76099550|FG001|Open-label Follow-up Phase|Other|1|||
42135892|NCT00267748|75946445|FG000|Randomized Period|randomized but not treated|0|||
42270288|NCT02678247|76099562|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
42004413|NCT01307579|75812451|FG000|Overall Study|Ineligible|3|||
42004414|NCT01307579|75812452|FG001|Overall Study|Ineligible|4|||
42004415|NCT01057693|75812458|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
42004416|NCT01057693|75812459|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
42004417|NCT01057693|75812460|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
42135893|NCT00267748|75946446|FG001|Randomized Period|randomized but not treated|0|||
42270289|NCT02678247|76099563|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
42270290|NCT02678247|76099562|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
42270291|NCT02678247|76099563|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
42270292|NCT02678247|76099562|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
42270293|NCT02678247|76099563|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
42270294|NCT02678247|76099562|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
42270295|NCT02678247|76099563|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
42270296|NCT02678247|76099562|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
42270297|NCT02678247|76099563|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
42270298|NCT02678247|76099562|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
42270299|NCT02678247|76099563|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
42270300|NCT02683785|76099576|FG000|Overall Study|Withdrawal by Subject|1|||
42270301|NCT02683785|76099577|FG001|Overall Study|Withdrawal by Subject|1|||
42270302|NCT02683785|76099576|FG000|Overall Study|Lost to Follow-up|0|||
42270303|NCT02683785|76099577|FG001|Overall Study|Lost to Follow-up|1|||
42344209|NCT01606761|76182767|FG002|Prior to Week 24|Physician Decision|1|||
42344210|NCT01606761|76182768|FG003|Prior to Week 24|Physician Decision|0|||
42344211|NCT01606761|76182769|FG004|Prior to Week 24|Physician Decision|0|||
42344212|NCT01606761|76182765|FG000|Prior to Week 24|Other|4|||
42344213|NCT01606761|76182766|FG001|Prior to Week 24|Other|7|||
42135894|NCT00267748|75946447|FG002|Randomized Period|randomized but not treated|3|||
42270304|NCT02683785|76099576|FG000|Overall Study|Adverse Event|0|||
42270305|NCT02683785|76099577|FG001|Overall Study|Adverse Event|2|||
42270306|NCT02543294|76099585|FG000|Overall Study|Lost to Follow-up|3|||
42004418|NCT01057693|75812458|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
42004419|NCT01057693|75812459|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
42004420|NCT01057693|75812460|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
42004421|NCT01057693|75812458|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
42004422|NCT01057693|75812459|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
42004423|NCT01057693|75812460|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
42344214|NCT01606761|76182767|FG002|Prior to Week 24|Other|5|||
42344215|NCT01606761|76182768|FG003|Prior to Week 24|Other|0|||
42344216|NCT01606761|76182769|FG004|Prior to Week 24|Other|0|||
42344217|NCT01606761|76182765|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
42344218|NCT01606761|76182766|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
42344219|NCT01606761|76182767|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
42344220|NCT01606761|76182768|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
42344221|NCT01606761|76182769|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
42344222|NCT01606761|76182765|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
42344223|NCT01606761|76182766|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
42344224|NCT01606761|76182767|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
42344225|NCT01606761|76182768|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
42344226|NCT01606761|76182769|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
42344227|NCT01606761|76182765|FG000|Week 24 to Week 52|Adverse Event|0|||
42344228|NCT01606761|76182766|FG001|Week 24 to Week 52|Adverse Event|11|||
42344229|NCT01606761|76182767|FG002|Week 24 to Week 52|Adverse Event|14|||
42344230|NCT01606761|76182768|FG003|Week 24 to Week 52|Adverse Event|3|||
42344231|NCT01606761|76182769|FG004|Week 24 to Week 52|Adverse Event|15|||
42344232|NCT01606761|76182765|FG000|Week 24 to Week 52|Death|0|||
42344233|NCT01606761|76182766|FG001|Week 24 to Week 52|Death|0|||
42344234|NCT01606761|76182767|FG002|Week 24 to Week 52|Death|2|||
42344235|NCT01606761|76182768|FG003|Week 24 to Week 52|Death|1|||
42344236|NCT01606761|76182769|FG004|Week 24 to Week 52|Death|0|||
42344237|NCT01606761|76182765|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
42344238|NCT01606761|76182766|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
42344239|NCT01606761|76182767|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
42344240|NCT01606761|76182768|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
42004424|NCT01057693|75812458|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
42344241|NCT01606761|76182769|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
42344242|NCT01606761|76182765|FG000|Week 24 to Week 52|Physician Decision|0|||
42344243|NCT01606761|76182766|FG001|Week 24 to Week 52|Physician Decision|1|||
42344244|NCT01606761|76182767|FG002|Week 24 to Week 52|Physician Decision|1|||
42344245|NCT01606761|76182768|FG003|Week 24 to Week 52|Physician Decision|0|||
42344246|NCT01606761|76182769|FG004|Week 24 to Week 52|Physician Decision|0|||
42344247|NCT01606761|76182765|FG000|Week 24 to Week 52|Other|0|||
42344248|NCT01606761|76182766|FG001|Week 24 to Week 52|Other|1|||
42344249|NCT01606761|76182767|FG002|Week 24 to Week 52|Other|5|||
42344250|NCT01606761|76182768|FG003|Week 24 to Week 52|Other|2|||
42344251|NCT01606761|76182769|FG004|Week 24 to Week 52|Other|2|||
42344252|NCT01606761|76182765|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
42344253|NCT01606761|76182766|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
42344254|NCT01606761|76182767|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
42344255|NCT01606761|76182768|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
42344256|NCT01606761|76182769|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
42135895|NCT00267202|75946456|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
42270307|NCT02543294|76099585|FG000|Overall Study|Physician Decision|2|||
42344257|NCT01606761|76182765|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
42344258|NCT01606761|76182766|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
42344259|NCT01606761|76182767|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
42344260|NCT01606761|76182768|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
42344261|NCT01606761|76182769|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
42344262|NCT01606761|76182765|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
42344263|NCT01606761|76182766|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
42344264|NCT01606761|76182767|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
42344265|NCT01606761|76182768|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
42344266|NCT01606761|76182769|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
42344267|NCT01606761|76182765|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
42344268|NCT01606761|76182766|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
42344269|NCT01606761|76182767|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
42344270|NCT01606761|76182768|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
42344271|NCT01606761|76182769|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
42344272|NCT01790295|76182784|FG000|Overall Study|Adverse Event|1|||
42344273|NCT01790295|76182784|FG000|Overall Study|Death|4|||
42344274|NCT01790295|76182784|FG000|Overall Study|Lack of Efficacy|2|||
42344275|NCT01790295|76182784|FG000|Overall Study|Study closure|4|||
42344276|NCT01597557|76182791|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
42344277|NCT01597557|76182792|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
42344278|NCT01760733|76182798|FG000|Waiting List|Death|18|||
42344279|NCT01760733|76182798|FG000|Waiting List|Removed from waiting list|41|||
42344280|NCT01760733|76182798|FG000|Waiting List|Not received a transplant yet|13|||
42344281|NCT01760733|76182798|FG000|Transplanted|Not reached 10 years post transplant|184|||
42344282|NCT01760733|76182798|FG000|Transplanted|Death|26|||
42344283|NCT01760733|76182798|FG000|Transplanted|Graft loss|7|||
42344284|NCT01914757|76182806|FG000|Overall Study|Severe non-compliance to protocol|3|||
42344285|NCT01914757|76182807|FG001|Overall Study|Severe non-compliance to protocol|1|||
42344286|NCT01914757|76182808|FG002|Overall Study|Severe non-compliance to protocol|2|||
42344287|NCT01914757|76182806|FG000|Overall Study|Lost to Follow-up|5|||
42344288|NCT01914757|76182807|FG001|Overall Study|Lost to Follow-up|8|||
42344289|NCT01914757|76182808|FG002|Overall Study|Lost to Follow-up|6|||
42344290|NCT01914757|76182806|FG000|Overall Study|Withdrawal by Subject|15|||
42344291|NCT01914757|76182807|FG001|Overall Study|Withdrawal by Subject|27|||
42344292|NCT01914757|76182808|FG002|Overall Study|Withdrawal by Subject|19|||
42344293|NCT01914757|76182806|FG000|Overall Study|Death|2|||
42344294|NCT01914757|76182807|FG001|Overall Study|Death|2|||
42270308|NCT02543294|76099585|FG000|Overall Study|Withdrawal by Subject|7|||
42270309|NCT02551874|76099592|FG000|Overall Study|Lost to Follow-up|0|||
42270310|NCT02551874|76099593|FG001|Overall Study|Lost to Follow-up|2|||
42270311|NCT02551874|76099592|FG000|Overall Study|Pregnancy|0|||
42270312|NCT02551874|76099593|FG001|Overall Study|Pregnancy|1|||
42270313|NCT02551874|76099592|FG000|Overall Study|Reason not reported|10|||
42270314|NCT02551874|76099593|FG001|Overall Study|Reason not reported|4|||
42344295|NCT01914757|76182808|FG002|Overall Study|Death|1|||
42344296|NCT01914757|76182806|FG000|Overall Study|Adverse Event|4|||
42344297|NCT01914757|76182807|FG001|Overall Study|Adverse Event|3|||
42344298|NCT01914757|76182808|FG002|Overall Study|Adverse Event|4|||
42344299|NCT01914757|76182806|FG000|Overall Study|Study specific withdrawal criteria|0|||
42344300|NCT01914757|76182807|FG001|Overall Study|Study specific withdrawal criteria|1|||
42344301|NCT01914757|76182808|FG002|Overall Study|Study specific withdrawal criteria|0|||
42344302|NCT01914757|76182806|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
42344303|NCT01914757|76182807|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
42344304|NCT01914757|76182808|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
42270315|NCT02551874|76099592|FG000|Overall Study|Did not receive randomized treatment|0|||
42135896|NCT00267202|75946457|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
42135897|NCT00267202|75946456|FG000|Overall Study|Withdrawal by Subject|12|||
42135898|NCT00267202|75946457|FG001|Overall Study|Withdrawal by Subject|15|||
42135899|NCT00267202|75946456|FG000|Overall Study|Adverse Event|13|||
42135900|NCT00267202|75946457|FG001|Overall Study|Adverse Event|7|||
42135901|NCT00267202|75946456|FG000|Overall Study|Protocol Violation|2|||
42135902|NCT00267202|75946457|FG001|Overall Study|Protocol Violation|3|||
42135903|NCT00267202|75946456|FG000|Overall Study|Administrative problems|2|||
42135904|NCT00267202|75946457|FG001|Overall Study|Administrative problems|1|||
42344305|NCT01914757|76182806|FG000|Overall Study|Other reasons|5|||
42344306|NCT01914757|76182807|FG001|Overall Study|Other reasons|9|||
42344307|NCT01914757|76182808|FG002|Overall Study|Other reasons|4|||
42344308|NCT02003573|76182819|FG000|Overall Study|Progressive disease|2|||
42344309|NCT02003573|76182820|FG001|Overall Study|Progressive disease|0|||
42344310|NCT02003573|76182821|FG002|Overall Study|Progressive disease|1|||
42344311|NCT02003573|76182819|FG000|Overall Study|Other Adverse event|0|||
42344312|NCT02003573|76182820|FG001|Overall Study|Other Adverse event|1|||
42344313|NCT02003573|76182821|FG002|Overall Study|Other Adverse event|1|||
42344314|NCT02003573|76182819|FG000|Overall Study|Refuse to take trial medication|0|||
42344315|NCT02003573|76182820|FG001|Overall Study|Refuse to take trial medication|1|||
42344316|NCT02003573|76182821|FG002|Overall Study|Refuse to take trial medication|1|||
42344317|NCT02003573|76182819|FG000|Overall Study|Other than specified|1|||
42344318|NCT02003573|76182820|FG001|Overall Study|Other than specified|2|||
42344319|NCT02003573|76182821|FG002|Overall Study|Other than specified|3|||
42344320|NCT01914679|76182831|FG000|Overall Study|Lack of Efficacy|1|||
42344321|NCT01914679|76182831|FG000|Overall Study|Sponsor terminated study|4|||
42344322|NCT01789281|76182837|FG000|Overall Study|Disease progression|15|||
42344323|NCT01789281|76182838|FG001|Overall Study|Disease progression|4|||
42344324|NCT01789281|76182837|FG000|Overall Study|Adverse Event|5|||
42344325|NCT01789281|76182838|FG001|Overall Study|Adverse Event|5|||
42344326|NCT01789281|76182837|FG000|Overall Study|Withdrawal by Subject|1|||
42344327|NCT01789281|76182838|FG001|Overall Study|Withdrawal by Subject|0|||
42344328|NCT01789281|76182837|FG000|Overall Study|Lost to Follow-up|1|||
42344329|NCT01789281|76182838|FG001|Overall Study|Lost to Follow-up|0|||
42344330|NCT01789281|76182837|FG000|Overall Study|Administrative problems|0|||
42344331|NCT01789281|76182838|FG001|Overall Study|Administrative problems|1|||
42344332|NCT01923740|76182847|FG000|Overall Study|Lost to Follow-up|4|||
42344333|NCT01923740|76182848|FG001|Overall Study|Lost to Follow-up|9|||
42344334|NCT01923740|76182847|FG000|Overall Study|Withdrawal by Subject|2|||
42344335|NCT01923740|76182848|FG001|Overall Study|Withdrawal by Subject|0|||
42344336|NCT01789203|76182856|FG000|Overall Study|Adverse Event|2|||
42344337|NCT01789203|76182857|FG001|Overall Study|Adverse Event|2|||
42344338|NCT01789203|76182856|FG000|Overall Study|Withdrawal by Subject|1|||
42344339|NCT01789203|76182857|FG001|Overall Study|Withdrawal by Subject|0|||
42344340|NCT01789203|76182856|FG000|Overall Study|Death|1|||
42344341|NCT01789203|76182857|FG001|Overall Study|Death|0|||
42344342|NCT01789203|76182856|FG000|Overall Study|Protocol Violation|2|||
42344343|NCT01789203|76182857|FG001|Overall Study|Protocol Violation|1|||
42344344|NCT01789203|76182856|FG000|Overall Study|Other|1|||
42344345|NCT01789203|76182857|FG001|Overall Study|Other|1|||
42344346|NCT01789203|76182856|FG000|Overall Study|patient non-adherent|2|||
42344347|NCT01789203|76182857|FG001|Overall Study|patient non-adherent|0|||
42344348|NCT01789047|76182867|FG000|Overall Study|Adverse Event|3|||
42344349|NCT01789047|76182868|FG001|Overall Study|Adverse Event|2|||
42344350|NCT01789047|76182867|FG000|Overall Study|Withdrawal by Subject|1|||
42135905|NCT00267202|75946456|FG000|Overall Study|Lost to Follow-up|3|||
42135906|NCT00267202|75946457|FG001|Overall Study|Lost to Follow-up|0|||
42344351|NCT01789047|76182868|FG001|Overall Study|Withdrawal by Subject|2|||
42344352|NCT01788423|76182877|FG000|Overall Study|See Comments in Completed (above)|0|||
42344353|NCT01788423|76182878|FG001|Overall Study|See Comments in Completed (above)|4|||
42344354|NCT01788423|76182879|FG002|Overall Study|See Comments in Completed (above)|5|||
42270316|NCT02551874|76099593|FG001|Overall Study|Did not receive randomized treatment|7|||
42344355|NCT01617187|76182891|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
42344356|NCT01617187|76182892|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
42344357|NCT01617187|76182893|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
42344358|NCT01617187|76182894|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
42344359|NCT01617187|76182891|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
42344360|NCT01617187|76182892|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
42344361|NCT01617187|76182893|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
42344362|NCT01617187|76182894|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
42344363|NCT01617187|76182891|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
42344364|NCT01617187|76182892|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
42344365|NCT01617187|76182893|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
42344366|NCT01617187|76182894|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
42344367|NCT01617187|76182891|FG000|Treatment Through Study Completion|Adverse Event|1|||
42344368|NCT01617187|76182892|FG001|Treatment Through Study Completion|Adverse Event|1|||
42344369|NCT01617187|76182893|FG002|Treatment Through Study Completion|Adverse Event|0|||
42344370|NCT01617187|76182894|FG003|Treatment Through Study Completion|Adverse Event|1|||
42270317|NCT02551874|76099592|FG000|Overall Study|Did not enter long-term study|18|||
42270318|NCT02551874|76099593|FG001|Overall Study|Did not enter long-term study|25|||
42270319|NCT02550938|76099616|FG000|Overall Study|Lost to Follow-up|8|||
42270320|NCT02550938|76099617|FG001|Overall Study|Lost to Follow-up|7|||
42344371|NCT01617187|76182891|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
42344372|NCT01617187|76182892|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
42344373|NCT01617187|76182893|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
42344374|NCT01617187|76182894|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
42344375|NCT01617187|76182891|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
42344376|NCT01617187|76182892|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
42344377|NCT01617187|76182893|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
42344378|NCT01617187|76182894|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
42344379|NCT01617187|76182891|FG000|Treatment Through Study Completion|Protocol Violation|1|||
42344380|NCT01617187|76182892|FG001|Treatment Through Study Completion|Protocol Violation|0|||
42344381|NCT01617187|76182893|FG002|Treatment Through Study Completion|Protocol Violation|0|||
42344382|NCT01617187|76182894|FG003|Treatment Through Study Completion|Protocol Violation|1|||
42344383|NCT01759407|76182906|FG000|Overall Study|Protocol Violation|0|||
42344384|NCT01759407|76182907|FG001|Overall Study|Protocol Violation|2|||
42344385|NCT01787331|76182913|FG000|Overall Study|Physician Decision|1|||
42344386|NCT01787331|76182913|FG000|Overall Study|Withdrawal by Subject|1|||
42344387|NCT01757847|76182919|FG000|Overall Study|Withdrawal by Subject|3|||
42344388|NCT01757847|76182920|FG001|Overall Study|Withdrawal by Subject|4|||
42344389|NCT01787097|76182926|FG000|Overall Study|Withdrawal by Subject|1|||
42344390|NCT01787097|76182927|FG001|Overall Study|Withdrawal by Subject|0|||
42344391|NCT01787097|76182928|FG002|Overall Study|Withdrawal by Subject|0|||
42344392|NCT01787097|76182929|FG003|Overall Study|Withdrawal by Subject|0|||
42135907|NCT00267046|75946466|FG000|Overall Study|Disease progression|4|||
42270321|NCT02550938|76099618|FG002|Overall Study|Lost to Follow-up|12|||
42270322|NCT02550938|76099619|FG003|Overall Study|Lost to Follow-up|11|||
42270323|NCT02769065|76099659|FG000|Overall Study|Voluntary Withdrawal|1|||
42270324|NCT02769065|76099660|FG001|Overall Study|Voluntary Withdrawal|0|||
42270325|NCT02769065|76099661|FG002|Overall Study|Voluntary Withdrawal|0|||
42270326|NCT02769065|76099662|FG003|Overall Study|Voluntary Withdrawal|0|||
42270327|NCT02769065|76099663|FG004|Overall Study|Voluntary Withdrawal|0|||
42270328|NCT02769065|76099664|FG005|Overall Study|Voluntary Withdrawal|0|||
42270329|NCT02769065|76099665|FG006|Overall Study|Voluntary Withdrawal|0|||
42270330|NCT02769065|76099666|FG007|Overall Study|Voluntary Withdrawal|0|||
42270331|NCT02769065|76099667|FG008|Overall Study|Voluntary Withdrawal|0|||
42270332|NCT02769065|76099668|FG009|Overall Study|Voluntary Withdrawal|0|||
42270333|NCT02769065|76099669|FG010|Overall Study|Voluntary Withdrawal|0|||
42270334|NCT02769065|76099670|FG011|Overall Study|Voluntary Withdrawal|0|||
42270335|NCT02769065|76099671|FG012|Overall Study|Voluntary Withdrawal|0|||
42270336|NCT02769065|76099672|FG013|Overall Study|Voluntary Withdrawal|0|||
42270337|NCT02769065|76099673|FG014|Overall Study|Voluntary Withdrawal|0|||
42270338|NCT02769065|76099674|FG015|Overall Study|Voluntary Withdrawal|0|||
42270339|NCT02769065|76099675|FG016|Overall Study|Voluntary Withdrawal|0|||
42270340|NCT02769065|76099676|FG017|Overall Study|Voluntary Withdrawal|0|||
42270341|NCT02769065|76099677|FG018|Overall Study|Voluntary Withdrawal|0|||
42270342|NCT02769065|76099678|FG019|Overall Study|Voluntary Withdrawal|0|||
42270343|NCT02769065|76099679|FG020|Overall Study|Voluntary Withdrawal|0|||
42270344|NCT02769065|76099680|FG021|Overall Study|Voluntary Withdrawal|0|||
42270345|NCT02769065|76099681|FG022|Overall Study|Voluntary Withdrawal|0|||
42344393|NCT01757691|76182949|FG000|Overall Study|Administrative problems|2|||
42344394|NCT01757691|76182950|FG001|Overall Study|Administrative problems|0|||
42344395|NCT01786707|76182958|FG000|Overall Study|Lost to Follow-up|1|||
42344396|NCT01786707|76182959|FG001|Overall Study|Lost to Follow-up|1|||
42344397|NCT01786629|76182967|FG000|Overall Study|Lack of Efficacy|0|||
42344398|NCT01786629|76182968|FG001|Overall Study|Lack of Efficacy|4|||
42344399|NCT01786629|76182967|FG000|Overall Study|Adverse Event|0|||
42344400|NCT01786629|76182968|FG001|Overall Study|Adverse Event|1|||
42344401|NCT01786551|76182974|FG000|Overall Study|Participant withdrew consent|2|||
42344402|NCT01973569|76182981|FG000|Overall Study|Adverse Event|9|||
42344403|NCT01973569|76182982|FG001|Overall Study|Adverse Event|2|||
42344404|NCT01973569|76182983|FG002|Overall Study|Adverse Event|4|||
42344405|NCT01973569|76182981|FG000|Overall Study|Protocol Violation|2|||
42344406|NCT01973569|76182982|FG001|Overall Study|Protocol Violation|1|||
42004425|NCT01057693|75812459|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
42270346|NCT02769065|76099682|FG023|Overall Study|Voluntary Withdrawal|0|||
42270347|NCT02769065|76099683|FG024|Overall Study|Voluntary Withdrawal|0|||
42270348|NCT02769065|76099684|FG025|Overall Study|Voluntary Withdrawal|0|||
42270349|NCT02769065|76099685|FG026|Overall Study|Voluntary Withdrawal|0|||
42270350|NCT02769065|76099686|FG027|Overall Study|Voluntary Withdrawal|0|||
42270351|NCT02769065|76099687|FG028|Overall Study|Voluntary Withdrawal|0|||
42270352|NCT02769065|76099688|FG029|Overall Study|Voluntary Withdrawal|0|||
42270353|NCT02769065|76099659|FG000|Overall Study|Reason Not Specified|0|||
42344407|NCT01973569|76182983|FG002|Overall Study|Protocol Violation|3|||
42344408|NCT01973569|76182981|FG000|Overall Study|Withdrawal by Subject|7|||
42344409|NCT01973569|76182982|FG001|Overall Study|Withdrawal by Subject|5|||
42344410|NCT01973569|76182983|FG002|Overall Study|Withdrawal by Subject|2|||
42344411|NCT01973569|76182981|FG000|Overall Study|Invasive dental treatment|3|||
42344412|NCT01973569|76182982|FG001|Overall Study|Invasive dental treatment|5|||
42344413|NCT01973569|76182983|FG002|Overall Study|Invasive dental treatment|6|||
42344414|NCT01973569|76182981|FG000|Overall Study|Prohibited concomitant d|1|||
42270354|NCT02769065|76099660|FG001|Overall Study|Reason Not Specified|0|||
42344415|NCT01973569|76182982|FG001|Overall Study|Prohibited concomitant d|5|||
42344416|NCT01973569|76182983|FG002|Overall Study|Prohibited concomitant d|0|||
42344417|NCT01973569|76182981|FG000|Overall Study|Disease progression|0|||
42344418|NCT01973569|76182982|FG001|Overall Study|Disease progression|3|||
42344419|NCT01973569|76182983|FG002|Overall Study|Disease progression|0|||
42344420|NCT01973569|76182981|FG000|Overall Study|Other|1|||
42344421|NCT01973569|76182982|FG001|Overall Study|Other|1|||
42344422|NCT01973569|76182983|FG002|Overall Study|Other|0|||
42344423|NCT01973569|76182981|FG000|Overall Study|Did not receive study drug|6|||
42344424|NCT01973569|76182982|FG001|Overall Study|Did not receive study drug|3|||
42344425|NCT01973569|76182983|FG002|Overall Study|Did not receive study drug|3|||
42344426|NCT01973491|76182991|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
42344427|NCT01973491|76182991|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
42004426|NCT01057693|75812460|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
42004427|NCT01057693|75812458|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
42004428|NCT01057693|75812459|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
42135908|NCT00267046|75946467|FG001|Overall Study|Disease progression|2|||
42135909|NCT00267046|75946466|FG000|Overall Study|Chemotoxicity|2|||
42344428|NCT01973491|76182991|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
42344429|NCT01951586|76182997|FG000|Overall Study|Death|61|||
42344430|NCT01951586|76182998|FG001|Overall Study|Death|120|||
42344431|NCT01951586|76182997|FG000|Overall Study|Withdrawal by Subject|8|||
42344432|NCT01951586|76182998|FG001|Overall Study|Withdrawal by Subject|17|||
42344433|NCT01951586|76182997|FG000|Overall Study|Lost to Follow-up|0|||
42344434|NCT01951586|76182998|FG001|Overall Study|Lost to Follow-up|1|||
42344435|NCT01951586|76182997|FG000|Overall Study|Sponsor Decision|9|||
42344436|NCT01951586|76182998|FG001|Overall Study|Sponsor Decision|10|||
42344437|NCT01785849|76183007|FG000|Overall Study|Death|7|||
42344438|NCT01785849|76183008|FG001|Overall Study|Death|9|||
42344439|NCT01785849|76183007|FG000|Overall Study|Protocol Specified Criteria|29|||
42344440|NCT01785849|76183008|FG001|Overall Study|Protocol Specified Criteria|1|||
42344441|NCT01785849|76183007|FG000|Overall Study|Withdrawal by Subject|15|||
42344442|NCT01785849|76183008|FG001|Overall Study|Withdrawal by Subject|12|||
42344443|NCT01785849|76183007|FG000|Overall Study|Sponsor Decision|0|||
42004429|NCT01057693|75812460|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
42344444|NCT01785849|76183008|FG001|Overall Study|Sponsor Decision|1|||
42344445|NCT01785849|76183007|FG000|Overall Study|Lost to Follow-up|10|||
42344446|NCT01785849|76183008|FG001|Overall Study|Lost to Follow-up|11|||
42135910|NCT00267046|75946467|FG001|Overall Study|Chemotoxicity|0|||
42344447|NCT01756833|76183016|FG000|Overall Study|Withdrawal by Subject|4|||
42344448|NCT01756833|76183017|FG001|Overall Study|Withdrawal by Subject|3|||
42344449|NCT01617967|76183029|FG000|Overall Study|Protocol Violation|0|||
42344450|NCT01617967|76183030|FG001|Overall Study|Protocol Violation|0|||
42135911|NCT00267046|75946466|FG000|Overall Study|Open-label palifermin|2|||
42270355|NCT02769065|76099661|FG002|Overall Study|Reason Not Specified|0|||
42270356|NCT02769065|76099662|FG003|Overall Study|Reason Not Specified|0|||
42270357|NCT02769065|76099663|FG004|Overall Study|Reason Not Specified|0|||
42270358|NCT02769065|76099664|FG005|Overall Study|Reason Not Specified|0|||
42270359|NCT02769065|76099665|FG006|Overall Study|Reason Not Specified|1|||
42270360|NCT02769065|76099666|FG007|Overall Study|Reason Not Specified|0|||
42344451|NCT01617967|76183031|FG002|Overall Study|Protocol Violation|0|||
42270361|NCT02769065|76099667|FG008|Overall Study|Reason Not Specified|0|||
42270362|NCT02769065|76099668|FG009|Overall Study|Reason Not Specified|0|||
42270363|NCT02769065|76099669|FG010|Overall Study|Reason Not Specified|0|||
42344452|NCT01617967|76183032|FG003|Overall Study|Protocol Violation|1|||
42344453|NCT01617967|76183033|FG004|Overall Study|Protocol Violation|0|||
42344454|NCT01617967|76183034|FG005|Overall Study|Protocol Violation|0|||
42344455|NCT01617967|76183029|FG000|Overall Study|Withdrawal by Subject|0|||
42344456|NCT01617967|76183030|FG001|Overall Study|Withdrawal by Subject|0|||
42344457|NCT01617967|76183031|FG002|Overall Study|Withdrawal by Subject|0|||
42344458|NCT01617967|76183032|FG003|Overall Study|Withdrawal by Subject|0|||
42344459|NCT01617967|76183033|FG004|Overall Study|Withdrawal by Subject|0|||
42344460|NCT01617967|76183034|FG005|Overall Study|Withdrawal by Subject|1|||
42344461|NCT01617967|76183029|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
42344462|NCT01617967|76183030|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
42344463|NCT01617967|76183031|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
42344464|NCT01617967|76183032|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
42344465|NCT01617967|76183033|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
42344466|NCT01617967|76183034|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
42344467|NCT01785615|76183052|FG000|Dietary Phase|Lost to Follow-up|0|||
42344468|NCT01785615|76183053|FG001|Dietary Phase|Lost to Follow-up|0|||
42344469|NCT01785615|76183054|FG002|Dietary Phase|Lost to Follow-up|0|||
42344470|NCT01785615|76183055|FG003|Dietary Phase|Lost to Follow-up|24|||
42344471|NCT01913041|76183067|FG000|Overall Study|Protocol Violation|35|||
42344472|NCT01913041|76183067|FG000|Overall Study|Withdrawal by Subject|3|||
42344473|NCT01913041|76183067|FG000|Overall Study|Physician Decision|1|||
42344474|NCT01756053|76183071|FG000|Period 1 (10 Days)|Protocol Violation|1|||
42344475|NCT01756053|76183072|FG001|Period 1 (10 Days)|Protocol Violation|1|||
42344476|NCT01756053|76183071|FG000|Period 2 (10 Days)|Protocol Violation|0|||
42270364|NCT02769065|76099670|FG011|Overall Study|Reason Not Specified|0|||
42270365|NCT02769065|76099671|FG012|Overall Study|Reason Not Specified|0|||
42270366|NCT02769065|76099672|FG013|Overall Study|Reason Not Specified|0|||
42270367|NCT02769065|76099673|FG014|Overall Study|Reason Not Specified|0|||
42270368|NCT02769065|76099674|FG015|Overall Study|Reason Not Specified|0|||
42270369|NCT02769065|76099675|FG016|Overall Study|Reason Not Specified|0|||
42270370|NCT02769065|76099676|FG017|Overall Study|Reason Not Specified|0|||
42270371|NCT02769065|76099677|FG018|Overall Study|Reason Not Specified|0|||
42270372|NCT02769065|76099678|FG019|Overall Study|Reason Not Specified|0|||
42270373|NCT02769065|76099679|FG020|Overall Study|Reason Not Specified|0|||
42270374|NCT02769065|76099680|FG021|Overall Study|Reason Not Specified|0|||
42270375|NCT02769065|76099681|FG022|Overall Study|Reason Not Specified|0|||
42344477|NCT01756053|76183072|FG001|Period 2 (10 Days)|Protocol Violation|2|||
42270376|NCT02769065|76099682|FG023|Overall Study|Reason Not Specified|0|||
42344478|NCT01785069|76183082|FG000|Overall Study|Implanted with nonstudy device|1|||
42270377|NCT02769065|76099683|FG024|Overall Study|Reason Not Specified|0|||
42270378|NCT02769065|76099684|FG025|Overall Study|Reason Not Specified|0|||
42344479|NCT01785069|76183083|FG001|Overall Study|Implanted with nonstudy device|2|||
42344480|NCT01785069|76183084|FG002|Overall Study|Implanted with nonstudy device|1|||
42344481|NCT01785069|76183085|FG003|Overall Study|Implanted with nonstudy device|0|||
42344482|NCT01785069|76183082|FG000|Overall Study|Death|0|||
42344483|NCT01785069|76183083|FG001|Overall Study|Death|0|||
42344484|NCT01785069|76183084|FG002|Overall Study|Death|2|||
42344485|NCT01785069|76183085|FG003|Overall Study|Death|0|||
42344486|NCT01785069|76183082|FG000|Overall Study|Subject choice|2|||
42344487|NCT01785069|76183083|FG001|Overall Study|Subject choice|2|||
42344488|NCT01785069|76183084|FG002|Overall Study|Subject choice|0|||
42344489|NCT01785069|76183085|FG003|Overall Study|Subject choice|1|||
42344490|NCT01785069|76183082|FG000|Overall Study|Lost to Follow-up|1|||
42344491|NCT01785069|76183083|FG001|Overall Study|Lost to Follow-up|2|||
42344492|NCT01785069|76183084|FG002|Overall Study|Lost to Follow-up|4|||
42004430|NCT01057693|75812458|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
42270379|NCT02769065|76099685|FG026|Overall Study|Reason Not Specified|0|||
42270380|NCT02769065|76099686|FG027|Overall Study|Reason Not Specified|0|||
42344493|NCT01785069|76183085|FG003|Overall Study|Lost to Follow-up|1|||
42344494|NCT01785069|76183082|FG000|Overall Study|Reason not Specified|1|||
42344495|NCT01785069|76183083|FG001|Overall Study|Reason not Specified|2|||
42344496|NCT01785069|76183084|FG002|Overall Study|Reason not Specified|1|||
42344497|NCT01785069|76183085|FG003|Overall Study|Reason not Specified|4|||
42344498|NCT01785069|76183082|FG000|Overall Study|Not evaluable|7|||
42344499|NCT01785069|76183083|FG001|Overall Study|Not evaluable|4|||
42344500|NCT01785069|76183084|FG002|Overall Study|Not evaluable|5|||
42344501|NCT01785069|76183085|FG003|Overall Study|Not evaluable|8|||
42344502|NCT01784523|76183097|FG000|Overall Study|Study closed early|7|||
42344503|NCT01784523|76183098|FG001|Overall Study|Study closed early|4|||
42270381|NCT02769065|76099687|FG028|Overall Study|Reason Not Specified|0|||
42270382|NCT02769065|76099688|FG029|Overall Study|Reason Not Specified|0|||
42270383|NCT02769065|76099659|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270384|NCT02769065|76099660|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270385|NCT02769065|76099661|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270386|NCT02769065|76099662|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
42344504|NCT01784211|76183106|FG000|Part A (Days 1-15)|Adverse Event|1|||
42344505|NCT01784211|76183107|FG001|Part A (Days 1-15)|Adverse Event|1|||
42344506|NCT01784211|76183108|FG002|Part A (Days 1-15)|Adverse Event|0|||
42344507|NCT01784211|76183109|FG003|Part A (Days 1-15)|Adverse Event|0|||
42344508|NCT01784211|76183110|FG004|Part A (Days 1-15)|Adverse Event|0|||
42344509|NCT01784211|76183111|FG005|Part A (Days 1-15)|Adverse Event|0|||
42344510|NCT01784211|76183106|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
42135912|NCT00267046|75946467|FG001|Overall Study|Open-label palifermin|7|||
42270387|NCT02769065|76099663|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
42344511|NCT01784211|76183107|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
42135913|NCT00267046|75946466|FG000|Overall Study|Surgery|3|||
42344512|NCT01784211|76183108|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
42344513|NCT01784211|76183109|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
42344514|NCT01784211|76183110|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
42344515|NCT01784211|76183111|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
42344516|NCT01783821|76183125|FG000|Overall Study|Screen Failure|1|||
42344517|NCT01783821|76183126|FG001|Overall Study|Screen Failure|1|||
42344518|NCT01783743|76183134|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
42344519|NCT01783743|76183135|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
42344520|NCT01783743|76183134|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
42344521|NCT01783743|76183135|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
42344522|NCT01783743|76183134|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
42344523|NCT01783743|76183135|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
42344524|NCT01608321|76183143|FG000|Overall Study|Withdrawal by Subject|1|||
42344525|NCT01608321|76183144|FG001|Overall Study|Withdrawal by Subject|0|||
42344526|NCT01608087|76183153|FG000|Overall Study|Lost to Follow-up|0|||
42344527|NCT01608087|76183154|FG001|Overall Study|Lost to Follow-up|1|||
42344528|NCT01608087|76183155|FG002|Overall Study|Lost to Follow-up|0|||
42344529|NCT01608087|76183153|FG000|Overall Study|Other Reason|0|||
42344530|NCT01608087|76183154|FG001|Overall Study|Other Reason|1|||
42344531|NCT01608087|76183155|FG002|Overall Study|Other Reason|0|||
42344532|NCT01912963|76183166|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
42344533|NCT01912963|76183167|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
42344534|NCT01912963|76183168|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
42344535|NCT01912963|76183166|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
42344536|NCT01912963|76183167|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
42344537|NCT01912963|76183168|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
42344538|NCT01912963|76183166|FG000|Overall Study|Adverse Event|0|||
42344539|NCT01912963|76183167|FG001|Overall Study|Adverse Event|1|||
42344540|NCT01912963|76183168|FG002|Overall Study|Adverse Event|1|||
42344541|NCT01912963|76183166|FG000|Overall Study|Withdrawal by Subject|0|||
42344542|NCT01912963|76183167|FG001|Overall Study|Withdrawal by Subject|1|||
42004431|NCT01057693|75812459|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
42344543|NCT01912963|76183168|FG002|Overall Study|Withdrawal by Subject|0|||
42344544|NCT01912963|76183166|FG000|Overall Study|Sought treatment locally|0|||
42344545|NCT01912963|76183167|FG001|Overall Study|Sought treatment locally|1|||
42344546|NCT01912963|76183168|FG002|Overall Study|Sought treatment locally|0|||
42344547|NCT01754727|76183176|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
42344548|NCT01912807|76183182|FG000|Overall Study|Did not meet elegibility criteria|6|||
42004432|NCT01057693|75812460|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
42004433|NCT01057693|75812458|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
42344549|NCT01912807|76183183|FG001|Overall Study|Did not meet elegibility criteria|4|||
42344550|NCT01912807|76183182|FG000|Overall Study|Lost to Follow-up|36|||
42344551|NCT01912807|76183183|FG001|Overall Study|Lost to Follow-up|37|||
42270388|NCT02769065|76099664|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270389|NCT02769065|76099665|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270390|NCT02769065|76099666|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270391|NCT02769065|76099667|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270392|NCT02769065|76099668|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270393|NCT02769065|76099669|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
42270394|NCT02769065|76099670|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
42344552|NCT01782885|76183191|FG000|Overall Study|Lost to Follow-up|4|||
42344553|NCT01782885|76183192|FG001|Overall Study|Lost to Follow-up|6|||
42344554|NCT01912729|76183200|FG000|Overall Study|Withdrawal by Subject|0|||
42344555|NCT01912729|76183201|FG001|Overall Study|Withdrawal by Subject|1|||
42344556|NCT01754493|76183207|FG000|Overall Study|Adverse Event|1|||
42344557|NCT01754493|76183207|FG000|Overall Study|Lost to Follow-up|3|||
42344558|NCT01754493|76183207|FG000|Overall Study|Withdrawal by Subject|1|||
42344559|NCT01754493|76183207|FG000|Overall Study|Moved out of town|1|||
42344560|NCT01754493|76183207|FG000|Overall Study|Scheduling conflict|1|||
42344561|NCT01972789|76183213|FG000|Overall Study|Adverse Event|11|||
42344562|NCT01972789|76183214|FG001|Overall Study|Adverse Event|4|||
42344563|NCT01972789|76183213|FG000|Overall Study|Subject withdrew consent|14|||
42344564|NCT01972789|76183214|FG001|Overall Study|Subject withdrew consent|12|||
42344565|NCT01972789|76183213|FG000|Overall Study|Lost to Follow-up|4|||
42344566|NCT01972789|76183214|FG001|Overall Study|Lost to Follow-up|7|||
42344567|NCT01972789|76183213|FG000|Overall Study|Death|7|||
42344568|NCT01972789|76183214|FG001|Overall Study|Death|5|||
42344569|NCT01972789|76183213|FG000|Overall Study|Protocol deviation|1|||
42344570|NCT01972789|76183214|FG001|Overall Study|Protocol deviation|0|||
42270395|NCT02769065|76099671|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270396|NCT02769065|76099672|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
42344571|NCT01972789|76183213|FG000|Overall Study|Physician Decision|3|||
42344572|NCT01972789|76183214|FG001|Overall Study|Physician Decision|2|||
42344573|NCT01934335|76183222|FG000|Overall Study|Withdrawal by Subject|1|||
42270397|NCT02769065|76099673|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
42344574|NCT01934335|76183223|FG001|Overall Study|Withdrawal by Subject|1|||
42344575|NCT01912339|76183231|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
42344576|NCT01912339|76183232|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
42344577|NCT01912339|76183233|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
42004434|NCT01057693|75812459|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
42135914|NCT00267046|75946467|FG001|Overall Study|Surgery|1|||
42135915|NCT00267046|75946466|FG000|Overall Study|Withdrawal by Subject|1|||
42135916|NCT00267046|75946467|FG001|Overall Study|Withdrawal by Subject|0|||
42344578|NCT01912339|76183231|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
42344579|NCT01912339|76183232|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
42135917|NCT00267046|75946466|FG000|Overall Study|Radiation|0|||
42344580|NCT01912339|76183233|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
42344581|NCT01912339|76183231|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
42344582|NCT01912339|76183232|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
42344583|NCT01912339|76183233|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
42344584|NCT01912339|76183231|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
42344585|NCT01912339|76183232|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
42344586|NCT01912339|76183233|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
42344587|NCT01912339|76183231|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
42344588|NCT01912339|76183232|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
42344589|NCT01912339|76183233|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
42344590|NCT01912339|76183231|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
42344591|NCT01912339|76183232|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
42344592|NCT01912339|76183233|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
42344593|NCT01912339|76183231|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
42344594|NCT01912339|76183232|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
42344595|NCT01912339|76183233|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
42344596|NCT01912339|76183231|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
42135918|NCT00267046|75946467|FG001|Overall Study|Radiation|1|||
42135919|NCT00441090|75946478|FG000|Overall Study|Adverse Event|0|||
42270398|NCT02769065|76099674|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270399|NCT02769065|76099675|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270400|NCT02769065|76099676|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270401|NCT02769065|76099677|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270402|NCT02769065|76099678|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270403|NCT02769065|76099679|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270404|NCT02769065|76099680|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270405|NCT02769065|76099681|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270406|NCT02769065|76099682|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270407|NCT02769065|76099683|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270408|NCT02769065|76099684|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270409|NCT02769065|76099685|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270410|NCT02769065|76099686|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270411|NCT02769065|76099687|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270412|NCT02769065|76099688|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
42270413|NCT02681523|76099781|FG000|Overall Study|Adverse Event|1|||
42270414|NCT02681523|76099781|FG000|Overall Study|Patient Non-compliance|1|||
42270415|NCT02540954|76099787|FG000|Overall Study|Physician Decision|3|||
42270416|NCT02540954|76099788|FG001|Overall Study|Physician Decision|1|||
42270417|NCT02540954|76099787|FG000|Overall Study|Withdrawal by Subject|6|||
42270418|NCT02540954|76099788|FG001|Overall Study|Withdrawal by Subject|5|||
42135920|NCT00441090|75946479|FG001|Overall Study|Adverse Event|1|||
42135921|NCT00441090|75946480|FG002|Overall Study|Adverse Event|1|||
42135922|NCT00441090|75946481|FG003|Overall Study|Adverse Event|0|||
42135923|NCT00441090|75946482|FG004|Overall Study|Adverse Event|0|||
42135924|NCT00441090|75946478|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
42135925|NCT00441090|75946479|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
42135926|NCT00441090|75946480|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
42135927|NCT00441090|75946481|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
42135928|NCT00441090|75946482|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
42270419|NCT02540954|76099787|FG000|Overall Study|Lost to Follow-up|1|||
42344597|NCT01912339|76183232|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
42344598|NCT01912339|76183233|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
42344599|NCT01912339|76183231|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
42004435|NCT01057693|75812460|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
42135929|NCT00441090|75946478|FG000|Overall Study|Withdrawal by Subject|1|||
42135930|NCT00441090|75946479|FG001|Overall Study|Withdrawal by Subject|0|||
42135931|NCT00441090|75946480|FG002|Overall Study|Withdrawal by Subject|1|||
42344600|NCT01912339|76183232|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
42344601|NCT01912339|76183233|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
42344602|NCT01912339|76183231|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
42135932|NCT00441090|75946481|FG003|Overall Study|Withdrawal by Subject|0|||
42270420|NCT02540954|76099788|FG001|Overall Study|Lost to Follow-up|1|||
42270421|NCT02540954|76099787|FG000|Overall Study|Adverse Event|4|||
42270422|NCT02540954|76099788|FG001|Overall Study|Adverse Event|2|||
42344603|NCT01912339|76183232|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
42344604|NCT01912339|76183233|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
42344605|NCT01912339|76183231|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
42344606|NCT01912339|76183232|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
42344607|NCT01912339|76183233|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
42344608|NCT01912339|76183231|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
42344609|NCT01912339|76183232|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
42344610|NCT01912339|76183233|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
42344611|NCT01912339|76183231|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
42344612|NCT01912339|76183232|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
42344613|NCT01912339|76183233|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
42344614|NCT01911793|76183241|FG000|Overall Study|Physician Decision|1|||
42344615|NCT01911793|76183242|FG001|Overall Study|Physician Decision|5|||
42270423|NCT02540954|76099787|FG000|Overall Study|Death|0|||
42270424|NCT02540954|76099788|FG001|Overall Study|Death|3|||
42270425|NCT02540954|76099787|FG000|Overall Study|Treatment failure|1|||
42270426|NCT02540954|76099788|FG001|Overall Study|Treatment failure|0|||
42270427|NCT02540954|76099787|FG000|Overall Study|Other reason|4|||
42270428|NCT02540954|76099788|FG001|Overall Study|Other reason|2|||
42270429|NCT02658812|76099794|FG000|Overall Study|Disease Progression|7|||
42270430|NCT02658812|76099794|FG000|Overall Study|Unrelated to study treatment|1|||
42270431|NCT02658812|76099794|FG000|Overall Study|Adverse Event|1|||
42270432|NCT02680665|76099798|FG000|Overall Study|No visit after the first prescription|5|||
42270433|NCT00154375|76099804|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
42270434|NCT00154375|76099805|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
42270435|NCT00154375|76099804|FG000|Overall Study|Adverse Event|18|||
42270436|NCT00154375|76099805|FG001|Overall Study|Adverse Event|20|||
42270437|NCT00154375|76099804|FG000|Overall Study|Withdrawal by Subject|14|||
42270438|NCT00154375|76099805|FG001|Overall Study|Withdrawal by Subject|10|||
42270439|NCT00154375|76099804|FG000|Overall Study|Death|5|||
42270440|NCT00154375|76099805|FG001|Overall Study|Death|13|||
42344616|NCT01933789|76183257|FG000|Overall Study|Death|0|||
42344617|NCT01933789|76183258|FG001|Overall Study|Death|0|||
42344618|NCT01933789|76183259|FG002|Overall Study|Death|0|||
42344619|NCT01933789|76183260|FG003|Overall Study|Death|0|||
42004436|NCT01057693|75812458|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
42004437|NCT01057693|75812459|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
42004438|NCT01057693|75812460|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
42004439|NCT01057693|75812458|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
42004440|NCT01057693|75812459|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
42004441|NCT01057693|75812460|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
42004442|NCT01057693|75812458|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
42004443|NCT01057693|75812459|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
42004444|NCT01057693|75812460|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
42004445|NCT01057693|75812458|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
42004446|NCT01057693|75812459|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
42004447|NCT01057693|75812460|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
42004448|NCT01057693|75812458|FG000|Between Single-Blind and Double-Blind|Other|6|||
42004449|NCT01057693|75812459|FG001|Between Single-Blind and Double-Blind|Other|0|||
42004450|NCT01057693|75812460|FG002|Between Single-Blind and Double-Blind|Other|0|||
42004451|NCT01057693|75812458|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
42004452|NCT01057693|75812459|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
42004453|NCT01057693|75812460|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
42004454|NCT01057693|75812458|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
42004455|NCT01057693|75812459|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
42004456|NCT01057693|75812460|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
42270441|NCT00154375|76099804|FG000|Overall Study|Study drug no longer required|5|||
42270442|NCT00154375|76099805|FG001|Overall Study|Study drug no longer required|3|||
42270443|NCT00154375|76099804|FG000|Overall Study|Lost to Follow-up|2|||
42270444|NCT00154375|76099805|FG001|Overall Study|Lost to Follow-up|1|||
42270445|NCT00154375|76099804|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42004457|NCT01057693|75812458|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
42004458|NCT01057693|75812459|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
42004459|NCT01057693|75812460|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
42004460|NCT01057693|75812458|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
42135933|NCT00441090|75946482|FG004|Overall Study|Withdrawal by Subject|0|||
42004461|NCT01057693|75812459|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
42004462|NCT01057693|75812460|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
42004463|NCT01057693|75812458|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
42004464|NCT01057693|75812459|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
42135934|NCT00441090|75946478|FG000|Overall Study|Lack of Efficacy|1|||
42270446|NCT00154375|76099805|FG001|Overall Study|Abnormal laboratory value(s)|2|||
42270447|NCT00154375|76099804|FG000|Overall Study|Protocol Violation|0|||
42270448|NCT00154375|76099805|FG001|Overall Study|Protocol Violation|1|||
42270449|NCT00154375|76099804|FG000|Overall Study|Suspected progression of disease|44|||
42270450|NCT00154375|76099805|FG001|Overall Study|Suspected progression of disease|30|||
42270451|NCT02765399|76099814|FG000|Overall Study|Nausea|1|||
42270452|NCT02765399|76099815|FG001|Overall Study|Nausea|0|||
42270453|NCT02676765|76099823|FG000|Overall Study|Lost to Follow-up|0|||
42270454|NCT02676765|76099824|FG001|Overall Study|Lost to Follow-up|1|||
42270455|NCT02680041|76099830|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
42004465|NCT01057693|75812460|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
42344620|NCT01933789|76183261|FG004|Overall Study|Death|21|||
42344621|NCT01933789|76183262|FG005|Overall Study|Death|32|||
42344622|NCT01933789|76183263|FG006|Overall Study|Death|0|||
42344623|NCT01933789|76183264|FG007|Overall Study|Death|0|||
42344624|NCT01933789|76183265|FG008|Overall Study|Death|0|||
42344625|NCT01933789|76183257|FG000|Overall Study|Lost to Follow-up|0|||
42270456|NCT02680041|76099830|FG000|Overall Study|Lost to Follow-up|2|||
42270457|NCT02547974|76099839|FG000|Overall Study|Withdrawal by Subject|1|||
42270458|NCT02547974|76099840|FG001|Overall Study|Withdrawal by Subject|0|||
42270459|NCT02547974|76099841|FG002|Overall Study|Withdrawal by Subject|0|||
42344626|NCT01933789|76183258|FG001|Overall Study|Lost to Follow-up|0|||
42344627|NCT01933789|76183259|FG002|Overall Study|Lost to Follow-up|0|||
42344628|NCT01933789|76183260|FG003|Overall Study|Lost to Follow-up|1|||
42344629|NCT01933789|76183261|FG004|Overall Study|Lost to Follow-up|8|||
42344630|NCT01933789|76183262|FG005|Overall Study|Lost to Follow-up|9|||
42344631|NCT01933789|76183263|FG006|Overall Study|Lost to Follow-up|1|||
42344632|NCT01933789|76183264|FG007|Overall Study|Lost to Follow-up|4|||
42344633|NCT01933789|76183265|FG008|Overall Study|Lost to Follow-up|0|||
42344634|NCT01933789|76183257|FG000|Overall Study|Withdrawal by Subject|2|||
42344635|NCT01933789|76183258|FG001|Overall Study|Withdrawal by Subject|1|||
42344636|NCT01933789|76183259|FG002|Overall Study|Withdrawal by Subject|0|||
42344637|NCT01933789|76183260|FG003|Overall Study|Withdrawal by Subject|0|||
42344638|NCT01933789|76183261|FG004|Overall Study|Withdrawal by Subject|17|||
42344639|NCT01933789|76183262|FG005|Overall Study|Withdrawal by Subject|16|||
42270460|NCT02547974|76099842|FG003|Overall Study|Withdrawal by Subject|0|||
42270461|NCT00154297|76099857|FG000|Overall Study|Death|5|||
42270462|NCT00154297|76099858|FG001|Overall Study|Death|2|||
42270463|NCT00154297|76099857|FG000|Overall Study|Withdrawal by Subject|0|||
42270464|NCT00154297|76099858|FG001|Overall Study|Withdrawal by Subject|5|||
42270465|NCT00154297|76099857|FG000|Overall Study|Lost to Follow-up|3|||
42270466|NCT00154297|76099858|FG001|Overall Study|Lost to Follow-up|0|||
42270467|NCT02679729|76099873|FG000|Overall Study|Lost to Follow-up|0|||
42270468|NCT02679729|76099874|FG001|Overall Study|Lost to Follow-up|1|||
42270469|NCT02679729|76099875|FG002|Overall Study|Lost to Follow-up|0|||
42270470|NCT02679729|76099876|FG003|Overall Study|Lost to Follow-up|0|||
42270471|NCT02679729|76099877|FG004|Overall Study|Lost to Follow-up|1|||
42270472|NCT02679729|76099878|FG005|Overall Study|Lost to Follow-up|0|||
42270473|NCT02679729|76099879|FG006|Overall Study|Lost to Follow-up|0|||
42270474|NCT02679729|76099880|FG007|Overall Study|Lost to Follow-up|0|||
42344640|NCT01933789|76183263|FG006|Overall Study|Withdrawal by Subject|1|||
42344641|NCT01933789|76183264|FG007|Overall Study|Withdrawal by Subject|4|||
42344642|NCT01933789|76183265|FG008|Overall Study|Withdrawal by Subject|0|||
42344643|NCT01933789|76183257|FG000|Overall Study|Became Ineligible|4|||
42270475|NCT02679729|76099881|FG008|Overall Study|Lost to Follow-up|0|||
42344644|NCT01933789|76183258|FG001|Overall Study|Became Ineligible|0|||
42344645|NCT01933789|76183259|FG002|Overall Study|Became Ineligible|0|||
42344646|NCT01933789|76183260|FG003|Overall Study|Became Ineligible|0|||
42270476|NCT02679729|76099873|FG000|Overall Study|Participant decision|0|||
42344647|NCT01933789|76183261|FG004|Overall Study|Became Ineligible|13|||
42344648|NCT01933789|76183262|FG005|Overall Study|Became Ineligible|10|||
42270477|NCT02679729|76099874|FG001|Overall Study|Participant decision|1|||
42270478|NCT02679729|76099875|FG002|Overall Study|Participant decision|0|||
42270479|NCT02679729|76099876|FG003|Overall Study|Participant decision|0|||
42270480|NCT02679729|76099877|FG004|Overall Study|Participant decision|0|||
42270481|NCT02679729|76099878|FG005|Overall Study|Participant decision|0|||
42270482|NCT02679729|76099879|FG006|Overall Study|Participant decision|1|||
42270483|NCT02679729|76099880|FG007|Overall Study|Participant decision|0|||
42270484|NCT02679729|76099881|FG008|Overall Study|Participant decision|0|||
42270485|NCT02765165|76099920|FG000|Treatment Period|Progressive disease|3|||
42270486|NCT02765165|76099921|FG001|Treatment Period|Progressive disease|2|||
42270487|NCT02765165|76099922|FG002|Treatment Period|Progressive disease|3|||
42344649|NCT01933789|76183263|FG006|Overall Study|Became Ineligible|13|||
42344650|NCT01933789|76183264|FG007|Overall Study|Became Ineligible|6|||
42344651|NCT01933789|76183265|FG008|Overall Study|Became Ineligible|0|||
42344652|NCT01910389|76183287|FG000|Overall Study|Withdrawal by Subject|2|||
42344653|NCT01910389|76183288|FG001|Overall Study|Withdrawal by Subject|0|||
42344654|NCT01910389|76183287|FG000|Overall Study|Study Closed|13|||
42344655|NCT01910389|76183288|FG001|Overall Study|Study Closed|8|||
42344656|NCT01970995|76183297|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
42344657|NCT01970995|76183298|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
42344658|NCT01970995|76183299|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
42135935|NCT00441090|75946479|FG001|Overall Study|Lack of Efficacy|0|||
42135936|NCT00441090|75946480|FG002|Overall Study|Lack of Efficacy|0|||
42135937|NCT00441090|75946481|FG003|Overall Study|Lack of Efficacy|0|||
42135938|NCT00441090|75946482|FG004|Overall Study|Lack of Efficacy|0|||
42135939|NCT00441012|75946496|FG000|Overall Study|Adverse Event|0|||
42135940|NCT00441012|75946497|FG001|Overall Study|Adverse Event|1|||
42135941|NCT00441012|75946496|FG000|Overall Study|Lost to Follow-up|3|||
42135942|NCT00441012|75946497|FG001|Overall Study|Lost to Follow-up|3|||
42135943|NCT00441012|75946496|FG000|Overall Study|Protocol Violation|10|||
42135944|NCT00441012|75946497|FG001|Overall Study|Protocol Violation|9|||
42135945|NCT00441012|75946496|FG000|Overall Study|Withdrawal by Subject|4|||
42270488|NCT02765165|76099923|FG003|Treatment Period|Progressive disease|3|||
42270489|NCT02765165|76099924|FG004|Treatment Period|Progressive disease|4|||
42270490|NCT02765165|76099925|FG005|Treatment Period|Progressive disease|2|||
42270491|NCT02765165|76099926|FG006|Treatment Period|Progressive disease|2|||
42270492|NCT02765165|76099920|FG000|Treatment Period|Physician Decision|0|||
42270493|NCT02765165|76099921|FG001|Treatment Period|Physician Decision|1|||
42270494|NCT02765165|76099922|FG002|Treatment Period|Physician Decision|0|||
42270495|NCT02765165|76099923|FG003|Treatment Period|Physician Decision|0|||
42270496|NCT02765165|76099924|FG004|Treatment Period|Physician Decision|0|||
42270497|NCT02765165|76099925|FG005|Treatment Period|Physician Decision|0|||
42270498|NCT02765165|76099926|FG006|Treatment Period|Physician Decision|0|||
42270499|NCT02765165|76099920|FG000|Treatment Period|Adverse Event|0|||
42270500|NCT02765165|76099921|FG001|Treatment Period|Adverse Event|1|||
42270501|NCT02765165|76099922|FG002|Treatment Period|Adverse Event|0|||
42270502|NCT02765165|76099923|FG003|Treatment Period|Adverse Event|0|||
42270503|NCT02765165|76099924|FG004|Treatment Period|Adverse Event|0|||
42270504|NCT02765165|76099925|FG005|Treatment Period|Adverse Event|0|||
42270505|NCT02765165|76099926|FG006|Treatment Period|Adverse Event|0|||
42270506|NCT02765165|76099920|FG000|Treatment Period|Withdrawal by Subject|0|||
42270507|NCT02765165|76099921|FG001|Treatment Period|Withdrawal by Subject|0|||
42270508|NCT02765165|76099922|FG002|Treatment Period|Withdrawal by Subject|0|||
42270509|NCT02765165|76099923|FG003|Treatment Period|Withdrawal by Subject|0|||
42270510|NCT02765165|76099924|FG004|Treatment Period|Withdrawal by Subject|2|||
42270511|NCT02765165|76099925|FG005|Treatment Period|Withdrawal by Subject|0|||
42270512|NCT02765165|76099926|FG006|Treatment Period|Withdrawal by Subject|0|||
42135946|NCT00441012|75946497|FG001|Overall Study|Withdrawal by Subject|0|||
42135947|NCT00441012|75946496|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
42135948|NCT00441012|75946497|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
42135949|NCT00286468|75946506|FG000|Overall Study|Hyperglycemic Rescue|28|||
42135950|NCT00286468|75946507|FG001|Overall Study|Hyperglycemic Rescue|30|||
42135951|NCT00286468|75946508|FG002|Overall Study|Hyperglycemic Rescue|31|||
42135952|NCT00286468|75946506|FG000|Overall Study|Adverse Event|2|||
42135953|NCT00286468|75946507|FG001|Overall Study|Adverse Event|6|||
42135954|NCT00286468|75946508|FG002|Overall Study|Adverse Event|4|||
42135955|NCT00286468|75946506|FG000|Overall Study|Protocol Violation|0|||
42135956|NCT00286468|75946507|FG001|Overall Study|Protocol Violation|3|||
42135957|NCT00286468|75946508|FG002|Overall Study|Protocol Violation|1|||
42135958|NCT00286468|75946506|FG000|Overall Study|Lost to Follow-up|1|||
42135959|NCT00286468|75946507|FG001|Overall Study|Lost to Follow-up|1|||
42135960|NCT00286468|75946508|FG002|Overall Study|Lost to Follow-up|2|||
42135961|NCT00286468|75946506|FG000|Overall Study|Withdrawal by Subject|3|||
42135962|NCT00286468|75946507|FG001|Overall Study|Withdrawal by Subject|8|||
42135963|NCT00286468|75946508|FG002|Overall Study|Withdrawal by Subject|11|||
42135964|NCT00286468|75946506|FG000|Overall Study|Physician Decision|3|||
42135965|NCT00286468|75946507|FG001|Overall Study|Physician Decision|2|||
42135966|NCT00286468|75946508|FG002|Overall Study|Physician Decision|1|||
42135967|NCT00507026|75946519|FG000|Overall Study|Lack of Efficacy|6|||
42135968|NCT00507026|75946520|FG001|Overall Study|Lack of Efficacy|4|||
42135969|NCT00507026|75946521|FG002|Overall Study|Lack of Efficacy|21|||
42270513|NCT02765165|76099920|FG000|Treatment Period|Study terminated|0|||
42270514|NCT02765165|76099921|FG001|Treatment Period|Study terminated|0|||
42344659|NCT01970995|76183297|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
42135970|NCT00507026|75946519|FG000|Overall Study|Withdrawal by Subject|2|||
42135971|NCT00507026|75946520|FG001|Overall Study|Withdrawal by Subject|0|||
42135972|NCT00507026|75946521|FG002|Overall Study|Withdrawal by Subject|0|||
42135973|NCT00507026|75946519|FG000|Overall Study|Investigator Decision|1|||
42344660|NCT01970995|76183298|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
42344661|NCT01970995|76183299|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
42344662|NCT01970527|76183309|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
42344663|NCT01970527|76183310|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
42344664|NCT01970527|76183309|FG000|Treatment|Disease progression|0|||
42344665|NCT01970527|76183310|FG001|Treatment|Disease progression|1|||
42344666|NCT01970527|76183309|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
42344667|NCT01970527|76183310|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
42344668|NCT01970527|76183309|FG000|Treatment|Death|0|||
42344669|NCT01970527|76183310|FG001|Treatment|Death|1|||
42344670|NCT01970527|76183309|FG000|Follow-up Clinic Visit|Disease progression|1|||
42344671|NCT01970527|76183310|FG001|Follow-up Clinic Visit|Disease progression|1|||
42344672|NCT01970527|76183309|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
42344673|NCT01970527|76183310|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
42344674|NCT01970527|76183309|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
42344675|NCT01970527|76183310|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
42344676|NCT01931995|76183321|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
42344677|NCT01931995|76183322|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
42344678|NCT01931995|76183321|FG000|First Intervention (1 Day)|Physician Decision|1|||
42344679|NCT01931995|76183322|FG001|First Intervention (1 Day)|Physician Decision|1|||
42344680|NCT01931995|76183321|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
42344681|NCT01931995|76183322|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
42344682|NCT01408576|76183331|FG000|Overall Study|Lack of Efficacy|17|||
42344683|NCT01408576|76183332|FG001|Overall Study|Lack of Efficacy|30|||
42344684|NCT01408576|76183333|FG002|Overall Study|Lack of Efficacy|48|||
42344685|NCT01408576|76183331|FG000|Overall Study|Protocol Violation|1|||
42344686|NCT01408576|76183332|FG001|Overall Study|Protocol Violation|2|||
42344687|NCT01408576|76183333|FG002|Overall Study|Protocol Violation|2|||
42344688|NCT01408576|76183331|FG000|Overall Study|Lost to Follow-up|10|||
42344689|NCT01408576|76183332|FG001|Overall Study|Lost to Follow-up|9|||
42344690|NCT01408576|76183333|FG002|Overall Study|Lost to Follow-up|17|||
42344691|NCT01408576|76183331|FG000|Overall Study|Withdrawal by Subject|34|||
42344692|NCT01408576|76183332|FG001|Overall Study|Withdrawal by Subject|60|||
42035191|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
42035192|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
42035193|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
42035194|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
42135974|NCT00507026|75946520|FG001|Overall Study|Investigator Decision|0|||
42135975|NCT00507026|75946521|FG002|Overall Study|Investigator Decision|0|||
42135976|NCT00507026|75946519|FG000|Overall Study|Adverse Event|2|||
42135977|NCT00507026|75946520|FG001|Overall Study|Adverse Event|0|||
42135978|NCT00507026|75946521|FG002|Overall Study|Adverse Event|0|||
42135979|NCT00507026|75946519|FG000|Overall Study|Protocol Violation|1|||
42135980|NCT00507026|75946520|FG001|Overall Study|Protocol Violation|0|||
42135981|NCT00507026|75946521|FG002|Overall Study|Protocol Violation|0|||
42135982|NCT00507026|75946519|FG000|Overall Study|Other|1|||
42135983|NCT00507026|75946520|FG001|Overall Study|Other|0|||
42135984|NCT00507026|75946521|FG002|Overall Study|Other|0|||
42344693|NCT01408576|76183333|FG002|Overall Study|Withdrawal by Subject|66|||
42344694|NCT01408576|76183331|FG000|Overall Study|Sponsor terminated study|89|||
42344695|NCT01408576|76183332|FG001|Overall Study|Sponsor terminated study|333|||
42344696|NCT01408576|76183333|FG002|Overall Study|Sponsor terminated study|330|||
42344697|NCT01408576|76183331|FG000|Overall Study|AE, serious fatal|4|||
42344698|NCT01408576|76183332|FG001|Overall Study|AE, serious fatal|4|||
42344699|NCT01408576|76183333|FG002|Overall Study|AE, serious fatal|1|||
42344700|NCT01408576|76183331|FG000|Overall Study|SAE, non-fatal|11|||
42344701|NCT01408576|76183332|FG001|Overall Study|SAE, non-fatal|23|||
42344702|NCT01408576|76183333|FG002|Overall Study|SAE, non-fatal|14|||
42344703|NCT01408576|76183331|FG000|Overall Study|AE, non-serious non-fatal|12|||
42344704|NCT01408576|76183332|FG001|Overall Study|AE, non-serious non-fatal|19|||
42344705|NCT01408576|76183333|FG002|Overall Study|AE, non-serious non-fatal|11|||
42344706|NCT01408576|76183331|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
42344707|NCT01408576|76183332|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
42135985|NCT00446550|75946531|FG000|Overall Study|Adverse Event|1|||
42135986|NCT00446550|75946532|FG001|Overall Study|Adverse Event|0|||
42135987|NCT03847974|75946539|FG000|Overall Study|relocated out of region|3|||
42135988|NCT03847974|75946539|FG000|Overall Study|Withdrawal by Subject|2|||
42135989|NCT03847974|75946539|FG000|Overall Study|Adverse Event|1|||
42135990|NCT03976102|75946545|FG000|Overall Study|Withdrawal by Subject|4|||
42135991|NCT03976102|75946546|FG001|Overall Study|Withdrawal by Subject|4|||
42135992|NCT03976102|75946545|FG000|Overall Study|Adverse Event|2|||
42135993|NCT03976102|75946546|FG001|Overall Study|Adverse Event|4|||
42135994|NCT03976102|75946545|FG000|Overall Study|Not related to Covid-19|9|||
42135995|NCT03976102|75946546|FG001|Overall Study|Not related to Covid-19|13|||
42135996|NCT03976102|75946545|FG000|Overall Study|Lost to Follow-up|0|||
42135997|NCT03976102|75946546|FG001|Overall Study|Lost to Follow-up|2|||
42135998|NCT03976102|75946545|FG000|Overall Study|Death|3|||
42135999|NCT03976102|75946546|FG001|Overall Study|Death|2|||
42136000|NCT03976102|75946545|FG000|Overall Study|Physician Decision|1|||
42136001|NCT03976102|75946546|FG001|Overall Study|Physician Decision|1|||
42136002|NCT00506948|75946555|FG000|Overall Study|Death|4|||
42136003|NCT00506948|75946555|FG000|Overall Study|Adverse Event|5|||
42136004|NCT00506948|75946555|FG000|Overall Study|Physician Decision|1|||
42136005|NCT00286234|75946563|FG000|Overall Study|Protocol Violation|1|||
42344708|NCT01408576|76183333|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
42344709|NCT01408576|76183331|FG000|Overall Study|AE, unknown type|0|||
42136006|NCT00286234|75946564|FG001|Overall Study|Protocol Violation|2|||
42136007|NCT00286234|75946565|FG002|Overall Study|Protocol Violation|0|||
42136008|NCT00286234|75946566|FG003|Overall Study|Protocol Violation|1|||
42136009|NCT00286234|75946563|FG000|Overall Study|Physician Decision|1|||
42136010|NCT00286234|75946564|FG001|Overall Study|Physician Decision|0|||
42344710|NCT01408576|76183332|FG001|Overall Study|AE, unknown type|1|||
42344711|NCT01408576|76183333|FG002|Overall Study|AE, unknown type|0|||
42136011|NCT00286234|75946565|FG002|Overall Study|Physician Decision|0|||
42344712|NCT01408576|76183331|FG000|Overall Study|Other|10|||
42344713|NCT01408576|76183332|FG001|Overall Study|Other|16|||
42344714|NCT01408576|76183333|FG002|Overall Study|Other|18|||
42344715|NCT01427920|76183355|FG000|Overall Study|Adverse Event|1|||
42344716|NCT01427920|76183356|FG001|Overall Study|Adverse Event|2|||
42344717|NCT01427920|76183355|FG000|Overall Study|Lack of Efficacy|1|||
42136012|NCT00286234|75946566|FG003|Overall Study|Physician Decision|1|||
42344718|NCT01427920|76183356|FG001|Overall Study|Lack of Efficacy|0|||
42344719|NCT01427920|76183355|FG000|Overall Study|Protocol Violation|1|||
42344720|NCT01427920|76183356|FG001|Overall Study|Protocol Violation|3|||
42344721|NCT01427920|76183355|FG000|Overall Study|Withdrawal Criteria|4|||
42344722|NCT01427920|76183356|FG001|Overall Study|Withdrawal Criteria|4|||
42344723|NCT01427920|76183355|FG000|Overall Study|Unclassified|2|||
42344724|NCT01427920|76183356|FG001|Overall Study|Unclassified|8|||
42344725|NCT01427608|76183364|FG000|Overall Study|Death|1|||
42344726|NCT01427608|76183365|FG001|Overall Study|Death|0|||
42344727|NCT01427608|76183364|FG000|Overall Study|Withdrawal by Subject|7|||
42344728|NCT01427608|76183365|FG001|Overall Study|Withdrawal by Subject|3|||
42344729|NCT01427608|76183364|FG000|Overall Study|Relapsed-all cause|13|||
42344730|NCT01427608|76183365|FG001|Overall Study|Relapsed-all cause|34|||
42344731|NCT01427608|76183364|FG000|Overall Study|Events not attributed to study meds|0|||
42344732|NCT01427608|76183365|FG001|Overall Study|Events not attributed to study meds|1|||
42344733|NCT01408030|76183377|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
42344734|NCT01408030|76183378|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
42344735|NCT01408030|76183379|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
42136013|NCT00286234|75946563|FG000|Overall Study|Adverse Event|0|||
42136014|NCT00286234|75946564|FG001|Overall Study|Adverse Event|0|||
42136015|NCT00286234|75946565|FG002|Overall Study|Adverse Event|0|||
42136016|NCT00286234|75946566|FG003|Overall Study|Adverse Event|1|||
42270515|NCT02765165|76099922|FG002|Treatment Period|Study terminated|0|||
42270516|NCT02765165|76099923|FG003|Treatment Period|Study terminated|0|||
42270517|NCT02765165|76099924|FG004|Treatment Period|Study terminated|0|||
42270518|NCT02765165|76099925|FG005|Treatment Period|Study terminated|1|||
42270519|NCT02765165|76099926|FG006|Treatment Period|Study terminated|2|||
42270520|NCT02765165|76099920|FG000|Post-treatment Follow-up|Death|1|||
42270521|NCT02765165|76099921|FG001|Post-treatment Follow-up|Death|2|||
42270522|NCT02765165|76099922|FG002|Post-treatment Follow-up|Death|1|||
42270523|NCT02765165|76099923|FG003|Post-treatment Follow-up|Death|1|||
42270524|NCT02765165|76099924|FG004|Post-treatment Follow-up|Death|1|||
42270525|NCT02765165|76099925|FG005|Post-treatment Follow-up|Death|1|||
42270526|NCT02765165|76099926|FG006|Post-treatment Follow-up|Death|0|||
42270527|NCT02765165|76099920|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
42270528|NCT02765165|76099921|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
42270529|NCT02765165|76099922|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
42270530|NCT02765165|76099923|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
42270531|NCT02765165|76099924|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
42270532|NCT02765165|76099925|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
42270533|NCT02765165|76099926|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
42344736|NCT01408030|76183380|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
42136017|NCT00286234|75946563|FG000|Overall Study|Adverse Event|0|||
42136018|NCT00286234|75946564|FG001|Overall Study|Adverse Event|0|||
42270534|NCT02765165|76099920|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
42344737|NCT01408030|76183377|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
42344738|NCT01408030|76183378|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
42136019|NCT00286234|75946565|FG002|Overall Study|Adverse Event|0|||
42270535|NCT02765165|76099921|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
42270536|NCT02765165|76099922|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
42270537|NCT02765165|76099923|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
42270538|NCT02765165|76099924|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
42270539|NCT02765165|76099925|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
42270540|NCT02765165|76099926|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
42270541|NCT02765165|76099920|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
42344739|NCT01408030|76183379|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
42344740|NCT01408030|76183380|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
42344741|NCT01408030|76183377|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
42344742|NCT01408030|76183378|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
42344743|NCT01408030|76183379|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
42344744|NCT01408030|76183380|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
42344745|NCT01408030|76183377|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
42344746|NCT01408030|76183378|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
42344747|NCT01408030|76183379|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
42344748|NCT01408030|76183380|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
42344749|NCT01408030|76183377|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
42344750|NCT01408030|76183378|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
42136020|NCT00286234|75946566|FG003|Overall Study|Adverse Event|1|||
42344751|NCT01408030|76183379|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
42344752|NCT01408030|76183380|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
42344753|NCT01408030|76183377|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
42344754|NCT01408030|76183378|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
42344755|NCT01408030|76183379|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
42344756|NCT01408030|76183380|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
42136021|NCT00445848|75946576|FG000|Overall Study|Adverse Event|14|||
42136022|NCT00445848|75946576|FG000|Overall Study|Withdrawal by Subject|4|||
42136023|NCT00445848|75946576|FG000|Overall Study|Progression|62|||
42136024|NCT00445848|75946576|FG000|Overall Study|Other-Not protocol specified|5|||
42344757|NCT01408030|76183377|FG000|Observation Phase (Off Drug)|Other|1|||
42136025|NCT00286156|75946583|FG000|Overall Study|Missed 12 month visit|0|||
42136026|NCT00286156|75946584|FG001|Overall Study|Missed 12 month visit|0|||
42344758|NCT01408030|76183378|FG001|Observation Phase (Off Drug)|Other|1|||
42344759|NCT01408030|76183379|FG002|Observation Phase (Off Drug)|Other|1|||
42344760|NCT01408030|76183380|FG003|Observation Phase (Off Drug)|Other|1|||
42344761|NCT01897532|76183392|FG000|Discontinuation From Treatment|Not Treated|7|||
42344762|NCT01897532|76183393|FG001|Discontinuation From Treatment|Not Treated|5|||
42344763|NCT01897532|76183392|FG000|Discontinuation From Treatment|Other reason than specified|196|||
42344764|NCT01897532|76183393|FG001|Discontinuation From Treatment|Other reason than specified|176|||
42344765|NCT01897532|76183392|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
42344766|NCT01897532|76183393|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
42344767|NCT01897532|76183392|FG000|Discontinuation From Treatment|Non compliance|24|||
42344768|NCT01897532|76183393|FG001|Discontinuation From Treatment|Non compliance|15|||
42344769|NCT01897532|76183392|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
42344770|NCT01897532|76183393|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
42344771|NCT01897532|76183392|FG000|Discontinuation From Trial|Not Treated|7|||
42344772|NCT01897532|76183393|FG001|Discontinuation From Trial|Not Treated|5|||
42344773|NCT01897532|76183392|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
42344774|NCT01897532|76183393|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
42344775|NCT01923428|76183403|FG000|Overall Study|Adverse Event|8|||
42344776|NCT01923428|76183404|FG001|Overall Study|Adverse Event|6|||
42344777|NCT01923428|76183405|FG002|Overall Study|Adverse Event|3|||
42344778|NCT01923428|76183406|FG003|Overall Study|Adverse Event|3|||
42344779|NCT01923428|76183403|FG000|Overall Study|Withdrawal by Subject|5|||
42344780|NCT01923428|76183404|FG001|Overall Study|Withdrawal by Subject|3|||
42344781|NCT01923428|76183405|FG002|Overall Study|Withdrawal by Subject|0|||
42344782|NCT01923428|76183406|FG003|Overall Study|Withdrawal by Subject|4|||
42344783|NCT01923428|76183403|FG000|Overall Study|Lost to Follow-up|2|||
42344784|NCT01923428|76183404|FG001|Overall Study|Lost to Follow-up|1|||
42344785|NCT01923428|76183405|FG002|Overall Study|Lost to Follow-up|5|||
42344786|NCT01923428|76183406|FG003|Overall Study|Lost to Follow-up|0|||
42344787|NCT01923428|76183403|FG000|Overall Study|Protocol Violation|3|||
42344788|NCT01923428|76183404|FG001|Overall Study|Protocol Violation|0|||
42344789|NCT01923428|76183405|FG002|Overall Study|Protocol Violation|2|||
42344790|NCT01923428|76183406|FG003|Overall Study|Protocol Violation|1|||
42344791|NCT01923428|76183403|FG000|Overall Study|Non Compliance to treatment|1|||
42344792|NCT01923428|76183404|FG001|Overall Study|Non Compliance to treatment|2|||
42344793|NCT01923428|76183405|FG002|Overall Study|Non Compliance to treatment|0|||
42344794|NCT01923428|76183406|FG003|Overall Study|Non Compliance to treatment|1|||
42344795|NCT01923428|76183403|FG000|Overall Study|Lack of Efficacy|0|||
42344796|NCT01923428|76183404|FG001|Overall Study|Lack of Efficacy|0|||
42344797|NCT01923428|76183405|FG002|Overall Study|Lack of Efficacy|1|||
42344798|NCT01923428|76183406|FG003|Overall Study|Lack of Efficacy|1|||
42344799|NCT01896986|76183418|FG000|Overall Study|samples lost|14|||
42344800|NCT01896986|76183419|FG001|Overall Study|samples lost|23|||
42344801|NCT01896128|76183427|FG000|Overall Study|Withdrawal by Subject|3|||
42344802|NCT01896128|76183428|FG001|Overall Study|Withdrawal by Subject|3|||
42344803|NCT01949870|76183434|FG000|Overall Study|Lack of Efficacy|2|||
42344804|NCT01949870|76183434|FG000|Overall Study|Adverse Event|1|||
42344805|NCT01949870|76183434|FG000|Overall Study|Study termination|1|||
42344806|NCT01949870|76183434|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
42344807|NCT01949480|76183440|FG000|Overall Study|Physician Decision|5|||
42344808|NCT01949480|76183441|FG001|Overall Study|Physician Decision|8|||
42344809|NCT01949090|76183452|FG000|Overall Study|Serious Adverse Event|0|||
42344810|NCT01949090|76183453|FG001|Overall Study|Serious Adverse Event|1|||
42344811|NCT01949090|76183454|FG002|Overall Study|Serious Adverse Event|2|||
42344812|NCT01949090|76183455|FG003|Overall Study|Serious Adverse Event|0|||
42344813|NCT01949090|76183456|FG004|Overall Study|Serious Adverse Event|1|||
42344814|NCT01949090|76183452|FG000|Overall Study|Withdrawal by Subject|2|||
42344815|NCT01949090|76183453|FG001|Overall Study|Withdrawal by Subject|0|||
42344816|NCT01949090|76183454|FG002|Overall Study|Withdrawal by Subject|0|||
42344817|NCT01949090|76183455|FG003|Overall Study|Withdrawal by Subject|0|||
42344818|NCT01949090|76183456|FG004|Overall Study|Withdrawal by Subject|1|||
42344819|NCT01949090|76183452|FG000|Overall Study|Protocol non-compliance|0|||
42344820|NCT01949090|76183453|FG001|Overall Study|Protocol non-compliance|0|||
42344821|NCT01949090|76183454|FG002|Overall Study|Protocol non-compliance|0|||
42344822|NCT01949090|76183455|FG003|Overall Study|Protocol non-compliance|0|||
42344823|NCT01949090|76183456|FG004|Overall Study|Protocol non-compliance|1|||
42344824|NCT01949090|76183452|FG000|Overall Study|Lost to Follow-up|2|||
42344825|NCT01949090|76183453|FG001|Overall Study|Lost to Follow-up|1|||
42136027|NCT00286156|75946585|FG002|Overall Study|Missed 12 month visit|1|||
42136028|NCT00286156|75946583|FG000|Overall Study|AE: pulmonary embolus|0|||
42136029|NCT00286156|75946584|FG001|Overall Study|AE: pulmonary embolus|1|||
42136030|NCT00286156|75946585|FG002|Overall Study|AE: pulmonary embolus|0|||
42136031|NCT00286156|75946583|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
42136032|NCT00286156|75946584|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
42136033|NCT00286156|75946585|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
42136034|NCT00286156|75946583|FG000|Overall Study|AE: pneumonia|1|||
42344826|NCT01949090|76183454|FG002|Overall Study|Lost to Follow-up|0|||
42344827|NCT01949090|76183455|FG003|Overall Study|Lost to Follow-up|1|||
42344828|NCT01949090|76183456|FG004|Overall Study|Lost to Follow-up|1|||
42344829|NCT01948076|76183471|FG000|Overall Study|Withdrawal by Subject|0|||
42344830|NCT01948076|76183472|FG001|Overall Study|Withdrawal by Subject|1|||
42344831|NCT01922258|76183482|FG000|Overall Study|Lost to Follow-up|1|||
42344832|NCT01922258|76183483|FG001|Overall Study|Lost to Follow-up|1|||
42344833|NCT01922258|76183482|FG000|Overall Study|Adverse Event|9|||
42344834|NCT01922258|76183483|FG001|Overall Study|Adverse Event|2|||
42344835|NCT01922258|76183482|FG000|Overall Study|Met Withdrawal Criteria|0|||
42344836|NCT01922258|76183483|FG001|Overall Study|Met Withdrawal Criteria|4|||
42344837|NCT01922258|76183482|FG000|Overall Study|Withdrawn by the Investigator|1|||
42344838|NCT01922258|76183483|FG001|Overall Study|Withdrawn by the Investigator|4|||
42344839|NCT01922258|76183482|FG000|Overall Study|Withdrawal by participant|5|||
42344840|NCT01922258|76183483|FG001|Overall Study|Withdrawal by participant|5|||
42344841|NCT01406938|76183491|FG000|Induction Period|Subject/guardian decision|6|||
42344842|NCT01406938|76183492|FG001|Induction Period|Subject/guardian decision|8|||
42344843|NCT01406938|76183493|FG002|Induction Period|Subject/guardian decision|0|||
42344844|NCT01406938|76183494|FG003|Induction Period|Subject/guardian decision|0|||
42344845|NCT01406938|76183495|FG004|Induction Period|Subject/guardian decision|0|||
42344846|NCT01406938|76183496|FG005|Induction Period|Subject/guardian decision|0|||
42344847|NCT01406938|76183491|FG000|Induction Period|Protocol deviation|1|||
42136035|NCT00286156|75946584|FG001|Overall Study|AE: pneumonia|0|||
42344848|NCT01406938|76183492|FG001|Induction Period|Protocol deviation|0|||
42344849|NCT01406938|76183493|FG002|Induction Period|Protocol deviation|0|||
42344850|NCT01406938|76183494|FG003|Induction Period|Protocol deviation|0|||
42344851|NCT01406938|76183495|FG004|Induction Period|Protocol deviation|0|||
42344852|NCT01406938|76183496|FG005|Induction Period|Protocol deviation|0|||
42344853|NCT01406938|76183491|FG000|Induction Period|Adverse Event|8|||
42344854|NCT01406938|76183492|FG001|Induction Period|Adverse Event|9|||
42344855|NCT01406938|76183493|FG002|Induction Period|Adverse Event|0|||
42136036|NCT00286156|75946585|FG002|Overall Study|AE: pneumonia|0|||
42344856|NCT01406938|76183494|FG003|Induction Period|Adverse Event|0|||
42344857|NCT01406938|76183495|FG004|Induction Period|Adverse Event|0|||
42344858|NCT01406938|76183496|FG005|Induction Period|Adverse Event|0|||
42344859|NCT01406938|76183491|FG000|Induction Period|Lack of Efficacy|1|||
42344860|NCT01406938|76183492|FG001|Induction Period|Lack of Efficacy|0|||
42344861|NCT01406938|76183493|FG002|Induction Period|Lack of Efficacy|0|||
42344862|NCT01406938|76183494|FG003|Induction Period|Lack of Efficacy|0|||
42344863|NCT01406938|76183495|FG004|Induction Period|Lack of Efficacy|0|||
42344864|NCT01406938|76183496|FG005|Induction Period|Lack of Efficacy|0|||
42270542|NCT02765165|76099921|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
42270543|NCT02765165|76099922|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
42270544|NCT02765165|76099923|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
42270545|NCT02765165|76099924|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
42270546|NCT02765165|76099925|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
42270547|NCT02765165|76099926|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
42344865|NCT01406938|76183491|FG000|Induction Period|Lost to Follow-up|2|||
42344866|NCT01406938|76183492|FG001|Induction Period|Lost to Follow-up|3|||
42344867|NCT01406938|76183493|FG002|Induction Period|Lost to Follow-up|0|||
42344868|NCT01406938|76183494|FG003|Induction Period|Lost to Follow-up|0|||
42344869|NCT01406938|76183495|FG004|Induction Period|Lost to Follow-up|0|||
42344870|NCT01406938|76183496|FG005|Induction Period|Lost to Follow-up|0|||
42344871|NCT01406938|76183491|FG000|Maintenance Period|Adverse Event|0|||
42344872|NCT01406938|76183492|FG001|Maintenance Period|Adverse Event|0|||
42344873|NCT01406938|76183493|FG002|Maintenance Period|Adverse Event|2|||
42270548|NCT02765165|76099920|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
42270549|NCT02765165|76099921|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
42270550|NCT02765165|76099922|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
42270551|NCT02765165|76099923|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
42270552|NCT02765165|76099924|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
42270553|NCT02765165|76099925|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
42270554|NCT02765165|76099926|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
42270555|NCT02765165|76099920|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
42270556|NCT02765165|76099921|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
42270557|NCT02765165|76099922|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
42270558|NCT02765165|76099923|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
42270559|NCT02765165|76099924|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
42270560|NCT02765165|76099925|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
42270561|NCT02765165|76099926|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
42270562|NCT02675907|76099948|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
42270563|NCT02675907|76099949|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
42270564|NCT02675907|76099948|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
42344874|NCT01406938|76183494|FG003|Maintenance Period|Adverse Event|8|||
42344875|NCT01406938|76183495|FG004|Maintenance Period|Adverse Event|4|||
42344876|NCT01406938|76183496|FG005|Maintenance Period|Adverse Event|2|||
42344877|NCT01406938|76183491|FG000|Maintenance Period|Death|0|||
42004466|NCT01057693|75812458|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
42270565|NCT02675907|76099949|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
42344878|NCT01406938|76183492|FG001|Maintenance Period|Death|0|||
42344879|NCT01406938|76183493|FG002|Maintenance Period|Death|0|||
42270566|NCT02675907|76099948|FG000|Study Overall|Lack of Efficacy|1|||
42270567|NCT02675907|76099949|FG001|Study Overall|Lack of Efficacy|0|||
42344880|NCT01406938|76183494|FG003|Maintenance Period|Death|0|||
42344881|NCT01406938|76183495|FG004|Maintenance Period|Death|1|||
42344882|NCT01406938|76183496|FG005|Maintenance Period|Death|0|||
42270568|NCT02675907|76099948|FG000|Study Overall|Withdrawal by Subject|2|||
42344883|NCT01406938|76183491|FG000|Maintenance Period|Subject/guardian decision|0|||
42344884|NCT01406938|76183492|FG001|Maintenance Period|Subject/guardian decision|0|||
42344885|NCT01406938|76183493|FG002|Maintenance Period|Subject/guardian decision|11|||
42344886|NCT01406938|76183494|FG003|Maintenance Period|Subject/guardian decision|7|||
42344887|NCT01406938|76183495|FG004|Maintenance Period|Subject/guardian decision|10|||
42344888|NCT01406938|76183496|FG005|Maintenance Period|Subject/guardian decision|7|||
42344889|NCT01406938|76183491|FG000|Maintenance Period|Protocol Violation|0|||
42344890|NCT01406938|76183492|FG001|Maintenance Period|Protocol Violation|0|||
42344891|NCT01406938|76183493|FG002|Maintenance Period|Protocol Violation|2|||
42344892|NCT01406938|76183494|FG003|Maintenance Period|Protocol Violation|2|||
42344893|NCT01406938|76183495|FG004|Maintenance Period|Protocol Violation|2|||
42344894|NCT01406938|76183496|FG005|Maintenance Period|Protocol Violation|2|||
42344895|NCT01406938|76183491|FG000|Maintenance Period|Pregnancy|0|||
42344896|NCT01406938|76183492|FG001|Maintenance Period|Pregnancy|0|||
42344897|NCT01406938|76183493|FG002|Maintenance Period|Pregnancy|0|||
42344898|NCT01406938|76183494|FG003|Maintenance Period|Pregnancy|0|||
42344899|NCT01406938|76183495|FG004|Maintenance Period|Pregnancy|1|||
42344900|NCT01406938|76183496|FG005|Maintenance Period|Pregnancy|0|||
42344901|NCT01406938|76183491|FG000|Maintenance Period|Lost to Follow-up|0|||
42344902|NCT01406938|76183492|FG001|Maintenance Period|Lost to Follow-up|0|||
42344903|NCT01406938|76183493|FG002|Maintenance Period|Lost to Follow-up|0|||
42344904|NCT01406938|76183494|FG003|Maintenance Period|Lost to Follow-up|0|||
42344905|NCT01406938|76183495|FG004|Maintenance Period|Lost to Follow-up|4|||
42344906|NCT01406938|76183496|FG005|Maintenance Period|Lost to Follow-up|0|||
42344907|NCT01406938|76183491|FG000|Maintenance Period|Lack of Efficacy|0|||
42344908|NCT01406938|76183492|FG001|Maintenance Period|Lack of Efficacy|0|||
42344909|NCT01406938|76183493|FG002|Maintenance Period|Lack of Efficacy|2|||
42344910|NCT01406938|76183494|FG003|Maintenance Period|Lack of Efficacy|1|||
42344911|NCT01406938|76183495|FG004|Maintenance Period|Lack of Efficacy|3|||
42344912|NCT01406938|76183496|FG005|Maintenance Period|Lack of Efficacy|5|||
42344913|NCT01406938|76183491|FG000|Follow up|Lack of Efficacy|3|||
42344914|NCT01406938|76183492|FG001|Follow up|Lack of Efficacy|2|||
42344915|NCT01406938|76183493|FG002|Follow up|Lack of Efficacy|1|||
42344916|NCT01406938|76183494|FG003|Follow up|Lack of Efficacy|0|||
42344917|NCT01406938|76183495|FG004|Follow up|Lack of Efficacy|0|||
42344918|NCT01406938|76183496|FG005|Follow up|Lack of Efficacy|0|||
42344919|NCT01406938|76183491|FG000|Follow up|Patient/guardian decision|4|||
42344920|NCT01406938|76183492|FG001|Follow up|Patient/guardian decision|2|||
42344921|NCT01406938|76183493|FG002|Follow up|Patient/guardian decision|4|||
42344922|NCT01406938|76183494|FG003|Follow up|Patient/guardian decision|2|||
42344923|NCT01406938|76183495|FG004|Follow up|Patient/guardian decision|4|||
42344924|NCT01406938|76183496|FG005|Follow up|Patient/guardian decision|1|||
42344925|NCT01406938|76183491|FG000|Follow up|Protocol Violation|0|||
42344926|NCT01406938|76183492|FG001|Follow up|Protocol Violation|0|||
42344927|NCT01406938|76183493|FG002|Follow up|Protocol Violation|1|||
42004467|NCT01057693|75812459|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
42136037|NCT00455520|75946595|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
42004468|NCT01057693|75812460|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
42004469|NCT01057693|75812458|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
42344928|NCT01406938|76183494|FG003|Follow up|Protocol Violation|0|||
42344929|NCT01406938|76183495|FG004|Follow up|Protocol Violation|0|||
42344930|NCT01406938|76183496|FG005|Follow up|Protocol Violation|0|||
42344931|NCT01406938|76183491|FG000|Follow up|Physician Decision|0|||
42344932|NCT01406938|76183492|FG001|Follow up|Physician Decision|0|||
42344933|NCT01406938|76183493|FG002|Follow up|Physician Decision|2|||
42344934|NCT01406938|76183494|FG003|Follow up|Physician Decision|0|||
42344935|NCT01406938|76183495|FG004|Follow up|Physician Decision|3|||
42004470|NCT01057693|75812459|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
42004471|NCT01057693|75812460|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
42004472|NCT01307501|75812468|FG000|Overall Study|Treatment Failure|1|||
42004473|NCT01307501|75812468|FG000|Overall Study|Death|20|||
42004474|NCT01307501|75812468|FG000|Overall Study|Lost to Follow-up|1|||
42004475|NCT01307501|75812468|FG000|Overall Study|Starting Hospice|1|||
42004476|NCT01034137|75812475|FG000|Overall Study|Adverse Event|9|||
42004477|NCT01034137|75812476|FG001|Overall Study|Adverse Event|10|||
42004478|NCT01034137|75812477|FG002|Overall Study|Adverse Event|8|||
42004479|NCT01034137|75812475|FG000|Overall Study|Withdrawal by Subject|4|||
42004480|NCT01034137|75812476|FG001|Overall Study|Withdrawal by Subject|3|||
42270569|NCT02675907|76099949|FG001|Study Overall|Withdrawal by Subject|2|||
42270570|NCT02675907|76099948|FG000|Study Overall|Lost to Follow-up|0|||
42270571|NCT02675907|76099949|FG001|Study Overall|Lost to Follow-up|2|||
42270572|NCT02675517|76099955|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
42270573|NCT02675517|76099955|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
42270574|NCT02764775|76099959|FG000|Overall Study|Death|1|||
42270575|NCT02764775|76099959|FG000|Overall Study|Lost to Follow-up|2|||
42270576|NCT02764775|76099959|FG000|Overall Study|Withdrawal by Subject|3|||
42270577|NCT02774681|76099963|FG000|Treatment on Study|Progressive Disease|7|||
42004481|NCT01034137|75812477|FG002|Overall Study|Withdrawal by Subject|3|||
42004482|NCT01034137|75812475|FG000|Overall Study|Lack of Efficacy|9|||
42004483|NCT01034137|75812476|FG001|Overall Study|Lack of Efficacy|4|||
42004484|NCT01034137|75812477|FG002|Overall Study|Lack of Efficacy|13|||
42035195|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
42035196|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
42035197|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
42136038|NCT00455520|75946596|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
42136039|NCT00455520|75946595|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
42136040|NCT00455520|75946596|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
42136041|NCT00455520|75946595|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
42136042|NCT00455520|75946596|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
42136043|NCT00455520|75946595|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
42136044|NCT00455520|75946596|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
42136045|NCT00455520|75946595|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
42136046|NCT00455520|75946596|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
42136047|NCT00455520|75946595|FG000|Open Label Tapentadol Extended Release|All other|33|||
42136048|NCT00455520|75946596|FG001|Open Label Tapentadol Extended Release|All other|0|||
42136049|NCT00455520|75946595|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
42136050|NCT00455520|75946596|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
42136051|NCT00455520|75946595|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
42136052|NCT00455520|75946596|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
42136053|NCT00455520|75946595|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
42136054|NCT00455520|75946596|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
42136055|NCT00455520|75946595|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
42136056|NCT00455520|75946596|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
42136057|NCT00455520|75946595|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
42136058|NCT00455520|75946596|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
42136059|NCT00455520|75946595|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
42136060|NCT00455520|75946596|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
42136061|NCT00440700|75946605|FG000|Overall Study|Withdrawal by Subject|8|||
42136062|NCT00440700|75946606|FG001|Overall Study|Withdrawal by Subject|8|||
42270578|NCT02774681|76099963|FG000|Follow-Up for 3 Years|Death|11|||
42270579|NCT02774681|76099963|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
42004485|NCT01034137|75812475|FG000|Overall Study|Protocol Violation|2|||
42004486|NCT01034137|75812476|FG001|Overall Study|Protocol Violation|2|||
42004487|NCT01034137|75812477|FG002|Overall Study|Protocol Violation|1|||
42004488|NCT01034137|75812475|FG000|Overall Study|Refused treatment or did not cooperate|2|||
42004489|NCT01034137|75812476|FG001|Overall Study|Refused treatment or did not cooperate|0|||
42004490|NCT01034137|75812477|FG002|Overall Study|Refused treatment or did not cooperate|1|||
42004491|NCT01034137|75812475|FG000|Overall Study|Administrative or other|2|||
42004492|NCT01034137|75812476|FG001|Overall Study|Administrative or other|3|||
42004493|NCT01034137|75812477|FG002|Overall Study|Administrative or other|4|||
42004494|NCT01056289|75812486|FG000|Open-label Phase|Adverse Event|29|||
42004495|NCT01056289|75812487|FG001|Open-label Phase|Adverse Event|0|||
42004496|NCT01056289|75812488|FG002|Open-label Phase|Adverse Event|0|||
42004497|NCT01056289|75812489|FG003|Open-label Phase|Adverse Event|0|||
42136063|NCT00440700|75946607|FG002|Overall Study|Withdrawal by Subject|4|||
42270580|NCT02547428|76099969|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
42270581|NCT02547428|76099970|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
42270582|NCT02547428|76099969|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
42270583|NCT02547428|76099970|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
42270584|NCT02547428|76099969|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
42270585|NCT02547428|76099970|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
42270586|NCT02547428|76099969|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
42270587|NCT02547428|76099970|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
42270588|NCT02547428|76099969|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
42270589|NCT02547428|76099970|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
42270590|NCT02547428|76099969|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
42004498|NCT01056289|75812486|FG000|Open-label Phase|Lost to Follow-up|30|||
42004499|NCT01056289|75812487|FG001|Open-label Phase|Lost to Follow-up|0|||
42004500|NCT01056289|75812488|FG002|Open-label Phase|Lost to Follow-up|0|||
42004501|NCT01056289|75812489|FG003|Open-label Phase|Lost to Follow-up|0|||
42004502|NCT01056289|75812486|FG000|Open-label Phase|Other|9|||
42004503|NCT01056289|75812487|FG001|Open-label Phase|Other|0|||
42004504|NCT01056289|75812488|FG002|Open-label Phase|Other|0|||
42004505|NCT01056289|75812489|FG003|Open-label Phase|Other|0|||
42004506|NCT01056289|75812486|FG000|Open-label Phase|Protocol Violation|6|||
42004507|NCT01056289|75812487|FG001|Open-label Phase|Protocol Violation|0|||
42344936|NCT01406938|76183496|FG005|Follow up|Physician Decision|1|||
42344937|NCT01406938|76183491|FG000|Follow up|Lost to Follow-up|1|||
42344938|NCT01406938|76183492|FG001|Follow up|Lost to Follow-up|1|||
42344939|NCT01406938|76183493|FG002|Follow up|Lost to Follow-up|0|||
42344940|NCT01406938|76183494|FG003|Follow up|Lost to Follow-up|1|||
42004508|NCT01056289|75812488|FG002|Open-label Phase|Protocol Violation|0|||
42004509|NCT01056289|75812489|FG003|Open-label Phase|Protocol Violation|0|||
42004510|NCT01056289|75812486|FG000|Open-label Phase|Withdrawal by Subject|26|||
42004511|NCT01056289|75812487|FG001|Open-label Phase|Withdrawal by Subject|0|||
42004512|NCT01056289|75812488|FG002|Open-label Phase|Withdrawal by Subject|0|||
42004513|NCT01056289|75812489|FG003|Open-label Phase|Withdrawal by Subject|0|||
42004514|NCT01056289|75812486|FG000|Open-label Phase|Lack of Efficacy|18|||
42004515|NCT01056289|75812487|FG001|Open-label Phase|Lack of Efficacy|0|||
42004516|NCT01056289|75812488|FG002|Open-label Phase|Lack of Efficacy|0|||
42004517|NCT01056289|75812489|FG003|Open-label Phase|Lack of Efficacy|0|||
42270591|NCT02547428|76099970|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
42270592|NCT02547428|76099969|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
42270593|NCT02547428|76099970|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
42270594|NCT02547428|76099969|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
42270595|NCT02547428|76099970|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
42270596|NCT01374087|76099985|FG000|Overall Study|Adverse Event|1|||
42270597|NCT01374087|76099986|FG001|Overall Study|Adverse Event|0|||
42270598|NCT01374087|76099985|FG000|Overall Study|Disease progression|2|||
42270599|NCT01374087|76099986|FG001|Overall Study|Disease progression|2|||
42270600|NCT01374087|76099985|FG000|Overall Study|Study discontinued|13|||
42270601|NCT01374087|76099986|FG001|Overall Study|Study discontinued|13|||
42004518|NCT01056289|75812486|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
42270602|NCT00152971|76099995|FG000|Overall Study|Adverse Event|12|||
42270603|NCT00152971|76099996|FG001|Overall Study|Adverse Event|10|||
42270604|NCT00152971|76099997|FG002|Overall Study|Adverse Event|9|||
42270605|NCT00152971|76099995|FG000|Overall Study|Protocol Violation|10|||
42270606|NCT00152971|76099996|FG001|Overall Study|Protocol Violation|11|||
42270607|NCT00152971|76099997|FG002|Overall Study|Protocol Violation|8|||
42270608|NCT00152971|76099995|FG000|Overall Study|Lost to Follow-up|17|||
42004519|NCT01056289|75812487|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
42270609|NCT00152971|76099996|FG001|Overall Study|Lost to Follow-up|14|||
42270610|NCT00152971|76099997|FG002|Overall Study|Lost to Follow-up|13|||
42270611|NCT00152971|76099995|FG000|Overall Study|Withdrawal by Subject|9|||
42344941|NCT01406938|76183495|FG004|Follow up|Lost to Follow-up|2|||
42344942|NCT01406938|76183496|FG005|Follow up|Lost to Follow-up|1|||
42004520|NCT01056289|75812488|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
42004521|NCT01056289|75812489|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
42004522|NCT01056289|75812486|FG000|Double-blind Phase|Adverse Event|0|||
42004523|NCT01056289|75812487|FG001|Double-blind Phase|Adverse Event|1|||
42344943|NCT01405924|76183516|FG000|Overall Study|Protocol Violation|8|||
42270612|NCT00152971|76099996|FG001|Overall Study|Withdrawal by Subject|8|||
42270613|NCT00152971|76099997|FG002|Overall Study|Withdrawal by Subject|14|||
42270614|NCT00152971|76099995|FG000|Overall Study|Other|3|||
42270615|NCT00152971|76099996|FG001|Overall Study|Other|5|||
42270616|NCT00152971|76099997|FG002|Overall Study|Other|5|||
42270617|NCT00152971|76099995|FG000|Treatment|Adverse Event|49|||
42270618|NCT00152971|76099996|FG001|Treatment|Adverse Event|40|||
42344944|NCT01405924|76183516|FG000|Overall Study|Missing/Incomplete Data|2|||
42344945|NCT01426438|76183524|FG000|Overall Study|Lost to Follow-up|1|||
42344946|NCT01426438|76183525|FG001|Overall Study|Lost to Follow-up|3|||
42344947|NCT01426438|76183524|FG000|Overall Study|Off study Treatment|9|||
42344948|NCT01426438|76183525|FG001|Overall Study|Off study Treatment|3|||
42344949|NCT01426438|76183524|FG000|Overall Study|Poor scan quality|3|||
42344950|NCT01426438|76183525|FG001|Overall Study|Poor scan quality|2|||
42344951|NCT01426438|76183524|FG000|Overall Study|Missed Scan|2|||
42344952|NCT01426438|76183525|FG001|Overall Study|Missed Scan|2|||
42344953|NCT01425814|76183531|FG000|Period 1|Stability criteria not fulfilled|0|||
42344954|NCT01425814|76183532|FG001|Period 1|Stability criteria not fulfilled|1|||
42344955|NCT01425814|76183533|FG002|Period 1|Stability criteria not fulfilled|0|||
42344956|NCT01425814|76183534|FG003|Period 1|Stability criteria not fulfilled|0|||
42344957|NCT01425814|76183535|FG004|Period 1|Stability criteria not fulfilled|0|||
42344958|NCT01425814|76183536|FG005|Period 1|Stability criteria not fulfilled|0|||
42344959|NCT01425814|76183531|FG000|Period 2|Stability criteria not fulfilled|0|||
42344960|NCT01425814|76183532|FG001|Period 2|Stability criteria not fulfilled|1|||
42344961|NCT01425814|76183533|FG002|Period 2|Stability criteria not fulfilled|0|||
42344962|NCT01425814|76183534|FG003|Period 2|Stability criteria not fulfilled|0|||
42344963|NCT01425814|76183535|FG004|Period 2|Stability criteria not fulfilled|0|||
42344964|NCT01425814|76183536|FG005|Period 2|Stability criteria not fulfilled|0|||
42344965|NCT01425814|76183531|FG000|Period 3|Adverse Event|0|||
42344966|NCT01425814|76183532|FG001|Period 3|Adverse Event|0|||
42344967|NCT01425814|76183533|FG002|Period 3|Adverse Event|0|||
42344968|NCT01425814|76183534|FG003|Period 3|Adverse Event|0|||
42344969|NCT01425814|76183535|FG004|Period 3|Adverse Event|0|||
42344970|NCT01425814|76183536|FG005|Period 3|Adverse Event|1|||
42344971|NCT01425814|76183531|FG000|Period 4|Adverse Event|1|||
42344972|NCT01425814|76183532|FG001|Period 4|Adverse Event|0|||
42344973|NCT01425814|76183533|FG002|Period 4|Adverse Event|1|||
42344974|NCT01425814|76183534|FG003|Period 4|Adverse Event|0|||
42344975|NCT01425814|76183535|FG004|Period 4|Adverse Event|0|||
42344976|NCT01425814|76183536|FG005|Period 4|Adverse Event|0|||
42344977|NCT01425814|76183531|FG000|Period 5|Stability criteria not fulfilled|0|||
42344978|NCT01425814|76183532|FG001|Period 5|Stability criteria not fulfilled|0|||
42344979|NCT01425814|76183533|FG002|Period 5|Stability criteria not fulfilled|1|||
42344980|NCT01425814|76183534|FG003|Period 5|Stability criteria not fulfilled|0|||
42344981|NCT01425814|76183535|FG004|Period 5|Stability criteria not fulfilled|0|||
42344982|NCT01425814|76183536|FG005|Period 5|Stability criteria not fulfilled|1|||
42344983|NCT01782495|76183561|FG000|Overall Study|Adverse Event|0|||
42344984|NCT01782495|76183562|FG001|Overall Study|Adverse Event|0|||
42004524|NCT01056289|75812488|FG002|Double-blind Phase|Adverse Event|2|||
42136064|NCT00284050|75946618|FG000|Overall Study|Adverse Event|1|||
42344985|NCT01782495|76183563|FG002|Overall Study|Adverse Event|0|||
42344986|NCT01782495|76183564|FG003|Overall Study|Adverse Event|0|||
42344987|NCT01782495|76183565|FG004|Overall Study|Adverse Event|0|||
42136065|NCT00284050|75946619|FG001|Overall Study|Adverse Event|1|||
42136066|NCT00284050|75946620|FG002|Overall Study|Adverse Event|1|||
42136067|NCT00284050|75946618|FG000|Overall Study|Lack of Efficacy|0|||
42136068|NCT00284050|75946619|FG001|Overall Study|Lack of Efficacy|1|||
42136069|NCT00284050|75946620|FG002|Overall Study|Lack of Efficacy|3|||
42136070|NCT00284050|75946618|FG000|Overall Study|Protocol Violation|0|||
42136071|NCT00284050|75946619|FG001|Overall Study|Protocol Violation|1|||
42270619|NCT00152971|76099997|FG002|Treatment|Adverse Event|54|||
42270620|NCT00152971|76099995|FG000|Treatment|Protocol Violation|8|||
42344988|NCT01782495|76183566|FG005|Overall Study|Adverse Event|0|||
42344989|NCT01782495|76183567|FG006|Overall Study|Adverse Event|0|||
42270621|NCT00152971|76099996|FG001|Treatment|Protocol Violation|6|||
42270622|NCT00152971|76099997|FG002|Treatment|Protocol Violation|10|||
42270623|NCT00152971|76099995|FG000|Treatment|Lost to Follow-up|1|||
42270624|NCT00152971|76099996|FG001|Treatment|Lost to Follow-up|2|||
42344990|NCT01782495|76183568|FG007|Overall Study|Adverse Event|2|||
42344991|NCT01782495|76183569|FG008|Overall Study|Adverse Event|0|||
42136072|NCT00284050|75946620|FG002|Overall Study|Protocol Violation|2|||
42270625|NCT00152971|76099997|FG002|Treatment|Lost to Follow-up|1|||
42270626|NCT00152971|76099995|FG000|Treatment|Withdrawal by Subject|4|||
42344992|NCT01782495|76183570|FG009|Overall Study|Adverse Event|0|||
42344993|NCT01782495|76183571|FG010|Overall Study|Adverse Event|0|||
42344994|NCT01782495|76183561|FG000|Overall Study|Withdrew Consent|0|||
42344995|NCT01782495|76183562|FG001|Overall Study|Withdrew Consent|1|||
42344996|NCT01782495|76183563|FG002|Overall Study|Withdrew Consent|0|||
42270627|NCT00152971|76099996|FG001|Treatment|Withdrawal by Subject|4|||
42270628|NCT00152971|76099997|FG002|Treatment|Withdrawal by Subject|5|||
42344997|NCT01782495|76183564|FG003|Overall Study|Withdrew Consent|0|||
42344998|NCT01782495|76183565|FG004|Overall Study|Withdrew Consent|0|||
42270629|NCT00152971|76099995|FG000|Treatment|Other|9|||
42270630|NCT00152971|76099996|FG001|Treatment|Other|11|||
42270631|NCT00152971|76099997|FG002|Treatment|Other|10|||
42270632|NCT02538614|76100005|FG000|Overall Study|Progressive Disease|2|||
42270633|NCT04620135|76100013|FG000|Study Completion|Adverse Event|2|||
42270634|NCT04620135|76100014|FG001|Study Completion|Adverse Event|3|||
42344999|NCT01782495|76183566|FG005|Overall Study|Withdrew Consent|0|||
42345000|NCT01782495|76183567|FG006|Overall Study|Withdrew Consent|0|||
42345001|NCT01782495|76183568|FG007|Overall Study|Withdrew Consent|1|||
42345002|NCT01782495|76183569|FG008|Overall Study|Withdrew Consent|0|||
42345003|NCT01782495|76183570|FG009|Overall Study|Withdrew Consent|0|||
42345004|NCT01782495|76183571|FG010|Overall Study|Withdrew Consent|0|||
42345005|NCT01922102|76183598|FG000|Overall Study|Withdrawal by Subject|7|||
42345006|NCT01922102|76183599|FG001|Overall Study|Withdrawal by Subject|3|||
42345007|NCT01922102|76183600|FG002|Overall Study|Withdrawal by Subject|7|||
42345008|NCT01922102|76183598|FG000|Overall Study|Physician Decision|0|||
42345009|NCT01922102|76183599|FG001|Overall Study|Physician Decision|2|||
42345010|NCT01922102|76183600|FG002|Overall Study|Physician Decision|1|||
42345011|NCT01922102|76183598|FG000|Overall Study|Adverse Event|1|||
42345012|NCT01922102|76183599|FG001|Overall Study|Adverse Event|2|||
42345013|NCT01922102|76183600|FG002|Overall Study|Adverse Event|0|||
42345014|NCT01922102|76183598|FG000|Overall Study|Lost to Follow-up|1|||
42345015|NCT01922102|76183599|FG001|Overall Study|Lost to Follow-up|0|||
42345016|NCT01922102|76183600|FG002|Overall Study|Lost to Follow-up|0|||
42345017|NCT01922102|76183598|FG000|Overall Study|Administrative problems|0|||
42345018|NCT01922102|76183599|FG001|Overall Study|Administrative problems|2|||
42345019|NCT01922102|76183600|FG002|Overall Study|Administrative problems|0|||
42345020|NCT01405768|76183614|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
42345021|NCT01405768|76183615|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
42270635|NCT04620135|76100013|FG000|Study Completion|Withdrawal by Subject|2|||
42270636|NCT04620135|76100014|FG001|Study Completion|Withdrawal by Subject|0|||
42345022|NCT01913353|76183623|FG000|Overall Study|Adverse Event|2|||
42345023|NCT01913353|76183624|FG001|Overall Study|Adverse Event|0|||
42345024|NCT01913353|76183623|FG000|Overall Study|Physician Decision|0|||
42270637|NCT02552966|76100020|FG000|Overall Study|Lost to Follow-up|2|||
42270638|NCT02552966|76100020|FG000|Overall Study|Withdrawal by Subject|3|||
42345025|NCT01913353|76183624|FG001|Overall Study|Physician Decision|2|||
42345026|NCT01913353|76183623|FG000|Overall Study|Withdrawal by Subject|20|||
42345027|NCT01913353|76183624|FG001|Overall Study|Withdrawal by Subject|6|||
42345028|NCT01913353|76183623|FG000|Overall Study|multiple reasons|10|||
42345029|NCT01913353|76183624|FG001|Overall Study|multiple reasons|7|||
42345030|NCT01754259|76183639|FG000|Overall Study|Withdrawal by Subject|2|||
42345031|NCT01754259|76183640|FG001|Overall Study|Withdrawal by Subject|4|||
42345032|NCT01754259|76183639|FG000|Overall Study|Adverse Event|3|||
42345033|NCT01754259|76183640|FG001|Overall Study|Adverse Event|1|||
42345034|NCT01754259|76183639|FG000|Overall Study|Lost to Follow-up|0|||
42345035|NCT01754259|76183640|FG001|Overall Study|Lost to Follow-up|1|||
42345036|NCT01405456|76183648|FG000|Overall Study|Lost to Follow-up|2|||
42136073|NCT00284050|75946618|FG000|Overall Study|Withdrawal by Subject|2|||
42136074|NCT00284050|75946619|FG001|Overall Study|Withdrawal by Subject|2|||
42136075|NCT00284050|75946620|FG002|Overall Study|Withdrawal by Subject|2|||
42136076|NCT00284050|75946618|FG000|Overall Study|Lost to Follow-up|1|||
42136077|NCT00284050|75946619|FG001|Overall Study|Lost to Follow-up|0|||
42136078|NCT00284050|75946620|FG002|Overall Study|Lost to Follow-up|1|||
42136079|NCT00284050|75946618|FG000|Overall Study|Death|1|||
42136080|NCT00284050|75946619|FG001|Overall Study|Death|0|||
42136081|NCT00284050|75946620|FG002|Overall Study|Death|0|||
42136082|NCT00293020|75946628|FG000|Overall Study|Withdrawal by Subject|34|||
42136083|NCT00293020|75946628|FG000|Overall Study|Adverse Event|30|||
42136084|NCT00293020|75946628|FG000|Overall Study|Death|32|||
42136085|NCT00293020|75946628|FG000|Overall Study|Lack of Efficacy|12|||
42136086|NCT00293020|75946628|FG000|Overall Study|Lost to Follow-up|4|||
42136087|NCT00293020|75946628|FG000|Overall Study|Protocol Violation|6|||
42136088|NCT00293020|75946628|FG000|Overall Study|Physician Decision|21|||
42136089|NCT00293020|75946628|FG000|Overall Study|Other Reason|22|||
42136090|NCT00293020|75946628|FG000|Overall Study|No dose taken|1|||
42136091|NCT00377637|75946636|FG000|Induction Phase|Adverse Event|12|||
42136092|NCT00377637|75946637|FG001|Induction Phase|Adverse Event|21|||
42136093|NCT00377637|75946638|FG002|Induction Phase|Adverse Event|0|||
42136094|NCT00377637|75946639|FG003|Induction Phase|Adverse Event|0|||
42136095|NCT00377637|75946636|FG000|Induction Phase|Deterioration/serum creatinine|2|||
42136096|NCT00377637|75946637|FG001|Induction Phase|Deterioration/serum creatinine|0|||
42136097|NCT00377637|75946638|FG002|Induction Phase|Deterioration/serum creatinine|0|||
42136098|NCT00377637|75946639|FG003|Induction Phase|Deterioration/serum creatinine|0|||
42136099|NCT00377637|75946636|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
42136100|NCT00377637|75946637|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
42136101|NCT00377637|75946638|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
42136102|NCT00377637|75946639|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
42136103|NCT00377637|75946636|FG000|Induction Phase|Lost to Follow-up|2|||
42136104|NCT00377637|75946637|FG001|Induction Phase|Lost to Follow-up|1|||
42136105|NCT00377637|75946638|FG002|Induction Phase|Lost to Follow-up|0|||
42136106|NCT00377637|75946639|FG003|Induction Phase|Lost to Follow-up|0|||
42136107|NCT00377637|75946636|FG000|Induction Phase|Death|1|||
42136108|NCT00377637|75946637|FG001|Induction Phase|Death|3|||
42136109|NCT00377637|75946638|FG002|Induction Phase|Death|0|||
42136110|NCT00377637|75946639|FG003|Induction Phase|Death|0|||
42136111|NCT00377637|75946636|FG000|Induction Phase|Withdrawal by Subject|5|||
42136112|NCT00377637|75946637|FG001|Induction Phase|Withdrawal by Subject|6|||
42136113|NCT00377637|75946638|FG002|Induction Phase|Withdrawal by Subject|0|||
42136114|NCT00377637|75946639|FG003|Induction Phase|Withdrawal by Subject|0|||
42136115|NCT00377637|75946636|FG000|Induction Phase|Physician Decision|3|||
42136116|NCT00377637|75946637|FG001|Induction Phase|Physician Decision|1|||
42136117|NCT00377637|75946638|FG002|Induction Phase|Physician Decision|0|||
42136118|NCT00377637|75946639|FG003|Induction Phase|Physician Decision|0|||
42136119|NCT00377637|75946636|FG000|Induction Phase|Sponsor decision|1|||
42136120|NCT00377637|75946637|FG001|Induction Phase|Sponsor decision|2|||
42136121|NCT00377637|75946638|FG002|Induction Phase|Sponsor decision|0|||
42136122|NCT00377637|75946639|FG003|Induction Phase|Sponsor decision|0|||
42136123|NCT00377637|75946636|FG000|Induction Phase|Non-Compliance|1|||
42136124|NCT00377637|75946637|FG001|Induction Phase|Non-Compliance|0|||
42136125|NCT00377637|75946638|FG002|Induction Phase|Non-Compliance|0|||
42136126|NCT00377637|75946639|FG003|Induction Phase|Non-Compliance|0|||
42136127|NCT00377637|75946636|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
42136128|NCT00377637|75946637|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
42136129|NCT00377637|75946638|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
42136130|NCT00377637|75946639|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
42136131|NCT00377637|75946636|FG000|Maintenance Phase|Adverse Event|0|||
42345037|NCT01405456|76183649|FG001|Overall Study|Lost to Follow-up|1|||
42345038|NCT01405456|76183648|FG000|Overall Study|Physician Decision|1|||
42136132|NCT00377637|75946637|FG001|Maintenance Phase|Adverse Event|0|||
42136133|NCT00377637|75946638|FG002|Maintenance Phase|Adverse Event|29|||
42136134|NCT00377637|75946639|FG003|Maintenance Phase|Adverse Event|43|||
42136135|NCT00377637|75946636|FG000|Maintenance Phase|Physician Decision|0|||
42136136|NCT00377637|75946637|FG001|Maintenance Phase|Physician Decision|0|||
42136137|NCT00377637|75946638|FG002|Maintenance Phase|Physician Decision|5|||
42270639|NCT02552888|76100026|FG000|Overall Study|Lost to Follow-up|1|||
42004525|NCT01056289|75812489|FG003|Double-blind Phase|Adverse Event|1|||
42004526|NCT01056289|75812486|FG000|Double-blind Phase|Lost to Follow-up|0|||
42004527|NCT01056289|75812487|FG001|Double-blind Phase|Lost to Follow-up|2|||
42270640|NCT02552888|76100027|FG001|Overall Study|Lost to Follow-up|1|||
42270641|NCT01373931|76100046|FG000|Lead-in Period|Adverse Event|2|||
42004528|NCT01056289|75812488|FG002|Double-blind Phase|Lost to Follow-up|2|||
42004529|NCT01056289|75812489|FG003|Double-blind Phase|Lost to Follow-up|2|||
42270642|NCT01373931|76100047|FG001|Lead-in Period|Adverse Event|0|||
42270643|NCT01373931|76100046|FG000|Period 1|Adverse Event|2|||
42270644|NCT01373931|76100047|FG001|Period 1|Adverse Event|0|||
42270645|NCT01373931|76100046|FG000|Period 1|Withdrawal by Subject|0|||
42270646|NCT01373931|76100047|FG001|Period 1|Withdrawal by Subject|2|||
42270647|NCT02552732|76100054|FG000|Overall Study|Lost to Follow-up|2|||
42270648|NCT02552732|76100054|FG000|Overall Study|Physician Decision|1|||
42004530|NCT01056289|75812486|FG000|Double-blind Phase|Other|0|||
42004531|NCT01056289|75812487|FG001|Double-blind Phase|Other|0|||
42270649|NCT02552732|76100054|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
42270650|NCT02552732|76100054|FG000|Overall Study|Withdrawal by Subject|6|||
42270651|NCT02547038|76100061|FG000|Overall Study|Lost to Follow-up|3|||
42270652|NCT02547038|76100062|FG001|Overall Study|Lost to Follow-up|2|||
42004532|NCT01056289|75812488|FG002|Double-blind Phase|Other|1|||
42004533|NCT01056289|75812489|FG003|Double-blind Phase|Other|2|||
42136138|NCT00377637|75946639|FG003|Maintenance Phase|Physician Decision|4|||
42136139|NCT00377637|75946636|FG000|Maintenance Phase|Lost to Follow-up|0|||
42136140|NCT00377637|75946637|FG001|Maintenance Phase|Lost to Follow-up|0|||
42270653|NCT02764697|76100068|FG000|Overall Study|Lack of Efficacy|3|||
42270654|NCT02673489|76100074|FG000|Treatment Period|Lost to Follow-up|3|||
42136141|NCT00377637|75946638|FG002|Maintenance Phase|Lost to Follow-up|3|||
42004534|NCT01056289|75812486|FG000|Double-blind Phase|Protocol Violation|0|||
42136142|NCT00377637|75946639|FG003|Maintenance Phase|Lost to Follow-up|1|||
42136143|NCT00377637|75946636|FG000|Maintenance Phase|Withdrawal by Subject|0|||
42136144|NCT00377637|75946637|FG001|Maintenance Phase|Withdrawal by Subject|0|||
42136145|NCT00377637|75946638|FG002|Maintenance Phase|Withdrawal by Subject|3|||
42136146|NCT00377637|75946639|FG003|Maintenance Phase|Withdrawal by Subject|3|||
42136147|NCT00377637|75946636|FG000|Maintenance Phase|Sponsor decision|0|||
42270655|NCT02673489|76100075|FG001|Treatment Period|Lost to Follow-up|0|||
42270656|NCT02673489|76100074|FG000|Treatment Period|Participant request to discontinue|1|||
42004535|NCT01056289|75812487|FG001|Double-blind Phase|Protocol Violation|0|||
42004536|NCT01056289|75812488|FG002|Double-blind Phase|Protocol Violation|1|||
42004537|NCT01056289|75812489|FG003|Double-blind Phase|Protocol Violation|1|||
42004538|NCT01056289|75812486|FG000|Double-blind Phase|Withdrawal by Subject|0|||
42270657|NCT02673489|76100075|FG001|Treatment Period|Participant request to discontinue|1|||
42270658|NCT02673489|76100074|FG000|Treatment Period|Participant moved to another province|1|||
42270659|NCT02673489|76100075|FG001|Treatment Period|Participant moved to another province|0|||
42270660|NCT02673489|76100074|FG000|Treatment Period|Participant was incarcerated|0|||
42270661|NCT02673489|76100075|FG001|Treatment Period|Participant was incarcerated|1|||
42270662|NCT02673489|76100074|FG000|Treatment Period|Adverse Event|0|||
42270663|NCT02673489|76100075|FG001|Treatment Period|Adverse Event|1|||
42270664|NCT02673489|76100074|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
42270665|NCT02673489|76100075|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
42270666|NCT02673489|76100074|FG000|Follow Up Period|Unable to return for follow-up|0|||
42270667|NCT02673489|76100075|FG001|Follow Up Period|Unable to return for follow-up|1|||
42270668|NCT02772809|76100082|FG000|Overall Study|not completed some tasks|6|||
42270669|NCT02537678|76100093|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
42270670|NCT02537678|76100094|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
42270671|NCT02537678|76100093|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
42270672|NCT02537678|76100094|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
42270673|NCT02537678|76100093|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
42270674|NCT02537678|76100094|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
42270675|NCT02537678|76100093|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
42270676|NCT02537678|76100094|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
42004539|NCT01056289|75812487|FG001|Double-blind Phase|Withdrawal by Subject|0|||
42004540|NCT01056289|75812488|FG002|Double-blind Phase|Withdrawal by Subject|4|||
42004541|NCT01056289|75812489|FG003|Double-blind Phase|Withdrawal by Subject|2|||
42035198|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
42136148|NCT00377637|75946637|FG001|Maintenance Phase|Sponsor decision|0|||
42272773|NCT02276482|76103186|FG001|Overall Study|Reason not specified|1|||
42136149|NCT00377637|75946638|FG002|Maintenance Phase|Sponsor decision|2|||
42136150|NCT00377637|75946639|FG003|Maintenance Phase|Sponsor decision|3|||
42136151|NCT00377637|75946636|FG000|Maintenance Phase|Non-compliance|0|||
42136152|NCT00377637|75946637|FG001|Maintenance Phase|Non-compliance|0|||
42136153|NCT00377637|75946638|FG002|Maintenance Phase|Non-compliance|1|||
42136154|NCT00377637|75946639|FG003|Maintenance Phase|Non-compliance|1|||
42136155|NCT00377637|75946636|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
42136156|NCT00377637|75946637|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
42136157|NCT00377637|75946638|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
42136158|NCT00377637|75946639|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
42136159|NCT00377637|75946636|FG000|Maintenance Phase|Death|0|||
42136160|NCT00377637|75946637|FG001|Maintenance Phase|Death|0|||
42136161|NCT00377637|75946638|FG002|Maintenance Phase|Death|0|||
42136162|NCT00377637|75946639|FG003|Maintenance Phase|Death|1|||
42136163|NCT00377403|75946655|FG000|Overall Study|Unable to contact for telephone intervie|4|||
42136164|NCT00377403|75946656|FG001|Overall Study|Unable to contact for telephone intervie|7|||
42136165|NCT00370149|75946664|FG000|Overall Study|Physician Decision|16|||
42136166|NCT00370149|75946665|FG001|Overall Study|Physician Decision|16|||
42136167|NCT00370149|75946664|FG000|Overall Study|Protocol Violation|1|||
42004542|NCT01056289|75812486|FG000|Double-blind Phase|Discontinuation symptom|0|||
42270677|NCT02537678|76100093|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
42136168|NCT00370149|75946665|FG001|Overall Study|Protocol Violation|0|||
42136169|NCT00370149|75946664|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
42136170|NCT00370149|75946665|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
42136171|NCT00370149|75946664|FG000|Overall Study|Pre-existing infection|0|||
42136172|NCT00370149|75946665|FG001|Overall Study|Pre-existing infection|1|||
42136173|NCT00370149|75946664|FG000|Overall Study|Antibiotic coated dressing placed|0|||
42136174|NCT00370149|75946665|FG001|Overall Study|Antibiotic coated dressing placed|1|||
42136175|NCT00292942|75946678|FG000|Overall Study|Withdrawal by Subject|0|||
42136176|NCT00292942|75946679|FG001|Overall Study|Withdrawal by Subject|0|||
42136177|NCT00292942|75946680|FG002|Overall Study|Withdrawal by Subject|1|||
42136178|NCT00292942|75946681|FG003|Overall Study|Withdrawal by Subject|0|||
42136179|NCT00292942|75946678|FG000|Overall Study|Adverse Event|0|||
42136180|NCT00292942|75946679|FG001|Overall Study|Adverse Event|0|||
42136181|NCT00292942|75946680|FG002|Overall Study|Adverse Event|0|||
42136182|NCT00292942|75946681|FG003|Overall Study|Adverse Event|1|||
42136183|NCT00483938|75946701|FG000|Overall Study|Protocol Violation|0|||
42136184|NCT00483938|75946702|FG001|Overall Study|Protocol Violation|0|||
42136185|NCT00483938|75946703|FG002|Overall Study|Protocol Violation|0|||
42136186|NCT00483938|75946704|FG003|Overall Study|Protocol Violation|0|||
42136187|NCT00483938|75946705|FG004|Overall Study|Protocol Violation|0|||
42136188|NCT00483938|75946706|FG005|Overall Study|Protocol Violation|0|||
42136189|NCT00483938|75946707|FG006|Overall Study|Protocol Violation|3|||
42136190|NCT00483938|75946701|FG000|Overall Study|Withdrawal by Subject|1|||
42004543|NCT01056289|75812487|FG001|Double-blind Phase|Discontinuation symptom|1|||
42136191|NCT00483938|75946702|FG001|Overall Study|Withdrawal by Subject|6|||
42270678|NCT02537678|76100094|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
42270679|NCT02537678|76100093|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
42270680|NCT02537678|76100094|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
42270681|NCT02537678|76100093|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
42270682|NCT02537678|76100094|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
42270683|NCT02766023|76100106|FG000|Overall Study|Lost to Follow-up|23|||
42270684|NCT02766023|76100107|FG001|Overall Study|Lost to Follow-up|11|||
42270685|NCT02766023|76100106|FG000|Overall Study|Pregnancy|1|||
42270686|NCT02766023|76100107|FG001|Overall Study|Pregnancy|0|||
42270687|NCT02766023|76100106|FG000|Overall Study|Adverse Event|1|||
42270688|NCT02766023|76100107|FG001|Overall Study|Adverse Event|0|||
42136192|NCT00483938|75946703|FG002|Overall Study|Withdrawal by Subject|0|||
42136193|NCT00483938|75946704|FG003|Overall Study|Withdrawal by Subject|0|||
42136194|NCT00483938|75946705|FG004|Overall Study|Withdrawal by Subject|1|||
42136195|NCT00483938|75946706|FG005|Overall Study|Withdrawal by Subject|3|||
42136196|NCT00483938|75946707|FG006|Overall Study|Withdrawal by Subject|2|||
42136197|NCT00483938|75946701|FG000|Overall Study|Lost to Follow-up|1|||
42136198|NCT00483938|75946702|FG001|Overall Study|Lost to Follow-up|2|||
42136199|NCT00483938|75946703|FG002|Overall Study|Lost to Follow-up|0|||
42136200|NCT00483938|75946704|FG003|Overall Study|Lost to Follow-up|2|||
42136201|NCT00483938|75946705|FG004|Overall Study|Lost to Follow-up|1|||
42270689|NCT02766023|76100106|FG000|Overall Study|Withdrawal by Subject|4|||
42270690|NCT02766023|76100107|FG001|Overall Study|Withdrawal by Subject|5|||
42270691|NCT02766023|76100106|FG000|Overall Study|Physician Decision|1|||
42270692|NCT02766023|76100107|FG001|Overall Study|Physician Decision|0|||
42270693|NCT02766023|76100106|FG000|Overall Study|Not Eligible at Enrollment|0|||
42270694|NCT02766023|76100107|FG001|Overall Study|Not Eligible at Enrollment|1|||
42270695|NCT02764229|76100113|FG000|Overall Study|Withdrawal by Subject|15|||
42270696|NCT02764229|76100113|FG000|Overall Study|Adverse Event|9|||
42270697|NCT02764229|76100113|FG000|Overall Study|Physician Decision|5|||
42270698|NCT02764229|76100113|FG000|Overall Study|Lost to Follow-up|3|||
42270699|NCT02764229|76100113|FG000|Overall Study|Lack of Efficacy|1|||
42270700|NCT02764229|76100113|FG000|Overall Study|Study Stopped by Sponsor|69|||
42270701|NCT02537522|76100117|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
42270702|NCT02537522|76100118|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
42270703|NCT02537522|76100119|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
42270704|NCT02537522|76100120|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
42270705|NCT02537522|76100117|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
42035199|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
42345039|NCT01405456|76183649|FG001|Overall Study|Physician Decision|0|||
42136202|NCT00483938|75946706|FG005|Overall Study|Lost to Follow-up|1|||
42136203|NCT00483938|75946707|FG006|Overall Study|Lost to Follow-up|3|||
42136204|NCT00483938|75946701|FG000|Overall Study|Death|0|||
42136205|NCT00483938|75946702|FG001|Overall Study|Death|2|||
42136206|NCT00483938|75946703|FG002|Overall Study|Death|0|||
42136207|NCT00483938|75946704|FG003|Overall Study|Death|0|||
42136208|NCT00483938|75946705|FG004|Overall Study|Death|0|||
42136209|NCT00483938|75946706|FG005|Overall Study|Death|0|||
42136210|NCT00483938|75946707|FG006|Overall Study|Death|0|||
42136211|NCT00483938|75946701|FG000|Overall Study|Other|3|||
42136212|NCT00483938|75946702|FG001|Overall Study|Other|9|||
42136213|NCT00483938|75946703|FG002|Overall Study|Other|0|||
42136214|NCT00483938|75946704|FG003|Overall Study|Other|4|||
42136215|NCT00483938|75946705|FG004|Overall Study|Other|0|||
42136216|NCT00483938|75946706|FG005|Overall Study|Other|4|||
42136217|NCT00483938|75946707|FG006|Overall Study|Other|32|||
42136218|NCT00370071|75946726|FG000|Overall Study|Withdrawal by Subject|2|||
42136219|NCT00369915|75946732|FG000|Overall Study|expected side effects|2|||
42136220|NCT00369915|75946733|FG001|Overall Study|expected side effects|1|||
42136221|NCT00369915|75946732|FG000|Overall Study|Withdrawal by Subject|4|||
42136222|NCT00369915|75946733|FG001|Overall Study|Withdrawal by Subject|1|||
42136223|NCT00369915|75946732|FG000|Overall Study|W/drawl by investigators|0|||
42136224|NCT00369915|75946733|FG001|Overall Study|W/drawl by investigators|1|||
42136225|NCT00369681|75946739|FG000|Overall Study|Death|1|||
42136226|NCT00266812|75946745|FG000|Overall Study|Disease Progression|9|||
42136227|NCT00266812|75946746|FG001|Overall Study|Disease Progression|3|||
42136228|NCT00266812|75946745|FG000|Overall Study|Death|5|||
42136229|NCT00266812|75946746|FG001|Overall Study|Death|4|||
42136230|NCT00266812|75946745|FG000|Overall Study|Adverse Event|3|||
42136231|NCT00266812|75946746|FG001|Overall Study|Adverse Event|1|||
42136232|NCT00266812|75946745|FG000|Overall Study|Protocol Violation|0|||
42136233|NCT00266812|75946746|FG001|Overall Study|Protocol Violation|1|||
42136234|NCT00266812|75946745|FG000|Overall Study|Withdrawal by Subject|0|||
42136235|NCT00266812|75946746|FG001|Overall Study|Withdrawal by Subject|2|||
42136236|NCT00266812|75946745|FG000|Overall Study|Discontinued before starting study drug|4|||
42136237|NCT00266812|75946746|FG001|Overall Study|Discontinued before starting study drug|0|||
42136238|NCT00488774|75946756|FG000|Overall Study|Withdrawal of consent|2|||
42136239|NCT00488774|75946757|FG001|Overall Study|Withdrawal of consent|2|||
42136240|NCT00488774|75946758|FG002|Overall Study|Withdrawal of consent|2|||
42136241|NCT00488774|75946759|FG003|Overall Study|Withdrawal of consent|0|||
42136242|NCT00488774|75946756|FG000|Overall Study|Other|6|||
42136243|NCT00488774|75946757|FG001|Overall Study|Other|3|||
42136244|NCT00488774|75946758|FG002|Overall Study|Other|2|||
42136245|NCT00488774|75946759|FG003|Overall Study|Other|2|||
42136246|NCT00488774|75946756|FG000|Overall Study|Lost to Follow-up|0|||
42136247|NCT00488774|75946757|FG001|Overall Study|Lost to Follow-up|0|||
42136248|NCT00488774|75946758|FG002|Overall Study|Lost to Follow-up|1|||
42136249|NCT00488774|75946759|FG003|Overall Study|Lost to Follow-up|1|||
42136250|NCT00361569|75946774|FG000|Overall Study|Protocol Violation|3|||
42136251|NCT00361569|75946775|FG001|Overall Study|Protocol Violation|2|||
42136252|NCT00361569|75946776|FG002|Overall Study|Protocol Violation|4|||
42136253|NCT00361569|75946777|FG003|Overall Study|Protocol Violation|2|||
42136254|NCT00361569|75946774|FG000|Overall Study|Withdrawal by Subject|2|||
42136255|NCT00361569|75946775|FG001|Overall Study|Withdrawal by Subject|1|||
42136256|NCT00361569|75946776|FG002|Overall Study|Withdrawal by Subject|9|||
42136257|NCT00361569|75946777|FG003|Overall Study|Withdrawal by Subject|14|||
42136258|NCT00361569|75946774|FG000|Overall Study|Adverse Event|3|||
42136259|NCT00361569|75946775|FG001|Overall Study|Adverse Event|5|||
42136260|NCT00361569|75946776|FG002|Overall Study|Adverse Event|2|||
42136261|NCT00361569|75946777|FG003|Overall Study|Adverse Event|2|||
42136262|NCT00361569|75946774|FG000|Overall Study|Lost to Follow-up|2|||
42136263|NCT00361569|75946775|FG001|Overall Study|Lost to Follow-up|3|||
42136264|NCT00361569|75946776|FG002|Overall Study|Lost to Follow-up|3|||
42136265|NCT00361569|75946777|FG003|Overall Study|Lost to Follow-up|2|||
42136266|NCT00361569|75946774|FG000|Overall Study|Not specified by investigator|2|||
42136267|NCT00361569|75946775|FG001|Overall Study|Not specified by investigator|0|||
42136268|NCT00361569|75946776|FG002|Overall Study|Not specified by investigator|0|||
42136269|NCT00361569|75946777|FG003|Overall Study|Not specified by investigator|1|||
42136270|NCT00488618|75946789|FG000|Overall Study|Adverse Event|13|||
42136271|NCT00488618|75946790|FG001|Overall Study|Adverse Event|17|||
42136272|NCT00488618|75946789|FG000|Overall Study|Insufficient Therapeutic Response|18|||
42136273|NCT00488618|75946790|FG001|Overall Study|Insufficient Therapeutic Response|11|||
42136274|NCT00488618|75946789|FG000|Overall Study|Protocol Violation|0|||
42136275|NCT00488618|75946790|FG001|Overall Study|Protocol Violation|2|||
42345040|NCT01404988|76183658|FG000|Overall Study|Death|2|||
42136276|NCT00488618|75946789|FG000|Overall Study|Withdrawal of Consent|15|||
42136277|NCT00488618|75946790|FG001|Overall Study|Withdrawal of Consent|13|||
42136278|NCT00488618|75946789|FG000|Overall Study|Lost to Follow-up|1|||
42136279|NCT00488618|75946790|FG001|Overall Study|Lost to Follow-up|0|||
42136280|NCT00266656|75946798|FG000|Overall Study|Death|1|||
42136281|NCT00266656|75946799|FG001|Overall Study|Death|0|||
42136282|NCT00266656|75946798|FG000|Overall Study|Lost to Follow-up|4|||
42136283|NCT00266656|75946799|FG001|Overall Study|Lost to Follow-up|1|||
42136284|NCT00266656|75946798|FG000|Overall Study|Withdrawal by Subject|4|||
42136285|NCT00266656|75946799|FG001|Overall Study|Withdrawal by Subject|2|||
42136286|NCT00266656|75946798|FG000|Overall Study|Did Not Reach Final Height|4|||
42136287|NCT00266656|75946799|FG001|Overall Study|Did Not Reach Final Height|8|||
42136288|NCT00266656|75946798|FG000|Overall Study|Parent/Caregiver Decision|1|||
42136289|NCT00266656|75946799|FG001|Overall Study|Parent/Caregiver Decision|2|||
42136290|NCT00483704|75946808|FG000|Randomization|Withdrawal by Subject|19|||
42136291|NCT00483704|75946809|FG001|Randomization|Withdrawal by Subject|28|||
42136292|NCT00483704|75946810|FG002|Randomization|Withdrawal by Subject|18|||
42136293|NCT00483704|75946808|FG000|Randomization|Protocol Violation|14|||
42136294|NCT00483704|75946809|FG001|Randomization|Protocol Violation|25|||
42136295|NCT00483704|75946810|FG002|Randomization|Protocol Violation|22|||
42136296|NCT00483704|75946808|FG000|Randomization|Lost to Follow-up|14|||
42136297|NCT00483704|75946809|FG001|Randomization|Lost to Follow-up|14|||
42136298|NCT00483704|75946810|FG002|Randomization|Lost to Follow-up|19|||
42136299|NCT00483704|75946808|FG000|Randomization|Pregnancy|1|||
42136300|NCT00483704|75946809|FG001|Randomization|Pregnancy|0|||
42136301|NCT00483704|75946810|FG002|Randomization|Pregnancy|0|||
42136302|NCT00483704|75946808|FG000|Randomization|Physician Decision|2|||
42136303|NCT00483704|75946809|FG001|Randomization|Physician Decision|4|||
42136304|NCT00483704|75946810|FG002|Randomization|Physician Decision|0|||
42136305|NCT00483704|75946808|FG000|Randomization|Progressive disease|0|||
42136306|NCT00483704|75946809|FG001|Randomization|Progressive disease|0|||
42136307|NCT00483704|75946810|FG002|Randomization|Progressive disease|1|||
42136308|NCT00483704|75946808|FG000|Randomization|Lack of qualifying migraines|21|||
42136309|NCT00483704|75946809|FG001|Randomization|Lack of qualifying migraines|25|||
42136310|NCT00483704|75946810|FG002|Randomization|Lack of qualifying migraines|31|||
42136311|NCT00483704|75946808|FG000|Treatment|Lack of qualifying migraines|101|||
42136312|NCT00483704|75946809|FG001|Treatment|Lack of qualifying migraines|99|||
42136313|NCT00483704|75946810|FG002|Treatment|Lack of qualifying migraines|116|||
42136314|NCT00483704|75946808|FG000|Treatment|Adverse Event|3|||
42136315|NCT00483704|75946809|FG001|Treatment|Adverse Event|5|||
42136316|NCT00483704|75946810|FG002|Treatment|Adverse Event|4|||
42136317|NCT00483704|75946808|FG000|Treatment|Withdrawal by Subject|16|||
42136318|NCT00483704|75946809|FG001|Treatment|Withdrawal by Subject|12|||
42136319|NCT00483704|75946810|FG002|Treatment|Withdrawal by Subject|21|||
42136320|NCT00483704|75946808|FG000|Treatment|Protocol Violation|6|||
42136321|NCT00483704|75946809|FG001|Treatment|Protocol Violation|3|||
42136322|NCT00483704|75946810|FG002|Treatment|Protocol Violation|5|||
42136323|NCT00483704|75946808|FG000|Treatment|Lost to Follow-up|2|||
42136324|NCT00483704|75946809|FG001|Treatment|Lost to Follow-up|7|||
42136325|NCT00483704|75946810|FG002|Treatment|Lost to Follow-up|5|||
42136326|NCT00483704|75946808|FG000|Treatment|Lack of Efficacy|1|||
42136327|NCT00483704|75946809|FG001|Treatment|Lack of Efficacy|1|||
42136328|NCT00483704|75946810|FG002|Treatment|Lack of Efficacy|1|||
42136329|NCT00483704|75946808|FG000|Treatment|Pregnancy|0|||
42136330|NCT00483704|75946809|FG001|Treatment|Pregnancy|1|||
42136331|NCT00483704|75946810|FG002|Treatment|Pregnancy|0|||
42136332|NCT00483704|75946808|FG000|Treatment|Physician Decision|0|||
42136333|NCT00483704|75946809|FG001|Treatment|Physician Decision|1|||
42136334|NCT00483704|75946810|FG002|Treatment|Physician Decision|4|||
42136335|NCT00483548|75946823|FG000|Overall Study|Randomized; not treated with study drug|1|||
42136336|NCT00483548|75946824|FG001|Overall Study|Randomized; not treated with study drug|3|||
42136337|NCT00483548|75946823|FG000|Overall Study|Adverse Event|25|||
42136338|NCT00483548|75946824|FG001|Overall Study|Adverse Event|14|||
42136339|NCT00483548|75946823|FG000|Overall Study|Laboratory abnormality|1|||
42136340|NCT00483548|75946824|FG001|Overall Study|Laboratory abnormality|2|||
42136341|NCT00483548|75946823|FG000|Overall Study|Lack of Efficacy|4|||
42004544|NCT01056289|75812488|FG002|Double-blind Phase|Discontinuation symptom|2|||
42136342|NCT00483548|75946824|FG001|Overall Study|Lack of Efficacy|8|||
42136343|NCT00483548|75946823|FG000|Overall Study|Protocol Violation|11|||
42136344|NCT00483548|75946824|FG001|Overall Study|Protocol Violation|7|||
42136345|NCT00483548|75946823|FG000|Overall Study|Pregnancy|1|||
42136346|NCT00483548|75946824|FG001|Overall Study|Pregnancy|0|||
42136347|NCT00483548|75946823|FG000|Overall Study|Protocol required discontinuation|6|||
42136348|NCT00483548|75946824|FG001|Overall Study|Protocol required discontinuation|6|||
42004545|NCT01056289|75812489|FG003|Double-blind Phase|Discontinuation symptom|2|||
42004546|NCT01056289|75812486|FG000|Double-blind Phase|Physician Decision|0|||
42136349|NCT00483548|75946823|FG000|Overall Study|Unable to comply with protocol schedule|1|||
42136350|NCT00483548|75946824|FG001|Overall Study|Unable to comply with protocol schedule|0|||
42136351|NCT00483548|75946823|FG000|Overall Study|Non-compliance with medication|2|||
42136352|NCT00483548|75946824|FG001|Overall Study|Non-compliance with medication|0|||
42136353|NCT00483548|75946823|FG000|Overall Study|Lost to Follow-up|3|||
42136354|NCT00483548|75946824|FG001|Overall Study|Lost to Follow-up|4|||
42004547|NCT01056289|75812487|FG001|Double-blind Phase|Physician Decision|0|||
42004548|NCT01056289|75812488|FG002|Double-blind Phase|Physician Decision|1|||
42136355|NCT00483548|75946823|FG000|Overall Study|Withdrawal by Subject|5|||
42136356|NCT00483548|75946824|FG001|Overall Study|Withdrawal by Subject|2|||
42270706|NCT02537522|76100118|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
42270707|NCT02537522|76100119|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
42270708|NCT02537522|76100120|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
42270709|NCT02537522|76100117|FG000|Phase I - Contralateral|incorrect randomization|0|||
42270710|NCT02537522|76100118|FG001|Phase I - Contralateral|incorrect randomization|1|||
42270711|NCT02537522|76100119|FG002|Phase I - Contralateral|incorrect randomization|0|||
42270712|NCT02537522|76100120|FG003|Phase I - Contralateral|incorrect randomization|0|||
42270713|NCT02537522|76100117|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
42270714|NCT02537522|76100118|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
42270715|NCT02537522|76100119|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
42270716|NCT02537522|76100120|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
42270717|NCT02537522|76100117|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
42270718|NCT02537522|76100118|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
42345041|NCT01404988|76183659|FG001|Overall Study|Death|0|||
42345042|NCT01404988|76183660|FG002|Overall Study|Death|2|||
42345043|NCT01404988|76183658|FG000|Overall Study|Adverse Event|1|||
42345044|NCT01404988|76183659|FG001|Overall Study|Adverse Event|0|||
42004549|NCT01056289|75812489|FG003|Double-blind Phase|Physician Decision|0|||
42004550|NCT01039675|75812501|FG000|Overall Study|Adverse Event|0|||
42136357|NCT00445770|75946833|FG000|Overall Study|Adverse Event|9|||
42270719|NCT02537522|76100119|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
42136358|NCT00445770|75946834|FG001|Overall Study|Adverse Event|15|||
42270720|NCT02537522|76100120|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
42270721|NCT02536976|76100128|FG000|Overall Study|Physician Decision|0|||
42004551|NCT01039675|75812502|FG001|Overall Study|Adverse Event|2|||
42136359|NCT00445770|75946835|FG002|Overall Study|Adverse Event|19|||
42004552|NCT01039675|75812501|FG000|Overall Study|Lack of Efficacy|0|||
42270722|NCT02536976|76100129|FG001|Overall Study|Physician Decision|1|||
42270723|NCT02672553|76100139|FG000|Overall Study|Death|3|||
42270724|NCT02672553|76100140|FG001|Overall Study|Death|5|||
42270725|NCT02672553|76100139|FG000|Overall Study|Valve Explant|1|||
42345045|NCT01404988|76183660|FG002|Overall Study|Adverse Event|0|||
42004553|NCT01039675|75812502|FG001|Overall Study|Lack of Efficacy|2|||
42004554|NCT01039675|75812501|FG000|Overall Study|Withdrawal by Subject|0|||
42004555|NCT01039675|75812502|FG001|Overall Study|Withdrawal by Subject|1|||
42136360|NCT00445770|75946833|FG000|Overall Study|Lack of Efficacy|38|||
42136361|NCT00445770|75946834|FG001|Overall Study|Lack of Efficacy|13|||
42136362|NCT00445770|75946835|FG002|Overall Study|Lack of Efficacy|6|||
42136363|NCT00445770|75946833|FG000|Overall Study|Lost to Follow-up|0|||
42136364|NCT00445770|75946834|FG001|Overall Study|Lost to Follow-up|2|||
42136365|NCT00445770|75946835|FG002|Overall Study|Lost to Follow-up|0|||
42136366|NCT00445770|75946833|FG000|Overall Study|Other|6|||
42136367|NCT00445770|75946834|FG001|Overall Study|Other|5|||
42136368|NCT00445770|75946835|FG002|Overall Study|Other|6|||
42136369|NCT00266032|75946848|FG000|Treatment|Adverse Event|42|||
42136370|NCT00266032|75946849|FG001|Treatment|Adverse Event|26|||
42136371|NCT00266032|75946850|FG002|Treatment|Adverse Event|10|||
42136372|NCT00266032|75946848|FG000|Treatment|Lost to Follow-up|19|||
42136373|NCT00266032|75946849|FG001|Treatment|Lost to Follow-up|4|||
42136374|NCT00266032|75946850|FG002|Treatment|Lost to Follow-up|2|||
42136375|NCT00266032|75946848|FG000|Treatment|Pregnancy|3|||
42004556|NCT01039675|75812501|FG000|Overall Study|Lost to Follow-up|0|||
42136376|NCT00266032|75946849|FG001|Treatment|Pregnancy|2|||
42004557|NCT01039675|75812502|FG001|Overall Study|Lost to Follow-up|1|||
42136377|NCT00266032|75946850|FG002|Treatment|Pregnancy|2|||
42136378|NCT00266032|75946848|FG000|Treatment|Protocol Violation|6|||
42136379|NCT00266032|75946849|FG001|Treatment|Protocol Violation|14|||
42136380|NCT00266032|75946850|FG002|Treatment|Protocol Violation|13|||
42136381|NCT00266032|75946848|FG000|Treatment|Withdrawal by Subject|28|||
42136382|NCT00266032|75946849|FG001|Treatment|Withdrawal by Subject|13|||
42136383|NCT00266032|75946850|FG002|Treatment|Withdrawal by Subject|12|||
42136384|NCT00266032|75946848|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
42136385|NCT00266032|75946849|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
42136386|NCT00266032|75946850|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
42136387|NCT00266032|75946848|FG000|Open-label Safety Extension|Adverse Event|5|||
42270726|NCT02672553|76100140|FG001|Overall Study|Valve Explant|0|||
42270727|NCT02672553|76100139|FG000|Overall Study|Conversion to Commercial Valve|3|||
42270728|NCT02672553|76100140|FG001|Overall Study|Conversion to Commercial Valve|0|||
42270729|NCT02672553|76100139|FG000|Overall Study|Withdrawal by Subject|3|||
42270730|NCT02672553|76100140|FG001|Overall Study|Withdrawal by Subject|3|||
42270731|NCT02672553|76100139|FG000|Overall Study|Intraoperative screen failure|2|||
42270732|NCT02672553|76100140|FG001|Overall Study|Intraoperative screen failure|0|||
42270733|NCT01373229|76100147|FG000|Overall Study|Death|3|||
42270734|NCT01373229|76100147|FG000|Overall Study|Physician Decision|3|||
42270735|NCT02671461|76100154|FG000|Treatment|Adverse Event|0|||
42270736|NCT02671461|76100155|FG001|Treatment|Adverse Event|0|||
42270737|NCT02671461|76100156|FG002|Treatment|Adverse Event|1|||
42270738|NCT02671461|76100154|FG000|Treatment|Administrative Reason by Sponsor|1|||
42136388|NCT00266032|75946849|FG001|Open-label Safety Extension|Adverse Event|0|||
42136389|NCT00266032|75946850|FG002|Open-label Safety Extension|Adverse Event|4|||
42136390|NCT00266032|75946848|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
42136391|NCT00266032|75946849|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
42136392|NCT00266032|75946850|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
42136393|NCT00266032|75946848|FG000|Open-label Safety Extension|Pregnancy|4|||
42136394|NCT00266032|75946849|FG001|Open-label Safety Extension|Pregnancy|1|||
42136395|NCT00266032|75946850|FG002|Open-label Safety Extension|Pregnancy|2|||
42136396|NCT00266032|75946848|FG000|Open-label Safety Extension|Protocol Violation|1|||
42345046|NCT01404988|76183658|FG000|Overall Study|Withdrawal by Subject|2|||
42345047|NCT01404988|76183659|FG001|Overall Study|Withdrawal by Subject|2|||
42345048|NCT01404988|76183660|FG002|Overall Study|Withdrawal by Subject|0|||
42345049|NCT01404988|76183658|FG000|Overall Study|Lost to Follow-up|1|||
42345050|NCT01404988|76183659|FG001|Overall Study|Lost to Follow-up|2|||
42345051|NCT01404988|76183660|FG002|Overall Study|Lost to Follow-up|1|||
42345052|NCT01389232|76183671|FG000|Overall Study|Had scaffold removed|15|||
42345053|NCT01389232|76183671|FG000|Overall Study|Personal reasons|2|||
42345054|NCT01389232|76183671|FG000|Overall Study|Adverse Event|1|||
42345055|NCT01389232|76183671|FG000|Overall Study|Death|1|||
42345056|NCT01404208|76183687|FG000|Overall Study|Discontinued|3|||
42345057|NCT01404208|76183688|FG001|Overall Study|Discontinued|0|||
42345058|NCT01617668|76183696|FG000|Overall Study|Adverse Event|7|||
42345059|NCT01617668|76183697|FG001|Overall Study|Adverse Event|0|||
42345060|NCT01617668|76183698|FG002|Overall Study|Adverse Event|12|||
42345061|NCT01617668|76183699|FG003|Overall Study|Adverse Event|5|||
42345062|NCT01617668|76183696|FG000|Overall Study|Physician Decision|1|||
42345063|NCT01617668|76183697|FG001|Overall Study|Physician Decision|2|||
42345064|NCT01617668|76183698|FG002|Overall Study|Physician Decision|3|||
42345065|NCT01617668|76183699|FG003|Overall Study|Physician Decision|0|||
42345066|NCT01617668|76183696|FG000|Overall Study|Progressive Disease|4|||
42270739|NCT02671461|76100155|FG001|Treatment|Administrative Reason by Sponsor|3|||
42270740|NCT02671461|76100156|FG002|Treatment|Administrative Reason by Sponsor|4|||
42270741|NCT02671461|76100154|FG000|Treatment|Randomized, not treated|1|||
42270742|NCT02671461|76100155|FG001|Treatment|Randomized, not treated|0|||
42270743|NCT02671461|76100156|FG002|Treatment|Randomized, not treated|0|||
42345067|NCT01617668|76183697|FG001|Overall Study|Progressive Disease|4|||
42345068|NCT01617668|76183698|FG002|Overall Study|Progressive Disease|6|||
42345069|NCT01617668|76183699|FG003|Overall Study|Progressive Disease|9|||
42345070|NCT01617668|76183696|FG000|Overall Study|Subject/guardian decision|1|||
42270744|NCT02671461|76100154|FG000|Follow-up|Withdrawal by Subject|1|||
42270745|NCT02671461|76100155|FG001|Follow-up|Withdrawal by Subject|0|||
42270746|NCT02671461|76100156|FG002|Follow-up|Withdrawal by Subject|0|||
42270747|NCT02671461|76100154|FG000|Follow-up|Lost to Follow-up|0|||
42345071|NCT01617668|76183697|FG001|Overall Study|Subject/guardian decision|3|||
42136397|NCT00266032|75946849|FG001|Open-label Safety Extension|Protocol Violation|3|||
42270748|NCT02671461|76100155|FG001|Follow-up|Lost to Follow-up|0|||
42345072|NCT01617668|76183698|FG002|Overall Study|Subject/guardian decision|2|||
42345073|NCT01617668|76183699|FG003|Overall Study|Subject/guardian decision|1|||
42345074|NCT01425268|76183715|FG000|Overall Study|Withdrawal by Subject|2|||
42345075|NCT01425268|76183716|FG001|Overall Study|Withdrawal by Subject|0|||
42345076|NCT01425268|76183715|FG000|Overall Study|Sponsor Decision|5|||
42345077|NCT01425268|76183716|FG001|Overall Study|Sponsor Decision|0|||
42345078|NCT01425268|76183715|FG000|Overall Study|Physician Decision|1|||
42345079|NCT01425268|76183716|FG001|Overall Study|Physician Decision|0|||
42270749|NCT02671461|76100156|FG002|Follow-up|Lost to Follow-up|1|||
42270750|NCT02671461|76100154|FG000|Follow-up|Administrative Reason by Sponsor|0|||
42270751|NCT02671461|76100155|FG001|Follow-up|Administrative Reason by Sponsor|1|||
42270752|NCT02671461|76100156|FG002|Follow-up|Administrative Reason by Sponsor|0|||
42270753|NCT02535416|76100173|FG000|Overall Study|Family bereavement overseas|1|||
42270754|NCT02535416|76100174|FG001|Overall Study|Family bereavement overseas|0|||
42270755|NCT02535416|76100175|FG002|Overall Study|Family bereavement overseas|0|||
42270756|NCT02535416|76100176|FG003|Overall Study|Family bereavement overseas|0|||
42270757|NCT02535416|76100177|FG004|Overall Study|Family bereavement overseas|0|||
42270758|NCT02535416|76100178|FG005|Overall Study|Family bereavement overseas|0|||
42345080|NCT01425190|76183725|FG000|Overall Study|Full dose not consumed.|1|||
42345081|NCT01425190|76183726|FG001|Overall Study|Full dose not consumed.|0|||
42345082|NCT01425190|76183727|FG002|Overall Study|Full dose not consumed.|0|||
42345083|NCT01388530|76183735|FG000|Overall Study|Lost to Follow-up|5|||
42136398|NCT00266032|75946850|FG002|Open-label Safety Extension|Protocol Violation|2|||
42136399|NCT00266032|75946848|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
42136400|NCT00266032|75946849|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
42136401|NCT00266032|75946850|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
42345084|NCT01895270|76183741|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
42345085|NCT01895270|76183742|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
42345086|NCT01895270|76183741|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
42345087|NCT01895270|76183742|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
42345088|NCT01895270|76183741|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
42345089|NCT01895270|76183742|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
42345090|NCT01895270|76183741|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
42345091|NCT01895270|76183742|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
42345092|NCT01895270|76183741|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
42345093|NCT01895270|76183742|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
42345094|NCT01895270|76183741|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
42345095|NCT01895270|76183742|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
42345096|NCT01895270|76183741|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
42345097|NCT01895270|76183742|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
42345098|NCT01424722|76183748|FG000|Overall Study|Sponsor terminated investigation|2258|||
42345099|NCT01424644|76183754|FG000|Overall Study|Adverse Event|2|||
42345100|NCT01424644|76183755|FG001|Overall Study|Adverse Event|0|||
42345101|NCT01424644|76183754|FG000|Overall Study|Withdrawal by Subject|9|||
42136402|NCT00266032|75946848|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
42136403|NCT00266032|75946849|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
42136404|NCT00266032|75946850|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
42136405|NCT00483002|75946858|FG000|Overall Study|Adverse Event|68|||
42136406|NCT00483002|75946858|FG000|Overall Study|Lack of Efficacy|555|||
42136407|NCT00483002|75946858|FG000|Overall Study|Lost to Follow-up|962|||
42136408|NCT00483002|75946858|FG000|Overall Study|Other|2|||
42136409|NCT00483002|75946858|FG000|Overall Study|Other|967|||
42136410|NCT00482612|75946866|FG000|In-treatment Period|No study medication administered|0|||
42136411|NCT00482612|75946867|FG001|In-treatment Period|No study medication administered|0|||
42270759|NCT02535416|76100179|FG006|Overall Study|Family bereavement overseas|0|||
42270760|NCT02535416|76100180|FG007|Overall Study|Family bereavement overseas|0|||
42270761|NCT02535416|76100181|FG008|Overall Study|Family bereavement overseas|0|||
42270762|NCT02670915|76100231|FG000|Overall Study|Withdrawal by Subject|0|||
42270763|NCT02670915|76100232|FG001|Overall Study|Withdrawal by Subject|1|||
42270764|NCT02670915|76100233|FG002|Overall Study|Withdrawal by Subject|4|||
42270765|NCT02670915|76100231|FG000|Overall Study|Withdrawal by parent/guardian|4|||
42270766|NCT02670915|76100232|FG001|Overall Study|Withdrawal by parent/guardian|4|||
42270767|NCT02670915|76100233|FG002|Overall Study|Withdrawal by parent/guardian|1|||
42270768|NCT02670915|76100231|FG000|Overall Study|Unclassified|0|||
42270769|NCT02670915|76100232|FG001|Overall Study|Unclassified|3|||
42136412|NCT00482612|75946868|FG002|In-treatment Period|No study medication administered|1|||
42136413|NCT00482612|75946869|FG003|In-treatment Period|No study medication administered|0|||
42136414|NCT00482612|75946866|FG000|Follow-up Period|Other|4|||
42270770|NCT02670915|76100233|FG002|Overall Study|Unclassified|0|||
42270771|NCT02545868|76100244|FG000|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33|||
42136415|NCT00482612|75946867|FG001|Follow-up Period|Other|2|||
42345102|NCT01424644|76183755|FG001|Overall Study|Withdrawal by Subject|12|||
42345103|NCT01424644|76183754|FG000|Overall Study|Lost to Follow-up|16|||
42345104|NCT01424644|76183755|FG001|Overall Study|Lost to Follow-up|12|||
42345105|NCT01424644|76183754|FG000|Overall Study|Protocol Violation|4|||
42345106|NCT01424644|76183755|FG001|Overall Study|Protocol Violation|3|||
42345107|NCT01424644|76183754|FG000|Overall Study|Administrative Reason|1|||
42345108|NCT01424644|76183755|FG001|Overall Study|Administrative Reason|0|||
42345109|NCT01424644|76183754|FG000|Overall Study|Unable to Classify|1|||
42136416|NCT00482612|75946868|FG002|Follow-up Period|Other|1|||
42345110|NCT01424644|76183755|FG001|Overall Study|Unable to Classify|0|||
42345111|NCT01920854|76183768|FG000|Overall Study|Withdrawal by Subject|1|||
42345112|NCT01920854|76183769|FG001|Overall Study|Withdrawal by Subject|0|||
42345113|NCT01920854|76183770|FG002|Overall Study|Withdrawal by Subject|0|||
42345114|NCT01920854|76183771|FG003|Overall Study|Withdrawal by Subject|0|||
42345115|NCT01920854|76183772|FG004|Overall Study|Withdrawal by Subject|1|||
42345116|NCT01920854|76183773|FG005|Overall Study|Withdrawal by Subject|0|||
42345117|NCT01920854|76183774|FG006|Overall Study|Withdrawal by Subject|1|||
42345118|NCT01403194|76183809|FG000|Overall Study|Screen Failure|2|||
42345119|NCT01403194|76183809|FG000|Overall Study|Lost to Follow-up|8|||
42345120|NCT01403116|76183815|FG000|Overall Study|Adverse Event|7|||
42345121|NCT01403116|76183816|FG001|Overall Study|Adverse Event|4|||
42345122|NCT01403116|76183815|FG000|Overall Study|Lost to Follow-up|7|||
42345123|NCT01403116|76183816|FG001|Overall Study|Lost to Follow-up|5|||
42345124|NCT01403116|76183815|FG000|Overall Study|Withdrawal by Subject|12|||
42345125|NCT01403116|76183816|FG001|Overall Study|Withdrawal by Subject|15|||
42345126|NCT01403116|76183815|FG000|Overall Study|Non-compliance of study drug|3|||
42345127|NCT01403116|76183816|FG001|Overall Study|Non-compliance of study drug|0|||
42345128|NCT01403116|76183815|FG000|Overall Study|Protocol Violation|0|||
42345129|NCT01403116|76183816|FG001|Overall Study|Protocol Violation|1|||
42345130|NCT01403116|76183815|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
42345131|NCT01403116|76183816|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
42345132|NCT01403116|76183815|FG000|Overall Study|Hct >54%|2|||
42345133|NCT01403116|76183816|FG001|Overall Study|Hct >54%|0|||
42345134|NCT01403116|76183815|FG000|Overall Study|unable to keep appointments|0|||
42345135|NCT01403116|76183816|FG001|Overall Study|unable to keep appointments|2|||
42345136|NCT01402570|76183822|FG000|Overall Study|Adverse Event|1|||
42345137|NCT01753401|76183829|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
42345138|NCT01753401|76183830|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
42345139|NCT01753401|76183831|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
42345140|NCT01753401|76183832|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
42345141|NCT01753401|76183829|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
42345142|NCT01753401|76183830|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
42345143|NCT01753401|76183831|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
42345144|NCT01753401|76183832|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
42345145|NCT01753401|76183829|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
42345146|NCT01753401|76183830|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
42345147|NCT01753401|76183831|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
42345148|NCT01753401|76183832|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
42345149|NCT01753401|76183829|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
42345150|NCT01753401|76183830|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
42345151|NCT01753401|76183831|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
42345152|NCT01753401|76183832|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
42004558|NCT01039675|75812501|FG000|Overall Study|Physician Decision|0|||
42004559|NCT01039675|75812502|FG001|Overall Study|Physician Decision|1|||
42004560|NCT01033825|75812515|FG000|Overall Study|Withdrawal by Subject|2|||
42136417|NCT00482612|75946869|FG003|Follow-up Period|Other|2|||
42136418|NCT00482612|75946866|FG000|Follow-up Period|Lack of compliance|0|||
42136419|NCT00482612|75946867|FG001|Follow-up Period|Lack of compliance|0|||
42136420|NCT00482612|75946868|FG002|Follow-up Period|Lack of compliance|1|||
42136421|NCT00482612|75946869|FG003|Follow-up Period|Lack of compliance|0|||
42136422|NCT00482612|75946866|FG000|Follow-up Period|Lost to Follow-up|0|||
42136423|NCT00482612|75946867|FG001|Follow-up Period|Lost to Follow-up|4|||
42136424|NCT00482612|75946868|FG002|Follow-up Period|Lost to Follow-up|2|||
42136425|NCT00482612|75946869|FG003|Follow-up Period|Lost to Follow-up|1|||
42136426|NCT00482612|75946866|FG000|Follow-up Period|Adverse Event|4|||
42345153|NCT01753401|76183829|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
42345154|NCT01753401|76183830|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
42345155|NCT01753401|76183831|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
42345156|NCT01753401|76183832|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
42136427|NCT00482612|75946867|FG001|Follow-up Period|Adverse Event|7|||
42136428|NCT00482612|75946868|FG002|Follow-up Period|Adverse Event|9|||
42136429|NCT00482612|75946869|FG003|Follow-up Period|Adverse Event|0|||
42136430|NCT00482612|75946866|FG000|Follow-up Period|Lack of Efficacy|2|||
42136431|NCT00482612|75946867|FG001|Follow-up Period|Lack of Efficacy|0|||
42136432|NCT00482612|75946868|FG002|Follow-up Period|Lack of Efficacy|1|||
42136433|NCT00482612|75946869|FG003|Follow-up Period|Lack of Efficacy|0|||
42136434|NCT00482612|75946866|FG000|Follow-up Period|Withdrawal by Subject|3|||
42345157|NCT01753401|76183829|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
42345158|NCT01753401|76183830|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
42345159|NCT01753401|76183831|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
42345160|NCT01753401|76183832|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
42345161|NCT01753401|76183829|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
42345162|NCT01753401|76183830|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
42345163|NCT01753401|76183831|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
42345164|NCT01753401|76183832|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
42345165|NCT01618916|76183848|FG000|Overall Study|Adverse Event|1|||
42345166|NCT01618916|76183849|FG001|Overall Study|Adverse Event|0|||
42345167|NCT01618916|76183850|FG002|Overall Study|Adverse Event|0|||
42345168|NCT01618916|76183851|FG003|Overall Study|Adverse Event|0|||
42345169|NCT01618916|76183852|FG004|Overall Study|Adverse Event|0|||
42345170|NCT01618916|76183853|FG005|Overall Study|Adverse Event|0|||
42345171|NCT01618916|76183848|FG000|Overall Study|Withdrawal by Subject|0|||
42345172|NCT01618916|76183849|FG001|Overall Study|Withdrawal by Subject|1|||
42345173|NCT01618916|76183850|FG002|Overall Study|Withdrawal by Subject|1|||
42345174|NCT01618916|76183851|FG003|Overall Study|Withdrawal by Subject|0|||
42345175|NCT01618916|76183852|FG004|Overall Study|Withdrawal by Subject|1|||
42345176|NCT01618916|76183853|FG005|Overall Study|Withdrawal by Subject|0|||
42345177|NCT01618916|76183848|FG000|Overall Study|Lost to Follow-up|1|||
42345178|NCT01618916|76183849|FG001|Overall Study|Lost to Follow-up|0|||
42345179|NCT01618916|76183850|FG002|Overall Study|Lost to Follow-up|0|||
42345180|NCT01618916|76183851|FG003|Overall Study|Lost to Follow-up|2|||
42345181|NCT01618916|76183852|FG004|Overall Study|Lost to Follow-up|0|||
42345182|NCT01618916|76183853|FG005|Overall Study|Lost to Follow-up|0|||
42345183|NCT01753323|76183869|FG000|Overall Study|Lack of Efficacy|0|||
42345184|NCT01753323|76183870|FG001|Overall Study|Lack of Efficacy|0|||
42136435|NCT00482612|75946867|FG001|Follow-up Period|Withdrawal by Subject|5|||
42136436|NCT00482612|75946868|FG002|Follow-up Period|Withdrawal by Subject|7|||
42136437|NCT00482612|75946869|FG003|Follow-up Period|Withdrawal by Subject|2|||
42345185|NCT01753323|76183871|FG002|Overall Study|Lack of Efficacy|8|||
42345186|NCT01753323|76183869|FG000|Overall Study|Protocol deviation|1|||
42345187|NCT01753323|76183870|FG001|Overall Study|Protocol deviation|0|||
42345188|NCT01753323|76183871|FG002|Overall Study|Protocol deviation|0|||
42136438|NCT00482612|75946866|FG000|Follow-up Period|Reasons not related to trial|1|||
42345189|NCT01753323|76183869|FG000|Overall Study|Adverse Event|0|||
42345190|NCT01753323|76183870|FG001|Overall Study|Adverse Event|0|||
42270772|NCT02545868|76100245|FG001|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35|||
42270773|NCT02545868|76100246|FG002|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34|||
42270774|NCT02764151|76100263|FG000|Overall Study|Subject refused further follow-up|0|||
42270775|NCT02764151|76100264|FG001|Overall Study|Subject refused further follow-up|0|||
42270776|NCT02764151|76100265|FG002|Overall Study|Subject refused further follow-up|0|||
42270777|NCT02764151|76100266|FG003|Overall Study|Subject refused further follow-up|1|||
42270778|NCT02764151|76100263|FG000|Overall Study|Other|0|||
42270779|NCT02764151|76100264|FG001|Overall Study|Other|0|||
42270780|NCT02764151|76100265|FG002|Overall Study|Other|0|||
42270781|NCT02764151|76100266|FG003|Overall Study|Other|2|||
42270782|NCT02545322|76100276|FG000|Overall Study|Withdrawal by Subject|3|||
42270783|NCT02763215|76100280|FG000|Overall Study|Participants withdrew from study|3|||
42270784|NCT02763215|76100280|FG000|Overall Study|Missed visit|1|||
42270785|NCT02763215|76100280|FG000|Overall Study|Visit outside visit-window|1|||
42270786|NCT02763215|76100280|FG000|Overall Study|Death|1|||
42270787|NCT02763215|76100280|FG000|Overall Study|Lost to Follow-up|1|||
42345191|NCT01753323|76183871|FG002|Overall Study|Adverse Event|1|||
42035200|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
42035201|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
42035202|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
42035203|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
42035204|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
42035205|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Death|2|||
42035206|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Death|1|||
42035207|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Death|2|||
42035208|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Graft loss|0|||
42035209|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Graft loss|2|||
42035210|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Graft loss|0|||
42035211|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
42035212|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
42035213|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
42035214|NCT01114529|75843548|FG000|Completed Study Medication at Month 24|Missing|2|||
42035215|NCT01114529|75843549|FG001|Completed Study Medication at Month 24|Missing|0|||
42270788|NCT02770547|76100299|FG000|Overall Study|Patient non-compliant|1|||
42270789|NCT02770547|76100300|FG001|Overall Study|Patient non-compliant|0|||
42270790|NCT02770547|76100299|FG000|Overall Study|Adverse Event|0|||
42270791|NCT02770547|76100300|FG001|Overall Study|Adverse Event|1|||
42270792|NCT01661972|76100308|FG000|Overall Study|Adverse Event|1|||
42345192|NCT01894568|76183882|FG000|Overall Study|Adverse Event|2|||
42345193|NCT01894568|76183883|FG001|Overall Study|Adverse Event|3|||
42345194|NCT01894568|76183882|FG000|Overall Study|Protocol required discontinuation|2|||
42345195|NCT01894568|76183883|FG001|Overall Study|Protocol required discontinuation|1|||
42345196|NCT01894568|76183882|FG000|Overall Study|Withdrawal by Subject|5|||
42345197|NCT01894568|76183883|FG001|Overall Study|Withdrawal by Subject|5|||
42345198|NCT01894568|76183882|FG000|Overall Study|Physician Decision|1|||
42345199|NCT01894568|76183883|FG001|Overall Study|Physician Decision|0|||
42345200|NCT01894568|76183882|FG000|Overall Study|Lost to Follow-up|0|||
42270793|NCT01661972|76100309|FG001|Overall Study|Adverse Event|2|||
42270794|NCT01661972|76100308|FG000|Overall Study|Death during Treatment period|1|||
42270795|NCT01661972|76100309|FG001|Overall Study|Death during Treatment period|1|||
42270796|NCT01661972|76100308|FG000|Overall Study|Withdrawal by Subject|0|||
42270797|NCT01661972|76100309|FG001|Overall Study|Withdrawal by Subject|1|||
42270798|NCT00888355|76100321|FG000|Overall Study|Adverse Event|10|||
42270799|NCT00888355|76100322|FG001|Overall Study|Adverse Event|0|||
42345201|NCT01894568|76183883|FG001|Overall Study|Lost to Follow-up|1|||
42345202|NCT01618838|76183890|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
42270800|NCT00888355|76100323|FG002|Overall Study|Adverse Event|3|||
42035216|NCT01114529|75843550|FG002|Completed Study Medication at Month 24|Missing|0|||
42270801|NCT00888355|76100324|FG003|Overall Study|Adverse Event|3|||
42345203|NCT01920152|76183897|FG000|Overall Study|Withdrawal by Subject|1|||
42345204|NCT01920152|76183898|FG001|Overall Study|Withdrawal by Subject|2|||
42345205|NCT01752933|76183906|FG000|Treatment|Disease Progression|3|||
42345206|NCT01752933|76183907|FG001|Treatment|Disease Progression|29|||
42345207|NCT01752933|76183906|FG000|Treatment|Withdrawal by Subject|0|||
42345208|NCT01752933|76183907|FG001|Treatment|Withdrawal by Subject|5|||
42345209|NCT01752933|76183906|FG000|Treatment|Adverse Event|1|||
42345210|NCT01752933|76183907|FG001|Treatment|Adverse Event|4|||
42345211|NCT01752933|76183906|FG000|Treatment|Physician Decision|0|||
42345212|NCT01752933|76183907|FG001|Treatment|Physician Decision|3|||
42345213|NCT01752933|76183906|FG000|Treatment|Death|0|||
42345214|NCT01752933|76183907|FG001|Treatment|Death|2|||
42345215|NCT01752933|76183906|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
42345216|NCT01752933|76183907|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
42345217|NCT01752933|76183906|FG000|Treatment|Patient noncompliant|0|||
42345218|NCT01752933|76183907|FG001|Treatment|Patient noncompliant|1|||
42345219|NCT01752933|76183906|FG000|Treatment|Patient unable to travel to appointments|0|||
42345220|NCT01752933|76183907|FG001|Treatment|Patient unable to travel to appointments|1|||
42345221|NCT01752933|76183906|FG000|Overall Study and Follow-up|Death|4|||
42270802|NCT00888355|76100321|FG000|Overall Study|Lack of Efficacy|9|||
42270803|NCT00888355|76100322|FG001|Overall Study|Lack of Efficacy|2|||
42270804|NCT00888355|76100323|FG002|Overall Study|Lack of Efficacy|5|||
42270805|NCT00888355|76100324|FG003|Overall Study|Lack of Efficacy|2|||
42270806|NCT00888355|76100321|FG000|Overall Study|Lost to Follow-up|0|||
42270807|NCT00888355|76100322|FG001|Overall Study|Lost to Follow-up|2|||
42270808|NCT00888355|76100323|FG002|Overall Study|Lost to Follow-up|2|||
42270809|NCT00888355|76100324|FG003|Overall Study|Lost to Follow-up|0|||
42270810|NCT00888355|76100321|FG000|Overall Study|Protocol Violation|3|||
42270811|NCT00888355|76100322|FG001|Overall Study|Protocol Violation|2|||
42270812|NCT00888355|76100323|FG002|Overall Study|Protocol Violation|1|||
42270813|NCT00888355|76100324|FG003|Overall Study|Protocol Violation|2|||
42270814|NCT00888355|76100321|FG000|Overall Study|Withdrawal by Subject|0|||
42270815|NCT00888355|76100322|FG001|Overall Study|Withdrawal by Subject|3|||
42345222|NCT01752933|76183907|FG001|Overall Study and Follow-up|Death|34|||
42345223|NCT01752933|76183906|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
42345224|NCT01752933|76183907|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
42345225|NCT01752933|76183906|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
42345226|NCT01752933|76183907|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
42270816|NCT00888355|76100323|FG002|Overall Study|Withdrawal by Subject|1|||
42345227|NCT01752933|76183906|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
42345228|NCT01752933|76183907|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
42345229|NCT01752855|76183916|FG000|Overall Study|Adverse Event|1|||
42345230|NCT01752855|76183917|FG001|Overall Study|Adverse Event|0|||
42270817|NCT00888355|76100324|FG003|Overall Study|Withdrawal by Subject|3|||
42270818|NCT00794677|76100332|FG000|First Intervention|Withdrawal by Subject|2|||
42270819|NCT00794677|76100333|FG001|First Intervention|Withdrawal by Subject|0|||
42270820|NCT02770391|76100337|FG000|Overall Study|Lost to Follow-up|2|||
42345231|NCT01752855|76183916|FG000|Overall Study|Withdrew Consent|0|||
42035217|NCT01114529|75843548|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
42136439|NCT00482612|75946867|FG001|Follow-up Period|Reasons not related to trial|0|||
42136440|NCT00482612|75946868|FG002|Follow-up Period|Reasons not related to trial|1|||
42136441|NCT00482612|75946869|FG003|Follow-up Period|Reasons not related to trial|3|||
42136442|NCT00282568|75946883|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
42136443|NCT00282568|75946883|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
42136444|NCT00282568|75946883|FG000|Extended Treatment Period|Adverse Event|17|||
42136445|NCT00282568|75946883|FG000|Extended Treatment Period|Non-compliance|4|||
42136446|NCT00282568|75946883|FG000|Extended Treatment Period|Physician Decision|1|||
42136447|NCT00282568|75946883|FG000|Extended Treatment Period|Lost to Follow-up|2|||
42136448|NCT00265564|75946889|FG000|Overall Study|Lost to Follow-up|5|||
42136449|NCT00265564|75946890|FG001|Overall Study|Lost to Follow-up|7|||
42136450|NCT00265564|75946889|FG000|Overall Study|met exclusion criteria|5|||
42136451|NCT00265564|75946890|FG001|Overall Study|met exclusion criteria|2|||
42136452|NCT00376623|75946899|FG000|Overall Study|Progressive disease|35|||
42136453|NCT00376623|75946900|FG001|Overall Study|Progressive disease|22|||
42136454|NCT00376623|75946901|FG002|Overall Study|Progressive disease|17|||
42136455|NCT00376623|75946899|FG000|Overall Study|Lost to Follow-up|0|||
42270821|NCT02770391|76100337|FG000|Overall Study|Withdrawal by Subject|1|||
42270822|NCT02770391|76100337|FG000|Overall Study|Surgery delayed unevaluable|2|||
42270823|NCT02770391|76100337|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
42270824|NCT02536508|76100344|FG000|Overall Study|Withdrawal by Subject|18|||
42270825|NCT02536508|76100345|FG001|Overall Study|Withdrawal by Subject|13|||
42270826|NCT02536508|76100346|FG002|Overall Study|Withdrawal by Subject|7|||
42270827|NCT02536508|76100344|FG000|Overall Study|Adverse Event|14|||
42345232|NCT01752855|76183917|FG001|Overall Study|Withdrew Consent|2|||
42345233|NCT01752855|76183916|FG000|Overall Study|Lack of Efficacy|0|||
42345234|NCT01752855|76183917|FG001|Overall Study|Lack of Efficacy|2|||
42345235|NCT01402492|76183926|FG000|Overall Study|Withdrawal by Subject|17|||
42345236|NCT01402492|76183927|FG001|Overall Study|Withdrawal by Subject|11|||
42345237|NCT01402492|76183928|FG002|Overall Study|Withdrawal by Subject|11|||
42345238|NCT01402492|76183926|FG000|Overall Study|Adverse Event|2|||
42345239|NCT01402492|76183927|FG001|Overall Study|Adverse Event|3|||
42345240|NCT01402492|76183928|FG002|Overall Study|Adverse Event|4|||
42345241|NCT01402492|76183926|FG000|Overall Study|Physician Decision|0|||
42345242|NCT01402492|76183927|FG001|Overall Study|Physician Decision|3|||
42345243|NCT01402492|76183928|FG002|Overall Study|Physician Decision|0|||
42345244|NCT01402492|76183926|FG000|Overall Study|Incarcerated (N=3)|2|||
42345245|NCT01402492|76183927|FG001|Overall Study|Incarcerated (N=3)|0|||
42345246|NCT01402492|76183928|FG002|Overall Study|Incarcerated (N=3)|1|||
42345247|NCT01402102|76183938|FG000|Overall Study|Protocol Violation|1|||
42345248|NCT01402102|76183939|FG001|Overall Study|Protocol Violation|0|||
42345249|NCT01402102|76183938|FG000|Overall Study|Insufficiency of compliance|1|||
42345250|NCT01402102|76183939|FG001|Overall Study|Insufficiency of compliance|1|||
42345251|NCT01402102|76183938|FG000|Overall Study|Withdrawal by Subject|0|||
42345252|NCT01402102|76183939|FG001|Overall Study|Withdrawal by Subject|2|||
42345253|NCT01423084|76183949|FG000|Overall Study|Adverse Event|0|||
42345254|NCT01423084|76183950|FG001|Overall Study|Adverse Event|1|||
42345255|NCT01423084|76183949|FG000|Overall Study|Withdrawal by Subject|2|||
42136456|NCT00376623|75946900|FG001|Overall Study|Lost to Follow-up|1|||
42345256|NCT01423084|76183950|FG001|Overall Study|Withdrawal by Subject|3|||
42345257|NCT01894256|76183960|FG000|Part A|Adverse Event|0|||
42136457|NCT00376623|75946901|FG002|Overall Study|Lost to Follow-up|0|||
42345258|NCT01894256|76183961|FG001|Part A|Adverse Event|1|||
42345259|NCT01894256|76183962|FG002|Part A|Adverse Event|0|||
42136458|NCT00376623|75946899|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
42270828|NCT02536508|76100345|FG001|Overall Study|Adverse Event|13|||
42270829|NCT02536508|76100346|FG002|Overall Study|Adverse Event|6|||
42345260|NCT01894256|76183960|FG000|Part B|Death|0|||
42136459|NCT00376623|75946900|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
42136460|NCT00376623|75946901|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
42136461|NCT00376623|75946899|FG000|Overall Study|Not treated with BI 2536|1|||
42136462|NCT00376623|75946900|FG001|Overall Study|Not treated with BI 2536|0|||
42136463|NCT00376623|75946901|FG002|Overall Study|Not treated with BI 2536|0|||
42136464|NCT00376623|75946899|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
42136465|NCT00376623|75946900|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
42345261|NCT01894256|76183961|FG001|Part B|Death|1|||
42136466|NCT00376623|75946901|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
42136467|NCT00376623|75946899|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
42136468|NCT00376623|75946900|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
42136469|NCT00376623|75946901|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
42136470|NCT00376623|75946899|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
42136471|NCT00376623|75946900|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
42136472|NCT00376623|75946901|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
42136473|NCT00376623|75946899|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
42136474|NCT00376623|75946900|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
42136475|NCT00376623|75946901|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
42136476|NCT00376623|75946899|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
42136477|NCT00376623|75946900|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
42136478|NCT00376623|75946901|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
42136479|NCT00376623|75946899|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
42136480|NCT00376623|75946900|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
42136481|NCT00376623|75946901|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
42136482|NCT00376623|75946899|FG000|Overall Study|Increase of tumour markers|0|||
42136483|NCT00376623|75946900|FG001|Overall Study|Increase of tumour markers|1|||
42136484|NCT00376623|75946901|FG002|Overall Study|Increase of tumour markers|0|||
42136485|NCT00376623|75946899|FG000|Overall Study|Bone metastasis|1|||
42136486|NCT00376623|75946900|FG001|Overall Study|Bone metastasis|0|||
42136487|NCT00376623|75946901|FG002|Overall Study|Bone metastasis|0|||
42136488|NCT00445692|75946915|FG000|Overall Study|Adverse Event|11|||
42270830|NCT02536508|76100344|FG000|Overall Study|Lost to Follow-up|12|||
42270831|NCT02536508|76100345|FG001|Overall Study|Lost to Follow-up|4|||
42345262|NCT01894256|76183962|FG002|Part B|Death|1|||
42345263|NCT01894256|76183960|FG000|Part B|Withdrawal by Subject|0|||
42345264|NCT01894256|76183961|FG001|Part B|Withdrawal by Subject|1|||
42345265|NCT01894256|76183962|FG002|Part B|Withdrawal by Subject|0|||
42345266|NCT01894256|76183960|FG000|Part B|Lack of Efficacy|15|||
42345267|NCT01894256|76183961|FG001|Part B|Lack of Efficacy|12|||
42345268|NCT01894256|76183962|FG002|Part B|Lack of Efficacy|13|||
42345269|NCT01780935|76183975|FG000|Overall Study|Admin problems due to early termination|321|||
42345270|NCT01780935|76183976|FG001|Overall Study|Admin problems due to early termination|309|||
42345271|NCT01780935|76183975|FG000|Overall Study|Adverse Event|2|||
42345272|NCT01780935|76183976|FG001|Overall Study|Adverse Event|4|||
42345273|NCT01780935|76183975|FG000|Overall Study|Death|1|||
42345274|NCT01780935|76183976|FG001|Overall Study|Death|6|||
42345275|NCT01780935|76183975|FG000|Overall Study|Lost to Follow-up|2|||
42345276|NCT01780935|76183976|FG001|Overall Study|Lost to Follow-up|6|||
42345277|NCT01780935|76183975|FG000|Overall Study|Physician Decision|1|||
42345278|NCT01780935|76183976|FG001|Overall Study|Physician Decision|1|||
42345279|NCT01780935|76183975|FG000|Overall Study|Protocol deviation|0|||
42345280|NCT01780935|76183976|FG001|Overall Study|Protocol deviation|1|||
42345281|NCT01780935|76183975|FG000|Overall Study|Patient withdrew consent|8|||
42270832|NCT02536508|76100346|FG002|Overall Study|Lost to Follow-up|0|||
42270833|NCT02536508|76100344|FG000|Overall Study|Lack of Efficacy|3|||
42270834|NCT02536508|76100345|FG001|Overall Study|Lack of Efficacy|5|||
42270835|NCT02536508|76100346|FG002|Overall Study|Lack of Efficacy|4|||
42270836|NCT02536508|76100344|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
42270837|NCT02536508|76100345|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
42270838|NCT02536508|76100346|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
42270839|NCT02536508|76100344|FG000|Overall Study|Physician Decision|0|||
42270840|NCT02536508|76100345|FG001|Overall Study|Physician Decision|4|||
42270841|NCT02536508|76100346|FG002|Overall Study|Physician Decision|2|||
42270842|NCT02536508|76100344|FG000|Overall Study|Major Protocol Deviation|2|||
42345282|NCT01780935|76183976|FG001|Overall Study|Patient withdrew consent|9|||
42345283|NCT01894100|76183984|FG000|Overall Study|Lost to Follow-up|0|||
42345284|NCT01894100|76183985|FG001|Overall Study|Lost to Follow-up|1|||
42345285|NCT01894100|76183984|FG000|Overall Study|Withdrawal by Subject|3|||
42345286|NCT01894100|76183985|FG001|Overall Study|Withdrawal by Subject|0|||
42345287|NCT01401478|76184031|FG000|Overall Study|Study drug not available|6|||
42345288|NCT01401478|76184031|FG000|Overall Study|Adverse Event|5|||
42345289|NCT01401478|76184031|FG000|Overall Study|Hyperphosphatemia|5|||
42345290|NCT01401478|76184031|FG000|Overall Study|Lost to Follow-up|5|||
42345291|NCT01401478|76184031|FG000|Overall Study|Kidney transplantation|3|||
42345292|NCT01401478|76184031|FG000|Overall Study|Withdrawal by Subject|3|||
42345293|NCT01401478|76184031|FG000|Overall Study|Blood samples not available|1|||
42345294|NCT01401478|76184031|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
42345295|NCT01401478|76184031|FG000|Overall Study|Low intact parathyroid hormone|1|||
42345296|NCT01401478|76184031|FG000|Overall Study|Serious adverse event|1|||
42345297|NCT01422850|76184035|FG000|Overall Study|Physician Decision|3|||
42136489|NCT00445692|75946915|FG000|Overall Study|Lack of Efficacy|5|||
42136490|NCT03824236|75946924|FG000|Overall Study|Lost to Follow-up|0|||
42136491|NCT03824236|75946925|FG001|Overall Study|Lost to Follow-up|0|||
42136492|NCT03824236|75946926|FG002|Overall Study|Lost to Follow-up|1|||
42136493|NCT00282412|75946934|FG000|Overall Study|Death|2|||
42136494|NCT00282334|75946940|FG000|Overall Study|Withdrawal by Subject|8|||
42136495|NCT00282334|75946941|FG001|Overall Study|Withdrawal by Subject|5|||
42136496|NCT00282256|75946947|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
42345298|NCT01422538|76184044|FG000|Overall Study|Lost to Follow-up|0|||
42345299|NCT01422538|76184045|FG001|Overall Study|Lost to Follow-up|1|||
42345300|NCT01422538|76184046|FG002|Overall Study|Lost to Follow-up|1|||
42345301|NCT01422538|76184044|FG000|Overall Study|Missed visit|0|||
42345302|NCT01422538|76184045|FG001|Overall Study|Missed visit|1|||
42345303|NCT01422538|76184046|FG002|Overall Study|Missed visit|1|||
42345304|NCT01422382|76184055|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
42345305|NCT01401322|76184059|FG000|Overall Study|Withdrawal by Subject|1|||
42345306|NCT01401322|76184059|FG000|Overall Study|Physician Decision|1|||
42345307|NCT01387594|76184065|FG000|Overall Study|Withdrawal by Subject|0|||
42345308|NCT01387594|76184066|FG001|Overall Study|Withdrawal by Subject|2|||
42345309|NCT01387594|76184065|FG000|Overall Study|Lost to Follow-up|0|||
42345310|NCT01387594|76184066|FG001|Overall Study|Lost to Follow-up|1|||
42345311|NCT01401010|76184077|FG000|Overall Study|Could not interpret assay results|1|||
42004561|NCT01033825|75812516|FG001|Overall Study|Withdrawal by Subject|3|||
42004562|NCT01033825|75812517|FG002|Overall Study|Withdrawal by Subject|2|||
42004563|NCT01033825|75812518|FG003|Overall Study|Withdrawal by Subject|1|||
42004564|NCT01033825|75812519|FG004|Overall Study|Withdrawal by Subject|1|||
42004565|NCT01033825|75812520|FG005|Overall Study|Withdrawal by Subject|0|||
42136497|NCT00282256|75946947|FG000|Extension Treatment Period|Adverse Event|2|||
42004566|NCT01033825|75812521|FG006|Overall Study|Withdrawal by Subject|0|||
42004567|NCT01033825|75812515|FG000|Overall Study|Adverse Event|0|||
42004568|NCT01033825|75812516|FG001|Overall Study|Adverse Event|0|||
42004569|NCT01033825|75812517|FG002|Overall Study|Adverse Event|0|||
42136498|NCT00265330|75946951|FG000|Overall Study|Adverse Event|41|||
42136499|NCT00265330|75946951|FG000|Overall Study|Lost to Follow-up|8|||
42136500|NCT00265330|75946951|FG000|Overall Study|Withdrawal by Subject|34|||
42136501|NCT00265330|75946951|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
42136502|NCT00265330|75946951|FG000|Overall Study|Lack of Efficacy|4|||
42136503|NCT00265330|75946951|FG000|Overall Study|Family Scheduling Conflicts|1|||
42136504|NCT00265330|75946951|FG000|Overall Study|Began Taking Formulary Geodon|1|||
42136505|NCT00265330|75946951|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
42136506|NCT00265330|75946951|FG000|Overall Study|Site Closed by Sponsor|1|||
42136507|NCT00265330|75946951|FG000|Overall Study|Principal Investigators Request|1|||
42136508|NCT00265330|75946951|FG000|Overall Study|Withdrew Consent|1|||
42136509|NCT00265330|75946951|FG000|Overall Study|Protocol Violation|1|||
42136510|NCT00292318|75946957|FG000|Overall Study|Study terminated by officials|2|||
42136511|NCT00292318|75946958|FG001|Overall Study|Study terminated by officials|1|||
42270843|NCT02536508|76100345|FG001|Overall Study|Major Protocol Deviation|2|||
42136512|NCT00281632|75946964|FG000|Overall Study|Adverse Event|7|||
42270844|NCT02536508|76100346|FG002|Overall Study|Major Protocol Deviation|2|||
42270845|NCT02536508|76100344|FG000|Overall Study|Administrative Reasons|0|||
42270846|NCT02536508|76100345|FG001|Overall Study|Administrative Reasons|1|||
42270847|NCT02536508|76100346|FG002|Overall Study|Administrative Reasons|0|||
42270848|NCT00103259|76100363|FG000|Overall Study|Death|3|||
42270849|NCT00103259|76100364|FG001|Overall Study|Death|2|||
42270850|NCT00103259|76100363|FG000|Overall Study|Withdrawal by Subject|2|||
42270851|NCT00103259|76100364|FG001|Overall Study|Withdrawal by Subject|3|||
42270852|NCT00103259|76100363|FG000|Overall Study|alternative therapy|1|||
42270853|NCT00103259|76100364|FG001|Overall Study|alternative therapy|0|||
42345312|NCT01401010|76184078|FG001|Overall Study|Could not interpret assay results|0|||
42345313|NCT01400932|76184091|FG000|Overall Study|Adverse Event|10|||
42004570|NCT01033825|75812518|FG003|Overall Study|Adverse Event|1|||
42136513|NCT00281632|75946964|FG000|Overall Study|Withdrawal by Subject|2|||
42136514|NCT00281632|75946964|FG000|Overall Study|Disease Progression|22|||
42136515|NCT00281632|75946964|FG000|Overall Study|Death|1|||
42136516|NCT00281632|75946964|FG000|Overall Study|Physician Decision|1|||
42136517|NCT00281632|75946964|FG000|Overall Study|Ongoing|3|||
42270854|NCT00103259|76100363|FG000|Overall Study|other (reasons were not specified)|2|||
42136518|NCT00543569|75946980|FG000|Overall Study|Death|2|||
42136519|NCT00543569|75946981|FG001|Overall Study|Death|2|||
42136520|NCT00543569|75946982|FG002|Overall Study|Death|3|||
42136521|NCT00543569|75946983|FG003|Overall Study|Death|1|||
42136522|NCT00543569|75946980|FG000|Overall Study|Lost to Follow-up|0|||
42136523|NCT00543569|75946981|FG001|Overall Study|Lost to Follow-up|0|||
42136524|NCT00543569|75946982|FG002|Overall Study|Lost to Follow-up|1|||
42136525|NCT00543569|75946983|FG003|Overall Study|Lost to Follow-up|1|||
42136526|NCT00543569|75946980|FG000|Overall Study|Miscellaneous Reasons|7|||
42136527|NCT00543569|75946981|FG001|Overall Study|Miscellaneous Reasons|3|||
42136528|NCT00543569|75946982|FG002|Overall Study|Miscellaneous Reasons|11|||
42136529|NCT00543569|75946983|FG003|Overall Study|Miscellaneous Reasons|4|||
42345314|NCT01400932|76184092|FG001|Overall Study|Adverse Event|5|||
42345315|NCT01400932|76184091|FG000|Overall Study|Lack of Efficacy|0|||
42345316|NCT01400932|76184092|FG001|Overall Study|Lack of Efficacy|3|||
42345317|NCT01400932|76184091|FG000|Overall Study|Withdrawal by Subject|2|||
42345318|NCT01400932|76184092|FG001|Overall Study|Withdrawal by Subject|6|||
42345319|NCT01400932|76184091|FG000|Overall Study|Lost to Follow-up|1|||
42345320|NCT01400932|76184092|FG001|Overall Study|Lost to Follow-up|0|||
42345321|NCT01400932|76184091|FG000|Overall Study|Protocol Deviation|0|||
42345322|NCT01400932|76184092|FG001|Overall Study|Protocol Deviation|1|||
42345323|NCT01400932|76184091|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
42345324|NCT01400932|76184092|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
42345325|NCT01400698|76184102|FG000|Overall Study|Lost to Follow-up|2|||
42345326|NCT01400698|76184103|FG001|Overall Study|Lost to Follow-up|5|||
42345327|NCT01400698|76184104|FG002|Overall Study|Lost to Follow-up|2|||
42345328|NCT01400698|76184105|FG003|Overall Study|Lost to Follow-up|1|||
42345329|NCT01400698|76184106|FG004|Overall Study|Lost to Follow-up|4|||
42004571|NCT01033825|75812519|FG004|Overall Study|Adverse Event|0|||
42004572|NCT01033825|75812520|FG005|Overall Study|Adverse Event|0|||
42136530|NCT00543569|75946980|FG000|Overall Study|Randomized but never received study drug|3|||
42136531|NCT00543569|75946981|FG001|Overall Study|Randomized but never received study drug|3|||
42136532|NCT00543569|75946982|FG002|Overall Study|Randomized but never received study drug|5|||
42136533|NCT00543569|75946983|FG003|Overall Study|Randomized but never received study drug|3|||
42136534|NCT00445458|75946997|FG000|Overall Study|Disease Progression|3|||
42136535|NCT00445458|75946998|FG001|Overall Study|Disease Progression|4|||
42270855|NCT00103259|76100364|FG001|Overall Study|other (reasons were not specified)|1|||
42270856|NCT00103259|76100363|FG000|Overall Study|ineligible/no protocol therapy|4|||
42270857|NCT00103259|76100364|FG001|Overall Study|ineligible/no protocol therapy|6|||
42136536|NCT00445458|75946999|FG002|Overall Study|Disease Progression|54|||
42136537|NCT00445458|75947000|FG003|Overall Study|Disease Progression|27|||
42136538|NCT00445458|75946997|FG000|Overall Study|Withdrawal by Subject|0|||
42270858|NCT02544152|76100374|FG000|Overall Study|Adverse Event|0|||
42270859|NCT02544152|76100375|FG001|Overall Study|Adverse Event|4|||
42270860|NCT02544152|76100374|FG000|Overall Study|Withdrawal by Subject|0|||
42270861|NCT02544152|76100375|FG001|Overall Study|Withdrawal by Subject|3|||
42270862|NCT02544152|76100374|FG000|Overall Study|Other|1|||
42270863|NCT02544152|76100375|FG001|Overall Study|Other|0|||
42270864|NCT02534324|76100383|FG000|Overall Study|Protocol Violation|4|||
42270865|NCT02534324|76100384|FG001|Overall Study|Protocol Violation|1|||
42270866|NCT02534324|76100383|FG000|Overall Study|Lost to Follow-up|20|||
42270867|NCT02534324|76100384|FG001|Overall Study|Lost to Follow-up|7|||
42270868|NCT02534324|76100383|FG000|Overall Study|Adverse Event|1|||
42270869|NCT02534324|76100384|FG001|Overall Study|Adverse Event|0|||
42270870|NCT02761733|76100394|FG000|Overall Study|Death|3|||
42270871|NCT02761733|76100395|FG001|Overall Study|Death|5|||
42345330|NCT01400698|76184107|FG005|Overall Study|Lost to Follow-up|3|||
42345331|NCT01400698|76184102|FG000|Overall Study|Withdrawal by Subject|8|||
42345332|NCT01400698|76184103|FG001|Overall Study|Withdrawal by Subject|2|||
42345333|NCT01400698|76184104|FG002|Overall Study|Withdrawal by Subject|0|||
42345334|NCT01400698|76184105|FG003|Overall Study|Withdrawal by Subject|4|||
42345335|NCT01400698|76184106|FG004|Overall Study|Withdrawal by Subject|1|||
42136539|NCT00445458|75946998|FG001|Overall Study|Withdrawal by Subject|0|||
42136540|NCT00445458|75946999|FG002|Overall Study|Withdrawal by Subject|7|||
42136541|NCT00445458|75947000|FG003|Overall Study|Withdrawal by Subject|0|||
42136542|NCT00445458|75946997|FG000|Overall Study|Adverse Event|0|||
42270872|NCT02761733|76100396|FG002|Overall Study|Death|1|||
42345336|NCT01400698|76184107|FG005|Overall Study|Withdrawal by Subject|3|||
42345337|NCT01400698|76184102|FG000|Overall Study|Protocol Violation|0|||
42345338|NCT01400698|76184103|FG001|Overall Study|Protocol Violation|1|||
42345339|NCT01400698|76184104|FG002|Overall Study|Protocol Violation|0|||
42345340|NCT01400698|76184105|FG003|Overall Study|Protocol Violation|0|||
42345341|NCT01400698|76184106|FG004|Overall Study|Protocol Violation|1|||
42345342|NCT01400698|76184107|FG005|Overall Study|Protocol Violation|0|||
42345343|NCT01400698|76184102|FG000|Overall Study|Non-compliance|0|||
42345344|NCT01400698|76184103|FG001|Overall Study|Non-compliance|1|||
42345345|NCT01400698|76184104|FG002|Overall Study|Non-compliance|0|||
42345346|NCT01400698|76184105|FG003|Overall Study|Non-compliance|1|||
42345347|NCT01400698|76184106|FG004|Overall Study|Non-compliance|0|||
42345348|NCT01400698|76184107|FG005|Overall Study|Non-compliance|0|||
42345349|NCT01400698|76184102|FG000|Overall Study|Adverse Event|1|||
42345350|NCT01400698|76184103|FG001|Overall Study|Adverse Event|0|||
42345351|NCT01400698|76184104|FG002|Overall Study|Adverse Event|0|||
42345352|NCT01400698|76184105|FG003|Overall Study|Adverse Event|0|||
42345353|NCT01400698|76184106|FG004|Overall Study|Adverse Event|0|||
42345354|NCT01400698|76184107|FG005|Overall Study|Adverse Event|0|||
42345355|NCT01400698|76184102|FG000|Overall Study|Other|4|||
42345356|NCT01400698|76184103|FG001|Overall Study|Other|2|||
42345357|NCT01400698|76184104|FG002|Overall Study|Other|0|||
42345358|NCT01400698|76184105|FG003|Overall Study|Other|2|||
42345359|NCT01400698|76184106|FG004|Overall Study|Other|1|||
42345360|NCT01400698|76184107|FG005|Overall Study|Other|0|||
42345361|NCT01890746|76184119|FG000|Overall Study|Death|39|||
42345362|NCT01890746|76184120|FG001|Overall Study|Death|30|||
42345363|NCT01890746|76184119|FG000|Overall Study|Adverse Event|1|||
42345364|NCT01890746|76184120|FG001|Overall Study|Adverse Event|0|||
42345365|NCT01890746|76184119|FG000|Overall Study|Lost to Follow-up|4|||
42345366|NCT01890746|76184120|FG001|Overall Study|Lost to Follow-up|1|||
42345367|NCT01890746|76184119|FG000|Overall Study|Physician Decision|3|||
42345368|NCT01890746|76184120|FG001|Overall Study|Physician Decision|2|||
42345369|NCT01890746|76184119|FG000|Overall Study|Withdrawal by Subject|5|||
42345370|NCT01890746|76184120|FG001|Overall Study|Withdrawal by Subject|8|||
42345371|NCT01422304|76184128|FG000|Overall Study|Adverse Event|0|||
42345372|NCT01422304|76184129|FG001|Overall Study|Adverse Event|1|||
42345373|NCT01422304|76184128|FG000|Overall Study|Lost to Follow-up|14|||
42345374|NCT01422304|76184129|FG001|Overall Study|Lost to Follow-up|20|||
42345375|NCT01422304|76184128|FG000|Overall Study|Never Entered Follow-up|2|||
42345376|NCT01422304|76184129|FG001|Overall Study|Never Entered Follow-up|1|||
42345377|NCT01422304|76184128|FG000|Overall Study|Protocol Violation|1|||
42345378|NCT01422304|76184129|FG001|Overall Study|Protocol Violation|0|||
42345379|NCT01422304|76184128|FG000|Overall Study|Withdrawal by Subject|4|||
42345380|NCT01422304|76184129|FG001|Overall Study|Withdrawal by Subject|2|||
42345381|NCT01422304|76184128|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
42345382|NCT01422304|76184129|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
42270873|NCT02761733|76100397|FG003|Overall Study|Death|1|||
42270874|NCT02761733|76100394|FG000|Overall Study|Lost to Follow-up|6|||
42270875|NCT02761733|76100395|FG001|Overall Study|Lost to Follow-up|7|||
42270876|NCT02761733|76100396|FG002|Overall Study|Lost to Follow-up|0|||
42270877|NCT02761733|76100397|FG003|Overall Study|Lost to Follow-up|3|||
42270878|NCT02761733|76100394|FG000|Overall Study|Physician Decision|4|||
42270879|NCT02761733|76100395|FG001|Overall Study|Physician Decision|0|||
42270880|NCT02761733|76100396|FG002|Overall Study|Physician Decision|0|||
42270881|NCT02761733|76100397|FG003|Overall Study|Physician Decision|0|||
42270882|NCT02761733|76100394|FG000|Overall Study|Withdrawal by Subject|2|||
42270883|NCT02761733|76100395|FG001|Overall Study|Withdrawal by Subject|0|||
42270884|NCT02761733|76100396|FG002|Overall Study|Withdrawal by Subject|0|||
42270885|NCT02761733|76100397|FG003|Overall Study|Withdrawal by Subject|0|||
42270886|NCT02761733|76100394|FG000|Overall Study|Discharged from Study Site|10|||
42270887|NCT02761733|76100395|FG001|Overall Study|Discharged from Study Site|9|||
42270888|NCT02761733|76100396|FG002|Overall Study|Discharged from Study Site|25|||
42270889|NCT02761733|76100397|FG003|Overall Study|Discharged from Study Site|11|||
42270890|NCT02761733|76100394|FG000|Overall Study|Cognitive Impairment|5|||
42270891|NCT02761733|76100395|FG001|Overall Study|Cognitive Impairment|0|||
42345383|NCT01422304|76184128|FG000|Overall Study|Not Treated|3|||
42345384|NCT01422304|76184129|FG001|Overall Study|Not Treated|11|||
42004573|NCT01033825|75812521|FG006|Overall Study|Adverse Event|0|||
42004574|NCT01033825|75812515|FG000|Overall Study|Protocol Violation|1|||
42345385|NCT01387516|76184139|FG000|Overall Study|Lost to Follow-up|4|||
42345386|NCT01387516|76184140|FG001|Overall Study|Lost to Follow-up|4|||
42345387|NCT01387516|76184141|FG002|Overall Study|Lost to Follow-up|2|||
42345388|NCT01387516|76184142|FG003|Overall Study|Lost to Follow-up|3|||
42345389|NCT01387516|76184139|FG000|Overall Study|Withdrawal by Subject|1|||
42345390|NCT01387516|76184140|FG001|Overall Study|Withdrawal by Subject|1|||
42345391|NCT01387516|76184141|FG002|Overall Study|Withdrawal by Subject|2|||
42345392|NCT01387516|76184142|FG003|Overall Study|Withdrawal by Subject|0|||
42270892|NCT02761733|76100396|FG002|Overall Study|Cognitive Impairment|1|||
42345393|NCT01387516|76184139|FG000|Overall Study|Death|0|||
42345394|NCT01387516|76184140|FG001|Overall Study|Death|0|||
42345395|NCT01387516|76184141|FG002|Overall Study|Death|0|||
42345396|NCT01387516|76184142|FG003|Overall Study|Death|1|||
42345397|NCT01421134|76184163|FG000|Overall Study|Adverse Event|3|||
42345398|NCT01421134|76184164|FG001|Overall Study|Adverse Event|5|||
42345399|NCT01421134|76184163|FG000|Overall Study|Lack of Efficacy|2|||
42345400|NCT01421134|76184164|FG001|Overall Study|Lack of Efficacy|4|||
42345401|NCT01421134|76184163|FG000|Overall Study|Protocol Violation|0|||
42345402|NCT01421134|76184164|FG001|Overall Study|Protocol Violation|3|||
42345403|NCT01421134|76184163|FG000|Overall Study|Withdrawal by Subject|1|||
42345404|NCT01421134|76184164|FG001|Overall Study|Withdrawal by Subject|1|||
42345405|NCT01421134|76184163|FG000|Overall Study|Administrative|0|||
42345406|NCT01421134|76184164|FG001|Overall Study|Administrative|1|||
42004575|NCT01033825|75812516|FG001|Overall Study|Protocol Violation|0|||
42004576|NCT01033825|75812517|FG002|Overall Study|Protocol Violation|0|||
42345407|NCT01421134|76184163|FG000|Overall Study|Lost to Follow-up|1|||
42345408|NCT01421134|76184164|FG001|Overall Study|Lost to Follow-up|1|||
42345409|NCT01894022|76184172|FG000|Overall Study|Death|1|||
42345410|NCT01894022|76184173|FG001|Overall Study|Death|0|||
42345411|NCT01894022|76184172|FG000|Overall Study|Adverse Event, non-fatal|1|||
42345412|NCT01894022|76184173|FG001|Overall Study|Adverse Event, non-fatal|0|||
42345413|NCT01894022|76184172|FG000|Overall Study|Study Closed/terminated|7|||
42345414|NCT01894022|76184173|FG001|Overall Study|Study Closed/terminated|10|||
42345415|NCT01615328|76184182|FG000|Overall Study|Lost to Follow-up|3|||
42345416|NCT01615328|76184183|FG001|Overall Study|Lost to Follow-up|5|||
42345417|NCT01890512|76184193|FG000|Overall Study|Physician Decision|1|||
42345418|NCT01890512|76184193|FG000|Overall Study|Withdrawal by Subject|1|||
42345419|NCT01890512|76184193|FG000|Overall Study|Protocol Violation|1|||
42345420|NCT01387282|76184199|FG000|Overall Study|Death|47|||
42345421|NCT01387282|76184200|FG001|Overall Study|Death|16|||
42345422|NCT01387282|76184199|FG000|Overall Study|Other|5|||
42345423|NCT01387282|76184200|FG001|Overall Study|Other|1|||
42345424|NCT01387282|76184199|FG000|Overall Study|Unrelated AE|6|||
42345425|NCT01387282|76184200|FG001|Overall Study|Unrelated AE|4|||
42345426|NCT01387282|76184199|FG000|Overall Study|Withdrawal by patient|33|||
42345427|NCT01387282|76184200|FG001|Overall Study|Withdrawal by patient|23|||
42345428|NCT01387282|76184199|FG000|Overall Study|Study drug-related AE|2|||
42345429|NCT01387282|76184200|FG001|Overall Study|Study drug-related AE|2|||
42345430|NCT01387282|76184199|FG000|Overall Study|Lost to Follow-up|4|||
42345431|NCT01387282|76184200|FG001|Overall Study|Lost to Follow-up|1|||
42345432|NCT01386970|76184208|FG000|Overall Study|Withdrawal by Subject|0|||
42345433|NCT01386970|76184209|FG001|Overall Study|Withdrawal by Subject|1|||
42345434|NCT01386970|76184208|FG000|Overall Study|Adverse Event|4|||
42345435|NCT01386970|76184209|FG001|Overall Study|Adverse Event|1|||
42345436|NCT01890434|76184217|FG000|Overall Study|Adverse Event|8|||
42345437|NCT01890434|76184217|FG000|Overall Study|PCI at external hospital|1|||
42345438|NCT01890434|76184217|FG000|Overall Study|Assessment discrepancy|1|||
42345439|NCT01890434|76184217|FG000|Overall Study|CRC didn't contact participant for FU|1|||
42345440|NCT01890434|76184217|FG000|Overall Study|Could not get whole set of images|1|||
42345441|NCT01890434|76184217|FG000|Overall Study|Decline to return for GSPECT|1|||
42004577|NCT01033825|75812518|FG003|Overall Study|Protocol Violation|0|||
42345442|NCT01890434|76184217|FG000|Overall Study|GSPECT at rest was not done|1|||
42345443|NCT01890434|76184217|FG000|Overall Study|Participant didn't complete MRI|1|||
42345444|NCT01890434|76184217|FG000|Overall Study|Uncontactable by phone|1|||
42345445|NCT01890434|76184217|FG000|Overall Study|Moved out of position|1|||
42345446|NCT01890434|76184217|FG000|Overall Study|Unable to contact|1|||
42345447|NCT01890434|76184217|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
42345448|NCT01385566|76184227|FG000|Overall Study|Lost to Follow-up|1|||
42345449|NCT01385566|76184228|FG001|Overall Study|Lost to Follow-up|0|||
42345450|NCT01385566|76184229|FG002|Overall Study|Lost to Follow-up|0|||
42345451|NCT01385566|76184230|FG003|Overall Study|Lost to Follow-up|0|||
42345452|NCT01385566|76184231|FG004|Overall Study|Lost to Follow-up|0|||
42136543|NCT00445458|75946998|FG001|Overall Study|Adverse Event|0|||
42136544|NCT00445458|75946999|FG002|Overall Study|Adverse Event|3|||
42270893|NCT02761733|76100397|FG003|Overall Study|Cognitive Impairment|0|||
42270894|NCT03715465|76100409|FG000|Overall Study|Withdrawal by Subject|1|||
42270895|NCT03715465|76100410|FG001|Overall Study|Withdrawal by Subject|2|||
42270896|NCT00840073|76100418|FG000|Second Intervention|Missed 72 hour blood draw|1|||
42270897|NCT00840073|76100419|FG001|Second Intervention|Missed 72 hour blood draw|1|||
42270898|NCT00838279|76100425|FG000|Washout|Protocol Violation|1|||
42270899|NCT00838279|76100426|FG001|Washout|Protocol Violation|0|||
42270900|NCT00838279|76100425|FG000|Washout|Withdrawal by Subject|0|||
42270901|NCT00838279|76100426|FG001|Washout|Withdrawal by Subject|1|||
42270902|NCT02759939|76100434|FG000|Overall Study|Missing data on first outcome assessed|11|||
42270903|NCT02759939|76100435|FG001|Overall Study|Missing data on first outcome assessed|2|||
42345453|NCT01385566|76184232|FG005|Overall Study|Lost to Follow-up|0|||
42345454|NCT01385566|76184227|FG000|Overall Study|Withdrawal by Subject|0|||
42345455|NCT01385566|76184228|FG001|Overall Study|Withdrawal by Subject|0|||
42345456|NCT01385566|76184229|FG002|Overall Study|Withdrawal by Subject|0|||
42136545|NCT00445458|75947000|FG003|Overall Study|Adverse Event|0|||
42136546|NCT00445458|75946997|FG000|Overall Study|Death|0|||
42270904|NCT02759939|76100436|FG002|Overall Study|Missing data on first outcome assessed|5|||
42004578|NCT01033825|75812519|FG004|Overall Study|Protocol Violation|0|||
42270905|NCT02759939|76100437|FG003|Overall Study|Missing data on first outcome assessed|2|||
42270906|NCT02759939|76100434|FG000|Overall Study|Ineligible for T2 and T3|310|||
42270907|NCT02759939|76100435|FG001|Overall Study|Ineligible for T2 and T3|179|||
42270908|NCT02759939|76100436|FG002|Overall Study|Ineligible for T2 and T3|366|||
42004579|NCT01033825|75812520|FG005|Overall Study|Protocol Violation|0|||
42270909|NCT02759939|76100437|FG003|Overall Study|Ineligible for T2 and T3|391|||
42270910|NCT02759939|76100434|FG000|Overall Study|Lost to Follow-up|735|||
42270911|NCT02759939|76100435|FG001|Overall Study|Lost to Follow-up|791|||
42270912|NCT02759939|76100436|FG002|Overall Study|Lost to Follow-up|783|||
42270913|NCT02759939|76100437|FG003|Overall Study|Lost to Follow-up|650|||
42270914|NCT00835705|76100456|FG000|First Intervention|Difficulty with vein|1|||
42270915|NCT00835705|76100457|FG001|First Intervention|Difficulty with vein|0|||
42270916|NCT00835705|76100456|FG000|Second Intervention|Difficulty with vein|1|||
42345457|NCT01385566|76184230|FG003|Overall Study|Withdrawal by Subject|1|||
42345458|NCT01385566|76184231|FG004|Overall Study|Withdrawal by Subject|0|||
42345459|NCT01385566|76184232|FG005|Overall Study|Withdrawal by Subject|0|||
42345460|NCT01780545|76184250|FG000|Overall Study|Withdrawal by Subject|3|||
42345461|NCT01780545|76184251|FG001|Overall Study|Withdrawal by Subject|1|||
42345462|NCT01780545|76184250|FG000|Overall Study|Lost to Follow-up|1|||
42345463|NCT01780545|76184251|FG001|Overall Study|Lost to Follow-up|1|||
42345464|NCT01780389|76184260|FG000|Overall Study|Adverse Event|1|||
42345465|NCT01778985|76184267|FG000|Overall Study|Lost to Follow-up|1|||
42345466|NCT01778985|76184268|FG001|Overall Study|Lost to Follow-up|0|||
42270917|NCT00835705|76100457|FG001|Second Intervention|Difficulty with vein|0|||
42345467|NCT01778985|76184267|FG000|Overall Study|Physician Decision|2|||
42270918|NCT02759471|76100461|FG000|Overall Study|discomfort|2|||
42270919|NCT00835549|76100469|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
42270920|NCT00835549|76100470|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
42270921|NCT03945825|76100480|FG000|Overall Study|Enrolled but treatment not administered|0|||
42270922|NCT03945825|76100481|FG001|Overall Study|Enrolled but treatment not administered|0|||
42270923|NCT03945825|76100482|FG002|Overall Study|Enrolled but treatment not administered|0|||
42270924|NCT03945825|76100483|FG003|Overall Study|Enrolled but treatment not administered|0|||
42004580|NCT01033825|75812521|FG006|Overall Study|Protocol Violation|0|||
42004581|NCT01033825|75812515|FG000|Overall Study|Other|0|||
42345468|NCT01778985|76184268|FG001|Overall Study|Physician Decision|2|||
42345469|NCT01778985|76184267|FG000|Overall Study|Protocol Violation|4|||
42345470|NCT01778985|76184268|FG001|Overall Study|Protocol Violation|1|||
42345471|NCT01778751|76184276|FG000|Overall Study|Lost to Follow-up|1|||
42345472|NCT01778751|76184277|FG001|Overall Study|Lost to Follow-up|0|||
42345473|NCT01778751|76184276|FG000|Overall Study|Withdrawal by Subject|0|||
42345474|NCT01778751|76184277|FG001|Overall Study|Withdrawal by Subject|2|||
42345475|NCT01778751|76184276|FG000|Overall Study|Transfered care|1|||
42345476|NCT01778751|76184277|FG001|Overall Study|Transfered care|0|||
42345477|NCT01865084|76184286|FG000|Double Blind Period (DB)|Adverse Event|2|||
42345478|NCT01865084|76184287|FG001|Double Blind Period (DB)|Adverse Event|2|||
42345479|NCT01865084|76184288|FG002|Double Blind Period (DB)|Adverse Event|1|||
42345480|NCT01865084|76184286|FG000|Double Blind Period (DB)|Protocol Violation|0|||
42345481|NCT01865084|76184287|FG001|Double Blind Period (DB)|Protocol Violation|0|||
42345482|NCT01865084|76184288|FG002|Double Blind Period (DB)|Protocol Violation|1|||
42345483|NCT01865084|76184286|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
42345484|NCT01865084|76184287|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
42345485|NCT01865084|76184288|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
42345486|NCT01865084|76184286|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
42345487|NCT01865084|76184287|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
42345488|NCT01865084|76184288|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
42345489|NCT01865084|76184286|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
42345490|NCT01865084|76184287|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
42345491|NCT01865084|76184288|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
42345492|NCT01865084|76184286|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
42345493|NCT01865084|76184287|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
42345494|NCT01865084|76184288|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
42345495|NCT01865084|76184286|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
42345496|NCT01865084|76184287|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
42345497|NCT01865084|76184288|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
42345498|NCT01865084|76184286|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
42345499|NCT01865084|76184287|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
42345500|NCT01865084|76184288|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
42345501|NCT01865084|76184286|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
42345502|NCT01865084|76184287|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
42345503|NCT01865084|76184288|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
42345504|NCT01778127|76184303|FG000|Overall Study|Lost to Follow-up|5|||
42345505|NCT01778127|76184304|FG001|Overall Study|Lost to Follow-up|1|||
42345506|NCT01778127|76184305|FG002|Overall Study|Lost to Follow-up|2|||
42345507|NCT01778127|76184303|FG000|Overall Study|Withdrawal by Subject|3|||
42345508|NCT01778127|76184304|FG001|Overall Study|Withdrawal by Subject|1|||
42345509|NCT01778127|76184305|FG002|Overall Study|Withdrawal by Subject|4|||
42345510|NCT01892540|76184316|FG000|Overall Study|Did not complete PET/MRI|0|||
42345511|NCT01892540|76184317|FG001|Overall Study|Did not complete PET/MRI|0|||
42345512|NCT01892540|76184318|FG002|Overall Study|Did not complete PET/MRI|2|||
42345513|NCT01892540|76184316|FG000|Overall Study|Did not fit in scanner|0|||
42004582|NCT01033825|75812516|FG001|Overall Study|Other|0|||
42270925|NCT03945825|76100484|FG004|Overall Study|Enrolled but treatment not administered|1|||
42270926|NCT03945825|76100485|FG005|Overall Study|Enrolled but treatment not administered|0|||
42270927|NCT03945825|76100480|FG000|Overall Study|Lost to Follow-up|1|||
42270928|NCT03945825|76100481|FG001|Overall Study|Lost to Follow-up|5|||
42270929|NCT03945825|76100482|FG002|Overall Study|Lost to Follow-up|0|||
42270930|NCT03945825|76100483|FG003|Overall Study|Lost to Follow-up|1|||
42270931|NCT03945825|76100484|FG004|Overall Study|Lost to Follow-up|2|||
42270932|NCT03945825|76100485|FG005|Overall Study|Lost to Follow-up|2|||
42270933|NCT03945825|76100480|FG000|Overall Study|Withdrawal by Subject|1|||
42270934|NCT03945825|76100481|FG001|Overall Study|Withdrawal by Subject|0|||
42270935|NCT03945825|76100482|FG002|Overall Study|Withdrawal by Subject|1|||
42270936|NCT03945825|76100483|FG003|Overall Study|Withdrawal by Subject|1|||
42270937|NCT03945825|76100484|FG004|Overall Study|Withdrawal by Subject|0|||
42270938|NCT03945825|76100485|FG005|Overall Study|Withdrawal by Subject|1|||
42270939|NCT02759315|76100513|FG000|Overall Study|Adverse Event|0|||
42270940|NCT02759315|76100514|FG001|Overall Study|Adverse Event|0|||
42270941|NCT02759315|76100515|FG002|Overall Study|Adverse Event|0|||
42270942|NCT02759315|76100516|FG003|Overall Study|Adverse Event|1|||
42270943|NCT02759315|76100517|FG004|Overall Study|Adverse Event|0|||
42270944|NCT02759315|76100513|FG000|Overall Study|Death|0|||
42270945|NCT02759315|76100514|FG001|Overall Study|Death|0|||
42270946|NCT02759315|76100515|FG002|Overall Study|Death|1|||
42270947|NCT02759315|76100516|FG003|Overall Study|Death|0|||
42345514|NCT01892540|76184317|FG001|Overall Study|Did not fit in scanner|0|||
42270948|NCT02759315|76100517|FG004|Overall Study|Death|0|||
42270949|NCT02759315|76100513|FG000|Overall Study|Lost to Follow-up|2|||
42270950|NCT02759315|76100514|FG001|Overall Study|Lost to Follow-up|0|||
42270951|NCT02759315|76100515|FG002|Overall Study|Lost to Follow-up|4|||
42270952|NCT02759315|76100516|FG003|Overall Study|Lost to Follow-up|0|||
42270953|NCT02759315|76100517|FG004|Overall Study|Lost to Follow-up|0|||
42270954|NCT02759315|76100513|FG000|Overall Study|Protocol Violation|0|||
42345515|NCT01892540|76184318|FG002|Overall Study|Did not fit in scanner|1|||
42035218|NCT01114529|75843549|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
42035219|NCT01114529|75843550|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
42035220|NCT01114529|75843548|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
42004583|NCT01033825|75812517|FG002|Overall Study|Other|0|||
42004584|NCT01033825|75812518|FG003|Overall Study|Other|0|||
42004585|NCT01033825|75812519|FG004|Overall Study|Other|1|||
42136547|NCT00445458|75946998|FG001|Overall Study|Death|1|||
42004586|NCT01033825|75812520|FG005|Overall Study|Other|0|||
42004587|NCT01033825|75812521|FG006|Overall Study|Other|0|||
42004588|NCT01033747|75812541|FG000|Overall Study|Adverse Event|9|||
42004589|NCT01033747|75812542|FG001|Overall Study|Adverse Event|4|||
42004590|NCT01033747|75812541|FG000|Overall Study|Abnormal Laboratory Value|1|||
42270955|NCT02759315|76100514|FG001|Overall Study|Protocol Violation|1|||
42270956|NCT02759315|76100515|FG002|Overall Study|Protocol Violation|0|||
42136548|NCT00445458|75946999|FG002|Overall Study|Death|2|||
42136549|NCT00445458|75947000|FG003|Overall Study|Death|0|||
42270957|NCT02759315|76100516|FG003|Overall Study|Protocol Violation|0|||
42004591|NCT01033747|75812542|FG001|Overall Study|Abnormal Laboratory Value|0|||
42270958|NCT02759315|76100517|FG004|Overall Study|Protocol Violation|0|||
42004592|NCT01033747|75812541|FG000|Overall Study|Abnormal test procedure|0|||
42270959|NCT02759315|76100513|FG000|Overall Study|Study terminated prior to completion|2|||
42345516|NCT01385098|76184326|FG000|Overall Study|Adverse Event|10|||
42345517|NCT01385098|76184326|FG000|Overall Study|Lost to Follow-up|4|||
42345518|NCT01398514|76184334|FG000|Overall Study|Adverse Event|1|||
42345519|NCT01398514|76184335|FG001|Overall Study|Adverse Event|0|||
42345520|NCT01398514|76184334|FG000|Overall Study|Non-compliance with study procedures|2|||
42345521|NCT01398514|76184335|FG001|Overall Study|Non-compliance with study procedures|0|||
42345522|NCT01398514|76184334|FG000|Overall Study|Physiologic non-responsiveness|1|||
42345523|NCT01398514|76184335|FG001|Overall Study|Physiologic non-responsiveness|3|||
42345524|NCT01398514|76184334|FG000|Overall Study|Failure to show a conditioned response|4|||
42345525|NCT01398514|76184335|FG001|Overall Study|Failure to show a conditioned response|3|||
42345526|NCT01398358|76184346|FG000|Overall Study|Lost to Follow-up|11|||
42345527|NCT01398358|76184347|FG001|Overall Study|Lost to Follow-up|21|||
42345528|NCT01398358|76184348|FG002|Overall Study|Lost to Follow-up|18|||
42345529|NCT01398358|76184346|FG000|Overall Study|Withdrawal by Subject|3|||
42345530|NCT01398358|76184347|FG001|Overall Study|Withdrawal by Subject|2|||
42345531|NCT01398358|76184348|FG002|Overall Study|Withdrawal by Subject|2|||
42345532|NCT01398358|76184346|FG000|Overall Study|no longer eligible|1|||
42345533|NCT01398358|76184347|FG001|Overall Study|no longer eligible|0|||
42345534|NCT01398358|76184348|FG002|Overall Study|no longer eligible|1|||
42345535|NCT01778049|76184358|FG000|Open Label Treatment Period|Adverse Event|5|||
42345536|NCT01778049|76184359|FG001|Open Label Treatment Period|Adverse Event|15|||
42345537|NCT01778049|76184360|FG002|Open Label Treatment Period|Adverse Event|0|||
42345538|NCT01778049|76184361|FG003|Open Label Treatment Period|Adverse Event|0|||
42345539|NCT01778049|76184362|FG004|Open Label Treatment Period|Adverse Event|0|||
42345540|NCT01778049|76184363|FG005|Open Label Treatment Period|Adverse Event|0|||
42345541|NCT01778049|76184358|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
42345542|NCT01778049|76184359|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
42345543|NCT01778049|76184360|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
42345544|NCT01778049|76184361|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
42345545|NCT01778049|76184362|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
42345546|NCT01778049|76184363|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
42345547|NCT01778049|76184358|FG000|Open Label Treatment Period|Protocol Violation|5|||
42345548|NCT01778049|76184359|FG001|Open Label Treatment Period|Protocol Violation|5|||
42345549|NCT01778049|76184360|FG002|Open Label Treatment Period|Protocol Violation|0|||
42345550|NCT01778049|76184361|FG003|Open Label Treatment Period|Protocol Violation|0|||
42345551|NCT01778049|76184362|FG004|Open Label Treatment Period|Protocol Violation|0|||
42345552|NCT01778049|76184363|FG005|Open Label Treatment Period|Protocol Violation|0|||
42345553|NCT01778049|76184358|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
42345554|NCT01778049|76184359|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
42345555|NCT01778049|76184360|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
42345556|NCT01778049|76184361|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
42345557|NCT01778049|76184362|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
42004593|NCT01033747|75812542|FG001|Overall Study|Abnormal test procedure|1|||
42004594|NCT01033747|75812541|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
42004595|NCT01033747|75812542|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
42004596|NCT01033747|75812541|FG000|Overall Study|Protocol Violation|1|||
42004597|NCT01033747|75812542|FG001|Overall Study|Protocol Violation|0|||
42004598|NCT01033747|75812541|FG000|Overall Study|Withdrawal by Subject|9|||
42004599|NCT01033747|75812542|FG001|Overall Study|Withdrawal by Subject|6|||
42004600|NCT01033747|75812541|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
42004601|NCT01033747|75812542|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
42004602|NCT01033747|75812541|FG000|Overall Study|Stopped at end of Extension 1|2|||
42004603|NCT01033747|75812542|FG001|Overall Study|Stopped at end of Extension 1|0|||
42004604|NCT01091428|75812552|FG000|Phase 1|Progressive Disease|24|||
42004605|NCT01091428|75812553|FG001|Phase 1|Progressive Disease|8|||
42136550|NCT00445458|75946997|FG000|Overall Study|Physician Decision|0|||
42136551|NCT00445458|75946998|FG001|Overall Study|Physician Decision|0|||
42004606|NCT01091428|75812554|FG002|Phase 1|Progressive Disease|0|||
42270960|NCT02759315|76100514|FG001|Overall Study|Study terminated prior to completion|0|||
42345558|NCT01778049|76184363|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
42345559|NCT01778049|76184358|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
42345560|NCT01778049|76184359|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
42345561|NCT01778049|76184360|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
42345562|NCT01778049|76184361|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
42345563|NCT01778049|76184362|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
42345564|NCT01778049|76184363|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
42345565|NCT01778049|76184358|FG000|Open Label Treatment Period|Not treated|2|||
42345566|NCT01778049|76184359|FG001|Open Label Treatment Period|Not treated|1|||
42345567|NCT01778049|76184360|FG002|Open Label Treatment Period|Not treated|0|||
42270961|NCT02759315|76100515|FG002|Overall Study|Study terminated prior to completion|5|||
42270962|NCT02759315|76100516|FG003|Overall Study|Study terminated prior to completion|0|||
42270963|NCT02759315|76100517|FG004|Overall Study|Study terminated prior to completion|1|||
42270964|NCT00835081|76100533|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
42270965|NCT00835081|76100534|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
42270966|NCT02543918|76100540|FG000|Overall Study|Never treated|0|||
42270967|NCT02543918|76100541|FG001|Overall Study|Never treated|1|||
42270968|NCT02543918|76100540|FG000|Overall Study|Lost to Follow-up|1|||
42270969|NCT02543918|76100541|FG001|Overall Study|Lost to Follow-up|1|||
42270970|NCT02543918|76100540|FG000|Overall Study|Withdrawal by Subject|1|||
42270971|NCT02543918|76100541|FG001|Overall Study|Withdrawal by Subject|1|||
42270972|NCT02543918|76100540|FG000|Overall Study|Adverse Event|1|||
42270973|NCT02543918|76100541|FG001|Overall Study|Adverse Event|1|||
42345568|NCT01778049|76184361|FG003|Open Label Treatment Period|Not treated|0|||
42345569|NCT01778049|76184362|FG004|Open Label Treatment Period|Not treated|0|||
42345570|NCT01778049|76184363|FG005|Open Label Treatment Period|Not treated|0|||
42345571|NCT01778049|76184358|FG000|Open Label Treatment Period|Other reason not defined above|77|||
42345572|NCT01778049|76184359|FG001|Open Label Treatment Period|Other reason not defined above|94|||
42345573|NCT01778049|76184360|FG002|Open Label Treatment Period|Other reason not defined above|0|||
42345574|NCT01778049|76184361|FG003|Open Label Treatment Period|Other reason not defined above|0|||
42345575|NCT01778049|76184362|FG004|Open Label Treatment Period|Other reason not defined above|0|||
42136552|NCT00445458|75946999|FG002|Overall Study|Physician Decision|1|||
42136553|NCT00445458|75947000|FG003|Overall Study|Physician Decision|1|||
42136554|NCT00445458|75946997|FG000|Overall Study|Surgery|0|||
42136555|NCT00445458|75946998|FG001|Overall Study|Surgery|0|||
42136556|NCT00445458|75946999|FG002|Overall Study|Surgery|1|||
42136557|NCT00445458|75947000|FG003|Overall Study|Surgery|0|||
42136558|NCT03914417|75947013|FG000|Overall Study|Withdrawal by Subject|2|||
42136559|NCT00541385|75947019|FG000|Overall Study|Adverse Event|6|||
42270974|NCT01372995|76100550|FG000|Overall Study|Spouse withdrew participant from study|0|||
42270975|NCT01372995|76100551|FG001|Overall Study|Spouse withdrew participant from study|1|||
42345576|NCT01778049|76184363|FG005|Open Label Treatment Period|Other reason not defined above|0|||
42345577|NCT01778049|76184358|FG000|Double Blind Treatment Period|Adverse Event|0|||
42345578|NCT01778049|76184359|FG001|Double Blind Treatment Period|Adverse Event|0|||
42136560|NCT00541385|75947020|FG001|Overall Study|Adverse Event|3|||
42136561|NCT00541385|75947019|FG000|Overall Study|Withdrawal by Subject|2|||
42270976|NCT01372995|76100552|FG002|Overall Study|Spouse withdrew participant from study|0|||
42270977|NCT01372995|76100550|FG000|Overall Study|Physician Decision|0|||
42270978|NCT01372995|76100551|FG001|Overall Study|Physician Decision|0|||
42270979|NCT01372995|76100552|FG002|Overall Study|Physician Decision|1|||
42270980|NCT02757521|76100562|FG000|Overall Study|Adverse Event|1|||
42270981|NCT02757521|76100563|FG001|Overall Study|Adverse Event|0|||
42270982|NCT00834613|76100571|FG000|First Intervention|Protocol Violation|1|||
42270983|NCT00834613|76100572|FG001|First Intervention|Protocol Violation|0|||
42345579|NCT01778049|76184360|FG002|Double Blind Treatment Period|Adverse Event|4|||
42345580|NCT01778049|76184361|FG003|Double Blind Treatment Period|Adverse Event|5|||
42136562|NCT00541385|75947020|FG001|Overall Study|Withdrawal by Subject|2|||
42136563|NCT00541385|75947019|FG000|Overall Study|Lost to Follow-up|6|||
42270984|NCT00834067|76100589|FG000|Washout of 21 Days|Protocol Violation|0|||
42270985|NCT00834067|76100590|FG001|Washout of 21 Days|Protocol Violation|1|||
42136564|NCT00541385|75947020|FG001|Overall Study|Lost to Follow-up|1|||
42136565|NCT00541385|75947019|FG000|Overall Study|Parasite reappearance/malaria|67|||
42345581|NCT01778049|76184362|FG004|Double Blind Treatment Period|Adverse Event|3|||
42345582|NCT01778049|76184363|FG005|Double Blind Treatment Period|Adverse Event|2|||
42345583|NCT01778049|76184358|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
42345584|NCT01778049|76184359|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
42345585|NCT01778049|76184360|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
42345586|NCT01778049|76184361|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
42345587|NCT01778049|76184362|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
42345588|NCT01778049|76184363|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
42345589|NCT01778049|76184358|FG000|Double Blind Treatment Period|Protocol Violation|0|||
42345590|NCT01778049|76184359|FG001|Double Blind Treatment Period|Protocol Violation|0|||
42345591|NCT01778049|76184360|FG002|Double Blind Treatment Period|Protocol Violation|2|||
42345592|NCT01778049|76184361|FG003|Double Blind Treatment Period|Protocol Violation|0|||
42345593|NCT01778049|76184362|FG004|Double Blind Treatment Period|Protocol Violation|0|||
42345594|NCT01778049|76184363|FG005|Double Blind Treatment Period|Protocol Violation|0|||
42345595|NCT01778049|76184358|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
42345596|NCT01778049|76184359|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
42345597|NCT01778049|76184360|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
42345598|NCT01778049|76184361|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
42345599|NCT01778049|76184362|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
42345600|NCT01778049|76184363|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
42345601|NCT01778049|76184358|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
42345602|NCT01778049|76184359|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
42345603|NCT01778049|76184360|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
42345604|NCT01778049|76184361|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
42345605|NCT01778049|76184362|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
42004607|NCT01091428|75812555|FG003|Phase 1|Progressive Disease|0|||
42270986|NCT02758613|76100598|FG000|Treatment|Physician and Sponsor Decision|1|||
42270987|NCT02758613|76100599|FG001|Treatment|Physician and Sponsor Decision|0|||
42270988|NCT02758613|76100600|FG002|Treatment|Physician and Sponsor Decision|0|||
42270989|NCT02758613|76100601|FG003|Treatment|Physician and Sponsor Decision|0|||
42270990|NCT02758613|76100598|FG000|Treatment|Withdrawal by Subject|1|||
42270991|NCT02758613|76100599|FG001|Treatment|Withdrawal by Subject|0|||
42270992|NCT02758613|76100600|FG002|Treatment|Withdrawal by Subject|1|||
42270993|NCT02758613|76100601|FG003|Treatment|Withdrawal by Subject|0|||
42270994|NCT02758301|76100616|FG000|Overall Study|Death|12|||
42270995|NCT02758301|76100617|FG001|Overall Study|Death|0|||
42270996|NCT02758301|76100616|FG000|Overall Study|Physician Decision|10|||
42270997|NCT02758301|76100617|FG001|Overall Study|Physician Decision|1|||
42270998|NCT02758301|76100616|FG000|Overall Study|Withdrawal by Subject|5|||
42270999|NCT02758301|76100617|FG001|Overall Study|Withdrawal by Subject|6|||
42271000|NCT02758301|76100616|FG000|Overall Study|Lost to Follow-up|7|||
42271001|NCT02758301|76100617|FG001|Overall Study|Lost to Follow-up|0|||
42271002|NCT02758301|76100616|FG000|Overall Study|Protocol Violation|0|||
42271003|NCT02758301|76100617|FG001|Overall Study|Protocol Violation|1|||
42271004|NCT02669667|76100637|FG000|Overall Study|Lost to Follow-up|0|||
42271005|NCT02669667|76100638|FG001|Overall Study|Lost to Follow-up|0|||
42271006|NCT02669667|76100639|FG002|Overall Study|Lost to Follow-up|0|||
42271007|NCT02669667|76100640|FG003|Overall Study|Lost to Follow-up|0|||
42271008|NCT02669667|76100641|FG004|Overall Study|Lost to Follow-up|0|||
42271009|NCT02669667|76100642|FG005|Overall Study|Lost to Follow-up|1|||
42271010|NCT02669667|76100643|FG006|Overall Study|Lost to Follow-up|0|||
42271011|NCT02669433|76100668|FG000|Overall Study|Protocol Violation|0|||
42271012|NCT02669433|76100669|FG001|Overall Study|Protocol Violation|4|||
42271013|NCT02669433|76100670|FG002|Overall Study|Protocol Violation|1|||
42271014|NCT02669433|76100668|FG000|Overall Study|Disease Progression|1|||
42271015|NCT02669433|76100669|FG001|Overall Study|Disease Progression|0|||
42271016|NCT02669433|76100670|FG002|Overall Study|Disease Progression|0|||
42271017|NCT02669433|76100668|FG000|Overall Study|Physician Decision|1|||
42271018|NCT02669433|76100669|FG001|Overall Study|Physician Decision|1|||
42271019|NCT02669433|76100670|FG002|Overall Study|Physician Decision|0|||
42271020|NCT02669433|76100668|FG000|Overall Study|Adverse Event|6|||
42271021|NCT02669433|76100669|FG001|Overall Study|Adverse Event|7|||
42271022|NCT02669433|76100670|FG002|Overall Study|Adverse Event|10|||
42271023|NCT02669433|76100668|FG000|Overall Study|Sponsor Termination|1|||
42271024|NCT02669433|76100669|FG001|Overall Study|Sponsor Termination|0|||
42345606|NCT01778049|76184363|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
42345607|NCT01778049|76184358|FG000|Double Blind Treatment Period|Not treated|0|||
42271025|NCT02669433|76100670|FG002|Overall Study|Sponsor Termination|1|||
42271026|NCT02669433|76100668|FG000|Overall Study|Withdrawal by Subject|5|||
42345608|NCT01778049|76184359|FG001|Double Blind Treatment Period|Not treated|0|||
42345609|NCT01778049|76184360|FG002|Double Blind Treatment Period|Not treated|0|||
42345610|NCT01778049|76184361|FG003|Double Blind Treatment Period|Not treated|2|||
42345611|NCT01778049|76184362|FG004|Double Blind Treatment Period|Not treated|2|||
42345612|NCT01778049|76184363|FG005|Double Blind Treatment Period|Not treated|0|||
42345613|NCT01778049|76184358|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
42345614|NCT01778049|76184359|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
42345615|NCT01778049|76184360|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
42345616|NCT01778049|76184361|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
42345617|NCT01778049|76184362|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
42271027|NCT02669433|76100669|FG001|Overall Study|Withdrawal by Subject|1|||
42271028|NCT02669433|76100670|FG002|Overall Study|Withdrawal by Subject|0|||
42271029|NCT02669433|76100668|FG000|Overall Study|Withdrawal by Caregiver|1|||
42271030|NCT02669433|76100669|FG001|Overall Study|Withdrawal by Caregiver|0|||
42271031|NCT02669433|76100670|FG002|Overall Study|Withdrawal by Caregiver|2|||
42271032|NCT02669433|76100668|FG000|Overall Study|Death|0|||
42271033|NCT02669433|76100669|FG001|Overall Study|Death|1|||
42271034|NCT02669433|76100670|FG002|Overall Study|Death|1|||
42271035|NCT02756819|76100678|FG000|Overall Study|Lost for observation|23|||
42271036|NCT02756819|76100678|FG000|Overall Study|Patient's unwillingness|16|||
42271037|NCT02756819|76100678|FG000|Overall Study|Insufficient efficacy|2|||
42345618|NCT01778049|76184363|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
42271038|NCT02756819|76100678|FG000|Overall Study|Adverse Event|2|||
42136566|NCT00541385|75947020|FG001|Overall Study|Parasite reappearance/malaria|32|||
42004608|NCT01091428|75812552|FG000|Phase 1|Symptomatic Deterioration|3|||
42004609|NCT01091428|75812553|FG001|Phase 1|Symptomatic Deterioration|2|||
42004610|NCT01091428|75812554|FG002|Phase 1|Symptomatic Deterioration|0|||
42004611|NCT01091428|75812555|FG003|Phase 1|Symptomatic Deterioration|0|||
42004612|NCT01091428|75812552|FG000|Phase 1|Adverse Event|2|||
42004613|NCT01091428|75812553|FG001|Phase 1|Adverse Event|0|||
42004614|NCT01091428|75812554|FG002|Phase 1|Adverse Event|0|||
42004615|NCT01091428|75812555|FG003|Phase 1|Adverse Event|0|||
42004616|NCT01091428|75812552|FG000|Phase 1|Withdrawal by Subject|7|||
42004617|NCT01091428|75812553|FG001|Phase 1|Withdrawal by Subject|0|||
42004618|NCT01091428|75812554|FG002|Phase 1|Withdrawal by Subject|0|||
42004619|NCT01091428|75812555|FG003|Phase 1|Withdrawal by Subject|0|||
42004620|NCT01091428|75812552|FG000|Phase 1|Reason not specified|0|||
42004621|NCT01091428|75812553|FG001|Phase 1|Reason not specified|1|||
42004622|NCT01091428|75812554|FG002|Phase 1|Reason not specified|0|||
42004623|NCT01091428|75812555|FG003|Phase 1|Reason not specified|0|||
42004624|NCT01091428|75812552|FG000|Phase 1|Single-Patient IND|2|||
42345619|NCT01777581|76184377|FG000|Overall Study|Lost to Follow-up|1|||
42345620|NCT01777581|76184378|FG001|Overall Study|Lost to Follow-up|1|||
42345621|NCT01777581|76184377|FG000|Overall Study|Adverse Event|2|||
42004625|NCT01091428|75812553|FG001|Phase 1|Single-Patient IND|0|||
42345622|NCT01777581|76184378|FG001|Overall Study|Adverse Event|0|||
42004626|NCT01091428|75812554|FG002|Phase 1|Single-Patient IND|0|||
42004627|NCT01091428|75812555|FG003|Phase 1|Single-Patient IND|0|||
42136567|NCT00265096|75947029|FG000|Overall Study|Adverse Event|14|||
42136568|NCT00265096|75947030|FG001|Overall Study|Adverse Event|18|||
42136569|NCT00265096|75947031|FG002|Overall Study|Adverse Event|18|||
42136570|NCT00265096|75947029|FG000|Overall Study|Lost to Follow-up|2|||
42136571|NCT00265096|75947030|FG001|Overall Study|Lost to Follow-up|5|||
42136572|NCT00265096|75947031|FG002|Overall Study|Lost to Follow-up|3|||
42136573|NCT00265096|75947029|FG000|Overall Study|Death|0|||
42136574|NCT00265096|75947030|FG001|Overall Study|Death|1|||
42136575|NCT00265096|75947031|FG002|Overall Study|Death|2|||
42136576|NCT00265096|75947029|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
42136577|NCT00265096|75947030|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
42136578|NCT00265096|75947031|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
42345623|NCT01777581|76184377|FG000|Overall Study|Lack of Efficacy|0|||
42345624|NCT01777581|76184378|FG001|Overall Study|Lack of Efficacy|1|||
42345625|NCT01864148|76184389|FG000|Overall Study|Other|2|||
42345626|NCT01864148|76184390|FG001|Overall Study|Other|1|||
42345627|NCT01864148|76184391|FG002|Overall Study|Other|1|||
42345628|NCT01864148|76184392|FG003|Overall Study|Other|3|||
42345629|NCT01864148|76184393|FG004|Overall Study|Other|1|||
42345630|NCT01864148|76184389|FG000|Overall Study|Death|0|||
42345631|NCT01864148|76184390|FG001|Overall Study|Death|0|||
42345632|NCT01864148|76184391|FG002|Overall Study|Death|0|||
42345633|NCT01864148|76184392|FG003|Overall Study|Death|1|||
42345634|NCT01864148|76184393|FG004|Overall Study|Death|0|||
42345635|NCT01864148|76184389|FG000|Overall Study|Investigator Decision|5|||
42345636|NCT01864148|76184390|FG001|Overall Study|Investigator Decision|0|||
42345637|NCT01864148|76184391|FG002|Overall Study|Investigator Decision|0|||
42345638|NCT01864148|76184392|FG003|Overall Study|Investigator Decision|4|||
42345639|NCT01864148|76184393|FG004|Overall Study|Investigator Decision|6|||
42004628|NCT01091428|75812552|FG000|Phase 2|Progressive Disease|0|||
42345640|NCT01864148|76184389|FG000|Overall Study|Withdrawal by Subject|9|||
42345641|NCT01864148|76184390|FG001|Overall Study|Withdrawal by Subject|2|||
42004629|NCT01091428|75812553|FG001|Phase 2|Progressive Disease|0|||
42004630|NCT01091428|75812554|FG002|Phase 2|Progressive Disease|44|||
42136579|NCT00265096|75947029|FG000|Overall Study|Other|11|||
42136580|NCT00265096|75947030|FG001|Overall Study|Other|19|||
42136581|NCT00265096|75947031|FG002|Overall Study|Other|10|||
42136582|NCT00281320|75947043|FG000|Overall Study|Adverse Event|12|||
42136583|NCT00281320|75947044|FG001|Overall Study|Adverse Event|9|||
42271039|NCT02756819|76100678|FG000|Overall Study|Reason not Specified|9|||
42271040|NCT00829309|76100684|FG000|Washout: 7 Days|Protocol Violation|1|||
42271041|NCT00829309|76100685|FG001|Washout: 7 Days|Protocol Violation|0|||
42004631|NCT01091428|75812555|FG003|Phase 2|Progressive Disease|46|||
42271042|NCT02669121|76100691|FG000|Overall Study|Adverse Event|4|||
42004632|NCT01091428|75812552|FG000|Phase 2|Symptomatic Deterioration|0|||
42136584|NCT00281320|75947043|FG000|Overall Study|Lack of Efficacy|4|||
42136585|NCT00281320|75947044|FG001|Overall Study|Lack of Efficacy|3|||
42136586|NCT00281320|75947043|FG000|Overall Study|Withdrawal by Subject|5|||
42136587|NCT00281320|75947044|FG001|Overall Study|Withdrawal by Subject|6|||
42271043|NCT02669121|76100692|FG001|Overall Study|Adverse Event|5|||
42271044|NCT02669121|76100691|FG000|Overall Study|Lost to Follow-up|15|||
42271045|NCT02669121|76100692|FG001|Overall Study|Lost to Follow-up|27|||
42271046|NCT02669121|76100691|FG000|Overall Study|Withdrawal by Subject|132|||
42271047|NCT02669121|76100692|FG001|Overall Study|Withdrawal by Subject|140|||
42271048|NCT02669121|76100691|FG000|Overall Study|Pregnancy|0|||
42271049|NCT02669121|76100692|FG001|Overall Study|Pregnancy|1|||
42271050|NCT02669121|76100691|FG000|Overall Study|Discharged from US Military Active Service|117|||
42271051|NCT02669121|76100692|FG001|Overall Study|Discharged from US Military Active Service|91|||
42271052|NCT02669121|76100691|FG000|Overall Study|Reason not Specified|22|||
42271053|NCT02669121|76100692|FG001|Overall Study|Reason not Specified|18|||
42345642|NCT01864148|76184391|FG002|Overall Study|Withdrawal by Subject|6|||
42345643|NCT01864148|76184392|FG003|Overall Study|Withdrawal by Subject|8|||
42345644|NCT01864148|76184393|FG004|Overall Study|Withdrawal by Subject|8|||
42345645|NCT01864148|76184389|FG000|Overall Study|Lost to Follow-up|0|||
42345646|NCT01864148|76184390|FG001|Overall Study|Lost to Follow-up|0|||
42345647|NCT01864148|76184391|FG002|Overall Study|Lost to Follow-up|0|||
42345648|NCT01864148|76184392|FG003|Overall Study|Lost to Follow-up|2|||
42345649|NCT01864148|76184393|FG004|Overall Study|Lost to Follow-up|1|||
42345650|NCT01864148|76184389|FG000|Overall Study|Adverse Event|4|||
42345651|NCT01864148|76184390|FG001|Overall Study|Adverse Event|2|||
42345652|NCT01864148|76184391|FG002|Overall Study|Adverse Event|4|||
42345653|NCT01864148|76184392|FG003|Overall Study|Adverse Event|7|||
42271054|NCT02743117|76100700|FG000|Overall Study|Lost to Follow-up|0|||
42271055|NCT02743117|76100701|FG001|Overall Study|Lost to Follow-up|1|||
42345654|NCT01864148|76184393|FG004|Overall Study|Adverse Event|7|||
42345655|NCT01864148|76184389|FG000|Overall Study|Not Dosed|0|||
42345656|NCT01864148|76184390|FG001|Overall Study|Not Dosed|0|||
42345657|NCT01864148|76184391|FG002|Overall Study|Not Dosed|0|||
42345658|NCT01864148|76184392|FG003|Overall Study|Not Dosed|1|||
42345659|NCT01864148|76184393|FG004|Overall Study|Not Dosed|0|||
42136588|NCT00281320|75947043|FG000|Overall Study|Lost to Follow-up|1|||
42136589|NCT00281320|75947044|FG001|Overall Study|Lost to Follow-up|2|||
42136590|NCT00281320|75947043|FG000|Overall Study|Other|3|||
42136591|NCT00281320|75947044|FG001|Overall Study|Other|1|||
42345660|NCT01751139|76184410|FG000|Overall Study|Other|135|||
42345661|NCT01751139|76184410|FG000|Overall Study|Sponsor study termination|1609|||
42035221|NCT01114529|75843549|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
42035222|NCT01114529|75843550|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
42035223|NCT01114529|75843548|FG000|Completed Study Phase at Month 24|Death|8|||
42035224|NCT01114529|75843549|FG001|Completed Study Phase at Month 24|Death|5|||
42271056|NCT02743117|76100700|FG000|Overall Study|Other|1|||
42271057|NCT02743117|76100701|FG001|Overall Study|Other|0|||
42271058|NCT02669043|76100716|FG000|Overall Study|Didn't meet I/E criteria|4|||
42345662|NCT01751139|76184410|FG000|Overall Study|Lost to Follow-up|240|||
42345663|NCT01751139|76184410|FG000|Overall Study|Withdrawal by Subject|251|||
42345664|NCT01751139|76184410|FG000|Overall Study|Adverse Event|1|||
42345665|NCT01751139|76184410|FG000|Overall Study|Death|31|||
42345666|NCT01890122|76184418|FG000|Overall Study|Adverse Event|1|||
42345667|NCT01890122|76184419|FG001|Overall Study|Adverse Event|1|||
42345668|NCT01890122|76184420|FG002|Overall Study|Adverse Event|1|||
42345669|NCT01890122|76184421|FG003|Overall Study|Adverse Event|2|||
42271059|NCT00805129|76100720|FG000|Overall Study|Not treated|1|||
42271060|NCT02668185|76100724|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
42271061|NCT02668185|76100725|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
42271062|NCT02668185|76100724|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
42271063|NCT02668185|76100725|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
42271064|NCT02668185|76100724|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
42271065|NCT02668185|76100725|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
42271066|NCT02668185|76100724|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
42271067|NCT02668185|76100725|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
42345670|NCT01890122|76184418|FG000|Overall Study|Major Protocol Deviation|3|||
42345671|NCT01890122|76184419|FG001|Overall Study|Major Protocol Deviation|1|||
42345672|NCT01890122|76184420|FG002|Overall Study|Major Protocol Deviation|0|||
42136592|NCT00541307|75947056|FG000|Overall Study|Death|5|||
42271068|NCT02742181|76100736|FG000|Overall Study|Physician Decision|1|||
42004633|NCT01091428|75812553|FG001|Phase 2|Symptomatic Deterioration|0|||
42004634|NCT01091428|75812554|FG002|Phase 2|Symptomatic Deterioration|1|||
42004635|NCT01091428|75812555|FG003|Phase 2|Symptomatic Deterioration|6|||
42004636|NCT01091428|75812552|FG000|Phase 2|Adverse Event|0|||
42004637|NCT01091428|75812553|FG001|Phase 2|Adverse Event|0|||
42004638|NCT01091428|75812554|FG002|Phase 2|Adverse Event|12|||
42345673|NCT01890122|76184421|FG003|Overall Study|Major Protocol Deviation|1|||
42004639|NCT01091428|75812555|FG003|Phase 2|Adverse Event|5|||
42004640|NCT01091428|75812552|FG000|Phase 2|Withdrawal by Subject|0|||
42004641|NCT01091428|75812553|FG001|Phase 2|Withdrawal by Subject|0|||
42271069|NCT02742181|76100737|FG001|Overall Study|Physician Decision|0|||
42004642|NCT01091428|75812554|FG002|Phase 2|Withdrawal by Subject|9|||
42004643|NCT01091428|75812555|FG003|Phase 2|Withdrawal by Subject|8|||
42136593|NCT00541307|75947056|FG000|Overall Study|Physician Decision|3|||
42136594|NCT00541307|75947056|FG000|Overall Study|Withdrawal by Subject|6|||
42345674|NCT01890122|76184418|FG000|Overall Study|Lost to Follow-up|0|||
42345675|NCT01890122|76184419|FG001|Overall Study|Lost to Follow-up|1|||
42345676|NCT01890122|76184420|FG002|Overall Study|Lost to Follow-up|2|||
42345677|NCT01890122|76184421|FG003|Overall Study|Lost to Follow-up|2|||
42345678|NCT01890122|76184418|FG000|Overall Study|Voluntary Withdrawal|8|||
42345679|NCT01890122|76184419|FG001|Overall Study|Voluntary Withdrawal|8|||
42345680|NCT01890122|76184420|FG002|Overall Study|Voluntary Withdrawal|2|||
42345681|NCT01890122|76184421|FG003|Overall Study|Voluntary Withdrawal|11|||
42345682|NCT01890122|76184418|FG000|Overall Study|Lack of Efficacy|14|||
42345683|NCT01890122|76184419|FG001|Overall Study|Lack of Efficacy|24|||
42345684|NCT01890122|76184420|FG002|Overall Study|Lack of Efficacy|7|||
42345685|NCT01890122|76184421|FG003|Overall Study|Lack of Efficacy|41|||
42345686|NCT01890122|76184418|FG000|Overall Study|Reason not Specified|0|||
42345687|NCT01890122|76184419|FG001|Overall Study|Reason not Specified|1|||
42345688|NCT01890122|76184420|FG002|Overall Study|Reason not Specified|1|||
42345689|NCT01890122|76184421|FG003|Overall Study|Reason not Specified|2|||
42345690|NCT01890122|76184418|FG000|Overall Study|Randomized but not Treated|1|||
42136595|NCT00541307|75947056|FG000|Overall Study|Lost to Follow-up|4|||
42136596|NCT00541307|75947056|FG000|Overall Study|Subject returned early (outside window)|1|||
42345691|NCT01890122|76184419|FG001|Overall Study|Randomized but not Treated|1|||
42345692|NCT01890122|76184420|FG002|Overall Study|Randomized but not Treated|0|||
42345693|NCT01890122|76184421|FG003|Overall Study|Randomized but not Treated|0|||
42345694|NCT01397890|76184433|FG000|Overall Study|Withdrawal by Subject|7|||
42136597|NCT00541307|75947056|FG000|Overall Study|Surgical Bypass|5|||
42004644|NCT01091428|75812552|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
42004645|NCT01091428|75812553|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
42004646|NCT01091428|75812554|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
42345695|NCT01397890|76184434|FG001|Overall Study|Withdrawal by Subject|11|||
42004647|NCT01091428|75812555|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
42004648|NCT01091428|75812552|FG000|Phase 2|Reason not specified|0|||
42004649|NCT01091428|75812553|FG001|Phase 2|Reason not specified|0|||
42004650|NCT01091428|75812554|FG002|Phase 2|Reason not specified|4|||
42004651|NCT01091428|75812555|FG003|Phase 2|Reason not specified|3|||
42004652|NCT01091428|75812552|FG000|Phase 2|Physician Decision|0|||
42004653|NCT01091428|75812553|FG001|Phase 2|Physician Decision|0|||
42004654|NCT01091428|75812554|FG002|Phase 2|Physician Decision|2|||
42004655|NCT01091428|75812555|FG003|Phase 2|Physician Decision|0|||
42004656|NCT01096342|75812574|FG000|Overall Study|Protocol Violation|1|||
42004657|NCT01039519|75812578|FG000|Treatment|Progressive disease|20|||
42004658|NCT01039519|75812578|FG000|Treatment|Treatment failure|2|||
42004659|NCT01039519|75812578|FG000|Treatment|Adverse Event|3|||
42004660|NCT01039519|75812578|FG000|Treatment|Physician Decision|2|||
42004661|NCT01039519|75812578|FG000|Survival Follow-up|Death|23|||
42004662|NCT01039519|75812578|FG000|Survival Follow-up|Sponsor decision|4|||
42345696|NCT01397890|76184433|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
42004663|NCT01096186|75812582|FG000|Overall Study|Adverse Event|16|||
42004664|NCT01096186|75812582|FG000|Overall Study|Death|4|||
42004665|NCT01096186|75812582|FG000|Overall Study|Lack of Efficacy|4|||
42136598|NCT00541229|75947066|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
42136599|NCT00541229|75947067|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
42136600|NCT00541229|75947068|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
42136601|NCT00541229|75947069|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
42136602|NCT00541229|75947070|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
42136603|NCT00541229|75947071|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
42136604|NCT00541229|75947066|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
42004666|NCT01096186|75812582|FG000|Overall Study|Lost to Follow-up|2|||
42004667|NCT01096186|75812582|FG000|Overall Study|Withdrawal by Subject|22|||
42004668|NCT01096186|75812582|FG000|Overall Study|Physician Decision|1|||
42004669|NCT01096186|75812582|FG000|Overall Study|Noncompliance with study drug|1|||
42004670|NCT01032889|75812589|FG000|Overall Study|Adverse Event|2|||
42136605|NCT00541229|75947067|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
42136606|NCT00541229|75947068|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
42136607|NCT00541229|75947069|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
42136608|NCT00541229|75947070|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
42004671|NCT01032889|75812590|FG001|Overall Study|Adverse Event|2|||
42004672|NCT01032889|75812591|FG002|Overall Study|Adverse Event|0|||
42345697|NCT01397890|76184434|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
42271070|NCT02742103|76100745|FG000|Overall Study|Protocol Violation|1|||
42271071|NCT02742103|76100746|FG001|Overall Study|Protocol Violation|0|||
42271072|NCT02742103|76100745|FG000|Overall Study|Death|2|||
42271073|NCT02742103|76100746|FG001|Overall Study|Death|2|||
42271074|NCT02742103|76100745|FG000|Overall Study|Adverse Event|1|||
42271075|NCT02742103|76100746|FG001|Overall Study|Adverse Event|0|||
42271076|NCT02742103|76100745|FG000|Overall Study|Moved to another town|0|||
42271077|NCT02742103|76100746|FG001|Overall Study|Moved to another town|1|||
42271078|NCT02742103|76100745|FG000|Overall Study|Withdrawal by Subject|5|||
42271079|NCT02742103|76100746|FG001|Overall Study|Withdrawal by Subject|2|||
42271080|NCT02741713|76100754|FG000|Overall Study|Surgery type changed intra-operatively|2|||
42271081|NCT02741713|76100755|FG001|Overall Study|Surgery type changed intra-operatively|1|||
42271082|NCT02663271|76100762|FG000|Overall Study|Withdrawal by Subject|5|||
42271083|NCT02663271|76100762|FG000|Overall Study|Lack of Efficacy|1|||
42271084|NCT02742649|76100769|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
42345698|NCT01397890|76184433|FG000|Overall Study|Death|2|||
42136609|NCT00541229|75947071|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
42271085|NCT02742649|76100770|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
42345699|NCT01397890|76184434|FG001|Overall Study|Death|3|||
42136610|NCT00541229|75947066|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
42271086|NCT02742649|76100771|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
42345700|NCT01397890|76184433|FG000|Overall Study|Lost to Follow-up|1|||
42004673|NCT01032889|75812589|FG000|Overall Study|Withdrawal of Consent|1|||
42004674|NCT01032889|75812590|FG001|Overall Study|Withdrawal of Consent|2|||
42004675|NCT01032889|75812591|FG002|Overall Study|Withdrawal of Consent|1|||
42004676|NCT01032889|75812589|FG000|Overall Study|Patient Request|0|||
42004677|NCT01032889|75812590|FG001|Overall Study|Patient Request|1|||
42004678|NCT01032889|75812591|FG002|Overall Study|Patient Request|0|||
42004679|NCT01032889|75812589|FG000|Overall Study|Lost to Follow-up|1|||
42004680|NCT01032889|75812590|FG001|Overall Study|Lost to Follow-up|1|||
42004681|NCT01032889|75812591|FG002|Overall Study|Lost to Follow-up|0|||
42004682|NCT01032889|75812589|FG000|Overall Study|Lack of Submental Fat|2|||
42004683|NCT01032889|75812590|FG001|Overall Study|Lack of Submental Fat|8|||
42004684|NCT01032889|75812591|FG002|Overall Study|Lack of Submental Fat|1|||
42004685|NCT01032889|75812589|FG000|Overall Study|Miscellaneous Reasons|2|||
42004686|NCT01032889|75812590|FG001|Overall Study|Miscellaneous Reasons|1|||
42004687|NCT01032889|75812591|FG002|Overall Study|Miscellaneous Reasons|1|||
42136611|NCT00541229|75947067|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
42004688|NCT01049503|75812605|FG000|Overall Study|Lost to Follow-up|11|||
42004689|NCT01049503|75812606|FG001|Overall Study|Lost to Follow-up|12|||
42004690|NCT01049503|75812607|FG002|Overall Study|Lost to Follow-up|24|||
42004691|NCT01049503|75812608|FG003|Overall Study|Lost to Follow-up|26|||
42004692|NCT01049503|75812609|FG004|Overall Study|Lost to Follow-up|27|||
42004693|NCT01049503|75812610|FG005|Overall Study|Lost to Follow-up|8|||
42004694|NCT01029925|75812633|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
42271087|NCT02742649|76100772|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
42271088|NCT02742649|76100773|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
42271089|NCT02742649|76100769|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42271090|NCT02742649|76100770|FG001|Double-Blind Treatment Period|Adverse Event|1|||
42271091|NCT02742649|76100771|FG002|Double-Blind Treatment Period|Adverse Event|0|||
42004695|NCT01029925|75812633|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
42271092|NCT02742649|76100772|FG003|Double-Blind Treatment Period|Adverse Event|0|||
42271093|NCT02742649|76100773|FG004|Double-Blind Treatment Period|Adverse Event|0|||
42271094|NCT02742649|76100769|FG000|Open-Label Period|Lost to Follow-up|0|||
42271095|NCT02742649|76100770|FG001|Open-Label Period|Lost to Follow-up|0|||
42271096|NCT02742649|76100771|FG002|Open-Label Period|Lost to Follow-up|0|||
42271097|NCT02742649|76100772|FG003|Open-Label Period|Lost to Follow-up|0|||
42271098|NCT02742649|76100773|FG004|Open-Label Period|Lost to Follow-up|1|||
42271099|NCT02665689|76100786|FG000|Overall Study|Adverse Event|1|||
42271100|NCT02665689|76100787|FG001|Overall Study|Adverse Event|0|||
42271101|NCT02665689|76100786|FG000|Overall Study|Trial termination|1|||
42271102|NCT02665689|76100787|FG001|Overall Study|Trial termination|1|||
42004696|NCT01029925|75812633|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
42136612|NCT00541229|75947068|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
42271103|NCT02665689|76100786|FG000|Overall Study|Lost to Follow-up|0|||
42271104|NCT02665689|76100787|FG001|Overall Study|Lost to Follow-up|1|||
42271105|NCT02665455|76100793|FG000|Overall Study|Withdrawal by Subject|6|||
42271106|NCT02665455|76100793|FG000|Overall Study|Lost to Follow-up|1|||
42271107|NCT02665455|76100793|FG000|Overall Study|Adverse Event|1|||
42271108|NCT02665455|76100793|FG000|Overall Study|Protocol Violation|1|||
42271109|NCT02755805|76100799|FG000|Overall Study|Lost to Follow-up|1|||
42271110|NCT02755805|76100800|FG001|Overall Study|Lost to Follow-up|2|||
42271111|NCT02755805|76100799|FG000|Overall Study|Refused assessments|1|||
42271112|NCT02755805|76100800|FG001|Overall Study|Refused assessments|0|||
42271113|NCT02755805|76100799|FG000|Overall Study|Withdrawal by Subject|0|||
42271114|NCT02755805|76100800|FG001|Overall Study|Withdrawal by Subject|2|||
42271115|NCT02755649|76100809|FG000|Overall Study|Transitioned into OLE study|99|||
42271116|NCT02755649|76100810|FG001|Overall Study|Transitioned into OLE study|98|||
42271117|NCT02755649|76100811|FG002|Overall Study|Transitioned into OLE study|100|||
42271118|NCT02755649|76100809|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
42271119|NCT02755649|76100810|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
42271120|NCT02755649|76100811|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
42271121|NCT02755649|76100809|FG000|Overall Study|Physician Decision|0|||
42271122|NCT02755649|76100810|FG001|Overall Study|Physician Decision|0|||
42271123|NCT02755649|76100811|FG002|Overall Study|Physician Decision|2|||
42271124|NCT02755649|76100809|FG000|Overall Study|Withdrawal by Subject|0|||
42271125|NCT02755649|76100810|FG001|Overall Study|Withdrawal by Subject|1|||
42271126|NCT02755649|76100811|FG002|Overall Study|Withdrawal by Subject|0|||
42271127|NCT02755649|76100809|FG000|Overall Study|Undecided|1|||
42271128|NCT02755649|76100810|FG001|Overall Study|Undecided|0|||
42271129|NCT02755649|76100811|FG002|Overall Study|Undecided|0|||
42271130|NCT00151411|76100821|FG000|Overall Study|Lost to Follow-up|15|||
42271131|NCT00151411|76100822|FG001|Overall Study|Lost to Follow-up|19|||
42271132|NCT00151411|76100821|FG000|Overall Study|Withdrawal by Subject|12|||
42271133|NCT00151411|76100822|FG001|Overall Study|Withdrawal by Subject|20|||
42271134|NCT00151411|76100821|FG000|Overall Study|Adverse Event|6|||
42271135|NCT00151411|76100822|FG001|Overall Study|Adverse Event|0|||
42271136|NCT00151411|76100821|FG000|Overall Study|Pregnancy|0|||
42271137|NCT00151411|76100822|FG001|Overall Study|Pregnancy|4|||
42271138|NCT02662569|76100832|FG000|Overall Study|Withdrawal by Subject|6|||
42271139|NCT02662569|76100833|FG001|Overall Study|Withdrawal by Subject|1|||
42271140|NCT02662569|76100834|FG002|Overall Study|Withdrawal by Subject|6|||
42271141|NCT02662569|76100835|FG003|Overall Study|Withdrawal by Subject|4|||
42271142|NCT02662569|76100832|FG000|Overall Study|Lost to Follow-up|1|||
42271143|NCT02662569|76100833|FG001|Overall Study|Lost to Follow-up|0|||
42271144|NCT02662569|76100834|FG002|Overall Study|Lost to Follow-up|0|||
42271145|NCT02662569|76100835|FG003|Overall Study|Lost to Follow-up|0|||
42271146|NCT02741635|76100845|FG000|Overall Study|Withdrawal by Subject|1|||
42271147|NCT02753075|76100853|FG000|Overall Study|Adverse Event|2|||
42271148|NCT02753075|76100854|FG001|Overall Study|Adverse Event|1|||
42271149|NCT02753075|76100855|FG002|Overall Study|Adverse Event|0|||
42271150|NCT02753075|76100853|FG000|Overall Study|Lost to Follow-up|2|||
42271151|NCT02753075|76100854|FG001|Overall Study|Lost to Follow-up|0|||
42271152|NCT02753075|76100855|FG002|Overall Study|Lost to Follow-up|0|||
42271153|NCT02753075|76100853|FG000|Overall Study|Withdrawal of Consent|1|||
42271154|NCT02753075|76100854|FG001|Overall Study|Withdrawal of Consent|1|||
42271155|NCT02753075|76100855|FG002|Overall Study|Withdrawal of Consent|3|||
42004697|NCT01029691|75812640|FG000|Continued APAP to Delivery|Death|0|||
42271156|NCT02753075|76100853|FG000|Overall Study|Physician Decision|3|||
42004698|NCT01029691|75812641|FG001|Continued APAP to Delivery|Death|0|||
42004699|NCT01029691|75812642|FG002|Continued APAP to Delivery|Death|1|||
42271157|NCT02753075|76100854|FG001|Overall Study|Physician Decision|1|||
42271158|NCT02753075|76100855|FG002|Overall Study|Physician Decision|0|||
42271159|NCT02332720|76100887|FG000|Part A and Part B|Lost to Follow-up|1|||
42271160|NCT02332720|76100888|FG001|Part A and Part B|Lost to Follow-up|0|||
42271161|NCT02332720|76100889|FG002|Part A and Part B|Lost to Follow-up|0|||
42271162|NCT02332720|76100890|FG003|Part A and Part B|Lost to Follow-up|0|||
42271163|NCT02332720|76100891|FG004|Part A and Part B|Lost to Follow-up|0|||
42271164|NCT02332720|76100892|FG005|Part A and Part B|Lost to Follow-up|2|||
42271165|NCT02332720|76100893|FG006|Part A and Part B|Lost to Follow-up|1|||
42271166|NCT02332720|76100894|FG007|Part A and Part B|Lost to Follow-up|1|||
42271167|NCT02332720|76100895|FG008|Part A and Part B|Lost to Follow-up|0|||
42271168|NCT02332720|76100896|FG009|Part A and Part B|Lost to Follow-up|0|||
42271169|NCT02332720|76100897|FG010|Part A and Part B|Lost to Follow-up|0|||
42271170|NCT02332720|76100898|FG011|Part A and Part B|Lost to Follow-up|0|||
42271171|NCT02332720|76100899|FG012|Part A and Part B|Lost to Follow-up|0|||
42271172|NCT02332720|76100900|FG013|Part A and Part B|Lost to Follow-up|0|||
42271173|NCT02332720|76100901|FG014|Part A and Part B|Lost to Follow-up|0|||
42271174|NCT02332720|76100902|FG015|Part A and Part B|Lost to Follow-up|1|||
42271175|NCT02332720|76100903|FG016|Part A and Part B|Lost to Follow-up|0|||
42271176|NCT02332720|76100904|FG017|Part A and Part B|Lost to Follow-up|0|||
42136613|NCT00541229|75947069|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
42136614|NCT00541229|75947070|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
42136615|NCT00541229|75947071|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
42136616|NCT00541229|75947066|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
42136617|NCT00541229|75947067|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
42271177|NCT02332720|76100905|FG018|Part A and Part B|Lost to Follow-up|0|||
42271178|NCT02332720|76100906|FG019|Part A and Part B|Lost to Follow-up|0|||
42136618|NCT00541229|75947068|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
42271179|NCT02332720|76100907|FG020|Part A and Part B|Lost to Follow-up|0|||
42271180|NCT02332720|76100908|FG021|Part A and Part B|Lost to Follow-up|0|||
42271181|NCT02332720|76100909|FG022|Part A and Part B|Lost to Follow-up|0|||
42271182|NCT02332720|76100887|FG000|Part A and Part B|Adverse Event|0|||
42271183|NCT02332720|76100888|FG001|Part A and Part B|Adverse Event|0|||
42271184|NCT02332720|76100889|FG002|Part A and Part B|Adverse Event|0|||
42271185|NCT02332720|76100890|FG003|Part A and Part B|Adverse Event|0|||
42271186|NCT02332720|76100891|FG004|Part A and Part B|Adverse Event|0|||
42271187|NCT02332720|76100892|FG005|Part A and Part B|Adverse Event|0|||
42271188|NCT02332720|76100893|FG006|Part A and Part B|Adverse Event|0|||
42271189|NCT02332720|76100894|FG007|Part A and Part B|Adverse Event|0|||
42271190|NCT02332720|76100895|FG008|Part A and Part B|Adverse Event|0|||
42271191|NCT02332720|76100896|FG009|Part A and Part B|Adverse Event|0|||
42271192|NCT02332720|76100897|FG010|Part A and Part B|Adverse Event|0|||
42271193|NCT02332720|76100898|FG011|Part A and Part B|Adverse Event|0|||
42271194|NCT02332720|76100899|FG012|Part A and Part B|Adverse Event|0|||
42271195|NCT02332720|76100900|FG013|Part A and Part B|Adverse Event|0|||
42271196|NCT02332720|76100901|FG014|Part A and Part B|Adverse Event|0|||
42271197|NCT02332720|76100902|FG015|Part A and Part B|Adverse Event|0|||
42271198|NCT02332720|76100903|FG016|Part A and Part B|Adverse Event|0|||
42271199|NCT02332720|76100904|FG017|Part A and Part B|Adverse Event|1|||
42271200|NCT02332720|76100905|FG018|Part A and Part B|Adverse Event|0|||
42271201|NCT02332720|76100906|FG019|Part A and Part B|Adverse Event|0|||
42271202|NCT02332720|76100907|FG020|Part A and Part B|Adverse Event|0|||
42271203|NCT02332720|76100908|FG021|Part A and Part B|Adverse Event|0|||
42271204|NCT02332720|76100909|FG022|Part A and Part B|Adverse Event|0|||
42271205|NCT02332720|76100887|FG000|Part A and Part B|Physician Decision|0|||
42271206|NCT02332720|76100888|FG001|Part A and Part B|Physician Decision|0|||
42271207|NCT02332720|76100889|FG002|Part A and Part B|Physician Decision|0|||
42271208|NCT02332720|76100890|FG003|Part A and Part B|Physician Decision|0|||
42136619|NCT00541229|75947069|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
42271209|NCT02332720|76100891|FG004|Part A and Part B|Physician Decision|0|||
42271210|NCT02332720|76100892|FG005|Part A and Part B|Physician Decision|0|||
42271211|NCT02332720|76100893|FG006|Part A and Part B|Physician Decision|0|||
42271212|NCT02332720|76100894|FG007|Part A and Part B|Physician Decision|0|||
42271213|NCT02332720|76100895|FG008|Part A and Part B|Physician Decision|0|||
42271214|NCT02332720|76100896|FG009|Part A and Part B|Physician Decision|0|||
42271215|NCT02332720|76100897|FG010|Part A and Part B|Physician Decision|0|||
42271216|NCT02332720|76100898|FG011|Part A and Part B|Physician Decision|0|||
42271217|NCT02332720|76100899|FG012|Part A and Part B|Physician Decision|0|||
42271218|NCT02332720|76100900|FG013|Part A and Part B|Physician Decision|0|||
42271219|NCT02332720|76100901|FG014|Part A and Part B|Physician Decision|0|||
42271220|NCT02332720|76100902|FG015|Part A and Part B|Physician Decision|0|||
42271221|NCT02332720|76100903|FG016|Part A and Part B|Physician Decision|0|||
42271222|NCT02332720|76100904|FG017|Part A and Part B|Physician Decision|0|||
42271223|NCT02332720|76100905|FG018|Part A and Part B|Physician Decision|1|||
42271224|NCT02332720|76100906|FG019|Part A and Part B|Physician Decision|0|||
42271225|NCT02332720|76100907|FG020|Part A and Part B|Physician Decision|0|||
42271226|NCT02332720|76100908|FG021|Part A and Part B|Physician Decision|0|||
42271227|NCT02332720|76100909|FG022|Part A and Part B|Physician Decision|0|||
42271228|NCT02332720|76100887|FG000|Part A and Part B|Withdrawal by Subject|0|||
42271229|NCT02332720|76100888|FG001|Part A and Part B|Withdrawal by Subject|0|||
42345701|NCT01397890|76184434|FG001|Overall Study|Lost to Follow-up|4|||
42004700|NCT01029535|75812651|FG000|Overall Study|Lost to Follow-up|24|||
42004701|NCT01029535|75812651|FG000|Overall Study|Protocol Violation|2|||
42004702|NCT01029535|75812651|FG000|Overall Study|Participant Withdrew Consent|2|||
42004703|NCT01029535|75812651|FG000|Overall Study|Adverse Event|1|||
42271230|NCT02332720|76100889|FG002|Part A and Part B|Withdrawal by Subject|0|||
42136620|NCT00541229|75947070|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
42136621|NCT00541229|75947071|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
42136622|NCT00541229|75947066|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
42136623|NCT00541229|75947067|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
42345702|NCT01397890|76184433|FG000|Overall Study|Condition under Investigation Worsened|1|||
42345703|NCT01397890|76184434|FG001|Overall Study|Condition under Investigation Worsened|3|||
42345704|NCT01397890|76184433|FG000|Overall Study|Adverse Event|1|||
42345705|NCT01397890|76184434|FG001|Overall Study|Adverse Event|2|||
42345706|NCT01397890|76184433|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
42345707|NCT01397890|76184434|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
42345708|NCT01397890|76184433|FG000|Overall Study|Others|2|||
42345709|NCT01397890|76184434|FG001|Overall Study|Others|1|||
42345710|NCT01777269|76184442|FG000|Overall Study|Adverse Event|24|||
42345711|NCT01777269|76184443|FG001|Overall Study|Adverse Event|33|||
42345712|NCT01777269|76184442|FG000|Overall Study|Lack of Efficacy|8|||
42345713|NCT01777269|76184443|FG001|Overall Study|Lack of Efficacy|10|||
42345714|NCT01777269|76184442|FG000|Overall Study|Protocol Violation|4|||
42345715|NCT01777269|76184443|FG001|Overall Study|Protocol Violation|4|||
42345716|NCT01777269|76184442|FG000|Overall Study|Participants reached stopping criteria|1|||
42345717|NCT01777269|76184443|FG001|Overall Study|Participants reached stopping criteria|1|||
42345718|NCT01777269|76184442|FG000|Overall Study|Lost to Follow-up|4|||
42345719|NCT01777269|76184443|FG001|Overall Study|Lost to Follow-up|0|||
42345720|NCT01777269|76184442|FG000|Overall Study|Physician Decision|5|||
42345721|NCT01777269|76184443|FG001|Overall Study|Physician Decision|2|||
42345722|NCT01777269|76184442|FG000|Overall Study|Withdrawal by Subject|9|||
42345723|NCT01777269|76184443|FG001|Overall Study|Withdrawal by Subject|9|||
42345724|NCT04016272|76184451|FG000|Overall Study|Withdrawal by Subject|1|||
42345725|NCT04016272|76184452|FG001|Overall Study|Withdrawal by Subject|2|||
42345726|NCT01751061|76184460|FG000|Overall Study|Death|1|||
42004704|NCT01029535|75812651|FG000|Overall Study|Use of Another Treatment|1|||
42004705|NCT01029535|75812651|FG000|Overall Study|Death|1|||
42004706|NCT01028053|75812656|FG000|Overall Study|Screen Failure|113|||
42345727|NCT01751061|76184461|FG001|Overall Study|Death|0|||
42345728|NCT01751061|76184460|FG000|Overall Study|patient death|5|||
42004707|NCT01028053|75812656|FG000|Overall Study|Patient Request|11|||
42136624|NCT00541229|75947068|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
42345729|NCT01751061|76184461|FG001|Overall Study|patient death|0|||
42345730|NCT01751061|76184460|FG000|Overall Study|Lost to Follow-up|40|||
42345731|NCT01751061|76184461|FG001|Overall Study|Lost to Follow-up|25|||
42345732|NCT01751061|76184460|FG000|Overall Study|patient regained decisional capacity|4|||
42345733|NCT01751061|76184461|FG001|Overall Study|patient regained decisional capacity|8|||
42136625|NCT00541229|75947069|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
42136626|NCT00541229|75947070|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
42136627|NCT00541229|75947071|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
42136628|NCT00541229|75947066|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
42136629|NCT00541229|75947067|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
42136630|NCT00541229|75947068|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
42136631|NCT00541229|75947069|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
42136632|NCT00541229|75947070|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
42004708|NCT01028053|75812656|FG000|Overall Study|Protocol Violation|1|||
42004709|NCT01028053|75812656|FG000|Overall Study|Physician Decision|2|||
42004710|NCT01028053|75812656|FG000|Overall Study|Technical Problem|1|||
42004711|NCT01028053|75812656|FG000|Overall Study|Terminated by Sponsor|1|||
42271231|NCT02332720|76100890|FG003|Part A and Part B|Withdrawal by Subject|0|||
42271232|NCT02332720|76100891|FG004|Part A and Part B|Withdrawal by Subject|0|||
42271233|NCT02332720|76100892|FG005|Part A and Part B|Withdrawal by Subject|1|||
42271234|NCT02332720|76100893|FG006|Part A and Part B|Withdrawal by Subject|0|||
42004712|NCT01028053|75812656|FG000|Overall Study|Various reasons|4|||
42004713|NCT01023217|75812664|FG000|Overall Study|Withdrawal by Subject|1|||
42271235|NCT02332720|76100894|FG007|Part A and Part B|Withdrawal by Subject|0|||
42271236|NCT02332720|76100895|FG008|Part A and Part B|Withdrawal by Subject|0|||
42004714|NCT01023217|75812665|FG001|Overall Study|Withdrawal by Subject|0|||
42004715|NCT01095796|75812673|FG000|Overall Study|Randomized but Not Treated|5|||
42004716|NCT01095796|75812674|FG001|Overall Study|Randomized but Not Treated|2|||
42004717|NCT01095796|75812673|FG000|Overall Study|Adverse Event|9|||
42004718|NCT01095796|75812674|FG001|Overall Study|Adverse Event|19|||
42004719|NCT01095796|75812673|FG000|Overall Study|Death|3|||
42345734|NCT01751061|76184460|FG000|Overall Study|Withdrawal by Subject|4|||
42345735|NCT01751061|76184461|FG001|Overall Study|Withdrawal by Subject|1|||
42345736|NCT01751061|76184460|FG000|Overall Study|Physician Decision|2|||
42345737|NCT01751061|76184461|FG001|Overall Study|Physician Decision|0|||
42345738|NCT01777191|76184469|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
42345739|NCT01777191|76184470|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
42345740|NCT01777191|76184469|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
42345741|NCT01777191|76184470|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
42345742|NCT01777191|76184469|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
42345743|NCT01777191|76184470|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
42345744|NCT01777191|76184469|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
42345745|NCT01777191|76184470|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
42345746|NCT01777191|76184469|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
42345747|NCT01777191|76184470|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
42345748|NCT01777191|76184469|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
42345749|NCT01777191|76184470|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
42345750|NCT01777191|76184469|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
42345751|NCT01777191|76184470|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
42345752|NCT01777191|76184469|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
42345753|NCT01777191|76184470|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
42345754|NCT01777191|76184469|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
42271237|NCT02332720|76100896|FG009|Part A and Part B|Withdrawal by Subject|0|||
42271238|NCT02332720|76100897|FG010|Part A and Part B|Withdrawal by Subject|0|||
42271239|NCT02332720|76100898|FG011|Part A and Part B|Withdrawal by Subject|0|||
42004720|NCT01095796|75812674|FG001|Overall Study|Death|2|||
42004721|NCT01095796|75812673|FG000|Overall Study|Pregnancy|2|||
42004722|NCT01095796|75812674|FG001|Overall Study|Pregnancy|0|||
42004723|NCT01095796|75812673|FG000|Overall Study|Lack of Efficacy|5|||
42271240|NCT02332720|76100899|FG012|Part A and Part B|Withdrawal by Subject|0|||
42271241|NCT02332720|76100900|FG013|Part A and Part B|Withdrawal by Subject|0|||
42271242|NCT02332720|76100901|FG014|Part A and Part B|Withdrawal by Subject|0|||
42271243|NCT02332720|76100902|FG015|Part A and Part B|Withdrawal by Subject|0|||
42271244|NCT02332720|76100903|FG016|Part A and Part B|Withdrawal by Subject|0|||
42271245|NCT02332720|76100904|FG017|Part A and Part B|Withdrawal by Subject|0|||
42345755|NCT01777191|76184470|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
42345756|NCT01777191|76184469|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
42345757|NCT01777191|76184470|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
42345758|NCT01777191|76184469|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
42345759|NCT01777191|76184470|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
42345760|NCT01896050|76184481|FG000|Overall Study|Adverse Event|37|||
42345761|NCT01896050|76184482|FG001|Overall Study|Adverse Event|2|||
42345762|NCT01896050|76184481|FG000|Overall Study|Death|1|||
42345763|NCT01896050|76184482|FG001|Overall Study|Death|0|||
42345764|NCT01775787|76184490|FG000|First 7-10 Days|Adverse Event|0|||
42345765|NCT01775787|76184491|FG001|First 7-10 Days|Adverse Event|1|||
42345766|NCT01775787|76184490|FG000|First 7-10 Days|family emergency|0|||
42345767|NCT01775787|76184491|FG001|First 7-10 Days|family emergency|1|||
42345768|NCT01775787|76184490|FG000|First 7-10 Days|time commitment|0|||
42345769|NCT01775787|76184491|FG001|First 7-10 Days|time commitment|2|||
42345770|NCT01775787|76184490|FG000|First 7-10 Days|concerns with using IV|1|||
42345771|NCT01775787|76184491|FG001|First 7-10 Days|concerns with using IV|2|||
42345772|NCT01775787|76184490|FG000|Second 7-10 Days|time commitment|0|||
42004724|NCT01095796|75812674|FG001|Overall Study|Lack of Efficacy|3|||
42004725|NCT01095796|75812673|FG000|Overall Study|Investigator's Discretion|7|||
42004726|NCT01095796|75812674|FG001|Overall Study|Investigator's Discretion|2|||
42004727|NCT01095796|75812673|FG000|Overall Study|Withdrew Consent|16|||
42004728|NCT01095796|75812674|FG001|Overall Study|Withdrew Consent|22|||
42345773|NCT01775787|76184491|FG001|Second 7-10 Days|time commitment|1|||
42345774|NCT01775787|76184490|FG000|Second 7-10 Days|concerns with using IV|0|||
42345775|NCT01775787|76184491|FG001|Second 7-10 Days|concerns with using IV|1|||
42004729|NCT01095796|75812673|FG000|Overall Study|Lost to Follow-up|27|||
42271246|NCT02332720|76100905|FG018|Part A and Part B|Withdrawal by Subject|0|||
42271247|NCT02332720|76100906|FG019|Part A and Part B|Withdrawal by Subject|1|||
42271248|NCT02332720|76100907|FG020|Part A and Part B|Withdrawal by Subject|0|||
42271249|NCT02332720|76100908|FG021|Part A and Part B|Withdrawal by Subject|0|||
42271250|NCT02332720|76100909|FG022|Part A and Part B|Withdrawal by Subject|0|||
42271251|NCT02331394|76100981|FG000|Overall Study|Disease progression|1|||
42271252|NCT01645930|76100992|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
42271253|NCT01645930|76100992|FG000|Overall Study|Progressive Disease|12|||
42271254|NCT01645930|76100992|FG000|Overall Study|Adverse Event|4|||
42271255|NCT01645930|76100992|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
42271256|NCT01645930|76100992|FG000|Overall Study|Withdrawal by Participant|2|||
42271257|NCT01645930|76100992|FG000|Overall Study|Reason not Defined|1|||
42271258|NCT02299336|76100996|FG000|Overall Study|Withdrawal by Subject|11|||
42271259|NCT02299336|76100996|FG000|Overall Study|Adverse Event|1|||
42271260|NCT02299336|76100996|FG000|Overall Study|Death|1|||
42271261|NCT02299336|76100996|FG000|Overall Study|Lost to Follow-up|1|||
42271262|NCT02664441|76101002|FG000|Randomization|Withdrawal by Subject|0|||
42271263|NCT02664441|76101003|FG001|Randomization|Withdrawal by Subject|1|||
42271264|NCT02664441|76101002|FG000|36-week Randomized Trial|Adverse Event|2|||
42271265|NCT02664441|76101003|FG001|36-week Randomized Trial|Adverse Event|0|||
42345776|NCT01775553|76184499|FG000|Overall Study|Adverse Event|1|||
42345777|NCT01775553|76184499|FG000|Overall Study|Disease Progression|12|||
42345778|NCT01775475|76184505|FG000|Overall Study|Death|3|||
42345779|NCT01775475|76184506|FG001|Overall Study|Death|3|||
42271266|NCT02664441|76101002|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
42271267|NCT02664441|76101003|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
42271268|NCT02664441|76101002|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
42271269|NCT02664441|76101003|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
42271270|NCT02664441|76101002|FG000|18-week Open Label Extension|Adverse Event|1|||
42271271|NCT02664441|76101003|FG001|18-week Open Label Extension|Adverse Event|0|||
42271272|NCT02664441|76101002|FG000|18-week Open Label Extension|Physician Decision|1|||
42271273|NCT02664441|76101003|FG001|18-week Open Label Extension|Physician Decision|0|||
42271274|NCT02664441|76101002|FG000|18-week Open Label Extension|Death|1|||
42271275|NCT02664441|76101003|FG001|18-week Open Label Extension|Death|0|||
42271276|NCT02664441|76101002|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
42271277|NCT02664441|76101003|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
42271278|NCT02298946|76101012|FG000|Overall Study|Did not receive treatment|2|||
42035225|NCT01114529|75843550|FG002|Completed Study Phase at Month 24|Death|4|||
42271279|NCT02298946|76101013|FG001|Overall Study|Did not receive treatment|0|||
42271280|NCT02298946|76101012|FG000|Overall Study|Unevaluable|2|||
42271281|NCT02298946|76101013|FG001|Overall Study|Unevaluable|1|||
42271282|NCT02328040|76101020|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
42271283|NCT02328040|76101021|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
42271284|NCT01647958|76101029|FG000|Initial Study|Lost to Follow-up|2|||
42271285|NCT01647958|76101030|FG001|Initial Study|Lost to Follow-up|3|||
42035226|NCT01114529|75843548|FG000|Completed Study Phase at Month 24|Other|2|||
42345780|NCT01774929|76184512|FG000|Overall Study|Adverse Event|3|||
42345781|NCT01888874|76184523|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
42271286|NCT01647958|76101029|FG000|Continuation Phase|treatment received during Overall Study|39|||
42271287|NCT01647958|76101030|FG001|Continuation Phase|treatment received during Overall Study|0|||
42271288|NCT01647958|76101029|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
42271289|NCT01647958|76101030|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
42271290|NCT02298868|76101045|FG000|Overall Study|Adverse Event|1|||
42271291|NCT02298868|76101045|FG000|Overall Study|Death|1|||
42345782|NCT01888874|76184524|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
42004730|NCT01095796|75812674|FG001|Overall Study|Lost to Follow-up|29|||
42004731|NCT01095796|75812673|FG000|Overall Study|Participant Noncompliance|5|||
42271292|NCT02298868|76101045|FG000|Overall Study|Patient underwent transplant|1|||
42271293|NCT02327260|76101052|FG000|Overall Study|Lost to Follow-up|2|||
42271294|NCT02327260|76101053|FG001|Overall Study|Lost to Follow-up|3|||
42271295|NCT02327260|76101054|FG002|Overall Study|Lost to Follow-up|2|||
42271296|NCT02327260|76101052|FG000|Overall Study|invalid phone number|1|||
42271297|NCT02327260|76101053|FG001|Overall Study|invalid phone number|1|||
42271298|NCT02327260|76101054|FG002|Overall Study|invalid phone number|0|||
42271299|NCT02327260|76101052|FG000|Overall Study|non-adherence to protocol|2|||
42271300|NCT02327260|76101053|FG001|Overall Study|non-adherence to protocol|0|||
42271301|NCT02327260|76101054|FG002|Overall Study|non-adherence to protocol|0|||
42271302|NCT02327260|76101052|FG000|Overall Study|cognitive concerns|1|||
42271303|NCT02327260|76101053|FG001|Overall Study|cognitive concerns|0|||
42271304|NCT02327260|76101054|FG002|Overall Study|cognitive concerns|0|||
42271305|NCT02296840|76101065|FG000|Overall Study|Adverse Event|1|||
42271306|NCT02296840|76101066|FG001|Overall Study|Adverse Event|1|||
42271307|NCT02296840|76101065|FG000|Overall Study|Protocol Violation|2|||
42271308|NCT02296840|76101066|FG001|Overall Study|Protocol Violation|1|||
42271309|NCT02296840|76101065|FG000|Overall Study|Lost to Follow-up|6|||
42271310|NCT02296840|76101066|FG001|Overall Study|Lost to Follow-up|17|||
42271311|NCT02663895|76101075|FG000|Overall Study|Adverse Event|3|||
42271312|NCT02663895|76101075|FG000|Overall Study|Physician Decision|2|||
42271313|NCT02663895|76101075|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
42271314|NCT02663895|76101075|FG000|Overall Study|Withdrawal by Subject|1|||
42271315|NCT02663817|76101080|FG000|Overall Study|Screen failure|2|||
42271316|NCT01372605|76101088|FG000|Overall Study|Death|1|||
42271317|NCT01372605|76101089|FG001|Overall Study|Death|2|||
42271318|NCT01372605|76101088|FG000|Overall Study|Lost to Follow-up|2|||
42271319|NCT01372605|76101089|FG001|Overall Study|Lost to Follow-up|1|||
42271320|NCT01372605|76101088|FG000|Overall Study|Withdrawal by Subject|4|||
42271321|NCT01372605|76101089|FG001|Overall Study|Withdrawal by Subject|7|||
42271322|NCT01372605|76101088|FG000|Overall Study|Moved|3|||
42271323|NCT01372605|76101089|FG001|Overall Study|Moved|0|||
42271324|NCT01372605|76101088|FG000|Overall Study|Changed medical home|2|||
42271325|NCT01372605|76101089|FG001|Overall Study|Changed medical home|0|||
42271326|NCT02751983|76101097|FG000|Treatment|Stopped ACT, but Remained in study|2|||
42271327|NCT02751983|76101098|FG001|Treatment|Stopped ACT, but Remained in study|0|||
42271328|NCT02751983|76101097|FG000|Treatment|Discharged prior to beginning ACT|2|||
42271329|NCT02751983|76101098|FG001|Treatment|Discharged prior to beginning ACT|0|||
42271330|NCT02751983|76101097|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
42271331|NCT02751983|76101098|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
42271332|NCT02751983|76101097|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
42271333|NCT02751983|76101098|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
42271334|NCT02751983|76101097|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
42271335|NCT02751983|76101098|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
42271336|NCT00232141|76101118|FG000|Overall Study|Adverse Event|9|||
42271337|NCT00232141|76101119|FG001|Overall Study|Adverse Event|4|||
42271338|NCT00232141|76101118|FG000|Overall Study|Lack of Efficacy|0|||
42271339|NCT00232141|76101119|FG001|Overall Study|Lack of Efficacy|3|||
42271340|NCT00232141|76101118|FG000|Overall Study|Lost to Follow-up|9|||
42271341|NCT00232141|76101119|FG001|Overall Study|Lost to Follow-up|6|||
42271342|NCT00232141|76101118|FG000|Overall Study|Other|8|||
42271343|NCT00232141|76101119|FG001|Overall Study|Other|10|||
42271344|NCT00232141|76101118|FG000|Overall Study|Withdrawal by Subject|5|||
42004732|NCT01095796|75812674|FG001|Overall Study|Participant Noncompliance|10|||
42004733|NCT01095796|75812673|FG000|Overall Study|Protocol Violation|1|||
42271345|NCT00232141|76101119|FG001|Overall Study|Withdrawal by Subject|3|||
42271346|NCT02741245|76101148|FG000|Overall Study|Adverse Event|0|||
42271347|NCT02741245|76101149|FG001|Overall Study|Adverse Event|0|||
42271348|NCT02741245|76101150|FG002|Overall Study|Adverse Event|0|||
42271349|NCT02741245|76101151|FG003|Overall Study|Adverse Event|2|||
42004734|NCT01095796|75812674|FG001|Overall Study|Protocol Violation|0|||
42271350|NCT02741245|76101152|FG004|Overall Study|Adverse Event|2|||
42271351|NCT02741245|76101148|FG000|Overall Study|Protocol Violation|0|||
42004735|NCT01095796|75812673|FG000|Overall Study|Participant Transferred to Another Study|215|||
42004736|NCT01095796|75812674|FG001|Overall Study|Participant Transferred to Another Study|200|||
42004737|NCT01023061|75812680|FG000|Overall Study|Withdrawal prior to treatment|2|||
42004738|NCT01027897|75812684|FG000|Overall Study|Protocol Violation|1|||
42004739|NCT01027897|75812684|FG000|Overall Study|Withdrawal by Subject|1|||
42004740|NCT01027351|75812694|FG000|Overall Study|Withdrawal by Subject|1|||
42004741|NCT01027351|75812695|FG001|Overall Study|Withdrawal by Subject|0|||
42004742|NCT01027351|75812696|FG002|Overall Study|Withdrawal by Subject|1|||
42004743|NCT01027351|75812697|FG003|Overall Study|Withdrawal by Subject|0|||
42004744|NCT01027351|75812698|FG004|Overall Study|Withdrawal by Subject|3|||
42004745|NCT01027351|75812699|FG005|Overall Study|Withdrawal by Subject|5|||
42035227|NCT01114529|75843549|FG001|Completed Study Phase at Month 24|Other|0|||
42035228|NCT01114529|75843550|FG002|Completed Study Phase at Month 24|Other|0|||
42035229|NCT01114529|75843548|FG000|Completed Study Phase at Month 24|Missing|2|||
42271352|NCT02741245|76101149|FG001|Overall Study|Protocol Violation|1|||
42004746|NCT01027351|75812694|FG000|Overall Study|Lost to Follow-up|1|||
42004747|NCT01027351|75812695|FG001|Overall Study|Lost to Follow-up|1|||
42004748|NCT01027351|75812696|FG002|Overall Study|Lost to Follow-up|0|||
42004749|NCT01027351|75812697|FG003|Overall Study|Lost to Follow-up|1|||
42004750|NCT01027351|75812698|FG004|Overall Study|Lost to Follow-up|6|||
42004751|NCT01027351|75812699|FG005|Overall Study|Lost to Follow-up|0|||
42004752|NCT01027351|75812694|FG000|Overall Study|Inappropriate enrollment|0|||
42004753|NCT01027351|75812695|FG001|Overall Study|Inappropriate enrollment|0|||
42004754|NCT01027351|75812696|FG002|Overall Study|Inappropriate enrollment|0|||
42004755|NCT01027351|75812697|FG003|Overall Study|Inappropriate enrollment|0|||
42004756|NCT01027351|75812698|FG004|Overall Study|Inappropriate enrollment|1|||
42004757|NCT01027351|75812699|FG005|Overall Study|Inappropriate enrollment|0|||
42004758|NCT01027351|75812694|FG000|Overall Study|Protocol Violation|1|||
42004759|NCT01027351|75812695|FG001|Overall Study|Protocol Violation|0|||
42271353|NCT02741245|76101150|FG002|Overall Study|Protocol Violation|0|||
42271354|NCT02741245|76101151|FG003|Overall Study|Protocol Violation|1|||
42271355|NCT02741245|76101152|FG004|Overall Study|Protocol Violation|0|||
42271356|NCT02741245|76101148|FG000|Overall Study|Withdrawal by Subject|0|||
42271357|NCT02741245|76101149|FG001|Overall Study|Withdrawal by Subject|0|||
42271358|NCT02741245|76101150|FG002|Overall Study|Withdrawal by Subject|0|||
42004760|NCT01027351|75812696|FG002|Overall Study|Protocol Violation|0|||
42004761|NCT01027351|75812697|FG003|Overall Study|Protocol Violation|1|||
42004762|NCT01027351|75812698|FG004|Overall Study|Protocol Violation|1|||
42271359|NCT02741245|76101151|FG003|Overall Study|Withdrawal by Subject|1|||
42345783|NCT01888874|76184525|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
42345784|NCT01888874|76184526|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
42345785|NCT01888874|76184527|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
42345786|NCT01888874|76184528|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
42345787|NCT01888874|76184529|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
42345788|NCT01888874|76184523|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
42345789|NCT01888874|76184524|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
42345790|NCT01888874|76184525|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
42345791|NCT01888874|76184526|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
42345792|NCT01888874|76184527|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
42345793|NCT01888874|76184528|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
42345794|NCT01888874|76184529|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
42345795|NCT01888874|76184523|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
42345796|NCT01888874|76184524|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
42345797|NCT01888874|76184525|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
42345798|NCT01888874|76184526|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
42345799|NCT01888874|76184527|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
42345800|NCT01888874|76184528|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
42345801|NCT01888874|76184529|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
42345802|NCT01888874|76184523|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
42345803|NCT01888874|76184524|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
42345804|NCT01888874|76184525|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
42345805|NCT01888874|76184526|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
42345806|NCT01888874|76184527|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
42345807|NCT01888874|76184528|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
42345808|NCT01888874|76184529|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
42345809|NCT01888874|76184523|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
42345810|NCT01888874|76184524|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
42345811|NCT01888874|76184525|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
42345812|NCT01888874|76184526|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
42345813|NCT01888874|76184527|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
42004763|NCT01027351|75812699|FG005|Overall Study|Protocol Violation|0|||
42271360|NCT02741245|76101152|FG004|Overall Study|Withdrawal by Subject|0|||
42271361|NCT02751827|76101167|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
42271362|NCT02751827|76101168|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
42345814|NCT01888874|76184528|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
42004764|NCT01027273|75812722|FG000|Overall Study|Lost to Follow-up|57|||
42004765|NCT01027273|75812723|FG001|Overall Study|Lost to Follow-up|31|||
42271363|NCT02751827|76101169|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
42271364|NCT04896593|76101177|FG000|Overall Study|Withdrawal by Subject|2|||
42271365|NCT04896593|76101177|FG000|Overall Study|Lost to Follow-up|1|||
42271366|NCT04896593|76101177|FG000|Overall Study|Did not complete onboarding|2|||
42271367|NCT04601272|76101184|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
42271368|NCT04601272|76101185|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
42271369|NCT04601272|76101186|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
42271370|NCT03965091|76101197|FG000|Overall Study|Adverse Event|0|||
42136633|NCT00541229|75947071|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
42346986|NCT01874145|76186029|FG000|Extension Period|Withdrawal by Subject|2|||
42004766|NCT01027273|75812722|FG000|Overall Study|Death|2|||
42004767|NCT01027273|75812723|FG001|Overall Study|Death|2|||
42004768|NCT01022203|75812731|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
42004769|NCT01022203|75812732|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
42004770|NCT01022203|75812731|FG000|Post Treatment Assessment|Physician Decision|2|||
42004771|NCT01022203|75812732|FG001|Post Treatment Assessment|Physician Decision|0|||
42004772|NCT01022203|75812731|FG000|Post Treatment Assessment|Adverse Event|0|||
42136634|NCT00541229|75947066|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
42136635|NCT00541229|75947067|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
42136636|NCT00541229|75947068|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
42136637|NCT00541229|75947069|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
42345815|NCT01888874|76184529|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
42345816|NCT01888874|76184523|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
42345817|NCT01888874|76184524|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
42345818|NCT01888874|76184525|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
42345819|NCT01888874|76184526|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
42345820|NCT01888874|76184527|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
42345821|NCT01888874|76184528|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
42345822|NCT01888874|76184529|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
42345823|NCT01888874|76184523|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
42345824|NCT01888874|76184524|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
42345825|NCT01888874|76184525|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
42345826|NCT01888874|76184526|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
42345827|NCT01888874|76184527|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
42345828|NCT01888874|76184528|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
42345829|NCT01888874|76184529|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
42345830|NCT01888874|76184523|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
42345831|NCT01888874|76184524|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
42004773|NCT01022203|75812732|FG001|Post Treatment Assessment|Adverse Event|2|||
42136638|NCT00541229|75947070|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
42136639|NCT00541229|75947071|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
42136640|NCT00541229|75947066|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
42136641|NCT00541229|75947067|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
42136642|NCT00541229|75947068|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
42136643|NCT00541229|75947069|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
42136644|NCT00541229|75947070|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
42136645|NCT00541229|75947071|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
42136646|NCT00541229|75947066|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
42136647|NCT00541229|75947067|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
42136648|NCT00541229|75947068|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
42136649|NCT00541229|75947069|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
42136650|NCT00541229|75947070|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
42345832|NCT01888874|76184525|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
42345833|NCT01888874|76184526|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
42345834|NCT01888874|76184527|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
42345835|NCT01888874|76184528|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
42345836|NCT01888874|76184529|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
42345837|NCT01888874|76184523|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
42345838|NCT01888874|76184524|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
42345839|NCT01888874|76184525|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
42345840|NCT01888874|76184526|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
42345841|NCT01888874|76184527|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
42004774|NCT01022203|75812731|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
42004775|NCT01022203|75812732|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
42345842|NCT01888874|76184528|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
42345843|NCT01888874|76184529|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
42345844|NCT01888874|76184523|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
42345845|NCT01888874|76184524|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
42345846|NCT01888874|76184525|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
42345847|NCT01888874|76184526|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
42345848|NCT01888874|76184527|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
42004776|NCT01296711|75812749|FG000|Overall Study|Adverse Event|3|||
42004777|NCT01296711|75812750|FG001|Overall Study|Adverse Event|1|||
42004778|NCT01296711|75812751|FG002|Overall Study|Adverse Event|4|||
42004779|NCT01296711|75812752|FG003|Overall Study|Adverse Event|3|||
42004780|NCT01296711|75812753|FG004|Overall Study|Adverse Event|1|||
42004781|NCT01296711|75812754|FG005|Overall Study|Adverse Event|6|||
42004782|NCT01296711|75812755|FG006|Overall Study|Adverse Event|11|||
42004783|NCT01296711|75812756|FG007|Overall Study|Adverse Event|3|||
42004784|NCT01296711|75812749|FG000|Overall Study|Lack of Efficacy|1|||
42004785|NCT01296711|75812750|FG001|Overall Study|Lack of Efficacy|4|||
42136651|NCT00541229|75947071|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
42136652|NCT00541229|75947066|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
42136653|NCT00541229|75947067|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
42136654|NCT00541229|75947068|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
42136655|NCT00541229|75947069|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
42136656|NCT00541229|75947070|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
42136657|NCT00541229|75947071|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
42136658|NCT00541229|75947066|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
42271371|NCT03965091|76101198|FG001|Overall Study|Adverse Event|2|||
42345849|NCT01888874|76184528|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
42346987|NCT01874145|76186030|FG001|Extension Period|Withdrawal by Subject|1|||
42004786|NCT01296711|75812751|FG002|Overall Study|Lack of Efficacy|1|||
42004787|NCT01296711|75812752|FG003|Overall Study|Lack of Efficacy|1|||
42345850|NCT01888874|76184529|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
42345851|NCT01888874|76184523|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
42136659|NCT00541229|75947067|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
42345852|NCT01888874|76184524|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
42345853|NCT01888874|76184525|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
42345854|NCT01888874|76184526|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
42004788|NCT01296711|75812753|FG004|Overall Study|Lack of Efficacy|1|||
42004789|NCT01296711|75812754|FG005|Overall Study|Lack of Efficacy|0|||
42004790|NCT01296711|75812755|FG006|Overall Study|Lack of Efficacy|2|||
42004791|NCT01296711|75812756|FG007|Overall Study|Lack of Efficacy|3|||
42004792|NCT01296711|75812749|FG000|Overall Study|Lost to Follow-up|0|||
42345855|NCT01888874|76184527|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
42345856|NCT01888874|76184528|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
42345857|NCT01888874|76184529|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
42345858|NCT01888874|76184523|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
42345859|NCT01888874|76184524|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
42345860|NCT01888874|76184525|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
42345861|NCT01888874|76184526|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
42345862|NCT01888874|76184527|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
42345863|NCT01888874|76184528|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
42345864|NCT01888874|76184529|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
42345865|NCT01888874|76184523|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
42345866|NCT01888874|76184524|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
42345867|NCT01888874|76184525|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
42345868|NCT01888874|76184526|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
42345869|NCT01888874|76184527|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
42345870|NCT01888874|76184528|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
42345871|NCT01888874|76184529|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
42345872|NCT01749735|76184548|FG000|Overall Study|Withdrawal by Subject|1|||
42345873|NCT01749735|76184549|FG001|Overall Study|Withdrawal by Subject|0|||
42345874|NCT01749033|76184558|FG000|Overall Study|Did not receive allocated intervention|3|||
42345875|NCT01749033|76184559|FG001|Overall Study|Did not receive allocated intervention|3|||
42345876|NCT01749033|76184560|FG002|Overall Study|Did not receive allocated intervention|0|||
42345877|NCT01749033|76184558|FG000|Overall Study|Lost to Follow-up|0|||
42345878|NCT01749033|76184559|FG001|Overall Study|Lost to Follow-up|2|||
42345879|NCT01749033|76184560|FG002|Overall Study|Lost to Follow-up|1|||
42345880|NCT01774305|76184571|FG000|Overall Study|Physician Decision|1|||
42345881|NCT01774305|76184572|FG001|Overall Study|Physician Decision|0|||
42345882|NCT01737021|76184580|FG000|Overall Study|Lost to Follow-up|5|||
42345883|NCT01737021|76184581|FG001|Overall Study|Lost to Follow-up|3|||
42345884|NCT01397422|76184591|FG000|Overall Study|Adverse Event|0|||
42345885|NCT01397422|76184592|FG001|Overall Study|Adverse Event|3|||
42345886|NCT01397422|76184593|FG002|Overall Study|Adverse Event|3|||
42345887|NCT01397422|76184594|FG003|Overall Study|Adverse Event|8|||
42345888|NCT01397422|76184591|FG000|Overall Study|Withdrawal by Subject|1|||
42345889|NCT01397422|76184592|FG001|Overall Study|Withdrawal by Subject|0|||
42345890|NCT01397422|76184593|FG002|Overall Study|Withdrawal by Subject|0|||
42345891|NCT01397422|76184594|FG003|Overall Study|Withdrawal by Subject|0|||
42345892|NCT01397422|76184591|FG000|Overall Study|Increased bradykinesia related to PD|1|||
42345893|NCT01397422|76184592|FG001|Overall Study|Increased bradykinesia related to PD|0|||
42345894|NCT01397422|76184593|FG002|Overall Study|Increased bradykinesia related to PD|0|||
42345895|NCT01397422|76184594|FG003|Overall Study|Increased bradykinesia related to PD|0|||
42345896|NCT01736553|76184608|FG000|Overall Study|Death|12|||
42345897|NCT01736553|76184609|FG001|Overall Study|Death|0|||
42345898|NCT01736553|76184608|FG000|Overall Study|Withdrawal by Subject|5|||
42345899|NCT01736553|76184609|FG001|Overall Study|Withdrawal by Subject|2|||
42345900|NCT01736553|76184608|FG000|Overall Study|Lost to Follow-up|2|||
42345901|NCT01736553|76184609|FG001|Overall Study|Lost to Follow-up|2|||
42345902|NCT01888640|76184636|FG000|Overall Study|Lost to Follow-up|1|||
42004793|NCT01296711|75812750|FG001|Overall Study|Lost to Follow-up|0|||
42345903|NCT01888640|76184637|FG001|Overall Study|Lost to Follow-up|2|||
42345904|NCT01888640|76184638|FG002|Overall Study|Lost to Follow-up|0|||
42345905|NCT01888640|76184636|FG000|Overall Study|Withdrawal by Subject|15|||
42345906|NCT01888640|76184637|FG001|Overall Study|Withdrawal by Subject|11|||
42345907|NCT01888640|76184638|FG002|Overall Study|Withdrawal by Subject|4|||
42345908|NCT01888640|76184636|FG000|Overall Study|Minimum dose not met|10|||
42345909|NCT01888640|76184637|FG001|Overall Study|Minimum dose not met|16|||
42345910|NCT01888640|76184638|FG002|Overall Study|Minimum dose not met|0|||
42345911|NCT01888640|76184636|FG000|Overall Study|Given wrong unit (placebo)|1|||
42345912|NCT01888640|76184637|FG001|Overall Study|Given wrong unit (placebo)|0|||
42345913|NCT01888640|76184638|FG002|Overall Study|Given wrong unit (placebo)|0|||
42345914|NCT01888640|76184636|FG000|Overall Study|Excluded for prior TENS|0|||
42345915|NCT01888640|76184637|FG001|Overall Study|Excluded for prior TENS|1|||
42345916|NCT01888640|76184638|FG002|Overall Study|Excluded for prior TENS|0|||
42345917|NCT01888640|76184636|FG000|Overall Study|Researcher Termination of Participant|0|||
42345918|NCT01888640|76184637|FG001|Overall Study|Researcher Termination of Participant|1|||
42345919|NCT01888640|76184638|FG002|Overall Study|Researcher Termination of Participant|1|||
42345920|NCT01736475|76184651|FG000|Overall Study|Adverse Event|4|||
42345921|NCT01736475|76184652|FG001|Overall Study|Adverse Event|0|||
42345922|NCT01736475|76184651|FG000|Overall Study|Withdrawal by Subject|2|||
42345923|NCT01736475|76184652|FG001|Overall Study|Withdrawal by Subject|0|||
42345924|NCT01736475|76184651|FG000|Overall Study|Protocol Violation|4|||
42345925|NCT01736475|76184652|FG001|Overall Study|Protocol Violation|0|||
42345926|NCT01736475|76184651|FG000|Overall Study|Other - Screen failure|1|||
42345927|NCT01736475|76184652|FG001|Overall Study|Other - Screen failure|0|||
42345928|NCT01736475|76184651|FG000|Overall Study|Other - Surgical procedure|1|||
42345929|NCT01736475|76184652|FG001|Overall Study|Other - Surgical procedure|0|||
42345930|NCT01863758|76184669|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
42345931|NCT01863758|76184669|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
42345932|NCT01863680|76184673|FG000|Overall Study|Adverse Event|17|||
42345933|NCT01863680|76184673|FG000|Overall Study|Risk of OHSS|17|||
42345934|NCT01863680|76184673|FG000|Overall Study|Spontaneous pregnancy|2|||
42345935|NCT01863680|76184673|FG000|Overall Study|Withdrawal by Subject|1|||
42345936|NCT01863680|76184673|FG000|Overall Study|Did not undergo IVF/ET|14|||
42345937|NCT01863680|76184673|FG000|Overall Study|Other|6|||
42345938|NCT01747629|76184679|FG000|Overall Study|Adverse Event|1|||
42345939|NCT01747629|76184680|FG001|Overall Study|Adverse Event|2|||
42345940|NCT01747629|76184679|FG000|Overall Study|Withdrawal by Subject|2|||
42345941|NCT01747629|76184680|FG001|Overall Study|Withdrawal by Subject|2|||
42345942|NCT01747629|76184679|FG000|Overall Study|Noncompliance|1|||
42345943|NCT01747629|76184680|FG001|Overall Study|Noncompliance|1|||
42345944|NCT01747629|76184679|FG000|Overall Study|Inclusion criteria not met|1|||
42345945|NCT01747629|76184680|FG001|Overall Study|Inclusion criteria not met|0|||
42345946|NCT01747629|76184679|FG000|Overall Study|Not treated|1|||
42345947|NCT01747629|76184680|FG001|Overall Study|Not treated|0|||
42345948|NCT01747629|76184679|FG000|Overall Study|Other|2|||
42345949|NCT01747629|76184680|FG001|Overall Study|Other|1|||
42345950|NCT01863368|76184688|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
42345951|NCT01863368|76184689|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
42345952|NCT01863368|76184688|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
42345953|NCT01863368|76184689|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
42345954|NCT01863368|76184688|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
42345955|NCT01863368|76184689|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
42004794|NCT01296711|75812751|FG002|Overall Study|Lost to Follow-up|1|||
42271372|NCT03965091|76101199|FG002|Overall Study|Adverse Event|3|||
42345956|NCT01863368|76184688|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
42345957|NCT01863368|76184689|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
42345958|NCT01863368|76184688|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
42345959|NCT01863368|76184689|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
42345960|NCT01863368|76184688|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
42345961|NCT01863368|76184689|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
42345962|NCT01886690|76184698|FG000|Overall Study|Protocol Violation|0|||
42345963|NCT01886690|76184699|FG001|Overall Study|Protocol Violation|1|||
42271373|NCT03965091|76101197|FG000|Overall Study|Withdrawal by Subject|11|||
42271374|NCT03965091|76101198|FG001|Overall Study|Withdrawal by Subject|3|||
42271375|NCT03965091|76101199|FG002|Overall Study|Withdrawal by Subject|5|||
42271376|NCT03965091|76101197|FG000|Overall Study|Non-compliance with study drug|0|||
42271377|NCT03965091|76101198|FG001|Overall Study|Non-compliance with study drug|0|||
42271378|NCT03965091|76101199|FG002|Overall Study|Non-compliance with study drug|1|||
42271379|NCT03965091|76101197|FG000|Overall Study|Lost to Follow-up|1|||
42271380|NCT03965091|76101198|FG001|Overall Study|Lost to Follow-up|1|||
42271381|NCT03965091|76101199|FG002|Overall Study|Lost to Follow-up|1|||
42271382|NCT03965091|76101197|FG000|Overall Study|Lack of Efficacy|2|||
42136660|NCT00541229|75947068|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
42271383|NCT03965091|76101198|FG001|Overall Study|Lack of Efficacy|0|||
42004795|NCT01296711|75812752|FG003|Overall Study|Lost to Follow-up|1|||
42004796|NCT01296711|75812753|FG004|Overall Study|Lost to Follow-up|2|||
42004797|NCT01296711|75812754|FG005|Overall Study|Lost to Follow-up|0|||
42004798|NCT01296711|75812755|FG006|Overall Study|Lost to Follow-up|4|||
42004799|NCT01296711|75812756|FG007|Overall Study|Lost to Follow-up|2|||
42136661|NCT00541229|75947069|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
42136662|NCT00541229|75947070|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
42136663|NCT00541229|75947071|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
42136664|NCT00541229|75947066|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
42271384|NCT03965091|76101199|FG002|Overall Study|Lack of Efficacy|0|||
42271385|NCT03965091|76101197|FG000|Overall Study|Other than specified|9|||
42271386|NCT03965091|76101198|FG001|Overall Study|Other than specified|11|||
42271387|NCT03965091|76101199|FG002|Overall Study|Other than specified|8|||
42271388|NCT03359096|76101226|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
42271389|NCT03359096|76101227|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
42271390|NCT03359096|76101226|FG000|First Intervention (4 Weeks)|Death|1|||
42271391|NCT03359096|76101227|FG001|First Intervention (4 Weeks)|Death|0|||
42271392|NCT03359096|76101226|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
42271393|NCT03359096|76101227|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
42271394|NCT03019588|76101244|FG000|Overall Study|Death|44|||
42271395|NCT03019588|76101245|FG001|Overall Study|Death|46|||
42271396|NCT03019588|76101244|FG000|Overall Study|Study terminated by Sponsor|3|||
42271397|NCT03019588|76101245|FG001|Overall Study|Study terminated by Sponsor|1|||
42271398|NCT02455557|76101273|FG000|Overall Study|Withdrawal by Subject|2|||
42271399|NCT02270450|76101281|FG000|Overall Study|Refusal unrelated to adverse event|3|||
42271400|NCT02270450|76101282|FG001|Overall Study|Refusal unrelated to adverse event|1|||
42271401|NCT02270450|76101283|FG002|Overall Study|Refusal unrelated to adverse event|5|||
42271402|NCT02270450|76101284|FG003|Overall Study|Refusal unrelated to adverse event|14|||
42271403|NCT02270450|76101281|FG000|Overall Study|Progression/relapse|1|||
42271404|NCT02270450|76101282|FG001|Overall Study|Progression/relapse|2|||
42345964|NCT01886690|76184698|FG000|Overall Study|Personal Reasons|0|||
42136665|NCT00541229|75947067|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
42136666|NCT00541229|75947068|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
42271405|NCT02270450|76101283|FG002|Overall Study|Progression/relapse|4|||
42271406|NCT02270450|76101284|FG003|Overall Study|Progression/relapse|9|||
42271407|NCT02270450|76101281|FG000|Overall Study|Death|19|||
42136667|NCT00541229|75947069|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
42136668|NCT00541229|75947070|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
42136669|NCT00541229|75947071|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
42136670|NCT00541229|75947066|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
42136671|NCT00541229|75947067|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
42271408|NCT02270450|76101282|FG001|Overall Study|Death|19|||
42271409|NCT02270450|76101283|FG002|Overall Study|Death|31|||
42004800|NCT01296711|75812749|FG000|Overall Study|Protocol Violation|0|||
42004801|NCT01296711|75812750|FG001|Overall Study|Protocol Violation|0|||
42004802|NCT01296711|75812751|FG002|Overall Study|Protocol Violation|0|||
42004803|NCT01296711|75812752|FG003|Overall Study|Protocol Violation|1|||
42004804|NCT01296711|75812753|FG004|Overall Study|Protocol Violation|1|||
42004805|NCT01296711|75812754|FG005|Overall Study|Protocol Violation|0|||
42004806|NCT01296711|75812755|FG006|Overall Study|Protocol Violation|0|||
42004807|NCT01296711|75812756|FG007|Overall Study|Protocol Violation|0|||
42004808|NCT01296711|75812749|FG000|Overall Study|Withdrawal by Subject|4|||
42004809|NCT01296711|75812750|FG001|Overall Study|Withdrawal by Subject|2|||
42004810|NCT01296711|75812751|FG002|Overall Study|Withdrawal by Subject|2|||
42004811|NCT01296711|75812752|FG003|Overall Study|Withdrawal by Subject|1|||
42004812|NCT01296711|75812753|FG004|Overall Study|Withdrawal by Subject|1|||
42004813|NCT01296711|75812754|FG005|Overall Study|Withdrawal by Subject|1|||
42004814|NCT01296711|75812755|FG006|Overall Study|Withdrawal by Subject|2|||
42004815|NCT01296711|75812756|FG007|Overall Study|Withdrawal by Subject|1|||
42004816|NCT01296711|75812749|FG000|Overall Study|Study termination|8|||
42004817|NCT01296711|75812750|FG001|Overall Study|Study termination|1|||
42004818|NCT01296711|75812751|FG002|Overall Study|Study termination|5|||
42004819|NCT01296711|75812752|FG003|Overall Study|Study termination|4|||
42004820|NCT01296711|75812753|FG004|Overall Study|Study termination|4|||
42004821|NCT01296711|75812754|FG005|Overall Study|Study termination|4|||
42004822|NCT01296711|75812755|FG006|Overall Study|Study termination|8|||
42004823|NCT01296711|75812756|FG007|Overall Study|Study termination|10|||
42004824|NCT01296711|75812749|FG000|Overall Study|Continued elevated liver enzymes|0|||
42271410|NCT02270450|76101284|FG003|Overall Study|Death|59|||
42271411|NCT01565499|76101305|FG000|Overall Study|Physician Decision|1|||
42271412|NCT01565499|76101305|FG000|Overall Study|Adverse Event|5|||
42136672|NCT00541229|75947068|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
42271413|NCT01565499|76101305|FG000|Overall Study|Withdrawal by Subject|2|||
42271414|NCT01036087|76101309|FG000|Overall Study|Adverse Event|2|||
42271415|NCT01036087|76101309|FG000|Overall Study|Lack of Efficacy|1|||
42345965|NCT01886690|76184699|FG001|Overall Study|Personal Reasons|1|||
42345966|NCT01886378|76184705|FG000|Overall Study|Adverse Event|1|||
42345967|NCT01886378|76184705|FG000|Overall Study|Withdrawal by Subject|4|||
42345968|NCT01886300|76184709|FG000|Overall Study|Trial terminated by sponsor|16|||
42345969|NCT01885208|76184715|FG000|Overall Study|Unclassified|32|||
42345970|NCT01885208|76184716|FG001|Overall Study|Unclassified|38|||
42345971|NCT01859702|76184722|FG000|Overall Study|Protocol deviation|3|||
42345972|NCT01859702|76184722|FG000|Overall Study|Adverse Event|2|||
42345973|NCT01835132|76184726|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
42345974|NCT01747551|76184732|FG000|Overall Study|Progressive Disease|24|||
42271416|NCT00572156|76101326|FG000|Overall Study|Adverse Event|3|||
42271417|NCT00572156|76101327|FG001|Overall Study|Adverse Event|1|||
42271418|NCT00572156|76101328|FG002|Overall Study|Adverse Event|5|||
42271419|NCT00572156|76101329|FG003|Overall Study|Adverse Event|1|||
42271420|NCT00572156|76101326|FG000|Overall Study|Lost to Follow-up|1|||
42271421|NCT00572156|76101327|FG001|Overall Study|Lost to Follow-up|1|||
42271422|NCT00572156|76101328|FG002|Overall Study|Lost to Follow-up|1|||
42271423|NCT00572156|76101329|FG003|Overall Study|Lost to Follow-up|0|||
42271424|NCT00572156|76101326|FG000|Overall Study|Protocol Violation|1|||
42345975|NCT01747551|76184733|FG001|Overall Study|Progressive Disease|17|||
42345976|NCT01747551|76184732|FG000|Overall Study|Death|3|||
42345977|NCT01747551|76184733|FG001|Overall Study|Death|1|||
42345978|NCT01747551|76184732|FG000|Overall Study|Adverse Event|7|||
42271425|NCT00572156|76101327|FG001|Overall Study|Protocol Violation|2|||
42345979|NCT01747551|76184733|FG001|Overall Study|Adverse Event|1|||
42345980|NCT01747551|76184732|FG000|Overall Study|Prolonged Treatment Delay|2|||
42271426|NCT00572156|76101328|FG002|Overall Study|Protocol Violation|0|||
42271427|NCT00572156|76101329|FG003|Overall Study|Protocol Violation|2|||
42271428|NCT00572156|76101326|FG000|Overall Study|Patient/Parent Decision|1|||
42271429|NCT00572156|76101327|FG001|Overall Study|Patient/Parent Decision|6|||
42271430|NCT00572156|76101328|FG002|Overall Study|Patient/Parent Decision|4|||
42271431|NCT00572156|76101329|FG003|Overall Study|Patient/Parent Decision|3|||
42271432|NCT00572156|76101326|FG000|Overall Study|Sponsor Decision|20|||
42271433|NCT00572156|76101327|FG001|Overall Study|Sponsor Decision|16|||
42345981|NCT01747551|76184733|FG001|Overall Study|Prolonged Treatment Delay|0|||
42345982|NCT01747551|76184732|FG000|Overall Study|Withdrawal by Subject|3|||
42345983|NCT01747551|76184733|FG001|Overall Study|Withdrawal by Subject|1|||
42345984|NCT01747551|76184732|FG000|Overall Study|Physician Decision|2|||
42345985|NCT01747551|76184733|FG001|Overall Study|Physician Decision|1|||
42345986|NCT01747551|76184732|FG000|Overall Study|Other|2|||
42345987|NCT01747551|76184733|FG001|Overall Study|Other|0|||
42345988|NCT01736397|76184741|FG000|Overall Study|Lack of Efficacy|1|||
42345989|NCT01736397|76184742|FG001|Overall Study|Lack of Efficacy|11|||
42345990|NCT01736397|76184741|FG000|Overall Study|Withdrawal by Subject|6|||
42345991|NCT01736397|76184742|FG001|Overall Study|Withdrawal by Subject|5|||
42271434|NCT00572156|76101328|FG002|Overall Study|Sponsor Decision|17|||
42271435|NCT00572156|76101329|FG003|Overall Study|Sponsor Decision|19|||
42345992|NCT01736397|76184741|FG000|Overall Study|Lost to Follow-up|0|||
42345993|NCT01736397|76184742|FG001|Overall Study|Lost to Follow-up|1|||
42345994|NCT01736397|76184741|FG000|Overall Study|Adverse Event|6|||
42345995|NCT01736397|76184742|FG001|Overall Study|Adverse Event|3|||
42345996|NCT01736397|76184741|FG000|Overall Study|Not stated|1|||
42345997|NCT01736397|76184742|FG001|Overall Study|Not stated|4|||
42345998|NCT01859390|76184750|FG000|Overall Study|Insufficient Sputum Collected|1|||
42271436|NCT00447772|76101339|FG000|Overall Study|Lack of Efficacy|3|||
42271437|NCT00447772|76101339|FG000|Overall Study|Insufficient compliance|6|||
42271438|NCT00447772|76101339|FG000|Overall Study|Discontinuation of drug therapy|1|||
42271439|NCT00447772|76101339|FG000|Overall Study|Lost to Follow-up|9|||
42271440|NCT00447772|76101339|FG000|Overall Study|Withdrawal by Subject|1|||
42271441|NCT00447772|76101339|FG000|Overall Study|Unable to attend all study visits|2|||
42345999|NCT01859390|76184751|FG001|Overall Study|Insufficient Sputum Collected|3|||
42346000|NCT01859390|76184750|FG000|Overall Study|Sample Missing Collection Date|0|||
42346001|NCT01859390|76184751|FG001|Overall Study|Sample Missing Collection Date|1|||
42346002|NCT01859390|76184750|FG000|Overall Study|Tube Cracked|0|||
42346003|NCT01859390|76184751|FG001|Overall Study|Tube Cracked|2|||
42346004|NCT01859390|76184750|FG000|Overall Study|Shipment Error|0|||
42346005|NCT01859390|76184751|FG001|Overall Study|Shipment Error|1|||
42346006|NCT01858766|76184776|FG000|Overall Study|Randomized but Never Treated|0|||
42346007|NCT01858766|76184777|FG001|Overall Study|Randomized but Never Treated|0|||
42271442|NCT00447772|76101339|FG000|Overall Study|Adverse Event|1|||
42271443|NCT00447772|76101339|FG000|Overall Study|Patient relocated|1|||
42271444|NCT00447772|76101339|FG000|Overall Study|Incomplete documentation at visit 1|1|||
42271445|NCT00447772|76101339|FG000|Overall Study|Chemotherapy for lung cancer|1|||
42271446|NCT00447772|76101339|FG000|Overall Study|Premature re-injection required|1|||
42271447|NCT02296138|76101348|FG000|Overall Study|Adverse Event|348|||
42271448|NCT02296138|76101349|FG001|Overall Study|Adverse Event|259|||
42271449|NCT02296138|76101348|FG000|Overall Study|Lack of Efficacy|59|||
42271450|NCT02296138|76101349|FG001|Overall Study|Lack of Efficacy|37|||
42271451|NCT02296138|76101348|FG000|Overall Study|Protocol Violation|35|||
42271452|NCT02296138|76101349|FG001|Overall Study|Protocol Violation|36|||
42271453|NCT02296138|76101348|FG000|Overall Study|Lost to Follow-up|9|||
42004825|NCT01296711|75812750|FG001|Overall Study|Continued elevated liver enzymes|0|||
42136673|NCT00541229|75947069|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
42136674|NCT00541229|75947070|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
42136675|NCT00541229|75947071|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
42136676|NCT00541229|75947066|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
42136677|NCT00541229|75947067|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
42136678|NCT00541229|75947068|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
42136679|NCT00541229|75947069|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
42136680|NCT00541229|75947070|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
42136681|NCT00541229|75947071|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
42271454|NCT02296138|76101349|FG001|Overall Study|Lost to Follow-up|12|||
42004826|NCT01296711|75812751|FG002|Overall Study|Continued elevated liver enzymes|0|||
42004827|NCT01296711|75812752|FG003|Overall Study|Continued elevated liver enzymes|1|||
42271455|NCT02296138|76101348|FG000|Overall Study|Withdrawal by Subject|184|||
42271456|NCT02296138|76101349|FG001|Overall Study|Withdrawal by Subject|131|||
42271457|NCT02296138|76101348|FG000|Overall Study|Not Treated|1|||
42271458|NCT02296138|76101349|FG001|Overall Study|Not Treated|1|||
42271459|NCT02296138|76101348|FG000|Overall Study|Patients with data irregularities|10|||
42346008|NCT01858766|76184778|FG002|Overall Study|Randomized but Never Treated|0|||
42346009|NCT01858766|76184779|FG003|Overall Study|Randomized but Never Treated|0|||
42346010|NCT01858766|76184780|FG004|Overall Study|Randomized but Never Treated|0|||
42346011|NCT01858766|76184781|FG005|Overall Study|Randomized but Never Treated|1|||
42346012|NCT01858766|76184782|FG006|Overall Study|Randomized but Never Treated|0|||
42346013|NCT01858766|76184783|FG007|Overall Study|Randomized but Never Treated|0|||
42346014|NCT01858766|76184784|FG008|Overall Study|Randomized but Never Treated|0|||
42346015|NCT01858766|76184785|FG009|Overall Study|Randomized but Never Treated|0|||
42346016|NCT01858766|76184786|FG010|Overall Study|Randomized but Never Treated|0|||
42346017|NCT01858766|76184787|FG011|Overall Study|Randomized but Never Treated|0|||
42346018|NCT01858766|76184788|FG012|Overall Study|Randomized but Never Treated|0|||
42346019|NCT01858766|76184789|FG013|Overall Study|Randomized but Never Treated|0|||
42346020|NCT01858766|76184790|FG014|Overall Study|Randomized but Never Treated|0|||
42271460|NCT02296138|76101349|FG001|Overall Study|Patients with data irregularities|11|||
42271461|NCT02296138|76101348|FG000|Overall Study|Other than specified|15|||
42271462|NCT02296138|76101349|FG001|Overall Study|Other than specified|13|||
42271463|NCT01306942|76101358|FG000|Phase I|Adverse Event|2|||
42271464|NCT01306942|76101359|FG001|Phase I|Adverse Event|2|||
42271465|NCT01306942|76101360|FG002|Phase I|Adverse Event|0|||
42271466|NCT01306942|76101361|FG003|Phase I|Adverse Event|0|||
42271467|NCT01306942|76101358|FG000|Phase I|Physician Decision|3|||
42271468|NCT01306942|76101359|FG001|Phase I|Physician Decision|1|||
42271469|NCT01306942|76101360|FG002|Phase I|Physician Decision|0|||
42271470|NCT01306942|76101361|FG003|Phase I|Physician Decision|0|||
42271471|NCT01306942|76101358|FG000|Phase II|Adverse Event|0|||
42271472|NCT01306942|76101359|FG001|Phase II|Adverse Event|0|||
42271473|NCT01306942|76101360|FG002|Phase II|Adverse Event|0|||
42271474|NCT01306942|76101361|FG003|Phase II|Adverse Event|6|||
42271475|NCT01306942|76101358|FG000|Phase II|Physician Decision|2|||
42271476|NCT01306942|76101359|FG001|Phase II|Physician Decision|0|||
42271477|NCT01306942|76101360|FG002|Phase II|Physician Decision|0|||
42271478|NCT01306942|76101361|FG003|Phase II|Physician Decision|5|||
42271479|NCT01306942|76101358|FG000|Phase II|Withdrawal by Subject|0|||
42271480|NCT01306942|76101359|FG001|Phase II|Withdrawal by Subject|0|||
42271481|NCT01306942|76101360|FG002|Phase II|Withdrawal by Subject|0|||
42271482|NCT01306942|76101361|FG003|Phase II|Withdrawal by Subject|2|||
42271483|NCT01306942|76101358|FG000|Phase II|Death|0|||
42271484|NCT01306942|76101359|FG001|Phase II|Death|0|||
42271485|NCT01306942|76101360|FG002|Phase II|Death|0|||
42271486|NCT01306942|76101361|FG003|Phase II|Death|1|||
42271487|NCT01306942|76101358|FG000|Phase II|Not finished treatment|0|||
42346021|NCT01858766|76184791|FG015|Overall Study|Randomized but Never Treated|0|||
42346022|NCT01858766|76184792|FG016|Overall Study|Randomized but Never Treated|0|||
42346023|NCT01858766|76184793|FG017|Overall Study|Randomized but Never Treated|1|||
42271488|NCT01306942|76101359|FG001|Phase II|Not finished treatment|0|||
42271489|NCT01306942|76101360|FG002|Phase II|Not finished treatment|0|||
42271490|NCT01306942|76101361|FG003|Phase II|Not finished treatment|1|||
42271491|NCT01306942|76101358|FG000|Phase II|Protocol Violation|0|||
42271492|NCT01306942|76101359|FG001|Phase II|Protocol Violation|0|||
42271493|NCT01306942|76101360|FG002|Phase II|Protocol Violation|0|||
42136682|NCT00541229|75947066|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
42136683|NCT00541229|75947067|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
42271494|NCT01306942|76101361|FG003|Phase II|Protocol Violation|1|||
42136684|NCT00541229|75947068|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
42271495|NCT02324842|76101376|FG000|Overall Study|Lost to Follow-up|1|||
42271496|NCT02324842|76101377|FG001|Overall Study|Lost to Follow-up|1|||
42271497|NCT02324842|76101378|FG002|Overall Study|Lost to Follow-up|2|||
42271498|NCT02295280|76101388|FG000|Overall Study|Adverse Event|0|||
42271499|NCT02295280|76101389|FG001|Overall Study|Adverse Event|1|||
42271500|NCT05263505|76101397|FG000|Overall Study|Adverse Event|0|||
42346024|NCT01858766|76184794|FG018|Overall Study|Randomized but Never Treated|0|||
42346025|NCT01858766|76184776|FG000|Overall Study|Death|0|||
42004828|NCT01296711|75812753|FG004|Overall Study|Continued elevated liver enzymes|0|||
42004829|NCT01296711|75812754|FG005|Overall Study|Continued elevated liver enzymes|0|||
42271501|NCT05263505|76101398|FG001|Overall Study|Adverse Event|1|||
42271502|NCT02294734|76101406|FG000|Overall Study|Adverse Event|5|||
42271503|NCT02294734|76101407|FG001|Overall Study|Adverse Event|5|||
42271504|NCT02294734|76101406|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
42271505|NCT02294734|76101407|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
42271506|NCT02294734|76101406|FG000|Overall Study|Lost to Follow-up|2|||
42271507|NCT02294734|76101407|FG001|Overall Study|Lost to Follow-up|0|||
42271508|NCT02294734|76101406|FG000|Overall Study|Physician Decision|2|||
42004830|NCT01296711|75812755|FG006|Overall Study|Continued elevated liver enzymes|0|||
42346026|NCT01858766|76184777|FG001|Overall Study|Death|0|||
42346027|NCT01858766|76184778|FG002|Overall Study|Death|1|||
42271509|NCT02294734|76101407|FG001|Overall Study|Physician Decision|1|||
42004831|NCT01296711|75812756|FG007|Overall Study|Continued elevated liver enzymes|0|||
42004832|NCT01296711|75812749|FG000|Overall Study|Methotrexate discontinued|0|||
42346028|NCT01858766|76184779|FG003|Overall Study|Death|0|||
42346029|NCT01858766|76184780|FG004|Overall Study|Death|0|||
42271510|NCT02294734|76101406|FG000|Overall Study|Withdrawal by Subject|4|||
42271511|NCT02294734|76101407|FG001|Overall Study|Withdrawal by Subject|2|||
42271512|NCT02323204|76101428|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
42271513|NCT02323204|76101429|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
42271514|NCT02323204|76101430|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
42271515|NCT02323204|76101431|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
42271516|NCT02323204|76101428|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
42004833|NCT01296711|75812750|FG001|Overall Study|Methotrexate discontinued|0|||
42004834|NCT01296711|75812751|FG002|Overall Study|Methotrexate discontinued|0|||
42004835|NCT01296711|75812752|FG003|Overall Study|Methotrexate discontinued|1|||
42004836|NCT01296711|75812753|FG004|Overall Study|Methotrexate discontinued|0|||
42271517|NCT02323204|76101429|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
42004837|NCT01296711|75812754|FG005|Overall Study|Methotrexate discontinued|0|||
42004838|NCT01296711|75812755|FG006|Overall Study|Methotrexate discontinued|0|||
42271518|NCT02323204|76101430|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
42004839|NCT01296711|75812756|FG007|Overall Study|Methotrexate discontinued|0|||
42004840|NCT01296711|75812749|FG000|Overall Study|Investigator discretion|0|||
42271519|NCT02323204|76101431|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
42271520|NCT02323204|76101428|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
42271521|NCT02323204|76101429|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
42271522|NCT02323204|76101430|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
42271523|NCT02323204|76101431|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
42271524|NCT02323204|76101428|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
42271525|NCT02323204|76101429|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
42346030|NCT01858766|76184781|FG005|Overall Study|Death|0|||
42346031|NCT01858766|76184782|FG006|Overall Study|Death|0|||
42346032|NCT01858766|76184783|FG007|Overall Study|Death|0|||
42346033|NCT01858766|76184784|FG008|Overall Study|Death|0|||
42346034|NCT01858766|76184785|FG009|Overall Study|Death|0|||
42346035|NCT01858766|76184786|FG010|Overall Study|Death|0|||
42346036|NCT01858766|76184787|FG011|Overall Study|Death|0|||
42346037|NCT01858766|76184788|FG012|Overall Study|Death|0|||
42346038|NCT01858766|76184789|FG013|Overall Study|Death|0|||
42346039|NCT01858766|76184790|FG014|Overall Study|Death|0|||
42346040|NCT01858766|76184791|FG015|Overall Study|Death|0|||
42346041|NCT01858766|76184792|FG016|Overall Study|Death|0|||
42346042|NCT01858766|76184793|FG017|Overall Study|Death|0|||
42346043|NCT01858766|76184794|FG018|Overall Study|Death|0|||
42346044|NCT01858766|76184776|FG000|Overall Study|Lack of Efficacy|1|||
42346045|NCT01858766|76184777|FG001|Overall Study|Lack of Efficacy|0|||
42346046|NCT01858766|76184778|FG002|Overall Study|Lack of Efficacy|0|||
42346047|NCT01858766|76184779|FG003|Overall Study|Lack of Efficacy|0|||
42346048|NCT01858766|76184780|FG004|Overall Study|Lack of Efficacy|1|||
42346049|NCT01858766|76184781|FG005|Overall Study|Lack of Efficacy|2|||
42346050|NCT01858766|76184782|FG006|Overall Study|Lack of Efficacy|0|||
42004841|NCT01296711|75812750|FG001|Overall Study|Investigator discretion|0|||
42136685|NCT00541229|75947069|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
42271526|NCT02323204|76101430|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
42271527|NCT02323204|76101431|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
42271528|NCT02323204|76101428|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
42271529|NCT02323204|76101429|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
42346051|NCT01858766|76184783|FG007|Overall Study|Lack of Efficacy|0|||
42346052|NCT01858766|76184784|FG008|Overall Study|Lack of Efficacy|0|||
42346053|NCT01858766|76184785|FG009|Overall Study|Lack of Efficacy|0|||
42346054|NCT01858766|76184786|FG010|Overall Study|Lack of Efficacy|0|||
42346055|NCT01858766|76184787|FG011|Overall Study|Lack of Efficacy|3|||
42346056|NCT01858766|76184788|FG012|Overall Study|Lack of Efficacy|5|||
42346057|NCT01858766|76184789|FG013|Overall Study|Lack of Efficacy|3|||
42271530|NCT02323204|76101430|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
42271531|NCT02323204|76101431|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
42271532|NCT02323204|76101428|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
42271533|NCT02323204|76101429|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
42271534|NCT02323204|76101430|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
42271535|NCT02323204|76101431|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
42271536|NCT02323204|76101428|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
42271537|NCT02323204|76101429|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
42271538|NCT02323204|76101430|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
42346058|NCT01858766|76184790|FG014|Overall Study|Lack of Efficacy|5|||
42346059|NCT01858766|76184791|FG015|Overall Study|Lack of Efficacy|5|||
42346060|NCT01858766|76184792|FG016|Overall Study|Lack of Efficacy|2|||
42346061|NCT01858766|76184793|FG017|Overall Study|Lack of Efficacy|3|||
42346062|NCT01858766|76184794|FG018|Overall Study|Lack of Efficacy|3|||
42346063|NCT01858766|76184776|FG000|Overall Study|Lost to Follow-up|0|||
42346064|NCT01858766|76184777|FG001|Overall Study|Lost to Follow-up|0|||
42346065|NCT01858766|76184778|FG002|Overall Study|Lost to Follow-up|0|||
42346066|NCT01858766|76184779|FG003|Overall Study|Lost to Follow-up|0|||
42346067|NCT01858766|76184780|FG004|Overall Study|Lost to Follow-up|0|||
42346068|NCT01858766|76184781|FG005|Overall Study|Lost to Follow-up|1|||
42346069|NCT01858766|76184782|FG006|Overall Study|Lost to Follow-up|0|||
42346070|NCT01858766|76184783|FG007|Overall Study|Lost to Follow-up|2|||
42346071|NCT01858766|76184784|FG008|Overall Study|Lost to Follow-up|0|||
42346072|NCT01858766|76184785|FG009|Overall Study|Lost to Follow-up|0|||
42346073|NCT01858766|76184786|FG010|Overall Study|Lost to Follow-up|0|||
42346074|NCT01858766|76184787|FG011|Overall Study|Lost to Follow-up|1|||
42346075|NCT01858766|76184788|FG012|Overall Study|Lost to Follow-up|0|||
42346076|NCT01858766|76184789|FG013|Overall Study|Lost to Follow-up|0|||
42346077|NCT01858766|76184790|FG014|Overall Study|Lost to Follow-up|3|||
42346078|NCT01858766|76184791|FG015|Overall Study|Lost to Follow-up|1|||
42346079|NCT01858766|76184792|FG016|Overall Study|Lost to Follow-up|1|||
42346080|NCT01858766|76184793|FG017|Overall Study|Lost to Follow-up|0|||
42346081|NCT01858766|76184794|FG018|Overall Study|Lost to Follow-up|1|||
42346082|NCT01858766|76184776|FG000|Overall Study|Withdrew Consent|0|||
42346083|NCT01858766|76184777|FG001|Overall Study|Withdrew Consent|0|||
42346084|NCT01858766|76184778|FG002|Overall Study|Withdrew Consent|0|||
42346085|NCT01858766|76184779|FG003|Overall Study|Withdrew Consent|0|||
42271539|NCT02323204|76101431|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
42271540|NCT02323204|76101428|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
42271541|NCT02323204|76101429|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
42271542|NCT02323204|76101430|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
42271543|NCT02323204|76101431|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
42271544|NCT02323204|76101428|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
42271545|NCT02323204|76101429|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
42271546|NCT02323204|76101430|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
42346086|NCT01858766|76184780|FG004|Overall Study|Withdrew Consent|0|||
42346087|NCT01858766|76184781|FG005|Overall Study|Withdrew Consent|0|||
42346088|NCT01858766|76184782|FG006|Overall Study|Withdrew Consent|0|||
42346089|NCT01858766|76184783|FG007|Overall Study|Withdrew Consent|0|||
42346090|NCT01858766|76184784|FG008|Overall Study|Withdrew Consent|0|||
42346091|NCT01858766|76184785|FG009|Overall Study|Withdrew Consent|0|||
42346092|NCT01858766|76184786|FG010|Overall Study|Withdrew Consent|0|||
42346093|NCT01858766|76184787|FG011|Overall Study|Withdrew Consent|1|||
42346094|NCT01858766|76184788|FG012|Overall Study|Withdrew Consent|0|||
42136686|NCT00541229|75947070|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
42136687|NCT00541229|75947071|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
42346095|NCT01858766|76184789|FG013|Overall Study|Withdrew Consent|0|||
42346096|NCT01858766|76184790|FG014|Overall Study|Withdrew Consent|0|||
42346097|NCT01858766|76184791|FG015|Overall Study|Withdrew Consent|0|||
42346098|NCT01858766|76184792|FG016|Overall Study|Withdrew Consent|0|||
42346099|NCT01858766|76184793|FG017|Overall Study|Withdrew Consent|0|||
42346100|NCT01858766|76184794|FG018|Overall Study|Withdrew Consent|0|||
42136688|NCT00541229|75947066|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
42136689|NCT00541229|75947067|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
42136690|NCT00541229|75947068|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
42271547|NCT02323204|76101431|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
42271548|NCT02322892|76101443|FG000|Overall Study|Surgery cancelled|1|||
42346101|NCT01734993|76184827|FG000|Overall Study|Adverse Event|1|||
42271549|NCT02322892|76101444|FG001|Overall Study|Surgery cancelled|2|||
42271550|NCT02322892|76101443|FG000|Overall Study|Met exclusion criteria|0|||
42346102|NCT01734993|76184827|FG000|Overall Study|Lack of Efficacy|1|||
42346103|NCT01745367|76184834|FG000|Overall Study|Death|1|||
42346104|NCT01745367|76184835|FG001|Overall Study|Death|0|||
42346105|NCT01745367|76184834|FG000|Overall Study|Withdrawal by Subject|1|||
42346106|NCT01745367|76184835|FG001|Overall Study|Withdrawal by Subject|2|||
42004842|NCT01296711|75812751|FG002|Overall Study|Investigator discretion|0|||
42004843|NCT01296711|75812752|FG003|Overall Study|Investigator discretion|0|||
42004844|NCT01296711|75812753|FG004|Overall Study|Investigator discretion|0|||
42004845|NCT01296711|75812754|FG005|Overall Study|Investigator discretion|0|||
42346107|NCT01745367|76184834|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
42346108|NCT01745367|76184835|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
42346109|NCT01745367|76184834|FG000|Overall Study|Other Reasons Unspecified|0|||
42346110|NCT01745367|76184835|FG001|Overall Study|Other Reasons Unspecified|2|||
42346111|NCT01733121|76184843|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
42346112|NCT01733121|76184844|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
42346113|NCT01733121|76184843|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
42346114|NCT01733121|76184844|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
42346115|NCT01733121|76184843|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
42346116|NCT01733121|76184844|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
42346117|NCT01733121|76184843|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
42346118|NCT01733121|76184844|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
42346119|NCT01744977|76184854|FG000|Overall Study|Withdrawal by Subject|1|||
42346120|NCT01744977|76184855|FG001|Overall Study|Withdrawal by Subject|2|||
42346121|NCT01744977|76184854|FG000|Overall Study|Death|2|||
42346122|NCT01744977|76184855|FG001|Overall Study|Death|3|||
42346123|NCT01744977|76184854|FG000|Overall Study|Lost to Follow-up|2|||
42346124|NCT01744977|76184855|FG001|Overall Study|Lost to Follow-up|0|||
42346125|NCT01744977|76184854|FG000|Overall Study|No longer meets inclusion|6|||
42346126|NCT01744977|76184855|FG001|Overall Study|No longer meets inclusion|0|||
42346127|NCT01383928|76184864|FG000|Overall Study|Initiation of ASCT|2|||
42346128|NCT01383928|76184865|FG001|Overall Study|Initiation of ASCT|1|||
42346129|NCT01383928|76184866|FG002|Overall Study|Initiation of ASCT|18|||
42346130|NCT01383928|76184864|FG000|Overall Study|Adverse Event|1|||
42346131|NCT01383928|76184865|FG001|Overall Study|Adverse Event|2|||
42346132|NCT01383928|76184866|FG002|Overall Study|Adverse Event|8|||
42346133|NCT01383928|76184864|FG000|Overall Study|Other|1|||
42346134|NCT01383928|76184865|FG001|Overall Study|Other|3|||
42346135|NCT01383928|76184866|FG002|Overall Study|Other|4|||
42346136|NCT01383928|76184864|FG000|Overall Study|Progressive Disease|1|||
42004846|NCT01296711|75812755|FG006|Overall Study|Investigator discretion|1|||
42346137|NCT01383928|76184865|FG001|Overall Study|Progressive Disease|1|||
42346138|NCT01383928|76184866|FG002|Overall Study|Progressive Disease|5|||
42346139|NCT01383928|76184864|FG000|Overall Study|Withdrawal by Subject|0|||
42346140|NCT01383928|76184865|FG001|Overall Study|Withdrawal by Subject|0|||
42346141|NCT01383928|76184866|FG002|Overall Study|Withdrawal by Subject|4|||
42004847|NCT01296711|75812756|FG007|Overall Study|Investigator discretion|0|||
42004848|NCT01296711|75812749|FG000|Overall Study|Other|0|||
42346142|NCT01383928|76184864|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
42004849|NCT01296711|75812750|FG001|Overall Study|Other|0|||
42271551|NCT02322892|76101444|FG001|Overall Study|Met exclusion criteria|1|||
42271552|NCT02322892|76101443|FG000|Overall Study|Protocol Violation|1|||
42271553|NCT02322892|76101444|FG001|Overall Study|Protocol Violation|0|||
42271554|NCT03916081|76101453|FG000|Overall Study|Adverse Event|1|||
42271555|NCT03916081|76101454|FG001|Overall Study|Adverse Event|0|||
42271556|NCT03916081|76101455|FG002|Overall Study|Adverse Event|0|||
42271557|NCT03916081|76101453|FG000|Overall Study|Physician Decision|0|||
42271558|NCT03916081|76101454|FG001|Overall Study|Physician Decision|0|||
42271559|NCT03916081|76101455|FG002|Overall Study|Physician Decision|1|||
42271560|NCT03916081|76101453|FG000|Overall Study|Lost to Follow-up|0|||
42271561|NCT03916081|76101454|FG001|Overall Study|Lost to Follow-up|1|||
42271562|NCT03916081|76101455|FG002|Overall Study|Lost to Follow-up|0|||
42271563|NCT03916081|76101453|FG000|Overall Study|Withdrawal by Subject|3|||
42271564|NCT03916081|76101454|FG001|Overall Study|Withdrawal by Subject|0|||
42271565|NCT03916081|76101455|FG002|Overall Study|Withdrawal by Subject|1|||
42271566|NCT03916081|76101453|FG000|Overall Study|Worsening of AD|0|||
42271567|NCT03916081|76101454|FG001|Overall Study|Worsening of AD|0|||
42271568|NCT03916081|76101455|FG002|Overall Study|Worsening of AD|1|||
42271569|NCT03116113|76101472|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
42271570|NCT03116113|76101473|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
42271571|NCT03116113|76101474|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
42271572|NCT03116113|76101475|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
42271573|NCT03116113|76101476|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
42271574|NCT03116113|76101477|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
42271575|NCT03116113|76101478|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
42271576|NCT03116113|76101479|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
42271577|NCT03116113|76101480|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
42271578|NCT02739997|76101505|FG000|Overall Study|Death|1|||
42271579|NCT02739997|76101505|FG000|Overall Study|Withdrawal by Subject|1|||
42271580|NCT02221037|76101513|FG000|Overall Study|Physician Decision|0|||
42271581|NCT02221037|76101514|FG001|Overall Study|Physician Decision|0|||
42271582|NCT02221037|76101515|FG002|Overall Study|Physician Decision|1|||
42271583|NCT02221037|76101516|FG003|Overall Study|Physician Decision|0|||
42271584|NCT02704429|76101532|FG000|Part A: 24 Weeks|Adverse Event|3|||
42271585|NCT02704429|76101533|FG001|Part A: 24 Weeks|Adverse Event|0|||
42271586|NCT02704429|76101532|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
42271587|NCT02704429|76101533|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
42271588|NCT02751359|76101540|FG000|Overall Study|Lost to Follow-up|1|||
42271589|NCT02750813|76101559|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
42271590|NCT02750813|76101560|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
42271591|NCT02750813|76101559|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
42271592|NCT02750813|76101560|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
42271593|NCT00503035|76101576|FG000|Overall Study|Lost to Follow-up|2|||
42271594|NCT00503035|76101576|FG000|Overall Study|Physician Decision|3|||
42271595|NCT00503035|76101576|FG000|Overall Study|Ineligible|15|||
42271596|NCT03137381|76101585|FG000|Overall Study|Adverse Event|3|||
42271597|NCT03137381|76101586|FG001|Overall Study|Adverse Event|0|||
42271598|NCT03137381|76101587|FG002|Overall Study|Adverse Event|2|||
42271599|NCT03137381|76101588|FG003|Overall Study|Adverse Event|0|||
42271600|NCT03137381|76101585|FG000|Overall Study|Lost to Follow-up|2|||
42271601|NCT03137381|76101586|FG001|Overall Study|Lost to Follow-up|1|||
42271602|NCT03137381|76101587|FG002|Overall Study|Lost to Follow-up|1|||
42271603|NCT03137381|76101588|FG003|Overall Study|Lost to Follow-up|0|||
42271604|NCT03137381|76101585|FG000|Overall Study|Protocol deviation|1|||
42004850|NCT01296711|75812751|FG002|Overall Study|Other|0|||
42004851|NCT01296711|75812752|FG003|Overall Study|Other|0|||
42004852|NCT01296711|75812753|FG004|Overall Study|Other|0|||
42004853|NCT01296711|75812754|FG005|Overall Study|Other|0|||
42004854|NCT01296711|75812755|FG006|Overall Study|Other|1|||
42004855|NCT01296711|75812756|FG007|Overall Study|Other|0|||
42004856|NCT01296711|75812749|FG000|Overall Study|Required restricted steroid injections|0|||
42004857|NCT01296711|75812750|FG001|Overall Study|Required restricted steroid injections|0|||
42004858|NCT01296711|75812751|FG002|Overall Study|Required restricted steroid injections|0|||
42004859|NCT01296711|75812752|FG003|Overall Study|Required restricted steroid injections|0|||
42004860|NCT01296711|75812753|FG004|Overall Study|Required restricted steroid injections|0|||
42004861|NCT01296711|75812754|FG005|Overall Study|Required restricted steroid injections|0|||
42004862|NCT01296711|75812755|FG006|Overall Study|Required restricted steroid injections|1|||
42004863|NCT01296711|75812756|FG007|Overall Study|Required restricted steroid injections|0|||
42004864|NCT01296711|75812749|FG000|Overall Study|Ongoing missed appointments|0|||
42004865|NCT01296711|75812750|FG001|Overall Study|Ongoing missed appointments|0|||
42004866|NCT01296711|75812751|FG002|Overall Study|Ongoing missed appointments|0|||
42004867|NCT01296711|75812752|FG003|Overall Study|Ongoing missed appointments|0|||
42004868|NCT01296711|75812753|FG004|Overall Study|Ongoing missed appointments|0|||
42004869|NCT01296711|75812754|FG005|Overall Study|Ongoing missed appointments|0|||
42004870|NCT01296711|75812755|FG006|Overall Study|Ongoing missed appointments|1|||
42004871|NCT01296711|75812756|FG007|Overall Study|Ongoing missed appointments|0|||
42004872|NCT01296711|75812749|FG000|Overall Study|Failure to comply with visits|0|||
42004873|NCT01296711|75812750|FG001|Overall Study|Failure to comply with visits|0|||
42004874|NCT01296711|75812751|FG002|Overall Study|Failure to comply with visits|0|||
42004875|NCT01296711|75812752|FG003|Overall Study|Failure to comply with visits|0|||
42004876|NCT01296711|75812753|FG004|Overall Study|Failure to comply with visits|0|||
42004877|NCT01296711|75812754|FG005|Overall Study|Failure to comply with visits|0|||
42004878|NCT01296711|75812755|FG006|Overall Study|Failure to comply with visits|0|||
42004879|NCT01296711|75812756|FG007|Overall Study|Failure to comply with visits|1|||
42004880|NCT01296711|75812749|FG000|Overall Study|Patient decision due to transport|0|||
42004881|NCT01296711|75812750|FG001|Overall Study|Patient decision due to transport|0|||
42004882|NCT01296711|75812751|FG002|Overall Study|Patient decision due to transport|0|||
42004883|NCT01296711|75812752|FG003|Overall Study|Patient decision due to transport|0|||
42004884|NCT01296711|75812753|FG004|Overall Study|Patient decision due to transport|0|||
42004885|NCT01296711|75812754|FG005|Overall Study|Patient decision due to transport|0|||
42004886|NCT01296711|75812755|FG006|Overall Study|Patient decision due to transport|0|||
42004887|NCT01296711|75812756|FG007|Overall Study|Patient decision due to transport|1|||
42004888|NCT01294917|75812774|FG000|Overall Study|Relocation|5|||
42004889|NCT01294917|75812774|FG000|Overall Study|Inconvenience|1|||
42004890|NCT01294683|75812782|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
42004891|NCT01294683|75812783|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
42004892|NCT01294683|75812782|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
42004893|NCT01294683|75812783|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
42004894|NCT01294683|75812782|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
42004895|NCT01294683|75812783|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
42271605|NCT03137381|76101586|FG001|Overall Study|Protocol deviation|1|||
42271606|NCT03137381|76101587|FG002|Overall Study|Protocol deviation|0|||
42346143|NCT01383928|76184865|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
42271607|NCT03137381|76101588|FG003|Overall Study|Protocol deviation|1|||
42271608|NCT03137381|76101585|FG000|Overall Study|Withdrawal by Investigator|0|||
42271609|NCT03137381|76101586|FG001|Overall Study|Withdrawal by Investigator|1|||
42271610|NCT03137381|76101587|FG002|Overall Study|Withdrawal by Investigator|1|||
42271611|NCT03137381|76101588|FG003|Overall Study|Withdrawal by Investigator|0|||
42271612|NCT03137381|76101585|FG000|Overall Study|Withdrawal by Subject|3|||
42271613|NCT03137381|76101586|FG001|Overall Study|Withdrawal by Subject|4|||
42271614|NCT03137381|76101587|FG002|Overall Study|Withdrawal by Subject|3|||
42271615|NCT03137381|76101588|FG003|Overall Study|Withdrawal by Subject|0|||
42271616|NCT03137381|76101585|FG000|Overall Study|Pregnancy|0|||
42271617|NCT03137381|76101586|FG001|Overall Study|Pregnancy|0|||
42346144|NCT01383928|76184866|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
42346145|NCT01382602|76184878|FG000|Overall Study|Protocol Violation|0|||
42346146|NCT01382602|76184879|FG001|Overall Study|Protocol Violation|3|||
42346147|NCT01382602|76184878|FG000|Overall Study|Withdrawal by Subject|0|||
42346148|NCT01382602|76184879|FG001|Overall Study|Withdrawal by Subject|1|||
42004896|NCT01294683|75812782|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
42004897|NCT01294683|75812783|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
42004898|NCT01294683|75812782|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
42004899|NCT01294683|75812783|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
42004900|NCT01294683|75812782|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
42004901|NCT01294683|75812783|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
42346149|NCT04801420|76184888|FG000|Overall Study|Other|1|||
42346150|NCT04801420|76184889|FG001|Overall Study|Other|2|||
42346151|NCT04801420|76184890|FG002|Overall Study|Other|1|||
42136691|NCT00541229|75947069|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
42271618|NCT03137381|76101587|FG002|Overall Study|Pregnancy|1|||
42271619|NCT03137381|76101588|FG003|Overall Study|Pregnancy|0|||
42271620|NCT03926117|76101602|FG000|Overall Study|Unclassified|1|||
42271621|NCT03926117|76101603|FG001|Overall Study|Unclassified|4|||
42271622|NCT03926117|76101604|FG002|Overall Study|Unclassified|1|||
42271623|NCT03926117|76101605|FG003|Overall Study|Unclassified|4|||
42271624|NCT03926117|76101602|FG000|Overall Study|Withdrawal by Subject|3|||
42271625|NCT03926117|76101603|FG001|Overall Study|Withdrawal by Subject|0|||
42271626|NCT03926117|76101604|FG002|Overall Study|Withdrawal by Subject|1|||
42346152|NCT04801420|76184888|FG000|Overall Study|Lost to Follow-up|7|||
42346153|NCT04801420|76184889|FG001|Overall Study|Lost to Follow-up|9|||
42346154|NCT04801420|76184890|FG002|Overall Study|Lost to Follow-up|10|||
42346155|NCT04801420|76184888|FG000|Overall Study|Moved from study area|0|||
42271627|NCT03926117|76101605|FG003|Overall Study|Withdrawal by Subject|1|||
42271628|NCT03926117|76101602|FG000|Overall Study|Lost to Follow-up|0|||
42271629|NCT03926117|76101603|FG001|Overall Study|Lost to Follow-up|2|||
42271630|NCT03926117|76101604|FG002|Overall Study|Lost to Follow-up|1|||
42271631|NCT03926117|76101605|FG003|Overall Study|Lost to Follow-up|0|||
42271632|NCT03926117|76101602|FG000|Overall Study|Adverse Event|1|||
42271633|NCT03926117|76101603|FG001|Overall Study|Adverse Event|2|||
42271634|NCT03926117|76101604|FG002|Overall Study|Adverse Event|3|||
42271635|NCT03926117|76101605|FG003|Overall Study|Adverse Event|1|||
42271636|NCT03926117|76101602|FG000|Overall Study|Randomized but not treated|1|||
42271637|NCT03926117|76101603|FG001|Overall Study|Randomized but not treated|1|||
42271638|NCT03926117|76101604|FG002|Overall Study|Randomized but not treated|0|||
42346156|NCT04801420|76184889|FG001|Overall Study|Moved from study area|1|||
42346157|NCT04801420|76184890|FG002|Overall Study|Moved from study area|1|||
42346158|NCT04801420|76184888|FG000|Overall Study|Withdrawal by Subject|5|||
42346159|NCT04801420|76184889|FG001|Overall Study|Withdrawal by Subject|1|||
42346160|NCT04801420|76184890|FG002|Overall Study|Withdrawal by Subject|4|||
42346161|NCT04801420|76184888|FG000|Overall Study|Individual stopping criteria reached|0|||
42346162|NCT04801420|76184889|FG001|Overall Study|Individual stopping criteria reached|1|||
42346163|NCT04801420|76184890|FG002|Overall Study|Individual stopping criteria reached|0|||
42346164|NCT04801420|76184888|FG000|Overall Study|Ongoing in the study|195|||
42346165|NCT04801420|76184889|FG001|Overall Study|Ongoing in the study|195|||
42346166|NCT04801420|76184890|FG002|Overall Study|Ongoing in the study|192|||
42346167|NCT04294472|76184905|FG000|Overall Study|Adverse Event|0|||
42271639|NCT03926117|76101605|FG003|Overall Study|Randomized but not treated|1|||
42346168|NCT04294472|76184906|FG001|Overall Study|Adverse Event|1|||
42346169|NCT04294472|76184907|FG002|Overall Study|Adverse Event|1|||
42271640|NCT02750501|76101632|FG000|Overall Study|Adverse Event|4|||
42271641|NCT02750501|76101632|FG000|Overall Study|Physician Decision|1|||
42271642|NCT02750501|76101632|FG000|Overall Study|Protocol Violation|1|||
42271643|NCT02750501|76101632|FG000|Overall Study|G-tube came out|1|||
42271644|NCT02750501|76101632|FG000|Overall Study|Non-compliant use of PERT|1|||
42346170|NCT04294472|76184905|FG000|Overall Study|Randomized but not treated|0|||
42346171|NCT04294472|76184906|FG001|Overall Study|Randomized but not treated|1|||
42346172|NCT04294472|76184907|FG002|Overall Study|Randomized but not treated|1|||
42346173|NCT04233918|76184917|FG000|Part C (Extension Period)|Ongoing in study|0|||
42346174|NCT04233918|76184918|FG001|Part C (Extension Period)|Ongoing in study|0|||
42271645|NCT01337297|76101655|FG000|Overall Study|They entered to single anodal tDCS|4|||
42346175|NCT04233918|76184919|FG002|Part C (Extension Period)|Ongoing in study|15|||
42346176|NCT04060251|76184931|FG000|Overall Study|Study terminated due to low enrollment.|7|||
42346177|NCT04060251|76184932|FG001|Overall Study|Study terminated due to low enrollment.|5|||
42346178|NCT04060251|76184933|FG002|Overall Study|Study terminated due to low enrollment.|7|||
42346179|NCT04060251|76184931|FG000|Overall Study|Adverse Event|1|||
42346180|NCT04060251|76184932|FG001|Overall Study|Adverse Event|1|||
42346181|NCT04060251|76184933|FG002|Overall Study|Adverse Event|0|||
42346182|NCT04048876|76184945|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
42346183|NCT04048876|76184946|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
42346184|NCT04048876|76184947|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
42346185|NCT04048876|76184948|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
42346186|NCT04048876|76184945|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
42346187|NCT04048876|76184946|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
42346188|NCT04048876|76184947|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
42346189|NCT04048876|76184948|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
42346190|NCT04048876|76184945|FG000|Placebo Controlled Phase|Adverse Event|0|||
42346191|NCT04048876|76184946|FG001|Placebo Controlled Phase|Adverse Event|1|||
42346192|NCT04048876|76184947|FG002|Placebo Controlled Phase|Adverse Event|0|||
42346193|NCT04048876|76184948|FG003|Placebo Controlled Phase|Adverse Event|0|||
42346194|NCT04048876|76184945|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
42346195|NCT04048876|76184946|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
42346196|NCT04048876|76184947|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
42346197|NCT04048876|76184948|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
42346198|NCT03921424|76184975|FG000|Overall Study|Lost to Follow-up|0|||
42004902|NCT01294683|75812782|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
42271646|NCT01337297|76101656|FG001|Overall Study|They entered to single anodal tDCS|3|||
42271647|NCT01337297|76101655|FG000|Overall Study|Lost to Follow-up|1|||
42271648|NCT01337297|76101656|FG001|Overall Study|Lost to Follow-up|3|||
42271649|NCT02302963|76101664|FG000|Overall Study|Withdrawal by Subject|2|||
42271650|NCT02302963|76101665|FG001|Overall Study|Withdrawal by Subject|1|||
42271651|NCT02302963|76101664|FG000|Overall Study|Steroid injection|0|||
42271652|NCT02302963|76101665|FG001|Overall Study|Steroid injection|1|||
42271653|NCT02302963|76101664|FG000|Overall Study|Physician Decision|1|||
42271654|NCT02302963|76101665|FG001|Overall Study|Physician Decision|0|||
42271655|NCT03507439|76101686|FG000|Overall Study|Other|2|||
42271656|NCT03507439|76101687|FG001|Overall Study|Other|1|||
42271657|NCT03507439|76101686|FG000|Overall Study|Withdrawal by Subject|1|||
42271658|NCT03507439|76101687|FG001|Overall Study|Withdrawal by Subject|0|||
42271659|NCT03507439|76101686|FG000|Overall Study|Death|1|||
42271660|NCT03507439|76101687|FG001|Overall Study|Death|1|||
42346199|NCT03921424|76184976|FG001|Overall Study|Lost to Follow-up|1|||
42346200|NCT03921424|76184975|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
42346201|NCT03921424|76184976|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
42346202|NCT03852628|76184999|FG000|Overall Study|Lost to Follow-up|7|||
42346203|NCT03852628|76185000|FG001|Overall Study|Lost to Follow-up|6|||
42346204|NCT03852628|76184999|FG000|Overall Study|Lack of Efficacy|6|||
42346205|NCT03852628|76185000|FG001|Overall Study|Lack of Efficacy|6|||
42346206|NCT03602976|76185006|FG000|Overall Study|Withdrawal by Subject|1|||
42346207|NCT03278106|76185022|FG000|Overall Study|No protocol treatment|1|||
42004903|NCT01294683|75812783|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
42271661|NCT03507127|76101695|FG000|Overall Study|Withdrawal by Subject|1|||
42271662|NCT03507127|76101696|FG001|Overall Study|Withdrawal by Subject|0|||
42271663|NCT03507127|76101695|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
42346208|NCT03214198|76185026|FG000|Overall Study|Case Report Forms Uncollected|18|||
42346209|NCT03214198|76185026|FG000|Overall Study|Protocol Deviation|18|||
42346210|NCT03052608|76185032|FG000|Treatment Phase|Adverse Event|10|||
42346211|NCT03052608|76185033|FG001|Treatment Phase|Adverse Event|12|||
42346212|NCT03052608|76185032|FG000|Treatment Phase|Death|6|||
42346213|NCT03052608|76185033|FG001|Treatment Phase|Death|4|||
42346214|NCT03052608|76185032|FG000|Treatment Phase|Withdrawal by Subject|4|||
42346215|NCT03052608|76185033|FG001|Treatment Phase|Withdrawal by Subject|12|||
42346216|NCT03052608|76185032|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
42346217|NCT03052608|76185033|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
42346218|NCT03052608|76185032|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
42346219|NCT03052608|76185033|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
42346220|NCT03052608|76185032|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
42004904|NCT01294683|75812782|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
42271664|NCT03507127|76101696|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
42271665|NCT02322190|76101719|FG000|Overall Study|Death on study|1|||
42271666|NCT02322190|76101720|FG001|Overall Study|Death on study|0|||
42271667|NCT02321800|76101736|FG000|Overall Study|Withdrawal by Subject|3|||
42271668|NCT02321800|76101737|FG001|Overall Study|Withdrawal by Subject|3|||
42271669|NCT02321800|76101736|FG000|Overall Study|Death|1|||
42271670|NCT02321800|76101737|FG001|Overall Study|Death|0|||
42346221|NCT03052608|76185033|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
42346222|NCT03052608|76185032|FG000|Treatment Phase|Ongoing|103|||
42346223|NCT03052608|76185033|FG001|Treatment Phase|Ongoing|31|||
42136692|NCT00541229|75947070|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
42346224|NCT03052608|76185032|FG000|Long-Term Follow-up Phase|Death|23|||
42346225|NCT03052608|76185033|FG001|Long-Term Follow-up Phase|Death|28|||
42346226|NCT03052608|76185032|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
42271671|NCT02321800|76101736|FG000|Overall Study|Protocol Violation|1|||
42271672|NCT02321800|76101737|FG001|Overall Study|Protocol Violation|0|||
42271673|NCT02321800|76101736|FG000|Overall Study|Lost to Follow-up|10|||
42271674|NCT02321800|76101737|FG001|Overall Study|Lost to Follow-up|4|||
42271675|NCT02321800|76101736|FG000|Overall Study|Adverse Event|2|||
42271676|NCT02321800|76101737|FG001|Overall Study|Adverse Event|3|||
42271677|NCT02321800|76101736|FG000|Overall Study|Other, Miscellaneous|3|||
42271678|NCT02321800|76101737|FG001|Overall Study|Other, Miscellaneous|1|||
42271679|NCT02292784|76101783|FG000|Overall Study|Lost to Follow-up|1|||
42271680|NCT02292784|76101784|FG001|Overall Study|Lost to Follow-up|17|||
42271681|NCT02292784|76101785|FG002|Overall Study|Lost to Follow-up|18|||
42271682|NCT02292784|76101783|FG000|Overall Study|Withdrawal by Subject|0|||
42271683|NCT02292784|76101784|FG001|Overall Study|Withdrawal by Subject|3|||
42271684|NCT02292784|76101785|FG002|Overall Study|Withdrawal by Subject|3|||
42271685|NCT02320396|76101795|FG000|Overall Study|Adverse Event|2|||
42271686|NCT02320396|76101796|FG001|Overall Study|Adverse Event|2|||
42271687|NCT02320396|76101795|FG000|Overall Study|Pregnancy|0|||
42271688|NCT02320396|76101796|FG001|Overall Study|Pregnancy|1|||
42271689|NCT02320396|76101795|FG000|Overall Study|Protocol Violation|0|||
42271690|NCT02320396|76101796|FG001|Overall Study|Protocol Violation|1|||
42271691|NCT02320396|76101795|FG000|Overall Study|Withdrawal by Subject|2|||
42271692|NCT02320396|76101796|FG001|Overall Study|Withdrawal by Subject|0|||
42271693|NCT02292238|76101804|FG000|Overall Study|Protocol Violation|1|||
42271694|NCT02292238|76101805|FG001|Overall Study|Protocol Violation|2|||
42271695|NCT02292238|76101804|FG000|Overall Study|Withdrawal by Subject|2|||
42271696|NCT02292238|76101805|FG001|Overall Study|Withdrawal by Subject|1|||
42271697|NCT02292238|76101804|FG000|Overall Study|Lost to Follow-up|1|||
42271698|NCT02292238|76101805|FG001|Overall Study|Lost to Follow-up|0|||
42271699|NCT02292238|76101804|FG000|Overall Study|Physician Decision|0|||
42271700|NCT02292238|76101805|FG001|Overall Study|Physician Decision|1|||
42271701|NCT02234843|76101842|FG000|Overall Study|Death|1|||
42271702|NCT02234843|76101843|FG001|Overall Study|Death|0|||
42271703|NCT02234843|76101844|FG002|Overall Study|Death|0|||
42271704|NCT02234843|76101845|FG003|Overall Study|Death|0|||
42271705|NCT02234843|76101846|FG004|Overall Study|Death|0|||
42271706|NCT02234843|76101847|FG005|Overall Study|Death|0|||
42271707|NCT02234843|76101848|FG006|Overall Study|Death|0|||
42271708|NCT02234843|76101849|FG007|Overall Study|Death|0|||
42271709|NCT02234843|76101850|FG008|Overall Study|Death|0|||
42271710|NCT02234843|76101851|FG009|Overall Study|Death|0|||
42271711|NCT02234843|76101842|FG000|Overall Study|Protocol Violation|1|||
42271712|NCT02234843|76101843|FG001|Overall Study|Protocol Violation|0|||
42271713|NCT02234843|76101844|FG002|Overall Study|Protocol Violation|1|||
42271714|NCT02234843|76101845|FG003|Overall Study|Protocol Violation|0|||
42271715|NCT02234843|76101846|FG004|Overall Study|Protocol Violation|0|||
42271716|NCT02234843|76101847|FG005|Overall Study|Protocol Violation|0|||
42271717|NCT02234843|76101848|FG006|Overall Study|Protocol Violation|0|||
42271718|NCT02234843|76101849|FG007|Overall Study|Protocol Violation|0|||
42271719|NCT02234843|76101850|FG008|Overall Study|Protocol Violation|0|||
42271720|NCT02234843|76101851|FG009|Overall Study|Protocol Violation|0|||
42271721|NCT02234843|76101842|FG000|Overall Study|Efficacy outcome reached|2|||
42271722|NCT02234843|76101843|FG001|Overall Study|Efficacy outcome reached|0|||
42271723|NCT02234843|76101844|FG002|Overall Study|Efficacy outcome reached|0|||
42271724|NCT02234843|76101845|FG003|Overall Study|Efficacy outcome reached|0|||
42271725|NCT02234843|76101846|FG004|Overall Study|Efficacy outcome reached|0|||
42271726|NCT02234843|76101847|FG005|Overall Study|Efficacy outcome reached|2|||
42271727|NCT02234843|76101848|FG006|Overall Study|Efficacy outcome reached|0|||
42271728|NCT02234843|76101849|FG007|Overall Study|Efficacy outcome reached|0|||
42271729|NCT02234843|76101850|FG008|Overall Study|Efficacy outcome reached|0|||
42035230|NCT01114529|75843549|FG001|Completed Study Phase at Month 24|Missing|0|||
42035231|NCT01114529|75843550|FG002|Completed Study Phase at Month 24|Missing|0|||
42346227|NCT03052608|76185033|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
42035232|NCT00926289|75843562|FG000|Overall Study|Adverse Event|9|||
42035233|NCT00926289|75843563|FG001|Overall Study|Adverse Event|11|||
42271730|NCT02234843|76101851|FG009|Overall Study|Efficacy outcome reached|0|||
42271731|NCT02234843|76101842|FG000|Overall Study|Patient convenience|2|||
42271732|NCT02234843|76101843|FG001|Overall Study|Patient convenience|0|||
42271733|NCT02234843|76101844|FG002|Overall Study|Patient convenience|0|||
42271734|NCT02234843|76101845|FG003|Overall Study|Patient convenience|0|||
42271735|NCT02234843|76101846|FG004|Overall Study|Patient convenience|0|||
42271736|NCT02234843|76101847|FG005|Overall Study|Patient convenience|1|||
42271737|NCT02234843|76101848|FG006|Overall Study|Patient convenience|0|||
42271738|NCT02234843|76101849|FG007|Overall Study|Patient convenience|0|||
42035234|NCT00926289|75843562|FG000|Overall Study|Protocol Violation|8|||
42271739|NCT02234843|76101850|FG008|Overall Study|Patient convenience|0|||
42271740|NCT02234843|76101851|FG009|Overall Study|Patient convenience|0|||
42271741|NCT02234843|76101842|FG000|Overall Study|Withdrawal by Subject|5|||
42271742|NCT02234843|76101843|FG001|Overall Study|Withdrawal by Subject|1|||
42271743|NCT02234843|76101844|FG002|Overall Study|Withdrawal by Subject|1|||
42271744|NCT02234843|76101845|FG003|Overall Study|Withdrawal by Subject|0|||
42271745|NCT02234843|76101846|FG004|Overall Study|Withdrawal by Subject|0|||
42271746|NCT02234843|76101847|FG005|Overall Study|Withdrawal by Subject|7|||
42271747|NCT02234843|76101848|FG006|Overall Study|Withdrawal by Subject|0|||
42271748|NCT02234843|76101849|FG007|Overall Study|Withdrawal by Subject|0|||
42271749|NCT02234843|76101850|FG008|Overall Study|Withdrawal by Subject|0|||
42271750|NCT02234843|76101851|FG009|Overall Study|Withdrawal by Subject|0|||
42271751|NCT02234843|76101842|FG000|Overall Study|Recovery|1|||
42271752|NCT02234843|76101843|FG001|Overall Study|Recovery|0|||
42271753|NCT02234843|76101844|FG002|Overall Study|Recovery|0|||
42271754|NCT02234843|76101845|FG003|Overall Study|Recovery|0|||
42271755|NCT02234843|76101846|FG004|Overall Study|Recovery|0|||
42271756|NCT02234843|76101847|FG005|Overall Study|Recovery|0|||
42271757|NCT02234843|76101848|FG006|Overall Study|Recovery|0|||
42271758|NCT02234843|76101849|FG007|Overall Study|Recovery|0|||
42271759|NCT02234843|76101850|FG008|Overall Study|Recovery|0|||
42271760|NCT02234843|76101851|FG009|Overall Study|Recovery|0|||
42271761|NCT02234843|76101842|FG000|Overall Study|Other|0|||
42271762|NCT02234843|76101843|FG001|Overall Study|Other|2|||
42271763|NCT02234843|76101844|FG002|Overall Study|Other|0|||
42271764|NCT02234843|76101845|FG003|Overall Study|Other|1|||
42271765|NCT02234843|76101846|FG004|Overall Study|Other|0|||
42271766|NCT02234843|76101847|FG005|Overall Study|Other|1|||
42271767|NCT02234843|76101848|FG006|Overall Study|Other|0|||
42271768|NCT02234843|76101849|FG007|Overall Study|Other|1|||
42271769|NCT02234843|76101850|FG008|Overall Study|Other|0|||
42271770|NCT02234843|76101851|FG009|Overall Study|Other|0|||
42346228|NCT03052608|76185032|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
42346229|NCT03052608|76185033|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
42346230|NCT03052608|76185032|FG000|Long-Term Follow-up Phase|Ongoing|122|||
42346231|NCT03052608|76185033|FG001|Long-Term Follow-up Phase|Ongoing|99|||
42346232|NCT02914639|76185041|FG000|Overall Study|Withdrawal by Subject|0|||
42346233|NCT02914639|76185042|FG001|Overall Study|Withdrawal by Subject|2|||
42346234|NCT02865018|76185049|FG000|Overall Study|Withdrawal by Subject|1|||
42346235|NCT02704208|76185064|FG000|Overall Study|Lost to Follow-up|42|||
42346236|NCT02704208|76185065|FG001|Overall Study|Lost to Follow-up|37|||
42346237|NCT02315898|76185084|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
42346238|NCT02315898|76185085|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
42346239|NCT02315898|76185086|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
42004905|NCT01294683|75812783|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
42271771|NCT02234843|76101842|FG000|Overall Study|Physician Decision|4|||
42271772|NCT02234843|76101843|FG001|Overall Study|Physician Decision|1|||
42271773|NCT02234843|76101844|FG002|Overall Study|Physician Decision|0|||
42271774|NCT02234843|76101845|FG003|Overall Study|Physician Decision|1|||
42346240|NCT02315898|76185087|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
42136693|NCT00541229|75947071|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
42271775|NCT02234843|76101846|FG004|Overall Study|Physician Decision|0|||
42271776|NCT02234843|76101847|FG005|Overall Study|Physician Decision|0|||
42271777|NCT02234843|76101848|FG006|Overall Study|Physician Decision|0|||
42346241|NCT02157883|76185094|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
42346242|NCT02157883|76185094|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
42346243|NCT02157883|76185094|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
42271778|NCT02234843|76101849|FG007|Overall Study|Physician Decision|1|||
42271779|NCT02234843|76101850|FG008|Overall Study|Physician Decision|0|||
42271780|NCT02234843|76101851|FG009|Overall Study|Physician Decision|0|||
42271781|NCT02234843|76101842|FG000|Overall Study|Adverse Event|5|||
42271782|NCT02234843|76101843|FG001|Overall Study|Adverse Event|1|||
42271783|NCT02234843|76101844|FG002|Overall Study|Adverse Event|1|||
42004906|NCT01294683|75812782|FG000|Post Crossover (Period III)|Adverse Event|6|||
42004907|NCT01294683|75812783|FG001|Post Crossover (Period III)|Adverse Event|6|||
42004908|NCT01294683|75812782|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
42004909|NCT01294683|75812783|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
42004910|NCT01294683|75812782|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
42004911|NCT01294683|75812783|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
42136694|NCT00481988|75947081|FG000|Overall Study|Withdrawal by Subject|1|||
42136695|NCT00481988|75947082|FG001|Overall Study|Withdrawal by Subject|1|||
42136696|NCT00481832|75947099|FG000|Enrollment|Physician Decision|8|||
42136697|NCT00481832|75947099|FG000|Enrollment|Unable to collect enough stem cells|2|||
42136698|NCT00481832|75947099|FG000|Inter-transplant Period|Adverse Event|4|||
42136699|NCT00481832|75947099|FG000|Inter-transplant Period|Death|3|||
42136700|NCT00481832|75947099|FG000|Inter-transplant Period|Physician Decision|4|||
42136701|NCT00481832|75947099|FG000|Inter-transplant Period|Disease relapse|11|||
42136702|NCT00481832|75947099|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
42136703|NCT00481676|75947105|FG000|Overall Study|Adverse Event|0|||
42136704|NCT00481676|75947106|FG001|Overall Study|Adverse Event|1|||
42136705|NCT00481676|75947105|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42136706|NCT00481676|75947106|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
42136707|NCT00481676|75947105|FG000|Overall Study|Administrative problem|1|||
42136708|NCT00481676|75947106|FG001|Overall Study|Administrative problem|0|||
42136709|NCT00542789|75947114|FG000|Overall Study|Adverse Event|18|||
42136710|NCT00542789|75947115|FG001|Overall Study|Adverse Event|17|||
42136711|NCT00542789|75947114|FG000|Overall Study|Withdrawal by Subject|7|||
42136712|NCT00542789|75947115|FG001|Overall Study|Withdrawal by Subject|3|||
42136713|NCT00542789|75947114|FG000|Overall Study|Protocol Violation|8|||
42136714|NCT00542789|75947115|FG001|Overall Study|Protocol Violation|1|||
42136715|NCT00542789|75947114|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
42136716|NCT00542789|75947115|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
42136717|NCT00464672|75947123|FG000|Overall Study|withdrawal of consent|0|||
42136718|NCT00464672|75947124|FG001|Overall Study|withdrawal of consent|0|||
42136719|NCT00464672|75947125|FG002|Overall Study|withdrawal of consent|0|||
42136720|NCT00464672|75947126|FG003|Overall Study|withdrawal of consent|1|||
42136721|NCT00464672|75947127|FG004|Overall Study|withdrawal of consent|9|||
42136722|NCT00464672|75947128|FG005|Overall Study|withdrawal of consent|4|||
42136723|NCT00464672|75947123|FG000|Overall Study|Lost to Follow-up|25|||
42136724|NCT00464672|75947124|FG001|Overall Study|Lost to Follow-up|10|||
42136725|NCT00464672|75947125|FG002|Overall Study|Lost to Follow-up|0|||
42136726|NCT00464672|75947126|FG003|Overall Study|Lost to Follow-up|0|||
42136727|NCT00464672|75947127|FG004|Overall Study|Lost to Follow-up|1|||
42136728|NCT00464672|75947128|FG005|Overall Study|Lost to Follow-up|0|||
42136729|NCT00473876|75947158|FG000|Overall Study|Lost to Follow-up|3|||
42136730|NCT00473876|75947159|FG001|Overall Study|Lost to Follow-up|1|||
42136731|NCT00463580|75947169|FG000|Overall Study|Lost to Follow-up|1|||
42346244|NCT02157883|76185094|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
42346245|NCT02157883|76185094|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
42346246|NCT02071290|76185103|FG000|Overall Study|Death|1|||
42346247|NCT02071290|76185104|FG001|Overall Study|Death|0|||
42346248|NCT02071290|76185103|FG000|Overall Study|Withdrawal by Subject|0|||
42346249|NCT02071290|76185104|FG001|Overall Study|Withdrawal by Subject|1|||
42346250|NCT02071290|76185103|FG000|Overall Study|Protocol Violation|3|||
42346251|NCT02071290|76185104|FG001|Overall Study|Protocol Violation|5|||
42346252|NCT02071290|76185103|FG000|Overall Study|Physician Decision|0|||
42346253|NCT02071290|76185104|FG001|Overall Study|Physician Decision|1|||
42346254|NCT02066181|76185112|FG000|Overall Study|Withdrawal by Subject|1|||
42346255|NCT02066181|76185113|FG001|Overall Study|Withdrawal by Subject|1|||
42346256|NCT01970865|76185139|FG000|Overall Study|Death|3|||
42346257|NCT01970865|76185140|FG001|Overall Study|Death|1|||
42346258|NCT01970865|76185141|FG002|Overall Study|Death|3|||
42346259|NCT01970865|76185142|FG003|Overall Study|Death|4|||
42346260|NCT01970865|76185143|FG004|Overall Study|Death|6|||
42346261|NCT01970865|76185144|FG005|Overall Study|Death|3|||
42346262|NCT01970865|76185145|FG006|Overall Study|Death|1|||
42346263|NCT01970865|76185146|FG007|Overall Study|Death|3|||
42346264|NCT01970865|76185147|FG008|Overall Study|Death|2|||
42346265|NCT01970865|76185148|FG009|Overall Study|Death|1|||
42346266|NCT01970865|76185149|FG010|Overall Study|Death|1|||
42346267|NCT01970865|76185150|FG011|Overall Study|Death|4|||
42346268|NCT01970865|76185151|FG012|Overall Study|Death|14|||
42346269|NCT01970865|76185152|FG013|Overall Study|Death|19|||
42346270|NCT01970865|76185153|FG014|Overall Study|Death|15|||
42346271|NCT01970865|76185154|FG015|Overall Study|Death|10|||
42346272|NCT01970865|76185155|FG016|Overall Study|Death|1|||
42346273|NCT01970865|76185139|FG000|Overall Study|Lost to Follow-up|0|||
42346274|NCT01970865|76185140|FG001|Overall Study|Lost to Follow-up|0|||
42346275|NCT01970865|76185141|FG002|Overall Study|Lost to Follow-up|0|||
42346276|NCT01970865|76185142|FG003|Overall Study|Lost to Follow-up|1|||
42346277|NCT01970865|76185143|FG004|Overall Study|Lost to Follow-up|1|||
42346278|NCT01970865|76185144|FG005|Overall Study|Lost to Follow-up|0|||
42346279|NCT01970865|76185145|FG006|Overall Study|Lost to Follow-up|0|||
42346280|NCT01970865|76185146|FG007|Overall Study|Lost to Follow-up|0|||
42346281|NCT01970865|76185147|FG008|Overall Study|Lost to Follow-up|0|||
42346282|NCT01970865|76185148|FG009|Overall Study|Lost to Follow-up|0|||
42346283|NCT01970865|76185149|FG010|Overall Study|Lost to Follow-up|0|||
42346284|NCT01970865|76185150|FG011|Overall Study|Lost to Follow-up|0|||
42346285|NCT01970865|76185151|FG012|Overall Study|Lost to Follow-up|1|||
42346286|NCT01970865|76185152|FG013|Overall Study|Lost to Follow-up|0|||
42346287|NCT01970865|76185153|FG014|Overall Study|Lost to Follow-up|0|||
42346288|NCT01970865|76185154|FG015|Overall Study|Lost to Follow-up|0|||
42346289|NCT01970865|76185155|FG016|Overall Study|Lost to Follow-up|0|||
42346290|NCT01970865|76185139|FG000|Overall Study|Withdrawal by Subject|0|||
42346291|NCT01970865|76185140|FG001|Overall Study|Withdrawal by Subject|0|||
42346292|NCT01970865|76185141|FG002|Overall Study|Withdrawal by Subject|0|||
42271784|NCT02234843|76101845|FG003|Overall Study|Adverse Event|3|||
42271785|NCT02234843|76101846|FG004|Overall Study|Adverse Event|2|||
42271786|NCT02234843|76101847|FG005|Overall Study|Adverse Event|1|||
42271787|NCT02234843|76101848|FG006|Overall Study|Adverse Event|0|||
42271788|NCT02234843|76101849|FG007|Overall Study|Adverse Event|0|||
42271789|NCT02234843|76101850|FG008|Overall Study|Adverse Event|1|||
42271790|NCT02234843|76101851|FG009|Overall Study|Adverse Event|0|||
42271791|NCT02234843|76101842|FG000|Overall Study|Non-compliance with study drug|1|||
42346293|NCT01970865|76185142|FG003|Overall Study|Withdrawal by Subject|1|||
42346294|NCT01970865|76185143|FG004|Overall Study|Withdrawal by Subject|2|||
42346295|NCT01970865|76185144|FG005|Overall Study|Withdrawal by Subject|0|||
42346296|NCT01970865|76185145|FG006|Overall Study|Withdrawal by Subject|0|||
42346297|NCT01970865|76185146|FG007|Overall Study|Withdrawal by Subject|0|||
42346298|NCT01970865|76185147|FG008|Overall Study|Withdrawal by Subject|0|||
42346299|NCT01970865|76185148|FG009|Overall Study|Withdrawal by Subject|0|||
42346300|NCT01970865|76185149|FG010|Overall Study|Withdrawal by Subject|0|||
42346301|NCT01970865|76185150|FG011|Overall Study|Withdrawal by Subject|1|||
42346302|NCT01970865|76185151|FG012|Overall Study|Withdrawal by Subject|2|||
42346303|NCT01970865|76185152|FG013|Overall Study|Withdrawal by Subject|5|||
42346304|NCT01970865|76185153|FG014|Overall Study|Withdrawal by Subject|2|||
42346305|NCT01970865|76185154|FG015|Overall Study|Withdrawal by Subject|7|||
42346306|NCT01970865|76185155|FG016|Overall Study|Withdrawal by Subject|0|||
42346307|NCT01970865|76185139|FG000|Overall Study|Other|0|||
42346308|NCT01970865|76185140|FG001|Overall Study|Other|0|||
42346309|NCT01970865|76185141|FG002|Overall Study|Other|0|||
42035235|NCT00926289|75843563|FG001|Overall Study|Protocol Violation|12|||
42035236|NCT00926289|75843562|FG000|Overall Study|Lost to Follow-up|3|||
42035237|NCT00926289|75843563|FG001|Overall Study|Lost to Follow-up|6|||
42035238|NCT00926289|75843562|FG000|Overall Study|Withdrawal by Subject|4|||
42035239|NCT00926289|75843563|FG001|Overall Study|Withdrawal by Subject|4|||
42035240|NCT00926289|75843562|FG000|Overall Study|Other|1|||
42035241|NCT00926289|75843563|FG001|Overall Study|Other|3|||
42035242|NCT03208036|75843588|FG000|Baseline Assessment|Withdrawal by Subject|1|||
42035243|NCT03208036|75843589|FG001|Baseline Assessment|Withdrawal by Subject|1|||
42035244|NCT03208036|75843588|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
42035245|NCT03208036|75843589|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
42035246|NCT03208036|75843588|FG000|Intervention|Withdrawal by Subject|3|||
42271792|NCT02234843|76101843|FG001|Overall Study|Non-compliance with study drug|0|||
42271793|NCT02234843|76101844|FG002|Overall Study|Non-compliance with study drug|0|||
42035247|NCT03208036|75843589|FG001|Intervention|Withdrawal by Subject|2|||
42036451|NCT01017120|75844852|FG000|Overall Study|Relocated Out of Town|0|||
42346310|NCT01970865|76185142|FG003|Overall Study|Other|1|||
42346311|NCT01970865|76185143|FG004|Overall Study|Other|0|||
42346312|NCT01970865|76185144|FG005|Overall Study|Other|0|||
42346313|NCT01970865|76185145|FG006|Overall Study|Other|0|||
42346314|NCT01970865|76185146|FG007|Overall Study|Other|0|||
42346315|NCT01970865|76185147|FG008|Overall Study|Other|0|||
42346316|NCT01970865|76185148|FG009|Overall Study|Other|0|||
42346317|NCT01970865|76185149|FG010|Overall Study|Other|0|||
42346318|NCT01970865|76185150|FG011|Overall Study|Other|0|||
42346319|NCT01970865|76185151|FG012|Overall Study|Other|0|||
42346320|NCT01970865|76185152|FG013|Overall Study|Other|1|||
42346321|NCT01970865|76185153|FG014|Overall Study|Other|0|||
42346322|NCT01970865|76185154|FG015|Overall Study|Other|1|||
42136732|NCT00463580|75947170|FG001|Overall Study|Lost to Follow-up|0|||
42346323|NCT01970865|76185155|FG016|Overall Study|Other|0|||
42346324|NCT01970865|76185139|FG000|Overall Study|Study ongoing|0|||
42346325|NCT01970865|76185140|FG001|Overall Study|Study ongoing|2|||
42346326|NCT01970865|76185141|FG002|Overall Study|Study ongoing|0|||
42346327|NCT01970865|76185142|FG003|Overall Study|Study ongoing|6|||
42346328|NCT01970865|76185143|FG004|Overall Study|Study ongoing|8|||
42004912|NCT01294683|75812782|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
42004913|NCT01294683|75812783|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
42004914|NCT01294449|75812797|FG000|Overall Study|Death|11|||
42035248|NCT03208036|75843588|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
42035249|NCT03208036|75843589|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
42035250|NCT00926211|75843595|FG000|Overall Study|Lost to Follow-up|1|||
42035251|NCT01114373|75843600|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
42035252|NCT01114373|75843601|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
42035253|NCT01114373|75843600|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
42136733|NCT00463580|75947169|FG000|Overall Study|Schedule conflict|2|||
42136734|NCT00463580|75947170|FG001|Overall Study|Schedule conflict|0|||
42136735|NCT00463580|75947169|FG000|Overall Study|Medical/psychiatric complications|0|||
42136736|NCT00463580|75947170|FG001|Overall Study|Medical/psychiatric complications|2|||
42271794|NCT02234843|76101845|FG003|Overall Study|Non-compliance with study drug|0|||
42035254|NCT01114373|75843601|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
42271795|NCT02234843|76101846|FG004|Overall Study|Non-compliance with study drug|0|||
42004915|NCT01294449|75812798|FG001|Overall Study|Death|12|||
42004916|NCT01294449|75812797|FG000|Overall Study|Withdrawal by Subject|1|||
42004917|NCT01294449|75812798|FG001|Overall Study|Withdrawal by Subject|3|||
42004918|NCT01294371|75812804|FG000|Overall Study|Adverse Event|1|||
42004919|NCT01294371|75812804|FG000|Overall Study|Withdrawal by Subject|12|||
42004920|NCT01294371|75812804|FG000|Overall Study|Lost to Follow-up|6|||
42004921|NCT01294371|75812804|FG000|Overall Study|Administrative Reason|1|||
42004922|NCT01294371|75812804|FG000|Overall Study|Other|14|||
42035255|NCT01114373|75843600|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
42136737|NCT00540449|75947184|FG000|Overall Study|Adverse Event|12|||
42136738|NCT00540449|75947185|FG001|Overall Study|Adverse Event|32|||
42346329|NCT01970865|76185144|FG005|Overall Study|Study ongoing|0|||
42346330|NCT01970865|76185145|FG006|Overall Study|Study ongoing|2|||
42004923|NCT01293123|75812813|FG000|Overall Study|Lost to Follow-up|0|||
42136739|NCT00540449|75947184|FG000|Overall Study|Sponsor's Decision|1|||
42136740|NCT00540449|75947185|FG001|Overall Study|Sponsor's Decision|1|||
42271796|NCT02234843|76101847|FG005|Overall Study|Non-compliance with study drug|1|||
42271797|NCT02234843|76101848|FG006|Overall Study|Non-compliance with study drug|1|||
42136741|NCT00540449|75947184|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
42136742|NCT00540449|75947185|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
42004924|NCT01293123|75812814|FG001|Overall Study|Lost to Follow-up|1|||
42035256|NCT01114373|75843601|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
42035257|NCT01114373|75843600|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
42035258|NCT01114373|75843601|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
42035259|NCT00925899|75843613|FG000|Part 1|Death|1|||
42035260|NCT00925899|75843614|FG001|Part 1|Death|2|||
42035261|NCT00925899|75843613|FG000|Part 1|Withdrawal by Subject|10|||
42035262|NCT00925899|75843614|FG001|Part 1|Withdrawal by Subject|9|||
42035263|NCT01114217|75843623|FG000|Overall Study|Adverse Event|5|||
42035264|NCT01114217|75843624|FG001|Overall Study|Adverse Event|3|||
42035265|NCT01114217|75843623|FG000|Overall Study|Lost to Follow-up|17|||
42035266|NCT01114217|75843624|FG001|Overall Study|Lost to Follow-up|33|||
42035267|NCT01114217|75843623|FG000|Overall Study|Withdrawal by Subject|21|||
42035268|NCT01114217|75843624|FG001|Overall Study|Withdrawal by Subject|28|||
42035269|NCT01114217|75843623|FG000|Overall Study|Other-Clerical Error|3|||
42035270|NCT01114217|75843624|FG001|Overall Study|Other-Clerical Error|0|||
42035271|NCT01114217|75843623|FG000|Overall Study|Other-Early termination|6|||
42035272|NCT01114217|75843624|FG001|Overall Study|Other-Early termination|10|||
42035273|NCT01114217|75843623|FG000|Overall Study|Other-Procedure|1|||
42035274|NCT01114217|75843624|FG001|Overall Study|Other-Procedure|1|||
42035275|NCT01114217|75843623|FG000|Overall Study|Other-Pregnancy|2|||
42035276|NCT01114217|75843624|FG001|Overall Study|Other-Pregnancy|4|||
42035277|NCT01114217|75843623|FG000|Overall Study|Other-Protocol Violation|1|||
42035278|NCT01114217|75843624|FG001|Overall Study|Other-Protocol Violation|3|||
42035279|NCT01114217|75843623|FG000|Overall Study|Other-Lack of Efficacy|1|||
42035280|NCT01114217|75843624|FG001|Overall Study|Other-Lack of Efficacy|0|||
42035281|NCT01114217|75843623|FG000|Overall Study|Other-Non Compliance|2|||
42035282|NCT01114217|75843624|FG001|Overall Study|Other-Non Compliance|0|||
42035283|NCT01114217|75843623|FG000|Overall Study|Other-Physician Decision|1|||
42035284|NCT01114217|75843624|FG001|Overall Study|Other-Physician Decision|1|||
42035285|NCT01114217|75843623|FG000|Overall Study|Other-Sponsor Decision|10|||
42035286|NCT01114217|75843624|FG001|Overall Study|Other-Sponsor Decision|12|||
42035287|NCT01114217|75843623|FG000|Overall Study|Other-Study Termination|0|||
42035288|NCT01114217|75843624|FG001|Overall Study|Other-Study Termination|1|||
42346331|NCT01970865|76185146|FG007|Overall Study|Study ongoing|0|||
42004925|NCT01292187|75812822|FG000|Overall Study|Adverse Event|10|||
42004926|NCT01292187|75812823|FG001|Overall Study|Adverse Event|5|||
42004927|NCT01292187|75812822|FG000|Overall Study|Withdrawal by Subject|6|||
42004928|NCT01292187|75812823|FG001|Overall Study|Withdrawal by Subject|5|||
42004929|NCT01292187|75812822|FG000|Overall Study|All other reasons|1|||
42004930|NCT01292187|75812823|FG001|Overall Study|All other reasons|3|||
42004931|NCT01026493|75812838|FG000|Overall Study|Protocol Violation|0|||
42004932|NCT01026493|75812839|FG001|Overall Study|Protocol Violation|1|||
42004933|NCT01026493|75812840|FG002|Overall Study|Protocol Violation|0|||
42004934|NCT01026493|75812841|FG003|Overall Study|Protocol Violation|0|||
42004935|NCT01026493|75812842|FG004|Overall Study|Protocol Violation|2|||
42004936|NCT01026493|75812843|FG005|Overall Study|Protocol Violation|3|||
42004937|NCT01026493|75812844|FG006|Overall Study|Protocol Violation|4|||
42004938|NCT01026493|75812845|FG007|Overall Study|Protocol Violation|1|||
42004939|NCT01026103|75812863|FG000|Overall Study|Physician Decision|1|||
42035289|NCT01114217|75843623|FG000|Overall Study|Other-Study Withdrawn|1|||
42035290|NCT01114217|75843624|FG001|Overall Study|Other-Study Withdrawn|1|||
42035291|NCT01114217|75843623|FG000|Overall Study|Other-Site Stopped Communicating|2|||
42035292|NCT01114217|75843624|FG001|Overall Study|Other-Site Stopped Communicating|0|||
42035293|NCT01114217|75843623|FG000|Overall Study|Other-Lost to Follow-up|1|||
42035294|NCT01114217|75843624|FG001|Overall Study|Other-Lost to Follow-up|0|||
42035295|NCT01114217|75843623|FG000|Overall Study|Other-Withdrawal by Subject|1|||
42136743|NCT00540449|75947184|FG000|Overall Study|Lost to Follow-up|19|||
42346332|NCT01970865|76185147|FG008|Overall Study|Study ongoing|1|||
42346333|NCT01970865|76185148|FG009|Overall Study|Study ongoing|3|||
42346334|NCT01970865|76185149|FG010|Overall Study|Study ongoing|29|||
42136744|NCT00540449|75947185|FG001|Overall Study|Lost to Follow-up|17|||
42136745|NCT00540449|75947184|FG000|Overall Study|Subject Non-Compliant|7|||
42136746|NCT00540449|75947185|FG001|Overall Study|Subject Non-Compliant|5|||
42136747|NCT00540449|75947184|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
42136748|NCT00540449|75947185|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
42136749|NCT00540449|75947184|FG000|Overall Study|Withdrawal by Subject|10|||
42136750|NCT00540449|75947185|FG001|Overall Study|Withdrawal by Subject|10|||
42136751|NCT00540449|75947184|FG000|Overall Study|Other|1|||
42136752|NCT00540449|75947185|FG001|Overall Study|Other|4|||
42136753|NCT03911843|75947193|FG000|Overall Study|Adverse Event|2|||
42136754|NCT03911843|75947194|FG001|Overall Study|Adverse Event|0|||
42136755|NCT03911843|75947193|FG000|Overall Study|Protocol Violation|2|||
42136756|NCT03911843|75947194|FG001|Overall Study|Protocol Violation|0|||
42136757|NCT03911843|75947193|FG000|Overall Study|Lost to Follow-up|0|||
42136758|NCT03911843|75947194|FG001|Overall Study|Lost to Follow-up|1|||
42136759|NCT00361335|75947205|FG000|IV Period: Baseline to E0|Adverse Event|9|||
42136760|NCT00361335|75947206|FG001|IV Period: Baseline to E0|Adverse Event|4|||
42136761|NCT00361335|75947207|FG002|IV Period: Baseline to E0|Adverse Event|5|||
42136762|NCT00361335|75947208|FG003|IV Period: Baseline to E0|Adverse Event|9|||
42136763|NCT00361335|75947209|FG004|IV Period: Baseline to E0|Adverse Event|8|||
42136764|NCT00361335|75947210|FG005|IV Period: Baseline to E0|Adverse Event|0|||
42136765|NCT00361335|75947211|FG006|IV Period: Baseline to E0|Adverse Event|0|||
42136766|NCT00361335|75947205|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
42136767|NCT00361335|75947206|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
42136768|NCT00361335|75947207|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
42136769|NCT00361335|75947208|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
42136770|NCT00361335|75947209|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
42136771|NCT00361335|75947210|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
42136772|NCT00361335|75947211|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
42136773|NCT00361335|75947205|FG000|IV Period: Baseline to E0|Death|1|||
42136774|NCT00361335|75947206|FG001|IV Period: Baseline to E0|Death|1|||
42271798|NCT02234843|76101849|FG007|Overall Study|Non-compliance with study drug|0|||
42136775|NCT00361335|75947207|FG002|IV Period: Baseline to E0|Death|1|||
42136776|NCT00361335|75947208|FG003|IV Period: Baseline to E0|Death|1|||
42136777|NCT00361335|75947209|FG004|IV Period: Baseline to E0|Death|0|||
42136778|NCT00361335|75947210|FG005|IV Period: Baseline to E0|Death|0|||
42136779|NCT00361335|75947211|FG006|IV Period: Baseline to E0|Death|0|||
42136780|NCT00361335|75947205|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
42136781|NCT00361335|75947206|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
42136782|NCT00361335|75947207|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
42136783|NCT00361335|75947208|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
42136784|NCT00361335|75947209|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
42136785|NCT00361335|75947210|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
42136786|NCT00361335|75947211|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
42136787|NCT00361335|75947205|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
42136788|NCT00361335|75947206|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
42136789|NCT00361335|75947207|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
42136790|NCT00361335|75947208|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
42136791|NCT00361335|75947209|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
42136792|NCT00361335|75947210|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
42136793|NCT00361335|75947211|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
42136794|NCT00361335|75947205|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
42136795|NCT00361335|75947206|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
42136796|NCT00361335|75947207|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
42136797|NCT00361335|75947208|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
42136798|NCT00361335|75947209|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
42136799|NCT00361335|75947210|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
42136800|NCT00361335|75947211|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
42136801|NCT00361335|75947205|FG000|IV Period: Baseline to E0|Other|2|||
42136802|NCT00361335|75947206|FG001|IV Period: Baseline to E0|Other|9|||
42136803|NCT00361335|75947207|FG002|IV Period: Baseline to E0|Other|9|||
42136804|NCT00361335|75947208|FG003|IV Period: Baseline to E0|Other|3|||
42136805|NCT00361335|75947209|FG004|IV Period: Baseline to E0|Other|2|||
42136806|NCT00361335|75947210|FG005|IV Period: Baseline to E0|Other|0|||
42136807|NCT00361335|75947211|FG006|IV Period: Baseline to E0|Other|0|||
42136808|NCT00361335|75947205|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
42136809|NCT00361335|75947206|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
42136810|NCT00361335|75947207|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
42136811|NCT00361335|75947208|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
42346335|NCT01970865|76185150|FG011|Overall Study|Study ongoing|22|||
42346336|NCT01970865|76185151|FG012|Overall Study|Study ongoing|43|||
42346337|NCT01970865|76185152|FG013|Overall Study|Study ongoing|41|||
42346338|NCT01970865|76185153|FG014|Overall Study|Study ongoing|29|||
42346339|NCT01970865|76185154|FG015|Overall Study|Study ongoing|29|||
42346340|NCT01970865|76185155|FG016|Overall Study|Study ongoing|2|||
42346341|NCT01711541|76185230|FG000|Overall Study|Cancel prior to treatment|0|||
42346342|NCT01711541|76185231|FG001|Overall Study|Cancel prior to treatment|0|||
42346343|NCT01711541|76185232|FG002|Overall Study|Cancel prior to treatment|0|||
42346344|NCT01711541|76185233|FG003|Overall Study|Cancel prior to treatment|1|||
42346345|NCT01711541|76185234|FG004|Overall Study|Cancel prior to treatment|0|||
42346346|NCT01711541|76185230|FG000|Overall Study|Ineligible|0|||
42346347|NCT01711541|76185231|FG001|Overall Study|Ineligible|1|||
42346348|NCT01711541|76185232|FG002|Overall Study|Ineligible|0|||
42346349|NCT01711541|76185233|FG003|Overall Study|Ineligible|0|||
42346350|NCT01711541|76185234|FG004|Overall Study|Ineligible|0|||
42346351|NCT01382446|76185270|FG000|Overall Study|Withdrawal by Subject|0|||
42346352|NCT01382446|76185271|FG001|Overall Study|Withdrawal by Subject|1|||
42346353|NCT01382446|76185270|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
42346354|NCT01382446|76185271|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
42346355|NCT01382212|76185277|FG000|Overall Study|Kidney transplant|1|||
42004940|NCT01026103|75812863|FG000|Overall Study|did not receive study device bc of error|1|||
42004941|NCT01291173|75812871|FG000|Overall Study|Adverse Event|0|||
42136812|NCT00361335|75947209|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
42136813|NCT00361335|75947210|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
42136814|NCT00361335|75947211|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
42136815|NCT00361335|75947205|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
42136816|NCT00361335|75947206|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
42346356|NCT01382212|76185277|FG000|Overall Study|Withdrew consent|1|||
42346357|NCT01381900|76185284|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
42346358|NCT01381900|76185285|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
42346359|NCT01381900|76185286|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
42004942|NCT01291173|75812872|FG001|Overall Study|Adverse Event|3|||
42136817|NCT00361335|75947207|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
42136818|NCT00361335|75947208|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
42136819|NCT00361335|75947209|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
42346360|NCT01381900|76185284|FG000|Overall Study|Adverse Event|4|||
42136820|NCT00361335|75947210|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
42136821|NCT00361335|75947211|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
42136822|NCT00361335|75947205|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
42136823|NCT00361335|75947206|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
42136824|NCT00361335|75947207|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
42136825|NCT00361335|75947208|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
42136826|NCT00361335|75947209|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
42136827|NCT00361335|75947210|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
42136828|NCT00361335|75947211|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
42136829|NCT00361335|75947205|FG000|SC Period: Week E0 to Week E24|Death|0|||
42136830|NCT00361335|75947206|FG001|SC Period: Week E0 to Week E24|Death|0|||
42136831|NCT00361335|75947207|FG002|SC Period: Week E0 to Week E24|Death|0|||
42136832|NCT00361335|75947208|FG003|SC Period: Week E0 to Week E24|Death|0|||
42136833|NCT00361335|75947209|FG004|SC Period: Week E0 to Week E24|Death|0|||
42136834|NCT00361335|75947210|FG005|SC Period: Week E0 to Week E24|Death|0|||
42136835|NCT00361335|75947211|FG006|SC Period: Week E0 to Week E24|Death|1|||
42136836|NCT00361335|75947205|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
42136837|NCT00361335|75947206|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
42136838|NCT00361335|75947207|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
42136839|NCT00361335|75947208|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
42136840|NCT00361335|75947209|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
42136841|NCT00361335|75947210|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
42136842|NCT00361335|75947211|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
42136843|NCT00361335|75947205|FG000|SC Period: Week E0 to Week E24|Other|1|||
42136844|NCT00361335|75947206|FG001|SC Period: Week E0 to Week E24|Other|0|||
42136845|NCT00361335|75947207|FG002|SC Period: Week E0 to Week E24|Other|0|||
42136846|NCT00361335|75947208|FG003|SC Period: Week E0 to Week E24|Other|1|||
42136847|NCT00361335|75947209|FG004|SC Period: Week E0 to Week E24|Other|0|||
42136848|NCT00361335|75947210|FG005|SC Period: Week E0 to Week E24|Other|1|||
42136849|NCT00361335|75947211|FG006|SC Period: Week E0 to Week E24|Other|2|||
42136850|NCT00361335|75947205|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
42136851|NCT00361335|75947206|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
42136852|NCT00361335|75947207|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
42136853|NCT00361335|75947208|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
42136854|NCT00361335|75947209|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
42136855|NCT00361335|75947210|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
42136856|NCT00361335|75947211|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
42136857|NCT00264550|75947231|FG000|Overall Study|Death|0|||
42136858|NCT00264550|75947232|FG001|Overall Study|Death|3|||
42136859|NCT00264550|75947233|FG002|Overall Study|Death|0|||
42136860|NCT00264550|75947234|FG003|Overall Study|Death|0|||
42035296|NCT01114217|75843624|FG001|Overall Study|Other-Withdrawal by Subject|1|||
42035297|NCT01030536|75843633|FG000|Overall Study|Withdrawal by Subject|0|||
42136861|NCT00264550|75947231|FG000|Overall Study|Lost to Follow-up|3|||
42136862|NCT00264550|75947232|FG001|Overall Study|Lost to Follow-up|1|||
42136863|NCT00264550|75947233|FG002|Overall Study|Lost to Follow-up|1|||
42136864|NCT00264550|75947234|FG003|Overall Study|Lost to Follow-up|1|||
42136865|NCT00264550|75947231|FG000|Overall Study|Adverse Event|23|||
42136866|NCT00264550|75947232|FG001|Overall Study|Adverse Event|18|||
42136867|NCT00264550|75947233|FG002|Overall Study|Adverse Event|9|||
42136868|NCT00264550|75947234|FG003|Overall Study|Adverse Event|14|||
42136869|NCT00264550|75947231|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
42136870|NCT00264550|75947232|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
42136871|NCT00264550|75947233|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
42136872|NCT00264550|75947234|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
42136873|NCT00264550|75947231|FG000|Overall Study|Discontinued oral study agent|0|||
42136874|NCT00264550|75947232|FG001|Overall Study|Discontinued oral study agent|1|||
42136875|NCT00264550|75947233|FG002|Overall Study|Discontinued oral study agent|0|||
42136876|NCT00264550|75947234|FG003|Overall Study|Discontinued oral study agent|0|||
42136877|NCT00264550|75947231|FG000|Overall Study|Other|13|||
42136878|NCT00264550|75947232|FG001|Overall Study|Other|7|||
42136879|NCT00264550|75947233|FG002|Overall Study|Other|3|||
42136880|NCT00264550|75947234|FG003|Overall Study|Other|9|||
42136881|NCT00541931|75947246|FG000|Overall Study|Adverse Event|1|||
42136882|NCT00541931|75947247|FG001|Overall Study|Adverse Event|0|||
42136883|NCT00541931|75947246|FG000|Overall Study|Lost to Follow-up|3|||
42136884|NCT00541931|75947247|FG001|Overall Study|Lost to Follow-up|3|||
42136885|NCT00541931|75947246|FG000|Overall Study|Withdrawal by Subject|1|||
42136886|NCT00541931|75947247|FG001|Overall Study|Withdrawal by Subject|0|||
42136887|NCT00541931|75947246|FG000|Overall Study|Transportation Issue|0|||
42136888|NCT00541931|75947247|FG001|Overall Study|Transportation Issue|1|||
42136889|NCT00368979|75947257|FG000|Overall Study|Adverse Event|9|||
42136890|NCT00368979|75947258|FG001|Overall Study|Adverse Event|16|||
42136891|NCT00368979|75947257|FG000|Overall Study|Lack of Efficacy|5|||
42136892|NCT00368979|75947258|FG001|Overall Study|Lack of Efficacy|3|||
42136893|NCT00368979|75947257|FG000|Overall Study|Other|3|||
42136894|NCT00368979|75947258|FG001|Overall Study|Other|1|||
42136895|NCT00368979|75947257|FG000|Overall Study|Lost to Follow-up|1|||
42136896|NCT00368979|75947258|FG001|Overall Study|Lost to Follow-up|0|||
42136897|NCT00368979|75947257|FG000|Overall Study|Protocol Violation|2|||
42136898|NCT00368979|75947258|FG001|Overall Study|Protocol Violation|1|||
42136899|NCT00368979|75947257|FG000|Overall Study|Withdrawal by Subject|5|||
42136900|NCT00368979|75947258|FG001|Overall Study|Withdrawal by Subject|9|||
42136901|NCT00264238|75947264|FG000|Overall Study|Protocol Violation|1|||
42136902|NCT00540293|75947270|FG000|Overall Study|Adverse event related to study drug|10|||
42136903|NCT00540293|75947270|FG000|Overall Study|Adverse event not related to study drug|7|||
42136904|NCT00540293|75947270|FG000|Overall Study|Withdrawal by Subject|6|||
42136905|NCT00540293|75947270|FG000|Overall Study|Protocol violation, & subject schedule|12|||
42136906|NCT00359073|75947311|FG000|Overall Study|Withdrawal by Subject|1|||
42136907|NCT00359073|75947312|FG001|Overall Study|Withdrawal by Subject|1|||
42136908|NCT00359073|75947311|FG000|Overall Study|Eligibility criteria no longer met|3|||
42136909|NCT00359073|75947312|FG001|Overall Study|Eligibility criteria no longer met|0|||
42136910|NCT00359073|75947311|FG000|Overall Study|developed RV16 antibody|0|||
42136911|NCT00359073|75947312|FG001|Overall Study|developed RV16 antibody|1|||
42136912|NCT03918239|75947322|FG000|Overall Study|Lost to Follow-up|3|||
42136913|NCT03918239|75947323|FG001|Overall Study|Lost to Follow-up|1|||
42136914|NCT03918239|75947322|FG000|Overall Study|Pregnancy|0|||
42136915|NCT03918239|75947323|FG001|Overall Study|Pregnancy|2|||
42136916|NCT03918239|75947322|FG000|Overall Study|Withdrawal by Subject|3|||
42136917|NCT03918239|75947323|FG001|Overall Study|Withdrawal by Subject|3|||
42136918|NCT03918239|75947322|FG000|Overall Study|positive urine drug screening results|4|||
42136919|NCT03918239|75947323|FG001|Overall Study|positive urine drug screening results|1|||
42136920|NCT00368745|75947331|FG000|Double-blind Treatment Period|Adverse Event|6|||
42136921|NCT00368745|75947332|FG001|Double-blind Treatment Period|Adverse Event|6|||
42136922|NCT00368745|75947331|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
42136923|NCT00368745|75947332|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
42136924|NCT00368745|75947331|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
42136925|NCT00368745|75947332|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
42136926|NCT00368745|75947331|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
42136927|NCT00368745|75947332|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
42136928|NCT00368745|75947331|FG000|Double-blind Treatment Period|Other|7|||
42136929|NCT00368745|75947332|FG001|Double-blind Treatment Period|Other|6|||
42136930|NCT00454818|75947346|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
42136931|NCT00454818|75947347|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
42136932|NCT00454818|75947348|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
42136933|NCT00454818|75947349|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
42136934|NCT00454818|75947350|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
42271799|NCT02234843|76101850|FG008|Overall Study|Non-compliance with study drug|0|||
42346361|NCT01381900|76185285|FG001|Overall Study|Adverse Event|6|||
42136935|NCT00454818|75947346|FG000|Phase I: Open-label Dose-escalation|Death|0|||
42136936|NCT00454818|75947347|FG001|Phase I: Open-label Dose-escalation|Death|1|||
42136937|NCT00454818|75947348|FG002|Phase I: Open-label Dose-escalation|Death|0|||
42136938|NCT00454818|75947349|FG003|Phase I: Open-label Dose-escalation|Death|0|||
42136939|NCT00454818|75947350|FG004|Phase I: Open-label Dose-escalation|Death|0|||
42136940|NCT00454818|75947346|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
42136941|NCT00454818|75947347|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
42136942|NCT00454818|75947348|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
42136943|NCT00454818|75947349|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
42136944|NCT00454818|75947350|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
42136945|NCT00454818|75947346|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
42136946|NCT00454818|75947347|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
42136947|NCT00454818|75947348|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
42136948|NCT00454818|75947349|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
42136949|NCT00454818|75947350|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
42136950|NCT00454818|75947346|FG000|Phase 2: Randomized Double-blind|Death|0|||
42136951|NCT00454818|75947347|FG001|Phase 2: Randomized Double-blind|Death|1|||
42136952|NCT00454818|75947348|FG002|Phase 2: Randomized Double-blind|Death|0|||
42136953|NCT00454818|75947349|FG003|Phase 2: Randomized Double-blind|Death|0|||
42136954|NCT00454818|75947350|FG004|Phase 2: Randomized Double-blind|Death|1|||
42136955|NCT00454818|75947346|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
42271800|NCT02234843|76101851|FG009|Overall Study|Non-compliance with study drug|0|||
42271801|NCT02234843|76101842|FG000|Overall Study|Lost to Follow-up|0|||
42271802|NCT02234843|76101843|FG001|Overall Study|Lost to Follow-up|1|||
42004943|NCT01291173|75812873|FG002|Overall Study|Adverse Event|1|||
42004944|NCT01291173|75812874|FG003|Overall Study|Adverse Event|3|||
42271803|NCT02234843|76101844|FG002|Overall Study|Lost to Follow-up|0|||
42271804|NCT02234843|76101845|FG003|Overall Study|Lost to Follow-up|0|||
42271805|NCT02234843|76101846|FG004|Overall Study|Lost to Follow-up|0|||
42271806|NCT02234843|76101847|FG005|Overall Study|Lost to Follow-up|0|||
42271807|NCT02234843|76101848|FG006|Overall Study|Lost to Follow-up|1|||
42271808|NCT02234843|76101849|FG007|Overall Study|Lost to Follow-up|0|||
42271809|NCT02234843|76101850|FG008|Overall Study|Lost to Follow-up|0|||
42271810|NCT02234843|76101851|FG009|Overall Study|Lost to Follow-up|0|||
42271811|NCT02740231|76101888|FG000|Overall Study|Withdrawal by Subject|1|||
42271812|NCT02740231|76101889|FG001|Overall Study|Withdrawal by Subject|1|||
42271813|NCT02740231|76101890|FG002|Overall Study|Withdrawal by Subject|1|||
42004945|NCT01291173|75812871|FG000|Overall Study|Protocol Violation|7|||
42004946|NCT01291173|75812872|FG001|Overall Study|Protocol Violation|2|||
42004947|NCT01291173|75812873|FG002|Overall Study|Protocol Violation|2|||
42271814|NCT02740231|76101891|FG003|Overall Study|Withdrawal by Subject|0|||
42271815|NCT02740231|76101888|FG000|Overall Study|Lack of Efficacy|0|||
42271816|NCT02740231|76101889|FG001|Overall Study|Lack of Efficacy|1|||
42004948|NCT01291173|75812874|FG003|Overall Study|Protocol Violation|5|||
42136956|NCT00454818|75947347|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
42136957|NCT00454818|75947348|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
42136958|NCT00454818|75947349|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
42004949|NCT01291173|75812871|FG000|Overall Study|Withdrawal by Subject|6|||
42004950|NCT01291173|75812872|FG001|Overall Study|Withdrawal by Subject|4|||
42004951|NCT01291173|75812873|FG002|Overall Study|Withdrawal by Subject|4|||
42004952|NCT01291173|75812874|FG003|Overall Study|Withdrawal by Subject|2|||
42004953|NCT01291173|75812871|FG000|Overall Study|Lost to Follow-up|4|||
42004954|NCT01291173|75812872|FG001|Overall Study|Lost to Follow-up|6|||
42136959|NCT00454818|75947350|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
42136960|NCT00454818|75947346|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
42136961|NCT00454818|75947347|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
42271817|NCT02740231|76101890|FG002|Overall Study|Lack of Efficacy|0|||
42271818|NCT02740231|76101891|FG003|Overall Study|Lack of Efficacy|4|||
42271819|NCT02740231|76101888|FG000|Overall Study|Lost to Follow-up|1|||
42271820|NCT02740231|76101889|FG001|Overall Study|Lost to Follow-up|3|||
42271821|NCT02740231|76101890|FG002|Overall Study|Lost to Follow-up|0|||
42271822|NCT02740231|76101891|FG003|Overall Study|Lost to Follow-up|3|||
42271823|NCT02740231|76101888|FG000|Overall Study|Adverse Event|0|||
42271824|NCT02740231|76101889|FG001|Overall Study|Adverse Event|1|||
42271825|NCT02740231|76101890|FG002|Overall Study|Adverse Event|0|||
42271826|NCT02740231|76101891|FG003|Overall Study|Adverse Event|1|||
42346362|NCT01381900|76185286|FG002|Overall Study|Adverse Event|7|||
42346363|NCT01381900|76185284|FG000|Overall Study|Noncompliance with study drug|0|||
42346364|NCT01381900|76185285|FG001|Overall Study|Noncompliance with study drug|0|||
42346365|NCT01381900|76185286|FG002|Overall Study|Noncompliance with study drug|1|||
42346366|NCT01381900|76185284|FG000|Overall Study|Physician Decision|0|||
42346367|NCT01381900|76185285|FG001|Overall Study|Physician Decision|1|||
42346368|NCT01381900|76185286|FG002|Overall Study|Physician Decision|1|||
42346369|NCT01381900|76185284|FG000|Overall Study|Protocol Violation|0|||
42346370|NCT01381900|76185285|FG001|Overall Study|Protocol Violation|1|||
42004955|NCT01291173|75812873|FG002|Overall Study|Lost to Follow-up|3|||
42004956|NCT01291173|75812874|FG003|Overall Study|Lost to Follow-up|2|||
42136962|NCT00454818|75947348|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
42271827|NCT02750345|76101901|FG000|Intervention 1|Adverse Event|0|||
42346371|NCT01381900|76185286|FG002|Overall Study|Protocol Violation|1|||
42004957|NCT01291173|75812871|FG000|Overall Study|Unable to meet visit schedule|0|||
42271828|NCT02750345|76101902|FG001|Intervention 1|Adverse Event|0|||
42271829|NCT02750345|76101903|FG002|Intervention 1|Adverse Event|0|||
42136963|NCT00454818|75947349|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
42136964|NCT00454818|75947350|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
42136965|NCT00445224|75947369|FG000|Specific Exercises|Withdrawal by Subject|3|||
42136966|NCT00445224|75947370|FG001|Specific Exercises|Withdrawal by Subject|3|||
42136967|NCT00445224|75947369|FG000|Specific Exercises|Withdrawal by Subject|1|||
42136968|NCT00445224|75947370|FG001|Specific Exercises|Withdrawal by Subject|0|||
42136969|NCT00358917|75947387|FG000|Overall Study|Adverse Event|14|||
42136970|NCT00358917|75947388|FG001|Overall Study|Adverse Event|21|||
42136971|NCT00358917|75947387|FG000|Overall Study|Withdrawal by Subject|5|||
42136972|NCT00358917|75947388|FG001|Overall Study|Withdrawal by Subject|7|||
42136973|NCT00358917|75947387|FG000|Overall Study|Lost to Follow-up|20|||
42136974|NCT00358917|75947388|FG001|Overall Study|Lost to Follow-up|17|||
42136975|NCT00358917|75947387|FG000|Overall Study|Noncompliance|12|||
42136976|NCT00358917|75947388|FG001|Overall Study|Noncompliance|11|||
42136977|NCT00358917|75947387|FG000|Overall Study|Death|2|||
42136978|NCT00358917|75947388|FG001|Overall Study|Death|3|||
42136979|NCT00358917|75947387|FG000|Overall Study|Virologic failure|11|||
42136980|NCT00358917|75947388|FG001|Overall Study|Virologic failure|8|||
42136981|NCT00358917|75947387|FG000|Overall Study|Unable to Continue Participation|2|||
42136982|NCT00358917|75947388|FG001|Overall Study|Unable to Continue Participation|2|||
42136983|NCT00264004|75947400|FG000|Overall Study|Adverse Event|2|||
42136984|NCT00264004|75947401|FG001|Overall Study|Adverse Event|3|||
42136985|NCT00264004|75947402|FG002|Overall Study|Adverse Event|6|||
42271830|NCT02750345|76101904|FG003|Intervention 1|Adverse Event|0|||
42271831|NCT02750345|76101905|FG004|Intervention 1|Adverse Event|1|||
42004958|NCT01291173|75812872|FG001|Overall Study|Unable to meet visit schedule|0|||
42004959|NCT01291173|75812873|FG002|Overall Study|Unable to meet visit schedule|1|||
42004960|NCT01291173|75812874|FG003|Overall Study|Unable to meet visit schedule|0|||
42004961|NCT01291173|75812871|FG000|Overall Study|Lack of compliance|0|||
42004962|NCT01291173|75812872|FG001|Overall Study|Lack of compliance|0|||
42004963|NCT01291173|75812873|FG002|Overall Study|Lack of compliance|0|||
42004964|NCT01291173|75812874|FG003|Overall Study|Lack of compliance|1|||
42004965|NCT01291173|75812871|FG000|Overall Study|Subject was unblinded|0|||
42004966|NCT01291173|75812872|FG001|Overall Study|Subject was unblinded|0|||
42136986|NCT00264004|75947403|FG003|Overall Study|Adverse Event|4|||
42136987|NCT00264004|75947400|FG000|Overall Study|Withdrawal by Subject|0|||
42136988|NCT00264004|75947401|FG001|Overall Study|Withdrawal by Subject|1|||
42136989|NCT00264004|75947402|FG002|Overall Study|Withdrawal by Subject|2|||
42004967|NCT01291173|75812873|FG002|Overall Study|Subject was unblinded|1|||
42136990|NCT00264004|75947403|FG003|Overall Study|Withdrawal by Subject|2|||
42136991|NCT00264004|75947400|FG000|Overall Study|Other|2|||
42271832|NCT02750345|76101906|FG005|Intervention 1|Adverse Event|0|||
42271833|NCT02640625|76101916|FG000|Overall Study|Adverse Event|1|||
42271834|NCT01329263|76101923|FG000|Overall Study|Lost to Follow-up|4|||
42271835|NCT01329263|76101924|FG001|Overall Study|Lost to Follow-up|21|||
42346372|NCT01381900|76185284|FG000|Overall Study|Withdrawal by Subject|0|||
42136992|NCT00264004|75947401|FG001|Overall Study|Other|2|||
42136993|NCT00264004|75947402|FG002|Overall Study|Other|0|||
42136994|NCT00264004|75947403|FG003|Overall Study|Other|3|||
42136995|NCT00264004|75947400|FG000|Overall Study|Development study specific disc. crit.|1|||
42136996|NCT00264004|75947401|FG001|Overall Study|Development study specific disc. crit.|0|||
42136997|NCT00264004|75947402|FG002|Overall Study|Development study specific disc. crit.|1|||
42136998|NCT00264004|75947403|FG003|Overall Study|Development study specific disc. crit.|0|||
42035298|NCT01030536|75843634|FG001|Overall Study|Withdrawal by Subject|0|||
42035299|NCT01030536|75843635|FG002|Overall Study|Withdrawal by Subject|1|||
42035300|NCT01030536|75843636|FG003|Overall Study|Withdrawal by Subject|0|||
42035301|NCT01030536|75843637|FG004|Overall Study|Withdrawal by Subject|0|||
42035302|NCT01030536|75843633|FG000|Overall Study|undefined|1|||
42035303|NCT01030536|75843634|FG001|Overall Study|undefined|0|||
42035304|NCT01030536|75843635|FG002|Overall Study|undefined|1|||
42035305|NCT01030536|75843636|FG003|Overall Study|undefined|1|||
42136999|NCT00264004|75947400|FG000|Overall Study|Cond. under inv. worsened|9|||
42137000|NCT00264004|75947401|FG001|Overall Study|Cond. under inv. worsened|5|||
42137001|NCT00264004|75947402|FG002|Overall Study|Cond. under inv. worsened|3|||
42137002|NCT00264004|75947403|FG003|Overall Study|Cond. under inv. worsened|4|||
42137003|NCT00264004|75947400|FG000|Overall Study|Not treated|3|||
42271836|NCT01329263|76101923|FG000|Overall Study|Withdrawal by Subject|1|||
42271837|NCT01329263|76101924|FG001|Overall Study|Withdrawal by Subject|2|||
42271838|NCT02474329|76101932|FG000|Overall Study|Withdraw or did not contribute data.|13|||
42271839|NCT01388491|76101939|FG000|Overall Study|Adverse Event|10|||
42271840|NCT01388491|76101940|FG001|Overall Study|Adverse Event|9|||
42271841|NCT01388491|76101939|FG000|Overall Study|Sponsor Request|9|||
42346373|NCT01381900|76185285|FG001|Overall Study|Withdrawal by Subject|0|||
42346374|NCT01381900|76185286|FG002|Overall Study|Withdrawal by Subject|1|||
42346375|NCT01381900|76185284|FG000|Overall Study|Early withdraw|3|||
42346376|NCT01381900|76185285|FG001|Overall Study|Early withdraw|1|||
42346377|NCT01381900|76185286|FG002|Overall Study|Early withdraw|1|||
42346378|NCT01744665|76185294|FG000|Monitoring Phase|Adverse Event|4|||
42346379|NCT01744665|76185294|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
42346380|NCT01744665|76185294|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
42346381|NCT01744665|76185294|FG000|Monitoring Phase|Withdrawal by Subject|5|||
42346382|NCT01744665|76185294|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
42004968|NCT01291173|75812874|FG003|Overall Study|Subject was unblinded|0|||
42004969|NCT01291173|75812871|FG000|Overall Study|Excluded therapy|0|||
42346383|NCT01744665|76185294|FG000|Consolidation Phase|Adverse Event|2|||
42346384|NCT01744665|76185294|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
42346385|NCT01744665|76185294|FG000|Consolidation Phase|Withdrawal by Subject|4|||
42346386|NCT01744665|76185294|FG000|Consolidation Phase|Administrative problems|9|||
42346387|NCT01744665|76185294|FG000|Re-initiation Phase|Administrative problems|10|||
42346388|NCT01744665|76185294|FG000|Re-initiation Phase|Adverse Event|1|||
42346389|NCT01744665|76185294|FG000|Re-initiation Phase|No longer required treatment|1|||
42346390|NCT01744665|76185294|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
42346391|NCT01744197|76185303|FG000|Overall Study|Received 1 patch|2|||
42271842|NCT01388491|76101940|FG001|Overall Study|Sponsor Request|7|||
42271843|NCT01388491|76101939|FG000|Overall Study|Withdrawal by Subject|6|||
42271844|NCT01388491|76101940|FG001|Overall Study|Withdrawal by Subject|10|||
42271845|NCT01388491|76101939|FG000|Overall Study|Lost to Follow-up|4|||
42271846|NCT01388491|76101940|FG001|Overall Study|Lost to Follow-up|3|||
42271847|NCT01388491|76101939|FG000|Overall Study|Protocol Violation|2|||
42346392|NCT01744197|76185304|FG001|Overall Study|Received 1 patch|1|||
42004970|NCT01291173|75812872|FG001|Overall Study|Excluded therapy|0|||
42004971|NCT01291173|75812873|FG002|Overall Study|Excluded therapy|1|||
42004972|NCT01291173|75812874|FG003|Overall Study|Excluded therapy|0|||
42004973|NCT01291017|75812884|FG000|Overall Study|Lost to Follow-up|2|||
42004974|NCT01291017|75812884|FG000|Overall Study|Withdrawal by Subject|3|||
42137004|NCT00264004|75947401|FG001|Overall Study|Not treated|0|||
42271848|NCT01388491|76101940|FG001|Overall Study|Protocol Violation|0|||
42271849|NCT01388491|76101939|FG000|Overall Study|Noncompliance|2|||
42271850|NCT01388491|76101940|FG001|Overall Study|Noncompliance|0|||
42346393|NCT01744197|76185303|FG000|Overall Study|No patch received|2|||
42004975|NCT01290315|75812892|FG000|Overall Study|Adverse Event|0|||
42271851|NCT01388491|76101939|FG000|Overall Study|Pregnancy|1|||
42004976|NCT01290315|75812893|FG001|Overall Study|Adverse Event|0|||
42004977|NCT01290315|75812894|FG002|Overall Study|Adverse Event|0|||
42004978|NCT01290315|75812895|FG003|Overall Study|Adverse Event|3|||
42035306|NCT01030536|75843637|FG004|Overall Study|undefined|0|||
42035307|NCT01030536|75843633|FG000|Overall Study|Adverse Event|0|||
42137005|NCT00264004|75947402|FG002|Overall Study|Not treated|2|||
42137006|NCT00264004|75947403|FG003|Overall Study|Not treated|2|||
42137007|NCT00368355|75947415|FG000|Overall Study|Adverse Event|1|||
42137008|NCT00368355|75947416|FG001|Overall Study|Adverse Event|0|||
42137009|NCT00368355|75947415|FG000|Overall Study|Death|2|||
42137010|NCT00368355|75947416|FG001|Overall Study|Death|4|||
42137011|NCT00368355|75947415|FG000|Overall Study|Relapse|6|||
42137012|NCT00368355|75947416|FG001|Overall Study|Relapse|10|||
42137013|NCT00368355|75947415|FG000|Overall Study|Subsequent transplant|0|||
42137014|NCT00368355|75947416|FG001|Overall Study|Subsequent transplant|3|||
42137015|NCT00368355|75947415|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
42137016|NCT00368355|75947416|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
42137017|NCT00445146|75947422|FG000|Overall Study|Withdrew Consent|29|||
42137018|NCT00445146|75947422|FG000|Overall Study|Lack of Efficacy|28|||
42137019|NCT00445146|75947422|FG000|Overall Study|Investigator's Discretion|22|||
42137020|NCT00445146|75947422|FG000|Overall Study|Adverse Event|13|||
42137021|NCT00445146|75947422|FG000|Overall Study|Lost to Follow-up|13|||
42137022|NCT00445146|75947422|FG000|Overall Study|Death|9|||
42137023|NCT00445146|75947422|FG000|Overall Study|Protocol Violation|4|||
42137024|NCT00445146|75947422|FG000|Overall Study|Pregnancy|1|||
42137025|NCT00368277|75947428|FG000|Overall Study|Adverse Event|33|||
42137026|NCT00368277|75947429|FG001|Overall Study|Adverse Event|49|||
42137027|NCT00368277|75947428|FG000|Overall Study|Death|2|||
42004979|NCT01290315|75812892|FG000|Overall Study|Selection criteria/compliance|2|||
42004980|NCT01290315|75812893|FG001|Overall Study|Selection criteria/compliance|1|||
42004981|NCT01290315|75812894|FG002|Overall Study|Selection criteria/compliance|0|||
42004982|NCT01290315|75812895|FG003|Overall Study|Selection criteria/compliance|2|||
42004983|NCT01290315|75812892|FG000|Overall Study|Lost to Follow-up|0|||
42004984|NCT01290315|75812893|FG001|Overall Study|Lost to Follow-up|1|||
42004985|NCT01290315|75812894|FG002|Overall Study|Lost to Follow-up|0|||
42035308|NCT01030536|75843634|FG001|Overall Study|Adverse Event|3|||
42035309|NCT01030536|75843635|FG002|Overall Study|Adverse Event|1|||
42035310|NCT01030536|75843636|FG003|Overall Study|Adverse Event|0|||
42035311|NCT01030536|75843637|FG004|Overall Study|Adverse Event|1|||
42035312|NCT01030536|75843633|FG000|Overall Study|Progressive disease|6|||
42035313|NCT01030536|75843634|FG001|Overall Study|Progressive disease|2|||
42035314|NCT01030536|75843635|FG002|Overall Study|Progressive disease|3|||
42035315|NCT01030536|75843636|FG003|Overall Study|Progressive disease|2|||
42035316|NCT01030536|75843637|FG004|Overall Study|Progressive disease|0|||
42035317|NCT01030536|75843633|FG000|Overall Study|Death|0|||
42035318|NCT01030536|75843634|FG001|Overall Study|Death|1|||
42035319|NCT01030536|75843635|FG002|Overall Study|Death|0|||
42035320|NCT01030536|75843636|FG003|Overall Study|Death|0|||
42137028|NCT00368277|75947429|FG001|Overall Study|Death|1|||
42137029|NCT00368277|75947428|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
42035321|NCT01030536|75843637|FG004|Overall Study|Death|0|||
42137030|NCT00368277|75947429|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
42004986|NCT01290315|75812895|FG003|Overall Study|Lost to Follow-up|0|||
42004987|NCT01290315|75812892|FG000|Overall Study|Withdrawal by Subject|1|||
42004988|NCT01290315|75812893|FG001|Overall Study|Withdrawal by Subject|1|||
42035322|NCT01030458|75843655|FG000|Overall Study|Lost to Follow-up|9|||
42035323|NCT01030458|75843656|FG001|Overall Study|Lost to Follow-up|10|||
42137031|NCT00368277|75947428|FG000|Overall Study|Protocol deviation|7|||
42137032|NCT00368277|75947429|FG001|Overall Study|Protocol deviation|0|||
42271852|NCT01388491|76101940|FG001|Overall Study|Pregnancy|0|||
42035324|NCT01030458|75843655|FG000|Overall Study|Withdrawal by Subject|2|||
42035325|NCT01030458|75843656|FG001|Overall Study|Withdrawal by Subject|3|||
42271853|NCT02749799|76101946|FG000|Overall Study|Adverse Event|2|||
42271854|NCT02749799|76101946|FG000|Overall Study|Lost to Follow-up|4|||
42271855|NCT02749799|76101946|FG000|Overall Study|Protocol Violation|1|||
42271856|NCT02749799|76101946|FG000|Overall Study|Withdrawal by Subject|1|||
42271857|NCT03253393|76101953|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
42271858|NCT03253393|76101954|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
42271859|NCT03253393|76101955|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
42271860|NCT03128671|76101971|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
42271861|NCT03128671|76101972|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
42271862|NCT03128671|76101971|FG000|Allocation|Death|1|||
42271863|NCT03128671|76101972|FG001|Allocation|Death|0|||
42271864|NCT03128671|76101971|FG000|Allocation|Withdrawal by Subject|4|||
42271865|NCT03128671|76101972|FG001|Allocation|Withdrawal by Subject|0|||
42271866|NCT03128671|76101971|FG000|Intervention|Withdrawal by Subject|11|||
42271867|NCT03128671|76101972|FG001|Intervention|Withdrawal by Subject|10|||
42035326|NCT01030458|75843655|FG000|Overall Study|Logistical reasons|9|||
42271868|NCT03128671|76101971|FG000|Intervention|Palliative/hospice care initiated|9|||
42271869|NCT03128671|76101972|FG001|Intervention|Palliative/hospice care initiated|10|||
42271870|NCT03128671|76101971|FG000|Intervention|Death|13|||
42271871|NCT03128671|76101972|FG001|Intervention|Death|11|||
42271872|NCT03128671|76101971|FG000|Intervention|Interrupted by hurricane|1|||
42137033|NCT00368277|75947428|FG000|Overall Study|Patient withdrew consent|32|||
42137034|NCT00368277|75947429|FG001|Overall Study|Patient withdrew consent|28|||
42137035|NCT00368277|75947428|FG000|Overall Study|Lost to Follow-up|8|||
42137036|NCT00368277|75947429|FG001|Overall Study|Lost to Follow-up|6|||
42137037|NCT00280150|75947439|FG000|Overall Study|Adverse Event|0|||
42271873|NCT03128671|76101972|FG001|Intervention|Interrupted by hurricane|0|||
42346394|NCT01744197|76185304|FG001|Overall Study|No patch received|2|||
42035327|NCT01030458|75843656|FG001|Overall Study|Logistical reasons|5|||
42271874|NCT03128671|76101971|FG000|Intervention|Physician Decision|2|||
42271875|NCT03128671|76101972|FG001|Intervention|Physician Decision|3|||
42271876|NCT02925338|76101983|FG000|Overall Study|Death|0|||
42346395|NCT01732107|76185310|FG000|Overall Study|Adverse Event|2|||
42346396|NCT01732107|76185310|FG000|Overall Study|Disease Progression|8|||
42346397|NCT01732107|76185310|FG000|Overall Study|Physician Decision|1|||
42035328|NCT01030458|75843655|FG000|Overall Study|Moved or changed job|6|||
42035329|NCT01030458|75843656|FG001|Overall Study|Moved or changed job|13|||
42035330|NCT01030458|75843655|FG000|Overall Study|Side effect of medication|1|||
42035331|NCT01030458|75843656|FG001|Overall Study|Side effect of medication|1|||
42035332|NCT00930969|75843662|FG000|Overall Study|Death|5|||
42035333|NCT00930969|75843662|FG000|Overall Study|Lost to Follow-up|1|||
42035334|NCT00930969|75843662|FG000|Overall Study|Physician Decision|13|||
42035335|NCT00930969|75843662|FG000|Overall Study|Withdrawal by Subject|19|||
42035336|NCT01114139|75843668|FG000|Overall Study|Adverse Event|3|||
42035337|NCT01114139|75843669|FG001|Overall Study|Adverse Event|2|||
42035338|NCT01114139|75843668|FG000|Overall Study|Lost to Follow-up|15|||
42035339|NCT01114139|75843669|FG001|Overall Study|Lost to Follow-up|3|||
42035340|NCT01114139|75843668|FG000|Overall Study|Withdrawal by Subject|17|||
42035341|NCT01114139|75843669|FG001|Overall Study|Withdrawal by Subject|6|||
42035342|NCT01114139|75843668|FG000|Overall Study|Other-Missed 1 visit|1|||
42035343|NCT01114139|75843669|FG001|Overall Study|Other-Missed 1 visit|0|||
42035344|NCT01114139|75843668|FG000|Overall Study|Other-Protocol Violation|1|||
42035345|NCT01114139|75843669|FG001|Overall Study|Other-Protocol Violation|0|||
42137038|NCT00280150|75947440|FG001|Overall Study|Adverse Event|1|||
42271877|NCT02925338|76101984|FG001|Overall Study|Death|2|||
42271878|NCT02925338|76101985|FG002|Overall Study|Death|1|||
42271879|NCT02925338|76101986|FG003|Overall Study|Death|0|||
42271880|NCT02925338|76101987|FG004|Overall Study|Death|0|||
42346398|NCT01732107|76185310|FG000|Overall Study|Withdrawal by Subject|2|||
42137039|NCT00280150|75947441|FG002|Overall Study|Adverse Event|2|||
42137040|NCT00280150|75947442|FG003|Overall Study|Adverse Event|3|||
42137041|NCT00280150|75947439|FG000|Overall Study|Lack of Efficacy|0|||
42137042|NCT00280150|75947440|FG001|Overall Study|Lack of Efficacy|0|||
42137043|NCT00280150|75947441|FG002|Overall Study|Lack of Efficacy|0|||
42137044|NCT00280150|75947442|FG003|Overall Study|Lack of Efficacy|3|||
42137045|NCT00280150|75947439|FG000|Overall Study|Physician Decision|0|||
42137046|NCT00280150|75947440|FG001|Overall Study|Physician Decision|0|||
42137047|NCT00280150|75947441|FG002|Overall Study|Physician Decision|0|||
42137048|NCT00280150|75947442|FG003|Overall Study|Physician Decision|1|||
42137049|NCT00280150|75947439|FG000|Overall Study|Protocol Violation|0|||
42137050|NCT00280150|75947440|FG001|Overall Study|Protocol Violation|0|||
42137051|NCT00280150|75947441|FG002|Overall Study|Protocol Violation|0|||
42137052|NCT00280150|75947442|FG003|Overall Study|Protocol Violation|1|||
42137053|NCT00280150|75947439|FG000|Overall Study|Withdrawal by Subject|0|||
42137054|NCT00280150|75947440|FG001|Overall Study|Withdrawal by Subject|0|||
42137055|NCT00280150|75947441|FG002|Overall Study|Withdrawal by Subject|0|||
42137056|NCT00280150|75947442|FG003|Overall Study|Withdrawal by Subject|1|||
42137057|NCT00280150|75947439|FG000|Overall Study|Did not get consolidation therapy|3|||
42137058|NCT00280150|75947440|FG001|Overall Study|Did not get consolidation therapy|0|||
42137059|NCT00280150|75947441|FG002|Overall Study|Did not get consolidation therapy|3|||
42137060|NCT00280150|75947442|FG003|Overall Study|Did not get consolidation therapy|0|||
42137061|NCT00280150|75947439|FG000|Overall Study|Declining Performance Status|0|||
42137062|NCT00280150|75947440|FG001|Overall Study|Declining Performance Status|0|||
42137063|NCT00280150|75947441|FG002|Overall Study|Declining Performance Status|0|||
42137064|NCT00280150|75947442|FG003|Overall Study|Declining Performance Status|1|||
42137065|NCT00279916|75947455|FG000|Overall Study|Withdrawal by Subject|4|||
42137066|NCT00279916|75947456|FG001|Overall Study|Withdrawal by Subject|3|||
42137067|NCT00279916|75947455|FG000|Overall Study|Lost to Follow-up|3|||
42137068|NCT00279916|75947456|FG001|Overall Study|Lost to Follow-up|2|||
42137069|NCT00358527|75947464|FG000|Overall Study|Adverse Event|4|||
42137070|NCT00358527|75947465|FG001|Overall Study|Adverse Event|0|||
42137071|NCT00358527|75947464|FG000|Overall Study|Withdrawal by Subject|1|||
42137072|NCT00358527|75947465|FG001|Overall Study|Withdrawal by Subject|1|||
42137073|NCT00358527|75947464|FG000|Overall Study|Non-compliance with protocol|6|||
42137074|NCT00358527|75947465|FG001|Overall Study|Non-compliance with protocol|1|||
42137075|NCT00358527|75947464|FG000|Overall Study|Administrative|2|||
42137076|NCT00358527|75947465|FG001|Overall Study|Administrative|1|||
42137077|NCT00251758|75947474|FG000|Overall Study|Adverse Event|7|||
42137078|NCT00251758|75947475|FG001|Overall Study|Adverse Event|9|||
42137079|NCT00251758|75947476|FG002|Overall Study|Adverse Event|11|||
42137080|NCT00251758|75947474|FG000|Overall Study|Lost to Follow-up|4|||
42137081|NCT00251758|75947475|FG001|Overall Study|Lost to Follow-up|2|||
42137082|NCT00251758|75947476|FG002|Overall Study|Lost to Follow-up|5|||
42137083|NCT00251758|75947474|FG000|Overall Study|Withdrawal by Subject|13|||
42137084|NCT00251758|75947475|FG001|Overall Study|Withdrawal by Subject|7|||
42137085|NCT00251758|75947476|FG002|Overall Study|Withdrawal by Subject|3|||
42137086|NCT00251758|75947474|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
42137087|NCT00251758|75947475|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
42137088|NCT00251758|75947476|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
42137089|NCT00251758|75947474|FG000|Overall Study|Lack of Efficacy|3|||
42137090|NCT00251758|75947475|FG001|Overall Study|Lack of Efficacy|0|||
42137091|NCT00251758|75947476|FG002|Overall Study|Lack of Efficacy|0|||
42137092|NCT00251758|75947474|FG000|Overall Study|Noncompliant|0|||
42137093|NCT00251758|75947475|FG001|Overall Study|Noncompliant|2|||
42137094|NCT00251758|75947476|FG002|Overall Study|Noncompliant|2|||
42271881|NCT02925338|76101983|FG000|Overall Study|Lost to Follow-up|30|||
42271882|NCT02925338|76101984|FG001|Overall Study|Lost to Follow-up|10|||
42271883|NCT02925338|76101985|FG002|Overall Study|Lost to Follow-up|1|||
42271884|NCT02925338|76101986|FG003|Overall Study|Lost to Follow-up|16|||
42271885|NCT02925338|76101987|FG004|Overall Study|Lost to Follow-up|3|||
42271886|NCT02925338|76101983|FG000|Overall Study|Withdrawal by Subject|3|||
42271887|NCT02925338|76101984|FG001|Overall Study|Withdrawal by Subject|0|||
42346399|NCT01743027|76185318|FG000|Overall Study|Adverse Event|2|||
42346400|NCT01743027|76185319|FG001|Overall Study|Adverse Event|0|||
42137095|NCT00251758|75947474|FG000|Overall Study|Pregnancy|0|||
42137096|NCT00251758|75947475|FG001|Overall Study|Pregnancy|1|||
42271888|NCT02925338|76101985|FG002|Overall Study|Withdrawal by Subject|3|||
42346401|NCT01743027|76185320|FG002|Overall Study|Adverse Event|0|||
42137097|NCT00251758|75947476|FG002|Overall Study|Pregnancy|0|||
42137098|NCT00251758|75947474|FG000|Overall Study|Per Subject Request|0|||
42346402|NCT01743027|76185321|FG003|Overall Study|Adverse Event|0|||
42137099|NCT00251758|75947475|FG001|Overall Study|Per Subject Request|0|||
42137100|NCT00251758|75947476|FG002|Overall Study|Per Subject Request|1|||
42137101|NCT00251758|75947474|FG000|Overall Study|Per Investigator Request|1|||
42271889|NCT02925338|76101986|FG003|Overall Study|Withdrawal by Subject|2|||
42271890|NCT02925338|76101987|FG004|Overall Study|Withdrawal by Subject|2|||
42271891|NCT02925338|76101983|FG000|Overall Study|Missing|38|||
42137102|NCT00251758|75947475|FG001|Overall Study|Per Investigator Request|0|||
42137103|NCT00251758|75947476|FG002|Overall Study|Per Investigator Request|0|||
42137104|NCT00279214|75947486|FG000|Overall Study|Physician Decision|3|||
42137105|NCT00279214|75947487|FG001|Overall Study|Physician Decision|2|||
42137106|NCT00262834|75947495|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
42137107|NCT00262834|75947496|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
42137108|NCT00541775|75947505|FG000|Overall Study|Adverse Event|3|||
42137109|NCT00541775|75947506|FG001|Overall Study|Adverse Event|2|||
42137110|NCT00541775|75947507|FG002|Overall Study|Adverse Event|1|||
42137111|NCT00541775|75947505|FG000|Overall Study|Lack of Efficacy|0|||
42137112|NCT00541775|75947506|FG001|Overall Study|Lack of Efficacy|0|||
42137113|NCT00541775|75947507|FG002|Overall Study|Lack of Efficacy|3|||
42137114|NCT00541775|75947505|FG000|Overall Study|Lost to Follow-up|0|||
42137115|NCT00541775|75947506|FG001|Overall Study|Lost to Follow-up|0|||
42137116|NCT00541775|75947507|FG002|Overall Study|Lost to Follow-up|2|||
42137117|NCT00541775|75947505|FG000|Overall Study|Protocol Violation|1|||
42137118|NCT00541775|75947506|FG001|Overall Study|Protocol Violation|0|||
42137119|NCT00541775|75947507|FG002|Overall Study|Protocol Violation|0|||
42137120|NCT00541775|75947505|FG000|Overall Study|Withdrawal by Subject and Other|5|||
42137121|NCT00541775|75947506|FG001|Overall Study|Withdrawal by Subject and Other|0|||
42137122|NCT00541775|75947507|FG002|Overall Study|Withdrawal by Subject and Other|2|||
42137123|NCT00539513|75947517|FG000|Overall Study|Withdrawal by Subject|2|||
42137124|NCT00539513|75947518|FG001|Overall Study|Withdrawal by Subject|1|||
42137125|NCT00539513|75947517|FG000|Overall Study|Lost to Follow-up|0|||
42137126|NCT00539513|75947518|FG001|Overall Study|Lost to Follow-up|1|||
42137127|NCT00454584|75947527|FG000|Controlled Period|Adverse Event|5|||
42137128|NCT00454584|75947528|FG001|Controlled Period|Adverse Event|2|||
42137129|NCT00454584|75947529|FG002|Controlled Period|Adverse Event|1|||
42137130|NCT00454584|75947530|FG003|Controlled Period|Adverse Event|0|||
42137131|NCT00454584|75947531|FG004|Controlled Period|Adverse Event|0|||
42137132|NCT00454584|75947532|FG005|Controlled Period|Adverse Event|0|||
42137133|NCT00454584|75947527|FG000|Controlled Period|Lost to Follow-up|1|||
42137134|NCT00454584|75947528|FG001|Controlled Period|Lost to Follow-up|2|||
42137135|NCT00454584|75947529|FG002|Controlled Period|Lost to Follow-up|2|||
42137136|NCT00454584|75947530|FG003|Controlled Period|Lost to Follow-up|0|||
42137137|NCT00454584|75947531|FG004|Controlled Period|Lost to Follow-up|0|||
42137138|NCT00454584|75947532|FG005|Controlled Period|Lost to Follow-up|0|||
42137139|NCT00454584|75947527|FG000|Controlled Period|Other|5|||
42137140|NCT00454584|75947528|FG001|Controlled Period|Other|4|||
42137141|NCT00454584|75947529|FG002|Controlled Period|Other|2|||
42137142|NCT00454584|75947530|FG003|Controlled Period|Other|0|||
42137143|NCT00454584|75947531|FG004|Controlled Period|Other|0|||
42137144|NCT00454584|75947532|FG005|Controlled Period|Other|0|||
42137145|NCT00454584|75947527|FG000|After Controlled Period|Adverse Event|0|||
42137146|NCT00454584|75947528|FG001|After Controlled Period|Adverse Event|0|||
42035346|NCT01114139|75843668|FG000|Overall Study|Other-Out of window for study drug dose|1|||
42035347|NCT01114139|75843669|FG001|Overall Study|Other-Out of window for study drug dose|0|||
42035348|NCT01114139|75843668|FG000|Overall Study|Other-Participant falsified records|0|||
42035349|NCT01114139|75843669|FG001|Overall Study|Other-Participant falsified records|1|||
42035350|NCT01114139|75843668|FG000|Overall Study|Other-Participant went on hospice|0|||
42035351|NCT01114139|75843669|FG001|Overall Study|Other-Participant went on hospice|1|||
42035352|NCT01114139|75843668|FG000|Overall Study|Other-Physician changed treatment|1|||
42035353|NCT01114139|75843669|FG001|Overall Study|Other-Physician changed treatment|0|||
42035354|NCT01114139|75843668|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
42035355|NCT01114139|75843669|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
42035356|NCT01027884|75843677|FG000|Overall Study|Adverse Event|2|||
42035357|NCT01027884|75843678|FG001|Overall Study|Adverse Event|1|||
42035358|NCT01027884|75843677|FG000|Overall Study|Protocol Violation|1|||
42035359|NCT01027884|75843678|FG001|Overall Study|Protocol Violation|0|||
42035360|NCT01027884|75843677|FG000|Overall Study|Non-compliance|1|||
42035361|NCT01027884|75843678|FG001|Overall Study|Non-compliance|1|||
42035362|NCT01027884|75843677|FG000|Overall Study|Withdrawal by Subject|0|||
42035363|NCT01027884|75843678|FG001|Overall Study|Withdrawal by Subject|1|||
42035364|NCT01027884|75843677|FG000|Overall Study|Lost to Follow-up|0|||
42137147|NCT00454584|75947529|FG002|After Controlled Period|Adverse Event|0|||
42137148|NCT00454584|75947530|FG003|After Controlled Period|Adverse Event|9|||
42137149|NCT00454584|75947531|FG004|After Controlled Period|Adverse Event|3|||
42271892|NCT02925338|76101984|FG001|Overall Study|Missing|27|||
42035365|NCT01027884|75843678|FG001|Overall Study|Lost to Follow-up|1|||
42035366|NCT01027884|75843677|FG000|Overall Study|Spinal fixation surgery|0|||
42137150|NCT00454584|75947532|FG005|After Controlled Period|Adverse Event|9|||
42137151|NCT00454584|75947527|FG000|After Controlled Period|Lack of Efficacy|0|||
42137152|NCT00454584|75947528|FG001|After Controlled Period|Lack of Efficacy|0|||
42035367|NCT01027884|75843678|FG001|Overall Study|Spinal fixation surgery|3|||
42137153|NCT00454584|75947529|FG002|After Controlled Period|Lack of Efficacy|0|||
42137154|NCT00454584|75947530|FG003|After Controlled Period|Lack of Efficacy|1|||
42271893|NCT02925338|76101985|FG002|Overall Study|Missing|0|||
42137155|NCT00454584|75947531|FG004|After Controlled Period|Lack of Efficacy|0|||
42137156|NCT00454584|75947532|FG005|After Controlled Period|Lack of Efficacy|0|||
42137157|NCT00454584|75947527|FG000|After Controlled Period|Lost to Follow-up|0|||
42137158|NCT00454584|75947528|FG001|After Controlled Period|Lost to Follow-up|0|||
42137159|NCT00454584|75947529|FG002|After Controlled Period|Lost to Follow-up|0|||
42137160|NCT00454584|75947530|FG003|After Controlled Period|Lost to Follow-up|2|||
42137161|NCT00454584|75947531|FG004|After Controlled Period|Lost to Follow-up|4|||
42137162|NCT00454584|75947532|FG005|After Controlled Period|Lost to Follow-up|6|||
42137163|NCT00454584|75947527|FG000|After Controlled Period|Other|0|||
42137164|NCT00454584|75947528|FG001|After Controlled Period|Other|0|||
42137165|NCT00454584|75947529|FG002|After Controlled Period|Other|0|||
42137166|NCT00454584|75947530|FG003|After Controlled Period|Other|1|||
42137167|NCT00454584|75947531|FG004|After Controlled Period|Other|0|||
42137168|NCT00454584|75947532|FG005|After Controlled Period|Other|0|||
42137169|NCT00454584|75947527|FG000|After Controlled Period|Other|0|||
42137170|NCT00454584|75947528|FG001|After Controlled Period|Other|0|||
42137171|NCT00454584|75947529|FG002|After Controlled Period|Other|0|||
42137172|NCT00454584|75947530|FG003|After Controlled Period|Other|13|||
42137173|NCT00454584|75947531|FG004|After Controlled Period|Other|5|||
42137174|NCT00454584|75947532|FG005|After Controlled Period|Other|17|||
42137175|NCT00445068|75947546|FG000|Overall Study|Disease progression|26|||
42137176|NCT00445068|75947546|FG000|Overall Study|Adverse Event|5|||
42137177|NCT00445068|75947546|FG000|Overall Study|Abnormal laboratory value|2|||
42137178|NCT00445068|75947546|FG000|Overall Study|Withdrawal by Subject|2|||
42137179|NCT00445068|75947546|FG000|Overall Study|Death|1|||
42137180|NCT00539279|75947552|FG000|Treatment|Withdrawal by Subject|10|||
42137181|NCT00539279|75947553|FG001|Treatment|Withdrawal by Subject|8|||
42137182|NCT00539279|75947552|FG000|Treatment|Death|1|||
42137183|NCT00539279|75947553|FG001|Treatment|Death|0|||
42137184|NCT00539279|75947552|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
42137185|NCT00539279|75947553|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
42137186|NCT00539279|75947552|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
42137187|NCT00539279|75947553|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
42137188|NCT00444912|75947561|FG000|Overall Study|Death|1|||
42137189|NCT00444912|75947562|FG001|Overall Study|Death|2|||
42137190|NCT00444912|75947561|FG000|Overall Study|Lost to Follow-up|1|||
42137191|NCT00444912|75947562|FG001|Overall Study|Lost to Follow-up|0|||
42137192|NCT00444912|75947561|FG000|Overall Study|Participant Failed Mobilization|1|||
42137193|NCT00444912|75947562|FG001|Overall Study|Participant Failed Mobilization|0|||
42137194|NCT00538733|75947568|FG000|Overall Study|Adverse Event|8|||
42137195|NCT00538733|75947568|FG000|Overall Study|Death|1|||
42137196|NCT00538733|75947568|FG000|Overall Study|declined to participate|2|||
42137197|NCT00538733|75947568|FG000|Overall Study|still on therapy|1|||
42137198|NCT00444678|75947575|FG000|Overall Study|Toxicity|11|||
42137199|NCT00444678|75947575|FG000|Overall Study|Disease Progression|12|||
42137200|NCT00444678|75947575|FG000|Overall Study|Death|3|||
42137201|NCT00444678|75947575|FG000|Overall Study|Physician Decision|3|||
42137202|NCT00444678|75947575|FG000|Overall Study|Withdrawal by Subject|2|||
42137203|NCT00358449|75947582|FG000|Overall Study|Adverse Event|1|||
42137204|NCT00358449|75947583|FG001|Overall Study|Adverse Event|0|||
42137205|NCT00358449|75947584|FG002|Overall Study|Adverse Event|1|||
42137206|NCT00358449|75947582|FG000|Overall Study|Lost to Follow-up|1|||
42137207|NCT00358449|75947583|FG001|Overall Study|Lost to Follow-up|0|||
42137208|NCT00358449|75947584|FG002|Overall Study|Lost to Follow-up|0|||
42137209|NCT00358449|75947582|FG000|Overall Study|Withdrawal by Subject|2|||
42137210|NCT00358449|75947583|FG001|Overall Study|Withdrawal by Subject|0|||
42137211|NCT00358449|75947584|FG002|Overall Study|Withdrawal by Subject|0|||
42137212|NCT00358449|75947582|FG000|Overall Study|Lack of Efficacy|0|||
42137213|NCT00358449|75947583|FG001|Overall Study|Lack of Efficacy|1|||
42137214|NCT00358449|75947584|FG002|Overall Study|Lack of Efficacy|0|||
42137215|NCT00358449|75947582|FG000|Overall Study|Steriod Inhaler was Increased|0|||
42137216|NCT00358449|75947583|FG001|Overall Study|Steriod Inhaler was Increased|0|||
42137217|NCT00358449|75947584|FG002|Overall Study|Steriod Inhaler was Increased|1|||
42137218|NCT00539981|75947596|FG000|Overall Study|Adverse events (AE)|3|||
42137219|NCT00539981|75947597|FG001|Overall Study|Adverse events (AE)|3|||
42137220|NCT00539981|75947596|FG000|Overall Study|Lost to Follow-up|260|||
42137221|NCT00539981|75947597|FG001|Overall Study|Lost to Follow-up|251|||
42137222|NCT00539981|75947596|FG000|Overall Study|Withdrew consent|22|||
42137223|NCT00539981|75947597|FG001|Overall Study|Withdrew consent|14|||
42137224|NCT00539981|75947596|FG000|Overall Study|Death|1|||
42137225|NCT00539981|75947597|FG001|Overall Study|Death|1|||
42137226|NCT00539981|75947596|FG000|Overall Study|Other reason-unspecified|9|||
42137227|NCT00539981|75947597|FG001|Overall Study|Other reason-unspecified|13|||
42137228|NCT00367341|75947608|FG000|Overall Study|Physician Decision|1|||
42137229|NCT00367341|75947609|FG001|Overall Study|Physician Decision|0|||
42137230|NCT00367341|75947608|FG000|Overall Study|Protocol Violation|1|||
42137231|NCT00367341|75947609|FG001|Overall Study|Protocol Violation|0|||
42137232|NCT00440466|75947618|FG000|Overall Study|Death|3|||
42137233|NCT00440466|75947619|FG001|Overall Study|Death|2|||
42137234|NCT00440466|75947620|FG002|Overall Study|Death|9|||
42137235|NCT00440466|75947618|FG000|Overall Study|Adverse Event|3|||
42137236|NCT00440466|75947619|FG001|Overall Study|Adverse Event|4|||
42137237|NCT00440466|75947620|FG002|Overall Study|Adverse Event|11|||
42137238|NCT00440466|75947618|FG000|Overall Study|Lost to Follow-up|1|||
42137239|NCT00440466|75947619|FG001|Overall Study|Lost to Follow-up|0|||
42137240|NCT00440466|75947620|FG002|Overall Study|Lost to Follow-up|2|||
42137241|NCT00440466|75947618|FG000|Overall Study|Physician Decision|2|||
42137242|NCT00440466|75947619|FG001|Overall Study|Physician Decision|0|||
42137243|NCT00440466|75947620|FG002|Overall Study|Physician Decision|1|||
42137244|NCT00440466|75947618|FG000|Overall Study|Protocol Violation|2|||
42004989|NCT01290315|75812894|FG002|Overall Study|Withdrawal by Subject|0|||
42004990|NCT01290315|75812895|FG003|Overall Study|Withdrawal by Subject|0|||
42004991|NCT01289847|75812904|FG000|Overall Study|Patient could not comply with visits|1|||
42004992|NCT01079182|75812908|FG000|Overall Study|Lost to Follow-up|1634|||
42004993|NCT01079182|75812908|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
42004994|NCT01079182|75812908|FG000|Overall Study|Lack of Efficacy|514|||
42004995|NCT01079182|75812908|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
42004996|NCT01079182|75812908|FG000|Overall Study|Reasons not Evaluated|271|||
42137245|NCT00440466|75947619|FG001|Overall Study|Protocol Violation|0|||
42004997|NCT01021813|75812914|FG000|DB Treatment Phase|Adverse Event|60|||
42004998|NCT01021813|75812915|FG001|DB Treatment Phase|Adverse Event|22|||
42137246|NCT00440466|75947620|FG002|Overall Study|Protocol Violation|4|||
42346403|NCT01743027|76185318|FG000|Overall Study|Lost to Follow-up|0|||
42004999|NCT01021813|75812916|FG002|DB Treatment Phase|Adverse Event|0|||
42137247|NCT00440466|75947618|FG000|Overall Study|Withdrawal by Subject|2|||
42271894|NCT02925338|76101986|FG003|Overall Study|Missing|3|||
42137248|NCT00440466|75947619|FG001|Overall Study|Withdrawal by Subject|5|||
42137249|NCT00440466|75947620|FG002|Overall Study|Withdrawal by Subject|9|||
42137250|NCT00440466|75947618|FG000|Overall Study|Began Dialysis|0|||
42137251|NCT00440466|75947619|FG001|Overall Study|Began Dialysis|0|||
42137252|NCT00440466|75947620|FG002|Overall Study|Began Dialysis|1|||
42137253|NCT00440466|75947618|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
42137254|NCT00440466|75947619|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
42137255|NCT00440466|75947620|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
42137256|NCT00537485|75947630|FG000|Overall Study|Adverse Event|10|||
42137257|NCT00537485|75947631|FG001|Overall Study|Adverse Event|5|||
42137258|NCT00537485|75947630|FG000|Overall Study|Withdrawal by Subject|3|||
42137259|NCT00537485|75947631|FG001|Overall Study|Withdrawal by Subject|2|||
42137260|NCT00537485|75947630|FG000|Overall Study|Withdrawal by Subject|1|||
42137261|NCT00537485|75947631|FG001|Overall Study|Withdrawal by Subject|3|||
42137262|NCT00537485|75947630|FG000|Overall Study|Physician Decision|1|||
42137263|NCT00537485|75947631|FG001|Overall Study|Physician Decision|0|||
42137264|NCT00616967|75947639|FG000|Overall Study|Withdrawal by Subject|0|||
42137265|NCT00616967|75947640|FG001|Overall Study|Withdrawal by Subject|0|||
42137266|NCT00616967|75947641|FG002|Overall Study|Withdrawal by Subject|1|||
42137267|NCT00537329|75947659|FG000|Overall Study|Death|10|||
42137268|NCT00537329|75947659|FG000|Overall Study|Adverse Event|3|||
42137269|NCT00537329|75947659|FG000|Overall Study|Lack of Efficacy|2|||
42137270|NCT00537329|75947659|FG000|Overall Study|Lost to Follow-up|6|||
42137271|NCT00537329|75947659|FG000|Overall Study|Withdrawal by Subject|4|||
42137272|NCT00537329|75947659|FG000|Overall Study|Other|1|||
42137273|NCT03897179|75947663|FG000|Overall Study|Withdrawal by Subject|1|||
42137274|NCT03905135|75947669|FG000|Dose Escalation|Adverse Event|1|||
42137275|NCT03905135|75947670|FG001|Dose Escalation|Adverse Event|1|||
42137276|NCT03905135|75947669|FG000|Dose Escalation|Progressive disease|3|||
42137277|NCT03905135|75947670|FG001|Dose Escalation|Progressive disease|1|||
42137278|NCT03905135|75947669|FG000|Dose Escalation|Intercurrent illness|1|||
42137279|NCT03905135|75947670|FG001|Dose Escalation|Intercurrent illness|0|||
42137280|NCT00357903|75947680|FG000|Overall Study|Adverse Event|87|||
42137281|NCT00357903|75947681|FG001|Overall Study|Adverse Event|4|||
42137282|NCT00357903|75947680|FG000|Overall Study|Death|33|||
42137283|NCT00357903|75947681|FG001|Overall Study|Death|0|||
42137284|NCT00357903|75947680|FG000|Overall Study|Lost to Follow-up|23|||
42137285|NCT00357903|75947681|FG001|Overall Study|Lost to Follow-up|4|||
42137286|NCT00357903|75947680|FG000|Overall Study|Physician Decision|39|||
42137287|NCT00357903|75947681|FG001|Overall Study|Physician Decision|5|||
42137288|NCT00357903|75947680|FG000|Overall Study|Withdrawal by Subject|57|||
42137289|NCT00357903|75947681|FG001|Overall Study|Withdrawal by Subject|7|||
42137290|NCT00357903|75947680|FG000|Overall Study|Completed month 12 only|0|||
42137291|NCT00357903|75947681|FG001|Overall Study|Completed month 12 only|1|||
42137292|NCT00357903|75947680|FG000|Overall Study|Protocol issues|14|||
42137293|NCT00357903|75947681|FG001|Overall Study|Protocol issues|3|||
42137294|NCT00357903|75947680|FG000|Overall Study|Response status|61|||
42137295|NCT00357903|75947681|FG001|Overall Study|Response status|9|||
42137296|NCT00357903|75947680|FG000|Overall Study|Other|49|||
42137297|NCT00357903|75947681|FG001|Overall Study|Other|10|||
42137298|NCT00348933|75947688|FG000|Overall Study|Withdrawal by Subject|10|||
42137299|NCT00348933|75947688|FG000|Overall Study|Lost to Follow-up|6|||
42137300|NCT00348933|75947688|FG000|Overall Study|Protocol Violation|2|||
42005000|NCT01021813|75812917|FG003|DB Treatment Phase|Adverse Event|0|||
42005001|NCT01021813|75812918|FG004|DB Treatment Phase|Adverse Event|0|||
42005002|NCT01021813|75812914|FG000|DB Treatment Phase|Lack of Efficacy|44|||
42137301|NCT00348933|75947688|FG000|Overall Study|Adverse Event|7|||
42137302|NCT03896477|75947696|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
42137303|NCT03896477|75947697|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
42137304|NCT03896477|75947698|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
42137305|NCT03896477|75947696|FG000|Overall Study|Parent Requested Withdrawal|8|||
42137306|NCT03896477|75947697|FG001|Overall Study|Parent Requested Withdrawal|12|||
42137307|NCT03896477|75947698|FG002|Overall Study|Parent Requested Withdrawal|9|||
42137308|NCT03896477|75947696|FG000|Overall Study|Adverse Event|0|||
42137309|NCT03896477|75947697|FG001|Overall Study|Adverse Event|0|||
42137310|NCT03896477|75947698|FG002|Overall Study|Adverse Event|1|||
42137311|NCT03896477|75947696|FG000|Overall Study|Death|1|||
42137312|NCT03896477|75947697|FG001|Overall Study|Death|0|||
42137313|NCT03896477|75947698|FG002|Overall Study|Death|0|||
42137314|NCT03896477|75947696|FG000|Overall Study|Other|5|||
42137315|NCT03896477|75947697|FG001|Overall Study|Other|6|||
42137316|NCT03896477|75947698|FG002|Overall Study|Other|7|||
42005003|NCT01021813|75812915|FG001|DB Treatment Phase|Lack of Efficacy|28|||
42137317|NCT03896477|75947696|FG000|Overall Study|Lost to Follow-up|2|||
42137318|NCT03896477|75947697|FG001|Overall Study|Lost to Follow-up|1|||
42137319|NCT03896477|75947698|FG002|Overall Study|Lost to Follow-up|1|||
42137320|NCT00444600|75947713|FG000|Overall Study|Death|7|||
42137321|NCT00444600|75947714|FG001|Overall Study|Death|5|||
42137322|NCT00444600|75947715|FG002|Overall Study|Death|3|||
42137323|NCT00444600|75947716|FG003|Overall Study|Death|2|||
42137324|NCT00444600|75947713|FG000|Overall Study|Dropped|11|||
42137325|NCT00444600|75947714|FG001|Overall Study|Dropped|11|||
42137326|NCT00444600|75947715|FG002|Overall Study|Dropped|7|||
42137327|NCT00444600|75947716|FG003|Overall Study|Dropped|7|||
42137328|NCT00444600|75947713|FG000|Overall Study|Missed visit|1|||
42137329|NCT00444600|75947714|FG001|Overall Study|Missed visit|0|||
42137330|NCT00444600|75947715|FG002|Overall Study|Missed visit|0|||
42137331|NCT00444600|75947716|FG003|Overall Study|Missed visit|1|||
42137332|NCT00537095|75947734|FG000|Overall Study|surgery|1|||
42137333|NCT00537095|75947735|FG001|Overall Study|surgery|0|||
42137334|NCT00537095|75947734|FG000|Overall Study|Adverse Event|24|||
42137335|NCT00537095|75947735|FG001|Overall Study|Adverse Event|4|||
42137336|NCT00537095|75947734|FG000|Overall Study|disease progression|21|||
42137337|NCT00537095|75947735|FG001|Overall Study|disease progression|48|||
42137338|NCT00537095|75947734|FG000|Overall Study|Death|3|||
42137339|NCT00537095|75947735|FG001|Overall Study|Death|1|||
42137340|NCT00537095|75947734|FG000|Overall Study|Withdrawal by Subject|2|||
42137341|NCT00537095|75947735|FG001|Overall Study|Withdrawal by Subject|2|||
42137342|NCT00537095|75947734|FG000|Overall Study|subjective disease progression|0|||
42137343|NCT00537095|75947735|FG001|Overall Study|subjective disease progression|1|||
42137344|NCT00537095|75947734|FG000|Overall Study|Incorrect enrolment|0|||
42137345|NCT00537095|75947735|FG001|Overall Study|Incorrect enrolment|1|||
42137346|NCT00443898|75947745|FG000|Overall Study|Adverse Event|0|||
42137347|NCT00443898|75947746|FG001|Overall Study|Adverse Event|0|||
42137348|NCT00443898|75947747|FG002|Overall Study|Adverse Event|1|||
42137349|NCT00443898|75947748|FG003|Overall Study|Adverse Event|1|||
42137350|NCT00443898|75947745|FG000|Overall Study|Lack of Efficacy|2|||
42137351|NCT00443898|75947746|FG001|Overall Study|Lack of Efficacy|3|||
42137352|NCT00443898|75947747|FG002|Overall Study|Lack of Efficacy|3|||
42137353|NCT00443898|75947748|FG003|Overall Study|Lack of Efficacy|1|||
42137354|NCT00443898|75947745|FG000|Overall Study|Protocol Violation|1|||
42137355|NCT00443898|75947746|FG001|Overall Study|Protocol Violation|1|||
42137356|NCT00443898|75947747|FG002|Overall Study|Protocol Violation|1|||
42137357|NCT00443898|75947748|FG003|Overall Study|Protocol Violation|0|||
42137358|NCT00443898|75947745|FG000|Overall Study|Withdrawal by Subject|11|||
42137359|NCT00443898|75947746|FG001|Overall Study|Withdrawal by Subject|10|||
42137360|NCT00443898|75947747|FG002|Overall Study|Withdrawal by Subject|10|||
42137361|NCT00443898|75947748|FG003|Overall Study|Withdrawal by Subject|6|||
42137362|NCT00443898|75947745|FG000|Overall Study|Lost to Follow-up|10|||
42137363|NCT00443898|75947746|FG001|Overall Study|Lost to Follow-up|10|||
42137364|NCT00443898|75947747|FG002|Overall Study|Lost to Follow-up|14|||
42137365|NCT00443898|75947748|FG003|Overall Study|Lost to Follow-up|10|||
42137366|NCT00443898|75947745|FG000|Overall Study|Death|0|||
42137367|NCT00443898|75947746|FG001|Overall Study|Death|1|||
42137368|NCT00443898|75947747|FG002|Overall Study|Death|0|||
42137369|NCT00443898|75947748|FG003|Overall Study|Death|0|||
42137370|NCT00537017|75947758|FG000|Treatment Phase|Adverse Event|19|||
42137371|NCT00537017|75947758|FG000|Treatment Phase|Withdrawal by Subject|13|||
42137372|NCT00537017|75947758|FG000|Treatment Phase|Protocol Violation|2|||
42137373|NCT00537017|75947758|FG000|Follow-up Phase|Withdrawal by Subject|9|||
42137374|NCT00348309|75947765|FG000|Overall Study|Adverse Event|56|||
42346404|NCT01743027|76185319|FG001|Overall Study|Lost to Follow-up|0|||
42346405|NCT01743027|76185320|FG002|Overall Study|Lost to Follow-up|2|||
42346406|NCT01743027|76185321|FG003|Overall Study|Lost to Follow-up|0|||
42346407|NCT01743027|76185318|FG000|Overall Study|Progressive Disease|1|||
42137375|NCT00348309|75947766|FG001|Overall Study|Adverse Event|28|||
42137376|NCT00348309|75947767|FG002|Overall Study|Adverse Event|63|||
42137377|NCT00348309|75947765|FG000|Overall Study|Lost to Follow-up|6|||
42137378|NCT00348309|75947766|FG001|Overall Study|Lost to Follow-up|7|||
42137379|NCT00348309|75947767|FG002|Overall Study|Lost to Follow-up|4|||
42137380|NCT00348309|75947765|FG000|Overall Study|Protocol Violation|7|||
42137381|NCT00348309|75947766|FG001|Overall Study|Protocol Violation|12|||
42137382|NCT00348309|75947767|FG002|Overall Study|Protocol Violation|7|||
42137383|NCT00348309|75947765|FG000|Overall Study|Withdrawal by Subject|33|||
42137384|NCT00348309|75947766|FG001|Overall Study|Withdrawal by Subject|37|||
42137385|NCT00348309|75947767|FG002|Overall Study|Withdrawal by Subject|40|||
42346408|NCT01743027|76185319|FG001|Overall Study|Progressive Disease|4|||
42137386|NCT00348309|75947765|FG000|Overall Study|Non-compliance|8|||
42346409|NCT01743027|76185320|FG002|Overall Study|Progressive Disease|3|||
42346410|NCT01743027|76185321|FG003|Overall Study|Progressive Disease|0|||
42346411|NCT01743027|76185318|FG000|Overall Study|Protocol Violation|1|||
42346412|NCT01743027|76185319|FG001|Overall Study|Protocol Violation|1|||
42346413|NCT01743027|76185320|FG002|Overall Study|Protocol Violation|1|||
42346414|NCT01743027|76185321|FG003|Overall Study|Protocol Violation|0|||
42346415|NCT01743027|76185318|FG000|Overall Study|Withdrawal by Subject|1|||
42346416|NCT01743027|76185319|FG001|Overall Study|Withdrawal by Subject|0|||
42346417|NCT01743027|76185320|FG002|Overall Study|Withdrawal by Subject|3|||
42346418|NCT01743027|76185321|FG003|Overall Study|Withdrawal by Subject|1|||
42346419|NCT01380730|76185339|FG000|Overall Study|Death|0|||
42346420|NCT01380730|76185340|FG001|Overall Study|Death|0|||
42137387|NCT00348309|75947766|FG001|Overall Study|Non-compliance|6|||
42137388|NCT00348309|75947767|FG002|Overall Study|Non-compliance|8|||
42137389|NCT00348309|75947765|FG000|Overall Study|Death of caregiver|1|||
42137390|NCT00348309|75947766|FG001|Overall Study|Death of caregiver|0|||
42137391|NCT00348309|75947767|FG002|Overall Study|Death of caregiver|1|||
42137392|NCT00348309|75947765|FG000|Overall Study|Lack of insight, dementia|1|||
42137393|NCT00348309|75947766|FG001|Overall Study|Lack of insight, dementia|0|||
42137394|NCT00348309|75947767|FG002|Overall Study|Lack of insight, dementia|0|||
42137395|NCT00348309|75947765|FG000|Overall Study|Wrong bottle allocated|1|||
42137396|NCT00348309|75947766|FG001|Overall Study|Wrong bottle allocated|0|||
42137397|NCT00348309|75947767|FG002|Overall Study|Wrong bottle allocated|0|||
42137398|NCT00348309|75947765|FG000|Overall Study|Caregiver sick|1|||
42137399|NCT00348309|75947766|FG001|Overall Study|Caregiver sick|0|||
42137400|NCT00348309|75947767|FG002|Overall Study|Caregiver sick|0|||
42137401|NCT00348309|75947765|FG000|Overall Study|Use of prohibited medication|5|||
42137402|NCT00348309|75947766|FG001|Overall Study|Use of prohibited medication|2|||
42137403|NCT00348309|75947767|FG002|Overall Study|Use of prohibited medication|2|||
42137404|NCT00348309|75947765|FG000|Overall Study|Caregiver withdrawal|3|||
42137405|NCT00348309|75947766|FG001|Overall Study|Caregiver withdrawal|0|||
42137406|NCT00348309|75947767|FG002|Overall Study|Caregiver withdrawal|7|||
42137407|NCT00348309|75947765|FG000|Overall Study|Unable to complete ET visit|1|||
42137408|NCT00348309|75947766|FG001|Overall Study|Unable to complete ET visit|0|||
42137409|NCT00348309|75947767|FG002|Overall Study|Unable to complete ET visit|0|||
42137410|NCT00348309|75947765|FG000|Overall Study|PI closing medical practice|1|||
42137411|NCT00348309|75947766|FG001|Overall Study|PI closing medical practice|0|||
42137412|NCT00348309|75947767|FG002|Overall Study|PI closing medical practice|0|||
42137413|NCT00348309|75947765|FG000|Overall Study|Principal investigator's decision|1|||
42137414|NCT00348309|75947766|FG001|Overall Study|Principal investigator's decision|0|||
42137415|NCT00348309|75947767|FG002|Overall Study|Principal investigator's decision|0|||
42137416|NCT00348309|75947765|FG000|Overall Study|No disponibility of medication|1|||
42137417|NCT00348309|75947766|FG001|Overall Study|No disponibility of medication|0|||
42137418|NCT00348309|75947767|FG002|Overall Study|No disponibility of medication|0|||
42137419|NCT00348309|75947765|FG000|Overall Study|Worsened neurodegenerative disease|1|||
42137420|NCT00348309|75947766|FG001|Overall Study|Worsened neurodegenerative disease|0|||
42137421|NCT00348309|75947767|FG002|Overall Study|Worsened neurodegenerative disease|0|||
42137422|NCT00348309|75947765|FG000|Overall Study|Cognitive and behaviour worsening|2|||
42137423|NCT00348309|75947766|FG001|Overall Study|Cognitive and behaviour worsening|0|||
42137424|NCT00348309|75947767|FG002|Overall Study|Cognitive and behaviour worsening|0|||
42137425|NCT00348309|75947765|FG000|Overall Study|Worsening of alzheimer|1|||
42137426|NCT00348309|75947766|FG001|Overall Study|Worsening of alzheimer|0|||
42137427|NCT00348309|75947767|FG002|Overall Study|Worsening of alzheimer|1|||
42137428|NCT00348309|75947765|FG000|Overall Study|Did not appear in time for Visit 3|1|||
42137429|NCT00348309|75947766|FG001|Overall Study|Did not appear in time for Visit 3|0|||
42137430|NCT00348309|75947767|FG002|Overall Study|Did not appear in time for Visit 3|0|||
42137431|NCT00348309|75947765|FG000|Overall Study|Participant died|2|||
42137432|NCT00348309|75947766|FG001|Overall Study|Participant died|1|||
42137433|NCT00348309|75947767|FG002|Overall Study|Participant died|1|||
42137434|NCT00348309|75947765|FG000|Overall Study|Decision of sponsor|1|||
42346421|NCT01380730|76185341|FG002|Overall Study|Death|0|||
42137435|NCT00348309|75947766|FG001|Overall Study|Decision of sponsor|0|||
42137436|NCT00348309|75947767|FG002|Overall Study|Decision of sponsor|0|||
42137437|NCT00348309|75947765|FG000|Overall Study|Ineffectiveness of treatment|0|||
42137438|NCT00348309|75947766|FG001|Overall Study|Ineffectiveness of treatment|1|||
42137439|NCT00348309|75947767|FG002|Overall Study|Ineffectiveness of treatment|0|||
42137440|NCT00348309|75947765|FG000|Overall Study|A foul of exclusion criteria|0|||
42137441|NCT00348309|75947766|FG001|Overall Study|A foul of exclusion criteria|1|||
42137442|NCT00348309|75947767|FG002|Overall Study|A foul of exclusion criteria|0|||
42137443|NCT00348309|75947765|FG000|Overall Study|Participant was hospitalized|0|||
42346422|NCT01380730|76185342|FG003|Overall Study|Death|0|||
42346423|NCT01380730|76185343|FG004|Overall Study|Death|1|||
42346424|NCT01380730|76185344|FG005|Overall Study|Death|0|||
42346425|NCT01380730|76185345|FG006|Overall Study|Death|0|||
42346426|NCT01380730|76185346|FG007|Overall Study|Death|0|||
42137444|NCT00348309|75947766|FG001|Overall Study|Participant was hospitalized|1|||
42137445|NCT00348309|75947767|FG002|Overall Study|Participant was hospitalized|0|||
42137446|NCT00348309|75947765|FG000|Overall Study|Sponsor refuseal|0|||
42137447|NCT00348309|75947766|FG001|Overall Study|Sponsor refuseal|1|||
42137448|NCT00348309|75947767|FG002|Overall Study|Sponsor refuseal|1|||
42137449|NCT00348309|75947765|FG000|Overall Study|Forgot often medication|0|||
42137450|NCT00348309|75947766|FG001|Overall Study|Forgot often medication|1|||
42137451|NCT00348309|75947767|FG002|Overall Study|Forgot often medication|0|||
42137452|NCT00348309|75947765|FG000|Overall Study|Medical Monitor decision|0|||
42137453|NCT00348309|75947766|FG001|Overall Study|Medical Monitor decision|0|||
42137454|NCT00348309|75947767|FG002|Overall Study|Medical Monitor decision|1|||
42137455|NCT00348309|75947765|FG000|Overall Study|Increased dose of Aricept|0|||
42137456|NCT00348309|75947766|FG001|Overall Study|Increased dose of Aricept|0|||
42137457|NCT00348309|75947767|FG002|Overall Study|Increased dose of Aricept|1|||
42137458|NCT00348309|75947765|FG000|Overall Study|Site closure|0|||
42137459|NCT00348309|75947766|FG001|Overall Study|Site closure|0|||
42137460|NCT00348309|75947767|FG002|Overall Study|Site closure|1|||
42137461|NCT00348309|75947765|FG000|Overall Study|Adverse event not attended|0|||
42137462|NCT00348309|75947766|FG001|Overall Study|Adverse event not attended|0|||
42137463|NCT00348309|75947767|FG002|Overall Study|Adverse event not attended|1|||
42137464|NCT00348309|75947765|FG000|Overall Study|ECG abnormal|0|||
42137465|NCT00348309|75947766|FG001|Overall Study|ECG abnormal|0|||
42137466|NCT00348309|75947767|FG002|Overall Study|ECG abnormal|2|||
42137467|NCT00348309|75947765|FG000|Overall Study|Cardiologist recommendations|0|||
42137468|NCT00348309|75947766|FG001|Overall Study|Cardiologist recommendations|0|||
42137469|NCT00348309|75947767|FG002|Overall Study|Cardiologist recommendations|1|||
42137470|NCT00348309|75947765|FG000|Overall Study|HCV career|0|||
42137471|NCT00348309|75947766|FG001|Overall Study|HCV career|0|||
42137472|NCT00348309|75947767|FG002|Overall Study|HCV career|1|||
42137473|NCT00440310|75947778|FG000|Overall Study|Lost to Follow-up|4|||
42346427|NCT01395784|76185364|FG000|Overall Study|Lost to Follow-up|7|||
42346428|NCT01395784|76185364|FG000|Overall Study|Withdrawal by Subject|3|||
42346429|NCT01395784|76185364|FG000|Overall Study|Physician Decision|5|||
42005004|NCT01021813|75812916|FG002|DB Treatment Phase|Lack of Efficacy|0|||
42005005|NCT01021813|75812917|FG003|DB Treatment Phase|Lack of Efficacy|0|||
42137474|NCT00440310|75947779|FG001|Overall Study|Lost to Follow-up|5|||
42137475|NCT00440310|75947778|FG000|Overall Study|Protocol Violation|0|||
42137476|NCT00440310|75947779|FG001|Overall Study|Protocol Violation|1|||
42137477|NCT00440310|75947778|FG000|Overall Study|Withdrawal by Subject|15|||
42137478|NCT00440310|75947779|FG001|Overall Study|Withdrawal by Subject|14|||
42137479|NCT00440310|75947778|FG000|Overall Study|No Reply at EOS|7|||
42137480|NCT00440310|75947779|FG001|Overall Study|No Reply at EOS|7|||
42137481|NCT00440310|75947778|FG000|Overall Study|Other|1|||
42137482|NCT00440310|75947779|FG001|Overall Study|Other|0|||
42005006|NCT01021813|75812918|FG004|DB Treatment Phase|Lack of Efficacy|0|||
42005007|NCT01021813|75812914|FG000|DB Treatment Phase|Lost to Follow-up|14|||
42005008|NCT01021813|75812915|FG001|DB Treatment Phase|Lost to Follow-up|12|||
42005009|NCT01021813|75812916|FG002|DB Treatment Phase|Lost to Follow-up|0|||
42346430|NCT01380184|76185368|FG000|Part 1 (19 Days)|Adverse Event|1|||
42005010|NCT01021813|75812917|FG003|DB Treatment Phase|Lost to Follow-up|0|||
42005011|NCT01021813|75812918|FG004|DB Treatment Phase|Lost to Follow-up|0|||
42005012|NCT01021813|75812914|FG000|DB Treatment Phase|Physician Decision|17|||
42005013|NCT01021813|75812915|FG001|DB Treatment Phase|Physician Decision|8|||
42346431|NCT01380184|76185368|FG000|Part 2|Adverse Event|5|||
42005014|NCT01021813|75812916|FG002|DB Treatment Phase|Physician Decision|0|||
42137483|NCT00440310|75947778|FG000|Overall Study|Status Unknown|1|||
42271895|NCT02925338|76101987|FG004|Overall Study|Missing|2|||
42271896|NCT02925338|76101983|FG000|Overall Study|Participant's Decision|11|||
42271897|NCT02925338|76101984|FG001|Overall Study|Participant's Decision|7|||
42271898|NCT02925338|76101985|FG002|Overall Study|Participant's Decision|3|||
42271899|NCT02925338|76101986|FG003|Overall Study|Participant's Decision|8|||
42271900|NCT02925338|76101987|FG004|Overall Study|Participant's Decision|1|||
42271901|NCT02925338|76101983|FG000|Overall Study|Treatment Discontinuation|144|||
42271902|NCT02925338|76101984|FG001|Overall Study|Treatment Discontinuation|65|||
42271903|NCT02925338|76101985|FG002|Overall Study|Treatment Discontinuation|56|||
42271904|NCT02925338|76101986|FG003|Overall Study|Treatment Discontinuation|131|||
42271905|NCT02925338|76101987|FG004|Overall Study|Treatment Discontinuation|22|||
42271906|NCT02543528|76102005|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
42271907|NCT02543528|76102006|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
42271908|NCT02543528|76102007|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
42271909|NCT02543528|76102008|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
42271910|NCT02543528|76102009|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
42271911|NCT02543528|76102005|FG000|Adaptation Period|Lens Handling Difficultes|0|||
42271912|NCT02543528|76102006|FG001|Adaptation Period|Lens Handling Difficultes|0|||
42271913|NCT02543528|76102007|FG002|Adaptation Period|Lens Handling Difficultes|0|||
42271914|NCT02543528|76102008|FG003|Adaptation Period|Lens Handling Difficultes|0|||
42271915|NCT02543528|76102009|FG004|Adaptation Period|Lens Handling Difficultes|8|||
42271916|NCT02543528|76102005|FG000|Adaptation Period|Lost to Follow-up|0|||
42271917|NCT02543528|76102006|FG001|Adaptation Period|Lost to Follow-up|0|||
42271918|NCT02543528|76102007|FG002|Adaptation Period|Lost to Follow-up|0|||
42271919|NCT02543528|76102008|FG003|Adaptation Period|Lost to Follow-up|0|||
42271920|NCT02543528|76102009|FG004|Adaptation Period|Lost to Follow-up|14|||
42271921|NCT02543528|76102005|FG000|Adaptation Period|Adverse Event|0|||
42271922|NCT02543528|76102006|FG001|Adaptation Period|Adverse Event|0|||
42271923|NCT02543528|76102007|FG002|Adaptation Period|Adverse Event|0|||
42271924|NCT02543528|76102008|FG003|Adaptation Period|Adverse Event|0|||
42271925|NCT02543528|76102009|FG004|Adaptation Period|Adverse Event|2|||
42271926|NCT02543528|76102005|FG000|Extended Wear Period|Adverse Event|17|||
42271927|NCT02543528|76102006|FG001|Extended Wear Period|Adverse Event|11|||
42271928|NCT02543528|76102007|FG002|Extended Wear Period|Adverse Event|16|||
42271929|NCT02543528|76102008|FG003|Extended Wear Period|Adverse Event|3|||
42271930|NCT02543528|76102009|FG004|Extended Wear Period|Adverse Event|0|||
42271931|NCT02543528|76102005|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
42271932|NCT02543528|76102006|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
42271933|NCT02543528|76102007|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
42271934|NCT02543528|76102008|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
42271935|NCT02543528|76102009|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
42346432|NCT01380184|76185368|FG000|Part 2|Disease Progression|8|||
42346433|NCT01380184|76185368|FG000|Part 2|Lost to Follow-up|1|||
42271936|NCT02543528|76102005|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
42271937|NCT02543528|76102006|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
42271938|NCT02543528|76102007|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
42271939|NCT02543528|76102008|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
42271940|NCT02543528|76102009|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
42271941|NCT02543528|76102005|FG000|Extended Wear Period|Lost to Follow-up|0|||
42271942|NCT02543528|76102006|FG001|Extended Wear Period|Lost to Follow-up|1|||
42271943|NCT02543528|76102007|FG002|Extended Wear Period|Lost to Follow-up|2|||
42271944|NCT02543528|76102008|FG003|Extended Wear Period|Lost to Follow-up|1|||
42271945|NCT02543528|76102009|FG004|Extended Wear Period|Lost to Follow-up|0|||
42346434|NCT01395394|76185375|FG000|Baseline Study Visit|Protocol Violation|1|||
42271946|NCT02543528|76102005|FG000|Extended Wear Period|Withdrawal by Subject|10|||
42271947|NCT02543528|76102006|FG001|Extended Wear Period|Withdrawal by Subject|9|||
42271948|NCT02543528|76102007|FG002|Extended Wear Period|Withdrawal by Subject|4|||
42346435|NCT01395394|76185376|FG001|Baseline Study Visit|Protocol Violation|0|||
42137484|NCT00440310|75947779|FG001|Overall Study|Status Unknown|3|||
42137485|NCT00440232|75947787|FG000|Overall Study|Lost to Follow-up|1|||
42271949|NCT02543528|76102008|FG003|Extended Wear Period|Withdrawal by Subject|5|||
42271950|NCT02543528|76102009|FG004|Extended Wear Period|Withdrawal by Subject|0|||
42137486|NCT00440232|75947788|FG001|Overall Study|Lost to Follow-up|1|||
42271951|NCT00156533|76102027|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
42271952|NCT00156533|76102028|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
42346436|NCT01395394|76185377|FG002|Baseline Study Visit|Protocol Violation|0|||
42346437|NCT01395316|76185385|FG000|Overall Study|Lost to Follow-up|2|||
42346438|NCT01395316|76185385|FG000|Overall Study|poor MRI quality|1|||
42346439|NCT01742091|76185395|FG000|Overall Study|Adverse Event|0|||
42346440|NCT01742091|76185396|FG001|Overall Study|Adverse Event|0|||
42346441|NCT01742091|76185397|FG002|Overall Study|Adverse Event|0|||
42346442|NCT01742091|76185398|FG003|Overall Study|Adverse Event|0|||
42346443|NCT01742091|76185399|FG004|Overall Study|Adverse Event|1|||
42346444|NCT01742091|76185400|FG005|Overall Study|Adverse Event|0|||
42346445|NCT01742091|76185395|FG000|Overall Study|Physician Decision|0|||
42346446|NCT01742091|76185396|FG001|Overall Study|Physician Decision|0|||
42346447|NCT01742091|76185397|FG002|Overall Study|Physician Decision|0|||
42346448|NCT01742091|76185398|FG003|Overall Study|Physician Decision|0|||
42346449|NCT01742091|76185399|FG004|Overall Study|Physician Decision|0|||
42346450|NCT01742091|76185400|FG005|Overall Study|Physician Decision|1|||
42346451|NCT01742091|76185395|FG000|Overall Study|Withdrawal by Subject|0|||
42346452|NCT01742091|76185396|FG001|Overall Study|Withdrawal by Subject|0|||
42346453|NCT01742091|76185397|FG002|Overall Study|Withdrawal by Subject|0|||
42346454|NCT01742091|76185398|FG003|Overall Study|Withdrawal by Subject|1|||
42346455|NCT01742091|76185399|FG004|Overall Study|Withdrawal by Subject|0|||
42346456|NCT01742091|76185400|FG005|Overall Study|Withdrawal by Subject|0|||
42346457|NCT01742091|76185395|FG000|Overall Study|Lost to Follow-up|0|||
42346458|NCT01742091|76185396|FG001|Overall Study|Lost to Follow-up|0|||
42346459|NCT01742091|76185397|FG002|Overall Study|Lost to Follow-up|0|||
42346460|NCT01742091|76185398|FG003|Overall Study|Lost to Follow-up|0|||
42346461|NCT01742091|76185399|FG004|Overall Study|Lost to Follow-up|0|||
42346462|NCT01742091|76185400|FG005|Overall Study|Lost to Follow-up|1|||
42346463|NCT01731951|76185420|FG000|Overall Study|Documented Disease Progression|1|||
42346464|NCT01731951|76185421|FG001|Overall Study|Documented Disease Progression|0|||
42346465|NCT01731951|76185422|FG002|Overall Study|Documented Disease Progression|0|||
42346466|NCT01731951|76185423|FG003|Overall Study|Documented Disease Progression|0|||
42346467|NCT01731951|76185424|FG004|Overall Study|Documented Disease Progression|0|||
42346468|NCT01731951|76185425|FG005|Overall Study|Documented Disease Progression|0|||
42271953|NCT00156533|76102029|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
42271954|NCT00156533|76102030|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
42346469|NCT01731951|76185420|FG000|Overall Study|Lost to Follow-up|2|||
42346470|NCT01731951|76185421|FG001|Overall Study|Lost to Follow-up|0|||
42271955|NCT00156533|76102027|FG000|Overall Study|Withdrawal by Subject|1|||
42271956|NCT00156533|76102028|FG001|Overall Study|Withdrawal by Subject|0|||
42271957|NCT00156533|76102029|FG002|Overall Study|Withdrawal by Subject|0|||
42271958|NCT00156533|76102030|FG003|Overall Study|Withdrawal by Subject|1|||
42271959|NCT00156533|76102027|FG000|Overall Study|Failed Screening|1|||
42271960|NCT00156533|76102028|FG001|Overall Study|Failed Screening|0|||
42271961|NCT00156533|76102029|FG002|Overall Study|Failed Screening|1|||
42271962|NCT00156533|76102030|FG003|Overall Study|Failed Screening|1|||
42346471|NCT01731951|76185422|FG002|Overall Study|Lost to Follow-up|0|||
42346472|NCT01731951|76185423|FG003|Overall Study|Lost to Follow-up|1|||
42346473|NCT01731951|76185424|FG004|Overall Study|Lost to Follow-up|3|||
42346474|NCT01731951|76185425|FG005|Overall Study|Lost to Follow-up|1|||
42346475|NCT01731951|76185420|FG000|Overall Study|Withdrawal of Consent|1|||
42346476|NCT01731951|76185421|FG001|Overall Study|Withdrawal of Consent|0|||
42346477|NCT01731951|76185422|FG002|Overall Study|Withdrawal of Consent|0|||
42346478|NCT01731951|76185423|FG003|Overall Study|Withdrawal of Consent|0|||
42346479|NCT01731951|76185424|FG004|Overall Study|Withdrawal of Consent|0|||
42346480|NCT01731951|76185425|FG005|Overall Study|Withdrawal of Consent|2|||
42346481|NCT01731951|76185420|FG000|Overall Study|Death|13|||
42346482|NCT01731951|76185421|FG001|Overall Study|Death|15|||
42346483|NCT01731951|76185422|FG002|Overall Study|Death|9|||
42346484|NCT01731951|76185423|FG003|Overall Study|Death|8|||
42346485|NCT01731951|76185424|FG004|Overall Study|Death|9|||
42005015|NCT01021813|75812917|FG003|DB Treatment Phase|Physician Decision|0|||
42005016|NCT01021813|75812918|FG004|DB Treatment Phase|Physician Decision|0|||
42005017|NCT01021813|75812914|FG000|DB Treatment Phase|Pregnancy|1|||
42005018|NCT01021813|75812915|FG001|DB Treatment Phase|Pregnancy|0|||
42271963|NCT01660022|76102048|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
42271964|NCT01660022|76102049|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
42271965|NCT01660022|76102050|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
42271966|NCT01660022|76102051|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
42005019|NCT01021813|75812916|FG002|DB Treatment Phase|Pregnancy|0|||
42005020|NCT01021813|75812917|FG003|DB Treatment Phase|Pregnancy|0|||
42005021|NCT01021813|75812918|FG004|DB Treatment Phase|Pregnancy|0|||
42005022|NCT01021813|75812914|FG000|DB Treatment Phase|Protocol Violation|4|||
42005023|NCT01021813|75812915|FG001|DB Treatment Phase|Protocol Violation|3|||
42005024|NCT01021813|75812916|FG002|DB Treatment Phase|Protocol Violation|0|||
42005025|NCT01021813|75812917|FG003|DB Treatment Phase|Protocol Violation|0|||
42005026|NCT01021813|75812918|FG004|DB Treatment Phase|Protocol Violation|0|||
42005027|NCT01021813|75812914|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
42005028|NCT01021813|75812915|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
42005029|NCT01021813|75812916|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
42005030|NCT01021813|75812917|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
42005031|NCT01021813|75812918|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
42005032|NCT01021813|75812914|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
42005033|NCT01021813|75812915|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
42005034|NCT01021813|75812916|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
42005035|NCT01021813|75812917|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
42271967|NCT01660022|76102052|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
42271968|NCT01660022|76102053|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
42271969|NCT01660022|76102048|FG000|First Sequence (7 Days)|Adverse Event|0|||
42005036|NCT01021813|75812918|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
42005037|NCT01021813|75812914|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
42005038|NCT01021813|75812915|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
42005039|NCT01021813|75812916|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
42005040|NCT01021813|75812917|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
42005041|NCT01021813|75812918|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
42005042|NCT01021813|75812914|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
42005043|NCT01021813|75812915|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
42005044|NCT01021813|75812916|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
42005045|NCT01021813|75812917|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
42271970|NCT01660022|76102049|FG001|First Sequence (7 Days)|Adverse Event|0|||
42271971|NCT01660022|76102050|FG002|First Sequence (7 Days)|Adverse Event|0|||
42271972|NCT01660022|76102051|FG003|First Sequence (7 Days)|Adverse Event|0|||
42005046|NCT01021813|75812918|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
42005047|NCT01021813|75812914|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
42005048|NCT01021813|75812915|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
42005049|NCT01021813|75812916|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
42005050|NCT01021813|75812917|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
42005051|NCT01021813|75812918|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
42005052|NCT01021813|75812914|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
42005053|NCT01021813|75812915|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
42005054|NCT01021813|75812916|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
42005055|NCT01021813|75812917|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
42005056|NCT01021813|75812918|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
42005057|NCT01025635|75812937|FG000|Overall Study|Withdrawal by Subject|6|||
42005058|NCT01025635|75812938|FG001|Overall Study|Withdrawal by Subject|7|||
42005059|NCT01025635|75812937|FG000|Overall Study|Protocol Violation|4|||
42005060|NCT01025635|75812938|FG001|Overall Study|Protocol Violation|2|||
42005061|NCT01025635|75812937|FG000|Overall Study|Lack of Efficacy|0|||
42005062|NCT01025635|75812938|FG001|Overall Study|Lack of Efficacy|1|||
42005063|NCT01025635|75812937|FG000|Overall Study|Lost to Follow-up|9|||
42005064|NCT01025635|75812938|FG001|Overall Study|Lost to Follow-up|13|||
42005065|NCT01025635|75812937|FG000|Overall Study|Reason not known|4|||
42005066|NCT01025635|75812938|FG001|Overall Study|Reason not known|2|||
42005067|NCT01021423|75812946|FG000|Overall Study|Study terminated|4|||
42005068|NCT01021423|75812947|FG001|Overall Study|Study terminated|5|||
42005069|NCT01020877|75812955|FG000|Second Intervention|Withdrawal by Subject|1|||
42005070|NCT01020877|75812956|FG001|Second Intervention|Withdrawal by Subject|0|||
42005071|NCT01020799|75812965|FG000|Overall Study|Adverse Event|4|||
42005072|NCT01020799|75812966|FG001|Overall Study|Adverse Event|3|||
42005073|NCT01020799|75812967|FG002|Overall Study|Adverse Event|2|||
42005074|NCT01020799|75812965|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
42005075|NCT01020799|75812966|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
42005076|NCT01020799|75812967|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
42005077|NCT01020799|75812965|FG000|Overall Study|Protocol Violation|3|||
42005078|NCT01020799|75812966|FG001|Overall Study|Protocol Violation|2|||
42005079|NCT01020799|75812967|FG002|Overall Study|Protocol Violation|0|||
42005080|NCT01020799|75812965|FG000|Overall Study|Withdrawal by Subject|2|||
42005081|NCT01020799|75812966|FG001|Overall Study|Withdrawal by Subject|2|||
42005082|NCT01020799|75812967|FG002|Overall Study|Withdrawal by Subject|3|||
42005083|NCT01020799|75812965|FG000|Overall Study|Lost to Follow-up|6|||
42005084|NCT01020799|75812966|FG001|Overall Study|Lost to Follow-up|4|||
42005085|NCT01020799|75812967|FG002|Overall Study|Lost to Follow-up|2|||
42346486|NCT01731951|76185425|FG005|Overall Study|Death|6|||
42346487|NCT01731171|76185445|FG000|Overall Study|Withdrawal by Subject|4|||
42346488|NCT01731171|76185446|FG001|Overall Study|Withdrawal by Subject|1|||
42346489|NCT01731171|76185445|FG000|Overall Study|Lost to Follow-up|3|||
42346490|NCT01731171|76185446|FG001|Overall Study|Lost to Follow-up|2|||
42346491|NCT01731171|76185445|FG000|Overall Study|Moved out of Area|0|||
42346492|NCT01731171|76185446|FG001|Overall Study|Moved out of Area|2|||
42346493|NCT01731171|76185445|FG000|Overall Study|Terminated for Lack of Adherence|0|||
42346494|NCT01731171|76185446|FG001|Overall Study|Terminated for Lack of Adherence|1|||
42346495|NCT01731171|76185445|FG000|Overall Study|Terminated for Safety Reasons|0|||
42346496|NCT01731171|76185446|FG001|Overall Study|Terminated for Safety Reasons|1|||
42346497|NCT01741701|76185454|FG000|Overall Study|Adverse Event|5|||
42346498|NCT01741701|76185455|FG001|Overall Study|Adverse Event|1|||
42346499|NCT01741701|76185454|FG000|Overall Study|Withdrawal by Subject|0|||
42346500|NCT01741701|76185455|FG001|Overall Study|Withdrawal by Subject|1|||
42346501|NCT01741545|76185463|FG000|Treatment Period|Lack of Efficacy|0|||
42346502|NCT01741545|76185464|FG001|Treatment Period|Lack of Efficacy|1|||
42346503|NCT01741545|76185463|FG000|Treatment Period|Adverse event, non-fatal|1|||
42346504|NCT01741545|76185464|FG001|Treatment Period|Adverse event, non-fatal|3|||
42346505|NCT01741545|76185463|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
42346506|NCT01741545|76185464|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
42346507|NCT01741545|76185463|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
42346508|NCT01741545|76185464|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
42346509|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
42346510|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
42346511|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
42346512|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
42346513|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
42005086|NCT01288989|75812980|FG000|Overall Study|Death|0|||
42005087|NCT01288989|75812981|FG001|Overall Study|Death|0|||
42137487|NCT00440232|75947787|FG000|Overall Study|Unable to treat within allowed time|0|||
42137488|NCT00440232|75947788|FG001|Overall Study|Unable to treat within allowed time|1|||
42137489|NCT00440232|75947787|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
42137490|NCT00440232|75947788|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
42137491|NCT00356889|75947794|FG000|Overall Study|Protocol Violation|2|||
42137492|NCT00356889|75947794|FG000|Overall Study|Adverse Event|1|||
42137493|NCT00356811|75947799|FG000|Overall Study|Death|35|||
42137494|NCT00356811|75947799|FG000|Overall Study|Lost to Follow-up|2|||
42137495|NCT00356811|75947799|FG000|Overall Study|Withdrawal by Subject|6|||
42137496|NCT00356811|75947799|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
42137497|NCT00356811|75947799|FG000|Overall Study|Study Is Terminating|3|||
42137498|NCT00356811|75947799|FG000|Overall Study|Site Closed during Follow-up|2|||
42137499|NCT00439218|75947804|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
42137500|NCT00535223|75947823|FG000|Overall Study|Withdrawal by Subject|4|||
42137501|NCT00535223|75947824|FG001|Overall Study|Withdrawal by Subject|1|||
42137502|NCT00536939|75947830|FG000|Overall Study|Withdrawal by Subject|1|||
42137503|NCT00536939|75947831|FG001|Overall Study|Withdrawal by Subject|0|||
42137504|NCT00536939|75947830|FG000|Overall Study|Other Complicating Disease|1|||
42137505|NCT00536939|75947831|FG001|Overall Study|Other Complicating Disease|0|||
42137506|NCT00347919|75947839|FG000|Overall Study|Lost to Follow-up|11|||
42137507|NCT00347919|75947840|FG001|Overall Study|Lost to Follow-up|13|||
42137508|NCT00347919|75947841|FG002|Overall Study|Lost to Follow-up|0|||
42137509|NCT00347919|75947839|FG000|Overall Study|Withdrawal by Subject|6|||
42271973|NCT01660022|76102052|FG004|First Sequence (7 Days)|Adverse Event|1|||
42271974|NCT01660022|76102053|FG005|First Sequence (7 Days)|Adverse Event|3|||
42137510|NCT00347919|75947840|FG001|Overall Study|Withdrawal by Subject|8|||
42137511|NCT00347919|75947841|FG002|Overall Study|Withdrawal by Subject|0|||
42137512|NCT00347919|75947839|FG000|Overall Study|Physician Decision|1|||
42137513|NCT00347919|75947840|FG001|Overall Study|Physician Decision|1|||
42137514|NCT00347919|75947841|FG002|Overall Study|Physician Decision|0|||
42137515|NCT00347919|75947839|FG000|Overall Study|Sponsor terminated study|15|||
42137516|NCT00347919|75947840|FG001|Overall Study|Sponsor terminated study|10|||
42137517|NCT00347919|75947841|FG002|Overall Study|Sponsor terminated study|16|||
42346514|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
42005088|NCT01288989|75812982|FG002|Overall Study|Death|0|||
42005089|NCT01288989|75812983|FG003|Overall Study|Death|1|||
42005090|NCT01288989|75812984|FG004|Overall Study|Death|0|||
42346515|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
42346516|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
42346517|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
42346518|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
42005091|NCT01288989|75812980|FG000|Overall Study|Dose limiting toxicity|1|||
42005092|NCT01288989|75812981|FG001|Overall Study|Dose limiting toxicity|0|||
42005093|NCT01288989|75812982|FG002|Overall Study|Dose limiting toxicity|0|||
42005094|NCT01288989|75812983|FG003|Overall Study|Dose limiting toxicity|0|||
42005095|NCT01288989|75812984|FG004|Overall Study|Dose limiting toxicity|0|||
42005096|NCT01288989|75812980|FG000|Overall Study|Adverse Event|0|||
42005097|NCT01288989|75812981|FG001|Overall Study|Adverse Event|0|||
42005098|NCT01288989|75812982|FG002|Overall Study|Adverse Event|0|||
42035368|NCT03387514|75843686|FG000|Overall Study|Withdrawal by Subject|2|||
42346519|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
42005099|NCT01288989|75812983|FG003|Overall Study|Adverse Event|0|||
42005100|NCT01288989|75812984|FG004|Overall Study|Adverse Event|2|||
42005101|NCT01288989|75812980|FG000|Overall Study|Physician Decision|0|||
42005102|NCT01288989|75812981|FG001|Overall Study|Physician Decision|0|||
42005103|NCT01288989|75812982|FG002|Overall Study|Physician Decision|0|||
42005104|NCT01288989|75812983|FG003|Overall Study|Physician Decision|0|||
42005105|NCT01288989|75812984|FG004|Overall Study|Physician Decision|1|||
42137518|NCT00347919|75947839|FG000|Overall Study|Death|35|||
42271975|NCT01660022|76102048|FG000|First Sequence (7 Days)|Protocol Violation|0|||
42346520|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
42346521|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
42271976|NCT01660022|76102049|FG001|First Sequence (7 Days)|Protocol Violation|0|||
42271977|NCT01660022|76102050|FG002|First Sequence (7 Days)|Protocol Violation|0|||
42271978|NCT01660022|76102051|FG003|First Sequence (7 Days)|Protocol Violation|0|||
42271979|NCT01660022|76102052|FG004|First Sequence (7 Days)|Protocol Violation|0|||
42005106|NCT01288989|75812980|FG000|Overall Study|Withdrawal by Subject|0|||
42005107|NCT01288989|75812981|FG001|Overall Study|Withdrawal by Subject|0|||
42137519|NCT00347919|75947840|FG001|Overall Study|Death|42|||
42271980|NCT01660022|76102053|FG005|First Sequence (7 Days)|Protocol Violation|1|||
42271981|NCT00156065|76102082|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
42005108|NCT01288989|75812982|FG002|Overall Study|Withdrawal by Subject|0|||
42005109|NCT01288989|75812983|FG003|Overall Study|Withdrawal by Subject|0|||
42005110|NCT01288989|75812984|FG004|Overall Study|Withdrawal by Subject|3|||
42035369|NCT03387514|75843686|FG000|Overall Study|Physician Decision|1|||
42005111|NCT01020487|75813005|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
42005112|NCT01020487|75813006|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
42005113|NCT01020487|75813007|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
42005114|NCT01020487|75813005|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
42137520|NCT00347919|75947841|FG002|Overall Study|Death|19|||
42137521|NCT00347919|75947839|FG000|Overall Study|Par. Started Other Treatment|1|||
42137522|NCT00347919|75947840|FG001|Overall Study|Par. Started Other Treatment|1|||
42035370|NCT03387514|75843686|FG000|Overall Study|Lost to Follow-up|2|||
42035371|NCT01022580|75843701|FG000|Overall Study|Death|18|||
42035372|NCT01022580|75843702|FG001|Overall Study|Death|22|||
42035373|NCT01107353|75843716|FG000|Overall Study|Positive Drug Screen|1|||
42035374|NCT01107353|75843717|FG001|Overall Study|Positive Drug Screen|0|||
42035375|NCT01107197|75843725|FG000|Overall Study|Death|12|||
42035376|NCT01107197|75843726|FG001|Overall Study|Death|10|||
42035377|NCT01107197|75843725|FG000|Overall Study|Lost to Follow-up|5|||
42035378|NCT01107197|75843726|FG001|Overall Study|Lost to Follow-up|8|||
42271982|NCT00156065|76102083|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
42035379|NCT01107197|75843725|FG000|Overall Study|Withdrawal by Subject|3|||
42035380|NCT01107197|75843726|FG001|Overall Study|Withdrawal by Subject|5|||
42035381|NCT01112579|75843743|FG000|Overall Study|Missed Visit|1|||
42137523|NCT00347919|75947841|FG002|Overall Study|Par. Started Other Treatment|1|||
42137524|NCT00347919|75947839|FG000|Overall Study|Missing|2|||
42137525|NCT00347919|75947840|FG001|Overall Study|Missing|1|||
42137526|NCT00347919|75947841|FG002|Overall Study|Missing|2|||
42137527|NCT00439140|75947854|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
42137528|NCT00439140|75947855|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
42137529|NCT00439140|75947856|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
42137530|NCT00439140|75947854|FG000|Treatment Cycle 1|Personal reasons|0|||
42137531|NCT00439140|75947855|FG001|Treatment Cycle 1|Personal reasons|2|||
42137532|NCT00439140|75947856|FG002|Treatment Cycle 1|Personal reasons|0|||
42137533|NCT00439140|75947854|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
42137534|NCT00439140|75947855|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
42137535|NCT00439140|75947856|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
42137536|NCT00439140|75947854|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
42137537|NCT00439140|75947855|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
42137538|NCT00439140|75947856|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
42137539|NCT00439140|75947854|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
42005115|NCT01020487|75813006|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
42005116|NCT01020487|75813007|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
42005117|NCT01020487|75813005|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
42005118|NCT01020487|75813006|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
42005119|NCT01020487|75813007|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
42005120|NCT01020487|75813005|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
42005121|NCT01020487|75813006|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
42005122|NCT01020487|75813007|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
42005123|NCT01020487|75813005|FG000|Part 2 Open-label Period|Adverse Event|0|||
42005124|NCT01020487|75813006|FG001|Part 2 Open-label Period|Adverse Event|4|||
42005125|NCT01020487|75813007|FG002|Part 2 Open-label Period|Adverse Event|1|||
42005126|NCT01024855|75813017|FG000|Overall Study|Inclusion/exclusion criteria|1|||
42005127|NCT01014013|75813024|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
42005128|NCT01014013|75813025|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
42005129|NCT01014013|75813024|FG000|Overall Study|Clinical adverse experience|4|||
42005130|NCT01014013|75813025|FG001|Overall Study|Clinical adverse experience|2|||
42005131|NCT01014013|75813024|FG000|Overall Study|Laboratory adverse experience|1|||
42005132|NCT01014013|75813025|FG001|Overall Study|Laboratory adverse experience|1|||
42005133|NCT01014013|75813024|FG000|Overall Study|Protocol Violation|1|||
42005134|NCT01014013|75813025|FG001|Overall Study|Protocol Violation|3|||
42346522|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
42346523|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
42346524|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
42346525|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
42346526|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
42346527|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
42346528|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
42346529|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
42346530|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
42346531|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
42346532|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
42346533|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
42346988|NCT01874145|76186029|FG000|Extension Period|Lost to Follow-up|1|||
42005135|NCT01014013|75813024|FG000|Overall Study|Withdrawal by Subject|7|||
42005136|NCT01014013|75813025|FG001|Overall Study|Withdrawal by Subject|4|||
42005137|NCT01014013|75813024|FG000|Overall Study|Clinical/microbiologic failure|1|||
42137540|NCT00439140|75947855|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
42346534|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
42346535|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
42346536|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
42346537|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
42346538|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
42346539|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
42346540|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
42346541|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
42346542|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
42346543|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
42346544|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
42346545|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
42346546|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
42346547|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
42346548|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
42346549|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
42346550|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
42346551|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
42346552|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
42346553|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
42346554|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
42346555|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
42346556|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
42346557|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
42346558|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
42346559|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
42346560|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
42346561|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
42346562|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
42346563|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
42346564|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
42346565|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
42346566|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
42346567|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
42346568|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
42346569|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
42346570|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
42346571|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
42346572|NCT01884350|76185472|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
42346573|NCT01884350|76185473|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
42346574|NCT01884350|76185474|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
42035382|NCT01112579|75843744|FG001|Overall Study|Missed Visit|1|||
42035383|NCT01112579|75843743|FG000|Overall Study|Death|0|||
42346575|NCT01614795|76185488|FG000|Overall Study|Adverse Event|0|||
42346576|NCT01614795|76185489|FG001|Overall Study|Adverse Event|0|||
42346577|NCT01614795|76185490|FG002|Overall Study|Adverse Event|1|||
42346578|NCT01614795|76185491|FG003|Overall Study|Adverse Event|1|||
42346579|NCT01614795|76185488|FG000|Overall Study|Lack of Efficacy|10|||
42346580|NCT01614795|76185489|FG001|Overall Study|Lack of Efficacy|10|||
42346581|NCT01614795|76185490|FG002|Overall Study|Lack of Efficacy|9|||
42346582|NCT01614795|76185491|FG003|Overall Study|Lack of Efficacy|8|||
42346583|NCT01614795|76185488|FG000|Overall Study|Physician Decision|1|||
42346584|NCT01614795|76185489|FG001|Overall Study|Physician Decision|0|||
42346585|NCT01614795|76185490|FG002|Overall Study|Physician Decision|1|||
42346586|NCT01614795|76185491|FG003|Overall Study|Physician Decision|1|||
42346587|NCT01614795|76185488|FG000|Overall Study|Withdrawal by Subject|0|||
42005138|NCT01014013|75813025|FG001|Overall Study|Clinical/microbiologic failure|2|||
42005139|NCT01014013|75813024|FG000|Overall Study|Pathogen culture = no growth|26|||
42005140|NCT01014013|75813025|FG001|Overall Study|Pathogen culture = no growth|34|||
42005141|NCT01014013|75813024|FG000|Overall Study|Negative urine culture|2|||
42005142|NCT01014013|75813025|FG001|Overall Study|Negative urine culture|0|||
42005143|NCT01014013|75813024|FG000|Overall Study|Pathogen resistant|7|||
42005144|NCT01014013|75813025|FG001|Overall Study|Pathogen resistant|4|||
42005145|NCT01014013|75813024|FG000|Overall Study|Physician Decision|0|||
42005146|NCT01014013|75813025|FG001|Overall Study|Physician Decision|1|||
42005147|NCT01014013|75813024|FG000|Overall Study|Another antibiotic therapy required|0|||
42005148|NCT01014013|75813025|FG001|Overall Study|Another antibiotic therapy required|1|||
42005149|NCT01014013|75813024|FG000|Overall Study|Appendectomy|1|||
42005150|NCT01014013|75813025|FG001|Overall Study|Appendectomy|0|||
42005151|NCT01014013|75813024|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
42005152|NCT01014013|75813025|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
42005153|NCT01013701|75813033|FG000|Overall Study|study prematurely terminated|7|||
42137541|NCT00439140|75947856|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
42137542|NCT00356421|75947866|FG000|Overall Study|Lack of Efficacy|3|||
42137543|NCT00356421|75947867|FG001|Overall Study|Lack of Efficacy|0|||
42005154|NCT01020019|75813040|FG000|Overall Study|Lost to Follow-up|21|||
42005155|NCT01020019|75813041|FG001|Overall Study|Lost to Follow-up|18|||
42005156|NCT01020019|75813040|FG000|Overall Study|Adverse Event|1|||
42137544|NCT00356421|75947866|FG000|Overall Study|Withdrawal by Subject|9|||
42346588|NCT01614795|76185489|FG001|Overall Study|Withdrawal by Subject|1|||
42346589|NCT01614795|76185490|FG002|Overall Study|Withdrawal by Subject|0|||
42137545|NCT00356421|75947867|FG001|Overall Study|Withdrawal by Subject|2|||
42137546|NCT00356421|75947866|FG000|Overall Study|Related to study drug|15|||
42137547|NCT00356421|75947867|FG001|Overall Study|Related to study drug|12|||
42137548|NCT00356421|75947866|FG000|Overall Study|Not related to study drug|5|||
42005157|NCT01020019|75813041|FG001|Overall Study|Adverse Event|5|||
42005158|NCT01020019|75813040|FG000|Overall Study|not interested in treatment|4|||
42005159|NCT01020019|75813041|FG001|Overall Study|not interested in treatment|4|||
42137549|NCT00356421|75947867|FG001|Overall Study|Not related to study drug|3|||
42346590|NCT01614795|76185491|FG003|Overall Study|Withdrawal by Subject|2|||
42346591|NCT01614795|76185488|FG000|Overall Study|Ineligible|0|||
42346592|NCT01614795|76185489|FG001|Overall Study|Ineligible|1|||
42346593|NCT01614795|76185490|FG002|Overall Study|Ineligible|0|||
42346594|NCT01614795|76185491|FG003|Overall Study|Ineligible|0|||
42346595|NCT01834586|76185502|FG000|Overall Study|Adverse Event|1|||
42346596|NCT01614249|76185508|FG000|Overall Study|Lost to Follow-up|11|||
42346597|NCT01614249|76185509|FG001|Overall Study|Lost to Follow-up|23|||
42346598|NCT01597778|76185517|FG000|Overall Study|Death|7|||
42346599|NCT01597778|76185518|FG001|Overall Study|Death|10|||
42346600|NCT01597778|76185517|FG000|Overall Study|Withdrawal by Subject|3|||
42346601|NCT01597778|76185518|FG001|Overall Study|Withdrawal by Subject|4|||
42346602|NCT01597778|76185517|FG000|Overall Study|Adverse Event|1|||
42346603|NCT01597778|76185518|FG001|Overall Study|Adverse Event|1|||
42346604|NCT01597778|76185517|FG000|Overall Study|Protocol Violation|1|||
42346605|NCT01597778|76185518|FG001|Overall Study|Protocol Violation|11|||
42346606|NCT01597778|76185517|FG000|Overall Study|Transplanted off protocol|2|||
42346607|NCT01597778|76185518|FG001|Overall Study|Transplanted off protocol|3|||
42346608|NCT01614093|76185524|FG000|Overall Study|Withdrawal by Subject|1|||
42346609|NCT01834274|76185531|FG000|Overall Study|Study Termination|41|||
42346610|NCT01834274|76185532|FG001|Overall Study|Study Termination|38|||
42346611|NCT01834274|76185531|FG000|Overall Study|Withdrawal by Subject|1|||
42005160|NCT01020019|75813040|FG000|Overall Study|moving|0|||
42005161|NCT01020019|75813041|FG001|Overall Study|moving|2|||
42005162|NCT01024465|75813047|FG000|Overall Study|Adverse Event|2|||
42005163|NCT01024465|75813047|FG000|Overall Study|Physician Decision|1|||
42346612|NCT01834274|76185532|FG001|Overall Study|Withdrawal by Subject|1|||
42346613|NCT01834274|76185531|FG000|Overall Study|Lost to Follow-up|3|||
42346614|NCT01834274|76185532|FG001|Overall Study|Lost to Follow-up|1|||
42346615|NCT01834274|76185531|FG000|Overall Study|Other|2|||
42005164|NCT01024387|75813051|FG000|Overall Study|Radiographic Progression|29|||
42005165|NCT01024387|75813051|FG000|Overall Study|Symptomatic Progression|10|||
42005166|NCT01024387|75813051|FG000|Overall Study|Physician Decision|5|||
42005167|NCT01024387|75813051|FG000|Overall Study|Withdrawal by Subject|5|||
42005168|NCT01024387|75813051|FG000|Overall Study|Death|2|||
42005169|NCT01024387|75813051|FG000|Overall Study|Prolonged Treatment Delay|1|||
42005170|NCT01024387|75813051|FG000|Overall Study|Adverse Event|3|||
42005171|NCT01024387|75813051|FG000|Overall Study|Other|5|||
42005172|NCT01019317|75813055|FG000|Overall Study|Not Eligible|4|||
42005173|NCT01024309|75813061|FG000|Overall Study|Physician Decision|4|||
42005174|NCT01024309|75813062|FG001|Overall Study|Physician Decision|0|||
42005175|NCT01024309|75813061|FG000|Overall Study|Withdrawal by Subject|4|||
42005176|NCT01024309|75813062|FG001|Overall Study|Withdrawal by Subject|4|||
42005177|NCT01090492|75813076|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
42005178|NCT01090492|75813077|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
42005179|NCT01090492|75813078|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
42005180|NCT01090492|75813079|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
42005181|NCT01090492|75813080|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
42005182|NCT01090492|75813081|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
42005183|NCT01090492|75813082|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
42005184|NCT01090492|75813083|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
42005185|NCT01090492|75813076|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
42346616|NCT01834274|76185532|FG001|Overall Study|Other|1|||
42346617|NCT01739595|76185541|FG000|Overall Study|Adverse Event|3|||
42346618|NCT01739595|76185542|FG001|Overall Study|Adverse Event|0|||
42346619|NCT01739595|76185543|FG002|Overall Study|Adverse Event|0|||
42346620|NCT01739595|76185541|FG000|Overall Study|Lost to Follow-up|2|||
42346621|NCT01739595|76185542|FG001|Overall Study|Lost to Follow-up|0|||
42346622|NCT01739595|76185543|FG002|Overall Study|Lost to Follow-up|0|||
42346623|NCT01739595|76185541|FG000|Overall Study|Withdrawal by Subject|2|||
42346624|NCT01739595|76185542|FG001|Overall Study|Withdrawal by Subject|1|||
42005186|NCT01090492|75813077|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
42005187|NCT01090492|75813078|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
42005188|NCT01090492|75813079|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
42005189|NCT01090492|75813080|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
42005190|NCT01090492|75813081|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
42005191|NCT01090492|75813082|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
42005192|NCT01090492|75813083|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
42346625|NCT01739595|76185543|FG002|Overall Study|Withdrawal by Subject|2|||
42005193|NCT01090492|75813076|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005194|NCT01090492|75813077|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005195|NCT01090492|75813078|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
42005196|NCT01090492|75813079|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42035384|NCT01112579|75843744|FG001|Overall Study|Death|2|||
42346626|NCT01739595|76185541|FG000|Overall Study|Eligibility issue|3|||
42346627|NCT01739595|76185542|FG001|Overall Study|Eligibility issue|0|||
42346628|NCT01739595|76185543|FG002|Overall Study|Eligibility issue|0|||
42346629|NCT01739595|76185541|FG000|Overall Study|Protocol Violation|1|||
42005197|NCT01090492|75813080|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005198|NCT01090492|75813081|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005199|NCT01090492|75813082|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005200|NCT01090492|75813083|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005201|NCT01090492|75813076|FG000|First Intervention Period (4 Weeks)|Other|0|||
42005202|NCT01090492|75813077|FG001|First Intervention Period (4 Weeks)|Other|0|||
42005203|NCT01090492|75813078|FG002|First Intervention Period (4 Weeks)|Other|1|||
42005204|NCT01090492|75813079|FG003|First Intervention Period (4 Weeks)|Other|1|||
42005205|NCT01090492|75813080|FG004|First Intervention Period (4 Weeks)|Other|2|||
42005206|NCT01090492|75813081|FG005|First Intervention Period (4 Weeks)|Other|0|||
42005207|NCT01090492|75813082|FG006|First Intervention Period (4 Weeks)|Other|0|||
42005208|NCT01090492|75813083|FG007|First Intervention Period (4 Weeks)|Other|0|||
42005209|NCT01090492|75813076|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
42005210|NCT01090492|75813077|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
42005211|NCT01090492|75813078|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
42005212|NCT01090492|75813079|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
42005213|NCT01090492|75813080|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
42005214|NCT01090492|75813081|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
42005215|NCT01090492|75813082|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
42137550|NCT00443820|75947877|FG000|Overall Study|Adverse Event|1|||
42005216|NCT01090492|75813083|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
42005217|NCT01090492|75813076|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
42005218|NCT01090492|75813077|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
42005219|NCT01090492|75813078|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
42005220|NCT01090492|75813079|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
42005221|NCT01090492|75813080|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
42005222|NCT01090492|75813081|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
42005223|NCT01090492|75813082|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
42005224|NCT01090492|75813083|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
42005225|NCT01090492|75813076|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
42005226|NCT01090492|75813077|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
42005227|NCT01090492|75813078|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
42005228|NCT01090492|75813079|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
42005229|NCT01090492|75813080|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
42005230|NCT01090492|75813081|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
42005231|NCT01090492|75813082|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
42005232|NCT01090492|75813083|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
42005233|NCT01090492|75813076|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
42005234|NCT01090492|75813077|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
42005235|NCT01090492|75813078|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
42005236|NCT01090492|75813079|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
42005237|NCT01090492|75813080|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
42005238|NCT01090492|75813081|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
42005239|NCT01090492|75813082|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
42005240|NCT01090492|75813083|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
42005241|NCT01090492|75813076|FG000|Second Intervention Period (4 Weeks)|Other|0|||
42005242|NCT01090492|75813077|FG001|Second Intervention Period (4 Weeks)|Other|1|||
42005243|NCT01090492|75813078|FG002|Second Intervention Period (4 Weeks)|Other|1|||
42005244|NCT01090492|75813079|FG003|Second Intervention Period (4 Weeks)|Other|0|||
42005245|NCT01090492|75813080|FG004|Second Intervention Period (4 Weeks)|Other|0|||
42005246|NCT01090492|75813081|FG005|Second Intervention Period (4 Weeks)|Other|0|||
42005247|NCT01090492|75813082|FG006|Second Intervention Period (4 Weeks)|Other|0|||
42005248|NCT01090492|75813083|FG007|Second Intervention Period (4 Weeks)|Other|0|||
42005249|NCT01090492|75813076|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
42005250|NCT01090492|75813077|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
42005251|NCT01090492|75813078|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
42005252|NCT01090492|75813079|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
42005253|NCT01090492|75813080|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
42005254|NCT01090492|75813081|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
42005255|NCT01090492|75813082|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
42005256|NCT01090492|75813083|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
42005257|NCT01090492|75813076|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005258|NCT01090492|75813077|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005259|NCT01090492|75813078|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005260|NCT01090492|75813079|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005261|NCT01090492|75813080|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005262|NCT01090492|75813081|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005263|NCT01090492|75813082|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
42005264|NCT01090492|75813083|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
42005265|NCT01288911|75813104|FG000|Double-blind Period|Death|11|||
42005266|NCT01288911|75813105|FG001|Double-blind Period|Death|7|||
42005267|NCT01288911|75813104|FG000|Double-blind Period|Lost to Follow-up|0|||
42005268|NCT01288911|75813105|FG001|Double-blind Period|Lost to Follow-up|2|||
42005269|NCT01288911|75813104|FG000|Double-blind Period|Progressive Disease|75|||
42035385|NCT01112267|75843752|FG000|Overall Study|Adverse Event|24|||
42005270|NCT01288911|75813105|FG001|Double-blind Period|Progressive Disease|103|||
42005271|NCT01288911|75813104|FG000|Double-blind Period|Protocol Violation|1|||
42005272|NCT01288911|75813105|FG001|Double-blind Period|Protocol Violation|0|||
42005273|NCT01288911|75813104|FG000|Double-blind Period|Withdrawal by Subject|25|||
42005274|NCT01288911|75813105|FG001|Double-blind Period|Withdrawal by Subject|26|||
42005275|NCT01288911|75813104|FG000|Double-blind Period|Miscellaneous Reason|29|||
42005276|NCT01288911|75813105|FG001|Double-blind Period|Miscellaneous Reason|42|||
42005277|NCT01288911|75813104|FG000|Double-blind Period|Randomized but never received study drug|1|||
42005278|NCT01288911|75813105|FG001|Double-blind Period|Randomized but never received study drug|2|||
42005279|NCT01288911|75813104|FG000|Open-label Period (All Enzalutamide)|Death|0|||
42005280|NCT01288911|75813105|FG001|Open-label Period (All Enzalutamide)|Death|1|||
42005281|NCT01288911|75813104|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
42005282|NCT01288911|75813105|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
42271983|NCT00156065|76102084|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
42005283|NCT01288911|75813104|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
42005284|NCT01288911|75813105|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
42005285|NCT01288911|75813104|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
42005286|NCT01288911|75813105|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
42005287|NCT01288911|75813104|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
42005288|NCT01288911|75813105|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
42005289|NCT01288911|75813104|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
42005290|NCT01288911|75813105|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
42005291|NCT01288443|75813120|FG000|Overall Study|Adverse Event|0|||
42005292|NCT01288443|75813121|FG001|Overall Study|Adverse Event|0|||
42005293|NCT01288443|75813122|FG002|Overall Study|Adverse Event|1|||
42005294|NCT01288443|75813123|FG003|Overall Study|Adverse Event|1|||
42005295|NCT01288443|75813124|FG004|Overall Study|Adverse Event|3|||
42005296|NCT01288443|75813125|FG005|Overall Study|Adverse Event|1|||
42005297|NCT01288443|75813120|FG000|Overall Study|Poor compliance to protocol|0|||
42005298|NCT01288443|75813121|FG001|Overall Study|Poor compliance to protocol|0|||
42005299|NCT01288443|75813122|FG002|Overall Study|Poor compliance to protocol|0|||
42005300|NCT01288443|75813123|FG003|Overall Study|Poor compliance to protocol|0|||
42005301|NCT01288443|75813124|FG004|Overall Study|Poor compliance to protocol|0|||
42005302|NCT01288443|75813125|FG005|Overall Study|Poor compliance to protocol|1|||
42005303|NCT01288443|75813120|FG000|Overall Study|Participant Moved|0|||
42005304|NCT01288443|75813121|FG001|Overall Study|Participant Moved|0|||
42005305|NCT01288443|75813122|FG002|Overall Study|Participant Moved|0|||
42005306|NCT01288443|75813123|FG003|Overall Study|Participant Moved|1|||
42005307|NCT01288443|75813124|FG004|Overall Study|Participant Moved|2|||
42005308|NCT01288443|75813125|FG005|Overall Study|Participant Moved|1|||
42005309|NCT01288443|75813120|FG000|Overall Study|Consent withdrawn by Participant|0|||
42005310|NCT01288443|75813121|FG001|Overall Study|Consent withdrawn by Participant|0|||
42005311|NCT01288443|75813122|FG002|Overall Study|Consent withdrawn by Participant|0|||
42005312|NCT01288443|75813123|FG003|Overall Study|Consent withdrawn by Participant|0|||
42005313|NCT01288443|75813124|FG004|Overall Study|Consent withdrawn by Participant|0|||
42005314|NCT01288443|75813125|FG005|Overall Study|Consent withdrawn by Participant|1|||
42005315|NCT01288443|75813120|FG000|Overall Study|Lost to Follow-up|0|||
42005316|NCT01288443|75813121|FG001|Overall Study|Lost to Follow-up|1|||
42005317|NCT01288443|75813122|FG002|Overall Study|Lost to Follow-up|0|||
42005318|NCT01288443|75813123|FG003|Overall Study|Lost to Follow-up|0|||
42005319|NCT01288443|75813124|FG004|Overall Study|Lost to Follow-up|0|||
42005320|NCT01288443|75813125|FG005|Overall Study|Lost to Follow-up|0|||
42005321|NCT01288443|75813120|FG000|Overall Study|Study drug auto-injector administration|0|||
42005322|NCT01288443|75813121|FG001|Overall Study|Study drug auto-injector administration|0|||
42005323|NCT01288443|75813122|FG002|Overall Study|Study drug auto-injector administration|0|||
42005324|NCT01288443|75813123|FG003|Overall Study|Study drug auto-injector administration|0|||
42005325|NCT01288443|75813124|FG004|Overall Study|Study drug auto-injector administration|1|||
42005326|NCT01288443|75813125|FG005|Overall Study|Study drug auto-injector administration|1|||
42005327|NCT01288443|75813120|FG000|Overall Study|Other than above|0|||
42005328|NCT01288443|75813121|FG001|Overall Study|Other than above|0|||
42005329|NCT01288443|75813122|FG002|Overall Study|Other than above|0|||
42005330|NCT01288443|75813123|FG003|Overall Study|Other than above|2|||
42005331|NCT01288443|75813124|FG004|Overall Study|Other than above|1|||
42005332|NCT01288443|75813125|FG005|Overall Study|Other than above|0|||
42005333|NCT01288287|75813139|FG000|Overall Study|Lost to Follow-up|8|||
42005334|NCT01288287|75813139|FG000|Overall Study|Withdrawal by Subject|4|||
42005335|NCT01288287|75813139|FG000|Overall Study|Lack of Efficacy|13|||
42005336|NCT01288287|75813139|FG000|Overall Study|Other Reason|13|||
42005337|NCT01288287|75813139|FG000|Overall Study|Unknown Reason|1|||
42005338|NCT01288287|75813139|FG000|Overall Study|Unknown Status|7|||
42005339|NCT01288209|75813146|FG000|Overall Study|Withdrawal by Subject|1|||
42005340|NCT01288209|75813147|FG001|Overall Study|Withdrawal by Subject|3|||
42005341|NCT01288209|75813146|FG000|Overall Study|Other|1|||
42035386|NCT01112267|75843753|FG001|Overall Study|Adverse Event|6|||
42035387|NCT01112267|75843752|FG000|Overall Study|Withdrawal by Subject|3|||
42035388|NCT01112267|75843753|FG001|Overall Study|Withdrawal by Subject|5|||
42005342|NCT01288209|75813147|FG001|Overall Study|Other|0|||
42005343|NCT01288053|75813153|FG000|Overall Study|Death|1|||
42005344|NCT01287195|75813157|FG000|Overall Study|Withdrawal by Subject|2|||
42005345|NCT01287117|75813165|FG000|Overall Study|Adverse Event|2|||
42005346|NCT01287117|75813166|FG001|Overall Study|Adverse Event|1|||
42005347|NCT01287117|75813167|FG002|Overall Study|Adverse Event|1|||
42005348|NCT01287117|75813168|FG003|Overall Study|Adverse Event|1|||
42005349|NCT01287117|75813165|FG000|Overall Study|Lost to Follow-up|1|||
42005350|NCT01287117|75813166|FG001|Overall Study|Lost to Follow-up|1|||
42005351|NCT01287117|75813167|FG002|Overall Study|Lost to Follow-up|0|||
42005352|NCT01287117|75813168|FG003|Overall Study|Lost to Follow-up|0|||
42005353|NCT01287117|75813165|FG000|Overall Study|Physician Decision|0|||
42035389|NCT01112267|75843752|FG000|Overall Study|Protocol Violation|5|||
42035390|NCT01112267|75843753|FG001|Overall Study|Protocol Violation|3|||
42005354|NCT01287117|75813166|FG001|Overall Study|Physician Decision|1|||
42005355|NCT01287117|75813167|FG002|Overall Study|Physician Decision|1|||
42005356|NCT01287117|75813168|FG003|Overall Study|Physician Decision|1|||
42005357|NCT01287117|75813165|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
42005358|NCT01287117|75813166|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
42005359|NCT01287117|75813167|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
42005360|NCT01287117|75813168|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
42005361|NCT01287117|75813165|FG000|Overall Study|Disease Progression|10|||
42005362|NCT01287117|75813166|FG001|Overall Study|Disease Progression|5|||
42005363|NCT01287117|75813167|FG002|Overall Study|Disease Progression|6|||
42005364|NCT01287117|75813168|FG003|Overall Study|Disease Progression|5|||
42005365|NCT01287039|75813180|FG000|Overall Study|Noncompliance with study procedures|0|||
42005366|NCT01287039|75813181|FG001|Overall Study|Noncompliance with study procedures|1|||
42005367|NCT01287039|75813180|FG000|Overall Study|Change of location/residence|0|||
42005368|NCT01287039|75813181|FG001|Overall Study|Change of location/residence|3|||
42005369|NCT01287039|75813180|FG000|Overall Study|Elective surgery|0|||
42005370|NCT01287039|75813181|FG001|Overall Study|Elective surgery|1|||
42005371|NCT01287039|75813180|FG000|Overall Study|Protocol Violation|2|||
42005372|NCT01287039|75813181|FG001|Overall Study|Protocol Violation|3|||
42005373|NCT01287039|75813180|FG000|Overall Study|Excluded medication taken|1|||
42005374|NCT01287039|75813181|FG001|Overall Study|Excluded medication taken|0|||
42005375|NCT01287039|75813180|FG000|Overall Study|Noncompliance with study medication|0|||
42005376|NCT01287039|75813181|FG001|Overall Study|Noncompliance with study medication|1|||
42005377|NCT01287039|75813180|FG000|Overall Study|Problem with travel|0|||
42005378|NCT01287039|75813181|FG001|Overall Study|Problem with travel|1|||
42005379|NCT01287039|75813180|FG000|Overall Study|Death|1|||
42005380|NCT01287039|75813181|FG001|Overall Study|Death|0|||
42005381|NCT01287039|75813180|FG000|Overall Study|Change of residence|1|||
42005382|NCT01287039|75813181|FG001|Overall Study|Change of residence|0|||
42005383|NCT01287039|75813180|FG000|Overall Study|Adverse Event|7|||
42005384|NCT01287039|75813181|FG001|Overall Study|Adverse Event|4|||
42005385|NCT01287039|75813180|FG000|Overall Study|Withdrawal by Subject|14|||
42005386|NCT01287039|75813181|FG001|Overall Study|Withdrawal by Subject|11|||
42005387|NCT01287039|75813180|FG000|Overall Study|Lost to Follow-up|3|||
42005388|NCT01287039|75813181|FG001|Overall Study|Lost to Follow-up|2|||
42005389|NCT01285401|75813189|FG000|Overall Study|Prematurely withdrawn from the study|17|||
42005390|NCT01285401|75813190|FG001|Overall Study|Prematurely withdrawn from the study|29|||
42005391|NCT01285323|75813198|FG000|Overall Study|Adverse Event|9|||
42005392|NCT01285323|75813199|FG001|Overall Study|Adverse Event|8|||
42005393|NCT01285323|75813198|FG000|Overall Study|Lack of Efficacy|4|||
42005394|NCT01285323|75813199|FG001|Overall Study|Lack of Efficacy|2|||
42005395|NCT01285323|75813198|FG000|Overall Study|Withdrawal by Subject|15|||
42005396|NCT01285323|75813199|FG001|Overall Study|Withdrawal by Subject|11|||
42005397|NCT01285323|75813198|FG000|Overall Study|Protocol Violation|1|||
42005398|NCT01285323|75813199|FG001|Overall Study|Protocol Violation|2|||
42005399|NCT01285323|75813198|FG000|Overall Study|Non-compliance with study procedures|2|||
42005400|NCT01285323|75813199|FG001|Overall Study|Non-compliance with study procedures|3|||
42005401|NCT01285323|75813198|FG000|Overall Study|Lost to Follow-up|1|||
42005402|NCT01285323|75813199|FG001|Overall Study|Lost to Follow-up|1|||
42005403|NCT01285323|75813198|FG000|Overall Study|Other|1|||
42005404|NCT01285323|75813199|FG001|Overall Study|Other|3|||
42005405|NCT01284621|75813205|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
42005406|NCT01284621|75813206|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
42005407|NCT01284621|75813207|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
42005408|NCT01284621|75813208|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
42005409|NCT01284621|75813209|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
42005410|NCT01284621|75813210|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
42005411|NCT01283139|75813224|FG000|Overall Study|Lost to Follow-up|5|||
42005412|NCT01283139|75813225|FG001|Overall Study|Lost to Follow-up|2|||
42005413|NCT01283139|75813226|FG002|Overall Study|Lost to Follow-up|3|||
42005414|NCT01283139|75813227|FG003|Overall Study|Lost to Follow-up|1|||
42005415|NCT01283139|75813224|FG000|Overall Study|Withdrawal by Subject|8|||
42005416|NCT01283139|75813225|FG001|Overall Study|Withdrawal by Subject|8|||
42005417|NCT01283139|75813226|FG002|Overall Study|Withdrawal by Subject|6|||
42005418|NCT01283139|75813227|FG003|Overall Study|Withdrawal by Subject|8|||
42005419|NCT01283139|75813224|FG000|Overall Study|Death|2|||
42005420|NCT01283139|75813225|FG001|Overall Study|Death|0|||
42005421|NCT01283139|75813226|FG002|Overall Study|Death|2|||
42005422|NCT01283139|75813227|FG003|Overall Study|Death|2|||
42005423|NCT01283139|75813224|FG000|Overall Study|Lack of Efficacy|1|||
42005424|NCT01283139|75813225|FG001|Overall Study|Lack of Efficacy|2|||
42005425|NCT01283139|75813226|FG002|Overall Study|Lack of Efficacy|2|||
42005426|NCT01283139|75813227|FG003|Overall Study|Lack of Efficacy|1|||
42005427|NCT01283139|75813224|FG000|Overall Study|Early termination due to AE/SAE|1|||
42005428|NCT01283139|75813225|FG001|Overall Study|Early termination due to AE/SAE|1|||
42005429|NCT01283139|75813226|FG002|Overall Study|Early termination due to AE/SAE|0|||
42005430|NCT01283139|75813227|FG003|Overall Study|Early termination due to AE/SAE|0|||
42005431|NCT01283139|75813224|FG000|Overall Study|Participant's refusal to continue|0|||
42005432|NCT01283139|75813225|FG001|Overall Study|Participant's refusal to continue|3|||
42005433|NCT01283139|75813226|FG002|Overall Study|Participant's refusal to continue|1|||
42005434|NCT01283139|75813227|FG003|Overall Study|Participant's refusal to continue|1|||
42005435|NCT01283139|75813224|FG000|Overall Study|Pregnancy|0|||
42005436|NCT01283139|75813225|FG001|Overall Study|Pregnancy|1|||
42005437|NCT01283139|75813226|FG002|Overall Study|Pregnancy|1|||
42005438|NCT01283139|75813227|FG003|Overall Study|Pregnancy|0|||
42005439|NCT01283139|75813224|FG000|Overall Study|Missed follow-up visit|0|||
42005440|NCT01283139|75813225|FG001|Overall Study|Missed follow-up visit|1|||
42005441|NCT01283139|75813226|FG002|Overall Study|Missed follow-up visit|2|||
42005442|NCT01283139|75813227|FG003|Overall Study|Missed follow-up visit|2|||
42005443|NCT01283139|75813224|FG000|Overall Study|Participant randomized in error|0|||
42005444|NCT01283139|75813225|FG001|Overall Study|Participant randomized in error|0|||
42005445|NCT01283139|75813226|FG002|Overall Study|Participant randomized in error|1|||
42005446|NCT01283139|75813227|FG003|Overall Study|Participant randomized in error|0|||
42005447|NCT01282203|75813237|FG000|Overall Study|Adverse Event|1|||
42005448|NCT01281969|75813246|FG000|Overall Study|not randomized didn't meet criteria|0|||
42005449|NCT01281969|75813247|FG001|Overall Study|not randomized didn't meet criteria|0|||
42005450|NCT01281969|75813248|FG002|Overall Study|not randomized didn't meet criteria|7|||
42005451|NCT01281969|75813246|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
42005452|NCT01281969|75813247|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
42005453|NCT01281969|75813248|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
42005454|NCT01281969|75813246|FG000|Overall Study|not randomized, child consent not given|0|||
42005455|NCT01281969|75813247|FG001|Overall Study|not randomized, child consent not given|0|||
42005456|NCT01281969|75813248|FG002|Overall Study|not randomized, child consent not given|2|||
42005457|NCT01281813|75813259|FG000|Overall Study|Adverse Event|0|||
42005458|NCT01281813|75813260|FG001|Overall Study|Adverse Event|0|||
42005459|NCT01281813|75813261|FG002|Overall Study|Adverse Event|10|||
42005460|NCT01281813|75813259|FG000|Overall Study|Lost to Follow-up|0|||
42005461|NCT01281813|75813260|FG001|Overall Study|Lost to Follow-up|0|||
42005462|NCT01281813|75813261|FG002|Overall Study|Lost to Follow-up|31|||
42005463|NCT01281813|75813259|FG000|Overall Study|Withdrawal by Subject|0|||
42005464|NCT01281813|75813260|FG001|Overall Study|Withdrawal by Subject|0|||
42005465|NCT01281813|75813261|FG002|Overall Study|Withdrawal by Subject|13|||
42005466|NCT01281813|75813259|FG000|Overall Study|Subject Non-Compliant|0|||
42005467|NCT01281813|75813260|FG001|Overall Study|Subject Non-Compliant|0|||
42005468|NCT01281813|75813261|FG002|Overall Study|Subject Non-Compliant|6|||
42005469|NCT01281813|75813259|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
42005470|NCT01281813|75813260|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
42005471|NCT01281813|75813261|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
42005472|NCT01281813|75813259|FG000|Overall Study|Sponsor's Decision|4|||
42005473|NCT01281813|75813260|FG001|Overall Study|Sponsor's Decision|3|||
42005474|NCT01281813|75813261|FG002|Overall Study|Sponsor's Decision|7|||
42005475|NCT01281813|75813259|FG000|Overall Study|Switched to Commercially Available Medication|0|||
42005476|NCT01281813|75813260|FG001|Overall Study|Switched to Commercially Available Medication|0|||
42005477|NCT01281813|75813261|FG002|Overall Study|Switched to Commercially Available Medication|26|||
42005478|NCT01281813|75813259|FG000|Overall Study|Other|0|||
42005479|NCT01281813|75813260|FG001|Overall Study|Other|1|||
42346630|NCT01739595|76185542|FG001|Overall Study|Protocol Violation|0|||
42346631|NCT01739595|76185543|FG002|Overall Study|Protocol Violation|0|||
42346632|NCT01739595|76185541|FG000|Overall Study|Lab assessment|1|||
42005480|NCT01281813|75813261|FG002|Overall Study|Other|39|||
42005481|NCT01090414|75813273|FG000|Study 101-99|Progressive Disease|28|||
42005482|NCT01090414|75813274|FG001|Study 101-99|Progressive Disease|48|||
42005483|NCT01090414|75813275|FG002|Study 101-99|Progressive Disease|10|||
42005484|NCT01090414|75813276|FG003|Study 101-99|Progressive Disease|4|||
42005485|NCT01090414|75813273|FG000|Study 101-99|Adverse Event|10|||
42005486|NCT01090414|75813274|FG001|Study 101-99|Adverse Event|28|||
42005487|NCT01090414|75813275|FG002|Study 101-99|Adverse Event|18|||
42005488|NCT01090414|75813276|FG003|Study 101-99|Adverse Event|0|||
42005489|NCT01090414|75813273|FG000|Study 101-99|Investigator Request|1|||
42005490|NCT01090414|75813274|FG001|Study 101-99|Investigator Request|11|||
42005491|NCT01090414|75813275|FG002|Study 101-99|Investigator Request|4|||
42005492|NCT01090414|75813276|FG003|Study 101-99|Investigator Request|0|||
42005493|NCT01090414|75813273|FG000|Study 101-99|Death|3|||
42005494|NCT01090414|75813274|FG001|Study 101-99|Death|8|||
42005495|NCT01090414|75813275|FG002|Study 101-99|Death|1|||
42005496|NCT01090414|75813276|FG003|Study 101-99|Death|0|||
42005497|NCT01090414|75813273|FG000|Study 101-99|Sponsor Discontinued Study|0|||
42005498|NCT01090414|75813274|FG001|Study 101-99|Sponsor Discontinued Study|7|||
42005499|NCT01090414|75813275|FG002|Study 101-99|Sponsor Discontinued Study|5|||
42005500|NCT01090414|75813276|FG003|Study 101-99|Sponsor Discontinued Study|0|||
42005501|NCT01090414|75813273|FG000|Study 101-99|Other (Unknown Reasons)|3|||
42005502|NCT01090414|75813274|FG001|Study 101-99|Other (Unknown Reasons)|3|||
42005503|NCT01090414|75813275|FG002|Study 101-99|Other (Unknown Reasons)|0|||
42005504|NCT01090414|75813276|FG003|Study 101-99|Other (Unknown Reasons)|0|||
42005505|NCT01090414|75813273|FG000|Study 101-99|Withdrew Consent|0|||
42005506|NCT01090414|75813274|FG001|Study 101-99|Withdrew Consent|2|||
42005507|NCT01090414|75813275|FG002|Study 101-99|Withdrew Consent|3|||
42005508|NCT01090414|75813276|FG003|Study 101-99|Withdrew Consent|1|||
42005509|NCT01090414|75813273|FG000|Study 101-99|Participant Request|3|||
42005510|NCT01090414|75813274|FG001|Study 101-99|Participant Request|1|||
42005511|NCT01090414|75813275|FG002|Study 101-99|Participant Request|0|||
42005512|NCT01090414|75813276|FG003|Study 101-99|Participant Request|0|||
42005513|NCT01090102|75813300|FG000|First 12 Weeks|Withdrawal by Subject|1|||
42005514|NCT01090102|75813301|FG001|First 12 Weeks|Withdrawal by Subject|1|||
42005515|NCT01090102|75813300|FG000|First 12 Weeks|Adverse Event|2|||
42005516|NCT01090102|75813301|FG001|First 12 Weeks|Adverse Event|0|||
42005517|NCT01090102|75813300|FG000|First 12 Weeks|Death|1|||
42005518|NCT01090102|75813301|FG001|First 12 Weeks|Death|1|||
42005519|NCT01090102|75813300|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
42005520|NCT01090102|75813301|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
42005521|NCT01287897|75813311|FG000|Overall Study|Adverse Event|5|||
42005522|NCT01287897|75813312|FG001|Overall Study|Adverse Event|3|||
42005523|NCT01287897|75813313|FG002|Overall Study|Adverse Event|6|||
42005524|NCT01287897|75813314|FG003|Overall Study|Adverse Event|4|||
42005525|NCT01287897|75813311|FG000|Overall Study|Lack of Efficacy|2|||
42005526|NCT01287897|75813312|FG001|Overall Study|Lack of Efficacy|0|||
42005527|NCT01287897|75813313|FG002|Overall Study|Lack of Efficacy|0|||
42005528|NCT01287897|75813314|FG003|Overall Study|Lack of Efficacy|0|||
42005529|NCT01287897|75813311|FG000|Overall Study|Protocol Violation|1|||
42005530|NCT01287897|75813312|FG001|Overall Study|Protocol Violation|1|||
42005531|NCT01287897|75813313|FG002|Overall Study|Protocol Violation|0|||
42005532|NCT01287897|75813314|FG003|Overall Study|Protocol Violation|1|||
42005533|NCT01287897|75813311|FG000|Overall Study|Lost to Follow-up|0|||
42005534|NCT01287897|75813312|FG001|Overall Study|Lost to Follow-up|0|||
42005535|NCT01287897|75813313|FG002|Overall Study|Lost to Follow-up|2|||
42005536|NCT01287897|75813314|FG003|Overall Study|Lost to Follow-up|0|||
42005537|NCT01287897|75813311|FG000|Overall Study|Withdrawal by Subject|1|||
42005538|NCT01287897|75813312|FG001|Overall Study|Withdrawal by Subject|5|||
42005539|NCT01287897|75813313|FG002|Overall Study|Withdrawal by Subject|3|||
42005540|NCT01287897|75813314|FG003|Overall Study|Withdrawal by Subject|2|||
42005541|NCT01287897|75813311|FG000|Overall Study|Not consented properly|0|||
42005542|NCT01287897|75813312|FG001|Overall Study|Not consented properly|1|||
42005543|NCT01287897|75813313|FG002|Overall Study|Not consented properly|0|||
42005544|NCT01287897|75813314|FG003|Overall Study|Not consented properly|0|||
42005545|NCT01287897|75813311|FG000|Overall Study|Not meeting entrance criteria|1|||
42005546|NCT01287897|75813312|FG001|Overall Study|Not meeting entrance criteria|1|||
42005547|NCT01287897|75813313|FG002|Overall Study|Not meeting entrance criteria|0|||
42005548|NCT01287897|75813314|FG003|Overall Study|Not meeting entrance criteria|0|||
42005549|NCT01287897|75813311|FG000|Overall Study|Other|1|||
42005550|NCT01287897|75813312|FG001|Overall Study|Other|0|||
42005551|NCT01287897|75813313|FG002|Overall Study|Other|1|||
42005552|NCT01287897|75813314|FG003|Overall Study|Other|0|||
42005553|NCT01090024|75813328|FG000|Period 1|Met exclusion criteria|0|||
42005554|NCT01090024|75813329|FG001|Period 1|Met exclusion criteria|0|||
42005555|NCT01090024|75813330|FG002|Period 1|Met exclusion criteria|0|||
42137551|NCT00443820|75947878|FG001|Overall Study|Adverse Event|1|||
42005556|NCT01090024|75813331|FG003|Period 1|Met exclusion criteria|0|||
42005557|NCT01090024|75813332|FG004|Period 1|Met exclusion criteria|0|||
42005558|NCT01090024|75813333|FG005|Period 1|Met exclusion criteria|0|||
42005559|NCT01090024|75813334|FG006|Period 1|Met exclusion criteria|0|||
42005560|NCT01090024|75813335|FG007|Period 1|Met exclusion criteria|0|||
42005561|NCT01090024|75813336|FG008|Period 1|Met exclusion criteria|0|||
42005562|NCT01090024|75813337|FG009|Period 1|Met exclusion criteria|0|||
42005563|NCT01090024|75813338|FG010|Period 1|Met exclusion criteria|0|||
42005564|NCT01090024|75813339|FG011|Period 1|Met exclusion criteria|0|||
42005565|NCT01090024|75813340|FG012|Period 1|Met exclusion criteria|0|||
42005566|NCT01090024|75813341|FG013|Period 1|Met exclusion criteria|0|||
42005567|NCT01090024|75813342|FG014|Period 1|Met exclusion criteria|1|||
42005568|NCT01090024|75813343|FG015|Period 1|Met exclusion criteria|0|||
42005569|NCT01090024|75813344|FG016|Period 1|Met exclusion criteria|0|||
42005570|NCT01090024|75813345|FG017|Period 1|Met exclusion criteria|0|||
42005571|NCT01090024|75813328|FG000|Period 1|Adverse Event|0|||
42005572|NCT01090024|75813329|FG001|Period 1|Adverse Event|0|||
42005573|NCT01090024|75813330|FG002|Period 1|Adverse Event|0|||
42005574|NCT01090024|75813331|FG003|Period 1|Adverse Event|0|||
42005575|NCT01090024|75813332|FG004|Period 1|Adverse Event|0|||
42005576|NCT01090024|75813333|FG005|Period 1|Adverse Event|0|||
42005577|NCT01090024|75813334|FG006|Period 1|Adverse Event|0|||
42005578|NCT01090024|75813335|FG007|Period 1|Adverse Event|0|||
42005579|NCT01090024|75813336|FG008|Period 1|Adverse Event|0|||
42005580|NCT01090024|75813337|FG009|Period 1|Adverse Event|1|||
42005581|NCT01090024|75813338|FG010|Period 1|Adverse Event|0|||
42005582|NCT01090024|75813339|FG011|Period 1|Adverse Event|1|||
42005583|NCT01090024|75813340|FG012|Period 1|Adverse Event|0|||
42005584|NCT01090024|75813341|FG013|Period 1|Adverse Event|0|||
42005585|NCT01090024|75813342|FG014|Period 1|Adverse Event|0|||
42005586|NCT01090024|75813343|FG015|Period 1|Adverse Event|0|||
42005587|NCT01090024|75813344|FG016|Period 1|Adverse Event|0|||
42005588|NCT01090024|75813345|FG017|Period 1|Adverse Event|1|||
42005589|NCT01090024|75813328|FG000|Period 1|Withdrawal by Subject|0|||
42005590|NCT01090024|75813329|FG001|Period 1|Withdrawal by Subject|0|||
42005591|NCT01090024|75813330|FG002|Period 1|Withdrawal by Subject|0|||
42005592|NCT01090024|75813331|FG003|Period 1|Withdrawal by Subject|1|||
42005593|NCT01090024|75813332|FG004|Period 1|Withdrawal by Subject|0|||
42005594|NCT01090024|75813333|FG005|Period 1|Withdrawal by Subject|0|||
42005595|NCT01090024|75813334|FG006|Period 1|Withdrawal by Subject|0|||
42005596|NCT01090024|75813335|FG007|Period 1|Withdrawal by Subject|0|||
42005597|NCT01090024|75813336|FG008|Period 1|Withdrawal by Subject|0|||
42005598|NCT01090024|75813337|FG009|Period 1|Withdrawal by Subject|0|||
42005599|NCT01090024|75813338|FG010|Period 1|Withdrawal by Subject|0|||
42005600|NCT01090024|75813339|FG011|Period 1|Withdrawal by Subject|0|||
42005601|NCT01090024|75813340|FG012|Period 1|Withdrawal by Subject|0|||
42005602|NCT01090024|75813341|FG013|Period 1|Withdrawal by Subject|0|||
42005603|NCT01090024|75813342|FG014|Period 1|Withdrawal by Subject|0|||
42005604|NCT01090024|75813343|FG015|Period 1|Withdrawal by Subject|0|||
42005605|NCT01090024|75813344|FG016|Period 1|Withdrawal by Subject|0|||
42005606|NCT01090024|75813345|FG017|Period 1|Withdrawal by Subject|0|||
42005607|NCT01090024|75813328|FG000|Period 1|Lost to Follow-up|0|||
42005608|NCT01090024|75813329|FG001|Period 1|Lost to Follow-up|1|||
42005609|NCT01090024|75813330|FG002|Period 1|Lost to Follow-up|0|||
42005610|NCT01090024|75813331|FG003|Period 1|Lost to Follow-up|0|||
42005611|NCT01090024|75813332|FG004|Period 1|Lost to Follow-up|0|||
42005612|NCT01090024|75813333|FG005|Period 1|Lost to Follow-up|0|||
42005613|NCT01090024|75813334|FG006|Period 1|Lost to Follow-up|0|||
42005614|NCT01090024|75813335|FG007|Period 1|Lost to Follow-up|0|||
42005615|NCT01090024|75813336|FG008|Period 1|Lost to Follow-up|0|||
42005616|NCT01090024|75813337|FG009|Period 1|Lost to Follow-up|0|||
42005617|NCT01090024|75813338|FG010|Period 1|Lost to Follow-up|0|||
42005618|NCT01090024|75813339|FG011|Period 1|Lost to Follow-up|0|||
42005619|NCT01090024|75813340|FG012|Period 1|Lost to Follow-up|0|||
42005620|NCT01090024|75813341|FG013|Period 1|Lost to Follow-up|0|||
42005621|NCT01090024|75813342|FG014|Period 1|Lost to Follow-up|0|||
42005622|NCT01090024|75813343|FG015|Period 1|Lost to Follow-up|0|||
42005623|NCT01090024|75813344|FG016|Period 1|Lost to Follow-up|0|||
42005624|NCT01090024|75813345|FG017|Period 1|Lost to Follow-up|0|||
42005625|NCT01090024|75813328|FG000|Period 2|Lost to Follow-up|0|||
42005626|NCT01090024|75813329|FG001|Period 2|Lost to Follow-up|0|||
42005627|NCT01090024|75813330|FG002|Period 2|Lost to Follow-up|0|||
42346633|NCT01739595|76185542|FG001|Overall Study|Lab assessment|0|||
42346634|NCT01739595|76185543|FG002|Overall Study|Lab assessment|0|||
42346635|NCT01739595|76185541|FG000|Overall Study|Drug discrepancy|1|||
42346636|NCT01739595|76185542|FG001|Overall Study|Drug discrepancy|0|||
42346637|NCT01739595|76185543|FG002|Overall Study|Drug discrepancy|0|||
42346638|NCT01833494|76185550|FG000|Overall Study|Adverse Event|24|||
42005628|NCT01090024|75813331|FG003|Period 2|Lost to Follow-up|1|||
42005629|NCT01090024|75813332|FG004|Period 2|Lost to Follow-up|0|||
42005630|NCT01090024|75813333|FG005|Period 2|Lost to Follow-up|0|||
42005631|NCT01090024|75813334|FG006|Period 2|Lost to Follow-up|0|||
42005632|NCT01090024|75813335|FG007|Period 2|Lost to Follow-up|0|||
42005633|NCT01090024|75813336|FG008|Period 2|Lost to Follow-up|0|||
42005634|NCT01090024|75813337|FG009|Period 2|Lost to Follow-up|0|||
42005635|NCT01090024|75813338|FG010|Period 2|Lost to Follow-up|0|||
42005636|NCT01090024|75813339|FG011|Period 2|Lost to Follow-up|0|||
42271984|NCT00156065|76102082|FG000|Overall Study|Adverse Event|8|||
42271985|NCT00156065|76102083|FG001|Overall Study|Adverse Event|11|||
42271986|NCT00156065|76102084|FG002|Overall Study|Adverse Event|4|||
42271987|NCT00156065|76102082|FG000|Overall Study|Lack of Efficacy|2|||
42271988|NCT00156065|76102083|FG001|Overall Study|Lack of Efficacy|9|||
42271989|NCT00156065|76102084|FG002|Overall Study|Lack of Efficacy|3|||
42271990|NCT00156065|76102082|FG000|Overall Study|Withdrawal by Subject|13|||
42271991|NCT00156065|76102083|FG001|Overall Study|Withdrawal by Subject|26|||
42271992|NCT00156065|76102084|FG002|Overall Study|Withdrawal by Subject|16|||
42271993|NCT00156065|76102082|FG000|Overall Study|Lost to Follow-up|5|||
42271994|NCT00156065|76102083|FG001|Overall Study|Lost to Follow-up|7|||
42271995|NCT00156065|76102084|FG002|Overall Study|Lost to Follow-up|1|||
42271996|NCT00156065|76102082|FG000|Overall Study|Other|2|||
42271997|NCT00156065|76102083|FG001|Overall Study|Other|9|||
42271998|NCT00156065|76102084|FG002|Overall Study|Other|3|||
42271999|NCT01554956|76102095|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
42272000|NCT01554956|76102096|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
42346639|NCT01833494|76185550|FG000|Overall Study|Physician Decision|6|||
42005637|NCT01090024|75813340|FG012|Period 2|Lost to Follow-up|0|||
42005638|NCT01090024|75813341|FG013|Period 2|Lost to Follow-up|0|||
42005639|NCT01090024|75813342|FG014|Period 2|Lost to Follow-up|0|||
42005640|NCT01090024|75813343|FG015|Period 2|Lost to Follow-up|0|||
42005641|NCT01090024|75813344|FG016|Period 2|Lost to Follow-up|0|||
42005642|NCT01090024|75813345|FG017|Period 2|Lost to Follow-up|0|||
42005643|NCT01090024|75813328|FG000|Period 2|Adverse Event|1|||
42005644|NCT01090024|75813329|FG001|Period 2|Adverse Event|0|||
42005645|NCT01090024|75813330|FG002|Period 2|Adverse Event|0|||
42005646|NCT01090024|75813331|FG003|Period 2|Adverse Event|0|||
42005647|NCT01090024|75813332|FG004|Period 2|Adverse Event|0|||
42005648|NCT01090024|75813333|FG005|Period 2|Adverse Event|0|||
42005649|NCT01090024|75813334|FG006|Period 2|Adverse Event|0|||
42005650|NCT01090024|75813335|FG007|Period 2|Adverse Event|0|||
42005651|NCT01090024|75813336|FG008|Period 2|Adverse Event|0|||
42005652|NCT01090024|75813337|FG009|Period 2|Adverse Event|0|||
42005653|NCT01090024|75813338|FG010|Period 2|Adverse Event|0|||
42005654|NCT01090024|75813339|FG011|Period 2|Adverse Event|0|||
42005655|NCT01090024|75813340|FG012|Period 2|Adverse Event|0|||
42005656|NCT01090024|75813341|FG013|Period 2|Adverse Event|0|||
42005657|NCT01090024|75813342|FG014|Period 2|Adverse Event|0|||
42005658|NCT01090024|75813343|FG015|Period 2|Adverse Event|0|||
42005659|NCT01090024|75813344|FG016|Period 2|Adverse Event|0|||
42005660|NCT01090024|75813345|FG017|Period 2|Adverse Event|0|||
42005661|NCT01090024|75813328|FG000|Period 3|Withdrawal by Subject|0|||
42005662|NCT01090024|75813329|FG001|Period 3|Withdrawal by Subject|0|||
42005663|NCT01090024|75813330|FG002|Period 3|Withdrawal by Subject|0|||
42005664|NCT01090024|75813331|FG003|Period 3|Withdrawal by Subject|0|||
42005665|NCT01090024|75813332|FG004|Period 3|Withdrawal by Subject|0|||
42005666|NCT01090024|75813333|FG005|Period 3|Withdrawal by Subject|0|||
42005667|NCT01090024|75813334|FG006|Period 3|Withdrawal by Subject|0|||
42005668|NCT01090024|75813335|FG007|Period 3|Withdrawal by Subject|0|||
42005669|NCT01090024|75813336|FG008|Period 3|Withdrawal by Subject|0|||
42005670|NCT01090024|75813337|FG009|Period 3|Withdrawal by Subject|0|||
42005671|NCT01090024|75813338|FG010|Period 3|Withdrawal by Subject|0|||
42005672|NCT01090024|75813339|FG011|Period 3|Withdrawal by Subject|0|||
42005673|NCT01090024|75813340|FG012|Period 3|Withdrawal by Subject|0|||
42005674|NCT01090024|75813341|FG013|Period 3|Withdrawal by Subject|0|||
42005675|NCT01090024|75813342|FG014|Period 3|Withdrawal by Subject|0|||
42005676|NCT01090024|75813343|FG015|Period 3|Withdrawal by Subject|1|||
42005677|NCT01090024|75813344|FG016|Period 3|Withdrawal by Subject|0|||
42005678|NCT01090024|75813345|FG017|Period 3|Withdrawal by Subject|0|||
42005679|NCT01090024|75813328|FG000|Period 3|Protocol Violation|0|||
42005680|NCT01090024|75813329|FG001|Period 3|Protocol Violation|0|||
42005681|NCT01090024|75813330|FG002|Period 3|Protocol Violation|0|||
42005682|NCT01090024|75813331|FG003|Period 3|Protocol Violation|0|||
42005683|NCT01090024|75813332|FG004|Period 3|Protocol Violation|0|||
42005684|NCT01090024|75813333|FG005|Period 3|Protocol Violation|0|||
42005685|NCT01090024|75813334|FG006|Period 3|Protocol Violation|0|||
42005686|NCT01090024|75813335|FG007|Period 3|Protocol Violation|0|||
42005687|NCT01090024|75813336|FG008|Period 3|Protocol Violation|1|||
42005688|NCT01090024|75813337|FG009|Period 3|Protocol Violation|0|||
42005689|NCT01090024|75813338|FG010|Period 3|Protocol Violation|0|||
42005690|NCT01090024|75813339|FG011|Period 3|Protocol Violation|0|||
42005691|NCT01090024|75813340|FG012|Period 3|Protocol Violation|0|||
42005692|NCT01090024|75813341|FG013|Period 3|Protocol Violation|0|||
42005693|NCT01090024|75813342|FG014|Period 3|Protocol Violation|0|||
42005694|NCT01090024|75813343|FG015|Period 3|Protocol Violation|0|||
42005695|NCT01090024|75813344|FG016|Period 3|Protocol Violation|0|||
42005696|NCT01090024|75813345|FG017|Period 3|Protocol Violation|0|||
42005697|NCT01090024|75813328|FG000|Period 3|Adverse Event|0|||
42005698|NCT01090024|75813329|FG001|Period 3|Adverse Event|0|||
42005699|NCT01090024|75813330|FG002|Period 3|Adverse Event|0|||
42005700|NCT01090024|75813331|FG003|Period 3|Adverse Event|0|||
42005701|NCT01090024|75813332|FG004|Period 3|Adverse Event|0|||
42137552|NCT00443820|75947879|FG002|Overall Study|Adverse Event|0|||
42005702|NCT01090024|75813333|FG005|Period 3|Adverse Event|1|||
42005703|NCT01090024|75813334|FG006|Period 3|Adverse Event|0|||
42005704|NCT01090024|75813335|FG007|Period 3|Adverse Event|0|||
42005705|NCT01090024|75813336|FG008|Period 3|Adverse Event|0|||
42005706|NCT01090024|75813337|FG009|Period 3|Adverse Event|0|||
42005707|NCT01090024|75813338|FG010|Period 3|Adverse Event|0|||
42005708|NCT01090024|75813339|FG011|Period 3|Adverse Event|0|||
42005709|NCT01090024|75813340|FG012|Period 3|Adverse Event|0|||
42005710|NCT01090024|75813341|FG013|Period 3|Adverse Event|0|||
42005711|NCT01090024|75813342|FG014|Period 3|Adverse Event|0|||
42005712|NCT01090024|75813343|FG015|Period 3|Adverse Event|0|||
42005713|NCT01090024|75813344|FG016|Period 3|Adverse Event|0|||
42005714|NCT01090024|75813345|FG017|Period 3|Adverse Event|0|||
42005715|NCT04868890|75813357|FG000|Overall Study|Death|2|||
42005716|NCT04868890|75813358|FG001|Overall Study|Death|1|||
42005717|NCT04868890|75813357|FG000|Overall Study|Withdrawal by Subject|1|||
42005718|NCT04868890|75813358|FG001|Overall Study|Withdrawal by Subject|5|||
42005719|NCT01281189|75813366|FG000|Overall Study|Adverse Event|7|||
42005720|NCT01281189|75813367|FG001|Overall Study|Adverse Event|9|||
42005721|NCT01281189|75813366|FG000|Overall Study|Lost to Follow-up|6|||
42005722|NCT01281189|75813367|FG001|Overall Study|Lost to Follow-up|4|||
42005723|NCT01281189|75813366|FG000|Overall Study|Withdrawal by Subject|21|||
42005724|NCT01281189|75813367|FG001|Overall Study|Withdrawal by Subject|24|||
42005725|NCT01281189|75813366|FG000|Overall Study|Physician Decision|2|||
42005726|NCT01281189|75813367|FG001|Overall Study|Physician Decision|3|||
42005727|NCT01281189|75813366|FG000|Overall Study|Death|103|||
42005728|NCT01281189|75813367|FG001|Overall Study|Death|91|||
42005729|NCT01281189|75813366|FG000|Overall Study|Other|8|||
42005730|NCT01281189|75813367|FG001|Overall Study|Other|12|||
42005731|NCT01280955|75813373|FG000|Overall Study|Death|2|||
42005732|NCT01280955|75813373|FG000|Overall Study|Withdrawal by Subject|1|||
42005733|NCT01280721|75813379|FG000|Overall Study|Adverse Event|4|||
42005734|NCT01280721|75813379|FG000|Overall Study|Physician Decision|3|||
42005735|NCT01280721|75813379|FG000|Overall Study|Withdrawal by Subject|6|||
42005736|NCT01280721|75813379|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
42005737|NCT01280721|75813379|FG000|Overall Study|No tolerability for the lowest dose|2|||
42005738|NCT01087762|75813397|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
42005739|NCT01087762|75813398|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
42005740|NCT01087762|75813399|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
42005741|NCT01087762|75813400|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
42005742|NCT01087762|75813401|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
42005743|NCT01087762|75813397|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
42005744|NCT01087762|75813398|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
42005745|NCT01087762|75813399|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
42005746|NCT01087762|75813400|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
42005747|NCT01087762|75813401|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
42005748|NCT01087762|75813397|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
42005749|NCT01087762|75813398|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
42005750|NCT01087762|75813399|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
42005751|NCT01087762|75813400|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
42005752|NCT01087762|75813401|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
42005753|NCT01087762|75813397|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
42005754|NCT01087762|75813398|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
42005755|NCT01087762|75813399|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
42005756|NCT01087762|75813400|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
42005757|NCT01087762|75813401|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
42005758|NCT01087762|75813397|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
42005759|NCT01087762|75813398|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
42005760|NCT01087762|75813399|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
42005761|NCT01087762|75813400|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
42005762|NCT01087762|75813401|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
42005763|NCT01087762|75813397|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
42005764|NCT01087762|75813398|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
42005765|NCT01087762|75813399|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
42005766|NCT01087762|75813400|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
42005767|NCT01087762|75813401|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
42005768|NCT01087762|75813397|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
42137553|NCT00443820|75947880|FG003|Overall Study|Adverse Event|0|||
42137554|NCT00443820|75947877|FG000|Overall Study|Lack of Efficacy|3|||
42137555|NCT00443820|75947878|FG001|Overall Study|Lack of Efficacy|2|||
42137556|NCT00443820|75947879|FG002|Overall Study|Lack of Efficacy|1|||
42137557|NCT00443820|75947880|FG003|Overall Study|Lack of Efficacy|1|||
42005769|NCT01087762|75813398|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
42005770|NCT01087762|75813399|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
42005771|NCT01087762|75813400|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
42005772|NCT01087762|75813401|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
42005773|NCT01087762|75813397|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
42005774|NCT01087762|75813398|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
42005775|NCT01087762|75813399|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
42005776|NCT01087762|75813400|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
42005777|NCT01087762|75813401|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
42005778|NCT01087762|75813397|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
42005779|NCT01087762|75813398|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
42005780|NCT01087762|75813399|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
42035391|NCT01112267|75843752|FG000|Overall Study|Participants not compliant|1|||
42137558|NCT00443820|75947877|FG000|Overall Study|Protocol Violation|2|||
42137559|NCT00443820|75947878|FG001|Overall Study|Protocol Violation|1|||
42137560|NCT00443820|75947879|FG002|Overall Study|Protocol Violation|2|||
42137561|NCT00443820|75947880|FG003|Overall Study|Protocol Violation|1|||
42005781|NCT01087762|75813400|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
42005782|NCT01087762|75813401|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
42005783|NCT01087762|75813397|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
42005784|NCT01087762|75813398|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
42005785|NCT01087762|75813399|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
42005786|NCT01087762|75813400|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
42005787|NCT01087762|75813401|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
42005788|NCT01087762|75813397|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
42005789|NCT01087762|75813398|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
42005790|NCT01087762|75813399|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
42005791|NCT01087762|75813400|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
42005792|NCT01087762|75813401|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
42005793|NCT01087762|75813397|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
42005794|NCT01087762|75813398|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
42005795|NCT01087762|75813399|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
42005796|NCT01087762|75813400|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
42005797|NCT01087762|75813401|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
42005798|NCT01087762|75813397|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
42005799|NCT01087762|75813398|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
42005800|NCT01087762|75813399|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
42005801|NCT01087762|75813400|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
42005802|NCT01087762|75813401|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
42005803|NCT01078168|75813413|FG000|Overall Study|Physician Decision|0|||
42005804|NCT01078168|75813414|FG001|Overall Study|Physician Decision|1|||
42005805|NCT01086358|75813420|FG000|First Intervention|Lost to Follow-up|9|||
42005806|NCT01086358|75813421|FG001|First Intervention|Lost to Follow-up|4|||
42005807|NCT01086358|75813420|FG000|First Intervention|Withdrawal by Subject|0|||
42005808|NCT01086358|75813421|FG001|First Intervention|Withdrawal by Subject|1|||
42005809|NCT01086358|75813420|FG000|Second Intervention|Lost to Follow-up|4|||
42005810|NCT01086358|75813421|FG001|Second Intervention|Lost to Follow-up|4|||
42005811|NCT01277601|75813431|FG000|Overall Study|Adverse Event|5|||
42005812|NCT01277601|75813432|FG001|Overall Study|Adverse Event|3|||
42005813|NCT01277601|75813433|FG002|Overall Study|Adverse Event|0|||
42005814|NCT01277601|75813434|FG003|Overall Study|Adverse Event|7|||
42005815|NCT01277601|75813431|FG000|Overall Study|Withdrawal by Subject|18|||
42005816|NCT01277601|75813432|FG001|Overall Study|Withdrawal by Subject|21|||
42005817|NCT01277601|75813433|FG002|Overall Study|Withdrawal by Subject|8|||
42005818|NCT01277601|75813434|FG003|Overall Study|Withdrawal by Subject|17|||
42005819|NCT01277601|75813431|FG000|Overall Study|Lost to Follow-up|7|||
42005820|NCT01277601|75813432|FG001|Overall Study|Lost to Follow-up|9|||
42005821|NCT01277601|75813433|FG002|Overall Study|Lost to Follow-up|4|||
42005822|NCT01277601|75813434|FG003|Overall Study|Lost to Follow-up|2|||
42005823|NCT01277601|75813431|FG000|Overall Study|Physician Decision|3|||
42005824|NCT01277601|75813432|FG001|Overall Study|Physician Decision|5|||
42005825|NCT01277601|75813433|FG002|Overall Study|Physician Decision|1|||
42005826|NCT01277601|75813434|FG003|Overall Study|Physician Decision|6|||
42005827|NCT01277601|75813431|FG000|Overall Study|Pregnancy|2|||
42005828|NCT01277601|75813432|FG001|Overall Study|Pregnancy|2|||
42005829|NCT01277601|75813433|FG002|Overall Study|Pregnancy|4|||
42005830|NCT01277601|75813434|FG003|Overall Study|Pregnancy|1|||
42005831|NCT01277601|75813431|FG000|Overall Study|Noncompliance with Study Drug|1|||
42005832|NCT01277601|75813432|FG001|Overall Study|Noncompliance with Study Drug|3|||
42005833|NCT01277601|75813433|FG002|Overall Study|Noncompliance with Study Drug|2|||
42005834|NCT01277601|75813434|FG003|Overall Study|Noncompliance with Study Drug|0|||
42005835|NCT01277601|75813431|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
42005836|NCT01277601|75813432|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
42005837|NCT01277601|75813433|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
42005838|NCT01277601|75813434|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
42005839|NCT01277601|75813431|FG000|Overall Study|Protocol Violation|0|||
42005840|NCT01277601|75813432|FG001|Overall Study|Protocol Violation|2|||
42005841|NCT01277601|75813433|FG002|Overall Study|Protocol Violation|5|||
42005842|NCT01277601|75813434|FG003|Overall Study|Protocol Violation|0|||
42005843|NCT01277601|75813431|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
42005844|NCT01277601|75813432|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
42005845|NCT01277601|75813433|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
42005846|NCT01277601|75813434|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
42005847|NCT01277523|75813464|FG000|Overall Study|Adverse Event|1|||
42005848|NCT01277523|75813465|FG001|Overall Study|Adverse Event|0|||
42005849|NCT01277523|75813466|FG002|Overall Study|Adverse Event|0|||
42137562|NCT00443820|75947877|FG000|Overall Study|Withdrawal by Subject|6|||
42005850|NCT01277523|75813464|FG000|Overall Study|Protocol Violation|2|||
42005851|NCT01277523|75813465|FG001|Overall Study|Protocol Violation|0|||
42005852|NCT01277523|75813466|FG002|Overall Study|Protocol Violation|0|||
42005853|NCT01277523|75813464|FG000|Overall Study|Other Reason not Defined|0|||
42005854|NCT01277523|75813465|FG001|Overall Study|Other Reason not Defined|1|||
42005855|NCT01277523|75813466|FG002|Overall Study|Other Reason not Defined|0|||
42005856|NCT01081834|75813479|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
42005857|NCT01081834|75813480|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
42005858|NCT01081834|75813481|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
42005859|NCT01081834|75813482|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
42005860|NCT01081834|75813483|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
42005861|NCT01081834|75813479|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
42005862|NCT01081834|75813480|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
42005863|NCT01081834|75813481|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
42005864|NCT01081834|75813482|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
42005865|NCT01081834|75813483|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
42005866|NCT01081834|75813479|FG000|Core Period: Baseline to Week 26|Death|1|||
42005867|NCT01081834|75813480|FG001|Core Period: Baseline to Week 26|Death|0|||
42005868|NCT01081834|75813481|FG002|Core Period: Baseline to Week 26|Death|0|||
42005869|NCT01081834|75813482|FG003|Core Period: Baseline to Week 26|Death|0|||
42005870|NCT01081834|75813483|FG004|Core Period: Baseline to Week 26|Death|0|||
42005871|NCT01081834|75813479|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
42005872|NCT01081834|75813480|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
42005873|NCT01081834|75813481|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
42005874|NCT01081834|75813482|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
42005875|NCT01081834|75813483|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
42005876|NCT01081834|75813479|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
42005877|NCT01081834|75813480|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
42005878|NCT01081834|75813481|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
42005879|NCT01081834|75813482|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
42005880|NCT01081834|75813483|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
42005881|NCT01081834|75813479|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
42005882|NCT01081834|75813480|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
42005883|NCT01081834|75813481|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
42005884|NCT01081834|75813482|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
42346640|NCT01833494|76185550|FG000|Overall Study|Withdrawal by Subject|6|||
42346641|NCT01833494|76185550|FG000|Overall Study|Decrease in serum phosphorus|4|||
42346642|NCT01833494|76185550|FG000|Overall Study|Decrease in serum calcium|4|||
42346643|NCT01833494|76185550|FG000|Overall Study|Increase in serum ferritin|1|||
42346644|NCT01738971|76185557|FG000|Overall Study|Lost to Follow-up|19|||
42346645|NCT01738971|76185558|FG001|Overall Study|Lost to Follow-up|30|||
42346646|NCT01738971|76185559|FG002|Overall Study|Lost to Follow-up|17|||
42346647|NCT01738581|76185569|FG000|Overall Study|Lost to Follow-up|1|||
42346648|NCT01738581|76185570|FG001|Overall Study|Lost to Follow-up|0|||
42346649|NCT01738503|76185582|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
42346650|NCT01738503|76185583|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
42346651|NCT01738503|76185584|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
42346652|NCT01738503|76185585|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
42346653|NCT01738503|76185586|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
42346654|NCT01738503|76185587|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
42346655|NCT01738503|76185588|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
42346656|NCT01738503|76185582|FG000|Treatment Period|Adverse Event|0|||
42346657|NCT01738503|76185583|FG001|Treatment Period|Adverse Event|1|||
42346658|NCT01738503|76185584|FG002|Treatment Period|Adverse Event|0|||
42346659|NCT01738503|76185585|FG003|Treatment Period|Adverse Event|1|||
42346660|NCT01738503|76185586|FG004|Treatment Period|Adverse Event|2|||
42005885|NCT01081834|75813483|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
42005886|NCT01081834|75813479|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
42272001|NCT01554956|76102097|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
42272002|NCT01554956|76102095|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
42272003|NCT01554956|76102096|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
42272004|NCT01554956|76102097|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
42272005|NCT01554956|76102095|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
42272006|NCT01554956|76102096|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
42272007|NCT01554956|76102097|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
42346661|NCT01738503|76185587|FG005|Treatment Period|Adverse Event|2|||
42346662|NCT01738503|76185588|FG006|Treatment Period|Adverse Event|2|||
42346663|NCT01738503|76185582|FG000|Treatment Period|Lost to Follow-up|0|||
42346664|NCT01738503|76185583|FG001|Treatment Period|Lost to Follow-up|0|||
42005887|NCT01081834|75813480|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
42005888|NCT01081834|75813481|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
42005889|NCT01081834|75813482|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
42005890|NCT01081834|75813483|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
42005891|NCT01081834|75813479|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
42005892|NCT01081834|75813480|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
42005893|NCT01081834|75813481|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
42005894|NCT01081834|75813482|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
42005895|NCT01081834|75813483|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
42005896|NCT01081834|75813479|FG000|Core Period: Baseline to Week 26|Other|4|||
42005897|NCT01081834|75813480|FG001|Core Period: Baseline to Week 26|Other|4|||
42005898|NCT01081834|75813481|FG002|Core Period: Baseline to Week 26|Other|3|||
42005899|NCT01081834|75813482|FG003|Core Period: Baseline to Week 26|Other|1|||
42005900|NCT01081834|75813483|FG004|Core Period: Baseline to Week 26|Other|0|||
42005901|NCT01081834|75813479|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
42005902|NCT01081834|75813480|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
42005903|NCT01081834|75813481|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
42005904|NCT01081834|75813482|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
42005905|NCT01081834|75813483|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
42005906|NCT01081834|75813479|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
42005907|NCT01081834|75813480|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
42005908|NCT01081834|75813481|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
42005909|NCT01081834|75813482|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
42005910|NCT01081834|75813483|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
42005911|NCT01081834|75813479|FG000|Extension Period: Week 26 to Week 52|Death|1|||
42005912|NCT01081834|75813480|FG001|Extension Period: Week 26 to Week 52|Death|0|||
42005913|NCT01081834|75813481|FG002|Extension Period: Week 26 to Week 52|Death|0|||
42005914|NCT01081834|75813482|FG003|Extension Period: Week 26 to Week 52|Death|0|||
42005915|NCT01081834|75813483|FG004|Extension Period: Week 26 to Week 52|Death|0|||
42005916|NCT01081834|75813479|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
42005917|NCT01081834|75813480|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
42005918|NCT01081834|75813481|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
42005919|NCT01081834|75813482|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
42005920|NCT01081834|75813483|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
42005921|NCT01081834|75813479|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
42005922|NCT01081834|75813480|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
42005923|NCT01081834|75813481|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
42005924|NCT01081834|75813482|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
42005925|NCT01081834|75813483|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
42005926|NCT01081834|75813479|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
42005927|NCT01081834|75813480|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
42005928|NCT01081834|75813481|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
42005929|NCT01081834|75813482|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
42005930|NCT01081834|75813483|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
42005931|NCT01081834|75813479|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
42005932|NCT01081834|75813480|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
42005933|NCT01081834|75813481|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
42005934|NCT01081834|75813482|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
42005935|NCT01081834|75813483|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
42005936|NCT01081834|75813479|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
42005937|NCT01081834|75813480|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
42005938|NCT01081834|75813481|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
42005939|NCT01081834|75813482|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
42005940|NCT01081834|75813483|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
42005941|NCT01081834|75813479|FG000|Extension Period: Week 26 to Week 52|Other|4|||
42005942|NCT01081834|75813480|FG001|Extension Period: Week 26 to Week 52|Other|5|||
42005943|NCT01081834|75813481|FG002|Extension Period: Week 26 to Week 52|Other|4|||
42005944|NCT01081834|75813482|FG003|Extension Period: Week 26 to Week 52|Other|0|||
42005945|NCT01081834|75813483|FG004|Extension Period: Week 26 to Week 52|Other|0|||
42005946|NCT01081834|75813479|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
42346665|NCT01738503|76185584|FG002|Treatment Period|Lost to Follow-up|3|||
42346666|NCT01738503|76185585|FG003|Treatment Period|Lost to Follow-up|4|||
42346667|NCT01738503|76185586|FG004|Treatment Period|Lost to Follow-up|1|||
42346668|NCT01738503|76185587|FG005|Treatment Period|Lost to Follow-up|1|||
42005947|NCT01081834|75813480|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
42005948|NCT01081834|75813481|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
42005949|NCT01081834|75813482|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
42005950|NCT01081834|75813483|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
42005951|NCT01081834|75813479|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
42005952|NCT01081834|75813480|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
42005953|NCT01081834|75813481|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
42005954|NCT01081834|75813482|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
42005955|NCT01081834|75813483|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
42005956|NCT01276509|75813506|FG000|Overall Study|Adverse Event|9|||
42346669|NCT01738503|76185588|FG006|Treatment Period|Lost to Follow-up|5|||
42005957|NCT01276509|75813507|FG001|Overall Study|Adverse Event|8|||
42005958|NCT01276509|75813508|FG002|Overall Study|Adverse Event|4|||
42005959|NCT01276509|75813509|FG003|Overall Study|Adverse Event|3|||
42005960|NCT01276509|75813506|FG000|Overall Study|Lack of Efficacy|2|||
42005961|NCT01276509|75813507|FG001|Overall Study|Lack of Efficacy|1|||
42005962|NCT01276509|75813508|FG002|Overall Study|Lack of Efficacy|1|||
42005963|NCT01276509|75813509|FG003|Overall Study|Lack of Efficacy|2|||
42005964|NCT01276509|75813506|FG000|Overall Study|Pregnancy|1|||
42005965|NCT01276509|75813507|FG001|Overall Study|Pregnancy|0|||
42005966|NCT01276509|75813508|FG002|Overall Study|Pregnancy|0|||
42005967|NCT01276509|75813509|FG003|Overall Study|Pregnancy|0|||
42005968|NCT01276509|75813506|FG000|Overall Study|Withdrawal by Subject|1|||
42005969|NCT01276509|75813507|FG001|Overall Study|Withdrawal by Subject|2|||
42005970|NCT01276509|75813508|FG002|Overall Study|Withdrawal by Subject|0|||
42005971|NCT01276509|75813509|FG003|Overall Study|Withdrawal by Subject|0|||
42005972|NCT01276509|75813506|FG000|Overall Study|Other|0|||
42005973|NCT01276509|75813507|FG001|Overall Study|Other|1|||
42005974|NCT01276509|75813508|FG002|Overall Study|Other|0|||
42005975|NCT01276509|75813509|FG003|Overall Study|Other|0|||
42005976|NCT01079962|75813521|FG000|Overall Study|Adverse Event|2|||
42005977|NCT01079962|75813522|FG001|Overall Study|Adverse Event|2|||
42005978|NCT01079962|75813521|FG000|Overall Study|Withdrawal by Subject|5|||
42005979|NCT01079962|75813522|FG001|Overall Study|Withdrawal by Subject|7|||
42005980|NCT01079962|75813521|FG000|Overall Study|Protocol Violation|2|||
42005981|NCT01079962|75813522|FG001|Overall Study|Protocol Violation|2|||
42005982|NCT01079962|75813521|FG000|Overall Study|No blood pressure (BP) control|3|||
42005983|NCT01079962|75813522|FG001|Overall Study|No blood pressure (BP) control|0|||
42005984|NCT01079962|75813521|FG000|Overall Study|Inclusion/exclusion criteria|1|||
42005985|NCT01079962|75813522|FG001|Overall Study|Inclusion/exclusion criteria|3|||
42005986|NCT01079962|75813521|FG000|Overall Study|Participant not returning for next visit|1|||
42005987|NCT01079962|75813522|FG001|Overall Study|Participant not returning for next visit|0|||
42005988|NCT01079962|75813521|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
42005989|NCT01079962|75813522|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
42005990|NCT01274637|75813530|FG000|Overall Study|Withdrawal by Subject|0|||
42005991|NCT01274637|75813531|FG001|Overall Study|Withdrawal by Subject|1|||
42005992|NCT01274637|75813530|FG000|Overall Study|Lost to Follow-up|0|||
42005993|NCT01274637|75813531|FG001|Overall Study|Lost to Follow-up|1|||
42005994|NCT01079806|75813539|FG000|Day 1 to Week 96|Adverse Event|0|||
42005995|NCT01079806|75813540|FG001|Day 1 to Week 96|Adverse Event|3|||
42005996|NCT01079806|75813539|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
42005997|NCT01079806|75813540|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
42005998|NCT01079806|75813539|FG000|Day 1 to Week 96|Pregnancy|0|||
42005999|NCT01079806|75813540|FG001|Day 1 to Week 96|Pregnancy|1|||
42006000|NCT01079806|75813539|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
42006001|NCT01079806|75813540|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
42006002|NCT01079806|75813539|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
42006003|NCT01079806|75813540|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
42006004|NCT01079806|75813539|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
42006005|NCT01079806|75813540|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
42006006|NCT01079806|75813539|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
42006007|NCT01079806|75813540|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
42006008|NCT01079806|75813539|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
42006009|NCT01079806|75813540|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
42006010|NCT01079806|75813539|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
42006011|NCT01079806|75813540|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
42006012|NCT01079806|75813539|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
42035392|NCT01112267|75843753|FG001|Overall Study|Participants not compliant|2|||
42346670|NCT01738503|76185582|FG000|Treatment Period|Withdrawal by Subject|0|||
42006013|NCT01079806|75813540|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
42006014|NCT01078090|75813548|FG000|Overall Study|Lost to Follow-up|2363|||
42006015|NCT01078090|75813548|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
42006016|NCT01078090|75813548|FG000|Overall Study|Lack of Efficacy|1193|||
42006017|NCT01078090|75813548|FG000|Overall Study|ADR and lack of efficacy|61|||
42006018|NCT01078090|75813548|FG000|Overall Study|Other|523|||
42006019|NCT01077622|75813566|FG000|Overall Study|Physician Decision|2|||
42006020|NCT01077622|75813566|FG000|Overall Study|Withdrawal by Subject|1|||
42006021|NCT01313676|75813574|FG000|Overall Study|Adverse Event|395|||
42006022|NCT01313676|75813575|FG001|Overall Study|Adverse Event|365|||
42006023|NCT01313676|75813576|FG002|Overall Study|Adverse Event|372|||
42006024|NCT01313676|75813577|FG003|Overall Study|Adverse Event|333|||
42006025|NCT01313676|75813574|FG000|Overall Study|Lack of Efficacy|98|||
42006026|NCT01313676|75813575|FG001|Overall Study|Lack of Efficacy|90|||
42006027|NCT01313676|75813576|FG002|Overall Study|Lack of Efficacy|65|||
42006028|NCT01313676|75813577|FG003|Overall Study|Lack of Efficacy|46|||
42006029|NCT01313676|75813574|FG000|Overall Study|Protocol Violation|37|||
42006030|NCT01313676|75813575|FG001|Overall Study|Protocol Violation|44|||
42006031|NCT01313676|75813576|FG002|Overall Study|Protocol Violation|46|||
42006032|NCT01313676|75813577|FG003|Overall Study|Protocol Violation|44|||
42006033|NCT01313676|75813574|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
42006034|NCT01313676|75813575|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
42006035|NCT01313676|75813576|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
42006036|NCT01313676|75813577|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
42006037|NCT01313676|75813574|FG000|Overall Study|Study Closed/terminated|7|||
42006038|NCT01313676|75813575|FG001|Overall Study|Study Closed/terminated|6|||
42006039|NCT01313676|75813576|FG002|Overall Study|Study Closed/terminated|9|||
42006040|NCT01313676|75813577|FG003|Overall Study|Study Closed/terminated|9|||
42006041|NCT01313676|75813574|FG000|Overall Study|Lost to Follow-up|0|||
42006042|NCT01313676|75813575|FG001|Overall Study|Lost to Follow-up|0|||
42006043|NCT01313676|75813576|FG002|Overall Study|Lost to Follow-up|1|||
42006044|NCT01313676|75813577|FG003|Overall Study|Lost to Follow-up|0|||
42006045|NCT01313676|75813574|FG000|Overall Study|Physician Decision|53|||
42006046|NCT01313676|75813575|FG001|Overall Study|Physician Decision|64|||
42006047|NCT01313676|75813576|FG002|Overall Study|Physician Decision|62|||
42006048|NCT01313676|75813577|FG003|Overall Study|Physician Decision|48|||
42006049|NCT01313676|75813574|FG000|Overall Study|Decision by Participant or Proxy|643|||
42006050|NCT01313676|75813575|FG001|Overall Study|Decision by Participant or Proxy|527|||
42006051|NCT01313676|75813576|FG002|Overall Study|Decision by Participant or Proxy|515|||
42006052|NCT01313676|75813577|FG003|Overall Study|Decision by Participant or Proxy|492|||
42006053|NCT01313676|75813574|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
42006054|NCT01313676|75813575|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
42006055|NCT01313676|75813576|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
42006056|NCT01313676|75813577|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
42006057|NCT01313676|75813574|FG000|Overall Study|Investigator Site Closed|12|||
42006058|NCT01313676|75813575|FG001|Overall Study|Investigator Site Closed|11|||
42006059|NCT01313676|75813576|FG002|Overall Study|Investigator Site Closed|15|||
42006060|NCT01313676|75813577|FG003|Overall Study|Investigator Site Closed|10|||
42006061|NCT01313676|75813574|FG000|Overall Study|Missing|1|||
42006062|NCT01313676|75813575|FG001|Overall Study|Missing|1|||
42006063|NCT01313676|75813576|FG002|Overall Study|Missing|1|||
42006064|NCT01313676|75813577|FG003|Overall Study|Missing|0|||
42006065|NCT01313286|75813588|FG000|Period 1|Withdrawal by Subject|2|||
42006066|NCT01313286|75813589|FG001|Period 1|Withdrawal by Subject|0|||
42006067|NCT01313208|75813597|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
42006068|NCT01313208|75813598|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
42006069|NCT01313208|75813597|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
42006070|NCT01313208|75813598|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
42006071|NCT01313208|75813597|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
42006072|NCT01313208|75813598|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
42006073|NCT01313208|75813597|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
42006074|NCT01313208|75813598|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
42006075|NCT01313208|75813597|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
42006076|NCT01313208|75813598|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
42006077|NCT01313208|75813597|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
42006078|NCT01313208|75813598|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
42006079|NCT01313208|75813597|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
42006080|NCT01313208|75813598|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
42006081|NCT01313208|75813597|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
42006082|NCT01313208|75813598|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
42006083|NCT01313208|75813597|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
42006084|NCT01313208|75813598|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
42006085|NCT01312428|75813608|FG000|Overall Study|Study Termination|3|||
42006086|NCT01312428|75813609|FG001|Overall Study|Study Termination|4|||
42006087|NCT01075984|75813622|FG000|Treatment Phase|Adverse Event|0|||
42006088|NCT01075984|75813623|FG001|Treatment Phase|Adverse Event|1|||
42006089|NCT01075984|75813624|FG002|Treatment Phase|Adverse Event|3|||
42006090|NCT01075984|75813625|FG003|Treatment Phase|Adverse Event|7|||
42006091|NCT01075984|75813626|FG004|Treatment Phase|Adverse Event|35|||
42006092|NCT01075984|75813622|FG000|Treatment Phase|Protocol Violation|0|||
42006093|NCT01075984|75813623|FG001|Treatment Phase|Protocol Violation|0|||
42006094|NCT01075984|75813624|FG002|Treatment Phase|Protocol Violation|1|||
42006095|NCT01075984|75813625|FG003|Treatment Phase|Protocol Violation|0|||
42006096|NCT01075984|75813626|FG004|Treatment Phase|Protocol Violation|3|||
42006097|NCT01075984|75813622|FG000|Treatment Phase|Withdrawal by Subject|0|||
42006098|NCT01075984|75813623|FG001|Treatment Phase|Withdrawal by Subject|0|||
42006099|NCT01075984|75813624|FG002|Treatment Phase|Withdrawal by Subject|2|||
42006100|NCT01075984|75813625|FG003|Treatment Phase|Withdrawal by Subject|0|||
42006101|NCT01075984|75813626|FG004|Treatment Phase|Withdrawal by Subject|15|||
42006102|NCT01075984|75813622|FG000|Treatment Phase|Treatment Failure|0|||
42006103|NCT01075984|75813623|FG001|Treatment Phase|Treatment Failure|0|||
42006104|NCT01075984|75813624|FG002|Treatment Phase|Treatment Failure|1|||
42006105|NCT01075984|75813625|FG003|Treatment Phase|Treatment Failure|0|||
42006106|NCT01075984|75813626|FG004|Treatment Phase|Treatment Failure|5|||
42006107|NCT01075984|75813622|FG000|Treatment Phase|Progression of disease|0|||
42006108|NCT01075984|75813623|FG001|Treatment Phase|Progression of disease|0|||
42006109|NCT01075984|75813624|FG002|Treatment Phase|Progression of disease|0|||
42006110|NCT01075984|75813625|FG003|Treatment Phase|Progression of disease|0|||
42006111|NCT01075984|75813626|FG004|Treatment Phase|Progression of disease|2|||
42006112|NCT01075984|75813622|FG000|Follow-up Phase|Protocol Violation|0|||
42006113|NCT01075984|75813623|FG001|Follow-up Phase|Protocol Violation|0|||
42006114|NCT01075984|75813624|FG002|Follow-up Phase|Protocol Violation|1|||
42006115|NCT01075984|75813625|FG003|Follow-up Phase|Protocol Violation|0|||
42006116|NCT01075984|75813626|FG004|Follow-up Phase|Protocol Violation|3|||
42006117|NCT01075984|75813622|FG000|Follow-up Phase|Adverse Event|0|||
42006118|NCT01075984|75813623|FG001|Follow-up Phase|Adverse Event|0|||
42006119|NCT01075984|75813624|FG002|Follow-up Phase|Adverse Event|0|||
42006120|NCT01075984|75813625|FG003|Follow-up Phase|Adverse Event|2|||
42006121|NCT01075984|75813626|FG004|Follow-up Phase|Adverse Event|27|||
42006122|NCT01075984|75813622|FG000|Follow-up Phase|Administrative|0|||
42006123|NCT01075984|75813623|FG001|Follow-up Phase|Administrative|0|||
42006124|NCT01075984|75813624|FG002|Follow-up Phase|Administrative|0|||
42006125|NCT01075984|75813625|FG003|Follow-up Phase|Administrative|0|||
42006126|NCT01075984|75813626|FG004|Follow-up Phase|Administrative|1|||
42006127|NCT01075984|75813622|FG000|Follow-up Phase|Withdrawal by Subject|0|||
42006128|NCT01075984|75813623|FG001|Follow-up Phase|Withdrawal by Subject|0|||
42006129|NCT01075984|75813624|FG002|Follow-up Phase|Withdrawal by Subject|0|||
42006130|NCT01075984|75813625|FG003|Follow-up Phase|Withdrawal by Subject|0|||
42006131|NCT01075984|75813626|FG004|Follow-up Phase|Withdrawal by Subject|10|||
42006132|NCT01075984|75813622|FG000|Follow-up Phase|Progression of disease|0|||
42006133|NCT01075984|75813623|FG001|Follow-up Phase|Progression of disease|0|||
42006134|NCT01075984|75813624|FG002|Follow-up Phase|Progression of disease|0|||
42006135|NCT01075984|75813625|FG003|Follow-up Phase|Progression of disease|0|||
42006136|NCT01075984|75813626|FG004|Follow-up Phase|Progression of disease|2|||
42006137|NCT01075984|75813622|FG000|Follow-up Phase|Treatment failure|0|||
42006138|NCT01075984|75813623|FG001|Follow-up Phase|Treatment failure|0|||
42006139|NCT01075984|75813624|FG002|Follow-up Phase|Treatment failure|0|||
42006140|NCT01075984|75813625|FG003|Follow-up Phase|Treatment failure|0|||
42006141|NCT01075984|75813626|FG004|Follow-up Phase|Treatment failure|4|||
42006142|NCT01024231|75813645|FG000|Overall Study|Other Reasons|1|||
42006143|NCT01024231|75813646|FG001|Overall Study|Other Reasons|2|||
42006144|NCT01024231|75813647|FG002|Overall Study|Other Reasons|0|||
42006145|NCT01024231|75813648|FG003|Overall Study|Other Reasons|0|||
42006146|NCT01024231|75813649|FG004|Overall Study|Other Reasons|2|||
42006147|NCT01024231|75813650|FG005|Overall Study|Other Reasons|0|||
42006148|NCT01024231|75813651|FG006|Overall Study|Other Reasons|1|||
42006149|NCT01024231|75813645|FG000|Overall Study|Maximum Clinical Benefit|1|||
42006150|NCT01024231|75813646|FG001|Overall Study|Maximum Clinical Benefit|2|||
42006151|NCT01024231|75813647|FG002|Overall Study|Maximum Clinical Benefit|0|||
42346671|NCT01738503|76185583|FG001|Treatment Period|Withdrawal by Subject|1|||
42346672|NCT01738503|76185584|FG002|Treatment Period|Withdrawal by Subject|0|||
42006152|NCT01024231|75813648|FG003|Overall Study|Maximum Clinical Benefit|1|||
42006153|NCT01024231|75813649|FG004|Overall Study|Maximum Clinical Benefit|1|||
42006154|NCT01024231|75813650|FG005|Overall Study|Maximum Clinical Benefit|0|||
42006155|NCT01024231|75813651|FG006|Overall Study|Maximum Clinical Benefit|0|||
42006156|NCT01024231|75813645|FG000|Overall Study|Disease Progression|3|||
42006157|NCT01024231|75813646|FG001|Overall Study|Disease Progression|1|||
42006158|NCT01024231|75813647|FG002|Overall Study|Disease Progression|3|||
42006159|NCT01024231|75813648|FG003|Overall Study|Disease Progression|0|||
42006160|NCT01024231|75813649|FG004|Overall Study|Disease Progression|4|||
42006161|NCT01024231|75813650|FG005|Overall Study|Disease Progression|11|||
42006162|NCT01024231|75813651|FG006|Overall Study|Disease Progression|6|||
42006163|NCT01024231|75813645|FG000|Overall Study|AE unrelated to Study Drug|0|||
42006164|NCT01024231|75813646|FG001|Overall Study|AE unrelated to Study Drug|1|||
42006165|NCT01024231|75813647|FG002|Overall Study|AE unrelated to Study Drug|0|||
42006166|NCT01024231|75813648|FG003|Overall Study|AE unrelated to Study Drug|0|||
42006167|NCT01024231|75813649|FG004|Overall Study|AE unrelated to Study Drug|0|||
42006168|NCT01024231|75813650|FG005|Overall Study|AE unrelated to Study Drug|0|||
42006169|NCT01024231|75813651|FG006|Overall Study|AE unrelated to Study Drug|0|||
42006170|NCT01024231|75813645|FG000|Overall Study|No longer meets criteria|0|||
42006171|NCT01024231|75813646|FG001|Overall Study|No longer meets criteria|0|||
42006172|NCT01024231|75813647|FG002|Overall Study|No longer meets criteria|0|||
42006173|NCT01024231|75813648|FG003|Overall Study|No longer meets criteria|0|||
42006174|NCT01024231|75813649|FG004|Overall Study|No longer meets criteria|1|||
42006175|NCT01024231|75813650|FG005|Overall Study|No longer meets criteria|0|||
42006176|NCT01024231|75813651|FG006|Overall Study|No longer meets criteria|1|||
42006177|NCT01024231|75813645|FG000|Overall Study|Study Drug Toxicity|1|||
42006178|NCT01024231|75813646|FG001|Overall Study|Study Drug Toxicity|6|||
42006179|NCT01024231|75813647|FG002|Overall Study|Study Drug Toxicity|6|||
42006180|NCT01024231|75813648|FG003|Overall Study|Study Drug Toxicity|4|||
42006181|NCT01024231|75813649|FG004|Overall Study|Study Drug Toxicity|2|||
42006182|NCT01024231|75813650|FG005|Overall Study|Study Drug Toxicity|0|||
42006183|NCT01024231|75813651|FG006|Overall Study|Study Drug Toxicity|7|||
42006184|NCT01024231|75813645|FG000|Overall Study|Death|6|||
42006185|NCT01024231|75813646|FG001|Overall Study|Death|2|||
42006186|NCT01024231|75813647|FG002|Overall Study|Death|1|||
42006187|NCT01024231|75813648|FG003|Overall Study|Death|0|||
42006188|NCT01024231|75813649|FG004|Overall Study|Death|4|||
42006189|NCT01024231|75813650|FG005|Overall Study|Death|3|||
42006190|NCT01024231|75813651|FG006|Overall Study|Death|5|||
42006191|NCT01024231|75813645|FG000|Overall Study|Lost to Follow-up|0|||
42006192|NCT01024231|75813646|FG001|Overall Study|Lost to Follow-up|0|||
42006193|NCT01024231|75813647|FG002|Overall Study|Lost to Follow-up|0|||
42006194|NCT01024231|75813648|FG003|Overall Study|Lost to Follow-up|0|||
42006195|NCT01024231|75813649|FG004|Overall Study|Lost to Follow-up|0|||
42006196|NCT01024231|75813650|FG005|Overall Study|Lost to Follow-up|0|||
42272008|NCT02138786|76102118|FG000|Overall Study|Adverse Event|0|||
42272009|NCT02138786|76102119|FG001|Overall Study|Adverse Event|2|||
42006197|NCT01024231|75813651|FG006|Overall Study|Lost to Follow-up|1|||
42006198|NCT01024231|75813645|FG000|Overall Study|Withdrew Consent|0|||
42006199|NCT01024231|75813646|FG001|Overall Study|Withdrew Consent|1|||
42272010|NCT02138786|76102120|FG002|Overall Study|Adverse Event|1|||
42272011|NCT02138786|76102118|FG000|Overall Study|Death|1|||
42006200|NCT01024231|75813647|FG002|Overall Study|Withdrew Consent|0|||
42006201|NCT01024231|75813648|FG003|Overall Study|Withdrew Consent|0|||
42006202|NCT01024231|75813649|FG004|Overall Study|Withdrew Consent|0|||
42006203|NCT01024231|75813650|FG005|Overall Study|Withdrew Consent|0|||
42272012|NCT02138786|76102119|FG001|Overall Study|Death|7|||
42272013|NCT02138786|76102120|FG002|Overall Study|Death|2|||
42272014|NCT02138786|76102118|FG000|Overall Study|Disease Progression|1|||
42346673|NCT01738503|76185585|FG003|Treatment Period|Withdrawal by Subject|1|||
42006204|NCT01024231|75813651|FG006|Overall Study|Withdrew Consent|0|||
42006205|NCT01024231|75813645|FG000|Overall Study|Continuing on Treatment|0|||
42006206|NCT01024231|75813646|FG001|Overall Study|Continuing on Treatment|0|||
42272015|NCT02138786|76102119|FG001|Overall Study|Disease Progression|1|||
42006207|NCT01024231|75813647|FG002|Overall Study|Continuing on Treatment|0|||
42006208|NCT01024231|75813648|FG003|Overall Study|Continuing on Treatment|0|||
42006209|NCT01024231|75813649|FG004|Overall Study|Continuing on Treatment|3|||
42006210|NCT01024231|75813650|FG005|Overall Study|Continuing on Treatment|2|||
42006211|NCT01024231|75813651|FG006|Overall Study|Continuing on Treatment|0|||
42006212|NCT01077544|75813674|FG000|Overall Study|New Cancer Therapy|3|||
42006213|NCT01077544|75813675|FG001|Overall Study|New Cancer Therapy|3|||
42006214|NCT01077544|75813674|FG000|Overall Study|Adverse Event|0|||
42006215|NCT01077544|75813675|FG001|Overall Study|Adverse Event|1|||
42006216|NCT01077544|75813674|FG000|Overall Study|Disease Progression|0|||
42006217|NCT01077544|75813675|FG001|Overall Study|Disease Progression|1|||
42006218|NCT01075516|75813683|FG000|Overall Study|Death|5|||
42006219|NCT01075516|75813684|FG001|Overall Study|Death|9|||
42006220|NCT01075516|75813683|FG000|Overall Study|Lost to Follow-up|10|||
42006221|NCT01075516|75813684|FG001|Overall Study|Lost to Follow-up|2|||
42006222|NCT01075516|75813683|FG000|Overall Study|Withdrawal by Subject|3|||
42006223|NCT01075516|75813684|FG001|Overall Study|Withdrawal by Subject|5|||
42006224|NCT01012999|75813690|FG000|Overall Study|Protocol Violation|1|||
42006225|NCT01017601|75813696|FG000|Overall Study|Disease Progression|12|||
42006226|NCT01017601|75813697|FG001|Overall Study|Disease Progression|12|||
42006227|NCT01017601|75813696|FG000|Overall Study|Withdrawal by Subject|0|||
42006228|NCT01017601|75813697|FG001|Overall Study|Withdrawal by Subject|1|||
42006229|NCT01016977|75813705|FG000|Overall Study|Lost to Follow-up|1|||
42006230|NCT01016977|75813706|FG001|Overall Study|Lost to Follow-up|0|||
42006231|NCT01016977|75813705|FG000|Overall Study|Withdrawal by Subject|2|||
42006232|NCT01016977|75813706|FG001|Overall Study|Withdrawal by Subject|2|||
42006233|NCT01012765|75813715|FG000|Treatment Period 1|Adverse Event|1|||
42006234|NCT01012765|75813716|FG001|Treatment Period 1|Adverse Event|0|||
42006235|NCT01012765|75813717|FG002|Treatment Period 1|Adverse Event|1|||
42006236|NCT01012765|75813718|FG003|Treatment Period 1|Adverse Event|0|||
42006237|NCT01012765|75813719|FG004|Treatment Period 1|Adverse Event|0|||
42006238|NCT01012765|75813720|FG005|Treatment Period 1|Adverse Event|0|||
42006239|NCT01012765|75813715|FG000|Treatment Period 1|Withdrawal by Subject|2|||
42006240|NCT01012765|75813716|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42006241|NCT01012765|75813717|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42006242|NCT01012765|75813718|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42006243|NCT01012765|75813719|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42006244|NCT01012765|75813720|FG005|Treatment Period 1|Withdrawal by Subject|0|||
42006245|NCT01012765|75813715|FG000|Treatment Period 1|Administrative problems|0|||
42006246|NCT01012765|75813716|FG001|Treatment Period 1|Administrative problems|0|||
42006247|NCT01012765|75813717|FG002|Treatment Period 1|Administrative problems|1|||
42006248|NCT01012765|75813718|FG003|Treatment Period 1|Administrative problems|1|||
42006249|NCT01012765|75813719|FG004|Treatment Period 1|Administrative problems|1|||
42006250|NCT01012765|75813720|FG005|Treatment Period 1|Administrative problems|0|||
42006251|NCT01012765|75813715|FG000|Treatment Period 1|Protocol Violation|0|||
42006252|NCT01012765|75813716|FG001|Treatment Period 1|Protocol Violation|0|||
42006253|NCT01012765|75813717|FG002|Treatment Period 1|Protocol Violation|0|||
42006254|NCT01012765|75813718|FG003|Treatment Period 1|Protocol Violation|2|||
42006255|NCT01012765|75813719|FG004|Treatment Period 1|Protocol Violation|1|||
42006256|NCT01012765|75813720|FG005|Treatment Period 1|Protocol Violation|0|||
42006257|NCT01012765|75813715|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
42006258|NCT01012765|75813716|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
42006259|NCT01012765|75813717|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
42006260|NCT01012765|75813718|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
42006261|NCT01012765|75813719|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
42006262|NCT01012765|75813720|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
42006263|NCT01012765|75813715|FG000|Treatment Period 2|Withdrawal by Subject|1|||
42006264|NCT01012765|75813716|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42006265|NCT01012765|75813717|FG002|Treatment Period 2|Withdrawal by Subject|1|||
42272016|NCT02138786|76102120|FG002|Overall Study|Disease Progression|3|||
42272017|NCT02138786|76102118|FG000|Overall Study|Withdrawal by Subject|1|||
42272018|NCT02138786|76102119|FG001|Overall Study|Withdrawal by Subject|2|||
42272019|NCT02138786|76102120|FG002|Overall Study|Withdrawal by Subject|0|||
42272020|NCT02138786|76102118|FG000|Overall Study|Patient's Wish|0|||
42272021|NCT02138786|76102119|FG001|Overall Study|Patient's Wish|2|||
42272022|NCT02138786|76102120|FG002|Overall Study|Patient's Wish|0|||
42272023|NCT02138786|76102118|FG000|Overall Study|Sponsor Terminated Study|0|||
42006266|NCT01012765|75813718|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42006267|NCT01012765|75813719|FG004|Treatment Period 2|Withdrawal by Subject|1|||
42006268|NCT01012765|75813720|FG005|Treatment Period 2|Withdrawal by Subject|0|||
42272024|NCT02138786|76102119|FG001|Overall Study|Sponsor Terminated Study|1|||
42272025|NCT02138786|76102120|FG002|Overall Study|Sponsor Terminated Study|1|||
42272026|NCT02138786|76102118|FG000|Overall Study|Non-Compliance|0|||
42006269|NCT01012765|75813715|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
42006270|NCT01012765|75813716|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
42006271|NCT01012765|75813717|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
42272027|NCT02138786|76102119|FG001|Overall Study|Non-Compliance|0|||
42006272|NCT01012765|75813718|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
42006273|NCT01012765|75813719|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
42006274|NCT01012765|75813720|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
42006275|NCT01012765|75813715|FG000|Treatment Period 2|Adverse Event|0|||
42006276|NCT01012765|75813716|FG001|Treatment Period 2|Adverse Event|1|||
42006277|NCT01012765|75813717|FG002|Treatment Period 2|Adverse Event|1|||
42006278|NCT01012765|75813718|FG003|Treatment Period 2|Adverse Event|0|||
42006279|NCT01012765|75813719|FG004|Treatment Period 2|Adverse Event|0|||
42006280|NCT01012765|75813720|FG005|Treatment Period 2|Adverse Event|0|||
42006281|NCT01012765|75813715|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
42006282|NCT01012765|75813716|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
42006283|NCT01012765|75813717|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
42006284|NCT01012765|75813718|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
42006285|NCT01012765|75813719|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
42006286|NCT01012765|75813720|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
42006287|NCT01010503|75813728|FG000|Overall Study|Adverse Event|1|||
42006288|NCT01010503|75813728|FG000|Overall Study|Death|1|||
42006289|NCT01006291|75813735|FG000|Overall Study|Adverse Event|2|||
42006290|NCT01006291|75813736|FG001|Overall Study|Adverse Event|1|||
42006291|NCT01006291|75813737|FG002|Overall Study|Adverse Event|2|||
42006292|NCT01006291|75813735|FG000|Overall Study|Lack of Efficacy|2|||
42006293|NCT01006291|75813736|FG001|Overall Study|Lack of Efficacy|2|||
42006294|NCT01006291|75813737|FG002|Overall Study|Lack of Efficacy|1|||
42006295|NCT01006291|75813735|FG000|Overall Study|Protocol Violation|3|||
42006296|NCT01006291|75813736|FG001|Overall Study|Protocol Violation|3|||
42006297|NCT01006291|75813737|FG002|Overall Study|Protocol Violation|3|||
42006298|NCT01006291|75813735|FG000|Overall Study|Withdrawal criteria|5|||
42006299|NCT01006291|75813736|FG001|Overall Study|Withdrawal criteria|4|||
42006300|NCT01006291|75813737|FG002|Overall Study|Withdrawal criteria|4|||
42006301|NCT01006291|75813735|FG000|Overall Study|Other|14|||
42006302|NCT01006291|75813736|FG001|Overall Study|Other|14|||
42006303|NCT01006291|75813737|FG002|Overall Study|Other|17|||
42006304|NCT01006135|75813745|FG000|Overall Study|Adverse Event|22|||
42006305|NCT01006135|75813745|FG000|Overall Study|Protocol Violation|14|||
42006306|NCT01006135|75813745|FG000|Overall Study|Lost to Follow-up|32|||
42006307|NCT01006135|75813745|FG000|Overall Study|Other|72|||
42006308|NCT01012609|75813751|FG000|Overall Study|Withdrawal by Subject|1|||
42006309|NCT01012609|75813752|FG001|Overall Study|Withdrawal by Subject|1|||
42006310|NCT01012219|75813759|FG000|Period 1|Withdrawal by Subject|1|||
42006311|NCT01012219|75813759|FG000|Period 2|Withdrawal by Subject|1|||
42006312|NCT01011907|75813768|FG000|Overall Study|Withdrawal by Subject|13|||
42006313|NCT01011907|75813769|FG001|Overall Study|Withdrawal by Subject|11|||
42035393|NCT01112267|75843752|FG000|Overall Study|Participants not receive any study drug|1|||
42272028|NCT02138786|76102120|FG002|Overall Study|Non-Compliance|1|||
42272029|NCT02529488|76102126|FG000|Overall Study|Adverse Event|1|||
42272030|NCT02529488|76102126|FG000|Overall Study|Death|3|||
42272031|NCT01329419|76102134|FG000|Overall Study|Protocol Violation|235|||
42272032|NCT01329341|76102139|FG000|Overall Study|Withdrawal by Subject|44|||
42272033|NCT02532764|76102153|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
42272034|NCT02532764|76102154|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
42346674|NCT01738503|76185586|FG004|Treatment Period|Withdrawal by Subject|1|||
42346675|NCT01738503|76185587|FG005|Treatment Period|Withdrawal by Subject|1|||
42346676|NCT01738503|76185588|FG006|Treatment Period|Withdrawal by Subject|1|||
42346677|NCT01738503|76185582|FG000|Treatment Period|Protocol Violation|0|||
42346678|NCT01738503|76185583|FG001|Treatment Period|Protocol Violation|3|||
42346679|NCT01738503|76185584|FG002|Treatment Period|Protocol Violation|1|||
42346680|NCT01738503|76185585|FG003|Treatment Period|Protocol Violation|0|||
42272035|NCT02532764|76102155|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
42272036|NCT02532764|76102156|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
42272037|NCT02532764|76102157|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
42346681|NCT01738503|76185586|FG004|Treatment Period|Protocol Violation|4|||
42346682|NCT01738503|76185587|FG005|Treatment Period|Protocol Violation|2|||
42346683|NCT01738503|76185588|FG006|Treatment Period|Protocol Violation|0|||
42346684|NCT01738503|76185582|FG000|Treatment Period|Other|0|||
42346685|NCT01738503|76185583|FG001|Treatment Period|Other|0|||
42272038|NCT02532764|76102158|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
42006314|NCT01011907|75813768|FG000|Overall Study|Adverse Event|1|||
42346686|NCT01738503|76185584|FG002|Treatment Period|Other|1|||
42346687|NCT01738503|76185585|FG003|Treatment Period|Other|0|||
42006315|NCT01011907|75813769|FG001|Overall Study|Adverse Event|4|||
42006316|NCT01011673|75813777|FG000|Randomized|Secondary headache|2|||
42006317|NCT01011673|75813778|FG001|Randomized|Secondary headache|1|||
42006318|NCT01011673|75813777|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
42006319|NCT01011673|75813778|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
42006320|NCT01011439|75813784|FG000|Overall Study|Death|37|||
42346688|NCT01738503|76185586|FG004|Treatment Period|Other|0|||
42346689|NCT01738503|76185587|FG005|Treatment Period|Other|0|||
42346690|NCT01738503|76185588|FG006|Treatment Period|Other|0|||
42346691|NCT01738503|76185582|FG000|PET Imaging Sub-study|Adverse Event|0|||
42346692|NCT01738503|76185583|FG001|PET Imaging Sub-study|Adverse Event|0|||
42346693|NCT01738503|76185584|FG002|PET Imaging Sub-study|Adverse Event|0|||
42346694|NCT01738503|76185585|FG003|PET Imaging Sub-study|Adverse Event|0|||
42346695|NCT01738503|76185586|FG004|PET Imaging Sub-study|Adverse Event|0|||
42346696|NCT01738503|76185587|FG005|PET Imaging Sub-study|Adverse Event|1|||
42346697|NCT01738503|76185588|FG006|PET Imaging Sub-study|Adverse Event|0|||
42346698|NCT01738503|76185582|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
42346699|NCT01738503|76185583|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
42346700|NCT01738503|76185584|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
42346701|NCT01738503|76185585|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
42346702|NCT01738503|76185586|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
42346703|NCT01738503|76185587|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
42346704|NCT01738503|76185588|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
42006321|NCT01011439|75813784|FG000|Overall Study|Lost to Follow-up|4|||
42006322|NCT01011439|75813784|FG000|Overall Study|Withdrawal by Subject|1|||
42006323|NCT01011439|75813784|FG000|Overall Study|Sponsor's decision|15|||
42006324|NCT01311024|75813791|FG000|Overall Study|Protocol Violation|35|||
42006325|NCT01311024|75813792|FG001|Overall Study|Protocol Violation|22|||
42006326|NCT01310868|75813798|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
42006327|NCT01273155|75813806|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
42006328|NCT01273155|75813807|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
42006329|NCT01273155|75813808|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
42006330|NCT01273155|75813809|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
42006331|NCT01273155|75813810|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
42006332|NCT01273155|75813811|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
42006333|NCT01273155|75813812|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
42006334|NCT01273155|75813806|FG000|Overall Study|Change in liver function/no longer eval.|0|||
42006335|NCT01273155|75813807|FG001|Overall Study|Change in liver function/no longer eval.|1|||
42006336|NCT01273155|75813808|FG002|Overall Study|Change in liver function/no longer eval.|0|||
42006337|NCT01273155|75813809|FG003|Overall Study|Change in liver function/no longer eval.|0|||
42006338|NCT01273155|75813810|FG004|Overall Study|Change in liver function/no longer eval.|1|||
42006339|NCT01273155|75813811|FG005|Overall Study|Change in liver function/no longer eval.|0|||
42006340|NCT01273155|75813812|FG006|Overall Study|Change in liver function/no longer eval.|0|||
42006341|NCT01273155|75813806|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
42006342|NCT01273155|75813807|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
42006343|NCT01273155|75813808|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
42006344|NCT01273155|75813809|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
42006345|NCT01273155|75813810|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
42006346|NCT01273155|75813811|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
42006347|NCT01273155|75813812|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
42006348|NCT01273155|75813806|FG000|Overall Study|Died during Cycle 1|0|||
42006349|NCT01273155|75813807|FG001|Overall Study|Died during Cycle 1|0|||
42006350|NCT01273155|75813808|FG002|Overall Study|Died during Cycle 1|1|||
42006351|NCT01273155|75813809|FG003|Overall Study|Died during Cycle 1|1|||
42006352|NCT01273155|75813810|FG004|Overall Study|Died during Cycle 1|0|||
42006353|NCT01273155|75813811|FG005|Overall Study|Died during Cycle 1|2|||
42006354|NCT01273155|75813812|FG006|Overall Study|Died during Cycle 1|2|||
42006355|NCT01273155|75813806|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
42035394|NCT01112267|75843753|FG001|Overall Study|Participants not receive any study drug|2|||
42272039|NCT02532764|76102159|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
42272040|NCT02532764|76102160|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
42272041|NCT02532764|76102161|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
42272042|NCT02532764|76102162|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
42272043|NCT02528942|76102189|FG000|Overall Study|Did not meet imaging criteria|9|||
42272044|NCT02528942|76102189|FG000|Overall Study|Lost to Follow-up|25|||
42272045|NCT02527148|76102195|FG000|Overall Study|Did not receive study intervention|1|||
42272046|NCT02527148|76102196|FG001|Overall Study|Did not receive study intervention|0|||
42272047|NCT02291614|76102215|FG000|Overall Study|Lost to Follow-up|0|||
42272048|NCT02291614|76102216|FG001|Overall Study|Lost to Follow-up|0|||
42272049|NCT02291614|76102217|FG002|Overall Study|Lost to Follow-up|0|||
42346705|NCT01738191|76185612|FG000|Overall Study|Withdrawal by Subject|4|||
42006356|NCT01273155|75813807|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
42006357|NCT01273155|75813808|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
42006358|NCT01273155|75813809|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
42006359|NCT01273155|75813810|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
42006360|NCT01273155|75813811|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
42006361|NCT01273155|75813812|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
42006362|NCT01005901|75813837|FG000|Overall Study|Withdrawal by Subject|38|||
42006363|NCT01005901|75813838|FG001|Overall Study|Withdrawal by Subject|14|||
42006364|NCT01005901|75813837|FG000|Overall Study|Adverse Event|30|||
42006365|NCT01005901|75813838|FG001|Overall Study|Adverse Event|16|||
42006366|NCT01005901|75813837|FG000|Overall Study|Administrative problems|21|||
42006367|NCT01005901|75813838|FG001|Overall Study|Administrative problems|13|||
42006368|NCT01005901|75813837|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
42006369|NCT01005901|75813838|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
42006370|NCT01005901|75813837|FG000|Overall Study|Protocol Violation|4|||
42006371|NCT01005901|75813838|FG001|Overall Study|Protocol Violation|3|||
42006372|NCT01005901|75813837|FG000|Overall Study|Death|2|||
42006373|NCT01005901|75813838|FG001|Overall Study|Death|3|||
42006374|NCT01005901|75813837|FG000|Overall Study|Lost to Follow-up|1|||
42006375|NCT01005901|75813838|FG001|Overall Study|Lost to Follow-up|2|||
42006376|NCT01005901|75813837|FG000|Overall Study|Patient's inability to use the device|1|||
42006377|NCT01005901|75813838|FG001|Overall Study|Patient's inability to use the device|1|||
42006378|NCT01005901|75813837|FG000|Overall Study|No longer requires study drug|0|||
42006379|NCT01005901|75813838|FG001|Overall Study|No longer requires study drug|1|||
42006380|NCT04968925|75813846|FG000|Phase I- Period 1|COVID-19 related|0|||
42006381|NCT04968925|75813847|FG001|Phase I- Period 1|COVID-19 related|1|||
42006382|NCT04968925|75813848|FG002|Phase I- Period 1|COVID-19 related|0|||
42006383|NCT04968925|75813849|FG003|Phase I- Period 1|COVID-19 related|0|||
42006384|NCT04968925|75813846|FG000|Phase I- Period 1|Subject enrolled in error|1|||
42006385|NCT04968925|75813847|FG001|Phase I- Period 1|Subject enrolled in error|1|||
42006386|NCT04968925|75813848|FG002|Phase I- Period 1|Subject enrolled in error|0|||
42006387|NCT04968925|75813849|FG003|Phase I- Period 1|Subject enrolled in error|0|||
42006388|NCT04968925|75813846|FG000|Phase II- Period 1|COVID-19 Related|0|||
42006389|NCT04968925|75813847|FG001|Phase II- Period 1|COVID-19 Related|0|||
42006390|NCT04968925|75813848|FG002|Phase II- Period 1|COVID-19 Related|6|||
42006391|NCT04968925|75813849|FG003|Phase II- Period 1|COVID-19 Related|6|||
42006392|NCT04968925|75813846|FG000|Phase II- Period 1|Subject enrolled in error|0|||
42006393|NCT04968925|75813847|FG001|Phase II- Period 1|Subject enrolled in error|0|||
42006394|NCT04968925|75813848|FG002|Phase II- Period 1|Subject enrolled in error|1|||
42006395|NCT04968925|75813849|FG003|Phase II- Period 1|Subject enrolled in error|0|||
42006396|NCT04968925|75813846|FG000|Phase II -Period 2|COVID-19 related|0|||
42006397|NCT04968925|75813847|FG001|Phase II -Period 2|COVID-19 related|0|||
42006398|NCT04968925|75813848|FG002|Phase II -Period 2|COVID-19 related|4|||
42006399|NCT04968925|75813849|FG003|Phase II -Period 2|COVID-19 related|3|||
42006400|NCT04968925|75813846|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
42006401|NCT04968925|75813847|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
42006402|NCT04968925|75813848|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
42006403|NCT04968925|75813849|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
42006404|NCT01266993|75813861|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
42006405|NCT01266993|75813862|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
42006406|NCT01266993|75813861|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
42006407|NCT01266993|75813862|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
42006408|NCT01309386|75813870|FG000|Overall Study|Other|2|||
42006409|NCT01309386|75813871|FG001|Overall Study|Other|0|||
42006410|NCT01309386|75813870|FG000|Overall Study|Withdrawal by Subject|2|||
42006411|NCT01309386|75813871|FG001|Overall Study|Withdrawal by Subject|0|||
42006412|NCT01309386|75813870|FG000|Overall Study|Progressive disease|9|||
42006413|NCT01309386|75813871|FG001|Overall Study|Progressive disease|11|||
42006414|NCT01309386|75813870|FG000|Overall Study|Physician Decision|1|||
42006415|NCT01309386|75813871|FG001|Overall Study|Physician Decision|1|||
42006416|NCT01309386|75813870|FG000|Overall Study|Lack of Efficacy|3|||
42006417|NCT01309386|75813871|FG001|Overall Study|Lack of Efficacy|1|||
42006418|NCT01309386|75813870|FG000|Overall Study|Adverse Event|5|||
42006419|NCT01309386|75813871|FG001|Overall Study|Adverse Event|8|||
42006420|NCT01266603|75813877|FG000|Overall Study|Adverse Event|1|||
42006421|NCT01266603|75813877|FG000|Overall Study|Lack of Efficacy|14|||
42006422|NCT01266603|75813877|FG000|Overall Study|Withdrawal by Subject|1|||
42006423|NCT01266603|75813877|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
42006424|NCT01309308|75813883|FG000|Overall Study|Lost to Follow-up|6|||
42006425|NCT01309308|75813884|FG001|Overall Study|Lost to Follow-up|4|||
42006426|NCT01266291|75813890|FG000|Overall Study|Adverse Event|1|||
42006427|NCT01004263|75813894|FG000|Overall Study|Adverse Event|15|||
42006428|NCT01004263|75813894|FG000|Overall Study|Withdrawal by Subject|58|||
42006429|NCT01004263|75813894|FG000|Overall Study|Protocol Violation|10|||
42006430|NCT01004263|75813894|FG000|Overall Study|Lost to Follow-up|64|||
42006431|NCT01004263|75813894|FG000|Overall Study|Lack of Efficacy|13|||
42006432|NCT01004263|75813894|FG000|Overall Study|Pregnancy|2|||
42006433|NCT01004263|75813894|FG000|Overall Study|Physician Decision|15|||
42006434|NCT01004263|75813894|FG000|Overall Study|Lack of Qualifying Event|2|||
42006435|NCT01308762|75813901|FG000|Overall Study|Protocol Violation|0|||
42006436|NCT01308762|75813902|FG001|Overall Study|Protocol Violation|1|||
42006437|NCT01308762|75813903|FG002|Overall Study|Protocol Violation|0|||
42272050|NCT02291614|76102218|FG003|Overall Study|Lost to Follow-up|0|||
42272051|NCT02291614|76102219|FG004|Overall Study|Lost to Follow-up|0|||
42272052|NCT02291614|76102220|FG005|Overall Study|Lost to Follow-up|0|||
42272053|NCT02291614|76102221|FG006|Overall Study|Lost to Follow-up|0|||
42272054|NCT02291614|76102222|FG007|Overall Study|Lost to Follow-up|1|||
42272055|NCT02291614|76102223|FG008|Overall Study|Lost to Follow-up|0|||
42272056|NCT02291614|76102224|FG009|Overall Study|Lost to Follow-up|0|||
42272057|NCT02291614|76102225|FG010|Overall Study|Lost to Follow-up|0|||
42272058|NCT02291614|76102215|FG000|Overall Study|Withdrawal by Subject|0|||
42272059|NCT02291614|76102216|FG001|Overall Study|Withdrawal by Subject|1|||
42272060|NCT02291614|76102217|FG002|Overall Study|Withdrawal by Subject|0|||
42272061|NCT02291614|76102218|FG003|Overall Study|Withdrawal by Subject|0|||
42272062|NCT02291614|76102219|FG004|Overall Study|Withdrawal by Subject|0|||
42272063|NCT02291614|76102220|FG005|Overall Study|Withdrawal by Subject|0|||
42272064|NCT02291614|76102221|FG006|Overall Study|Withdrawal by Subject|0|||
42272065|NCT02291614|76102222|FG007|Overall Study|Withdrawal by Subject|0|||
42272066|NCT02291614|76102223|FG008|Overall Study|Withdrawal by Subject|0|||
42272067|NCT02291614|76102224|FG009|Overall Study|Withdrawal by Subject|2|||
42272068|NCT02291614|76102225|FG010|Overall Study|Withdrawal by Subject|2|||
42272069|NCT02291614|76102215|FG000|Overall Study|Decision by sponsor|0|||
42272070|NCT02291614|76102216|FG001|Overall Study|Decision by sponsor|0|||
42272071|NCT02291614|76102217|FG002|Overall Study|Decision by sponsor|0|||
42272072|NCT02291614|76102218|FG003|Overall Study|Decision by sponsor|1|||
42272073|NCT02291614|76102219|FG004|Overall Study|Decision by sponsor|0|||
42272074|NCT02291614|76102220|FG005|Overall Study|Decision by sponsor|0|||
42272075|NCT02291614|76102221|FG006|Overall Study|Decision by sponsor|0|||
42272076|NCT02291614|76102222|FG007|Overall Study|Decision by sponsor|0|||
42272077|NCT02291614|76102223|FG008|Overall Study|Decision by sponsor|0|||
42272078|NCT02291614|76102224|FG009|Overall Study|Decision by sponsor|0|||
42272079|NCT02291614|76102225|FG010|Overall Study|Decision by sponsor|0|||
42272080|NCT02291614|76102215|FG000|Overall Study|Death|0|||
42272081|NCT02291614|76102216|FG001|Overall Study|Death|0|||
42272082|NCT02291614|76102217|FG002|Overall Study|Death|1|||
42272083|NCT02291614|76102218|FG003|Overall Study|Death|0|||
42272084|NCT02291614|76102219|FG004|Overall Study|Death|1|||
42272085|NCT02291614|76102220|FG005|Overall Study|Death|1|||
42272086|NCT02291614|76102221|FG006|Overall Study|Death|1|||
42272087|NCT02291614|76102222|FG007|Overall Study|Death|0|||
42272088|NCT02291614|76102223|FG008|Overall Study|Death|0|||
42272089|NCT02291614|76102224|FG009|Overall Study|Death|0|||
42272090|NCT02291614|76102225|FG010|Overall Study|Death|0|||
42272091|NCT02526524|76102261|FG000|Overall Study|Withdrawal by Subject|3|||
42272092|NCT02526524|76102262|FG001|Overall Study|Withdrawal by Subject|3|||
42272093|NCT02526524|76102263|FG002|Overall Study|Withdrawal by Subject|6|||
42272094|NCT02526524|76102264|FG003|Overall Study|Withdrawal by Subject|1|||
42272095|NCT02526524|76102265|FG004|Overall Study|Withdrawal by Subject|9|||
42272096|NCT02526524|76102266|FG005|Overall Study|Withdrawal by Subject|5|||
42272097|NCT02526524|76102261|FG000|Overall Study|Adverse Event|3|||
42272098|NCT02526524|76102262|FG001|Overall Study|Adverse Event|2|||
42272099|NCT02526524|76102263|FG002|Overall Study|Adverse Event|4|||
42272100|NCT02526524|76102264|FG003|Overall Study|Adverse Event|2|||
42272101|NCT02526524|76102265|FG004|Overall Study|Adverse Event|6|||
42006438|NCT01265823|75813914|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
42272102|NCT02526524|76102266|FG005|Overall Study|Adverse Event|8|||
42272103|NCT02526524|76102261|FG000|Overall Study|Lost to Follow-up|2|||
42346706|NCT01738191|76185613|FG001|Overall Study|Withdrawal by Subject|1|||
42346707|NCT01737879|76185619|FG000|Overall Study|Death|1|||
42006439|NCT01265823|75813914|FG000|Overall Study|Failure to Return|4|||
42006440|NCT01265823|75813914|FG000|Overall Study|Protocol Violation|1|||
42006441|NCT01265823|75813914|FG000|Overall Study|Participant Request|1|||
42006442|NCT01004185|75813924|FG000|Overall Study|Adverse Event|1|||
42006443|NCT01004185|75813925|FG001|Overall Study|Adverse Event|1|||
42006444|NCT01004185|75813924|FG000|Overall Study|Lost to Follow-up|0|||
42346708|NCT01737879|76185619|FG000|Overall Study|Sponsor decision|40|||
42346709|NCT01879683|76185623|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
42346710|NCT01605825|76185629|FG000|Overall Study|Adverse Event|4|||
42346711|NCT01605825|76185630|FG001|Overall Study|Adverse Event|2|||
42346712|NCT01605825|76185629|FG000|Overall Study|Withdrawal by Subject|0|||
42346713|NCT01605825|76185630|FG001|Overall Study|Withdrawal by Subject|1|||
42346714|NCT01605825|76185629|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
42346715|NCT01605825|76185630|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
42346716|NCT01605825|76185629|FG000|Overall Study|Non-Compliance with Protocol|3|||
42346717|NCT01605825|76185630|FG001|Overall Study|Non-Compliance with Protocol|0|||
42346718|NCT01727505|76185636|FG000|First 24 Hours|Adverse Event|0|||
42346719|NCT01727505|76185637|FG001|First 24 Hours|Adverse Event|1|||
42346720|NCT01727505|76185636|FG000|Second 24 Hours|Missing data|0|||
42346721|NCT01727505|76185637|FG001|Second 24 Hours|Missing data|1|||
42346722|NCT01726803|76185645|FG000|Overall Study|Lost to Follow-up|6|||
42346723|NCT01726803|76185646|FG001|Overall Study|Lost to Follow-up|1|||
42346724|NCT01726803|76185645|FG000|Overall Study|Withdrawal by Subject|1|||
42346725|NCT01726803|76185646|FG001|Overall Study|Withdrawal by Subject|0|||
42346726|NCT01726335|76185652|FG000|Overall Study|Lost to Follow-up|2|||
42346727|NCT01726335|76185652|FG000|Overall Study|Withdrawal by Subject|15|||
42346728|NCT01726335|76185652|FG000|Overall Study|Adverse Event|4|||
42346729|NCT01726335|76185652|FG000|Overall Study|Lost to Follow-up|2|||
42006445|NCT01004185|75813925|FG001|Overall Study|Lost to Follow-up|1|||
42006446|NCT01004185|75813924|FG000|Overall Study|Lack of Efficacy|2|||
42006447|NCT01004185|75813925|FG001|Overall Study|Lack of Efficacy|1|||
42006448|NCT01004185|75813924|FG000|Overall Study|Sponsor Terminated Study|4|||
42006449|NCT01004185|75813925|FG001|Overall Study|Sponsor Terminated Study|5|||
42006450|NCT01004185|75813924|FG000|Overall Study|Withdrawal by Subject|2|||
42006451|NCT01004185|75813925|FG001|Overall Study|Withdrawal by Subject|1|||
42006452|NCT01265511|75813933|FG000|Overall Study|Lack of Efficacy|2|||
42006453|NCT01265511|75813934|FG001|Overall Study|Lack of Efficacy|1|||
42006454|NCT01265511|75813933|FG000|Overall Study|Met stopping rules|0|||
42006455|NCT01265511|75813934|FG001|Overall Study|Met stopping rules|2|||
42006456|NCT01264965|75813940|FG000|Overall Study|Withdrawal by Subject|10|||
42006457|NCT01264887|75813944|FG000|Overall Study|Adverse Event|5|||
42272104|NCT02526524|76102262|FG001|Overall Study|Lost to Follow-up|3|||
42272105|NCT02526524|76102263|FG002|Overall Study|Lost to Follow-up|8|||
42272106|NCT02526524|76102264|FG003|Overall Study|Lost to Follow-up|1|||
42272107|NCT02526524|76102265|FG004|Overall Study|Lost to Follow-up|2|||
42272108|NCT02526524|76102266|FG005|Overall Study|Lost to Follow-up|5|||
42272109|NCT02526524|76102261|FG000|Overall Study|Protocol Violation|3|||
42272110|NCT02526524|76102262|FG001|Overall Study|Protocol Violation|1|||
42272111|NCT02526524|76102263|FG002|Overall Study|Protocol Violation|5|||
42272112|NCT02526524|76102264|FG003|Overall Study|Protocol Violation|3|||
42272113|NCT02526524|76102265|FG004|Overall Study|Protocol Violation|4|||
42272114|NCT02526524|76102266|FG005|Overall Study|Protocol Violation|3|||
42272115|NCT02526524|76102261|FG000|Overall Study|Loss of Glucose Control|0|||
42272116|NCT02526524|76102262|FG001|Overall Study|Loss of Glucose Control|0|||
42272117|NCT02526524|76102263|FG002|Overall Study|Loss of Glucose Control|3|||
42272118|NCT02526524|76102264|FG003|Overall Study|Loss of Glucose Control|0|||
42272119|NCT02526524|76102265|FG004|Overall Study|Loss of Glucose Control|2|||
42346730|NCT01726335|76185652|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
42006458|NCT01264887|75813944|FG000|Overall Study|Death|7|||
42006459|NCT01264887|75813944|FG000|Overall Study|Lack of Efficacy|5|||
42006460|NCT01264887|75813944|FG000|Overall Study|Physician Decision|4|||
42006461|NCT01264887|75813944|FG000|Overall Study|Withdrawal by Subject|6|||
42006462|NCT01264887|75813944|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
42006463|NCT01264887|75813944|FG000|Overall Study|Other|2|||
42006464|NCT01306968|75813954|FG000|Overall Study|Lost to Follow-up|1|||
42006465|NCT01306968|75813955|FG001|Overall Study|Lost to Follow-up|1|||
42272120|NCT02526524|76102266|FG005|Overall Study|Loss of Glucose Control|0|||
42272121|NCT02526524|76102261|FG000|Overall Study|Physician Decision|0|||
42272122|NCT02526524|76102262|FG001|Overall Study|Physician Decision|0|||
42272123|NCT02526524|76102263|FG002|Overall Study|Physician Decision|0|||
42346731|NCT01877421|76185688|FG000|Phase 2|Lost to Follow-up|0|||
42346732|NCT01877421|76185689|FG001|Phase 2|Lost to Follow-up|0|||
42346733|NCT01877421|76185690|FG002|Phase 2|Lost to Follow-up|0|||
42346734|NCT01877421|76185691|FG003|Phase 2|Lost to Follow-up|0|||
42346735|NCT01877421|76185692|FG004|Phase 2|Lost to Follow-up|0|||
42346736|NCT01877421|76185693|FG005|Phase 2|Lost to Follow-up|0|||
42272124|NCT02526524|76102264|FG003|Overall Study|Physician Decision|0|||
42006466|NCT01306968|75813956|FG002|Overall Study|Lost to Follow-up|0|||
42006467|NCT01306968|75813957|FG003|Overall Study|Lost to Follow-up|0|||
42006468|NCT01306968|75813954|FG000|Overall Study|Physician Decision|0|||
42006469|NCT01306968|75813955|FG001|Overall Study|Physician Decision|1|||
42006470|NCT01306968|75813956|FG002|Overall Study|Physician Decision|0|||
42006471|NCT01306968|75813957|FG003|Overall Study|Physician Decision|0|||
42006472|NCT01306968|75813954|FG000|Overall Study|Relocated and left active duty|0|||
42006473|NCT01306968|75813955|FG001|Overall Study|Relocated and left active duty|1|||
42006474|NCT01306968|75813956|FG002|Overall Study|Relocated and left active duty|1|||
42006475|NCT01306968|75813957|FG003|Overall Study|Relocated and left active duty|1|||
42006476|NCT01306968|75813954|FG000|Overall Study|Withdrew - time commitment|0|||
42006477|NCT01306968|75813955|FG001|Overall Study|Withdrew - time commitment|0|||
42006478|NCT01306968|75813956|FG002|Overall Study|Withdrew - time commitment|0|||
42006479|NCT01306968|75813957|FG003|Overall Study|Withdrew - time commitment|2|||
42006480|NCT01306968|75813954|FG000|Overall Study|Withdrew over privacy concerns|0|||
42006481|NCT01306968|75813955|FG001|Overall Study|Withdrew over privacy concerns|0|||
42006482|NCT01306968|75813956|FG002|Overall Study|Withdrew over privacy concerns|0|||
42006483|NCT01306968|75813957|FG003|Overall Study|Withdrew over privacy concerns|1|||
42006484|NCT01264419|75813969|FG000|Overall Study|Lost to Follow-up|3|||
42006485|NCT01263873|75813975|FG000|Overall Study|One provider unable to complete numbers|1|||
42006486|NCT01263873|75813976|FG001|Overall Study|One provider unable to complete numbers|1|||
42006487|NCT01263639|75813984|FG000|Overall Study|Lost to Follow-up|66|||
42006488|NCT01263639|75813985|FG001|Overall Study|Lost to Follow-up|70|||
42006489|NCT01263639|75813984|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
42006490|NCT01263639|75813985|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
42006491|NCT01011283|75813993|FG000|Overall Study|Adverse Event|4|||
42006492|NCT01011283|75813994|FG001|Overall Study|Adverse Event|2|||
42006493|NCT01011283|75813993|FG000|Overall Study|Progressive Disease|0|||
42006494|NCT01011283|75813994|FG001|Overall Study|Progressive Disease|2|||
42006495|NCT01011283|75813993|FG000|Overall Study|Terminated by Sponsor|5|||
42006496|NCT01011283|75813994|FG001|Overall Study|Terminated by Sponsor|5|||
42006497|NCT01011283|75813993|FG000|Overall Study|Other|2|||
42006498|NCT01011283|75813994|FG001|Overall Study|Other|2|||
42006499|NCT01263561|75814002|FG000|Overall Study|Death|1|||
42006500|NCT01263561|75814003|FG001|Overall Study|Death|2|||
42006501|NCT01009099|75814011|FG000|Overall Study|Lost to Follow-up|1|||
42006502|NCT01009099|75814012|FG001|Overall Study|Lost to Follow-up|0|||
42006503|NCT01009099|75814011|FG000|Overall Study|Physician Decision|3|||
42006504|NCT01009099|75814012|FG001|Overall Study|Physician Decision|2|||
42006505|NCT01009099|75814011|FG000|Overall Study|Withdrawal by Subject|1|||
42006506|NCT01009099|75814012|FG001|Overall Study|Withdrawal by Subject|1|||
42006507|NCT01009099|75814011|FG000|Overall Study|Death|0|||
42006508|NCT01009099|75814012|FG001|Overall Study|Death|1|||
42006509|NCT01263483|75814021|FG000|Overall Study|Adverse Event|4|||
42006510|NCT01263483|75814022|FG001|Overall Study|Adverse Event|0|||
42006511|NCT01263483|75814023|FG002|Overall Study|Adverse Event|3|||
42006512|NCT01263483|75814021|FG000|Overall Study|Withdrawal by Subject|1|||
42006513|NCT01263483|75814022|FG001|Overall Study|Withdrawal by Subject|0|||
42006514|NCT01263483|75814023|FG002|Overall Study|Withdrawal by Subject|0|||
42006515|NCT01263483|75814021|FG000|Overall Study|Lack of Efficacy|2|||
42006516|NCT01263483|75814022|FG001|Overall Study|Lack of Efficacy|0|||
42006517|NCT01263483|75814023|FG002|Overall Study|Lack of Efficacy|0|||
42006518|NCT01263483|75814021|FG000|Overall Study|Protocol Violation|0|||
42006519|NCT01263483|75814022|FG001|Overall Study|Protocol Violation|1|||
42006520|NCT01263483|75814023|FG002|Overall Study|Protocol Violation|1|||
42006521|NCT01263483|75814021|FG000|Overall Study|Participant Unavailability|0|||
42006522|NCT01263483|75814022|FG001|Overall Study|Participant Unavailability|1|||
42272125|NCT02526524|76102265|FG004|Overall Study|Physician Decision|1|||
42272126|NCT02526524|76102266|FG005|Overall Study|Physician Decision|0|||
42006523|NCT01263483|75814023|FG002|Overall Study|Participant Unavailability|1|||
42006524|NCT01306890|75814031|FG000|Overall Study|Adverse Event|2|||
42006525|NCT01306890|75814031|FG000|Overall Study|Death|1223|||
42006526|NCT01306890|75814031|FG000|Overall Study|Lost to Follow-up|58|||
42006527|NCT01306890|75814031|FG000|Overall Study|Withdrawal by Subject|88|||
42006528|NCT01306890|75814031|FG000|Overall Study|Unspecified reasons|104|||
42272127|NCT02526524|76102261|FG000|Overall Study|Sponsor Decision|1|||
42272128|NCT02526524|76102262|FG001|Overall Study|Sponsor Decision|0|||
42006529|NCT01306890|75814031|FG000|Overall Study|Study Termination|3|||
42006530|NCT01306890|75814031|FG000|Overall Study|No discontinuation documentation|41|||
42272129|NCT02526524|76102263|FG002|Overall Study|Sponsor Decision|0|||
42006531|NCT01011049|75814039|FG000|Overall Study|Protocol Violation|0|||
42006532|NCT01011049|75814040|FG001|Overall Study|Protocol Violation|0|||
42272130|NCT02526524|76102264|FG003|Overall Study|Sponsor Decision|0|||
42272131|NCT02526524|76102265|FG004|Overall Study|Sponsor Decision|0|||
42006533|NCT01011049|75814041|FG002|Overall Study|Protocol Violation|2|||
42006534|NCT01011049|75814042|FG003|Overall Study|Protocol Violation|0|||
42006535|NCT01011049|75814039|FG000|Overall Study|Lost to Follow-up|1|||
42272132|NCT02526524|76102266|FG005|Overall Study|Sponsor Decision|0|||
42006536|NCT01011049|75814040|FG001|Overall Study|Lost to Follow-up|2|||
42006537|NCT01011049|75814041|FG002|Overall Study|Lost to Follow-up|1|||
42006538|NCT01011049|75814042|FG003|Overall Study|Lost to Follow-up|0|||
42006539|NCT01011049|75814039|FG000|Overall Study|Withdrawal by Subject|0|||
42006540|NCT01011049|75814040|FG001|Overall Study|Withdrawal by Subject|0|||
42006541|NCT01011049|75814041|FG002|Overall Study|Withdrawal by Subject|1|||
42006542|NCT01011049|75814042|FG003|Overall Study|Withdrawal by Subject|0|||
42006543|NCT01263093|75814054|FG000|Washout|Physician Decision|1|||
42137563|NCT00443820|75947878|FG001|Overall Study|Withdrawal by Subject|7|||
42272133|NCT02526290|76102280|FG000|Overall Study|Adverse Event|3|||
42272134|NCT02526290|76102280|FG000|Overall Study|Withdrawal by Subject|4|||
42272135|NCT02526290|76102280|FG000|Overall Study|Physician Decision|1|||
42346737|NCT01877421|76185694|FG006|Phase 2|Lost to Follow-up|1|||
42346738|NCT01877421|76185695|FG007|Phase 2|Lost to Follow-up|0|||
42272136|NCT02319148|76102287|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
42272137|NCT02319148|76102288|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
42272138|NCT02319148|76102289|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
42272139|NCT02319148|76102290|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
42346739|NCT01877421|76185696|FG008|Phase 2|Lost to Follow-up|0|||
42346740|NCT01877421|76185697|FG009|Phase 2|Lost to Follow-up|0|||
42346741|NCT01877421|76185698|FG010|Phase 2|Lost to Follow-up|0|||
42346742|NCT01877421|76185699|FG011|Phase 2|Lost to Follow-up|0|||
42346743|NCT01877421|76185700|FG012|Phase 2|Lost to Follow-up|0|||
42346744|NCT01877421|76185701|FG013|Phase 2|Lost to Follow-up|0|||
42346745|NCT01877421|76185702|FG014|Phase 2|Lost to Follow-up|0|||
42346746|NCT01877421|76185703|FG015|Phase 2|Lost to Follow-up|0|||
42346747|NCT01877421|76185704|FG016|Phase 2|Lost to Follow-up|0|||
42346748|NCT01877421|76185705|FG017|Phase 2|Lost to Follow-up|0|||
42346749|NCT01877421|76185688|FG000|Phase 2|Withdrawal by Subject|0|||
42346750|NCT01877421|76185689|FG001|Phase 2|Withdrawal by Subject|0|||
42346751|NCT01877421|76185690|FG002|Phase 2|Withdrawal by Subject|0|||
42006544|NCT01263093|75814055|FG001|Washout|Physician Decision|0|||
42137564|NCT00443820|75947879|FG002|Overall Study|Withdrawal by Subject|8|||
42272140|NCT02319148|76102287|FG000|Second Intervention Period|No longer willing to participate|0|||
42346752|NCT01877421|76185691|FG003|Phase 2|Withdrawal by Subject|0|||
42346753|NCT01877421|76185692|FG004|Phase 2|Withdrawal by Subject|0|||
42006545|NCT01263093|75814054|FG000|Period 2|Adverse Event|1|||
42346754|NCT01877421|76185693|FG005|Phase 2|Withdrawal by Subject|0|||
42346755|NCT01877421|76185694|FG006|Phase 2|Withdrawal by Subject|0|||
42346756|NCT01877421|76185695|FG007|Phase 2|Withdrawal by Subject|0|||
42346757|NCT01877421|76185696|FG008|Phase 2|Withdrawal by Subject|1|||
42006546|NCT01263093|75814055|FG001|Period 2|Adverse Event|0|||
42006547|NCT01010971|75814065|FG000|Overall Study|Adverse Event|2|||
42006548|NCT01010971|75814066|FG001|Overall Study|Adverse Event|4|||
42006549|NCT01010971|75814067|FG002|Overall Study|Adverse Event|3|||
42006550|NCT01010971|75814065|FG000|Overall Study|Withdrawal by Subject|0|||
42006551|NCT01010971|75814066|FG001|Overall Study|Withdrawal by Subject|2|||
42006552|NCT01010971|75814067|FG002|Overall Study|Withdrawal by Subject|5|||
42006553|NCT01010971|75814065|FG000|Overall Study|Lost to Follow-up|0|||
42272141|NCT02319148|76102288|FG001|Second Intervention Period|No longer willing to participate|1|||
42272142|NCT02319148|76102289|FG002|Second Intervention Period|No longer willing to participate|0|||
42272143|NCT02319148|76102290|FG003|Second Intervention Period|No longer willing to participate|0|||
42272144|NCT02319148|76102287|FG000|Second Intervention Period|Other|0|||
42006554|NCT01010971|75814066|FG001|Overall Study|Lost to Follow-up|2|||
42006555|NCT01010971|75814067|FG002|Overall Study|Lost to Follow-up|3|||
42006556|NCT01010971|75814065|FG000|Overall Study|Other|1|||
42006557|NCT01010971|75814066|FG001|Overall Study|Other|0|||
42006558|NCT01010971|75814067|FG002|Overall Study|Other|2|||
42006559|NCT01306656|75814077|FG000|Overall Study|Lost to Follow-up|1|||
42006560|NCT01306656|75814078|FG001|Overall Study|Lost to Follow-up|0|||
42006561|NCT01008943|75814086|FG000|Overall Study|Withdrawal by Subject|1|||
42006562|NCT01003639|75814092|FG000|Overall Study|Lost to Follow-up|6|||
42006563|NCT01003639|75814093|FG001|Overall Study|Lost to Follow-up|9|||
42006564|NCT01003639|75814092|FG000|Overall Study|Withdrawal by Subject|9|||
42006565|NCT01003639|75814093|FG001|Overall Study|Withdrawal by Subject|5|||
42006566|NCT01003639|75814092|FG000|Overall Study|Lack of Efficacy|1|||
42006567|NCT01003639|75814093|FG001|Overall Study|Lack of Efficacy|6|||
42006568|NCT01003639|75814092|FG000|Overall Study|Adverse Event|0|||
42006569|NCT01003639|75814093|FG001|Overall Study|Adverse Event|1|||
42006570|NCT01003639|75814092|FG000|Overall Study|Protocol Violation|0|||
42006571|NCT01003639|75814093|FG001|Overall Study|Protocol Violation|1|||
42006572|NCT01003639|75814092|FG000|Overall Study|Physician Decision|1|||
42006573|NCT01003639|75814093|FG001|Overall Study|Physician Decision|0|||
42006574|NCT01003249|75814099|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
42006575|NCT01003249|75814100|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
42006576|NCT01003249|75814099|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
42006577|NCT01003249|75814100|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
42006578|NCT01003249|75814099|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
42006579|NCT01003249|75814100|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
42006580|NCT01003249|75814099|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
42006581|NCT01003249|75814100|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
42006582|NCT01001767|75814112|FG000|Overall Study|no baseline study performed|1|||
42006583|NCT01001767|75814113|FG001|Overall Study|no baseline study performed|0|||
42006584|NCT01001767|75814112|FG000|Overall Study|Protocol Violation|1|||
42006585|NCT01001767|75814113|FG001|Overall Study|Protocol Violation|0|||
42006586|NCT01001767|75814112|FG000|Overall Study|Lost to Follow-up|1|||
42006587|NCT01001767|75814113|FG001|Overall Study|Lost to Follow-up|0|||
42006588|NCT01001767|75814112|FG000|Overall Study|Physician Decision|1|||
42006589|NCT01001767|75814113|FG001|Overall Study|Physician Decision|0|||
42006590|NCT01306032|75814125|FG000|First Intervention|Adverse Event|1|||
42006591|NCT01306032|75814126|FG001|First Intervention|Adverse Event|0|||
42006592|NCT01306032|75814127|FG002|First Intervention|Adverse Event|1|||
42006593|NCT01306032|75814128|FG003|First Intervention|Adverse Event|0|||
42006594|NCT01306032|75814129|FG004|First Intervention|Adverse Event|0|||
42006595|NCT01306032|75814130|FG005|First Intervention|Adverse Event|1|||
42006596|NCT01306032|75814125|FG000|First Intervention|Withdrawal by Subject|0|||
42006597|NCT01306032|75814126|FG001|First Intervention|Withdrawal by Subject|2|||
42006598|NCT01306032|75814127|FG002|First Intervention|Withdrawal by Subject|0|||
42006599|NCT01306032|75814128|FG003|First Intervention|Withdrawal by Subject|1|||
42006600|NCT01306032|75814129|FG004|First Intervention|Withdrawal by Subject|0|||
42006601|NCT01306032|75814130|FG005|First Intervention|Withdrawal by Subject|0|||
42006602|NCT01306032|75814125|FG000|First Intervention|Death|0|||
42006603|NCT01306032|75814126|FG001|First Intervention|Death|0|||
42006604|NCT01306032|75814127|FG002|First Intervention|Death|1|||
42006605|NCT01306032|75814128|FG003|First Intervention|Death|0|||
42006606|NCT01306032|75814129|FG004|First Intervention|Death|0|||
42006607|NCT01306032|75814130|FG005|First Intervention|Death|0|||
42006608|NCT01306032|75814125|FG000|First Intervention|Ineligible|0|||
42006609|NCT01306032|75814126|FG001|First Intervention|Ineligible|0|||
42272145|NCT02319148|76102288|FG001|Second Intervention Period|Other|0|||
42006610|NCT01306032|75814127|FG002|First Intervention|Ineligible|0|||
42006611|NCT01306032|75814128|FG003|First Intervention|Ineligible|0|||
42006612|NCT01306032|75814129|FG004|First Intervention|Ineligible|0|||
42006613|NCT01306032|75814130|FG005|First Intervention|Ineligible|1|||
42006614|NCT01306032|75814125|FG000|First Intervention|Progressive disease|0|||
42006615|NCT01306032|75814126|FG001|First Intervention|Progressive disease|0|||
42006616|NCT01306032|75814127|FG002|First Intervention|Progressive disease|0|||
42006617|NCT01306032|75814128|FG003|First Intervention|Progressive disease|0|||
42272146|NCT02319148|76102289|FG002|Second Intervention Period|Other|0|||
42006618|NCT01306032|75814129|FG004|First Intervention|Progressive disease|2|||
42006619|NCT01306032|75814130|FG005|First Intervention|Progressive disease|0|||
42006620|NCT01306032|75814125|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
42006621|NCT01306032|75814126|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
42006622|NCT01306032|75814127|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
42006623|NCT01306032|75814128|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
42006624|NCT01306032|75814129|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
42006625|NCT01306032|75814130|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
42006626|NCT01306032|75814125|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
42006627|NCT01306032|75814126|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
42006628|NCT01306032|75814127|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
42006629|NCT01306032|75814128|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
42006630|NCT01306032|75814129|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
42006631|NCT01306032|75814130|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
42006632|NCT01263015|75814158|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
42006633|NCT01263015|75814159|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
42006634|NCT01263015|75814158|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
42006635|NCT01263015|75814159|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
42006636|NCT01263015|75814158|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
42006637|NCT01263015|75814159|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
42006638|NCT01263015|75814158|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
42006639|NCT01263015|75814159|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
42006640|NCT01263015|75814158|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
42006641|NCT01263015|75814159|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
42006642|NCT01263015|75814158|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
42006643|NCT01263015|75814159|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
42006644|NCT01263015|75814158|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
42006645|NCT01263015|75814159|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
42006646|NCT01263015|75814158|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
42006647|NCT01263015|75814159|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
42006648|NCT01263015|75814158|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
42006649|NCT01263015|75814159|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
42006650|NCT01263015|75814158|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
42006651|NCT01263015|75814159|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
42006652|NCT01263015|75814158|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
42006653|NCT01263015|75814159|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
42006654|NCT01263015|75814158|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
42006655|NCT01263015|75814159|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
42006656|NCT01305564|75814165|FG000|Overall Study|Death|21|||
42006657|NCT01305564|75814165|FG000|Overall Study|Lost to Follow-up|12|||
42006658|NCT01305564|75814165|FG000|Overall Study|Withdrawal by Subject|1|||
42006659|NCT01305564|75814165|FG000|Overall Study|Physician Decision|3|||
42006660|NCT01305408|75814182|FG000|Overall Study|Adverse Event|10|||
42035395|NCT00925587|75843761|FG000|Overall Study|Protocol Specified Criteria|6|||
42035396|NCT00925587|75843762|FG001|Overall Study|Protocol Specified Criteria|6|||
42035397|NCT00925587|75843761|FG000|Overall Study|Physician Decision|4|||
42137565|NCT00443820|75947880|FG003|Overall Study|Withdrawal by Subject|9|||
42272147|NCT02319148|76102290|FG003|Second Intervention Period|Other|1|||
42272148|NCT02526212|76102311|FG000|Overall Study|Incarceration|1|||
42272149|NCT02526212|76102312|FG001|Overall Study|Incarceration|0|||
42272150|NCT02526212|76102311|FG000|Overall Study|Lost to Follow-up|1|||
42272151|NCT02526212|76102312|FG001|Overall Study|Lost to Follow-up|0|||
42272152|NCT02526212|76102311|FG000|Overall Study|Death|0|||
42272153|NCT02526212|76102312|FG001|Overall Study|Death|1|||
42272154|NCT02532374|76102318|FG000|Overall Study|Withdrawal by Subject|1|||
42272155|NCT02532374|76102318|FG000|Overall Study|Physician Decision|1|||
42272156|NCT02525744|76102330|FG000|Period 1|Physician Decision|0|||
42272157|NCT02525744|76102331|FG001|Period 1|Physician Decision|0|||
42272158|NCT02525744|76102332|FG002|Period 1|Physician Decision|1|||
42272159|NCT02525744|76102333|FG003|Period 1|Physician Decision|0|||
42272160|NCT02525744|76102330|FG000|Period 3|Adverse Event|0|||
42272161|NCT02525744|76102331|FG001|Period 3|Adverse Event|1|||
42346758|NCT01877421|76185697|FG009|Phase 2|Withdrawal by Subject|0|||
42006661|NCT01305408|75814183|FG001|Overall Study|Adverse Event|7|||
42272162|NCT02525744|76102332|FG002|Period 3|Adverse Event|0|||
42346759|NCT01877421|76185698|FG010|Phase 2|Withdrawal by Subject|1|||
42006662|NCT01305408|75814182|FG000|Overall Study|Lack of Efficacy|3|||
42035398|NCT00925587|75843762|FG001|Overall Study|Physician Decision|1|||
42272163|NCT02525744|76102333|FG003|Period 3|Adverse Event|0|||
42272164|NCT02525744|76102330|FG000|Period 4|Withdrawal by Subject|1|||
42272165|NCT02525744|76102331|FG001|Period 4|Withdrawal by Subject|0|||
42272166|NCT02525744|76102332|FG002|Period 4|Withdrawal by Subject|0|||
42006663|NCT01305408|75814183|FG001|Overall Study|Lack of Efficacy|4|||
42006664|NCT01305408|75814182|FG000|Overall Study|Withdrawal by Subject|9|||
42006665|NCT01305408|75814183|FG001|Overall Study|Withdrawal by Subject|9|||
42006666|NCT01305408|75814182|FG000|Overall Study|Protocol Violation|4|||
42006667|NCT01305408|75814183|FG001|Overall Study|Protocol Violation|6|||
42006668|NCT01305408|75814182|FG000|Overall Study|Lost to Follow-up|5|||
42006669|NCT01305408|75814183|FG001|Overall Study|Lost to Follow-up|3|||
42006670|NCT01305408|75814182|FG000|Overall Study|Noncompliance with study medication|0|||
42006671|NCT01305408|75814183|FG001|Overall Study|Noncompliance with study medication|1|||
42006672|NCT01305408|75814182|FG000|Overall Study|Noncompliance with study procedures|0|||
42006673|NCT01305408|75814183|FG001|Overall Study|Noncompliance with study procedures|1|||
42006674|NCT01305408|75814182|FG000|Overall Study|Other|1|||
42006675|NCT01305408|75814183|FG001|Overall Study|Other|0|||
42006676|NCT01304940|75814191|FG000|Overall Study|not meet symptom severity requirement|3|||
42006677|NCT01304940|75814192|FG001|Overall Study|not meet symptom severity requirement|0|||
42006678|NCT01261611|75814201|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
42006679|NCT01261611|75814202|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
42006680|NCT01261611|75814203|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
42006681|NCT01261611|75814201|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
42006682|NCT01261611|75814202|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
42006683|NCT01261611|75814203|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
42006684|NCT01261611|75814201|FG000|Treatment Cycle 1|Adverse Event|0|||
42006685|NCT01261611|75814202|FG001|Treatment Cycle 1|Adverse Event|1|||
42006686|NCT01261611|75814203|FG002|Treatment Cycle 1|Adverse Event|0|||
42006687|NCT01261611|75814201|FG000|Treatment Cycle 1|Protocol Violation|0|||
42006688|NCT01261611|75814202|FG001|Treatment Cycle 1|Protocol Violation|0|||
42006689|NCT01261611|75814203|FG002|Treatment Cycle 1|Protocol Violation|2|||
42006690|NCT01261611|75814201|FG000|Treatment Cycle 2|Completed study|4|||
42006691|NCT01261611|75814202|FG001|Treatment Cycle 2|Completed study|0|||
42006692|NCT01261611|75814203|FG002|Treatment Cycle 2|Completed study|0|||
42006693|NCT01261611|75814201|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
42006694|NCT01261611|75814202|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
42006695|NCT01261611|75814203|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
42006696|NCT01261611|75814201|FG000|Treatment Cycle 2|Adverse Event|1|||
42006697|NCT01261611|75814202|FG001|Treatment Cycle 2|Adverse Event|0|||
42006698|NCT01261611|75814203|FG002|Treatment Cycle 2|Adverse Event|0|||
42006699|NCT01261611|75814201|FG000|Treatment Cycle 2|Protocol Violation|2|||
42006700|NCT01261611|75814202|FG001|Treatment Cycle 2|Protocol Violation|0|||
42006701|NCT01261611|75814203|FG002|Treatment Cycle 2|Protocol Violation|0|||
42006702|NCT01261611|75814201|FG000|Treatment Cycle 2|Not otherwise specified|2|||
42006703|NCT01261611|75814202|FG001|Treatment Cycle 2|Not otherwise specified|0|||
42006704|NCT01261611|75814203|FG002|Treatment Cycle 2|Not otherwise specified|0|||
42006705|NCT01261611|75814201|FG000|Treatment Cycle 3|Completed study|24|||
42006706|NCT01261611|75814202|FG001|Treatment Cycle 3|Completed study|0|||
42006707|NCT01261611|75814203|FG002|Treatment Cycle 3|Completed study|0|||
42006708|NCT01261611|75814201|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
42006709|NCT01261611|75814202|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
42006710|NCT01261611|75814203|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
42137566|NCT00443820|75947877|FG000|Overall Study|Lost to Follow-up|9|||
42137567|NCT00443820|75947878|FG001|Overall Study|Lost to Follow-up|8|||
42137568|NCT00443820|75947879|FG002|Overall Study|Lost to Follow-up|6|||
42272167|NCT02525744|76102333|FG003|Period 4|Withdrawal by Subject|0|||
42272168|NCT02525744|76102330|FG000|Period 5|Physician Decision|1|||
42006711|NCT01261611|75814201|FG000|Treatment Cycle 3|Adverse Event|1|||
42006712|NCT01261611|75814202|FG001|Treatment Cycle 3|Adverse Event|0|||
42006713|NCT01261611|75814203|FG002|Treatment Cycle 3|Adverse Event|0|||
42006714|NCT01261611|75814201|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
42006715|NCT01261611|75814202|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
42006716|NCT01261611|75814203|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
42006717|NCT01261611|75814201|FG000|Treatment Cycle 4|Completed study|87|||
42006718|NCT01261611|75814202|FG001|Treatment Cycle 4|Completed study|0|||
42006719|NCT01261611|75814203|FG002|Treatment Cycle 4|Completed study|0|||
42006720|NCT01261611|75814201|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
42272169|NCT02525744|76102331|FG001|Period 5|Physician Decision|0|||
42006721|NCT01261611|75814202|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
42006722|NCT01261611|75814203|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
42006723|NCT01261611|75814201|FG000|Treatment Cycle 4|Adverse Event|1|||
42272170|NCT02525744|76102332|FG002|Period 5|Physician Decision|0|||
42006724|NCT01261611|75814202|FG001|Treatment Cycle 4|Adverse Event|0|||
42006725|NCT01261611|75814203|FG002|Treatment Cycle 4|Adverse Event|0|||
42006726|NCT01261611|75814201|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
42137569|NCT00443820|75947880|FG003|Overall Study|Lost to Follow-up|5|||
42272171|NCT02525744|76102333|FG003|Period 5|Physician Decision|0|||
42272172|NCT00152477|76102346|FG000|Chemotherapy Period|Adverse Event|9|||
42006727|NCT01261611|75814202|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
42006728|NCT01261611|75814203|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
42137570|NCT00443820|75947877|FG000|Overall Study|Administrative problems|0|||
42272173|NCT00152477|76102347|FG001|Chemotherapy Period|Adverse Event|4|||
42006729|NCT01261611|75814201|FG000|Treatment Cycle 4|Not otherwise specified|3|||
42006730|NCT01261611|75814202|FG001|Treatment Cycle 4|Not otherwise specified|0|||
42006731|NCT01261611|75814203|FG002|Treatment Cycle 4|Not otherwise specified|0|||
42006732|NCT01261611|75814201|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
42006733|NCT01261611|75814202|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
42006734|NCT01261611|75814203|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
42006735|NCT01261611|75814201|FG000|Treatment Cycle 5|Adverse Event|1|||
42006736|NCT01261611|75814202|FG001|Treatment Cycle 5|Adverse Event|0|||
42006737|NCT01261611|75814203|FG002|Treatment Cycle 5|Adverse Event|0|||
42006738|NCT01261611|75814201|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
42006739|NCT01261611|75814202|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
42006740|NCT01261611|75814203|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
42006741|NCT01304706|75814215|FG000|Overall Study|Adverse Event|2|||
42006742|NCT01304706|75814215|FG000|Overall Study|Lack of Efficacy|1|||
42006743|NCT01304706|75814215|FG000|Overall Study|Death|3|||
42006744|NCT01304706|75814215|FG000|Overall Study|Withdrawal by Subject|3|||
42006745|NCT01304706|75814215|FG000|Overall Study|Lost to Follow-up|7|||
42006746|NCT01304706|75814215|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
42006747|NCT01303380|75814219|FG000|Overall Study|Lack of compliance to study procedures|1|||
42006748|NCT01008553|75814223|FG000|Period 1 (Titration Period)|Physician Decision|2|||
42006749|NCT01008553|75814224|FG001|Period 1 (Titration Period)|Physician Decision|0|||
42006750|NCT01008553|75814225|FG002|Period 1 (Titration Period)|Physician Decision|0|||
42006751|NCT01008553|75814223|FG000|Period 1 (Titration Period)|Adverse Event|33|||
42006752|NCT01008553|75814224|FG001|Period 1 (Titration Period)|Adverse Event|0|||
42006753|NCT01008553|75814225|FG002|Period 1 (Titration Period)|Adverse Event|0|||
42006754|NCT01008553|75814223|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
42006755|NCT01008553|75814224|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
42006756|NCT01008553|75814225|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
42006757|NCT01008553|75814223|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
42006758|NCT01008553|75814224|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
42006759|NCT01008553|75814225|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
42006760|NCT01008553|75814223|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
42006761|NCT01008553|75814224|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
42006762|NCT01008553|75814225|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
42006763|NCT01008553|75814223|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
42006764|NCT01008553|75814224|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
42006765|NCT01008553|75814225|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
42006766|NCT01008553|75814223|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
42006767|NCT01008553|75814224|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
42006768|NCT01008553|75814225|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
42006769|NCT01008553|75814223|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
42006770|NCT01008553|75814224|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
42006771|NCT01008553|75814225|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
42006772|NCT01008553|75814223|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
42006773|NCT01008553|75814224|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
42006774|NCT01008553|75814225|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
42006775|NCT01008553|75814223|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
42006776|NCT01008553|75814224|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
42006777|NCT01008553|75814225|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
42006778|NCT01008553|75814223|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
42006779|NCT01008553|75814224|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
42006780|NCT01008553|75814225|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
42006781|NCT01008553|75814223|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
42006782|NCT01008553|75814224|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
42006783|NCT01008553|75814225|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
42006784|NCT01008553|75814223|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
42006785|NCT01008553|75814224|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
42006786|NCT01008553|75814225|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
42006787|NCT01008553|75814223|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
42035399|NCT00925587|75843761|FG000|Overall Study|Protocol Violation|6|||
42035400|NCT00925587|75843762|FG001|Overall Study|Protocol Violation|4|||
42035401|NCT00925587|75843761|FG000|Overall Study|Withdrawal by Subject|9|||
42035402|NCT00925587|75843762|FG001|Overall Study|Withdrawal by Subject|6|||
42035403|NCT00925587|75843761|FG000|Overall Study|Death|5|||
42035404|NCT00925587|75843762|FG001|Overall Study|Death|5|||
42346760|NCT01877421|76185699|FG011|Phase 2|Withdrawal by Subject|0|||
42006788|NCT01008553|75814224|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
42035405|NCT00925587|75843761|FG000|Overall Study|Adverse Event|6|||
42035406|NCT00925587|75843762|FG001|Overall Study|Adverse Event|2|||
42006789|NCT01008553|75814225|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
42006790|NCT01259115|75814234|FG000|Period 1|Adverse Event|1|||
42006791|NCT01259115|75814235|FG001|Period 1|Adverse Event|0|||
42006792|NCT01259115|75814234|FG000|Period 1|Protocol Violation|2|||
42006793|NCT01259115|75814235|FG001|Period 1|Protocol Violation|0|||
42006794|NCT01259115|75814234|FG000|Period 1|Lost to Follow-up|0|||
42006795|NCT01259115|75814235|FG001|Period 1|Lost to Follow-up|1|||
42006796|NCT01259115|75814234|FG000|Period 2|Adverse Event|1|||
42006797|NCT01259115|75814235|FG001|Period 2|Adverse Event|0|||
42006798|NCT01302366|75814246|FG000|Overall Study|patient choice or noncompliance|5|||
42006799|NCT01302054|75814250|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
42006800|NCT01302054|75814251|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
42006801|NCT01302054|75814252|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
42006802|NCT01302054|75814250|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
42006803|NCT01302054|75814251|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
42006804|NCT01302054|75814252|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
42006805|NCT01302054|75814250|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
42006806|NCT01302054|75814251|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
42006807|NCT01302054|75814252|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
42006808|NCT01302054|75814250|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
42006809|NCT01302054|75814251|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
42006810|NCT01302054|75814252|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
42006811|NCT01302054|75814250|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
42006812|NCT01302054|75814251|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
42006813|NCT01302054|75814252|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
42006814|NCT01302054|75814250|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
42006815|NCT01302054|75814251|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
42006816|NCT01302054|75814252|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
42006817|NCT01302054|75814250|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
42006818|NCT01302054|75814251|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
42006819|NCT01302054|75814252|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
42006820|NCT01302054|75814250|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
42006821|NCT01302054|75814251|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
42006822|NCT01302054|75814252|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
42006823|NCT01302054|75814250|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
42006824|NCT01302054|75814251|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
42006825|NCT01302054|75814252|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
42006826|NCT01302054|75814250|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
42006827|NCT01302054|75814251|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
42006828|NCT01302054|75814252|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
42006829|NCT01302054|75814250|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
42006830|NCT01302054|75814251|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
42006831|NCT01302054|75814252|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
42006832|NCT01302054|75814250|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
42006833|NCT01302054|75814251|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
42006834|NCT01302054|75814252|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
42006835|NCT01302054|75814250|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
42006836|NCT01302054|75814251|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
42006837|NCT01302054|75814252|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
42006838|NCT01302054|75814250|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
42006839|NCT01302054|75814251|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
42006840|NCT01302054|75814252|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
42006841|NCT01302054|75814250|FG000|Double-Blind Treatment Phase|Other|0|||
42006842|NCT01302054|75814251|FG001|Double-Blind Treatment Phase|Other|4|||
42006843|NCT01302054|75814252|FG002|Double-Blind Treatment Phase|Other|9|||
42006844|NCT01301508|75814263|FG000|Overall Study|Withdrawal by Subject|1|||
42006845|NCT01301508|75814264|FG001|Overall Study|Withdrawal by Subject|2|||
42006846|NCT01301508|75814263|FG000|Overall Study|Lost to Follow-up|0|||
42006847|NCT01301508|75814264|FG001|Overall Study|Lost to Follow-up|1|||
42006848|NCT01301274|75814272|FG000|Overall Study|Physician Decision|2|||
42006849|NCT01301274|75814273|FG001|Overall Study|Physician Decision|1|||
42006850|NCT01300650|75814284|FG000|Overall Study|Adverse Event|1|||
42006851|NCT01300572|75814289|FG000|Overall Study|HAMA + post dosimetry|1|||
42006852|NCT01077154|75814296|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
42006853|NCT01077154|75814297|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
42006854|NCT01077154|75814296|FG000|Overall Study|Withdrawal by Subject|369|||
42006855|NCT01077154|75814297|FG001|Overall Study|Withdrawal by Subject|385|||
42006856|NCT01077154|75814296|FG000|Overall Study|Death|215|||
42006857|NCT01077154|75814297|FG001|Overall Study|Death|214|||
42006858|NCT01077154|75814296|FG000|Overall Study|Lost to Follow-up|43|||
42006859|NCT01077154|75814297|FG001|Overall Study|Lost to Follow-up|35|||
42006860|NCT01077154|75814296|FG000|Overall Study|Noncompliance|22|||
42006861|NCT01077154|75814297|FG001|Overall Study|Noncompliance|20|||
42006862|NCT01077154|75814296|FG000|Overall Study|Disease Progression|18|||
42006863|NCT01077154|75814297|FG001|Overall Study|Disease Progression|20|||
42006864|NCT01077154|75814296|FG000|Overall Study|Ineligibility Determined|10|||
42006865|NCT01077154|75814297|FG001|Overall Study|Ineligibility Determined|14|||
42006866|NCT01077154|75814296|FG000|Overall Study|Other|14|||
42006867|NCT01077154|75814297|FG001|Overall Study|Other|11|||
42006868|NCT01077154|75814296|FG000|Overall Study|Adverse Event|9|||
42006869|NCT01077154|75814297|FG001|Overall Study|Adverse Event|9|||
42006870|NCT01077154|75814296|FG000|Overall Study|Administrative Decision|1|||
42006871|NCT01077154|75814297|FG001|Overall Study|Administrative Decision|6|||
42006872|NCT01077154|75814296|FG000|Overall Study|Protocol Deviation|1|||
42006873|NCT01077154|75814297|FG001|Overall Study|Protocol Deviation|0|||
42006874|NCT01258101|75814307|FG000|Overall Study|Adverse Event|5|||
42006875|NCT01258101|75814308|FG001|Overall Study|Adverse Event|6|||
42006876|NCT01258101|75814309|FG002|Overall Study|Adverse Event|0|||
42006877|NCT01258101|75814310|FG003|Overall Study|Adverse Event|0|||
42006878|NCT01258101|75814307|FG000|Overall Study|Extra exclusion criterion amended|2|||
42006879|NCT01258101|75814308|FG001|Overall Study|Extra exclusion criterion amended|1|||
42006880|NCT01258101|75814309|FG002|Overall Study|Extra exclusion criterion amended|1|||
42006881|NCT01258101|75814310|FG003|Overall Study|Extra exclusion criterion amended|1|||
42006882|NCT01258101|75814307|FG000|Overall Study|Informed consent has been withdrawn|2|||
42006883|NCT01258101|75814308|FG001|Overall Study|Informed consent has been withdrawn|2|||
42006884|NCT01258101|75814309|FG002|Overall Study|Informed consent has been withdrawn|1|||
42006885|NCT01258101|75814310|FG003|Overall Study|Informed consent has been withdrawn|1|||
42006886|NCT01258101|75814307|FG000|Overall Study|Patient is not able to attend visits|8|||
42006887|NCT01258101|75814308|FG001|Overall Study|Patient is not able to attend visits|9|||
42006888|NCT01258101|75814309|FG002|Overall Study|Patient is not able to attend visits|7|||
42006889|NCT01258101|75814310|FG003|Overall Study|Patient is not able to attend visits|6|||
42006890|NCT01258101|75814307|FG000|Overall Study|Patient´s compliance|4|||
42006891|NCT01258101|75814308|FG001|Overall Study|Patient´s compliance|3|||
42006892|NCT01258101|75814309|FG002|Overall Study|Patient´s compliance|1|||
42006893|NCT01258101|75814310|FG003|Overall Study|Patient´s compliance|2|||
42006894|NCT01258101|75814307|FG000|Overall Study|Lost to Follow-up|5|||
42006895|NCT01258101|75814308|FG001|Overall Study|Lost to Follow-up|5|||
42006896|NCT01258101|75814309|FG002|Overall Study|Lost to Follow-up|0|||
42006897|NCT01258101|75814310|FG003|Overall Study|Lost to Follow-up|6|||
42006898|NCT01258101|75814307|FG000|Overall Study|PCR positive at week 24|0|||
42006899|NCT01258101|75814308|FG001|Overall Study|PCR positive at week 24|0|||
42006900|NCT01258101|75814309|FG002|Overall Study|PCR positive at week 24|0|||
42006901|NCT01258101|75814310|FG003|Overall Study|PCR positive at week 24|1|||
42006902|NCT01258101|75814307|FG000|Overall Study|Other reason|7|||
42006903|NCT01258101|75814308|FG001|Overall Study|Other reason|8|||
42006904|NCT01258101|75814309|FG002|Overall Study|Other reason|1|||
42006905|NCT01258101|75814310|FG003|Overall Study|Other reason|8|||
42006906|NCT01300338|75814322|FG000|Overall Study|Lost to Follow-up|5|||
42006907|NCT01300338|75814323|FG001|Overall Study|Lost to Follow-up|0|||
42006908|NCT01300260|75814331|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
42006909|NCT01300260|75814332|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
42006910|NCT01300260|75814331|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
42006911|NCT01300260|75814332|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
42006912|NCT01300260|75814331|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
42006913|NCT01300260|75814332|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
42006914|NCT01256385|75814351|FG000|Overall Study|Physician Decision|1|||
42006915|NCT01256385|75814352|FG001|Overall Study|Physician Decision|1|||
42006916|NCT01256385|75814351|FG000|Overall Study|Withdrawal by Subject|2|||
42137571|NCT00443820|75947878|FG001|Overall Study|Administrative problems|0|||
42137572|NCT00443820|75947879|FG002|Overall Study|Administrative problems|0|||
42137573|NCT00443820|75947880|FG003|Overall Study|Administrative problems|1|||
42035407|NCT00925587|75843761|FG000|Overall Study|Lost to Follow-up|0|||
42272174|NCT00152477|76102348|FG002|Chemotherapy Period|Adverse Event|5|||
42272175|NCT00152477|76102346|FG000|Chemotherapy Period|Death|1|||
42272176|NCT00152477|76102347|FG001|Chemotherapy Period|Death|3|||
42272177|NCT00152477|76102348|FG002|Chemotherapy Period|Death|3|||
42272178|NCT00152477|76102346|FG000|Chemotherapy Period|Lack of Efficacy|4|||
42006917|NCT01256385|75814352|FG001|Overall Study|Withdrawal by Subject|2|||
42006918|NCT01298778|75814360|FG000|Overall Study|Lost to Follow-up|2|||
42006919|NCT01298778|75814361|FG001|Overall Study|Lost to Follow-up|3|||
42006920|NCT01298778|75814360|FG000|Overall Study|Incorrect use of VAS|1|||
42006921|NCT01298778|75814361|FG001|Overall Study|Incorrect use of VAS|0|||
42006922|NCT01298778|75814360|FG000|Overall Study|Withdrawal by Subject|0|||
42006923|NCT01298778|75814361|FG001|Overall Study|Withdrawal by Subject|1|||
42137574|NCT00443820|75947877|FG000|Overall Study|Death|0|||
42272179|NCT00152477|76102347|FG001|Chemotherapy Period|Lack of Efficacy|5|||
42006924|NCT01298778|75814360|FG000|Overall Study|Protocol Violation|0|||
42006925|NCT01298778|75814361|FG001|Overall Study|Protocol Violation|1|||
42006926|NCT01298778|75814360|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
42006927|NCT01298778|75814361|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
42006928|NCT01298700|75814371|FG000|Overall Study|Adverse Event|50|||
42006929|NCT01298700|75814372|FG001|Overall Study|Adverse Event|51|||
42006930|NCT01298700|75814371|FG000|Overall Study|Lack of Efficacy|9|||
42006931|NCT01298700|75814372|FG001|Overall Study|Lack of Efficacy|14|||
42006932|NCT01298700|75814371|FG000|Overall Study|Lost to Follow-up|5|||
42006933|NCT01298700|75814372|FG001|Overall Study|Lost to Follow-up|2|||
42006934|NCT01298700|75814371|FG000|Overall Study|Withdrawal by Subject|12|||
42006935|NCT01298700|75814372|FG001|Overall Study|Withdrawal by Subject|9|||
42006936|NCT01298700|75814371|FG000|Overall Study|Protocol Violation|6|||
42006937|NCT01298700|75814372|FG001|Overall Study|Protocol Violation|4|||
42006938|NCT01298700|75814371|FG000|Overall Study|Other Miscellaneous Reasons|16|||
42006939|NCT01298700|75814372|FG001|Overall Study|Other Miscellaneous Reasons|15|||
42006940|NCT01298700|75814371|FG000|Overall Study|Did not Receive Study Drug|3|||
42006941|NCT01298700|75814372|FG001|Overall Study|Did not Receive Study Drug|5|||
42006942|NCT01297920|75814381|FG000|Overall Study|Adverse Event|42|||
42006943|NCT01297920|75814382|FG001|Overall Study|Adverse Event|10|||
42006944|NCT01297920|75814383|FG002|Overall Study|Adverse Event|38|||
42006945|NCT01297920|75814381|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
42006946|NCT01297920|75814382|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
42006947|NCT01297920|75814383|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
42006948|NCT01297920|75814381|FG000|Overall Study|Noncompliance|1|||
42006949|NCT01297920|75814382|FG001|Overall Study|Noncompliance|0|||
42006950|NCT01297920|75814383|FG002|Overall Study|Noncompliance|0|||
42006951|NCT01297920|75814381|FG000|Overall Study|Protocol Violation|1|||
42006952|NCT01297920|75814382|FG001|Overall Study|Protocol Violation|3|||
42006953|NCT01297920|75814383|FG002|Overall Study|Protocol Violation|0|||
42006954|NCT01297920|75814381|FG000|Overall Study|Inadequate Control of IOP|7|||
42006955|NCT01297920|75814382|FG001|Overall Study|Inadequate Control of IOP|9|||
42035408|NCT00925587|75843762|FG001|Overall Study|Lost to Follow-up|1|||
42035409|NCT00928707|75843774|FG000|Overall Study|Protocol Violation|1|||
42035410|NCT00928707|75843775|FG001|Overall Study|Protocol Violation|0|||
42035411|NCT00930813|75843783|FG000|Overall Study|Death|4|||
42035412|NCT00930813|75843784|FG001|Overall Study|Death|5|||
42035413|NCT00930813|75843783|FG000|Overall Study|Withdrawal by Subject|2|||
42035414|NCT00930813|75843784|FG001|Overall Study|Withdrawal by Subject|5|||
42035415|NCT00930813|75843783|FG000|Overall Study|Lost to Follow-up|2|||
42035416|NCT00930813|75843784|FG001|Overall Study|Lost to Follow-up|4|||
42035417|NCT00930579|75843792|FG000|Overall Study|Withdrawal by Subject|1|||
42035418|NCT00930579|75843792|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
42035419|NCT00925353|75843796|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
42035420|NCT01106651|75843820|FG000|Overall Study|Adverse Event|17|||
42035421|NCT01106651|75843821|FG001|Overall Study|Adverse Event|9|||
42035422|NCT01106651|75843822|FG002|Overall Study|Adverse Event|23|||
42035423|NCT01106651|75843820|FG000|Overall Study|Lost to Follow-up|8|||
42035424|NCT01106651|75843821|FG001|Overall Study|Lost to Follow-up|2|||
42272180|NCT00152477|76102348|FG002|Chemotherapy Period|Lack of Efficacy|6|||
42272181|NCT00152477|76102346|FG000|Chemotherapy Period|Lost to Follow-up|1|||
42272182|NCT00152477|76102347|FG001|Chemotherapy Period|Lost to Follow-up|0|||
42006956|NCT01297920|75814383|FG002|Overall Study|Inadequate Control of IOP|17|||
42006957|NCT01297920|75814381|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
42006958|NCT01297920|75814382|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
42006959|NCT01297920|75814383|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
42006960|NCT01255761|75814393|FG000|Overall Study|Adverse Event|29|||
42006961|NCT01255761|75814394|FG001|Overall Study|Adverse Event|43|||
42006962|NCT01255761|75814393|FG000|Overall Study|Lack of Efficacy|86|||
42006963|NCT01255761|75814394|FG001|Overall Study|Lack of Efficacy|74|||
42035425|NCT01106651|75843822|FG002|Overall Study|Lost to Follow-up|6|||
42006964|NCT01255761|75814393|FG000|Overall Study|Protocol Violation|9|||
42006965|NCT01255761|75814394|FG001|Overall Study|Protocol Violation|5|||
42006966|NCT01255761|75814393|FG000|Overall Study|Lost to Follow-up|10|||
42006967|NCT01255761|75814394|FG001|Overall Study|Lost to Follow-up|8|||
42006968|NCT01255761|75814393|FG000|Overall Study|Withdrawal by Subject|11|||
42035426|NCT01106651|75843820|FG000|Overall Study|Physician Decision|4|||
42035427|NCT01106651|75843821|FG001|Overall Study|Physician Decision|3|||
42035428|NCT01106651|75843822|FG002|Overall Study|Physician Decision|1|||
42272183|NCT00152477|76102348|FG002|Chemotherapy Period|Lost to Follow-up|1|||
42006969|NCT01255761|75814394|FG001|Overall Study|Withdrawal by Subject|27|||
42006970|NCT01255761|75814393|FG000|Overall Study|Other Reasons|37|||
42006971|NCT01255761|75814394|FG001|Overall Study|Other Reasons|18|||
42006972|NCT01297062|75814406|FG000|Overall Study|Adverse Event|2|||
42006973|NCT01297062|75814407|FG001|Overall Study|Adverse Event|0|||
42006974|NCT01297062|75814408|FG002|Overall Study|Adverse Event|1|||
42035429|NCT01106651|75843820|FG000|Overall Study|Protocol Violation|1|||
42272184|NCT00152477|76102346|FG000|Chemotherapy Period|Protocol Violation|1|||
42035430|NCT01106651|75843821|FG001|Overall Study|Protocol Violation|2|||
42035431|NCT01106651|75843822|FG002|Overall Study|Protocol Violation|1|||
42035432|NCT01106651|75843820|FG000|Overall Study|Withdrawal by Subject|14|||
42035433|NCT01106651|75843821|FG001|Overall Study|Withdrawal by Subject|7|||
42035434|NCT01106651|75843822|FG002|Overall Study|Withdrawal by Subject|4|||
42035435|NCT01106651|75843820|FG000|Overall Study|Noncompliance with study drug|1|||
42035436|NCT01106651|75843821|FG001|Overall Study|Noncompliance with study drug|0|||
42035437|NCT01106651|75843822|FG002|Overall Study|Noncompliance with study drug|2|||
42035438|NCT01106651|75843820|FG000|Overall Study|Other|34|||
42035439|NCT01106651|75843821|FG001|Overall Study|Other|31|||
42035440|NCT01106651|75843822|FG002|Overall Study|Other|21|||
42035441|NCT01106651|75843820|FG000|Overall Study|Death|0|||
42035442|NCT01106651|75843821|FG001|Overall Study|Death|3|||
42035443|NCT01106651|75843822|FG002|Overall Study|Death|0|||
42035444|NCT01027650|75843841|FG000|Overall Study|Personal Reasons|0|||
42035445|NCT01027650|75843842|FG001|Overall Study|Personal Reasons|0|||
42035446|NCT01027650|75843843|FG002|Overall Study|Personal Reasons|0|||
42035447|NCT01027650|75843844|FG003|Overall Study|Personal Reasons|0|||
42035448|NCT01027650|75843845|FG004|Overall Study|Personal Reasons|2|||
42035449|NCT01027650|75843846|FG005|Overall Study|Personal Reasons|1|||
42035450|NCT01027650|75843847|FG006|Overall Study|Personal Reasons|0|||
42035451|NCT01027650|75843848|FG007|Overall Study|Personal Reasons|0|||
42035452|NCT01027650|75843841|FG000|Overall Study|Lost to Follow-up|0|||
42035453|NCT01027650|75843842|FG001|Overall Study|Lost to Follow-up|0|||
42035454|NCT01027650|75843843|FG002|Overall Study|Lost to Follow-up|0|||
42035455|NCT01027650|75843844|FG003|Overall Study|Lost to Follow-up|0|||
42035456|NCT01027650|75843845|FG004|Overall Study|Lost to Follow-up|0|||
42035457|NCT01027650|75843846|FG005|Overall Study|Lost to Follow-up|0|||
42035458|NCT01027650|75843847|FG006|Overall Study|Lost to Follow-up|1|||
42006975|NCT01297062|75814409|FG003|Overall Study|Adverse Event|0|||
42006976|NCT01297062|75814410|FG004|Overall Study|Adverse Event|0|||
42006977|NCT01297062|75814411|FG005|Overall Study|Adverse Event|0|||
42006978|NCT01297062|75814412|FG006|Overall Study|Adverse Event|0|||
42006979|NCT01297062|75814406|FG000|Overall Study|Physician Decision|1|||
42006980|NCT01297062|75814407|FG001|Overall Study|Physician Decision|0|||
42006981|NCT01297062|75814408|FG002|Overall Study|Physician Decision|1|||
42006982|NCT01297062|75814409|FG003|Overall Study|Physician Decision|0|||
42006983|NCT01297062|75814410|FG004|Overall Study|Physician Decision|0|||
42006984|NCT01297062|75814411|FG005|Overall Study|Physician Decision|0|||
42006985|NCT01297062|75814412|FG006|Overall Study|Physician Decision|6|||
42006986|NCT01297062|75814406|FG000|Overall Study|Protocol Violation|0|||
42006987|NCT01297062|75814407|FG001|Overall Study|Protocol Violation|0|||
42006988|NCT01297062|75814408|FG002|Overall Study|Protocol Violation|0|||
42006989|NCT01297062|75814409|FG003|Overall Study|Protocol Violation|0|||
42006990|NCT01297062|75814410|FG004|Overall Study|Protocol Violation|1|||
42006991|NCT01297062|75814411|FG005|Overall Study|Protocol Violation|0|||
42006992|NCT01297062|75814412|FG006|Overall Study|Protocol Violation|0|||
42006993|NCT01297062|75814406|FG000|Overall Study|Subject Decision|1|||
42006994|NCT01297062|75814407|FG001|Overall Study|Subject Decision|1|||
42006995|NCT01297062|75814408|FG002|Overall Study|Subject Decision|0|||
42035459|NCT01027650|75843848|FG007|Overall Study|Lost to Follow-up|0|||
42035460|NCT01027650|75843841|FG000|Overall Study|Lack of Efficacy|0|||
42035461|NCT01027650|75843842|FG001|Overall Study|Lack of Efficacy|0|||
42006996|NCT01297062|75814409|FG003|Overall Study|Subject Decision|1|||
42006997|NCT01297062|75814410|FG004|Overall Study|Subject Decision|1|||
42006998|NCT01297062|75814411|FG005|Overall Study|Subject Decision|1|||
42006999|NCT01297062|75814412|FG006|Overall Study|Subject Decision|2|||
42007000|NCT01254747|75814424|FG000|Overall Study|Unacceptable subjective vision|0|||
42007001|NCT01254747|75814425|FG001|Overall Study|Unacceptable subjective vision|0|||
42035462|NCT01027650|75843843|FG002|Overall Study|Lack of Efficacy|0|||
42272185|NCT00152477|76102347|FG001|Chemotherapy Period|Protocol Violation|1|||
42272186|NCT00152477|76102348|FG002|Chemotherapy Period|Protocol Violation|0|||
42272187|NCT00152477|76102346|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
42007002|NCT01254747|75814426|FG002|Overall Study|Unacceptable subjective vision|0|||
42007003|NCT01254747|75814427|FG003|Overall Study|Unacceptable subjective vision|2|||
42007004|NCT01254747|75814424|FG000|Overall Study|Difficult removal handling|0|||
42007005|NCT01254747|75814425|FG001|Overall Study|Difficult removal handling|0|||
42007006|NCT01254747|75814426|FG002|Overall Study|Difficult removal handling|1|||
42035463|NCT01027650|75843844|FG003|Overall Study|Lack of Efficacy|0|||
42035464|NCT01027650|75843845|FG004|Overall Study|Lack of Efficacy|0|||
42035465|NCT01027650|75843846|FG005|Overall Study|Lack of Efficacy|1|||
42035466|NCT01027650|75843847|FG006|Overall Study|Lack of Efficacy|0|||
42035467|NCT01027650|75843848|FG007|Overall Study|Lack of Efficacy|0|||
42035468|NCT01106027|75843866|FG000|Overall Study|Lost graft early, discontinued|1|||
42035469|NCT00927927|75843885|FG000|Overall Study|Withdrawal by Subject|0|||
42346761|NCT01877421|76185700|FG012|Phase 2|Withdrawal by Subject|1|||
42007007|NCT01254747|75814427|FG003|Overall Study|Difficult removal handling|0|||
42007008|NCT01254747|75814424|FG000|Overall Study|Symptoms and problems|0|||
42035470|NCT00927927|75843886|FG001|Overall Study|Withdrawal by Subject|0|||
42035471|NCT00927927|75843887|FG002|Overall Study|Withdrawal by Subject|0|||
42035472|NCT00927927|75843888|FG003|Overall Study|Withdrawal by Subject|0|||
42035473|NCT00927927|75843889|FG004|Overall Study|Withdrawal by Subject|0|||
42035474|NCT00927927|75843890|FG005|Overall Study|Withdrawal by Subject|0|||
42035475|NCT00927927|75843891|FG006|Overall Study|Withdrawal by Subject|0|||
42035476|NCT00927927|75843892|FG007|Overall Study|Withdrawal by Subject|2|||
42035477|NCT00927927|75843893|FG008|Overall Study|Withdrawal by Subject|0|||
42035478|NCT00927927|75843894|FG009|Overall Study|Withdrawal by Subject|0|||
42035479|NCT00927927|75843895|FG010|Overall Study|Withdrawal by Subject|0|||
42035480|NCT00927927|75843896|FG011|Overall Study|Withdrawal by Subject|2|||
42035481|NCT00927927|75843897|FG012|Overall Study|Withdrawal by Subject|0|||
42035482|NCT00927927|75843898|FG013|Overall Study|Withdrawal by Subject|0|||
42035483|NCT00927927|75843899|FG014|Overall Study|Withdrawal by Subject|0|||
42035484|NCT01027416|75843933|FG000|Overall Study|Withdrawal by Subject|0|||
42035485|NCT01027416|75843934|FG001|Overall Study|Withdrawal by Subject|1|||
42035486|NCT01027416|75843933|FG000|Overall Study|Physician Decision|1|||
42035487|NCT01027416|75843934|FG001|Overall Study|Physician Decision|4|||
42035488|NCT00923559|75843942|FG000|Overall Study|Lost to Follow-up|2|||
42035489|NCT00923559|75843943|FG001|Overall Study|Lost to Follow-up|3|||
42035490|NCT01015638|75843953|FG000|Overall Study|Withdrawal by Subject|1|||
42035491|NCT01015638|75843954|FG001|Overall Study|Withdrawal by Subject|0|||
42035492|NCT01022502|75843960|FG000|Overall Study|Adverse Event|1|||
42035493|NCT01022502|75843960|FG000|Overall Study|employment related reasons|1|||
42035494|NCT01022502|75843960|FG000|Overall Study|Withdrawal by Subject|1|||
42035495|NCT01105091|75843968|FG000|Overall Study|Death|2|||
42035496|NCT01105091|75843969|FG001|Overall Study|Death|0|||
42035497|NCT00924729|75843979|FG000|Overall Study|insufficient volume for analysis|1|||
42035498|NCT00924729|75843980|FG001|Overall Study|insufficient volume for analysis|0|||
42035499|NCT00924729|75843979|FG000|Overall Study|Protocol Violation|1|||
42035500|NCT00924729|75843980|FG001|Overall Study|Protocol Violation|0|||
42035501|NCT01099709|75843988|FG000|Period 1|Withdrawal by Subject|0|||
42035502|NCT01099709|75843989|FG001|Period 1|Withdrawal by Subject|1|||
42035503|NCT01099709|75843988|FG000|Period 1|Positive cotinine test|0|||
42035504|NCT01099709|75843989|FG001|Period 1|Positive cotinine test|1|||
42035505|NCT01099709|75843988|FG000|Period 1|Adverse Event|1|||
42035506|NCT01099709|75843989|FG001|Period 1|Adverse Event|0|||
42007009|NCT01254747|75814425|FG001|Overall Study|Symptoms and problems|2|||
42007010|NCT01254747|75814426|FG002|Overall Study|Symptoms and problems|1|||
42007011|NCT01254747|75814427|FG003|Overall Study|Symptoms and problems|0|||
42007012|NCT01254747|75814424|FG000|Overall Study|Lost to Follow-up|0|||
42007013|NCT01254747|75814425|FG001|Overall Study|Lost to Follow-up|0|||
42035507|NCT01099397|75843996|FG000|Overall Study|Lost to Follow-up|4|||
42035508|NCT01099397|75843996|FG000|Overall Study|Protocol Violation|4|||
42035509|NCT01099397|75843996|FG000|Overall Study|Withdrawal by Subject|5|||
42035510|NCT01022424|75844001|FG000|Overall Study|Adverse Event|1|||
42035511|NCT01022424|75844001|FG000|Overall Study|Physician Decision|1|||
42035512|NCT01022424|75844001|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
42035513|NCT01098851|75844011|FG000|Overall Study|Equipment failure|1|||
42035514|NCT01098851|75844012|FG001|Overall Study|Equipment failure|0|||
42035515|NCT01026948|75844018|FG000|Overall Study|Physician Decision|8|||
42035516|NCT01104779|75844026|FG000|Overall Study|Protocol Violation|1|||
42035517|NCT01104779|75844027|FG001|Overall Study|Protocol Violation|2|||
42035518|NCT01104779|75844028|FG002|Overall Study|Protocol Violation|2|||
42035519|NCT01104779|75844026|FG000|Overall Study|Lack of Efficacy|26|||
42035520|NCT01104779|75844027|FG001|Overall Study|Lack of Efficacy|12|||
42272188|NCT00152477|76102347|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
42272189|NCT00152477|76102348|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
42035521|NCT01104779|75844028|FG002|Overall Study|Lack of Efficacy|13|||
42035522|NCT01104779|75844026|FG000|Overall Study|Adverse Event|13|||
42035523|NCT01104779|75844027|FG001|Overall Study|Adverse Event|14|||
42035524|NCT01104779|75844028|FG002|Overall Study|Adverse Event|13|||
42272190|NCT00152477|76102346|FG000|Chemotherapy Period|Progression of Disease|6|||
42007014|NCT01254747|75814426|FG002|Overall Study|Lost to Follow-up|1|||
42007015|NCT01254747|75814427|FG003|Overall Study|Lost to Follow-up|0|||
42035525|NCT01104779|75844026|FG000|Overall Study|Did not meet inc/exc criteria|1|||
42035526|NCT01104779|75844027|FG001|Overall Study|Did not meet inc/exc criteria|1|||
42035527|NCT01104779|75844028|FG002|Overall Study|Did not meet inc/exc criteria|1|||
42035528|NCT01104779|75844026|FG000|Overall Study|Other reasons|0|||
42035529|NCT01104779|75844027|FG001|Overall Study|Other reasons|1|||
42035530|NCT01104779|75844028|FG002|Overall Study|Other reasons|0|||
42035531|NCT01104779|75844026|FG000|Overall Study|Lost to Follow-up|2|||
42035532|NCT01104779|75844027|FG001|Overall Study|Lost to Follow-up|0|||
42035533|NCT01104779|75844028|FG002|Overall Study|Lost to Follow-up|1|||
42035534|NCT01104779|75844026|FG000|Overall Study|Withdrawal by Subject|16|||
42035535|NCT01104779|75844027|FG001|Overall Study|Withdrawal by Subject|25|||
42035536|NCT01104779|75844028|FG002|Overall Study|Withdrawal by Subject|32|||
42035537|NCT00918957|75844038|FG000|Overall Study|Adverse Event|2|||
42007016|NCT01254747|75814424|FG000|Overall Study|Biomicroscopy|0|||
42007017|NCT01254747|75814425|FG001|Overall Study|Biomicroscopy|0|||
42007018|NCT01254747|75814426|FG002|Overall Study|Biomicroscopy|1|||
42007019|NCT01254747|75814427|FG003|Overall Study|Biomicroscopy|0|||
42007020|NCT01254747|75814424|FG000|Overall Study|Discomfort|0|||
42007021|NCT01254747|75814425|FG001|Overall Study|Discomfort|4|||
42007022|NCT01254747|75814426|FG002|Overall Study|Discomfort|0|||
42007023|NCT01254747|75814427|FG003|Overall Study|Discomfort|0|||
42007024|NCT01296672|75814439|FG000|Overall Study|Lost to Follow-up|73|||
42035538|NCT00918957|75844039|FG001|Overall Study|Adverse Event|0|||
42035539|NCT00918957|75844038|FG000|Overall Study|Withdrawal by Subject|1|||
42035540|NCT00918957|75844039|FG001|Overall Study|Withdrawal by Subject|0|||
42035541|NCT01022268|75844047|FG000|Overall Study|Withdrawal by Subject|1|||
42035542|NCT01022268|75844048|FG001|Overall Study|Withdrawal by Subject|0|||
42035543|NCT01022268|75844047|FG000|Overall Study|Withdrawal by Subject|1|||
42035544|NCT01022268|75844048|FG001|Overall Study|Withdrawal by Subject|0|||
42035545|NCT01015560|75844054|FG000|Overall Study|Adverse Event|1|||
42035546|NCT01015560|75844054|FG000|Overall Study|Not protocol specified|1|||
42035547|NCT01015560|75844054|FG000|Overall Study|Withdrawal by Subject|1|||
42035548|NCT00918879|75844060|FG000|Overall Study|Withdrawal by Subject|4|||
42035549|NCT00918879|75844061|FG001|Overall Study|Withdrawal by Subject|4|||
42035550|NCT00918879|75844060|FG000|Overall Study|Lost to Follow-up|1|||
42035551|NCT00918879|75844061|FG001|Overall Study|Lost to Follow-up|1|||
42035552|NCT00918879|75844060|FG000|Overall Study|Severe non-compliance to protocol|1|||
42035553|NCT00918879|75844061|FG001|Overall Study|Severe non-compliance to protocol|1|||
42035554|NCT01026792|75844067|FG000|Overall Study|Protocol Violation|1|||
42035555|NCT01026324|75844074|FG000|Follow up/Survival|Withdrawal by Subject|1|||
42035556|NCT01026324|75844075|FG001|Follow up/Survival|Withdrawal by Subject|0|||
42035557|NCT01026324|75844076|FG002|Follow up/Survival|Withdrawal by Subject|0|||
42035558|NCT01098539|75844087|FG000|Overall Study|Adverse Event|26|||
42035559|NCT01098539|75844088|FG001|Overall Study|Adverse Event|26|||
42035560|NCT01098539|75844087|FG000|Overall Study|Protocol Violation|1|||
42035561|NCT01098539|75844088|FG001|Overall Study|Protocol Violation|4|||
42035562|NCT01098539|75844087|FG000|Overall Study|Noncompliance|3|||
42035563|NCT01098539|75844088|FG001|Overall Study|Noncompliance|5|||
42035564|NCT01098539|75844087|FG000|Overall Study|Lost to Follow-up|4|||
42035565|NCT01098539|75844088|FG001|Overall Study|Lost to Follow-up|4|||
42035566|NCT01098539|75844087|FG000|Overall Study|Withdrawal by Subject|12|||
42035567|NCT01098539|75844088|FG001|Overall Study|Withdrawal by Subject|26|||
42035568|NCT01098539|75844087|FG000|Overall Study|Physician Decision|5|||
42035569|NCT01098539|75844088|FG001|Overall Study|Physician Decision|3|||
42035570|NCT01098461|75844098|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
42007025|NCT01296672|75814440|FG001|Overall Study|Lost to Follow-up|18|||
42007026|NCT01254669|75814450|FG000|Overall Study|Withdrawal by Subject|0|||
42007027|NCT01254669|75814451|FG001|Overall Study|Withdrawal by Subject|1|||
42007028|NCT01254669|75814450|FG000|Overall Study|time constraint|2|||
42007029|NCT01254669|75814451|FG001|Overall Study|time constraint|2|||
42007030|NCT01254669|75814450|FG000|Overall Study|called to clinic during intervention|1|||
42007031|NCT01254669|75814451|FG001|Overall Study|called to clinic during intervention|1|||
42007032|NCT01295814|75814461|FG000|Overall Study|Lack of Efficacy|0|||
42007033|NCT01295814|75814462|FG001|Overall Study|Lack of Efficacy|2|||
42007034|NCT01295814|75814461|FG000|Overall Study|Withdrawal by Subject|2|||
42035571|NCT01098461|75844099|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
42035572|NCT01098461|75844100|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
42035573|NCT01098461|75844101|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
42035574|NCT01098461|75844098|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
42035575|NCT01098461|75844099|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
42035576|NCT01098461|75844100|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
42007035|NCT01295814|75814462|FG001|Overall Study|Withdrawal by Subject|0|||
42007036|NCT01254045|75814468|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
42007037|NCT01254045|75814469|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
42007038|NCT01254045|75814470|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
42007039|NCT01254045|75814471|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
42035577|NCT01098461|75844101|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
42035578|NCT01098461|75844098|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
42035579|NCT01098461|75844099|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
42035580|NCT01098461|75844100|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
42035581|NCT01098461|75844101|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
42035582|NCT01098461|75844098|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
42035583|NCT01098461|75844099|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
42035584|NCT01098461|75844100|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
42035585|NCT01098461|75844101|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
42035586|NCT01098461|75844098|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
42035587|NCT01098461|75844099|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
42035588|NCT01098461|75844100|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
42007040|NCT01254045|75814472|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
42007041|NCT01254045|75814473|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
42007042|NCT01075282|75814486|FG000|Overall Study|Withdrawal by Subject|11|||
42007043|NCT01075282|75814487|FG001|Overall Study|Withdrawal by Subject|7|||
42007044|NCT01075282|75814488|FG002|Overall Study|Withdrawal by Subject|11|||
42007045|NCT01075282|75814486|FG000|Overall Study|Adverse Event|9|||
42007046|NCT01075282|75814487|FG001|Overall Study|Adverse Event|8|||
42007047|NCT01075282|75814488|FG002|Overall Study|Adverse Event|5|||
42007048|NCT01075282|75814486|FG000|Overall Study|Entry Criteria Not Met|3|||
42035589|NCT01098461|75844101|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
42035590|NCT01098461|75844098|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
42035591|NCT01098461|75844099|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
42035592|NCT01098461|75844100|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
42035593|NCT01098461|75844101|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
42035594|NCT01098461|75844098|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
42035595|NCT01098461|75844099|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
42035596|NCT01098461|75844100|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
42035597|NCT01098461|75844101|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
42035598|NCT01098305|75844114|FG000|Overall Study|Lost to Follow-up|31|||
42035599|NCT01098305|75844115|FG001|Overall Study|Lost to Follow-up|33|||
42035600|NCT00833833|75844127|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
42035601|NCT00833833|75844128|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
42035602|NCT00833833|75844129|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
42035603|NCT00833833|75844130|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
42035604|NCT00833833|75844131|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
42035605|NCT00833833|75844132|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
42035606|NCT00833833|75844127|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
42035607|NCT00833833|75844128|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
42035608|NCT00833833|75844129|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
42035609|NCT00833833|75844130|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
42007049|NCT01075282|75814487|FG001|Overall Study|Entry Criteria Not Met|2|||
42007050|NCT01075282|75814488|FG002|Overall Study|Entry Criteria Not Met|0|||
42007051|NCT01075282|75814486|FG000|Overall Study|Lost to Follow-up|3|||
42035610|NCT00833833|75844131|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
42035611|NCT00833833|75844132|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
42035612|NCT00833833|75844127|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
42035613|NCT00833833|75844128|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
42035614|NCT00833833|75844129|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
42035615|NCT00833833|75844130|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
42035616|NCT00833833|75844131|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
42035617|NCT00833833|75844132|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
42035618|NCT00833833|75844127|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
42137575|NCT00443820|75947878|FG001|Overall Study|Death|0|||
42137576|NCT00443820|75947879|FG002|Overall Study|Death|1|||
42137577|NCT00443820|75947880|FG003|Overall Study|Death|0|||
42137578|NCT00438672|75947892|FG000|Overall Study|Lost to Follow-up|7|||
42137579|NCT00438672|75947893|FG001|Overall Study|Lost to Follow-up|9|||
42137580|NCT00438360|75947901|FG000|Overall Study|Adverse Event|6|||
42137581|NCT00438360|75947902|FG001|Overall Study|Adverse Event|1|||
42137582|NCT00438360|75947901|FG000|Overall Study|Lack of Efficacy|42|||
42007052|NCT01075282|75814487|FG001|Overall Study|Lost to Follow-up|3|||
42007053|NCT01075282|75814488|FG002|Overall Study|Lost to Follow-up|3|||
42007054|NCT01075282|75814486|FG000|Overall Study|Physician Decision|3|||
42007055|NCT01075282|75814487|FG001|Overall Study|Physician Decision|3|||
42007056|NCT01075282|75814488|FG002|Overall Study|Physician Decision|3|||
42007057|NCT01075282|75814486|FG000|Overall Study|Lack of Efficacy|1|||
42007058|NCT01075282|75814487|FG001|Overall Study|Lack of Efficacy|1|||
42007059|NCT01075282|75814488|FG002|Overall Study|Lack of Efficacy|0|||
42007060|NCT01075282|75814486|FG000|Overall Study|Treatment Non-compliance|1|||
42007061|NCT01075282|75814487|FG001|Overall Study|Treatment Non-compliance|2|||
42007062|NCT01075282|75814488|FG002|Overall Study|Treatment Non-compliance|2|||
42007063|NCT01075282|75814486|FG000|Overall Study|Protocol Violation|0|||
42007064|NCT01075282|75814487|FG001|Overall Study|Protocol Violation|2|||
42035619|NCT00833833|75844128|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
42035620|NCT00833833|75844129|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
42035621|NCT00833833|75844130|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
42137583|NCT00438360|75947902|FG001|Overall Study|Lack of Efficacy|27|||
42137584|NCT00438360|75947901|FG000|Overall Study|Other|24|||
42137585|NCT00438360|75947902|FG001|Overall Study|Other|15|||
42007065|NCT01075282|75814488|FG002|Overall Study|Protocol Violation|1|||
42007066|NCT01075282|75814486|FG000|Overall Study|Death|0|||
42007067|NCT01075282|75814487|FG001|Overall Study|Death|1|||
42007068|NCT01075282|75814488|FG002|Overall Study|Death|2|||
42007069|NCT01253811|75814497|FG000|Overall Study|Withdrawal criteria|1|||
42007070|NCT01295580|75814503|FG000|Overall Study|Protocol Violation|4|||
42007071|NCT01295580|75814504|FG001|Overall Study|Protocol Violation|2|||
42007072|NCT01295580|75814503|FG000|Overall Study|Withdrawal by Subject|1|||
42007073|NCT01295580|75814504|FG001|Overall Study|Withdrawal by Subject|4|||
42007074|NCT01295580|75814503|FG000|Overall Study|Adverse Event|2|||
42007075|NCT01295580|75814504|FG001|Overall Study|Adverse Event|1|||
42007076|NCT01295580|75814503|FG000|Overall Study|Lost to Follow-up|1|||
42007077|NCT01295580|75814504|FG001|Overall Study|Lost to Follow-up|0|||
42007078|NCT01295580|75814503|FG000|Overall Study|Lack of Efficacy|1|||
42007079|NCT01295580|75814504|FG001|Overall Study|Lack of Efficacy|0|||
42007080|NCT01295580|75814503|FG000|Overall Study|Other: inconvenience|1|||
42007081|NCT01295580|75814504|FG001|Overall Study|Other: inconvenience|0|||
42007082|NCT01295580|75814503|FG000|Overall Study|Other: family objection|0|||
42007083|NCT01295580|75814504|FG001|Overall Study|Other: family objection|1|||
42007084|NCT01253577|75814510|FG000|Overall Study|Lost to Follow-up|3|||
42007085|NCT01295034|75814518|FG000|Overall Study|Lost to Follow-up|5|||
42007086|NCT01295034|75814519|FG001|Overall Study|Lost to Follow-up|5|||
42007087|NCT01253421|75814530|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
42007088|NCT01253421|75814531|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
42007089|NCT01253421|75814532|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
42007090|NCT01253421|75814533|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
42007091|NCT01253421|75814534|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
42007092|NCT01253421|75814530|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
42007093|NCT01253421|75814531|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
42007094|NCT01253421|75814532|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
42007095|NCT01253421|75814533|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
42007096|NCT01253421|75814534|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
42007097|NCT01253421|75814530|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
42007098|NCT01253421|75814531|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
42007099|NCT01253421|75814532|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
42007100|NCT01253421|75814533|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
42007101|NCT01253421|75814534|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
42007102|NCT01253421|75814530|FG000|Assessment and Scheduling|Physician Decision|1|||
42007103|NCT01253421|75814531|FG001|Assessment and Scheduling|Physician Decision|0|||
42007104|NCT01253421|75814532|FG002|Assessment and Scheduling|Physician Decision|0|||
42007105|NCT01253421|75814533|FG003|Assessment and Scheduling|Physician Decision|0|||
42007106|NCT01253421|75814534|FG004|Assessment and Scheduling|Physician Decision|0|||
42007107|NCT01253421|75814530|FG000|Drug+Scanning Visit|Physician Decision|0|||
42007108|NCT01253421|75814531|FG001|Drug+Scanning Visit|Physician Decision|0|||
42007109|NCT01253421|75814532|FG002|Drug+Scanning Visit|Physician Decision|0|||
42007110|NCT01253421|75814533|FG003|Drug+Scanning Visit|Physician Decision|0|||
42007111|NCT01253421|75814534|FG004|Drug+Scanning Visit|Physician Decision|1|||
42007112|NCT01077076|75814544|FG000|First Intervention|Withdrawal by Subject|1|||
42007113|NCT01077076|75814545|FG001|First Intervention|Withdrawal by Subject|0|||
42007114|NCT01077076|75814546|FG002|First Intervention|Withdrawal by Subject|0|||
42007115|NCT01077076|75814547|FG003|First Intervention|Withdrawal by Subject|0|||
42007116|NCT01077076|75814548|FG004|First Intervention|Withdrawal by Subject|0|||
42007117|NCT01077076|75814549|FG005|First Intervention|Withdrawal by Subject|0|||
42007118|NCT01077076|75814544|FG000|Third Intervention|Death in the participant's family|0|||
42007119|NCT01077076|75814545|FG001|Third Intervention|Death in the participant's family|0|||
42007120|NCT01077076|75814546|FG002|Third Intervention|Death in the participant's family|0|||
42007121|NCT01077076|75814547|FG003|Third Intervention|Death in the participant's family|0|||
42007122|NCT01077076|75814548|FG004|Third Intervention|Death in the participant's family|0|||
42007123|NCT01077076|75814549|FG005|Third Intervention|Death in the participant's family|1|||
42007124|NCT01294800|75814561|FG000|Overall Study|Adverse Event|7|||
42007125|NCT01294800|75814562|FG001|Overall Study|Adverse Event|6|||
42007126|NCT01294800|75814563|FG002|Overall Study|Adverse Event|12|||
42007127|NCT01294800|75814564|FG003|Overall Study|Adverse Event|5|||
42007128|NCT01294800|75814561|FG000|Overall Study|Subject Withdrew Consent|2|||
42007129|NCT01294800|75814562|FG001|Overall Study|Subject Withdrew Consent|2|||
42007130|NCT01294800|75814563|FG002|Overall Study|Subject Withdrew Consent|2|||
42007131|NCT01294800|75814564|FG003|Overall Study|Subject Withdrew Consent|11|||
42007132|NCT01294800|75814561|FG000|Overall Study|Lost to Follow-up|0|||
42007133|NCT01294800|75814562|FG001|Overall Study|Lost to Follow-up|0|||
42007134|NCT01294800|75814563|FG002|Overall Study|Lost to Follow-up|1|||
42007135|NCT01294800|75814564|FG003|Overall Study|Lost to Follow-up|0|||
42007136|NCT01294800|75814561|FG000|Overall Study|Non-compliance With Protocol|0|||
42007137|NCT01294800|75814562|FG001|Overall Study|Non-compliance With Protocol|1|||
42007138|NCT01294800|75814563|FG002|Overall Study|Non-compliance With Protocol|1|||
42137586|NCT00536471|75947912|FG000|Overall Study|Lost to Follow-up|48|||
42007139|NCT01294800|75814564|FG003|Overall Study|Non-compliance With Protocol|0|||
42007140|NCT01294800|75814561|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
42007141|NCT01294800|75814562|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
42007142|NCT01294800|75814563|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
42007143|NCT01294800|75814564|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
42007144|NCT01294644|75814577|FG000|Overall Study|Adverse Event|2|||
42007145|NCT01294644|75814578|FG001|Overall Study|Adverse Event|0|||
42007146|NCT01294644|75814579|FG002|Overall Study|Adverse Event|1|||
42007147|NCT01294644|75814577|FG000|Overall Study|Withdrawal by Subject|3|||
42007148|NCT01294644|75814578|FG001|Overall Study|Withdrawal by Subject|7|||
42007149|NCT01294644|75814579|FG002|Overall Study|Withdrawal by Subject|4|||
42007150|NCT01294644|75814577|FG000|Overall Study|Lost to Follow-up|3|||
42007151|NCT01294644|75814578|FG001|Overall Study|Lost to Follow-up|2|||
42272191|NCT00152477|76102347|FG001|Chemotherapy Period|Progression of Disease|8|||
42272192|NCT00152477|76102348|FG002|Chemotherapy Period|Progression of Disease|4|||
42272193|NCT00152477|76102346|FG000|Chemotherapy Period|Investigator decision|0|||
42272194|NCT00152477|76102347|FG001|Chemotherapy Period|Investigator decision|0|||
42007152|NCT01294644|75814579|FG002|Overall Study|Lost to Follow-up|5|||
42007153|NCT01294644|75814577|FG000|Overall Study|Miscellaneous Reason|2|||
42007154|NCT01294644|75814578|FG001|Overall Study|Miscellaneous Reason|1|||
42007155|NCT01294644|75814579|FG002|Overall Study|Miscellaneous Reason|4|||
42007156|NCT01293240|75814587|FG000|Overall Study|Noncompliance|2|||
42007157|NCT01253265|75814596|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
42007158|NCT01253265|75814597|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
42007159|NCT01253265|75814598|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
42007160|NCT01253265|75814599|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
42007161|NCT01253265|75814600|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
42007162|NCT01253265|75814596|FG000|Overall Study|Withdrawal by Subject|0|||
42007163|NCT01253265|75814597|FG001|Overall Study|Withdrawal by Subject|0|||
42007164|NCT01253265|75814598|FG002|Overall Study|Withdrawal by Subject|0|||
42007165|NCT01253265|75814599|FG003|Overall Study|Withdrawal by Subject|0|||
42007166|NCT01253265|75814600|FG004|Overall Study|Withdrawal by Subject|1|||
42007167|NCT01293084|75814612|FG000|Overall Study|Physician Decision|3|||
42007168|NCT01293084|75814612|FG000|Overall Study|Withdrawal by Subject|2|||
42007169|NCT01293006|75814622|FG000|Period 2|Lost to Follow-up|1|||
42007170|NCT01293006|75814623|FG001|Period 2|Lost to Follow-up|0|||
42007171|NCT01293006|75814624|FG002|Period 2|Lost to Follow-up|0|||
42007172|NCT01293006|75814625|FG003|Period 2|Lost to Follow-up|0|||
42007173|NCT01253187|75814644|FG000|Period 2|Withdrawal by Subject|0|||
42007174|NCT01253187|75814645|FG001|Period 2|Withdrawal by Subject|0|||
42007175|NCT01253187|75814646|FG002|Period 2|Withdrawal by Subject|0|||
42007176|NCT01253187|75814647|FG003|Period 2|Withdrawal by Subject|0|||
42007177|NCT01253187|75814648|FG004|Period 2|Withdrawal by Subject|1|||
42007178|NCT01253187|75814649|FG005|Period 2|Withdrawal by Subject|0|||
42007179|NCT01253187|75814644|FG000|Period 3|Pregnancy|1|||
42007180|NCT01253187|75814645|FG001|Period 3|Pregnancy|0|||
42007181|NCT01253187|75814646|FG002|Period 3|Pregnancy|0|||
42007182|NCT01253187|75814647|FG003|Period 3|Pregnancy|0|||
42007183|NCT01253187|75814648|FG004|Period 3|Pregnancy|0|||
42007184|NCT01253187|75814649|FG005|Period 3|Pregnancy|0|||
42007185|NCT01253187|75814644|FG000|Period 3|difficulty with blood sampling|0|||
42007186|NCT01253187|75814645|FG001|Period 3|difficulty with blood sampling|1|||
42007187|NCT01253187|75814646|FG002|Period 3|difficulty with blood sampling|0|||
42007188|NCT01253187|75814647|FG003|Period 3|difficulty with blood sampling|0|||
42007189|NCT01253187|75814648|FG004|Period 3|difficulty with blood sampling|0|||
42007190|NCT01253187|75814649|FG005|Period 3|difficulty with blood sampling|0|||
42007191|NCT01253187|75814644|FG000|Period 3|non-compliance|0|||
42007192|NCT01253187|75814645|FG001|Period 3|non-compliance|0|||
42007193|NCT01253187|75814646|FG002|Period 3|non-compliance|0|||
42007194|NCT01253187|75814647|FG003|Period 3|non-compliance|0|||
42007195|NCT01253187|75814648|FG004|Period 3|non-compliance|1|||
42007196|NCT01253187|75814649|FG005|Period 3|non-compliance|0|||
42007197|NCT01252563|75814660|FG000|Overall Study|Contract Deviation|41|||
42007198|NCT01252563|75814660|FG000|Overall Study|Centralized Registration Deviation|30|||
42007199|NCT01252563|75814660|FG000|Overall Study|Lost to Follow-up|161|||
42007200|NCT01252563|75814660|FG000|Overall Study|No visit after first day of treatment|194|||
42007201|NCT01252563|75814660|FG000|Overall Study|No drug administration|6|||
42007202|NCT01292226|75814695|FG000|Overall Study|Adverse Event|5|||
42007203|NCT01292226|75814695|FG000|Overall Study|Death|1|||
42007204|NCT01292226|75814695|FG000|Overall Study|Graft loss|1|||
42007205|NCT01292226|75814695|FG000|Overall Study|Protocol Violation|3|||
42007206|NCT01292226|75814695|FG000|Overall Study|Withdrawal by Subject|1|||
42007207|NCT01292226|75814695|FG000|Overall Study|Other|2|||
42007208|NCT01290822|75814699|FG000|Overall Study|Withdrawal by Subject|1|||
42007209|NCT01290822|75814699|FG000|Overall Study|Physician Decision|10|||
42007210|NCT01075048|75814706|FG000|Overall Study|Death|4|||
42007211|NCT01075048|75814707|FG001|Overall Study|Death|17|||
42007212|NCT01075048|75814708|FG002|Overall Study|Death|12|||
42007213|NCT01075048|75814706|FG000|Overall Study|Start of other or new therapy|4|||
42007214|NCT01075048|75814707|FG001|Overall Study|Start of other or new therapy|36|||
42007215|NCT01075048|75814708|FG002|Overall Study|Start of other or new therapy|46|||
42007216|NCT01075048|75814706|FG000|Overall Study|Withdrawal by Subject|1|||
42007217|NCT01075048|75814707|FG001|Overall Study|Withdrawal by Subject|6|||
42007218|NCT01075048|75814708|FG002|Overall Study|Withdrawal by Subject|3|||
42007219|NCT01075048|75814706|FG000|Overall Study|Lost to Follow-up|0|||
42007220|NCT01075048|75814707|FG001|Overall Study|Lost to Follow-up|1|||
42007221|NCT01075048|75814708|FG002|Overall Study|Lost to Follow-up|1|||
42007222|NCT01290666|75814719|FG000|Overall Study|Lost to Follow-up|11|||
42007223|NCT01290666|75814719|FG000|Overall Study|Withdrawal by Subject|23|||
42007224|NCT01290666|75814719|FG000|Overall Study|Early Termination of Study|4|||
42007225|NCT01252251|75814723|FG000|Overall Study|Withdrawal by Subject|1|||
42007226|NCT01289574|75814730|FG000|Overall Study|Lack of Efficacy|4|||
42007227|NCT01289574|75814731|FG001|Overall Study|Lack of Efficacy|0|||
42007228|NCT01289574|75814732|FG002|Overall Study|Lack of Efficacy|1|||
42007229|NCT01289574|75814730|FG000|Overall Study|Lost to Follow-up|2|||
42007230|NCT01289574|75814731|FG001|Overall Study|Lost to Follow-up|0|||
42007231|NCT01289574|75814732|FG002|Overall Study|Lost to Follow-up|1|||
42007232|NCT01289574|75814730|FG000|Overall Study|Withdrawal by Subject|1|||
42007233|NCT01289574|75814731|FG001|Overall Study|Withdrawal by Subject|1|||
42007234|NCT01289574|75814732|FG002|Overall Study|Withdrawal by Subject|1|||
42007235|NCT01289574|75814730|FG000|Overall Study|Adverse Event|0|||
42007236|NCT01289574|75814731|FG001|Overall Study|Adverse Event|1|||
42007237|NCT01289574|75814732|FG002|Overall Study|Adverse Event|0|||
42007238|NCT01289574|75814730|FG000|Overall Study|Subject wanted alternate treatment|0|||
42007239|NCT01289574|75814731|FG001|Overall Study|Subject wanted alternate treatment|1|||
42007240|NCT01289574|75814732|FG002|Overall Study|Subject wanted alternate treatment|0|||
42007241|NCT01252095|75814743|FG000|Overall Study|Disease progression|1|||
42007242|NCT01252095|75814744|FG001|Overall Study|Disease progression|0|||
42007243|NCT01289418|75814753|FG000|Day 8 Survey|email address invalid|283|||
42007244|NCT01289418|75814753|FG000|Day 8 Survey|participants did not complete the survey|1935|||
42007245|NCT01289418|75814753|FG000|Day 29 Survey|email address invalid|283|||
42007246|NCT01289418|75814753|FG000|Day 29 Survey|participants did not complete the survey|2185|||
42007247|NCT01074658|75814759|FG000|Overall Study|No implant attempted|19|||
42007248|NCT01074502|75814763|FG000|Overall Study|Withdrawal by Subject|1|||
42007249|NCT01289028|75814767|FG000|Overall Study|Progressive Disease|49|||
42007250|NCT01289028|75814767|FG000|Overall Study|Adverse Event|14|||
42007251|NCT01289028|75814767|FG000|Overall Study|Withdrawal by Subject|6|||
42007252|NCT01289028|75814767|FG000|Overall Study|Death|4|||
42007253|NCT01289028|75814767|FG000|Overall Study|Lack of Efficacy|2|||
42007254|NCT01289028|75814767|FG000|Overall Study|No longer required|2|||
42007255|NCT01289028|75814767|FG000|Overall Study|Lost to Follow-up|2|||
42007256|NCT01289028|75814767|FG000|Overall Study|New Cancer Therapy|2|||
42007257|NCT01289028|75814767|FG000|Overall Study|Abnormal Lab Value|1|||
42007258|NCT01289028|75814767|FG000|Overall Study|Missing reason for discon|1|||
42007259|NCT01250925|75814776|FG000|Overall Study|Lost to Follow-up|1|||
42007260|NCT01250925|75814777|FG001|Overall Study|Lost to Follow-up|1|||
42007261|NCT01250925|75814778|FG002|Overall Study|Lost to Follow-up|0|||
42007262|NCT01250925|75814776|FG000|Overall Study|Withdrawal by Subject|2|||
42007263|NCT01250925|75814777|FG001|Overall Study|Withdrawal by Subject|0|||
42007264|NCT01250925|75814778|FG002|Overall Study|Withdrawal by Subject|0|||
42007265|NCT01250925|75814776|FG000|Overall Study|Protocol Violation|2|||
42346762|NCT01877421|76185701|FG013|Phase 2|Withdrawal by Subject|0|||
42346763|NCT01877421|76185702|FG014|Phase 2|Withdrawal by Subject|0|||
42346764|NCT01877421|76185703|FG015|Phase 2|Withdrawal by Subject|1|||
42007266|NCT01250925|75814777|FG001|Overall Study|Protocol Violation|0|||
42007267|NCT01250925|75814778|FG002|Overall Study|Protocol Violation|0|||
42007268|NCT01250925|75814776|FG000|Overall Study|Physician Decision|0|||
42007269|NCT01250925|75814777|FG001|Overall Study|Physician Decision|2|||
42007270|NCT01250925|75814778|FG002|Overall Study|Physician Decision|1|||
42035622|NCT00833833|75844131|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
42035623|NCT00833833|75844132|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
42035624|NCT00833833|75844127|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
42007271|NCT01250925|75814776|FG000|Overall Study|Adverse Event|0|||
42007272|NCT01250925|75814777|FG001|Overall Study|Adverse Event|0|||
42007273|NCT01250925|75814778|FG002|Overall Study|Adverse Event|1|||
42007274|NCT01285908|75814786|FG000|Baseline Measurement|unable to insert catheter|1|||
42007275|NCT01285908|75814787|FG001|Baseline Measurement|unable to insert catheter|0|||
42007276|NCT01285908|75814788|FG002|Baseline Measurement|unable to insert catheter|0|||
42007277|NCT01285908|75814786|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
42007278|NCT01285908|75814787|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
42007279|NCT01285908|75814788|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
42346765|NCT01877421|76185704|FG016|Phase 2|Withdrawal by Subject|0|||
42346766|NCT01877421|76185705|FG017|Phase 2|Withdrawal by Subject|0|||
42007280|NCT01285908|75814786|FG000|Baseline Measurement|unable to tolerate procedure|1|||
42007281|NCT01285908|75814787|FG001|Baseline Measurement|unable to tolerate procedure|0|||
42007282|NCT01285908|75814788|FG002|Baseline Measurement|unable to tolerate procedure|0|||
42007283|NCT01250769|75814822|FG000|Overall Study|Withdrawal by Subject|0|||
42007284|NCT01250769|75814823|FG001|Overall Study|Withdrawal by Subject|1|||
42007285|NCT01250769|75814824|FG002|Overall Study|Withdrawal by Subject|1|||
42007286|NCT01250769|75814825|FG003|Overall Study|Withdrawal by Subject|0|||
42007287|NCT01250769|75814822|FG000|Overall Study|Adverse Event|0|||
42007288|NCT01250769|75814823|FG001|Overall Study|Adverse Event|0|||
42007289|NCT01250769|75814824|FG002|Overall Study|Adverse Event|1|||
42007290|NCT01250769|75814825|FG003|Overall Study|Adverse Event|0|||
42007291|NCT01074268|75814837|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
42007292|NCT01074268|75814838|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
42007293|NCT01074268|75814837|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
42007294|NCT01074268|75814838|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
42007295|NCT01074268|75814837|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
42007296|NCT01074268|75814838|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
42007297|NCT01074268|75814837|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
42007298|NCT01074268|75814838|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
42007299|NCT01074268|75814837|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
42007300|NCT01074268|75814838|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
42007301|NCT01074268|75814837|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
42007302|NCT01074268|75814838|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
42007303|NCT01074268|75814837|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
42007304|NCT01074268|75814838|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
42007305|NCT01074268|75814837|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
42007306|NCT01074268|75814838|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
42007307|NCT01074268|75814837|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
42007308|NCT01074268|75814838|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
42007309|NCT01074190|75814847|FG000|Overall Study|Emergency Cesarean Delivery|1|||
42007310|NCT01074190|75814848|FG001|Overall Study|Emergency Cesarean Delivery|2|||
42007311|NCT01074190|75814849|FG002|Overall Study|Emergency Cesarean Delivery|1|||
42007312|NCT01074190|75814847|FG000|Overall Study|Protocol Violation|2|||
42007313|NCT01074190|75814848|FG001|Overall Study|Protocol Violation|1|||
42007314|NCT01074190|75814849|FG002|Overall Study|Protocol Violation|0|||
42007315|NCT01074190|75814847|FG000|Overall Study|Delivered in under 90 minutes|0|||
42007316|NCT01074190|75814848|FG001|Overall Study|Delivered in under 90 minutes|2|||
42007317|NCT01074190|75814849|FG002|Overall Study|Delivered in under 90 minutes|1|||
42007318|NCT01074190|75814847|FG000|Overall Study|Subject withdrew consent|1|||
42007319|NCT01074190|75814848|FG001|Overall Study|Subject withdrew consent|1|||
42007320|NCT01074190|75814849|FG002|Overall Study|Subject withdrew consent|1|||
42007321|NCT01073566|75814862|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
42007322|NCT01073566|75814863|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
42007323|NCT01072396|75814871|FG000|Period One|Adverse Event|1|||
42007324|NCT01072396|75814872|FG001|Period One|Adverse Event|1|||
42007325|NCT01072396|75814871|FG000|Period One|Protocol Violation|2|||
42007326|NCT01072396|75814872|FG001|Period One|Protocol Violation|1|||
42007327|NCT01072396|75814871|FG000|Period One|Withdrawal by Subject|2|||
42007328|NCT01072396|75814872|FG001|Period One|Withdrawal by Subject|0|||
42007329|NCT01072396|75814871|FG000|Washout Period|Missing termination information|0|||
42007330|NCT01072396|75814872|FG001|Washout Period|Missing termination information|1|||
42007331|NCT01072396|75814871|FG000|Period Two|Adverse Event|0|||
42007332|NCT01072396|75814872|FG001|Period Two|Adverse Event|3|||
42007333|NCT01072396|75814871|FG000|Period Two|Lost to Follow-up|1|||
42007334|NCT01072396|75814872|FG001|Period Two|Lost to Follow-up|0|||
42007335|NCT01045096|75814881|FG000|Overall Study|Withdrawal by Subject|2|||
42007336|NCT01045096|75814882|FG001|Overall Study|Withdrawal by Subject|0|||
42007337|NCT01045096|75814883|FG002|Overall Study|Withdrawal by Subject|0|||
42007338|NCT01045096|75814881|FG000|Overall Study|Other|1|||
42007339|NCT01045096|75814882|FG001|Overall Study|Other|0|||
42007340|NCT01045096|75814883|FG002|Overall Study|Other|0|||
42007341|NCT01285518|75814899|FG000|Overall Study|Lost to Follow-up|0|||
42007342|NCT01285518|75814900|FG001|Overall Study|Lost to Follow-up|0|||
42007343|NCT01285518|75814901|FG002|Overall Study|Lost to Follow-up|0|||
42007344|NCT01285518|75814902|FG003|Overall Study|Lost to Follow-up|0|||
42007345|NCT01285518|75814903|FG004|Overall Study|Lost to Follow-up|0|||
42007346|NCT01285518|75814904|FG005|Overall Study|Lost to Follow-up|1|||
42007347|NCT01285518|75814905|FG006|Overall Study|Lost to Follow-up|0|||
42007348|NCT01285518|75814906|FG007|Overall Study|Lost to Follow-up|0|||
42272195|NCT00152477|76102348|FG002|Chemotherapy Period|Investigator decision|1|||
42007349|NCT01073020|75814929|FG000|Overall Study|Withdrawal by Subject|6|||
42007350|NCT01073020|75814930|FG001|Overall Study|Withdrawal by Subject|4|||
42272196|NCT00152477|76102346|FG000|Chemotherapy Period|Patient condition worsened|1|||
42272197|NCT00152477|76102347|FG001|Chemotherapy Period|Patient condition worsened|0|||
42346767|NCT01877421|76185688|FG000|Phase 2|Protocol Violation|0|||
42007351|NCT01073020|75814931|FG002|Overall Study|Withdrawal by Subject|1|||
42007352|NCT01073020|75814932|FG003|Overall Study|Withdrawal by Subject|2|||
42007353|NCT01073020|75814929|FG000|Overall Study|Physician Decision|1|||
42007354|NCT01073020|75814930|FG001|Overall Study|Physician Decision|0|||
42007355|NCT01073020|75814931|FG002|Overall Study|Physician Decision|2|||
42007356|NCT01073020|75814932|FG003|Overall Study|Physician Decision|0|||
42007357|NCT01073020|75814929|FG000|Overall Study|Death|0|||
42007358|NCT01073020|75814930|FG001|Overall Study|Death|1|||
42007359|NCT01073020|75814931|FG002|Overall Study|Death|0|||
42007360|NCT01073020|75814932|FG003|Overall Study|Death|0|||
42007361|NCT01284114|75814942|FG000|Overall Study|viral infection|1|||
42007362|NCT01284114|75814942|FG000|Overall Study|From the results of ALLTITUDE study|1|||
42007363|NCT01284114|75814942|FG000|Overall Study|Symptomatic hypotension|1|||
42007364|NCT01284114|75814942|FG000|Overall Study|dizziness|1|||
42007365|NCT01283334|75814947|FG000|Overall Study|Withdrawal by Subject|1|||
42007366|NCT01283334|75814947|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
42272198|NCT00152477|76102348|FG002|Chemotherapy Period|Patient condition worsened|0|||
42272199|NCT00152477|76102346|FG000|Monotherapy Period|Adverse Event|1|||
42272200|NCT00152477|76102347|FG001|Monotherapy Period|Adverse Event|0|||
42272201|NCT00152477|76102348|FG002|Monotherapy Period|Adverse Event|5|||
42272202|NCT00152477|76102346|FG000|Monotherapy Period|Death|2|||
42272203|NCT00152477|76102347|FG001|Monotherapy Period|Death|0|||
42272204|NCT00152477|76102348|FG002|Monotherapy Period|Death|1|||
42272205|NCT00152477|76102346|FG000|Monotherapy Period|Lack of Efficacy|7|||
42272206|NCT00152477|76102347|FG001|Monotherapy Period|Lack of Efficacy|16|||
42272207|NCT00152477|76102348|FG002|Monotherapy Period|Lack of Efficacy|10|||
42272208|NCT00152477|76102346|FG000|Monotherapy Period|Protocol Violation|0|||
42272209|NCT00152477|76102347|FG001|Monotherapy Period|Protocol Violation|1|||
42272210|NCT00152477|76102348|FG002|Monotherapy Period|Protocol Violation|0|||
42272211|NCT00152477|76102346|FG000|Monotherapy Period|Withdrawal by Subject|0|||
42272212|NCT00152477|76102347|FG001|Monotherapy Period|Withdrawal by Subject|0|||
42272213|NCT00152477|76102348|FG002|Monotherapy Period|Withdrawal by Subject|4|||
42272214|NCT00152477|76102346|FG000|Monotherapy Period|Progression of Disease|5|||
42272215|NCT00152477|76102347|FG001|Monotherapy Period|Progression of Disease|11|||
42346768|NCT01877421|76185689|FG001|Phase 2|Protocol Violation|0|||
42346769|NCT01877421|76185690|FG002|Phase 2|Protocol Violation|0|||
42346770|NCT01877421|76185691|FG003|Phase 2|Protocol Violation|0|||
42346771|NCT01877421|76185692|FG004|Phase 2|Protocol Violation|0|||
42346772|NCT01877421|76185693|FG005|Phase 2|Protocol Violation|0|||
42346773|NCT01877421|76185694|FG006|Phase 2|Protocol Violation|0|||
42346774|NCT01877421|76185695|FG007|Phase 2|Protocol Violation|0|||
42346775|NCT01877421|76185696|FG008|Phase 2|Protocol Violation|0|||
42346776|NCT01877421|76185697|FG009|Phase 2|Protocol Violation|0|||
42007367|NCT01283334|75814947|FG000|Overall Study|Adverse Event|4|||
42007368|NCT01283334|75814947|FG000|Overall Study|Physician Decision|1|||
42007369|NCT01282866|75814953|FG000|Overall Study|Adverse Event|1|||
42007370|NCT01071070|75814959|FG000|Overall Study|Adverse Event|0|||
42007371|NCT01071070|75814960|FG001|Overall Study|Adverse Event|3|||
42007372|NCT01071070|75814959|FG000|Overall Study|Withdrawal by Subject|1|||
42007373|NCT01071070|75814960|FG001|Overall Study|Withdrawal by Subject|0|||
42007374|NCT01071070|75814959|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
42007375|NCT01071070|75814960|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
42035625|NCT00833833|75844128|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
42137587|NCT00536471|75947913|FG001|Overall Study|Lost to Follow-up|23|||
42272216|NCT00152477|76102348|FG002|Monotherapy Period|Progression of Disease|12|||
42007376|NCT01071070|75814959|FG000|Overall Study|Hypercalcemia|1|||
42007377|NCT01071070|75814960|FG001|Overall Study|Hypercalcemia|0|||
42007378|NCT01282476|75814966|FG000|Overall Study|Death|11|||
42007379|NCT01282164|75814972|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
42272217|NCT00152477|76102346|FG000|Monotherapy Period|Patient decision|0|||
42346777|NCT01877421|76185698|FG010|Phase 2|Protocol Violation|1|||
42007380|NCT01282164|75814973|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
42346778|NCT01877421|76185699|FG011|Phase 2|Protocol Violation|0|||
42346779|NCT01877421|76185700|FG012|Phase 2|Protocol Violation|0|||
42007381|NCT01250379|75814989|FG000|Overall Study|Death|141|||
42272218|NCT00152477|76102347|FG001|Monotherapy Period|Patient decision|1|||
42272219|NCT00152477|76102348|FG002|Monotherapy Period|Patient decision|1|||
42007382|NCT01250379|75814990|FG001|Overall Study|Death|148|||
42007383|NCT01250379|75814989|FG000|Overall Study|Withdrawal by Subject|32|||
42007384|NCT01250379|75814990|FG001|Overall Study|Withdrawal by Subject|20|||
42007385|NCT01250379|75814989|FG000|Overall Study|Physician Decision|11|||
42007386|NCT01250379|75814990|FG001|Overall Study|Physician Decision|3|||
42007387|NCT01250379|75814989|FG000|Overall Study|Protocol Violation|2|||
42007388|NCT01250379|75814990|FG001|Overall Study|Protocol Violation|8|||
42007389|NCT01250379|75814989|FG000|Overall Study|Lost to Follow-up|9|||
42007390|NCT01250379|75814990|FG001|Overall Study|Lost to Follow-up|6|||
42007391|NCT01250379|75814989|FG000|Overall Study|Adverse Event|5|||
42007392|NCT01250379|75814990|FG001|Overall Study|Adverse Event|4|||
42007393|NCT01250379|75814989|FG000|Overall Study|Other|0|||
42007394|NCT01250379|75814990|FG001|Overall Study|Other|4|||
42007395|NCT01250379|75814989|FG000|Overall Study|Participant noncompliance|2|||
42007396|NCT01250379|75814990|FG001|Overall Study|Participant noncompliance|0|||
42007397|NCT01072630|75814999|FG000|Overall Study|Adverse Event|11|||
42007398|NCT01072630|75815000|FG001|Overall Study|Adverse Event|19|||
42007399|NCT01072630|75815001|FG002|Overall Study|Adverse Event|2|||
42007400|NCT01072630|75814999|FG000|Overall Study|Lack of Efficacy|10|||
42007401|NCT01072630|75815000|FG001|Overall Study|Lack of Efficacy|10|||
42007402|NCT01072630|75815001|FG002|Overall Study|Lack of Efficacy|1|||
42007403|NCT01072630|75814999|FG000|Overall Study|Withdrawal by Subject|8|||
42007404|NCT01072630|75815000|FG001|Overall Study|Withdrawal by Subject|7|||
42007405|NCT01072630|75815001|FG002|Overall Study|Withdrawal by Subject|2|||
42007406|NCT01072630|75814999|FG000|Overall Study|Protocol Violation|10|||
42007407|NCT01072630|75815000|FG001|Overall Study|Protocol Violation|8|||
42007408|NCT01072630|75815001|FG002|Overall Study|Protocol Violation|4|||
42007409|NCT01072630|75814999|FG000|Overall Study|Lost to Follow-up|11|||
42007410|NCT01072630|75815000|FG001|Overall Study|Lost to Follow-up|11|||
42007411|NCT01072630|75815001|FG002|Overall Study|Lost to Follow-up|1|||
42007412|NCT01072630|75814999|FG000|Overall Study|Noncompliance with study medication|1|||
42007413|NCT01072630|75815000|FG001|Overall Study|Noncompliance with study medication|1|||
42007414|NCT01072630|75815001|FG002|Overall Study|Noncompliance with study medication|1|||
42007415|NCT01072630|75814999|FG000|Overall Study|Noncompliance with study procedures|1|||
42007416|NCT01072630|75815000|FG001|Overall Study|Noncompliance with study procedures|2|||
42007417|NCT01072630|75815001|FG002|Overall Study|Noncompliance with study procedures|1|||
42007418|NCT01072630|75814999|FG000|Overall Study|Other|3|||
42007419|NCT01072630|75815000|FG001|Overall Study|Other|2|||
42007420|NCT01072630|75815001|FG002|Overall Study|Other|1|||
42007421|NCT01281306|75815017|FG000|Overall Study|Lack of Efficacy|0|||
42007422|NCT01281306|75815018|FG001|Overall Study|Lack of Efficacy|1|||
42007423|NCT01281306|75815019|FG002|Overall Study|Lack of Efficacy|3|||
42007424|NCT01281306|75815020|FG003|Overall Study|Lack of Efficacy|0|||
42007425|NCT01281306|75815021|FG004|Overall Study|Lack of Efficacy|2|||
42007426|NCT01281306|75815022|FG005|Overall Study|Lack of Efficacy|0|||
42007427|NCT01281306|75815023|FG006|Overall Study|Lack of Efficacy|1|||
42007428|NCT01281306|75815017|FG000|Overall Study|Withdrawal by Subject|1|||
42007429|NCT01281306|75815018|FG001|Overall Study|Withdrawal by Subject|0|||
42007430|NCT01281306|75815019|FG002|Overall Study|Withdrawal by Subject|2|||
42007431|NCT01281306|75815020|FG003|Overall Study|Withdrawal by Subject|4|||
42007432|NCT01281306|75815021|FG004|Overall Study|Withdrawal by Subject|1|||
42007433|NCT01281306|75815022|FG005|Overall Study|Withdrawal by Subject|3|||
42007434|NCT01281306|75815023|FG006|Overall Study|Withdrawal by Subject|1|||
42007435|NCT01281306|75815017|FG000|Overall Study|Protocol deviation|0|||
42007436|NCT01281306|75815018|FG001|Overall Study|Protocol deviation|1|||
42007437|NCT01281306|75815019|FG002|Overall Study|Protocol deviation|1|||
42007438|NCT01281306|75815020|FG003|Overall Study|Protocol deviation|1|||
42007439|NCT01281306|75815021|FG004|Overall Study|Protocol deviation|1|||
42007440|NCT01281306|75815022|FG005|Overall Study|Protocol deviation|0|||
42007441|NCT01281306|75815023|FG006|Overall Study|Protocol deviation|0|||
42007442|NCT01281306|75815017|FG000|Overall Study|Condition no longer requires study drug|1|||
42007443|NCT01281306|75815018|FG001|Overall Study|Condition no longer requires study drug|0|||
42007444|NCT01281306|75815019|FG002|Overall Study|Condition no longer requires study drug|0|||
42007445|NCT01281306|75815020|FG003|Overall Study|Condition no longer requires study drug|0|||
42007446|NCT01281306|75815021|FG004|Overall Study|Condition no longer requires study drug|0|||
42007447|NCT01281306|75815022|FG005|Overall Study|Condition no longer requires study drug|1|||
42007448|NCT01281306|75815023|FG006|Overall Study|Condition no longer requires study drug|1|||
42007449|NCT01281306|75815017|FG000|Overall Study|Lost to Follow-up|1|||
42007450|NCT01281306|75815018|FG001|Overall Study|Lost to Follow-up|0|||
42007451|NCT01281306|75815019|FG002|Overall Study|Lost to Follow-up|0|||
42007452|NCT01281306|75815020|FG003|Overall Study|Lost to Follow-up|2|||
42007453|NCT01281306|75815021|FG004|Overall Study|Lost to Follow-up|0|||
42007454|NCT01281306|75815022|FG005|Overall Study|Lost to Follow-up|0|||
42007455|NCT01281306|75815023|FG006|Overall Study|Lost to Follow-up|1|||
42007456|NCT01281306|75815017|FG000|Overall Study|Death|1|||
42007457|NCT01281306|75815018|FG001|Overall Study|Death|0|||
42007458|NCT01281306|75815019|FG002|Overall Study|Death|0|||
42007459|NCT01281306|75815020|FG003|Overall Study|Death|0|||
42007460|NCT01281306|75815021|FG004|Overall Study|Death|0|||
42007461|NCT01281306|75815022|FG005|Overall Study|Death|0|||
42007462|NCT01281306|75815023|FG006|Overall Study|Death|0|||
42007463|NCT01281306|75815017|FG000|Overall Study|Adverse Event|3|||
42007464|NCT01281306|75815018|FG001|Overall Study|Adverse Event|2|||
42007465|NCT01281306|75815019|FG002|Overall Study|Adverse Event|2|||
42007466|NCT01281306|75815020|FG003|Overall Study|Adverse Event|3|||
42007467|NCT01281306|75815021|FG004|Overall Study|Adverse Event|5|||
42007468|NCT01281306|75815022|FG005|Overall Study|Adverse Event|3|||
42007469|NCT01281306|75815023|FG006|Overall Study|Adverse Event|3|||
42007470|NCT01281306|75815017|FG000|Overall Study|Randomized in error|1|||
42007471|NCT01281306|75815018|FG001|Overall Study|Randomized in error|0|||
42007472|NCT01281306|75815019|FG002|Overall Study|Randomized in error|0|||
42007473|NCT01281306|75815020|FG003|Overall Study|Randomized in error|1|||
42007474|NCT01281306|75815021|FG004|Overall Study|Randomized in error|0|||
42007475|NCT01281306|75815022|FG005|Overall Study|Randomized in error|0|||
42007476|NCT01281306|75815023|FG006|Overall Study|Randomized in error|0|||
42007477|NCT01250145|75815041|FG000|Overall Study|Adverse Event|2|||
42007478|NCT01250145|75815042|FG001|Overall Study|Adverse Event|1|||
42007479|NCT01250145|75815041|FG000|Overall Study|Withdrawal by Subject|0|||
42007480|NCT01250145|75815042|FG001|Overall Study|Withdrawal by Subject|4|||
42007481|NCT01067326|75815064|FG000|Overall Study|Adverse Event|0|||
42007482|NCT01067326|75815065|FG001|Overall Study|Adverse Event|2|||
42007483|NCT01067326|75815064|FG000|Overall Study|Withdrawal by Subject|1|||
42007484|NCT01067326|75815065|FG001|Overall Study|Withdrawal by Subject|0|||
42007485|NCT01067326|75815064|FG000|Overall Study|Early Study Termination|1|||
42007486|NCT01067326|75815065|FG001|Overall Study|Early Study Termination|1|||
42007487|NCT01279200|75815073|FG000|Overall Study|Withdrawal by Subject|1|||
42007488|NCT01279200|75815074|FG001|Overall Study|Withdrawal by Subject|3|||
42007489|NCT01279200|75815073|FG000|Overall Study|Patient withdrawal due to high cost|0|||
42007490|NCT01279200|75815074|FG001|Overall Study|Patient withdrawal due to high cost|1|||
42007491|NCT01279200|75815073|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
42007492|NCT01279200|75815074|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
42007493|NCT01279200|75815073|FG000|Overall Study|ultrasound screening failure|0|||
42007494|NCT01279200|75815074|FG001|Overall Study|ultrasound screening failure|1|||
42007495|NCT01279200|75815073|FG000|Overall Study|Lost to Follow-up|0|||
42007496|NCT01279200|75815074|FG001|Overall Study|Lost to Follow-up|1|||
42007497|NCT01279200|75815073|FG000|Overall Study|Adverse Event|1|||
42007498|NCT01279200|75815074|FG001|Overall Study|Adverse Event|0|||
42007499|NCT01273818|75815083|FG000|Overall Study|Physician Decision|13|||
42007500|NCT01273818|75815084|FG001|Overall Study|Physician Decision|2|||
42007501|NCT01273818|75815085|FG002|Overall Study|Physician Decision|9|||
42007502|NCT01245387|75815093|FG000|Overall Study|Lost to Follow-up|106|||
42007503|NCT01245387|75815093|FG000|Overall Study|Lack of Efficacy|195|||
42007504|NCT01245387|75815093|FG000|Overall Study|Adverse Event|9|||
42007505|NCT01245387|75815093|FG000|Overall Study|Death|3|||
42007506|NCT01245387|75815093|FG000|Overall Study|Other|131|||
42007507|NCT01245387|75815093|FG000|Overall Study|Missing discontinuation status|369|||
42007508|NCT01037218|75815101|FG000|Overall Study|Adverse Event|4|||
42007509|NCT01037218|75815102|FG001|Overall Study|Adverse Event|2|||
42007510|NCT01037218|75815103|FG002|Overall Study|Adverse Event|2|||
42007511|NCT01037218|75815104|FG003|Overall Study|Adverse Event|1|||
42007512|NCT01037218|75815101|FG000|Overall Study|Lack of Efficacy|0|||
42007513|NCT01037218|75815102|FG001|Overall Study|Lack of Efficacy|2|||
42007514|NCT01037218|75815103|FG002|Overall Study|Lack of Efficacy|1|||
42007515|NCT01037218|75815104|FG003|Overall Study|Lack of Efficacy|5|||
42007516|NCT01037218|75815101|FG000|Overall Study|Lost to Follow-up|3|||
42007517|NCT01037218|75815102|FG001|Overall Study|Lost to Follow-up|5|||
42007518|NCT01037218|75815103|FG002|Overall Study|Lost to Follow-up|4|||
42007519|NCT01037218|75815104|FG003|Overall Study|Lost to Follow-up|2|||
42137588|NCT00536471|75947914|FG002|Overall Study|Lost to Follow-up|48|||
42137589|NCT00536471|75947915|FG003|Overall Study|Lost to Follow-up|22|||
42137590|NCT00536471|75947912|FG000|Overall Study|Adverse Event|32|||
42007520|NCT01037218|75815101|FG000|Overall Study|Withdrawal by Subject|6|||
42007521|NCT01037218|75815102|FG001|Overall Study|Withdrawal by Subject|7|||
42007522|NCT01037218|75815103|FG002|Overall Study|Withdrawal by Subject|7|||
42007523|NCT01037218|75815104|FG003|Overall Study|Withdrawal by Subject|4|||
42007524|NCT01037218|75815101|FG000|Overall Study|Partner Withdrew Consent|0|||
42007525|NCT01037218|75815102|FG001|Overall Study|Partner Withdrew Consent|3|||
42007526|NCT01037218|75815103|FG002|Overall Study|Partner Withdrew Consent|2|||
42137591|NCT00536471|75947913|FG001|Overall Study|Adverse Event|16|||
42137592|NCT00536471|75947914|FG002|Overall Study|Adverse Event|28|||
42007527|NCT01037218|75815104|FG003|Overall Study|Partner Withdrew Consent|1|||
42007528|NCT01037218|75815101|FG000|Overall Study|Protocol Violation|0|||
42007529|NCT01037218|75815102|FG001|Overall Study|Protocol Violation|0|||
42007530|NCT01037218|75815103|FG002|Overall Study|Protocol Violation|2|||
42007531|NCT01037218|75815104|FG003|Overall Study|Protocol Violation|2|||
42007532|NCT01037218|75815101|FG000|Overall Study|Various|3|||
42007533|NCT01037218|75815102|FG001|Overall Study|Various|2|||
42007534|NCT01037218|75815103|FG002|Overall Study|Various|3|||
42007535|NCT01037218|75815104|FG003|Overall Study|Various|1|||
42007536|NCT01038856|75815114|FG000|Overall Study|Adverse Event|2|||
42007537|NCT01066546|75815120|FG000|Overall Study|Study terminated by sponsor|5|||
42007538|NCT01272804|75815130|FG000|Overall Study|Adverse Event|1|||
42007539|NCT01272804|75815131|FG001|Overall Study|Adverse Event|0|||
42007540|NCT01272804|75815132|FG002|Overall Study|Adverse Event|0|||
42007541|NCT01272804|75815133|FG003|Overall Study|Adverse Event|0|||
42007542|NCT01272804|75815134|FG004|Overall Study|Adverse Event|2|||
42007543|NCT01272804|75815135|FG005|Overall Study|Adverse Event|1|||
42007544|NCT01269918|75815151|FG000|Overall Study|Did not receive study drug|0|||
42007545|NCT01269918|75815152|FG001|Overall Study|Did not receive study drug|3|||
42007546|NCT01036594|75815158|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
42007547|NCT01036594|75815159|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
42007548|NCT01036594|75815158|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
42007549|NCT01036594|75815159|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
42007550|NCT01036594|75815158|FG000|Week 12 Evaluation|Adverse Event|5|||
42007551|NCT01036594|75815159|FG001|Week 12 Evaluation|Adverse Event|0|||
42007552|NCT01036594|75815158|FG000|Week 12 Evaluation|Physician Decision|1|||
42007553|NCT01036594|75815159|FG001|Week 12 Evaluation|Physician Decision|0|||
42007554|NCT01036594|75815158|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
42007555|NCT01036594|75815159|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
42007556|NCT01036594|75815158|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
42007557|NCT01036594|75815159|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
42007558|NCT01036594|75815158|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
42007559|NCT01036594|75815159|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
42007560|NCT01036594|75815158|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
42007561|NCT01036594|75815159|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
42007562|NCT01036594|75815158|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
42007563|NCT01036594|75815159|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
42007564|NCT01036438|75815167|FG000|Overall Study|Adverse Event|7|||
42007565|NCT01036438|75815168|FG001|Overall Study|Adverse Event|8|||
42007566|NCT01036438|75815167|FG000|Overall Study|Death|0|||
42007567|NCT01036438|75815168|FG001|Overall Study|Death|1|||
42007568|NCT01036438|75815167|FG000|Overall Study|No effect of study treatment|3|||
42007569|NCT01036438|75815168|FG001|Overall Study|No effect of study treatment|1|||
42007570|NCT01268046|75815178|FG000|Overall Study|Withdrawal by Subject|1|||
42007571|NCT01268046|75815179|FG001|Overall Study|Withdrawal by Subject|0|||
42007572|NCT01268046|75815180|FG002|Overall Study|Withdrawal by Subject|0|||
42007573|NCT01268046|75815181|FG003|Overall Study|Withdrawal by Subject|1|||
42007574|NCT01268046|75815178|FG000|Overall Study|Lost to Follow-up|0|||
42007575|NCT01268046|75815179|FG001|Overall Study|Lost to Follow-up|0|||
42007576|NCT01268046|75815180|FG002|Overall Study|Lost to Follow-up|1|||
42007577|NCT01268046|75815181|FG003|Overall Study|Lost to Follow-up|0|||
42007578|NCT01267266|75815191|FG000|Enrollment Phase|Withdrawal by Subject|2|||
42007579|NCT01267266|75815192|FG001|Enrollment Phase|Withdrawal by Subject|0|||
42007580|NCT01267266|75815191|FG000|Lead-in Phase|Lack of Efficacy|20|||
42007581|NCT01267266|75815192|FG001|Lead-in Phase|Lack of Efficacy|0|||
42007582|NCT01267266|75815191|FG000|Lead-in Phase|Adverse Event|2|||
42007583|NCT01267266|75815192|FG001|Lead-in Phase|Adverse Event|0|||
42007584|NCT01267266|75815191|FG000|Lead-in Phase|Withdrawal by Subject|1|||
42007585|NCT01267266|75815192|FG001|Lead-in Phase|Withdrawal by Subject|0|||
42007586|NCT01034176|75815203|FG000|Overall Study|Physician Decision|2|||
42007587|NCT01034176|75815204|FG001|Overall Study|Physician Decision|0|||
42007588|NCT01034176|75815203|FG000|Overall Study|Withdrawal by Subject|0|||
42007589|NCT01034176|75815204|FG001|Overall Study|Withdrawal by Subject|1|||
42007590|NCT01034176|75815203|FG000|Overall Study|Lost to Follow-up|0|||
42007591|NCT01034176|75815204|FG001|Overall Study|Lost to Follow-up|1|||
42007592|NCT01033942|75815213|FG000|Overall Study|Withdrawal by Subject|1|||
42007593|NCT01033942|75815214|FG001|Overall Study|Withdrawal by Subject|1|||
42007594|NCT01033942|75815215|FG002|Overall Study|Withdrawal by Subject|1|||
42007595|NCT01033942|75815213|FG000|Overall Study|Lost to Follow-up|1|||
42007596|NCT01033942|75815214|FG001|Overall Study|Lost to Follow-up|0|||
42137593|NCT00536471|75947915|FG003|Overall Study|Adverse Event|13|||
42007597|NCT01033942|75815215|FG002|Overall Study|Lost to Follow-up|0|||
42007598|NCT01033942|75815213|FG000|Overall Study|Enrolled in Extension Study|0|||
42007599|NCT01033942|75815214|FG001|Overall Study|Enrolled in Extension Study|3|||
42007600|NCT01033942|75815215|FG002|Overall Study|Enrolled in Extension Study|0|||
42007601|NCT01062256|75815228|FG000|Overall Study|Adverse Event|1|||
42137594|NCT00536471|75947912|FG000|Overall Study|Withdrawal by Subject|40|||
42007602|NCT01062256|75815229|FG001|Overall Study|Adverse Event|0|||
42007603|NCT01062256|75815230|FG002|Overall Study|Adverse Event|0|||
42007604|NCT01062256|75815228|FG000|Overall Study|Withdrawal by Subject|1|||
42007605|NCT01062256|75815229|FG001|Overall Study|Withdrawal by Subject|1|||
42007606|NCT01062256|75815230|FG002|Overall Study|Withdrawal by Subject|1|||
42007607|NCT01062256|75815228|FG000|Overall Study|Ineligible|1|||
42007608|NCT01062256|75815229|FG001|Overall Study|Ineligible|4|||
42007609|NCT01062256|75815230|FG002|Overall Study|Ineligible|3|||
42007610|NCT01062256|75815228|FG000|Overall Study|Administrative|0|||
42007611|NCT01062256|75815229|FG001|Overall Study|Administrative|2|||
42007612|NCT01062256|75815230|FG002|Overall Study|Administrative|0|||
42007613|NCT01029886|75815240|FG000|Overall Study|Adverse Event|12|||
42007614|NCT01029886|75815241|FG001|Overall Study|Adverse Event|25|||
42007615|NCT01029886|75815240|FG000|Overall Study|Lost to Follow-up|1|||
42007616|NCT01029886|75815241|FG001|Overall Study|Lost to Follow-up|0|||
42007617|NCT01029886|75815240|FG000|Overall Study|Physician Decision|2|||
42007618|NCT01029886|75815241|FG001|Overall Study|Physician Decision|6|||
42007619|NCT01029886|75815240|FG000|Overall Study|Protocol Violation|17|||
42007620|NCT01029886|75815241|FG001|Overall Study|Protocol Violation|5|||
42007621|NCT01029886|75815240|FG000|Overall Study|Withdrawal by Subject|8|||
42007622|NCT01029886|75815241|FG001|Overall Study|Withdrawal by Subject|18|||
42007623|NCT01029886|75815240|FG000|Overall Study|Entry Criteria Not Met|13|||
42007624|NCT01029886|75815241|FG001|Overall Study|Entry Criteria Not Met|5|||
42007625|NCT01029886|75815240|FG000|Overall Study|Sponsor Decision|1|||
42007626|NCT01029886|75815241|FG001|Overall Study|Sponsor Decision|0|||
42007627|NCT01029886|75815240|FG000|Overall Study|Loss Glucose Control|7|||
42007628|NCT01029886|75815241|FG001|Overall Study|Loss Glucose Control|1|||
42007629|NCT01244763|75815257|FG000|Overall Study|Adverse Event|1|||
42007630|NCT01244763|75815258|FG001|Overall Study|Adverse Event|0|||
42007631|NCT01244763|75815259|FG002|Overall Study|Adverse Event|0|||
42007632|NCT01244763|75815260|FG003|Overall Study|Adverse Event|0|||
42007633|NCT01244763|75815261|FG004|Overall Study|Adverse Event|0|||
42007634|NCT01244763|75815262|FG005|Overall Study|Adverse Event|1|||
42007635|NCT01244763|75815257|FG000|Overall Study|Death|1|||
42007636|NCT01244763|75815258|FG001|Overall Study|Death|0|||
42007637|NCT01244763|75815259|FG002|Overall Study|Death|1|||
42007638|NCT01244763|75815260|FG003|Overall Study|Death|0|||
42007639|NCT01244763|75815261|FG004|Overall Study|Death|2|||
42007640|NCT01244763|75815262|FG005|Overall Study|Death|0|||
42007641|NCT01244763|75815257|FG000|Overall Study|Physician Decision|0|||
42007642|NCT01244763|75815258|FG001|Overall Study|Physician Decision|0|||
42007643|NCT01244763|75815259|FG002|Overall Study|Physician Decision|1|||
42007644|NCT01244763|75815260|FG003|Overall Study|Physician Decision|0|||
42007645|NCT01244763|75815261|FG004|Overall Study|Physician Decision|0|||
42007646|NCT01244763|75815262|FG005|Overall Study|Physician Decision|0|||
42007647|NCT01244763|75815257|FG000|Overall Study|Withdrawal by Subject|1|||
42007648|NCT01244763|75815258|FG001|Overall Study|Withdrawal by Subject|2|||
42007649|NCT01244763|75815259|FG002|Overall Study|Withdrawal by Subject|0|||
42007650|NCT01244763|75815260|FG003|Overall Study|Withdrawal by Subject|1|||
42007651|NCT01244763|75815261|FG004|Overall Study|Withdrawal by Subject|1|||
42007652|NCT01244763|75815262|FG005|Overall Study|Withdrawal by Subject|2|||
42007653|NCT01244763|75815257|FG000|Overall Study|Lost to Follow-up|0|||
42007654|NCT01244763|75815258|FG001|Overall Study|Lost to Follow-up|1|||
42007655|NCT01244763|75815259|FG002|Overall Study|Lost to Follow-up|0|||
42272220|NCT00152477|76102346|FG000|Monotherapy Period|Study personel decision|0|||
42272221|NCT00152477|76102347|FG001|Monotherapy Period|Study personel decision|0|||
42272222|NCT00152477|76102348|FG002|Monotherapy Period|Study personel decision|1|||
42272223|NCT02525588|76102361|FG000|Overall Study|Death|3|||
42272224|NCT02525588|76102362|FG001|Overall Study|Death|1|||
42272225|NCT02525588|76102361|FG000|Overall Study|Lost to Follow-up|2|||
42272226|NCT02525588|76102362|FG001|Overall Study|Lost to Follow-up|0|||
42346780|NCT01877421|76185701|FG013|Phase 2|Protocol Violation|0|||
42346781|NCT01877421|76185702|FG014|Phase 2|Protocol Violation|0|||
42007656|NCT01244763|75815260|FG003|Overall Study|Lost to Follow-up|0|||
42007657|NCT01244763|75815261|FG004|Overall Study|Lost to Follow-up|0|||
42007658|NCT01244763|75815262|FG005|Overall Study|Lost to Follow-up|0|||
42007659|NCT01244763|75815257|FG000|Overall Study|Enrolled into the Extension Study|0|||
42007660|NCT01244763|75815258|FG001|Overall Study|Enrolled into the Extension Study|0|||
42007661|NCT01244763|75815259|FG002|Overall Study|Enrolled into the Extension Study|0|||
42007662|NCT01244763|75815260|FG003|Overall Study|Enrolled into the Extension Study|0|||
42007663|NCT01244763|75815261|FG004|Overall Study|Enrolled into the Extension Study|0|||
42007664|NCT01244763|75815262|FG005|Overall Study|Enrolled into the Extension Study|1|||
42007665|NCT01244061|75815278|FG000|Overall Study|Death|1|||
42007666|NCT01244061|75815279|FG001|Overall Study|Death|0|||
42007667|NCT01244061|75815278|FG000|Overall Study|Did not meet entrance criteria|1|||
42007668|NCT01244061|75815279|FG001|Overall Study|Did not meet entrance criteria|0|||
42007669|NCT01244061|75815278|FG000|Overall Study|Lack of Efficacy|1|||
42007670|NCT01244061|75815279|FG001|Overall Study|Lack of Efficacy|3|||
42272227|NCT02525588|76102361|FG000|Overall Study|Withdrawal by Subject|1|||
42007671|NCT01244061|75815278|FG000|Overall Study|Lost to Follow-up|34|||
42007672|NCT01244061|75815279|FG001|Overall Study|Lost to Follow-up|30|||
42007673|NCT01244061|75815278|FG000|Overall Study|Withdrawal by Subject|29|||
42007674|NCT01244061|75815279|FG001|Overall Study|Withdrawal by Subject|46|||
42007675|NCT01244061|75815278|FG000|Overall Study|Other|8|||
42007676|NCT01244061|75815279|FG001|Overall Study|Other|19|||
42007677|NCT01244061|75815278|FG000|Overall Study|Protocol Violation|1|||
42007678|NCT01244061|75815279|FG001|Overall Study|Protocol Violation|1|||
42007679|NCT01244061|75815278|FG000|Overall Study|Adverse Event|5|||
42007680|NCT01244061|75815279|FG001|Overall Study|Adverse Event|2|||
42007681|NCT01244061|75815278|FG000|Overall Study|Randomized but not treated|2|||
42007682|NCT01244061|75815279|FG001|Overall Study|Randomized but not treated|2|||
42007683|NCT01243671|75815285|FG000|Overall Study|Adverse Event|3|||
42007684|NCT01243671|75815285|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
42007685|NCT01243671|75815285|FG000|Overall Study|Other|1|||
42007686|NCT01240785|75815291|FG000|Overall Study|Lost to Follow-up|1|||
42007687|NCT01240785|75815292|FG001|Overall Study|Lost to Follow-up|0|||
42007688|NCT01240785|75815291|FG000|Overall Study|Protocol Violation|0|||
42007689|NCT01240785|75815292|FG001|Overall Study|Protocol Violation|3|||
42007690|NCT01240551|75815300|FG000|Overall Study|Refused further treatment|3|||
42007691|NCT01240551|75815301|FG001|Overall Study|Refused further treatment|2|||
42007692|NCT01240551|75815300|FG000|Overall Study|Lost to Follow-up|1|||
42007693|NCT01240551|75815301|FG001|Overall Study|Lost to Follow-up|1|||
42007694|NCT01239381|75815307|FG000|Overall Study|Protocol Violation|1|||
42007695|NCT01239381|75815307|FG000|Overall Study|Withdrawal by Subject|1|||
42007696|NCT01266876|75815317|FG000|Overall Study|Adverse Event|0|||
42007697|NCT01266876|75815318|FG001|Overall Study|Adverse Event|0|||
42007698|NCT01266876|75815319|FG002|Overall Study|Adverse Event|0|||
42007699|NCT01266876|75815320|FG003|Overall Study|Adverse Event|1|||
42007700|NCT01266876|75815321|FG004|Overall Study|Adverse Event|0|||
42007701|NCT01033240|75815336|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
42007702|NCT01033240|75815337|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
42007703|NCT01033240|75815338|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
42007704|NCT01033240|75815336|FG000|Overall Study|Death|2|||
42007705|NCT01033240|75815337|FG001|Overall Study|Death|0|||
42007706|NCT01033240|75815338|FG002|Overall Study|Death|0|||
42007707|NCT01033240|75815336|FG000|Overall Study|Withdrew Consent|2|||
42007708|NCT01033240|75815337|FG001|Overall Study|Withdrew Consent|9|||
42007709|NCT01033240|75815338|FG002|Overall Study|Withdrew Consent|2|||
42007710|NCT01033240|75815336|FG000|Overall Study|Disease Progression|35|||
42007711|NCT01033240|75815337|FG001|Overall Study|Disease Progression|32|||
42007712|NCT01033240|75815338|FG002|Overall Study|Disease Progression|41|||
42007713|NCT01033240|75815336|FG000|Overall Study|Investigator Discretion|0|||
42007714|NCT01033240|75815337|FG001|Overall Study|Investigator Discretion|0|||
42007715|NCT01033240|75815338|FG002|Overall Study|Investigator Discretion|2|||
42007716|NCT01033240|75815336|FG000|Overall Study|Other|0|||
42007717|NCT01033240|75815337|FG001|Overall Study|Other|1|||
42007718|NCT01033240|75815338|FG002|Overall Study|Other|2|||
42007719|NCT01266018|75815346|FG000|Overall Study|Physician Decision|1|||
42007720|NCT01266018|75815347|FG001|Overall Study|Physician Decision|0|||
42007721|NCT01266018|75815346|FG000|Overall Study|Progressive disease|0|||
42007722|NCT01266018|75815347|FG001|Overall Study|Progressive disease|1|||
42007723|NCT01032382|75815355|FG000|Overall Study|Disease dissemination|1|||
42007724|NCT01032382|75815356|FG001|Overall Study|Disease dissemination|1|||
42007725|NCT01032382|75815355|FG000|Overall Study|Treatment failure|3|||
42007726|NCT01032382|75815356|FG001|Overall Study|Treatment failure|1|||
42007727|NCT01032382|75815355|FG000|Overall Study|Index lesion relapse|1|||
42007728|NCT01032382|75815356|FG001|Overall Study|Index lesion relapse|3|||
42007729|NCT01029652|75815364|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
42007730|NCT01029652|75815365|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
42007731|NCT01029652|75815364|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
42007732|NCT01029652|75815365|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
42007733|NCT01029652|75815364|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
42007734|NCT01029652|75815365|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
42007735|NCT01029652|75815364|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
42007736|NCT01029652|75815365|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
42007737|NCT01029652|75815364|FG000|Core Study (0-12 Weeks)|Death|0|||
42007738|NCT01029652|75815365|FG001|Core Study (0-12 Weeks)|Death|1|||
42007739|NCT01029652|75815364|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
42007740|NCT01029652|75815365|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
42007741|NCT01029652|75815364|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
42007742|NCT01029652|75815365|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
42007743|NCT01029652|75815364|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
42007744|NCT01029652|75815365|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
42007745|NCT01029652|75815364|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
42007746|NCT01029652|75815365|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
42007747|NCT01029652|75815364|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
42007748|NCT01029652|75815365|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
42007749|NCT01029652|75815364|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
42007750|NCT01029652|75815365|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
42007751|NCT01029652|75815364|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
42007752|NCT01029652|75815365|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
42007753|NCT01029340|75815394|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
42007754|NCT01029340|75815395|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
42007755|NCT01029340|75815396|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
42007756|NCT01029340|75815397|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
42007757|NCT01029340|75815398|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
42007758|NCT01029340|75815399|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
42007759|NCT01029340|75815394|FG000|Part B Treatment Period|Protocol Violation|0|||
42007760|NCT01029340|75815395|FG001|Part B Treatment Period|Protocol Violation|0|||
42007761|NCT01029340|75815396|FG002|Part B Treatment Period|Protocol Violation|1|||
42007762|NCT01029340|75815397|FG003|Part B Treatment Period|Protocol Violation|0|||
42007763|NCT01029340|75815398|FG004|Part B Treatment Period|Protocol Violation|0|||
42007764|NCT01029340|75815399|FG005|Part B Treatment Period|Protocol Violation|0|||
42007765|NCT01029340|75815394|FG000|Extension Period|Adverse Event|0|||
42007766|NCT01029340|75815395|FG001|Extension Period|Adverse Event|0|||
42007767|NCT01029340|75815396|FG002|Extension Period|Adverse Event|0|||
42007768|NCT01029340|75815397|FG003|Extension Period|Adverse Event|0|||
42007769|NCT01029340|75815398|FG004|Extension Period|Adverse Event|0|||
42007770|NCT01029340|75815399|FG005|Extension Period|Adverse Event|1|||
42007771|NCT01029340|75815394|FG000|Extension Period|starting another study|0|||
42007772|NCT01029340|75815395|FG001|Extension Period|starting another study|0|||
42007773|NCT01029340|75815396|FG002|Extension Period|starting another study|0|||
42007774|NCT01029340|75815397|FG003|Extension Period|starting another study|0|||
42007775|NCT01029340|75815398|FG004|Extension Period|starting another study|0|||
42007776|NCT01029340|75815399|FG005|Extension Period|starting another study|8|||
42007777|NCT01029340|75815394|FG000|Extension Period|non-compliance|0|||
42007778|NCT01029340|75815395|FG001|Extension Period|non-compliance|0|||
42007779|NCT01029340|75815396|FG002|Extension Period|non-compliance|0|||
42007780|NCT01029340|75815397|FG003|Extension Period|non-compliance|0|||
42007781|NCT01029340|75815398|FG004|Extension Period|non-compliance|0|||
42007782|NCT01029340|75815399|FG005|Extension Period|non-compliance|1|||
42007783|NCT01029340|75815394|FG000|Extension Period|Withdrawal by Subject|0|||
42007784|NCT01029340|75815395|FG001|Extension Period|Withdrawal by Subject|0|||
42007785|NCT01029340|75815396|FG002|Extension Period|Withdrawal by Subject|0|||
42007786|NCT01029340|75815397|FG003|Extension Period|Withdrawal by Subject|0|||
42007787|NCT01029340|75815398|FG004|Extension Period|Withdrawal by Subject|0|||
42007788|NCT01029340|75815399|FG005|Extension Period|Withdrawal by Subject|1|||
42007789|NCT01029340|75815394|FG000|Extension Period|Physician Decision|0|||
42007790|NCT01029340|75815395|FG001|Extension Period|Physician Decision|0|||
42007791|NCT01029340|75815396|FG002|Extension Period|Physician Decision|0|||
42007792|NCT01029340|75815397|FG003|Extension Period|Physician Decision|0|||
42007793|NCT01029340|75815398|FG004|Extension Period|Physician Decision|0|||
42007794|NCT01029340|75815399|FG005|Extension Period|Physician Decision|1|||
42007795|NCT01265550|75815416|FG000|Pre Randomization|Withdrawal by Subject|0|||
42007796|NCT01265550|75815417|FG001|Pre Randomization|Withdrawal by Subject|0|||
42007797|NCT01265550|75815418|FG002|Pre Randomization|Withdrawal by Subject|0|||
42007798|NCT01265550|75815419|FG003|Pre Randomization|Withdrawal by Subject|70|||
42007799|NCT01265550|75815416|FG000|Pre Randomization|Technical Exclusions|0|||
42007800|NCT01265550|75815417|FG001|Pre Randomization|Technical Exclusions|0|||
42007801|NCT01265550|75815418|FG002|Pre Randomization|Technical Exclusions|0|||
42007802|NCT01265550|75815419|FG003|Pre Randomization|Technical Exclusions|54|||
42007803|NCT01265550|75815416|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
42007804|NCT01265550|75815417|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
42007805|NCT01265550|75815418|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
42007806|NCT01265550|75815419|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
42137595|NCT00536471|75947913|FG001|Overall Study|Withdrawal by Subject|24|||
42137596|NCT00536471|75947914|FG002|Overall Study|Withdrawal by Subject|43|||
42137597|NCT00536471|75947915|FG003|Overall Study|Withdrawal by Subject|21|||
42272228|NCT02525588|76102362|FG001|Overall Study|Withdrawal by Subject|1|||
42272229|NCT02525588|76102361|FG000|Overall Study|Adverse Event|0|||
42007807|NCT01265550|75815416|FG000|Pre Randomization|Non-GERD organic disorders|0|||
42007808|NCT01265550|75815417|FG001|Pre Randomization|Non-GERD organic disorders|0|||
42007809|NCT01265550|75815418|FG002|Pre Randomization|Non-GERD organic disorders|0|||
42007810|NCT01265550|75815419|FG003|Pre Randomization|Non-GERD organic disorders|23|||
42007811|NCT01265550|75815416|FG000|Pre Randomization|Functional heartburn|0|||
42035626|NCT00833833|75844129|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
42035627|NCT00833833|75844130|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
42035628|NCT00833833|75844131|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
42272230|NCT02525588|76102362|FG001|Overall Study|Adverse Event|1|||
42007812|NCT01265550|75815417|FG001|Pre Randomization|Functional heartburn|0|||
42007813|NCT01265550|75815418|FG002|Pre Randomization|Functional heartburn|0|||
42007814|NCT01265550|75815419|FG003|Pre Randomization|Functional heartburn|99|||
42007815|NCT01265394|75815433|FG000|Overall Study|Subjects withdrawn|37|||
42007816|NCT01029262|75815440|FG000|Overall Study|Adverse Event|9|||
42007817|NCT01029262|75815441|FG001|Overall Study|Adverse Event|52|||
42007818|NCT01029262|75815440|FG000|Overall Study|Lack of therapeutic effect|57|||
42007819|NCT01029262|75815441|FG001|Overall Study|Lack of therapeutic effect|76|||
42007820|NCT01029262|75815440|FG000|Overall Study|Withdrawal by Subject|10|||
42007821|NCT01029262|75815441|FG001|Overall Study|Withdrawal by Subject|17|||
42007822|NCT01029262|75815440|FG000|Overall Study|Protocol Violation|2|||
42007823|NCT01029262|75815441|FG001|Overall Study|Protocol Violation|3|||
42007824|NCT01029262|75815440|FG000|Overall Study|Miscellaneous|1|||
42007825|NCT01029262|75815441|FG001|Overall Study|Miscellaneous|9|||
42007826|NCT01029262|75815440|FG000|Overall Study|Death|0|||
42007827|NCT01029262|75815441|FG001|Overall Study|Death|3|||
42007828|NCT01028560|75815454|FG000|Overall Study|Lack of Efficacy|3|||
42007829|NCT01028560|75815455|FG001|Overall Study|Lack of Efficacy|6|||
42007830|NCT01028560|75815454|FG000|Overall Study|Withdrawal by Subject|7|||
42007831|NCT01028560|75815455|FG001|Overall Study|Withdrawal by Subject|12|||
42007832|NCT01061710|75815462|FG000|Overall Study|Protocol Violation|14|||
42007833|NCT01028014|75815472|FG000|Overall Study|Lost to Follow-up|1|||
42007834|NCT01028014|75815473|FG001|Overall Study|Lost to Follow-up|2|||
42007835|NCT01028014|75815474|FG002|Overall Study|Lost to Follow-up|0|||
42007836|NCT01028014|75815475|FG003|Overall Study|Lost to Follow-up|1|||
42007837|NCT01028014|75815476|FG004|Overall Study|Lost to Follow-up|1|||
42007838|NCT01028014|75815477|FG005|Overall Study|Lost to Follow-up|2|||
42007839|NCT01264770|75815497|FG000|Overall Study|Not reported|0|||
42007840|NCT01264770|75815498|FG001|Overall Study|Not reported|0|||
42007841|NCT01264770|75815499|FG002|Overall Study|Not reported|1|||
42007842|NCT01264770|75815500|FG003|Overall Study|Not reported|0|||
42007843|NCT01264770|75815501|FG004|Overall Study|Not reported|0|||
42007844|NCT01264770|75815502|FG005|Overall Study|Not reported|0|||
42007845|NCT01264770|75815497|FG000|Overall Study|e.g., change in circumstances|8|||
42007846|NCT01264770|75815498|FG001|Overall Study|e.g., change in circumstances|3|||
42007847|NCT01264770|75815499|FG002|Overall Study|e.g., change in circumstances|3|||
42007848|NCT01264770|75815500|FG003|Overall Study|e.g., change in circumstances|3|||
42007849|NCT01264770|75815501|FG004|Overall Study|e.g., change in circumstances|4|||
42007850|NCT01264770|75815502|FG005|Overall Study|e.g., change in circumstances|4|||
42007851|NCT01264770|75815497|FG000|Overall Study|Severe non-compliance to protocol|0|||
42007852|NCT01264770|75815498|FG001|Overall Study|Severe non-compliance to protocol|0|||
42007853|NCT01264770|75815499|FG002|Overall Study|Severe non-compliance to protocol|1|||
42007854|NCT01264770|75815500|FG003|Overall Study|Severe non-compliance to protocol|1|||
42007855|NCT01264770|75815501|FG004|Overall Study|Severe non-compliance to protocol|0|||
42007856|NCT01264770|75815502|FG005|Overall Study|Severe non-compliance to protocol|0|||
42007857|NCT01264770|75815497|FG000|Overall Study|Lack of therapeutic response|1|||
42007858|NCT01264770|75815498|FG001|Overall Study|Lack of therapeutic response|0|||
42007859|NCT01264770|75815499|FG002|Overall Study|Lack of therapeutic response|2|||
42007860|NCT01264770|75815500|FG003|Overall Study|Lack of therapeutic response|1|||
42007861|NCT01264770|75815501|FG004|Overall Study|Lack of therapeutic response|1|||
42007862|NCT01264770|75815502|FG005|Overall Study|Lack of therapeutic response|0|||
42007863|NCT01264770|75815497|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
42007864|NCT01264770|75815498|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
42007865|NCT01264770|75815499|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
42007866|NCT01264770|75815500|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
42007867|NCT01264770|75815501|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
42007868|NCT01264770|75815502|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
42007869|NCT01264770|75815497|FG000|Overall Study|Lost to Follow-up|0|||
42007870|NCT01264770|75815498|FG001|Overall Study|Lost to Follow-up|0|||
42007871|NCT01264770|75815499|FG002|Overall Study|Lost to Follow-up|1|||
42007872|NCT01264770|75815500|FG003|Overall Study|Lost to Follow-up|1|||
42007873|NCT01264770|75815501|FG004|Overall Study|Lost to Follow-up|0|||
42007874|NCT01264770|75815502|FG005|Overall Study|Lost to Follow-up|0|||
42007875|NCT01264770|75815497|FG000|Overall Study|Adverse Event|7|||
42007876|NCT01264770|75815498|FG001|Overall Study|Adverse Event|7|||
42007877|NCT01264770|75815499|FG002|Overall Study|Adverse Event|8|||
42346782|NCT01877421|76185703|FG015|Phase 2|Protocol Violation|0|||
42007878|NCT01264770|75815500|FG003|Overall Study|Adverse Event|0|||
42007879|NCT01264770|75815501|FG004|Overall Study|Adverse Event|2|||
42007880|NCT01264770|75815502|FG005|Overall Study|Adverse Event|1|||
42007881|NCT01027702|75815522|FG000|Overall Study|Received subsequent therapy|1|||
42007882|NCT01027702|75815523|FG001|Overall Study|Received subsequent therapy|2|||
42007883|NCT01027702|75815524|FG002|Overall Study|Received subsequent therapy|0|||
42007884|NCT01027702|75815525|FG003|Overall Study|Received subsequent therapy|4|||
42007885|NCT01027702|75815526|FG004|Overall Study|Received subsequent therapy|1|||
42007886|NCT01027702|75815527|FG005|Overall Study|Received subsequent therapy|0|||
42007887|NCT01027702|75815528|FG006|Overall Study|Received subsequent therapy|1|||
42007888|NCT01027702|75815522|FG000|Overall Study|Death|0|||
42007889|NCT01027702|75815523|FG001|Overall Study|Death|0|||
42007890|NCT01027702|75815524|FG002|Overall Study|Death|1|||
42007891|NCT01027702|75815525|FG003|Overall Study|Death|0|||
42007892|NCT01027702|75815526|FG004|Overall Study|Death|0|||
42007893|NCT01027702|75815527|FG005|Overall Study|Death|0|||
42007894|NCT01027702|75815528|FG006|Overall Study|Death|0|||
42007895|NCT01302080|75815542|FG000|Overall Study|Withdrew Consent|92|||
42007896|NCT01302080|75815543|FG001|Overall Study|Withdrew Consent|39|||
42007897|NCT01302080|75815542|FG000|Overall Study|Patient/Family Moved|28|||
42007898|NCT01302080|75815543|FG001|Overall Study|Patient/Family Moved|3|||
42007899|NCT01302080|75815542|FG000|Overall Study|Lost to Follow-up|192|||
42007900|NCT01302080|75815543|FG001|Overall Study|Lost to Follow-up|93|||
42007901|NCT01302080|75815542|FG000|Overall Study|Death|1|||
42007902|NCT01302080|75815543|FG001|Overall Study|Death|0|||
42007903|NCT01302080|75815542|FG000|Overall Study|Other|52|||
42007904|NCT01302080|75815543|FG001|Overall Study|Other|8|||
42007905|NCT01302080|75815542|FG000|Overall Study|Reason Missing For Discontinuation|1|||
42007906|NCT01302080|75815543|FG001|Overall Study|Reason Missing For Discontinuation|0|||
42007907|NCT01238991|75815583|FG000|Overall Study|Adverse Event|1|||
42007908|NCT01238991|75815584|FG001|Overall Study|Adverse Event|0|||
42007909|NCT01238991|75815585|FG002|Overall Study|Adverse Event|3|||
42007910|NCT01238991|75815586|FG003|Overall Study|Adverse Event|1|||
42007911|NCT01238991|75815587|FG004|Overall Study|Adverse Event|1|||
42007912|NCT01238991|75815588|FG005|Overall Study|Adverse Event|0|||
42007913|NCT01238991|75815589|FG006|Overall Study|Adverse Event|1|||
42007914|NCT01238991|75815590|FG007|Overall Study|Adverse Event|1|||
42007915|NCT01238991|75815591|FG008|Overall Study|Adverse Event|0|||
42007916|NCT01238991|75815592|FG009|Overall Study|Adverse Event|0|||
42007917|NCT01238991|75815583|FG000|Overall Study|Death|0|||
42007918|NCT01238991|75815584|FG001|Overall Study|Death|0|||
42007919|NCT01238991|75815585|FG002|Overall Study|Death|0|||
42007920|NCT01238991|75815586|FG003|Overall Study|Death|1|||
42007921|NCT01238991|75815587|FG004|Overall Study|Death|0|||
42007922|NCT01238991|75815588|FG005|Overall Study|Death|0|||
42007923|NCT01238991|75815589|FG006|Overall Study|Death|0|||
42007924|NCT01238991|75815590|FG007|Overall Study|Death|0|||
42007925|NCT01238991|75815591|FG008|Overall Study|Death|0|||
42007926|NCT01238991|75815592|FG009|Overall Study|Death|0|||
42007927|NCT01238991|75815583|FG000|Overall Study|Lack of Efficacy|0|||
42007928|NCT01238991|75815584|FG001|Overall Study|Lack of Efficacy|0|||
42007929|NCT01238991|75815585|FG002|Overall Study|Lack of Efficacy|1|||
42007930|NCT01238991|75815586|FG003|Overall Study|Lack of Efficacy|0|||
42007931|NCT01238991|75815587|FG004|Overall Study|Lack of Efficacy|0|||
42007932|NCT01238991|75815588|FG005|Overall Study|Lack of Efficacy|0|||
42007933|NCT01238991|75815589|FG006|Overall Study|Lack of Efficacy|0|||
42007934|NCT01238991|75815590|FG007|Overall Study|Lack of Efficacy|0|||
42007935|NCT01238991|75815591|FG008|Overall Study|Lack of Efficacy|1|||
42007936|NCT01238991|75815592|FG009|Overall Study|Lack of Efficacy|0|||
42007937|NCT01238991|75815583|FG000|Overall Study|Withdrawal by Subject|0|||
42007938|NCT01238991|75815584|FG001|Overall Study|Withdrawal by Subject|0|||
42007939|NCT01238991|75815585|FG002|Overall Study|Withdrawal by Subject|1|||
42007940|NCT01238991|75815586|FG003|Overall Study|Withdrawal by Subject|0|||
42007941|NCT01238991|75815587|FG004|Overall Study|Withdrawal by Subject|0|||
42007942|NCT01238991|75815588|FG005|Overall Study|Withdrawal by Subject|0|||
42007943|NCT01238991|75815589|FG006|Overall Study|Withdrawal by Subject|0|||
42007944|NCT01238991|75815590|FG007|Overall Study|Withdrawal by Subject|0|||
42007945|NCT01238991|75815591|FG008|Overall Study|Withdrawal by Subject|0|||
42007946|NCT01238991|75815592|FG009|Overall Study|Withdrawal by Subject|0|||
42007947|NCT01238991|75815583|FG000|Overall Study|Study Terminated by Sponsor|0|||
42007948|NCT01238991|75815584|FG001|Overall Study|Study Terminated by Sponsor|0|||
42007949|NCT01238991|75815585|FG002|Overall Study|Study Terminated by Sponsor|0|||
42007950|NCT01238991|75815586|FG003|Overall Study|Study Terminated by Sponsor|0|||
42007951|NCT01238991|75815587|FG004|Overall Study|Study Terminated by Sponsor|1|||
42007952|NCT01238991|75815588|FG005|Overall Study|Study Terminated by Sponsor|0|||
42007953|NCT01238991|75815589|FG006|Overall Study|Study Terminated by Sponsor|7|||
42007954|NCT01238991|75815590|FG007|Overall Study|Study Terminated by Sponsor|4|||
42007955|NCT01238991|75815591|FG008|Overall Study|Study Terminated by Sponsor|2|||
42007956|NCT01238991|75815592|FG009|Overall Study|Study Terminated by Sponsor|2|||
42007957|NCT01238991|75815583|FG000|Overall Study|Caregiver's request|0|||
42007958|NCT01238991|75815584|FG001|Overall Study|Caregiver's request|0|||
42007959|NCT01238991|75815585|FG002|Overall Study|Caregiver's request|0|||
42007960|NCT01238991|75815586|FG003|Overall Study|Caregiver's request|0|||
42007961|NCT01238991|75815587|FG004|Overall Study|Caregiver's request|0|||
42007962|NCT01238991|75815588|FG005|Overall Study|Caregiver's request|0|||
42007963|NCT01238991|75815589|FG006|Overall Study|Caregiver's request|0|||
42007964|NCT01238991|75815590|FG007|Overall Study|Caregiver's request|0|||
42007965|NCT01238991|75815591|FG008|Overall Study|Caregiver's request|1|||
42007966|NCT01238991|75815592|FG009|Overall Study|Caregiver's request|0|||
42007967|NCT01238991|75815583|FG000|Overall Study|Admission to a nursing home|1|||
42007968|NCT01238991|75815584|FG001|Overall Study|Admission to a nursing home|0|||
42007969|NCT01238991|75815585|FG002|Overall Study|Admission to a nursing home|1|||
42007970|NCT01238991|75815586|FG003|Overall Study|Admission to a nursing home|0|||
42007971|NCT01238991|75815587|FG004|Overall Study|Admission to a nursing home|0|||
42007972|NCT01238991|75815588|FG005|Overall Study|Admission to a nursing home|0|||
42007973|NCT01238991|75815589|FG006|Overall Study|Admission to a nursing home|0|||
42007974|NCT01238991|75815590|FG007|Overall Study|Admission to a nursing home|0|||
42007975|NCT01238991|75815591|FG008|Overall Study|Admission to a nursing home|0|||
42007976|NCT01238991|75815592|FG009|Overall Study|Admission to a nursing home|0|||
42007977|NCT01238835|75815617|FG000|Overall Study|Death|124|||
42007978|NCT01238835|75815617|FG000|Overall Study|Withdrawal by Subject|9|||
42007979|NCT01238835|75815617|FG000|Overall Study|Lost to Follow-up|1|||
42007980|NCT01238835|75815617|FG000|Overall Study|Site early discontinuation|2|||
42007981|NCT01032070|75815623|FG000|Overall Study|Disease progression|13|||
42007982|NCT01032070|75815624|FG001|Overall Study|Disease progression|8|||
42007983|NCT01032070|75815623|FG000|Overall Study|Medical or ethical reasons|0|||
42007984|NCT01032070|75815624|FG001|Overall Study|Medical or ethical reasons|2|||
42007985|NCT01032070|75815623|FG000|Overall Study|Withdrawal by Subject|0|||
42007986|NCT01032070|75815624|FG001|Overall Study|Withdrawal by Subject|2|||
42007987|NCT01237899|75815641|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
42007988|NCT01237899|75815642|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
42007989|NCT01237899|75815643|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
42007990|NCT01237899|75815644|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
42007991|NCT01237899|75815645|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
42007992|NCT01237899|75815646|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
42007993|NCT01237899|75815647|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
42007994|NCT01237899|75815648|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
42007995|NCT01237899|75815649|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
42007996|NCT01237899|75815650|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
42007997|NCT01237899|75815651|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
42007998|NCT01264380|75815669|FG000|Period C|Disease Progression|0|||
42007999|NCT01264380|75815670|FG001|Period C|Disease Progression|0|||
42008000|NCT01264380|75815671|FG002|Period C|Disease Progression|4|||
42008001|NCT01264380|75815669|FG000|Period C|Death|0|||
42008002|NCT01264380|75815670|FG001|Period C|Death|0|||
42008003|NCT01264380|75815671|FG002|Period C|Death|2|||
42008004|NCT01264380|75815669|FG000|Period C|Follow-up for survival status|0|||
42008005|NCT01264380|75815670|FG001|Period C|Follow-up for survival status|0|||
42008006|NCT01264380|75815671|FG002|Period C|Follow-up for survival status|6|||
42008007|NCT01264380|75815669|FG000|Period C|Withdrawal by Subject|0|||
42008008|NCT01264380|75815670|FG001|Period C|Withdrawal by Subject|0|||
42008009|NCT01264380|75815671|FG002|Period C|Withdrawal by Subject|1|||
42272231|NCT00153179|76102370|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
42272232|NCT00153179|76102371|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
42008010|NCT01264380|75815669|FG000|Period C|Adverse Event|0|||
42008011|NCT01264380|75815670|FG001|Period C|Adverse Event|0|||
42008012|NCT01264380|75815671|FG002|Period C|Adverse Event|1|||
42008013|NCT01263444|75815679|FG000|Overall Study|Adverse Event|8|||
42137598|NCT00536471|75947912|FG000|Overall Study|Lack of Efficacy|17|||
42272233|NCT00153179|76102372|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
42272234|NCT00153179|76102373|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
42008014|NCT01263444|75815679|FG000|Overall Study|Withdrawal by Subject|1|||
42008015|NCT01263444|75815679|FG000|Overall Study|Protocol Violation|1|||
42008016|NCT01263054|75815685|FG000|Overall Study|Death|1|||
42008017|NCT01263054|75815686|FG001|Overall Study|Death|0|||
42008018|NCT01263054|75815685|FG000|Overall Study|Lost to Follow-up|2|||
42008019|NCT01263054|75815686|FG001|Overall Study|Lost to Follow-up|2|||
42008020|NCT01263054|75815685|FG000|Overall Study|Withdrawal by Subject|1|||
42008021|NCT01263054|75815686|FG001|Overall Study|Withdrawal by Subject|3|||
42272235|NCT02743949|76102384|FG000|Overall Study|Adverse Event|0|||
42008022|NCT01263054|75815685|FG000|Overall Study|Qualification Violation|1|||
42008023|NCT01263054|75815686|FG001|Overall Study|Qualification Violation|0|||
42008024|NCT01263054|75815685|FG000|Overall Study|Other|0|||
42008025|NCT01263054|75815686|FG001|Overall Study|Other|1|||
42008026|NCT01031836|75815698|FG000|Stage I|Adverse Event|1|||
42008027|NCT01031836|75815699|FG001|Stage I|Adverse Event|1|||
42346783|NCT01877421|76185704|FG016|Phase 2|Protocol Violation|0|||
42008028|NCT01031836|75815700|FG002|Stage I|Adverse Event|0|||
42008029|NCT01031836|75815701|FG003|Stage I|Adverse Event|0|||
42008030|NCT01031836|75815702|FG004|Stage I|Adverse Event|0|||
42008031|NCT01031836|75815703|FG005|Stage I|Adverse Event|0|||
42008032|NCT01031836|75815698|FG000|Stage I|Other|0|||
42008033|NCT01031836|75815699|FG001|Stage I|Other|1|||
42008034|NCT01031836|75815700|FG002|Stage I|Other|0|||
42008035|NCT01031836|75815701|FG003|Stage I|Other|0|||
42008036|NCT01031836|75815702|FG004|Stage I|Other|0|||
42008037|NCT01031836|75815703|FG005|Stage I|Other|1|||
42008038|NCT01031836|75815698|FG000|Stage II|Adverse Event|0|||
42008039|NCT01031836|75815699|FG001|Stage II|Adverse Event|0|||
42008040|NCT01031836|75815700|FG002|Stage II|Adverse Event|2|||
42008041|NCT01031836|75815701|FG003|Stage II|Adverse Event|2|||
42272236|NCT02743949|76102385|FG001|Overall Study|Adverse Event|0|||
42272237|NCT02743949|76102386|FG002|Overall Study|Adverse Event|2|||
42272238|NCT02743949|76102384|FG000|Overall Study|Significant Protocol Deviation|2|||
42272239|NCT02743949|76102385|FG001|Overall Study|Significant Protocol Deviation|0|||
42272240|NCT02743949|76102386|FG002|Overall Study|Significant Protocol Deviation|1|||
42272241|NCT02743949|76102384|FG000|Overall Study|Voluntary Withdrawal|2|||
42008042|NCT01031836|75815702|FG004|Stage II|Adverse Event|1|||
42008043|NCT01031836|75815703|FG005|Stage II|Adverse Event|1|||
42008044|NCT01031836|75815698|FG000|Stage II|Other|2|||
42008045|NCT01031836|75815699|FG001|Stage II|Other|0|||
42008046|NCT01031836|75815700|FG002|Stage II|Other|0|||
42008047|NCT01031836|75815701|FG003|Stage II|Other|1|||
42008048|NCT01031836|75815702|FG004|Stage II|Other|1|||
42008049|NCT01031836|75815703|FG005|Stage II|Other|0|||
42008050|NCT01237587|75815719|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
42008051|NCT01237587|75815720|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
42008052|NCT01237587|75815719|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
42008053|NCT01237587|75815720|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
42008054|NCT01237587|75815719|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
42008055|NCT01237587|75815720|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
42008056|NCT01237587|75815719|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
42008057|NCT01237587|75815720|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
42008058|NCT01237587|75815719|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
42008059|NCT01237587|75815720|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
42008060|NCT01237587|75815719|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
42008061|NCT01237587|75815720|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
42008062|NCT01237587|75815719|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
42008063|NCT01237587|75815720|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
42008064|NCT01237587|75815719|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
42008065|NCT01237587|75815720|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
42008066|NCT01237587|75815719|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
42008067|NCT01237587|75815720|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
42008068|NCT01237587|75815719|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
42008069|NCT01237587|75815720|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
42008070|NCT01237587|75815719|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
42008071|NCT01237587|75815720|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
42008072|NCT01237587|75815719|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
42008073|NCT01237587|75815720|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
42008074|NCT01237587|75815719|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
42008075|NCT01237587|75815720|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
42272242|NCT02743949|76102385|FG001|Overall Study|Voluntary Withdrawal|1|||
42272243|NCT02743949|76102386|FG002|Overall Study|Voluntary Withdrawal|0|||
42272244|NCT02531438|76102396|FG000|Overall Study|Adverse Event|7|||
42008076|NCT01237587|75815719|FG000|Taper Phase|Adverse Event|0|||
42008077|NCT01237587|75815720|FG001|Taper Phase|Adverse Event|2|||
42008078|NCT01237587|75815719|FG000|Taper Phase|Protocol Violation|2|||
42008079|NCT01237587|75815720|FG001|Taper Phase|Protocol Violation|0|||
42008080|NCT01237587|75815719|FG000|Taper Phase|Lack of Efficacy|2|||
42008081|NCT01237587|75815720|FG001|Taper Phase|Lack of Efficacy|5|||
42008082|NCT01237587|75815719|FG000|Taper Phase|Parent/Guardian Decision|0|||
42008083|NCT01237587|75815720|FG001|Taper Phase|Parent/Guardian Decision|2|||
42008084|NCT01237587|75815719|FG000|Taper Phase|Sponsor Decision|1|||
42008085|NCT01237587|75815720|FG001|Taper Phase|Sponsor Decision|0|||
42035629|NCT00833833|75844132|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
42272245|NCT02531438|76102397|FG001|Overall Study|Adverse Event|9|||
42008086|NCT01237587|75815719|FG000|Taper Phase|Withdrawal by Subject|0|||
42008087|NCT01237587|75815720|FG001|Taper Phase|Withdrawal by Subject|1|||
42008088|NCT01031680|75815735|FG000|Overall Study|Adverse Event|8|||
42008089|NCT01031680|75815736|FG001|Overall Study|Adverse Event|3|||
42008090|NCT01031680|75815735|FG000|Overall Study|Lost to Follow-up|2|||
42008091|NCT01031680|75815736|FG001|Overall Study|Lost to Follow-up|10|||
42008092|NCT01031680|75815735|FG000|Overall Study|Withdrawal by Subject|12|||
42008093|NCT01031680|75815736|FG001|Overall Study|Withdrawal by Subject|16|||
42008094|NCT01031680|75815735|FG000|Overall Study|Death|2|||
42008095|NCT01031680|75815736|FG001|Overall Study|Death|1|||
42008096|NCT01031680|75815735|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
42008097|NCT01031680|75815736|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
42008098|NCT01031680|75815735|FG000|Overall Study|Poor/Non-compliance|5|||
42008099|NCT01031680|75815736|FG001|Overall Study|Poor/Non-compliance|6|||
42008100|NCT01031680|75815735|FG000|Overall Study|Safety|1|||
42008101|NCT01031680|75815736|FG001|Overall Study|Safety|0|||
42008102|NCT01031680|75815735|FG000|Overall Study|Incorrect Enrolment|1|||
42008103|NCT01031680|75815736|FG001|Overall Study|Incorrect Enrolment|2|||
42008104|NCT01031680|75815735|FG000|Overall Study|Administrative Reason by Sponsor|0|||
42008105|NCT01031680|75815736|FG001|Overall Study|Administrative Reason by Sponsor|1|||
42008106|NCT01031680|75815735|FG000|Overall Study|Various|0|||
42008107|NCT01031680|75815736|FG001|Overall Study|Various|2|||
42008108|NCT01031446|75815742|FG000|Overall Study|Disease Progression|38|||
42008109|NCT01031446|75815742|FG000|Overall Study|Adverse Event|9|||
42008110|NCT01031446|75815742|FG000|Overall Study|Physician Decision|4|||
42008111|NCT01031446|75815742|FG000|Overall Study|Withdrawal by Subject|3|||
42008112|NCT01031446|75815742|FG000|Overall Study|Still on treatment|1|||
42008113|NCT01030900|75815748|FG000|Overall Study|Not treated due to congestive heart failure|1|||
42008114|NCT01030900|75815748|FG000|Overall Study|Not treated due to rapid disease|1|||
42008115|NCT01030822|75815755|FG000|Overall Study|Moved/migrated from study area|6|||
42008116|NCT01030822|75815756|FG001|Overall Study|Moved/migrated from study area|7|||
42008117|NCT01030822|75815757|FG002|Overall Study|Moved/migrated from study area|3|||
42008118|NCT01030822|75815755|FG000|Overall Study|Withdrawal by Subject|16|||
42008119|NCT01030822|75815756|FG001|Overall Study|Withdrawal by Subject|13|||
42008120|NCT01030822|75815757|FG002|Overall Study|Withdrawal by Subject|16|||
42008121|NCT01030822|75815755|FG000|Overall Study|Lost to Follow-up|9|||
42008122|NCT01030822|75815756|FG001|Overall Study|Lost to Follow-up|4|||
42008123|NCT01030822|75815757|FG002|Overall Study|Lost to Follow-up|7|||
42008124|NCT01026454|75815768|FG000|Second Intervention|Pregnancy|1|||
42008125|NCT01026454|75815769|FG001|Second Intervention|Pregnancy|1|||
42008126|NCT01026220|75815775|FG000|Induction|Death|1|||
42008127|NCT01026220|75815776|FG001|Induction|Death|0|||
42008128|NCT01026220|75815777|FG002|Induction|Death|0|||
42008129|NCT01026220|75815775|FG000|Induction|Lack of Efficacy|2|||
42008130|NCT01026220|75815776|FG001|Induction|Lack of Efficacy|0|||
42008131|NCT01026220|75815777|FG002|Induction|Lack of Efficacy|0|||
42008132|NCT01026220|75815775|FG000|Induction|Physician Decision|12|||
42008133|NCT01026220|75815776|FG001|Induction|Physician Decision|0|||
42008134|NCT01026220|75815777|FG002|Induction|Physician Decision|0|||
42008135|NCT01026220|75815775|FG000|Induction|Withdrawal by Subject|9|||
42008136|NCT01026220|75815776|FG001|Induction|Withdrawal by Subject|0|||
42008137|NCT01026220|75815777|FG002|Induction|Withdrawal by Subject|0|||
42008138|NCT01026220|75815775|FG000|Induction|Ineligible|1|||
42008139|NCT01026220|75815776|FG001|Induction|Ineligible|0|||
42008140|NCT01026220|75815777|FG002|Induction|Ineligible|0|||
42008141|NCT01026220|75815775|FG000|Consolidation Maintenance|Death|0|||
42008142|NCT01026220|75815776|FG001|Consolidation Maintenance|Death|1|||
42008143|NCT01026220|75815777|FG002|Consolidation Maintenance|Death|0|||
42008144|NCT01026220|75815775|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
42008145|NCT01026220|75815776|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
42008146|NCT01026220|75815777|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
42008147|NCT01026220|75815775|FG000|Consolidation Maintenance|Physician Decision|0|||
42008148|NCT01026220|75815776|FG001|Consolidation Maintenance|Physician Decision|2|||
42008149|NCT01026220|75815777|FG002|Consolidation Maintenance|Physician Decision|7|||
42008150|NCT01026220|75815775|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
42008151|NCT01026220|75815776|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
42008152|NCT01026220|75815777|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
42008153|NCT01026142|75815794|FG000|Overall Study|Death|136|||
42272246|NCT02531438|76102396|FG000|Overall Study|Lost to Follow-up|0|||
42008154|NCT01026142|75815795|FG001|Overall Study|Death|134|||
42008155|NCT01026142|75815794|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
42272247|NCT02531438|76102397|FG001|Overall Study|Lost to Follow-up|3|||
42008156|NCT01026142|75815795|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
42008157|NCT04615403|75815810|FG000|Overall Study|Death|1|||
42008158|NCT04368429|75815820|FG000|Overall Study|Adverse Event|1|||
42008159|NCT04368429|75815821|FG001|Overall Study|Adverse Event|0|||
42346784|NCT01877421|76185705|FG017|Phase 2|Protocol Violation|0|||
42008160|NCT04091438|75815838|FG000|Treatment Period 1 (1 Day)|Other|1|||
42008161|NCT04091438|75815839|FG001|Treatment Period 1 (1 Day)|Other|0|||
42008162|NCT04091438|75815838|FG000|Washout Period (1 Day)|Protocol deviation|0|||
42008163|NCT04091438|75815839|FG001|Washout Period (1 Day)|Protocol deviation|1|||
42008164|NCT04091438|75815838|FG000|Washout Period (1 Day)|Other|0|||
42008165|NCT04091438|75815839|FG001|Washout Period (1 Day)|Other|1|||
42008166|NCT04084769|75815851|FG000|Overall Study|Protocol Violation|1|||
42008167|NCT04084769|75815852|FG001|Overall Study|Protocol Violation|3|||
42008168|NCT04084769|75815853|FG002|Overall Study|Protocol Violation|0|||
42008169|NCT04084769|75815854|FG003|Overall Study|Protocol Violation|1|||
42008170|NCT04084769|75815851|FG000|Overall Study|Withdrawal by Subject|0|||
42008171|NCT04084769|75815852|FG001|Overall Study|Withdrawal by Subject|1|||
42008172|NCT04084769|75815853|FG002|Overall Study|Withdrawal by Subject|0|||
42008173|NCT04084769|75815854|FG003|Overall Study|Withdrawal by Subject|0|||
42008174|NCT04084769|75815851|FG000|Overall Study|Withdrawal by parent/guardian|1|||
42008175|NCT04084769|75815852|FG001|Overall Study|Withdrawal by parent/guardian|0|||
42008176|NCT04084769|75815853|FG002|Overall Study|Withdrawal by parent/guardian|0|||
42008177|NCT04084769|75815854|FG003|Overall Study|Withdrawal by parent/guardian|1|||
42008178|NCT04084769|75815851|FG000|Overall Study|Lost to Follow-up|2|||
42008179|NCT04084769|75815852|FG001|Overall Study|Lost to Follow-up|0|||
42008180|NCT04084769|75815853|FG002|Overall Study|Lost to Follow-up|0|||
42008181|NCT04084769|75815854|FG003|Overall Study|Lost to Follow-up|0|||
42008182|NCT03890367|75815872|FG000|Overall Study|Withdrawal by parent/guardian|1|||
42008183|NCT03890367|75815873|FG001|Overall Study|Withdrawal by parent/guardian|3|||
42008184|NCT03890367|75815874|FG002|Overall Study|Withdrawal by parent/guardian|0|||
42008185|NCT03890367|75815872|FG000|Overall Study|Protocol deviation|2|||
42008186|NCT03890367|75815873|FG001|Overall Study|Protocol deviation|2|||
42008187|NCT03890367|75815874|FG002|Overall Study|Protocol deviation|1|||
42008188|NCT03890367|75815872|FG000|Overall Study|Lost to Follow-up|1|||
42008189|NCT03890367|75815873|FG001|Overall Study|Lost to Follow-up|1|||
42008190|NCT03890367|75815874|FG002|Overall Study|Lost to Follow-up|0|||
42008191|NCT03868124|75815885|FG000|Overall Study|Withdrawal by Subject|4|||
42008192|NCT03868124|75815886|FG001|Overall Study|Withdrawal by Subject|0|||
42008193|NCT03868124|75815887|FG002|Overall Study|Withdrawal by Subject|1|||
42008194|NCT03868124|75815885|FG000|Overall Study|Physician Decision|1|||
42008195|NCT03868124|75815886|FG001|Overall Study|Physician Decision|0|||
42008196|NCT03868124|75815887|FG002|Overall Study|Physician Decision|1|||
42008197|NCT03868124|75815885|FG000|Overall Study|Lost to Follow-up|1|||
42008198|NCT03868124|75815886|FG001|Overall Study|Lost to Follow-up|1|||
42008199|NCT03868124|75815887|FG002|Overall Study|Lost to Follow-up|2|||
42008200|NCT03868124|75815885|FG000|Overall Study|Death|1|||
42008201|NCT03868124|75815886|FG001|Overall Study|Death|1|||
42008202|NCT03868124|75815887|FG002|Overall Study|Death|2|||
42008203|NCT03868124|75815885|FG000|Overall Study|Adverse Event|0|||
42008204|NCT03868124|75815886|FG001|Overall Study|Adverse Event|0|||
42008205|NCT03868124|75815887|FG002|Overall Study|Adverse Event|3|||
42008206|NCT03868124|75815885|FG000|Overall Study|Explanted|2|||
42008207|NCT03868124|75815886|FG001|Overall Study|Explanted|1|||
42008208|NCT03868124|75815887|FG002|Overall Study|Explanted|0|||
42008209|NCT03868124|75815885|FG000|Overall Study|Ongoing in study|176|||
42008210|NCT03868124|75815886|FG001|Overall Study|Ongoing in study|180|||
42008211|NCT03868124|75815887|FG002|Overall Study|Ongoing in study|183|||
42008212|NCT03733249|75815895|FG000|Overall Study|Death|7|||
42008213|NCT03733249|75815895|FG000|Overall Study|Disease relapse|16|||
42008214|NCT03733249|75815895|FG000|Overall Study|Lost to Follow-up|4|||
42008215|NCT03733249|75815895|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
42008216|NCT03733249|75815895|FG000|Overall Study|Withdrawal by Subject|1|||
42008217|NCT03469271|75815907|FG000|Overall Study|Withdrawal by Subject|2|||
42008218|NCT03469271|75815908|FG001|Overall Study|Withdrawal by Subject|0|||
42008219|NCT03469271|75815909|FG002|Overall Study|Withdrawal by Subject|0|||
42035630|NCT00833833|75844127|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
42035631|NCT00833833|75844128|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
42008220|NCT03469271|75815910|FG003|Overall Study|Withdrawal by Subject|1|||
42008221|NCT03302234|75815926|FG000|Overall Study|Death|191|||
42008222|NCT03302234|75815927|FG001|Overall Study|Death|192|||
42008223|NCT03302234|75815926|FG000|Overall Study|Withdrawal by Subject|2|||
42008224|NCT03302234|75815927|FG001|Overall Study|Withdrawal by Subject|2|||
42008225|NCT03302234|75815926|FG000|Overall Study|Sponsor Decision|90|||
42008226|NCT03302234|75815927|FG001|Overall Study|Sponsor Decision|89|||
42008227|NCT03302234|75815926|FG000|Overall Study|Laryngeal carcinoma|0|||
42008228|NCT03302234|75815927|FG001|Overall Study|Laryngeal carcinoma|1|||
42008229|NCT03302234|75815926|FG000|Overall Study|Not Reported|1|||
42008230|NCT03302234|75815927|FG001|Overall Study|Not Reported|0|||
42008231|NCT02754596|75815937|FG000|Overall Study|Withdrawal by Subject|3|||
42008232|NCT02754596|75815938|FG001|Overall Study|Withdrawal by Subject|4|||
42346785|NCT01726023|76185787|FG000|Overall Study|Death|1|||
42346786|NCT01726023|76185788|FG001|Overall Study|Death|1|||
42008233|NCT02754596|75815939|FG002|Overall Study|Withdrawal by Subject|0|||
42008234|NCT02754596|75815937|FG000|Overall Study|Physician Decision|1|||
42008235|NCT02754596|75815938|FG001|Overall Study|Physician Decision|1|||
42008236|NCT02754596|75815939|FG002|Overall Study|Physician Decision|1|||
42008237|NCT02754596|75815937|FG000|Overall Study|Lost to Follow-up|1|||
42008238|NCT02754596|75815938|FG001|Overall Study|Lost to Follow-up|1|||
42008239|NCT02754596|75815939|FG002|Overall Study|Lost to Follow-up|2|||
42008240|NCT02754596|75815937|FG000|Overall Study|Death|0|||
42008241|NCT02754596|75815938|FG001|Overall Study|Death|2|||
42008242|NCT02754596|75815939|FG002|Overall Study|Death|0|||
42008243|NCT02754596|75815937|FG000|Overall Study|Adverse Event|1|||
42008244|NCT02754596|75815938|FG001|Overall Study|Adverse Event|0|||
42008245|NCT02754596|75815939|FG002|Overall Study|Adverse Event|1|||
42008246|NCT02754596|75815937|FG000|Overall Study|Other|1|||
42008247|NCT02754596|75815938|FG001|Overall Study|Other|0|||
42008248|NCT02754596|75815939|FG002|Overall Study|Other|0|||
42008249|NCT02744898|75815947|FG000|Overall Study|Progressive Disease|2|||
42008250|NCT02744898|75815947|FG000|Overall Study|Physician Decision|1|||
42008251|NCT02744898|75815947|FG000|Overall Study|Toxicity|1|||
42008252|NCT02095132|75815960|FG000|Overall Study|Adverse Event|0|||
42008253|NCT02095132|75815961|FG001|Overall Study|Adverse Event|0|||
42008254|NCT02095132|75815962|FG002|Overall Study|Adverse Event|0|||
42008255|NCT02095132|75815963|FG003|Overall Study|Adverse Event|0|||
42008256|NCT02095132|75815964|FG004|Overall Study|Adverse Event|1|||
42008257|NCT02095132|75815965|FG005|Overall Study|Adverse Event|0|||
42008258|NCT02095132|75815966|FG006|Overall Study|Adverse Event|1|||
42008259|NCT02095132|75815967|FG007|Overall Study|Adverse Event|0|||
42008260|NCT02095132|75815968|FG008|Overall Study|Adverse Event|0|||
42008261|NCT02095132|75815960|FG000|Overall Study|Death|0|||
42008262|NCT02095132|75815961|FG001|Overall Study|Death|0|||
42008263|NCT02095132|75815962|FG002|Overall Study|Death|0|||
42008264|NCT02095132|75815963|FG003|Overall Study|Death|0|||
42035632|NCT00833833|75844129|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
42035633|NCT00833833|75844130|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
42035634|NCT00833833|75844131|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
42035635|NCT00833833|75844132|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
42035636|NCT00833833|75844127|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
42035637|NCT00833833|75844128|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
42137599|NCT00536471|75947913|FG001|Overall Study|Lack of Efficacy|18|||
42137600|NCT00536471|75947914|FG002|Overall Study|Lack of Efficacy|11|||
42137601|NCT00536471|75947915|FG003|Overall Study|Lack of Efficacy|9|||
42137602|NCT00536471|75947912|FG000|Overall Study|Protocol Violation|8|||
42137603|NCT00536471|75947913|FG001|Overall Study|Protocol Violation|1|||
42137604|NCT00536471|75947914|FG002|Overall Study|Protocol Violation|2|||
42137605|NCT00536471|75947915|FG003|Overall Study|Protocol Violation|3|||
42137606|NCT00536471|75947912|FG000|Overall Study|Physician Decision|11|||
42137607|NCT00536471|75947913|FG001|Overall Study|Physician Decision|1|||
42137608|NCT00536471|75947914|FG002|Overall Study|Physician Decision|3|||
42137609|NCT00536471|75947915|FG003|Overall Study|Physician Decision|2|||
42137610|NCT00536471|75947912|FG000|Overall Study|Death|0|||
42137611|NCT00536471|75947913|FG001|Overall Study|Death|0|||
42346787|NCT01726023|76185787|FG000|Overall Study|Lost to Follow-up|5|||
42346788|NCT01726023|76185788|FG001|Overall Study|Lost to Follow-up|10|||
42035638|NCT00833833|75844129|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
42035639|NCT00833833|75844130|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
42035640|NCT00833833|75844131|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
42035641|NCT00833833|75844132|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
42035642|NCT00833833|75844127|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
42035643|NCT00833833|75844128|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
42035644|NCT00833833|75844129|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
42035645|NCT00833833|75844130|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
42346789|NCT01726023|76185787|FG000|Overall Study|Other Eligibility criteria|7|||
42008265|NCT02095132|75815964|FG004|Overall Study|Death|0|||
42008266|NCT02095132|75815965|FG005|Overall Study|Death|0|||
42008267|NCT02095132|75815966|FG006|Overall Study|Death|1|||
42008268|NCT02095132|75815967|FG007|Overall Study|Death|0|||
42008269|NCT02095132|75815968|FG008|Overall Study|Death|0|||
42008270|NCT02095132|75815960|FG000|Overall Study|Lack of Efficacy|3|||
42008271|NCT02095132|75815961|FG001|Overall Study|Lack of Efficacy|5|||
42008272|NCT02095132|75815962|FG002|Overall Study|Lack of Efficacy|2|||
42008273|NCT02095132|75815963|FG003|Overall Study|Lack of Efficacy|8|||
42008274|NCT02095132|75815964|FG004|Overall Study|Lack of Efficacy|3|||
42008275|NCT02095132|75815965|FG005|Overall Study|Lack of Efficacy|6|||
42008276|NCT02095132|75815966|FG006|Overall Study|Lack of Efficacy|10|||
42035646|NCT00833833|75844131|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
42137612|NCT00536471|75947914|FG002|Overall Study|Death|1|||
42137613|NCT00536471|75947915|FG003|Overall Study|Death|2|||
42137614|NCT00536471|75947912|FG000|Overall Study|Sponsor Decision|0|||
42008277|NCT02095132|75815967|FG007|Overall Study|Lack of Efficacy|9|||
42137615|NCT00536471|75947913|FG001|Overall Study|Sponsor Decision|1|||
42137616|NCT00536471|75947914|FG002|Overall Study|Sponsor Decision|3|||
42137617|NCT00536471|75947915|FG003|Overall Study|Sponsor Decision|2|||
42137618|NCT00359619|75947939|FG000|Overall Study|Adverse Event|0|||
42137619|NCT00359619|75947940|FG001|Overall Study|Adverse Event|0|||
42137620|NCT00359619|75947941|FG002|Overall Study|Adverse Event|1|||
42137621|NCT00359619|75947942|FG003|Overall Study|Adverse Event|0|||
42137622|NCT00359619|75947943|FG004|Overall Study|Adverse Event|0|||
42137623|NCT00359619|75947944|FG005|Overall Study|Adverse Event|0|||
42137624|NCT00359619|75947945|FG006|Overall Study|Adverse Event|1|||
42137625|NCT00359619|75947939|FG000|Overall Study|Withdrawal by Subject|3|||
42137626|NCT00359619|75947940|FG001|Overall Study|Withdrawal by Subject|1|||
42137627|NCT00359619|75947941|FG002|Overall Study|Withdrawal by Subject|4|||
42137628|NCT00359619|75947942|FG003|Overall Study|Withdrawal by Subject|2|||
42137629|NCT00359619|75947943|FG004|Overall Study|Withdrawal by Subject|2|||
42137630|NCT00359619|75947944|FG005|Overall Study|Withdrawal by Subject|0|||
42137631|NCT00359619|75947945|FG006|Overall Study|Withdrawal by Subject|3|||
42137632|NCT00359619|75947939|FG000|Overall Study|Other|1|||
42137633|NCT00359619|75947940|FG001|Overall Study|Other|0|||
42137634|NCT00359619|75947941|FG002|Overall Study|Other|0|||
42137635|NCT00359619|75947942|FG003|Overall Study|Other|0|||
42137636|NCT00359619|75947943|FG004|Overall Study|Other|0|||
42137637|NCT00359619|75947944|FG005|Overall Study|Other|0|||
42137638|NCT00359619|75947945|FG006|Overall Study|Other|0|||
42137639|NCT00359619|75947939|FG000|Overall Study|Lost to Follow-up|4|||
42137640|NCT00359619|75947940|FG001|Overall Study|Lost to Follow-up|4|||
42137641|NCT00359619|75947941|FG002|Overall Study|Lost to Follow-up|2|||
42137642|NCT00359619|75947942|FG003|Overall Study|Lost to Follow-up|1|||
42137643|NCT00359619|75947943|FG004|Overall Study|Lost to Follow-up|1|||
42137644|NCT00359619|75947944|FG005|Overall Study|Lost to Follow-up|5|||
42137645|NCT00359619|75947945|FG006|Overall Study|Lost to Follow-up|0|||
42137646|NCT00437658|75947964|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
42137647|NCT00437658|75947965|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
42137648|NCT00437658|75947966|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
42137649|NCT00437658|75947964|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
42137650|NCT00437658|75947965|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
42137651|NCT00437658|75947966|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
42137652|NCT00437658|75947964|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
42137653|NCT00437658|75947965|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
42137654|NCT00437658|75947966|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
42137655|NCT00437658|75947964|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
42137656|NCT00437658|75947965|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
42137657|NCT00437658|75947966|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
42137658|NCT00437658|75947964|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
42137659|NCT00437658|75947965|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
42137660|NCT00437658|75947966|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
42137661|NCT00437658|75947964|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
42137662|NCT00437658|75947965|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
42137663|NCT00437658|75947966|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
42137664|NCT00437658|75947964|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
42137665|NCT00437658|75947965|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
42137666|NCT00437658|75947966|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
42137667|NCT00437658|75947964|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
42137668|NCT00437658|75947965|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
42137669|NCT00437658|75947966|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
42137670|NCT00437658|75947964|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
42137671|NCT00437658|75947965|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
42008278|NCT02095132|75815968|FG008|Overall Study|Lack of Efficacy|8|||
42008279|NCT02095132|75815960|FG000|Overall Study|Physician Decision|1|||
42008280|NCT02095132|75815961|FG001|Overall Study|Physician Decision|0|||
42008281|NCT02095132|75815962|FG002|Overall Study|Physician Decision|0|||
42008282|NCT02095132|75815963|FG003|Overall Study|Physician Decision|0|||
42008283|NCT02095132|75815964|FG004|Overall Study|Physician Decision|0|||
42008284|NCT02095132|75815965|FG005|Overall Study|Physician Decision|0|||
42008285|NCT02095132|75815966|FG006|Overall Study|Physician Decision|1|||
42137672|NCT00437658|75947966|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
42137673|NCT00437658|75947964|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
42137674|NCT00437658|75947965|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
42137675|NCT00437658|75947966|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
42137676|NCT00437658|75947964|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
42137677|NCT00437658|75947965|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
42137678|NCT00437658|75947966|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
42008286|NCT02095132|75815967|FG007|Overall Study|Physician Decision|0|||
42008287|NCT02095132|75815968|FG008|Overall Study|Physician Decision|2|||
42008288|NCT02095132|75815960|FG000|Overall Study|Withdrawal by Subject|0|||
42272248|NCT02531438|76102396|FG000|Overall Study|Withdrawal by Subject|7|||
42272249|NCT02531438|76102397|FG001|Overall Study|Withdrawal by Subject|8|||
42272250|NCT02531438|76102396|FG000|Overall Study|Physician Decision|0|||
42272251|NCT02531438|76102397|FG001|Overall Study|Physician Decision|1|||
42272252|NCT02531438|76102396|FG000|Overall Study|Death|6|||
42346790|NCT01726023|76185788|FG001|Overall Study|Other Eligibility criteria|7|||
42346791|NCT01726023|76185787|FG000|Overall Study|Withdrawal by Subject|16|||
42346792|NCT01726023|76185788|FG001|Overall Study|Withdrawal by Subject|8|||
42346793|NCT01877265|76185801|FG000|Treatment Period 1|Sponsor Decision|0|||
42346794|NCT01877265|76185802|FG001|Treatment Period 1|Sponsor Decision|0|||
42346795|NCT01877265|76185803|FG002|Treatment Period 1|Sponsor Decision|1|||
42346796|NCT01877265|76185804|FG003|Treatment Period 1|Sponsor Decision|0|||
42346797|NCT01877265|76185805|FG004|Treatment Period 1|Sponsor Decision|0|||
42346798|NCT01877265|76185806|FG005|Treatment Period 1|Sponsor Decision|0|||
42346799|NCT01877265|76185801|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
42346800|NCT01877265|76185802|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
42346801|NCT01877265|76185803|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
42346802|NCT01877265|76185804|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
42008289|NCT02095132|75815961|FG001|Overall Study|Withdrawal by Subject|0|||
42008290|NCT02095132|75815962|FG002|Overall Study|Withdrawal by Subject|2|||
42008291|NCT02095132|75815963|FG003|Overall Study|Withdrawal by Subject|2|||
42272253|NCT02531438|76102397|FG001|Overall Study|Death|3|||
42272254|NCT02531438|76102396|FG000|Overall Study|Randomized, but Not Treated|4|||
42272255|NCT02531438|76102397|FG001|Overall Study|Randomized, but Not Treated|0|||
42272256|NCT02531438|76102396|FG000|Overall Study|Missed EOT/PTE Visit|5|||
42272257|NCT02531438|76102397|FG001|Overall Study|Missed EOT/PTE Visit|2|||
42272258|NCT02531438|76102396|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
42272259|NCT02531438|76102397|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
42272260|NCT02289898|76102406|FG000|Overall Study|Death|5|||
42272261|NCT02289898|76102407|FG001|Overall Study|Death|4|||
42272262|NCT02289898|76102408|FG002|Overall Study|Death|3|||
42272263|NCT02289898|76102406|FG000|Overall Study|Physician Decision|2|||
42272264|NCT02289898|76102407|FG001|Overall Study|Physician Decision|5|||
42272265|NCT02289898|76102408|FG002|Overall Study|Physician Decision|2|||
42272266|NCT02289898|76102406|FG000|Overall Study|Withdrawal by Subject|0|||
42272267|NCT02289898|76102407|FG001|Overall Study|Withdrawal by Subject|4|||
42272268|NCT02289898|76102408|FG002|Overall Study|Withdrawal by Subject|1|||
42272269|NCT02289898|76102406|FG000|Overall Study|Adverse Event|3|||
42272270|NCT02289898|76102407|FG001|Overall Study|Adverse Event|5|||
42272271|NCT02289898|76102408|FG002|Overall Study|Adverse Event|5|||
42272272|NCT02289898|76102406|FG000|Overall Study|Disease progression|34|||
42272273|NCT02289898|76102407|FG001|Overall Study|Disease progression|28|||
42272274|NCT02289898|76102408|FG002|Overall Study|Disease progression|34|||
42008292|NCT02095132|75815964|FG004|Overall Study|Withdrawal by Subject|3|||
42008293|NCT02095132|75815965|FG005|Overall Study|Withdrawal by Subject|0|||
42008294|NCT02095132|75815966|FG006|Overall Study|Withdrawal by Subject|5|||
42008295|NCT02095132|75815967|FG007|Overall Study|Withdrawal by Subject|0|||
42272275|NCT02289898|76102406|FG000|Overall Study|Use of another anticancer therapy|0|||
42272276|NCT02289898|76102407|FG001|Overall Study|Use of another anticancer therapy|0|||
42346803|NCT01877265|76185805|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
42346804|NCT01877265|76185806|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
42272277|NCT02289898|76102408|FG002|Overall Study|Use of another anticancer therapy|1|||
42272278|NCT02289898|76102406|FG000|Overall Study|Other|8|||
42272279|NCT02289898|76102407|FG001|Overall Study|Other|7|||
42272280|NCT02289898|76102408|FG002|Overall Study|Other|10|||
42272281|NCT01660412|76102415|FG000|Overall Study|Protocol Violation|0|||
42272282|NCT01660412|76102416|FG001|Overall Study|Protocol Violation|3|||
42272283|NCT01659554|76102422|FG000|Overall Study|Study Termination|4|||
42008296|NCT02095132|75815968|FG008|Overall Study|Withdrawal by Subject|0|||
42008297|NCT01867333|75815993|FG000|Overall Study|Withdrawal by Subject|1|||
42008298|NCT01867333|75815994|FG001|Overall Study|Withdrawal by Subject|0|||
42008299|NCT01867333|75815993|FG000|Overall Study|Adverse Event|1|||
42008300|NCT01867333|75815994|FG001|Overall Study|Adverse Event|0|||
42008301|NCT01867333|75815993|FG000|Overall Study|Participant choice|1|||
42008302|NCT01867333|75815994|FG001|Overall Study|Participant choice|2|||
42008303|NCT01867333|75815993|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
42008304|NCT01867333|75815994|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
42008305|NCT01867333|75815993|FG000|Overall Study|Death|0|||
42008306|NCT01867333|75815994|FG001|Overall Study|Death|1|||
42008307|NCT01867333|75815993|FG000|Overall Study|Physician Decision|3|||
42008308|NCT01867333|75815994|FG001|Overall Study|Physician Decision|2|||
42008309|NCT01867333|75815993|FG000|Overall Study|Switched to alternative treatment|1|||
42008310|NCT01867333|75815994|FG001|Overall Study|Switched to alternative treatment|0|||
42008311|NCT01534494|75816000|FG000|Overall Study|Withdrawal by Subject|1|||
42008312|NCT00788671|75816013|FG000|Overall Study|Death|2|||
42008313|NCT00788671|75816013|FG000|Overall Study|Unable to biopsy|1|||
42008314|NCT00788671|75816013|FG000|Overall Study|Withdrawal by Subject|4|||
42008315|NCT00788671|75816013|FG000|Overall Study|IUD expulsed|1|||
42008316|NCT00788671|75816013|FG000|Overall Study|Lost to follow up|2|||
42008317|NCT00602797|75816017|FG000|Overall Study|Adverse Event|1|||
42008318|NCT00550615|75816024|FG000|Overall Study|Withdrawal by Subject|0|||
42008319|NCT00550615|75816025|FG001|Overall Study|Withdrawal by Subject|0|||
42008320|NCT00550615|75816026|FG002|Overall Study|Withdrawal by Subject|2|||
42008321|NCT00550615|75816027|FG003|Overall Study|Withdrawal by Subject|3|||
42008322|NCT00550615|75816024|FG000|Overall Study|Not evaluable|0|||
42008323|NCT00550615|75816025|FG001|Overall Study|Not evaluable|0|||
42008324|NCT00550615|75816026|FG002|Overall Study|Not evaluable|2|||
42008325|NCT00550615|75816027|FG003|Overall Study|Not evaluable|7|||
42008326|NCT00006721|75816040|FG000|Overall Study|Adverse Event|0|||
42008327|NCT00006721|75816041|FG001|Overall Study|Adverse Event|4|||
42008328|NCT00006721|75816042|FG002|Overall Study|Adverse Event|4|||
42008329|NCT00006721|75816040|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
42008330|NCT00006721|75816041|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
42008331|NCT00006721|75816042|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
42008332|NCT00006721|75816040|FG000|Overall Study|Progression/Relapse|0|||
42008333|NCT00006721|75816041|FG001|Overall Study|Progression/Relapse|1|||
42008334|NCT00006721|75816042|FG002|Overall Study|Progression/Relapse|2|||
42008335|NCT00006721|75816040|FG000|Overall Study|Death|0|||
42008336|NCT00006721|75816041|FG001|Overall Study|Death|1|||
42008337|NCT00006721|75816042|FG002|Overall Study|Death|2|||
42008338|NCT00006721|75816040|FG000|Overall Study|Other - Not Protocol Specified|0|||
42008339|NCT00006721|75816041|FG001|Overall Study|Other - Not Protocol Specified|7|||
42008340|NCT00006721|75816042|FG002|Overall Study|Other - Not Protocol Specified|7|||
42008341|NCT00006721|75816040|FG000|Overall Study|Ineligible|2|||
42008342|NCT00006721|75816041|FG001|Overall Study|Ineligible|12|||
42008343|NCT00006721|75816042|FG002|Overall Study|Ineligible|10|||
42008344|NCT00006721|75816040|FG000|Overall Study|Eligible but no Treatment Received|1|||
42008345|NCT00006721|75816041|FG001|Overall Study|Eligible but no Treatment Received|0|||
42008346|NCT00006721|75816042|FG002|Overall Study|Eligible but no Treatment Received|0|||
42008347|NCT01030666|75816054|FG000|Overall Study|Lost to Follow-up|3|||
42008348|NCT01030666|75816055|FG001|Overall Study|Lost to Follow-up|2|||
42008349|NCT01025752|75816064|FG000|Overall Study|Lost to Follow-up|7|||
42008350|NCT01025752|75816065|FG001|Overall Study|Lost to Follow-up|10|||
42008351|NCT01025752|75816064|FG000|Overall Study|Physician Decision|1|||
42272284|NCT01659320|76102426|FG000|Overall Study|Withdrawal by Subject|2|||
42272285|NCT01659320|76102426|FG000|Overall Study|Physician Decision|1|||
42272286|NCT01660334|76102430|FG000|Overall Study|Lost to Follow-up|1|||
42272287|NCT01660256|76102437|FG000|Overall Study|Adverse Event|4|||
42272288|NCT01660256|76102438|FG001|Overall Study|Adverse Event|0|||
42272289|NCT01660256|76102439|FG002|Overall Study|Adverse Event|2|||
42272290|NCT01660256|76102437|FG000|Overall Study|Withdrawal by Subject|1|||
42272291|NCT01660256|76102438|FG001|Overall Study|Withdrawal by Subject|0|||
42272292|NCT01660256|76102439|FG002|Overall Study|Withdrawal by Subject|2|||
42272293|NCT02034123|76102465|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272294|NCT02034123|76102466|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272295|NCT02034123|76102467|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272296|NCT02034123|76102468|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272297|NCT02034123|76102469|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
42008352|NCT01025752|75816065|FG001|Overall Study|Physician Decision|3|||
42008353|NCT01030198|75816073|FG000|Overall Study|Could not measure efficacy accurately|0|||
42008354|NCT01030198|75816074|FG001|Overall Study|Could not measure efficacy accurately|7|||
42008355|NCT01301456|75816092|FG000|Stage 1|Withdrawal by Subject|0|||
42008356|NCT01301456|75816093|FG001|Stage 1|Withdrawal by Subject|0|||
42008357|NCT01301456|75816094|FG002|Stage 1|Withdrawal by Subject|1|||
42008358|NCT01301456|75816095|FG003|Stage 1|Withdrawal by Subject|0|||
42008359|NCT01301456|75816096|FG004|Stage 1|Withdrawal by Subject|1|||
42008360|NCT01301456|75816097|FG005|Stage 1|Withdrawal by Subject|0|||
42008361|NCT01301456|75816098|FG006|Stage 1|Withdrawal by Subject|0|||
42008362|NCT01301456|75816099|FG007|Stage 1|Withdrawal by Subject|0|||
42008363|NCT01301456|75816100|FG008|Stage 1|Withdrawal by Subject|0|||
42008364|NCT01301456|75816101|FG009|Stage 1|Withdrawal by Subject|0|||
42008365|NCT01301456|75816102|FG010|Stage 1|Withdrawal by Subject|0|||
42008366|NCT01301456|75816103|FG011|Stage 1|Withdrawal by Subject|0|||
42008367|NCT01301456|75816092|FG000|Stage 1|Randomized but not treated|0|||
42008368|NCT01301456|75816093|FG001|Stage 1|Randomized but not treated|0|||
42008369|NCT01301456|75816094|FG002|Stage 1|Randomized but not treated|0|||
42008370|NCT01301456|75816095|FG003|Stage 1|Randomized but not treated|0|||
42008371|NCT01301456|75816096|FG004|Stage 1|Randomized but not treated|0|||
42008372|NCT01301456|75816097|FG005|Stage 1|Randomized but not treated|0|||
42008373|NCT01301456|75816098|FG006|Stage 1|Randomized but not treated|1|||
42008374|NCT01301456|75816099|FG007|Stage 1|Randomized but not treated|0|||
42008375|NCT01301456|75816100|FG008|Stage 1|Randomized but not treated|0|||
42008376|NCT01301456|75816101|FG009|Stage 1|Randomized but not treated|0|||
42008377|NCT01301456|75816102|FG010|Stage 1|Randomized but not treated|0|||
42008378|NCT01301456|75816103|FG011|Stage 1|Randomized but not treated|0|||
42008379|NCT01301456|75816092|FG000|Stage 2|Adverse Event|0|||
42008380|NCT01301456|75816093|FG001|Stage 2|Adverse Event|0|||
42008381|NCT01301456|75816094|FG002|Stage 2|Adverse Event|0|||
42008382|NCT01301456|75816095|FG003|Stage 2|Adverse Event|0|||
42008383|NCT01301456|75816096|FG004|Stage 2|Adverse Event|0|||
42008384|NCT01301456|75816097|FG005|Stage 2|Adverse Event|0|||
42008385|NCT01301456|75816098|FG006|Stage 2|Adverse Event|0|||
42008386|NCT01301456|75816099|FG007|Stage 2|Adverse Event|0|||
42008387|NCT01301456|75816100|FG008|Stage 2|Adverse Event|0|||
42008388|NCT01301456|75816101|FG009|Stage 2|Adverse Event|0|||
42008389|NCT01301456|75816102|FG010|Stage 2|Adverse Event|1|||
42008390|NCT01301456|75816103|FG011|Stage 2|Adverse Event|0|||
42008391|NCT01023256|75816151|FG000|Overall Study|Protocol Violation|2|||
42035647|NCT00833833|75844132|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
42035648|NCT00833833|75844127|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
42035649|NCT00833833|75844128|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
42008392|NCT01023256|75816152|FG001|Overall Study|Protocol Violation|3|||
42035650|NCT00833833|75844129|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
42272298|NCT02034123|76102470|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272299|NCT02034123|76102471|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272300|NCT02034123|76102472|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
42272301|NCT02034123|76102473|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
42272302|NCT02034123|76102474|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272303|NCT02034123|76102475|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272304|NCT02034123|76102476|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272305|NCT02034123|76102477|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272306|NCT02034123|76102478|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272307|NCT02034123|76102479|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272308|NCT02034123|76102480|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272309|NCT02034123|76102481|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272310|NCT02034123|76102482|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
42272311|NCT02034123|76102465|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272312|NCT02034123|76102466|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272313|NCT02034123|76102467|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272314|NCT02034123|76102468|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
42272315|NCT02034123|76102469|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272316|NCT02034123|76102470|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272317|NCT02034123|76102471|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272318|NCT02034123|76102472|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272319|NCT02034123|76102473|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272320|NCT02034123|76102474|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272321|NCT02034123|76102475|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272322|NCT02034123|76102476|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272323|NCT02034123|76102477|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272324|NCT02034123|76102478|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42008393|NCT01023256|75816153|FG002|Overall Study|Protocol Violation|0|||
42008394|NCT01023256|75816154|FG003|Overall Study|Protocol Violation|0|||
42035651|NCT00833833|75844130|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
42137679|NCT00437658|75947964|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
42137680|NCT00437658|75947965|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
42137681|NCT00437658|75947966|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
42137682|NCT00356265|75947977|FG000|Overall Study|Withdrawal by Subject|0|||
42137683|NCT00356265|75947978|FG001|Overall Study|Withdrawal by Subject|0|||
42137684|NCT00356265|75947979|FG002|Overall Study|Withdrawal by Subject|1|||
42137685|NCT00535145|75947988|FG000|Phase I|Adverse Event|3|||
42008395|NCT01023256|75816151|FG000|Overall Study|Randomized but not treated|1|||
42008396|NCT01023256|75816152|FG001|Overall Study|Randomized but not treated|0|||
42008397|NCT01023256|75816153|FG002|Overall Study|Randomized but not treated|1|||
42008398|NCT01023256|75816154|FG003|Overall Study|Randomized but not treated|0|||
42008399|NCT01023256|75816151|FG000|Overall Study|Other|1|||
42008400|NCT01023256|75816152|FG001|Overall Study|Other|0|||
42008401|NCT01023256|75816153|FG002|Overall Study|Other|0|||
42008402|NCT01023256|75816154|FG003|Overall Study|Other|2|||
42008403|NCT01023256|75816151|FG000|Overall Study|Adverse Event|0|||
42008404|NCT01023256|75816152|FG001|Overall Study|Adverse Event|0|||
42008405|NCT01023256|75816153|FG002|Overall Study|Adverse Event|0|||
42008406|NCT01023256|75816154|FG003|Overall Study|Adverse Event|1|||
42008407|NCT01023256|75816151|FG000|Overall Study|Withdrawal by Subject|0|||
42008408|NCT01023256|75816152|FG001|Overall Study|Withdrawal by Subject|0|||
42008409|NCT01023256|75816153|FG002|Overall Study|Withdrawal by Subject|0|||
42008410|NCT01023256|75816154|FG003|Overall Study|Withdrawal by Subject|2|||
42008411|NCT01023022|75816167|FG000|Overall Study|Death|5|||
42272325|NCT02034123|76102479|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272326|NCT02034123|76102480|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272327|NCT02034123|76102481|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272328|NCT02034123|76102482|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
42272329|NCT02034123|76102465|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272330|NCT02034123|76102466|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272331|NCT02034123|76102467|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272332|NCT02034123|76102468|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272333|NCT02034123|76102469|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272334|NCT02034123|76102470|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272335|NCT02034123|76102471|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272336|NCT02034123|76102472|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272337|NCT02034123|76102473|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
42272338|NCT02034123|76102474|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272339|NCT02034123|76102475|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272340|NCT02034123|76102476|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272341|NCT02034123|76102477|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42008412|NCT01023022|75816167|FG000|Overall Study|Lost to Follow-up|7|||
42008413|NCT01023022|75816167|FG000|Overall Study|due to technical issues|2|||
42008414|NCT01058668|75816174|FG000|Double-blind Treatment Phase|Adverse Event|8|||
42008415|NCT01058668|75816175|FG001|Double-blind Treatment Phase|Adverse Event|15|||
42008416|NCT01058668|75816176|FG002|Double-blind Treatment Phase|Adverse Event|25|||
42035652|NCT00833833|75844131|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
42035653|NCT00833833|75844132|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
42035654|NCT00833833|75844127|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
42035655|NCT00833833|75844128|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
42035656|NCT00833833|75844129|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
42035657|NCT00833833|75844130|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
42035658|NCT00833833|75844131|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
42035659|NCT00833833|75844132|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
42035660|NCT00833833|75844127|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
42035661|NCT00833833|75844128|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
42035662|NCT00833833|75844129|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
42137686|NCT00535145|75947988|FG000|Phase I|Lost to Follow-up|7|||
42137687|NCT00535145|75947988|FG000|Phase I|Withdrawal by Subject|6|||
42137688|NCT00535145|75947988|FG000|Phase I|(eligibility)|8|||
42137689|NCT00535145|75947988|FG000|Phase I|(protocol violation)|1|||
42137690|NCT00535145|75947988|FG000|Phase I|(PI decision)|1|||
42137691|NCT00535145|75947988|FG000|Phase I|(diagnosis)|3|||
42008417|NCT01058668|75816174|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
42008418|NCT01058668|75816175|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
42008419|NCT01058668|75816176|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
42137692|NCT00535145|75947988|FG000|Phase II|Adverse Event|2|||
42137693|NCT00535145|75947988|FG000|Phase II|Lack of Efficacy|1|||
42137694|NCT00535145|75947988|FG000|Phase II|Lost to Follow-up|5|||
42008420|NCT01058668|75816174|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
42008421|NCT01058668|75816175|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
42008422|NCT01058668|75816176|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
42008423|NCT01058668|75816174|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
42008424|NCT01058668|75816175|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
42008425|NCT01058668|75816176|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
42008426|NCT01058668|75816174|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
42008427|NCT01058668|75816175|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
42008428|NCT01058668|75816176|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
42008429|NCT01058668|75816174|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
42008430|NCT01058668|75816175|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
42008431|NCT01058668|75816176|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
42008432|NCT01301066|75816186|FG000|Overall Study|Lost to Follow-up|5|||
42008433|NCT01301066|75816187|FG001|Overall Study|Lost to Follow-up|11|||
42008434|NCT01301066|75816186|FG000|Overall Study|Protocol Violation|8|||
42008435|NCT01301066|75816187|FG001|Overall Study|Protocol Violation|7|||
42008436|NCT01301066|75816186|FG000|Overall Study|Withdrawal by Subject|4|||
42008437|NCT01301066|75816187|FG001|Overall Study|Withdrawal by Subject|9|||
42008438|NCT01301066|75816186|FG000|Overall Study|Adverse Event|6|||
42008439|NCT01301066|75816187|FG001|Overall Study|Adverse Event|6|||
42008440|NCT01301066|75816186|FG000|Overall Study|Sponsor Decision|2|||
42008441|NCT01301066|75816187|FG001|Overall Study|Sponsor Decision|1|||
42008442|NCT01301066|75816186|FG000|Overall Study|Physician Decision|0|||
42008443|NCT01301066|75816187|FG001|Overall Study|Physician Decision|1|||
42008444|NCT01301066|75816186|FG000|Overall Study|Other|2|||
42008445|NCT01301066|75816187|FG001|Overall Study|Other|0|||
42008446|NCT01022398|75816195|FG000|Overall Study|Study terminated|2|||
42008447|NCT01022398|75816196|FG001|Overall Study|Study terminated|2|||
42008448|NCT01262976|75816207|FG000|Up to Month 2|Serious Adverse Event|0|||
42008449|NCT01262976|75816208|FG001|Up to Month 2|Serious Adverse Event|0|||
42008450|NCT01262976|75816209|FG002|Up to Month 2|Serious Adverse Event|1|||
42008451|NCT01262976|75816210|FG003|Up to Month 2|Serious Adverse Event|0|||
42008452|NCT01262976|75816211|FG004|Up to Month 2|Serious Adverse Event|0|||
42008453|NCT01262976|75816212|FG005|Up to Month 2|Serious Adverse Event|0|||
42008454|NCT01262976|75816207|FG000|Up to Month 2|Withdrawal by Subject|1|||
42008455|NCT01262976|75816208|FG001|Up to Month 2|Withdrawal by Subject|0|||
42008456|NCT01262976|75816209|FG002|Up to Month 2|Withdrawal by Subject|0|||
42008457|NCT01262976|75816210|FG003|Up to Month 2|Withdrawal by Subject|0|||
42008458|NCT01262976|75816211|FG004|Up to Month 2|Withdrawal by Subject|0|||
42008459|NCT01262976|75816212|FG005|Up to Month 2|Withdrawal by Subject|0|||
42008460|NCT01262976|75816207|FG000|Up to Month 2|Migrated/moved from study area|0|||
42008461|NCT01262976|75816208|FG001|Up to Month 2|Migrated/moved from study area|1|||
42008462|NCT01262976|75816209|FG002|Up to Month 2|Migrated/moved from study area|0|||
42008463|NCT01262976|75816210|FG003|Up to Month 2|Migrated/moved from study area|0|||
42008464|NCT01262976|75816211|FG004|Up to Month 2|Migrated/moved from study area|1|||
42008465|NCT01262976|75816212|FG005|Up to Month 2|Migrated/moved from study area|1|||
42008466|NCT01262976|75816207|FG000|Up to Month 2|Lost to Follow-up|1|||
42008467|NCT01262976|75816208|FG001|Up to Month 2|Lost to Follow-up|0|||
42008468|NCT01262976|75816209|FG002|Up to Month 2|Lost to Follow-up|0|||
42008469|NCT01262976|75816210|FG003|Up to Month 2|Lost to Follow-up|1|||
42008470|NCT01262976|75816211|FG004|Up to Month 2|Lost to Follow-up|1|||
42008471|NCT01262976|75816212|FG005|Up to Month 2|Lost to Follow-up|1|||
42008472|NCT01262976|75816207|FG000|Up to Month 2|Other|1|||
42008473|NCT01262976|75816208|FG001|Up to Month 2|Other|0|||
42008474|NCT01262976|75816209|FG002|Up to Month 2|Other|0|||
42008475|NCT01262976|75816210|FG003|Up to Month 2|Other|1|||
42008476|NCT01262976|75816211|FG004|Up to Month 2|Other|0|||
42272342|NCT02034123|76102478|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272343|NCT02034123|76102479|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42008477|NCT01262976|75816212|FG005|Up to Month 2|Other|2|||
42008478|NCT01262976|75816207|FG000|Up to Month 7|Serious Adverse Event|0|||
42008479|NCT01262976|75816208|FG001|Up to Month 7|Serious Adverse Event|0|||
42272344|NCT02034123|76102480|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42008480|NCT01262976|75816209|FG002|Up to Month 7|Serious Adverse Event|2|||
42008481|NCT01262976|75816210|FG003|Up to Month 7|Serious Adverse Event|0|||
42008482|NCT01262976|75816211|FG004|Up to Month 7|Serious Adverse Event|0|||
42008483|NCT01262976|75816212|FG005|Up to Month 7|Serious Adverse Event|0|||
42008484|NCT01262976|75816207|FG000|Up to Month 7|Withdrawal by Subject|1|||
42008485|NCT01262976|75816208|FG001|Up to Month 7|Withdrawal by Subject|0|||
42008486|NCT01262976|75816209|FG002|Up to Month 7|Withdrawal by Subject|0|||
42008487|NCT01262976|75816210|FG003|Up to Month 7|Withdrawal by Subject|0|||
42008488|NCT01262976|75816211|FG004|Up to Month 7|Withdrawal by Subject|0|||
42008489|NCT01262976|75816212|FG005|Up to Month 7|Withdrawal by Subject|0|||
42008490|NCT01262976|75816207|FG000|Up to Month 7|Migrated/moved from study area|0|||
42137695|NCT00535145|75947988|FG000|Phase II|Withdrawal by Subject|5|||
42008491|NCT01262976|75816208|FG001|Up to Month 7|Migrated/moved from study area|0|||
42008492|NCT01262976|75816209|FG002|Up to Month 7|Migrated/moved from study area|1|||
42008493|NCT01262976|75816210|FG003|Up to Month 7|Migrated/moved from study area|3|||
42008494|NCT01262976|75816211|FG004|Up to Month 7|Migrated/moved from study area|1|||
42008495|NCT01262976|75816212|FG005|Up to Month 7|Migrated/moved from study area|1|||
42008496|NCT01262976|75816207|FG000|Up to Month 7|Lost to Follow-up|1|||
42008497|NCT01262976|75816208|FG001|Up to Month 7|Lost to Follow-up|0|||
42008498|NCT01262976|75816209|FG002|Up to Month 7|Lost to Follow-up|1|||
42008499|NCT01262976|75816210|FG003|Up to Month 7|Lost to Follow-up|3|||
42008500|NCT01262976|75816211|FG004|Up to Month 7|Lost to Follow-up|1|||
42008501|NCT01262976|75816212|FG005|Up to Month 7|Lost to Follow-up|3|||
42008502|NCT01262976|75816207|FG000|Up to Month 7|Other|3|||
42008503|NCT01262976|75816208|FG001|Up to Month 7|Other|0|||
42008504|NCT01262976|75816209|FG002|Up to Month 7|Other|2|||
42008505|NCT01262976|75816210|FG003|Up to Month 7|Other|0|||
42008506|NCT01262976|75816211|FG004|Up to Month 7|Other|0|||
42008507|NCT01262976|75816212|FG005|Up to Month 7|Other|0|||
42008508|NCT01262976|75816207|FG000|Up to Year 1|Serious Adverse Event|0|||
42008509|NCT01262976|75816208|FG001|Up to Year 1|Serious Adverse Event|0|||
42008510|NCT01262976|75816209|FG002|Up to Year 1|Serious Adverse Event|2|||
42008511|NCT01262976|75816210|FG003|Up to Year 1|Serious Adverse Event|0|||
42008512|NCT01262976|75816211|FG004|Up to Year 1|Serious Adverse Event|0|||
42008513|NCT01262976|75816212|FG005|Up to Year 1|Serious Adverse Event|0|||
42008514|NCT01262976|75816207|FG000|Up to Year 1|Withdrawal by Subject|1|||
42008515|NCT01262976|75816208|FG001|Up to Year 1|Withdrawal by Subject|0|||
42008516|NCT01262976|75816209|FG002|Up to Year 1|Withdrawal by Subject|0|||
42008517|NCT01262976|75816210|FG003|Up to Year 1|Withdrawal by Subject|0|||
42008518|NCT01262976|75816211|FG004|Up to Year 1|Withdrawal by Subject|0|||
42008519|NCT01262976|75816212|FG005|Up to Year 1|Withdrawal by Subject|0|||
42008520|NCT01262976|75816207|FG000|Up to Year 1|Migrated/moved from study area|1|||
42008521|NCT01262976|75816208|FG001|Up to Year 1|Migrated/moved from study area|0|||
42008522|NCT01262976|75816209|FG002|Up to Year 1|Migrated/moved from study area|0|||
42008523|NCT01262976|75816210|FG003|Up to Year 1|Migrated/moved from study area|3|||
42008524|NCT01262976|75816211|FG004|Up to Year 1|Migrated/moved from study area|3|||
42008525|NCT01262976|75816212|FG005|Up to Year 1|Migrated/moved from study area|2|||
42008526|NCT01262976|75816207|FG000|Up to Year 1|Lost to Follow-up|4|||
42008527|NCT01262976|75816208|FG001|Up to Year 1|Lost to Follow-up|0|||
42008528|NCT01262976|75816209|FG002|Up to Year 1|Lost to Follow-up|0|||
42008529|NCT01262976|75816210|FG003|Up to Year 1|Lost to Follow-up|1|||
42008530|NCT01262976|75816211|FG004|Up to Year 1|Lost to Follow-up|6|||
42008531|NCT01262976|75816212|FG005|Up to Year 1|Lost to Follow-up|5|||
42008532|NCT01262976|75816207|FG000|Up to Year 1|Other|3|||
42008533|NCT01262976|75816208|FG001|Up to Year 1|Other|1|||
42008534|NCT01262976|75816209|FG002|Up to Year 1|Other|0|||
42008535|NCT01262976|75816210|FG003|Up to Year 1|Other|0|||
42008536|NCT01262976|75816211|FG004|Up to Year 1|Other|2|||
42008537|NCT01262976|75816212|FG005|Up to Year 1|Other|1|||
42008538|NCT01262976|75816207|FG000|Up to Year 1|Subjects with unknown completion status|0|||
42008539|NCT01262976|75816208|FG001|Up to Year 1|Subjects with unknown completion status|0|||
42008540|NCT01262976|75816209|FG002|Up to Year 1|Subjects with unknown completion status|1|||
42008541|NCT01262976|75816210|FG003|Up to Year 1|Subjects with unknown completion status|0|||
42008542|NCT01262976|75816211|FG004|Up to Year 1|Subjects with unknown completion status|0|||
42008543|NCT01262976|75816212|FG005|Up to Year 1|Subjects with unknown completion status|1|||
42008544|NCT01262976|75816207|FG000|Up to Year 2|Serious Adverse Event|0|||
42272345|NCT02034123|76102481|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272346|NCT02034123|76102482|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
42272347|NCT02034123|76102465|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272348|NCT02034123|76102466|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42008545|NCT01262976|75816208|FG001|Up to Year 2|Serious Adverse Event|0|||
42008546|NCT01262976|75816209|FG002|Up to Year 2|Serious Adverse Event|2|||
42008547|NCT01262976|75816210|FG003|Up to Year 2|Serious Adverse Event|0|||
42008548|NCT01262976|75816211|FG004|Up to Year 2|Serious Adverse Event|0|||
42008549|NCT01262976|75816212|FG005|Up to Year 2|Serious Adverse Event|0|||
42008550|NCT01262976|75816207|FG000|Up to Year 2|Withdrawal by Subject|1|||
42008551|NCT01262976|75816208|FG001|Up to Year 2|Withdrawal by Subject|0|||
42272349|NCT02034123|76102467|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42008552|NCT01262976|75816209|FG002|Up to Year 2|Withdrawal by Subject|0|||
42035663|NCT00833833|75844130|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
42272350|NCT02034123|76102468|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
42008553|NCT01262976|75816210|FG003|Up to Year 2|Withdrawal by Subject|0|||
42008554|NCT01262976|75816211|FG004|Up to Year 2|Withdrawal by Subject|0|||
42008555|NCT01262976|75816212|FG005|Up to Year 2|Withdrawal by Subject|0|||
42008556|NCT01262976|75816207|FG000|Up to Year 2|Migrated/moved from study area|0|||
42272351|NCT02034123|76102469|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
42272352|NCT02034123|76102470|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272353|NCT02034123|76102471|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42008557|NCT01262976|75816208|FG001|Up to Year 2|Migrated/moved from study area|0|||
42008558|NCT01262976|75816209|FG002|Up to Year 2|Migrated/moved from study area|0|||
42008559|NCT01262976|75816210|FG003|Up to Year 2|Migrated/moved from study area|2|||
42008560|NCT01262976|75816211|FG004|Up to Year 2|Migrated/moved from study area|1|||
42008561|NCT01262976|75816212|FG005|Up to Year 2|Migrated/moved from study area|2|||
42008562|NCT01262976|75816207|FG000|Up to Year 2|Lost to Follow-up|1|||
42008563|NCT01262976|75816208|FG001|Up to Year 2|Lost to Follow-up|1|||
42008564|NCT01262976|75816209|FG002|Up to Year 2|Lost to Follow-up|2|||
42008565|NCT01262976|75816210|FG003|Up to Year 2|Lost to Follow-up|2|||
42008566|NCT01262976|75816211|FG004|Up to Year 2|Lost to Follow-up|3|||
42008567|NCT01262976|75816212|FG005|Up to Year 2|Lost to Follow-up|3|||
42008568|NCT01262976|75816207|FG000|Up to Year 2|Subjects with unknown completion status|0|||
42008569|NCT01262976|75816208|FG001|Up to Year 2|Subjects with unknown completion status|0|||
42008570|NCT01262976|75816209|FG002|Up to Year 2|Subjects with unknown completion status|1|||
42008571|NCT01262976|75816210|FG003|Up to Year 2|Subjects with unknown completion status|0|||
42008572|NCT01262976|75816211|FG004|Up to Year 2|Subjects with unknown completion status|0|||
42008573|NCT01262976|75816212|FG005|Up to Year 2|Subjects with unknown completion status|0|||
42008574|NCT01262976|75816207|FG000|Up to Year 2|Other|3|||
42008575|NCT01262976|75816208|FG001|Up to Year 2|Other|0|||
42008576|NCT01262976|75816209|FG002|Up to Year 2|Other|0|||
42008577|NCT01262976|75816210|FG003|Up to Year 2|Other|0|||
42008578|NCT01262976|75816211|FG004|Up to Year 2|Other|0|||
42008579|NCT01262976|75816212|FG005|Up to Year 2|Other|0|||
42008580|NCT01262976|75816207|FG000|Up to Year 3|Serious Adverse Event|0|||
42008581|NCT01262976|75816208|FG001|Up to Year 3|Serious Adverse Event|0|||
42008582|NCT01262976|75816209|FG002|Up to Year 3|Serious Adverse Event|2|||
42008583|NCT01262976|75816210|FG003|Up to Year 3|Serious Adverse Event|0|||
42008584|NCT01262976|75816211|FG004|Up to Year 3|Serious Adverse Event|0|||
42008585|NCT01262976|75816212|FG005|Up to Year 3|Serious Adverse Event|0|||
42008586|NCT01262976|75816207|FG000|Up to Year 3|Withdrawal by Subject|1|||
42008587|NCT01262976|75816208|FG001|Up to Year 3|Withdrawal by Subject|0|||
42008588|NCT01262976|75816209|FG002|Up to Year 3|Withdrawal by Subject|0|||
42008589|NCT01262976|75816210|FG003|Up to Year 3|Withdrawal by Subject|0|||
42008590|NCT01262976|75816211|FG004|Up to Year 3|Withdrawal by Subject|0|||
42008591|NCT01262976|75816212|FG005|Up to Year 3|Withdrawal by Subject|0|||
42008592|NCT01262976|75816207|FG000|Up to Year 3|Migrated/moved from study area|0|||
42008593|NCT01262976|75816208|FG001|Up to Year 3|Migrated/moved from study area|0|||
42008594|NCT01262976|75816209|FG002|Up to Year 3|Migrated/moved from study area|0|||
42008595|NCT01262976|75816210|FG003|Up to Year 3|Migrated/moved from study area|2|||
42008596|NCT01262976|75816211|FG004|Up to Year 3|Migrated/moved from study area|1|||
42008597|NCT01262976|75816212|FG005|Up to Year 3|Migrated/moved from study area|1|||
42008598|NCT01262976|75816207|FG000|Up to Year 3|Lost to Follow-up|2|||
42008599|NCT01262976|75816208|FG001|Up to Year 3|Lost to Follow-up|2|||
42008600|NCT01262976|75816209|FG002|Up to Year 3|Lost to Follow-up|4|||
42008601|NCT01262976|75816210|FG003|Up to Year 3|Lost to Follow-up|3|||
42008602|NCT01262976|75816211|FG004|Up to Year 3|Lost to Follow-up|1|||
42008603|NCT01262976|75816212|FG005|Up to Year 3|Lost to Follow-up|3|||
42008604|NCT01262976|75816207|FG000|Up to Year 3|Subjects with unknown completion status|0|||
42008605|NCT01262976|75816208|FG001|Up to Year 3|Subjects with unknown completion status|0|||
42008606|NCT01262976|75816209|FG002|Up to Year 3|Subjects with unknown completion status|1|||
42008607|NCT01262976|75816210|FG003|Up to Year 3|Subjects with unknown completion status|0|||
42272354|NCT02034123|76102472|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272355|NCT02034123|76102473|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272356|NCT02034123|76102474|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272357|NCT02034123|76102475|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272358|NCT02034123|76102476|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272359|NCT02034123|76102477|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272360|NCT02034123|76102478|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272361|NCT02034123|76102479|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272362|NCT02034123|76102480|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272363|NCT02034123|76102481|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272364|NCT02034123|76102482|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
42272365|NCT02318602|76102528|FG000|Overall Study|Adverse Event|0|||
42346805|NCT01877265|76185801|FG000|Treatment Period 3|Lost to Follow-up|1|||
42008608|NCT01262976|75816211|FG004|Up to Year 3|Subjects with unknown completion status|0|||
42008609|NCT01262976|75816212|FG005|Up to Year 3|Subjects with unknown completion status|0|||
42008610|NCT01262976|75816207|FG000|Up to Year 3|Other|3|||
42008611|NCT01262976|75816208|FG001|Up to Year 3|Other|0|||
42008612|NCT01262976|75816209|FG002|Up to Year 3|Other|0|||
42008613|NCT01262976|75816210|FG003|Up to Year 3|Other|0|||
42008614|NCT01262976|75816211|FG004|Up to Year 3|Other|0|||
42008615|NCT01262976|75816212|FG005|Up to Year 3|Other|0|||
42008616|NCT01300286|75816227|FG000|Overall Study|did not get dosed|1|||
42008617|NCT01300052|75816234|FG000|Overall Study|Adverse Event|3|||
42008618|NCT01300052|75816235|FG001|Overall Study|Adverse Event|0|||
42008619|NCT01300052|75816234|FG000|Overall Study|Withdrawal by Subject|2|||
42008620|NCT01300052|75816235|FG001|Overall Study|Withdrawal by Subject|2|||
42008621|NCT01300052|75816234|FG000|Overall Study|Protocol Violation|1|||
42008622|NCT01300052|75816235|FG001|Overall Study|Protocol Violation|1|||
42008623|NCT01299896|75816243|FG000|Overall Study|Withdrawal by Subject|1|||
42008624|NCT01299896|75816244|FG001|Overall Study|Withdrawal by Subject|7|||
42008625|NCT01299896|75816243|FG000|Overall Study|Lost to Follow-up|0|||
42008626|NCT01299896|75816244|FG001|Overall Study|Lost to Follow-up|11|||
42008627|NCT01299584|75816250|FG000|Overall Study|Protocol Violation|9|||
42008628|NCT01236573|75816265|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
42008629|NCT01236573|75816266|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
42008630|NCT01236573|75816267|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
42008631|NCT01236573|75816268|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
42008632|NCT01236573|75816269|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
42008633|NCT01236573|75816270|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
42008634|NCT01236573|75816271|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
42008635|NCT01236573|75816272|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
42008636|NCT01236573|75816273|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
42008637|NCT01236573|75816274|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
42008638|NCT01236573|75816275|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
42008639|NCT01236573|75816265|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
42008640|NCT01236573|75816266|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
42008641|NCT01236573|75816267|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
42008642|NCT01236573|75816268|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
42008643|NCT01236573|75816269|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
42008644|NCT01236573|75816270|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
42008645|NCT01236573|75816271|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
42008646|NCT01236573|75816272|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
42008647|NCT01236573|75816273|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
42008648|NCT01236573|75816274|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
42008649|NCT01236573|75816275|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
42008650|NCT01236573|75816265|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
42008651|NCT01236573|75816266|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
42008652|NCT01236573|75816267|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
42008653|NCT01236573|75816268|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
42008654|NCT01236573|75816269|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
42008655|NCT01236573|75816270|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
42008656|NCT01236573|75816271|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
42008657|NCT01236573|75816272|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
42008658|NCT01236573|75816273|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
42008659|NCT01236573|75816274|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
42008660|NCT01236573|75816275|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
42008661|NCT01236339|75816302|FG000|Overall Study|Termination of study by sponsor|11|||
42008662|NCT01236339|75816303|FG001|Overall Study|Termination of study by sponsor|13|||
42008663|NCT01262898|75816314|FG000|Overall Study|Protocol Violation|1|||
42008664|NCT01262898|75816315|FG001|Overall Study|Protocol Violation|1|||
42008665|NCT01262898|75816316|FG002|Overall Study|Protocol Violation|0|||
42008666|NCT01262898|75816317|FG003|Overall Study|Protocol Violation|0|||
42008667|NCT01262898|75816314|FG000|Overall Study|Lost to Follow-up|1|||
42008668|NCT01262898|75816315|FG001|Overall Study|Lost to Follow-up|0|||
42008669|NCT01262898|75816316|FG002|Overall Study|Lost to Follow-up|0|||
42137696|NCT00535145|75947988|FG000|Phase II|Subject non-compliance|2|||
42137697|NCT00437268|75947998|FG000|Overall Study|Adverse Event|1|||
42137698|NCT00437268|75947999|FG001|Overall Study|Adverse Event|1|||
42137699|NCT00437268|75947998|FG000|Overall Study|Withdrawal by Subject|2|||
42137700|NCT00437268|75947999|FG001|Overall Study|Withdrawal by Subject|2|||
42346806|NCT01877265|76185802|FG001|Treatment Period 3|Lost to Follow-up|0|||
42008670|NCT01262898|75816317|FG003|Overall Study|Lost to Follow-up|0|||
42008671|NCT01262898|75816314|FG000|Overall Study|Withdrawal by Subject|1|||
42008672|NCT01262898|75816315|FG001|Overall Study|Withdrawal by Subject|1|||
42008673|NCT01262898|75816316|FG002|Overall Study|Withdrawal by Subject|0|||
42008674|NCT01262898|75816317|FG003|Overall Study|Withdrawal by Subject|0|||
42008675|NCT01262820|75816330|FG000|Overall Study|Adverse Event|5|||
42346807|NCT01877265|76185803|FG002|Treatment Period 3|Lost to Follow-up|0|||
42008676|NCT01262820|75816330|FG000|Overall Study|Lack of Efficacy|9|||
42008677|NCT01262820|75816330|FG000|Overall Study|Drug held for 21+ days|1|||
42008678|NCT01057810|75816336|FG000|Overall Study|Disease progression|156|||
42008679|NCT01057810|75816337|FG001|Overall Study|Disease progression|197|||
42008680|NCT01057810|75816336|FG000|Overall Study|Study drug toxicity|5|||
42008681|NCT01057810|75816337|FG001|Overall Study|Study drug toxicity|114|||
42008682|NCT01057810|75816336|FG000|Overall Study|Adverse event unrelated to study drug|13|||
42008683|NCT01057810|75816337|FG001|Overall Study|Adverse event unrelated to study drug|29|||
42008684|NCT01057810|75816336|FG000|Overall Study|Withdrawal by Subject|10|||
42008685|NCT01057810|75816337|FG001|Overall Study|Withdrawal by Subject|25|||
42008686|NCT01057810|75816336|FG000|Overall Study|Death|2|||
42008687|NCT01057810|75816337|FG001|Overall Study|Death|12|||
42008688|NCT01057810|75816336|FG000|Overall Study|Maximum clinical benefit|5|||
42008689|NCT01057810|75816337|FG001|Overall Study|Maximum clinical benefit|5|||
42008690|NCT01057810|75816336|FG000|Overall Study|Poor/non-compliance|0|||
42008691|NCT01057810|75816337|FG001|Overall Study|Poor/non-compliance|1|||
42008692|NCT01057810|75816336|FG000|Overall Study|No longer met study criteria|0|||
42008693|NCT01057810|75816337|FG001|Overall Study|No longer met study criteria|1|||
42008694|NCT01057810|75816336|FG000|Overall Study|Other|7|||
42008695|NCT01057810|75816337|FG001|Overall Study|Other|14|||
42008696|NCT01262352|75816345|FG000|Period 1|Illness after randomization|1|||
42008697|NCT01262352|75816346|FG001|Period 1|Illness after randomization|0|||
42008698|NCT01262352|75816345|FG000|Washout|Adverse Event|1|||
42035664|NCT00833833|75844131|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
42035665|NCT00833833|75844132|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
42035666|NCT00833833|75844127|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
42035667|NCT00833833|75844128|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
42035668|NCT00833833|75844129|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
42035669|NCT00833833|75844130|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
42035670|NCT00833833|75844131|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
42035671|NCT00833833|75844132|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
42035672|NCT00833833|75844127|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
42035673|NCT00833833|75844128|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
42035674|NCT00833833|75844129|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
42035675|NCT00833833|75844130|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
42035676|NCT00833833|75844131|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
42035677|NCT00833833|75844132|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
42035678|NCT01098071|75844152|FG000|Overall Study|Surgery (adenoidectomy)|2|||
42035679|NCT01098071|75844152|FG000|Overall Study|Lost to Follow-up|13|||
42035680|NCT01097057|75844156|FG000|Overall Study|Physician Decision|3|||
42035681|NCT01022112|75844165|FG000|Overall Study|Adverse Event|1|||
42035682|NCT01022112|75844166|FG001|Overall Study|Adverse Event|2|||
42035683|NCT01022112|75844167|FG002|Overall Study|Adverse Event|0|||
42035684|NCT01022112|75844168|FG003|Overall Study|Adverse Event|1|||
42035685|NCT01022112|75844169|FG004|Overall Study|Adverse Event|0|||
42035686|NCT01022112|75844165|FG000|Overall Study|Lack of Efficacy|1|||
42008699|NCT01262352|75816346|FG001|Washout|Adverse Event|1|||
42008700|NCT01262352|75816345|FG000|Washout|Extended Washout|0|||
42008701|NCT01262352|75816346|FG001|Washout|Extended Washout|1|||
42008702|NCT01299272|75816352|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
42035687|NCT01022112|75844166|FG001|Overall Study|Lack of Efficacy|0|||
42035688|NCT01022112|75844167|FG002|Overall Study|Lack of Efficacy|0|||
42035689|NCT01022112|75844168|FG003|Overall Study|Lack of Efficacy|0|||
42008703|NCT01299272|75816353|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
42008704|NCT01299272|75816354|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
42008705|NCT01299272|75816355|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
42008706|NCT01299272|75816352|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
42008707|NCT01299272|75816353|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
42008708|NCT01299272|75816354|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
42008709|NCT01299272|75816355|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
42008710|NCT01299272|75816352|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
42035690|NCT01022112|75844169|FG004|Overall Study|Lack of Efficacy|1|||
42008711|NCT01299272|75816353|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
42008712|NCT01299272|75816354|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
42008713|NCT01299272|75816355|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
42008714|NCT01299272|75816352|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
42008715|NCT01299272|75816353|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
42008716|NCT01299272|75816354|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
42035691|NCT01022112|75844165|FG000|Overall Study|Physician Decision|0|||
42035692|NCT01022112|75844166|FG001|Overall Study|Physician Decision|0|||
42035693|NCT01022112|75844167|FG002|Overall Study|Physician Decision|1|||
42035694|NCT01022112|75844168|FG003|Overall Study|Physician Decision|0|||
42035695|NCT01022112|75844169|FG004|Overall Study|Physician Decision|1|||
42035696|NCT01022112|75844165|FG000|Overall Study|Withdrawal by Subject|0|||
42035697|NCT01022112|75844166|FG001|Overall Study|Withdrawal by Subject|1|||
42008717|NCT01299272|75816355|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
42008718|NCT01299272|75816352|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
42008719|NCT01299272|75816353|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
42008720|NCT01299272|75816354|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
42008721|NCT01299272|75816355|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
42008722|NCT01299272|75816352|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
42008723|NCT01299272|75816353|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
42008724|NCT01299272|75816354|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
42008725|NCT01299272|75816355|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
42008726|NCT01299272|75816352|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
42008727|NCT01299272|75816353|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
42008728|NCT01299272|75816354|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
42008729|NCT01299272|75816355|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
42008730|NCT01299272|75816352|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
42008731|NCT01299272|75816353|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
42008732|NCT01299272|75816354|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
42008733|NCT01299272|75816355|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
42008734|NCT01299272|75816352|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
42008735|NCT01299272|75816353|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
42008736|NCT01299272|75816354|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
42008737|NCT01299272|75816355|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
42008738|NCT01299272|75816352|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
42008739|NCT01299272|75816353|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
42008740|NCT01299272|75816354|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
42008741|NCT01299272|75816355|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
42008742|NCT01299272|75816352|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
42008743|NCT01299272|75816353|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
42008744|NCT01299272|75816354|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
42008745|NCT01299272|75816355|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
42008746|NCT01299272|75816352|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
42008747|NCT01299272|75816353|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
42008748|NCT01299272|75816354|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
42008749|NCT01299272|75816355|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
42008750|NCT01299272|75816352|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
42008751|NCT01299272|75816353|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
42008752|NCT01299272|75816354|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
42008753|NCT01299272|75816355|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
42008754|NCT01299272|75816352|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
42008755|NCT01299272|75816353|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
42008756|NCT01299272|75816354|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
42008757|NCT01299272|75816355|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
42008758|NCT01299272|75816352|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
42008759|NCT01299272|75816353|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
42008760|NCT01299272|75816354|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
42008761|NCT01299272|75816355|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
42008762|NCT01299272|75816352|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
42008763|NCT01299272|75816353|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
42008764|NCT01299272|75816354|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
42008765|NCT01299272|75816355|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
42008766|NCT01299272|75816352|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
42008767|NCT01299272|75816353|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
42008768|NCT01299272|75816354|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
42008769|NCT01299272|75816355|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
42008770|NCT01299272|75816352|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
42008771|NCT01299272|75816353|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
42008772|NCT01299272|75816354|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
42008773|NCT01299272|75816355|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
42008774|NCT01299272|75816352|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
42008775|NCT01299272|75816353|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
42008776|NCT01299272|75816354|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
42008777|NCT01299272|75816355|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
42008778|NCT01299272|75816352|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
42008779|NCT01299272|75816353|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
42008780|NCT01299272|75816354|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
42035698|NCT01022112|75844167|FG002|Overall Study|Withdrawal by Subject|2|||
42008781|NCT01299272|75816355|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
42008782|NCT01299272|75816352|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
42008783|NCT01299272|75816353|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
42008784|NCT01299272|75816354|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
42008785|NCT01299272|75816355|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
42008786|NCT01299272|75816352|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
42008787|NCT01299272|75816353|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
42008788|NCT01299272|75816354|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
42008789|NCT01299272|75816355|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
42008790|NCT01299272|75816352|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
42008791|NCT01299272|75816353|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
42008792|NCT01299272|75816354|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
42008793|NCT01299272|75816355|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
42008794|NCT01299272|75816352|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
42008795|NCT01299272|75816353|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
42008796|NCT01299272|75816354|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
42008797|NCT01299272|75816355|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
42008798|NCT01299272|75816352|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
42008799|NCT01299272|75816353|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
42008800|NCT01299272|75816354|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
42008801|NCT01299272|75816355|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
42008802|NCT01299116|75816372|FG000|Overall Study|Lost to Follow-up|65|||
42008803|NCT01299116|75816373|FG001|Overall Study|Lost to Follow-up|9|||
42008804|NCT01299116|75816374|FG002|Overall Study|Lost to Follow-up|11|||
42008805|NCT01299038|75816387|FG000|Overall Study|Withdrawal by Subject|1|||
42008806|NCT01299038|75816388|FG001|Overall Study|Withdrawal by Subject|0|||
42010573|NCT00993421|75817696|FG002|Overall Study|Withdrawal by Subject|3|||
42010574|NCT00993421|75817697|FG003|Overall Study|Withdrawal by Subject|3|||
42010575|NCT00993421|75817698|FG004|Overall Study|Withdrawal by Subject|3|||
42010576|NCT00993421|75817699|FG005|Overall Study|Withdrawal by Subject|5|||
42010577|NCT00993421|75817700|FG006|Overall Study|Withdrawal by Subject|3|||
42010578|NCT00993421|75817694|FG000|Overall Study|Death|0|||
42010579|NCT00993421|75817695|FG001|Overall Study|Death|0|||
42010580|NCT00993421|75817696|FG002|Overall Study|Death|0|||
42010581|NCT00993421|75817697|FG003|Overall Study|Death|0|||
42010582|NCT00993421|75817698|FG004|Overall Study|Death|0|||
42010583|NCT00993421|75817699|FG005|Overall Study|Death|0|||
42010584|NCT00993421|75817700|FG006|Overall Study|Death|1|||
42010585|NCT00993421|75817694|FG000|Overall Study|Entry Criteria Exclusion|0|||
42010586|NCT00993421|75817695|FG001|Overall Study|Entry Criteria Exclusion|0|||
42010587|NCT00993421|75817696|FG002|Overall Study|Entry Criteria Exclusion|1|||
42010588|NCT00993421|75817697|FG003|Overall Study|Entry Criteria Exclusion|3|||
42010589|NCT00993421|75817698|FG004|Overall Study|Entry Criteria Exclusion|0|||
42010590|NCT00993421|75817699|FG005|Overall Study|Entry Criteria Exclusion|1|||
42010591|NCT00993421|75817700|FG006|Overall Study|Entry Criteria Exclusion|0|||
42010592|NCT00993421|75817694|FG000|Overall Study|Physician Decision|0|||
42010593|NCT00993421|75817695|FG001|Overall Study|Physician Decision|0|||
42010594|NCT00993421|75817696|FG002|Overall Study|Physician Decision|0|||
42010595|NCT00993421|75817697|FG003|Overall Study|Physician Decision|0|||
42010596|NCT00993421|75817698|FG004|Overall Study|Physician Decision|0|||
42010597|NCT00993421|75817699|FG005|Overall Study|Physician Decision|1|||
42010598|NCT00993421|75817700|FG006|Overall Study|Physician Decision|1|||
42010599|NCT00993421|75817694|FG000|Overall Study|Protocol Violation|0|||
42010600|NCT00993421|75817695|FG001|Overall Study|Protocol Violation|0|||
42010601|NCT00993421|75817696|FG002|Overall Study|Protocol Violation|0|||
42010602|NCT00993421|75817697|FG003|Overall Study|Protocol Violation|0|||
42010603|NCT00993421|75817698|FG004|Overall Study|Protocol Violation|0|||
42010604|NCT00993421|75817699|FG005|Overall Study|Protocol Violation|2|||
42010605|NCT00993421|75817700|FG006|Overall Study|Protocol Violation|1|||
42010606|NCT01014208|75817718|FG000|Overall Study|Lost to Follow-up|2|||
42010607|NCT01014208|75817719|FG001|Overall Study|Lost to Follow-up|5|||
42010608|NCT01014208|75817718|FG000|Overall Study|Participant Withdrew Consent|12|||
42010609|NCT01014208|75817719|FG001|Overall Study|Participant Withdrew Consent|12|||
42272366|NCT02318602|76102529|FG001|Overall Study|Adverse Event|1|||
42272367|NCT02318602|76102530|FG002|Overall Study|Adverse Event|1|||
42272368|NCT02318602|76102528|FG000|Overall Study|Withdrawal by Subject|0|||
42010610|NCT01014208|75817718|FG000|Overall Study|Did Not Receive Study Drug|2|||
42010611|NCT01014208|75817719|FG001|Overall Study|Did Not Receive Study Drug|0|||
42010612|NCT01014208|75817718|FG000|Overall Study|Study Closed/terminated|78|||
42010613|NCT01014208|75817719|FG001|Overall Study|Study Closed/terminated|83|||
42010614|NCT00991939|75817727|FG000|Overall Study|Lost to Follow-up|0|||
42010615|NCT00991939|75817728|FG001|Overall Study|Lost to Follow-up|1|||
42010616|NCT00991939|75817727|FG000|Overall Study|Withdrawal by Subject|1|||
42272369|NCT02318602|76102529|FG001|Overall Study|Withdrawal by Subject|3|||
42008807|NCT01298648|75816394|FG000|Overall Study|Withdrawal by Subject|2|||
42008808|NCT01298648|75816394|FG000|Overall Study|Lost to Follow-up|21|||
42008809|NCT01261338|75816400|FG000|Overall Study|Withdrawal by Subject|3|||
42008810|NCT01261338|75816401|FG001|Overall Study|Withdrawal by Subject|2|||
42008811|NCT01260948|75816409|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
42008812|NCT01260948|75816410|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
42008813|NCT01260948|75816409|FG000|Second Intervention|Emesis|0|||
42008814|NCT01260948|75816410|FG001|Second Intervention|Emesis|1|||
42008815|NCT01025284|75816419|FG000|Overall Study|Investigator Decision|0|||
42008816|NCT01025284|75816420|FG001|Overall Study|Investigator Decision|1|||
42008817|NCT01025284|75816421|FG002|Overall Study|Investigator Decision|0|||
42008818|NCT01025284|75816419|FG000|Overall Study|Withdrawal by Subject|0|||
42008819|NCT01025284|75816420|FG001|Overall Study|Withdrawal by Subject|1|||
42008820|NCT01025284|75816421|FG002|Overall Study|Withdrawal by Subject|0|||
42008821|NCT01021852|75816439|FG000|Treatment Period 1|Adverse Event|3|||
42008822|NCT01021852|75816440|FG001|Treatment Period 1|Adverse Event|1|||
42008823|NCT01021852|75816441|FG002|Treatment Period 1|Adverse Event|1|||
42008824|NCT01021852|75816442|FG003|Treatment Period 1|Adverse Event|0|||
42008825|NCT01021852|75816443|FG004|Treatment Period 1|Adverse Event|2|||
42008826|NCT01021852|75816444|FG005|Treatment Period 1|Adverse Event|2|||
42008827|NCT01021852|75816445|FG006|Treatment Period 1|Adverse Event|0|||
42008828|NCT01021852|75816446|FG007|Treatment Period 1|Adverse Event|0|||
42008829|NCT01021852|75816439|FG000|Treatment Period 1|Pregnancy|0|||
42008830|NCT01021852|75816440|FG001|Treatment Period 1|Pregnancy|0|||
42008831|NCT01021852|75816441|FG002|Treatment Period 1|Pregnancy|1|||
42008832|NCT01021852|75816442|FG003|Treatment Period 1|Pregnancy|0|||
42008833|NCT01021852|75816443|FG004|Treatment Period 1|Pregnancy|0|||
42008834|NCT01021852|75816444|FG005|Treatment Period 1|Pregnancy|0|||
42008835|NCT01021852|75816445|FG006|Treatment Period 1|Pregnancy|0|||
42008836|NCT01021852|75816446|FG007|Treatment Period 1|Pregnancy|0|||
42008837|NCT01021852|75816439|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42008838|NCT01021852|75816440|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42008839|NCT01021852|75816441|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42008840|NCT01021852|75816442|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42008841|NCT01021852|75816443|FG004|Treatment Period 1|Withdrawal by Subject|1|||
42008842|NCT01021852|75816444|FG005|Treatment Period 1|Withdrawal by Subject|0|||
42008843|NCT01021852|75816445|FG006|Treatment Period 1|Withdrawal by Subject|0|||
42008844|NCT01021852|75816446|FG007|Treatment Period 1|Withdrawal by Subject|1|||
42008845|NCT01021852|75816439|FG000|Treatment Period 1|Not Treated|0|||
42008846|NCT01021852|75816440|FG001|Treatment Period 1|Not Treated|0|||
42008847|NCT01021852|75816441|FG002|Treatment Period 1|Not Treated|0|||
42008848|NCT01021852|75816442|FG003|Treatment Period 1|Not Treated|2|||
42008849|NCT01021852|75816443|FG004|Treatment Period 1|Not Treated|0|||
42008850|NCT01021852|75816444|FG005|Treatment Period 1|Not Treated|0|||
42008851|NCT01021852|75816445|FG006|Treatment Period 1|Not Treated|0|||
42008852|NCT01021852|75816446|FG007|Treatment Period 1|Not Treated|0|||
42008853|NCT01021852|75816439|FG000|Washout Period-Placebo|Adverse Event|0|||
42008854|NCT01021852|75816440|FG001|Washout Period-Placebo|Adverse Event|0|||
42008855|NCT01021852|75816441|FG002|Washout Period-Placebo|Adverse Event|0|||
42008856|NCT01021852|75816442|FG003|Washout Period-Placebo|Adverse Event|1|||
42008857|NCT01021852|75816443|FG004|Washout Period-Placebo|Adverse Event|0|||
42008858|NCT01021852|75816444|FG005|Washout Period-Placebo|Adverse Event|1|||
42008859|NCT01021852|75816445|FG006|Washout Period-Placebo|Adverse Event|0|||
42008860|NCT01021852|75816446|FG007|Washout Period-Placebo|Adverse Event|0|||
42008861|NCT01021852|75816439|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
42008862|NCT01021852|75816440|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
42008863|NCT01021852|75816441|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
42008864|NCT01021852|75816442|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
42008865|NCT01021852|75816443|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
42008866|NCT01021852|75816444|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
42272370|NCT02318602|76102530|FG002|Overall Study|Withdrawal by Subject|0|||
42272371|NCT02318602|76102528|FG000|Overall Study|Death|1|||
42272372|NCT02318602|76102529|FG001|Overall Study|Death|0|||
42008867|NCT01021852|75816445|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
42008868|NCT01021852|75816446|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
42008869|NCT01021852|75816439|FG000|Washout Period-Placebo|Protocol Violation|0|||
42008870|NCT01021852|75816440|FG001|Washout Period-Placebo|Protocol Violation|0|||
42008871|NCT01021852|75816441|FG002|Washout Period-Placebo|Protocol Violation|0|||
42008872|NCT01021852|75816442|FG003|Washout Period-Placebo|Protocol Violation|0|||
42272373|NCT02318602|76102530|FG002|Overall Study|Death|0|||
42008873|NCT01021852|75816443|FG004|Washout Period-Placebo|Protocol Violation|0|||
42008874|NCT01021852|75816444|FG005|Washout Period-Placebo|Protocol Violation|0|||
42008875|NCT01021852|75816445|FG006|Washout Period-Placebo|Protocol Violation|1|||
42008876|NCT01021852|75816446|FG007|Washout Period-Placebo|Protocol Violation|0|||
42008877|NCT01021852|75816439|FG000|Washout Period-No Drug|Adverse Event|1|||
42008878|NCT01021852|75816440|FG001|Washout Period-No Drug|Adverse Event|0|||
42272374|NCT02318602|76102528|FG000|Overall Study|Guardian decision to withdraw|0|||
42008879|NCT01021852|75816441|FG002|Washout Period-No Drug|Adverse Event|0|||
42008880|NCT01021852|75816442|FG003|Washout Period-No Drug|Adverse Event|0|||
42008881|NCT01021852|75816443|FG004|Washout Period-No Drug|Adverse Event|0|||
42008882|NCT01021852|75816444|FG005|Washout Period-No Drug|Adverse Event|1|||
42008883|NCT01021852|75816445|FG006|Washout Period-No Drug|Adverse Event|0|||
42008884|NCT01021852|75816446|FG007|Washout Period-No Drug|Adverse Event|0|||
42008885|NCT01021852|75816439|FG000|Treatment Period 2|Adverse Event|0|||
42008886|NCT01021852|75816440|FG001|Treatment Period 2|Adverse Event|1|||
42008887|NCT01021852|75816441|FG002|Treatment Period 2|Adverse Event|0|||
42008888|NCT01021852|75816442|FG003|Treatment Period 2|Adverse Event|0|||
42008889|NCT01021852|75816443|FG004|Treatment Period 2|Adverse Event|1|||
42008890|NCT01021852|75816444|FG005|Treatment Period 2|Adverse Event|0|||
42008891|NCT01021852|75816445|FG006|Treatment Period 2|Adverse Event|1|||
42008892|NCT01021852|75816446|FG007|Treatment Period 2|Adverse Event|0|||
42008893|NCT01021852|75816439|FG000|Treatment Period 2|Lack of Efficacy|0|||
42008894|NCT01021852|75816440|FG001|Treatment Period 2|Lack of Efficacy|0|||
42008895|NCT01021852|75816441|FG002|Treatment Period 2|Lack of Efficacy|0|||
42008896|NCT01021852|75816442|FG003|Treatment Period 2|Lack of Efficacy|0|||
42008897|NCT01021852|75816443|FG004|Treatment Period 2|Lack of Efficacy|0|||
42008898|NCT01021852|75816444|FG005|Treatment Period 2|Lack of Efficacy|1|||
42008899|NCT01021852|75816445|FG006|Treatment Period 2|Lack of Efficacy|0|||
42008900|NCT01021852|75816446|FG007|Treatment Period 2|Lack of Efficacy|0|||
42008901|NCT01021852|75816439|FG000|Treatment Period 2|Physician Decision|0|||
42008902|NCT01021852|75816440|FG001|Treatment Period 2|Physician Decision|0|||
42008903|NCT01021852|75816441|FG002|Treatment Period 2|Physician Decision|1|||
42008904|NCT01021852|75816442|FG003|Treatment Period 2|Physician Decision|0|||
42008905|NCT01021852|75816443|FG004|Treatment Period 2|Physician Decision|0|||
42008906|NCT01021852|75816444|FG005|Treatment Period 2|Physician Decision|0|||
42008907|NCT01021852|75816445|FG006|Treatment Period 2|Physician Decision|0|||
42008908|NCT01021852|75816446|FG007|Treatment Period 2|Physician Decision|0|||
42008909|NCT01021852|75816439|FG000|Treatment Period 2|Protocol Violation|0|||
42008910|NCT01021852|75816440|FG001|Treatment Period 2|Protocol Violation|0|||
42008911|NCT01021852|75816441|FG002|Treatment Period 2|Protocol Violation|0|||
42008912|NCT01021852|75816442|FG003|Treatment Period 2|Protocol Violation|0|||
42008913|NCT01021852|75816443|FG004|Treatment Period 2|Protocol Violation|1|||
42008914|NCT01021852|75816444|FG005|Treatment Period 2|Protocol Violation|0|||
42008915|NCT01021852|75816445|FG006|Treatment Period 2|Protocol Violation|1|||
42008916|NCT01021852|75816446|FG007|Treatment Period 2|Protocol Violation|0|||
42008917|NCT01021852|75816439|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42008918|NCT01021852|75816440|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42008919|NCT01021852|75816441|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42008920|NCT01021852|75816442|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42008921|NCT01021852|75816443|FG004|Treatment Period 2|Withdrawal by Subject|0|||
42008922|NCT01021852|75816444|FG005|Treatment Period 2|Withdrawal by Subject|0|||
42008923|NCT01021852|75816445|FG006|Treatment Period 2|Withdrawal by Subject|1|||
42008924|NCT01021852|75816446|FG007|Treatment Period 2|Withdrawal by Subject|2|||
42008925|NCT01056718|75816460|FG000|Overall Study|Withdrawal by Subject|2|||
42008926|NCT01056718|75816460|FG000|Overall Study|Ischemia on baseline stress test|1|||
42008927|NCT01298570|75816467|FG000|Overall Study|Disease progression, relapse during acti|64|||
42008928|NCT01298570|75816468|FG001|Overall Study|Disease progression, relapse during acti|40|||
42008929|NCT01298570|75816467|FG000|Overall Study|Adverse Event|20|||
42008930|NCT01298570|75816468|FG001|Overall Study|Adverse Event|2|||
42008931|NCT01298570|75816467|FG000|Overall Study|Withdrawal by Subject|21|||
42008932|NCT01298570|75816468|FG001|Overall Study|Withdrawal by Subject|6|||
42008933|NCT01298570|75816467|FG000|Overall Study|Treatment delay > 4 weeks|4|||
42008934|NCT01298570|75816468|FG001|Overall Study|Treatment delay > 4 weeks|5|||
42008935|NCT01298570|75816467|FG000|Overall Study|Physician Decision|4|||
42008936|NCT01298570|75816468|FG001|Overall Study|Physician Decision|2|||
42008937|NCT01298570|75816467|FG000|Overall Study|Other complicating disease|2|||
42008938|NCT01298570|75816468|FG001|Overall Study|Other complicating disease|1|||
42008939|NCT01298570|75816467|FG000|Overall Study|Surgery|2|||
42008940|NCT01298570|75816468|FG001|Overall Study|Surgery|1|||
42008941|NCT01298570|75816467|FG000|Overall Study|Symptomatic progression/deterioration|3|||
42008942|NCT01298570|75816468|FG001|Overall Study|Symptomatic progression/deterioration|2|||
42008943|NCT01298570|75816467|FG000|Overall Study|Death|0|||
42008944|NCT01298570|75816468|FG001|Overall Study|Death|1|||
42008945|NCT01298570|75816467|FG000|Overall Study|Ineligibility|0|||
42008946|NCT01298570|75816468|FG001|Overall Study|Ineligibility|1|||
42035699|NCT01022112|75844168|FG003|Overall Study|Withdrawal by Subject|2|||
42137701|NCT00437268|75947998|FG000|Overall Study|Progressive disease|9|||
42272375|NCT02318602|76102529|FG001|Overall Study|Guardian decision to withdraw|0|||
42008947|NCT01259856|75816476|FG000|Overall Study|Adverse Event|12|||
42008948|NCT01259856|75816477|FG001|Overall Study|Adverse Event|9|||
42008949|NCT01259856|75816476|FG000|Overall Study|Death|0|||
42008950|NCT01259856|75816477|FG001|Overall Study|Death|1|||
42008951|NCT01259856|75816476|FG000|Overall Study|Lack of Efficacy|3|||
42008952|NCT01259856|75816477|FG001|Overall Study|Lack of Efficacy|1|||
42008953|NCT01259856|75816476|FG000|Overall Study|Lost to Follow-up|1|||
42008954|NCT01259856|75816477|FG001|Overall Study|Lost to Follow-up|1|||
42008955|NCT01259856|75816476|FG000|Overall Study|Physician Decision|2|||
42008956|NCT01259856|75816477|FG001|Overall Study|Physician Decision|1|||
42008957|NCT01259856|75816476|FG000|Overall Study|Withdrawal by Subject|9|||
42008958|NCT01259856|75816477|FG001|Overall Study|Withdrawal by Subject|10|||
42008959|NCT01259856|75816476|FG000|Overall Study|Treatment never started|0|||
42008960|NCT01259856|75816477|FG001|Overall Study|Treatment never started|6|||
42008961|NCT01259856|75816476|FG000|Overall Study|Study closure by sponsor|40|||
42008962|NCT01259856|75816477|FG001|Overall Study|Study closure by sponsor|41|||
42008963|NCT01259856|75816476|FG000|Overall Study|Patient developed other disease|0|||
42008964|NCT01259856|75816477|FG001|Overall Study|Patient developed other disease|1|||
42008965|NCT01259856|75816476|FG000|Overall Study|Transfer to another study|0|||
42008966|NCT01259856|75816477|FG001|Overall Study|Transfer to another study|1|||
42008967|NCT01259856|75816476|FG000|Overall Study|Unknown/missing|2|||
42008968|NCT01259856|75816477|FG001|Overall Study|Unknown/missing|2|||
42008969|NCT01020838|75816483|FG000|Overall Study|Death|90|||
42008970|NCT01020838|75816483|FG000|Overall Study|Adverse Event|1|||
42008971|NCT01020838|75816483|FG000|Overall Study|Withdrawal by Subject|9|||
42008972|NCT01020838|75816483|FG000|Overall Study|Lost to Follow-up|6|||
42008973|NCT01020838|75816483|FG000|Overall Study|Most common: Study ended by sponsor|77|||
42008974|NCT01259466|75816498|FG000|Overall Study|Withdrawal by Subject|1|||
42008975|NCT01259466|75816499|FG001|Overall Study|Withdrawal by Subject|9|||
42008976|NCT01259388|75816507|FG000|Overall Study|Adverse Event|3|||
42008977|NCT01259388|75816508|FG001|Overall Study|Adverse Event|0|||
42008978|NCT01259388|75816507|FG000|Overall Study|Withdrawal by Subject|1|||
42008979|NCT01259388|75816508|FG001|Overall Study|Withdrawal by Subject|1|||
42008980|NCT01259388|75816507|FG000|Overall Study|Physician Decision|1|||
42008981|NCT01259388|75816508|FG001|Overall Study|Physician Decision|0|||
42008982|NCT01298492|75816514|FG000|Overall Study|Death|2|||
42008983|NCT01298492|75816514|FG000|Overall Study|Insufficient Clinical Response|22|||
42008984|NCT01298492|75816514|FG000|Overall Study|Lost to Follow-up|12|||
42008985|NCT01298492|75816514|FG000|Overall Study|Withdrawal by Subject|47|||
42008986|NCT01298492|75816514|FG000|Overall Study|Other (Unspecified)|7|||
42008987|NCT01298492|75816514|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
42008988|NCT01298492|75816514|FG000|Overall Study|Protocol Violation|2|||
42008989|NCT01298492|75816514|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
42008990|NCT01298492|75816514|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
42008991|NCT01297322|75816520|FG000|Overall Study|Lost to Follow-up|1|||
42008992|NCT01297322|75816521|FG001|Overall Study|Lost to Follow-up|0|||
42008993|NCT01297322|75816520|FG000|Overall Study|Withdrawal by Subject|0|||
42008994|NCT01297322|75816521|FG001|Overall Study|Withdrawal by Subject|1|||
42008995|NCT01297322|75816520|FG000|Overall Study|Protocol Violation|0|||
42008996|NCT01297322|75816521|FG001|Overall Study|Protocol Violation|3|||
42008997|NCT01297244|75816530|FG000|Overall Study|Progressive disease|22|||
42008998|NCT01297244|75816531|FG001|Overall Study|Progressive disease|3|||
42008999|NCT01297244|75816530|FG000|Overall Study|Adverse Event|9|||
42009000|NCT01297244|75816531|FG001|Overall Study|Adverse Event|1|||
42009001|NCT01297244|75816530|FG000|Overall Study|Death|1|||
42009002|NCT01297244|75816531|FG001|Overall Study|Death|1|||
42009003|NCT01297244|75816530|FG000|Overall Study|Clinical progression|1|||
42272376|NCT02318602|76102530|FG002|Overall Study|Guardian decision to withdraw|1|||
42272377|NCT02318368|76102546|FG000|Overall Study|Withdrawal by Subject|2|||
42272378|NCT02318368|76102547|FG001|Overall Study|Withdrawal by Subject|0|||
42272379|NCT02318368|76102546|FG000|Overall Study|Study terminated by the sponsor|5|||
42272380|NCT02318368|76102547|FG001|Overall Study|Study terminated by the sponsor|2|||
42009004|NCT01297244|75816531|FG001|Overall Study|Clinical progression|1|||
42009005|NCT01297244|75816530|FG000|Overall Study|Withdrawal by Subject|2|||
42009006|NCT01297244|75816531|FG001|Overall Study|Withdrawal by Subject|0|||
42009007|NCT03456726|75816544|FG000|Overall Study|Disease Progression|6|||
42009008|NCT03456726|75816545|FG001|Overall Study|Disease Progression|1|||
42009009|NCT03456726|75816544|FG000|Overall Study|Adverse Event|4|||
42009010|NCT03456726|75816545|FG001|Overall Study|Adverse Event|2|||
42009011|NCT03456726|75816544|FG000|Overall Study|Withdrawal by Subject|1|||
42009012|NCT03456726|75816545|FG001|Overall Study|Withdrawal by Subject|0|||
42009013|NCT03456726|75816544|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
42009014|NCT03456726|75816545|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
42009015|NCT03181932|75816553|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
42009016|NCT03181932|75816554|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
42009017|NCT03181932|75816553|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
42009018|NCT03181932|75816554|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
42272381|NCT02318368|76102546|FG000|Overall Study|Death|0|||
42272382|NCT02318368|76102547|FG001|Overall Study|Death|1|||
42009019|NCT03181932|75816553|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
42137702|NCT00437268|75947999|FG001|Overall Study|Progressive disease|9|||
42272383|NCT02318134|76102555|FG000|Overall Study|Withdrawal by Subject|2|||
42009020|NCT03181932|75816554|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
42009021|NCT03181932|75816553|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
42009022|NCT03181932|75816554|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
42009023|NCT03181932|75816553|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
42009024|NCT03181932|75816554|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
42009025|NCT03181932|75816553|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
42009026|NCT03181932|75816554|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
42009027|NCT03181932|75816553|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
42009028|NCT03181932|75816554|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
42009029|NCT03181932|75816553|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
42009030|NCT03181932|75816554|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
42009031|NCT03181932|75816553|FG000|Period 2 (Open-label Period)|Reason missing|2|||
42009032|NCT03181932|75816554|FG001|Period 2 (Open-label Period)|Reason missing|0|||
42009033|NCT02864862|75816564|FG000|Overall Study|Lost to Follow-up|1|||
42009034|NCT02864862|75816565|FG001|Overall Study|Lost to Follow-up|0|||
42009035|NCT02864862|75816566|FG002|Overall Study|Lost to Follow-up|1|||
42009036|NCT02864862|75816564|FG000|Overall Study|Protocol Violation|0|||
42009037|NCT02864862|75816565|FG001|Overall Study|Protocol Violation|0|||
42009038|NCT02864862|75816566|FG002|Overall Study|Protocol Violation|1|||
42009039|NCT01598298|75816578|FG000|Overall Study|Not eligible|5|||
42009040|NCT01598298|75816579|FG001|Overall Study|Not eligible|5|||
42009041|NCT01598298|75816578|FG000|Overall Study|Adverse Event|21|||
42009042|NCT01598298|75816579|FG001|Overall Study|Adverse Event|19|||
42009043|NCT01598298|75816578|FG000|Overall Study|Progression/relapse|0|||
42009044|NCT01598298|75816579|FG001|Overall Study|Progression/relapse|2|||
42009045|NCT01598298|75816578|FG000|Overall Study|Withdrawal by Subject|10|||
42009046|NCT01598298|75816579|FG001|Overall Study|Withdrawal by Subject|15|||
42009047|NCT01598298|75816578|FG000|Overall Study|Other reason (not protocol specified)|4|||
42009048|NCT01598298|75816579|FG001|Overall Study|Other reason (not protocol specified)|0|||
42009049|NCT01235949|75816603|FG000|Primary Phase|Migrated/moved from study area|1|||
42009050|NCT01235949|75816604|FG001|Primary Phase|Migrated/moved from study area|1|||
42009051|NCT01235949|75816605|FG002|Primary Phase|Migrated/moved from study area|0|||
42009052|NCT01235949|75816606|FG003|Primary Phase|Migrated/moved from study area|0|||
42009053|NCT01235949|75816607|FG004|Primary Phase|Migrated/moved from study area|1|||
42009054|NCT01235949|75816608|FG005|Primary Phase|Migrated/moved from study area|2|||
42009055|NCT01235949|75816609|FG006|Primary Phase|Migrated/moved from study area|0|||
42009056|NCT01235949|75816610|FG007|Primary Phase|Migrated/moved from study area|0|||
42009057|NCT01235949|75816611|FG008|Primary Phase|Migrated/moved from study area|0|||
42009058|NCT01235949|75816612|FG009|Primary Phase|Migrated/moved from study area|0|||
42009059|NCT01235949|75816613|FG010|Primary Phase|Migrated/moved from study area|0|||
42009060|NCT01235949|75816614|FG011|Primary Phase|Migrated/moved from study area|0|||
42009061|NCT01235949|75816615|FG012|Primary Phase|Migrated/moved from study area|0|||
42009062|NCT01235949|75816616|FG013|Primary Phase|Migrated/moved from study area|0|||
42009063|NCT01235949|75816617|FG014|Primary Phase|Migrated/moved from study area|0|||
42009064|NCT01235949|75816618|FG015|Primary Phase|Migrated/moved from study area|0|||
42009065|NCT01235949|75816619|FG016|Primary Phase|Migrated/moved from study area|0|||
42009066|NCT01235949|75816620|FG017|Primary Phase|Migrated/moved from study area|0|||
42009067|NCT01235949|75816603|FG000|Primary Phase|Adverse Event|0|||
42009068|NCT01235949|75816604|FG001|Primary Phase|Adverse Event|0|||
42009069|NCT01235949|75816605|FG002|Primary Phase|Adverse Event|0|||
42009070|NCT01235949|75816606|FG003|Primary Phase|Adverse Event|1|||
42009071|NCT01235949|75816607|FG004|Primary Phase|Adverse Event|0|||
42009072|NCT01235949|75816608|FG005|Primary Phase|Adverse Event|0|||
42009073|NCT01235949|75816609|FG006|Primary Phase|Adverse Event|0|||
42009074|NCT01235949|75816610|FG007|Primary Phase|Adverse Event|0|||
42009075|NCT01235949|75816611|FG008|Primary Phase|Adverse Event|0|||
42009076|NCT01235949|75816612|FG009|Primary Phase|Adverse Event|0|||
42009077|NCT01235949|75816613|FG010|Primary Phase|Adverse Event|0|||
42009078|NCT01235949|75816614|FG011|Primary Phase|Adverse Event|0|||
42009079|NCT01235949|75816615|FG012|Primary Phase|Adverse Event|0|||
42009080|NCT01235949|75816616|FG013|Primary Phase|Adverse Event|0|||
42009081|NCT01235949|75816617|FG014|Primary Phase|Adverse Event|0|||
42009082|NCT01235949|75816618|FG015|Primary Phase|Adverse Event|0|||
42009083|NCT01235949|75816619|FG016|Primary Phase|Adverse Event|0|||
42009084|NCT01235949|75816620|FG017|Primary Phase|Adverse Event|0|||
42009085|NCT01235949|75816603|FG000|Primary Phase|Withdrawal by Subject|3|||
42009086|NCT01235949|75816604|FG001|Primary Phase|Withdrawal by Subject|2|||
42009087|NCT01235949|75816605|FG002|Primary Phase|Withdrawal by Subject|2|||
42009088|NCT01235949|75816606|FG003|Primary Phase|Withdrawal by Subject|0|||
42009089|NCT01235949|75816607|FG004|Primary Phase|Withdrawal by Subject|0|||
42009090|NCT01235949|75816608|FG005|Primary Phase|Withdrawal by Subject|3|||
42137703|NCT00437268|75947998|FG000|Overall Study|Physician Decision|1|||
42009091|NCT01235949|75816609|FG006|Primary Phase|Withdrawal by Subject|0|||
42009092|NCT01235949|75816610|FG007|Primary Phase|Withdrawal by Subject|0|||
42009093|NCT01235949|75816611|FG008|Primary Phase|Withdrawal by Subject|0|||
42009094|NCT01235949|75816612|FG009|Primary Phase|Withdrawal by Subject|0|||
42009095|NCT01235949|75816613|FG010|Primary Phase|Withdrawal by Subject|0|||
42009096|NCT01235949|75816614|FG011|Primary Phase|Withdrawal by Subject|0|||
42009097|NCT01235949|75816615|FG012|Primary Phase|Withdrawal by Subject|0|||
42009098|NCT01235949|75816616|FG013|Primary Phase|Withdrawal by Subject|0|||
42009099|NCT01235949|75816617|FG014|Primary Phase|Withdrawal by Subject|0|||
42009100|NCT01235949|75816618|FG015|Primary Phase|Withdrawal by Subject|0|||
42009101|NCT01235949|75816619|FG016|Primary Phase|Withdrawal by Subject|0|||
42009102|NCT01235949|75816620|FG017|Primary Phase|Withdrawal by Subject|0|||
42009103|NCT01235949|75816603|FG000|Primary Phase|Lost to Follow-up|0|||
42009104|NCT01235949|75816604|FG001|Primary Phase|Lost to Follow-up|0|||
42009105|NCT01235949|75816605|FG002|Primary Phase|Lost to Follow-up|1|||
42009106|NCT01235949|75816606|FG003|Primary Phase|Lost to Follow-up|1|||
42009107|NCT01235949|75816607|FG004|Primary Phase|Lost to Follow-up|0|||
42009108|NCT01235949|75816608|FG005|Primary Phase|Lost to Follow-up|2|||
42009109|NCT01235949|75816609|FG006|Primary Phase|Lost to Follow-up|0|||
42009110|NCT01235949|75816610|FG007|Primary Phase|Lost to Follow-up|0|||
42009111|NCT01235949|75816611|FG008|Primary Phase|Lost to Follow-up|0|||
42009112|NCT01235949|75816612|FG009|Primary Phase|Lost to Follow-up|0|||
42009113|NCT01235949|75816613|FG010|Primary Phase|Lost to Follow-up|0|||
42009114|NCT01235949|75816614|FG011|Primary Phase|Lost to Follow-up|0|||
42009115|NCT01235949|75816615|FG012|Primary Phase|Lost to Follow-up|0|||
42009116|NCT01235949|75816616|FG013|Primary Phase|Lost to Follow-up|0|||
42009117|NCT01235949|75816617|FG014|Primary Phase|Lost to Follow-up|0|||
42009118|NCT01235949|75816618|FG015|Primary Phase|Lost to Follow-up|0|||
42009119|NCT01235949|75816619|FG016|Primary Phase|Lost to Follow-up|0|||
42009120|NCT01235949|75816620|FG017|Primary Phase|Lost to Follow-up|0|||
42009121|NCT01235949|75816603|FG000|Booster Phase|Migrated/moved from study area|0|||
42009122|NCT01235949|75816604|FG001|Booster Phase|Migrated/moved from study area|0|||
42009123|NCT01235949|75816605|FG002|Booster Phase|Migrated/moved from study area|0|||
42009124|NCT01235949|75816606|FG003|Booster Phase|Migrated/moved from study area|0|||
42009125|NCT01235949|75816607|FG004|Booster Phase|Migrated/moved from study area|0|||
42009126|NCT01235949|75816608|FG005|Booster Phase|Migrated/moved from study area|0|||
42009127|NCT01235949|75816609|FG006|Booster Phase|Migrated/moved from study area|0|||
42009128|NCT01235949|75816610|FG007|Booster Phase|Migrated/moved from study area|0|||
42009129|NCT01235949|75816611|FG008|Booster Phase|Migrated/moved from study area|0|||
42009130|NCT01235949|75816612|FG009|Booster Phase|Migrated/moved from study area|0|||
42009131|NCT01235949|75816613|FG010|Booster Phase|Migrated/moved from study area|0|||
42009132|NCT01235949|75816614|FG011|Booster Phase|Migrated/moved from study area|1|||
42009133|NCT01235949|75816615|FG012|Booster Phase|Migrated/moved from study area|1|||
42009134|NCT01235949|75816616|FG013|Booster Phase|Migrated/moved from study area|0|||
42009135|NCT01235949|75816617|FG014|Booster Phase|Migrated/moved from study area|0|||
42009136|NCT01235949|75816618|FG015|Booster Phase|Migrated/moved from study area|0|||
42009137|NCT01235949|75816619|FG016|Booster Phase|Migrated/moved from study area|0|||
42009138|NCT01235949|75816620|FG017|Booster Phase|Migrated/moved from study area|1|||
42009139|NCT01235949|75816603|FG000|Booster Phase|Adverse Event|0|||
42009140|NCT01235949|75816604|FG001|Booster Phase|Adverse Event|0|||
42009141|NCT01235949|75816605|FG002|Booster Phase|Adverse Event|0|||
42009142|NCT01235949|75816606|FG003|Booster Phase|Adverse Event|0|||
42009143|NCT01235949|75816607|FG004|Booster Phase|Adverse Event|0|||
42009144|NCT01235949|75816608|FG005|Booster Phase|Adverse Event|0|||
42009145|NCT01235949|75816609|FG006|Booster Phase|Adverse Event|0|||
42009146|NCT01235949|75816610|FG007|Booster Phase|Adverse Event|0|||
42009147|NCT01235949|75816611|FG008|Booster Phase|Adverse Event|0|||
42009148|NCT01235949|75816612|FG009|Booster Phase|Adverse Event|0|||
42009149|NCT01235949|75816613|FG010|Booster Phase|Adverse Event|0|||
42009150|NCT01235949|75816614|FG011|Booster Phase|Adverse Event|0|||
42009151|NCT01235949|75816615|FG012|Booster Phase|Adverse Event|0|||
42009152|NCT01235949|75816616|FG013|Booster Phase|Adverse Event|0|||
42137704|NCT00437268|75947999|FG001|Overall Study|Physician Decision|0|||
42009153|NCT01235949|75816617|FG014|Booster Phase|Adverse Event|0|||
42009154|NCT01235949|75816618|FG015|Booster Phase|Adverse Event|1|||
42009155|NCT01235949|75816619|FG016|Booster Phase|Adverse Event|0|||
42009156|NCT01235949|75816620|FG017|Booster Phase|Adverse Event|0|||
42009157|NCT01235949|75816603|FG000|Booster Phase|Withdrawal by Subject|0|||
42009158|NCT01235949|75816604|FG001|Booster Phase|Withdrawal by Subject|0|||
42009159|NCT01235949|75816605|FG002|Booster Phase|Withdrawal by Subject|0|||
42009160|NCT01235949|75816606|FG003|Booster Phase|Withdrawal by Subject|0|||
42009161|NCT01235949|75816607|FG004|Booster Phase|Withdrawal by Subject|0|||
42009162|NCT01235949|75816608|FG005|Booster Phase|Withdrawal by Subject|0|||
42009163|NCT01235949|75816609|FG006|Booster Phase|Withdrawal by Subject|0|||
42009164|NCT01235949|75816610|FG007|Booster Phase|Withdrawal by Subject|1|||
42009165|NCT01235949|75816611|FG008|Booster Phase|Withdrawal by Subject|1|||
42137705|NCT00437268|75947998|FG000|Overall Study|Death|0|||
42009166|NCT01235949|75816612|FG009|Booster Phase|Withdrawal by Subject|0|||
42009167|NCT01235949|75816613|FG010|Booster Phase|Withdrawal by Subject|1|||
42009168|NCT01235949|75816614|FG011|Booster Phase|Withdrawal by Subject|1|||
42009169|NCT01235949|75816615|FG012|Booster Phase|Withdrawal by Subject|2|||
42009170|NCT01235949|75816616|FG013|Booster Phase|Withdrawal by Subject|0|||
42009171|NCT01235949|75816617|FG014|Booster Phase|Withdrawal by Subject|2|||
42009172|NCT01235949|75816618|FG015|Booster Phase|Withdrawal by Subject|0|||
42009173|NCT01235949|75816619|FG016|Booster Phase|Withdrawal by Subject|0|||
42009174|NCT01235949|75816620|FG017|Booster Phase|Withdrawal by Subject|0|||
42009175|NCT01235949|75816603|FG000|Booster Phase|Lost to Follow-up|0|||
42009176|NCT01235949|75816604|FG001|Booster Phase|Lost to Follow-up|0|||
42009177|NCT01235949|75816605|FG002|Booster Phase|Lost to Follow-up|0|||
42009178|NCT01235949|75816606|FG003|Booster Phase|Lost to Follow-up|0|||
42009179|NCT01235949|75816607|FG004|Booster Phase|Lost to Follow-up|0|||
42009180|NCT01235949|75816608|FG005|Booster Phase|Lost to Follow-up|0|||
42009181|NCT01235949|75816609|FG006|Booster Phase|Lost to Follow-up|0|||
42009182|NCT01235949|75816610|FG007|Booster Phase|Lost to Follow-up|0|||
42009183|NCT01235949|75816611|FG008|Booster Phase|Lost to Follow-up|1|||
42009184|NCT01235949|75816612|FG009|Booster Phase|Lost to Follow-up|1|||
42009185|NCT01235949|75816613|FG010|Booster Phase|Lost to Follow-up|1|||
42009186|NCT01235949|75816614|FG011|Booster Phase|Lost to Follow-up|1|||
42009187|NCT01235949|75816615|FG012|Booster Phase|Lost to Follow-up|0|||
42009188|NCT01235949|75816616|FG013|Booster Phase|Lost to Follow-up|0|||
42009189|NCT01235949|75816617|FG014|Booster Phase|Lost to Follow-up|0|||
42009190|NCT01235949|75816618|FG015|Booster Phase|Lost to Follow-up|0|||
42009191|NCT01235949|75816619|FG016|Booster Phase|Lost to Follow-up|0|||
42009192|NCT01235949|75816620|FG017|Booster Phase|Lost to Follow-up|1|||
42009193|NCT01235793|75816658|FG000|Overall Study|Death|6|||
42009194|NCT01258998|75816663|FG000|Overall Study|Ineligible|1|||
42009195|NCT01235715|75816669|FG000|Overall Study|Physician Decision|0|||
42009196|NCT01235715|75816670|FG001|Overall Study|Physician Decision|2|||
42009197|NCT01235403|75816677|FG000|Overall Study|Adverse Event|14|||
42009198|NCT01235403|75816677|FG000|Overall Study|Lost to Follow-up|2|||
42009199|NCT01235403|75816677|FG000|Overall Study|Withdrawal by Subject|4|||
42009200|NCT01235403|75816677|FG000|Overall Study|Lack of Efficacy|2|||
42009201|NCT01235403|75816677|FG000|Overall Study|Other reasons for premature termination|4|||
42009202|NCT01024036|75816683|FG000|Blinded Treatment|Adverse Event|1|||
42009203|NCT01024036|75816684|FG001|Blinded Treatment|Adverse Event|1|||
42009204|NCT01024036|75816683|FG000|Blinded Treatment|Lack of Efficacy|16|||
42009205|NCT01024036|75816684|FG001|Blinded Treatment|Lack of Efficacy|14|||
42009206|NCT01024036|75816683|FG000|Blinded Treatment|Physician Decision|1|||
42009207|NCT01024036|75816684|FG001|Blinded Treatment|Physician Decision|0|||
42009208|NCT01024036|75816683|FG000|Blinded Treatment|Death|0|||
42009209|NCT01024036|75816684|FG001|Blinded Treatment|Death|2|||
42009210|NCT01024036|75816683|FG000|Blinded Treatment|Withdrawal by Subject|4|||
42009211|NCT01024036|75816684|FG001|Blinded Treatment|Withdrawal by Subject|3|||
42009212|NCT01024036|75816683|FG000|Unblinded Treatment|Adverse Event|0|||
42009213|NCT01024036|75816684|FG001|Unblinded Treatment|Adverse Event|1|||
42009214|NCT01024036|75816683|FG000|Unblinded Treatment|Lack of Efficacy|0|||
42009215|NCT01024036|75816684|FG001|Unblinded Treatment|Lack of Efficacy|2|||
42009216|NCT01024036|75816683|FG000|Follow-Up Period|Lost to Follow-up|1|||
42009217|NCT01024036|75816684|FG001|Follow-Up Period|Lost to Follow-up|1|||
42009218|NCT01024036|75816683|FG000|Follow-Up Period|Withdrawal by Subject|0|||
42009219|NCT01024036|75816684|FG001|Follow-Up Period|Withdrawal by Subject|1|||
42009220|NCT01024036|75816683|FG000|Follow-Up Period|Adverse Event|4|||
42009221|NCT01024036|75816684|FG001|Follow-Up Period|Adverse Event|1|||
42009222|NCT01234467|75816693|FG000|Overall Study|Adverse Event|3|||
42009223|NCT01234467|75816693|FG000|Overall Study|Death|2|||
42009224|NCT01234467|75816693|FG000|Overall Study|Withdrawal by Subject|2|||
42009225|NCT01234467|75816693|FG000|Overall Study|Disease Progression|2|||
42009226|NCT01234467|75816693|FG000|Overall Study|Clinical deterioration|1|||
42009227|NCT01234467|75816693|FG000|Overall Study|Physician Decision|1|||
42009228|NCT01234467|75816693|FG000|Overall Study|Other complicating disease (stroke)|1|||
42009229|NCT01233999|75816697|FG000|Overall Study|Withdrawal by Subject|1|||
42009230|NCT01233999|75816697|FG000|Overall Study|Lost to Follow-up|1|||
42009231|NCT01233687|75816701|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
42009232|NCT01233687|75816701|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
42009233|NCT01233687|75816701|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
42009234|NCT01023958|75816705|FG000|Overall Study|Progressive disease|48|||
42009235|NCT01023958|75816705|FG000|Overall Study|Other adverse event|1|||
42009236|NCT01023958|75816705|FG000|Overall Study|Refused to continue medication|1|||
42009237|NCT01233609|75816711|FG000|Overall Study|Death|1|||
42009238|NCT01233609|75816712|FG001|Overall Study|Death|0|||
42009239|NCT01233609|75816711|FG000|Overall Study|Lost to Follow-up|3|||
42009240|NCT01233609|75816712|FG001|Overall Study|Lost to Follow-up|1|||
42009241|NCT01233609|75816711|FG000|Overall Study|Adverse Event|2|||
42009242|NCT01233609|75816712|FG001|Overall Study|Adverse Event|1|||
42009243|NCT01233609|75816711|FG000|Overall Study|Withdrawal by Subject|3|||
42009244|NCT01233609|75816712|FG001|Overall Study|Withdrawal by Subject|0|||
42009245|NCT01232283|75816728|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
42009246|NCT01232283|75816729|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
42009247|NCT01232283|75816730|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
42009248|NCT01232283|75816731|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
42009249|NCT01232283|75816732|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
42009250|NCT01232283|75816733|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
42009251|NCT01232283|75816734|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
42009252|NCT01232283|75816735|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
42009253|NCT01232283|75816736|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
42009254|NCT01232283|75816737|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
42009255|NCT01232283|75816728|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
42009256|NCT01232283|75816729|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
42009257|NCT01232283|75816730|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42009258|NCT01232283|75816731|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42009259|NCT01232283|75816732|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42009260|NCT01232283|75816733|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42009261|NCT01232283|75816734|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42009262|NCT01232283|75816735|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42009263|NCT01232283|75816736|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42009264|NCT01232283|75816737|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42009265|NCT01232283|75816728|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
42009266|NCT01232283|75816729|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
42009267|NCT01232283|75816730|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
42009268|NCT01232283|75816731|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
42009269|NCT01232283|75816732|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
42009270|NCT01232283|75816733|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
42009271|NCT01232283|75816734|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
42009272|NCT01232283|75816735|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
42009273|NCT01232283|75816736|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
42009274|NCT01232283|75816737|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
42009275|NCT01232283|75816728|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
42009276|NCT01232283|75816729|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
42009277|NCT01232283|75816730|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42009278|NCT01232283|75816731|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42009279|NCT01232283|75816732|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42009280|NCT01232283|75816733|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42009281|NCT01232283|75816734|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42009282|NCT01232283|75816735|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42009283|NCT01232283|75816736|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42009284|NCT01232283|75816737|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42009285|NCT01232283|75816728|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
42009286|NCT01232283|75816729|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
42009287|NCT01232283|75816730|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
42009288|NCT01232283|75816731|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
42009289|NCT01232283|75816732|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
42009290|NCT01232283|75816733|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
42009291|NCT01232283|75816734|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
42009292|NCT01232283|75816735|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
42009293|NCT01232283|75816736|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
42009294|NCT01232283|75816737|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
42009295|NCT01232283|75816728|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
42009296|NCT01232283|75816729|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
42009297|NCT01232283|75816730|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
42009298|NCT01232283|75816731|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
42009299|NCT01232283|75816732|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
42009300|NCT01232283|75816733|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
42009301|NCT01232283|75816734|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
42009302|NCT01232283|75816735|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
42137706|NCT00437268|75947999|FG001|Overall Study|Death|1|||
42137707|NCT00437034|75948007|FG000|Overall Study|Adverse Event|1|||
42009303|NCT01232283|75816736|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
42009304|NCT01232283|75816737|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
42009305|NCT01232283|75816728|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
42009306|NCT01232283|75816729|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
42009307|NCT01232283|75816730|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
42009308|NCT01232283|75816731|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
42009309|NCT01232283|75816732|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
42009310|NCT01232283|75816733|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
42009311|NCT01232283|75816734|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
42009312|NCT01232283|75816735|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
42009313|NCT01232283|75816736|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
42009314|NCT01232283|75816737|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
42009315|NCT01232283|75816728|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
42009316|NCT01232283|75816729|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
42009317|NCT01232283|75816730|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
42009318|NCT01232283|75816731|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
42009319|NCT01232283|75816732|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
42009320|NCT01232283|75816733|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
42009321|NCT01232283|75816734|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
42009322|NCT01232283|75816735|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
42009323|NCT01232283|75816736|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
42009324|NCT01232283|75816737|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
42009325|NCT01232283|75816728|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
42009326|NCT01232283|75816729|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
42009327|NCT01232283|75816730|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
42009328|NCT01232283|75816731|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
42009329|NCT01232283|75816732|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
42009330|NCT01232283|75816733|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
42009331|NCT01232283|75816734|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
42009332|NCT01232283|75816735|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
42009333|NCT01232283|75816736|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
42009334|NCT01232283|75816737|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
42009335|NCT01232283|75816728|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
42009336|NCT01232283|75816729|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
42009337|NCT01232283|75816730|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
42009338|NCT01232283|75816731|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
42009339|NCT01232283|75816732|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
42009340|NCT01232283|75816733|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
42009341|NCT01232283|75816734|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
42009342|NCT01232283|75816735|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
42009343|NCT01232283|75816736|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
42009344|NCT01232283|75816737|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
42009345|NCT01232283|75816728|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
42009346|NCT01232283|75816729|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
42009347|NCT01232283|75816730|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
42009348|NCT01232283|75816731|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
42009349|NCT01232283|75816732|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
42009350|NCT01232283|75816733|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
42009351|NCT01232283|75816734|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
42009352|NCT01232283|75816735|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
42009353|NCT01232283|75816736|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
42009354|NCT01232283|75816737|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
42009355|NCT01232283|75816728|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
42009356|NCT01232283|75816729|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
42009357|NCT01232283|75816730|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
42009358|NCT01232283|75816731|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
42009359|NCT01232283|75816732|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
42009360|NCT01232283|75816733|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
42009361|NCT01232283|75816734|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
42272384|NCT02318134|76102556|FG001|Overall Study|Withdrawal by Subject|1|||
42272385|NCT02317510|76102566|FG000|Overall Study|Adverse Event|0|||
42272386|NCT02317510|76102567|FG001|Overall Study|Adverse Event|1|||
42009362|NCT01232283|75816735|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
42009363|NCT01232283|75816736|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
42009364|NCT01232283|75816737|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
42272387|NCT02317432|76102578|FG000|Overall Study|Death|4|||
42272388|NCT02317432|76102579|FG001|Overall Study|Death|1|||
42272389|NCT02317432|76102578|FG000|Overall Study|Lost to Follow-up|0|||
42272390|NCT02317432|76102579|FG001|Overall Study|Lost to Follow-up|5|||
42009365|NCT01232283|75816728|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
42009366|NCT01232283|75816729|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
42009367|NCT01232283|75816730|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
42009368|NCT01232283|75816731|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
42009369|NCT01232283|75816732|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
42009370|NCT01232283|75816733|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
42009371|NCT01232283|75816734|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
42009372|NCT01232283|75816735|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
42009373|NCT01232283|75816736|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
42009374|NCT01232283|75816737|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
42009375|NCT01232283|75816728|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
42009376|NCT01232283|75816729|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
42009377|NCT01232283|75816730|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
42009378|NCT01232283|75816731|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
42272391|NCT02317432|76102578|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
42272392|NCT02317432|76102579|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
42009379|NCT01232283|75816732|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
42009380|NCT01232283|75816733|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
42009381|NCT01232283|75816734|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
42009382|NCT01232283|75816735|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
42009383|NCT01232283|75816736|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
42009384|NCT01232283|75816737|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
42009385|NCT01232283|75816728|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
42009386|NCT01232283|75816729|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
42272393|NCT02289820|76102592|FG000|Overall Study|Withdrawal by Subject|2|||
42272394|NCT02289820|76102593|FG001|Overall Study|Withdrawal by Subject|1|||
42272395|NCT02289820|76102594|FG002|Overall Study|Withdrawal by Subject|2|||
42272396|NCT02289820|76102595|FG003|Overall Study|Withdrawal by Subject|1|||
42272397|NCT02289820|76102596|FG004|Overall Study|Withdrawal by Subject|0|||
42272398|NCT02289820|76102597|FG005|Overall Study|Withdrawal by Subject|0|||
42272399|NCT02289820|76102598|FG006|Overall Study|Withdrawal by Subject|1|||
42272400|NCT02289820|76102592|FG000|Overall Study|Death|0|||
42272401|NCT02289820|76102593|FG001|Overall Study|Death|0|||
42272402|NCT02289820|76102594|FG002|Overall Study|Death|1|||
42272403|NCT02289820|76102595|FG003|Overall Study|Death|0|||
42272404|NCT02289820|76102596|FG004|Overall Study|Death|0|||
42272405|NCT02289820|76102597|FG005|Overall Study|Death|0|||
42272406|NCT02289820|76102598|FG006|Overall Study|Death|0|||
42272407|NCT02289820|76102592|FG000|Overall Study|Lost to Follow-up|0|||
42272408|NCT02289820|76102593|FG001|Overall Study|Lost to Follow-up|0|||
42272409|NCT02289820|76102594|FG002|Overall Study|Lost to Follow-up|3|||
42272410|NCT02289820|76102595|FG003|Overall Study|Lost to Follow-up|1|||
42272411|NCT02289820|76102596|FG004|Overall Study|Lost to Follow-up|0|||
42272412|NCT02289820|76102597|FG005|Overall Study|Lost to Follow-up|1|||
42272413|NCT02289820|76102598|FG006|Overall Study|Lost to Follow-up|1|||
42272414|NCT02289820|76102592|FG000|Overall Study|withdrawal of consent|0|||
42272415|NCT02289820|76102593|FG001|Overall Study|withdrawal of consent|1|||
42272416|NCT02289820|76102594|FG002|Overall Study|withdrawal of consent|0|||
42272417|NCT02289820|76102595|FG003|Overall Study|withdrawal of consent|0|||
42272418|NCT02289820|76102596|FG004|Overall Study|withdrawal of consent|0|||
42272419|NCT02289820|76102597|FG005|Overall Study|withdrawal of consent|0|||
42272420|NCT02289820|76102598|FG006|Overall Study|withdrawal of consent|0|||
42272421|NCT02289742|76102620|FG000|First Wear Period|Adverse event prior to treatment|0|||
42009387|NCT01232283|75816730|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
42009388|NCT01232283|75816731|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
42009389|NCT01232283|75816732|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
42009390|NCT01232283|75816733|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
42009391|NCT01232283|75816734|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
42009392|NCT01232283|75816735|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
42009393|NCT01232283|75816736|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
42009394|NCT01232283|75816737|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
42272422|NCT02289742|76102621|FG001|First Wear Period|Adverse event prior to treatment|1|||
42272423|NCT02289742|76102622|FG002|First Wear Period|Adverse event prior to treatment|0|||
42009395|NCT01232283|75816728|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
42009396|NCT01232283|75816729|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
42272424|NCT02289742|76102623|FG003|First Wear Period|Adverse event prior to treatment|0|||
42272425|NCT02289742|76102620|FG000|First Wear Period|Adverse Event|0|||
42272426|NCT02289742|76102621|FG001|First Wear Period|Adverse Event|0|||
42272427|NCT02289742|76102622|FG002|First Wear Period|Adverse Event|1|||
42272428|NCT02289742|76102623|FG003|First Wear Period|Adverse Event|0|||
42272429|NCT02289742|76102620|FG000|First Wear Period|Other prior to treatment|0|||
42272430|NCT02289742|76102621|FG001|First Wear Period|Other prior to treatment|0|||
42009397|NCT01232283|75816730|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
42009398|NCT01232283|75816731|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
42009399|NCT01232283|75816732|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
42009400|NCT01232283|75816733|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
42009401|NCT01232283|75816734|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
42009402|NCT01232283|75816735|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
42009403|NCT01232283|75816736|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
42009404|NCT01232283|75816737|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
42009405|NCT01232283|75816728|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
42009406|NCT01232283|75816729|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
42009407|NCT01232283|75816730|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
42009408|NCT01232283|75816731|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
42009409|NCT01232283|75816732|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
42009410|NCT01232283|75816733|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
42009411|NCT01232283|75816734|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
42009412|NCT01232283|75816735|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
42009413|NCT01232283|75816736|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
42009414|NCT01232283|75816737|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
42009415|NCT01232283|75816728|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
42009416|NCT01232283|75816729|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
42009417|NCT01232283|75816730|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
42009418|NCT01232283|75816731|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
42009419|NCT01232283|75816732|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
42009420|NCT01232283|75816733|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
42009421|NCT01232283|75816734|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
42009422|NCT01232283|75816735|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
42009423|NCT01232283|75816736|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
42009424|NCT01232283|75816737|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
42009425|NCT01232283|75816728|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
42009426|NCT01232283|75816729|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
42009427|NCT01232283|75816730|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
42009428|NCT01232283|75816731|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
42009429|NCT01232283|75816732|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
42009430|NCT01232283|75816733|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
42009431|NCT01232283|75816734|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
42009432|NCT01232283|75816735|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
42009433|NCT01232283|75816736|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
42009434|NCT01232283|75816737|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
42009435|NCT01232283|75816728|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
42009436|NCT01232283|75816729|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
42009437|NCT01232283|75816730|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
42009438|NCT01232283|75816731|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
42009439|NCT01232283|75816732|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
42009440|NCT01232283|75816733|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
42009441|NCT01232283|75816734|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
42009442|NCT01232283|75816735|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
42009443|NCT01232283|75816736|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
42009444|NCT01232283|75816737|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
42009445|NCT01232283|75816728|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
42009446|NCT01232283|75816729|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
42009447|NCT01232283|75816730|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
42009448|NCT01232283|75816731|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
42009449|NCT01232283|75816732|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
42009450|NCT01232283|75816733|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
42009451|NCT01232283|75816734|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
42009452|NCT01232283|75816735|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
42009453|NCT01232283|75816736|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
42009454|NCT01232283|75816737|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
42009455|NCT01232283|75816728|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
42009456|NCT01232283|75816729|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
42009457|NCT01232283|75816730|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
42009458|NCT01232283|75816731|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
42009459|NCT01232283|75816732|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
42009460|NCT01232283|75816733|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
42137708|NCT00437034|75948007|FG000|Overall Study|Disease progression during treatment|5|||
42009461|NCT01232283|75816734|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
42009462|NCT01232283|75816735|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
42009463|NCT01232283|75816736|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
42009464|NCT01232283|75816737|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
42009465|NCT01232283|75816728|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
42009466|NCT01232283|75816729|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
42009467|NCT01232283|75816730|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
42009468|NCT01232283|75816731|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
42009469|NCT01232283|75816732|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
42009470|NCT01232283|75816733|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
42009471|NCT01232283|75816734|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
42009472|NCT01232283|75816735|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
42009473|NCT01232283|75816736|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
42009474|NCT01232283|75816737|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
42009475|NCT01232283|75816728|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
42009476|NCT01232283|75816729|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
42009477|NCT01232283|75816730|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
42009478|NCT01232283|75816731|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
42009479|NCT01232283|75816732|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
42009480|NCT01232283|75816733|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
42009481|NCT01232283|75816734|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
42009482|NCT01232283|75816735|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
42009483|NCT01232283|75816736|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
42009484|NCT01232283|75816737|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
42009485|NCT01232283|75816728|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
42009486|NCT01232283|75816729|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
42009487|NCT01232283|75816730|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
42009488|NCT01232283|75816731|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
42009489|NCT01232283|75816732|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
42009490|NCT01232283|75816733|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
42009491|NCT01232283|75816734|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
42009492|NCT01232283|75816735|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
42009493|NCT01232283|75816736|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
42009494|NCT01232283|75816737|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
42009495|NCT01232283|75816728|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
42009496|NCT01232283|75816729|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
42009497|NCT01232283|75816730|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
42009498|NCT01232283|75816731|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
42009499|NCT01232283|75816732|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
42009500|NCT01232283|75816733|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
42009501|NCT01232283|75816734|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
42009502|NCT01232283|75816735|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
42009503|NCT01232283|75816736|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
42009504|NCT01232283|75816737|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
42009505|NCT01232283|75816728|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
42009506|NCT01232283|75816729|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
42009507|NCT01232283|75816730|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
42009508|NCT01232283|75816731|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
42009509|NCT01232283|75816732|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
42009510|NCT01232283|75816733|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
42009511|NCT01232283|75816734|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
42009512|NCT01232283|75816735|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
42009513|NCT01232283|75816736|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
42009514|NCT01232283|75816737|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
42009515|NCT01232283|75816728|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
42009516|NCT01232283|75816729|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
42009517|NCT01232283|75816730|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
42009518|NCT01232283|75816731|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
42009519|NCT01232283|75816732|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
42009520|NCT01232283|75816733|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
42009521|NCT01232283|75816734|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
42009522|NCT01232283|75816735|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
42009523|NCT01232283|75816736|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
42009524|NCT01232283|75816737|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
42009525|NCT01232127|75816759|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
42009526|NCT01232127|75816760|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
42009527|NCT01232127|75816761|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
42009528|NCT01258608|75816775|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
42009529|NCT01258608|75816776|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
42009530|NCT01258608|75816775|FG000|Overall Study|Clinical progression|1|||
42009531|NCT01258608|75816776|FG001|Overall Study|Clinical progression|0|||
42009532|NCT01258608|75816775|FG000|Overall Study|Sponsor decision|0|||
42009533|NCT01258608|75816776|FG001|Overall Study|Sponsor decision|1|||
42009534|NCT01258608|75816775|FG000|Overall Study|Physician Decision|6|||
42009535|NCT01258608|75816776|FG001|Overall Study|Physician Decision|1|||
42009536|NCT01258608|75816775|FG000|Overall Study|Lost to Follow-up|0|||
42009537|NCT01258608|75816776|FG001|Overall Study|Lost to Follow-up|1|||
42009538|NCT01258608|75816775|FG000|Overall Study|Lack of compliance|1|||
42009539|NCT01258608|75816776|FG001|Overall Study|Lack of compliance|0|||
42009540|NCT01258608|75816775|FG000|Overall Study|Lack of Efficacy|0|||
42009541|NCT01258608|75816776|FG001|Overall Study|Lack of Efficacy|1|||
42009542|NCT01258608|75816775|FG000|Overall Study|Adverse Event|6|||
42009543|NCT01258608|75816776|FG001|Overall Study|Adverse Event|10|||
42009544|NCT01258608|75816775|FG000|Overall Study|Withdrawal by Subject|6|||
42009545|NCT01258608|75816776|FG001|Overall Study|Withdrawal by Subject|5|||
42009546|NCT01015612|75816783|FG000|Overall Study|Death|113|||
42009547|NCT01015612|75816783|FG000|Overall Study|Withdrawal by Subject|40|||
42009548|NCT01231659|75816787|FG000|Overall Study|Adverse Event|9|||
42009549|NCT01231659|75816787|FG000|Overall Study|Disease Progression|48|||
42009550|NCT01231659|75816787|FG000|Overall Study|Death|2|||
42009551|NCT01231659|75816787|FG000|Overall Study|Patient refused to complete study visit|1|||
42009552|NCT01231659|75816787|FG000|Overall Study|Other protocol defined criteria|12|||
42009553|NCT01054222|75816791|FG000|Overall Study|Lack of Efficacy|1|||
42009554|NCT01054222|75816791|FG000|Overall Study|Lost to Follow-up|4|||
42009555|NCT01054222|75816791|FG000|Overall Study|Withdrawal by Subject|6|||
42009556|NCT01052428|75816797|FG000|Overall Study|Death|1|||
42009557|NCT01052428|75816798|FG001|Overall Study|Death|0|||
42009558|NCT01052428|75816797|FG000|Overall Study|Withdrawal by Subject|0|||
42009559|NCT01052428|75816798|FG001|Overall Study|Withdrawal by Subject|1|||
42009560|NCT01052272|75816808|FG000|Overall Study|Death|0|||
42009561|NCT01052272|75816809|FG001|Overall Study|Death|0|||
42009562|NCT01052272|75816810|FG002|Overall Study|Death|1|||
42009563|NCT01052272|75816811|FG003|Overall Study|Death|1|||
42009564|NCT01052272|75816808|FG000|Overall Study|Physician Decision|0|||
42009565|NCT01052272|75816809|FG001|Overall Study|Physician Decision|1|||
42009566|NCT01052272|75816810|FG002|Overall Study|Physician Decision|0|||
42009567|NCT01052272|75816811|FG003|Overall Study|Physician Decision|0|||
42009568|NCT01052272|75816808|FG000|Overall Study|patient refuses follow-up|5|||
42009569|NCT01052272|75816809|FG001|Overall Study|patient refuses follow-up|4|||
42009570|NCT01052272|75816810|FG002|Overall Study|patient refuses follow-up|2|||
42009571|NCT01052272|75816811|FG003|Overall Study|patient refuses follow-up|4|||
42009572|NCT01052272|75816808|FG000|Overall Study|Withdrawal by Subject|0|||
42009573|NCT01052272|75816809|FG001|Overall Study|Withdrawal by Subject|2|||
42009574|NCT01052272|75816810|FG002|Overall Study|Withdrawal by Subject|3|||
42009575|NCT01052272|75816811|FG003|Overall Study|Withdrawal by Subject|2|||
42009576|NCT01052272|75816808|FG000|Overall Study|placed in long-term care|0|||
42009577|NCT01052272|75816809|FG001|Overall Study|placed in long-term care|0|||
42009578|NCT01052272|75816810|FG002|Overall Study|placed in long-term care|1|||
42009579|NCT01052272|75816811|FG003|Overall Study|placed in long-term care|0|||
42009580|NCT01052272|75816808|FG000|Overall Study|decline in health|0|||
42009581|NCT01052272|75816809|FG001|Overall Study|decline in health|0|||
42009582|NCT01052272|75816810|FG002|Overall Study|decline in health|1|||
42009583|NCT01052272|75816811|FG003|Overall Study|decline in health|0|||
42009584|NCT01257204|75816824|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
42009585|NCT01257204|75816825|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
42009586|NCT01257204|75816826|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
42009587|NCT01257204|75816824|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
42009588|NCT01257204|75816825|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
42009589|NCT01257204|75816826|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
42009590|NCT01257204|75816824|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
42009591|NCT01257204|75816825|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
42009592|NCT01257204|75816826|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
42009593|NCT01257204|75816824|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
42009594|NCT01257204|75816825|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
42009595|NCT01257204|75816826|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
42009596|NCT01257204|75816824|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
42009597|NCT01257204|75816825|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
42009598|NCT01257204|75816826|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
42009599|NCT01257204|75816824|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
42272431|NCT02289742|76102622|FG002|First Wear Period|Other prior to treatment|0|||
42272432|NCT02289742|76102623|FG003|First Wear Period|Other prior to treatment|1|||
42272433|NCT02289742|76102620|FG000|Third Wear Period|Adverse Event|0|||
42137709|NCT00337467|75948011|FG000|Overall Study|Adverse Event|3|||
42137710|NCT00337467|75948011|FG000|Overall Study|Subject Withdrew Consent|2|||
42137711|NCT00337467|75948011|FG000|Overall Study|Pregnancy|1|||
42137712|NCT00337467|75948011|FG000|Overall Study|Lost to Follow-up|2|||
42137713|NCT00337467|75948011|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
42137714|NCT00337077|75948021|FG000|Overall Study|Progressive disease|25|||
42137715|NCT00337077|75948022|FG001|Overall Study|Progressive disease|37|||
42009600|NCT01257204|75816825|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
42272434|NCT02289742|76102621|FG001|Third Wear Period|Adverse Event|1|||
42272435|NCT02289742|76102622|FG002|Third Wear Period|Adverse Event|0|||
42272436|NCT02289742|76102623|FG003|Third Wear Period|Adverse Event|0|||
42272437|NCT02289742|76102620|FG000|Third Wear Period|Reason not given|0|||
42272438|NCT02289742|76102621|FG001|Third Wear Period|Reason not given|0|||
42272439|NCT02289742|76102622|FG002|Third Wear Period|Reason not given|0|||
42272440|NCT02289742|76102623|FG003|Third Wear Period|Reason not given|1|||
42272441|NCT02289352|76102640|FG000|Overall Study|Withdrawal by Subject|1|||
42009601|NCT01257204|75816826|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
42009602|NCT01257204|75816824|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
42009603|NCT01257204|75816825|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
42009604|NCT01257204|75816826|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
42009605|NCT01257204|75816824|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
42009606|NCT01257204|75816825|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
42009607|NCT01257204|75816826|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
42009608|NCT01257204|75816824|FG000|Follow-up Period (up to Week 48)|Other|0|||
42009609|NCT01257204|75816825|FG001|Follow-up Period (up to Week 48)|Other|0|||
42009610|NCT01257204|75816826|FG002|Follow-up Period (up to Week 48)|Other|5|||
42009611|NCT01231581|75816848|FG000|Overall Study|Lost to Follow-up|2|||
42009612|NCT01231581|75816849|FG001|Overall Study|Lost to Follow-up|2|||
42009613|NCT01231581|75816848|FG000|Overall Study|Withdrawal by Subject|6|||
42009614|NCT01231581|75816849|FG001|Overall Study|Withdrawal by Subject|9|||
42009615|NCT01231581|75816848|FG000|Overall Study|Study Closed/Terminated|6|||
42009616|NCT01231581|75816849|FG001|Overall Study|Study Closed/Terminated|5|||
42009617|NCT01231581|75816848|FG000|Overall Study|Death|65|||
42009618|NCT01231581|75816849|FG001|Overall Study|Death|64|||
42009619|NCT01231581|75816848|FG000|Overall Study|Ongoing|1|||
42009620|NCT01231581|75816849|FG001|Overall Study|Ongoing|0|||
42009621|NCT01050634|75816855|FG000|Overall Study|Enrolled, but Not Treated|56|||
42009622|NCT01050634|75816855|FG000|Overall Study|Death|2|||
42009623|NCT01050634|75816855|FG000|Overall Study|Adverse Event|42|||
42009624|NCT01050634|75816855|FG000|Overall Study|Lost to Follow-up|2|||
42009625|NCT01050634|75816855|FG000|Overall Study|Other|21|||
42009626|NCT01050634|75816855|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
42009627|NCT01020526|75816859|FG000|Overall Study|Withdrawal by Subject|5|||
42009628|NCT01020526|75816859|FG000|Overall Study|Other reasons|3|||
42009629|NCT01020526|75816859|FG000|Overall Study|Insufficient clinical response|3|||
42009630|NCT01020526|75816859|FG000|Overall Study|Lost to Follow-up|1|||
42009631|NCT01020526|75816859|FG000|Overall Study|Adverse Event|2|||
42009632|NCT01020448|75816863|FG000|Pre-assignment|Adverse Event|6|||
42009633|NCT01020448|75816863|FG000|Pre-assignment|Withdrawal by Subject|5|||
42009634|NCT01020448|75816863|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
42009635|NCT01020448|75816863|FG000|Treatment|Adverse Event|11|||
42035700|NCT01022112|75844169|FG004|Overall Study|Withdrawal by Subject|1|||
42272442|NCT02289352|76102641|FG001|Overall Study|Withdrawal by Subject|1|||
42272443|NCT02289352|76102642|FG002|Overall Study|Withdrawal by Subject|0|||
42035701|NCT01022112|75844165|FG000|Overall Study|Fasting plasma glucose level increased|1|||
42137716|NCT00337077|75948023|FG002|Overall Study|Progressive disease|19|||
42137717|NCT00337077|75948021|FG000|Overall Study|Adverse Event|7|||
42009636|NCT01020448|75816863|FG000|Treatment|Consent Withdrawn|3|||
42009637|NCT01020448|75816863|FG000|Treatment|Disease Progression|2|||
42009638|NCT01020448|75816863|FG000|Treatment|Lack of Efficacy|8|||
42009639|NCT01020448|75816863|FG000|Treatment|Lost to Follow-up|2|||
42035702|NCT01022112|75844166|FG001|Overall Study|Fasting plasma glucose level increased|0|||
42137718|NCT00337077|75948022|FG001|Overall Study|Adverse Event|7|||
42272444|NCT02315560|76102651|FG000|Overall Study|noncompliance by subjects|3|||
42009640|NCT01256658|75816870|FG000|Period 1|Lost to Follow-up|837|||
42009641|NCT01256658|75816871|FG001|Period 1|Lost to Follow-up|661|||
42009642|NCT01256658|75816870|FG000|Period 1|Withdrawal by Subject|35|||
42009643|NCT01256658|75816871|FG001|Period 1|Withdrawal by Subject|43|||
42009644|NCT01256658|75816870|FG000|Period 1|Death|48|||
42009645|NCT01256658|75816871|FG001|Period 1|Death|44|||
42009646|NCT01256502|75816880|FG000|Overall Study|Had scaffold removed|4|||
42009647|NCT01256502|75816880|FG000|Overall Study|Personal reasons|5|||
42009648|NCT01256502|75816880|FG000|Overall Study|Protocol deviation|1|||
42009649|NCT01256190|75816891|FG000|Overall Study|Lost to Follow-up|2|||
42009650|NCT01256190|75816892|FG001|Overall Study|Lost to Follow-up|0|||
42009651|NCT01255722|75816901|FG000|Overall Study|Adverse Event|0|||
42009652|NCT01255722|75816902|FG001|Overall Study|Adverse Event|1|||
42009653|NCT01255722|75816903|FG002|Overall Study|Adverse Event|1|||
42346808|NCT01877265|76185804|FG003|Treatment Period 3|Lost to Follow-up|0|||
42346809|NCT01877265|76185805|FG004|Treatment Period 3|Lost to Follow-up|0|||
42346810|NCT01877265|76185806|FG005|Treatment Period 3|Lost to Follow-up|0|||
42346811|NCT01877187|76185817|FG000|Overall Study|Death|2|||
42346812|NCT01877187|76185817|FG000|Overall Study|Withdrawal by Subject|4|||
42346813|NCT01877187|76185817|FG000|Overall Study|Lost to Follow-up|3|||
42346814|NCT01877187|76185817|FG000|Overall Study|Declining clinical status|11|||
42346815|NCT01877187|76185817|FG000|Overall Study|Liver transplant|2|||
42346816|NCT01858532|76185828|FG000|Overall Study|Adverse Event|58|||
42346817|NCT01858532|76185829|FG001|Overall Study|Adverse Event|50|||
42009654|NCT01255722|75816901|FG000|Overall Study|asymptomatic patient|1|||
42009655|NCT01255722|75816902|FG001|Overall Study|asymptomatic patient|0|||
42009656|NCT01255722|75816903|FG002|Overall Study|asymptomatic patient|0|||
42009657|NCT01255722|75816901|FG000|Overall Study|beta-blocker contraindicated|2|||
42009658|NCT01255722|75816902|FG001|Overall Study|beta-blocker contraindicated|0|||
42009659|NCT01255722|75816903|FG002|Overall Study|beta-blocker contraindicated|0|||
42009660|NCT01231503|75816920|FG000|Overall Study|Adverse Event|0|||
42009661|NCT01231503|75816921|FG001|Overall Study|Adverse Event|0|||
42009662|NCT01231503|75816922|FG002|Overall Study|Adverse Event|0|||
42009663|NCT01231503|75816923|FG003|Overall Study|Adverse Event|0|||
42009664|NCT01231503|75816924|FG004|Overall Study|Adverse Event|0|||
42009665|NCT01231503|75816925|FG005|Overall Study|Adverse Event|1|||
42009666|NCT01231503|75816926|FG006|Overall Study|Adverse Event|0|||
42009667|NCT01231503|75816927|FG007|Overall Study|Adverse Event|0|||
42009668|NCT01231503|75816920|FG000|Overall Study|Adverse event, serious fatal|0|||
42009669|NCT01231503|75816921|FG001|Overall Study|Adverse event, serious fatal|0|||
42009670|NCT01231503|75816922|FG002|Overall Study|Adverse event, serious fatal|1|||
42009671|NCT01231503|75816923|FG003|Overall Study|Adverse event, serious fatal|1|||
42009672|NCT01231503|75816924|FG004|Overall Study|Adverse event, serious fatal|0|||
42009673|NCT01231503|75816925|FG005|Overall Study|Adverse event, serious fatal|1|||
42009674|NCT01231503|75816926|FG006|Overall Study|Adverse event, serious fatal|0|||
42009675|NCT01231503|75816927|FG007|Overall Study|Adverse event, serious fatal|0|||
42009676|NCT01231503|75816920|FG000|Overall Study|Withdrawal by Subject|6|||
42009677|NCT01231503|75816921|FG001|Overall Study|Withdrawal by Subject|3|||
42009678|NCT01231503|75816922|FG002|Overall Study|Withdrawal by Subject|3|||
42009679|NCT01231503|75816923|FG003|Overall Study|Withdrawal by Subject|1|||
42009680|NCT01231503|75816924|FG004|Overall Study|Withdrawal by Subject|3|||
42009681|NCT01231503|75816925|FG005|Overall Study|Withdrawal by Subject|5|||
42009682|NCT01231503|75816926|FG006|Overall Study|Withdrawal by Subject|1|||
42009683|NCT01231503|75816927|FG007|Overall Study|Withdrawal by Subject|2|||
42009684|NCT01231503|75816920|FG000|Overall Study|Lost to Follow-up|8|||
42009685|NCT01231503|75816921|FG001|Overall Study|Lost to Follow-up|10|||
42009686|NCT01231503|75816922|FG002|Overall Study|Lost to Follow-up|8|||
42009687|NCT01231503|75816923|FG003|Overall Study|Lost to Follow-up|5|||
42009688|NCT01231503|75816924|FG004|Overall Study|Lost to Follow-up|7|||
42009689|NCT01231503|75816925|FG005|Overall Study|Lost to Follow-up|9|||
42009690|NCT01231503|75816926|FG006|Overall Study|Lost to Follow-up|6|||
42009691|NCT01231503|75816927|FG007|Overall Study|Lost to Follow-up|6|||
42009692|NCT01231503|75816920|FG000|Overall Study|Protocol Violation|0|||
42009693|NCT01231503|75816921|FG001|Overall Study|Protocol Violation|0|||
42009694|NCT01231503|75816922|FG002|Overall Study|Protocol Violation|0|||
42009695|NCT01231503|75816923|FG003|Overall Study|Protocol Violation|1|||
42009696|NCT01231503|75816924|FG004|Overall Study|Protocol Violation|0|||
42009697|NCT01231503|75816925|FG005|Overall Study|Protocol Violation|0|||
42009698|NCT01231503|75816926|FG006|Overall Study|Protocol Violation|0|||
42137719|NCT00337077|75948023|FG002|Overall Study|Adverse Event|1|||
42009699|NCT01231503|75816927|FG007|Overall Study|Protocol Violation|0|||
42009700|NCT01230489|75816955|FG000|Overall Study|Death|2|||
42009701|NCT01230489|75816955|FG000|Overall Study|Adverse Event|2|||
42009702|NCT01230489|75816955|FG000|Overall Study|Treatment modality changed|1|||
42137720|NCT00337077|75948021|FG000|Overall Study|Death|0|||
42009703|NCT01229397|75816961|FG000|Overall Study|Withdrawal by Subject|3|||
42009704|NCT01229397|75816962|FG001|Overall Study|Withdrawal by Subject|3|||
42346818|NCT01858532|76185830|FG002|Overall Study|Adverse Event|23|||
42009705|NCT01229397|75816961|FG000|Overall Study|Lost to Follow-up|7|||
42009706|NCT01229397|75816962|FG001|Overall Study|Lost to Follow-up|6|||
42009707|NCT01229397|75816961|FG000|Overall Study|Migrated/moved from study area|1|||
42009708|NCT01229397|75816962|FG001|Overall Study|Migrated/moved from study area|0|||
42009709|NCT01228071|75816972|FG000|Overall Study|Protocol Violation|1|||
42009710|NCT01228071|75816972|FG000|Overall Study|Withdrawal by Subject|1|||
42009711|NCT01008475|75816983|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
42009712|NCT01008475|75816984|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
42009713|NCT01008475|75816985|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
42009714|NCT01008475|75816986|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
42009715|NCT01008475|75816987|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
42009716|NCT01008475|75816988|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
42009717|NCT01008475|75816989|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
42009718|NCT01226745|75817011|FG000|Overall Study|Did not complete schedule of assessments|8|||
42009719|NCT01226745|75817012|FG001|Overall Study|Did not complete schedule of assessments|3|||
42009720|NCT01226745|75817013|FG002|Overall Study|Did not complete schedule of assessments|6|||
42009721|NCT01226745|75817014|FG003|Overall Study|Did not complete schedule of assessments|0|||
42009722|NCT01226745|75817015|FG004|Overall Study|Did not complete schedule of assessments|0|||
42009723|NCT01226745|75817016|FG005|Overall Study|Did not complete schedule of assessments|1|||
42009724|NCT01226745|75817011|FG000|Overall Study|Lost to Follow-up|2|||
42009725|NCT01226745|75817012|FG001|Overall Study|Lost to Follow-up|6|||
42009726|NCT01226745|75817013|FG002|Overall Study|Lost to Follow-up|6|||
42009727|NCT01226745|75817014|FG003|Overall Study|Lost to Follow-up|1|||
42009728|NCT01226745|75817015|FG004|Overall Study|Lost to Follow-up|1|||
42009729|NCT01226745|75817016|FG005|Overall Study|Lost to Follow-up|2|||
42009730|NCT01226745|75817011|FG000|Overall Study|Death|1|||
42009731|NCT01226745|75817012|FG001|Overall Study|Death|0|||
42009732|NCT01226745|75817013|FG002|Overall Study|Death|0|||
42009733|NCT01226745|75817014|FG003|Overall Study|Death|0|||
42009734|NCT01226745|75817015|FG004|Overall Study|Death|0|||
42009735|NCT01226745|75817016|FG005|Overall Study|Death|1|||
42009736|NCT01226745|75817011|FG000|Overall Study|Other|6|||
42009737|NCT01226745|75817012|FG001|Overall Study|Other|7|||
42009738|NCT01226745|75817013|FG002|Overall Study|Other|8|||
42009739|NCT01226745|75817014|FG003|Overall Study|Other|4|||
42009740|NCT01226745|75817015|FG004|Overall Study|Other|3|||
42009741|NCT01226745|75817016|FG005|Overall Study|Other|1|||
42009742|NCT01226511|75817033|FG000|Acute Treatment Period|Adverse Event|7|||
42009743|NCT01226511|75817034|FG001|Acute Treatment Period|Adverse Event|6|||
42009744|NCT01226511|75817033|FG000|Acute Treatment Period|Lack of Efficacy|2|||
42009745|NCT01226511|75817034|FG001|Acute Treatment Period|Lack of Efficacy|1|||
42009746|NCT01226511|75817033|FG000|Acute Treatment Period|Lost to Follow-up|3|||
42009747|NCT01226511|75817034|FG001|Acute Treatment Period|Lost to Follow-up|6|||
42009748|NCT01226511|75817033|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
42009749|NCT01226511|75817034|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
42009750|NCT01226511|75817033|FG000|Acute Treatment Period|Protocol Violation|5|||
42009751|NCT01226511|75817034|FG001|Acute Treatment Period|Protocol Violation|5|||
42009752|NCT01226511|75817033|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
42009753|NCT01226511|75817034|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
42009754|NCT01226511|75817033|FG000|Extension Treatment Period|Adverse Event|8|||
42009755|NCT01226511|75817034|FG001|Extension Treatment Period|Adverse Event|8|||
42009756|NCT01226511|75817033|FG000|Extension Treatment Period|Lack of Efficacy|3|||
42009757|NCT01226511|75817034|FG001|Extension Treatment Period|Lack of Efficacy|2|||
42009758|NCT01226511|75817033|FG000|Extension Treatment Period|Lost to Follow-up|4|||
42009759|NCT01226511|75817034|FG001|Extension Treatment Period|Lost to Follow-up|3|||
42009760|NCT01226511|75817033|FG000|Extension Treatment Period|Protocol Violation|2|||
42009761|NCT01226511|75817034|FG001|Extension Treatment Period|Protocol Violation|2|||
42009762|NCT01226511|75817033|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
42009763|NCT01226511|75817034|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
42009764|NCT01226511|75817033|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
42009765|NCT01226511|75817034|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
42009766|NCT01226511|75817033|FG000|Extension Treatment Period|Sponsor Decision|1|||
42009767|NCT01226511|75817034|FG001|Extension Treatment Period|Sponsor Decision|1|||
42035703|NCT01022112|75844167|FG002|Overall Study|Fasting plasma glucose level increased|0|||
42035704|NCT01022112|75844168|FG003|Overall Study|Fasting plasma glucose level increased|0|||
42009768|NCT01226511|75817033|FG000|Taper Period|Adverse Event|1|||
42009769|NCT01226511|75817034|FG001|Taper Period|Adverse Event|0|||
42009770|NCT01226511|75817033|FG000|Taper Period|Lost to Follow-up|2|||
42009771|NCT01226511|75817034|FG001|Taper Period|Lost to Follow-up|2|||
42035705|NCT01022112|75844169|FG004|Overall Study|Fasting plasma glucose level increased|7|||
42035706|NCT01096667|75844186|FG000|Overall Study|Lost to Follow-up|1|||
42009772|NCT01226511|75817033|FG000|Taper Period|Protocol Violation|1|||
42009773|NCT01226511|75817034|FG001|Taper Period|Protocol Violation|0|||
42009774|NCT01226511|75817033|FG000|Taper Period|Parent/Caregiver Decision|1|||
42009775|NCT01226511|75817034|FG001|Taper Period|Parent/Caregiver Decision|1|||
42009776|NCT01226121|75817049|FG000|Overall Study|Lost to Follow-up|2|||
42009777|NCT01226121|75817050|FG001|Overall Study|Lost to Follow-up|0|||
42009778|NCT01226121|75817051|FG002|Overall Study|Lost to Follow-up|1|||
42009779|NCT01226043|75817061|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
42009780|NCT01226043|75817062|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
42009781|NCT01226043|75817063|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
42009782|NCT01226043|75817064|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
42009783|NCT01226043|75817061|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
42009784|NCT01226043|75817062|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
42009785|NCT01226043|75817063|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
42009786|NCT01226043|75817064|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
42009787|NCT01226043|75817061|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
42009788|NCT01226043|75817062|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
42009789|NCT01226043|75817063|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
42009790|NCT01226043|75817064|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
42009791|NCT01226043|75817061|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
42009792|NCT01226043|75817062|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
42009793|NCT01226043|75817063|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
42009794|NCT01226043|75817064|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
42009795|NCT01226043|75817061|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
42346819|NCT01858532|76185831|FG003|Overall Study|Adverse Event|28|||
42346820|NCT01858532|76185828|FG000|Overall Study|Withdrew consent|71|||
42346821|NCT01858532|76185829|FG001|Overall Study|Withdrew consent|93|||
42346822|NCT01858532|76185830|FG002|Overall Study|Withdrew consent|46|||
42346823|NCT01858532|76185831|FG003|Overall Study|Withdrew consent|27|||
42346824|NCT01858532|76185828|FG000|Overall Study|Lost to Follow-up|17|||
42346825|NCT01858532|76185829|FG001|Overall Study|Lost to Follow-up|26|||
42346826|NCT01858532|76185830|FG002|Overall Study|Lost to Follow-up|11|||
42346827|NCT01858532|76185831|FG003|Overall Study|Lost to Follow-up|14|||
42346828|NCT01858532|76185828|FG000|Overall Study|Deterioration of medical status|3|||
42346829|NCT01858532|76185829|FG001|Overall Study|Deterioration of medical status|4|||
42346830|NCT01858532|76185830|FG002|Overall Study|Deterioration of medical status|3|||
42346831|NCT01858532|76185831|FG003|Overall Study|Deterioration of medical status|7|||
42346832|NCT01858532|76185828|FG000|Overall Study|Investigator request|3|||
42346833|NCT01858532|76185829|FG001|Overall Study|Investigator request|4|||
42346834|NCT01858532|76185830|FG002|Overall Study|Investigator request|2|||
42346835|NCT01858532|76185831|FG003|Overall Study|Investigator request|6|||
42346836|NCT01858532|76185828|FG000|Overall Study|Other, not specified|29|||
42346837|NCT01858532|76185829|FG001|Overall Study|Other, not specified|15|||
42346838|NCT01858532|76185830|FG002|Overall Study|Other, not specified|13|||
42346839|NCT01858532|76185831|FG003|Overall Study|Other, not specified|11|||
42346840|NCT01883492|76185843|FG000|Overall Study|Lost to Follow-up|3|||
42346841|NCT01883492|76185844|FG001|Overall Study|Lost to Follow-up|4|||
42346842|NCT01883492|76185843|FG000|Overall Study|Surgery on contra-lateral hip|0|||
42346843|NCT01883492|76185844|FG001|Overall Study|Surgery on contra-lateral hip|1|||
42346844|NCT01883492|76185843|FG000|Overall Study|Poor X-ray quality|7|||
42035707|NCT01096667|75844187|FG001|Overall Study|Lost to Follow-up|1|||
42035708|NCT01096667|75844188|FG002|Overall Study|Lost to Follow-up|1|||
42035709|NCT01096667|75844189|FG003|Overall Study|Lost to Follow-up|0|||
42035710|NCT01096667|75844190|FG004|Overall Study|Lost to Follow-up|0|||
42035711|NCT01096667|75844186|FG000|Overall Study|Withdrawal by Subject|1|||
42035712|NCT01096667|75844187|FG001|Overall Study|Withdrawal by Subject|0|||
42035713|NCT01096667|75844188|FG002|Overall Study|Withdrawal by Subject|0|||
42035714|NCT01096667|75844189|FG003|Overall Study|Withdrawal by Subject|1|||
42035715|NCT01096667|75844190|FG004|Overall Study|Withdrawal by Subject|0|||
42035716|NCT01096667|75844186|FG000|Overall Study|Reason not available|0|||
42035717|NCT01096667|75844187|FG001|Overall Study|Reason not available|1|||
42035718|NCT01096667|75844188|FG002|Overall Study|Reason not available|1|||
42346845|NCT01883492|76185844|FG001|Overall Study|Poor X-ray quality|4|||
42035719|NCT01096667|75844189|FG003|Overall Study|Reason not available|1|||
42035720|NCT01096667|75844190|FG004|Overall Study|Reason not available|0|||
42346846|NCT01883492|76185843|FG000|Overall Study|Withdrawal by Subject|1|||
42346847|NCT01883492|76185844|FG001|Overall Study|Withdrawal by Subject|0|||
42346848|NCT01883492|76185843|FG000|Overall Study|inappropriate implant used|1|||
42346849|NCT01883492|76185844|FG001|Overall Study|inappropriate implant used|1|||
42346850|NCT01883492|76185843|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
42009796|NCT01226043|75817062|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
42035721|NCT01096667|75844186|FG000|Overall Study|Protocol Violation|0|||
42035722|NCT01096667|75844187|FG001|Overall Study|Protocol Violation|0|||
42137721|NCT00337077|75948022|FG001|Overall Study|Death|1|||
42137722|NCT00337077|75948023|FG002|Overall Study|Death|0|||
42137723|NCT00337077|75948021|FG000|Overall Study|Withdrawal by Subject|7|||
42346851|NCT01883492|76185844|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
42346852|NCT01832480|76185852|FG000|Overall Study|Lost to Follow-up|33|||
42346853|NCT01832480|76185853|FG001|Overall Study|Lost to Follow-up|30|||
42346854|NCT01832480|76185852|FG000|Overall Study|Withdrawal by Subject|0|||
42346855|NCT01832480|76185853|FG001|Overall Study|Withdrawal by Subject|2|||
42346856|NCT01832480|76185852|FG000|Overall Study|post randomization ineligible|8|||
42346857|NCT01832480|76185853|FG001|Overall Study|post randomization ineligible|10|||
42009797|NCT01226043|75817063|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
42009798|NCT01226043|75817064|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
42009799|NCT01226043|75817061|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
42009800|NCT01226043|75817062|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
42009801|NCT01226043|75817063|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
42009802|NCT01226043|75817064|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
42009803|NCT01226043|75817061|FG000|6-week Re-randomization Phase|Adverse Event|0|||
42009804|NCT01226043|75817062|FG001|6-week Re-randomization Phase|Adverse Event|0|||
42009805|NCT01226043|75817063|FG002|6-week Re-randomization Phase|Adverse Event|1|||
42009806|NCT01226043|75817064|FG003|6-week Re-randomization Phase|Adverse Event|1|||
42009807|NCT01226043|75817061|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
42009808|NCT01226043|75817062|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
42009809|NCT01226043|75817063|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
42009810|NCT01226043|75817064|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
42009811|NCT01226043|75817061|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
42009812|NCT01226043|75817062|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
42009813|NCT01226043|75817063|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
42009814|NCT01226043|75817064|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
42009815|NCT01226043|75817061|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
42009816|NCT01226043|75817062|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
42009817|NCT01226043|75817063|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
42009818|NCT01226043|75817064|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
42009819|NCT01226043|75817061|FG000|6-week Re-randomization Phase|Physician Decision|0|||
42009820|NCT01226043|75817062|FG001|6-week Re-randomization Phase|Physician Decision|0|||
42009821|NCT01226043|75817063|FG002|6-week Re-randomization Phase|Physician Decision|3|||
42009822|NCT01226043|75817064|FG003|6-week Re-randomization Phase|Physician Decision|2|||
42009823|NCT01226043|75817061|FG000|6-week Re-randomization Phase|completed in error|0|||
42009824|NCT01226043|75817062|FG001|6-week Re-randomization Phase|completed in error|0|||
42009825|NCT01226043|75817063|FG002|6-week Re-randomization Phase|completed in error|0|||
42009826|NCT01226043|75817064|FG003|6-week Re-randomization Phase|completed in error|1|||
42009827|NCT01226043|75817061|FG000|30-week Observational Phase|Adverse Event|0|||
42009828|NCT01226043|75817062|FG001|30-week Observational Phase|Adverse Event|0|||
42009829|NCT01226043|75817063|FG002|30-week Observational Phase|Adverse Event|1|||
42009830|NCT01226043|75817064|FG003|30-week Observational Phase|Adverse Event|1|||
42009831|NCT01226043|75817061|FG000|30-week Observational Phase|Protocol Violation|0|||
42009832|NCT01226043|75817062|FG001|30-week Observational Phase|Protocol Violation|0|||
42009833|NCT01226043|75817063|FG002|30-week Observational Phase|Protocol Violation|0|||
42009834|NCT01226043|75817064|FG003|30-week Observational Phase|Protocol Violation|1|||
42009835|NCT01226043|75817061|FG000|30-week Observational Phase|Lost to Follow-up|0|||
42009836|NCT01226043|75817062|FG001|30-week Observational Phase|Lost to Follow-up|0|||
42009837|NCT01226043|75817063|FG002|30-week Observational Phase|Lost to Follow-up|2|||
42009838|NCT01226043|75817064|FG003|30-week Observational Phase|Lost to Follow-up|2|||
42346858|NCT01858376|76185859|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
42346859|NCT01831856|76185865|FG000|Overall Study|Adverse Event|5|||
42346860|NCT01831856|76185866|FG001|Overall Study|Adverse Event|8|||
42346861|NCT01831856|76185865|FG000|Overall Study|Lack of Efficacy|13|||
42346862|NCT01831856|76185866|FG001|Overall Study|Lack of Efficacy|11|||
42346863|NCT01831856|76185865|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
42346864|NCT01831856|76185866|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
42346865|NCT01831544|76185872|FG000|Overall Study|Death|1|||
42346866|NCT01831544|76185872|FG000|Overall Study|Still on original MVAD device|2|||
42272445|NCT02522624|76102657|FG000|Overall Study|Technical failure|1|||
42272446|NCT02522624|76102658|FG001|Overall Study|Technical failure|0|||
42346867|NCT01857206|76185878|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
42346868|NCT01857206|76185879|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
42346869|NCT01857206|76185878|FG000|Overall Study|Lost to Follow-up|9|||
42346870|NCT01857206|76185879|FG001|Overall Study|Lost to Follow-up|6|||
42346871|NCT01857206|76185878|FG000|Overall Study|Unclassified|3|||
42346872|NCT01857206|76185879|FG001|Overall Study|Unclassified|3|||
42009839|NCT01226043|75817061|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
42009840|NCT01226043|75817062|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
42009841|NCT01226043|75817063|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
42009842|NCT01226043|75817064|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
42009843|NCT01226043|75817061|FG000|30-week Observational Phase|Physician Decision|0|||
42009844|NCT01226043|75817062|FG001|30-week Observational Phase|Physician Decision|0|||
42009845|NCT01226043|75817063|FG002|30-week Observational Phase|Physician Decision|2|||
42009846|NCT01226043|75817064|FG003|30-week Observational Phase|Physician Decision|2|||
42009847|NCT01001377|75817096|FG000|Overall Study|Ineligibility determined|2|||
42009848|NCT01001377|75817097|FG001|Overall Study|Ineligibility determined|0|||
42009849|NCT01001377|75817096|FG000|Overall Study|Withdrawal by Subject|19|||
42009850|NCT01001377|75817097|FG001|Overall Study|Withdrawal by Subject|20|||
42009851|NCT01001377|75817096|FG000|Overall Study|Lost to Follow-up|14|||
42009852|NCT01001377|75817097|FG001|Overall Study|Lost to Follow-up|17|||
42009853|NCT01001377|75817096|FG000|Overall Study|Death|391|||
42009854|NCT01001377|75817097|FG001|Overall Study|Death|384|||
42009855|NCT01225887|75817103|FG000|Overall Study|Ineligible:required test not done|2|||
42009856|NCT01225887|75817103|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
42009857|NCT01225887|75817103|FG000|Overall Study|Ineligible:inadequate pathology|2|||
42137724|NCT00337077|75948022|FG001|Overall Study|Withdrawal by Subject|2|||
42137725|NCT00337077|75948023|FG002|Overall Study|Withdrawal by Subject|2|||
42272447|NCT02287402|76102664|FG000|Treatment Period|Adverse Event|17|||
42272448|NCT02287402|76102664|FG000|Treatment Period|Voluntary Withdrawal|10|||
42272449|NCT02287402|76102664|FG000|Follow-up|Lost to Follow-up|1|||
42272450|NCT02287402|76102664|FG000|Follow-up|Voluntary Withdrawal|2|||
42272451|NCT02314780|76102671|FG000|Overall Study|organizational reasons|0|||
42272452|NCT02314780|76102672|FG001|Overall Study|organizational reasons|2|||
42272453|NCT02314780|76102673|FG002|Overall Study|organizational reasons|0|||
42272454|NCT02314780|76102671|FG000|Overall Study|Adverse Event|0|||
42272455|NCT02314780|76102672|FG001|Overall Study|Adverse Event|1|||
42272456|NCT02314780|76102673|FG002|Overall Study|Adverse Event|0|||
42346873|NCT01857206|76185878|FG000|Overall Study|Withdrawal by Subject|1|||
42346874|NCT01857206|76185879|FG001|Overall Study|Withdrawal by Subject|0|||
42346875|NCT01882088|76185889|FG000|Overall Study|Intolerance of esophageal manometry|1|||
42346876|NCT01882088|76185889|FG000|Overall Study|no possibility to place the catheter|1|||
42346877|NCT01882088|76185889|FG000|Overall Study|Protocol Violation|1|||
42346878|NCT01882088|76185889|FG000|Overall Study|inadequate pH-impedance tracings|2|||
42346879|NCT01881776|76185896|FG000|Overall Study|Lost to Follow-up|1|||
42346880|NCT01881776|76185897|FG001|Overall Study|Lost to Follow-up|2|||
42346881|NCT01881776|76185898|FG002|Overall Study|Lost to Follow-up|1|||
42346882|NCT01881776|76185896|FG000|Overall Study|Protocol Violation|0|||
42346883|NCT01881776|76185897|FG001|Overall Study|Protocol Violation|2|||
42346884|NCT01881776|76185898|FG002|Overall Study|Protocol Violation|1|||
42346885|NCT01708161|76185912|FG000|Overall Study|Adverse Event|1|||
42346886|NCT01708161|76185913|FG001|Overall Study|Adverse Event|3|||
42346887|NCT01708161|76185914|FG002|Overall Study|Adverse Event|4|||
42009858|NCT01001299|75817107|FG000|Overall Study|Insufficient Therapeutic Response|20|||
42035723|NCT01096667|75844188|FG002|Overall Study|Protocol Violation|0|||
42346888|NCT01708161|76185915|FG003|Overall Study|Adverse Event|2|||
42009859|NCT01001299|75817107|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
42009860|NCT01001299|75817107|FG000|Overall Study|Death|1|||
42009861|NCT01001299|75817107|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
42009862|NCT01001299|75817107|FG000|Overall Study|Withdrew Consent|1|||
42009863|NCT01296932|75817120|FG000|Overall Study|Dose limiting toxicity|0|||
42009864|NCT01296932|75817121|FG001|Overall Study|Dose limiting toxicity|0|||
42009865|NCT01296932|75817122|FG002|Overall Study|Dose limiting toxicity|0|||
42009866|NCT01296932|75817123|FG003|Overall Study|Dose limiting toxicity|0|||
42009867|NCT01296932|75817124|FG004|Overall Study|Dose limiting toxicity|0|||
42009868|NCT01296932|75817125|FG005|Overall Study|Dose limiting toxicity|0|||
42009869|NCT01296932|75817126|FG006|Overall Study|Dose limiting toxicity|1|||
42009870|NCT01296932|75817127|FG007|Overall Study|Dose limiting toxicity|0|||
42009871|NCT01296932|75817128|FG008|Overall Study|Dose limiting toxicity|1|||
42009872|NCT01296932|75817120|FG000|Overall Study|Progressive disease|2|||
42009873|NCT01296932|75817121|FG001|Overall Study|Progressive disease|0|||
42009874|NCT01296932|75817122|FG002|Overall Study|Progressive disease|1|||
42009875|NCT01296932|75817123|FG003|Overall Study|Progressive disease|1|||
42009876|NCT01296932|75817124|FG004|Overall Study|Progressive disease|2|||
42009877|NCT01296932|75817125|FG005|Overall Study|Progressive disease|3|||
42009878|NCT01296932|75817126|FG006|Overall Study|Progressive disease|1|||
42009879|NCT01296932|75817127|FG007|Overall Study|Progressive disease|0|||
42009880|NCT01296932|75817128|FG008|Overall Study|Progressive disease|0|||
42009881|NCT01296932|75817120|FG000|Overall Study|Withdrawal by Subject|0|||
42009882|NCT01296932|75817121|FG001|Overall Study|Withdrawal by Subject|0|||
42009883|NCT01296932|75817122|FG002|Overall Study|Withdrawal by Subject|1|||
42009884|NCT01296932|75817123|FG003|Overall Study|Withdrawal by Subject|1|||
42009885|NCT01296932|75817124|FG004|Overall Study|Withdrawal by Subject|0|||
42009886|NCT01296932|75817125|FG005|Overall Study|Withdrawal by Subject|0|||
42009887|NCT01296932|75817126|FG006|Overall Study|Withdrawal by Subject|3|||
42009888|NCT01296932|75817127|FG007|Overall Study|Withdrawal by Subject|0|||
42009889|NCT01296932|75817128|FG008|Overall Study|Withdrawal by Subject|0|||
42009890|NCT01296932|75817120|FG000|Overall Study|Adverse Event|1|||
42272457|NCT02288182|76102683|FG000|Overall Study|Adverse Event|0|||
42272458|NCT02288182|76102684|FG001|Overall Study|Adverse Event|1|||
42272459|NCT02288182|76102683|FG000|Overall Study|Lost to Follow-up|0|||
42272460|NCT02288182|76102684|FG001|Overall Study|Lost to Follow-up|1|||
42009891|NCT01296932|75817121|FG001|Overall Study|Adverse Event|1|||
42009892|NCT01296932|75817122|FG002|Overall Study|Adverse Event|1|||
42009893|NCT01296932|75817123|FG003|Overall Study|Adverse Event|2|||
42009894|NCT01296932|75817124|FG004|Overall Study|Adverse Event|1|||
42009895|NCT01296932|75817125|FG005|Overall Study|Adverse Event|0|||
42009896|NCT01296932|75817126|FG006|Overall Study|Adverse Event|0|||
42009897|NCT01296932|75817127|FG007|Overall Study|Adverse Event|0|||
42009898|NCT01296932|75817128|FG008|Overall Study|Adverse Event|1|||
42009899|NCT01296932|75817120|FG000|Overall Study|Investigator decision|0|||
42009900|NCT01296932|75817121|FG001|Overall Study|Investigator decision|1|||
42009901|NCT01296932|75817122|FG002|Overall Study|Investigator decision|0|||
42009902|NCT01296932|75817123|FG003|Overall Study|Investigator decision|1|||
42009903|NCT01296932|75817124|FG004|Overall Study|Investigator decision|0|||
42009904|NCT01296932|75817125|FG005|Overall Study|Investigator decision|0|||
42009905|NCT01296932|75817126|FG006|Overall Study|Investigator decision|1|||
42009906|NCT01296932|75817127|FG007|Overall Study|Investigator decision|0|||
42009907|NCT01296932|75817128|FG008|Overall Study|Investigator decision|1|||
42009908|NCT01296932|75817120|FG000|Overall Study|No clinical benefit anymore|0|||
42009909|NCT01296932|75817121|FG001|Overall Study|No clinical benefit anymore|1|||
42009910|NCT01296932|75817122|FG002|Overall Study|No clinical benefit anymore|0|||
42009911|NCT01296932|75817123|FG003|Overall Study|No clinical benefit anymore|0|||
42009912|NCT01296932|75817124|FG004|Overall Study|No clinical benefit anymore|0|||
42009913|NCT01296932|75817125|FG005|Overall Study|No clinical benefit anymore|0|||
42009914|NCT01296932|75817126|FG006|Overall Study|No clinical benefit anymore|0|||
42009915|NCT01296932|75817127|FG007|Overall Study|No clinical benefit anymore|0|||
42009916|NCT01296932|75817128|FG008|Overall Study|No clinical benefit anymore|0|||
42009917|NCT01296932|75817120|FG000|Overall Study|Physician Decision|0|||
42009918|NCT01296932|75817121|FG001|Overall Study|Physician Decision|0|||
42009919|NCT01296932|75817122|FG002|Overall Study|Physician Decision|1|||
42009920|NCT01296932|75817123|FG003|Overall Study|Physician Decision|0|||
42009921|NCT01296932|75817124|FG004|Overall Study|Physician Decision|0|||
42009922|NCT01296932|75817125|FG005|Overall Study|Physician Decision|0|||
42009923|NCT01296932|75817126|FG006|Overall Study|Physician Decision|0|||
42009924|NCT01296932|75817127|FG007|Overall Study|Physician Decision|0|||
42009925|NCT01296932|75817128|FG008|Overall Study|Physician Decision|0|||
42272461|NCT02286466|76102694|FG000|Overall Study|Death|1|||
42009926|NCT01296932|75817120|FG000|Overall Study|IV problems, administration not possible|0|||
42009927|NCT01296932|75817121|FG001|Overall Study|IV problems, administration not possible|0|||
42009928|NCT01296932|75817122|FG002|Overall Study|IV problems, administration not possible|1|||
42009929|NCT01296932|75817123|FG003|Overall Study|IV problems, administration not possible|0|||
42035724|NCT01096667|75844189|FG003|Overall Study|Protocol Violation|1|||
42009930|NCT01296932|75817124|FG004|Overall Study|IV problems, administration not possible|0|||
42009931|NCT01296932|75817125|FG005|Overall Study|IV problems, administration not possible|0|||
42009932|NCT01296932|75817126|FG006|Overall Study|IV problems, administration not possible|0|||
42009933|NCT01296932|75817127|FG007|Overall Study|IV problems, administration not possible|0|||
42009934|NCT01296932|75817128|FG008|Overall Study|IV problems, administration not possible|0|||
42009935|NCT01296932|75817120|FG000|Overall Study|per protocol|0|||
42009936|NCT01296932|75817121|FG001|Overall Study|per protocol|0|||
42009937|NCT01296932|75817122|FG002|Overall Study|per protocol|1|||
42009938|NCT01296932|75817123|FG003|Overall Study|per protocol|1|||
42009939|NCT01296932|75817124|FG004|Overall Study|per protocol|0|||
42009940|NCT01296932|75817125|FG005|Overall Study|per protocol|0|||
42009941|NCT01296932|75817126|FG006|Overall Study|per protocol|0|||
42009942|NCT01296932|75817127|FG007|Overall Study|per protocol|0|||
42009943|NCT01296932|75817128|FG008|Overall Study|per protocol|0|||
42009944|NCT01296932|75817120|FG000|Overall Study|Low benefit and too many side effects|0|||
42009945|NCT01296932|75817121|FG001|Overall Study|Low benefit and too many side effects|0|||
42009946|NCT01296932|75817122|FG002|Overall Study|Low benefit and too many side effects|0|||
42009947|NCT01296932|75817123|FG003|Overall Study|Low benefit and too many side effects|0|||
42009948|NCT01296932|75817124|FG004|Overall Study|Low benefit and too many side effects|0|||
42009949|NCT01296932|75817125|FG005|Overall Study|Low benefit and too many side effects|0|||
42009950|NCT01296932|75817126|FG006|Overall Study|Low benefit and too many side effects|0|||
42009951|NCT01296932|75817127|FG007|Overall Study|Low benefit and too many side effects|1|||
42009952|NCT01296932|75817128|FG008|Overall Study|Low benefit and too many side effects|0|||
42009953|NCT01296932|75817120|FG000|Overall Study|No adequate treatment response|0|||
42009954|NCT01296932|75817121|FG001|Overall Study|No adequate treatment response|0|||
42009955|NCT01296932|75817122|FG002|Overall Study|No adequate treatment response|0|||
42009956|NCT01296932|75817123|FG003|Overall Study|No adequate treatment response|0|||
42009957|NCT01296932|75817124|FG004|Overall Study|No adequate treatment response|0|||
42009958|NCT01296932|75817125|FG005|Overall Study|No adequate treatment response|0|||
42009959|NCT01296932|75817126|FG006|Overall Study|No adequate treatment response|0|||
42009960|NCT01296932|75817127|FG007|Overall Study|No adequate treatment response|1|||
42009961|NCT01296932|75817128|FG008|Overall Study|No adequate treatment response|0|||
42009962|NCT01296932|75817120|FG000|Overall Study|Dosage already reduced, AE still present|0|||
42009963|NCT01296932|75817121|FG001|Overall Study|Dosage already reduced, AE still present|0|||
42009964|NCT01296932|75817122|FG002|Overall Study|Dosage already reduced, AE still present|0|||
42009965|NCT01296932|75817123|FG003|Overall Study|Dosage already reduced, AE still present|0|||
42009966|NCT01296932|75817124|FG004|Overall Study|Dosage already reduced, AE still present|0|||
42009967|NCT01296932|75817125|FG005|Overall Study|Dosage already reduced, AE still present|0|||
42009968|NCT01296932|75817126|FG006|Overall Study|Dosage already reduced, AE still present|0|||
42009969|NCT01296932|75817127|FG007|Overall Study|Dosage already reduced, AE still present|0|||
42009970|NCT01296932|75817128|FG008|Overall Study|Dosage already reduced, AE still present|1|||
42009971|NCT01296698|75817151|FG000|Overall Study|Adverse Event|1|||
42009972|NCT01296698|75817152|FG001|Overall Study|Adverse Event|0|||
42009973|NCT01296698|75817151|FG000|Overall Study|Death|1|||
42009974|NCT01296698|75817152|FG001|Overall Study|Death|0|||
42009975|NCT01296698|75817151|FG000|Overall Study|Lost to Follow-up|19|||
42009976|NCT01296698|75817152|FG001|Overall Study|Lost to Follow-up|1|||
42009977|NCT01296698|75817151|FG000|Overall Study|Withdrawal by Subject|12|||
42009978|NCT01296698|75817152|FG001|Overall Study|Withdrawal by Subject|0|||
42009979|NCT01296698|75817151|FG000|Overall Study|Difficulty Contacting Subject|2|||
42009980|NCT01296698|75817152|FG001|Overall Study|Difficulty Contacting Subject|0|||
42009981|NCT01296698|75817151|FG000|Overall Study|Study Terminated by Sponsor|209|||
42009982|NCT01296698|75817152|FG001|Overall Study|Study Terminated by Sponsor|12|||
42009983|NCT01001221|75817162|FG000|Overall Study|Adverse Event|1|||
42009984|NCT01001221|75817163|FG001|Overall Study|Adverse Event|2|||
42009985|NCT01001221|75817164|FG002|Overall Study|Adverse Event|0|||
42009986|NCT01001221|75817165|FG003|Overall Study|Adverse Event|2|||
42009987|NCT01001221|75817166|FG004|Overall Study|Adverse Event|0|||
42009988|NCT01001221|75817162|FG000|Overall Study|Disease progression|3|||
42009989|NCT01001221|75817163|FG001|Overall Study|Disease progression|2|||
42009990|NCT01001221|75817164|FG002|Overall Study|Disease progression|2|||
42009991|NCT01001221|75817165|FG003|Overall Study|Disease progression|4|||
42009992|NCT01001221|75817166|FG004|Overall Study|Disease progression|0|||
42009993|NCT01001221|75817162|FG000|Overall Study|Other|1|||
42009994|NCT01001221|75817163|FG001|Overall Study|Other|1|||
42009995|NCT01001221|75817164|FG002|Overall Study|Other|0|||
42009996|NCT01001221|75817165|FG003|Overall Study|Other|0|||
42009997|NCT01001221|75817166|FG004|Overall Study|Other|0|||
42009998|NCT01001221|75817162|FG000|Overall Study|Not treated; protocol exclusion|0|||
42009999|NCT01001221|75817163|FG001|Overall Study|Not treated; protocol exclusion|0|||
42010000|NCT01001221|75817164|FG002|Overall Study|Not treated; protocol exclusion|1|||
42010001|NCT01001221|75817165|FG003|Overall Study|Not treated; protocol exclusion|0|||
42010002|NCT01001221|75817166|FG004|Overall Study|Not treated; protocol exclusion|0|||
42010003|NCT01296152|75817177|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
42010004|NCT01002547|75817184|FG000|Overall Study|Withdrawal by Subject|4|||
42010005|NCT01002547|75817185|FG001|Overall Study|Withdrawal by Subject|0|||
42010006|NCT01002547|75817186|FG002|Overall Study|Withdrawal by Subject|5|||
42010007|NCT01002547|75817184|FG000|Overall Study|Lost to Follow-up|2|||
42010008|NCT01002547|75817185|FG001|Overall Study|Lost to Follow-up|1|||
42010009|NCT01002547|75817186|FG002|Overall Study|Lost to Follow-up|1|||
42010010|NCT01002547|75817184|FG000|Overall Study|Physician Decision|1|||
42010011|NCT01002547|75817185|FG001|Overall Study|Physician Decision|0|||
42010012|NCT01002547|75817186|FG002|Overall Study|Physician Decision|0|||
42010013|NCT01002547|75817184|FG000|Overall Study|Death|0|||
42010014|NCT01002547|75817185|FG001|Overall Study|Death|2|||
42010015|NCT01002547|75817186|FG002|Overall Study|Death|2|||
42010016|NCT01002547|75817184|FG000|Overall Study|Adverse Event|1|||
42010017|NCT01002547|75817185|FG001|Overall Study|Adverse Event|0|||
42010018|NCT01002547|75817186|FG002|Overall Study|Adverse Event|0|||
42010019|NCT01225731|75817199|FG000|Part 1|Did not meet eligibility criteria|1|||
42010020|NCT01225731|75817200|FG001|Part 1|Did not meet eligibility criteria|0|||
42010021|NCT01225731|75817201|FG002|Part 1|Did not meet eligibility criteria|0|||
42010022|NCT01225731|75817202|FG003|Part 1|Did not meet eligibility criteria|0|||
42010023|NCT01225731|75817203|FG004|Part 1|Did not meet eligibility criteria|1|||
42010024|NCT01225731|75817204|FG005|Part 1|Did not meet eligibility criteria|0|||
42010025|NCT01225731|75817205|FG006|Part 1|Did not meet eligibility criteria|0|||
42010026|NCT01225731|75817206|FG007|Part 1|Did not meet eligibility criteria|0|||
42010027|NCT01225731|75817207|FG008|Part 1|Did not meet eligibility criteria|0|||
42010028|NCT01225731|75817208|FG009|Part 1|Did not meet eligibility criteria|0|||
42010029|NCT01225731|75817209|FG010|Part 1|Did not meet eligibility criteria|0|||
42010030|NCT01225731|75817210|FG011|Part 1|Did not meet eligibility criteria|0|||
42010031|NCT01225731|75817211|FG012|Part 1|Did not meet eligibility criteria|0|||
42010032|NCT01225731|75817199|FG000|Part 1|Adverse Event|1|||
42010033|NCT01225731|75817200|FG001|Part 1|Adverse Event|2|||
42010034|NCT01225731|75817201|FG002|Part 1|Adverse Event|1|||
42010035|NCT01225731|75817202|FG003|Part 1|Adverse Event|1|||
42010036|NCT01225731|75817203|FG004|Part 1|Adverse Event|1|||
42010037|NCT01225731|75817204|FG005|Part 1|Adverse Event|0|||
42010038|NCT01225731|75817205|FG006|Part 1|Adverse Event|0|||
42010039|NCT01225731|75817206|FG007|Part 1|Adverse Event|0|||
42010040|NCT01225731|75817207|FG008|Part 1|Adverse Event|0|||
42010041|NCT01225731|75817208|FG009|Part 1|Adverse Event|0|||
42010042|NCT01225731|75817209|FG010|Part 1|Adverse Event|0|||
42010043|NCT01225731|75817210|FG011|Part 1|Adverse Event|0|||
42010044|NCT01225731|75817211|FG012|Part 1|Adverse Event|0|||
42010045|NCT01225731|75817199|FG000|Part 1|Withdrawal by Subject|0|||
42010046|NCT01225731|75817200|FG001|Part 1|Withdrawal by Subject|3|||
42010047|NCT01225731|75817201|FG002|Part 1|Withdrawal by Subject|0|||
42272462|NCT02286466|76102695|FG001|Overall Study|Death|3|||
42272463|NCT02286466|76102694|FG000|Overall Study|Withdrawal by Subject|5|||
42272464|NCT02286466|76102695|FG001|Overall Study|Withdrawal by Subject|2|||
42272465|NCT02286466|76102694|FG000|Overall Study|Lost to Follow-up|1|||
42272466|NCT02286466|76102695|FG001|Overall Study|Lost to Follow-up|4|||
42272467|NCT02286466|76102694|FG000|Overall Study|Declined Clinician Assessment|0|||
42272468|NCT02286466|76102695|FG001|Overall Study|Declined Clinician Assessment|1|||
42272469|NCT02313766|76102704|FG000|Overall Study|surgery cancelled|1|||
42272470|NCT02313766|76102705|FG001|Overall Study|surgery cancelled|0|||
42272471|NCT02313766|76102706|FG002|Overall Study|surgery cancelled|0|||
42272472|NCT02313766|76102704|FG000|Overall Study|Lost to Follow-up|0|||
42272473|NCT02313766|76102705|FG001|Overall Study|Lost to Follow-up|2|||
42272474|NCT02313766|76102706|FG002|Overall Study|Lost to Follow-up|0|||
42272475|NCT02313766|76102704|FG000|Overall Study|Adverse Event|0|||
42272476|NCT02313766|76102705|FG001|Overall Study|Adverse Event|1|||
42272477|NCT02313766|76102706|FG002|Overall Study|Adverse Event|0|||
42272478|NCT01646398|76102716|FG000|Overall Study|Withdrawal by Subject|1|||
42272479|NCT01646398|76102717|FG001|Overall Study|Withdrawal by Subject|0|||
42272480|NCT01646320|76102725|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
42272481|NCT01646320|76102726|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
42272482|NCT01646320|76102725|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
42272483|NCT01646320|76102726|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
42010048|NCT01225731|75817202|FG003|Part 1|Withdrawal by Subject|0|||
42010049|NCT01225731|75817203|FG004|Part 1|Withdrawal by Subject|4|||
42010050|NCT01225731|75817204|FG005|Part 1|Withdrawal by Subject|0|||
42010051|NCT01225731|75817205|FG006|Part 1|Withdrawal by Subject|0|||
42010052|NCT01225731|75817206|FG007|Part 1|Withdrawal by Subject|0|||
42010053|NCT01225731|75817207|FG008|Part 1|Withdrawal by Subject|0|||
42010054|NCT01225731|75817208|FG009|Part 1|Withdrawal by Subject|0|||
42010055|NCT01225731|75817209|FG010|Part 1|Withdrawal by Subject|0|||
42010056|NCT01225731|75817210|FG011|Part 1|Withdrawal by Subject|0|||
42272484|NCT01646320|76102725|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
42272485|NCT01646320|76102726|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
42272486|NCT01646320|76102725|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
42272487|NCT01646320|76102726|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
42272488|NCT01646320|76102725|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
42272489|NCT01646320|76102726|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
42272490|NCT01646320|76102725|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
42272491|NCT01646320|76102726|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
42272492|NCT01646320|76102725|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
42272493|NCT01646320|76102726|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
42272494|NCT01646320|76102725|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
42010057|NCT01225731|75817211|FG012|Part 1|Withdrawal by Subject|0|||
42010058|NCT01225731|75817199|FG000|Part 1|Protocol Violation|0|||
42010059|NCT01225731|75817200|FG001|Part 1|Protocol Violation|0|||
42010060|NCT01225731|75817201|FG002|Part 1|Protocol Violation|0|||
42010061|NCT01225731|75817202|FG003|Part 1|Protocol Violation|1|||
42010062|NCT01225731|75817203|FG004|Part 1|Protocol Violation|0|||
42010063|NCT01225731|75817204|FG005|Part 1|Protocol Violation|0|||
42010064|NCT01225731|75817205|FG006|Part 1|Protocol Violation|0|||
42010065|NCT01225731|75817206|FG007|Part 1|Protocol Violation|0|||
42010066|NCT01225731|75817207|FG008|Part 1|Protocol Violation|0|||
42010067|NCT01225731|75817208|FG009|Part 1|Protocol Violation|0|||
42010068|NCT01225731|75817209|FG010|Part 1|Protocol Violation|0|||
42010069|NCT01225731|75817210|FG011|Part 1|Protocol Violation|0|||
42010070|NCT01225731|75817211|FG012|Part 1|Protocol Violation|0|||
42010071|NCT01225731|75817199|FG000|Part 2|Protocol Violation|0|||
42010072|NCT01225731|75817200|FG001|Part 2|Protocol Violation|0|||
42010073|NCT01225731|75817201|FG002|Part 2|Protocol Violation|0|||
42010074|NCT01225731|75817202|FG003|Part 2|Protocol Violation|0|||
42010075|NCT01225731|75817203|FG004|Part 2|Protocol Violation|0|||
42010076|NCT01225731|75817204|FG005|Part 2|Protocol Violation|1|||
42010077|NCT01225731|75817205|FG006|Part 2|Protocol Violation|0|||
42010078|NCT01225731|75817206|FG007|Part 2|Protocol Violation|0|||
42010079|NCT01225731|75817207|FG008|Part 2|Protocol Violation|1|||
42010080|NCT01225731|75817208|FG009|Part 2|Protocol Violation|0|||
42010081|NCT01225731|75817209|FG010|Part 2|Protocol Violation|0|||
42010082|NCT01225731|75817210|FG011|Part 2|Protocol Violation|0|||
42010083|NCT01225731|75817211|FG012|Part 2|Protocol Violation|0|||
42010084|NCT01225731|75817199|FG000|Part 2|Adverse Event|0|||
42010085|NCT01225731|75817200|FG001|Part 2|Adverse Event|0|||
42010086|NCT01225731|75817201|FG002|Part 2|Adverse Event|0|||
42010087|NCT01225731|75817202|FG003|Part 2|Adverse Event|0|||
42010088|NCT01225731|75817203|FG004|Part 2|Adverse Event|0|||
42010089|NCT01225731|75817204|FG005|Part 2|Adverse Event|0|||
42010090|NCT01225731|75817205|FG006|Part 2|Adverse Event|4|||
42010091|NCT01225731|75817206|FG007|Part 2|Adverse Event|4|||
42035725|NCT01096667|75844190|FG004|Overall Study|Protocol Violation|0|||
42035726|NCT01096667|75844186|FG000|Overall Study|Not treated|1|||
42035727|NCT01096667|75844187|FG001|Overall Study|Not treated|0|||
42035728|NCT01096667|75844188|FG002|Overall Study|Not treated|0|||
42035729|NCT01096667|75844189|FG003|Overall Study|Not treated|0|||
42035730|NCT01096667|75844190|FG004|Overall Study|Not treated|0|||
42035731|NCT01014624|75844205|FG000|Overall Study|Adverse Event|0|||
42035732|NCT01014624|75844206|FG001|Overall Study|Adverse Event|1|||
42035733|NCT01014624|75844205|FG000|Overall Study|Protocol Violation|1|||
42035734|NCT01014624|75844206|FG001|Overall Study|Protocol Violation|0|||
42035735|NCT01014624|75844205|FG000|Overall Study|Withdrawal by Subject|1|||
42035736|NCT01014624|75844206|FG001|Overall Study|Withdrawal by Subject|0|||
42035737|NCT01021878|75844216|FG000|Overall Study|Lost to Follow-up|4|||
42035738|NCT01021878|75844217|FG001|Overall Study|Lost to Follow-up|3|||
42035739|NCT01021878|75844216|FG000|Overall Study|Death|0|||
42272495|NCT01646320|76102726|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
42272496|NCT01646320|76102725|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
42346889|NCT01708161|76185916|FG004|Overall Study|Adverse Event|3|||
42010092|NCT01225731|75817207|FG008|Part 2|Adverse Event|2|||
42010093|NCT01225731|75817208|FG009|Part 2|Adverse Event|0|||
42010094|NCT01225731|75817209|FG010|Part 2|Adverse Event|0|||
42010095|NCT01225731|75817210|FG011|Part 2|Adverse Event|0|||
42010096|NCT01225731|75817211|FG012|Part 2|Adverse Event|0|||
42010097|NCT01225731|75817199|FG000|Part 2|Lack of Efficacy|0|||
42010098|NCT01225731|75817200|FG001|Part 2|Lack of Efficacy|0|||
42010099|NCT01225731|75817201|FG002|Part 2|Lack of Efficacy|0|||
42035740|NCT01021878|75844217|FG001|Overall Study|Death|1|||
42035741|NCT01021878|75844216|FG000|Overall Study|Adverse Event|6|||
42035742|NCT01021878|75844217|FG001|Overall Study|Adverse Event|5|||
42035743|NCT01021878|75844216|FG000|Overall Study|Transplantation|6|||
42010100|NCT01225731|75817202|FG003|Part 2|Lack of Efficacy|0|||
42010101|NCT01225731|75817203|FG004|Part 2|Lack of Efficacy|0|||
42010102|NCT01225731|75817204|FG005|Part 2|Lack of Efficacy|1|||
42010103|NCT01225731|75817205|FG006|Part 2|Lack of Efficacy|0|||
42010104|NCT01225731|75817206|FG007|Part 2|Lack of Efficacy|12|||
42010105|NCT01225731|75817207|FG008|Part 2|Lack of Efficacy|3|||
42010106|NCT01225731|75817208|FG009|Part 2|Lack of Efficacy|0|||
42010107|NCT01225731|75817209|FG010|Part 2|Lack of Efficacy|0|||
42010108|NCT01225731|75817210|FG011|Part 2|Lack of Efficacy|0|||
42010109|NCT01225731|75817211|FG012|Part 2|Lack of Efficacy|0|||
42010110|NCT01225731|75817199|FG000|Part 2|Pregnancy|0|||
42010111|NCT01225731|75817200|FG001|Part 2|Pregnancy|0|||
42010112|NCT01225731|75817201|FG002|Part 2|Pregnancy|0|||
42010113|NCT01225731|75817202|FG003|Part 2|Pregnancy|0|||
42010114|NCT01225731|75817203|FG004|Part 2|Pregnancy|0|||
42010115|NCT01225731|75817204|FG005|Part 2|Pregnancy|0|||
42010116|NCT01225731|75817205|FG006|Part 2|Pregnancy|1|||
42035744|NCT01021878|75844217|FG001|Overall Study|Transplantation|1|||
42035745|NCT00854113|75844237|FG000|Overall Study|Adverse Event|0|||
42035746|NCT00854113|75844238|FG001|Overall Study|Adverse Event|0|||
42010117|NCT01225731|75817206|FG007|Part 2|Pregnancy|0|||
42010118|NCT01225731|75817207|FG008|Part 2|Pregnancy|1|||
42035747|NCT00854113|75844239|FG002|Overall Study|Adverse Event|0|||
42035748|NCT00854113|75844240|FG003|Overall Study|Adverse Event|0|||
42035749|NCT00854113|75844241|FG004|Overall Study|Adverse Event|0|||
42035750|NCT00854113|75844242|FG005|Overall Study|Adverse Event|0|||
42035751|NCT00854113|75844243|FG006|Overall Study|Adverse Event|0|||
42035752|NCT00854113|75844244|FG007|Overall Study|Adverse Event|2|||
42035753|NCT00854113|75844245|FG008|Overall Study|Adverse Event|0|||
42035754|NCT00854113|75844246|FG009|Overall Study|Adverse Event|0|||
42035755|NCT00854113|75844247|FG010|Overall Study|Adverse Event|0|||
42035756|NCT00854113|75844237|FG000|Overall Study|Withdrawal by Subject|0|||
42035757|NCT00854113|75844238|FG001|Overall Study|Withdrawal by Subject|0|||
42035758|NCT00854113|75844239|FG002|Overall Study|Withdrawal by Subject|0|||
42035759|NCT00854113|75844240|FG003|Overall Study|Withdrawal by Subject|0|||
42035760|NCT00854113|75844241|FG004|Overall Study|Withdrawal by Subject|0|||
42035761|NCT00854113|75844242|FG005|Overall Study|Withdrawal by Subject|0|||
42035762|NCT00854113|75844243|FG006|Overall Study|Withdrawal by Subject|0|||
42035763|NCT00854113|75844244|FG007|Overall Study|Withdrawal by Subject|1|||
42035764|NCT00854113|75844245|FG008|Overall Study|Withdrawal by Subject|1|||
42035765|NCT00854113|75844246|FG009|Overall Study|Withdrawal by Subject|0|||
42035766|NCT00854113|75844247|FG010|Overall Study|Withdrawal by Subject|0|||
42035767|NCT00845845|75844273|FG000|Overall Study|Lost to Follow-up|0|||
42035768|NCT00845845|75844274|FG001|Overall Study|Lost to Follow-up|4|||
42035769|NCT01104701|75844284|FG000|Overall Study|Withdrawal by Subject|0|||
42035770|NCT01104701|75844285|FG001|Overall Study|Withdrawal by Subject|1|||
42035771|NCT01104701|75844286|FG002|Overall Study|Withdrawal by Subject|2|||
42035772|NCT01104701|75844287|FG003|Overall Study|Withdrawal by Subject|1|||
42035773|NCT01104701|75844284|FG000|Overall Study|Adverse Event|0|||
42035774|NCT01104701|75844285|FG001|Overall Study|Adverse Event|0|||
42035775|NCT01104701|75844286|FG002|Overall Study|Adverse Event|0|||
42035776|NCT01104701|75844287|FG003|Overall Study|Adverse Event|1|||
42035777|NCT01104701|75844284|FG000|Overall Study|Physician Decision|0|||
42035778|NCT01104701|75844285|FG001|Overall Study|Physician Decision|2|||
42035779|NCT01104701|75844286|FG002|Overall Study|Physician Decision|0|||
42035780|NCT01104701|75844287|FG003|Overall Study|Physician Decision|0|||
42035781|NCT00833755|75844301|FG000|Overall Study|Physician Decision|4|||
42035782|NCT00833755|75844302|FG001|Overall Study|Physician Decision|4|||
42035783|NCT00833755|75844303|FG002|Overall Study|Physician Decision|2|||
42137726|NCT00337077|75948021|FG000|Overall Study|Alternative therapy|1|||
42272497|NCT01646320|76102726|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
42010119|NCT01225731|75817208|FG009|Part 2|Pregnancy|0|||
42010120|NCT01225731|75817209|FG010|Part 2|Pregnancy|0|||
42010121|NCT01225731|75817210|FG011|Part 2|Pregnancy|0|||
42010122|NCT01225731|75817211|FG012|Part 2|Pregnancy|0|||
42272498|NCT01646320|76102725|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
42272499|NCT01646320|76102726|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
42010123|NCT01225731|75817199|FG000|Part 2|Lost to Follow-up|0|||
42010124|NCT01225731|75817200|FG001|Part 2|Lost to Follow-up|0|||
42010125|NCT01225731|75817201|FG002|Part 2|Lost to Follow-up|0|||
42035784|NCT00833755|75844304|FG003|Overall Study|Physician Decision|6|||
42035785|NCT00833755|75844301|FG000|Overall Study|Subject had scheduling issues|0|||
42035786|NCT00833755|75844302|FG001|Overall Study|Subject had scheduling issues|1|||
42035787|NCT00833755|75844303|FG002|Overall Study|Subject had scheduling issues|0|||
42035788|NCT00833755|75844304|FG003|Overall Study|Subject had scheduling issues|0|||
42035789|NCT01021332|75844315|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
42035790|NCT01021332|75844315|FG000|Overall Study|Adverse Event|43|||
42035791|NCT01021332|75844315|FG000|Overall Study|Lack of Efficacy|19|||
42035792|NCT01021332|75844315|FG000|Overall Study|Withdrawal of Consent|23|||
42035793|NCT01021332|75844315|FG000|Overall Study|Lost to Follow-up|4|||
42035794|NCT01021332|75844315|FG000|Overall Study|Protocol Violation|9|||
42010126|NCT01225731|75817202|FG003|Part 2|Lost to Follow-up|0|||
42010127|NCT01225731|75817203|FG004|Part 2|Lost to Follow-up|0|||
42010128|NCT01225731|75817204|FG005|Part 2|Lost to Follow-up|0|||
42010129|NCT01225731|75817205|FG006|Part 2|Lost to Follow-up|0|||
42035795|NCT01021332|75844315|FG000|Overall Study|Miscellaneous|3|||
42035796|NCT00923091|75844329|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
42035797|NCT00923091|75844330|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
42035798|NCT00923091|75844331|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
42035799|NCT00923091|75844332|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
42035800|NCT00923091|75844333|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
42035801|NCT00923091|75844334|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
42035802|NCT00923091|75844335|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
42035803|NCT00923091|75844336|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
42035804|NCT00923091|75844337|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
42035805|NCT00923091|75844338|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
42035806|NCT00923091|75844339|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
42035807|NCT00923091|75844340|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
42035808|NCT00923091|75844341|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
42035809|NCT00923091|75844329|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
42035810|NCT00923091|75844330|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
42035811|NCT00923091|75844331|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
42035812|NCT00923091|75844332|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
42035813|NCT00923091|75844333|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
42035814|NCT00923091|75844334|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
42035815|NCT00923091|75844335|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
42035816|NCT00923091|75844336|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
42035817|NCT00923091|75844337|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
42035818|NCT00923091|75844338|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
42035819|NCT00923091|75844339|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
42035820|NCT00923091|75844340|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
42035821|NCT00923091|75844341|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
42035822|NCT00923091|75844329|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
42035823|NCT00923091|75844330|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
42035824|NCT00923091|75844331|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
42035825|NCT00923091|75844332|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
42035826|NCT00923091|75844333|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
42035827|NCT00923091|75844334|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
42035828|NCT00923091|75844335|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
42035829|NCT00923091|75844336|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
42035830|NCT00923091|75844337|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
42035831|NCT00923091|75844338|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
42035832|NCT00923091|75844339|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
42035833|NCT00923091|75844340|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
42035834|NCT00923091|75844341|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
42035835|NCT00923091|75844329|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035836|NCT00923091|75844330|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035837|NCT00923091|75844331|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035838|NCT00923091|75844332|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035839|NCT00923091|75844333|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035840|NCT00923091|75844334|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
42035841|NCT00923091|75844335|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035842|NCT00923091|75844336|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035843|NCT00923091|75844337|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035844|NCT00923091|75844338|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035845|NCT00923091|75844339|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035846|NCT00923091|75844340|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035847|NCT00923091|75844341|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
42035848|NCT00923091|75844329|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
42035849|NCT00923091|75844330|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
42035850|NCT00923091|75844331|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
42035851|NCT00923091|75844332|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
42035852|NCT00923091|75844333|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
42035853|NCT00923091|75844334|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
42272500|NCT01646320|76102725|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
42272501|NCT01646320|76102726|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
42272502|NCT02524730|76102732|FG000|Overall Study|Lost to Follow-up|5|||
42272503|NCT02524730|76102732|FG000|Overall Study|Withdrawal by Subject|18|||
42272504|NCT02524730|76102732|FG000|Overall Study|Death|10|||
42272505|NCT02524730|76102732|FG000|Overall Study|Adverse Event|8|||
42272506|NCT02524730|76102732|FG000|Overall Study|Protocol Violation|1|||
42346890|NCT01708161|76185917|FG005|Overall Study|Adverse Event|0|||
42035854|NCT00923091|75844335|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
42035855|NCT00923091|75844336|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
42035856|NCT00923091|75844337|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
42035857|NCT00923091|75844338|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
42035858|NCT00923091|75844339|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
42035859|NCT00923091|75844340|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
42035860|NCT00923091|75844341|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
42035861|NCT00923091|75844329|FG000|Period III (Single-Blind)|Adverse Event|5|||
42035862|NCT00923091|75844330|FG001|Period III (Single-Blind)|Adverse Event|0|||
42035863|NCT00923091|75844331|FG002|Period III (Single-Blind)|Adverse Event|0|||
42035864|NCT00923091|75844332|FG003|Period III (Single-Blind)|Adverse Event|0|||
42035865|NCT00923091|75844333|FG004|Period III (Single-Blind)|Adverse Event|0|||
42035866|NCT00923091|75844334|FG005|Period III (Single-Blind)|Adverse Event|0|||
42035867|NCT00923091|75844335|FG006|Period III (Single-Blind)|Adverse Event|0|||
42035868|NCT00923091|75844336|FG007|Period III (Single-Blind)|Adverse Event|0|||
42035869|NCT00923091|75844337|FG008|Period III (Single-Blind)|Adverse Event|0|||
42035870|NCT00923091|75844338|FG009|Period III (Single-Blind)|Adverse Event|0|||
42035871|NCT00923091|75844339|FG010|Period III (Single-Blind)|Adverse Event|0|||
42035872|NCT00923091|75844340|FG011|Period III (Single-Blind)|Adverse Event|0|||
42035873|NCT00923091|75844341|FG012|Period III (Single-Blind)|Adverse Event|0|||
42035874|NCT00923091|75844329|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
42035875|NCT00923091|75844330|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035876|NCT00923091|75844331|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035877|NCT00923091|75844332|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035878|NCT00923091|75844333|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035879|NCT00923091|75844334|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035880|NCT00923091|75844335|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035881|NCT00923091|75844336|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035882|NCT00923091|75844337|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035883|NCT00923091|75844338|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035884|NCT00923091|75844339|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035885|NCT00923091|75844340|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035886|NCT00923091|75844341|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
42035887|NCT00923091|75844329|FG000|Period III (Single-Blind)|Protocol Violation|3|||
42035888|NCT00923091|75844330|FG001|Period III (Single-Blind)|Protocol Violation|0|||
42035889|NCT00923091|75844331|FG002|Period III (Single-Blind)|Protocol Violation|0|||
42035890|NCT00923091|75844332|FG003|Period III (Single-Blind)|Protocol Violation|0|||
42035891|NCT00923091|75844333|FG004|Period III (Single-Blind)|Protocol Violation|0|||
42035892|NCT00923091|75844334|FG005|Period III (Single-Blind)|Protocol Violation|0|||
42035893|NCT00923091|75844335|FG006|Period III (Single-Blind)|Protocol Violation|0|||
42035894|NCT00923091|75844336|FG007|Period III (Single-Blind)|Protocol Violation|0|||
42035895|NCT00923091|75844337|FG008|Period III (Single-Blind)|Protocol Violation|0|||
42035896|NCT00923091|75844338|FG009|Period III (Single-Blind)|Protocol Violation|0|||
42035897|NCT00923091|75844339|FG010|Period III (Single-Blind)|Protocol Violation|0|||
42035898|NCT00923091|75844340|FG011|Period III (Single-Blind)|Protocol Violation|0|||
42035899|NCT00923091|75844341|FG012|Period III (Single-Blind)|Protocol Violation|0|||
42035900|NCT00923091|75844329|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
42035901|NCT00923091|75844330|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
42035902|NCT00923091|75844331|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
42035903|NCT00923091|75844332|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
42035904|NCT00923091|75844333|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
42035905|NCT00923091|75844334|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
42010130|NCT01225731|75817206|FG007|Part 2|Lost to Follow-up|3|||
42010131|NCT01225731|75817207|FG008|Part 2|Lost to Follow-up|1|||
42010132|NCT01225731|75817208|FG009|Part 2|Lost to Follow-up|0|||
42010133|NCT01225731|75817209|FG010|Part 2|Lost to Follow-up|0|||
42010134|NCT01225731|75817210|FG011|Part 2|Lost to Follow-up|0|||
42010135|NCT01225731|75817211|FG012|Part 2|Lost to Follow-up|0|||
42010136|NCT01225731|75817199|FG000|Part 2|Physician Decision|0|||
42010137|NCT01225731|75817200|FG001|Part 2|Physician Decision|0|||
42010138|NCT01225731|75817201|FG002|Part 2|Physician Decision|0|||
42010139|NCT01225731|75817202|FG003|Part 2|Physician Decision|0|||
42010140|NCT01225731|75817203|FG004|Part 2|Physician Decision|0|||
42010141|NCT01225731|75817204|FG005|Part 2|Physician Decision|0|||
42010142|NCT01225731|75817205|FG006|Part 2|Physician Decision|0|||
42035906|NCT00923091|75844335|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
42035907|NCT00923091|75844336|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
42035908|NCT00923091|75844337|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
42035909|NCT00923091|75844338|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
42035910|NCT00923091|75844339|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
42010143|NCT01225731|75817206|FG007|Part 2|Physician Decision|2|||
42010144|NCT01225731|75817207|FG008|Part 2|Physician Decision|2|||
42010145|NCT01225731|75817208|FG009|Part 2|Physician Decision|0|||
42010146|NCT01225731|75817209|FG010|Part 2|Physician Decision|0|||
42035911|NCT00923091|75844340|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
42035912|NCT00923091|75844341|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
42035913|NCT00923091|75844329|FG000|Period IV (Double-Blind)|Adverse Event|2|||
42035914|NCT00923091|75844330|FG001|Period IV (Double-Blind)|Adverse Event|0|||
42035915|NCT00923091|75844331|FG002|Period IV (Double-Blind)|Adverse Event|0|||
42035916|NCT00923091|75844332|FG003|Period IV (Double-Blind)|Adverse Event|0|||
42035917|NCT00923091|75844333|FG004|Period IV (Double-Blind)|Adverse Event|0|||
42035918|NCT00923091|75844334|FG005|Period IV (Double-Blind)|Adverse Event|0|||
42035919|NCT00923091|75844335|FG006|Period IV (Double-Blind)|Adverse Event|0|||
42035920|NCT00923091|75844336|FG007|Period IV (Double-Blind)|Adverse Event|0|||
42035921|NCT00923091|75844337|FG008|Period IV (Double-Blind)|Adverse Event|0|||
42035922|NCT00923091|75844338|FG009|Period IV (Double-Blind)|Adverse Event|0|||
42035923|NCT00923091|75844339|FG010|Period IV (Double-Blind)|Adverse Event|0|||
42035924|NCT00923091|75844340|FG011|Period IV (Double-Blind)|Adverse Event|0|||
42035925|NCT00923091|75844341|FG012|Period IV (Double-Blind)|Adverse Event|0|||
42035926|NCT00923091|75844329|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035927|NCT00923091|75844330|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
42035928|NCT00923091|75844331|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035929|NCT00923091|75844332|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035930|NCT00923091|75844333|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035931|NCT00923091|75844334|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035932|NCT00923091|75844335|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035933|NCT00923091|75844336|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035934|NCT00923091|75844337|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035935|NCT00923091|75844338|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035936|NCT00923091|75844339|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035937|NCT00923091|75844340|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035938|NCT00923091|75844341|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
42035939|NCT00923091|75844329|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
42035940|NCT00923091|75844330|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
42035941|NCT00923091|75844331|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
42035942|NCT00923091|75844332|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
42035943|NCT00923091|75844333|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
42035944|NCT00923091|75844334|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
42035945|NCT00923091|75844335|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
42035946|NCT00923091|75844336|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
42035947|NCT00923091|75844337|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
42035948|NCT00923091|75844338|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
42035949|NCT00923091|75844339|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
42035950|NCT00923091|75844340|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
42035951|NCT00923091|75844341|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
42035952|NCT00923091|75844329|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
42035953|NCT00923091|75844330|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
42035954|NCT00923091|75844331|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
42035955|NCT00923091|75844332|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
42346891|NCT01708161|76185912|FG000|Overall Study|Death|0|||
42010147|NCT01225731|75817210|FG011|Part 2|Physician Decision|0|||
42010148|NCT01225731|75817211|FG012|Part 2|Physician Decision|0|||
42010149|NCT01225731|75817199|FG000|Part 2|Withdrawal by Subject|0|||
42010150|NCT01225731|75817200|FG001|Part 2|Withdrawal by Subject|0|||
42010151|NCT01225731|75817201|FG002|Part 2|Withdrawal by Subject|0|||
42010152|NCT01225731|75817202|FG003|Part 2|Withdrawal by Subject|0|||
42010153|NCT01225731|75817203|FG004|Part 2|Withdrawal by Subject|0|||
42010154|NCT01225731|75817204|FG005|Part 2|Withdrawal by Subject|1|||
42010155|NCT01225731|75817205|FG006|Part 2|Withdrawal by Subject|3|||
42010156|NCT01225731|75817206|FG007|Part 2|Withdrawal by Subject|4|||
42010157|NCT01225731|75817207|FG008|Part 2|Withdrawal by Subject|1|||
42010158|NCT01225731|75817208|FG009|Part 2|Withdrawal by Subject|0|||
42010159|NCT01225731|75817209|FG010|Part 2|Withdrawal by Subject|0|||
42010160|NCT01225731|75817210|FG011|Part 2|Withdrawal by Subject|0|||
42010161|NCT01225731|75817211|FG012|Part 2|Withdrawal by Subject|0|||
42010162|NCT01225731|75817199|FG000|Part 3|Adverse Event|0|||
42010163|NCT01225731|75817200|FG001|Part 3|Adverse Event|0|||
42010164|NCT01225731|75817201|FG002|Part 3|Adverse Event|0|||
42035956|NCT00923091|75844333|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
42035957|NCT00923091|75844334|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
42035958|NCT00923091|75844335|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
42035959|NCT00923091|75844336|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
42035960|NCT00923091|75844337|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
42035961|NCT00923091|75844338|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
42035962|NCT00923091|75844339|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
42035963|NCT00923091|75844340|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
42010165|NCT01225731|75817202|FG003|Part 3|Adverse Event|0|||
42035964|NCT00923091|75844341|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
42035965|NCT00923091|75844329|FG000|Period V (Double -Blind)|Protocol Violation|0|||
42035966|NCT00923091|75844330|FG001|Period V (Double -Blind)|Protocol Violation|0|||
42035967|NCT00923091|75844331|FG002|Period V (Double -Blind)|Protocol Violation|0|||
42035968|NCT00923091|75844332|FG003|Period V (Double -Blind)|Protocol Violation|0|||
42035969|NCT00923091|75844333|FG004|Period V (Double -Blind)|Protocol Violation|0|||
42035970|NCT00923091|75844334|FG005|Period V (Double -Blind)|Protocol Violation|0|||
42035971|NCT00923091|75844335|FG006|Period V (Double -Blind)|Protocol Violation|0|||
42035972|NCT00923091|75844336|FG007|Period V (Double -Blind)|Protocol Violation|0|||
42035973|NCT00923091|75844337|FG008|Period V (Double -Blind)|Protocol Violation|0|||
42035974|NCT00923091|75844338|FG009|Period V (Double -Blind)|Protocol Violation|0|||
42035975|NCT00923091|75844339|FG010|Period V (Double -Blind)|Protocol Violation|0|||
42035976|NCT00923091|75844340|FG011|Period V (Double -Blind)|Protocol Violation|0|||
42035977|NCT00923091|75844341|FG012|Period V (Double -Blind)|Protocol Violation|1|||
42010166|NCT01225731|75817203|FG004|Part 3|Adverse Event|0|||
42010167|NCT01225731|75817204|FG005|Part 3|Adverse Event|0|||
42010168|NCT01225731|75817205|FG006|Part 3|Adverse Event|0|||
42010169|NCT01225731|75817206|FG007|Part 3|Adverse Event|0|||
42010170|NCT01225731|75817207|FG008|Part 3|Adverse Event|0|||
42010171|NCT01225731|75817208|FG009|Part 3|Adverse Event|0|||
42035978|NCT00923091|75844329|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
42035979|NCT00923091|75844330|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
42137727|NCT00337077|75948022|FG001|Overall Study|Alternative therapy|0|||
42137728|NCT00337077|75948023|FG002|Overall Study|Alternative therapy|0|||
42137729|NCT00337077|75948021|FG000|Overall Study|Physician Decision|1|||
42137730|NCT00337077|75948022|FG001|Overall Study|Physician Decision|4|||
42137731|NCT00337077|75948023|FG002|Overall Study|Physician Decision|2|||
42137732|NCT00337077|75948021|FG000|Overall Study|Never started treatment|1|||
42137733|NCT00337077|75948022|FG001|Overall Study|Never started treatment|1|||
42137734|NCT00337077|75948023|FG002|Overall Study|Never started treatment|0|||
42137735|NCT00337077|75948021|FG000|Overall Study|Ineligible|1|||
42137736|NCT00337077|75948022|FG001|Overall Study|Ineligible|1|||
42137737|NCT00337077|75948023|FG002|Overall Study|Ineligible|1|||
42137738|NCT00428220|75948029|FG000|Overall Study|Participant died|8|||
42137739|NCT00428220|75948029|FG000|Overall Study|Global deterioration of health status|7|||
42137740|NCT00428220|75948029|FG000|Overall Study|Lost to Follow-up|4|||
42137741|NCT00428220|75948029|FG000|Overall Study|Objective progression or relapse|123|||
42137742|NCT00428220|75948029|FG000|Overall Study|Participant refused continued treatment|7|||
42137743|NCT00428220|75948029|FG000|Overall Study|Adverse Event|51|||
42137744|NCT00428220|75948029|FG000|Overall Study|Other|23|||
42137745|NCT00345579|75948059|FG000|Overall Study|Adverse Event|9|||
42137746|NCT00345579|75948060|FG001|Overall Study|Adverse Event|6|||
42137747|NCT00345579|75948059|FG000|Overall Study|Protocol Violation|14|||
42137748|NCT00345579|75948060|FG001|Overall Study|Protocol Violation|5|||
42137749|NCT00345579|75948059|FG000|Overall Study|Withdrawal by Subject|50|||
42137750|NCT00345579|75948060|FG001|Overall Study|Withdrawal by Subject|17|||
42137751|NCT00345579|75948059|FG000|Overall Study|Lost to Follow-up|82|||
42272507|NCT02524730|76102732|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
42035980|NCT00923091|75844331|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
42035981|NCT00923091|75844332|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
42035982|NCT00923091|75844333|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
42035983|NCT00923091|75844334|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
42035984|NCT00923091|75844335|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
42035985|NCT00923091|75844336|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
42035986|NCT00923091|75844337|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
42035987|NCT00923091|75844338|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
42035988|NCT00923091|75844339|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
42035989|NCT00923091|75844340|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
42035990|NCT00923091|75844341|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
42010172|NCT01225731|75817209|FG010|Part 3|Adverse Event|1|||
42010173|NCT01225731|75817210|FG011|Part 3|Adverse Event|1|||
42010174|NCT01225731|75817211|FG012|Part 3|Adverse Event|0|||
42010175|NCT01225731|75817199|FG000|Part 3|Lost to Follow-up|0|||
42010176|NCT01225731|75817200|FG001|Part 3|Lost to Follow-up|0|||
42010177|NCT01225731|75817201|FG002|Part 3|Lost to Follow-up|0|||
42035991|NCT00923091|75844329|FG000|Period VI (Open-Label)|Adverse Event|17|||
42137752|NCT00345579|75948060|FG001|Overall Study|Lost to Follow-up|36|||
42137753|NCT00345579|75948059|FG000|Overall Study|Other|9|||
42137754|NCT00345579|75948060|FG001|Overall Study|Other|1|||
42272508|NCT01658150|76102736|FG000|Overall Study|Withdrawal by Subject|1|||
42272509|NCT02285998|76102743|FG000|Overall Study|Adverse Event|9|||
42010178|NCT01225731|75817202|FG003|Part 3|Lost to Follow-up|0|||
42035992|NCT00923091|75844330|FG001|Period VI (Open-Label)|Adverse Event|0|||
42137755|NCT00335829|75948067|FG000|Overall Study|Withdrawal by Subject|1|||
42137756|NCT00335829|75948067|FG000|Overall Study|Lost to Follow-up|1|||
42272510|NCT02285998|76102744|FG001|Overall Study|Adverse Event|8|||
42010179|NCT01225731|75817203|FG004|Part 3|Lost to Follow-up|0|||
42272511|NCT02285998|76102743|FG000|Overall Study|Physician Decision|1|||
42272512|NCT02285998|76102744|FG001|Overall Study|Physician Decision|2|||
42272513|NCT02285998|76102743|FG000|Overall Study|Lost to Follow-up|176|||
42272514|NCT02285998|76102744|FG001|Overall Study|Lost to Follow-up|172|||
42272515|NCT02285998|76102743|FG000|Overall Study|Withdrawal by Subject|53|||
42272516|NCT02285998|76102744|FG001|Overall Study|Withdrawal by Subject|61|||
42272517|NCT02285998|76102743|FG000|Overall Study|Other Reasons|7|||
42272518|NCT02285998|76102744|FG001|Overall Study|Other Reasons|10|||
42272519|NCT01658072|76102752|FG000|Overall Study|Protocol Violation|4|||
42272520|NCT01658072|76102753|FG001|Overall Study|Protocol Violation|2|||
42272521|NCT02285920|76102763|FG000|Overall Study|Kidney transplantation|2|||
42272522|NCT02285920|76102764|FG001|Overall Study|Kidney transplantation|2|||
42272523|NCT02285920|76102765|FG002|Overall Study|Kidney transplantation|2|||
42272524|NCT02285920|76102766|FG003|Overall Study|Kidney transplantation|0|||
42272525|NCT02285920|76102763|FG000|Overall Study|Change to peritoneal dialysis|0|||
42272526|NCT02285920|76102764|FG001|Overall Study|Change to peritoneal dialysis|0|||
42272527|NCT02285920|76102765|FG002|Overall Study|Change to peritoneal dialysis|1|||
42272528|NCT02285920|76102766|FG003|Overall Study|Change to peritoneal dialysis|0|||
42272529|NCT02285920|76102763|FG000|Overall Study|Transfer to non-participating unit|0|||
42272530|NCT02285920|76102764|FG001|Overall Study|Transfer to non-participating unit|1|||
42272531|NCT02285920|76102765|FG002|Overall Study|Transfer to non-participating unit|0|||
42272532|NCT02285920|76102766|FG003|Overall Study|Transfer to non-participating unit|0|||
42272533|NCT02285920|76102763|FG000|Overall Study|Dialysis discontinuation|0|||
42272534|NCT02285920|76102764|FG001|Overall Study|Dialysis discontinuation|1|||
42272535|NCT02285920|76102765|FG002|Overall Study|Dialysis discontinuation|0|||
42272536|NCT02285920|76102766|FG003|Overall Study|Dialysis discontinuation|0|||
42272537|NCT02285920|76102763|FG000|Overall Study|Death|2|||
42272538|NCT02285920|76102764|FG001|Overall Study|Death|0|||
42272539|NCT02285920|76102765|FG002|Overall Study|Death|2|||
42272540|NCT02285920|76102766|FG003|Overall Study|Death|1|||
42272541|NCT02035137|76102779|FG000|Overall Study|Physician Decision|0|||
42272542|NCT02035137|76102780|FG001|Overall Study|Physician Decision|0|||
42272543|NCT02035137|76102781|FG002|Overall Study|Physician Decision|1|||
42272544|NCT02035137|76102779|FG000|Overall Study|Withdrawal by Subject|0|||
42272545|NCT02035137|76102780|FG001|Overall Study|Withdrawal by Subject|1|||
42272546|NCT02035137|76102781|FG002|Overall Study|Withdrawal by Subject|2|||
42272547|NCT02035137|76102779|FG000|Overall Study|Ineligible|0|||
42272548|NCT02035137|76102780|FG001|Overall Study|Ineligible|1|||
42272549|NCT02035137|76102781|FG002|Overall Study|Ineligible|2|||
42272550|NCT02035137|76102779|FG000|Overall Study|Disease progression prior to treatment start|2|||
42272551|NCT02035137|76102780|FG001|Overall Study|Disease progression prior to treatment start|0|||
42272552|NCT02035137|76102781|FG002|Overall Study|Disease progression prior to treatment start|0|||
42272553|NCT02522780|76102791|FG000|Overall Study|Consent withdrawn by subject|5|||
42272554|NCT02522780|76102792|FG001|Overall Study|Consent withdrawn by subject|7|||
42272555|NCT02522780|76102791|FG000|Overall Study|Protocol deviation|1|||
42272556|NCT02522780|76102792|FG001|Overall Study|Protocol deviation|3|||
42272557|NCT02522780|76102791|FG000|Overall Study|Subject refused endoscopic procedure|0|||
42272558|NCT02522780|76102792|FG001|Overall Study|Subject refused endoscopic procedure|1|||
42272559|NCT02522780|76102791|FG000|Overall Study|Adverse event, non-fatal|11|||
42272560|NCT02522780|76102792|FG001|Overall Study|Adverse event, non-fatal|16|||
42346892|NCT01708161|76185913|FG001|Overall Study|Death|0|||
42346893|NCT01708161|76185914|FG002|Overall Study|Death|0|||
42272561|NCT02285062|76102812|FG000|Pre-Treatment Period|Protocol Violation|0|||
42272562|NCT02285062|76102813|FG001|Pre-Treatment Period|Protocol Violation|2|||
42272563|NCT02285062|76102812|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
42272564|NCT02285062|76102813|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
42272565|NCT01352741|76102819|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
42272566|NCT01352741|76102820|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
42346894|NCT01708161|76185915|FG003|Overall Study|Death|1|||
42010180|NCT01225731|75817204|FG005|Part 3|Lost to Follow-up|0|||
42010181|NCT01225731|75817205|FG006|Part 3|Lost to Follow-up|0|||
42272567|NCT01352741|76102819|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
42272568|NCT01352741|76102820|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
42272569|NCT01352741|76102819|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
42272570|NCT01352741|76102820|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
42272571|NCT01352741|76102819|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
42346895|NCT01708161|76185916|FG004|Overall Study|Death|0|||
42272572|NCT01352741|76102820|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
42272774|NCT00835211|76103204|FG000|First Intervention|Withdrawal by Subject|0|||
42346896|NCT01708161|76185917|FG005|Overall Study|Death|1|||
42035993|NCT00923091|75844331|FG002|Period VI (Open-Label)|Adverse Event|4|||
42035994|NCT00923091|75844332|FG003|Period VI (Open-Label)|Adverse Event|1|||
42035995|NCT00923091|75844333|FG004|Period VI (Open-Label)|Adverse Event|1|||
42035996|NCT00923091|75844334|FG005|Period VI (Open-Label)|Adverse Event|0|||
42035997|NCT00923091|75844335|FG006|Period VI (Open-Label)|Adverse Event|0|||
42035998|NCT00923091|75844336|FG007|Period VI (Open-Label)|Adverse Event|0|||
42035999|NCT00923091|75844337|FG008|Period VI (Open-Label)|Adverse Event|0|||
42036000|NCT00923091|75844338|FG009|Period VI (Open-Label)|Adverse Event|0|||
42036001|NCT00923091|75844339|FG010|Period VI (Open-Label)|Adverse Event|0|||
42036002|NCT00923091|75844340|FG011|Period VI (Open-Label)|Adverse Event|0|||
42036003|NCT00923091|75844341|FG012|Period VI (Open-Label)|Adverse Event|0|||
42036004|NCT00923091|75844329|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
42036005|NCT00923091|75844330|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
42036006|NCT00923091|75844331|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
42036007|NCT00923091|75844332|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
42036008|NCT00923091|75844333|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
42036009|NCT00923091|75844334|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
42036010|NCT00923091|75844335|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
42036011|NCT00923091|75844336|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
42036012|NCT00923091|75844337|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
42036013|NCT00923091|75844338|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
42036014|NCT00923091|75844339|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
42036015|NCT00923091|75844340|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
42036016|NCT00923091|75844341|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
42036017|NCT00923091|75844329|FG000|Period VI (Open-Label)|Protocol Violation|6|||
42036018|NCT00923091|75844330|FG001|Period VI (Open-Label)|Protocol Violation|1|||
42036019|NCT00923091|75844331|FG002|Period VI (Open-Label)|Protocol Violation|3|||
42036020|NCT00923091|75844332|FG003|Period VI (Open-Label)|Protocol Violation|1|||
42036021|NCT00923091|75844333|FG004|Period VI (Open-Label)|Protocol Violation|4|||
42036022|NCT00923091|75844334|FG005|Period VI (Open-Label)|Protocol Violation|0|||
42036023|NCT00923091|75844335|FG006|Period VI (Open-Label)|Protocol Violation|0|||
42036024|NCT00923091|75844336|FG007|Period VI (Open-Label)|Protocol Violation|0|||
42036025|NCT00923091|75844337|FG008|Period VI (Open-Label)|Protocol Violation|0|||
42036026|NCT00923091|75844338|FG009|Period VI (Open-Label)|Protocol Violation|0|||
42036027|NCT00923091|75844339|FG010|Period VI (Open-Label)|Protocol Violation|0|||
42036028|NCT00923091|75844340|FG011|Period VI (Open-Label)|Protocol Violation|0|||
42036029|NCT00923091|75844341|FG012|Period VI (Open-Label)|Protocol Violation|0|||
42036030|NCT00923091|75844329|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
42036031|NCT00923091|75844330|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
42036032|NCT00923091|75844331|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
42036033|NCT00923091|75844332|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
42036034|NCT00923091|75844333|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
42036035|NCT00923091|75844334|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
42036036|NCT00923091|75844335|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
42036037|NCT00923091|75844336|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
42036038|NCT00923091|75844337|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
42036039|NCT00923091|75844338|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
42036040|NCT00923091|75844339|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
42036041|NCT00923091|75844340|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
42036042|NCT00923091|75844341|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
42036043|NCT00923091|75844329|FG000|Period VI (Open-Label)|Other Reason|0|||
42036044|NCT00923091|75844330|FG001|Period VI (Open-Label)|Other Reason|0|||
42036045|NCT00923091|75844331|FG002|Period VI (Open-Label)|Other Reason|0|||
42036046|NCT00923091|75844332|FG003|Period VI (Open-Label)|Other Reason|1|||
42036047|NCT00923091|75844333|FG004|Period VI (Open-Label)|Other Reason|1|||
42036048|NCT00923091|75844334|FG005|Period VI (Open-Label)|Other Reason|0|||
42036049|NCT00923091|75844335|FG006|Period VI (Open-Label)|Other Reason|0|||
42036050|NCT00923091|75844336|FG007|Period VI (Open-Label)|Other Reason|0|||
42036051|NCT00923091|75844337|FG008|Period VI (Open-Label)|Other Reason|0|||
42036052|NCT00923091|75844338|FG009|Period VI (Open-Label)|Other Reason|0|||
42036053|NCT00923091|75844339|FG010|Period VI (Open-Label)|Other Reason|0|||
42036054|NCT00923091|75844340|FG011|Period VI (Open-Label)|Other Reason|0|||
42036055|NCT00923091|75844341|FG012|Period VI (Open-Label)|Other Reason|0|||
42036056|NCT00853957|75844368|FG000|Overall Study|Adverse Event|9|||
42036057|NCT00853957|75844369|FG001|Overall Study|Adverse Event|3|||
42036058|NCT00853957|75844368|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42036059|NCT00853957|75844369|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42036060|NCT00853957|75844368|FG000|Overall Study|Subject withdrew consent|4|||
42036061|NCT00853957|75844369|FG001|Overall Study|Subject withdrew consent|5|||
42036062|NCT00853957|75844368|FG000|Overall Study|Lost to Follow-up|1|||
42272573|NCT01352741|76102819|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
42272574|NCT01352741|76102820|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
42036063|NCT00853957|75844369|FG001|Overall Study|Lost to Follow-up|6|||
42036064|NCT00853957|75844368|FG000|Overall Study|Protocol deviation|0|||
42036065|NCT00853957|75844369|FG001|Overall Study|Protocol deviation|3|||
42036066|NCT01021020|75844375|FG000|Period I|Protocol Violation|1|||
42036067|NCT01021020|75844375|FG000|Period I|Withdrawal by Subject|1|||
42036068|NCT01021020|75844375|FG000|14 Day Washout Period A|Physician Decision|1|||
42036069|NCT00833053|75844389|FG000|Overall Study|Adverse Event|4|||
42036070|NCT00833053|75844390|FG001|Overall Study|Adverse Event|0|||
42036071|NCT00833053|75844389|FG000|Overall Study|Treatment Failure|3|||
42036072|NCT00833053|75844390|FG001|Overall Study|Treatment Failure|1|||
42036073|NCT00833053|75844389|FG000|Overall Study|Withdrawal by Subject|0|||
42036074|NCT00833053|75844390|FG001|Overall Study|Withdrawal by Subject|1|||
42036075|NCT00833053|75844389|FG000|Overall Study|Protocol Violation|2|||
42036076|NCT00833053|75844390|FG001|Overall Study|Protocol Violation|1|||
42036077|NCT00832975|75844396|FG000|Overall Study|Lost to Follow-up|7|||
42036078|NCT00832975|75844396|FG000|Overall Study|Protocol Violation|6|||
42036079|NCT00832975|75844396|FG000|Overall Study|Death|5|||
42036080|NCT00832975|75844396|FG000|Overall Study|Physician Decision|4|||
42036081|NCT00832975|75844396|FG000|Overall Study|Withdrawal by Subject|3|||
42036082|NCT00832975|75844396|FG000|Overall Study|Other reasons|14|||
42036083|NCT01020786|75844400|FG000|Induction Period|Entry Criteria Not Met|2|||
42036084|NCT01020786|75844400|FG000|Induction Period|Adverse Event|10|||
42036085|NCT01020786|75844400|FG000|Induction Period|Progressive Disease|31|||
42036086|NCT01020786|75844400|FG000|Induction Period|Investigator Decision|3|||
42036087|NCT01020786|75844400|FG000|Induction Period|Withdrawal by Subject|3|||
42036088|NCT01020786|75844400|FG000|Maintenance Period|Adverse Event|8|||
42036089|NCT01020786|75844400|FG000|Maintenance Period|Progressive Disease|43|||
42036090|NCT01020786|75844400|FG000|Maintenance Period|Withdrawal by Subject|8|||
42036091|NCT01020786|75844400|FG000|Maintenance Period|Sponsor Decision|1|||
42036092|NCT00918645|75844405|FG000|Overall Study|Withdrawal by Subject|1|||
42036093|NCT00922935|75844412|FG000|Overall Study|Protocol Violation|0|||
42036094|NCT00922935|75844413|FG001|Overall Study|Protocol Violation|3|||
42036095|NCT00922935|75844414|FG002|Overall Study|Protocol Violation|0|||
42036096|NCT00922935|75844412|FG000|Overall Study|Physician Decision|1|||
42036097|NCT00922935|75844413|FG001|Overall Study|Physician Decision|1|||
42036098|NCT00922935|75844414|FG002|Overall Study|Physician Decision|0|||
42036099|NCT00922935|75844412|FG000|Overall Study|Lost to Follow-up|0|||
42036100|NCT00922935|75844413|FG001|Overall Study|Lost to Follow-up|1|||
42036101|NCT00922935|75844414|FG002|Overall Study|Lost to Follow-up|0|||
42036102|NCT01020474|75844424|FG000|Overall Study|Adverse Event|4|||
42036103|NCT01020474|75844425|FG001|Overall Study|Adverse Event|4|||
42036104|NCT01020474|75844424|FG000|Overall Study|Protocol Violation|0|||
42036105|NCT01020474|75844425|FG001|Overall Study|Protocol Violation|2|||
42036106|NCT01020474|75844424|FG000|Overall Study|Withdrawal by Subject|5|||
42346897|NCT01708161|76185912|FG000|Overall Study|Withdrawal by Subject|0|||
42346898|NCT01708161|76185913|FG001|Overall Study|Withdrawal by Subject|1|||
42010182|NCT01225731|75817206|FG007|Part 3|Lost to Follow-up|0|||
42010183|NCT01225731|75817207|FG008|Part 3|Lost to Follow-up|0|||
42010184|NCT01225731|75817208|FG009|Part 3|Lost to Follow-up|0|||
42010185|NCT01225731|75817209|FG010|Part 3|Lost to Follow-up|1|||
42010186|NCT01225731|75817210|FG011|Part 3|Lost to Follow-up|2|||
42010187|NCT01225731|75817211|FG012|Part 3|Lost to Follow-up|1|||
42010188|NCT01225731|75817199|FG000|Part 3|Physician Decision|0|||
42010189|NCT01225731|75817200|FG001|Part 3|Physician Decision|0|||
42010190|NCT01225731|75817201|FG002|Part 3|Physician Decision|0|||
42010191|NCT01225731|75817202|FG003|Part 3|Physician Decision|0|||
42010192|NCT01225731|75817203|FG004|Part 3|Physician Decision|0|||
42036107|NCT01020474|75844425|FG001|Overall Study|Withdrawal by Subject|7|||
42010193|NCT01225731|75817204|FG005|Part 3|Physician Decision|0|||
42010194|NCT01225731|75817205|FG006|Part 3|Physician Decision|0|||
42010195|NCT01225731|75817206|FG007|Part 3|Physician Decision|0|||
42036108|NCT01020474|75844424|FG000|Overall Study|Other Reasons|1|||
42036109|NCT01020474|75844425|FG001|Overall Study|Other Reasons|1|||
42036110|NCT01020474|75844424|FG000|Overall Study|Insufficient Clinical Response|0|||
42010196|NCT01225731|75817207|FG008|Part 3|Physician Decision|0|||
42137757|NCT00335829|75948067|FG000|Overall Study|Adverse Event|1|||
42036111|NCT01020474|75844425|FG001|Overall Study|Insufficient Clinical Response|3|||
42036112|NCT00922779|75844431|FG000|Overall Study|Adverse Event|67|||
42036113|NCT00922779|75844431|FG000|Overall Study|Pregnancy|7|||
42036114|NCT00922779|75844431|FG000|Overall Study|Withdrawal by Subject|308|||
42036115|NCT00922779|75844431|FG000|Overall Study|Lost to Follow-up|44|||
42036116|NCT00922779|75844431|FG000|Overall Study|Other|27|||
42036117|NCT00922779|75844431|FG000|Overall Study|Missing|1874|||
42036118|NCT00924651|75844437|FG000|Overall Study|Chemo started too soon|2|||
42036119|NCT00924651|75844438|FG001|Overall Study|Chemo started too soon|3|||
42036120|NCT00924651|75844437|FG000|Overall Study|No Reason|3|||
42036121|NCT00924651|75844438|FG001|Overall Study|No Reason|7|||
42036122|NCT00924651|75844437|FG000|Overall Study|Overwhelmed|6|||
42036123|NCT00924651|75844438|FG001|Overall Study|Overwhelmed|6|||
42036124|NCT00924651|75844437|FG000|Overall Study|Noncompliant|1|||
42036125|NCT00924651|75844438|FG001|Overall Study|Noncompliant|4|||
42036126|NCT00924651|75844437|FG000|Overall Study|Medical|1|||
42036127|NCT00924651|75844438|FG001|Overall Study|Medical|3|||
42036128|NCT00924651|75844437|FG000|Overall Study|Changed Mind|10|||
42036129|NCT00924651|75844438|FG001|Overall Study|Changed Mind|1|||
42036130|NCT00924651|75844437|FG000|Overall Study|Incomplete Form|2|||
42036131|NCT00924651|75844438|FG001|Overall Study|Incomplete Form|1|||
42036132|NCT00922623|75844444|FG000|Overall Study|Other|4|||
42036133|NCT00922623|75844444|FG000|Overall Study|Lost to Follow-up|1|||
42036134|NCT01025232|75844452|FG000|Overall Study|Study drug no longer available|3|||
42036135|NCT01025232|75844453|FG001|Overall Study|Study drug no longer available|6|||
42036136|NCT01025154|75844459|FG000|Overall Study|Lost to Follow-up|1|||
42036137|NCT01025154|75844459|FG000|Overall Study|Withdrawal by Subject|1|||
42036138|NCT00832819|75844466|FG000|Overall Study|Adverse Event|0|||
42036139|NCT00832819|75844467|FG001|Overall Study|Adverse Event|1|||
42036140|NCT00832819|75844468|FG002|Overall Study|Adverse Event|0|||
42036141|NCT00832819|75844466|FG000|Overall Study|Protocol Violation|0|||
42036142|NCT00832819|75844467|FG001|Overall Study|Protocol Violation|0|||
42036143|NCT00832819|75844468|FG002|Overall Study|Protocol Violation|1|||
42036144|NCT00853723|75844477|FG000|Overall Study|Adverse Event|3|||
42036145|NCT00853723|75844478|FG001|Overall Study|Adverse Event|4|||
42036146|NCT00853723|75844479|FG002|Overall Study|Adverse Event|1|||
42036147|NCT00853723|75844477|FG000|Overall Study|Withdrawal by Subject|2|||
42036148|NCT00853723|75844478|FG001|Overall Study|Withdrawal by Subject|1|||
42036149|NCT00853723|75844479|FG002|Overall Study|Withdrawal by Subject|0|||
42036150|NCT00853723|75844477|FG000|Overall Study|Protocol Violation|1|||
42036151|NCT00853723|75844478|FG001|Overall Study|Protocol Violation|2|||
42036152|NCT00853723|75844479|FG002|Overall Study|Protocol Violation|1|||
42036153|NCT01104545|75844493|FG000|Overall Study|Adverse Event|0|||
42036154|NCT01104545|75844494|FG001|Overall Study|Adverse Event|1|||
42036155|NCT01104545|75844495|FG002|Overall Study|Adverse Event|2|||
42036156|NCT00918255|75844543|FG000|Overall Study|Adverse Event|1|||
42036157|NCT00918255|75844544|FG001|Overall Study|Adverse Event|0|||
42036158|NCT00918255|75844545|FG002|Overall Study|Adverse Event|0|||
42036159|NCT00918255|75844543|FG000|Overall Study|Withdrawal by Subject|1|||
42036160|NCT00918255|75844544|FG001|Overall Study|Withdrawal by Subject|0|||
42036161|NCT00918255|75844545|FG002|Overall Study|Withdrawal by Subject|2|||
42036162|NCT00918255|75844543|FG000|Overall Study|Lack of Efficacy|1|||
42036163|NCT00918255|75844544|FG001|Overall Study|Lack of Efficacy|0|||
42036164|NCT00918255|75844545|FG002|Overall Study|Lack of Efficacy|0|||
42036165|NCT00918255|75844543|FG000|Overall Study|Lost to Follow-up|1|||
42036166|NCT00918255|75844544|FG001|Overall Study|Lost to Follow-up|0|||
42036167|NCT00918255|75844545|FG002|Overall Study|Lost to Follow-up|2|||
42036168|NCT00918255|75844543|FG000|Overall Study|Exceeded allowed number of interventions|0|||
42036169|NCT00918255|75844544|FG001|Overall Study|Exceeded allowed number of interventions|0|||
42036170|NCT00918255|75844545|FG002|Overall Study|Exceeded allowed number of interventions|1|||
42036171|NCT00918255|75844543|FG000|Overall Study|Non-compliance|1|||
42036172|NCT00918255|75844544|FG001|Overall Study|Non-compliance|0|||
42036173|NCT00918255|75844545|FG002|Overall Study|Non-compliance|0|||
42036174|NCT00918255|75844543|FG000|Overall Study|Investigator discretion|1|||
42036175|NCT00918255|75844544|FG001|Overall Study|Investigator discretion|0|||
42036176|NCT00918255|75844545|FG002|Overall Study|Investigator discretion|0|||
42036177|NCT01096589|75844557|FG000|Overall Study|Adverse Event|2|||
42036178|NCT01096589|75844558|FG001|Overall Study|Adverse Event|1|||
42036179|NCT01096589|75844559|FG002|Overall Study|Adverse Event|2|||
42036180|NCT01096589|75844560|FG003|Overall Study|Adverse Event|1|||
42036181|NCT01096589|75844557|FG000|Overall Study|Withdrawal by Subject|2|||
42036182|NCT01096589|75844558|FG001|Overall Study|Withdrawal by Subject|1|||
42036183|NCT01096589|75844559|FG002|Overall Study|Withdrawal by Subject|1|||
42036184|NCT01096589|75844560|FG003|Overall Study|Withdrawal by Subject|1|||
42036185|NCT01096589|75844557|FG000|Overall Study|Compliance with protocol|0|||
42036186|NCT01096589|75844558|FG001|Overall Study|Compliance with protocol|0|||
42036187|NCT01096589|75844559|FG002|Overall Study|Compliance with protocol|1|||
42036188|NCT01096589|75844560|FG003|Overall Study|Compliance with protocol|0|||
42036189|NCT01096589|75844557|FG000|Overall Study|found treatment exhausting|0|||
42036190|NCT01096589|75844558|FG001|Overall Study|found treatment exhausting|0|||
42036191|NCT01096589|75844559|FG002|Overall Study|found treatment exhausting|0|||
42036192|NCT01096589|75844560|FG003|Overall Study|found treatment exhausting|1|||
42036193|NCT00845065|75844576|FG000|Overall Study|Adverse Event|3|||
42036194|NCT00845065|75844577|FG001|Overall Study|Adverse Event|23|||
42036195|NCT00845065|75844576|FG000|Overall Study|Lack of Efficacy|43|||
42036196|NCT00845065|75844577|FG001|Overall Study|Lack of Efficacy|21|||
42036197|NCT00845065|75844576|FG000|Overall Study|Non-Medical Reasons|1|||
42036198|NCT00845065|75844577|FG001|Overall Study|Non-Medical Reasons|11|||
42036199|NCT00832585|75844583|FG000|Overall Study|Withdrawal by Subject|1|||
42036200|NCT00832585|75844583|FG000|Overall Study|Lost to Follow-up|1|||
42036201|NCT00918567|75844589|FG000|Overall Study|Lack of Efficacy|3|||
42036202|NCT00918567|75844590|FG001|Overall Study|Lack of Efficacy|1|||
42036203|NCT00918567|75844589|FG000|Overall Study|Withdrawal by Subject|1|||
42036204|NCT00918567|75844590|FG001|Overall Study|Withdrawal by Subject|1|||
42036205|NCT00918567|75844589|FG000|Overall Study|Adverse Event|1|||
42036206|NCT00918567|75844590|FG001|Overall Study|Adverse Event|0|||
42036207|NCT01024920|75844598|FG000|Overall Study|Progressive disease|47|||
42036208|NCT01024920|75844599|FG001|Overall Study|Progressive disease|25|||
42036209|NCT01024920|75844598|FG000|Overall Study|Adverse Event|8|||
42137758|NCT00344019|75948074|FG000|Overall Study|did not meet final inclusion criteria|0|||
42137759|NCT00344019|75948075|FG001|Overall Study|did not meet final inclusion criteria|0|||
42137760|NCT00344019|75948076|FG002|Overall Study|did not meet final inclusion criteria|74|||
42137761|NCT00535847|75948090|FG000|Overall Study|Adverse Event|5|||
42137762|NCT00535847|75948091|FG001|Overall Study|Adverse Event|3|||
42137763|NCT00535847|75948092|FG002|Overall Study|Adverse Event|2|||
42137764|NCT00535847|75948090|FG000|Overall Study|Non compliance|1|||
42137765|NCT00535847|75948091|FG001|Overall Study|Non compliance|1|||
42137766|NCT00535847|75948092|FG002|Overall Study|Non compliance|0|||
42137767|NCT00535847|75948090|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
42137768|NCT00535847|75948091|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
42137769|NCT00535847|75948092|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
42010197|NCT01225731|75817208|FG009|Part 3|Physician Decision|0|||
42010198|NCT01225731|75817209|FG010|Part 3|Physician Decision|0|||
42010199|NCT01225731|75817210|FG011|Part 3|Physician Decision|1|||
42010200|NCT01225731|75817211|FG012|Part 3|Physician Decision|2|||
42010201|NCT01225731|75817199|FG000|Part 3|Withdrawal by Subject|0|||
42010202|NCT01225731|75817200|FG001|Part 3|Withdrawal by Subject|0|||
42010203|NCT01225731|75817201|FG002|Part 3|Withdrawal by Subject|0|||
42010204|NCT01225731|75817202|FG003|Part 3|Withdrawal by Subject|0|||
42010205|NCT01225731|75817203|FG004|Part 3|Withdrawal by Subject|0|||
42010206|NCT01225731|75817204|FG005|Part 3|Withdrawal by Subject|0|||
42010207|NCT01225731|75817205|FG006|Part 3|Withdrawal by Subject|0|||
42010208|NCT01225731|75817206|FG007|Part 3|Withdrawal by Subject|0|||
42010209|NCT01225731|75817207|FG008|Part 3|Withdrawal by Subject|0|||
42010210|NCT01225731|75817208|FG009|Part 3|Withdrawal by Subject|0|||
42010211|NCT01225731|75817209|FG010|Part 3|Withdrawal by Subject|4|||
42036210|NCT01024920|75844599|FG001|Overall Study|Adverse Event|4|||
42036211|NCT01024920|75844598|FG000|Overall Study|Lost to Follow-up|0|||
42036212|NCT01024920|75844599|FG001|Overall Study|Lost to Follow-up|1|||
42036213|NCT01024920|75844598|FG000|Overall Study|Patient refusal to continue|4|||
42036214|NCT01024920|75844599|FG001|Overall Study|Patient refusal to continue|0|||
42137770|NCT00334893|75948106|FG000|Overall Study|Not Treated|1|||
42137771|NCT00334893|75948107|FG001|Overall Study|Not Treated|0|||
42010212|NCT01225731|75817210|FG011|Part 3|Withdrawal by Subject|6|||
42036215|NCT01024920|75844598|FG000|Overall Study|Other than listed|5|||
42036216|NCT01024920|75844599|FG001|Overall Study|Other than listed|1|||
42036217|NCT01024920|75844598|FG000|Overall Study|Not treated|3|||
42137772|NCT00334737|75948118|FG000|Hospital Phase|Death|1|||
42137773|NCT00334737|75948119|FG001|Hospital Phase|Death|2|||
42010213|NCT01225731|75817211|FG012|Part 3|Withdrawal by Subject|4|||
42010214|NCT01007149|75817242|FG000|Overall Study|Administrative problems|0|||
42036218|NCT01024920|75844599|FG001|Overall Study|Not treated|0|||
42036219|NCT01024920|75844598|FG000|Overall Study|Protocol Violation|0|||
42036220|NCT01024920|75844599|FG001|Overall Study|Protocol Violation|1|||
42036221|NCT00832117|75844607|FG000|Overall Study|Death|1|||
42036222|NCT00832117|75844607|FG000|Overall Study|Disease Progression|11|||
42036223|NCT01104311|75844616|FG000|Overall Study|Withdrawal by Subject|6|||
42036224|NCT01104311|75844617|FG001|Overall Study|Withdrawal by Subject|6|||
42036225|NCT01104311|75844616|FG000|Overall Study|Protocol Violation|0|||
42272575|NCT01352741|76102819|FG000|Open-label Tapentadol Titration Period|Other|4|||
42272576|NCT01352741|76102820|FG001|Open-label Tapentadol Titration Period|Other|0|||
42272577|NCT01352741|76102819|FG000|Double-blind Comparative Period|Protocol Violation|2|||
42010215|NCT01007149|75817243|FG001|Overall Study|Administrative problems|1|||
42010216|NCT00998335|75817251|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
42010217|NCT00998335|75817252|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
42010218|NCT01294670|75817269|FG000|Overall Study|Not treated|1|||
42010219|NCT01294670|75817270|FG001|Overall Study|Not treated|0|||
42036226|NCT01104311|75844617|FG001|Overall Study|Protocol Violation|1|||
42036227|NCT01104311|75844616|FG000|Overall Study|Physician Decision|2|||
42036228|NCT01104311|75844617|FG001|Overall Study|Physician Decision|2|||
42036229|NCT01104311|75844616|FG000|Overall Study|low compliance|1|||
42036230|NCT01104311|75844617|FG001|Overall Study|low compliance|1|||
42010220|NCT01294670|75817271|FG002|Overall Study|Not treated|0|||
42010221|NCT01294670|75817272|FG003|Overall Study|Not treated|0|||
42010222|NCT01294670|75817273|FG004|Overall Study|Not treated|0|||
42010223|NCT01006603|75817287|FG000|Overall Study|Withdrawal by Subject|17|||
42010224|NCT01006603|75817288|FG001|Overall Study|Withdrawal by Subject|19|||
42010225|NCT01006603|75817287|FG000|Overall Study|Lost to Follow-up|0|||
42010226|NCT01006603|75817288|FG001|Overall Study|Lost to Follow-up|1|||
42010227|NCT01006603|75817287|FG000|Overall Study|Safety reason|1|||
42010228|NCT01006603|75817288|FG001|Overall Study|Safety reason|1|||
42010229|NCT01006603|75817287|FG000|Overall Study|Protocol Violation|1|||
42036231|NCT01104311|75844616|FG000|Overall Study|Adverse Event|1|||
42036232|NCT01104311|75844617|FG001|Overall Study|Adverse Event|2|||
42036233|NCT00831493|75844627|FG000|Overall Study|Intractable nausea and vomiting|1|||
42036234|NCT00853567|75844634|FG000|Overall Study|Study prematurely terminated|71|||
42036235|NCT00853489|75844644|FG000|Overall Study|Lost to Follow-up|5|||
42036236|NCT00853489|75844645|FG001|Overall Study|Lost to Follow-up|2|||
42036237|NCT01019694|75844654|FG000|Overall Study|Adverse Event|12|||
42036238|NCT01019694|75844655|FG001|Overall Study|Adverse Event|16|||
42036239|NCT01019694|75844656|FG002|Overall Study|Adverse Event|19|||
42036240|NCT01019694|75844654|FG000|Overall Study|Protocol Violation|2|||
42036241|NCT01019694|75844655|FG001|Overall Study|Protocol Violation|6|||
42036242|NCT01019694|75844656|FG002|Overall Study|Protocol Violation|4|||
42036243|NCT01019694|75844654|FG000|Overall Study|Lost to Follow-up|5|||
42036244|NCT01019694|75844655|FG001|Overall Study|Lost to Follow-up|3|||
42036245|NCT01019694|75844656|FG002|Overall Study|Lost to Follow-up|3|||
42036246|NCT01019694|75844654|FG000|Overall Study|Withdrawal by Subject|4|||
42036247|NCT01019694|75844655|FG001|Overall Study|Withdrawal by Subject|6|||
42036248|NCT01019694|75844656|FG002|Overall Study|Withdrawal by Subject|12|||
42036249|NCT01019694|75844654|FG000|Overall Study|Not treated|0|||
42036250|NCT01019694|75844655|FG001|Overall Study|Not treated|2|||
42036251|NCT01019694|75844656|FG002|Overall Study|Not treated|3|||
42036252|NCT01019694|75844654|FG000|Overall Study|Other reason (not specified)|1|||
42010230|NCT01006603|75817288|FG001|Overall Study|Protocol Violation|3|||
42036253|NCT01019694|75844655|FG001|Overall Study|Other reason (not specified)|5|||
42036254|NCT01019694|75844656|FG002|Overall Study|Other reason (not specified)|6|||
42036255|NCT00831415|75844664|FG000|Overall Study|Adverse Event|14|||
42036256|NCT00831415|75844664|FG000|Overall Study|Failed to return|3|||
42036257|NCT00831415|75844664|FG000|Overall Study|Physician Decision|6|||
42036258|NCT00831415|75844664|FG000|Overall Study|Lost to Follow-up|9|||
42036259|NCT00831415|75844664|FG000|Overall Study|Protocol Violation|3|||
42036260|NCT00831415|75844664|FG000|Overall Study|Withdrawal by Subject|35|||
42272578|NCT01352741|76102820|FG001|Double-blind Comparative Period|Protocol Violation|0|||
42010231|NCT01006603|75817287|FG000|Overall Study|Incorrect enrolment|0|||
42010232|NCT01006603|75817288|FG001|Overall Study|Incorrect enrolment|2|||
42010233|NCT01006603|75817287|FG000|Overall Study|Adverse Event|15|||
42036261|NCT00831415|75844664|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
42272579|NCT01352741|76102819|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
42010234|NCT01006603|75817288|FG001|Overall Study|Adverse Event|7|||
42010235|NCT01006603|75817287|FG000|Overall Study|Death|1|||
42036262|NCT00831415|75844664|FG000|Overall Study|Death|1|||
42036263|NCT01095653|75844671|FG000|Overall Study|Lack of Efficacy|3|||
42036264|NCT01095653|75844672|FG001|Overall Study|Lack of Efficacy|0|||
42036265|NCT01095653|75844673|FG002|Overall Study|Lack of Efficacy|0|||
42036266|NCT01095653|75844671|FG000|Overall Study|Adverse Event|1|||
42036267|NCT01095653|75844672|FG001|Overall Study|Adverse Event|4|||
42036268|NCT01095653|75844673|FG002|Overall Study|Adverse Event|4|||
42036269|NCT01095653|75844671|FG000|Overall Study|Lost to Follow-up|1|||
42036270|NCT01095653|75844672|FG001|Overall Study|Lost to Follow-up|0|||
42036271|NCT01095653|75844673|FG002|Overall Study|Lost to Follow-up|4|||
42036272|NCT01095653|75844671|FG000|Overall Study|Withdrawal by Subject|4|||
42036273|NCT01095653|75844672|FG001|Overall Study|Withdrawal by Subject|5|||
42036274|NCT01095653|75844673|FG002|Overall Study|Withdrawal by Subject|3|||
42036275|NCT01095653|75844671|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
42036276|NCT01095653|75844672|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
42036277|NCT01095653|75844673|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
42036278|NCT00920907|75844683|FG000|Induction Period|Adverse Event|0|||
42010236|NCT01006603|75817288|FG001|Overall Study|Death|1|||
42010237|NCT01006603|75817287|FG000|Overall Study|Study specific discontinuation criteria|33|||
42010238|NCT01006603|75817288|FG001|Overall Study|Study specific discontinuation criteria|34|||
42010239|NCT01006603|75817287|FG000|Overall Study|Other|3|||
42010240|NCT01006603|75817288|FG001|Overall Study|Other|7|||
42010241|NCT00997321|75817296|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
42010242|NCT00997321|75817297|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
42010243|NCT01294592|75817311|FG000|Overall Study|Adverse Event|28|||
42010244|NCT01294592|75817312|FG001|Overall Study|Adverse Event|13|||
42010245|NCT01294592|75817311|FG000|Overall Study|Lack of Efficacy|7|||
42010246|NCT01294592|75817312|FG001|Overall Study|Lack of Efficacy|5|||
42010247|NCT01294592|75817311|FG000|Overall Study|Protocol Violation|1|||
42010248|NCT01294592|75817312|FG001|Overall Study|Protocol Violation|7|||
42010249|NCT01294592|75817311|FG000|Overall Study|Lost to Follow-up|7|||
42010250|NCT01294592|75817312|FG001|Overall Study|Lost to Follow-up|9|||
42010251|NCT01294592|75817311|FG000|Overall Study|Physician Decision|6|||
42010252|NCT01294592|75817312|FG001|Overall Study|Physician Decision|11|||
42010253|NCT01294592|75817311|FG000|Overall Study|Withdrawal by Subject|28|||
42010254|NCT01294592|75817312|FG001|Overall Study|Withdrawal by Subject|28|||
42010255|NCT00997243|75817321|FG000|Overall Study|Early termination of study by sponsor|7|||
42010256|NCT01294514|75817325|FG000|Overall Study|Excluded due to Arrhythmia|1|||
42010257|NCT00999661|75817333|FG000|Overall Study|Lost to Follow-up|59|||
42010258|NCT00999661|75817333|FG000|Overall Study|Adverse Event|1|||
42010259|NCT00999661|75817333|FG000|Overall Study|Withdrawal by Subject|1|||
42010260|NCT00999661|75817333|FG000|Overall Study|Not meeting eligibility criteria|9|||
42010261|NCT01294436|75817339|FG000|Overall Study|Adverse Event|10|||
42010262|NCT01294436|75817340|FG001|Overall Study|Adverse Event|17|||
42036279|NCT00920907|75844684|FG001|Induction Period|Adverse Event|2|||
42036280|NCT00920907|75844683|FG000|Induction Period|Death|1|||
42036281|NCT00920907|75844684|FG001|Induction Period|Death|1|||
42036282|NCT00920907|75844683|FG000|Induction Period|Disease Progression|12|||
42036283|NCT00920907|75844684|FG001|Induction Period|Disease Progression|11|||
42036284|NCT00920907|75844683|FG000|Induction Period|Study Drug Toxicity|8|||
42036285|NCT00920907|75844684|FG001|Induction Period|Study Drug Toxicity|6|||
42036286|NCT00920907|75844683|FG000|Induction Period|No longer meets study criteria|0|||
42036287|NCT00920907|75844684|FG001|Induction Period|No longer meets study criteria|1|||
42036288|NCT00920907|75844683|FG000|Induction Period|Withdrawal by Subject|1|||
42036289|NCT00920907|75844684|FG001|Induction Period|Withdrawal by Subject|1|||
42036290|NCT00920907|75844683|FG000|Maintenance Period|Disease Progression|3|||
42036291|NCT00920907|75844684|FG001|Maintenance Period|Disease Progression|7|||
42036292|NCT00920907|75844683|FG000|Maintenance Period|Administrative (study closure)|7|||
42036293|NCT00920907|75844684|FG001|Maintenance Period|Administrative (study closure)|2|||
42036294|NCT00920907|75844683|FG000|Maintenance Period|Study Drug Toxicity|0|||
42036295|NCT00920907|75844684|FG001|Maintenance Period|Study Drug Toxicity|2|||
42036296|NCT00920907|75844683|FG000|Maintenance Period|Death|1|||
42036297|NCT00920907|75844684|FG001|Maintenance Period|Death|1|||
42036298|NCT00920907|75844683|FG000|Maintenance Period|Withdrawal by Subject|1|||
42010263|NCT01294436|75817339|FG000|Overall Study|Withdrawal by Subject|11|||
42010264|NCT01294436|75817340|FG001|Overall Study|Withdrawal by Subject|28|||
42036299|NCT00920907|75844684|FG001|Maintenance Period|Withdrawal by Subject|0|||
42036300|NCT00920907|75844683|FG000|Maintenance Period|Adverse Event|0|||
42036301|NCT00920907|75844684|FG001|Maintenance Period|Adverse Event|1|||
42036302|NCT01103141|75844694|FG000|Overall Study|Death|0|||
42036303|NCT01103141|75844695|FG001|Overall Study|Death|1|||
42137774|NCT00334737|75948120|FG002|Hospital Phase|Death|3|||
42272580|NCT01352741|76102820|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
42010265|NCT01294436|75817339|FG000|Overall Study|subject no longer meets study criteria|5|||
42010266|NCT01294436|75817340|FG001|Overall Study|subject no longer meets study criteria|20|||
42010267|NCT01294436|75817339|FG000|Overall Study|poor/non-compliance|2|||
42010268|NCT01294436|75817340|FG001|Overall Study|poor/non-compliance|5|||
42036304|NCT01103141|75844694|FG000|Overall Study|Lost to Follow-up|2|||
42036305|NCT01103141|75844695|FG001|Overall Study|Lost to Follow-up|1|||
42036306|NCT00844831|75844701|FG000|Overall Study|Withdrawal by Subject|4|||
42036307|NCT00844831|75844701|FG000|Overall Study|Adverse Event|1|||
42036308|NCT00844831|75844701|FG000|Overall Study|Physician Decision|1|||
42036309|NCT00920829|75844713|FG000|Allocation|No post randomization data|3|||
42036310|NCT00920829|75844714|FG001|Allocation|No post randomization data|1|||
42036311|NCT00920829|75844715|FG002|Allocation|No post randomization data|0|||
42036312|NCT00920829|75844716|FG003|Allocation|No post randomization data|2|||
42036313|NCT00920829|75844713|FG000|Available for Analysis|Withdrawal by Subject|6|||
42036314|NCT00920829|75844714|FG001|Available for Analysis|Withdrawal by Subject|6|||
42036315|NCT00920829|75844715|FG002|Available for Analysis|Withdrawal by Subject|6|||
42036316|NCT00920829|75844716|FG003|Available for Analysis|Withdrawal by Subject|10|||
42036317|NCT00920829|75844713|FG000|Available for Analysis|Required Medical Treatment|0|||
42036318|NCT00920829|75844714|FG001|Available for Analysis|Required Medical Treatment|1|||
42036319|NCT00920829|75844715|FG002|Available for Analysis|Required Medical Treatment|2|||
42036320|NCT00920829|75844716|FG003|Available for Analysis|Required Medical Treatment|0|||
42036321|NCT00920829|75844713|FG000|Available for Analysis|Adverse Event|1|||
42036322|NCT00920829|75844714|FG001|Available for Analysis|Adverse Event|2|||
42036323|NCT00920829|75844715|FG002|Available for Analysis|Adverse Event|1|||
42036324|NCT00920829|75844716|FG003|Available for Analysis|Adverse Event|0|||
42036325|NCT00920829|75844713|FG000|Available for Analysis|Death|1|||
42036326|NCT00920829|75844714|FG001|Available for Analysis|Death|0|||
42036327|NCT00920829|75844715|FG002|Available for Analysis|Death|0|||
42010269|NCT00995371|75817348|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
42010270|NCT00995371|75817349|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
42010271|NCT01294358|75817357|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
42010272|NCT01294358|75817358|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
42010273|NCT01294358|75817359|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
42010274|NCT01294358|75817360|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
42010275|NCT01294358|75817361|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
42010276|NCT01294358|75817357|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
42010277|NCT01294358|75817358|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
42010278|NCT01294358|75817359|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
42010279|NCT01294358|75817360|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
42010280|NCT01294358|75817361|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
42010281|NCT01294358|75817357|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
42010282|NCT01294358|75817358|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
42010283|NCT01294358|75817359|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
42010284|NCT01294358|75817360|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
42010285|NCT01294358|75817361|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
42010286|NCT01294358|75817357|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
42036328|NCT00920829|75844716|FG003|Available for Analysis|Death|0|||
42036329|NCT00920829|75844713|FG000|Available for Analysis|Protocol Violation|0|||
42036330|NCT00920829|75844714|FG001|Available for Analysis|Protocol Violation|0|||
42036331|NCT00920829|75844715|FG002|Available for Analysis|Protocol Violation|1|||
42036332|NCT00920829|75844716|FG003|Available for Analysis|Protocol Violation|0|||
42036333|NCT00920829|75844713|FG000|Available for Analysis|Required more treatment|0|||
42036334|NCT00920829|75844714|FG001|Available for Analysis|Required more treatment|2|||
42036335|NCT00920829|75844715|FG002|Available for Analysis|Required more treatment|0|||
42036336|NCT00920829|75844716|FG003|Available for Analysis|Required more treatment|1|||
42036337|NCT00831181|75844726|FG000|Overall Study|Adverse Event|12|||
42036338|NCT01023672|75844731|FG000|Overall Study|Worsening disease|2|||
42036339|NCT01023672|75844731|FG000|Overall Study|Death|1|||
42036340|NCT01094171|75844735|FG000|Overall Study|Lost to Follow-up|2|||
42036341|NCT01094171|75844735|FG000|Overall Study|Informed consent withdrawal|4|||
42036342|NCT01094171|75844735|FG000|Overall Study|Migration from the study area|3|||
42036343|NCT01094171|75844735|FG000|Overall Study|Other|1|||
42010287|NCT01294358|75817358|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
42036344|NCT01093625|75844741|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
42036345|NCT01093625|75844742|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
42036346|NCT01093625|75844741|FG000|2-Week Visit|Withdrawal by Subject|1|||
42036347|NCT01093625|75844742|FG001|2-Week Visit|Withdrawal by Subject|0|||
42036348|NCT01093625|75844741|FG000|1-Month Visit|Lost to Follow-up|2|||
42036349|NCT01093625|75844742|FG001|1-Month Visit|Lost to Follow-up|0|||
42036350|NCT01093625|75844741|FG000|3-Month Visit|Lost to Follow-up|2|||
42036351|NCT01093625|75844742|FG001|3-Month Visit|Lost to Follow-up|0|||
42036352|NCT01093625|75844741|FG000|6-Month Visit|Withdrawal by Subject|6|||
42036353|NCT01093625|75844742|FG001|6-Month Visit|Withdrawal by Subject|7|||
42346899|NCT01708161|76185914|FG002|Overall Study|Withdrawal by Subject|1|||
42010288|NCT01294358|75817359|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
42036354|NCT01093625|75844741|FG000|6-Month Visit|Lost to Follow-up|2|||
42036355|NCT01093625|75844742|FG001|6-Month Visit|Lost to Follow-up|2|||
42036356|NCT01093625|75844741|FG000|1-Year Visit|Lost to Follow-up|5|||
42036357|NCT01093625|75844742|FG001|1-Year Visit|Lost to Follow-up|3|||
42036358|NCT01023516|75844750|FG000|Overall Study|Voluntary discontinuation|7|||
42036359|NCT01023516|75844751|FG001|Overall Study|Voluntary discontinuation|5|||
42036360|NCT01023516|75844750|FG000|Overall Study|Adverse Event|9|||
42036361|NCT01023516|75844751|FG001|Overall Study|Adverse Event|6|||
42036362|NCT01023516|75844750|FG000|Overall Study|Safety reason|0|||
42036363|NCT01023516|75844751|FG001|Overall Study|Safety reason|3|||
42036364|NCT01023516|75844750|FG000|Overall Study|Study-specific criteria|4|||
42036365|NCT01023516|75844751|FG001|Overall Study|Study-specific criteria|2|||
42036366|NCT01023516|75844750|FG000|Overall Study|Incorrect enrolment|4|||
42036367|NCT01023516|75844751|FG001|Overall Study|Incorrect enrolment|2|||
42036368|NCT00844753|75844761|FG000|Overall Study|Lack of Efficacy|1|||
42036369|NCT00844753|75844762|FG001|Overall Study|Lack of Efficacy|0|||
42036370|NCT00844753|75844763|FG002|Overall Study|Lack of Efficacy|2|||
42036371|NCT00844753|75844764|FG003|Overall Study|Lack of Efficacy|2|||
42137775|NCT00334737|75948118|FG000|Hospital Phase|Withdrawal by Subject|0|||
42272581|NCT01352741|76102819|FG000|Double-blind Comparative Period|Adverse Event|16|||
42272582|NCT01352741|76102820|FG001|Double-blind Comparative Period|Adverse Event|17|||
42272583|NCT01352741|76102819|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
42272584|NCT01352741|76102820|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
42272585|NCT01352741|76102819|FG000|Double-blind Comparative Period|Death|0|||
42272586|NCT01352741|76102820|FG001|Double-blind Comparative Period|Death|1|||
42272587|NCT01352741|76102819|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
42272588|NCT01352741|76102820|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
42272589|NCT01352741|76102819|FG000|Double-blind Comparative Period|Other|1|||
42272590|NCT01352741|76102820|FG001|Double-blind Comparative Period|Other|2|||
42272591|NCT01352741|76102819|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
42272592|NCT01352741|76102820|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
42346900|NCT01708161|76185915|FG003|Overall Study|Withdrawal by Subject|0|||
42346901|NCT01708161|76185916|FG004|Overall Study|Withdrawal by Subject|0|||
42346902|NCT01708161|76185917|FG005|Overall Study|Withdrawal by Subject|0|||
42346903|NCT01708161|76185912|FG000|Overall Study|Administrative problems|0|||
42346904|NCT01708161|76185913|FG001|Overall Study|Administrative problems|1|||
42010289|NCT01294358|75817360|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
42010290|NCT01294358|75817361|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
42346905|NCT01708161|76185914|FG002|Overall Study|Administrative problems|0|||
42346906|NCT01708161|76185915|FG003|Overall Study|Administrative problems|0|||
42346907|NCT01708161|76185916|FG004|Overall Study|Administrative problems|0|||
42346908|NCT01708161|76185917|FG005|Overall Study|Administrative problems|0|||
42346909|NCT01708161|76185912|FG000|Overall Study|Disease progression|3|||
42346910|NCT01708161|76185913|FG001|Overall Study|Disease progression|5|||
42346911|NCT01708161|76185914|FG002|Overall Study|Disease progression|5|||
42346912|NCT01708161|76185915|FG003|Overall Study|Disease progression|13|||
42346913|NCT01708161|76185916|FG004|Overall Study|Disease progression|3|||
42010291|NCT00994279|75817380|FG000|Overall Study|Withdrawal by Subject|2|||
42010292|NCT00994279|75817381|FG001|Overall Study|Withdrawal by Subject|2|||
42010293|NCT00994279|75817380|FG000|Overall Study|Toxicity|1|||
42010294|NCT00994279|75817381|FG001|Overall Study|Toxicity|0|||
42010295|NCT00994279|75817380|FG000|Overall Study|Multiple reasons|1|||
42010296|NCT00994279|75817381|FG001|Overall Study|Multiple reasons|3|||
42010297|NCT01294046|75817387|FG000|Overall Study|Infection and surgical explant|1|||
42010298|NCT01294046|75817387|FG000|Overall Study|Eligibility criteria expanded|1|||
42010299|NCT01294046|75817387|FG000|Overall Study|Stimulation response inadqequate|1|||
42010300|NCT01224639|75817402|FG000|Overall Study|Withdrawal by Subject|0|||
42010301|NCT01224639|75817403|FG001|Overall Study|Withdrawal by Subject|0|||
42010302|NCT01224639|75817404|FG002|Overall Study|Withdrawal by Subject|0|||
42010303|NCT01224639|75817405|FG003|Overall Study|Withdrawal by Subject|0|||
42010304|NCT01224639|75817406|FG004|Overall Study|Withdrawal by Subject|2|||
42036372|NCT00844753|75844761|FG000|Overall Study|Adverse Event|3|||
42036373|NCT00844753|75844762|FG001|Overall Study|Adverse Event|2|||
42036374|NCT00844753|75844763|FG002|Overall Study|Adverse Event|5|||
42036375|NCT00844753|75844764|FG003|Overall Study|Adverse Event|5|||
42137776|NCT00334737|75948119|FG001|Hospital Phase|Withdrawal by Subject|0|||
42272593|NCT01352741|76102819|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
42272594|NCT01352741|76102820|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
42010305|NCT01224639|75817407|FG005|Overall Study|Withdrawal by Subject|0|||
42036376|NCT00844753|75844761|FG000|Overall Study|Lost to Follow-up|1|||
42036377|NCT00844753|75844762|FG001|Overall Study|Lost to Follow-up|1|||
42346914|NCT01708161|76185917|FG005|Overall Study|Disease progression|0|||
42036378|NCT00844753|75844763|FG002|Overall Study|Lost to Follow-up|0|||
42036379|NCT00844753|75844764|FG003|Overall Study|Lost to Follow-up|1|||
42036380|NCT00844753|75844761|FG000|Overall Study|could not swallow medication|2|||
42036381|NCT00844753|75844762|FG001|Overall Study|could not swallow medication|0|||
42036382|NCT00844753|75844763|FG002|Overall Study|could not swallow medication|0|||
42036383|NCT00844753|75844764|FG003|Overall Study|could not swallow medication|0|||
42036384|NCT00844753|75844761|FG000|Overall Study|Withdrawal by Subject|1|||
42036385|NCT00844753|75844762|FG001|Overall Study|Withdrawal by Subject|0|||
42036386|NCT00844753|75844763|FG002|Overall Study|Withdrawal by Subject|0|||
42036387|NCT00844753|75844764|FG003|Overall Study|Withdrawal by Subject|3|||
42036388|NCT00830947|75844774|FG000|Overall Study|Lost to Follow-up|4|||
42036389|NCT00830947|75844775|FG001|Overall Study|Lost to Follow-up|4|||
42036390|NCT01018992|75844783|FG000|Overall Study|Adverse Event|8|||
42036391|NCT01018992|75844784|FG001|Overall Study|Adverse Event|3|||
42036392|NCT01018992|75844783|FG000|Overall Study|Withdrawal by Subject|3|||
42036393|NCT01018992|75844784|FG001|Overall Study|Withdrawal by Subject|8|||
42036394|NCT01018992|75844783|FG000|Overall Study|Protocol Violation|0|||
42036395|NCT01018992|75844784|FG001|Overall Study|Protocol Violation|4|||
42036396|NCT01018992|75844783|FG000|Overall Study|Lost to Follow-up|5|||
42036397|NCT01018992|75844784|FG001|Overall Study|Lost to Follow-up|1|||
42036398|NCT00917553|75844792|FG000|Overall Study|Lost to Follow-up|2|||
42036399|NCT00917553|75844793|FG001|Overall Study|Lost to Follow-up|1|||
42036400|NCT01018680|75844801|FG000|Overall Study|Adverse Event|23|||
42036401|NCT01018680|75844802|FG001|Overall Study|Adverse Event|40|||
42036402|NCT01018680|75844801|FG000|Overall Study|Withdrawal by Subject|10|||
42036403|NCT01018680|75844802|FG001|Overall Study|Withdrawal by Subject|10|||
42036404|NCT01018680|75844801|FG000|Overall Study|Protocol Violation|5|||
42036405|NCT01018680|75844802|FG001|Overall Study|Protocol Violation|8|||
42036406|NCT01018680|75844801|FG000|Overall Study|Sponsor Decision|6|||
42036407|NCT01018680|75844802|FG001|Overall Study|Sponsor Decision|7|||
42036408|NCT01018680|75844801|FG000|Overall Study|Lack of Efficacy|8|||
42036409|NCT01018680|75844802|FG001|Overall Study|Lack of Efficacy|2|||
42036410|NCT01018680|75844801|FG000|Overall Study|Lost to Follow-up|5|||
42036411|NCT01018680|75844802|FG001|Overall Study|Lost to Follow-up|3|||
42036412|NCT01018680|75844801|FG000|Overall Study|Entry Criteria Not Met|1|||
42036413|NCT01018680|75844802|FG001|Overall Study|Entry Criteria Not Met|4|||
42036414|NCT01018680|75844801|FG000|Overall Study|Physician Decision|3|||
42036415|NCT01018680|75844802|FG001|Overall Study|Physician Decision|1|||
42036416|NCT01012440|75844808|FG000|Overall Study|Withdrawal by Subject|2|||
42036417|NCT00916929|75844814|FG000|Overall Study|Lost to Follow-up|1|||
42010306|NCT01224639|75817408|FG006|Overall Study|Withdrawal by Subject|1|||
42010307|NCT01224639|75817409|FG007|Overall Study|Withdrawal by Subject|1|||
42010308|NCT01224639|75817402|FG000|Overall Study|Adverse Event|0|||
42036418|NCT00916929|75844815|FG001|Overall Study|Lost to Follow-up|3|||
42036419|NCT00916929|75844814|FG000|Overall Study|Death|5|||
42010309|NCT01224639|75817403|FG001|Overall Study|Adverse Event|0|||
42010310|NCT01224639|75817404|FG002|Overall Study|Adverse Event|0|||
42010311|NCT01224639|75817405|FG003|Overall Study|Adverse Event|0|||
42010312|NCT01224639|75817406|FG004|Overall Study|Adverse Event|0|||
42010313|NCT01224639|75817407|FG005|Overall Study|Adverse Event|0|||
42010314|NCT01224639|75817408|FG006|Overall Study|Adverse Event|0|||
42010315|NCT01224639|75817409|FG007|Overall Study|Adverse Event|1|||
42010316|NCT01293968|75817429|FG000|Overall Study|non-cooperation|3|||
42010317|NCT01293968|75817430|FG001|Overall Study|non-cooperation|3|||
42010318|NCT01293032|75817440|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
42036420|NCT00916929|75844815|FG001|Overall Study|Death|10|||
42036421|NCT00916929|75844814|FG000|Overall Study|Withdrawal by Subject|1|||
42036422|NCT00916929|75844815|FG001|Overall Study|Withdrawal by Subject|5|||
42036423|NCT00916929|75844814|FG000|Overall Study|Left ventricular epicardial lead|1|||
42036424|NCT00916929|75844815|FG001|Overall Study|Left ventricular epicardial lead|2|||
42036425|NCT00916929|75844814|FG000|Overall Study|Transferred to hospice care|1|||
42036426|NCT00916929|75844815|FG001|Overall Study|Transferred to hospice care|1|||
42036427|NCT00916929|75844814|FG000|Overall Study|System explant|1|||
42036428|NCT00916929|75844815|FG001|Overall Study|System explant|0|||
42036429|NCT00916929|75844814|FG000|Overall Study|Moved to another state|0|||
42036430|NCT00916929|75844815|FG001|Overall Study|Moved to another state|1|||
42010319|NCT01293032|75817441|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
42010320|NCT01293032|75817442|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
42010321|NCT01293032|75817443|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
42010322|NCT01293032|75817440|FG000|Treatment|Adverse Event|0|||
42010323|NCT01293032|75817441|FG001|Treatment|Adverse Event|0|||
42010324|NCT01293032|75817442|FG002|Treatment|Adverse Event|1|||
42010325|NCT01293032|75817443|FG003|Treatment|Adverse Event|1|||
42010326|NCT01293032|75817440|FG000|Treatment|Withdrawal by Subject|2|||
42010327|NCT01293032|75817441|FG001|Treatment|Withdrawal by Subject|4|||
42010328|NCT01293032|75817442|FG002|Treatment|Withdrawal by Subject|0|||
42010329|NCT01293032|75817443|FG003|Treatment|Withdrawal by Subject|0|||
42010330|NCT01293032|75817440|FG000|Treatment|Disease Progression, relapse|0|||
42010331|NCT01293032|75817441|FG001|Treatment|Disease Progression, relapse|1|||
42010332|NCT01293032|75817442|FG002|Treatment|Disease Progression, relapse|0|||
42010333|NCT01293032|75817443|FG003|Treatment|Disease Progression, relapse|0|||
42010334|NCT01292876|75817450|FG000|Overall Study|Physician Decision|4|||
42010335|NCT01224171|75817458|FG000|Overall Study|Adverse Event|8|||
42010336|NCT01224171|75817459|FG001|Overall Study|Adverse Event|4|||
42010337|NCT01224171|75817458|FG000|Overall Study|Protocol Violation|0|||
42010338|NCT01224171|75817459|FG001|Overall Study|Protocol Violation|1|||
42010339|NCT01224171|75817458|FG000|Overall Study|Lack of Efficacy|5|||
42010340|NCT01224171|75817459|FG001|Overall Study|Lack of Efficacy|1|||
42036431|NCT00916929|75844814|FG000|Overall Study|Device unable to process impedance data|0|||
42036432|NCT00916929|75844815|FG001|Overall Study|Device unable to process impedance data|7|||
42036433|NCT00844597|75844829|FG000|Overall Study|Adverse Event|0|||
42036434|NCT00844597|75844830|FG001|Overall Study|Adverse Event|0|||
42036435|NCT00844597|75844831|FG002|Overall Study|Adverse Event|0|||
42036436|NCT00844597|75844832|FG003|Overall Study|Adverse Event|1|||
42137777|NCT00334737|75948120|FG002|Hospital Phase|Withdrawal by Subject|1|||
42010341|NCT01224171|75817458|FG000|Overall Study|Withdrawal of Consent|2|||
42010342|NCT01224171|75817459|FG001|Overall Study|Withdrawal of Consent|4|||
42010343|NCT01224171|75817458|FG000|Overall Study|Lost to Follow-up|0|||
42010344|NCT01224171|75817459|FG001|Overall Study|Lost to Follow-up|3|||
42010345|NCT01292486|75817465|FG000|Overall Study|Protocol Violation|2|||
42010346|NCT01292486|75817465|FG000|Overall Study|Did not meet screening criteria|2|||
42010347|NCT01292486|75817465|FG000|Overall Study|Adverse Event|1|||
42010348|NCT01292486|75817465|FG000|Overall Study|Physician Decision|1|||
42010349|NCT01223937|75817472|FG000|Overall Study|Withdrawal by Subject|3|||
42010350|NCT01223937|75817473|FG001|Overall Study|Withdrawal by Subject|2|||
42010351|NCT01223937|75817472|FG000|Overall Study|Lost to Follow-up|1|||
42137778|NCT00334737|75948118|FG000|Hospital Phase|Did not receive study drug|1|||
42272595|NCT01352741|76102819|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
42010352|NCT01223937|75817473|FG001|Overall Study|Lost to Follow-up|4|||
42010353|NCT01223937|75817472|FG000|Overall Study|Adverse Event|1|||
42010354|NCT01223937|75817473|FG001|Overall Study|Adverse Event|4|||
42010355|NCT01223937|75817472|FG000|Overall Study|Protocol Violation|8|||
42010356|NCT01223937|75817473|FG001|Overall Study|Protocol Violation|7|||
42010357|NCT01223937|75817472|FG000|Overall Study|Other|4|||
42010358|NCT01223937|75817473|FG001|Overall Study|Other|1|||
42272596|NCT01352741|76102820|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
42272597|NCT01352741|76102819|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
42036437|NCT00844597|75844833|FG004|Overall Study|Adverse Event|0|||
42137779|NCT00334737|75948119|FG001|Hospital Phase|Did not receive study drug|0|||
42010359|NCT01290224|75817479|FG000|Overall Study|Adverse Event|1|||
42010360|NCT01290224|75817479|FG000|Overall Study|Refused Further Treatment|4|||
42010361|NCT01223235|75817485|FG000|Overall Study|Withdrawal by Subject|1|||
42036438|NCT00844597|75844834|FG005|Overall Study|Adverse Event|0|||
42036439|NCT01017120|75844852|FG000|Overall Study|Adverse Event|9|||
42137804|NCT00416598|75948179|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
42137805|NCT00416598|75948179|FG000|Induction & Intensification|Relapse/progression|29|||
42137806|NCT00416598|75948179|FG000|Induction & Intensification|Failed induction|87|||
42137807|NCT00416598|75948179|FG000|Decitabine Maintenance|Adverse Event|5|||
42137808|NCT00416598|75948179|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
42137809|NCT00416598|75948179|FG000|Decitabine Maintenance|Progression/relapse|38|||
42137810|NCT00416598|75948179|FG000|Decitabine Maintenance|Alternative treatment|2|||
42346989|NCT01874145|76186030|FG001|Extension Period|Lost to Follow-up|1|||
42346990|NCT01720797|76186042|FG000|Overall Study|Withdrawal by Subject|3|||
42346991|NCT01720797|76186043|FG001|Overall Study|Withdrawal by Subject|0|||
42346992|NCT01831466|76186061|FG000|Overall Study|Protocol Violation|1|||
42346993|NCT01831466|76186062|FG001|Overall Study|Protocol Violation|1|||
42137811|NCT00416598|75948179|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
42137812|NCT00534599|75948185|FG000|Overall Study|Adverse Event|25|||
42137813|NCT00534599|75948186|FG001|Overall Study|Adverse Event|4|||
42137814|NCT00534599|75948185|FG000|Overall Study|Incorrect enrollment|2|||
42137815|NCT00534599|75948186|FG001|Overall Study|Incorrect enrollment|1|||
42346994|NCT01831466|76186063|FG002|Overall Study|Protocol Violation|2|||
42346995|NCT01831466|76186064|FG003|Overall Study|Protocol Violation|0|||
42346996|NCT01831466|76186065|FG004|Overall Study|Protocol Violation|0|||
42346997|NCT01831466|76186066|FG005|Overall Study|Protocol Violation|1|||
42346998|NCT01831466|76186067|FG006|Overall Study|Protocol Violation|0|||
42346999|NCT01831466|76186068|FG007|Overall Study|Protocol Violation|0|||
42347000|NCT01831466|76186069|FG008|Overall Study|Protocol Violation|0|||
42137816|NCT00534599|75948185|FG000|Overall Study|Mis-randomization|2|||
42137817|NCT00534599|75948186|FG001|Overall Study|Mis-randomization|2|||
42137818|NCT00534599|75948185|FG000|Overall Study|Developed study-specific d/c criteria|5|||
42137819|NCT00534599|75948186|FG001|Overall Study|Developed study-specific d/c criteria|0|||
42137820|NCT00534599|75948185|FG000|Overall Study|Lack of Efficacy|0|||
42137821|NCT00534599|75948186|FG001|Overall Study|Lack of Efficacy|1|||
42137822|NCT00534599|75948185|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
42137823|NCT00534599|75948186|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
42137824|NCT00534599|75948185|FG000|Overall Study|Protocol Violation|1|||
42137825|NCT00534599|75948186|FG001|Overall Study|Protocol Violation|3|||
42137826|NCT00534599|75948185|FG000|Overall Study|Lost to Follow-up|11|||
42137827|NCT00534599|75948186|FG001|Overall Study|Lost to Follow-up|14|||
42137828|NCT00534599|75948185|FG000|Overall Study|Withdrawal by Subject|4|||
42137829|NCT00534599|75948186|FG001|Overall Study|Withdrawal by Subject|6|||
42137830|NCT00534599|75948185|FG000|Overall Study|Other|7|||
42137831|NCT00534599|75948186|FG001|Overall Study|Other|0|||
42137832|NCT03892889|75948209|FG000|Overall Study|Adverse Event|17|||
42137833|NCT03892889|75948209|FG000|Overall Study|Lack of Efficacy|1|||
42137834|NCT03892889|75948209|FG000|Overall Study|Lost to Follow-up|46|||
42137835|NCT03892889|75948209|FG000|Overall Study|Non-compliance with study drug|22|||
42137836|NCT03892889|75948209|FG000|Overall Study|Pregnancy|1|||
42137837|NCT03892889|75948209|FG000|Overall Study|Protocol Deviation|3|||
42137838|NCT03892889|75948209|FG000|Overall Study|Withdrawal by Subject|50|||
42137839|NCT03892889|75948209|FG000|Overall Study|Withdrawal by Caregiver|1|||
42137840|NCT03892889|75948209|FG000|Overall Study|Study Terminated by Sponsor|50|||
42137841|NCT03892889|75948209|FG000|Overall Study|Physician Decision|8|||
42137842|NCT03892889|75948209|FG000|Overall Study|Reason not Specified|5|||
42137843|NCT00473330|75948216|FG000|Core Study|Adverse Event|4|||
42137844|NCT00473330|75948217|FG001|Core Study|Adverse Event|4|||
42137845|NCT00473330|75948218|FG002|Core Study|Adverse Event|1|||
42137846|NCT00473330|75948216|FG000|Core Study|Death|6|||
42137847|NCT00473330|75948217|FG001|Core Study|Death|4|||
42137848|NCT00473330|75948218|FG002|Core Study|Death|4|||
42137849|NCT00473330|75948216|FG000|Core Study|Lost to Follow-up|5|||
42137850|NCT00473330|75948217|FG001|Core Study|Lost to Follow-up|5|||
42137851|NCT00473330|75948218|FG002|Core Study|Lost to Follow-up|10|||
42137852|NCT00473330|75948216|FG000|Core Study|Physician Decision|2|||
42137853|NCT00473330|75948217|FG001|Core Study|Physician Decision|1|||
42137854|NCT00473330|75948218|FG002|Core Study|Physician Decision|3|||
42137855|NCT00473330|75948216|FG000|Core Study|Subject Non-compliance|1|||
42137856|NCT00473330|75948217|FG001|Core Study|Subject Non-compliance|2|||
42137857|NCT00473330|75948218|FG002|Core Study|Subject Non-compliance|1|||
42137858|NCT00473330|75948216|FG000|Core Study|Subject Required Other Therapy|0|||
42137859|NCT00473330|75948217|FG001|Core Study|Subject Required Other Therapy|1|||
42347001|NCT01831466|76186070|FG009|Overall Study|Protocol Violation|0|||
42347002|NCT01831466|76186071|FG010|Overall Study|Protocol Violation|0|||
42347003|NCT01831466|76186072|FG011|Overall Study|Protocol Violation|0|||
42137860|NCT00473330|75948218|FG002|Core Study|Subject Required Other Therapy|3|||
42137861|NCT00473330|75948216|FG000|Core Study|Subject's Decision|9|||
42137862|NCT00473330|75948217|FG001|Core Study|Subject's Decision|8|||
42137863|NCT00473330|75948218|FG002|Core Study|Subject's Decision|19|||
42137864|NCT00473330|75948216|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
42347004|NCT01831466|76186061|FG000|Overall Study|Other|2|||
42347005|NCT01831466|76186062|FG001|Overall Study|Other|3|||
42347006|NCT01831466|76186063|FG002|Overall Study|Other|2|||
42137865|NCT00473330|75948217|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
42347007|NCT01831466|76186064|FG003|Overall Study|Other|2|||
42347008|NCT01831466|76186065|FG004|Overall Study|Other|2|||
42347009|NCT01831466|76186066|FG005|Overall Study|Other|1|||
42347010|NCT01831466|76186067|FG006|Overall Study|Other|0|||
42347011|NCT01831466|76186068|FG007|Overall Study|Other|0|||
42347012|NCT01831466|76186069|FG008|Overall Study|Other|0|||
42347013|NCT01831466|76186070|FG009|Overall Study|Other|0|||
42347014|NCT01831466|76186071|FG010|Overall Study|Other|0|||
42347015|NCT01831466|76186072|FG011|Overall Study|Other|0|||
42347016|NCT01831466|76186061|FG000|Overall Study|Non-compliance with study treatment|2|||
42347017|NCT01831466|76186062|FG001|Overall Study|Non-compliance with study treatment|1|||
42347018|NCT01831466|76186063|FG002|Overall Study|Non-compliance with study treatment|1|||
42347019|NCT01831466|76186064|FG003|Overall Study|Non-compliance with study treatment|0|||
42347020|NCT01831466|76186065|FG004|Overall Study|Non-compliance with study treatment|0|||
42347021|NCT01831466|76186066|FG005|Overall Study|Non-compliance with study treatment|1|||
42347022|NCT01831466|76186067|FG006|Overall Study|Non-compliance with study treatment|0|||
42347023|NCT01831466|76186068|FG007|Overall Study|Non-compliance with study treatment|0|||
42347024|NCT01831466|76186069|FG008|Overall Study|Non-compliance with study treatment|0|||
42347025|NCT01831466|76186070|FG009|Overall Study|Non-compliance with study treatment|0|||
42347026|NCT01831466|76186071|FG010|Overall Study|Non-compliance with study treatment|0|||
42347027|NCT01831466|76186072|FG011|Overall Study|Non-compliance with study treatment|0|||
42347028|NCT01831466|76186061|FG000|Overall Study|Death|0|||
42347029|NCT01831466|76186062|FG001|Overall Study|Death|1|||
42347030|NCT01831466|76186063|FG002|Overall Study|Death|0|||
42347031|NCT01831466|76186064|FG003|Overall Study|Death|0|||
42347032|NCT01831466|76186065|FG004|Overall Study|Death|0|||
42347033|NCT01831466|76186066|FG005|Overall Study|Death|0|||
42347034|NCT01831466|76186067|FG006|Overall Study|Death|0|||
42347035|NCT01831466|76186068|FG007|Overall Study|Death|0|||
42347036|NCT01831466|76186069|FG008|Overall Study|Death|0|||
42347037|NCT01831466|76186070|FG009|Overall Study|Death|0|||
42347038|NCT01831466|76186071|FG010|Overall Study|Death|0|||
42347039|NCT01831466|76186072|FG011|Overall Study|Death|0|||
42347040|NCT01831466|76186061|FG000|Overall Study|Withdrawal by Subject|6|||
42347041|NCT01831466|76186062|FG001|Overall Study|Withdrawal by Subject|3|||
42347042|NCT01831466|76186063|FG002|Overall Study|Withdrawal by Subject|3|||
42347043|NCT01831466|76186064|FG003|Overall Study|Withdrawal by Subject|3|||
42036452|NCT01017120|75844853|FG001|Overall Study|Relocated Out of Town|2|||
42347044|NCT01831466|76186065|FG004|Overall Study|Withdrawal by Subject|3|||
42347045|NCT01831466|76186066|FG005|Overall Study|Withdrawal by Subject|5|||
42347046|NCT01831466|76186067|FG006|Overall Study|Withdrawal by Subject|0|||
42347047|NCT01831466|76186068|FG007|Overall Study|Withdrawal by Subject|0|||
42036453|NCT01017120|75844852|FG000|Overall Study|Protocol Violation|1|||
42036454|NCT01017120|75844853|FG001|Overall Study|Protocol Violation|0|||
42137866|NCT00473330|75948218|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
42137867|NCT00473330|75948216|FG000|Open-label Extension Through Month 48|Death|2|||
42137868|NCT00473330|75948217|FG001|Open-label Extension Through Month 48|Death|0|||
42137869|NCT00473330|75948218|FG002|Open-label Extension Through Month 48|Death|0|||
42137870|NCT00473330|75948216|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
42137871|NCT00473330|75948217|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
42137872|NCT00473330|75948218|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
42137873|NCT00473330|75948216|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
42137874|NCT00473330|75948217|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
42137875|NCT00473330|75948218|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
42137876|NCT00473330|75948216|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
42137877|NCT00473330|75948217|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
42137878|NCT00473330|75948218|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
42137879|NCT00473330|75948216|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
42137880|NCT00473330|75948217|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
42347048|NCT01831466|76186069|FG008|Overall Study|Withdrawal by Subject|0|||
42347049|NCT01831466|76186070|FG009|Overall Study|Withdrawal by Subject|1|||
42036455|NCT01017120|75844852|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
42347050|NCT01831466|76186071|FG010|Overall Study|Withdrawal by Subject|0|||
42347051|NCT01831466|76186072|FG011|Overall Study|Withdrawal by Subject|1|||
42347052|NCT01831466|76186061|FG000|Overall Study|Lost to Follow-up|0|||
42347053|NCT01831466|76186062|FG001|Overall Study|Lost to Follow-up|1|||
42347054|NCT01831466|76186063|FG002|Overall Study|Lost to Follow-up|4|||
42347055|NCT01831466|76186064|FG003|Overall Study|Lost to Follow-up|2|||
42347056|NCT01831466|76186065|FG004|Overall Study|Lost to Follow-up|0|||
42036456|NCT01017120|75844853|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
42347057|NCT01831466|76186066|FG005|Overall Study|Lost to Follow-up|3|||
42347058|NCT01831466|76186067|FG006|Overall Study|Lost to Follow-up|0|||
42347059|NCT01831466|76186068|FG007|Overall Study|Lost to Follow-up|0|||
42347060|NCT01831466|76186069|FG008|Overall Study|Lost to Follow-up|0|||
42347061|NCT01831466|76186070|FG009|Overall Study|Lost to Follow-up|1|||
42347062|NCT01831466|76186071|FG010|Overall Study|Lost to Follow-up|0|||
42347063|NCT01831466|76186072|FG011|Overall Study|Lost to Follow-up|1|||
42347064|NCT01831466|76186061|FG000|Overall Study|Lack of Efficacy|5|||
42347065|NCT01831466|76186062|FG001|Overall Study|Lack of Efficacy|8|||
42347066|NCT01831466|76186063|FG002|Overall Study|Lack of Efficacy|7|||
42347067|NCT01831466|76186064|FG003|Overall Study|Lack of Efficacy|6|||
42347068|NCT01831466|76186065|FG004|Overall Study|Lack of Efficacy|9|||
42347069|NCT01831466|76186066|FG005|Overall Study|Lack of Efficacy|8|||
42347070|NCT01831466|76186067|FG006|Overall Study|Lack of Efficacy|1|||
42347071|NCT01831466|76186068|FG007|Overall Study|Lack of Efficacy|1|||
42347072|NCT01831466|76186069|FG008|Overall Study|Lack of Efficacy|2|||
42347073|NCT01831466|76186070|FG009|Overall Study|Lack of Efficacy|2|||
42347074|NCT01831466|76186071|FG010|Overall Study|Lack of Efficacy|2|||
42347075|NCT01831466|76186072|FG011|Overall Study|Lack of Efficacy|0|||
42347076|NCT01831466|76186061|FG000|Overall Study|Adverse Event|0|||
42347077|NCT01831466|76186062|FG001|Overall Study|Adverse Event|0|||
42347078|NCT01831466|76186063|FG002|Overall Study|Adverse Event|4|||
42347079|NCT01831466|76186064|FG003|Overall Study|Adverse Event|6|||
42347080|NCT01831466|76186065|FG004|Overall Study|Adverse Event|3|||
42347081|NCT01831466|76186066|FG005|Overall Study|Adverse Event|7|||
42347082|NCT01831466|76186067|FG006|Overall Study|Adverse Event|0|||
42347083|NCT01831466|76186068|FG007|Overall Study|Adverse Event|1|||
42347084|NCT01831466|76186069|FG008|Overall Study|Adverse Event|1|||
42347085|NCT01831466|76186070|FG009|Overall Study|Adverse Event|1|||
42347086|NCT01831466|76186071|FG010|Overall Study|Adverse Event|0|||
42347087|NCT01831466|76186072|FG011|Overall Study|Adverse Event|2|||
42347088|NCT01881620|76186092|FG000|Overall Study|Protocol Violation|4|||
42347089|NCT01830920|76186101|FG000|Overall Study|Adverse Event|1|||
42347090|NCT01830920|76186102|FG001|Overall Study|Adverse Event|0|||
42347091|NCT01830920|76186103|FG002|Overall Study|Adverse Event|1|||
42347092|NCT01830920|76186104|FG003|Overall Study|Adverse Event|0|||
42347093|NCT01830920|76186105|FG004|Overall Study|Adverse Event|0|||
42347094|NCT01830920|76186101|FG000|Overall Study|Withdrawal by Subject|2|||
42347095|NCT01830920|76186102|FG001|Overall Study|Withdrawal by Subject|2|||
42347096|NCT01830920|76186103|FG002|Overall Study|Withdrawal by Subject|1|||
42347097|NCT01830920|76186104|FG003|Overall Study|Withdrawal by Subject|7|||
42347098|NCT01830920|76186105|FG004|Overall Study|Withdrawal by Subject|1|||
42347099|NCT01830920|76186101|FG000|Overall Study|Death|3|||
42347100|NCT01830920|76186102|FG001|Overall Study|Death|3|||
42137881|NCT00473330|75948218|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
42137882|NCT00473330|75948216|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
42137883|NCT00473330|75948217|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
42347101|NCT01830920|76186103|FG002|Overall Study|Death|5|||
42347102|NCT01830920|76186104|FG003|Overall Study|Death|4|||
42347103|NCT01830920|76186105|FG004|Overall Study|Death|4|||
42137884|NCT00473330|75948218|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
42137885|NCT00473330|75948216|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
42137886|NCT00473330|75948217|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
42347104|NCT01830920|76186101|FG000|Overall Study|Other|15|||
42347105|NCT01830920|76186102|FG001|Overall Study|Other|1|||
42347106|NCT01830920|76186103|FG002|Overall Study|Other|1|||
42347107|NCT01830920|76186104|FG003|Overall Study|Other|5|||
42347108|NCT01830920|76186105|FG004|Overall Study|Other|3|||
42010625|NCT00993265|75817739|FG001|Overall Study|Non-compliant with study medication|0|||
42347109|NCT01881230|76186120|FG000|Overall Study|Death|2|||
42347110|NCT01881230|76186121|FG001|Overall Study|Death|0|||
42347111|NCT01881230|76186122|FG002|Overall Study|Death|1|||
42347112|NCT01881230|76186120|FG000|Overall Study|Adverse Event|9|||
42347113|NCT01881230|76186121|FG001|Overall Study|Adverse Event|13|||
42347114|NCT01881230|76186122|FG002|Overall Study|Adverse Event|12|||
42347115|NCT01881230|76186120|FG000|Overall Study|Progressive Disease|31|||
42347116|NCT01881230|76186121|FG001|Overall Study|Progressive Disease|35|||
42347117|NCT01881230|76186122|FG002|Overall Study|Progressive Disease|36|||
42010626|NCT04211389|75817747|FG000|Overall Study|Adverse Event|1|||
42010627|NCT04211389|75817748|FG001|Overall Study|Adverse Event|2|||
42010628|NCT04211389|75817747|FG000|Overall Study|Lost to Follow-up|15|||
42010629|NCT04211389|75817748|FG001|Overall Study|Lost to Follow-up|7|||
42347118|NCT01881230|76186120|FG000|Overall Study|Symptomatic Deterioration|3|||
42347119|NCT01881230|76186121|FG001|Overall Study|Symptomatic Deterioration|3|||
42347120|NCT01881230|76186122|FG002|Overall Study|Symptomatic Deterioration|1|||
42347121|NCT01881230|76186120|FG000|Overall Study|Withdrawal by Subject|6|||
42347122|NCT01881230|76186121|FG001|Overall Study|Withdrawal by Subject|4|||
42347123|NCT01881230|76186122|FG002|Overall Study|Withdrawal by Subject|6|||
42347124|NCT01881230|76186120|FG000|Overall Study|Physician Decision|4|||
42347125|NCT01881230|76186121|FG001|Overall Study|Physician Decision|3|||
42347126|NCT01881230|76186122|FG002|Overall Study|Physician Decision|6|||
42347127|NCT01881230|76186120|FG000|Overall Study|Non-Compliance with Study Drug|1|||
42347128|NCT01881230|76186121|FG001|Overall Study|Non-Compliance with Study Drug|2|||
42347129|NCT01881230|76186122|FG002|Overall Study|Non-Compliance with Study Drug|0|||
42347130|NCT01881230|76186120|FG000|Overall Study|Given Commercially Available Drug|0|||
42347131|NCT01881230|76186121|FG001|Overall Study|Given Commercially Available Drug|0|||
42347132|NCT01881230|76186122|FG002|Overall Study|Given Commercially Available Drug|2|||
42347133|NCT01881230|76186120|FG000|Overall Study|Protocol Violation|1|||
42347134|NCT01881230|76186121|FG001|Overall Study|Protocol Violation|1|||
42347135|NCT01881230|76186122|FG002|Overall Study|Protocol Violation|0|||
42347136|NCT01881230|76186120|FG000|Overall Study|Miscellaneous|3|||
42347137|NCT01881230|76186121|FG001|Overall Study|Miscellaneous|3|||
42347138|NCT01881230|76186122|FG002|Overall Study|Miscellaneous|0|||
42347139|NCT01881230|76186120|FG000|Overall Study|Untreated: Other|0|||
42347140|NCT01881230|76186121|FG001|Overall Study|Untreated: Other|0|||
42347141|NCT01881230|76186122|FG002|Overall Study|Untreated: Other|1|||
42347142|NCT01881230|76186120|FG000|Overall Study|Untreated: Death|0|||
42347143|NCT01881230|76186121|FG001|Overall Study|Untreated: Death|0|||
42347144|NCT01881230|76186122|FG002|Overall Study|Untreated: Death|1|||
42347145|NCT01881230|76186120|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
42347146|NCT01881230|76186121|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
42347147|NCT01881230|76186122|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
42137887|NCT00473330|75948218|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
42272775|NCT00835211|76103205|FG001|First Intervention|Withdrawal by Subject|1|||
42272776|NCT00835211|76103204|FG000|Washout: 7 Days|Adverse Event|2|||
42347148|NCT01856582|76186130|FG000|Overall Study|Died prior to Boost infusion|1|||
42347149|NCT01829360|76186138|FG000|Overall Study|Protocol Violation|0|||
42347150|NCT01829360|76186139|FG001|Overall Study|Protocol Violation|0|||
42347151|NCT01829360|76186140|FG002|Overall Study|Protocol Violation|1|||
42347152|NCT01829360|76186141|FG003|Overall Study|Protocol Violation|0|||
42347153|NCT01856114|76186157|FG000|Overall Study|Withdrawal by Subject|1|||
42347154|NCT01856114|76186158|FG001|Overall Study|Withdrawal by Subject|0|||
42347155|NCT01856114|76186157|FG000|Overall Study|Adverse Event|1|||
42347156|NCT01856114|76186158|FG001|Overall Study|Adverse Event|0|||
42347157|NCT01855958|76186166|FG000|Overall Study|Withdrawal by Subject|1|||
42347158|NCT01855958|76186167|FG001|Overall Study|Withdrawal by Subject|0|||
42347159|NCT01855412|76186178|FG000|Overall Study|Death|77|||
42347160|NCT01855412|76186179|FG001|Overall Study|Death|123|||
42347161|NCT01855412|76186180|FG002|Overall Study|Death|30|||
42347162|NCT01855412|76186178|FG000|Overall Study|Lost to Follow-up|28|||
42347163|NCT01855412|76186179|FG001|Overall Study|Lost to Follow-up|46|||
42347164|NCT01855412|76186180|FG002|Overall Study|Lost to Follow-up|15|||
42347165|NCT01855412|76186178|FG000|Overall Study|Withdrawal by Subject|77|||
42272777|NCT00835211|76103205|FG001|Washout: 7 Days|Adverse Event|1|||
42272778|NCT00835211|76103204|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
42272779|NCT00835211|76103205|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
42272780|NCT00834743|76103218|FG000|Second Intervention|Withdrawal by Subject|1|||
42272781|NCT00834743|76103219|FG001|Second Intervention|Withdrawal by Subject|0|||
42272782|NCT00834587|76103225|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
42347166|NCT01855412|76186179|FG001|Overall Study|Withdrawal by Subject|123|||
42137888|NCT00473330|75948216|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
42137889|NCT00473330|75948217|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
42137890|NCT00473330|75948218|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
42137891|NCT00473330|75948216|FG000|Open-label Extension Through Month 60|Death|2|||
42137892|NCT00473330|75948217|FG001|Open-label Extension Through Month 60|Death|2|||
42137893|NCT00473330|75948218|FG002|Open-label Extension Through Month 60|Death|1|||
42137894|NCT00473330|75948216|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
42137895|NCT00473330|75948217|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
42137896|NCT00473330|75948218|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
42137897|NCT00473330|75948216|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
42137898|NCT00473330|75948217|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
42137899|NCT00473330|75948218|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
42137900|NCT00473330|75948216|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
42137901|NCT00473330|75948217|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
42347167|NCT01855412|76186180|FG002|Overall Study|Withdrawal by Subject|24|||
42347168|NCT01855412|76186178|FG000|Overall Study|Physician Decision|25|||
42347169|NCT01855412|76186179|FG001|Overall Study|Physician Decision|31|||
42347170|NCT01855412|76186180|FG002|Overall Study|Physician Decision|3|||
42347171|NCT01855412|76186178|FG000|Overall Study|Site Closure|4|||
42347172|NCT01855412|76186179|FG001|Overall Study|Site Closure|18|||
42347173|NCT01855412|76186180|FG002|Overall Study|Site Closure|1|||
42347174|NCT01855412|76186178|FG000|Overall Study|Reason not Specified|1|||
42347175|NCT01855412|76186179|FG001|Overall Study|Reason not Specified|2|||
42347176|NCT01855412|76186180|FG002|Overall Study|Reason not Specified|3|||
42137902|NCT00473330|75948218|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
42272783|NCT00834587|76103226|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
42272784|NCT00834431|76103232|FG000|First Intervention|Adverse Event|0|||
42272785|NCT00834431|76103233|FG001|First Intervention|Adverse Event|1|||
42137903|NCT00473330|75948216|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
42137904|NCT00473330|75948217|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
42137905|NCT00473330|75948218|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
42137906|NCT00473330|75948216|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
42137907|NCT00473330|75948217|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
42137908|NCT00473330|75948218|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
42137909|NCT00473330|75948216|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
42137910|NCT00473330|75948217|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
42137911|NCT00473330|75948218|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
42137912|NCT00416520|75948248|FG000|Open-label Period|Adverse Event|28|||
42137913|NCT00416520|75948249|FG001|Open-label Period|Adverse Event|10|||
42137914|NCT00416520|75948250|FG002|Open-label Period|Adverse Event|0|||
42137915|NCT00416520|75948251|FG003|Open-label Period|Adverse Event|0|||
42137916|NCT00416520|75948248|FG000|Open-label Period|Death|2|||
42272786|NCT00834431|76103232|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
42272787|NCT00834431|76103233|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
42347177|NCT01614470|76186196|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
42347178|NCT01614470|76186197|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
42347179|NCT01614470|76186198|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
42347180|NCT01614470|76186196|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
42347181|NCT01614470|76186197|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
42347182|NCT01614470|76186198|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
42347183|NCT01880528|76186209|FG000|Overall Study|Other|1|||
42347184|NCT01880528|76186210|FG001|Overall Study|Other|1|||
42347185|NCT01854944|76186219|FG000|Overall Study|Withdrawal by Subject|0|||
42347186|NCT01854944|76186220|FG001|Overall Study|Withdrawal by Subject|0|||
42347187|NCT01854944|76186221|FG002|Overall Study|Withdrawal by Subject|1|||
42347188|NCT01829048|76186248|FG000|Overall Study|Withdrawal by Subject|0|||
42347189|NCT01829048|76186249|FG001|Overall Study|Withdrawal by Subject|0|||
42272788|NCT00830219|76103253|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
42272789|NCT00830219|76103254|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
42272790|NCT02274766|76103260|FG000|Overall Study|Withdrawal by Subject|3|||
42272791|NCT02274766|76103261|FG001|Overall Study|Withdrawal by Subject|6|||
42272792|NCT02274766|76103260|FG000|Overall Study|Did Not Receive Study Drug|1|||
42272793|NCT02274766|76103261|FG001|Overall Study|Did Not Receive Study Drug|1|||
42272794|NCT02274766|76103260|FG000|Overall Study|Subject Unwilling to Proceed|0|||
42347190|NCT01829048|76186250|FG002|Overall Study|Withdrawal by Subject|0|||
42347191|NCT01829048|76186251|FG003|Overall Study|Withdrawal by Subject|2|||
42347192|NCT01829048|76186252|FG004|Overall Study|Withdrawal by Subject|0|||
42347193|NCT01854710|76186265|FG000|Overall Study|Withdrawal by Subject|2|||
42347194|NCT01854710|76186266|FG001|Overall Study|Withdrawal by Subject|1|||
42347195|NCT01854710|76186267|FG002|Overall Study|Withdrawal by Subject|0|||
42010630|NCT04211389|75817747|FG000|Overall Study|Protocol Violation|0|||
42137917|NCT00416520|75948249|FG001|Open-label Period|Death|1|||
42137918|NCT00416520|75948250|FG002|Open-label Period|Death|0|||
42137919|NCT00416520|75948251|FG003|Open-label Period|Death|0|||
42137920|NCT00416520|75948248|FG000|Open-label Period|Lack of Efficacy|8|||
42137921|NCT00416520|75948249|FG001|Open-label Period|Lack of Efficacy|1|||
42137922|NCT00416520|75948250|FG002|Open-label Period|Lack of Efficacy|0|||
42272795|NCT02274766|76103261|FG001|Overall Study|Subject Unwilling to Proceed|1|||
42137923|NCT00416520|75948251|FG003|Open-label Period|Lack of Efficacy|0|||
42137924|NCT00416520|75948248|FG000|Open-label Period|Protocol Violation|3|||
42137925|NCT00416520|75948249|FG001|Open-label Period|Protocol Violation|3|||
42137926|NCT00416520|75948250|FG002|Open-label Period|Protocol Violation|0|||
42137927|NCT00416520|75948251|FG003|Open-label Period|Protocol Violation|0|||
42137928|NCT00416520|75948248|FG000|Open-label Period|Withdrawal by Subject|16|||
42137929|NCT00416520|75948249|FG001|Open-label Period|Withdrawal by Subject|5|||
42137930|NCT00416520|75948250|FG002|Open-label Period|Withdrawal by Subject|0|||
42137931|NCT00416520|75948251|FG003|Open-label Period|Withdrawal by Subject|0|||
42272796|NCT02274766|76103260|FG000|Overall Study|Adverse Event|0|||
42272797|NCT02274766|76103261|FG001|Overall Study|Adverse Event|1|||
42272798|NCT00829673|76103269|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
42272799|NCT00829673|76103270|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
42272800|NCT02370238|76103276|FG000|Overall Study|Death|42|||
42137932|NCT00416520|75948248|FG000|Open-label Period|Other Reasons|3|||
42137933|NCT00416520|75948249|FG001|Open-label Period|Other Reasons|12|||
42137934|NCT00416520|75948250|FG002|Open-label Period|Other Reasons|0|||
42137935|NCT00416520|75948251|FG003|Open-label Period|Other Reasons|0|||
42137936|NCT00416520|75948248|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
42137937|NCT00416520|75948249|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
42137938|NCT00416520|75948250|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
42137939|NCT00416520|75948251|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
42137940|NCT00416520|75948248|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
42137941|NCT00416520|75948249|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
42137942|NCT00416520|75948250|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
42137943|NCT00416520|75948251|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
42137944|NCT00416520|75948248|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
42137945|NCT00416520|75948249|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
42137946|NCT00416520|75948250|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
42137947|NCT00416520|75948251|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
42137948|NCT00533429|75948263|FG000|Overall Study|Adverse Event|3|||
42137949|NCT00533429|75948264|FG001|Overall Study|Adverse Event|1|||
42137950|NCT00533429|75948263|FG000|Overall Study|Death|1|||
42137951|NCT00533429|75948264|FG001|Overall Study|Death|0|||
42137952|NCT00533429|75948263|FG000|Overall Study|Withdrawal by Subject|2|||
42137953|NCT00533429|75948264|FG001|Overall Study|Withdrawal by Subject|0|||
42137954|NCT00533429|75948263|FG000|Overall Study|Progressive Disease|12|||
42137955|NCT00533429|75948264|FG001|Overall Study|Progressive Disease|13|||
42137956|NCT00533429|75948263|FG000|Overall Study|Symptomatic deterioration|1|||
42137957|NCT00533429|75948264|FG001|Overall Study|Symptomatic deterioration|2|||
42137958|NCT00533273|75948274|FG000|Double-blind|Withdrew consent|0|||
42137959|NCT00533273|75948275|FG001|Double-blind|Withdrew consent|2|||
42137960|NCT00533273|75948274|FG000|Open-label|Withdrawal by Subject|6|||
42137961|NCT00533273|75948275|FG001|Open-label|Withdrawal by Subject|0|||
42137962|NCT03891641|75948283|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
42137963|NCT03891641|75948284|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
42137964|NCT00339183|75948292|FG000|Overall Study|Adverse Event|5|||
42137965|NCT00339183|75948293|FG001|Overall Study|Adverse Event|3|||
42137966|NCT00339183|75948292|FG000|Overall Study|Withdrawal by Subject|16|||
42137967|NCT00339183|75948293|FG001|Overall Study|Withdrawal by Subject|19|||
42137968|NCT00339183|75948292|FG000|Overall Study|Physician Decision|2|||
42137969|NCT00339183|75948293|FG001|Overall Study|Physician Decision|4|||
42137970|NCT00339183|75948292|FG000|Overall Study|Lost to Follow-up|17|||
42137971|NCT00339183|75948293|FG001|Overall Study|Lost to Follow-up|17|||
42137972|NCT00339183|75948292|FG000|Overall Study|Protocol-specified criteria|12|||
42272801|NCT02370238|76103277|FG001|Overall Study|Death|35|||
42272802|NCT02370238|76103276|FG000|Overall Study|Lost to Follow-up|1|||
42272803|NCT02370238|76103277|FG001|Overall Study|Lost to Follow-up|3|||
42272804|NCT02370238|76103276|FG000|Overall Study|Withdrawal by Subject|2|||
42272805|NCT02370238|76103277|FG001|Overall Study|Withdrawal by Subject|6|||
42272806|NCT02370238|76103276|FG000|Overall Study|Other|2|||
42272807|NCT02370238|76103277|FG001|Overall Study|Other|1|||
42272808|NCT02370160|76103287|FG000|Overall Study|Death|3|||
42272809|NCT02370160|76103288|FG001|Overall Study|Death|4|||
42272810|NCT02370160|76103289|FG002|Overall Study|Death|1|||
42272811|NCT02273908|76103304|FG000|Overall Study|Adverse Event|16|||
42272812|NCT02273908|76103305|FG001|Overall Study|Adverse Event|0|||
42272813|NCT02273908|76103304|FG000|Overall Study|Lost to Follow-up|10|||
42272814|NCT02273908|76103305|FG001|Overall Study|Lost to Follow-up|1|||
42272815|NCT02273908|76103304|FG000|Overall Study|Did not meet entrance criteria|3|||
42272816|NCT02273908|76103305|FG001|Overall Study|Did not meet entrance criteria|2|||
42272817|NCT02273908|76103304|FG000|Overall Study|Withdrawal by Subject|4|||
42272818|NCT02273908|76103305|FG001|Overall Study|Withdrawal by Subject|2|||
42272819|NCT02273752|76103315|FG000|Overall Study|Trial was terminated early|2|||
42272820|NCT05180630|76103319|FG000|First Intervention|Physician Decision|0|||
42272821|NCT05180630|76103320|FG001|First Intervention|Physician Decision|0|||
42272822|NCT05180630|76103321|FG002|First Intervention|Physician Decision|3|||
42272823|NCT02273596|76103330|FG000|24-Week Treatment Period|Adverse Event|3|||
42272824|NCT02273596|76103330|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
42272825|NCT02273596|76103330|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
42272826|NCT02273596|76103330|FG000|24-Week Treatment Period|Physician Decision|1|||
42272827|NCT02273596|76103330|FG000|24-Week Treatment Period|Protocol Deviation|1|||
42272828|NCT02273596|76103330|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
42272829|NCT02273596|76103330|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
42272830|NCT02273596|76103330|FG000|Extension Period|Lost to Follow-up|1|||
42272831|NCT02273596|76103330|FG000|Extension Period|Protocol Deviation|1|||
42272832|NCT01656200|76103340|FG000|Overall Study|Withdrawal by Subject|1|||
42272833|NCT02369848|76103344|FG000|Overall Study|Death|1|||
42272834|NCT02369848|76103344|FG000|Overall Study|Withdrawal by Subject|2|||
42272835|NCT02369848|76103344|FG000|Overall Study|Lost to Follow-up|1|||
42272836|NCT02368210|76103350|FG000|Overall Study|Withdrawal by Subject|1|||
42272837|NCT02368210|76103351|FG001|Overall Study|Withdrawal by Subject|0|||
42272838|NCT02368210|76103350|FG000|Overall Study|Adverse Event|0|||
42272839|NCT02368210|76103351|FG001|Overall Study|Adverse Event|1|||
42272840|NCT02273050|76103360|FG000|Overall Study|Adverse Event|4|||
42272841|NCT02273050|76103361|FG001|Overall Study|Adverse Event|3|||
42272842|NCT02273050|76103362|FG002|Overall Study|Adverse Event|3|||
42272843|NCT02273050|76103360|FG000|Overall Study|Death|0|||
42272844|NCT02273050|76103361|FG001|Overall Study|Death|0|||
42272845|NCT02273050|76103362|FG002|Overall Study|Death|1|||
42272846|NCT02273050|76103360|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
42347196|NCT01854710|76186268|FG003|Overall Study|Withdrawal by Subject|0|||
42347197|NCT01854710|76186269|FG004|Overall Study|Withdrawal by Subject|0|||
42347198|NCT01854710|76186270|FG005|Overall Study|Withdrawal by Subject|0|||
42347199|NCT01854710|76186265|FG000|Overall Study|CRI procedural error|2|||
42347200|NCT01854710|76186266|FG001|Overall Study|CRI procedural error|2|||
42347201|NCT01854710|76186267|FG002|Overall Study|CRI procedural error|2|||
42347202|NCT01854710|76186268|FG003|Overall Study|CRI procedural error|2|||
42347203|NCT01854710|76186269|FG004|Overall Study|CRI procedural error|2|||
42347204|NCT01854710|76186270|FG005|Overall Study|CRI procedural error|2|||
42347205|NCT01828034|76186284|FG000|Overall Study|Withdrawal by Subject|0|||
42347206|NCT01828034|76186285|FG001|Overall Study|Withdrawal by Subject|0|||
42347207|NCT01828034|76186286|FG002|Overall Study|Withdrawal by Subject|0|||
42347208|NCT01828034|76186287|FG003|Overall Study|Withdrawal by Subject|1|||
42347209|NCT01853696|76186296|FG000|Overall Study|Withdrawal by Subject|1|||
42347210|NCT01853696|76186297|FG001|Overall Study|Withdrawal by Subject|1|||
42347211|NCT01853696|76186296|FG000|Overall Study|Lost to Follow-up|5|||
42347212|NCT01853696|76186297|FG001|Overall Study|Lost to Follow-up|4|||
42347213|NCT01871805|76186309|FG000|Phase I|Death|7|||
42347214|NCT01871805|76186310|FG001|Phase I|Death|4|||
42347215|NCT01871805|76186311|FG002|Phase I|Death|6|||
42347216|NCT01871805|76186312|FG003|Phase I|Death|2|||
42347217|NCT01871805|76186313|FG004|Phase I|Death|9|||
42347218|NCT01871805|76186314|FG005|Phase I|Death|0|||
42347219|NCT01871805|76186309|FG000|Phase I|Alive in Survival Follow-up|0|||
42347220|NCT01871805|76186310|FG001|Phase I|Alive in Survival Follow-up|2|||
42347221|NCT01871805|76186311|FG002|Phase I|Alive in Survival Follow-up|4|||
42347222|NCT01871805|76186312|FG003|Phase I|Alive in Survival Follow-up|5|||
42347223|NCT01871805|76186313|FG004|Phase I|Alive in Survival Follow-up|4|||
42347224|NCT01871805|76186314|FG005|Phase I|Alive in Survival Follow-up|0|||
42347225|NCT01871805|76186309|FG000|Phase I|Lost to Follow-up|0|||
42347226|NCT01871805|76186310|FG001|Phase I|Lost to Follow-up|1|||
42347227|NCT01871805|76186311|FG002|Phase I|Lost to Follow-up|3|||
42347228|NCT01871805|76186312|FG003|Phase I|Lost to Follow-up|0|||
42347229|NCT01871805|76186313|FG004|Phase I|Lost to Follow-up|0|||
42347230|NCT01871805|76186314|FG005|Phase I|Lost to Follow-up|0|||
42347231|NCT01871805|76186309|FG000|Phase II|Death|0|||
42347232|NCT01871805|76186310|FG001|Phase II|Death|0|||
42347233|NCT01871805|76186311|FG002|Phase II|Death|0|||
42347234|NCT01871805|76186312|FG003|Phase II|Death|0|||
42347235|NCT01871805|76186313|FG004|Phase II|Death|0|||
42347236|NCT01871805|76186314|FG005|Phase II|Death|45|||
42272847|NCT02273050|76103361|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
42347237|NCT01871805|76186309|FG000|Phase II|Alive in Survival Follow-up|0|||
42347238|NCT01871805|76186310|FG001|Phase II|Alive in Survival Follow-up|0|||
42272848|NCT02273050|76103362|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
42272849|NCT02273050|76103360|FG000|Overall Study|Lack of Efficacy|0|||
42347239|NCT01871805|76186311|FG002|Phase II|Alive in Survival Follow-up|0|||
42347240|NCT01871805|76186312|FG003|Phase II|Alive in Survival Follow-up|0|||
42347241|NCT01871805|76186313|FG004|Phase II|Alive in Survival Follow-up|0|||
42347242|NCT01871805|76186314|FG005|Phase II|Alive in Survival Follow-up|29|||
42347243|NCT01871805|76186309|FG000|Phase II|Lost to Follow-up|0|||
42347244|NCT01871805|76186310|FG001|Phase II|Lost to Follow-up|0|||
42347245|NCT01871805|76186311|FG002|Phase II|Lost to Follow-up|0|||
42347246|NCT01871805|76186312|FG003|Phase II|Lost to Follow-up|0|||
42347247|NCT01871805|76186313|FG004|Phase II|Lost to Follow-up|0|||
42347248|NCT01871805|76186314|FG005|Phase II|Lost to Follow-up|13|||
42347249|NCT01719861|76186345|FG000|Cycle 1|Death|4|||
42347250|NCT01719861|76186345|FG000|Cycle 2|Death|1|||
42347251|NCT01853618|76186355|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
42347252|NCT01853618|76186356|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
42347253|NCT01853618|76186357|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
42347254|NCT01853618|76186358|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
42347255|NCT01853618|76186359|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
42347256|NCT01853618|76186355|FG000|Overall Study|Progressive disease|1|||
42347257|NCT01853618|76186356|FG001|Overall Study|Progressive disease|1|||
42347258|NCT01853618|76186357|FG002|Overall Study|Progressive disease|1|||
42347259|NCT01853618|76186358|FG003|Overall Study|Progressive disease|1|||
42347260|NCT01853618|76186359|FG004|Overall Study|Progressive disease|2|||
42347261|NCT01853618|76186355|FG000|Overall Study|Physician Decision|0|||
42347262|NCT01853618|76186356|FG001|Overall Study|Physician Decision|1|||
42347263|NCT01853618|76186357|FG002|Overall Study|Physician Decision|1|||
42347264|NCT01853618|76186358|FG003|Overall Study|Physician Decision|0|||
42347265|NCT01853618|76186359|FG004|Overall Study|Physician Decision|0|||
42010631|NCT04211389|75817748|FG001|Overall Study|Protocol Violation|1|||
42010632|NCT04211389|75817747|FG000|Overall Study|Withdrawal by Subject|10|||
42010633|NCT04211389|75817748|FG001|Overall Study|Withdrawal by Subject|11|||
42010634|NCT00993031|75817756|FG000|Overall Study|Death|0|||
42010635|NCT00993031|75817757|FG001|Overall Study|Death|1|||
42010636|NCT00993031|75817756|FG000|Overall Study|Physician Decision|0|||
42010637|NCT00993031|75817757|FG001|Overall Study|Physician Decision|2|||
42010638|NCT00993031|75817756|FG000|Overall Study|Withdrawal by Subject|3|||
42010639|NCT00993031|75817757|FG001|Overall Study|Withdrawal by Subject|3|||
42010640|NCT00993031|75817756|FG000|Overall Study|Lost to Follow-up|19|||
42137973|NCT00339183|75948293|FG001|Overall Study|Protocol-specified criteria|8|||
42272850|NCT02273050|76103361|FG001|Overall Study|Lack of Efficacy|1|||
42272851|NCT02273050|76103362|FG002|Overall Study|Lack of Efficacy|1|||
42272852|NCT02273050|76103360|FG000|Overall Study|Withdrawal by Subject|17|||
42272853|NCT02273050|76103361|FG001|Overall Study|Withdrawal by Subject|14|||
42272854|NCT02273050|76103362|FG002|Overall Study|Withdrawal by Subject|16|||
42347266|NCT01853618|76186355|FG000|Overall Study|Refused further treatment|0|||
42347267|NCT01853618|76186356|FG001|Overall Study|Refused further treatment|0|||
42347268|NCT01853618|76186357|FG002|Overall Study|Refused further treatment|0|||
42347269|NCT01853618|76186358|FG003|Overall Study|Refused further treatment|0|||
42347270|NCT01853618|76186359|FG004|Overall Study|Refused further treatment|1|||
42347271|NCT01853462|76186374|FG000|Overall Study|Withdrawal by Subject|1|||
42347272|NCT01853462|76186375|FG001|Overall Study|Withdrawal by Subject|1|||
42347273|NCT01719783|76186385|FG000|Dose 2|Physician Decision|1|||
42347274|NCT01719783|76186386|FG001|Dose 2|Physician Decision|0|||
42347275|NCT01853384|76186414|FG000|Randomized|Adverse Event|5|||
42347276|NCT01853384|76186415|FG001|Randomized|Adverse Event|3|||
42347277|NCT01853384|76186414|FG000|Randomized|Death|1|||
42137974|NCT00339183|75948292|FG000|Overall Study|Missing reason|3|||
42137975|NCT00339183|75948293|FG001|Overall Study|Missing reason|1|||
42137976|NCT00339183|75948292|FG000|Overall Study|Other|46|||
42272855|NCT02273050|76103360|FG000|Overall Study|Lost to Follow-up|0|||
42272856|NCT02273050|76103361|FG001|Overall Study|Lost to Follow-up|2|||
42272857|NCT02273050|76103362|FG002|Overall Study|Lost to Follow-up|3|||
42272858|NCT02273050|76103360|FG000|Overall Study|Protocol Violation|3|||
42272859|NCT02273050|76103361|FG001|Overall Study|Protocol Violation|1|||
42272860|NCT02273050|76103362|FG002|Overall Study|Protocol Violation|4|||
42272861|NCT02272816|76103370|FG000|Overall Study|Adverse Event|1|||
42272862|NCT02271880|76103376|FG000|Overall Study|Premature discontinuation of study|3|||
42272863|NCT02271880|76103377|FG001|Overall Study|Premature discontinuation of study|4|||
42347278|NCT01853384|76186415|FG001|Randomized|Death|2|||
42137977|NCT00339183|75948293|FG001|Overall Study|Other|40|||
42347279|NCT01853384|76186414|FG000|Randomized|Lost to Follow-up|1|||
42347280|NCT01853384|76186415|FG001|Randomized|Lost to Follow-up|1|||
42347281|NCT01853384|76186414|FG000|Randomized|Withdrawal by Subject|5|||
42347282|NCT01853384|76186415|FG001|Randomized|Withdrawal by Subject|3|||
42347283|NCT01853384|76186414|FG000|Randomized|Sponsor Decision|47|||
42347284|NCT01853384|76186415|FG001|Randomized|Sponsor Decision|34|||
42347285|NCT01853384|76186414|FG000|Randomized|Other|3|||
42010641|NCT00993031|75817757|FG001|Overall Study|Lost to Follow-up|13|||
42272864|NCT02367352|76103385|FG000|Overall Study|Progressive disease|7|||
42272865|NCT02367352|76103386|FG001|Overall Study|Progressive disease|0|||
42347286|NCT01853384|76186415|FG001|Randomized|Other|3|||
42347287|NCT01853384|76186414|FG000|Completed Follow up Visit 1|Early Termination|13|||
42272866|NCT02367352|76103387|FG002|Overall Study|Progressive disease|0|||
42137978|NCT00339183|75948292|FG000|Overall Study|Ongoing|20|||
42347288|NCT01853384|76186415|FG001|Completed Follow up Visit 1|Early Termination|9|||
42137979|NCT00339183|75948293|FG001|Overall Study|Ongoing|13|||
42272867|NCT02367352|76103385|FG000|Overall Study|Participant Received Alternative Therapy|1|||
42272868|NCT02367352|76103386|FG001|Overall Study|Participant Received Alternative Therapy|0|||
42272869|NCT02367352|76103387|FG002|Overall Study|Participant Received Alternative Therapy|0|||
42272870|NCT02367352|76103385|FG000|Overall Study|Adverse Event|1|||
42272871|NCT02367352|76103386|FG001|Overall Study|Adverse Event|0|||
42272872|NCT02367352|76103387|FG002|Overall Study|Adverse Event|0|||
42272873|NCT02365636|76103396|FG000|Overall Study|Adverse Event|3|||
42272874|NCT02365636|76103397|FG001|Overall Study|Adverse Event|3|||
42272875|NCT02365636|76103398|FG002|Overall Study|Adverse Event|2|||
42272876|NCT02365636|76103396|FG000|Overall Study|Protocol Violation|1|||
42272877|NCT02365636|76103397|FG001|Overall Study|Protocol Violation|4|||
42347289|NCT01853384|76186414|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
42272878|NCT02365636|76103398|FG002|Overall Study|Protocol Violation|0|||
42272879|NCT02365636|76103396|FG000|Overall Study|Lost to Follow-up|0|||
42272880|NCT02365636|76103397|FG001|Overall Study|Lost to Follow-up|0|||
42272881|NCT02365636|76103398|FG002|Overall Study|Lost to Follow-up|1|||
42272882|NCT02365636|76103396|FG000|Overall Study|Other|2|||
42272883|NCT02365636|76103397|FG001|Overall Study|Other|0|||
42272884|NCT02365636|76103398|FG002|Overall Study|Other|0|||
42272885|NCT01655498|76103406|FG000|Overall Study|Unrelated health issue|2|||
42272886|NCT01655498|76103406|FG000|Overall Study|Protocol Violation|2|||
42272887|NCT01655498|76103406|FG000|Overall Study|Withdrawal by Subject|1|||
42272888|NCT02270944|76103415|FG000|Overall Study|Lost to Follow-up|9|||
42272889|NCT02270944|76103416|FG001|Overall Study|Lost to Follow-up|4|||
42272890|NCT02270944|76103415|FG000|Overall Study|Withdrawal by Subject|2|||
42272891|NCT02270944|76103416|FG001|Overall Study|Withdrawal by Subject|1|||
42272892|NCT02365558|76103423|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
42272893|NCT02365558|76103424|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
42272894|NCT02365558|76103423|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
42272895|NCT02365558|76103424|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
42272896|NCT02365480|76103435|FG000|Overall Study|Withdrawal by Subject|2|||
42272897|NCT02365480|76103436|FG001|Overall Study|Withdrawal by Subject|0|||
42272898|NCT02270242|76103444|FG000|Overall Study|Withdrawal by Subject|18|||
42272899|NCT02270242|76103445|FG001|Overall Study|Withdrawal by Subject|25|||
42272900|NCT02270242|76103444|FG000|Overall Study|Lost to Follow-up|41|||
42347290|NCT01853384|76186415|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
42347291|NCT01853384|76186414|FG000|Completed Follow up Visit 2|Adverse Event|1|||
42347292|NCT01853384|76186415|FG001|Completed Follow up Visit 2|Adverse Event|0|||
42347293|NCT01853384|76186414|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
42347294|NCT01853384|76186415|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
42347295|NCT01853384|76186414|FG000|Completed Follow up Visit 2|Death|1|||
42347296|NCT01853384|76186415|FG001|Completed Follow up Visit 2|Death|0|||
42347297|NCT01853384|76186414|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
42347298|NCT01853384|76186415|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
42347299|NCT01878890|76186425|FG000|Overall Study|Protocol Violation|0|||
42347300|NCT01878890|76186426|FG001|Overall Study|Protocol Violation|1|||
42347301|NCT01878890|76186427|FG002|Overall Study|Protocol Violation|0|||
42347302|NCT01878890|76186428|FG003|Overall Study|Protocol Violation|0|||
42347303|NCT01827332|76186441|FG000|Overall Study|Lost to Follow-up|2|||
42347304|NCT01827332|76186442|FG001|Overall Study|Lost to Follow-up|1|||
42347305|NCT01719003|76186456|FG000|Overall Study|Non compliant with protocol|1|||
42347306|NCT01719003|76186457|FG001|Overall Study|Non compliant with protocol|1|||
42347307|NCT01719003|76186458|FG002|Overall Study|Non compliant with protocol|0|||
42347308|NCT01719003|76186459|FG003|Overall Study|Non compliant with protocol|1|||
42347309|NCT01719003|76186460|FG004|Overall Study|Non compliant with protocol|2|||
42347310|NCT01719003|76186461|FG005|Overall Study|Non compliant with protocol|1|||
42347311|NCT01719003|76186462|FG006|Overall Study|Non compliant with protocol|2|||
42347312|NCT01719003|76186463|FG007|Overall Study|Non compliant with protocol|3|||
42347313|NCT01719003|76186464|FG008|Overall Study|Non compliant with protocol|0|||
42347314|NCT01719003|76186456|FG000|Overall Study|Adverse Event|6|||
42272901|NCT02270242|76103445|FG001|Overall Study|Lost to Follow-up|27|||
42347315|NCT01719003|76186457|FG001|Overall Study|Adverse Event|5|||
42347316|NCT01719003|76186458|FG002|Overall Study|Adverse Event|4|||
42347317|NCT01719003|76186459|FG003|Overall Study|Adverse Event|3|||
42347318|NCT01719003|76186460|FG004|Overall Study|Adverse Event|4|||
42347319|NCT01719003|76186461|FG005|Overall Study|Adverse Event|3|||
42272902|NCT02270242|76103444|FG000|Overall Study|Physician Decision|0|||
42272903|NCT02270242|76103445|FG001|Overall Study|Physician Decision|1|||
42272904|NCT02364388|76103451|FG000|Overall Study|Protocol Violation|1|||
42272905|NCT02364388|76103451|FG000|Overall Study|Technical Failure|3|||
42272906|NCT02364388|76103451|FG000|Overall Study|No OA/US data|2|||
42272907|NCT02364388|76103451|FG000|Overall Study|No Biopsy|2|||
42272908|NCT02363686|76103455|FG000|Overall Study|Withdrawal by Subject|22|||
42272909|NCT02363686|76103455|FG000|Overall Study|incomplete FEES examinations|13|||
42347320|NCT01719003|76186462|FG006|Overall Study|Adverse Event|6|||
42347321|NCT01719003|76186463|FG007|Overall Study|Adverse Event|5|||
42137980|NCT00333801|75948305|FG000|Overall Study|Moved to another state|5|||
42137981|NCT00333801|75948306|FG001|Overall Study|Moved to another state|3|||
42137982|NCT00333801|75948305|FG000|Overall Study|Lost to Follow-up|2|||
42137983|NCT00333801|75948306|FG001|Overall Study|Lost to Follow-up|0|||
42010642|NCT01010776|75817767|FG000|Main Phase|Withdrawal by Subject|14|||
42272910|NCT02268916|76103461|FG000|Overall Study|Lost to Follow-up|1|||
42137984|NCT00333801|75948305|FG000|Overall Study|Incarcerated|1|||
42137985|NCT00333801|75948306|FG001|Overall Study|Incarcerated|2|||
42137986|NCT00333801|75948305|FG000|Overall Study|Withdrawal by Subject|0|||
42137987|NCT00333801|75948306|FG001|Overall Study|Withdrawal by Subject|1|||
42137988|NCT00532883|75948316|FG000|Overall Study|Adverse Event|1|||
42137989|NCT00532883|75948317|FG001|Overall Study|Adverse Event|0|||
42137990|NCT00532883|75948318|FG002|Overall Study|Adverse Event|0|||
42137991|NCT00532883|75948319|FG003|Overall Study|Adverse Event|1|||
42137992|NCT00532883|75948316|FG000|Overall Study|Lost to Follow-up|1|||
42137993|NCT00532883|75948317|FG001|Overall Study|Lost to Follow-up|1|||
42137994|NCT00532883|75948318|FG002|Overall Study|Lost to Follow-up|1|||
42137995|NCT00532883|75948319|FG003|Overall Study|Lost to Follow-up|0|||
42137996|NCT00532883|75948316|FG000|Overall Study|Withdrawal by Subject|0|||
42137997|NCT00532883|75948317|FG001|Overall Study|Withdrawal by Subject|1|||
42137998|NCT00532883|75948318|FG002|Overall Study|Withdrawal by Subject|1|||
42137999|NCT00532883|75948319|FG003|Overall Study|Withdrawal by Subject|0|||
42138000|NCT00532883|75948316|FG000|Overall Study|Subject was Nonadherent|0|||
42138001|NCT00532883|75948317|FG001|Overall Study|Subject was Nonadherent|1|||
42138002|NCT00532883|75948318|FG002|Overall Study|Subject was Nonadherent|1|||
42138003|NCT00532883|75948319|FG003|Overall Study|Subject was Nonadherent|0|||
42138004|NCT00532883|75948316|FG000|Overall Study|Early Study Termination|4|||
42138005|NCT00532883|75948317|FG001|Overall Study|Early Study Termination|4|||
42138006|NCT00532883|75948318|FG002|Overall Study|Early Study Termination|1|||
42138007|NCT00532883|75948319|FG003|Overall Study|Early Study Termination|4|||
42138008|NCT00354159|75948331|FG000|Randomized Study Period|Withdrawal by Subject|5|||
42138009|NCT00354159|75948332|FG001|Randomized Study Period|Withdrawal by Subject|3|||
42138010|NCT00354159|75948331|FG000|Randomized Study Period|Physician Decision|6|||
42138011|NCT00354159|75948332|FG001|Randomized Study Period|Physician Decision|10|||
42138012|NCT00354159|75948331|FG000|Randomized Study Period|Lost to Follow-up|4|||
42138013|NCT00354159|75948332|FG001|Randomized Study Period|Lost to Follow-up|0|||
42138014|NCT00354159|75948331|FG000|Randomized Study Period|Death|7|||
42138015|NCT00354159|75948332|FG001|Randomized Study Period|Death|9|||
42138016|NCT00354159|75948331|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
42138017|NCT00354159|75948332|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
42138018|NCT00354159|75948331|FG000|Long-term Follow-up|Physician Decision|127|||
42138019|NCT00354159|75948332|FG001|Long-term Follow-up|Physician Decision|122|||
42138020|NCT00354159|75948331|FG000|Long-term Follow-up|Lost to Follow-up|1|||
42272911|NCT02268916|76103462|FG001|Overall Study|Lost to Follow-up|1|||
42272912|NCT02268916|76103461|FG000|Overall Study|Withdrawal by Subject|6|||
42272913|NCT02268916|76103462|FG001|Overall Study|Withdrawal by Subject|5|||
42272914|NCT02268916|76103461|FG000|Overall Study|Participant did not have diabetes|1|||
42272915|NCT02268916|76103462|FG001|Overall Study|Participant did not have diabetes|0|||
42272916|NCT02268916|76103461|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
42272917|NCT02268916|76103462|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
42347322|NCT01719003|76186464|FG008|Overall Study|Adverse Event|0|||
42347323|NCT01719003|76186456|FG000|Overall Study|Lost to Follow-up|0|||
42010643|NCT01010776|75817767|FG000|Main Phase|Lack of Efficacy|8|||
42010644|NCT01010776|75817767|FG000|Main Phase|Adverse Event|7|||
42138021|NCT00354159|75948332|FG001|Long-term Follow-up|Lost to Follow-up|0|||
42138022|NCT00354159|75948331|FG000|Long-term Follow-up|Death|14|||
42138023|NCT00354159|75948332|FG001|Long-term Follow-up|Death|11|||
42138024|NCT00354159|75948331|FG000|Long-term Follow-up|Study Closed|29|||
42138025|NCT00354159|75948332|FG001|Long-term Follow-up|Study Closed|34|||
42138026|NCT00338949|75948347|FG000|Subject Screening|Screen failures|11|||
42138027|NCT00338949|75948348|FG001|Subject Screening|Screen failures|11|||
42138028|NCT00338949|75948347|FG000|Randomization|Withdrawal by Subject|1|||
42138029|NCT00338949|75948348|FG001|Randomization|Withdrawal by Subject|0|||
42138030|NCT00338949|75948347|FG000|Randomization|Adverse Event|0|||
42138031|NCT00338949|75948348|FG001|Randomization|Adverse Event|5|||
42138032|NCT00332709|75948356|FG000|Overall Study|Adverse Event|11|||
42138033|NCT00332709|75948357|FG001|Overall Study|Adverse Event|14|||
42138034|NCT00332709|75948356|FG000|Overall Study|Withdrawal by Subject|2|||
42138035|NCT00332709|75948357|FG001|Overall Study|Withdrawal by Subject|3|||
42138036|NCT00332709|75948356|FG000|Overall Study|Lost to Follow-up|2|||
42138037|NCT00332709|75948357|FG001|Overall Study|Lost to Follow-up|0|||
42138038|NCT00332709|75948356|FG000|Overall Study|Administrative Problems|0|||
42138039|NCT00332709|75948357|FG001|Overall Study|Administrative Problems|3|||
42138040|NCT00332709|75948356|FG000|Overall Study|Abnormal test procedure result|1|||
42138041|NCT00332709|75948357|FG001|Overall Study|Abnormal test procedure result|0|||
42138042|NCT00332241|75948365|FG000|Overall Study|Lack of Efficacy|6|||
42138043|NCT00332241|75948366|FG001|Overall Study|Lack of Efficacy|1|||
42138044|NCT00332241|75948365|FG000|Overall Study|Adverse Event|3|||
42138045|NCT00332241|75948366|FG001|Overall Study|Adverse Event|5|||
42138046|NCT00332241|75948365|FG000|Overall Study|Withdrawal by Subject|2|||
42138047|NCT00332241|75948366|FG001|Overall Study|Withdrawal by Subject|1|||
42138048|NCT00332241|75948365|FG000|Overall Study|Lost to Follow-up|4|||
42138049|NCT00332241|75948366|FG001|Overall Study|Lost to Follow-up|1|||
42272918|NCT02518490|76103469|FG000|Overall Study|Withdrawal by Subject|1|||
42272919|NCT02518490|76103470|FG001|Overall Study|Withdrawal by Subject|1|||
42272920|NCT01364870|76103480|FG000|Overall Study|Withdrawal by Subject|13|||
42272921|NCT01364870|76103481|FG001|Overall Study|Withdrawal by Subject|24|||
42272922|NCT01364870|76103482|FG002|Overall Study|Withdrawal by Subject|10|||
42272923|NCT01364870|76103480|FG000|Overall Study|Adverse Event|8|||
42272924|NCT01364870|76103481|FG001|Overall Study|Adverse Event|6|||
42272925|NCT01364870|76103482|FG002|Overall Study|Adverse Event|4|||
42138050|NCT00337935|75948374|FG000|Overall Study|Adverse Event|2|||
42138051|NCT00337935|75948375|FG001|Overall Study|Adverse Event|5|||
42138052|NCT00337935|75948374|FG000|Overall Study|Death|2|||
42138053|NCT00337935|75948375|FG001|Overall Study|Death|8|||
42138054|NCT00337935|75948374|FG000|Overall Study|Physician Decision|1|||
42138055|NCT00337935|75948375|FG001|Overall Study|Physician Decision|1|||
42138056|NCT00337935|75948374|FG000|Overall Study|Lost to Follow-up|0|||
42138057|NCT00337935|75948375|FG001|Overall Study|Lost to Follow-up|1|||
42138058|NCT00337935|75948374|FG000|Overall Study|Protocol Violation|4|||
42138059|NCT00337935|75948375|FG001|Overall Study|Protocol Violation|3|||
42272926|NCT01364870|76103480|FG000|Overall Study|Protocol Violation|1|||
42272927|NCT01364870|76103481|FG001|Overall Study|Protocol Violation|0|||
42272928|NCT01364870|76103482|FG002|Overall Study|Protocol Violation|0|||
42272929|NCT02268526|76103493|FG000|Overall Study|Adverse Event|0|||
42272930|NCT02268526|76103494|FG001|Overall Study|Adverse Event|2|||
42272931|NCT02268526|76103495|FG002|Overall Study|Adverse Event|1|||
42272932|NCT02268526|76103493|FG000|Overall Study|Death|1|||
42272933|NCT02268526|76103494|FG001|Overall Study|Death|11|||
42272934|NCT02268526|76103495|FG002|Overall Study|Death|0|||
42272935|NCT02268526|76103493|FG000|Overall Study|protocol deviation|0|||
42138060|NCT00337935|75948374|FG000|Overall Study|Withdrawal by Subject|1|||
42138061|NCT00337935|75948375|FG001|Overall Study|Withdrawal by Subject|7|||
42138062|NCT00337935|75948374|FG000|Overall Study|Other|0|||
42138063|NCT00337935|75948375|FG001|Overall Study|Other|1|||
42138064|NCT00337935|75948374|FG000|Overall Study|Lack of Efficacy|0|||
42138065|NCT00337935|75948375|FG001|Overall Study|Lack of Efficacy|1|||
42138066|NCT00337779|75948384|FG000|Overall Study|Withdrawal by Subject|10|||
42138067|NCT00337779|75948385|FG001|Overall Study|Withdrawal by Subject|12|||
42138068|NCT00337779|75948384|FG000|Overall Study|Sponsor decision|1|||
42138069|NCT00337779|75948385|FG001|Overall Study|Sponsor decision|1|||
42138070|NCT00337779|75948384|FG000|Overall Study|Physician Decision|3|||
42138071|NCT00337779|75948385|FG001|Overall Study|Physician Decision|6|||
42138072|NCT00337779|75948384|FG000|Overall Study|Protocol Violation|1|||
42138073|NCT00337779|75948385|FG001|Overall Study|Protocol Violation|1|||
42138074|NCT00337779|75948384|FG000|Overall Study|Lost to Follow-up|6|||
42138075|NCT00337779|75948385|FG001|Overall Study|Lost to Follow-up|5|||
42138076|NCT00337779|75948384|FG000|Overall Study|Adverse Event|28|||
42138077|NCT00337779|75948385|FG001|Overall Study|Adverse Event|51|||
42138078|NCT00337779|75948384|FG000|Overall Study|Pregnancy|3|||
42138079|NCT00337779|75948385|FG001|Overall Study|Pregnancy|2|||
42138080|NCT00337779|75948384|FG000|Overall Study|Death|0|||
42272936|NCT02268526|76103494|FG001|Overall Study|protocol deviation|1|||
42272937|NCT02268526|76103495|FG002|Overall Study|protocol deviation|0|||
42138081|NCT00337779|75948385|FG001|Overall Study|Death|1|||
42272938|NCT02268526|76103493|FG000|Overall Study|Physician Decision|0|||
42272939|NCT02268526|76103494|FG001|Overall Study|Physician Decision|0|||
42272940|NCT02268526|76103495|FG002|Overall Study|Physician Decision|1|||
42138082|NCT00352755|75948391|FG000|Overall Study|Physician Decision|1|||
42138083|NCT00352755|75948391|FG000|Overall Study|Adverse Event|1|||
42138084|NCT00533897|75948398|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
42138085|NCT00533897|75948399|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
42138086|NCT00533897|75948400|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
42138087|NCT00533897|75948401|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
42138088|NCT00533897|75948402|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
42138089|NCT00533897|75948403|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
42138090|NCT00533897|75948404|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
42138091|NCT00533897|75948405|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
42138092|NCT00533897|75948398|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
42138093|NCT00533897|75948399|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
42138094|NCT00533897|75948400|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
42138095|NCT00533897|75948401|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
42138096|NCT00533897|75948402|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
42138097|NCT00533897|75948403|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
42138098|NCT00533897|75948404|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
42138099|NCT00533897|75948405|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
42138100|NCT00533897|75948398|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
42138101|NCT00533897|75948399|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
42138102|NCT00533897|75948400|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
42138103|NCT00533897|75948401|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
42138104|NCT00533897|75948402|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
42138105|NCT00533897|75948403|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
42138106|NCT00533897|75948404|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
42138107|NCT00533897|75948405|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
42138108|NCT00533897|75948398|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
42138109|NCT00533897|75948399|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
42138110|NCT00533897|75948400|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
42138111|NCT00533897|75948401|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
42138112|NCT00533897|75948402|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
42138113|NCT00533897|75948403|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
42138114|NCT00533897|75948404|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
42138115|NCT00533897|75948405|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
42138116|NCT00533897|75948398|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
42138117|NCT00533897|75948399|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
42138118|NCT00533897|75948400|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
42138119|NCT00533897|75948401|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
42138120|NCT00533897|75948402|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
42138121|NCT00533897|75948403|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
42138122|NCT00533897|75948404|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
42138123|NCT00533897|75948405|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
42138124|NCT00533897|75948398|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
42138125|NCT00533897|75948399|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
42138126|NCT00533897|75948400|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
42138127|NCT00533897|75948401|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
42138128|NCT00533897|75948402|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
42272941|NCT02268526|76103493|FG000|Overall Study|Subject/guardian decision|0|||
42272942|NCT02268526|76103494|FG001|Overall Study|Subject/guardian decision|7|||
42272943|NCT02268526|76103495|FG002|Overall Study|Subject/guardian decision|3|||
42272944|NCT02268214|76103508|FG000|Overall Study|Subject no longer meets study criteria|0|||
42272945|NCT02268214|76103509|FG001|Overall Study|Subject no longer meets study criteria|2|||
42272946|NCT02268214|76103510|FG002|Overall Study|Subject no longer meets study criteria|0|||
42272947|NCT02268214|76103508|FG000|Overall Study|Pregnancy|2|||
42272948|NCT02268214|76103509|FG001|Overall Study|Pregnancy|2|||
42272949|NCT02268214|76103510|FG002|Overall Study|Pregnancy|1|||
42272950|NCT02268214|76103508|FG000|Overall Study|Lost to Follow-up|3|||
42272951|NCT02268214|76103509|FG001|Overall Study|Lost to Follow-up|3|||
42272952|NCT02268214|76103510|FG002|Overall Study|Lost to Follow-up|4|||
42272953|NCT02268214|76103508|FG000|Overall Study|Lack of Efficacy|1|||
42272954|NCT02268214|76103509|FG001|Overall Study|Lack of Efficacy|0|||
42272955|NCT02268214|76103510|FG002|Overall Study|Lack of Efficacy|2|||
42272956|NCT02268214|76103508|FG000|Overall Study|Adverse Event|11|||
42272957|NCT02268214|76103509|FG001|Overall Study|Adverse Event|14|||
42272958|NCT02268214|76103510|FG002|Overall Study|Adverse Event|9|||
42272959|NCT02268214|76103508|FG000|Overall Study|Withdrawal by Subject|4|||
42272960|NCT02268214|76103509|FG001|Overall Study|Withdrawal by Subject|5|||
42272961|NCT02268214|76103510|FG002|Overall Study|Withdrawal by Subject|10|||
42272962|NCT02268214|76103508|FG000|Overall Study|Subject request to discontinue treatment|10|||
42272963|NCT02268214|76103509|FG001|Overall Study|Subject request to discontinue treatment|8|||
42272964|NCT02268214|76103510|FG002|Overall Study|Subject request to discontinue treatment|6|||
42272965|NCT02268214|76103508|FG000|Overall Study|Poor/non-compliance|2|||
42272966|NCT02268214|76103509|FG001|Overall Study|Poor/non-compliance|1|||
42347324|NCT01719003|76186457|FG001|Overall Study|Lost to Follow-up|6|||
42272967|NCT02268214|76103510|FG002|Overall Study|Poor/non-compliance|2|||
42347325|NCT01719003|76186458|FG002|Overall Study|Lost to Follow-up|7|||
42010645|NCT01010776|75817767|FG000|Main Phase|Lost to Follow-up|6|||
42010646|NCT01010776|75817767|FG000|Main Phase|Non-compliance to study medication|5|||
42010647|NCT01010776|75817767|FG000|Main Phase|Selection failure|2|||
42010648|NCT01010776|75817767|FG000|Main Phase|Inform consent withdrawal|1|||
42010649|NCT01010776|75817767|FG000|Main Phase|Other|1|||
42010650|NCT01010776|75817767|FG000|Main Phase|Did not received study medication|5|||
42010651|NCT01010776|75817767|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
42010652|NCT01010776|75817767|FG000|Extension Phase|Other|3|||
42010653|NCT01018810|75817787|FG000|Overall Study|Withdrawal by Subject|0|||
42010654|NCT01018810|75817788|FG001|Overall Study|Withdrawal by Subject|1|||
42010655|NCT01018810|75817789|FG002|Overall Study|Withdrawal by Subject|0|||
42010656|NCT01018810|75817790|FG003|Overall Study|Withdrawal by Subject|0|||
42010657|NCT01018810|75817791|FG004|Overall Study|Withdrawal by Subject|0|||
42010658|NCT01018810|75817787|FG000|Overall Study|Sponsor Decision|2|||
42010659|NCT01018810|75817788|FG001|Overall Study|Sponsor Decision|0|||
42010660|NCT01018810|75817789|FG002|Overall Study|Sponsor Decision|1|||
42010661|NCT01018810|75817790|FG003|Overall Study|Sponsor Decision|1|||
42010662|NCT01018810|75817791|FG004|Overall Study|Sponsor Decision|1|||
42010663|NCT01018732|75817806|FG000|Overall Study|Lost to Follow-up|0|||
42010664|NCT01018732|75817807|FG001|Overall Study|Lost to Follow-up|0|||
42010665|NCT01018732|75817808|FG002|Overall Study|Lost to Follow-up|3|||
42010666|NCT01018732|75817806|FG000|Overall Study|Protocol Violation|1|||
42010667|NCT01018732|75817807|FG001|Overall Study|Protocol Violation|1|||
42010668|NCT01018732|75817808|FG002|Overall Study|Protocol Violation|0|||
42036457|NCT01016964|75844861|FG000|Overall Study|Lost to Follow-up|3|||
42036458|NCT01016964|75844862|FG001|Overall Study|Lost to Follow-up|3|||
42036459|NCT02996110|75844873|FG000|Pre-Treatment|Other Reasons|0|||
42036460|NCT02996110|75844874|FG001|Pre-Treatment|Other Reasons|1|||
42036461|NCT02996110|75844875|FG002|Pre-Treatment|Other Reasons|0|||
42036462|NCT02996110|75844876|FG003|Pre-Treatment|Other Reasons|0|||
42036463|NCT02996110|75844877|FG004|Pre-Treatment|Other Reasons|1|||
42036464|NCT02996110|75844873|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
42036465|NCT02996110|75844874|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
42036466|NCT02996110|75844875|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
42036467|NCT02996110|75844876|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
42036468|NCT02996110|75844877|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
42036469|NCT02996110|75844873|FG000|Track 1|Disease Progression|15|||
42036470|NCT02996110|75844874|FG001|Track 1|Disease Progression|17|||
42036471|NCT02996110|75844875|FG002|Track 1|Disease Progression|0|||
42036472|NCT02996110|75844876|FG003|Track 1|Disease Progression|0|||
42036473|NCT02996110|75844877|FG004|Track 1|Disease Progression|0|||
42036474|NCT02996110|75844873|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
42036475|NCT02996110|75844874|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
42036476|NCT02996110|75844875|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
42036477|NCT02996110|75844876|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
42036478|NCT02996110|75844877|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
42036479|NCT02996110|75844873|FG000|Track 1|Study Drug Toxicity|5|||
42036480|NCT02996110|75844874|FG001|Track 1|Study Drug Toxicity|3|||
42036481|NCT02996110|75844875|FG002|Track 1|Study Drug Toxicity|0|||
42036482|NCT02996110|75844876|FG003|Track 1|Study Drug Toxicity|0|||
42036483|NCT02996110|75844877|FG004|Track 1|Study Drug Toxicity|0|||
42036484|NCT02996110|75844873|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
42036485|NCT02996110|75844874|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
42036486|NCT02996110|75844875|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
42036487|NCT02996110|75844876|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
42036488|NCT02996110|75844877|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
42036489|NCT02996110|75844873|FG000|Track 1|Administrative Reason by Sponsor|0|||
42036490|NCT02996110|75844874|FG001|Track 1|Administrative Reason by Sponsor|1|||
42036491|NCT02996110|75844875|FG002|Track 1|Administrative Reason by Sponsor|0|||
42036492|NCT02996110|75844876|FG003|Track 1|Administrative Reason by Sponsor|0|||
42036493|NCT02996110|75844877|FG004|Track 1|Administrative Reason by Sponsor|0|||
42036494|NCT02996110|75844873|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
42036495|NCT02996110|75844874|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
42036496|NCT02996110|75844875|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
42036497|NCT02996110|75844876|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
42036498|NCT02996110|75844877|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
42036499|NCT02996110|75844873|FG000|Track 2|Disease Progression|33|||
42036500|NCT02996110|75844874|FG001|Track 2|Disease Progression|26|||
42036501|NCT02996110|75844875|FG002|Track 2|Disease Progression|19|||
42036502|NCT02996110|75844876|FG003|Track 2|Disease Progression|16|||
42036503|NCT02996110|75844877|FG004|Track 2|Disease Progression|15|||
42036504|NCT02996110|75844873|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
42010669|NCT01018732|75817806|FG000|Overall Study|Inappropriate Enrollment|0|||
42010670|NCT01018732|75817807|FG001|Overall Study|Inappropriate Enrollment|1|||
42138129|NCT00533897|75948403|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
42138130|NCT00533897|75948404|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
42138131|NCT00533897|75948405|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
42138132|NCT00533897|75948398|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
42138133|NCT00533897|75948399|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
42138134|NCT00533897|75948400|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
42138135|NCT00533897|75948401|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
42138136|NCT00533897|75948402|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
42138137|NCT00533897|75948403|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
42138138|NCT00533897|75948404|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
42138139|NCT00533897|75948405|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
42138140|NCT00533897|75948398|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
42138141|NCT00533897|75948399|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
42138142|NCT00533897|75948400|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
42138143|NCT00533897|75948401|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
42138144|NCT00533897|75948402|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
42138145|NCT00533897|75948403|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
42138146|NCT00533897|75948404|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
42138147|NCT00533897|75948405|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
42138148|NCT00533897|75948398|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
42138149|NCT00533897|75948399|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
42138150|NCT00533897|75948400|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
42138151|NCT00533897|75948401|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
42138152|NCT00533897|75948402|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
42138153|NCT00533897|75948403|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
42138154|NCT00533897|75948404|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
42138155|NCT00533897|75948405|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
42138156|NCT00533897|75948398|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
42138157|NCT00533897|75948399|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
42138158|NCT00533897|75948400|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
42138159|NCT00533897|75948401|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
42138160|NCT00533897|75948402|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
42138161|NCT00533897|75948403|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
42138162|NCT00533897|75948404|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
42138163|NCT00533897|75948405|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
42138164|NCT00533897|75948398|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
42138165|NCT00533897|75948399|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
42138166|NCT00533897|75948400|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
42138167|NCT00533897|75948401|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
42138168|NCT00533897|75948402|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
42138169|NCT00533897|75948403|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
42138170|NCT00533897|75948404|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
42138171|NCT00533897|75948405|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
42138172|NCT00533897|75948398|FG000|Long Term Extension (LTE)|Death|0|||
42138173|NCT00533897|75948399|FG001|Long Term Extension (LTE)|Death|0|||
42138174|NCT00533897|75948400|FG002|Long Term Extension (LTE)|Death|0|||
42138175|NCT00533897|75948401|FG003|Long Term Extension (LTE)|Death|0|||
42036505|NCT02996110|75844874|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
42036506|NCT02996110|75844875|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
42036507|NCT02996110|75844876|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
42036508|NCT02996110|75844877|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
42036509|NCT02996110|75844873|FG000|Track 2|Death|0|||
42036510|NCT02996110|75844874|FG001|Track 2|Death|0|||
42138176|NCT00533897|75948402|FG004|Long Term Extension (LTE)|Death|0|||
42138177|NCT00533897|75948403|FG005|Long Term Extension (LTE)|Death|0|||
42138178|NCT00533897|75948404|FG006|Long Term Extension (LTE)|Death|1|||
42138179|NCT00533897|75948405|FG007|Long Term Extension (LTE)|Death|3|||
42138180|NCT00533897|75948398|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
42138181|NCT00533897|75948399|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
42138182|NCT00533897|75948400|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
42138183|NCT00533897|75948401|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
42138184|NCT00533897|75948402|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
42138185|NCT00533897|75948403|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
42138186|NCT00533897|75948404|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
42138187|NCT00533897|75948405|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
42036511|NCT02996110|75844875|FG002|Track 2|Death|1|||
42036512|NCT02996110|75844876|FG003|Track 2|Death|0|||
42272968|NCT02268214|76103508|FG000|Overall Study|Other reasons|7|||
42272969|NCT02268214|76103509|FG001|Overall Study|Other reasons|3|||
42272970|NCT02268214|76103510|FG002|Overall Study|Other reasons|3|||
42272971|NCT02268214|76103508|FG000|Overall Study|Not entering long-term period|2|||
42272972|NCT02268214|76103509|FG001|Overall Study|Not entering long-term period|3|||
42010671|NCT01018732|75817808|FG002|Overall Study|Inappropriate Enrollment|0|||
42010672|NCT01018732|75817806|FG000|Overall Study|Unable to Classify|0|||
42036513|NCT02996110|75844877|FG004|Track 2|Death|1|||
42036514|NCT02996110|75844873|FG000|Track 2|Study Drug Toxicity|4|||
42036515|NCT02996110|75844874|FG001|Track 2|Study Drug Toxicity|1|||
42036516|NCT02996110|75844875|FG002|Track 2|Study Drug Toxicity|4|||
42036517|NCT02996110|75844876|FG003|Track 2|Study Drug Toxicity|1|||
42036518|NCT02996110|75844877|FG004|Track 2|Study Drug Toxicity|0|||
42036519|NCT02996110|75844873|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
42036520|NCT02996110|75844874|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
42036521|NCT02996110|75844875|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
42272973|NCT02268214|76103510|FG002|Overall Study|Not entering long-term period|5|||
42272974|NCT02521376|76103522|FG000|Overall Study|Enrolled, But Not Treated|1|||
42010673|NCT01018732|75817807|FG001|Overall Study|Unable to Classify|0|||
42010674|NCT01018732|75817808|FG002|Overall Study|Unable to Classify|1|||
42010675|NCT01218867|75817827|FG000|Overall Study|Death during treatment|0|||
42010676|NCT01218867|75817828|FG001|Overall Study|Death during treatment|0|||
42010677|NCT01218867|75817829|FG002|Overall Study|Death during treatment|0|||
42010678|NCT01218867|75817830|FG003|Overall Study|Death during treatment|0|||
42010679|NCT01218867|75817831|FG004|Overall Study|Death during treatment|0|||
42010680|NCT01218867|75817832|FG005|Overall Study|Death during treatment|0|||
42010681|NCT01218867|75817833|FG006|Overall Study|Death during treatment|1|||
42010682|NCT01218867|75817834|FG007|Overall Study|Death during treatment|0|||
42010683|NCT01218867|75817835|FG008|Overall Study|Death during treatment|0|||
42010684|NCT01218867|75817836|FG009|Overall Study|Death during treatment|0|||
42010685|NCT01218867|75817837|FG010|Overall Study|Death during treatment|0|||
42010686|NCT01018264|75817874|FG000|Overall Study|Withdrawal by Subject|1|||
42010687|NCT01018264|75817875|FG001|Overall Study|Withdrawal by Subject|0|||
42010688|NCT01018264|75817874|FG000|Overall Study|Lost to Follow-up|0|||
42010689|NCT01018264|75817875|FG001|Overall Study|Lost to Follow-up|1|||
42010690|NCT01018186|75817884|FG000|2-week Run-in Period|Protocol Violation|1|||
42010691|NCT01018186|75817885|FG001|2-week Run-in Period|Protocol Violation|0|||
42010692|NCT01018186|75817886|FG002|2-week Run-in Period|Protocol Violation|0|||
42010693|NCT01018186|75817887|FG003|2-week Run-in Period|Protocol Violation|0|||
42010694|NCT01018186|75817884|FG000|2-week Run-in Period|Lost to Follow-up|2|||
42010695|NCT01018186|75817885|FG001|2-week Run-in Period|Lost to Follow-up|0|||
42010696|NCT01018186|75817886|FG002|2-week Run-in Period|Lost to Follow-up|0|||
42010697|NCT01018186|75817887|FG003|2-week Run-in Period|Lost to Follow-up|0|||
42010698|NCT01018186|75817884|FG000|2-week Run-in Period|Physician Decision|3|||
42010699|NCT01018186|75817885|FG001|2-week Run-in Period|Physician Decision|0|||
42010700|NCT01018186|75817886|FG002|2-week Run-in Period|Physician Decision|0|||
42010701|NCT01018186|75817887|FG003|2-week Run-in Period|Physician Decision|0|||
42010702|NCT01018186|75817884|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
42010703|NCT01018186|75817885|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
42010704|NCT01018186|75817886|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
42010705|NCT01018186|75817887|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
42010706|NCT01018186|75817884|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
42010707|NCT01018186|75817885|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
42010708|NCT01018186|75817886|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
42010709|NCT01018186|75817887|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
42010710|NCT01018186|75817884|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
42010711|NCT01018186|75817885|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
42010712|NCT01018186|75817886|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
42010713|NCT01018186|75817887|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
42010714|NCT01018186|75817884|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
42010715|NCT01018186|75817885|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
42010716|NCT01018186|75817886|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
42010717|NCT01018186|75817887|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
42010718|NCT01018186|75817884|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
42010719|NCT01018186|75817885|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
42010720|NCT01018186|75817886|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
42010721|NCT01018186|75817887|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
42010722|NCT01018186|75817884|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
42010723|NCT01018186|75817885|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
42036522|NCT02996110|75844876|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
42272975|NCT02521376|76103523|FG001|Overall Study|Enrolled, But Not Treated|0|||
42272976|NCT02521376|76103524|FG002|Overall Study|Enrolled, But Not Treated|0|||
42272977|NCT02521376|76103525|FG003|Overall Study|Enrolled, But Not Treated|0|||
42272978|NCT02268058|76103547|FG000|Overall Study|Protocol Violation|1|||
42272979|NCT02268058|76103548|FG001|Overall Study|Protocol Violation|0|||
42272980|NCT02268058|76103549|FG002|Overall Study|Protocol Violation|0|||
42272981|NCT02268058|76103550|FG003|Overall Study|Protocol Violation|0|||
42272982|NCT02267824|76103562|FG000|Overall Study|Pregnancy|1|||
42272983|NCT02267824|76103563|FG001|Overall Study|Pregnancy|1|||
42272984|NCT02267824|76103562|FG000|Overall Study|Lost to Follow-up|4|||
42272985|NCT02267824|76103563|FG001|Overall Study|Lost to Follow-up|0|||
42272986|NCT02267824|76103562|FG000|Overall Study|Protocol Violation|3|||
42272987|NCT02267824|76103563|FG001|Overall Study|Protocol Violation|0|||
42272988|NCT02267824|76103562|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
42272989|NCT02267824|76103563|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
42272990|NCT02267746|76103572|FG000|Overall Study|Adverse Event|0|||
42272991|NCT02267746|76103573|FG001|Overall Study|Adverse Event|2|||
42272992|NCT02267746|76103574|FG002|Overall Study|Adverse Event|1|||
42272993|NCT02267746|76103572|FG000|Overall Study|Protocol Violation|8|||
42272994|NCT02267746|76103573|FG001|Overall Study|Protocol Violation|7|||
42272995|NCT02267746|76103574|FG002|Overall Study|Protocol Violation|3|||
42272996|NCT02267746|76103572|FG000|Overall Study|Lack of Efficacy|11|||
42272997|NCT02267746|76103573|FG001|Overall Study|Lack of Efficacy|11|||
42272998|NCT02267746|76103574|FG002|Overall Study|Lack of Efficacy|15|||
42272999|NCT02267746|76103572|FG000|Overall Study|Protocol Violation|1|||
42273000|NCT02267746|76103573|FG001|Overall Study|Protocol Violation|2|||
42273001|NCT02267746|76103574|FG002|Overall Study|Protocol Violation|1|||
42273002|NCT02267746|76103572|FG000|Overall Study|Miscellaneous|1|||
42273003|NCT02267746|76103573|FG001|Overall Study|Miscellaneous|0|||
42273004|NCT02267746|76103574|FG002|Overall Study|Miscellaneous|1|||
42273005|NCT02362360|76103584|FG000|Period 1|Lack of Efficacy|1|||
42273006|NCT02362360|76103585|FG001|Period 1|Lack of Efficacy|0|||
42273007|NCT02362360|76103584|FG000|Period 1|Withdrawal by Subject|2|||
42273008|NCT02362360|76103585|FG001|Period 1|Withdrawal by Subject|1|||
42273009|NCT02362282|76103593|FG000|Overall Study|Withdrawal by Subject|1|||
42273010|NCT02362282|76103594|FG001|Overall Study|Withdrawal by Subject|0|||
42273011|NCT02361580|76103602|FG000|Overall Study|Lost to Follow-up|6|||
42273012|NCT02361580|76103603|FG001|Overall Study|Lost to Follow-up|3|||
42273013|NCT02520284|76103612|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
42273014|NCT02520284|76103613|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
42273015|NCT02520284|76103614|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
42273016|NCT02520284|76103612|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
42273017|NCT02520284|76103613|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
42273018|NCT02520284|76103614|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
42273019|NCT02520284|76103612|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
42273020|NCT02520284|76103613|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
42138188|NCT00533897|75948398|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
42138189|NCT00533897|75948399|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
42138190|NCT00533897|75948400|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
42138191|NCT00533897|75948401|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
42138192|NCT00533897|75948402|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
42138193|NCT00533897|75948403|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
42347326|NCT01719003|76186459|FG003|Overall Study|Lost to Follow-up|2|||
42138194|NCT00533897|75948404|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
42138195|NCT00533897|75948405|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
42138196|NCT00533897|75948398|FG000|Long Term Extension (LTE)|Adverse Event|0|||
42138197|NCT00533897|75948399|FG001|Long Term Extension (LTE)|Adverse Event|0|||
42138198|NCT00533897|75948400|FG002|Long Term Extension (LTE)|Adverse Event|0|||
42138199|NCT00533897|75948401|FG003|Long Term Extension (LTE)|Adverse Event|0|||
42138200|NCT00533897|75948402|FG004|Long Term Extension (LTE)|Adverse Event|0|||
42138201|NCT00533897|75948403|FG005|Long Term Extension (LTE)|Adverse Event|0|||
42138202|NCT00533897|75948404|FG006|Long Term Extension (LTE)|Adverse Event|2|||
42273021|NCT02520284|76103614|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
42273022|NCT02520284|76103612|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
42273023|NCT02520284|76103613|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
42273024|NCT02520284|76103614|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
42273025|NCT02520284|76103612|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
42273026|NCT02520284|76103613|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
42273027|NCT02520284|76103614|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
42273028|NCT02520284|76103612|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
42273029|NCT02520284|76103613|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
42273030|NCT02520284|76103614|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
42273031|NCT02520284|76103612|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
42273032|NCT02520284|76103613|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
42273033|NCT02520284|76103614|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
42273034|NCT02520284|76103612|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
42273035|NCT02520284|76103613|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
42273036|NCT02520284|76103614|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
42273037|NCT02520284|76103612|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
42273038|NCT02520284|76103613|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
42273039|NCT02520284|76103614|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
42273040|NCT02520284|76103612|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
42273041|NCT02520284|76103613|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
42273042|NCT02520284|76103614|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
42273043|NCT02520284|76103612|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
42273044|NCT02520284|76103613|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
42273045|NCT02520284|76103614|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
42273046|NCT02517866|76103628|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
42273047|NCT02517866|76103629|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
42273048|NCT02517866|76103630|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
42138203|NCT00533897|75948405|FG007|Long Term Extension (LTE)|Adverse Event|5|||
42036523|NCT02996110|75844877|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
42036524|NCT02996110|75844873|FG000|Track 2|Participant Withdrew Consent|1|||
42036525|NCT02996110|75844874|FG001|Track 2|Participant Withdrew Consent|2|||
42036526|NCT02996110|75844875|FG002|Track 2|Participant Withdrew Consent|3|||
42036527|NCT02996110|75844876|FG003|Track 2|Participant Withdrew Consent|1|||
42036528|NCT02996110|75844877|FG004|Track 2|Participant Withdrew Consent|1|||
42036529|NCT02996110|75844873|FG000|Track 2|Other Reasons|0|||
42036530|NCT02996110|75844874|FG001|Track 2|Other Reasons|0|||
42036531|NCT02996110|75844875|FG002|Track 2|Other Reasons|1|||
42036532|NCT02996110|75844876|FG003|Track 2|Other Reasons|0|||
42036533|NCT02996110|75844877|FG004|Track 2|Other Reasons|1|||
42036534|NCT00916617|75844895|FG000|Overall Study|Adverse Event|3|||
42036535|NCT00916617|75844896|FG001|Overall Study|Adverse Event|2|||
42036536|NCT00916617|75844897|FG002|Overall Study|Adverse Event|6|||
42138204|NCT00533897|75948398|FG000|Long Term Extension (LTE)|Pregnancy|0|||
42138205|NCT00533897|75948399|FG001|Long Term Extension (LTE)|Pregnancy|0|||
42138206|NCT00533897|75948400|FG002|Long Term Extension (LTE)|Pregnancy|0|||
42138207|NCT00533897|75948401|FG003|Long Term Extension (LTE)|Pregnancy|0|||
42138208|NCT00533897|75948402|FG004|Long Term Extension (LTE)|Pregnancy|0|||
42138209|NCT00533897|75948403|FG005|Long Term Extension (LTE)|Pregnancy|0|||
42138210|NCT00533897|75948404|FG006|Long Term Extension (LTE)|Pregnancy|0|||
42138211|NCT00533897|75948405|FG007|Long Term Extension (LTE)|Pregnancy|2|||
42138212|NCT00533897|75948398|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
42138213|NCT00533897|75948399|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
42138214|NCT00533897|75948400|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
42138215|NCT00533897|75948401|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
42138216|NCT00533897|75948402|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
42138217|NCT00533897|75948403|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
42138218|NCT00533897|75948404|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
42138219|NCT00533897|75948405|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
42138220|NCT00533897|75948398|FG000|Long Term Extension (LTE)|Other|0|||
42138221|NCT00533897|75948399|FG001|Long Term Extension (LTE)|Other|0|||
42273049|NCT02517866|76103628|FG000|Overall Study|Significant Protocol Deviation|4|||
42273050|NCT02517866|76103629|FG001|Overall Study|Significant Protocol Deviation|1|||
42273051|NCT02517866|76103630|FG002|Overall Study|Significant Protocol Deviation|0|||
42347327|NCT01719003|76186460|FG004|Overall Study|Lost to Follow-up|3|||
42138222|NCT00533897|75948400|FG002|Long Term Extension (LTE)|Other|0|||
42138223|NCT00533897|75948401|FG003|Long Term Extension (LTE)|Other|0|||
42036537|NCT00916617|75844898|FG003|Overall Study|Adverse Event|3|||
42036538|NCT00916617|75844895|FG000|Overall Study|Withdrawal by Subject|3|||
42036539|NCT00916617|75844896|FG001|Overall Study|Withdrawal by Subject|2|||
42036540|NCT00916617|75844897|FG002|Overall Study|Withdrawal by Subject|0|||
42036541|NCT00916617|75844898|FG003|Overall Study|Withdrawal by Subject|1|||
42036542|NCT00916617|75844895|FG000|Overall Study|Caregiver Request|3|||
42036543|NCT00916617|75844896|FG001|Overall Study|Caregiver Request|2|||
42138224|NCT00533897|75948402|FG004|Long Term Extension (LTE)|Other|0|||
42036544|NCT00916617|75844897|FG002|Overall Study|Caregiver Request|1|||
42036545|NCT00916617|75844898|FG003|Overall Study|Caregiver Request|0|||
42036546|NCT00916617|75844895|FG000|Overall Study|Physician Decision|1|||
42036547|NCT00916617|75844896|FG001|Overall Study|Physician Decision|1|||
42036548|NCT00916617|75844897|FG002|Overall Study|Physician Decision|0|||
42138225|NCT00533897|75948403|FG005|Long Term Extension (LTE)|Other|0|||
42036549|NCT00916617|75844898|FG003|Overall Study|Physician Decision|0|||
42036550|NCT00916617|75844895|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
42036551|NCT00916617|75844896|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
42036552|NCT00916617|75844897|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
42273052|NCT02517866|76103628|FG000|Overall Study|Lost to Follow-up|1|||
42273053|NCT02517866|76103629|FG001|Overall Study|Lost to Follow-up|0|||
42273054|NCT02517866|76103630|FG002|Overall Study|Lost to Follow-up|0|||
42273055|NCT02517866|76103628|FG000|Overall Study|Voluntary Withdrawal|2|||
42273056|NCT02517866|76103629|FG001|Overall Study|Voluntary Withdrawal|2|||
42273057|NCT02517866|76103630|FG002|Overall Study|Voluntary Withdrawal|0|||
42273058|NCT02517866|76103628|FG000|Overall Study|Investigator Decision|2|||
42273059|NCT02517866|76103629|FG001|Overall Study|Investigator Decision|1|||
42273060|NCT02517866|76103630|FG002|Overall Study|Investigator Decision|0|||
42273061|NCT02517866|76103628|FG000|Overall Study|Reason not specified|2|||
42273062|NCT02517866|76103629|FG001|Overall Study|Reason not specified|0|||
42273063|NCT02517866|76103630|FG002|Overall Study|Reason not specified|0|||
42273064|NCT02515994|76103642|FG000|Overall Study|Protocol Violation|3|||
42273065|NCT02515994|76103643|FG001|Overall Study|Protocol Violation|5|||
42273066|NCT02515994|76103642|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
42273067|NCT02515994|76103643|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
42273068|NCT02515994|76103642|FG000|Overall Study|Adverse Event|3|||
42273069|NCT02515994|76103643|FG001|Overall Study|Adverse Event|1|||
42273070|NCT02515994|76103642|FG000|Overall Study|Withdrawal by Subject|2|||
42273071|NCT02515994|76103643|FG001|Overall Study|Withdrawal by Subject|0|||
42273072|NCT02516306|76103651|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
42273073|NCT02516306|76103652|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
42273074|NCT02516228|76103658|FG000|Overall Study|Lost to Follow-up|1|||
42273075|NCT02516228|76103658|FG000|Overall Study|Withdrawal by Subject|1|||
42273076|NCT02516228|76103658|FG000|Overall Study|Physician Decision|1|||
42273077|NCT02519504|76103664|FG000|Overall Study|Protocol Violation|6|||
42273078|NCT02519504|76103665|FG001|Overall Study|Protocol Violation|5|||
42273079|NCT02519504|76103664|FG000|Overall Study|Ineligible for direct testing|12|||
42273080|NCT02519504|76103665|FG001|Overall Study|Ineligible for direct testing|12|||
42273081|NCT02519504|76103664|FG000|Overall Study|Did not participate in direct testing|95|||
42273082|NCT02519504|76103665|FG001|Overall Study|Did not participate in direct testing|86|||
42273083|NCT02514824|76103673|FG000|Overall Study|Withdrawal by Subject|1|||
42273084|NCT02514824|76103674|FG001|Overall Study|Withdrawal by Subject|0|||
42273085|NCT02514824|76103675|FG002|Overall Study|Withdrawal by Subject|0|||
42273086|NCT02514824|76103676|FG003|Overall Study|Withdrawal by Subject|0|||
42273087|NCT02514824|76103673|FG000|Overall Study|Dose-Limiting Toxicity|0|||
42273088|NCT02514824|76103674|FG001|Overall Study|Dose-Limiting Toxicity|1|||
42273089|NCT02514824|76103675|FG002|Overall Study|Dose-Limiting Toxicity|0|||
42273090|NCT02514824|76103676|FG003|Overall Study|Dose-Limiting Toxicity|0|||
42138226|NCT00533897|75948404|FG006|Long Term Extension (LTE)|Other|1|||
42138227|NCT00533897|75948405|FG007|Long Term Extension (LTE)|Other|6|||
42138228|NCT00426660|75948436|FG000|Overall Study|Death|14|||
42138229|NCT00426660|75948436|FG000|Overall Study|Adverse Event|23|||
42138230|NCT00426660|75948436|FG000|Overall Study|Insufficient Clinical Response|22|||
42138231|NCT00426660|75948436|FG000|Overall Study|Lost to Follow-up|15|||
42138232|NCT00426660|75948436|FG000|Overall Study|Other|23|||
42138233|NCT00426660|75948436|FG000|Overall Study|Withdrawal by Subject|18|||
42138234|NCT00426660|75948436|FG000|Overall Study|Protocol Violation|1|||
42138235|NCT00426660|75948436|FG000|Overall Study|Enrolled Not Treated|15|||
42138236|NCT00426270|75948440|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
42138237|NCT00426270|75948440|FG000|Overall Study|Adverse Event|5|||
42138238|NCT00330681|75948446|FG000|Overall Study|Adverse Event|3|||
42138239|NCT00330681|75948447|FG001|Overall Study|Adverse Event|6|||
42138240|NCT00330681|75948446|FG000|Overall Study|Protocol Violation|0|||
42138241|NCT00330681|75948447|FG001|Overall Study|Protocol Violation|1|||
42138242|NCT00330681|75948446|FG000|Overall Study|Withdrawal by Subject|5|||
42138243|NCT00330681|75948447|FG001|Overall Study|Withdrawal by Subject|5|||
42138244|NCT00330681|75948446|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
42138245|NCT00330681|75948447|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
42273091|NCT02514746|76103685|FG000|Overall Study|Chronically Ill|1|||
42273092|NCT02514746|76103686|FG001|Overall Study|Chronically Ill|2|||
42273093|NCT02514746|76103685|FG000|Overall Study|Physician Decision|4|||
42273094|NCT02514746|76103686|FG001|Overall Study|Physician Decision|2|||
42138246|NCT00329901|75948456|FG000|Overall Study|Withdrawal by Subject|4|||
42138247|NCT00329901|75948457|FG001|Overall Study|Withdrawal by Subject|3|||
42138248|NCT00329901|75948458|FG002|Overall Study|Withdrawal by Subject|2|||
42138249|NCT00329901|75948456|FG000|Overall Study|Lost to Follow-up|2|||
42273095|NCT02514746|76103685|FG000|Overall Study|Withdrawal by Subject|12|||
42273096|NCT02514746|76103686|FG001|Overall Study|Withdrawal by Subject|10|||
42273097|NCT02514746|76103685|FG000|Overall Study|Other|5|||
42273098|NCT02514746|76103686|FG001|Overall Study|Other|1|||
42273099|NCT02483078|76103696|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
42273100|NCT02483078|76103697|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
42273101|NCT02483078|76103696|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
42273102|NCT02483078|76103697|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
42273103|NCT02483078|76103696|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
42273104|NCT02483078|76103697|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
42273105|NCT02483078|76103696|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
42273106|NCT02483078|76103697|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
42273107|NCT02483078|76103696|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
42273108|NCT02483078|76103697|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
42010724|NCT01018186|75817886|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
42138250|NCT00329901|75948457|FG001|Overall Study|Lost to Follow-up|0|||
42138251|NCT00329901|75948458|FG002|Overall Study|Lost to Follow-up|1|||
42138252|NCT00329901|75948456|FG000|Overall Study|Protocol Violation|1|||
42138253|NCT00329901|75948457|FG001|Overall Study|Protocol Violation|0|||
42138254|NCT00329901|75948458|FG002|Overall Study|Protocol Violation|1|||
42138255|NCT00329901|75948456|FG000|Overall Study|Unable to classify|2|||
42138256|NCT00329901|75948457|FG001|Overall Study|Unable to classify|2|||
42138257|NCT00329901|75948458|FG002|Overall Study|Unable to classify|0|||
42138258|NCT00436956|75948470|FG000|Overall Study|Not evaluable|1|||
42138259|NCT00436956|75948471|FG001|Overall Study|Not evaluable|0|||
42138260|NCT00329745|75948480|FG000|Overall Study|Protocol Violation|1|||
42138261|NCT00329745|75948481|FG001|Overall Study|Protocol Violation|0|||
42138262|NCT00329745|75948480|FG000|Overall Study|Withdrawal by Subject|0|||
42138263|NCT00329745|75948481|FG001|Overall Study|Withdrawal by Subject|1|||
42138264|NCT00329745|75948480|FG000|Overall Study|Lost to Follow-up|86|||
42138265|NCT00329745|75948481|FG001|Overall Study|Lost to Follow-up|101|||
42138266|NCT00436644|75948487|FG000|Overall Study|Adverse Event|2|||
42138267|NCT00436644|75948487|FG000|Overall Study|Death|1|||
42138268|NCT00324987|75948493|FG000|Overall Study|Adverse Event|2|||
42138269|NCT00324987|75948494|FG001|Overall Study|Adverse Event|1|||
42138270|NCT00324987|75948493|FG000|Overall Study|Withdrawal by Subject|1|||
42138271|NCT00324987|75948494|FG001|Overall Study|Withdrawal by Subject|1|||
42138272|NCT00324987|75948493|FG000|Overall Study|Progression|1|||
42138273|NCT00324987|75948494|FG001|Overall Study|Progression|1|||
42138274|NCT00324987|75948493|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
42138275|NCT00324987|75948494|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
42036553|NCT00916617|75844898|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
42036554|NCT00916617|75844895|FG000|Overall Study|Lost to Follow-up|2|||
42138276|NCT00324675|75948502|FG000|Overall Study|Adverse Event|1|||
42138277|NCT00324675|75948503|FG001|Overall Study|Adverse Event|0|||
42138278|NCT00436566|75948509|FG000|Overall Study|Withdrawal by Subject|2|||
42273109|NCT02483078|76103696|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
42273110|NCT02483078|76103697|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
42273111|NCT02452190|76103711|FG000|Overall Study|Withdrawal by Sponsor|1|||
42273112|NCT02452190|76103712|FG001|Overall Study|Withdrawal by Sponsor|3|||
42273113|NCT02452190|76103711|FG000|Overall Study|Pregnancy|1|||
42273114|NCT02452190|76103712|FG001|Overall Study|Pregnancy|0|||
42010725|NCT01018186|75817887|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
42010726|NCT01018186|75817884|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
42010727|NCT01018186|75817885|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
42010728|NCT01018186|75817886|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
42010729|NCT01018186|75817887|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
42010730|NCT01018186|75817884|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
42010731|NCT01018186|75817885|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
42010732|NCT01018186|75817886|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
42010733|NCT01018186|75817887|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
42010734|NCT01018186|75817884|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
42010735|NCT01018186|75817885|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
42010736|NCT01018186|75817886|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
42010737|NCT01018186|75817887|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
42010738|NCT00987337|75817902|FG000|Overall Study|Adverse Event|10|||
42010739|NCT00987337|75817903|FG001|Overall Study|Adverse Event|9|||
42036555|NCT00916617|75844896|FG001|Overall Study|Lost to Follow-up|1|||
42138279|NCT00436566|75948509|FG000|Overall Study|Protocol Violation|1|||
42138280|NCT00352365|75948513|FG000|Induction Therapy|Adverse Event|7|||
42138281|NCT00352365|75948513|FG000|Induction Therapy|Progression/Relapse|8|||
42138282|NCT00352365|75948513|FG000|Induction Therapy|Death|7|||
42138283|NCT00352365|75948513|FG000|Induction Therapy|Not protocol specified|1|||
42138284|NCT00352365|75948513|FG000|Induction Therapy|Not eligible|3|||
42273115|NCT02452190|76103711|FG000|Overall Study|Investigator's Decision|2|||
42138285|NCT00352365|75948513|FG000|Induction Therapy|Death before starting protocol therapy|1|||
42138286|NCT00352365|75948513|FG000|Maintenance Therapy|Progression/Relapse|3|||
42138287|NCT00352365|75948513|FG000|Maintenance Therapy|Death|2|||
42138288|NCT00352365|75948513|FG000|Maintenance Therapy|Not protocol specified|3|||
42138289|NCT00352365|75948513|FG000|Maintenance Therapy|Not eligible|4|||
42138290|NCT00532493|75948523|FG000|Overall Study|Death|1|||
42138291|NCT00532493|75948524|FG001|Overall Study|Death|1|||
42138292|NCT00532493|75948523|FG000|Overall Study|Lost to Follow-up|10|||
42138293|NCT00532493|75948524|FG001|Overall Study|Lost to Follow-up|7|||
42138294|NCT00532493|75948523|FG000|Overall Study|Withdrawal by Subject|7|||
42138295|NCT00532493|75948524|FG001|Overall Study|Withdrawal by Subject|9|||
42138296|NCT00532493|75948523|FG000|Overall Study|Physician Decision|1|||
42138297|NCT00532493|75948524|FG001|Overall Study|Physician Decision|6|||
42138298|NCT00532493|75948523|FG000|Overall Study|Adverse Event|6|||
42138299|NCT00532493|75948524|FG001|Overall Study|Adverse Event|5|||
42138300|NCT00532493|75948523|FG000|Overall Study|Protocol Deviation|1|||
42138301|NCT00532493|75948524|FG001|Overall Study|Protocol Deviation|0|||
42138302|NCT00532493|75948523|FG000|Overall Study|Subject Moved Away|3|||
42138303|NCT00532493|75948524|FG001|Overall Study|Subject Moved Away|1|||
42138304|NCT00532493|75948523|FG000|Overall Study|Contraindicative Medication|1|||
42138305|NCT00532493|75948524|FG001|Overall Study|Contraindicative Medication|0|||
42138306|NCT00533507|75948532|FG000|Overall Study|Withdrawal by Subject|1|||
42138307|NCT03886493|75948536|FG000|Overall Study|Adverse Event|1|||
42138308|NCT00352053|75948542|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
42138309|NCT00352053|75948543|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
42138310|NCT00352053|75948542|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
42138311|NCT00352053|75948543|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
42138312|NCT00352053|75948542|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
42138313|NCT00352053|75948543|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
42138314|NCT00352053|75948542|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
42138315|NCT00352053|75948543|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
42138316|NCT00352053|75948542|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
42138317|NCT00352053|75948543|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
42138318|NCT00352053|75948542|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
42138319|NCT00352053|75948543|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
42138320|NCT00352053|75948542|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
42138321|NCT00352053|75948543|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
42138322|NCT00352053|75948542|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
42138323|NCT00352053|75948543|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
42138324|NCT00352053|75948542|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
42138325|NCT00352053|75948543|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
42138326|NCT00352053|75948542|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
42138327|NCT00352053|75948543|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
42138328|NCT00352053|75948542|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
42138329|NCT00352053|75948543|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
42138330|NCT00352053|75948542|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
42138331|NCT00352053|75948543|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
42138332|NCT00352053|75948542|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
42138333|NCT00352053|75948543|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
42138334|NCT00351819|75948559|FG000|Overall Study|Lost to Follow-up|4|||
42138335|NCT00351819|75948560|FG001|Overall Study|Lost to Follow-up|4|||
42138336|NCT00351819|75948559|FG000|Overall Study|Withdrawal by Subject|0|||
42138337|NCT00351819|75948560|FG001|Overall Study|Withdrawal by Subject|4|||
42138338|NCT00351819|75948559|FG000|Overall Study|Elevated PSA|1|||
42138339|NCT00351819|75948560|FG001|Overall Study|Elevated PSA|1|||
42138340|NCT00351819|75948559|FG000|Overall Study|Traumatic ankle fracture|1|||
42138341|NCT00351819|75948560|FG001|Overall Study|Traumatic ankle fracture|0|||
42138342|NCT00351819|75948559|FG000|Overall Study|Unprofessional behavior|1|||
42138343|NCT00351819|75948560|FG001|Overall Study|Unprofessional behavior|0|||
42138344|NCT00351819|75948559|FG000|Overall Study|Non-compliance|0|||
42138345|NCT00351819|75948560|FG001|Overall Study|Non-compliance|1|||
42138346|NCT00351819|75948559|FG000|Overall Study|Incarcerated|0|||
42138347|NCT00351819|75948560|FG001|Overall Study|Incarcerated|1|||
42138348|NCT00351819|75948559|FG000|Overall Study|Enrolled in another trial|0|||
42138349|NCT00351819|75948560|FG001|Overall Study|Enrolled in another trial|1|||
42138350|NCT00351351|75948568|FG000|Overall Study|surgical access pbs; device issues|9|||
42138351|NCT00351351|75948569|FG001|Overall Study|surgical access pbs; device issues|4|||
42138352|NCT00323115|75948575|FG000|Vaccine Administration|Adverse Event|1|||
42138353|NCT00323115|75948575|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
42138354|NCT00322881|75948584|FG000|Overall Study|Death|2|||
42138355|NCT00322881|75948584|FG000|Overall Study|Adverse Event|1|||
42138356|NCT00322881|75948584|FG000|Overall Study|Disease Progression|2|||
42138357|NCT00415194|75948590|FG000|Overall Study|Adverse Event|37|||
42138358|NCT00415194|75948591|FG001|Overall Study|Adverse Event|32|||
42138359|NCT00415194|75948590|FG000|Overall Study|Entry Criteria Not Met|4|||
42138360|NCT00415194|75948591|FG001|Overall Study|Entry Criteria Not Met|8|||
42138361|NCT00415194|75948590|FG000|Overall Study|Lost to Follow-up|1|||
42138362|NCT00415194|75948591|FG001|Overall Study|Lost to Follow-up|0|||
42138363|NCT00415194|75948590|FG000|Overall Study|Physician Decision|10|||
42138364|NCT00415194|75948591|FG001|Overall Study|Physician Decision|16|||
42138365|NCT00415194|75948590|FG000|Overall Study|Progressive Disease|180|||
42273116|NCT02452190|76103712|FG001|Overall Study|Investigator's Decision|0|||
42138366|NCT00415194|75948591|FG001|Overall Study|Progressive Disease|217|||
42138367|NCT00415194|75948590|FG000|Overall Study|Protocol Violation|4|||
42138368|NCT00415194|75948591|FG001|Overall Study|Protocol Violation|2|||
42138369|NCT00415194|75948590|FG000|Overall Study|Withdrawal by Subject|28|||
42138370|NCT00415194|75948591|FG001|Overall Study|Withdrawal by Subject|21|||
42138371|NCT00415194|75948590|FG000|Overall Study|Death Due to Study Disease|26|||
42138372|NCT00415194|75948591|FG001|Overall Study|Death Due to Study Disease|29|||
42138373|NCT00415194|75948590|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
42138374|NCT00415194|75948591|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
42138375|NCT00415194|75948590|FG000|Overall Study|Death Due to Procedural Related AE|0|||
42138376|NCT00415194|75948591|FG001|Overall Study|Death Due to Procedural Related AE|1|||
42273117|NCT02452190|76103711|FG000|Overall Study|Lack of Efficacy|3|||
42273118|NCT02452190|76103712|FG001|Overall Study|Lack of Efficacy|1|||
42273119|NCT02452190|76103711|FG000|Overall Study|Lost to Follow-up|4|||
42347328|NCT01719003|76186461|FG005|Overall Study|Lost to Follow-up|4|||
42347329|NCT01719003|76186462|FG006|Overall Study|Lost to Follow-up|3|||
42347330|NCT01719003|76186463|FG007|Overall Study|Lost to Follow-up|2|||
42347331|NCT01719003|76186464|FG008|Overall Study|Lost to Follow-up|2|||
42347332|NCT01719003|76186456|FG000|Overall Study|Refusal to continue, not due to AE|2|||
42347333|NCT01719003|76186457|FG001|Overall Study|Refusal to continue, not due to AE|5|||
42347334|NCT01719003|76186458|FG002|Overall Study|Refusal to continue, not due to AE|4|||
42347335|NCT01719003|76186459|FG003|Overall Study|Refusal to continue, not due to AE|4|||
42347336|NCT01719003|76186460|FG004|Overall Study|Refusal to continue, not due to AE|4|||
42347337|NCT01719003|76186461|FG005|Overall Study|Refusal to continue, not due to AE|3|||
42347338|NCT01719003|76186462|FG006|Overall Study|Refusal to continue, not due to AE|8|||
42347339|NCT01719003|76186463|FG007|Overall Study|Refusal to continue, not due to AE|7|||
42347340|NCT01719003|76186464|FG008|Overall Study|Refusal to continue, not due to AE|1|||
42347341|NCT01719003|76186456|FG000|Overall Study|Reason other than those specified|0|||
42347342|NCT01719003|76186457|FG001|Overall Study|Reason other than those specified|0|||
42347343|NCT01719003|76186458|FG002|Overall Study|Reason other than those specified|2|||
42036556|NCT00916617|75844897|FG002|Overall Study|Lost to Follow-up|0|||
42036557|NCT00916617|75844898|FG003|Overall Study|Lost to Follow-up|0|||
42036558|NCT00916617|75844895|FG000|Overall Study|Lack of Efficacy|1|||
42036559|NCT00916617|75844896|FG001|Overall Study|Lack of Efficacy|0|||
42036560|NCT00916617|75844897|FG002|Overall Study|Lack of Efficacy|0|||
42036561|NCT00916617|75844898|FG003|Overall Study|Lack of Efficacy|0|||
42036562|NCT00916617|75844895|FG000|Overall Study|Other|2|||
42036563|NCT00916617|75844896|FG001|Overall Study|Other|0|||
42036564|NCT00916617|75844897|FG002|Overall Study|Other|0|||
42036565|NCT00916617|75844898|FG003|Overall Study|Other|2|||
42036566|NCT01103063|75844910|FG000|Overall Study|Adverse Event|3|||
42036567|NCT01103063|75844911|FG001|Overall Study|Adverse Event|1|||
42273120|NCT02452190|76103712|FG001|Overall Study|Lost to Follow-up|3|||
42273121|NCT02452190|76103711|FG000|Overall Study|Adverse Event|2|||
42273122|NCT02452190|76103712|FG001|Overall Study|Adverse Event|5|||
42273123|NCT02452190|76103711|FG000|Overall Study|Withdrawal by Subject|20|||
42036568|NCT01103063|75844910|FG000|Overall Study|Lost to Follow-up|68|||
42036569|NCT01103063|75844911|FG001|Overall Study|Lost to Follow-up|51|||
42036570|NCT01103063|75844910|FG000|Overall Study|Withdrawal by Subject|60|||
42036571|NCT01103063|75844911|FG001|Overall Study|Withdrawal by Subject|15|||
42036572|NCT01103063|75844910|FG000|Overall Study|Other|16|||
42036573|NCT01103063|75844911|FG001|Overall Study|Other|11|||
42036574|NCT01103063|75844910|FG000|Overall Study|Protocol Violation|1|||
42036575|NCT01103063|75844911|FG001|Overall Study|Protocol Violation|0|||
42138377|NCT00415194|75948590|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
42273124|NCT02452190|76103712|FG001|Overall Study|Withdrawal by Subject|11|||
42273125|NCT02452190|76103711|FG000|Overall Study|Noncompliance with study drug|1|||
42273126|NCT02452190|76103712|FG001|Overall Study|Noncompliance with study drug|0|||
42273127|NCT02452190|76103711|FG000|Overall Study|Participant traveled abroad|1|||
42273128|NCT02452190|76103712|FG001|Overall Study|Participant traveled abroad|0|||
42347344|NCT01719003|76186459|FG003|Overall Study|Reason other than those specified|3|||
42138378|NCT00415194|75948591|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
42347345|NCT01719003|76186460|FG004|Overall Study|Reason other than those specified|4|||
42347346|NCT01719003|76186461|FG005|Overall Study|Reason other than those specified|1|||
42036576|NCT01103063|75844910|FG000|Overall Study|Study terminated by Sponsor|326|||
42036577|NCT01103063|75844911|FG001|Overall Study|Study terminated by Sponsor|342|||
42138379|NCT00436332|75948597|FG000|Overall Study|Adverse Event|9|||
42036578|NCT01103063|75844910|FG000|Overall Study|Death|3|||
42036579|NCT01103063|75844911|FG001|Overall Study|Death|1|||
42036580|NCT01091675|75844919|FG000|Overall Study|Adverse Event|7|||
42273129|NCT02452190|76103711|FG000|Overall Study|Death|0|||
42273130|NCT02452190|76103712|FG001|Overall Study|Death|1|||
42273131|NCT02514122|76103720|FG000|Overall Study|Withdrawal by Subject|2|||
42273132|NCT02514122|76103721|FG001|Overall Study|Withdrawal by Subject|0|||
42273133|NCT00730639|76103732|FG000|Overall Study|Adverse Event|3|||
42273134|NCT00730639|76103733|FG001|Overall Study|Adverse Event|0|||
42273135|NCT00730639|76103734|FG002|Overall Study|Adverse Event|9|||
42273136|NCT00730639|76103735|FG003|Overall Study|Adverse Event|8|||
42273137|NCT00730639|76103736|FG004|Overall Study|Adverse Event|23|||
42273138|NCT00730639|76103732|FG000|Overall Study|Complete Response|0|||
42273139|NCT00730639|76103733|FG001|Overall Study|Complete Response|0|||
42347347|NCT01719003|76186462|FG006|Overall Study|Reason other than those specified|0|||
42347348|NCT01719003|76186463|FG007|Overall Study|Reason other than those specified|3|||
42347349|NCT01719003|76186464|FG008|Overall Study|Reason other than those specified|1|||
42347350|NCT01719003|76186456|FG000|Overall Study|Lack of Efficacy|0|||
42347351|NCT01719003|76186457|FG001|Overall Study|Lack of Efficacy|0|||
42347352|NCT01719003|76186458|FG002|Overall Study|Lack of Efficacy|0|||
42347353|NCT01719003|76186459|FG003|Overall Study|Lack of Efficacy|0|||
42347354|NCT01719003|76186460|FG004|Overall Study|Lack of Efficacy|0|||
42347355|NCT01719003|76186461|FG005|Overall Study|Lack of Efficacy|0|||
42347356|NCT01719003|76186462|FG006|Overall Study|Lack of Efficacy|1|||
42347357|NCT01719003|76186463|FG007|Overall Study|Lack of Efficacy|0|||
42347358|NCT01719003|76186464|FG008|Overall Study|Lack of Efficacy|0|||
42347359|NCT01853228|76186483|FG000|Phase 1|Lack of Efficacy|8|||
42347360|NCT01853228|76186484|FG001|Phase 1|Lack of Efficacy|0|||
42347361|NCT01853228|76186483|FG000|Phase 1|Other|1|||
42347362|NCT01853228|76186484|FG001|Phase 1|Other|0|||
42347363|NCT01853228|76186483|FG000|Phase 2|Physician Decision|0|||
42347364|NCT01853228|76186484|FG001|Phase 2|Physician Decision|1|||
42347365|NCT01853228|76186483|FG000|Phase 2|Proceed To Transplant|0|||
42347366|NCT01853228|76186484|FG001|Phase 2|Proceed To Transplant|3|||
42347367|NCT01853228|76186483|FG000|Phase 2|Lack of Efficacy|0|||
42347368|NCT01853228|76186484|FG001|Phase 2|Lack of Efficacy|4|||
42347369|NCT01705587|76186491|FG000|Overall Study|Withdrawal by Subject|0|||
42347370|NCT01705587|76186492|FG001|Overall Study|Withdrawal by Subject|1|||
42347371|NCT01718535|76186508|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
42347372|NCT01718535|76186509|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
42347373|NCT01718535|76186510|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
42347374|NCT01718535|76186511|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
42347375|NCT01718535|76186512|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
42347376|NCT01718535|76186513|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
42347377|NCT01718535|76186514|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
42347378|NCT01718535|76186515|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
42347379|NCT01718535|76186516|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
42347380|NCT01718535|76186517|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
42347381|NCT01717989|76186539|FG000|Overall Study|Ineligibility determined|6|||
42347382|NCT01717989|76186539|FG000|Overall Study|Protocol deviation|6|||
42347383|NCT01717989|76186539|FG000|Overall Study|Withdrawal by Subject|11|||
42347384|NCT01717989|76186539|FG000|Overall Study|Physician Decision|2|||
42347385|NCT01717989|76186539|FG000|Overall Study|Lost to Follow-up|11|||
42347386|NCT01717989|76186539|FG000|Overall Study|Death|439|||
42347387|NCT01717989|76186539|FG000|Overall Study|Protocol-specified criteria|551|||
42347388|NCT01717989|76186539|FG000|Overall Study|Other|40|||
42347389|NCT01705509|76186558|FG000|Inclusion CPET|Screen Failure|5|||
42347390|NCT01705509|76186558|FG000|Inclusion CPET|Withdrawal by Subject|2|||
42010740|NCT00987337|75817904|FG002|Overall Study|Adverse Event|8|||
42010741|NCT00987337|75817902|FG000|Overall Study|Insufficient Virologic Response|10|||
42010742|NCT00987337|75817903|FG001|Overall Study|Insufficient Virologic Response|7|||
42010743|NCT00987337|75817904|FG002|Overall Study|Insufficient Virologic Response|12|||
42010744|NCT00987337|75817902|FG000|Overall Study|Virologic Breakthrough|2|||
42010745|NCT00987337|75817903|FG001|Overall Study|Virologic Breakthrough|2|||
42010746|NCT00987337|75817904|FG002|Overall Study|Virologic Breakthrough|8|||
42010747|NCT00987337|75817902|FG000|Overall Study|Lost to Follow-up|10|||
42010748|NCT00987337|75817903|FG001|Overall Study|Lost to Follow-up|6|||
42010749|NCT00987337|75817904|FG002|Overall Study|Lost to Follow-up|2|||
42010750|NCT00987337|75817902|FG000|Overall Study|Withdrawal by Subject|6|||
42010751|NCT00987337|75817903|FG001|Overall Study|Withdrawal by Subject|9|||
42010752|NCT00987337|75817904|FG002|Overall Study|Withdrawal by Subject|9|||
42036581|NCT01091675|75844919|FG000|Overall Study|Lack of Efficacy|27|||
42273140|NCT00730639|76103734|FG002|Overall Study|Complete Response|2|||
42273141|NCT00730639|76103735|FG003|Overall Study|Complete Response|2|||
42010753|NCT00987337|75817902|FG000|Overall Study|Other|0|||
42036582|NCT01091519|75844925|FG000|Overall Study|Adverse Event|12|||
42010754|NCT00987337|75817903|FG001|Overall Study|Other|2|||
42273142|NCT00730639|76103736|FG004|Overall Study|Complete Response|1|||
42010755|NCT00987337|75817904|FG002|Overall Study|Other|5|||
42010756|NCT00987337|75817902|FG000|Overall Study|Protocol Violation|1|||
42010757|NCT00987337|75817903|FG001|Overall Study|Protocol Violation|0|||
42010758|NCT00987337|75817904|FG002|Overall Study|Protocol Violation|2|||
42010759|NCT00987337|75817902|FG000|Overall Study|Participant Relapsed|18|||
42010760|NCT00987337|75817903|FG001|Overall Study|Participant Relapsed|20|||
42010761|NCT00987337|75817904|FG002|Overall Study|Participant Relapsed|5|||
42010762|NCT00992407|75817916|FG000|Overall Study|Protocol Violation|2|||
42010763|NCT00992407|75817917|FG001|Overall Study|Protocol Violation|1|||
42010764|NCT00992407|75817916|FG000|Overall Study|Lost to Follow-up|3|||
42010765|NCT00992407|75817917|FG001|Overall Study|Lost to Follow-up|3|||
42138380|NCT00436332|75948597|FG000|Overall Study|Withdrawal by Subject|2|||
42347391|NCT01705509|76186558|FG000|CPET w/ Ranexa|Screen Failure|2|||
42010766|NCT00992407|75817916|FG000|Overall Study|Adverse Event|3|||
42010767|NCT00992407|75817917|FG001|Overall Study|Adverse Event|2|||
42010768|NCT00992407|75817916|FG000|Overall Study|protocol Violation & Adverse events|2|||
42273143|NCT00730639|76103732|FG000|Overall Study|Completed Maximum Cycles|0|||
42273144|NCT00730639|76103733|FG001|Overall Study|Completed Maximum Cycles|0|||
42273145|NCT00730639|76103734|FG002|Overall Study|Completed Maximum Cycles|11|||
42273146|NCT00730639|76103735|FG003|Overall Study|Completed Maximum Cycles|3|||
42138381|NCT00436332|75948597|FG000|Overall Study|Progression|59|||
42273147|NCT00730639|76103736|FG004|Overall Study|Completed Maximum Cycles|6|||
42273148|NCT00730639|76103732|FG000|Overall Study|Death|0|||
42273149|NCT00730639|76103733|FG001|Overall Study|Death|0|||
42273150|NCT00730639|76103734|FG002|Overall Study|Death|0|||
42273151|NCT00730639|76103735|FG003|Overall Study|Death|0|||
42273152|NCT00730639|76103736|FG004|Overall Study|Death|2|||
42273153|NCT00730639|76103732|FG000|Overall Study|Disease Progression|12|||
42273154|NCT00730639|76103733|FG001|Overall Study|Disease Progression|13|||
42273155|NCT00730639|76103734|FG002|Overall Study|Disease Progression|48|||
42273156|NCT00730639|76103735|FG003|Overall Study|Disease Progression|32|||
42273157|NCT00730639|76103736|FG004|Overall Study|Disease Progression|88|||
42347392|NCT01853072|76186564|FG000|Overall Study|Adverse event prior to treatment|0|||
42347393|NCT01853072|76186565|FG001|Overall Study|Adverse event prior to treatment|1|||
42347394|NCT01853072|76186564|FG000|Overall Study|Adverse Event|0|||
42347395|NCT01853072|76186565|FG001|Overall Study|Adverse Event|3|||
42347396|NCT01853072|76186564|FG000|Overall Study|Death|1|||
42347397|NCT01853072|76186565|FG001|Overall Study|Death|4|||
42347398|NCT01853072|76186564|FG000|Overall Study|Lost to Follow-up|0|||
42347399|NCT01853072|76186565|FG001|Overall Study|Lost to Follow-up|3|||
42347400|NCT01853072|76186564|FG000|Overall Study|Non-compliance with study drug|0|||
42347401|NCT01853072|76186565|FG001|Overall Study|Non-compliance with study drug|1|||
42347402|NCT01853072|76186564|FG000|Overall Study|Physician Decision|1|||
42347403|NCT01853072|76186565|FG001|Overall Study|Physician Decision|1|||
42347404|NCT01853072|76186564|FG000|Overall Study|Withdrawal by Subject|1|||
42347405|NCT01853072|76186565|FG001|Overall Study|Withdrawal by Subject|2|||
42347406|NCT01853072|76186564|FG000|Overall Study|Reason not specified|9|||
42347407|NCT01853072|76186565|FG001|Overall Study|Reason not specified|6|||
42347408|NCT01877720|76186573|FG000|Overall Study|Adverse Event|1|||
42347409|NCT01877720|76186574|FG001|Overall Study|Adverse Event|0|||
42347410|NCT01870869|76186584|FG000|Overall Study|Implanted with nonstudy device|1|||
42347411|NCT01870869|76186585|FG001|Overall Study|Implanted with nonstudy device|3|||
42347412|NCT01870869|76186586|FG002|Overall Study|Implanted with nonstudy device|14|||
42347413|NCT01870869|76186587|FG003|Overall Study|Implanted with nonstudy device|4|||
42347414|NCT01870869|76186584|FG000|Overall Study|Death|0|||
42347415|NCT01870869|76186585|FG001|Overall Study|Death|0|||
42347416|NCT01870869|76186586|FG002|Overall Study|Death|7|||
42347417|NCT01870869|76186587|FG003|Overall Study|Death|1|||
42347418|NCT01870869|76186584|FG000|Overall Study|Subject choice|6|||
42347419|NCT01870869|76186585|FG001|Overall Study|Subject choice|2|||
42347420|NCT01870869|76186586|FG002|Overall Study|Subject choice|22|||
42347421|NCT01870869|76186587|FG003|Overall Study|Subject choice|8|||
42347422|NCT01870869|76186584|FG000|Overall Study|Lost to Follow-up|10|||
42347423|NCT01870869|76186585|FG001|Overall Study|Lost to Follow-up|2|||
42347424|NCT01870869|76186586|FG002|Overall Study|Lost to Follow-up|25|||
42347425|NCT01870869|76186587|FG003|Overall Study|Lost to Follow-up|3|||
42347426|NCT01870869|76186584|FG000|Overall Study|Reason not Specified|1|||
42347427|NCT01870869|76186585|FG001|Overall Study|Reason not Specified|2|||
42347428|NCT01870869|76186586|FG002|Overall Study|Reason not Specified|20|||
42347429|NCT01870869|76186587|FG003|Overall Study|Reason not Specified|4|||
42347430|NCT01870869|76186584|FG000|Overall Study|Not evaluable|10|||
42347431|NCT01870869|76186585|FG001|Overall Study|Not evaluable|5|||
42347432|NCT01870869|76186586|FG002|Overall Study|Not evaluable|42|||
42347433|NCT01870869|76186587|FG003|Overall Study|Not evaluable|10|||
42347434|NCT01877408|76186599|FG000|Overall Study|Lost to Follow-up|0|||
42347435|NCT01877408|76186600|FG001|Overall Study|Lost to Follow-up|2|||
42347436|NCT01717287|76186609|FG000|Overall Study|Lost to Follow-up|0|||
42347437|NCT01717287|76186610|FG001|Overall Study|Lost to Follow-up|2|||
42347438|NCT01717287|76186609|FG000|Overall Study|Protocol Violation|0|||
42347439|NCT01717287|76186610|FG001|Overall Study|Protocol Violation|1|||
42347440|NCT01827254|76186616|FG000|Overall Study|Death|10|||
42036583|NCT01091519|75844926|FG001|Overall Study|Adverse Event|16|||
42036584|NCT01091519|75844925|FG000|Overall Study|Death|1|||
42273158|NCT00730639|76103732|FG000|Overall Study|non-specified|0|||
42273159|NCT00730639|76103733|FG001|Overall Study|non-specified|0|||
42273160|NCT00730639|76103734|FG002|Overall Study|non-specified|4|||
42273161|NCT00730639|76103735|FG003|Overall Study|non-specified|2|||
42273162|NCT00730639|76103736|FG004|Overall Study|non-specified|3|||
42273163|NCT00730639|76103732|FG000|Overall Study|Protocol Violation|0|||
42273164|NCT00730639|76103733|FG001|Overall Study|Protocol Violation|0|||
42273165|NCT00730639|76103734|FG002|Overall Study|Protocol Violation|1|||
42273166|NCT00730639|76103735|FG003|Overall Study|Protocol Violation|0|||
42273167|NCT00730639|76103736|FG004|Overall Study|Protocol Violation|0|||
42273168|NCT00730639|76103732|FG000|Overall Study|Withdrawal by Subject|0|||
42273169|NCT00730639|76103733|FG001|Overall Study|Withdrawal by Subject|0|||
42273170|NCT00730639|76103734|FG002|Overall Study|Withdrawal by Subject|6|||
42273171|NCT00730639|76103735|FG003|Overall Study|Withdrawal by Subject|3|||
42347441|NCT01827254|76186616|FG000|Overall Study|Case report form not completed|4|||
42347442|NCT01827254|76186616|FG000|Overall Study|Invalidated centre|3|||
42036585|NCT01091519|75844926|FG001|Overall Study|Death|0|||
42273172|NCT00730639|76103736|FG004|Overall Study|Withdrawal by Subject|4|||
42273173|NCT00730639|76103732|FG000|Overall Study|Treatment on-going|2|||
42273174|NCT00730639|76103733|FG001|Overall Study|Treatment on-going|5|||
42347443|NCT01827254|76186616|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
42138382|NCT00436332|75948597|FG000|Overall Study|Death|2|||
42138383|NCT00436332|75948597|FG000|Overall Study|Not Protocol Specified|6|||
42138384|NCT00436332|75948597|FG000|Overall Study|Ineligible|2|||
42138385|NCT00436332|75948597|FG000|Overall Study|Never Received Treatment|3|||
42138386|NCT00532259|75948601|FG000|Overall Study|Withdrawal by Subject|2|||
42138387|NCT00532259|75948601|FG000|Overall Study|Adverse Event|1|||
42138388|NCT00532259|75948601|FG000|Overall Study|Death|1|||
42138389|NCT00532259|75948601|FG000|Overall Study|Lack of Efficacy|21|||
42273175|NCT00730639|76103734|FG002|Overall Study|Treatment on-going|5|||
42273176|NCT00730639|76103735|FG003|Overall Study|Treatment on-going|4|||
42273177|NCT00730639|76103736|FG004|Overall Study|Treatment on-going|4|||
42273178|NCT02536339|76103759|FG000|Overall Study|Death|20|||
42138390|NCT00532259|75948601|FG000|Overall Study|Lost to Follow-up|3|||
42138391|NCT00532259|75948601|FG000|Overall Study|Physician Decision|3|||
42138392|NCT00532259|75948601|FG000|Overall Study|Protocol Violation|1|||
42138393|NCT00322491|75948608|FG000|Overall Study|Adverse Event|1|||
42138394|NCT00322491|75948609|FG001|Overall Study|Adverse Event|0|||
42138395|NCT00322491|75948608|FG000|Overall Study|Death|1|||
42138396|NCT00322491|75948609|FG001|Overall Study|Death|2|||
42138397|NCT00322023|75948619|FG000|Overall Study|various|0|||
42138398|NCT00322023|75948620|FG001|Overall Study|various|2|||
42138399|NCT00322023|75948621|FG002|Overall Study|various|6|||
42138400|NCT00414960|75948631|FG000|Overall Study|Adverse Event|4|||
42138401|NCT00414960|75948632|FG001|Overall Study|Adverse Event|0|||
42138402|NCT00414960|75948631|FG000|Overall Study|Withdrawal by Subject|3|||
42138403|NCT00414960|75948632|FG001|Overall Study|Withdrawal by Subject|0|||
42138404|NCT00414960|75948631|FG000|Overall Study|Physician Decision|0|||
42138405|NCT00414960|75948632|FG001|Overall Study|Physician Decision|1|||
42138406|NCT00321789|75948640|FG000|Overall Study|Lost to Follow-up|4|||
42138407|NCT00321789|75948641|FG001|Overall Study|Lost to Follow-up|7|||
42138408|NCT00321789|75948640|FG000|Overall Study|Withdrawal by Subject|6|||
42138409|NCT00321789|75948641|FG001|Overall Study|Withdrawal by Subject|6|||
42138410|NCT00321789|75948640|FG000|Overall Study|Protocol Violation|5|||
42138411|NCT00321789|75948641|FG001|Overall Study|Protocol Violation|3|||
42138412|NCT00414726|75948649|FG000|Overall Study|Withdrawal by Subject|0|||
42138413|NCT00414726|75948650|FG001|Overall Study|Withdrawal by Subject|1|||
42138414|NCT00531947|75948658|FG000|Overall Study|Adverse Event|5|||
42138415|NCT00531947|75948659|FG001|Overall Study|Adverse Event|10|||
42138416|NCT00531947|75948658|FG000|Overall Study|Lost to Follow-up|12|||
42138417|NCT00531947|75948659|FG001|Overall Study|Lost to Follow-up|9|||
42138418|NCT00531947|75948658|FG000|Overall Study|Withdrawal by Subject|14|||
42138419|NCT00531947|75948659|FG001|Overall Study|Withdrawal by Subject|19|||
42138420|NCT00531947|75948658|FG000|Overall Study|Protocol Violation|2|||
42138421|NCT00531947|75948659|FG001|Overall Study|Protocol Violation|1|||
42138422|NCT00531947|75948658|FG000|Overall Study|Non-Compliance|4|||
42138423|NCT00531947|75948659|FG001|Overall Study|Non-Compliance|7|||
42138424|NCT00531947|75948658|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
42138425|NCT00531947|75948659|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
42138426|NCT00530855|75948665|FG000|Overall Study|Lack of Efficacy|20|||
42138427|NCT00530855|75948665|FG000|Overall Study|Withdrawal by Subject|30|||
42347444|NCT01827254|76186616|FG000|Overall Study|Did not complete re-challenge|1|||
42138428|NCT00530855|75948665|FG000|Overall Study|Fatal Serious AE|3|||
42138429|NCT00530855|75948665|FG000|Overall Study|Non Fatal Serious AE|7|||
42138430|NCT00530855|75948665|FG000|Overall Study|Non Fatal Non Serious AE|12|||
42138431|NCT00530855|75948665|FG000|Overall Study|Protocol Violation|3|||
42138432|NCT00530855|75948665|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
42138433|NCT00530855|75948665|FG000|Overall Study|Lost to Follow-up|9|||
42138434|NCT00530855|75948665|FG000|Overall Study|Other reason for premature termination|17|||
42138435|NCT00530777|75948671|FG000|Overall Study|Lost to Follow-up|0|||
42273179|NCT02536339|76103759|FG000|Overall Study|Withdrawal by Subject|3|||
42273180|NCT02536339|76103759|FG000|Overall Study|Lost to Follow-up|2|||
42273181|NCT02536339|76103759|FG000|Overall Study|Treatment discontinued|2|||
42138436|NCT00530777|75948672|FG001|Overall Study|Lost to Follow-up|1|||
42138437|NCT00530777|75948671|FG000|Overall Study|Death|1|||
42138438|NCT00530777|75948672|FG001|Overall Study|Death|2|||
42273182|NCT02536339|76103759|FG000|Overall Study|Physician Decision|1|||
42273183|NCT02743871|76103793|FG000|Overall Study|Lost to Follow-up|0|||
42273184|NCT02743871|76103794|FG001|Overall Study|Lost to Follow-up|0|||
42273185|NCT02743871|76103795|FG002|Overall Study|Lost to Follow-up|0|||
42273186|NCT02743871|76103796|FG003|Overall Study|Lost to Follow-up|1|||
42273187|NCT02743871|76103797|FG004|Overall Study|Lost to Follow-up|0|||
42273188|NCT02743871|76103798|FG005|Overall Study|Lost to Follow-up|0|||
42273189|NCT02743871|76103799|FG006|Overall Study|Lost to Follow-up|1|||
42138439|NCT00530777|75948671|FG000|Overall Study|Physician Decision|1|||
42138440|NCT00530777|75948672|FG001|Overall Study|Physician Decision|0|||
42273190|NCT02743871|76103800|FG007|Overall Study|Lost to Follow-up|0|||
42273191|NCT02743871|76103801|FG008|Overall Study|Lost to Follow-up|0|||
42273192|NCT02743871|76103802|FG009|Overall Study|Lost to Follow-up|0|||
42273193|NCT02743871|76103803|FG010|Overall Study|Lost to Follow-up|0|||
42347445|NCT01827254|76186616|FG000|Overall Study|Disease progression|36|||
42347446|NCT01827254|76186616|FG000|Overall Study|Intolerance to treatment|4|||
42347447|NCT01824602|76186628|FG000|Overall Study|Withdrawal by Subject|0|||
42347448|NCT01824602|76186629|FG001|Overall Study|Withdrawal by Subject|0|||
42347449|NCT01824602|76186630|FG002|Overall Study|Withdrawal by Subject|1|||
42347450|NCT01824602|76186631|FG003|Overall Study|Withdrawal by Subject|2|||
42138441|NCT00530777|75948671|FG000|Overall Study|Withdrawal by Subject|0|||
42138442|NCT00530777|75948672|FG001|Overall Study|Withdrawal by Subject|1|||
42138443|NCT00530777|75948671|FG000|Overall Study|Unable to adhere to visit schedule|5|||
42138444|NCT00530777|75948672|FG001|Overall Study|Unable to adhere to visit schedule|1|||
42138445|NCT03882047|75948681|FG000|Overall Study|Adverse Event|0|||
42138446|NCT03882047|75948682|FG001|Overall Study|Adverse Event|2|||
42138447|NCT03882047|75948683|FG002|Overall Study|Adverse Event|2|||
42138448|NCT03882047|75948681|FG000|Overall Study|Treatment Failure|3|||
42138449|NCT03882047|75948682|FG001|Overall Study|Treatment Failure|3|||
42138450|NCT03882047|75948683|FG002|Overall Study|Treatment Failure|12|||
42138451|NCT03882047|75948681|FG000|Overall Study|Lost to Follow-up|0|||
42138452|NCT03882047|75948682|FG001|Overall Study|Lost to Follow-up|1|||
42138453|NCT03882047|75948683|FG002|Overall Study|Lost to Follow-up|0|||
42138454|NCT03882047|75948681|FG000|Overall Study|Did Not Wish to Continue|1|||
42138455|NCT03882047|75948682|FG001|Overall Study|Did Not Wish to Continue|4|||
42273194|NCT02743871|76103804|FG011|Overall Study|Lost to Follow-up|2|||
42273195|NCT02743871|76103805|FG012|Overall Study|Lost to Follow-up|0|||
42273196|NCT02743871|76103806|FG013|Overall Study|Lost to Follow-up|0|||
42273197|NCT02743871|76103793|FG000|Overall Study|Withdrawal by Subject|0|||
42273198|NCT02743871|76103794|FG001|Overall Study|Withdrawal by Subject|0|||
42273199|NCT02743871|76103795|FG002|Overall Study|Withdrawal by Subject|0|||
42273200|NCT02743871|76103796|FG003|Overall Study|Withdrawal by Subject|0|||
42273201|NCT02743871|76103797|FG004|Overall Study|Withdrawal by Subject|0|||
42273202|NCT02743871|76103798|FG005|Overall Study|Withdrawal by Subject|0|||
42273203|NCT02743871|76103799|FG006|Overall Study|Withdrawal by Subject|0|||
42273204|NCT02743871|76103800|FG007|Overall Study|Withdrawal by Subject|0|||
42273205|NCT02743871|76103801|FG008|Overall Study|Withdrawal by Subject|0|||
42273206|NCT02743871|76103802|FG009|Overall Study|Withdrawal by Subject|0|||
42273207|NCT02743871|76103803|FG010|Overall Study|Withdrawal by Subject|1|||
42273208|NCT02743871|76103804|FG011|Overall Study|Withdrawal by Subject|0|||
42273209|NCT02743871|76103805|FG012|Overall Study|Withdrawal by Subject|12|||
42273210|NCT02743871|76103806|FG013|Overall Study|Withdrawal by Subject|6|||
42273211|NCT02743871|76103793|FG000|Overall Study|Adverse Event|1|||
42273212|NCT02743871|76103794|FG001|Overall Study|Adverse Event|0|||
42273213|NCT02743871|76103795|FG002|Overall Study|Adverse Event|0|||
42273214|NCT02743871|76103796|FG003|Overall Study|Adverse Event|0|||
42273215|NCT02743871|76103797|FG004|Overall Study|Adverse Event|0|||
42273216|NCT02743871|76103798|FG005|Overall Study|Adverse Event|0|||
42273217|NCT02743871|76103799|FG006|Overall Study|Adverse Event|0|||
42273218|NCT02743871|76103800|FG007|Overall Study|Adverse Event|0|||
42273219|NCT02743871|76103801|FG008|Overall Study|Adverse Event|0|||
42273220|NCT02743871|76103802|FG009|Overall Study|Adverse Event|0|||
42273221|NCT02743871|76103803|FG010|Overall Study|Adverse Event|0|||
42273222|NCT02743871|76103804|FG011|Overall Study|Adverse Event|0|||
42273223|NCT02743871|76103805|FG012|Overall Study|Adverse Event|0|||
42273224|NCT02743871|76103806|FG013|Overall Study|Adverse Event|0|||
42273225|NCT02743871|76103793|FG000|Overall Study|Other|0|||
42273226|NCT02743871|76103794|FG001|Overall Study|Other|0|||
42347451|NCT01824602|76186628|FG000|Overall Study|Patient non-compliance|0|||
42138456|NCT03882047|75948683|FG002|Overall Study|Did Not Wish to Continue|1|||
42138457|NCT03882047|75948681|FG000|Overall Study|Noncompliance With Protocol|2|||
42138458|NCT03882047|75948682|FG001|Overall Study|Noncompliance With Protocol|0|||
42273227|NCT02743871|76103795|FG002|Overall Study|Other|0|||
42273228|NCT02743871|76103796|FG003|Overall Study|Other|0|||
42273229|NCT02743871|76103797|FG004|Overall Study|Other|0|||
42273230|NCT02743871|76103798|FG005|Overall Study|Other|0|||
42273231|NCT02743871|76103799|FG006|Overall Study|Other|0|||
42273232|NCT02743871|76103800|FG007|Overall Study|Other|0|||
42273233|NCT02743871|76103801|FG008|Overall Study|Other|0|||
42273234|NCT02743871|76103802|FG009|Overall Study|Other|0|||
42273235|NCT02743871|76103803|FG010|Overall Study|Other|0|||
42273236|NCT02743871|76103804|FG011|Overall Study|Other|1|||
42273237|NCT02743871|76103805|FG012|Overall Study|Other|1|||
42273238|NCT02743871|76103806|FG013|Overall Study|Other|1|||
42273239|NCT02743871|76103793|FG000|Overall Study|Protocol Violation|0|||
42273240|NCT02743871|76103794|FG001|Overall Study|Protocol Violation|0|||
42273241|NCT02743871|76103795|FG002|Overall Study|Protocol Violation|0|||
42273242|NCT02743871|76103796|FG003|Overall Study|Protocol Violation|0|||
42273243|NCT02743871|76103797|FG004|Overall Study|Protocol Violation|0|||
42273244|NCT02743871|76103798|FG005|Overall Study|Protocol Violation|0|||
42138459|NCT03882047|75948683|FG002|Overall Study|Noncompliance With Protocol|0|||
42273245|NCT02743871|76103799|FG006|Overall Study|Protocol Violation|0|||
42273246|NCT02743871|76103800|FG007|Overall Study|Protocol Violation|0|||
42273247|NCT02743871|76103801|FG008|Overall Study|Protocol Violation|0|||
42273248|NCT02743871|76103802|FG009|Overall Study|Protocol Violation|0|||
42273249|NCT02743871|76103803|FG010|Overall Study|Protocol Violation|0|||
42273250|NCT02743871|76103804|FG011|Overall Study|Protocol Violation|0|||
42273251|NCT02743871|76103805|FG012|Overall Study|Protocol Violation|2|||
42273252|NCT02743871|76103806|FG013|Overall Study|Protocol Violation|0|||
42273253|NCT01704547|76103848|FG000|Overall Study|Physician Decision|4|||
42273254|NCT01704547|76103848|FG000|Overall Study|Withdrawal by Subject|1|||
42273255|NCT00796523|76103868|FG000|Overall Study|Lost to Follow-up|9|||
42273256|NCT00796523|76103869|FG001|Overall Study|Lost to Follow-up|7|||
42273257|NCT01352585|76103884|FG000|Overall Study|Adverse Event|2|||
42138460|NCT03882047|75948681|FG000|Overall Study|Did Not Meet Eligibility|0|||
42138461|NCT03882047|75948682|FG001|Overall Study|Did Not Meet Eligibility|0|||
42138462|NCT03882047|75948683|FG002|Overall Study|Did Not Meet Eligibility|1|||
42138463|NCT00530621|75948693|FG000|Overall Study|Adverse Event|11|||
42138464|NCT00530621|75948694|FG001|Overall Study|Adverse Event|8|||
42138465|NCT00530621|75948693|FG000|Overall Study|Physician Decision|2|||
42138466|NCT00530621|75948694|FG001|Overall Study|Physician Decision|4|||
42138467|NCT00530621|75948693|FG000|Overall Study|Progressive Disease (PD)|47|||
42138468|NCT00530621|75948694|FG001|Overall Study|Progressive Disease (PD)|40|||
42138469|NCT00530621|75948693|FG000|Overall Study|Sponsor Decision|12|||
42138470|NCT00530621|75948694|FG001|Overall Study|Sponsor Decision|15|||
42138471|NCT00530621|75948693|FG000|Overall Study|Subject Decision|4|||
42138472|NCT00530621|75948694|FG001|Overall Study|Subject Decision|7|||
42138473|NCT00530621|75948693|FG000|Overall Study|Death|3|||
42138474|NCT00530621|75948694|FG001|Overall Study|Death|6|||
42138475|NCT00530621|75948693|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
42138476|NCT00530621|75948694|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
42138477|NCT00531479|75948706|FG000|Overall Study|Death|68|||
42138478|NCT00531479|75948707|FG001|Overall Study|Death|71|||
42138479|NCT00531479|75948706|FG000|Overall Study|Lost to Follow-up|0|||
42138480|NCT00531479|75948707|FG001|Overall Study|Lost to Follow-up|2|||
42138481|NCT00531479|75948706|FG000|Overall Study|Other|0|||
42138482|NCT00531479|75948707|FG001|Overall Study|Other|1|||
42138483|NCT00531479|75948706|FG000|Overall Study|Withdrawal by Subject|6|||
42138484|NCT00531479|75948707|FG001|Overall Study|Withdrawal by Subject|6|||
42138485|NCT00531479|75948706|FG000|Overall Study|Did not receive treatment|2|||
42138486|NCT00531479|75948707|FG001|Overall Study|Did not receive treatment|3|||
42138487|NCT00530075|75948713|FG000|Overall Study|Adverse Event|1|||
42138488|NCT00530075|75948713|FG000|Overall Study|Death|1|||
42138489|NCT00530075|75948713|FG000|Overall Study|Lack of Efficacy|3|||
42138490|NCT00530075|75948713|FG000|Overall Study|Protocol Violation|1|||
42138491|NCT00530075|75948713|FG000|Overall Study|Withdrawal by Subject|1|||
42138492|NCT00531011|75948719|FG000|Overall Study|Withdrawal by Subject|2|||
42138493|NCT00531011|75948720|FG001|Overall Study|Withdrawal by Subject|4|||
42138494|NCT00531011|75948719|FG000|Overall Study|Death|1|||
42138495|NCT00531011|75948720|FG001|Overall Study|Death|0|||
42138496|NCT00531011|75948719|FG000|Overall Study|Lost to Follow-up|1|||
42138497|NCT00531011|75948720|FG001|Overall Study|Lost to Follow-up|0|||
42138498|NCT00531011|75948719|FG000|Overall Study|Physician Decision|0|||
42138499|NCT00531011|75948720|FG001|Overall Study|Physician Decision|3|||
42138500|NCT00529217|75948726|FG000|Overall Study|Lack of Efficacy|2|||
42138501|NCT00529217|75948726|FG000|Overall Study|Unable to adhere to study schedule|2|||
42273258|NCT01352585|76103885|FG001|Overall Study|Adverse Event|1|||
42273259|NCT01352585|76103884|FG000|Overall Study|Lost to Follow-up|1|||
42273260|NCT01352585|76103885|FG001|Overall Study|Lost to Follow-up|0|||
42273261|NCT01352585|76103884|FG000|Overall Study|Other|5|||
42273262|NCT01352585|76103885|FG001|Overall Study|Other|2|||
42273263|NCT01352507|76103894|FG000|Treatment Period 1|Adverse Event|3|||
42273264|NCT01352507|76103895|FG001|Treatment Period 1|Adverse Event|0|||
42273265|NCT01352507|76103894|FG000|Treatment Period 1|Lost to Follow-up|3|||
42273266|NCT01352507|76103895|FG001|Treatment Period 1|Lost to Follow-up|4|||
42273267|NCT01352507|76103894|FG000|Treatment Period 1|Withdrawal by Subject|7|||
42138502|NCT00471146|75948733|FG000|Overall Study|Adverse Event|32|||
42138503|NCT00471146|75948734|FG001|Overall Study|Adverse Event|33|||
42138504|NCT00471146|75948733|FG000|Overall Study|Withdrawal by Subject|14|||
42138505|NCT00471146|75948734|FG001|Overall Study|Withdrawal by Subject|11|||
42138506|NCT00471146|75948733|FG000|Overall Study|Death|11|||
42273268|NCT01352507|76103895|FG001|Treatment Period 1|Withdrawal by Subject|5|||
42010769|NCT00992407|75817917|FG001|Overall Study|protocol Violation & Adverse events|4|||
42010770|NCT00992407|75817916|FG000|Overall Study|Other|2|||
42010771|NCT00992407|75817917|FG001|Overall Study|Other|0|||
42010772|NCT00992407|75817916|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
42010773|NCT00992407|75817917|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
42010774|NCT00992407|75817916|FG000|Overall Study|Study medication not administered|17|||
42138507|NCT00471146|75948734|FG001|Overall Study|Death|12|||
42138508|NCT00471146|75948733|FG000|Overall Study|Lost to Follow-up|4|||
42138509|NCT00471146|75948734|FG001|Overall Study|Lost to Follow-up|2|||
42273269|NCT01352507|76103894|FG000|Treatment Period 1|Physician Decision|1|||
42273270|NCT01352507|76103895|FG001|Treatment Period 1|Physician Decision|0|||
42273271|NCT01352507|76103894|FG000|Washout Period|Withdrawal by Subject|0|||
42273272|NCT01352507|76103895|FG001|Washout Period|Withdrawal by Subject|1|||
42273273|NCT01352507|76103894|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
42273274|NCT01352507|76103895|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
42273275|NCT01352507|76103894|FG000|Treatment Period 2|Withdrawal by Subject|4|||
42273276|NCT01352507|76103895|FG001|Treatment Period 2|Withdrawal by Subject|3|||
42273277|NCT01352507|76103894|FG000|Treatment Period 2|Lack of Efficacy|1|||
42273278|NCT01352507|76103895|FG001|Treatment Period 2|Lack of Efficacy|0|||
42273279|NCT02361346|76103916|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
42273280|NCT02361346|76103917|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
42273281|NCT02361346|76103918|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
42273282|NCT02361346|76103919|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
42273283|NCT02361346|76103920|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
42273284|NCT02361346|76103921|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
42273285|NCT02361346|76103922|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
42273286|NCT02361346|76103923|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
42273287|NCT02361346|76103924|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
42273288|NCT02361346|76103916|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
42273289|NCT02361346|76103917|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
42273290|NCT02361346|76103918|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
42273291|NCT02361346|76103919|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
42273292|NCT02361346|76103920|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
42273293|NCT02361346|76103921|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
42273294|NCT02361346|76103922|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
42273295|NCT02361346|76103923|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
42273296|NCT02361346|76103924|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
42273297|NCT02361346|76103916|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
42010775|NCT00992407|75817917|FG001|Overall Study|Study medication not administered|13|||
42138510|NCT00471146|75948733|FG000|Overall Study|Protocol Violation|2|||
42138511|NCT00471146|75948734|FG001|Overall Study|Protocol Violation|2|||
42138512|NCT00471146|75948733|FG000|Overall Study|Objective progression or relapse|84|||
42273298|NCT02361346|76103917|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
42273299|NCT02361346|76103918|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
42273300|NCT02361346|76103919|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
42273301|NCT02361346|76103920|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
42273302|NCT02361346|76103921|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
42273303|NCT02361346|76103922|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
42273304|NCT02361346|76103923|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
42273305|NCT02361346|76103924|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
42273306|NCT02361346|76103916|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
42273307|NCT02361346|76103917|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
42273308|NCT02361346|76103918|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
42273309|NCT02361346|76103919|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
42138513|NCT00471146|75948734|FG001|Overall Study|Objective progression or relapse|87|||
42138514|NCT00471146|75948733|FG000|Overall Study|Global deterioration of health status|12|||
42138515|NCT00471146|75948734|FG001|Overall Study|Global deterioration of health status|14|||
42138516|NCT00471146|75948733|FG000|Overall Study|Randomized but not treated|9|||
42138517|NCT00471146|75948734|FG001|Overall Study|Randomized but not treated|8|||
42138518|NCT00471146|75948733|FG000|Overall Study|Other|4|||
42138519|NCT00471146|75948734|FG001|Overall Study|Other|5|||
42138520|NCT00469898|75948740|FG000|Overall Study|Adverse Event|7|||
42347452|NCT01824602|76186629|FG001|Overall Study|Patient non-compliance|0|||
42347453|NCT01824602|76186630|FG002|Overall Study|Patient non-compliance|1|||
42347454|NCT01824602|76186631|FG003|Overall Study|Patient non-compliance|0|||
42347455|NCT01824602|76186628|FG000|Overall Study|Adverse Event|1|||
42347456|NCT01824602|76186629|FG001|Overall Study|Adverse Event|0|||
42347457|NCT01824602|76186630|FG002|Overall Study|Adverse Event|2|||
42347458|NCT01824602|76186631|FG003|Overall Study|Adverse Event|2|||
42347459|NCT01824602|76186628|FG000|Overall Study|Treatment failure|0|||
42347460|NCT01824602|76186629|FG001|Overall Study|Treatment failure|0|||
42347461|NCT01824602|76186630|FG002|Overall Study|Treatment failure|0|||
42138521|NCT00469898|75948740|FG000|Overall Study|Withdrawal by Subject|4|||
42347462|NCT01824602|76186631|FG003|Overall Study|Treatment failure|1|||
42347463|NCT01704651|76186643|FG000|Overall Study|Pre-op withdrawal by subject|1|||
42347464|NCT01704651|76186644|FG001|Overall Study|Pre-op withdrawal by subject|1|||
42347465|NCT01704651|76186643|FG000|Overall Study|Pre-op change in treatment plan|1|||
42347466|NCT01704651|76186644|FG001|Overall Study|Pre-op change in treatment plan|4|||
42347467|NCT01704651|76186643|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
42347468|NCT01704651|76186644|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
42347469|NCT01704651|76186643|FG000|Overall Study|Post-op did not have laparotomy|2|||
42347470|NCT01704651|76186644|FG001|Overall Study|Post-op did not have laparotomy|1|||
42347471|NCT01876706|76186650|FG000|Overall Study|BPH Intervention|9|||
42347472|NCT01876706|76186650|FG000|Overall Study|Lost to Follow-up|7|||
42347473|NCT01876706|76186650|FG000|Overall Study|Withdrawals|6|||
42138522|NCT00469898|75948740|FG000|Overall Study|Death|4|||
42138523|NCT00469898|75948740|FG000|Overall Study|Disease progression|9|||
42138524|NCT00469898|75948740|FG000|Overall Study|Decreased performance status|1|||
42138525|NCT00529763|75948747|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
42138526|NCT00529763|75948748|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
42138527|NCT00529763|75948749|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
42138528|NCT00529763|75948747|FG000|Overall Study|Death|1|||
42138529|NCT00529763|75948748|FG001|Overall Study|Death|1|||
42138530|NCT00529763|75948749|FG002|Overall Study|Death|1|||
42138531|NCT00529763|75948747|FG000|Overall Study|Disease Progression|10|||
42138532|NCT00529763|75948748|FG001|Overall Study|Disease Progression|16|||
42138533|NCT00529763|75948749|FG002|Overall Study|Disease Progression|11|||
42138534|NCT00529763|75948747|FG000|Overall Study|Lost to Follow-up|1|||
42138535|NCT00529763|75948748|FG001|Overall Study|Lost to Follow-up|2|||
42138536|NCT00529763|75948749|FG002|Overall Study|Lost to Follow-up|3|||
42138537|NCT00529763|75948747|FG000|Overall Study|Stem Cell Transplant|0|||
42138538|NCT00529763|75948748|FG001|Overall Study|Stem Cell Transplant|3|||
42138539|NCT00529763|75948749|FG002|Overall Study|Stem Cell Transplant|1|||
42138540|NCT00529763|75948747|FG000|Overall Study|Study Drug Toxicity|3|||
42138541|NCT00529763|75948748|FG001|Overall Study|Study Drug Toxicity|6|||
42138542|NCT00529763|75948749|FG002|Overall Study|Study Drug Toxicity|4|||
42138543|NCT00529763|75948747|FG000|Overall Study|Participant Withdrew Consent|2|||
42138544|NCT00529763|75948748|FG001|Overall Study|Participant Withdrew Consent|3|||
42138545|NCT00529763|75948749|FG002|Overall Study|Participant Withdrew Consent|4|||
42138546|NCT00529763|75948747|FG000|Overall Study|Other reasons|2|||
42138547|NCT00529763|75948748|FG001|Overall Study|Other reasons|0|||
42138548|NCT00529763|75948749|FG002|Overall Study|Other reasons|2|||
42138549|NCT00529763|75948747|FG000|Overall Study|Participant request to discontinue treatment|1|||
42138550|NCT00529763|75948748|FG001|Overall Study|Participant request to discontinue treatment|1|||
42138551|NCT00529763|75948749|FG002|Overall Study|Participant request to discontinue treatment|3|||
42138552|NCT00486902|75948764|FG000|Overall Study|Withdrawal by Subject|1|||
42138553|NCT00486902|75948765|FG001|Overall Study|Withdrawal by Subject|2|||
42138554|NCT00486902|75948764|FG000|Overall Study|decision for postpartum tubal ligation|3|||
42138555|NCT00486902|75948765|FG001|Overall Study|decision for postpartum tubal ligation|1|||
42138556|NCT00486902|75948764|FG000|Overall Study|spinal anesthetic protocal violation|1|||
42138557|NCT00486902|75948765|FG001|Overall Study|spinal anesthetic protocal violation|1|||
42347474|NCT01876706|76186650|FG000|Overall Study|Death|3|||
42138558|NCT00486902|75948764|FG000|Overall Study|Did not meet inclusion criteria|1|||
42138559|NCT00486902|75948765|FG001|Overall Study|Did not meet inclusion criteria|0|||
42347475|NCT01876082|76186656|FG000|Overall Study|Withdrawal by Subject|0|||
42347476|NCT01876082|76186657|FG001|Overall Study|Withdrawal by Subject|2|||
42347477|NCT01876082|76186656|FG000|Overall Study|Protocol Violation|1|||
42347478|NCT01876082|76186657|FG001|Overall Study|Protocol Violation|0|||
42347479|NCT01876082|76186656|FG000|Overall Study|Adverse Event|1|||
42347480|NCT01876082|76186657|FG001|Overall Study|Adverse Event|1|||
42347481|NCT01876082|76186656|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
42347482|NCT01876082|76186657|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
42347483|NCT01704495|76186667|FG000|Subjects Randomized|Other Reason|3|||
42347484|NCT01704495|76186668|FG001|Subjects Randomized|Other Reason|2|||
42347485|NCT01704495|76186669|FG002|Subjects Randomized|Other Reason|3|||
42347486|NCT01704495|76186670|FG003|Subjects Randomized|Other Reason|2|||
42347487|NCT01704495|76186667|FG000|Subjects Randomized|Discontinuation criteria met|4|||
42347488|NCT01704495|76186668|FG001|Subjects Randomized|Discontinuation criteria met|2|||
42347489|NCT01704495|76186669|FG002|Subjects Randomized|Discontinuation criteria met|2|||
42347490|NCT01704495|76186670|FG003|Subjects Randomized|Discontinuation criteria met|0|||
42347491|NCT01704495|76186667|FG000|Subjects Randomized|Adverse Event|8|||
42347492|NCT01704495|76186668|FG001|Subjects Randomized|Adverse Event|2|||
42347493|NCT01704495|76186669|FG002|Subjects Randomized|Adverse Event|0|||
42347494|NCT01704495|76186670|FG003|Subjects Randomized|Adverse Event|7|||
42347495|NCT01704495|76186667|FG000|Subjects Randomized|Withdrawal by Subject|5|||
42347496|NCT01704495|76186668|FG001|Subjects Randomized|Withdrawal by Subject|5|||
42347497|NCT01704495|76186669|FG002|Subjects Randomized|Withdrawal by Subject|5|||
42347498|NCT01704495|76186670|FG003|Subjects Randomized|Withdrawal by Subject|5|||
42347499|NCT01704495|76186667|FG000|Subjects Randomized|Protocol Violation|1|||
42347500|NCT01704495|76186668|FG001|Subjects Randomized|Protocol Violation|1|||
42347501|NCT01704495|76186669|FG002|Subjects Randomized|Protocol Violation|2|||
42347502|NCT01704495|76186670|FG003|Subjects Randomized|Protocol Violation|0|||
42347503|NCT01704495|76186667|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
42347504|NCT01704495|76186668|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
42347505|NCT01704495|76186669|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
42273310|NCT02361346|76103920|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
42273311|NCT02361346|76103921|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
42273312|NCT02361346|76103922|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
42273313|NCT02361346|76103923|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
42273314|NCT02361346|76103924|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
42273315|NCT02361346|76103916|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
42273316|NCT02361346|76103917|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
42273317|NCT02361346|76103918|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
42273318|NCT02361346|76103919|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
42273319|NCT02361346|76103920|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
42273320|NCT02361346|76103921|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
42273321|NCT02361346|76103922|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
42273322|NCT02361346|76103923|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
42273323|NCT02361346|76103924|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
42273324|NCT02361346|76103916|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
42273325|NCT02361346|76103917|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
42273326|NCT02361346|76103918|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
42273327|NCT02361346|76103919|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
42273328|NCT02361346|76103920|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
42273329|NCT02361346|76103921|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
42273330|NCT02361346|76103922|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
42273331|NCT02361346|76103923|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
42273332|NCT02361346|76103924|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
42273333|NCT02267278|76103966|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
42273334|NCT02267278|76103966|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
42273335|NCT02267278|76103966|FG000|Overall Study|Developed new cancer diagnoses|2|||
42273336|NCT02267278|76103966|FG000|Overall Study|prescribed prohibited medication|1|||
42273337|NCT02360098|76103972|FG000|Overall Study|Physician Decision|7|||
42347506|NCT01704495|76186670|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
42347507|NCT01704495|76186667|FG000|Optional Safety Extension|Adverse Event|0|||
42347508|NCT01704495|76186668|FG001|Optional Safety Extension|Adverse Event|4|||
42347509|NCT01704495|76186669|FG002|Optional Safety Extension|Adverse Event|0|||
42347510|NCT01704495|76186670|FG003|Optional Safety Extension|Adverse Event|1|||
42347511|NCT01704495|76186667|FG000|Optional Safety Extension|Other reason|27|||
42347512|NCT01704495|76186668|FG001|Optional Safety Extension|Other reason|29|||
42347513|NCT01704495|76186669|FG002|Optional Safety Extension|Other reason|30|||
42138560|NCT00486902|75948764|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
42138561|NCT00486902|75948765|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
42273338|NCT02266888|76103983|FG000|Overall Study|Death|2|||
42273339|NCT02266888|76103984|FG001|Overall Study|Death|2|||
42347514|NCT01704495|76186670|FG003|Optional Safety Extension|Other reason|28|||
42347515|NCT01704495|76186667|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
42036586|NCT01091519|75844925|FG000|Overall Study|Lack of Efficacy|16|||
42138562|NCT03687827|75948771|FG000|Treatment Period 1|Death|0|||
42138563|NCT03687827|75948772|FG001|Treatment Period 1|Death|1|||
42273340|NCT02266888|76103985|FG002|Overall Study|Death|4|||
42273341|NCT02266888|76103986|FG003|Overall Study|Death|2|||
42273342|NCT02266888|76103983|FG000|Overall Study|Physician Decision|0|||
42273343|NCT02266888|76103984|FG001|Overall Study|Physician Decision|1|||
42273344|NCT02266888|76103985|FG002|Overall Study|Physician Decision|2|||
42273345|NCT02266888|76103986|FG003|Overall Study|Physician Decision|2|||
42273346|NCT02266888|76103983|FG000|Overall Study|Study Terminated|5|||
42347516|NCT01704495|76186668|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
42347517|NCT01704495|76186669|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
42347518|NCT01704495|76186670|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
42347519|NCT01716663|76186680|FG000|Overall Study|Withdrawn prior to procedure|4|||
42347520|NCT01716663|76186680|FG000|Overall Study|Treated with non-study catheter|2|||
42347521|NCT01716585|76186686|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
42347522|NCT01716585|76186687|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
42347523|NCT01716585|76186686|FG000|Double-blind Treatment|Adverse Event|2|||
42347524|NCT01716585|76186687|FG001|Double-blind Treatment|Adverse Event|1|||
42347525|NCT01716585|76186686|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
42347526|NCT01716585|76186687|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
42347527|NCT01716585|76186686|FG000|Double-blind Treatment|Lost to Follow-up|2|||
42347528|NCT01716585|76186687|FG001|Double-blind Treatment|Lost to Follow-up|0|||
42347529|NCT01716585|76186686|FG000|Double-blind Treatment|Subject Noncompliant|1|||
42138564|NCT03687827|75948771|FG000|Treatment Period 1|Lost to Follow-up|2|||
42138565|NCT03687827|75948772|FG001|Treatment Period 1|Lost to Follow-up|2|||
42138566|NCT03687827|75948771|FG000|Treatment Period 1|Physician Decision|5|||
42138567|NCT03687827|75948772|FG001|Treatment Period 1|Physician Decision|2|||
42138568|NCT03687827|75948771|FG000|Treatment Period 1|Withdrawal by Subject|7|||
42138569|NCT03687827|75948772|FG001|Treatment Period 1|Withdrawal by Subject|3|||
42138570|NCT03687827|75948771|FG000|Treatment Period 2|Physician Decision|4|||
42138571|NCT03687827|75948772|FG001|Treatment Period 2|Physician Decision|1|||
42138572|NCT03687827|75948771|FG000|Treatment Period 2|Withdrawal by Subject|1|||
42273347|NCT02266888|76103984|FG001|Overall Study|Study Terminated|1|||
42273348|NCT02266888|76103985|FG002|Overall Study|Study Terminated|0|||
42273349|NCT02266888|76103986|FG003|Overall Study|Study Terminated|0|||
42347530|NCT01716585|76186687|FG001|Double-blind Treatment|Subject Noncompliant|0|||
42347531|NCT01716585|76186686|FG000|Double-blind Treatment|Other|1|||
42347532|NCT01716585|76186687|FG001|Double-blind Treatment|Other|0|||
42347533|NCT01716585|76186686|FG000|Open-label Treatment|Adverse Event|0|||
42347534|NCT01716585|76186687|FG001|Open-label Treatment|Adverse Event|2|||
42347535|NCT01716585|76186686|FG000|Open-label Treatment|Virologic Failure|0|||
42347536|NCT01716585|76186687|FG001|Open-label Treatment|Virologic Failure|2|||
42347537|NCT01716585|76186686|FG000|Open-label Treatment|Withdrawal by Subject|0|||
42347538|NCT01716585|76186687|FG001|Open-label Treatment|Withdrawal by Subject|3|||
42347539|NCT01852292|76186696|FG000|Overall Study|Untreated - did not receive study drug|3|||
42347540|NCT01852292|76186697|FG001|Overall Study|Untreated - did not receive study drug|1|||
42010776|NCT00986479|75817928|FG000|Period 1|Improved mood|1|||
42010777|NCT00986479|75817929|FG001|Period 1|Improved mood|0|||
42347541|NCT01852292|76186696|FG000|Overall Study|Death|9|||
42010778|NCT00986479|75817928|FG000|Period 1|Administrative reasons|1|||
42010779|NCT00986479|75817929|FG001|Period 1|Administrative reasons|0|||
42138573|NCT03687827|75948772|FG001|Treatment Period 2|Withdrawal by Subject|2|||
42138574|NCT00529529|75948781|FG000|Overall Study|Adverse Event|12|||
42138575|NCT00529529|75948782|FG001|Overall Study|Adverse Event|17|||
42138576|NCT00529529|75948783|FG002|Overall Study|Adverse Event|8|||
42273350|NCT02266888|76103983|FG000|Overall Study|No Longer Eligible|0|||
42273351|NCT02266888|76103984|FG001|Overall Study|No Longer Eligible|0|||
42273352|NCT02266888|76103985|FG002|Overall Study|No Longer Eligible|0|||
42347542|NCT01852292|76186697|FG001|Overall Study|Death|8|||
42347543|NCT01852292|76186696|FG000|Overall Study|Patient/guardian decision|8|||
42347544|NCT01852292|76186697|FG001|Overall Study|Patient/guardian decision|4|||
42347545|NCT01852292|76186696|FG000|Overall Study|Adverse Event|8|||
42347546|NCT01852292|76186697|FG001|Overall Study|Adverse Event|11|||
42347547|NCT01852292|76186696|FG000|Overall Study|Physician Decision|6|||
42347548|NCT01852292|76186697|FG001|Overall Study|Physician Decision|2|||
42347549|NCT01852292|76186696|FG000|Overall Study|Protocol Violation|2|||
42347550|NCT01852292|76186697|FG001|Overall Study|Protocol Violation|0|||
42347551|NCT01852292|76186696|FG000|Overall Study|Non-compliance with study treatment|1|||
42347552|NCT01852292|76186697|FG001|Overall Study|Non-compliance with study treatment|0|||
42347553|NCT01852292|76186696|FG000|Overall Study|Study terminated by Sponsor|0|||
42347554|NCT01852292|76186697|FG001|Overall Study|Study terminated by Sponsor|1|||
42347555|NCT01852292|76186696|FG000|Overall Study|Progressive disease|42|||
42347556|NCT01852292|76186697|FG001|Overall Study|Progressive disease|52|||
42347557|NCT01715805|76186703|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
42347558|NCT01715805|76186704|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
42347559|NCT01715805|76186705|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
42347560|NCT01715805|76186706|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
42347561|NCT01715805|76186703|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
42347562|NCT01715805|76186704|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
42347563|NCT01715805|76186705|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
42347564|NCT01715805|76186706|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
42347565|NCT01715805|76186703|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
42347566|NCT01715805|76186704|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
42347567|NCT01715805|76186705|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
42347568|NCT01715805|76186706|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
42347569|NCT01715805|76186703|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
42347570|NCT01715805|76186704|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
42347571|NCT01715805|76186705|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
42347572|NCT01715805|76186706|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
42347573|NCT01715805|76186703|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
42347574|NCT01715805|76186704|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
42347575|NCT01715805|76186705|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
42347576|NCT01715805|76186706|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
42347577|NCT01715805|76186703|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
42347578|NCT01715805|76186704|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
42347579|NCT01715805|76186705|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
42036587|NCT01091519|75844926|FG001|Overall Study|Lack of Efficacy|19|||
42347580|NCT01715805|76186706|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
42036588|NCT01091519|75844925|FG000|Overall Study|Lost to Follow-up|14|||
42036589|NCT01091519|75844926|FG001|Overall Study|Lost to Follow-up|24|||
42036590|NCT01091519|75844925|FG000|Overall Study|Withdrawal by Subject|2|||
42036591|NCT01091519|75844926|FG001|Overall Study|Withdrawal by Subject|2|||
42036592|NCT01091519|75844925|FG000|Overall Study|Other|6|||
42036593|NCT01091519|75844926|FG001|Overall Study|Other|8|||
42036594|NCT01091519|75844925|FG000|Overall Study|Randomized not treated|4|||
42138577|NCT00529529|75948781|FG000|Overall Study|Subject withdrew consent|12|||
42347581|NCT01715805|76186703|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
42347582|NCT01715805|76186704|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
42347583|NCT01715805|76186705|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
42347584|NCT01715805|76186706|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
42347585|NCT01715805|76186703|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
42347586|NCT01715805|76186704|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
42347587|NCT01715805|76186705|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
42347588|NCT01715805|76186706|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
42347589|NCT01715805|76186703|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
42347590|NCT01715805|76186704|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
42347591|NCT01715805|76186705|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
42347592|NCT01715805|76186706|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
42347593|NCT01715805|76186703|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
42347594|NCT01715805|76186704|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
42347595|NCT01715805|76186705|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
42347596|NCT01715805|76186706|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
42347597|NCT01715805|76186703|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
42347598|NCT01715805|76186704|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
42347599|NCT01715805|76186705|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
42138578|NCT00529529|75948782|FG001|Overall Study|Subject withdrew consent|9|||
42138579|NCT00529529|75948783|FG002|Overall Study|Subject withdrew consent|12|||
42138580|NCT00529529|75948781|FG000|Overall Study|Protocol deviation|8|||
42138581|NCT00529529|75948782|FG001|Overall Study|Protocol deviation|12|||
42138582|NCT00529529|75948783|FG002|Overall Study|Protocol deviation|5|||
42138583|NCT00529529|75948781|FG000|Overall Study|Lost to Follow-up|5|||
42347600|NCT01715805|76186706|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
42347601|NCT01715805|76186703|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
42347602|NCT01715805|76186704|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
42347603|NCT01715805|76186705|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
42347604|NCT01715805|76186706|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
42347605|NCT01715805|76186703|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
42347606|NCT01715805|76186704|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
42347607|NCT01715805|76186705|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
42347608|NCT01715805|76186706|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
42347609|NCT01715805|76186703|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
42347610|NCT01715805|76186704|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
42347611|NCT01715805|76186705|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
42347612|NCT01715805|76186706|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
42347613|NCT01852214|76186714|FG000|Period 1|Adverse Event|1|||
42347614|NCT01852214|76186715|FG001|Period 1|Adverse Event|2|||
42347615|NCT01852214|76186714|FG000|Period 1|Withdrawal by Subject|0|||
42347616|NCT01852214|76186715|FG001|Period 1|Withdrawal by Subject|1|||
42347617|NCT01852214|76186714|FG000|Washout Period|Withdrawal by Subject|0|||
42347618|NCT01852214|76186715|FG001|Washout Period|Withdrawal by Subject|1|||
42347619|NCT01393990|76186740|FG000|Overall Study|Adverse Event|0|||
42347620|NCT01393990|76186741|FG001|Overall Study|Adverse Event|0|||
42347621|NCT01393990|76186742|FG002|Overall Study|Adverse Event|0|||
42036595|NCT01091519|75844926|FG001|Overall Study|Randomized not treated|4|||
42036596|NCT01011738|75844935|FG000|Overall Study|Death|12|||
42138584|NCT00529529|75948782|FG001|Overall Study|Lost to Follow-up|3|||
42138585|NCT00529529|75948783|FG002|Overall Study|Lost to Follow-up|1|||
42138586|NCT00529529|75948781|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
42138587|NCT00529529|75948782|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42138588|NCT00529529|75948783|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
42138589|NCT00529529|75948781|FG000|Overall Study|Death|2|||
42138590|NCT00529529|75948782|FG001|Overall Study|Death|0|||
42347622|NCT01393990|76186743|FG003|Overall Study|Adverse Event|0|||
42347623|NCT01393990|76186744|FG004|Overall Study|Adverse Event|0|||
42036597|NCT01011738|75844936|FG001|Overall Study|Death|3|||
42138591|NCT00529529|75948783|FG002|Overall Study|Death|0|||
42273353|NCT02266888|76103986|FG003|Overall Study|No Longer Eligible|2|||
42273354|NCT02266888|76103983|FG000|Overall Study|Randomization Closed|0|||
42273355|NCT02266888|76103984|FG001|Overall Study|Randomization Closed|0|||
42273356|NCT02266888|76103985|FG002|Overall Study|Randomization Closed|4|||
42273357|NCT02266888|76103986|FG003|Overall Study|Randomization Closed|0|||
42273358|NCT02266888|76103983|FG000|Overall Study|Personnel unavailable at transplant|0|||
42273359|NCT02266888|76103984|FG001|Overall Study|Personnel unavailable at transplant|0|||
42273360|NCT02266888|76103985|FG002|Overall Study|Personnel unavailable at transplant|0|||
42273361|NCT02266888|76103986|FG003|Overall Study|Personnel unavailable at transplant|1|||
42273362|NCT02266888|76103983|FG000|Overall Study|Transfer of care|0|||
42273363|NCT02266888|76103984|FG001|Overall Study|Transfer of care|0|||
42273364|NCT02266888|76103985|FG002|Overall Study|Transfer of care|1|||
42273365|NCT02266888|76103986|FG003|Overall Study|Transfer of care|0|||
42347624|NCT01393990|76186745|FG005|Overall Study|Adverse Event|0|||
42347625|NCT01393990|76186746|FG006|Overall Study|Adverse Event|0|||
42347626|NCT01393990|76186747|FG007|Overall Study|Adverse Event|0|||
42347627|NCT01393990|76186748|FG008|Overall Study|Adverse Event|0|||
42347628|NCT01393990|76186749|FG009|Overall Study|Adverse Event|0|||
42347629|NCT01393990|76186750|FG010|Overall Study|Adverse Event|0|||
42347630|NCT01393990|76186751|FG011|Overall Study|Adverse Event|0|||
42347631|NCT01393990|76186752|FG012|Overall Study|Adverse Event|0|||
42347632|NCT01393990|76186753|FG013|Overall Study|Adverse Event|0|||
42273366|NCT01641952|76103994|FG000|Overall Study|Lost to Follow-up|28|||
42273367|NCT01641952|76103994|FG000|Overall Study|Adverse Event|6|||
42273368|NCT02359552|76104000|FG000|Overall Study|Lost to Follow-up|3|||
42273369|NCT02359552|76104001|FG001|Overall Study|Lost to Follow-up|4|||
42273370|NCT02743793|76104009|FG000|Overall Study|Death|1|||
42273371|NCT02743793|76104010|FG001|Overall Study|Death|1|||
42347633|NCT01393990|76186754|FG014|Overall Study|Adverse Event|1|||
42347634|NCT01393990|76186755|FG015|Overall Study|Adverse Event|1|||
42347635|NCT01393990|76186756|FG016|Overall Study|Adverse Event|0|||
42347636|NCT01393990|76186757|FG017|Overall Study|Adverse Event|0|||
42347637|NCT01393990|76186740|FG000|Overall Study|Progressive Disease|1|||
42347638|NCT01393990|76186741|FG001|Overall Study|Progressive Disease|0|||
42347639|NCT01393990|76186742|FG002|Overall Study|Progressive Disease|0|||
42010780|NCT00986245|75817935|FG000|First Intervention|Poor compliance|8|||
42010781|NCT00986245|75817936|FG001|First Intervention|Poor compliance|4|||
42010782|NCT00986245|75817935|FG000|First Intervention|Lack of Efficacy|1|||
42010783|NCT00986245|75817936|FG001|First Intervention|Lack of Efficacy|2|||
42010784|NCT00986245|75817935|FG000|First Intervention|Withdrawal by Subject|0|||
42010785|NCT00986245|75817936|FG001|First Intervention|Withdrawal by Subject|1|||
42010786|NCT00986245|75817935|FG000|First Intervention|Protocol Violation|0|||
42010787|NCT00986245|75817936|FG001|First Intervention|Protocol Violation|1|||
42010788|NCT00986245|75817935|FG000|First Intervention|Out of indication|1|||
42010789|NCT00986245|75817936|FG001|First Intervention|Out of indication|0|||
42273372|NCT02743793|76104009|FG000|Overall Study|Withdrawal by Subject|0|||
42273373|NCT02743793|76104010|FG001|Overall Study|Withdrawal by Subject|1|||
42273374|NCT02743793|76104009|FG000|Overall Study|Screen Failure|4|||
42347640|NCT01393990|76186743|FG003|Overall Study|Progressive Disease|1|||
42347641|NCT01393990|76186744|FG004|Overall Study|Progressive Disease|1|||
42010790|NCT00986245|75817935|FG000|Second Intervention|Poor compliance|1|||
42010791|NCT00986245|75817936|FG001|Second Intervention|Poor compliance|0|||
42010792|NCT00986245|75817935|FG000|Second Intervention|Lost to Follow-up|1|||
42347642|NCT01393990|76186745|FG005|Overall Study|Progressive Disease|1|||
42347643|NCT01393990|76186746|FG006|Overall Study|Progressive Disease|1|||
42347644|NCT01393990|76186747|FG007|Overall Study|Progressive Disease|1|||
42347645|NCT01393990|76186748|FG008|Overall Study|Progressive Disease|3|||
42347646|NCT01393990|76186749|FG009|Overall Study|Progressive Disease|1|||
42347647|NCT01393990|76186750|FG010|Overall Study|Progressive Disease|0|||
42347648|NCT01393990|76186751|FG011|Overall Study|Progressive Disease|0|||
42347649|NCT01393990|76186752|FG012|Overall Study|Progressive Disease|0|||
42347650|NCT01393990|76186753|FG013|Overall Study|Progressive Disease|1|||
42347651|NCT01393990|76186754|FG014|Overall Study|Progressive Disease|6|||
42347652|NCT01393990|76186755|FG015|Overall Study|Progressive Disease|1|||
42347653|NCT01393990|76186756|FG016|Overall Study|Progressive Disease|0|||
42347654|NCT01393990|76186757|FG017|Overall Study|Progressive Disease|0|||
42347655|NCT01393990|76186740|FG000|Overall Study|Death|0|||
42347656|NCT01393990|76186741|FG001|Overall Study|Death|0|||
42347657|NCT01393990|76186742|FG002|Overall Study|Death|0|||
42347658|NCT01393990|76186743|FG003|Overall Study|Death|0|||
42347659|NCT01393990|76186744|FG004|Overall Study|Death|1|||
42347660|NCT01393990|76186745|FG005|Overall Study|Death|0|||
42347661|NCT01393990|76186746|FG006|Overall Study|Death|0|||
42347662|NCT01393990|76186747|FG007|Overall Study|Death|0|||
42010793|NCT00986245|75817936|FG001|Second Intervention|Lost to Follow-up|0|||
42010794|NCT00986245|75817935|FG000|Second Intervention|Protocol Violation|0|||
42010795|NCT00986245|75817936|FG001|Second Intervention|Protocol Violation|1|||
42010796|NCT00989833|75817950|FG000|Overall Study|Lost to Follow-up|0|||
42010797|NCT00989833|75817951|FG001|Overall Study|Lost to Follow-up|1|||
42347663|NCT01393990|76186748|FG008|Overall Study|Death|0|||
42347664|NCT01393990|76186749|FG009|Overall Study|Death|0|||
42347665|NCT01393990|76186750|FG010|Overall Study|Death|0|||
42347666|NCT01393990|76186751|FG011|Overall Study|Death|0|||
42347667|NCT01393990|76186752|FG012|Overall Study|Death|0|||
42347668|NCT01393990|76186753|FG013|Overall Study|Death|1|||
42347669|NCT01393990|76186754|FG014|Overall Study|Death|1|||
42347670|NCT01393990|76186755|FG015|Overall Study|Death|0|||
42347671|NCT01393990|76186756|FG016|Overall Study|Death|0|||
42347672|NCT01393990|76186757|FG017|Overall Study|Death|0|||
42347673|NCT01393990|76186740|FG000|Overall Study|Withdrawal by Subject|0|||
42347674|NCT01393990|76186741|FG001|Overall Study|Withdrawal by Subject|0|||
42347675|NCT01393990|76186742|FG002|Overall Study|Withdrawal by Subject|0|||
42347676|NCT01393990|76186743|FG003|Overall Study|Withdrawal by Subject|0|||
42347677|NCT01393990|76186744|FG004|Overall Study|Withdrawal by Subject|0|||
42347678|NCT01393990|76186745|FG005|Overall Study|Withdrawal by Subject|0|||
42347679|NCT01393990|76186746|FG006|Overall Study|Withdrawal by Subject|0|||
42347680|NCT01393990|76186747|FG007|Overall Study|Withdrawal by Subject|0|||
42347681|NCT01393990|76186748|FG008|Overall Study|Withdrawal by Subject|0|||
42347682|NCT01393990|76186749|FG009|Overall Study|Withdrawal by Subject|0|||
42347683|NCT01393990|76186750|FG010|Overall Study|Withdrawal by Subject|0|||
42347684|NCT01393990|76186751|FG011|Overall Study|Withdrawal by Subject|0|||
42347685|NCT01393990|76186752|FG012|Overall Study|Withdrawal by Subject|0|||
42347686|NCT01393990|76186753|FG013|Overall Study|Withdrawal by Subject|0|||
42347687|NCT01393990|76186754|FG014|Overall Study|Withdrawal by Subject|1|||
42347688|NCT01393990|76186755|FG015|Overall Study|Withdrawal by Subject|1|||
42347689|NCT01393990|76186756|FG016|Overall Study|Withdrawal by Subject|0|||
42347690|NCT01393990|76186757|FG017|Overall Study|Withdrawal by Subject|0|||
42347691|NCT00210184|76186806|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
42347692|NCT00210106|76186810|FG000|Overall Study|Death|1|||
42347693|NCT00210106|76186810|FG000|Overall Study|Protocol Violation|13|||
42347694|NCT01851590|76186818|FG000|Overall Study|Withdrawal by Subject|0|||
42347695|NCT01851590|76186819|FG001|Overall Study|Withdrawal by Subject|0|||
42347696|NCT01851590|76186820|FG002|Overall Study|Withdrawal by Subject|1|||
42347697|NCT01851590|76186818|FG000|Overall Study|Adverse Event|0|||
42347698|NCT01851590|76186819|FG001|Overall Study|Adverse Event|0|||
42347699|NCT01851590|76186820|FG002|Overall Study|Adverse Event|2|||
42347700|NCT01851590|76186818|FG000|Overall Study|Lack of Efficacy|0|||
42347701|NCT01851590|76186819|FG001|Overall Study|Lack of Efficacy|1|||
42347702|NCT01851590|76186820|FG002|Overall Study|Lack of Efficacy|0|||
42347703|NCT01852058|76186835|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
42347704|NCT01852058|76186836|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
42347705|NCT01852058|76186837|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
42347706|NCT01852058|76186838|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
42347707|NCT01852058|76186839|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
42347708|NCT01852058|76186840|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
42347709|NCT01852058|76186841|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
42347710|NCT01852058|76186842|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
42347711|NCT01852058|76186843|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
42347712|NCT01852058|76186844|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
42347713|NCT01852058|76186845|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
42347714|NCT01852058|76186846|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
42347715|NCT01852058|76186835|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
42347716|NCT01852058|76186836|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
42347717|NCT01852058|76186837|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
42347718|NCT01852058|76186838|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
42347719|NCT01852058|76186839|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
42347720|NCT01852058|76186840|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
42347721|NCT01852058|76186841|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
42347722|NCT01852058|76186842|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
42347723|NCT01852058|76186843|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
42347724|NCT01852058|76186844|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
42347725|NCT01852058|76186845|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
42347726|NCT01852058|76186846|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
42347727|NCT01852058|76186835|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
42347728|NCT01852058|76186836|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
42347729|NCT01852058|76186837|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
42347730|NCT01852058|76186838|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
42347731|NCT01852058|76186839|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
42347732|NCT01852058|76186840|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
42347733|NCT01852058|76186841|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
42347734|NCT01852058|76186842|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
42347735|NCT01852058|76186843|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
42347736|NCT01852058|76186844|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
42347737|NCT01852058|76186845|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
42347738|NCT01852058|76186846|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
42036598|NCT01011738|75844937|FG002|Overall Study|Death|0|||
42036599|NCT01011738|75844935|FG000|Overall Study|Unknown reasons|312|||
42036600|NCT01011738|75844936|FG001|Overall Study|Unknown reasons|291|||
42036601|NCT01011738|75844937|FG002|Overall Study|Unknown reasons|17|||
42347739|NCT01852058|76186835|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
42347740|NCT01852058|76186836|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
42347741|NCT01852058|76186837|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
42347742|NCT01852058|76186838|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
42347743|NCT01852058|76186839|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
42347744|NCT01852058|76186840|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
42347745|NCT01852058|76186841|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
42347746|NCT01852058|76186842|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
42347747|NCT01852058|76186843|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
42347748|NCT01852058|76186844|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
42347749|NCT01852058|76186845|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
42347750|NCT01852058|76186846|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
42347751|NCT01852058|76186835|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
42347752|NCT01852058|76186836|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
42347753|NCT01852058|76186837|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
42347754|NCT01852058|76186838|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
42347755|NCT01852058|76186839|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
42347756|NCT01852058|76186840|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
42347757|NCT01852058|76186841|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
42347758|NCT01852058|76186842|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
42347759|NCT01852058|76186843|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
42347760|NCT01852058|76186844|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
42347761|NCT01852058|76186845|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
42347762|NCT01852058|76186846|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
42347763|NCT01852058|76186835|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
42347764|NCT01852058|76186836|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
42347765|NCT01852058|76186837|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
42347766|NCT01852058|76186838|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
42347767|NCT01852058|76186839|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
42347768|NCT01852058|76186840|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
42347769|NCT01852058|76186841|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
42347770|NCT01852058|76186842|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
42347771|NCT01852058|76186843|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
42347772|NCT01852058|76186844|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
42347773|NCT01852058|76186845|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
42347774|NCT01852058|76186846|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
42347775|NCT01852058|76186835|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
42347776|NCT01852058|76186836|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
42347777|NCT01852058|76186837|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
42347778|NCT01852058|76186838|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
42347779|NCT01852058|76186839|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
42347780|NCT01852058|76186840|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
42347781|NCT01852058|76186841|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
42347782|NCT01852058|76186842|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
42347783|NCT01852058|76186843|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
42347784|NCT01852058|76186844|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
42347785|NCT01852058|76186845|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
42347786|NCT01852058|76186846|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
42347787|NCT01852058|76186835|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
42347788|NCT01852058|76186836|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
42036602|NCT00918333|75844948|FG000|Overall Study|Drug not taken per protocol|1|||
42036603|NCT00918333|75844949|FG001|Overall Study|Drug not taken per protocol|0|||
42036604|NCT00918333|75844948|FG000|Overall Study|Inadequate amount of drugs provided|1|||
42036605|NCT00918333|75844949|FG001|Overall Study|Inadequate amount of drugs provided|4|||
42036606|NCT00918333|75844948|FG000|Overall Study|Ineligible|1|||
42138592|NCT00529529|75948781|FG000|Overall Study|Abnormal test procedure result(s)|1|||
42273375|NCT02743793|76104010|FG001|Overall Study|Screen Failure|0|||
42273376|NCT02743793|76104009|FG000|Overall Study|No Primary Care Physician|0|||
42273377|NCT02743793|76104010|FG001|Overall Study|No Primary Care Physician|1|||
42273378|NCT02743793|76104009|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
42273379|NCT02743793|76104010|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
42273380|NCT02743793|76104009|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
42273381|NCT02743793|76104010|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
42273382|NCT00152009|76104019|FG000|Overall Study|Adverse Event|9|||
42273383|NCT00152009|76104020|FG001|Overall Study|Adverse Event|13|||
42273384|NCT00152009|76104021|FG002|Overall Study|Adverse Event|20|||
42273385|NCT00152009|76104022|FG003|Overall Study|Adverse Event|1|||
42273386|NCT00152009|76104019|FG000|Overall Study|Protocol Violation|3|||
42273387|NCT00152009|76104020|FG001|Overall Study|Protocol Violation|0|||
42273388|NCT00152009|76104021|FG002|Overall Study|Protocol Violation|0|||
42273389|NCT00152009|76104022|FG003|Overall Study|Protocol Violation|1|||
42273390|NCT00152009|76104019|FG000|Overall Study|Withdrawal by Subject|2|||
42273391|NCT00152009|76104020|FG001|Overall Study|Withdrawal by Subject|3|||
42273392|NCT00152009|76104021|FG002|Overall Study|Withdrawal by Subject|4|||
42273393|NCT00152009|76104022|FG003|Overall Study|Withdrawal by Subject|9|||
42273394|NCT00152009|76104019|FG000|Overall Study|Lost to Follow-up|2|||
42273395|NCT00152009|76104020|FG001|Overall Study|Lost to Follow-up|4|||
42273396|NCT00152009|76104021|FG002|Overall Study|Lost to Follow-up|3|||
42273397|NCT00152009|76104022|FG003|Overall Study|Lost to Follow-up|3|||
42273398|NCT00152009|76104019|FG000|Overall Study|Lack of Efficacy|8|||
42273399|NCT00152009|76104020|FG001|Overall Study|Lack of Efficacy|6|||
42273400|NCT00152009|76104021|FG002|Overall Study|Lack of Efficacy|7|||
42273401|NCT00152009|76104022|FG003|Overall Study|Lack of Efficacy|15|||
42273402|NCT00152009|76104019|FG000|Overall Study|ECG abnormalities|2|||
42273403|NCT00152009|76104020|FG001|Overall Study|ECG abnormalities|2|||
42273404|NCT00152009|76104021|FG002|Overall Study|ECG abnormalities|2|||
42273405|NCT00152009|76104022|FG003|Overall Study|ECG abnormalities|1|||
42273406|NCT00152009|76104019|FG000|Overall Study|Sponsor's decision|3|||
42273407|NCT00152009|76104020|FG001|Overall Study|Sponsor's decision|3|||
42273408|NCT00152009|76104021|FG002|Overall Study|Sponsor's decision|1|||
42273409|NCT00152009|76104022|FG003|Overall Study|Sponsor's decision|3|||
42273410|NCT02265952|76104032|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
42273411|NCT02265952|76104033|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
42273412|NCT02265952|76104032|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
42347789|NCT01852058|76186837|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
42347790|NCT01852058|76186838|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
42347791|NCT01852058|76186839|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
42347792|NCT01852058|76186840|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
42347793|NCT01852058|76186841|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
42347794|NCT01852058|76186842|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
42347795|NCT01852058|76186843|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
42347796|NCT01852058|76186844|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
42347797|NCT01852058|76186845|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
42347798|NCT01852058|76186846|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
42347799|NCT01852058|76186835|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
42347800|NCT01852058|76186836|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
42347801|NCT01852058|76186837|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
42347802|NCT01852058|76186838|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
42347803|NCT01852058|76186839|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
42347804|NCT01852058|76186840|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
42347805|NCT01852058|76186841|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
42347806|NCT01852058|76186842|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
42347807|NCT01852058|76186843|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
42347808|NCT01852058|76186844|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
42347809|NCT01852058|76186845|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
42347810|NCT01852058|76186846|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
42347811|NCT00218296|76186883|FG000|Overall Study|Lost to Follow-up|9|||
42347812|NCT00218296|76186884|FG001|Overall Study|Lost to Follow-up|7|||
42347813|NCT00218296|76186883|FG000|Overall Study|Withdrawal by Subject|36|||
42347814|NCT00218296|76186884|FG001|Overall Study|Withdrawal by Subject|47|||
42347815|NCT00218296|76186883|FG000|Overall Study|Randomized but did not enter treatment|66|||
42347816|NCT00218296|76186884|FG001|Overall Study|Randomized but did not enter treatment|67|||
42347817|NCT00217672|76186892|FG000|Allocation|Ineligible|2|||
42347818|NCT00217672|76186893|FG001|Allocation|Ineligible|0|||
42347819|NCT00217672|76186892|FG000|Treatment|disease progression|33|||
42347820|NCT00217672|76186893|FG001|Treatment|disease progression|4|||
42347821|NCT00217672|76186892|FG000|Treatment|Adverse Event|18|||
42347822|NCT00217672|76186893|FG001|Treatment|Adverse Event|2|||
42347823|NCT00217672|76186892|FG000|Treatment|reqd treatment not permitted by protocol|6|||
42347824|NCT00217672|76186893|FG001|Treatment|reqd treatment not permitted by protocol|0|||
42347825|NCT00217672|76186892|FG000|Treatment|Physician Decision|6|||
42347826|NCT00217672|76186893|FG001|Treatment|Physician Decision|0|||
42347827|NCT00217672|76186892|FG000|Treatment|insurance issues|1|||
42347828|NCT00217672|76186893|FG001|Treatment|insurance issues|1|||
42347829|NCT00217672|76186892|FG000|Treatment|Death|2|||
42347830|NCT00217672|76186893|FG001|Treatment|Death|0|||
42347831|NCT00217672|76186892|FG000|Treatment|secondary malignancy|1|||
42347832|NCT00217672|76186893|FG001|Treatment|secondary malignancy|0|||
42347833|NCT00217672|76186892|FG000|Follow-up|Withdrawal by Subject|4|||
42347834|NCT00217672|76186893|FG001|Follow-up|Withdrawal by Subject|0|||
42347835|NCT00217672|76186892|FG000|Follow-up|Lost to Follow-up|1|||
42347836|NCT00217672|76186893|FG001|Follow-up|Lost to Follow-up|0|||
42347837|NCT00216736|76186899|FG000|Overall Study|Lost to Follow-up|1|||
42347838|NCT00216736|76186900|FG001|Overall Study|Lost to Follow-up|1|||
42010798|NCT00989833|75817952|FG002|Overall Study|Lost to Follow-up|0|||
42347839|NCT01850030|76186908|FG000|Overall Study|Adverse Event|64|||
42347840|NCT01850030|76186909|FG001|Overall Study|Adverse Event|82|||
42347841|NCT01850030|76186908|FG000|Overall Study|Lack of Efficacy|3|||
42347842|NCT01850030|76186909|FG001|Overall Study|Lack of Efficacy|1|||
42347843|NCT01850030|76186908|FG000|Overall Study|Lost to Follow-up|5|||
42347844|NCT01850030|76186909|FG001|Overall Study|Lost to Follow-up|5|||
42347845|NCT01850030|76186908|FG000|Overall Study|Withdrawal by Subject|3|||
42347846|NCT01850030|76186909|FG001|Overall Study|Withdrawal by Subject|4|||
42347847|NCT01850030|76186908|FG000|Overall Study|Protocol Violation|24|||
42347848|NCT01850030|76186909|FG001|Overall Study|Protocol Violation|28|||
42347849|NCT01850030|76186908|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
42347850|NCT01850030|76186909|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
42347851|NCT00215644|76186917|FG000|Overall Study|Disease Progression|28|||
42347852|NCT00215644|76186918|FG001|Overall Study|Disease Progression|10|||
42347853|NCT00215644|76186917|FG000|Overall Study|Adverse Event|2|||
42347854|NCT00215644|76186918|FG001|Overall Study|Adverse Event|9|||
42347855|NCT00215644|76186917|FG000|Overall Study|Death|1|||
42347856|NCT00215644|76186918|FG001|Overall Study|Death|2|||
42347857|NCT00215644|76186917|FG000|Overall Study|Withdrawal by Subject|1|||
42347858|NCT00215644|76186918|FG001|Overall Study|Withdrawal by Subject|0|||
42347859|NCT00215644|76186917|FG000|Overall Study|Other|3|||
42347860|NCT00215644|76186918|FG001|Overall Study|Other|15|||
42347861|NCT00215644|76186917|FG000|Overall Study|Randomized but Not Treated|1|||
42347862|NCT00215644|76186918|FG001|Overall Study|Randomized but Not Treated|0|||
42347863|NCT01870401|76186926|FG000|Overall Study|Death|48|||
42347864|NCT01870401|76186927|FG001|Overall Study|Death|24|||
42347865|NCT01870401|76186926|FG000|Overall Study|Withdrawal by Subject|39|||
42347866|NCT01870401|76186927|FG001|Overall Study|Withdrawal by Subject|26|||
42347867|NCT01870401|76186926|FG000|Overall Study|Lost to Follow-up|19|||
42347868|NCT01870401|76186927|FG001|Overall Study|Lost to Follow-up|14|||
42347869|NCT01870401|76186926|FG000|Overall Study|Other|9|||
42347870|NCT01870401|76186927|FG001|Overall Study|Other|7|||
42347871|NCT01870401|76186926|FG000|Overall Study|On-going in the Study|35|||
42347872|NCT01870401|76186927|FG001|Overall Study|On-going in the Study|25|||
42347873|NCT00213148|76186939|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
42347874|NCT00213148|76186940|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
42347875|NCT00213148|76186941|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
42347876|NCT00213148|76186942|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
42347877|NCT00213148|76186943|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
42347878|NCT00213148|76186939|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
42347879|NCT00213148|76186940|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
42347880|NCT00213148|76186941|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
42347881|NCT00213148|76186942|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
42347882|NCT00213148|76186943|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
42347883|NCT00213148|76186939|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
42347884|NCT00213148|76186940|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
42347885|NCT00213148|76186941|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
42347886|NCT00213148|76186942|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
42347887|NCT00213148|76186943|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
42010799|NCT00989833|75817950|FG000|Overall Study|Protocol Violation|1|||
42347888|NCT00213148|76186939|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
42347889|NCT00213148|76186940|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
42347890|NCT00213148|76186941|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
42347891|NCT00213148|76186942|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
42010800|NCT00989833|75817951|FG001|Overall Study|Protocol Violation|2|||
42010801|NCT00989833|75817952|FG002|Overall Study|Protocol Violation|1|||
42273413|NCT02265952|76104033|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
42273414|NCT02265796|76104041|FG000|Overall Study|Death|1|||
42273415|NCT02265796|76104042|FG001|Overall Study|Death|0|||
42273416|NCT02265796|76104041|FG000|Overall Study|started on excluded medication|1|||
42273417|NCT02265796|76104042|FG001|Overall Study|started on excluded medication|0|||
42273418|NCT02265796|76104041|FG000|Overall Study|Withdrawal by Subject|1|||
42273419|NCT02265796|76104042|FG001|Overall Study|Withdrawal by Subject|1|||
42273420|NCT02357368|76104052|FG000|Overall Study|Lost to Follow-up|0|||
42273421|NCT02357368|76104053|FG001|Overall Study|Lost to Follow-up|0|||
42273422|NCT02357368|76104054|FG002|Overall Study|Lost to Follow-up|0|||
42347892|NCT00213148|76186943|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
42273423|NCT02357368|76104055|FG003|Overall Study|Lost to Follow-up|1|||
42273424|NCT02357368|76104052|FG000|Overall Study|Pregnancy|3|||
42347893|NCT00213148|76186939|FG000|Cycle 1 (1 Month)|Other|3|||
42347894|NCT00213148|76186940|FG001|Cycle 1 (1 Month)|Other|0|||
42010802|NCT00989833|75817950|FG000|Overall Study|Withdrawal by Subject|0|||
42347895|NCT00213148|76186941|FG002|Cycle 1 (1 Month)|Other|2|||
42347896|NCT00213148|76186942|FG003|Cycle 1 (1 Month)|Other|2|||
42347897|NCT00213148|76186943|FG004|Cycle 1 (1 Month)|Other|7|||
42347898|NCT00213148|76186939|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
42347899|NCT00213148|76186940|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
42347900|NCT00213148|76186941|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
42347901|NCT00213148|76186942|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
42347902|NCT00213148|76186943|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
42347903|NCT00213148|76186939|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
42347904|NCT00213148|76186940|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
42347905|NCT00213148|76186941|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
42347906|NCT00213148|76186942|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
42347907|NCT00213148|76186943|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
42347908|NCT00213148|76186939|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
42347909|NCT00213148|76186940|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
42347910|NCT00213148|76186941|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
42347911|NCT00213148|76186942|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
42347912|NCT00213148|76186943|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
42347913|NCT00213148|76186939|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
42347914|NCT00213148|76186940|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
42347915|NCT00213148|76186941|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
42347916|NCT00213148|76186942|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
42347917|NCT00213148|76186943|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
42347918|NCT00213148|76186939|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
42347919|NCT00213148|76186940|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
42347920|NCT00213148|76186941|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
42347921|NCT00213148|76186942|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
42347922|NCT00213148|76186943|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
42347923|NCT00213148|76186939|FG000|Cycle 2 (1 Month)|Other|2|||
42347924|NCT00213148|76186940|FG001|Cycle 2 (1 Month)|Other|1|||
42347925|NCT00213148|76186941|FG002|Cycle 2 (1 Month)|Other|2|||
42347926|NCT00213148|76186942|FG003|Cycle 2 (1 Month)|Other|8|||
42347927|NCT00213148|76186943|FG004|Cycle 2 (1 Month)|Other|7|||
42347928|NCT00213148|76186939|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
42347929|NCT00213148|76186940|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
42347930|NCT00213148|76186941|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
42347931|NCT00213148|76186942|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
42347932|NCT00213148|76186943|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
42347933|NCT00213148|76186939|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
42347934|NCT00213148|76186940|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
42347935|NCT00213148|76186941|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
42347936|NCT00213148|76186942|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
42347937|NCT00213148|76186943|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
42347938|NCT00213148|76186939|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
42347939|NCT00213148|76186940|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
42347940|NCT00213148|76186941|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
42347941|NCT00213148|76186942|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
42347942|NCT00213148|76186943|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
42347943|NCT00213148|76186939|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
42347944|NCT00213148|76186940|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
42347945|NCT00213148|76186941|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
42347946|NCT00213148|76186942|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
42347947|NCT00213148|76186943|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
42347948|NCT00213148|76186939|FG000|Cycle 3 (1 Month)|Other|0|||
42347949|NCT00213148|76186940|FG001|Cycle 3 (1 Month)|Other|0|||
42347950|NCT00213148|76186941|FG002|Cycle 3 (1 Month)|Other|1|||
42036607|NCT00918333|75844949|FG001|Overall Study|Ineligible|0|||
42347951|NCT00213148|76186942|FG003|Cycle 3 (1 Month)|Other|1|||
42347952|NCT00213148|76186943|FG004|Cycle 3 (1 Month)|Other|0|||
42347953|NCT01704261|76186965|FG000|Overall Study|Withdrawal by Subject|12|||
42347954|NCT01704261|76186966|FG001|Overall Study|Withdrawal by Subject|15|||
42347955|NCT01704261|76186965|FG000|Overall Study|Lost to Follow-up|1|||
42347956|NCT01704261|76186966|FG001|Overall Study|Lost to Follow-up|0|||
42347957|NCT01715571|76186972|FG000|Overall Study|Lost to Follow-up|8|||
42347958|NCT00212758|76186976|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
42347959|NCT00212758|76186977|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
42347960|NCT00212758|76186976|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
42347961|NCT00212758|76186977|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
42347962|NCT01824290|76186985|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
42347963|NCT01824290|76186986|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
42347964|NCT01824290|76186987|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
42347965|NCT01824290|76186988|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
42347966|NCT01824290|76186985|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
42347967|NCT01824290|76186986|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
42347968|NCT01824290|76186987|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
42347969|NCT01824290|76186988|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
42347970|NCT01824290|76186985|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
42347971|NCT01824290|76186986|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
42347972|NCT01824290|76186987|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
42347973|NCT01824290|76186988|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
42347974|NCT01824290|76186985|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
42347975|NCT01824290|76186986|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
42347976|NCT01824290|76186987|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
42347977|NCT01824290|76186988|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
42347978|NCT01824290|76186985|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
42347979|NCT01824290|76186986|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
42347980|NCT01824290|76186987|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
42347981|NCT01824290|76186988|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
42347982|NCT01824290|76186985|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
42347983|NCT01824290|76186986|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
42347984|NCT01824290|76186987|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
42347985|NCT01824290|76186988|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
42347986|NCT01715415|76187002|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
42347987|NCT01715415|76187003|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
42347988|NCT01715415|76187002|FG000|Double-blind Treatment|Adverse Event|3|||
42347989|NCT01715415|76187003|FG001|Double-blind Treatment|Adverse Event|0|||
42347990|NCT01715415|76187002|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
42347991|NCT01715415|76187003|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
42347992|NCT01715415|76187002|FG000|Double-blind Treatment|Other|1|||
42347993|NCT01715415|76187003|FG001|Double-blind Treatment|Other|0|||
42347994|NCT01715415|76187002|FG000|Open-label Treatment|Adverse Event|0|||
42347995|NCT01715415|76187003|FG001|Open-label Treatment|Adverse Event|1|||
42347996|NCT01715415|76187002|FG000|Open-label Treatment|Subject Noncompliant|0|||
42347997|NCT01715415|76187003|FG001|Open-label Treatment|Subject Noncompliant|1|||
42347998|NCT00211510|76187012|FG000|Overall Study|Physician Decision|3|||
42347999|NCT00211510|76187013|FG001|Overall Study|Physician Decision|1|||
42348000|NCT00211510|76187012|FG000|Overall Study|Withdrawal by Subject|3|||
42348001|NCT00211510|76187013|FG001|Overall Study|Withdrawal by Subject|1|||
42348002|NCT01869777|76187022|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
42348003|NCT01714947|76187026|FG000|Part B|Progressive Disease|3|||
42348004|NCT01869699|76187032|FG000|Overall Study|Withdrawal by Subject|1|||
42348005|NCT01869699|76187033|FG001|Overall Study|Withdrawal by Subject|0|||
42348006|NCT01714635|76187042|FG000|Overall Study|Discontinued|1|||
42348007|NCT01714635|76187043|FG001|Overall Study|Discontinued|0|||
42348008|NCT01714635|76187044|FG002|Overall Study|Discontinued|2|||
42348009|NCT01714635|76187042|FG000|Overall Study|Missed 6-month exam|1|||
42348010|NCT01714635|76187043|FG001|Overall Study|Missed 6-month exam|0|||
42348011|NCT01714635|76187044|FG002|Overall Study|Missed 6-month exam|0|||
42348012|NCT01713933|76187052|FG000|Overall Study|Lost to Follow-up|2|||
42348013|NCT01713933|76187052|FG000|Overall Study|Withdrawal by Subject|3|||
42348014|NCT01713933|76187052|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
42348015|NCT01868997|76187058|FG000|Overall Study|Adverse Event|2|||
42348016|NCT01868997|76187059|FG001|Overall Study|Adverse Event|5|||
42348017|NCT01868997|76187058|FG000|Overall Study|Lack of Efficacy|2|||
42348018|NCT01868997|76187059|FG001|Overall Study|Lack of Efficacy|0|||
42348019|NCT01868997|76187058|FG000|Overall Study|Other|3|||
42348020|NCT01868997|76187059|FG001|Overall Study|Other|1|||
42348021|NCT01875848|76187067|FG000|Overall Study|Withdrawal by Subject|2|||
42348022|NCT01875848|76187068|FG001|Overall Study|Withdrawal by Subject|0|||
42348023|NCT04191382|76187077|FG000|Overall Study|Withdrawal by Subject|1|||
42348024|NCT04191382|76187078|FG001|Overall Study|Withdrawal by Subject|0|||
42348025|NCT04191382|76187079|FG002|Overall Study|Withdrawal by Subject|0|||
42348026|NCT01703091|76187089|FG000|Overall Study|Adverse Event|5|||
42348027|NCT01703091|76187090|FG001|Overall Study|Adverse Event|3|||
42348028|NCT01703091|76187089|FG000|Overall Study|Physician Decision|2|||
42348029|NCT01703091|76187090|FG001|Overall Study|Physician Decision|1|||
42348030|NCT01703091|76187089|FG000|Overall Study|Withdrawal by Subject|1|||
42348031|NCT01703091|76187090|FG001|Overall Study|Withdrawal by Subject|0|||
42348032|NCT01703091|76187089|FG000|Overall Study|Sponsor Decision|1|||
42348033|NCT01703091|76187090|FG001|Overall Study|Sponsor Decision|0|||
42348034|NCT01712685|76187096|FG000|Overall Study|pt declined to participate before trmt|1|||
42138593|NCT00529529|75948782|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42348035|NCT01867671|76187102|FG000|Overall Study|Adverse Event|5|||
42036608|NCT00918333|75844948|FG000|Overall Study|Withdrawal by Subject|0|||
42348036|NCT01867671|76187103|FG001|Overall Study|Adverse Event|3|||
42348037|NCT01867671|76187102|FG000|Overall Study|Anaphylaxis|0|||
42348038|NCT01867671|76187103|FG001|Overall Study|Anaphylaxis|1|||
42348039|NCT01867671|76187102|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
42348040|NCT01867671|76187103|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
42348041|NCT01867671|76187102|FG000|Overall Study|Lost to Follow-up|0|||
42348042|NCT01867671|76187103|FG001|Overall Study|Lost to Follow-up|1|||
42348043|NCT01867671|76187102|FG000|Overall Study|Non-compliance with Study Drug|1|||
42348044|NCT01867671|76187103|FG001|Overall Study|Non-compliance with Study Drug|2|||
42348045|NCT01867671|76187102|FG000|Overall Study|Withdrawal by Subject|21|||
42348046|NCT01867671|76187103|FG001|Overall Study|Withdrawal by Subject|21|||
42348047|NCT01702311|76187111|FG000|Overall Study|Withdrawal by Subject|3|||
42348048|NCT01702311|76187112|FG001|Overall Study|Withdrawal by Subject|2|||
42348049|NCT01702311|76187111|FG000|Overall Study|Discharge less than 24 hours|10|||
42348050|NCT01702311|76187112|FG001|Overall Study|Discharge less than 24 hours|7|||
42348051|NCT01702311|76187111|FG000|Overall Study|Physician Decision|3|||
42348052|NCT01702311|76187112|FG001|Overall Study|Physician Decision|4|||
42348053|NCT01712061|76187128|FG000|Overall Study|Adverse Event|4|||
42348054|NCT01712061|76187129|FG001|Overall Study|Adverse Event|9|||
42348055|NCT01712061|76187130|FG002|Overall Study|Adverse Event|5|||
42348056|NCT01712061|76187128|FG000|Overall Study|Death|0|||
42348057|NCT01712061|76187129|FG001|Overall Study|Death|0|||
42348058|NCT01712061|76187130|FG002|Overall Study|Death|1|||
42348059|NCT01712061|76187128|FG000|Overall Study|Lost to Follow-up|1|||
42348060|NCT01712061|76187129|FG001|Overall Study|Lost to Follow-up|0|||
42348061|NCT01712061|76187130|FG002|Overall Study|Lost to Follow-up|1|||
42348062|NCT01712061|76187128|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
42348063|NCT01712061|76187129|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
42348064|NCT01712061|76187130|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
42348065|NCT01712061|76187128|FG000|Overall Study|Medication Error Without Associated AE|0|||
42348066|NCT01712061|76187129|FG001|Overall Study|Medication Error Without Associated AE|1|||
42348067|NCT01712061|76187130|FG002|Overall Study|Medication Error Without Associated AE|0|||
42348068|NCT01712061|76187128|FG000|Overall Study|Withdrawal by Subject|1|||
42348069|NCT01712061|76187129|FG001|Overall Study|Withdrawal by Subject|7|||
42348070|NCT01712061|76187130|FG002|Overall Study|Withdrawal by Subject|1|||
42348071|NCT01712061|76187128|FG000|Overall Study|Other|0|||
42348072|NCT01712061|76187129|FG001|Overall Study|Other|3|||
42348073|NCT01712061|76187130|FG002|Overall Study|Other|0|||
42348074|NCT03592186|76187141|FG000|Overall Study|Withdrawal by Subject|1|||
42348075|NCT03592186|76187142|FG001|Overall Study|Withdrawal by Subject|0|||
42348076|NCT03592186|76187141|FG000|Overall Study|Lost to Follow-up|16|||
42348077|NCT03592186|76187142|FG001|Overall Study|Lost to Follow-up|11|||
42036609|NCT00918333|75844949|FG001|Overall Study|Withdrawal by Subject|1|||
42036610|NCT01091363|75844960|FG000|Overall Study|Withdrawal by Subject|11|||
42138594|NCT00529529|75948783|FG002|Overall Study|Abnormal test procedure result(s)|0|||
42138595|NCT00529529|75948781|FG000|Overall Study|Administrative problems|1|||
42138596|NCT00529529|75948782|FG001|Overall Study|Administrative problems|0|||
42348078|NCT03598114|76187150|FG000|Overall Study|Staff turnover/left the program|3|||
42348079|NCT03598114|76187151|FG001|Overall Study|Staff turnover/left the program|39|||
42348080|NCT01711983|76187178|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
42348081|NCT01711983|76187178|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
42348082|NCT01711983|76187178|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
42348083|NCT01711983|76187178|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
42348084|NCT01874288|76187192|FG000|Overall Study|Withdrawal by Subject|1|||
42348085|NCT01874288|76187193|FG001|Overall Study|Withdrawal by Subject|0|||
42348086|NCT01874288|76187194|FG002|Overall Study|Withdrawal by Subject|2|||
42348087|NCT01874288|76187195|FG003|Overall Study|Withdrawal by Subject|1|||
42348088|NCT01874288|76187196|FG004|Overall Study|Withdrawal by Subject|1|||
42348089|NCT01874288|76187192|FG000|Overall Study|Physician Decision|0|||
42348090|NCT01874288|76187193|FG001|Overall Study|Physician Decision|0|||
42348091|NCT01874288|76187194|FG002|Overall Study|Physician Decision|0|||
42348092|NCT01874288|76187195|FG003|Overall Study|Physician Decision|1|||
42348093|NCT01874288|76187196|FG004|Overall Study|Physician Decision|0|||
42348094|NCT01874288|76187192|FG000|Overall Study|Progressive disease|2|||
42348095|NCT01874288|76187193|FG001|Overall Study|Progressive disease|0|||
42348096|NCT01874288|76187194|FG002|Overall Study|Progressive disease|3|||
42348097|NCT01874288|76187195|FG003|Overall Study|Progressive disease|5|||
42348098|NCT01874288|76187196|FG004|Overall Study|Progressive disease|1|||
42348099|NCT01874054|76187225|FG000|Overall Study|Withdrawal by Subject|3|||
42348100|NCT01874054|76187225|FG000|Overall Study|Study Termination by Sponsor|42|||
42138597|NCT00529529|75948783|FG002|Overall Study|Administrative problems|3|||
42138598|NCT05655377|75948791|FG000|Overall Study|Withdrawal by Subject|2|||
42348101|NCT01874054|76187225|FG000|Overall Study|Lost to Follow-up|5|||
42348102|NCT01874054|76187225|FG000|Overall Study|Death|5|||
42348103|NCT01873742|76187231|FG000|Overall Study|Lost to Follow-up|68|||
42348104|NCT01873742|76187232|FG001|Overall Study|Lost to Follow-up|76|||
42348105|NCT01873586|76187238|FG000|Overall Study|Lost to Follow-up|3|||
42348106|NCT04027348|76187272|FG000|Overall Study|Adverse Event|2|||
42348107|NCT04196686|76187285|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
42348108|NCT04196686|76187286|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
42348109|NCT02708680|76187295|FG000|Overall Study|Withdrawal by Subject|4|||
42348110|NCT02708680|76187296|FG001|Overall Study|Withdrawal by Subject|12|||
42348111|NCT02708680|76187297|FG002|Overall Study|Withdrawal by Subject|12|||
42348112|NCT02708680|76187295|FG000|Overall Study|Death|4|||
42348113|NCT02708680|76187296|FG001|Overall Study|Death|19|||
42348114|NCT02708680|76187297|FG002|Overall Study|Death|21|||
42348115|NCT02708680|76187295|FG000|Overall Study|Lost to Follow-up|0|||
42348116|NCT02708680|76187296|FG001|Overall Study|Lost to Follow-up|3|||
42348117|NCT02708680|76187297|FG002|Overall Study|Lost to Follow-up|3|||
42348118|NCT02708680|76187295|FG000|Overall Study|Study Terminated By Sponsor|0|||
42348119|NCT02708680|76187296|FG001|Overall Study|Study Terminated By Sponsor|5|||
42348120|NCT02708680|76187297|FG002|Overall Study|Study Terminated By Sponsor|4|||
42348121|NCT02708680|76187295|FG000|Overall Study|Other than Specified|0|||
42348122|NCT02708680|76187296|FG001|Overall Study|Other than Specified|0|||
42348123|NCT02708680|76187297|FG002|Overall Study|Other than Specified|1|||
42348124|NCT02708680|76187295|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
42348125|NCT02708680|76187296|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
42348126|NCT02708680|76187297|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
42348127|NCT01611974|76187311|FG000|Overall Study|Death|10|||
42348128|NCT01611974|76187312|FG001|Overall Study|Death|12|||
42348129|NCT01611974|76187313|FG002|Overall Study|Death|10|||
42348130|NCT01611974|76187311|FG000|Overall Study|Lost to Follow-up|0|||
42348131|NCT01611974|76187312|FG001|Overall Study|Lost to Follow-up|1|||
42348132|NCT01611974|76187313|FG002|Overall Study|Lost to Follow-up|0|||
42348133|NCT01611974|76187311|FG000|Overall Study|Physician Decision|5|||
42348134|NCT01611974|76187312|FG001|Overall Study|Physician Decision|1|||
42348135|NCT01611974|76187313|FG002|Overall Study|Physician Decision|2|||
42348136|NCT01611974|76187311|FG000|Overall Study|Withdrawal by Subject|0|||
42348137|NCT01611974|76187312|FG001|Overall Study|Withdrawal by Subject|1|||
42348138|NCT01611974|76187313|FG002|Overall Study|Withdrawal by Subject|4|||
42348139|NCT01848938|76187323|FG000|Overall Study|Lost to Follow-up|1|||
42348140|NCT01848938|76187324|FG001|Overall Study|Lost to Follow-up|1|||
42348141|NCT01871870|76187330|FG000|Overall Study|Hardware issues|7|||
42348142|NCT01871870|76187330|FG000|Overall Study|hyperglycemia|2|||
42348143|NCT01871558|76187343|FG000|Overall Study|Other reason|0|||
42273425|NCT02357368|76104053|FG001|Overall Study|Pregnancy|2|||
42273426|NCT02357368|76104054|FG002|Overall Study|Pregnancy|0|||
42348144|NCT01871558|76187344|FG001|Overall Study|Other reason|1|||
42348145|NCT01871558|76187343|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
42348146|NCT01871558|76187344|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
42348147|NCT01871558|76187343|FG000|Overall Study|Withdrawal by Subject|2|||
42273427|NCT02357368|76104055|FG003|Overall Study|Pregnancy|0|||
42273428|NCT02357368|76104052|FG000|Overall Study|Withdrawal by Subject|3|||
42273429|NCT02357368|76104053|FG001|Overall Study|Withdrawal by Subject|1|||
42273430|NCT02357368|76104054|FG002|Overall Study|Withdrawal by Subject|1|||
42273431|NCT02357368|76104055|FG003|Overall Study|Withdrawal by Subject|2|||
42273432|NCT03287245|76104069|FG000|Overall Study|Study terminated by sponsor|3|||
42273433|NCT03287245|76104070|FG001|Overall Study|Study terminated by sponsor|0|||
42348148|NCT01871558|76187344|FG001|Overall Study|Withdrawal by Subject|0|||
42348149|NCT01711359|76187353|FG000|Treatment Period|Withdrawal by Subject|18|||
42348150|NCT01711359|76187354|FG001|Treatment Period|Withdrawal by Subject|7|||
42348151|NCT01711359|76187355|FG002|Treatment Period|Withdrawal by Subject|13|||
42273434|NCT03287245|76104071|FG002|Overall Study|Study terminated by sponsor|3|||
42273435|NCT03287245|76104072|FG003|Overall Study|Study terminated by sponsor|1|||
42273436|NCT03287245|76104069|FG000|Overall Study|Adverse Event|1|||
42273437|NCT03287245|76104070|FG001|Overall Study|Adverse Event|0|||
42036611|NCT01091363|75844961|FG001|Overall Study|Withdrawal by Subject|15|||
42036612|NCT01091363|75844960|FG000|Overall Study|Lost to Follow-up|2|||
42273438|NCT03287245|76104071|FG002|Overall Study|Adverse Event|0|||
42273439|NCT03287245|76104072|FG003|Overall Study|Adverse Event|0|||
42348152|NCT01711359|76187353|FG000|Treatment Period|Lack of Efficacy|13|||
42348153|NCT01711359|76187354|FG001|Treatment Period|Lack of Efficacy|2|||
42348154|NCT01711359|76187355|FG002|Treatment Period|Lack of Efficacy|2|||
42348155|NCT01711359|76187353|FG000|Treatment Period|Adverse Event|8|||
42348156|NCT01711359|76187354|FG001|Treatment Period|Adverse Event|10|||
42348157|NCT01711359|76187355|FG002|Treatment Period|Adverse Event|24|||
42348158|NCT01711359|76187353|FG000|Treatment Period|Physician Decision|4|||
42348159|NCT01711359|76187354|FG001|Treatment Period|Physician Decision|3|||
42348160|NCT01711359|76187355|FG002|Treatment Period|Physician Decision|2|||
42348161|NCT01711359|76187353|FG000|Treatment Period|Death|3|||
42348162|NCT01711359|76187354|FG001|Treatment Period|Death|0|||
42348163|NCT01711359|76187355|FG002|Treatment Period|Death|0|||
42348164|NCT01711359|76187353|FG000|Treatment Period|Entry Criteria Not Met|1|||
42348165|NCT01711359|76187354|FG001|Treatment Period|Entry Criteria Not Met|0|||
42348166|NCT01711359|76187355|FG002|Treatment Period|Entry Criteria Not Met|0|||
42348167|NCT01711359|76187353|FG000|Treatment Period|Sponsor Decision|1|||
42348168|NCT01711359|76187354|FG001|Treatment Period|Sponsor Decision|0|||
42348169|NCT01711359|76187355|FG002|Treatment Period|Sponsor Decision|0|||
42348170|NCT01711359|76187353|FG000|Treatment Period|Lost to Follow-up|1|||
42348171|NCT01711359|76187354|FG001|Treatment Period|Lost to Follow-up|1|||
42348172|NCT01711359|76187355|FG002|Treatment Period|Lost to Follow-up|1|||
42348173|NCT01711359|76187353|FG000|Treatment Period|Randomized, Not Treated|3|||
42348174|NCT01711359|76187354|FG001|Treatment Period|Randomized, Not Treated|1|||
42348175|NCT01711359|76187355|FG002|Treatment Period|Randomized, Not Treated|0|||
42348176|NCT01710657|76187382|FG000|Overall Study|Lost to Follow-up|2|||
42348177|NCT01710657|76187383|FG001|Overall Study|Lost to Follow-up|0|||
42348178|NCT01710657|76187384|FG002|Overall Study|Lost to Follow-up|1|||
42348179|NCT01710657|76187382|FG000|Overall Study|Protocol Violation|2|||
42348180|NCT01710657|76187383|FG001|Overall Study|Protocol Violation|2|||
42348181|NCT01710657|76187384|FG002|Overall Study|Protocol Violation|0|||
42348182|NCT01710657|76187382|FG000|Overall Study|Adverse Event|14|||
42348183|NCT01710657|76187383|FG001|Overall Study|Adverse Event|8|||
42273440|NCT03287245|76104069|FG000|Overall Study|Withdrawal by Subject|8|||
42273441|NCT03287245|76104070|FG001|Overall Study|Withdrawal by Subject|3|||
42273442|NCT03287245|76104071|FG002|Overall Study|Withdrawal by Subject|3|||
42273443|NCT03287245|76104072|FG003|Overall Study|Withdrawal by Subject|0|||
42273444|NCT03287245|76104069|FG000|Overall Study|Physician Decision|3|||
42273445|NCT03287245|76104070|FG001|Overall Study|Physician Decision|2|||
42273446|NCT03287245|76104071|FG002|Overall Study|Physician Decision|0|||
42273447|NCT03287245|76104072|FG003|Overall Study|Physician Decision|0|||
42273448|NCT04495179|76104104|FG000|Overall Study|Lost to Follow-up|0|||
42273449|NCT04495179|76104105|FG001|Overall Study|Lost to Follow-up|1|||
42348184|NCT01710657|76187384|FG002|Overall Study|Adverse Event|28|||
42273450|NCT04495179|76104104|FG000|Overall Study|Withdrawal by Subject|2|||
42348185|NCT01710657|76187382|FG000|Overall Study|Withdrawal by Subject|0|||
42348186|NCT01710657|76187383|FG001|Overall Study|Withdrawal by Subject|1|||
42010803|NCT00989833|75817951|FG001|Overall Study|Withdrawal by Subject|0|||
42010804|NCT00989833|75817952|FG002|Overall Study|Withdrawal by Subject|1|||
42010805|NCT00989833|75817950|FG000|Overall Study|Incorrectly randomized|1|||
42010806|NCT00989833|75817951|FG001|Overall Study|Incorrectly randomized|0|||
42010807|NCT00989833|75817952|FG002|Overall Study|Incorrectly randomized|0|||
42010808|NCT01218477|75817964|FG000|Overall Study|Disease progression|2|||
42010809|NCT01218477|75817965|FG001|Overall Study|Disease progression|3|||
42010810|NCT01218477|75817966|FG002|Overall Study|Disease progression|6|||
42010811|NCT01218477|75817967|FG003|Overall Study|Disease progression|2|||
42010812|NCT01218477|75817964|FG000|Overall Study|Study drug toxicity|0|||
42010813|NCT01218477|75817965|FG001|Overall Study|Study drug toxicity|2|||
42010814|NCT01218477|75817966|FG002|Overall Study|Study drug toxicity|5|||
42010815|NCT01218477|75817967|FG003|Overall Study|Study drug toxicity|0|||
42010816|NCT01218477|75817964|FG000|Overall Study|No longer meets study criteria|1|||
42348187|NCT01710657|76187384|FG002|Overall Study|Withdrawal by Subject|2|||
42348188|NCT01710657|76187382|FG000|Overall Study|Lack of Efficacy|0|||
42010817|NCT01218477|75817965|FG001|Overall Study|No longer meets study criteria|0|||
42348189|NCT01710657|76187383|FG001|Overall Study|Lack of Efficacy|1|||
42348190|NCT01710657|76187384|FG002|Overall Study|Lack of Efficacy|1|||
42010818|NCT01218477|75817966|FG002|Overall Study|No longer meets study criteria|0|||
42010819|NCT01218477|75817967|FG003|Overall Study|No longer meets study criteria|0|||
42010820|NCT01218477|75817964|FG000|Overall Study|Withdrawal by Subject|0|||
42010821|NCT01218477|75817965|FG001|Overall Study|Withdrawal by Subject|0|||
42348191|NCT01701063|76187395|FG000|Overall Study|Lost to Follow-up|0|||
42348192|NCT01701063|76187396|FG001|Overall Study|Lost to Follow-up|1|||
42348193|NCT01701063|76187397|FG002|Overall Study|Lost to Follow-up|0|||
42348194|NCT01701063|76187395|FG000|Overall Study|Withdrawal by Subject|0|||
42348195|NCT01701063|76187396|FG001|Overall Study|Withdrawal by Subject|0|||
42348196|NCT01701063|76187397|FG002|Overall Study|Withdrawal by Subject|1|||
42348197|NCT01701063|76187395|FG000|Overall Study|Other|0|||
42348198|NCT01701063|76187396|FG001|Overall Study|Other|0|||
42348199|NCT01701063|76187397|FG002|Overall Study|Other|1|||
42348200|NCT01700985|76187408|FG000|Overall Study|Incarcerated|0|||
42348201|NCT01700985|76187409|FG001|Overall Study|Incarcerated|1|||
42273451|NCT04495179|76104105|FG001|Overall Study|Withdrawal by Subject|4|||
42273452|NCT04495179|76104104|FG000|Overall Study|Study terminated by sponsor|0|||
42273453|NCT04495179|76104105|FG001|Overall Study|Study terminated by sponsor|18|||
42273454|NCT04495179|76104104|FG000|Overall Study|Death|0|||
42348202|NCT01710501|76187418|FG000|Overall Study|Lost to Follow-up|2|||
42348203|NCT01710501|76187419|FG001|Overall Study|Lost to Follow-up|0|||
42348204|NCT01710501|76187420|FG002|Overall Study|Lost to Follow-up|0|||
42348205|NCT01700829|76187430|FG000|Overall Study|Withdrawal by Subject|1|||
42348206|NCT01700829|76187431|FG001|Overall Study|Withdrawal by Subject|1|||
42348207|NCT01710345|76187440|FG000|Overall Study|Adverse Event|0|||
42348208|NCT01710345|76187441|FG001|Overall Study|Adverse Event|2|||
42348209|NCT01710345|76187442|FG002|Overall Study|Adverse Event|0|||
42010822|NCT01218477|75817966|FG002|Overall Study|Withdrawal by Subject|1|||
42010823|NCT01218477|75817967|FG003|Overall Study|Withdrawal by Subject|0|||
42010824|NCT01218477|75817964|FG000|Overall Study|Prepared for cell transplantation|0|||
42273455|NCT04495179|76104105|FG001|Overall Study|Death|4|||
42273456|NCT04495179|76104104|FG000|Overall Study|Adverse Event|0|||
42273457|NCT04495179|76104105|FG001|Overall Study|Adverse Event|1|||
42273458|NCT04201262|76104130|FG000|Overall Study|Adverse Event|1|||
42273459|NCT04201262|76104131|FG001|Overall Study|Adverse Event|2|||
42273460|NCT04201262|76104130|FG000|Overall Study|Continuing in the study|57|||
42273461|NCT04201262|76104131|FG001|Overall Study|Continuing in the study|0|||
42273462|NCT04201262|76104130|FG000|Overall Study|Withdrawal by Subject|0|||
42273463|NCT04201262|76104131|FG001|Overall Study|Withdrawal by Subject|1|||
42273464|NCT03831100|76104143|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
42273465|NCT03831100|76104144|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
42273466|NCT03689244|76104163|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
42273467|NCT03689244|76104164|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
42273468|NCT03689244|76104165|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
42273469|NCT03689244|76104166|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
42273470|NCT03689244|76104163|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
42273471|NCT03689244|76104164|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
42273472|NCT03689244|76104165|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
42273473|NCT03689244|76104166|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
42273474|NCT03689244|76104163|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
42273475|NCT03689244|76104164|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
42273476|NCT03689244|76104165|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
42273477|NCT03689244|76104166|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
42273478|NCT03689244|76104163|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
42273479|NCT03689244|76104164|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
42273480|NCT03689244|76104165|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
42273481|NCT03689244|76104166|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
42273482|NCT03689244|76104163|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
42273483|NCT03689244|76104164|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
42273484|NCT03689244|76104165|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
42273485|NCT03689244|76104166|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
42273486|NCT03689244|76104163|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
42273487|NCT03689244|76104164|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
42273488|NCT03689244|76104165|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
42273489|NCT03689244|76104166|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
42273490|NCT03689244|76104163|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
42273491|NCT03689244|76104164|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
42273492|NCT03689244|76104165|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
42348210|NCT01710345|76187440|FG000|Overall Study|Lack of Efficacy|2|||
42348211|NCT01710345|76187441|FG001|Overall Study|Lack of Efficacy|3|||
42348212|NCT01710345|76187442|FG002|Overall Study|Lack of Efficacy|1|||
42348213|NCT01710345|76187440|FG000|Overall Study|Drug Dosing Error|1|||
42348214|NCT01710345|76187441|FG001|Overall Study|Drug Dosing Error|0|||
42348215|NCT01710345|76187442|FG002|Overall Study|Drug Dosing Error|0|||
42348216|NCT01710033|76187458|FG000|Stage 2|Adverse Event|0|||
42348217|NCT01710033|76187459|FG001|Stage 2|Adverse Event|0|||
42348218|NCT01710033|76187460|FG002|Stage 2|Adverse Event|0|||
42348219|NCT01710033|76187461|FG003|Stage 2|Adverse Event|0|||
42273493|NCT03689244|76104166|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
42273494|NCT03689244|76104163|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
42273495|NCT03689244|76104164|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
42273496|NCT03689244|76104165|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
42273497|NCT03689244|76104166|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
42273498|NCT03649074|76104176|FG000|Overall Study|Lost to Follow-up|2|||
42273499|NCT03649074|76104177|FG001|Overall Study|Lost to Follow-up|1|||
42273500|NCT03649074|76104176|FG000|Overall Study|Adverse Event|1|||
42273501|NCT03649074|76104177|FG001|Overall Study|Adverse Event|0|||
42273502|NCT03649074|76104176|FG000|Overall Study|Physician Decision|1|||
42273503|NCT03649074|76104177|FG001|Overall Study|Physician Decision|0|||
42273504|NCT03649074|76104176|FG000|Overall Study|Withdrawal by Subject|0|||
42273505|NCT03649074|76104177|FG001|Overall Study|Withdrawal by Subject|2|||
42273506|NCT03649074|76104176|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
42273507|NCT03649074|76104177|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
42273508|NCT03649074|76104176|FG000|Overall Study|Other|1|||
42273509|NCT03649074|76104177|FG001|Overall Study|Other|0|||
42273510|NCT02133573|76104194|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
42273511|NCT02133573|76104195|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
42273512|NCT02133573|76104194|FG000|Overall Study|Child Deaths|3|||
42273513|NCT02133573|76104195|FG001|Overall Study|Child Deaths|5|||
42273514|NCT02133573|76104194|FG000|Overall Study|Child Declined Follow Ups|2|||
42348220|NCT01710033|76187462|FG004|Stage 2|Adverse Event|1|||
42348221|NCT01822496|76187479|FG000|Overall Study|Protocol Violation|2|||
42348222|NCT01822496|76187480|FG001|Overall Study|Protocol Violation|2|||
42348223|NCT01822496|76187481|FG002|Overall Study|Protocol Violation|0|||
42348224|NCT01822496|76187482|FG003|Overall Study|Protocol Violation|1|||
42348225|NCT01822496|76187479|FG000|Overall Study|Withdrawal by Subject|0|||
42348226|NCT01822496|76187480|FG001|Overall Study|Withdrawal by Subject|0|||
42348227|NCT01822496|76187481|FG002|Overall Study|Withdrawal by Subject|0|||
42348228|NCT01822496|76187482|FG003|Overall Study|Withdrawal by Subject|3|||
42348229|NCT01867047|76187494|FG000|Overall Study|Lost to Follow-up|3|||
42348230|NCT01867047|76187495|FG001|Overall Study|Lost to Follow-up|3|||
42348231|NCT01867047|76187494|FG000|Overall Study|Withdrawal by Subject|2|||
42348232|NCT01867047|76187495|FG001|Overall Study|Withdrawal by Subject|0|||
42348233|NCT01867047|76187494|FG000|Overall Study|Physician Decision|2|||
42273515|NCT02133573|76104195|FG001|Overall Study|Child Declined Follow Ups|1|||
42273516|NCT02133573|76104194|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
42273517|NCT02133573|76104195|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
42273518|NCT00686595|76104230|FG000|Overall Study|Adverse Event|3|||
42273519|NCT00686595|76104230|FG000|Overall Study|Protocol Violation|1|||
42273520|NCT00686595|76104230|FG000|Overall Study|Lost to Follow-up|1|||
42273521|NCT00686595|76104230|FG000|Overall Study|Lack of Efficacy|1|||
42348234|NCT01867047|76187495|FG001|Overall Study|Physician Decision|0|||
42348235|NCT01867047|76187494|FG000|Overall Study|surgery not indicated in protocol|1|||
42348236|NCT01867047|76187495|FG001|Overall Study|surgery not indicated in protocol|2|||
42348237|NCT01821560|76187507|FG000|Overall Study|Lost to Follow-up|5|||
42348238|NCT01821560|76187508|FG001|Overall Study|Lost to Follow-up|5|||
42348239|NCT01821560|76187507|FG000|Overall Study|Withdrawal by Subject|1|||
42348240|NCT01821560|76187508|FG001|Overall Study|Withdrawal by Subject|1|||
42348241|NCT01821560|76187507|FG000|Overall Study|Protocol Violation|0|||
42348242|NCT01821560|76187508|FG001|Overall Study|Protocol Violation|1|||
42348243|NCT01871402|76187516|FG000|Overall Study|Lost to Follow-up|1|||
42348244|NCT01871402|76187517|FG001|Overall Study|Lost to Follow-up|0|||
42348245|NCT01871402|76187516|FG000|Overall Study|Withdrawal by Subject|0|||
42348246|NCT01871402|76187517|FG001|Overall Study|Withdrawal by Subject|2|||
42348247|NCT01871402|76187516|FG000|Overall Study|Non-compliance|0|||
42348248|NCT01871402|76187517|FG001|Overall Study|Non-compliance|1|||
42348249|NCT01846442|76187536|FG000|Overall Study|Adverse Event|2|||
42348250|NCT01846442|76187537|FG001|Overall Study|Adverse Event|4|||
42036613|NCT01091363|75844961|FG001|Overall Study|Lost to Follow-up|2|||
42036614|NCT01090973|75844967|FG000|Overall Study|Disease progression|1|||
42273522|NCT00686595|76104230|FG000|Overall Study|Poor Compliance|1|||
42273523|NCT00640159|76104234|FG000|Overall Study|Lost to Follow-up|2|||
42273524|NCT02262754|76104244|FG000|Overall Study|Adverse Event|3|||
42273525|NCT02262754|76104245|FG001|Overall Study|Adverse Event|4|||
42348251|NCT01846442|76187538|FG002|Overall Study|Adverse Event|2|||
42348252|NCT01846442|76187539|FG003|Overall Study|Adverse Event|1|||
42348253|NCT01846442|76187536|FG000|Overall Study|Lost to Follow-up|0|||
42348254|NCT01846442|76187537|FG001|Overall Study|Lost to Follow-up|0|||
42273526|NCT02262754|76104246|FG002|Overall Study|Adverse Event|0|||
42273527|NCT02262754|76104244|FG000|Overall Study|Lack of Efficacy|2|||
42348255|NCT01846442|76187538|FG002|Overall Study|Lost to Follow-up|1|||
42348256|NCT01846442|76187539|FG003|Overall Study|Lost to Follow-up|0|||
42348257|NCT01846442|76187536|FG000|Overall Study|Withdrawal by Subject|3|||
42348258|NCT01846442|76187537|FG001|Overall Study|Withdrawal by Subject|2|||
42348259|NCT01846442|76187538|FG002|Overall Study|Withdrawal by Subject|0|||
42273528|NCT02262754|76104245|FG001|Overall Study|Lack of Efficacy|0|||
42273529|NCT02262754|76104246|FG002|Overall Study|Lack of Efficacy|1|||
42273530|NCT02262754|76104244|FG000|Overall Study|Lost to Follow-up|0|||
42273531|NCT02262754|76104245|FG001|Overall Study|Lost to Follow-up|0|||
42273532|NCT02262754|76104246|FG002|Overall Study|Lost to Follow-up|1|||
42273533|NCT02262754|76104244|FG000|Overall Study|No longer meets eligibility criteria|0|||
42273534|NCT02262754|76104245|FG001|Overall Study|No longer meets eligibility criteria|1|||
42273535|NCT02262754|76104246|FG002|Overall Study|No longer meets eligibility criteria|0|||
42273536|NCT02262754|76104244|FG000|Overall Study|Study terminated by sponsor|5|||
42273537|NCT02262754|76104245|FG001|Overall Study|Study terminated by sponsor|4|||
42273538|NCT02262754|76104246|FG002|Overall Study|Study terminated by sponsor|4|||
42348260|NCT01846442|76187539|FG003|Overall Study|Withdrawal by Subject|1|||
42348261|NCT01846442|76187536|FG000|Overall Study|Left the city/Lost medication|1|||
42348262|NCT01846442|76187537|FG001|Overall Study|Left the city/Lost medication|0|||
42348263|NCT01846442|76187538|FG002|Overall Study|Left the city/Lost medication|1|||
42348264|NCT01846442|76187539|FG003|Overall Study|Left the city/Lost medication|1|||
42348265|NCT01709721|76187552|FG000|Open Label Phase|Withdrawal by Subject|0|||
42348266|NCT01709721|76187553|FG001|Open Label Phase|Withdrawal by Subject|0|||
42348267|NCT01709721|76187554|FG002|Open Label Phase|Withdrawal by Subject|5|||
42348268|NCT01709721|76187552|FG000|Open Label Phase|Adverse Event|0|||
42348269|NCT01709721|76187553|FG001|Open Label Phase|Adverse Event|0|||
42348270|NCT01709721|76187554|FG002|Open Label Phase|Adverse Event|8|||
42348271|NCT01709721|76187552|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
42036615|NCT01090739|75844971|FG000|Enrollment|Withdrawal by Subject|24|||
42036616|NCT01090739|75844971|FG000|Enrollment|Protocol Violation|14|||
42036617|NCT01090739|75844971|FG000|Enrollment|Lost to Follow-up|5|||
42348272|NCT01709721|76187553|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
42036618|NCT01090739|75844971|FG000|Enrollment|Physician Decision|5|||
42036619|NCT01090739|75844971|FG000|Enrollment|Sponsor termination of site|4|||
42036620|NCT01090739|75844971|FG000|Enrollment|Study implant limit reached|2|||
42036621|NCT01090739|75844971|FG000|Enrollment|Adverse Event|1|||
42036622|NCT01090739|75844971|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
42036623|NCT01090739|75844971|FG000|12 Month Follow-up|Lost to Follow-up|1|||
42036624|NCT01090739|75844971|FG000|12 Month Follow-up|Physician Decision|1|||
42036625|NCT01090739|75844971|FG000|12 Month Follow-up|Death|1|||
42036626|NCT01090739|75844971|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
42036627|NCT01090739|75844971|FG000|24 Month Follow-up|Lost to Follow-up|1|||
42036628|NCT01090739|75844971|FG000|24 Month Follow-up|Death|1|||
42036629|NCT01090739|75844971|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
42036630|NCT01090739|75844971|FG000|36 Month Follow-up|Visit still pending|17|||
42036631|NCT00916383|75844989|FG000|Overall Study|Adverse Event|1|||
42036632|NCT00916383|75844989|FG000|Overall Study|Death|1|||
42036633|NCT00916383|75844989|FG000|Overall Study|Protocol Violation|1|||
42036634|NCT00916305|75844999|FG000|Overall Study|Lost to Follow-up|21|||
42036635|NCT00916305|75845000|FG001|Overall Study|Lost to Follow-up|27|||
42036636|NCT00916305|75844999|FG000|Overall Study|Withdrawal by Subject|0|||
42036637|NCT00916305|75845000|FG001|Overall Study|Withdrawal by Subject|1|||
42036638|NCT00916149|75845009|FG000|Overall Study|Lost to Follow-up|3|||
42036639|NCT00916149|75845010|FG001|Overall Study|Lost to Follow-up|2|||
42036640|NCT00916149|75845011|FG002|Overall Study|Lost to Follow-up|0|||
42036641|NCT00916149|75845009|FG000|Overall Study|Unable to place scalp EEG leads|1|||
42036642|NCT00916149|75845010|FG001|Overall Study|Unable to place scalp EEG leads|0|||
42036643|NCT00916149|75845011|FG002|Overall Study|Unable to place scalp EEG leads|0|||
42036644|NCT01090427|75845021|FG000|After Controlled Period|Death|0|||
42036645|NCT01090427|75845022|FG001|After Controlled Period|Death|0|||
42036646|NCT01090427|75845023|FG002|After Controlled Period|Death|0|||
42036647|NCT01090427|75845024|FG003|After Controlled Period|Death|0|||
42036648|NCT01090427|75845025|FG004|After Controlled Period|Death|0|||
42036649|NCT01090427|75845026|FG005|After Controlled Period|Death|1|||
42036650|NCT01090427|75845027|FG006|After Controlled Period|Death|0|||
42036651|NCT01090427|75845021|FG000|After Controlled Period|Lack of Efficacy|0|||
42036652|NCT01090427|75845022|FG001|After Controlled Period|Lack of Efficacy|0|||
42036653|NCT01090427|75845023|FG002|After Controlled Period|Lack of Efficacy|0|||
42273539|NCT02262754|76104244|FG000|Overall Study|Protocol Violation|1|||
42273540|NCT02262754|76104245|FG001|Overall Study|Protocol Violation|0|||
42348273|NCT01709721|76187554|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
42348274|NCT01709721|76187552|FG000|Open Label Phase|Investigator Decision|0|||
42036654|NCT01090427|75845024|FG003|After Controlled Period|Lack of Efficacy|0|||
42036655|NCT01090427|75845025|FG004|After Controlled Period|Lack of Efficacy|0|||
42036656|NCT01090427|75845026|FG005|After Controlled Period|Lack of Efficacy|3|||
42036657|NCT01090427|75845027|FG006|After Controlled Period|Lack of Efficacy|2|||
42036658|NCT01090427|75845021|FG000|After Controlled Period|Adverse Event|0|||
42036659|NCT01090427|75845022|FG001|After Controlled Period|Adverse Event|0|||
42036660|NCT01090427|75845023|FG002|After Controlled Period|Adverse Event|0|||
42036661|NCT01090427|75845024|FG003|After Controlled Period|Adverse Event|2|||
42348275|NCT01709721|76187553|FG001|Open Label Phase|Investigator Decision|0|||
42348276|NCT01709721|76187554|FG002|Open Label Phase|Investigator Decision|1|||
42273541|NCT02262754|76104246|FG002|Overall Study|Protocol Violation|0|||
42273542|NCT02262754|76104244|FG000|Overall Study|Withdrawal by Subject|1|||
42273543|NCT02262754|76104245|FG001|Overall Study|Withdrawal by Subject|0|||
42273544|NCT02262754|76104246|FG002|Overall Study|Withdrawal by Subject|1|||
42273545|NCT02262754|76104244|FG000|Overall Study|Other|4|||
42273546|NCT02262754|76104245|FG001|Overall Study|Other|0|||
42273547|NCT02262754|76104246|FG002|Overall Study|Other|2|||
42273548|NCT02262364|76104256|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
42273549|NCT02261974|76104262|FG000|Overall Study|Withdrawal by Subject|3|||
42273550|NCT02261974|76104263|FG001|Overall Study|Withdrawal by Subject|2|||
42273551|NCT02261974|76104262|FG000|Overall Study|Pregnancy|0|||
42273552|NCT02261974|76104263|FG001|Overall Study|Pregnancy|1|||
42273553|NCT02261974|76104262|FG000|Overall Study|Missed treatment cut-off date|6|||
42273554|NCT02261974|76104263|FG001|Overall Study|Missed treatment cut-off date|3|||
42273555|NCT02261974|76104262|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
42273556|NCT02261974|76104263|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
42273557|NCT02261974|76104262|FG000|Overall Study|Lost to Follow-up|2|||
42273558|NCT02261974|76104263|FG001|Overall Study|Lost to Follow-up|0|||
42273559|NCT02261974|76104262|FG000|Overall Study|Adverse Event|1|||
42273560|NCT02261974|76104263|FG001|Overall Study|Adverse Event|0|||
42273561|NCT02356588|76104271|FG000|Overall Study|Lack of Efficacy|4|||
42273562|NCT02356588|76104272|FG001|Overall Study|Lack of Efficacy|10|||
42273563|NCT02356588|76104271|FG000|Overall Study|Adverse Event|0|||
42273564|NCT02356588|76104272|FG001|Overall Study|Adverse Event|2|||
42273565|NCT02356588|76104271|FG000|Overall Study|Withdrawal by Subject|1|||
42273566|NCT02356588|76104272|FG001|Overall Study|Withdrawal by Subject|0|||
42273567|NCT02356588|76104271|FG000|Overall Study|Protocol Violation|0|||
42273568|NCT02356588|76104272|FG001|Overall Study|Protocol Violation|1|||
42348277|NCT01709721|76187552|FG000|Open Label Phase|Sponsor Decision|0|||
42348278|NCT01709721|76187553|FG001|Open Label Phase|Sponsor Decision|0|||
42348279|NCT01709721|76187554|FG002|Open Label Phase|Sponsor Decision|2|||
42348280|NCT01709721|76187552|FG000|Open Label Phase|Protocol Violation|0|||
42348281|NCT01709721|76187553|FG001|Open Label Phase|Protocol Violation|0|||
42348282|NCT01709721|76187554|FG002|Open Label Phase|Protocol Violation|1|||
42348283|NCT01709721|76187552|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
42348284|NCT01709721|76187553|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
42348285|NCT01709721|76187554|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
42348286|NCT01709721|76187552|FG000|Open Label Phase|Inadequate Pain Control|0|||
42348287|NCT01709721|76187553|FG001|Open Label Phase|Inadequate Pain Control|0|||
42348288|NCT01709721|76187554|FG002|Open Label Phase|Inadequate Pain Control|37|||
42348289|NCT01709721|76187552|FG000|Open Label Phase|Other, Specify in text field in database|0|||
42348290|NCT01709721|76187553|FG001|Open Label Phase|Other, Specify in text field in database|0|||
42348291|NCT01709721|76187554|FG002|Open Label Phase|Other, Specify in text field in database|14|||
42348292|NCT01709721|76187552|FG000|Randomized Phase|Adverse Event|0|||
42348293|NCT01709721|76187553|FG001|Randomized Phase|Adverse Event|1|||
42348294|NCT01709721|76187554|FG002|Randomized Phase|Adverse Event|0|||
42348295|NCT01709721|76187552|FG000|Randomized Phase|Lost to Follow-up|1|||
42348296|NCT01709721|76187553|FG001|Randomized Phase|Lost to Follow-up|0|||
42348297|NCT01709721|76187554|FG002|Randomized Phase|Lost to Follow-up|0|||
42348298|NCT01709721|76187552|FG000|Randomized Phase|Inadequate Pain Control|1|||
42348299|NCT01709721|76187553|FG001|Randomized Phase|Inadequate Pain Control|2|||
42348300|NCT01709721|76187554|FG002|Randomized Phase|Inadequate Pain Control|0|||
42348301|NCT01709721|76187552|FG000|Randomized Phase|Other, Specify text field in database|1|||
42348302|NCT01709721|76187553|FG001|Randomized Phase|Other, Specify text field in database|3|||
42348303|NCT01709721|76187554|FG002|Randomized Phase|Other, Specify text field in database|0|||
42348304|NCT01866657|76187564|FG000|Overall Study|Surgery canceled|2|||
42348305|NCT01866657|76187565|FG001|Overall Study|Surgery canceled|0|||
42348306|NCT01700205|76187573|FG000|Overall Study|Withdrawal by Subject|13|||
42348307|NCT01700205|76187574|FG001|Overall Study|Withdrawal by Subject|13|||
42348308|NCT01700205|76187573|FG000|Overall Study|Protocol Violation|2|||
42348309|NCT01700205|76187574|FG001|Overall Study|Protocol Violation|2|||
42348310|NCT01700049|76187580|FG000|Overall Study|Withdrawal by Subject|1|||
42273569|NCT02355028|76104280|FG000|Overall Study|Adverse Event|2|||
42273570|NCT02355028|76104281|FG001|Overall Study|Adverse Event|0|||
42348311|NCT01699815|76187587|FG000|Overall Study|Protocol Violation|4|||
42348312|NCT01699815|76187588|FG001|Overall Study|Protocol Violation|7|||
42348313|NCT01699815|76187587|FG000|Overall Study|record could not be located|1|||
42348314|NCT01699815|76187588|FG001|Overall Study|record could not be located|0|||
42273571|NCT02355028|76104280|FG000|Overall Study|Withdrawal by Subject|1|||
42273572|NCT02355028|76104281|FG001|Overall Study|Withdrawal by Subject|1|||
42273573|NCT02355028|76104280|FG000|Overall Study|Deemed ineligible after randomization|8|||
42273574|NCT02355028|76104281|FG001|Overall Study|Deemed ineligible after randomization|4|||
42010825|NCT01218477|75817965|FG001|Overall Study|Prepared for cell transplantation|1|||
42273575|NCT01643668|76104296|FG000|Overall Study|Death|1|||
42273576|NCT02260882|76104302|FG000|Overall Study|Protocol Violation|0|||
42273577|NCT02260882|76104303|FG001|Overall Study|Protocol Violation|1|||
42273578|NCT02260804|76104312|FG000|Induction Study Period|Protocol Violation|2|||
42010826|NCT01218477|75817966|FG002|Overall Study|Prepared for cell transplantation|1|||
42010827|NCT01218477|75817967|FG003|Overall Study|Prepared for cell transplantation|0|||
42010828|NCT01218477|75817964|FG000|Overall Study|Administrative reason by sponsor|0|||
42010829|NCT01218477|75817965|FG001|Overall Study|Administrative reason by sponsor|0|||
42010830|NCT01218477|75817966|FG002|Overall Study|Administrative reason by sponsor|1|||
42010831|NCT01218477|75817967|FG003|Overall Study|Administrative reason by sponsor|0|||
42010832|NCT01218477|75817964|FG000|Overall Study|Maximum clinical benefit|0|||
42010833|NCT01218477|75817965|FG001|Overall Study|Maximum clinical benefit|2|||
42010834|NCT01218477|75817966|FG002|Overall Study|Maximum clinical benefit|0|||
42010835|NCT01218477|75817967|FG003|Overall Study|Maximum clinical benefit|0|||
42010836|NCT01218243|75817983|FG000|Overall Study|Lack of Efficacy|1|||
42010837|NCT01218243|75817984|FG001|Overall Study|Lack of Efficacy|1|||
42273579|NCT02260804|76104313|FG001|Induction Study Period|Protocol Violation|0|||
42273580|NCT02260804|76104312|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
42010838|NCT01218243|75817983|FG000|Overall Study|Lost to Follow-up|3|||
42010839|NCT01218243|75817984|FG001|Overall Study|Lost to Follow-up|3|||
42010840|NCT01218243|75817983|FG000|Overall Study|Protocol Violation|5|||
42010841|NCT01218243|75817984|FG001|Overall Study|Protocol Violation|10|||
42010842|NCT00989287|75817992|FG000|Overall Study|Adverse Event|1|||
42010843|NCT00989287|75817993|FG001|Overall Study|Adverse Event|0|||
42036662|NCT01090427|75845025|FG004|After Controlled Period|Adverse Event|0|||
42036663|NCT01090427|75845026|FG005|After Controlled Period|Adverse Event|1|||
42036664|NCT01090427|75845027|FG006|After Controlled Period|Adverse Event|0|||
42036665|NCT01016262|75845051|FG000|Double-blind Phase|Adverse Event|0|||
42036666|NCT01016262|75845052|FG001|Double-blind Phase|Adverse Event|0|||
42036667|NCT01016262|75845053|FG002|Double-blind Phase|Adverse Event|1|||
42036668|NCT01016262|75845054|FG003|Double-blind Phase|Adverse Event|0|||
42036669|NCT01016262|75845055|FG004|Double-blind Phase|Adverse Event|0|||
42036670|NCT01016262|75845056|FG005|Double-blind Phase|Adverse Event|0|||
42036671|NCT01016262|75845051|FG000|Double-blind Phase|Lack of Efficacy|1|||
42036672|NCT01016262|75845052|FG001|Double-blind Phase|Lack of Efficacy|0|||
42036673|NCT01016262|75845053|FG002|Double-blind Phase|Lack of Efficacy|5|||
42036674|NCT01016262|75845054|FG003|Double-blind Phase|Lack of Efficacy|0|||
42036675|NCT01016262|75845055|FG004|Double-blind Phase|Lack of Efficacy|0|||
42036676|NCT01016262|75845056|FG005|Double-blind Phase|Lack of Efficacy|0|||
42036677|NCT01016262|75845051|FG000|Double-blind Phase|Disease Progression|0|||
42036678|NCT01016262|75845052|FG001|Double-blind Phase|Disease Progression|1|||
42036679|NCT01016262|75845053|FG002|Double-blind Phase|Disease Progression|2|||
42036680|NCT01016262|75845054|FG003|Double-blind Phase|Disease Progression|0|||
42036681|NCT01016262|75845055|FG004|Double-blind Phase|Disease Progression|0|||
42036682|NCT01016262|75845056|FG005|Double-blind Phase|Disease Progression|0|||
42273581|NCT02260804|76104313|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
42273582|NCT02260804|76104312|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
42273583|NCT02260804|76104313|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
42273584|NCT02260804|76104312|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
42273585|NCT02260804|76104313|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
42273586|NCT02260804|76104312|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
42273587|NCT02260804|76104313|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
42273588|NCT02260804|76104312|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
42273589|NCT02260804|76104313|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
42273590|NCT02260804|76104312|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
42273591|NCT02260804|76104313|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
42273592|NCT02260804|76104312|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
42273593|NCT02260804|76104313|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
42273594|NCT02260804|76104312|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
42273595|NCT02260804|76104313|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
42273596|NCT02260804|76104312|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
42273597|NCT02260804|76104313|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
42273598|NCT02260804|76104312|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
42273599|NCT02260804|76104313|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
42273600|NCT02260648|76104322|FG000|Overall Study|Adverse Event|3|||
42010844|NCT00989287|75817992|FG000|Overall Study|Lost to Follow-up|0|||
42010845|NCT00989287|75817993|FG001|Overall Study|Lost to Follow-up|1|||
42010846|NCT01218087|75818014|FG000|Overall Study|Death|2|||
42010847|NCT01218087|75818015|FG001|Overall Study|Death|1|||
42010848|NCT01218087|75818014|FG000|Overall Study|Withdrawal by Subject|5|||
42010849|NCT01218087|75818015|FG001|Overall Study|Withdrawal by Subject|0|||
42036683|NCT01016262|75845051|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
42273601|NCT02260648|76104323|FG001|Overall Study|Adverse Event|0|||
42273602|NCT02260648|76104324|FG002|Overall Study|Adverse Event|1|||
42273603|NCT02260648|76104322|FG000|Overall Study|Withdrawal by Subject|1|||
42273604|NCT02260648|76104323|FG001|Overall Study|Withdrawal by Subject|1|||
42273605|NCT02260648|76104324|FG002|Overall Study|Withdrawal by Subject|0|||
42273606|NCT02260648|76104322|FG000|Overall Study|Protocol Violation|1|||
42273607|NCT02260648|76104323|FG001|Overall Study|Protocol Violation|0|||
42273608|NCT02260648|76104324|FG002|Overall Study|Protocol Violation|0|||
42273609|NCT02260648|76104322|FG000|Overall Study|Discontinue Due to Study Termination|13|||
42273610|NCT02260648|76104323|FG001|Overall Study|Discontinue Due to Study Termination|12|||
42273611|NCT02260648|76104324|FG002|Overall Study|Discontinue Due to Study Termination|7|||
42273612|NCT02260492|76104335|FG000|Overall Study|Adverse Event|6|||
42273613|NCT02260492|76104336|FG001|Overall Study|Adverse Event|1|||
42273614|NCT02260492|76104337|FG002|Overall Study|Adverse Event|2|||
42273615|NCT02260492|76104335|FG000|Overall Study|Death|0|||
42273616|NCT02260492|76104336|FG001|Overall Study|Death|1|||
42273617|NCT02260492|76104337|FG002|Overall Study|Death|0|||
42273618|NCT02260492|76104335|FG000|Overall Study|Lost to Follow-up|12|||
42273619|NCT02260492|76104336|FG001|Overall Study|Lost to Follow-up|9|||
42273620|NCT02260492|76104337|FG002|Overall Study|Lost to Follow-up|0|||
42273621|NCT02260492|76104335|FG000|Overall Study|Physician Decision|2|||
42273622|NCT02260492|76104336|FG001|Overall Study|Physician Decision|0|||
42273623|NCT02260492|76104337|FG002|Overall Study|Physician Decision|1|||
42348315|NCT01699815|76187587|FG000|Overall Study|Adverse Event|0|||
42348316|NCT01699815|76187588|FG001|Overall Study|Adverse Event|1|||
42348317|NCT01866423|76187594|FG000|Overall Study|Lack of Efficacy|3|||
42348318|NCT01866423|76187594|FG000|Overall Study|Sponsor Decision|1|||
42348319|NCT01846208|76187601|FG000|Overall Study|Withdrew prior to treatment|1|||
42348320|NCT01846208|76187602|FG001|Overall Study|Withdrew prior to treatment|1|||
42348321|NCT01846208|76187603|FG002|Overall Study|Withdrew prior to treatment|1|||
42348322|NCT01846208|76187601|FG000|Overall Study|Dosing Symptoms|1|||
42348323|NCT01846208|76187602|FG001|Overall Study|Dosing Symptoms|2|||
42348324|NCT01846208|76187603|FG002|Overall Study|Dosing Symptoms|6|||
42348325|NCT01846208|76187601|FG000|Overall Study|Withdrawal by Subject|5|||
42348326|NCT01846208|76187602|FG001|Overall Study|Withdrawal by Subject|0|||
42348327|NCT01846208|76187603|FG002|Overall Study|Withdrawal by Subject|0|||
42348328|NCT01846208|76187601|FG000|Overall Study|Non-compliance|1|||
42273624|NCT02260492|76104335|FG000|Overall Study|Withdrawal by Subject|3|||
42273625|NCT02260492|76104336|FG001|Overall Study|Withdrawal by Subject|2|||
42273626|NCT02260492|76104337|FG002|Overall Study|Withdrawal by Subject|2|||
42273627|NCT02260258|76104347|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
42348329|NCT01846208|76187602|FG001|Overall Study|Non-compliance|1|||
42348330|NCT01846208|76187603|FG002|Overall Study|Non-compliance|0|||
42348331|NCT01846208|76187601|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
42348332|NCT01846208|76187602|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
42348333|NCT01846208|76187603|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
42273628|NCT02260258|76104348|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
42273629|NCT02260180|76104358|FG000|Overall Study|Adverse Event|2|||
42273630|NCT02260180|76104359|FG001|Overall Study|Adverse Event|0|||
42273631|NCT02260180|76104360|FG002|Overall Study|Adverse Event|1|||
42273632|NCT02353468|76104368|FG000|Overall Study|Study terminated|3|||
42273633|NCT02349412|76104374|FG000|Overall Study|Withdrawal by Subject|7|||
42273634|NCT02349412|76104375|FG001|Overall Study|Withdrawal by Subject|7|||
42273635|NCT02259400|76104383|FG000|Overall Study|Death|0|||
42273636|NCT02259400|76104384|FG001|Overall Study|Death|2|||
42273637|NCT01530997|76104390|FG000|Overall Study|Physician Decision|1|||
42273638|NCT01530997|76104390|FG000|Overall Study|Withdrawal by Subject|1|||
42273639|NCT02259088|76104403|FG000|Overall Study|Adverse Event|6|||
42273640|NCT02259088|76104404|FG001|Overall Study|Adverse Event|4|||
42273641|NCT02259088|76104403|FG000|Overall Study|Lost to Follow-up|2|||
42348334|NCT01846208|76187601|FG000|Overall Study|Refused SU OFC|0|||
42348335|NCT01846208|76187602|FG001|Overall Study|Refused SU OFC|0|||
42348336|NCT01846208|76187603|FG002|Overall Study|Refused SU OFC|1|||
42348337|NCT01845974|76187613|FG000|Overall Study|screen failure|1|||
42348338|NCT01845974|76187614|FG001|Overall Study|screen failure|0|||
42010850|NCT01218087|75818014|FG000|Overall Study|Transferred|8|||
42010851|NCT01218087|75818015|FG001|Overall Study|Transferred|5|||
42273642|NCT02259088|76104404|FG001|Overall Study|Lost to Follow-up|0|||
42273643|NCT02259088|76104403|FG000|Overall Study|Death|2|||
42273644|NCT02259088|76104404|FG001|Overall Study|Death|0|||
42273645|NCT02259088|76104403|FG000|Overall Study|Physician Decision|5|||
42010852|NCT01218009|75818023|FG000|Overall Study|Protocol Violation|2|||
42273646|NCT02259088|76104404|FG001|Overall Study|Physician Decision|2|||
42273647|NCT02259088|76104403|FG000|Overall Study|Protocol deviation|5|||
42273648|NCT02259088|76104404|FG001|Overall Study|Protocol deviation|0|||
42273649|NCT02259088|76104403|FG000|Overall Study|Subject/guardian decision|8|||
42348339|NCT01865487|76187626|FG000|Overall Study|Lost to Follow-up|0|||
42348340|NCT01865487|76187627|FG001|Overall Study|Lost to Follow-up|0|||
42273650|NCT02259088|76104404|FG001|Overall Study|Subject/guardian decision|8|||
42273651|NCT02880241|76104416|FG000|Overall Study|Lack of Efficacy|1|||
42273652|NCT02880241|76104417|FG001|Overall Study|Lack of Efficacy|0|||
42348341|NCT01865487|76187628|FG002|Overall Study|Lost to Follow-up|0|||
42348342|NCT01865487|76187629|FG003|Overall Study|Lost to Follow-up|1|||
42348343|NCT01865487|76187630|FG004|Overall Study|Lost to Follow-up|0|||
42348344|NCT01865487|76187631|FG005|Overall Study|Lost to Follow-up|0|||
42348345|NCT01865487|76187632|FG006|Overall Study|Lost to Follow-up|1|||
42348346|NCT01865487|76187633|FG007|Overall Study|Lost to Follow-up|0|||
42348347|NCT01865487|76187634|FG008|Overall Study|Lost to Follow-up|0|||
42348348|NCT01865487|76187635|FG009|Overall Study|Lost to Follow-up|0|||
42348349|NCT01865487|76187626|FG000|Overall Study|Withdrawal by Subject|0|||
42273653|NCT02880241|76104418|FG002|Overall Study|Lack of Efficacy|0|||
42273654|NCT02880241|76104419|FG003|Overall Study|Lack of Efficacy|0|||
42273655|NCT02880241|76104420|FG004|Overall Study|Lack of Efficacy|0|||
42273656|NCT02880241|76104421|FG005|Overall Study|Lack of Efficacy|0|||
42273657|NCT02259010|76104437|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
42273658|NCT02021773|76104446|FG000|Overall Study|Adverse Event|1|||
42273659|NCT02021773|76104447|FG001|Overall Study|Adverse Event|4|||
42273660|NCT02021773|76104448|FG002|Overall Study|Adverse Event|3|||
42273661|NCT02021773|76104446|FG000|Overall Study|Lack of Efficacy|2|||
42273662|NCT02021773|76104447|FG001|Overall Study|Lack of Efficacy|2|||
42273663|NCT02021773|76104448|FG002|Overall Study|Lack of Efficacy|2|||
42273664|NCT02021773|76104446|FG000|Overall Study|Protocol Violation|2|||
42273665|NCT02021773|76104447|FG001|Overall Study|Protocol Violation|3|||
42273666|NCT02021773|76104448|FG002|Overall Study|Protocol Violation|1|||
42273667|NCT02021773|76104446|FG000|Overall Study|Withdrawal by Subject|3|||
42273668|NCT02021773|76104447|FG001|Overall Study|Withdrawal by Subject|4|||
42273669|NCT02021773|76104448|FG002|Overall Study|Withdrawal by Subject|5|||
42273670|NCT02021773|76104446|FG000|Overall Study|Lost to Follow-up|1|||
42273671|NCT02021773|76104447|FG001|Overall Study|Lost to Follow-up|3|||
42273672|NCT02021773|76104448|FG002|Overall Study|Lost to Follow-up|0|||
42273673|NCT02021773|76104446|FG000|Overall Study|Reason not specified|3|||
42273674|NCT02021773|76104447|FG001|Overall Study|Reason not specified|0|||
42273675|NCT02021773|76104448|FG002|Overall Study|Reason not specified|0|||
42273676|NCT00151775|76104461|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
42273677|NCT00151775|76104462|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
42273678|NCT00151775|76104463|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
42273679|NCT00151775|76104464|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
42273680|NCT00151775|76104465|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
42036684|NCT01016262|75845052|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
42036685|NCT01016262|75845053|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
42036686|NCT01016262|75845054|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
42036687|NCT01016262|75845055|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
42036688|NCT01016262|75845056|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
42273681|NCT00151775|76104466|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
42273682|NCT00151775|76104467|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
42273683|NCT00151775|76104468|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
42273684|NCT00151775|76104469|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
42273685|NCT00151775|76104470|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
42273686|NCT00151775|76104471|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
42273687|NCT00151775|76104472|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
42273688|NCT00151775|76104461|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
42036689|NCT01016262|75845051|FG000|Open-Label Phase|Adverse Event|0|||
42036690|NCT01016262|75845052|FG001|Open-Label Phase|Adverse Event|0|||
42036691|NCT01016262|75845053|FG002|Open-Label Phase|Adverse Event|0|||
42036692|NCT01016262|75845054|FG003|Open-Label Phase|Adverse Event|1|||
42036693|NCT01016262|75845055|FG004|Open-Label Phase|Adverse Event|0|||
42036694|NCT01016262|75845056|FG005|Open-Label Phase|Adverse Event|0|||
42036695|NCT01016262|75845051|FG000|Open-Label Phase|Lost to Follow-up|0|||
42036696|NCT01016262|75845052|FG001|Open-Label Phase|Lost to Follow-up|0|||
42036697|NCT01016262|75845053|FG002|Open-Label Phase|Lost to Follow-up|0|||
42273689|NCT00151775|76104462|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
42273690|NCT00151775|76104463|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
42273691|NCT00151775|76104464|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
42273692|NCT00151775|76104465|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
42348350|NCT01865487|76187627|FG001|Overall Study|Withdrawal by Subject|0|||
42273693|NCT00151775|76104466|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
42348351|NCT01865487|76187628|FG002|Overall Study|Withdrawal by Subject|0|||
42036698|NCT01016262|75845054|FG003|Open-Label Phase|Lost to Follow-up|0|||
42036699|NCT01016262|75845055|FG004|Open-Label Phase|Lost to Follow-up|1|||
42273694|NCT00151775|76104467|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
42348352|NCT01865487|76187629|FG003|Overall Study|Withdrawal by Subject|0|||
42348353|NCT01865487|76187630|FG004|Overall Study|Withdrawal by Subject|1|||
42273695|NCT00151775|76104468|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
42273696|NCT00151775|76104469|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
42273697|NCT00151775|76104470|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
42273698|NCT00151775|76104471|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
42273699|NCT00151775|76104472|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
42273700|NCT00151775|76104461|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
42273701|NCT00151775|76104462|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
42273702|NCT00151775|76104463|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
42273703|NCT00151775|76104464|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
42273704|NCT00151775|76104465|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
42273705|NCT00151775|76104466|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
42273706|NCT00151775|76104467|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
42273707|NCT00151775|76104468|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
42273708|NCT00151775|76104469|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
42273709|NCT00151775|76104470|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
42273710|NCT00151775|76104471|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
42273711|NCT00151775|76104472|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
42273712|NCT00151775|76104461|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
42273713|NCT00151775|76104462|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
42273714|NCT00151775|76104463|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
42273715|NCT00151775|76104464|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
42273716|NCT00151775|76104465|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
42273717|NCT00151775|76104466|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
42273718|NCT00151775|76104467|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
42273719|NCT00151775|76104468|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
42273720|NCT00151775|76104469|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
42273721|NCT00151775|76104470|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
42273722|NCT00151775|76104471|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
42273723|NCT00151775|76104472|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
42273724|NCT00151775|76104461|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
42273725|NCT00151775|76104462|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
42273726|NCT00151775|76104463|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
42273727|NCT00151775|76104464|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
42273728|NCT00151775|76104465|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
42273729|NCT00151775|76104466|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
42273730|NCT00151775|76104467|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
42273731|NCT00151775|76104468|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
42273732|NCT00151775|76104469|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
42273733|NCT00151775|76104470|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
42273734|NCT00151775|76104471|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
42273735|NCT00151775|76104472|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
42273736|NCT00151775|76104461|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
42273737|NCT00151775|76104462|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
42273738|NCT00151775|76104463|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
42273739|NCT00151775|76104464|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
42273740|NCT00151775|76104465|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
42273741|NCT00151775|76104466|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
42273742|NCT00151775|76104467|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
42273743|NCT00151775|76104468|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
42273744|NCT00151775|76104469|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
42273745|NCT00151775|76104470|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
42273746|NCT00151775|76104471|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
42273747|NCT00151775|76104472|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
42273748|NCT00151775|76104461|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
42273749|NCT00151775|76104462|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
42273750|NCT00151775|76104463|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
42273751|NCT00151775|76104464|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
42348354|NCT01865487|76187631|FG005|Overall Study|Withdrawal by Subject|0|||
42036700|NCT01016262|75845056|FG005|Open-Label Phase|Lost to Follow-up|0|||
42036701|NCT01016262|75845051|FG000|Open-Label Phase|Lack of Efficacy|0|||
42036702|NCT01016262|75845052|FG001|Open-Label Phase|Lack of Efficacy|0|||
42036703|NCT01016262|75845053|FG002|Open-Label Phase|Lack of Efficacy|0|||
42036704|NCT01016262|75845054|FG003|Open-Label Phase|Lack of Efficacy|1|||
42036705|NCT01016262|75845055|FG004|Open-Label Phase|Lack of Efficacy|0|||
42036706|NCT01016262|75845056|FG005|Open-Label Phase|Lack of Efficacy|0|||
42036707|NCT01016262|75845051|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
42273752|NCT00151775|76104465|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
42273753|NCT00151775|76104466|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
42273754|NCT00151775|76104467|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
42273755|NCT00151775|76104468|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
42273756|NCT00151775|76104469|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
42273757|NCT00151775|76104470|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
42273758|NCT00151775|76104471|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
42273759|NCT00151775|76104472|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
42273760|NCT00151775|76104461|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
42273761|NCT00151775|76104462|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
42273762|NCT00151775|76104463|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
42273763|NCT00151775|76104464|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
42273764|NCT00151775|76104465|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
42273765|NCT00151775|76104466|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
42273766|NCT00151775|76104467|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
42273767|NCT00151775|76104468|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
42273768|NCT00151775|76104469|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
42273769|NCT00151775|76104470|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
42273770|NCT00151775|76104471|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
42273771|NCT00151775|76104472|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
42273772|NCT00151775|76104461|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
42273773|NCT00151775|76104462|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
42273774|NCT00151775|76104463|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
42273775|NCT00151775|76104464|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
42273776|NCT00151775|76104465|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
42273777|NCT00151775|76104466|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
42273778|NCT00151775|76104467|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
42273779|NCT00151775|76104468|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
42273780|NCT00151775|76104469|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
42273781|NCT00151775|76104470|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
42273782|NCT00151775|76104471|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
42273783|NCT00151775|76104472|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
42273784|NCT00151775|76104461|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
42273785|NCT00151775|76104462|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
42273786|NCT00151775|76104463|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
42273787|NCT00151775|76104464|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
42273788|NCT00151775|76104465|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
42273789|NCT00151775|76104466|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
42273790|NCT00151775|76104467|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
42273791|NCT00151775|76104468|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
42273792|NCT00151775|76104469|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
42273793|NCT00151775|76104470|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
42273794|NCT00151775|76104471|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
42273795|NCT00151775|76104472|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
42273796|NCT00151775|76104461|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
42273797|NCT00151775|76104462|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
42273798|NCT00151775|76104463|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
42273799|NCT00151775|76104464|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
42273800|NCT00151775|76104465|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
42273801|NCT00151775|76104466|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
42273802|NCT00151775|76104467|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
42273803|NCT00151775|76104468|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
42273804|NCT00151775|76104469|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
42273805|NCT00151775|76104470|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
42273806|NCT00151775|76104471|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
42273807|NCT00151775|76104472|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
42273808|NCT00151775|76104461|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
42273809|NCT00151775|76104462|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
42273810|NCT00151775|76104463|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
42348355|NCT01865487|76187632|FG006|Overall Study|Withdrawal by Subject|0|||
42036708|NCT01016262|75845052|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
42273811|NCT00151775|76104464|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
42273812|NCT00151775|76104465|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
42273813|NCT00151775|76104466|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
42273814|NCT00151775|76104467|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
42036709|NCT01016262|75845053|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
42273815|NCT00151775|76104468|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
42273816|NCT00151775|76104469|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
42273817|NCT00151775|76104470|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
42273818|NCT00151775|76104471|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
42273819|NCT00151775|76104472|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
42273820|NCT00151775|76104461|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
42273821|NCT00151775|76104462|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
42273822|NCT00151775|76104463|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
42273823|NCT00151775|76104464|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
42273824|NCT00151775|76104465|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
42273825|NCT00151775|76104466|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
42273826|NCT00151775|76104467|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
42273827|NCT00151775|76104468|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
42273828|NCT00151775|76104469|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
42273829|NCT00151775|76104470|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
42273830|NCT00151775|76104471|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
42273831|NCT00151775|76104472|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
42273832|NCT00151775|76104461|FG000|Period 4: Open Label|Increased blood pressure|0|||
42273833|NCT00151775|76104462|FG001|Period 4: Open Label|Increased blood pressure|0|||
42273834|NCT00151775|76104463|FG002|Period 4: Open Label|Increased blood pressure|0|||
42273835|NCT00151775|76104464|FG003|Period 4: Open Label|Increased blood pressure|0|||
42273836|NCT00151775|76104465|FG004|Period 4: Open Label|Increased blood pressure|1|||
42273837|NCT00151775|76104466|FG005|Period 4: Open Label|Increased blood pressure|0|||
42273838|NCT00151775|76104467|FG006|Period 4: Open Label|Increased blood pressure|0|||
42273839|NCT00151775|76104468|FG007|Period 4: Open Label|Increased blood pressure|0|||
42273840|NCT00151775|76104469|FG008|Period 4: Open Label|Increased blood pressure|0|||
42273841|NCT00151775|76104470|FG009|Period 4: Open Label|Increased blood pressure|1|||
42273842|NCT00151775|76104471|FG010|Period 4: Open Label|Increased blood pressure|0|||
42273843|NCT00151775|76104472|FG011|Period 4: Open Label|Increased blood pressure|0|||
42273844|NCT00151775|76104461|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
42273845|NCT00151775|76104462|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
42273846|NCT00151775|76104463|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
42273847|NCT00151775|76104464|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
42273848|NCT00151775|76104465|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
42273849|NCT00151775|76104466|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
42273850|NCT00151775|76104467|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
42273851|NCT00151775|76104468|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
42273852|NCT00151775|76104469|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
42273853|NCT00151775|76104470|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
42273854|NCT00151775|76104471|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
42138599|NCT00486434|75948797|FG000|Overall Study|Withdrawal by Subject|34|||
42138600|NCT00486434|75948798|FG001|Overall Study|Withdrawal by Subject|39|||
42138601|NCT00486434|75948797|FG000|Overall Study|Adverse Event|118|||
42138602|NCT00486434|75948798|FG001|Overall Study|Adverse Event|44|||
42138603|NCT00486434|75948797|FG000|Overall Study|Protocol Violation|22|||
42138604|NCT00486434|75948798|FG001|Overall Study|Protocol Violation|21|||
42138605|NCT00486434|75948797|FG000|Overall Study|Lack of Efficacy|12|||
42138606|NCT00486434|75948798|FG001|Overall Study|Lack of Efficacy|19|||
42138607|NCT00486434|75948797|FG000|Overall Study|Lost to Follow-up|2|||
42138608|NCT00486434|75948798|FG001|Overall Study|Lost to Follow-up|3|||
42138609|NCT00486434|75948797|FG000|Overall Study|Death|1|||
42138610|NCT00486434|75948798|FG001|Overall Study|Death|2|||
42273855|NCT00151775|76104472|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
42273856|NCT00151775|76104461|FG000|Period 4: Open Label|Adverse Event|0|||
42273857|NCT00151775|76104462|FG001|Period 4: Open Label|Adverse Event|0|||
42273858|NCT00151775|76104463|FG002|Period 4: Open Label|Adverse Event|0|||
42273859|NCT00151775|76104464|FG003|Period 4: Open Label|Adverse Event|0|||
42273860|NCT00151775|76104465|FG004|Period 4: Open Label|Adverse Event|1|||
42273861|NCT00151775|76104466|FG005|Period 4: Open Label|Adverse Event|0|||
42273862|NCT00151775|76104467|FG006|Period 4: Open Label|Adverse Event|0|||
42273863|NCT00151775|76104468|FG007|Period 4: Open Label|Adverse Event|0|||
42273864|NCT00151775|76104469|FG008|Period 4: Open Label|Adverse Event|0|||
42273865|NCT00151775|76104470|FG009|Period 4: Open Label|Adverse Event|2|||
42348356|NCT01865487|76187633|FG007|Overall Study|Withdrawal by Subject|0|||
42348357|NCT01865487|76187634|FG008|Overall Study|Withdrawal by Subject|0|||
42138611|NCT00486434|75948797|FG000|Overall Study|Personal reasons|5|||
42138612|NCT00486434|75948798|FG001|Overall Study|Personal reasons|6|||
42138613|NCT00424632|75948807|FG000|Overall Study|Death|0|||
42273866|NCT00151775|76104471|FG010|Period 4: Open Label|Adverse Event|0|||
42273867|NCT00151775|76104472|FG011|Period 4: Open Label|Adverse Event|0|||
42138614|NCT00424632|75948808|FG001|Overall Study|Death|0|||
42138615|NCT00424632|75948809|FG002|Overall Study|Death|0|||
42273868|NCT00151775|76104461|FG000|Period 4: Open Label|Lost to Follow-up|0|||
42273869|NCT00151775|76104462|FG001|Period 4: Open Label|Lost to Follow-up|0|||
42273870|NCT00151775|76104463|FG002|Period 4: Open Label|Lost to Follow-up|0|||
42273871|NCT00151775|76104464|FG003|Period 4: Open Label|Lost to Follow-up|0|||
42273872|NCT00151775|76104465|FG004|Period 4: Open Label|Lost to Follow-up|17|||
42273873|NCT00151775|76104466|FG005|Period 4: Open Label|Lost to Follow-up|0|||
42273874|NCT00151775|76104467|FG006|Period 4: Open Label|Lost to Follow-up|0|||
42273875|NCT00151775|76104468|FG007|Period 4: Open Label|Lost to Follow-up|0|||
42273876|NCT00151775|76104469|FG008|Period 4: Open Label|Lost to Follow-up|0|||
42273877|NCT00151775|76104470|FG009|Period 4: Open Label|Lost to Follow-up|7|||
42273878|NCT00151775|76104471|FG010|Period 4: Open Label|Lost to Follow-up|0|||
42273879|NCT00151775|76104472|FG011|Period 4: Open Label|Lost to Follow-up|0|||
42010853|NCT01218009|75818024|FG001|Overall Study|Protocol Violation|1|||
42010854|NCT01218009|75818023|FG000|Overall Study|Withdrawal by Subject|3|||
42010855|NCT01218009|75818024|FG001|Overall Study|Withdrawal by Subject|1|||
42010856|NCT01218009|75818023|FG000|Overall Study|Sponsor terminated study|161|||
42010857|NCT01218009|75818024|FG001|Overall Study|Sponsor terminated study|163|||
42010858|NCT00992017|75818030|FG000|Overall Study|Lost to Follow-up|2|||
42010859|NCT00992017|75818030|FG000|Overall Study|Withdrawal by Subject|2|||
42010860|NCT00992017|75818030|FG000|Overall Study|Unable to get to clinic|5|||
42010861|NCT00992017|75818030|FG000|Overall Study|Not adhere to study requirements|1|||
42010862|NCT01217463|75818041|FG000|Overall Study|Adverse Event|8|||
42010863|NCT01217463|75818042|FG001|Overall Study|Adverse Event|5|||
42036710|NCT01016262|75845054|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
42036711|NCT01016262|75845055|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
42036712|NCT01016262|75845056|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
42036713|NCT01001910|75845067|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
42036714|NCT01009554|75845073|FG000|Overall Study|Adverse Event|1|||
42036715|NCT01009554|75845074|FG001|Overall Study|Adverse Event|1|||
42036716|NCT01009554|75845073|FG000|Overall Study|Withdrawal by Subject|1|||
42036717|NCT01009554|75845074|FG001|Overall Study|Withdrawal by Subject|3|||
42036718|NCT01009554|75845073|FG000|Overall Study|Noncompliant with Study Product|0|||
42036719|NCT01009554|75845074|FG001|Overall Study|Noncompliant with Study Product|3|||
42036720|NCT01006590|75845082|FG000|Overall Study|Adverse Event|2|||
42036721|NCT01006590|75845083|FG001|Overall Study|Adverse Event|3|||
42036722|NCT01006590|75845082|FG000|Overall Study|Death|1|||
42036723|NCT01006590|75845083|FG001|Overall Study|Death|1|||
42036724|NCT01006590|75845082|FG000|Overall Study|Lost to Follow-up|1|||
42036725|NCT01006590|75845083|FG001|Overall Study|Lost to Follow-up|1|||
42036726|NCT01006590|75845082|FG000|Overall Study|Protocol Violation|1|||
42036727|NCT01006590|75845083|FG001|Overall Study|Protocol Violation|0|||
42036728|NCT01006590|75845082|FG000|Overall Study|Withdrawal by Subject|4|||
42036729|NCT01006590|75845083|FG001|Overall Study|Withdrawal by Subject|2|||
42036730|NCT01006590|75845082|FG000|Overall Study|Study specific discontinuation criteria|16|||
42036731|NCT01006590|75845083|FG001|Overall Study|Study specific discontinuation criteria|23|||
42036732|NCT01006590|75845082|FG000|Overall Study|Other|3|||
42036733|NCT01006590|75845083|FG001|Overall Study|Other|2|||
42036734|NCT01001832|75845091|FG000|Short-term Period|Adverse Event|2|||
42036735|NCT01001832|75845092|FG001|Short-term Period|Adverse Event|3|||
42036736|NCT01001832|75845091|FG000|Long-term Period|Adverse Event|2|||
42138616|NCT00424632|75948810|FG003|Overall Study|Death|0|||
42138617|NCT00424632|75948811|FG004|Overall Study|Death|0|||
42273880|NCT00151775|76104461|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
42138618|NCT00424632|75948812|FG005|Overall Study|Death|2|||
42138619|NCT00424632|75948813|FG006|Overall Study|Death|0|||
42138620|NCT00424632|75948814|FG007|Overall Study|Death|0|||
42138621|NCT00424632|75948815|FG008|Overall Study|Death|0|||
42138622|NCT00424632|75948816|FG009|Overall Study|Death|0|||
42138623|NCT00424632|75948807|FG000|Overall Study|Adverse Event|0|||
42138624|NCT00424632|75948808|FG001|Overall Study|Adverse Event|0|||
42138625|NCT00424632|75948809|FG002|Overall Study|Adverse Event|0|||
42273881|NCT00151775|76104462|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
42138626|NCT00424632|75948810|FG003|Overall Study|Adverse Event|0|||
42138627|NCT00424632|75948811|FG004|Overall Study|Adverse Event|0|||
42273882|NCT00151775|76104463|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
42273883|NCT00151775|76104464|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
42273884|NCT00151775|76104465|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
42348358|NCT01865487|76187635|FG009|Overall Study|Withdrawal by Subject|0|||
42138628|NCT00424632|75948812|FG005|Overall Study|Adverse Event|0|||
42273885|NCT00151775|76104466|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
42010864|NCT01217463|75818041|FG000|Overall Study|Physician Decision|0|||
42010865|NCT01217463|75818042|FG001|Overall Study|Physician Decision|1|||
42010866|NCT01217463|75818041|FG000|Overall Study|Withdrawal by Subject|3|||
42036737|NCT01001832|75845092|FG001|Long-term Period|Adverse Event|1|||
42036738|NCT01001832|75845091|FG000|Long-term Period|Withdrawal by Subject|1|||
42036739|NCT01001832|75845092|FG001|Long-term Period|Withdrawal by Subject|0|||
42036740|NCT01001832|75845091|FG000|Long-term Period|Lack of Efficacy|0|||
42273886|NCT00151775|76104467|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
42273887|NCT00151775|76104468|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
42273888|NCT00151775|76104469|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
42273889|NCT00151775|76104470|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
42273890|NCT00151775|76104471|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
42273891|NCT00151775|76104472|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
42273892|NCT00151775|76104461|FG000|Period 4: Open Label|Other|0|||
42273893|NCT00151775|76104462|FG001|Period 4: Open Label|Other|0|||
42010867|NCT01217463|75818042|FG001|Overall Study|Withdrawal by Subject|0|||
42010868|NCT01217463|75818041|FG000|Overall Study|Surgery on the Target Limb|0|||
42010869|NCT01217463|75818042|FG001|Overall Study|Surgery on the Target Limb|1|||
42010870|NCT01217463|75818041|FG000|Overall Study|Patient Non-compliant|1|||
42010871|NCT01217463|75818042|FG001|Overall Study|Patient Non-compliant|0|||
42010872|NCT01217463|75818041|FG000|Overall Study|Other|1|||
42010873|NCT01217463|75818042|FG001|Overall Study|Other|1|||
42010874|NCT01217307|75818052|FG000|Overall Study|Withdrawal by Subject|0|||
42010875|NCT01217307|75818053|FG001|Overall Study|Withdrawal by Subject|1|||
42010876|NCT01217229|75818059|FG000|Overall Study|Adverse Event|1|||
42010877|NCT01217229|75818059|FG000|Overall Study|Disease progression, deterioration|2|||
42010878|NCT01217229|75818059|FG000|Overall Study|Disease progression, Cheson criteria|14|||
42010879|NCT01217229|75818059|FG000|Overall Study|Protocol Violation|1|||
42010880|NCT01217229|75818059|FG000|Overall Study|Disease progression not confirmed|2|||
42010881|NCT01013740|75818065|FG000|Overall Study|Lost to Follow-up|3|||
42010882|NCT01013740|75818066|FG001|Overall Study|Lost to Follow-up|5|||
42010883|NCT01013740|75818065|FG000|Overall Study|Physician Decision|2|||
42010884|NCT01013740|75818066|FG001|Overall Study|Physician Decision|0|||
42010885|NCT01013740|75818065|FG000|Overall Study|Withdrawal by Subject|2|||
42010886|NCT01013740|75818066|FG001|Overall Study|Withdrawal by Subject|10|||
42010887|NCT01013740|75818065|FG000|Overall Study|study close / terminated : done in error|2|||
42010888|NCT01013740|75818066|FG001|Overall Study|study close / terminated : done in error|1|||
42010889|NCT01013740|75818065|FG000|Overall Study|Missing|2|||
42010890|NCT01013740|75818066|FG001|Overall Study|Missing|1|||
42010891|NCT01013740|75818065|FG000|Overall Study|Ongoing: Study records not completed|0|||
42010892|NCT01013740|75818066|FG001|Overall Study|Ongoing: Study records not completed|2|||
42010893|NCT01013350|75818076|FG000|Overall Study|Lost to Follow-up|15|||
42010894|NCT01013350|75818077|FG001|Overall Study|Lost to Follow-up|95|||
42010895|NCT01013350|75818076|FG000|Overall Study|Adverse Event|0|||
42010896|NCT01013350|75818077|FG001|Overall Study|Adverse Event|1|||
42010897|NCT01013350|75818076|FG000|Overall Study|Physician Decision|4|||
42010898|NCT01013350|75818077|FG001|Overall Study|Physician Decision|20|||
42010899|NCT01013350|75818076|FG000|Overall Study|Withdrawal by Subject|15|||
42010900|NCT01013350|75818077|FG001|Overall Study|Withdrawal by Subject|38|||
42010901|NCT01013350|75818076|FG000|Overall Study|Death|3|||
42010902|NCT01013350|75818077|FG001|Overall Study|Death|5|||
42010903|NCT01013350|75818076|FG000|Overall Study|Participant entered interventional study|0|||
42010904|NCT01013350|75818077|FG001|Overall Study|Participant entered interventional study|8|||
42010905|NCT01013350|75818076|FG000|Overall Study|Other|1|||
42010906|NCT01013350|75818077|FG001|Overall Study|Other|25|||
42010907|NCT01018030|75818087|FG000|Overall Study|Adverse Event|10|||
42010908|NCT01018030|75818088|FG001|Overall Study|Adverse Event|5|||
42010909|NCT01018030|75818089|FG002|Overall Study|Adverse Event|5|||
42010910|NCT01018030|75818087|FG000|Overall Study|Withdrawal by Subject|2|||
42010911|NCT01018030|75818088|FG001|Overall Study|Withdrawal by Subject|2|||
42010912|NCT01018030|75818089|FG002|Overall Study|Withdrawal by Subject|4|||
42010913|NCT01018030|75818087|FG000|Overall Study|Lost to Follow-up|2|||
42010914|NCT01018030|75818088|FG001|Overall Study|Lost to Follow-up|0|||
42273894|NCT00151775|76104463|FG002|Period 4: Open Label|Other|0|||
42010915|NCT01018030|75818089|FG002|Overall Study|Lost to Follow-up|3|||
42010916|NCT01018030|75818087|FG000|Overall Study|Protocol Violation|2|||
42010917|NCT01018030|75818088|FG001|Overall Study|Protocol Violation|1|||
42010918|NCT01018030|75818089|FG002|Overall Study|Protocol Violation|0|||
42138629|NCT00424632|75948813|FG006|Overall Study|Adverse Event|0|||
42348359|NCT01699503|76187665|FG000|Overall Study|Death|31|||
42010919|NCT01018030|75818087|FG000|Overall Study|Physician Decision|1|||
42010920|NCT01018030|75818088|FG001|Overall Study|Physician Decision|0|||
42010921|NCT01018030|75818089|FG002|Overall Study|Physician Decision|1|||
42010922|NCT01018030|75818087|FG000|Overall Study|Lack of Efficacy|1|||
42010923|NCT01018030|75818088|FG001|Overall Study|Lack of Efficacy|0|||
42273895|NCT00151775|76104464|FG003|Period 4: Open Label|Other|0|||
42273896|NCT00151775|76104465|FG004|Period 4: Open Label|Other|1|||
42273897|NCT00151775|76104466|FG005|Period 4: Open Label|Other|0|||
42273898|NCT00151775|76104467|FG006|Period 4: Open Label|Other|0|||
42273899|NCT00151775|76104468|FG007|Period 4: Open Label|Other|0|||
42273900|NCT00151775|76104469|FG008|Period 4: Open Label|Other|0|||
42273901|NCT00151775|76104470|FG009|Period 4: Open Label|Other|3|||
42273902|NCT00151775|76104471|FG010|Period 4: Open Label|Other|0|||
42273903|NCT00151775|76104472|FG011|Period 4: Open Label|Other|0|||
42273904|NCT00151775|76104461|FG000|Period 4: Open Label|Physician Decision|0|||
42273905|NCT00151775|76104462|FG001|Period 4: Open Label|Physician Decision|0|||
42273906|NCT00151775|76104463|FG002|Period 4: Open Label|Physician Decision|0|||
42273907|NCT00151775|76104464|FG003|Period 4: Open Label|Physician Decision|0|||
42273908|NCT00151775|76104465|FG004|Period 4: Open Label|Physician Decision|0|||
42273909|NCT00151775|76104466|FG005|Period 4: Open Label|Physician Decision|0|||
42273910|NCT00151775|76104467|FG006|Period 4: Open Label|Physician Decision|0|||
42273911|NCT00151775|76104468|FG007|Period 4: Open Label|Physician Decision|0|||
42273912|NCT00151775|76104469|FG008|Period 4: Open Label|Physician Decision|0|||
42273913|NCT00151775|76104470|FG009|Period 4: Open Label|Physician Decision|2|||
42273914|NCT00151775|76104471|FG010|Period 4: Open Label|Physician Decision|0|||
42273915|NCT00151775|76104472|FG011|Period 4: Open Label|Physician Decision|0|||
42273916|NCT00151775|76104461|FG000|Period 4: Open Label|Protocol Violation|0|||
42273917|NCT00151775|76104462|FG001|Period 4: Open Label|Protocol Violation|0|||
42273918|NCT00151775|76104463|FG002|Period 4: Open Label|Protocol Violation|0|||
42273919|NCT00151775|76104464|FG003|Period 4: Open Label|Protocol Violation|0|||
42273920|NCT00151775|76104465|FG004|Period 4: Open Label|Protocol Violation|1|||
42273921|NCT00151775|76104466|FG005|Period 4: Open Label|Protocol Violation|0|||
42273922|NCT00151775|76104467|FG006|Period 4: Open Label|Protocol Violation|0|||
42273923|NCT00151775|76104468|FG007|Period 4: Open Label|Protocol Violation|0|||
42273924|NCT00151775|76104469|FG008|Period 4: Open Label|Protocol Violation|0|||
42273925|NCT00151775|76104470|FG009|Period 4: Open Label|Protocol Violation|0|||
42273926|NCT00151775|76104471|FG010|Period 4: Open Label|Protocol Violation|0|||
42273927|NCT00151775|76104472|FG011|Period 4: Open Label|Protocol Violation|0|||
42273928|NCT02258464|76104515|FG000|Overall Study|Progressive disease (PD)|9|||
42273929|NCT02258464|76104516|FG001|Overall Study|Progressive disease (PD)|17|||
42273930|NCT02258464|76104515|FG000|Overall Study|Study drug never administered|1|||
42273931|NCT02258464|76104516|FG001|Overall Study|Study drug never administered|1|||
42273932|NCT02258464|76104515|FG000|Overall Study|AE not related to clinical PD|1|||
42273933|NCT02258464|76104516|FG001|Overall Study|AE not related to clinical PD|3|||
42273934|NCT02258464|76104515|FG000|Overall Study|Withdrawal by Subject|5|||
42273935|NCT02258464|76104516|FG001|Overall Study|Withdrawal by Subject|4|||
42273936|NCT02258464|76104515|FG000|Overall Study|AE related to clinical PD|1|||
42273937|NCT02258464|76104516|FG001|Overall Study|AE related to clinical PD|0|||
42273938|NCT02682901|76104524|FG000|Overall Study|Adverse Event|10|||
42273939|NCT02682901|76104525|FG001|Overall Study|Adverse Event|3|||
42273940|NCT02682901|76104524|FG000|Overall Study|Lack of Efficacy|0|||
42273941|NCT02682901|76104525|FG001|Overall Study|Lack of Efficacy|1|||
42273942|NCT02258074|76104535|FG000|Overall Study|Withdrawal by Subject|1|||
42273943|NCT02258074|76104536|FG001|Overall Study|Withdrawal by Subject|0|||
42273944|NCT02258074|76104537|FG002|Overall Study|Withdrawal by Subject|0|||
42273945|NCT02258074|76104538|FG003|Overall Study|Withdrawal by Subject|0|||
42273946|NCT01643044|76104550|FG000|Overall Study|Lost to Follow-up|1|||
42273947|NCT01643044|76104551|FG001|Overall Study|Lost to Follow-up|1|||
42273948|NCT01643044|76104550|FG000|Overall Study|Miscarried baby|2|||
42273949|NCT01643044|76104551|FG001|Overall Study|Miscarried baby|2|||
42273950|NCT01643044|76104550|FG000|Overall Study|Delivered outside of hospital|1|||
42273951|NCT01643044|76104551|FG001|Overall Study|Delivered outside of hospital|2|||
42273952|NCT01642732|76104557|FG000|Overall Study|Withdrawal by Subject|1|||
42273953|NCT02257684|76104561|FG000|Overall Study|Adverse Event|2|||
42273954|NCT02257684|76104561|FG000|Overall Study|Lack of Efficacy|1|||
42273955|NCT02257684|76104561|FG000|Overall Study|Sponsor's Decision|1|||
42273956|NCT02190721|76104568|FG000|Overall Study|Patient was out of the city|0|||
42273957|NCT02190721|76104569|FG001|Overall Study|Patient was out of the city|1|||
42273958|NCT02190721|76104570|FG002|Overall Study|Patient was out of the city|0|||
42273959|NCT00581477|76104578|FG000|Overall Study|Physician Decision|2|||
42273960|NCT02348008|76104594|FG000|Overall Study|Adverse Event|2|||
42273961|NCT02348008|76104595|FG001|Overall Study|Adverse Event|3|||
42273962|NCT02348008|76104596|FG002|Overall Study|Adverse Event|3|||
42273963|NCT02348008|76104594|FG000|Overall Study|Disease Progression|1|||
42273964|NCT02348008|76104595|FG001|Overall Study|Disease Progression|5|||
42273965|NCT02348008|76104596|FG002|Overall Study|Disease Progression|16|||
42273966|NCT02348008|76104594|FG000|Overall Study|Withdrawal by Subject|0|||
42273967|NCT02348008|76104595|FG001|Overall Study|Withdrawal by Subject|1|||
42273968|NCT02348008|76104596|FG002|Overall Study|Withdrawal by Subject|0|||
42348360|NCT01699503|76187666|FG001|Overall Study|Death|40|||
42348361|NCT01699503|76187665|FG000|Overall Study|Withdrawal by Subject|65|||
42273969|NCT02348008|76104594|FG000|Overall Study|Symptomatic Deterioration|0|||
42273970|NCT02348008|76104595|FG001|Overall Study|Symptomatic Deterioration|1|||
42273971|NCT02348008|76104596|FG002|Overall Study|Symptomatic Deterioration|0|||
42273972|NCT04962022|76104602|FG000|Period 1|Withdrawal by Subject|1|||
42273973|NCT04962022|76104603|FG001|Period 1|Withdrawal by Subject|0|||
42273974|NCT04740905|76104620|FG000|Overall Study|Ongoing in the Study at the Primary Completion Date|272|||
42273975|NCT04740905|76104621|FG001|Overall Study|Ongoing in the Study at the Primary Completion Date|274|||
42273976|NCT04740905|76104620|FG000|Overall Study|Protocol Violation|0|||
42273977|NCT04740905|76104621|FG001|Overall Study|Protocol Violation|3|||
42273978|NCT04740905|76104620|FG000|Overall Study|Lost to Follow-up|2|||
42273979|NCT04740905|76104621|FG001|Overall Study|Lost to Follow-up|0|||
42273980|NCT04740905|76104620|FG000|Overall Study|Adverse Event|1|||
42273981|NCT04740905|76104621|FG001|Overall Study|Adverse Event|0|||
42273982|NCT04740905|76104620|FG000|Overall Study|Withdrawal by Subject|1|||
42273983|NCT04740905|76104621|FG001|Overall Study|Withdrawal by Subject|0|||
42273984|NCT04210843|76104680|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
42273985|NCT04210843|76104681|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
42273986|NCT04210843|76104680|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
42273987|NCT04210843|76104681|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
42273988|NCT04210843|76104680|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
42273989|NCT04210843|76104681|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
42273990|NCT04210843|76104680|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
42273991|NCT04210843|76104681|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
42273992|NCT04210843|76104680|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
42273993|NCT04210843|76104681|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
42273994|NCT04210843|76104680|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
42273995|NCT04210843|76104681|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
42273996|NCT04210843|76104680|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
42273997|NCT04210843|76104681|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
42273998|NCT04210843|76104680|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
42273999|NCT04210843|76104681|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
42274000|NCT04210843|76104680|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
42274001|NCT04210843|76104681|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
42274002|NCT04210843|76104680|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
42274003|NCT04210843|76104681|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
42274004|NCT04210843|76104680|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
42274005|NCT04210843|76104681|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
42274006|NCT04210843|76104680|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
42274007|NCT04210843|76104681|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
42274008|NCT04210843|76104680|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
42274009|NCT04210843|76104681|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
42274010|NCT04210843|76104680|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
42348362|NCT01699503|76187666|FG001|Overall Study|Withdrawal by Subject|57|||
42348363|NCT01699503|76187665|FG000|Overall Study|Lost to Follow-up|121|||
42348364|NCT01699503|76187666|FG001|Overall Study|Lost to Follow-up|117|||
42348365|NCT01699503|76187665|FG000|Overall Study|Excluded due to quality|783|||
42348366|NCT01699503|76187666|FG001|Overall Study|Excluded due to quality|791|||
42348367|NCT01709409|76187674|FG000|Overall Study|Protocol Violation|1|||
42348368|NCT01709409|76187675|FG001|Overall Study|Protocol Violation|0|||
42348369|NCT01698879|76187684|FG000|Overall Study|Withdrawal by Subject|1|||
42348370|NCT01698879|76187685|FG001|Overall Study|Withdrawal by Subject|0|||
42348371|NCT01698879|76187686|FG002|Overall Study|Withdrawal by Subject|0|||
42348372|NCT01698801|76187725|FG000|Treatment Phase|Adverse Event|4|||
42348373|NCT01698801|76187725|FG000|Treatment Phase|Protocol Violation|1|||
42348374|NCT01698801|76187725|FG000|Treatment Phase|Other|4|||
42348375|NCT01698801|76187725|FG000|Treatment Phase|Withdrawal by Subject|1|||
42348376|NCT01698801|76187725|FG000|Treatment Phase|Disease progression|1|||
42348377|NCT01698801|76187725|FG000|Follow Up Phase|Withdrawal by Subject|1|||
42348378|NCT01698801|76187725|FG000|Follow Up Phase|Death|4|||
42348379|NCT01682811|76187737|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
42348380|NCT01682811|76187738|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
42274011|NCT04210843|76104681|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
42036741|NCT01001832|75845092|FG001|Long-term Period|Lack of Efficacy|2|||
42274012|NCT04210843|76104680|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
42348381|NCT01682811|76187739|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
42348382|NCT01682811|76187740|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
42348383|NCT01682811|76187741|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
42348384|NCT01682811|76187742|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
42348385|NCT01682811|76187743|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
42348386|NCT01682811|76187737|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
42274013|NCT04210843|76104681|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
42274014|NCT04210843|76104680|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
42274015|NCT04210843|76104681|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
42274016|NCT04210843|76104680|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
42274017|NCT04210843|76104681|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
42274018|NCT04210843|76104680|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
42274019|NCT04210843|76104681|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
42274020|NCT04210843|76104680|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
42274021|NCT04210843|76104681|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
42274022|NCT04210843|76104680|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
42274023|NCT04210843|76104681|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
42274024|NCT04210843|76104680|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
42274025|NCT04210843|76104681|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
42274026|NCT04210843|76104680|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
42010924|NCT01018030|75818089|FG002|Overall Study|Lack of Efficacy|0|||
42010925|NCT01018030|75818087|FG000|Overall Study|Did Not Receive Study Drug|1|||
42010926|NCT01018030|75818088|FG001|Overall Study|Did Not Receive Study Drug|3|||
42010927|NCT01018030|75818089|FG002|Overall Study|Did Not Receive Study Drug|0|||
42010928|NCT01217073|75818105|FG000|Base Period|Adverse Event|1|||
42010929|NCT01217073|75818106|FG001|Base Period|Adverse Event|0|||
42010930|NCT01217073|75818107|FG002|Base Period|Adverse Event|1|||
42010931|NCT01217073|75818108|FG003|Base Period|Adverse Event|0|||
42010932|NCT01217073|75818109|FG004|Base Period|Adverse Event|4|||
42010933|NCT01217073|75818110|FG005|Base Period|Adverse Event|1|||
42010934|NCT01217073|75818111|FG006|Base Period|Adverse Event|0|||
42036742|NCT01001832|75845091|FG000|Long-term Period|Other|1|||
42036743|NCT01001832|75845092|FG001|Long-term Period|Other|2|||
42036744|NCT01001832|75845091|FG000|Follow-up Period|Withdrawal by Subject|1|||
42036745|NCT01001832|75845092|FG001|Follow-up Period|Withdrawal by Subject|0|||
42036746|NCT01001832|75845091|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
42036747|NCT01001832|75845092|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
42036748|NCT01001832|75845091|FG000|Follow-up Period|Other|2|||
42036749|NCT01001832|75845092|FG001|Follow-up Period|Other|1|||
42036750|NCT01001598|75845101|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
42036751|NCT01001598|75845101|FG000|Overall Study|Adverse Event|1|||
42036752|NCT01006356|75845105|FG000|Overall Study|Adverse Event|6|||
42138630|NCT00424632|75948814|FG007|Overall Study|Adverse Event|0|||
42138631|NCT00424632|75948815|FG008|Overall Study|Adverse Event|3|||
42138632|NCT00424632|75948816|FG009|Overall Study|Adverse Event|2|||
42138633|NCT00424632|75948807|FG000|Overall Study|Global deterioration of health status|0|||
42138634|NCT00424632|75948808|FG001|Overall Study|Global deterioration of health status|0|||
42138635|NCT00424632|75948809|FG002|Overall Study|Global deterioration of health status|0|||
42138636|NCT00424632|75948810|FG003|Overall Study|Global deterioration of health status|1|||
42138637|NCT00424632|75948811|FG004|Overall Study|Global deterioration of health status|1|||
42138638|NCT00424632|75948812|FG005|Overall Study|Global deterioration of health status|0|||
42138639|NCT00424632|75948813|FG006|Overall Study|Global deterioration of health status|0|||
42138640|NCT00424632|75948814|FG007|Overall Study|Global deterioration of health status|0|||
42138641|NCT00424632|75948815|FG008|Overall Study|Global deterioration of health status|0|||
42138642|NCT00424632|75948816|FG009|Overall Study|Global deterioration of health status|0|||
42138643|NCT00424632|75948807|FG000|Overall Study|Objective progression or relapse|1|||
42138644|NCT00424632|75948808|FG001|Overall Study|Objective progression or relapse|1|||
42138645|NCT00424632|75948809|FG002|Overall Study|Objective progression or relapse|1|||
42138646|NCT00424632|75948810|FG003|Overall Study|Objective progression or relapse|2|||
42138647|NCT00424632|75948811|FG004|Overall Study|Objective progression or relapse|2|||
42138648|NCT00424632|75948812|FG005|Overall Study|Objective progression or relapse|13|||
42138649|NCT00424632|75948813|FG006|Overall Study|Objective progression or relapse|7|||
42138650|NCT00424632|75948814|FG007|Overall Study|Objective progression or relapse|3|||
42138651|NCT00424632|75948815|FG008|Overall Study|Objective progression or relapse|12|||
42138652|NCT00424632|75948816|FG009|Overall Study|Objective progression or relapse|4|||
42138653|NCT00424632|75948807|FG000|Overall Study|Other|0|||
42138654|NCT00424632|75948808|FG001|Overall Study|Other|0|||
42138655|NCT00424632|75948809|FG002|Overall Study|Other|0|||
42138656|NCT00424632|75948810|FG003|Overall Study|Other|1|||
42138657|NCT00424632|75948811|FG004|Overall Study|Other|0|||
42138658|NCT00424632|75948812|FG005|Overall Study|Other|0|||
42138659|NCT00424632|75948813|FG006|Overall Study|Other|0|||
42138660|NCT00424632|75948814|FG007|Overall Study|Other|0|||
42138661|NCT00424632|75948815|FG008|Overall Study|Other|1|||
42138662|NCT00424632|75948816|FG009|Overall Study|Other|0|||
42138663|NCT00529451|75948851|FG000|Overall Study|Subject withdrew consent|16|||
42138664|NCT00529451|75948852|FG001|Overall Study|Subject withdrew consent|21|||
42036753|NCT01006356|75845105|FG000|Overall Study|Physician Decision|1|||
42138665|NCT00529451|75948853|FG002|Overall Study|Subject withdrew consent|13|||
42274027|NCT04210843|76104681|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
42274028|NCT04210843|76104680|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
42274029|NCT04210843|76104681|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
42274030|NCT04210843|76104680|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
42274031|NCT04210843|76104681|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
42274032|NCT02651675|76104704|FG000|Overall Study|Death|0|||
42274033|NCT02651675|76104705|FG001|Overall Study|Death|0|||
42274034|NCT02651675|76104706|FG002|Overall Study|Death|1|||
42274035|NCT02611960|76104716|FG000|Overall Study|Adverse Event|7|||
42274036|NCT02611960|76104717|FG001|Overall Study|Adverse Event|8|||
42274037|NCT02611960|76104716|FG000|Overall Study|Death|98|||
42274038|NCT02611960|76104717|FG001|Overall Study|Death|92|||
42274039|NCT02611960|76104716|FG000|Overall Study|Withdrawal by Subject|1|||
42274040|NCT02611960|76104717|FG001|Overall Study|Withdrawal by Subject|5|||
42274041|NCT02611960|76104716|FG000|Overall Study|Sponsor Decision|11|||
42274042|NCT02611960|76104717|FG001|Overall Study|Sponsor Decision|11|||
42274043|NCT01845597|76104724|FG000|Overall Study|Death|8|||
42274044|NCT01845597|76104724|FG000|Overall Study|Lost to Follow-up|22|||
42274045|NCT00713206|76104743|FG000|Overall Study|Lost to Follow-up|4|||
42274046|NCT00713206|76104744|FG001|Overall Study|Lost to Follow-up|4|||
42274047|NCT00713206|76104743|FG000|Overall Study|Death|1|||
42274048|NCT00713206|76104744|FG001|Overall Study|Death|0|||
42274049|NCT00495131|76104752|FG000|Overall Study|Adverse Event|6|||
42274050|NCT00495131|76104753|FG001|Overall Study|Adverse Event|2|||
42274051|NCT00495131|76104752|FG000|Overall Study|Lack of Efficacy|0|||
42274052|NCT00495131|76104753|FG001|Overall Study|Lack of Efficacy|2|||
42274053|NCT00495131|76104752|FG000|Overall Study|Lost to Follow-up|0|||
42274054|NCT00495131|76104753|FG001|Overall Study|Lost to Follow-up|2|||
42274055|NCT00495131|76104752|FG000|Overall Study|Withdrawal by Subject|1|||
42274056|NCT00495131|76104753|FG001|Overall Study|Withdrawal by Subject|0|||
42274057|NCT02257372|76104759|FG000|Overall Study|Adverse Event|3|||
42274058|NCT02257372|76104760|FG001|Overall Study|Adverse Event|7|||
42274059|NCT02257372|76104759|FG000|Overall Study|Lack of Efficacy|2|||
42274060|NCT02257372|76104760|FG001|Overall Study|Lack of Efficacy|1|||
42274061|NCT02257372|76104759|FG000|Overall Study|Protocol Violation|1|||
42274062|NCT02257372|76104760|FG001|Overall Study|Protocol Violation|1|||
42274063|NCT02257372|76104759|FG000|Overall Study|Lost to Follow-up|0|||
42274064|NCT02257372|76104760|FG001|Overall Study|Lost to Follow-up|1|||
42274065|NCT02257372|76104759|FG000|Overall Study|Withdrew consent|1|||
42274066|NCT02257372|76104760|FG001|Overall Study|Withdrew consent|0|||
42274067|NCT02256982|76104768|FG000|Overall Study|Disease Progression|0|||
42274068|NCT02256982|76104769|FG001|Overall Study|Disease Progression|1|||
42274069|NCT02736721|76104775|FG000|Overall Study|Adverse Event|8|||
42274070|NCT02736721|76104775|FG000|Overall Study|Lost to Follow-up|3|||
42274071|NCT02736721|76104775|FG000|Overall Study|Other|5|||
42274072|NCT04176445|76104779|FG000|Overall Study|Adverse Event|0|||
42274073|NCT04176445|76104780|FG001|Overall Study|Adverse Event|1|||
42274074|NCT04176445|76104779|FG000|Overall Study|change plans weaning after first intervention|0|||
42274075|NCT04176445|76104780|FG001|Overall Study|change plans weaning after first intervention|1|||
42274076|NCT02738203|76104788|FG000|Overall Study|Failed IUD Insertion|2|||
42274077|NCT02738203|76104789|FG001|Overall Study|Failed IUD Insertion|2|||
42348387|NCT01682811|76187738|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
42348388|NCT01682811|76187739|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
42348389|NCT01682811|76187740|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
42348390|NCT01682811|76187741|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
42138666|NCT00529451|75948854|FG003|Overall Study|Subject withdrew consent|12|||
42138667|NCT00529451|75948851|FG000|Overall Study|Adverse Event|9|||
42138668|NCT00529451|75948852|FG001|Overall Study|Adverse Event|16|||
42138669|NCT00529451|75948853|FG002|Overall Study|Adverse Event|14|||
42138670|NCT00529451|75948854|FG003|Overall Study|Adverse Event|8|||
42138671|NCT00529451|75948851|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
42138672|NCT00529451|75948852|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
42138673|NCT00529451|75948853|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
42138674|NCT00529451|75948854|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
42138675|NCT00529451|75948851|FG000|Overall Study|Lost to Follow-up|4|||
42348391|NCT01682811|76187742|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
42138676|NCT00529451|75948852|FG001|Overall Study|Lost to Follow-up|7|||
42138677|NCT00529451|75948853|FG002|Overall Study|Lost to Follow-up|4|||
42138678|NCT00529451|75948854|FG003|Overall Study|Lost to Follow-up|4|||
42138679|NCT00529451|75948851|FG000|Overall Study|Protocol deviation|1|||
42274078|NCT02738203|76104788|FG000|Overall Study|Protocol Violation|0|||
42274079|NCT02738203|76104789|FG001|Overall Study|Protocol Violation|1|||
42274080|NCT02452034|76104801|FG000|Overall Study|Adverse Event|0|||
42274081|NCT02452034|76104802|FG001|Overall Study|Adverse Event|0|||
42274082|NCT02452034|76104803|FG002|Overall Study|Adverse Event|0|||
42274083|NCT02452034|76104804|FG003|Overall Study|Adverse Event|0|||
42274084|NCT02452034|76104805|FG004|Overall Study|Adverse Event|0|||
42274085|NCT02452034|76104806|FG005|Overall Study|Adverse Event|1|||
42274086|NCT02452034|76104801|FG000|Overall Study|Death|0|||
42274087|NCT02452034|76104802|FG001|Overall Study|Death|0|||
42274088|NCT02452034|76104803|FG002|Overall Study|Death|0|||
42274089|NCT02452034|76104804|FG003|Overall Study|Death|0|||
42274090|NCT02452034|76104805|FG004|Overall Study|Death|1|||
42274091|NCT02452034|76104806|FG005|Overall Study|Death|1|||
42274092|NCT02452034|76104801|FG000|Overall Study|Physician Decision|0|||
42274093|NCT02452034|76104802|FG001|Overall Study|Physician Decision|1|||
42274094|NCT02452034|76104803|FG002|Overall Study|Physician Decision|1|||
42348392|NCT01682811|76187743|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
42348393|NCT01682811|76187737|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
42348394|NCT01682811|76187738|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
42348395|NCT01682811|76187739|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
42348396|NCT01682811|76187740|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
42348397|NCT01682811|76187741|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
42348398|NCT01682811|76187742|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
42348399|NCT01682811|76187743|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
42348400|NCT01682811|76187737|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
42348401|NCT01682811|76187738|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
42348402|NCT01682811|76187739|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
42348403|NCT01682811|76187740|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
42348404|NCT01682811|76187741|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
42348405|NCT01682811|76187742|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
42348406|NCT01682811|76187743|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
42348407|NCT01682031|76187764|FG000|Overall Study|Withdrawal by Subject|0|||
42348408|NCT01682031|76187765|FG001|Overall Study|Withdrawal by Subject|1|||
42348409|NCT01682031|76187764|FG000|Overall Study|Adverse Event|0|||
42348410|NCT01682031|76187765|FG001|Overall Study|Adverse Event|2|||
42348411|NCT01682031|76187764|FG000|Overall Study|MRI results indicate increased nodul|0|||
42348412|NCT01682031|76187765|FG001|Overall Study|MRI results indicate increased nodul|1|||
42348413|NCT01682031|76187764|FG000|Overall Study|Patient could not swallow tablets|1|||
42348414|NCT01682031|76187765|FG001|Overall Study|Patient could not swallow tablets|0|||
42348415|NCT01682031|76187764|FG000|Overall Study|Patient stopped selenium on his own|0|||
42348416|NCT01682031|76187765|FG001|Overall Study|Patient stopped selenium on his own|1|||
42348417|NCT01567527|76187786|FG000|Conversion Phase.|Protocol deviation|3|||
42348418|NCT01567527|76187787|FG001|Conversion Phase.|Protocol deviation|0|||
42348419|NCT01567527|76187788|FG002|Conversion Phase.|Protocol deviation|0|||
42348420|NCT01567527|76187789|FG003|Conversion Phase.|Protocol deviation|0|||
42348421|NCT01567527|76187790|FG004|Conversion Phase.|Protocol deviation|0|||
42348422|NCT01567527|76187786|FG000|Conversion Phase.|Met withdrawal criteria|10|||
42348423|NCT01567527|76187787|FG001|Conversion Phase.|Met withdrawal criteria|0|||
42348424|NCT01567527|76187788|FG002|Conversion Phase.|Met withdrawal criteria|0|||
42348425|NCT01567527|76187789|FG003|Conversion Phase.|Met withdrawal criteria|0|||
42348426|NCT01567527|76187790|FG004|Conversion Phase.|Met withdrawal criteria|0|||
42348427|NCT01567527|76187786|FG000|Conversion Phase.|Withdrawal by Subject|32|||
42348428|NCT01567527|76187787|FG001|Conversion Phase.|Withdrawal by Subject|0|||
42348429|NCT01567527|76187788|FG002|Conversion Phase.|Withdrawal by Subject|0|||
42348430|NCT01567527|76187789|FG003|Conversion Phase.|Withdrawal by Subject|0|||
42348431|NCT01567527|76187790|FG004|Conversion Phase.|Withdrawal by Subject|0|||
42348432|NCT01567527|76187786|FG000|Conversion Phase.|Lost to Follow-up|16|||
42348433|NCT01567527|76187787|FG001|Conversion Phase.|Lost to Follow-up|0|||
42348434|NCT01567527|76187788|FG002|Conversion Phase.|Lost to Follow-up|0|||
42348435|NCT01567527|76187789|FG003|Conversion Phase.|Lost to Follow-up|0|||
42348436|NCT01567527|76187790|FG004|Conversion Phase.|Lost to Follow-up|0|||
42348437|NCT01567527|76187786|FG000|Conversion Phase.|Lack of Efficacy|2|||
42348438|NCT01567527|76187787|FG001|Conversion Phase.|Lack of Efficacy|0|||
42348439|NCT01567527|76187788|FG002|Conversion Phase.|Lack of Efficacy|0|||
42348440|NCT01567527|76187789|FG003|Conversion Phase.|Lack of Efficacy|0|||
42348441|NCT01567527|76187790|FG004|Conversion Phase.|Lack of Efficacy|0|||
42348442|NCT01567527|76187786|FG000|Conversion Phase.|Adverse Event|33|||
42348443|NCT01567527|76187787|FG001|Conversion Phase.|Adverse Event|0|||
42348444|NCT01567527|76187788|FG002|Conversion Phase.|Adverse Event|0|||
42348445|NCT01567527|76187789|FG003|Conversion Phase.|Adverse Event|0|||
42348446|NCT01567527|76187790|FG004|Conversion Phase.|Adverse Event|0|||
42348447|NCT01567527|76187786|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
42348448|NCT01567527|76187787|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
42348449|NCT01567527|76187788|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
42348450|NCT01567527|76187789|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
42348451|NCT01567527|76187790|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
42348452|NCT01567527|76187786|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
42348453|NCT01567527|76187787|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
42348454|NCT01567527|76187788|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
42348455|NCT01567527|76187789|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
42274095|NCT02452034|76104804|FG003|Overall Study|Physician Decision|0|||
42274096|NCT02452034|76104805|FG004|Overall Study|Physician Decision|0|||
42274097|NCT02452034|76104806|FG005|Overall Study|Physician Decision|0|||
42274098|NCT02452034|76104801|FG000|Overall Study|Protocol Violation|0|||
42274099|NCT02452034|76104802|FG001|Overall Study|Protocol Violation|0|||
42274100|NCT02452034|76104803|FG002|Overall Study|Protocol Violation|0|||
42274101|NCT02452034|76104804|FG003|Overall Study|Protocol Violation|0|||
42274102|NCT02452034|76104805|FG004|Overall Study|Protocol Violation|0|||
42274103|NCT02452034|76104806|FG005|Overall Study|Protocol Violation|1|||
42274104|NCT02452034|76104801|FG000|Overall Study|Screen Failure|1|||
42274105|NCT02452034|76104802|FG001|Overall Study|Screen Failure|0|||
42274106|NCT02452034|76104803|FG002|Overall Study|Screen Failure|0|||
42274107|NCT02452034|76104804|FG003|Overall Study|Screen Failure|1|||
42274108|NCT02452034|76104805|FG004|Overall Study|Screen Failure|0|||
42274109|NCT02452034|76104806|FG005|Overall Study|Screen Failure|0|||
42274110|NCT02452034|76104801|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
42274111|NCT02452034|76104802|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
42274112|NCT02452034|76104803|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
42274113|NCT02452034|76104804|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
42274114|NCT02452034|76104805|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
42274115|NCT02452034|76104806|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
42274116|NCT02482298|76104833|FG000|Overall Study|Withdrawal by Subject|2|||
42274117|NCT02482298|76104834|FG001|Overall Study|Withdrawal by Subject|1|||
42274118|NCT02482298|76104835|FG002|Overall Study|Withdrawal by Subject|2|||
42274119|NCT02482298|76104833|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
42274120|NCT02482298|76104834|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
42348456|NCT01567527|76187790|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
42348457|NCT01567527|76187786|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
42348458|NCT01567527|76187787|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
42036754|NCT01006356|75845105|FG000|Overall Study|Paticipants did not cooperate|6|||
42036755|NCT01006356|75845105|FG000|Overall Study|Withdrawal by Subject|1|||
42036756|NCT01006356|75845105|FG000|Overall Study|Choice by participants|2|||
42036757|NCT01006356|75845105|FG000|Overall Study|Protocol Violation|3|||
42036758|NCT01006356|75845105|FG000|Overall Study|Other|23|||
42036759|NCT01089725|75845114|FG000|Overall Study|Adverse Event|1|||
42036760|NCT01089725|75845115|FG001|Overall Study|Adverse Event|1|||
42036761|NCT01089725|75845116|FG002|Overall Study|Adverse Event|0|||
42036762|NCT01089725|75845117|FG003|Overall Study|Adverse Event|0|||
42036763|NCT01089725|75845118|FG004|Overall Study|Adverse Event|2|||
42036764|NCT01089725|75845114|FG000|Overall Study|Lack of Efficacy|4|||
42036765|NCT01089725|75845115|FG001|Overall Study|Lack of Efficacy|3|||
42036766|NCT01089725|75845116|FG002|Overall Study|Lack of Efficacy|1|||
42036767|NCT01089725|75845117|FG003|Overall Study|Lack of Efficacy|0|||
42036768|NCT01089725|75845118|FG004|Overall Study|Lack of Efficacy|4|||
42036769|NCT01089725|75845114|FG000|Overall Study|Lost to Follow-up|2|||
42036770|NCT01089725|75845115|FG001|Overall Study|Lost to Follow-up|2|||
42036771|NCT01089725|75845116|FG002|Overall Study|Lost to Follow-up|0|||
42036772|NCT01089725|75845117|FG003|Overall Study|Lost to Follow-up|3|||
42036773|NCT01089725|75845118|FG004|Overall Study|Lost to Follow-up|0|||
42036774|NCT01089725|75845114|FG000|Overall Study|Protocol Violation|0|||
42036775|NCT01089725|75845115|FG001|Overall Study|Protocol Violation|0|||
42036776|NCT01089725|75845116|FG002|Overall Study|Protocol Violation|1|||
42036777|NCT01089725|75845117|FG003|Overall Study|Protocol Violation|1|||
42036778|NCT01089725|75845118|FG004|Overall Study|Protocol Violation|0|||
42036779|NCT01089725|75845114|FG000|Overall Study|Withdrawal by Subject|5|||
42036780|NCT01089725|75845115|FG001|Overall Study|Withdrawal by Subject|5|||
42036781|NCT01089725|75845116|FG002|Overall Study|Withdrawal by Subject|4|||
42036782|NCT01089725|75845117|FG003|Overall Study|Withdrawal by Subject|5|||
42036783|NCT01089725|75845118|FG004|Overall Study|Withdrawal by Subject|4|||
42036784|NCT01089725|75845114|FG000|Overall Study|Study Terminated by Sponsor|51|||
42274121|NCT02482298|76104835|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
42274122|NCT02482298|76104833|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
42274123|NCT02482298|76104834|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
42274124|NCT02482298|76104835|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
42348459|NCT01567527|76187788|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
42348460|NCT01567527|76187789|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
42036785|NCT01089725|75845115|FG001|Overall Study|Study Terminated by Sponsor|56|||
42036786|NCT01089725|75845116|FG002|Overall Study|Study Terminated by Sponsor|53|||
42036787|NCT01089725|75845117|FG003|Overall Study|Study Terminated by Sponsor|68|||
42036788|NCT01089725|75845118|FG004|Overall Study|Study Terminated by Sponsor|68|||
42036789|NCT01089725|75845114|FG000|Overall Study|Randomized, but not treated|0|||
42036790|NCT01089725|75845115|FG001|Overall Study|Randomized, but not treated|1|||
42036791|NCT01089725|75845116|FG002|Overall Study|Randomized, but not treated|2|||
42036792|NCT01089725|75845117|FG003|Overall Study|Randomized, but not treated|1|||
42274125|NCT02482298|76104833|FG000|Overall Study|Lost to Follow-up|0|||
42274126|NCT02482298|76104834|FG001|Overall Study|Lost to Follow-up|1|||
42274127|NCT02482298|76104835|FG002|Overall Study|Lost to Follow-up|0|||
42274128|NCT00440531|76104846|FG000|Overall Study|Adverse Event|1|||
42274129|NCT00440531|76104847|FG001|Overall Study|Adverse Event|0|||
42274130|NCT00440531|76104848|FG002|Overall Study|Adverse Event|2|||
42274131|NCT00440531|76104846|FG000|Overall Study|Withdrawal by Subject|2|||
42274132|NCT00440531|76104847|FG001|Overall Study|Withdrawal by Subject|0|||
42274133|NCT00440531|76104848|FG002|Overall Study|Withdrawal by Subject|0|||
42274134|NCT00440531|76104846|FG000|Overall Study|Protocol Violation|1|||
42274135|NCT00440531|76104847|FG001|Overall Study|Protocol Violation|2|||
42274136|NCT00440531|76104848|FG002|Overall Study|Protocol Violation|0|||
42274137|NCT00440531|76104846|FG000|Overall Study|Lost to Follow-up|4|||
42274138|NCT00440531|76104847|FG001|Overall Study|Lost to Follow-up|3|||
42274139|NCT00440531|76104848|FG002|Overall Study|Lost to Follow-up|5|||
42274140|NCT00440531|76104846|FG000|Overall Study|see pre-assignment details|2|||
42274141|NCT00440531|76104847|FG001|Overall Study|see pre-assignment details|0|||
42274142|NCT00440531|76104848|FG002|Overall Study|see pre-assignment details|0|||
42274143|NCT02513732|76104854|FG000|Overall Study|Lost to Follow-up|11|||
42274144|NCT02513732|76104854|FG000|Overall Study|Death|9|||
42274145|NCT02513732|76104854|FG000|Overall Study|Changing hospital|2|||
42274146|NCT00429923|76104861|FG000|Overall Study|Adverse Event|0|||
42274147|NCT00429923|76104862|FG001|Overall Study|Adverse Event|2|||
42274148|NCT00429923|76104863|FG002|Overall Study|Adverse Event|3|||
42274149|NCT00429923|76104861|FG000|Overall Study|Lack of Efficacy|4|||
42274150|NCT00429923|76104862|FG001|Overall Study|Lack of Efficacy|1|||
42274151|NCT00429923|76104863|FG002|Overall Study|Lack of Efficacy|33|||
42274152|NCT00429923|76104861|FG000|Overall Study|Lost to Follow-up|0|||
42274153|NCT00429923|76104862|FG001|Overall Study|Lost to Follow-up|0|||
42274154|NCT00429923|76104863|FG002|Overall Study|Lost to Follow-up|2|||
42274155|NCT00429923|76104861|FG000|Overall Study|Withdrew Consent|1|||
42274156|NCT00429923|76104862|FG001|Overall Study|Withdrew Consent|0|||
42274157|NCT00429923|76104863|FG002|Overall Study|Withdrew Consent|1|||
42274158|NCT00429923|76104861|FG000|Overall Study|Early Termination|0|||
42274159|NCT00429923|76104862|FG001|Overall Study|Early Termination|1|||
42274160|NCT00429923|76104863|FG002|Overall Study|Early Termination|0|||
42274161|NCT02256436|76104870|FG000|Overall Study|Adverse Event|9|||
42274162|NCT02256436|76104871|FG001|Overall Study|Adverse Event|14|||
42274163|NCT02256436|76104870|FG000|Overall Study|Death|216|||
42274164|NCT02256436|76104871|FG001|Overall Study|Death|208|||
42274165|NCT02256436|76104870|FG000|Overall Study|Lost to Follow-up|1|||
42274166|NCT02256436|76104871|FG001|Overall Study|Lost to Follow-up|2|||
42274167|NCT02256436|76104870|FG000|Overall Study|Physician Decision|1|||
42274168|NCT02256436|76104871|FG001|Overall Study|Physician Decision|0|||
42274169|NCT02256436|76104870|FG000|Overall Study|Protocol Violation|0|||
42274170|NCT02256436|76104871|FG001|Overall Study|Protocol Violation|1|||
42274171|NCT02256436|76104870|FG000|Overall Study|Withdrawal by Subject|26|||
42274172|NCT02256436|76104871|FG001|Overall Study|Withdrawal by Subject|10|||
42274173|NCT02256436|76104870|FG000|Overall Study|Transferred to Extension Study|11|||
42274174|NCT02256436|76104871|FG001|Overall Study|Transferred to Extension Study|23|||
42010935|NCT01217073|75818112|FG007|Base Period|Adverse Event|0|||
42036793|NCT01089725|75845118|FG004|Overall Study|Randomized, but not treated|2|||
42036794|NCT01089725|75845114|FG000|Overall Study|Other|3|||
42036795|NCT01089725|75845115|FG001|Overall Study|Other|0|||
42036796|NCT01089725|75845116|FG002|Overall Study|Other|0|||
42010936|NCT01217073|75818105|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
42010937|NCT01217073|75818106|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
42010938|NCT01217073|75818107|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
42010939|NCT01217073|75818108|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
42010940|NCT01217073|75818109|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
42010941|NCT01217073|75818110|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
42010942|NCT01217073|75818111|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
42036797|NCT01089725|75845117|FG003|Overall Study|Other|1|||
42036798|NCT01089725|75845118|FG004|Overall Study|Other|0|||
42036799|NCT01101191|75845134|FG000|Period 1|Withdrawal by Subject|1|||
42036800|NCT01101191|75845135|FG001|Period 1|Withdrawal by Subject|0|||
42036801|NCT01101191|75845134|FG000|Period 1|Adverse Event|1|||
42036802|NCT01101191|75845135|FG001|Period 1|Adverse Event|2|||
42274175|NCT02256436|76104870|FG000|Overall Study|Did Not Continue on Extension Study|8|||
42274176|NCT02256436|76104871|FG001|Overall Study|Did Not Continue on Extension Study|12|||
42274177|NCT00326183|76104880|FG000|Overall Study|Lost to Follow-up|104|||
42274178|NCT00326183|76104881|FG001|Overall Study|Lost to Follow-up|56|||
42274179|NCT00326183|76104880|FG000|Overall Study|Protocol Violation|6|||
42274180|NCT00326183|76104881|FG001|Overall Study|Protocol Violation|3|||
42274181|NCT00326183|76104880|FG000|Overall Study|Withdrawal by Subject|35|||
42274182|NCT00326183|76104881|FG001|Overall Study|Withdrawal by Subject|7|||
42274183|NCT00326183|76104880|FG000|Overall Study|Subject Moved|7|||
42274184|NCT00326183|76104881|FG001|Overall Study|Subject Moved|4|||
42274185|NCT00326183|76104880|FG000|Overall Study|Other|47|||
42274186|NCT00326183|76104881|FG001|Overall Study|Other|13|||
42274187|NCT00326183|76104880|FG000|Overall Study|Adverse Event|1|||
42274188|NCT00326183|76104881|FG001|Overall Study|Adverse Event|0|||
42274189|NCT02481050|76104885|FG000|Overall Study|Adverse Event|1|||
42274190|NCT02481050|76104885|FG000|Overall Study|Disease Progression|47|||
42274191|NCT02481050|76104885|FG000|Overall Study|Withdrawal by Subject|7|||
42274192|NCT02481050|76104885|FG000|Overall Study|Other|3|||
42274193|NCT02511782|76104892|FG000|Overall Study|Withdrawal by Subject|1|||
42274194|NCT02511782|76104893|FG001|Overall Study|Withdrawal by Subject|0|||
42274195|NCT02511782|76104894|FG002|Overall Study|Withdrawal by Subject|0|||
42274196|NCT02480114|76104904|FG000|Overall Study|Not completing surveys|3|||
42274197|NCT02480114|76104905|FG001|Overall Study|Not completing surveys|2|||
42274198|NCT02480114|76104904|FG000|Overall Study|Withdrawal by Subject|2|||
42274199|NCT02480114|76104905|FG001|Overall Study|Withdrawal by Subject|4|||
42274200|NCT02480114|76104904|FG000|Overall Study|Disease progression|3|||
42274201|NCT02480114|76104905|FG001|Overall Study|Disease progression|0|||
42274202|NCT02480114|76104904|FG000|Overall Study|Improper completion of survey|1|||
42274203|NCT02480114|76104905|FG001|Overall Study|Improper completion of survey|1|||
42274204|NCT02480114|76104904|FG000|Overall Study|Not eligible|0|||
42274205|NCT02480114|76104905|FG001|Overall Study|Not eligible|1|||
42274206|NCT02479880|76104913|FG000|Overall Study|Study Terminated by Sponsor|13|||
42274207|NCT02479880|76104914|FG001|Overall Study|Study Terminated by Sponsor|12|||
42274208|NCT02479880|76104913|FG000|Overall Study|Pregnancy|0|||
42274209|NCT02479880|76104914|FG001|Overall Study|Pregnancy|1|||
42274210|NCT02479802|76104920|FG000|Overall Study|Lost to Follow-up|1|||
42274211|NCT02479802|76104920|FG000|Overall Study|Adverse Event|1|||
42274212|NCT02479412|76104933|FG000|Overall Study|Adverse Event|0|||
42274213|NCT02479412|76104934|FG001|Overall Study|Adverse Event|0|||
42274214|NCT02479412|76104935|FG002|Overall Study|Adverse Event|1|||
42274215|NCT02479412|76104936|FG003|Overall Study|Adverse Event|0|||
42274216|NCT02479412|76104937|FG004|Overall Study|Adverse Event|0|||
42274217|NCT02479412|76104938|FG005|Overall Study|Adverse Event|0|||
42348461|NCT01567527|76187790|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
42348462|NCT01567527|76187786|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
42348463|NCT01567527|76187787|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
42348464|NCT01567527|76187788|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
42348465|NCT01567527|76187789|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
42348466|NCT01567527|76187790|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
42348467|NCT01567527|76187786|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
42348468|NCT01567527|76187787|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
42348469|NCT01567527|76187788|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
42348470|NCT01567527|76187789|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
42348471|NCT01567527|76187790|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
42348472|NCT01567527|76187786|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
42348473|NCT01567527|76187787|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
42348474|NCT01567527|76187788|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
42348475|NCT01567527|76187789|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
42348476|NCT01567527|76187790|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
42348477|NCT01567527|76187786|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
42348478|NCT01567527|76187787|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
42348479|NCT01567527|76187788|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
42348480|NCT01567527|76187789|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
42348481|NCT01567527|76187790|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
42348482|NCT01567527|76187786|FG000|IM Depot Stabilization.|Protocol deviation|0|||
42348483|NCT01567527|76187787|FG001|IM Depot Stabilization.|Protocol deviation|0|||
42348484|NCT01567527|76187788|FG002|IM Depot Stabilization.|Protocol deviation|5|||
42348485|NCT01567527|76187789|FG003|IM Depot Stabilization.|Protocol deviation|0|||
42010943|NCT01217073|75818112|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
42010944|NCT01217073|75818105|FG000|Base Period|Excluded medication|0|||
42010945|NCT01217073|75818106|FG001|Base Period|Excluded medication|0|||
42010946|NCT01217073|75818107|FG002|Base Period|Excluded medication|0|||
42010947|NCT01217073|75818108|FG003|Base Period|Excluded medication|0|||
42010948|NCT01217073|75818109|FG004|Base Period|Excluded medication|1|||
42010949|NCT01217073|75818110|FG005|Base Period|Excluded medication|0|||
42010950|NCT01217073|75818111|FG006|Base Period|Excluded medication|0|||
42274218|NCT02479412|76104939|FG006|Overall Study|Adverse Event|0|||
42348486|NCT01567527|76187790|FG004|IM Depot Stabilization.|Protocol deviation|0|||
42348487|NCT01567527|76187786|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
42010951|NCT01217073|75818112|FG007|Base Period|Excluded medication|0|||
42274219|NCT02479412|76104940|FG007|Overall Study|Adverse Event|0|||
42274220|NCT02479412|76104941|FG008|Overall Study|Adverse Event|0|||
42274221|NCT02479412|76104933|FG000|Overall Study|Study-specific withdrawal criteria|0|||
42274222|NCT02479412|76104934|FG001|Overall Study|Study-specific withdrawal criteria|0|||
42274223|NCT02479412|76104935|FG002|Overall Study|Study-specific withdrawal criteria|1|||
42274224|NCT02479412|76104936|FG003|Overall Study|Study-specific withdrawal criteria|1|||
42348488|NCT01567527|76187787|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
42348489|NCT01567527|76187788|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
42348490|NCT01567527|76187789|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
42348491|NCT01567527|76187790|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
42348492|NCT01567527|76187786|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
42348493|NCT01567527|76187787|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
42348494|NCT01567527|76187788|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
42348495|NCT01567527|76187789|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
42348496|NCT01567527|76187790|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
42348497|NCT01567527|76187786|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
42348498|NCT01567527|76187787|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
42348499|NCT01567527|76187788|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
42348500|NCT01567527|76187789|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
42348501|NCT01567527|76187790|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
42348502|NCT01567527|76187786|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
42348503|NCT01567527|76187787|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
42348504|NCT01567527|76187788|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
42348505|NCT01567527|76187789|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
42348506|NCT01567527|76187790|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
42348507|NCT01567527|76187786|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
42348508|NCT01567527|76187787|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
42348509|NCT01567527|76187788|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
42348510|NCT01567527|76187789|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
42348511|NCT01567527|76187790|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
42348512|NCT01567527|76187786|FG000|IM Depot Stabilization.|Adverse Event|0|||
42348513|NCT01567527|76187787|FG001|IM Depot Stabilization.|Adverse Event|0|||
42348514|NCT01567527|76187788|FG002|IM Depot Stabilization.|Adverse Event|37|||
42348515|NCT01567527|76187789|FG003|IM Depot Stabilization.|Adverse Event|0|||
42348516|NCT01567527|76187790|FG004|IM Depot Stabilization.|Adverse Event|0|||
42348517|NCT01567527|76187786|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
42348518|NCT01567527|76187787|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
42348519|NCT01567527|76187788|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
42348520|NCT01567527|76187789|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
42348521|NCT01567527|76187790|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
42348522|NCT01567527|76187786|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
42348523|NCT01567527|76187787|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
42348524|NCT01567527|76187788|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
42348525|NCT01567527|76187789|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
42348526|NCT01567527|76187790|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
42348527|NCT01567527|76187786|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
42348528|NCT01567527|76187787|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
42348529|NCT01567527|76187788|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
42348530|NCT01567527|76187789|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
42348531|NCT01567527|76187790|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
42010952|NCT01217073|75818105|FG000|Base Period|Lack of Efficacy|0|||
42010953|NCT01217073|75818106|FG001|Base Period|Lack of Efficacy|0|||
42010954|NCT01217073|75818107|FG002|Base Period|Lack of Efficacy|0|||
42348532|NCT01567527|76187786|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
42348533|NCT01567527|76187787|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
42010955|NCT01217073|75818108|FG003|Base Period|Lack of Efficacy|0|||
42010956|NCT01217073|75818109|FG004|Base Period|Lack of Efficacy|0|||
42010957|NCT01217073|75818110|FG005|Base Period|Lack of Efficacy|1|||
42010958|NCT01217073|75818111|FG006|Base Period|Lack of Efficacy|0|||
42010959|NCT01217073|75818112|FG007|Base Period|Lack of Efficacy|0|||
42348534|NCT01567527|76187788|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
42348535|NCT01567527|76187789|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
42348536|NCT01567527|76187790|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
42348537|NCT01567527|76187786|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
42348538|NCT01567527|76187787|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
42348539|NCT01567527|76187788|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
42348540|NCT01567527|76187789|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
42348541|NCT01567527|76187790|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
42348542|NCT01567527|76187786|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
42348543|NCT01567527|76187787|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
42348544|NCT01567527|76187788|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
42348545|NCT01567527|76187789|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
42348546|NCT01567527|76187790|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
42348547|NCT01567527|76187786|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
42348548|NCT01567527|76187787|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
42348549|NCT01567527|76187788|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
42348550|NCT01567527|76187789|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
42348551|NCT01567527|76187790|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
42348552|NCT01567527|76187786|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
42348553|NCT01567527|76187787|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
42348554|NCT01567527|76187788|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
42036803|NCT01178762|75845142|FG000|Overall Study|Lost to Follow-up|15|||
42036804|NCT01178294|75845146|FG000|Overall Study|Adverse Event|4|||
42036805|NCT01178294|75845146|FG000|Overall Study|Lost to Follow-up|2|||
42348555|NCT01567527|76187789|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
42348556|NCT01567527|76187790|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
42348557|NCT01567527|76187786|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
42348558|NCT01567527|76187787|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
42348559|NCT01567527|76187788|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
42348560|NCT01567527|76187789|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
42348561|NCT01567527|76187790|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
42348562|NCT01818752|76187801|FG000|Overall Study|Adverse Event|64|||
42348563|NCT01818752|76187802|FG001|Overall Study|Adverse Event|74|||
42348564|NCT01818752|76187801|FG000|Overall Study|Death|14|||
42348565|NCT01818752|76187802|FG001|Overall Study|Death|18|||
42348566|NCT01818752|76187801|FG000|Overall Study|Non-compliance|16|||
42348567|NCT01818752|76187802|FG001|Overall Study|Non-compliance|20|||
42348568|NCT01818752|76187801|FG000|Overall Study|Withdrawal by Subject|15|||
42348569|NCT01818752|76187802|FG001|Overall Study|Withdrawal by Subject|14|||
42348570|NCT01818752|76187801|FG000|Overall Study|Physician Decision|9|||
42274225|NCT02479412|76104937|FG004|Overall Study|Study-specific withdrawal criteria|0|||
42274226|NCT02479412|76104938|FG005|Overall Study|Study-specific withdrawal criteria|0|||
42274227|NCT02479412|76104939|FG006|Overall Study|Study-specific withdrawal criteria|0|||
42274228|NCT02479412|76104940|FG007|Overall Study|Study-specific withdrawal criteria|1|||
42274229|NCT02479412|76104941|FG008|Overall Study|Study-specific withdrawal criteria|1|||
42274230|NCT02479412|76104933|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
42348571|NCT01818752|76187802|FG001|Overall Study|Physician Decision|8|||
42348572|NCT01818752|76187801|FG000|Overall Study|Disease Progression|54|||
42348573|NCT01818752|76187802|FG001|Overall Study|Disease Progression|48|||
42348574|NCT01818752|76187801|FG000|Overall Study|Other|7|||
42348575|NCT01818752|76187802|FG001|Overall Study|Other|8|||
42348576|NCT01818752|76187801|FG000|Overall Study|Continuing Treatment|1|||
42348577|NCT01818752|76187802|FG001|Overall Study|Continuing Treatment|4|||
42348578|NCT01818752|76187801|FG000|Overall Study|Randomized but not Dosed|7|||
42348579|NCT01818752|76187802|FG001|Overall Study|Randomized but not Dosed|4|||
42348580|NCT01845818|76187810|FG000|Overall Study|Withdrawal by Subject|0|||
42348581|NCT01845818|76187811|FG001|Overall Study|Withdrawal by Subject|1|||
42348582|NCT01845818|76187810|FG000|Overall Study|Lost to Follow-up|7|||
42348583|NCT01845818|76187811|FG001|Overall Study|Lost to Follow-up|5|||
42348584|NCT01845818|76187810|FG000|Overall Study|Administrative Reasons|3|||
42348585|NCT01845818|76187811|FG001|Overall Study|Administrative Reasons|1|||
42348586|NCT01845818|76187810|FG000|Overall Study|Serious Adverse Event|1|||
42348587|NCT01845818|76187811|FG001|Overall Study|Serious Adverse Event|1|||
42348588|NCT01845818|76187810|FG000|Overall Study|Other|25|||
42010960|NCT01217073|75818105|FG000|Base Period|Lost to Follow-up|0|||
42010961|NCT01217073|75818106|FG001|Base Period|Lost to Follow-up|0|||
42138680|NCT00529451|75948852|FG001|Overall Study|Protocol deviation|1|||
42138681|NCT00529451|75948853|FG002|Overall Study|Protocol deviation|4|||
42138682|NCT00529451|75948854|FG003|Overall Study|Protocol deviation|1|||
42138683|NCT00529451|75948851|FG000|Overall Study|Administrative problems|1|||
42138684|NCT00529451|75948852|FG001|Overall Study|Administrative problems|1|||
42138685|NCT00529451|75948853|FG002|Overall Study|Administrative problems|0|||
42274231|NCT02479412|76104934|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
42274232|NCT02479412|76104935|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
42274233|NCT02479412|76104936|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
42274234|NCT02479412|76104937|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
42348589|NCT01845818|76187811|FG001|Overall Study|Other|8|||
42348590|NCT01845818|76187810|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
42348591|NCT01845818|76187811|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
42010962|NCT01217073|75818107|FG002|Base Period|Lost to Follow-up|1|||
42010963|NCT01217073|75818108|FG003|Base Period|Lost to Follow-up|1|||
42010964|NCT01217073|75818109|FG004|Base Period|Lost to Follow-up|3|||
42010965|NCT01217073|75818110|FG005|Base Period|Lost to Follow-up|0|||
42010966|NCT01217073|75818111|FG006|Base Period|Lost to Follow-up|0|||
42274235|NCT02479412|76104938|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
42348592|NCT01845818|76187810|FG000|Overall Study|No Follow-Up Data Available|4|||
42348593|NCT01845818|76187811|FG001|Overall Study|No Follow-Up Data Available|1|||
42348594|NCT01362608|76187821|FG000|Overall Study|Protocol Violation|0|||
42348595|NCT01362608|76187822|FG001|Overall Study|Protocol Violation|1|||
42348596|NCT01362608|76187821|FG000|Overall Study|Lost to Follow-up|3|||
42348597|NCT01362608|76187822|FG001|Overall Study|Lost to Follow-up|1|||
42348598|NCT01362608|76187821|FG000|Overall Study|Withdrawal by Subject|1|||
42348599|NCT01362608|76187822|FG001|Overall Study|Withdrawal by Subject|2|||
42348600|NCT01362608|76187821|FG000|Overall Study|Lack of Efficacy|0|||
42348601|NCT01362608|76187822|FG001|Overall Study|Lack of Efficacy|2|||
42348602|NCT01362608|76187821|FG000|Overall Study|Adverse Event|0|||
42348603|NCT01362608|76187822|FG001|Overall Study|Adverse Event|2|||
42348604|NCT01871090|76187830|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
42348605|NCT01871090|76187831|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
42348606|NCT01871090|76187830|FG000|Overall Study|Interrogation not completed correctly|1|||
42348607|NCT01871090|76187831|FG001|Overall Study|Interrogation not completed correctly|0|||
42348608|NCT01871090|76187830|FG000|Overall Study|Subject Non-Compliance|0|||
42348609|NCT01871090|76187831|FG001|Overall Study|Subject Non-Compliance|1|||
42348610|NCT01818596|76187839|FG000|Overall Study|Enrolled but Not Treated|4|||
42348611|NCT01818596|76187840|FG001|Overall Study|Enrolled but Not Treated|0|||
42348612|NCT01818596|76187839|FG000|Overall Study|Adverse Event|7|||
42348613|NCT01818596|76187840|FG001|Overall Study|Adverse Event|0|||
42348614|NCT01818596|76187839|FG000|Overall Study|Death|3|||
42348615|NCT01818596|76187840|FG001|Overall Study|Death|0|||
42348616|NCT01818596|76187839|FG000|Overall Study|Investigator's Discretion|4|||
42348617|NCT01818596|76187840|FG001|Overall Study|Investigator's Discretion|0|||
42348618|NCT01818596|76187839|FG000|Overall Study|Protocol Violation|1|||
42348619|NCT01818596|76187840|FG001|Overall Study|Protocol Violation|0|||
42348620|NCT01818596|76187839|FG000|Overall Study|Withdrew Consent|5|||
42348621|NCT01818596|76187840|FG001|Overall Study|Withdrew Consent|0|||
42348622|NCT01818596|76187839|FG000|Overall Study|Lost to Follow-up|7|||
42348623|NCT01818596|76187840|FG001|Overall Study|Lost to Follow-up|0|||
42348624|NCT04577794|76187853|FG000|Overall Study|Adverse Event|1|||
42348625|NCT04577794|76187854|FG001|Overall Study|Adverse Event|1|||
42348626|NCT01594281|76187871|FG000|Interventional Core Phase|Protocol Deviation|1|||
42348627|NCT01594281|76187872|FG001|Interventional Core Phase|Protocol Deviation|0|||
42348628|NCT01594281|76187873|FG002|Interventional Core Phase|Protocol Deviation|0|||
42348629|NCT01594281|76187871|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
42348630|NCT01594281|76187872|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
42348631|NCT01594281|76187873|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
42348632|NCT01594281|76187871|FG000|Interventional Core Phase|Death|1|||
42348633|NCT01594281|76187872|FG001|Interventional Core Phase|Death|1|||
42348634|NCT01594281|76187873|FG002|Interventional Core Phase|Death|2|||
42348635|NCT01594281|76187871|FG000|Interventional Core Phase|Lost to Follow-up|1|||
42348636|NCT01594281|76187872|FG001|Interventional Core Phase|Lost to Follow-up|4|||
42348637|NCT01594281|76187873|FG002|Interventional Core Phase|Lost to Follow-up|1|||
42348638|NCT01594281|76187871|FG000|Interventional Core Phase|Adverse Event|4|||
42348639|NCT01594281|76187872|FG001|Interventional Core Phase|Adverse Event|4|||
42348640|NCT01594281|76187873|FG002|Interventional Core Phase|Adverse Event|4|||
42348641|NCT01594281|76187871|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
42348642|NCT01594281|76187872|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
42010967|NCT01217073|75818112|FG007|Base Period|Lost to Follow-up|0|||
42010968|NCT01217073|75818105|FG000|Base Period|Physician Decision|0|||
42010969|NCT01217073|75818106|FG001|Base Period|Physician Decision|0|||
42010970|NCT01217073|75818107|FG002|Base Period|Physician Decision|0|||
42010971|NCT01217073|75818108|FG003|Base Period|Physician Decision|0|||
42274236|NCT02479412|76104939|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
42274237|NCT02479412|76104940|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
42274238|NCT02479412|76104941|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
42274239|NCT00224003|76104957|FG000|Overall Study|Adverse Event|1|||
42274240|NCT00224003|76104957|FG000|Overall Study|Protocol Violation|2|||
42274241|NCT00224003|76104957|FG000|Overall Study|Withdrawal by Subject|1|||
42274242|NCT00224003|76104957|FG000|Overall Study|unk|3|||
42274243|NCT02450552|76104963|FG000|Overall Study|Withdrawal by Subject|4|||
42274244|NCT02450552|76104964|FG001|Overall Study|Withdrawal by Subject|0|||
42274245|NCT02450552|76104965|FG002|Overall Study|Withdrawal by Subject|4|||
42274246|NCT02450552|76104963|FG000|Overall Study|Physician Decision|1|||
42274247|NCT02450552|76104964|FG001|Overall Study|Physician Decision|0|||
42274248|NCT02450552|76104965|FG002|Overall Study|Physician Decision|1|||
42274249|NCT02508428|76104975|FG000|Overall Study|Death|32|||
42274250|NCT02508428|76104976|FG001|Overall Study|Death|33|||
42348643|NCT01594281|76187873|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
42348644|NCT01594281|76187871|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
42348645|NCT01594281|76187872|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
42348646|NCT01594281|76187873|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
42348647|NCT01594281|76187871|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
42036806|NCT01178294|75845146|FG000|Overall Study|Lack of Efficacy|1|||
42036807|NCT01178294|75845146|FG000|Overall Study|Death|1|||
42036808|NCT01178294|75845146|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
42036809|NCT01178294|75845146|FG000|Overall Study|Subject status is terminal|1|||
42036810|NCT01178294|75845146|FG000|Overall Study|Completion status could not be verified|1|||
42036811|NCT01178138|75845150|FG000|Overall Study|Lost to Follow-up|8|||
42036812|NCT01178138|75845150|FG000|Overall Study|Withdrawal by Subject|7|||
42036813|NCT01178138|75845150|FG000|Overall Study|Physician Decision|8|||
42036814|NCT01177670|75845159|FG000|Overall Study|Study Terminated|115|||
42036815|NCT01177670|75845159|FG000|Overall Study|Physician Decision|50|||
42036816|NCT01177670|75845159|FG000|Overall Study|Withdrawal by Subject|4|||
42036817|NCT01190228|75845166|FG000|Overall Study|Protocol Violation|4|||
42036818|NCT01190228|75845167|FG001|Overall Study|Protocol Violation|0|||
42036819|NCT01190228|75845168|FG002|Overall Study|Protocol Violation|0|||
42036820|NCT01190228|75845166|FG000|Overall Study|Withdrawal by Subject|1|||
42036821|NCT01190228|75845167|FG001|Overall Study|Withdrawal by Subject|0|||
42036822|NCT01190228|75845168|FG002|Overall Study|Withdrawal by Subject|0|||
42036823|NCT01009086|75845181|FG000|Overall Study|Lack of Efficacy|16|||
42036824|NCT01009086|75845182|FG001|Overall Study|Lack of Efficacy|15|||
42036825|NCT01009086|75845183|FG002|Overall Study|Lack of Efficacy|9|||
42036826|NCT01009086|75845181|FG000|Overall Study|Lost to Follow-up|4|||
42036827|NCT01009086|75845182|FG001|Overall Study|Lost to Follow-up|5|||
42036828|NCT01009086|75845183|FG002|Overall Study|Lost to Follow-up|3|||
42036829|NCT01009086|75845181|FG000|Overall Study|Adverse Event|12|||
42036830|NCT01009086|75845182|FG001|Overall Study|Adverse Event|11|||
42036831|NCT01009086|75845183|FG002|Overall Study|Adverse Event|8|||
42036832|NCT01009086|75845181|FG000|Overall Study|Withdrawal by Subject|9|||
42036833|NCT01009086|75845182|FG001|Overall Study|Withdrawal by Subject|11|||
42036834|NCT01009086|75845183|FG002|Overall Study|Withdrawal by Subject|13|||
42036835|NCT01009086|75845181|FG000|Overall Study|Other|3|||
42036836|NCT01009086|75845182|FG001|Overall Study|Other|5|||
42036837|NCT01009086|75845183|FG002|Overall Study|Other|1|||
42036838|NCT01190150|75845198|FG000|First Treatment|Withdrawal by Subject|1|||
42036839|NCT01190150|75845199|FG001|First Treatment|Withdrawal by Subject|0|||
42036840|NCT01190150|75845198|FG000|Washout|Withdrawal by Subject|0|||
42036841|NCT01190150|75845199|FG001|Washout|Withdrawal by Subject|1|||
42036842|NCT01190150|75845198|FG000|Washout|Difficulty in adherence|0|||
42036843|NCT01190150|75845199|FG001|Washout|Difficulty in adherence|1|||
42036844|NCT01001520|75845205|FG000|Medication Period 1|Withdrawal by Subject|2|||
42036845|NCT01001520|75845206|FG001|Medication Period 1|Withdrawal by Subject|2|||
42036846|NCT01001520|75845205|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
42036847|NCT01001520|75845206|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
42036848|NCT01001520|75845205|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
42036849|NCT01001520|75845206|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
42036850|NCT01001520|75845205|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
42036851|NCT01001520|75845206|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
42036852|NCT01001520|75845205|FG000|Washout Period|Withdrawal by Subject|2|||
42036853|NCT01001520|75845206|FG001|Washout Period|Withdrawal by Subject|1|||
42036854|NCT01001520|75845205|FG000|Medication Period 2|Withdrawal by Subject|0|||
42036855|NCT01001520|75845206|FG001|Medication Period 2|Withdrawal by Subject|3|||
42036856|NCT01189604|75845239|FG000|Overall Study|Impossible to visit|0|||
42274251|NCT02508428|76104975|FG000|Overall Study|Liner revised|3|||
42274252|NCT02508428|76104976|FG001|Overall Study|Liner revised|19|||
42274253|NCT02508428|76104975|FG000|Overall Study|Incomplete follow-up|17|||
42274254|NCT02508428|76104976|FG001|Overall Study|Incomplete follow-up|15|||
42274255|NCT02448680|76104984|FG000|Overall Study|Physician Decision|1|||
42274256|NCT02448680|76104985|FG001|Overall Study|Physician Decision|1|||
42274257|NCT02448680|76104984|FG000|Overall Study|Withdrawal by Subject|0|||
42036857|NCT01189604|75845240|FG001|Overall Study|Impossible to visit|0|||
42036858|NCT01189604|75845241|FG002|Overall Study|Impossible to visit|0|||
42036859|NCT01189604|75845242|FG003|Overall Study|Impossible to visit|0|||
42036860|NCT01189604|75845243|FG004|Overall Study|Impossible to visit|0|||
42036861|NCT01189604|75845244|FG005|Overall Study|Impossible to visit|1|||
42036862|NCT01189604|75845245|FG006|Overall Study|Impossible to visit|0|||
42036863|NCT01189604|75845239|FG000|Overall Study|Adverse Event|0|||
42036864|NCT01189604|75845240|FG001|Overall Study|Adverse Event|1|||
42036865|NCT01189604|75845241|FG002|Overall Study|Adverse Event|0|||
42036866|NCT01189604|75845242|FG003|Overall Study|Adverse Event|0|||
42036867|NCT01189604|75845243|FG004|Overall Study|Adverse Event|2|||
42036868|NCT01189604|75845244|FG005|Overall Study|Adverse Event|0|||
42274258|NCT02448680|76104985|FG001|Overall Study|Withdrawal by Subject|2|||
42274259|NCT02448446|76104995|FG000|Overall Study|Withdrawal by Subject|1|||
42348648|NCT01594281|76187872|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
42348649|NCT01594281|76187873|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
42348650|NCT01566981|76187886|FG000|Overall Study|Lost to Follow-up|5|||
42348651|NCT01566981|76187887|FG001|Overall Study|Lost to Follow-up|8|||
42348652|NCT01870778|76187897|FG000|Overall Study|Withdrawal by Subject|8|||
42348653|NCT01870778|76187898|FG001|Overall Study|Withdrawal by Subject|7|||
42348654|NCT01870778|76187897|FG000|Overall Study|Lost to Follow-up|0|||
42348655|NCT01870778|76187898|FG001|Overall Study|Lost to Follow-up|2|||
42348656|NCT01818284|76187911|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
42348657|NCT01818284|76187912|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
42348658|NCT01818284|76187911|FG000|Overall Study|Death|0|||
42348659|NCT01818284|76187912|FG001|Overall Study|Death|2|||
42348660|NCT01610492|76187948|FG000|Overall Study|Adverse Event|1|||
42348661|NCT01610492|76187948|FG000|Overall Study|Lack of Efficacy|3|||
42348662|NCT01610492|76187948|FG000|Overall Study|Other: Reached stopping criteria|1|||
42348663|NCT01610492|76187948|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
42348664|NCT01817582|76187955|FG000|Overall Study|Withdrawal by Subject|0|||
42348665|NCT01817582|76187956|FG001|Overall Study|Withdrawal by Subject|1|||
42348666|NCT01817582|76187957|FG002|Overall Study|Withdrawal by Subject|0|||
42348667|NCT01817582|76187955|FG000|Overall Study|Participant revealed masked treatment|1|||
42348668|NCT01817582|76187956|FG001|Overall Study|Participant revealed masked treatment|0|||
42348669|NCT01817582|76187957|FG002|Overall Study|Participant revealed masked treatment|0|||
42348670|NCT01817582|76187955|FG000|Overall Study|Randomized but exclusion criteria met|1|||
42348671|NCT01817582|76187956|FG001|Overall Study|Randomized but exclusion criteria met|0|||
42010972|NCT01217073|75818109|FG004|Base Period|Physician Decision|1|||
42010973|NCT01217073|75818110|FG005|Base Period|Physician Decision|0|||
42010974|NCT01217073|75818111|FG006|Base Period|Physician Decision|0|||
42010975|NCT01217073|75818112|FG007|Base Period|Physician Decision|0|||
42010976|NCT01217073|75818105|FG000|Base Period|Protocol Violation|1|||
42010977|NCT01217073|75818106|FG001|Base Period|Protocol Violation|0|||
42010978|NCT01217073|75818107|FG002|Base Period|Protocol Violation|0|||
42010979|NCT01217073|75818108|FG003|Base Period|Protocol Violation|0|||
42010980|NCT01217073|75818109|FG004|Base Period|Protocol Violation|1|||
42010981|NCT01217073|75818110|FG005|Base Period|Protocol Violation|2|||
42010982|NCT01217073|75818111|FG006|Base Period|Protocol Violation|0|||
42348672|NCT01817582|76187957|FG002|Overall Study|Randomized but exclusion criteria met|0|||
42348673|NCT01594125|76187970|FG000|Overall Study|Withdrawal by Subject|1|||
42348674|NCT01594125|76187971|FG001|Overall Study|Withdrawal by Subject|0|||
42348675|NCT01594125|76187972|FG002|Overall Study|Withdrawal by Subject|0|||
42348676|NCT01594125|76187973|FG003|Overall Study|Withdrawal by Subject|1|||
42348677|NCT01594125|76187974|FG004|Overall Study|Withdrawal by Subject|0|||
42010983|NCT01217073|75818112|FG007|Base Period|Protocol Violation|0|||
42348678|NCT01594125|76187970|FG000|Overall Study|Progressive Disease|3|||
42348679|NCT01594125|76187971|FG001|Overall Study|Progressive Disease|12|||
42348680|NCT01594125|76187972|FG002|Overall Study|Progressive Disease|3|||
42348681|NCT01594125|76187973|FG003|Overall Study|Progressive Disease|3|||
42348682|NCT01594125|76187974|FG004|Overall Study|Progressive Disease|7|||
42348683|NCT01870076|76187990|FG000|Overall Study|Withdrawal by Subject|1|||
42348684|NCT01870076|76187991|FG001|Overall Study|Withdrawal by Subject|0|||
42348685|NCT01870076|76187992|FG002|Overall Study|Withdrawal by Subject|1|||
42348686|NCT01870076|76187993|FG003|Overall Study|Withdrawal by Subject|0|||
42348687|NCT01592721|76188003|FG000|Long-term Follow-up|Death|1|||
42348688|NCT01613378|76188007|FG000|Overall Study|Lack of Efficacy|13|||
42348689|NCT01613378|76188007|FG000|Overall Study|Adverse Event|11|||
42348690|NCT01613378|76188007|FG000|Overall Study|Withdrawal by Subject|8|||
42348691|NCT01613378|76188007|FG000|Overall Study|Death|2|||
42348692|NCT01613378|76188007|FG000|Overall Study|Lost to Follow-up|1|||
42348693|NCT01613378|76188007|FG000|Overall Study|Other Reason|4|||
42348694|NCT01592409|76188013|FG000|Overall Study|Withdrawal by Subject|0|||
42348695|NCT01592409|76188014|FG001|Overall Study|Withdrawal by Subject|1|||
42348696|NCT01697319|76188033|FG000|Primary Phase|Withdrawal by Subject|1|||
42348697|NCT01697319|76188033|FG000|Extension Phase|Terminated by Sponsor|15|||
42348698|NCT01566435|76188048|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
42348699|NCT01696929|76188056|FG000|Overall Study|Physician Decision|1|||
42348700|NCT01696773|76188066|FG000|Days 15-27, Washout|Adverse Event|1|||
42348701|NCT01696773|76188067|FG001|Days 15-27, Washout|Adverse Event|0|||
42010984|NCT01217073|75818105|FG000|Base Period|Withdrawal by Subject|4|||
42010985|NCT01217073|75818106|FG001|Base Period|Withdrawal by Subject|5|||
42010986|NCT01217073|75818107|FG002|Base Period|Withdrawal by Subject|5|||
42348702|NCT01696695|76188082|FG000|Overall Study|Disease progression|373|||
42348703|NCT01696695|76188082|FG000|Overall Study|Death|29|||
42348704|NCT01696695|76188082|FG000|Overall Study|Adverse Event|74|||
42348705|NCT01696695|76188082|FG000|Overall Study|Withdrawal by Subject|92|||
42348706|NCT01696695|76188082|FG000|Overall Study|Lost to Follow-up|48|||
42348707|NCT01696695|76188082|FG000|Overall Study|Other|74|||
42348708|NCT01696695|76188082|FG000|Overall Study|Major Protocol Violation|192|||
42348709|NCT01565889|76188114|FG000|Part A|Withdrawal by Subject|1|||
42348710|NCT01565889|76188115|FG001|Part A|Withdrawal by Subject|0|||
42348711|NCT01565889|76188116|FG002|Part A|Withdrawal by Subject|0|||
42348712|NCT01565889|76188117|FG003|Part A|Withdrawal by Subject|0|||
42348713|NCT01565889|76188118|FG004|Part A|Withdrawal by Subject|0|||
42348714|NCT01565889|76188119|FG005|Part A|Withdrawal by Subject|0|||
42348715|NCT01565889|76188114|FG000|Part B|Withdrawal by Subject|0|||
42348716|NCT01565889|76188115|FG001|Part B|Withdrawal by Subject|0|||
42348717|NCT01565889|76188116|FG002|Part B|Withdrawal by Subject|0|||
42348718|NCT01565889|76188117|FG003|Part B|Withdrawal by Subject|0|||
42348719|NCT01565889|76188118|FG004|Part B|Withdrawal by Subject|0|||
42348720|NCT01565889|76188119|FG005|Part B|Withdrawal by Subject|1|||
42348721|NCT01565889|76188114|FG000|Part B|Lack of Efficacy|0|||
42348722|NCT01565889|76188115|FG001|Part B|Lack of Efficacy|0|||
42348723|NCT01565889|76188116|FG002|Part B|Lack of Efficacy|0|||
42348724|NCT01565889|76188117|FG003|Part B|Lack of Efficacy|0|||
42348725|NCT01565889|76188118|FG004|Part B|Lack of Efficacy|0|||
42348726|NCT01565889|76188119|FG005|Part B|Lack of Efficacy|2|||
42348727|NCT01565889|76188114|FG000|Part B|Lost to Follow-up|0|||
42348728|NCT01565889|76188115|FG001|Part B|Lost to Follow-up|0|||
42348729|NCT01565889|76188116|FG002|Part B|Lost to Follow-up|0|||
42348730|NCT01565889|76188117|FG003|Part B|Lost to Follow-up|0|||
42348731|NCT01565889|76188118|FG004|Part B|Lost to Follow-up|0|||
42348732|NCT01565889|76188119|FG005|Part B|Lost to Follow-up|1|||
42010987|NCT01217073|75818108|FG003|Base Period|Withdrawal by Subject|1|||
42010988|NCT01217073|75818109|FG004|Base Period|Withdrawal by Subject|5|||
42010989|NCT01217073|75818110|FG005|Base Period|Withdrawal by Subject|5|||
42010990|NCT01217073|75818111|FG006|Base Period|Withdrawal by Subject|0|||
42348733|NCT01696071|76188134|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
42348734|NCT01696071|76188135|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
42348735|NCT01591863|76188146|FG000|Overall Study|Adverse Event|3|||
42348736|NCT01591863|76188146|FG000|Overall Study|Withdrawal by Subject|1|||
42348737|NCT01591863|76188146|FG000|Overall Study|recurrence|9|||
42348738|NCT01591863|76188146|FG000|Overall Study|Lack of Efficacy|1|||
42348739|NCT01591785|76188152|FG000|Overall Study|worsening condition|1|||
42348740|NCT01591785|76188153|FG001|Overall Study|worsening condition|2|||
42348741|NCT01591785|76188152|FG000|Overall Study|Protocol Violation|2|||
42348742|NCT01591785|76188153|FG001|Overall Study|Protocol Violation|0|||
42348743|NCT01591785|76188152|FG000|Overall Study|Lost to Follow-up|1|||
42348744|NCT01591785|76188153|FG001|Overall Study|Lost to Follow-up|0|||
42348745|NCT01695993|76188162|FG000|Overall Study|Lost to Follow-up|2|||
42348746|NCT01695993|76188163|FG001|Overall Study|Lost to Follow-up|1|||
42348747|NCT01695993|76188164|FG002|Overall Study|Lost to Follow-up|3|||
42348748|NCT01695993|76188162|FG000|Overall Study|Withdrawal by Subject|2|||
42348749|NCT01695993|76188163|FG001|Overall Study|Withdrawal by Subject|2|||
42348750|NCT01695993|76188164|FG002|Overall Study|Withdrawal by Subject|2|||
42348751|NCT01695993|76188162|FG000|Overall Study|To ill to continue|1|||
42348752|NCT01695993|76188163|FG001|Overall Study|To ill to continue|2|||
42348753|NCT01695993|76188164|FG002|Overall Study|To ill to continue|0|||
42348754|NCT01695993|76188162|FG000|Overall Study|Changed Medical Facility|0|||
42348755|NCT01695993|76188163|FG001|Overall Study|Changed Medical Facility|0|||
42348756|NCT01695993|76188164|FG002|Overall Study|Changed Medical Facility|1|||
42348757|NCT01565343|76188175|FG000|Overall Study|Administrative decision/technical issues|1|||
42348758|NCT01565343|76188176|FG001|Overall Study|Administrative decision/technical issues|0|||
42348759|NCT01565343|76188177|FG002|Overall Study|Administrative decision/technical issues|0|||
42348760|NCT01695135|76188202|FG000|Double-blind Treatment Phase|Progressive disease|50|||
42348761|NCT01695135|76188203|FG001|Double-blind Treatment Phase|Progressive disease|110|||
42348762|NCT01695135|76188204|FG002|Double-blind Treatment Phase|Progressive disease|0|||
42348763|NCT01695135|76188205|FG003|Double-blind Treatment Phase|Progressive disease|0|||
42348764|NCT01695135|76188202|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
42348765|NCT01695135|76188203|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
42348766|NCT01695135|76188204|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
42348767|NCT01695135|76188205|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
42348768|NCT01695135|76188202|FG000|Double-blind Treatment Phase|Adverse Event|7|||
42348769|NCT01695135|76188203|FG001|Double-blind Treatment Phase|Adverse Event|7|||
42348770|NCT01695135|76188204|FG002|Double-blind Treatment Phase|Adverse Event|0|||
42348771|NCT01695135|76188205|FG003|Double-blind Treatment Phase|Adverse Event|0|||
42348772|NCT01695135|76188202|FG000|Double-blind Treatment Phase|Other|1|||
42348773|NCT01695135|76188203|FG001|Double-blind Treatment Phase|Other|3|||
42348774|NCT01695135|76188204|FG002|Double-blind Treatment Phase|Other|0|||
42348775|NCT01695135|76188205|FG003|Double-blind Treatment Phase|Other|0|||
42348776|NCT01695135|76188202|FG000|Double-blind Treatment Phase|Physician Decision|6|||
42348777|NCT01695135|76188203|FG001|Double-blind Treatment Phase|Physician Decision|3|||
42348778|NCT01695135|76188204|FG002|Double-blind Treatment Phase|Physician Decision|0|||
42348779|NCT01695135|76188205|FG003|Double-blind Treatment Phase|Physician Decision|0|||
42348780|NCT01695135|76188202|FG000|Double-blind Treatment Phase|Death|1|||
42348781|NCT01695135|76188203|FG001|Double-blind Treatment Phase|Death|1|||
42348782|NCT01695135|76188204|FG002|Double-blind Treatment Phase|Death|0|||
42348783|NCT01695135|76188205|FG003|Double-blind Treatment Phase|Death|0|||
42348784|NCT01695135|76188202|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
42348785|NCT01695135|76188203|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
42348786|NCT01695135|76188204|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
42348787|NCT01695135|76188205|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
42348788|NCT01695135|76188202|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
42348789|NCT01695135|76188203|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
42348790|NCT01695135|76188204|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
42348791|NCT01695135|76188205|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
42348792|NCT01695135|76188202|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
42348793|NCT01695135|76188203|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
42348794|NCT01695135|76188204|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
42348795|NCT01695135|76188205|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
42348796|NCT01695135|76188202|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
42348797|NCT01695135|76188203|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
42348798|NCT01695135|76188204|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
42348799|NCT01695135|76188205|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
42348800|NCT01695135|76188202|FG000|Open Label Extension Treatment Phase|Other|0|||
42348801|NCT01695135|76188203|FG001|Open Label Extension Treatment Phase|Other|0|||
42348802|NCT01695135|76188204|FG002|Open Label Extension Treatment Phase|Other|4|||
42348803|NCT01695135|76188205|FG003|Open Label Extension Treatment Phase|Other|7|||
42348804|NCT01695135|76188202|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
42348805|NCT01695135|76188203|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
42348806|NCT01695135|76188204|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
42348807|NCT01695135|76188205|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
42348808|NCT01695135|76188202|FG000|Open Label Extension Treatment Phase|Death|0|||
42348809|NCT01695135|76188203|FG001|Open Label Extension Treatment Phase|Death|0|||
42348810|NCT01695135|76188204|FG002|Open Label Extension Treatment Phase|Death|2|||
42348811|NCT01695135|76188205|FG003|Open Label Extension Treatment Phase|Death|7|||
42348812|NCT01695135|76188202|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
42348813|NCT01695135|76188203|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
42348814|NCT01695135|76188204|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
42348815|NCT01695135|76188205|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
42348816|NCT01610414|76188215|FG000|Study Start - Month 13|Serious Adverse Event|65|||
42348817|NCT01610414|76188216|FG001|Study Start - Month 13|Serious Adverse Event|67|||
42348818|NCT01610414|76188215|FG000|Study Start - Month 13|Adverse Event|14|||
42348819|NCT01610414|76188216|FG001|Study Start - Month 13|Adverse Event|14|||
42348820|NCT01610414|76188215|FG000|Study Start - Month 13|Protocol Violation|3|||
42348821|NCT01610414|76188216|FG001|Study Start - Month 13|Protocol Violation|1|||
42348822|NCT01610414|76188215|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
42348823|NCT01610414|76188216|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
42348824|NCT01610414|76188215|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
42348825|NCT01610414|76188216|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
42348826|NCT01610414|76188215|FG000|Study Start - Month 13|Lost to Follow-up|4|||
42348827|NCT01610414|76188216|FG001|Study Start - Month 13|Lost to Follow-up|6|||
42348828|NCT01610414|76188215|FG000|Study Start - Month 13|Suspected HZ episode|1|||
42348829|NCT01610414|76188216|FG001|Study Start - Month 13|Suspected HZ episode|3|||
42348830|NCT01610414|76188215|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
42348831|NCT01610414|76188216|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
42348832|NCT01610414|76188215|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
42348833|NCT01610414|76188216|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
42348834|NCT01610414|76188215|FG000|Month 13 - Month 25|Adverse Event|8|||
42274260|NCT02448446|76104996|FG001|Overall Study|Withdrawal by Subject|0|||
42274261|NCT02447744|76105004|FG000|Overall Study|Withdrawal by Subject|3|||
42274262|NCT02447744|76105005|FG001|Overall Study|Withdrawal by Subject|1|||
42274263|NCT02447744|76105004|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
42274264|NCT02447744|76105005|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
42274265|NCT02478632|76105013|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
42274266|NCT02478632|76105014|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
42274267|NCT02478632|76105013|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
42274268|NCT02478632|76105014|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
42274269|NCT02478632|76105013|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
42274270|NCT02478632|76105014|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
42274271|NCT02478398|76105025|FG000|Overall Study|Adverse Event|20|||
42348835|NCT01610414|76188216|FG001|Month 13 - Month 25|Adverse Event|4|||
42274272|NCT02478398|76105026|FG001|Overall Study|Adverse Event|5|||
42274273|NCT02478398|76105025|FG000|Overall Study|Lost to Follow-up|5|||
42274274|NCT02478398|76105026|FG001|Overall Study|Lost to Follow-up|4|||
42274275|NCT02478398|76105025|FG000|Overall Study|Non-Compliance With Study Drug|5|||
42274276|NCT02478398|76105026|FG001|Overall Study|Non-Compliance With Study Drug|1|||
42274277|NCT02478398|76105025|FG000|Overall Study|Protocol Violation|3|||
42274278|NCT02478398|76105026|FG001|Overall Study|Protocol Violation|1|||
42274279|NCT02478398|76105025|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
42274280|NCT02478398|76105026|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
42274281|NCT02478398|76105025|FG000|Overall Study|Withdrawal By Participant|10|||
42274282|NCT02478398|76105026|FG001|Overall Study|Withdrawal By Participant|4|||
42274283|NCT02478164|76105033|FG000|Overall Study|Lack of Efficacy|13|||
42274284|NCT02478164|76105033|FG000|Overall Study|Adverse Event|1|||
42274285|NCT02478164|76105033|FG000|Overall Study|Withdrawal by Subject|1|||
42274286|NCT02476994|76105039|FG000|Overall Study|Based on feedback from FDA|1|||
42274287|NCT02476994|76105040|FG001|Overall Study|Based on feedback from FDA|0|||
42274288|NCT02508194|76105048|FG000|Overall Study|Death|5|||
42274289|NCT02508194|76105049|FG001|Overall Study|Death|3|||
42348836|NCT01610414|76188215|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
42348837|NCT01610414|76188216|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
42348838|NCT01610414|76188215|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
42348839|NCT01610414|76188216|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
42348840|NCT01610414|76188215|FG000|Month 13 - Month 25|Protocol Violation|0|||
42348841|NCT01610414|76188216|FG001|Month 13 - Month 25|Protocol Violation|2|||
42348842|NCT01610414|76188215|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
42348843|NCT01610414|76188216|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
42348844|NCT01610414|76188215|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
42348845|NCT01610414|76188216|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
42348846|NCT01610414|76188215|FG000|After Month 25|Study end not reached|48|||
42274290|NCT02508194|76105048|FG000|Overall Study|Lost to Follow-up|25|||
42274291|NCT02508194|76105049|FG001|Overall Study|Lost to Follow-up|18|||
42274292|NCT02508194|76105048|FG000|Overall Study|Withdrawal by Subject|20|||
42274293|NCT02508194|76105049|FG001|Overall Study|Withdrawal by Subject|18|||
42348847|NCT01610414|76188216|FG001|After Month 25|Study end not reached|53|||
42348848|NCT01564407|76188252|FG000|Overall Study|Lost to Follow-up|0|||
42348849|NCT01564407|76188253|FG001|Overall Study|Lost to Follow-up|1|||
42348850|NCT01564407|76188254|FG002|Overall Study|Lost to Follow-up|0|||
42348851|NCT01564407|76188255|FG003|Overall Study|Lost to Follow-up|0|||
42348852|NCT01564407|76188256|FG004|Overall Study|Lost to Follow-up|0|||
42348853|NCT01564407|76188252|FG000|Overall Study|Withdrawal by Subject|0|||
42348854|NCT01564407|76188253|FG001|Overall Study|Withdrawal by Subject|1|||
42348855|NCT01564407|76188254|FG002|Overall Study|Withdrawal by Subject|0|||
42348856|NCT01564407|76188255|FG003|Overall Study|Withdrawal by Subject|0|||
42348857|NCT01564407|76188256|FG004|Overall Study|Withdrawal by Subject|0|||
42348858|NCT01564407|76188252|FG000|Overall Study|funding lost, study ended|0|||
42348859|NCT01564407|76188253|FG001|Overall Study|funding lost, study ended|0|||
42348860|NCT01564407|76188254|FG002|Overall Study|funding lost, study ended|0|||
42348861|NCT01564407|76188255|FG003|Overall Study|funding lost, study ended|1|||
42348862|NCT01564407|76188256|FG004|Overall Study|funding lost, study ended|0|||
42348863|NCT01590771|76188279|FG000|Overall Study|Other Protocol Specified Criteria|5|||
42348864|NCT01590771|76188280|FG001|Overall Study|Other Protocol Specified Criteria|14|||
42348865|NCT01590771|76188279|FG000|Overall Study|Withdrawal by Subject|8|||
42348866|NCT01590771|76188280|FG001|Overall Study|Withdrawal by Subject|15|||
42348867|NCT01590771|76188279|FG000|Overall Study|Protocol Violation|1|||
42348868|NCT01590771|76188280|FG001|Overall Study|Protocol Violation|2|||
42348869|NCT01590771|76188279|FG000|Overall Study|Lost to Follow-up|1|||
42348870|NCT01590771|76188280|FG001|Overall Study|Lost to Follow-up|1|||
42348871|NCT01590771|76188279|FG000|Overall Study|Lack of Efficacy|1|||
42348872|NCT01590771|76188280|FG001|Overall Study|Lack of Efficacy|0|||
42348873|NCT01590771|76188279|FG000|Overall Study|Adverse Event|3|||
42348874|NCT01590771|76188280|FG001|Overall Study|Adverse Event|7|||
42036869|NCT01189604|75845245|FG006|Overall Study|Adverse Event|1|||
42036870|NCT01189604|75845239|FG000|Overall Study|Withdrawal by Subject|1|||
42036871|NCT01189604|75845240|FG001|Overall Study|Withdrawal by Subject|0|||
42036872|NCT01189604|75845241|FG002|Overall Study|Withdrawal by Subject|0|||
42036873|NCT01189604|75845242|FG003|Overall Study|Withdrawal by Subject|0|||
42036874|NCT01189604|75845243|FG004|Overall Study|Withdrawal by Subject|0|||
42036875|NCT01189604|75845244|FG005|Overall Study|Withdrawal by Subject|0|||
42036876|NCT01189604|75845245|FG006|Overall Study|Withdrawal by Subject|0|||
42036877|NCT01008696|75845263|FG000|Overall Study|Participant's evasion of hospital visit|5|||
42036878|NCT01008696|75845264|FG001|Overall Study|Participant's evasion of hospital visit|4|||
42036879|NCT01008696|75845263|FG000|Overall Study|Withdrawal by Subject|2|||
42036880|NCT01008696|75845264|FG001|Overall Study|Withdrawal by Subject|4|||
42036881|NCT01008696|75845263|FG000|Overall Study|Physician Decision|5|||
42036882|NCT01008696|75845264|FG001|Overall Study|Physician Decision|1|||
42036883|NCT01008696|75845263|FG000|Overall Study|Adverse Event|1|||
42036884|NCT01008696|75845264|FG001|Overall Study|Adverse Event|0|||
42036885|NCT01008696|75845263|FG000|Overall Study|Participants' non-cooperation|2|||
42036886|NCT01008696|75845264|FG001|Overall Study|Participants' non-cooperation|3|||
42036887|NCT01008696|75845263|FG000|Overall Study|Other|2|||
42138686|NCT00529451|75948854|FG003|Overall Study|Administrative problems|2|||
42138687|NCT03876743|75948871|FG000|Overall Study|Lost to Follow-up|6|||
42348875|NCT01563237|76188286|FG000|Overall Study|Lost to Follow-up|6|||
42348876|NCT01563237|76188287|FG001|Overall Study|Lost to Follow-up|0|||
42348877|NCT01563237|76188286|FG000|Overall Study|Withdrawal by Subject|1|||
42348878|NCT01563237|76188287|FG001|Overall Study|Withdrawal by Subject|0|||
42348879|NCT01563237|76188286|FG000|Overall Study|Adverse Event|1|||
42348880|NCT01563237|76188287|FG001|Overall Study|Adverse Event|0|||
42036888|NCT01008696|75845264|FG001|Overall Study|Other|3|||
42036889|NCT01008696|75845263|FG000|Overall Study|Other|0|||
42036890|NCT01008696|75845264|FG001|Overall Study|Other|2|||
42138688|NCT03876743|75948872|FG001|Overall Study|Lost to Follow-up|4|||
42036891|NCT01176968|75845283|FG000|Overall Study|Adverse Event|10|||
42274294|NCT02508194|76105048|FG000|Overall Study|Error in Randomization|1|||
42274295|NCT02508194|76105049|FG001|Overall Study|Error in Randomization|3|||
42274296|NCT02508194|76105048|FG000|Overall Study|Principal Investigator Decision|1|||
42274297|NCT02508194|76105049|FG001|Overall Study|Principal Investigator Decision|2|||
42274298|NCT02508116|76105057|FG000|Overall Study|Lost to Follow-up|2|||
42274299|NCT02508116|76105058|FG001|Overall Study|Lost to Follow-up|3|||
42274300|NCT02508116|76105057|FG000|Overall Study|Withdrawal by Subject|3|||
42274301|NCT02508116|76105058|FG001|Overall Study|Withdrawal by Subject|2|||
42274302|NCT02508116|76105057|FG000|Overall Study|Protocol Violation|1|||
42274303|NCT02508116|76105058|FG001|Overall Study|Protocol Violation|2|||
42274304|NCT02508116|76105057|FG000|Overall Study|Physician Decision|2|||
42274305|NCT02508116|76105058|FG001|Overall Study|Physician Decision|0|||
42348881|NCT01563237|76188286|FG000|Overall Study|Medical Reasons|1|||
42348882|NCT01563237|76188287|FG001|Overall Study|Medical Reasons|0|||
42348883|NCT01563237|76188286|FG000|Overall Study|Death|1|||
42348884|NCT01563237|76188287|FG001|Overall Study|Death|0|||
42348885|NCT01694433|76188303|FG000|Overall Study|Adverse Event|7|||
42348886|NCT01694433|76188304|FG001|Overall Study|Adverse Event|0|||
42348887|NCT01694433|76188303|FG000|Overall Study|Physician Decision|1|||
42348888|NCT01694433|76188304|FG001|Overall Study|Physician Decision|0|||
42348889|NCT01694433|76188303|FG000|Overall Study|Withdrawal by Subject|3|||
42348890|NCT01694433|76188304|FG001|Overall Study|Withdrawal by Subject|4|||
42348891|NCT01694121|76188312|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
42348892|NCT01694121|76188313|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
42348893|NCT01562613|76188319|FG000|Overall Study|Lost to Follow-up|2|||
42348894|NCT01562613|76188319|FG000|Overall Study|Withdrawal by Subject|2|||
42348895|NCT01693185|76188325|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
42348896|NCT01693185|76188326|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
42348897|NCT01693029|76188366|FG000|Overall Study|Withdrawal by Subject|15|||
42348898|NCT01693029|76188367|FG001|Overall Study|Withdrawal by Subject|22|||
42348899|NCT01693029|76188366|FG000|Overall Study|Kidney transplantation|7|||
42348900|NCT01693029|76188367|FG001|Overall Study|Kidney transplantation|7|||
42348901|NCT01693029|76188366|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
42348902|NCT01693029|76188367|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
42348903|NCT01693029|76188366|FG000|Overall Study|Protocol Violation|6|||
42348904|NCT01693029|76188367|FG001|Overall Study|Protocol Violation|7|||
42348905|NCT01693029|76188366|FG000|Overall Study|Change in dialysis modality|2|||
42348906|NCT01693029|76188367|FG001|Overall Study|Change in dialysis modality|1|||
42348907|NCT01693029|76188366|FG000|Overall Study|Physician Decision|0|||
42348908|NCT01693029|76188367|FG001|Overall Study|Physician Decision|2|||
42348909|NCT01693029|76188366|FG000|Overall Study|Lost to Follow-up|0|||
42348910|NCT01693029|76188367|FG001|Overall Study|Lost to Follow-up|1|||
42348911|NCT01693029|76188366|FG000|Overall Study|Adverse Event|1|||
42348912|NCT01693029|76188367|FG001|Overall Study|Adverse Event|6|||
42348913|NCT01693029|76188366|FG000|Overall Study|Death|5|||
42348914|NCT01693029|76188367|FG001|Overall Study|Death|8|||
42348915|NCT01693029|76188366|FG000|Overall Study|Non-compliance|2|||
42010991|NCT01217073|75818112|FG007|Base Period|Withdrawal by Subject|0|||
42010992|NCT01217073|75818105|FG000|Extension Period|Adverse Event|0|||
42348916|NCT01693029|76188367|FG001|Overall Study|Non-compliance|1|||
42348917|NCT01589445|76188373|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
42348918|NCT01589445|76188373|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
42348919|NCT01589445|76188373|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
42348920|NCT01589445|76188373|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
42348921|NCT01589445|76188373|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
42348922|NCT01589445|76188373|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
42348923|NCT01589445|76188373|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
42348924|NCT01589445|76188373|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
42348925|NCT01589445|76188373|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
42348926|NCT01589445|76188373|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
42348927|NCT01588509|76188383|FG000|Overall Study|Lost to Follow-up|1|||
42348928|NCT01588509|76188384|FG001|Overall Study|Lost to Follow-up|0|||
42138689|NCT03876743|75948873|FG002|Overall Study|Lost to Follow-up|4|||
42138690|NCT03876743|75948874|FG003|Overall Study|Lost to Follow-up|7|||
42138691|NCT00486278|75948888|FG000|Overall Study|Adverse Event|5|||
42010993|NCT01217073|75818106|FG001|Extension Period|Adverse Event|0|||
42010994|NCT01217073|75818107|FG002|Extension Period|Adverse Event|0|||
42010995|NCT01217073|75818108|FG003|Extension Period|Adverse Event|0|||
42010996|NCT01217073|75818109|FG004|Extension Period|Adverse Event|0|||
42010997|NCT01217073|75818110|FG005|Extension Period|Adverse Event|0|||
42010998|NCT01217073|75818111|FG006|Extension Period|Adverse Event|19|||
42010999|NCT01217073|75818112|FG007|Extension Period|Adverse Event|5|||
42011000|NCT01217073|75818105|FG000|Extension Period|ALT/AST|0|||
42011001|NCT01217073|75818106|FG001|Extension Period|ALT/AST|0|||
42011002|NCT01217073|75818107|FG002|Extension Period|ALT/AST|0|||
42011003|NCT01217073|75818108|FG003|Extension Period|ALT/AST|0|||
42011004|NCT01217073|75818109|FG004|Extension Period|ALT/AST|0|||
42348929|NCT01588353|76188393|FG000|Step2|Withdrawal by Subject|0|||
42348930|NCT01588353|76188394|FG001|Step2|Withdrawal by Subject|1|||
42348931|NCT01588353|76188395|FG002|Step2|Withdrawal by Subject|0|||
42348932|NCT01588353|76188393|FG000|Step3|Adverse Event|0|||
42011005|NCT01217073|75818110|FG005|Extension Period|ALT/AST|0|||
42011006|NCT01217073|75818111|FG006|Extension Period|ALT/AST|2|||
42011007|NCT01217073|75818112|FG007|Extension Period|ALT/AST|0|||
42011008|NCT01217073|75818105|FG000|Extension Period|Contraindication to study medication|0|||
42011009|NCT01217073|75818106|FG001|Extension Period|Contraindication to study medication|0|||
42348933|NCT01588353|76188394|FG001|Step3|Adverse Event|0|||
42348934|NCT01588353|76188395|FG002|Step3|Adverse Event|2|||
42011010|NCT01217073|75818107|FG002|Extension Period|Contraindication to study medication|0|||
42011011|NCT01217073|75818108|FG003|Extension Period|Contraindication to study medication|0|||
42011012|NCT01217073|75818109|FG004|Extension Period|Contraindication to study medication|0|||
42011013|NCT01217073|75818110|FG005|Extension Period|Contraindication to study medication|0|||
42011014|NCT01217073|75818111|FG006|Extension Period|Contraindication to study medication|1|||
42011015|NCT01217073|75818112|FG007|Extension Period|Contraindication to study medication|0|||
42011016|NCT01217073|75818105|FG000|Extension Period|Creatinine/eGFR|0|||
42011017|NCT01217073|75818106|FG001|Extension Period|Creatinine/eGFR|0|||
42011018|NCT01217073|75818107|FG002|Extension Period|Creatinine/eGFR|0|||
42011019|NCT01217073|75818108|FG003|Extension Period|Creatinine/eGFR|0|||
42348935|NCT01588197|76188404|FG000|Overall Study|Lack of Efficacy|0|||
42348936|NCT01588197|76188405|FG001|Overall Study|Lack of Efficacy|1|||
42348937|NCT01588197|76188404|FG000|Overall Study|No MRI|1|||
42348938|NCT01588197|76188405|FG001|Overall Study|No MRI|0|||
42348939|NCT01561989|76188413|FG000|Overall Study|accural target not met.|5|||
42348940|NCT01561989|76188414|FG001|Overall Study|accural target not met.|6|||
42348941|NCT01587885|76188429|FG000|Treatment Period 1|Failure to Return|0|||
42011020|NCT01217073|75818109|FG004|Extension Period|Creatinine/eGFR|0|||
42348942|NCT01587885|76188430|FG001|Treatment Period 1|Failure to Return|1|||
42348943|NCT01587885|76188429|FG000|Treatment Period 1|Protocol Violation|0|||
42011021|NCT01217073|75818110|FG005|Extension Period|Creatinine/eGFR|0|||
42011022|NCT01217073|75818111|FG006|Extension Period|Creatinine/eGFR|11|||
42011023|NCT01217073|75818112|FG007|Extension Period|Creatinine/eGFR|1|||
42011024|NCT01217073|75818105|FG000|Extension Period|Death|0|||
42011025|NCT01217073|75818106|FG001|Extension Period|Death|0|||
42011026|NCT01217073|75818107|FG002|Extension Period|Death|0|||
42011027|NCT01217073|75818108|FG003|Extension Period|Death|0|||
42011028|NCT01217073|75818109|FG004|Extension Period|Death|0|||
42011029|NCT01217073|75818110|FG005|Extension Period|Death|0|||
42011030|NCT01217073|75818111|FG006|Extension Period|Death|1|||
42011031|NCT01217073|75818112|FG007|Extension Period|Death|0|||
42011032|NCT01217073|75818105|FG000|Extension Period|Excluded medication|0|||
42011033|NCT01217073|75818106|FG001|Extension Period|Excluded medication|0|||
42011034|NCT01217073|75818107|FG002|Extension Period|Excluded medication|0|||
42011035|NCT01217073|75818108|FG003|Extension Period|Excluded medication|0|||
42011036|NCT01217073|75818109|FG004|Extension Period|Excluded medication|0|||
42011037|NCT01217073|75818110|FG005|Extension Period|Excluded medication|0|||
42011038|NCT01217073|75818111|FG006|Extension Period|Excluded medication|2|||
42011039|NCT01217073|75818112|FG007|Extension Period|Excluded medication|0|||
42011040|NCT01217073|75818105|FG000|Extension Period|Lack of Efficacy|0|||
42011041|NCT01217073|75818106|FG001|Extension Period|Lack of Efficacy|0|||
42011042|NCT01217073|75818107|FG002|Extension Period|Lack of Efficacy|0|||
42011043|NCT01217073|75818108|FG003|Extension Period|Lack of Efficacy|0|||
42036892|NCT01176968|75845284|FG001|Overall Study|Adverse Event|11|||
42036893|NCT01176968|75845283|FG000|Overall Study|Death|2|||
42036894|NCT01176968|75845284|FG001|Overall Study|Death|3|||
42036895|NCT01176968|75845283|FG000|Overall Study|Lack of Efficacy|0|||
42036896|NCT01176968|75845284|FG001|Overall Study|Lack of Efficacy|1|||
42036897|NCT01176968|75845283|FG000|Overall Study|Lost to Follow-up|16|||
42036898|NCT01176968|75845284|FG001|Overall Study|Lost to Follow-up|14|||
42036899|NCT01176968|75845283|FG000|Overall Study|Withdrawal by Subject|48|||
42036900|NCT01176968|75845284|FG001|Overall Study|Withdrawal by Subject|48|||
42036901|NCT01176968|75845283|FG000|Overall Study|Protocol Violation|2|||
42138692|NCT00486278|75948888|FG000|Overall Study|Withdrawal by Subject|2|||
42138693|NCT00486278|75948888|FG000|Overall Study|Physician Decision|2|||
42274306|NCT01653782|76105067|FG000|Overall Study|Withdrawal by Subject|9|||
42274307|NCT01653782|76105068|FG001|Overall Study|Withdrawal by Subject|15|||
42274308|NCT01653782|76105069|FG002|Overall Study|Withdrawal by Subject|4|||
42274309|NCT01653782|76105067|FG000|Overall Study|Lost to Follow-up|7|||
42274310|NCT01653782|76105068|FG001|Overall Study|Lost to Follow-up|3|||
42274311|NCT01653782|76105069|FG002|Overall Study|Lost to Follow-up|2|||
42348944|NCT01587885|76188430|FG001|Treatment Period 1|Protocol Violation|2|||
42274312|NCT02318329|76105087|FG000|Overall Study|Progressive Disease|2|||
42348945|NCT01587651|76188440|FG000|Overall Study|Adverse Event|0|||
42348946|NCT01587651|76188441|FG001|Overall Study|Adverse Event|1|||
42348947|NCT01587651|76188442|FG002|Overall Study|Adverse Event|0|||
42348948|NCT01587651|76188440|FG000|Overall Study|Protocol Violation|0|||
42348949|NCT01587651|76188441|FG001|Overall Study|Protocol Violation|1|||
42348950|NCT01587651|76188442|FG002|Overall Study|Protocol Violation|1|||
42348951|NCT01587651|76188440|FG000|Overall Study|Withdrawal by Subject|0|||
42348952|NCT01587651|76188441|FG001|Overall Study|Withdrawal by Subject|1|||
42348953|NCT01587651|76188442|FG002|Overall Study|Withdrawal by Subject|0|||
42348954|NCT01691859|76188464|FG000|Overall Study|Adverse Event|19|||
42348955|NCT01691859|76188464|FG000|Overall Study|Lack of Efficacy|11|||
42348956|NCT01691859|76188464|FG000|Overall Study|Protocol Violation|4|||
42348957|NCT01691859|76188464|FG000|Overall Study|Product commercially available|221|||
42348958|NCT01691859|76188464|FG000|Overall Study|Study closed/terminated|50|||
42348959|NCT01691859|76188464|FG000|Overall Study|Lost to Follow-up|5|||
42036902|NCT01176968|75845284|FG001|Overall Study|Protocol Violation|1|||
42036903|NCT01176968|75845283|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
42036904|NCT01176968|75845284|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
42036905|NCT01176968|75845283|FG000|Overall Study|Study terminated by sponsor|0|||
42036906|NCT01176968|75845284|FG001|Overall Study|Study terminated by sponsor|1|||
42036907|NCT01176968|75845283|FG000|Overall Study|Reason not defined|5|||
42036908|NCT01176968|75845284|FG001|Overall Study|Reason not defined|3|||
42036909|NCT01006122|75845295|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
42036910|NCT01006122|75845296|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
42036911|NCT01006122|75845295|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
42036912|NCT01006122|75845296|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
42036913|NCT01006122|75845295|FG000|First Double-blind Intervention Period|Pregnancy|0|||
42036914|NCT01006122|75845296|FG001|First Double-blind Intervention Period|Pregnancy|1|||
42036915|NCT01006122|75845295|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
42036916|NCT01006122|75845296|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
42036917|NCT01006122|75845295|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
42036918|NCT01006122|75845296|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
42036919|NCT01006122|75845295|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
42036920|NCT01006122|75845296|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
42036921|NCT01006122|75845295|FG000|First Double-blind Intervention Period|Other|3|||
42036922|NCT01006122|75845296|FG001|First Double-blind Intervention Period|Other|0|||
42036923|NCT01006122|75845295|FG000|First Double-blind Intervention Period|Adverse Event|0|||
42036924|NCT01006122|75845296|FG001|First Double-blind Intervention Period|Adverse Event|4|||
42036925|NCT01006122|75845295|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
42036926|NCT01006122|75845296|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
42036927|NCT01006122|75845295|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
42036928|NCT01006122|75845296|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
42036929|NCT01006122|75845295|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
42036930|NCT01006122|75845296|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
42036931|NCT01006122|75845295|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
42036932|NCT01006122|75845296|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
42036933|NCT01006122|75845295|FG000|Second Double-blind Intervention Period|Death|0|||
42036934|NCT01006122|75845296|FG001|Second Double-blind Intervention Period|Death|1|||
42036935|NCT01005966|75845302|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
42036936|NCT01005966|75845303|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
42036937|NCT01005966|75845304|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
42036938|NCT01005966|75845305|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
42036939|NCT01005966|75845306|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
42036940|NCT01005966|75845302|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
42036941|NCT01005966|75845303|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
42036942|NCT01005966|75845304|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
42036943|NCT01005966|75845305|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
42036944|NCT01005966|75845306|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
42036945|NCT01005966|75845302|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
42036946|NCT01005966|75845303|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
42036947|NCT01005966|75845304|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
42036948|NCT01005966|75845305|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
42036949|NCT01005966|75845306|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
42036950|NCT01005966|75845302|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
42036951|NCT01005966|75845303|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
42036952|NCT01005966|75845304|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
42036953|NCT01005966|75845305|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
42036954|NCT01005966|75845306|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
42036955|NCT01005966|75845302|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
42036956|NCT01005966|75845303|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
42036957|NCT01005966|75845304|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
42036958|NCT01005966|75845305|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
42036959|NCT01005966|75845306|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
42036960|NCT01005966|75845302|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
42036961|NCT01005966|75845303|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
42036962|NCT01005966|75845304|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
42036963|NCT01005966|75845305|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
42036964|NCT01005966|75845306|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
42036965|NCT01005966|75845302|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
42036966|NCT01005966|75845303|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
42036967|NCT01005966|75845304|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
42036968|NCT01005966|75845305|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
42274313|NCT02318329|76105088|FG001|Overall Study|Progressive Disease|3|||
42274314|NCT02318329|76105089|FG002|Overall Study|Progressive Disease|2|||
42274315|NCT02318329|76105090|FG003|Overall Study|Progressive Disease|3|||
42274316|NCT02318329|76105091|FG004|Overall Study|Progressive Disease|3|||
42274317|NCT02318329|76105092|FG005|Overall Study|Progressive Disease|3|||
42274318|NCT02318329|76105093|FG006|Overall Study|Progressive Disease|1|||
42274319|NCT02318329|76105094|FG007|Overall Study|Progressive Disease|1|||
42274320|NCT02318329|76105095|FG008|Overall Study|Progressive Disease|5|||
42274321|NCT02318329|76105096|FG009|Overall Study|Progressive Disease|39|||
42274322|NCT02318329|76105087|FG000|Overall Study|Death|0|||
42274323|NCT02318329|76105088|FG001|Overall Study|Death|0|||
42274324|NCT02318329|76105089|FG002|Overall Study|Death|0|||
42274325|NCT02318329|76105090|FG003|Overall Study|Death|0|||
42274326|NCT02318329|76105091|FG004|Overall Study|Death|0|||
42138694|NCT00321711|75948907|FG000|Part A|Adverse Event|3|||
42138695|NCT00321711|75948908|FG001|Part A|Adverse Event|3|||
42138696|NCT00321711|75948909|FG002|Part A|Adverse Event|2|||
42138697|NCT00321711|75948910|FG003|Part A|Adverse Event|0|||
42138698|NCT00321711|75948911|FG004|Part A|Adverse Event|0|||
42138699|NCT00321711|75948907|FG000|Part A|Withdrawal by Subject|1|||
42138700|NCT00321711|75948908|FG001|Part A|Withdrawal by Subject|1|||
42138701|NCT00321711|75948909|FG002|Part A|Withdrawal by Subject|1|||
42274327|NCT02318329|76105092|FG005|Overall Study|Death|0|||
42274328|NCT02318329|76105093|FG006|Overall Study|Death|0|||
42274329|NCT02318329|76105094|FG007|Overall Study|Death|0|||
42274330|NCT02318329|76105095|FG008|Overall Study|Death|0|||
42274331|NCT02318329|76105096|FG009|Overall Study|Death|5|||
42274332|NCT02318329|76105087|FG000|Overall Study|Lost to Follow-up|0|||
42274333|NCT02318329|76105088|FG001|Overall Study|Lost to Follow-up|0|||
42274334|NCT02318329|76105089|FG002|Overall Study|Lost to Follow-up|0|||
42274335|NCT02318329|76105090|FG003|Overall Study|Lost to Follow-up|0|||
42274336|NCT02318329|76105091|FG004|Overall Study|Lost to Follow-up|0|||
42274337|NCT02318329|76105092|FG005|Overall Study|Lost to Follow-up|0|||
42274338|NCT02318329|76105093|FG006|Overall Study|Lost to Follow-up|0|||
42274339|NCT02318329|76105094|FG007|Overall Study|Lost to Follow-up|0|||
42274340|NCT02318329|76105095|FG008|Overall Study|Lost to Follow-up|0|||
42274341|NCT02318329|76105096|FG009|Overall Study|Lost to Follow-up|1|||
42274342|NCT02318329|76105087|FG000|Overall Study|Withdrawal by Subject|0|||
42274343|NCT02318329|76105088|FG001|Overall Study|Withdrawal by Subject|0|||
42274344|NCT02318329|76105089|FG002|Overall Study|Withdrawal by Subject|0|||
42138702|NCT00321711|75948910|FG003|Part A|Withdrawal by Subject|0|||
42138703|NCT00321711|75948911|FG004|Part A|Withdrawal by Subject|0|||
42274345|NCT02318329|76105090|FG003|Overall Study|Withdrawal by Subject|0|||
42274346|NCT02318329|76105091|FG004|Overall Study|Withdrawal by Subject|0|||
42274347|NCT02318329|76105092|FG005|Overall Study|Withdrawal by Subject|0|||
42274348|NCT02318329|76105093|FG006|Overall Study|Withdrawal by Subject|0|||
42274349|NCT02318329|76105094|FG007|Overall Study|Withdrawal by Subject|0|||
42138704|NCT00321711|75948907|FG000|Part A|Disease progression|0|||
42138705|NCT00321711|75948908|FG001|Part A|Disease progression|1|||
42274350|NCT02318329|76105095|FG008|Overall Study|Withdrawal by Subject|0|||
42274351|NCT02318329|76105096|FG009|Overall Study|Withdrawal by Subject|6|||
42274352|NCT02318329|76105087|FG000|Overall Study|Other|1|||
42274353|NCT02318329|76105088|FG001|Overall Study|Other|1|||
42274354|NCT02318329|76105089|FG002|Overall Study|Other|1|||
42274355|NCT02318329|76105090|FG003|Overall Study|Other|0|||
42274356|NCT02318329|76105091|FG004|Overall Study|Other|0|||
42274357|NCT02318329|76105092|FG005|Overall Study|Other|0|||
42274358|NCT02318329|76105093|FG006|Overall Study|Other|0|||
42274359|NCT02318329|76105094|FG007|Overall Study|Other|0|||
42274360|NCT02318329|76105095|FG008|Overall Study|Other|1|||
42138706|NCT00321711|75948909|FG002|Part A|Disease progression|0|||
42138707|NCT00321711|75948910|FG003|Part A|Disease progression|0|||
42138708|NCT00321711|75948911|FG004|Part A|Disease progression|0|||
42138709|NCT00321711|75948907|FG000|Part A|Requirement for alternative therapy|0|||
42138710|NCT00321711|75948908|FG001|Part A|Requirement for alternative therapy|2|||
42138711|NCT00321711|75948909|FG002|Part A|Requirement for alternative therapy|1|||
42138712|NCT00321711|75948910|FG003|Part A|Requirement for alternative therapy|0|||
42138713|NCT00321711|75948911|FG004|Part A|Requirement for alternative therapy|0|||
42138714|NCT00321711|75948907|FG000|Part A|Physician Decision|0|||
42138715|NCT00321711|75948908|FG001|Part A|Physician Decision|1|||
42138716|NCT00321711|75948909|FG002|Part A|Physician Decision|3|||
42138717|NCT00321711|75948910|FG003|Part A|Physician Decision|0|||
42274361|NCT02318329|76105096|FG009|Overall Study|Other|1|||
42274362|NCT02255656|76105137|FG000|Overall Study|Adverse Event|11|||
42274363|NCT02255656|76105137|FG000|Overall Study|Poor compliance to protocol|3|||
42011044|NCT01217073|75818109|FG004|Extension Period|Lack of Efficacy|0|||
42011045|NCT01217073|75818110|FG005|Extension Period|Lack of Efficacy|0|||
42036969|NCT01005966|75845306|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
42036970|NCT01005966|75845302|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
42036971|NCT01005966|75845303|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
42036972|NCT01005966|75845304|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
42036973|NCT01005966|75845305|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
42036974|NCT01005966|75845306|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
42036975|NCT01005966|75845302|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
42036976|NCT01005966|75845303|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
42036977|NCT01005966|75845304|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
42036978|NCT01005966|75845305|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
42036979|NCT01005966|75845306|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
42036980|NCT01005732|75845332|FG000|Overall Study|Lost to Follow-up|10|||
42036981|NCT01005732|75845332|FG000|Overall Study|Death|1|||
42036982|NCT00603382|75845346|FG000|Overall Study|Adverse Event|0|||
42036983|NCT00603382|75845347|FG001|Overall Study|Adverse Event|1|||
42036984|NCT00603382|75845348|FG002|Overall Study|Adverse Event|1|||
42036985|NCT00603382|75845349|FG003|Overall Study|Adverse Event|2|||
42036986|NCT00603382|75845350|FG004|Overall Study|Adverse Event|1|||
42036987|NCT00603382|75845351|FG005|Overall Study|Adverse Event|2|||
42036988|NCT00603382|75845346|FG000|Overall Study|Lack of Efficacy|14|||
42036989|NCT00603382|75845347|FG001|Overall Study|Lack of Efficacy|9|||
42274364|NCT02255656|76105137|FG000|Overall Study|Lost to Follow-up|30|||
42274365|NCT02255656|76105137|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
42274366|NCT02255656|76105137|FG000|Overall Study|Other|126|||
42274367|NCT02255500|76105150|FG000|Overall Study|Withdrawal by Subject|1|||
42274368|NCT02255500|76105151|FG001|Overall Study|Withdrawal by Subject|0|||
42011046|NCT01217073|75818111|FG006|Extension Period|Lack of Efficacy|3|||
42011047|NCT01217073|75818112|FG007|Extension Period|Lack of Efficacy|0|||
42011048|NCT01217073|75818105|FG000|Extension Period|Lost to Follow-up|0|||
42011049|NCT01217073|75818106|FG001|Extension Period|Lost to Follow-up|0|||
42011050|NCT01217073|75818107|FG002|Extension Period|Lost to Follow-up|0|||
42011051|NCT01217073|75818108|FG003|Extension Period|Lost to Follow-up|0|||
42036990|NCT00603382|75845348|FG002|Overall Study|Lack of Efficacy|3|||
42036991|NCT00603382|75845349|FG003|Overall Study|Lack of Efficacy|6|||
42036992|NCT00603382|75845350|FG004|Overall Study|Lack of Efficacy|6|||
42036993|NCT00603382|75845351|FG005|Overall Study|Lack of Efficacy|11|||
42036994|NCT00603382|75845346|FG000|Overall Study|Protocol Violation|1|||
42036995|NCT00603382|75845347|FG001|Overall Study|Protocol Violation|0|||
42036996|NCT00603382|75845348|FG002|Overall Study|Protocol Violation|1|||
42036997|NCT00603382|75845349|FG003|Overall Study|Protocol Violation|2|||
42036998|NCT00603382|75845350|FG004|Overall Study|Protocol Violation|1|||
42274369|NCT02505542|76105157|FG000|Part A: Open-Label Period|Adverse Event|31|||
42274370|NCT02505542|76105158|FG001|Part A: Open-Label Period|Adverse Event|0|||
42274371|NCT02505542|76105159|FG002|Part A: Open-Label Period|Adverse Event|0|||
42274372|NCT02505542|76105160|FG003|Part A: Open-Label Period|Adverse Event|0|||
42274373|NCT02505542|76105157|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
42274374|NCT02505542|76105158|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
42274375|NCT02505542|76105159|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
42274376|NCT02505542|76105160|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
42011052|NCT01217073|75818109|FG004|Extension Period|Lost to Follow-up|0|||
42011053|NCT01217073|75818110|FG005|Extension Period|Lost to Follow-up|0|||
42011054|NCT01217073|75818111|FG006|Extension Period|Lost to Follow-up|9|||
42011055|NCT01217073|75818112|FG007|Extension Period|Lost to Follow-up|1|||
42011056|NCT01217073|75818105|FG000|Extension Period|Non-compliance with study drug|0|||
42011057|NCT01217073|75818106|FG001|Extension Period|Non-compliance with study drug|0|||
42011058|NCT01217073|75818107|FG002|Extension Period|Non-compliance with study drug|0|||
42011059|NCT01217073|75818108|FG003|Extension Period|Non-compliance with study drug|0|||
42011060|NCT01217073|75818109|FG004|Extension Period|Non-compliance with study drug|0|||
42011061|NCT01217073|75818110|FG005|Extension Period|Non-compliance with study drug|0|||
42011062|NCT01217073|75818111|FG006|Extension Period|Non-compliance with study drug|0|||
42011063|NCT01217073|75818112|FG007|Extension Period|Non-compliance with study drug|1|||
42011064|NCT01217073|75818105|FG000|Extension Period|Physician Decision|0|||
42011065|NCT01217073|75818106|FG001|Extension Period|Physician Decision|0|||
42274377|NCT02505542|76105157|FG000|Part A: Open-Label Period|Protocol Violation|1|||
42274378|NCT02505542|76105158|FG001|Part A: Open-Label Period|Protocol Violation|0|||
42274379|NCT02505542|76105159|FG002|Part A: Open-Label Period|Protocol Violation|0|||
42274380|NCT02505542|76105160|FG003|Part A: Open-Label Period|Protocol Violation|0|||
42274381|NCT02505542|76105157|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
42274382|NCT02505542|76105158|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
42274383|NCT02505542|76105159|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
42011066|NCT01217073|75818107|FG002|Extension Period|Physician Decision|0|||
42011067|NCT01217073|75818108|FG003|Extension Period|Physician Decision|0|||
42011068|NCT01217073|75818109|FG004|Extension Period|Physician Decision|0|||
42036999|NCT00603382|75845351|FG005|Overall Study|Protocol Violation|0|||
42274384|NCT02505542|76105160|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
42011069|NCT01217073|75818110|FG005|Extension Period|Physician Decision|0|||
42011070|NCT01217073|75818111|FG006|Extension Period|Physician Decision|4|||
42011071|NCT01217073|75818112|FG007|Extension Period|Physician Decision|1|||
42011072|NCT01217073|75818105|FG000|Extension Period|Protocol Violation|0|||
42011073|NCT01217073|75818106|FG001|Extension Period|Protocol Violation|0|||
42011074|NCT01217073|75818107|FG002|Extension Period|Protocol Violation|0|||
42011075|NCT01217073|75818108|FG003|Extension Period|Protocol Violation|0|||
42011076|NCT01217073|75818109|FG004|Extension Period|Protocol Violation|0|||
42011077|NCT01217073|75818110|FG005|Extension Period|Protocol Violation|0|||
42011078|NCT01217073|75818111|FG006|Extension Period|Protocol Violation|2|||
42011079|NCT01217073|75818112|FG007|Extension Period|Protocol Violation|1|||
42037000|NCT00603382|75845346|FG000|Overall Study|Lost to Follow-up|0|||
42274385|NCT02505542|76105157|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
42348960|NCT01691859|76188464|FG000|Overall Study|Physician Decision|6|||
42348961|NCT01691859|76188464|FG000|Overall Study|Withdrawal by Subject|31|||
42348962|NCT01691781|76188508|FG000|Overall Study|Withdrawal by Subject|4|||
42348963|NCT01691781|76188509|FG001|Overall Study|Withdrawal by Subject|3|||
42348964|NCT01691781|76188508|FG000|Overall Study|Physician Decision|1|||
42348965|NCT01691781|76188509|FG001|Overall Study|Physician Decision|1|||
42348966|NCT01691781|76188508|FG000|Overall Study|Protocol Violation|2|||
42011080|NCT01217073|75818105|FG000|Extension Period|Site discontinued study participation|0|||
42011081|NCT01217073|75818106|FG001|Extension Period|Site discontinued study participation|0|||
42011082|NCT01217073|75818107|FG002|Extension Period|Site discontinued study participation|0|||
42348967|NCT01691781|76188509|FG001|Overall Study|Protocol Violation|2|||
42348968|NCT01691781|76188508|FG000|Overall Study|Adverse Event|0|||
42037001|NCT00603382|75845347|FG001|Overall Study|Lost to Follow-up|1|||
42037002|NCT00603382|75845348|FG002|Overall Study|Lost to Follow-up|1|||
42274386|NCT02505542|76105158|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
42348969|NCT01691781|76188509|FG001|Overall Study|Adverse Event|1|||
42348970|NCT01561755|76188517|FG000|Overall Study|Lost to Follow-up|0|||
42348971|NCT01561755|76188518|FG001|Overall Study|Lost to Follow-up|1|||
42011083|NCT01217073|75818108|FG003|Extension Period|Site discontinued study participation|0|||
42011084|NCT01217073|75818109|FG004|Extension Period|Site discontinued study participation|0|||
42011085|NCT01217073|75818110|FG005|Extension Period|Site discontinued study participation|0|||
42011086|NCT01217073|75818111|FG006|Extension Period|Site discontinued study participation|7|||
42011087|NCT01217073|75818112|FG007|Extension Period|Site discontinued study participation|2|||
42037003|NCT00603382|75845349|FG003|Overall Study|Lost to Follow-up|1|||
42037004|NCT00603382|75845350|FG004|Overall Study|Lost to Follow-up|0|||
42274387|NCT02505542|76105159|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
42274388|NCT02505542|76105160|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
42348972|NCT01585155|76188538|FG000|Overall Study|Adverse Event|1|||
42348973|NCT01585155|76188538|FG000|Overall Study|Lack of Efficacy|2|||
42348974|NCT01585155|76188538|FG000|Overall Study|Worsening ulcerative colitis|2|||
42348975|NCT01560507|76188545|FG000|Overall Study|Lost to Follow-up|3|||
42348976|NCT01560507|76188546|FG001|Overall Study|Lost to Follow-up|1|||
42348977|NCT01560507|76188547|FG002|Overall Study|Lost to Follow-up|2|||
42348978|NCT01560507|76188545|FG000|Overall Study|Withdrawal by Subject|1|||
42348979|NCT01560507|76188546|FG001|Overall Study|Withdrawal by Subject|1|||
42348980|NCT01560507|76188547|FG002|Overall Study|Withdrawal by Subject|0|||
42348981|NCT01584843|76188562|FG000|First Treatment Period|Adverse Event|0|||
42348982|NCT01584843|76188563|FG001|First Treatment Period|Adverse Event|0|||
42348983|NCT01584843|76188564|FG002|First Treatment Period|Adverse Event|1|||
42348984|NCT01584843|76188565|FG003|First Treatment Period|Adverse Event|0|||
42348985|NCT01584843|76188566|FG004|First Treatment Period|Adverse Event|0|||
42348986|NCT01584843|76188567|FG005|First Treatment Period|Adverse Event|0|||
42348987|NCT01584843|76188562|FG000|First Treatment Period|Protocol Violation|0|||
42348988|NCT01584843|76188563|FG001|First Treatment Period|Protocol Violation|0|||
42348989|NCT01584843|76188564|FG002|First Treatment Period|Protocol Violation|0|||
42348990|NCT01584843|76188565|FG003|First Treatment Period|Protocol Violation|0|||
42348991|NCT01584843|76188566|FG004|First Treatment Period|Protocol Violation|0|||
42348992|NCT01584843|76188567|FG005|First Treatment Period|Protocol Violation|1|||
42348993|NCT01584843|76188562|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
42348994|NCT01584843|76188563|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
42348995|NCT01584843|76188564|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
42348996|NCT01584843|76188565|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
42348997|NCT01584843|76188566|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
42348998|NCT01584843|76188567|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
42348999|NCT01584843|76188562|FG000|Second Treatment Period|Withdrawal by Subject|0|||
42349000|NCT01584843|76188563|FG001|Second Treatment Period|Withdrawal by Subject|0|||
42349001|NCT01584843|76188564|FG002|Second Treatment Period|Withdrawal by Subject|0|||
42349002|NCT01584843|76188565|FG003|Second Treatment Period|Withdrawal by Subject|0|||
42349003|NCT01584843|76188566|FG004|Second Treatment Period|Withdrawal by Subject|0|||
42349004|NCT01584843|76188567|FG005|Second Treatment Period|Withdrawal by Subject|1|||
42349005|NCT01560429|76188585|FG000|Overall Study|Protocol Violation|3|||
42349006|NCT01560429|76188586|FG001|Overall Study|Protocol Violation|6|||
42349007|NCT01582971|76188596|FG000|Overall Study|Death|2|||
42349008|NCT01582971|76188597|FG001|Overall Study|Death|1|||
42349009|NCT01582971|76188596|FG000|Overall Study|Lost to Follow-up|18|||
42349010|NCT01582971|76188597|FG001|Overall Study|Lost to Follow-up|21|||
42349011|NCT01582971|76188596|FG000|Overall Study|Withdrawal by Subject|4|||
42349012|NCT01582971|76188597|FG001|Overall Study|Withdrawal by Subject|2|||
42349013|NCT01582971|76188596|FG000|Overall Study|Other|15|||
42349014|NCT01582971|76188597|FG001|Overall Study|Other|13|||
42349015|NCT01690299|76188612|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
42349016|NCT01690299|76188613|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
42349017|NCT01690299|76188614|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
42349018|NCT01690299|76188615|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
42349019|NCT01690299|76188616|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
42349020|NCT01690299|76188617|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
42349021|NCT01690299|76188612|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
42349022|NCT01690299|76188613|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42349023|NCT01690299|76188614|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42349024|NCT01690299|76188615|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42349025|NCT01690299|76188616|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42349026|NCT01690299|76188617|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
42349027|NCT01690299|76188612|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
42011088|NCT01217073|75818105|FG000|Extension Period|Withdrawal by Subject|0|||
42011089|NCT01217073|75818106|FG001|Extension Period|Withdrawal by Subject|0|||
42011090|NCT01217073|75818107|FG002|Extension Period|Withdrawal by Subject|0|||
42011091|NCT01217073|75818108|FG003|Extension Period|Withdrawal by Subject|0|||
42011092|NCT01217073|75818109|FG004|Extension Period|Withdrawal by Subject|0|||
42274389|NCT02505542|76105157|FG000|Part A: Open-Label Period|New medical history available|1|||
42349028|NCT01690299|76188613|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
42349029|NCT01690299|76188614|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42274390|NCT02505542|76105158|FG001|Part A: Open-Label Period|New medical history available|0|||
42274391|NCT02505542|76105159|FG002|Part A: Open-Label Period|New medical history available|0|||
42274392|NCT02505542|76105160|FG003|Part A: Open-Label Period|New medical history available|0|||
42274393|NCT02505542|76105157|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
42274394|NCT02505542|76105158|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
42274395|NCT02505542|76105159|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
42274396|NCT02505542|76105160|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
42037005|NCT00603382|75845351|FG005|Overall Study|Lost to Follow-up|1|||
42274397|NCT02505542|76105157|FG000|Part A: Open-Label Period|Pregnancy|2|||
42274398|NCT02505542|76105158|FG001|Part A: Open-Label Period|Pregnancy|0|||
42274399|NCT02505542|76105159|FG002|Part A: Open-Label Period|Pregnancy|0|||
42274400|NCT02505542|76105160|FG003|Part A: Open-Label Period|Pregnancy|0|||
42274401|NCT02505542|76105157|FG000|Part A: Open-Label Period|Sponsor directive|1|||
42274402|NCT02505542|76105158|FG001|Part A: Open-Label Period|Sponsor directive|0|||
42274403|NCT02505542|76105159|FG002|Part A: Open-Label Period|Sponsor directive|0|||
42274404|NCT02505542|76105160|FG003|Part A: Open-Label Period|Sponsor directive|0|||
42274405|NCT02505542|76105157|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
42274406|NCT02505542|76105158|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
42274407|NCT02505542|76105159|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
42274408|NCT02505542|76105160|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
42274409|NCT02505542|76105157|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
42274410|NCT02505542|76105158|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
42274411|NCT02505542|76105159|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
42274412|NCT02505542|76105160|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
42274413|NCT02505542|76105157|FG000|Part A: Open-Label Period|Non-compliance|1|||
42274414|NCT02505542|76105158|FG001|Part A: Open-Label Period|Non-compliance|0|||
42274415|NCT02505542|76105159|FG002|Part A: Open-Label Period|Non-compliance|0|||
42274416|NCT02505542|76105160|FG003|Part A: Open-Label Period|Non-compliance|0|||
42274417|NCT02505542|76105157|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
42274418|NCT02505542|76105158|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
42274419|NCT02505542|76105159|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
42274420|NCT02505542|76105160|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
42274421|NCT02505542|76105157|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
42274422|NCT02505542|76105158|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
42349030|NCT01690299|76188615|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42011093|NCT01217073|75818110|FG005|Extension Period|Withdrawal by Subject|0|||
42011094|NCT01217073|75818111|FG006|Extension Period|Withdrawal by Subject|30|||
42011095|NCT01217073|75818112|FG007|Extension Period|Withdrawal by Subject|8|||
42011096|NCT00985621|75818140|FG000|Overall Study|Adverse Event|2|||
42011097|NCT00985621|75818141|FG001|Overall Study|Adverse Event|3|||
42011098|NCT00985621|75818142|FG002|Overall Study|Adverse Event|4|||
42011099|NCT00985621|75818143|FG003|Overall Study|Adverse Event|16|||
42011100|NCT00985621|75818140|FG000|Overall Study|Lack of Efficacy|10|||
42011101|NCT00985621|75818141|FG001|Overall Study|Lack of Efficacy|6|||
42011102|NCT00985621|75818142|FG002|Overall Study|Lack of Efficacy|5|||
42011103|NCT00985621|75818143|FG003|Overall Study|Lack of Efficacy|12|||
42011104|NCT00985621|75818140|FG000|Overall Study|Lost to Follow-up|2|||
42011105|NCT00985621|75818141|FG001|Overall Study|Lost to Follow-up|3|||
42011106|NCT00985621|75818142|FG002|Overall Study|Lost to Follow-up|4|||
42011107|NCT00985621|75818143|FG003|Overall Study|Lost to Follow-up|4|||
42011108|NCT00985621|75818140|FG000|Overall Study|Study Terminated by Sponsor|89|||
42011109|NCT00985621|75818141|FG001|Overall Study|Study Terminated by Sponsor|108|||
42011110|NCT00985621|75818142|FG002|Overall Study|Study Terminated by Sponsor|99|||
42011111|NCT00985621|75818143|FG003|Overall Study|Study Terminated by Sponsor|92|||
42011112|NCT00985621|75818140|FG000|Overall Study|Protocol Violation|1|||
42037006|NCT00603382|75845346|FG000|Overall Study|Physician Decision|0|||
42037007|NCT00603382|75845347|FG001|Overall Study|Physician Decision|0|||
42037008|NCT00603382|75845348|FG002|Overall Study|Physician Decision|2|||
42037009|NCT00603382|75845349|FG003|Overall Study|Physician Decision|0|||
42037010|NCT00603382|75845350|FG004|Overall Study|Physician Decision|1|||
42011113|NCT00985621|75818141|FG001|Overall Study|Protocol Violation|1|||
42011114|NCT00985621|75818142|FG002|Overall Study|Protocol Violation|1|||
42011115|NCT00985621|75818143|FG003|Overall Study|Protocol Violation|0|||
42011116|NCT00985621|75818140|FG000|Overall Study|Withdrawal by Subject|8|||
42037011|NCT00603382|75845351|FG005|Overall Study|Physician Decision|3|||
42037012|NCT00603382|75845346|FG000|Overall Study|Withdrawal by Subject|3|||
42274423|NCT02505542|76105159|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
42349031|NCT01690299|76188616|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42349032|NCT01690299|76188617|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
42349033|NCT01690299|76188612|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
42349034|NCT01690299|76188613|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
42349035|NCT01690299|76188614|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
42349036|NCT01690299|76188615|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
42349037|NCT01690299|76188616|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
42349038|NCT01690299|76188617|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
42349039|NCT01690299|76188612|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
42349040|NCT01690299|76188613|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
42349041|NCT01690299|76188614|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
42349042|NCT01690299|76188615|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
42349043|NCT01690299|76188616|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
42349044|NCT01690299|76188617|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
42349045|NCT01690299|76188612|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
42349046|NCT01690299|76188613|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
42349047|NCT01690299|76188614|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
42349048|NCT01690299|76188615|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
42349049|NCT01690299|76188616|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
42349050|NCT01690299|76188617|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
42349051|NCT01690299|76188612|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
42349052|NCT01690299|76188613|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
42349053|NCT01690299|76188614|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
42349054|NCT01690299|76188615|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
42349055|NCT01690299|76188616|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
42349056|NCT01690299|76188617|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
42349057|NCT01690299|76188612|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
42011117|NCT00985621|75818141|FG001|Overall Study|Withdrawal by Subject|10|||
42274424|NCT02505542|76105160|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
42274425|NCT02505542|76105157|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
42274426|NCT02505542|76105158|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
42274427|NCT02505542|76105159|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
42037013|NCT00603382|75845347|FG001|Overall Study|Withdrawal by Subject|3|||
42037014|NCT00603382|75845348|FG002|Overall Study|Withdrawal by Subject|1|||
42037015|NCT00603382|75845349|FG003|Overall Study|Withdrawal by Subject|1|||
42274428|NCT02505542|76105160|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
42274429|NCT02505542|76105157|FG000|Part B: Double-Blind Period|Adverse Event|0|||
42274430|NCT02505542|76105158|FG001|Part B: Double-Blind Period|Adverse Event|0|||
42274431|NCT02505542|76105159|FG002|Part B: Double-Blind Period|Adverse Event|1|||
42274432|NCT02505542|76105160|FG003|Part B: Double-Blind Period|Adverse Event|3|||
42349058|NCT01690299|76188613|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
42011118|NCT00985621|75818142|FG002|Overall Study|Withdrawal by Subject|8|||
42011119|NCT00985621|75818143|FG003|Overall Study|Withdrawal by Subject|12|||
42011120|NCT00985621|75818140|FG000|Overall Study|Other|1|||
42011121|NCT00985621|75818141|FG001|Overall Study|Other|0|||
42011122|NCT00985621|75818142|FG002|Overall Study|Other|0|||
42011123|NCT00985621|75818143|FG003|Overall Study|Other|0|||
42011124|NCT00985621|75818140|FG000|Overall Study|Randomized but not Treated|1|||
42011125|NCT00985621|75818141|FG001|Overall Study|Randomized but not Treated|0|||
42011126|NCT00985621|75818142|FG002|Overall Study|Randomized but not Treated|2|||
42011127|NCT00985621|75818143|FG003|Overall Study|Randomized but not Treated|1|||
42011128|NCT01215981|75818157|FG000|Overall Study|Physician Decision|0|||
42011129|NCT01215981|75818158|FG001|Overall Study|Physician Decision|1|||
42011130|NCT01215981|75818157|FG000|Overall Study|Protocol Violation|1|||
42011131|NCT01215981|75818158|FG001|Overall Study|Protocol Violation|0|||
42011132|NCT01215981|75818157|FG000|Overall Study|Withdrawal by Subject|1|||
42011133|NCT01215981|75818158|FG001|Overall Study|Withdrawal by Subject|0|||
42011134|NCT01215513|75818164|FG000|Overall Study|Not completed CS42|9|||
42011135|NCT01215513|75818164|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
42011136|NCT01215513|75818164|FG000|Overall Study|Adverse event (CS42A)|2|||
42011137|NCT01215513|75818164|FG000|Overall Study|Physician decision (CS42A)|6|||
42037016|NCT00603382|75845350|FG004|Overall Study|Withdrawal by Subject|0|||
42011138|NCT01215513|75818164|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
42011139|NCT01215513|75818164|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
42011140|NCT01215435|75818171|FG000|Overall Study|Adverse Event|1|||
42011141|NCT01215435|75818172|FG001|Overall Study|Adverse Event|0|||
42274433|NCT02505542|76105157|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
42274434|NCT02505542|76105158|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
42349059|NCT01690299|76188614|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
42349060|NCT01690299|76188615|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
42274435|NCT02505542|76105159|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
42274436|NCT02505542|76105160|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
42274437|NCT02505542|76105157|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
42274438|NCT02505542|76105158|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
42274439|NCT02505542|76105159|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
42274440|NCT02505542|76105160|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
42274441|NCT02505542|76105157|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
42274442|NCT02505542|76105158|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
42274443|NCT02505542|76105159|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
42274444|NCT02505542|76105160|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
42349061|NCT01690299|76188616|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
42349062|NCT01690299|76188617|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
42349063|NCT01690299|76188612|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
42349064|NCT01690299|76188613|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
42349065|NCT01690299|76188614|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
42349066|NCT01690299|76188615|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
42274445|NCT02505542|76105157|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
42274446|NCT02505542|76105158|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
42349067|NCT01690299|76188616|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
42349068|NCT01690299|76188617|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
42349069|NCT01690299|76188612|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
42349070|NCT01690299|76188613|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
42349071|NCT01690299|76188614|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
42349072|NCT01690299|76188615|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
42349073|NCT01690299|76188616|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
42349074|NCT01690299|76188617|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
42349075|NCT01690143|76188646|FG000|Overall Study|Withdrawal by Subject|1|||
42349076|NCT01559259|76188665|FG000|Overall Study|Withdrawal by Subject|0|||
42349077|NCT01559259|76188666|FG001|Overall Study|Withdrawal by Subject|0|||
42349078|NCT01559259|76188667|FG002|Overall Study|Withdrawal by Subject|0|||
42349079|NCT01559259|76188668|FG003|Overall Study|Withdrawal by Subject|1|||
42349080|NCT01559259|76188669|FG004|Overall Study|Withdrawal by Subject|0|||
42349081|NCT01559259|76188665|FG000|Overall Study|Adverse Event|0|||
42349082|NCT01559259|76188666|FG001|Overall Study|Adverse Event|1|||
42349083|NCT01559259|76188667|FG002|Overall Study|Adverse Event|1|||
42349084|NCT01559259|76188668|FG003|Overall Study|Adverse Event|0|||
42349085|NCT01559259|76188669|FG004|Overall Study|Adverse Event|0|||
42349086|NCT01670500|76188693|FG000|Overall Study|Withdrawal by Subject|1|||
42349087|NCT01670500|76188694|FG001|Overall Study|Withdrawal by Subject|0|||
42349088|NCT02400736|76188702|FG000|Overall Study|Lost to Follow-up|6|||
42349089|NCT02400736|76188703|FG001|Overall Study|Lost to Follow-up|6|||
42349090|NCT02400736|76188702|FG000|Overall Study|Withdrawal by Subject|2|||
42349091|NCT02400736|76188703|FG001|Overall Study|Withdrawal by Subject|1|||
42349092|NCT02400736|76188702|FG000|Overall Study|Moved from the area|3|||
42349093|NCT02400736|76188703|FG001|Overall Study|Moved from the area|1|||
42349094|NCT01689519|76188715|FG000|Intent to Treat|Death|157|||
42349095|NCT01689519|76188716|FG001|Intent to Treat|Death|167|||
42349096|NCT01689519|76188715|FG000|Intent to Treat|Lost to Follow-up|4|||
42349097|NCT01689519|76188716|FG001|Intent to Treat|Lost to Follow-up|8|||
42349098|NCT01689519|76188715|FG000|Intent to Treat|Other|2|||
42349099|NCT01689519|76188716|FG001|Intent to Treat|Other|4|||
42349100|NCT01689519|76188715|FG000|Intent to Treat|Physician Decision|4|||
42349101|NCT01689519|76188716|FG001|Intent to Treat|Physician Decision|1|||
42349102|NCT01689519|76188715|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
42349103|NCT01689519|76188716|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
42349104|NCT01689519|76188715|FG000|Intent to Treat|Withdrawal by Subject|21|||
42349105|NCT01689519|76188716|FG001|Intent to Treat|Withdrawal by Subject|20|||
42349106|NCT01689519|76188715|FG000|Safety Population|Death|158|||
42349107|NCT01689519|76188716|FG001|Safety Population|Death|165|||
42274447|NCT02505542|76105159|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
42274448|NCT02505542|76105160|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
42349108|NCT01689519|76188715|FG000|Safety Population|Lost to Follow-up|4|||
42349109|NCT01689519|76188716|FG001|Safety Population|Lost to Follow-up|8|||
42349110|NCT01689519|76188715|FG000|Safety Population|Other|2|||
42349111|NCT01689519|76188716|FG001|Safety Population|Other|4|||
42349112|NCT01689519|76188715|FG000|Safety Population|Physician Decision|4|||
42274449|NCT02505542|76105157|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
42274450|NCT02505542|76105158|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
42011142|NCT01215435|75818171|FG000|Overall Study|Protocol Violation|2|||
42011143|NCT01215435|75818172|FG001|Overall Study|Protocol Violation|0|||
42011144|NCT01215435|75818171|FG000|Overall Study|Withdrawal Criteria|8|||
42011145|NCT01215435|75818172|FG001|Overall Study|Withdrawal Criteria|11|||
42274451|NCT02505542|76105159|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
42274452|NCT02505542|76105160|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
42274453|NCT02505542|76105157|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
42274454|NCT02505542|76105158|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
42274455|NCT02505542|76105159|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
42274456|NCT02505542|76105160|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
42274457|NCT02505542|76105157|FG000|Part B: Double-Blind Period|Miscalculation|0|||
42274458|NCT02505542|76105158|FG001|Part B: Double-Blind Period|Miscalculation|1|||
42274459|NCT02505542|76105159|FG002|Part B: Double-Blind Period|Miscalculation|0|||
42274460|NCT02505542|76105160|FG003|Part B: Double-Blind Period|Miscalculation|0|||
42349113|NCT01689519|76188716|FG001|Safety Population|Physician Decision|1|||
42349114|NCT01689519|76188715|FG000|Safety Population|Study Terminated By Sponsor|60|||
42349115|NCT01689519|76188716|FG001|Safety Population|Study Terminated By Sponsor|47|||
42349116|NCT01689519|76188715|FG000|Safety Population|Withdrawal by Subject|20|||
42349117|NCT01689519|76188716|FG001|Safety Population|Withdrawal by Subject|20|||
42349118|NCT01689363|76188722|FG000|Overall Study|Protocol Violation|0|||
42349119|NCT01689363|76188723|FG001|Overall Study|Protocol Violation|1|||
42349120|NCT01689363|76188724|FG002|Overall Study|Protocol Violation|0|||
42349121|NCT01689363|76188725|FG003|Overall Study|Protocol Violation|0|||
42349122|NCT01689363|76188726|FG004|Overall Study|Protocol Violation|0|||
42011146|NCT01215435|75818171|FG000|Overall Study|Lost to Follow-up|3|||
42011147|NCT01215435|75818172|FG001|Overall Study|Lost to Follow-up|0|||
42011148|NCT01215435|75818171|FG000|Overall Study|Unclassified|5|||
42011149|NCT01215435|75818172|FG001|Overall Study|Unclassified|5|||
42274461|NCT02505542|76105157|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
42349123|NCT01689363|76188727|FG005|Overall Study|Protocol Violation|0|||
42349124|NCT01689363|76188728|FG006|Overall Study|Protocol Violation|0|||
42349125|NCT01689363|76188729|FG007|Overall Study|Protocol Violation|0|||
42349126|NCT01558635|76188745|FG000|Overall Study|Death|1|||
42349127|NCT01558635|76188745|FG000|Overall Study|Withdrawal by Subject|2|||
42349128|NCT01558635|76188745|FG000|Overall Study|Physician Decision|1|||
42349129|NCT01558635|76188745|FG000|Overall Study|Subject received other treatment|1|||
42037017|NCT00603382|75845351|FG005|Overall Study|Withdrawal by Subject|1|||
42037018|NCT01176266|75845365|FG000|Overall Study|Death|6|||
42037019|NCT01176266|75845365|FG000|Overall Study|Withdrawal by Subject|3|||
42037020|NCT01182428|75845375|FG000|Overall Study|Physician Decision|1|||
42037021|NCT01182428|75845376|FG001|Overall Study|Physician Decision|0|||
42037022|NCT01182428|75845375|FG000|Overall Study|Lost to Follow-up|9|||
42037023|NCT01182428|75845376|FG001|Overall Study|Lost to Follow-up|1|||
42037024|NCT01182428|75845375|FG000|Overall Study|Withdrawal by Subject|1|||
42037025|NCT01182428|75845376|FG001|Overall Study|Withdrawal by Subject|0|||
42037026|NCT00603304|75845384|FG000|Overall Study|Lost to Follow-up|5|||
42037027|NCT00603304|75845385|FG001|Overall Study|Lost to Follow-up|7|||
42037028|NCT00603304|75845384|FG000|Overall Study|Withdrawal by Subject|8|||
42037029|NCT00603304|75845385|FG001|Overall Study|Withdrawal by Subject|5|||
42037030|NCT00603304|75845384|FG000|Overall Study|Protocol Violation|1|||
42037031|NCT00603304|75845385|FG001|Overall Study|Protocol Violation|0|||
42037032|NCT00603304|75845384|FG000|Overall Study|Adverse Event|4|||
42037033|NCT00603304|75845385|FG001|Overall Study|Adverse Event|2|||
42138718|NCT00321711|75948911|FG004|Part A|Physician Decision|0|||
42138719|NCT00321711|75948907|FG000|Part A|Other|1|||
42138720|NCT00321711|75948908|FG001|Part A|Other|2|||
42138721|NCT00321711|75948909|FG002|Part A|Other|3|||
42138722|NCT00321711|75948910|FG003|Part A|Other|0|||
42138723|NCT00321711|75948911|FG004|Part A|Other|0|||
42138724|NCT00321711|75948907|FG000|Part A|Protocol deviation|0|||
42138725|NCT00321711|75948908|FG001|Part A|Protocol deviation|0|||
42138726|NCT00321711|75948909|FG002|Part A|Protocol deviation|1|||
42138727|NCT00321711|75948910|FG003|Part A|Protocol deviation|0|||
42138728|NCT00321711|75948911|FG004|Part A|Protocol deviation|0|||
42138729|NCT00321711|75948907|FG000|Part B|Noncompliance|0|||
42138730|NCT00321711|75948908|FG001|Part B|Noncompliance|0|||
42138731|NCT00321711|75948909|FG002|Part B|Noncompliance|0|||
42138732|NCT00321711|75948910|FG003|Part B|Noncompliance|0|||
42138733|NCT00321711|75948911|FG004|Part B|Noncompliance|1|||
42138734|NCT00321711|75948907|FG000|Part B|Adverse Event|0|||
42138735|NCT00321711|75948908|FG001|Part B|Adverse Event|0|||
42138736|NCT00321711|75948909|FG002|Part B|Adverse Event|0|||
42138737|NCT00321711|75948910|FG003|Part B|Adverse Event|2|||
42138738|NCT00321711|75948911|FG004|Part B|Adverse Event|1|||
42274462|NCT02505542|76105158|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
42274463|NCT02505542|76105159|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
42274464|NCT02505542|76105160|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
42274465|NCT02475980|76105209|FG000|Overall Study|Lost to Follow-up|4|||
42274466|NCT02475980|76105209|FG000|Overall Study|Withdrawal by Subject|1|||
42274467|NCT02447432|76105215|FG000|Epoch 001|Adverse Event|1|||
42274468|NCT02447432|76105216|FG001|Epoch 001|Adverse Event|1|||
42274469|NCT02447432|76105215|FG000|Epoch 001|Withdrawal by Subject|0|||
42037034|NCT00603304|75845384|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
42037035|NCT00603304|75845385|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
42037036|NCT00603304|75845384|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
42037037|NCT00603304|75845385|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
42037038|NCT00603304|75845384|FG000|Overall Study|Exclusionary Medication|2|||
42037039|NCT00603304|75845385|FG001|Overall Study|Exclusionary Medication|3|||
42037040|NCT00603304|75845384|FG000|Overall Study|Non-Compliant|0|||
42037041|NCT00603304|75845385|FG001|Overall Study|Non-Compliant|1|||
42037042|NCT00603304|75845384|FG000|Overall Study|Moved Away|0|||
42037043|NCT00603304|75845385|FG001|Overall Study|Moved Away|2|||
42037044|NCT00603304|75845384|FG000|Overall Study|Other|2|||
42037045|NCT00603304|75845385|FG001|Overall Study|Other|0|||
42037046|NCT00603304|75845384|FG000|Overall Study|Patient Decision|2|||
42037047|NCT00603304|75845385|FG001|Overall Study|Patient Decision|0|||
42037048|NCT01176032|75845395|FG000|Overall Study|Adverse Event|1|||
42037049|NCT01176032|75845396|FG001|Overall Study|Adverse Event|0|||
42037050|NCT01176032|75845395|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42037051|NCT01176032|75845396|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
42037052|NCT01176032|75845395|FG000|Overall Study|Protocol Violation|1|||
42037053|NCT01176032|75845396|FG001|Overall Study|Protocol Violation|0|||
42138739|NCT00321711|75948907|FG000|Part B|Disease progression|0|||
42349130|NCT01558635|76188745|FG000|Overall Study|Reveal XT was explanted|1|||
42037054|NCT01176032|75845395|FG000|Overall Study|Informed consent withdrawn|3|||
42138740|NCT00321711|75948908|FG001|Part B|Disease progression|0|||
42138741|NCT00321711|75948909|FG002|Part B|Disease progression|0|||
42138742|NCT00321711|75948910|FG003|Part B|Disease progression|1|||
42349131|NCT00089986|76188759|FG000|Overall Study|Adverse Event|6|||
42037055|NCT01176032|75845396|FG001|Overall Study|Informed consent withdrawn|0|||
42037056|NCT01176032|75845395|FG000|Overall Study|Other|1|||
42037057|NCT01176032|75845396|FG001|Overall Study|Other|0|||
42037058|NCT01008618|75845407|FG000|Period 1 (Titration Period)|Physician Decision|2|||
42037059|NCT01008618|75845408|FG001|Period 1 (Titration Period)|Physician Decision|0|||
42037060|NCT01008618|75845409|FG002|Period 1 (Titration Period)|Physician Decision|0|||
42037061|NCT01008618|75845407|FG000|Period 1 (Titration Period)|Adverse Event|33|||
42037062|NCT01008618|75845408|FG001|Period 1 (Titration Period)|Adverse Event|0|||
42037063|NCT01008618|75845409|FG002|Period 1 (Titration Period)|Adverse Event|0|||
42037064|NCT01008618|75845407|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
42037065|NCT01008618|75845408|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
42037066|NCT01008618|75845409|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
42037067|NCT01008618|75845407|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
42037068|NCT01008618|75845408|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
42037069|NCT01008618|75845409|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
42037070|NCT01008618|75845407|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
42037071|NCT01008618|75845408|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
42037072|NCT01008618|75845409|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
42037073|NCT01008618|75845407|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
42037074|NCT01008618|75845408|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
42037075|NCT01008618|75845409|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
42037076|NCT01008618|75845407|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
42037077|NCT01008618|75845408|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
42011150|NCT01215357|75818178|FG000|Overall Study|Withdrawal by Subject|3|||
42011151|NCT01215357|75818178|FG000|Overall Study|Protocol Violation|9|||
42011152|NCT00984295|75818185|FG000|Overall Study|Lost to Follow-up|31|||
42011153|NCT00984295|75818186|FG001|Overall Study|Lost to Follow-up|12|||
42011154|NCT00984295|75818187|FG002|Overall Study|Lost to Follow-up|13|||
42011155|NCT00984295|75818185|FG000|Overall Study|Protocol Violation|2|||
42011156|NCT00984295|75818186|FG001|Overall Study|Protocol Violation|1|||
42011157|NCT00984295|75818187|FG002|Overall Study|Protocol Violation|4|||
42011158|NCT00984295|75818185|FG000|Overall Study|Withdrawal by Subject|18|||
42011159|NCT00984295|75818186|FG001|Overall Study|Withdrawal by Subject|9|||
42011160|NCT00984295|75818187|FG002|Overall Study|Withdrawal by Subject|12|||
42011161|NCT00984295|75818185|FG000|Overall Study|CAE - discontinued test vaccine|0|||
42011162|NCT00984295|75818186|FG001|Overall Study|CAE - discontinued test vaccine|1|||
42011163|NCT00984295|75818187|FG002|Overall Study|CAE - discontinued test vaccine|3|||
42011164|NCT00984295|75818185|FG000|Overall Study|Missed one or more blood samplings|3|||
42011165|NCT00984295|75818186|FG001|Overall Study|Missed one or more blood samplings|7|||
42011166|NCT00984295|75818187|FG002|Overall Study|Missed one or more blood samplings|2|||
42011167|NCT00984295|75818185|FG000|Overall Study|Incomplete safety follow-up|11|||
42011168|NCT00984295|75818186|FG001|Overall Study|Incomplete safety follow-up|2|||
42011169|NCT00984295|75818187|FG002|Overall Study|Incomplete safety follow-up|3|||
42011170|NCT01017952|75818199|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
42011171|NCT01017952|75818200|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
42011172|NCT01017952|75818201|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
42011173|NCT01017952|75818202|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
42011174|NCT01017952|75818203|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
42011175|NCT01017952|75818199|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
42011176|NCT01017952|75818200|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
42011177|NCT01017952|75818201|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
42011178|NCT01017952|75818202|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
42011179|NCT01017952|75818203|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
42011180|NCT01017952|75818199|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
42011181|NCT01017952|75818200|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
42011182|NCT01017952|75818201|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
42011183|NCT01017952|75818202|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
42011184|NCT01017952|75818203|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
42011185|NCT01017952|75818199|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
42011186|NCT01017952|75818200|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
42011187|NCT01017952|75818201|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
42011188|NCT01017952|75818202|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
42011189|NCT01017952|75818203|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
42011190|NCT01017952|75818199|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
42011191|NCT01017952|75818200|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
42011192|NCT01017952|75818201|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
42011193|NCT01017952|75818202|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
42037078|NCT01008618|75845409|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
42037079|NCT01008618|75845407|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
42037080|NCT01008618|75845408|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
42037081|NCT01008618|75845409|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
42037082|NCT01008618|75845407|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
42037083|NCT01008618|75845408|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
42037084|NCT01008618|75845409|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
42037085|NCT01008618|75845407|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
42037086|NCT01008618|75845408|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
42037087|NCT01008618|75845409|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
42037088|NCT01008618|75845407|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
42037089|NCT01008618|75845408|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
42037090|NCT01008618|75845409|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
42037091|NCT01008618|75845407|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
42037092|NCT01008618|75845408|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
42037093|NCT01008618|75845409|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
42037094|NCT01001208|75845420|FG000|Overall Study|Adverse Event|10|||
42037095|NCT01001208|75845421|FG001|Overall Study|Adverse Event|5|||
42037096|NCT01001208|75845420|FG000|Overall Study|Lost to Follow-up|5|||
42037097|NCT01001208|75845421|FG001|Overall Study|Lost to Follow-up|9|||
42037098|NCT01001208|75845420|FG000|Overall Study|Physician Decision|1|||
42037099|NCT01001208|75845421|FG001|Overall Study|Physician Decision|0|||
42037100|NCT01001208|75845420|FG000|Overall Study|Withdrawal by Subject|4|||
42037101|NCT01001208|75845421|FG001|Overall Study|Withdrawal by Subject|5|||
42037102|NCT01001208|75845420|FG000|Overall Study|Ineligibility Determined|4|||
42037103|NCT01001208|75845421|FG001|Overall Study|Ineligibility Determined|2|||
42037104|NCT01001208|75845420|FG000|Overall Study|Noncompliance|4|||
42037105|NCT01001208|75845421|FG001|Overall Study|Noncompliance|7|||
42274470|NCT02447432|76105216|FG001|Epoch 001|Withdrawal by Subject|4|||
42274471|NCT02447432|76105215|FG000|Epoch 001|Migrated/moved from study area|3|||
42274472|NCT02447432|76105216|FG001|Epoch 001|Migrated/moved from study area|5|||
42274473|NCT02447432|76105215|FG000|Epoch 001|Lost to Follow-up|1|||
42011194|NCT01017952|75818203|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
42011195|NCT01017952|75818199|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
42011196|NCT01017952|75818200|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
42011197|NCT01017952|75818201|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
42011198|NCT01017952|75818202|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
42011199|NCT01017952|75818203|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
42011200|NCT01017952|75818199|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
42011201|NCT01017952|75818200|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
42011202|NCT01017952|75818201|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
42011203|NCT01017952|75818202|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
42011204|NCT01017952|75818203|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
42349132|NCT00089986|76188760|FG001|Overall Study|Adverse Event|9|||
42011205|NCT01017952|75818199|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
42011206|NCT01017952|75818200|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
42011207|NCT01017952|75818201|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
42011208|NCT01017952|75818202|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
42011209|NCT01017952|75818203|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
42011210|NCT01017952|75818199|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
42011211|NCT01017952|75818200|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
42274474|NCT02447432|76105216|FG001|Epoch 001|Lost to Follow-up|3|||
42037106|NCT01001208|75845420|FG000|Overall Study|Disease Progression|0|||
42037107|NCT01001208|75845421|FG001|Overall Study|Disease Progression|3|||
42274475|NCT02446886|76105224|FG000|Overall Study|Adverse Event|1|||
42274476|NCT02446886|76105225|FG001|Overall Study|Adverse Event|3|||
42274477|NCT02446886|76105224|FG000|Overall Study|Withdrawal by Subject|1|||
42274478|NCT02446886|76105225|FG001|Overall Study|Withdrawal by Subject|1|||
42274479|NCT03448939|76105243|FG000|Overall Study|Adverse Event|5|||
42274480|NCT03448939|76105244|FG001|Overall Study|Adverse Event|1|||
42274481|NCT03448939|76105243|FG000|Overall Study|Lost to Follow-up|6|||
42037108|NCT01001208|75845420|FG000|Overall Study|Other|0|||
42037109|NCT01001208|75845421|FG001|Overall Study|Other|2|||
42037110|NCT01000974|75845430|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
42138743|NCT00321711|75948911|FG004|Part B|Disease progression|0|||
42274482|NCT03448939|76105244|FG001|Overall Study|Lost to Follow-up|6|||
42349133|NCT00089986|76188761|FG002|Overall Study|Adverse Event|6|||
42349134|NCT00089986|76188759|FG000|Overall Study|Lost to Follow-up|3|||
42011212|NCT01017952|75818201|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
42011213|NCT01017952|75818202|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
42274483|NCT03448939|76105243|FG000|Overall Study|Pregnancy|1|||
42274484|NCT03448939|76105244|FG001|Overall Study|Pregnancy|1|||
42274485|NCT03448939|76105243|FG000|Overall Study|Withdrawal by Subject|9|||
42274486|NCT03448939|76105244|FG001|Overall Study|Withdrawal by Subject|3|||
42274487|NCT02504294|76105262|FG000|Overall Study|Adverse Event|15|||
42274488|NCT02504294|76105263|FG001|Overall Study|Adverse Event|12|||
42274489|NCT02504294|76105262|FG000|Overall Study|Withdrawal by Subject|7|||
42274490|NCT02504294|76105263|FG001|Overall Study|Withdrawal by Subject|1|||
42274491|NCT02504294|76105262|FG000|Overall Study|Protocol Violation|27|||
42274492|NCT02504294|76105263|FG001|Overall Study|Protocol Violation|26|||
42274493|NCT02504294|76105262|FG000|Overall Study|Physician Decision|1|||
42274494|NCT02504294|76105263|FG001|Overall Study|Physician Decision|2|||
42274495|NCT02504294|76105262|FG000|Overall Study|Lost to Follow-up|6|||
42274496|NCT02504294|76105263|FG001|Overall Study|Lost to Follow-up|7|||
42274497|NCT02446418|76105271|FG000|Overall Study|Adverse Event|4|||
42274498|NCT02446418|76105272|FG001|Overall Study|Adverse Event|8|||
42274499|NCT02446418|76105271|FG000|Overall Study|Physician Decision|5|||
42274500|NCT02446418|76105272|FG001|Overall Study|Physician Decision|1|||
42274501|NCT02446418|76105271|FG000|Overall Study|Withdrawal by Subject|3|||
42274502|NCT02446418|76105272|FG001|Overall Study|Withdrawal by Subject|3|||
42274503|NCT02446418|76105271|FG000|Overall Study|Lost to Follow-up|2|||
42274504|NCT02446418|76105272|FG001|Overall Study|Lost to Follow-up|2|||
42274505|NCT02446418|76105271|FG000|Overall Study|Protocol Violation|1|||
42274506|NCT02446418|76105272|FG001|Overall Study|Protocol Violation|2|||
42274507|NCT02446418|76105271|FG000|Overall Study|Lack of Efficacy|2|||
42274508|NCT02446418|76105272|FG001|Overall Study|Lack of Efficacy|0|||
42274509|NCT02446418|76105271|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
42274510|NCT02446418|76105272|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
42274511|NCT02445794|76105282|FG000|Overall Study|Adverse Event|0|||
42274512|NCT02445794|76105283|FG001|Overall Study|Adverse Event|0|||
42274513|NCT02445794|76105284|FG002|Overall Study|Adverse Event|2|||
42274514|NCT02445794|76105285|FG003|Overall Study|Adverse Event|0|||
42274515|NCT02475278|76105300|FG000|Overall Study|Lost to Follow-up|1|||
42274516|NCT02475278|76105300|FG000|Overall Study|Reason Not Specified|1|||
42274517|NCT02254486|76105306|FG000|Overall Study|Adverse Event|1|||
42274518|NCT02254486|76105307|FG001|Overall Study|Adverse Event|1|||
42274519|NCT02254486|76105306|FG000|Overall Study|Lack of Efficacy|1|||
42274520|NCT02254486|76105307|FG001|Overall Study|Lack of Efficacy|0|||
42274521|NCT02254486|76105306|FG000|Overall Study|Lost to Follow-up|2|||
42274522|NCT02254486|76105307|FG001|Overall Study|Lost to Follow-up|4|||
42011214|NCT01017952|75818203|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
42011215|NCT01017952|75818199|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
42011216|NCT01017952|75818200|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
42011217|NCT01017952|75818201|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
42011218|NCT01017952|75818202|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
42011219|NCT01017952|75818203|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
42011220|NCT01017952|75818199|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
42011221|NCT01017952|75818200|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
42011222|NCT01017952|75818201|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
42011223|NCT01017952|75818202|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
42011224|NCT01017952|75818203|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
42011225|NCT01017952|75818199|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
42011226|NCT01017952|75818200|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
42011227|NCT01017952|75818201|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
42011228|NCT01017952|75818202|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
42011229|NCT01017952|75818203|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
42011230|NCT01017952|75818199|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
42274523|NCT02254486|76105306|FG000|Overall Study|Protocol Violation|1|||
42274524|NCT02254486|76105307|FG001|Overall Study|Protocol Violation|2|||
42274525|NCT02254486|76105306|FG000|Overall Study|Withdrawal by Subject|17|||
42274526|NCT02254486|76105307|FG001|Overall Study|Withdrawal by Subject|15|||
42138744|NCT00321711|75948907|FG000|Part B|Physician Decision|0|||
42274527|NCT02254486|76105306|FG000|Overall Study|GFR<60mL/min|16|||
42274528|NCT02254486|76105307|FG001|Overall Study|GFR<60mL/min|21|||
42274529|NCT02254486|76105306|FG000|Overall Study|Various|12|||
42274530|NCT02254486|76105307|FG001|Overall Study|Various|12|||
42274531|NCT01641640|76105313|FG000|Overall Study|Enrolled but not treated|1|||
42274532|NCT01641640|76105313|FG000|Overall Study|Efficacy failure|29|||
42274533|NCT01641640|76105313|FG000|Overall Study|Lost to Follow-up|3|||
42274534|NCT01641640|76105313|FG000|Overall Study|Withdrawal by Subject|2|||
42274535|NCT01641640|76105313|FG000|Overall Study|Adverse Event|1|||
42274536|NCT01639144|76105319|FG000|Overall Study|Withdrawal by Subject|4|||
42274537|NCT01639144|76105320|FG001|Overall Study|Withdrawal by Subject|2|||
42274538|NCT01639144|76105319|FG000|Overall Study|Physician Decision|2|||
42274539|NCT01639144|76105320|FG001|Overall Study|Physician Decision|0|||
42274540|NCT01639144|76105319|FG000|Overall Study|Met postoperative exclusion criteria|4|||
42274541|NCT01639144|76105320|FG001|Overall Study|Met postoperative exclusion criteria|3|||
42274542|NCT01601626|76105329|FG000|Overall Study|Death|1|||
42274543|NCT01601626|76105330|FG001|Overall Study|Death|1|||
42274544|NCT01601626|76105331|FG002|Overall Study|Death|1|||
42274545|NCT01601626|76105329|FG000|Overall Study|Lost to Follow-up|1|||
42274546|NCT01601626|76105330|FG001|Overall Study|Lost to Follow-up|2|||
42274547|NCT01601626|76105331|FG002|Overall Study|Lost to Follow-up|0|||
42274548|NCT01601626|76105329|FG000|Overall Study|Unable to Get to Clinic|0|||
42274549|NCT01601626|76105330|FG001|Overall Study|Unable to Get to Clinic|1|||
42274550|NCT01601626|76105331|FG002|Overall Study|Unable to Get to Clinic|0|||
42274551|NCT01601626|76105329|FG000|Overall Study|Withdrawal by Subject|0|||
42274552|NCT01601626|76105330|FG001|Overall Study|Withdrawal by Subject|1|||
42274553|NCT01601626|76105331|FG002|Overall Study|Withdrawal by Subject|1|||
42274554|NCT01601626|76105329|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
42274555|NCT01601626|76105330|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
42274556|NCT01601626|76105331|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
42274557|NCT02737501|76105341|FG000|Randomized Phase|Died|41|||
42274558|NCT02737501|76105342|FG001|Randomized Phase|Died|29|||
42274559|NCT02737501|76105343|FG002|Randomized Phase|Died|0|||
42274560|NCT02737501|76105341|FG000|Randomized Phase|Withdrawal by Subject|16|||
42274561|NCT02737501|76105342|FG001|Randomized Phase|Withdrawal by Subject|6|||
42274562|NCT02737501|76105343|FG002|Randomized Phase|Withdrawal by Subject|0|||
42274563|NCT02737501|76105341|FG000|Randomized Phase|Lost to Follow-up|0|||
42274564|NCT02737501|76105342|FG001|Randomized Phase|Lost to Follow-up|1|||
42274565|NCT02737501|76105343|FG002|Randomized Phase|Lost to Follow-up|0|||
42274566|NCT02737501|76105341|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
42274567|NCT02737501|76105342|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
42349135|NCT00089986|76188760|FG001|Overall Study|Lost to Follow-up|1|||
42349136|NCT00089986|76188761|FG002|Overall Study|Lost to Follow-up|1|||
42349137|NCT00089986|76188759|FG000|Overall Study|Protocol Violation|0|||
42349138|NCT00089986|76188760|FG001|Overall Study|Protocol Violation|1|||
42349139|NCT00089986|76188761|FG002|Overall Study|Protocol Violation|0|||
42349140|NCT00089986|76188759|FG000|Overall Study|Patient transferred to another hospital|2|||
42349141|NCT00089986|76188760|FG001|Overall Study|Patient transferred to another hospital|1|||
42349142|NCT00089986|76188761|FG002|Overall Study|Patient transferred to another hospital|0|||
42349143|NCT00089986|76188759|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
42349144|NCT00089986|76188760|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
42349145|NCT00089986|76188761|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
42349146|NCT00089986|76188759|FG000|Overall Study|Hemohlobin stopping rule|0|||
42349147|NCT00089986|76188760|FG001|Overall Study|Hemohlobin stopping rule|1|||
42349148|NCT00089986|76188761|FG002|Overall Study|Hemohlobin stopping rule|0|||
42349149|NCT00089986|76188759|FG000|Overall Study|Investigator decision to withdrew|0|||
42349150|NCT00089986|76188760|FG001|Overall Study|Investigator decision to withdrew|1|||
42349151|NCT00089986|76188761|FG002|Overall Study|Investigator decision to withdrew|0|||
42349152|NCT00089986|76188759|FG000|Overall Study|Enrollment in another study|0|||
42349153|NCT00089986|76188760|FG001|Overall Study|Enrollment in another study|1|||
42274568|NCT02737501|76105343|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
42274569|NCT02737501|76105341|FG000|Randomized Phase|Reason not Specified|1|||
42274570|NCT02737501|76105342|FG001|Randomized Phase|Reason not Specified|1|||
42274571|NCT02737501|76105343|FG002|Randomized Phase|Reason not Specified|0|||
42274572|NCT02737501|76105341|FG000|Randomized Phase|Never Treated|1|||
42274573|NCT02737501|76105342|FG001|Randomized Phase|Never Treated|1|||
42274574|NCT02737501|76105343|FG002|Randomized Phase|Never Treated|0|||
42274575|NCT02737501|76105341|FG000|Crossover Phase|Died|0|||
42274576|NCT02737501|76105342|FG001|Crossover Phase|Died|0|||
42274577|NCT02737501|76105343|FG002|Crossover Phase|Died|22|||
42274578|NCT02737501|76105341|FG000|Crossover Phase|Withdrew Consent|0|||
42274579|NCT02737501|76105342|FG001|Crossover Phase|Withdrew Consent|0|||
42274580|NCT02737501|76105343|FG002|Crossover Phase|Withdrew Consent|9|||
42274581|NCT02737501|76105341|FG000|Crossover Phase|Physician Decision|0|||
42274582|NCT02737501|76105342|FG001|Crossover Phase|Physician Decision|0|||
42349154|NCT00089986|76188761|FG002|Overall Study|Enrollment in another study|0|||
42349155|NCT00089986|76188759|FG000|Overall Study|Family decision|0|||
42349156|NCT00089986|76188760|FG001|Overall Study|Family decision|1|||
42349157|NCT00089986|76188761|FG002|Overall Study|Family decision|0|||
42011231|NCT01017952|75818200|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
42349158|NCT00089986|76188759|FG000|Overall Study|Do not resuscitate (DNR)|0|||
42274583|NCT02737501|76105343|FG002|Crossover Phase|Physician Decision|1|||
42274584|NCT02737501|76105341|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
42274585|NCT02737501|76105342|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
42274586|NCT02737501|76105343|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
42274587|NCT01640314|76105353|FG000|Overall Study|Protocol Violation|0|||
42274588|NCT01640314|76105354|FG001|Overall Study|Protocol Violation|1|||
42274589|NCT02740049|76105436|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
42274590|NCT01601704|76105442|FG000|Overall Study|Randomized but not dispensed study med|1|||
42274591|NCT01601704|76105443|FG001|Overall Study|Randomized but not dispensed study med|4|||
42274592|NCT01601470|76105449|FG000|Period 2 - LCZ696|Physician Decision|1|||
42274593|NCT03248375|76105473|FG000|Overall Study|Lost to Follow-up|5|||
42274594|NCT01637272|76105477|FG000|Overall Study|Adverse Event|6|||
42274595|NCT01637272|76105477|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
42274596|NCT01637272|76105477|FG000|Overall Study|Withdrawal by Subject|3|||
42349159|NCT00089986|76188760|FG001|Overall Study|Do not resuscitate (DNR)|0|||
42349160|NCT00089986|76188761|FG002|Overall Study|Do not resuscitate (DNR)|1|||
42349161|NCT00089986|76188759|FG000|Overall Study|Withdrawal by Subject|3|||
42349162|NCT00089986|76188760|FG001|Overall Study|Withdrawal by Subject|6|||
42349163|NCT00089986|76188761|FG002|Overall Study|Withdrawal by Subject|2|||
42349164|NCT01689207|76188784|FG000|Overall Study|Adverse Event|0|||
42349165|NCT01689207|76188785|FG001|Overall Study|Adverse Event|1|||
42349166|NCT01689207|76188786|FG002|Overall Study|Adverse Event|0|||
42349167|NCT01689207|76188787|FG003|Overall Study|Adverse Event|0|||
42349168|NCT01689207|76188788|FG004|Overall Study|Adverse Event|2|||
42274597|NCT01637272|76105477|FG000|Overall Study|Lost to Follow-up|2|||
42274598|NCT01637272|76105477|FG000|Overall Study|completed core, did not enter ext. phase|4|||
42274599|NCT01637272|76105477|FG000|Overall Study|Administrative problems|1|||
42274600|NCT01637272|76105477|FG000|Overall Study|Protocol Violation|2|||
42274601|NCT01636960|76105496|FG000|Induction Phase|Adverse Event|2|||
42274602|NCT01636960|76105496|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
42274603|NCT01636960|76105496|FG000|Maintenance Phase|Adverse Event|3|||
42274604|NCT01636960|76105496|FG000|Maintenance Phase|Progressive disease|1|||
42274605|NCT01636258|76105502|FG000|Overall Study|Lost to Follow-up|1|||
42274606|NCT01636258|76105503|FG001|Overall Study|Lost to Follow-up|0|||
42274607|NCT02504216|76105512|FG000|Overall Study|Lost to Follow-up|3|||
42274608|NCT02504216|76105513|FG001|Overall Study|Lost to Follow-up|3|||
42274609|NCT02504216|76105512|FG000|Overall Study|Withdrawal by Subject|8|||
42274610|NCT02504216|76105513|FG001|Overall Study|Withdrawal by Subject|12|||
42274611|NCT04354870|76105521|FG000|Overall Study|Lost to Follow-up|32|||
42274612|NCT04354870|76105522|FG001|Overall Study|Lost to Follow-up|12|||
42274613|NCT04354870|76105521|FG000|Overall Study|Withdrawal by Subject|10|||
42274614|NCT04354870|76105522|FG001|Overall Study|Withdrawal by Subject|16|||
42274615|NCT04354870|76105521|FG000|Overall Study|Did not complete all study visits|6|||
42274616|NCT04354870|76105522|FG001|Overall Study|Did not complete all study visits|5|||
42274617|NCT02473952|76105530|FG000|Overall Study|Adverse Event|2|||
42274618|NCT02473952|76105531|FG001|Overall Study|Adverse Event|2|||
42274619|NCT02473952|76105530|FG000|Overall Study|Withdrawal by Subject|0|||
42349169|NCT01689207|76188789|FG005|Overall Study|Adverse Event|1|||
42349170|NCT01689207|76188790|FG006|Overall Study|Adverse Event|0|||
42349171|NCT01689207|76188791|FG007|Overall Study|Adverse Event|0|||
42349172|NCT01689207|76188792|FG008|Overall Study|Adverse Event|1|||
42349173|NCT01689207|76188793|FG009|Overall Study|Adverse Event|0|||
42349174|NCT01689207|76188794|FG010|Overall Study|Adverse Event|0|||
42349175|NCT00089284|76188829|FG000|Overall Study|Adverse event before starting treatment|0|||
42349176|NCT00089284|76188830|FG001|Overall Study|Adverse event before starting treatment|0|||
42349177|NCT00089284|76188831|FG002|Overall Study|Adverse event before starting treatment|0|||
42349178|NCT00089284|76188832|FG003|Overall Study|Adverse event before starting treatment|0|||
42349179|NCT00089284|76188833|FG004|Overall Study|Adverse event before starting treatment|0|||
42349180|NCT00089284|76188834|FG005|Overall Study|Adverse event before starting treatment|0|||
42349181|NCT00089284|76188835|FG006|Overall Study|Adverse event before starting treatment|1|||
42349182|NCT01688973|76188859|FG000|Overall Study|Ineligible|2|||
42349183|NCT01688973|76188860|FG001|Overall Study|Ineligible|3|||
42349184|NCT00087646|76188871|FG000|Overall Study|Adverse Event|37|||
42349185|NCT00087646|76188872|FG001|Overall Study|Adverse Event|6|||
42349186|NCT00087646|76188873|FG002|Overall Study|Adverse Event|18|||
42349187|NCT00087646|76188874|FG003|Overall Study|Adverse Event|20|||
42349188|NCT00087646|76188871|FG000|Overall Study|Death|0|||
42349189|NCT00087646|76188872|FG001|Overall Study|Death|1|||
42274620|NCT02473952|76105531|FG001|Overall Study|Withdrawal by Subject|6|||
42274621|NCT02473640|76105537|FG000|Treatment Period 1|Adverse Event|1|||
42274622|NCT01637584|76105546|FG000|Overall Study|Withdrawal by Subject|1|||
42349190|NCT00087646|76188873|FG002|Overall Study|Death|0|||
42349191|NCT00087646|76188874|FG003|Overall Study|Death|0|||
42349192|NCT00087646|76188871|FG000|Overall Study|Withdrawal by Subject|6|||
42349193|NCT00087646|76188872|FG001|Overall Study|Withdrawal by Subject|1|||
42349194|NCT00087646|76188873|FG002|Overall Study|Withdrawal by Subject|2|||
42274623|NCT01637584|76105547|FG001|Overall Study|Withdrawal by Subject|3|||
42274624|NCT03883906|76105554|FG000|Overall Study|Withdrawal by Subject|2|||
42274625|NCT03883906|76105554|FG000|Overall Study|Physician Decision|5|||
42349195|NCT00087646|76188874|FG003|Overall Study|Withdrawal by Subject|2|||
42349196|NCT00087646|76188871|FG000|Overall Study|Insufficient therapeutic response|64|||
42037111|NCT01000974|75845431|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
42037112|NCT01000974|75845432|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
42037113|NCT01000974|75845430|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
42037114|NCT01000974|75845431|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
42037115|NCT01000974|75845432|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
42037116|NCT01000974|75845430|FG000|Primary Vaccination Phase|Protocol Violation|40|||
42037117|NCT01000974|75845431|FG001|Primary Vaccination Phase|Protocol Violation|3|||
42037118|NCT01000974|75845432|FG002|Primary Vaccination Phase|Protocol Violation|2|||
42037119|NCT01000974|75845430|FG000|Primary Vaccination Phase|Adverse Event|14|||
42037120|NCT01000974|75845431|FG001|Primary Vaccination Phase|Adverse Event|2|||
42037121|NCT01000974|75845432|FG002|Primary Vaccination Phase|Adverse Event|2|||
42037122|NCT01000974|75845430|FG000|Primary Vaccination Phase|Other|4|||
42037123|NCT01000974|75845431|FG001|Primary Vaccination Phase|Other|9|||
42037124|NCT01000974|75845432|FG002|Primary Vaccination Phase|Other|12|||
42037125|NCT01000974|75845430|FG000|Booster Vaccination Phase|Protocol Violation|0|||
42037126|NCT01000974|75845431|FG001|Booster Vaccination Phase|Protocol Violation|0|||
42037127|NCT01000974|75845432|FG002|Booster Vaccination Phase|Protocol Violation|2|||
42037128|NCT01000974|75845430|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
42037129|NCT01000974|75845431|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
42037130|NCT01000974|75845432|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
42037131|NCT01000974|75845430|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
42037132|NCT01000974|75845431|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
42037133|NCT01000974|75845432|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
42037134|NCT01000974|75845430|FG000|Booster Vaccination Phase|Other|24|||
42037135|NCT01000974|75845431|FG001|Booster Vaccination Phase|Other|6|||
42037136|NCT01000974|75845432|FG002|Booster Vaccination Phase|Other|4|||
42037137|NCT01004406|75845445|FG000|Overall Study|Withdrawal by Subject|2|||
42037138|NCT01004406|75845446|FG001|Overall Study|Withdrawal by Subject|0|||
42037139|NCT01004406|75845445|FG000|Overall Study|Lost to Follow-up|1|||
42037140|NCT01004406|75845446|FG001|Overall Study|Lost to Follow-up|0|||
42037141|NCT01182350|75845461|FG000|Overall Study|Adverse Event|5|||
42037142|NCT01182350|75845462|FG001|Overall Study|Adverse Event|0|||
42037143|NCT01182350|75845463|FG002|Overall Study|Adverse Event|0|||
42037144|NCT01182350|75845464|FG003|Overall Study|Adverse Event|0|||
42037145|NCT01182350|75845465|FG004|Overall Study|Adverse Event|0|||
42037146|NCT01182350|75845461|FG000|Overall Study|Disease Progression|15|||
42037147|NCT01182350|75845462|FG001|Overall Study|Disease Progression|12|||
42037148|NCT01182350|75845463|FG002|Overall Study|Disease Progression|0|||
42037149|NCT01182350|75845464|FG003|Overall Study|Disease Progression|1|||
42037150|NCT01182350|75845465|FG004|Overall Study|Disease Progression|0|||
42037151|NCT01182350|75845461|FG000|Overall Study|Death|0|||
42037152|NCT01182350|75845462|FG001|Overall Study|Death|1|||
42037153|NCT01182350|75845463|FG002|Overall Study|Death|1|||
42037154|NCT01182350|75845464|FG003|Overall Study|Death|0|||
42037155|NCT01182350|75845465|FG004|Overall Study|Death|0|||
42037156|NCT01182350|75845461|FG000|Overall Study|Withdrawal by Subject|3|||
42037157|NCT01182350|75845462|FG001|Overall Study|Withdrawal by Subject|1|||
42037158|NCT01182350|75845463|FG002|Overall Study|Withdrawal by Subject|0|||
42037159|NCT01182350|75845464|FG003|Overall Study|Withdrawal by Subject|1|||
42037160|NCT01182350|75845465|FG004|Overall Study|Withdrawal by Subject|0|||
42037161|NCT01182350|75845461|FG000|Overall Study|Alternative Therapy|2|||
42037162|NCT01182350|75845462|FG001|Overall Study|Alternative Therapy|0|||
42037163|NCT01182350|75845463|FG002|Overall Study|Alternative Therapy|1|||
42037164|NCT01182350|75845464|FG003|Overall Study|Alternative Therapy|0|||
42037165|NCT01182350|75845465|FG004|Overall Study|Alternative Therapy|0|||
42274626|NCT02503202|76105563|FG000|Base Study: Up to Month 6|Death|1|||
42274627|NCT02503202|76105564|FG001|Base Study: Up to Month 6|Death|1|||
42274628|NCT02503202|76105565|FG002|Base Study: Up to Month 6|Death|0|||
42274629|NCT02503202|76105566|FG003|Base Study: Up to Month 6|Death|0|||
42274630|NCT02503202|76105567|FG004|Base Study: Up to Month 6|Death|0|||
42274631|NCT02503202|76105563|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
42274632|NCT02503202|76105564|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
42274633|NCT02503202|76105565|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
42274634|NCT02503202|76105566|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
42274635|NCT02503202|76105567|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
42274636|NCT02503202|76105563|FG000|Base Study: Up to Month 6|Physician Decision|0|||
42274637|NCT02503202|76105564|FG001|Base Study: Up to Month 6|Physician Decision|0|||
42274638|NCT02503202|76105565|FG002|Base Study: Up to Month 6|Physician Decision|0|||
42274639|NCT02503202|76105566|FG003|Base Study: Up to Month 6|Physician Decision|0|||
42274640|NCT02503202|76105567|FG004|Base Study: Up to Month 6|Physician Decision|1|||
42349197|NCT00087646|76188872|FG001|Overall Study|Insufficient therapeutic response|24|||
42138745|NCT00321711|75948908|FG001|Part B|Physician Decision|0|||
42138746|NCT00321711|75948909|FG002|Part B|Physician Decision|0|||
42274641|NCT02503202|76105563|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
42274642|NCT02503202|76105564|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
42274643|NCT02503202|76105565|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
42274644|NCT02503202|76105566|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
42274645|NCT02503202|76105567|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
42274646|NCT02503202|76105563|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
42274647|NCT02503202|76105564|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
42349198|NCT00087646|76188873|FG002|Overall Study|Insufficient therapeutic response|38|||
42349199|NCT00087646|76188874|FG003|Overall Study|Insufficient therapeutic response|51|||
42349200|NCT00087646|76188871|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
42349201|NCT00087646|76188872|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
42349202|NCT00087646|76188873|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
42349203|NCT00087646|76188874|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
42349204|NCT00087646|76188871|FG000|Overall Study|Failure to Return|5|||
42349205|NCT00087646|76188872|FG001|Overall Study|Failure to Return|2|||
42349206|NCT00087646|76188873|FG002|Overall Study|Failure to Return|2|||
42349207|NCT00087646|76188874|FG003|Overall Study|Failure to Return|3|||
42349208|NCT00087646|76188871|FG000|Overall Study|Administrative/Other|6|||
42349209|NCT00087646|76188872|FG001|Overall Study|Administrative/Other|1|||
42349210|NCT00087646|76188873|FG002|Overall Study|Administrative/Other|1|||
42349211|NCT00087646|76188874|FG003|Overall Study|Administrative/Other|2|||
42349212|NCT00087646|76188871|FG000|Overall Study|Other Protocol Violation|3|||
42349213|NCT00087646|76188872|FG001|Overall Study|Other Protocol Violation|1|||
42349214|NCT00087646|76188873|FG002|Overall Study|Other Protocol Violation|0|||
42349215|NCT00087646|76188874|FG003|Overall Study|Other Protocol Violation|0|||
42011232|NCT01017952|75818201|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
42011233|NCT01017952|75818202|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
42011234|NCT01017952|75818203|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
42011235|NCT01017952|75818199|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
42011236|NCT01017952|75818200|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
42011237|NCT01017952|75818201|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
42011238|NCT01017952|75818202|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
42011239|NCT01017952|75818203|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
42011240|NCT01214655|75818216|FG000|Part A|Progressive Disease|7|||
42011241|NCT01214655|75818217|FG001|Part A|Progressive Disease|0|||
42011242|NCT01214655|75818218|FG002|Part A|Progressive Disease|0|||
42011243|NCT01214655|75818216|FG000|Part A|Physician Decision|1|||
42011244|NCT01214655|75818217|FG001|Part A|Physician Decision|0|||
42011245|NCT01214655|75818218|FG002|Part A|Physician Decision|0|||
42011246|NCT01214655|75818216|FG000|Part B|Progressive disease|0|||
42037166|NCT01182350|75845461|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
42037167|NCT01182350|75845462|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
42037168|NCT01182350|75845463|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
42037169|NCT01182350|75845464|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
42037170|NCT01182350|75845465|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
42037171|NCT01182350|75845461|FG000|Overall Study|Unevaluable for Biopsy|0|||
42037172|NCT01182350|75845462|FG001|Overall Study|Unevaluable for Biopsy|0|||
42037173|NCT01182350|75845463|FG002|Overall Study|Unevaluable for Biopsy|0|||
42037174|NCT01182350|75845464|FG003|Overall Study|Unevaluable for Biopsy|0|||
42037175|NCT01182350|75845465|FG004|Overall Study|Unevaluable for Biopsy|3|||
42037176|NCT01163474|75845481|FG000|Overall Study|Withdrawal by Subject|1|||
42037177|NCT01163474|75845481|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
42037178|NCT01163474|75845481|FG000|Overall Study|Lost to Follow-up|3|||
42037179|NCT00603538|75845491|FG000|Overall Study|Adverse Event|0|||
42037180|NCT00603538|75845492|FG001|Overall Study|Adverse Event|4|||
42037181|NCT00603538|75845493|FG002|Overall Study|Adverse Event|2|||
42037182|NCT00603538|75845491|FG000|Overall Study|Objective progression or relapse|3|||
42037183|NCT00603538|75845492|FG001|Overall Study|Objective progression or relapse|0|||
42037184|NCT00603538|75845493|FG002|Overall Study|Objective progression or relapse|0|||
42037185|NCT01163318|75845504|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
42037186|NCT01163318|75845504|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
42349216|NCT00087646|76188871|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
42349217|NCT00087646|76188872|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
42011247|NCT01214655|75818217|FG001|Part B|Progressive disease|10|||
42011248|NCT01214655|75818218|FG002|Part B|Progressive disease|0|||
42011249|NCT01214655|75818216|FG000|Part B|Death|0|||
42274648|NCT02503202|76105565|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
42011250|NCT01214655|75818217|FG001|Part B|Death|1|||
42037187|NCT01163318|75845504|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
42037188|NCT01163318|75845504|FG000|Overall Study|Participants Without Case Report Form|7|||
42011251|NCT01214655|75818218|FG002|Part B|Death|0|||
42011252|NCT01214655|75818216|FG000|Part B|Withdrawal by Subject|0|||
42037189|NCT01163318|75845504|FG000|Overall Study|Multiple Reasons Per Participant|224|||
42349218|NCT00087646|76188873|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
42037190|NCT01162304|75845508|FG000|Overall Study|Beck scale to high|11|||
42274649|NCT02503202|76105566|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
42274650|NCT02503202|76105567|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
42274651|NCT02503202|76105563|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
42274652|NCT02503202|76105564|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
42274653|NCT02503202|76105565|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
42274654|NCT02503202|76105566|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
42274655|NCT02503202|76105567|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
42274656|NCT02503202|76105563|FG000|Extension: Month 6 to 24|Death|1|||
42274657|NCT02503202|76105564|FG001|Extension: Month 6 to 24|Death|0|||
42274658|NCT02503202|76105565|FG002|Extension: Month 6 to 24|Death|0|||
42274659|NCT02503202|76105566|FG003|Extension: Month 6 to 24|Death|0|||
42274660|NCT02503202|76105567|FG004|Extension: Month 6 to 24|Death|0|||
42274661|NCT02503202|76105563|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
42274662|NCT02503202|76105564|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
42274663|NCT02503202|76105565|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
42274664|NCT02503202|76105566|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
42274665|NCT02503202|76105567|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
42274666|NCT02503202|76105563|FG000|Extension: Month 6 to 24|Physician Decision|1|||
42274667|NCT02503202|76105564|FG001|Extension: Month 6 to 24|Physician Decision|0|||
42274668|NCT02503202|76105565|FG002|Extension: Month 6 to 24|Physician Decision|1|||
42274669|NCT02503202|76105566|FG003|Extension: Month 6 to 24|Physician Decision|3|||
42037191|NCT04515394|75845514|FG000|Overall Study|Participant did not receive treatment|1|||
42037192|NCT01175018|75845520|FG000|Overall Study|Adverse Event|3|||
42274670|NCT02503202|76105567|FG004|Extension: Month 6 to 24|Physician Decision|0|||
42274671|NCT02503202|76105563|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
42011253|NCT01214655|75818217|FG001|Part B|Withdrawal by Subject|2|||
42274672|NCT02503202|76105564|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
42274673|NCT02503202|76105565|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
42274674|NCT02503202|76105566|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
42274675|NCT02503202|76105567|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
42274676|NCT02502734|76105579|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
42274677|NCT02502734|76105580|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
42274678|NCT02502734|76105579|FG000|Washout Period|Adverse Event|1|||
42274679|NCT02502734|76105580|FG001|Washout Period|Adverse Event|0|||
42274680|NCT02473250|76105588|FG000|Overall Study|Lost to Follow-up|10|||
42274681|NCT02473250|76105588|FG000|Overall Study|Physician Decision|5|||
42274682|NCT02473250|76105588|FG000|Overall Study|Did not tolerate medication washout|3|||
42274683|NCT02473250|76105588|FG000|Overall Study|Antidepressant effect of divalproex|2|||
42274684|NCT02706730|76105593|FG000|Overall Study|Adverse Event|3|||
42274685|NCT02706730|76105593|FG000|Overall Study|Lack of Efficacy|5|||
42349219|NCT00087646|76188874|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
42011254|NCT01214655|75818218|FG002|Part B|Withdrawal by Subject|0|||
42011255|NCT01214655|75818216|FG000|Part C|Progressive Disease|0|||
42011256|NCT01214655|75818217|FG001|Part C|Progressive Disease|0|||
42011257|NCT01214655|75818218|FG002|Part C|Progressive Disease|5|||
42011258|NCT01214655|75818216|FG000|Part C|Death|0|||
42011259|NCT01214655|75818217|FG001|Part C|Death|0|||
42011260|NCT01214655|75818218|FG002|Part C|Death|1|||
42274686|NCT02706730|76105593|FG000|Overall Study|Withdrawal by Subject|11|||
42274687|NCT02706730|76105593|FG000|Overall Study|Study Terminated by Sponsor|11|||
42274688|NCT02706730|76105593|FG000|Overall Study|Subject chose not to receive injection|3|||
42349220|NCT00087568|76188891|FG000|Overall Study|Adverse Event|4|||
42349221|NCT00087568|76188892|FG001|Overall Study|Adverse Event|0|||
42349222|NCT00087568|76188891|FG000|Overall Study|Withdrawal by Subject|1|||
42349223|NCT00087568|76188892|FG001|Overall Study|Withdrawal by Subject|1|||
42349224|NCT00087568|76188891|FG000|Overall Study|Lost to Follow-up|1|||
42349225|NCT00087568|76188892|FG001|Overall Study|Lost to Follow-up|0|||
42349226|NCT00087568|76188891|FG000|Overall Study|Lack of Efficacy|24|||
42349227|NCT00087568|76188892|FG001|Overall Study|Lack of Efficacy|1|||
42349228|NCT00085540|76188900|FG000|Overall Study|Withdrawal by Subject|0|||
42349229|NCT00085540|76188901|FG001|Overall Study|Withdrawal by Subject|1|||
42349230|NCT00085540|76188900|FG000|Overall Study|Protocol Violation|0|||
42349231|NCT00085540|76188901|FG001|Overall Study|Protocol Violation|1|||
42349232|NCT01688739|76188917|FG000|Overall Study|Administrative Decision|1|||
42037193|NCT01175018|75845521|FG001|Overall Study|Adverse Event|1|||
42011261|NCT01214655|75818216|FG000|Part C|Physician Decision|0|||
42037194|NCT01174784|75845529|FG000|Overall Study|Screen fails|4|||
42037195|NCT01174550|75845536|FG000|Overall Study|Death|75|||
42349233|NCT01688739|76188918|FG001|Overall Study|Administrative Decision|0|||
42011262|NCT01214655|75818217|FG001|Part C|Physician Decision|0|||
42274689|NCT02443688|76105600|FG000|Overall Study|Adverse Event|2|||
42274690|NCT02443688|76105601|FG001|Overall Study|Adverse Event|3|||
42274691|NCT02443688|76105602|FG002|Overall Study|Adverse Event|2|||
42274692|NCT02443688|76105600|FG000|Overall Study|Lost to Follow-up|1|||
42274693|NCT02443688|76105601|FG001|Overall Study|Lost to Follow-up|0|||
42274694|NCT02443688|76105602|FG002|Overall Study|Lost to Follow-up|0|||
42274695|NCT02443688|76105600|FG000|Overall Study|Physician Decision|3|||
42274696|NCT02443688|76105601|FG001|Overall Study|Physician Decision|0|||
42274697|NCT02443688|76105602|FG002|Overall Study|Physician Decision|1|||
42274698|NCT02443688|76105600|FG000|Overall Study|Pregnancy|0|||
42274699|NCT02443688|76105601|FG001|Overall Study|Pregnancy|0|||
42274700|NCT02443688|76105602|FG002|Overall Study|Pregnancy|1|||
42274701|NCT02443688|76105600|FG000|Overall Study|Withdrawal by Subject|3|||
42274702|NCT02443688|76105601|FG001|Overall Study|Withdrawal by Subject|3|||
42274703|NCT02443688|76105602|FG002|Overall Study|Withdrawal by Subject|4|||
42274704|NCT02443688|76105600|FG000|Overall Study|Non-compliance with study drug|1|||
42274705|NCT02443688|76105601|FG001|Overall Study|Non-compliance with study drug|2|||
42274706|NCT02443688|76105602|FG002|Overall Study|Non-compliance with study drug|4|||
42274707|NCT02443688|76105600|FG000|Overall Study|Sponsor Request|2|||
42274708|NCT02443688|76105601|FG001|Overall Study|Sponsor Request|1|||
42274709|NCT02443688|76105602|FG002|Overall Study|Sponsor Request|0|||
42274710|NCT02443298|76105616|FG000|Overall Study|Adverse Event|3|||
42274711|NCT02443298|76105617|FG001|Overall Study|Adverse Event|3|||
42274712|NCT02443298|76105616|FG000|Overall Study|Withdrawal by Subject|1|||
42274713|NCT02443298|76105617|FG001|Overall Study|Withdrawal by Subject|2|||
42349234|NCT01688739|76188919|FG002|Overall Study|Administrative Decision|0|||
42349235|NCT01688739|76188920|FG003|Overall Study|Administrative Decision|0|||
42349236|NCT01688739|76188921|FG004|Overall Study|Administrative Decision|0|||
42349237|NCT01688739|76188922|FG005|Overall Study|Administrative Decision|0|||
42349238|NCT01688739|76188923|FG006|Overall Study|Administrative Decision|0|||
42349239|NCT01688739|76188924|FG007|Overall Study|Administrative Decision|0|||
42349240|NCT01688739|76188925|FG008|Overall Study|Administrative Decision|0|||
42349241|NCT01688739|76188926|FG009|Overall Study|Administrative Decision|0|||
42349242|NCT00084838|76188956|FG000|Overall Study|Death|1|||
42349243|NCT00084838|76188956|FG000|Overall Study|Adverse Event|2|||
42349244|NCT00084838|76188956|FG000|Overall Study|Withdrawal by Subject|1|||
42349245|NCT00084838|76188956|FG000|Overall Study|Progressive Disease|4|||
42349246|NCT00084838|76188956|FG000|Overall Study|Pt Non-Compliance|1|||
42349247|NCT00084838|76188956|FG000|Overall Study|Ineligible|4|||
42349248|NCT01558089|76188962|FG000|Overall Study|Adverse Event|1|||
42349249|NCT01558089|76188962|FG000|Overall Study|Lack of Efficacy|1|||
42349250|NCT01558089|76188962|FG000|Overall Study|Lost to Follow-up|5|||
42349251|NCT01558089|76188962|FG000|Overall Study|Withdrawal by Subject|6|||
42349252|NCT01581021|76188968|FG000|Overall Study|Lost to Follow-up|4|||
42349253|NCT01581021|76188969|FG001|Overall Study|Lost to Follow-up|6|||
42349254|NCT01581021|76188968|FG000|Overall Study|More than 2 hooks in thoracic|3|||
42349255|NCT01581021|76188969|FG001|Overall Study|More than 2 hooks in thoracic|0|||
42349256|NCT01581021|76188968|FG000|Overall Study|Neuromuscular|2|||
42349257|NCT01581021|76188969|FG001|Overall Study|Neuromuscular|1|||
42349258|NCT01581021|76188968|FG000|Overall Study|Not Randomized|1|||
42349259|NCT01581021|76188969|FG001|Overall Study|Not Randomized|2|||
42349260|NCT01581021|76188968|FG000|Overall Study|Lenke 6 Classification|0|||
42349261|NCT01581021|76188969|FG001|Overall Study|Lenke 6 Classification|1|||
42349262|NCT01581021|76188968|FG000|Overall Study|Lack of Efficacy|0|||
42349263|NCT01581021|76188969|FG001|Overall Study|Lack of Efficacy|1|||
42349264|NCT00084682|76188975|FG000|Overall Study|Withdrawal by Subject|1|||
42349265|NCT01556997|76188983|FG000|Overall Study|Adverse Event|10|||
42011263|NCT01214655|75818218|FG002|Part C|Physician Decision|1|||
42274714|NCT02500706|76105626|FG000|Overall Study|Adverse Event|0|||
42274715|NCT02500706|76105627|FG001|Overall Study|Adverse Event|0|||
42274716|NCT02500706|76105628|FG002|Overall Study|Adverse Event|1|||
42274717|NCT02500706|76105626|FG000|Overall Study|Lost to Follow-up|0|||
42274718|NCT02500706|76105627|FG001|Overall Study|Lost to Follow-up|1|||
42274719|NCT02500706|76105628|FG002|Overall Study|Lost to Follow-up|1|||
42274720|NCT02500706|76105626|FG000|Overall Study|Withdrawal by Subject|4|||
42349266|NCT01556997|76188984|FG001|Overall Study|Adverse Event|12|||
42349267|NCT01556997|76188985|FG002|Overall Study|Adverse Event|12|||
42349268|NCT01556997|76188983|FG000|Overall Study|Lost to Follow-up|6|||
42349269|NCT01556997|76188984|FG001|Overall Study|Lost to Follow-up|6|||
42349270|NCT01556997|76188985|FG002|Overall Study|Lost to Follow-up|4|||
42349271|NCT01556997|76188983|FG000|Overall Study|Physician Decision|1|||
42349272|NCT01556997|76188984|FG001|Overall Study|Physician Decision|1|||
42349273|NCT01556997|76188985|FG002|Overall Study|Physician Decision|1|||
42349274|NCT01556997|76188983|FG000|Overall Study|Withdrawal by Subject|7|||
42349275|NCT01556997|76188984|FG001|Overall Study|Withdrawal by Subject|6|||
42349276|NCT01556997|76188985|FG002|Overall Study|Withdrawal by Subject|8|||
42349277|NCT01556997|76188983|FG000|Overall Study|Other|2|||
42349278|NCT01556997|76188984|FG001|Overall Study|Other|3|||
42349279|NCT01556997|76188985|FG002|Overall Study|Other|7|||
42349280|NCT00082888|76188996|FG000|Overall Study|Ineligible|1|||
42349281|NCT00082888|76188997|FG001|Overall Study|Ineligible|0|||
42349282|NCT00082888|76188998|FG002|Overall Study|Ineligible|0|||
42349283|NCT00082810|76189007|FG000|Overall Study|Adverse Event|3|||
42349284|NCT00082810|76189007|FG000|Overall Study|Progressive disease|24|||
42349285|NCT00082810|76189007|FG000|Overall Study|Withdrawal by Subject|4|||
42349286|NCT01577745|76189018|FG000|Overall Study|Withdrawal by Subject|0|||
42349287|NCT01577745|76189019|FG001|Overall Study|Withdrawal by Subject|1|||
42349288|NCT01577745|76189020|FG002|Overall Study|Withdrawal by Subject|0|||
42349289|NCT01577745|76189021|FG003|Overall Study|Withdrawal by Subject|3|||
42349290|NCT01577745|76189022|FG004|Overall Study|Withdrawal by Subject|2|||
42349291|NCT01577745|76189023|FG005|Overall Study|Withdrawal by Subject|0|||
42349292|NCT01577745|76189018|FG000|Overall Study|Death|3|||
42349293|NCT01577745|76189019|FG001|Overall Study|Death|2|||
42349294|NCT01577745|76189020|FG002|Overall Study|Death|2|||
42349295|NCT01577745|76189021|FG003|Overall Study|Death|1|||
42349296|NCT01577745|76189022|FG004|Overall Study|Death|1|||
42349297|NCT01577745|76189023|FG005|Overall Study|Death|3|||
42349298|NCT01577745|76189018|FG000|Overall Study|Physician Decision|0|||
42349299|NCT01577745|76189019|FG001|Overall Study|Physician Decision|0|||
42349300|NCT01577745|76189020|FG002|Overall Study|Physician Decision|0|||
42349301|NCT01577745|76189021|FG003|Overall Study|Physician Decision|1|||
42349302|NCT01577745|76189022|FG004|Overall Study|Physician Decision|1|||
42349303|NCT01577745|76189023|FG005|Overall Study|Physician Decision|0|||
42349304|NCT01577745|76189018|FG000|Overall Study|Lost to Follow-up|0|||
42349305|NCT01577745|76189019|FG001|Overall Study|Lost to Follow-up|0|||
42349306|NCT01577745|76189020|FG002|Overall Study|Lost to Follow-up|0|||
42349307|NCT01577745|76189021|FG003|Overall Study|Lost to Follow-up|0|||
42349308|NCT01577745|76189022|FG004|Overall Study|Lost to Follow-up|0|||
42349309|NCT01577745|76189023|FG005|Overall Study|Lost to Follow-up|1|||
42349310|NCT01577745|76189018|FG000|Overall Study|Alternative Therapy|0|||
42349311|NCT01577745|76189019|FG001|Overall Study|Alternative Therapy|0|||
42349312|NCT01577745|76189020|FG002|Overall Study|Alternative Therapy|0|||
42349313|NCT01577745|76189021|FG003|Overall Study|Alternative Therapy|1|||
42349314|NCT01577745|76189022|FG004|Overall Study|Alternative Therapy|1|||
42349315|NCT01577745|76189023|FG005|Overall Study|Alternative Therapy|0|||
42349316|NCT01688037|76189045|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
42349317|NCT01688037|76189046|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
42349318|NCT01688037|76189047|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
42349319|NCT01688037|76189045|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
42349320|NCT01688037|76189046|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
42349321|NCT01688037|76189047|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
42349322|NCT01688037|76189045|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
42349323|NCT01688037|76189046|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
42349324|NCT01688037|76189047|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
42349325|NCT01688037|76189045|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
42349326|NCT01688037|76189046|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
42349327|NCT01688037|76189047|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
42349328|NCT01688037|76189045|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
42349329|NCT01688037|76189046|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
42349330|NCT01688037|76189047|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
42349331|NCT01688037|76189045|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
42349332|NCT01688037|76189046|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
42349333|NCT01688037|76189047|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
42349334|NCT01688037|76189045|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
42349335|NCT01688037|76189046|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
42349336|NCT01688037|76189047|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
42349337|NCT01688037|76189045|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
42349338|NCT01688037|76189046|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
42349339|NCT01688037|76189047|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
42349340|NCT01688037|76189045|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
42349341|NCT01688037|76189046|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
42349342|NCT01688037|76189047|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
42349343|NCT01688037|76189045|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
42349344|NCT01688037|76189046|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
42349345|NCT01688037|76189047|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
42349346|NCT01610336|76189070|FG000|Overall Study|Progressive Disease|4|||
42349347|NCT01610336|76189071|FG001|Overall Study|Progressive Disease|6|||
42349348|NCT01610336|76189072|FG002|Overall Study|Progressive Disease|6|||
42349349|NCT01610336|76189073|FG003|Overall Study|Progressive Disease|5|||
42349350|NCT01610336|76189074|FG004|Overall Study|Progressive Disease|3|||
42349351|NCT01610336|76189075|FG005|Overall Study|Progressive Disease|10|||
42349352|NCT01610336|76189076|FG006|Overall Study|Progressive Disease|1|||
42349353|NCT01610336|76189077|FG007|Overall Study|Progressive Disease|6|||
42349354|NCT01610336|76189078|FG008|Overall Study|Progressive Disease|6|||
42349355|NCT01610336|76189079|FG009|Overall Study|Progressive Disease|40|||
42349356|NCT01610336|76189080|FG010|Overall Study|Progressive Disease|36|||
42349357|NCT01610336|76189070|FG000|Overall Study|Adverse Event|0|||
42349358|NCT01610336|76189071|FG001|Overall Study|Adverse Event|0|||
42349359|NCT01610336|76189072|FG002|Overall Study|Adverse Event|0|||
42349360|NCT01610336|76189073|FG003|Overall Study|Adverse Event|1|||
42349361|NCT01610336|76189074|FG004|Overall Study|Adverse Event|1|||
42349362|NCT01610336|76189075|FG005|Overall Study|Adverse Event|1|||
42349363|NCT01610336|76189076|FG006|Overall Study|Adverse Event|0|||
42349364|NCT01610336|76189077|FG007|Overall Study|Adverse Event|0|||
42349365|NCT01610336|76189078|FG008|Overall Study|Adverse Event|2|||
42349366|NCT01610336|76189079|FG009|Overall Study|Adverse Event|8|||
42349367|NCT01610336|76189080|FG010|Overall Study|Adverse Event|6|||
42349368|NCT01610336|76189070|FG000|Overall Study|Subject/Guardian decision|1|||
42349369|NCT01610336|76189071|FG001|Overall Study|Subject/Guardian decision|1|||
42349370|NCT01610336|76189072|FG002|Overall Study|Subject/Guardian decision|0|||
42349371|NCT01610336|76189073|FG003|Overall Study|Subject/Guardian decision|1|||
42349372|NCT01610336|76189074|FG004|Overall Study|Subject/Guardian decision|0|||
42349373|NCT01610336|76189075|FG005|Overall Study|Subject/Guardian decision|0|||
42349374|NCT01610336|76189076|FG006|Overall Study|Subject/Guardian decision|0|||
42349375|NCT01610336|76189077|FG007|Overall Study|Subject/Guardian decision|1|||
42349376|NCT01610336|76189078|FG008|Overall Study|Subject/Guardian decision|0|||
42349377|NCT01610336|76189079|FG009|Overall Study|Subject/Guardian decision|2|||
42349378|NCT01610336|76189080|FG010|Overall Study|Subject/Guardian decision|2|||
42349379|NCT01610336|76189070|FG000|Overall Study|Death|0|||
42349380|NCT01610336|76189071|FG001|Overall Study|Death|0|||
42349381|NCT01610336|76189072|FG002|Overall Study|Death|0|||
42349382|NCT01610336|76189073|FG003|Overall Study|Death|0|||
42349383|NCT01610336|76189074|FG004|Overall Study|Death|0|||
42274721|NCT02500706|76105627|FG001|Overall Study|Withdrawal by Subject|6|||
42274722|NCT02500706|76105628|FG002|Overall Study|Withdrawal by Subject|4|||
42274723|NCT02500706|76105626|FG000|Overall Study|Unclassified|0|||
42274724|NCT02500706|76105627|FG001|Overall Study|Unclassified|0|||
42274725|NCT02500706|76105628|FG002|Overall Study|Unclassified|1|||
42274726|NCT02442830|76105638|FG000|Overall Study|Technical Failure|0|||
42274727|NCT02442830|76105639|FG001|Overall Study|Technical Failure|1|||
42274728|NCT02471612|76105646|FG000|Overall Study|Lost to Follow-up|2|||
42274729|NCT02500550|76105663|FG000|Overall Study|Death|7|||
42274730|NCT02499770|76105669|FG000|Overall Study|Death|17|||
42274731|NCT02499770|76105670|FG001|Overall Study|Death|56|||
42349384|NCT01610336|76189075|FG005|Overall Study|Death|1|||
42349385|NCT01610336|76189076|FG006|Overall Study|Death|3|||
42349386|NCT01610336|76189077|FG007|Overall Study|Death|0|||
42349387|NCT01610336|76189078|FG008|Overall Study|Death|0|||
42349388|NCT01610336|76189079|FG009|Overall Study|Death|1|||
42349389|NCT01610336|76189080|FG010|Overall Study|Death|2|||
42349390|NCT01610336|76189070|FG000|Overall Study|Non-Compliance with study treatment|0|||
42349391|NCT01610336|76189071|FG001|Overall Study|Non-Compliance with study treatment|0|||
42349392|NCT01610336|76189072|FG002|Overall Study|Non-Compliance with study treatment|0|||
42349393|NCT01610336|76189073|FG003|Overall Study|Non-Compliance with study treatment|0|||
42349394|NCT01610336|76189074|FG004|Overall Study|Non-Compliance with study treatment|0|||
42349395|NCT01610336|76189075|FG005|Overall Study|Non-Compliance with study treatment|0|||
42349396|NCT01610336|76189076|FG006|Overall Study|Non-Compliance with study treatment|0|||
42349397|NCT01610336|76189077|FG007|Overall Study|Non-Compliance with study treatment|0|||
42349398|NCT01610336|76189078|FG008|Overall Study|Non-Compliance with study treatment|0|||
42349399|NCT01610336|76189079|FG009|Overall Study|Non-Compliance with study treatment|1|||
42349400|NCT01610336|76189080|FG010|Overall Study|Non-Compliance with study treatment|0|||
42349401|NCT01610336|76189070|FG000|Overall Study|Physician Decision|0|||
42349402|NCT01610336|76189071|FG001|Overall Study|Physician Decision|0|||
42349403|NCT01610336|76189072|FG002|Overall Study|Physician Decision|0|||
42349404|NCT01610336|76189073|FG003|Overall Study|Physician Decision|0|||
42349405|NCT01610336|76189074|FG004|Overall Study|Physician Decision|0|||
42349406|NCT01610336|76189075|FG005|Overall Study|Physician Decision|0|||
42349407|NCT01610336|76189076|FG006|Overall Study|Physician Decision|1|||
42274732|NCT02499770|76105669|FG000|Overall Study|Study completion|1|||
42274733|NCT02499770|76105670|FG001|Overall Study|Study completion|10|||
42349408|NCT01610336|76189077|FG007|Overall Study|Physician Decision|0|||
42349409|NCT01610336|76189078|FG008|Overall Study|Physician Decision|0|||
42274734|NCT02499770|76105669|FG000|Overall Study|Withdrawal by Subject|0|||
42274735|NCT02499770|76105670|FG001|Overall Study|Withdrawal by Subject|7|||
42349410|NCT01610336|76189079|FG009|Overall Study|Physician Decision|0|||
42274736|NCT02499770|76105669|FG000|Overall Study|Lost to Follow-up|0|||
42349411|NCT01610336|76189080|FG010|Overall Study|Physician Decision|0|||
42349412|NCT01610336|76189070|FG000|Overall Study|Protocol Deviation|0|||
42349413|NCT01610336|76189071|FG001|Overall Study|Protocol Deviation|0|||
42349414|NCT01610336|76189072|FG002|Overall Study|Protocol Deviation|0|||
42349415|NCT01610336|76189073|FG003|Overall Study|Protocol Deviation|0|||
42349416|NCT01610336|76189074|FG004|Overall Study|Protocol Deviation|0|||
42349417|NCT01610336|76189075|FG005|Overall Study|Protocol Deviation|0|||
42349418|NCT01610336|76189076|FG006|Overall Study|Protocol Deviation|0|||
42349419|NCT01610336|76189077|FG007|Overall Study|Protocol Deviation|0|||
42349420|NCT01610336|76189078|FG008|Overall Study|Protocol Deviation|0|||
42274737|NCT02499770|76105670|FG001|Overall Study|Lost to Follow-up|2|||
42349421|NCT01610336|76189079|FG009|Overall Study|Protocol Deviation|1|||
42349422|NCT01610336|76189080|FG010|Overall Study|Protocol Deviation|0|||
42274738|NCT02499770|76105669|FG000|Overall Study|Subject declined further treatment|1|||
42274739|NCT02499770|76105670|FG001|Overall Study|Subject declined further treatment|0|||
42274740|NCT02499770|76105669|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
42274741|NCT02499770|76105670|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
42274742|NCT02499770|76105669|FG000|Overall Study|Randomized but not enrolled|0|||
42274743|NCT02499770|76105670|FG001|Overall Study|Randomized but not enrolled|1|||
42274744|NCT02442284|76105682|FG000|Overall Study|Adverse Event|1|||
42274745|NCT02442284|76105682|FG000|Overall Study|Withdrew Consent|2|||
42274746|NCT02442284|76105682|FG000|Overall Study|Lost to Follow-up|3|||
42274747|NCT02442284|76105682|FG000|Overall Study|Other|1|||
42274748|NCT02442206|76105692|FG000|Period 1|Adverse Event|1|||
42274749|NCT02442206|76105693|FG001|Period 1|Adverse Event|1|||
42274750|NCT02442206|76105692|FG000|Period 1|withdrew consent|0|||
42274751|NCT02442206|76105693|FG001|Period 1|withdrew consent|1|||
42274752|NCT02442206|76105692|FG000|Period 1|COPD exacerbation|0|||
42274753|NCT02442206|76105693|FG001|Period 1|COPD exacerbation|1|||
42274754|NCT02442206|76105692|FG000|Period 2|Adverse Event|1|||
42274755|NCT02442206|76105693|FG001|Period 2|Adverse Event|0|||
42274756|NCT02499146|76105700|FG000|Overall Study|Lost to Follow-up|1|||
42274757|NCT02499146|76105700|FG000|Overall Study|Withdrawal by Subject|1|||
42274758|NCT02499146|76105700|FG000|Overall Study|Other|2|||
42274759|NCT02499146|76105700|FG000|Overall Study|Ongoing at date of cut-off|9|||
42274760|NCT02499146|76105700|FG000|Overall Study|Began other treatment/therapy|13|||
42274761|NCT03544138|76105704|FG000|Overall Study|Lost to Follow-up|29|||
42274762|NCT01634854|76105710|FG000|Overall Study|Cesarean delivery|2|||
42274763|NCT01634854|76105711|FG001|Overall Study|Cesarean delivery|7|||
42274764|NCT02469896|76105719|FG000|Overall Study|Withdrawal by Subject|2|||
42274765|NCT02469896|76105720|FG001|Overall Study|Withdrawal by Subject|0|||
42274766|NCT02441114|76105730|FG000|Washout2|Withdrawal by Subject|4|||
42274767|NCT02498678|76105736|FG000|Overall Study|interference from the surgical team|0|||
42349423|NCT01610336|76189070|FG000|Overall Study|Transfer to another trial|0|||
42349424|NCT01610336|76189071|FG001|Overall Study|Transfer to another trial|0|||
42349425|NCT01610336|76189072|FG002|Overall Study|Transfer to another trial|0|||
42349426|NCT01610336|76189073|FG003|Overall Study|Transfer to another trial|0|||
42349427|NCT01610336|76189074|FG004|Overall Study|Transfer to another trial|0|||
42349428|NCT01610336|76189075|FG005|Overall Study|Transfer to another trial|0|||
42349429|NCT01610336|76189076|FG006|Overall Study|Transfer to another trial|0|||
42349430|NCT01610336|76189077|FG007|Overall Study|Transfer to another trial|0|||
42349431|NCT01610336|76189078|FG008|Overall Study|Transfer to another trial|0|||
42349432|NCT01610336|76189079|FG009|Overall Study|Transfer to another trial|0|||
42349433|NCT01610336|76189080|FG010|Overall Study|Transfer to another trial|1|||
42349434|NCT01613222|76189108|FG000|Overall Study|Physician Decision|1|||
42349435|NCT01613222|76189108|FG000|Overall Study|Unable to place arterial line|1|||
42349436|NCT01613222|76189108|FG000|Overall Study|Reused disposable sensors|10|||
42349437|NCT01612676|76189155|FG000|Overall Study|Adverse Event|2|||
42349438|NCT01612676|76189156|FG001|Overall Study|Adverse Event|3|||
42349439|NCT01612676|76189157|FG002|Overall Study|Adverse Event|1|||
42349440|NCT01612676|76189158|FG003|Overall Study|Adverse Event|3|||
42349441|NCT01612676|76189155|FG000|Overall Study|Protocol Violation|0|||
42349442|NCT01612676|76189156|FG001|Overall Study|Protocol Violation|1|||
42349443|NCT01612676|76189157|FG002|Overall Study|Protocol Violation|0|||
42349444|NCT01612676|76189158|FG003|Overall Study|Protocol Violation|0|||
42349445|NCT01869764|76189172|FG000|Overall Study|Withdrawal by Subject|0|||
42349446|NCT01869764|76189173|FG001|Overall Study|Withdrawal by Subject|2|||
42349447|NCT01842620|76189179|FG000|Period 1|Withdrawal by Subject|1|||
42274768|NCT02498678|76105737|FG001|Overall Study|interference from the surgical team|2|||
42274769|NCT02441036|76105748|FG000|Overall Study|No tissue resected|0|||
42274770|NCT02441036|76105749|FG001|Overall Study|No tissue resected|1|||
42274771|NCT02441036|76105750|FG002|Overall Study|No tissue resected|0|||
42274772|NCT02441036|76105751|FG003|Overall Study|No tissue resected|1|||
42274773|NCT02441036|76105752|FG004|Overall Study|No tissue resected|0|||
42274774|NCT02498444|76105767|FG000|Overall Study|Withdrawal by Subject|3|||
42274775|NCT02498444|76105768|FG001|Overall Study|Withdrawal by Subject|0|||
42349448|NCT01842620|76189180|FG001|Period 1|Withdrawal by Subject|0|||
42349449|NCT01931839|76189206|FG000|Overall Study|Death|0|||
42349450|NCT01931839|76189207|FG001|Overall Study|Death|1|||
42349451|NCT01931839|76189208|FG002|Overall Study|Death|2|||
42349452|NCT01931839|76189209|FG003|Overall Study|Death|0|||
42349453|NCT01931839|76189210|FG004|Overall Study|Death|0|||
42349454|NCT01931839|76189211|FG005|Overall Study|Death|0|||
42349455|NCT01931839|76189212|FG006|Overall Study|Death|0|||
42274776|NCT02498444|76105767|FG000|Overall Study|Physician Decision|1|||
42274777|NCT02498444|76105768|FG001|Overall Study|Physician Decision|0|||
42274778|NCT02497976|76105776|FG000|Overall Study|Withdrawal by Subject|2|||
42274779|NCT02497976|76105777|FG001|Overall Study|Withdrawal by Subject|0|||
42274780|NCT02497976|76105776|FG000|Overall Study|Moved out of area|0|||
42274781|NCT02497976|76105777|FG001|Overall Study|Moved out of area|1|||
42274782|NCT03347188|76105785|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
42274783|NCT03347188|76105786|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
42274784|NCT03347188|76105785|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
42274785|NCT03347188|76105786|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
42274786|NCT03347188|76105785|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
42349456|NCT01931839|76189206|FG000|Overall Study|Physician Decision|1|||
42349457|NCT01931839|76189207|FG001|Overall Study|Physician Decision|0|||
42349458|NCT01931839|76189208|FG002|Overall Study|Physician Decision|1|||
42349459|NCT01931839|76189209|FG003|Overall Study|Physician Decision|0|||
42349460|NCT01931839|76189210|FG004|Overall Study|Physician Decision|0|||
42349461|NCT01931839|76189211|FG005|Overall Study|Physician Decision|0|||
42349462|NCT01931839|76189212|FG006|Overall Study|Physician Decision|1|||
42349463|NCT01931839|76189206|FG000|Overall Study|Withdrawal of consent|0|||
42349464|NCT01931839|76189207|FG001|Overall Study|Withdrawal of consent|0|||
42349465|NCT01931839|76189208|FG002|Overall Study|Withdrawal of consent|0|||
42349466|NCT01931839|76189209|FG003|Overall Study|Withdrawal of consent|0|||
42349467|NCT01931839|76189210|FG004|Overall Study|Withdrawal of consent|1|||
42349468|NCT01931839|76189211|FG005|Overall Study|Withdrawal of consent|0|||
42349469|NCT01931839|76189212|FG006|Overall Study|Withdrawal of consent|0|||
42349470|NCT01931839|76189206|FG000|Overall Study|Adverse Event|9|||
42349471|NCT01931839|76189207|FG001|Overall Study|Adverse Event|4|||
42349472|NCT01931839|76189208|FG002|Overall Study|Adverse Event|1|||
42349473|NCT01931839|76189209|FG003|Overall Study|Adverse Event|3|||
42349474|NCT01931839|76189210|FG004|Overall Study|Adverse Event|0|||
42349475|NCT01931839|76189211|FG005|Overall Study|Adverse Event|0|||
42349476|NCT01931839|76189212|FG006|Overall Study|Adverse Event|1|||
42349477|NCT01931839|76189206|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
42349478|NCT01931839|76189207|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
42349479|NCT01931839|76189208|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
42349480|NCT01931839|76189209|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
42349481|NCT01931839|76189210|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
42349482|NCT01931839|76189211|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
42349483|NCT01931839|76189212|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
42349484|NCT01931839|76189206|FG000|Overall Study|Other non-compliance|15|||
42349485|NCT01931839|76189207|FG001|Overall Study|Other non-compliance|9|||
42349486|NCT01931839|76189208|FG002|Overall Study|Other non-compliance|12|||
42349487|NCT01931839|76189209|FG003|Overall Study|Other non-compliance|3|||
42349488|NCT01931839|76189210|FG004|Overall Study|Other non-compliance|0|||
42349489|NCT01931839|76189211|FG005|Overall Study|Other non-compliance|3|||
42349490|NCT01931839|76189212|FG006|Overall Study|Other non-compliance|0|||
42349491|NCT01931839|76189206|FG000|Overall Study|Lost to Follow-up|1|||
42349492|NCT01931839|76189207|FG001|Overall Study|Lost to Follow-up|2|||
42349493|NCT01931839|76189208|FG002|Overall Study|Lost to Follow-up|4|||
42349494|NCT01931839|76189209|FG003|Overall Study|Lost to Follow-up|5|||
42349495|NCT01931839|76189210|FG004|Overall Study|Lost to Follow-up|0|||
42349496|NCT01931839|76189211|FG005|Overall Study|Lost to Follow-up|0|||
42349497|NCT01931839|76189212|FG006|Overall Study|Lost to Follow-up|0|||
42349498|NCT01931839|76189206|FG000|Overall Study|Other|4|||
42349499|NCT01931839|76189207|FG001|Overall Study|Other|2|||
42349500|NCT01931839|76189208|FG002|Overall Study|Other|6|||
42349501|NCT01931839|76189209|FG003|Overall Study|Other|0|||
42349502|NCT01931839|76189210|FG004|Overall Study|Other|0|||
42349503|NCT01931839|76189211|FG005|Overall Study|Other|0|||
42349504|NCT01931839|76189212|FG006|Overall Study|Other|0|||
42037196|NCT01174550|75845537|FG001|Overall Study|Death|74|||
42037197|NCT01174550|75845536|FG000|Overall Study|Lost to Follow-up|652|||
42037198|NCT01174550|75845537|FG001|Overall Study|Lost to Follow-up|510|||
42349505|NCT01842308|76189237|FG000|Overall Study|Withdrawal by Subject|0|||
42349506|NCT01842308|76189238|FG001|Overall Study|Withdrawal by Subject|0|||
42349507|NCT01842308|76189239|FG002|Overall Study|Withdrawal by Subject|0|||
42274787|NCT03347188|76105786|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
42349508|NCT01842308|76189240|FG003|Overall Study|Withdrawal by Subject|0|||
42349509|NCT01842308|76189241|FG004|Overall Study|Withdrawal by Subject|1|||
42349510|NCT01931059|76189256|FG000|Day 1|Pregnancy|0|||
42349511|NCT01931059|76189257|FG001|Day 1|Pregnancy|1|||
42349512|NCT01931059|76189256|FG000|Day3|Lost to Follow-up|1|||
42349513|NCT01931059|76189257|FG001|Day3|Lost to Follow-up|0|||
42349514|NCT01841762|76189269|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
42349515|NCT01841762|76189269|FG000|Treatment Period|Adverse Event|16|||
42274788|NCT03347188|76105785|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
42274789|NCT03347188|76105786|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
42274790|NCT03347188|76105785|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
42274791|NCT03347188|76105786|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
42274792|NCT03347188|76105785|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
42274793|NCT03347188|76105786|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
42274794|NCT03347188|76105785|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
42274795|NCT03347188|76105786|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
42274796|NCT03347188|76105785|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
42274797|NCT03347188|76105786|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
42274798|NCT02440568|76105796|FG000|Overall Study|Death|1|||
42274799|NCT02440568|76105797|FG001|Overall Study|Death|3|||
42274800|NCT02440568|76105798|FG002|Overall Study|Death|4|||
42274801|NCT02440568|76105799|FG003|Overall Study|Death|2|||
42274802|NCT02440568|76105796|FG000|Overall Study|Lack of Efficacy|2|||
42274803|NCT02440568|76105797|FG001|Overall Study|Lack of Efficacy|0|||
42274804|NCT02440568|76105798|FG002|Overall Study|Lack of Efficacy|1|||
42274805|NCT02440568|76105799|FG003|Overall Study|Lack of Efficacy|0|||
42274806|NCT02440568|76105796|FG000|Overall Study|Lost to Follow-up|1|||
42274807|NCT02440568|76105797|FG001|Overall Study|Lost to Follow-up|0|||
42274808|NCT02440568|76105798|FG002|Overall Study|Lost to Follow-up|0|||
42274809|NCT02440568|76105799|FG003|Overall Study|Lost to Follow-up|0|||
42274810|NCT03090191|76105812|FG000|Overall Study|Adverse Event|90|||
42274811|NCT03090191|76105813|FG001|Overall Study|Adverse Event|72|||
42274812|NCT03090191|76105812|FG000|Overall Study|Death|365|||
42274813|NCT03090191|76105813|FG001|Overall Study|Death|358|||
42274814|NCT03090191|76105812|FG000|Overall Study|Lost to Follow-up|382|||
42274815|NCT03090191|76105813|FG001|Overall Study|Lost to Follow-up|394|||
42274816|NCT03090191|76105812|FG000|Overall Study|Physician Decision|77|||
42274817|NCT03090191|76105813|FG001|Overall Study|Physician Decision|66|||
42274818|NCT03090191|76105812|FG000|Overall Study|Protocol Violation|43|||
42274819|NCT03090191|76105813|FG001|Overall Study|Protocol Violation|52|||
42274820|NCT03090191|76105812|FG000|Overall Study|Withdrawal by Subject|2160|||
42274821|NCT03090191|76105813|FG001|Overall Study|Withdrawal by Subject|2133|||
42274822|NCT03090191|76105812|FG000|Overall Study|Site terminated|7|||
42274823|NCT03090191|76105813|FG001|Overall Study|Site terminated|8|||
42274824|NCT03090191|76105812|FG000|Overall Study|Other|66|||
42274825|NCT03090191|76105813|FG001|Overall Study|Other|60|||
42274826|NCT03090191|76105812|FG000|Overall Study|Withdrawn before any study vaccination|43|||
42274827|NCT03090191|76105813|FG001|Overall Study|Withdrawn before any study vaccination|52|||
42274828|NCT02439320|76105835|FG000|Overall Study|Adverse Event|0|||
42274829|NCT02439320|76105836|FG001|Overall Study|Adverse Event|2|||
42274830|NCT02439320|76105837|FG002|Overall Study|Adverse Event|0|||
42274831|NCT02439320|76105835|FG000|Overall Study|Lost to Follow-up|37|||
42274832|NCT02439320|76105836|FG001|Overall Study|Lost to Follow-up|34|||
42274833|NCT02439320|76105837|FG002|Overall Study|Lost to Follow-up|42|||
42274834|NCT02439320|76105835|FG000|Overall Study|Death|0|||
42274835|NCT02439320|76105836|FG001|Overall Study|Death|1|||
42274836|NCT02439320|76105837|FG002|Overall Study|Death|0|||
42274837|NCT02439320|76105835|FG000|Overall Study|Noncompliance with Protocol|10|||
42274838|NCT02439320|76105836|FG001|Overall Study|Noncompliance with Protocol|11|||
42274839|NCT02439320|76105837|FG002|Overall Study|Noncompliance with Protocol|7|||
42274840|NCT02439320|76105835|FG000|Overall Study|Pregnancy|0|||
42274841|NCT02439320|76105836|FG001|Overall Study|Pregnancy|1|||
42274842|NCT02439320|76105837|FG002|Overall Study|Pregnancy|1|||
42349516|NCT01841762|76189269|FG000|Treatment Period|Death|1|||
42274843|NCT02439320|76105835|FG000|Overall Study|Withdrawal by Subject|12|||
42037199|NCT01174550|75845536|FG000|Overall Study|Withdrawal by Subject|543|||
42274844|NCT02439320|76105836|FG001|Overall Study|Withdrawal by Subject|16|||
42274845|NCT02439320|76105837|FG002|Overall Study|Withdrawal by Subject|14|||
42274846|NCT02439320|76105835|FG000|Overall Study|Physician Decision|2|||
42274847|NCT02439320|76105836|FG001|Overall Study|Physician Decision|1|||
42274848|NCT02439320|76105837|FG002|Overall Study|Physician Decision|0|||
42274849|NCT02439320|76105835|FG000|Overall Study|Sponsor Request|0|||
42274850|NCT02439320|76105836|FG001|Overall Study|Sponsor Request|2|||
42274851|NCT02439320|76105837|FG002|Overall Study|Sponsor Request|1|||
42274852|NCT02439320|76105835|FG000|Overall Study|Randomization Failure|35|||
42349517|NCT01841762|76189269|FG000|Treatment Period|Withdrawal by Subject|7|||
42349518|NCT01841762|76189269|FG000|Treatment Period|Lost to Follow-up|1|||
42138747|NCT00321711|75948910|FG003|Part B|Physician Decision|1|||
42138748|NCT00321711|75948911|FG004|Part B|Physician Decision|2|||
42138749|NCT00321711|75948907|FG000|Part B|Death|0|||
42138750|NCT00321711|75948908|FG001|Part B|Death|0|||
42138751|NCT00321711|75948909|FG002|Part B|Death|0|||
42138752|NCT00321711|75948910|FG003|Part B|Death|2|||
42138753|NCT00321711|75948911|FG004|Part B|Death|1|||
42138754|NCT00486044|75948925|FG000|Overall Study|Withdrawal by Subject|2|||
42138755|NCT00486044|75948926|FG001|Overall Study|Withdrawal by Subject|1|||
42138756|NCT00486044|75948925|FG000|Overall Study|Adverse Event|0|||
42138757|NCT00486044|75948926|FG001|Overall Study|Adverse Event|1|||
42138758|NCT00486044|75948925|FG000|Overall Study|Lost to Follow-up|0|||
42138759|NCT00486044|75948926|FG001|Overall Study|Lost to Follow-up|1|||
42138760|NCT00351273|75948935|FG000|Overall Study|Lost to Follow-up|1|||
42138761|NCT00351273|75948936|FG001|Overall Study|Lost to Follow-up|2|||
42138762|NCT00351273|75948937|FG002|Overall Study|Lost to Follow-up|5|||
42138763|NCT00327717|75948952|FG000|Overall Study|Adverse Event|6|||
42138764|NCT00327717|75948953|FG001|Overall Study|Adverse Event|6|||
42138765|NCT00327717|75948952|FG000|Overall Study|Lack of Efficacy|0|||
42138766|NCT00327717|75948953|FG001|Overall Study|Lack of Efficacy|1|||
42138767|NCT00327717|75948952|FG000|Overall Study|Withdrawal by Subject|3|||
42138768|NCT00327717|75948953|FG001|Overall Study|Withdrawal by Subject|7|||
42138769|NCT00463346|75948961|FG000|Overall Study|Withdrawal by Subject|3|||
42138770|NCT00463346|75948962|FG001|Overall Study|Withdrawal by Subject|3|||
42138771|NCT00462488|75948972|FG000|Overall Study|Protocol Violation|1|||
42138772|NCT00462488|75948973|FG001|Overall Study|Protocol Violation|0|||
42138773|NCT00462488|75948972|FG000|Overall Study|Lack of Efficacy|19|||
42138774|NCT00462488|75948973|FG001|Overall Study|Lack of Efficacy|17|||
42138775|NCT00454142|75948979|FG000|Overall Study|Withdrawal by Subject|1|||
42138776|NCT00424476|75948988|FG000|Overall Study|Withdrawal by Subject|7|||
42138777|NCT00424476|75948989|FG001|Overall Study|Withdrawal by Subject|6|||
42138778|NCT00424476|75948990|FG002|Overall Study|Withdrawal by Subject|3|||
42138779|NCT00424476|75948988|FG000|Overall Study|Adverse Event|19|||
42138780|NCT00424476|75948989|FG001|Overall Study|Adverse Event|16|||
42138781|NCT00424476|75948990|FG002|Overall Study|Adverse Event|15|||
42138782|NCT00424476|75948988|FG000|Overall Study|Lack of Efficacy|16|||
42138783|NCT00424476|75948989|FG001|Overall Study|Lack of Efficacy|12|||
42138784|NCT00424476|75948990|FG002|Overall Study|Lack of Efficacy|12|||
42138785|NCT00424476|75948988|FG000|Overall Study|Lack of Compliance|1|||
42138786|NCT00424476|75948989|FG001|Overall Study|Lack of Compliance|1|||
42138787|NCT00424476|75948990|FG002|Overall Study|Lack of Compliance|1|||
42138788|NCT00424476|75948988|FG000|Overall Study|Lost to Follow-up|4|||
42138789|NCT00424476|75948989|FG001|Overall Study|Lost to Follow-up|6|||
42138790|NCT00424476|75948990|FG002|Overall Study|Lost to Follow-up|3|||
42138791|NCT00424476|75948988|FG000|Overall Study|Protocol Violation|7|||
42138792|NCT00424476|75948989|FG001|Overall Study|Protocol Violation|2|||
42138793|NCT00424476|75948990|FG002|Overall Study|Protocol Violation|3|||
42138794|NCT00424476|75948988|FG000|Overall Study|Physician Decision|3|||
42138795|NCT00424476|75948989|FG001|Overall Study|Physician Decision|2|||
42138796|NCT00424476|75948990|FG002|Overall Study|Physician Decision|3|||
42138797|NCT00424476|75948988|FG000|Overall Study|Other|4|||
42138798|NCT00424476|75948989|FG001|Overall Study|Other|3|||
42138799|NCT00424476|75948990|FG002|Overall Study|Other|9|||
42138800|NCT00453986|75949003|FG000|Overall Study|Lost to Follow-up|6|||
42138801|NCT00453986|75949004|FG001|Overall Study|Lost to Follow-up|5|||
42138802|NCT00453986|75949005|FG002|Overall Study|Lost to Follow-up|6|||
42138803|NCT00453986|75949006|FG003|Overall Study|Lost to Follow-up|2|||
42138804|NCT00453986|75949007|FG004|Overall Study|Lost to Follow-up|0|||
42138805|NCT00435942|75949025|FG000|Overall Study|Death|17|||
42138806|NCT00435942|75949026|FG001|Overall Study|Death|10|||
42349519|NCT01841762|76189269|FG000|Treatment Period|Physician Decision|2|||
42138807|NCT00435942|75949025|FG000|Overall Study|Withdrawal by Subject|2|||
42138808|NCT00435942|75949026|FG001|Overall Study|Withdrawal by Subject|0|||
42138809|NCT00435942|75949025|FG000|Overall Study|Lost to Follow-up|0|||
42138810|NCT00435942|75949026|FG001|Overall Study|Lost to Follow-up|16|||
42138811|NCT00435942|75949025|FG000|Overall Study|Conversion to Open Repair|1|||
42138812|NCT00435942|75949026|FG001|Overall Study|Conversion to Open Repair|0|||
42138813|NCT00435942|75949025|FG000|Overall Study|Technical Failure|3|||
42138814|NCT00435942|75949026|FG001|Overall Study|Technical Failure|0|||
42138815|NCT00435942|75949025|FG000|Overall Study|Other|0|||
42138816|NCT00435942|75949026|FG001|Overall Study|Other|1|||
42138817|NCT00453362|75949032|FG000|Overall Study|Adverse Event|5|||
42349520|NCT01841762|76189269|FG000|Treatment Period|Other, including non-compliance|5|||
42274853|NCT02439320|76105836|FG001|Overall Study|Randomization Failure|46|||
42274854|NCT02439320|76105837|FG002|Overall Study|Randomization Failure|34|||
42274855|NCT02469038|76105853|FG000|Overall Study|Physician Decision|4|||
42274856|NCT02469038|76105854|FG001|Overall Study|Physician Decision|5|||
42274857|NCT02468648|76105860|FG000|Overall Study|Death|1|||
42274858|NCT02468414|76105866|FG000|Overall Study|Early Study Termination by Sponsor|1|||
42274859|NCT02468414|76105867|FG001|Overall Study|Early Study Termination by Sponsor|0|||
42274860|NCT02468414|76105866|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
42037200|NCT01174550|75845537|FG001|Overall Study|Withdrawal by Subject|289|||
42037201|NCT01008150|75845547|FG000|Overall Study|did not receive study drug|1|||
42037202|NCT01008150|75845548|FG001|Overall Study|did not receive study drug|1|||
42037203|NCT01008150|75845549|FG002|Overall Study|did not receive study drug|1|||
42037204|NCT01008150|75845550|FG003|Overall Study|did not receive study drug|0|||
42037205|NCT01007916|75845561|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
42037206|NCT01007916|75845562|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
42037207|NCT01007916|75845561|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
42037208|NCT01007916|75845562|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
42037209|NCT01007838|75845572|FG000|Overall Study|Withdrawal by Subject|1|||
42037210|NCT01007838|75845573|FG001|Overall Study|Withdrawal by Subject|0|||
42037211|NCT01007838|75845574|FG002|Overall Study|Withdrawal by Subject|0|||
42037212|NCT01007838|75845575|FG003|Overall Study|Withdrawal by Subject|0|||
42037213|NCT01007838|75845572|FG000|Overall Study|Physician Decision|1|||
42037214|NCT01007838|75845573|FG001|Overall Study|Physician Decision|0|||
42037215|NCT01007838|75845574|FG002|Overall Study|Physician Decision|0|||
42037216|NCT01007838|75845575|FG003|Overall Study|Physician Decision|0|||
42037217|NCT01007838|75845572|FG000|Overall Study|Started home haemodialysis|1|||
42037218|NCT01007838|75845573|FG001|Overall Study|Started home haemodialysis|0|||
42037219|NCT01007838|75845574|FG002|Overall Study|Started home haemodialysis|0|||
42037220|NCT01007838|75845575|FG003|Overall Study|Started home haemodialysis|0|||
42037221|NCT01007448|75845587|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
42037222|NCT01007448|75845588|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
42037223|NCT01007448|75845587|FG000|Overall Study|Staph Skin Infection Flare|1|||
42037224|NCT01007448|75845588|FG001|Overall Study|Staph Skin Infection Flare|0|||
42037225|NCT01007448|75845587|FG000|Overall Study|Participant Leaving the Country|1|||
42037226|NCT01007448|75845588|FG001|Overall Study|Participant Leaving the Country|0|||
42037227|NCT01007448|75845587|FG000|Overall Study|Participant Given Prohibited Medication|1|||
42037228|NCT01007448|75845588|FG001|Overall Study|Participant Given Prohibited Medication|0|||
42037229|NCT01007448|75845587|FG000|Overall Study|Progressive Disease|1|||
42037230|NCT01007448|75845588|FG001|Overall Study|Progressive Disease|2|||
42037231|NCT01007448|75845587|FG000|Overall Study|Lack of Efficacy|2|||
42037232|NCT01007448|75845588|FG001|Overall Study|Lack of Efficacy|0|||
42037233|NCT01007448|75845587|FG000|Overall Study|Withdrawal by Subject|2|||
42037234|NCT01007448|75845588|FG001|Overall Study|Withdrawal by Subject|3|||
42037235|NCT01007448|75845587|FG000|Overall Study|Adverse Event|1|||
42037236|NCT01007448|75845588|FG001|Overall Study|Adverse Event|4|||
42037237|NCT03538756|75845594|FG000|Long-Term Follow-up|Adverse Event|0|||
42037238|NCT03538756|75845595|FG001|Long-Term Follow-up|Adverse Event|0|||
42037239|NCT03538756|75845596|FG002|Long-Term Follow-up|Adverse Event|6|||
42037240|NCT03538756|75845594|FG000|Long-Term Follow-up|Death|0|||
42037241|NCT03538756|75845595|FG001|Long-Term Follow-up|Death|0|||
42037242|NCT03538756|75845596|FG002|Long-Term Follow-up|Death|1|||
42037243|NCT03538756|75845594|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
42037244|NCT03538756|75845595|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
42274861|NCT02468414|76105867|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
42274862|NCT02468414|76105866|FG000|Overall Study|Screen Failure|1|||
42274863|NCT02468414|76105867|FG001|Overall Study|Screen Failure|0|||
42274864|NCT02466386|76105873|FG000|Overall Study|Adverse Event|5|||
42274865|NCT02466386|76105873|FG000|Overall Study|Protocol Violation|2|||
42274866|NCT02466386|76105873|FG000|Overall Study|Withdrawal by Subject|14|||
42274867|NCT02466386|76105873|FG000|Overall Study|Lost to Follow-up|5|||
42138818|NCT00453362|75949032|FG000|Overall Study|Death|7|||
42274868|NCT02466386|76105873|FG000|Overall Study|Lack of Efficacy|8|||
42274869|NCT02466386|76105873|FG000|Overall Study|Other|10|||
42274870|NCT01633060|76105879|FG000|Randomization Phase|Protocol deviation|1|||
42037245|NCT03538756|75845596|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
42037246|NCT03538756|75845594|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
42037247|NCT03538756|75845595|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
42037248|NCT03538756|75845596|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
42037249|NCT03538756|75845594|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
42037250|NCT03538756|75845595|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
42037251|NCT03538756|75845596|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
42037252|NCT01004250|75845606|FG000|Induction Therapy Period|Adverse Event|10|||
42138819|NCT00453362|75949032|FG000|Overall Study|Physician Decision|2|||
42274871|NCT01633060|76105880|FG001|Randomization Phase|Protocol deviation|2|||
42274872|NCT01633060|76105879|FG000|Randomization Phase|Technical problem|0|||
42274873|NCT01633060|76105880|FG001|Randomization Phase|Technical problem|1|||
42037253|NCT01004250|75845606|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
42037254|NCT01004250|75845606|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
42037255|NCT01004250|75845606|FG000|Induction Therapy Period|Physician Decision|2|||
42037256|NCT01004250|75845606|FG000|Maintenance Therapy Period|Adverse Event|15|||
42037257|NCT01004250|75845606|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
42037258|NCT01004250|75845606|FG000|Maintenance Therapy Period|Protocol Violation|1|||
42037259|NCT01004250|75845606|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
42037260|NCT01004250|75845606|FG000|Maintenance Therapy Period|Physician Decision|4|||
42037261|NCT01004250|75845606|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
42037262|NCT01004172|75845614|FG000|Overall Study|Progressive Disease in CNS Only|16|||
42037263|NCT01004172|75845614|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
42037264|NCT01004172|75845614|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
42037265|NCT01004172|75845614|FG000|Overall Study|Adverse Event|1|||
42037266|NCT01004172|75845614|FG000|Overall Study|Physician Decision|1|||
42037267|NCT01004172|75845614|FG000|Overall Study|Symptomatic Deterioration|2|||
42037268|NCT01161524|75845621|FG000|Core Study (23 Weeks)|Adverse Event|3|||
42037269|NCT01161524|75845622|FG001|Core Study (23 Weeks)|Adverse Event|0|||
42037270|NCT01161524|75845623|FG002|Core Study (23 Weeks)|Adverse Event|0|||
42037271|NCT01161524|75845621|FG000|Core Study (23 Weeks)|Other|1|||
42037272|NCT01161524|75845622|FG001|Core Study (23 Weeks)|Other|0|||
42037273|NCT01161524|75845623|FG002|Core Study (23 Weeks)|Other|0|||
42037274|NCT01161524|75845621|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
42037275|NCT01161524|75845622|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
42037276|NCT01161524|75845623|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
42037277|NCT01161524|75845621|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
42037278|NCT01161524|75845622|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
42037279|NCT01161524|75845623|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
42037280|NCT01161524|75845621|FG000|Core Study (23 Weeks)|Subject Choice|3|||
42037281|NCT01161524|75845622|FG001|Core Study (23 Weeks)|Subject Choice|2|||
42037282|NCT01161524|75845623|FG002|Core Study (23 Weeks)|Subject Choice|0|||
42037283|NCT01161524|75845621|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
42037284|NCT01161524|75845622|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
42037285|NCT01161524|75845623|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
42037286|NCT01161524|75845621|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
42037287|NCT01161524|75845622|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
42037288|NCT01161524|75845623|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
42037289|NCT01161524|75845621|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
42037290|NCT01161524|75845622|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
42037291|NCT01161524|75845623|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
42037292|NCT01161524|75845621|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
42037293|NCT01161524|75845622|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
42037294|NCT01161524|75845623|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
42037295|NCT01161524|75845621|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
42037296|NCT01161524|75845622|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
42037297|NCT01161524|75845623|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
42037298|NCT01000506|75845636|FG000|Overall Study|Adverse Event|6|||
42037299|NCT01000506|75845637|FG001|Overall Study|Adverse Event|5|||
42037300|NCT01000506|75845638|FG002|Overall Study|Adverse Event|8|||
42037301|NCT01000506|75845639|FG003|Overall Study|Adverse Event|9|||
42037302|NCT01000506|75845636|FG000|Overall Study|Lack of Efficacy|8|||
42037303|NCT01000506|75845637|FG001|Overall Study|Lack of Efficacy|6|||
42037304|NCT01000506|75845638|FG002|Overall Study|Lack of Efficacy|4|||
42037305|NCT01000506|75845639|FG003|Overall Study|Lack of Efficacy|4|||
42037306|NCT01000506|75845636|FG000|Overall Study|Protocol Violation|1|||
42037307|NCT01000506|75845637|FG001|Overall Study|Protocol Violation|1|||
42037308|NCT01000506|75845638|FG002|Overall Study|Protocol Violation|0|||
42037309|NCT01000506|75845639|FG003|Overall Study|Protocol Violation|0|||
42037310|NCT01000506|75845636|FG000|Overall Study|Lost to Follow-up|1|||
42037311|NCT01000506|75845637|FG001|Overall Study|Lost to Follow-up|1|||
42037312|NCT01000506|75845638|FG002|Overall Study|Lost to Follow-up|4|||
42037313|NCT01000506|75845639|FG003|Overall Study|Lost to Follow-up|0|||
42037314|NCT01000506|75845636|FG000|Overall Study|Physician Decision|1|||
42037315|NCT01000506|75845637|FG001|Overall Study|Physician Decision|3|||
42037316|NCT01000506|75845638|FG002|Overall Study|Physician Decision|3|||
42037317|NCT01000506|75845639|FG003|Overall Study|Physician Decision|3|||
42037318|NCT01000506|75845636|FG000|Overall Study|Withdrawal by Subject|11|||
42037319|NCT01000506|75845637|FG001|Overall Study|Withdrawal by Subject|8|||
42037320|NCT01000506|75845638|FG002|Overall Study|Withdrawal by Subject|2|||
42037321|NCT01000506|75845639|FG003|Overall Study|Withdrawal by Subject|7|||
42037322|NCT01174238|75845649|FG000|Overall Study|Lost to Follow-up|2|||
42037323|NCT01174160|75845658|FG000|Overall Study|Adverse Event|1|||
42037324|NCT01174160|75845659|FG001|Overall Study|Adverse Event|0|||
42037325|NCT01174160|75845658|FG000|Overall Study|Lost to Follow-up|1|||
42037326|NCT01174160|75845659|FG001|Overall Study|Lost to Follow-up|0|||
42349521|NCT01841762|76189269|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
42349522|NCT01841762|76189269|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
42349523|NCT01841762|76189269|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
42349524|NCT01841762|76189269|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
42349525|NCT01841060|76189286|FG000|Overall Study|Protocol Violation|10|||
42349526|NCT01814696|76189292|FG000|Overall Study|Withdrawal by Subject|1|||
42349527|NCT01814696|76189293|FG001|Overall Study|Withdrawal by Subject|0|||
42349528|NCT01814696|76189292|FG000|Overall Study|Randomized to wrong group|1|||
42349529|NCT01814696|76189293|FG001|Overall Study|Randomized to wrong group|0|||
42349530|NCT01970371|76189302|FG000|Overall Study|Death|8|||
42349531|NCT01970371|76189303|FG001|Overall Study|Death|13|||
42349532|NCT01970371|76189304|FG002|Overall Study|Death|12|||
42349533|NCT01970371|76189302|FG000|Overall Study|Lost to Follow-up|0|||
42349534|NCT01970371|76189303|FG001|Overall Study|Lost to Follow-up|0|||
42349535|NCT01970371|76189304|FG002|Overall Study|Lost to Follow-up|1|||
42349536|NCT01868594|76189325|FG000|Overall Study|Do not meet inclusion criteria|4|||
42349537|NCT01868594|76189326|FG001|Overall Study|Do not meet inclusion criteria|3|||
42349538|NCT01616953|76189336|FG000|Overall Study|Lost to Follow-up|1|||
42349539|NCT01616953|76189337|FG001|Overall Study|Lost to Follow-up|0|||
42349540|NCT01616953|76189336|FG000|Overall Study|lack of bone and soft tissue|1|||
42011264|NCT01017874|75818266|FG000|Overall Study|Withdrawal by Subject|23|||
42011265|NCT01017874|75818267|FG001|Overall Study|Withdrawal by Subject|20|||
42011266|NCT01017874|75818266|FG000|Overall Study|Sponsor decision|3|||
42011267|NCT01017874|75818267|FG001|Overall Study|Sponsor decision|1|||
42011268|NCT01017874|75818266|FG000|Overall Study|Lost to Follow-up|3|||
42011269|NCT01017874|75818267|FG001|Overall Study|Lost to Follow-up|2|||
42011270|NCT01017874|75818266|FG000|Overall Study|Physician Decision|1|||
42011271|NCT01017874|75818267|FG001|Overall Study|Physician Decision|3|||
42011272|NCT01015768|75818273|FG000|Overall Study|Some subject data unuseable|4|||
42011273|NCT01015768|75818274|FG001|Overall Study|Some subject data unuseable|4|||
42011274|NCT04426630|75818282|FG000|Overall Study|Death|4|||
42011275|NCT04426630|75818282|FG000|Overall Study|Lost to Follow-up|2|||
42011276|NCT01010230|75818288|FG000|Overall Study|Withdrawal by Subject|6|||
42011277|NCT01010230|75818289|FG001|Overall Study|Withdrawal by Subject|5|||
42011278|NCT01010230|75818288|FG000|Overall Study|Lost to Follow-up|4|||
42011279|NCT01010230|75818289|FG001|Overall Study|Lost to Follow-up|2|||
42011280|NCT01009840|75818295|FG000|Overall Study|Lost to Follow-up|1|||
42011281|NCT01009840|75818295|FG000|Overall Study|Adverse Event|4|||
42037327|NCT01174160|75845658|FG000|Overall Study|Physician Decision|1|||
42037328|NCT01174160|75845659|FG001|Overall Study|Physician Decision|0|||
42037329|NCT01174160|75845658|FG000|Overall Study|Protocol Violation|4|||
42037330|NCT01174160|75845659|FG001|Overall Study|Protocol Violation|6|||
42037331|NCT01174160|75845658|FG000|Overall Study|Withdrawal by Subject|1|||
42037332|NCT01174160|75845659|FG001|Overall Study|Withdrawal by Subject|0|||
42037333|NCT01161446|75845667|FG000|Overall Study|Lost to Follow-up|18|||
42037334|NCT01161446|75845668|FG001|Overall Study|Lost to Follow-up|14|||
42037335|NCT01161446|75845667|FG000|Overall Study|Withdrawal by Subject|0|||
42037336|NCT01161446|75845668|FG001|Overall Study|Withdrawal by Subject|1|||
42037337|NCT01174004|75845676|FG000|Overall Study|Adverse Event|2|||
42037338|NCT01174004|75845677|FG001|Overall Study|Adverse Event|10|||
42037339|NCT01174004|75845676|FG000|Overall Study|Withdrawal by Subject|2|||
42274874|NCT01633060|76105879|FG000|Treatment Phase|Adverse Event|24|||
42011282|NCT01009840|75818295|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
42011283|NCT01009840|75818295|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
42037340|NCT01174004|75845677|FG001|Overall Study|Withdrawal by Subject|3|||
42138820|NCT00453362|75949032|FG000|Overall Study|Withdrawal by Subject|3|||
42138821|NCT00453362|75949032|FG000|Overall Study|Progression of disease|56|||
42274875|NCT01633060|76105880|FG001|Treatment Phase|Adverse Event|3|||
42274876|NCT01633060|76105879|FG000|Treatment Phase|Lost to Follow-up|1|||
42274877|NCT01633060|76105880|FG001|Treatment Phase|Lost to Follow-up|0|||
42274878|NCT01633060|76105879|FG000|Treatment Phase|Physician Decision|16|||
42274879|NCT01633060|76105880|FG001|Treatment Phase|Physician Decision|7|||
42274880|NCT01633060|76105879|FG000|Treatment Phase|Progressive Disease|210|||
42274881|NCT01633060|76105880|FG001|Treatment Phase|Progressive Disease|120|||
42349541|NCT01616953|76189337|FG001|Overall Study|lack of bone and soft tissue|0|||
42349542|NCT01867658|76189343|FG000|Overall Study|Withdrawal by Subject|6|||
42011284|NCT01009840|75818295|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
42138822|NCT00453362|75949032|FG000|Overall Study|Screening Failure|14|||
42349543|NCT01867658|76189343|FG000|Overall Study|Death|2|||
42011285|NCT00982657|75818303|FG000|Overall Study|Death|1|||
42011286|NCT00982657|75818304|FG001|Overall Study|Death|0|||
42037341|NCT01174004|75845676|FG000|Overall Study|At Discretion of Sponsor|2|||
42037342|NCT01174004|75845677|FG001|Overall Study|At Discretion of Sponsor|2|||
42037343|NCT01174004|75845676|FG000|Overall Study|Protocol Violation|0|||
42274882|NCT01633060|76105879|FG000|Treatment Phase|Protocol Deviation|1|||
42274883|NCT01633060|76105880|FG001|Treatment Phase|Protocol Deviation|0|||
42349544|NCT01867658|76189343|FG000|Overall Study|Subject could not be contacted|1|||
42011287|NCT00982657|75818305|FG002|Overall Study|Death|1|||
42037344|NCT01174004|75845677|FG001|Overall Study|Protocol Violation|1|||
42037345|NCT01174004|75845676|FG000|Overall Study|Physician Decision|1|||
42037346|NCT01174004|75845677|FG001|Overall Study|Physician Decision|0|||
42037347|NCT01173692|75845685|FG000|Overall Study|Adverse Event|1|||
42274884|NCT01633060|76105879|FG000|Treatment Phase|Study Terminated by sponsor|7|||
42274885|NCT01633060|76105880|FG001|Treatment Phase|Study Terminated by sponsor|3|||
42274886|NCT01633060|76105879|FG000|Treatment Phase|Subject/guardian decision|25|||
42274887|NCT01633060|76105880|FG001|Treatment Phase|Subject/guardian decision|4|||
42274888|NCT01633060|76105879|FG000|Treatment Phase|Death|4|||
42274889|NCT01633060|76105880|FG001|Treatment Phase|Death|3|||
42274890|NCT01633060|76105879|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
42349545|NCT01867580|76189349|FG000|Overall Study|Withdrawal by Subject|2|||
42349546|NCT01867580|76189350|FG001|Overall Study|Withdrawal by Subject|3|||
42011288|NCT00982657|75818306|FG003|Overall Study|Death|1|||
42011289|NCT00982657|75818303|FG000|Overall Study|Withdrawal by Subject|0|||
42349547|NCT01867580|76189349|FG000|Overall Study|Physician Decision|17|||
42349548|NCT01867580|76189350|FG001|Overall Study|Physician Decision|12|||
42349549|NCT01867580|76189349|FG000|Overall Study|Lost to Follow-up|3|||
42349550|NCT01867580|76189350|FG001|Overall Study|Lost to Follow-up|5|||
42349551|NCT01867580|76189349|FG000|Overall Study|Sponsor terminated study|1|||
42349552|NCT01867580|76189350|FG001|Overall Study|Sponsor terminated study|0|||
42349553|NCT01867580|76189349|FG000|Overall Study|Missed follow-up assessment|2|||
42349554|NCT01867580|76189350|FG001|Overall Study|Missed follow-up assessment|1|||
42349555|NCT01867580|76189349|FG000|Overall Study|Interruption to therapy|3|||
42349556|NCT01867580|76189350|FG001|Overall Study|Interruption to therapy|0|||
42349557|NCT01867580|76189349|FG000|Overall Study|Osteomyelitis|0|||
42349558|NCT01867580|76189350|FG001|Overall Study|Osteomyelitis|1|||
42349559|NCT01867580|76189349|FG000|Overall Study|Continuation of therapy|0|||
42349560|NCT01867580|76189350|FG001|Overall Study|Continuation of therapy|1|||
42349561|NCT01867580|76189349|FG000|Overall Study|Wound recurrence|0|||
42349562|NCT01867580|76189350|FG001|Overall Study|Wound recurrence|1|||
42349563|NCT01839656|76189364|FG000|Overall Study|Withdrawal by Subject|1|||
42349564|NCT01839656|76189365|FG001|Overall Study|Withdrawal by Subject|1|||
42349565|NCT01839656|76189364|FG000|Overall Study|Adverse event, serious fatal|1|||
42349566|NCT01839656|76189365|FG001|Overall Study|Adverse event, serious fatal|4|||
42349567|NCT01839656|76189364|FG000|Overall Study|Early study closure|0|||
42349568|NCT01839656|76189365|FG001|Overall Study|Early study closure|11|||
42349569|NCT01839656|76189364|FG000|Overall Study|Adverse Event|1|||
42349570|NCT01839656|76189365|FG001|Overall Study|Adverse Event|0|||
42349571|NCT01839188|76189371|FG000|Overall Study|Withdrawal by Subject|1|||
42349572|NCT01838876|76189380|FG000|Overall Study|Adverse Event|49|||
42349573|NCT01838876|76189380|FG000|Overall Study|Insufficient Therapeutic Response|10|||
42349574|NCT01838876|76189380|FG000|Overall Study|Protocol Violation|34|||
42349575|NCT01838876|76189380|FG000|Overall Study|Withdrawal of Consent|33|||
42349576|NCT01838876|76189380|FG000|Overall Study|Lost to Follow-up|21|||
42349577|NCT01838876|76189380|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
42349578|NCT01838876|76189380|FG000|Overall Study|Reason not Specified|7|||
42349579|NCT01838876|76189380|FG000|Overall Study|Did not meet eligibility criteria|78|||
42349580|NCT01838642|76189395|FG000|Overall Study|Died on study|1|||
42349581|NCT01611194|76189402|FG000|Overall Study|Lost to Follow-up|0|||
42011290|NCT00982657|75818304|FG001|Overall Study|Withdrawal by Subject|0|||
42011291|NCT00982657|75818305|FG002|Overall Study|Withdrawal by Subject|1|||
42011292|NCT00982657|75818306|FG003|Overall Study|Withdrawal by Subject|3|||
42011293|NCT00982657|75818303|FG000|Overall Study|Other|0|||
42011294|NCT00982657|75818304|FG001|Overall Study|Other|0|||
42011295|NCT00982657|75818305|FG002|Overall Study|Other|0|||
42011296|NCT00982657|75818306|FG003|Overall Study|Other|4|||
42011297|NCT00982657|75818303|FG000|Overall Study|On going at date of cut-off|0|||
42011298|NCT00982657|75818304|FG001|Overall Study|On going at date of cut-off|0|||
42037348|NCT01173692|75845686|FG001|Overall Study|Adverse Event|2|||
42037349|NCT01173692|75845685|FG000|Overall Study|Withdrawal by Subject|1|||
42274891|NCT01633060|76105880|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
42274892|NCT01633060|76105879|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
42349582|NCT01611194|76189403|FG001|Overall Study|Lost to Follow-up|1|||
42349583|NCT01611194|76189402|FG000|Overall Study|Withdrawal by Subject|0|||
42349584|NCT01611194|76189403|FG001|Overall Study|Withdrawal by Subject|1|||
42349585|NCT01611194|76189402|FG000|Overall Study|drug use|0|||
42349586|NCT01611194|76189403|FG001|Overall Study|drug use|1|||
42349587|NCT01813058|76189411|FG000|Overall Study|Withdrawal by Subject|5|||
42349588|NCT01813058|76189412|FG001|Overall Study|Withdrawal by Subject|4|||
42349589|NCT01867424|76189420|FG000|Overall Study|Patient noncompliance|2|||
42349590|NCT01867424|76189421|FG001|Overall Study|Patient noncompliance|1|||
42349591|NCT01811732|76189429|FG000|Overall Study|Lost to Follow-up|24|||
42011299|NCT00982657|75818305|FG002|Overall Study|On going at date of cut-off|0|||
42037350|NCT01173692|75845686|FG001|Overall Study|Withdrawal by Subject|3|||
42274893|NCT01633060|76105880|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
42349592|NCT01811732|76189430|FG001|Overall Study|Lost to Follow-up|30|||
42349593|NCT01811732|76189429|FG000|Overall Study|Withdrawal by Subject|16|||
42349594|NCT01811732|76189430|FG001|Overall Study|Withdrawal by Subject|10|||
42037351|NCT01101035|75845694|FG000|Overall Study|Adverse Event|191|||
42037352|NCT01101035|75845695|FG001|Overall Study|Adverse Event|172|||
42037353|NCT01101035|75845694|FG000|Overall Study|Major Protocol Deviation|52|||
42349595|NCT01811732|76189429|FG000|Overall Study|Adverse Event|3|||
42349596|NCT01811732|76189430|FG001|Overall Study|Adverse Event|9|||
42349597|NCT01811732|76189429|FG000|Overall Study|Lack of Efficacy|3|||
42349598|NCT01811732|76189430|FG001|Overall Study|Lack of Efficacy|1|||
42349599|NCT01811732|76189429|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
42349600|NCT01811732|76189430|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
42037354|NCT01101035|75845695|FG001|Overall Study|Major Protocol Deviation|46|||
42037355|NCT01101035|75845694|FG000|Overall Study|Lost to Follow-up|226|||
42037356|NCT01101035|75845695|FG001|Overall Study|Lost to Follow-up|223|||
42037357|NCT01101035|75845694|FG000|Overall Study|Voluntary Withdrawal|595|||
42037358|NCT01101035|75845695|FG001|Overall Study|Voluntary Withdrawal|587|||
42037359|NCT01101035|75845694|FG000|Overall Study|Reason not Specified|333|||
42138823|NCT00424398|75949051|FG000|Overall Study|Withdrawal by Subject|2|||
42138824|NCT00424398|75949052|FG001|Overall Study|Withdrawal by Subject|1|||
42274894|NCT01633060|76105879|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
42274895|NCT01633060|76105880|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
42274896|NCT01633060|76105879|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
42274897|NCT01633060|76105880|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
42274898|NCT01633060|76105879|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
42274899|NCT01633060|76105880|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
42274900|NCT01633060|76105879|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
42274901|NCT01633060|76105880|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
42274902|NCT01632904|76105889|FG000|Overall Study|Adverse Event|4|||
42274903|NCT01632904|76105890|FG001|Overall Study|Adverse Event|1|||
42274904|NCT01632904|76105889|FG000|Overall Study|Physician Decision|0|||
42274905|NCT01632904|76105890|FG001|Overall Study|Physician Decision|1|||
42274906|NCT01632904|76105889|FG000|Overall Study|Subject decision|3|||
42274907|NCT01632904|76105890|FG001|Overall Study|Subject decision|2|||
42274908|NCT01632904|76105889|FG000|Overall Study|Disease Progression|0|||
42349601|NCT01811732|76189429|FG000|Overall Study|Physician Decision|2|||
42349602|NCT01811732|76189430|FG001|Overall Study|Physician Decision|0|||
42037360|NCT01101035|75845695|FG001|Overall Study|Reason not Specified|363|||
42349603|NCT01811732|76189429|FG000|Overall Study|Death|1|||
42349604|NCT01811732|76189430|FG001|Overall Study|Death|1|||
42037361|NCT01100567|75845703|FG000|Overall Study|Withdrawal by Subject|5|||
42274909|NCT01632904|76105890|FG001|Overall Study|Disease Progression|1|||
42349605|NCT01811732|76189429|FG000|Overall Study|Insufficient venous access|0|||
42349606|NCT01811732|76189430|FG001|Overall Study|Insufficient venous access|1|||
42349607|NCT01811732|76189429|FG000|Overall Study|Protocol Violation|0|||
42349608|NCT01811732|76189430|FG001|Overall Study|Protocol Violation|1|||
42349609|NCT01811732|76189429|FG000|Overall Study|Subject incarcerated|1|||
42349610|NCT01811732|76189430|FG001|Overall Study|Subject incarcerated|2|||
42349611|NCT01811732|76189429|FG000|Overall Study|Admitted to another facility|1|||
42349612|NCT01811732|76189430|FG001|Overall Study|Admitted to another facility|0|||
42349613|NCT01811732|76189429|FG000|Overall Study|Correct study drug not available on site|1|||
42349614|NCT01811732|76189430|FG001|Overall Study|Correct study drug not available on site|0|||
42349615|NCT01836458|76189441|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
42349616|NCT01836458|76189442|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42349617|NCT01836458|76189443|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
42349618|NCT01836458|76189444|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
42349619|NCT01811186|76189456|FG000|Overall Study|Adverse Event|54|||
42349620|NCT01811186|76189457|FG001|Overall Study|Adverse Event|38|||
42349621|NCT01811186|76189456|FG000|Overall Study|Protocol Violation|5|||
42349622|NCT01811186|76189457|FG001|Overall Study|Protocol Violation|6|||
42349623|NCT01811186|76189456|FG000|Overall Study|Withdrawal by Subject|5|||
42011300|NCT00982657|75818306|FG003|Overall Study|On going at date of cut-off|1|||
42011301|NCT01005316|75818329|FG000|Overall Study|Adverse Event|0|||
42011302|NCT01005316|75818330|FG001|Overall Study|Adverse Event|0|||
42011303|NCT01005316|75818331|FG002|Overall Study|Adverse Event|0|||
42011304|NCT01005316|75818332|FG003|Overall Study|Adverse Event|1|||
42011305|NCT01005316|75818329|FG000|Overall Study|Death|20|||
42011306|NCT01005316|75818330|FG001|Overall Study|Death|5|||
42011307|NCT01005316|75818331|FG002|Overall Study|Death|1|||
42011308|NCT01005316|75818332|FG003|Overall Study|Death|15|||
42011309|NCT01005316|75818329|FG000|Overall Study|Study Termination|5|||
42011310|NCT01005316|75818330|FG001|Overall Study|Study Termination|63|||
42011311|NCT01005316|75818331|FG002|Overall Study|Study Termination|9|||
42011312|NCT01005316|75818332|FG003|Overall Study|Study Termination|85|||
42011313|NCT01005316|75818329|FG000|Overall Study|Lost to Follow-up|1|||
42037362|NCT01100567|75845704|FG001|Overall Study|Withdrawal by Subject|8|||
42037363|NCT01100567|75845703|FG000|Overall Study|Early Hospital Discharge|6|||
42037364|NCT01100567|75845704|FG001|Overall Study|Early Hospital Discharge|4|||
42037365|NCT01100567|75845703|FG000|Overall Study|Lost to Follow-up|1|||
42037366|NCT01100567|75845704|FG001|Overall Study|Lost to Follow-up|2|||
42037367|NCT01100567|75845703|FG000|Overall Study|Physician Decision|0|||
42037368|NCT01100567|75845704|FG001|Overall Study|Physician Decision|1|||
42037369|NCT01100567|75845703|FG000|Overall Study|Deemed ineligible after consent|0|||
42037370|NCT01100567|75845704|FG001|Overall Study|Deemed ineligible after consent|1|||
42037371|NCT01160822|75845717|FG000|Overall Study|Adverse Event|0|||
42037372|NCT01160822|75845718|FG001|Overall Study|Adverse Event|0|||
42037373|NCT01160822|75845719|FG002|Overall Study|Adverse Event|0|||
42037374|NCT01160822|75845720|FG003|Overall Study|Adverse Event|0|||
42037375|NCT01160822|75845721|FG004|Overall Study|Adverse Event|1|||
42037376|NCT01160822|75845722|FG005|Overall Study|Adverse Event|2|||
42274910|NCT01632904|76105889|FG000|Overall Study|Reason for discontinuation not available|0|||
42011314|NCT01005316|75818330|FG001|Overall Study|Lost to Follow-up|3|||
42011315|NCT01005316|75818331|FG002|Overall Study|Lost to Follow-up|0|||
42011316|NCT01005316|75818332|FG003|Overall Study|Lost to Follow-up|2|||
42011317|NCT01005316|75818329|FG000|Overall Study|Physician Decision|6|||
42011318|NCT01005316|75818330|FG001|Overall Study|Physician Decision|0|||
42011319|NCT01005316|75818331|FG002|Overall Study|Physician Decision|0|||
42037377|NCT01160822|75845723|FG006|Overall Study|Adverse Event|5|||
42037378|NCT01160822|75845717|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42274911|NCT01632904|76105890|FG001|Overall Study|Reason for discontinuation not available|1|||
42274912|NCT03834779|76105898|FG000|Overall Study|Death|1|||
42274913|NCT03834779|76105899|FG001|Overall Study|Death|2|||
42274914|NCT03834779|76105898|FG000|Overall Study|Lost to Follow-up|6|||
42274915|NCT03834779|76105899|FG001|Overall Study|Lost to Follow-up|4|||
42274916|NCT03726437|76105908|FG000|Overall Study|Lost to Follow-up|85|||
42274917|NCT03726437|76105909|FG001|Overall Study|Lost to Follow-up|76|||
42274918|NCT02465528|76105919|FG000|Overall Study|Progressive disease|0|||
42274919|NCT02465528|76105920|FG001|Overall Study|Progressive disease|2|||
42274920|NCT02465528|76105921|FG002|Overall Study|Progressive disease|9|||
42274921|NCT02465528|76105922|FG003|Overall Study|Progressive disease|4|||
42274922|NCT02465528|76105919|FG000|Overall Study|Study terminated by sponsor|1|||
42274923|NCT02465528|76105920|FG001|Overall Study|Study terminated by sponsor|2|||
42274924|NCT02465528|76105921|FG002|Overall Study|Study terminated by sponsor|0|||
42274925|NCT02465528|76105922|FG003|Overall Study|Study terminated by sponsor|0|||
42274926|NCT02465528|76105919|FG000|Overall Study|Withdrawal by Subject|0|||
42274927|NCT02465528|76105920|FG001|Overall Study|Withdrawal by Subject|0|||
42274928|NCT02465528|76105921|FG002|Overall Study|Withdrawal by Subject|2|||
42037379|NCT01160822|75845718|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42274929|NCT02465528|76105922|FG003|Overall Study|Withdrawal by Subject|0|||
42274930|NCT02465528|76105919|FG000|Overall Study|Adverse Event|0|||
42274931|NCT02465528|76105920|FG001|Overall Study|Adverse Event|0|||
42274932|NCT02465528|76105921|FG002|Overall Study|Adverse Event|0|||
42274933|NCT02465528|76105922|FG003|Overall Study|Adverse Event|1|||
42274934|NCT02465528|76105919|FG000|Overall Study|Physician Decision|0|||
42274935|NCT02465528|76105920|FG001|Overall Study|Physician Decision|0|||
42274936|NCT02465528|76105921|FG002|Overall Study|Physician Decision|1|||
42274937|NCT02465528|76105922|FG003|Overall Study|Physician Decision|0|||
42274938|NCT02438384|76105937|FG000|Overall Study|Lost to Follow-up|8|||
42274939|NCT02438384|76105938|FG001|Overall Study|Lost to Follow-up|6|||
42274940|NCT02438384|76105939|FG002|Overall Study|Lost to Follow-up|4|||
42274941|NCT02463032|76105949|FG000|Overall Study|Lack of Efficacy|61|||
42274942|NCT02463032|76105950|FG001|Overall Study|Lack of Efficacy|50|||
42274943|NCT02463032|76105949|FG000|Overall Study|Death|8|||
42349624|NCT01811186|76189457|FG001|Overall Study|Withdrawal by Subject|10|||
42349625|NCT01811186|76189456|FG000|Overall Study|Lack of Efficacy|3|||
42011320|NCT01005316|75818332|FG003|Overall Study|Physician Decision|0|||
42011321|NCT01005316|75818329|FG000|Overall Study|Sponsor Decision|6|||
42011322|NCT01005316|75818330|FG001|Overall Study|Sponsor Decision|3|||
42011323|NCT01005316|75818331|FG002|Overall Study|Sponsor Decision|0|||
42011324|NCT01005316|75818332|FG003|Overall Study|Sponsor Decision|0|||
42011325|NCT01005316|75818329|FG000|Overall Study|Withdrawal by Subject|1|||
42011326|NCT01005316|75818330|FG001|Overall Study|Withdrawal by Subject|1|||
42138825|NCT00424398|75949053|FG002|Overall Study|Withdrawal by Subject|0|||
42138826|NCT00424398|75949051|FG000|Overall Study|Subject met exclusion criteria|1|||
42138827|NCT00424398|75949052|FG001|Overall Study|Subject met exclusion criteria|0|||
42138828|NCT00424398|75949053|FG002|Overall Study|Subject met exclusion criteria|0|||
42138829|NCT00461786|75949061|FG000|Overall Study|Entry Criteria Not Met|2|||
42138830|NCT00461786|75949061|FG000|Overall Study|Inevaluable (Never Treated)|1|||
42138831|NCT00435162|75949068|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
42138832|NCT00435162|75949069|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
42138833|NCT00435162|75949070|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
42138834|NCT00435162|75949071|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
42138835|NCT00435162|75949072|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
42138836|NCT00435162|75949073|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
42138837|NCT03836664|75949088|FG000|Overall Study|Didn't complete forms and lost drug|3|||
42138838|NCT03836664|75949089|FG001|Overall Study|Didn't complete forms and lost drug|3|||
42138839|NCT00350727|75949102|FG000|Phase I: Dose Escalation|Adverse Event|4|||
42138840|NCT00350727|75949103|FG001|Phase I: Dose Escalation|Adverse Event|0|||
42138841|NCT00350727|75949104|FG002|Phase I: Dose Escalation|Adverse Event|0|||
42138842|NCT00350727|75949102|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
42011327|NCT01005316|75818331|FG002|Overall Study|Withdrawal by Subject|0|||
42138843|NCT00350727|75949103|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
42138844|NCT00350727|75949104|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
42349626|NCT01811186|76189457|FG001|Overall Study|Lack of Efficacy|6|||
42349627|NCT01811186|76189456|FG000|Overall Study|Lost to Follow-up|4|||
42349628|NCT01811186|76189457|FG001|Overall Study|Lost to Follow-up|2|||
42349629|NCT01866098|76189470|FG000|Overall Study|Lost to Follow-up|11|||
42011328|NCT01005316|75818332|FG003|Overall Study|Withdrawal by Subject|2|||
42011329|NCT01005316|75818329|FG000|Overall Study|Consented to Another Study|2|||
42011330|NCT01005316|75818330|FG001|Overall Study|Consented to Another Study|0|||
42011331|NCT01005316|75818331|FG002|Overall Study|Consented to Another Study|0|||
42011332|NCT01005316|75818332|FG003|Overall Study|Consented to Another Study|0|||
42011333|NCT01005316|75818329|FG000|Overall Study|Delisted|8|||
42011334|NCT01005316|75818330|FG001|Overall Study|Delisted|0|||
42138845|NCT00350727|75949102|FG000|Phase I: Dose Escalation|Death|1|||
42138846|NCT00350727|75949103|FG001|Phase I: Dose Escalation|Death|0|||
42349630|NCT01866098|76189471|FG001|Overall Study|Lost to Follow-up|18|||
42349631|NCT01866098|76189472|FG002|Overall Study|Lost to Follow-up|13|||
42349632|NCT01866098|76189470|FG000|Overall Study|Physician Decision|0|||
42349633|NCT01866098|76189471|FG001|Overall Study|Physician Decision|1|||
42349634|NCT01866098|76189472|FG002|Overall Study|Physician Decision|2|||
42349635|NCT01866098|76189470|FG000|Overall Study|Adverse Event|1|||
42349636|NCT01866098|76189471|FG001|Overall Study|Adverse Event|5|||
42349637|NCT01866098|76189472|FG002|Overall Study|Adverse Event|4|||
42349638|NCT01866098|76189470|FG000|Overall Study|Protocol Violation|1|||
42349639|NCT01866098|76189471|FG001|Overall Study|Protocol Violation|0|||
42349640|NCT01866098|76189472|FG002|Overall Study|Protocol Violation|0|||
42011335|NCT01005316|75818331|FG002|Overall Study|Delisted|0|||
42138847|NCT00350727|75949104|FG002|Phase I: Dose Escalation|Death|0|||
42138848|NCT00350727|75949102|FG000|Phase I: Dose Escalation|Physician Decision|1|||
42349641|NCT01866098|76189470|FG000|Overall Study|Withdrawal by Subject|1|||
42011336|NCT01005316|75818332|FG003|Overall Study|Delisted|0|||
42011337|NCT01005316|75818329|FG000|Overall Study|Transferred Care|1|||
42138849|NCT00350727|75949103|FG001|Phase I: Dose Escalation|Physician Decision|0|||
42138850|NCT00350727|75949104|FG002|Phase I: Dose Escalation|Physician Decision|0|||
42274944|NCT02463032|76105950|FG001|Overall Study|Death|8|||
42274945|NCT02463032|76105949|FG000|Overall Study|Adverse Event|2|||
42349642|NCT01866098|76189471|FG001|Overall Study|Withdrawal by Subject|2|||
42274946|NCT02463032|76105950|FG001|Overall Study|Adverse Event|6|||
42274947|NCT02496884|76105960|FG000|Overall Study|Counted twice as enrolled|2|||
42274948|NCT02496884|76105961|FG001|Overall Study|Counted twice as enrolled|0|||
42274949|NCT02496884|76105962|FG002|Overall Study|Counted twice as enrolled|0|||
42349643|NCT01866098|76189472|FG002|Overall Study|Withdrawal by Subject|0|||
42349644|NCT01866098|76189470|FG000|Overall Study|Unrelated Hospitalization|2|||
42349645|NCT01866098|76189471|FG001|Overall Study|Unrelated Hospitalization|0|||
42349646|NCT01866098|76189472|FG002|Overall Study|Unrelated Hospitalization|1|||
42349647|NCT01866098|76189470|FG000|Overall Study|Non-compliance|1|||
42349648|NCT01866098|76189471|FG001|Overall Study|Non-compliance|0|||
42349649|NCT01866098|76189472|FG002|Overall Study|Non-compliance|1|||
42349650|NCT01866098|76189470|FG000|Overall Study|Pregnancy|2|||
42349651|NCT01866098|76189471|FG001|Overall Study|Pregnancy|0|||
42349652|NCT01866098|76189472|FG002|Overall Study|Pregnancy|0|||
42349653|NCT01866098|76189470|FG000|Overall Study|Death|0|||
42349654|NCT01866098|76189471|FG001|Overall Study|Death|1|||
42349655|NCT01866098|76189472|FG002|Overall Study|Death|0|||
42349656|NCT01865552|76189486|FG000|Period 1|Adverse Event|1|||
42349657|NCT01865552|76189487|FG001|Period 1|Adverse Event|0|||
42349658|NCT01865552|76189488|FG002|Period 1|Adverse Event|0|||
42349659|NCT01865552|76189489|FG003|Period 1|Adverse Event|1|||
42349660|NCT01865552|76189490|FG004|Period 1|Adverse Event|1|||
42274950|NCT02496884|76105963|FG003|Overall Study|Counted twice as enrolled|0|||
42274951|NCT02496884|76105960|FG000|Overall Study|Withdrawal by Subject|0|||
42274952|NCT02496884|76105961|FG001|Overall Study|Withdrawal by Subject|3|||
42274953|NCT02496884|76105962|FG002|Overall Study|Withdrawal by Subject|0|||
42274954|NCT02496884|76105963|FG003|Overall Study|Withdrawal by Subject|0|||
42274955|NCT02462876|76105973|FG000|Overall Study|Death|3|||
42274956|NCT02462876|76105973|FG000|Overall Study|Lost to Follow-up|7|||
42274957|NCT02462876|76105973|FG000|Overall Study|Surgical Bypass|9|||
42274958|NCT02462876|76105973|FG000|Overall Study|Amputation Above the Metatarsals|1|||
42274959|NCT02462876|76105973|FG000|Overall Study|36 months follow-up visit missed|1|||
42349661|NCT01865552|76189491|FG005|Period 1|Adverse Event|1|||
42349662|NCT01865552|76189486|FG000|Period 1|Pathological lab|0|||
42349663|NCT01865552|76189487|FG001|Period 1|Pathological lab|0|||
42349664|NCT01865552|76189488|FG002|Period 1|Pathological lab|0|||
42349665|NCT01865552|76189489|FG003|Period 1|Pathological lab|0|||
42011338|NCT01005316|75818330|FG001|Overall Study|Transferred Care|0|||
42011339|NCT01005316|75818331|FG002|Overall Study|Transferred Care|1|||
42011340|NCT01005316|75818332|FG003|Overall Study|Transferred Care|3|||
42011341|NCT01005316|75818329|FG000|Overall Study|Retransplanted|0|||
42138851|NCT00350727|75949102|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
42349666|NCT01865552|76189490|FG004|Period 1|Pathological lab|1|||
42349667|NCT01865552|76189491|FG005|Period 1|Pathological lab|0|||
42349668|NCT01865552|76189486|FG000|Period 1|Other|0|||
42349669|NCT01865552|76189487|FG001|Period 1|Other|0|||
42349670|NCT01865552|76189488|FG002|Period 1|Other|0|||
42349671|NCT01865552|76189489|FG003|Period 1|Other|0|||
42349672|NCT01865552|76189490|FG004|Period 1|Other|1|||
42349673|NCT01865552|76189491|FG005|Period 1|Other|0|||
42349674|NCT01809314|76189505|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
42349675|NCT01809314|76189505|FG000|Overall Study|Adverse Event|6|||
42349676|NCT01809314|76189505|FG000|Overall Study|Insufficient Therapeutic Response|14|||
42349677|NCT01809314|76189505|FG000|Overall Study|Lost to Follow-up|724|||
42349678|NCT01803464|76189513|FG000|Overall Study|Incomplete data|0|||
42349679|NCT01803464|76189514|FG001|Overall Study|Incomplete data|0|||
42349680|NCT01803464|76189515|FG002|Overall Study|Incomplete data|4|||
42349681|NCT01803464|76189516|FG003|Overall Study|Incomplete data|0|||
42349682|NCT01803464|76189513|FG000|Overall Study|Withdrawal by Subject|1|||
42349683|NCT01803464|76189514|FG001|Overall Study|Withdrawal by Subject|0|||
42349684|NCT01803464|76189515|FG002|Overall Study|Withdrawal by Subject|0|||
42349685|NCT01803464|76189516|FG003|Overall Study|Withdrawal by Subject|0|||
42349686|NCT01808690|76189532|FG000|Overall Study|Withdrawal by Subject|1|||
42349687|NCT01808690|76189533|FG001|Overall Study|Withdrawal by Subject|2|||
42349688|NCT01363297|76189544|FG000|Overall Study|Other|0|||
42349689|NCT01363297|76189545|FG001|Overall Study|Other|0|||
42349690|NCT01363297|76189546|FG002|Overall Study|Other|0|||
42349691|NCT01363297|76189547|FG003|Overall Study|Other|0|||
42349692|NCT01363297|76189548|FG004|Overall Study|Other|1|||
42349693|NCT01363297|76189544|FG000|Overall Study|Death|3|||
42349694|NCT01363297|76189545|FG001|Overall Study|Death|6|||
42349695|NCT01363297|76189546|FG002|Overall Study|Death|6|||
42138852|NCT00350727|75949103|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
42138853|NCT00350727|75949104|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
42138854|NCT00350727|75949102|FG000|Phase II|Disease Progression|0|||
42138855|NCT00350727|75949103|FG001|Phase II|Disease Progression|15|||
42138856|NCT00350727|75949104|FG002|Phase II|Disease Progression|16|||
42138857|NCT00350727|75949102|FG000|Phase II|Clinical Deterioration|0|||
42138858|NCT00350727|75949103|FG001|Phase II|Clinical Deterioration|1|||
42274960|NCT02462876|76105973|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
42274961|NCT02462876|76105973|FG000|Overall Study|Patient did not come back to the vascular department|1|||
42274962|NCT02462876|76105973|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
42274963|NCT02462876|76105973|FG000|Overall Study|Patient refused to come back|1|||
42274964|NCT02462876|76105973|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
42274965|NCT02462876|76105973|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
42274966|NCT03386721|76105992|FG000|Overall Study|Death|12|||
42274967|NCT03386721|76105993|FG001|Overall Study|Death|21|||
42274968|NCT03386721|76105994|FG002|Overall Study|Death|2|||
42274969|NCT03386721|76105995|FG003|Overall Study|Death|5|||
42274970|NCT03386721|76105996|FG004|Overall Study|Death|1|||
42138859|NCT00350727|75949104|FG002|Phase II|Clinical Deterioration|0|||
42274971|NCT03386721|76105997|FG005|Overall Study|Death|12|||
42349696|NCT01363297|76189547|FG003|Overall Study|Death|10|||
42349697|NCT01363297|76189548|FG004|Overall Study|Death|30|||
42349698|NCT01908907|76189567|FG000|Overall Study|Physician Decision|1|||
42138860|NCT00350727|75949102|FG000|Phase II|Withdrawal by Subject|0|||
42349699|NCT01908907|76189568|FG001|Overall Study|Physician Decision|0|||
42138861|NCT00350727|75949103|FG001|Phase II|Withdrawal by Subject|2|||
42349700|NCT01908907|76189567|FG000|Overall Study|Protocol Violation|1|||
42349701|NCT01908907|76189568|FG001|Overall Study|Protocol Violation|0|||
42349702|NCT01808612|76189581|FG000|Treatment Period|Adverse Event|8|||
42349703|NCT01808612|76189582|FG001|Treatment Period|Adverse Event|4|||
42274972|NCT03386721|76105998|FG006|Overall Study|Death|1|||
42274973|NCT03386721|76105999|FG007|Overall Study|Death|1|||
42274974|NCT03386721|76106000|FG008|Overall Study|Death|12|||
42274975|NCT03386721|76106001|FG009|Overall Study|Death|20|||
42274976|NCT03386721|76106002|FG010|Overall Study|Death|21|||
42274977|NCT03386721|76106003|FG011|Overall Study|Death|21|||
42349704|NCT01808612|76189583|FG002|Treatment Period|Adverse Event|3|||
42349705|NCT01808612|76189581|FG000|Treatment Period|Lost to Follow-up|2|||
42011342|NCT01005316|75818330|FG001|Overall Study|Retransplanted|1|||
42011343|NCT01005316|75818331|FG002|Overall Study|Retransplanted|0|||
42274978|NCT03386721|76106004|FG012|Overall Study|Death|14|||
42274979|NCT03386721|76106005|FG013|Overall Study|Death|2|||
42349706|NCT01808612|76189582|FG001|Treatment Period|Lost to Follow-up|2|||
42349707|NCT01808612|76189583|FG002|Treatment Period|Lost to Follow-up|1|||
42349708|NCT01808612|76189581|FG000|Treatment Period|Protocol Violation|1|||
42349709|NCT01808612|76189582|FG001|Treatment Period|Protocol Violation|0|||
42349710|NCT01808612|76189583|FG002|Treatment Period|Protocol Violation|0|||
42349711|NCT01808612|76189581|FG000|Treatment Period|Withdrawal by Subject|1|||
42349712|NCT01808612|76189582|FG001|Treatment Period|Withdrawal by Subject|0|||
42349713|NCT01808612|76189583|FG002|Treatment Period|Withdrawal by Subject|4|||
42349714|NCT01808612|76189581|FG000|Treatment Period|Physician Decision|1|||
42349715|NCT01808612|76189582|FG001|Treatment Period|Physician Decision|0|||
42349716|NCT01808612|76189583|FG002|Treatment Period|Physician Decision|4|||
42349717|NCT01808612|76189581|FG000|Treatment Period|Sponsor Decision|1|||
42349718|NCT01808612|76189582|FG001|Treatment Period|Sponsor Decision|0|||
42349719|NCT01808612|76189583|FG002|Treatment Period|Sponsor Decision|0|||
42349720|NCT01808612|76189581|FG000|Treatment Period|Lack of Efficacy|1|||
42349721|NCT01808612|76189582|FG001|Treatment Period|Lack of Efficacy|1|||
42349722|NCT01808612|76189583|FG002|Treatment Period|Lack of Efficacy|2|||
42349723|NCT01808612|76189581|FG000|Discontinuation Period|Adverse Event|1|||
42349724|NCT01808612|76189582|FG001|Discontinuation Period|Adverse Event|0|||
42349725|NCT01808612|76189583|FG002|Discontinuation Period|Adverse Event|0|||
42349726|NCT01808612|76189581|FG000|Discontinuation Period|Physician Decision|1|||
42349727|NCT01808612|76189582|FG001|Discontinuation Period|Physician Decision|0|||
42349728|NCT01808612|76189583|FG002|Discontinuation Period|Physician Decision|0|||
42349729|NCT01808612|76189581|FG000|Discontinuation Period|Lost to Follow-up|0|||
42349730|NCT01808612|76189582|FG001|Discontinuation Period|Lost to Follow-up|1|||
42349731|NCT01808612|76189583|FG002|Discontinuation Period|Lost to Follow-up|0|||
42349732|NCT01908829|76189597|FG000|Overall Study|Adverse Event|13|||
42349733|NCT01908829|76189598|FG001|Overall Study|Adverse Event|11|||
42349734|NCT01908829|76189599|FG002|Overall Study|Adverse Event|13|||
42349735|NCT01908829|76189597|FG000|Overall Study|Lost to Follow-up|4|||
42349736|NCT01908829|76189598|FG001|Overall Study|Lost to Follow-up|2|||
42349737|NCT01908829|76189599|FG002|Overall Study|Lost to Follow-up|1|||
42037380|NCT01160822|75845719|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
42274980|NCT03386721|76106006|FG014|Overall Study|Death|1|||
42274981|NCT03386721|76105992|FG000|Overall Study|Lost to Follow-up|1|||
42274982|NCT03386721|76105993|FG001|Overall Study|Lost to Follow-up|3|||
42274983|NCT03386721|76105994|FG002|Overall Study|Lost to Follow-up|0|||
42274984|NCT03386721|76105995|FG003|Overall Study|Lost to Follow-up|0|||
42349738|NCT01908829|76189597|FG000|Overall Study|Randomized no double-blind drug received|1|||
42349739|NCT01908829|76189598|FG001|Overall Study|Randomized no double-blind drug received|0|||
42349740|NCT01908829|76189599|FG002|Overall Study|Randomized no double-blind drug received|1|||
42349741|NCT01908829|76189597|FG000|Overall Study|Discontinued (no EoT page)|2|||
42349742|NCT01908829|76189598|FG001|Overall Study|Discontinued (no EoT page)|0|||
42349743|NCT01908829|76189599|FG002|Overall Study|Discontinued (no EoT page)|0|||
42349744|NCT01908829|76189597|FG000|Overall Study|Miscellaneous|0|||
42349745|NCT01908829|76189598|FG001|Overall Study|Miscellaneous|2|||
42037381|NCT01160822|75845720|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
42274985|NCT03386721|76105996|FG004|Overall Study|Lost to Follow-up|0|||
42274986|NCT03386721|76105997|FG005|Overall Study|Lost to Follow-up|2|||
42274987|NCT03386721|76105998|FG006|Overall Study|Lost to Follow-up|1|||
42274988|NCT03386721|76105999|FG007|Overall Study|Lost to Follow-up|0|||
42274989|NCT03386721|76106000|FG008|Overall Study|Lost to Follow-up|1|||
42274990|NCT03386721|76106001|FG009|Overall Study|Lost to Follow-up|2|||
42274991|NCT03386721|76106002|FG010|Overall Study|Lost to Follow-up|1|||
42274992|NCT03386721|76106003|FG011|Overall Study|Lost to Follow-up|0|||
42274993|NCT03386721|76106004|FG012|Overall Study|Lost to Follow-up|0|||
42274994|NCT03386721|76106005|FG013|Overall Study|Lost to Follow-up|0|||
42274995|NCT03386721|76106006|FG014|Overall Study|Lost to Follow-up|0|||
42274996|NCT03386721|76105992|FG000|Overall Study|Reason not specified|3|||
42274997|NCT03386721|76105993|FG001|Overall Study|Reason not specified|0|||
42274998|NCT03386721|76105994|FG002|Overall Study|Reason not specified|0|||
42037382|NCT01160822|75845721|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
42274999|NCT03386721|76105995|FG003|Overall Study|Reason not specified|0|||
42275000|NCT03386721|76105996|FG004|Overall Study|Reason not specified|0|||
42275001|NCT03386721|76105997|FG005|Overall Study|Reason not specified|3|||
42275002|NCT03386721|76105998|FG006|Overall Study|Reason not specified|1|||
42349746|NCT01908829|76189599|FG002|Overall Study|Miscellaneous|0|||
42349747|NCT01908829|76189597|FG000|Overall Study|Protocol Violation|2|||
42349748|NCT01908829|76189598|FG001|Overall Study|Protocol Violation|2|||
42349749|NCT01908829|76189599|FG002|Overall Study|Protocol Violation|0|||
42349750|NCT01908829|76189597|FG000|Overall Study|Lack of Efficacy|1|||
42349751|NCT01908829|76189598|FG001|Overall Study|Lack of Efficacy|3|||
42349752|NCT01908829|76189599|FG002|Overall Study|Lack of Efficacy|2|||
42275003|NCT03386721|76105999|FG007|Overall Study|Reason not specified|0|||
42275004|NCT03386721|76106000|FG008|Overall Study|Reason not specified|0|||
42349753|NCT01908829|76189597|FG000|Overall Study|Withdrawal by Subject|26|||
42275005|NCT03386721|76106001|FG009|Overall Study|Reason not specified|1|||
42349754|NCT01908829|76189598|FG001|Overall Study|Withdrawal by Subject|29|||
42349755|NCT01908829|76189599|FG002|Overall Study|Withdrawal by Subject|22|||
42275006|NCT03386721|76106002|FG010|Overall Study|Reason not specified|2|||
42275007|NCT03386721|76106003|FG011|Overall Study|Reason not specified|6|||
42275008|NCT03386721|76106004|FG012|Overall Study|Reason not specified|1|||
42275009|NCT03386721|76106005|FG013|Overall Study|Reason not specified|0|||
42275010|NCT03386721|76106006|FG014|Overall Study|Reason not specified|0|||
42275011|NCT03386721|76105992|FG000|Overall Study|Progressive Disease|0|||
42275012|NCT03386721|76105993|FG001|Overall Study|Progressive Disease|0|||
42275013|NCT03386721|76105994|FG002|Overall Study|Progressive Disease|1|||
42275014|NCT03386721|76105995|FG003|Overall Study|Progressive Disease|0|||
42349756|NCT01773122|76189611|FG000|Overall Study|Due to amended age eligibility criteria|3|||
42349757|NCT01773122|76189612|FG001|Overall Study|Due to amended age eligibility criteria|1|||
42349758|NCT01773122|76189613|FG002|Overall Study|Due to amended age eligibility criteria|0|||
42349759|NCT01773122|76189614|FG003|Overall Study|Due to amended age eligibility criteria|1|||
42011344|NCT01005316|75818332|FG003|Overall Study|Retransplanted|0|||
42011345|NCT01004848|75818345|FG000|Overall Study|Lost to Follow-up|55|||
42011346|NCT01004848|75818346|FG001|Overall Study|Lost to Follow-up|45|||
42011347|NCT01009294|75818354|FG000|Overall Study|Study discontinued by Sponsor|6|||
42011348|NCT01009060|75818360|FG000|Overall Study|Adverse Event|1|||
42011349|NCT01009060|75818361|FG001|Overall Study|Adverse Event|2|||
42011350|NCT01009060|75818360|FG000|Overall Study|Protocol Violation|0|||
42011351|NCT01009060|75818361|FG001|Overall Study|Protocol Violation|1|||
42011352|NCT01009060|75818360|FG000|Overall Study|Lost to Follow-up|1|||
42011353|NCT01009060|75818361|FG001|Overall Study|Lost to Follow-up|0|||
42011354|NCT01009060|75818360|FG000|Overall Study|Physician Decision|1|||
42011355|NCT01009060|75818361|FG001|Overall Study|Physician Decision|1|||
42011356|NCT01009060|75818360|FG000|Overall Study|Withdrawal by Subject|1|||
42011357|NCT01009060|75818361|FG001|Overall Study|Withdrawal by Subject|1|||
42011358|NCT00988429|75818374|FG000|Overall Study|Adverse Event|9|||
42011359|NCT00988429|75818375|FG001|Overall Study|Adverse Event|21|||
42011360|NCT00988429|75818376|FG002|Overall Study|Adverse Event|45|||
42011361|NCT00988429|75818374|FG000|Overall Study|Lack of Efficacy|0|||
42011362|NCT00988429|75818375|FG001|Overall Study|Lack of Efficacy|0|||
42011363|NCT00988429|75818376|FG002|Overall Study|Lack of Efficacy|1|||
42011364|NCT00988429|75818374|FG000|Overall Study|Non-Compliance with Study Drug|5|||
42011365|NCT00988429|75818375|FG001|Overall Study|Non-Compliance with Study Drug|1|||
42011366|NCT00988429|75818376|FG002|Overall Study|Non-Compliance with Study Drug|3|||
42011367|NCT00988429|75818374|FG000|Overall Study|Physician Decision|1|||
42011368|NCT00988429|75818375|FG001|Overall Study|Physician Decision|0|||
42011369|NCT00988429|75818376|FG002|Overall Study|Physician Decision|3|||
42011370|NCT00988429|75818374|FG000|Overall Study|Pregnancy|2|||
42011371|NCT00988429|75818375|FG001|Overall Study|Pregnancy|1|||
42011372|NCT00988429|75818376|FG002|Overall Study|Pregnancy|0|||
42011373|NCT00988429|75818374|FG000|Overall Study|Protocol Violation|4|||
42011374|NCT00988429|75818375|FG001|Overall Study|Protocol Violation|3|||
42011375|NCT00988429|75818376|FG002|Overall Study|Protocol Violation|3|||
42011376|NCT00988429|75818374|FG000|Overall Study|Withdrawal by Subject|7|||
42011377|NCT00988429|75818375|FG001|Overall Study|Withdrawal by Subject|7|||
42011378|NCT00988429|75818376|FG002|Overall Study|Withdrawal by Subject|12|||
42011379|NCT00988429|75818374|FG000|Overall Study|Administrative Reasons|1|||
42011380|NCT00988429|75818375|FG001|Overall Study|Administrative Reasons|2|||
42011381|NCT00988429|75818376|FG002|Overall Study|Administrative Reasons|1|||
42011382|NCT00988429|75818374|FG000|Overall Study|other reasons|8|||
42011383|NCT00988429|75818375|FG001|Overall Study|other reasons|8|||
42011384|NCT00988429|75818376|FG002|Overall Study|other reasons|1|||
42011385|NCT01008904|75818385|FG000|Overall Study|Lost to Follow-up|1|||
42011386|NCT01008904|75818385|FG000|Overall Study|Adverse Event|2|||
42011387|NCT01008904|75818385|FG000|Overall Study|unexpected unrelated surgery|1|||
42011388|NCT01004614|75818393|FG000|Washout|Withdrawal by Subject|0|||
42011389|NCT01004614|75818394|FG001|Washout|Withdrawal by Subject|1|||
42011390|NCT01004614|75818395|FG002|Washout|Withdrawal by Subject|0|||
42011391|NCT01004614|75818396|FG003|Washout|Withdrawal by Subject|0|||
42011392|NCT00981409|75818408|FG000|Overall Study|Adverse Event|4|||
42011393|NCT00981409|75818409|FG001|Overall Study|Adverse Event|0|||
42011394|NCT00981409|75818408|FG000|Overall Study|Protocol Violation|0|||
42011395|NCT00981409|75818409|FG001|Overall Study|Protocol Violation|1|||
42275015|NCT03386721|76105996|FG004|Overall Study|Progressive Disease|0|||
42349760|NCT01808534|76189624|FG000|Overall Study|Disease progression|3|||
42011396|NCT00981409|75818408|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
42011397|NCT00981409|75818409|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
42011398|NCT01008748|75818415|FG000|Overall Study|Lost to Follow-up|80|||
42011399|NCT01008748|75818415|FG000|Overall Study|Other|1|||
42011400|NCT01004146|75818421|FG000|Overall Study|Withdrawal by Subject|4|||
42011401|NCT01004146|75818422|FG001|Overall Study|Withdrawal by Subject|5|||
42275016|NCT03386721|76105997|FG005|Overall Study|Progressive Disease|1|||
42275017|NCT03386721|76105998|FG006|Overall Study|Progressive Disease|0|||
42011402|NCT01012414|75818428|FG000|Overall Study|Withdrawal by Subject|2|||
42275018|NCT03386721|76105999|FG007|Overall Study|Progressive Disease|0|||
42275019|NCT03386721|76106000|FG008|Overall Study|Progressive Disease|2|||
42275020|NCT03386721|76106001|FG009|Overall Study|Progressive Disease|1|||
42275021|NCT03386721|76106002|FG010|Overall Study|Progressive Disease|1|||
42275022|NCT03386721|76106003|FG011|Overall Study|Progressive Disease|0|||
42275023|NCT03386721|76106004|FG012|Overall Study|Progressive Disease|1|||
42275024|NCT03386721|76106005|FG013|Overall Study|Progressive Disease|0|||
42349761|NCT01808534|76189624|FG000|Overall Study|Physician Decision|1|||
42349762|NCT01808222|76189628|FG000|Overall Study|mpMR scan was not performed|1|||
42349763|NCT01772576|76189632|FG000|Overall Study|Death|15|||
42349764|NCT01772576|76189632|FG000|Overall Study|Protocol Violation|1|||
42349765|NCT01772576|76189632|FG000|Overall Study|Lost to Follow-up|3|||
42349766|NCT01772576|76189632|FG000|Overall Study|Study device not used|3|||
42349767|NCT01772576|76189632|FG000|Overall Study|Adverse Event|6|||
42349768|NCT01772576|76189632|FG000|Overall Study|Withdrawal by Subject|6|||
42349769|NCT01802216|76189659|FG000|4 Month Visit|Participant did not show to visit|3|||
42349770|NCT01802216|76189660|FG001|4 Month Visit|Participant did not show to visit|4|||
42349771|NCT01802216|76189659|FG000|8 Month Visit|Participant did not show to visit|3|||
42349772|NCT01802216|76189660|FG001|8 Month Visit|Participant did not show to visit|5|||
42349773|NCT01802216|76189659|FG000|12 Month Visit|Participant did not show to visit|3|||
42349774|NCT01802216|76189660|FG001|12 Month Visit|Participant did not show to visit|4|||
42349775|NCT01808144|76189668|FG000|Overall Study|Death|1|||
42349776|NCT01808144|76189669|FG001|Overall Study|Death|0|||
42349777|NCT01808144|76189668|FG000|Overall Study|Withdrawal by Subject|16|||
42349778|NCT01808144|76189669|FG001|Overall Study|Withdrawal by Subject|23|||
42349779|NCT01808144|76189668|FG000|Overall Study|Lost to Follow-up|6|||
42349780|NCT01808144|76189669|FG001|Overall Study|Lost to Follow-up|3|||
42349781|NCT01808144|76189668|FG000|Overall Study|Protocol Violation|6|||
42349782|NCT01808144|76189669|FG001|Overall Study|Protocol Violation|6|||
42349783|NCT01808144|76189668|FG000|Overall Study|Gout flare|0|||
42349784|NCT01808144|76189669|FG001|Overall Study|Gout flare|1|||
42275025|NCT03386721|76106006|FG014|Overall Study|Progressive Disease|0|||
42275026|NCT03386721|76105992|FG000|Overall Study|Site Terminated by Sponsor|5|||
42275027|NCT03386721|76105993|FG001|Overall Study|Site Terminated by Sponsor|5|||
42275028|NCT03386721|76105994|FG002|Overall Study|Site Terminated by Sponsor|0|||
42275029|NCT03386721|76105995|FG003|Overall Study|Site Terminated by Sponsor|0|||
42275030|NCT03386721|76105996|FG004|Overall Study|Site Terminated by Sponsor|1|||
42275031|NCT03386721|76105997|FG005|Overall Study|Site Terminated by Sponsor|3|||
42275032|NCT03386721|76105998|FG006|Overall Study|Site Terminated by Sponsor|0|||
42275033|NCT03386721|76105999|FG007|Overall Study|Site Terminated by Sponsor|1|||
42275034|NCT03386721|76106000|FG008|Overall Study|Site Terminated by Sponsor|4|||
42275035|NCT03386721|76106001|FG009|Overall Study|Site Terminated by Sponsor|5|||
42275036|NCT03386721|76106002|FG010|Overall Study|Site Terminated by Sponsor|3|||
42275037|NCT03386721|76106003|FG011|Overall Study|Site Terminated by Sponsor|11|||
42275038|NCT03386721|76106004|FG012|Overall Study|Site Terminated by Sponsor|6|||
42275039|NCT03386721|76106005|FG013|Overall Study|Site Terminated by Sponsor|0|||
42275040|NCT03386721|76106006|FG014|Overall Study|Site Terminated by Sponsor|0|||
42349785|NCT01808144|76189668|FG000|Overall Study|Adverse Event|11|||
42011403|NCT01012414|75818428|FG000|Overall Study|Lost to Follow-up|1|||
42011404|NCT01012414|75818428|FG000|Overall Study|Trial was stopped before completed|7|||
42011405|NCT00975715|75818436|FG000|Titration Period|Adverse Event|6|||
42011406|NCT00975715|75818437|FG001|Titration Period|Adverse Event|0|||
42011407|NCT00975715|75818436|FG000|Titration Period|Protocol Violation|1|||
42349786|NCT01808144|76189669|FG001|Overall Study|Adverse Event|15|||
42349787|NCT01801982|76189675|FG000|Overall Study|Lost to Follow-up|1|||
42011408|NCT00975715|75818437|FG001|Titration Period|Protocol Violation|0|||
42275041|NCT03386721|76105992|FG000|Overall Study|Symptomatic Deterioration|0|||
42275042|NCT03386721|76105993|FG001|Overall Study|Symptomatic Deterioration|0|||
42275043|NCT03386721|76105994|FG002|Overall Study|Symptomatic Deterioration|0|||
42275044|NCT03386721|76105995|FG003|Overall Study|Symptomatic Deterioration|0|||
42349788|NCT01808066|76189688|FG000|Overall Study|Withdrawal by Subject|15|||
42349789|NCT01604343|76189696|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
42011409|NCT00975715|75818436|FG000|Maintenance Period|Adverse Event|2|||
42275045|NCT03386721|76105996|FG004|Overall Study|Symptomatic Deterioration|0|||
42275046|NCT03386721|76105997|FG005|Overall Study|Symptomatic Deterioration|0|||
42275047|NCT03386721|76105998|FG006|Overall Study|Symptomatic Deterioration|0|||
42275048|NCT03386721|76105999|FG007|Overall Study|Symptomatic Deterioration|0|||
42275049|NCT03386721|76106000|FG008|Overall Study|Symptomatic Deterioration|1|||
42275050|NCT03386721|76106001|FG009|Overall Study|Symptomatic Deterioration|0|||
42275051|NCT03386721|76106002|FG010|Overall Study|Symptomatic Deterioration|0|||
42275052|NCT03386721|76106003|FG011|Overall Study|Symptomatic Deterioration|1|||
42275053|NCT03386721|76106004|FG012|Overall Study|Symptomatic Deterioration|0|||
42275054|NCT03386721|76106005|FG013|Overall Study|Symptomatic Deterioration|0|||
42275055|NCT03386721|76106006|FG014|Overall Study|Symptomatic Deterioration|0|||
42275056|NCT03386721|76105992|FG000|Overall Study|Withdrawal by Subject|1|||
42011410|NCT00975715|75818437|FG001|Maintenance Period|Adverse Event|1|||
42011411|NCT03962491|75818445|FG000|Overall Study|Lost to Follow-up|4|||
42275057|NCT03386721|76105993|FG001|Overall Study|Withdrawal by Subject|2|||
42275058|NCT03386721|76105994|FG002|Overall Study|Withdrawal by Subject|0|||
42275059|NCT03386721|76105995|FG003|Overall Study|Withdrawal by Subject|0|||
42275060|NCT03386721|76105996|FG004|Overall Study|Withdrawal by Subject|0|||
42349790|NCT01604343|76189697|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
42349791|NCT01604343|76189698|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
42349792|NCT01604343|76189699|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
42275061|NCT03386721|76105997|FG005|Overall Study|Withdrawal by Subject|0|||
42275062|NCT03386721|76105998|FG006|Overall Study|Withdrawal by Subject|0|||
42275063|NCT03386721|76105999|FG007|Overall Study|Withdrawal by Subject|0|||
42275064|NCT03386721|76106000|FG008|Overall Study|Withdrawal by Subject|2|||
42275065|NCT03386721|76106001|FG009|Overall Study|Withdrawal by Subject|1|||
42275066|NCT03386721|76106002|FG010|Overall Study|Withdrawal by Subject|3|||
42011412|NCT03962491|75818446|FG001|Overall Study|Lost to Follow-up|5|||
42275067|NCT03386721|76106003|FG011|Overall Study|Withdrawal by Subject|2|||
42275068|NCT03386721|76106004|FG012|Overall Study|Withdrawal by Subject|3|||
42275069|NCT03386721|76106005|FG013|Overall Study|Withdrawal by Subject|0|||
42275070|NCT03386721|76106006|FG014|Overall Study|Withdrawal by Subject|0|||
42275071|NCT02462720|76106038|FG000|Part 2|Withdrawal by Subject|1|||
42349793|NCT01604343|76189700|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
42349794|NCT01604343|76189696|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
42275072|NCT02462720|76106039|FG001|Part 2|Withdrawal by Subject|0|||
42275073|NCT02462720|76106038|FG000|Part 2|Protocol Violation|0|||
42275074|NCT02462720|76106039|FG001|Part 2|Protocol Violation|1|||
42011413|NCT00978757|75818454|FG000|Overall Study|Physician Decision|1|||
42275075|NCT02246218|76106049|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42275076|NCT02246218|76106050|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
42275077|NCT02246218|76106049|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
42349795|NCT01604343|76189697|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
42349796|NCT01604343|76189698|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
42349797|NCT01604343|76189699|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
42349798|NCT01604343|76189700|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
42349799|NCT01604343|76189696|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
42349800|NCT01604343|76189697|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
42349801|NCT01604343|76189698|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
42349802|NCT01604343|76189699|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
42349803|NCT01604343|76189700|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
42349804|NCT01604343|76189696|FG000|Prior to W52 Administration(Through W52)|Death|5|||
42349805|NCT01604343|76189697|FG001|Prior to W52 Administration(Through W52)|Death|0|||
42349806|NCT01604343|76189698|FG002|Prior to W52 Administration(Through W52)|Death|2|||
42349807|NCT01604343|76189699|FG003|Prior to W52 Administration(Through W52)|Death|0|||
42349808|NCT01604343|76189700|FG004|Prior to W52 Administration(Through W52)|Death|4|||
42349809|NCT01604343|76189696|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
42349810|NCT01604343|76189697|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
42349811|NCT01604343|76189698|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
42349812|NCT01604343|76189699|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
42349813|NCT01604343|76189700|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
42349814|NCT01604343|76189696|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
42349815|NCT01604343|76189697|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
42349816|NCT01604343|76189698|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
42349817|NCT01604343|76189699|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
42349818|NCT01604343|76189700|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
42349819|NCT01604343|76189696|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
42349820|NCT01604343|76189697|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
42349821|NCT01604343|76189698|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
42349822|NCT01604343|76189699|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
42349823|NCT01604343|76189700|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
42349824|NCT01604343|76189696|FG000|Prior to W52 Administration(Through W52)|Other|15|||
42349825|NCT01604343|76189697|FG001|Prior to W52 Administration(Through W52)|Other|0|||
42349826|NCT01604343|76189698|FG002|Prior to W52 Administration(Through W52)|Other|10|||
42349827|NCT01604343|76189699|FG003|Prior to W52 Administration(Through W52)|Other|0|||
42349828|NCT01604343|76189700|FG004|Prior to W52 Administration(Through W52)|Other|6|||
42349829|NCT01604343|76189696|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
42349830|NCT01604343|76189697|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
42349831|NCT01604343|76189698|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
42349832|NCT01604343|76189699|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
42349833|NCT01604343|76189700|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
42349834|NCT01604343|76189696|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
42349835|NCT01604343|76189697|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
42349836|NCT01604343|76189698|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
42011414|NCT00978757|75818455|FG001|Overall Study|Physician Decision|3|||
42275078|NCT02246218|76106050|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
42275079|NCT02246218|76106049|FG000|Overall Study|Adverse Event|1|||
42275080|NCT02246218|76106050|FG001|Overall Study|Adverse Event|1|||
42275081|NCT02246218|76106049|FG000|Overall Study|Lost to Follow-up|1|||
42275082|NCT02246218|76106050|FG001|Overall Study|Lost to Follow-up|0|||
42275083|NCT02244580|76106056|FG000|Overall Study|No cancer tissues available|241|||
42275084|NCT02244424|76106066|FG000|Overall Study|Lost to Follow-up|20|||
42275085|NCT02244424|76106067|FG001|Overall Study|Lost to Follow-up|10|||
42275086|NCT00159783|76106076|FG000|Overall Study|Adverse Event|5|||
42275087|NCT00159783|76106077|FG001|Overall Study|Adverse Event|7|||
42275088|NCT00159783|76106078|FG002|Overall Study|Adverse Event|9|||
42275089|NCT00159783|76106076|FG000|Overall Study|Lack of Efficacy|1|||
42275090|NCT00159783|76106077|FG001|Overall Study|Lack of Efficacy|2|||
42275091|NCT00159783|76106078|FG002|Overall Study|Lack of Efficacy|3|||
42275092|NCT00159783|76106076|FG000|Overall Study|Withdrawal by Subject|7|||
42275093|NCT00159783|76106077|FG001|Overall Study|Withdrawal by Subject|11|||
42275094|NCT00159783|76106078|FG002|Overall Study|Withdrawal by Subject|12|||
42275095|NCT00159783|76106076|FG000|Overall Study|Lost to Follow-up|6|||
42349837|NCT01604343|76189699|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
42349838|NCT01604343|76189700|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
42349839|NCT01604343|76189696|FG000|Week 52 to Week 104|Adverse Event|0|||
42349840|NCT01604343|76189697|FG001|Week 52 to Week 104|Adverse Event|12|||
42275096|NCT00159783|76106077|FG001|Overall Study|Lost to Follow-up|5|||
42011415|NCT01214421|75818465|FG000|Overall Study|Lost to Follow-up|7|||
42011416|NCT01214421|75818466|FG001|Overall Study|Lost to Follow-up|3|||
42011417|NCT01214421|75818467|FG002|Overall Study|Lost to Follow-up|7|||
42011418|NCT01214421|75818468|FG003|Overall Study|Lost to Follow-up|3|||
42011419|NCT01214421|75818465|FG000|Overall Study|Adverse Event|16|||
42011420|NCT01214421|75818466|FG001|Overall Study|Adverse Event|35|||
42011421|NCT01214421|75818467|FG002|Overall Study|Adverse Event|14|||
42011422|NCT01214421|75818468|FG003|Overall Study|Adverse Event|3|||
42011423|NCT01214421|75818465|FG000|Overall Study|Sponsor Discontinued Site|1|||
42011424|NCT01214421|75818466|FG001|Overall Study|Sponsor Discontinued Site|2|||
42011425|NCT01214421|75818467|FG002|Overall Study|Sponsor Discontinued Site|0|||
42011426|NCT01214421|75818468|FG003|Overall Study|Sponsor Discontinued Site|0|||
42037383|NCT01160822|75845722|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
42037384|NCT01160822|75845723|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
42037385|NCT01160822|75845717|FG000|Overall Study|Withdrawal by Subject|0|||
42037386|NCT01160822|75845718|FG001|Overall Study|Withdrawal by Subject|0|||
42037387|NCT01160822|75845719|FG002|Overall Study|Withdrawal by Subject|0|||
42037388|NCT01160822|75845720|FG003|Overall Study|Withdrawal by Subject|0|||
42011427|NCT01214421|75818465|FG000|Overall Study|Withdrawal Criteria Met|3|||
42011428|NCT01214421|75818466|FG001|Overall Study|Withdrawal Criteria Met|0|||
42011429|NCT01214421|75818467|FG002|Overall Study|Withdrawal Criteria Met|2|||
42037389|NCT01160822|75845721|FG004|Overall Study|Withdrawal by Subject|0|||
42037390|NCT01160822|75845722|FG005|Overall Study|Withdrawal by Subject|0|||
42037391|NCT01160822|75845723|FG006|Overall Study|Withdrawal by Subject|1|||
42037392|NCT01160822|75845717|FG000|Overall Study|Lost to Follow-up|0|||
42037393|NCT01160822|75845718|FG001|Overall Study|Lost to Follow-up|0|||
42037394|NCT01160822|75845719|FG002|Overall Study|Lost to Follow-up|0|||
42138862|NCT00350727|75949104|FG002|Phase II|Withdrawal by Subject|1|||
42011430|NCT01214421|75818468|FG003|Overall Study|Withdrawal Criteria Met|1|||
42011431|NCT01214421|75818465|FG000|Overall Study|Physician Decision|2|||
42037395|NCT01160822|75845720|FG003|Overall Study|Lost to Follow-up|0|||
42011432|NCT01214421|75818466|FG001|Overall Study|Physician Decision|0|||
42011433|NCT01214421|75818467|FG002|Overall Study|Physician Decision|4|||
42011434|NCT01214421|75818468|FG003|Overall Study|Physician Decision|0|||
42037396|NCT01160822|75845721|FG004|Overall Study|Lost to Follow-up|1|||
42037397|NCT01160822|75845722|FG005|Overall Study|Lost to Follow-up|0|||
42349841|NCT01604343|76189698|FG002|Week 52 to Week 104|Adverse Event|26|||
42349842|NCT01604343|76189699|FG003|Week 52 to Week 104|Adverse Event|21|||
42349843|NCT01604343|76189700|FG004|Week 52 to Week 104|Adverse Event|27|||
42349844|NCT01604343|76189696|FG000|Week 52 to Week 104|Death|0|||
42349845|NCT01604343|76189697|FG001|Week 52 to Week 104|Death|4|||
42349846|NCT01604343|76189698|FG002|Week 52 to Week 104|Death|2|||
42349847|NCT01604343|76189699|FG003|Week 52 to Week 104|Death|5|||
42349848|NCT01604343|76189700|FG004|Week 52 to Week 104|Death|0|||
42349849|NCT01604343|76189696|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
42349850|NCT01604343|76189697|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
42349851|NCT01604343|76189698|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
42349852|NCT01604343|76189699|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
42349853|NCT01604343|76189700|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
42349854|NCT01604343|76189696|FG000|Week 52 to Week 104|Physician Decision|0|||
42349855|NCT01604343|76189697|FG001|Week 52 to Week 104|Physician Decision|1|||
42349856|NCT01604343|76189698|FG002|Week 52 to Week 104|Physician Decision|0|||
42037398|NCT01160822|75845723|FG006|Overall Study|Lost to Follow-up|0|||
42138863|NCT00350727|75949102|FG000|Phase II|Adverse Event|0|||
42349857|NCT01604343|76189699|FG003|Week 52 to Week 104|Physician Decision|0|||
42349858|NCT01604343|76189700|FG004|Week 52 to Week 104|Physician Decision|2|||
42349859|NCT01604343|76189696|FG000|Week 52 to Week 104|Pregnancy|0|||
42037399|NCT01160822|75845717|FG000|Overall Study|Administrative problems|0|||
42138864|NCT00350727|75949103|FG001|Phase II|Adverse Event|1|||
42349860|NCT01604343|76189697|FG001|Week 52 to Week 104|Pregnancy|0|||
42349861|NCT01604343|76189698|FG002|Week 52 to Week 104|Pregnancy|1|||
42349862|NCT01604343|76189699|FG003|Week 52 to Week 104|Pregnancy|2|||
42349863|NCT01604343|76189700|FG004|Week 52 to Week 104|Pregnancy|1|||
42349864|NCT01604343|76189696|FG000|Week 52 to Week 104|Other|0|||
42349865|NCT01604343|76189697|FG001|Week 52 to Week 104|Other|11|||
42349866|NCT01604343|76189698|FG002|Week 52 to Week 104|Other|11|||
42349867|NCT01604343|76189699|FG003|Week 52 to Week 104|Other|6|||
42349868|NCT01604343|76189700|FG004|Week 52 to Week 104|Other|3|||
42349869|NCT01604343|76189696|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
42349870|NCT01604343|76189697|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
42349871|NCT01604343|76189698|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
42349872|NCT01604343|76189699|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
42349873|NCT01604343|76189700|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
42349874|NCT01604343|76189696|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
42349875|NCT01604343|76189697|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
42349876|NCT01604343|76189698|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
42349877|NCT01604343|76189699|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
42349878|NCT01604343|76189700|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
42349879|NCT01604343|76189696|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
42349880|NCT01604343|76189697|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
42349881|NCT01604343|76189698|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
42349882|NCT01604343|76189699|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
42275097|NCT00159783|76106078|FG002|Overall Study|Lost to Follow-up|11|||
42275098|NCT00159783|76106076|FG000|Overall Study|Other|0|||
42275099|NCT00159783|76106077|FG001|Overall Study|Other|2|||
42275100|NCT00159783|76106078|FG002|Overall Study|Other|4|||
42275101|NCT00646204|76106089|FG000|Overall Study|Adverse Event|3|||
42275102|NCT00646204|76106090|FG001|Overall Study|Adverse Event|0|||
42275103|NCT00646204|76106089|FG000|Overall Study|Withdrawal by Subject|1|||
42275104|NCT00646204|76106090|FG001|Overall Study|Withdrawal by Subject|0|||
42275105|NCT02936323|76106107|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
42275106|NCT02936323|76106108|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
42275107|NCT02936323|76106109|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
42275108|NCT02936323|76106110|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
42275109|NCT02936323|76106111|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
42275110|NCT02936323|76106112|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
42275111|NCT02936323|76106113|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
42275112|NCT02936323|76106114|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
42275113|NCT02936323|76106115|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
42275114|NCT02936323|76106116|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
42275115|NCT02936323|76106107|FG000|Phase 1 Dose Escalation|Death|2|||
42275116|NCT02936323|76106108|FG001|Phase 1 Dose Escalation|Death|1|||
42275117|NCT02936323|76106109|FG002|Phase 1 Dose Escalation|Death|3|||
42275118|NCT02936323|76106110|FG003|Phase 1 Dose Escalation|Death|1|||
42275119|NCT02936323|76106111|FG004|Phase 1 Dose Escalation|Death|2|||
42138865|NCT00350727|75949104|FG002|Phase II|Adverse Event|1|||
42138866|NCT00350727|75949102|FG000|Phase II|Death|0|||
42138867|NCT00350727|75949103|FG001|Phase II|Death|0|||
42138868|NCT00350727|75949104|FG002|Phase II|Death|2|||
42138869|NCT00350727|75949102|FG000|Phase II|Sponsor Terminated Study|0|||
42138870|NCT00350727|75949103|FG001|Phase II|Sponsor Terminated Study|0|||
42275120|NCT02936323|76106112|FG005|Phase 1 Dose Escalation|Death|3|||
42275121|NCT02936323|76106113|FG006|Phase 1 Dose Escalation|Death|3|||
42275122|NCT02936323|76106114|FG007|Phase 1 Dose Escalation|Death|0|||
42275123|NCT02936323|76106115|FG008|Phase 1 Dose Escalation|Death|0|||
42275124|NCT02936323|76106116|FG009|Phase 1 Dose Escalation|Death|0|||
42275125|NCT02936323|76106107|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
42275126|NCT02936323|76106108|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
42011435|NCT01214421|75818465|FG000|Overall Study|Withdrawal by Subject|21|||
42011436|NCT01214421|75818466|FG001|Overall Study|Withdrawal by Subject|18|||
42011437|NCT01214421|75818467|FG002|Overall Study|Withdrawal by Subject|11|||
42138871|NCT00350727|75949104|FG002|Phase II|Sponsor Terminated Study|1|||
42138872|NCT00350727|75949102|FG000|Phase II|Enrolled in Rollover Study|0|||
42275127|NCT02936323|76106109|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
42275128|NCT02936323|76106110|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
42138873|NCT00350727|75949103|FG001|Phase II|Enrolled in Rollover Study|0|||
42275129|NCT02936323|76106111|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
42275130|NCT02936323|76106112|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
42349883|NCT01604343|76189700|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
42349884|NCT01801436|76189710|FG000|Overall Study|Withdrawal by Subject|3|||
42349885|NCT01801436|76189710|FG000|Overall Study|Adverse Event|2|||
42138874|NCT00350727|75949104|FG002|Phase II|Enrolled in Rollover Study|1|||
42138875|NCT00434304|75949123|FG000|Overall Study|Adverse Event|14|||
42275131|NCT02936323|76106113|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
42275132|NCT02936323|76106114|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
42275133|NCT02936323|76106115|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
42275134|NCT02936323|76106116|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
42275135|NCT02936323|76106107|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
42275136|NCT02936323|76106108|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
42275137|NCT02936323|76106109|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
42275138|NCT02936323|76106110|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
42275139|NCT02936323|76106111|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
42275140|NCT02936323|76106112|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
42275141|NCT02936323|76106113|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
42275142|NCT02936323|76106114|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
42275143|NCT02936323|76106115|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
42275144|NCT02936323|76106116|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
42275145|NCT02936323|76106107|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
42275146|NCT02936323|76106108|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
42275147|NCT02936323|76106109|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
42275148|NCT02936323|76106110|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
42275149|NCT02936323|76106111|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
42275150|NCT02936323|76106112|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
42275151|NCT02936323|76106113|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
42275152|NCT02936323|76106114|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
42275153|NCT02936323|76106115|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
42275154|NCT02936323|76106116|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
42275155|NCT02936323|76106107|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
42275156|NCT02936323|76106108|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
42275157|NCT02936323|76106109|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
42275158|NCT02936323|76106110|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
42275159|NCT02936323|76106111|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
42275160|NCT02936323|76106112|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
42275161|NCT02936323|76106113|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
42275162|NCT02936323|76106114|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
42275163|NCT02936323|76106115|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
42275164|NCT02936323|76106116|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
42275165|NCT02936323|76106107|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
42349886|NCT01801436|76189710|FG000|Overall Study|Progressive disease|4|||
42349887|NCT01771250|76189714|FG000|Period 1|Met exclusion criteria|1|||
42349888|NCT01771250|76189715|FG001|Period 1|Met exclusion criteria|0|||
42349889|NCT01770860|76189721|FG000|Overall Study|Withdrawal by Subject|4|||
42349890|NCT01770860|76189721|FG000|Overall Study|Lost to Follow-up|1|||
42349891|NCT01770860|76189721|FG000|Overall Study|Administrative decision made by the PI|1|||
42349892|NCT01603875|76189732|FG000|Overall Study|Preexisting rabies antibody|3|||
42349893|NCT01603875|76189733|FG001|Overall Study|Preexisting rabies antibody|4|||
42349894|NCT01603875|76189734|FG002|Overall Study|Preexisting rabies antibody|3|||
42349895|NCT01603875|76189732|FG000|Overall Study|Lost to Follow-up|4|||
42349896|NCT01603875|76189733|FG001|Overall Study|Lost to Follow-up|3|||
42349897|NCT01603875|76189734|FG002|Overall Study|Lost to Follow-up|6|||
42349898|NCT01603875|76189732|FG000|Overall Study|Protocol Violation|0|||
42349899|NCT01603875|76189733|FG001|Overall Study|Protocol Violation|1|||
42011438|NCT01214421|75818468|FG003|Overall Study|Withdrawal by Subject|2|||
42011439|NCT04102111|75818480|FG000|Overall Study|Withdrawal by Subject|2|||
42011440|NCT04102111|75818481|FG001|Overall Study|Withdrawal by Subject|3|||
42011441|NCT04102111|75818480|FG000|Overall Study|Adverse Event|1|||
42011442|NCT04102111|75818481|FG001|Overall Study|Adverse Event|1|||
42275166|NCT02936323|76106108|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
42349900|NCT01603875|76189734|FG002|Overall Study|Protocol Violation|0|||
42011443|NCT04102111|75818480|FG000|Overall Study|Study terminated by sponsor|1|||
42275167|NCT02936323|76106109|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
42275168|NCT02936323|76106110|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
42275169|NCT02936323|76106111|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
42275170|NCT02936323|76106112|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
42349901|NCT01770392|76189742|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
42349902|NCT01603641|76189752|FG000|Overall Study|Did not Receive Treatment|3|||
42349903|NCT01603641|76189752|FG000|Overall Study|Adverse Event|1|||
42349904|NCT01603641|76189752|FG000|Overall Study|Lack of Efficacy|1|||
42349905|NCT01603641|76189752|FG000|Overall Study|Lost to Follow-up|6|||
42349906|NCT01603641|76189752|FG000|Overall Study|Personal Reasons|18|||
42349907|NCT01603641|76189752|FG000|Overall Study|Other Miscellaneous Reasons|6|||
42349908|NCT01556763|76189759|FG000|Overall Study|Withdrawal by Subject|0|||
42349909|NCT01556763|76189760|FG001|Overall Study|Withdrawal by Subject|1|||
42349910|NCT01556763|76189761|FG002|Overall Study|Withdrawal by Subject|0|||
42349911|NCT01576575|76189771|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
42349912|NCT01576575|76189771|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
42349913|NCT01576575|76189771|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
42349914|NCT01555983|76189781|FG000|Overall Study|Withdrawal by Subject|1|||
42349915|NCT01555983|76189782|FG001|Overall Study|Withdrawal by Subject|0|||
42349916|NCT01555983|76189783|FG002|Overall Study|Withdrawal by Subject|0|||
42349917|NCT01555983|76189784|FG003|Overall Study|Withdrawal by Subject|0|||
42349918|NCT01555983|76189785|FG004|Overall Study|Withdrawal by Subject|1|||
42349919|NCT01555983|76189786|FG005|Overall Study|Withdrawal by Subject|1|||
42349920|NCT01576341|76189794|FG000|Overall Study|Withdrawal by Subject|24|||
42349921|NCT01576341|76189794|FG000|Overall Study|Adverse Event|10|||
42349922|NCT01576341|76189794|FG000|Overall Study|Death|21|||
42349923|NCT01576341|76189794|FG000|Overall Study|Physician Decision|2|||
42349924|NCT01576341|76189794|FG000|Overall Study|Lost to Follow-up|2|||
42349925|NCT01576341|76189794|FG000|Overall Study|Kidney transplantation|10|||
42349926|NCT01576341|76189794|FG000|Overall Study|Protocol Violation|12|||
42349927|NCT01576341|76189794|FG000|Overall Study|Other|12|||
42349928|NCT01687413|76189812|FG000|Overall Study|Withdrawal by Subject|0|||
42349929|NCT01687413|76189813|FG001|Overall Study|Withdrawal by Subject|2|||
42349930|NCT01687413|76189812|FG000|Overall Study|Not eligible|0|||
42349931|NCT01687413|76189813|FG001|Overall Study|Not eligible|2|||
42349932|NCT01687413|76189812|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
42349933|NCT01687413|76189813|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
42349934|NCT01555671|76189839|FG000|Overall Study|Physician Decision|20|||
42349935|NCT01555671|76189840|FG001|Overall Study|Physician Decision|25|||
42349936|NCT01801358|76189854|FG000|Overall Study|Adverse Event|0|||
42349937|NCT01801358|76189855|FG001|Overall Study|Adverse Event|2|||
42349938|NCT01801358|76189856|FG002|Overall Study|Adverse Event|1|||
42349939|NCT01801358|76189857|FG003|Overall Study|Adverse Event|0|||
42349940|NCT01801358|76189858|FG004|Overall Study|Adverse Event|0|||
42349941|NCT01801358|76189859|FG005|Overall Study|Adverse Event|1|||
42349942|NCT01801358|76189854|FG000|Overall Study|Physician Decision|0|||
42349943|NCT01801358|76189855|FG001|Overall Study|Physician Decision|0|||
42349944|NCT01801358|76189856|FG002|Overall Study|Physician Decision|1|||
42349945|NCT01801358|76189857|FG003|Overall Study|Physician Decision|0|||
42011444|NCT04102111|75818481|FG001|Overall Study|Study terminated by sponsor|3|||
42011445|NCT01214187|75818489|FG000|Overall Study|Adverse Event|6|||
42349946|NCT01801358|76189858|FG004|Overall Study|Physician Decision|0|||
42349947|NCT01801358|76189859|FG005|Overall Study|Physician Decision|0|||
42011446|NCT01214187|75818490|FG001|Overall Study|Adverse Event|2|||
42349948|NCT01801358|76189854|FG000|Overall Study|Progressive Disease|6|||
42349949|NCT01801358|76189855|FG001|Overall Study|Progressive Disease|4|||
42011447|NCT01214187|75818489|FG000|Overall Study|Death|1|||
42011448|NCT01214187|75818490|FG001|Overall Study|Death|1|||
42349950|NCT01801358|76189856|FG002|Overall Study|Progressive Disease|4|||
42011449|NCT01214187|75818489|FG000|Overall Study|Withdrawal by Subject|0|||
42011450|NCT01214187|75818490|FG001|Overall Study|Withdrawal by Subject|3|||
42349951|NCT01801358|76189857|FG003|Overall Study|Progressive Disease|5|||
42349952|NCT01801358|76189858|FG004|Overall Study|Progressive Disease|6|||
42349953|NCT01801358|76189859|FG005|Overall Study|Progressive Disease|5|||
42349954|NCT01801358|76189854|FG000|Overall Study|Withdrawal by Subject|0|||
42349955|NCT01801358|76189855|FG001|Overall Study|Withdrawal by Subject|0|||
42349956|NCT01801358|76189856|FG002|Overall Study|Withdrawal by Subject|0|||
42349957|NCT01801358|76189857|FG003|Overall Study|Withdrawal by Subject|1|||
42349958|NCT01801358|76189858|FG004|Overall Study|Withdrawal by Subject|0|||
42349959|NCT01801358|76189859|FG005|Overall Study|Withdrawal by Subject|2|||
42349960|NCT01807598|76189894|FG000|Overall Study|Withdrawal by Subject|4|||
42349961|NCT01807598|76189894|FG000|Overall Study|Adverse Event|1|||
42349962|NCT01807598|76189894|FG000|Overall Study|Other Physician Decision|1|||
42349963|NCT01801280|76189902|FG000|Period 1|Withdrawal by Subject|0|||
42349964|NCT01801280|76189903|FG001|Period 1|Withdrawal by Subject|1|||
42349965|NCT01801280|76189904|FG002|Period 1|Withdrawal by Subject|0|||
42349966|NCT01801280|76189905|FG003|Period 1|Withdrawal by Subject|0|||
42349967|NCT01801280|76189902|FG000|Period 2|Withdrawal by Subject|1|||
42349968|NCT01801280|76189903|FG001|Period 2|Withdrawal by Subject|0|||
42349969|NCT01801280|76189904|FG002|Period 2|Withdrawal by Subject|0|||
42349970|NCT01801280|76189905|FG003|Period 2|Withdrawal by Subject|0|||
42349971|NCT01801280|76189902|FG000|Period 4|Protocol Violation|0|||
42349972|NCT01801280|76189903|FG001|Period 4|Protocol Violation|0|||
42349973|NCT01801280|76189904|FG002|Period 4|Protocol Violation|1|||
42349974|NCT01801280|76189905|FG003|Period 4|Protocol Violation|0|||
42349975|NCT01769456|76189915|FG000|Overall Study|Lost to Follow-up|19|||
42349976|NCT01769456|76189915|FG000|Overall Study|Withdrawal by Subject|3|||
42349977|NCT01769456|76189915|FG000|Overall Study|Did not receive PCC intervention|6|||
42349978|NCT01769456|76189915|FG000|Overall Study|Moved out of the area|3|||
42349979|NCT01769456|76189915|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
42349980|NCT01769456|76189915|FG000|Overall Study|Parental request to youth to withdraw|1|||
42349981|NCT01769378|76189922|FG000|Overall Study|Adverse Event|10|||
42349982|NCT01769378|76189923|FG001|Overall Study|Adverse Event|0|||
42349983|NCT01769378|76189922|FG000|Overall Study|Entry criteria not met|1|||
42349984|NCT01769378|76189923|FG001|Overall Study|Entry criteria not met|0|||
42349985|NCT01769378|76189922|FG000|Overall Study|Protocol Violation|1|||
42349986|NCT01769378|76189923|FG001|Overall Study|Protocol Violation|1|||
42349987|NCT01769378|76189922|FG000|Overall Study|Withdrawal by Subject|10|||
42349988|NCT01769378|76189923|FG001|Overall Study|Withdrawal by Subject|3|||
42349989|NCT01769378|76189922|FG000|Overall Study|Sponsor Decision|1|||
42349990|NCT01769378|76189923|FG001|Overall Study|Sponsor Decision|0|||
42349991|NCT01769378|76189922|FG000|Overall Study|Lost to Follow-up|2|||
42349992|NCT01769378|76189923|FG001|Overall Study|Lost to Follow-up|0|||
42349993|NCT01807520|76189932|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
42349994|NCT01807520|76189933|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
42349995|NCT01807520|76189934|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
42349996|NCT01807520|76189935|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
42349997|NCT01807520|76189936|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
42349998|NCT01807520|76189937|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
42349999|NCT01807520|76189938|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
42350000|NCT01807520|76189932|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
42350001|NCT01807520|76189933|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
42350002|NCT01807520|76189934|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
42350003|NCT01807520|76189935|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
42350004|NCT01807520|76189936|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
42350005|NCT01807520|76189937|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
42011451|NCT01003990|75818499|FG000|Overall Study|Adverse Event|8|||
42011452|NCT01003990|75818500|FG001|Overall Study|Adverse Event|5|||
42011453|NCT01003990|75818501|FG002|Overall Study|Adverse Event|11|||
42350006|NCT01807520|76189938|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
42350007|NCT01807520|76189932|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
42350008|NCT01807520|76189933|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
42350009|NCT01807520|76189934|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
42350010|NCT01807520|76189935|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
42350011|NCT01807520|76189936|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
42350012|NCT01807520|76189937|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
42350013|NCT01807520|76189938|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
42350014|NCT01807520|76189932|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
42350015|NCT01807520|76189933|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
42350016|NCT01807520|76189934|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
42350017|NCT01807520|76189935|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
42350018|NCT01807520|76189936|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
42350019|NCT01807520|76189937|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
42350020|NCT01807520|76189938|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
42350021|NCT01807520|76189932|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
42350022|NCT01807520|76189933|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
42350023|NCT01807520|76189934|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
42350024|NCT01807520|76189935|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
42350025|NCT01807520|76189936|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
42350026|NCT01807520|76189937|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
42350027|NCT01807520|76189938|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
42350028|NCT01807520|76189932|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
42350029|NCT01807520|76189933|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
42350030|NCT01807520|76189934|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
42350031|NCT01807520|76189935|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
42350032|NCT01807520|76189936|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
42350033|NCT01807520|76189937|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
42350034|NCT01807520|76189938|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
42350035|NCT01807520|76189932|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
42350036|NCT01807520|76189933|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
42350037|NCT01807520|76189934|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
42350038|NCT01807520|76189935|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
42350039|NCT01807520|76189936|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
42350040|NCT01807520|76189937|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
42350041|NCT01807520|76189938|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
42350042|NCT01807520|76189932|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
42350043|NCT01807520|76189933|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
42350044|NCT01807520|76189934|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
42350045|NCT01807520|76189935|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
42350046|NCT01807520|76189936|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
42350047|NCT01807520|76189937|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
42350048|NCT01807520|76189938|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
42350049|NCT01807520|76189932|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
42350050|NCT01807520|76189933|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
42350051|NCT01807520|76189934|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
42350052|NCT01807520|76189935|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
42350053|NCT01807520|76189936|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
42350054|NCT01807520|76189937|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
42350055|NCT01807520|76189938|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
42350056|NCT01807520|76189932|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
42350057|NCT01807520|76189933|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
42350058|NCT01807520|76189934|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
42350059|NCT01807520|76189935|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
42350060|NCT01807520|76189936|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
42350061|NCT01807520|76189937|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
42350062|NCT01807520|76189938|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
42350063|NCT01807520|76189932|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
42350064|NCT01807520|76189933|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
42350065|NCT01807520|76189934|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
42350066|NCT01807520|76189935|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
42350067|NCT01807520|76189936|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
42350068|NCT01807520|76189937|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
42350069|NCT01807520|76189938|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
42350070|NCT01807520|76189932|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
42350071|NCT01807520|76189933|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
42350072|NCT01807520|76189934|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
42350073|NCT01807520|76189935|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
42350074|NCT01807520|76189936|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
42350075|NCT01807520|76189937|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
42350076|NCT01807520|76189938|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
42350077|NCT01807520|76189932|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
42350078|NCT01807520|76189933|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
42350079|NCT01807520|76189934|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
42350080|NCT01807520|76189935|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
42350081|NCT01807520|76189936|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
42350082|NCT01807520|76189937|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
42350083|NCT01807520|76189938|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
42350084|NCT01807520|76189932|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
42350085|NCT01807520|76189933|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
42350086|NCT01807520|76189934|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
42350087|NCT01807520|76189935|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
42350088|NCT01807520|76189936|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
42350089|NCT01807520|76189937|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
42350090|NCT01807520|76189938|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
42350091|NCT01807520|76189932|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
42350092|NCT01807520|76189933|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
42350093|NCT01807520|76189934|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
42350094|NCT01807520|76189935|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
42350095|NCT01807520|76189936|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
42350096|NCT01807520|76189937|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
42350097|NCT01807520|76189938|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
42350098|NCT01807520|76189932|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
42350099|NCT01807520|76189933|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
42350100|NCT01807520|76189934|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
42350101|NCT01807520|76189935|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
42350102|NCT01807520|76189936|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
42350103|NCT01807520|76189937|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
42350104|NCT01807520|76189938|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
42350105|NCT01807520|76189932|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
42350106|NCT01807520|76189933|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
42350107|NCT01807520|76189934|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
42350108|NCT01807520|76189935|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
42350109|NCT01807520|76189936|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
42350110|NCT01807520|76189937|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
42350111|NCT01807520|76189938|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
42350112|NCT01806896|76189951|FG000|Overall Study|Adverse Event|2|||
42350113|NCT01806896|76189952|FG001|Overall Study|Adverse Event|0|||
42350114|NCT01806896|76189951|FG000|Overall Study|Other|1|||
42350115|NCT01806896|76189952|FG001|Overall Study|Other|0|||
42350116|NCT01768676|76189960|FG000|Overall Study|Adverse Event|3|||
42350117|NCT01768676|76189961|FG001|Overall Study|Adverse Event|3|||
42350118|NCT01768676|76189960|FG000|Overall Study|Lost to Follow-up|13|||
42350119|NCT01768676|76189961|FG001|Overall Study|Lost to Follow-up|16|||
42350120|NCT01768676|76189960|FG000|Overall Study|Protocol Violation|1|||
42350121|NCT01768676|76189961|FG001|Overall Study|Protocol Violation|1|||
42350122|NCT01768676|76189960|FG000|Overall Study|Physician Decision|4|||
42350123|NCT01768676|76189961|FG001|Overall Study|Physician Decision|1|||
42350124|NCT01768676|76189960|FG000|Overall Study|Withdrawal by Subject|3|||
42350125|NCT01768676|76189961|FG001|Overall Study|Withdrawal by Subject|10|||
42350126|NCT01555125|76189970|FG000|Induction Period|Lost to Follow-up|0|||
42350127|NCT01555125|76189971|FG001|Induction Period|Lost to Follow-up|2|||
42350128|NCT01555125|76189972|FG002|Induction Period|Lost to Follow-up|0|||
42350129|NCT01555125|76189973|FG003|Induction Period|Lost to Follow-up|0|||
42350130|NCT01555125|76189974|FG004|Induction Period|Lost to Follow-up|0|||
42350131|NCT01555125|76189970|FG000|Induction Period|Adverse Event|0|||
42350132|NCT01555125|76189971|FG001|Induction Period|Adverse Event|1|||
42350133|NCT01555125|76189972|FG002|Induction Period|Adverse Event|0|||
42350134|NCT01555125|76189973|FG003|Induction Period|Adverse Event|0|||
42350135|NCT01555125|76189974|FG004|Induction Period|Adverse Event|1|||
42350136|NCT01555125|76189970|FG000|Induction Period|Subject / guardian decision|0|||
42350137|NCT01555125|76189971|FG001|Induction Period|Subject / guardian decision|0|||
42350138|NCT01555125|76189972|FG002|Induction Period|Subject / guardian decision|0|||
42350139|NCT01555125|76189973|FG003|Induction Period|Subject / guardian decision|0|||
42350140|NCT01555125|76189974|FG004|Induction Period|Subject / guardian decision|2|||
42037400|NCT01160822|75845718|FG001|Overall Study|Administrative problems|0|||
42037401|NCT01160822|75845719|FG002|Overall Study|Administrative problems|0|||
42350141|NCT01555125|76189970|FG000|Induction Period|Death|1|||
42350142|NCT01555125|76189971|FG001|Induction Period|Death|0|||
42350143|NCT01555125|76189972|FG002|Induction Period|Death|0|||
42350144|NCT01555125|76189973|FG003|Induction Period|Death|0|||
42350145|NCT01555125|76189974|FG004|Induction Period|Death|0|||
42350146|NCT01555125|76189970|FG000|Maintenance Period|Adverse Event|1|||
42350147|NCT01555125|76189971|FG001|Maintenance Period|Adverse Event|1|||
42350148|NCT01555125|76189972|FG002|Maintenance Period|Adverse Event|0|||
42350149|NCT01555125|76189973|FG003|Maintenance Period|Adverse Event|0|||
42350150|NCT01555125|76189974|FG004|Maintenance Period|Adverse Event|0|||
42350151|NCT01555125|76189970|FG000|Maintenance Period|Subject / guardian decision|1|||
42350152|NCT01555125|76189971|FG001|Maintenance Period|Subject / guardian decision|2|||
42350153|NCT01555125|76189972|FG002|Maintenance Period|Subject / guardian decision|0|||
42350154|NCT01555125|76189973|FG003|Maintenance Period|Subject / guardian decision|0|||
42350155|NCT01555125|76189974|FG004|Maintenance Period|Subject / guardian decision|0|||
42350156|NCT01555125|76189970|FG000|Maintenance Period|Lost to Follow-up|2|||
42350157|NCT01555125|76189971|FG001|Maintenance Period|Lost to Follow-up|0|||
42350158|NCT01555125|76189972|FG002|Maintenance Period|Lost to Follow-up|0|||
42350159|NCT01555125|76189973|FG003|Maintenance Period|Lost to Follow-up|1|||
42350160|NCT01555125|76189974|FG004|Maintenance Period|Lost to Follow-up|0|||
42350161|NCT01555125|76189970|FG000|Maintenance Period|Lack of Efficacy|6|||
42350162|NCT01555125|76189971|FG001|Maintenance Period|Lack of Efficacy|1|||
42350163|NCT01555125|76189972|FG002|Maintenance Period|Lack of Efficacy|3|||
42350164|NCT01555125|76189973|FG003|Maintenance Period|Lack of Efficacy|0|||
42350165|NCT01555125|76189974|FG004|Maintenance Period|Lack of Efficacy|0|||
42350166|NCT01555125|76189970|FG000|Maintenance Period|Physician Decision|0|||
42350167|NCT01555125|76189971|FG001|Maintenance Period|Physician Decision|0|||
42350168|NCT01555125|76189972|FG002|Maintenance Period|Physician Decision|1|||
42350169|NCT01555125|76189973|FG003|Maintenance Period|Physician Decision|0|||
42350170|NCT01555125|76189974|FG004|Maintenance Period|Physician Decision|0|||
42350171|NCT01555125|76189970|FG000|Maintenance Period|Death|0|||
42037402|NCT01160822|75845720|FG003|Overall Study|Administrative problems|0|||
42037403|NCT01160822|75845721|FG004|Overall Study|Administrative problems|1|||
42037404|NCT01160822|75845722|FG005|Overall Study|Administrative problems|0|||
42037405|NCT01160822|75845723|FG006|Overall Study|Administrative problems|0|||
42011454|NCT01003990|75818499|FG000|Overall Study|Death|0|||
42011455|NCT01003990|75818500|FG001|Overall Study|Death|8|||
42011456|NCT01003990|75818501|FG002|Overall Study|Death|1|||
42011457|NCT01003990|75818499|FG000|Overall Study|Lack of Efficacy|10|||
42011458|NCT01003990|75818500|FG001|Overall Study|Lack of Efficacy|2|||
42011459|NCT01003990|75818501|FG002|Overall Study|Lack of Efficacy|3|||
42011460|NCT01003990|75818499|FG000|Overall Study|Lost to Follow-up|30|||
42011461|NCT01003990|75818500|FG001|Overall Study|Lost to Follow-up|12|||
42011462|NCT01003990|75818501|FG002|Overall Study|Lost to Follow-up|7|||
42011463|NCT01003990|75818499|FG000|Overall Study|Reasons Not Identified|14|||
42011464|NCT01003990|75818500|FG001|Overall Study|Reasons Not Identified|13|||
42011465|NCT01003990|75818501|FG002|Overall Study|Reasons Not Identified|8|||
42011466|NCT01003990|75818499|FG000|Overall Study|Poor/Non-compliance|4|||
42011467|NCT01003990|75818500|FG001|Overall Study|Poor/Non-compliance|3|||
42011468|NCT01003990|75818501|FG002|Overall Study|Poor/Non-compliance|2|||
42011469|NCT01003990|75818499|FG000|Overall Study|Pregnancy|10|||
42037406|NCT01160822|75845717|FG000|Overall Study|Protocol deviation|0|||
42037407|NCT01160822|75845718|FG001|Overall Study|Protocol deviation|0|||
42037408|NCT01160822|75845719|FG002|Overall Study|Protocol deviation|0|||
42037409|NCT01160822|75845720|FG003|Overall Study|Protocol deviation|0|||
42037410|NCT01160822|75845721|FG004|Overall Study|Protocol deviation|2|||
42037411|NCT01160822|75845722|FG005|Overall Study|Protocol deviation|0|||
42275171|NCT02936323|76106113|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
42011470|NCT01003990|75818500|FG001|Overall Study|Pregnancy|2|||
42011471|NCT01003990|75818501|FG002|Overall Study|Pregnancy|4|||
42011472|NCT01003990|75818499|FG000|Overall Study|No Longer Met Study Criteria|4|||
42011473|NCT01003990|75818500|FG001|Overall Study|No Longer Met Study Criteria|1|||
42011474|NCT01003990|75818501|FG002|Overall Study|No Longer Met Study Criteria|0|||
42011475|NCT01003990|75818499|FG000|Overall Study|Subject Withdrew Consent|12|||
42011476|NCT01003990|75818500|FG001|Overall Study|Subject Withdrew Consent|5|||
42011477|NCT01003990|75818501|FG002|Overall Study|Subject Withdrew Consent|7|||
42011478|NCT01003210|75818511|FG000|Overall Study|Lost to Follow-up|1|||
42037412|NCT01160822|75845723|FG006|Overall Study|Protocol deviation|0|||
42138876|NCT00434304|75949123|FG000|Overall Study|Lack of Efficacy|2|||
42275172|NCT02936323|76106114|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
42275173|NCT02936323|76106115|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
42275174|NCT02936323|76106116|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
42275175|NCT02936323|76106107|FG000|Phase 2a Dose Expansion|Death|0|||
42275176|NCT02936323|76106108|FG001|Phase 2a Dose Expansion|Death|0|||
42275177|NCT02936323|76106109|FG002|Phase 2a Dose Expansion|Death|0|||
42275178|NCT02936323|76106110|FG003|Phase 2a Dose Expansion|Death|0|||
42275179|NCT02936323|76106111|FG004|Phase 2a Dose Expansion|Death|0|||
42350172|NCT01555125|76189971|FG001|Maintenance Period|Death|0|||
42350173|NCT01555125|76189972|FG002|Maintenance Period|Death|0|||
42350174|NCT01555125|76189973|FG003|Maintenance Period|Death|1|||
42350175|NCT01555125|76189974|FG004|Maintenance Period|Death|0|||
42350176|NCT01555125|76189970|FG000|Extension|Adverse Event|1|||
42350177|NCT01555125|76189971|FG001|Extension|Adverse Event|2|||
42011479|NCT01003210|75818512|FG001|Overall Study|Lost to Follow-up|3|||
42350178|NCT01555125|76189972|FG002|Extension|Adverse Event|1|||
42350179|NCT01555125|76189973|FG003|Extension|Adverse Event|1|||
42350180|NCT01555125|76189974|FG004|Extension|Adverse Event|0|||
42350181|NCT01555125|76189970|FG000|Extension|Protocol deviation|1|||
42350182|NCT01555125|76189971|FG001|Extension|Protocol deviation|0|||
42350183|NCT01555125|76189972|FG002|Extension|Protocol deviation|0|||
42350184|NCT01555125|76189973|FG003|Extension|Protocol deviation|0|||
42350185|NCT01555125|76189974|FG004|Extension|Protocol deviation|0|||
42350186|NCT01555125|76189970|FG000|Extension|Lack of Efficacy|7|||
42350187|NCT01555125|76189971|FG001|Extension|Lack of Efficacy|6|||
42350188|NCT01555125|76189972|FG002|Extension|Lack of Efficacy|3|||
42350189|NCT01555125|76189973|FG003|Extension|Lack of Efficacy|0|||
42350190|NCT01555125|76189974|FG004|Extension|Lack of Efficacy|0|||
42350191|NCT01555125|76189970|FG000|Extension|Lost to Follow-up|2|||
42350192|NCT01555125|76189971|FG001|Extension|Lost to Follow-up|1|||
42350193|NCT01555125|76189972|FG002|Extension|Lost to Follow-up|2|||
42350194|NCT01555125|76189973|FG003|Extension|Lost to Follow-up|0|||
42350195|NCT01555125|76189974|FG004|Extension|Lost to Follow-up|0|||
42350196|NCT01555125|76189970|FG000|Extension|Study terminated by sponsor|32|||
42350197|NCT01555125|76189971|FG001|Extension|Study terminated by sponsor|33|||
42350198|NCT01555125|76189972|FG002|Extension|Study terminated by sponsor|16|||
42350199|NCT01555125|76189973|FG003|Extension|Study terminated by sponsor|20|||
42350200|NCT01555125|76189974|FG004|Extension|Study terminated by sponsor|0|||
42350201|NCT01555125|76189970|FG000|Extension|Subject/guardian decision|1|||
42350202|NCT01555125|76189971|FG001|Extension|Subject/guardian decision|9|||
42350203|NCT01555125|76189972|FG002|Extension|Subject/guardian decision|1|||
42350204|NCT01555125|76189973|FG003|Extension|Subject/guardian decision|0|||
42350205|NCT01555125|76189974|FG004|Extension|Subject/guardian decision|0|||
42350206|NCT01555125|76189970|FG000|Extension|Technical Problems|1|||
42350207|NCT01555125|76189971|FG001|Extension|Technical Problems|0|||
42350208|NCT01555125|76189972|FG002|Extension|Technical Problems|0|||
42350209|NCT01555125|76189973|FG003|Extension|Technical Problems|1|||
42350210|NCT01555125|76189974|FG004|Extension|Technical Problems|0|||
42350211|NCT01555125|76189970|FG000|Follow-Up Period|Lost to Follow-up|1|||
42350212|NCT01555125|76189971|FG001|Follow-Up Period|Lost to Follow-up|0|||
42350213|NCT01555125|76189972|FG002|Follow-Up Period|Lost to Follow-up|0|||
42350214|NCT01555125|76189973|FG003|Follow-Up Period|Lost to Follow-up|0|||
42350215|NCT01555125|76189974|FG004|Follow-Up Period|Lost to Follow-up|0|||
42350216|NCT01555125|76189970|FG000|Follow-Up Period|Subject / guardian decision|3|||
42350217|NCT01555125|76189971|FG001|Follow-Up Period|Subject / guardian decision|1|||
42350218|NCT01555125|76189972|FG002|Follow-Up Period|Subject / guardian decision|1|||
42350219|NCT01555125|76189973|FG003|Follow-Up Period|Subject / guardian decision|1|||
42350220|NCT01555125|76189974|FG004|Follow-Up Period|Subject / guardian decision|0|||
42350221|NCT01768286|76189993|FG000|Overall Study|Randomized But Not Treated|0|||
42350222|NCT01768286|76189994|FG001|Overall Study|Randomized But Not Treated|0|||
42350223|NCT01768286|76189995|FG002|Overall Study|Randomized But Not Treated|1|||
42350224|NCT01768286|76189996|FG003|Overall Study|Randomized But Not Treated|0|||
42350225|NCT01768286|76189993|FG000|Overall Study|Lack of Efficacy|7|||
42350226|NCT01768286|76189994|FG001|Overall Study|Lack of Efficacy|4|||
42037413|NCT01006980|75845742|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
42350227|NCT01768286|76189995|FG002|Overall Study|Lack of Efficacy|0|||
42350228|NCT01768286|76189996|FG003|Overall Study|Lack of Efficacy|1|||
42350229|NCT01768286|76189993|FG000|Overall Study|Withdrew Consent|0|||
42350230|NCT01768286|76189994|FG001|Overall Study|Withdrew Consent|0|||
42350231|NCT01768286|76189995|FG002|Overall Study|Withdrew Consent|1|||
42350232|NCT01768286|76189996|FG003|Overall Study|Withdrew Consent|0|||
42350233|NCT01800968|76190008|FG000|Overall Study|Death|23|||
42350234|NCT01800968|76190009|FG001|Overall Study|Death|16|||
42350235|NCT01800968|76190008|FG000|Overall Study|Lost to Follow-up|5|||
42350236|NCT01800968|76190009|FG001|Overall Study|Lost to Follow-up|7|||
42350237|NCT01800968|76190008|FG000|Overall Study|Withdrawal by Subject|7|||
42350238|NCT01800968|76190009|FG001|Overall Study|Withdrawal by Subject|9|||
42350239|NCT01800968|76190008|FG000|Overall Study|Physician Decision|1|||
42350240|NCT01800968|76190009|FG001|Overall Study|Physician Decision|0|||
42350241|NCT01799720|76190018|FG000|Overall Study|Withdrawal by Subject|3|||
42350242|NCT01799720|76190019|FG001|Overall Study|Withdrawal by Subject|0|||
42350243|NCT01799720|76190020|FG002|Overall Study|Withdrawal by Subject|0|||
42350244|NCT01799720|76190018|FG000|Overall Study|Protocol Violation|0|||
42350245|NCT01799720|76190019|FG001|Overall Study|Protocol Violation|1|||
42350246|NCT01799720|76190020|FG002|Overall Study|Protocol Violation|0|||
42350247|NCT01799720|76190018|FG000|Overall Study|Pregnancy|0|||
42350248|NCT01799720|76190019|FG001|Overall Study|Pregnancy|0|||
42350249|NCT01799720|76190020|FG002|Overall Study|Pregnancy|1|||
42350250|NCT01687257|76190030|FG000|Overall Study|Efficacy Failure|6|||
42350251|NCT01687257|76190031|FG001|Overall Study|Efficacy Failure|0|||
42350252|NCT01687257|76190032|FG002|Overall Study|Efficacy Failure|5|||
42350253|NCT01687257|76190030|FG000|Overall Study|Subject Withdrew Consent|1|||
42350254|NCT01687257|76190031|FG001|Overall Study|Subject Withdrew Consent|1|||
42350255|NCT01687257|76190032|FG002|Overall Study|Subject Withdrew Consent|1|||
42350256|NCT01687257|76190030|FG000|Overall Study|Adverse Event|1|||
42350257|NCT01687257|76190031|FG001|Overall Study|Adverse Event|0|||
42350258|NCT01687257|76190032|FG002|Overall Study|Adverse Event|0|||
42350259|NCT01687257|76190030|FG000|Overall Study|Investigator's Discretion|0|||
42350260|NCT01687257|76190031|FG001|Overall Study|Investigator's Discretion|3|||
42350261|NCT01687257|76190032|FG002|Overall Study|Investigator's Discretion|0|||
42350262|NCT01806740|76190046|FG000|Overall Study|Withdrawal by Subject|4|||
42350263|NCT01806740|76190046|FG000|Overall Study|Physician Decision|1|||
42350264|NCT01806740|76190046|FG000|Overall Study|Patient's refusal of treatment|1|||
42350265|NCT01687101|76190053|FG000|Overall Study|Lost to Follow-up|7|||
42350266|NCT01968967|76190059|FG000|Treatment Period|Other|22|||
42350267|NCT01968967|76190060|FG001|Treatment Period|Other|22|||
42350268|NCT01968967|76190061|FG002|Treatment Period|Other|0|||
42350269|NCT01968967|76190062|FG003|Treatment Period|Other|0|||
42350270|NCT01968967|76190063|FG004|Treatment Period|Other|0|||
42350271|NCT01968967|76190059|FG000|Treatment Period|Withdrawal by Subject|71|||
42350272|NCT01968967|76190060|FG001|Treatment Period|Withdrawal by Subject|61|||
42350273|NCT01968967|76190061|FG002|Treatment Period|Withdrawal by Subject|0|||
42350274|NCT01968967|76190062|FG003|Treatment Period|Withdrawal by Subject|0|||
42350275|NCT01968967|76190063|FG004|Treatment Period|Withdrawal by Subject|0|||
42350276|NCT01968967|76190059|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
42350277|NCT01968967|76190060|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
42350278|NCT01968967|76190061|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
42350279|NCT01968967|76190062|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
42350280|NCT01968967|76190063|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
42350281|NCT01968967|76190059|FG000|Treatment Period|Lost to Follow-up|26|||
42350282|NCT01968967|76190060|FG001|Treatment Period|Lost to Follow-up|31|||
42350283|NCT01968967|76190061|FG002|Treatment Period|Lost to Follow-up|0|||
42350284|NCT01968967|76190062|FG003|Treatment Period|Lost to Follow-up|0|||
42350285|NCT01968967|76190063|FG004|Treatment Period|Lost to Follow-up|0|||
42350286|NCT01968967|76190059|FG000|Treatment Period|Protocol Violation|1|||
42350287|NCT01968967|76190060|FG001|Treatment Period|Protocol Violation|2|||
42350288|NCT01968967|76190061|FG002|Treatment Period|Protocol Violation|0|||
42350289|NCT01968967|76190062|FG003|Treatment Period|Protocol Violation|0|||
42350290|NCT01968967|76190063|FG004|Treatment Period|Protocol Violation|0|||
42350291|NCT01968967|76190059|FG000|Treatment Period|Adverse Event|9|||
42350292|NCT01968967|76190060|FG001|Treatment Period|Adverse Event|8|||
42350293|NCT01968967|76190061|FG002|Treatment Period|Adverse Event|0|||
42350294|NCT01968967|76190062|FG003|Treatment Period|Adverse Event|0|||
42350295|NCT01968967|76190063|FG004|Treatment Period|Adverse Event|0|||
42350296|NCT01968967|76190059|FG000|Treatment Period|Death|9|||
42350297|NCT01968967|76190060|FG001|Treatment Period|Death|2|||
42350298|NCT01968967|76190061|FG002|Treatment Period|Death|0|||
42350299|NCT01968967|76190062|FG003|Treatment Period|Death|0|||
42350300|NCT01968967|76190063|FG004|Treatment Period|Death|0|||
42350301|NCT01968967|76190059|FG000|Treatment Period|Randomized Not Treated|6|||
42350302|NCT01968967|76190060|FG001|Treatment Period|Randomized Not Treated|5|||
42350303|NCT01968967|76190061|FG002|Treatment Period|Randomized Not Treated|0|||
42350304|NCT01968967|76190062|FG003|Treatment Period|Randomized Not Treated|0|||
42350305|NCT01968967|76190063|FG004|Treatment Period|Randomized Not Treated|0|||
42350306|NCT01968967|76190059|FG000|Extension Period|Withdrew Consent|0|||
42011480|NCT01002820|75818518|FG000|Overall Study|Adverse Event|1|||
42350307|NCT01968967|76190060|FG001|Extension Period|Withdrew Consent|0|||
42011481|NCT01002820|75818518|FG000|Overall Study|Withdrawal by Subject|2|||
42350308|NCT01968967|76190061|FG002|Extension Period|Withdrew Consent|2|||
42350309|NCT01968967|76190062|FG003|Extension Period|Withdrew Consent|0|||
42350310|NCT01968967|76190063|FG004|Extension Period|Withdrew Consent|5|||
42350311|NCT01554579|76190079|FG000|Overall Study|Adverse Event|6|||
42350312|NCT01554579|76190080|FG001|Overall Study|Adverse Event|25|||
42350313|NCT01554579|76190079|FG000|Overall Study|Lack of Efficacy|2|||
42350314|NCT01554579|76190080|FG001|Overall Study|Lack of Efficacy|1|||
42350315|NCT01554579|76190079|FG000|Overall Study|Withdrawal by Subject|2|||
42011482|NCT01002820|75818518|FG000|Overall Study|Lack of Efficacy|1|||
42011483|NCT01012258|75818522|FG000|Overall Study|Death|14|||
42011484|NCT01012258|75818522|FG000|Overall Study|Lost to Follow-up|1|||
42011485|NCT01012258|75818522|FG000|Overall Study|Adverse Event|1|||
42011486|NCT01012258|75818522|FG000|Overall Study|Progressive Disease (PD)|18|||
42011487|NCT01012258|75818522|FG000|Overall Study|Symptomatic Deterioration|1|||
42011488|NCT01012258|75818522|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
42011489|NCT01012258|75818522|FG000|Overall Study|Another Tumor Discovered|1|||
42037414|NCT01006980|75845743|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
42138877|NCT00434304|75949123|FG000|Overall Study|Withdrawal by Subject|4|||
42138878|NCT00424008|75949130|FG000|Overall Study|Adverse Event|8|||
42350316|NCT01554579|76190080|FG001|Overall Study|Withdrawal by Subject|1|||
42350317|NCT01806662|76190087|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
42350318|NCT01806662|76190088|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
42350319|NCT01806662|76190087|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
42350320|NCT01806662|76190088|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
42011490|NCT01012258|75818522|FG000|Overall Study|Ongoing|29|||
42138879|NCT00424008|75949131|FG001|Overall Study|Adverse Event|6|||
42138880|NCT00424008|75949130|FG000|Overall Study|Lack of Efficacy|40|||
42138881|NCT00424008|75949131|FG001|Overall Study|Lack of Efficacy|34|||
42138882|NCT00424008|75949130|FG000|Overall Study|Lost to Follow-up|1|||
42275180|NCT02936323|76106112|FG005|Phase 2a Dose Expansion|Death|0|||
42275181|NCT02936323|76106113|FG006|Phase 2a Dose Expansion|Death|0|||
42138883|NCT00424008|75949131|FG001|Overall Study|Lost to Follow-up|2|||
42138884|NCT00424008|75949130|FG000|Overall Study|Withdrawal by Subject|5|||
42275182|NCT02936323|76106114|FG007|Phase 2a Dose Expansion|Death|4|||
42275183|NCT02936323|76106115|FG008|Phase 2a Dose Expansion|Death|8|||
42275184|NCT02936323|76106116|FG009|Phase 2a Dose Expansion|Death|10|||
42275185|NCT02243176|76106150|FG000|Overall Study|Other reason|1|||
42275186|NCT02243176|76106151|FG001|Overall Study|Other reason|2|||
42275187|NCT02243176|76106150|FG000|Overall Study|protocol specified withdrawal critera|1|||
42275188|NCT02243176|76106151|FG001|Overall Study|protocol specified withdrawal critera|3|||
42275189|NCT02243176|76106150|FG000|Overall Study|Protocol Violation|2|||
42275190|NCT02243176|76106151|FG001|Overall Study|Protocol Violation|1|||
42275191|NCT02243176|76106150|FG000|Overall Study|Withdrawal by Subject|8|||
42275192|NCT02243176|76106151|FG001|Overall Study|Withdrawal by Subject|7|||
42275193|NCT02243176|76106150|FG000|Overall Study|Adverse Event|2|||
42275194|NCT02243176|76106151|FG001|Overall Study|Adverse Event|2|||
42275195|NCT00002663|76106162|FG000|Overall Study|Death|4|||
42275196|NCT00002663|76106163|FG001|Overall Study|Death|1|||
42275197|NCT00002663|76106164|FG002|Overall Study|Death|1|||
42350321|NCT01806662|76190087|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
42350322|NCT01806662|76190088|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
42350323|NCT01806662|76190087|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
42350324|NCT01806662|76190088|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
42350325|NCT01930123|76190096|FG000|Overall Study|Adverse Event|1|||
42011491|NCT01011946|75818527|FG000|Overall Study|Transferred to another hospital|2|||
42011492|NCT01011946|75818527|FG000|Overall Study|No pathological lab value|1|||
42011493|NCT00975481|75818531|FG000|Second Intervention Period|Adverse Event|2|||
42011494|NCT00975481|75818532|FG001|Second Intervention Period|Adverse Event|1|||
42011495|NCT00975481|75818533|FG002|Second Intervention Period|Adverse Event|0|||
42037415|NCT01006980|75845742|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
42138885|NCT00424008|75949131|FG001|Overall Study|Withdrawal by Subject|8|||
42138886|NCT00424008|75949130|FG000|Overall Study|Noncompliance with protocol|13|||
42138887|NCT00424008|75949131|FG001|Overall Study|Noncompliance with protocol|7|||
42138888|NCT00424008|75949130|FG000|Overall Study|Did not meet protocol eligibility|16|||
42275198|NCT00002663|76106165|FG003|Overall Study|Death|0|||
42275199|NCT00002663|76106166|FG004|Overall Study|Death|0|||
42275200|NCT00002663|76106167|FG005|Overall Study|Death|13|||
42275201|NCT00002663|76106168|FG006|Overall Study|Death|0|||
42350326|NCT01930123|76190097|FG001|Overall Study|Adverse Event|0|||
42275202|NCT00002663|76106169|FG007|Overall Study|Death|1|||
42350327|NCT01930123|76190096|FG000|Overall Study|Physician Decision|21|||
42350328|NCT01930123|76190097|FG001|Overall Study|Physician Decision|8|||
42350329|NCT01930123|76190096|FG000|Overall Study|Withdrawal by Subject|1|||
42350330|NCT01930123|76190097|FG001|Overall Study|Withdrawal by Subject|0|||
42350331|NCT01930045|76190103|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
42350332|NCT01930045|76190104|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
42350333|NCT01930045|76190105|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
42350334|NCT01930045|76190106|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
42350335|NCT01930045|76190107|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
42350336|NCT01930045|76190108|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
42350337|NCT01930045|76190103|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
42350338|NCT01930045|76190104|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
42350339|NCT01930045|76190105|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
42350340|NCT01930045|76190106|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
42350341|NCT01930045|76190107|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
42350342|NCT01930045|76190108|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
42350343|NCT01929343|76190123|FG000|Overall Study|Physician Decision|0|||
42350344|NCT01929343|76190124|FG001|Overall Study|Physician Decision|2|||
42350345|NCT01929343|76190125|FG002|Overall Study|Physician Decision|0|||
42350346|NCT01929343|76190123|FG000|Overall Study|Withdrawal by Subject|1|||
42350347|NCT01929343|76190124|FG001|Overall Study|Withdrawal by Subject|0|||
42350348|NCT01929343|76190125|FG002|Overall Study|Withdrawal by Subject|0|||
42350349|NCT01968811|76190133|FG000|Overall Study|Protocol Violation|4|||
42350350|NCT01968811|76190133|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
42350351|NCT01806584|76190139|FG000|Overall Study|Adverse Event|2|||
42350352|NCT01806584|76190140|FG001|Overall Study|Adverse Event|1|||
42350353|NCT01806584|76190139|FG000|Overall Study|Death|1|||
42350354|NCT01806584|76190140|FG001|Overall Study|Death|0|||
42350355|NCT01806584|76190139|FG000|Overall Study|Lost to Follow-up|0|||
42350356|NCT01806584|76190140|FG001|Overall Study|Lost to Follow-up|2|||
42350357|NCT01806584|76190139|FG000|Overall Study|Study terminated by sponsor|9|||
42350358|NCT01806584|76190140|FG001|Overall Study|Study terminated by sponsor|14|||
42350359|NCT01806584|76190139|FG000|Overall Study|Withdrawal by Subject|1|||
42350360|NCT01806584|76190140|FG001|Overall Study|Withdrawal by Subject|1|||
42350361|NCT01806584|76190139|FG000|Overall Study|Other unspecified|1|||
42350362|NCT01806584|76190140|FG001|Overall Study|Other unspecified|0|||
42350363|NCT01798706|76190148|FG000|Overall Study|Adverse Event|15|||
42350364|NCT01798706|76190149|FG001|Overall Study|Adverse Event|10|||
42350365|NCT01798706|76190148|FG000|Overall Study|Lack of Efficacy|0|||
42350366|NCT01798706|76190149|FG001|Overall Study|Lack of Efficacy|2|||
42350367|NCT01798706|76190148|FG000|Overall Study|Poor compliance to protocol|1|||
42350368|NCT01798706|76190149|FG001|Overall Study|Poor compliance to protocol|0|||
42350369|NCT01798706|76190148|FG000|Overall Study|Other than specified above|5|||
42350370|NCT01798706|76190149|FG001|Overall Study|Other than specified above|9|||
42350371|NCT01767194|76190157|FG000|Overall Study|Adverse Event|1|||
42350372|NCT01767194|76190158|FG001|Overall Study|Adverse Event|1|||
42350373|NCT01767194|76190157|FG000|Overall Study|Death|0|||
42350374|NCT01767194|76190158|FG001|Overall Study|Death|1|||
42350375|NCT01767194|76190157|FG000|Overall Study|Lack of Efficacy|12|||
42350376|NCT01767194|76190158|FG001|Overall Study|Lack of Efficacy|11|||
42350377|NCT01767194|76190157|FG000|Overall Study|Physician Decision|2|||
42350378|NCT01767194|76190158|FG001|Overall Study|Physician Decision|23|||
42350379|NCT01767194|76190157|FG000|Overall Study|Withdrawal by Subject|0|||
42350380|NCT01767194|76190158|FG001|Overall Study|Withdrawal by Subject|1|||
42350381|NCT01767194|76190157|FG000|Overall Study|Ineligible|1|||
42350382|NCT01767194|76190158|FG001|Overall Study|Ineligible|1|||
42350383|NCT01767194|76190157|FG000|Overall Study|Refusal by patient/parent|2|||
42350384|NCT01767194|76190158|FG001|Overall Study|Refusal by patient/parent|4|||
42350385|NCT01767194|76190157|FG000|Overall Study|Criteria not met on time for next cycle|0|||
42350386|NCT01767194|76190158|FG001|Overall Study|Criteria not met on time for next cycle|1|||
42350387|NCT01575873|76190169|FG000|Overall Study|Withdrawal by Subject|15|||
42350388|NCT01575873|76190170|FG001|Overall Study|Withdrawal by Subject|20|||
42350389|NCT01575873|76190171|FG002|Overall Study|Withdrawal by Subject|34|||
42350390|NCT01575873|76190172|FG003|Overall Study|Withdrawal by Subject|34|||
42350391|NCT01575873|76190169|FG000|Overall Study|Adverse Event|7|||
42350392|NCT01575873|76190170|FG001|Overall Study|Adverse Event|7|||
42350393|NCT01575873|76190171|FG002|Overall Study|Adverse Event|9|||
42350394|NCT01575873|76190172|FG003|Overall Study|Adverse Event|12|||
42350395|NCT01575873|76190169|FG000|Overall Study|Lost to Follow-up|1|||
42350396|NCT01575873|76190170|FG001|Overall Study|Lost to Follow-up|3|||
42350397|NCT01575873|76190171|FG002|Overall Study|Lost to Follow-up|13|||
42350398|NCT01575873|76190172|FG003|Overall Study|Lost to Follow-up|5|||
42350399|NCT01575873|76190169|FG000|Overall Study|Death|3|||
42350400|NCT01575873|76190170|FG001|Overall Study|Death|2|||
42350401|NCT01575873|76190171|FG002|Overall Study|Death|8|||
42350402|NCT01575873|76190172|FG003|Overall Study|Death|9|||
42350403|NCT01575873|76190169|FG000|Overall Study|Noncompliance|1|||
42350404|NCT01575873|76190170|FG001|Overall Study|Noncompliance|2|||
42350405|NCT01575873|76190171|FG002|Overall Study|Noncompliance|4|||
42350406|NCT01575873|76190172|FG003|Overall Study|Noncompliance|3|||
42350407|NCT01575873|76190169|FG000|Overall Study|Administrative decision|1|||
42138889|NCT00424008|75949131|FG001|Overall Study|Did not meet protocol eligibility|21|||
42275203|NCT00002663|76106170|FG008|Overall Study|Death|1|||
42275204|NCT00002663|76106171|FG009|Overall Study|Death|1|||
42275205|NCT00002663|76106162|FG000|Overall Study|Lost to Follow-up|3|||
42275206|NCT00002663|76106163|FG001|Overall Study|Lost to Follow-up|0|||
42275207|NCT00002663|76106164|FG002|Overall Study|Lost to Follow-up|0|||
42275208|NCT00002663|76106165|FG003|Overall Study|Lost to Follow-up|1|||
42275209|NCT00002663|76106166|FG004|Overall Study|Lost to Follow-up|0|||
42275210|NCT00002663|76106167|FG005|Overall Study|Lost to Follow-up|1|||
42275211|NCT00002663|76106168|FG006|Overall Study|Lost to Follow-up|0|||
42275212|NCT00002663|76106169|FG007|Overall Study|Lost to Follow-up|0|||
42275213|NCT00002663|76106170|FG008|Overall Study|Lost to Follow-up|0|||
42275214|NCT00002663|76106171|FG009|Overall Study|Lost to Follow-up|0|||
42275215|NCT00002663|76106162|FG000|Overall Study|Other|0|||
42138890|NCT00424008|75949130|FG000|Overall Study|Administrative|266|||
42138891|NCT00424008|75949131|FG001|Overall Study|Administrative|257|||
42138892|NCT00423930|75949138|FG000|Overall Study|Withdrawal by Subject|2|||
42138893|NCT00423852|75949142|FG000|Overall Study|Removed pior to the high-dose portion|3|||
42138894|NCT00461708|75949148|FG000|Overall Study|Adverse Event|17|||
42138895|NCT00461708|75949149|FG001|Overall Study|Adverse Event|7|||
42275216|NCT00002663|76106163|FG001|Overall Study|Other|1|||
42275217|NCT00002663|76106164|FG002|Overall Study|Other|0|||
42275218|NCT00002663|76106165|FG003|Overall Study|Other|0|||
42275219|NCT00002663|76106166|FG004|Overall Study|Other|0|||
42275220|NCT00002663|76106167|FG005|Overall Study|Other|1|||
42350408|NCT01575873|76190170|FG001|Overall Study|Administrative decision|1|||
42350409|NCT01575873|76190171|FG002|Overall Study|Administrative decision|1|||
42138896|NCT00461708|75949148|FG000|Overall Study|Lack of Efficacy|68|||
42138897|NCT00461708|75949149|FG001|Overall Study|Lack of Efficacy|20|||
42350410|NCT01575873|76190172|FG003|Overall Study|Administrative decision|0|||
42350411|NCT01575873|76190169|FG000|Overall Study|Protocol deviation|0|||
42350412|NCT01575873|76190170|FG001|Overall Study|Protocol deviation|1|||
42138898|NCT00461708|75949148|FG000|Overall Study|Physician Decision|10|||
42275221|NCT00002663|76106168|FG006|Overall Study|Other|1|||
42275222|NCT00002663|76106169|FG007|Overall Study|Other|0|||
42275223|NCT00002663|76106170|FG008|Overall Study|Other|0|||
42275224|NCT00002663|76106171|FG009|Overall Study|Other|0|||
42350413|NCT01575873|76190171|FG002|Overall Study|Protocol deviation|0|||
42350414|NCT01575873|76190172|FG003|Overall Study|Protocol deviation|1|||
42275225|NCT00002663|76106162|FG000|Overall Study|Physician Decision|0|||
42275226|NCT00002663|76106163|FG001|Overall Study|Physician Decision|0|||
42275227|NCT00002663|76106164|FG002|Overall Study|Physician Decision|0|||
42275228|NCT00002663|76106165|FG003|Overall Study|Physician Decision|0|||
42275229|NCT00002663|76106166|FG004|Overall Study|Physician Decision|1|||
42275230|NCT00002663|76106167|FG005|Overall Study|Physician Decision|0|||
42275231|NCT00002663|76106168|FG006|Overall Study|Physician Decision|0|||
42275232|NCT00002663|76106169|FG007|Overall Study|Physician Decision|0|||
42275233|NCT00002663|76106170|FG008|Overall Study|Physician Decision|1|||
42275234|NCT00002663|76106171|FG009|Overall Study|Physician Decision|1|||
42275235|NCT00002663|76106162|FG000|Overall Study|Adverse Event|0|||
42275236|NCT00002663|76106163|FG001|Overall Study|Adverse Event|0|||
42275237|NCT00002663|76106164|FG002|Overall Study|Adverse Event|0|||
42275238|NCT00002663|76106165|FG003|Overall Study|Adverse Event|1|||
42275239|NCT00002663|76106166|FG004|Overall Study|Adverse Event|0|||
42275240|NCT00002663|76106167|FG005|Overall Study|Adverse Event|0|||
42275241|NCT00002663|76106168|FG006|Overall Study|Adverse Event|0|||
42275242|NCT00002663|76106169|FG007|Overall Study|Adverse Event|1|||
42275243|NCT00002663|76106170|FG008|Overall Study|Adverse Event|0|||
42275244|NCT00002663|76106171|FG009|Overall Study|Adverse Event|0|||
42275245|NCT02240680|76106182|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
42275246|NCT02240680|76106183|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
42275247|NCT02240680|76106184|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
42275248|NCT02240680|76106185|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
42275249|NCT02240680|76106182|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
42275250|NCT02240680|76106183|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
42275251|NCT02240680|76106184|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
42275252|NCT02240680|76106185|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
42275253|NCT02240680|76106182|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
42275254|NCT02240680|76106183|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
42275255|NCT02240680|76106184|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
42275256|NCT02240680|76106185|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
42275257|NCT02240680|76106182|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
42275258|NCT02240680|76106183|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
42275259|NCT02240680|76106184|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
42275260|NCT02240680|76106185|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
42275261|NCT02240680|76106182|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
42275262|NCT02240680|76106183|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
42275263|NCT02240680|76106184|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
42275264|NCT02240680|76106185|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
42275265|NCT02240680|76106182|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
42275266|NCT02240680|76106183|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
42275267|NCT02240680|76106184|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
42275268|NCT02240680|76106185|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
42275269|NCT02240680|76106182|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
42275270|NCT02240680|76106183|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
42275271|NCT02240680|76106184|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
42350415|NCT01575873|76190169|FG000|Overall Study|Requirement for Alternative Therapy|0|||
42350416|NCT01575873|76190170|FG001|Overall Study|Requirement for Alternative Therapy|0|||
42350417|NCT01575873|76190171|FG002|Overall Study|Requirement for Alternative Therapy|1|||
42350418|NCT01575873|76190172|FG003|Overall Study|Requirement for Alternative Therapy|1|||
42350419|NCT01575873|76190169|FG000|Overall Study|Other|0|||
42350420|NCT01575873|76190170|FG001|Overall Study|Other|0|||
42350421|NCT01575873|76190171|FG002|Overall Study|Other|4|||
42350422|NCT01575873|76190172|FG003|Overall Study|Other|2|||
42350423|NCT01575561|76190180|FG000|Overall Study|Adverse Event|9|||
42350424|NCT01575561|76190180|FG000|Overall Study|Lack of Efficacy|8|||
42350425|NCT01575561|76190180|FG000|Overall Study|Lost to Follow-up|6|||
42011496|NCT00975481|75818534|FG003|Second Intervention Period|Adverse Event|0|||
42011497|NCT00975481|75818535|FG004|Second Intervention Period|Adverse Event|0|||
42275272|NCT02240680|76106185|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
42275273|NCT02240680|76106182|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
42275274|NCT02240680|76106183|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
42275275|NCT02240680|76106184|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
42275276|NCT02240680|76106185|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
42275277|NCT02240368|76106196|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
42350426|NCT01575561|76190180|FG000|Overall Study|Protocol Violation|4|||
42350427|NCT01575561|76190180|FG000|Overall Study|Withdrawal by Subject|11|||
42350428|NCT01575561|76190180|FG000|Overall Study|administration|1|||
42350429|NCT01609790|76190187|FG000|Overall Study|Protocol Violation|1|||
42275278|NCT02240368|76106197|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
42275279|NCT02240368|76106198|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
42275280|NCT02240368|76106196|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
42275281|NCT02240368|76106197|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
42275282|NCT02240368|76106198|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
42275283|NCT02239978|76106208|FG000|Overall Study|Withdrawal by Subject|2|||
42275284|NCT02239978|76106209|FG001|Overall Study|Withdrawal by Subject|0|||
42275285|NCT02239510|76106219|FG000|Overall Study|Lost to Follow-up|2|||
42275286|NCT02239510|76106220|FG001|Overall Study|Lost to Follow-up|1|||
42275287|NCT02462486|76106229|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
42275288|NCT02462486|76106230|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
42275289|NCT02462486|76106231|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
42275290|NCT02462486|76106229|FG000|Overall Study|Adverse Event|53|||
42275291|NCT02462486|76106230|FG001|Overall Study|Adverse Event|48|||
42275292|NCT02462486|76106231|FG002|Overall Study|Adverse Event|21|||
42275293|NCT02462486|76106229|FG000|Overall Study|Lack of Efficacy|6|||
42275294|NCT02462486|76106230|FG001|Overall Study|Lack of Efficacy|12|||
42275295|NCT02462486|76106231|FG002|Overall Study|Lack of Efficacy|3|||
42275296|NCT02462486|76106229|FG000|Overall Study|Lost to Follow-up|3|||
42275297|NCT02462486|76106230|FG001|Overall Study|Lost to Follow-up|4|||
42275298|NCT02462486|76106231|FG002|Overall Study|Lost to Follow-up|2|||
42275299|NCT02462486|76106229|FG000|Overall Study|Withdrawal by Subject|25|||
42275300|NCT02462486|76106230|FG001|Overall Study|Withdrawal by Subject|22|||
42275301|NCT02462486|76106231|FG002|Overall Study|Withdrawal by Subject|19|||
42275302|NCT02462486|76106229|FG000|Overall Study|Protocol Violation|3|||
42275303|NCT02462486|76106230|FG001|Overall Study|Protocol Violation|1|||
42275304|NCT02462486|76106231|FG002|Overall Study|Protocol Violation|1|||
42275305|NCT02462486|76106229|FG000|Overall Study|Reason not Specified|3|||
42275306|NCT02462486|76106230|FG001|Overall Study|Reason not Specified|4|||
42275307|NCT02462486|76106231|FG002|Overall Study|Reason not Specified|3|||
42275308|NCT02495948|76106239|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
42275309|NCT02495948|76106240|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
42275310|NCT02495948|76106239|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
42275311|NCT02495948|76106240|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
42275312|NCT02461628|76106249|FG000|Overall Study|Refused to complete survey|4|||
42275313|NCT02461628|76106250|FG001|Overall Study|Refused to complete survey|7|||
42275314|NCT02461160|76106269|FG000|Overall Study|Lost to Follow-up|0|||
42275315|NCT02461160|76106270|FG001|Overall Study|Lost to Follow-up|0|||
42275316|NCT02461160|76106271|FG002|Overall Study|Lost to Follow-up|0|||
42275317|NCT02461160|76106272|FG003|Overall Study|Lost to Follow-up|0|||
42275318|NCT02461160|76106273|FG004|Overall Study|Lost to Follow-up|0|||
42275319|NCT02461160|76106274|FG005|Overall Study|Lost to Follow-up|0|||
42275320|NCT02461160|76106275|FG006|Overall Study|Lost to Follow-up|0|||
42275321|NCT02461160|76106276|FG007|Overall Study|Lost to Follow-up|1|||
42275322|NCT02461160|76106277|FG008|Overall Study|Lost to Follow-up|0|||
42275323|NCT02461160|76106278|FG009|Overall Study|Lost to Follow-up|0|||
42275324|NCT02461160|76106279|FG010|Overall Study|Lost to Follow-up|0|||
42275325|NCT02461160|76106280|FG011|Overall Study|Lost to Follow-up|0|||
42275326|NCT02461160|76106281|FG012|Overall Study|Lost to Follow-up|0|||
42275327|NCT01653704|76106332|FG000|Overall Study|Technical failure during recording|1|||
42275328|NCT01653704|76106333|FG001|Overall Study|Technical failure during recording|1|||
42275329|NCT01653704|76106332|FG000|Overall Study|Performance not reflective of training|1|||
42275330|NCT01653704|76106333|FG001|Overall Study|Performance not reflective of training|0|||
42275331|NCT02495168|76106342|FG000|Overall Study|Other than Specified|18|||
42275332|NCT02495168|76106343|FG001|Overall Study|Other than Specified|22|||
42275333|NCT02495168|76106344|FG002|Overall Study|Other than Specified|5|||
42275334|NCT02495168|76106342|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
42275335|NCT02495168|76106343|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
42275336|NCT02495168|76106344|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
42275337|NCT02495168|76106342|FG000|Overall Study|Physician Decision|1|||
42275338|NCT02495168|76106343|FG001|Overall Study|Physician Decision|1|||
42275339|NCT02495168|76106344|FG002|Overall Study|Physician Decision|0|||
42275340|NCT02495168|76106342|FG000|Overall Study|Lost to Follow-up|10|||
42275341|NCT02495168|76106343|FG001|Overall Study|Lost to Follow-up|6|||
42275342|NCT02495168|76106344|FG002|Overall Study|Lost to Follow-up|1|||
42275343|NCT02495168|76106342|FG000|Overall Study|Withdrawal by Subject|1|||
42275344|NCT02495168|76106343|FG001|Overall Study|Withdrawal by Subject|4|||
42275345|NCT02495168|76106344|FG002|Overall Study|Withdrawal by Subject|2|||
42275346|NCT02495168|76106342|FG000|Overall Study|Protocol Violation|0|||
42275347|NCT02495168|76106343|FG001|Overall Study|Protocol Violation|10|||
42275348|NCT02495168|76106344|FG002|Overall Study|Protocol Violation|1|||
42275349|NCT02495168|76106342|FG000|Overall Study|Adverse Event|4|||
42275350|NCT02495168|76106343|FG001|Overall Study|Adverse Event|8|||
42275351|NCT02495168|76106344|FG002|Overall Study|Adverse Event|3|||
42275352|NCT02495168|76106342|FG000|Overall Study|Lack of Efficacy|0|||
42275353|NCT02495168|76106343|FG001|Overall Study|Lack of Efficacy|0|||
42275354|NCT02495168|76106344|FG002|Overall Study|Lack of Efficacy|3|||
42275355|NCT02494778|76106352|FG000|Overall Study|Death|3|||
42275356|NCT02494778|76106352|FG000|Overall Study|Other|173|||
42275357|NCT02494778|76106352|FG000|Overall Study|Lack of Efficacy|4|||
42275358|NCT02494778|76106352|FG000|Overall Study|Adverse Event|18|||
42275359|NCT02494778|76106352|FG000|Overall Study|Withdrawal by Subject|20|||
42011498|NCT00975481|75818536|FG005|Second Intervention Period|Adverse Event|0|||
42011499|NCT00975481|75818531|FG000|Second Intervention Period|Withdrawal by Subject|0|||
42011500|NCT00975481|75818532|FG001|Second Intervention Period|Withdrawal by Subject|0|||
42011501|NCT00975481|75818533|FG002|Second Intervention Period|Withdrawal by Subject|1|||
42011502|NCT00975481|75818534|FG003|Second Intervention Period|Withdrawal by Subject|0|||
42011503|NCT00975481|75818535|FG004|Second Intervention Period|Withdrawal by Subject|0|||
42011504|NCT00975481|75818536|FG005|Second Intervention Period|Withdrawal by Subject|0|||
42011505|NCT00975481|75818531|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
42011506|NCT00975481|75818532|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
42037416|NCT01006980|75845743|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
42037417|NCT01006980|75845742|FG000|Vemurafenib and Dacarbazine|Death|13|||
42275360|NCT02494778|76106352|FG000|Overall Study|Lost to Follow-up|2|||
42275361|NCT02494778|76106352|FG000|Overall Study|Noncompliant with study drug admin.|1|||
42275362|NCT02493764|76106358|FG000|Overall Study|Adverse Event|2|||
42275363|NCT02493764|76106359|FG001|Overall Study|Adverse Event|2|||
42275364|NCT02493764|76106358|FG000|Overall Study|Death|44|||
42275365|NCT02493764|76106359|FG001|Overall Study|Death|58|||
42275366|NCT02493764|76106358|FG000|Overall Study|Lost to Follow-up|2|||
42275367|NCT02493764|76106359|FG001|Overall Study|Lost to Follow-up|1|||
42275368|NCT02493764|76106358|FG000|Overall Study|Protocol Violation|6|||
42275369|NCT02493764|76106359|FG001|Overall Study|Protocol Violation|7|||
42275370|NCT02493764|76106358|FG000|Overall Study|Physician Decision|1|||
42275371|NCT02493764|76106359|FG001|Overall Study|Physician Decision|1|||
42275372|NCT02493764|76106358|FG000|Overall Study|Participant moved|17|||
42275373|NCT02493764|76106359|FG001|Overall Study|Participant moved|5|||
42275374|NCT02493764|76106358|FG000|Overall Study|Withdrawal parent/guardian|0|||
42275375|NCT02493764|76106359|FG001|Overall Study|Withdrawal parent/guardian|1|||
42275376|NCT02493764|76106358|FG000|Overall Study|Withdrawal by Subject|11|||
42275377|NCT02493764|76106359|FG001|Overall Study|Withdrawal by Subject|7|||
42275378|NCT02460380|76106367|FG000|Overall Study|Withdrawal by Subject|10|||
42275379|NCT02460380|76106368|FG001|Overall Study|Withdrawal by Subject|5|||
42275380|NCT02493062|76106375|FG000|Overall Study|Physician Decision|12|||
42275381|NCT02492984|76106381|FG000|Overall Study|Adverse Event|1|||
42275382|NCT02492984|76106382|FG001|Overall Study|Adverse Event|0|||
42275383|NCT02492984|76106381|FG000|Overall Study|Protocol Violation|1|||
42275384|NCT02492984|76106382|FG001|Overall Study|Protocol Violation|0|||
42275385|NCT02492984|76106381|FG000|Overall Study|Withdrawal by Subject|1|||
42275386|NCT02492984|76106382|FG001|Overall Study|Withdrawal by Subject|0|||
42275387|NCT01680159|76106395|FG000|Screening Period|Not meet criteria for dose-up period|7|||
42275388|NCT01680159|76106395|FG000|Increased Dose Period|Adverse Event|6|||
42275389|NCT01680159|76106395|FG000|Increased Dose Period|Withdrawal by Subject|2|||
42275390|NCT02491892|76106417|FG000|Overall Study|Adverse Event|1|||
42275391|NCT02491892|76106418|FG001|Overall Study|Adverse Event|1|||
42275392|NCT02491892|76106417|FG000|Overall Study|Death|1|||
42275393|NCT02491892|76106418|FG001|Overall Study|Death|1|||
42275394|NCT02491892|76106417|FG000|Overall Study|Lack of Efficacy|37|||
42350430|NCT01609790|76190188|FG001|Overall Study|Protocol Violation|7|||
42011507|NCT00975481|75818533|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
42037418|NCT01006980|75845743|FG001|Vemurafenib and Dacarbazine|Death|12|||
42037419|NCT01006980|75845742|FG000|Vemurafenib and Dacarbazine|Progression|257|||
42037420|NCT01006980|75845743|FG001|Vemurafenib and Dacarbazine|Progression|218|||
42037421|NCT01006980|75845742|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
42037422|NCT01006980|75845743|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
42037423|NCT01006980|75845742|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
42037424|NCT01006980|75845743|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
42037425|NCT01006980|75845742|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
42037426|NCT01006980|75845743|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
42275395|NCT02491892|76106418|FG001|Overall Study|Lack of Efficacy|36|||
42275396|NCT02491892|76106417|FG000|Overall Study|Refused Treatment|1|||
42275397|NCT02491892|76106418|FG001|Overall Study|Refused Treatment|0|||
42275398|NCT02491892|76106417|FG000|Overall Study|Lost to Follow-up|1|||
42275399|NCT02491892|76106418|FG001|Overall Study|Lost to Follow-up|0|||
42275400|NCT04931888|76106428|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
42275401|NCT04931888|76106429|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
42350431|NCT01609790|76190189|FG002|Overall Study|Protocol Violation|8|||
42037427|NCT01006980|75845742|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
42350432|NCT01767116|76190199|FG000|Overall Study|Lost to Follow-up|2|||
42275402|NCT04931888|76106430|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
42275403|NCT04931888|76106431|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
42275404|NCT02436356|76106460|FG000|Overall Study|Excluded by MRI Screening|0|||
42275405|NCT02436356|76106461|FG001|Overall Study|Excluded by MRI Screening|0|||
42275406|NCT02436356|76106462|FG002|Overall Study|Excluded by MRI Screening|2|||
42275407|NCT02436356|76106460|FG000|Overall Study|Lost to Follow-up|0|||
42275408|NCT02436356|76106461|FG001|Overall Study|Lost to Follow-up|1|||
42275409|NCT02436356|76106462|FG002|Overall Study|Lost to Follow-up|0|||
42275410|NCT02436356|76106460|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
42275411|NCT02436356|76106461|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
42275412|NCT02436356|76106462|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
42275413|NCT02436356|76106460|FG000|Overall Study|Excluded due to other medical conditions|3|||
42275414|NCT02436356|76106461|FG001|Overall Study|Excluded due to other medical conditions|0|||
42275415|NCT02436356|76106462|FG002|Overall Study|Excluded due to other medical conditions|0|||
42275416|NCT02436356|76106460|FG000|Overall Study|Withdrawal by Subject|1|||
42275417|NCT02436356|76106461|FG001|Overall Study|Withdrawal by Subject|0|||
42275418|NCT02436356|76106462|FG002|Overall Study|Withdrawal by Subject|0|||
42275419|NCT02436200|76106475|FG000|Overall Study|Significant outlier|1|||
42275420|NCT01679613|76106479|FG000|Overall Study|other than stated above|0|||
42275421|NCT01679613|76106480|FG001|Overall Study|other than stated above|1|||
42275422|NCT01679613|76106481|FG002|Overall Study|other than stated above|2|||
42275423|NCT01679613|76106482|FG003|Overall Study|other than stated above|2|||
42275424|NCT02489630|76106491|FG000|Overall Study|Oversedation|1|||
42275425|NCT02489630|76106492|FG001|Overall Study|Oversedation|1|||
42275426|NCT02489630|76106491|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
42275427|NCT02489630|76106492|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
42275428|NCT02739347|76106500|FG000|Overall Study|Adverse Event|3|||
42275429|NCT02739347|76106501|FG001|Overall Study|Adverse Event|0|||
42275430|NCT02739347|76106500|FG000|Overall Study|Protocol Violation|0|||
42275431|NCT02739347|76106501|FG001|Overall Study|Protocol Violation|1|||
42275432|NCT02739347|76106500|FG000|Overall Study|Lost to Follow-up|0|||
42275433|NCT02739347|76106501|FG001|Overall Study|Lost to Follow-up|2|||
42275434|NCT02435966|76106510|FG000|Overall Study|Withdrawal by Subject|0|||
42275435|NCT02435966|76106511|FG001|Overall Study|Withdrawal by Subject|1|||
42275436|NCT02435966|76106512|FG002|Overall Study|Withdrawal by Subject|0|||
42275437|NCT01679301|76106520|FG000|Screening Period|screen failure|3|||
42275438|NCT01679301|76106521|FG001|Screening Period|screen failure|0|||
42275439|NCT01679301|76106522|FG002|Screening Period|screen failure|0|||
42275440|NCT01678911|76106528|FG000|Second Intervention|Lost to Follow-up|2|||
42275441|NCT01678911|76106529|FG001|Second Intervention|Lost to Follow-up|0|||
42275442|NCT02487446|76106535|FG000|Period 1|Physician Decision|0|||
42275443|NCT02487446|76106536|FG001|Period 1|Physician Decision|1|||
42275444|NCT02487446|76106535|FG000|Period 1|Lack of Efficacy|1|||
42275445|NCT02487446|76106536|FG001|Period 1|Lack of Efficacy|0|||
42275446|NCT02487446|76106535|FG000|Period 1|Protocol deviation|3|||
42275447|NCT02487446|76106536|FG001|Period 1|Protocol deviation|2|||
42275448|NCT02487446|76106535|FG000|Period 1|Lost to Follow-up|2|||
42275449|NCT02487446|76106536|FG001|Period 1|Lost to Follow-up|0|||
42275450|NCT02487446|76106535|FG000|Period 1|Withdrawal by Subject|2|||
42275451|NCT02487446|76106536|FG001|Period 1|Withdrawal by Subject|0|||
42275452|NCT02487446|76106535|FG000|Period 1|Adverse Event|5|||
42275453|NCT02487446|76106536|FG001|Period 1|Adverse Event|5|||
42275454|NCT02487446|76106535|FG000|Washout|Lost to Follow-up|0|||
42275455|NCT02487446|76106536|FG001|Washout|Lost to Follow-up|2|||
42275456|NCT02487446|76106535|FG000|Washout|Withdrawal by Subject|1|||
42275457|NCT02487446|76106536|FG001|Washout|Withdrawal by Subject|4|||
42275458|NCT02487446|76106535|FG000|Washout|Adverse Event|2|||
42275459|NCT02487446|76106536|FG001|Washout|Adverse Event|2|||
42350433|NCT01767116|76190200|FG001|Overall Study|Lost to Follow-up|2|||
42350434|NCT01574703|76190210|FG000|Overall Study|Adverse Event|0|||
42350435|NCT01574703|76190211|FG001|Overall Study|Adverse Event|2|||
42350436|NCT01574703|76190212|FG002|Overall Study|Adverse Event|1|||
42275460|NCT02487446|76106535|FG000|Period 2|Protocol deviation|0|||
42275461|NCT02487446|76106536|FG001|Period 2|Protocol deviation|1|||
42275462|NCT02487446|76106535|FG000|Period 2|Lost to Follow-up|1|||
42275463|NCT02487446|76106536|FG001|Period 2|Lost to Follow-up|1|||
42275464|NCT02487446|76106535|FG000|Period 2|Withdrawal by Subject|1|||
42275465|NCT02487446|76106536|FG001|Period 2|Withdrawal by Subject|1|||
42275466|NCT02487446|76106535|FG000|Period 2|Adverse Event|6|||
42275467|NCT02487446|76106536|FG001|Period 2|Adverse Event|2|||
42275468|NCT02739269|76106545|FG000|Overall Study|Protocol Violation|5|||
42275469|NCT02739269|76106546|FG001|Overall Study|Protocol Violation|0|||
42275470|NCT02739269|76106545|FG000|Overall Study|Cycle cancellation|2|||
42350437|NCT01574703|76190213|FG003|Overall Study|Adverse Event|1|||
42275471|NCT02739269|76106546|FG001|Overall Study|Cycle cancellation|2|||
42275472|NCT02739269|76106545|FG000|Overall Study|Withdrawal by Subject|0|||
42275473|NCT02739269|76106546|FG001|Overall Study|Withdrawal by Subject|2|||
42275474|NCT03318523|76106556|FG000|PC Period: Up to Year 1|Adverse Event|1|||
42275475|NCT03318523|76106557|FG001|PC Period: Up to Year 1|Adverse Event|0|||
42275476|NCT03318523|76106558|FG002|PC Period: Up to Year 1|Adverse Event|2|||
42275477|NCT03318523|76106559|FG003|PC Period: Up to Year 1|Adverse Event|0|||
42275478|NCT03318523|76106560|FG004|PC Period: Up to Year 1|Adverse Event|0|||
42275479|NCT03318523|76106561|FG005|PC Period: Up to Year 1|Adverse Event|0|||
42275480|NCT03318523|76106562|FG006|PC Period: Up to Year 1|Adverse Event|0|||
42275481|NCT03318523|76106563|FG007|PC Period: Up to Year 1|Adverse Event|0|||
42275482|NCT03318523|76106564|FG008|PC Period: Up to Year 1|Adverse Event|0|||
42275483|NCT03318523|76106565|FG009|PC Period: Up to Year 1|Adverse Event|0|||
42275484|NCT03318523|76106556|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
42275485|NCT03318523|76106557|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
42275486|NCT03318523|76106558|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
42275487|NCT03318523|76106559|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
42275488|NCT03318523|76106560|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
42275489|NCT03318523|76106561|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
42275490|NCT03318523|76106562|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
42275491|NCT03318523|76106563|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
42275492|NCT03318523|76106564|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
42275493|NCT03318523|76106565|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
42275494|NCT03318523|76106556|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
42275495|NCT03318523|76106557|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
42275496|NCT03318523|76106558|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
42275497|NCT03318523|76106559|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
42275498|NCT03318523|76106560|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
42275499|NCT03318523|76106561|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
42275500|NCT03318523|76106562|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
42275501|NCT03318523|76106563|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
42275502|NCT03318523|76106564|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
42275503|NCT03318523|76106565|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
42275504|NCT03318523|76106556|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
42275505|NCT03318523|76106557|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
42275506|NCT03318523|76106558|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
42275507|NCT03318523|76106559|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
42275508|NCT03318523|76106560|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
42275509|NCT03318523|76106561|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
42275510|NCT03318523|76106562|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
42275511|NCT03318523|76106563|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
42275512|NCT03318523|76106564|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
42275513|NCT03318523|76106565|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
42275514|NCT03318523|76106556|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
42275515|NCT03318523|76106557|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
42275516|NCT03318523|76106558|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
42275517|NCT03318523|76106559|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
42275518|NCT03318523|76106560|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
42275519|NCT03318523|76106561|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
42275520|NCT03318523|76106562|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
42275521|NCT03318523|76106563|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
42275522|NCT03318523|76106564|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
42275523|NCT03318523|76106565|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
42275524|NCT03318523|76106556|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
42275525|NCT03318523|76106557|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
42275526|NCT03318523|76106558|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
42275527|NCT03318523|76106559|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
42275528|NCT03318523|76106560|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
42350438|NCT01574703|76190210|FG000|Overall Study|Protocol Violation|0|||
42350439|NCT01574703|76190211|FG001|Overall Study|Protocol Violation|0|||
42350440|NCT01574703|76190212|FG002|Overall Study|Protocol Violation|0|||
42350441|NCT01574703|76190213|FG003|Overall Study|Protocol Violation|1|||
42275529|NCT03318523|76106561|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
42275530|NCT03318523|76106562|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
42275531|NCT03318523|76106563|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
42275532|NCT03318523|76106564|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
42275533|NCT03318523|76106565|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
42275534|NCT03318523|76106556|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
42275535|NCT03318523|76106557|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
42350442|NCT01574703|76190210|FG000|Overall Study|Unspecified Reason|27|||
42350443|NCT01574703|76190211|FG001|Overall Study|Unspecified Reason|15|||
42350444|NCT01574703|76190212|FG002|Overall Study|Unspecified Reason|20|||
42350445|NCT01574703|76190213|FG003|Overall Study|Unspecified Reason|16|||
42350446|NCT01574703|76190210|FG000|Overall Study|Withdrawal by Subject|53|||
42350447|NCT01574703|76190211|FG001|Overall Study|Withdrawal by Subject|52|||
42275536|NCT03318523|76106558|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
42275537|NCT03318523|76106559|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
42275538|NCT03318523|76106560|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
42275539|NCT03318523|76106561|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
42275540|NCT03318523|76106562|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
42275541|NCT03318523|76106563|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
42350448|NCT01574703|76190212|FG002|Overall Study|Withdrawal by Subject|36|||
42350449|NCT01574703|76190213|FG003|Overall Study|Withdrawal by Subject|61|||
42350450|NCT01574703|76190210|FG000|Overall Study|Met Withdrawal Criteria|0|||
42350451|NCT01574703|76190211|FG001|Overall Study|Met Withdrawal Criteria|1|||
42350452|NCT01574703|76190212|FG002|Overall Study|Met Withdrawal Criteria|1|||
42350453|NCT01574703|76190213|FG003|Overall Study|Met Withdrawal Criteria|0|||
42350454|NCT01574703|76190210|FG000|Overall Study|Lost to Follow-up|43|||
42350455|NCT01574703|76190211|FG001|Overall Study|Lost to Follow-up|41|||
42350456|NCT01574703|76190212|FG002|Overall Study|Lost to Follow-up|46|||
42350457|NCT01574703|76190213|FG003|Overall Study|Lost to Follow-up|35|||
42350458|NCT01574703|76190210|FG000|Overall Study|Death|2|||
42350459|NCT01574703|76190211|FG001|Overall Study|Death|1|||
42350460|NCT01574703|76190212|FG002|Overall Study|Death|1|||
42350461|NCT01574703|76190213|FG003|Overall Study|Death|0|||
42350462|NCT01686633|76190226|FG000|Overall Study|Lack of Efficacy|33|||
42350463|NCT01686633|76190227|FG001|Overall Study|Lack of Efficacy|13|||
42350464|NCT01686633|76190228|FG002|Overall Study|Lack of Efficacy|11|||
42350465|NCT01686633|76190226|FG000|Overall Study|Withdrawal by Subject|8|||
42350466|NCT01686633|76190227|FG001|Overall Study|Withdrawal by Subject|8|||
42350467|NCT01686633|76190228|FG002|Overall Study|Withdrawal by Subject|5|||
42350468|NCT01686633|76190226|FG000|Overall Study|Physician Decision|3|||
42350469|NCT01686633|76190227|FG001|Overall Study|Physician Decision|4|||
42350470|NCT01686633|76190228|FG002|Overall Study|Physician Decision|4|||
42350471|NCT01686633|76190226|FG000|Overall Study|Adverse Event|4|||
42350472|NCT01686633|76190227|FG001|Overall Study|Adverse Event|3|||
42350473|NCT01686633|76190228|FG002|Overall Study|Adverse Event|3|||
42350474|NCT01686633|76190226|FG000|Overall Study|Protocol Violation|2|||
42350475|NCT01686633|76190227|FG001|Overall Study|Protocol Violation|3|||
42350476|NCT01686633|76190228|FG002|Overall Study|Protocol Violation|0|||
42350477|NCT01686633|76190226|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
42350478|NCT01686633|76190227|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
42350479|NCT01686633|76190228|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
42350480|NCT01686633|76190226|FG000|Overall Study|Lost to Follow-up|0|||
42350481|NCT01686633|76190227|FG001|Overall Study|Lost to Follow-up|1|||
42350482|NCT01686633|76190228|FG002|Overall Study|Lost to Follow-up|1|||
42350483|NCT01685697|76190238|FG000|Overall Study|Protocol Violation|3|||
42350484|NCT01685697|76190239|FG001|Overall Study|Protocol Violation|3|||
42350485|NCT02395120|76190250|FG000|Overall Study|Missed follow-up dental exam|57|||
42350486|NCT02395120|76190251|FG001|Overall Study|Missed follow-up dental exam|62|||
42350487|NCT02395120|76190252|FG002|Overall Study|Missed follow-up dental exam|6|||
42350488|NCT02395120|76190253|FG003|Overall Study|Missed follow-up dental exam|6|||
42350489|NCT02395120|76190254|FG004|Overall Study|Missed follow-up dental exam|51|||
42011508|NCT00975481|75818534|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
42011509|NCT00975481|75818535|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
42011510|NCT00975481|75818536|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
42275542|NCT03318523|76106564|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
42275543|NCT03318523|76106565|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
42275544|NCT03318523|76106556|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
42275545|NCT03318523|76106557|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
42275546|NCT03318523|76106558|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
42350490|NCT01685229|76190268|FG000|Overall Study|Subjects missing Study Exit form|3|||
42350491|NCT01685229|76190269|FG001|Overall Study|Subjects missing Study Exit form|1|||
42350492|NCT01685229|76190268|FG000|Overall Study|Lost to Follow-up|16|||
42350493|NCT01685229|76190269|FG001|Overall Study|Lost to Follow-up|10|||
42350494|NCT01685229|76190268|FG000|Overall Study|Withdrawal by Subject|6|||
42350495|NCT01685229|76190269|FG001|Overall Study|Withdrawal by Subject|5|||
42350496|NCT01685229|76190268|FG000|Overall Study|Death|1|||
42350497|NCT01685229|76190269|FG001|Overall Study|Death|0|||
42350498|NCT01551693|76190280|FG000|Overall Study|Disease Progression|1|||
42350499|NCT01551693|76190281|FG001|Overall Study|Disease Progression|0|||
42350500|NCT01551693|76190280|FG000|Overall Study|Adverse Event|0|||
42350501|NCT01551693|76190281|FG001|Overall Study|Adverse Event|1|||
42350502|NCT01551693|76190280|FG000|Overall Study|Withdrawal by Subject|0|||
42350503|NCT01551693|76190281|FG001|Overall Study|Withdrawal by Subject|1|||
42275547|NCT03318523|76106559|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
42275548|NCT03318523|76106560|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
42275549|NCT03318523|76106561|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
42275550|NCT03318523|76106562|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
42275551|NCT03318523|76106563|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
42350504|NCT01574157|76190289|FG000|Overall Study|Withdrawal by Subject|4|||
42011511|NCT00975481|75818531|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
42011512|NCT00975481|75818532|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
42275552|NCT03318523|76106564|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
42275553|NCT03318523|76106565|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
42275554|NCT01678209|76106592|FG000|Overall Study|could not scan twice|1|||
42275555|NCT01678209|76106593|FG001|Overall Study|could not scan twice|1|||
42275556|NCT01678209|76106594|FG002|Overall Study|could not scan twice|1|||
42275557|NCT01678209|76106592|FG000|Overall Study|scheduling conflicts|0|||
42275558|NCT01678209|76106593|FG001|Overall Study|scheduling conflicts|0|||
42275559|NCT01678209|76106594|FG002|Overall Study|scheduling conflicts|1|||
42275560|NCT01678209|76106592|FG000|Overall Study|screen fail|16|||
42275561|NCT01678209|76106593|FG001|Overall Study|screen fail|17|||
42275562|NCT01678209|76106594|FG002|Overall Study|screen fail|16|||
42275563|NCT02239120|76106604|FG000|Overall Study|Death|56|||
42275564|NCT02239120|76106605|FG001|Overall Study|Death|58|||
42275565|NCT02239120|76106604|FG000|Overall Study|Lost to Follow-up|19|||
42275566|NCT02239120|76106605|FG001|Overall Study|Lost to Follow-up|14|||
42275567|NCT01603407|76106614|FG000|Overall Study|Adverse Event|1|||
42275568|NCT01603407|76106615|FG001|Overall Study|Adverse Event|1|||
42275569|NCT01603407|76106616|FG002|Overall Study|Adverse Event|1|||
42275570|NCT01603407|76106614|FG000|Overall Study|Protocol Violation|2|||
42275571|NCT01603407|76106615|FG001|Overall Study|Protocol Violation|2|||
42275572|NCT01603407|76106616|FG002|Overall Study|Protocol Violation|0|||
42275573|NCT01603407|76106614|FG000|Overall Study|Withdrawal by Subject|8|||
42275574|NCT01603407|76106615|FG001|Overall Study|Withdrawal by Subject|5|||
42275575|NCT01603407|76106616|FG002|Overall Study|Withdrawal by Subject|7|||
42275576|NCT01603407|76106614|FG000|Overall Study|Lost to Follow-up|0|||
42275577|NCT01603407|76106615|FG001|Overall Study|Lost to Follow-up|3|||
42275578|NCT01603407|76106616|FG002|Overall Study|Lost to Follow-up|2|||
42275579|NCT02235454|76106646|FG000|Overall Study|Withdrawal by Subject|2|||
42275580|NCT02235298|76106652|FG000|Overall Study|Lost to Follow-up|6|||
42275581|NCT02235298|76106653|FG001|Overall Study|Lost to Follow-up|5|||
42275582|NCT02235298|76106652|FG000|Overall Study|Adverse Event|2|||
42275583|NCT02235298|76106653|FG001|Overall Study|Adverse Event|2|||
42275584|NCT02235298|76106652|FG000|Overall Study|Withdrawal by Subject|0|||
42275585|NCT02235298|76106653|FG001|Overall Study|Withdrawal by Subject|1|||
42275586|NCT02234596|76106659|FG000|Overall Study|Participant not treated|2|||
42275587|NCT02234362|76106663|FG000|Overall Study|Not eligible after first screening visit|17|||
42275588|NCT02234362|76106663|FG000|Overall Study|Lost to Follow-up|6|||
42275589|NCT02234362|76106663|FG000|Overall Study|Withdrawal by Subject|3|||
42275590|NCT02234284|76106669|FG000|Overall Study|Death|4|||
42275591|NCT02234284|76106670|FG001|Overall Study|Death|2|||
42275592|NCT02234284|76106669|FG000|Overall Study|Withdrawal by Subject|1|||
42275593|NCT02234284|76106670|FG001|Overall Study|Withdrawal by Subject|0|||
42275594|NCT02234284|76106669|FG000|Overall Study|Lost to Follow-up|20|||
42275595|NCT02234284|76106670|FG001|Overall Study|Lost to Follow-up|7|||
42275596|NCT02232880|76106680|FG000|Overall Study|study stopped prior to randomization|1|||
42275597|NCT02896855|76106686|FG000|Overall Study|Death|50|||
42275598|NCT02896855|76106687|FG001|Overall Study|Death|40|||
42275599|NCT02896855|76106686|FG000|Overall Study|Lost to Follow-up|15|||
42275600|NCT02896855|76106687|FG001|Overall Study|Lost to Follow-up|9|||
42275601|NCT02896855|76106686|FG000|Overall Study|Withdrawal by Subject|7|||
42275602|NCT02896855|76106687|FG001|Overall Study|Withdrawal by Subject|4|||
42275603|NCT02232802|76106698|FG000|Period 1|Sponsor request|1|||
42011513|NCT00975481|75818533|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
42011514|NCT00975481|75818534|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
42275604|NCT02232802|76106699|FG001|Period 1|Sponsor request|0|||
42275605|NCT02232802|76106698|FG000|Period 1|Adverse Event|1|||
42275606|NCT02232802|76106699|FG001|Period 1|Adverse Event|1|||
42275607|NCT02434328|76106707|FG000|Overall Study|Adverse Event|9|||
42350505|NCT01574157|76190290|FG001|Overall Study|Withdrawal by Subject|5|||
42350506|NCT01574157|76190289|FG000|Overall Study|Lost to Follow-up|0|||
42350507|NCT01574157|76190290|FG001|Overall Study|Lost to Follow-up|3|||
42275608|NCT02434328|76106708|FG001|Overall Study|Adverse Event|4|||
42350508|NCT01574079|76190302|FG000|Overall Study|Physician Decision|0|||
42350509|NCT01574079|76190303|FG001|Overall Study|Physician Decision|2|||
42011515|NCT00975481|75818535|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
42275609|NCT02434328|76106707|FG000|Overall Study|Lack of Efficacy|0|||
42275610|NCT02434328|76106708|FG001|Overall Study|Lack of Efficacy|2|||
42275611|NCT02434328|76106707|FG000|Overall Study|Physician Decision|0|||
42275612|NCT02434328|76106708|FG001|Overall Study|Physician Decision|1|||
42350510|NCT01574079|76190302|FG000|Overall Study|Lost to Follow-up|1|||
42275613|NCT02434328|76106707|FG000|Overall Study|Withdrawal by Subject|12|||
42275614|NCT02434328|76106708|FG001|Overall Study|Withdrawal by Subject|21|||
42275615|NCT02434328|76106707|FG000|Overall Study|Death|4|||
42275616|NCT02434328|76106708|FG001|Overall Study|Death|7|||
42275617|NCT02434328|76106707|FG000|Overall Study|Lost to Follow-up|1|||
42275618|NCT02434328|76106708|FG001|Overall Study|Lost to Follow-up|6|||
42275619|NCT02434328|76106707|FG000|Overall Study|Other|4|||
42275620|NCT02434328|76106708|FG001|Overall Study|Other|1|||
42275621|NCT02660229|76106717|FG000|Overall Study|Adverse Event|2|||
42275622|NCT02660229|76106718|FG001|Overall Study|Adverse Event|0|||
42275623|NCT02660229|76106717|FG000|Overall Study|Withdrawal by Subject|0|||
42275624|NCT02660229|76106718|FG001|Overall Study|Withdrawal by Subject|1|||
42275625|NCT02232178|76106727|FG000|Overall Study|Lost to Follow-up|0|||
42275626|NCT02232178|76106728|FG001|Overall Study|Lost to Follow-up|1|||
42275627|NCT02232178|76106729|FG002|Overall Study|Lost to Follow-up|0|||
42275628|NCT02232178|76106727|FG000|Overall Study|ineligibility|0|||
42275629|NCT02232178|76106728|FG001|Overall Study|ineligibility|0|||
42275630|NCT02232178|76106729|FG002|Overall Study|ineligibility|1|||
42275631|NCT02232178|76106727|FG000|Overall Study|surgical complication|1|||
42275632|NCT02232178|76106728|FG001|Overall Study|surgical complication|0|||
42350511|NCT01574079|76190303|FG001|Overall Study|Lost to Follow-up|0|||
42350512|NCT01573767|76190313|FG000|Overall Study|Adverse Event|0|||
42350513|NCT01573767|76190314|FG001|Overall Study|Adverse Event|1|||
42350514|NCT01573767|76190315|FG002|Overall Study|Adverse Event|0|||
42275633|NCT02232178|76106729|FG002|Overall Study|surgical complication|0|||
42275634|NCT01678131|76106740|FG000|Overall Study|Adverse Event|0|||
42275635|NCT01678131|76106741|FG001|Overall Study|Adverse Event|1|||
42275636|NCT01678131|76106742|FG002|Overall Study|Adverse Event|0|||
42275637|NCT01678131|76106740|FG000|Overall Study|Withdrawal by Subject|0|||
42275638|NCT01678131|76106741|FG001|Overall Study|Withdrawal by Subject|0|||
42275639|NCT01678131|76106742|FG002|Overall Study|Withdrawal by Subject|2|||
42275640|NCT02231164|76106752|FG000|Overall Study|Adverse Event|1|||
42275641|NCT02231164|76106753|FG001|Overall Study|Adverse Event|1|||
42275642|NCT02231164|76106752|FG000|Overall Study|Lack of Efficacy|4|||
42275643|NCT02231164|76106753|FG001|Overall Study|Lack of Efficacy|3|||
42275644|NCT02231164|76106752|FG000|Overall Study|Withdrawal by Subject|1|||
42275645|NCT02231164|76106753|FG001|Overall Study|Withdrawal by Subject|2|||
42275646|NCT02457182|76106761|FG000|Overall Study|Lost to Follow-up|1|||
42275647|NCT02457182|76106762|FG001|Overall Study|Lost to Follow-up|0|||
42275648|NCT02230384|76106770|FG000|Phase 1|Lost to Follow-up|1|||
42275649|NCT02230384|76106771|FG001|Phase 1|Lost to Follow-up|0|||
42275650|NCT02230384|76106770|FG000|Phase 1|Physician Decision|0|||
42275651|NCT02230384|76106771|FG001|Phase 1|Physician Decision|1|||
42275652|NCT02230384|76106770|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
42275653|NCT02230384|76106771|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
42275654|NCT02230384|76106770|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
42275655|NCT02230384|76106771|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
42275656|NCT02230384|76106770|FG000|Phase 2 - Switch|Adverse Event|2|||
42275657|NCT02230384|76106771|FG001|Phase 2 - Switch|Adverse Event|0|||
42350515|NCT01573767|76190316|FG003|Overall Study|Adverse Event|1|||
42350516|NCT01573767|76190313|FG000|Overall Study|Lack of Efficacy|18|||
42275658|NCT02738801|76106787|FG000|Overall Study|Adverse Event|1|||
42275659|NCT02738801|76106788|FG001|Overall Study|Adverse Event|1|||
42350517|NCT01573767|76190314|FG001|Overall Study|Lack of Efficacy|15|||
42350518|NCT01573767|76190315|FG002|Overall Study|Lack of Efficacy|12|||
42350519|NCT01573767|76190316|FG003|Overall Study|Lack of Efficacy|17|||
42350520|NCT01573767|76190313|FG000|Overall Study|Protocol Violation|3|||
42275660|NCT02738801|76106787|FG000|Overall Study|Withdrawal by Subject|0|||
42275661|NCT02738801|76106788|FG001|Overall Study|Withdrawal by Subject|1|||
42275662|NCT02230306|76106804|FG000|Overall Study|Did not receive study treatment|1|||
42275663|NCT01680861|76106810|FG000|Early Post-transplant Period|Protocol Violation|1|||
42275664|NCT01680861|76106811|FG001|Early Post-transplant Period|Protocol Violation|1|||
42275665|NCT02229214|76106821|FG000|Overall Study|Adverse Event|2|||
42350521|NCT01573767|76190314|FG001|Overall Study|Protocol Violation|1|||
42275666|NCT02229214|76106822|FG001|Overall Study|Adverse Event|0|||
42350522|NCT01573767|76190315|FG002|Overall Study|Protocol Violation|1|||
42350523|NCT01573767|76190316|FG003|Overall Study|Protocol Violation|3|||
42350524|NCT01573767|76190313|FG000|Overall Study|Lost to Follow-up|0|||
42275667|NCT02229214|76106821|FG000|Overall Study|Withdrawal by Subject|4|||
42275668|NCT02229214|76106822|FG001|Overall Study|Withdrawal by Subject|0|||
42275669|NCT02228980|76106834|FG000|Overall Study|Adverse Event|14|||
42275670|NCT02228980|76106835|FG001|Overall Study|Adverse Event|0|||
42138899|NCT00461708|75949149|FG001|Overall Study|Physician Decision|4|||
42138900|NCT00461708|75949148|FG000|Overall Study|Withdrawal by Subject|8|||
42138901|NCT00461708|75949149|FG001|Overall Study|Withdrawal by Subject|2|||
42138902|NCT00461708|75949148|FG000|Overall Study|Other|4|||
42138903|NCT00461708|75949149|FG001|Overall Study|Other|4|||
42138904|NCT00461708|75949148|FG000|Overall Study|Death|8|||
42138905|NCT00461708|75949149|FG001|Overall Study|Death|1|||
42138906|NCT00327171|75949160|FG000|Overall Study|Did not receive study medication|3|||
42138907|NCT00327171|75949161|FG001|Overall Study|Did not receive study medication|0|||
42138908|NCT00327171|75949160|FG000|Overall Study|Adverse Event|23|||
42138909|NCT00327171|75949161|FG001|Overall Study|Adverse Event|23|||
42138910|NCT00327171|75949160|FG000|Overall Study|Disease progression/lack of efficacy|68|||
42138911|NCT00327171|75949161|FG001|Overall Study|Disease progression/lack of efficacy|69|||
42138912|NCT00327171|75949160|FG000|Overall Study|Investigator/participant request|1|||
42138913|NCT00327171|75949161|FG001|Overall Study|Investigator/participant request|8|||
42138914|NCT00327171|75949160|FG000|Overall Study|Clinical progression|12|||
42138915|NCT00327171|75949161|FG001|Overall Study|Clinical progression|8|||
42138916|NCT00327171|75949160|FG000|Overall Study|Undisclosed history of ischemia|0|||
42138917|NCT00327171|75949161|FG001|Overall Study|Undisclosed history of ischemia|1|||
42138918|NCT00327171|75949160|FG000|Overall Study|Other|1|||
42138919|NCT00327171|75949161|FG001|Overall Study|Other|0|||
42138920|NCT00461630|75949169|FG000|Overall Study|Death|798|||
42138921|NCT00461630|75949170|FG001|Overall Study|Death|732|||
42138922|NCT00461630|75949169|FG000|Overall Study|Lost to Follow-up|108|||
42138923|NCT00461630|75949170|FG001|Overall Study|Lost to Follow-up|95|||
42138924|NCT00461552|75949178|FG000|Overall Study|Drug Dispensing error|0|||
42138925|NCT00461552|75949179|FG001|Overall Study|Drug Dispensing error|2|||
42138926|NCT00453206|75949185|FG000|Overall Study|Death|1|||
42138927|NCT03850496|75949192|FG000|Overall Study|Withdrawal by Subject|1|||
42138928|NCT03850496|75949193|FG001|Overall Study|Withdrawal by Subject|0|||
42138929|NCT03850496|75949194|FG002|Overall Study|Withdrawal by Subject|0|||
42138930|NCT03850496|75949192|FG000|Overall Study|Lost to Follow-up|0|||
42138931|NCT03850496|75949193|FG001|Overall Study|Lost to Follow-up|1|||
42138932|NCT03850496|75949194|FG002|Overall Study|Lost to Follow-up|4|||
42138933|NCT00327015|75949206|FG000|Overall Study|Lack of Efficacy|18|||
42138934|NCT00327015|75949207|FG001|Overall Study|Lack of Efficacy|18|||
42138935|NCT00327015|75949208|FG002|Overall Study|Lack of Efficacy|35|||
42138936|NCT00327015|75949209|FG003|Overall Study|Lack of Efficacy|29|||
42138937|NCT00327015|75949206|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
42138938|NCT00327015|75949207|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
42138939|NCT00327015|75949208|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
42138940|NCT00327015|75949209|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
42138941|NCT00327015|75949206|FG000|Overall Study|Lost to Follow-up|22|||
42138942|NCT00327015|75949207|FG001|Overall Study|Lost to Follow-up|23|||
42138943|NCT00327015|75949208|FG002|Overall Study|Lost to Follow-up|29|||
42138944|NCT00327015|75949209|FG003|Overall Study|Lost to Follow-up|22|||
42138945|NCT00327015|75949206|FG000|Overall Study|Adverse Event|14|||
42138946|NCT00327015|75949207|FG001|Overall Study|Adverse Event|10|||
42138947|NCT00327015|75949208|FG002|Overall Study|Adverse Event|14|||
42138948|NCT00327015|75949209|FG003|Overall Study|Adverse Event|14|||
42138949|NCT00327015|75949206|FG000|Overall Study|Subject no longer meets study criteria|4|||
42138950|NCT00327015|75949207|FG001|Overall Study|Subject no longer meets study criteria|2|||
42138951|NCT00327015|75949208|FG002|Overall Study|Subject no longer meets study criteria|8|||
42138952|NCT00327015|75949209|FG003|Overall Study|Subject no longer meets study criteria|7|||
42138953|NCT00327015|75949206|FG000|Overall Study|Poor/Noncompliance|11|||
42275671|NCT02228980|76106836|FG002|Overall Study|Adverse Event|0|||
42138954|NCT00327015|75949207|FG001|Overall Study|Poor/Noncompliance|8|||
42138955|NCT00327015|75949208|FG002|Overall Study|Poor/Noncompliance|4|||
42138956|NCT00327015|75949209|FG003|Overall Study|Poor/Noncompliance|5|||
42138957|NCT00327015|75949206|FG000|Overall Study|Physician Decision|0|||
42138958|NCT00327015|75949207|FG001|Overall Study|Physician Decision|1|||
42138959|NCT00327015|75949208|FG002|Overall Study|Physician Decision|3|||
42138960|NCT00327015|75949209|FG003|Overall Study|Physician Decision|2|||
42138961|NCT00327015|75949206|FG000|Overall Study|Death|1|||
42138962|NCT00327015|75949207|FG001|Overall Study|Death|2|||
42138963|NCT00327015|75949208|FG002|Overall Study|Death|2|||
42138964|NCT00327015|75949209|FG003|Overall Study|Death|3|||
42138965|NCT00327015|75949206|FG000|Overall Study|Pregnancy|0|||
42138966|NCT00327015|75949207|FG001|Overall Study|Pregnancy|2|||
42138967|NCT00327015|75949208|FG002|Overall Study|Pregnancy|1|||
42138968|NCT00327015|75949209|FG003|Overall Study|Pregnancy|1|||
42275672|NCT02228980|76106837|FG003|Overall Study|Adverse Event|0|||
42275673|NCT02228980|76106834|FG000|Overall Study|Protocol Violation|7|||
42138969|NCT00327015|75949206|FG000|Overall Study|Administrative Reason by Sponsor|1|||
42138970|NCT00327015|75949207|FG001|Overall Study|Administrative Reason by Sponsor|2|||
42138971|NCT00327015|75949208|FG002|Overall Study|Administrative Reason by Sponsor|2|||
42138972|NCT00327015|75949209|FG003|Overall Study|Administrative Reason by Sponsor|1|||
42138973|NCT00434148|75949221|FG000|Overall Study|Adverse Event|18|||
42138974|NCT00434148|75949222|FG001|Overall Study|Adverse Event|18|||
42138975|NCT00434148|75949221|FG000|Overall Study|Lack of Efficacy|25|||
42138976|NCT00434148|75949222|FG001|Overall Study|Lack of Efficacy|28|||
42138977|NCT00434148|75949221|FG000|Overall Study|Withdrawal by Subject|15|||
42138978|NCT00434148|75949222|FG001|Overall Study|Withdrawal by Subject|15|||
42138979|NCT00434148|75949221|FG000|Overall Study|Protocol Violation|4|||
42138980|NCT00434148|75949222|FG001|Overall Study|Protocol Violation|0|||
42138981|NCT00434148|75949221|FG000|Overall Study|Administrative problems|6|||
42138982|NCT00434148|75949222|FG001|Overall Study|Administrative problems|10|||
42138983|NCT00434148|75949221|FG000|Overall Study|Lost to Follow-up|0|||
42138984|NCT00434148|75949222|FG001|Overall Study|Lost to Follow-up|1|||
42138985|NCT00434148|75949221|FG000|Overall Study|Condition no longer requires study drug|1|||
42138986|NCT00434148|75949222|FG001|Overall Study|Condition no longer requires study drug|0|||
42138987|NCT00434148|75949221|FG000|Overall Study|Abnormal test procedure result|0|||
42138988|NCT00434148|75949222|FG001|Overall Study|Abnormal test procedure result|1|||
42138989|NCT00468728|75949230|FG000|Treatment|criteria for mITT population|4|||
42138990|NCT00468728|75949231|FG001|Treatment|criteria for mITT population|11|||
42138991|NCT00468728|75949230|FG000|Follow-up|mITT failure|34|||
42138992|NCT00468728|75949231|FG001|Follow-up|mITT failure|31|||
42138993|NCT00433914|75949241|FG000|Overall Study|Withdrawal by Subject|0|||
42138994|NCT00433914|75949242|FG001|Overall Study|Withdrawal by Subject|2|||
42138995|NCT00433914|75949241|FG000|Overall Study|Lost to Follow-up|0|||
42138996|NCT00433914|75949242|FG001|Overall Study|Lost to Follow-up|1|||
42138997|NCT00468650|75949248|FG000|Overall Study|Lost to Follow-up|4|||
42138998|NCT00468650|75949248|FG000|Overall Study|Withdrawal by Subject|2|||
42138999|NCT00468650|75949248|FG000|Overall Study|Protocol Violation|1|||
42139000|NCT00423150|75949253|FG000|Overall Study|Adverse Event|11|||
42139001|NCT00423150|75949253|FG000|Overall Study|Progression of disease being studied|69|||
42139002|NCT00423150|75949253|FG000|Overall Study|Withdrawal by Subject|1|||
42139003|NCT00423150|75949253|FG000|Overall Study|Non-compliance with protocol|1|||
42139004|NCT00423150|75949253|FG000|Overall Study|Administrative|4|||
42139005|NCT00433836|75949259|FG000|Overall Study|Adverse Event|7|||
42139006|NCT00433836|75949260|FG001|Overall Study|Adverse Event|0|||
42139007|NCT00433836|75949259|FG000|Overall Study|Lost to Follow-up|3|||
42139008|NCT00433836|75949260|FG001|Overall Study|Lost to Follow-up|0|||
42139009|NCT00433836|75949259|FG000|Overall Study|Withdrawal by Subject|2|||
42139010|NCT00433836|75949260|FG001|Overall Study|Withdrawal by Subject|1|||
42139011|NCT00433836|75949259|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42139012|NCT00433836|75949260|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
42139013|NCT00433836|75949259|FG000|Overall Study|Protocol Violation|0|||
42139014|NCT00433836|75949260|FG001|Overall Study|Protocol Violation|2|||
42139015|NCT00433836|75949259|FG000|Overall Study|Condition no longer requires study drug|0|||
42139016|NCT00433836|75949260|FG001|Overall Study|Condition no longer requires study drug|1|||
42139017|NCT00433836|75949259|FG000|Overall Study|Abnormal laboratory values|0|||
42139018|NCT00433836|75949260|FG001|Overall Study|Abnormal laboratory values|1|||
42139019|NCT00433446|75949266|FG000|Overall Study|Adverse Event|4|||
42139020|NCT00433446|75949266|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
42275674|NCT02228980|76106835|FG001|Overall Study|Protocol Violation|0|||
42275675|NCT02228980|76106836|FG002|Overall Study|Protocol Violation|0|||
42275676|NCT02228980|76106837|FG003|Overall Study|Protocol Violation|0|||
42275677|NCT02228980|76106834|FG000|Overall Study|Withdrawal by Subject|3|||
42275678|NCT02228980|76106835|FG001|Overall Study|Withdrawal by Subject|3|||
42275679|NCT02228980|76106836|FG002|Overall Study|Withdrawal by Subject|2|||
42275680|NCT02228980|76106837|FG003|Overall Study|Withdrawal by Subject|3|||
42037428|NCT01006980|75845743|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
42037429|NCT01006980|75845742|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
42037430|NCT01006980|75845743|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
42037431|NCT01006980|75845742|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
42139021|NCT00433446|75949266|FG000|Overall Study|Progression|44|||
42139022|NCT00433446|75949266|FG000|Overall Study|Other - Not Protocol specified|3|||
42139023|NCT00433446|75949266|FG000|Overall Study|Ineligible|9|||
42139024|NCT00468104|75949270|FG000|First Intervention|Protocol Violation|2|||
42139025|NCT00468104|75949271|FG001|First Intervention|Protocol Violation|1|||
42139026|NCT00468104|75949270|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
42139027|NCT00468104|75949271|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
42275681|NCT02228590|76106851|FG000|Overall Study|Withdrawal by Subject|1|||
42275682|NCT02227108|76106856|FG000|Overall Study|Did not receive treatment|2|||
42139028|NCT00468104|75949270|FG000|First Intervention|died within 3 weeks|1|||
42139029|NCT00468104|75949271|FG001|First Intervention|died within 3 weeks|0|||
42139030|NCT00468104|75949270|FG000|First Intervention|malposition/blocked chest tube tube|2|||
42139031|NCT00468104|75949271|FG001|First Intervention|malposition/blocked chest tube tube|0|||
42139032|NCT00468104|75949270|FG000|First Intervention|large lung mass with minimal effusion|1|||
42139033|NCT00468104|75949271|FG001|First Intervention|large lung mass with minimal effusion|0|||
42139034|NCT00468104|75949270|FG000|First Intervention|associated prolonged pneumothorax|1|||
42037432|NCT01006980|75845743|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
42037433|NCT01006980|75845742|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
42037434|NCT01006980|75845743|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
42037435|NCT01006980|75845742|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
42037436|NCT01006980|75845743|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
42037437|NCT01006980|75845742|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
42037438|NCT01006980|75845743|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
42037439|NCT00887926|75845754|FG000|Overall Study|Withdrawal by Subject|0|||
42037440|NCT00887926|75845755|FG001|Overall Study|Withdrawal by Subject|1|||
42037441|NCT00887926|75845756|FG002|Overall Study|Withdrawal by Subject|0|||
42037442|NCT00887926|75845757|FG003|Overall Study|Withdrawal by Subject|0|||
42037443|NCT00998400|75845771|FG000|Overall Study|Lack of interest/motivation|1|||
42037444|NCT00998400|75845772|FG001|Overall Study|Lack of interest/motivation|2|||
42037445|NCT00998400|75845771|FG000|Overall Study|Logistical problems|1|||
42037446|NCT00998400|75845772|FG001|Overall Study|Logistical problems|0|||
42037447|NCT00997386|75845779|FG000|Overall Study|Death|7|||
42037448|NCT00996996|75845783|FG000|Overall Study|Progressive Disease|10|||
42037449|NCT00996996|75845783|FG000|Overall Study|Non-compliance|8|||
42037450|NCT00996996|75845783|FG000|Overall Study|Lost to Follow-up|9|||
42037451|NCT00996996|75845783|FG000|Overall Study|Death|5|||
42037452|NCT00996996|75845783|FG000|Overall Study|Did Not Receive Study Medications|1|||
42037453|NCT00996918|75845792|FG000|Overall Study|Lack of Efficacy|1|||
42037454|NCT00996918|75845793|FG001|Overall Study|Lack of Efficacy|1|||
42037455|NCT00996918|75845794|FG002|Overall Study|Lack of Efficacy|2|||
42037456|NCT00996918|75845795|FG003|Overall Study|Lack of Efficacy|2|||
42037457|NCT00996918|75845796|FG004|Overall Study|Lack of Efficacy|0|||
42037458|NCT00996918|75845792|FG000|Overall Study|Adverse Event|2|||
42037459|NCT00996918|75845793|FG001|Overall Study|Adverse Event|5|||
42037460|NCT00996918|75845794|FG002|Overall Study|Adverse Event|2|||
42037461|NCT00996918|75845795|FG003|Overall Study|Adverse Event|6|||
42037462|NCT00996918|75845796|FG004|Overall Study|Adverse Event|0|||
42037463|NCT00996918|75845792|FG000|Overall Study|Withdrawal by Subject|1|||
42037464|NCT00996918|75845793|FG001|Overall Study|Withdrawal by Subject|4|||
42037465|NCT00996918|75845794|FG002|Overall Study|Withdrawal by Subject|3|||
42037466|NCT00996918|75845795|FG003|Overall Study|Withdrawal by Subject|3|||
42037467|NCT00996918|75845796|FG004|Overall Study|Withdrawal by Subject|2|||
42037468|NCT00996918|75845792|FG000|Overall Study|Physician Decision|1|||
42037469|NCT00996918|75845793|FG001|Overall Study|Physician Decision|0|||
42037470|NCT00996918|75845794|FG002|Overall Study|Physician Decision|0|||
42037471|NCT00996918|75845795|FG003|Overall Study|Physician Decision|0|||
42037472|NCT00996918|75845796|FG004|Overall Study|Physician Decision|0|||
42037473|NCT00996918|75845792|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
42037474|NCT00996918|75845793|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
42037475|NCT00996918|75845794|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
42037476|NCT00996918|75845795|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
42037477|NCT00996918|75845796|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
42037478|NCT00996918|75845792|FG000|Overall Study|Loss of Caregiver|0|||
42037479|NCT00996918|75845793|FG001|Overall Study|Loss of Caregiver|1|||
42011516|NCT00975481|75818536|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
42011517|NCT01011868|75818557|FG000|After Week 18 Follow-up|Adverse Event|8|||
42011518|NCT01011868|75818558|FG001|After Week 18 Follow-up|Adverse Event|6|||
42011519|NCT01011868|75818559|FG002|After Week 18 Follow-up|Adverse Event|13|||
42011520|NCT01011868|75818557|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
42011521|NCT01011868|75818558|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
42011522|NCT01011868|75818559|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
42011523|NCT01011868|75818557|FG000|After Week 18 Follow-up|Protocol Violation|1|||
42011524|NCT01011868|75818558|FG001|After Week 18 Follow-up|Protocol Violation|1|||
42011525|NCT01011868|75818559|FG002|After Week 18 Follow-up|Protocol Violation|1|||
42037480|NCT00996918|75845794|FG002|Overall Study|Loss of Caregiver|0|||
42037481|NCT00996918|75845795|FG003|Overall Study|Loss of Caregiver|0|||
42037482|NCT00996918|75845796|FG004|Overall Study|Loss of Caregiver|0|||
42037483|NCT00996918|75845792|FG000|Overall Study|Other|3|||
42037484|NCT00996918|75845793|FG001|Overall Study|Other|1|||
42037485|NCT00996918|75845794|FG002|Overall Study|Other|0|||
42139035|NCT00468104|75949271|FG001|First Intervention|associated prolonged pneumothorax|0|||
42139036|NCT00468104|75949270|FG000|First Intervention|trapped lung|1|||
42139037|NCT00468104|75949271|FG001|First Intervention|trapped lung|0|||
42139038|NCT00468104|75949270|FG000|Second Intervention|Withdrawal by Subject|5|||
42139039|NCT00468104|75949271|FG001|Second Intervention|Withdrawal by Subject|2|||
42139040|NCT00468104|75949270|FG000|Second Intervention|discarded for malposition of chest tube|0|||
42139041|NCT00468104|75949271|FG001|Second Intervention|discarded for malposition of chest tube|2|||
42139042|NCT00326625|75949282|FG000|Overall Study|Adverse Event|20|||
42139043|NCT00326625|75949283|FG001|Overall Study|Adverse Event|9|||
42139044|NCT00326625|75949282|FG000|Overall Study|Withdrawal by Subject|15|||
42139045|NCT00326625|75949283|FG001|Overall Study|Withdrawal by Subject|12|||
42139046|NCT00326625|75949282|FG000|Overall Study|Death|18|||
42139047|NCT00326625|75949283|FG001|Overall Study|Death|16|||
42139048|NCT00326625|75949282|FG000|Overall Study|Lost to Follow-up|1|||
42139049|NCT00326625|75949283|FG001|Overall Study|Lost to Follow-up|0|||
42139050|NCT00326625|75949282|FG000|Overall Study|prescheduled medical intervention|0|||
42139051|NCT00326625|75949283|FG001|Overall Study|prescheduled medical intervention|1|||
42139052|NCT00433290|75949291|FG000|Overall Study|Adverse Event|24|||
42139053|NCT00433290|75949292|FG001|Overall Study|Adverse Event|7|||
42139054|NCT00433290|75949291|FG000|Overall Study|Lack of Efficacy|1|||
42139055|NCT00433290|75949292|FG001|Overall Study|Lack of Efficacy|5|||
42139056|NCT00433290|75949291|FG000|Overall Study|Withdrawal by Subject|4|||
42139057|NCT00433290|75949292|FG001|Overall Study|Withdrawal by Subject|2|||
42139058|NCT00433290|75949291|FG000|Overall Study|Protocol Violation|3|||
42139059|NCT00433290|75949292|FG001|Overall Study|Protocol Violation|2|||
42139060|NCT00433290|75949291|FG000|Overall Study|Physician Decision|2|||
42139061|NCT00433290|75949292|FG001|Overall Study|Physician Decision|0|||
42139062|NCT00433290|75949291|FG000|Overall Study|Entry Criteria Not Met|0|||
42139063|NCT00433290|75949292|FG001|Overall Study|Entry Criteria Not Met|1|||
42139064|NCT00433290|75949291|FG000|Overall Study|Lost to Follow-up|1|||
42139065|NCT00433290|75949292|FG001|Overall Study|Lost to Follow-up|0|||
42139066|NCT00467870|75949304|FG000|Overall Study|Adverse Event|13|||
42139067|NCT00467870|75949305|FG001|Overall Study|Adverse Event|9|||
42139068|NCT00467870|75949306|FG002|Overall Study|Adverse Event|1|||
42139069|NCT00467870|75949307|FG003|Overall Study|Adverse Event|15|||
42037486|NCT00996918|75845795|FG003|Overall Study|Other|0|||
42037487|NCT00996918|75845796|FG004|Overall Study|Other|0|||
42037488|NCT01160744|75845812|FG000|Overall Study|Withdrawal by Subject|11|||
42037489|NCT01160744|75845813|FG001|Overall Study|Withdrawal by Subject|5|||
42037490|NCT01160744|75845814|FG002|Overall Study|Withdrawal by Subject|6|||
42037491|NCT01160744|75845815|FG003|Overall Study|Withdrawal by Subject|4|||
42139070|NCT00467870|75949308|FG004|Overall Study|Adverse Event|15|||
42139071|NCT00467870|75949309|FG005|Overall Study|Adverse Event|1|||
42139072|NCT00467870|75949304|FG000|Overall Study|Protocol Violation|2|||
42139073|NCT00467870|75949305|FG001|Overall Study|Protocol Violation|1|||
42139074|NCT00467870|75949306|FG002|Overall Study|Protocol Violation|1|||
42139075|NCT00467870|75949307|FG003|Overall Study|Protocol Violation|2|||
42139076|NCT00467870|75949308|FG004|Overall Study|Protocol Violation|0|||
42275683|NCT02227108|76106856|FG000|Overall Study|Other|3|||
42011526|NCT01011868|75818557|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
42011527|NCT01011868|75818558|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
42011528|NCT01011868|75818559|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
42011529|NCT01011868|75818557|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
42011530|NCT01011868|75818558|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
42011531|NCT01011868|75818559|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
42011532|NCT01011868|75818557|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
42011533|NCT01011868|75818558|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
42011534|NCT01011868|75818559|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
42011535|NCT01011868|75818557|FG000|After Week 78 Follow-up|Adverse Event|14|||
42011536|NCT01011868|75818558|FG001|After Week 78 Follow-up|Adverse Event|18|||
42011537|NCT01011868|75818559|FG002|After Week 78 Follow-up|Adverse Event|21|||
42011538|NCT01011868|75818557|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
42011539|NCT01011868|75818558|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
42011540|NCT01011868|75818559|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
42011541|NCT01011868|75818557|FG000|After Week 78 Follow-up|Protocol Violation|9|||
42139077|NCT00467870|75949309|FG005|Overall Study|Protocol Violation|0|||
42139078|NCT00467870|75949304|FG000|Overall Study|Withdrawal by Subject|14|||
42139079|NCT00467870|75949305|FG001|Overall Study|Withdrawal by Subject|21|||
42011542|NCT01011868|75818558|FG001|After Week 78 Follow-up|Protocol Violation|1|||
42037492|NCT01160744|75845812|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
42037493|NCT01160744|75845813|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
42275684|NCT02227108|76106856|FG000|Overall Study|Progressive disease|17|||
42139080|NCT00467870|75949306|FG002|Overall Study|Withdrawal by Subject|0|||
42139081|NCT00467870|75949307|FG003|Overall Study|Withdrawal by Subject|9|||
42139082|NCT00467870|75949308|FG004|Overall Study|Withdrawal by Subject|10|||
42139083|NCT00467870|75949309|FG005|Overall Study|Withdrawal by Subject|1|||
42037494|NCT01160744|75845814|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
42037495|NCT01160744|75845815|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
42037496|NCT01160354|75845830|FG000|Overall Study|Death|0|||
42037497|NCT01160354|75845831|FG001|Overall Study|Death|1|||
42037498|NCT01160354|75845832|FG002|Overall Study|Death|1|||
42037499|NCT01160198|75845843|FG000|Overall Study|Withdrawal by Subject|2|||
42139084|NCT00467870|75949304|FG000|Overall Study|Lost to Follow-up|5|||
42139085|NCT00467870|75949305|FG001|Overall Study|Lost to Follow-up|3|||
42139086|NCT00467870|75949306|FG002|Overall Study|Lost to Follow-up|1|||
42139087|NCT00467870|75949307|FG003|Overall Study|Lost to Follow-up|1|||
42139088|NCT00467870|75949308|FG004|Overall Study|Lost to Follow-up|3|||
42139089|NCT00467870|75949309|FG005|Overall Study|Lost to Follow-up|0|||
42139090|NCT00467870|75949304|FG000|Overall Study|Subject Non-compliance|3|||
42139091|NCT00467870|75949305|FG001|Overall Study|Subject Non-compliance|4|||
42139092|NCT00467870|75949306|FG002|Overall Study|Subject Non-compliance|0|||
42139093|NCT00467870|75949307|FG003|Overall Study|Subject Non-compliance|1|||
42139094|NCT00467870|75949308|FG004|Overall Study|Subject Non-compliance|5|||
42139095|NCT00467870|75949309|FG005|Overall Study|Subject Non-compliance|0|||
42139096|NCT00467870|75949304|FG000|Overall Study|Other/Unknown|8|||
42139097|NCT00467870|75949305|FG001|Overall Study|Other/Unknown|5|||
42139098|NCT00467870|75949306|FG002|Overall Study|Other/Unknown|1|||
42139099|NCT00467870|75949307|FG003|Overall Study|Other/Unknown|5|||
42139100|NCT00467870|75949308|FG004|Overall Study|Other/Unknown|4|||
42139101|NCT00467870|75949309|FG005|Overall Study|Other/Unknown|0|||
42139102|NCT00467558|75949321|FG000|Overall Study|Lost to Follow-up|2|||
42139103|NCT00467558|75949322|FG001|Overall Study|Lost to Follow-up|0|||
42139104|NCT00422292|75949332|FG000|Overall Study|Serious adverse events|1|||
42139105|NCT00422292|75949333|FG001|Overall Study|Serious adverse events|4|||
42139106|NCT00422292|75949334|FG002|Overall Study|Serious adverse events|0|||
42139107|NCT00422292|75949335|FG003|Overall Study|Serious adverse events|0|||
42139108|NCT00422292|75949332|FG000|Overall Study|Adverse Event|1|||
42139109|NCT00422292|75949333|FG001|Overall Study|Adverse Event|0|||
42139110|NCT00422292|75949334|FG002|Overall Study|Adverse Event|1|||
42139111|NCT00422292|75949335|FG003|Overall Study|Adverse Event|0|||
42139112|NCT00422292|75949332|FG000|Overall Study|Protocol Violation|4|||
42139113|NCT00422292|75949333|FG001|Overall Study|Protocol Violation|25|||
42139114|NCT00422292|75949334|FG002|Overall Study|Protocol Violation|8|||
42139115|NCT00422292|75949335|FG003|Overall Study|Protocol Violation|5|||
42139116|NCT00422292|75949332|FG000|Overall Study|Lost to Follow-up|6|||
42139117|NCT00422292|75949333|FG001|Overall Study|Lost to Follow-up|12|||
42139118|NCT00422292|75949334|FG002|Overall Study|Lost to Follow-up|6|||
42139119|NCT00422292|75949335|FG003|Overall Study|Lost to Follow-up|6|||
42139120|NCT00422292|75949332|FG000|Overall Study|Withdrawal by Subject|6|||
42139121|NCT00422292|75949333|FG001|Overall Study|Withdrawal by Subject|25|||
42139122|NCT00422292|75949334|FG002|Overall Study|Withdrawal by Subject|7|||
42139123|NCT00422292|75949335|FG003|Overall Study|Withdrawal by Subject|13|||
42139124|NCT00452348|75949347|FG000|Overall Study|Adverse Event|6|||
42139125|NCT00452348|75949348|FG001|Overall Study|Adverse Event|9|||
42139126|NCT00452348|75949347|FG000|Overall Study|Lack of Efficacy|10|||
42139127|NCT00452348|75949348|FG001|Overall Study|Lack of Efficacy|9|||
42139128|NCT00452348|75949347|FG000|Overall Study|Lost to Follow-up|14|||
42139129|NCT00452348|75949348|FG001|Overall Study|Lost to Follow-up|8|||
42139130|NCT00452348|75949347|FG000|Overall Study|Protocol Violation|22|||
42139131|NCT00452348|75949348|FG001|Overall Study|Protocol Violation|28|||
42139132|NCT00452348|75949347|FG000|Overall Study|Withdrawal by Subject|18|||
42139133|NCT00452348|75949348|FG001|Overall Study|Withdrawal by Subject|21|||
42139134|NCT00452348|75949347|FG000|Overall Study|Other|9|||
42139135|NCT00452348|75949348|FG001|Overall Study|Other|9|||
42139136|NCT00452114|75949356|FG000|Overall Study|Physician Decision|3|||
42139137|NCT00452114|75949357|FG001|Overall Study|Physician Decision|3|||
42275685|NCT02227108|76106856|FG000|Overall Study|Initiation of alternative therapy|2|||
42275686|NCT02227108|76106856|FG000|Overall Study|Investigator discretion|1|||
42275687|NCT02227108|76106856|FG000|Overall Study|Adverse Event|6|||
42275688|NCT03564145|76106860|FG000|Overall Study|Adverse Event|4|||
42275689|NCT03564145|76106860|FG000|Overall Study|Lost to Follow-up|21|||
42139138|NCT00320541|75949365|FG000|Overall Study|Adverse Event|21|||
42139139|NCT00320541|75949366|FG001|Overall Study|Adverse Event|19|||
42139140|NCT00320541|75949365|FG000|Overall Study|Protocol Violation|0|||
42037500|NCT01160198|75845844|FG001|Overall Study|Withdrawal by Subject|1|||
42037501|NCT01160198|75845845|FG002|Overall Study|Withdrawal by Subject|0|||
42139141|NCT00320541|75949366|FG001|Overall Study|Protocol Violation|1|||
42139142|NCT00320541|75949365|FG000|Overall Study|Withdrawal by Subject|12|||
42139143|NCT00320541|75949366|FG001|Overall Study|Withdrawal by Subject|16|||
42139144|NCT00320541|75949365|FG000|Overall Study|Physician Decision|9|||
42139145|NCT00320541|75949366|FG001|Overall Study|Physician Decision|13|||
42139146|NCT00320541|75949365|FG000|Overall Study|Other|3|||
42139147|NCT00320541|75949366|FG001|Overall Study|Other|4|||
42139148|NCT00320541|75949365|FG000|Overall Study|Sponsor Decision|2|||
42139149|NCT00320541|75949366|FG001|Overall Study|Sponsor Decision|1|||
42139150|NCT00320541|75949365|FG000|Overall Study|Death due to Study Disease|1|||
42139151|NCT00320541|75949366|FG001|Overall Study|Death due to Study Disease|3|||
42275690|NCT03564145|76106860|FG000|Overall Study|Protocol Violation|2|||
42275691|NCT03564145|76106860|FG000|Overall Study|Withdrawal by Subject|48|||
42275692|NCT03564145|76106860|FG000|Overall Study|Study Terminated by Sponsor|146|||
42275693|NCT03564145|76106860|FG000|Overall Study|Physician Decision|1|||
42275694|NCT03564145|76106860|FG000|Overall Study|Other Than Specified|1|||
42275695|NCT03564145|76106860|FG000|Overall Study|Pregnancy|1|||
42275696|NCT02226562|76106866|FG000|Overall Study|Lost to Follow-up|0|||
42275697|NCT02226562|76106867|FG001|Overall Study|Lost to Follow-up|1|||
42275698|NCT02456636|76106901|FG000|Overall Study|Death|0|||
42275699|NCT02456636|76106902|FG001|Overall Study|Death|3|||
42275700|NCT02456636|76106903|FG002|Overall Study|Death|0|||
42011543|NCT01011868|75818559|FG002|After Week 78 Follow-up|Protocol Violation|2|||
42011544|NCT01011868|75818557|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
42011545|NCT01011868|75818558|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
42011546|NCT01011868|75818559|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
42011547|NCT01011868|75818557|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
42011548|NCT01011868|75818558|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
42011549|NCT01011868|75818559|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
42011550|NCT01011868|75818557|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
42011551|NCT01011868|75818558|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
42011552|NCT01011868|75818559|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
42011553|NCT01213251|75818570|FG000|Overall Study|Death|2|||
42011554|NCT01213251|75818571|FG001|Overall Study|Death|1|||
42011555|NCT01213251|75818572|FG002|Overall Study|Death|2|||
42011556|NCT01213251|75818570|FG000|Overall Study|Exit|3|||
42011557|NCT01213251|75818571|FG001|Overall Study|Exit|2|||
42011558|NCT01213251|75818572|FG002|Overall Study|Exit|8|||
42011559|NCT01213251|75818570|FG000|Overall Study|Protocol Violation|1|||
42139152|NCT00320541|75949365|FG000|Overall Study|Death due to Adverse Event(s)|1|||
42275701|NCT02456636|76106901|FG000|Overall Study|Pregnancy|1|||
42139153|NCT00320541|75949366|FG001|Overall Study|Death due to Adverse Event(s)|0|||
42139154|NCT00320541|75949365|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
42139155|NCT00320541|75949366|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
42139156|NCT00320385|75949374|FG000|Overall Study|Lost to Follow-up|7|||
42139157|NCT00320385|75949375|FG001|Overall Study|Lost to Follow-up|10|||
42139158|NCT00320385|75949374|FG000|Overall Study|Withdrawal by Subject|6|||
42139159|NCT00320385|75949375|FG001|Overall Study|Withdrawal by Subject|7|||
42139160|NCT00320385|75949374|FG000|Overall Study|Sponsor Terminated Study|2|||
42139161|NCT00320385|75949375|FG001|Overall Study|Sponsor Terminated Study|1|||
42139162|NCT00320385|75949374|FG000|Overall Study|Investigator Decision|0|||
42139163|NCT00320385|75949375|FG001|Overall Study|Investigator Decision|1|||
42139164|NCT00320385|75949374|FG000|Overall Study|Death|1|||
42139165|NCT00320385|75949375|FG001|Overall Study|Death|2|||
42139166|NCT00320385|75949374|FG000|Overall Study|Serious Adverse Event|1|||
42139167|NCT00320385|75949375|FG001|Overall Study|Serious Adverse Event|0|||
42139168|NCT00320385|75949374|FG000|Overall Study|Withdrew Consent|1|||
42139169|NCT00320385|75949375|FG001|Overall Study|Withdrew Consent|0|||
42139170|NCT00320385|75949374|FG000|Overall Study|Adverse Event|0|||
42139171|NCT00320385|75949375|FG001|Overall Study|Adverse Event|1|||
42139172|NCT00326001|75949383|FG000|Overall Study|Adverse Event|4|||
42139173|NCT00326001|75949384|FG001|Overall Study|Adverse Event|5|||
42139174|NCT00326001|75949383|FG000|Overall Study|Physician Decision|3|||
42139175|NCT00326001|75949384|FG001|Overall Study|Physician Decision|3|||
42139176|NCT00309777|75949394|FG000|Overall Study|Adverse Event|13|||
42139177|NCT00309777|75949395|FG001|Overall Study|Adverse Event|2|||
42139178|NCT00309777|75949396|FG002|Overall Study|Adverse Event|8|||
42139179|NCT00309777|75949397|FG003|Overall Study|Adverse Event|1|||
42139180|NCT00309777|75949394|FG000|Overall Study|Protocol Violation|4|||
42139181|NCT00309777|75949395|FG001|Overall Study|Protocol Violation|1|||
42139182|NCT00309777|75949396|FG002|Overall Study|Protocol Violation|3|||
42139183|NCT00309777|75949397|FG003|Overall Study|Protocol Violation|1|||
42139184|NCT00309777|75949394|FG000|Overall Study|Withdrawal by Subject|6|||
42139185|NCT00309777|75949395|FG001|Overall Study|Withdrawal by Subject|5|||
42139186|NCT00309777|75949396|FG002|Overall Study|Withdrawal by Subject|7|||
42139187|NCT00309777|75949397|FG003|Overall Study|Withdrawal by Subject|2|||
42139188|NCT00309777|75949394|FG000|Overall Study|Lost to Follow-up|0|||
42139189|NCT00309777|75949395|FG001|Overall Study|Lost to Follow-up|0|||
42139190|NCT00309777|75949396|FG002|Overall Study|Lost to Follow-up|1|||
42139191|NCT00309777|75949397|FG003|Overall Study|Lost to Follow-up|0|||
42139192|NCT00309777|75949394|FG000|Overall Study|Death|0|||
42139193|NCT00309777|75949395|FG001|Overall Study|Death|1|||
42139194|NCT00309777|75949396|FG002|Overall Study|Death|0|||
42139195|NCT00309777|75949397|FG003|Overall Study|Death|0|||
42139196|NCT00309387|75949409|FG000|Overall Study|Death|72|||
42139197|NCT00309387|75949410|FG001|Overall Study|Death|73|||
42139198|NCT00309387|75949409|FG000|Overall Study|Lost to Follow-up|70|||
42139199|NCT00309387|75949410|FG001|Overall Study|Lost to Follow-up|86|||
42139200|NCT00325143|75949417|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
42139201|NCT00325143|75949417|FG000|Overall Study|Migrated/moved from study area|1|||
42139202|NCT00325143|75949417|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
42139203|NCT00325143|75949417|FG000|Overall Study|Withdrawal by Subject|8|||
42139204|NCT00319839|75949421|FG000|Overall Study|Adverse Event|5|||
42139205|NCT00319839|75949421|FG000|Overall Study|Withdrawal by Subject|1|||
42139206|NCT00319449|75949427|FG000|Overall Study|Subject did not wish to continue|1|||
42350525|NCT01573767|76190314|FG001|Overall Study|Lost to Follow-up|1|||
42350526|NCT01573767|76190315|FG002|Overall Study|Lost to Follow-up|1|||
42350527|NCT01573767|76190316|FG003|Overall Study|Lost to Follow-up|1|||
42350528|NCT01573767|76190313|FG000|Overall Study|Physician Decision|1|||
42350529|NCT01573767|76190314|FG001|Overall Study|Physician Decision|2|||
42350530|NCT01573767|76190315|FG002|Overall Study|Physician Decision|0|||
42350531|NCT01573767|76190316|FG003|Overall Study|Physician Decision|2|||
42350532|NCT01573767|76190313|FG000|Overall Study|Withdrawal by Subject|0|||
42350533|NCT01573767|76190314|FG001|Overall Study|Withdrawal by Subject|1|||
42350534|NCT01573767|76190315|FG002|Overall Study|Withdrawal by Subject|0|||
42350535|NCT01573767|76190316|FG003|Overall Study|Withdrawal by Subject|0|||
42139207|NCT00319449|75949428|FG001|Overall Study|Subject did not wish to continue|0|||
42139208|NCT00319449|75949427|FG000|Overall Study|Noncompliance with the protocol|1|||
42139209|NCT00319449|75949428|FG001|Overall Study|Noncompliance with the protocol|0|||
42139210|NCT00308997|75949436|FG000|Overall Study|Subject feigned clinical data|0|||
42139211|NCT00308997|75949437|FG001|Overall Study|Subject feigned clinical data|1|||
42139212|NCT00308997|75949436|FG000|Overall Study|Unable to tolerate intervention|1|||
42139213|NCT00308997|75949437|FG001|Overall Study|Unable to tolerate intervention|0|||
42139214|NCT00308685|75949445|FG000|Overall Study|Lost to Follow-up|1|||
42139215|NCT00308685|75949446|FG001|Overall Study|Lost to Follow-up|0|||
42139216|NCT00308685|75949445|FG000|Overall Study|Need to administer prohibited medication|1|||
42350536|NCT01551303|76190328|FG000|Overall Study|failed awareness check on vision test|4|||
42350537|NCT01551303|76190329|FG001|Overall Study|failed awareness check on vision test|7|||
42139217|NCT00308685|75949446|FG001|Overall Study|Need to administer prohibited medication|2|||
42139218|NCT00308685|75949445|FG000|Overall Study|Other than specified|1|||
42139219|NCT00308685|75949446|FG001|Overall Study|Other than specified|3|||
42139220|NCT00317109|75949454|FG000|Overall Study|Withdrawal by Subject|2|||
42139221|NCT00317109|75949455|FG001|Overall Study|Withdrawal by Subject|0|||
42139222|NCT00317109|75949454|FG000|Overall Study|Migated/moved from study area|1|||
42139223|NCT00317109|75949455|FG001|Overall Study|Migated/moved from study area|0|||
42139224|NCT00316719|75949463|FG000|Overall Study|Adverse Event|0|||
42139225|NCT00316719|75949464|FG001|Overall Study|Adverse Event|6|||
42139226|NCT00316719|75949463|FG000|Overall Study|Consent withdrawn|2|||
42139227|NCT00316719|75949464|FG001|Overall Study|Consent withdrawn|0|||
42139228|NCT00422058|75949476|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
42139229|NCT00422058|75949477|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
42139230|NCT00422058|75949478|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
42139231|NCT00422058|75949479|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
42139232|NCT00422058|75949480|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
42139233|NCT00422058|75949481|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
42275702|NCT02456636|76106902|FG001|Overall Study|Pregnancy|3|||
42275703|NCT02456636|76106903|FG002|Overall Study|Pregnancy|5|||
42275704|NCT02456636|76106901|FG000|Overall Study|Physician Decision|4|||
42275705|NCT02456636|76106902|FG001|Overall Study|Physician Decision|5|||
42275706|NCT02456636|76106903|FG002|Overall Study|Physician Decision|4|||
42139234|NCT00422058|75949476|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
42139235|NCT00422058|75949477|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
42139236|NCT00422058|75949478|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
42139237|NCT00422058|75949479|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
42275707|NCT02456636|76106901|FG000|Overall Study|Withdrawal by Subject|13|||
42275708|NCT02456636|76106902|FG001|Overall Study|Withdrawal by Subject|14|||
42275709|NCT02456636|76106903|FG002|Overall Study|Withdrawal by Subject|16|||
42275710|NCT02456636|76106901|FG000|Overall Study|Lost to Follow-up|50|||
42350538|NCT00638404|76190337|FG000|Overall Study|Physician Decision|8|||
42350539|NCT00638404|76190338|FG001|Overall Study|Physician Decision|0|||
42350540|NCT01550757|76190352|FG000|Overall Study|Lost to Follow-up|21|||
42350541|NCT01550757|76190353|FG001|Overall Study|Lost to Follow-up|14|||
42350542|NCT01550757|76190354|FG002|Overall Study|Lost to Follow-up|42|||
42011560|NCT01213251|75818571|FG001|Overall Study|Protocol Violation|1|||
42011561|NCT01213251|75818572|FG002|Overall Study|Protocol Violation|0|||
42011562|NCT01213251|75818570|FG000|Overall Study|Missed 18-Month Follow-up|0|||
42011563|NCT01213251|75818571|FG001|Overall Study|Missed 18-Month Follow-up|0|||
42011564|NCT01213251|75818572|FG002|Overall Study|Missed 18-Month Follow-up|1|||
42011565|NCT01213173|75818587|FG000|Overall Study|Protocol Violation|2|||
42011566|NCT01213173|75818588|FG001|Overall Study|Protocol Violation|0|||
42011567|NCT01213173|75818587|FG000|Overall Study|Adverse Event|4|||
42011568|NCT01213173|75818588|FG001|Overall Study|Adverse Event|8|||
42011569|NCT01213173|75818587|FG000|Overall Study|Withdrawal by Subject|5|||
42011570|NCT01213173|75818588|FG001|Overall Study|Withdrawal by Subject|5|||
42011571|NCT01213173|75818587|FG000|Overall Study|Incorrect Enrollment|1|||
42011572|NCT01213173|75818588|FG001|Overall Study|Incorrect Enrollment|3|||
42011573|NCT01212159|75818596|FG000|Overall Study|Withdrawal by Subject|12|||
42011574|NCT01212159|75818597|FG001|Overall Study|Withdrawal by Subject|12|||
42011575|NCT00973765|75818605|FG000|Overall Study|Lost to Follow-up|8|||
42011576|NCT00973765|75818606|FG001|Overall Study|Lost to Follow-up|14|||
42011577|NCT01211769|75818616|FG000|Overall Study|Lost to Follow-up|7|||
42011578|NCT01211769|75818617|FG001|Overall Study|Lost to Follow-up|9|||
42011579|NCT01211769|75818618|FG002|Overall Study|Lost to Follow-up|5|||
42011580|NCT01211769|75818619|FG003|Overall Study|Lost to Follow-up|9|||
42011581|NCT01211769|75818616|FG000|Overall Study|Physician Decision|2|||
42011582|NCT01211769|75818617|FG001|Overall Study|Physician Decision|0|||
42011583|NCT01211769|75818618|FG002|Overall Study|Physician Decision|2|||
42011584|NCT01211769|75818619|FG003|Overall Study|Physician Decision|1|||
42011585|NCT01211769|75818616|FG000|Overall Study|Adverse Event|0|||
42011586|NCT01211769|75818617|FG001|Overall Study|Adverse Event|1|||
42011587|NCT01211769|75818618|FG002|Overall Study|Adverse Event|1|||
42011588|NCT01211769|75818619|FG003|Overall Study|Adverse Event|1|||
42011589|NCT01211613|75818632|FG000|Overall Study|Lost to Follow-up|2|||
42139238|NCT00422058|75949480|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
42139239|NCT00422058|75949481|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
42139240|NCT00422058|75949476|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
42139241|NCT00422058|75949477|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
42139242|NCT00422058|75949478|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
42139243|NCT00422058|75949479|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
42139244|NCT00422058|75949480|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
42139245|NCT00422058|75949481|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
42139246|NCT00422058|75949476|FG000|Double-Blind, Week 0-20|Other|11|||
42139247|NCT00422058|75949477|FG001|Double-Blind, Week 0-20|Other|3|||
42139248|NCT00422058|75949478|FG002|Double-Blind, Week 0-20|Other|8|||
42139249|NCT00422058|75949479|FG003|Double-Blind, Week 0-20|Other|8|||
42139250|NCT00422058|75949480|FG004|Double-Blind, Week 0-20|Other|4|||
42139251|NCT00422058|75949481|FG005|Double-Blind, Week 0-20|Other|10|||
42139252|NCT00422058|75949476|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
42139253|NCT00422058|75949477|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
42139254|NCT00422058|75949478|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
42139255|NCT00422058|75949479|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
42139256|NCT00422058|75949480|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
42139257|NCT00422058|75949481|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
42139258|NCT00422058|75949476|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
42139259|NCT00422058|75949477|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
42139260|NCT00422058|75949478|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
42139261|NCT00422058|75949479|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
42139262|NCT00422058|75949480|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
42139263|NCT00422058|75949481|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
42139264|NCT00422058|75949476|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
42139265|NCT00422058|75949477|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
42139266|NCT00422058|75949478|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
42139267|NCT00422058|75949479|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
42350543|NCT01550757|76190355|FG003|Overall Study|Lost to Follow-up|53|||
42037502|NCT01160198|75845843|FG000|Overall Study|Adverse Event|0|||
42037503|NCT01160198|75845844|FG001|Overall Study|Adverse Event|1|||
42037504|NCT01160198|75845845|FG002|Overall Study|Adverse Event|0|||
42037505|NCT01160198|75845843|FG000|Overall Study|Lost to Follow-up|0|||
42037506|NCT01160198|75845844|FG001|Overall Study|Lost to Follow-up|1|||
42037507|NCT01160198|75845845|FG002|Overall Study|Lost to Follow-up|0|||
42037508|NCT01160198|75845843|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
42037509|NCT01160198|75845844|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
42037510|NCT01160198|75845845|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
42037511|NCT01159574|75845853|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
42037512|NCT01159574|75845853|FG000|Treatment Phase|Adverse Event|3|||
42037513|NCT01159574|75845853|FG000|Treatment Phase|Death|6|||
42037514|NCT01159574|75845853|FG000|Treatment Phase|Physician Decision|2|||
42037515|NCT01159574|75845853|FG000|Treatment Phase|Withdrawal by Subject|7|||
42037516|NCT01159574|75845853|FG000|Treatment Phase|still on treatment|2|||
42037517|NCT01159574|75845853|FG000|Follow Up Phase|Lost to Follow-up|2|||
42037518|NCT01159574|75845853|FG000|Follow Up Phase|still being followed for overall surviva|18|||
42037519|NCT01158950|75845857|FG000|1st Intervention (1 Day)|Physician Decision|1|||
42037520|NCT01158950|75845858|FG001|1st Intervention (1 Day)|Physician Decision|2|||
42037521|NCT01172288|75845865|FG000|Overall Study|Adverse Event|1|||
42037522|NCT01172288|75845866|FG001|Overall Study|Adverse Event|0|||
42037523|NCT01172288|75845865|FG000|Overall Study|Protocol Violation|0|||
42037524|NCT01172288|75845866|FG001|Overall Study|Protocol Violation|1|||
42037525|NCT00996840|75845877|FG000|Overall Study|Adverse Event|0|||
42037526|NCT00996840|75845878|FG001|Overall Study|Adverse Event|1|||
42037527|NCT00996840|75845879|FG002|Overall Study|Adverse Event|0|||
42037528|NCT00996840|75845880|FG003|Overall Study|Adverse Event|0|||
42037529|NCT00996840|75845881|FG004|Overall Study|Adverse Event|0|||
42037530|NCT00996840|75845877|FG000|Overall Study|Physician Decision|0|||
42037531|NCT00996840|75845878|FG001|Overall Study|Physician Decision|0|||
42037532|NCT00996840|75845879|FG002|Overall Study|Physician Decision|1|||
42037533|NCT00996840|75845880|FG003|Overall Study|Physician Decision|1|||
42139268|NCT00422058|75949480|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
42275711|NCT02456636|76106902|FG001|Overall Study|Lost to Follow-up|44|||
42275712|NCT02456636|76106903|FG002|Overall Study|Lost to Follow-up|50|||
42275713|NCT02226172|76106911|FG000|Overall Study|Participant refused further follow-up|4|||
42275714|NCT02226172|76106911|FG000|Overall Study|Other|5|||
42275715|NCT02226172|76106911|FG000|Overall Study|Death|1|||
42037534|NCT00996840|75845881|FG004|Overall Study|Physician Decision|2|||
42037535|NCT00996840|75845877|FG000|Overall Study|Withdrawal by Subject|1|||
42037536|NCT00996840|75845878|FG001|Overall Study|Withdrawal by Subject|1|||
42037537|NCT00996840|75845879|FG002|Overall Study|Withdrawal by Subject|0|||
42037538|NCT00996840|75845880|FG003|Overall Study|Withdrawal by Subject|0|||
42275716|NCT02226172|76106911|FG000|Overall Study|Study terminated by sponsor|1|||
42275717|NCT02226172|76106911|FG000|Overall Study|Adverse Event|6|||
42275718|NCT01676961|76106915|FG000|Overall Study|Death|3|||
42275719|NCT01676961|76106915|FG000|Overall Study|Lost to Follow-up|1|||
42275720|NCT01676961|76106915|FG000|Overall Study|Withdrawal by Subject|1|||
42275721|NCT01676727|76106937|FG000|Overall Study|Death|18|||
42275722|NCT01676727|76106937|FG000|Overall Study|Withdrawal by Subject|6|||
42275723|NCT01676727|76106937|FG000|Overall Study|Screening failure|5|||
42037539|NCT00996840|75845881|FG004|Overall Study|Withdrawal by Subject|0|||
42037540|NCT00998946|75845897|FG000|Overall Study|Lost to Follow-up|1|||
42037541|NCT00998946|75845897|FG000|Overall Study|Withdrawal by Subject|1|||
42037542|NCT00998946|75845897|FG000|Overall Study|Death|2|||
42037543|NCT00998946|75845897|FG000|Overall Study|Reason Unspecified|3|||
42037544|NCT00998946|75845897|FG000|Overall Study|Enrolled but not Dosed|2|||
42037545|NCT01158404|75845909|FG000|Overall Study|Withdrawal by Subject|0|||
42037546|NCT01158404|75845910|FG001|Overall Study|Withdrawal by Subject|1|||
42037547|NCT01158404|75845911|FG002|Overall Study|Withdrawal by Subject|0|||
42037548|NCT01158404|75845912|FG003|Overall Study|Withdrawal by Subject|0|||
42037549|NCT01158404|75845913|FG004|Overall Study|Withdrawal by Subject|3|||
42037550|NCT01158404|75845914|FG005|Overall Study|Withdrawal by Subject|1|||
42037551|NCT01158404|75845915|FG006|Overall Study|Withdrawal by Subject|0|||
42037552|NCT01158404|75845916|FG007|Overall Study|Withdrawal by Subject|1|||
42037553|NCT01158404|75845909|FG000|Overall Study|Physician Decision|0|||
42037554|NCT01158404|75845910|FG001|Overall Study|Physician Decision|0|||
42037555|NCT01158404|75845911|FG002|Overall Study|Physician Decision|0|||
42037556|NCT01158404|75845912|FG003|Overall Study|Physician Decision|0|||
42037557|NCT01158404|75845913|FG004|Overall Study|Physician Decision|0|||
42037558|NCT01158404|75845914|FG005|Overall Study|Physician Decision|0|||
42037559|NCT01158404|75845915|FG006|Overall Study|Physician Decision|0|||
42037560|NCT01158404|75845916|FG007|Overall Study|Physician Decision|1|||
42037561|NCT01158404|75845909|FG000|Overall Study|Progressive Disease|0|||
42037562|NCT01158404|75845910|FG001|Overall Study|Progressive Disease|0|||
42037563|NCT01158404|75845911|FG002|Overall Study|Progressive Disease|0|||
42037564|NCT01158404|75845912|FG003|Overall Study|Progressive Disease|0|||
42037565|NCT01158404|75845913|FG004|Overall Study|Progressive Disease|0|||
42037566|NCT01158404|75845914|FG005|Overall Study|Progressive Disease|0|||
42037567|NCT01158404|75845915|FG006|Overall Study|Progressive Disease|1|||
42037568|NCT01158404|75845916|FG007|Overall Study|Progressive Disease|0|||
42037569|NCT00998790|75845936|FG000|Overall Study|Withdrawal by Subject|21|||
42037570|NCT01001988|75845940|FG000|Overall Study|Protocol Violation|84|||
42037571|NCT01001988|75845940|FG000|Overall Study|Withdrawal by Subject|18|||
42037572|NCT01001988|75845940|FG000|Overall Study|Lost to Follow-up|15|||
42037573|NCT00996606|75845944|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
42037574|NCT00996606|75845944|FG000|Overall Study|Insufficient Therapeutic Response|2|||
42037575|NCT00996606|75845944|FG000|Overall Study|Protocol Violation|1|||
42037576|NCT00996606|75845944|FG000|Overall Study|Withdrawal by Subject|3|||
42037577|NCT00995436|75845951|FG000|Overall Study|Withdrawal by Subject|2|||
42037578|NCT00995436|75845952|FG001|Overall Study|Withdrawal by Subject|5|||
42037579|NCT00995436|75845953|FG002|Overall Study|Withdrawal by Subject|0|||
42037580|NCT00994890|75845964|FG000|Overall Study|Adverse Event|13|||
42037581|NCT00994890|75845965|FG001|Overall Study|Adverse Event|9|||
42037582|NCT00994890|75845966|FG002|Overall Study|Adverse Event|11|||
42037583|NCT00994890|75845964|FG000|Overall Study|Lack of Efficacy|0|||
42037584|NCT00994890|75845965|FG001|Overall Study|Lack of Efficacy|0|||
42037585|NCT00994890|75845966|FG002|Overall Study|Lack of Efficacy|1|||
42037586|NCT00994890|75845964|FG000|Overall Study|Lost to Follow-up|6|||
42037587|NCT00994890|75845965|FG001|Overall Study|Lost to Follow-up|1|||
42037588|NCT00994890|75845966|FG002|Overall Study|Lost to Follow-up|3|||
42037589|NCT00994890|75845964|FG000|Overall Study|No longer willing to participate|8|||
42037590|NCT00994890|75845965|FG001|Overall Study|No longer willing to participate|5|||
42037591|NCT00994890|75845966|FG002|Overall Study|No longer willing to participate|13|||
42037592|NCT00994890|75845964|FG000|Overall Study|Protocol Violation|2|||
42037593|NCT00994890|75845965|FG001|Overall Study|Protocol Violation|4|||
42037594|NCT00994890|75845966|FG002|Overall Study|Protocol Violation|0|||
42037595|NCT00994890|75845964|FG000|Overall Study|Study terminated by sponsor|199|||
42037596|NCT00994890|75845965|FG001|Overall Study|Study terminated by sponsor|201|||
42037597|NCT00994890|75845966|FG002|Overall Study|Study terminated by sponsor|197|||
42037598|NCT00994890|75845964|FG000|Overall Study|Randomized, but not treated|1|||
42037599|NCT00994890|75845965|FG001|Overall Study|Randomized, but not treated|0|||
42037600|NCT00994890|75845966|FG002|Overall Study|Randomized, but not treated|0|||
42350544|NCT01550757|76190352|FG000|Overall Study|Withdrawal by Subject|2|||
42350545|NCT01550757|76190353|FG001|Overall Study|Withdrawal by Subject|0|||
42350546|NCT01550757|76190354|FG002|Overall Study|Withdrawal by Subject|3|||
42350547|NCT01550757|76190355|FG003|Overall Study|Withdrawal by Subject|1|||
42350548|NCT01685073|76190367|FG000|Overall Study|Lost to Follow-up|6|||
42350549|NCT01685073|76190368|FG001|Overall Study|Lost to Follow-up|8|||
42350550|NCT01685073|76190367|FG000|Overall Study|Withdrawal by Subject|24|||
42350551|NCT01685073|76190368|FG001|Overall Study|Withdrawal by Subject|24|||
42350552|NCT01572909|76190376|FG000|Overall Study|Adverse Event|7|||
42350553|NCT01572909|76190377|FG001|Overall Study|Adverse Event|2|||
42350554|NCT01572909|76190376|FG000|Overall Study|Death|3|||
42350555|NCT01572909|76190377|FG001|Overall Study|Death|1|||
42350556|NCT01572909|76190376|FG000|Overall Study|Lost to Follow-up|8|||
42350557|NCT01572909|76190377|FG001|Overall Study|Lost to Follow-up|7|||
42350558|NCT01572909|76190376|FG000|Overall Study|Physician Decision|1|||
42350559|NCT01572909|76190377|FG001|Overall Study|Physician Decision|1|||
42350560|NCT01572909|76190376|FG000|Overall Study|Technical Issues|1|||
42350561|NCT01572909|76190377|FG001|Overall Study|Technical Issues|0|||
42350562|NCT01572909|76190376|FG000|Overall Study|Withdrawal by Subject|12|||
42350563|NCT01572909|76190377|FG001|Overall Study|Withdrawal by Subject|11|||
42350564|NCT01572909|76190376|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
42350565|NCT01572909|76190377|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
42350566|NCT01572675|76190387|FG000|Overall Study|End of prescribed treatment|140|||
42350567|NCT01572675|76190388|FG001|Overall Study|End of prescribed treatment|118|||
42037601|NCT00994890|75845964|FG000|Overall Study|Other|2|||
42350568|NCT01572675|76190387|FG000|Overall Study|Recovery|16|||
42350569|NCT01572675|76190388|FG001|Overall Study|Recovery|23|||
42037602|NCT00994890|75845965|FG001|Overall Study|Other|2|||
42037603|NCT00994890|75845966|FG002|Overall Study|Other|1|||
42037604|NCT00994422|75845976|FG000|Overall Study|Lost to Follow-up|7|||
42037605|NCT00994422|75845977|FG001|Overall Study|Lost to Follow-up|1|||
42037606|NCT01171976|75845988|FG000|Overall Study|Protocol Violation|0|||
42037607|NCT01171976|75845989|FG001|Overall Study|Protocol Violation|0|||
42037608|NCT01171976|75845990|FG002|Overall Study|Protocol Violation|1|||
42139269|NCT00422058|75949481|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
42139270|NCT00422058|75949476|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
42139271|NCT00422058|75949477|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
42139272|NCT00422058|75949478|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
42139273|NCT00422058|75949479|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
42139274|NCT00422058|75949480|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
42139275|NCT00422058|75949481|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
42139276|NCT00422058|75949476|FG000|Open-Label Extension, Week 20-104|Other|13|||
42139277|NCT00422058|75949477|FG001|Open-Label Extension, Week 20-104|Other|14|||
42139278|NCT00422058|75949478|FG002|Open-Label Extension, Week 20-104|Other|6|||
42275724|NCT01676727|76106937|FG000|Overall Study|Not willing to attend 1-year visit|2|||
42275725|NCT01676727|76106937|FG000|Overall Study|Valve explanted|1|||
42275726|NCT02738879|76106944|FG000|Overall Study|Adverse Event|1|||
42275727|NCT02738879|76106945|FG001|Overall Study|Adverse Event|1|||
42275728|NCT02738879|76106944|FG000|Overall Study|Death|0|||
42275729|NCT02738879|76106945|FG001|Overall Study|Death|2|||
42275730|NCT02738879|76106944|FG000|Overall Study|Lost to Follow-up|1|||
42275731|NCT02738879|76106945|FG001|Overall Study|Lost to Follow-up|5|||
42275732|NCT02738879|76106944|FG000|Overall Study|Protocol Violation|1|||
42275733|NCT02738879|76106945|FG001|Overall Study|Protocol Violation|3|||
42275734|NCT02738879|76106944|FG000|Overall Study|Physician Decision|3|||
42350570|NCT01572675|76190387|FG000|Overall Study|Lack of Efficacy|31|||
42350571|NCT01572675|76190388|FG001|Overall Study|Lack of Efficacy|31|||
42350572|NCT01572675|76190387|FG000|Overall Study|Intolerance|6|||
42350573|NCT01572675|76190388|FG001|Overall Study|Intolerance|5|||
42350574|NCT01572675|76190387|FG000|Overall Study|Improved symptoms|8|||
42350575|NCT01572675|76190388|FG001|Overall Study|Improved symptoms|2|||
42350576|NCT01572675|76190387|FG000|Overall Study|Surgical intervention|3|||
42037609|NCT01171976|75845988|FG000|Overall Study|Death|2|||
42037610|NCT01171976|75845989|FG001|Overall Study|Death|4|||
42037611|NCT01171976|75845990|FG002|Overall Study|Death|1|||
42139279|NCT00422058|75949479|FG003|Open-Label Extension, Week 20-104|Other|13|||
42139280|NCT00422058|75949480|FG004|Open-Label Extension, Week 20-104|Other|16|||
42139281|NCT00422058|75949481|FG005|Open-Label Extension, Week 20-104|Other|18|||
42139282|NCT00413244|75949505|FG000|Overall Study|Withdrawal by Subject|10|||
42139283|NCT00413244|75949506|FG001|Overall Study|Withdrawal by Subject|1|||
42139284|NCT00420420|75949534|FG000|Overall Study|Adverse Event|5|||
42139285|NCT00420420|75949535|FG001|Overall Study|Adverse Event|3|||
42139286|NCT00420420|75949534|FG000|Overall Study|Protocol Violation|1|||
42139287|NCT00420420|75949535|FG001|Overall Study|Protocol Violation|1|||
42139288|NCT00420420|75949534|FG000|Overall Study|Withdrawal by Subject|1|||
42139289|NCT00420420|75949535|FG001|Overall Study|Withdrawal by Subject|0|||
42139290|NCT00420420|75949534|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
42139291|NCT00420420|75949535|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
42139292|NCT00420342|75949544|FG000|Overall Study|Lost to Follow-up|1|||
42139293|NCT00420342|75949545|FG001|Overall Study|Lost to Follow-up|0|||
42139294|NCT00420342|75949546|FG002|Overall Study|Lost to Follow-up|1|||
42139295|NCT00420342|75949544|FG000|Overall Study|Withdrawal by Subject|0|||
42139296|NCT00420342|75949545|FG001|Overall Study|Withdrawal by Subject|2|||
42139297|NCT00420342|75949546|FG002|Overall Study|Withdrawal by Subject|0|||
42139298|NCT00432744|75949556|FG000|Months 0-6|Withdrawal by Subject|4|||
42139299|NCT00432744|75949557|FG001|Months 0-6|Withdrawal by Subject|4|||
42139300|NCT00432744|75949556|FG000|Months 0-6|Too disabled to score|1|||
42139301|NCT00432744|75949557|FG001|Months 0-6|Too disabled to score|0|||
42139302|NCT00432744|75949556|FG000|Months 7 - 12|Withdrawal by Subject|1|||
42139303|NCT00432744|75949557|FG001|Months 7 - 12|Withdrawal by Subject|0|||
42139304|NCT00432744|75949556|FG000|Months 7 - 12|Too disabled to score|0|||
42139305|NCT00432744|75949557|FG001|Months 7 - 12|Too disabled to score|1|||
42139306|NCT00432666|75949565|FG000|Main Period|Adverse Event|1|||
42139307|NCT00432666|75949566|FG001|Main Period|Adverse Event|1|||
42139308|NCT00432666|75949565|FG000|Main Period|Consent Withdrawn|1|||
42139309|NCT00432666|75949566|FG001|Main Period|Consent Withdrawn|0|||
42139310|NCT00432666|75949565|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
42139311|NCT00432666|75949566|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
42139312|NCT00432666|75949565|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
42139313|NCT00432666|75949566|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
42139314|NCT00432666|75949565|FG000|Open-Label Extension Period|Adverse Event|5|||
42139315|NCT00432666|75949566|FG001|Open-Label Extension Period|Adverse Event|0|||
42139316|NCT00432666|75949565|FG000|Open-Label Extension Period|Consent withdrawn|10|||
42139317|NCT00432666|75949566|FG001|Open-Label Extension Period|Consent withdrawn|0|||
42139318|NCT00432666|75949565|FG000|Open-Label Extension Period|Physician Decision|3|||
42139319|NCT00432666|75949566|FG001|Open-Label Extension Period|Physician Decision|0|||
42139320|NCT00451958|75949576|FG000|CS21A (NCT00451958)|Adverse Event|21|||
42139321|NCT00451958|75949577|FG001|CS21A (NCT00451958)|Adverse Event|34|||
42139322|NCT00451958|75949578|FG002|CS21A (NCT00451958)|Adverse Event|14|||
42139323|NCT00451958|75949579|FG003|CS21A (NCT00451958)|Adverse Event|17|||
42139324|NCT00451958|75949580|FG004|CS21A (NCT00451958)|Adverse Event|0|||
42139325|NCT00451958|75949576|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
42139326|NCT00451958|75949577|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
42139327|NCT00451958|75949578|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
42139328|NCT00451958|75949579|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
42139329|NCT00451958|75949580|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
42139330|NCT00451958|75949576|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
42139331|NCT00451958|75949577|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
42139332|NCT00451958|75949578|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
42139333|NCT00451958|75949579|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
42139334|NCT00451958|75949580|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
42139335|NCT00451958|75949576|FG000|CS21A (NCT00451958)|Physician Decision|2|||
42139336|NCT00451958|75949577|FG001|CS21A (NCT00451958)|Physician Decision|4|||
42139337|NCT00451958|75949578|FG002|CS21A (NCT00451958)|Physician Decision|4|||
42139338|NCT00451958|75949579|FG003|CS21A (NCT00451958)|Physician Decision|4|||
42139339|NCT00451958|75949580|FG004|CS21A (NCT00451958)|Physician Decision|0|||
42139340|NCT00451958|75949576|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
42275735|NCT02738879|76106945|FG001|Overall Study|Physician Decision|4|||
42139341|NCT00451958|75949577|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
42139342|NCT00451958|75949578|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
42139343|NCT00451958|75949579|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
42139344|NCT00451958|75949580|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
42139345|NCT00451958|75949576|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
42139346|NCT00451958|75949577|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
42139347|NCT00451958|75949578|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
42139348|NCT00451958|75949579|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
42275736|NCT02738879|76106944|FG000|Overall Study|Pregnancy|0|||
42139349|NCT00451958|75949580|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
42139350|NCT00432276|75949596|FG000|Overall Study|Hyperglycemic Rescue|44|||
42139351|NCT00432276|75949597|FG001|Overall Study|Hyperglycemic Rescue|87|||
42139352|NCT00432276|75949596|FG000|Overall Study|Adverse Event|13|||
42139353|NCT00432276|75949597|FG001|Overall Study|Adverse Event|16|||
42139354|NCT00432276|75949596|FG000|Overall Study|Protocol Violation|25|||
42139355|NCT00432276|75949597|FG001|Overall Study|Protocol Violation|20|||
42139356|NCT00432276|75949596|FG000|Overall Study|Lost to Follow-up|6|||
42139357|NCT00432276|75949597|FG001|Overall Study|Lost to Follow-up|2|||
42139358|NCT00432276|75949596|FG000|Overall Study|Withdrawal by Subject|25|||
42139359|NCT00432276|75949597|FG001|Overall Study|Withdrawal by Subject|20|||
42139360|NCT00432276|75949596|FG000|Overall Study|Physician Decision|6|||
42139361|NCT00432276|75949597|FG001|Overall Study|Physician Decision|8|||
42139362|NCT00432276|75949596|FG000|Overall Study|Other|2|||
42139363|NCT00432276|75949597|FG001|Overall Study|Other|3|||
42139364|NCT00413010|75949605|FG000|Overall Study|Adverse Event|8|||
42139365|NCT00413010|75949606|FG001|Overall Study|Adverse Event|4|||
42139366|NCT00413010|75949605|FG000|Overall Study|Laboratory abnormality|0|||
42139367|NCT00413010|75949606|FG001|Overall Study|Laboratory abnormality|2|||
42139368|NCT00413010|75949605|FG000|Overall Study|Lack of Efficacy|0|||
42139369|NCT00413010|75949606|FG001|Overall Study|Lack of Efficacy|3|||
42139370|NCT00413010|75949605|FG000|Overall Study|Lost to Follow-up|3|||
42139371|NCT00413010|75949606|FG001|Overall Study|Lost to Follow-up|0|||
42139372|NCT00413010|75949605|FG000|Overall Study|Withdrawal by Subject|7|||
42139373|NCT00413010|75949606|FG001|Overall Study|Withdrawal by Subject|2|||
42139374|NCT00413010|75949605|FG000|Overall Study|Due to termination of the study|54|||
42139375|NCT00413010|75949606|FG001|Overall Study|Due to termination of the study|52|||
42139376|NCT00459290|75949612|FG000|Overall Study|Adverse Event|3|||
42139377|NCT00459290|75949612|FG000|Overall Study|Ineligible|2|||
42139378|NCT00443534|75949623|FG000|Overall Study|Lack of Efficacy|67|||
42139379|NCT00443534|75949623|FG000|Overall Study|Adverse Event|16|||
42139380|NCT00443534|75949623|FG000|Overall Study|Death|9|||
42139381|NCT00443534|75949623|FG000|Overall Study|Withdrawal by Subject|8|||
42139382|NCT00443534|75949623|FG000|Overall Study|Study Terminated by Sponsor|12|||
42139383|NCT00443534|75949623|FG000|Overall Study|Other|10|||
42139384|NCT00443534|75949623|FG000|Overall Study|Enrolled, Not Treated|1|||
42139385|NCT00419952|75949629|FG000|Overall Study|Adverse Event|8|||
42139386|NCT00419952|75949630|FG001|Overall Study|Adverse Event|10|||
42139387|NCT00419952|75949629|FG000|Overall Study|Withdrawal by Subject|44|||
42139388|NCT00419952|75949630|FG001|Overall Study|Withdrawal by Subject|43|||
42139389|NCT00419952|75949629|FG000|Overall Study|Lost to Follow-up|43|||
42139390|NCT00419952|75949630|FG001|Overall Study|Lost to Follow-up|34|||
42139391|NCT00419952|75949629|FG000|Overall Study|Protocol Violation|32|||
42139392|NCT00419952|75949630|FG001|Overall Study|Protocol Violation|24|||
42139393|NCT00419952|75949629|FG000|Overall Study|Pregnancy|4|||
42139394|NCT00419952|75949630|FG001|Overall Study|Pregnancy|2|||
42139395|NCT00419952|75949629|FG000|Overall Study|Physician Decision|1|||
42139396|NCT00419952|75949630|FG001|Overall Study|Physician Decision|3|||
42139397|NCT00419952|75949629|FG000|Overall Study|Incorrectly enrolled|10|||
42139398|NCT00419952|75949630|FG001|Overall Study|Incorrectly enrolled|3|||
42139399|NCT00419952|75949629|FG000|Overall Study|Intake of prohibited medication|2|||
42139400|NCT00419952|75949630|FG001|Overall Study|Intake of prohibited medication|2|||
42139401|NCT00419952|75949629|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
42139402|NCT00419952|75949630|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
42139403|NCT00419952|75949629|FG000|Overall Study|Diary or medication non-compliance|2|||
42139404|NCT00419952|75949630|FG001|Overall Study|Diary or medication non-compliance|4|||
42275737|NCT02738879|76106945|FG001|Overall Study|Pregnancy|1|||
42139405|NCT00419952|75949629|FG000|Overall Study|Abnormal ECG|1|||
42275738|NCT02738879|76106944|FG000|Overall Study|Screen Failure|1|||
42139406|NCT00419952|75949630|FG001|Overall Study|Abnormal ECG|0|||
42139407|NCT00443456|75949636|FG000|Overall Study|Adverse Event|16|||
42139408|NCT00443456|75949636|FG000|Overall Study|Move|1|||
42139409|NCT00443456|75949636|FG000|Overall Study|Withdrawal by Subject|1|||
42139410|NCT00419562|75949646|FG000|Overall Study|Lost to Follow-up|12|||
42139411|NCT00419562|75949647|FG001|Overall Study|Lost to Follow-up|13|||
42139412|NCT00419562|75949646|FG000|Overall Study|Withdrawal by Subject|20|||
42139413|NCT00419562|75949647|FG001|Overall Study|Withdrawal by Subject|18|||
42139414|NCT00419562|75949646|FG000|Overall Study|Participant Institutionalized|1|||
42350577|NCT01572675|76190388|FG001|Overall Study|Surgical intervention|6|||
42350578|NCT01572675|76190387|FG000|Overall Study|Withdrawal by Subject|5|||
42350579|NCT01572675|76190388|FG001|Overall Study|Withdrawal by Subject|1|||
42350580|NCT01572675|76190387|FG000|Overall Study|Physician Decision|2|||
42350581|NCT01572675|76190388|FG001|Overall Study|Physician Decision|2|||
42350582|NCT01572675|76190387|FG000|Overall Study|Death unrelated to coxibs|1|||
42350583|NCT01572675|76190388|FG001|Overall Study|Death unrelated to coxibs|1|||
42350584|NCT01572675|76190387|FG000|Overall Study|Other disease detected|1|||
42350585|NCT01572675|76190388|FG001|Overall Study|Other disease detected|1|||
42350586|NCT01572675|76190387|FG000|Overall Study|Unknown reason|1|||
42350587|NCT01572675|76190388|FG001|Overall Study|Unknown reason|1|||
42350588|NCT01572675|76190387|FG000|Overall Study|Rheumatologist new evaluation|0|||
42350589|NCT01572675|76190388|FG001|Overall Study|Rheumatologist new evaluation|1|||
42350590|NCT01572675|76190387|FG000|Overall Study|Missing data|1|||
42350591|NCT01572675|76190388|FG001|Overall Study|Missing data|4|||
42350592|NCT01572675|76190387|FG000|Overall Study|Lost to Follow-up|22|||
42350593|NCT01572675|76190388|FG001|Overall Study|Lost to Follow-up|27|||
42350594|NCT05065983|76190407|FG000|Overall Study|Lost to Follow-up|2|||
42350595|NCT04797650|76190414|FG000|Overall Study|Reason Not Specified|5|||
42011590|NCT01211613|75818633|FG001|Overall Study|Lost to Follow-up|2|||
42011591|NCT01211613|75818634|FG002|Overall Study|Lost to Follow-up|2|||
42011592|NCT01211613|75818632|FG000|Overall Study|Withdrawal by Subject|1|||
42139415|NCT00419562|75949647|FG001|Overall Study|Participant Institutionalized|0|||
42275739|NCT02738879|76106945|FG001|Overall Study|Screen Failure|2|||
42275740|NCT02738879|76106944|FG000|Overall Study|Site Discontinued Study Participation|1|||
42275741|NCT02738879|76106945|FG001|Overall Study|Site Discontinued Study Participation|0|||
42275742|NCT02738879|76106944|FG000|Overall Study|Withdrawal by Subject|5|||
42275743|NCT02738879|76106945|FG001|Overall Study|Withdrawal by Subject|7|||
42275744|NCT03502811|76106951|FG000|Overall Study|Death|157|||
42275745|NCT03502811|76106951|FG000|Overall Study|Withdrawal by Subject|105|||
42275746|NCT03502811|76106951|FG000|Overall Study|Lost to Follow-up|26|||
42275747|NCT03502811|76106951|FG000|Overall Study|No Visits (Missed)|31|||
42011593|NCT01211613|75818633|FG001|Overall Study|Withdrawal by Subject|0|||
42011594|NCT01211613|75818634|FG002|Overall Study|Withdrawal by Subject|0|||
42011595|NCT01211535|75818644|FG000|Overall Study|Adverse Event|0|||
42011596|NCT01211535|75818645|FG001|Overall Study|Adverse Event|1|||
42011597|NCT01011556|75818655|FG000|Overall Study|Adverse Event|1|||
42011598|NCT01011556|75818656|FG001|Overall Study|Adverse Event|3|||
42011599|NCT01011556|75818657|FG002|Overall Study|Adverse Event|2|||
42011600|NCT01011556|75818658|FG003|Overall Study|Adverse Event|1|||
42011601|NCT01011556|75818655|FG000|Overall Study|Lost to Follow-up|1|||
42011602|NCT01011556|75818656|FG001|Overall Study|Lost to Follow-up|0|||
42011603|NCT01011556|75818657|FG002|Overall Study|Lost to Follow-up|0|||
42011604|NCT01011556|75818658|FG003|Overall Study|Lost to Follow-up|0|||
42011605|NCT01011556|75818655|FG000|Overall Study|Physician Decision|1|||
42011606|NCT01011556|75818656|FG001|Overall Study|Physician Decision|0|||
42011607|NCT01011556|75818657|FG002|Overall Study|Physician Decision|0|||
42011608|NCT01011556|75818658|FG003|Overall Study|Physician Decision|1|||
42011609|NCT01011556|75818655|FG000|Overall Study|Protocol Violation|0|||
42011610|NCT01011556|75818656|FG001|Overall Study|Protocol Violation|1|||
42011611|NCT01011556|75818657|FG002|Overall Study|Protocol Violation|0|||
42011612|NCT01011556|75818658|FG003|Overall Study|Protocol Violation|0|||
42011613|NCT01011556|75818655|FG000|Overall Study|Withdrawal by Subject|1|||
42011614|NCT01011556|75818656|FG001|Overall Study|Withdrawal by Subject|2|||
42011615|NCT01011556|75818657|FG002|Overall Study|Withdrawal by Subject|4|||
42011616|NCT01011556|75818658|FG003|Overall Study|Withdrawal by Subject|4|||
42011617|NCT01011556|75818655|FG000|Overall Study|Sponsor decision|0|||
42011618|NCT01011556|75818656|FG001|Overall Study|Sponsor decision|1|||
42011619|NCT01011556|75818657|FG002|Overall Study|Sponsor decision|1|||
42011620|NCT01011556|75818658|FG003|Overall Study|Sponsor decision|2|||
42011621|NCT01011556|75818655|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
42011622|NCT01011556|75818656|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
42011623|NCT01011556|75818657|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
42011624|NCT01011556|75818658|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
42011625|NCT01211145|75818675|FG000|Overall Study|Reason not specified|3|||
42350596|NCT04797650|76190415|FG001|Overall Study|Reason Not Specified|12|||
42011626|NCT01211145|75818676|FG001|Overall Study|Reason not specified|2|||
42011627|NCT01211145|75818677|FG002|Overall Study|Reason not specified|2|||
42011628|NCT01211145|75818678|FG003|Overall Study|Reason not specified|1|||
42011629|NCT01211145|75818675|FG000|Overall Study|Lost to Follow-up|3|||
42350597|NCT04797650|76190416|FG002|Overall Study|Reason Not Specified|5|||
42350598|NCT04797650|76190414|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
42350599|NCT04797650|76190415|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
42011630|NCT01211145|75818676|FG001|Overall Study|Lost to Follow-up|2|||
42350600|NCT04797650|76190416|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
42139416|NCT00432042|75949656|FG000|Overall Study|Protocol Violation|2|||
42139417|NCT00432042|75949657|FG001|Overall Study|Protocol Violation|0|||
42139418|NCT00432042|75949658|FG002|Overall Study|Protocol Violation|0|||
42139419|NCT00432042|75949656|FG000|Overall Study|Withdrawal by Subject|0|||
42139420|NCT00432042|75949657|FG001|Overall Study|Withdrawal by Subject|0|||
42139421|NCT00432042|75949658|FG002|Overall Study|Withdrawal by Subject|2|||
42139422|NCT00432042|75949656|FG000|Overall Study|Lost to Follow-up|5|||
42139423|NCT00432042|75949657|FG001|Overall Study|Lost to Follow-up|1|||
42350601|NCT04797650|76190414|FG000|Overall Study|Lack of Efficacy|1|||
42350602|NCT04797650|76190415|FG001|Overall Study|Lack of Efficacy|0|||
42350603|NCT04797650|76190416|FG002|Overall Study|Lack of Efficacy|1|||
42350604|NCT04797650|76190414|FG000|Overall Study|Non-compliance with Study Drug|0|||
42350605|NCT04797650|76190415|FG001|Overall Study|Non-compliance with Study Drug|0|||
42350606|NCT04797650|76190416|FG002|Overall Study|Non-compliance with Study Drug|2|||
42350607|NCT04797650|76190414|FG000|Overall Study|Lost to Follow-up|4|||
42350608|NCT04797650|76190415|FG001|Overall Study|Lost to Follow-up|6|||
42350609|NCT04797650|76190416|FG002|Overall Study|Lost to Follow-up|1|||
42350610|NCT04705597|76190428|FG000|Overall Study|Death|16|||
42350611|NCT04705597|76190429|FG001|Overall Study|Death|9|||
42350612|NCT04705597|76190428|FG000|Overall Study|Lost to Follow-up|1|||
42350613|NCT04705597|76190429|FG001|Overall Study|Lost to Follow-up|0|||
42350614|NCT04705597|76190428|FG000|Overall Study|Withdrawal by Subject|1|||
42350615|NCT04705597|76190429|FG001|Overall Study|Withdrawal by Subject|2|||
42350616|NCT04534114|76190439|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
42350617|NCT04534114|76190440|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
42350618|NCT04534114|76190441|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
42350619|NCT04534114|76190442|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
42350620|NCT04534114|76190439|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
42350621|NCT04534114|76190440|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
42350622|NCT04534114|76190441|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
42350623|NCT04534114|76190442|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
42350624|NCT04534114|76190439|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
42350625|NCT04534114|76190440|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
42350626|NCT04534114|76190441|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
42350627|NCT04534114|76190442|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
42350628|NCT04534114|76190439|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
42350629|NCT04534114|76190440|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
42350630|NCT04534114|76190441|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
42350631|NCT04534114|76190442|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
42011631|NCT01211145|75818677|FG002|Overall Study|Lost to Follow-up|1|||
42011632|NCT01211145|75818678|FG003|Overall Study|Lost to Follow-up|2|||
42139424|NCT00432042|75949658|FG002|Overall Study|Lost to Follow-up|0|||
42139425|NCT00308139|75949668|FG000|Overall Study|Adverse Event|20|||
42139426|NCT00308139|75949669|FG001|Overall Study|Adverse Event|14|||
42139427|NCT00308139|75949668|FG000|Overall Study|Lost to Follow-up|13|||
42139428|NCT00308139|75949669|FG001|Overall Study|Lost to Follow-up|8|||
42139429|NCT00308139|75949668|FG000|Overall Study|Protocol Violation|3|||
42139430|NCT00308139|75949669|FG001|Overall Study|Protocol Violation|2|||
42139431|NCT00308139|75949668|FG000|Overall Study|Withdrawal of Consent|40|||
42139432|NCT00308139|75949669|FG001|Overall Study|Withdrawal of Consent|42|||
42011633|NCT01211145|75818675|FG000|Overall Study|Study-specific withdrawal criteria|1|||
42011634|NCT01211145|75818676|FG001|Overall Study|Study-specific withdrawal criteria|0|||
42011635|NCT01211145|75818677|FG002|Overall Study|Study-specific withdrawal criteria|0|||
42011636|NCT01211145|75818678|FG003|Overall Study|Study-specific withdrawal criteria|0|||
42011637|NCT01211145|75818675|FG000|Overall Study|Severe noncompliance to protocol|1|||
42011638|NCT01211145|75818676|FG001|Overall Study|Severe noncompliance to protocol|0|||
42011639|NCT01211145|75818677|FG002|Overall Study|Severe noncompliance to protocol|0|||
42011640|NCT01211145|75818678|FG003|Overall Study|Severe noncompliance to protocol|0|||
42011641|NCT01211145|75818675|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
42011642|NCT01211145|75818676|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
42037612|NCT01171976|75845988|FG000|Overall Study|Lost to Follow-up|4|||
42139433|NCT00308139|75949668|FG000|Overall Study|Investigator Decision|11|||
42139434|NCT00308139|75949669|FG001|Overall Study|Investigator Decision|10|||
42139435|NCT00308139|75949668|FG000|Overall Study|Loss of Glucose Control|5|||
42350632|NCT04534114|76190439|FG000|Main Treatment Period|Physician Decision|0|||
42350633|NCT04534114|76190440|FG001|Main Treatment Period|Physician Decision|0|||
42350634|NCT04534114|76190441|FG002|Main Treatment Period|Physician Decision|0|||
42350635|NCT04534114|76190442|FG003|Main Treatment Period|Physician Decision|1|||
42139436|NCT00308139|75949669|FG001|Overall Study|Loss of Glucose Control|7|||
42139437|NCT00308139|75949668|FG000|Overall Study|Administrative|1|||
42139438|NCT00308139|75949669|FG001|Overall Study|Administrative|4|||
42139439|NCT00308139|75949668|FG000|Overall Study|Other|1|||
42139440|NCT00308139|75949669|FG001|Overall Study|Other|0|||
42139441|NCT00459134|75949697|FG000|Overall Study|Physician Decision|1|||
42139442|NCT00459134|75949698|FG001|Overall Study|Physician Decision|1|||
42139443|NCT00459134|75949697|FG000|Overall Study|Withdrawal by Subject|8|||
42139444|NCT00459134|75949698|FG001|Overall Study|Withdrawal by Subject|7|||
42139445|NCT00459134|75949697|FG000|Overall Study|Lost to Follow-up|6|||
42139446|NCT00459134|75949698|FG001|Overall Study|Lost to Follow-up|7|||
42139447|NCT00459134|75949697|FG000|Overall Study|Surgery|1|||
42139448|NCT00459134|75949698|FG001|Overall Study|Surgery|2|||
42139449|NCT00459134|75949697|FG000|Overall Study|Toxicity|4|||
42139450|NCT00459134|75949698|FG001|Overall Study|Toxicity|5|||
42139451|NCT00459134|75949697|FG000|Overall Study|Progression|1|||
42139452|NCT00459134|75949698|FG001|Overall Study|Progression|0|||
42139453|NCT00459134|75949697|FG000|Overall Study|Multiple Reasons|2|||
42139454|NCT00459134|75949698|FG001|Overall Study|Multiple Reasons|3|||
42139455|NCT00459056|75949706|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
42139456|NCT00459056|75949707|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
42139457|NCT00431964|75949715|FG000|Overall Study|Adverse Event|1|||
42139458|NCT00431964|75949716|FG001|Overall Study|Adverse Event|0|||
42139459|NCT00431964|75949715|FG000|Overall Study|Lost to Follow-up|1|||
42139460|NCT00431964|75949716|FG001|Overall Study|Lost to Follow-up|2|||
42139461|NCT00431964|75949715|FG000|Overall Study|Physician Decision|2|||
42139462|NCT00431964|75949716|FG001|Overall Study|Physician Decision|2|||
42139463|NCT00431964|75949715|FG000|Overall Study|Withdrawal by Subject|2|||
42139464|NCT00431964|75949716|FG001|Overall Study|Withdrawal by Subject|1|||
42139465|NCT00431964|75949715|FG000|Overall Study|Parental Consent Withdrawn|0|||
42139466|NCT00431964|75949716|FG001|Overall Study|Parental Consent Withdrawn|2|||
42139467|NCT00431964|75949715|FG000|Overall Study|Due to Unstable Health|0|||
42139468|NCT00431964|75949716|FG001|Overall Study|Due to Unstable Health|1|||
42139469|NCT00412854|75949724|FG000|Overall Study|Withdrawn due to adverse events|1|||
42139470|NCT00412854|75949725|FG001|Overall Study|Withdrawn due to adverse events|5|||
42139471|NCT00412854|75949724|FG000|Overall Study|Withdrawn for other reasons|13|||
42139472|NCT00412854|75949725|FG001|Overall Study|Withdrawn for other reasons|11|||
42139473|NCT00431496|75949731|FG000|Overall Study|Adverse Event|3|||
42139474|NCT00431496|75949731|FG000|Overall Study|Lost to Follow-up|1|||
42139475|NCT00431496|75949731|FG000|Overall Study|Withdrawal by Subject|2|||
42139476|NCT00431496|75949731|FG000|Overall Study|Protocol-specified criteria|5|||
42139477|NCT00316173|75949737|FG000|Run-in Phase|Adverse Event|1|||
42139478|NCT00316173|75949738|FG001|Run-in Phase|Adverse Event|0|||
42139479|NCT00316173|75949737|FG000|Run-in Phase|Protocol Violation|1|||
42139480|NCT00316173|75949738|FG001|Run-in Phase|Protocol Violation|0|||
42139481|NCT00316173|75949737|FG000|Run-in Phase|Study Follow-up Stopped|5|||
42139482|NCT00316173|75949738|FG001|Run-in Phase|Study Follow-up Stopped|0|||
42139483|NCT00316173|75949737|FG000|Treatment Phase|Adverse Event|0|||
42139484|NCT00316173|75949738|FG001|Treatment Phase|Adverse Event|1|||
42139485|NCT00316173|75949737|FG000|Treatment Phase|Lack of Efficacy|0|||
42139486|NCT00316173|75949738|FG001|Treatment Phase|Lack of Efficacy|3|||
42139487|NCT00316173|75949737|FG000|Treatment Phase|Lost to Follow-up|0|||
42139488|NCT00316173|75949738|FG001|Treatment Phase|Lost to Follow-up|3|||
42139489|NCT00316173|75949737|FG000|Treatment Phase|Withdrawal by Subject|0|||
42139490|NCT00316173|75949738|FG001|Treatment Phase|Withdrawal by Subject|1|||
42139491|NCT00316173|75949737|FG000|Treatment Phase|Study Follow-up Stopped|0|||
42139492|NCT00316173|75949738|FG001|Treatment Phase|Study Follow-up Stopped|34|||
42275748|NCT00515671|76106963|FG000|Overall Study|Lost to Follow-up|13|||
42037613|NCT01171976|75845989|FG001|Overall Study|Lost to Follow-up|0|||
42037614|NCT01171976|75845990|FG002|Overall Study|Lost to Follow-up|2|||
42037615|NCT01171976|75845988|FG000|Overall Study|Withdrawal by Subject|1|||
42037616|NCT01171976|75845989|FG001|Overall Study|Withdrawal by Subject|5|||
42037617|NCT01171976|75845990|FG002|Overall Study|Withdrawal by Subject|6|||
42037618|NCT01171976|75845988|FG000|Overall Study|Abnormal test result|1|||
42037619|NCT01171976|75845989|FG001|Overall Study|Abnormal test result|0|||
42037620|NCT01171976|75845990|FG002|Overall Study|Abnormal test result|0|||
42037621|NCT01171976|75845988|FG000|Overall Study|Adverse Event|6|||
42037622|NCT01171976|75845989|FG001|Overall Study|Adverse Event|2|||
42037623|NCT01171976|75845990|FG002|Overall Study|Adverse Event|5|||
42037624|NCT00996216|75845998|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
42037625|NCT00996216|75845998|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
42037626|NCT00996216|75845998|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
42037627|NCT00830869|75846015|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
42037628|NCT00830869|75846016|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
42037629|NCT00830869|75846017|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
42037630|NCT00830869|75846018|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
42037631|NCT00830869|75846019|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
42037632|NCT00830869|75846020|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
42037633|NCT00830869|75846021|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
42037634|NCT00830869|75846022|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
42037635|NCT00830869|75846023|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
42037636|NCT00830869|75846024|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
42037637|NCT00830869|75846025|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
42037638|NCT00830869|75846026|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
42037639|NCT00830869|75846015|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
42037640|NCT00830869|75846016|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
42037641|NCT00830869|75846017|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
42037642|NCT00830869|75846018|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
42037643|NCT00830869|75846019|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
42037644|NCT00830869|75846020|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
42037645|NCT00830869|75846021|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
42037646|NCT00830869|75846022|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
42037647|NCT00830869|75846023|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
42037648|NCT00830869|75846024|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
42037649|NCT00830869|75846025|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
42037650|NCT00830869|75846026|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
42037651|NCT00830869|75846015|FG000|Period 1: Part 1|Adverse Event|0|||
42037652|NCT00830869|75846016|FG001|Period 1: Part 1|Adverse Event|0|||
42037653|NCT00830869|75846017|FG002|Period 1: Part 1|Adverse Event|0|||
42037654|NCT00830869|75846018|FG003|Period 1: Part 1|Adverse Event|0|||
42037655|NCT00830869|75846019|FG004|Period 1: Part 1|Adverse Event|0|||
42037656|NCT00830869|75846020|FG005|Period 1: Part 1|Adverse Event|1|||
42037657|NCT00830869|75846021|FG006|Period 1: Part 1|Adverse Event|1|||
42037658|NCT00830869|75846022|FG007|Period 1: Part 1|Adverse Event|0|||
42037659|NCT00830869|75846023|FG008|Period 1: Part 1|Adverse Event|0|||
42037660|NCT00830869|75846024|FG009|Period 1: Part 1|Adverse Event|0|||
42037661|NCT00830869|75846025|FG010|Period 1: Part 1|Adverse Event|0|||
42037662|NCT00830869|75846026|FG011|Period 1: Part 1|Adverse Event|0|||
42037663|NCT00830869|75846015|FG000|Period 1: Part 1|Progressive disease|1|||
42037664|NCT00830869|75846016|FG001|Period 1: Part 1|Progressive disease|0|||
42037665|NCT00830869|75846017|FG002|Period 1: Part 1|Progressive disease|1|||
42037666|NCT00830869|75846018|FG003|Period 1: Part 1|Progressive disease|6|||
42037667|NCT00830869|75846019|FG004|Period 1: Part 1|Progressive disease|4|||
42037668|NCT00830869|75846020|FG005|Period 1: Part 1|Progressive disease|4|||
42037669|NCT00830869|75846021|FG006|Period 1: Part 1|Progressive disease|1|||
42275749|NCT00515671|76106964|FG001|Overall Study|Lost to Follow-up|10|||
42275750|NCT00515671|76106963|FG000|Overall Study|Withdrawal by Subject|3|||
42275751|NCT00515671|76106964|FG001|Overall Study|Withdrawal by Subject|5|||
42275752|NCT00515671|76106963|FG000|Overall Study|incarcerated|1|||
42275753|NCT00515671|76106964|FG001|Overall Study|incarcerated|2|||
42275754|NCT01677195|76106973|FG000|Overall Study|Lost to Follow-up|14|||
42275755|NCT01677195|76106974|FG001|Overall Study|Lost to Follow-up|22|||
42037670|NCT00830869|75846022|FG007|Period 1: Part 1|Progressive disease|0|||
42037671|NCT00830869|75846023|FG008|Period 1: Part 1|Progressive disease|0|||
42037672|NCT00830869|75846024|FG009|Period 1: Part 1|Progressive disease|0|||
42037673|NCT00830869|75846025|FG010|Period 1: Part 1|Progressive disease|0|||
42275756|NCT01677195|76106975|FG002|Overall Study|Lost to Follow-up|22|||
42275757|NCT01677195|76106973|FG000|Overall Study|Withdrawal by Subject|1|||
42037674|NCT00830869|75846026|FG011|Period 1: Part 1|Progressive disease|0|||
42037675|NCT00830869|75846015|FG000|Period 2: Part 2|Protocol Violation|0|||
42037676|NCT00830869|75846016|FG001|Period 2: Part 2|Protocol Violation|0|||
42037677|NCT00830869|75846017|FG002|Period 2: Part 2|Protocol Violation|0|||
42275758|NCT01677195|76106974|FG001|Overall Study|Withdrawal by Subject|0|||
42139493|NCT00412542|75949745|FG000|Overall Study|Withdrawal by Subject|0|||
42139494|NCT00412542|75949746|FG001|Overall Study|Withdrawal by Subject|2|||
42139495|NCT00412542|75949745|FG000|Overall Study|Not Eligible|0|||
42139496|NCT00412542|75949746|FG001|Overall Study|Not Eligible|1|||
42139497|NCT00316017|75949753|FG000|Overall Study|Protocol Violation|11|||
42139498|NCT00316017|75949754|FG001|Overall Study|Protocol Violation|13|||
42139499|NCT00316017|75949755|FG002|Overall Study|Protocol Violation|19|||
42139500|NCT00451178|75949765|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
42139501|NCT00451178|75949766|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
42139502|NCT00451178|75949765|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
42139503|NCT00451178|75949766|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
42139504|NCT00451178|75949765|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
42139505|NCT00451178|75949766|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
42139506|NCT00451178|75949765|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
42139507|NCT00451178|75949766|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
42139508|NCT00451178|75949765|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
42139509|NCT00451178|75949766|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
42139510|NCT00451178|75949765|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
42139511|NCT00451178|75949766|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
42139512|NCT00451178|75949765|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
42139513|NCT00451178|75949766|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
42139514|NCT00451178|75949765|FG000|Prior to Maintenance Therapy|PD|2|||
42139515|NCT00451178|75949766|FG001|Prior to Maintenance Therapy|PD|0|||
42139516|NCT00451178|75949765|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
42139517|NCT00451178|75949766|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
42139518|NCT00451178|75949765|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
42139519|NCT00451178|75949766|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
42139520|NCT00451178|75949765|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
42139521|NCT00451178|75949766|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
42275759|NCT01677195|76106975|FG002|Overall Study|Withdrawal by Subject|1|||
42275760|NCT01677195|76106973|FG000|Overall Study|Adverse Event|6|||
42275761|NCT01677195|76106974|FG001|Overall Study|Adverse Event|4|||
42037678|NCT00830869|75846018|FG003|Period 2: Part 2|Protocol Violation|0|||
42037679|NCT00830869|75846019|FG004|Period 2: Part 2|Protocol Violation|0|||
42037680|NCT00830869|75846020|FG005|Period 2: Part 2|Protocol Violation|0|||
42275762|NCT01677195|76106975|FG002|Overall Study|Adverse Event|1|||
42275763|NCT01677195|76106973|FG000|Overall Study|Physician Decision|1|||
42275764|NCT01677195|76106974|FG001|Overall Study|Physician Decision|2|||
42275765|NCT01677195|76106975|FG002|Overall Study|Physician Decision|2|||
42275766|NCT01677195|76106973|FG000|Overall Study|Pregnancy|0|||
42275767|NCT01677195|76106974|FG001|Overall Study|Pregnancy|1|||
42275768|NCT01677195|76106975|FG002|Overall Study|Pregnancy|0|||
42275769|NCT01677195|76106973|FG000|Overall Study|Protocol Violation|7|||
42275770|NCT01677195|76106974|FG001|Overall Study|Protocol Violation|3|||
42275771|NCT01677195|76106975|FG002|Overall Study|Protocol Violation|4|||
42275772|NCT00928447|76106987|FG000|Overall Study|Withdrawal by Subject|1|||
42275773|NCT00928447|76106987|FG000|Overall Study|Investigator's decision|1|||
42275774|NCT02224846|76106993|FG000|Period 1 (Month 3)|Adverse Event|2|||
42275775|NCT02224846|76106994|FG001|Period 1 (Month 3)|Adverse Event|1|||
42275776|NCT02224846|76106993|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
42275777|NCT02224846|76106994|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
42011643|NCT01211145|75818677|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
42011644|NCT01211145|75818678|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
42011645|NCT01211145|75818675|FG000|Overall Study|Patient decision|2|||
42011646|NCT01211145|75818676|FG001|Overall Study|Patient decision|1|||
42011647|NCT01211145|75818677|FG002|Overall Study|Patient decision|0|||
42011648|NCT01211145|75818678|FG003|Overall Study|Patient decision|2|||
42011649|NCT00977665|75818690|FG000|Overall Study|Withdrawal by Subject|1|||
42011650|NCT00977665|75818691|FG001|Overall Study|Withdrawal by Subject|3|||
42011651|NCT00977665|75818690|FG000|Overall Study|Physician Decision|2|||
42011652|NCT00977665|75818691|FG001|Overall Study|Physician Decision|1|||
42011653|NCT00977665|75818690|FG000|Overall Study|Sponsor requested withdrawal|0|||
42011654|NCT00977665|75818691|FG001|Overall Study|Sponsor requested withdrawal|1|||
42011655|NCT00977665|75818690|FG000|Overall Study|Lost to Follow-up|1|||
42037681|NCT00830869|75846021|FG006|Period 2: Part 2|Protocol Violation|0|||
42037682|NCT00830869|75846022|FG007|Period 2: Part 2|Protocol Violation|1|||
42275778|NCT02224846|76106993|FG000|Period 1 (Month 3)|Protocol Violation|4|||
42275779|NCT02224846|76106994|FG001|Period 1 (Month 3)|Protocol Violation|8|||
42037683|NCT00830869|75846023|FG008|Period 2: Part 2|Protocol Violation|0|||
42139522|NCT00451178|75949765|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
42139523|NCT00451178|75949766|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
42275780|NCT02224846|76106993|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
42275781|NCT02224846|76106994|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
42275782|NCT02224846|76106993|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
42139524|NCT00451178|75949765|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
42139525|NCT00451178|75949766|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
42139526|NCT00451178|75949765|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
42139527|NCT00451178|75949766|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
42139528|NCT00451178|75949765|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
42139529|NCT00451178|75949766|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
42139530|NCT00450866|75949776|FG000|Overall Study|Adverse Event|0|||
42139531|NCT00450866|75949777|FG001|Overall Study|Adverse Event|1|||
42139532|NCT00450866|75949776|FG000|Overall Study|Withdrawal by Subject|5|||
42139533|NCT00450866|75949777|FG001|Overall Study|Withdrawal by Subject|2|||
42139534|NCT00450866|75949776|FG000|Overall Study|Death|1|||
42139535|NCT00450866|75949777|FG001|Overall Study|Death|0|||
42139536|NCT00450866|75949776|FG000|Overall Study|Physician Decision|1|||
42139537|NCT00450866|75949777|FG001|Overall Study|Physician Decision|0|||
42139538|NCT00442598|75949786|FG000|Overall Study|Adverse Event|1|||
42139539|NCT00442598|75949787|FG001|Overall Study|Adverse Event|0|||
42139540|NCT00442598|75949788|FG002|Overall Study|Adverse Event|0|||
42139541|NCT00442598|75949786|FG000|Overall Study|Tumor progression|3|||
42139542|NCT00442598|75949787|FG001|Overall Study|Tumor progression|4|||
42139543|NCT00442598|75949788|FG002|Overall Study|Tumor progression|0|||
42139544|NCT00442598|75949786|FG000|Overall Study|Clinical deterioration|1|||
42139545|NCT00442598|75949787|FG001|Overall Study|Clinical deterioration|2|||
42139546|NCT00442598|75949788|FG002|Overall Study|Clinical deterioration|0|||
42139547|NCT00442598|75949786|FG000|Overall Study|CA125 progression|0|||
42139548|NCT00442598|75949787|FG001|Overall Study|CA125 progression|1|||
42139549|NCT00442598|75949788|FG002|Overall Study|CA125 progression|0|||
42139550|NCT00442598|75949786|FG000|Overall Study|Reduced creatinine clearance|1|||
42139551|NCT00442598|75949787|FG001|Overall Study|Reduced creatinine clearance|0|||
42139552|NCT00442598|75949788|FG002|Overall Study|Reduced creatinine clearance|0|||
42139553|NCT00442598|75949786|FG000|Overall Study|Death|0|||
42139554|NCT00442598|75949787|FG001|Overall Study|Death|1|||
42139555|NCT00442598|75949788|FG002|Overall Study|Death|0|||
42139556|NCT00442286|75949798|FG000|Overall Study|Death|2|||
42139557|NCT00442286|75949799|FG001|Overall Study|Death|2|||
42139558|NCT00442286|75949798|FG000|Overall Study|Lost to Follow-up|1|||
42037684|NCT00830869|75846024|FG009|Period 2: Part 2|Protocol Violation|1|||
42139559|NCT00442286|75949799|FG001|Overall Study|Lost to Follow-up|0|||
42139560|NCT00442286|75949798|FG000|Overall Study|Withdrawal by Subject|2|||
42139561|NCT00442286|75949799|FG001|Overall Study|Withdrawal by Subject|0|||
42139562|NCT00442286|75949798|FG000|Overall Study|System explanted|1|||
42139563|NCT00442286|75949799|FG001|Overall Study|System explanted|0|||
42139564|NCT00442286|75949798|FG000|Overall Study|Patient Injury|1|||
42139565|NCT00442286|75949799|FG001|Overall Study|Patient Injury|0|||
42139566|NCT00441974|75949807|FG000|Overall Study|Adverse Event|6|||
42139567|NCT00441974|75949807|FG000|Overall Study|Consent Withdrawn|35|||
42139568|NCT00441974|75949807|FG000|Overall Study|Lost to Follow-up|80|||
42139569|NCT00441974|75949807|FG000|Overall Study|Protocol Violation|7|||
42139570|NCT00441584|75949814|FG000|Overall Study|Lack of Efficacy|79|||
42037685|NCT00830869|75846025|FG010|Period 2: Part 2|Protocol Violation|0|||
42037686|NCT00830869|75846026|FG011|Period 2: Part 2|Protocol Violation|0|||
42037687|NCT00830869|75846015|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
42037688|NCT00830869|75846016|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
42037689|NCT00830869|75846017|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
42037690|NCT00830869|75846018|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
42037691|NCT00830869|75846019|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
42037692|NCT00830869|75846020|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
42037693|NCT00830869|75846021|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
42037694|NCT00830869|75846022|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
42037695|NCT00830869|75846023|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
42037696|NCT00830869|75846024|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
42139571|NCT00441584|75949814|FG000|Overall Study|Withdrawal by Subject|8|||
42139572|NCT00441584|75949814|FG000|Overall Study|Adverse Event|6|||
42139573|NCT00441584|75949814|FG000|Overall Study|Protocol Violation|5|||
42139574|NCT00441584|75949814|FG000|Overall Study|Lost to Follow-up|4|||
42139575|NCT00441584|75949814|FG000|Overall Study|Failure to meet eligibility criteria|3|||
42139576|NCT00430716|75949821|FG000|Double Blind Phase|Death|1|||
42350636|NCT04534114|76190439|FG000|Main Treatment Period|Death|1|||
42139577|NCT00430716|75949822|FG001|Double Blind Phase|Death|0|||
42139578|NCT00430716|75949823|FG002|Double Blind Phase|Death|0|||
42139579|NCT00430716|75949821|FG000|Double Blind Phase|No longer willing to participate|2|||
42139580|NCT00430716|75949822|FG001|Double Blind Phase|No longer willing to participate|1|||
42139581|NCT00430716|75949823|FG002|Double Blind Phase|No longer willing to participate|1|||
42037697|NCT00830869|75846025|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
42037698|NCT00830869|75846026|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
42037699|NCT00830869|75846015|FG000|Period 2: Part 2|Adverse Event|0|||
42037700|NCT00830869|75846016|FG001|Period 2: Part 2|Adverse Event|0|||
42037701|NCT00830869|75846017|FG002|Period 2: Part 2|Adverse Event|0|||
42139582|NCT00430716|75949821|FG000|Double Blind Phase|Other|0|||
42139583|NCT00430716|75949822|FG001|Double Blind Phase|Other|2|||
42139584|NCT00430716|75949823|FG002|Double Blind Phase|Other|0|||
42139585|NCT00430716|75949821|FG000|Double Blind Phase|Study terminated by sponsor|1|||
42139586|NCT00430716|75949822|FG001|Double Blind Phase|Study terminated by sponsor|1|||
42139587|NCT00430716|75949823|FG002|Double Blind Phase|Study terminated by sponsor|2|||
42139588|NCT00430716|75949821|FG000|Double Blind Phase|Adverse Event|1|||
42350637|NCT04534114|76190440|FG001|Main Treatment Period|Death|0|||
42350638|NCT04534114|76190441|FG002|Main Treatment Period|Death|0|||
42139589|NCT00430716|75949822|FG001|Double Blind Phase|Adverse Event|1|||
42139590|NCT00430716|75949823|FG002|Double Blind Phase|Adverse Event|3|||
42139591|NCT00430716|75949821|FG000|Double Blind Phase|Not treated|1|||
42139592|NCT00430716|75949822|FG001|Double Blind Phase|Not treated|0|||
42139593|NCT00430716|75949823|FG002|Double Blind Phase|Not treated|0|||
42139594|NCT00430716|75949821|FG000|Open Label Phase|Lost to Follow-up|1|||
42139595|NCT00430716|75949822|FG001|Open Label Phase|Lost to Follow-up|0|||
42139596|NCT00430716|75949823|FG002|Open Label Phase|Lost to Follow-up|1|||
42139597|NCT00430716|75949821|FG000|Open Label Phase|No longer willing to participate|0|||
42139598|NCT00430716|75949822|FG001|Open Label Phase|No longer willing to participate|1|||
42139599|NCT00430716|75949823|FG002|Open Label Phase|No longer willing to participate|1|||
42139600|NCT00430716|75949821|FG000|Open Label Phase|Other|3|||
42139601|NCT00430716|75949822|FG001|Open Label Phase|Other|1|||
42139602|NCT00430716|75949823|FG002|Open Label Phase|Other|1|||
42139603|NCT00430716|75949821|FG000|Open Label Phase|Protocol Violation|1|||
42139604|NCT00430716|75949822|FG001|Open Label Phase|Protocol Violation|0|||
42139605|NCT00430716|75949823|FG002|Open Label Phase|Protocol Violation|0|||
42139606|NCT00430716|75949821|FG000|Open Label Phase|Study terminated by sponsor|4|||
42139607|NCT00430716|75949822|FG001|Open Label Phase|Study terminated by sponsor|5|||
42139608|NCT00430716|75949823|FG002|Open Label Phase|Study terminated by sponsor|4|||
42139609|NCT00441272|75949833|FG000|Overall Study|Study terminated prior to enrollment|25|||
42139610|NCT00441272|75949834|FG001|Overall Study|Study terminated prior to enrollment|25|||
42139611|NCT00430638|75949842|FG000|Overall Study|Adverse Event|15|||
42139612|NCT00430638|75949843|FG001|Overall Study|Adverse Event|15|||
42139613|NCT00430638|75949842|FG000|Overall Study|Uncontrolled blood pressure|48|||
42139614|NCT00430638|75949843|FG001|Overall Study|Uncontrolled blood pressure|13|||
42139615|NCT00430638|75949842|FG000|Overall Study|Lost to Follow-up|1|||
42139616|NCT00430638|75949843|FG001|Overall Study|Lost to Follow-up|7|||
42139617|NCT00430638|75949842|FG000|Overall Study|Protocol Violation|6|||
42139618|NCT00430638|75949843|FG001|Overall Study|Protocol Violation|4|||
42139619|NCT00430638|75949842|FG000|Overall Study|Withdrawal by Subject|4|||
42139620|NCT00430638|75949843|FG001|Overall Study|Withdrawal by Subject|6|||
42139621|NCT00430638|75949842|FG000|Overall Study|Non-compliant|2|||
42139622|NCT00430638|75949843|FG001|Overall Study|Non-compliant|1|||
42139623|NCT00430638|75949842|FG000|Overall Study|Other|2|||
42139624|NCT00430638|75949843|FG001|Overall Study|Other|2|||
42139625|NCT00430482|75949855|FG000|Completed Treatment|Insufficient Treatment|7|||
42139626|NCT00430482|75949856|FG001|Completed Treatment|Insufficient Treatment|11|||
42139627|NCT00449930|75949864|FG000|Overall Study|Adverse Event|9|||
42139628|NCT00449930|75949865|FG001|Overall Study|Adverse Event|19|||
42139629|NCT00449930|75949864|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
42139630|NCT00449930|75949865|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
42139631|NCT00449930|75949864|FG000|Overall Study|Lack of Efficacy|10|||
42139632|NCT00449930|75949865|FG001|Overall Study|Lack of Efficacy|1|||
42139633|NCT00449930|75949864|FG000|Overall Study|Lost to Follow-up|9|||
42139634|NCT00449930|75949865|FG001|Overall Study|Lost to Follow-up|14|||
42139635|NCT00449930|75949864|FG000|Overall Study|Physician Decision|1|||
42139636|NCT00449930|75949865|FG001|Overall Study|Physician Decision|2|||
42139637|NCT00449930|75949864|FG000|Overall Study|Protocol Violation|14|||
42139638|NCT00449930|75949865|FG001|Overall Study|Protocol Violation|15|||
42139639|NCT00449930|75949864|FG000|Overall Study|Withdrawal by Subject|16|||
42139640|NCT00449930|75949865|FG001|Overall Study|Withdrawal by Subject|23|||
42139641|NCT00449930|75949864|FG000|Overall Study|Glycemic discontinuation criteria|1|||
42139642|NCT00449930|75949865|FG001|Overall Study|Glycemic discontinuation criteria|1|||
42350639|NCT04534114|76190442|FG003|Main Treatment Period|Death|1|||
42011656|NCT00977665|75818691|FG001|Overall Study|Lost to Follow-up|0|||
42139643|NCT00449696|75949873|FG000|Overall Study|Other Treatment Required|6|||
42139644|NCT00449696|75949874|FG001|Overall Study|Other Treatment Required|1|||
42139645|NCT00449696|75949873|FG000|Overall Study|Withdrawal by Subject|5|||
42139646|NCT00449696|75949874|FG001|Overall Study|Withdrawal by Subject|5|||
42139647|NCT00449696|75949873|FG000|Overall Study|Lost to Follow-up|2|||
42350640|NCT04534114|76190439|FG000|Main Treatment Period|Other reason|1|||
42139648|NCT00449696|75949874|FG001|Overall Study|Lost to Follow-up|3|||
42011657|NCT00977665|75818690|FG000|Overall Study|Death|3|||
42011658|NCT00977665|75818691|FG001|Overall Study|Death|2|||
42011659|NCT00977665|75818690|FG000|Overall Study|Adverse Event|14|||
42011660|NCT00977665|75818691|FG001|Overall Study|Adverse Event|7|||
42011661|NCT00977665|75818690|FG000|Overall Study|Treatment failure|0|||
42139649|NCT00449696|75949873|FG000|Overall Study|Others|7|||
42139650|NCT00449696|75949874|FG001|Overall Study|Others|0|||
42139651|NCT00441116|75949882|FG000|Overall Study|Adverse Event|1|||
42139652|NCT00441116|75949883|FG001|Overall Study|Adverse Event|1|||
42139653|NCT00441116|75949882|FG000|Overall Study|Withdrawal by Subject|1|||
42139654|NCT00441116|75949883|FG001|Overall Study|Withdrawal by Subject|0|||
42139655|NCT00441116|75949882|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
42139656|NCT00441116|75949883|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
42139657|NCT00430248|75949892|FG000|Overall Study|Adverse Event|49|||
42139658|NCT00430248|75949893|FG001|Overall Study|Adverse Event|61|||
42139659|NCT00430248|75949894|FG002|Overall Study|Adverse Event|64|||
42139660|NCT00430248|75949892|FG000|Overall Study|Protocol Violation|10|||
42139661|NCT00430248|75949893|FG001|Overall Study|Protocol Violation|2|||
42139662|NCT00430248|75949894|FG002|Overall Study|Protocol Violation|4|||
42139663|NCT00430248|75949892|FG000|Overall Study|Personal Reasons|12|||
42139664|NCT00430248|75949893|FG001|Overall Study|Personal Reasons|24|||
42139665|NCT00430248|75949894|FG002|Overall Study|Personal Reasons|9|||
42139666|NCT00430248|75949892|FG000|Overall Study|Lost to Follow-up|28|||
42139667|NCT00430248|75949893|FG001|Overall Study|Lost to Follow-up|33|||
42139668|NCT00430248|75949894|FG002|Overall Study|Lost to Follow-up|28|||
42139669|NCT00430248|75949892|FG000|Overall Study|Therapeutic Failure|1|||
42139670|NCT00430248|75949893|FG001|Overall Study|Therapeutic Failure|1|||
42139671|NCT00430248|75949894|FG002|Overall Study|Therapeutic Failure|1|||
42139672|NCT00430248|75949892|FG000|Overall Study|Withdrawal by Subject|14|||
42139673|NCT00430248|75949893|FG001|Overall Study|Withdrawal by Subject|20|||
42139674|NCT00430248|75949894|FG002|Overall Study|Withdrawal by Subject|16|||
42139675|NCT00430248|75949892|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42139676|NCT00430248|75949893|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
42139677|NCT00430248|75949894|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42139678|NCT00430248|75949892|FG000|Overall Study|Gout Flare|3|||
42139679|NCT00430248|75949893|FG001|Overall Study|Gout Flare|7|||
42139680|NCT00430248|75949894|FG002|Overall Study|Gout Flare|2|||
42139681|NCT00430248|75949892|FG000|Overall Study|Reason Not Specified|8|||
42139682|NCT00430248|75949893|FG001|Overall Study|Reason Not Specified|8|||
42139683|NCT00430248|75949894|FG002|Overall Study|Reason Not Specified|11|||
42139684|NCT00449540|75949904|FG000|Pretreatment Phase|No migraine experienced|66|||
42139685|NCT00449540|75949905|FG001|Pretreatment Phase|No migraine experienced|0|||
42139686|NCT00449540|75949906|FG002|Pretreatment Phase|No migraine experienced|0|||
42139687|NCT00449540|75949904|FG000|Treatment Phase|did not experience or treat migraine|0|||
42139688|NCT00449540|75949905|FG001|Treatment Phase|did not experience or treat migraine|20|||
42139689|NCT00449540|75949906|FG002|Treatment Phase|did not experience or treat migraine|17|||
42139690|NCT00411762|75949914|FG000|Overall Study|Withdrawal by Subject|5|||
42139691|NCT00429858|75949918|FG000|Overall Study|Withdrawal by Subject|1|||
42139692|NCT00429858|75949918|FG000|Overall Study|Study Termination|1|||
42139693|NCT00449150|75949926|FG000|Overall Study|Adverse Event|11|||
42139694|NCT00449150|75949927|FG001|Overall Study|Adverse Event|18|||
42139695|NCT00449150|75949928|FG002|Overall Study|Adverse Event|9|||
42139696|NCT00449150|75949926|FG000|Overall Study|Lack of Efficacy|1|||
42139697|NCT00449150|75949927|FG001|Overall Study|Lack of Efficacy|2|||
42139698|NCT00449150|75949928|FG002|Overall Study|Lack of Efficacy|2|||
42139699|NCT00449150|75949926|FG000|Overall Study|Other|16|||
42275783|NCT02224846|76106994|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
42275784|NCT02224846|76106993|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
42275785|NCT02224846|76106994|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
42275786|NCT02224846|76106993|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
42275787|NCT02224846|76106994|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
42275788|NCT02224846|76106993|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
42011662|NCT00977665|75818691|FG001|Overall Study|Treatment failure|1|||
42011663|NCT01210443|75818697|FG000|Overall Study|Study terminated by sponsor|2|||
42011664|NCT01007812|75818701|FG000|Period 1, One Week|Lost to Follow-up|0|||
42011665|NCT01007812|75818702|FG001|Period 1, One Week|Lost to Follow-up|1|||
42011666|NCT01007812|75818701|FG000|Period 1, One Week|Discomfort|1|||
42011667|NCT01007812|75818702|FG001|Period 1, One Week|Discomfort|0|||
42011668|NCT01208961|75818708|FG000|High-Fat Period III|Protocol Violation|1|||
42011669|NCT01208961|75818709|FG001|High-Fat Period III|Protocol Violation|0|||
42011670|NCT01001572|75818716|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
42011671|NCT01001572|75818717|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
42011672|NCT01001572|75818718|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
42011673|NCT01001572|75818716|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
42037702|NCT00830869|75846018|FG003|Period 2: Part 2|Adverse Event|0|||
42139700|NCT00449150|75949927|FG001|Overall Study|Other|13|||
42139701|NCT00449150|75949928|FG002|Overall Study|Other|14|||
42139702|NCT00449150|75949926|FG000|Overall Study|Withdrawal by Subject|17|||
42139703|NCT00449150|75949927|FG001|Overall Study|Withdrawal by Subject|18|||
42139704|NCT00449150|75949928|FG002|Overall Study|Withdrawal by Subject|21|||
42139705|NCT00449150|75949926|FG000|Overall Study|Protocol Violation|1|||
42037703|NCT00830869|75846019|FG004|Period 2: Part 2|Adverse Event|0|||
42139706|NCT00449150|75949927|FG001|Overall Study|Protocol Violation|2|||
42139707|NCT00449150|75949928|FG002|Overall Study|Protocol Violation|1|||
42139708|NCT00428844|75949942|FG000|Completed Study Drug Treatment|Adverse Event|2|||
42139709|NCT00428844|75949943|FG001|Completed Study Drug Treatment|Adverse Event|4|||
42139710|NCT00428844|75949944|FG002|Completed Study Drug Treatment|Adverse Event|4|||
42139711|NCT00428844|75949942|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
42139712|NCT00428844|75949943|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
42139713|NCT00428844|75949944|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
42139714|NCT00428844|75949942|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
42139715|NCT00428844|75949943|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
42139716|NCT00428844|75949944|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
42139717|NCT00428844|75949942|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
42139718|NCT00428844|75949943|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
42139719|NCT00428844|75949944|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
42139720|NCT00428844|75949942|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
42139721|NCT00428844|75949943|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
42139722|NCT00428844|75949944|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
42350641|NCT04534114|76190440|FG001|Main Treatment Period|Other reason|1|||
42350642|NCT04534114|76190441|FG002|Main Treatment Period|Other reason|0|||
42350643|NCT04534114|76190442|FG003|Main Treatment Period|Other reason|0|||
42350644|NCT04534114|76190439|FG000|Main Treatment Period|Participant decision|1|||
42350645|NCT04534114|76190440|FG001|Main Treatment Period|Participant decision|3|||
42350646|NCT04534114|76190441|FG002|Main Treatment Period|Participant decision|3|||
42350647|NCT04534114|76190442|FG003|Main Treatment Period|Participant decision|1|||
42350648|NCT04534114|76190439|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
42350649|NCT04534114|76190440|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
42350650|NCT04534114|76190441|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
42350651|NCT04534114|76190442|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
42037704|NCT00830869|75846020|FG005|Period 2: Part 2|Adverse Event|0|||
42037705|NCT00830869|75846021|FG006|Period 2: Part 2|Adverse Event|0|||
42139723|NCT00428844|75949942|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
42139724|NCT00428844|75949943|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
42139725|NCT00428844|75949944|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
42139726|NCT00428844|75949942|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
42139727|NCT00428844|75949943|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
42139728|NCT00428844|75949944|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
42139729|NCT00428844|75949942|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
42139730|NCT00428844|75949943|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
42139731|NCT00428844|75949944|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
42139732|NCT00428844|75949942|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
42139733|NCT00428844|75949943|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
42139734|NCT00428844|75949944|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
42139735|NCT00457418|75949952|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
42139736|NCT00457418|75949952|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
42139737|NCT00457418|75949952|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
42139738|NCT00457418|75949952|FG000|Post PK Maintenance|Adverse Event|10|||
42139739|NCT00457418|75949952|FG000|Post PK Maintenance|Progression of Disease|6|||
42139740|NCT00457418|75949952|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
42139741|NCT00457418|75949952|FG000|Post PK Maintenance|Lost to Follow-up|1|||
42139742|NCT00449072|75949958|FG000|Overall Study|Adverse Event|3|||
42275789|NCT02224846|76106994|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
42275790|NCT02224846|76106993|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
42275791|NCT02224846|76106994|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
42275792|NCT02224846|76106993|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
42275793|NCT02224846|76106994|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
42275794|NCT02224846|76106993|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
42275795|NCT02224846|76106994|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
42275796|NCT02224846|76106993|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
42275797|NCT02224846|76106994|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
42037706|NCT00830869|75846022|FG007|Period 2: Part 2|Adverse Event|4|||
42037707|NCT00830869|75846023|FG008|Period 2: Part 2|Adverse Event|3|||
42037708|NCT00830869|75846024|FG009|Period 2: Part 2|Adverse Event|2|||
42037709|NCT00830869|75846025|FG010|Period 2: Part 2|Adverse Event|2|||
42037710|NCT00830869|75846026|FG011|Period 2: Part 2|Adverse Event|0|||
42350652|NCT04534114|76190439|FG000|Main Treatment Period|Adverse Event|4|||
42350653|NCT04534114|76190440|FG001|Main Treatment Period|Adverse Event|2|||
42350654|NCT04534114|76190441|FG002|Main Treatment Period|Adverse Event|1|||
42037711|NCT00830869|75846015|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
42139743|NCT00449072|75949959|FG001|Overall Study|Adverse Event|1|||
42139744|NCT00449072|75949958|FG000|Overall Study|Protocol Violation|14|||
42139745|NCT00449072|75949959|FG001|Overall Study|Protocol Violation|12|||
42139746|NCT00449072|75949958|FG000|Overall Study|Lost to Follow-up|5|||
42139747|NCT00449072|75949959|FG001|Overall Study|Lost to Follow-up|7|||
42139748|NCT00449072|75949958|FG000|Overall Study|Withdrawal by Subject|11|||
42139749|NCT00449072|75949959|FG001|Overall Study|Withdrawal by Subject|8|||
42139750|NCT00449072|75949958|FG000|Overall Study|Lack of Efficacy|1|||
42139751|NCT00449072|75949959|FG001|Overall Study|Lack of Efficacy|1|||
42139752|NCT00449072|75949958|FG000|Overall Study|Physician Decision|1|||
42139753|NCT00449072|75949959|FG001|Overall Study|Physician Decision|0|||
42139754|NCT00449072|75949958|FG000|Overall Study|Not treated|0|||
42139755|NCT00449072|75949959|FG001|Overall Study|Not treated|1|||
42139756|NCT00449072|75949958|FG000|Overall Study|Excluded medication|0|||
42139757|NCT00449072|75949959|FG001|Overall Study|Excluded medication|2|||
42139758|NCT00449072|75949958|FG000|Overall Study|Non-compliance|2|||
42139759|NCT00449072|75949959|FG001|Overall Study|Non-compliance|5|||
42139760|NCT00449072|75949958|FG000|Overall Study|Sponsor decision|1|||
42139761|NCT00449072|75949959|FG001|Overall Study|Sponsor decision|3|||
42139762|NCT00449072|75949958|FG000|Overall Study|Relocation|3|||
42139763|NCT00449072|75949959|FG001|Overall Study|Relocation|2|||
42139764|NCT00428610|75949968|FG000|Overall Study|Death Due to Adverse Event|3|||
42139765|NCT00428610|75949969|FG001|Overall Study|Death Due to Adverse Event|0|||
42139766|NCT00428610|75949970|FG002|Overall Study|Death Due to Adverse Event|5|||
42139767|NCT00428610|75949968|FG000|Overall Study|Death Due to Progressive Disease|0|||
42139768|NCT00428610|75949969|FG001|Overall Study|Death Due to Progressive Disease|0|||
42139769|NCT00428610|75949970|FG002|Overall Study|Death Due to Progressive Disease|2|||
42139770|NCT00428610|75949968|FG000|Overall Study|Adverse Event|2|||
42139771|NCT00428610|75949969|FG001|Overall Study|Adverse Event|3|||
42139772|NCT00428610|75949970|FG002|Overall Study|Adverse Event|2|||
42139773|NCT00428610|75949968|FG000|Overall Study|Investigator Decision|2|||
42139774|NCT00428610|75949969|FG001|Overall Study|Investigator Decision|1|||
42139775|NCT00428610|75949970|FG002|Overall Study|Investigator Decision|1|||
42139776|NCT00428610|75949968|FG000|Overall Study|Progressive Disease|42|||
42139777|NCT00428610|75949969|FG001|Overall Study|Progressive Disease|14|||
42139778|NCT00428610|75949970|FG002|Overall Study|Progressive Disease|22|||
42139779|NCT00428610|75949968|FG000|Overall Study|Withdrawal by Subject|4|||
42139780|NCT00428610|75949969|FG001|Overall Study|Withdrawal by Subject|0|||
42139781|NCT00428610|75949970|FG002|Overall Study|Withdrawal by Subject|0|||
42139782|NCT00419094|75949980|FG000|Overall Study|Adverse Event|3|||
42139783|NCT00419094|75949981|FG001|Overall Study|Adverse Event|7|||
42139784|NCT00419094|75949980|FG000|Overall Study|Lack of Efficacy|1|||
42139785|NCT00419094|75949981|FG001|Overall Study|Lack of Efficacy|0|||
42139786|NCT00419094|75949980|FG000|Overall Study|Lost to Follow-up|0|||
42139787|NCT00419094|75949981|FG001|Overall Study|Lost to Follow-up|2|||
42139788|NCT00419094|75949980|FG000|Overall Study|Protocol Violation|1|||
42139789|NCT00419094|75949981|FG001|Overall Study|Protocol Violation|14|||
42139790|NCT00419094|75949980|FG000|Overall Study|Withdrawal of consent|1|||
42139791|NCT00419094|75949981|FG001|Overall Study|Withdrawal of consent|5|||
42139792|NCT00419094|75949980|FG000|Overall Study|Other: Error determining exit criteria|1|||
42139793|NCT00419094|75949981|FG001|Overall Study|Other: Error determining exit criteria|0|||
42139794|NCT00419094|75949980|FG000|Overall Study|Other: Patient non-compliant|0|||
42139795|NCT00419094|75949981|FG001|Overall Study|Other: Patient non-compliant|1|||
42139796|NCT00419094|75949980|FG000|Overall Study|Other: No contact for extended period|0|||
42139797|NCT00419094|75949981|FG001|Overall Study|Other: No contact for extended period|1|||
42139798|NCT00448916|75949991|FG000|Overall Study|Adverse Event|2|||
42139799|NCT00448916|75949992|FG001|Overall Study|Adverse Event|2|||
42139800|NCT00448916|75949993|FG002|Overall Study|Adverse Event|3|||
42139801|NCT00448916|75949994|FG003|Overall Study|Adverse Event|2|||
42139802|NCT00448916|75949991|FG000|Overall Study|Lack of Efficacy|1|||
42139803|NCT00448916|75949992|FG001|Overall Study|Lack of Efficacy|0|||
42139804|NCT00448916|75949993|FG002|Overall Study|Lack of Efficacy|2|||
42139805|NCT00448916|75949994|FG003|Overall Study|Lack of Efficacy|1|||
42139806|NCT00448916|75949991|FG000|Overall Study|Withdrawal by Subject|3|||
42139807|NCT00448916|75949992|FG001|Overall Study|Withdrawal by Subject|3|||
42139808|NCT00448916|75949993|FG002|Overall Study|Withdrawal by Subject|1|||
42139809|NCT00448916|75949994|FG003|Overall Study|Withdrawal by Subject|1|||
42139810|NCT00448916|75949991|FG000|Overall Study|Other|1|||
42139811|NCT00448916|75949992|FG001|Overall Study|Other|0|||
42139812|NCT00448916|75949993|FG002|Overall Study|Other|0|||
42139813|NCT00448916|75949994|FG003|Overall Study|Other|0|||
42011674|NCT01001572|75818717|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
42011675|NCT01001572|75818718|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
42011676|NCT01001572|75818716|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
42139814|NCT00448916|75949991|FG000|Overall Study|Lost to Follow-up|0|||
42139815|NCT00448916|75949992|FG001|Overall Study|Lost to Follow-up|1|||
42139816|NCT00448916|75949993|FG002|Overall Study|Lost to Follow-up|0|||
42139817|NCT00448916|75949994|FG003|Overall Study|Lost to Follow-up|1|||
42139818|NCT00448916|75949991|FG000|Overall Study|Protocol Violation|0|||
42139819|NCT00448916|75949992|FG001|Overall Study|Protocol Violation|0|||
42139820|NCT00448916|75949993|FG002|Overall Study|Protocol Violation|0|||
42139821|NCT00448916|75949994|FG003|Overall Study|Protocol Violation|1|||
42139822|NCT00418938|75950008|FG000|Overall Study|Reimbursement|1|||
42139823|NCT00418938|75950009|FG001|Overall Study|Reimbursement|0|||
42139824|NCT00418938|75950008|FG000|Overall Study|Administrative decision|3|||
42139825|NCT00418938|75950009|FG001|Overall Study|Administrative decision|3|||
42139826|NCT00418938|75950008|FG000|Overall Study|Withdrawal by Subject|16|||
42139827|NCT00418938|75950009|FG001|Overall Study|Withdrawal by Subject|15|||
42139828|NCT00418938|75950008|FG000|Overall Study|Lost to Follow-up|1|||
42139829|NCT00418938|75950009|FG001|Overall Study|Lost to Follow-up|3|||
42139830|NCT00418938|75950008|FG000|Overall Study|Adverse Event|1|||
42139831|NCT00418938|75950009|FG001|Overall Study|Adverse Event|1|||
42139832|NCT00418938|75950008|FG000|Overall Study|On-going|1|||
42139833|NCT00418938|75950009|FG001|Overall Study|On-going|1|||
42139834|NCT00418938|75950008|FG000|Overall Study|Ineligibility Determined|1|||
42139835|NCT00418938|75950009|FG001|Overall Study|Ineligibility Determined|0|||
42139836|NCT00448760|75950015|FG000|Overall Study|Death|3|||
42139837|NCT00418314|75950021|FG000|Overall Study|Withdrawal by Subject|1|||
42139838|NCT00418314|75950022|FG001|Overall Study|Withdrawal by Subject|2|||
42139839|NCT00448448|75950030|FG000|Overall Study|Withdrawal by Subject|13|||
42139840|NCT00448448|75950031|FG001|Overall Study|Withdrawal by Subject|2|||
42139841|NCT00448448|75950030|FG000|Overall Study|On protocol when study ended|83|||
42139842|NCT00448448|75950031|FG001|Overall Study|On protocol when study ended|36|||
42139843|NCT00448448|75950030|FG000|Overall Study|Lost to Follow-up|2|||
42139844|NCT00448448|75950031|FG001|Overall Study|Lost to Follow-up|1|||
42139845|NCT00448448|75950030|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
42139846|NCT00448448|75950031|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
42139847|NCT00448448|75950030|FG000|Overall Study|Signed consent lost|0|||
42139848|NCT00448448|75950031|FG001|Overall Study|Signed consent lost|1|||
42139849|NCT00405912|75950040|FG000|Overall Study|Withdrawal by Subject|12|||
42139850|NCT00405912|75950041|FG001|Overall Study|Withdrawal by Subject|11|||
42139851|NCT00405912|75950042|FG002|Overall Study|Withdrawal by Subject|12|||
42139852|NCT00405912|75950040|FG000|Overall Study|Lost to Follow-up|4|||
42139853|NCT00405912|75950041|FG001|Overall Study|Lost to Follow-up|8|||
42139854|NCT00405912|75950042|FG002|Overall Study|Lost to Follow-up|4|||
42139855|NCT00448136|75950052|FG000|Overall Study|Death|3|||
42139856|NCT00448136|75950053|FG001|Overall Study|Death|8|||
42139857|NCT00448136|75950052|FG000|Overall Study|Investigator's decision (progression)|1|||
42139858|NCT00448136|75950053|FG001|Overall Study|Investigator's decision (progression)|0|||
42139859|NCT00447902|75950061|FG000|Overall Study|Adverse Event|0|||
42139860|NCT00447902|75950062|FG001|Overall Study|Adverse Event|3|||
42139861|NCT00447902|75950061|FG000|Overall Study|Protocol Violation|1|||
42139862|NCT00447902|75950062|FG001|Overall Study|Protocol Violation|0|||
42139863|NCT00447902|75950061|FG000|Overall Study|Withdrawal by Subject|0|||
42139864|NCT00447902|75950062|FG001|Overall Study|Withdrawal by Subject|1|||
42139865|NCT00447902|75950061|FG000|Overall Study|included patients who discontinued|1|||
42139866|NCT00447902|75950062|FG001|Overall Study|included patients who discontinued|1|||
42139867|NCT00447902|75950061|FG000|Overall Study|Lack of Efficacy|2|||
42139868|NCT00447902|75950062|FG001|Overall Study|Lack of Efficacy|1|||
42139869|NCT00307437|75950071|FG000|Controlled Period|Adverse Event|7|||
42139870|NCT00307437|75950072|FG001|Controlled Period|Adverse Event|2|||
42139871|NCT00307437|75950073|FG002|Controlled Period|Adverse Event|5|||
42139872|NCT00307437|75950074|FG003|Controlled Period|Adverse Event|0|||
42139873|NCT00307437|75950075|FG004|Controlled Period|Adverse Event|0|||
42139874|NCT00307437|75950076|FG005|Controlled Period|Adverse Event|0|||
42275798|NCT02224846|76106993|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
42275799|NCT02224846|76106994|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
42275800|NCT02224846|76106993|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
42275801|NCT02224846|76106994|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
42275802|NCT02224846|76106993|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
42275803|NCT02224846|76106994|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
42275804|NCT02224846|76106993|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
42139875|NCT00307437|75950077|FG006|Controlled Period|Adverse Event|0|||
42275805|NCT02224846|76106994|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
42275806|NCT02224846|76106993|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
42139876|NCT00307437|75950071|FG000|Controlled Period|Death|0|||
42139877|NCT00307437|75950072|FG001|Controlled Period|Death|0|||
42139878|NCT00307437|75950073|FG002|Controlled Period|Death|1|||
42139879|NCT00307437|75950074|FG003|Controlled Period|Death|0|||
42139880|NCT00307437|75950075|FG004|Controlled Period|Death|0|||
42139881|NCT00307437|75950076|FG005|Controlled Period|Death|0|||
42139882|NCT00307437|75950077|FG006|Controlled Period|Death|0|||
42139883|NCT00307437|75950071|FG000|Controlled Period|Lack of Efficacy|2|||
42350655|NCT04534114|76190442|FG003|Main Treatment Period|Adverse Event|2|||
42139884|NCT00307437|75950072|FG001|Controlled Period|Lack of Efficacy|0|||
42139885|NCT00307437|75950073|FG002|Controlled Period|Lack of Efficacy|0|||
42139886|NCT00307437|75950074|FG003|Controlled Period|Lack of Efficacy|0|||
42139887|NCT00307437|75950075|FG004|Controlled Period|Lack of Efficacy|0|||
42139888|NCT00307437|75950076|FG005|Controlled Period|Lack of Efficacy|0|||
42139889|NCT00307437|75950077|FG006|Controlled Period|Lack of Efficacy|0|||
42139890|NCT00307437|75950071|FG000|Controlled Period|Lost to Follow-up|2|||
42139891|NCT00307437|75950072|FG001|Controlled Period|Lost to Follow-up|3|||
42139892|NCT00307437|75950073|FG002|Controlled Period|Lost to Follow-up|0|||
42139893|NCT00307437|75950074|FG003|Controlled Period|Lost to Follow-up|0|||
42139894|NCT00307437|75950075|FG004|Controlled Period|Lost to Follow-up|0|||
42139895|NCT00307437|75950076|FG005|Controlled Period|Lost to Follow-up|0|||
42139896|NCT00307437|75950077|FG006|Controlled Period|Lost to Follow-up|0|||
42139897|NCT00307437|75950071|FG000|Controlled Period|Other|5|||
42139898|NCT00307437|75950072|FG001|Controlled Period|Other|1|||
42139899|NCT00307437|75950073|FG002|Controlled Period|Other|3|||
42139900|NCT00307437|75950074|FG003|Controlled Period|Other|0|||
42139901|NCT00307437|75950075|FG004|Controlled Period|Other|0|||
42139902|NCT00307437|75950076|FG005|Controlled Period|Other|0|||
42139903|NCT00307437|75950077|FG006|Controlled Period|Other|0|||
42139904|NCT00307437|75950071|FG000|After Controlled Period|Adverse Event|0|||
42139905|NCT00307437|75950072|FG001|After Controlled Period|Adverse Event|0|||
42139906|NCT00307437|75950073|FG002|After Controlled Period|Adverse Event|0|||
42139907|NCT00307437|75950074|FG003|After Controlled Period|Adverse Event|18|||
42139908|NCT00307437|75950075|FG004|After Controlled Period|Adverse Event|16|||
42139909|NCT00307437|75950076|FG005|After Controlled Period|Adverse Event|31|||
42139910|NCT00307437|75950077|FG006|After Controlled Period|Adverse Event|40|||
42139911|NCT00307437|75950071|FG000|After Controlled Period|Death|0|||
42139912|NCT00307437|75950072|FG001|After Controlled Period|Death|0|||
42139913|NCT00307437|75950073|FG002|After Controlled Period|Death|0|||
42139914|NCT00307437|75950074|FG003|After Controlled Period|Death|3|||
42139915|NCT00307437|75950075|FG004|After Controlled Period|Death|1|||
42139916|NCT00307437|75950076|FG005|After Controlled Period|Death|1|||
42139917|NCT00307437|75950077|FG006|After Controlled Period|Death|3|||
42139918|NCT00307437|75950071|FG000|After Controlled Period|Lack of Efficacy|0|||
42139919|NCT00307437|75950072|FG001|After Controlled Period|Lack of Efficacy|0|||
42139920|NCT00307437|75950073|FG002|After Controlled Period|Lack of Efficacy|0|||
42139921|NCT00307437|75950074|FG003|After Controlled Period|Lack of Efficacy|15|||
42139922|NCT00307437|75950075|FG004|After Controlled Period|Lack of Efficacy|17|||
42139923|NCT00307437|75950076|FG005|After Controlled Period|Lack of Efficacy|37|||
42139924|NCT00307437|75950077|FG006|After Controlled Period|Lack of Efficacy|24|||
42011677|NCT01001572|75818717|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
42011678|NCT01001572|75818718|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
42011679|NCT01001572|75818716|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
42011680|NCT01001572|75818717|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
42011681|NCT01001572|75818718|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
42011682|NCT01001572|75818716|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
42011683|NCT01001572|75818717|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
42011684|NCT01001572|75818718|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
42011685|NCT01001572|75818716|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
42011686|NCT01001572|75818717|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
42011687|NCT01001572|75818718|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
42037712|NCT00830869|75846016|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
42037713|NCT00830869|75846017|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
42037714|NCT00830869|75846018|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
42037715|NCT00830869|75846019|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
42037716|NCT00830869|75846020|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
42037717|NCT00830869|75846021|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
42037718|NCT00830869|75846022|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
42139925|NCT00307437|75950071|FG000|After Controlled Period|Lost to Follow-up|0|||
42139926|NCT00307437|75950072|FG001|After Controlled Period|Lost to Follow-up|0|||
42139927|NCT00307437|75950073|FG002|After Controlled Period|Lost to Follow-up|0|||
42139928|NCT00307437|75950074|FG003|After Controlled Period|Lost to Follow-up|7|||
42139929|NCT00307437|75950075|FG004|After Controlled Period|Lost to Follow-up|12|||
42139930|NCT00307437|75950076|FG005|After Controlled Period|Lost to Follow-up|13|||
42139931|NCT00307437|75950077|FG006|After Controlled Period|Lost to Follow-up|18|||
42139932|NCT00307437|75950071|FG000|After Controlled Period|Other|0|||
42139933|NCT00307437|75950072|FG001|After Controlled Period|Other|0|||
42139934|NCT00307437|75950073|FG002|After Controlled Period|Other|0|||
42139935|NCT00307437|75950074|FG003|After Controlled Period|Other|15|||
42139936|NCT00307437|75950075|FG004|After Controlled Period|Other|9|||
42037719|NCT00830869|75846023|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
42011688|NCT01001572|75818716|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
42139937|NCT00307437|75950076|FG005|After Controlled Period|Other|40|||
42139938|NCT00307437|75950077|FG006|After Controlled Period|Other|28|||
42139939|NCT00440726|75950102|FG000|Phase 1|Dose-Limiting Toxicity|0|||
42139940|NCT00440726|75950103|FG001|Phase 1|Dose-Limiting Toxicity|1|||
42139941|NCT00440726|75950104|FG002|Phase 1|Dose-Limiting Toxicity|0|||
42139942|NCT00440726|75950102|FG000|Phase 1|Physician Decision|1|||
42139943|NCT00440726|75950103|FG001|Phase 1|Physician Decision|0|||
42139944|NCT00440726|75950104|FG002|Phase 1|Physician Decision|0|||
42275807|NCT02224846|76106994|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
42275808|NCT01632280|76107002|FG000|Overall Study|Withdrawal by Subject|1|||
42275809|NCT01632280|76107003|FG001|Overall Study|Withdrawal by Subject|0|||
42275810|NCT02224690|76107011|FG000|Overall Study|Adverse Event|8|||
42275811|NCT02224690|76107012|FG001|Overall Study|Adverse Event|1|||
42275812|NCT02224690|76107011|FG000|Overall Study|Met Withdrawal Criteria|4|||
42037720|NCT00830869|75846024|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
42037721|NCT00830869|75846025|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
42011689|NCT01001572|75818717|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
42011690|NCT01001572|75818718|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
42011691|NCT01001572|75818716|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
42011692|NCT01001572|75818717|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
42011693|NCT01001572|75818718|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
42011694|NCT01001572|75818716|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
42011695|NCT01001572|75818717|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
42011696|NCT01001572|75818718|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
42011697|NCT01001572|75818716|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
42011698|NCT01001572|75818717|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
42037722|NCT00830869|75846026|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
42037723|NCT00830869|75846015|FG000|Period 2: Part 2|Progressive disease|0|||
42037724|NCT00830869|75846016|FG001|Period 2: Part 2|Progressive disease|0|||
42037725|NCT00830869|75846017|FG002|Period 2: Part 2|Progressive disease|0|||
42037726|NCT00830869|75846018|FG003|Period 2: Part 2|Progressive disease|0|||
42037727|NCT00830869|75846019|FG004|Period 2: Part 2|Progressive disease|0|||
42037728|NCT00830869|75846020|FG005|Period 2: Part 2|Progressive disease|0|||
42037729|NCT00830869|75846021|FG006|Period 2: Part 2|Progressive disease|0|||
42139945|NCT00440726|75950102|FG000|Phase 2|Death|0|||
42139946|NCT00440726|75950103|FG001|Phase 2|Death|0|||
42139947|NCT00440726|75950104|FG002|Phase 2|Death|1|||
42275813|NCT02224690|76107012|FG001|Overall Study|Met Withdrawal Criteria|0|||
42275814|NCT02224690|76107011|FG000|Overall Study|Use of G-tube|1|||
42275815|NCT02224690|76107012|FG001|Overall Study|Use of G-tube|0|||
42275816|NCT02224690|76107011|FG000|Overall Study|Did not meet eligibility criteria|1|||
42275817|NCT02224690|76107012|FG001|Overall Study|Did not meet eligibility criteria|0|||
42275818|NCT01634152|76107021|FG000|Overall Study|Adverse Event|2|||
42275819|NCT01634152|76107022|FG001|Overall Study|Adverse Event|0|||
42275820|NCT01634152|76107023|FG002|Overall Study|Adverse Event|2|||
42139948|NCT00440726|75950102|FG000|Phase 2|Adverse Event|0|||
42139949|NCT00440726|75950103|FG001|Phase 2|Adverse Event|0|||
42139950|NCT00440726|75950104|FG002|Phase 2|Adverse Event|1|||
42139951|NCT00447590|75950115|FG000|Overall Study|Withdrawal by Subject|26|||
42139952|NCT00447590|75950115|FG000|Overall Study|Lost to Follow-up|24|||
42139953|NCT00447590|75950115|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
42139954|NCT00447278|75950121|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
42139955|NCT00447278|75950122|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
42139956|NCT00447278|75950121|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
42139957|NCT00447278|75950122|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
42139958|NCT00447278|75950121|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
42139959|NCT00447278|75950122|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
42139960|NCT00447278|75950121|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
42139961|NCT00447278|75950122|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
42139962|NCT00447278|75950121|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
42139963|NCT00447278|75950122|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
42139964|NCT00447278|75950121|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
42139965|NCT00447278|75950122|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
42139966|NCT00447278|75950121|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
42139967|NCT00447278|75950122|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
42139968|NCT00447278|75950121|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
42139969|NCT00447278|75950122|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
42139970|NCT00447278|75950121|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
42139971|NCT00447278|75950122|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
42139972|NCT00447278|75950121|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
42139973|NCT00447278|75950122|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
42139974|NCT00447278|75950121|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
42139975|NCT00447278|75950122|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
42139976|NCT00447278|75950121|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
42139977|NCT00447278|75950122|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
42139978|NCT00447278|75950121|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
42139979|NCT00447278|75950122|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
42139980|NCT00447278|75950121|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
42139981|NCT00447278|75950122|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
42139982|NCT00446966|75950131|FG000|Overall Study|Lost to Follow-up|10|||
42139983|NCT00446966|75950132|FG001|Overall Study|Lost to Follow-up|7|||
42139984|NCT00446654|75950140|FG000|Overall Study|Withdrawal by Subject|1|||
42139985|NCT00446654|75950141|FG001|Overall Study|Withdrawal by Subject|0|||
42139986|NCT00446654|75950140|FG000|Overall Study|Adverse Event|1|||
42139987|NCT00446654|75950141|FG001|Overall Study|Adverse Event|0|||
42139988|NCT00405756|75950150|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
42139989|NCT00405756|75950151|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
42139990|NCT00405756|75950152|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
42139991|NCT00405756|75950150|FG000|Double-blind Treatment|Adverse Event|31|||
42139992|NCT00405756|75950151|FG001|Double-blind Treatment|Adverse Event|27|||
42139993|NCT00405756|75950152|FG002|Double-blind Treatment|Adverse Event|12|||
42139994|NCT00405756|75950150|FG000|Double-blind Treatment|Disease Progression|47|||
42139995|NCT00405756|75950151|FG001|Double-blind Treatment|Disease Progression|81|||
42139996|NCT00405756|75950152|FG002|Double-blind Treatment|Disease Progression|102|||
42139997|NCT00405756|75950150|FG000|Double-blind Treatment|Lack of Efficacy|1|||
42139998|NCT00405756|75950151|FG001|Double-blind Treatment|Lack of Efficacy|4|||
42139999|NCT00405756|75950152|FG002|Double-blind Treatment|Lack of Efficacy|2|||
42140000|NCT00405756|75950150|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
42140001|NCT00405756|75950151|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
42140002|NCT00405756|75950152|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
42140003|NCT00405756|75950150|FG000|Double-blind Treatment|Lost to Follow-up|1|||
42140004|NCT00405756|75950151|FG001|Double-blind Treatment|Lost to Follow-up|0|||
42140005|NCT00405756|75950152|FG002|Double-blind Treatment|Lost to Follow-up|0|||
42140006|NCT00405756|75950150|FG000|Double-blind Treatment|Death|4|||
42140007|NCT00405756|75950151|FG001|Double-blind Treatment|Death|4|||
42140008|NCT00405756|75950152|FG002|Double-blind Treatment|Death|4|||
42140009|NCT00405756|75950150|FG000|Double-blind Treatment|Protocol Violation|1|||
42140010|NCT00405756|75950151|FG001|Double-blind Treatment|Protocol Violation|0|||
42140011|NCT00405756|75950152|FG002|Double-blind Treatment|Protocol Violation|2|||
42275821|NCT01634152|76107021|FG000|Overall Study|Consent withdrawn not due to AE|1|||
42140012|NCT00405756|75950150|FG000|Double-blind Treatment|Other|7|||
42140013|NCT00405756|75950151|FG001|Double-blind Treatment|Other|4|||
42275822|NCT01634152|76107022|FG001|Overall Study|Consent withdrawn not due to AE|0|||
42275823|NCT01634152|76107023|FG002|Overall Study|Consent withdrawn not due to AE|1|||
42275824|NCT01634152|76107021|FG000|Overall Study|Not treated|0|||
42275825|NCT01634152|76107022|FG001|Overall Study|Not treated|1|||
42275826|NCT01634152|76107023|FG002|Overall Study|Not treated|0|||
42350656|NCT04534114|76190439|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
42350657|NCT04534114|76190440|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
42011699|NCT01001572|75818718|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
42011700|NCT01001572|75818716|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
42011701|NCT01001572|75818717|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
42011702|NCT01001572|75818718|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
42011703|NCT01001572|75818716|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
42011704|NCT01001572|75818717|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
42011705|NCT01001572|75818718|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
42011706|NCT01001572|75818716|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
42037730|NCT00830869|75846022|FG007|Period 2: Part 2|Progressive disease|14|||
42037731|NCT00830869|75846023|FG008|Period 2: Part 2|Progressive disease|11|||
42037732|NCT00830869|75846024|FG009|Period 2: Part 2|Progressive disease|12|||
42037733|NCT00830869|75846025|FG010|Period 2: Part 2|Progressive disease|8|||
42037734|NCT00830869|75846026|FG011|Period 2: Part 2|Progressive disease|15|||
42037735|NCT00830869|75846015|FG000|Period 2: Part 2|Other|0|||
42037736|NCT00830869|75846016|FG001|Period 2: Part 2|Other|0|||
42037737|NCT00830869|75846017|FG002|Period 2: Part 2|Other|0|||
42037738|NCT00830869|75846018|FG003|Period 2: Part 2|Other|0|||
42037739|NCT00830869|75846019|FG004|Period 2: Part 2|Other|0|||
42037740|NCT00830869|75846020|FG005|Period 2: Part 2|Other|0|||
42037741|NCT00830869|75846021|FG006|Period 2: Part 2|Other|0|||
42037742|NCT00830869|75846022|FG007|Period 2: Part 2|Other|0|||
42037743|NCT00830869|75846023|FG008|Period 2: Part 2|Other|0|||
42037744|NCT00830869|75846024|FG009|Period 2: Part 2|Other|1|||
42037745|NCT00830869|75846025|FG010|Period 2: Part 2|Other|0|||
42037746|NCT00830869|75846026|FG011|Period 2: Part 2|Other|0|||
42037747|NCT00844519|75846055|FG000|Overall Study|Withdrawal by Subject|1|||
42037748|NCT00844519|75846056|FG001|Overall Study|Withdrawal by Subject|1|||
42037749|NCT00844519|75846055|FG000|Overall Study|Adverse Event|1|||
42037750|NCT00844519|75846056|FG001|Overall Study|Adverse Event|0|||
42037751|NCT01171820|75846064|FG000|Overall Study|Death|3|||
42037752|NCT01171820|75846065|FG001|Overall Study|Death|3|||
42037753|NCT01171820|75846064|FG000|Overall Study|Lost to Follow-up|0|||
42037754|NCT01171820|75846065|FG001|Overall Study|Lost to Follow-up|1|||
42037755|NCT01171820|75846064|FG000|Overall Study|Withdrawal by Subject|2|||
42037756|NCT01171820|75846065|FG001|Overall Study|Withdrawal by Subject|0|||
42037757|NCT01171820|75846064|FG000|Overall Study|Physician Decision|0|||
42037758|NCT01171820|75846065|FG001|Overall Study|Physician Decision|1|||
42037759|NCT01171820|75846064|FG000|Overall Study|1-Year Missed Visit|1|||
42037760|NCT01171820|75846065|FG001|Overall Study|1-Year Missed Visit|1|||
42037761|NCT00994110|75846073|FG000|Overall Study|Withdrawal by Subject|9|||
42037762|NCT00994110|75846074|FG001|Overall Study|Withdrawal by Subject|9|||
42037763|NCT00994110|75846073|FG000|Overall Study|Not Treated|4|||
42037764|NCT00994110|75846074|FG001|Overall Study|Not Treated|8|||
42037765|NCT00994110|75846073|FG000|Overall Study|Adverse Event|1|||
42037766|NCT00994110|75846074|FG001|Overall Study|Adverse Event|0|||
42037767|NCT00994110|75846073|FG000|Overall Study|Patient not resected|41|||
42037768|NCT00994110|75846074|FG001|Overall Study|Patient not resected|52|||
42037769|NCT00994110|75846073|FG000|Overall Study|Pt not eligible|10|||
42037770|NCT00994110|75846074|FG001|Overall Study|Pt not eligible|5|||
42037771|NCT00993954|75846082|FG000|Overall Study|Protocol Violation|21|||
42037772|NCT00993954|75846083|FG001|Overall Study|Protocol Violation|2|||
42037773|NCT01157234|75846091|FG000|Overall Study|Withdrawal by Subject|1|||
42037774|NCT01157234|75846092|FG001|Overall Study|Withdrawal by Subject|0|||
42037775|NCT00991302|75846107|FG000|Overall Study|Death|0|||
42037776|NCT00991302|75846108|FG001|Overall Study|Death|1|||
42037777|NCT00991302|75846107|FG000|Overall Study|Lost to Follow-up|14|||
42037778|NCT00991302|75846108|FG001|Overall Study|Lost to Follow-up|12|||
42037779|NCT00995670|75846117|FG000|Overall Study|Failed arterial cannulation|1|||
42037780|NCT00995670|75846118|FG001|Overall Study|Failed arterial cannulation|0|||
42037781|NCT00995670|75846119|FG002|Overall Study|Failed arterial cannulation|3|||
42037782|NCT00601354|75846129|FG000|Overall Study|Lost to Follow-up|4|||
42037783|NCT00601354|75846130|FG001|Overall Study|Lost to Follow-up|5|||
42037784|NCT00853099|75846139|FG000|Double-blind Period|Adverse Event|7|||
42037785|NCT00853099|75846140|FG001|Double-blind Period|Adverse Event|9|||
42037786|NCT00853099|75846141|FG002|Double-blind Period|Adverse Event|13|||
42037787|NCT00853099|75846142|FG003|Double-blind Period|Adverse Event|0|||
42037788|NCT00853099|75846139|FG000|Double-blind Period|Withdrawal by Subject|2|||
42037789|NCT00853099|75846140|FG001|Double-blind Period|Withdrawal by Subject|3|||
42037790|NCT00853099|75846141|FG002|Double-blind Period|Withdrawal by Subject|0|||
42037791|NCT00853099|75846142|FG003|Double-blind Period|Withdrawal by Subject|0|||
42037792|NCT00853099|75846139|FG000|Double-blind Period|Lack of Efficacy|14|||
42037793|NCT00853099|75846140|FG001|Double-blind Period|Lack of Efficacy|17|||
42037794|NCT00853099|75846141|FG002|Double-blind Period|Lack of Efficacy|16|||
42037795|NCT00853099|75846142|FG003|Double-blind Period|Lack of Efficacy|0|||
42037796|NCT00853099|75846139|FG000|Double-blind Period|Other|0|||
42037797|NCT00853099|75846140|FG001|Double-blind Period|Other|0|||
42037798|NCT00853099|75846141|FG002|Double-blind Period|Other|1|||
42037799|NCT00853099|75846142|FG003|Double-blind Period|Other|0|||
42140014|NCT00405756|75950152|FG002|Double-blind Treatment|Other|4|||
42140015|NCT00405756|75950150|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
42140016|NCT00405756|75950151|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
42140017|NCT00405756|75950152|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
42140018|NCT00405756|75950150|FG000|Open-label Extension|Adverse Event|1|||
42140019|NCT00405756|75950151|FG001|Open-label Extension|Adverse Event|3|||
42140020|NCT00405756|75950152|FG002|Open-label Extension|Adverse Event|7|||
42140021|NCT00405756|75950150|FG000|Open-label Extension|Disease Progression|8|||
42140022|NCT00405756|75950151|FG001|Open-label Extension|Disease Progression|23|||
42140023|NCT00405756|75950152|FG002|Open-label Extension|Disease Progression|26|||
42140024|NCT00405756|75950150|FG000|Open-label Extension|Withdrawal by Subject|2|||
42140025|NCT00405756|75950151|FG001|Open-label Extension|Withdrawal by Subject|3|||
42140026|NCT00405756|75950152|FG002|Open-label Extension|Withdrawal by Subject|3|||
42140027|NCT00405756|75950150|FG000|Open-label Extension|Death|1|||
42140028|NCT00405756|75950151|FG001|Open-label Extension|Death|2|||
42140029|NCT00405756|75950152|FG002|Open-label Extension|Death|4|||
42140030|NCT00405756|75950150|FG000|Open-label Extension|Other|0|||
42140031|NCT00405756|75950151|FG001|Open-label Extension|Other|1|||
42140032|NCT00405756|75950152|FG002|Open-label Extension|Other|7|||
42140033|NCT00405756|75950150|FG000|Follow-up|Ongoing in Follow-up Period|52|||
42140034|NCT00405756|75950151|FG001|Follow-up|Ongoing in Follow-up Period|51|||
42140035|NCT00405756|75950152|FG002|Follow-up|Ongoing in Follow-up Period|60|||
42140036|NCT00405756|75950150|FG000|Follow-up|Death|21|||
42140037|NCT00405756|75950151|FG001|Follow-up|Death|31|||
42140038|NCT00405756|75950152|FG002|Follow-up|Death|24|||
42140039|NCT00405756|75950150|FG000|Follow-up|Lost to Follow-up|2|||
42140040|NCT00405756|75950151|FG001|Follow-up|Lost to Follow-up|8|||
42140041|NCT00405756|75950152|FG002|Follow-up|Lost to Follow-up|4|||
42140042|NCT00456092|75950163|FG000|Extension Phase|Grade 2 or Greater AE|2|||
42140043|NCT00456092|75950164|FG001|Extension Phase|Grade 2 or Greater AE|2|||
42140044|NCT00456092|75950165|FG002|Extension Phase|Grade 2 or Greater AE|0|||
42140045|NCT00456092|75950166|FG003|Extension Phase|Grade 2 or Greater AE|0|||
42140046|NCT00456092|75950167|FG004|Extension Phase|Grade 2 or Greater AE|2|||
42140047|NCT00456092|75950163|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
42140048|NCT00456092|75950164|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
42140049|NCT00456092|75950165|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
42140050|NCT00456092|75950166|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
42140051|NCT00456092|75950167|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
42140052|NCT00456092|75950163|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
42140053|NCT00456092|75950164|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
42140054|NCT00456092|75950165|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
42140055|NCT00456092|75950166|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
42140056|NCT00456092|75950167|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
42140057|NCT00456092|75950163|FG000|Extension Phase|Withdrew Consent|2|||
42140058|NCT00456092|75950164|FG001|Extension Phase|Withdrew Consent|0|||
42140059|NCT00456092|75950165|FG002|Extension Phase|Withdrew Consent|0|||
42140060|NCT00456092|75950166|FG003|Extension Phase|Withdrew Consent|0|||
42140061|NCT00456092|75950167|FG004|Extension Phase|Withdrew Consent|0|||
42140062|NCT00456092|75950163|FG000|Extension Phase|Lost to Follow-up|1|||
42140063|NCT00456092|75950164|FG001|Extension Phase|Lost to Follow-up|1|||
42011707|NCT01001572|75818717|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
42011708|NCT01001572|75818718|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
42011709|NCT01001572|75818716|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
42011710|NCT01001572|75818717|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
42011711|NCT01001572|75818718|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
42011712|NCT01208415|75818724|FG000|Overall Study|Death|1|||
42011713|NCT01208415|75818724|FG000|Overall Study|Lost to Follow-up|2|||
42011714|NCT01208415|75818724|FG000|Overall Study|Withdrawal by Subject|3|||
42011715|NCT01208415|75818724|FG000|Overall Study|Device not placed|1|||
42011716|NCT01208415|75818724|FG000|Overall Study|Still be eligible for follow-up|33|||
42011717|NCT01208337|75818728|FG000|Overall Study|Death|3|||
42350658|NCT04534114|76190441|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
42350659|NCT04534114|76190442|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
42350660|NCT04534114|76190439|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
42037800|NCT00853099|75846139|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
42037801|NCT00853099|75846140|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
42140064|NCT00456092|75950165|FG002|Extension Phase|Lost to Follow-up|0|||
42140065|NCT00456092|75950166|FG003|Extension Phase|Lost to Follow-up|0|||
42140066|NCT00456092|75950167|FG004|Extension Phase|Lost to Follow-up|1|||
42140067|NCT00456092|75950163|FG000|Extension Phase|Other|2|||
42140068|NCT00456092|75950164|FG001|Extension Phase|Other|0|||
42140069|NCT00456092|75950165|FG002|Extension Phase|Other|0|||
42140070|NCT00456092|75950166|FG003|Extension Phase|Other|1|||
42275827|NCT01634152|76107021|FG000|Overall Study|Other reason not defined above|1|||
42275828|NCT01634152|76107022|FG001|Overall Study|Other reason not defined above|0|||
42275829|NCT01634152|76107023|FG002|Overall Study|Other reason not defined above|1|||
42275830|NCT03862807|76107031|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
42275831|NCT04906499|76107044|FG000|Overall Study|Lack of time|1|||
42275832|NCT04757649|76107048|FG000|Overall Study|Withdrawal by Subject|1|||
42275833|NCT04757649|76107048|FG000|Overall Study|Adverse Event|1|||
42140071|NCT00456092|75950167|FG004|Extension Phase|Other|1|||
42140072|NCT00456092|75950163|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
42140073|NCT00456092|75950164|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
42140074|NCT00456092|75950165|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
42140075|NCT00456092|75950166|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
42140076|NCT00456092|75950167|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
42140077|NCT00456092|75950163|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
42140078|NCT00456092|75950164|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
42140079|NCT00456092|75950165|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
42140080|NCT00456092|75950166|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
42140081|NCT00456092|75950167|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
42140082|NCT00456092|75950163|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
42140083|NCT00456092|75950164|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
42140084|NCT00456092|75950165|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
42140085|NCT00456092|75950166|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
42140086|NCT00456092|75950167|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
42140087|NCT00456092|75950163|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
42140088|NCT00456092|75950164|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
42140089|NCT00456092|75950165|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
42140090|NCT00456092|75950166|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
42140091|NCT00456092|75950167|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
42140092|NCT00456092|75950163|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
42140093|NCT00456092|75950164|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
42140094|NCT00456092|75950165|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
42140095|NCT00456092|75950166|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
42140096|NCT00456092|75950167|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
42140097|NCT00456092|75950163|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
42140098|NCT00456092|75950164|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
42140099|NCT00456092|75950165|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
42140100|NCT00456092|75950166|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
42140101|NCT00456092|75950167|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
42140102|NCT00456092|75950163|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
42140103|NCT00456092|75950164|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
42140104|NCT00456092|75950165|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
42140105|NCT00456092|75950166|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
42140106|NCT00456092|75950167|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
42140107|NCT00456092|75950163|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
42140108|NCT00456092|75950164|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
42140109|NCT00456092|75950165|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
42140110|NCT00456092|75950166|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
42140111|NCT00456092|75950167|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
42140112|NCT00456092|75950163|FG000|Treatment Phase (12 Weeks)|Other|1|||
42140113|NCT00456092|75950164|FG001|Treatment Phase (12 Weeks)|Other|0|||
42140114|NCT00456092|75950165|FG002|Treatment Phase (12 Weeks)|Other|1|||
42140115|NCT00456092|75950166|FG003|Treatment Phase (12 Weeks)|Other|0|||
42140116|NCT00456092|75950167|FG004|Treatment Phase (12 Weeks)|Other|0|||
42140117|NCT00411450|75950181|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
42140118|NCT00404820|75950189|FG000|Overall Study|Adverse Event|4|||
42140119|NCT00404820|75950190|FG001|Overall Study|Adverse Event|16|||
42140120|NCT00404820|75950189|FG000|Overall Study|Withdrawal by Subject|5|||
42140121|NCT00404820|75950190|FG001|Overall Study|Withdrawal by Subject|3|||
42140122|NCT00404820|75950189|FG000|Overall Study|Lost to Follow-up|7|||
42140123|NCT00404820|75950190|FG001|Overall Study|Lost to Follow-up|3|||
42140124|NCT00404820|75950189|FG000|Overall Study|Administrative problems|2|||
42275834|NCT04393779|76107052|FG000|Overall Study|Death|1|||
42275835|NCT04393779|76107052|FG000|Overall Study|Device reintervention or explant|4|||
42140125|NCT00404820|75950190|FG001|Overall Study|Administrative problems|0|||
42275836|NCT03718884|76107056|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
42275837|NCT03718884|76107057|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
42275838|NCT03718884|76107056|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
42275839|NCT03718884|76107057|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
42140126|NCT00404820|75950189|FG000|Overall Study|Death|1|||
42140127|NCT00404820|75950190|FG001|Overall Study|Death|0|||
42140128|NCT00404820|75950189|FG000|Overall Study|Other|0|||
42140129|NCT00404820|75950190|FG001|Overall Study|Other|2|||
42140130|NCT00417612|75950198|FG000|Overall Study|Errant diagnosis|0|||
42140131|NCT00417612|75950199|FG001|Overall Study|Errant diagnosis|1|||
42140132|NCT00417612|75950198|FG000|Overall Study|Adverse Event|2|||
42140133|NCT00417612|75950199|FG001|Overall Study|Adverse Event|0|||
42140134|NCT00417612|75950198|FG000|Overall Study|Protocol Violation|0|||
42140135|NCT00417612|75950199|FG001|Overall Study|Protocol Violation|2|||
42140136|NCT00417612|75950198|FG000|Overall Study|Lost to Follow-up|1|||
42140137|NCT00417612|75950199|FG001|Overall Study|Lost to Follow-up|0|||
42140138|NCT00446030|75950209|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
42140139|NCT00446030|75950210|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
42140140|NCT00446030|75950209|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
42140141|NCT00446030|75950210|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
42140142|NCT00446030|75950209|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
42140143|NCT00446030|75950210|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
42140144|NCT00446030|75950209|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
42140145|NCT00446030|75950210|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
42140146|NCT00446030|75950209|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
42140147|NCT00446030|75950210|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
42140148|NCT00446030|75950209|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
42140149|NCT00446030|75950210|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
42140150|NCT00446030|75950209|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
42037802|NCT00853099|75846141|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
42037803|NCT00853099|75846142|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
42037804|NCT00853099|75846139|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
42037805|NCT00853099|75846140|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
42140151|NCT00446030|75950210|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
42140152|NCT00446030|75950209|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
42140153|NCT00446030|75950210|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
42140154|NCT00446030|75950209|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
42140155|NCT00446030|75950210|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
42140156|NCT00446030|75950209|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
42140157|NCT00446030|75950210|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
42140158|NCT00446030|75950209|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
42140159|NCT00446030|75950210|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
42140160|NCT00446030|75950209|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
42140161|NCT00446030|75950210|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
42140162|NCT00446030|75950209|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
42140163|NCT00446030|75950210|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
42140164|NCT00446030|75950209|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
42140165|NCT00446030|75950210|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
42140166|NCT00446030|75950209|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
42140167|NCT00446030|75950210|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
42140168|NCT00446030|75950209|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
42140169|NCT00446030|75950210|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
42140170|NCT00446030|75950209|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
42140171|NCT00446030|75950210|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
42140172|NCT00446030|75950209|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
42140173|NCT00446030|75950210|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
42140174|NCT00446030|75950209|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
42140175|NCT00446030|75950210|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
42140176|NCT00411216|75950218|FG000|Overall Study|Ten participants were entered into the c|0|||
42140177|NCT00411216|75950219|FG001|Overall Study|Ten participants were entered into the c|2|||
42140178|NCT00410514|75950228|FG000|Overall Study|Adverse Event|2|||
42140179|NCT00410514|75950229|FG001|Overall Study|Adverse Event|2|||
42140180|NCT00410514|75950230|FG002|Overall Study|Adverse Event|2|||
42140181|NCT00410514|75950228|FG000|Overall Study|Protocol Violation|0|||
42140182|NCT00410514|75950229|FG001|Overall Study|Protocol Violation|1|||
42140183|NCT00410514|75950230|FG002|Overall Study|Protocol Violation|1|||
42275840|NCT03509467|76107080|FG000|Overall Study|Withdrawal by Subject|5|||
42037806|NCT00853099|75846141|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
42140184|NCT00410514|75950228|FG000|Overall Study|Lost to Follow-up|0|||
42140185|NCT00410514|75950229|FG001|Overall Study|Lost to Follow-up|0|||
42275841|NCT03509467|76107081|FG001|Overall Study|Withdrawal by Subject|1|||
42037807|NCT00853099|75846142|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
42140186|NCT00410514|75950230|FG002|Overall Study|Lost to Follow-up|2|||
42140187|NCT00410514|75950228|FG000|Overall Study|Non-compliant with study procedures|0|||
42275842|NCT03509467|76107082|FG002|Overall Study|Withdrawal by Subject|6|||
42140188|NCT00410514|75950229|FG001|Overall Study|Non-compliant with study procedures|0|||
42140189|NCT00410514|75950230|FG002|Overall Study|Non-compliant with study procedures|2|||
42140190|NCT03847610|75950238|FG000|Overall Study|Withdrawal by Subject|1|||
42140191|NCT03843632|75950246|FG000|Overall Study|Withdrawal by Subject|1|||
42140192|NCT03843632|75950247|FG001|Overall Study|Withdrawal by Subject|0|||
42140193|NCT03843632|75950248|FG002|Overall Study|Withdrawal by Subject|0|||
42037808|NCT00853099|75846139|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
42140194|NCT03843632|75950249|FG003|Overall Study|Withdrawal by Subject|0|||
42140195|NCT00455858|75950259|FG000|Overall Study|Lost to Follow-up|2|||
42140196|NCT00455858|75950259|FG000|Overall Study|Protocol Violation|1|||
42140197|NCT00455858|75950259|FG000|Overall Study|Lack of Efficacy|1|||
42140198|NCT00455858|75950259|FG000|Overall Study|Well controlled FPG without insulin|1|||
42140199|NCT00455858|75950259|FG000|Overall Study|Withdrawal|1|||
42140200|NCT00439556|75950266|FG000|Overall Study|Patient was taken off study for non-comp|0|||
42140201|NCT00439556|75950267|FG001|Overall Study|Patient was taken off study for non-comp|1|||
42140202|NCT00439556|75950268|FG002|Overall Study|Patient was taken off study for non-comp|0|||
42140203|NCT00410202|75950280|FG000|On-Treatment|Continuing treatment|69|||
42140204|NCT00410202|75950281|FG001|On-Treatment|Continuing treatment|71|||
42140205|NCT00410202|75950282|FG002|On-Treatment|Continuing treatment|66|||
42140206|NCT00410202|75950280|FG000|On-Treatment|Adverse Event|1|||
42140207|NCT00410202|75950281|FG001|On-Treatment|Adverse Event|3|||
42140208|NCT00410202|75950282|FG002|On-Treatment|Adverse Event|2|||
42140209|NCT00410202|75950280|FG000|On-Treatment|Death|1|||
42140210|NCT00410202|75950281|FG001|On-Treatment|Death|0|||
42140211|NCT00410202|75950282|FG002|On-Treatment|Death|0|||
42140212|NCT00410202|75950280|FG000|On-Treatment|Lost to Follow-up|1|||
42140213|NCT00410202|75950281|FG001|On-Treatment|Lost to Follow-up|0|||
42140214|NCT00410202|75950282|FG002|On-Treatment|Lost to Follow-up|1|||
42140215|NCT00410202|75950280|FG000|On-Treatment|Lack of Efficacy|1|||
42140216|NCT00410202|75950281|FG001|On-Treatment|Lack of Efficacy|4|||
42140217|NCT00410202|75950282|FG002|On-Treatment|Lack of Efficacy|0|||
42140218|NCT00410202|75950280|FG000|On-Treatment|Withdrawal by Subject|2|||
42140219|NCT00410202|75950281|FG001|On-Treatment|Withdrawal by Subject|1|||
42140220|NCT00410202|75950282|FG002|On-Treatment|Withdrawal by Subject|1|||
42140221|NCT00410202|75950280|FG000|On-Treatment|Other Reason|0|||
42140222|NCT00410202|75950281|FG001|On-Treatment|Other Reason|0|||
42140223|NCT00410202|75950282|FG002|On-Treatment|Other Reason|1|||
42011718|NCT01208181|75818744|FG000|Part 1|Withdrawal by Subject|11|||
42011719|NCT01208181|75818745|FG001|Part 1|Withdrawal by Subject|10|||
42011720|NCT01208181|75818746|FG002|Part 1|Withdrawal by Subject|0|||
42011721|NCT01208181|75818747|FG003|Part 1|Withdrawal by Subject|0|||
42011722|NCT01208181|75818748|FG004|Part 1|Withdrawal by Subject|0|||
42011723|NCT01208181|75818744|FG000|Part 1|Technical problem|5|||
42011724|NCT01208181|75818745|FG001|Part 1|Technical problem|0|||
42037809|NCT00853099|75846140|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
42037810|NCT00853099|75846141|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
42037811|NCT00853099|75846142|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
42037812|NCT00853099|75846139|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
42037813|NCT00853099|75846140|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
42037814|NCT00853099|75846141|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
42037815|NCT00853099|75846142|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
42037816|NCT00853099|75846139|FG000|Double-blind + Open-label Periods|Other|0|||
42037817|NCT00853099|75846140|FG001|Double-blind + Open-label Periods|Other|0|||
42037818|NCT00853099|75846141|FG002|Double-blind + Open-label Periods|Other|0|||
42011725|NCT01208181|75818746|FG002|Part 1|Technical problem|0|||
42011726|NCT01208181|75818747|FG003|Part 1|Technical problem|0|||
42011727|NCT01208181|75818748|FG004|Part 1|Technical problem|0|||
42037819|NCT00853099|75846142|FG003|Double-blind + Open-label Periods|Other|6|||
42037820|NCT00992784|75846155|FG000|Overall Study|Adverse Event|2|||
42037821|NCT00992784|75846156|FG001|Overall Study|Adverse Event|1|||
42037822|NCT00992784|75846157|FG002|Overall Study|Adverse Event|0|||
42037823|NCT00992784|75846155|FG000|Overall Study|Withdrawal by Subject|1|||
42037824|NCT00992784|75846156|FG001|Overall Study|Withdrawal by Subject|1|||
42037825|NCT00992784|75846157|FG002|Overall Study|Withdrawal by Subject|1|||
42037826|NCT00830167|75846167|FG000|Overall Study|Lack of Efficacy|26|||
42037827|NCT00830167|75846168|FG001|Overall Study|Lack of Efficacy|10|||
42037828|NCT00830167|75846167|FG000|Overall Study|Adverse Event|8|||
42037829|NCT00830167|75846168|FG001|Overall Study|Adverse Event|24|||
42037830|NCT00830167|75846167|FG000|Overall Study|Not meeting entrance criteria|2|||
42037831|NCT00830167|75846168|FG001|Overall Study|Not meeting entrance criteria|5|||
42037832|NCT00830167|75846167|FG000|Overall Study|Withdrawal by Subject|2|||
42140224|NCT00410202|75950280|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
42011728|NCT01208181|75818744|FG000|Part 1|Protocol Violation|10|||
42037833|NCT00830167|75846168|FG001|Overall Study|Withdrawal by Subject|0|||
42037834|NCT00830167|75846167|FG000|Overall Study|Lost to Follow-up|0|||
42037835|NCT00830167|75846168|FG001|Overall Study|Lost to Follow-up|1|||
42140225|NCT00410202|75950281|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
42140226|NCT00410202|75950282|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
42140227|NCT00410202|75950280|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
42140228|NCT00410202|75950281|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
42140229|NCT00410202|75950282|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
42140230|NCT00410202|75950280|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
42140231|NCT00410202|75950281|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
42140232|NCT00410202|75950282|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
42140233|NCT00445328|75950293|FG000|Overall Study|Death|0|||
42140234|NCT00445328|75950294|FG001|Overall Study|Death|1|||
42140235|NCT00445328|75950293|FG000|Overall Study|Adverse Event|0|||
42140236|NCT00445328|75950294|FG001|Overall Study|Adverse Event|3|||
42140237|NCT00445328|75950293|FG000|Overall Study|Other|0|||
42140238|NCT00445328|75950294|FG001|Overall Study|Other|2|||
42140239|NCT00445328|75950293|FG000|Overall Study|Withdrawal by Subject|2|||
42140240|NCT00445328|75950294|FG001|Overall Study|Withdrawal by Subject|0|||
42140241|NCT00445328|75950293|FG000|Overall Study|Protocol Violation|1|||
42140242|NCT00445328|75950294|FG001|Overall Study|Protocol Violation|0|||
42140243|NCT00455312|75950302|FG000|Overall Study|Death|0|||
42140244|NCT00455312|75950303|FG001|Overall Study|Death|1|||
42140245|NCT00444626|75950309|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
42140246|NCT00444626|75950309|FG000|Initial Treatment Period|Adverse Event|1|||
42140247|NCT00444626|75950309|FG000|Initial Treatment Period|Lost to Follow-up|9|||
42140248|NCT00404352|75950336|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
42140249|NCT00404352|75950337|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
42140250|NCT00404352|75950338|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
42140251|NCT00404352|75950339|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
42140252|NCT00404352|75950340|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
42140253|NCT00404352|75950341|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
42140254|NCT00404352|75950342|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
42140255|NCT00404352|75950343|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
42140256|NCT00404352|75950344|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
42140257|NCT00404352|75950336|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
42140258|NCT00404352|75950337|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
42140259|NCT00404352|75950338|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
42140260|NCT00404352|75950339|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
42140261|NCT00404352|75950340|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
42140262|NCT00404352|75950341|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
42140263|NCT00404352|75950342|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
42140264|NCT00404352|75950343|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
42140265|NCT00404352|75950344|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
42140266|NCT00404352|75950336|FG000|Double Blind (up to 24 Month)|Death|0|||
42140267|NCT00404352|75950337|FG001|Double Blind (up to 24 Month)|Death|0|||
42140268|NCT00404352|75950338|FG002|Double Blind (up to 24 Month)|Death|1|||
42140269|NCT00404352|75950339|FG003|Double Blind (up to 24 Month)|Death|0|||
42140270|NCT00404352|75950340|FG004|Double Blind (up to 24 Month)|Death|0|||
42140271|NCT00404352|75950341|FG005|Double Blind (up to 24 Month)|Death|0|||
42140272|NCT00404352|75950342|FG006|Double Blind (up to 24 Month)|Death|0|||
42140273|NCT00404352|75950343|FG007|Double Blind (up to 24 Month)|Death|0|||
42140274|NCT00404352|75950344|FG008|Double Blind (up to 24 Month)|Death|0|||
42140275|NCT00404352|75950336|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
42140276|NCT00404352|75950337|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
42140277|NCT00404352|75950338|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
42140278|NCT00404352|75950339|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
42140279|NCT00404352|75950340|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
42140280|NCT00404352|75950341|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
42140281|NCT00404352|75950342|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
42140282|NCT00404352|75950343|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
42140283|NCT00404352|75950344|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
42140284|NCT00404352|75950336|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
42140285|NCT00404352|75950337|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
42140286|NCT00404352|75950338|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
42140287|NCT00404352|75950339|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
42140288|NCT00404352|75950340|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
42140289|NCT00404352|75950341|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
42140290|NCT00404352|75950342|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
42140291|NCT00404352|75950343|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
42140292|NCT00404352|75950344|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
42275843|NCT03509467|76107083|FG003|Overall Study|Withdrawal by Subject|7|||
42275844|NCT03509467|76107084|FG004|Overall Study|Withdrawal by Subject|10|||
42350661|NCT04534114|76190440|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
42350662|NCT04534114|76190441|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
42140293|NCT00404352|75950336|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
42140294|NCT00404352|75950337|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
42140295|NCT00404352|75950338|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
42140296|NCT00404352|75950339|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
42140297|NCT00404352|75950340|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
42011729|NCT01208181|75818745|FG001|Part 1|Protocol Violation|5|||
42011730|NCT01208181|75818746|FG002|Part 1|Protocol Violation|0|||
42011731|NCT01208181|75818747|FG003|Part 1|Protocol Violation|0|||
42011732|NCT01208181|75818748|FG004|Part 1|Protocol Violation|0|||
42011733|NCT01208181|75818744|FG000|Part 1|Physician Decision|4|||
42011734|NCT01208181|75818745|FG001|Part 1|Physician Decision|0|||
42011735|NCT01208181|75818746|FG002|Part 1|Physician Decision|0|||
42011736|NCT01208181|75818747|FG003|Part 1|Physician Decision|0|||
42011737|NCT01208181|75818748|FG004|Part 1|Physician Decision|0|||
42011738|NCT01208181|75818744|FG000|Part 1|Non-compliance with study drug|1|||
42011739|NCT01208181|75818745|FG001|Part 1|Non-compliance with study drug|1|||
42011740|NCT01208181|75818746|FG002|Part 1|Non-compliance with study drug|0|||
42011741|NCT01208181|75818747|FG003|Part 1|Non-compliance with study drug|0|||
42011742|NCT01208181|75818748|FG004|Part 1|Non-compliance with study drug|0|||
42011743|NCT01208181|75818744|FG000|Part 1|Lost to Follow-up|5|||
42011744|NCT01208181|75818745|FG001|Part 1|Lost to Follow-up|3|||
42011745|NCT01208181|75818746|FG002|Part 1|Lost to Follow-up|0|||
42011746|NCT01208181|75818747|FG003|Part 1|Lost to Follow-up|0|||
42011747|NCT01208181|75818748|FG004|Part 1|Lost to Follow-up|1|||
42011748|NCT01208181|75818744|FG000|Part 1|Lack of Efficacy|37|||
42011749|NCT01208181|75818745|FG001|Part 1|Lack of Efficacy|12|||
42037836|NCT00830167|75846167|FG000|Overall Study|Protocol Violation|0|||
42037837|NCT00830167|75846168|FG001|Overall Study|Protocol Violation|1|||
42037838|NCT00830167|75846167|FG000|Overall Study|Other|2|||
42037839|NCT00830167|75846168|FG001|Overall Study|Other|2|||
42037840|NCT00992394|75846176|FG000|Overall Study|Lack of Efficacy|6|||
42037841|NCT00992394|75846177|FG001|Overall Study|Lack of Efficacy|3|||
42037842|NCT00992394|75846176|FG000|Overall Study|Adverse Event|4|||
42037843|NCT00992394|75846177|FG001|Overall Study|Adverse Event|5|||
42037844|NCT00992394|75846176|FG000|Overall Study|Withdrawal by Subject|8|||
42037845|NCT00992394|75846177|FG001|Overall Study|Withdrawal by Subject|2|||
42037846|NCT00992394|75846176|FG000|Overall Study|Physician Decision|1|||
42037847|NCT00992394|75846177|FG001|Overall Study|Physician Decision|0|||
42037848|NCT00992394|75846176|FG000|Overall Study|Protocol Violation|2|||
42037849|NCT00992394|75846177|FG001|Overall Study|Protocol Violation|4|||
42037850|NCT00992394|75846176|FG000|Overall Study|Lost to Follow-up|2|||
42037851|NCT00992394|75846177|FG001|Overall Study|Lost to Follow-up|0|||
42037852|NCT00992394|75846176|FG000|Overall Study|Other event|1|||
42037853|NCT00992394|75846177|FG001|Overall Study|Other event|0|||
42037854|NCT00829933|75846187|FG000|Overall Study|Adverse Event|2|||
42037855|NCT00829933|75846188|FG001|Overall Study|Adverse Event|3|||
42037856|NCT00829933|75846189|FG002|Overall Study|Adverse Event|2|||
42037857|NCT00829933|75846190|FG003|Overall Study|Adverse Event|1|||
42037858|NCT00829933|75846187|FG000|Overall Study|Death|0|||
42037859|NCT00829933|75846188|FG001|Overall Study|Death|0|||
42037860|NCT00829933|75846189|FG002|Overall Study|Death|1|||
42037861|NCT00829933|75846190|FG003|Overall Study|Death|1|||
42037862|NCT00829933|75846187|FG000|Overall Study|Lack of Efficacy|0|||
42037863|NCT00829933|75846188|FG001|Overall Study|Lack of Efficacy|1|||
42037864|NCT00829933|75846189|FG002|Overall Study|Lack of Efficacy|0|||
42037865|NCT00829933|75846190|FG003|Overall Study|Lack of Efficacy|0|||
42037866|NCT00829933|75846187|FG000|Overall Study|Physician Decision|5|||
42037867|NCT00829933|75846188|FG001|Overall Study|Physician Decision|7|||
42037868|NCT00829933|75846189|FG002|Overall Study|Physician Decision|8|||
42037869|NCT00829933|75846190|FG003|Overall Study|Physician Decision|1|||
42037870|NCT00829933|75846187|FG000|Overall Study|Pregnancy|0|||
42037871|NCT00829933|75846188|FG001|Overall Study|Pregnancy|0|||
42037872|NCT00829933|75846189|FG002|Overall Study|Pregnancy|0|||
42011750|NCT01208181|75818746|FG002|Part 1|Lack of Efficacy|0|||
42011751|NCT01208181|75818747|FG003|Part 1|Lack of Efficacy|0|||
42037873|NCT00829933|75846190|FG003|Overall Study|Pregnancy|2|||
42037874|NCT00829933|75846187|FG000|Overall Study|Protocol Violation|2|||
42037875|NCT00829933|75846188|FG001|Overall Study|Protocol Violation|1|||
42037876|NCT00829933|75846189|FG002|Overall Study|Protocol Violation|0|||
42037877|NCT00829933|75846190|FG003|Overall Study|Protocol Violation|0|||
42037878|NCT00829933|75846187|FG000|Overall Study|withdrew before treatment started|5|||
42037879|NCT00829933|75846188|FG001|Overall Study|withdrew before treatment started|1|||
42037880|NCT00829933|75846189|FG002|Overall Study|withdrew before treatment started|2|||
42037881|NCT00829933|75846190|FG003|Overall Study|withdrew before treatment started|9|||
42037882|NCT01170962|75846203|FG000|Treatment Period|Lack of Efficacy|96|||
42037883|NCT01170962|75846204|FG001|Treatment Period|Lack of Efficacy|91|||
42140298|NCT00404352|75950341|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
42011752|NCT01208181|75818748|FG004|Part 1|Lack of Efficacy|17|||
42011753|NCT01208181|75818744|FG000|Part 1|Adverse Event|26|||
42011754|NCT01208181|75818745|FG001|Part 1|Adverse Event|24|||
42140299|NCT00404352|75950342|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
42140300|NCT00404352|75950343|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
42140301|NCT00404352|75950344|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
42140302|NCT00404352|75950336|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
42140303|NCT00404352|75950337|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
42140304|NCT00404352|75950338|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
42140305|NCT00404352|75950339|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
42140306|NCT00404352|75950340|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
42140307|NCT00404352|75950341|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
42140308|NCT00404352|75950342|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
42140309|NCT00404352|75950343|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
42140310|NCT00404352|75950344|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
42140311|NCT00404352|75950336|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
42140312|NCT00404352|75950337|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
42140313|NCT00404352|75950338|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
42140314|NCT00404352|75950339|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
42140315|NCT00404352|75950340|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
42140316|NCT00404352|75950341|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
42140317|NCT00404352|75950342|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
42140318|NCT00404352|75950343|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
42140319|NCT00404352|75950344|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
42140320|NCT00404352|75950336|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
42140321|NCT00404352|75950337|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
42140322|NCT00404352|75950338|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
42140323|NCT00404352|75950339|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
42140324|NCT00404352|75950340|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
42140325|NCT00404352|75950341|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
42140326|NCT00404352|75950342|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
42140327|NCT00404352|75950343|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
42140328|NCT00404352|75950344|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
42140329|NCT00404352|75950336|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
42140330|NCT00404352|75950337|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
42140331|NCT00404352|75950338|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
42140332|NCT00404352|75950339|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
42140333|NCT00404352|75950340|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
42140334|NCT00404352|75950341|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
42140335|NCT00404352|75950342|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
42140336|NCT00404352|75950343|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
42140337|NCT00404352|75950344|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
42140338|NCT00404352|75950336|FG000|Double Blind (up to 24 Month)|Other|0|||
42140339|NCT00404352|75950337|FG001|Double Blind (up to 24 Month)|Other|1|||
42140340|NCT00404352|75950338|FG002|Double Blind (up to 24 Month)|Other|0|||
42140341|NCT00404352|75950339|FG003|Double Blind (up to 24 Month)|Other|0|||
42140342|NCT00404352|75950340|FG004|Double Blind (up to 24 Month)|Other|0|||
42140343|NCT00404352|75950341|FG005|Double Blind (up to 24 Month)|Other|0|||
42140344|NCT00404352|75950342|FG006|Double Blind (up to 24 Month)|Other|0|||
42140345|NCT00404352|75950343|FG007|Double Blind (up to 24 Month)|Other|0|||
42140346|NCT00404352|75950344|FG008|Double Blind (up to 24 Month)|Other|0|||
42037884|NCT01170962|75846205|FG002|Treatment Period|Lack of Efficacy|7|||
42037885|NCT01170962|75846203|FG000|Treatment Period|Adverse Event|11|||
42037886|NCT01170962|75846204|FG001|Treatment Period|Adverse Event|12|||
42037887|NCT01170962|75846205|FG002|Treatment Period|Adverse Event|3|||
42037888|NCT01170962|75846203|FG000|Treatment Period|Withdrawal by Subject|2|||
42037889|NCT01170962|75846204|FG001|Treatment Period|Withdrawal by Subject|1|||
42037890|NCT01170962|75846205|FG002|Treatment Period|Withdrawal by Subject|0|||
42037891|NCT01170962|75846203|FG000|Treatment Period|Lost to Follow-up|1|||
42037892|NCT01170962|75846204|FG001|Treatment Period|Lost to Follow-up|1|||
42037893|NCT01170962|75846205|FG002|Treatment Period|Lost to Follow-up|1|||
42037894|NCT01170962|75846203|FG000|Treatment Period|Participant no longer meets criteria|0|||
42037895|NCT01170962|75846204|FG001|Treatment Period|Participant no longer meets criteria|1|||
42037896|NCT01170962|75846205|FG002|Treatment Period|Participant no longer meets criteria|0|||
42037897|NCT01170962|75846203|FG000|Treatment Period|Request to discontinue treatment|7|||
42037898|NCT01170962|75846204|FG001|Treatment Period|Request to discontinue treatment|3|||
42037899|NCT01170962|75846205|FG002|Treatment Period|Request to discontinue treatment|1|||
42037900|NCT01170962|75846203|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
42037901|NCT01170962|75846204|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
42140347|NCT00404352|75950336|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
42140348|NCT00404352|75950337|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
42037902|NCT01170962|75846205|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
42140349|NCT00404352|75950338|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
42140350|NCT00404352|75950339|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
42140351|NCT00404352|75950340|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
42140352|NCT00404352|75950341|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
42140353|NCT00404352|75950342|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
42140354|NCT00404352|75950343|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
42140355|NCT00404352|75950344|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
42140356|NCT00404352|75950336|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
42140357|NCT00404352|75950337|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
42140358|NCT00404352|75950338|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
42140359|NCT00404352|75950339|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
42140360|NCT00404352|75950340|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
42140361|NCT00404352|75950341|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
42140362|NCT00404352|75950342|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
42140363|NCT00404352|75950343|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
42140364|NCT00404352|75950344|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
42140365|NCT00404352|75950336|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
42350663|NCT04534114|76190442|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
42350664|NCT04534114|76190439|FG000|Extension Treatment Period|Other reason|0|||
42350665|NCT04534114|76190440|FG001|Extension Treatment Period|Other reason|1|||
42350666|NCT04534114|76190441|FG002|Extension Treatment Period|Other reason|0|||
42350667|NCT04534114|76190442|FG003|Extension Treatment Period|Other reason|0|||
42350668|NCT04534114|76190439|FG000|Extension Treatment Period|Death|0|||
42350669|NCT04534114|76190440|FG001|Extension Treatment Period|Death|0|||
42350670|NCT04534114|76190441|FG002|Extension Treatment Period|Death|1|||
42350671|NCT04534114|76190442|FG003|Extension Treatment Period|Death|2|||
42350672|NCT04534114|76190439|FG000|Extension Treatment Period|Adverse Event|0|||
42350673|NCT04534114|76190440|FG001|Extension Treatment Period|Adverse Event|1|||
42350674|NCT04534114|76190441|FG002|Extension Treatment Period|Adverse Event|0|||
42140366|NCT00404352|75950337|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
42011755|NCT01208181|75818746|FG002|Part 1|Adverse Event|0|||
42011756|NCT01208181|75818747|FG003|Part 1|Adverse Event|0|||
42011757|NCT01208181|75818748|FG004|Part 1|Adverse Event|4|||
42011758|NCT01208181|75818744|FG000|Part 2|Adverse Event|0|||
42011759|NCT01208181|75818745|FG001|Part 2|Adverse Event|0|||
42011760|NCT01208181|75818746|FG002|Part 2|Adverse Event|6|||
42011761|NCT01208181|75818747|FG003|Part 2|Adverse Event|7|||
42011762|NCT01208181|75818748|FG004|Part 2|Adverse Event|0|||
42140367|NCT00404352|75950338|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
42140368|NCT00404352|75950339|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
42140369|NCT00404352|75950340|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
42140370|NCT00404352|75950341|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
42275845|NCT03509467|76107085|FG005|Overall Study|Withdrawal by Subject|10|||
42140371|NCT00404352|75950342|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
42275846|NCT03509467|76107086|FG006|Overall Study|Withdrawal by Subject|10|||
42275847|NCT03509467|76107087|FG007|Overall Study|Withdrawal by Subject|10|||
42275848|NCT03509467|76107080|FG000|Overall Study|Death|0|||
42275849|NCT03509467|76107081|FG001|Overall Study|Death|0|||
42275850|NCT03509467|76107082|FG002|Overall Study|Death|2|||
42275851|NCT03509467|76107083|FG003|Overall Study|Death|2|||
42275852|NCT03509467|76107084|FG004|Overall Study|Death|1|||
42275853|NCT03509467|76107085|FG005|Overall Study|Death|0|||
42350675|NCT04534114|76190442|FG003|Extension Treatment Period|Adverse Event|1|||
42140372|NCT00404352|75950343|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
42140373|NCT00404352|75950344|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
42275854|NCT03509467|76107086|FG006|Overall Study|Death|1|||
42275855|NCT03509467|76107087|FG007|Overall Study|Death|0|||
42275856|NCT03509467|76107080|FG000|Overall Study|Proxy Withdrawal|0|||
42350676|NCT04534114|76190439|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
42011763|NCT01208181|75818744|FG000|Part 2|Withdrawal by Subject|0|||
42011764|NCT01208181|75818745|FG001|Part 2|Withdrawal by Subject|0|||
42037903|NCT01170962|75846203|FG000|Follow up Period|Withdrawal by Subject|14|||
42037904|NCT01170962|75846204|FG001|Follow up Period|Withdrawal by Subject|10|||
42037905|NCT01170962|75846205|FG002|Follow up Period|Withdrawal by Subject|2|||
42037906|NCT01170962|75846203|FG000|Follow up Period|Lost to Follow-up|13|||
42037907|NCT01170962|75846204|FG001|Follow up Period|Lost to Follow-up|8|||
42037908|NCT01170962|75846205|FG002|Follow up Period|Lost to Follow-up|1|||
42140374|NCT00404352|75950336|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
42140375|NCT00404352|75950337|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
42140376|NCT00404352|75950338|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
42140377|NCT00404352|75950339|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
42140378|NCT00404352|75950340|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
42140379|NCT00404352|75950341|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
42140380|NCT00404352|75950342|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
42140381|NCT00404352|75950343|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
42140382|NCT00404352|75950344|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
42140383|NCT00404352|75950336|FG000|Open Label (up to 24 Month)|Disease progression|0|||
42140384|NCT00404352|75950337|FG001|Open Label (up to 24 Month)|Disease progression|0|||
42140385|NCT00404352|75950338|FG002|Open Label (up to 24 Month)|Disease progression|0|||
42140386|NCT00404352|75950339|FG003|Open Label (up to 24 Month)|Disease progression|1|||
42140387|NCT00404352|75950340|FG004|Open Label (up to 24 Month)|Disease progression|0|||
42140388|NCT00404352|75950341|FG005|Open Label (up to 24 Month)|Disease progression|0|||
42140389|NCT00404352|75950342|FG006|Open Label (up to 24 Month)|Disease progression|0|||
42140390|NCT00404352|75950343|FG007|Open Label (up to 24 Month)|Disease progression|0|||
42140391|NCT00404352|75950344|FG008|Open Label (up to 24 Month)|Disease progression|0|||
42140392|NCT00404352|75950336|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
42140393|NCT00404352|75950337|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
42140394|NCT00404352|75950338|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
42140395|NCT00404352|75950339|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
42140396|NCT00404352|75950340|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
42140397|NCT00404352|75950341|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
42140398|NCT00404352|75950342|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
42140399|NCT00404352|75950343|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
42140400|NCT00404352|75950344|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
42140401|NCT00404352|75950336|FG000|Open Label Extension (up to 36 Months)|Other|0|||
42140402|NCT00404352|75950337|FG001|Open Label Extension (up to 36 Months)|Other|0|||
42140403|NCT00404352|75950338|FG002|Open Label Extension (up to 36 Months)|Other|0|||
42140404|NCT00404352|75950339|FG003|Open Label Extension (up to 36 Months)|Other|0|||
42140405|NCT00404352|75950340|FG004|Open Label Extension (up to 36 Months)|Other|0|||
42140406|NCT00404352|75950341|FG005|Open Label Extension (up to 36 Months)|Other|0|||
42140407|NCT00404352|75950342|FG006|Open Label Extension (up to 36 Months)|Other|0|||
42140408|NCT00404352|75950343|FG007|Open Label Extension (up to 36 Months)|Other|0|||
42140409|NCT00404352|75950344|FG008|Open Label Extension (up to 36 Months)|Other|2|||
42037909|NCT01170962|75846203|FG000|Follow up Period|Death|2|||
42037910|NCT01170962|75846204|FG001|Follow up Period|Death|2|||
42037911|NCT01170962|75846205|FG002|Follow up Period|Death|0|||
42037912|NCT01170962|75846203|FG000|Follow up Period|Others|10|||
42037913|NCT01170962|75846204|FG001|Follow up Period|Others|7|||
42037914|NCT01170962|75846205|FG002|Follow up Period|Others|3|||
42037915|NCT00843193|75846224|FG000|Overall Study|Adverse Event|2|||
42037916|NCT00843193|75846225|FG001|Overall Study|Adverse Event|4|||
42037917|NCT00843193|75846224|FG000|Overall Study|Lack of Efficacy|1|||
42037918|NCT00843193|75846225|FG001|Overall Study|Lack of Efficacy|1|||
42037919|NCT00843193|75846224|FG000|Overall Study|Protocol Violation|1|||
42037920|NCT00843193|75846225|FG001|Overall Study|Protocol Violation|2|||
42037921|NCT00843193|75846224|FG000|Overall Study|Lost to Follow-up|1|||
42037922|NCT00843193|75846225|FG001|Overall Study|Lost to Follow-up|0|||
42037923|NCT00843193|75846224|FG000|Overall Study|Physician Decision|0|||
42140410|NCT00439244|75950364|FG000|Overall Study|Adverse Event|5|||
42140411|NCT00439244|75950365|FG001|Overall Study|Adverse Event|2|||
42140412|NCT00439244|75950366|FG002|Overall Study|Adverse Event|3|||
42140413|NCT00439244|75950364|FG000|Overall Study|Withdrawal by Subject|3|||
42140414|NCT00439244|75950365|FG001|Overall Study|Withdrawal by Subject|1|||
42037924|NCT00843193|75846225|FG001|Overall Study|Physician Decision|1|||
42037925|NCT00843193|75846224|FG000|Overall Study|Withdrawal by Subject|3|||
42140415|NCT00439244|75950366|FG002|Overall Study|Withdrawal by Subject|2|||
42140416|NCT00439244|75950364|FG000|Overall Study|Lost to Follow-up|2|||
42140417|NCT00439244|75950365|FG001|Overall Study|Lost to Follow-up|1|||
42140418|NCT00439244|75950366|FG002|Overall Study|Lost to Follow-up|2|||
42140419|NCT00439244|75950364|FG000|Overall Study|Death|0|||
42140420|NCT00439244|75950365|FG001|Overall Study|Death|1|||
42037926|NCT00843193|75846225|FG001|Overall Study|Withdrawal by Subject|3|||
42037927|NCT00829621|75846234|FG000|Overall Study|Death|1|||
42037928|NCT00829621|75846235|FG001|Overall Study|Death|0|||
42350677|NCT04534114|76190440|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
42350678|NCT04534114|76190441|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
42350679|NCT04534114|76190442|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
42037929|NCT00829621|75846234|FG000|Overall Study|Lost to Follow-up|3|||
42037930|NCT00829621|75846235|FG001|Overall Study|Lost to Follow-up|4|||
42037931|NCT01157078|75846243|FG000|Overall Study|Withdrawal by Subject|12|||
42037932|NCT01157078|75846244|FG001|Overall Study|Withdrawal by Subject|14|||
42037933|NCT01157078|75846243|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
42037934|NCT01157078|75846244|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
42037935|NCT01157078|75846243|FG000|Overall Study|Adverse Event|6|||
42037936|NCT01157078|75846244|FG001|Overall Study|Adverse Event|6|||
42037937|NCT01157078|75846243|FG000|Overall Study|Severe non-compliance to protocol|2|||
42037938|NCT01157078|75846244|FG001|Overall Study|Severe non-compliance to protocol|4|||
42037939|NCT01157078|75846243|FG000|Overall Study|Condition under investigation worsened|0|||
42037940|NCT01157078|75846244|FG001|Overall Study|Condition under investigation worsened|1|||
42037941|NCT01157078|75846243|FG000|Overall Study|Lack of Efficacy|2|||
42037942|NCT01157078|75846244|FG001|Overall Study|Lack of Efficacy|0|||
42037943|NCT01157078|75846243|FG000|Overall Study|Study-specific withdrawal criteria|2|||
42037944|NCT01157078|75846244|FG001|Overall Study|Study-specific withdrawal criteria|2|||
42037945|NCT01157078|75846243|FG000|Overall Study|Lost to Follow-up|7|||
42037946|NCT01157078|75846244|FG001|Overall Study|Lost to Follow-up|5|||
42037947|NCT01157078|75846243|FG000|Overall Study|Other|2|||
42037948|NCT01157078|75846244|FG001|Overall Study|Other|4|||
42037949|NCT00591721|75846252|FG000|Overall Study|Withdrawal by Subject|10|||
42037950|NCT00591721|75846253|FG001|Overall Study|Withdrawal by Subject|10|||
42037951|NCT00591721|75846252|FG000|Overall Study|Lost to Follow-up|1|||
42037952|NCT00591721|75846253|FG001|Overall Study|Lost to Follow-up|4|||
42037953|NCT00591721|75846252|FG000|Overall Study|Intervention not received|10|||
42037954|NCT00591721|75846253|FG001|Overall Study|Intervention not received|8|||
42037955|NCT01156844|75846263|FG000|Overall Study|Adverse Event|0|||
42037956|NCT01156844|75846264|FG001|Overall Study|Adverse Event|0|||
42037957|NCT01156844|75846265|FG002|Overall Study|Adverse Event|1|||
42037958|NCT01156844|75846266|FG003|Overall Study|Adverse Event|1|||
42037959|NCT01156844|75846263|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42037960|NCT01156844|75846264|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42037961|NCT01156844|75846265|FG002|Overall Study|Abnormal test procedure result(s)|2|||
42037962|NCT01156844|75846266|FG003|Overall Study|Abnormal test procedure result(s)|2|||
42037963|NCT01156844|75846263|FG000|Overall Study|Withdrawal by Subject|0|||
42037964|NCT01156844|75846264|FG001|Overall Study|Withdrawal by Subject|0|||
42037965|NCT01156844|75846265|FG002|Overall Study|Withdrawal by Subject|2|||
42037966|NCT01156844|75846266|FG003|Overall Study|Withdrawal by Subject|2|||
42037967|NCT01156844|75846263|FG000|Overall Study|Lost to Follow-up|0|||
42037968|NCT01156844|75846264|FG001|Overall Study|Lost to Follow-up|0|||
42037969|NCT01156844|75846265|FG002|Overall Study|Lost to Follow-up|1|||
42037970|NCT01156844|75846266|FG003|Overall Study|Lost to Follow-up|0|||
42037971|NCT01156844|75846263|FG000|Overall Study|Administrative problems|0|||
42037972|NCT01156844|75846264|FG001|Overall Study|Administrative problems|1|||
42037973|NCT01156844|75846265|FG002|Overall Study|Administrative problems|0|||
42037974|NCT01156844|75846266|FG003|Overall Study|Administrative problems|1|||
42037975|NCT01156844|75846263|FG000|Overall Study|Protocol deviation|2|||
42037976|NCT01156844|75846264|FG001|Overall Study|Protocol deviation|0|||
42037977|NCT01156844|75846265|FG002|Overall Study|Protocol deviation|0|||
42037978|NCT01156844|75846266|FG003|Overall Study|Protocol deviation|0|||
42037979|NCT00853021|75846279|FG000|Overall Study|Adverse Event|2|||
42037980|NCT00853021|75846279|FG000|Overall Study|Withdrawal by Subject|2|||
42037981|NCT00853021|75846279|FG000|Overall Study|Death|1|||
42037982|NCT01156532|75846283|FG000|Overall Study|Family Reasons|1|||
42037983|NCT01156532|75846283|FG000|Overall Study|Lost to Follow-up|1|||
42037984|NCT00843115|75846287|FG000|Overall Study|Death|4|||
42037985|NCT00843115|75846287|FG000|Overall Study|Adverse Event|30|||
42037986|NCT00843115|75846287|FG000|Overall Study|Lost to Follow-up|4|||
42037987|NCT00843115|75846287|FG000|Overall Study|Withdrawal by Subject|17|||
42275857|NCT03509467|76107081|FG001|Overall Study|Proxy Withdrawal|0|||
42275858|NCT03509467|76107082|FG002|Overall Study|Proxy Withdrawal|0|||
42275859|NCT03509467|76107083|FG003|Overall Study|Proxy Withdrawal|0|||
42275860|NCT03509467|76107084|FG004|Overall Study|Proxy Withdrawal|0|||
42275861|NCT03509467|76107085|FG005|Overall Study|Proxy Withdrawal|0|||
42275862|NCT03509467|76107086|FG006|Overall Study|Proxy Withdrawal|0|||
42275863|NCT03509467|76107087|FG007|Overall Study|Proxy Withdrawal|1|||
42275864|NCT03406156|76107111|FG000|Overall Study|Death|6|||
42037988|NCT00843115|75846287|FG000|Overall Study|Family wanted meds stopped|1|||
42037989|NCT00843115|75846287|FG000|Overall Study|Family does not want continuation|1|||
42275865|NCT03406156|76107112|FG001|Overall Study|Death|2|||
42275866|NCT03406156|76107111|FG000|Overall Study|Withdrawal by Subject|0|||
42275867|NCT03406156|76107112|FG001|Overall Study|Withdrawal by Subject|2|||
42140421|NCT00439244|75950366|FG002|Overall Study|Death|0|||
42140422|NCT00439244|75950364|FG000|Overall Study|Protocol Violation|0|||
42140423|NCT00439244|75950365|FG001|Overall Study|Protocol Violation|1|||
42140424|NCT00439244|75950366|FG002|Overall Study|Protocol Violation|0|||
42140425|NCT00439244|75950364|FG000|Overall Study|Administrative problems|1|||
42140426|NCT00439244|75950365|FG001|Overall Study|Administrative problems|0|||
42140427|NCT00439244|75950366|FG002|Overall Study|Administrative problems|0|||
42140428|NCT00438464|75950385|FG000|Overall Study|Terminated Early|14|||
42140429|NCT00438464|75950386|FG001|Overall Study|Terminated Early|5|||
42140430|NCT00438464|75950385|FG000|Overall Study|Incomplete data submission|0|||
42140431|NCT00438464|75950386|FG001|Overall Study|Incomplete data submission|2|||
42140432|NCT00437294|75950406|FG000|Overall Study|Adverse Event|5|||
42140433|NCT00437294|75950407|FG001|Overall Study|Adverse Event|4|||
42140434|NCT00437294|75950406|FG000|Overall Study|Death|5|||
42140435|NCT00437294|75950407|FG001|Overall Study|Death|2|||
42140436|NCT00437294|75950406|FG000|Overall Study|Physician Decision|0|||
42140437|NCT00437294|75950407|FG001|Overall Study|Physician Decision|3|||
42140438|NCT00437294|75950406|FG000|Overall Study|Withdrawal by Subject|5|||
42140439|NCT00437294|75950407|FG001|Overall Study|Withdrawal by Subject|0|||
42140440|NCT00437294|75950406|FG000|Overall Study|Progressive Disease|19|||
42140441|NCT00437294|75950407|FG001|Overall Study|Progressive Disease|23|||
42140442|NCT00437294|75950406|FG000|Overall Study|Sponsor Decision|8|||
42140443|NCT00437294|75950407|FG001|Overall Study|Sponsor Decision|9|||
42140444|NCT00437294|75950406|FG000|Overall Study|Protocol Violation|0|||
42140445|NCT00437294|75950407|FG001|Overall Study|Protocol Violation|1|||
42140446|NCT00437294|75950406|FG000|Overall Study|Entry criteria not met|1|||
42140447|NCT00437294|75950407|FG001|Overall Study|Entry criteria not met|1|||
42140448|NCT00436982|75950421|FG000|Overall Study|Withdrawal by Subject|3|||
42140449|NCT00436982|75950422|FG001|Overall Study|Withdrawal by Subject|1|||
42140450|NCT00436982|75950421|FG000|Overall Study|Did not receive allocated intervention|0|||
42140451|NCT00436982|75950422|FG001|Overall Study|Did not receive allocated intervention|1|||
42140452|NCT00436982|75950421|FG000|Overall Study|no RSA data|1|||
42140453|NCT00436982|75950422|FG001|Overall Study|no RSA data|2|||
42140454|NCT00443846|75950434|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
42140455|NCT00443846|75950435|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
42140456|NCT00443846|75950434|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
42140457|NCT00443846|75950435|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
42140458|NCT00443846|75950434|FG000|Overall Study|Adverse Event|0|||
42011765|NCT01208181|75818746|FG002|Part 2|Withdrawal by Subject|1|||
42140459|NCT00443846|75950435|FG001|Overall Study|Adverse Event|1|||
42140460|NCT00443846|75950434|FG000|Overall Study|Personal reason|8|||
42140461|NCT00443846|75950435|FG001|Overall Study|Personal reason|3|||
42140462|NCT00443846|75950434|FG000|Overall Study|Lost to Follow-up|1|||
42275868|NCT03406156|76107111|FG000|Overall Study|COVID-19 infection|1|||
42275869|NCT03406156|76107112|FG001|Overall Study|COVID-19 infection|0|||
42275870|NCT03406156|76107111|FG000|Overall Study|Non-compliance with study procedures|0|||
42275871|NCT03406156|76107112|FG001|Overall Study|Non-compliance with study procedures|1|||
42275872|NCT03406156|76107111|FG000|Overall Study|Other, not specified|0|||
42275873|NCT03406156|76107112|FG001|Overall Study|Other, not specified|1|||
42275874|NCT03021954|76107122|FG000|Overall Study|Lost to Follow-up|10|||
42350680|NCT04474366|76190463|FG000|Overall Study|Lost to Follow-up|2|||
42350681|NCT04474366|76190464|FG001|Overall Study|Lost to Follow-up|5|||
42350682|NCT04422431|76190470|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
42350683|NCT04422431|76190470|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
42350684|NCT04422431|76190470|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
42350685|NCT04422431|76190470|FG000|Extension Period (48 Weeks)|ongoing in the Extension Period|25|||
42011766|NCT01208181|75818747|FG003|Part 2|Withdrawal by Subject|1|||
42011767|NCT01208181|75818748|FG004|Part 2|Withdrawal by Subject|0|||
42011768|NCT01208181|75818744|FG000|Part 2|Protocol Violation|0|||
42140463|NCT00443846|75950435|FG001|Overall Study|Lost to Follow-up|2|||
42140464|NCT00436826|75950443|FG000|Double Blind Period (DBP)|Adverse Event|2|||
42275875|NCT03021954|76107123|FG001|Overall Study|Lost to Follow-up|43|||
42275876|NCT03021954|76107122|FG000|Overall Study|Subjects had avulsion trauma|4|||
42275877|NCT03021954|76107123|FG001|Overall Study|Subjects had avulsion trauma|1|||
42140465|NCT00436826|75950444|FG001|Double Blind Period (DBP)|Adverse Event|0|||
42275878|NCT02994927|76107133|FG000|Overall Study|Withdrawal by parent/guardian|0|||
42350686|NCT04115488|76190481|FG000|Overall Study|Adverse Event|8|||
42140466|NCT00436826|75950445|FG002|Double Blind Period (DBP)|Adverse Event|0|||
42140467|NCT00436826|75950446|FG003|Double Blind Period (DBP)|Adverse Event|0|||
42140468|NCT00436826|75950447|FG004|Double Blind Period (DBP)|Adverse Event|0|||
42140469|NCT00436826|75950448|FG005|Double Blind Period (DBP)|Adverse Event|0|||
42140470|NCT00436826|75950443|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
42140471|NCT00436826|75950444|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
42011769|NCT01208181|75818745|FG001|Part 2|Protocol Violation|0|||
42275879|NCT02994927|76107134|FG001|Overall Study|Withdrawal by parent/guardian|1|||
42275880|NCT02994927|76107133|FG000|Overall Study|Did not meet eligibility criteria|0|||
42350687|NCT04115488|76190482|FG001|Overall Study|Adverse Event|4|||
42350688|NCT04115488|76190481|FG000|Overall Study|Withdrawal by Subject|3|||
42011770|NCT01208181|75818746|FG002|Part 2|Protocol Violation|1|||
42011771|NCT01208181|75818747|FG003|Part 2|Protocol Violation|0|||
42011772|NCT01208181|75818748|FG004|Part 2|Protocol Violation|0|||
42275881|NCT02994927|76107134|FG001|Overall Study|Did not meet eligibility criteria|1|||
42275882|NCT02994927|76107133|FG000|Overall Study|Physician Decision|4|||
42275883|NCT02994927|76107134|FG001|Overall Study|Physician Decision|3|||
42275884|NCT02994927|76107133|FG000|Overall Study|Death|4|||
42275885|NCT02994927|76107134|FG001|Overall Study|Death|2|||
42275886|NCT02994927|76107133|FG000|Overall Study|Adverse Event|2|||
42275887|NCT02994927|76107134|FG001|Overall Study|Adverse Event|1|||
42275888|NCT02994927|76107133|FG000|Overall Study|Withdrawal by Subject|3|||
42275889|NCT02994927|76107134|FG001|Overall Study|Withdrawal by Subject|6|||
42275890|NCT02994927|76107133|FG000|Overall Study|Lost to Follow-up|2|||
42275891|NCT02994927|76107134|FG001|Overall Study|Lost to Follow-up|1|||
42275892|NCT02718716|76107145|FG000|Overall Study|Lack of Efficacy|1|||
42275893|NCT02718716|76107146|FG001|Overall Study|Lack of Efficacy|0|||
42275894|NCT02718716|76107147|FG002|Overall Study|Lack of Efficacy|0|||
42275895|NCT02718716|76107148|FG003|Overall Study|Lack of Efficacy|0|||
42275896|NCT02718716|76107149|FG004|Overall Study|Lack of Efficacy|0|||
42275897|NCT02032823|76107172|FG000|Overall Study|Death|75|||
42275898|NCT02032823|76107173|FG001|Overall Study|Death|109|||
42275899|NCT02032823|76107172|FG000|Overall Study|Lost to Follow-up|18|||
42275900|NCT02032823|76107173|FG001|Overall Study|Lost to Follow-up|17|||
42275901|NCT02032823|76107172|FG000|Overall Study|Withdrawal by Subject|70|||
42275902|NCT02032823|76107173|FG001|Overall Study|Withdrawal by Subject|53|||
42350689|NCT04115488|76190482|FG001|Overall Study|Withdrawal by Subject|6|||
42350690|NCT04115488|76190481|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
42350691|NCT04115488|76190482|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
42350692|NCT04115488|76190481|FG000|Overall Study|Patient 's location change|1|||
42350693|NCT04115488|76190482|FG001|Overall Study|Patient 's location change|0|||
42350694|NCT04115488|76190481|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
42350695|NCT04115488|76190482|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
42350696|NCT04080752|76190506|FG000|Overall Study|Adverse Event|2|||
42350697|NCT04080752|76190507|FG001|Overall Study|Adverse Event|3|||
42350698|NCT04080752|76190506|FG000|Overall Study|Lack of Efficacy|1|||
42350699|NCT04080752|76190507|FG001|Overall Study|Lack of Efficacy|0|||
42350700|NCT04080752|76190506|FG000|Overall Study|Lost to Follow-up|1|||
42275903|NCT02032823|76107172|FG000|Overall Study|Ongoing study at data cut-off|755|||
42275904|NCT02032823|76107173|FG001|Overall Study|Ongoing study at data cut-off|731|||
42275905|NCT02032823|76107172|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
42350701|NCT04080752|76190507|FG001|Overall Study|Lost to Follow-up|0|||
42011773|NCT01208181|75818744|FG000|Part 2|Physician Decision|0|||
42275906|NCT02032823|76107173|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
42350702|NCT04080752|76190506|FG000|Overall Study|Pregnancy|0|||
42275907|NCT01708954|76107182|FG000|Step 1|Disease progression|26|||
42275908|NCT01708954|76107183|FG001|Step 1|Disease progression|17|||
42350703|NCT04080752|76190507|FG001|Overall Study|Pregnancy|1|||
42037990|NCT00843115|75846287|FG000|Overall Study|Patient forgot to take meds|1|||
42037991|NCT00843115|75846287|FG000|Overall Study|Does not meet entrance criteria|1|||
42037992|NCT00843115|75846287|FG000|Overall Study|Physician Decision|1|||
42037993|NCT00843115|75846287|FG000|Overall Study|Family discontinued meds|1|||
42037994|NCT00843115|75846287|FG000|Overall Study|patient took for 2 days then stopped|1|||
42140472|NCT00436826|75950445|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
42140473|NCT00436826|75950446|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
42140474|NCT00436826|75950447|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
42140475|NCT00436826|75950448|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
42140476|NCT00436826|75950443|FG000|Double Blind Period (DBP)|Other|10|||
42140477|NCT00436826|75950444|FG001|Double Blind Period (DBP)|Other|11|||
42140478|NCT00436826|75950445|FG002|Double Blind Period (DBP)|Other|0|||
42140479|NCT00436826|75950446|FG003|Double Blind Period (DBP)|Other|0|||
42140480|NCT00436826|75950447|FG004|Double Blind Period (DBP)|Other|0|||
42140481|NCT00436826|75950448|FG005|Double Blind Period (DBP)|Other|0|||
42140482|NCT00436826|75950443|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
42140483|NCT00436826|75950444|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
42140484|NCT00436826|75950445|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
42140485|NCT00436826|75950446|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
42140486|NCT00436826|75950447|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
42140487|NCT00436826|75950448|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
42140488|NCT00436826|75950443|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
42140489|NCT00436826|75950444|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
42140490|NCT00436826|75950445|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
42140491|NCT00436826|75950446|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
42140492|NCT00436826|75950447|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
42140493|NCT00436826|75950448|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
42140494|NCT00436826|75950443|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
42140495|NCT00436826|75950444|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
42140496|NCT00436826|75950445|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
42140497|NCT00436826|75950446|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
42140498|NCT00436826|75950447|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
42140499|NCT00436826|75950448|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
42140500|NCT00410124|75950466|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
42140501|NCT00410124|75950467|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
42140502|NCT00410124|75950466|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
42140503|NCT00410124|75950467|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
42140504|NCT00410124|75950466|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
42140505|NCT00410124|75950467|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
42140506|NCT00410124|75950466|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
42275909|NCT01708954|76107184|FG002|Step 1|Disease progression|14|||
42011774|NCT01208181|75818745|FG001|Part 2|Physician Decision|0|||
42011775|NCT01208181|75818746|FG002|Part 2|Physician Decision|1|||
42011776|NCT01208181|75818747|FG003|Part 2|Physician Decision|2|||
42011777|NCT01208181|75818748|FG004|Part 2|Physician Decision|0|||
42011778|NCT01208181|75818744|FG000|Part 2|Non-compliance with study drug|0|||
42011779|NCT01208181|75818745|FG001|Part 2|Non-compliance with study drug|0|||
42011780|NCT01208181|75818746|FG002|Part 2|Non-compliance with study drug|1|||
42011781|NCT01208181|75818747|FG003|Part 2|Non-compliance with study drug|1|||
42011782|NCT01208181|75818748|FG004|Part 2|Non-compliance with study drug|0|||
42011783|NCT01208181|75818744|FG000|Part 2|Lost to Follow-up|0|||
42011784|NCT01208181|75818745|FG001|Part 2|Lost to Follow-up|0|||
42011785|NCT01208181|75818746|FG002|Part 2|Lost to Follow-up|1|||
42011786|NCT01208181|75818747|FG003|Part 2|Lost to Follow-up|2|||
42011787|NCT01208181|75818748|FG004|Part 2|Lost to Follow-up|0|||
42011788|NCT01208181|75818744|FG000|Part 2|Lack of Efficacy|0|||
42011789|NCT01208181|75818745|FG001|Part 2|Lack of Efficacy|0|||
42140507|NCT00410124|75950467|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
42140508|NCT00410124|75950466|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
42140509|NCT00410124|75950467|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
42140510|NCT00410124|75950466|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
42140511|NCT00410124|75950467|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
42140512|NCT00410124|75950466|FG000|Core Phase Double Blind (15 Months)|Death|7|||
42140513|NCT00410124|75950467|FG001|Core Phase Double Blind (15 Months)|Death|4|||
42140514|NCT00410124|75950466|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
42140515|NCT00410124|75950467|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
42140516|NCT00410124|75950466|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
42140517|NCT00410124|75950467|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
42140518|NCT00410124|75950466|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
42140519|NCT00410124|75950467|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
42140520|NCT00410124|75950466|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
42140521|NCT00410124|75950467|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
42140522|NCT00410124|75950466|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
42140523|NCT00410124|75950467|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
42140524|NCT00410124|75950466|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
42140525|NCT00410124|75950467|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
42140526|NCT00410124|75950466|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
42140527|NCT00410124|75950467|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
42140528|NCT00410124|75950466|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
42140529|NCT00410124|75950467|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
42140530|NCT00410124|75950466|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
42140531|NCT00410124|75950467|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
42140532|NCT00410046|75950477|FG000|Overall Study|Adverse Event|3|||
42140533|NCT00410046|75950477|FG000|Overall Study|Withdrawal by Subject|1|||
42140534|NCT00410046|75950477|FG000|Overall Study|Lost to Follow-up|1|||
42140535|NCT00416624|75950486|FG000|Overall Study|Withdrawal by Subject|1|||
42140536|NCT00416624|75950487|FG001|Overall Study|Withdrawal by Subject|6|||
42140537|NCT00416624|75950488|FG002|Overall Study|Withdrawal by Subject|4|||
42140538|NCT00416624|75950489|FG003|Overall Study|Withdrawal by Subject|9|||
42140539|NCT00416624|75950486|FG000|Overall Study|Death|4|||
42140540|NCT00416624|75950487|FG001|Overall Study|Death|7|||
42140541|NCT00416624|75950488|FG002|Overall Study|Death|7|||
42140542|NCT00416624|75950489|FG003|Overall Study|Death|1|||
42140543|NCT00416624|75950486|FG000|Overall Study|Adverse Event|8|||
42140544|NCT00416624|75950487|FG001|Overall Study|Adverse Event|3|||
42140545|NCT00416624|75950488|FG002|Overall Study|Adverse Event|2|||
42140546|NCT00416624|75950489|FG003|Overall Study|Adverse Event|2|||
42140547|NCT00416624|75950486|FG000|Overall Study|Other|8|||
42140548|NCT00416624|75950487|FG001|Overall Study|Other|11|||
42140549|NCT00416624|75950488|FG002|Overall Study|Other|5|||
42140550|NCT00416624|75950489|FG003|Overall Study|Other|5|||
42140551|NCT00416624|75950486|FG000|Overall Study|Cancel|1|||
42140552|NCT00416624|75950487|FG001|Overall Study|Cancel|0|||
42140553|NCT00416624|75950488|FG002|Overall Study|Cancel|0|||
42140554|NCT00416624|75950489|FG003|Overall Study|Cancel|0|||
42140555|NCT00262600|75950502|FG000|Overall Study|Lost to Follow-up|17|||
42140556|NCT00262600|75950503|FG001|Overall Study|Lost to Follow-up|31|||
42140557|NCT00262600|75950504|FG002|Overall Study|Lost to Follow-up|41|||
42140558|NCT00262600|75950502|FG000|Overall Study|Withdrawal by Subject|128|||
42140559|NCT00262600|75950503|FG001|Overall Study|Withdrawal by Subject|145|||
42140560|NCT00262600|75950504|FG002|Overall Study|Withdrawal by Subject|139|||
42140561|NCT00262600|75950502|FG000|Overall Study|Not Treated|32|||
42275910|NCT01708954|76107182|FG000|Step 1|Adverse Event|3|||
42275911|NCT01708954|76107183|FG001|Step 1|Adverse Event|11|||
42275912|NCT01708954|76107184|FG002|Step 1|Adverse Event|13|||
42275913|NCT01708954|76107182|FG000|Step 1|Death|3|||
42275914|NCT01708954|76107183|FG001|Step 1|Death|2|||
42275915|NCT01708954|76107184|FG002|Step 1|Death|3|||
42140562|NCT00262600|75950503|FG001|Overall Study|Not Treated|17|||
42140563|NCT00262600|75950504|FG002|Overall Study|Not Treated|24|||
42140564|NCT00262600|75950502|FG000|Overall Study|Other|58|||
42140565|NCT00262600|75950503|FG001|Overall Study|Other|59|||
42140566|NCT00262600|75950504|FG002|Overall Study|Other|62|||
42140567|NCT00409578|75950516|FG000|Overall Study|Adverse Event|27|||
42140568|NCT00409578|75950517|FG001|Overall Study|Adverse Event|37|||
42275916|NCT01708954|76107182|FG000|Step 1|Withdrawal by Subject|2|||
42140569|NCT00409578|75950518|FG002|Overall Study|Adverse Event|25|||
42140570|NCT00409578|75950519|FG003|Overall Study|Adverse Event|33|||
42275917|NCT01708954|76107183|FG001|Step 1|Withdrawal by Subject|5|||
42275918|NCT01708954|76107184|FG002|Step 1|Withdrawal by Subject|3|||
42140571|NCT00409578|75950516|FG000|Overall Study|Abnormal laboratory value(s)|2|||
42140572|NCT00409578|75950517|FG001|Overall Study|Abnormal laboratory value(s)|2|||
42037995|NCT00843115|75846287|FG000|Overall Study|patient never took the medication|1|||
42037996|NCT00843115|75846287|FG000|Overall Study|hospitalized due to deterioration|1|||
42037997|NCT00843115|75846287|FG000|Overall Study|week 12 not done|1|||
42037998|NCT00843115|75846287|FG000|Overall Study|Syndrome De Glissement|1|||
42037999|NCT01156376|75846294|FG000|Overall Study|Adverse Event|1|||
42038000|NCT01156376|75846295|FG001|Overall Study|Adverse Event|0|||
42038001|NCT01156376|75846296|FG002|Overall Study|Adverse Event|1|||
42038002|NCT01156376|75846294|FG000|Overall Study|Withdrawal by Subject|0|||
42038003|NCT01156376|75846295|FG001|Overall Study|Withdrawal by Subject|0|||
42038004|NCT01156376|75846296|FG002|Overall Study|Withdrawal by Subject|3|||
42038005|NCT00829387|75846306|FG000|Overall Study|Withdrawal by Subject|2|||
42038006|NCT00829387|75846307|FG001|Overall Study|Withdrawal by Subject|3|||
42038007|NCT00829387|75846306|FG000|Overall Study|Disqualified by PI|1|||
42038008|NCT00829387|75846307|FG001|Overall Study|Disqualified by PI|0|||
42038009|NCT01156142|75846315|FG000|Overall Study|Withdrawal by Subject|8|||
42038010|NCT01156142|75846316|FG001|Overall Study|Withdrawal by Subject|6|||
42038011|NCT01156142|75846315|FG000|Overall Study|Ineligible|0|||
42038012|NCT01156142|75846316|FG001|Overall Study|Ineligible|1|||
42038013|NCT00842257|75846322|FG000|Overall Study|Adverse Event|1|||
42038014|NCT00852475|75846328|FG000|Overall Study|Lost to Follow-up|3|||
42038015|NCT00852475|75846329|FG001|Overall Study|Lost to Follow-up|4|||
42038016|NCT01155284|75846339|FG000|Overall Study|Withdrawal by Subject|4|||
42038017|NCT01155284|75846340|FG001|Overall Study|Withdrawal by Subject|3|||
42038018|NCT01155284|75846339|FG000|Overall Study|Lost to Follow-up|1|||
42038019|NCT01155284|75846340|FG001|Overall Study|Lost to Follow-up|2|||
42038020|NCT01155284|75846339|FG000|Overall Study|Physician Decision|1|||
42038021|NCT01155284|75846340|FG001|Overall Study|Physician Decision|0|||
42038022|NCT01155284|75846339|FG000|Overall Study|Adverse Event|1|||
42038023|NCT01155284|75846340|FG001|Overall Study|Adverse Event|0|||
42038024|NCT00852397|75846351|FG000|Overall Study|Adverse Event|4|||
42038025|NCT00852397|75846352|FG001|Overall Study|Adverse Event|6|||
42038026|NCT00852397|75846353|FG002|Overall Study|Adverse Event|4|||
42038027|NCT00852397|75846351|FG000|Overall Study|Death|0|||
42038028|NCT00852397|75846352|FG001|Overall Study|Death|0|||
42038029|NCT00852397|75846353|FG002|Overall Study|Death|1|||
42038030|NCT00852397|75846351|FG000|Overall Study|Withdrawal by Subject|4|||
42038031|NCT00852397|75846352|FG001|Overall Study|Withdrawal by Subject|1|||
42038032|NCT00852397|75846353|FG002|Overall Study|Withdrawal by Subject|2|||
42038033|NCT00852397|75846351|FG000|Overall Study|Study terminated by sponsor|2|||
42038034|NCT00852397|75846352|FG001|Overall Study|Study terminated by sponsor|1|||
42038035|NCT00852397|75846353|FG002|Overall Study|Study terminated by sponsor|6|||
42038036|NCT00852397|75846351|FG000|Overall Study|Difficulty in study site visit|1|||
42038037|NCT00852397|75846352|FG001|Overall Study|Difficulty in study site visit|0|||
42038038|NCT00852397|75846353|FG002|Overall Study|Difficulty in study site visit|0|||
42038039|NCT00852397|75846351|FG000|Overall Study|Protocol Violation|0|||
42038040|NCT00852397|75846352|FG001|Overall Study|Protocol Violation|0|||
42038041|NCT00852397|75846353|FG002|Overall Study|Protocol Violation|1|||
42038042|NCT00841321|75846363|FG000|Overall Study|Lost to Follow-up|1|||
42038043|NCT00841321|75846364|FG001|Overall Study|Lost to Follow-up|1|||
42038044|NCT00841321|75846363|FG000|Overall Study|Adverse Event|0|||
42038045|NCT00841321|75846364|FG001|Overall Study|Adverse Event|2|||
42038046|NCT00986232|75846376|FG000|Overall Study|Adverse Event|1|||
42038047|NCT00986232|75846377|FG001|Overall Study|Adverse Event|2|||
42038048|NCT00986232|75846378|FG002|Overall Study|Adverse Event|3|||
42038049|NCT00986232|75846379|FG003|Overall Study|Adverse Event|0|||
42038050|NCT00986232|75846376|FG000|Overall Study|Lost to Follow-up|19|||
42038051|NCT00986232|75846377|FG001|Overall Study|Lost to Follow-up|12|||
42038052|NCT00986232|75846378|FG002|Overall Study|Lost to Follow-up|12|||
42038053|NCT00986232|75846379|FG003|Overall Study|Lost to Follow-up|7|||
42038054|NCT00986232|75846376|FG000|Overall Study|Protocol Violation|2|||
42038055|NCT00986232|75846377|FG001|Overall Study|Protocol Violation|3|||
42038056|NCT00986232|75846378|FG002|Overall Study|Protocol Violation|0|||
42140573|NCT00409578|75950518|FG002|Overall Study|Abnormal laboratory value(s)|2|||
42038057|NCT00986232|75846379|FG003|Overall Study|Protocol Violation|1|||
42038058|NCT00986232|75846376|FG000|Overall Study|Withdrawal by Subject|13|||
42038059|NCT00986232|75846377|FG001|Overall Study|Withdrawal by Subject|16|||
42038060|NCT00986232|75846378|FG002|Overall Study|Withdrawal by Subject|12|||
42038061|NCT00986232|75846379|FG003|Overall Study|Withdrawal by Subject|3|||
42038062|NCT00986232|75846376|FG000|Overall Study|Missed one or more bleeds|13|||
42038063|NCT00986232|75846377|FG001|Overall Study|Missed one or more bleeds|10|||
42140574|NCT00409578|75950519|FG003|Overall Study|Abnormal laboratory value(s)|4|||
42038064|NCT00986232|75846378|FG002|Overall Study|Missed one or more bleeds|6|||
42140575|NCT00409578|75950516|FG000|Overall Study|Lack of Efficacy|0|||
42038065|NCT00986232|75846379|FG003|Overall Study|Missed one or more bleeds|7|||
42038066|NCT00986232|75846376|FG000|Overall Study|Incomplete safety follow-up|3|||
42038067|NCT00986232|75846377|FG001|Overall Study|Incomplete safety follow-up|7|||
42140576|NCT00409578|75950517|FG001|Overall Study|Lack of Efficacy|0|||
42140577|NCT00409578|75950518|FG002|Overall Study|Lack of Efficacy|0|||
42140578|NCT00409578|75950519|FG003|Overall Study|Lack of Efficacy|2|||
42140579|NCT00409578|75950516|FG000|Overall Study|Subject no longer requires study drug|0|||
42140580|NCT00409578|75950517|FG001|Overall Study|Subject no longer requires study drug|0|||
42140581|NCT00409578|75950518|FG002|Overall Study|Subject no longer requires study drug|0|||
42140582|NCT00409578|75950519|FG003|Overall Study|Subject no longer requires study drug|1|||
42140583|NCT00409578|75950516|FG000|Overall Study|Withdrawal by Subject|8|||
42140584|NCT00409578|75950517|FG001|Overall Study|Withdrawal by Subject|15|||
42140585|NCT00409578|75950518|FG002|Overall Study|Withdrawal by Subject|16|||
42140586|NCT00409578|75950519|FG003|Overall Study|Withdrawal by Subject|17|||
42140587|NCT00409578|75950516|FG000|Overall Study|Lost to Follow-up|2|||
42140588|NCT00409578|75950517|FG001|Overall Study|Lost to Follow-up|0|||
42140589|NCT00409578|75950518|FG002|Overall Study|Lost to Follow-up|2|||
42140590|NCT00409578|75950519|FG003|Overall Study|Lost to Follow-up|2|||
42140591|NCT00409578|75950516|FG000|Overall Study|Administrative problems|8|||
42140592|NCT00409578|75950517|FG001|Overall Study|Administrative problems|9|||
42140593|NCT00409578|75950518|FG002|Overall Study|Administrative problems|2|||
42140594|NCT00409578|75950519|FG003|Overall Study|Administrative problems|4|||
42140595|NCT00409578|75950516|FG000|Overall Study|Death|2|||
42140596|NCT00409578|75950517|FG001|Overall Study|Death|4|||
42140597|NCT00409578|75950518|FG002|Overall Study|Death|4|||
42140598|NCT00409578|75950519|FG003|Overall Study|Death|2|||
42140599|NCT00409578|75950516|FG000|Overall Study|Protocol Violation|3|||
42275919|NCT01708954|76107182|FG000|Step 1|Other complicating disease|0|||
42275920|NCT01708954|76107183|FG001|Step 1|Other complicating disease|2|||
42275921|NCT01708954|76107184|FG002|Step 1|Other complicating disease|0|||
42275922|NCT01708954|76107182|FG000|Step 1|Crossed over to Step 2|2|||
42011790|NCT01208181|75818746|FG002|Part 2|Lack of Efficacy|5|||
42011791|NCT01208181|75818747|FG003|Part 2|Lack of Efficacy|7|||
42011792|NCT01208181|75818748|FG004|Part 2|Lack of Efficacy|0|||
42011793|NCT01208103|75818765|FG000|Overall Study|Adverse Event|1|||
42011794|NCT01208103|75818765|FG000|Overall Study|Withdrawal by Subject|1|||
42011795|NCT01206777|75818770|FG000|Overall Study|Death|1|||
42011796|NCT01206777|75818770|FG000|Overall Study|Adverse Event|1|||
42011797|NCT01001494|75818777|FG000|Overall Study|Adverse Event|8|||
42011798|NCT01001494|75818778|FG001|Overall Study|Adverse Event|4|||
42011799|NCT01001494|75818779|FG002|Overall Study|Adverse Event|6|||
42011800|NCT01001494|75818777|FG000|Overall Study|Protocol Violation|0|||
42011801|NCT01001494|75818778|FG001|Overall Study|Protocol Violation|1|||
42011802|NCT01001494|75818779|FG002|Overall Study|Protocol Violation|1|||
42011803|NCT01001494|75818777|FG000|Overall Study|Lost to Follow-up|2|||
42011804|NCT01001494|75818778|FG001|Overall Study|Lost to Follow-up|0|||
42011805|NCT01001494|75818779|FG002|Overall Study|Lost to Follow-up|1|||
42038068|NCT00986232|75846378|FG002|Overall Study|Incomplete safety follow-up|2|||
42038069|NCT00986232|75846379|FG003|Overall Study|Incomplete safety follow-up|2|||
42038070|NCT00852241|75846395|FG000|Overall Study|Physician Decision|18|||
42038071|NCT01169636|75846404|FG000|Overall Study|Adverse Event|0|||
42038072|NCT01169636|75846405|FG001|Overall Study|Adverse Event|0|||
42038073|NCT01169636|75846406|FG002|Overall Study|Adverse Event|1|||
42038074|NCT01169636|75846407|FG003|Overall Study|Adverse Event|1|||
42038075|NCT01169636|75846408|FG004|Overall Study|Adverse Event|0|||
42140600|NCT00409578|75950517|FG001|Overall Study|Protocol Violation|2|||
42038076|NCT01169636|75846404|FG000|Overall Study|Screen failure|0|||
42140601|NCT00409578|75950518|FG002|Overall Study|Protocol Violation|3|||
42140602|NCT00409578|75950519|FG003|Overall Study|Protocol Violation|1|||
42140603|NCT00409578|75950516|FG000|Overall Study|Missing|0|||
42140604|NCT00409578|75950517|FG001|Overall Study|Missing|1|||
42038077|NCT01169636|75846405|FG001|Overall Study|Screen failure|0|||
42038078|NCT01169636|75846406|FG002|Overall Study|Screen failure|2|||
42140605|NCT00409578|75950518|FG002|Overall Study|Missing|0|||
42140606|NCT00409578|75950519|FG003|Overall Study|Missing|1|||
42140607|NCT00428090|75950533|FG000|Overall Study|Adverse Event|10|||
42140608|NCT00428090|75950534|FG001|Overall Study|Adverse Event|8|||
42140609|NCT00428090|75950535|FG002|Overall Study|Adverse Event|10|||
42140610|NCT00428090|75950536|FG003|Overall Study|Adverse Event|11|||
42140611|NCT00428090|75950533|FG000|Overall Study|Lost to Follow-up|3|||
42140612|NCT00428090|75950534|FG001|Overall Study|Lost to Follow-up|6|||
42140613|NCT00428090|75950535|FG002|Overall Study|Lost to Follow-up|1|||
42140614|NCT00428090|75950536|FG003|Overall Study|Lost to Follow-up|4|||
42140615|NCT00428090|75950533|FG000|Overall Study|Protocol Violation|3|||
42140616|NCT00428090|75950534|FG001|Overall Study|Protocol Violation|1|||
42140617|NCT00428090|75950535|FG002|Overall Study|Protocol Violation|3|||
42140618|NCT00428090|75950536|FG003|Overall Study|Protocol Violation|3|||
42140619|NCT00428090|75950533|FG000|Overall Study|Withdrawal by Subject|10|||
42140620|NCT00428090|75950534|FG001|Overall Study|Withdrawal by Subject|12|||
42140621|NCT00428090|75950535|FG002|Overall Study|Withdrawal by Subject|15|||
42140622|NCT00428090|75950536|FG003|Overall Study|Withdrawal by Subject|5|||
42140623|NCT00428090|75950533|FG000|Overall Study|Sponsor terminated study|0|||
42140624|NCT00428090|75950534|FG001|Overall Study|Sponsor terminated study|1|||
42140625|NCT00428090|75950535|FG002|Overall Study|Sponsor terminated study|0|||
42140626|NCT00428090|75950536|FG003|Overall Study|Sponsor terminated study|0|||
42038079|NCT01169636|75846407|FG003|Overall Study|Screen failure|0|||
42038080|NCT01169636|75846408|FG004|Overall Study|Screen failure|0|||
42038081|NCT01169636|75846404|FG000|Overall Study|Withdrawal by Subject|0|||
42038082|NCT01169636|75846405|FG001|Overall Study|Withdrawal by Subject|0|||
42038083|NCT01169636|75846406|FG002|Overall Study|Withdrawal by Subject|0|||
42038084|NCT01169636|75846407|FG003|Overall Study|Withdrawal by Subject|0|||
42038085|NCT01169636|75846408|FG004|Overall Study|Withdrawal by Subject|3|||
42011806|NCT01001494|75818777|FG000|Overall Study|Withdrawal by Subject|9|||
42011807|NCT01001494|75818778|FG001|Overall Study|Withdrawal by Subject|7|||
42011808|NCT01001494|75818779|FG002|Overall Study|Withdrawal by Subject|17|||
42011809|NCT01001494|75818777|FG000|Overall Study|COPD exacerbation|3|||
42011810|NCT01001494|75818778|FG001|Overall Study|COPD exacerbation|4|||
42011811|NCT01001494|75818779|FG002|Overall Study|COPD exacerbation|5|||
42011812|NCT01001494|75818777|FG000|Overall Study|Lack of Efficacy|2|||
42011813|NCT01001494|75818778|FG001|Overall Study|Lack of Efficacy|0|||
42011814|NCT01001494|75818779|FG002|Overall Study|Lack of Efficacy|8|||
42011815|NCT01001494|75818777|FG000|Overall Study|Other|0|||
42011816|NCT01001494|75818778|FG001|Overall Study|Other|1|||
42011817|NCT01001494|75818779|FG002|Overall Study|Other|3|||
42011818|NCT01205685|75818787|FG000|Overall Study|Disease Progression|10|||
42011819|NCT01205685|75818787|FG000|Overall Study|Withdrawal by Subject|1|||
42011820|NCT01205529|75818791|FG000|Overall Study|Procedure Cancelled|4|||
42011821|NCT01205529|75818791|FG000|Overall Study|Withdrawal by Subject|2|||
42011822|NCT01205529|75818791|FG000|Overall Study|Physician Decision|4|||
42011823|NCT01205529|75818791|FG000|Overall Study|Unstable post op|15|||
42011824|NCT01205529|75818791|FG000|Overall Study|No longer met criteria|30|||
42140627|NCT00428090|75950533|FG000|Overall Study|Non-compliance|4|||
42140628|NCT00428090|75950534|FG001|Overall Study|Non-compliance|0|||
42140629|NCT00428090|75950535|FG002|Overall Study|Non-compliance|1|||
42140630|NCT00428090|75950536|FG003|Overall Study|Non-compliance|3|||
42011825|NCT01205451|75818797|FG000|Overall Study|Lost to Follow-up|1|||
42011826|NCT01205451|75818798|FG001|Overall Study|Lost to Follow-up|1|||
42011827|NCT01205451|75818797|FG000|Overall Study|Withdrawal by Subject|5|||
42011828|NCT01205451|75818798|FG001|Overall Study|Withdrawal by Subject|9|||
42275923|NCT01708954|76107183|FG001|Step 1|Crossed over to Step 2|0|||
42038086|NCT01169558|75846418|FG000|Overall Study|Disease progression|98|||
42140631|NCT00428090|75950533|FG000|Overall Study|Par. did not returned to visit|1|||
42275924|NCT01708954|76107184|FG002|Step 1|Crossed over to Step 2|0|||
42038087|NCT01169558|75846418|FG000|Overall Study|Adverse Event|25|||
42140632|NCT00428090|75950534|FG001|Overall Study|Par. did not returned to visit|0|||
42275925|NCT01708954|76107182|FG000|Step 1|Symptomatic deterioration|1|||
42011829|NCT01001104|75818808|FG000|Overall Study|Adverse Event|2|||
42011830|NCT01001104|75818809|FG001|Overall Study|Adverse Event|1|||
42011831|NCT01001104|75818810|FG002|Overall Study|Adverse Event|0|||
42011832|NCT01001104|75818811|FG003|Overall Study|Adverse Event|0|||
42011833|NCT01001104|75818808|FG000|Overall Study|Lost to Follow-up|0|||
42011834|NCT01001104|75818809|FG001|Overall Study|Lost to Follow-up|0|||
42011835|NCT01001104|75818810|FG002|Overall Study|Lost to Follow-up|1|||
42011836|NCT01001104|75818811|FG003|Overall Study|Lost to Follow-up|0|||
42011837|NCT01001104|75818808|FG000|Overall Study|Entry Criteria Not Met|0|||
42038088|NCT01169558|75846418|FG000|Overall Study|Withdrawal of Consent|8|||
42038089|NCT01169558|75846418|FG000|Overall Study|Medical Decision|7|||
42140633|NCT00428090|75950535|FG002|Overall Study|Par. did not returned to visit|0|||
42140634|NCT00428090|75950536|FG003|Overall Study|Par. did not returned to visit|1|||
42140635|NCT00428090|75950533|FG000|Overall Study|Follow-Up visit not possible|1|||
42140636|NCT00428090|75950534|FG001|Overall Study|Follow-Up visit not possible|0|||
42140637|NCT00428090|75950535|FG002|Overall Study|Follow-Up visit not possible|0|||
42140638|NCT00428090|75950536|FG003|Overall Study|Follow-Up visit not possible|0|||
42140639|NCT00428090|75950533|FG000|Overall Study|Prohibited medication used for SAE|1|||
42140640|NCT00428090|75950534|FG001|Overall Study|Prohibited medication used for SAE|0|||
42140641|NCT00428090|75950535|FG002|Overall Study|Prohibited medication used for SAE|0|||
42140642|NCT00428090|75950536|FG003|Overall Study|Prohibited medication used for SAE|0|||
42140643|NCT00428090|75950533|FG000|Overall Study|Death of par.|1|||
42140644|NCT00428090|75950534|FG001|Overall Study|Death of par.|0|||
42140645|NCT00428090|75950535|FG002|Overall Study|Death of par.|1|||
42140646|NCT00428090|75950536|FG003|Overall Study|Death of par.|0|||
42140647|NCT00428090|75950533|FG000|Overall Study|Visit 7 exceed the visit window|0|||
42140648|NCT00428090|75950534|FG001|Overall Study|Visit 7 exceed the visit window|1|||
42140649|NCT00428090|75950535|FG002|Overall Study|Visit 7 exceed the visit window|0|||
42140650|NCT00428090|75950536|FG003|Overall Study|Visit 7 exceed the visit window|0|||
42140651|NCT00428090|75950533|FG000|Overall Study|Medical monitor terminated par.|0|||
42140652|NCT00428090|75950534|FG001|Overall Study|Medical monitor terminated par.|1|||
42140653|NCT00428090|75950535|FG002|Overall Study|Medical monitor terminated par.|0|||
42140654|NCT00428090|75950536|FG003|Overall Study|Medical monitor terminated par.|0|||
42140655|NCT00428090|75950533|FG000|Overall Study|Mental status of par. was|0|||
42140656|NCT00428090|75950534|FG001|Overall Study|Mental status of par. was|1|||
42140657|NCT00428090|75950535|FG002|Overall Study|Mental status of par. was|0|||
42140658|NCT00428090|75950536|FG003|Overall Study|Mental status of par. was|0|||
42140659|NCT00428090|75950533|FG000|Overall Study|Worsening of AD|0|||
42140660|NCT00428090|75950534|FG001|Overall Study|Worsening of AD|0|||
42140661|NCT00428090|75950535|FG002|Overall Study|Worsening of AD|1|||
42140662|NCT00428090|75950536|FG003|Overall Study|Worsening of AD|0|||
42140663|NCT00428090|75950533|FG000|Overall Study|Excluded for concerning QTc value|0|||
42140664|NCT00428090|75950534|FG001|Overall Study|Excluded for concerning QTc value|0|||
42140665|NCT00428090|75950535|FG002|Overall Study|Excluded for concerning QTc value|1|||
42140666|NCT00428090|75950536|FG003|Overall Study|Excluded for concerning QTc value|0|||
42140667|NCT00428090|75950533|FG000|Overall Study|Insufficient AD documentation|0|||
42140668|NCT00428090|75950534|FG001|Overall Study|Insufficient AD documentation|0|||
42140669|NCT00428090|75950535|FG002|Overall Study|Insufficient AD documentation|1|||
42140670|NCT00428090|75950536|FG003|Overall Study|Insufficient AD documentation|0|||
42140671|NCT00428090|75950533|FG000|Overall Study|High MMSE scores|0|||
42140672|NCT00428090|75950534|FG001|Overall Study|High MMSE scores|0|||
42140673|NCT00428090|75950535|FG002|Overall Study|High MMSE scores|1|||
42140674|NCT00428090|75950536|FG003|Overall Study|High MMSE scores|0|||
42140675|NCT00428090|75950533|FG000|Overall Study|Deterioration of cognitive status|0|||
42275926|NCT01708954|76107183|FG001|Step 1|Symptomatic deterioration|0|||
42275927|NCT01708954|76107184|FG002|Step 1|Symptomatic deterioration|1|||
42275928|NCT01708954|76107182|FG000|Step 1|Off-treatment reason not submitted|1|||
42275929|NCT01708954|76107183|FG001|Step 1|Off-treatment reason not submitted|1|||
42011838|NCT01001104|75818809|FG001|Overall Study|Entry Criteria Not Met|0|||
42011839|NCT01001104|75818810|FG002|Overall Study|Entry Criteria Not Met|0|||
42011840|NCT01001104|75818811|FG003|Overall Study|Entry Criteria Not Met|1|||
42011841|NCT01001104|75818808|FG000|Overall Study|Withdrawal by Subject|0|||
42011842|NCT01001104|75818809|FG001|Overall Study|Withdrawal by Subject|0|||
42011843|NCT01001104|75818810|FG002|Overall Study|Withdrawal by Subject|0|||
42011844|NCT01001104|75818811|FG003|Overall Study|Withdrawal by Subject|2|||
42011845|NCT00998764|75818826|FG000|Overall Study|Lack of Efficacy|3|||
42011846|NCT00998764|75818827|FG001|Overall Study|Lack of Efficacy|6|||
42011847|NCT00998764|75818826|FG000|Overall Study|Adverse Event|17|||
42011848|NCT00998764|75818827|FG001|Overall Study|Adverse Event|12|||
42011849|NCT00998764|75818826|FG000|Overall Study|Withdrawal by Subject|19|||
42275930|NCT01708954|76107184|FG002|Step 1|Off-treatment reason not submitted|1|||
42011850|NCT00998764|75818827|FG001|Overall Study|Withdrawal by Subject|25|||
42011851|NCT00998764|75818826|FG000|Overall Study|Physician Decision|3|||
42038090|NCT01169558|75846418|FG000|Overall Study|Stable Disease|4|||
42011852|NCT00998764|75818827|FG001|Overall Study|Physician Decision|3|||
42140676|NCT00428090|75950534|FG001|Overall Study|Deterioration of cognitive status|0|||
42140677|NCT00428090|75950535|FG002|Overall Study|Deterioration of cognitive status|1|||
42140678|NCT00428090|75950536|FG003|Overall Study|Deterioration of cognitive status|0|||
42140679|NCT00428090|75950533|FG000|Overall Study|Serious adverse event|0|||
42140680|NCT00428090|75950534|FG001|Overall Study|Serious adverse event|0|||
42140681|NCT00428090|75950535|FG002|Overall Study|Serious adverse event|1|||
42140682|NCT00428090|75950536|FG003|Overall Study|Serious adverse event|0|||
42140683|NCT00428090|75950533|FG000|Overall Study|Excluded for heart insufficiency|0|||
42140684|NCT00428090|75950534|FG001|Overall Study|Excluded for heart insufficiency|0|||
42140685|NCT00428090|75950535|FG002|Overall Study|Excluded for heart insufficiency|1|||
42140686|NCT00428090|75950536|FG003|Overall Study|Excluded for heart insufficiency|0|||
42140687|NCT00428090|75950533|FG000|Overall Study|Raised Creatinine Value|0|||
42140688|NCT00428090|75950534|FG001|Overall Study|Raised Creatinine Value|0|||
42140689|NCT00428090|75950535|FG002|Overall Study|Raised Creatinine Value|0|||
42140690|NCT00428090|75950536|FG003|Overall Study|Raised Creatinine Value|1|||
42140691|NCT00416312|75950554|FG000|Overall Study|tumors not visible on imaging|2|||
42140692|NCT00436436|75950558|FG000|Overall Study|Progression|4|||
42140693|NCT00436436|75950558|FG000|Overall Study|Adverse Event|2|||
42140694|NCT00436436|75950558|FG000|Overall Study|Death|6|||
42140695|NCT00262522|75950566|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
42140696|NCT00262522|75950567|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
42140697|NCT00262522|75950568|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
42140698|NCT00262522|75950569|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
42140699|NCT00262522|75950566|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
42140700|NCT00262522|75950567|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
42140701|NCT00262522|75950568|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
42140702|NCT00262522|75950569|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
42140703|NCT00262522|75950566|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
42140704|NCT00262522|75950567|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
42140705|NCT00262522|75950568|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
42140706|NCT00262522|75950569|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
42140707|NCT00262522|75950566|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
42140708|NCT00262522|75950567|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
42140709|NCT00262522|75950568|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
42275931|NCT01708954|76107182|FG000|Step 1|Ineligible or never received treatment|4|||
42275932|NCT01708954|76107183|FG001|Step 1|Ineligible or never received treatment|2|||
42275933|NCT01708954|76107184|FG002|Step 1|Ineligible or never received treatment|8|||
42275934|NCT01708954|76107182|FG000|Step 2|Disease progression|9|||
42275935|NCT01708954|76107183|FG001|Step 2|Disease progression|4|||
42275936|NCT01708954|76107184|FG002|Step 2|Disease progression|0|||
42350704|NCT04080752|76190506|FG000|Overall Study|Withdrawal by Subject|7|||
42011853|NCT00998764|75818826|FG000|Overall Study|Death|3|||
42011854|NCT00998764|75818827|FG001|Overall Study|Death|1|||
42011855|NCT00998764|75818826|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
42011856|NCT00998764|75818827|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
42011857|NCT00998764|75818826|FG000|Overall Study|Protocol Violation|0|||
42011858|NCT00998764|75818827|FG001|Overall Study|Protocol Violation|1|||
42011859|NCT00998764|75818826|FG000|Overall Study|Failed to Return|1|||
42011860|NCT00998764|75818827|FG001|Overall Study|Failed to Return|1|||
42011861|NCT00998764|75818826|FG000|Overall Study|Lost to Follow-up|1|||
42011862|NCT00998764|75818827|FG001|Overall Study|Lost to Follow-up|1|||
42011863|NCT00998764|75818826|FG000|Overall Study|Loss of Caregiver|0|||
42011864|NCT00998764|75818827|FG001|Overall Study|Loss of Caregiver|3|||
42011865|NCT00998764|75818826|FG000|Overall Study|Other|4|||
42275937|NCT01708954|76107182|FG000|Step 2|Adverse Event|3|||
42275938|NCT01708954|76107183|FG001|Step 2|Adverse Event|2|||
42275939|NCT01708954|76107184|FG002|Step 2|Adverse Event|0|||
42275940|NCT01708954|76107182|FG000|Step 2|Withdrawal by Subject|1|||
42275941|NCT01708954|76107183|FG001|Step 2|Withdrawal by Subject|1|||
42275942|NCT01708954|76107184|FG002|Step 2|Withdrawal by Subject|0|||
42275943|NCT01267955|76107193|FG000|Stage 1 (6 Months)|Death|3|||
42275944|NCT01267955|76107193|FG000|Stage 2 (6 Months)|Death|5|||
42275945|NCT01267955|76107193|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
42275946|NCT01251861|76107199|FG000|Overall Study|Disease progression|6|||
42275947|NCT01251861|76107200|FG001|Overall Study|Disease progression|6|||
42038091|NCT01169558|75846418|FG000|Overall Study|Lost to Follow-up|4|||
42350705|NCT04080752|76190507|FG001|Overall Study|Withdrawal by Subject|0|||
42350706|NCT04080752|76190506|FG000|Overall Study|Non-Compliance with Study Drug|0|||
42350707|NCT04080752|76190507|FG001|Overall Study|Non-Compliance with Study Drug|1|||
42350708|NCT04080752|76190506|FG000|Overall Study|Other|2|||
42350709|NCT04080752|76190507|FG001|Overall Study|Other|1|||
42275948|NCT01251861|76107199|FG000|Overall Study|Adverse Event|2|||
42350710|NCT03968419|76190517|FG000|Treatment Period|Adverse Event|0|||
42350711|NCT03968419|76190518|FG001|Treatment Period|Adverse Event|0|||
42350712|NCT03968419|76190519|FG002|Treatment Period|Adverse Event|1|||
42350713|NCT03968419|76190517|FG000|Safety Follow-up Period|Death|3|||
42350714|NCT03968419|76190518|FG001|Safety Follow-up Period|Death|2|||
42350715|NCT03968419|76190519|FG002|Safety Follow-up Period|Death|1|||
42011866|NCT00998764|75818827|FG001|Overall Study|Other|4|||
42011867|NCT00998764|75818826|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
42011868|NCT00998764|75818827|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
42011869|NCT01204671|75818840|FG000|Overall Study|Adverse Event|4|||
42011870|NCT01204671|75818841|FG001|Overall Study|Adverse Event|3|||
42011871|NCT01204671|75818842|FG002|Overall Study|Adverse Event|3|||
42011872|NCT01204671|75818843|FG003|Overall Study|Adverse Event|3|||
42011873|NCT01204671|75818844|FG004|Overall Study|Adverse Event|1|||
42011874|NCT01204671|75818840|FG000|Overall Study|Withdrawal by Subject|2|||
42038092|NCT01169558|75846418|FG000|Overall Study|Need for Surgery|4|||
42038093|NCT01169558|75846418|FG000|Overall Study|Non-compliance|2|||
42038094|NCT01169558|75846418|FG000|Overall Study|Protocol Violation|2|||
42038095|NCT01169558|75846418|FG000|Overall Study|Partial response|2|||
42038096|NCT00840463|75846424|FG000|Overall Study|Adverse Event|1|||
42038097|NCT00840463|75846425|FG001|Overall Study|Adverse Event|0|||
42038098|NCT01168856|75846433|FG000|Overall Study|Lost to Follow-up|4|||
42038099|NCT01168856|75846434|FG001|Overall Study|Lost to Follow-up|34|||
42038100|NCT01168856|75846433|FG000|Overall Study|Withdrawal by Subject|6|||
42038101|NCT01168856|75846434|FG001|Overall Study|Withdrawal by Subject|8|||
42038102|NCT01168856|75846433|FG000|Overall Study|Physician Decision|2|||
42038103|NCT01168856|75846434|FG001|Overall Study|Physician Decision|1|||
42038104|NCT01168856|75846433|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
42038105|NCT01168856|75846434|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
42038106|NCT01168856|75846433|FG000|Overall Study|Participant received anti-HCV treatment|1|||
42038107|NCT01168856|75846434|FG001|Overall Study|Participant received anti-HCV treatment|0|||
42038108|NCT01168856|75846433|FG000|Overall Study|Death|0|||
42038109|NCT01168856|75846434|FG001|Overall Study|Death|2|||
42038110|NCT01168856|75846433|FG000|Overall Study|Other|1|||
42038111|NCT01168856|75846434|FG001|Overall Study|Other|291|||
42038112|NCT01168856|75846433|FG000|Overall Study|Protocol Violation|4|||
42038113|NCT01168856|75846434|FG001|Overall Study|Protocol Violation|6|||
42038114|NCT00828451|75846445|FG000|Overall Study|Death|2|||
42038115|NCT00828451|75846445|FG000|Overall Study|Lack of intravenous line|7|||
42038116|NCT00828451|75846445|FG000|Overall Study|Withdrawal by Subject|1|||
42038117|NCT00828451|75846445|FG000|Overall Study|Deterioration in clinical status|1|||
42038118|NCT00839917|75846451|FG000|Overall Study|Lost to Follow-up|1|||
42038119|NCT00839917|75846452|FG001|Overall Study|Lost to Follow-up|0|||
42038120|NCT00839917|75846451|FG000|Overall Study|Did not receive vaccine|0|||
42038121|NCT00839917|75846452|FG001|Overall Study|Did not receive vaccine|1|||
42275949|NCT01251861|76107200|FG001|Overall Study|Adverse Event|17|||
42275950|NCT01251861|76107199|FG000|Overall Study|Withdrawal by Subject|2|||
42275951|NCT01251861|76107200|FG001|Overall Study|Withdrawal by Subject|2|||
42011875|NCT01204671|75818841|FG001|Overall Study|Withdrawal by Subject|3|||
42038122|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
42038123|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
42038124|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
42038125|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
42038126|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
42038127|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
42275952|NCT01251861|76107199|FG000|Overall Study|Alternative therapy|1|||
42275953|NCT01251861|76107200|FG001|Overall Study|Alternative therapy|0|||
42275954|NCT01251861|76107199|FG000|Overall Study|Other complicating disease|0|||
42350716|NCT03968419|76190517|FG000|Safety Follow-up Period|Subject Decision|2|||
42350717|NCT03968419|76190518|FG001|Safety Follow-up Period|Subject Decision|1|||
42140710|NCT00262522|75950569|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
42140711|NCT00262522|75950566|FG000|Study Start Through 8 Weeks|Death|1|||
42140712|NCT00262522|75950567|FG001|Study Start Through 8 Weeks|Death|0|||
42140713|NCT00262522|75950568|FG002|Study Start Through 8 Weeks|Death|0|||
42140714|NCT00262522|75950569|FG003|Study Start Through 8 Weeks|Death|0|||
42140715|NCT00262522|75950566|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
42140716|NCT00262522|75950567|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
42140717|NCT00262522|75950568|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
42140718|NCT00262522|75950569|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
42140719|NCT00262522|75950566|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
42140720|NCT00262522|75950567|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
42140721|NCT00262522|75950568|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
42140722|NCT00262522|75950569|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
42038128|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
42140723|NCT00262522|75950566|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
42140724|NCT00262522|75950567|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
42140725|NCT00262522|75950568|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
42140726|NCT00262522|75950569|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
42140727|NCT00262522|75950566|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
42140728|NCT00262522|75950567|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
42275955|NCT01251861|76107200|FG001|Overall Study|Other complicating disease|1|||
42275956|NCT01251861|76107199|FG000|Overall Study|Physician Decision|1|||
42275957|NCT01251861|76107200|FG001|Overall Study|Physician Decision|0|||
42140729|NCT00262522|75950568|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
42140730|NCT00262522|75950569|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
42140731|NCT00262522|75950566|FG000|Study Start Through 48 Weeks|Death|2|||
42140732|NCT00262522|75950567|FG001|Study Start Through 48 Weeks|Death|0|||
42140733|NCT00262522|75950568|FG002|Study Start Through 48 Weeks|Death|1|||
42140734|NCT00262522|75950569|FG003|Study Start Through 48 Weeks|Death|0|||
42140735|NCT00262522|75950566|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
42140736|NCT00262522|75950567|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
42140737|NCT00262522|75950568|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
42140738|NCT00262522|75950569|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
42140739|NCT00262522|75950566|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
42038129|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
42038130|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
42038131|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
42038132|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
42038133|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
42038134|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
42038135|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
42038136|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
42038137|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
42038138|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
42038139|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
42038140|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
42140740|NCT00262522|75950567|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
42140741|NCT00262522|75950568|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
42140742|NCT00262522|75950569|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
42140743|NCT00262522|75950566|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
42140744|NCT00262522|75950567|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
42140745|NCT00262522|75950568|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
42140746|NCT00262522|75950569|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
42140747|NCT00262522|75950566|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
42140748|NCT00262522|75950567|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
42140749|NCT00262522|75950568|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
42140750|NCT00262522|75950569|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
42140751|NCT00262522|75950566|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
42140752|NCT00262522|75950567|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
42140753|NCT00262522|75950568|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
42275958|NCT01251861|76107199|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
42275959|NCT01251861|76107200|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
42038141|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
42275960|NCT01251861|76107199|FG000|Overall Study|Other|1|||
42275961|NCT01251861|76107200|FG001|Overall Study|Other|0|||
42140754|NCT00262522|75950569|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
42140755|NCT00262522|75950566|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
42275962|NCT01251861|76107199|FG000|Overall Study|Never started therapy|4|||
42275963|NCT01251861|76107200|FG001|Overall Study|Never started therapy|1|||
42140756|NCT00262522|75950567|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
42140757|NCT00262522|75950568|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
42140758|NCT00262522|75950569|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
42140759|NCT00262522|75950566|FG000|Study Start Through 96 Weeks|Death|2|||
42140760|NCT00262522|75950567|FG001|Study Start Through 96 Weeks|Death|0|||
42140761|NCT00262522|75950568|FG002|Study Start Through 96 Weeks|Death|2|||
42140762|NCT00262522|75950569|FG003|Study Start Through 96 Weeks|Death|0|||
42140763|NCT00262522|75950566|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
42140764|NCT00262522|75950567|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
42140765|NCT00262522|75950568|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
42140766|NCT00262522|75950569|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
42140767|NCT00262522|75950566|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
42140768|NCT00262522|75950567|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
42140769|NCT00262522|75950568|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
42140770|NCT00262522|75950569|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
42140771|NCT00436280|75950577|FG000|Period 1: Induction|Adverse Event|8|||
42140772|NCT00436280|75950577|FG000|Period 1: Induction|Progressive Disease|12|||
42140773|NCT00436280|75950577|FG000|Period 1: Induction|Stable Disease|6|||
42140774|NCT00436280|75950577|FG000|Period 1: Induction|Withdrawal by Subject|1|||
42140775|NCT00436280|75950577|FG000|Period 1: Induction|Death|1|||
42140776|NCT00436280|75950577|FG000|Period 2: Consolidation|Adverse Event|1|||
42140777|NCT00436280|75950577|FG000|Period 2: Consolidation|Progressive Disease|10|||
42140778|NCT00436280|75950577|FG000|Period 2: Consolidation|Stable Disease|1|||
42140779|NCT00436280|75950577|FG000|Period 2: Consolidation|Physician Decision|2|||
42140780|NCT00436280|75950577|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
42140781|NCT00436280|75950577|FG000|Period 2: Consolidation|Death|1|||
42140782|NCT00436280|75950577|FG000|Period 3: Maintenance|Adverse Event|6|||
42140783|NCT00436280|75950577|FG000|Period 3: Maintenance|Progressive Disease|12|||
42140784|NCT00394836|75950583|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
42140785|NCT00394836|75950584|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
42140786|NCT00394836|75950583|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
42140787|NCT00394836|75950584|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
42140788|NCT00394836|75950583|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
42140789|NCT00394836|75950584|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
42140790|NCT00394836|75950583|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
42140791|NCT00394836|75950584|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
42140792|NCT00394836|75950583|FG000|Teatment or Follow-up Phase|Death|0|||
42140793|NCT00394836|75950584|FG001|Teatment or Follow-up Phase|Death|1|||
42140794|NCT00394836|75950583|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
42140795|NCT00394836|75950584|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
42140796|NCT00394836|75950583|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
42140797|NCT00394836|75950584|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
42140798|NCT00394836|75950583|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
42275964|NCT01251861|76107199|FG000|Overall Study|Potential interaction of drugs|0|||
42275965|NCT01251861|76107200|FG001|Overall Study|Potential interaction of drugs|1|||
42275966|NCT00890045|76107208|FG000|Overall Study|Death|0|||
42140799|NCT00394836|75950584|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
42140800|NCT00394836|75950583|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
42140801|NCT00394836|75950584|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
42140802|NCT00394836|75950583|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
42140803|NCT00394836|75950584|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
42140804|NCT00394836|75950583|FG000|Teatment or Follow-up Phase|Non compliance|0|||
42140805|NCT00394836|75950584|FG001|Teatment or Follow-up Phase|Non compliance|1|||
42140806|NCT00394836|75950583|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
42140807|NCT00394836|75950584|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
42275967|NCT00890045|76107209|FG001|Overall Study|Death|1|||
42275968|NCT00890045|76107208|FG000|Overall Study|Did not receive HeRO Graft|0|||
42275969|NCT00890045|76107209|FG001|Overall Study|Did not receive HeRO Graft|2|||
42011876|NCT01204671|75818842|FG002|Overall Study|Withdrawal by Subject|4|||
42011877|NCT01204671|75818843|FG003|Overall Study|Withdrawal by Subject|5|||
42011878|NCT01204671|75818844|FG004|Overall Study|Withdrawal by Subject|3|||
42011879|NCT01204671|75818840|FG000|Overall Study|Lost to Follow-up|7|||
42011880|NCT01204671|75818841|FG001|Overall Study|Lost to Follow-up|8|||
42011881|NCT01204671|75818842|FG002|Overall Study|Lost to Follow-up|6|||
42011882|NCT01204671|75818843|FG003|Overall Study|Lost to Follow-up|4|||
42011883|NCT01204671|75818844|FG004|Overall Study|Lost to Follow-up|0|||
42011884|NCT01204671|75818840|FG000|Overall Study|Unknown Completion Status|1|||
42011885|NCT01204671|75818841|FG001|Overall Study|Unknown Completion Status|1|||
42011886|NCT01204671|75818842|FG002|Overall Study|Unknown Completion Status|0|||
42011887|NCT01204671|75818843|FG003|Overall Study|Unknown Completion Status|0|||
42011888|NCT01204671|75818844|FG004|Overall Study|Unknown Completion Status|0|||
42140808|NCT00394836|75950583|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
42140809|NCT00394836|75950584|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
42140810|NCT00394836|75950583|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
42140811|NCT00394836|75950584|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
42140812|NCT00394836|75950583|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
42140813|NCT00394836|75950584|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
42140814|NCT00250588|75950595|FG000|Overall Study|Withdrawal by Subject|3|||
42140815|NCT00250588|75950596|FG001|Overall Study|Withdrawal by Subject|6|||
42140816|NCT00250588|75950597|FG002|Overall Study|Withdrawal by Subject|0|||
42140817|NCT00250588|75950595|FG000|Overall Study|Lost to Follow-up|6|||
42140818|NCT00250588|75950596|FG001|Overall Study|Lost to Follow-up|13|||
42140819|NCT00250588|75950597|FG002|Overall Study|Lost to Follow-up|13|||
42140820|NCT00416078|75950607|FG000|Overall Study|Death|3|||
42140821|NCT00416078|75950608|FG001|Overall Study|Death|4|||
42140822|NCT00416078|75950607|FG000|Overall Study|Withdrawal by Subject|3|||
42140823|NCT00416078|75950608|FG001|Overall Study|Withdrawal by Subject|2|||
42140824|NCT00416078|75950607|FG000|Overall Study|Physician Decision|1|||
42140825|NCT00416078|75950608|FG001|Overall Study|Physician Decision|0|||
42140826|NCT00416078|75950607|FG000|Overall Study|Lost to Follow-up|4|||
42350718|NCT03968419|76190519|FG002|Safety Follow-up Period|Subject Decision|0|||
42350719|NCT03784846|76190533|FG000|Pre-COVID Study|Lost to Follow-up|3|||
42350720|NCT03784846|76190534|FG001|Pre-COVID Study|Lost to Follow-up|3|||
42350721|NCT03784846|76190535|FG002|Pre-COVID Study|Lost to Follow-up|2|||
42350722|NCT03784846|76190533|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
42350723|NCT03784846|76190534|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
42350724|NCT03784846|76190535|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
42350725|NCT03784846|76190533|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
42350726|NCT03784846|76190534|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
42350727|NCT03784846|76190535|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
42350728|NCT03784846|76190533|FG000|Post-COVID Study|Lost to Follow-up|3|||
42011889|NCT01204671|75818840|FG000|Overall Study|Physician Decision|0|||
42011890|NCT01204671|75818841|FG001|Overall Study|Physician Decision|0|||
42011891|NCT01204671|75818842|FG002|Overall Study|Physician Decision|0|||
42011892|NCT01204671|75818843|FG003|Overall Study|Physician Decision|1|||
42011893|NCT01204671|75818844|FG004|Overall Study|Physician Decision|0|||
42011894|NCT01202955|75818862|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
42011895|NCT01202955|75818863|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
42011896|NCT01202877|75818872|FG000|Overall Study|Disease Progression|0|||
42011897|NCT01202877|75818873|FG001|Overall Study|Disease Progression|1|||
42011898|NCT01202877|75818874|FG002|Overall Study|Disease Progression|2|||
42011899|NCT01202877|75818872|FG000|Overall Study|Adverse Event|0|||
42011900|NCT01202877|75818873|FG001|Overall Study|Adverse Event|0|||
42011901|NCT01202877|75818874|FG002|Overall Study|Adverse Event|2|||
42011902|NCT01202877|75818872|FG000|Overall Study|Withdrawal by Subject|0|||
42011903|NCT01202877|75818873|FG001|Overall Study|Withdrawal by Subject|0|||
42011904|NCT01202877|75818874|FG002|Overall Study|Withdrawal by Subject|1|||
42011905|NCT01202877|75818872|FG000|Overall Study|Death|0|||
42011906|NCT01202877|75818873|FG001|Overall Study|Death|0|||
42011907|NCT01202877|75818874|FG002|Overall Study|Death|1|||
42011908|NCT01202409|75818882|FG000|Overall Study|Adverse Event|1|||
42011909|NCT01202409|75818882|FG000|Overall Study|Ineligible - KRAS mutants|7|||
42140827|NCT00416078|75950608|FG001|Overall Study|Lost to Follow-up|2|||
42140828|NCT00394524|75950616|FG000|Overall Study|Protocol Violation|2|||
42140829|NCT00394524|75950617|FG001|Overall Study|Protocol Violation|3|||
42140830|NCT00394524|75950616|FG000|Overall Study|Death|1|||
42140831|NCT00394524|75950617|FG001|Overall Study|Death|0|||
42140832|NCT00394524|75950616|FG000|Overall Study|Withdrawal by Subject|0|||
42140833|NCT00394524|75950617|FG001|Overall Study|Withdrawal by Subject|1|||
42275970|NCT00890045|76107208|FG000|Overall Study|Lost to Follow-up|5|||
42275971|NCT00890045|76107209|FG001|Overall Study|Lost to Follow-up|7|||
42275972|NCT00598481|76107222|FG000|Treatment|Physician Decision|1|||
42350729|NCT03784846|76190534|FG001|Post-COVID Study|Lost to Follow-up|5|||
42350730|NCT03784846|76190535|FG002|Post-COVID Study|Lost to Follow-up|1|||
42350731|NCT03784846|76190533|FG000|Post-COVID Study|Withdrawal by Subject|1|||
42350732|NCT03784846|76190534|FG001|Post-COVID Study|Withdrawal by Subject|2|||
42350733|NCT03784846|76190535|FG002|Post-COVID Study|Withdrawal by Subject|0|||
42350734|NCT03756350|76190543|FG000|Overall Study|Lost to Follow-up|1|||
42350735|NCT03648996|76190565|FG000|Overall Study|Withdrawal by Subject|0|||
42350736|NCT03648996|76190566|FG001|Overall Study|Withdrawal by Subject|2|||
42350737|NCT03648996|76190567|FG002|Overall Study|Withdrawal by Subject|2|||
42350738|NCT03648996|76190565|FG000|Overall Study|Physician Decision|2|||
42011910|NCT01202175|75818888|FG000|Overall Study|Lost to Follow-up|2|||
42140834|NCT00409344|75950627|FG000|Overall Study|no enrollment|0|||
42140835|NCT00409344|75950628|FG001|Overall Study|no enrollment|0|||
42140836|NCT00415610|75950637|FG000|Overall Study|Death|3|||
42140837|NCT00415610|75950638|FG001|Overall Study|Death|2|||
42140838|NCT00415610|75950639|FG002|Overall Study|Death|5|||
42140839|NCT00394212|75950649|FG000|Overall Study|Lost to Follow-up|3|||
42140840|NCT00394212|75950650|FG001|Overall Study|Lost to Follow-up|0|||
42140841|NCT00394212|75950649|FG000|Overall Study|Withdrawal by Subject|4|||
42140842|NCT00394212|75950650|FG001|Overall Study|Withdrawal by Subject|1|||
42140843|NCT00250432|75950658|FG000|Overall Study|Adverse Event|25|||
42140844|NCT00250432|75950659|FG001|Overall Study|Adverse Event|29|||
42140845|NCT00250432|75950658|FG000|Overall Study|Lack of Efficacy|2|||
42140846|NCT00250432|75950659|FG001|Overall Study|Lack of Efficacy|1|||
42140847|NCT00250432|75950658|FG000|Overall Study|Lost to Follow-up|6|||
42140848|NCT00250432|75950659|FG001|Overall Study|Lost to Follow-up|5|||
42140849|NCT00250432|75950658|FG000|Overall Study|Patient Moved|0|||
42140850|NCT00250432|75950659|FG001|Overall Study|Patient Moved|1|||
42140851|NCT00250432|75950658|FG000|Overall Study|Protocol Violation|0|||
42140852|NCT00250432|75950659|FG001|Overall Study|Protocol Violation|3|||
42275973|NCT01378429|76107249|FG000|Overall Study|Noncompliance with study drug|1|||
42275974|NCT01378429|76107250|FG001|Overall Study|Noncompliance with study drug|0|||
42011911|NCT01202175|75818888|FG000|Overall Study|Withdrawal by Subject|1|||
42011912|NCT01202175|75818888|FG000|Overall Study|Adverse Event|2|||
42011913|NCT01201785|75818893|FG000|Overall Study|Lost to Follow-up|16|||
42011914|NCT01201317|75818900|FG000|Overall Study|Withdrawal by Subject|5|||
42011915|NCT01201317|75818901|FG001|Overall Study|Withdrawal by Subject|0|||
42011916|NCT01201317|75818902|FG002|Overall Study|Withdrawal by Subject|3|||
42011917|NCT01201317|75818900|FG000|Overall Study|Adverse Event|2|||
42011918|NCT01201317|75818901|FG001|Overall Study|Adverse Event|2|||
42011919|NCT01201317|75818902|FG002|Overall Study|Adverse Event|2|||
42011920|NCT01201317|75818900|FG000|Overall Study|Screen failure|1|||
42011921|NCT01201317|75818901|FG001|Overall Study|Screen failure|1|||
42011922|NCT01201317|75818902|FG002|Overall Study|Screen failure|0|||
42011923|NCT01201317|75818900|FG000|Overall Study|Protocol Violation|0|||
42011924|NCT01201317|75818901|FG001|Overall Study|Protocol Violation|1|||
42011925|NCT01201317|75818902|FG002|Overall Study|Protocol Violation|1|||
42011926|NCT01201317|75818900|FG000|Overall Study|Death|0|||
42011927|NCT01201317|75818901|FG001|Overall Study|Death|1|||
42011928|NCT01201317|75818902|FG002|Overall Study|Death|0|||
42011929|NCT01201317|75818900|FG000|Overall Study|Study-specific withdrawal criteria|0|||
42011930|NCT01201317|75818901|FG001|Overall Study|Study-specific withdrawal criteria|0|||
42011931|NCT01201317|75818902|FG002|Overall Study|Study-specific withdrawal criteria|1|||
42011932|NCT01201317|75818900|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
42011933|NCT01201317|75818901|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
42011934|NCT01201317|75818902|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
42011935|NCT01201317|75818900|FG000|Overall Study|Decrease in renal function|0|||
42011936|NCT01201317|75818901|FG001|Overall Study|Decrease in renal function|1|||
42011937|NCT01201317|75818902|FG002|Overall Study|Decrease in renal function|0|||
42011938|NCT01201317|75818900|FG000|Overall Study|Lack of Efficacy|1|||
42011939|NCT01201317|75818901|FG001|Overall Study|Lack of Efficacy|0|||
42011940|NCT01201317|75818902|FG002|Overall Study|Lack of Efficacy|0|||
42011941|NCT01201317|75818900|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
42011942|NCT01201317|75818901|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
42011943|NCT01201317|75818902|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
42011944|NCT01200069|75818912|FG000|Overall Study|Withdrawal by Subject|0|||
42011945|NCT01200069|75818913|FG001|Overall Study|Withdrawal by Subject|1|||
42011946|NCT01199601|75818964|FG000|Overall Study|Lost to Follow-up|47|||
42011947|NCT01199601|75818965|FG001|Overall Study|Lost to Follow-up|66|||
42011948|NCT01199601|75818964|FG000|Overall Study|Withdrawal by Subject|15|||
42011949|NCT01199601|75818965|FG001|Overall Study|Withdrawal by Subject|3|||
42011950|NCT01199601|75818964|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
42275975|NCT01599754|76107261|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
42275976|NCT01599754|76107262|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
42275977|NCT01599754|76107261|FG000|Overall Study|Participant noncompliance|4|||
42011951|NCT01199601|75818965|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
42011952|NCT01199289|75818975|FG000|Overall Study|Ineligibility determined|2|||
42011953|NCT01199289|75818976|FG001|Overall Study|Ineligibility determined|1|||
42011954|NCT01199289|75818977|FG002|Overall Study|Ineligibility determined|0|||
42011955|NCT01199289|75818978|FG003|Overall Study|Ineligibility determined|0|||
42140853|NCT00250432|75950658|FG000|Overall Study|Withdrawal by Subject|6|||
42140854|NCT00250432|75950659|FG001|Overall Study|Withdrawal by Subject|2|||
42140855|NCT00250432|75950658|FG000|Overall Study|Pt died out of posttherapy report period|6|||
42140856|NCT00250432|75950659|FG001|Overall Study|Pt died out of posttherapy report period|5|||
42140857|NCT00250432|75950658|FG000|Overall Study|Pt was considered untreatable|0|||
42275978|NCT01599754|76107262|FG001|Overall Study|Participant noncompliance|4|||
42140858|NCT00250432|75950659|FG001|Overall Study|Pt was considered untreatable|1|||
42140859|NCT00250276|75950669|FG000|Overall Study|Serious Adverse Event|0|||
42140860|NCT00250276|75950670|FG001|Overall Study|Serious Adverse Event|0|||
42140861|NCT00250276|75950671|FG002|Overall Study|Serious Adverse Event|1|||
42140862|NCT00250276|75950672|FG003|Overall Study|Serious Adverse Event|0|||
42140863|NCT00250276|75950669|FG000|Overall Study|Non-serious Adverse Event|2|||
42140864|NCT00250276|75950670|FG001|Overall Study|Non-serious Adverse Event|0|||
42140865|NCT00250276|75950671|FG002|Overall Study|Non-serious Adverse Event|0|||
42140866|NCT00250276|75950672|FG003|Overall Study|Non-serious Adverse Event|2|||
42140867|NCT00250276|75950669|FG000|Overall Study|Protocol Violation|0|||
42140868|NCT00250276|75950670|FG001|Overall Study|Protocol Violation|1|||
42140869|NCT00250276|75950671|FG002|Overall Study|Protocol Violation|0|||
42140870|NCT00250276|75950672|FG003|Overall Study|Protocol Violation|0|||
42140871|NCT00250276|75950669|FG000|Overall Study|Withdrawal by Subject|1|||
42140872|NCT00250276|75950670|FG001|Overall Study|Withdrawal by Subject|2|||
42140873|NCT00250276|75950671|FG002|Overall Study|Withdrawal by Subject|3|||
42140874|NCT00250276|75950672|FG003|Overall Study|Withdrawal by Subject|2|||
42140875|NCT00250276|75950669|FG000|Overall Study|Migrated/moved from study area|3|||
42140876|NCT00250276|75950670|FG001|Overall Study|Migrated/moved from study area|0|||
42140877|NCT00250276|75950671|FG002|Overall Study|Migrated/moved from study area|2|||
42140878|NCT00250276|75950672|FG003|Overall Study|Migrated/moved from study area|7|||
42140879|NCT00250276|75950669|FG000|Overall Study|Lost to Follow-up|11|||
42140880|NCT00250276|75950670|FG001|Overall Study|Lost to Follow-up|18|||
42140881|NCT00250276|75950671|FG002|Overall Study|Lost to Follow-up|13|||
42140882|NCT00250276|75950672|FG003|Overall Study|Lost to Follow-up|8|||
42140883|NCT00249808|75950687|FG000|Overall Study|Other|27|||
42140884|NCT00249808|75950687|FG000|Overall Study|Protocol Violation|3|||
42038142|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
42140885|NCT00249808|75950687|FG000|Overall Study|Lost to Follow-up|8|||
42140886|NCT00249808|75950687|FG000|Overall Study|Adverse Event|81|||
42140887|NCT00249808|75950687|FG000|Overall Study|Lack of Efficacy|52|||
42140888|NCT00249808|75950687|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
42140889|NCT00278512|75950693|FG000|Overall Study|Death|1|||
42140890|NCT00278512|75950694|FG001|Overall Study|Death|0|||
42140891|NCT00427934|75950704|FG000|Overall Study|Adverse Event|1|||
42140892|NCT00427934|75950705|FG001|Overall Study|Adverse Event|0|||
42140893|NCT00427934|75950706|FG002|Overall Study|Adverse Event|5|||
42140894|NCT00427934|75950707|FG003|Overall Study|Adverse Event|4|||
42140895|NCT00427934|75950704|FG000|Overall Study|Lack of Efficacy|0|||
42140896|NCT00427934|75950705|FG001|Overall Study|Lack of Efficacy|0|||
42140897|NCT00427934|75950706|FG002|Overall Study|Lack of Efficacy|5|||
42140898|NCT00427934|75950707|FG003|Overall Study|Lack of Efficacy|2|||
42140899|NCT00427934|75950704|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
42140900|NCT00427934|75950705|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
42140901|NCT00427934|75950706|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
42140902|NCT00427934|75950707|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
42140903|NCT00427934|75950704|FG000|Overall Study|Other|0|||
42140904|NCT00427934|75950705|FG001|Overall Study|Other|0|||
42140905|NCT00427934|75950706|FG002|Overall Study|Other|11|||
42140906|NCT00427934|75950707|FG003|Overall Study|Other|5|||
42140907|NCT00427934|75950704|FG000|Overall Study|Withdrawal by Subject|0|||
42140908|NCT00427934|75950705|FG001|Overall Study|Withdrawal by Subject|0|||
42140909|NCT00427934|75950706|FG002|Overall Study|Withdrawal by Subject|1|||
42140910|NCT00427934|75950707|FG003|Overall Study|Withdrawal by Subject|3|||
42140911|NCT00435188|75950721|FG000|Overall Study|Death|1|||
42140912|NCT00435188|75950722|FG001|Overall Study|Death|6|||
42140913|NCT00435188|75950721|FG000|Overall Study|Withdrawal by Subject|16|||
42140914|NCT00435188|75950722|FG001|Overall Study|Withdrawal by Subject|11|||
42140915|NCT00435188|75950721|FG000|Overall Study|Lost to Follow-up|5|||
42140916|NCT00435188|75950722|FG001|Overall Study|Lost to Follow-up|6|||
42140917|NCT00427778|75950730|FG000|First Intervention (4 Weeks)|no longer interested|1|||
42140918|NCT00427778|75950731|FG001|First Intervention (4 Weeks)|no longer interested|0|||
42140919|NCT00427778|75950730|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
42038143|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
42140920|NCT00427778|75950731|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
42140921|NCT00427778|75950730|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
42140922|NCT00427778|75950731|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
42140923|NCT00427778|75950730|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
42140924|NCT00427778|75950731|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
42140925|NCT00427700|75950752|FG000|Overall Study|Lost to Follow-up|2|||
42140926|NCT00427700|75950753|FG001|Overall Study|Lost to Follow-up|5|||
42140927|NCT00427700|75950752|FG000|Overall Study|no induction of menses|1|||
42140928|NCT00427700|75950753|FG001|Overall Study|no induction of menses|4|||
42140929|NCT00427700|75950752|FG000|Overall Study|Pregnancy|0|||
42140930|NCT00427700|75950753|FG001|Overall Study|Pregnancy|2|||
42140931|NCT00409188|75950762|FG000|Overall Study|Ongoing at data cut-off|383|||
42140932|NCT00409188|75950763|FG001|Overall Study|Ongoing at data cut-off|175|||
42140933|NCT00434954|75950771|FG000|Overall Study|Adverse Event|17|||
42140934|NCT00434954|75950772|FG001|Overall Study|Adverse Event|2|||
42140935|NCT00434954|75950771|FG000|Overall Study|Entry criteria not met|14|||
42140936|NCT00434954|75950772|FG001|Overall Study|Entry criteria not met|16|||
42140937|NCT00434954|75950771|FG000|Overall Study|Lost to Follow-up|0|||
42140938|NCT00434954|75950772|FG001|Overall Study|Lost to Follow-up|1|||
42140939|NCT00434954|75950771|FG000|Overall Study|Physician Decision|6|||
42140940|NCT00434954|75950772|FG001|Overall Study|Physician Decision|3|||
42140941|NCT00434954|75950771|FG000|Overall Study|Protocol Violation|36|||
42140942|NCT00434954|75950772|FG001|Overall Study|Protocol Violation|27|||
42038144|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
42038145|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
42038146|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
42140943|NCT00434954|75950771|FG000|Overall Study|Sponsor decision|1|||
42140944|NCT00434954|75950772|FG001|Overall Study|Sponsor decision|0|||
42140945|NCT00434954|75950771|FG000|Overall Study|Subject decision|8|||
42140946|NCT00434954|75950772|FG001|Overall Study|Subject decision|22|||
42140947|NCT00276484|75950780|FG000|Overall Study|Adverse Event|4|||
42140948|NCT00276484|75950781|FG001|Overall Study|Adverse Event|7|||
42140949|NCT00276484|75950780|FG000|Overall Study|Lost to Follow-up|1|||
42140950|NCT00276484|75950781|FG001|Overall Study|Lost to Follow-up|1|||
42140951|NCT00276484|75950780|FG000|Overall Study|Protocol Violation|0|||
42140952|NCT00276484|75950781|FG001|Overall Study|Protocol Violation|1|||
42140953|NCT00276484|75950780|FG000|Overall Study|Withdrawal by Subject|4|||
42140954|NCT00276484|75950781|FG001|Overall Study|Withdrawal by Subject|3|||
42140955|NCT00276484|75950780|FG000|Overall Study|Could not take time off work|0|||
42140956|NCT00276484|75950781|FG001|Overall Study|Could not take time off work|1|||
42140957|NCT00426842|75950787|FG000|Overall Study|Lost to Follow-up|1|||
42140958|NCT00434876|75950795|FG000|Overall Study|Lost to Follow-up|1|||
42140959|NCT00434876|75950796|FG001|Overall Study|Lost to Follow-up|1|||
42140960|NCT00276094|75950805|FG000|Overall Study|Adverse Event|15|||
42140961|NCT00276094|75950806|FG001|Overall Study|Adverse Event|13|||
42140962|NCT00276094|75950807|FG002|Overall Study|Adverse Event|11|||
42140963|NCT00276094|75950805|FG000|Overall Study|Withdrawal by Subject|14|||
42011956|NCT01199289|75818975|FG000|Overall Study|Protocol Violation|1|||
42038147|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
42038148|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
42038149|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
42038150|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
42038151|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
42038152|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
42038153|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
42038154|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
42038155|NCT00839527|75846461|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
42038156|NCT00839527|75846462|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
42038157|NCT00839527|75846463|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
42038158|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
42038159|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
42038160|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
42038161|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
42038162|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
42038163|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
42038164|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
42038165|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
42140964|NCT00276094|75950806|FG001|Overall Study|Withdrawal by Subject|14|||
42140965|NCT00276094|75950807|FG002|Overall Study|Withdrawal by Subject|12|||
42140966|NCT00276094|75950805|FG000|Overall Study|Protocol Violation|16|||
42140967|NCT00276094|75950806|FG001|Overall Study|Protocol Violation|7|||
42140968|NCT00276094|75950807|FG002|Overall Study|Protocol Violation|10|||
42140969|NCT00276094|75950805|FG000|Overall Study|Lost to Follow-up|8|||
42140970|NCT00276094|75950806|FG001|Overall Study|Lost to Follow-up|6|||
42140971|NCT00276094|75950807|FG002|Overall Study|Lost to Follow-up|4|||
42140972|NCT00276094|75950805|FG000|Overall Study|Other-Subject moved out of country|1|||
42011957|NCT01199289|75818976|FG001|Overall Study|Protocol Violation|0|||
42011958|NCT01199289|75818977|FG002|Overall Study|Protocol Violation|0|||
42011959|NCT01199289|75818978|FG003|Overall Study|Protocol Violation|1|||
42011960|NCT01199289|75818975|FG000|Overall Study|Noncompliance|1|||
42011961|NCT01199289|75818976|FG001|Overall Study|Noncompliance|0|||
42011962|NCT01199289|75818977|FG002|Overall Study|Noncompliance|2|||
42011963|NCT01199289|75818978|FG003|Overall Study|Noncompliance|0|||
42011964|NCT01199289|75818975|FG000|Overall Study|Adverse Event|0|||
42011965|NCT01199289|75818976|FG001|Overall Study|Adverse Event|3|||
42011966|NCT01199289|75818977|FG002|Overall Study|Adverse Event|1|||
42140973|NCT00276094|75950806|FG001|Overall Study|Other-Subject moved out of country|0|||
42140974|NCT00276094|75950807|FG002|Overall Study|Other-Subject moved out of country|0|||
42140975|NCT00276094|75950805|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
42140976|NCT00276094|75950806|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
42140977|NCT00276094|75950807|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
42140978|NCT00276094|75950805|FG000|Overall Study|Other-Lack of efficacy|1|||
42140979|NCT00276094|75950806|FG001|Overall Study|Other-Lack of efficacy|0|||
42140980|NCT00276094|75950807|FG002|Overall Study|Other-Lack of efficacy|0|||
42140981|NCT00276094|75950805|FG000|Overall Study|Other-Refused follow-up visit|1|||
42140982|NCT00276094|75950806|FG001|Overall Study|Other-Refused follow-up visit|0|||
42140983|NCT00276094|75950807|FG002|Overall Study|Other-Refused follow-up visit|0|||
42140984|NCT00276094|75950805|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
42140985|NCT00276094|75950806|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
42140986|NCT00276094|75950807|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
42140987|NCT00276094|75950805|FG000|Overall Study|Other-Relocation|0|||
42140988|NCT00276094|75950806|FG001|Overall Study|Other-Relocation|1|||
42140989|NCT00276094|75950807|FG002|Overall Study|Other-Relocation|0|||
42140990|NCT00276094|75950805|FG000|Overall Study|Other-Study medication lost|0|||
42140991|NCT00276094|75950806|FG001|Overall Study|Other-Study medication lost|0|||
42038166|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
42038167|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
42038168|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
42038169|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
42038170|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
42038171|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
42038172|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
42038173|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
42038174|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
42038175|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
42038176|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
42038177|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
42038178|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
42038179|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
42038180|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
42038181|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
42140992|NCT00276094|75950807|FG002|Overall Study|Other-Study medication lost|1|||
42140993|NCT00276016|75950821|FG000|Intervention 1|Withdrawal by Subject|0|||
42140994|NCT00276016|75950822|FG001|Intervention 1|Withdrawal by Subject|1|||
42140995|NCT00276016|75950823|FG002|Intervention 1|Withdrawal by Subject|0|||
42140996|NCT00276016|75950824|FG003|Intervention 1|Withdrawal by Subject|0|||
42140997|NCT00276016|75950825|FG004|Intervention 1|Withdrawal by Subject|0|||
42140998|NCT00276016|75950826|FG005|Intervention 1|Withdrawal by Subject|0|||
42140999|NCT00434642|75950837|FG000|Blinded Treatment Phase|Adverse Event|12|||
42141000|NCT00434642|75950838|FG001|Blinded Treatment Phase|Adverse Event|58|||
42141001|NCT00434642|75950837|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
42141002|NCT00434642|75950838|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
42275979|NCT01599754|76107261|FG000|Overall Study|Lost to Follow-up|13|||
42275980|NCT01599754|76107262|FG001|Overall Study|Lost to Follow-up|6|||
42275981|NCT01599754|76107261|FG000|Overall Study|Death|31|||
42275982|NCT01599754|76107262|FG001|Overall Study|Death|33|||
42011967|NCT01199289|75818978|FG003|Overall Study|Adverse Event|4|||
42011968|NCT01199289|75818975|FG000|Overall Study|Full consent withdrawn|2|||
42011969|NCT01199289|75818976|FG001|Overall Study|Full consent withdrawn|2|||
42011970|NCT01199289|75818977|FG002|Overall Study|Full consent withdrawn|2|||
42011971|NCT01199289|75818978|FG003|Overall Study|Full consent withdrawn|3|||
42011972|NCT01199289|75818975|FG000|Overall Study|Administrative decision|0|||
42011973|NCT01199289|75818976|FG001|Overall Study|Administrative decision|0|||
42011974|NCT01199289|75818977|FG002|Overall Study|Administrative decision|0|||
42011975|NCT01199289|75818978|FG003|Overall Study|Administrative decision|1|||
42011976|NCT01199289|75818975|FG000|Overall Study|Lost to Follow-up|0|||
42038182|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
42141003|NCT00434642|75950837|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
42141004|NCT00434642|75950838|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
42141005|NCT00434642|75950837|FG000|Blinded Treatment Phase|Physician Decision|19|||
42141006|NCT00434642|75950838|FG001|Blinded Treatment Phase|Physician Decision|27|||
42141007|NCT00434642|75950837|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
42141008|NCT00434642|75950838|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
42141009|NCT00434642|75950837|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
42011977|NCT01199289|75818976|FG001|Overall Study|Lost to Follow-up|0|||
42141010|NCT00434642|75950838|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
42141011|NCT00434642|75950837|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
42141012|NCT00434642|75950838|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
42141013|NCT00434642|75950837|FG000|Open-label Treatment Phase|Adverse Event|0|||
42141014|NCT00434642|75950838|FG001|Open-label Treatment Phase|Adverse Event|5|||
42141015|NCT00434642|75950837|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
42141016|NCT00434642|75950838|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
42141017|NCT00434330|75950850|FG000|Overall Study|Adverse Event|0|||
42141018|NCT00434330|75950851|FG001|Overall Study|Adverse Event|0|||
42141019|NCT00434330|75950852|FG002|Overall Study|Adverse Event|1|||
42141020|NCT00434330|75950853|FG003|Overall Study|Adverse Event|0|||
42141021|NCT00434330|75950854|FG004|Overall Study|Adverse Event|0|||
42141022|NCT00434330|75950855|FG005|Overall Study|Adverse Event|0|||
42141023|NCT00434330|75950850|FG000|Overall Study|Death|1|||
42141024|NCT00434330|75950851|FG001|Overall Study|Death|0|||
42141025|NCT00434330|75950852|FG002|Overall Study|Death|0|||
42141026|NCT00434330|75950853|FG003|Overall Study|Death|0|||
42141027|NCT00434330|75950854|FG004|Overall Study|Death|1|||
42141028|NCT00434330|75950855|FG005|Overall Study|Death|1|||
42141029|NCT00434330|75950850|FG000|Overall Study|Withdrawal by Subject|0|||
42141030|NCT00434330|75950851|FG001|Overall Study|Withdrawal by Subject|0|||
42141031|NCT00434330|75950852|FG002|Overall Study|Withdrawal by Subject|1|||
42141032|NCT00434330|75950853|FG003|Overall Study|Withdrawal by Subject|1|||
42141033|NCT00434330|75950854|FG004|Overall Study|Withdrawal by Subject|0|||
42141034|NCT00434330|75950855|FG005|Overall Study|Withdrawal by Subject|0|||
42141035|NCT00434330|75950850|FG000|Overall Study|Renal transplant|0|||
42141036|NCT00434330|75950851|FG001|Overall Study|Renal transplant|0|||
42141037|NCT00434330|75950852|FG002|Overall Study|Renal transplant|0|||
42141038|NCT00434330|75950853|FG003|Overall Study|Renal transplant|1|||
42141039|NCT00434330|75950854|FG004|Overall Study|Renal transplant|0|||
42141040|NCT00434330|75950855|FG005|Overall Study|Renal transplant|0|||
42141041|NCT00434330|75950850|FG000|Overall Study|Subject Not Compliant With Study|0|||
42141042|NCT00434330|75950851|FG001|Overall Study|Subject Not Compliant With Study|0|||
42141043|NCT00434330|75950852|FG002|Overall Study|Subject Not Compliant With Study|1|||
42141044|NCT00434330|75950853|FG003|Overall Study|Subject Not Compliant With Study|0|||
42141045|NCT00434330|75950854|FG004|Overall Study|Subject Not Compliant With Study|0|||
42141046|NCT00434330|75950855|FG005|Overall Study|Subject Not Compliant With Study|0|||
42141047|NCT00426764|75950869|FG000|Overall Study|Protocol Violation|1|||
42141048|NCT00426764|75950869|FG000|Overall Study|Withdrawal by Subject|4|||
42141049|NCT00426764|75950869|FG000|Overall Study|Physician Decision|6|||
42141050|NCT00426764|75950869|FG000|Overall Study|Compassionate Use|1|||
42141051|NCT00426764|75950869|FG000|Overall Study|Progressive Disease|83|||
42141052|NCT00426764|75950869|FG000|Overall Study|Adverse Event|24|||
42141053|NCT00426764|75950869|FG000|Overall Study|Other|1|||
42141054|NCT00426764|75950869|FG000|Overall Study|Death|1|||
42141055|NCT00426764|75950869|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
42141056|NCT00434252|75950881|FG000|Overall Study|Lack of Efficacy|50|||
42141057|NCT00434252|75950882|FG001|Overall Study|Lack of Efficacy|100|||
42141058|NCT00434252|75950881|FG000|Overall Study|Adverse Event|6|||
42141059|NCT00434252|75950882|FG001|Overall Study|Adverse Event|13|||
42141060|NCT00434252|75950881|FG000|Overall Study|Death|1|||
42141061|NCT00434252|75950882|FG001|Overall Study|Death|2|||
42141062|NCT00434252|75950881|FG000|Overall Study|Lost to Follow-up|0|||
42141063|NCT00434252|75950882|FG001|Overall Study|Lost to Follow-up|1|||
42141064|NCT00434252|75950881|FG000|Overall Study|Physician Decision|4|||
42141065|NCT00434252|75950882|FG001|Overall Study|Physician Decision|8|||
42141066|NCT00434252|75950881|FG000|Overall Study|Withdrawal by Subject|3|||
42141067|NCT00434252|75950882|FG001|Overall Study|Withdrawal by Subject|7|||
42141068|NCT00425750|75950888|FG000|Overall Study|Death|1|||
42141069|NCT00425750|75950888|FG000|Overall Study|Withdrawal by Subject|3|||
42141070|NCT00425750|75950888|FG000|Overall Study|Adverse Event|3|||
42011978|NCT01199289|75818977|FG002|Overall Study|Lost to Follow-up|0|||
42141071|NCT00425750|75950888|FG000|Overall Study|Progression of disease|18|||
42141072|NCT00414908|75950894|FG000|Overall Study|Protocol Violation|1|||
42141073|NCT00414908|75950895|FG001|Overall Study|Protocol Violation|1|||
42141074|NCT00242710|75950907|FG000|Core Study (up to Year 1)|Adverse Event|30|||
42141075|NCT00242710|75950908|FG001|Core Study (up to Year 1)|Adverse Event|25|||
42141076|NCT00242710|75950909|FG002|Core Study (up to Year 1)|Adverse Event|23|||
42011979|NCT01199289|75818978|FG003|Overall Study|Lost to Follow-up|1|||
42141077|NCT00242710|75950910|FG003|Core Study (up to Year 1)|Adverse Event|14|||
42141078|NCT00242710|75950907|FG000|Core Study (up to Year 1)|Death|0|||
42141079|NCT00242710|75950908|FG001|Core Study (up to Year 1)|Death|0|||
42141080|NCT00242710|75950909|FG002|Core Study (up to Year 1)|Death|1|||
42141081|NCT00242710|75950910|FG003|Core Study (up to Year 1)|Death|0|||
42141082|NCT00242710|75950907|FG000|Core Study (up to Year 1)|Physician Decision|0|||
42141083|NCT00242710|75950908|FG001|Core Study (up to Year 1)|Physician Decision|1|||
42141084|NCT00242710|75950909|FG002|Core Study (up to Year 1)|Physician Decision|0|||
42141085|NCT00242710|75950910|FG003|Core Study (up to Year 1)|Physician Decision|1|||
42141086|NCT00242710|75950907|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
42141087|NCT00242710|75950908|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
42141088|NCT00242710|75950909|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
42141089|NCT00242710|75950910|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
42141090|NCT00242710|75950907|FG000|Core Study (up to Year 1)|Other|6|||
42141091|NCT00242710|75950908|FG001|Core Study (up to Year 1)|Other|1|||
42141092|NCT00242710|75950909|FG002|Core Study (up to Year 1)|Other|0|||
42141093|NCT00242710|75950910|FG003|Core Study (up to Year 1)|Other|2|||
42141094|NCT00242710|75950907|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
42141095|NCT00242710|75950908|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
42141096|NCT00242710|75950909|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
42141097|NCT00242710|75950910|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
42141098|NCT00242710|75950907|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
42141099|NCT00242710|75950908|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
42141100|NCT00242710|75950909|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
42141101|NCT00242710|75950910|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
42141102|NCT00242710|75950907|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
42141103|NCT00242710|75950908|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
42141104|NCT00242710|75950909|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
42141105|NCT00242710|75950910|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
42141106|NCT00242710|75950907|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
42141107|NCT00242710|75950908|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
42141108|NCT00242710|75950909|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
42141109|NCT00242710|75950910|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
42141110|NCT00242710|75950907|FG000|Period Between Core Study and Extension|Adverse Event|2|||
42275983|NCT01599754|76107261|FG000|Overall Study|Adverse Event|3|||
42275984|NCT01599754|76107262|FG001|Overall Study|Adverse Event|2|||
42141111|NCT00242710|75950908|FG001|Period Between Core Study and Extension|Adverse Event|3|||
42141112|NCT00242710|75950909|FG002|Period Between Core Study and Extension|Adverse Event|5|||
42275985|NCT01599754|76107261|FG000|Overall Study|Investigator decision|1|||
42275986|NCT01599754|76107262|FG001|Overall Study|Investigator decision|3|||
42275987|NCT01599754|76107261|FG000|Overall Study|Withdrawal by Subject|24|||
42275988|NCT01599754|76107262|FG001|Overall Study|Withdrawal by Subject|25|||
42275989|NCT01599754|76107261|FG000|Overall Study|Study terminated by sponsor|282|||
42275990|NCT01599754|76107262|FG001|Overall Study|Study terminated by sponsor|285|||
42275991|NCT02223754|76107270|FG000|Period 1|Adverse Event|1|||
42038183|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
42275992|NCT02223754|76107271|FG001|Period 1|Adverse Event|0|||
42275993|NCT02223754|76107270|FG000|Period 1|Lost to Follow-up|0|||
42275994|NCT02223754|76107271|FG001|Period 1|Lost to Follow-up|1|||
42350739|NCT03648996|76190566|FG001|Overall Study|Physician Decision|0|||
42350740|NCT03648996|76190567|FG002|Overall Study|Physician Decision|0|||
42350741|NCT03483961|76190592|FG000|Overall Study|Lost to Follow-up|7|||
42350742|NCT03483961|76190593|FG001|Overall Study|Lost to Follow-up|6|||
42350743|NCT03483961|76190594|FG002|Overall Study|Lost to Follow-up|6|||
42350744|NCT03483961|76190595|FG003|Overall Study|Lost to Follow-up|6|||
42038184|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
42038185|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
42038186|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
42038187|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
42038188|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
42038189|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
42038190|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
42038191|NCT00839527|75846461|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
42038192|NCT00839527|75846462|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
42141113|NCT00242710|75950910|FG003|Period Between Core Study and Extension|Adverse Event|2|||
42141114|NCT00242710|75950907|FG000|Period Between Core Study and Extension|Physician Decision|1|||
42141115|NCT00242710|75950908|FG001|Period Between Core Study and Extension|Physician Decision|1|||
42141116|NCT00242710|75950909|FG002|Period Between Core Study and Extension|Physician Decision|0|||
42141117|NCT00242710|75950910|FG003|Period Between Core Study and Extension|Physician Decision|0|||
42275995|NCT02223754|76107270|FG000|Period 1|Protocol Violation|2|||
42275996|NCT02223754|76107271|FG001|Period 1|Protocol Violation|4|||
42038193|NCT00839527|75846463|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
42275997|NCT02223754|76107270|FG000|Period 1|Withdrawal by Subject|0|||
42350745|NCT03483961|76190596|FG004|Overall Study|Lost to Follow-up|6|||
42350746|NCT03483961|76190597|FG005|Overall Study|Lost to Follow-up|4|||
42350747|NCT03483961|76190598|FG006|Overall Study|Lost to Follow-up|4|||
42350748|NCT03483961|76190599|FG007|Overall Study|Lost to Follow-up|11|||
42350749|NCT03483961|76190600|FG008|Overall Study|Lost to Follow-up|1|||
42275998|NCT02223754|76107271|FG001|Period 1|Withdrawal by Subject|4|||
42275999|NCT02223754|76107270|FG000|Period 1|Test Article No Longer Available|1|||
42276000|NCT02223754|76107271|FG001|Period 1|Test Article No Longer Available|5|||
42276001|NCT02223754|76107270|FG000|Period 1|Unsatisfactory Visual Response|0|||
42276002|NCT02223754|76107271|FG001|Period 1|Unsatisfactory Visual Response|1|||
42276003|NCT02223754|76107270|FG000|Period 2|Adverse Event|0|||
42276004|NCT02223754|76107271|FG001|Period 2|Adverse Event|1|||
42038194|NCT00600886|75846475|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
42038195|NCT00600886|75846476|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
42141118|NCT00242710|75950907|FG000|Period Between Core Study and Extension|Other|24|||
42141119|NCT00242710|75950908|FG001|Period Between Core Study and Extension|Other|24|||
42141120|NCT00242710|75950909|FG002|Period Between Core Study and Extension|Other|9|||
42141121|NCT00242710|75950910|FG003|Period Between Core Study and Extension|Other|11|||
42141122|NCT00242710|75950907|FG000|Period Between Core Study and Extension|Extension not Available|17|||
42141123|NCT00242710|75950908|FG001|Period Between Core Study and Extension|Extension not Available|21|||
42141124|NCT00242710|75950909|FG002|Period Between Core Study and Extension|Extension not Available|8|||
42141125|NCT00242710|75950910|FG003|Period Between Core Study and Extension|Extension not Available|7|||
42141126|NCT00242710|75950907|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
42141127|NCT00242710|75950908|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
42141128|NCT00242710|75950909|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
42141129|NCT00242710|75950910|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
42141130|NCT00242710|75950907|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
42141131|NCT00242710|75950908|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
42141132|NCT00242710|75950909|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
42141133|NCT00242710|75950910|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
42141134|NCT00242710|75950907|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
42141135|NCT00242710|75950908|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
42141136|NCT00242710|75950909|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
42141137|NCT00242710|75950910|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
42141138|NCT00242710|75950907|FG000|Study Extension (up to Year 2)|Death|0|||
42141139|NCT00242710|75950908|FG001|Study Extension (up to Year 2)|Death|0|||
42141140|NCT00242710|75950909|FG002|Study Extension (up to Year 2)|Death|0|||
42038196|NCT00600886|75846475|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
42038197|NCT00600886|75846476|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
42038198|NCT00600886|75846475|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
42038199|NCT00600886|75846476|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
42038200|NCT00600886|75846475|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
42038201|NCT00600886|75846476|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
42038202|NCT00600886|75846475|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
42038203|NCT00600886|75846476|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
42141141|NCT00242710|75950910|FG003|Study Extension (up to Year 2)|Death|1|||
42141142|NCT00242710|75950907|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
42141143|NCT00242710|75950908|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
42141144|NCT00242710|75950909|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
42141145|NCT00242710|75950910|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
42141146|NCT00242710|75950907|FG000|Study Extension (up to Year 2)|Other|3|||
42141147|NCT00242710|75950908|FG001|Study Extension (up to Year 2)|Other|5|||
42141148|NCT00242710|75950909|FG002|Study Extension (up to Year 2)|Other|4|||
42141149|NCT00242710|75950910|FG003|Study Extension (up to Year 2)|Other|3|||
42276005|NCT02223754|76107270|FG000|Period 2|Protocol Violation|1|||
42276006|NCT02223754|76107271|FG001|Period 2|Protocol Violation|0|||
42276007|NCT02223754|76107270|FG000|Period 2|Lens Discomfort|1|||
42350750|NCT03483961|76190601|FG009|Overall Study|Lost to Follow-up|0|||
42350751|NCT03483961|76190592|FG000|Overall Study|Withdrawal by Subject|3|||
42011980|NCT01199289|75818975|FG000|Overall Study|Protocol-specified criteria|3|||
42011981|NCT01199289|75818976|FG001|Overall Study|Protocol-specified criteria|0|||
42011982|NCT01199289|75818977|FG002|Overall Study|Protocol-specified criteria|0|||
42011983|NCT01199289|75818978|FG003|Overall Study|Protocol-specified criteria|1|||
42011984|NCT01199289|75818975|FG000|Overall Study|Pregnancy|0|||
42011985|NCT01199289|75818976|FG001|Overall Study|Pregnancy|1|||
42011986|NCT01199289|75818977|FG002|Overall Study|Pregnancy|0|||
42011987|NCT01199289|75818978|FG003|Overall Study|Pregnancy|1|||
42011988|NCT01199055|75818994|FG000|Overall Study|Death|0|||
42011989|NCT01199055|75818995|FG001|Overall Study|Death|1|||
42011990|NCT01199055|75818996|FG002|Overall Study|Death|0|||
42011991|NCT01199055|75818994|FG000|Overall Study|Physician Decision|0|||
42038204|NCT00600886|75846475|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
42276008|NCT02223754|76107271|FG001|Period 2|Lens Discomfort|1|||
42276009|NCT02223754|76107270|FG000|Period 2|Lost to Follow-up|1|||
42350752|NCT03483961|76190593|FG001|Overall Study|Withdrawal by Subject|4|||
42011992|NCT01199055|75818995|FG001|Overall Study|Physician Decision|1|||
42011993|NCT01199055|75818996|FG002|Overall Study|Physician Decision|1|||
42141150|NCT00242710|75950907|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
42038205|NCT00600886|75846476|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
42038206|NCT00600886|75846475|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
42276010|NCT02223754|76107271|FG001|Period 2|Lost to Follow-up|0|||
42276011|NCT02223754|76107270|FG000|Period 2|Test Article No Longer Available|0|||
42276012|NCT02223754|76107271|FG001|Period 2|Test Article No Longer Available|1|||
42276013|NCT02223364|76107281|FG000|Overall Study|Protocol Violation|3|||
42276014|NCT02223364|76107282|FG001|Overall Study|Protocol Violation|0|||
42276015|NCT02223364|76107283|FG002|Overall Study|Protocol Violation|3|||
42276016|NCT02223364|76107281|FG000|Overall Study|subject expired before surgery|1|||
42276017|NCT02223364|76107282|FG001|Overall Study|subject expired before surgery|0|||
42276018|NCT02223364|76107283|FG002|Overall Study|subject expired before surgery|0|||
42276019|NCT02223364|76107281|FG000|Overall Study|Physician Decision|1|||
42276020|NCT02223364|76107282|FG001|Overall Study|Physician Decision|0|||
42276021|NCT02223364|76107283|FG002|Overall Study|Physician Decision|0|||
42276022|NCT01378975|76107293|FG000|Overall Study|Death|77|||
42350753|NCT03483961|76190594|FG002|Overall Study|Withdrawal by Subject|5|||
42350754|NCT03483961|76190595|FG003|Overall Study|Withdrawal by Subject|3|||
42011994|NCT01199055|75818994|FG000|Overall Study|Progressive disease|2|||
42011995|NCT01199055|75818995|FG001|Overall Study|Progressive disease|1|||
42011996|NCT01199055|75818996|FG002|Overall Study|Progressive disease|2|||
42011997|NCT01199055|75818994|FG000|Overall Study|Withdrawal by Subject|0|||
42011998|NCT01199055|75818995|FG001|Overall Study|Withdrawal by Subject|0|||
42011999|NCT01199055|75818996|FG002|Overall Study|Withdrawal by Subject|1|||
42012000|NCT01198977|75819008|FG000|Overall Study|Lost to Follow-up|1|||
42012001|NCT01198977|75819009|FG001|Overall Study|Lost to Follow-up|0|||
42012002|NCT01198587|75819021|FG000|Overall Study|Lost to Follow-up|8|||
42012003|NCT01198587|75819022|FG001|Overall Study|Lost to Follow-up|0|||
42012004|NCT01198587|75819023|FG002|Overall Study|Lost to Follow-up|9|||
42012005|NCT01198587|75819024|FG003|Overall Study|Lost to Follow-up|0|||
42038207|NCT00600886|75846476|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
42038208|NCT00600886|75846475|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
42038209|NCT00600886|75846476|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
42038210|NCT00600886|75846475|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
42038211|NCT00600886|75846476|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
42038212|NCT00600886|75846475|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
42038213|NCT00600886|75846476|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
42038214|NCT00600886|75846475|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
42141151|NCT00242710|75950908|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
42141152|NCT00242710|75950909|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
42141153|NCT00242710|75950910|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
42141154|NCT00242710|75950907|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
42141155|NCT00242710|75950908|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
42141156|NCT00242710|75950909|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
42141157|NCT00242710|75950910|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
42141158|NCT00408876|75950924|FG000|Overall Study|Adverse Event|9|||
42141159|NCT00408876|75950925|FG001|Overall Study|Adverse Event|17|||
42141160|NCT00408876|75950926|FG002|Overall Study|Adverse Event|27|||
42141161|NCT00408876|75950927|FG003|Overall Study|Adverse Event|10|||
42141162|NCT00408876|75950924|FG000|Overall Study|Withdrawal by Subject|3|||
42141163|NCT00408876|75950925|FG001|Overall Study|Withdrawal by Subject|6|||
42141164|NCT00408876|75950926|FG002|Overall Study|Withdrawal by Subject|6|||
42141165|NCT00408876|75950927|FG003|Overall Study|Withdrawal by Subject|14|||
42141166|NCT00408876|75950924|FG000|Overall Study|Lack of Efficacy|2|||
42141167|NCT00408876|75950925|FG001|Overall Study|Lack of Efficacy|4|||
42141168|NCT00408876|75950926|FG002|Overall Study|Lack of Efficacy|5|||
42141169|NCT00408876|75950927|FG003|Overall Study|Lack of Efficacy|6|||
42141170|NCT00408876|75950924|FG000|Overall Study|Lost to Follow-up|1|||
42141171|NCT00408876|75950925|FG001|Overall Study|Lost to Follow-up|6|||
42141172|NCT00408876|75950926|FG002|Overall Study|Lost to Follow-up|5|||
42141173|NCT00408876|75950927|FG003|Overall Study|Lost to Follow-up|2|||
42141174|NCT00408876|75950924|FG000|Overall Study|Protocol Violation|0|||
42141175|NCT00408876|75950925|FG001|Overall Study|Protocol Violation|3|||
42141176|NCT00408876|75950926|FG002|Overall Study|Protocol Violation|4|||
42141177|NCT00408876|75950927|FG003|Overall Study|Protocol Violation|3|||
42141178|NCT00408876|75950924|FG000|Overall Study|Physician Decision|1|||
42141179|NCT00408876|75950925|FG001|Overall Study|Physician Decision|0|||
42141180|NCT00408876|75950926|FG002|Overall Study|Physician Decision|3|||
42141181|NCT00408876|75950927|FG003|Overall Study|Physician Decision|0|||
42141182|NCT00240994|75950937|FG000|Overall Study|Lost to Follow-up|1|||
42276023|NCT01378975|76107294|FG001|Overall Study|Death|46|||
42276024|NCT01378975|76107293|FG000|Overall Study|Investigator Request|1|||
42350755|NCT03483961|76190596|FG004|Overall Study|Withdrawal by Subject|4|||
42012006|NCT01198509|75819045|FG000|Overall Study|Withdrawal by Subject|1|||
42038215|NCT00600886|75846476|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
42350756|NCT03483961|76190597|FG005|Overall Study|Withdrawal by Subject|2|||
42350757|NCT03483961|76190598|FG006|Overall Study|Withdrawal by Subject|1|||
42350758|NCT03483961|76190599|FG007|Overall Study|Withdrawal by Subject|2|||
42276025|NCT01378975|76107294|FG001|Overall Study|Investigator Request|0|||
42276026|NCT01378975|76107293|FG000|Overall Study|Lost to Follow-up|4|||
42276027|NCT01378975|76107294|FG001|Overall Study|Lost to Follow-up|1|||
42276028|NCT01378975|76107293|FG000|Overall Study|Withdrew Consent|4|||
42276029|NCT01378975|76107294|FG001|Overall Study|Withdrew Consent|3|||
42276030|NCT02222896|76107301|FG000|Abdomen|Did not qualify|34|||
42276031|NCT02222896|76107302|FG001|Abdomen|Did not qualify|10|||
42276032|NCT02222896|76107303|FG002|Abdomen|Did not qualify|32|||
42276033|NCT02222896|76107301|FG000|Groin|Did not qualify|43|||
42276034|NCT02222896|76107302|FG001|Groin|Did not qualify|9|||
42276035|NCT02222896|76107303|FG002|Groin|Did not qualify|40|||
42276036|NCT02222818|76107316|FG000|Period 1|Eligibility criteria not met|0|||
42276037|NCT02222818|76107317|FG001|Period 1|Eligibility criteria not met|3|||
42276038|NCT01378195|76107324|FG000|Overall Study|Lost to Follow-up|29|||
42276039|NCT01378195|76107325|FG001|Overall Study|Lost to Follow-up|18|||
42276040|NCT01378117|76107334|FG000|Overall Study|withdrawal|2|||
42276041|NCT01378117|76107335|FG001|Overall Study|withdrawal|1|||
42141183|NCT00240994|75950937|FG000|Overall Study|Protocol Violation|1|||
42141184|NCT00240994|75950937|FG000|Overall Study|Graft failure|1|||
42276042|NCT01378117|76107336|FG002|Overall Study|withdrawal|2|||
42276043|NCT01378117|76107334|FG000|Overall Study|discharged before med given|2|||
42276044|NCT01378117|76107335|FG001|Overall Study|discharged before med given|0|||
42276045|NCT01378117|76107336|FG002|Overall Study|discharged before med given|1|||
42276046|NCT04254809|76107371|FG000|Overall Study|Lost to Follow-up|5|||
42276047|NCT04254809|76107372|FG001|Overall Study|Lost to Follow-up|10|||
42276048|NCT02736409|76107382|FG000|Overall Study|Withdrawal by Subject|4|||
42276049|NCT02736409|76107383|FG001|Overall Study|Withdrawal by Subject|2|||
42276050|NCT02736409|76107384|FG002|Overall Study|Withdrawal by Subject|17|||
42276051|NCT02736409|76107385|FG003|Overall Study|Withdrawal by Subject|3|||
42276052|NCT02736409|76107382|FG000|Overall Study|Non-Compliance with Study Drug|0|||
42276053|NCT02736409|76107383|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42276054|NCT02736409|76107384|FG002|Overall Study|Non-Compliance with Study Drug|0|||
42276055|NCT02736409|76107385|FG003|Overall Study|Non-Compliance with Study Drug|1|||
42276056|NCT02736409|76107382|FG000|Overall Study|Adverse Event|0|||
42276057|NCT02736409|76107383|FG001|Overall Study|Adverse Event|1|||
42276058|NCT02736409|76107384|FG002|Overall Study|Adverse Event|5|||
42350759|NCT03483961|76190600|FG008|Overall Study|Withdrawal by Subject|1|||
42350760|NCT03483961|76190601|FG009|Overall Study|Withdrawal by Subject|0|||
42141185|NCT00239590|75950941|FG000|Randomized|Lost to Follow-up|0|||
42141186|NCT00239590|75950942|FG001|Randomized|Lost to Follow-up|1|||
42141187|NCT00239590|75950941|FG000|Randomized|Withdrawal by Subject|0|||
42141188|NCT00239590|75950942|FG001|Randomized|Withdrawal by Subject|1|||
42141189|NCT00239590|75950941|FG000|Completed Study Protocol|Adverse Event|1|||
42141190|NCT00239590|75950942|FG001|Completed Study Protocol|Adverse Event|1|||
42141191|NCT00239590|75950941|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
42012007|NCT01198509|75819046|FG001|Overall Study|Withdrawal by Subject|0|||
42012008|NCT01198509|75819047|FG002|Overall Study|Withdrawal by Subject|0|||
42012009|NCT01198509|75819048|FG003|Overall Study|Withdrawal by Subject|0|||
42012010|NCT01198509|75819049|FG004|Overall Study|Withdrawal by Subject|0|||
42012011|NCT01198509|75819050|FG005|Overall Study|Withdrawal by Subject|0|||
42012012|NCT01198275|75819064|FG000|Overall Study|Adverse Event|2|||
42012013|NCT01198275|75819065|FG001|Overall Study|Adverse Event|3|||
42012014|NCT01198275|75819064|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
42012015|NCT01198275|75819065|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
42012016|NCT01197417|75819073|FG000|Overall Study|Physician Decision|3|||
42012017|NCT01197417|75819074|FG001|Overall Study|Physician Decision|2|||
42012018|NCT01197417|75819073|FG000|Overall Study|Withdrawal by Subject|2|||
42012019|NCT01197417|75819074|FG001|Overall Study|Withdrawal by Subject|4|||
42012020|NCT01197417|75819073|FG000|Overall Study|Site miscommunication|0|||
42012021|NCT01197417|75819074|FG001|Overall Study|Site miscommunication|1|||
42012022|NCT01197417|75819073|FG000|Overall Study|Subject transferred to intensive care|0|||
42141192|NCT00239590|75950942|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
42141193|NCT00433160|75950952|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
42141194|NCT00433160|75950953|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
42141195|NCT00433160|75950952|FG000|52-Week Double-Blind (DB) Period|Death|0|||
42141196|NCT00433160|75950953|FG001|52-Week Double-Blind (DB) Period|Death|0|||
42276059|NCT02736409|76107385|FG003|Overall Study|Adverse Event|4|||
42276060|NCT02736409|76107382|FG000|Overall Study|Other|0|||
42276061|NCT02736409|76107383|FG001|Overall Study|Other|0|||
42276062|NCT02736409|76107384|FG002|Overall Study|Other|1|||
42276063|NCT02736409|76107385|FG003|Overall Study|Other|1|||
42276064|NCT02736409|76107382|FG000|Overall Study|Pregnancy|0|||
42350761|NCT03483961|76190592|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
42276065|NCT02736409|76107383|FG001|Overall Study|Pregnancy|0|||
42276066|NCT02736409|76107384|FG002|Overall Study|Pregnancy|1|||
42276067|NCT02736409|76107385|FG003|Overall Study|Pregnancy|0|||
42276068|NCT02736409|76107382|FG000|Overall Study|Lost to Follow-up|0|||
42276069|NCT02736409|76107383|FG001|Overall Study|Lost to Follow-up|0|||
42276070|NCT02736409|76107384|FG002|Overall Study|Lost to Follow-up|2|||
42276071|NCT02736409|76107385|FG003|Overall Study|Lost to Follow-up|1|||
42276072|NCT02736409|76107382|FG000|Overall Study|Physician Decision|0|||
42276073|NCT02736409|76107383|FG001|Overall Study|Physician Decision|0|||
42276074|NCT02736409|76107384|FG002|Overall Study|Physician Decision|0|||
42012023|NCT01197417|75819074|FG001|Overall Study|Subject transferred to intensive care|1|||
42012024|NCT01197417|75819073|FG000|Overall Study|Not consented in time to receive drug|0|||
42012025|NCT01197417|75819074|FG001|Overall Study|Not consented in time to receive drug|1|||
42012026|NCT01197417|75819073|FG000|Overall Study|Hypotension|1|||
42012027|NCT01197417|75819074|FG001|Overall Study|Hypotension|2|||
42012028|NCT01197417|75819073|FG000|Overall Study|Found to be ineligible|2|||
42012029|NCT01197417|75819074|FG001|Overall Study|Found to be ineligible|5|||
42012030|NCT01197417|75819073|FG000|Overall Study|No 25-hour magnesium level|0|||
42012031|NCT01197417|75819074|FG001|Overall Study|No 25-hour magnesium level|2|||
42012032|NCT00977431|75819085|FG000|Overall Study|Other than listed|1|||
42012033|NCT00977431|75819086|FG001|Overall Study|Other than listed|0|||
42012034|NCT00977431|75819087|FG002|Overall Study|Other than listed|0|||
42012035|NCT00977431|75819088|FG003|Overall Study|Other than listed|0|||
42012036|NCT00977431|75819089|FG004|Overall Study|Other than listed|2|||
42012037|NCT00977431|75819085|FG000|Overall Study|Protocol Violation|0|||
42012038|NCT00977431|75819086|FG001|Overall Study|Protocol Violation|0|||
42012039|NCT00977431|75819087|FG002|Overall Study|Protocol Violation|1|||
42012040|NCT00977431|75819088|FG003|Overall Study|Protocol Violation|0|||
42012041|NCT00977431|75819089|FG004|Overall Study|Protocol Violation|0|||
42012042|NCT00977431|75819085|FG000|Overall Study|Adverse Event|3|||
42012043|NCT00977431|75819086|FG001|Overall Study|Adverse Event|0|||
42012044|NCT00977431|75819087|FG002|Overall Study|Adverse Event|4|||
42012045|NCT00977431|75819088|FG003|Overall Study|Adverse Event|0|||
42012046|NCT00977431|75819089|FG004|Overall Study|Adverse Event|6|||
42012047|NCT00977431|75819085|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
42012048|NCT00977431|75819086|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
42012049|NCT00977431|75819087|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
42012050|NCT00977431|75819088|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
42012051|NCT00977431|75819089|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
42012052|NCT00977431|75819085|FG000|Overall Study|Progressive disease|2|||
42012053|NCT00977431|75819086|FG001|Overall Study|Progressive disease|6|||
42012054|NCT00977431|75819087|FG002|Overall Study|Progressive disease|1|||
42012055|NCT00977431|75819088|FG003|Overall Study|Progressive disease|3|||
42012056|NCT00977431|75819089|FG004|Overall Study|Progressive disease|5|||
42012057|NCT00977197|75819107|FG000|Overall Study|Withdrawal by Subject|3|||
42012058|NCT00977197|75819108|FG001|Overall Study|Withdrawal by Subject|4|||
42012059|NCT00977197|75819107|FG000|Overall Study|Adverse Event|3|||
42012060|NCT00977197|75819108|FG001|Overall Study|Adverse Event|1|||
42012061|NCT00977197|75819107|FG000|Overall Study|Lack of Efficacy|1|||
42012062|NCT00977197|75819108|FG001|Overall Study|Lack of Efficacy|0|||
42012063|NCT00977197|75819107|FG000|Overall Study|Lost to Follow-up|1|||
42012064|NCT00977197|75819108|FG001|Overall Study|Lost to Follow-up|3|||
42012065|NCT00977197|75819107|FG000|Overall Study|Nonadherence|1|||
42012066|NCT00977197|75819108|FG001|Overall Study|Nonadherence|1|||
42012067|NCT00974311|75819116|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
42012068|NCT00974311|75819117|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
42012069|NCT00974311|75819116|FG000|DB Phase (up to 24 Months)|Death|561|||
42012070|NCT00974311|75819117|FG001|DB Phase (up to 24 Months)|Death|298|||
42012071|NCT00974311|75819116|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
42012072|NCT00974311|75819117|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
42012073|NCT00974311|75819116|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
42012074|NCT00974311|75819117|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
42012075|NCT00974311|75819116|FG000|DB Phase (up to 24 Months)|Other|1|||
42012076|NCT00974311|75819117|FG001|DB Phase (up to 24 Months)|Other|0|||
42012077|NCT00974311|75819116|FG000|OLE Phase (up to 77 Months)|Death|14|||
42012078|NCT00974311|75819117|FG001|OLE Phase (up to 77 Months)|Death|21|||
42012079|NCT00974311|75819116|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
42012080|NCT00974311|75819117|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
42012081|NCT00974311|75819116|FG000|OLE Phase (up to 77 Months)|Other|15|||
42012082|NCT00974311|75819117|FG001|OLE Phase (up to 77 Months)|Other|2|||
42012083|NCT00974311|75819116|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
42012084|NCT00974311|75819117|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
42012085|NCT00974233|75819126|FG000|Induction Chemoimmunotherapy|Death|2|||
42012086|NCT00974233|75819126|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
42012087|NCT00974233|75819126|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
42141197|NCT00433160|75950952|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
42276075|NCT02736409|76107385|FG003|Overall Study|Physician Decision|2|||
42276076|NCT03099707|76107398|FG000|Overall Study|Withdrawal by Subject|0|||
42012088|NCT00974233|75819126|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
42141198|NCT00433160|75950953|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
42038216|NCT00600886|75846475|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
42038217|NCT00600886|75846476|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
42038218|NCT00600886|75846475|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
42038219|NCT00600886|75846476|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
42141199|NCT00433160|75950952|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
42141200|NCT00433160|75950953|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
42141201|NCT00433160|75950952|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
42141202|NCT00433160|75950953|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
42141203|NCT00433160|75950952|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
42141204|NCT00433160|75950953|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
42141205|NCT00433160|75950952|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
42350762|NCT03483961|76190593|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
42350763|NCT03483961|76190594|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
42350764|NCT03483961|76190595|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
42350765|NCT03483961|76190596|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
42350766|NCT03483961|76190597|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
42350767|NCT03483961|76190598|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
42038220|NCT00600886|75846475|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
42038221|NCT00600886|75846476|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
42038222|NCT00600886|75846475|FG000|Extension - Same Treatment (FAS)|Death|1|||
42038223|NCT00600886|75846476|FG001|Extension - Same Treatment (FAS)|Death|1|||
42038224|NCT00600886|75846475|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
42038225|NCT00600886|75846476|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
42038226|NCT00600886|75846475|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
42038227|NCT00600886|75846476|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
42038228|NCT00600886|75846475|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
42038229|NCT00600886|75846476|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
42038230|NCT00600886|75846475|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
42038231|NCT00600886|75846476|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
42038232|NCT00600886|75846475|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
42038233|NCT00600886|75846476|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
42038234|NCT00600886|75846475|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
42038235|NCT00600886|75846476|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
42038236|NCT00600886|75846475|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
42141206|NCT00433160|75950953|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
42141207|NCT00433160|75950952|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
42141208|NCT00433160|75950953|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
42141209|NCT00433160|75950952|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
42141210|NCT00433160|75950953|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
42141211|NCT00433160|75950952|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
42141212|NCT00433160|75950953|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
42141213|NCT00433160|75950952|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
42141214|NCT00433160|75950953|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
42141215|NCT00433160|75950952|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
42141216|NCT00433160|75950953|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
42141217|NCT00433160|75950952|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
42141218|NCT00433160|75950953|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
42141219|NCT00433160|75950952|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
42276077|NCT03099707|76107399|FG001|Overall Study|Withdrawal by Subject|3|||
42276078|NCT03099707|76107398|FG000|Overall Study|Lost to Follow-up|0|||
42276079|NCT03099707|76107399|FG001|Overall Study|Lost to Follow-up|1|||
42276080|NCT02906033|76107407|FG000|Baseline|Protocol Violation|37|||
42276081|NCT02906033|76107408|FG001|Baseline|Protocol Violation|33|||
42276082|NCT02906033|76107407|FG000|Follow-up|Lost to Follow-up|46|||
42276083|NCT02906033|76107408|FG001|Follow-up|Lost to Follow-up|62|||
42276084|NCT02221882|76107420|FG000|Overall Study|Withdrawal by Subject|0|||
42038237|NCT00600886|75846476|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
42038238|NCT00600886|75846475|FG000|Extension - After Crossover (CAS)|Death|1|||
42141220|NCT00433160|75950953|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
42141221|NCT00433160|75950952|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
42141222|NCT00433160|75950953|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
42141223|NCT00433160|75950952|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
42141224|NCT00433160|75950953|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
42141225|NCT00239356|75950965|FG000|Overall Study|Lack of Efficacy|1|||
42141226|NCT00239356|75950966|FG001|Overall Study|Lack of Efficacy|0|||
42141227|NCT00239356|75950965|FG000|Overall Study|Adverse Event|6|||
42141228|NCT00239356|75950966|FG001|Overall Study|Adverse Event|0|||
42141229|NCT00239356|75950965|FG000|Overall Study|Withdrawal by Subject|15|||
42141230|NCT00239356|75950966|FG001|Overall Study|Withdrawal by Subject|6|||
42141231|NCT00239356|75950965|FG000|Overall Study|Lost to Follow-up|3|||
42141232|NCT00239356|75950966|FG001|Overall Study|Lost to Follow-up|0|||
42141233|NCT00239356|75950965|FG000|Overall Study|poor/non-compliance|2|||
42141234|NCT00239356|75950966|FG001|Overall Study|poor/non-compliance|0|||
42141235|NCT00239356|75950965|FG000|Overall Study|Pregnancy|1|||
42141236|NCT00239356|75950966|FG001|Overall Study|Pregnancy|0|||
42141237|NCT00239356|75950965|FG000|Overall Study|Administrative reason|0|||
42141238|NCT00239356|75950966|FG001|Overall Study|Administrative reason|1|||
42141239|NCT00239356|75950965|FG000|Overall Study|Drug available on market|11|||
42141240|NCT00239356|75950966|FG001|Overall Study|Drug available on market|2|||
42141241|NCT00393510|75950974|FG000|Overall Study|Physician Decision|3|||
42141242|NCT00393510|75950975|FG001|Overall Study|Physician Decision|9|||
42141243|NCT00425438|75950983|FG000|Overall Study|Termination by Sponsor|25|||
42141244|NCT00425438|75950984|FG001|Overall Study|Termination by Sponsor|27|||
42141245|NCT00275002|75950992|FG000|Overall Study|Death|1|||
42141246|NCT00275002|75950993|FG001|Overall Study|Death|0|||
42141247|NCT00275002|75950992|FG000|Overall Study|Disease progression|21|||
42141248|NCT00275002|75950993|FG001|Overall Study|Disease progression|15|||
42141249|NCT00275002|75950992|FG000|Overall Study|Adverse Event|0|||
42141250|NCT00275002|75950993|FG001|Overall Study|Adverse Event|1|||
42141251|NCT00433004|75951001|FG000|Overall Study|Lost to Follow-up|5|||
42141252|NCT00433004|75951002|FG001|Overall Study|Lost to Follow-up|7|||
42141253|NCT00238264|75951008|FG000|Overall Study|Death|7|||
42141254|NCT00238264|75951008|FG000|Overall Study|Lost to Follow-up|18|||
42141255|NCT00238264|75951008|FG000|Overall Study|Withdrawal by Subject|4|||
42141256|NCT00238264|75951008|FG000|Overall Study|Ineligible|7|||
42141257|NCT00414596|75951012|FG000|Overall Study|Protocol Violation|2|||
42141258|NCT00393042|75951016|FG000|First Intervention|Withdrawal by Subject|1|||
42141259|NCT00393042|75951017|FG001|First Intervention|Withdrawal by Subject|2|||
42141260|NCT00393042|75951016|FG000|First Intervention|Lost to Follow-up|3|||
42141261|NCT00393042|75951017|FG001|First Intervention|Lost to Follow-up|3|||
42350768|NCT03483961|76190599|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
42038239|NCT00600886|75846476|FG001|Extension - After Crossover (CAS)|Death|0|||
42141262|NCT00393042|75951016|FG000|First Intervention|Protocol Violation|1|||
42141263|NCT00393042|75951017|FG001|First Intervention|Protocol Violation|0|||
42141264|NCT00393042|75951016|FG000|First Intervention|Adverse Event|0|||
42141265|NCT00393042|75951017|FG001|First Intervention|Adverse Event|1|||
42141266|NCT00393042|75951016|FG000|Second Intervetion|Adverse Event|0|||
42141267|NCT00393042|75951017|FG001|Second Intervetion|Adverse Event|3|||
42350769|NCT03483961|76190600|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
42141268|NCT00393042|75951016|FG000|Second Intervetion|Withdrawal by Subject|0|||
42141269|NCT00393042|75951017|FG001|Second Intervetion|Withdrawal by Subject|2|||
42141270|NCT00393042|75951016|FG000|Second Intervetion|Lack of Efficacy|1|||
42038240|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
42038241|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
42038242|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
42038243|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
42038244|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
42038245|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
42038246|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
42038247|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
42038248|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
42038249|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
42141271|NCT00393042|75951017|FG001|Second Intervetion|Lack of Efficacy|0|||
42141272|NCT00393042|75951016|FG000|Second Intervetion|Lost to Follow-up|0|||
42350770|NCT03483961|76190601|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
42350771|NCT03483961|76190592|FG000|Overall Study|Adverse Event|0|||
42350772|NCT03483961|76190593|FG001|Overall Study|Adverse Event|0|||
42350773|NCT03483961|76190594|FG002|Overall Study|Adverse Event|1|||
42038250|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
42141273|NCT00393042|75951017|FG001|Second Intervetion|Lost to Follow-up|2|||
42141274|NCT00393042|75951016|FG000|Second Intervetion|Protocol Violation|1|||
42141275|NCT00393042|75951017|FG001|Second Intervetion|Protocol Violation|1|||
42141276|NCT00392808|75951075|FG000|Overall Study|Lost to Follow-up|3|||
42141277|NCT00392808|75951076|FG001|Overall Study|Lost to Follow-up|2|||
42141278|NCT00392808|75951077|FG002|Overall Study|Lost to Follow-up|1|||
42141279|NCT00392808|75951078|FG003|Overall Study|Lost to Follow-up|2|||
42141280|NCT00392808|75951075|FG000|Overall Study|Unable to withdraw blood|3|||
42141281|NCT00392808|75951076|FG001|Overall Study|Unable to withdraw blood|1|||
42141282|NCT00392808|75951077|FG002|Overall Study|Unable to withdraw blood|1|||
42141283|NCT00392808|75951078|FG003|Overall Study|Unable to withdraw blood|2|||
42141284|NCT00274846|75951097|FG000|Overall Study|Did not receive adequate NK cells|1|||
42141285|NCT00237796|75951104|FG000|Overall Study|Baseline and one other ILSS required|10|||
42141286|NCT00237796|75951105|FG001|Overall Study|Baseline and one other ILSS required|5|||
42141287|NCT00414440|75951114|FG000|Core Period|Withdrawal by Subject|70|||
42141288|NCT00414440|75951115|FG001|Core Period|Withdrawal by Subject|32|||
42141289|NCT00414440|75951114|FG000|Extension Period|Lost to Follow-up|44|||
42141290|NCT00414440|75951115|FG001|Extension Period|Lost to Follow-up|52|||
42141291|NCT00414440|75951114|FG000|Extension Period|Did not consent to continue follow up|61|||
42141292|NCT00414440|75951115|FG001|Extension Period|Did not consent to continue follow up|54|||
42141293|NCT00414440|75951114|FG000|Extension Period|Other|1|||
42141294|NCT00414440|75951115|FG001|Extension Period|Other|1|||
42141295|NCT00414440|75951114|FG000|Extension Period|Administrative|16|||
42141296|NCT00414440|75951115|FG001|Extension Period|Administrative|16|||
42141297|NCT00414440|75951114|FG000|Extension Period|Death|1|||
42141298|NCT00414440|75951115|FG001|Extension Period|Death|2|||
42141299|NCT00414440|75951114|FG000|Extension Period|Withdrawal by Subject|9|||
42141300|NCT00414440|75951115|FG001|Extension Period|Withdrawal by Subject|7|||
42141301|NCT00414440|75951114|FG000|Extension Period|Not included in follow up period|18|||
42141302|NCT00414440|75951115|FG001|Extension Period|Not included in follow up period|8|||
42141303|NCT00209560|75951123|FG000|Overall Study|Lack of Efficacy|1|||
42141304|NCT00209560|75951124|FG001|Overall Study|Lack of Efficacy|0|||
42141305|NCT00236080|75951135|FG000|Overall Study|Adverse Event|0|||
42141306|NCT00236080|75951136|FG001|Overall Study|Adverse Event|0|||
42141307|NCT00236080|75951137|FG002|Overall Study|Adverse Event|3|||
42141308|NCT00236080|75951138|FG003|Overall Study|Adverse Event|1|||
42141309|NCT00236080|75951139|FG004|Overall Study|Adverse Event|0|||
42141310|NCT00236080|75951135|FG000|Overall Study|Lost to Follow-up|0|||
42141311|NCT00236080|75951136|FG001|Overall Study|Lost to Follow-up|1|||
42141312|NCT00236080|75951137|FG002|Overall Study|Lost to Follow-up|0|||
42141313|NCT00236080|75951138|FG003|Overall Study|Lost to Follow-up|0|||
42141314|NCT00236080|75951139|FG004|Overall Study|Lost to Follow-up|0|||
42141315|NCT00236080|75951135|FG000|Overall Study|Physician Decision|1|||
42141316|NCT00236080|75951136|FG001|Overall Study|Physician Decision|0|||
42141317|NCT00236080|75951137|FG002|Overall Study|Physician Decision|1|||
42141318|NCT00236080|75951138|FG003|Overall Study|Physician Decision|1|||
42141319|NCT00236080|75951139|FG004|Overall Study|Physician Decision|1|||
42141320|NCT00236080|75951135|FG000|Overall Study|Withdrawal by Subject|1|||
42141321|NCT00236080|75951136|FG001|Overall Study|Withdrawal by Subject|0|||
42141322|NCT00236080|75951137|FG002|Overall Study|Withdrawal by Subject|0|||
42141323|NCT00236080|75951138|FG003|Overall Study|Withdrawal by Subject|0|||
42141324|NCT00236080|75951139|FG004|Overall Study|Withdrawal by Subject|0|||
42141325|NCT00236080|75951135|FG000|Overall Study|Miscellaneous|0|||
42141326|NCT00236080|75951136|FG001|Overall Study|Miscellaneous|0|||
42141327|NCT00236080|75951137|FG002|Overall Study|Miscellaneous|1|||
42141328|NCT00236080|75951138|FG003|Overall Study|Miscellaneous|0|||
42141329|NCT00236080|75951139|FG004|Overall Study|Miscellaneous|0|||
42141330|NCT00432380|75951154|FG000|Overall Study|Migrated/moved from study area|3|||
42141331|NCT00432380|75951155|FG001|Overall Study|Migrated/moved from study area|4|||
42141332|NCT00432380|75951156|FG002|Overall Study|Migrated/moved from study area|1|||
42141333|NCT00432380|75951154|FG000|Overall Study|Adverse Event|1|||
42141334|NCT00432380|75951155|FG001|Overall Study|Adverse Event|0|||
42038251|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
42038252|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
42038253|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
42038254|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
42038255|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
42038256|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
42038257|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
42038258|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
42141335|NCT00432380|75951156|FG002|Overall Study|Adverse Event|0|||
42038259|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
42038260|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
42038261|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
42141336|NCT00234052|75951165|FG000|Treatment|Withdrawal by Subject|3|||
42141337|NCT00234052|75951165|FG000|Treatment|Adverse Event|5|||
42141338|NCT00234052|75951165|FG000|Treatment|Death|2|||
42141339|NCT00234052|75951165|FG000|Treatment|Progressive Disease|11|||
42141340|NCT00234052|75951165|FG000|Follow-up for 5 Years|Death|41|||
42141341|NCT00234052|75951165|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
42038262|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
42038263|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
42038264|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
42038265|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
42038266|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
42038267|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
42038268|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
42038269|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
42038270|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
42038271|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
42038272|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
42038273|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
42141342|NCT00234052|75951165|FG000|Follow-up for 5 Years|Other|7|||
42141343|NCT00408408|75951175|FG000|Overall Study|No follow up data|2|||
42141344|NCT00408408|75951176|FG001|Overall Study|No follow up data|3|||
42141345|NCT00408408|75951177|FG002|Overall Study|No follow up data|0|||
42141346|NCT00408408|75951178|FG003|Overall Study|No follow up data|7|||
42141347|NCT00408408|75951179|FG004|Overall Study|No follow up data|5|||
42141348|NCT00408408|75951180|FG005|Overall Study|No follow up data|3|||
42141349|NCT00414050|75951198|FG000|Overall Study|Adverse Event|1|||
42141350|NCT00414050|75951199|FG001|Overall Study|Adverse Event|1|||
42141351|NCT00414050|75951200|FG002|Overall Study|Adverse Event|1|||
42141352|NCT00414050|75951201|FG003|Overall Study|Adverse Event|1|||
42276085|NCT02221882|76107421|FG001|Overall Study|Withdrawal by Subject|0|||
42276086|NCT02221882|76107422|FG002|Overall Study|Withdrawal by Subject|4|||
42276087|NCT02221882|76107423|FG003|Overall Study|Withdrawal by Subject|2|||
42276088|NCT02221882|76107424|FG004|Overall Study|Withdrawal by Subject|2|||
42276089|NCT02221882|76107425|FG005|Overall Study|Withdrawal by Subject|2|||
42276090|NCT02221882|76107420|FG000|Overall Study|Death|0|||
42276091|NCT02221882|76107421|FG001|Overall Study|Death|1|||
42276092|NCT02221882|76107422|FG002|Overall Study|Death|0|||
42276093|NCT02221882|76107423|FG003|Overall Study|Death|0|||
42276094|NCT02221882|76107424|FG004|Overall Study|Death|0|||
42276095|NCT02221882|76107425|FG005|Overall Study|Death|0|||
42276096|NCT02837783|76107446|FG000|Overall Study|Adverse Event|1|||
42276097|NCT02837783|76107447|FG001|Overall Study|Adverse Event|0|||
42276098|NCT02837783|76107446|FG000|Overall Study|Other, Not Specified|1|||
42276099|NCT02837783|76107447|FG001|Overall Study|Other, Not Specified|2|||
42276100|NCT02221648|76107455|FG000|Overall Study|Withdrawal by Subject|3|||
42276101|NCT02221648|76107456|FG001|Overall Study|Withdrawal by Subject|3|||
42276102|NCT02220712|76107466|FG000|Overall Study|Adverse Event|1|||
42276103|NCT02220712|76107466|FG000|Overall Study|Withdrawal by Subject|2|||
42276104|NCT02220712|76107466|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
42276105|NCT02219932|76107476|FG000|Overall Study|Other|5|||
42276106|NCT02219932|76107477|FG001|Overall Study|Other|11|||
42276107|NCT02219932|76107476|FG000|Overall Study|Death|1|||
42276108|NCT02219932|76107477|FG001|Overall Study|Death|1|||
42276109|NCT02219932|76107476|FG000|Overall Study|Investigator Decision|0|||
42276110|NCT02219932|76107477|FG001|Overall Study|Investigator Decision|1|||
42276111|NCT02219932|76107476|FG000|Overall Study|Consent Withdrawn|11|||
42276112|NCT02219932|76107477|FG001|Overall Study|Consent Withdrawn|7|||
42276113|NCT02219932|76107476|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
42276114|NCT02219932|76107477|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
42276115|NCT02219932|76107476|FG000|Overall Study|Protocol Violation|10|||
42276116|NCT02219932|76107477|FG001|Overall Study|Protocol Violation|6|||
42276117|NCT02219932|76107476|FG000|Overall Study|Pregnancy|1|||
42276118|NCT02219932|76107477|FG001|Overall Study|Pregnancy|0|||
42276119|NCT02219932|76107476|FG000|Overall Study|Lost to Follow-up|4|||
42276120|NCT02219932|76107477|FG001|Overall Study|Lost to Follow-up|2|||
42350774|NCT03483961|76190595|FG003|Overall Study|Adverse Event|0|||
42350775|NCT03483961|76190596|FG004|Overall Study|Adverse Event|0|||
42350776|NCT03483961|76190597|FG005|Overall Study|Adverse Event|0|||
42141353|NCT00414050|75951198|FG000|Overall Study|Lost to Follow-up|2|||
42141354|NCT00414050|75951199|FG001|Overall Study|Lost to Follow-up|2|||
42276121|NCT02219932|76107476|FG000|Overall Study|Adverse Event|23|||
42276122|NCT02219932|76107477|FG001|Overall Study|Adverse Event|21|||
42276123|NCT02219464|76107489|FG000|Overall Study|Withdrawal by Subject|1|||
42276124|NCT02219464|76107490|FG001|Overall Study|Withdrawal by Subject|0|||
42276125|NCT02219464|76107489|FG000|Overall Study|case cancelled|1|||
42276126|NCT02219464|76107490|FG001|Overall Study|case cancelled|0|||
42276127|NCT02219464|76107489|FG000|Overall Study|catheter malfunction|1|||
42276128|NCT02219464|76107490|FG001|Overall Study|catheter malfunction|0|||
42276129|NCT02219308|76107498|FG000|Overall Study|Withdrawal by Subject|1|||
42276130|NCT02219308|76107499|FG001|Overall Study|Withdrawal by Subject|2|||
42350777|NCT03483961|76190598|FG006|Overall Study|Adverse Event|0|||
42276131|NCT02218372|76107507|FG000|Overall Study|Adverse Event|1|||
42276132|NCT02218372|76107508|FG001|Overall Study|Adverse Event|1|||
42276133|NCT02218372|76107507|FG000|Overall Study|Miscellaneous|2|||
42276134|NCT02218372|76107508|FG001|Overall Study|Miscellaneous|1|||
42276135|NCT02218372|76107507|FG000|Overall Study|Randomized but did not receive treatment|2|||
42276136|NCT02218372|76107508|FG001|Overall Study|Randomized but did not receive treatment|3|||
42276137|NCT02218372|76107507|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42276138|NCT02218372|76107508|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
42141355|NCT00414050|75951200|FG002|Overall Study|Lost to Follow-up|1|||
42141356|NCT00414050|75951201|FG003|Overall Study|Lost to Follow-up|1|||
42141357|NCT00414050|75951198|FG000|Overall Study|Withdrawal by Subject|5|||
42141358|NCT00414050|75951199|FG001|Overall Study|Withdrawal by Subject|3|||
42141359|NCT00414050|75951200|FG002|Overall Study|Withdrawal by Subject|2|||
42141360|NCT00414050|75951201|FG003|Overall Study|Withdrawal by Subject|4|||
42141361|NCT00414050|75951198|FG000|Overall Study|Subject discontinued for other reason|1|||
42141362|NCT00414050|75951199|FG001|Overall Study|Subject discontinued for other reason|2|||
42141363|NCT00414050|75951200|FG002|Overall Study|Subject discontinued for other reason|2|||
42141364|NCT00414050|75951201|FG003|Overall Study|Subject discontinued for other reason|1|||
42141365|NCT00414050|75951198|FG000|Overall Study|Subject Moved|0|||
42141366|NCT00414050|75951199|FG001|Overall Study|Subject Moved|0|||
42141367|NCT00414050|75951200|FG002|Overall Study|Subject Moved|0|||
42141368|NCT00414050|75951201|FG003|Overall Study|Subject Moved|1|||
42141369|NCT00413972|75951215|FG000|Overall Study|Adverse Event|2|||
42141370|NCT00413972|75951216|FG001|Overall Study|Adverse Event|1|||
42141371|NCT00413972|75951217|FG002|Overall Study|Adverse Event|0|||
42141372|NCT00413972|75951218|FG003|Overall Study|Adverse Event|0|||
42141373|NCT00413972|75951215|FG000|Overall Study|Lost to Follow-up|1|||
42141374|NCT00413972|75951216|FG001|Overall Study|Lost to Follow-up|2|||
42141375|NCT00413972|75951217|FG002|Overall Study|Lost to Follow-up|1|||
42141376|NCT00413972|75951218|FG003|Overall Study|Lost to Follow-up|0|||
42141377|NCT00413972|75951215|FG000|Overall Study|Withdrawal by Subject|4|||
42276139|NCT02218216|76107521|FG000|Overall Study|Study terminated before completed|6|||
42276140|NCT02218216|76107522|FG001|Overall Study|Study terminated before completed|0|||
42038274|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
42038275|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
42038276|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
42038277|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
42038278|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
42038279|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
42038280|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
42038281|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
42038282|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
42038283|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
42038284|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
42038285|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
42038286|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
42038287|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
42038288|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
42038289|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
42276141|NCT02218216|76107523|FG002|Overall Study|Study terminated before completed|0|||
42276142|NCT02217982|76107533|FG000|Overall Study|Trial discontinued|1|||
42276143|NCT02217982|76107534|FG001|Overall Study|Trial discontinued|0|||
42276144|NCT02217982|76107533|FG000|Overall Study|Adverse Event|0|||
42038290|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
42038291|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
42038292|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Site closed|0|||
42038293|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Site closed|0|||
42038294|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Site closed|1|||
42038295|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Site closed|0|||
42038296|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
42038297|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
42038298|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
42038299|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
42038300|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
42038301|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
42038302|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
42038303|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
42038304|NCT00838903|75846500|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
42038305|NCT00838903|75846501|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
42038306|NCT00838903|75846502|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
42038307|NCT00838903|75846503|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
42038308|NCT00838903|75846500|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
42038309|NCT00838903|75846501|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
42038310|NCT00838903|75846502|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
42038311|NCT00838903|75846503|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
42038312|NCT00838903|75846500|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
42038313|NCT00838903|75846501|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
42038314|NCT00838903|75846502|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
42038315|NCT00838903|75846503|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
42038316|NCT00838903|75846500|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
42038317|NCT00838903|75846501|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
42038318|NCT00838903|75846502|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
42038319|NCT00838903|75846503|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
42038320|NCT00838903|75846500|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
42038321|NCT00838903|75846501|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
42038322|NCT00838903|75846502|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
42038323|NCT00838903|75846503|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
42038324|NCT00838903|75846500|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
42038325|NCT00838903|75846501|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
42038326|NCT00838903|75846502|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
42038327|NCT00838903|75846503|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
42038328|NCT00838903|75846500|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
42038329|NCT00838903|75846501|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
42038330|NCT00838903|75846502|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
42038331|NCT00838903|75846503|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
42038332|NCT00838903|75846500|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
42038333|NCT00838903|75846501|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
42038334|NCT00838903|75846502|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
42038335|NCT00838903|75846503|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
42038336|NCT00838903|75846500|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
42038337|NCT00838903|75846501|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
42038338|NCT00838903|75846502|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
42038339|NCT00838903|75846503|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
42038340|NCT00838903|75846500|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
42038341|NCT00838903|75846501|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
42038342|NCT00838903|75846502|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
42038343|NCT00838903|75846503|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
42038344|NCT00838903|75846500|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
42038345|NCT00838903|75846501|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
42038346|NCT00838903|75846502|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
42038347|NCT00838903|75846503|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
42038348|NCT00838903|75846500|FG000|Follow-up Period (8 Weeks)|Missing|1|||
42038349|NCT00838903|75846501|FG001|Follow-up Period (8 Weeks)|Missing|2|||
42276145|NCT02217982|76107534|FG001|Overall Study|Adverse Event|1|||
42276146|NCT02254408|76107542|FG000|Overall Study|Randomized But Not Treated|1|||
42276147|NCT02254408|76107543|FG001|Overall Study|Randomized But Not Treated|3|||
42276148|NCT02254408|76107542|FG000|Overall Study|Adverse Event|1|||
42038350|NCT00838903|75846502|FG002|Follow-up Period (8 Weeks)|Missing|1|||
42038351|NCT00838903|75846503|FG003|Follow-up Period (8 Weeks)|Missing|1|||
42038352|NCT00828139|75846517|FG000|Overall Study|Adverse Event|8|||
42038353|NCT00828139|75846518|FG001|Overall Study|Adverse Event|1|||
42038354|NCT00828139|75846519|FG002|Overall Study|Adverse Event|10|||
42038355|NCT00828139|75846520|FG003|Overall Study|Adverse Event|5|||
42038356|NCT00828139|75846517|FG000|Overall Study|Death|2|||
42038357|NCT00828139|75846518|FG001|Overall Study|Death|1|||
42038358|NCT00828139|75846519|FG002|Overall Study|Death|0|||
42038359|NCT00828139|75846520|FG003|Overall Study|Death|2|||
42141378|NCT00413972|75951216|FG001|Overall Study|Withdrawal by Subject|5|||
42141379|NCT00413972|75951217|FG002|Overall Study|Withdrawal by Subject|7|||
42141380|NCT00413972|75951218|FG003|Overall Study|Withdrawal by Subject|2|||
42141381|NCT00413972|75951215|FG000|Overall Study|Protocol Violation|0|||
42141382|NCT00413972|75951216|FG001|Overall Study|Protocol Violation|0|||
42141383|NCT00413972|75951217|FG002|Overall Study|Protocol Violation|2|||
42141384|NCT00413972|75951218|FG003|Overall Study|Protocol Violation|0|||
42141385|NCT00413972|75951215|FG000|Overall Study|Other|0|||
42141386|NCT00413972|75951216|FG001|Overall Study|Other|0|||
42141387|NCT00413972|75951217|FG002|Overall Study|Other|0|||
42141388|NCT00413972|75951218|FG003|Overall Study|Other|1|||
42141389|NCT00259012|75951230|FG000|Overall Study|Adverse Event|0|||
42141390|NCT00259012|75951231|FG001|Overall Study|Adverse Event|1|||
42141391|NCT00259012|75951230|FG000|Overall Study|Withdrawal by Subject|1|||
42141392|NCT00259012|75951231|FG001|Overall Study|Withdrawal by Subject|0|||
42141393|NCT00259012|75951230|FG000|Overall Study|Physician Decision|0|||
42141394|NCT00259012|75951231|FG001|Overall Study|Physician Decision|1|||
42141395|NCT00259012|75951230|FG000|Overall Study|Lost to Follow-up|0|||
42141396|NCT00259012|75951231|FG001|Overall Study|Lost to Follow-up|1|||
42141397|NCT00259012|75951230|FG000|Overall Study|Protocol Violation|1|||
42141398|NCT00259012|75951231|FG001|Overall Study|Protocol Violation|1|||
42141399|NCT00209170|75951239|FG000|Overall Study|Adverse Event|0|||
42141400|NCT00209170|75951240|FG001|Overall Study|Adverse Event|1|||
42141401|NCT00209170|75951239|FG000|Overall Study|Withdrawal by Subject|2|||
42141402|NCT00209170|75951240|FG001|Overall Study|Withdrawal by Subject|1|||
42141403|NCT00209170|75951239|FG000|Overall Study|Lack of Efficacy|0|||
42141404|NCT00209170|75951240|FG001|Overall Study|Lack of Efficacy|1|||
42141405|NCT00413894|75951246|FG000|Overall Study|Withdrawal by Subject|10|||
42141406|NCT00413894|75951246|FG000|Overall Study|Administrative Reasons|1|||
42141407|NCT00413894|75951246|FG000|Overall Study|Hb <10 grams/deciliter|12|||
42141408|NCT00413894|75951246|FG000|Overall Study|Adverse Event|28|||
42141409|NCT00413894|75951246|FG000|Overall Study|Protocol Violation|11|||
42141410|NCT00413894|75951246|FG000|Overall Study|Other|18|||
42141411|NCT00407550|75951255|FG000|Overall Study|Adverse Event|0|||
42141412|NCT00407550|75951256|FG001|Overall Study|Adverse Event|1|||
42141413|NCT00407550|75951255|FG000|Overall Study|Withdrawal by Subject|0|||
42141414|NCT00407550|75951256|FG001|Overall Study|Withdrawal by Subject|2|||
42141415|NCT00407550|75951255|FG000|Overall Study|Death|1|||
42141416|NCT00407550|75951256|FG001|Overall Study|Death|0|||
42276149|NCT02254408|76107543|FG001|Overall Study|Adverse Event|0|||
42276150|NCT02254408|76107542|FG000|Overall Study|Death|2|||
42276151|NCT02254408|76107543|FG001|Overall Study|Death|3|||
42276152|NCT02254408|76107542|FG000|Overall Study|Investigator's Discretion|0|||
42276153|NCT02254408|76107543|FG001|Overall Study|Investigator's Discretion|1|||
42038360|NCT00828139|75846517|FG000|Overall Study|Refusal unrelated to toxicity|3|||
42038361|NCT00828139|75846518|FG001|Overall Study|Refusal unrelated to toxicity|4|||
42038362|NCT00828139|75846519|FG002|Overall Study|Refusal unrelated to toxicity|5|||
42038363|NCT00828139|75846520|FG003|Overall Study|Refusal unrelated to toxicity|3|||
42276154|NCT02254408|76107542|FG000|Overall Study|Withdrawal by Subject|3|||
42276155|NCT02254408|76107543|FG001|Overall Study|Withdrawal by Subject|3|||
42276156|NCT02254408|76107542|FG000|Overall Study|Lost to Follow-up|1|||
42276157|NCT02254408|76107543|FG001|Overall Study|Lost to Follow-up|0|||
42038364|NCT00828139|75846517|FG000|Overall Study|Disease Progression|24|||
42141417|NCT00407550|75951255|FG000|Overall Study|Insurance or Other medical condition|2|||
42141418|NCT00407550|75951256|FG001|Overall Study|Insurance or Other medical condition|1|||
42141419|NCT00209092|75951264|FG000|Overall Study|Progression of disease|7|||
42141420|NCT00209092|75951265|FG001|Overall Study|Progression of disease|1|||
42276158|NCT02207608|76107551|FG000|Overall Study|Adverse Event|1|||
42276159|NCT02207608|76107552|FG001|Overall Study|Adverse Event|0|||
42276160|NCT03530995|76107560|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
42141421|NCT00209092|75951264|FG000|Overall Study|Adverse Event|0|||
42141422|NCT00209092|75951265|FG001|Overall Study|Adverse Event|1|||
42141423|NCT00209092|75951264|FG000|Overall Study|Withdrawal by Subject|1|||
42276161|NCT03530995|76107561|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
42038365|NCT00828139|75846518|FG001|Overall Study|Disease Progression|33|||
42141424|NCT00209092|75951265|FG001|Overall Study|Withdrawal by Subject|0|||
42038366|NCT00828139|75846519|FG002|Overall Study|Disease Progression|35|||
42350778|NCT03483961|76190599|FG007|Overall Study|Adverse Event|0|||
42276162|NCT03530995|76107560|FG000|Part 1 Period 3|Protocol Violation|1|||
42276163|NCT03530995|76107561|FG001|Part 1 Period 3|Protocol Violation|0|||
42276164|NCT03530995|76107560|FG000|Part 1 Period 4|Physician Decision|1|||
42276165|NCT03530995|76107561|FG001|Part 1 Period 4|Physician Decision|0|||
42276166|NCT03530995|76107560|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
42276167|NCT03530995|76107561|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
42276168|NCT02217436|76107585|FG000|Overall Study|Protocol Violation|1|||
42276169|NCT02217436|76107586|FG001|Overall Study|Protocol Violation|1|||
42276170|NCT02217436|76107585|FG000|Overall Study|Incomplete data|0|||
42276171|NCT02217436|76107586|FG001|Overall Study|Incomplete data|1|||
42276172|NCT02207530|76107592|FG000|Overall Study|Worsening condition under investigation|78|||
42276173|NCT02207530|76107592|FG000|Overall Study|Patient decision to stop study treatment|5|||
42276174|NCT02207530|76107592|FG000|Overall Study|Adverse Event|8|||
42276175|NCT02207374|76107599|FG000|Overall Study|Withdrawal by Subject|5|||
42276176|NCT02207374|76107600|FG001|Overall Study|Withdrawal by Subject|9|||
42276177|NCT02207374|76107601|FG002|Overall Study|Withdrawal by Subject|4|||
42276178|NCT02207374|76107599|FG000|Overall Study|Death|1|||
42276179|NCT02207374|76107600|FG001|Overall Study|Death|0|||
42276180|NCT02207374|76107601|FG002|Overall Study|Death|1|||
42276181|NCT02207374|76107599|FG000|Overall Study|Missing follow-up information|0|||
42276182|NCT02207374|76107600|FG001|Overall Study|Missing follow-up information|1|||
42276183|NCT02207374|76107601|FG002|Overall Study|Missing follow-up information|1|||
42276184|NCT02217280|76107609|FG000|Overall Study|Withdrawal by Subject|2|||
42276185|NCT02217280|76107609|FG000|Overall Study|Post-consent sceen fail|2|||
42276186|NCT02786537|76107620|FG000|As Randomized|Adverse Event|0|||
42276187|NCT02786537|76107621|FG001|As Randomized|Adverse Event|11|||
42276188|NCT02786537|76107622|FG002|As Randomized|Adverse Event|0|||
42276189|NCT02786537|76107623|FG003|As Randomized|Adverse Event|4|||
42276190|NCT02786537|76107624|FG004|As Randomized|Adverse Event|6|||
42276191|NCT02786537|76107625|FG005|As Randomized|Adverse Event|2|||
42276192|NCT02786537|76107620|FG000|As Randomized|Lack of Efficacy|0|||
42276193|NCT02786537|76107621|FG001|As Randomized|Lack of Efficacy|0|||
42276194|NCT02786537|76107622|FG002|As Randomized|Lack of Efficacy|0|||
42276195|NCT02786537|76107623|FG003|As Randomized|Lack of Efficacy|1|||
42276196|NCT02786537|76107624|FG004|As Randomized|Lack of Efficacy|0|||
42276197|NCT02786537|76107625|FG005|As Randomized|Lack of Efficacy|0|||
42276198|NCT02786537|76107620|FG000|As Randomized|Withdrawal by Subject|1|||
42276199|NCT02786537|76107621|FG001|As Randomized|Withdrawal by Subject|2|||
42276200|NCT02786537|76107622|FG002|As Randomized|Withdrawal by Subject|0|||
42276201|NCT02786537|76107623|FG003|As Randomized|Withdrawal by Subject|1|||
42276202|NCT02786537|76107624|FG004|As Randomized|Withdrawal by Subject|1|||
42038367|NCT00828139|75846520|FG003|Overall Study|Disease Progression|39|||
42038368|NCT00828139|75846517|FG000|Overall Study|Other|4|||
42038369|NCT00828139|75846518|FG001|Overall Study|Other|2|||
42038370|NCT00828139|75846519|FG002|Overall Study|Other|5|||
42038371|NCT00828139|75846520|FG003|Overall Study|Other|2|||
42038372|NCT00838513|75846530|FG000|Screening Period|Screen Failure|3|||
42038373|NCT00838513|75846530|FG000|Extension Treatment Period|Death|1|||
42038374|NCT00838513|75846530|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
42038375|NCT00600106|75846536|FG000|Overall Study|Withdrawal by Subject|1|||
42038376|NCT00600106|75846537|FG001|Overall Study|Withdrawal by Subject|1|||
42276203|NCT02786537|76107625|FG005|As Randomized|Withdrawal by Subject|0|||
42276204|NCT02786537|76107620|FG000|As Randomized|Death|0|||
42276205|NCT02786537|76107621|FG001|As Randomized|Death|2|||
42276206|NCT02786537|76107622|FG002|As Randomized|Death|0|||
42276207|NCT02786537|76107623|FG003|As Randomized|Death|3|||
42276208|NCT02786537|76107624|FG004|As Randomized|Death|1|||
42276209|NCT02786537|76107625|FG005|As Randomized|Death|0|||
42276210|NCT02786537|76107620|FG000|As Randomized|Non-compliance with study drug|1|||
42276211|NCT02786537|76107621|FG001|As Randomized|Non-compliance with study drug|11|||
42276212|NCT02786537|76107622|FG002|As Randomized|Non-compliance with study drug|0|||
42276213|NCT02786537|76107623|FG003|As Randomized|Non-compliance with study drug|1|||
42276214|NCT02786537|76107624|FG004|As Randomized|Non-compliance with study drug|0|||
42276215|NCT02786537|76107625|FG005|As Randomized|Non-compliance with study drug|1|||
42276216|NCT02786537|76107620|FG000|As Randomized|Lost to treatment follow-up|4|||
42276217|NCT02786537|76107621|FG001|As Randomized|Lost to treatment follow-up|32|||
42276218|NCT02786537|76107622|FG002|As Randomized|Lost to treatment follow-up|0|||
42276219|NCT02786537|76107623|FG003|As Randomized|Lost to treatment follow-up|24|||
42276220|NCT02786537|76107624|FG004|As Randomized|Lost to treatment follow-up|4|||
42276221|NCT02786537|76107625|FG005|As Randomized|Lost to treatment follow-up|4|||
42276222|NCT02786537|76107620|FG000|As Randomized|Incarceration|0|||
42038377|NCT00850993|75846547|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
42276223|NCT02786537|76107621|FG001|As Randomized|Incarceration|1|||
42350779|NCT03483961|76190600|FG008|Overall Study|Adverse Event|0|||
42141425|NCT00403494|75951273|FG000|Overall Study|Adverse Event|10|||
42141426|NCT00403494|75951274|FG001|Overall Study|Adverse Event|8|||
42141427|NCT00403494|75951273|FG000|Overall Study|Withdrew Consent|3|||
42141428|NCT00403494|75951274|FG001|Overall Study|Withdrew Consent|2|||
42141429|NCT00403494|75951273|FG000|Overall Study|Inappropriately enrolled|0|||
42141430|NCT00403494|75951274|FG001|Overall Study|Inappropriately enrolled|1|||
42141431|NCT00403494|75951273|FG000|Overall Study|Lost to Follow-up|0|||
42141432|NCT00403494|75951274|FG001|Overall Study|Lost to Follow-up|2|||
42141433|NCT00403494|75951273|FG000|Overall Study|Protocol noncompliance|0|||
42141434|NCT00403494|75951274|FG001|Overall Study|Protocol noncompliance|1|||
42141435|NCT00403494|75951273|FG000|Overall Study|Death|1|||
42141436|NCT00403494|75951274|FG001|Overall Study|Death|0|||
42141437|NCT00403494|75951273|FG000|Overall Study|Sponsor Request|1|||
42141438|NCT00403494|75951274|FG001|Overall Study|Sponsor Request|0|||
42141439|NCT00403260|75951284|FG000|Overall Study|Adverse Event|5|||
42141440|NCT00403260|75951285|FG001|Overall Study|Adverse Event|4|||
42141441|NCT00403260|75951284|FG000|Overall Study|Withdrawal by Subject|5|||
42141442|NCT00403260|75951285|FG001|Overall Study|Withdrawal by Subject|6|||
42141443|NCT00403260|75951284|FG000|Overall Study|Lost to Follow-up|49|||
42141444|NCT00403260|75951285|FG001|Overall Study|Lost to Follow-up|25|||
42276224|NCT02786537|76107622|FG002|As Randomized|Incarceration|0|||
42276225|NCT02786537|76107623|FG003|As Randomized|Incarceration|0|||
42276226|NCT02786537|76107624|FG004|As Randomized|Incarceration|0|||
42276227|NCT02786537|76107625|FG005|As Randomized|Incarceration|0|||
42276228|NCT02786537|76107620|FG000|As Randomized|Opiate Dependency Relapse|0|||
42276229|NCT02786537|76107621|FG001|As Randomized|Opiate Dependency Relapse|1|||
42276230|NCT02786537|76107622|FG002|As Randomized|Opiate Dependency Relapse|0|||
42276231|NCT02786537|76107623|FG003|As Randomized|Opiate Dependency Relapse|0|||
42276232|NCT02786537|76107624|FG004|As Randomized|Opiate Dependency Relapse|0|||
42276233|NCT02786537|76107625|FG005|As Randomized|Opiate Dependency Relapse|0|||
42276234|NCT02786537|76107620|FG000|As Randomized|HCV drugs stolen from pt|0|||
42276235|NCT02786537|76107621|FG001|As Randomized|HCV drugs stolen from pt|1|||
42276236|NCT02786537|76107622|FG002|As Randomized|HCV drugs stolen from pt|0|||
42276237|NCT02786537|76107623|FG003|As Randomized|HCV drugs stolen from pt|0|||
42276238|NCT02786537|76107624|FG004|As Randomized|HCV drugs stolen from pt|0|||
42276239|NCT02786537|76107625|FG005|As Randomized|HCV drugs stolen from pt|0|||
42276240|NCT02786537|76107620|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
42276241|NCT02786537|76107621|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
42276242|NCT02786537|76107622|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
42276243|NCT02786537|76107623|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
42276244|NCT02786537|76107624|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
42276245|NCT02786537|76107625|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
42276246|NCT02786537|76107620|FG000|As Randomized|Subject lost insurance|0|||
42276247|NCT02786537|76107621|FG001|As Randomized|Subject lost insurance|0|||
42276248|NCT02786537|76107622|FG002|As Randomized|Subject lost insurance|0|||
42276249|NCT02786537|76107623|FG003|As Randomized|Subject lost insurance|1|||
42276250|NCT02786537|76107624|FG004|As Randomized|Subject lost insurance|0|||
42276251|NCT02786537|76107625|FG005|As Randomized|Subject lost insurance|0|||
42276252|NCT02786537|76107620|FG000|As Treated|Adverse Event|0|||
42276253|NCT02786537|76107621|FG001|As Treated|Adverse Event|11|||
42276254|NCT02786537|76107622|FG002|As Treated|Adverse Event|0|||
42141445|NCT00403260|75951284|FG000|Overall Study|Re-appearance of P. falciparum|34|||
42141446|NCT00403260|75951285|FG001|Overall Study|Re-appearance of P. falciparum|25|||
42141447|NCT00403260|75951284|FG000|Overall Study|P. vivax infection|26|||
42141448|NCT00403260|75951285|FG001|Overall Study|P. vivax infection|4|||
42276255|NCT02786537|76107623|FG003|As Treated|Adverse Event|4|||
42276256|NCT02786537|76107624|FG004|As Treated|Adverse Event|6|||
42276257|NCT02786537|76107625|FG005|As Treated|Adverse Event|2|||
42276258|NCT02786537|76107620|FG000|As Treated|Death|0|||
42276259|NCT02786537|76107621|FG001|As Treated|Death|2|||
42276260|NCT02786537|76107622|FG002|As Treated|Death|0|||
42276261|NCT02786537|76107623|FG003|As Treated|Death|3|||
42350780|NCT03483961|76190601|FG009|Overall Study|Adverse Event|0|||
42276262|NCT02786537|76107624|FG004|As Treated|Death|1|||
42276263|NCT02786537|76107625|FG005|As Treated|Death|0|||
42276264|NCT02786537|76107620|FG000|As Treated|Lack of Efficacy|0|||
42276265|NCT02786537|76107621|FG001|As Treated|Lack of Efficacy|0|||
42276266|NCT02786537|76107622|FG002|As Treated|Lack of Efficacy|0|||
42276267|NCT02786537|76107623|FG003|As Treated|Lack of Efficacy|1|||
42141449|NCT00403260|75951284|FG000|Overall Study|Mixed infection with P. vivax|2|||
42141450|NCT00403260|75951285|FG001|Overall Study|Mixed infection with P. vivax|0|||
42276268|NCT02786537|76107624|FG004|As Treated|Lack of Efficacy|0|||
42276269|NCT02786537|76107625|FG005|As Treated|Lack of Efficacy|0|||
42276270|NCT02786537|76107620|FG000|As Treated|Lost to Follow-up|4|||
42141451|NCT00403260|75951284|FG000|Overall Study|Mixed infection with P. falciparum|1|||
42141452|NCT00403260|75951285|FG001|Overall Study|Mixed infection with P. falciparum|0|||
42276271|NCT02786537|76107621|FG001|As Treated|Lost to Follow-up|32|||
42276272|NCT02786537|76107622|FG002|As Treated|Lost to Follow-up|0|||
42276273|NCT02786537|76107623|FG003|As Treated|Lost to Follow-up|25|||
42276274|NCT02786537|76107624|FG004|As Treated|Lost to Follow-up|4|||
42276275|NCT02786537|76107625|FG005|As Treated|Lost to Follow-up|4|||
42276276|NCT02786537|76107620|FG000|As Treated|Non-compliance with study drug|1|||
42276277|NCT02786537|76107621|FG001|As Treated|Non-compliance with study drug|11|||
42276278|NCT02786537|76107622|FG002|As Treated|Non-compliance with study drug|0|||
42276279|NCT02786537|76107623|FG003|As Treated|Non-compliance with study drug|1|||
42276280|NCT02786537|76107624|FG004|As Treated|Non-compliance with study drug|0|||
42276281|NCT02786537|76107625|FG005|As Treated|Non-compliance with study drug|1|||
42276282|NCT02786537|76107620|FG000|As Treated|Lost insurance|0|||
42276283|NCT02786537|76107621|FG001|As Treated|Lost insurance|0|||
42276284|NCT02786537|76107622|FG002|As Treated|Lost insurance|0|||
42276285|NCT02786537|76107623|FG003|As Treated|Lost insurance|1|||
42276286|NCT02786537|76107624|FG004|As Treated|Lost insurance|0|||
42276287|NCT02786537|76107625|FG005|As Treated|Lost insurance|0|||
42276288|NCT02786537|76107620|FG000|As Treated|Withdrawal by Subject|1|||
42276289|NCT02786537|76107621|FG001|As Treated|Withdrawal by Subject|2|||
42276290|NCT02786537|76107622|FG002|As Treated|Withdrawal by Subject|0|||
42276291|NCT02786537|76107623|FG003|As Treated|Withdrawal by Subject|0|||
42276292|NCT02786537|76107624|FG004|As Treated|Withdrawal by Subject|1|||
42276293|NCT02786537|76107625|FG005|As Treated|Withdrawal by Subject|0|||
42350781|NCT03459807|76190624|FG000|Overall Study|Withdrawal due to transplant|0|||
42350782|NCT03459807|76190625|FG001|Overall Study|Withdrawal due to transplant|1|||
42350783|NCT03439293|76190638|FG000|Overall Study|Ongoing on Treatment|15|||
42141453|NCT00403260|75951284|FG000|Overall Study|P. vivax infection at screening|1|||
42141454|NCT00403260|75951285|FG001|Overall Study|P. vivax infection at screening|0|||
42350784|NCT03439293|76190638|FG000|Overall Study|Ongoing off Treatment|19|||
42350785|NCT03439293|76190638|FG000|Overall Study|Death|18|||
42350786|NCT03439293|76190638|FG000|Overall Study|Withdrawal by Subject|7|||
42350787|NCT03439293|76190638|FG000|Overall Study|Lost to Follow-up|2|||
42350788|NCT03423979|76190643|FG000|Overall Study|Death|1|||
42276294|NCT02786537|76107620|FG000|As Treated|Incarceration|0|||
42276295|NCT02786537|76107621|FG001|As Treated|Incarceration|1|||
42141455|NCT00403260|75951284|FG000|Overall Study|P. ovale infection|1|||
42276296|NCT02786537|76107622|FG002|As Treated|Incarceration|0|||
42276297|NCT02786537|76107623|FG003|As Treated|Incarceration|0|||
42276298|NCT02786537|76107624|FG004|As Treated|Incarceration|0|||
42276299|NCT02786537|76107625|FG005|As Treated|Incarceration|0|||
42276300|NCT02786537|76107620|FG000|As Treated|Opiate dependency relapse|0|||
42276301|NCT02786537|76107621|FG001|As Treated|Opiate dependency relapse|1|||
42276302|NCT02786537|76107622|FG002|As Treated|Opiate dependency relapse|0|||
42276303|NCT02786537|76107623|FG003|As Treated|Opiate dependency relapse|0|||
42276304|NCT02786537|76107624|FG004|As Treated|Opiate dependency relapse|0|||
42276305|NCT02786537|76107625|FG005|As Treated|Opiate dependency relapse|0|||
42276306|NCT02786537|76107620|FG000|As Treated|Drugs stolen from patient|0|||
42276307|NCT02786537|76107621|FG001|As Treated|Drugs stolen from patient|1|||
42276308|NCT02786537|76107622|FG002|As Treated|Drugs stolen from patient|0|||
42276309|NCT02786537|76107623|FG003|As Treated|Drugs stolen from patient|0|||
42350789|NCT03239210|76190649|FG000|Overall Study|Lost to Follow-up|2|||
42350790|NCT03239210|76190650|FG001|Overall Study|Lost to Follow-up|2|||
42350791|NCT03239210|76190649|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
42350792|NCT03239210|76190650|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
42350793|NCT03239210|76190649|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
42350794|NCT03239210|76190650|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
42350795|NCT03227224|76190660|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
42350796|NCT03227224|76190661|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
42350797|NCT03227224|76190662|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
42350798|NCT03227224|76190663|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
42350799|NCT03227224|76190660|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
42350800|NCT03227224|76190661|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
42350801|NCT03227224|76190662|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
42350802|NCT03227224|76190663|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
42350803|NCT03227224|76190660|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
42350804|NCT03227224|76190661|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
42350805|NCT03227224|76190662|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
42350806|NCT03227224|76190663|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
42350807|NCT03227224|76190660|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
42350808|NCT03227224|76190661|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
42350809|NCT03227224|76190662|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
42350810|NCT03227224|76190663|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
42350811|NCT03227224|76190660|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
42350812|NCT03227224|76190661|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
42012089|NCT00974233|75819126|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
42276310|NCT02786537|76107624|FG004|As Treated|Drugs stolen from patient|0|||
42276311|NCT02786537|76107625|FG005|As Treated|Drugs stolen from patient|0|||
42276312|NCT02786537|76107620|FG000|As Treated|Advised to stop tx after loss of meds|0|||
42276313|NCT02786537|76107621|FG001|As Treated|Advised to stop tx after loss of meds|1|||
42276314|NCT02786537|76107622|FG002|As Treated|Advised to stop tx after loss of meds|0|||
42276315|NCT02786537|76107623|FG003|As Treated|Advised to stop tx after loss of meds|0|||
42276316|NCT02786537|76107624|FG004|As Treated|Advised to stop tx after loss of meds|0|||
42276317|NCT02786537|76107625|FG005|As Treated|Advised to stop tx after loss of meds|0|||
42276318|NCT02216812|76107733|FG000|Overall Study|Lost to Follow-up|10|||
42276319|NCT02216812|76107734|FG001|Overall Study|Lost to Follow-up|5|||
42276320|NCT02252536|76107742|FG000|Overall Study|Lost to Follow-up|5|||
42276321|NCT02252536|76107743|FG001|Overall Study|Lost to Follow-up|3|||
42276322|NCT02206828|76107749|FG000|Overall Study|Lost to Follow-up|7|||
42276323|NCT01209767|76107776|FG000|Overall Study|Withdrawal by Subject|1|||
42276324|NCT01209767|76107776|FG000|Overall Study|Lost to Follow-up|3|||
42276325|NCT02252146|76107784|FG000|Overall Study|Lack of Efficacy|4|||
42276326|NCT02252146|76107784|FG000|Overall Study|Entered hospice care|1|||
42276327|NCT02252146|76107784|FG000|Overall Study|Inability to travel to study site|1|||
42012090|NCT00974233|75819126|FG000|Maintenance Lenalidomide|Adverse Event|8|||
42012091|NCT00973921|75819138|FG000|Overall Study|IVUS results were not available|9|||
42012092|NCT00972595|75819142|FG000|Period 1|Adverse Event|1|||
42012093|NCT00972595|75819143|FG001|Period 1|Adverse Event|0|||
42012094|NCT01196091|75819152|FG000|Overall Study|Adverse Event|22|||
42276328|NCT02251990|76107790|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
42276329|NCT02251990|76107791|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
42276330|NCT02251990|76107790|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
42276331|NCT02251990|76107791|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
42276332|NCT02251990|76107790|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
42276333|NCT02251990|76107791|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
42276334|NCT02251990|76107790|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
42350813|NCT03227224|76190662|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
42276335|NCT02251990|76107791|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
42276336|NCT02251990|76107790|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
42276337|NCT02251990|76107791|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
42350814|NCT03227224|76190663|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
42350815|NCT03227224|76190660|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
42350816|NCT03227224|76190661|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
42350817|NCT03227224|76190662|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
42350818|NCT03227224|76190663|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
42350819|NCT03227224|76190660|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
42350820|NCT03227224|76190661|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
42350821|NCT03227224|76190662|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
42350822|NCT03227224|76190663|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
42350823|NCT03227224|76190660|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
42350824|NCT03227224|76190661|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
42350825|NCT03227224|76190662|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
42350826|NCT03227224|76190663|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
42350827|NCT03227224|76190660|FG000|Follow-up Phase (2 Weeks)|Other|4|||
42350828|NCT03227224|76190661|FG001|Follow-up Phase (2 Weeks)|Other|4|||
42350829|NCT03227224|76190662|FG002|Follow-up Phase (2 Weeks)|Other|6|||
42350830|NCT03227224|76190663|FG003|Follow-up Phase (2 Weeks)|Other|3|||
42350831|NCT03086343|76190682|FG000|Overall Study|Adverse Event|7|||
42350832|NCT03086343|76190683|FG001|Overall Study|Adverse Event|7|||
42350833|NCT03086343|76190682|FG000|Overall Study|Withdrawal by Subject|10|||
42350834|NCT03086343|76190683|FG001|Overall Study|Withdrawal by Subject|6|||
42350835|NCT03086343|76190682|FG000|Overall Study|Lost to Follow-up|3|||
42350836|NCT03086343|76190683|FG001|Overall Study|Lost to Follow-up|1|||
42276338|NCT02251990|76107790|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
42276339|NCT02251990|76107791|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
42276340|NCT02251912|76107800|FG000|Overall Study|Withdrawal by Subject|2|||
42276341|NCT02251912|76107801|FG001|Overall Study|Withdrawal by Subject|3|||
42276342|NCT02251912|76107800|FG000|Overall Study|Adverse Event|0|||
42276343|NCT02251912|76107801|FG001|Overall Study|Adverse Event|2|||
42276344|NCT02206048|76107816|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
42276345|NCT02205814|76107828|FG000|Overall Study|Lost to Follow-up|0|||
42276346|NCT02205814|76107829|FG001|Overall Study|Lost to Follow-up|0|||
42276347|NCT02205814|76107830|FG002|Overall Study|Lost to Follow-up|0|||
42276348|NCT02205814|76107831|FG003|Overall Study|Lost to Follow-up|1|||
42276349|NCT02205814|76107828|FG000|Overall Study|Lack of Efficacy|1|||
42276350|NCT02205814|76107829|FG001|Overall Study|Lack of Efficacy|0|||
42276351|NCT02205814|76107830|FG002|Overall Study|Lack of Efficacy|1|||
42276352|NCT02205814|76107831|FG003|Overall Study|Lack of Efficacy|1|||
42276353|NCT02205814|76107828|FG000|Overall Study|Physician Decision|0|||
42276354|NCT02205814|76107829|FG001|Overall Study|Physician Decision|0|||
42276355|NCT02205814|76107830|FG002|Overall Study|Physician Decision|1|||
42276356|NCT02205814|76107831|FG003|Overall Study|Physician Decision|0|||
42276357|NCT02205814|76107828|FG000|Overall Study|Protocol Violation|1|||
42276358|NCT02205814|76107829|FG001|Overall Study|Protocol Violation|0|||
42276359|NCT02205814|76107830|FG002|Overall Study|Protocol Violation|0|||
42038378|NCT00850993|75846548|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
42038379|NCT00850993|75846549|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
42038380|NCT00850993|75846550|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
42038381|NCT00818779|75846562|FG000|Overall Study|Protocol Violation|1|||
42038382|NCT00818779|75846563|FG001|Overall Study|Protocol Violation|0|||
42038383|NCT00818779|75846562|FG000|Overall Study|Lost to Follow-up|1|||
42038384|NCT00818779|75846563|FG001|Overall Study|Lost to Follow-up|0|||
42038385|NCT00818779|75846562|FG000|Overall Study|Adverse Event|4|||
42038386|NCT00818779|75846563|FG001|Overall Study|Adverse Event|1|||
42276360|NCT02205814|76107831|FG003|Overall Study|Protocol Violation|1|||
42276361|NCT02205814|76107828|FG000|Overall Study|Withdrawal by Subject|0|||
42276362|NCT02205814|76107829|FG001|Overall Study|Withdrawal by Subject|1|||
42276363|NCT02205814|76107830|FG002|Overall Study|Withdrawal by Subject|2|||
42276364|NCT02205814|76107831|FG003|Overall Study|Withdrawal by Subject|1|||
42276365|NCT02205814|76107828|FG000|Overall Study|not compliant with study procedures|0|||
42276366|NCT02205814|76107829|FG001|Overall Study|not compliant with study procedures|0|||
42276367|NCT02205814|76107830|FG002|Overall Study|not compliant with study procedures|1|||
42350837|NCT03086343|76190682|FG000|Overall Study|Lack of Efficacy|4|||
42350838|NCT03086343|76190683|FG001|Overall Study|Lack of Efficacy|6|||
42038387|NCT00850759|75846573|FG000|Overall Study|Lost to Follow-up|7|||
42038388|NCT00850759|75846574|FG001|Overall Study|Lost to Follow-up|5|||
42038389|NCT00850759|75846575|FG002|Overall Study|Lost to Follow-up|5|||
42038390|NCT00850759|75846576|FG003|Overall Study|Lost to Follow-up|3|||
42038391|NCT00827827|75846588|FG000|Overall Study|Lost to Follow-up|3|||
42038392|NCT00827827|75846589|FG001|Overall Study|Lost to Follow-up|0|||
42038393|NCT00827827|75846588|FG000|Overall Study|Fall at home- hospitalization|1|||
42038394|NCT00827827|75846589|FG001|Overall Study|Fall at home- hospitalization|0|||
42038395|NCT00827827|75846588|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
42038396|NCT00827827|75846589|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
42038397|NCT00827827|75846588|FG000|Overall Study|Gout|1|||
42276368|NCT02205814|76107831|FG003|Overall Study|not compliant with study procedures|0|||
42276369|NCT02662985|76107843|FG000|Treatment Period 1|Adverse Event|0|||
42276370|NCT02662985|76107844|FG001|Treatment Period 1|Adverse Event|2|||
42276371|NCT02662985|76107843|FG000|Treatment Period 1|Protocol Violation|0|||
42276372|NCT02662985|76107844|FG001|Treatment Period 1|Protocol Violation|1|||
42276373|NCT02662985|76107843|FG000|Treatment Period 1|Physician Decision|1|||
42276374|NCT02662985|76107844|FG001|Treatment Period 1|Physician Decision|0|||
42276375|NCT02662985|76107843|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42276376|NCT02662985|76107844|FG001|Treatment Period 1|Withdrawal by Subject|1|||
42276377|NCT02662985|76107843|FG000|Treatment Period 2|Lack of Efficacy|0|||
42038398|NCT00827827|75846589|FG001|Overall Study|Gout|0|||
42038399|NCT00827827|75846588|FG000|Overall Study|Transportation issues|1|||
42038400|NCT00827827|75846589|FG001|Overall Study|Transportation issues|0|||
42038401|NCT00827827|75846588|FG000|Overall Study|Burned with water at home|1|||
42038402|NCT00827827|75846589|FG001|Overall Study|Burned with water at home|0|||
42276378|NCT02662985|76107844|FG001|Treatment Period 2|Lack of Efficacy|1|||
42276379|NCT02662985|76107843|FG000|Treatment Period 2|Lost to Follow-up|1|||
42276380|NCT02662985|76107844|FG001|Treatment Period 2|Lost to Follow-up|0|||
42276381|NCT02662985|76107843|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
42276382|NCT02662985|76107844|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
42276383|NCT02662985|76107843|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
42276384|NCT02662985|76107844|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
42276385|NCT02662985|76107843|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
42276386|NCT02662985|76107844|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
42276387|NCT02662985|76107843|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
42276388|NCT02662985|76107844|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
42276389|NCT02662985|76107843|FG000|Treatment Period 3 (Extension Period)|Death|0|||
42276390|NCT02662985|76107844|FG001|Treatment Period 3 (Extension Period)|Death|1|||
42276391|NCT01631812|76107850|FG000|Overall Study|Adverse Event|25|||
42141456|NCT00403260|75951285|FG001|Overall Study|P. ovale infection|0|||
42141457|NCT00403260|75951284|FG000|Overall Study|Gametocyte re-appearance|1|||
42141458|NCT00403260|75951285|FG001|Overall Study|Gametocyte re-appearance|1|||
42141459|NCT00403260|75951284|FG000|Overall Study|Withdrawn from study accidentally|0|||
42141460|NCT00403260|75951285|FG001|Overall Study|Withdrawn from study accidentally|1|||
42141461|NCT00406848|75951293|FG000|Overall Study|Withdrawal by Subject|27|||
42141462|NCT00406848|75951294|FG001|Overall Study|Withdrawal by Subject|22|||
42141463|NCT00406848|75951293|FG000|Overall Study|Adverse Event|38|||
42141464|NCT00406848|75951294|FG001|Overall Study|Adverse Event|7|||
42141465|NCT00406848|75951293|FG000|Overall Study|Lack of Efficacy|9|||
42141466|NCT00406848|75951294|FG001|Overall Study|Lack of Efficacy|14|||
42141467|NCT00406848|75951293|FG000|Overall Study|Protocol Violation|10|||
42141468|NCT00406848|75951294|FG001|Overall Study|Protocol Violation|6|||
42141469|NCT00406848|75951293|FG000|Overall Study|Lost to Follow-up|6|||
42141470|NCT00406848|75951294|FG001|Overall Study|Lost to Follow-up|2|||
42141471|NCT00406848|75951293|FG000|Overall Study|Physician Decision|2|||
42141472|NCT00406848|75951294|FG001|Overall Study|Physician Decision|2|||
42141473|NCT00406848|75951293|FG000|Overall Study|Sponsor Decision|1|||
42141474|NCT00406848|75951294|FG001|Overall Study|Sponsor Decision|1|||
42141475|NCT00406692|75951303|FG000|Overall Study|Withdrawal by Subject|4|||
42141476|NCT00406692|75951303|FG000|Overall Study|Physician Decision|1|||
42141477|NCT00406692|75951303|FG000|Overall Study|Adverse Event|1|||
42141478|NCT00406692|75951303|FG000|Overall Study|Lack of Efficacy|1|||
42141479|NCT00315705|75951309|FG000|Phase 1|Refused further treatment|1|||
42141480|NCT00315705|75951309|FG000|Phase 1|Failure to achieve response|8|||
42141481|NCT00315705|75951309|FG000|Phase 1|Disease relapse|4|||
42141482|NCT00315705|75951309|FG000|Phase 1|Scheduled for transplant|9|||
42141483|NCT00315705|75951309|FG000|Phase 1|Death|3|||
42141484|NCT00315705|75951309|FG000|Phase 2|Physician Decision|4|||
42141485|NCT00315705|75951309|FG000|Phase 2|Adverse Event|1|||
42141486|NCT00315705|75951309|FG000|Phase 2|Failure to achieve response|3|||
42141487|NCT00315705|75951309|FG000|Phase 2|Disease relapse|1|||
42141488|NCT00315705|75951309|FG000|Phase 2|Scheduled for transplant|8|||
42141489|NCT00315705|75951309|FG000|Phase 2|Other|1|||
42141490|NCT00315705|75951309|FG000|Phase 2|Death|7|||
42141491|NCT00307125|75951328|FG000|Screening Phase|Adverse Event|1|||
42276392|NCT01631812|76107850|FG000|Overall Study|Lack of Efficacy|5|||
42276393|NCT01631812|76107850|FG000|Overall Study|Withdrawal by Subject|4|||
42276394|NCT01631812|76107850|FG000|Overall Study|Physician Decision|3|||
42276395|NCT02323295|76107856|FG000|Overall Study|Adverse Event|0|||
42276396|NCT02323295|76107857|FG001|Overall Study|Adverse Event|1|||
42276397|NCT02323295|76107856|FG000|Overall Study|Withdrawal by Subject|0|||
42276398|NCT02323295|76107857|FG001|Overall Study|Withdrawal by Subject|1|||
42276399|NCT02323295|76107856|FG000|Overall Study|Patient did not have surgery as planned.|0|||
42276400|NCT02323295|76107857|FG001|Overall Study|Patient did not have surgery as planned.|1|||
42276401|NCT02215954|76107866|FG000|Overall Study|Adverse Event|0|||
42276402|NCT02215954|76107867|FG001|Overall Study|Adverse Event|0|||
42276403|NCT02215954|76107868|FG002|Overall Study|Adverse Event|1|||
42276404|NCT02215954|76107866|FG000|Overall Study|Withdrawal by Subject|0|||
42276405|NCT02215954|76107867|FG001|Overall Study|Withdrawal by Subject|0|||
42276406|NCT02215954|76107868|FG002|Overall Study|Withdrawal by Subject|2|||
42276407|NCT02215954|76107866|FG000|Overall Study|Not exposed|1|||
42038403|NCT00600028|75846598|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
42141492|NCT00307125|75951329|FG001|Screening Phase|Adverse Event|0|||
42141493|NCT00307125|75951330|FG002|Screening Phase|Adverse Event|0|||
42141494|NCT00307125|75951328|FG000|Screening Phase|Protocol Violation|27|||
42141495|NCT00307125|75951329|FG001|Screening Phase|Protocol Violation|0|||
42141496|NCT00307125|75951330|FG002|Screening Phase|Protocol Violation|0|||
42141497|NCT00307125|75951328|FG000|Screening Phase|Lost to Follow-up|87|||
42141498|NCT00307125|75951329|FG001|Screening Phase|Lost to Follow-up|0|||
42141499|NCT00307125|75951330|FG002|Screening Phase|Lost to Follow-up|0|||
42141500|NCT00307125|75951328|FG000|Screening Phase|Death|10|||
42141501|NCT00307125|75951329|FG001|Screening Phase|Death|0|||
42276408|NCT02215954|76107867|FG001|Overall Study|Not exposed|1|||
42276409|NCT02215954|76107868|FG002|Overall Study|Not exposed|3|||
42276410|NCT01941719|76107879|FG000|Overall Study|Lost to Follow-up|20|||
42276411|NCT01941719|76107880|FG001|Overall Study|Lost to Follow-up|19|||
42276412|NCT02215252|76107890|FG000|Overall Study|Adverse Event|1|||
42276413|NCT02215252|76107891|FG001|Overall Study|Adverse Event|5|||
42276414|NCT02215252|76107892|FG002|Overall Study|Adverse Event|2|||
42276415|NCT02215252|76107890|FG000|Overall Study|Lost to Follow-up|0|||
42276416|NCT02215252|76107891|FG001|Overall Study|Lost to Follow-up|0|||
42276417|NCT02215252|76107892|FG002|Overall Study|Lost to Follow-up|1|||
42276418|NCT02215252|76107890|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
42276419|NCT02215252|76107891|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
42276420|NCT02215252|76107892|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
42276421|NCT02215252|76107890|FG000|Overall Study|Protocol Violation|0|||
42276422|NCT02215252|76107891|FG001|Overall Study|Protocol Violation|1|||
42276423|NCT02215252|76107892|FG002|Overall Study|Protocol Violation|0|||
42276424|NCT02215252|76107890|FG000|Overall Study|Withdrawal by Subject|1|||
42276425|NCT02215252|76107891|FG001|Overall Study|Withdrawal by Subject|0|||
42276426|NCT02215252|76107892|FG002|Overall Study|Withdrawal by Subject|0|||
42276427|NCT02215252|76107890|FG000|Overall Study|Other|0|||
42276428|NCT02215252|76107891|FG001|Overall Study|Other|1|||
42350839|NCT03086343|76190682|FG000|Overall Study|Other, not specified|8|||
42350840|NCT03086343|76190683|FG001|Overall Study|Other, not specified|4|||
42350841|NCT03086343|76190682|FG000|Overall Study|Missing|0|||
42350842|NCT03086343|76190683|FG001|Overall Study|Missing|1|||
42350843|NCT02788045|76190727|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
42350844|NCT02788045|76190728|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
42350845|NCT02788045|76190729|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
42350846|NCT02788045|76190727|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
42350847|NCT02788045|76190728|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
42350848|NCT02788045|76190729|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
42350849|NCT02788045|76190727|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
42350850|NCT02788045|76190728|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
42350851|NCT02788045|76190729|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
42350852|NCT02788045|76190727|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
42350853|NCT02788045|76190728|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
42350854|NCT02788045|76190729|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
42350855|NCT02788045|76190727|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
42350856|NCT02788045|76190728|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
42350857|NCT02788045|76190729|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
42350858|NCT02788045|76190727|FG000|Main Study (Up to Week 72)|Other|3|||
42350859|NCT02788045|76190728|FG001|Main Study (Up to Week 72)|Other|0|||
42350860|NCT02788045|76190729|FG002|Main Study (Up to Week 72)|Other|0|||
42350861|NCT02788045|76190727|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
42350862|NCT02788045|76190728|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
42276429|NCT02215252|76107892|FG002|Overall Study|Other|1|||
42276430|NCT02204410|76107904|FG000|Overall Study|Lost to Follow-up|5|||
42276431|NCT02204410|76107904|FG000|Overall Study|Physician Decision|2|||
42276432|NCT02204410|76107904|FG000|Overall Study|Protocol Violation|1|||
42276433|NCT02204410|76107904|FG000|Overall Study|Withdrawal by Subject|3|||
42276434|NCT02250274|76107910|FG000|Overall Study|Insufficient blood draw amount|7|||
42276435|NCT02250274|76107911|FG001|Overall Study|Insufficient blood draw amount|6|||
42276436|NCT02213458|76107925|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
42276437|NCT02213458|76107926|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
42276438|NCT02213458|76107925|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
42276439|NCT02213458|76107926|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
42276440|NCT02213458|76107925|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
42276441|NCT02213458|76107926|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
42276442|NCT02213458|76107925|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
42276443|NCT02213458|76107926|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
42276444|NCT02213458|76107925|FG000|Overall Study|Refused re-consent|6|||
42276445|NCT02213458|76107926|FG001|Overall Study|Refused re-consent|0|||
42276446|NCT02213458|76107925|FG000|Overall Study|Lost to Follow-up|2|||
42350863|NCT02788045|76190729|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
42350864|NCT02788045|76190727|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
42350865|NCT02788045|76190728|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
42350866|NCT02788045|76190729|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
42350867|NCT02788045|76190727|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
42350868|NCT02788045|76190728|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
42276447|NCT02213458|76107926|FG001|Overall Study|Lost to Follow-up|2|||
42276448|NCT02213458|76107925|FG000|Overall Study|Withdrawal by Subject|26|||
42350869|NCT02788045|76190729|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
42350870|NCT02315703|76190763|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
42350871|NCT02315703|76190764|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
42350872|NCT02315703|76190765|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
42350873|NCT02315703|76190766|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
42350874|NCT02315703|76190767|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
42350875|NCT02315703|76190768|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
42276449|NCT02213458|76107926|FG001|Overall Study|Withdrawal by Subject|8|||
42276450|NCT02213380|76107934|FG000|Underwent Randomization|Withdrawal by Subject|2|||
42276451|NCT02213380|76107935|FG001|Underwent Randomization|Withdrawal by Subject|0|||
42276452|NCT02213380|76107934|FG000|Underwent Randomization|Not treated|3|||
42276453|NCT02213380|76107935|FG001|Underwent Randomization|Not treated|3|||
42276454|NCT02213380|76107934|FG000|Per-protocol Analysis|Protocol Violation|32|||
42276455|NCT02213380|76107935|FG001|Per-protocol Analysis|Protocol Violation|36|||
42276456|NCT02202850|76107943|FG000|Overall Study|Other|2|||
42276457|NCT02202850|76107944|FG001|Overall Study|Other|2|||
42276458|NCT02202850|76107943|FG000|Overall Study|Enbrel treatment discontinued|15|||
42276459|NCT02202850|76107944|FG001|Overall Study|Enbrel treatment discontinued|3|||
42276460|NCT02202850|76107943|FG000|Overall Study|Lost to Follow-up|7|||
42276461|NCT02202850|76107944|FG001|Overall Study|Lost to Follow-up|1|||
42350876|NCT02315703|76190769|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
42350877|NCT02315703|76190770|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
42350878|NCT02315703|76190763|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
42350879|NCT02315703|76190764|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
42350880|NCT02315703|76190765|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
42350881|NCT02315703|76190766|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
42012095|NCT01196091|75819153|FG001|Overall Study|Adverse Event|27|||
42141502|NCT00307125|75951330|FG002|Screening Phase|Death|0|||
42141503|NCT00307125|75951328|FG000|Screening Phase|Withdrawal by Subject|77|||
42141504|NCT00307125|75951329|FG001|Screening Phase|Withdrawal by Subject|0|||
42141505|NCT00307125|75951330|FG002|Screening Phase|Withdrawal by Subject|0|||
42141506|NCT00307125|75951328|FG000|Screening Phase|Physician Decision|26|||
42141507|NCT00307125|75951329|FG001|Screening Phase|Physician Decision|0|||
42276462|NCT02212678|76107950|FG000|Overall Study|Adverse Event|1|||
42276463|NCT03104075|76107956|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
42276464|NCT03104075|76107957|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
42276465|NCT03038087|76107964|FG000|Overall Study|lost data|1|||
42276466|NCT02249182|76107975|FG000|Treatment Phase|Lost to Follow-up|4|||
42276467|NCT02249182|76107976|FG001|Treatment Phase|Lost to Follow-up|0|||
42276468|NCT02249182|76107977|FG002|Treatment Phase|Lost to Follow-up|0|||
42276469|NCT02249182|76107978|FG003|Treatment Phase|Lost to Follow-up|0|||
42276470|NCT02249182|76107979|FG004|Treatment Phase|Lost to Follow-up|0|||
42276471|NCT03641339|76108010|FG000|Overall Study|Physician Decision|1|||
42276472|NCT03641339|76108011|FG001|Overall Study|Physician Decision|0|||
42276473|NCT03641339|76108012|FG002|Overall Study|Physician Decision|0|||
42276474|NCT03641339|76108013|FG003|Overall Study|Physician Decision|0|||
42276475|NCT03641339|76108014|FG004|Overall Study|Physician Decision|0|||
42276476|NCT03641339|76108015|FG005|Overall Study|Physician Decision|0|||
42276477|NCT03641339|76108010|FG000|Overall Study|Withdrawal by Subject|0|||
42276478|NCT03641339|76108011|FG001|Overall Study|Withdrawal by Subject|2|||
42276479|NCT03641339|76108012|FG002|Overall Study|Withdrawal by Subject|0|||
42276480|NCT03641339|76108013|FG003|Overall Study|Withdrawal by Subject|2|||
42276481|NCT03641339|76108014|FG004|Overall Study|Withdrawal by Subject|0|||
42276482|NCT03641339|76108015|FG005|Overall Study|Withdrawal by Subject|1|||
42276483|NCT02248480|76108031|FG000|Overall Study|Lack of Efficacy|4|||
42276484|NCT02248480|76108032|FG001|Overall Study|Lack of Efficacy|6|||
42276485|NCT02248480|76108031|FG000|Overall Study|Adverse Event|11|||
42276486|NCT02248480|76108032|FG001|Overall Study|Adverse Event|2|||
42276487|NCT02248480|76108031|FG000|Overall Study|Withdrawal by Subject|2|||
42276488|NCT02248480|76108032|FG001|Overall Study|Withdrawal by Subject|4|||
42276489|NCT02248480|76108031|FG000|Overall Study|Entry Criteria Not Met|0|||
42350882|NCT02315703|76190767|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
42350883|NCT02315703|76190768|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
42350884|NCT02315703|76190769|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
42012096|NCT01196091|75819154|FG002|Overall Study|Adverse Event|26|||
42012097|NCT01196091|75819152|FG000|Overall Study|Death|3|||
42012098|NCT01196091|75819153|FG001|Overall Study|Death|2|||
42012099|NCT01196091|75819154|FG002|Overall Study|Death|2|||
42141508|NCT00307125|75951330|FG002|Screening Phase|Physician Decision|0|||
42012100|NCT01196091|75819152|FG000|Overall Study|Entry Criteria Not Met|11|||
42012101|NCT01196091|75819153|FG001|Overall Study|Entry Criteria Not Met|11|||
42012102|NCT01196091|75819154|FG002|Overall Study|Entry Criteria Not Met|10|||
42012103|NCT01196091|75819152|FG000|Overall Study|Lack of Efficacy|15|||
42012104|NCT01196091|75819153|FG001|Overall Study|Lack of Efficacy|12|||
42276490|NCT02248480|76108032|FG001|Overall Study|Entry Criteria Not Met|1|||
42038404|NCT00600028|75846599|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
42038405|NCT00600028|75846598|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
42038406|NCT00600028|75846599|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
42038407|NCT00600028|75846598|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
42038408|NCT00600028|75846599|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
42038409|NCT03542266|75846608|FG000|Treatment Phase|Withdrawal by Subject|1|||
42038410|NCT03542266|75846608|FG000|Treatment Phase|Adverse Event|1|||
42038411|NCT03542266|75846608|FG000|Treatment Phase|PD|1|||
42038412|NCT00827359|75846612|FG000|Overall Study|Progressive Diseas|19|||
42038413|NCT00827359|75846612|FG000|Overall Study|Unacceptable Toxicity|5|||
42038414|NCT00827359|75846612|FG000|Overall Study|Ineligible|1|||
42038415|NCT00818389|75846618|FG000|Overall Study|Death|1|||
42038416|NCT00818389|75846619|FG001|Overall Study|Death|3|||
42038417|NCT00818389|75846618|FG000|Overall Study|ALS Disease Progression|1|||
42038418|NCT00818389|75846619|FG001|Overall Study|ALS Disease Progression|0|||
42038419|NCT00818389|75846618|FG000|Overall Study|Withdrawal by Subject|2|||
42038420|NCT00818389|75846619|FG001|Overall Study|Withdrawal by Subject|2|||
42038421|NCT00818389|75846618|FG000|Overall Study|Adverse Event|0|||
42038422|NCT00818389|75846619|FG001|Overall Study|Adverse Event|1|||
42038423|NCT00850135|75846625|FG000|Overall Study|Physician Decision|1|||
42038424|NCT01154816|75846643|FG000|Overall Study|Withdrawal by Subject|1|||
42038425|NCT01154816|75846644|FG001|Overall Study|Withdrawal by Subject|0|||
42038426|NCT01154816|75846645|FG002|Overall Study|Withdrawal by Subject|0|||
42038427|NCT01154816|75846646|FG003|Overall Study|Withdrawal by Subject|1|||
42038428|NCT01154816|75846647|FG004|Overall Study|Withdrawal by Subject|0|||
42038429|NCT01154816|75846648|FG005|Overall Study|Withdrawal by Subject|0|||
42038430|NCT01154816|75846649|FG006|Overall Study|Withdrawal by Subject|0|||
42038431|NCT01154816|75846650|FG007|Overall Study|Withdrawal by Subject|0|||
42038432|NCT01154816|75846651|FG008|Overall Study|Withdrawal by Subject|1|||
42038433|NCT01154816|75846652|FG009|Overall Study|Withdrawal by Subject|3|||
42038434|NCT01154816|75846653|FG010|Overall Study|Withdrawal by Subject|0|||
42038435|NCT01154816|75846654|FG011|Overall Study|Withdrawal by Subject|0|||
42038436|NCT01154816|75846643|FG000|Overall Study|Progressive Disease|13|||
42038437|NCT01154816|75846644|FG001|Overall Study|Progressive Disease|8|||
42038438|NCT01154816|75846645|FG002|Overall Study|Progressive Disease|9|||
42038439|NCT01154816|75846646|FG003|Overall Study|Progressive Disease|9|||
42038440|NCT01154816|75846647|FG004|Overall Study|Progressive Disease|8|||
42038441|NCT01154816|75846648|FG005|Overall Study|Progressive Disease|8|||
42038442|NCT01154816|75846649|FG006|Overall Study|Progressive Disease|5|||
42038443|NCT01154816|75846650|FG007|Overall Study|Progressive Disease|6|||
42038444|NCT01154816|75846651|FG008|Overall Study|Progressive Disease|8|||
42038445|NCT01154816|75846652|FG009|Overall Study|Progressive Disease|6|||
42038446|NCT01154816|75846653|FG010|Overall Study|Progressive Disease|10|||
42038447|NCT01154816|75846654|FG011|Overall Study|Progressive Disease|3|||
42038448|NCT01154816|75846643|FG000|Overall Study|Physician Decision|1|||
42038449|NCT01154816|75846644|FG001|Overall Study|Physician Decision|0|||
42038450|NCT01154816|75846645|FG002|Overall Study|Physician Decision|1|||
42038451|NCT01154816|75846646|FG003|Overall Study|Physician Decision|0|||
42038452|NCT01154816|75846647|FG004|Overall Study|Physician Decision|2|||
42038453|NCT01154816|75846648|FG005|Overall Study|Physician Decision|0|||
42038454|NCT01154816|75846649|FG006|Overall Study|Physician Decision|0|||
42038455|NCT01154816|75846650|FG007|Overall Study|Physician Decision|0|||
42038456|NCT01154816|75846651|FG008|Overall Study|Physician Decision|0|||
42038457|NCT01154816|75846652|FG009|Overall Study|Physician Decision|1|||
42038458|NCT01154816|75846653|FG010|Overall Study|Physician Decision|1|||
42038459|NCT01154816|75846654|FG011|Overall Study|Physician Decision|1|||
42038460|NCT01154816|75846643|FG000|Overall Study|Adverse Event|5|||
42038461|NCT01154816|75846644|FG001|Overall Study|Adverse Event|2|||
42038462|NCT01154816|75846645|FG002|Overall Study|Adverse Event|0|||
42038463|NCT01154816|75846646|FG003|Overall Study|Adverse Event|0|||
42038464|NCT01154816|75846647|FG004|Overall Study|Adverse Event|0|||
42038465|NCT01154816|75846648|FG005|Overall Study|Adverse Event|0|||
42038466|NCT01154816|75846649|FG006|Overall Study|Adverse Event|1|||
42038467|NCT01154816|75846650|FG007|Overall Study|Adverse Event|1|||
42038468|NCT01154816|75846651|FG008|Overall Study|Adverse Event|0|||
42038469|NCT01154816|75846652|FG009|Overall Study|Adverse Event|0|||
42038470|NCT01154816|75846653|FG010|Overall Study|Adverse Event|0|||
42038471|NCT01154816|75846654|FG011|Overall Study|Adverse Event|0|||
42038472|NCT00849901|75846700|FG000|Acute Treatment Phase|Adverse Event|9|||
42038473|NCT00849901|75846701|FG001|Acute Treatment Phase|Adverse Event|1|||
42038474|NCT00849901|75846702|FG002|Acute Treatment Phase|Adverse Event|3|||
42038475|NCT00849901|75846700|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
42038476|NCT00849901|75846701|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
42038477|NCT00849901|75846702|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
42038478|NCT00849901|75846700|FG000|Acute Treatment Phase|Protocol Violation|0|||
42038479|NCT00849901|75846701|FG001|Acute Treatment Phase|Protocol Violation|2|||
42141509|NCT00307125|75951328|FG000|Screening Phase|Sponsor Decision|4|||
42141510|NCT00307125|75951329|FG001|Screening Phase|Sponsor Decision|0|||
42141511|NCT00307125|75951330|FG002|Screening Phase|Sponsor Decision|0|||
42141512|NCT00307125|75951328|FG000|Screening Phase|Study Terminated|17|||
42141513|NCT00307125|75951329|FG001|Screening Phase|Study Terminated|0|||
42141514|NCT00307125|75951330|FG002|Screening Phase|Study Terminated|0|||
42141515|NCT00307125|75951328|FG000|Screening Phase|Graft Loss|3|||
42141516|NCT00307125|75951329|FG001|Screening Phase|Graft Loss|0|||
42141517|NCT00307125|75951330|FG002|Screening Phase|Graft Loss|0|||
42141518|NCT00307125|75951328|FG000|Screening Phase|Graft Failure|8|||
42141519|NCT00307125|75951329|FG001|Screening Phase|Graft Failure|0|||
42141520|NCT00307125|75951330|FG002|Screening Phase|Graft Failure|0|||
42141521|NCT00307125|75951328|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
42141522|NCT00307125|75951329|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
42141523|NCT00307125|75951330|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
42141524|NCT00307125|75951328|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
42141525|NCT00307125|75951329|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
42141526|NCT00307125|75951330|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
42141527|NCT00307125|75951328|FG000|Screening Phase|Moved or transferred facilities|34|||
42141528|NCT00307125|75951329|FG001|Screening Phase|Moved or transferred facilities|0|||
42141529|NCT00307125|75951330|FG002|Screening Phase|Moved or transferred facilities|0|||
42141530|NCT00307125|75951328|FG000|Screening Phase|Received Pancreas Transplant|8|||
42141531|NCT00307125|75951329|FG001|Screening Phase|Received Pancreas Transplant|0|||
42141532|NCT00307125|75951330|FG002|Screening Phase|Received Pancreas Transplant|0|||
42141533|NCT00307125|75951328|FG000|Screening Phase|Ineligible for pilot|4|||
42276491|NCT02248480|76108031|FG000|Overall Study|Other:Physician Decision|0|||
42276492|NCT02248480|76108032|FG001|Overall Study|Other:Physician Decision|1|||
42038480|NCT00849901|75846702|FG002|Acute Treatment Phase|Protocol Violation|1|||
42012105|NCT01196091|75819154|FG002|Overall Study|Lack of Efficacy|17|||
42012106|NCT01196091|75819152|FG000|Overall Study|Lost to Follow-up|5|||
42012107|NCT01196091|75819153|FG001|Overall Study|Lost to Follow-up|5|||
42012108|NCT01196091|75819154|FG002|Overall Study|Lost to Follow-up|6|||
42012109|NCT01196091|75819152|FG000|Overall Study|Parent/Caregiver Decision|0|||
42012110|NCT01196091|75819153|FG001|Overall Study|Parent/Caregiver Decision|0|||
42012111|NCT01196091|75819154|FG002|Overall Study|Parent/Caregiver Decision|1|||
42038481|NCT00849901|75846700|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
42038482|NCT00849901|75846701|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
42038483|NCT00849901|75846702|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
42038484|NCT00849901|75846700|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
42038485|NCT00849901|75846701|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
42038486|NCT00849901|75846702|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
42038487|NCT00849901|75846700|FG000|Acute Treatment Phase|Physician Decision|1|||
42038488|NCT00849901|75846701|FG001|Acute Treatment Phase|Physician Decision|1|||
42038489|NCT00849901|75846702|FG002|Acute Treatment Phase|Physician Decision|1|||
42038490|NCT00849901|75846700|FG000|Acute Treatment Phase|Sponsor Decision|1|||
42038491|NCT00849901|75846701|FG001|Acute Treatment Phase|Sponsor Decision|0|||
42038492|NCT00849901|75846702|FG002|Acute Treatment Phase|Sponsor Decision|0|||
42038493|NCT00849901|75846700|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
42038494|NCT00849901|75846701|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
42038495|NCT00849901|75846702|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
42038496|NCT00849901|75846700|FG000|Extension Phase|Adverse Event|2|||
42038497|NCT00849901|75846701|FG001|Extension Phase|Adverse Event|8|||
42038498|NCT00849901|75846702|FG002|Extension Phase|Adverse Event|4|||
42038499|NCT00849901|75846700|FG000|Extension Phase|Lost to Follow-up|3|||
42276493|NCT01653158|76108039|FG000|Overall Study|Death|0|||
42038500|NCT00849901|75846701|FG001|Extension Phase|Lost to Follow-up|0|||
42012112|NCT01196091|75819152|FG000|Overall Study|Withdrawal by Subject|16|||
42012113|NCT01196091|75819153|FG001|Overall Study|Withdrawal by Subject|19|||
42038501|NCT00849901|75846702|FG002|Extension Phase|Lost to Follow-up|1|||
42141534|NCT00307125|75951329|FG001|Screening Phase|Ineligible for pilot|0|||
42141535|NCT00307125|75951330|FG002|Screening Phase|Ineligible for pilot|0|||
42012114|NCT01196091|75819154|FG002|Overall Study|Withdrawal by Subject|22|||
42012115|NCT01196091|75819152|FG000|Overall Study|Physician Decision|3|||
42012116|NCT01196091|75819153|FG001|Overall Study|Physician Decision|3|||
42038502|NCT00849901|75846700|FG000|Extension Phase|Protocol Violation|2|||
42141536|NCT00307125|75951328|FG000|Screening Phase|Try to get pregnant|1|||
42141537|NCT00307125|75951329|FG001|Screening Phase|Try to get pregnant|0|||
42276494|NCT01653158|76108040|FG001|Overall Study|Death|0|||
42276495|NCT01653158|76108041|FG002|Overall Study|Death|0|||
42276496|NCT01653158|76108042|FG003|Overall Study|Death|1|||
42276497|NCT01653158|76108043|FG004|Overall Study|Death|0|||
42276498|NCT01653158|76108044|FG005|Overall Study|Death|0|||
42276499|NCT01653158|76108045|FG006|Overall Study|Death|0|||
42276500|NCT01653158|76108046|FG007|Overall Study|Death|2|||
42276501|NCT01653158|76108039|FG000|Overall Study|Adverse Event|0|||
42276502|NCT01653158|76108040|FG001|Overall Study|Adverse Event|0|||
42276503|NCT01653158|76108041|FG002|Overall Study|Adverse Event|0|||
42276504|NCT01653158|76108042|FG003|Overall Study|Adverse Event|1|||
42276505|NCT01653158|76108043|FG004|Overall Study|Adverse Event|0|||
42276506|NCT01653158|76108044|FG005|Overall Study|Adverse Event|0|||
42276507|NCT01653158|76108045|FG006|Overall Study|Adverse Event|0|||
42276508|NCT01653158|76108046|FG007|Overall Study|Adverse Event|3|||
42276509|NCT01653158|76108039|FG000|Overall Study|Other|0|||
42276510|NCT01653158|76108040|FG001|Overall Study|Other|0|||
42276511|NCT01653158|76108041|FG002|Overall Study|Other|0|||
42276512|NCT01653158|76108042|FG003|Overall Study|Other|0|||
42276513|NCT01653158|76108043|FG004|Overall Study|Other|0|||
42276514|NCT01653158|76108044|FG005|Overall Study|Other|0|||
42276515|NCT01653158|76108045|FG006|Overall Study|Other|0|||
42276516|NCT01653158|76108046|FG007|Overall Study|Other|1|||
42276517|NCT01653158|76108039|FG000|Overall Study|Progressive disease|0|||
42276518|NCT01653158|76108040|FG001|Overall Study|Progressive disease|0|||
42276519|NCT01653158|76108041|FG002|Overall Study|Progressive disease|0|||
42276520|NCT01653158|76108042|FG003|Overall Study|Progressive disease|0|||
42276521|NCT01653158|76108043|FG004|Overall Study|Progressive disease|1|||
42276522|NCT01653158|76108044|FG005|Overall Study|Progressive disease|1|||
42276523|NCT01653158|76108045|FG006|Overall Study|Progressive disease|2|||
42276524|NCT01653158|76108046|FG007|Overall Study|Progressive disease|9|||
42276525|NCT01653158|76108039|FG000|Overall Study|Withdrawal by Subject|1|||
42276526|NCT01653158|76108040|FG001|Overall Study|Withdrawal by Subject|0|||
42276527|NCT01653158|76108041|FG002|Overall Study|Withdrawal by Subject|0|||
42276528|NCT01653158|76108042|FG003|Overall Study|Withdrawal by Subject|0|||
42276529|NCT01653158|76108043|FG004|Overall Study|Withdrawal by Subject|0|||
42276530|NCT01653158|76108044|FG005|Overall Study|Withdrawal by Subject|0|||
42276531|NCT01653158|76108045|FG006|Overall Study|Withdrawal by Subject|0|||
42276532|NCT01653158|76108046|FG007|Overall Study|Withdrawal by Subject|0|||
42276533|NCT02247466|76108071|FG000|Overall Study|Procedure changed to open surgery|0|||
42276534|NCT02247466|76108072|FG001|Overall Study|Procedure changed to open surgery|3|||
42276535|NCT03317795|76108080|FG000|Overall Study|IUD Expulsion|1|||
42276536|NCT03317795|76108081|FG001|Overall Study|IUD Expulsion|0|||
42276537|NCT03317795|76108080|FG000|Overall Study|Lost to Follow-up|1|||
42276538|NCT03317795|76108081|FG001|Overall Study|Lost to Follow-up|3|||
42276539|NCT03317795|76108080|FG000|Overall Study|Treatment change|0|||
42276540|NCT03317795|76108081|FG001|Overall Study|Treatment change|3|||
42276541|NCT03317795|76108080|FG000|Overall Study|Intolerance of medication|0|||
42276542|NCT03317795|76108081|FG001|Overall Study|Intolerance of medication|1|||
42276543|NCT02202616|76108087|FG000|Overall Study|Screen failed|24|||
42276544|NCT02202616|76108087|FG000|Overall Study|Adverse Event|32|||
42276545|NCT02202616|76108087|FG000|Overall Study|Protocol deviation|18|||
42276546|NCT02202616|76108087|FG000|Overall Study|Patient withdrew consent|12|||
42276547|NCT02202616|76108087|FG000|Overall Study|Lost to Follow-up|6|||
42276548|NCT02202616|76108087|FG000|Overall Study|Administrative problems|6|||
42038503|NCT00849901|75846701|FG001|Extension Phase|Protocol Violation|2|||
42038504|NCT00849901|75846702|FG002|Extension Phase|Protocol Violation|4|||
42038505|NCT00849901|75846700|FG000|Extension Phase|Withdrawal by Subject|7|||
42038506|NCT00849901|75846701|FG001|Extension Phase|Withdrawal by Subject|6|||
42038507|NCT00849901|75846702|FG002|Extension Phase|Withdrawal by Subject|3|||
42038508|NCT00849901|75846700|FG000|Extension Phase|Parent or Caregiver Decision|10|||
42038509|NCT00849901|75846701|FG001|Extension Phase|Parent or Caregiver Decision|4|||
42038510|NCT00849901|75846702|FG002|Extension Phase|Parent or Caregiver Decision|4|||
42038511|NCT00849901|75846700|FG000|Extension Phase|Physician Decision|1|||
42038512|NCT00849901|75846701|FG001|Extension Phase|Physician Decision|2|||
42038513|NCT00849901|75846702|FG002|Extension Phase|Physician Decision|0|||
42038514|NCT00849901|75846700|FG000|Extension Phase|Lack of Efficacy|2|||
42038515|NCT00849901|75846701|FG001|Extension Phase|Lack of Efficacy|4|||
42038516|NCT00849901|75846702|FG002|Extension Phase|Lack of Efficacy|1|||
42038517|NCT01168232|75846716|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
42038518|NCT01168232|75846716|FG000|Overall Study|Ineligible- Wrong cell type|6|||
42038519|NCT01168232|75846716|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
42038520|NCT00817531|75846720|FG000|Overall Study|Adverse Event|1|||
42038521|NCT00817531|75846720|FG000|Overall Study|Lack of Efficacy|1|||
42038522|NCT00817063|75846726|FG000|Overall Study|Adverse Event|32|||
42276549|NCT02202616|76108087|FG000|Overall Study|Abnormal test procedure result|1|||
42038523|NCT00817063|75846727|FG001|Overall Study|Adverse Event|13|||
42276550|NCT02202616|76108087|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42276551|NCT02455388|76108094|FG000|Overall Study|Protocol Violation|1|||
42276552|NCT02455388|76108095|FG001|Overall Study|Protocol Violation|0|||
42276553|NCT02455388|76108096|FG002|Overall Study|Protocol Violation|4|||
42276554|NCT02455388|76108094|FG000|Overall Study|Withdrawal by Subject|0|||
42038524|NCT00817063|75846726|FG000|Overall Study|Death|1|||
42038525|NCT00817063|75846727|FG001|Overall Study|Death|1|||
42276555|NCT02455388|76108095|FG001|Overall Study|Withdrawal by Subject|0|||
42276556|NCT02455388|76108096|FG002|Overall Study|Withdrawal by Subject|7|||
42276557|NCT02455076|76108109|FG000|Inpatient|Withdrawal by Subject|1|||
42141538|NCT00307125|75951330|FG002|Screening Phase|Try to get pregnant|0|||
42141539|NCT00307125|75951328|FG000|Screening Phase|Developed acute leukemia|1|||
42141540|NCT00307125|75951329|FG001|Screening Phase|Developed acute leukemia|0|||
42141541|NCT00307125|75951330|FG002|Screening Phase|Developed acute leukemia|0|||
42141542|NCT00307125|75951328|FG000|Screening Phase|Metastatic colon cancer|1|||
42141543|NCT00307125|75951329|FG001|Screening Phase|Metastatic colon cancer|0|||
42141544|NCT00307125|75951330|FG002|Screening Phase|Metastatic colon cancer|0|||
42141545|NCT00307125|75951328|FG000|Screening Phase|Malignancy|1|||
42141546|NCT00307125|75951329|FG001|Screening Phase|Malignancy|0|||
42141547|NCT00307125|75951330|FG002|Screening Phase|Malignancy|0|||
42276558|NCT02455076|76108110|FG001|Inpatient|Withdrawal by Subject|0|||
42276559|NCT02455076|76108111|FG002|Inpatient|Withdrawal by Subject|0|||
42276560|NCT02455076|76108112|FG003|Inpatient|Withdrawal by Subject|0|||
42276561|NCT02455076|76108113|FG004|Inpatient|Withdrawal by Subject|0|||
42276562|NCT02455076|76108109|FG000|Inpatient|Discharged <24 h after admission|0|||
42276563|NCT02455076|76108110|FG001|Inpatient|Discharged <24 h after admission|1|||
42276564|NCT02455076|76108111|FG002|Inpatient|Discharged <24 h after admission|0|||
42276565|NCT02455076|76108112|FG003|Inpatient|Discharged <24 h after admission|0|||
42276566|NCT02455076|76108113|FG004|Inpatient|Discharged <24 h after admission|0|||
42276567|NCT02455076|76108109|FG000|Inpatient|Adverse Event|3|||
42276568|NCT02455076|76108110|FG001|Inpatient|Adverse Event|0|||
42276569|NCT02455076|76108111|FG002|Inpatient|Adverse Event|0|||
42276570|NCT02455076|76108112|FG003|Inpatient|Adverse Event|0|||
42276571|NCT02455076|76108113|FG004|Inpatient|Adverse Event|0|||
42276572|NCT02455076|76108109|FG000|Outpatient|Adverse Event|0|||
42276573|NCT02455076|76108110|FG001|Outpatient|Adverse Event|0|||
42276574|NCT02455076|76108111|FG002|Outpatient|Adverse Event|0|||
42276575|NCT02455076|76108112|FG003|Outpatient|Adverse Event|5|||
42276576|NCT02455076|76108113|FG004|Outpatient|Adverse Event|0|||
42350885|NCT02315703|76190770|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
42350886|NCT02315703|76190763|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
42350887|NCT02315703|76190764|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
42276577|NCT02455076|76108109|FG000|Outpatient|Lost to Follow-up|0|||
42276578|NCT02455076|76108110|FG001|Outpatient|Lost to Follow-up|0|||
42276579|NCT02455076|76108111|FG002|Outpatient|Lost to Follow-up|0|||
42276580|NCT02455076|76108112|FG003|Outpatient|Lost to Follow-up|1|||
42276581|NCT02455076|76108113|FG004|Outpatient|Lost to Follow-up|12|||
42276582|NCT02433080|76108127|FG000|Overall Study|Lost to Follow-up|1|||
42276583|NCT02433080|76108128|FG001|Overall Study|Lost to Follow-up|2|||
42276584|NCT02433080|76108127|FG000|Overall Study|Withdrawal by Subject|0|||
42276585|NCT02433080|76108128|FG001|Overall Study|Withdrawal by Subject|2|||
42276586|NCT03092219|76108137|FG000|Overall Study|Protocol Violation|7|||
42276587|NCT03092219|76108138|FG001|Overall Study|Protocol Violation|4|||
42276588|NCT02432846|76108153|FG000|Overall Study (4 Arms/Strata)|Death|3|||
42276589|NCT02432846|76108154|FG001|Overall Study (4 Arms/Strata)|Death|2|||
42276590|NCT02432846|76108155|FG002|Overall Study (4 Arms/Strata)|Death|4|||
42276591|NCT02432846|76108156|FG003|Overall Study (4 Arms/Strata)|Death|3|||
42276592|NCT02432846|76108157|FG004|Overall Study (4 Arms/Strata)|Death|0|||
42276593|NCT02432846|76108158|FG005|Overall Study (4 Arms/Strata)|Death|0|||
42276594|NCT02432846|76108153|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
42276595|NCT02432846|76108154|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
42276596|NCT02432846|76108155|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
42276597|NCT02432846|76108156|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
42276598|NCT02432846|76108157|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
42276599|NCT02432846|76108158|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
42276600|NCT02432846|76108153|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
42276601|NCT02432846|76108154|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
42276602|NCT02432846|76108155|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
42276603|NCT02432846|76108156|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
42350888|NCT02315703|76190765|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
42350889|NCT02315703|76190766|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
42141548|NCT00307125|75951328|FG000|Screening Phase|PAK|1|||
42276604|NCT02432846|76108157|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
42276605|NCT02432846|76108158|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
42276606|NCT02432846|76108153|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
42276607|NCT02432846|76108154|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
42141549|NCT00307125|75951329|FG001|Screening Phase|PAK|0|||
42141550|NCT00307125|75951330|FG002|Screening Phase|PAK|0|||
42141551|NCT00307125|75951328|FG000|Screening Phase|Ineligible|1|||
42276608|NCT02432846|76108155|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
42038526|NCT00817063|75846726|FG000|Overall Study|Lack of Efficacy|33|||
42038527|NCT00817063|75846727|FG001|Overall Study|Lack of Efficacy|86|||
42038528|NCT00817063|75846726|FG000|Overall Study|Failure to Return|13|||
42038529|NCT00817063|75846727|FG001|Overall Study|Failure to Return|12|||
42038530|NCT00817063|75846726|FG000|Overall Study|Violation of Selection at Entry|7|||
42038531|NCT00817063|75846727|FG001|Overall Study|Violation of Selection at Entry|4|||
42038532|NCT00817063|75846726|FG000|Overall Study|Protocol Violation|3|||
42038533|NCT00817063|75846727|FG001|Overall Study|Protocol Violation|8|||
42038534|NCT00817063|75846726|FG000|Overall Study|Withdrawal by Subject|17|||
42038535|NCT00817063|75846727|FG001|Overall Study|Withdrawal by Subject|37|||
42038536|NCT00817063|75846726|FG000|Overall Study|Early Improvement|19|||
42038537|NCT00817063|75846727|FG001|Overall Study|Early Improvement|4|||
42038538|NCT00817063|75846726|FG000|Overall Study|Administrative|10|||
42038539|NCT00817063|75846727|FG001|Overall Study|Administrative|4|||
42038540|NCT00817063|75846726|FG000|Overall Study|Abnormality of Laboratory Test|2|||
42038541|NCT00817063|75846727|FG001|Overall Study|Abnormality of Laboratory Test|1|||
42038542|NCT01166750|75846735|FG000|Overall Study|Lost to Follow-up|1|||
42038543|NCT01166750|75846736|FG001|Overall Study|Lost to Follow-up|0|||
42038544|NCT00826267|75846745|FG000|Overall Study|Other Adverse Event|1|||
42038545|NCT00826267|75846746|FG001|Overall Study|Other Adverse Event|0|||
42038546|NCT00826267|75846747|FG002|Overall Study|Other Adverse Event|0|||
42038547|NCT00986154|75846758|FG000|Overall Study|Death|136|||
42038548|NCT00986154|75846759|FG001|Overall Study|Death|127|||
42038549|NCT00986154|75846758|FG000|Overall Study|Lost to Follow-up|7|||
42038550|NCT00986154|75846759|FG001|Overall Study|Lost to Follow-up|4|||
42038551|NCT00986154|75846758|FG000|Overall Study|Withdrawal by Subject|32|||
42038552|NCT00986154|75846759|FG001|Overall Study|Withdrawal by Subject|33|||
42038553|NCT00986154|75846758|FG000|Overall Study|investigator/subject decide not continue|6|||
42038554|NCT00986154|75846759|FG001|Overall Study|investigator/subject decide not continue|3|||
42038555|NCT00986154|75846758|FG000|Overall Study|never received study drug|25|||
42038556|NCT00986154|75846759|FG001|Overall Study|never received study drug|27|||
42038557|NCT00848965|75846765|FG000|Overall Study|Adverse Event|1|||
42038558|NCT00848965|75846765|FG000|Overall Study|Withdrawal by Subject|1|||
42038559|NCT01154036|75846784|FG000|Phase I|Physician Decision|0|||
42038560|NCT01154036|75846785|FG001|Phase I|Physician Decision|1|||
42038561|NCT01154036|75846786|FG002|Phase I|Physician Decision|0|||
42012117|NCT01196091|75819154|FG002|Overall Study|Physician Decision|4|||
42276609|NCT02432846|76108156|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
42276610|NCT02432846|76108157|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
42276611|NCT02432846|76108158|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
42276612|NCT02432846|76108153|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
42276613|NCT02432846|76108154|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
42276614|NCT02432846|76108155|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
42276615|NCT02432846|76108156|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
42276616|NCT02432846|76108157|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
42276617|NCT02432846|76108158|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
42276618|NCT02432846|76108153|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
42276619|NCT02432846|76108154|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
42276620|NCT02432846|76108155|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
42276621|NCT02432846|76108156|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
42276622|NCT02432846|76108157|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
42012118|NCT01196091|75819152|FG000|Overall Study|Protocol Violation|1|||
42012119|NCT01196091|75819153|FG001|Overall Study|Protocol Violation|3|||
42012120|NCT01196091|75819154|FG002|Overall Study|Protocol Violation|3|||
42012121|NCT01196091|75819152|FG000|Overall Study|Sponsor Decision|6|||
42012122|NCT01196091|75819153|FG001|Overall Study|Sponsor Decision|5|||
42012123|NCT01196091|75819154|FG002|Overall Study|Sponsor Decision|4|||
42012124|NCT01196091|75819152|FG000|Overall Study|Excluded Site|5|||
42012125|NCT01196091|75819153|FG001|Overall Study|Excluded Site|11|||
42012126|NCT01196091|75819154|FG002|Overall Study|Excluded Site|8|||
42038562|NCT01154036|75846787|FG003|Phase I|Physician Decision|0|||
42276623|NCT02432846|76108158|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
42038563|NCT01154036|75846788|FG004|Phase I|Physician Decision|0|||
42038564|NCT01154036|75846789|FG005|Phase I|Physician Decision|0|||
42350890|NCT02315703|76190767|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
42038565|NCT01154036|75846790|FG006|Phase I|Physician Decision|0|||
42038566|NCT01154036|75846791|FG007|Phase I|Physician Decision|0|||
42038567|NCT01154036|75846784|FG000|Phase I|Lost to Follow-up|0|||
42141552|NCT00307125|75951329|FG001|Screening Phase|Ineligible|0|||
42012127|NCT01196091|75819152|FG000|Overall Study|Randomized, No Study Drug Received|1|||
42038568|NCT01154036|75846785|FG001|Phase I|Lost to Follow-up|3|||
42038569|NCT01154036|75846786|FG002|Phase I|Lost to Follow-up|6|||
42038570|NCT01154036|75846787|FG003|Phase I|Lost to Follow-up|0|||
42038571|NCT01154036|75846788|FG004|Phase I|Lost to Follow-up|0|||
42038572|NCT01154036|75846789|FG005|Phase I|Lost to Follow-up|0|||
42276624|NCT02432846|76108153|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
42141553|NCT00307125|75951330|FG002|Screening Phase|Ineligible|0|||
42141554|NCT00307125|75951328|FG000|Screening Phase|Screen Error|1|||
42141555|NCT00307125|75951329|FG001|Screening Phase|Screen Error|0|||
42141556|NCT00307125|75951330|FG002|Screening Phase|Screen Error|0|||
42141557|NCT00307125|75951328|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
42141558|NCT00307125|75951329|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
42141559|NCT00307125|75951330|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
42141560|NCT00307125|75951328|FG000|Screening Phase|AMR and treated with rituximab|1|||
42141561|NCT00307125|75951329|FG001|Screening Phase|AMR and treated with rituximab|0|||
42141562|NCT00307125|75951330|FG002|Screening Phase|AMR and treated with rituximab|0|||
42141563|NCT00307125|75951328|FG000|Screening Phase|Coronary artery bypass|1|||
42141564|NCT00307125|75951329|FG001|Screening Phase|Coronary artery bypass|0|||
42141565|NCT00307125|75951330|FG002|Screening Phase|Coronary artery bypass|0|||
42141566|NCT00307125|75951328|FG000|Pilot Phase|Lost to Follow-up|0|||
42141567|NCT00307125|75951329|FG001|Pilot Phase|Lost to Follow-up|1|||
42141568|NCT00307125|75951330|FG002|Pilot Phase|Lost to Follow-up|0|||
42141569|NCT00307125|75951328|FG000|Pilot Phase|Withdrawal by Subject|0|||
42141570|NCT00307125|75951329|FG001|Pilot Phase|Withdrawal by Subject|1|||
42141571|NCT00307125|75951330|FG002|Pilot Phase|Withdrawal by Subject|1|||
42141572|NCT00307047|75951342|FG000|Overall Study|Lost to Follow-up|35|||
42141573|NCT00307047|75951343|FG001|Overall Study|Lost to Follow-up|24|||
42141574|NCT00307047|75951342|FG000|Overall Study|Withdrawal by Subject|6|||
42141575|NCT00307047|75951343|FG001|Overall Study|Withdrawal by Subject|6|||
42141576|NCT00307047|75951342|FG000|Overall Study|Physician Decision|1|||
42141577|NCT00307047|75951343|FG001|Overall Study|Physician Decision|2|||
42276625|NCT02432846|76108154|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
42276626|NCT02432846|76108155|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
42141578|NCT00307047|75951342|FG000|Overall Study|Lost to follow-up for other reasons|0|||
42141579|NCT00307047|75951343|FG001|Overall Study|Lost to follow-up for other reasons|1|||
42141580|NCT00307047|75951342|FG000|Overall Study|All death, all MI, all Revascularization|27|||
42141581|NCT00307047|75951343|FG001|Overall Study|All death, all MI, all Revascularization|16|||
42141582|NCT00306891|75951353|FG000|Part A|Withdrawal by Subject|1|||
42141583|NCT00306891|75951354|FG001|Part A|Withdrawal by Subject|1|||
42141584|NCT00306891|75951355|FG002|Part A|Withdrawal by Subject|0|||
42141585|NCT00306891|75951356|FG003|Part A|Withdrawal by Subject|0|||
42141586|NCT00306891|75951353|FG000|Part A|Condition under investigation worsened|2|||
42141587|NCT00306891|75951354|FG001|Part A|Condition under investigation worsened|2|||
42141588|NCT00306891|75951355|FG002|Part A|Condition under investigation worsened|0|||
42141589|NCT00306891|75951356|FG003|Part A|Condition under investigation worsened|0|||
42141590|NCT00306891|75951353|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
42141591|NCT00306891|75951354|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
42141592|NCT00306891|75951355|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
42141593|NCT00306891|75951356|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
42141594|NCT00306891|75951353|FG000|Part A|Partial bowel obstruction|1|||
42141595|NCT00306891|75951354|FG001|Part A|Partial bowel obstruction|0|||
42141596|NCT00306891|75951355|FG002|Part A|Partial bowel obstruction|0|||
42141597|NCT00306891|75951356|FG003|Part A|Partial bowel obstruction|0|||
42141598|NCT00306891|75951353|FG000|Part A|Reaccumul. of ascites following drainage|0|||
42141599|NCT00306891|75951354|FG001|Part A|Reaccumul. of ascites following drainage|1|||
42141600|NCT00306891|75951355|FG002|Part A|Reaccumul. of ascites following drainage|0|||
42141601|NCT00306891|75951356|FG003|Part A|Reaccumul. of ascites following drainage|0|||
42141602|NCT00306891|75951353|FG000|Part A|Suspicion of second malignancy|0|||
42141603|NCT00306891|75951354|FG001|Part A|Suspicion of second malignancy|1|||
42141604|NCT00306891|75951355|FG002|Part A|Suspicion of second malignancy|0|||
42141605|NCT00306891|75951356|FG003|Part A|Suspicion of second malignancy|0|||
42141606|NCT00306891|75951353|FG000|Part A|QTC interval outwith elig. criteria|1|||
42141607|NCT00306891|75951354|FG001|Part A|QTC interval outwith elig. criteria|0|||
42141608|NCT00306891|75951355|FG002|Part A|QTC interval outwith elig. criteria|0|||
42141609|NCT00306891|75951356|FG003|Part A|QTC interval outwith elig. criteria|0|||
42141610|NCT00306891|75951353|FG000|Part B|Death|0|||
42141611|NCT00306891|75951354|FG001|Part B|Death|0|||
42141612|NCT00306891|75951355|FG002|Part B|Death|1|||
42141613|NCT00306891|75951356|FG003|Part B|Death|2|||
42141614|NCT00306891|75951353|FG000|Part B|Adverse Event|0|||
42141615|NCT00306891|75951354|FG001|Part B|Adverse Event|0|||
42141616|NCT00306891|75951355|FG002|Part B|Adverse Event|5|||
42141617|NCT00306891|75951356|FG003|Part B|Adverse Event|5|||
42141618|NCT00306891|75951353|FG000|Part B|Withdrawal by Subject|0|||
42141619|NCT00306891|75951354|FG001|Part B|Withdrawal by Subject|0|||
42141620|NCT00306891|75951355|FG002|Part B|Withdrawal by Subject|3|||
42141621|NCT00306891|75951356|FG003|Part B|Withdrawal by Subject|1|||
42141622|NCT00306891|75951353|FG000|Part B|Condition under investigation worsened|0|||
42141623|NCT00306891|75951354|FG001|Part B|Condition under investigation worsened|0|||
42141624|NCT00306891|75951355|FG002|Part B|Condition under investigation worsened|2|||
42141625|NCT00306891|75951356|FG003|Part B|Condition under investigation worsened|8|||
42141626|NCT00306891|75951353|FG000|Part B|Development of study specific disc crit.|0|||
42141627|NCT00306891|75951354|FG001|Part B|Development of study specific disc crit.|0|||
42141628|NCT00306891|75951355|FG002|Part B|Development of study specific disc crit.|0|||
42141629|NCT00306891|75951356|FG003|Part B|Development of study specific disc crit.|1|||
42141630|NCT00314145|75951369|FG000|Overall Study|Withdrawal by Subject|8|||
42141631|NCT00314145|75951370|FG001|Overall Study|Withdrawal by Subject|10|||
42141632|NCT00314145|75951369|FG000|Overall Study|Lost to Follow-up|5|||
42141633|NCT00314145|75951370|FG001|Overall Study|Lost to Follow-up|12|||
42141634|NCT00314145|75951369|FG000|Overall Study|Physician Decision|3|||
42141635|NCT00314145|75951370|FG001|Overall Study|Physician Decision|4|||
42141636|NCT00314145|75951369|FG000|Overall Study|Adverse Event|0|||
42141637|NCT00314145|75951370|FG001|Overall Study|Adverse Event|3|||
42141638|NCT00314145|75951369|FG000|Overall Study|Protocol Violation|3|||
42141639|NCT00314145|75951370|FG001|Overall Study|Protocol Violation|0|||
42141640|NCT00314145|75951369|FG000|Overall Study|Sponsor Decision|2|||
42141641|NCT00314145|75951370|FG001|Overall Study|Sponsor Decision|0|||
42141642|NCT00313911|75951379|FG000|Overall Study|Serious adverse event|6|||
42141643|NCT00313911|75951380|FG001|Overall Study|Serious adverse event|1|||
42141644|NCT00313911|75951379|FG000|Overall Study|Adverse Event|2|||
42141645|NCT00313911|75951380|FG001|Overall Study|Adverse Event|3|||
42141646|NCT00313911|75951379|FG000|Overall Study|Protocol Violation|19|||
42141647|NCT00313911|75951380|FG001|Overall Study|Protocol Violation|10|||
42141648|NCT00313911|75951379|FG000|Overall Study|Lost to Follow-up|27|||
42141649|NCT00313911|75951380|FG001|Overall Study|Lost to Follow-up|14|||
42141650|NCT00313911|75951379|FG000|Overall Study|Withdrawal by Subject|39|||
42141651|NCT00313911|75951380|FG001|Overall Study|Withdrawal by Subject|12|||
42141652|NCT00313911|75951379|FG000|Overall Study|Did not meet age criteria|1|||
42141653|NCT00313911|75951380|FG001|Overall Study|Did not meet age criteria|1|||
42141654|NCT00391872|75951388|FG000|Overall Study|Protocol Violation|7|||
42141655|NCT00391872|75951389|FG001|Overall Study|Protocol Violation|2|||
42141656|NCT00391872|75951388|FG000|Overall Study|Withdrawal by Subject|296|||
42141657|NCT00391872|75951389|FG001|Overall Study|Withdrawal by Subject|249|||
42141658|NCT00391872|75951388|FG000|Overall Study|Reason unknown|2|||
42141659|NCT00391872|75951389|FG001|Overall Study|Reason unknown|4|||
42141660|NCT00391872|75951388|FG000|Overall Study|Lost to Follow-up|2|||
42141661|NCT00391872|75951389|FG001|Overall Study|Lost to Follow-up|0|||
42141662|NCT00391170|75951397|FG000|Overall Study|Withdrawal by Subject|1|||
42012128|NCT01196091|75819153|FG001|Overall Study|Randomized, No Study Drug Received|0|||
42012129|NCT01196091|75819154|FG002|Overall Study|Randomized, No Study Drug Received|1|||
42012130|NCT01195623|75819169|FG000|Overall Study|Lost to Follow-up|35|||
42012131|NCT01195623|75819170|FG001|Overall Study|Lost to Follow-up|37|||
42012132|NCT01195545|75819176|FG000|Overall Study|Protocol Violation|4|||
42012133|NCT01194999|75819180|FG000|Overall Study|Lost to Follow-up|17|||
42012134|NCT01194531|75819186|FG000|Overall Study|Withdrawal by Subject|1|||
42012135|NCT01194531|75819187|FG001|Overall Study|Withdrawal by Subject|0|||
42012136|NCT01194531|75819186|FG000|Overall Study|Protocol Violation|4|||
42012137|NCT01194531|75819187|FG001|Overall Study|Protocol Violation|1|||
42012138|NCT01194531|75819186|FG000|Overall Study|Physician Decision|0|||
42012139|NCT01194531|75819187|FG001|Overall Study|Physician Decision|2|||
42012140|NCT00972517|75819193|FG000|Overall Study|Adverse Event|0|||
42012141|NCT00972517|75819194|FG001|Overall Study|Adverse Event|0|||
42012142|NCT00972517|75819195|FG002|Overall Study|Adverse Event|0|||
42012143|NCT00972517|75819196|FG003|Overall Study|Adverse Event|1|||
42012144|NCT00972517|75819197|FG004|Overall Study|Adverse Event|0|||
42276627|NCT02432846|76108156|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
42141663|NCT00391170|75951398|FG001|Overall Study|Withdrawal by Subject|0|||
42141664|NCT00391170|75951397|FG000|Overall Study|Adverse Event|3|||
42141665|NCT00391170|75951398|FG001|Overall Study|Adverse Event|2|||
42141666|NCT00391170|75951397|FG000|Overall Study|Physician Decision|2|||
42141667|NCT00391170|75951398|FG001|Overall Study|Physician Decision|2|||
42141668|NCT00402324|75951406|FG000|Overall Study|Lost to Follow-up|11|||
42141669|NCT00402324|75951407|FG001|Overall Study|Lost to Follow-up|11|||
42141670|NCT00402324|75951406|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
42141671|NCT00402324|75951407|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
42276628|NCT02432846|76108157|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
42276629|NCT02432846|76108158|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
42276630|NCT02432846|76108153|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
42276631|NCT02432846|76108154|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
42276632|NCT02432846|76108155|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
42276633|NCT02432846|76108156|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
42012145|NCT00972517|75819198|FG005|Overall Study|Adverse Event|0|||
42012146|NCT00972517|75819193|FG000|Overall Study|Withdrawal by Subject|0|||
42012147|NCT00972517|75819194|FG001|Overall Study|Withdrawal by Subject|1|||
42012148|NCT00972517|75819195|FG002|Overall Study|Withdrawal by Subject|0|||
42012149|NCT00972517|75819196|FG003|Overall Study|Withdrawal by Subject|2|||
42012150|NCT00972517|75819197|FG004|Overall Study|Withdrawal by Subject|1|||
42012151|NCT00972517|75819198|FG005|Overall Study|Withdrawal by Subject|0|||
42012152|NCT00972283|75819220|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
42012153|NCT00972283|75819221|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
42012154|NCT00972283|75819220|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
42012155|NCT00972283|75819221|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
42012156|NCT00972283|75819220|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
42012157|NCT00972283|75819221|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
42141672|NCT00402324|75951406|FG000|Overall Study|Protocol Violation|8|||
42141673|NCT00402324|75951407|FG001|Overall Study|Protocol Violation|7|||
42276634|NCT02432846|76108157|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
42276635|NCT02432846|76108158|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
42276636|NCT02432846|76108153|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
42276637|NCT02432846|76108154|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
42276638|NCT02432846|76108155|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
42276639|NCT02432846|76108156|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
42276640|NCT02432846|76108157|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
42276641|NCT02432846|76108158|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
42276642|NCT02432846|76108153|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
42276643|NCT02432846|76108154|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
42276644|NCT02432846|76108155|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
42276645|NCT02432846|76108156|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
42276646|NCT02432846|76108157|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
42276647|NCT02432846|76108158|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
42276648|NCT02432846|76108153|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
42012158|NCT00972283|75819220|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
42012159|NCT00972283|75819221|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
42141674|NCT00402324|75951406|FG000|Overall Study|Withdrawal by Subject|5|||
42141675|NCT00402324|75951407|FG001|Overall Study|Withdrawal by Subject|2|||
42141676|NCT00402324|75951406|FG000|Overall Study|Physician Decision|2|||
42141677|NCT00402324|75951407|FG001|Overall Study|Physician Decision|4|||
42038573|NCT01154036|75846790|FG006|Phase I|Lost to Follow-up|0|||
42038574|NCT01154036|75846791|FG007|Phase I|Lost to Follow-up|0|||
42038575|NCT01154036|75846784|FG000|Phase I|Protocol Violation|0|||
42038576|NCT01154036|75846785|FG001|Phase I|Protocol Violation|3|||
42038577|NCT01154036|75846786|FG002|Phase I|Protocol Violation|9|||
42038578|NCT01154036|75846787|FG003|Phase I|Protocol Violation|0|||
42038579|NCT01154036|75846788|FG004|Phase I|Protocol Violation|0|||
42038580|NCT01154036|75846789|FG005|Phase I|Protocol Violation|0|||
42038581|NCT01154036|75846790|FG006|Phase I|Protocol Violation|0|||
42038582|NCT01154036|75846791|FG007|Phase I|Protocol Violation|0|||
42038583|NCT01154036|75846784|FG000|Phase I|Withdrawal by Subject|2|||
42038584|NCT01154036|75846785|FG001|Phase I|Withdrawal by Subject|10|||
42038585|NCT01154036|75846786|FG002|Phase I|Withdrawal by Subject|29|||
42038586|NCT01154036|75846787|FG003|Phase I|Withdrawal by Subject|0|||
42038587|NCT01154036|75846788|FG004|Phase I|Withdrawal by Subject|0|||
42038588|NCT01154036|75846789|FG005|Phase I|Withdrawal by Subject|0|||
42038589|NCT01154036|75846790|FG006|Phase I|Withdrawal by Subject|0|||
42038590|NCT01154036|75846791|FG007|Phase I|Withdrawal by Subject|0|||
42141678|NCT00402324|75951406|FG000|Overall Study|Sponsor Decision|4|||
42141679|NCT00402324|75951407|FG001|Overall Study|Sponsor Decision|5|||
42141680|NCT00402324|75951406|FG000|Overall Study|Lack of Efficacy|1|||
42141681|NCT00402324|75951407|FG001|Overall Study|Lack of Efficacy|4|||
42141682|NCT00402324|75951406|FG000|Overall Study|Adverse Event|6|||
42141683|NCT00402324|75951407|FG001|Overall Study|Adverse Event|4|||
42141684|NCT00402324|75951406|FG000|Overall Study|Death|1|||
42141685|NCT00402324|75951407|FG001|Overall Study|Death|0|||
42141686|NCT00294723|75951416|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
42141687|NCT00294723|75951417|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
42141688|NCT00294723|75951418|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
42141689|NCT00294723|75951416|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
42141690|NCT00294723|75951417|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
42141691|NCT00294723|75951418|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
42141692|NCT00294723|75951416|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
42141693|NCT00294723|75951417|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
42141694|NCT00294723|75951418|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
42141695|NCT00294723|75951416|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
42141696|NCT00294723|75951417|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
42141697|NCT00294723|75951418|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
42141698|NCT00294723|75951416|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
42141699|NCT00294723|75951417|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
42141700|NCT00294723|75951418|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
42141701|NCT00294723|75951416|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
42141702|NCT00294723|75951417|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
42141703|NCT00294723|75951418|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
42141704|NCT00294723|75951416|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
42141705|NCT00294723|75951417|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
42141706|NCT00294723|75951418|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
42141707|NCT00294723|75951416|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
42141708|NCT00294723|75951417|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
42141709|NCT00294723|75951418|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
42141710|NCT00294723|75951416|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
42141711|NCT00294723|75951417|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
42141712|NCT00294723|75951418|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
42141713|NCT00294723|75951416|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
42141714|NCT00294723|75951417|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
42141715|NCT00294723|75951418|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
42141716|NCT00294723|75951416|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
42141717|NCT00294723|75951417|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
42141718|NCT00294723|75951418|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
42141719|NCT00294723|75951416|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
42350891|NCT02315703|76190768|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
42350892|NCT02315703|76190769|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
42141720|NCT00294723|75951417|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
42141721|NCT00294723|75951418|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
42038591|NCT01154036|75846784|FG000|Phase I|Adverse Event|1|||
42141722|NCT00402246|75951431|FG000|Overall Study|Death|62|||
42141723|NCT00402246|75951432|FG001|Overall Study|Death|58|||
42038592|NCT01154036|75846785|FG001|Phase I|Adverse Event|11|||
42038593|NCT01154036|75846786|FG002|Phase I|Adverse Event|12|||
42038594|NCT01154036|75846787|FG003|Phase I|Adverse Event|0|||
42038595|NCT01154036|75846788|FG004|Phase I|Adverse Event|0|||
42038596|NCT01154036|75846789|FG005|Phase I|Adverse Event|0|||
42141724|NCT00402246|75951431|FG000|Overall Study|Lost to Follow-up|20|||
42141725|NCT00402246|75951432|FG001|Overall Study|Lost to Follow-up|28|||
42141726|NCT00402246|75951431|FG000|Overall Study|Withdrawal by Subject|72|||
42141727|NCT00402246|75951432|FG001|Overall Study|Withdrawal by Subject|87|||
42141728|NCT00402246|75951431|FG000|Overall Study|Physician Decision|24|||
42012160|NCT00972283|75819220|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
42012161|NCT00972283|75819221|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
42012162|NCT00972283|75819220|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
42012163|NCT00972283|75819221|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
42012164|NCT00972283|75819220|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
42012165|NCT00972283|75819221|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
42012166|NCT00972283|75819220|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
42012167|NCT00972283|75819221|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
42012168|NCT00972283|75819220|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
42012169|NCT00972283|75819221|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
42012170|NCT00972283|75819220|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
42012171|NCT00972283|75819221|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
42038597|NCT01154036|75846790|FG006|Phase I|Adverse Event|0|||
42038598|NCT01154036|75846791|FG007|Phase I|Adverse Event|0|||
42038599|NCT01154036|75846784|FG000|Phase II|Adverse Event|0|||
42276649|NCT02432846|76108154|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
42276650|NCT02432846|76108155|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
42276651|NCT02432846|76108156|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
42276652|NCT02432846|76108157|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
42012172|NCT00969709|75819231|FG000|Overall Study|Adverse Event|3|||
42012173|NCT00969709|75819232|FG001|Overall Study|Adverse Event|13|||
42012174|NCT00969709|75819233|FG002|Overall Study|Adverse Event|26|||
42038600|NCT01154036|75846785|FG001|Phase II|Adverse Event|0|||
42038601|NCT01154036|75846786|FG002|Phase II|Adverse Event|0|||
42038602|NCT01154036|75846787|FG003|Phase II|Adverse Event|0|||
42038603|NCT01154036|75846788|FG004|Phase II|Adverse Event|1|||
42038604|NCT01154036|75846789|FG005|Phase II|Adverse Event|1|||
42038605|NCT01154036|75846790|FG006|Phase II|Adverse Event|1|||
42038606|NCT01154036|75846791|FG007|Phase II|Adverse Event|1|||
42038607|NCT01154036|75846784|FG000|Phase II|Physician Decision|0|||
42038608|NCT01154036|75846785|FG001|Phase II|Physician Decision|0|||
42038609|NCT01154036|75846786|FG002|Phase II|Physician Decision|0|||
42038610|NCT01154036|75846787|FG003|Phase II|Physician Decision|0|||
42038611|NCT01154036|75846788|FG004|Phase II|Physician Decision|0|||
42038612|NCT01154036|75846789|FG005|Phase II|Physician Decision|0|||
42038613|NCT01154036|75846790|FG006|Phase II|Physician Decision|1|||
42038614|NCT01154036|75846791|FG007|Phase II|Physician Decision|0|||
42038615|NCT01154036|75846784|FG000|Phase II|Lost to Follow-up|0|||
42038616|NCT01154036|75846785|FG001|Phase II|Lost to Follow-up|0|||
42038617|NCT01154036|75846786|FG002|Phase II|Lost to Follow-up|0|||
42038618|NCT01154036|75846787|FG003|Phase II|Lost to Follow-up|1|||
42038619|NCT01154036|75846788|FG004|Phase II|Lost to Follow-up|2|||
42038620|NCT01154036|75846789|FG005|Phase II|Lost to Follow-up|0|||
42038621|NCT01154036|75846790|FG006|Phase II|Lost to Follow-up|2|||
42038622|NCT01154036|75846791|FG007|Phase II|Lost to Follow-up|1|||
42038623|NCT01154036|75846784|FG000|Phase II|Protocol Violation|0|||
42038624|NCT01154036|75846785|FG001|Phase II|Protocol Violation|0|||
42038625|NCT01154036|75846786|FG002|Phase II|Protocol Violation|0|||
42038626|NCT01154036|75846787|FG003|Phase II|Protocol Violation|0|||
42038627|NCT01154036|75846788|FG004|Phase II|Protocol Violation|1|||
42038628|NCT01154036|75846789|FG005|Phase II|Protocol Violation|2|||
42038629|NCT01154036|75846790|FG006|Phase II|Protocol Violation|0|||
42038630|NCT01154036|75846791|FG007|Phase II|Protocol Violation|0|||
42141729|NCT00402246|75951432|FG001|Overall Study|Physician Decision|26|||
42141730|NCT00402246|75951431|FG000|Overall Study|Protocol Violation|25|||
42141731|NCT00402246|75951432|FG001|Overall Study|Protocol Violation|24|||
42141732|NCT00402246|75951431|FG000|Overall Study|Missed Final Visit|1|||
42141733|NCT00402246|75951432|FG001|Overall Study|Missed Final Visit|2|||
42038631|NCT01154036|75846784|FG000|Phase II|Withdrawal by Subject|0|||
42038632|NCT01154036|75846785|FG001|Phase II|Withdrawal by Subject|0|||
42038633|NCT01154036|75846786|FG002|Phase II|Withdrawal by Subject|0|||
42038634|NCT01154036|75846787|FG003|Phase II|Withdrawal by Subject|0|||
42038635|NCT01154036|75846788|FG004|Phase II|Withdrawal by Subject|4|||
42012175|NCT00969709|75819234|FG003|Overall Study|Adverse Event|12|||
42038636|NCT01154036|75846789|FG005|Phase II|Withdrawal by Subject|2|||
42038637|NCT01154036|75846790|FG006|Phase II|Withdrawal by Subject|5|||
42038638|NCT01154036|75846791|FG007|Phase II|Withdrawal by Subject|4|||
42038639|NCT00816595|75846813|FG000|Overall Study|Withdrawal by Subject|2|||
42038640|NCT00816595|75846814|FG001|Overall Study|Withdrawal by Subject|0|||
42038641|NCT01166438|75846824|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
42038642|NCT01166438|75846825|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
42038643|NCT01166438|75846824|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
42141734|NCT00402246|75951431|FG000|Overall Study|Insurance Issues|2|||
42141735|NCT00402246|75951432|FG001|Overall Study|Insurance Issues|1|||
42141736|NCT00402246|75951431|FG000|Overall Study|Heart Transplant|0|||
42141737|NCT00402246|75951432|FG001|Overall Study|Heart Transplant|1|||
42141738|NCT00402246|75951431|FG000|Overall Study|Patient's device explanted|6|||
42141739|NCT00402246|75951432|FG001|Overall Study|Patient's device explanted|2|||
42141740|NCT00402246|75951431|FG000|Overall Study|Center Closure|5|||
42141741|NCT00402246|75951432|FG001|Overall Study|Center Closure|3|||
42141742|NCT00402246|75951431|FG000|Overall Study|Deterioriating Condition|3|||
42141743|NCT00402246|75951432|FG001|Overall Study|Deterioriating Condition|2|||
42141744|NCT00375492|75951442|FG000|Overall Study|Adverse Event|4|||
42141745|NCT00375492|75951443|FG001|Overall Study|Adverse Event|5|||
42141746|NCT00375492|75951442|FG000|Overall Study|Entry Criteria Not Met|0|||
42141747|NCT00375492|75951443|FG001|Overall Study|Entry Criteria Not Met|1|||
42141748|NCT00375492|75951442|FG000|Overall Study|Loss of Glucose Control|0|||
42141749|NCT00375492|75951443|FG001|Overall Study|Loss of Glucose Control|1|||
42141750|NCT00375492|75951442|FG000|Overall Study|Lost to Follow-up|10|||
42141751|NCT00375492|75951443|FG001|Overall Study|Lost to Follow-up|5|||
42141752|NCT00375492|75951442|FG000|Overall Study|Physician Decision|0|||
42141753|NCT00375492|75951443|FG001|Overall Study|Physician Decision|4|||
42141754|NCT00375492|75951442|FG000|Overall Study|Protocol Violation|6|||
42141755|NCT00375492|75951443|FG001|Overall Study|Protocol Violation|3|||
42141756|NCT00375492|75951442|FG000|Overall Study|Sponsor Decision|0|||
42141757|NCT00375492|75951443|FG001|Overall Study|Sponsor Decision|1|||
42141758|NCT00375492|75951442|FG000|Overall Study|Withdrawal by Subject|6|||
42141759|NCT00375492|75951443|FG001|Overall Study|Withdrawal by Subject|6|||
42141760|NCT00306189|75951453|FG000|Overall Study|Physician Decision|0|||
42141761|NCT00306189|75951454|FG001|Overall Study|Physician Decision|0|||
42141762|NCT00306189|75951455|FG002|Overall Study|Physician Decision|0|||
42141763|NCT00306189|75951456|FG003|Overall Study|Physician Decision|1|||
42141764|NCT00306189|75951453|FG000|Overall Study|Adverse Event|3|||
42141765|NCT00306189|75951454|FG001|Overall Study|Adverse Event|3|||
42141766|NCT00306189|75951455|FG002|Overall Study|Adverse Event|2|||
42141767|NCT00306189|75951456|FG003|Overall Study|Adverse Event|2|||
42141768|NCT00306189|75951453|FG000|Overall Study|Withdrawal by Subject|4|||
42141769|NCT00306189|75951454|FG001|Overall Study|Withdrawal by Subject|2|||
42141770|NCT00306189|75951455|FG002|Overall Study|Withdrawal by Subject|8|||
42141771|NCT00306189|75951456|FG003|Overall Study|Withdrawal by Subject|1|||
42141772|NCT00306189|75951453|FG000|Overall Study|Ineligibility determined|1|||
42141773|NCT00306189|75951454|FG001|Overall Study|Ineligibility determined|1|||
42141774|NCT00306189|75951455|FG002|Overall Study|Ineligibility determined|1|||
42141775|NCT00306189|75951456|FG003|Overall Study|Ineligibility determined|1|||
42141776|NCT00306189|75951453|FG000|Overall Study|Other|1|||
42141777|NCT00306189|75951454|FG001|Overall Study|Other|0|||
42141778|NCT00306189|75951455|FG002|Overall Study|Other|0|||
42141779|NCT00306189|75951456|FG003|Overall Study|Other|0|||
42141780|NCT00312897|75951468|FG000|Overall Study|Adverse Event|1|||
42141781|NCT00312897|75951469|FG001|Overall Study|Adverse Event|0|||
42141782|NCT00312897|75951468|FG000|Overall Study|Lost to Follow-up|2|||
42141783|NCT00312897|75951469|FG001|Overall Study|Lost to Follow-up|0|||
42141784|NCT00312897|75951468|FG000|Overall Study|Physician Decision|1|||
42141785|NCT00312897|75951469|FG001|Overall Study|Physician Decision|0|||
42012176|NCT00969709|75819231|FG000|Overall Study|Lack of Efficacy|7|||
42012177|NCT00969709|75819232|FG001|Overall Study|Lack of Efficacy|4|||
42012178|NCT00969709|75819233|FG002|Overall Study|Lack of Efficacy|1|||
42012179|NCT00969709|75819234|FG003|Overall Study|Lack of Efficacy|3|||
42012180|NCT00969709|75819231|FG000|Overall Study|Protocol Violation|9|||
42012181|NCT00969709|75819232|FG001|Overall Study|Protocol Violation|5|||
42012182|NCT00969709|75819233|FG002|Overall Study|Protocol Violation|9|||
42012183|NCT00969709|75819234|FG003|Overall Study|Protocol Violation|10|||
42012184|NCT00969709|75819231|FG000|Overall Study|Withdrawal by Subject|9|||
42141786|NCT00312897|75951468|FG000|Overall Study|Withdrawal by Subject|1|||
42141787|NCT00312897|75951469|FG001|Overall Study|Withdrawal by Subject|3|||
42141788|NCT00312897|75951468|FG000|Overall Study|Pregnancy|1|||
42141789|NCT00312897|75951469|FG001|Overall Study|Pregnancy|0|||
42141790|NCT00312897|75951468|FG000|Overall Study|discontinued prior to getting treatment|0|||
42141791|NCT00312897|75951469|FG001|Overall Study|discontinued prior to getting treatment|3|||
42141792|NCT00312663|75951478|FG000|Immunization Phase|Adverse Event|0|||
42141793|NCT00312663|75951479|FG001|Immunization Phase|Adverse Event|1|||
42141794|NCT00312663|75951480|FG002|Immunization Phase|Adverse Event|0|||
42141795|NCT00294645|75951491|FG000|Overall Study|Death|10|||
42012185|NCT00969709|75819232|FG001|Overall Study|Withdrawal by Subject|12|||
42012186|NCT00969709|75819233|FG002|Overall Study|Withdrawal by Subject|11|||
42141796|NCT00294645|75951492|FG001|Overall Study|Death|18|||
42141797|NCT00294645|75951491|FG000|Overall Study|Lost to Follow-up|1|||
42141798|NCT00294645|75951492|FG001|Overall Study|Lost to Follow-up|10|||
42141799|NCT00294645|75951491|FG000|Overall Study|Withdrawal by Subject|18|||
42141800|NCT00294645|75951492|FG001|Overall Study|Withdrawal by Subject|34|||
42141801|NCT00294645|75951491|FG000|Overall Study|Physician Decision|15|||
42141802|NCT00294645|75951492|FG001|Overall Study|Physician Decision|20|||
42141803|NCT00294645|75951491|FG000|Overall Study|Other|4|||
42141804|NCT00294645|75951492|FG001|Overall Study|Other|10|||
42141805|NCT00305877|75951500|FG000|Overall Study|Lack of Efficacy|6|||
42141806|NCT00305877|75951501|FG001|Overall Study|Lack of Efficacy|9|||
42141807|NCT00305877|75951500|FG000|Overall Study|Adverse Event|9|||
42141808|NCT00305877|75951501|FG001|Overall Study|Adverse Event|14|||
42141809|NCT00305877|75951500|FG000|Overall Study|Death|0|||
42141810|NCT00305877|75951501|FG001|Overall Study|Death|1|||
42141811|NCT00305877|75951500|FG000|Overall Study|Withdrawal by Subject|4|||
42141812|NCT00305877|75951501|FG001|Overall Study|Withdrawal by Subject|2|||
42141813|NCT00305877|75951500|FG000|Overall Study|Physician Decision|1|||
42141814|NCT00305877|75951501|FG001|Overall Study|Physician Decision|1|||
42141815|NCT00305877|75951500|FG000|Overall Study|Never start treatment|2|||
42141816|NCT00305877|75951501|FG001|Overall Study|Never start treatment|5|||
42141817|NCT00305877|75951500|FG000|Overall Study|Ineligible|2|||
42141818|NCT00305877|75951501|FG001|Overall Study|Ineligible|1|||
42141819|NCT00305877|75951500|FG000|Overall Study|Transportation issue with daily RT|0|||
42141820|NCT00305877|75951501|FG001|Overall Study|Transportation issue with daily RT|1|||
42141821|NCT00312195|75951509|FG000|Overall Study|Adverse Event|4|||
42141822|NCT00312195|75951510|FG001|Overall Study|Adverse Event|6|||
42141823|NCT00312195|75951509|FG000|Overall Study|Lost to Follow-up|1|||
42141824|NCT00312195|75951510|FG001|Overall Study|Lost to Follow-up|0|||
42141825|NCT00312195|75951509|FG000|Overall Study|Protocol Violation|1|||
42141826|NCT00312195|75951510|FG001|Overall Study|Protocol Violation|0|||
42141827|NCT00305253|75951520|FG000|Overall Study|Withdrawal by Subject|0|||
42141828|NCT00305253|75951521|FG001|Overall Study|Withdrawal by Subject|1|||
42141829|NCT00293709|75951527|FG000|Overall Study|Other|47|||
42141830|NCT00311181|75951531|FG000|Overall Study|Final DFTs were not obtained|96|||
42141831|NCT00293397|75951535|FG000|Overall Study|Death|2|||
42141832|NCT00290745|75951540|FG000|Overall Study|Withdrawal by Subject|4|||
42141833|NCT00290745|75951540|FG000|Overall Study|Physician Decision|2|||
42141834|NCT00290745|75951540|FG000|Overall Study|Surgery after 3 months for progression|3|||
42141835|NCT00290745|75951540|FG000|Overall Study|Baseline MRI not available|3|||
42141836|NCT00402168|75951546|FG000|Randomized|Lost to Follow-up|1|||
42141837|NCT00402168|75951547|FG001|Randomized|Lost to Follow-up|0|||
42141838|NCT00402168|75951546|FG000|Randomized|Withdrawal by Subject|0|||
42141839|NCT00402168|75951547|FG001|Randomized|Withdrawal by Subject|1|||
42276653|NCT02432846|76108158|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
42276654|NCT02432846|76108153|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
42276655|NCT02432846|76108154|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
42012187|NCT00969709|75819234|FG003|Overall Study|Withdrawal by Subject|23|||
42012188|NCT00969709|75819231|FG000|Overall Study|Lost to Follow-up|10|||
42276656|NCT02432846|76108155|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
42276657|NCT02432846|76108156|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
42276658|NCT02432846|76108157|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
42276659|NCT02432846|76108158|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
42012189|NCT00969709|75819232|FG001|Overall Study|Lost to Follow-up|14|||
42141840|NCT00402168|75951546|FG000|Treatment (up to 12 Months)|Death|0|||
42141841|NCT00402168|75951547|FG001|Treatment (up to 12 Months)|Death|1|||
42141842|NCT00402168|75951546|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
42141843|NCT00402168|75951547|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
42141844|NCT00402168|75951546|FG000|Treatment (up to 12 Months)|non-specified|0|||
42141845|NCT00402168|75951547|FG001|Treatment (up to 12 Months)|non-specified|1|||
42141846|NCT00402168|75951546|FG000|Long Term (LT)|Adverse Event|1|||
42141847|NCT00402168|75951547|FG001|Long Term (LT)|Adverse Event|5|||
42141848|NCT00402168|75951546|FG000|Long Term (LT)|Withdrawal by Subject|4|||
42141849|NCT00402168|75951547|FG001|Long Term (LT)|Withdrawal by Subject|7|||
42141850|NCT00402168|75951546|FG000|Long Term (LT)|Pregnancy|0|||
42141851|NCT00402168|75951547|FG001|Long Term (LT)|Pregnancy|1|||
42141852|NCT00402168|75951546|FG000|Long Term (LT)|Lost to Follow-up|1|||
42141853|NCT00402168|75951547|FG001|Long Term (LT)|Lost to Follow-up|0|||
42141854|NCT00402168|75951546|FG000|Long Term (LT)|Death|4|||
42141855|NCT00402168|75951547|FG001|Long Term (LT)|Death|0|||
42141856|NCT00402168|75951546|FG000|Long Term (LT)|Lack of Efficacy|0|||
42141857|NCT00402168|75951547|FG001|Long Term (LT)|Lack of Efficacy|2|||
42141858|NCT00402168|75951546|FG000|Long Term (LT)|non-specified|1|||
42141859|NCT00402168|75951547|FG001|Long Term (LT)|non-specified|2|||
42141860|NCT00402168|75951546|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
42141861|NCT00402168|75951547|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
42141862|NCT00402168|75951546|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
42141863|NCT00402168|75951547|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
42141864|NCT00290589|75951563|FG000|Overall Study|Lost to Follow-up|2|||
42141865|NCT00290589|75951564|FG001|Overall Study|Lost to Follow-up|2|||
42141866|NCT00290511|75951570|FG000|Overall Study|Adverse Event|1|||
42141867|NCT00290511|75951570|FG000|Overall Study|Death|1|||
42350893|NCT02315703|76190770|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
42350894|NCT02315703|76190763|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
42350895|NCT02315703|76190764|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
42350896|NCT02315703|76190765|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
42350897|NCT02315703|76190766|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
42350898|NCT02315703|76190767|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
42350899|NCT02315703|76190768|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
42350900|NCT02315703|76190769|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
42350901|NCT02315703|76190770|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
42350902|NCT02315703|76190763|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
42350903|NCT02315703|76190764|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
42350904|NCT02315703|76190765|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
42350905|NCT02315703|76190766|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
42350906|NCT02315703|76190767|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
42350907|NCT02315703|76190768|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
42350908|NCT02315703|76190769|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
42350909|NCT02315703|76190770|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
42350910|NCT02315703|76190763|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
42350911|NCT02315703|76190764|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
42350912|NCT02315703|76190765|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
42350913|NCT02315703|76190766|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
42350914|NCT02315703|76190767|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
42350915|NCT02315703|76190768|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
42350916|NCT02315703|76190769|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
42350917|NCT02315703|76190770|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
42350918|NCT02315703|76190763|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
42350919|NCT02315703|76190764|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
42350920|NCT02315703|76190765|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
42350921|NCT02315703|76190766|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
42141868|NCT00290511|75951570|FG000|Overall Study|Physician Decision|1|||
42141869|NCT00290511|75951570|FG000|Overall Study|Withdrawal by Subject|1|||
42141870|NCT00290433|75951574|FG000|Overall Study|Disease Progression|13|||
42141871|NCT00290433|75951574|FG000|Overall Study|Adverse Event|14|||
42141872|NCT00290433|75951574|FG000|Overall Study|Withdrawal by Subject|1|||
42141873|NCT00290433|75951574|FG000|Overall Study|Non-Compliance|1|||
42141874|NCT00290433|75951574|FG000|Overall Study|Congestive Heart Failure|1|||
42141875|NCT00290433|75951574|FG000|Overall Study|Transplant in CR|5|||
42141876|NCT00290433|75951574|FG000|Overall Study|Unrelated Infection/Death|1|||
42141877|NCT00304083|75951580|FG000|Overall Study|Withdrawal by Subject|4|||
42141878|NCT00304083|75951581|FG001|Overall Study|Withdrawal by Subject|2|||
42141879|NCT00304083|75951580|FG000|Overall Study|Physician Decision|8|||
42141880|NCT00304083|75951581|FG001|Overall Study|Physician Decision|3|||
42141881|NCT00304083|75951580|FG000|Overall Study|Disease Progression|5|||
42141882|NCT00304083|75951581|FG001|Overall Study|Disease Progression|1|||
42141883|NCT00304083|75951580|FG000|Overall Study|Other|5|||
42350922|NCT02315703|76190767|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
42141884|NCT00304083|75951581|FG001|Overall Study|Other|2|||
42141885|NCT00293241|75951589|FG000|Overall Study|Lost to Follow-up|9|||
42141886|NCT00293241|75951590|FG001|Overall Study|Lost to Follow-up|16|||
42141887|NCT00293241|75951589|FG000|Overall Study|Physician Decision|23|||
42141888|NCT00293241|75951590|FG001|Overall Study|Physician Decision|17|||
42141889|NCT00293241|75951589|FG000|Overall Study|Withdrawal by Subject|4|||
42141890|NCT00293241|75951590|FG001|Overall Study|Withdrawal by Subject|8|||
42141891|NCT00391092|75951601|FG000|Overall Study|Death|78|||
42141892|NCT00391092|75951602|FG001|Overall Study|Death|81|||
42141893|NCT00391092|75951601|FG000|Overall Study|Lost to Follow-up|13|||
42141894|NCT00391092|75951602|FG001|Overall Study|Lost to Follow-up|18|||
42141895|NCT00391092|75951601|FG000|Overall Study|Alive on treatment|29|||
42141896|NCT00391092|75951602|FG001|Overall Study|Alive on treatment|33|||
42141897|NCT00391092|75951601|FG000|Overall Study|Alive in follow-up|88|||
42141898|NCT00391092|75951602|FG001|Overall Study|Alive in follow-up|84|||
42141899|NCT00374868|75951608|FG000|Overall Study|Adverse Event|12|||
42141900|NCT00374868|75951608|FG000|Overall Study|Progressive Disease|7|||
42141901|NCT00374868|75951608|FG000|Overall Study|Physician Decision|13|||
42141902|NCT00374868|75951608|FG000|Overall Study|Lost to Follow-up|1|||
42141903|NCT00374868|75951608|FG000|Overall Study|Death|2|||
42141904|NCT00374868|75951608|FG000|Overall Study|Other - Not Specified|1|||
42141905|NCT00374556|75951614|FG000|Overall Study|Lost to Follow-up|1|||
42141906|NCT00374556|75951615|FG001|Overall Study|Lost to Follow-up|0|||
42141907|NCT00374556|75951614|FG000|Overall Study|Removed at baseline due to medical cond|0|||
42141908|NCT00374556|75951615|FG001|Overall Study|Removed at baseline due to medical cond|1|||
42141909|NCT00290355|75951623|FG000|Overall Study|Serious adverse event|7|||
42141910|NCT00290355|75951624|FG001|Overall Study|Serious adverse event|4|||
42141911|NCT00290355|75951623|FG000|Overall Study|Study product reactogenicity|1|||
42141912|NCT00290355|75951624|FG001|Overall Study|Study product reactogenicity|0|||
42141913|NCT00290355|75951623|FG000|Overall Study|Protocol Violation|1|||
42141914|NCT00290355|75951624|FG001|Overall Study|Protocol Violation|0|||
42141915|NCT00290355|75951623|FG000|Overall Study|Withdrawal by Subject|2|||
42012190|NCT00969709|75819233|FG002|Overall Study|Lost to Follow-up|8|||
42012191|NCT00969709|75819234|FG003|Overall Study|Lost to Follow-up|15|||
42038644|NCT01166438|75846825|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
42038645|NCT01166438|75846824|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
42038646|NCT01166438|75846825|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
42038647|NCT01166438|75846824|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
42038648|NCT01166438|75846825|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
42038649|NCT01166438|75846824|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
42038650|NCT01166438|75846825|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
42038651|NCT01166438|75846824|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
42038652|NCT01166438|75846825|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
42038653|NCT01153958|75846834|FG000|Overall Study|Study Terminated|36|||
42038654|NCT01153958|75846835|FG001|Overall Study|Study Terminated|32|||
42038655|NCT00599638|75846845|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
42038656|NCT00599638|75846846|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
42038657|NCT00599638|75846847|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
42038658|NCT00599638|75846848|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
42038659|NCT00599638|75846845|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
42038660|NCT00599638|75846846|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
42038661|NCT00599638|75846847|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
42038662|NCT00599638|75846848|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
42038663|NCT00599638|75846845|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
42038664|NCT00599638|75846846|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
42038665|NCT00599638|75846847|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
42141916|NCT00290355|75951624|FG001|Overall Study|Withdrawal by Subject|0|||
42141917|NCT00290355|75951623|FG000|Overall Study|Migrated / moved from the study area|1|||
42141918|NCT00290355|75951624|FG001|Overall Study|Migrated / moved from the study area|0|||
42012192|NCT00969709|75819231|FG000|Overall Study|Other reasons|0|||
42012193|NCT00969709|75819232|FG001|Overall Study|Other reasons|0|||
42012194|NCT00969709|75819233|FG002|Overall Study|Other reasons|3|||
42012195|NCT00969709|75819234|FG003|Overall Study|Other reasons|0|||
42012196|NCT01193517|75819251|FG000|Overall Study|Early Progression|1|||
42012197|NCT01193517|75819252|FG001|Overall Study|Early Progression|0|||
42012198|NCT01193517|75819253|FG002|Overall Study|Early Progression|0|||
42038666|NCT00599638|75846848|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
42141919|NCT00290355|75951623|FG000|Overall Study|Lost to Follow-up|3|||
42141920|NCT00290355|75951624|FG001|Overall Study|Lost to Follow-up|1|||
42276660|NCT02432846|76108153|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
42012199|NCT01193283|75819262|FG000|Overall Study|Death|1|||
42038667|NCT00599638|75846845|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
42038668|NCT00599638|75846846|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
42141921|NCT00290355|75951623|FG000|Overall Study|Other|2|||
42012200|NCT00971425|75819268|FG000|Overall Study|Adverse Event|1|||
42012201|NCT00971425|75819269|FG001|Overall Study|Adverse Event|1|||
42141922|NCT00290355|75951624|FG001|Overall Study|Other|0|||
42038669|NCT00599638|75846847|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
42038670|NCT00599638|75846848|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
42038671|NCT00599638|75846845|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
42038672|NCT00599638|75846846|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
42038673|NCT00599638|75846847|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
42038674|NCT00599638|75846848|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
42038675|NCT00599638|75846845|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
42038676|NCT00599638|75846846|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
42141923|NCT00374322|75951632|FG000|Overall Study|Lost to Follow-up|92|||
42141924|NCT00374322|75951633|FG001|Overall Study|Lost to Follow-up|90|||
42141925|NCT00374322|75951632|FG000|Overall Study|Protocol Violation|8|||
42141926|NCT00374322|75951633|FG001|Overall Study|Protocol Violation|3|||
42141927|NCT00374322|75951632|FG000|Overall Study|Withdrawal by Subject|235|||
42141928|NCT00374322|75951633|FG001|Overall Study|Withdrawal by Subject|167|||
42141929|NCT00374322|75951632|FG000|Overall Study|Sponsor Terminated Study|866|||
42141930|NCT00374322|75951633|FG001|Overall Study|Sponsor Terminated Study|990|||
42141931|NCT00374322|75951632|FG000|Overall Study|Physician Decision|36|||
42141932|NCT00374322|75951633|FG001|Overall Study|Physician Decision|32|||
42141933|NCT00374322|75951632|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
42141934|NCT00374322|75951633|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
42141935|NCT00374322|75951632|FG000|Overall Study|Sponsor Decision|2|||
42141936|NCT00374322|75951633|FG001|Overall Study|Sponsor Decision|3|||
42141937|NCT00374322|75951632|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
42141938|NCT00374322|75951633|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
42141939|NCT00374322|75951632|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
42141940|NCT00374322|75951633|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
42141941|NCT00374322|75951632|FG000|Overall Study|Severe Toxicity|1|||
42141942|NCT00374322|75951633|FG001|Overall Study|Severe Toxicity|0|||
42141943|NCT00374322|75951632|FG000|Overall Study|Site Closed|2|||
42141944|NCT00374322|75951633|FG001|Overall Study|Site Closed|2|||
42141945|NCT00374322|75951632|FG000|Overall Study|Participant Changed Physician|1|||
42141946|NCT00374322|75951633|FG001|Overall Study|Participant Changed Physician|0|||
42141947|NCT00374322|75951632|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
42141948|NCT00374322|75951633|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
42141949|NCT00374322|75951632|FG000|Overall Study|Noncompliance with Study Requirements|0|||
42141950|NCT00374322|75951633|FG001|Overall Study|Noncompliance with Study Requirements|1|||
42141951|NCT00374322|75951632|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
42141952|NCT00374322|75951633|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
42141953|NCT00374322|75951632|FG000|Overall Study|Did Not Receive Study Medication|8|||
42141954|NCT00374322|75951633|FG001|Overall Study|Did Not Receive Study Medication|6|||
42141955|NCT00303459|75951642|FG000|Overall Study|Death|33|||
42141956|NCT00303459|75951643|FG001|Overall Study|Death|44|||
42141957|NCT00303459|75951642|FG000|Overall Study|Withdrawal of consent|32|||
42141958|NCT00303459|75951643|FG001|Overall Study|Withdrawal of consent|26|||
42141959|NCT00303459|75951642|FG000|Overall Study|Lost to Follow-up|5|||
42141960|NCT00303459|75951643|FG001|Overall Study|Lost to Follow-up|4|||
42141961|NCT00303459|75951642|FG000|Overall Study|Administrative reason|7|||
42141962|NCT00303459|75951643|FG001|Overall Study|Administrative reason|7|||
42276661|NCT02432846|76108154|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
42276662|NCT02432846|76108155|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
42276663|NCT02432846|76108156|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
42012202|NCT00971425|75819268|FG000|Overall Study|Withdrawal by Subject|0|||
42012203|NCT00971425|75819269|FG001|Overall Study|Withdrawal by Subject|1|||
42012204|NCT01193127|75819279|FG000|Randomized|Surgery Cancelled|0|||
42012205|NCT01193127|75819280|FG001|Randomized|Surgery Cancelled|0|||
42012206|NCT01193127|75819281|FG002|Randomized|Surgery Cancelled|0|||
42012207|NCT01193127|75819282|FG003|Randomized|Surgery Cancelled|1|||
42012208|NCT01193127|75819279|FG000|Treated|Withdrawal by Subject|0|||
42012209|NCT01193127|75819280|FG001|Treated|Withdrawal by Subject|0|||
42012210|NCT01193127|75819281|FG002|Treated|Withdrawal by Subject|0|||
42012211|NCT01193127|75819282|FG003|Treated|Withdrawal by Subject|1|||
42012212|NCT01192815|75819294|FG000|Overall Study|Withdrawal by Subject|1|||
42038677|NCT00599638|75846847|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
42012213|NCT01192815|75819294|FG000|Overall Study|Lack of Efficacy|1|||
42038678|NCT00599638|75846848|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
42038679|NCT00599638|75846845|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
42012214|NCT01192347|75819298|FG000|Overall Study|Death|3|||
42038680|NCT00599638|75846846|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
42038681|NCT00599638|75846847|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
42038682|NCT00599638|75846848|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
42038683|NCT00599638|75846845|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
42038684|NCT00599638|75846846|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
42038685|NCT00599638|75846847|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
42038686|NCT00599638|75846848|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
42038687|NCT00599638|75846845|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
42012215|NCT01192347|75819298|FG000|Overall Study|Lost to Follow-up|3|||
42012216|NCT01192347|75819298|FG000|Overall Study|Withdrawal by Subject|1|||
42012217|NCT01192347|75819298|FG000|Overall Study|Adverse Event|1|||
42012218|NCT01192347|75819298|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
42012219|NCT01192347|75819298|FG000|Overall Study|Patient seen in different hospital|1|||
42012220|NCT01192347|75819298|FG000|Overall Study|Patient not visiting hospital regularly|1|||
42012221|NCT01192347|75819298|FG000|Overall Study|Patient did not show up for visits|1|||
42012222|NCT01192191|75819304|FG000|Overall Study|Adverse Event|7|||
42012223|NCT01192191|75819305|FG001|Overall Study|Adverse Event|12|||
42141963|NCT00303459|75951642|FG000|Overall Study|Decision by the investigator|5|||
42141964|NCT00303459|75951643|FG001|Overall Study|Decision by the investigator|7|||
42141965|NCT00303459|75951642|FG000|Overall Study|Lung transplantation|1|||
42141966|NCT00303459|75951643|FG001|Overall Study|Lung transplantation|1|||
42141967|NCT00289887|75951652|FG000|Overall Study|Adverse Event|3|||
42141968|NCT00289887|75951653|FG001|Overall Study|Adverse Event|3|||
42141969|NCT00289887|75951652|FG000|Overall Study|Lack of Efficacy|3|||
42141970|NCT00289887|75951653|FG001|Overall Study|Lack of Efficacy|11|||
42141971|NCT00289887|75951652|FG000|Overall Study|Lost to Follow-up|3|||
42141972|NCT00289887|75951653|FG001|Overall Study|Lost to Follow-up|3|||
42141973|NCT00289887|75951652|FG000|Overall Study|Protocol Violation|3|||
42141974|NCT00289887|75951653|FG001|Overall Study|Protocol Violation|1|||
42141975|NCT00289887|75951652|FG000|Overall Study|Withdrawal by Subject|3|||
42141976|NCT00289887|75951653|FG001|Overall Study|Withdrawal by Subject|8|||
42141977|NCT00289887|75951652|FG000|Overall Study|Other|7|||
42141978|NCT00289887|75951653|FG001|Overall Study|Other|3|||
42141979|NCT00303069|75951663|FG000|Overall Study|Lost to Follow-up|1|||
42141980|NCT00303069|75951664|FG001|Overall Study|Lost to Follow-up|0|||
42141981|NCT00303069|75951665|FG002|Overall Study|Lost to Follow-up|0|||
42141982|NCT00303069|75951666|FG003|Overall Study|Lost to Follow-up|2|||
42141983|NCT00303069|75951663|FG000|Overall Study|subject moved|1|||
42141984|NCT00303069|75951664|FG001|Overall Study|subject moved|0|||
42141985|NCT00303069|75951665|FG002|Overall Study|subject moved|0|||
42141986|NCT00303069|75951666|FG003|Overall Study|subject moved|0|||
42141987|NCT00303069|75951663|FG000|Overall Study|Recruitment into Army Reserves|0|||
42141988|NCT00303069|75951664|FG001|Overall Study|Recruitment into Army Reserves|0|||
42141989|NCT00303069|75951665|FG002|Overall Study|Recruitment into Army Reserves|1|||
42141990|NCT00303069|75951666|FG003|Overall Study|Recruitment into Army Reserves|0|||
42012224|NCT01192191|75819304|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
42012225|NCT01192191|75819305|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
42012226|NCT01192191|75819304|FG000|Overall Study|Lost to Follow-up|0|||
42012227|NCT01192191|75819305|FG001|Overall Study|Lost to Follow-up|1|||
42038688|NCT00599638|75846846|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
42038689|NCT00599638|75846847|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
42038690|NCT00599638|75846848|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
42038691|NCT01166282|75846858|FG000|Open-label Period|Adverse Event|0|||
42038692|NCT01166282|75846859|FG001|Open-label Period|Adverse Event|0|||
42038693|NCT01166282|75846860|FG002|Open-label Period|Adverse Event|6|||
42141991|NCT00401544|75951680|FG000|Overall Study|Adverse Event|5|||
42141992|NCT00401544|75951681|FG001|Overall Study|Adverse Event|1|||
42141993|NCT00401544|75951682|FG002|Overall Study|Adverse Event|1|||
42038694|NCT01166282|75846858|FG000|Open-label Period|Withdrawal by Subject|0|||
42141994|NCT00401544|75951683|FG003|Overall Study|Adverse Event|1|||
42141995|NCT00401544|75951680|FG000|Overall Study|Death|3|||
42141996|NCT00401544|75951681|FG001|Overall Study|Death|6|||
42141997|NCT00401544|75951682|FG002|Overall Study|Death|2|||
42141998|NCT00401544|75951683|FG003|Overall Study|Death|5|||
42141999|NCT00401544|75951680|FG000|Overall Study|Lost to Follow-up|2|||
42350923|NCT02315703|76190768|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
42012228|NCT01192191|75819304|FG000|Overall Study|Withdrawal by Subject|1|||
42038695|NCT01166282|75846859|FG001|Open-label Period|Withdrawal by Subject|0|||
42038696|NCT01166282|75846860|FG002|Open-label Period|Withdrawal by Subject|4|||
42012229|NCT01192191|75819305|FG001|Overall Study|Withdrawal by Subject|6|||
42038697|NCT01166282|75846858|FG000|Open-label Period|Lack of Efficacy|0|||
42012230|NCT01307267|75819334|FG000|Overall Study|Death|4|||
42038698|NCT01166282|75846859|FG001|Open-label Period|Lack of Efficacy|0|||
42038699|NCT01166282|75846860|FG002|Open-label Period|Lack of Efficacy|2|||
42142000|NCT00401544|75951681|FG001|Overall Study|Lost to Follow-up|0|||
42142001|NCT00401544|75951682|FG002|Overall Study|Lost to Follow-up|1|||
42142002|NCT00401544|75951683|FG003|Overall Study|Lost to Follow-up|1|||
42142003|NCT00401544|75951680|FG000|Overall Study|Withdrawal by Subject|7|||
42142004|NCT00401544|75951681|FG001|Overall Study|Withdrawal by Subject|6|||
42142005|NCT00401544|75951682|FG002|Overall Study|Withdrawal by Subject|6|||
42142006|NCT00401544|75951683|FG003|Overall Study|Withdrawal by Subject|5|||
42142007|NCT00401544|75951680|FG000|Overall Study|Physician Decision|1|||
42038700|NCT01166282|75846858|FG000|Open-label Period|Remission|0|||
42038701|NCT01166282|75846859|FG001|Open-label Period|Remission|0|||
42038702|NCT01166282|75846860|FG002|Open-label Period|Remission|4|||
42142008|NCT00401544|75951681|FG001|Overall Study|Physician Decision|3|||
42142009|NCT00401544|75951682|FG002|Overall Study|Physician Decision|0|||
42142010|NCT00401544|75951683|FG003|Overall Study|Physician Decision|0|||
42142011|NCT00401544|75951680|FG000|Overall Study|Ineligibility determined|0|||
42142012|NCT00401544|75951681|FG001|Overall Study|Ineligibility determined|1|||
42142013|NCT00401544|75951682|FG002|Overall Study|Ineligibility determined|0|||
42142014|NCT00401544|75951683|FG003|Overall Study|Ineligibility determined|2|||
42142015|NCT00401544|75951680|FG000|Overall Study|Disease progression|0|||
42142016|NCT00401544|75951681|FG001|Overall Study|Disease progression|1|||
42142017|NCT00401544|75951682|FG002|Overall Study|Disease progression|0|||
42142018|NCT00401544|75951683|FG003|Overall Study|Disease progression|0|||
42142019|NCT00401544|75951680|FG000|Overall Study|Other|0|||
42142020|NCT00401544|75951681|FG001|Overall Study|Other|0|||
42142021|NCT00401544|75951682|FG002|Overall Study|Other|2|||
42142022|NCT00401544|75951683|FG003|Overall Study|Other|2|||
42142023|NCT00289731|75951701|FG000|Overall Study|Adverse Event|1|||
42142024|NCT00289731|75951702|FG001|Overall Study|Adverse Event|2|||
42142025|NCT00289731|75951703|FG002|Overall Study|Adverse Event|2|||
42142026|NCT00289731|75951701|FG000|Overall Study|Other|1|||
42142027|NCT00289731|75951702|FG001|Overall Study|Other|0|||
42142028|NCT00289731|75951703|FG002|Overall Study|Other|0|||
42142029|NCT00289185|75951715|FG000|Overall Study|Withdrawal by Subject|4|||
42142030|NCT00289185|75951716|FG001|Overall Study|Withdrawal by Subject|8|||
42142031|NCT00289185|75951715|FG000|Overall Study|Lost to Follow-up|23|||
42142032|NCT00289185|75951716|FG001|Overall Study|Lost to Follow-up|17|||
42142033|NCT00289185|75951715|FG000|Overall Study|Death|1|||
42142034|NCT00289185|75951716|FG001|Overall Study|Death|1|||
42142035|NCT00292461|75951725|FG000|Overall Study|Adverse Event|4|||
42142036|NCT00292461|75951726|FG001|Overall Study|Adverse Event|2|||
42142037|NCT00292461|75951725|FG000|Overall Study|Lack of Efficacy|1|||
42142038|NCT00292461|75951726|FG001|Overall Study|Lack of Efficacy|0|||
42142039|NCT00292461|75951725|FG000|Overall Study|Withdrawal by Subject|0|||
42038703|NCT01166282|75846858|FG000|Open-label Period|Irregular Compliance|0|||
42038704|NCT01166282|75846859|FG001|Open-label Period|Irregular Compliance|0|||
42038705|NCT01166282|75846860|FG002|Open-label Period|Irregular Compliance|1|||
42038706|NCT01153724|75846868|FG000|Treatment Period 1|Withdrawal by Subject|1|||
42038707|NCT01153724|75846868|FG000|Treatment Period 2|Adverse Event|1|||
42142040|NCT00292461|75951726|FG001|Overall Study|Withdrawal by Subject|1|||
42142041|NCT00292461|75951725|FG000|Overall Study|Protocol Violation|4|||
42142042|NCT00292461|75951726|FG001|Overall Study|Protocol Violation|3|||
42142043|NCT00292461|75951725|FG000|Overall Study|Lost to Follow-up|1|||
42142044|NCT00292461|75951726|FG001|Overall Study|Lost to Follow-up|0|||
42142045|NCT00288639|75951732|FG000|Overall Study|Adverse Event|5|||
42142046|NCT00288639|75951732|FG000|Overall Study|Lack of Efficacy|4|||
42142047|NCT00288639|75951732|FG000|Overall Study|Withdrawal by Subject|2|||
42142048|NCT00288639|75951732|FG000|Overall Study|Other|1|||
42142049|NCT00390858|75951738|FG000|Overall Study|Adverse Event|6|||
42142050|NCT00390858|75951739|FG001|Overall Study|Adverse Event|2|||
42142051|NCT00390858|75951738|FG000|Overall Study|Lack of Efficacy|0|||
42142052|NCT00390858|75951739|FG001|Overall Study|Lack of Efficacy|1|||
42142053|NCT00390858|75951738|FG000|Overall Study|Withdrawal by Subject|3|||
42142054|NCT00390858|75951739|FG001|Overall Study|Withdrawal by Subject|4|||
42142055|NCT00390780|75951747|FG000|Overall Study|Not completed|10|||
42142056|NCT00390780|75951748|FG001|Overall Study|Not completed|4|||
42142057|NCT00390780|75951747|FG000|Overall Study|Protocol Violation|6|||
42142058|NCT00390780|75951748|FG001|Overall Study|Protocol Violation|4|||
42142059|NCT00390780|75951747|FG000|Overall Study|Lost to Follow-up|3|||
42142060|NCT00390780|75951748|FG001|Overall Study|Lost to Follow-up|6|||
42276664|NCT02432846|76108157|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
42276665|NCT02432846|76108158|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
42276666|NCT02432846|76108153|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
42142061|NCT00390780|75951747|FG000|Overall Study|Adverse Event|2|||
42142062|NCT00390780|75951748|FG001|Overall Study|Adverse Event|3|||
42276667|NCT02432846|76108154|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
42276668|NCT02432846|76108155|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
42276669|NCT02432846|76108156|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
42038708|NCT01153724|75846868|FG000|Treatment Period 2|Other reason not defined above|1|||
42142063|NCT00390780|75951747|FG000|Overall Study|Death|1|||
42142064|NCT00390780|75951748|FG001|Overall Study|Death|3|||
42142065|NCT00390780|75951747|FG000|Overall Study|Withdrawal by Subject|1|||
42038709|NCT01152788|75846876|FG000|Overall Study|Withdrawal by Subject|0|||
42142066|NCT00390780|75951748|FG001|Overall Study|Withdrawal by Subject|2|||
42142067|NCT00390780|75951747|FG000|Overall Study|Inclusion criteria not satisfied|0|||
42142068|NCT00390780|75951748|FG001|Overall Study|Inclusion criteria not satisfied|2|||
42142069|NCT00390780|75951747|FG000|Overall Study|Lost to follow up and other reasons|0|||
42276670|NCT02432846|76108157|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
42276671|NCT02432846|76108158|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
42276672|NCT02432144|76108171|FG000|Overall Study|Participant Non-Compliance|1|||
42276673|NCT02246998|76108179|FG000|Overall Study|Adverse Event|0|||
42038710|NCT01152788|75846877|FG001|Overall Study|Withdrawal by Subject|3|||
42038711|NCT01152788|75846876|FG000|Overall Study|No treatment|0|||
42038712|NCT01152788|75846877|FG001|Overall Study|No treatment|1|||
42038713|NCT01165424|75846883|FG000|Overall Study|Clinical adverse experiences|1|||
42038714|NCT01165424|75846883|FG000|Overall Study|Laboratory adverse experiences|1|||
42038715|NCT01165424|75846883|FG000|Overall Study|Did not meet entry criteria|1|||
42038716|NCT01165424|75846883|FG000|Overall Study|Participant moved (relocated)|1|||
42038717|NCT01152554|75846889|FG000|Overall Study|Withdrawal by Subject|73|||
42038718|NCT01152554|75846890|FG001|Overall Study|Withdrawal by Subject|28|||
42038719|NCT01152554|75846889|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
42038720|NCT01152554|75846890|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
42038721|NCT01152554|75846889|FG000|Overall Study|Adverse Event|67|||
42038722|NCT01152554|75846890|FG001|Overall Study|Adverse Event|14|||
42038723|NCT01152554|75846889|FG000|Overall Study|Severe non-compliance to protocol|36|||
42038724|NCT01152554|75846890|FG001|Overall Study|Severe non-compliance to protocol|14|||
42038725|NCT01152554|75846889|FG000|Overall Study|Condition under investigation worsened|5|||
42038726|NCT01152554|75846890|FG001|Overall Study|Condition under investigation worsened|2|||
42038727|NCT01152554|75846889|FG000|Overall Study|Lack of Efficacy|20|||
42038728|NCT01152554|75846890|FG001|Overall Study|Lack of Efficacy|3|||
42038729|NCT01152554|75846889|FG000|Overall Study|Study-specific withdrawal criteria|17|||
42038730|NCT01152554|75846890|FG001|Overall Study|Study-specific withdrawal criteria|8|||
42038731|NCT01152554|75846889|FG000|Overall Study|Lost to Follow-up|87|||
42038732|NCT01152554|75846890|FG001|Overall Study|Lost to Follow-up|32|||
42038733|NCT01152554|75846889|FG000|Overall Study|Other|28|||
42038734|NCT01152554|75846890|FG001|Overall Study|Other|8|||
42038735|NCT01152554|75846889|FG000|Overall Study|Death|1|||
42038736|NCT01152554|75846890|FG001|Overall Study|Death|1|||
42038737|NCT00598702|75846904|FG000|Overall Study|Other|0|||
42038738|NCT00598702|75846905|FG001|Overall Study|Other|2|||
42038739|NCT00598702|75846906|FG002|Overall Study|Other|0|||
42038740|NCT00598702|75846907|FG003|Overall Study|Other|0|||
42038741|NCT00598702|75846908|FG004|Overall Study|Other|0|||
42038742|NCT00598702|75846909|FG005|Overall Study|Other|1|||
42038743|NCT00598702|75846910|FG006|Overall Study|Other|0|||
42038744|NCT00598702|75846911|FG007|Overall Study|Other|0|||
42038745|NCT00598702|75846904|FG000|Overall Study|Early discharge from hospital|0|||
42038746|NCT00598702|75846905|FG001|Overall Study|Early discharge from hospital|0|||
42038747|NCT00598702|75846906|FG002|Overall Study|Early discharge from hospital|2|||
42038748|NCT00598702|75846907|FG003|Overall Study|Early discharge from hospital|5|||
42038749|NCT00598702|75846908|FG004|Overall Study|Early discharge from hospital|0|||
42038750|NCT00598702|75846909|FG005|Overall Study|Early discharge from hospital|10|||
42038751|NCT00598702|75846910|FG006|Overall Study|Early discharge from hospital|1|||
42038752|NCT00598702|75846911|FG007|Overall Study|Early discharge from hospital|0|||
42038753|NCT00598702|75846904|FG000|Overall Study|Adverse Event|0|||
42038754|NCT00598702|75846905|FG001|Overall Study|Adverse Event|0|||
42038755|NCT00598702|75846906|FG002|Overall Study|Adverse Event|0|||
42038756|NCT00598702|75846907|FG003|Overall Study|Adverse Event|1|||
42038757|NCT00598702|75846908|FG004|Overall Study|Adverse Event|0|||
42038758|NCT00598702|75846909|FG005|Overall Study|Adverse Event|0|||
42038759|NCT00598702|75846910|FG006|Overall Study|Adverse Event|0|||
42038760|NCT00598702|75846911|FG007|Overall Study|Adverse Event|0|||
42038761|NCT00598702|75846904|FG000|Overall Study|Withdrawal by Subject|0|||
42038762|NCT00598702|75846905|FG001|Overall Study|Withdrawal by Subject|0|||
42038763|NCT00598702|75846906|FG002|Overall Study|Withdrawal by Subject|0|||
42038764|NCT00598702|75846907|FG003|Overall Study|Withdrawal by Subject|1|||
42038765|NCT00598702|75846908|FG004|Overall Study|Withdrawal by Subject|1|||
42038766|NCT00598702|75846909|FG005|Overall Study|Withdrawal by Subject|0|||
42038767|NCT00598702|75846910|FG006|Overall Study|Withdrawal by Subject|0|||
42038768|NCT00598702|75846911|FG007|Overall Study|Withdrawal by Subject|0|||
42038769|NCT00598702|75846904|FG000|Overall Study|Physician Decision|0|||
42038770|NCT00598702|75846905|FG001|Overall Study|Physician Decision|0|||
42038771|NCT00598702|75846906|FG002|Overall Study|Physician Decision|0|||
42038772|NCT00598702|75846907|FG003|Overall Study|Physician Decision|0|||
42038773|NCT00598702|75846908|FG004|Overall Study|Physician Decision|1|||
42038774|NCT00598702|75846909|FG005|Overall Study|Physician Decision|0|||
42038775|NCT00598702|75846910|FG006|Overall Study|Physician Decision|0|||
42038776|NCT00598702|75846911|FG007|Overall Study|Physician Decision|0|||
42038777|NCT00598702|75846904|FG000|Overall Study|Dose limiting toxicity|0|||
42038778|NCT00598702|75846905|FG001|Overall Study|Dose limiting toxicity|0|||
42276674|NCT02246998|76108180|FG001|Overall Study|Adverse Event|1|||
42038779|NCT00598702|75846906|FG002|Overall Study|Dose limiting toxicity|0|||
42038780|NCT00598702|75846907|FG003|Overall Study|Dose limiting toxicity|1|||
42142070|NCT00390780|75951748|FG001|Overall Study|Lost to follow up and other reasons|1|||
42142071|NCT00390780|75951747|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
42142072|NCT00390780|75951748|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
42142073|NCT00390780|75951747|FG000|Overall Study|SAE, death|0|||
42142074|NCT00390780|75951748|FG001|Overall Study|SAE, death|1|||
42142075|NCT00390546|75951756|FG000|Overall Study|Renal impairment|1|||
42142076|NCT00390546|75951757|FG001|Overall Study|Renal impairment|0|||
42142077|NCT00390546|75951756|FG000|Overall Study|Physician Decision|5|||
42142078|NCT00390546|75951757|FG001|Overall Study|Physician Decision|5|||
42142079|NCT00390468|75951764|FG000|Overall Study|Protocol Violation|2|||
42142080|NCT00390468|75951764|FG000|Overall Study|Lack of Efficacy|1|||
42142081|NCT00400764|75951773|FG000|Phase Ib|Adverse Event|1|||
42142082|NCT00400764|75951774|FG001|Phase Ib|Adverse Event|0|||
42142083|NCT00400764|75951775|FG002|Phase Ib|Adverse Event|0|||
42142084|NCT00400764|75951776|FG003|Phase Ib|Adverse Event|0|||
42142085|NCT00400764|75951777|FG004|Phase Ib|Adverse Event|0|||
42142086|NCT00400764|75951773|FG000|Phase Ib|Death|1|||
42142087|NCT00400764|75951774|FG001|Phase Ib|Death|0|||
42142088|NCT00400764|75951775|FG002|Phase Ib|Death|0|||
42142089|NCT00400764|75951776|FG003|Phase Ib|Death|0|||
42142090|NCT00400764|75951777|FG004|Phase Ib|Death|0|||
42142091|NCT00400764|75951773|FG000|Phase Ib|Disease Progression|4|||
42142092|NCT00400764|75951774|FG001|Phase Ib|Disease Progression|4|||
42142093|NCT00400764|75951775|FG002|Phase Ib|Disease Progression|0|||
42142094|NCT00400764|75951776|FG003|Phase Ib|Disease Progression|0|||
42142095|NCT00400764|75951777|FG004|Phase Ib|Disease Progression|0|||
42142096|NCT00400764|75951773|FG000|Phase II|Death|0|||
42142097|NCT00400764|75951774|FG001|Phase II|Death|0|||
42142098|NCT00400764|75951775|FG002|Phase II|Death|1|||
42142099|NCT00400764|75951776|FG003|Phase II|Death|2|||
42142100|NCT00400764|75951777|FG004|Phase II|Death|0|||
42142101|NCT00400764|75951773|FG000|Phase II|Lost to Follow-up|0|||
42142102|NCT00400764|75951774|FG001|Phase II|Lost to Follow-up|0|||
42142103|NCT00400764|75951775|FG002|Phase II|Lost to Follow-up|1|||
42142104|NCT00400764|75951776|FG003|Phase II|Lost to Follow-up|0|||
42142105|NCT00400764|75951777|FG004|Phase II|Lost to Follow-up|0|||
42142106|NCT00400764|75951773|FG000|Phase II|Physician Decision|0|||
42142107|NCT00400764|75951774|FG001|Phase II|Physician Decision|0|||
42142108|NCT00400764|75951775|FG002|Phase II|Physician Decision|1|||
42142109|NCT00400764|75951776|FG003|Phase II|Physician Decision|1|||
42142110|NCT00400764|75951777|FG004|Phase II|Physician Decision|0|||
42142111|NCT00400764|75951773|FG000|Phase II|Sponsor's decision to terminate|0|||
42142112|NCT00400764|75951774|FG001|Phase II|Sponsor's decision to terminate|0|||
42142113|NCT00400764|75951775|FG002|Phase II|Sponsor's decision to terminate|18|||
42142114|NCT00400764|75951776|FG003|Phase II|Sponsor's decision to terminate|22|||
42142115|NCT00400764|75951777|FG004|Phase II|Sponsor's decision to terminate|11|||
42142116|NCT00400764|75951773|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
42142117|NCT00400764|75951774|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
42142118|NCT00400764|75951775|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
42142119|NCT00400764|75951776|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
42142120|NCT00400764|75951777|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
42142121|NCT00400764|75951773|FG000|Phase II|Withdrawal by Subject|0|||
42142122|NCT00400764|75951774|FG001|Phase II|Withdrawal by Subject|0|||
42142123|NCT00400764|75951775|FG002|Phase II|Withdrawal by Subject|1|||
42142124|NCT00400764|75951776|FG003|Phase II|Withdrawal by Subject|1|||
42142125|NCT00400764|75951777|FG004|Phase II|Withdrawal by Subject|0|||
42142126|NCT00302211|75951797|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
42142127|NCT00302211|75951798|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
42142128|NCT00302211|75951799|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
42142129|NCT00302211|75951800|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
42142130|NCT00302211|75951801|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
42012231|NCT01307267|75819335|FG001|Overall Study|Death|3|||
42012232|NCT01307267|75819336|FG002|Overall Study|Death|5|||
42012233|NCT01307267|75819337|FG003|Overall Study|Death|3|||
42012234|NCT01307267|75819338|FG004|Overall Study|Death|1|||
42012235|NCT01307267|75819339|FG005|Overall Study|Death|26|||
42012236|NCT01307267|75819340|FG006|Overall Study|Death|2|||
42012237|NCT01307267|75819341|FG007|Overall Study|Death|2|||
42142131|NCT00302211|75951797|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
42142132|NCT00302211|75951798|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
42142133|NCT00302211|75951799|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
42142134|NCT00302211|75951800|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
42142135|NCT00302211|75951801|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
42012238|NCT01307267|75819342|FG008|Overall Study|Death|21|||
42012239|NCT01307267|75819343|FG009|Overall Study|Death|2|||
42012240|NCT01307267|75819344|FG010|Overall Study|Death|3|||
42142136|NCT00302211|75951797|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
42142137|NCT00302211|75951798|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
42276675|NCT02246998|76108181|FG002|Overall Study|Adverse Event|1|||
42012241|NCT01307267|75819345|FG011|Overall Study|Death|9|||
42142138|NCT00302211|75951799|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
42142139|NCT00302211|75951800|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
42142140|NCT00302211|75951801|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
42142141|NCT00302211|75951797|FG000|Double Blind Period (New Patients)|Disease progression|0|||
42142142|NCT00302211|75951798|FG001|Double Blind Period (New Patients)|Disease progression|1|||
42142143|NCT00302211|75951799|FG002|Double Blind Period (New Patients)|Disease progression|1|||
42142144|NCT00302211|75951800|FG003|Double Blind Period (New Patients)|Disease progression|0|||
42142145|NCT00302211|75951801|FG004|Double Blind Period (New Patients)|Disease progression|0|||
42142146|NCT00302211|75951797|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
42142147|NCT00302211|75951798|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
42142148|NCT00302211|75951799|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
42142149|NCT00302211|75951800|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
42142150|NCT00302211|75951801|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
42142151|NCT00302211|75951797|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
42142152|NCT00302211|75951798|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
42142153|NCT00302211|75951799|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
42142154|NCT00302211|75951800|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
42142155|NCT00302211|75951801|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
42142156|NCT00302211|75951797|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
42142157|NCT00302211|75951798|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
42142158|NCT00302211|75951799|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
42142159|NCT00302211|75951800|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
42142160|NCT00302211|75951801|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
42142161|NCT00302211|75951797|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
42142162|NCT00302211|75951798|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
42142163|NCT00302211|75951799|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
42142164|NCT00302211|75951800|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
42142165|NCT00302211|75951801|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
42142166|NCT00302211|75951797|FG000|Open Label-Patients From Double-Blind|Death|0|||
42142167|NCT00302211|75951798|FG001|Open Label-Patients From Double-Blind|Death|0|||
42142168|NCT00302211|75951799|FG002|Open Label-Patients From Double-Blind|Death|0|||
42142169|NCT00302211|75951800|FG003|Open Label-Patients From Double-Blind|Death|1|||
42142170|NCT00302211|75951801|FG004|Open Label-Patients From Double-Blind|Death|1|||
42142171|NCT00302211|75951797|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
42142172|NCT00302211|75951798|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
42142173|NCT00302211|75951799|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
42142174|NCT00302211|75951800|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
42142175|NCT00302211|75951801|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
42142176|NCT00302211|75951797|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
42142177|NCT00302211|75951798|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
42142178|NCT00302211|75951799|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
42142179|NCT00302211|75951800|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
42142180|NCT00302211|75951801|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
42142181|NCT00302211|75951797|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
42142182|NCT00302211|75951798|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
42142183|NCT00302211|75951799|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
42142184|NCT00302211|75951800|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
42142185|NCT00302211|75951801|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
42142186|NCT00288015|75951813|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
42142187|NCT00288015|75951813|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
42142188|NCT00288015|75951813|FG000|First Response Assessment|Withdrawal by Subject|1|||
42142189|NCT00288015|75951813|FG000|First Response Assessment|Death|1|||
42142190|NCT00288015|75951813|FG000|First Response Assessment|Physician Decision|2|||
42142191|NCT00288015|75951813|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
42142192|NCT00288015|75951813|FG000|Follow up for Survival x 2 Years|Death|13|||
42276676|NCT02246998|76108182|FG003|Overall Study|Adverse Event|0|||
42276677|NCT02246998|76108179|FG000|Overall Study|Lost to Follow-up|1|||
42276678|NCT02246998|76108180|FG001|Overall Study|Lost to Follow-up|0|||
42038781|NCT00598702|75846908|FG004|Overall Study|Dose limiting toxicity|1|||
42038782|NCT00598702|75846909|FG005|Overall Study|Dose limiting toxicity|1|||
42038783|NCT00598702|75846910|FG006|Overall Study|Dose limiting toxicity|0|||
42276679|NCT02246998|76108181|FG002|Overall Study|Lost to Follow-up|0|||
42276680|NCT02246998|76108182|FG003|Overall Study|Lost to Follow-up|1|||
42038784|NCT00598702|75846911|FG007|Overall Study|Dose limiting toxicity|0|||
42142193|NCT00288015|75951813|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
42142194|NCT00288015|75951813|FG000|Follow up for Survival x 2 Years|Other|9|||
42142195|NCT00389064|75951819|FG000|Overall Study|Adverse Event|11|||
42142196|NCT00389064|75951820|FG001|Overall Study|Adverse Event|3|||
42142197|NCT00389064|75951819|FG000|Overall Study|Lack of Efficacy|3|||
42142198|NCT00389064|75951820|FG001|Overall Study|Lack of Efficacy|14|||
42142199|NCT00389064|75951819|FG000|Overall Study|Withdrawal by Subject|17|||
42142200|NCT00389064|75951820|FG001|Overall Study|Withdrawal by Subject|27|||
42142201|NCT00389064|75951819|FG000|Overall Study|Physician Decision|2|||
42142202|NCT00389064|75951820|FG001|Overall Study|Physician Decision|2|||
42142203|NCT00389064|75951819|FG000|Overall Study|Lost to Follow-up|1|||
42142204|NCT00389064|75951820|FG001|Overall Study|Lost to Follow-up|2|||
42142205|NCT00389064|75951819|FG000|Overall Study|Protocol Violation|2|||
42142206|NCT00389064|75951820|FG001|Overall Study|Protocol Violation|0|||
42142207|NCT00389064|75951819|FG000|Overall Study|Multiple Reasons|9|||
42142208|NCT00389064|75951820|FG001|Overall Study|Multiple Reasons|11|||
42142209|NCT00388674|75951828|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
42142210|NCT00388674|75951829|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
42142211|NCT00388674|75951828|FG000|Initial Treatment|Adverse Event|22|||
42142212|NCT00388674|75951829|FG001|Initial Treatment|Adverse Event|87|||
42142213|NCT00388674|75951828|FG000|Initial Treatment|Death|215|||
42142214|NCT00388674|75951829|FG001|Initial Treatment|Death|216|||
42142215|NCT00388674|75951828|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
42142216|NCT00388674|75951829|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
42142217|NCT00388674|75951828|FG000|Initial Treatment|HCC|12|||
42142218|NCT00388674|75951829|FG001|Initial Treatment|HCC|20|||
42142219|NCT00388674|75951828|FG000|Initial Treatment|Lost to Follow-up|526|||
42142220|NCT00388674|75951829|FG001|Initial Treatment|Lost to Follow-up|624|||
42142221|NCT00388674|75951828|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
42142222|NCT00388674|75951829|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
42142223|NCT00388674|75951828|FG000|Initial Treatment|Never Treated with Study Medication|1|||
42142224|NCT00388674|75951829|FG001|Initial Treatment|Never Treated with Study Medication|7|||
42142225|NCT00388674|75951828|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
42142226|NCT00388674|75951829|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
42142227|NCT00388674|75951828|FG000|Initial Treatment|Not Defined|125|||
42142228|NCT00388674|75951829|FG001|Initial Treatment|Not Defined|172|||
42142229|NCT00388674|75951828|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
42142230|NCT00388674|75951829|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
42142231|NCT00388674|75951828|FG000|Initial Treatment|Pregnancy|26|||
42142232|NCT00388674|75951829|FG001|Initial Treatment|Pregnancy|16|||
42142233|NCT00388674|75951828|FG000|Initial Treatment|Study Drug Toxicity|5|||
42142234|NCT00388674|75951829|FG001|Initial Treatment|Study Drug Toxicity|92|||
42142235|NCT00388674|75951828|FG000|Initial Treatment|Participant Request|501|||
42142236|NCT00388674|75951829|FG001|Initial Treatment|Participant Request|673|||
42142237|NCT00388674|75951828|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
42142238|NCT00388674|75951829|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
42142239|NCT00388674|75951828|FG000|Initial Treatment|Not Reported|10|||
42142240|NCT00388674|75951829|FG001|Initial Treatment|Not Reported|12|||
42142241|NCT00388674|75951828|FG000|End of Study|Administrative Reason By Sponsor|299|||
42142242|NCT00388674|75951829|FG001|End of Study|Administrative Reason By Sponsor|253|||
42142243|NCT00388674|75951828|FG000|End of Study|Death|239|||
42142244|NCT00388674|75951829|FG001|End of Study|Death|262|||
42142245|NCT00388674|75951828|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
42142246|NCT00388674|75951829|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
42142247|NCT00388674|75951828|FG000|End of Study|HCC|8|||
42012242|NCT01307267|75819346|FG012|Overall Study|Death|0|||
42012243|NCT01307267|75819347|FG013|Overall Study|Death|0|||
42012244|NCT01307267|75819348|FG014|Overall Study|Death|0|||
42012245|NCT01307267|75819349|FG015|Overall Study|Death|0|||
42012246|NCT01307267|75819350|FG016|Overall Study|Death|1|||
42012247|NCT01307267|75819351|FG017|Overall Study|Death|1|||
42012248|NCT01307267|75819352|FG018|Overall Study|Death|2|||
42012249|NCT01307267|75819353|FG019|Overall Study|Death|8|||
42142248|NCT00388674|75951829|FG001|End of Study|HCC|7|||
42142249|NCT00388674|75951828|FG000|End of Study|Lost to Follow-up|587|||
42142250|NCT00388674|75951829|FG001|End of Study|Lost to Follow-up|715|||
42142251|NCT00388674|75951828|FG000|End of Study|Malignancy (Non-HCC)|1|||
42142252|NCT00388674|75951829|FG001|End of Study|Malignancy (Non-HCC)|1|||
42142253|NCT00388674|75951828|FG000|End of Study|Non-Study Related Comorbidities|3|||
42142254|NCT00388674|75951829|FG001|End of Study|Non-Study Related Comorbidities|4|||
42350924|NCT02315703|76190769|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
42142255|NCT00388674|75951828|FG000|End of Study|Not Defined|135|||
42142256|NCT00388674|75951829|FG001|End of Study|Not Defined|214|||
42142257|NCT00388674|75951828|FG000|End of Study|Participant Withdrew Consent|437|||
42142258|NCT00388674|75951829|FG001|End of Study|Participant Withdrew Consent|673|||
42142259|NCT00388674|75951828|FG000|End of Study|No Off-Treatment Status Data|22|||
42142260|NCT00388674|75951829|FG001|End of Study|No Off-Treatment Status Data|30|||
42012250|NCT01307267|75819354|FG020|Overall Study|Death|1|||
42038785|NCT01148810|75846931|FG000|Overall Study|Adverse Event|0|||
42038786|NCT01148810|75846932|FG001|Overall Study|Adverse Event|2|||
42038787|NCT01148810|75846931|FG000|Overall Study|Lack of Efficacy|0|||
42038788|NCT01148810|75846932|FG001|Overall Study|Lack of Efficacy|1|||
42038789|NCT01148810|75846931|FG000|Overall Study|Withdrawal by Subject|0|||
42038790|NCT01148810|75846932|FG001|Overall Study|Withdrawal by Subject|2|||
42142261|NCT00388674|75951828|FG000|End of Study|Not Reported|0|||
42142262|NCT00388674|75951829|FG001|End of Study|Not Reported|1|||
42142263|NCT00388362|75951835|FG000|Enrolled|Ineligible|1|||
42142264|NCT00388362|75951835|FG000|Enrolled|Adverse Event|9|||
42142265|NCT00388362|75951835|FG000|Enrolled|Death|1|||
42142266|NCT00388362|75951835|FG000|Enrolled|Loss insurance|1|||
42142267|NCT00388362|75951835|FG000|Enrolled|Withdrawal by Subject|1|||
42142268|NCT00388362|75951835|FG000|Remained on Study Median of 514 Days|Death|2|||
42142269|NCT00387894|75951839|FG000|Overall Study|Withdrawal by Subject|1|||
42142270|NCT00387426|75951843|FG000|Overall Study|Lack of Response|7|||
42142271|NCT00387426|75951843|FG000|Overall Study|Toxicities|4|||
42142272|NCT00387426|75951843|FG000|Overall Study|Disease Progression|3|||
42142273|NCT00387348|75951850|FG000|Overall Study|Death|1|||
42142274|NCT00387348|75951851|FG001|Overall Study|Death|1|||
42142275|NCT00387348|75951852|FG002|Overall Study|Death|0|||
42142276|NCT00387348|75951850|FG000|Overall Study|Physician Decision|1|||
42142277|NCT00387348|75951851|FG001|Overall Study|Physician Decision|0|||
42142278|NCT00387348|75951852|FG002|Overall Study|Physician Decision|1|||
42142279|NCT00387348|75951850|FG000|Overall Study|Withdrawal by Subject|0|||
42142280|NCT00387348|75951851|FG001|Overall Study|Withdrawal by Subject|2|||
42142281|NCT00387348|75951852|FG002|Overall Study|Withdrawal by Subject|2|||
42142282|NCT00387348|75951850|FG000|Overall Study|Adverse Event|1|||
42142283|NCT00387348|75951851|FG001|Overall Study|Adverse Event|0|||
42142284|NCT00387348|75951852|FG002|Overall Study|Adverse Event|1|||
42142285|NCT00413660|75951872|FG000|Up To Week 12|Adverse Event|1|||
42142286|NCT00413660|75951873|FG001|Up To Week 12|Adverse Event|3|||
42142287|NCT00413660|75951874|FG002|Up To Week 12|Adverse Event|1|||
42142288|NCT00413660|75951875|FG003|Up To Week 12|Adverse Event|4|||
42142289|NCT00413660|75951876|FG004|Up To Week 12|Adverse Event|6|||
42142290|NCT00413660|75951877|FG005|Up To Week 12|Adverse Event|4|||
42142291|NCT00413660|75951878|FG006|Up To Week 12|Adverse Event|1|||
42142292|NCT00413660|75951879|FG007|Up To Week 12|Adverse Event|0|||
42142293|NCT00413660|75951880|FG008|Up To Week 12|Adverse Event|0|||
42142294|NCT00413660|75951881|FG009|Up To Week 12|Adverse Event|0|||
42142295|NCT00413660|75951882|FG010|Up To Week 12|Adverse Event|0|||
42142296|NCT00413660|75951872|FG000|Up To Week 12|Lack of Efficacy|2|||
42038791|NCT01148810|75846931|FG000|Overall Study|Protocol Violation|1|||
42038792|NCT01148810|75846932|FG001|Overall Study|Protocol Violation|0|||
42038793|NCT01151618|75846939|FG000|Overall Study|Adverse Event|2|||
42038794|NCT01151618|75846939|FG000|Overall Study|Withdrawal by Subject|7|||
42142297|NCT00413660|75951873|FG001|Up To Week 12|Lack of Efficacy|0|||
42142298|NCT00413660|75951874|FG002|Up To Week 12|Lack of Efficacy|0|||
42142299|NCT00413660|75951875|FG003|Up To Week 12|Lack of Efficacy|0|||
42142300|NCT00413660|75951876|FG004|Up To Week 12|Lack of Efficacy|0|||
42142301|NCT00413660|75951877|FG005|Up To Week 12|Lack of Efficacy|0|||
42142302|NCT00413660|75951878|FG006|Up To Week 12|Lack of Efficacy|5|||
42142303|NCT00413660|75951879|FG007|Up To Week 12|Lack of Efficacy|0|||
42142304|NCT00413660|75951880|FG008|Up To Week 12|Lack of Efficacy|0|||
42142305|NCT00413660|75951881|FG009|Up To Week 12|Lack of Efficacy|0|||
42142306|NCT00413660|75951882|FG010|Up To Week 12|Lack of Efficacy|0|||
42142307|NCT00413660|75951872|FG000|Up To Week 12|Lost to Follow-up|0|||
42142308|NCT00413660|75951873|FG001|Up To Week 12|Lost to Follow-up|1|||
42142309|NCT00413660|75951874|FG002|Up To Week 12|Lost to Follow-up|0|||
42142310|NCT00413660|75951875|FG003|Up To Week 12|Lost to Follow-up|0|||
42038795|NCT01164956|75846943|FG000|Overall Study|Side Effects|1|||
42142311|NCT00413660|75951876|FG004|Up To Week 12|Lost to Follow-up|1|||
42142312|NCT00413660|75951877|FG005|Up To Week 12|Lost to Follow-up|0|||
42142313|NCT00413660|75951878|FG006|Up To Week 12|Lost to Follow-up|0|||
42142314|NCT00413660|75951879|FG007|Up To Week 12|Lost to Follow-up|0|||
42142315|NCT00413660|75951880|FG008|Up To Week 12|Lost to Follow-up|0|||
42142316|NCT00413660|75951881|FG009|Up To Week 12|Lost to Follow-up|0|||
42038796|NCT01164956|75846944|FG001|Overall Study|Side Effects|0|||
42142317|NCT00413660|75951882|FG010|Up To Week 12|Lost to Follow-up|0|||
42038797|NCT01164956|75846945|FG002|Overall Study|Side Effects|1|||
42142318|NCT00413660|75951872|FG000|Up To Week 12|Withdrawal by Subject|0|||
42142319|NCT00413660|75951873|FG001|Up To Week 12|Withdrawal by Subject|2|||
42142320|NCT00413660|75951874|FG002|Up To Week 12|Withdrawal by Subject|0|||
42038798|NCT01164722|75846955|FG000|Overall Study|Adverse Event|0|||
42038799|NCT01164722|75846956|FG001|Overall Study|Adverse Event|1|||
42142321|NCT00413660|75951875|FG003|Up To Week 12|Withdrawal by Subject|2|||
42142322|NCT00413660|75951876|FG004|Up To Week 12|Withdrawal by Subject|0|||
42142323|NCT00413660|75951877|FG005|Up To Week 12|Withdrawal by Subject|2|||
42038800|NCT01164722|75846955|FG000|Overall Study|Withdrawal by Subject|3|||
42142324|NCT00413660|75951878|FG006|Up To Week 12|Withdrawal by Subject|2|||
42142325|NCT00413660|75951879|FG007|Up To Week 12|Withdrawal by Subject|0|||
42142326|NCT00413660|75951880|FG008|Up To Week 12|Withdrawal by Subject|0|||
42142327|NCT00413660|75951881|FG009|Up To Week 12|Withdrawal by Subject|0|||
42142328|NCT00413660|75951882|FG010|Up To Week 12|Withdrawal by Subject|0|||
42142329|NCT00413660|75951872|FG000|Up To Week 12|Randomized, Not Treated|1|||
42142330|NCT00413660|75951873|FG001|Up To Week 12|Randomized, Not Treated|0|||
42142331|NCT00413660|75951874|FG002|Up To Week 12|Randomized, Not Treated|0|||
42142332|NCT00413660|75951875|FG003|Up To Week 12|Randomized, Not Treated|1|||
42142333|NCT00413660|75951876|FG004|Up To Week 12|Randomized, Not Treated|0|||
42142334|NCT00413660|75951877|FG005|Up To Week 12|Randomized, Not Treated|0|||
42142335|NCT00413660|75951878|FG006|Up To Week 12|Randomized, Not Treated|0|||
42142336|NCT00413660|75951879|FG007|Up To Week 12|Randomized, Not Treated|0|||
42142337|NCT00413660|75951880|FG008|Up To Week 12|Randomized, Not Treated|0|||
42142338|NCT00413660|75951881|FG009|Up To Week 12|Randomized, Not Treated|0|||
42142339|NCT00413660|75951882|FG010|Up To Week 12|Randomized, Not Treated|0|||
42142340|NCT00413660|75951872|FG000|Up To Week 12|Other|3|||
42142341|NCT00413660|75951873|FG001|Up To Week 12|Other|1|||
42142342|NCT00413660|75951874|FG002|Up To Week 12|Other|6|||
42142343|NCT00413660|75951875|FG003|Up To Week 12|Other|1|||
42142344|NCT00413660|75951876|FG004|Up To Week 12|Other|2|||
42142345|NCT00413660|75951877|FG005|Up To Week 12|Other|4|||
42142346|NCT00413660|75951878|FG006|Up To Week 12|Other|3|||
42142347|NCT00413660|75951879|FG007|Up To Week 12|Other|0|||
42142348|NCT00413660|75951880|FG008|Up To Week 12|Other|0|||
42142349|NCT00413660|75951881|FG009|Up To Week 12|Other|0|||
42142350|NCT00413660|75951882|FG010|Up To Week 12|Other|0|||
42142351|NCT00413660|75951872|FG000|Post Week 12|Adverse Event|2|||
42142352|NCT00413660|75951873|FG001|Post Week 12|Adverse Event|0|||
42142353|NCT00413660|75951874|FG002|Post Week 12|Adverse Event|2|||
42142354|NCT00413660|75951875|FG003|Post Week 12|Adverse Event|1|||
42142355|NCT00413660|75951876|FG004|Post Week 12|Adverse Event|4|||
42142356|NCT00413660|75951877|FG005|Post Week 12|Adverse Event|2|||
42038801|NCT01164722|75846956|FG001|Overall Study|Withdrawal by Subject|4|||
42038802|NCT01164722|75846955|FG000|Overall Study|Lost to Follow-up|3|||
42038803|NCT01164722|75846956|FG001|Overall Study|Lost to Follow-up|6|||
42038804|NCT01164722|75846955|FG000|Overall Study|met protocol criteria for non-treatment|11|||
42038805|NCT01164722|75846956|FG001|Overall Study|met protocol criteria for non-treatment|1|||
42038806|NCT01164722|75846955|FG000|Overall Study|enrolled on other study, concomitant med|1|||
42038807|NCT01164722|75846956|FG001|Overall Study|enrolled on other study, concomitant med|3|||
42038808|NCT01151540|75846962|FG000|Overall Study|Other|2|||
42038809|NCT01151540|75846962|FG000|Overall Study|Adverse event, non-fatal|4|||
42038810|NCT01151540|75846962|FG000|Overall Study|Withdrawal by Subject|7|||
42038811|NCT01163786|75846966|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
42038812|NCT01163786|75846966|FG000|Treatment With Bortezomib|Adverse Event|2|||
42038813|NCT01163786|75846966|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
42038814|NCT00984282|75846972|FG000|Double Blind Treatment|Adverse Event|40|||
42038815|NCT00984282|75846973|FG001|Double Blind Treatment|Adverse Event|6|||
42038816|NCT00984282|75846972|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
42038817|NCT00984282|75846973|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
42038818|NCT00984282|75846972|FG000|Double Blind Treatment|Physician Decision|1|||
42038819|NCT00984282|75846973|FG001|Double Blind Treatment|Physician Decision|2|||
42038820|NCT00984282|75846972|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
42038821|NCT00984282|75846973|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
42038822|NCT00984282|75846972|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
42142357|NCT00413660|75951878|FG006|Post Week 12|Adverse Event|2|||
42142358|NCT00413660|75951879|FG007|Post Week 12|Adverse Event|0|||
42142359|NCT00413660|75951880|FG008|Post Week 12|Adverse Event|0|||
42142360|NCT00413660|75951881|FG009|Post Week 12|Adverse Event|0|||
42142361|NCT00413660|75951882|FG010|Post Week 12|Adverse Event|0|||
42142362|NCT00413660|75951872|FG000|Post Week 12|Lack of Efficacy|0|||
42038823|NCT00984282|75846973|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
42038824|NCT00984282|75846972|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
42038825|NCT00984282|75846973|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
42038826|NCT00984282|75846972|FG000|Double Blind Treatment|Lost to Follow-up|3|||
42038827|NCT00984282|75846973|FG001|Double Blind Treatment|Lost to Follow-up|0|||
42038828|NCT00984282|75846972|FG000|Double Blind Treatment|Death|8|||
42142363|NCT00413660|75951873|FG001|Post Week 12|Lack of Efficacy|0|||
42142364|NCT00413660|75951874|FG002|Post Week 12|Lack of Efficacy|1|||
42142365|NCT00413660|75951875|FG003|Post Week 12|Lack of Efficacy|0|||
42142366|NCT00413660|75951876|FG004|Post Week 12|Lack of Efficacy|0|||
42142367|NCT00413660|75951877|FG005|Post Week 12|Lack of Efficacy|0|||
42142368|NCT00413660|75951878|FG006|Post Week 12|Lack of Efficacy|0|||
42142369|NCT00413660|75951879|FG007|Post Week 12|Lack of Efficacy|0|||
42142370|NCT00413660|75951880|FG008|Post Week 12|Lack of Efficacy|0|||
42142371|NCT00413660|75951881|FG009|Post Week 12|Lack of Efficacy|1|||
42142372|NCT00413660|75951882|FG010|Post Week 12|Lack of Efficacy|0|||
42142373|NCT00413660|75951872|FG000|Post Week 12|Lost to Follow-up|0|||
42142374|NCT00413660|75951873|FG001|Post Week 12|Lost to Follow-up|1|||
42142375|NCT00413660|75951874|FG002|Post Week 12|Lost to Follow-up|1|||
42142376|NCT00413660|75951875|FG003|Post Week 12|Lost to Follow-up|0|||
42142377|NCT00413660|75951876|FG004|Post Week 12|Lost to Follow-up|0|||
42142378|NCT00413660|75951877|FG005|Post Week 12|Lost to Follow-up|0|||
42142379|NCT00413660|75951878|FG006|Post Week 12|Lost to Follow-up|0|||
42142380|NCT00413660|75951879|FG007|Post Week 12|Lost to Follow-up|0|||
42142381|NCT00413660|75951880|FG008|Post Week 12|Lost to Follow-up|0|||
42142382|NCT00413660|75951881|FG009|Post Week 12|Lost to Follow-up|0|||
42142383|NCT00413660|75951882|FG010|Post Week 12|Lost to Follow-up|0|||
42142384|NCT00413660|75951872|FG000|Post Week 12|Withdrawal by Subject|0|||
42142385|NCT00413660|75951873|FG001|Post Week 12|Withdrawal by Subject|1|||
42276681|NCT02246998|76108179|FG000|Overall Study|Randomized but Never Dosed|1|||
42276682|NCT02246998|76108180|FG001|Overall Study|Randomized but Never Dosed|2|||
42038829|NCT00984282|75846973|FG001|Double Blind Treatment|Death|4|||
42038830|NCT00984282|75846972|FG000|Double Blind Treatment|Not treated|0|||
42038831|NCT00984282|75846973|FG001|Double Blind Treatment|Not treated|1|||
42038832|NCT00984282|75846972|FG000|Double Blind Treatment|Switched to commercial drug|6|||
42038833|NCT00984282|75846973|FG001|Double Blind Treatment|Switched to commercial drug|1|||
42038834|NCT00984282|75846972|FG000|Double Blind Treatment|protocol driven decision point|1|||
42038835|NCT00984282|75846973|FG001|Double Blind Treatment|protocol driven decision point|1|||
42038836|NCT00984282|75846972|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
42038837|NCT00984282|75846973|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
42038838|NCT00984282|75846972|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
42038839|NCT00984282|75846973|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
42038840|NCT00984282|75846972|FG000|Open-label Treatment|Adverse Event|20|||
42038841|NCT00984282|75846973|FG001|Open-label Treatment|Adverse Event|30|||
42038842|NCT00984282|75846972|FG000|Open-label Treatment|Withdrawal by Subject|6|||
42038843|NCT00984282|75846973|FG001|Open-label Treatment|Withdrawal by Subject|21|||
42038844|NCT00984282|75846972|FG000|Open-label Treatment|Death|7|||
42038845|NCT00984282|75846973|FG001|Open-label Treatment|Death|15|||
42038846|NCT00984282|75846972|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
42038847|NCT00984282|75846973|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
42038848|NCT00984282|75846972|FG000|Open-label Treatment|Lost to Follow-up|1|||
42038849|NCT00984282|75846973|FG001|Open-label Treatment|Lost to Follow-up|1|||
42038850|NCT00984282|75846972|FG000|Open-label Treatment|Patient convenience|1|||
42038851|NCT00984282|75846973|FG001|Open-label Treatment|Patient convenience|0|||
42038852|NCT00984282|75846972|FG000|Open-label Treatment|Non-compliant with study medication|1|||
42038853|NCT00984282|75846973|FG001|Open-label Treatment|Non-compliant with study medication|0|||
42038854|NCT00984282|75846972|FG000|Open-label Treatment|Target lesion removed|0|||
42038855|NCT00984282|75846973|FG001|Open-label Treatment|Target lesion removed|1|||
42038856|NCT00984282|75846972|FG000|Open-label Treatment|Protocol driven decision point|1|||
42038857|NCT00984282|75846973|FG001|Open-label Treatment|Protocol driven decision point|1|||
42038858|NCT00984282|75846972|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
42038859|NCT00984282|75846973|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
42038860|NCT00984282|75846972|FG000|Open-label Treatment|Switched to commercial drug|6|||
42038861|NCT00984282|75846973|FG001|Open-label Treatment|Switched to commercial drug|7|||
42038862|NCT00984282|75846972|FG000|Open-label Treatment|Physician Decision|1|||
42038863|NCT00984282|75846973|FG001|Open-label Treatment|Physician Decision|0|||
42038864|NCT00984282|75846972|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
42038865|NCT00984282|75846973|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
42038866|NCT00984282|75846972|FG000|Long Term Follow-up|Death|27|||
42038867|NCT00984282|75846973|FG001|Long Term Follow-up|Death|68|||
42038868|NCT00984282|75846972|FG000|Long Term Follow-up|Lost to Follow-up|3|||
42038869|NCT00984282|75846973|FG001|Long Term Follow-up|Lost to Follow-up|6|||
42038870|NCT00984282|75846972|FG000|Long Term Follow-up|Protocol driven decision point|25|||
42038871|NCT00984282|75846973|FG001|Long Term Follow-up|Protocol driven decision point|26|||
42276683|NCT02246998|76108181|FG002|Overall Study|Randomized but Never Dosed|2|||
42276684|NCT02246998|76108182|FG003|Overall Study|Randomized but Never Dosed|1|||
42038872|NCT00984282|75846972|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
42038873|NCT00984282|75846973|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
42038874|NCT00984282|75846972|FG000|Long Term Follow-up|Switched to commercial drug|4|||
42038875|NCT00984282|75846973|FG001|Long Term Follow-up|Switched to commercial drug|2|||
42038876|NCT00984282|75846972|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
42038877|NCT00984282|75846973|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
42038878|NCT01147874|75846981|FG000|Overall Study|Adverse Event|5|||
42038879|NCT01147874|75846981|FG000|Overall Study|Investigator's Request|1|||
42142386|NCT00413660|75951874|FG002|Post Week 12|Withdrawal by Subject|1|||
42142387|NCT00413660|75951875|FG003|Post Week 12|Withdrawal by Subject|0|||
42142388|NCT00413660|75951876|FG004|Post Week 12|Withdrawal by Subject|1|||
42142389|NCT00413660|75951877|FG005|Post Week 12|Withdrawal by Subject|0|||
42276685|NCT02486588|76108201|FG000|Overall Study|Randomized in error- ineligible|738|||
42276686|NCT02486588|76108202|FG001|Overall Study|Randomized in error- ineligible|750|||
42038880|NCT01147874|75846981|FG000|Overall Study|Lost to Follow-up|25|||
42038881|NCT01147874|75846981|FG000|Overall Study|Other|5|||
42038882|NCT01147874|75846981|FG000|Overall Study|Protocol Violation|5|||
42038883|NCT01147874|75846981|FG000|Overall Study|Sponsor's Decision|2|||
42142390|NCT00413660|75951878|FG006|Post Week 12|Withdrawal by Subject|0|||
42142391|NCT00413660|75951879|FG007|Post Week 12|Withdrawal by Subject|0|||
42142392|NCT00413660|75951880|FG008|Post Week 12|Withdrawal by Subject|0|||
42142393|NCT00413660|75951881|FG009|Post Week 12|Withdrawal by Subject|0|||
42142394|NCT00413660|75951882|FG010|Post Week 12|Withdrawal by Subject|1|||
42142395|NCT00413660|75951872|FG000|Post Week 12|Other|1|||
42142396|NCT00413660|75951873|FG001|Post Week 12|Other|2|||
42142397|NCT00413660|75951874|FG002|Post Week 12|Other|3|||
42142398|NCT00413660|75951875|FG003|Post Week 12|Other|0|||
42142399|NCT00413660|75951876|FG004|Post Week 12|Other|1|||
42142400|NCT00413660|75951877|FG005|Post Week 12|Other|1|||
42142401|NCT00413660|75951878|FG006|Post Week 12|Other|1|||
42142402|NCT00413660|75951879|FG007|Post Week 12|Other|0|||
42142403|NCT00413660|75951880|FG008|Post Week 12|Other|0|||
42142404|NCT00413660|75951881|FG009|Post Week 12|Other|0|||
42142405|NCT00413660|75951882|FG010|Post Week 12|Other|0|||
42142406|NCT00431834|75951916|FG000|Overall Study|Withdrawal by Subject|7|||
42142407|NCT00431834|75951916|FG000|Overall Study|Death|3|||
42142408|NCT00431834|75951916|FG000|Overall Study|Missed Endpoint Visit|2|||
42142409|NCT00431834|75951916|FG000|Overall Study|Lost to Follow-up|1|||
42142410|NCT00431444|75951925|FG000|Overall Study|Protocol Violation|1|||
42142411|NCT00431444|75951926|FG001|Overall Study|Protocol Violation|4|||
42142412|NCT00431444|75951925|FG000|Overall Study|Adverse Event|2|||
42142413|NCT00431444|75951926|FG001|Overall Study|Adverse Event|1|||
42142414|NCT00431444|75951925|FG000|Overall Study|Withdrawal by Subject|1|||
42142415|NCT00431444|75951926|FG001|Overall Study|Withdrawal by Subject|1|||
42142416|NCT00431444|75951925|FG000|Overall Study|Lost to Follow-up|1|||
42142417|NCT00431444|75951926|FG001|Overall Study|Lost to Follow-up|0|||
42142418|NCT00431444|75951925|FG000|Overall Study|Administrative Problems|0|||
42142419|NCT00431444|75951926|FG001|Overall Study|Administrative Problems|1|||
42142420|NCT00430352|75951932|FG000|Overall Study|Disease progression|58|||
42142421|NCT00430352|75951932|FG000|Overall Study|Withdrawal by Subject|11|||
42142422|NCT00430352|75951932|FG000|Overall Study|Adverse Event|16|||
42142423|NCT00430352|75951932|FG000|Overall Study|Death|5|||
42142424|NCT00430352|75951932|FG000|Overall Study|Other|48|||
42350925|NCT02315703|76190770|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
42038884|NCT01147874|75846981|FG000|Overall Study|Withdrawal by Subject|24|||
42038885|NCT01147640|75846987|FG000|Overall Study|Adverse Event|2|||
42038886|NCT01147640|75846988|FG001|Overall Study|Adverse Event|0|||
42038887|NCT01147640|75846987|FG000|Overall Study|Physician Decision|1|||
42038888|NCT01147640|75846988|FG001|Overall Study|Physician Decision|0|||
42038889|NCT01147640|75846987|FG000|Overall Study|Withdrawal by Subject|1|||
42038890|NCT01147640|75846988|FG001|Overall Study|Withdrawal by Subject|0|||
42038891|NCT01147640|75846987|FG000|Overall Study|Lost to Follow-up|0|||
42038892|NCT01147640|75846988|FG001|Overall Study|Lost to Follow-up|1|||
42038893|NCT01147640|75846987|FG000|Overall Study|Didn't meet eligibility criteria|1|||
42038894|NCT01147640|75846988|FG001|Overall Study|Didn't meet eligibility criteria|0|||
42038895|NCT01121900|75846994|FG000|First Intervention Period|Adverse Event|1|||
42038896|NCT01121900|75846995|FG001|First Intervention Period|Adverse Event|1|||
42038897|NCT01121900|75846994|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
42038898|NCT01121900|75846995|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
42038899|NCT01121666|75847003|FG000|Overall Study|Protocol Violation|29|||
42038900|NCT01121666|75847004|FG001|Overall Study|Protocol Violation|10|||
42038901|NCT00984126|75847014|FG000|Overall Study|Protocol Violation|0|||
42038902|NCT00984126|75847015|FG001|Overall Study|Protocol Violation|0|||
42038903|NCT00984126|75847016|FG002|Overall Study|Protocol Violation|1|||
42038904|NCT00984126|75847017|FG003|Overall Study|Protocol Violation|2|||
42038905|NCT00984126|75847014|FG000|Overall Study|Adverse Event|0|||
42038906|NCT00984126|75847015|FG001|Overall Study|Adverse Event|0|||
42038907|NCT00984126|75847016|FG002|Overall Study|Adverse Event|0|||
42038908|NCT00984126|75847017|FG003|Overall Study|Adverse Event|2|||
42038909|NCT00984126|75847014|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
42038910|NCT00984126|75847015|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
42038911|NCT00984126|75847016|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
42038912|NCT00984126|75847017|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
42142425|NCT00287469|75951938|FG000|Overall Study|serious adverse event|1|||
42142426|NCT00287469|75951939|FG001|Overall Study|serious adverse event|6|||
42142427|NCT00287469|75951938|FG000|Overall Study|Adverse Event|1|||
42142428|NCT00287469|75951939|FG001|Overall Study|Adverse Event|1|||
42142429|NCT00287469|75951938|FG000|Overall Study|moved from area|144|||
42142430|NCT00287469|75951939|FG001|Overall Study|moved from area|138|||
42142431|NCT00287469|75951938|FG000|Overall Study|Lost to Follow-up|74|||
42142432|NCT00287469|75951939|FG001|Overall Study|Lost to Follow-up|69|||
42142433|NCT00429572|75951947|FG000|Overall Study|Disease progression|1|||
42142434|NCT00287079|75951953|FG000|Overall Study|Qualifying relapse|12|||
42142435|NCT00287079|75951954|FG001|Overall Study|Qualifying relapse|1|||
42142436|NCT00287079|75951953|FG000|Overall Study|Non-qualifying relapse|1|||
42142437|NCT00287079|75951954|FG001|Overall Study|Non-qualifying relapse|0|||
42038913|NCT00984126|75847014|FG000|Overall Study|Withdrawal criteria|0|||
42038914|NCT00984126|75847015|FG001|Overall Study|Withdrawal criteria|1|||
42142438|NCT00287079|75951953|FG000|Overall Study|Adverse Event|5|||
42142439|NCT00287079|75951954|FG001|Overall Study|Adverse Event|0|||
42142440|NCT00287079|75951953|FG000|Overall Study|Protocol Violation|1|||
42142441|NCT00287079|75951954|FG001|Overall Study|Protocol Violation|0|||
42142442|NCT00287079|75951953|FG000|Overall Study|Other|3|||
42142443|NCT00287079|75951954|FG001|Overall Study|Other|0|||
42142444|NCT00429494|75951960|FG000|Overall Study|Withdrawal by Subject|9|||
42142445|NCT00429494|75951960|FG000|Overall Study|Death|6|||
42142446|NCT00429416|75951964|FG000|Overall Study|Death|1|||
42142447|NCT00429182|75951968|FG000|Overall Study|Not evaluable, Disease Progression|2|||
42038915|NCT00984126|75847016|FG002|Overall Study|Withdrawal criteria|3|||
42142448|NCT00429182|75951968|FG000|Overall Study|Not eligible|5|||
42142449|NCT00429104|75951972|FG000|Overall Study|Protocol Violation|1|||
42142450|NCT00429026|75951976|FG000|Overall Study|Inevaluable for response.|40|||
42142451|NCT00301821|75951980|FG000|Overall Study|Ineligible|25|||
42142452|NCT00301821|75951980|FG000|Overall Study|Cancel|1|||
42142453|NCT00372996|75951986|FG000|Overall Study|Death|11|||
42142454|NCT00372996|75951987|FG001|Overall Study|Death|4|||
42142455|NCT00372996|75951988|FG002|Overall Study|Death|8|||
42142456|NCT00372996|75951989|FG003|Overall Study|Death|7|||
42142457|NCT00372996|75951986|FG000|Overall Study|Lost to Follow-up|0|||
42142458|NCT00372996|75951987|FG001|Overall Study|Lost to Follow-up|2|||
42142459|NCT00372996|75951988|FG002|Overall Study|Lost to Follow-up|0|||
42142460|NCT00372996|75951989|FG003|Overall Study|Lost to Follow-up|1|||
42142461|NCT00372996|75951986|FG000|Overall Study|Withdrawal by Subject|12|||
42142462|NCT00372996|75951987|FG001|Overall Study|Withdrawal by Subject|6|||
42142463|NCT00372996|75951988|FG002|Overall Study|Withdrawal by Subject|9|||
42142464|NCT00372996|75951989|FG003|Overall Study|Withdrawal by Subject|5|||
42012251|NCT01307267|75819355|FG021|Overall Study|Death|2|||
42012252|NCT01307267|75819356|FG022|Overall Study|Death|2|||
42012253|NCT01307267|75819334|FG000|Overall Study|Lost to Follow-up|0|||
42012254|NCT01307267|75819335|FG001|Overall Study|Lost to Follow-up|0|||
42038916|NCT00984126|75847017|FG003|Overall Study|Withdrawal criteria|9|||
42038917|NCT00979602|75847038|FG000|Overall Study|Serious Adverse Event|5|||
42012255|NCT01307267|75819336|FG002|Overall Study|Lost to Follow-up|0|||
42012256|NCT01307267|75819337|FG003|Overall Study|Lost to Follow-up|0|||
42012257|NCT01307267|75819338|FG004|Overall Study|Lost to Follow-up|0|||
42012258|NCT01307267|75819339|FG005|Overall Study|Lost to Follow-up|7|||
42012259|NCT01307267|75819340|FG006|Overall Study|Lost to Follow-up|0|||
42012260|NCT01307267|75819341|FG007|Overall Study|Lost to Follow-up|0|||
42012261|NCT01307267|75819342|FG008|Overall Study|Lost to Follow-up|1|||
42038918|NCT00979602|75847039|FG001|Overall Study|Serious Adverse Event|3|||
42038919|NCT00979602|75847038|FG000|Overall Study|Protocol Violation|3|||
42038920|NCT00979602|75847039|FG001|Overall Study|Protocol Violation|0|||
42038921|NCT00979602|75847038|FG000|Overall Study|Withdrawal by Subject|31|||
42038922|NCT00979602|75847039|FG001|Overall Study|Withdrawal by Subject|25|||
42038923|NCT00979602|75847038|FG000|Overall Study|Lost to Follow-up|100|||
42038924|NCT00979602|75847039|FG001|Overall Study|Lost to Follow-up|96|||
42038925|NCT00979602|75847038|FG000|Overall Study|Migrated/moved from study area|3|||
42038926|NCT00979602|75847039|FG001|Overall Study|Migrated/moved from study area|6|||
42038927|NCT00979602|75847038|FG000|Overall Study|Others|3|||
42038928|NCT00979602|75847039|FG001|Overall Study|Others|3|||
42038929|NCT00816361|75847064|FG000|Overall Study|Withdrawal by Subject|0|||
42038930|NCT00816361|75847065|FG001|Overall Study|Withdrawal by Subject|0|||
42038931|NCT00816361|75847066|FG002|Overall Study|Withdrawal by Subject|0|||
42012262|NCT01307267|75819343|FG009|Overall Study|Lost to Follow-up|2|||
42012263|NCT01307267|75819344|FG010|Overall Study|Lost to Follow-up|1|||
42012264|NCT01307267|75819345|FG011|Overall Study|Lost to Follow-up|0|||
42012265|NCT01307267|75819346|FG012|Overall Study|Lost to Follow-up|0|||
42038932|NCT00816361|75847067|FG003|Overall Study|Withdrawal by Subject|0|||
42038933|NCT00816361|75847068|FG004|Overall Study|Withdrawal by Subject|1|||
42038934|NCT00816361|75847069|FG005|Overall Study|Withdrawal by Subject|2|||
42038935|NCT00816361|75847070|FG006|Overall Study|Withdrawal by Subject|0|||
42012266|NCT01307267|75819347|FG013|Overall Study|Lost to Follow-up|0|||
42012267|NCT01307267|75819348|FG014|Overall Study|Lost to Follow-up|0|||
42038936|NCT00816361|75847071|FG007|Overall Study|Withdrawal by Subject|2|||
42038937|NCT00816361|75847072|FG008|Overall Study|Withdrawal by Subject|1|||
42142465|NCT00372996|75951986|FG000|Overall Study|Study Terminated by Sponsor|4|||
42142466|NCT00372996|75951987|FG001|Overall Study|Study Terminated by Sponsor|0|||
42142467|NCT00372996|75951988|FG002|Overall Study|Study Terminated by Sponsor|4|||
42142468|NCT00372996|75951989|FG003|Overall Study|Study Terminated by Sponsor|0|||
42142469|NCT00372996|75951986|FG000|Overall Study|Other|10|||
42142470|NCT00372996|75951987|FG001|Overall Study|Other|2|||
42142471|NCT00372996|75951988|FG002|Overall Study|Other|7|||
42142472|NCT00372996|75951989|FG003|Overall Study|Other|7|||
42142473|NCT00399516|75951999|FG000|Overall Study|Lost to Follow-up|2|||
42142474|NCT00399360|75952007|FG000|Overall Study|Lost to Follow-up|2|||
42142475|NCT00399360|75952008|FG001|Overall Study|Lost to Follow-up|1|||
42142476|NCT00399360|75952009|FG002|Overall Study|Lost to Follow-up|2|||
42142477|NCT00399360|75952010|FG003|Overall Study|Lost to Follow-up|4|||
42142478|NCT00399360|75952007|FG000|Overall Study|Adverse Event|0|||
42142479|NCT00399360|75952008|FG001|Overall Study|Adverse Event|0|||
42142480|NCT00399360|75952009|FG002|Overall Study|Adverse Event|1|||
42142481|NCT00399360|75952010|FG003|Overall Study|Adverse Event|0|||
42142482|NCT00399360|75952007|FG000|Overall Study|Withdrawal by Subject|0|||
42142483|NCT00399360|75952008|FG001|Overall Study|Withdrawal by Subject|2|||
42142484|NCT00399360|75952009|FG002|Overall Study|Withdrawal by Subject|0|||
42142485|NCT00399360|75952010|FG003|Overall Study|Withdrawal by Subject|2|||
42142486|NCT00428948|75952027|FG000|Overall Study|Lost to Follow-up|15|||
42142487|NCT00428948|75952028|FG001|Overall Study|Lost to Follow-up|8|||
42142488|NCT00428948|75952027|FG000|Overall Study|Adverse Event|148|||
42142489|NCT00428948|75952028|FG001|Overall Study|Adverse Event|24|||
42142490|NCT00428948|75952027|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
42142491|NCT00428948|75952028|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
42142492|NCT00428948|75952027|FG000|Overall Study|Investigator Withdrew Subject|3|||
42142493|NCT00428948|75952028|FG001|Overall Study|Investigator Withdrew Subject|4|||
42142494|NCT00428948|75952027|FG000|Overall Study|Subject Withdrew Consent|50|||
42142495|NCT00428948|75952028|FG001|Overall Study|Subject Withdrew Consent|30|||
42142496|NCT00428948|75952027|FG000|Overall Study|Protocol Deviation|1|||
42142497|NCT00428948|75952028|FG001|Overall Study|Protocol Deviation|1|||
42142498|NCT00428792|75952036|FG000|Overall Study|Lack of Efficacy|1|||
42142499|NCT00428792|75952037|FG001|Overall Study|Lack of Efficacy|3|||
42142500|NCT00428792|75952036|FG000|Overall Study|Lost to Follow-up|0|||
42142501|NCT00428792|75952037|FG001|Overall Study|Lost to Follow-up|1|||
42142502|NCT00300885|75952045|FG000|Treatment|Adverse Event|134|||
42142503|NCT00300885|75952046|FG001|Treatment|Adverse Event|82|||
42142504|NCT00300885|75952045|FG000|Treatment|Death|20|||
42142505|NCT00300885|75952046|FG001|Treatment|Death|7|||
42142506|NCT00300885|75952045|FG000|Treatment|Lack of Efficacy|1|||
42142507|NCT00300885|75952046|FG001|Treatment|Lack of Efficacy|1|||
42142508|NCT00300885|75952045|FG000|Treatment|Lost to Follow-up|3|||
42142509|NCT00300885|75952046|FG001|Treatment|Lost to Follow-up|2|||
42142510|NCT00300885|75952045|FG000|Treatment|Physician Decision|4|||
42142511|NCT00300885|75952046|FG001|Treatment|Physician Decision|5|||
42142512|NCT00300885|75952045|FG000|Treatment|Protocol Violation|11|||
42142513|NCT00300885|75952046|FG001|Treatment|Protocol Violation|11|||
42142514|NCT00300885|75952045|FG000|Treatment|Withdrawal by Subject|26|||
42142515|NCT00300885|75952046|FG001|Treatment|Withdrawal by Subject|23|||
42142516|NCT00300885|75952045|FG000|Treatment|Disease progression|171|||
42142517|NCT00300885|75952046|FG001|Treatment|Disease progression|238|||
42142518|NCT00300885|75952045|FG000|Treatment|Random code broken (subject died)|0|||
42142519|NCT00300885|75952046|FG001|Treatment|Random code broken (subject died)|1|||
42142520|NCT00300885|75952045|FG000|Treatment|Non-compliant with study medication|3|||
42142521|NCT00300885|75952046|FG001|Treatment|Non-compliant with study medication|4|||
42142522|NCT00300885|75952045|FG000|Follow-up|Death|141|||
42142523|NCT00300885|75952046|FG001|Follow-up|Death|163|||
42142524|NCT00300885|75952045|FG000|Follow-up|Lost to Follow-up|11|||
42142525|NCT00300885|75952046|FG001|Follow-up|Lost to Follow-up|7|||
42276687|NCT02486588|76108203|FG002|Overall Study|Randomized in error- ineligible|755|||
42276688|NCT02486588|76108204|FG003|Overall Study|Randomized in error- ineligible|738|||
42142526|NCT00300885|75952045|FG000|Follow-up|Withdrawal by Subject|26|||
42142527|NCT00300885|75952046|FG001|Follow-up|Withdrawal by Subject|25|||
42142528|NCT00386334|75952054|FG000|Double Blind Period|Adverse Event|9|||
42142529|NCT00386334|75952055|FG001|Double Blind Period|Adverse Event|14|||
42142530|NCT00386334|75952054|FG000|Double Blind Period|Protocol Violation|1|||
42276689|NCT02486588|76108205|FG004|Overall Study|Randomized in error- ineligible|746|||
42276690|NCT02486588|76108206|FG005|Overall Study|Randomized in error- ineligible|746|||
42142531|NCT00386334|75952055|FG001|Double Blind Period|Protocol Violation|1|||
42142532|NCT00386334|75952054|FG000|Double Blind Period|Withdrawal by Subject|9|||
42142533|NCT00386334|75952055|FG001|Double Blind Period|Withdrawal by Subject|13|||
42142534|NCT00386334|75952054|FG000|Double Blind Period|Lack of Efficacy|20|||
42142535|NCT00386334|75952055|FG001|Double Blind Period|Lack of Efficacy|11|||
42142536|NCT00386334|75952054|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
42142537|NCT00386334|75952055|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
42142538|NCT00386334|75952054|FG000|Double Blind Period|Other|3|||
42142539|NCT00386334|75952055|FG001|Double Blind Period|Other|3|||
42142540|NCT00386334|75952054|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
42142541|NCT00386334|75952055|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
42142542|NCT00428714|75952072|FG000|Overall Study|Progressive Disease|28|||
42142543|NCT00428714|75952073|FG001|Overall Study|Progressive Disease|36|||
42142544|NCT00428714|75952072|FG000|Overall Study|Withdrawal by Subject|0|||
42142545|NCT00428714|75952073|FG001|Overall Study|Withdrawal by Subject|3|||
42142546|NCT00428714|75952072|FG000|Overall Study|Adverse Event|0|||
42142547|NCT00428714|75952073|FG001|Overall Study|Adverse Event|2|||
42142548|NCT00428714|75952072|FG000|Overall Study|Physician Decision|1|||
42142549|NCT00428714|75952073|FG001|Overall Study|Physician Decision|1|||
42142550|NCT00428714|75952072|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
42142551|NCT00428714|75952073|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
42142552|NCT00428714|75952072|FG000|Overall Study|Death due to other then PD|1|||
42142553|NCT00428714|75952073|FG001|Overall Study|Death due to other then PD|0|||
42142554|NCT00292227|75952082|FG000|Patch Period|Adverse Event|1|||
42038938|NCT00816361|75847064|FG000|Overall Study|Death|4|||
42038939|NCT00816361|75847065|FG001|Overall Study|Death|3|||
42038940|NCT00816361|75847066|FG002|Overall Study|Death|3|||
42038941|NCT00816361|75847067|FG003|Overall Study|Death|3|||
42038942|NCT00816361|75847068|FG004|Overall Study|Death|1|||
42038943|NCT00816361|75847069|FG005|Overall Study|Death|1|||
42038944|NCT00816361|75847070|FG006|Overall Study|Death|3|||
42038945|NCT00816361|75847071|FG007|Overall Study|Death|7|||
42038946|NCT00816361|75847072|FG008|Overall Study|Death|8|||
42038947|NCT00816361|75847064|FG000|Overall Study|Other|0|||
42038948|NCT00816361|75847065|FG001|Overall Study|Other|0|||
42038949|NCT00816361|75847066|FG002|Overall Study|Other|0|||
42038950|NCT00816361|75847067|FG003|Overall Study|Other|0|||
42038951|NCT00816361|75847068|FG004|Overall Study|Other|0|||
42142555|NCT00292227|75952083|FG001|Patch Period|Adverse Event|0|||
42142556|NCT00292227|75952084|FG002|Patch Period|Adverse Event|2|||
42142557|NCT00292227|75952082|FG000|Patch Period|Withdrawal by Subject|0|||
42142558|NCT00292227|75952083|FG001|Patch Period|Withdrawal by Subject|0|||
42142559|NCT00292227|75952084|FG002|Patch Period|Withdrawal by Subject|1|||
42142560|NCT00386100|75952094|FG000|Overall Study|Did not receive study medication|6|||
42142561|NCT00386100|75952095|FG001|Overall Study|Did not receive study medication|4|||
42142562|NCT00386100|75952094|FG000|Overall Study|Adverse Event|15|||
42142563|NCT00386100|75952095|FG001|Overall Study|Adverse Event|25|||
42142564|NCT00386100|75952094|FG000|Overall Study|Death|0|||
42142565|NCT00386100|75952095|FG001|Overall Study|Death|1|||
42142566|NCT00386100|75952094|FG000|Overall Study|Insufficient therapeutic effect|30|||
42142567|NCT00386100|75952095|FG001|Overall Study|Insufficient therapeutic effect|6|||
42142568|NCT00386100|75952094|FG000|Overall Study|Lost to Follow-up|29|||
42142569|NCT00386100|75952095|FG001|Overall Study|Lost to Follow-up|29|||
42142570|NCT00386100|75952094|FG000|Overall Study|Non-compliance|18|||
42142571|NCT00386100|75952095|FG001|Overall Study|Non-compliance|19|||
42142572|NCT00386100|75952094|FG000|Overall Study|Protocol Violation|5|||
42142573|NCT00386100|75952095|FG001|Overall Study|Protocol Violation|3|||
42142574|NCT00386100|75952094|FG000|Overall Study|Withdrawal by Subject|32|||
42142575|NCT00386100|75952095|FG001|Overall Study|Withdrawal by Subject|31|||
42142576|NCT00386100|75952094|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
42142577|NCT00386100|75952095|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
42142578|NCT00386100|75952094|FG000|Overall Study|BMD <2.5|1|||
42142579|NCT00386100|75952095|FG001|Overall Study|BMD <2.5|0|||
42142580|NCT00386100|75952094|FG000|Overall Study|Consecutive elevated Hba1C|1|||
42142581|NCT00386100|75952095|FG001|Overall Study|Consecutive elevated Hba1C|0|||
42142582|NCT00386100|75952094|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
42142583|NCT00386100|75952095|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
42038952|NCT00816361|75847069|FG005|Overall Study|Other|0|||
42038953|NCT00816361|75847070|FG006|Overall Study|Other|0|||
42038954|NCT00816361|75847071|FG007|Overall Study|Other|0|||
42142584|NCT00386100|75952094|FG000|Overall Study|Laboratory findings|1|||
42038955|NCT00816361|75847072|FG008|Overall Study|Other|1|||
42038956|NCT00826111|75847095|FG000|Overall Study|Lost to Follow-up|0|||
42038957|NCT00826111|75847096|FG001|Overall Study|Lost to Follow-up|1|||
42038958|NCT00826111|75847095|FG000|Overall Study|Protocol Violation|1|||
42142585|NCT00386100|75952095|FG001|Overall Study|Laboratory findings|0|||
42142586|NCT00386100|75952094|FG000|Overall Study|Participant's concern due to CPK levels|1|||
42142587|NCT00386100|75952095|FG001|Overall Study|Participant's concern due to CPK levels|0|||
42142588|NCT00386100|75952094|FG000|Overall Study|Participant moving out of state|2|||
42142589|NCT00386100|75952095|FG001|Overall Study|Participant moving out of state|0|||
42038959|NCT00826111|75847096|FG001|Overall Study|Protocol Violation|0|||
42038960|NCT00826111|75847095|FG000|Overall Study|Withdrawal by Subject|5|||
42038961|NCT00826111|75847096|FG001|Overall Study|Withdrawal by Subject|0|||
42038962|NCT00826111|75847095|FG000|Overall Study|Physician Decision|1|||
42038963|NCT00826111|75847096|FG001|Overall Study|Physician Decision|1|||
42142590|NCT00386100|75952094|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
42038964|NCT00982644|75847107|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
42038965|NCT00982644|75847108|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
42038966|NCT00982644|75847107|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
42038967|NCT00982644|75847108|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
42038968|NCT00982644|75847107|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
42142591|NCT00386100|75952095|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
42142592|NCT00386100|75952094|FG000|Overall Study|Didn't meet entry criteria|1|||
42142593|NCT00386100|75952095|FG001|Overall Study|Didn't meet entry criteria|1|||
42038969|NCT00982644|75847108|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
42038970|NCT00982644|75847107|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
42142594|NCT00386100|75952094|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
42142595|NCT00386100|75952095|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
42142596|NCT00386100|75952094|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
42142597|NCT00386100|75952095|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
42142598|NCT00386100|75952094|FG000|Overall Study|Bad metabolic control & patient security|1|||
42142599|NCT00386100|75952095|FG001|Overall Study|Bad metabolic control & patient security|0|||
42142600|NCT00386100|75952094|FG000|Overall Study|Bone loss by DXA bone scan|1|||
42038971|NCT00982644|75847108|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
42038972|NCT00982644|75847107|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
42038973|NCT00982644|75847108|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
42038974|NCT00982644|75847107|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
42038975|NCT00982644|75847108|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
42038976|NCT00982644|75847107|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
42038977|NCT00982644|75847108|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
42038978|NCT00982644|75847107|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
42038979|NCT00982644|75847108|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
42038980|NCT00982644|75847107|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
42038981|NCT00982644|75847108|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
42038982|NCT00982644|75847107|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
42038983|NCT00982644|75847108|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
42038984|NCT00815659|75847114|FG000|Overall Study|Adverse Event|9|||
42038985|NCT00815659|75847114|FG000|Overall Study|Withdrawal by Subject|9|||
42038986|NCT00815659|75847114|FG000|Overall Study|Lost to Follow-up|4|||
42038987|NCT00815659|75847114|FG000|Overall Study|Protocol Violation|1|||
42038988|NCT00825175|75847120|FG000|Overall Study|Withdrawal by Subject|0|||
42038989|NCT00825175|75847121|FG001|Overall Study|Withdrawal by Subject|5|||
42038990|NCT00824473|75847129|FG000|Overall Study|Adverse Event|4|||
42038991|NCT00824473|75847130|FG001|Overall Study|Adverse Event|5|||
42142601|NCT00386100|75952095|FG001|Overall Study|Bone loss by DXA bone scan|0|||
42276691|NCT00805961|76108225|FG000|Modality Therapy|Withdrawal by Subject|1|||
42276692|NCT00805961|76108225|FG000|Modality Therapy|Adverse Event|1|||
42276693|NCT00805961|76108225|FG000|Modality Therapy|Disease Progression|2|||
42276694|NCT00805961|76108225|FG000|Treatment-Free Interval|Adverse Event|3|||
42276695|NCT00805961|76108225|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
42276696|NCT00805961|76108225|FG000|Treatment-Free Interval|Physician Decision|1|||
42276697|NCT00805961|76108225|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
42276698|NCT00805961|76108225|FG000|Maintenance Treatment|Lack of Efficacy|13|||
42276699|NCT00805961|76108225|FG000|Maintenance Treatment|Intercurrent Illness|7|||
42276700|NCT00805961|76108225|FG000|Maintenance Treatment|Adverse Event|6|||
42350926|NCT02315703|76190763|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
42276701|NCT00805961|76108225|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
42276702|NCT00805961|76108225|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
42276703|NCT00805961|76108225|FG000|Maintenance Treatment|Withdrawn Consent|1|||
42276704|NCT02202538|76108229|FG000|Overall Study|Withdrawal by Subject|5|||
42350927|NCT02315703|76190764|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
42276705|NCT02202538|76108229|FG000|Overall Study|Did not meet all inclusion criteria|2|||
42276706|NCT02202538|76108229|FG000|Overall Study|Investigator Decision|1|||
42276707|NCT02454608|76108236|FG000|Double-Blind Period|Lack of Efficacy|0|||
42276708|NCT02454608|76108237|FG001|Double-Blind Period|Lack of Efficacy|2|||
42276709|NCT02454608|76108238|FG002|Double-Blind Period|Lack of Efficacy|0|||
42276710|NCT02454608|76108236|FG000|Open Label Period|Lost to Follow-up|0|||
42038992|NCT00824473|75847129|FG000|Overall Study|Lack of Efficacy|2|||
42038993|NCT00824473|75847130|FG001|Overall Study|Lack of Efficacy|2|||
42038994|NCT00824473|75847129|FG000|Overall Study|Protocol Violation|2|||
42038995|NCT00824473|75847130|FG001|Overall Study|Protocol Violation|0|||
42038996|NCT00824473|75847129|FG000|Overall Study|Non-Compliance|4|||
42038997|NCT00824473|75847130|FG001|Overall Study|Non-Compliance|2|||
42142602|NCT00386100|75952094|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
42142603|NCT00386100|75952095|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
42142604|NCT00386100|75952094|FG000|Overall Study|7.6% bone loss|1|||
42038998|NCT00824473|75847129|FG000|Overall Study|Withdrawal by Subject|2|||
42038999|NCT00824473|75847130|FG001|Overall Study|Withdrawal by Subject|3|||
42039000|NCT00824473|75847129|FG000|Overall Study|Other|1|||
42039001|NCT00824473|75847130|FG001|Overall Study|Other|1|||
42039002|NCT00815191|75847142|FG000|Overall Study|Protocol Violation|1|||
42039003|NCT00815191|75847143|FG001|Overall Study|Protocol Violation|1|||
42039004|NCT00812929|75847149|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
42039005|NCT00812929|75847150|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
42142605|NCT00386100|75952095|FG001|Overall Study|7.6% bone loss|0|||
42142606|NCT00386100|75952094|FG000|Overall Study|Osteoporosis|0|||
42142607|NCT00386100|75952095|FG001|Overall Study|Osteoporosis|1|||
42142608|NCT00386100|75952094|FG000|Overall Study|Positive pregnancy test|1|||
42142609|NCT00386100|75952095|FG001|Overall Study|Positive pregnancy test|3|||
42142610|NCT00386100|75952094|FG000|Overall Study|Out of country for 5 months|1|||
42142611|NCT00386100|75952095|FG001|Overall Study|Out of country for 5 months|0|||
42142612|NCT00386100|75952094|FG000|Overall Study|Hb1Ac >8%|0|||
42142613|NCT00386100|75952095|FG001|Overall Study|Hb1Ac >8%|1|||
42039006|NCT00812929|75847151|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
42142614|NCT00386100|75952094|FG000|Overall Study|Participant randomized in error|1|||
42142615|NCT00386100|75952095|FG001|Overall Study|Participant randomized in error|0|||
42142616|NCT00300495|75952103|FG000|Overall Study|Protocol Violation|4|||
42142617|NCT00300495|75952104|FG001|Overall Study|Protocol Violation|1|||
42142618|NCT00386022|75952112|FG000|Plus Estrogen|Lost to Follow-up|2|||
42142619|NCT00386022|75952113|FG001|Plus Estrogen|Lost to Follow-up|0|||
42142620|NCT00386022|75952112|FG000|Plus Estrogen|Adverse Event|0|||
42142621|NCT00386022|75952113|FG001|Plus Estrogen|Adverse Event|1|||
42142622|NCT00286455|75952124|FG000|Overall Study|Hyperglycemia rescue|19|||
42142623|NCT00286455|75952125|FG001|Overall Study|Hyperglycemia rescue|13|||
42142624|NCT00286455|75952126|FG002|Overall Study|Hyperglycemia rescue|10|||
42142625|NCT00286455|75952124|FG000|Overall Study|Adverse Event|1|||
42142626|NCT00286455|75952125|FG001|Overall Study|Adverse Event|3|||
42142627|NCT00286455|75952126|FG002|Overall Study|Adverse Event|2|||
42142628|NCT00286455|75952124|FG000|Overall Study|Lost to Follow-up|0|||
42142629|NCT00286455|75952125|FG001|Overall Study|Lost to Follow-up|3|||
42142630|NCT00286455|75952126|FG002|Overall Study|Lost to Follow-up|3|||
42142631|NCT00286455|75952124|FG000|Overall Study|Physician Decision|3|||
42142632|NCT00286455|75952125|FG001|Overall Study|Physician Decision|0|||
42142633|NCT00286455|75952126|FG002|Overall Study|Physician Decision|2|||
42142634|NCT00286455|75952124|FG000|Overall Study|Protocol Violation|1|||
42142635|NCT00286455|75952125|FG001|Overall Study|Protocol Violation|1|||
42012268|NCT01307267|75819349|FG015|Overall Study|Lost to Follow-up|0|||
42012269|NCT01307267|75819350|FG016|Overall Study|Lost to Follow-up|0|||
42012270|NCT01307267|75819351|FG017|Overall Study|Lost to Follow-up|0|||
42012271|NCT01307267|75819352|FG018|Overall Study|Lost to Follow-up|0|||
42012272|NCT01307267|75819353|FG019|Overall Study|Lost to Follow-up|2|||
42012273|NCT01307267|75819354|FG020|Overall Study|Lost to Follow-up|0|||
42012274|NCT01307267|75819355|FG021|Overall Study|Lost to Follow-up|0|||
42012275|NCT01307267|75819356|FG022|Overall Study|Lost to Follow-up|0|||
42012276|NCT01307267|75819334|FG000|Overall Study|Withdrawal by Subject|0|||
42012277|NCT01307267|75819335|FG001|Overall Study|Withdrawal by Subject|0|||
42012278|NCT01307267|75819336|FG002|Overall Study|Withdrawal by Subject|0|||
42012279|NCT01307267|75819337|FG003|Overall Study|Withdrawal by Subject|0|||
42012280|NCT01307267|75819338|FG004|Overall Study|Withdrawal by Subject|0|||
42012281|NCT01307267|75819339|FG005|Overall Study|Withdrawal by Subject|1|||
42012282|NCT01307267|75819340|FG006|Overall Study|Withdrawal by Subject|0|||
42012283|NCT01307267|75819341|FG007|Overall Study|Withdrawal by Subject|1|||
42012284|NCT01307267|75819342|FG008|Overall Study|Withdrawal by Subject|5|||
42012285|NCT01307267|75819343|FG009|Overall Study|Withdrawal by Subject|1|||
42012286|NCT01307267|75819344|FG010|Overall Study|Withdrawal by Subject|1|||
42012287|NCT01307267|75819345|FG011|Overall Study|Withdrawal by Subject|1|||
42012288|NCT01307267|75819346|FG012|Overall Study|Withdrawal by Subject|0|||
42012289|NCT01307267|75819347|FG013|Overall Study|Withdrawal by Subject|0|||
42012290|NCT01307267|75819348|FG014|Overall Study|Withdrawal by Subject|0|||
42012291|NCT01307267|75819349|FG015|Overall Study|Withdrawal by Subject|0|||
42142636|NCT00286455|75952126|FG002|Overall Study|Protocol Violation|0|||
42142637|NCT00286455|75952124|FG000|Overall Study|Participant Non-compliance|1|||
42012292|NCT01307267|75819350|FG016|Overall Study|Withdrawal by Subject|0|||
42012293|NCT01307267|75819351|FG017|Overall Study|Withdrawal by Subject|0|||
42012294|NCT01307267|75819352|FG018|Overall Study|Withdrawal by Subject|0|||
42012295|NCT01307267|75819353|FG019|Overall Study|Withdrawal by Subject|3|||
42039007|NCT00812929|75847152|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
42142638|NCT00286455|75952125|FG001|Overall Study|Participant Non-compliance|0|||
42142639|NCT00286455|75952126|FG002|Overall Study|Participant Non-compliance|0|||
42142640|NCT00286455|75952124|FG000|Overall Study|Withdrawal by Subject|0|||
42142641|NCT00286455|75952125|FG001|Overall Study|Withdrawal by Subject|8|||
42142642|NCT00286455|75952126|FG002|Overall Study|Withdrawal by Subject|7|||
42142643|NCT00385944|75952136|FG000|1st Maintenance Dose Period|Physician Decision|1|||
42142644|NCT00385944|75952137|FG001|1st Maintenance Dose Period|Physician Decision|0|||
42142645|NCT00385944|75952138|FG002|1st Maintenance Dose Period|Physician Decision|0|||
42142646|NCT00385944|75952136|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
42142647|NCT00385944|75952137|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
42142648|NCT00385944|75952138|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
42142649|NCT00385944|75952136|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
42142650|NCT00385944|75952137|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
42142651|NCT00385944|75952138|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
42142652|NCT00385944|75952136|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
42142653|NCT00385944|75952137|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
42142654|NCT00385944|75952138|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
42142655|NCT00286221|75952157|FG000|Overall Study|Protocol Violation|2|||
42142656|NCT00286221|75952158|FG001|Overall Study|Protocol Violation|1|||
42142657|NCT00286221|75952159|FG002|Overall Study|Protocol Violation|6|||
42142658|NCT00286221|75952160|FG003|Overall Study|Protocol Violation|4|||
42142659|NCT00286221|75952157|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
42142660|NCT00286221|75952158|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
42142661|NCT00286221|75952159|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
42142662|NCT00286221|75952160|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
42142663|NCT00286221|75952157|FG000|Overall Study|Inability to trigger PCA|2|||
42142664|NCT00286221|75952158|FG001|Overall Study|Inability to trigger PCA|0|||
42142665|NCT00286221|75952159|FG002|Overall Study|Inability to trigger PCA|0|||
42142666|NCT00286221|75952160|FG003|Overall Study|Inability to trigger PCA|0|||
42142667|NCT00286221|75952157|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
42142668|NCT00286221|75952158|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
42142669|NCT00286221|75952159|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
42142670|NCT00286221|75952160|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
42142671|NCT00285207|75952172|FG000|Overall Study|Lost to Follow-up|3|||
42142672|NCT00285207|75952173|FG001|Overall Study|Lost to Follow-up|2|||
42142673|NCT00285207|75952172|FG000|Overall Study|Withdrawal by Subject|5|||
42142674|NCT00285207|75952173|FG001|Overall Study|Withdrawal by Subject|2|||
42142675|NCT00285207|75952172|FG000|Overall Study|Pregnancy|1|||
42142676|NCT00285207|75952173|FG001|Overall Study|Pregnancy|1|||
42142677|NCT00285207|75952172|FG000|Overall Study|non-compliance|0|||
42142678|NCT00285207|75952173|FG001|Overall Study|non-compliance|1|||
42142679|NCT00398112|75952179|FG000|Overall Study|Adverse Event|4|||
42142680|NCT00398112|75952179|FG000|Overall Study|Disease progression|9|||
42142681|NCT00398112|75952179|FG000|Overall Study|Alternative treatment|1|||
42142682|NCT00398112|75952179|FG000|Overall Study|Withdrawal by Subject|3|||
42142683|NCT00398112|75952179|FG000|Overall Study|Death|1|||
42142684|NCT00424346|75952187|FG000|Core Study|Adverse Event|5|||
42142685|NCT00424346|75952188|FG001|Core Study|Adverse Event|3|||
42142686|NCT00424346|75952189|FG002|Core Study|Adverse Event|1|||
42142687|NCT00424346|75952190|FG003|Core Study|Adverse Event|1|||
42142688|NCT00424346|75952187|FG000|Core Study|Abnormal Laboratory Values|0|||
42142689|NCT00424346|75952188|FG001|Core Study|Abnormal Laboratory Values|1|||
42142690|NCT00424346|75952189|FG002|Core Study|Abnormal Laboratory Values|0|||
42142691|NCT00424346|75952190|FG003|Core Study|Abnormal Laboratory Values|0|||
42142692|NCT00424346|75952187|FG000|Core Study|Lack of Efficacy|1|||
42142693|NCT00424346|75952188|FG001|Core Study|Lack of Efficacy|3|||
42142694|NCT00424346|75952189|FG002|Core Study|Lack of Efficacy|0|||
42276711|NCT02454608|76108237|FG001|Open Label Period|Lost to Follow-up|0|||
42276712|NCT02454608|76108238|FG002|Open Label Period|Lost to Follow-up|11|||
42276713|NCT02454608|76108236|FG000|Open Label Period|Withdrawal by Subject|0|||
42276714|NCT02454608|76108237|FG001|Open Label Period|Withdrawal by Subject|0|||
42012296|NCT01307267|75819354|FG020|Overall Study|Withdrawal by Subject|0|||
42012297|NCT01307267|75819355|FG021|Overall Study|Withdrawal by Subject|0|||
42012298|NCT01307267|75819356|FG022|Overall Study|Withdrawal by Subject|0|||
42012299|NCT01307267|75819334|FG000|Overall Study|Other|0|||
42012300|NCT01307267|75819335|FG001|Overall Study|Other|0|||
42012301|NCT01307267|75819336|FG002|Overall Study|Other|0|||
42012302|NCT01307267|75819337|FG003|Overall Study|Other|0|||
42012303|NCT01307267|75819338|FG004|Overall Study|Other|0|||
42012304|NCT01307267|75819339|FG005|Overall Study|Other|7|||
42012305|NCT01307267|75819340|FG006|Overall Study|Other|0|||
42012306|NCT01307267|75819341|FG007|Overall Study|Other|1|||
42142695|NCT00424346|75952190|FG003|Core Study|Lack of Efficacy|4|||
42276715|NCT02454608|76108238|FG002|Open Label Period|Withdrawal by Subject|8|||
42142696|NCT00424346|75952187|FG000|Core Study|Withdrawal by Subject|1|||
42012307|NCT01307267|75819342|FG008|Overall Study|Other|3|||
42142697|NCT00424346|75952188|FG001|Core Study|Withdrawal by Subject|0|||
42142698|NCT00424346|75952189|FG002|Core Study|Withdrawal by Subject|0|||
42142699|NCT00424346|75952190|FG003|Core Study|Withdrawal by Subject|2|||
42012308|NCT01307267|75819343|FG009|Overall Study|Other|0|||
42012309|NCT01307267|75819344|FG010|Overall Study|Other|1|||
42142700|NCT00424346|75952187|FG000|Core Study|Lost to Follow-up|1|||
42142701|NCT00424346|75952188|FG001|Core Study|Lost to Follow-up|1|||
42142702|NCT00424346|75952189|FG002|Core Study|Lost to Follow-up|0|||
42142703|NCT00424346|75952190|FG003|Core Study|Lost to Follow-up|0|||
42142704|NCT00424346|75952187|FG000|Core Study|Administrative Problems|1|||
42039008|NCT00812929|75847153|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
42039009|NCT00812929|75847154|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
42039010|NCT00812929|75847155|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
42142705|NCT00424346|75952188|FG001|Core Study|Administrative Problems|0|||
42142706|NCT00424346|75952189|FG002|Core Study|Administrative Problems|1|||
42142707|NCT00424346|75952190|FG003|Core Study|Administrative Problems|0|||
42142708|NCT00424346|75952187|FG000|Core Study|Protocol Violation|0|||
42142709|NCT00424346|75952188|FG001|Core Study|Protocol Violation|0|||
42142710|NCT00424346|75952189|FG002|Core Study|Protocol Violation|2|||
42142711|NCT00424346|75952190|FG003|Core Study|Protocol Violation|0|||
42142712|NCT00424346|75952187|FG000|Extension Phase|Adverse Event|0|||
42142713|NCT00424346|75952188|FG001|Extension Phase|Adverse Event|9|||
42142714|NCT00424346|75952189|FG002|Extension Phase|Adverse Event|5|||
42142715|NCT00424346|75952190|FG003|Extension Phase|Adverse Event|4|||
42142716|NCT00424346|75952187|FG000|Extension Phase|Lack of Efficacy|0|||
42142717|NCT00424346|75952188|FG001|Extension Phase|Lack of Efficacy|16|||
42142718|NCT00424346|75952189|FG002|Extension Phase|Lack of Efficacy|14|||
42142719|NCT00424346|75952190|FG003|Extension Phase|Lack of Efficacy|11|||
42142720|NCT00424346|75952187|FG000|Extension Phase|Withdrawal by Subject|0|||
42142721|NCT00424346|75952188|FG001|Extension Phase|Withdrawal by Subject|5|||
42142722|NCT00424346|75952189|FG002|Extension Phase|Withdrawal by Subject|3|||
42142723|NCT00424346|75952190|FG003|Extension Phase|Withdrawal by Subject|4|||
42142724|NCT00424346|75952187|FG000|Extension Phase|Lost to Follow-up|0|||
42142725|NCT00424346|75952188|FG001|Extension Phase|Lost to Follow-up|2|||
42039011|NCT00812929|75847156|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
42039012|NCT00812929|75847157|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
42039013|NCT00812929|75847158|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
42142726|NCT00424346|75952189|FG002|Extension Phase|Lost to Follow-up|0|||
42142727|NCT00424346|75952190|FG003|Extension Phase|Lost to Follow-up|0|||
42142728|NCT00424346|75952187|FG000|Extension Phase|Administrative Problems|0|||
42142729|NCT00424346|75952188|FG001|Extension Phase|Administrative Problems|69|||
42142730|NCT00424346|75952189|FG002|Extension Phase|Administrative Problems|32|||
42142731|NCT00424346|75952190|FG003|Extension Phase|Administrative Problems|35|||
42142732|NCT00424346|75952187|FG000|Extension Phase|Death|0|||
42142733|NCT00424346|75952188|FG001|Extension Phase|Death|0|||
42142734|NCT00424346|75952189|FG002|Extension Phase|Death|0|||
42142735|NCT00424346|75952190|FG003|Extension Phase|Death|1|||
42142736|NCT00424346|75952187|FG000|Extension Phase|Protocol Violation|0|||
42142737|NCT00424346|75952188|FG001|Extension Phase|Protocol Violation|1|||
42142738|NCT00424346|75952189|FG002|Extension Phase|Protocol Violation|1|||
42142739|NCT00424346|75952190|FG003|Extension Phase|Protocol Violation|0|||
42142740|NCT00283959|75952203|FG000|Extension Period|Low Compliance|1|||
42142741|NCT00372528|75952207|FG000|Overall Study|Lack of Efficacy|1|||
42142742|NCT00372528|75952207|FG000|Overall Study|Adverse Event|1|||
42142743|NCT00372528|75952207|FG000|Overall Study|Study Terminated by Sponsor|18|||
42142744|NCT00372528|75952207|FG000|Overall Study|Other|1|||
42142745|NCT00283803|75952211|FG000|Overall Study|Physician Decision|9|||
42142746|NCT00283803|75952211|FG000|Overall Study|Withdrawal by Subject|4|||
42142747|NCT00397488|75952215|FG000|Overall Study|Withdrawal by Subject|3|||
42142748|NCT00397488|75952215|FG000|Overall Study|Adverse Event|3|||
42142749|NCT00397488|75952215|FG000|Overall Study|Death|1|||
42142750|NCT00424190|75952221|FG000|Overall Study|Withdrew consent|3|||
42039014|NCT00812929|75847149|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
42039015|NCT00812929|75847150|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
42039016|NCT00812929|75847151|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
42142751|NCT00424190|75952222|FG001|Overall Study|Withdrew consent|4|||
42142752|NCT00424190|75952221|FG000|Overall Study|Death|3|||
42039017|NCT00812929|75847152|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
42142753|NCT00424190|75952222|FG001|Overall Study|Death|0|||
42142754|NCT00424190|75952221|FG000|Overall Study|Noncompliance|1|||
42142755|NCT00424190|75952222|FG001|Overall Study|Noncompliance|2|||
42142756|NCT00424190|75952221|FG000|Overall Study|Request of sponsor or investigator|0|||
42142757|NCT00424190|75952222|FG001|Overall Study|Request of sponsor or investigator|2|||
42142758|NCT00424190|75952221|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
42142759|NCT00424190|75952222|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
42142760|NCT00424190|75952221|FG000|Overall Study|Other|15|||
42142761|NCT00424190|75952222|FG001|Overall Study|Other|21|||
42142762|NCT00428246|75952231|FG000|Overall Study|Withdrawal by Subject|0|||
42142763|NCT00428246|75952232|FG001|Overall Study|Withdrawal by Subject|0|||
42142764|NCT00428246|75952233|FG002|Overall Study|Withdrawal by Subject|1|||
42142765|NCT00428246|75952231|FG000|Overall Study|Adverse Event|1|||
42142766|NCT00428246|75952232|FG001|Overall Study|Adverse Event|0|||
42142767|NCT00428246|75952233|FG002|Overall Study|Adverse Event|0|||
42142768|NCT00274287|75952241|FG000|Overall Study|Withdrawal by Subject|1|||
42142769|NCT00274287|75952241|FG000|Overall Study|subject non-compliance|1|||
42142770|NCT00423800|75952248|FG000|Overall Study|Protocol Violation|0|||
42142771|NCT00423800|75952249|FG001|Overall Study|Protocol Violation|1|||
42142772|NCT00405548|75952258|FG000|Overall Study|Cognitive Memory problems on study day|1|||
42142773|NCT00405548|75952259|FG001|Overall Study|Cognitive Memory problems on study day|0|||
42142774|NCT00405548|75952258|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
42142775|NCT00405548|75952259|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
42142776|NCT00405548|75952258|FG000|Overall Study|Unable to self-administer shots|1|||
42142777|NCT00405548|75952259|FG001|Overall Study|Unable to self-administer shots|0|||
42142778|NCT00405548|75952258|FG000|Overall Study|Venous access failed during study day|1|||
42142779|NCT00405548|75952259|FG001|Overall Study|Venous access failed during study day|0|||
42142780|NCT00405548|75952258|FG000|Overall Study|Withdrawal by Subject|1|||
42142781|NCT00405548|75952259|FG001|Overall Study|Withdrawal by Subject|0|||
42142782|NCT00405392|75952267|FG000|Overall Study|Adverse Event|15|||
42142783|NCT00405392|75952268|FG001|Overall Study|Adverse Event|14|||
42142784|NCT00405392|75952267|FG000|Overall Study|Did not meet Eligibility criteria|7|||
42142785|NCT00405392|75952268|FG001|Overall Study|Did not meet Eligibility criteria|2|||
42142786|NCT00405392|75952267|FG000|Overall Study|Withdrawal by Subject|4|||
42142787|NCT00405392|75952268|FG001|Overall Study|Withdrawal by Subject|3|||
42142788|NCT00405392|75952267|FG000|Overall Study|Lost to Follow-up|1|||
42142789|NCT00405392|75952268|FG001|Overall Study|Lost to Follow-up|2|||
42142790|NCT00405392|75952267|FG000|Overall Study|Data missing|2|||
42142791|NCT00405392|75952268|FG001|Overall Study|Data missing|0|||
42142792|NCT00405392|75952267|FG000|Overall Study|Non-compliance|0|||
42142793|NCT00405392|75952268|FG001|Overall Study|Non-compliance|1|||
42142794|NCT00405392|75952267|FG000|Overall Study|Other|1|||
42142795|NCT00405392|75952268|FG001|Overall Study|Other|5|||
42142796|NCT00282243|75952274|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
42142797|NCT00282243|75952274|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
42142798|NCT00282243|75952274|FG000|Extension Treatment Period|Adverse Event|15|||
42142799|NCT00282243|75952274|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
42142800|NCT00282243|75952274|FG000|Extension Treatment Period|Non-compliance|2|||
42142801|NCT00282243|75952274|FG000|Extension Treatment Period|Physician Decision|1|||
42142802|NCT00272961|75952283|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
42142803|NCT00272961|75952284|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
42142804|NCT00272961|75952285|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
42142805|NCT00272961|75952286|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
42142806|NCT00272961|75952287|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
42142807|NCT00272961|75952283|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
42142808|NCT00272961|75952284|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
42142809|NCT00272961|75952285|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
42142810|NCT00272961|75952286|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
42142811|NCT00272961|75952287|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
42142812|NCT00272961|75952283|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
42142813|NCT00272961|75952284|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
42142814|NCT00272961|75952285|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
42142815|NCT00272961|75952286|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
42142816|NCT00272961|75952287|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
42142817|NCT00272961|75952283|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
42142818|NCT00272961|75952284|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
42142819|NCT00272961|75952285|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
42142820|NCT00272961|75952286|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
42142821|NCT00272961|75952287|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
42142822|NCT00272961|75952283|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
42142823|NCT00272961|75952284|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
42142824|NCT00272961|75952285|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
42142825|NCT00272961|75952286|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
42142826|NCT00272961|75952287|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
42142827|NCT00272961|75952283|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
42142828|NCT00272961|75952284|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
42142829|NCT00272961|75952285|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
42142830|NCT00272961|75952286|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
42142831|NCT00272961|75952287|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
42142832|NCT00272961|75952283|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
42142833|NCT00272961|75952284|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
42142834|NCT00272961|75952285|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
42142835|NCT00272961|75952286|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
42142836|NCT00272961|75952287|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
42142837|NCT00272961|75952283|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
42142838|NCT00272961|75952284|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
42142839|NCT00272961|75952285|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
42142840|NCT00272961|75952286|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
42142841|NCT00272961|75952287|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
42142842|NCT00282087|75952299|FG000|Overall Study|Death|1|||
42142843|NCT00404924|75952306|FG000|Overall Study|Adverse Event|75|||
42142844|NCT00404924|75952307|FG001|Overall Study|Adverse Event|16|||
42142845|NCT00404924|75952306|FG000|Overall Study|Condition under investigation worsened|475|||
42142846|NCT00404924|75952307|FG001|Overall Study|Condition under investigation worsened|264|||
42142847|NCT00404924|75952306|FG000|Overall Study|Lost to Follow-up|1|||
42142848|NCT00404924|75952307|FG001|Overall Study|Lost to Follow-up|1|||
42142849|NCT00404924|75952306|FG000|Overall Study|Withdrawal by Subject|26|||
42142850|NCT00404924|75952307|FG001|Overall Study|Withdrawal by Subject|13|||
42142851|NCT00404924|75952306|FG000|Overall Study|Other|25|||
42142852|NCT00404924|75952307|FG001|Overall Study|Other|11|||
42142853|NCT00404924|75952306|FG000|Overall Study|Randomised but not received treatment|1|||
42142854|NCT00404924|75952307|FG001|Overall Study|Randomised but not received treatment|1|||
42142855|NCT00281697|75952315|FG000|Overall Study|> 60 days since last dose of study drug|4|||
42142856|NCT00281697|75952316|FG001|Overall Study|> 60 days since last dose of study drug|4|||
42142857|NCT00281697|75952315|FG000|Overall Study|Adverse Event|54|||
42142858|NCT00281697|75952316|FG001|Overall Study|Adverse Event|15|||
42142859|NCT00281697|75952315|FG000|Overall Study|Death|8|||
42142860|NCT00281697|75952316|FG001|Overall Study|Death|3|||
42142861|NCT00281697|75952315|FG000|Overall Study|Disease progression|279|||
42142862|NCT00281697|75952316|FG001|Overall Study|Disease progression|149|||
42142863|NCT00281697|75952315|FG000|Overall Study|Other|5|||
42142864|NCT00281697|75952316|FG001|Overall Study|Other|6|||
42142865|NCT00281697|75952315|FG000|Overall Study|Physician's decision to withdraw|15|||
42142866|NCT00281697|75952316|FG001|Overall Study|Physician's decision to withdraw|12|||
42142867|NCT00281697|75952315|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
42142868|NCT00281697|75952316|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
42142869|NCT00281697|75952315|FG000|Overall Study|Did not receive study drug|3|||
42142870|NCT00281697|75952316|FG001|Overall Study|Did not receive study drug|2|||
42142871|NCT00271947|75952322|FG000|Overall Study|Lost to Follow-up|1|||
42142872|NCT00232180|75952328|FG000|Double-blind (DB) Phase|Death|186|||
42142873|NCT00232180|75952329|FG001|Double-blind (DB) Phase|Death|222|||
42142874|NCT00232180|75952330|FG002|Double-blind (DB) Phase|Death|0|||
42142875|NCT00232180|75952328|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
42142876|NCT00232180|75952329|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
42142877|NCT00232180|75952330|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
42142878|NCT00232180|75952328|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
42142879|NCT00232180|75952329|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
42142880|NCT00232180|75952330|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
42142881|NCT00232180|75952328|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
42142882|NCT00232180|75952329|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
42142883|NCT00232180|75952330|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
42142884|NCT00232180|75952328|FG000|Double-blind (DB) Phase|Adverse Event|83|||
42142885|NCT00232180|75952329|FG001|Double-blind (DB) Phase|Adverse Event|100|||
42142886|NCT00232180|75952330|FG002|Double-blind (DB) Phase|Adverse Event|0|||
42142887|NCT00232180|75952328|FG000|Double-blind (DB) Phase|Other|70|||
42142888|NCT00232180|75952329|FG001|Double-blind (DB) Phase|Other|75|||
42142889|NCT00232180|75952330|FG002|Double-blind (DB) Phase|Other|0|||
42142890|NCT00232180|75952328|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
42142891|NCT00232180|75952329|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
42142892|NCT00232180|75952330|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
42142893|NCT00232180|75952328|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
42012310|NCT01307267|75819345|FG011|Overall Study|Other|1|||
42012311|NCT01307267|75819346|FG012|Overall Study|Other|1|||
42012312|NCT01307267|75819347|FG013|Overall Study|Other|0|||
42012313|NCT01307267|75819348|FG014|Overall Study|Other|2|||
42012314|NCT01307267|75819349|FG015|Overall Study|Other|1|||
42012315|NCT01307267|75819350|FG016|Overall Study|Other|0|||
42012316|NCT01307267|75819351|FG017|Overall Study|Other|0|||
42012317|NCT01307267|75819352|FG018|Overall Study|Other|0|||
42012318|NCT01307267|75819353|FG019|Overall Study|Other|19|||
42012319|NCT01307267|75819354|FG020|Overall Study|Other|2|||
42012320|NCT01307267|75819355|FG021|Overall Study|Other|3|||
42142894|NCT00232180|75952329|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
42142895|NCT00232180|75952330|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
42142896|NCT00232180|75952328|FG000|Open Label Phase|Death|0|||
42142897|NCT00232180|75952329|FG001|Open Label Phase|Death|0|||
42142898|NCT00232180|75952330|FG002|Open Label Phase|Death|48|||
42142899|NCT00232180|75952328|FG000|Open Label Phase|Lost to Follow-up|0|||
42142900|NCT00232180|75952329|FG001|Open Label Phase|Lost to Follow-up|0|||
42142901|NCT00232180|75952330|FG002|Open Label Phase|Lost to Follow-up|5|||
42142902|NCT00232180|75952328|FG000|Open Label Phase|Protocol Violation|0|||
42142903|NCT00232180|75952329|FG001|Open Label Phase|Protocol Violation|0|||
42142904|NCT00232180|75952330|FG002|Open Label Phase|Protocol Violation|3|||
42142905|NCT00232180|75952328|FG000|Open Label Phase|Study terminated by sponsor|0|||
42142906|NCT00232180|75952329|FG001|Open Label Phase|Study terminated by sponsor|0|||
42142907|NCT00232180|75952330|FG002|Open Label Phase|Study terminated by sponsor|3|||
42142908|NCT00232180|75952328|FG000|Open Label Phase|Withdrawal by Subject|0|||
42142909|NCT00232180|75952329|FG001|Open Label Phase|Withdrawal by Subject|0|||
42142910|NCT00232180|75952330|FG002|Open Label Phase|Withdrawal by Subject|37|||
42142911|NCT00232180|75952328|FG000|Open Label Phase|Other|0|||
42142912|NCT00232180|75952329|FG001|Open Label Phase|Other|0|||
42142913|NCT00232180|75952330|FG002|Open Label Phase|Other|16|||
42142914|NCT00232180|75952328|FG000|Open Label Phase|Adverse Event|0|||
42142915|NCT00232180|75952329|FG001|Open Label Phase|Adverse Event|0|||
42142916|NCT00232180|75952330|FG002|Open Label Phase|Adverse Event|25|||
42142917|NCT00232180|75952328|FG000|Open Label Phase|Laboratory abnormality|0|||
42142918|NCT00232180|75952329|FG001|Open Label Phase|Laboratory abnormality|0|||
42142919|NCT00232180|75952330|FG002|Open Label Phase|Laboratory abnormality|10|||
42142920|NCT00232180|75952328|FG000|Open Label Phase|Randomized but not treated|0|||
42142921|NCT00232180|75952329|FG001|Open Label Phase|Randomized but not treated|0|||
42142922|NCT00232180|75952330|FG002|Open Label Phase|Randomized but not treated|1|||
42142923|NCT00280683|75952341|FG000|Overall Study|Withdrawal by Subject|1|||
42142924|NCT00280683|75952342|FG001|Overall Study|Withdrawal by Subject|2|||
42142925|NCT00280683|75952341|FG000|Overall Study|Adverse Event|1|||
42142926|NCT00280683|75952342|FG001|Overall Study|Adverse Event|1|||
42142927|NCT00270855|75952352|FG000|Overall Study|Withdrawal by Subject|8|||
42142928|NCT00270855|75952353|FG001|Overall Study|Withdrawal by Subject|8|||
42142929|NCT00404768|75952365|FG000|Part A and B|Withdrawn due to labor progression|1|||
42142930|NCT00404768|75952366|FG001|Part A and B|Withdrawn due to labor progression|0|||
42142931|NCT00404768|75952367|FG002|Part A and B|Withdrawn due to labor progression|0|||
42142932|NCT00404768|75952368|FG003|Part A and B|Withdrawn due to labor progression|0|||
42142933|NCT00404768|75952365|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
42142934|NCT00404768|75952366|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
42142935|NCT00404768|75952367|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
42142936|NCT00404768|75952368|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
42142937|NCT00404768|75952365|FG000|Part C|Adverse Event|0|||
42142938|NCT00404768|75952366|FG001|Part C|Adverse Event|0|||
42142939|NCT00404768|75952367|FG002|Part C|Adverse Event|0|||
42142940|NCT00404768|75952368|FG003|Part C|Adverse Event|3|||
42142941|NCT00404768|75952365|FG000|Part C|Lost to Follow-up|0|||
42142942|NCT00404768|75952366|FG001|Part C|Lost to Follow-up|0|||
42142943|NCT00404768|75952367|FG002|Part C|Lost to Follow-up|3|||
42142944|NCT00404768|75952368|FG003|Part C|Lost to Follow-up|1|||
42142945|NCT00404768|75952365|FG000|Part C|Withdrawal by Subject|0|||
42142946|NCT00404768|75952366|FG001|Part C|Withdrawal by Subject|0|||
42142947|NCT00404768|75952367|FG002|Part C|Withdrawal by Subject|2|||
42142948|NCT00404768|75952368|FG003|Part C|Withdrawal by Subject|1|||
42142949|NCT00404768|75952365|FG000|Part C|Early withdrawal from study medication|0|||
42142950|NCT00404768|75952366|FG001|Part C|Early withdrawal from study medication|0|||
42142951|NCT00404768|75952367|FG002|Part C|Early withdrawal from study medication|1|||
42142952|NCT00404768|75952368|FG003|Part C|Early withdrawal from study medication|0|||
42142953|NCT00404768|75952365|FG000|Part C|Participant did not respond to therapy|0|||
42142954|NCT00404768|75952366|FG001|Part C|Participant did not respond to therapy|0|||
42142955|NCT00404768|75952367|FG002|Part C|Participant did not respond to therapy|1|||
42142956|NCT00404768|75952368|FG003|Part C|Participant did not respond to therapy|1|||
42142957|NCT00404768|75952365|FG000|Part C|Physician withdrew the study medication|0|||
42142958|NCT00404768|75952366|FG001|Part C|Physician withdrew the study medication|0|||
42142959|NCT00404768|75952367|FG002|Part C|Physician withdrew the study medication|1|||
42142960|NCT00404768|75952368|FG003|Part C|Physician withdrew the study medication|0|||
42142961|NCT00404768|75952365|FG000|Part C|Participant delivered baby|0|||
42142962|NCT00404768|75952366|FG001|Part C|Participant delivered baby|0|||
42142963|NCT00404768|75952367|FG002|Part C|Participant delivered baby|0|||
42142964|NCT00404768|75952368|FG003|Part C|Participant delivered baby|1|||
42142965|NCT00404768|75952365|FG000|Part C|Unsatisfactory uterine response to IP|0|||
42142966|NCT00404768|75952366|FG001|Part C|Unsatisfactory uterine response to IP|0|||
42142967|NCT00404768|75952367|FG002|Part C|Unsatisfactory uterine response to IP|0|||
42142968|NCT00404768|75952368|FG003|Part C|Unsatisfactory uterine response to IP|1|||
42142969|NCT00404768|75952365|FG000|Part C|Active labor|0|||
42276716|NCT02246764|76108249|FG000|Overall Study|Adverse Event|15|||
42276717|NCT02246764|76108250|FG001|Overall Study|Adverse Event|29|||
42142970|NCT00404768|75952366|FG001|Part C|Active labor|0|||
42142971|NCT00404768|75952367|FG002|Part C|Active labor|0|||
42142972|NCT00404768|75952368|FG003|Part C|Active labor|1|||
42142973|NCT00404768|75952365|FG000|Part C|Lack of Efficacy|0|||
42142974|NCT00404768|75952366|FG001|Part C|Lack of Efficacy|0|||
42276718|NCT02246764|76108251|FG002|Overall Study|Adverse Event|1|||
42142975|NCT00404768|75952367|FG002|Part C|Lack of Efficacy|0|||
42142976|NCT00404768|75952368|FG003|Part C|Lack of Efficacy|2|||
42142977|NCT00404768|75952365|FG000|Part C|Treatment failure|0|||
42142978|NCT00404768|75952366|FG001|Part C|Treatment failure|0|||
42142979|NCT00404768|75952367|FG002|Part C|Treatment failure|0|||
42142980|NCT00404768|75952368|FG003|Part C|Treatment failure|1|||
42142981|NCT00404768|75952365|FG000|Part C|Investigator discretion|0|||
42142982|NCT00404768|75952366|FG001|Part C|Investigator discretion|0|||
42142983|NCT00404768|75952367|FG002|Part C|Investigator discretion|0|||
42142984|NCT00404768|75952368|FG003|Part C|Investigator discretion|1|||
42142985|NCT00404768|75952365|FG000|Part C|Researcher suspended study medication|0|||
42142986|NCT00404768|75952366|FG001|Part C|Researcher suspended study medication|0|||
42142987|NCT00404768|75952367|FG002|Part C|Researcher suspended study medication|0|||
42142988|NCT00404768|75952368|FG003|Part C|Researcher suspended study medication|1|||
42142989|NCT00270231|75952383|FG000|First Intervention|Lost to Follow-up|1|||
42142990|NCT00270231|75952384|FG001|First Intervention|Lost to Follow-up|1|||
42142991|NCT00270231|75952383|FG000|Washout Period|Lost to Follow-up|1|||
42142992|NCT00270231|75952384|FG001|Washout Period|Lost to Follow-up|0|||
42142993|NCT00270231|75952383|FG000|Second Intervention|Lost to Follow-up|0|||
42142994|NCT00270231|75952384|FG001|Second Intervention|Lost to Follow-up|1|||
42142995|NCT00258856|75952394|FG000|Overall Study|Lost to Follow-up|1|||
42142996|NCT00258856|75952395|FG001|Overall Study|Lost to Follow-up|0|||
42142997|NCT00258856|75952396|FG002|Overall Study|Lost to Follow-up|2|||
42142998|NCT00258856|75952397|FG003|Overall Study|Lost to Follow-up|0|||
42142999|NCT00258856|75952394|FG000|Overall Study|Non-compliance|2|||
42143000|NCT00258856|75952395|FG001|Overall Study|Non-compliance|0|||
42143001|NCT00258856|75952396|FG002|Overall Study|Non-compliance|0|||
42143002|NCT00258856|75952397|FG003|Overall Study|Non-compliance|1|||
42143003|NCT00269919|75952407|FG000|Overall Study|Other|26|||
42143004|NCT00269919|75952407|FG000|Overall Study|Started but not treated|1|||
42143005|NCT00258154|75952414|FG000|Overall Study|Adverse Event|1|||
42143006|NCT00258154|75952415|FG001|Overall Study|Adverse Event|0|||
42143007|NCT00258154|75952414|FG000|Overall Study|Lost to Follow-up|0|||
42143008|NCT00258154|75952415|FG001|Overall Study|Lost to Follow-up|1|||
42143009|NCT00258154|75952414|FG000|Overall Study|Protocol Violation|2|||
42143010|NCT00258154|75952415|FG001|Overall Study|Protocol Violation|1|||
42143011|NCT00258154|75952414|FG000|Overall Study|Withdrawal by Subject|3|||
42143012|NCT00258154|75952415|FG001|Overall Study|Withdrawal by Subject|4|||
42143013|NCT00258154|75952414|FG000|Overall Study|Patient Moved|3|||
42143014|NCT00258154|75952415|FG001|Overall Study|Patient Moved|1|||
42143015|NCT00257920|75952423|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
42143016|NCT00257920|75952424|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
42143017|NCT00257920|75952423|FG000|Period: Second Intervention|Other|2|||
42143018|NCT00257920|75952424|FG001|Period: Second Intervention|Other|1|||
42143019|NCT00268983|75952433|FG000|Overall Study|Death|3|||
42143020|NCT00268983|75952434|FG001|Overall Study|Death|0|||
42143021|NCT00257608|75952442|FG000|Chemotherapy Phase|Adverse Event|138|||
42143022|NCT00257608|75952443|FG001|Chemotherapy Phase|Adverse Event|0|||
42143023|NCT00257608|75952444|FG002|Chemotherapy Phase|Adverse Event|0|||
42143024|NCT00257608|75952442|FG000|Chemotherapy Phase|Disease progression|139|||
42143025|NCT00257608|75952443|FG001|Chemotherapy Phase|Disease progression|0|||
42143026|NCT00257608|75952444|FG002|Chemotherapy Phase|Disease progression|0|||
42143027|NCT00257608|75952442|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
42143028|NCT00257608|75952443|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
42143029|NCT00257608|75952444|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
42143030|NCT00257608|75952442|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
42143031|NCT00257608|75952443|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
42143032|NCT00257608|75952444|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
42276719|NCT02246764|76108249|FG000|Overall Study|Withdrawal by Subject|0|||
42143033|NCT00257608|75952442|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
42276720|NCT02246764|76108250|FG001|Overall Study|Withdrawal by Subject|0|||
42276721|NCT02246764|76108251|FG002|Overall Study|Withdrawal by Subject|1|||
42276722|NCT02246764|76108249|FG000|Overall Study|Disallowed Concomitant Medication|1|||
42276723|NCT02246764|76108250|FG001|Overall Study|Disallowed Concomitant Medication|0|||
42276724|NCT02246764|76108251|FG002|Overall Study|Disallowed Concomitant Medication|0|||
42276725|NCT02246764|76108249|FG000|Overall Study|Physician Decision|0|||
42143034|NCT00257608|75952443|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
42143035|NCT00257608|75952444|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
42143036|NCT00257608|75952442|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
42143037|NCT00257608|75952443|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
42143038|NCT00257608|75952444|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
42143039|NCT00257608|75952442|FG000|Chemotherapy Phase|Physician Decision|28|||
42143040|NCT00257608|75952443|FG001|Chemotherapy Phase|Physician Decision|0|||
42143041|NCT00257608|75952444|FG002|Chemotherapy Phase|Physician Decision|0|||
42143042|NCT00257608|75952442|FG000|Post Chemotherapy Phase|Adverse Event|0|||
42143043|NCT00257608|75952443|FG001|Post Chemotherapy Phase|Adverse Event|34|||
42276726|NCT02246764|76108250|FG001|Overall Study|Physician Decision|2|||
42143044|NCT00257608|75952444|FG002|Post Chemotherapy Phase|Adverse Event|38|||
42143045|NCT00257608|75952442|FG000|Post Chemotherapy Phase|Disease progression|0|||
42143046|NCT00257608|75952443|FG001|Post Chemotherapy Phase|Disease progression|204|||
42143047|NCT00257608|75952444|FG002|Post Chemotherapy Phase|Disease progression|168|||
42143048|NCT00257608|75952442|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
42143049|NCT00257608|75952443|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
42143050|NCT00257608|75952444|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
42143051|NCT00257608|75952442|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
42143052|NCT00257608|75952443|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
42143053|NCT00257608|75952444|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
42143054|NCT00257608|75952442|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
42143055|NCT00257608|75952443|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
42143056|NCT00257608|75952444|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
42143057|NCT00257608|75952442|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
42143058|NCT00257608|75952443|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
42143059|NCT00257608|75952444|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
42143060|NCT00257608|75952442|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
42143061|NCT00257608|75952443|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
42143062|NCT00257608|75952444|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
42143063|NCT00257608|75952442|FG000|Post Chemotherapy Phase|Physician Decision|0|||
42143064|NCT00257608|75952443|FG001|Post Chemotherapy Phase|Physician Decision|8|||
42143065|NCT00257608|75952444|FG002|Post Chemotherapy Phase|Physician Decision|11|||
42143066|NCT00257608|75952442|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
42143067|NCT00257608|75952443|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
42143068|NCT00257608|75952444|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
42143069|NCT00257608|75952442|FG000|Post Chemotherapy Phase|Not treated|0|||
42143070|NCT00257608|75952443|FG001|Post Chemotherapy Phase|Not treated|4|||
42143071|NCT00257608|75952444|FG002|Post Chemotherapy Phase|Not treated|7|||
42143072|NCT00231478|75952459|FG000|Overall Study|Protocol Violation|3|||
42143073|NCT00231478|75952460|FG001|Overall Study|Protocol Violation|2|||
42143074|NCT00231478|75952459|FG000|Overall Study|Refused Treatment|1|||
42143075|NCT00231478|75952460|FG001|Overall Study|Refused Treatment|1|||
42143076|NCT00231478|75952459|FG000|Overall Study|Withdrawal by Subject|1|||
42143077|NCT00231478|75952460|FG001|Overall Study|Withdrawal by Subject|0|||
42143078|NCT00231478|75952459|FG000|Overall Study|Adverse Event|0|||
42143079|NCT00231478|75952460|FG001|Overall Study|Adverse Event|1|||
42143080|NCT00231478|75952459|FG000|Overall Study|Administrative|3|||
42143081|NCT00231478|75952460|FG001|Overall Study|Administrative|2|||
42143082|NCT00413192|75952470|FG000|Overall Study|Disease progression|26|||
42143083|NCT00413192|75952471|FG001|Overall Study|Disease progression|31|||
42143084|NCT00413192|75952472|FG002|Overall Study|Disease progression|16|||
42143085|NCT00413192|75952473|FG003|Overall Study|Disease progression|25|||
42143086|NCT00413192|75952470|FG000|Overall Study|Toxicity|3|||
42143087|NCT00413192|75952471|FG001|Overall Study|Toxicity|2|||
42143088|NCT00413192|75952472|FG002|Overall Study|Toxicity|2|||
42143089|NCT00413192|75952473|FG003|Overall Study|Toxicity|2|||
42143090|NCT00413192|75952470|FG000|Overall Study|Withdrawal by Subject|3|||
42143091|NCT00413192|75952471|FG001|Overall Study|Withdrawal by Subject|5|||
42143092|NCT00413192|75952472|FG002|Overall Study|Withdrawal by Subject|0|||
42143093|NCT00413192|75952473|FG003|Overall Study|Withdrawal by Subject|1|||
42143094|NCT00413192|75952470|FG000|Overall Study|Intercurrent illness|0|||
42143095|NCT00413192|75952471|FG001|Overall Study|Intercurrent illness|0|||
42143096|NCT00413192|75952472|FG002|Overall Study|Intercurrent illness|0|||
42143097|NCT00413192|75952473|FG003|Overall Study|Intercurrent illness|1|||
42143098|NCT00413192|75952470|FG000|Overall Study|Intercurrent death|0|||
42143099|NCT00413192|75952471|FG001|Overall Study|Intercurrent death|1|||
42143100|NCT00413192|75952472|FG002|Overall Study|Intercurrent death|0|||
42143101|NCT00413192|75952473|FG003|Overall Study|Intercurrent death|0|||
42276727|NCT02246764|76108251|FG002|Overall Study|Physician Decision|1|||
42276728|NCT02246764|76108249|FG000|Overall Study|Protocol Violation|2|||
42276729|NCT02246764|76108250|FG001|Overall Study|Protocol Violation|1|||
42276730|NCT02246764|76108251|FG002|Overall Study|Protocol Violation|1|||
42276731|NCT02454530|76108261|FG000|Overall Study|Other|8|||
42276732|NCT02454530|76108262|FG001|Overall Study|Other|13|||
42276733|NCT02454530|76108261|FG000|Overall Study|Missing information|56|||
42276734|NCT02454530|76108262|FG001|Overall Study|Missing information|69|||
42276735|NCT02454530|76108261|FG000|Overall Study|Death|2|||
42276736|NCT02454530|76108262|FG001|Overall Study|Death|41|||
42276737|NCT02454530|76108261|FG000|Overall Study|Lost to Follow-up|4|||
42143102|NCT00413192|75952470|FG000|Overall Study|Other|5|||
42143103|NCT00413192|75952471|FG001|Overall Study|Other|1|||
42143104|NCT00413192|75952472|FG002|Overall Study|Other|1|||
42143105|NCT00413192|75952473|FG003|Overall Study|Other|2|||
42143106|NCT00413192|75952470|FG000|Overall Study|Not treated|0|||
42276738|NCT02454530|76108262|FG001|Overall Study|Lost to Follow-up|4|||
42276739|NCT02431676|76108272|FG000|Overall Study|no lab obtained|0|||
42012321|NCT01307267|75819356|FG022|Overall Study|Other|2|||
42039018|NCT00812929|75847153|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
42039019|NCT00812929|75847154|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
42039020|NCT00812929|75847155|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
42039021|NCT00812929|75847156|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
42039022|NCT00812929|75847157|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
42039023|NCT00812929|75847158|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
42039024|NCT00812929|75847149|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
42039025|NCT00812929|75847150|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
42039026|NCT00812929|75847151|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
42039027|NCT00812929|75847152|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
42039028|NCT00812929|75847153|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
42039029|NCT00812929|75847154|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
42039030|NCT00812929|75847155|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
42039031|NCT00812929|75847156|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
42039032|NCT00812929|75847157|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
42012322|NCT01307111|75819418|FG000|IUD Insertion|Lost to Follow-up|2|||
42012323|NCT01307111|75819419|FG001|IUD Insertion|Lost to Follow-up|0|||
42012324|NCT01307111|75819418|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
42012325|NCT01307111|75819419|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
42039033|NCT00812929|75847158|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
42039034|NCT00824161|75847175|FG000|Overall Study|Withdrawal by Subject|1|||
42039035|NCT00824161|75847175|FG000|Overall Study|Screen Failure|1|||
42039036|NCT00979134|75847184|FG000|Overall Study|Disease progression|18|||
42039037|NCT00979134|75847185|FG001|Overall Study|Disease progression|2|||
42039038|NCT00979134|75847186|FG002|Overall Study|Disease progression|5|||
42039039|NCT00979134|75847184|FG000|Overall Study|Adverse Event|0|||
42039040|NCT00979134|75847185|FG001|Overall Study|Adverse Event|0|||
42039041|NCT00979134|75847186|FG002|Overall Study|Adverse Event|2|||
42039042|NCT00979134|75847184|FG000|Overall Study|Withdrawal by Subject|1|||
42039043|NCT00979134|75847185|FG001|Overall Study|Withdrawal by Subject|1|||
42039044|NCT00979134|75847186|FG002|Overall Study|Withdrawal by Subject|2|||
42039045|NCT00979134|75847184|FG000|Overall Study|Lost to Follow-up|2|||
42039046|NCT00979134|75847185|FG001|Overall Study|Lost to Follow-up|2|||
42039047|NCT00979134|75847186|FG002|Overall Study|Lost to Follow-up|0|||
42039048|NCT00979134|75847184|FG000|Overall Study|Death|4|||
42039049|NCT00979134|75847185|FG001|Overall Study|Death|0|||
42276740|NCT02431676|76108273|FG001|Overall Study|no lab obtained|1|||
42012326|NCT01306877|75819427|FG000|Overall Study|Lost to Follow-up|3|||
42012327|NCT01306877|75819428|FG001|Overall Study|Lost to Follow-up|3|||
42012328|NCT01306877|75819427|FG000|Overall Study|Physician Decision|0|||
42012329|NCT01306877|75819428|FG001|Overall Study|Physician Decision|1|||
42012330|NCT01191801|75819436|FG000|Overall Study|Death|36|||
42012331|NCT01191801|75819437|FG001|Overall Study|Death|12|||
42012332|NCT01191801|75819436|FG000|Overall Study|Lack of Efficacy|176|||
42012333|NCT01191801|75819437|FG001|Overall Study|Lack of Efficacy|258|||
42012334|NCT01191801|75819436|FG000|Overall Study|Adverse Event|9|||
42012335|NCT01191801|75819437|FG001|Overall Study|Adverse Event|8|||
42012336|NCT01191801|75819436|FG000|Overall Study|Protocol Violation|2|||
42012337|NCT01191801|75819437|FG001|Overall Study|Protocol Violation|4|||
42012338|NCT01191801|75819436|FG000|Overall Study|Physician Decision|47|||
42039050|NCT00979134|75847186|FG002|Overall Study|Death|26|||
42039051|NCT00979134|75847184|FG000|Overall Study|Other|8|||
42039052|NCT00979134|75847185|FG001|Overall Study|Other|1|||
42039053|NCT00979134|75847186|FG002|Overall Study|Other|5|||
42276741|NCT02431676|76108274|FG002|Overall Study|no lab obtained|2|||
42276742|NCT01654250|76108284|FG000|Overall Study|Lost to Follow-up|1|||
42276743|NCT01654250|76108285|FG001|Overall Study|Lost to Follow-up|0|||
42276744|NCT01652690|76108294|FG000|Overall Study|Withdrawal by Subject|16|||
42276745|NCT01652690|76108295|FG001|Overall Study|Withdrawal by Subject|4|||
42276746|NCT01652690|76108294|FG000|Overall Study|Other|8|||
42276747|NCT01652690|76108295|FG001|Overall Study|Other|9|||
42276748|NCT01652690|76108294|FG000|Overall Study|Lost to Follow-up|6|||
42276749|NCT01652690|76108295|FG001|Overall Study|Lost to Follow-up|6|||
42276750|NCT01652690|76108294|FG000|Overall Study|Death|5|||
42276751|NCT01652690|76108295|FG001|Overall Study|Death|2|||
42276752|NCT02429258|76108303|FG000|Overall Study|Withdrawal by Subject|2|||
42276753|NCT02429258|76108304|FG001|Overall Study|Withdrawal by Subject|0|||
42276754|NCT02429258|76108303|FG000|Overall Study|Protocol Violation|0|||
42276755|NCT02429258|76108304|FG001|Overall Study|Protocol Violation|1|||
42276756|NCT02201524|76108314|FG000|Overall Study|Adverse Event|0|||
42012339|NCT01191801|75819437|FG001|Overall Study|Physician Decision|24|||
42012340|NCT01191801|75819436|FG000|Overall Study|Withdrawal by Subject|1|||
42012341|NCT01191801|75819437|FG001|Overall Study|Withdrawal by Subject|4|||
42012342|NCT01191801|75819436|FG000|Overall Study|Not Provided|45|||
42012343|NCT01191801|75819437|FG001|Overall Study|Not Provided|27|||
42039054|NCT00824005|75847201|FG000|Overall Study|Death|0|||
42039055|NCT00824005|75847202|FG001|Overall Study|Death|1|||
42276757|NCT02201524|76108315|FG001|Overall Study|Adverse Event|2|||
42276758|NCT02201524|76108316|FG002|Overall Study|Adverse Event|1|||
42143107|NCT00413192|75952471|FG001|Overall Study|Not treated|0|||
42143108|NCT00413192|75952472|FG002|Overall Study|Not treated|0|||
42143109|NCT00413192|75952473|FG003|Overall Study|Not treated|1|||
42143110|NCT00207142|75952486|FG000|Induction Phase|Adverse Event|9|||
42143111|NCT00207142|75952487|FG001|Induction Phase|Adverse Event|0|||
42143112|NCT00207142|75952488|FG002|Induction Phase|Adverse Event|0|||
42143113|NCT00207142|75952489|FG003|Induction Phase|Adverse Event|0|||
42143114|NCT00207142|75952486|FG000|Induction Phase|Death|1|||
42143115|NCT00207142|75952487|FG001|Induction Phase|Death|0|||
42143116|NCT00207142|75952488|FG002|Induction Phase|Death|0|||
42143117|NCT00207142|75952489|FG003|Induction Phase|Death|0|||
42143118|NCT00207142|75952486|FG000|Induction Phase|Lack of Efficacy|1|||
42143119|NCT00207142|75952487|FG001|Induction Phase|Lack of Efficacy|0|||
42143120|NCT00207142|75952488|FG002|Induction Phase|Lack of Efficacy|0|||
42143121|NCT00207142|75952489|FG003|Induction Phase|Lack of Efficacy|0|||
42143122|NCT00207142|75952486|FG000|Induction Phase|Lost to Follow-up|5|||
42143123|NCT00207142|75952487|FG001|Induction Phase|Lost to Follow-up|0|||
42143124|NCT00207142|75952488|FG002|Induction Phase|Lost to Follow-up|0|||
42143125|NCT00207142|75952489|FG003|Induction Phase|Lost to Follow-up|0|||
42143126|NCT00207142|75952486|FG000|Induction Phase|Physician Decision|2|||
42143127|NCT00207142|75952487|FG001|Induction Phase|Physician Decision|0|||
42143128|NCT00207142|75952488|FG002|Induction Phase|Physician Decision|0|||
42143129|NCT00207142|75952489|FG003|Induction Phase|Physician Decision|0|||
42143130|NCT00207142|75952486|FG000|Induction Phase|Poor/noncompliance|2|||
42143131|NCT00207142|75952487|FG001|Induction Phase|Poor/noncompliance|0|||
42143132|NCT00207142|75952488|FG002|Induction Phase|Poor/noncompliance|0|||
42143133|NCT00207142|75952489|FG003|Induction Phase|Poor/noncompliance|0|||
42143134|NCT00207142|75952486|FG000|Induction Phase|Pregnancy|1|||
42143135|NCT00207142|75952487|FG001|Induction Phase|Pregnancy|0|||
42143136|NCT00207142|75952488|FG002|Induction Phase|Pregnancy|0|||
42143137|NCT00207142|75952489|FG003|Induction Phase|Pregnancy|0|||
42143138|NCT00207142|75952486|FG000|Induction Phase|Subject no longer meets study criteria|3|||
42143139|NCT00207142|75952487|FG001|Induction Phase|Subject no longer meets study criteria|0|||
42143140|NCT00207142|75952488|FG002|Induction Phase|Subject no longer meets study criteria|0|||
42143141|NCT00207142|75952489|FG003|Induction Phase|Subject no longer meets study criteria|0|||
42143142|NCT00207142|75952486|FG000|Induction Phase|Withdrawal by Subject|4|||
42143143|NCT00207142|75952487|FG001|Induction Phase|Withdrawal by Subject|0|||
42143144|NCT00207142|75952488|FG002|Induction Phase|Withdrawal by Subject|0|||
42143145|NCT00207142|75952489|FG003|Induction Phase|Withdrawal by Subject|0|||
42143146|NCT00207142|75952486|FG000|Induction Phase|Incarceration|1|||
42143147|NCT00207142|75952487|FG001|Induction Phase|Incarceration|0|||
42143148|NCT00207142|75952488|FG002|Induction Phase|Incarceration|0|||
42143149|NCT00207142|75952489|FG003|Induction Phase|Incarceration|0|||
42143150|NCT00207142|75952486|FG000|Induction Phase|Missing lab data|1|||
42143151|NCT00207142|75952487|FG001|Induction Phase|Missing lab data|0|||
42143152|NCT00207142|75952488|FG002|Induction Phase|Missing lab data|0|||
42143153|NCT00207142|75952489|FG003|Induction Phase|Missing lab data|0|||
42143154|NCT00207142|75952486|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
42143155|NCT00207142|75952487|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
42143156|NCT00207142|75952488|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
42143157|NCT00207142|75952489|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
42143158|NCT00207142|75952486|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
42143159|NCT00207142|75952487|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
42143160|NCT00207142|75952488|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
42143161|NCT00207142|75952489|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
42143162|NCT00207142|75952486|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
42143163|NCT00207142|75952487|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
42143164|NCT00207142|75952488|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
42143165|NCT00207142|75952489|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
42143166|NCT00207142|75952486|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
42143167|NCT00207142|75952487|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
42143168|NCT00207142|75952488|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
42143169|NCT00207142|75952489|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
42143170|NCT00207142|75952486|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
42143171|NCT00207142|75952487|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
42143172|NCT00207142|75952488|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
42143173|NCT00207142|75952489|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
42143174|NCT00207142|75952486|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
42143175|NCT00207142|75952487|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
42143176|NCT00207142|75952488|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
42143177|NCT00207142|75952489|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
42143178|NCT00207142|75952486|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
42143179|NCT00207142|75952487|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
42143180|NCT00207142|75952488|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
42276759|NCT02201524|76108317|FG003|Overall Study|Adverse Event|0|||
42143181|NCT00207142|75952489|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
42143182|NCT00207142|75952486|FG000|Maintenance Phase/Rescue Phase|Death|0|||
42143183|NCT00207142|75952487|FG001|Maintenance Phase/Rescue Phase|Death|0|||
42143184|NCT00207142|75952488|FG002|Maintenance Phase/Rescue Phase|Death|0|||
42143185|NCT00207142|75952489|FG003|Maintenance Phase/Rescue Phase|Death|1|||
42143186|NCT00207142|75952486|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
42143187|NCT00207142|75952487|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
42143188|NCT00207142|75952488|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
42143189|NCT00207142|75952489|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
42143190|NCT00268905|75952507|FG000|Overall Study|Adverse Event|3|||
42143191|NCT00268905|75952508|FG001|Overall Study|Adverse Event|0|||
42143192|NCT00268905|75952509|FG002|Overall Study|Adverse Event|4|||
42143193|NCT00268905|75952507|FG000|Overall Study|Lost to Follow-up|0|||
42143194|NCT00268905|75952508|FG001|Overall Study|Lost to Follow-up|1|||
42143195|NCT00268905|75952509|FG002|Overall Study|Lost to Follow-up|0|||
42143196|NCT00268905|75952507|FG000|Overall Study|Withdrawal by Subject|0|||
42276760|NCT02201524|76108314|FG000|Overall Study|Insufficient clinical response|1|||
42143197|NCT00268905|75952508|FG001|Overall Study|Withdrawal by Subject|0|||
42143198|NCT00268905|75952509|FG002|Overall Study|Withdrawal by Subject|3|||
42143199|NCT00268905|75952507|FG000|Overall Study|Progressive Disease|28|||
42143200|NCT00268905|75952508|FG001|Overall Study|Progressive Disease|4|||
42143201|NCT00268905|75952509|FG002|Overall Study|Progressive Disease|3|||
42143202|NCT00268905|75952507|FG000|Overall Study|Physician Decision|3|||
42143203|NCT00268905|75952508|FG001|Overall Study|Physician Decision|0|||
42143204|NCT00268905|75952509|FG002|Overall Study|Physician Decision|1|||
42143205|NCT00268905|75952507|FG000|Overall Study|Clinical Progression|9|||
42143206|NCT00268905|75952508|FG001|Overall Study|Clinical Progression|4|||
42143207|NCT00268905|75952509|FG002|Overall Study|Clinical Progression|1|||
42143208|NCT00206518|75952519|FG000|Overall Study|Lack of Efficacy|6|||
42143209|NCT00206518|75952520|FG001|Overall Study|Lack of Efficacy|4|||
42143210|NCT00206518|75952519|FG000|Overall Study|Adverse Event|2|||
42143211|NCT00206518|75952520|FG001|Overall Study|Adverse Event|1|||
42143212|NCT00206518|75952519|FG000|Overall Study|Physician Decision|1|||
42143213|NCT00206518|75952520|FG001|Overall Study|Physician Decision|0|||
42143214|NCT00206518|75952519|FG000|Overall Study|Protocol Violation|1|||
42143215|NCT00206518|75952520|FG001|Overall Study|Protocol Violation|1|||
42143216|NCT00423722|75952528|FG000|Overall Study|Death|4|||
42143217|NCT00423722|75952529|FG001|Overall Study|Death|4|||
42143218|NCT00423722|75952528|FG000|Overall Study|Declined to participate|2|||
42143219|NCT00423722|75952529|FG001|Overall Study|Declined to participate|3|||
42143220|NCT00423722|75952528|FG000|Overall Study|Unable to complete questionnaires|4|||
42143221|NCT00423722|75952529|FG001|Overall Study|Unable to complete questionnaires|4|||
42143222|NCT00423722|75952528|FG000|Overall Study|Withdrawal by Subject|4|||
42143223|NCT00423722|75952529|FG001|Overall Study|Withdrawal by Subject|2|||
42143224|NCT00206440|75952543|FG000|Overall Study|Protocol Violation|1|||
42143225|NCT00206440|75952544|FG001|Overall Study|Protocol Violation|2|||
42143226|NCT00206440|75952543|FG000|Overall Study|Adverse Event|4|||
42276761|NCT02201524|76108315|FG001|Overall Study|Insufficient clinical response|0|||
42276762|NCT02201524|76108316|FG002|Overall Study|Insufficient clinical response|0|||
42276763|NCT02201524|76108317|FG003|Overall Study|Insufficient clinical response|0|||
42276764|NCT02201524|76108314|FG000|Overall Study|Lost to Follow-up|0|||
42276765|NCT02201524|76108315|FG001|Overall Study|Lost to Follow-up|0|||
42276766|NCT02201524|76108316|FG002|Overall Study|Lost to Follow-up|2|||
42276767|NCT02201524|76108317|FG003|Overall Study|Lost to Follow-up|0|||
42143227|NCT00206440|75952544|FG001|Overall Study|Adverse Event|2|||
42143228|NCT00268437|75952550|FG000|Overall Study|Ineligible|1|||
42276768|NCT02201524|76108314|FG000|Overall Study|No longer meets eligibility criteria|0|||
42276769|NCT02201524|76108315|FG001|Overall Study|No longer meets eligibility criteria|0|||
42276770|NCT02201524|76108316|FG002|Overall Study|No longer meets eligibility criteria|0|||
42276771|NCT02201524|76108317|FG003|Overall Study|No longer meets eligibility criteria|2|||
42276772|NCT02201524|76108314|FG000|Overall Study|Protocol Violation|0|||
42276773|NCT02201524|76108315|FG001|Overall Study|Protocol Violation|0|||
42276774|NCT02201524|76108316|FG002|Overall Study|Protocol Violation|0|||
42276775|NCT02201524|76108317|FG003|Overall Study|Protocol Violation|1|||
42143229|NCT00423488|75952557|FG000|Overall Study|No evidence of study drug intake|2|||
42143230|NCT00423488|75952558|FG001|Overall Study|No evidence of study drug intake|1|||
42143231|NCT00423488|75952557|FG000|Overall Study|No post baseline data|3|||
42143232|NCT00423488|75952558|FG001|Overall Study|No post baseline data|0|||
42143233|NCT00404066|75952564|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
42143234|NCT00404066|75952564|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
42143235|NCT00423332|75952570|FG000|Overall Study|Adverse Event|6|||
42143236|NCT00423332|75952571|FG001|Overall Study|Adverse Event|2|||
42143237|NCT00423332|75952570|FG000|Overall Study|Withdrawal by Subject|1|||
42143238|NCT00423332|75952571|FG001|Overall Study|Withdrawal by Subject|0|||
42276776|NCT02201524|76108314|FG000|Overall Study|Withdrawal by Subject|0|||
42276777|NCT02201524|76108315|FG001|Overall Study|Withdrawal by Subject|0|||
42143239|NCT00423332|75952570|FG000|Overall Study|Condition under investigation worsened|1|||
42143240|NCT00423332|75952571|FG001|Overall Study|Condition under investigation worsened|1|||
42143241|NCT00423332|75952570|FG000|Overall Study|Progressive at Week 6|0|||
42143242|NCT00423332|75952571|FG001|Overall Study|Progressive at Week 6|1|||
42143243|NCT00423332|75952570|FG000|Overall Study|Unblinded before 12 weeks|1|||
42143244|NCT00423332|75952571|FG001|Overall Study|Unblinded before 12 weeks|3|||
42143245|NCT00413036|75952578|FG000|Overall Study|Adverse Event|44|||
42143246|NCT00413036|75952578|FG000|Overall Study|Lack of Efficacy|129|||
42143247|NCT00413036|75952578|FG000|Overall Study|Withdrawal by Subject|7|||
42143248|NCT00413036|75952578|FG000|Overall Study|Death|9|||
42143249|NCT00413036|75952578|FG000|Overall Study|Other|26|||
42143250|NCT00413036|75952578|FG000|Overall Study|Missing|2|||
42143251|NCT00412958|75952586|FG000|Overall Study|Withdrawal by Subject|3|||
42143252|NCT00412958|75952587|FG001|Overall Study|Withdrawal by Subject|0|||
42143253|NCT00412958|75952588|FG002|Overall Study|Withdrawal by Subject|0|||
42143254|NCT00412958|75952589|FG003|Overall Study|Withdrawal by Subject|1|||
42143255|NCT00412958|75952586|FG000|Overall Study|Adverse Event|0|||
42143256|NCT00412958|75952587|FG001|Overall Study|Adverse Event|1|||
42143257|NCT00412958|75952588|FG002|Overall Study|Adverse Event|0|||
42143258|NCT00412958|75952589|FG003|Overall Study|Adverse Event|0|||
42143259|NCT00412958|75952586|FG000|Overall Study|Lost to Follow-up|0|||
42143260|NCT00412958|75952587|FG001|Overall Study|Lost to Follow-up|1|||
42143261|NCT00412958|75952588|FG002|Overall Study|Lost to Follow-up|0|||
42143262|NCT00412958|75952589|FG003|Overall Study|Lost to Follow-up|0|||
42143263|NCT00412958|75952586|FG000|Overall Study|Death|0|||
42143264|NCT00412958|75952587|FG001|Overall Study|Death|1|||
42143265|NCT00412958|75952588|FG002|Overall Study|Death|0|||
42143266|NCT00412958|75952589|FG003|Overall Study|Death|0|||
42143267|NCT00412958|75952586|FG000|Overall Study|Transport issue|0|||
42143268|NCT00412958|75952587|FG001|Overall Study|Transport issue|1|||
42276778|NCT02201524|76108316|FG002|Overall Study|Withdrawal by Subject|1|||
42350928|NCT02315703|76190765|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
42350929|NCT02315703|76190766|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
42350930|NCT02315703|76190767|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
42350931|NCT02315703|76190768|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
42350932|NCT02315703|76190769|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
42350933|NCT02315703|76190770|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
42350934|NCT02315703|76190763|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
42350935|NCT02315703|76190764|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
42350936|NCT02315703|76190765|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
42350937|NCT02315703|76190766|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
42350938|NCT02315703|76190767|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
42350939|NCT02315703|76190768|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
42350940|NCT02315703|76190769|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
42039056|NCT00824005|75847201|FG000|Overall Study|Lost to Follow-up|0|||
42039057|NCT00824005|75847202|FG001|Overall Study|Lost to Follow-up|1|||
42039058|NCT00814879|75847210|FG000|By Week 24|Cancer Diagnosis|1|||
42039059|NCT00814879|75847211|FG001|By Week 24|Cancer Diagnosis|0|||
42143269|NCT00412958|75952588|FG002|Overall Study|Transport issue|0|||
42276779|NCT02201524|76108317|FG003|Overall Study|Withdrawal by Subject|1|||
42276780|NCT02201524|76108314|FG000|Overall Study|Other|1|||
42276781|NCT02201524|76108315|FG001|Overall Study|Other|1|||
42276782|NCT02201524|76108316|FG002|Overall Study|Other|0|||
42276783|NCT02201524|76108317|FG003|Overall Study|Other|0|||
42276784|NCT02453048|76108332|FG000|Overall Study|Only part of initial 6 mo. study|0|||
42276785|NCT02453048|76108333|FG001|Overall Study|Only part of initial 6 mo. study|0|||
42276786|NCT02453048|76108334|FG002|Overall Study|Only part of initial 6 mo. study|0|||
42276787|NCT02453048|76108335|FG003|Overall Study|Only part of initial 6 mo. study|0|||
42276788|NCT02453048|76108336|FG004|Overall Study|Only part of initial 6 mo. study|6|||
42276789|NCT02453048|76108332|FG000|Overall Study|Lost to Follow-up|0|||
42276790|NCT02453048|76108333|FG001|Overall Study|Lost to Follow-up|1|||
42276791|NCT02453048|76108334|FG002|Overall Study|Lost to Follow-up|2|||
42276792|NCT02453048|76108335|FG003|Overall Study|Lost to Follow-up|0|||
42350941|NCT02315703|76190770|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
42350942|NCT02049359|76190790|FG000|Overall Study|Lost to Follow-up|26|||
42350943|NCT02049359|76190791|FG001|Overall Study|Lost to Follow-up|19|||
42039060|NCT00814879|75847210|FG000|By Week 24|Incarceration|0|||
42143270|NCT00412958|75952589|FG003|Overall Study|Transport issue|0|||
42143271|NCT00423176|75952601|FG000|Overall Study|Adverse Event|4|||
42143272|NCT00423176|75952602|FG001|Overall Study|Adverse Event|6|||
42143273|NCT00423176|75952601|FG000|Overall Study|Treatment Failure|1|||
42143274|NCT00423176|75952602|FG001|Overall Study|Treatment Failure|6|||
42276793|NCT02453048|76108336|FG004|Overall Study|Lost to Follow-up|0|||
42276794|NCT02137252|76108350|FG000|Overall Study|trial terminated early|2|||
42276795|NCT02137252|76108351|FG001|Overall Study|trial terminated early|1|||
42276796|NCT02201290|76108357|FG000|Overall Study|Withdrawal by Subject|2|||
42276797|NCT02201290|76108357|FG000|Overall Study|Lack of Efficacy|2|||
42276798|NCT02201290|76108357|FG000|Overall Study|Adverse Event|1|||
42350944|NCT01698905|76190821|FG000|Overall Study|Adverse Event|4|||
42012344|NCT01306643|75819443|FG000|Overall Study|Adverse Event|5|||
42012345|NCT01306643|75819443|FG000|Overall Study|Disease Progression|7|||
42012346|NCT01306643|75819443|FG000|Overall Study|Other: Change in Eligibility Status|1|||
42012347|NCT01306331|75819449|FG000|Overall Study|Adverse Event|28|||
42012348|NCT01306331|75819450|FG001|Overall Study|Adverse Event|25|||
42012349|NCT01306331|75819449|FG000|Overall Study|Lost to Follow-up|321|||
42012350|NCT01306331|75819450|FG001|Overall Study|Lost to Follow-up|323|||
42012351|NCT01306331|75819449|FG000|Overall Study|Physician Decision|26|||
42012352|NCT01306331|75819450|FG001|Overall Study|Physician Decision|22|||
42012353|NCT01306331|75819449|FG000|Overall Study|Pregnancy|136|||
42012354|NCT01306331|75819450|FG001|Overall Study|Pregnancy|151|||
42012355|NCT01306331|75819449|FG000|Overall Study|Protocol Violation|154|||
42012356|NCT01306331|75819450|FG001|Overall Study|Protocol Violation|124|||
42012357|NCT01306331|75819449|FG000|Overall Study|Withdrawal by Subject|163|||
42012358|NCT01306331|75819450|FG001|Overall Study|Withdrawal by Subject|152|||
42012359|NCT01306331|75819449|FG000|Overall Study|Not sexually active|29|||
42143275|NCT00423176|75952601|FG000|Overall Study|Lost to Follow-up|4|||
42143276|NCT00423176|75952602|FG001|Overall Study|Lost to Follow-up|7|||
42143277|NCT00423176|75952601|FG000|Overall Study|Withdrawal by Subject|4|||
42143278|NCT00423176|75952602|FG001|Overall Study|Withdrawal by Subject|3|||
42143279|NCT00423176|75952601|FG000|Overall Study|Protocol Violation|1|||
42143280|NCT00423176|75952602|FG001|Overall Study|Protocol Violation|3|||
42143281|NCT00423176|75952601|FG000|Overall Study|Did not meet protocol eligibility|2|||
42143282|NCT00423176|75952602|FG001|Overall Study|Did not meet protocol eligibility|4|||
42143283|NCT00412880|75952608|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
42143284|NCT00412880|75952608|FG000|Overall Study|Consent withdrawn|1|||
42143285|NCT00412880|75952608|FG000|Overall Study|Adverse Event|1|||
42143286|NCT00412880|75952608|FG000|Overall Study|Progressive disease|20|||
42143287|NCT00268203|75952612|FG000|Overall Study|Lost to Follow-up|92|||
42143288|NCT00268203|75952612|FG000|Overall Study|Withdrawal by Subject|9|||
42143289|NCT00268203|75952612|FG000|Overall Study|Received Other NHL Therapy|7|||
42143290|NCT00268203|75952612|FG000|Overall Study|Progressive Disease|359|||
42143291|NCT00268203|75952612|FG000|Overall Study|Death|84|||
42143292|NCT00268203|75952612|FG000|Overall Study|Reason Not Specified|34|||
42143293|NCT00268203|75952612|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
42143294|NCT00384930|75952621|FG000|Overall Study|Adverse Event|5|||
42143295|NCT00384930|75952622|FG001|Overall Study|Adverse Event|4|||
42143296|NCT00384930|75952623|FG002|Overall Study|Adverse Event|12|||
42143297|NCT00384930|75952624|FG003|Overall Study|Adverse Event|11|||
42143298|NCT00384930|75952625|FG004|Overall Study|Adverse Event|14|||
42143299|NCT00384930|75952621|FG000|Overall Study|Entry Criteria Not Met|2|||
42143300|NCT00384930|75952622|FG001|Overall Study|Entry Criteria Not Met|6|||
42143301|NCT00384930|75952623|FG002|Overall Study|Entry Criteria Not Met|7|||
42143302|NCT00384930|75952624|FG003|Overall Study|Entry Criteria Not Met|8|||
42143303|NCT00384930|75952625|FG004|Overall Study|Entry Criteria Not Met|4|||
42276799|NCT02200510|76108363|FG000|Overall Study|Death|1|||
42276800|NCT02200510|76108364|FG001|Overall Study|Death|1|||
42276801|NCT02200510|76108363|FG000|Overall Study|Protocol Violation|0|||
42276802|NCT02200510|76108364|FG001|Overall Study|Protocol Violation|1|||
42276803|NCT02200510|76108363|FG000|Overall Study|Lost to Follow-up|7|||
42276804|NCT02200510|76108364|FG001|Overall Study|Lost to Follow-up|1|||
42276805|NCT02200510|76108363|FG000|Overall Study|potential COI - joined study team|1|||
42276806|NCT02200510|76108364|FG001|Overall Study|potential COI - joined study team|0|||
42276807|NCT02452892|76108374|FG000|Week 1 Initial Randommization|Adverse Event|1|||
42276808|NCT02452892|76108375|FG001|Week 1 Initial Randommization|Adverse Event|0|||
42276809|NCT02452892|76108376|FG002|Week 1 Initial Randommization|Adverse Event|0|||
42276810|NCT02452892|76108377|FG003|Week 1 Initial Randommization|Adverse Event|0|||
42350945|NCT01698905|76190821|FG000|Overall Study|Physician Decision|2|||
42012360|NCT01306331|75819450|FG001|Overall Study|Not sexually active|28|||
42012361|NCT01306331|75819449|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
42012362|NCT01306331|75819450|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
42012363|NCT01306331|75819449|FG000|Overall Study|Other|34|||
42012364|NCT01306331|75819450|FG001|Overall Study|Other|32|||
42012365|NCT01306253|75819458|FG000|Overall Study|Lost to Follow-up|1|||
42143304|NCT00384930|75952621|FG000|Overall Study|Lack of Efficacy|1|||
42143305|NCT00384930|75952622|FG001|Overall Study|Lack of Efficacy|1|||
42143306|NCT00384930|75952623|FG002|Overall Study|Lack of Efficacy|2|||
42143307|NCT00384930|75952624|FG003|Overall Study|Lack of Efficacy|1|||
42143308|NCT00384930|75952625|FG004|Overall Study|Lack of Efficacy|2|||
42143309|NCT00384930|75952621|FG000|Overall Study|Lost to Follow-up|5|||
42143310|NCT00384930|75952622|FG001|Overall Study|Lost to Follow-up|3|||
42143311|NCT00384930|75952623|FG002|Overall Study|Lost to Follow-up|0|||
42143312|NCT00384930|75952624|FG003|Overall Study|Lost to Follow-up|4|||
42276811|NCT02452892|76108374|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
42276812|NCT02452892|76108375|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
42276813|NCT02452892|76108376|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
42276814|NCT02452892|76108377|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
42143313|NCT00384930|75952625|FG004|Overall Study|Lost to Follow-up|6|||
42143314|NCT00384930|75952621|FG000|Overall Study|Physician Decision|0|||
42143315|NCT00384930|75952622|FG001|Overall Study|Physician Decision|1|||
42143316|NCT00384930|75952623|FG002|Overall Study|Physician Decision|1|||
42143317|NCT00384930|75952624|FG003|Overall Study|Physician Decision|0|||
42143318|NCT00384930|75952625|FG004|Overall Study|Physician Decision|1|||
42143319|NCT00384930|75952621|FG000|Overall Study|Protocol Violation|1|||
42143320|NCT00384930|75952622|FG001|Overall Study|Protocol Violation|0|||
42143321|NCT00384930|75952623|FG002|Overall Study|Protocol Violation|1|||
42143322|NCT00384930|75952624|FG003|Overall Study|Protocol Violation|6|||
42143323|NCT00384930|75952625|FG004|Overall Study|Protocol Violation|4|||
42143324|NCT00384930|75952621|FG000|Overall Study|Sponsor Decision|3|||
42143325|NCT00384930|75952622|FG001|Overall Study|Sponsor Decision|4|||
42143326|NCT00384930|75952623|FG002|Overall Study|Sponsor Decision|0|||
42143327|NCT00384930|75952624|FG003|Overall Study|Sponsor Decision|5|||
42143328|NCT00384930|75952625|FG004|Overall Study|Sponsor Decision|0|||
42143329|NCT00384930|75952621|FG000|Overall Study|Withdrawal by Subject|9|||
42143330|NCT00384930|75952622|FG001|Overall Study|Withdrawal by Subject|7|||
42143331|NCT00384930|75952623|FG002|Overall Study|Withdrawal by Subject|7|||
42143332|NCT00384930|75952624|FG003|Overall Study|Withdrawal by Subject|6|||
42143333|NCT00384930|75952625|FG004|Overall Study|Withdrawal by Subject|16|||
42143334|NCT00384930|75952621|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
42143335|NCT00384930|75952622|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
42143336|NCT00384930|75952623|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
42143337|NCT00384930|75952624|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
42143338|NCT00384930|75952625|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
42143339|NCT00423098|75952642|FG000|Overall Study|Adverse Event|1|||
42143340|NCT00423098|75952643|FG001|Overall Study|Adverse Event|2|||
42143341|NCT00423098|75952642|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42143342|NCT00423098|75952643|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
42143343|NCT00423098|75952642|FG000|Overall Study|Administrative problems|0|||
42143344|NCT00423098|75952643|FG001|Overall Study|Administrative problems|1|||
42143345|NCT00423098|75952642|FG000|Overall Study|Death|2|||
42143346|NCT00423098|75952643|FG001|Overall Study|Death|0|||
42143347|NCT00750698|75952651|FG000|Overall Study|Withdrawal by Subject|1|||
42143348|NCT00750698|75952652|FG001|Overall Study|Withdrawal by Subject|0|||
42143349|NCT00750698|75952651|FG000|Overall Study|Progressive disease|5|||
42143350|NCT00750698|75952652|FG001|Overall Study|Progressive disease|2|||
42143351|NCT00411788|75952658|FG000|Overall Study|Protocol Violation|1|||
42143352|NCT00411788|75952658|FG000|Overall Study|Adverse Event|1|||
42143353|NCT00422942|75952662|FG000|Overall Study|Study terminated by Sponsor|3|||
42143354|NCT00422162|75952668|FG000|Overall Study|Adverse Event|11|||
42143355|NCT00422162|75952669|FG001|Overall Study|Adverse Event|9|||
42143356|NCT00422162|75952668|FG000|Overall Study|Lack of Efficacy|4|||
42143357|NCT00422162|75952669|FG001|Overall Study|Lack of Efficacy|10|||
42143358|NCT00422162|75952668|FG000|Overall Study|Withdrawal by Subject|7|||
42143359|NCT00422162|75952669|FG001|Overall Study|Withdrawal by Subject|6|||
42143360|NCT00422162|75952668|FG000|Overall Study|Lost to Follow-up|1|||
42143361|NCT00422162|75952669|FG001|Overall Study|Lost to Follow-up|2|||
42143362|NCT00422162|75952668|FG000|Overall Study|Non-Compliant with Protocol|1|||
42143363|NCT00422162|75952669|FG001|Overall Study|Non-Compliant with Protocol|1|||
42143364|NCT00422162|75952668|FG000|Overall Study|Other|0|||
42143365|NCT00422162|75952669|FG001|Overall Study|Other|1|||
42143366|NCT00422162|75952668|FG000|Overall Study|Didn't Receive Treatment|0|||
42143367|NCT00422162|75952669|FG001|Overall Study|Didn't Receive Treatment|1|||
42143368|NCT00411632|75952685|FG000|Overall Study|Death|1|||
42143369|NCT00422084|75952691|FG000|Overall Study|Adverse Event|21|||
42143370|NCT00422084|75952692|FG001|Overall Study|Adverse Event|7|||
42143371|NCT00422084|75952691|FG000|Overall Study|Withdrawal by Subject|12|||
42143372|NCT00422084|75952692|FG001|Overall Study|Withdrawal by Subject|9|||
42143373|NCT00422084|75952691|FG000|Overall Study|Lost to Follow-up|14|||
42143374|NCT00422084|75952692|FG001|Overall Study|Lost to Follow-up|9|||
42012366|NCT01306253|75819459|FG001|Overall Study|Lost to Follow-up|1|||
42012367|NCT01305941|75819465|FG000|Overall Study|Adverse Event|6|||
42012368|NCT01305941|75819465|FG000|Overall Study|Clinical decline|2|||
42012369|NCT01305941|75819465|FG000|Overall Study|Withdrawal by Subject|1|||
42012370|NCT01305941|75819465|FG000|Overall Study|Death|1|||
42143375|NCT00422084|75952691|FG000|Overall Study|Protocol Violation|4|||
42143376|NCT00422084|75952692|FG001|Overall Study|Protocol Violation|1|||
42143377|NCT00422084|75952691|FG000|Overall Study|Lack of Efficacy|40|||
42143378|NCT00422084|75952692|FG001|Overall Study|Lack of Efficacy|42|||
42012371|NCT01305239|75819469|FG000|Overall Study|Adverse Event|22|||
42012372|NCT01305239|75819469|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
42012373|NCT01194219|75819475|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
42143379|NCT00422084|75952691|FG000|Overall Study|P. vivax infection|3|||
42143380|NCT00422084|75952692|FG001|Overall Study|P. vivax infection|6|||
42143381|NCT00422084|75952691|FG000|Overall Study|Cyesis|1|||
42143382|NCT00422084|75952692|FG001|Overall Study|Cyesis|0|||
42143383|NCT00422084|75952691|FG000|Overall Study|Withdrawn from study accidentally|1|||
42143384|NCT00422084|75952692|FG001|Overall Study|Withdrawn from study accidentally|0|||
42143385|NCT00422084|75952691|FG000|Overall Study|Non-compliance|1|||
42143386|NCT00422084|75952692|FG001|Overall Study|Non-compliance|0|||
42143387|NCT00422084|75952691|FG000|Overall Study|Re-location|0|||
42143388|NCT00422084|75952692|FG001|Overall Study|Re-location|1|||
42143389|NCT00422084|75952691|FG000|Overall Study|Not defined|1|||
42143390|NCT00422084|75952692|FG001|Overall Study|Not defined|1|||
42143391|NCT00421928|75952701|FG000|Overall Study|Adverse Event|61|||
42143392|NCT00421928|75952702|FG001|Overall Study|Adverse Event|140|||
42143393|NCT00421928|75952703|FG002|Overall Study|Adverse Event|22|||
42143394|NCT00421928|75952701|FG000|Overall Study|Lost to Follow-up|5|||
42143395|NCT00421928|75952702|FG001|Overall Study|Lost to Follow-up|0|||
42143396|NCT00421928|75952703|FG002|Overall Study|Lost to Follow-up|3|||
42039061|NCT00814879|75847211|FG001|By Week 24|Incarceration|1|||
42039062|NCT00814879|75847210|FG000|By Week 48|Lost to Follow-up|2|||
42039063|NCT00814879|75847211|FG001|By Week 48|Lost to Follow-up|2|||
42039064|NCT00814879|75847210|FG000|By Week 48|Death|0|||
42039065|NCT00814879|75847211|FG001|By Week 48|Death|1|||
42039066|NCT03347422|75847220|FG000|Part A (26 Weeks)|Adverse Event|3|||
42039067|NCT03347422|75847221|FG001|Part A (26 Weeks)|Adverse Event|0|||
42039068|NCT03347422|75847220|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
42143397|NCT00421928|75952701|FG000|Overall Study|Withdrawal by Subject|50|||
42143398|NCT00421928|75952702|FG001|Overall Study|Withdrawal by Subject|48|||
42143399|NCT00421928|75952703|FG002|Overall Study|Withdrawal by Subject|43|||
42143400|NCT00421928|75952701|FG000|Overall Study|Lack of Efficacy|15|||
42143401|NCT00421928|75952702|FG001|Overall Study|Lack of Efficacy|7|||
42143402|NCT00421928|75952703|FG002|Overall Study|Lack of Efficacy|35|||
42143403|NCT00421928|75952701|FG000|Overall Study|Study drug non-compliant|6|||
42143404|NCT00421928|75952702|FG001|Overall Study|Study drug non-compliant|7|||
42143405|NCT00421928|75952703|FG002|Overall Study|Study drug non-compliant|4|||
42143406|NCT00421928|75952701|FG000|Overall Study|All other|26|||
42143407|NCT00421928|75952702|FG001|Overall Study|All other|21|||
42143408|NCT00421928|75952703|FG002|Overall Study|All other|27|||
42143409|NCT00421928|75952701|FG000|Overall Study|Death|0|||
42143410|NCT00421928|75952702|FG001|Overall Study|Death|1|||
42143411|NCT00421928|75952703|FG002|Overall Study|Death|0|||
42143412|NCT00383292|75952714|FG000|Overall Study|Adverse Event|4|||
42143413|NCT00383292|75952715|FG001|Overall Study|Adverse Event|1|||
42143414|NCT00383292|75952716|FG002|Overall Study|Adverse Event|2|||
42143415|NCT00383292|75952714|FG000|Overall Study|Death|3|||
42143416|NCT00383292|75952715|FG001|Overall Study|Death|3|||
42143417|NCT00383292|75952716|FG002|Overall Study|Death|3|||
42143418|NCT00383292|75952714|FG000|Overall Study|Physician Decision|4|||
42143419|NCT00383292|75952715|FG001|Overall Study|Physician Decision|0|||
42143420|NCT00383292|75952716|FG002|Overall Study|Physician Decision|1|||
42143421|NCT00383292|75952714|FG000|Overall Study|Withdrawal by Subject|3|||
42276815|NCT02452892|76108374|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
42276816|NCT02452892|76108375|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
42350946|NCT01698905|76190821|FG000|Overall Study|Pregnancy|1|||
42012374|NCT01194219|75819476|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
42012375|NCT01194219|75819477|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
42012376|NCT01194219|75819478|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
42012377|NCT01194219|75819479|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
42012378|NCT01194219|75819480|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
42012379|NCT01194219|75819481|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
42012380|NCT01194219|75819482|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
42012381|NCT01194219|75819483|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
42012382|NCT01194219|75819484|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
42012383|NCT01194219|75819475|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
42012384|NCT01194219|75819476|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
42012385|NCT01194219|75819477|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
42012386|NCT01194219|75819478|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
42012387|NCT01194219|75819479|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
42012388|NCT01194219|75819480|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
42012389|NCT01194219|75819481|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
42012390|NCT01194219|75819482|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
42012391|NCT01194219|75819483|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
42012392|NCT01194219|75819484|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
42012393|NCT01194219|75819475|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
42039069|NCT03347422|75847221|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
42039070|NCT03347422|75847220|FG000|Part B (149 Weeks)|Adverse Event|0|||
42039071|NCT03347422|75847221|FG001|Part B (149 Weeks)|Adverse Event|1|||
42039072|NCT03347422|75847220|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
42143422|NCT00383292|75952715|FG001|Overall Study|Withdrawal by Subject|2|||
42143423|NCT00383292|75952716|FG002|Overall Study|Withdrawal by Subject|2|||
42143424|NCT00383292|75952714|FG000|Overall Study|Other|1|||
42143425|NCT00383292|75952715|FG001|Overall Study|Other|0|||
42143426|NCT00383292|75952716|FG002|Overall Study|Other|0|||
42143427|NCT00372060|75952727|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
42276817|NCT02452892|76108376|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
42143428|NCT00372060|75952728|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
42143429|NCT00372060|75952727|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
42143430|NCT00372060|75952728|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
42143431|NCT00372060|75952727|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
42143432|NCT00372060|75952728|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
42143433|NCT00372060|75952727|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
42143434|NCT00372060|75952728|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
42143435|NCT00372060|75952727|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
42143436|NCT00372060|75952728|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
42143437|NCT00372060|75952727|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
42143438|NCT00372060|75952728|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
42143439|NCT00421304|75952740|FG000|Overall Study|Lost to Follow-up|5|||
42143440|NCT00421304|75952741|FG001|Overall Study|Lost to Follow-up|2|||
42143441|NCT00421304|75952742|FG002|Overall Study|Lost to Follow-up|5|||
42143442|NCT00421304|75952740|FG000|Overall Study|Withdrawal by Subject|2|||
42143443|NCT00421304|75952741|FG001|Overall Study|Withdrawal by Subject|2|||
42143444|NCT00421304|75952742|FG002|Overall Study|Withdrawal by Subject|2|||
42143445|NCT00421304|75952740|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
42143446|NCT00421304|75952741|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
42143447|NCT00421304|75952742|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
42143448|NCT00421304|75952740|FG000|Overall Study|Did not attend Day 360 visit|0|||
42143449|NCT00421304|75952741|FG001|Overall Study|Did not attend Day 360 visit|0|||
42143450|NCT00421304|75952742|FG002|Overall Study|Did not attend Day 360 visit|1|||
42143451|NCT00396630|75952754|FG000|Overall Study|Lost to Follow-up|1|||
42143452|NCT00396630|75952755|FG001|Overall Study|Lost to Follow-up|1|||
42143453|NCT00396630|75952754|FG000|Overall Study|Withdrawal by Subject|1|||
42143454|NCT00396630|75952755|FG001|Overall Study|Withdrawal by Subject|1|||
42143455|NCT00396630|75952754|FG000|Overall Study|Not vaccinated at Visit 3|3|||
42143456|NCT00396630|75952755|FG001|Overall Study|Not vaccinated at Visit 3|3|||
42143457|NCT00396318|75952762|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
42143458|NCT00396162|75952768|FG000|Overall Study|Withdrawal by Subject|2|||
42143459|NCT00396162|75952769|FG001|Overall Study|Withdrawal by Subject|3|||
42143460|NCT00381888|75952779|FG000|Overall Study|Death|1|||
42143461|NCT00381888|75952779|FG000|Overall Study|Withdrawal by Subject|1|||
42143462|NCT00381888|75952779|FG000|Overall Study|Physician Decision|1|||
42143463|NCT00381888|75952779|FG000|Overall Study|Protocol Violation|9|||
42143464|NCT00381888|75952779|FG000|Overall Study|Had laparoscopic surgery|2|||
42143465|NCT00381888|75952779|FG000|Overall Study|Surgery was cancelled|2|||
42143466|NCT00381888|75952779|FG000|Overall Study|Adverse Event|1|||
42143467|NCT00267969|75952786|FG000|Controlled Period|Adverse Event|6|||
42143468|NCT00267969|75952787|FG001|Controlled Period|Adverse Event|0|||
42143469|NCT00267969|75952788|FG002|Controlled Period|Adverse Event|2|||
42143470|NCT00267969|75952789|FG003|Controlled Period|Adverse Event|0|||
42143471|NCT00267969|75952790|FG004|Controlled Period|Adverse Event|0|||
42143472|NCT00267969|75952791|FG005|Controlled Period|Adverse Event|0|||
42143473|NCT00267969|75952792|FG006|Controlled Period|Adverse Event|0|||
42143474|NCT00267969|75952786|FG000|Controlled Period|Lack of Efficacy|3|||
42143475|NCT00267969|75952787|FG001|Controlled Period|Lack of Efficacy|0|||
42143476|NCT00267969|75952788|FG002|Controlled Period|Lack of Efficacy|1|||
42143477|NCT00267969|75952789|FG003|Controlled Period|Lack of Efficacy|0|||
42143478|NCT00267969|75952790|FG004|Controlled Period|Lack of Efficacy|0|||
42143479|NCT00267969|75952791|FG005|Controlled Period|Lack of Efficacy|0|||
42143480|NCT00267969|75952792|FG006|Controlled Period|Lack of Efficacy|0|||
42143481|NCT00267969|75952786|FG000|Controlled Period|Lost to Follow-up|1|||
42143482|NCT00267969|75952787|FG001|Controlled Period|Lost to Follow-up|0|||
42143483|NCT00267969|75952788|FG002|Controlled Period|Lost to Follow-up|1|||
42143484|NCT00267969|75952789|FG003|Controlled Period|Lost to Follow-up|0|||
42143485|NCT00267969|75952790|FG004|Controlled Period|Lost to Follow-up|0|||
42143486|NCT00267969|75952791|FG005|Controlled Period|Lost to Follow-up|0|||
42143487|NCT00267969|75952792|FG006|Controlled Period|Lost to Follow-up|0|||
42143488|NCT00267969|75952786|FG000|Controlled Period|Randomized but not treated|0|||
42143489|NCT00267969|75952787|FG001|Controlled Period|Randomized but not treated|0|||
42143490|NCT00267969|75952788|FG002|Controlled Period|Randomized but not treated|1|||
42143491|NCT00267969|75952789|FG003|Controlled Period|Randomized but not treated|0|||
42143492|NCT00267969|75952790|FG004|Controlled Period|Randomized but not treated|0|||
42143493|NCT00267969|75952791|FG005|Controlled Period|Randomized but not treated|0|||
42143494|NCT00267969|75952792|FG006|Controlled Period|Randomized but not treated|0|||
42143495|NCT00267969|75952786|FG000|Controlled Period|Other|2|||
42143496|NCT00267969|75952787|FG001|Controlled Period|Other|1|||
42143497|NCT00267969|75952788|FG002|Controlled Period|Other|6|||
42143498|NCT00267969|75952789|FG003|Controlled Period|Other|0|||
42143499|NCT00267969|75952790|FG004|Controlled Period|Other|0|||
42143500|NCT00267969|75952791|FG005|Controlled Period|Other|0|||
42143501|NCT00267969|75952792|FG006|Controlled Period|Other|0|||
42143502|NCT00267969|75952786|FG000|After Controlled Period|Adverse Event|0|||
42143503|NCT00267969|75952787|FG001|After Controlled Period|Adverse Event|0|||
42143504|NCT00267969|75952788|FG002|After Controlled Period|Adverse Event|0|||
42143505|NCT00267969|75952789|FG003|After Controlled Period|Adverse Event|7|||
42143506|NCT00267969|75952790|FG004|After Controlled Period|Adverse Event|8|||
42143507|NCT00267969|75952791|FG005|After Controlled Period|Adverse Event|23|||
42143508|NCT00267969|75952792|FG006|After Controlled Period|Adverse Event|21|||
42143509|NCT00267969|75952786|FG000|After Controlled Period|Death|0|||
42143510|NCT00267969|75952787|FG001|After Controlled Period|Death|0|||
42143511|NCT00267969|75952788|FG002|After Controlled Period|Death|0|||
42143512|NCT00267969|75952789|FG003|After Controlled Period|Death|1|||
42143513|NCT00267969|75952790|FG004|After Controlled Period|Death|2|||
42143514|NCT00267969|75952791|FG005|After Controlled Period|Death|0|||
42143515|NCT00267969|75952792|FG006|After Controlled Period|Death|1|||
42143516|NCT00267969|75952786|FG000|After Controlled Period|Lack of Efficacy|0|||
42143517|NCT00267969|75952787|FG001|After Controlled Period|Lack of Efficacy|0|||
42143518|NCT00267969|75952788|FG002|After Controlled Period|Lack of Efficacy|0|||
42143519|NCT00267969|75952789|FG003|After Controlled Period|Lack of Efficacy|10|||
42143520|NCT00267969|75952790|FG004|After Controlled Period|Lack of Efficacy|6|||
42143521|NCT00267969|75952791|FG005|After Controlled Period|Lack of Efficacy|28|||
42143522|NCT00267969|75952792|FG006|After Controlled Period|Lack of Efficacy|15|||
42143523|NCT00267969|75952786|FG000|After Controlled Period|Lost to Follow-up|0|||
42143524|NCT00267969|75952787|FG001|After Controlled Period|Lost to Follow-up|0|||
42143525|NCT00267969|75952788|FG002|After Controlled Period|Lost to Follow-up|0|||
42143526|NCT00267969|75952789|FG003|After Controlled Period|Lost to Follow-up|5|||
42143527|NCT00267969|75952790|FG004|After Controlled Period|Lost to Follow-up|8|||
42143528|NCT00267969|75952791|FG005|After Controlled Period|Lost to Follow-up|9|||
42143529|NCT00267969|75952792|FG006|After Controlled Period|Lost to Follow-up|10|||
42143530|NCT00267969|75952786|FG000|After Controlled Period|Other|0|||
42143531|NCT00267969|75952787|FG001|After Controlled Period|Other|0|||
42143532|NCT00267969|75952788|FG002|After Controlled Period|Other|0|||
42143533|NCT00267969|75952789|FG003|After Controlled Period|Other|13|||
42143534|NCT00267969|75952790|FG004|After Controlled Period|Other|11|||
42143535|NCT00267969|75952791|FG005|After Controlled Period|Other|22|||
42143536|NCT00267969|75952792|FG006|After Controlled Period|Other|25|||
42143537|NCT00280293|75952812|FG000|Overall Study|Protocol Violation|3|||
42143538|NCT00280293|75952813|FG001|Overall Study|Protocol Violation|0|||
42143539|NCT00280293|75952812|FG000|Overall Study|Physician Decision|5|||
42143540|NCT00280293|75952813|FG001|Overall Study|Physician Decision|4|||
42143541|NCT00280293|75952812|FG000|Overall Study|Lost to Follow-up|14|||
42143542|NCT00280293|75952813|FG001|Overall Study|Lost to Follow-up|12|||
42143543|NCT00280293|75952812|FG000|Overall Study|Withdrawal by Subject|3|||
42143544|NCT00280293|75952813|FG001|Overall Study|Withdrawal by Subject|5|||
42143545|NCT00280293|75952812|FG000|Overall Study|Incarceration/Legal Reasons|1|||
42143546|NCT00280293|75952813|FG001|Overall Study|Incarceration/Legal Reasons|1|||
42143547|NCT00280293|75952812|FG000|Overall Study|Adverse Event|0|||
42143548|NCT00280293|75952813|FG001|Overall Study|Adverse Event|1|||
42143549|NCT00421148|75952839|FG000|Overall Study|Lost to Follow-up|0|||
42143550|NCT00421148|75952840|FG001|Overall Study|Lost to Follow-up|0|||
42143551|NCT00421148|75952841|FG002|Overall Study|Lost to Follow-up|0|||
42143552|NCT00421148|75952842|FG003|Overall Study|Lost to Follow-up|0|||
42143553|NCT00421148|75952843|FG004|Overall Study|Lost to Follow-up|0|||
42143554|NCT00421148|75952844|FG005|Overall Study|Lost to Follow-up|0|||
42350947|NCT01698905|76190821|FG000|Overall Study|Protocol Violation|1|||
42012394|NCT01194219|75819476|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
42012395|NCT01194219|75819477|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
42012396|NCT01194219|75819478|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
42012397|NCT01194219|75819479|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
42012398|NCT01194219|75819480|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
42012399|NCT01194219|75819481|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
42012400|NCT01194219|75819482|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
42012401|NCT01194219|75819483|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
42012402|NCT01194219|75819484|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
42012403|NCT01194219|75819475|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
42012404|NCT01194219|75819476|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
42143555|NCT00421148|75952845|FG006|Overall Study|Lost to Follow-up|0|||
42143556|NCT00421148|75952846|FG007|Overall Study|Lost to Follow-up|0|||
42143557|NCT00421148|75952847|FG008|Overall Study|Lost to Follow-up|0|||
42143558|NCT00421148|75952848|FG009|Overall Study|Lost to Follow-up|0|||
42143559|NCT00421148|75952849|FG010|Overall Study|Lost to Follow-up|0|||
42143560|NCT00421148|75952850|FG011|Overall Study|Lost to Follow-up|0|||
42143561|NCT00421148|75952851|FG012|Overall Study|Lost to Follow-up|0|||
42143562|NCT00421148|75952852|FG013|Overall Study|Lost to Follow-up|0|||
42143563|NCT00421148|75952853|FG014|Overall Study|Lost to Follow-up|0|||
42143564|NCT00421148|75952854|FG015|Overall Study|Lost to Follow-up|0|||
42143565|NCT00421148|75952855|FG016|Overall Study|Lost to Follow-up|0|||
42143566|NCT00421148|75952856|FG017|Overall Study|Lost to Follow-up|1|||
42143567|NCT00421148|75952857|FG018|Overall Study|Lost to Follow-up|0|||
42143568|NCT00421148|75952858|FG019|Overall Study|Lost to Follow-up|0|||
42143569|NCT00421148|75952839|FG000|Overall Study|Withdrawal by Subject|0|||
42143570|NCT00421148|75952840|FG001|Overall Study|Withdrawal by Subject|0|||
42143571|NCT00421148|75952841|FG002|Overall Study|Withdrawal by Subject|0|||
42143572|NCT00421148|75952842|FG003|Overall Study|Withdrawal by Subject|0|||
42143573|NCT00421148|75952843|FG004|Overall Study|Withdrawal by Subject|0|||
42143574|NCT00421148|75952844|FG005|Overall Study|Withdrawal by Subject|0|||
42143575|NCT00421148|75952845|FG006|Overall Study|Withdrawal by Subject|0|||
42143576|NCT00421148|75952846|FG007|Overall Study|Withdrawal by Subject|0|||
42143577|NCT00421148|75952847|FG008|Overall Study|Withdrawal by Subject|0|||
42143578|NCT00421148|75952848|FG009|Overall Study|Withdrawal by Subject|0|||
42143579|NCT00421148|75952849|FG010|Overall Study|Withdrawal by Subject|0|||
42143580|NCT00421148|75952850|FG011|Overall Study|Withdrawal by Subject|0|||
42143581|NCT00421148|75952851|FG012|Overall Study|Withdrawal by Subject|0|||
42143582|NCT00421148|75952852|FG013|Overall Study|Withdrawal by Subject|0|||
42143583|NCT00421148|75952853|FG014|Overall Study|Withdrawal by Subject|0|||
42143584|NCT00421148|75952854|FG015|Overall Study|Withdrawal by Subject|0|||
42143585|NCT00421148|75952855|FG016|Overall Study|Withdrawal by Subject|0|||
42143586|NCT00421148|75952856|FG017|Overall Study|Withdrawal by Subject|1|||
42143587|NCT00421148|75952857|FG018|Overall Study|Withdrawal by Subject|0|||
42143588|NCT00421148|75952858|FG019|Overall Study|Withdrawal by Subject|0|||
42143589|NCT00421148|75952839|FG000|Overall Study|Protocol Violation|0|||
42143590|NCT00421148|75952840|FG001|Overall Study|Protocol Violation|0|||
42143591|NCT00421148|75952841|FG002|Overall Study|Protocol Violation|0|||
42143592|NCT00421148|75952842|FG003|Overall Study|Protocol Violation|0|||
42143593|NCT00421148|75952843|FG004|Overall Study|Protocol Violation|0|||
42143594|NCT00421148|75952844|FG005|Overall Study|Protocol Violation|1|||
42143595|NCT00421148|75952845|FG006|Overall Study|Protocol Violation|0|||
42143596|NCT00421148|75952846|FG007|Overall Study|Protocol Violation|0|||
42143597|NCT00421148|75952847|FG008|Overall Study|Protocol Violation|0|||
42143598|NCT00421148|75952848|FG009|Overall Study|Protocol Violation|0|||
42143599|NCT00421148|75952849|FG010|Overall Study|Protocol Violation|0|||
42143600|NCT00421148|75952850|FG011|Overall Study|Protocol Violation|0|||
42143601|NCT00421148|75952851|FG012|Overall Study|Protocol Violation|0|||
42143602|NCT00421148|75952852|FG013|Overall Study|Protocol Violation|0|||
42276818|NCT02452892|76108377|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
42276819|NCT02452892|76108374|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
42276820|NCT02452892|76108375|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
42012405|NCT01194219|75819477|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
42012406|NCT01194219|75819478|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
42012407|NCT01194219|75819479|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
42143603|NCT00421148|75952853|FG014|Overall Study|Protocol Violation|0|||
42143604|NCT00421148|75952854|FG015|Overall Study|Protocol Violation|0|||
42143605|NCT00421148|75952855|FG016|Overall Study|Protocol Violation|0|||
42143606|NCT00421148|75952856|FG017|Overall Study|Protocol Violation|0|||
42143607|NCT00421148|75952857|FG018|Overall Study|Protocol Violation|1|||
42143608|NCT00421148|75952858|FG019|Overall Study|Protocol Violation|0|||
42143609|NCT00403754|75952900|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
42143610|NCT00403754|75952901|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
42143611|NCT00403754|75952902|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
42143612|NCT00403754|75952903|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
42143613|NCT00403754|75952900|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
42143614|NCT00403754|75952901|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
42143615|NCT00403754|75952902|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
42143616|NCT00403754|75952903|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
42143617|NCT00280059|75952917|FG000|Efficacy Assessment Phase|Death|2|||
42143618|NCT00280059|75952918|FG001|Efficacy Assessment Phase|Death|0|||
42143619|NCT00280059|75952917|FG000|Efficacy Assessment Phase|Adverse Event|33|||
42143620|NCT00280059|75952918|FG001|Efficacy Assessment Phase|Adverse Event|31|||
42143621|NCT00280059|75952917|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
42143622|NCT00280059|75952918|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
42143623|NCT00280059|75952917|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
42012408|NCT01194219|75819480|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
42143624|NCT00280059|75952918|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
42143625|NCT00280059|75952917|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
42143626|NCT00280059|75952918|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
42143627|NCT00280059|75952917|FG000|Efficacy Assessment Phase|Other|7|||
42143628|NCT00280059|75952918|FG001|Efficacy Assessment Phase|Other|8|||
42143629|NCT00280059|75952917|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
42143630|NCT00280059|75952918|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
42143631|NCT00403130|75952932|FG000|2 Years From Start of Treatment|Not Eligible|3|||
42276821|NCT02452892|76108376|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
42143632|NCT00403130|75952932|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
42143633|NCT00403130|75952932|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
42143634|NCT00403130|75952932|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
42143635|NCT00402740|75952936|FG000|Overall Study|Withdrawal by Subject|18|||
42143636|NCT00402740|75952936|FG000|Overall Study|Death|50|||
42143637|NCT00402740|75952936|FG000|Overall Study|Lost to Follow-up|6|||
42143638|NCT00402740|75952936|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
42143639|NCT00402740|75952936|FG000|Overall Study|Subject disposition unknown.|1|||
42143640|NCT00420290|75952946|FG000|Overall Study|Adverse Event|3|||
42143641|NCT00420290|75952947|FG001|Overall Study|Adverse Event|1|||
42143642|NCT00420290|75952946|FG000|Overall Study|Withdrawal by Subject|0|||
42143643|NCT00420290|75952947|FG001|Overall Study|Withdrawal by Subject|2|||
42143644|NCT00420290|75952946|FG000|Overall Study|did not meet inclusion/exclusion|1|||
42143645|NCT00420290|75952947|FG001|Overall Study|did not meet inclusion/exclusion|1|||
42143646|NCT00267189|75952955|FG000|Overall Study|Patient withdrew consent|1|||
42143647|NCT00267189|75952956|FG001|Overall Study|Patient withdrew consent|1|||
42143648|NCT00267189|75952955|FG000|Overall Study|Death|1|||
42143649|NCT00267189|75952956|FG001|Overall Study|Death|0|||
42143650|NCT00267189|75952955|FG000|Overall Study|Missing|3|||
42143651|NCT00267189|75952956|FG001|Overall Study|Missing|0|||
42143652|NCT03834350|75952962|FG000|Overall Study|Withdrawal by Subject|1|||
42143653|NCT00402116|75952970|FG000|Overall Study|Jaw infection after surgery-other|1|||
42143654|NCT00402116|75952971|FG001|Overall Study|Jaw infection after surgery-other|0|||
42143655|NCT00402116|75952972|FG002|Overall Study|Jaw infection after surgery-other|0|||
42143656|NCT00402116|75952970|FG000|Overall Study|Withdrawal by Subject|1|||
42143657|NCT00402116|75952971|FG001|Overall Study|Withdrawal by Subject|0|||
42143658|NCT00402116|75952972|FG002|Overall Study|Withdrawal by Subject|5|||
42143659|NCT00402116|75952970|FG000|Overall Study|Treatment completed per protocol|1|||
42143660|NCT00402116|75952971|FG001|Overall Study|Treatment completed per protocol|1|||
42143661|NCT00402116|75952972|FG002|Overall Study|Treatment completed per protocol|2|||
42143662|NCT00402116|75952970|FG000|Overall Study|other complicating disease|0|||
42143663|NCT00402116|75952971|FG001|Overall Study|other complicating disease|0|||
42143664|NCT00402116|75952972|FG002|Overall Study|other complicating disease|2|||
42143665|NCT00402116|75952970|FG000|Overall Study|Disease Progression|0|||
42143666|NCT00402116|75952971|FG001|Overall Study|Disease Progression|4|||
42143667|NCT00402116|75952972|FG002|Overall Study|Disease Progression|38|||
42143668|NCT00402116|75952970|FG000|Overall Study|mistaken thrombocytopenia|0|||
42143669|NCT00402116|75952971|FG001|Overall Study|mistaken thrombocytopenia|0|||
42143670|NCT00402116|75952972|FG002|Overall Study|mistaken thrombocytopenia|1|||
42143671|NCT00402116|75952970|FG000|Overall Study|decline related hyponatremia/tumor|0|||
42143672|NCT00402116|75952971|FG001|Overall Study|decline related hyponatremia/tumor|0|||
42143673|NCT00402116|75952972|FG002|Overall Study|decline related hyponatremia/tumor|1|||
42143674|NCT00402116|75952970|FG000|Overall Study|Adverse Event|0|||
42143675|NCT00402116|75952971|FG001|Overall Study|Adverse Event|1|||
42143676|NCT00402116|75952972|FG002|Overall Study|Adverse Event|6|||
42143677|NCT00401960|75953002|FG000|Overall Study|Lost to Follow-up|3|||
42143678|NCT00401960|75953003|FG001|Overall Study|Lost to Follow-up|0|||
42143679|NCT00401960|75953002|FG000|Overall Study|Death|2|||
42143680|NCT00401960|75953003|FG001|Overall Study|Death|0|||
42143681|NCT00401726|75953013|FG000|Overall Study|Adverse Event|34|||
42143682|NCT00401726|75953014|FG001|Overall Study|Adverse Event|45|||
42143683|NCT00401726|75953013|FG000|Overall Study|Death|0|||
42143684|NCT00401726|75953014|FG001|Overall Study|Death|3|||
42276822|NCT02452892|76108377|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
42012409|NCT01194219|75819481|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
42012410|NCT01194219|75819482|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
42012411|NCT01194219|75819483|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
42012412|NCT01194219|75819484|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
42012413|NCT01194219|75819475|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
42012414|NCT01194219|75819476|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
42012415|NCT01194219|75819477|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
42012416|NCT01194219|75819478|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
42012417|NCT01194219|75819479|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
42012418|NCT01194219|75819480|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
42276823|NCT02452892|76108374|FG000|Follow-up|Withdrawal by Subject|0|||
42276824|NCT02452892|76108375|FG001|Follow-up|Withdrawal by Subject|0|||
42012419|NCT01194219|75819481|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
42143685|NCT00401726|75953013|FG000|Overall Study|Sponsor Request|0|||
42143686|NCT00401726|75953014|FG001|Overall Study|Sponsor Request|1|||
42143687|NCT00401726|75953013|FG000|Overall Study|Physician Decision|3|||
42012420|NCT01194219|75819482|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
42143688|NCT00401726|75953014|FG001|Overall Study|Physician Decision|6|||
42143689|NCT00401726|75953013|FG000|Overall Study|Lost to Follow-up|23|||
42143690|NCT00401726|75953014|FG001|Overall Study|Lost to Follow-up|20|||
42143691|NCT00401726|75953013|FG000|Overall Study|Protocol Violation|6|||
42143692|NCT00401726|75953014|FG001|Overall Study|Protocol Violation|3|||
42143693|NCT00401726|75953013|FG000|Overall Study|Withdrawal by Subject|18|||
42143694|NCT00401726|75953014|FG001|Overall Study|Withdrawal by Subject|24|||
42143695|NCT00401726|75953013|FG000|Overall Study|Lack of Efficacy|4|||
42143696|NCT00401726|75953014|FG001|Overall Study|Lack of Efficacy|6|||
42143697|NCT00401726|75953013|FG000|Overall Study|Protocol Deviation|9|||
42143698|NCT00401726|75953014|FG001|Overall Study|Protocol Deviation|4|||
42143699|NCT00371826|75953023|FG000|Core Phase (12 Months)|Adverse Event|15|||
42143700|NCT00371826|75953024|FG001|Core Phase (12 Months)|Adverse Event|4|||
42039073|NCT03347422|75847221|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
42039074|NCT03347422|75847220|FG000|Part B (149 Weeks)|Other|1|||
42039075|NCT03347422|75847221|FG001|Part B (149 Weeks)|Other|0|||
42039076|NCT00814801|75847237|FG000|Overall Study|Adverse Event|15|||
42039077|NCT00814801|75847238|FG001|Overall Study|Adverse Event|16|||
42039078|NCT00814801|75847239|FG002|Overall Study|Adverse Event|19|||
42039079|NCT00814801|75847237|FG000|Overall Study|Withdrawal by Subject|9|||
42039080|NCT00814801|75847238|FG001|Overall Study|Withdrawal by Subject|11|||
42039081|NCT00814801|75847239|FG002|Overall Study|Withdrawal by Subject|14|||
42143701|NCT00371826|75953025|FG002|Core Phase (12 Months)|Adverse Event|9|||
42143702|NCT00371826|75953023|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
42143703|NCT00371826|75953024|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
42143704|NCT00371826|75953025|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
42143705|NCT00371826|75953023|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
42143706|NCT00371826|75953024|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
42143707|NCT00371826|75953025|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
42143708|NCT00371826|75953023|FG000|Core Phase (12 Months)|Protocol Violation|1|||
42143709|NCT00371826|75953024|FG001|Core Phase (12 Months)|Protocol Violation|0|||
42143710|NCT00371826|75953025|FG002|Core Phase (12 Months)|Protocol Violation|1|||
42143711|NCT00371826|75953023|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
42143712|NCT00371826|75953024|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
42143713|NCT00371826|75953025|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
42143714|NCT00371826|75953023|FG000|Core Phase (12 Months)|Administrative problems|1|||
42143715|NCT00371826|75953024|FG001|Core Phase (12 Months)|Administrative problems|0|||
42143716|NCT00371826|75953025|FG002|Core Phase (12 Months)|Administrative problems|8|||
42143717|NCT00371826|75953023|FG000|Core Phase (12 Months)|Graft Loss|0|||
42143718|NCT00371826|75953024|FG001|Core Phase (12 Months)|Graft Loss|1|||
42143719|NCT00371826|75953025|FG002|Core Phase (12 Months)|Graft Loss|0|||
42143720|NCT00371826|75953023|FG000|Extension Phase (24 Months)|Adverse Event|4|||
42143721|NCT00371826|75953024|FG001|Extension Phase (24 Months)|Adverse Event|5|||
42143722|NCT00371826|75953025|FG002|Extension Phase (24 Months)|Adverse Event|0|||
42143723|NCT00371826|75953023|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
42143724|NCT00371826|75953024|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
42143725|NCT00371826|75953025|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
42143726|NCT00371826|75953023|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
42143727|NCT00371826|75953024|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
42143728|NCT00371826|75953025|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
42143729|NCT00371826|75953023|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
42143730|NCT00371826|75953024|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
42143731|NCT00371826|75953025|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
42039082|NCT00814801|75847237|FG000|Overall Study|Inappropriate as a subject|1|||
42039083|NCT00814801|75847238|FG001|Overall Study|Inappropriate as a subject|1|||
42039084|NCT00814801|75847239|FG002|Overall Study|Inappropriate as a subject|1|||
42039085|NCT00814801|75847237|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
42039086|NCT00814801|75847238|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
42039087|NCT00814801|75847239|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
42039088|NCT00814801|75847237|FG000|Overall Study|Missing or change of caregiver|6|||
42143732|NCT00371826|75953023|FG000|Extension Phase (24 Months)|Administrative problems|0|||
42143733|NCT00371826|75953024|FG001|Extension Phase (24 Months)|Administrative problems|0|||
42143734|NCT00371826|75953025|FG002|Extension Phase (24 Months)|Administrative problems|2|||
42143735|NCT00396084|75953039|FG000|Overall Study|Adverse Event|0|||
42143736|NCT00396084|75953040|FG001|Overall Study|Adverse Event|0|||
42143737|NCT00396084|75953041|FG002|Overall Study|Adverse Event|0|||
42143738|NCT00396084|75953042|FG003|Overall Study|Adverse Event|0|||
42143739|NCT00396084|75953043|FG004|Overall Study|Adverse Event|1|||
42143740|NCT00396084|75953044|FG005|Overall Study|Adverse Event|2|||
42143741|NCT00396084|75953039|FG000|Overall Study|Withdrawal by Subject|0|||
42143742|NCT00396084|75953040|FG001|Overall Study|Withdrawal by Subject|0|||
42143743|NCT00396084|75953041|FG002|Overall Study|Withdrawal by Subject|0|||
42350948|NCT01698905|76190821|FG000|Overall Study|Subject/guardian decision|2|||
42350949|NCT01698905|76190821|FG000|Overall Study|Death|1|||
42039089|NCT00814801|75847238|FG001|Overall Study|Missing or change of caregiver|2|||
42039090|NCT00814801|75847239|FG002|Overall Study|Missing or change of caregiver|4|||
42039091|NCT00814801|75847237|FG000|Overall Study|Non-compliance|0|||
42039092|NCT00814801|75847238|FG001|Overall Study|Non-compliance|1|||
42143744|NCT00396084|75953042|FG003|Overall Study|Withdrawal by Subject|1|||
42143745|NCT00396084|75953043|FG004|Overall Study|Withdrawal by Subject|0|||
42143746|NCT00396084|75953044|FG005|Overall Study|Withdrawal by Subject|0|||
42143747|NCT00395850|75953066|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
42143748|NCT00395850|75953067|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
42143749|NCT00395850|75953068|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
42143750|NCT00395850|75953069|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
42143751|NCT00395850|75953066|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
42143752|NCT00395850|75953067|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
42143753|NCT00395850|75953068|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
42143754|NCT00395850|75953069|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
42143755|NCT00395850|75953066|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
42143756|NCT00395850|75953067|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
42143757|NCT00395850|75953068|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
42143758|NCT00395850|75953069|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
42143759|NCT00395850|75953066|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
42143760|NCT00395850|75953067|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
42143761|NCT00395850|75953068|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
42143762|NCT00395850|75953069|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
42350950|NCT01466686|76190832|FG000|Overall Study|Withdrawal by Subject|1|||
42039093|NCT00814801|75847239|FG002|Overall Study|Non-compliance|1|||
42039094|NCT00814801|75847237|FG000|Overall Study|Other|2|||
42039095|NCT00814801|75847238|FG001|Overall Study|Other|6|||
42039096|NCT00814801|75847239|FG002|Overall Study|Other|4|||
42039097|NCT00823615|75847247|FG000|Period 2|Lost to Follow-up|2|||
42039098|NCT00823615|75847248|FG001|Period 2|Lost to Follow-up|0|||
42039099|NCT00823615|75847247|FG000|Period 2|Time/Job Conflict|1|||
42350951|NCT01550289|76190838|FG000|Overall Study|Protocol Violation|1|||
42012421|NCT01194219|75819483|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
42012422|NCT01194219|75819484|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
42012423|NCT01194219|75819475|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
42012424|NCT01194219|75819476|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
42012425|NCT01194219|75819477|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
42012426|NCT01194219|75819478|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
42012427|NCT01194219|75819479|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
42012428|NCT01194219|75819480|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
42012429|NCT01194219|75819481|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
42012430|NCT01194219|75819482|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
42012431|NCT01194219|75819483|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
42012432|NCT01194219|75819484|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
42012433|NCT01194219|75819475|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
42012434|NCT01194219|75819476|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
42012435|NCT01194219|75819477|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
42012436|NCT01194219|75819478|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
42012437|NCT01194219|75819479|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
42012438|NCT01194219|75819480|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
42012439|NCT01194219|75819481|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
42012440|NCT01194219|75819482|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
42012441|NCT01194219|75819483|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
42012442|NCT01194219|75819484|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
42012443|NCT01194219|75819475|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
42012444|NCT01194219|75819476|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
42012445|NCT01194219|75819477|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
42012446|NCT01194219|75819478|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
42012447|NCT01194219|75819479|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
42012448|NCT01194219|75819480|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
42012449|NCT01194219|75819481|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
42012450|NCT01194219|75819482|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
42012451|NCT01194219|75819483|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
42012452|NCT01194219|75819484|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
42039100|NCT00823615|75847248|FG001|Period 2|Time/Job Conflict|2|||
42039101|NCT00812461|75847256|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
42039102|NCT00812461|75847257|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
42039103|NCT00812461|75847256|FG000|All Treated Patients|Adverse Event|8|||
42012453|NCT01194219|75819475|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
42039104|NCT00812461|75847257|FG001|All Treated Patients|Adverse Event|15|||
42039105|NCT00812461|75847256|FG000|All Treated Patients|Lack of Efficacy|13|||
42039106|NCT00812461|75847257|FG001|All Treated Patients|Lack of Efficacy|7|||
42143763|NCT00395850|75953066|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
42143764|NCT00395850|75953067|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
42143765|NCT00395850|75953068|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
42143766|NCT00395850|75953069|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
42143767|NCT00395850|75953066|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
42143768|NCT00395850|75953067|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
42143769|NCT00395850|75953068|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
42143770|NCT00395850|75953069|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
42143771|NCT00395850|75953066|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
42143772|NCT00395850|75953067|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
42143773|NCT00395850|75953068|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
42143774|NCT00395850|75953069|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
42143775|NCT00420212|75953082|FG000|Overall Study|Adverse Event|22|||
42143776|NCT00420212|75953083|FG001|Overall Study|Adverse Event|40|||
42143777|NCT00420212|75953084|FG002|Overall Study|Adverse Event|36|||
42143778|NCT00420212|75953082|FG000|Overall Study|Lost to Follow-up|9|||
42143779|NCT00420212|75953083|FG001|Overall Study|Lost to Follow-up|11|||
42143780|NCT00420212|75953084|FG002|Overall Study|Lost to Follow-up|11|||
42143781|NCT00420212|75953082|FG000|Overall Study|Withdrawal by Subject|31|||
42143782|NCT00420212|75953083|FG001|Overall Study|Withdrawal by Subject|22|||
42143783|NCT00420212|75953084|FG002|Overall Study|Withdrawal by Subject|19|||
42143784|NCT00420212|75953082|FG000|Overall Study|Physician Decision|4|||
42143785|NCT00420212|75953083|FG001|Overall Study|Physician Decision|4|||
42143786|NCT00420212|75953084|FG002|Overall Study|Physician Decision|3|||
42143787|NCT00420212|75953082|FG000|Overall Study|Protocol Violation|4|||
42143788|NCT00420212|75953083|FG001|Overall Study|Protocol Violation|4|||
42143789|NCT00420212|75953084|FG002|Overall Study|Protocol Violation|8|||
42143790|NCT00420212|75953082|FG000|Overall Study|Death|0|||
42143791|NCT00420212|75953083|FG001|Overall Study|Death|0|||
42143792|NCT00420212|75953084|FG002|Overall Study|Death|1|||
42143793|NCT00420212|75953082|FG000|Overall Study|Other-Unspecified|21|||
42143794|NCT00420212|75953083|FG001|Overall Study|Other-Unspecified|14|||
42143795|NCT00420212|75953084|FG002|Overall Study|Other-Unspecified|18|||
42143796|NCT00401258|75953095|FG000|Overall Study|Adverse Event|7|||
42143797|NCT00380874|75953101|FG000|Overall Study|Adverse Event|7|||
42143798|NCT00380874|75953102|FG001|Overall Study|Adverse Event|7|||
42143799|NCT00380874|75953101|FG000|Overall Study|Death|1|||
42143800|NCT00380874|75953102|FG001|Overall Study|Death|0|||
42143801|NCT00380874|75953101|FG000|Overall Study|Withdrawal by Subject|2|||
42143802|NCT00380874|75953102|FG001|Overall Study|Withdrawal by Subject|1|||
42143803|NCT00380874|75953101|FG000|Overall Study|Not related to study drug|3|||
42143804|NCT00380874|75953102|FG001|Overall Study|Not related to study drug|2|||
42143805|NCT00420056|75953108|FG000|Overall Study|Objective progression or relapse|17|||
42143806|NCT00411554|75953114|FG000|Overall Study|Adverse Event|2|||
42143807|NCT00411554|75953115|FG001|Overall Study|Adverse Event|4|||
42143808|NCT00411554|75953114|FG000|Overall Study|Lack of Efficacy|2|||
42143809|NCT00411554|75953115|FG001|Overall Study|Lack of Efficacy|5|||
42143810|NCT00411554|75953114|FG000|Overall Study|Withdrawal by Subject|3|||
42143811|NCT00411554|75953115|FG001|Overall Study|Withdrawal by Subject|0|||
42143812|NCT00411554|75953114|FG000|Overall Study|Patient Moved|1|||
42143813|NCT00411554|75953115|FG001|Overall Study|Patient Moved|0|||
42143814|NCT00400712|75953123|FG000|Overall Study|Death|1|||
42143815|NCT00400712|75953124|FG001|Overall Study|Death|0|||
42143816|NCT00400712|75953123|FG000|Overall Study|Withdrawal by Subject|11|||
42143817|NCT00400712|75953124|FG001|Overall Study|Withdrawal by Subject|12|||
42143818|NCT00400712|75953123|FG000|Overall Study|Physician Decision|5|||
42143819|NCT00400712|75953124|FG001|Overall Study|Physician Decision|4|||
42143820|NCT00380718|75953132|FG000|Overall Study|Adverse Event|1|||
42143821|NCT00380718|75953132|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
42143822|NCT00380250|75953138|FG000|Overall Study|Withdrawal by Subject|39|||
42143823|NCT00380250|75953139|FG001|Overall Study|Withdrawal by Subject|28|||
42143824|NCT00380250|75953138|FG000|Overall Study|Adverse Event|20|||
42143825|NCT00380250|75953139|FG001|Overall Study|Adverse Event|9|||
42143826|NCT00380250|75953138|FG000|Overall Study|Lack of Efficacy|10|||
42143827|NCT00380250|75953139|FG001|Overall Study|Lack of Efficacy|8|||
42143828|NCT00380250|75953138|FG000|Overall Study|Protocol Violation|15|||
42143829|NCT00380250|75953139|FG001|Overall Study|Protocol Violation|5|||
42143830|NCT00380250|75953138|FG000|Overall Study|Lost to Follow-up|14|||
42143831|NCT00380250|75953139|FG001|Overall Study|Lost to Follow-up|5|||
42143832|NCT00380250|75953138|FG000|Overall Study|Physician Decision|1|||
42143833|NCT00380250|75953139|FG001|Overall Study|Physician Decision|0|||
42143834|NCT00400400|75953147|FG000|Overall Study|Adverse Event|9|||
42143835|NCT00400400|75953148|FG001|Overall Study|Adverse Event|8|||
42143836|NCT00400400|75953147|FG000|Overall Study|Protocol Violation|2|||
42143837|NCT00400400|75953148|FG001|Overall Study|Protocol Violation|0|||
42143838|NCT00400400|75953147|FG000|Overall Study|Withdrawal by Subject|1|||
42143839|NCT00400400|75953148|FG001|Overall Study|Withdrawal by Subject|3|||
42143840|NCT00400400|75953147|FG000|Overall Study|Administrative Problem|1|||
42143841|NCT00400400|75953148|FG001|Overall Study|Administrative Problem|0|||
42143842|NCT00400400|75953147|FG000|Overall Study|Lost to Follow-up|0|||
42143843|NCT00400400|75953148|FG001|Overall Study|Lost to Follow-up|1|||
42143844|NCT00400400|75953147|FG000|Overall Study|Did not receive study drug|1|||
42143845|NCT00400400|75953148|FG001|Overall Study|Did not receive study drug|3|||
42143846|NCT00395694|75953156|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
42143847|NCT00395694|75953157|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
42143848|NCT00395694|75953156|FG000|Continuation Phase|Adverse Event|1|||
42143849|NCT00395694|75953157|FG001|Continuation Phase|Adverse Event|0|||
42143850|NCT00395694|75953156|FG000|Continuation Phase|Lack of Efficacy|12|||
42143851|NCT00395694|75953157|FG001|Continuation Phase|Lack of Efficacy|11|||
42143852|NCT00395694|75953156|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
42143853|NCT00395694|75953157|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
42143854|NCT00395694|75953156|FG000|Continuation Phase|Poor Compliance|1|||
42143855|NCT00395694|75953157|FG001|Continuation Phase|Poor Compliance|0|||
42143856|NCT00395694|75953156|FG000|Continuation Phase|Withdrawal by Subject|0|||
42143857|NCT00395694|75953157|FG001|Continuation Phase|Withdrawal by Subject|2|||
42143858|NCT00419744|75953169|FG000|Overall Study|Adverse Event|39|||
42143859|NCT00419744|75953170|FG001|Overall Study|Adverse Event|40|||
42143860|NCT00419744|75953171|FG002|Overall Study|Adverse Event|50|||
42143861|NCT00419744|75953169|FG000|Overall Study|Withdrawal by Subject|45|||
42143862|NCT00419744|75953170|FG001|Overall Study|Withdrawal by Subject|49|||
42143863|NCT00419744|75953171|FG002|Overall Study|Withdrawal by Subject|52|||
42143864|NCT00419744|75953169|FG000|Overall Study|Lost to Follow-up|8|||
42143865|NCT00419744|75953170|FG001|Overall Study|Lost to Follow-up|10|||
42143866|NCT00419744|75953171|FG002|Overall Study|Lost to Follow-up|6|||
42143867|NCT00419744|75953169|FG000|Overall Study|Protocol Violation|4|||
42143868|NCT00419744|75953170|FG001|Overall Study|Protocol Violation|7|||
42143869|NCT00419744|75953171|FG002|Overall Study|Protocol Violation|8|||
42143870|NCT00419744|75953169|FG000|Overall Study|Randomized in error|9|||
42143871|NCT00419744|75953170|FG001|Overall Study|Randomized in error|6|||
42143872|NCT00419744|75953171|FG002|Overall Study|Randomized in error|7|||
42143873|NCT00419744|75953169|FG000|Overall Study|Moving out of state|2|||
42143874|NCT00419744|75953170|FG001|Overall Study|Moving out of state|0|||
42143875|NCT00419744|75953171|FG002|Overall Study|Moving out of state|1|||
42143876|NCT00419744|75953169|FG000|Overall Study|Physician Decision|10|||
42143877|NCT00419744|75953170|FG001|Overall Study|Physician Decision|5|||
42143878|NCT00419744|75953171|FG002|Overall Study|Physician Decision|6|||
42143879|NCT00419744|75953169|FG000|Overall Study|Spirometry mouthpiece issues|0|||
42143880|NCT00419744|75953170|FG001|Overall Study|Spirometry mouthpiece issues|1|||
42143881|NCT00419744|75953171|FG002|Overall Study|Spirometry mouthpiece issues|2|||
42143882|NCT00419744|75953169|FG000|Overall Study|Incorrect medication kit dispensed|0|||
42143883|NCT00419744|75953170|FG001|Overall Study|Incorrect medication kit dispensed|0|||
42143884|NCT00419744|75953171|FG002|Overall Study|Incorrect medication kit dispensed|1|||
42143885|NCT00395538|75953182|FG000|Overall Study|Did not re-consent to revised protocol|1|||
42143886|NCT00395538|75953183|FG001|Overall Study|Did not re-consent to revised protocol|10|||
42143887|NCT00395538|75953184|FG002|Overall Study|Did not re-consent to revised protocol|0|||
42143888|NCT00395538|75953182|FG000|Overall Study|FDA partial hold on PTH|0|||
42143889|NCT00395538|75953183|FG001|Overall Study|FDA partial hold on PTH|0|||
42143890|NCT00395538|75953184|FG002|Overall Study|FDA partial hold on PTH|11|||
42143891|NCT00395538|75953182|FG000|Overall Study|Failed screening|0|||
42143892|NCT00395538|75953183|FG001|Overall Study|Failed screening|0|||
42143893|NCT00395538|75953184|FG002|Overall Study|Failed screening|4|||
42143894|NCT00395538|75953182|FG000|Overall Study|Switch to Natpara|0|||
42143895|NCT00395538|75953183|FG001|Overall Study|Switch to Natpara|0|||
42143896|NCT00395538|75953184|FG002|Overall Study|Switch to Natpara|3|||
42143897|NCT00395538|75953182|FG000|Overall Study|Adverse Event|1|||
42143898|NCT00395538|75953183|FG001|Overall Study|Adverse Event|0|||
42143899|NCT00395538|75953184|FG002|Overall Study|Adverse Event|2|||
42143900|NCT00395538|75953182|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
42143901|NCT00395538|75953183|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
42143902|NCT00395538|75953184|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
42143903|NCT00395538|75953182|FG000|Overall Study|Non-compliance with study protocol|0|||
42143904|NCT00395538|75953183|FG001|Overall Study|Non-compliance with study protocol|1|||
42143905|NCT00395538|75953184|FG002|Overall Study|Non-compliance with study protocol|0|||
42143906|NCT00395538|75953182|FG000|Overall Study|PTH resistance|0|||
42143907|NCT00395538|75953183|FG001|Overall Study|PTH resistance|0|||
42143908|NCT00395538|75953184|FG002|Overall Study|PTH resistance|1|||
42143909|NCT00395538|75953182|FG000|Overall Study|Pregnancy|1|||
42143910|NCT00395538|75953183|FG001|Overall Study|Pregnancy|0|||
42143911|NCT00395538|75953184|FG002|Overall Study|Pregnancy|0|||
42143912|NCT00395538|75953182|FG000|Overall Study|Partial recovery of parathyroid function|0|||
42143913|NCT00395538|75953183|FG001|Overall Study|Partial recovery of parathyroid function|0|||
42143914|NCT00395538|75953184|FG002|Overall Study|Partial recovery of parathyroid function|1|||
42143915|NCT00395538|75953182|FG000|Overall Study|Participant elected to discontinue|0|||
42143916|NCT00395538|75953183|FG001|Overall Study|Participant elected to discontinue|0|||
42143917|NCT00395538|75953184|FG002|Overall Study|Participant elected to discontinue|1|||
42143918|NCT00395460|75953194|FG000|Overall Study|Withdrawal by Subject|1|||
42143919|NCT00395460|75953195|FG001|Overall Study|Withdrawal by Subject|0|||
42143920|NCT00395304|75953201|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42143921|NCT00395304|75953202|FG001|Treatment Period 1|Withdrawal by Subject|3|||
42143922|NCT00395304|75953203|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42143923|NCT00395304|75953204|FG003|Treatment Period 1|Withdrawal by Subject|2|||
42143924|NCT00395304|75953205|FG004|Treatment Period 1|Withdrawal by Subject|1|||
42143925|NCT00395304|75953206|FG005|Treatment Period 1|Withdrawal by Subject|1|||
42143926|NCT00395304|75953201|FG000|Treatment Period 1|Lost to Follow-up|1|||
42143927|NCT00395304|75953202|FG001|Treatment Period 1|Lost to Follow-up|0|||
42143928|NCT00395304|75953203|FG002|Treatment Period 1|Lost to Follow-up|0|||
42143929|NCT00395304|75953204|FG003|Treatment Period 1|Lost to Follow-up|1|||
42143930|NCT00395304|75953205|FG004|Treatment Period 1|Lost to Follow-up|0|||
42143931|NCT00395304|75953206|FG005|Treatment Period 1|Lost to Follow-up|1|||
42143932|NCT00395304|75953201|FG000|Treatment Period 1|Physician Decision|0|||
42143933|NCT00395304|75953202|FG001|Treatment Period 1|Physician Decision|1|||
42143934|NCT00395304|75953203|FG002|Treatment Period 1|Physician Decision|0|||
42143935|NCT00395304|75953204|FG003|Treatment Period 1|Physician Decision|0|||
42143936|NCT00395304|75953205|FG004|Treatment Period 1|Physician Decision|0|||
42143937|NCT00395304|75953206|FG005|Treatment Period 1|Physician Decision|0|||
42143938|NCT00395304|75953201|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42143939|NCT00395304|75953202|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42143940|NCT00395304|75953203|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42039107|NCT00812461|75847256|FG000|All Treated Patients|Non-compliance|6|||
42039108|NCT00812461|75847257|FG001|All Treated Patients|Non-compliance|9|||
42039109|NCT00812461|75847256|FG000|All Treated Patients|Protocol Violation|36|||
42039110|NCT00812461|75847257|FG001|All Treated Patients|Protocol Violation|27|||
42039111|NCT00812461|75847256|FG000|All Treated Patients|Withdrawal by Subject|45|||
42039112|NCT00812461|75847257|FG001|All Treated Patients|Withdrawal by Subject|54|||
42039113|NCT00812461|75847256|FG000|All Treated Patients|Lost to Follow-up|11|||
42039114|NCT00812461|75847257|FG001|All Treated Patients|Lost to Follow-up|14|||
42039115|NCT00812461|75847256|FG000|All Treated Patients|Other Reason|13|||
42039116|NCT00812461|75847257|FG001|All Treated Patients|Other Reason|21|||
42039117|NCT00599326|75847263|FG000|Overall Study|Lost to Follow-up|1|||
42039118|NCT00599326|75847263|FG000|Overall Study|Noncompliant|1|||
42039119|NCT00978432|75847270|FG000|Overall Study|Withdrawal by Subject|0|||
42039120|NCT00978432|75847271|FG001|Overall Study|Withdrawal by Subject|0|||
42039121|NCT00978432|75847272|FG002|Overall Study|Withdrawal by Subject|1|||
42039122|NCT00978432|75847270|FG000|Overall Study|Lack of Efficacy|1|||
42039123|NCT00978432|75847271|FG001|Overall Study|Lack of Efficacy|1|||
42039124|NCT00978432|75847272|FG002|Overall Study|Lack of Efficacy|3|||
42039125|NCT00978432|75847270|FG000|Overall Study|Adverse Event|2|||
42039126|NCT00978432|75847271|FG001|Overall Study|Adverse Event|0|||
42039127|NCT00978432|75847272|FG002|Overall Study|Adverse Event|1|||
42039128|NCT00975780|75847282|FG000|Follow Up|Death|88|||
42039129|NCT00975780|75847283|FG001|Follow Up|Death|122|||
42039130|NCT00975780|75847282|FG000|Follow Up|Facility Withdrawal|7|||
42039131|NCT00975780|75847283|FG001|Follow Up|Facility Withdrawal|23|||
42039132|NCT00975780|75847282|FG000|Follow Up|Discharged from Facility|7|||
42039133|NCT00975780|75847283|FG001|Follow Up|Discharged from Facility|12|||
42039134|NCT00814489|75847292|FG000|Overall Study|Other|2|||
42039135|NCT00814489|75847293|FG001|Overall Study|Other|0|||
42039136|NCT00814489|75847294|FG002|Overall Study|Other|1|||
42039137|NCT00814333|75847306|FG000|Enrollment|Lost to Follow-up|1|||
42039138|NCT00814333|75847307|FG001|Enrollment|Lost to Follow-up|0|||
42039139|NCT01147250|75847315|FG000|Overall Study|Lost to Follow-up|14|||
42039140|NCT01147250|75847316|FG001|Overall Study|Lost to Follow-up|11|||
42039141|NCT01147250|75847315|FG000|Overall Study|Withdrawal by Subject|83|||
42039142|NCT01147250|75847316|FG001|Overall Study|Withdrawal by Subject|88|||
42143941|NCT00395304|75953204|FG003|Treatment Period 2|Withdrawal by Subject|1|||
42143942|NCT00395304|75953205|FG004|Treatment Period 2|Withdrawal by Subject|0|||
42039143|NCT01147250|75847315|FG000|Overall Study|Site termination by sponsor|13|||
42039144|NCT01147250|75847316|FG001|Overall Study|Site termination by sponsor|5|||
42143943|NCT00395304|75953206|FG005|Treatment Period 2|Withdrawal by Subject|2|||
42143944|NCT00395304|75953201|FG000|Treatment Period 2|Lost to Follow-up|0|||
42143945|NCT00395304|75953202|FG001|Treatment Period 2|Lost to Follow-up|3|||
42276825|NCT02452892|76108376|FG002|Follow-up|Withdrawal by Subject|0|||
42039145|NCT01147250|75847315|FG000|Overall Study|Other than specified|0|||
42039146|NCT01147250|75847316|FG001|Overall Study|Other than specified|1|||
42039147|NCT00813943|75847325|FG000|Overall Study|Ongoing at cut-off date|5|||
42039148|NCT00813943|75847326|FG001|Overall Study|Ongoing at cut-off date|5|||
42039149|NCT00813943|75847327|FG002|Overall Study|Ongoing at cut-off date|3|||
42039150|NCT00821509|75847339|FG000|Overall Study|Withdrawal by Subject|12|||
42143946|NCT00395304|75953203|FG002|Treatment Period 2|Lost to Follow-up|0|||
42143947|NCT00395304|75953204|FG003|Treatment Period 2|Lost to Follow-up|0|||
42143948|NCT00395304|75953205|FG004|Treatment Period 2|Lost to Follow-up|0|||
42143949|NCT00395304|75953206|FG005|Treatment Period 2|Lost to Follow-up|0|||
42143950|NCT00395304|75953201|FG000|Treatment Period 2|Physician Decision|0|||
42143951|NCT00395304|75953202|FG001|Treatment Period 2|Physician Decision|0|||
42143952|NCT00395304|75953203|FG002|Treatment Period 2|Physician Decision|1|||
42143953|NCT00395304|75953204|FG003|Treatment Period 2|Physician Decision|0|||
42143954|NCT00395304|75953205|FG004|Treatment Period 2|Physician Decision|0|||
42143955|NCT00395304|75953206|FG005|Treatment Period 2|Physician Decision|0|||
42143956|NCT00395304|75953201|FG000|Treatment Period 2|Other|0|||
42143957|NCT00395304|75953202|FG001|Treatment Period 2|Other|1|||
42143958|NCT00395304|75953203|FG002|Treatment Period 2|Other|0|||
42143959|NCT00395304|75953204|FG003|Treatment Period 2|Other|0|||
42143960|NCT00395304|75953205|FG004|Treatment Period 2|Other|0|||
42143961|NCT00395304|75953206|FG005|Treatment Period 2|Other|0|||
42143962|NCT00395304|75953201|FG000|Treatment Period 3|Withdrawal by Subject|0|||
42143963|NCT00395304|75953202|FG001|Treatment Period 3|Withdrawal by Subject|0|||
42143964|NCT00395304|75953203|FG002|Treatment Period 3|Withdrawal by Subject|0|||
42143965|NCT00395304|75953204|FG003|Treatment Period 3|Withdrawal by Subject|1|||
42143966|NCT00395304|75953205|FG004|Treatment Period 3|Withdrawal by Subject|0|||
42143967|NCT00395304|75953206|FG005|Treatment Period 3|Withdrawal by Subject|1|||
42143968|NCT00395304|75953201|FG000|Treatment Period 3|Lost to Follow-up|1|||
42143969|NCT00395304|75953202|FG001|Treatment Period 3|Lost to Follow-up|1|||
42143970|NCT00395304|75953203|FG002|Treatment Period 3|Lost to Follow-up|0|||
42143971|NCT00395304|75953204|FG003|Treatment Period 3|Lost to Follow-up|0|||
42143972|NCT00395304|75953205|FG004|Treatment Period 3|Lost to Follow-up|0|||
42143973|NCT00395304|75953206|FG005|Treatment Period 3|Lost to Follow-up|0|||
42143974|NCT00395304|75953201|FG000|Treatment Period 3|Physician Decision|0|||
42143975|NCT00395304|75953202|FG001|Treatment Period 3|Physician Decision|1|||
42143976|NCT00395304|75953203|FG002|Treatment Period 3|Physician Decision|0|||
42143977|NCT00395304|75953204|FG003|Treatment Period 3|Physician Decision|0|||
42143978|NCT00395304|75953205|FG004|Treatment Period 3|Physician Decision|0|||
42143979|NCT00395304|75953206|FG005|Treatment Period 3|Physician Decision|0|||
42143980|NCT00395304|75953201|FG000|Treatment Period 3|Other|0|||
42143981|NCT00395304|75953202|FG001|Treatment Period 3|Other|0|||
42143982|NCT00395304|75953203|FG002|Treatment Period 3|Other|0|||
42143983|NCT00395304|75953204|FG003|Treatment Period 3|Other|1|||
42143984|NCT00395304|75953205|FG004|Treatment Period 3|Other|0|||
42143985|NCT00395304|75953206|FG005|Treatment Period 3|Other|0|||
42143986|NCT00395226|75953215|FG000|Overall Study|Adverse Event|4|||
42143987|NCT00395226|75953216|FG001|Overall Study|Adverse Event|3|||
42143988|NCT00395226|75953215|FG000|Overall Study|Withdrawal by Subject|0|||
42143989|NCT00395226|75953216|FG001|Overall Study|Withdrawal by Subject|1|||
42143990|NCT00395226|75953215|FG000|Overall Study|Lost to Follow-up|0|||
42143991|NCT00395226|75953216|FG001|Overall Study|Lost to Follow-up|1|||
42143992|NCT00394914|75953224|FG000|Treatment Period|Adverse Event|0|||
42143993|NCT00394914|75953225|FG001|Treatment Period|Adverse Event|3|||
42012454|NCT01194219|75819476|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
42012455|NCT01194219|75819477|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
42012456|NCT01194219|75819478|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
42012457|NCT01194219|75819479|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
42012458|NCT01194219|75819480|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
42143994|NCT00394914|75953226|FG002|Treatment Period|Adverse Event|1|||
42143995|NCT00394914|75953224|FG000|Treatment Period|Lost to Follow-up|0|||
42143996|NCT00394914|75953225|FG001|Treatment Period|Lost to Follow-up|1|||
42143997|NCT00394914|75953226|FG002|Treatment Period|Lost to Follow-up|0|||
42143998|NCT00394914|75953224|FG000|Treatment Period|Withdrawal by Subject|0|||
42143999|NCT00394914|75953225|FG001|Treatment Period|Withdrawal by Subject|2|||
42144000|NCT00394914|75953226|FG002|Treatment Period|Withdrawal by Subject|2|||
42144001|NCT00394914|75953224|FG000|Treatment Period|Noncompliance with protocol|0|||
42350952|NCT01550289|76190839|FG001|Overall Study|Protocol Violation|0|||
42012459|NCT01194219|75819481|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
42012460|NCT01194219|75819482|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
42144002|NCT00394914|75953225|FG001|Treatment Period|Noncompliance with protocol|3|||
42144003|NCT00394914|75953226|FG002|Treatment Period|Noncompliance with protocol|2|||
42144004|NCT00394914|75953224|FG000|Treatment Period|Did not meet protocol eligibility|0|||
42144005|NCT00394914|75953225|FG001|Treatment Period|Did not meet protocol eligibility|1|||
42144006|NCT00394914|75953226|FG002|Treatment Period|Did not meet protocol eligibility|1|||
42144007|NCT00366444|75953234|FG000|Overall Study|Withdrawal by Subject|1|||
42144008|NCT00366444|75953235|FG001|Overall Study|Withdrawal by Subject|1|||
42144009|NCT00366444|75953234|FG000|Overall Study|Lack of Efficacy|0|||
42144010|NCT00366444|75953235|FG001|Overall Study|Lack of Efficacy|1|||
42144011|NCT00365976|75953243|FG000|Overall Study|Withdrawal by Subject|1|||
42144012|NCT00365976|75953244|FG001|Overall Study|Withdrawal by Subject|5|||
42144013|NCT00379236|75953252|FG000|Double-blind|Adverse Event|11|||
42144014|NCT00379236|75953253|FG001|Double-blind|Adverse Event|6|||
42144015|NCT00379236|75953254|FG002|Double-blind|Adverse Event|0|||
42144016|NCT00379236|75953252|FG000|Double-blind|Protocol Violation|3|||
42144017|NCT00379236|75953253|FG001|Double-blind|Protocol Violation|3|||
42144018|NCT00379236|75953254|FG002|Double-blind|Protocol Violation|0|||
42144019|NCT00379236|75953252|FG000|Double-blind|Withdrawal by Subject|12|||
42144020|NCT00379236|75953253|FG001|Double-blind|Withdrawal by Subject|13|||
42144021|NCT00379236|75953254|FG002|Double-blind|Withdrawal by Subject|0|||
42144022|NCT00379236|75953252|FG000|Double-blind|Lost to Follow-up|4|||
42144023|NCT00379236|75953253|FG001|Double-blind|Lost to Follow-up|3|||
42144024|NCT00379236|75953254|FG002|Double-blind|Lost to Follow-up|0|||
42039151|NCT00821509|75847340|FG001|Overall Study|Withdrawal by Subject|11|||
42144025|NCT00379236|75953252|FG000|Double-blind|Use of exclusionary medication|1|||
42144026|NCT00379236|75953253|FG001|Double-blind|Use of exclusionary medication|2|||
42144027|NCT00379236|75953254|FG002|Double-blind|Use of exclusionary medication|0|||
42144028|NCT00379236|75953252|FG000|Double-blind|Other|3|||
42144029|NCT00379236|75953253|FG001|Double-blind|Other|7|||
42144030|NCT00379236|75953254|FG002|Double-blind|Other|0|||
42144031|NCT00379236|75953252|FG000|Double-blind|Data could not be retrieved|2|||
42144032|NCT00379236|75953253|FG001|Double-blind|Data could not be retrieved|2|||
42144033|NCT00379236|75953254|FG002|Double-blind|Data could not be retrieved|0|||
42144034|NCT00379236|75953252|FG000|Open-label Extension|Adverse Event|0|||
42144035|NCT00379236|75953253|FG001|Open-label Extension|Adverse Event|0|||
42144036|NCT00379236|75953254|FG002|Open-label Extension|Adverse Event|13|||
42144037|NCT00379236|75953252|FG000|Open-label Extension|Protocol Violation|0|||
42144038|NCT00379236|75953253|FG001|Open-label Extension|Protocol Violation|0|||
42144039|NCT00379236|75953254|FG002|Open-label Extension|Protocol Violation|7|||
42144040|NCT00379236|75953252|FG000|Open-label Extension|Withdrawal by Subject|0|||
42144041|NCT00379236|75953253|FG001|Open-label Extension|Withdrawal by Subject|0|||
42144042|NCT00379236|75953254|FG002|Open-label Extension|Withdrawal by Subject|13|||
42144043|NCT00379236|75953252|FG000|Open-label Extension|Lost to Follow-up|0|||
42144044|NCT00379236|75953253|FG001|Open-label Extension|Lost to Follow-up|0|||
42144045|NCT00379236|75953254|FG002|Open-label Extension|Lost to Follow-up|12|||
42144046|NCT00379236|75953252|FG000|Open-label Extension|Use of exclusionary medication|0|||
42144047|NCT00379236|75953253|FG001|Open-label Extension|Use of exclusionary medication|0|||
42144048|NCT00379236|75953254|FG002|Open-label Extension|Use of exclusionary medication|3|||
42144049|NCT00379236|75953252|FG000|Open-label Extension|Other|0|||
42144050|NCT00379236|75953253|FG001|Open-label Extension|Other|0|||
42144051|NCT00379236|75953254|FG002|Open-label Extension|Other|7|||
42144052|NCT00379080|75953269|FG000|Overall Study|Withdrawal by Subject|0|||
42144053|NCT00379080|75953270|FG001|Overall Study|Withdrawal by Subject|4|||
42144054|NCT00379080|75953271|FG002|Overall Study|Withdrawal by Subject|0|||
42144055|NCT00378534|75953296|FG000|Overall Study|Participants did not receive transplant|3|||
42144056|NCT00378534|75953297|FG001|Overall Study|Participants did not receive transplant|0|||
42144057|NCT00377676|75953304|FG000|Overall Study|Adverse Event|498|||
42144058|NCT00377676|75953305|FG001|Overall Study|Adverse Event|107|||
42144059|NCT00377676|75953304|FG000|Overall Study|Protocol Violation|33|||
42144060|NCT00377676|75953305|FG001|Overall Study|Protocol Violation|27|||
42144061|NCT00377676|75953304|FG000|Overall Study|Death|5|||
42144062|NCT00377676|75953305|FG001|Overall Study|Death|2|||
42144063|NCT00377676|75953304|FG000|Overall Study|Withdrawal by Subject|187|||
42144064|NCT00377676|75953305|FG001|Overall Study|Withdrawal by Subject|72|||
42144065|NCT00377676|75953304|FG000|Overall Study|Lost to Follow-up|120|||
42144066|NCT00377676|75953305|FG001|Overall Study|Lost to Follow-up|56|||
42144067|NCT00377676|75953304|FG000|Overall Study|Other|118|||
42144068|NCT00377676|75953305|FG001|Overall Study|Other|58|||
42012461|NCT01194219|75819483|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
42012462|NCT01194219|75819484|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
42012463|NCT01194219|75819475|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
42012464|NCT01194219|75819476|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
42012465|NCT01194219|75819477|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
42012466|NCT01194219|75819478|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
42012467|NCT01194219|75819479|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
42012468|NCT01194219|75819480|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
42012469|NCT01194219|75819481|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
42039152|NCT00821509|75847341|FG002|Overall Study|Withdrawal by Subject|34|||
42039153|NCT00821431|75847351|FG000|Overall Study|Adverse Event|6|||
42039154|NCT00821431|75847352|FG001|Overall Study|Adverse Event|3|||
42039155|NCT00821431|75847351|FG000|Overall Study|Withdrawal by Subject|5|||
42144069|NCT00377520|75953311|FG000|Overall Study|Ineligible (Prior radiation)|1|||
42144070|NCT00377364|75953317|FG000|Overall Study|Lost to Follow-up|1|||
42144071|NCT00377364|75953318|FG001|Overall Study|Lost to Follow-up|0|||
42144072|NCT00377364|75953317|FG000|Overall Study|Withdrawal by Subject|1|||
42144073|NCT00377364|75953318|FG001|Overall Study|Withdrawal by Subject|0|||
42144074|NCT03831282|75953326|FG000|Overall Study|Could not place sensor|1|||
42144075|NCT00365508|75953332|FG000|Overall Study|Lost to Follow-up|139|||
42144076|NCT00365508|75953333|FG001|Overall Study|Lost to Follow-up|154|||
42144077|NCT00365352|75953342|FG000|Overall Study|Adverse Event|6|||
42144078|NCT00365352|75953343|FG001|Overall Study|Adverse Event|7|||
42144079|NCT00365352|75953344|FG002|Overall Study|Adverse Event|8|||
42144080|NCT00365352|75953342|FG000|Overall Study|Participant Withdrew Consent|8|||
42144081|NCT00365352|75953343|FG001|Overall Study|Participant Withdrew Consent|3|||
42144082|NCT00365352|75953344|FG002|Overall Study|Participant Withdrew Consent|4|||
42144083|NCT00365352|75953342|FG000|Overall Study|Lack of Efficacy|3|||
42144084|NCT00365352|75953343|FG001|Overall Study|Lack of Efficacy|0|||
42144085|NCT00365352|75953344|FG002|Overall Study|Lack of Efficacy|0|||
42144086|NCT00365352|75953342|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
42144087|NCT00365352|75953343|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
42144088|NCT00365352|75953344|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
42144089|NCT00365352|75953342|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
42144090|NCT00365352|75953343|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
42144091|NCT00365352|75953344|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
42144092|NCT00365352|75953342|FG000|Overall Study|Lost to Follow-up|1|||
42144093|NCT00365352|75953343|FG001|Overall Study|Lost to Follow-up|1|||
42144094|NCT00365352|75953344|FG002|Overall Study|Lost to Follow-up|0|||
42144095|NCT00365352|75953342|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
42144096|NCT00365352|75953343|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
42144097|NCT00365352|75953344|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
42144098|NCT00376506|75953357|FG000|Overall Study|Death|0|||
42144099|NCT00376506|75953358|FG001|Overall Study|Death|2|||
42144100|NCT00410384|75953370|FG000|Overall Study|Withdrawal by Subject|28|||
42144101|NCT00410384|75953371|FG001|Overall Study|Withdrawal by Subject|17|||
42144102|NCT00410384|75953372|FG002|Overall Study|Withdrawal by Subject|20|||
42144103|NCT00410384|75953370|FG000|Overall Study|Adverse Event|23|||
42144104|NCT00410384|75953371|FG001|Overall Study|Adverse Event|18|||
42144105|NCT00410384|75953372|FG002|Overall Study|Adverse Event|23|||
42144106|NCT00410384|75953370|FG000|Overall Study|Lack of Efficacy|20|||
42144107|NCT00410384|75953371|FG001|Overall Study|Lack of Efficacy|12|||
42144108|NCT00410384|75953372|FG002|Overall Study|Lack of Efficacy|17|||
42144109|NCT00410384|75953370|FG000|Overall Study|Lack of Compliance|2|||
42144110|NCT00410384|75953371|FG001|Overall Study|Lack of Compliance|2|||
42144111|NCT00410384|75953372|FG002|Overall Study|Lack of Compliance|2|||
42144112|NCT00410384|75953370|FG000|Overall Study|Lost to Follow-up|4|||
42144113|NCT00410384|75953371|FG001|Overall Study|Lost to Follow-up|6|||
42144114|NCT00410384|75953372|FG002|Overall Study|Lost to Follow-up|6|||
42144115|NCT00410384|75953370|FG000|Overall Study|Protocol Violation|6|||
42144116|NCT00410384|75953371|FG001|Overall Study|Protocol Violation|6|||
42144117|NCT00410384|75953372|FG002|Overall Study|Protocol Violation|6|||
42144118|NCT00410384|75953370|FG000|Overall Study|Physician Decision|3|||
42144119|NCT00410384|75953371|FG001|Overall Study|Physician Decision|3|||
42144120|NCT00410384|75953372|FG002|Overall Study|Physician Decision|4|||
42144121|NCT00410384|75953370|FG000|Overall Study|Other|3|||
42144122|NCT00410384|75953371|FG001|Overall Study|Other|8|||
42144123|NCT00410384|75953372|FG002|Overall Study|Other|4|||
42144124|NCT00370032|75953382|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
42144125|NCT00370032|75953383|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
42144126|NCT00370032|75953382|FG000|Washout Period|Withdrawal by Subject|0|||
42144127|NCT00370032|75953383|FG001|Washout Period|Withdrawal by Subject|1|||
42144128|NCT00370032|75953382|FG000|Washout Period|Lost to Follow-up|0|||
42144129|NCT00370032|75953383|FG001|Washout Period|Lost to Follow-up|1|||
42144130|NCT00370032|75953382|FG000|Washout Period|Adverse Event|1|||
42144131|NCT00370032|75953383|FG001|Washout Period|Adverse Event|0|||
42144132|NCT00370032|75953382|FG000|Follow-up Period|Withdrawal by Subject|1|||
42276826|NCT02452892|76108377|FG003|Follow-up|Withdrawal by Subject|1|||
42012470|NCT01194219|75819482|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
42012471|NCT01194219|75819483|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
42012472|NCT01194219|75819484|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
42144133|NCT00370032|75953383|FG001|Follow-up Period|Withdrawal by Subject|0|||
42144134|NCT00410072|75953400|FG000|Day 1 to Week 48|Adverse Event|1|||
42144135|NCT00410072|75953401|FG001|Day 1 to Week 48|Adverse Event|2|||
42144136|NCT00410072|75953400|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
42144137|NCT00410072|75953401|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
42144138|NCT00410072|75953400|FG000|Day 1 to Week 48|Other|0|||
42144139|NCT00410072|75953401|FG001|Day 1 to Week 48|Other|1|||
42144140|NCT00410072|75953400|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
42144141|NCT00410072|75953401|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
42144142|NCT00410072|75953400|FG000|Day 1 to Week 48|Pregnancy|0|||
42144143|NCT00410072|75953401|FG001|Day 1 to Week 48|Pregnancy|2|||
42144144|NCT00410072|75953400|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
42276827|NCT02452892|76108374|FG000|Follow-up|Subject left town on Day 42|1|||
42276828|NCT02452892|76108375|FG001|Follow-up|Subject left town on Day 42|0|||
42276829|NCT02452892|76108376|FG002|Follow-up|Subject left town on Day 42|0|||
42144145|NCT00410072|75953401|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
42144146|NCT00410072|75953400|FG000|After Week 48 to Week 96|Adverse Event|1|||
42144147|NCT00410072|75953401|FG001|After Week 48 to Week 96|Adverse Event|2|||
42144148|NCT00410072|75953400|FG000|After Week 48 to Week 96|Death|0|||
42144149|NCT00410072|75953401|FG001|After Week 48 to Week 96|Death|1|||
42350953|NCT01550289|76190838|FG000|Overall Study|Lost to Follow-up|1|||
42012473|NCT01194219|75819475|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
42012474|NCT01194219|75819476|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
42012475|NCT01194219|75819477|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
42012476|NCT01194219|75819478|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
42012477|NCT01194219|75819479|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
42039156|NCT00821431|75847352|FG001|Overall Study|Withdrawal by Subject|0|||
42039157|NCT00821431|75847351|FG000|Overall Study|Lost to Follow-up|1|||
42039158|NCT00821431|75847352|FG001|Overall Study|Lost to Follow-up|0|||
42039159|NCT00821431|75847351|FG000|Overall Study|Protocol Violation|3|||
42039160|NCT00821431|75847352|FG001|Overall Study|Protocol Violation|1|||
42039161|NCT00821431|75847351|FG000|Overall Study|Physician Decision|0|||
42039162|NCT00821431|75847352|FG001|Overall Study|Physician Decision|1|||
42039163|NCT00813865|75847358|FG000|Overall Study|Failure to Respond|3|||
42039164|NCT00813865|75847358|FG000|Overall Study|Lost to Follow-up|3|||
42039165|NCT00813865|75847358|FG000|Overall Study|Withdrawal by Subject|1|||
42039166|NCT01147172|75847362|FG000|Overall Study|Withdrawal by Subject|2|||
42039167|NCT01147172|75847362|FG000|Overall Study|Lost to Follow-up|2|||
42039168|NCT01120964|75847370|FG000|Overall Study|Did not receive full treatment|1|||
42039169|NCT01120964|75847371|FG001|Overall Study|Did not receive full treatment|0|||
42039170|NCT01146860|75847379|FG000|Overall Study|Withdrawal by Subject|0|||
42039171|NCT01146860|75847380|FG001|Overall Study|Withdrawal by Subject|1|||
42039172|NCT00591565|75847386|FG000|Overall Study|lost follow up, withdrawn|5|||
42039173|NCT01146782|75847390|FG000|Screening Cohort|Screen Failure|187|||
42039174|NCT01146782|75847390|FG000|Screening Cohort|Lost to Follow-up|4|||
42039175|NCT01146782|75847390|FG000|Screening Cohort|Physician Decision|1|||
42039176|NCT01146782|75847390|FG000|Screening Cohort|Withdrawal by Subject|29|||
42039177|NCT01146782|75847390|FG000|Safety Cohort|Screen Failure|61|||
42039178|NCT01146782|75847390|FG000|Safety Cohort|Withdrawal by Subject|4|||
42039179|NCT01146782|75847390|FG000|Safety Cohort|Control AHI <5|4|||
42039180|NCT01146782|75847390|FG000|Safety Cohort|TST <4 hrs|14|||
42039181|NCT01146782|75847390|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
42039182|NCT01146782|75847390|FG000|Primary Endpoint Cohort|Physician Decision|1|||
42039183|NCT00978120|75847399|FG000|Overall Study|Death|0|||
42039184|NCT00978120|75847400|FG001|Overall Study|Death|0|||
42039185|NCT00978120|75847401|FG002|Overall Study|Death|0|||
42039186|NCT00978120|75847402|FG003|Overall Study|Death|1|||
42039187|NCT00978120|75847399|FG000|Overall Study|Lost to Follow-up|0|||
42039188|NCT00978120|75847400|FG001|Overall Study|Lost to Follow-up|0|||
42039189|NCT00978120|75847401|FG002|Overall Study|Lost to Follow-up|3|||
42039190|NCT00978120|75847402|FG003|Overall Study|Lost to Follow-up|0|||
42039191|NCT00978120|75847399|FG000|Overall Study|Withdrawal by Subject|2|||
42039192|NCT00978120|75847400|FG001|Overall Study|Withdrawal by Subject|0|||
42039193|NCT00978120|75847401|FG002|Overall Study|Withdrawal by Subject|0|||
42039194|NCT00978120|75847402|FG003|Overall Study|Withdrawal by Subject|0|||
42039195|NCT00978120|75847399|FG000|Overall Study|Moved out of state|0|||
42039196|NCT00978120|75847400|FG001|Overall Study|Moved out of state|0|||
42039197|NCT00978120|75847401|FG002|Overall Study|Moved out of state|0|||
42039198|NCT00978120|75847402|FG003|Overall Study|Moved out of state|1|||
42039199|NCT00978042|75847418|FG000|Initial Treatment Period|Treated in Error|0|||
42039200|NCT00978042|75847419|FG001|Initial Treatment Period|Treated in Error|3|||
42039201|NCT00978042|75847418|FG000|Initial Treatment Period|Ineligibility|1|||
42039202|NCT00978042|75847419|FG001|Initial Treatment Period|Ineligibility|0|||
42039203|NCT00978042|75847418|FG000|Initial Treatment Period|Lost to Follow-up|21|||
42039204|NCT00978042|75847419|FG001|Initial Treatment Period|Lost to Follow-up|3|||
42039205|NCT00978042|75847418|FG000|Initial Treatment Period|Adverse Event|2|||
42039206|NCT00978042|75847419|FG001|Initial Treatment Period|Adverse Event|0|||
42012478|NCT01194219|75819480|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
42012479|NCT01194219|75819481|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
42039207|NCT00978042|75847418|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
42039208|NCT00978042|75847419|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
42039209|NCT00978042|75847418|FG000|Initial Treatment Period|Consent withdrawn|22|||
42039210|NCT00978042|75847419|FG001|Initial Treatment Period|Consent withdrawn|9|||
42039211|NCT00978042|75847418|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
42039212|NCT00978042|75847419|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
42039213|NCT01133678|75847427|FG000|Overall Study|Death|1|||
42039214|NCT01133678|75847428|FG001|Overall Study|Death|1|||
42039215|NCT01133522|75847444|FG000|Overall Study|Withdrawal by Subject|0|||
42039216|NCT01133522|75847445|FG001|Overall Study|Withdrawal by Subject|1|||
42144150|NCT00410072|75953400|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
42144151|NCT00410072|75953401|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
42144152|NCT00410072|75953400|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
42144153|NCT00410072|75953401|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
42144154|NCT00410072|75953400|FG000|After Week 48 to Week 96|Other|2|||
42144155|NCT00410072|75953401|FG001|After Week 48 to Week 96|Other|0|||
42144156|NCT00410072|75953400|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
42144157|NCT00410072|75953401|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
42144158|NCT00410072|75953400|FG000|After Week 48 to Week 96|Pregnancy|0|||
42144159|NCT00410072|75953401|FG001|After Week 48 to Week 96|Pregnancy|2|||
42144160|NCT00410072|75953400|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
42144161|NCT00410072|75953401|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
42144162|NCT00409838|75953409|FG000|Short-term Period|Adverse Event|0|||
42144163|NCT00409838|75953410|FG001|Short-term Period|Adverse Event|1|||
42144164|NCT00409838|75953409|FG000|Short-term Period|Lost to Follow-up|0|||
42144165|NCT00409838|75953410|FG001|Short-term Period|Lost to Follow-up|1|||
42144166|NCT00409838|75953409|FG000|Short-term Period|Withdrawal by Subject|2|||
42144167|NCT00409838|75953410|FG001|Short-term Period|Withdrawal by Subject|3|||
42144168|NCT00409838|75953409|FG000|Short-term Period|Never Treated|1|||
42144169|NCT00409838|75953410|FG001|Short-term Period|Never Treated|0|||
42144170|NCT00409838|75953409|FG000|Long-term Extension Period|Adverse Event|10|||
42144171|NCT00409838|75953410|FG001|Long-term Extension Period|Adverse Event|0|||
42144172|NCT00409838|75953409|FG000|Long-term Extension Period|Death|1|||
42144173|NCT00409838|75953410|FG001|Long-term Extension Period|Death|0|||
42144174|NCT00409838|75953409|FG000|Long-term Extension Period|Lack of Efficacy|2|||
42144175|NCT00409838|75953410|FG001|Long-term Extension Period|Lack of Efficacy|0|||
42144176|NCT00409838|75953409|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
42144177|NCT00409838|75953410|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
42144178|NCT00409838|75953409|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
42144179|NCT00409838|75953410|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
42144180|NCT00409838|75953409|FG000|Long-term Extension Period|Pregnancy|1|||
42144181|NCT00409838|75953410|FG001|Long-term Extension Period|Pregnancy|0|||
42144182|NCT00399542|75953435|FG000|Overall Study|Adverse Event|18|||
42144183|NCT00399542|75953436|FG001|Overall Study|Adverse Event|15|||
42144184|NCT00399542|75953435|FG000|Overall Study|Protocol Violation|13|||
42144185|NCT00399542|75953436|FG001|Overall Study|Protocol Violation|3|||
42144186|NCT00399542|75953435|FG000|Overall Study|Withdrawal by Subject|28|||
42144187|NCT00399542|75953436|FG001|Overall Study|Withdrawal by Subject|10|||
42144188|NCT00399542|75953435|FG000|Overall Study|Lack of Efficacy|18|||
42144189|NCT00399542|75953436|FG001|Overall Study|Lack of Efficacy|8|||
42144190|NCT00399542|75953435|FG000|Overall Study|Lost to Follow-up|6|||
42144191|NCT00399542|75953436|FG001|Overall Study|Lost to Follow-up|6|||
42144192|NCT00399542|75953435|FG000|Overall Study|Other|1|||
42144193|NCT00399542|75953436|FG001|Overall Study|Other|0|||
42144194|NCT00399542|75953435|FG000|Overall Study|Physician Decision|0|||
42144195|NCT00399542|75953436|FG001|Overall Study|Physician Decision|1|||
42144196|NCT00409682|75953445|FG000|Open-label Induction Period|Adverse Event|1|||
42144197|NCT00409682|75953446|FG001|Open-label Induction Period|Adverse Event|0|||
42144198|NCT00409682|75953447|FG002|Open-label Induction Period|Adverse Event|0|||
42144199|NCT00409682|75953445|FG000|Open-label Induction Period|Lack of Efficacy|1|||
42144200|NCT00409682|75953446|FG001|Open-label Induction Period|Lack of Efficacy|0|||
42144201|NCT00409682|75953447|FG002|Open-label Induction Period|Lack of Efficacy|0|||
42144202|NCT00409682|75953445|FG000|Open-label Induction Period|Protocol Violation|1|||
42350954|NCT01550289|76190839|FG001|Overall Study|Lost to Follow-up|1|||
42350955|NCT01550289|76190838|FG000|Overall Study|Withdrawal by Subject|11|||
42039217|NCT01133522|75847446|FG002|Overall Study|Withdrawal by Subject|0|||
42039218|NCT01133522|75847447|FG003|Overall Study|Withdrawal by Subject|1|||
42039219|NCT01133522|75847448|FG004|Overall Study|Withdrawal by Subject|0|||
42039220|NCT01133522|75847449|FG005|Overall Study|Withdrawal by Subject|0|||
42039221|NCT01133522|75847450|FG006|Overall Study|Withdrawal by Subject|0|||
42039222|NCT01133522|75847451|FG007|Overall Study|Withdrawal by Subject|0|||
42039223|NCT01133522|75847452|FG008|Overall Study|Withdrawal by Subject|0|||
42039224|NCT01133522|75847453|FG009|Overall Study|Withdrawal by Subject|0|||
42039225|NCT01133522|75847444|FG000|Overall Study|Physician Decision|0|||
42039226|NCT01133522|75847445|FG001|Overall Study|Physician Decision|0|||
42039227|NCT01133522|75847446|FG002|Overall Study|Physician Decision|0|||
42039228|NCT01133522|75847447|FG003|Overall Study|Physician Decision|0|||
42144203|NCT00409682|75953446|FG001|Open-label Induction Period|Protocol Violation|0|||
42144204|NCT00409682|75953447|FG002|Open-label Induction Period|Protocol Violation|0|||
42350956|NCT01550289|76190839|FG001|Overall Study|Withdrawal by Subject|3|||
42350957|NCT01968031|76190850|FG000|Overall Study|Adverse Event|13|||
42039229|NCT01133522|75847448|FG004|Overall Study|Physician Decision|1|||
42039230|NCT01133522|75847449|FG005|Overall Study|Physician Decision|0|||
42144205|NCT00409682|75953445|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
42144206|NCT00409682|75953446|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
42144207|NCT00409682|75953447|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
42144208|NCT00409682|75953445|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
42144209|NCT00409682|75953446|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
42144210|NCT00409682|75953447|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
42144211|NCT00409682|75953445|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
42144212|NCT00409682|75953446|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
42144213|NCT00409682|75953447|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
42144214|NCT00409682|75953445|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
42144215|NCT00409682|75953446|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
42144216|NCT00409682|75953447|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
42144217|NCT00409682|75953445|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
42144218|NCT00409682|75953446|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
42144219|NCT00409682|75953447|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
42144220|NCT00409682|75953445|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
42144221|NCT00409682|75953446|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
42144222|NCT00409682|75953447|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
42144223|NCT00409682|75953445|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
42144224|NCT00409682|75953446|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
42144225|NCT00409682|75953447|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
42144226|NCT00398216|75953459|FG000|Overall Study|Adverse Event|4|||
42144227|NCT00398216|75953460|FG001|Overall Study|Adverse Event|2|||
42144228|NCT00398216|75953461|FG002|Overall Study|Adverse Event|5|||
42144229|NCT00398216|75953462|FG003|Overall Study|Adverse Event|7|||
42144230|NCT00398216|75953463|FG004|Overall Study|Adverse Event|2|||
42144231|NCT00398216|75953459|FG000|Overall Study|Protocol Violation|2|||
42144232|NCT00398216|75953460|FG001|Overall Study|Protocol Violation|4|||
42144233|NCT00398216|75953461|FG002|Overall Study|Protocol Violation|5|||
42144234|NCT00398216|75953462|FG003|Overall Study|Protocol Violation|7|||
42144235|NCT00398216|75953463|FG004|Overall Study|Protocol Violation|5|||
42144236|NCT00398216|75953459|FG000|Overall Study|Lost to Follow-up|1|||
42144237|NCT00398216|75953460|FG001|Overall Study|Lost to Follow-up|6|||
42144238|NCT00398216|75953461|FG002|Overall Study|Lost to Follow-up|4|||
42144239|NCT00398216|75953462|FG003|Overall Study|Lost to Follow-up|4|||
42144240|NCT00398216|75953463|FG004|Overall Study|Lost to Follow-up|1|||
42144241|NCT00398216|75953459|FG000|Overall Study|Death|0|||
42144242|NCT00398216|75953460|FG001|Overall Study|Death|3|||
42144243|NCT00398216|75953461|FG002|Overall Study|Death|0|||
42144244|NCT00398216|75953462|FG003|Overall Study|Death|0|||
42144245|NCT00398216|75953463|FG004|Overall Study|Death|0|||
42144246|NCT00398216|75953459|FG000|Overall Study|Withdrawal by Subject|1|||
42144247|NCT00398216|75953460|FG001|Overall Study|Withdrawal by Subject|0|||
42144248|NCT00398216|75953461|FG002|Overall Study|Withdrawal by Subject|3|||
42144249|NCT00398216|75953462|FG003|Overall Study|Withdrawal by Subject|1|||
42144250|NCT00398216|75953463|FG004|Overall Study|Withdrawal by Subject|2|||
42144251|NCT00398216|75953459|FG000|Overall Study|administrative reasons|3|||
42144252|NCT00398216|75953460|FG001|Overall Study|administrative reasons|4|||
42144253|NCT00398216|75953461|FG002|Overall Study|administrative reasons|4|||
42144254|NCT00398216|75953462|FG003|Overall Study|administrative reasons|3|||
42144255|NCT00398216|75953463|FG004|Overall Study|administrative reasons|3|||
42144256|NCT00398216|75953459|FG000|Overall Study|entrance criteria|0|||
42276830|NCT02452892|76108377|FG003|Follow-up|Subject left town on Day 42|0|||
42276831|NCT02135848|76108392|FG000|Overall Study|Adverse Event|2|||
42276832|NCT02135848|76108393|FG001|Overall Study|Adverse Event|0|||
42276833|NCT02135848|76108392|FG000|Overall Study|Withdrawal by Subject|1|||
42012480|NCT01194219|75819482|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
42276834|NCT02135848|76108393|FG001|Overall Study|Withdrawal by Subject|1|||
42276835|NCT02738333|76108413|FG000|Overall Study|Death|1|||
42276836|NCT02738333|76108414|FG001|Overall Study|Death|0|||
42276837|NCT02738333|76108415|FG002|Overall Study|Death|0|||
42276838|NCT02738333|76108413|FG000|Overall Study|Lost to Follow-up|1|||
42276839|NCT02738333|76108414|FG001|Overall Study|Lost to Follow-up|0|||
42276840|NCT02738333|76108415|FG002|Overall Study|Lost to Follow-up|0|||
42012481|NCT01194219|75819483|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
42012482|NCT01194219|75819484|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
42012483|NCT01194219|75819475|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
42012484|NCT01194219|75819476|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
42012485|NCT01194219|75819477|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
42039231|NCT01133522|75847450|FG006|Overall Study|Physician Decision|0|||
42144257|NCT00398216|75953460|FG001|Overall Study|entrance criteria|0|||
42144258|NCT00398216|75953461|FG002|Overall Study|entrance criteria|0|||
42144259|NCT00398216|75953462|FG003|Overall Study|entrance criteria|0|||
42144260|NCT00398216|75953463|FG004|Overall Study|entrance criteria|2|||
42276841|NCT02135692|76108423|FG000|Overall Study|Adverse Event|3|||
42276842|NCT02135692|76108423|FG000|Overall Study|Lack of Efficacy|2|||
42276843|NCT02135692|76108423|FG000|Overall Study|Protocol Violation|2|||
42276844|NCT02135692|76108423|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
42350958|NCT01968031|76190851|FG001|Overall Study|Adverse Event|10|||
42350959|NCT01968031|76190852|FG002|Overall Study|Adverse Event|22|||
42350960|NCT01968031|76190850|FG000|Overall Study|Withdrawal by Subject|3|||
42350961|NCT01968031|76190851|FG001|Overall Study|Withdrawal by Subject|7|||
42350962|NCT01968031|76190852|FG002|Overall Study|Withdrawal by Subject|3|||
42350963|NCT01968031|76190850|FG000|Overall Study|Did not meet entry criteria|1|||
42350964|NCT01968031|76190851|FG001|Overall Study|Did not meet entry criteria|1|||
42350965|NCT01968031|76190852|FG002|Overall Study|Did not meet entry criteria|1|||
42350966|NCT01968031|76190850|FG000|Overall Study|Noncompliance|0|||
42350967|NCT01968031|76190851|FG001|Overall Study|Noncompliance|0|||
42350968|NCT01968031|76190852|FG002|Overall Study|Noncompliance|2|||
42039232|NCT01133522|75847451|FG007|Overall Study|Physician Decision|0|||
42350969|NCT01968031|76190850|FG000|Overall Study|Failed inclusion criteria|0|||
42350970|NCT01968031|76190851|FG001|Overall Study|Failed inclusion criteria|2|||
42350971|NCT01968031|76190852|FG002|Overall Study|Failed inclusion criteria|0|||
42350972|NCT01968031|76190850|FG000|Overall Study|Death|0|||
42350973|NCT01968031|76190851|FG001|Overall Study|Death|0|||
42350974|NCT01968031|76190852|FG002|Overall Study|Death|1|||
42039233|NCT01133522|75847452|FG008|Overall Study|Physician Decision|0|||
42144261|NCT00398138|75953475|FG000|Overall Study|Adverse Event|2|||
42144262|NCT00397982|75953479|FG000|Overall Study|Withdrawal by Subject|1|||
42144263|NCT00397982|75953479|FG000|Overall Study|Adverse Event|1|||
42144264|NCT00397982|75953479|FG000|Overall Study|noncompliance|1|||
42144265|NCT00397982|75953479|FG000|Overall Study|Unrelated health issues|1|||
42144266|NCT00408902|75953484|FG000|Overall Study|Lack of Efficacy|7|||
42144267|NCT00408902|75953484|FG000|Overall Study|Adverse Event|3|||
42144268|NCT00397514|75953489|FG000|Overall Study|Withdrawal by Subject|1|||
42144269|NCT00397514|75953489|FG000|Overall Study|Pacing wire malfunction|1|||
42144270|NCT00397514|75953489|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
42144271|NCT00397514|75953489|FG000|Overall Study|early extubation|2|||
42144272|NCT00397514|75953489|FG000|Overall Study|poor echocardiographic windows|1|||
42144273|NCT00397046|75953503|FG000|Overall Study|Disease Progression|3|||
42144274|NCT00397046|75953504|FG001|Overall Study|Disease Progression|3|||
42144275|NCT00397046|75953505|FG002|Overall Study|Disease Progression|10|||
42144276|NCT00397046|75953506|FG003|Overall Study|Disease Progression|5|||
42144277|NCT00396812|75953517|FG000|Overall Study|Physician Decision|1|||
42144278|NCT00396656|75953521|FG000|First Treatment Period|Withdrawal by Subject|0|||
42144279|NCT00396656|75953522|FG001|First Treatment Period|Withdrawal by Subject|2|||
42144280|NCT00396656|75953521|FG000|Second Treatment Period|Adverse Event|0|||
42144281|NCT00396656|75953522|FG001|Second Treatment Period|Adverse Event|1|||
42144282|NCT00408434|75953535|FG000|Overall Study|Adverse Event|0|||
42144283|NCT00408434|75953536|FG001|Overall Study|Adverse Event|0|||
42144284|NCT00408434|75953537|FG002|Overall Study|Adverse Event|1|||
42144285|NCT00408434|75953538|FG003|Overall Study|Adverse Event|0|||
42144286|NCT00408434|75953539|FG004|Overall Study|Adverse Event|0|||
42144287|NCT00408434|75953540|FG005|Overall Study|Adverse Event|0|||
42144288|NCT00408434|75953541|FG006|Overall Study|Adverse Event|0|||
42144289|NCT00408434|75953535|FG000|Overall Study|Progressive disease|6|||
42144290|NCT00408434|75953536|FG001|Overall Study|Progressive disease|3|||
42144291|NCT00408434|75953537|FG002|Overall Study|Progressive disease|4|||
42144292|NCT00408434|75953538|FG003|Overall Study|Progressive disease|3|||
42144293|NCT00408434|75953539|FG004|Overall Study|Progressive disease|3|||
42144294|NCT00408434|75953540|FG005|Overall Study|Progressive disease|1|||
42144295|NCT00408434|75953541|FG006|Overall Study|Progressive disease|4|||
42144296|NCT00408434|75953535|FG000|Overall Study|Other|0|||
42144297|NCT00408434|75953536|FG001|Overall Study|Other|0|||
42144298|NCT00408434|75953537|FG002|Overall Study|Other|1|||
42144299|NCT00408434|75953538|FG003|Overall Study|Other|0|||
42144300|NCT00408434|75953539|FG004|Overall Study|Other|2|||
42144301|NCT00408434|75953540|FG005|Overall Study|Other|1|||
42276845|NCT02135692|76108423|FG000|Overall Study|Product commercially available|159|||
42276846|NCT02135692|76108423|FG000|Overall Study|Study closed/terminated|153|||
42276847|NCT02135692|76108423|FG000|Overall Study|Lost to Follow-up|4|||
42276848|NCT02135692|76108423|FG000|Overall Study|Withdrawal by Subject|15|||
42276849|NCT02429414|76108429|FG000|Overall Study|Physician Decision|0|||
42276850|NCT02429414|76108430|FG001|Overall Study|Physician Decision|1|||
42276851|NCT02135614|76108438|FG000|Overall Study|Randomized but Not Treated|2|||
42276852|NCT02135614|76108439|FG001|Overall Study|Randomized but Not Treated|1|||
42276853|NCT02135614|76108438|FG000|Overall Study|Adverse Event|0|||
42276854|NCT02135614|76108439|FG001|Overall Study|Adverse Event|1|||
42276855|NCT02135614|76108438|FG000|Overall Study|Death|1|||
42276856|NCT02135614|76108439|FG001|Overall Study|Death|0|||
42276857|NCT02135614|76108438|FG000|Overall Study|Investigator's Discretion|0|||
42276858|NCT02135614|76108439|FG001|Overall Study|Investigator's Discretion|1|||
42276859|NCT02135614|76108438|FG000|Overall Study|Withdrew Consent|2|||
42276860|NCT02135614|76108439|FG001|Overall Study|Withdrew Consent|2|||
42276861|NCT02135614|76108438|FG000|Overall Study|Lost to Follow-up|3|||
42276862|NCT02135614|76108439|FG001|Overall Study|Lost to Follow-up|0|||
42276863|NCT02168842|76108447|FG000|Overall Study|Withdrawal by Subject|5|||
42276864|NCT02168842|76108448|FG001|Overall Study|Withdrawal by Subject|3|||
42276865|NCT02168842|76108447|FG000|Overall Study|Lost to Follow-up|0|||
42276866|NCT02168842|76108448|FG001|Overall Study|Lost to Follow-up|2|||
42276867|NCT02168842|76108447|FG000|Overall Study|Death|2|||
42276868|NCT02168842|76108448|FG001|Overall Study|Death|1|||
42276869|NCT02168842|76108447|FG000|Overall Study|Physician Decision|1|||
42350975|NCT01968031|76190850|FG000|Overall Study|Prohibited concomitant medication|1|||
42350976|NCT01968031|76190851|FG001|Overall Study|Prohibited concomitant medication|0|||
42144302|NCT00408434|75953541|FG006|Overall Study|Other|0|||
42144303|NCT00408434|75953535|FG000|Overall Study|Terminated by Investigator|0|||
42144304|NCT00408434|75953536|FG001|Overall Study|Terminated by Investigator|0|||
42144305|NCT00408434|75953537|FG002|Overall Study|Terminated by Investigator|0|||
42144306|NCT00408434|75953538|FG003|Overall Study|Terminated by Investigator|0|||
42276870|NCT02168842|76108448|FG001|Overall Study|Physician Decision|2|||
42276871|NCT02200042|76108458|FG000|Overall Study|Withdrawal by Subject|0|||
42276872|NCT02200042|76108459|FG001|Overall Study|Withdrawal by Subject|1|||
42276873|NCT02199028|76108467|FG000|Week 1|Adverse Event|1|||
42276874|NCT02199028|76108468|FG001|Week 1|Adverse Event|0|||
42276875|NCT02199028|76108467|FG000|Week 3|Adverse Event|1|||
42276876|NCT02199028|76108468|FG001|Week 3|Adverse Event|0|||
42144307|NCT00408434|75953539|FG004|Overall Study|Terminated by Investigator|1|||
42144308|NCT00408434|75953540|FG005|Overall Study|Terminated by Investigator|1|||
42144309|NCT00408434|75953541|FG006|Overall Study|Terminated by Investigator|0|||
42144310|NCT00418184|75953560|FG000|Double-blind Phase|Withdrawal by Subject|22|||
42144311|NCT00418184|75953561|FG001|Double-blind Phase|Withdrawal by Subject|9|||
42144312|NCT00418184|75953560|FG000|Double-blind Phase|Adverse Event|2|||
42144313|NCT00418184|75953561|FG001|Double-blind Phase|Adverse Event|1|||
42144314|NCT00418184|75953560|FG000|Double-blind Phase|Poor compliance|3|||
42144315|NCT00418184|75953561|FG001|Double-blind Phase|Poor compliance|1|||
42144316|NCT00407030|75953570|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
42144317|NCT00407030|75953571|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
42144318|NCT00407030|75953572|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
42144319|NCT00407030|75953570|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
42144320|NCT00407030|75953571|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
42144321|NCT00407030|75953572|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
42144322|NCT00407030|75953570|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
42144323|NCT00407030|75953571|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
42144324|NCT00407030|75953572|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
42144325|NCT00407030|75953570|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
42144326|NCT00407030|75953571|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
42144327|NCT00407030|75953572|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
42144328|NCT00407030|75953570|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
42144329|NCT00407030|75953571|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
42144330|NCT00407030|75953572|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
42144331|NCT00407030|75953570|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
42144332|NCT00407030|75953571|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
42144333|NCT00407030|75953572|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
42144334|NCT00407030|75953570|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
42144335|NCT00407030|75953571|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
42144336|NCT00407030|75953572|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
42144337|NCT00407030|75953570|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
42144338|NCT00407030|75953571|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
42144339|NCT00407030|75953572|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
42144340|NCT00407030|75953570|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
42144341|NCT00407030|75953571|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
42144342|NCT00407030|75953572|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
42144343|NCT00407030|75953570|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
42144344|NCT00407030|75953571|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
42144345|NCT00407030|75953572|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
42144346|NCT00407030|75953570|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
42144347|NCT00407030|75953571|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
42144348|NCT00407030|75953572|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
42012486|NCT01194219|75819478|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
42012487|NCT01194219|75819479|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
42012488|NCT01194219|75819480|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
42012489|NCT01194219|75819481|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
42012490|NCT01194219|75819482|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
42012491|NCT01194219|75819483|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
42012492|NCT01194219|75819484|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
42012493|NCT01194219|75819475|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
42012494|NCT01194219|75819476|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
42012495|NCT01194219|75819477|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
42012496|NCT01194219|75819478|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
42012497|NCT01194219|75819479|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
42012498|NCT01194219|75819480|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
42012499|NCT01194219|75819481|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
42012500|NCT01194219|75819482|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
42012501|NCT01194219|75819483|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
42012502|NCT01194219|75819484|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
42012503|NCT01194219|75819475|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
42012504|NCT01194219|75819476|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
42012505|NCT01194219|75819477|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
42012506|NCT01194219|75819478|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
42039234|NCT01133522|75847453|FG009|Overall Study|Physician Decision|0|||
42144349|NCT00407030|75953570|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
42144350|NCT00407030|75953571|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
42144351|NCT00407030|75953572|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
42144352|NCT00407030|75953570|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
42012507|NCT01194219|75819479|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
42144353|NCT00407030|75953571|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
42144354|NCT00407030|75953572|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
42144355|NCT00406718|75953585|FG000|Overall Study|Withdrawal by Subject|2|||
42144356|NCT00406718|75953586|FG001|Overall Study|Withdrawal by Subject|9|||
42144357|NCT00406718|75953587|FG002|Overall Study|Withdrawal by Subject|4|||
42144358|NCT00406718|75953585|FG000|Overall Study|Lost to Follow-up|2|||
42144359|NCT00406718|75953586|FG001|Overall Study|Lost to Follow-up|5|||
42144360|NCT00406718|75953587|FG002|Overall Study|Lost to Follow-up|4|||
42144361|NCT00394706|75953605|FG000|Overall Study|Withdrawal by Subject|2|||
42144362|NCT00394706|75953606|FG001|Overall Study|Withdrawal by Subject|0|||
42144363|NCT00394706|75953607|FG002|Overall Study|Withdrawal by Subject|1|||
42144364|NCT00394706|75953608|FG003|Overall Study|Withdrawal by Subject|0|||
42144365|NCT00394706|75953609|FG004|Overall Study|Withdrawal by Subject|0|||
42144366|NCT00394706|75953610|FG005|Overall Study|Withdrawal by Subject|2|||
42144367|NCT00394706|75953611|FG006|Overall Study|Withdrawal by Subject|1|||
42144368|NCT00394706|75953612|FG007|Overall Study|Withdrawal by Subject|0|||
42144369|NCT00394706|75953605|FG000|Overall Study|Lost to Follow-up|2|||
42144370|NCT00394706|75953606|FG001|Overall Study|Lost to Follow-up|2|||
42144371|NCT00394706|75953607|FG002|Overall Study|Lost to Follow-up|8|||
42144372|NCT00394706|75953608|FG003|Overall Study|Lost to Follow-up|1|||
42144373|NCT00394706|75953609|FG004|Overall Study|Lost to Follow-up|2|||
42144374|NCT00394706|75953610|FG005|Overall Study|Lost to Follow-up|5|||
42144375|NCT00394706|75953611|FG006|Overall Study|Lost to Follow-up|2|||
42144376|NCT00394706|75953612|FG007|Overall Study|Lost to Follow-up|0|||
42144377|NCT00394472|75953628|FG000|Overall Study|Protocol Violation|1|||
42144378|NCT00394472|75953629|FG001|Overall Study|Protocol Violation|3|||
42144379|NCT00394472|75953628|FG000|Overall Study|incorrect enrolment|4|||
42144380|NCT00394472|75953629|FG001|Overall Study|incorrect enrolment|2|||
42144381|NCT00394472|75953628|FG000|Overall Study|Adverse Event|4|||
42144382|NCT00394472|75953629|FG001|Overall Study|Adverse Event|2|||
42144383|NCT00394472|75953628|FG000|Overall Study|Withdrawal by Subject|0|||
42144384|NCT00394472|75953629|FG001|Overall Study|Withdrawal by Subject|2|||
42144385|NCT00394472|75953628|FG000|Overall Study|Physician Decision|0|||
42144386|NCT00394472|75953629|FG001|Overall Study|Physician Decision|1|||
42144387|NCT00394472|75953628|FG000|Overall Study|Lost to Follow-up|0|||
42144388|NCT00394472|75953629|FG001|Overall Study|Lost to Follow-up|1|||
42144389|NCT00419120|75953635|FG000|Long Term Follow up Period|study ongoing|10|||
42144390|NCT00395642|75953639|FG000|Overall Study|Death|4|||
42276877|NCT03347123|76108477|FG000|Overall Study|Death|1|||
42276878|NCT03347123|76108478|FG001|Overall Study|Death|2|||
42350977|NCT01968031|76190852|FG002|Overall Study|Prohibited concomitant medication|0|||
42350978|NCT01684215|76190864|FG000|Phase 1, Part 1|Adverse Event|1|||
42350979|NCT01684215|76190865|FG001|Phase 1, Part 1|Adverse Event|0|||
42350980|NCT01684215|76190866|FG002|Phase 1, Part 1|Adverse Event|0|||
42350981|NCT01684215|76190867|FG003|Phase 1, Part 1|Adverse Event|0|||
42350982|NCT01684215|76190864|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
42350983|NCT01684215|76190865|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
42350984|NCT01684215|76190866|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
42350985|NCT01684215|76190867|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
42350986|NCT01684215|76190864|FG000|Phase 1, Part 2|Adverse Event|0|||
42350987|NCT01684215|76190865|FG001|Phase 1, Part 2|Adverse Event|0|||
42350988|NCT01684215|76190866|FG002|Phase 1, Part 2|Adverse Event|1|||
42276879|NCT03347123|76108479|FG002|Overall Study|Death|0|||
42276880|NCT03347123|76108480|FG003|Overall Study|Death|0|||
42350989|NCT01684215|76190867|FG003|Phase 1, Part 2|Adverse Event|0|||
42350990|NCT01684215|76190864|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
42012508|NCT01194219|75819480|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
42276881|NCT03347123|76108481|FG004|Overall Study|Death|0|||
42276882|NCT03347123|76108482|FG005|Overall Study|Death|0|||
42276883|NCT03347123|76108483|FG006|Overall Study|Death|0|||
42276884|NCT03347123|76108477|FG000|Overall Study|Withdrawal by Subject|1|||
42276885|NCT03347123|76108478|FG001|Overall Study|Withdrawal by Subject|0|||
42350991|NCT01684215|76190865|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
42012509|NCT01194219|75819481|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
42144391|NCT00395642|75953639|FG000|Overall Study|Lost to Follow-up|1|||
42350992|NCT01684215|76190866|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
42350993|NCT01684215|76190867|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
42350994|NCT01684215|76190864|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
42144392|NCT00395642|75953639|FG000|Overall Study|Physician Decision|7|||
42144393|NCT00395642|75953639|FG000|Overall Study|Withdrawal by Subject|1|||
42144394|NCT00395486|75953645|FG000|Overall Study|Adverse Event|1|||
42144395|NCT00395486|75953646|FG001|Overall Study|Adverse Event|2|||
42144396|NCT00395486|75953645|FG000|Overall Study|Withdrawal by Subject|5|||
42144397|NCT00395486|75953646|FG001|Overall Study|Withdrawal by Subject|2|||
42276886|NCT03347123|76108479|FG002|Overall Study|Withdrawal by Subject|0|||
42276887|NCT03347123|76108480|FG003|Overall Study|Withdrawal by Subject|0|||
42276888|NCT03347123|76108481|FG004|Overall Study|Withdrawal by Subject|0|||
42350995|NCT01684215|76190865|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
42350996|NCT01684215|76190866|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
42350997|NCT01684215|76190867|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
42350998|NCT01684215|76190864|FG000|Phase 2|Death|0|||
42350999|NCT01684215|76190865|FG001|Phase 2|Death|0|||
42351000|NCT01684215|76190866|FG002|Phase 2|Death|0|||
42351001|NCT01684215|76190867|FG003|Phase 2|Death|8|||
42351002|NCT01684215|76190864|FG000|Phase 2|Study terminated by sponsor|0|||
42351003|NCT01684215|76190865|FG001|Phase 2|Study terminated by sponsor|0|||
42351004|NCT01684215|76190866|FG002|Phase 2|Study terminated by sponsor|0|||
42351005|NCT01684215|76190867|FG003|Phase 2|Study terminated by sponsor|30|||
42351006|NCT01684215|76190864|FG000|Phase 2|Enrolled but not treated|0|||
42351007|NCT01684215|76190865|FG001|Phase 2|Enrolled but not treated|0|||
42351008|NCT01684215|76190866|FG002|Phase 2|Enrolled but not treated|0|||
42351009|NCT01684215|76190867|FG003|Phase 2|Enrolled but not treated|1|||
42351010|NCT01684215|76190864|FG000|Phase 2|Lost to Follow-up|0|||
42351011|NCT01684215|76190865|FG001|Phase 2|Lost to Follow-up|0|||
42351012|NCT01684215|76190866|FG002|Phase 2|Lost to Follow-up|0|||
42351013|NCT01684215|76190867|FG003|Phase 2|Lost to Follow-up|4|||
42351014|NCT01549275|76190882|FG000|Overall Study|Lost to Follow-up|1|||
42351015|NCT01549275|76190883|FG001|Overall Study|Lost to Follow-up|0|||
42351016|NCT01908205|76190895|FG000|Overall Study|Lost to Follow-up|2|||
42351017|NCT01908205|76190896|FG001|Overall Study|Lost to Follow-up|0|||
42351018|NCT01908205|76190895|FG000|Overall Study|Withdrawal by Subject|3|||
42351019|NCT01908205|76190896|FG001|Overall Study|Withdrawal by Subject|1|||
42351020|NCT01549041|76190917|FG000|Overall Study|Lack of Efficacy|2|||
42351021|NCT01549041|76190918|FG001|Overall Study|Lack of Efficacy|4|||
42351022|NCT01549041|76190917|FG000|Overall Study|Adverse Event|0|||
42351023|NCT01549041|76190918|FG001|Overall Study|Adverse Event|4|||
42351024|NCT01907815|76190926|FG000|Overall Study|Withdrawal by Subject|1|||
42351025|NCT01907815|76190927|FG001|Overall Study|Withdrawal by Subject|0|||
42351026|NCT01548573|76190935|FG000|Overall Study|Death|3|||
42351027|NCT01548573|76190935|FG000|Overall Study|Withdrawal by Subject|2|||
42351028|NCT01907737|76190940|FG000|Overall Study|Withdrawal by Subject|1|||
42351029|NCT01570491|76190952|FG000|Overall Study|Lost to Follow-up|3|||
42351030|NCT01570491|76190953|FG001|Overall Study|Lost to Follow-up|1|||
42351031|NCT01570491|76190952|FG000|Overall Study|treatment: not given or discontinued|2|||
42351032|NCT01570491|76190953|FG001|Overall Study|treatment: not given or discontinued|0|||
42351033|NCT01929109|76190964|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
42351034|NCT01929109|76190965|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
42351035|NCT01929109|76190966|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
42351036|NCT01929109|76190967|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
42351037|NCT01929109|76190968|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
42351038|NCT01518153|76190983|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
42351039|NCT01518153|76190984|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
42351040|NCT01518153|76190985|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
42351041|NCT01518153|76190983|FG000|Stem Cell Transplant|Death|2|||
42351042|NCT01518153|76190984|FG001|Stem Cell Transplant|Death|0|||
42351043|NCT01518153|76190985|FG002|Stem Cell Transplant|Death|0|||
42039235|NCT01133288|75847482|FG000|Eligibility Assessment|met exclusion criteria|5|||
42039236|NCT01133288|75847482|FG000|Intervention Allocation|study terminated|2|||
42276889|NCT03347123|76108482|FG005|Overall Study|Withdrawal by Subject|0|||
42276890|NCT03347123|76108483|FG006|Overall Study|Withdrawal by Subject|0|||
42276891|NCT03347123|76108477|FG000|Overall Study|Reason not Specified|3|||
42276892|NCT03347123|76108478|FG001|Overall Study|Reason not Specified|4|||
42276893|NCT03347123|76108479|FG002|Overall Study|Reason not Specified|0|||
42276894|NCT03347123|76108480|FG003|Overall Study|Reason not Specified|0|||
42276895|NCT03347123|76108481|FG004|Overall Study|Reason not Specified|0|||
42276896|NCT03347123|76108482|FG005|Overall Study|Reason not Specified|0|||
42351044|NCT01518153|76190983|FG000|Stem Cell Transplant|Secondary graft failure|1|||
42351045|NCT01518153|76190984|FG001|Stem Cell Transplant|Secondary graft failure|0|||
42351046|NCT01518153|76190985|FG002|Stem Cell Transplant|Secondary graft failure|0|||
42351047|NCT01518153|76190983|FG000|Stem Cell Transplant|Adverse Event|1|||
42351048|NCT01518153|76190984|FG001|Stem Cell Transplant|Adverse Event|0|||
42351049|NCT01518153|76190985|FG002|Stem Cell Transplant|Adverse Event|0|||
42351050|NCT01518153|76190983|FG000|Donor Lymphocyte Infusion|Death|0|||
42351051|NCT01518153|76190984|FG001|Donor Lymphocyte Infusion|Death|2|||
42351052|NCT01518153|76190985|FG002|Donor Lymphocyte Infusion|Death|1|||
42351053|NCT01906489|76190995|FG000|Overall Study|Adverse Event|10|||
42351054|NCT01906489|76190996|FG001|Overall Study|Adverse Event|3|||
42351055|NCT01906489|76190995|FG000|Overall Study|Worsening of CKD|6|||
42276897|NCT03347123|76108483|FG006|Overall Study|Reason not Specified|0|||
42351056|NCT01906489|76190996|FG001|Overall Study|Worsening of CKD|4|||
42039237|NCT00883090|75847490|FG000|Overall Study|Sponsor's decision|1|||
42144398|NCT00395486|75953645|FG000|Overall Study|Lost to Follow-up|0|||
42144399|NCT00395486|75953646|FG001|Overall Study|Lost to Follow-up|1|||
42144400|NCT00395018|75953652|FG000|On-Treatment|Death|4|||
42144401|NCT00395018|75953652|FG000|On-Treatment|Other Reason|2|||
42144402|NCT00395018|75953652|FG000|On-Treatment|Poor/non-compliance|2|||
42144403|NCT00395018|75953652|FG000|On-Treatment|Subject no longer meets study criteria|2|||
42144404|NCT00395018|75953652|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
42144405|NCT00395018|75953652|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
42144406|NCT00395018|75953652|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
42144407|NCT00375518|75953658|FG000|Overall Study|Withdrawal by Subject|2|||
42144408|NCT00375518|75953659|FG001|Overall Study|Withdrawal by Subject|10|||
42144409|NCT00375518|75953658|FG000|Overall Study|Patient Not Treated|6|||
42144410|NCT00375518|75953659|FG001|Overall Study|Patient Not Treated|6|||
42144411|NCT00375518|75953658|FG000|Overall Study|Death|0|||
42144412|NCT00375518|75953659|FG001|Overall Study|Death|1|||
42144413|NCT00256750|75953668|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
42144414|NCT00256750|75953669|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
42144415|NCT00256750|75953670|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
42144416|NCT00256750|75953668|FG000|Transplanted Pre-Treatment|Other|2|||
42144417|NCT00256750|75953669|FG001|Transplanted Pre-Treatment|Other|0|||
42144418|NCT00256750|75953670|FG002|Transplanted Pre-Treatment|Other|0|||
42144419|NCT00256750|75953668|FG000|Transplanted Pre-Treatment|Death|1|||
42144420|NCT00256750|75953669|FG001|Transplanted Pre-Treatment|Death|0|||
42144421|NCT00256750|75953670|FG002|Transplanted Pre-Treatment|Death|0|||
42144422|NCT00256750|75953668|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
42144423|NCT00256750|75953669|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
42144424|NCT00256750|75953670|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
42144425|NCT00256750|75953668|FG000|Post-Transplant Treated (12 Months)|Death|3|||
42144426|NCT00256750|75953669|FG001|Post-Transplant Treated (12 Months)|Death|2|||
42039238|NCT00883090|75847490|FG000|Overall Study|Withdrawal by Subject|1|||
42039239|NCT01132820|75847494|FG000|Overall Study|Ineligible: wrong cell type|1|||
42039240|NCT01132820|75847494|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
42039241|NCT01132820|75847494|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
42039242|NCT01132820|75847494|FG000|Overall Study|Never treated|1|||
42039243|NCT01132820|75847494|FG000|Overall Study|Inadequate data|1|||
42039244|NCT00885352|75847513|FG000|Overall Study|Adverse Event|2|||
42039245|NCT00885352|75847514|FG001|Overall Study|Adverse Event|3|||
42039246|NCT00885352|75847513|FG000|Overall Study|Lost to Follow-up|2|||
42039247|NCT00885352|75847514|FG001|Overall Study|Lost to Follow-up|2|||
42039248|NCT00885352|75847513|FG000|Overall Study|Physician Decision|0|||
42039249|NCT00885352|75847514|FG001|Overall Study|Physician Decision|3|||
42039250|NCT00885352|75847513|FG000|Overall Study|Protocol Violation|0|||
42039251|NCT00885352|75847514|FG001|Overall Study|Protocol Violation|2|||
42039252|NCT00885352|75847513|FG000|Overall Study|Withdrawal by Subject|1|||
42039253|NCT00885352|75847514|FG001|Overall Study|Withdrawal by Subject|5|||
42039254|NCT00885352|75847513|FG000|Overall Study|Contradiction to study medication|0|||
42039255|NCT00885352|75847514|FG001|Overall Study|Contradiction to study medication|2|||
42039256|NCT00885352|75847513|FG000|Overall Study|Excluded medication|2|||
42039257|NCT00885352|75847514|FG001|Overall Study|Excluded medication|2|||
42039258|NCT00885352|75847513|FG000|Overall Study|Lab abnormalities|1|||
42039259|NCT00885352|75847514|FG001|Overall Study|Lab abnormalities|1|||
42039260|NCT00885118|75847525|FG000|Overall Study|Adverse Event|1|||
42039261|NCT00885118|75847526|FG001|Overall Study|Adverse Event|0|||
42039262|NCT00885118|75847527|FG002|Overall Study|Adverse Event|0|||
42039263|NCT00885118|75847528|FG003|Overall Study|Adverse Event|0|||
42039264|NCT00885118|75847529|FG004|Overall Study|Adverse Event|0|||
42039265|NCT00885118|75847525|FG000|Overall Study|Withdrawal by Subject|0|||
42039266|NCT00885118|75847526|FG001|Overall Study|Withdrawal by Subject|0|||
42039267|NCT00885118|75847527|FG002|Overall Study|Withdrawal by Subject|0|||
42039268|NCT00885118|75847528|FG003|Overall Study|Withdrawal by Subject|0|||
42039269|NCT00885118|75847529|FG004|Overall Study|Withdrawal by Subject|1|||
42039270|NCT00885118|75847525|FG000|Overall Study|Other reason not defined above|0|||
42144427|NCT00256750|75953670|FG002|Post-Transplant Treated (12 Months)|Death|4|||
42144428|NCT00256750|75953668|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
42144429|NCT00256750|75953669|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
42144430|NCT00256750|75953670|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
42144431|NCT00256750|75953668|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
42144432|NCT00256750|75953669|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
42039271|NCT00885118|75847526|FG001|Overall Study|Other reason not defined above|0|||
42039272|NCT00885118|75847527|FG002|Overall Study|Other reason not defined above|1|||
42039273|NCT00885118|75847528|FG003|Overall Study|Other reason not defined above|0|||
42039274|NCT00885118|75847529|FG004|Overall Study|Other reason not defined above|0|||
42039275|NCT00880906|75847547|FG000|Overall Study|Lost to Follow-up|0|||
42144433|NCT00256750|75953670|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
42144434|NCT00256750|75953668|FG000|Post-Transplant Treated (12 Months)|Other|5|||
42144435|NCT00256750|75953669|FG001|Post-Transplant Treated (12 Months)|Other|4|||
42144436|NCT00256750|75953670|FG002|Post-Transplant Treated (12 Months)|Other|2|||
42144437|NCT00256750|75953668|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
42144438|NCT00256750|75953669|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
42144439|NCT00256750|75953670|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
42144440|NCT00256750|75953668|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
42144441|NCT00256750|75953669|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
42144442|NCT00256750|75953670|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
42144443|NCT00256750|75953668|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
42144444|NCT00256750|75953669|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
42144445|NCT00256750|75953670|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
42144446|NCT00256750|75953668|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
42144447|NCT00256750|75953669|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
42144448|NCT00256750|75953670|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
42144449|NCT00256750|75953668|FG000|Post-Transplant Treated (24 Months)|Death|3|||
42144450|NCT00256750|75953669|FG001|Post-Transplant Treated (24 Months)|Death|0|||
42144451|NCT00256750|75953670|FG002|Post-Transplant Treated (24 Months)|Death|0|||
42144452|NCT00256750|75953668|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
42144453|NCT00256750|75953669|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
42144454|NCT00256750|75953670|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
42144455|NCT00256750|75953668|FG000|Post-Transplant Treated (24 Months)|Other|2|||
42144456|NCT00256750|75953669|FG001|Post-Transplant Treated (24 Months)|Other|0|||
42144457|NCT00256750|75953670|FG002|Post-Transplant Treated (24 Months)|Other|1|||
42144458|NCT00256750|75953668|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
42144459|NCT00256750|75953669|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
42144460|NCT00256750|75953670|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
42144461|NCT00256750|75953668|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
42144462|NCT00256750|75953669|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
42144463|NCT00256750|75953670|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
42144464|NCT00256750|75953668|FG000|Post-Transplant Treated (36 Months)|Death|0|||
42144465|NCT00256750|75953669|FG001|Post-Transplant Treated (36 Months)|Death|2|||
42144466|NCT00256750|75953670|FG002|Post-Transplant Treated (36 Months)|Death|1|||
42144467|NCT00256750|75953668|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
42144468|NCT00256750|75953669|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
42144469|NCT00256750|75953670|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
42144470|NCT00256750|75953668|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
42144471|NCT00256750|75953669|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
42144472|NCT00256750|75953670|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
42144473|NCT00256750|75953668|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
42144474|NCT00256750|75953669|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
42144475|NCT00256750|75953670|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
42144476|NCT00256750|75953668|FG000|Post-Transplant Treated (36 Months)|Other|0|||
42144477|NCT00256750|75953669|FG001|Post-Transplant Treated (36 Months)|Other|1|||
42144478|NCT00256750|75953670|FG002|Post-Transplant Treated (36 Months)|Other|1|||
42144479|NCT00256750|75953668|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
42144480|NCT00256750|75953669|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
42144481|NCT00256750|75953670|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
42144482|NCT00256750|75953668|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
42144483|NCT00256750|75953669|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
42144484|NCT00256750|75953670|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
42144485|NCT00256750|75953668|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
42144486|NCT00256750|75953669|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
42144487|NCT00256750|75953670|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
42144488|NCT00256750|75953668|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
42144489|NCT00256750|75953669|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
42144490|NCT00256750|75953670|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
42144491|NCT00256750|75953668|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
42144492|NCT00256750|75953669|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
42276898|NCT02198794|76108494|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
42276899|NCT02198794|76108495|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
42144493|NCT00256750|75953670|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
42144494|NCT00256750|75953668|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
42144495|NCT00256750|75953669|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
42276900|NCT02198794|76108496|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
42276901|NCT02198794|76108497|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
42144496|NCT00256750|75953670|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
42144497|NCT00256750|75953668|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
42144498|NCT00256750|75953669|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
42144499|NCT00256750|75953670|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
42144500|NCT00256750|75953668|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
42144501|NCT00256750|75953669|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
42144502|NCT00256750|75953670|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
42144503|NCT00256750|75953668|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
42144504|NCT00256750|75953669|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
42144505|NCT00256750|75953670|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
42144506|NCT00279201|75953681|FG000|Initiation|Death|1|||
42144507|NCT00279201|75953682|FG001|Initiation|Death|5|||
42144508|NCT00279201|75953683|FG002|Initiation|Death|0|||
42144509|NCT00279201|75953684|FG003|Initiation|Death|0|||
42144510|NCT00279201|75953685|FG004|Initiation|Death|0|||
42144511|NCT00279201|75953686|FG005|Initiation|Death|0|||
42144512|NCT00279201|75953681|FG000|Initiation|Adverse Event|6|||
42144513|NCT00279201|75953682|FG001|Initiation|Adverse Event|15|||
42144514|NCT00279201|75953683|FG002|Initiation|Adverse Event|0|||
42144515|NCT00279201|75953684|FG003|Initiation|Adverse Event|0|||
42144516|NCT00279201|75953685|FG004|Initiation|Adverse Event|0|||
42144517|NCT00279201|75953686|FG005|Initiation|Adverse Event|0|||
42144518|NCT00279201|75953681|FG000|Initiation|Lost to Follow-up|42|||
42144519|NCT00279201|75953682|FG001|Initiation|Lost to Follow-up|41|||
42144520|NCT00279201|75953683|FG002|Initiation|Lost to Follow-up|0|||
42144521|NCT00279201|75953684|FG003|Initiation|Lost to Follow-up|0|||
42144522|NCT00279201|75953685|FG004|Initiation|Lost to Follow-up|0|||
42144523|NCT00279201|75953686|FG005|Initiation|Lost to Follow-up|0|||
42144524|NCT00279201|75953681|FG000|Initiation|Entry Criteria Exclusion|7|||
42144525|NCT00279201|75953682|FG001|Initiation|Entry Criteria Exclusion|9|||
42144526|NCT00279201|75953683|FG002|Initiation|Entry Criteria Exclusion|0|||
42144527|NCT00279201|75953684|FG003|Initiation|Entry Criteria Exclusion|0|||
42144528|NCT00279201|75953685|FG004|Initiation|Entry Criteria Exclusion|0|||
42144529|NCT00279201|75953686|FG005|Initiation|Entry Criteria Exclusion|0|||
42144530|NCT00279201|75953681|FG000|Initiation|Protocol Violation|9|||
42144531|NCT00279201|75953682|FG001|Initiation|Protocol Violation|10|||
42144532|NCT00279201|75953683|FG002|Initiation|Protocol Violation|0|||
42144533|NCT00279201|75953684|FG003|Initiation|Protocol Violation|0|||
42144534|NCT00279201|75953685|FG004|Initiation|Protocol Violation|0|||
42144535|NCT00279201|75953686|FG005|Initiation|Protocol Violation|0|||
42144536|NCT00279201|75953681|FG000|Initiation|Withdrawal by Subject|35|||
42144537|NCT00279201|75953682|FG001|Initiation|Withdrawal by Subject|41|||
42144538|NCT00279201|75953683|FG002|Initiation|Withdrawal by Subject|0|||
42144539|NCT00279201|75953684|FG003|Initiation|Withdrawal by Subject|0|||
42144540|NCT00279201|75953685|FG004|Initiation|Withdrawal by Subject|0|||
42144541|NCT00279201|75953686|FG005|Initiation|Withdrawal by Subject|0|||
42144542|NCT00279201|75953681|FG000|Initiation|Physician Decision|15|||
42144543|NCT00279201|75953682|FG001|Initiation|Physician Decision|18|||
42144544|NCT00279201|75953683|FG002|Initiation|Physician Decision|0|||
42144545|NCT00279201|75953684|FG003|Initiation|Physician Decision|0|||
42144546|NCT00279201|75953685|FG004|Initiation|Physician Decision|0|||
42144547|NCT00279201|75953686|FG005|Initiation|Physician Decision|0|||
42144548|NCT00279201|75953681|FG000|Initiation|Sponsor Decision|13|||
42144549|NCT00279201|75953682|FG001|Initiation|Sponsor Decision|5|||
42144550|NCT00279201|75953683|FG002|Initiation|Sponsor Decision|0|||
42144551|NCT00279201|75953684|FG003|Initiation|Sponsor Decision|0|||
42144552|NCT00279201|75953685|FG004|Initiation|Sponsor Decision|0|||
42144553|NCT00279201|75953686|FG005|Initiation|Sponsor Decision|0|||
42144554|NCT00279201|75953681|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
42144555|NCT00279201|75953682|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
42144556|NCT00279201|75953683|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
42144557|NCT00279201|75953684|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
42144558|NCT00279201|75953685|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
42144559|NCT00279201|75953686|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
42144560|NCT00279201|75953681|FG000|Maintenance|Lack of Efficacy|32|||
42144561|NCT00279201|75953682|FG001|Maintenance|Lack of Efficacy|30|||
42144562|NCT00279201|75953683|FG002|Maintenance|Lack of Efficacy|0|||
42144563|NCT00279201|75953684|FG003|Maintenance|Lack of Efficacy|0|||
42144564|NCT00279201|75953685|FG004|Maintenance|Lack of Efficacy|0|||
42144565|NCT00279201|75953686|FG005|Maintenance|Lack of Efficacy|0|||
42144566|NCT00279201|75953681|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
42144567|NCT00279201|75953682|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
42144568|NCT00279201|75953683|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
42144569|NCT00279201|75953684|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
42144570|NCT00279201|75953685|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
42144571|NCT00279201|75953686|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
42144572|NCT00279201|75953681|FG000|Maintenance|Adverse Event|4|||
42144573|NCT00279201|75953682|FG001|Maintenance|Adverse Event|4|||
42276902|NCT02198794|76108494|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
42276903|NCT02198794|76108495|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
42276904|NCT02198794|76108496|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
42276905|NCT02198794|76108497|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
42276906|NCT02198794|76108494|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
42276907|NCT02198794|76108495|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
42276908|NCT02198794|76108496|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
42276909|NCT02198794|76108497|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
42276910|NCT02198794|76108494|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
42276911|NCT02198794|76108495|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
42276912|NCT02198794|76108496|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
42276913|NCT02198794|76108497|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
42276914|NCT02198794|76108494|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
42276915|NCT02198794|76108495|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
42276916|NCT02198794|76108496|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
42276917|NCT02198794|76108497|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
42276918|NCT02198794|76108494|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
42276919|NCT02198794|76108495|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
42276920|NCT02198794|76108496|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
42276921|NCT02198794|76108497|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
42276922|NCT02198794|76108494|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
42276923|NCT02198794|76108495|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
42276924|NCT02198794|76108496|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
42276925|NCT02198794|76108497|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
42276926|NCT02198794|76108494|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
42276927|NCT02198794|76108495|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
42276928|NCT02198794|76108496|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
42276929|NCT02198794|76108497|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
42276930|NCT02198794|76108494|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
42276931|NCT02198794|76108495|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
42276932|NCT02198794|76108496|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
42276933|NCT02198794|76108497|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
42276934|NCT02198794|76108494|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
42276935|NCT02198794|76108495|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
42276936|NCT02198794|76108496|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
42276937|NCT02198794|76108497|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
42276938|NCT02198794|76108494|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
42276939|NCT02198794|76108495|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
42276940|NCT02198794|76108496|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
42276941|NCT02198794|76108497|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
42276942|NCT02198794|76108494|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
42276943|NCT02198794|76108495|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
42276944|NCT02198794|76108496|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
42276945|NCT02198794|76108497|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
42276946|NCT02198794|76108494|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
42276947|NCT02198794|76108495|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
42276948|NCT02198794|76108496|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
42276949|NCT02198794|76108497|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
42276950|NCT02198794|76108494|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
42276951|NCT02198794|76108495|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
42276952|NCT02198794|76108496|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
42276953|NCT02198794|76108497|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
42276954|NCT02198794|76108494|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
42276955|NCT02198794|76108495|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
42276956|NCT02198794|76108496|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
42276957|NCT02198794|76108497|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
42012510|NCT01194219|75819482|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
42012511|NCT01194219|75819483|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
42012512|NCT01194219|75819484|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
42144574|NCT00279201|75953683|FG002|Maintenance|Adverse Event|0|||
42276958|NCT02133664|76108508|FG000|Overall Study|Lost to Follow-up|2|||
42012513|NCT01194219|75819475|FG000|Maintenance Phase Weeks16-32|Other|0|||
42012514|NCT01194219|75819476|FG001|Maintenance Phase Weeks16-32|Other|0|||
42144575|NCT00279201|75953684|FG003|Maintenance|Adverse Event|0|||
42144576|NCT00279201|75953685|FG004|Maintenance|Adverse Event|0|||
42144577|NCT00279201|75953686|FG005|Maintenance|Adverse Event|0|||
42144578|NCT00279201|75953681|FG000|Maintenance|Death|4|||
42144579|NCT00279201|75953682|FG001|Maintenance|Death|4|||
42144580|NCT00279201|75953683|FG002|Maintenance|Death|0|||
42144581|NCT00279201|75953684|FG003|Maintenance|Death|0|||
42144582|NCT00279201|75953685|FG004|Maintenance|Death|0|||
42144583|NCT00279201|75953686|FG005|Maintenance|Death|0|||
42144584|NCT00279201|75953681|FG000|Maintenance|Lost to Follow-up|17|||
42144585|NCT00279201|75953682|FG001|Maintenance|Lost to Follow-up|13|||
42144586|NCT00279201|75953683|FG002|Maintenance|Lost to Follow-up|0|||
42144587|NCT00279201|75953684|FG003|Maintenance|Lost to Follow-up|0|||
42144588|NCT00279201|75953685|FG004|Maintenance|Lost to Follow-up|0|||
42144589|NCT00279201|75953686|FG005|Maintenance|Lost to Follow-up|0|||
42144590|NCT00279201|75953681|FG000|Maintenance|Entry Criteria Exclusion|1|||
42144591|NCT00279201|75953682|FG001|Maintenance|Entry Criteria Exclusion|4|||
42144592|NCT00279201|75953683|FG002|Maintenance|Entry Criteria Exclusion|0|||
42144593|NCT00279201|75953684|FG003|Maintenance|Entry Criteria Exclusion|0|||
42144594|NCT00279201|75953685|FG004|Maintenance|Entry Criteria Exclusion|0|||
42144595|NCT00279201|75953686|FG005|Maintenance|Entry Criteria Exclusion|0|||
42144596|NCT00279201|75953681|FG000|Maintenance|Protocol Violation|16|||
42144597|NCT00279201|75953682|FG001|Maintenance|Protocol Violation|24|||
42144598|NCT00279201|75953683|FG002|Maintenance|Protocol Violation|0|||
42144599|NCT00279201|75953684|FG003|Maintenance|Protocol Violation|0|||
42144600|NCT00279201|75953685|FG004|Maintenance|Protocol Violation|0|||
42144601|NCT00279201|75953686|FG005|Maintenance|Protocol Violation|0|||
42144602|NCT00279201|75953681|FG000|Maintenance|Withdrawal by Subject|18|||
42144603|NCT00279201|75953682|FG001|Maintenance|Withdrawal by Subject|18|||
42144604|NCT00279201|75953683|FG002|Maintenance|Withdrawal by Subject|0|||
42144605|NCT00279201|75953684|FG003|Maintenance|Withdrawal by Subject|0|||
42144606|NCT00279201|75953685|FG004|Maintenance|Withdrawal by Subject|0|||
42144607|NCT00279201|75953686|FG005|Maintenance|Withdrawal by Subject|0|||
42144608|NCT00279201|75953681|FG000|Maintenance|Physician Decision|9|||
42144609|NCT00279201|75953682|FG001|Maintenance|Physician Decision|9|||
42144610|NCT00279201|75953683|FG002|Maintenance|Physician Decision|0|||
42144611|NCT00279201|75953684|FG003|Maintenance|Physician Decision|0|||
42144612|NCT00279201|75953685|FG004|Maintenance|Physician Decision|0|||
42144613|NCT00279201|75953686|FG005|Maintenance|Physician Decision|0|||
42144614|NCT00279201|75953681|FG000|Maintenance|Sponsor Decision|4|||
42144615|NCT00279201|75953682|FG001|Maintenance|Sponsor Decision|0|||
42144616|NCT00279201|75953683|FG002|Maintenance|Sponsor Decision|0|||
42144617|NCT00279201|75953684|FG003|Maintenance|Sponsor Decision|0|||
42144618|NCT00279201|75953685|FG004|Maintenance|Sponsor Decision|0|||
42144619|NCT00279201|75953686|FG005|Maintenance|Sponsor Decision|0|||
42144620|NCT00279201|75953681|FG000|Maintenance|HbA1c>7.5%|123|||
42144621|NCT00279201|75953682|FG001|Maintenance|HbA1c>7.5%|126|||
42144622|NCT00279201|75953683|FG002|Maintenance|HbA1c>7.5%|0|||
42144623|NCT00279201|75953684|FG003|Maintenance|HbA1c>7.5%|0|||
42144624|NCT00279201|75953685|FG004|Maintenance|HbA1c>7.5%|0|||
42144625|NCT00279201|75953686|FG005|Maintenance|HbA1c>7.5%|0|||
42144626|NCT00279201|75953681|FG000|Intensification Addendum|Withdrawal by Subject|0|||
42144627|NCT00279201|75953682|FG001|Intensification Addendum|Withdrawal by Subject|0|||
42144628|NCT00279201|75953683|FG002|Intensification Addendum|Withdrawal by Subject|12|||
42039276|NCT00880906|75847548|FG001|Overall Study|Lost to Follow-up|1|||
42039277|NCT00880906|75847547|FG000|Overall Study|Did not meet criteria following patholog|12|||
42039278|NCT00880906|75847548|FG001|Overall Study|Did not meet criteria following patholog|6|||
42039279|NCT00882310|75847554|FG000|Overall Study|Screen Failure|10|||
42039280|NCT00882310|75847554|FG000|Overall Study|Never received treatment|1|||
42039281|NCT00882310|75847554|FG000|Overall Study|Death|6|||
42039282|NCT00882310|75847554|FG000|Overall Study|Progression of disease|4|||
42039283|NCT00882310|75847554|FG000|Overall Study|Adverse Event|1|||
42039284|NCT00884650|75847560|FG000|Overall Study|Did not return complete pain diaries|7|||
42039285|NCT00884650|75847561|FG001|Overall Study|Did not return complete pain diaries|7|||
42039286|NCT00884650|75847560|FG000|Overall Study|Admitted Post-Op|1|||
42039287|NCT00884650|75847561|FG001|Overall Study|Admitted Post-Op|0|||
42144629|NCT00279201|75953684|FG003|Intensification Addendum|Withdrawal by Subject|14|||
42144630|NCT00279201|75953685|FG004|Intensification Addendum|Withdrawal by Subject|9|||
42144631|NCT00279201|75953686|FG005|Intensification Addendum|Withdrawal by Subject|18|||
42144632|NCT00279201|75953681|FG000|Intensification Addendum|Lost to Follow-up|0|||
42144633|NCT00279201|75953682|FG001|Intensification Addendum|Lost to Follow-up|0|||
42144634|NCT00279201|75953683|FG002|Intensification Addendum|Lost to Follow-up|4|||
42144635|NCT00279201|75953684|FG003|Intensification Addendum|Lost to Follow-up|6|||
42144636|NCT00279201|75953685|FG004|Intensification Addendum|Lost to Follow-up|7|||
42144637|NCT00279201|75953686|FG005|Intensification Addendum|Lost to Follow-up|7|||
42144638|NCT00279201|75953681|FG000|Intensification Addendum|Protocol Violation|0|||
42039288|NCT00884650|75847560|FG000|Overall Study|Femoral Stress Fracture|1|||
42039289|NCT00884650|75847561|FG001|Overall Study|Femoral Stress Fracture|0|||
42039290|NCT00884650|75847560|FG000|Overall Study|Pain Pump Complication|0|||
42144639|NCT00279201|75953682|FG001|Intensification Addendum|Protocol Violation|0|||
42144640|NCT00279201|75953683|FG002|Intensification Addendum|Protocol Violation|2|||
42144641|NCT00279201|75953684|FG003|Intensification Addendum|Protocol Violation|2|||
42144642|NCT00279201|75953685|FG004|Intensification Addendum|Protocol Violation|6|||
42144643|NCT00279201|75953686|FG005|Intensification Addendum|Protocol Violation|6|||
42144644|NCT00279201|75953681|FG000|Intensification Addendum|Adverse Event|0|||
42144645|NCT00279201|75953682|FG001|Intensification Addendum|Adverse Event|0|||
42144646|NCT00279201|75953683|FG002|Intensification Addendum|Adverse Event|0|||
42144647|NCT00279201|75953684|FG003|Intensification Addendum|Adverse Event|4|||
42144648|NCT00279201|75953685|FG004|Intensification Addendum|Adverse Event|1|||
42144649|NCT00279201|75953686|FG005|Intensification Addendum|Adverse Event|3|||
42144650|NCT00279201|75953681|FG000|Intensification Addendum|Physician Decision|0|||
42144651|NCT00279201|75953682|FG001|Intensification Addendum|Physician Decision|0|||
42144652|NCT00279201|75953683|FG002|Intensification Addendum|Physician Decision|4|||
42144653|NCT00279201|75953684|FG003|Intensification Addendum|Physician Decision|1|||
42144654|NCT00279201|75953685|FG004|Intensification Addendum|Physician Decision|3|||
42144655|NCT00279201|75953686|FG005|Intensification Addendum|Physician Decision|2|||
42144656|NCT00279201|75953681|FG000|Intensification Addendum|Sponsor Decision|0|||
42144657|NCT00279201|75953682|FG001|Intensification Addendum|Sponsor Decision|0|||
42144658|NCT00279201|75953683|FG002|Intensification Addendum|Sponsor Decision|0|||
42144659|NCT00279201|75953684|FG003|Intensification Addendum|Sponsor Decision|0|||
42144660|NCT00279201|75953685|FG004|Intensification Addendum|Sponsor Decision|1|||
42144661|NCT00279201|75953686|FG005|Intensification Addendum|Sponsor Decision|1|||
42144662|NCT00279201|75953681|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
42144663|NCT00279201|75953682|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
42144664|NCT00279201|75953683|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
42144665|NCT00279201|75953684|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
42144666|NCT00279201|75953685|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
42144667|NCT00279201|75953686|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
42144668|NCT00279201|75953681|FG000|Intensification Addendum|Lack of Efficacy|0|||
42144669|NCT00279201|75953682|FG001|Intensification Addendum|Lack of Efficacy|0|||
42144670|NCT00279201|75953683|FG002|Intensification Addendum|Lack of Efficacy|0|||
42144671|NCT00279201|75953684|FG003|Intensification Addendum|Lack of Efficacy|1|||
42144672|NCT00279201|75953685|FG004|Intensification Addendum|Lack of Efficacy|1|||
42144673|NCT00279201|75953686|FG005|Intensification Addendum|Lack of Efficacy|0|||
42144674|NCT00279201|75953681|FG000|Intensification Addendum|Death|0|||
42144675|NCT00279201|75953682|FG001|Intensification Addendum|Death|0|||
42144676|NCT00279201|75953683|FG002|Intensification Addendum|Death|0|||
42144677|NCT00279201|75953684|FG003|Intensification Addendum|Death|0|||
42144678|NCT00279201|75953685|FG004|Intensification Addendum|Death|1|||
42144679|NCT00279201|75953686|FG005|Intensification Addendum|Death|0|||
42144680|NCT00203476|75953722|FG000|Overall Study|Lost to Follow-up|1|||
42144681|NCT00203476|75953723|FG001|Overall Study|Lost to Follow-up|0|||
42144682|NCT00203476|75953724|FG002|Overall Study|Lost to Follow-up|0|||
42144683|NCT00203476|75953722|FG000|Overall Study|Withdrawal by Subject|0|||
42144684|NCT00203476|75953723|FG001|Overall Study|Withdrawal by Subject|1|||
42144685|NCT00203476|75953724|FG002|Overall Study|Withdrawal by Subject|0|||
42144686|NCT00203242|75953732|FG000|Overall Study|Lost to Follow-up|1|||
42144687|NCT00200356|75953738|FG000|Overall Study|Lack of Efficacy|3|||
42144688|NCT00200356|75953739|FG001|Overall Study|Lack of Efficacy|3|||
42144689|NCT00200356|75953738|FG000|Overall Study|Protocol Violation|4|||
42144690|NCT00200356|75953739|FG001|Overall Study|Protocol Violation|4|||
42144691|NCT00200356|75953738|FG000|Overall Study|Nontreatment|1|||
42144692|NCT00200356|75953739|FG001|Overall Study|Nontreatment|0|||
42144693|NCT00227344|75953747|FG000|Overall Study|study terminated early|12|||
42012515|NCT01194219|75819477|FG002|Maintenance Phase Weeks16-32|Other|2|||
42012516|NCT01194219|75819478|FG003|Maintenance Phase Weeks16-32|Other|1|||
42012517|NCT01194219|75819479|FG004|Maintenance Phase Weeks16-32|Other|0|||
42012518|NCT01194219|75819480|FG005|Maintenance Phase Weeks16-32|Other|0|||
42012519|NCT01194219|75819481|FG006|Maintenance Phase Weeks16-32|Other|0|||
42012520|NCT01194219|75819482|FG007|Maintenance Phase Weeks16-32|Other|0|||
42012521|NCT01194219|75819483|FG008|Maintenance Phase Weeks16-32|Other|0|||
42144694|NCT00227344|75953748|FG001|Overall Study|study terminated early|5|||
42276959|NCT02133664|76108509|FG001|Overall Study|Lost to Follow-up|1|||
42276960|NCT02133664|76108508|FG000|Overall Study|Adverse Event|3|||
42012522|NCT01194219|75819484|FG009|Maintenance Phase Weeks16-32|Other|0|||
42144695|NCT00227266|75953757|FG000|Overall Study|Withdrawal by Subject|0|||
42144696|NCT00227266|75953758|FG001|Overall Study|Withdrawal by Subject|0|||
42144697|NCT00227266|75953759|FG002|Overall Study|Withdrawal by Subject|1|||
42144698|NCT00227266|75953757|FG000|Overall Study|Protocol Violation|1|||
42144699|NCT00227266|75953758|FG001|Overall Study|Protocol Violation|0|||
42144700|NCT00227266|75953759|FG002|Overall Study|Protocol Violation|1|||
42144701|NCT00227266|75953757|FG000|Overall Study|Excessive weight gain|0|||
42144702|NCT00227266|75953758|FG001|Overall Study|Excessive weight gain|0|||
42276961|NCT02133664|76108509|FG001|Overall Study|Adverse Event|6|||
42144703|NCT00227266|75953759|FG002|Overall Study|Excessive weight gain|2|||
42144704|NCT00256282|75953770|FG000|Overall Study|Disease progression, relapse during acti|12|||
42144705|NCT00256282|75953770|FG000|Overall Study|Adverse Event|3|||
42144706|NCT00256282|75953770|FG000|Overall Study|Physician Decision|1|||
42144707|NCT00266877|75953777|FG000|Overall Study|Death|1|||
42144708|NCT00266877|75953778|FG001|Overall Study|Death|1|||
42144709|NCT00266877|75953779|FG002|Overall Study|Death|1|||
42144710|NCT00266877|75953777|FG000|Overall Study|Adverse Event|6|||
42144711|NCT00266877|75953778|FG001|Overall Study|Adverse Event|4|||
42144712|NCT00266877|75953779|FG002|Overall Study|Adverse Event|1|||
42144713|NCT00266877|75953777|FG000|Overall Study|Physician Decision|2|||
42144714|NCT00266877|75953778|FG001|Overall Study|Physician Decision|1|||
42144715|NCT00266877|75953779|FG002|Overall Study|Physician Decision|1|||
42144716|NCT00266877|75953777|FG000|Overall Study|Withdrawal by Subject|3|||
42144717|NCT00266877|75953778|FG001|Overall Study|Withdrawal by Subject|1|||
42144718|NCT00266877|75953779|FG002|Overall Study|Withdrawal by Subject|1|||
42144719|NCT00266877|75953777|FG000|Overall Study|Disease Progression|72|||
42144720|NCT00266877|75953778|FG001|Overall Study|Disease Progression|37|||
42144721|NCT00266877|75953779|FG002|Overall Study|Disease Progression|23|||
42144722|NCT00266877|75953777|FG000|Overall Study|Symptomatic Deterioration|6|||
42144723|NCT00266877|75953778|FG001|Overall Study|Symptomatic Deterioration|3|||
42144724|NCT00266877|75953779|FG002|Overall Study|Symptomatic Deterioration|1|||
42144725|NCT00266877|75953777|FG000|Overall Study|Hospitalization|1|||
42144726|NCT00266877|75953778|FG001|Overall Study|Hospitalization|0|||
42144727|NCT00266877|75953779|FG002|Overall Study|Hospitalization|0|||
42144728|NCT00266877|75953777|FG000|Overall Study|Concomitant Radiotherapy|0|||
42144729|NCT00266877|75953778|FG001|Overall Study|Concomitant Radiotherapy|1|||
42144730|NCT00266877|75953779|FG002|Overall Study|Concomitant Radiotherapy|0|||
42144731|NCT00256204|75953791|FG000|Overall Study|Adverse Event|10|||
42144732|NCT00256204|75953792|FG001|Overall Study|Adverse Event|14|||
42144733|NCT00256204|75953793|FG002|Overall Study|Adverse Event|16|||
42144734|NCT00256204|75953794|FG003|Overall Study|Adverse Event|14|||
42144735|NCT00256204|75953791|FG000|Overall Study|Death|0|||
42144736|NCT00256204|75953792|FG001|Overall Study|Death|1|||
42144737|NCT00256204|75953793|FG002|Overall Study|Death|0|||
42144738|NCT00256204|75953794|FG003|Overall Study|Death|0|||
42144739|NCT00256204|75953791|FG000|Overall Study|Lost to Follow-up|1|||
42144740|NCT00256204|75953792|FG001|Overall Study|Lost to Follow-up|1|||
42144741|NCT00256204|75953793|FG002|Overall Study|Lost to Follow-up|1|||
42144742|NCT00256204|75953794|FG003|Overall Study|Lost to Follow-up|2|||
42144743|NCT00256204|75953791|FG000|Overall Study|Protocol Violation|1|||
42144744|NCT00256204|75953792|FG001|Overall Study|Protocol Violation|0|||
42144745|NCT00256204|75953793|FG002|Overall Study|Protocol Violation|2|||
42144746|NCT00256204|75953794|FG003|Overall Study|Protocol Violation|1|||
42144747|NCT00256204|75953791|FG000|Overall Study|Physician Decision|0|||
42144748|NCT00256204|75953792|FG001|Overall Study|Physician Decision|0|||
42144749|NCT00256204|75953793|FG002|Overall Study|Physician Decision|1|||
42144750|NCT00256204|75953794|FG003|Overall Study|Physician Decision|2|||
42144751|NCT00256204|75953791|FG000|Overall Study|Withdrawal by Subject|17|||
42144752|NCT00256204|75953792|FG001|Overall Study|Withdrawal by Subject|6|||
42144753|NCT00256204|75953793|FG002|Overall Study|Withdrawal by Subject|7|||
42144754|NCT00256204|75953794|FG003|Overall Study|Withdrawal by Subject|5|||
42144755|NCT00256204|75953791|FG000|Overall Study|Need for additional prohibited treatment|38|||
42144756|NCT00256204|75953792|FG001|Overall Study|Need for additional prohibited treatment|28|||
42144757|NCT00256204|75953793|FG002|Overall Study|Need for additional prohibited treatment|27|||
42144758|NCT00256204|75953794|FG003|Overall Study|Need for additional prohibited treatment|25|||
42144759|NCT00256126|75953809|FG000|Overall Study|Adverse Event|1|||
42144760|NCT00256126|75953810|FG001|Overall Study|Adverse Event|0|||
42144761|NCT00256126|75953809|FG000|Overall Study|Other|1|||
42144762|NCT00256126|75953810|FG001|Overall Study|Other|2|||
42276962|NCT02133508|76108515|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
42276963|NCT02133508|76108515|FG000|Overall Study|Death|12|||
42144763|NCT00278889|75953819|FG000|Overall Study|Withdrawal by Subject|0|||
42144764|NCT00278889|75953820|FG001|Overall Study|Withdrawal by Subject|5|||
42144765|NCT00278889|75953821|FG002|Overall Study|Withdrawal by Subject|3|||
42144766|NCT00278889|75953819|FG000|Overall Study|Lost to Follow-up|1|||
42144767|NCT00278889|75953820|FG001|Overall Study|Lost to Follow-up|1|||
42144768|NCT00278889|75953821|FG002|Overall Study|Lost to Follow-up|0|||
42144769|NCT00278889|75953819|FG000|Overall Study|Death|24|||
42144770|NCT00278889|75953820|FG001|Overall Study|Death|21|||
42144771|NCT00278889|75953821|FG002|Overall Study|Death|17|||
42144772|NCT00278109|75953829|FG000|Overall Study|Adverse Event|3|||
42144773|NCT00278109|75953829|FG000|Overall Study|social circumstances|1|||
42144774|NCT00296517|75953835|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
42144775|NCT00296517|75953836|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
42144776|NCT00296517|75953835|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
42144777|NCT00296517|75953836|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
42144778|NCT00296517|75953835|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
42144779|NCT00296517|75953836|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
42144780|NCT00296517|75953835|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
42144781|NCT00296517|75953836|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
42144782|NCT00296517|75953835|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
42144783|NCT00296517|75953836|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
42144784|NCT00296517|75953835|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
42144785|NCT00296517|75953836|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
42144786|NCT00296517|75953835|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
42144787|NCT00296517|75953836|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
42144788|NCT00296517|75953835|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
42144789|NCT00296517|75953836|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
42144790|NCT00296517|75953835|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
42144791|NCT00296517|75953836|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
42144792|NCT00224770|75953845|FG000|Overall Study|Lost to Follow-up|4|||
42144793|NCT00224770|75953846|FG001|Overall Study|Lost to Follow-up|2|||
42144794|NCT00224770|75953847|FG002|Overall Study|Lost to Follow-up|0|||
42144795|NCT00266409|75953860|FG000|Overall Study|Lack of Efficacy|2|||
42144796|NCT00266409|75953861|FG001|Overall Study|Lack of Efficacy|6|||
42144797|NCT00266409|75953862|FG002|Overall Study|Lack of Efficacy|1|||
42144798|NCT00266409|75953863|FG003|Overall Study|Lack of Efficacy|2|||
42144799|NCT00266409|75953860|FG000|Overall Study|Adverse Event|7|||
42144800|NCT00266409|75953861|FG001|Overall Study|Adverse Event|2|||
42144801|NCT00266409|75953862|FG002|Overall Study|Adverse Event|1|||
42144802|NCT00266409|75953863|FG003|Overall Study|Adverse Event|1|||
42144803|NCT00266409|75953860|FG000|Overall Study|Lost to Follow-up|18|||
42144804|NCT00266409|75953861|FG001|Overall Study|Lost to Follow-up|21|||
42144805|NCT00266409|75953862|FG002|Overall Study|Lost to Follow-up|6|||
42144806|NCT00266409|75953863|FG003|Overall Study|Lost to Follow-up|8|||
42144807|NCT00266409|75953860|FG000|Overall Study|Withdrawal by Subject|6|||
42144808|NCT00266409|75953861|FG001|Overall Study|Withdrawal by Subject|10|||
42144809|NCT00266409|75953862|FG002|Overall Study|Withdrawal by Subject|3|||
42144810|NCT00266409|75953863|FG003|Overall Study|Withdrawal by Subject|9|||
42144811|NCT00266409|75953860|FG000|Overall Study|Protocol Violation|5|||
42144812|NCT00266409|75953861|FG001|Overall Study|Protocol Violation|3|||
42144813|NCT00266409|75953862|FG002|Overall Study|Protocol Violation|4|||
42144814|NCT00266409|75953863|FG003|Overall Study|Protocol Violation|2|||
42144815|NCT00266409|75953860|FG000|Overall Study|Other|7|||
42144816|NCT00266409|75953861|FG001|Overall Study|Other|4|||
42144817|NCT00266409|75953862|FG002|Overall Study|Other|2|||
42144818|NCT00266409|75953863|FG003|Overall Study|Other|0|||
42144819|NCT00277095|75953873|FG000|Overall Study|Death|2|||
42144820|NCT00277095|75953873|FG000|Overall Study|Explanted|7|||
42144821|NCT00277095|75953873|FG000|Overall Study|Lost to Follow-up|2|||
42144822|NCT00277095|75953873|FG000|Overall Study|Missed Follow-up|9|||
42144823|NCT00277095|75953873|FG000|Overall Study|Physician Decision|1|||
42144824|NCT00265785|75953877|FG000|Overall Study|Adverse Event|4|||
42144825|NCT00265785|75953877|FG000|Overall Study|Withdrawal by Subject|3|||
42144826|NCT00265785|75953877|FG000|Overall Study|Progression/Relapse|15|||
42144827|NCT00265785|75953877|FG000|Overall Study|Not protocol specified|2|||
42144828|NCT00265785|75953877|FG000|Overall Study|Ineligible|1|||
42144829|NCT00265785|75953877|FG000|Overall Study|Did not receive protocol treatment|2|||
42144830|NCT00276159|75953881|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
42144831|NCT00265395|75953887|FG000|Overall Study|Adverse Event|3|||
42144832|NCT00265395|75953888|FG001|Overall Study|Adverse Event|6|||
42144833|NCT00265395|75953887|FG000|Overall Study|Lost to Follow-up|2|||
42144834|NCT00265395|75953888|FG001|Overall Study|Lost to Follow-up|1|||
42144835|NCT00265395|75953887|FG000|Overall Study|Withdrawal by Subject|1|||
42144836|NCT00265395|75953888|FG001|Overall Study|Withdrawal by Subject|6|||
42144837|NCT00265395|75953887|FG000|Overall Study|Protocol Violation|2|||
42144838|NCT00265395|75953888|FG001|Overall Study|Protocol Violation|2|||
42144839|NCT00265395|75953887|FG000|Overall Study|Lack of Efficacy|0|||
42144840|NCT00265395|75953888|FG001|Overall Study|Lack of Efficacy|1|||
42144841|NCT00265395|75953887|FG000|Overall Study|Administrative|0|||
42144842|NCT00265395|75953888|FG001|Overall Study|Administrative|1|||
42144843|NCT00195442|75953893|FG000|Overall Study|Less than expected therapeutic effect|38|||
42144844|NCT00195442|75953893|FG000|Overall Study|Lost to Follow-up|27|||
42144845|NCT00195442|75953893|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
42144846|NCT00195442|75953893|FG000|Overall Study|Intermittent product shortage|21|||
42144847|NCT00195442|75953893|FG000|Overall Study|Death|7|||
42144848|NCT00195442|75953893|FG000|Overall Study|No reason specified|4|||
42144849|NCT00195442|75953893|FG000|Overall Study|Poor cooperation|2|||
42144850|NCT00195442|75953893|FG000|Overall Study|Other|14|||
42144851|NCT00275301|75953897|FG000|Overall Study|Adverse Event|5|||
42144852|NCT00251745|75953904|FG000|Overall Study|Adverse Event|7|||
42144853|NCT00251745|75953905|FG001|Overall Study|Adverse Event|9|||
42144854|NCT00251745|75953906|FG002|Overall Study|Adverse Event|11|||
42144855|NCT00251745|75953904|FG000|Overall Study|Lost to Follow-up|4|||
42144856|NCT00251745|75953905|FG001|Overall Study|Lost to Follow-up|2|||
42144857|NCT00251745|75953906|FG002|Overall Study|Lost to Follow-up|5|||
42144858|NCT00251745|75953904|FG000|Overall Study|Withdrawal by Subject|13|||
42144859|NCT00251745|75953905|FG001|Overall Study|Withdrawal by Subject|7|||
42144860|NCT00251745|75953906|FG002|Overall Study|Withdrawal by Subject|3|||
42144861|NCT00251745|75953904|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
42144862|NCT00251745|75953905|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
42144863|NCT00251745|75953906|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
42144864|NCT00251745|75953904|FG000|Overall Study|Lack of Efficacy|3|||
42144865|NCT00251745|75953905|FG001|Overall Study|Lack of Efficacy|0|||
42144866|NCT00251745|75953906|FG002|Overall Study|Lack of Efficacy|0|||
42144867|NCT00251745|75953904|FG000|Overall Study|Noncompliant|0|||
42144868|NCT00251745|75953905|FG001|Overall Study|Noncompliant|2|||
42144869|NCT00251745|75953906|FG002|Overall Study|Noncompliant|2|||
42144870|NCT00251745|75953904|FG000|Overall Study|Pregnancy|0|||
42144871|NCT00251745|75953905|FG001|Overall Study|Pregnancy|1|||
42144872|NCT00251745|75953906|FG002|Overall Study|Pregnancy|0|||
42144873|NCT00251745|75953904|FG000|Overall Study|Per Subject Request|0|||
42144874|NCT00251745|75953905|FG001|Overall Study|Per Subject Request|0|||
42144875|NCT00251745|75953906|FG002|Overall Study|Per Subject Request|1|||
42144876|NCT00251745|75953904|FG000|Overall Study|Per Investigator Request|1|||
42144877|NCT00251745|75953905|FG001|Overall Study|Per Investigator Request|0|||
42144878|NCT00251745|75953906|FG002|Overall Study|Per Investigator Request|0|||
42144879|NCT00255190|75953916|FG000|Overall Study|Adverse Event|17|||
42144880|NCT00255190|75953917|FG001|Overall Study|Adverse Event|36|||
42144881|NCT00255190|75953916|FG000|Overall Study|Protocol Violation|2|||
42144882|NCT00255190|75953917|FG001|Overall Study|Protocol Violation|2|||
42144883|NCT00255190|75953916|FG000|Overall Study|Lost to Follow-up|10|||
42144884|NCT00255190|75953917|FG001|Overall Study|Lost to Follow-up|27|||
42144885|NCT00255190|75953916|FG000|Overall Study|Withdrew Consent|17|||
42144886|NCT00255190|75953917|FG001|Overall Study|Withdrew Consent|48|||
42144887|NCT00255190|75953916|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
42144888|NCT00255190|75953917|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
42144889|NCT00255190|75953916|FG000|Overall Study|Erosive esophagitis not healed|0|||
42144890|NCT00255190|75953917|FG001|Overall Study|Erosive esophagitis not healed|20|||
42144891|NCT00255190|75953916|FG000|Overall Study|Various|4|||
42144892|NCT00255190|75953917|FG001|Overall Study|Various|23|||
42144893|NCT00359424|75953925|FG000|Overall Study|Death|99|||
42144894|NCT00359424|75953926|FG001|Overall Study|Death|58|||
42144895|NCT00359424|75953925|FG000|Overall Study|Lost to Follow-up|19|||
42144896|NCT00359424|75953926|FG001|Overall Study|Lost to Follow-up|7|||
42144897|NCT00359424|75953925|FG000|Overall Study|Withdrawal by Subject|10|||
42144898|NCT00359424|75953926|FG001|Overall Study|Withdrawal by Subject|2|||
42144899|NCT00359424|75953925|FG000|Overall Study|follow up not conducted|2|||
42144900|NCT00359424|75953926|FG001|Overall Study|follow up not conducted|0|||
42144901|NCT00255034|75953934|FG000|Overall Study|Withdrawal by Subject|15|||
42144902|NCT00255034|75953935|FG001|Overall Study|Withdrawal by Subject|38|||
42144903|NCT00254566|75953943|FG000|Overall Study|Death|1|||
42144904|NCT00254566|75953944|FG001|Overall Study|Death|0|||
42144905|NCT00254566|75953943|FG000|Overall Study|Adverse Event|5|||
42144906|NCT00254566|75953944|FG001|Overall Study|Adverse Event|4|||
42144907|NCT00254566|75953943|FG000|Overall Study|Lack of Efficacy|12|||
42144908|NCT00254566|75953944|FG001|Overall Study|Lack of Efficacy|9|||
42144909|NCT00254566|75953943|FG000|Overall Study|Other|1|||
42144910|NCT00254566|75953944|FG001|Overall Study|Other|5|||
42144911|NCT00254566|75953943|FG000|Overall Study|Withdrawal by Subject|5|||
42144912|NCT00254566|75953944|FG001|Overall Study|Withdrawal by Subject|6|||
42144913|NCT00254566|75953943|FG000|Overall Study|Lost to Follow-up|7|||
42144914|NCT00254566|75953944|FG001|Overall Study|Lost to Follow-up|2|||
42144915|NCT00358956|75953950|FG000|Overall Study|Adverse Event|3|||
42144916|NCT00358956|75953950|FG000|Overall Study|condition under investigation worsened|4|||
42144917|NCT00358956|75953950|FG000|Overall Study|Withdrawal by Subject|1|||
42144918|NCT03830892|75953956|FG000|Overall Study|Physician Decision|2|||
42144919|NCT03830892|75953957|FG001|Overall Study|Physician Decision|3|||
42144920|NCT03830892|75953956|FG000|Overall Study|Study terminated due to COVID|4|||
42144921|NCT03830892|75953957|FG001|Overall Study|Study terminated due to COVID|0|||
42144922|NCT03830892|75953956|FG000|Overall Study|Protocol Violation|0|||
42144923|NCT03830892|75953957|FG001|Overall Study|Protocol Violation|1|||
42144924|NCT03830892|75953956|FG000|Overall Study|Withdrawal by Subject|0|||
42144925|NCT03830892|75953957|FG001|Overall Study|Withdrawal by Subject|2|||
42144926|NCT00253630|75953963|FG000|Overall Study|ineligible|2|||
42144927|NCT00358644|75953967|FG000|Overall Study|Progressive Disease|21|||
42144928|NCT00358644|75953967|FG000|Overall Study|Adverse Event|7|||
42144929|NCT00358644|75953967|FG000|Overall Study|Death|11|||
42144930|NCT00358644|75953967|FG000|Overall Study|Withdrawal by Subject|4|||
42144931|NCT00358644|75953967|FG000|Overall Study|Physician Decision|6|||
42144932|NCT00358644|75953967|FG000|Overall Study|Patient not eligible for study|1|||
42144933|NCT00364182|75953974|FG000|First Intervention|Secondary prophylaxis|1|||
42144934|NCT00364182|75953975|FG001|First Intervention|Secondary prophylaxis|0|||
42144935|NCT00364182|75953976|FG002|First Intervention|Secondary prophylaxis|0|||
42144936|NCT00364182|75953974|FG000|First Intervention|Withdrawal by Subject|2|||
42276964|NCT02133508|76108515|FG000|Overall Study|Lost to Follow-up|2|||
42144937|NCT00364182|75953975|FG001|First Intervention|Withdrawal by Subject|0|||
42144938|NCT00364182|75953976|FG002|First Intervention|Withdrawal by Subject|0|||
42144939|NCT00364182|75953974|FG000|Second Intervention|non-compliance|0|||
42144940|NCT00364182|75953975|FG001|Second Intervention|non-compliance|1|||
42144941|NCT00364182|75953976|FG002|Second Intervention|non-compliance|1|||
42144942|NCT00364182|75953974|FG000|Second Intervention|Protocol Violation|0|||
42144943|NCT00364182|75953975|FG001|Second Intervention|Protocol Violation|1|||
42144944|NCT00364182|75953976|FG002|Second Intervention|Protocol Violation|0|||
42144945|NCT00364182|75953974|FG000|Second Intervention|Adverse Event|0|||
42144946|NCT00364182|75953975|FG001|Second Intervention|Adverse Event|0|||
42144947|NCT00364182|75953976|FG002|Second Intervention|Adverse Event|1|||
42144948|NCT00364182|75953974|FG000|Third Intervention|non-compliance|0|||
42144949|NCT00364182|75953975|FG001|Third Intervention|non-compliance|1|||
42144950|NCT00364182|75953976|FG002|Third Intervention|non-compliance|0|||
42144951|NCT00364182|75953974|FG000|Third Intervention|Lost to Follow-up|0|||
42144952|NCT00364182|75953975|FG001|Third Intervention|Lost to Follow-up|0|||
42144953|NCT00364182|75953976|FG002|Third Intervention|Lost to Follow-up|1|||
42144954|NCT00369486|75953991|FG000|4-Week Visit|Missed visit|2|||
42144955|NCT00369486|75953992|FG001|4-Week Visit|Missed visit|2|||
42144956|NCT00369486|75953993|FG002|4-Week Visit|Missed visit|0|||
42144957|NCT00369486|75953994|FG003|4-Week Visit|Missed visit|2|||
42144958|NCT00369486|75953995|FG004|4-Week Visit|Missed visit|1|||
42144959|NCT00369486|75953991|FG000|4-Week Visit|Dropped|0|||
42144960|NCT00369486|75953992|FG001|4-Week Visit|Dropped|0|||
42144961|NCT00369486|75953993|FG002|4-Week Visit|Dropped|1|||
42144962|NCT00369486|75953994|FG003|4-Week Visit|Dropped|0|||
42144963|NCT00369486|75953995|FG004|4-Week Visit|Dropped|0|||
42144964|NCT00369486|75953991|FG000|8-Week Visit|Missed visit|0|||
42144965|NCT00369486|75953992|FG001|8-Week Visit|Missed visit|1|||
42144966|NCT00369486|75953993|FG002|8-Week Visit|Missed visit|0|||
42144967|NCT00369486|75953994|FG003|8-Week Visit|Missed visit|0|||
42144968|NCT00369486|75953995|FG004|8-Week Visit|Missed visit|1|||
42144969|NCT00369486|75953991|FG000|8-Week Visit|Dropped|0|||
42144970|NCT00369486|75953992|FG001|8-Week Visit|Dropped|0|||
42144971|NCT00369486|75953993|FG002|8-Week Visit|Dropped|0|||
42276965|NCT02133352|76108519|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
42276966|NCT02167594|76108526|FG000|Overall Study|Withdrawal by Subject|2|||
42276967|NCT02167594|76108527|FG001|Overall Study|Withdrawal by Subject|0|||
42276968|NCT02167594|76108528|FG002|Overall Study|Withdrawal by Subject|0|||
42012523|NCT01194219|75819475|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
42012524|NCT01194219|75819476|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
42012525|NCT01194219|75819477|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
42012526|NCT01194219|75819478|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
42012527|NCT01194219|75819479|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
42012528|NCT01194219|75819480|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
42012529|NCT01194219|75819481|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
42012530|NCT01194219|75819482|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
42012531|NCT01194219|75819483|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
42012532|NCT01194219|75819484|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
42012533|NCT01194219|75819475|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
42012534|NCT01194219|75819476|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
42012535|NCT01194219|75819477|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
42012536|NCT01194219|75819478|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
42012537|NCT01194219|75819479|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
42012538|NCT01194219|75819480|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
42012539|NCT01194219|75819481|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
42012540|NCT01194219|75819482|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
42012541|NCT01194219|75819483|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
42012542|NCT01194219|75819484|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
42012543|NCT01194219|75819475|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
42012544|NCT01194219|75819476|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
42012545|NCT01194219|75819477|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
42012546|NCT01194219|75819478|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
42012547|NCT01194219|75819479|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
42012548|NCT01194219|75819480|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
42144972|NCT00369486|75953994|FG003|8-Week Visit|Dropped|1|||
42276969|NCT02167594|76108526|FG000|Overall Study|Death|0|||
42144973|NCT00369486|75953995|FG004|8-Week Visit|Dropped|0|||
42144974|NCT00369486|75953991|FG000|17-Week Visit|Missed visit|0|||
42144975|NCT00369486|75953992|FG001|17-Week Visit|Missed visit|0|||
42144976|NCT00369486|75953993|FG002|17-Week Visit|Missed visit|1|||
42144977|NCT00369486|75953994|FG003|17-Week Visit|Missed visit|1|||
42144978|NCT00369486|75953995|FG004|17-Week Visit|Missed visit|1|||
42144979|NCT00369486|75953991|FG000|34-Week Visit|Dropped|0|||
42144980|NCT00369486|75953992|FG001|34-Week Visit|Dropped|1|||
42144981|NCT00369486|75953993|FG002|34-Week Visit|Dropped|1|||
42144982|NCT00369486|75953994|FG003|34-Week Visit|Dropped|3|||
42144983|NCT00369486|75953995|FG004|34-Week Visit|Dropped|3|||
42144984|NCT00363480|75954007|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
42144985|NCT00363480|75954007|FG000|Overall Study|Adverse Event|4|||
42144986|NCT00363480|75954007|FG000|Overall Study|Lost to Follow-up|5|||
42144987|NCT00363480|75954007|FG000|Overall Study|Withdrawal by Subject|5|||
42144988|NCT00363480|75954007|FG000|Overall Study|Non-compliance of subject|1|||
42144989|NCT00363480|75954007|FG000|Overall Study|Participant discontinued on its own|1|||
42144990|NCT00363246|75954011|FG000|Overall Study|Death|40|||
42144991|NCT00363246|75954011|FG000|Overall Study|Withdrawal by Subject|19|||
42144992|NCT00363246|75954011|FG000|Overall Study|Lost to Follow-up|14|||
42144993|NCT00363246|75954011|FG000|Overall Study|Bad health|6|||
42144994|NCT00363246|75954011|FG000|Overall Study|Stopped using wheelchair|11|||
42144995|NCT00363246|75954011|FG000|Overall Study|Subject expressed security concerns|2|||
42144996|NCT00363246|75954011|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
42144997|NCT00223990|75954018|FG000|Overall Study|Moved from area|2|||
42144998|NCT00223990|75954019|FG001|Overall Study|Moved from area|1|||
42144999|NCT00223990|75954018|FG000|Overall Study|Withdrawal by Subject|4|||
42145000|NCT00223990|75954019|FG001|Overall Study|Withdrawal by Subject|8|||
42145001|NCT00223990|75954018|FG000|Overall Study|Lost to Follow-up|1|||
42145002|NCT00223990|75954019|FG001|Overall Study|Lost to Follow-up|0|||
42145003|NCT00221104|75954027|FG000|Overall Study|Adverse Event|1|||
42145004|NCT00221104|75954028|FG001|Overall Study|Adverse Event|0|||
42145005|NCT00221104|75954027|FG000|Overall Study|Physician Decision|1|||
42145006|NCT00221104|75954028|FG001|Overall Study|Physician Decision|0|||
42145007|NCT00221104|75954027|FG000|Overall Study|Protocol Violation|2|||
42145008|NCT00221104|75954028|FG001|Overall Study|Protocol Violation|0|||
42145009|NCT00221104|75954027|FG000|Overall Study|Withdrawal by Subject|42|||
42145010|NCT00221104|75954028|FG001|Overall Study|Withdrawal by Subject|29|||
42145011|NCT00221104|75954027|FG000|Overall Study|Others|37|||
42145012|NCT00221104|75954028|FG001|Overall Study|Others|47|||
42145013|NCT00189202|75954036|FG000|Overall Study|Physician Decision|5|||
42145014|NCT00187486|75954040|FG000|Overall Study|Protocol Violation|1|||
42145015|NCT00220636|75954044|FG000|Overall Study|Withdrawal by Subject|4|||
42145016|NCT00362232|75954051|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
42145017|NCT00362232|75954052|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
42145018|NCT00362232|75954051|FG000|Treatment (12 +/- 2 Days)|Death|1|||
42145019|NCT00362232|75954052|FG001|Treatment (12 +/- 2 Days)|Death|3|||
42145020|NCT00362232|75954051|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
42145021|NCT00362232|75954052|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
42145022|NCT00362232|75954051|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
42145023|NCT00362232|75954052|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
42145024|NCT00362232|75954051|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
42145025|NCT00362232|75954052|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
42145026|NCT00362232|75954051|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
42145027|NCT00362232|75954052|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
42145028|NCT00362232|75954051|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
42145029|NCT00362232|75954052|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
42145030|NCT00362232|75954051|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
42145031|NCT00362232|75954052|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
42145032|NCT00362232|75954051|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
42145033|NCT00362232|75954052|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
42145034|NCT00362232|75954051|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
42145035|NCT00362232|75954052|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
42145036|NCT00362232|75954051|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
42145037|NCT00362232|75954052|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
42145038|NCT00362232|75954051|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
42145039|NCT00362232|75954052|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
42012549|NCT01194219|75819481|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
42012550|NCT01194219|75819482|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
42012551|NCT01194219|75819483|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
42145040|NCT00362232|75954051|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
42145041|NCT00362232|75954052|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
42145042|NCT00219544|75954058|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
42145043|NCT00219544|75954059|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
42145044|NCT00219544|75954058|FG000|Single Blind Treatment Period|Adverse Event|9|||
42145045|NCT00219544|75954059|FG001|Single Blind Treatment Period|Adverse Event|0|||
42145046|NCT00219544|75954058|FG000|Single Blind Treatment Period|Protocol Violation|4|||
42145047|NCT00219544|75954059|FG001|Single Blind Treatment Period|Protocol Violation|0|||
42145048|NCT00219544|75954058|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
42145049|NCT00219544|75954059|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
42145050|NCT00219544|75954058|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
42145051|NCT00219544|75954059|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
42145052|NCT00219544|75954058|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
42145053|NCT00219544|75954059|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
42145054|NCT00357552|75954067|FG000|Screening|Did not meet eligibility criteria|84|||
42145055|NCT00357552|75954067|FG000|Weeks 0 to 24|Death|1|||
42145056|NCT00357552|75954067|FG000|Weeks 24 to 104|Death|3|||
42145057|NCT00357552|75954067|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
42145058|NCT00187096|75954078|FG000|Overall Study|unacceptable toxicity|0|||
42145059|NCT00187096|75954079|FG001|Overall Study|unacceptable toxicity|0|||
42145060|NCT00187096|75954080|FG002|Overall Study|unacceptable toxicity|1|||
42145061|NCT00357396|75954090|FG000|Overall Study|Adverse Event|1|||
42145062|NCT00357396|75954091|FG001|Overall Study|Adverse Event|0|||
42145063|NCT00186628|75954096|FG000|Overall Study|Death|2|||
42145064|NCT00186628|75954096|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
42145065|NCT00368550|75954104|FG000|Overall Study|Adverse Event|7|||
42145066|NCT00368550|75954105|FG001|Overall Study|Adverse Event|4|||
42145067|NCT00368550|75954104|FG000|Overall Study|Lack of Efficacy|4|||
42145068|NCT00368550|75954105|FG001|Overall Study|Lack of Efficacy|9|||
42145069|NCT00368550|75954104|FG000|Overall Study|Withdrawal by Subject|17|||
42145070|NCT00368550|75954105|FG001|Overall Study|Withdrawal by Subject|10|||
42145071|NCT00368472|75954111|FG000|Overall Study|Adverse Event|22|||
42145072|NCT00368472|75954111|FG000|Overall Study|Medication non-compliance|4|||
42145073|NCT00368472|75954111|FG000|Overall Study|Protocol Violation|2|||
42145074|NCT00368472|75954111|FG000|Overall Study|Request of Investigator or Sponsor|3|||
42145075|NCT00368472|75954111|FG000|Overall Study|Withdrawal by Subject|40|||
42145076|NCT00368472|75954111|FG000|Overall Study|Diary non-compliance|1|||
42145077|NCT00368472|75954111|FG000|Overall Study|Other|32|||
42145078|NCT00368472|75954111|FG000|Overall Study|Missing Final Disposition Date|1|||
42145079|NCT00357006|75954118|FG000|Overall Study|Lost to Follow-up|1|||
42145080|NCT00357006|75954119|FG001|Overall Study|Lost to Follow-up|2|||
42145081|NCT00357006|75954120|FG002|Overall Study|Lost to Follow-up|1|||
42145082|NCT00357006|75954118|FG000|Overall Study|Withdrawal by Subject|1|||
42145083|NCT00357006|75954119|FG001|Overall Study|Withdrawal by Subject|3|||
42145084|NCT00357006|75954120|FG002|Overall Study|Withdrawal by Subject|2|||
42145085|NCT00165646|75954131|FG000|Overall Study|Adverse Event|1|||
42145086|NCT00165646|75954132|FG001|Overall Study|Adverse Event|1|||
42145087|NCT00165646|75954133|FG002|Overall Study|Adverse Event|1|||
42145088|NCT00165646|75954131|FG000|Overall Study|Lack of Efficacy|1|||
42145089|NCT00165646|75954132|FG001|Overall Study|Lack of Efficacy|2|||
42145090|NCT00165646|75954133|FG002|Overall Study|Lack of Efficacy|0|||
42145091|NCT00165646|75954131|FG000|Overall Study|Withdrawal by Subject|0|||
42351057|NCT01906489|76190995|FG000|Overall Study|Withdrawal by Subject|5|||
42351058|NCT01906489|76190996|FG001|Overall Study|Withdrawal by Subject|0|||
42012552|NCT01194219|75819484|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
42012553|NCT01194219|75819475|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
42012554|NCT01194219|75819476|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
42039291|NCT00884650|75847561|FG001|Overall Study|Pain Pump Complication|1|||
42039292|NCT00881608|75847573|FG000|Overall Study|Study prematurely terminated|11|||
42039293|NCT01088399|75847588|FG000|Overall Study|Adverse Event|211|||
42039294|NCT01088399|75847589|FG001|Overall Study|Adverse Event|16|||
42039295|NCT01088399|75847590|FG002|Overall Study|Adverse Event|0|||
42039296|NCT01088399|75847588|FG000|Overall Study|Death|204|||
42039297|NCT01088399|75847589|FG001|Overall Study|Death|45|||
42039298|NCT01088399|75847590|FG002|Overall Study|Death|0|||
42039299|NCT01088399|75847588|FG000|Overall Study|Lack of Efficacy|298|||
42039300|NCT01088399|75847589|FG001|Overall Study|Lack of Efficacy|7|||
42039301|NCT01088399|75847590|FG002|Overall Study|Lack of Efficacy|5|||
42039302|NCT01088399|75847588|FG000|Overall Study|Lost to Follow-up|1070|||
42145092|NCT00165646|75954132|FG001|Overall Study|Withdrawal by Subject|2|||
42012555|NCT01194219|75819477|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
42012556|NCT01194219|75819478|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
42012557|NCT01194219|75819479|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
42012558|NCT01194219|75819480|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
42012559|NCT01194219|75819481|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
42039303|NCT01088399|75847589|FG001|Overall Study|Lost to Follow-up|278|||
42039304|NCT01088399|75847590|FG002|Overall Study|Lost to Follow-up|58|||
42145093|NCT00165646|75954133|FG002|Overall Study|Withdrawal by Subject|1|||
42145094|NCT00165646|75954131|FG000|Overall Study|Physician Decision|2|||
42145095|NCT00165646|75954132|FG001|Overall Study|Physician Decision|0|||
42145096|NCT00165646|75954133|FG002|Overall Study|Physician Decision|2|||
42145097|NCT00165646|75954131|FG000|Overall Study|Protocol Violation|1|||
42145098|NCT00165646|75954132|FG001|Overall Study|Protocol Violation|0|||
42145099|NCT00165646|75954133|FG002|Overall Study|Protocol Violation|0|||
42039305|NCT01088399|75847588|FG000|Overall Study|Physician Decision|531|||
42145100|NCT00367770|75954141|FG000|Overall Study|Adverse Event|1|||
42145101|NCT00367770|75954141|FG000|Overall Study|Withdrawal by Subject|1|||
42145102|NCT00185614|75954145|FG000|Inter-treatment Period|Physician Decision|1|||
42276970|NCT02167594|76108527|FG001|Overall Study|Death|1|||
42276971|NCT02167594|76108528|FG002|Overall Study|Death|0|||
42276972|NCT02555657|76108539|FG000|Overall Study|Death|274|||
42276973|NCT02555657|76108540|FG001|Overall Study|Death|262|||
42276974|NCT02555657|76108539|FG000|Overall Study|Physician Decision|0|||
42276975|NCT02555657|76108540|FG001|Overall Study|Physician Decision|1|||
42276976|NCT02555657|76108539|FG000|Overall Study|Sponsor Decision|27|||
42276977|NCT02555657|76108540|FG001|Overall Study|Sponsor Decision|15|||
42276978|NCT02555657|76108539|FG000|Overall Study|Withdrawal by Subject|11|||
42276979|NCT02555657|76108540|FG001|Overall Study|Withdrawal by Subject|32|||
42276980|NCT02195518|76108572|FG000|Overall Study|Adverse Event|1|||
42276981|NCT02195518|76108572|FG000|Overall Study|Protocol Violation|4|||
42276982|NCT02195518|76108572|FG000|Overall Study|Pregnancy|2|||
42276983|NCT02195518|76108572|FG000|Overall Study|Withdrawal by Subject|1|||
42276984|NCT02195518|76108572|FG000|Overall Study|Lost to Follow-up|1|||
42276985|NCT02133742|76108602|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
42276986|NCT02133742|76108602|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
42276987|NCT02133742|76108602|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
42276988|NCT02133742|76108602|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
42276989|NCT02133742|76108602|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
42276990|NCT03032705|76108610|FG000|Overall Study|Lost to Follow-up|16|||
42276991|NCT03032705|76108611|FG001|Overall Study|Lost to Follow-up|17|||
42276992|NCT03032705|76108610|FG000|Overall Study|did not quality|6|||
42276993|NCT03032705|76108611|FG001|Overall Study|did not quality|6|||
42276994|NCT04476251|76108617|FG000|Overall Study|Not treated|1|||
42276995|NCT03795233|76108623|FG000|Overall Study|Withdrawal by Subject|2|||
42276996|NCT03795233|76108624|FG001|Overall Study|Withdrawal by Subject|1|||
42276997|NCT03795233|76108623|FG000|Overall Study|Lost to Follow-up|1|||
42276998|NCT03795233|76108624|FG001|Overall Study|Lost to Follow-up|0|||
42276999|NCT03795233|76108623|FG000|Overall Study|Death|1|||
42277000|NCT03795233|76108624|FG001|Overall Study|Death|0|||
42277001|NCT03564119|76108632|FG000|Overall Study|Adverse Event|4|||
42277002|NCT03564119|76108633|FG001|Overall Study|Adverse Event|0|||
42277003|NCT03564119|76108632|FG000|Overall Study|Lost to Follow-up|1|||
42277004|NCT03564119|76108633|FG001|Overall Study|Lost to Follow-up|4|||
42277005|NCT03564119|76108632|FG000|Overall Study|Protocol Violation|1|||
42277006|NCT03564119|76108633|FG001|Overall Study|Protocol Violation|0|||
42277007|NCT03564119|76108632|FG000|Overall Study|Withdrawal by Subject|9|||
42277008|NCT03564119|76108633|FG001|Overall Study|Withdrawal by Subject|4|||
42277009|NCT03564119|76108632|FG000|Overall Study|Other Than Specified|0|||
42277010|NCT03564119|76108633|FG001|Overall Study|Other Than Specified|1|||
42277011|NCT04531241|76108639|FG000|Period 1|Withdrawal by Subject|2|||
42277012|NCT04531241|76108640|FG001|Period 1|Withdrawal by Subject|0|||
42277013|NCT04531241|76108639|FG000|Period 1|Dispesed incorrect lens power|1|||
42277014|NCT04531241|76108640|FG001|Period 1|Dispesed incorrect lens power|0|||
42277015|NCT04531241|76108639|FG000|Period 1|Protocol Violation|1|||
42277016|NCT04531241|76108640|FG001|Period 1|Protocol Violation|0|||
42277017|NCT04531241|76108639|FG000|Period 1|No longer eligible|0|||
42277018|NCT04531241|76108640|FG001|Period 1|No longer eligible|1|||
42277019|NCT04531241|76108639|FG000|Period 1|Lens Discomfort|0|||
42277020|NCT04531241|76108640|FG001|Period 1|Lens Discomfort|1|||
42012560|NCT01194219|75819482|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
42012561|NCT01194219|75819483|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
42012562|NCT01194219|75819484|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
42012563|NCT01194219|75819475|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
42012564|NCT01194219|75819476|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
42012565|NCT01194219|75819477|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
42012566|NCT01194219|75819478|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
42012567|NCT01194219|75819479|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
42012568|NCT01194219|75819480|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
42039306|NCT01088399|75847589|FG001|Overall Study|Physician Decision|88|||
42039307|NCT01088399|75847590|FG002|Overall Study|Physician Decision|16|||
42145103|NCT00185614|75954145|FG000|Inter-treatment Period|Relapse|2|||
42145104|NCT00185614|75954145|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
42277021|NCT04531241|76108639|FG000|Period 2|Covid-19 Related|1|||
42277022|NCT04531241|76108640|FG001|Period 2|Covid-19 Related|1|||
42277023|NCT03181529|76108648|FG000|Overall Study|Withdrawal by Subject|1|||
42145105|NCT00162370|75954149|FG000|Efficacy Population|Lost to Follow-up|51|||
42277024|NCT03181529|76108649|FG001|Overall Study|Withdrawal by Subject|1|||
42277025|NCT03181529|76108648|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
42277026|NCT03181529|76108649|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
42277027|NCT03470441|76108663|FG000|Overall Study|Death|0|||
42277028|NCT03470441|76108664|FG001|Overall Study|Death|1|||
42277029|NCT03470441|76108665|FG002|Overall Study|Death|1|||
42145106|NCT00361842|75954158|FG000|Overall Study|Withdrawal by Subject|2|||
42145107|NCT00361842|75954159|FG001|Overall Study|Withdrawal by Subject|3|||
42145108|NCT00361842|75954158|FG000|Overall Study|Death|2|||
42145109|NCT00361842|75954159|FG001|Overall Study|Death|1|||
42145110|NCT00361842|75954158|FG000|Overall Study|Disease progression|19|||
42145111|NCT00361842|75954159|FG001|Overall Study|Disease progression|20|||
42145112|NCT00361842|75954158|FG000|Overall Study|Adverse Event|2|||
42012569|NCT01194219|75819481|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
42012570|NCT01194219|75819482|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
42012571|NCT01194219|75819483|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
42012572|NCT01194219|75819484|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
42012573|NCT01194219|75819475|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
42145113|NCT00361842|75954159|FG001|Overall Study|Adverse Event|3|||
42145114|NCT00361842|75954158|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
42145115|NCT00361842|75954159|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
42145116|NCT00361842|75954158|FG000|Overall Study|Other|1|||
42145117|NCT00361842|75954159|FG001|Overall Study|Other|0|||
42145118|NCT00361842|75954158|FG000|Overall Study|Other|0|||
42145119|NCT00361842|75954159|FG001|Overall Study|Other|2|||
42145120|NCT00361296|75954167|FG000|Overall Study|Physician Decision|1|||
42145121|NCT00361296|75954167|FG000|Overall Study|Lack of Efficacy|2|||
42145122|NCT00356148|75954173|FG000|Overall Study|Reoperation within 30 days|2|||
42145123|NCT00356148|75954174|FG001|Overall Study|Reoperation within 30 days|1|||
42145124|NCT00361218|75954181|FG000|Overall Study|Lost to Follow-up|11|||
42145125|NCT00361218|75954181|FG000|Overall Study|Personal Reasons|7|||
42145126|NCT00361218|75954181|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
42145127|NCT00367458|75954187|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
42145128|NCT00367458|75954188|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
42145129|NCT00162136|75954200|FG000|Overall Study|Adverse Event|1|||
42145130|NCT00162136|75954200|FG000|Overall Study|Death|1|||
42145131|NCT00162136|75954200|FG000|Overall Study|Disease Progression/Relapse|23|||
42145132|NCT00162136|75954200|FG000|Overall Study|Investigator Request|5|||
42145133|NCT00162136|75954200|FG000|Overall Study|Study Drug Toxicity|4|||
42039308|NCT01088399|75847588|FG000|Overall Study|Withdrawal by Subject|544|||
42012574|NCT01194219|75819476|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
42012575|NCT01194219|75819477|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
42012576|NCT01194219|75819478|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
42012577|NCT01194219|75819479|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
42012578|NCT01194219|75819480|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
42012579|NCT01194219|75819481|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
42012580|NCT01194219|75819482|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
42012581|NCT01194219|75819483|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
42012582|NCT01194219|75819484|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
42012583|NCT01194219|75819475|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
42012584|NCT01194219|75819476|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
42012585|NCT01194219|75819477|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
42012586|NCT01194219|75819478|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
42012587|NCT01194219|75819479|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
42012588|NCT01194219|75819480|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
42012589|NCT01194219|75819481|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
42012590|NCT01194219|75819482|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
42012591|NCT01194219|75819483|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
42012592|NCT01194219|75819484|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
42012593|NCT01194219|75819475|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
42012594|NCT01194219|75819476|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
42012595|NCT01194219|75819477|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
42012596|NCT01194219|75819478|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
42012597|NCT01194219|75819479|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
42012598|NCT01194219|75819480|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
42012599|NCT01194219|75819481|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
42039309|NCT01088399|75847589|FG001|Overall Study|Withdrawal by Subject|195|||
42039310|NCT01088399|75847590|FG002|Overall Study|Withdrawal by Subject|33|||
42039311|NCT01088399|75847588|FG000|Overall Study|Change to or start of somatropin therapy|234|||
42039312|NCT01088399|75847589|FG001|Overall Study|Change to or start of somatropin therapy|17|||
42012600|NCT01194219|75819482|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
42012601|NCT01194219|75819483|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
42145134|NCT00162136|75954200|FG000|Overall Study|Withdrawal by Subject|1|||
42145135|NCT00252694|75954226|FG000|Overall Study|Withdrawal by Subject|83|||
42145136|NCT00252694|75954227|FG001|Overall Study|Withdrawal by Subject|91|||
42039313|NCT01088399|75847590|FG002|Overall Study|Change to or start of somatropin therapy|12|||
42039314|NCT01088399|75847588|FG000|Overall Study|Sponsor decision|1573|||
42039315|NCT01088399|75847589|FG001|Overall Study|Sponsor decision|298|||
42039316|NCT01088399|75847590|FG002|Overall Study|Sponsor decision|7|||
42039317|NCT01088399|75847588|FG000|Overall Study|Protocol Violation|10|||
42145137|NCT00252694|75954226|FG000|Overall Study|Death|36|||
42145138|NCT00252694|75954227|FG001|Overall Study|Death|34|||
42145139|NCT00252694|75954226|FG000|Overall Study|Mostly Lost to Follow Up|8|||
42145140|NCT00252694|75954227|FG001|Overall Study|Mostly Lost to Follow Up|13|||
42145141|NCT00252694|75954226|FG000|Overall Study|Patient Moving|17|||
42145142|NCT00252694|75954227|FG001|Overall Study|Patient Moving|16|||
42145143|NCT00185458|75954233|FG000|Contraception Phase|Adverse Event|37|||
42145144|NCT00185458|75954233|FG000|Contraception Phase|Lost to Follow-up|10|||
42145145|NCT00185458|75954233|FG000|Contraception Phase|Protocol Violation|2|||
42145146|NCT00185458|75954233|FG000|Contraception Phase|Physician Decision|2|||
42145147|NCT00185458|75954233|FG000|Contraception Phase|Withdrawal by Subject|7|||
42145148|NCT00185458|75954233|FG000|HRT Phase|Adverse Event|18|||
42145149|NCT00185458|75954233|FG000|HRT Phase|Lost to Follow-up|4|||
42145150|NCT00185458|75954233|FG000|HRT Phase|Protocol Violation|2|||
42277030|NCT03470441|76108666|FG003|Overall Study|Death|0|||
42277031|NCT03470441|76108663|FG000|Overall Study|Adverse Event|0|||
42277032|NCT03470441|76108664|FG001|Overall Study|Adverse Event|0|||
42277033|NCT03470441|76108665|FG002|Overall Study|Adverse Event|0|||
42277034|NCT03470441|76108666|FG003|Overall Study|Adverse Event|1|||
42277035|NCT03470441|76108663|FG000|Overall Study|Withdrawal by Subject|1|||
42277036|NCT03470441|76108664|FG001|Overall Study|Withdrawal by Subject|4|||
42277037|NCT03470441|76108665|FG002|Overall Study|Withdrawal by Subject|1|||
42277038|NCT03470441|76108666|FG003|Overall Study|Withdrawal by Subject|3|||
42277039|NCT03361865|76108678|FG000|Overall Study|Death|17|||
42277040|NCT03361865|76108679|FG001|Overall Study|Death|18|||
42277041|NCT03361865|76108678|FG000|Overall Study|Physician Decision|1|||
42277042|NCT03361865|76108679|FG001|Overall Study|Physician Decision|9|||
42277043|NCT03361865|76108678|FG000|Overall Study|Withdrawal by Subject|1|||
42277044|NCT03361865|76108679|FG001|Overall Study|Withdrawal by Subject|0|||
42277045|NCT02149121|76108693|FG000|Main Study Period|Lack of Efficacy|2|||
42277046|NCT02149121|76108694|FG001|Main Study Period|Lack of Efficacy|2|||
42277047|NCT02149121|76108695|FG002|Main Study Period|Lack of Efficacy|1|||
42277048|NCT02149121|76108696|FG003|Main Study Period|Lack of Efficacy|0|||
42277049|NCT02149121|76108697|FG004|Main Study Period|Lack of Efficacy|0|||
42277050|NCT02149121|76108698|FG005|Main Study Period|Lack of Efficacy|0|||
42277051|NCT02149121|76108699|FG006|Main Study Period|Lack of Efficacy|0|||
42277052|NCT02149121|76108693|FG000|Main Study Period|Withdrawal by Subject|9|||
42277053|NCT02149121|76108694|FG001|Main Study Period|Withdrawal by Subject|5|||
42277054|NCT02149121|76108695|FG002|Main Study Period|Withdrawal by Subject|1|||
42277055|NCT02149121|76108696|FG003|Main Study Period|Withdrawal by Subject|0|||
42277056|NCT02149121|76108697|FG004|Main Study Period|Withdrawal by Subject|0|||
42277057|NCT02149121|76108698|FG005|Main Study Period|Withdrawal by Subject|0|||
42277058|NCT02149121|76108699|FG006|Main Study Period|Withdrawal by Subject|0|||
42277059|NCT02149121|76108693|FG000|Main Study Period|Adverse Event|2|||
42277060|NCT02149121|76108694|FG001|Main Study Period|Adverse Event|5|||
42277061|NCT02149121|76108695|FG002|Main Study Period|Adverse Event|1|||
42277062|NCT02149121|76108696|FG003|Main Study Period|Adverse Event|0|||
42277063|NCT02149121|76108697|FG004|Main Study Period|Adverse Event|0|||
42277064|NCT02149121|76108698|FG005|Main Study Period|Adverse Event|0|||
42277065|NCT02149121|76108699|FG006|Main Study Period|Adverse Event|0|||
42277066|NCT02149121|76108693|FG000|Main Study Period|Protocol Violation|2|||
42277067|NCT02149121|76108694|FG001|Main Study Period|Protocol Violation|0|||
42277068|NCT02149121|76108695|FG002|Main Study Period|Protocol Violation|0|||
42277069|NCT02149121|76108696|FG003|Main Study Period|Protocol Violation|0|||
42145151|NCT00185458|75954233|FG000|HRT Phase|Withdrawal by Subject|3|||
42145152|NCT00185380|75954248|FG000|Overall Study|Adverse Event|41|||
42145153|NCT00185380|75954249|FG001|Overall Study|Adverse Event|43|||
42277070|NCT02149121|76108697|FG004|Main Study Period|Protocol Violation|0|||
42277071|NCT02149121|76108698|FG005|Main Study Period|Protocol Violation|0|||
42277072|NCT02149121|76108699|FG006|Main Study Period|Protocol Violation|0|||
42277073|NCT02149121|76108693|FG000|Main Study Period|Lost to Follow-up|2|||
42277074|NCT02149121|76108694|FG001|Main Study Period|Lost to Follow-up|1|||
42145154|NCT00185380|75954250|FG002|Overall Study|Adverse Event|48|||
42277075|NCT02149121|76108695|FG002|Main Study Period|Lost to Follow-up|0|||
42277076|NCT02149121|76108696|FG003|Main Study Period|Lost to Follow-up|0|||
42277077|NCT02149121|76108697|FG004|Main Study Period|Lost to Follow-up|0|||
42277078|NCT02149121|76108698|FG005|Main Study Period|Lost to Follow-up|0|||
42277079|NCT02149121|76108699|FG006|Main Study Period|Lost to Follow-up|0|||
42277080|NCT02149121|76108693|FG000|Main Study Period|Death|1|||
42277081|NCT02149121|76108694|FG001|Main Study Period|Death|0|||
42145155|NCT00185380|75954248|FG000|Overall Study|Lost to Follow-up|0|||
42145156|NCT00185380|75954249|FG001|Overall Study|Lost to Follow-up|4|||
42277082|NCT02149121|76108695|FG002|Main Study Period|Death|0|||
42277083|NCT02149121|76108696|FG003|Main Study Period|Death|0|||
42277084|NCT02149121|76108697|FG004|Main Study Period|Death|0|||
42277085|NCT02149121|76108698|FG005|Main Study Period|Death|0|||
42277086|NCT02149121|76108699|FG006|Main Study Period|Death|0|||
42277087|NCT02149121|76108693|FG000|Main Study Period|Physician Decision|1|||
42277088|NCT02149121|76108694|FG001|Main Study Period|Physician Decision|0|||
42277089|NCT02149121|76108695|FG002|Main Study Period|Physician Decision|0|||
42277090|NCT02149121|76108696|FG003|Main Study Period|Physician Decision|0|||
42277091|NCT02149121|76108697|FG004|Main Study Period|Physician Decision|0|||
42277092|NCT02149121|76108698|FG005|Main Study Period|Physician Decision|0|||
42351059|NCT01906489|76190995|FG000|Overall Study|Worsening of Anemia|1|||
42351060|NCT01906489|76190996|FG001|Overall Study|Worsening of Anemia|0|||
42351061|NCT01906489|76190995|FG000|Overall Study|Protocol Violation|0|||
42351062|NCT01906489|76190996|FG001|Overall Study|Protocol Violation|1|||
42351063|NCT01906489|76190995|FG000|Overall Study|Non- Compliance|1|||
42351064|NCT01906489|76190996|FG001|Overall Study|Non- Compliance|0|||
42351065|NCT01906489|76190995|FG000|Overall Study|Sponsor Decision|1|||
42351066|NCT01906489|76190996|FG001|Overall Study|Sponsor Decision|0|||
42351067|NCT01906489|76190995|FG000|Overall Study|Lost to Follow-up|1|||
42351068|NCT01906489|76190996|FG001|Overall Study|Lost to Follow-up|1|||
42351069|NCT01906489|76190995|FG000|Overall Study|Other|1|||
42351070|NCT01906489|76190996|FG001|Overall Study|Other|0|||
42351071|NCT01517373|76191007|FG000|Run-in Period|Death|1|||
42351072|NCT01517373|76191008|FG001|Run-in Period|Death|0|||
42351073|NCT01517373|76191009|FG002|Run-in Period|Death|0|||
42351074|NCT01517373|76191010|FG003|Run-in Period|Death|0|||
42351075|NCT01517373|76191011|FG004|Run-in Period|Death|0|||
42351076|NCT01517373|76191012|FG005|Run-in Period|Death|0|||
42351077|NCT01517373|76191007|FG000|Run-in Period|Adverse Event|5|||
42351078|NCT01517373|76191008|FG001|Run-in Period|Adverse Event|0|||
42351079|NCT01517373|76191009|FG002|Run-in Period|Adverse Event|0|||
42351080|NCT01517373|76191010|FG003|Run-in Period|Adverse Event|0|||
42351081|NCT01517373|76191011|FG004|Run-in Period|Adverse Event|0|||
42351082|NCT01517373|76191012|FG005|Run-in Period|Adverse Event|0|||
42351083|NCT01517373|76191007|FG000|Run-in Period|Did not meet eligibility criteria|34|||
42351084|NCT01517373|76191008|FG001|Run-in Period|Did not meet eligibility criteria|0|||
42351085|NCT01517373|76191009|FG002|Run-in Period|Did not meet eligibility criteria|0|||
42351086|NCT01517373|76191010|FG003|Run-in Period|Did not meet eligibility criteria|0|||
42351087|NCT01517373|76191011|FG004|Run-in Period|Did not meet eligibility criteria|0|||
42351088|NCT01517373|76191012|FG005|Run-in Period|Did not meet eligibility criteria|0|||
42351089|NCT01517373|76191007|FG000|Run-in Period|Lost to Follow-up|1|||
42351090|NCT01517373|76191008|FG001|Run-in Period|Lost to Follow-up|0|||
42351091|NCT01517373|76191009|FG002|Run-in Period|Lost to Follow-up|0|||
42039318|NCT01088399|75847589|FG001|Overall Study|Protocol Violation|1|||
42039319|NCT01088399|75847590|FG002|Overall Study|Protocol Violation|0|||
42039320|NCT01088399|75847588|FG000|Overall Study|Enrollment criteria not met|48|||
42039321|NCT01088399|75847589|FG001|Overall Study|Enrollment criteria not met|119|||
42039322|NCT01088399|75847590|FG002|Overall Study|Enrollment criteria not met|70|||
42039323|NCT01088399|75847588|FG000|Overall Study|Study summary visit not completed|2398|||
42039324|NCT01088399|75847589|FG001|Overall Study|Study summary visit not completed|283|||
42039325|NCT01088399|75847590|FG002|Overall Study|Study summary visit not completed|80|||
42039326|NCT00598078|75847598|FG000|Period 2 (Day 2)|Adverse Event|1|||
42145157|NCT00185380|75954250|FG002|Overall Study|Lost to Follow-up|3|||
42145158|NCT00185380|75954248|FG000|Overall Study|Pregnancy|1|||
42145159|NCT00185380|75954249|FG001|Overall Study|Pregnancy|4|||
42145160|NCT00185380|75954250|FG002|Overall Study|Pregnancy|0|||
42145161|NCT00185380|75954248|FG000|Overall Study|Protocol Violation|2|||
42145162|NCT00185380|75954249|FG001|Overall Study|Protocol Violation|2|||
42145163|NCT00185380|75954250|FG002|Overall Study|Protocol Violation|1|||
42145164|NCT00185380|75954248|FG000|Overall Study|Withdrawal by Subject|1|||
42145165|NCT00185380|75954249|FG001|Overall Study|Withdrawal by Subject|2|||
42145166|NCT00185380|75954250|FG002|Overall Study|Withdrawal by Subject|0|||
42145167|NCT00185380|75954248|FG000|Overall Study|Failed insertion|1|||
42145168|NCT00185380|75954249|FG001|Overall Study|Failed insertion|1|||
42145169|NCT00185380|75954250|FG002|Overall Study|Failed insertion|2|||
42351092|NCT01517373|76191010|FG003|Run-in Period|Lost to Follow-up|0|||
42351093|NCT01517373|76191011|FG004|Run-in Period|Lost to Follow-up|0|||
42039327|NCT00598078|75847599|FG001|Period 2 (Day 2)|Adverse Event|0|||
42351094|NCT01517373|76191012|FG005|Run-in Period|Lost to Follow-up|0|||
42351095|NCT01517373|76191007|FG000|Run-in Period|Withdrawal by Subject|12|||
42351096|NCT01517373|76191008|FG001|Run-in Period|Withdrawal by Subject|0|||
42039328|NCT01079195|75847607|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
42145170|NCT00185380|75954248|FG000|Overall Study|Planned pregnancy|9|||
42145171|NCT00185380|75954249|FG001|Overall Study|Planned pregnancy|12|||
42351097|NCT01517373|76191009|FG002|Run-in Period|Withdrawal by Subject|0|||
42351098|NCT01517373|76191010|FG003|Run-in Period|Withdrawal by Subject|0|||
42351099|NCT01517373|76191011|FG004|Run-in Period|Withdrawal by Subject|0|||
42012602|NCT01194219|75819484|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
42145172|NCT00185380|75954250|FG002|Overall Study|Planned pregnancy|12|||
42145173|NCT00185380|75954248|FG000|Overall Study|No need for contraception|3|||
42145174|NCT00185380|75954249|FG001|Overall Study|No need for contraception|3|||
42145175|NCT00185380|75954250|FG002|Overall Study|No need for contraception|3|||
42145176|NCT00185380|75954248|FG000|Overall Study|Could not attend visits|2|||
42145177|NCT00185380|75954249|FG001|Overall Study|Could not attend visits|0|||
42145178|NCT00185380|75954250|FG002|Overall Study|Could not attend visits|4|||
42145179|NCT00185380|75954248|FG000|Overall Study|personal reason|6|||
42145180|NCT00185380|75954249|FG001|Overall Study|personal reason|1|||
42145181|NCT00185380|75954250|FG002|Overall Study|personal reason|1|||
42145182|NCT00160654|75954258|FG000|Overall Study|Adverse Event|14|||
42145183|NCT00160654|75954258|FG000|Overall Study|Lack of Efficacy|4|||
42145184|NCT00160654|75954258|FG000|Overall Study|Lost to Follow-up|2|||
42145185|NCT00160654|75954258|FG000|Overall Study|Intake of expired drug|7|||
42145186|NCT00160654|75954258|FG000|Overall Study|Psychological trauma|1|||
42145187|NCT00160654|75954258|FG000|Overall Study|Sponsor decision|1|||
42145188|NCT00160654|75954258|FG000|Overall Study|Patient met exclusion criteria|1|||
42145189|NCT00160654|75954258|FG000|Overall Study|Patient decision|1|||
42145190|NCT00160654|75954258|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
42145191|NCT00160654|75954258|FG000|Overall Study|Met exclusion criteria|1|||
42145192|NCT00366678|75954264|FG000|Infant Series|Withdrawal by Subject|8|||
42145193|NCT00366678|75954265|FG001|Infant Series|Withdrawal by Subject|6|||
42145194|NCT00366678|75954266|FG002|Infant Series|Withdrawal by Subject|0|||
42145195|NCT00366678|75954264|FG000|Infant Series|Protocol Violation|4|||
42145196|NCT00366678|75954265|FG001|Infant Series|Protocol Violation|3|||
42145197|NCT00366678|75954266|FG002|Infant Series|Protocol Violation|0|||
42145198|NCT00366678|75954264|FG000|Infant Series|Failed to return|1|||
42145199|NCT00366678|75954265|FG001|Infant Series|Failed to return|1|||
42145200|NCT00366678|75954266|FG002|Infant Series|Failed to return|0|||
42145201|NCT00366678|75954264|FG000|Infant Series|Adverse Event|1|||
42145202|NCT00366678|75954265|FG001|Infant Series|Adverse Event|0|||
42145203|NCT00366678|75954266|FG002|Infant Series|Adverse Event|0|||
42145204|NCT00366678|75954264|FG000|After Infant|Withdrawal by Subject|8|||
42145205|NCT00366678|75954265|FG001|After Infant|Withdrawal by Subject|4|||
42145206|NCT00366678|75954266|FG002|After Infant|Withdrawal by Subject|0|||
42145207|NCT00366678|75954264|FG000|After Infant|Lost to Follow-up|2|||
42145208|NCT00366678|75954265|FG001|After Infant|Lost to Follow-up|1|||
42145209|NCT00366678|75954266|FG002|After Infant|Lost to Follow-up|0|||
42145210|NCT00366678|75954264|FG000|After Infant|Failed to return|5|||
42145211|NCT00366678|75954265|FG001|After Infant|Failed to return|5|||
42145212|NCT00366678|75954266|FG002|After Infant|Failed to return|0|||
42145213|NCT00366678|75954264|FG000|After Infant|Adverse Event|1|||
42145214|NCT00366678|75954265|FG001|After Infant|Adverse Event|0|||
42145215|NCT00366678|75954266|FG002|After Infant|Adverse Event|0|||
42145216|NCT00366678|75954264|FG000|After Infant|Protocol Violation|1|||
42145217|NCT00366678|75954265|FG001|After Infant|Protocol Violation|0|||
42145218|NCT00366678|75954266|FG002|After Infant|Protocol Violation|0|||
42145219|NCT00366678|75954264|FG000|Toddler Dose|Protocol Violation|2|||
42145220|NCT00366678|75954265|FG001|Toddler Dose|Protocol Violation|1|||
42145221|NCT00366678|75954266|FG002|Toddler Dose|Protocol Violation|0|||
42145222|NCT00366678|75954264|FG000|Toddler Dose|Failed to return|1|||
42145223|NCT00366678|75954265|FG001|Toddler Dose|Failed to return|0|||
42145224|NCT00366678|75954266|FG002|Toddler Dose|Failed to return|0|||
42145225|NCT00366678|75954264|FG000|Toddler Dose|Withdrawal by Subject|1|||
42145226|NCT00366678|75954265|FG001|Toddler Dose|Withdrawal by Subject|0|||
42145227|NCT00366678|75954266|FG002|Toddler Dose|Withdrawal by Subject|0|||
42145228|NCT00366678|75954264|FG000|Toddler Dose|protocol deviation|1|||
42145229|NCT00366678|75954265|FG001|Toddler Dose|protocol deviation|0|||
42145230|NCT00366678|75954266|FG002|Toddler Dose|protocol deviation|0|||
42145231|NCT00355368|75954313|FG000|Overall Study|Protocol Violation|8|||
42145232|NCT00355368|75954314|FG001|Overall Study|Protocol Violation|7|||
42145233|NCT00355368|75954313|FG000|Overall Study|cardiac arrest prior to intubation|2|||
42145234|NCT00355368|75954314|FG001|Overall Study|cardiac arrest prior to intubation|2|||
42145235|NCT00360282|75954320|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
42145236|NCT00360282|75954321|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
42145237|NCT00360282|75954322|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
42277093|NCT02149121|76108699|FG006|Main Study Period|Physician Decision|0|||
42277094|NCT02149121|76108693|FG000|Main Study Period|Developed any malignancy|0|||
42039329|NCT01079195|75847607|FG000|Overall Study|No Documentation Available|437|||
42039330|NCT01079195|75847607|FG000|Overall Study|Adverse Event|157|||
42145238|NCT00360282|75954323|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
42145239|NCT00360282|75954320|FG000|Second Intervention|Adverse Event|0|||
42145240|NCT00360282|75954321|FG001|Second Intervention|Adverse Event|1|||
42145241|NCT00360282|75954322|FG002|Second Intervention|Adverse Event|0|||
42145242|NCT00360282|75954323|FG003|Second Intervention|Adverse Event|0|||
42145243|NCT00373958|75954333|FG000|Infant Series|Withdrawal by Subject|13|||
42277095|NCT02149121|76108694|FG001|Main Study Period|Developed any malignancy|1|||
42145244|NCT00373958|75954334|FG001|Infant Series|Withdrawal by Subject|15|||
42039331|NCT01079195|75847607|FG000|Overall Study|Reason Unknown|39|||
42145245|NCT00373958|75954333|FG000|Infant Series|Failed to return|8|||
42145246|NCT00373958|75954334|FG001|Infant Series|Failed to return|13|||
42145247|NCT00373958|75954333|FG000|Infant Series|Lost to Follow-up|6|||
42145248|NCT00373958|75954334|FG001|Infant Series|Lost to Follow-up|5|||
42145249|NCT00373958|75954333|FG000|Infant Series|Protocol Violation|3|||
42145250|NCT00373958|75954334|FG001|Infant Series|Protocol Violation|7|||
42145251|NCT00373958|75954333|FG000|Infant Series|Lost Kaiser coverage|4|||
42145252|NCT00373958|75954334|FG001|Infant Series|Lost Kaiser coverage|0|||
42145253|NCT00373958|75954333|FG000|Infant Series|Child relocated|1|||
42145254|NCT00373958|75954334|FG001|Infant Series|Child relocated|0|||
42145255|NCT00373958|75954333|FG000|Infant Series|Consent was not received|1|||
42145256|NCT00373958|75954334|FG001|Infant Series|Consent was not received|0|||
42145257|NCT00373958|75954333|FG000|Infant Series|Adverse Event|3|||
42145258|NCT00373958|75954334|FG001|Infant Series|Adverse Event|1|||
42145259|NCT00373958|75954333|FG000|Infant Series|Physician Decision|1|||
42145260|NCT00373958|75954334|FG001|Infant Series|Physician Decision|1|||
42145261|NCT00373958|75954333|FG000|Toddler Dose|Lost to Follow-up|5|||
42145262|NCT00373958|75954334|FG001|Toddler Dose|Lost to Follow-up|8|||
42145263|NCT00373958|75954333|FG000|Toddler Dose|Withdrawal by Subject|2|||
42145264|NCT00373958|75954334|FG001|Toddler Dose|Withdrawal by Subject|2|||
42145265|NCT00373958|75954333|FG000|Toddler Dose|Failed to return|1|||
42145266|NCT00373958|75954334|FG001|Toddler Dose|Failed to return|2|||
42145267|NCT00373958|75954333|FG000|Toddler Dose|Protocol Violation|0|||
42145268|NCT00373958|75954334|FG001|Toddler Dose|Protocol Violation|1|||
42145269|NCT00373958|75954333|FG000|Toddler Dose|Withdrawn after infant series|22|||
42145270|NCT00373958|75954334|FG001|Toddler Dose|Withdrawn after infant series|25|||
42145271|NCT00373880|75954363|FG000|Overall Study|Physician Decision|3|||
42145272|NCT00373880|75954363|FG000|Overall Study|Arrested|1|||
42145273|NCT00373880|75954363|FG000|Overall Study|Protocol Violation|14|||
42145274|NCT00184600|75954378|FG000|Overall Study|Adverse Event|9|||
42145275|NCT00184600|75954379|FG001|Overall Study|Adverse Event|0|||
42145276|NCT00184600|75954380|FG002|Overall Study|Adverse Event|5|||
42145277|NCT00184600|75954378|FG000|Overall Study|Death|3|||
42145278|NCT00184600|75954379|FG001|Overall Study|Death|9|||
42145279|NCT00184600|75954380|FG002|Overall Study|Death|7|||
42145280|NCT00184600|75954378|FG000|Overall Study|Lack of Efficacy|3|||
42145281|NCT00184600|75954379|FG001|Overall Study|Lack of Efficacy|1|||
42145282|NCT00184600|75954380|FG002|Overall Study|Lack of Efficacy|3|||
42145283|NCT00184600|75954378|FG000|Overall Study|Lost to Follow-up|4|||
42145284|NCT00184600|75954379|FG001|Overall Study|Lost to Follow-up|6|||
42145285|NCT00184600|75954380|FG002|Overall Study|Lost to Follow-up|1|||
42145286|NCT00184600|75954378|FG000|Overall Study|Protocol Violation|2|||
42145287|NCT00184600|75954379|FG001|Overall Study|Protocol Violation|2|||
42145288|NCT00184600|75954380|FG002|Overall Study|Protocol Violation|3|||
42145289|NCT00184600|75954378|FG000|Overall Study|Withdrawal by Subject|20|||
42145290|NCT00184600|75954379|FG001|Overall Study|Withdrawal by Subject|28|||
42145291|NCT00184600|75954380|FG002|Overall Study|Withdrawal by Subject|12|||
42145292|NCT00184600|75954378|FG000|Overall Study|Unclassified|4|||
42145293|NCT00184600|75954379|FG001|Overall Study|Unclassified|5|||
42145294|NCT00184600|75954380|FG002|Overall Study|Unclassified|3|||
42145295|NCT00265317|75954392|FG000|Lead-In|Objective progression or relapse|6|||
42145296|NCT00265317|75954393|FG001|Lead-In|Objective progression or relapse|11|||
42145297|NCT00265317|75954394|FG002|Lead-In|Objective progression or relapse|0|||
42145298|NCT00265317|75954395|FG003|Lead-In|Objective progression or relapse|0|||
42145299|NCT00265317|75954392|FG000|Lead-In|Adverse Event|2|||
42145300|NCT00265317|75954393|FG001|Lead-In|Adverse Event|1|||
42145301|NCT00265317|75954394|FG002|Lead-In|Adverse Event|0|||
42145302|NCT00265317|75954395|FG003|Lead-In|Adverse Event|0|||
42145303|NCT00265317|75954392|FG000|Lead-In|Death|3|||
42145304|NCT00265317|75954393|FG001|Lead-In|Death|5|||
42145305|NCT00265317|75954394|FG002|Lead-In|Death|0|||
42145306|NCT00265317|75954395|FG003|Lead-In|Death|0|||
42145307|NCT00265317|75954392|FG000|Lead-In|Withdrawal/other than adverse event|1|||
42145308|NCT00265317|75954393|FG001|Lead-In|Withdrawal/other than adverse event|0|||
42145309|NCT00265317|75954394|FG002|Lead-In|Withdrawal/other than adverse event|0|||
42145310|NCT00265317|75954395|FG003|Lead-In|Withdrawal/other than adverse event|0|||
42145311|NCT00265317|75954392|FG000|Phase 2|Objective progression or relapse|0|||
42145312|NCT00265317|75954393|FG001|Phase 2|Objective progression or relapse|0|||
42145313|NCT00265317|75954394|FG002|Phase 2|Objective progression or relapse|37|||
42145314|NCT00265317|75954395|FG003|Phase 2|Objective progression or relapse|38|||
42145315|NCT00265317|75954392|FG000|Phase 2|Global deterioration of health status|0|||
42145316|NCT00265317|75954393|FG001|Phase 2|Global deterioration of health status|0|||
42145317|NCT00265317|75954394|FG002|Phase 2|Global deterioration of health status|3|||
42145318|NCT00265317|75954395|FG003|Phase 2|Global deterioration of health status|0|||
42145319|NCT00265317|75954392|FG000|Phase 2|Adverse Event|0|||
42145320|NCT00265317|75954393|FG001|Phase 2|Adverse Event|0|||
42145321|NCT00265317|75954394|FG002|Phase 2|Adverse Event|7|||
42145322|NCT00265317|75954395|FG003|Phase 2|Adverse Event|5|||
42145323|NCT00265317|75954392|FG000|Phase 2|Death|0|||
42145324|NCT00265317|75954393|FG001|Phase 2|Death|0|||
42145325|NCT00265317|75954394|FG002|Phase 2|Death|12|||
42145326|NCT00265317|75954395|FG003|Phase 2|Death|15|||
42145327|NCT00265317|75954392|FG000|Phase 2|Protocol Violation|0|||
42145328|NCT00265317|75954393|FG001|Phase 2|Protocol Violation|0|||
42145329|NCT00265317|75954394|FG002|Phase 2|Protocol Violation|1|||
42145330|NCT00265317|75954395|FG003|Phase 2|Protocol Violation|4|||
42145331|NCT00265317|75954392|FG000|Phase 2|Lost to Follow-up|0|||
42145332|NCT00265317|75954393|FG001|Phase 2|Lost to Follow-up|0|||
42145333|NCT00265317|75954394|FG002|Phase 2|Lost to Follow-up|0|||
42145334|NCT00265317|75954395|FG003|Phase 2|Lost to Follow-up|1|||
42145335|NCT00265317|75954392|FG000|Phase 2|Withdrawal/other than adverse event|0|||
42145336|NCT00265317|75954393|FG001|Phase 2|Withdrawal/other than adverse event|0|||
42145337|NCT00265317|75954394|FG002|Phase 2|Withdrawal/other than adverse event|2|||
42145338|NCT00265317|75954395|FG003|Phase 2|Withdrawal/other than adverse event|1|||
42145339|NCT00265317|75954392|FG000|Phase 2|Study terminated by sponsor|0|||
42145340|NCT00265317|75954393|FG001|Phase 2|Study terminated by sponsor|0|||
42145341|NCT00265317|75954394|FG002|Phase 2|Study terminated by sponsor|1|||
42145342|NCT00265317|75954395|FG003|Phase 2|Study terminated by sponsor|0|||
42145343|NCT00265317|75954392|FG000|Phase 2|Other|0|||
42145344|NCT00265317|75954393|FG001|Phase 2|Other|0|||
42145345|NCT00265317|75954394|FG002|Phase 2|Other|1|||
42145346|NCT00265317|75954395|FG003|Phase 2|Other|1|||
42145347|NCT00373490|75954416|FG000|Overall Study|Adverse Event|0|||
42145348|NCT00373490|75954417|FG001|Overall Study|Adverse Event|1|||
42145349|NCT00373490|75954416|FG000|Overall Study|Lack of Efficacy|9|||
42145350|NCT00373490|75954417|FG001|Overall Study|Lack of Efficacy|4|||
42145351|NCT00373490|75954416|FG000|Overall Study|Withdrawal by Subject|0|||
42145352|NCT00373490|75954417|FG001|Overall Study|Withdrawal by Subject|1|||
42145353|NCT00251589|75954427|FG000|Overall Study|Adverse Event|5|||
42145354|NCT00251589|75954428|FG001|Overall Study|Adverse Event|1|||
42145355|NCT00251589|75954429|FG002|Overall Study|Adverse Event|2|||
42145356|NCT00251589|75954430|FG003|Overall Study|Adverse Event|1|||
42145357|NCT00251589|75954427|FG000|Overall Study|Withdrawal by Subject|1|||
42145358|NCT00251589|75954428|FG001|Overall Study|Withdrawal by Subject|1|||
42145359|NCT00251589|75954429|FG002|Overall Study|Withdrawal by Subject|0|||
42145360|NCT00251589|75954430|FG003|Overall Study|Withdrawal by Subject|0|||
42145361|NCT00251589|75954427|FG000|Overall Study|Discontinued due to progressive disease|9|||
42145362|NCT00251589|75954428|FG001|Overall Study|Discontinued due to progressive disease|1|||
42145363|NCT00251589|75954429|FG002|Overall Study|Discontinued due to progressive disease|0|||
42145364|NCT00251589|75954430|FG003|Overall Study|Discontinued due to progressive disease|1|||
42145365|NCT00265239|75954442|FG000|Overall Study|Adverse Event|2|||
42145366|NCT00265239|75954443|FG001|Overall Study|Adverse Event|1|||
42145367|NCT00350298|75954451|FG000|Overall Study|Death|7|||
42145368|NCT00350298|75954452|FG001|Overall Study|Death|8|||
42145369|NCT00350298|75954451|FG000|Overall Study|Lost to Follow-up|1|||
42145370|NCT00350298|75954452|FG001|Overall Study|Lost to Follow-up|2|||
42145371|NCT00350298|75954451|FG000|Overall Study|Withdrawal by Subject|1|||
42145372|NCT00350298|75954452|FG001|Overall Study|Withdrawal by Subject|3|||
42145373|NCT00159874|75954465|FG000|Overall Study|Adverse Event|2|||
42145374|NCT00159874|75954466|FG001|Overall Study|Adverse Event|2|||
42145375|NCT00159874|75954467|FG002|Overall Study|Adverse Event|5|||
42145376|NCT00159874|75954468|FG003|Overall Study|Adverse Event|1|||
42145377|NCT00159874|75954469|FG004|Overall Study|Adverse Event|1|||
42145378|NCT00159874|75954470|FG005|Overall Study|Adverse Event|2|||
42145379|NCT00159874|75954471|FG006|Overall Study|Adverse Event|0|||
42145380|NCT00159874|75954465|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
42145381|NCT00159874|75954466|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
42145382|NCT00159874|75954467|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
42145383|NCT00159874|75954468|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
42145384|NCT00159874|75954469|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
42145385|NCT00159874|75954470|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
42145386|NCT00159874|75954471|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
42351100|NCT01517373|76191012|FG005|Run-in Period|Withdrawal by Subject|0|||
42351101|NCT01517373|76191007|FG000|Run-in Period|Sponsor Decision|3|||
42145387|NCT00159874|75954465|FG000|Overall Study|Lack of Efficacy|2|||
42145388|NCT00159874|75954466|FG001|Overall Study|Lack of Efficacy|0|||
42145389|NCT00159874|75954467|FG002|Overall Study|Lack of Efficacy|1|||
42145390|NCT00159874|75954468|FG003|Overall Study|Lack of Efficacy|1|||
42145391|NCT00159874|75954469|FG004|Overall Study|Lack of Efficacy|0|||
42145392|NCT00159874|75954470|FG005|Overall Study|Lack of Efficacy|3|||
42145393|NCT00159874|75954471|FG006|Overall Study|Lack of Efficacy|0|||
42145394|NCT00159874|75954465|FG000|Overall Study|Lost to Follow-up|1|||
42145395|NCT00159874|75954466|FG001|Overall Study|Lost to Follow-up|0|||
42145396|NCT00159874|75954467|FG002|Overall Study|Lost to Follow-up|3|||
42145397|NCT00159874|75954468|FG003|Overall Study|Lost to Follow-up|0|||
42145398|NCT00159874|75954469|FG004|Overall Study|Lost to Follow-up|1|||
42145399|NCT00159874|75954470|FG005|Overall Study|Lost to Follow-up|2|||
42145400|NCT00159874|75954471|FG006|Overall Study|Lost to Follow-up|1|||
42145401|NCT00159874|75954465|FG000|Overall Study|Other|8|||
42145402|NCT00159874|75954466|FG001|Overall Study|Other|8|||
42145403|NCT00159874|75954467|FG002|Overall Study|Other|8|||
42145404|NCT00159874|75954468|FG003|Overall Study|Other|0|||
42145405|NCT00159874|75954469|FG004|Overall Study|Other|2|||
42145406|NCT00159874|75954470|FG005|Overall Study|Other|1|||
42145407|NCT00159874|75954471|FG006|Overall Study|Other|3|||
42039332|NCT01079195|75847607|FG000|Overall Study|Withdrawal by Subject|18|||
42039333|NCT01079195|75847607|FG000|Overall Study|Financial Reasons|15|||
42039334|NCT01079195|75847607|FG000|Overall Study|Lack of Effectiveness|12|||
42039335|NCT01079195|75847607|FG000|Overall Study|Physician Decision|4|||
42039336|NCT01079195|75847607|FG000|Overall Study|Improved Status of Participant|4|||
42039337|NCT01079195|75847607|FG000|Overall Study|No Follow-up Documentation Available|4|||
42039338|NCT01079195|75847607|FG000|Overall Study|Non-compliance|2|||
42039339|NCT00883558|75847611|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
42039340|NCT00883558|75847612|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
42039341|NCT00883558|75847613|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
42039342|NCT00883558|75847611|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
42039343|NCT00883558|75847612|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
42039344|NCT00883558|75847613|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
42039345|NCT00883558|75847611|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
42039346|NCT00883558|75847612|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
42039347|NCT00883558|75847613|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
42039348|NCT00883558|75847611|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
42039349|NCT00883558|75847612|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
42039350|NCT00883558|75847613|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
42039351|NCT00883558|75847611|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
42039352|NCT00883558|75847612|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
42039353|NCT00883558|75847613|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
42039354|NCT00880750|75847621|FG000|First Intervention|Adverse Event|1|||
42039355|NCT00880750|75847622|FG001|First Intervention|Adverse Event|0|||
42039356|NCT00880750|75847621|FG000|First Intervention|Unable to collect urine|4|||
42039357|NCT00880750|75847622|FG001|First Intervention|Unable to collect urine|0|||
42039358|NCT00880750|75847621|FG000|First Intervention|Non-compliance with meals|0|||
42039359|NCT00880750|75847622|FG001|First Intervention|Non-compliance with meals|1|||
42039360|NCT00880750|75847621|FG000|First Intervention|Withdrawal by Subject|2|||
42039361|NCT00880750|75847622|FG001|First Intervention|Withdrawal by Subject|0|||
42039362|NCT00880750|75847621|FG000|First Intervention|Lost to Follow-up|2|||
42039363|NCT00880750|75847622|FG001|First Intervention|Lost to Follow-up|0|||
42039364|NCT00880750|75847621|FG000|Second Intervention|Withdrawal by Subject|2|||
42145408|NCT00159874|75954465|FG000|Overall Study|Protocol Violation|0|||
42145409|NCT00159874|75954466|FG001|Overall Study|Protocol Violation|5|||
42145410|NCT00159874|75954467|FG002|Overall Study|Protocol Violation|2|||
42145411|NCT00159874|75954468|FG003|Overall Study|Protocol Violation|0|||
42145412|NCT00159874|75954469|FG004|Overall Study|Protocol Violation|0|||
42145413|NCT00159874|75954470|FG005|Overall Study|Protocol Violation|0|||
42039365|NCT00880750|75847622|FG001|Second Intervention|Withdrawal by Subject|2|||
42039366|NCT00880750|75847621|FG000|Second Intervention|Protocol Violation|1|||
42039367|NCT00880750|75847622|FG001|Second Intervention|Protocol Violation|0|||
42039368|NCT00880750|75847621|FG000|Second Intervention|Unable to collect urine|1|||
42145414|NCT00159874|75954471|FG006|Overall Study|Protocol Violation|0|||
42145415|NCT00159874|75954465|FG000|Overall Study|Death|3|||
42145416|NCT00159874|75954466|FG001|Overall Study|Death|8|||
42145417|NCT00159874|75954467|FG002|Overall Study|Death|15|||
42145418|NCT00159874|75954468|FG003|Overall Study|Death|0|||
42145419|NCT00159874|75954469|FG004|Overall Study|Death|1|||
42145420|NCT00159874|75954470|FG005|Overall Study|Death|2|||
42145421|NCT00159874|75954471|FG006|Overall Study|Death|0|||
42145422|NCT00159874|75954465|FG000|Overall Study|Withdrawal by Subject|2|||
42145423|NCT00159874|75954466|FG001|Overall Study|Withdrawal by Subject|6|||
42145424|NCT00159874|75954467|FG002|Overall Study|Withdrawal by Subject|8|||
42145425|NCT00159874|75954468|FG003|Overall Study|Withdrawal by Subject|4|||
42145426|NCT00159874|75954469|FG004|Overall Study|Withdrawal by Subject|3|||
42145427|NCT00159874|75954470|FG005|Overall Study|Withdrawal by Subject|2|||
42145428|NCT00159874|75954471|FG006|Overall Study|Withdrawal by Subject|1|||
42145429|NCT00159874|75954465|FG000|Overall Study|Pregnancy|1|||
42145430|NCT00159874|75954466|FG001|Overall Study|Pregnancy|1|||
42145431|NCT00159874|75954467|FG002|Overall Study|Pregnancy|0|||
42145432|NCT00159874|75954468|FG003|Overall Study|Pregnancy|0|||
42145433|NCT00159874|75954469|FG004|Overall Study|Pregnancy|0|||
42145434|NCT00159874|75954470|FG005|Overall Study|Pregnancy|0|||
42145435|NCT00159874|75954471|FG006|Overall Study|Pregnancy|0|||
42145436|NCT00349908|75954489|FG000|Overall Study|Withdrawal by Subject|0|||
42145437|NCT00349908|75954490|FG001|Overall Study|Withdrawal by Subject|4|||
42145438|NCT00184054|75954497|FG000|Overall Study|Adverse Event|1|||
42145439|NCT00183430|75954503|FG000|Overall Study|Adverse Event|1|||
42145440|NCT00183430|75954504|FG001|Overall Study|Adverse Event|0|||
42145441|NCT00183430|75954503|FG000|Overall Study|Lost to Follow-up|3|||
42145442|NCT00183430|75954504|FG001|Overall Study|Lost to Follow-up|0|||
42145443|NCT00183430|75954503|FG000|Overall Study|did not meet inclusion criteria|1|||
42145444|NCT00183430|75954504|FG001|Overall Study|did not meet inclusion criteria|0|||
42145445|NCT00183430|75954503|FG000|Overall Study|Withdrawal by Subject|1|||
42145446|NCT00183430|75954504|FG001|Overall Study|Withdrawal by Subject|0|||
42145447|NCT00183274|75954510|FG000|Phase 1: Open-Label|Adverse Event|31|||
42145448|NCT00183274|75954511|FG001|Phase 1: Open-Label|Adverse Event|0|||
42145449|NCT00183274|75954512|FG002|Phase 1: Open-Label|Adverse Event|0|||
42145450|NCT00183274|75954513|FG003|Phase 1: Open-Label|Adverse Event|0|||
42145451|NCT00183274|75954514|FG004|Phase 1: Open-Label|Adverse Event|0|||
42145452|NCT00183274|75954515|FG005|Phase 1: Open-Label|Adverse Event|0|||
42145453|NCT00183274|75954510|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
42145454|NCT00183274|75954511|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
42145455|NCT00183274|75954512|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
42145456|NCT00183274|75954513|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
42145457|NCT00183274|75954514|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
42145458|NCT00183274|75954515|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
42145459|NCT00183274|75954510|FG000|Phase 1: Open-Label|Protocol Violation|11|||
42145460|NCT00183274|75954511|FG001|Phase 1: Open-Label|Protocol Violation|0|||
42145461|NCT00183274|75954512|FG002|Phase 1: Open-Label|Protocol Violation|0|||
42145462|NCT00183274|75954513|FG003|Phase 1: Open-Label|Protocol Violation|0|||
42145463|NCT00183274|75954514|FG004|Phase 1: Open-Label|Protocol Violation|0|||
42145464|NCT00183274|75954515|FG005|Phase 1: Open-Label|Protocol Violation|0|||
42145465|NCT00183274|75954510|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
42145466|NCT00183274|75954511|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
42039369|NCT00880750|75847622|FG001|Second Intervention|Unable to collect urine|0|||
42039370|NCT00597766|75847631|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
42039371|NCT00597766|75847632|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
42039372|NCT00597766|75847633|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
42039373|NCT00597766|75847631|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
42039374|NCT00597766|75847632|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
42145467|NCT00183274|75954512|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
42145468|NCT00183274|75954513|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
42145469|NCT00183274|75954514|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
42145470|NCT00183274|75954515|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
42145471|NCT00183274|75954510|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
42145472|NCT00183274|75954511|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
42145473|NCT00183274|75954512|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
42145474|NCT00183274|75954513|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
42145475|NCT00183274|75954514|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
42145476|NCT00183274|75954515|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
42039375|NCT00597766|75847633|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
42145477|NCT00183274|75954510|FG000|Phase 1: Open-Label|Other|9|||
42145478|NCT00183274|75954511|FG001|Phase 1: Open-Label|Other|0|||
42145479|NCT00183274|75954512|FG002|Phase 1: Open-Label|Other|0|||
42145480|NCT00183274|75954513|FG003|Phase 1: Open-Label|Other|0|||
42145481|NCT00183274|75954514|FG004|Phase 1: Open-Label|Other|0|||
42145482|NCT00183274|75954515|FG005|Phase 1: Open-Label|Other|0|||
42145483|NCT00183274|75954510|FG000|Phase 2: Double-Blind|Relapsed|0|||
42145484|NCT00183274|75954511|FG001|Phase 2: Double-Blind|Relapsed|8|||
42145485|NCT00183274|75954512|FG002|Phase 2: Double-Blind|Relapsed|29|||
42145486|NCT00183274|75954513|FG003|Phase 2: Double-Blind|Relapsed|0|||
42145487|NCT00183274|75954514|FG004|Phase 2: Double-Blind|Relapsed|0|||
42145488|NCT00183274|75954515|FG005|Phase 2: Double-Blind|Relapsed|0|||
42145489|NCT00183274|75954510|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
42145490|NCT00183274|75954511|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
42145491|NCT00183274|75954512|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
42145492|NCT00183274|75954513|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
42145493|NCT00183274|75954514|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
42145494|NCT00183274|75954515|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
42145495|NCT00183274|75954510|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
42145496|NCT00183274|75954511|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
42145497|NCT00183274|75954512|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
42145498|NCT00183274|75954513|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
42145499|NCT00183274|75954514|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
42145500|NCT00183274|75954515|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
42145501|NCT00183274|75954510|FG000|Phase 3: Double-Blind|Relapsed|0|||
42145502|NCT00183274|75954511|FG001|Phase 3: Double-Blind|Relapsed|0|||
42145503|NCT00183274|75954512|FG002|Phase 3: Double-Blind|Relapsed|0|||
42145504|NCT00183274|75954513|FG003|Phase 3: Double-Blind|Relapsed|1|||
42145505|NCT00183274|75954514|FG004|Phase 3: Double-Blind|Relapsed|11|||
42145506|NCT00183274|75954515|FG005|Phase 3: Double-Blind|Relapsed|2|||
42145507|NCT00183196|75954533|FG000|Overall Study|Withdrawal by Subject|18|||
42145508|NCT00183196|75954534|FG001|Overall Study|Withdrawal by Subject|11|||
42145509|NCT00183196|75954535|FG002|Overall Study|Withdrawal by Subject|13|||
42145510|NCT00183196|75954533|FG000|Overall Study|Adverse Event|1|||
42145511|NCT00183196|75954534|FG001|Overall Study|Adverse Event|2|||
42145512|NCT00183196|75954535|FG002|Overall Study|Adverse Event|2|||
42145513|NCT00183196|75954533|FG000|Overall Study|Legal event|1|||
42145514|NCT00183196|75954534|FG001|Overall Study|Legal event|1|||
42145515|NCT00183196|75954535|FG002|Overall Study|Legal event|1|||
42145516|NCT00183196|75954533|FG000|Overall Study|Required more intensive care|0|||
42145517|NCT00183196|75954534|FG001|Overall Study|Required more intensive care|1|||
42145518|NCT00183196|75954535|FG002|Overall Study|Required more intensive care|2|||
42145519|NCT00349752|75954545|FG000|Overall Study|Adverse Event|8|||
42145520|NCT00349752|75954546|FG001|Overall Study|Adverse Event|12|||
42039376|NCT00979992|75847641|FG000|Overall Study|Ineligible - inadequate pathology|1|||
42039377|NCT00979992|75847641|FG000|Overall Study|Ineligible - wrong cell type|2|||
42039378|NCT00979992|75847641|FG000|Overall Study|Refused - Never Treated|2|||
42039379|NCT01079741|75847650|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
42039380|NCT01079741|75847651|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
42039381|NCT01079741|75847652|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
42039382|NCT01079741|75847653|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
42039383|NCT01079741|75847654|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
42039384|NCT01079741|75847650|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
42039385|NCT01079741|75847651|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
42039386|NCT01079741|75847652|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
42039387|NCT01079741|75847653|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
42039388|NCT01079741|75847654|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
42039389|NCT01079663|75847668|FG000|Overall Study|Adverse Event|0|||
42039390|NCT01079663|75847669|FG001|Overall Study|Adverse Event|2|||
42039391|NCT01079663|75847668|FG000|Overall Study|Protocol Violation|0|||
42039392|NCT01079663|75847669|FG001|Overall Study|Protocol Violation|2|||
42145521|NCT00349752|75954545|FG000|Overall Study|Lack of Efficacy|37|||
42145522|NCT00349752|75954546|FG001|Overall Study|Lack of Efficacy|42|||
42145523|NCT00349752|75954545|FG000|Overall Study|Lost to Follow-up|4|||
42145524|NCT00349752|75954546|FG001|Overall Study|Lost to Follow-up|2|||
42145525|NCT00349752|75954545|FG000|Overall Study|Personal reasons|6|||
42145526|NCT00349752|75954546|FG001|Overall Study|Personal reasons|5|||
42145527|NCT00349752|75954545|FG000|Overall Study|Other: Required exclusionary medication|0|||
42145528|NCT00349752|75954546|FG001|Overall Study|Other: Required exclusionary medication|1|||
42039393|NCT00879814|75847679|FG000|Overall Study|Adverse Event|0|||
42039394|NCT00879814|75847680|FG001|Overall Study|Adverse Event|1|||
42039395|NCT00879814|75847681|FG002|Overall Study|Adverse Event|0|||
42145529|NCT00349752|75954545|FG000|Overall Study|Other: Non compliance|0|||
42145530|NCT00349752|75954546|FG001|Overall Study|Other: Non compliance|1|||
42145531|NCT00349752|75954545|FG000|Overall Study|Other: Patient stopped steroids|0|||
42145532|NCT00349752|75954546|FG001|Overall Study|Other: Patient stopped steroids|1|||
42145533|NCT00349752|75954545|FG000|Overall Study|Other: Patient's steroid use|1|||
42145534|NCT00349752|75954546|FG001|Overall Study|Other: Patient's steroid use|0|||
42039396|NCT00879814|75847682|FG003|Overall Study|Adverse Event|0|||
42145535|NCT00349752|75954545|FG000|Overall Study|Other: Ineligible|1|||
42145536|NCT00349752|75954546|FG001|Overall Study|Other: Ineligible|0|||
42145537|NCT00349752|75954545|FG000|Overall Study|Other: Inadvertently unblinded|1|||
42145538|NCT00349752|75954546|FG001|Overall Study|Other: Inadvertently unblinded|0|||
42145539|NCT00349752|75954545|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
42145540|NCT00349752|75954546|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
42145541|NCT00174460|75954554|FG000|Overall Study|Withdrawal by Subject|0|||
42145542|NCT00174460|75954555|FG001|Overall Study|Withdrawal by Subject|1|||
42145543|NCT00348816|75954562|FG000|Overall Study|Noncompliance with radiation treatment|1|||
42145544|NCT00265083|75954571|FG000|Overall Study|Adverse Event|5|||
42145545|NCT00265083|75954572|FG001|Overall Study|Adverse Event|13|||
42145546|NCT00265083|75954573|FG002|Overall Study|Adverse Event|15|||
42145547|NCT00265083|75954571|FG000|Overall Study|Lost to Follow-up|3|||
42145548|NCT00265083|75954572|FG001|Overall Study|Lost to Follow-up|4|||
42145549|NCT00265083|75954573|FG002|Overall Study|Lost to Follow-up|4|||
42145550|NCT00265083|75954571|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
42145551|NCT00265083|75954572|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
42145552|NCT00265083|75954573|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
42145553|NCT00265083|75954571|FG000|Overall Study|Other|1|||
42145554|NCT00265083|75954572|FG001|Overall Study|Other|12|||
42145555|NCT00265083|75954573|FG002|Overall Study|Other|9|||
42145556|NCT00264849|75954584|FG000|Overall Study|Adverse Event|7|||
42145557|NCT00264849|75954585|FG001|Overall Study|Adverse Event|2|||
42145558|NCT00264849|75954584|FG000|Overall Study|Withdrawal by Subject|7|||
42145559|NCT00264849|75954585|FG001|Overall Study|Withdrawal by Subject|11|||
42145560|NCT00264849|75954584|FG000|Overall Study|Protocol Violation|5|||
42145561|NCT00264849|75954585|FG001|Overall Study|Protocol Violation|3|||
42012603|NCT01194219|75819475|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
42012604|NCT01194219|75819476|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
42012605|NCT01194219|75819477|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
42012606|NCT01194219|75819478|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
42012607|NCT01194219|75819479|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
42012608|NCT01194219|75819480|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
42012609|NCT01194219|75819481|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
42012610|NCT01194219|75819482|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
42012611|NCT01194219|75819483|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
42012612|NCT01194219|75819484|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
42145562|NCT00264849|75954584|FG000|Overall Study|Lack of Efficacy|1|||
42145563|NCT00264849|75954585|FG001|Overall Study|Lack of Efficacy|6|||
42145564|NCT00264849|75954584|FG000|Overall Study|Lost to Follow-up|0|||
42145565|NCT00264849|75954585|FG001|Overall Study|Lost to Follow-up|2|||
42145566|NCT00264849|75954584|FG000|Overall Study|Death|0|||
42145567|NCT00264849|75954585|FG001|Overall Study|Death|1|||
42145568|NCT00264849|75954584|FG000|Overall Study|Administrative Problems|2|||
42145569|NCT00264849|75954585|FG001|Overall Study|Administrative Problems|0|||
42145570|NCT00211809|75954591|FG000|Overall Study|Lack of Efficacy|1|||
42145571|NCT00211809|75954591|FG000|Overall Study|Lost to Follow-up|2|||
42145572|NCT00211809|75954591|FG000|Overall Study|Pregnancy|1|||
42145573|NCT00211809|75954591|FG000|Overall Study|side effects|2|||
42145574|NCT00129766|75954599|FG000|Overall Study|Death|3|||
42145575|NCT00129766|75954600|FG001|Overall Study|Death|8|||
42145576|NCT00129766|75954599|FG000|Overall Study|Withdrawal of consent|31|||
42145577|NCT00129766|75954600|FG001|Overall Study|Withdrawal of consent|30|||
42145578|NCT00129766|75954599|FG000|Overall Study|Lost to Follow-up|26|||
42145579|NCT00129766|75954600|FG001|Overall Study|Lost to Follow-up|21|||
42145580|NCT00150592|75954609|FG000|Overall Study|Adverse Event|4|||
42145581|NCT00150592|75954610|FG001|Overall Study|Adverse Event|1|||
42145582|NCT00150592|75954609|FG000|Overall Study|Protocol Violation|1|||
42145583|NCT00150592|75954610|FG001|Overall Study|Protocol Violation|0|||
42145584|NCT00150592|75954609|FG000|Overall Study|Withdrawal by Subject|1|||
42277096|NCT02149121|76108695|FG002|Main Study Period|Developed any malignancy|1|||
42277097|NCT02149121|76108696|FG003|Main Study Period|Developed any malignancy|0|||
42277098|NCT02149121|76108697|FG004|Main Study Period|Developed any malignancy|0|||
42012613|NCT01194219|75819475|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
42012614|NCT01194219|75819476|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
42145585|NCT00150592|75954610|FG001|Overall Study|Withdrawal by Subject|2|||
42145586|NCT00150592|75954609|FG000|Overall Study|Non-compliance|1|||
42145587|NCT00150592|75954610|FG001|Overall Study|Non-compliance|0|||
42145588|NCT00149890|75954618|FG000|Overall Study|Adverse Event|1|||
42145589|NCT00149890|75954619|FG001|Overall Study|Adverse Event|8|||
42145590|NCT00149890|75954618|FG000|Overall Study|Lack of Efficacy|8|||
42145591|NCT00149890|75954619|FG001|Overall Study|Lack of Efficacy|9|||
42145592|NCT00149890|75954618|FG000|Overall Study|Protocol Violation|1|||
42145593|NCT00149890|75954619|FG001|Overall Study|Protocol Violation|0|||
42145594|NCT00149890|75954618|FG000|Overall Study|Lost to Follow-up|1|||
42145595|NCT00149890|75954619|FG001|Overall Study|Lost to Follow-up|0|||
42145596|NCT00149890|75954618|FG000|Overall Study|Graft Loss|2|||
42145597|NCT00149890|75954619|FG001|Overall Study|Graft Loss|1|||
42145598|NCT00174382|75954625|FG000|Overall Study|Death|2|||
42145599|NCT00174382|75954625|FG000|Overall Study|Adverse Event|19|||
42145600|NCT00174382|75954625|FG000|Overall Study|Withdrawal by Subject|6|||
42145601|NCT00174382|75954625|FG000|Overall Study|Protocol Violation|3|||
42145602|NCT00174382|75954625|FG000|Overall Study|Arrived early for last visit in error|1|||
42145603|NCT00174382|75954625|FG000|Overall Study|Subject felt pill not effective enough|1|||
42145604|NCT00174382|75954625|FG000|Overall Study|Lost to Follow-up|1|||
42145605|NCT00355134|75954634|FG000|Core Phase|Withdrawal by Subject|35|||
42145606|NCT00355134|75954635|FG001|Core Phase|Withdrawal by Subject|24|||
42145607|NCT00355134|75954636|FG002|Core Phase|Withdrawal by Subject|35|||
42145608|NCT00355134|75954637|FG003|Core Phase|Withdrawal by Subject|0|||
42145609|NCT00355134|75954638|FG004|Core Phase|Withdrawal by Subject|0|||
42145610|NCT00355134|75954634|FG000|Core Phase|Adverse Event|28|||
42145611|NCT00355134|75954635|FG001|Core Phase|Adverse Event|22|||
42145612|NCT00355134|75954636|FG002|Core Phase|Adverse Event|16|||
42145613|NCT00355134|75954637|FG003|Core Phase|Adverse Event|0|||
42145614|NCT00355134|75954638|FG004|Core Phase|Adverse Event|0|||
42145615|NCT00355134|75954634|FG000|Core Phase|Lost to Follow-up|17|||
42145616|NCT00355134|75954635|FG001|Core Phase|Lost to Follow-up|13|||
42145617|NCT00355134|75954636|FG002|Core Phase|Lost to Follow-up|21|||
42145618|NCT00355134|75954637|FG003|Core Phase|Lost to Follow-up|0|||
42145619|NCT00355134|75954638|FG004|Core Phase|Lost to Follow-up|0|||
42145620|NCT00355134|75954634|FG000|Core Phase|Abnormal laboratory value(s)|19|||
42145621|NCT00355134|75954635|FG001|Core Phase|Abnormal laboratory value(s)|14|||
42145622|NCT00355134|75954636|FG002|Core Phase|Abnormal laboratory value(s)|2|||
42145623|NCT00355134|75954637|FG003|Core Phase|Abnormal laboratory value(s)|0|||
42145624|NCT00355134|75954638|FG004|Core Phase|Abnormal laboratory value(s)|0|||
42145625|NCT00355134|75954634|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
42145626|NCT00355134|75954635|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
42145627|NCT00355134|75954636|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
42277099|NCT02149121|76108698|FG005|Main Study Period|Developed any malignancy|0|||
42277100|NCT02149121|76108699|FG006|Main Study Period|Developed any malignancy|0|||
42277101|NCT02149121|76108693|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
42277102|NCT02149121|76108694|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
42277103|NCT02149121|76108695|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
42277104|NCT02149121|76108696|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
42277105|NCT02149121|76108697|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
42277106|NCT02149121|76108698|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
42277107|NCT02149121|76108699|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
42277108|NCT02149121|76108693|FG000|Main Study Period|Disease progression|0|||
42277109|NCT02149121|76108694|FG001|Main Study Period|Disease progression|1|||
42277110|NCT02149121|76108695|FG002|Main Study Period|Disease progression|0|||
42277111|NCT02149121|76108696|FG003|Main Study Period|Disease progression|0|||
42277112|NCT02149121|76108697|FG004|Main Study Period|Disease progression|0|||
42277113|NCT02149121|76108698|FG005|Main Study Period|Disease progression|0|||
42277114|NCT02149121|76108699|FG006|Main Study Period|Disease progression|0|||
42277115|NCT02149121|76108693|FG000|Extension Study Period|Withdrawal by Subject|0|||
42277116|NCT02149121|76108694|FG001|Extension Study Period|Withdrawal by Subject|0|||
42277117|NCT02149121|76108695|FG002|Extension Study Period|Withdrawal by Subject|0|||
42277118|NCT02149121|76108696|FG003|Extension Study Period|Withdrawal by Subject|1|||
42277119|NCT02149121|76108697|FG004|Extension Study Period|Withdrawal by Subject|0|||
42277120|NCT02149121|76108698|FG005|Extension Study Period|Withdrawal by Subject|2|||
42277121|NCT02149121|76108699|FG006|Extension Study Period|Withdrawal by Subject|0|||
42277122|NCT01865617|76108751|FG000|Overall Study|Death|27|||
42145628|NCT00355134|75954637|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
42145629|NCT00355134|75954638|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
42145630|NCT00355134|75954634|FG000|Core Phase|Administrative problems|5|||
42145631|NCT00355134|75954635|FG001|Core Phase|Administrative problems|3|||
42145632|NCT00355134|75954636|FG002|Core Phase|Administrative problems|5|||
42145633|NCT00355134|75954637|FG003|Core Phase|Administrative problems|0|||
42145634|NCT00355134|75954638|FG004|Core Phase|Administrative problems|0|||
42145635|NCT00355134|75954634|FG000|Core Phase|Protocol Violation|3|||
42145636|NCT00355134|75954635|FG001|Core Phase|Protocol Violation|2|||
42145637|NCT00355134|75954636|FG002|Core Phase|Protocol Violation|2|||
42145638|NCT00355134|75954637|FG003|Core Phase|Protocol Violation|0|||
42145639|NCT00355134|75954638|FG004|Core Phase|Protocol Violation|0|||
42145640|NCT00355134|75954634|FG000|Core Phase|Abnormal test procedure result(s)|1|||
42145641|NCT00355134|75954635|FG001|Core Phase|Abnormal test procedure result(s)|2|||
42277123|NCT01865617|76108752|FG001|Overall Study|Death|3|||
42277124|NCT01865617|76108753|FG002|Overall Study|Death|1|||
42277125|NCT01865617|76108754|FG003|Overall Study|Death|1|||
42277126|NCT01865617|76108755|FG004|Overall Study|Death|5|||
42145642|NCT00355134|75954636|FG002|Core Phase|Abnormal test procedure result(s)|1|||
42145643|NCT00355134|75954637|FG003|Core Phase|Abnormal test procedure result(s)|0|||
42145644|NCT00355134|75954638|FG004|Core Phase|Abnormal test procedure result(s)|0|||
42145645|NCT00355134|75954634|FG000|Core Phase|Condition no longer requires study drug|1|||
42145646|NCT00355134|75954635|FG001|Core Phase|Condition no longer requires study drug|0|||
42277127|NCT01865617|76108756|FG005|Overall Study|Death|1|||
42277128|NCT01865617|76108757|FG006|Overall Study|Death|11|||
42277129|NCT01865617|76108758|FG007|Overall Study|Death|1|||
42277130|NCT01865617|76108759|FG008|Overall Study|Death|11|||
42277131|NCT01865617|76108760|FG009|Overall Study|Death|3|||
42277132|NCT01865617|76108761|FG010|Overall Study|Death|32|||
42277133|NCT01865617|76108762|FG011|Overall Study|Death|6|||
42277134|NCT01865617|76108763|FG012|Overall Study|Death|13|||
42277135|NCT01865617|76108751|FG000|Overall Study|Lost to Follow-up|2|||
42277136|NCT01865617|76108752|FG001|Overall Study|Lost to Follow-up|0|||
42277137|NCT01865617|76108753|FG002|Overall Study|Lost to Follow-up|0|||
42277138|NCT01865617|76108754|FG003|Overall Study|Lost to Follow-up|0|||
42277139|NCT01865617|76108755|FG004|Overall Study|Lost to Follow-up|0|||
42277140|NCT01865617|76108756|FG005|Overall Study|Lost to Follow-up|0|||
42277141|NCT01865617|76108757|FG006|Overall Study|Lost to Follow-up|0|||
42277142|NCT01865617|76108758|FG007|Overall Study|Lost to Follow-up|0|||
42277143|NCT01865617|76108759|FG008|Overall Study|Lost to Follow-up|0|||
42277144|NCT01865617|76108760|FG009|Overall Study|Lost to Follow-up|0|||
42277145|NCT01865617|76108761|FG010|Overall Study|Lost to Follow-up|0|||
42277146|NCT01865617|76108762|FG011|Overall Study|Lost to Follow-up|0|||
42277147|NCT01865617|76108763|FG012|Overall Study|Lost to Follow-up|0|||
42277148|NCT01865617|76108751|FG000|Overall Study|Withdrawal by Subject|1|||
42277149|NCT01865617|76108752|FG001|Overall Study|Withdrawal by Subject|0|||
42277150|NCT01865617|76108753|FG002|Overall Study|Withdrawal by Subject|0|||
42277151|NCT01865617|76108754|FG003|Overall Study|Withdrawal by Subject|0|||
42277152|NCT01865617|76108755|FG004|Overall Study|Withdrawal by Subject|0|||
42277153|NCT01865617|76108756|FG005|Overall Study|Withdrawal by Subject|0|||
42277154|NCT01865617|76108757|FG006|Overall Study|Withdrawal by Subject|0|||
42277155|NCT01865617|76108758|FG007|Overall Study|Withdrawal by Subject|0|||
42277156|NCT01865617|76108759|FG008|Overall Study|Withdrawal by Subject|0|||
42277157|NCT01865617|76108760|FG009|Overall Study|Withdrawal by Subject|0|||
42277158|NCT01865617|76108761|FG010|Overall Study|Withdrawal by Subject|0|||
42277159|NCT01865617|76108762|FG011|Overall Study|Withdrawal by Subject|0|||
42277160|NCT01865617|76108763|FG012|Overall Study|Withdrawal by Subject|0|||
42277161|NCT01865617|76108751|FG000|Overall Study|Patient proceeded to new therapy|0|||
42277162|NCT01865617|76108752|FG001|Overall Study|Patient proceeded to new therapy|0|||
42277163|NCT01865617|76108753|FG002|Overall Study|Patient proceeded to new therapy|0|||
42277164|NCT01865617|76108754|FG003|Overall Study|Patient proceeded to new therapy|0|||
42277165|NCT01865617|76108755|FG004|Overall Study|Patient proceeded to new therapy|2|||
42277166|NCT01865617|76108756|FG005|Overall Study|Patient proceeded to new therapy|0|||
42277167|NCT01865617|76108757|FG006|Overall Study|Patient proceeded to new therapy|0|||
42277168|NCT01865617|76108758|FG007|Overall Study|Patient proceeded to new therapy|0|||
42277169|NCT01865617|76108759|FG008|Overall Study|Patient proceeded to new therapy|0|||
42277170|NCT01865617|76108760|FG009|Overall Study|Patient proceeded to new therapy|0|||
42277171|NCT01865617|76108761|FG010|Overall Study|Patient proceeded to new therapy|0|||
42277172|NCT01865617|76108762|FG011|Overall Study|Patient proceeded to new therapy|0|||
42277173|NCT01865617|76108763|FG012|Overall Study|Patient proceeded to new therapy|0|||
42277174|NCT01865617|76108751|FG000|Overall Study|Other|0|||
42351102|NCT01517373|76191008|FG001|Run-in Period|Sponsor Decision|0|||
42277175|NCT01865617|76108752|FG001|Overall Study|Other|0|||
42277176|NCT01865617|76108753|FG002|Overall Study|Other|0|||
42277177|NCT01865617|76108754|FG003|Overall Study|Other|0|||
42277178|NCT01865617|76108755|FG004|Overall Study|Other|0|||
42277179|NCT01865617|76108756|FG005|Overall Study|Other|0|||
42277180|NCT01865617|76108757|FG006|Overall Study|Other|1|||
42277181|NCT01865617|76108758|FG007|Overall Study|Other|0|||
42277182|NCT01865617|76108759|FG008|Overall Study|Other|0|||
42277183|NCT01865617|76108760|FG009|Overall Study|Other|0|||
42145647|NCT00355134|75954636|FG002|Core Phase|Condition no longer requires study drug|1|||
42145648|NCT00355134|75954637|FG003|Core Phase|Condition no longer requires study drug|0|||
42145649|NCT00355134|75954638|FG004|Core Phase|Condition no longer requires study drug|0|||
42145650|NCT00355134|75954634|FG000|Extension Phase|Withdrawal by Subject|7|||
42145651|NCT00355134|75954635|FG001|Extension Phase|Withdrawal by Subject|11|||
42145652|NCT00355134|75954636|FG002|Extension Phase|Withdrawal by Subject|0|||
42145653|NCT00355134|75954637|FG003|Extension Phase|Withdrawal by Subject|7|||
42145654|NCT00355134|75954638|FG004|Extension Phase|Withdrawal by Subject|5|||
42145655|NCT00355134|75954634|FG000|Extension Phase|Adverse Event|13|||
42145656|NCT00355134|75954635|FG001|Extension Phase|Adverse Event|9|||
42145657|NCT00355134|75954636|FG002|Extension Phase|Adverse Event|0|||
42145658|NCT00355134|75954637|FG003|Extension Phase|Adverse Event|3|||
42145659|NCT00355134|75954638|FG004|Extension Phase|Adverse Event|5|||
42145660|NCT00355134|75954634|FG000|Extension Phase|Lost to Follow-up|2|||
42145661|NCT00355134|75954635|FG001|Extension Phase|Lost to Follow-up|6|||
42145662|NCT00355134|75954636|FG002|Extension Phase|Lost to Follow-up|0|||
42145663|NCT00355134|75954637|FG003|Extension Phase|Lost to Follow-up|2|||
42145664|NCT00355134|75954638|FG004|Extension Phase|Lost to Follow-up|4|||
42145665|NCT00355134|75954634|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
42145666|NCT00355134|75954635|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
42145667|NCT00355134|75954636|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
42145668|NCT00355134|75954637|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
42145669|NCT00355134|75954638|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
42145670|NCT00355134|75954634|FG000|Extension Phase|Administrative problems|2|||
42145671|NCT00355134|75954635|FG001|Extension Phase|Administrative problems|4|||
42145672|NCT00355134|75954636|FG002|Extension Phase|Administrative problems|0|||
42145673|NCT00355134|75954637|FG003|Extension Phase|Administrative problems|1|||
42145674|NCT00355134|75954638|FG004|Extension Phase|Administrative problems|1|||
42145675|NCT00355134|75954634|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
42145676|NCT00355134|75954635|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
42145677|NCT00355134|75954636|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
42145678|NCT00355134|75954637|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
42145679|NCT00355134|75954638|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
42145680|NCT00355134|75954634|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
42145681|NCT00355134|75954635|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
42145682|NCT00355134|75954636|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
42145683|NCT00355134|75954637|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
42145684|NCT00355134|75954638|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
42145685|NCT00355134|75954634|FG000|Extension Phase|Protocol Violation|0|||
42145686|NCT00355134|75954635|FG001|Extension Phase|Protocol Violation|0|||
42145687|NCT00355134|75954636|FG002|Extension Phase|Protocol Violation|0|||
42145688|NCT00355134|75954637|FG003|Extension Phase|Protocol Violation|1|||
42145689|NCT00355134|75954638|FG004|Extension Phase|Protocol Violation|0|||
42145690|NCT00171730|75954648|FG000|Overall Study|Adverse Event|3|||
42145691|NCT00171730|75954648|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
42145692|NCT00171730|75954648|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
42145693|NCT00171730|75954648|FG000|Overall Study|Withdrawal by Subject|3|||
42145694|NCT00355056|75954660|FG000|Randomization Period|Early Termination|4|||
42145695|NCT00355056|75954661|FG001|Randomization Period|Early Termination|6|||
42145696|NCT00348348|75954677|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
42145697|NCT00348348|75954678|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
42145698|NCT00348348|75954677|FG000|Overall Study|Lack of Efficacy|1|||
42145699|NCT00348348|75954678|FG001|Overall Study|Lack of Efficacy|1|||
42145700|NCT00348348|75954677|FG000|Overall Study|Lost to Follow-up|8|||
42145701|NCT00348348|75954678|FG001|Overall Study|Lost to Follow-up|10|||
42145702|NCT00348348|75954677|FG000|Overall Study|Withdrawal by Subject|4|||
42145703|NCT00348348|75954678|FG001|Overall Study|Withdrawal by Subject|1|||
42145704|NCT00348348|75954677|FG000|Overall Study|Other|7|||
42145705|NCT00348348|75954678|FG001|Overall Study|Other|4|||
42145706|NCT00348348|75954677|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
42145707|NCT00348348|75954678|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
42145708|NCT00348348|75954677|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
42145709|NCT00348348|75954678|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
42145710|NCT00348348|75954677|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
42145711|NCT00348348|75954678|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
42145712|NCT00348348|75954677|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
42145713|NCT00348348|75954678|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
42145714|NCT00348348|75954677|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
42145715|NCT00348348|75954678|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
42145716|NCT00348348|75954677|FG000|Overall Study|Adverse event probably related to study|1|||
42145717|NCT00348348|75954678|FG001|Overall Study|Adverse event probably related to study|0|||
42145718|NCT00347958|75954684|FG000|Overall Study|Adverse Event|1|||
42145719|NCT00347958|75954684|FG000|Overall Study|Protocol Violation|2|||
42145720|NCT00347958|75954684|FG000|Overall Study|Withdrawal by Subject|1|||
42145721|NCT00354744|75954688|FG000|Overall Study|Adverse Event|2|||
42145722|NCT00354744|75954688|FG000|Overall Study|Death|2|||
42145723|NCT00354744|75954688|FG000|Overall Study|Lack of Efficacy|11|||
42145724|NCT00354744|75954688|FG000|Overall Study|Lost to Follow-up|2|||
42145725|NCT00354744|75954688|FG000|Overall Study|Physician Decision|11|||
42145726|NCT00354744|75954688|FG000|Overall Study|Withdrawal by Subject|14|||
42145727|NCT00373256|75954696|FG000|Overall Study|Adverse Event (AE)|1|||
42145728|NCT00373256|75954697|FG001|Overall Study|Adverse Event (AE)|5|||
42145729|NCT00373256|75954696|FG000|Overall Study|Lost to Follow-up|2|||
42145730|NCT00373256|75954697|FG001|Overall Study|Lost to Follow-up|1|||
42145731|NCT00373256|75954696|FG000|Overall Study|Death|9|||
42145732|NCT00373256|75954697|FG001|Overall Study|Death|8|||
42145733|NCT00373256|75954696|FG000|Overall Study|Objective Progression or Relapse|111|||
42145734|NCT00373256|75954697|FG001|Overall Study|Objective Progression or Relapse|104|||
42145735|NCT00373256|75954696|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
42145736|NCT00373256|75954697|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
42145737|NCT00373256|75954696|FG000|Overall Study|Other|73|||
42145738|NCT00373256|75954697|FG001|Overall Study|Other|107|||
42145739|NCT00373256|75954696|FG000|Overall Study|Protocol Violation|0|||
42145740|NCT00373256|75954697|FG001|Overall Study|Protocol Violation|2|||
42145741|NCT00373256|75954696|FG000|Overall Study|Study Terminated by Sponsor|41|||
42145742|NCT00373256|75954697|FG001|Overall Study|Study Terminated by Sponsor|13|||
42145743|NCT00394082|75954703|FG000|Overall Study|Unacceptable toxicity|15|||
42145744|NCT00394082|75954703|FG000|Overall Study|Adverse Event|4|||
42145745|NCT00394082|75954703|FG000|Overall Study|Physician Decision|4|||
42145746|NCT00394082|75954703|FG000|Overall Study|Withdrawal by Subject|2|||
42145747|NCT00394082|75954703|FG000|Overall Study|Other|1|||
42145748|NCT00393848|75954711|FG000|Overall Study|Surgical schedule|0|||
42145749|NCT00393848|75954712|FG001|Overall Study|Surgical schedule|0|||
42145750|NCT00393848|75954713|FG002|Overall Study|Surgical schedule|0|||
42145751|NCT00393848|75954714|FG003|Overall Study|Surgical schedule|1|||
42145752|NCT00393848|75954711|FG000|Overall Study|Personal reasons|0|||
42145753|NCT00393848|75954712|FG001|Overall Study|Personal reasons|0|||
42145754|NCT00393848|75954713|FG002|Overall Study|Personal reasons|2|||
42145755|NCT00393848|75954714|FG003|Overall Study|Personal reasons|0|||
42145756|NCT00393458|75954729|FG000|Overall Study|Adverse Event|35|||
42145757|NCT00393458|75954730|FG001|Overall Study|Adverse Event|24|||
42145758|NCT00393458|75954731|FG002|Overall Study|Adverse Event|40|||
42145759|NCT00393458|75954732|FG003|Overall Study|Adverse Event|35|||
42145760|NCT00393458|75954729|FG000|Overall Study|Subject withdrew consent|27|||
42145761|NCT00393458|75954730|FG001|Overall Study|Subject withdrew consent|40|||
42145762|NCT00393458|75954731|FG002|Overall Study|Subject withdrew consent|33|||
42145763|NCT00393458|75954732|FG003|Overall Study|Subject withdrew consent|50|||
42145764|NCT00393458|75954729|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
42145765|NCT00393458|75954730|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
42145766|NCT00393458|75954731|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
42145767|NCT00393458|75954732|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
42145768|NCT00393458|75954729|FG000|Overall Study|Protocol deviation|11|||
42145769|NCT00393458|75954730|FG001|Overall Study|Protocol deviation|11|||
42145770|NCT00393458|75954731|FG002|Overall Study|Protocol deviation|11|||
42145771|NCT00393458|75954732|FG003|Overall Study|Protocol deviation|10|||
42145772|NCT00393458|75954729|FG000|Overall Study|Administrative problems|7|||
42145773|NCT00393458|75954730|FG001|Overall Study|Administrative problems|8|||
42145774|NCT00393458|75954731|FG002|Overall Study|Administrative problems|5|||
42145775|NCT00393458|75954732|FG003|Overall Study|Administrative problems|2|||
42145776|NCT00393458|75954729|FG000|Overall Study|Lost to Follow-up|5|||
42012615|NCT01194219|75819477|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
42012616|NCT01194219|75819478|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
42145777|NCT00393458|75954730|FG001|Overall Study|Lost to Follow-up|6|||
42145778|NCT00393458|75954731|FG002|Overall Study|Lost to Follow-up|5|||
42145779|NCT00393458|75954732|FG003|Overall Study|Lost to Follow-up|3|||
42145780|NCT00393458|75954729|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42145781|NCT00393458|75954730|FG001|Overall Study|Abnormal laboratory value(s)|1|||
42145782|NCT00393458|75954731|FG002|Overall Study|Abnormal laboratory value(s)|0|||
42145783|NCT00393458|75954732|FG003|Overall Study|Abnormal laboratory value(s)|0|||
42145784|NCT00393458|75954729|FG000|Overall Study|Death|1|||
42145785|NCT00393458|75954730|FG001|Overall Study|Death|1|||
42145786|NCT00393458|75954731|FG002|Overall Study|Death|5|||
42145787|NCT00393458|75954732|FG003|Overall Study|Death|5|||
42012617|NCT01194219|75819479|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
42145788|NCT00393458|75954729|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42145789|NCT00393458|75954730|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42145790|NCT00393458|75954731|FG002|Overall Study|Abnormal test procedure result(s)|1|||
42145791|NCT00393458|75954732|FG003|Overall Study|Abnormal test procedure result(s)|2|||
42145792|NCT00393458|75954729|FG000|Overall Study|Subject no longer requires study drug|0|||
42145793|NCT00393458|75954730|FG001|Overall Study|Subject no longer requires study drug|1|||
42145794|NCT00393458|75954731|FG002|Overall Study|Subject no longer requires study drug|0|||
42145795|NCT00393458|75954732|FG003|Overall Study|Subject no longer requires study drug|0|||
42145796|NCT00417482|75954745|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
42145797|NCT00417482|75954746|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
42012618|NCT01194219|75819480|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
42012619|NCT01194219|75819481|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
42012620|NCT01194219|75819482|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
42012621|NCT01194219|75819483|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
42012622|NCT01194219|75819484|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
42145798|NCT00417482|75954747|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
42145799|NCT00417482|75954745|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
42145800|NCT00417482|75954746|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
42145801|NCT00417482|75954747|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
42145802|NCT00417482|75954745|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
42145803|NCT00417482|75954746|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
42145804|NCT00417482|75954747|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
42145805|NCT00417482|75954745|FG000|Phase B 1st 16 Weeks|Death|1|||
42145806|NCT00417482|75954746|FG001|Phase B 1st 16 Weeks|Death|0|||
42145807|NCT00417482|75954747|FG002|Phase B 1st 16 Weeks|Death|0|||
42145808|NCT00417482|75954745|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
42145809|NCT00417482|75954746|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
42145810|NCT00417482|75954747|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
42145811|NCT00417482|75954745|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
42145812|NCT00417482|75954746|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
42145813|NCT00417482|75954747|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
42145814|NCT00417482|75954745|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
42145815|NCT00417482|75954746|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
42145816|NCT00417482|75954747|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
42145817|NCT00417482|75954745|FG000|Phase B 2nd 16 Weeks|Death|1|||
42145818|NCT00417482|75954746|FG001|Phase B 2nd 16 Weeks|Death|1|||
42145819|NCT00417482|75954747|FG002|Phase B 2nd 16 Weeks|Death|0|||
42145820|NCT00417248|75954761|FG000|Overall Study|Study Terminated|6|||
42145821|NCT00417248|75954761|FG000|Overall Study|Death|1|||
42145822|NCT00417248|75954761|FG000|Overall Study|Lack of Efficacy|1|||
42145823|NCT00392288|75954769|FG000|Overall Study|Adverse Event|17|||
42145824|NCT00392288|75954770|FG001|Overall Study|Adverse Event|7|||
42145825|NCT00392288|75954771|FG002|Overall Study|Adverse Event|8|||
42145826|NCT00392288|75954769|FG000|Overall Study|Lack of Efficacy|8|||
42145827|NCT00392288|75954770|FG001|Overall Study|Lack of Efficacy|5|||
42145828|NCT00392288|75954771|FG002|Overall Study|Lack of Efficacy|3|||
42145829|NCT00392288|75954769|FG000|Overall Study|Protocol Violation|1|||
42145830|NCT00392288|75954770|FG001|Overall Study|Protocol Violation|3|||
42145831|NCT00392288|75954771|FG002|Overall Study|Protocol Violation|1|||
42145832|NCT00392288|75954769|FG000|Overall Study|Lost to Follow-up|1|||
42145833|NCT00392288|75954770|FG001|Overall Study|Lost to Follow-up|1|||
42145834|NCT00392288|75954771|FG002|Overall Study|Lost to Follow-up|1|||
42145835|NCT00392288|75954769|FG000|Overall Study|Withdrawal by Subject|1|||
42145836|NCT00392288|75954770|FG001|Overall Study|Withdrawal by Subject|0|||
42145837|NCT00392288|75954771|FG002|Overall Study|Withdrawal by Subject|2|||
42145838|NCT00392288|75954769|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
42145839|NCT00392288|75954770|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
42145840|NCT00392288|75954771|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
42145841|NCT00392288|75954769|FG000|Overall Study|Other|3|||
42012623|NCT01194219|75819475|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
42012624|NCT01194219|75819476|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
42145842|NCT00392288|75954770|FG001|Overall Study|Other|4|||
42145843|NCT00392288|75954771|FG002|Overall Study|Other|1|||
42145844|NCT00417170|75954781|FG000|Overall Study|Adverse Event|1|||
42145845|NCT00417170|75954782|FG001|Overall Study|Adverse Event|1|||
42145846|NCT00417170|75954781|FG000|Overall Study|Withdrawal by Subject|1|||
42145847|NCT00417170|75954782|FG001|Overall Study|Withdrawal by Subject|1|||
42145848|NCT00417170|75954781|FG000|Overall Study|Lost to Follow-up|0|||
42145849|NCT00417170|75954782|FG001|Overall Study|Lost to Follow-up|1|||
42145850|NCT00392990|75954790|FG000|Treatment on Study|Adverse Event|3|||
42145851|NCT00392990|75954791|FG001|Treatment on Study|Adverse Event|1|||
42145852|NCT00392990|75954790|FG000|Follow up for 2 Years|Death|4|||
42145853|NCT00392990|75954791|FG001|Follow up for 2 Years|Death|0|||
42145854|NCT00249873|75954799|FG000|Overall Study|Not treated|7|||
42145855|NCT00249873|75954800|FG001|Overall Study|Not treated|8|||
42277184|NCT01865617|76108761|FG010|Overall Study|Other|0|||
42145856|NCT00249873|75954799|FG000|Overall Study|Significant thrombocytopenia|9|||
42145857|NCT00249873|75954800|FG001|Overall Study|Significant thrombocytopenia|8|||
42145858|NCT00249873|75954799|FG000|Overall Study|Severe allergic reaction|8|||
42145859|NCT00249873|75954800|FG001|Overall Study|Severe allergic reaction|1|||
42145860|NCT00249873|75954799|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
42145861|NCT00249873|75954800|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
42145862|NCT00249873|75954799|FG000|Overall Study|Other Serious Adverse Event|86|||
42145863|NCT00249873|75954800|FG001|Overall Study|Other Serious Adverse Event|97|||
42145864|NCT00249873|75954799|FG000|Overall Study|Qualifying condition not present|20|||
42145865|NCT00249873|75954800|FG001|Overall Study|Qualifying condition not present|23|||
42145866|NCT00249873|75954799|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
42145867|NCT00249873|75954800|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
42145868|NCT00249873|75954799|FG000|Overall Study|Withdrawal by Subject|504|||
42145869|NCT00249873|75954800|FG001|Overall Study|Withdrawal by Subject|466|||
42145870|NCT00249873|75954799|FG000|Overall Study|Lost to Follow-up|4|||
42145871|NCT00249873|75954800|FG001|Overall Study|Lost to Follow-up|7|||
42145872|NCT00249873|75954799|FG000|Overall Study|Minor bleeding|99|||
42145873|NCT00249873|75954800|FG001|Overall Study|Minor bleeding|37|||
42145874|NCT00249873|75954799|FG000|Overall Study|Non-compliance|41|||
42145875|NCT00249873|75954800|FG001|Overall Study|Non-compliance|46|||
42145876|NCT00249873|75954799|FG000|Overall Study|Other non serious Adverse Event|112|||
42145877|NCT00249873|75954800|FG001|Overall Study|Other non serious Adverse Event|108|||
42145878|NCT00249873|75954799|FG000|Overall Study|Other contraindicated medication|1|||
42145879|NCT00249873|75954800|FG001|Overall Study|Other contraindicated medication|0|||
42145880|NCT00249873|75954799|FG000|Overall Study|Patient not wish to continue after May08|3|||
42145881|NCT00249873|75954800|FG001|Overall Study|Patient not wish to continue after May08|4|||
42145882|NCT00249873|75954799|FG000|Overall Study|Physician withdrew consent|59|||
42145883|NCT00249873|75954800|FG001|Overall Study|Physician withdrew consent|60|||
42145884|NCT00249873|75954799|FG000|Overall Study|Open label clopidogrel required|31|||
42145885|NCT00249873|75954800|FG001|Overall Study|Open label clopidogrel required|42|||
42145886|NCT00249873|75954799|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
42145887|NCT00249873|75954800|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
42145888|NCT00249873|75954799|FG000|Overall Study|Oral anticoagulant required|159|||
42145889|NCT00249873|75954800|FG001|Overall Study|Oral anticoagulant required|157|||
42145890|NCT00249873|75954799|FG000|Overall Study|Study drug intolerance|5|||
42145891|NCT00249873|75954800|FG001|Overall Study|Study drug intolerance|0|||
42145892|NCT00249873|75954799|FG000|Overall Study|Surgery/ procedure|9|||
42145893|NCT00249873|75954800|FG001|Overall Study|Surgery/ procedure|9|||
42145894|NCT00249873|75954799|FG000|Overall Study|Event related to cardiac condition|12|||
42145895|NCT00249873|75954800|FG001|Overall Study|Event related to cardiac condition|21|||
42145896|NCT00249873|75954799|FG000|Overall Study|Thromboembolic/outcome event|82|||
42145897|NCT00249873|75954800|FG001|Overall Study|Thromboembolic/outcome event|122|||
42145898|NCT00392210|75954808|FG000|First Voiding Trial|Physician Decision|2|||
42145899|NCT00392210|75954809|FG001|First Voiding Trial|Physician Decision|2|||
42145900|NCT00391976|75954818|FG000|Overall Study|Adverse Event|0|||
42145901|NCT00391976|75954819|FG001|Overall Study|Adverse Event|0|||
42145902|NCT00391976|75954820|FG002|Overall Study|Adverse Event|1|||
42145903|NCT00391976|75954818|FG000|Overall Study|Withdrawal of consent|0|||
42145904|NCT00391976|75954819|FG001|Overall Study|Withdrawal of consent|1|||
42145905|NCT00391976|75954820|FG002|Overall Study|Withdrawal of consent|1|||
42145906|NCT00391976|75954818|FG000|Overall Study|Lost to Follow-up|1|||
42145907|NCT00391976|75954819|FG001|Overall Study|Lost to Follow-up|2|||
42145908|NCT00391976|75954820|FG002|Overall Study|Lost to Follow-up|0|||
42145909|NCT00391976|75954818|FG000|Overall Study|Inappropriate enrollment|1|||
42145910|NCT00391976|75954819|FG001|Overall Study|Inappropriate enrollment|1|||
42145911|NCT00391976|75954820|FG002|Overall Study|Inappropriate enrollment|0|||
42145912|NCT00391976|75954818|FG000|Overall Study|Protocol deviation/violation|4|||
42145913|NCT00391976|75954819|FG001|Overall Study|Protocol deviation/violation|2|||
42145914|NCT00391976|75954820|FG002|Overall Study|Protocol deviation/violation|1|||
42145915|NCT00391976|75954818|FG000|Overall Study|Recurrence/no eradication of infection|21|||
42145916|NCT00391976|75954819|FG001|Overall Study|Recurrence/no eradication of infection|19|||
42145917|NCT00391976|75954820|FG002|Overall Study|Recurrence/no eradication of infection|0|||
42145918|NCT00391976|75954818|FG000|Overall Study|Unable to classify|0|||
42145919|NCT00391976|75954819|FG001|Overall Study|Unable to classify|0|||
42145920|NCT00391976|75954820|FG002|Overall Study|Unable to classify|1|||
42145921|NCT00391976|75954818|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
42145922|NCT00391976|75954819|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
42145923|NCT00391976|75954820|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
42277185|NCT01865617|76108762|FG011|Overall Study|Other|0|||
42277186|NCT01865617|76108763|FG012|Overall Study|Other|0|||
42277187|NCT02458313|76108796|FG000|Overall Study|Withdrawal by Subject|6|||
42145924|NCT00391898|75954832|FG000|Overall Study|Adverse Event|3|||
42145925|NCT00391898|75954833|FG001|Overall Study|Adverse Event|0|||
42277188|NCT02458313|76108797|FG001|Overall Study|Withdrawal by Subject|8|||
42145926|NCT00391898|75954832|FG000|Overall Study|Other|8|||
42145927|NCT00391898|75954833|FG001|Overall Study|Other|10|||
42145928|NCT00391586|75954839|FG000|Overall Study|Progressive disease|13|||
42145929|NCT00391586|75954839|FG000|Overall Study|Adverse Event|5|||
42145930|NCT00391586|75954839|FG000|Overall Study|Physician Decision|2|||
42145931|NCT00391586|75954839|FG000|Overall Study|Death|4|||
42145932|NCT00391430|75954846|FG000|Overall Study|Withdrawal by Subject|3|||
42145933|NCT00391430|75954847|FG001|Overall Study|Withdrawal by Subject|0|||
42145934|NCT00391430|75954848|FG002|Overall Study|Withdrawal by Subject|12|||
42145935|NCT00391274|75954858|FG000|Overall Study|Death Due to Study Disease|55|||
42145936|NCT00391274|75954859|FG001|Overall Study|Death Due to Study Disease|45|||
42145937|NCT00391274|75954858|FG000|Overall Study|Lost to Follow-up|0|||
42145938|NCT00391274|75954859|FG001|Overall Study|Lost to Follow-up|3|||
42039397|NCT00879814|75847679|FG000|Overall Study|Lost to Follow-up|1|||
42039398|NCT00879814|75847680|FG001|Overall Study|Lost to Follow-up|0|||
42039399|NCT00879814|75847681|FG002|Overall Study|Lost to Follow-up|0|||
42039400|NCT00879814|75847682|FG003|Overall Study|Lost to Follow-up|2|||
42039401|NCT00879814|75847679|FG000|Overall Study|Participant Failed to Return|0|||
42145939|NCT00391274|75954858|FG000|Overall Study|Physician Decision|4|||
42145940|NCT00391274|75954859|FG001|Overall Study|Physician Decision|2|||
42145941|NCT00391274|75954858|FG000|Overall Study|Withdrawal by Subject|0|||
42145942|NCT00391274|75954859|FG001|Overall Study|Withdrawal by Subject|3|||
42145943|NCT00391274|75954858|FG000|Overall Study|Death Due to Adverse Event|1|||
42145944|NCT00391274|75954859|FG001|Overall Study|Death Due to Adverse Event|3|||
42145945|NCT00391274|75954858|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
42145946|NCT00391274|75954859|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
42145947|NCT00391274|75954858|FG000|Overall Study|Death Not Study Related|0|||
42145948|NCT00391274|75954859|FG001|Overall Study|Death Not Study Related|1|||
42145949|NCT00391118|75954868|FG000|Overall Study|Adverse Event|3|||
42145950|NCT00391118|75954869|FG001|Overall Study|Adverse Event|10|||
42145951|NCT00391118|75954870|FG002|Overall Study|Adverse Event|7|||
42145952|NCT00391118|75954868|FG000|Overall Study|Lost to Follow-up|0|||
42145953|NCT00391118|75954869|FG001|Overall Study|Lost to Follow-up|2|||
42145954|NCT00391118|75954870|FG002|Overall Study|Lost to Follow-up|3|||
42145955|NCT00391118|75954868|FG000|Overall Study|Withdrawal by Subject|0|||
42145956|NCT00391118|75954869|FG001|Overall Study|Withdrawal by Subject|9|||
42145957|NCT00391118|75954870|FG002|Overall Study|Withdrawal by Subject|1|||
42145958|NCT00391118|75954868|FG000|Overall Study|Death|0|||
42145959|NCT00391118|75954869|FG001|Overall Study|Death|1|||
42145960|NCT00391118|75954870|FG002|Overall Study|Death|0|||
42145961|NCT00391118|75954868|FG000|Overall Study|Physician Decision|0|||
42145962|NCT00391118|75954869|FG001|Overall Study|Physician Decision|3|||
42145963|NCT00391118|75954870|FG002|Overall Study|Physician Decision|0|||
42145964|NCT00391118|75954868|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
42145965|NCT00391118|75954869|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
42145966|NCT00391118|75954870|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
42145967|NCT00391118|75954868|FG000|Overall Study|Progressive Disease|7|||
42145968|NCT00391118|75954869|FG001|Overall Study|Progressive Disease|26|||
42145969|NCT00391118|75954870|FG002|Overall Study|Progressive Disease|43|||
42145970|NCT00391118|75954868|FG000|Overall Study|Sponsor Decision|0|||
42145971|NCT00391118|75954869|FG001|Overall Study|Sponsor Decision|1|||
42145972|NCT00391118|75954870|FG002|Overall Study|Sponsor Decision|3|||
42145973|NCT00391118|75954868|FG000|Overall Study|Protocol Violation|1|||
42145974|NCT00391118|75954869|FG001|Overall Study|Protocol Violation|0|||
42145975|NCT00391118|75954870|FG002|Overall Study|Protocol Violation|0|||
42145976|NCT00390884|75954883|FG000|Overall Study|Withdrawal by Subject|2|||
42145977|NCT00390884|75954884|FG001|Overall Study|Withdrawal by Subject|2|||
42351103|NCT01517373|76191009|FG002|Run-in Period|Sponsor Decision|0|||
42351104|NCT01517373|76191010|FG003|Run-in Period|Sponsor Decision|0|||
42351105|NCT01517373|76191011|FG004|Run-in Period|Sponsor Decision|0|||
42351106|NCT01517373|76191012|FG005|Run-in Period|Sponsor Decision|0|||
42039402|NCT00879814|75847680|FG001|Overall Study|Participant Failed to Return|0|||
42039403|NCT00879814|75847681|FG002|Overall Study|Participant Failed to Return|0|||
42145978|NCT00365846|75954890|FG000|Overall Study|Lost to Follow-up|1|||
42145979|NCT00264537|75954900|FG000|Overall Study|Death|0|||
42145980|NCT00264537|75954901|FG001|Overall Study|Death|3|||
42145981|NCT00264537|75954902|FG002|Overall Study|Death|3|||
42145982|NCT00264537|75954903|FG003|Overall Study|Death|2|||
42039404|NCT00879814|75847682|FG003|Overall Study|Participant Failed to Return|1|||
42039405|NCT00879814|75847679|FG000|Overall Study|Withdrawal by Subject|3|||
42145983|NCT00264537|75954900|FG000|Overall Study|Lost to Follow-up|3|||
42145984|NCT00264537|75954901|FG001|Overall Study|Lost to Follow-up|4|||
42145985|NCT00264537|75954902|FG002|Overall Study|Lost to Follow-up|7|||
42145986|NCT00264537|75954903|FG003|Overall Study|Lost to Follow-up|6|||
42145987|NCT00264537|75954900|FG000|Overall Study|Adverse Event|21|||
42145988|NCT00264537|75954901|FG001|Overall Study|Adverse Event|32|||
42145989|NCT00264537|75954902|FG002|Overall Study|Adverse Event|24|||
42351107|NCT01517373|76191007|FG000|Run-in Period|Other|1|||
42145990|NCT00264537|75954903|FG003|Overall Study|Adverse Event|34|||
42145991|NCT00264537|75954900|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
42145992|NCT00264537|75954901|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
42145993|NCT00264537|75954902|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
42145994|NCT00264537|75954903|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
42145995|NCT00264537|75954900|FG000|Overall Study|Other|21|||
42145996|NCT00264537|75954901|FG001|Overall Study|Other|11|||
42145997|NCT00264537|75954902|FG002|Overall Study|Other|10|||
42145998|NCT00264537|75954903|FG003|Overall Study|Other|11|||
42145999|NCT00264537|75954900|FG000|Overall Study|Not treated|0|||
42146000|NCT00264537|75954901|FG001|Overall Study|Not treated|2|||
42146001|NCT00264537|75954902|FG002|Overall Study|Not treated|1|||
42146002|NCT00264537|75954903|FG003|Overall Study|Not treated|0|||
42146003|NCT00371462|75954917|FG000|Overall Study|Withdrawal by Subject|1|||
42146004|NCT00371462|75954918|FG001|Overall Study|Withdrawal by Subject|0|||
42146005|NCT00371462|75954917|FG000|Overall Study|Other|7|||
42146006|NCT00371462|75954918|FG001|Overall Study|Other|8|||
42146007|NCT00371150|75954926|FG000|Overall Study|Lost to Follow-up|3|||
42146008|NCT00371150|75954927|FG001|Overall Study|Lost to Follow-up|2|||
42146009|NCT00264303|75954939|FG000|Overall Study|Adverse Event|4|||
42146010|NCT00264303|75954940|FG001|Overall Study|Adverse Event|3|||
42146011|NCT00264303|75954939|FG000|Overall Study|Lack of Efficacy|10|||
42146012|NCT00264303|75954940|FG001|Overall Study|Lack of Efficacy|13|||
42146013|NCT00264303|75954939|FG000|Overall Study|Lost to Follow-up|3|||
42146014|NCT00264303|75954940|FG001|Overall Study|Lost to Follow-up|3|||
42146015|NCT00264303|75954939|FG000|Overall Study|Withdrawal by Subject|2|||
42146016|NCT00264303|75954940|FG001|Overall Study|Withdrawal by Subject|3|||
42146017|NCT00264303|75954939|FG000|Overall Study|Various reasons listed in study report|6|||
42146018|NCT00264303|75954940|FG001|Overall Study|Various reasons listed in study report|7|||
42146019|NCT00370682|75954949|FG000|Overall Study|Moved from area|0|||
42146020|NCT00370682|75954950|FG001|Overall Study|Moved from area|2|||
42146021|NCT00370682|75954951|FG002|Overall Study|Moved from area|0|||
42146022|NCT00370682|75954949|FG000|Overall Study|Lost to Follow-up|0|||
42146023|NCT00370682|75954950|FG001|Overall Study|Lost to Follow-up|1|||
42146024|NCT00370682|75954951|FG002|Overall Study|Lost to Follow-up|1|||
42146025|NCT00264147|75954968|FG000|Treatment I Period|Adverse Event|3|||
42146026|NCT00264147|75954969|FG001|Treatment I Period|Adverse Event|6|||
42146027|NCT00264147|75954970|FG002|Treatment I Period|Adverse Event|3|||
42146028|NCT00264147|75954971|FG003|Treatment I Period|Adverse Event|5|||
42351108|NCT01517373|76191008|FG001|Run-in Period|Other|0|||
42146029|NCT00264147|75954972|FG004|Treatment I Period|Adverse Event|7|||
42146030|NCT00264147|75954973|FG005|Treatment I Period|Adverse Event|0|||
42146031|NCT00264147|75954968|FG000|Treatment I Period|Laboratory Adverse Event|0|||
42146032|NCT00264147|75954969|FG001|Treatment I Period|Laboratory Adverse Event|0|||
42146033|NCT00264147|75954970|FG002|Treatment I Period|Laboratory Adverse Event|0|||
42146034|NCT00264147|75954971|FG003|Treatment I Period|Laboratory Adverse Event|1|||
42146035|NCT00264147|75954972|FG004|Treatment I Period|Laboratory Adverse Event|0|||
42146036|NCT00264147|75954973|FG005|Treatment I Period|Laboratory Adverse Event|0|||
42146037|NCT00264147|75954968|FG000|Treatment I Period|Lack of Efficacy|6|||
42146038|NCT00264147|75954969|FG001|Treatment I Period|Lack of Efficacy|2|||
42146039|NCT00264147|75954970|FG002|Treatment I Period|Lack of Efficacy|8|||
42351109|NCT01517373|76191009|FG002|Run-in Period|Other|0|||
42351110|NCT01517373|76191010|FG003|Run-in Period|Other|0|||
42351111|NCT01517373|76191011|FG004|Run-in Period|Other|0|||
42351112|NCT01517373|76191012|FG005|Run-in Period|Other|0|||
42351113|NCT01517373|76191007|FG000|Treatment Period|Adverse Event|0|||
42351114|NCT01517373|76191008|FG001|Treatment Period|Adverse Event|0|||
42351115|NCT01517373|76191009|FG002|Treatment Period|Adverse Event|0|||
42351116|NCT01517373|76191010|FG003|Treatment Period|Adverse Event|0|||
42351117|NCT01517373|76191011|FG004|Treatment Period|Adverse Event|0|||
42351118|NCT01517373|76191012|FG005|Treatment Period|Adverse Event|2|||
42351119|NCT01517373|76191007|FG000|Treatment Period|Lost to Follow-up|0|||
42351120|NCT01517373|76191008|FG001|Treatment Period|Lost to Follow-up|0|||
42351121|NCT01517373|76191009|FG002|Treatment Period|Lost to Follow-up|1|||
42351122|NCT01517373|76191010|FG003|Treatment Period|Lost to Follow-up|1|||
42351123|NCT01517373|76191011|FG004|Treatment Period|Lost to Follow-up|0|||
42351124|NCT01517373|76191012|FG005|Treatment Period|Lost to Follow-up|0|||
42351125|NCT01517373|76191007|FG000|Treatment Period|Withdrawal by Subject|0|||
42351126|NCT01517373|76191008|FG001|Treatment Period|Withdrawal by Subject|3|||
42351127|NCT01517373|76191009|FG002|Treatment Period|Withdrawal by Subject|2|||
42351128|NCT01517373|76191010|FG003|Treatment Period|Withdrawal by Subject|2|||
42351129|NCT01517373|76191011|FG004|Treatment Period|Withdrawal by Subject|2|||
42146040|NCT00264147|75954971|FG003|Treatment I Period|Lack of Efficacy|0|||
42146041|NCT00264147|75954972|FG004|Treatment I Period|Lack of Efficacy|1|||
42146042|NCT00264147|75954973|FG005|Treatment I Period|Lack of Efficacy|0|||
42146043|NCT00264147|75954968|FG000|Treatment I Period|Lost to Follow-up|1|||
42146044|NCT00264147|75954969|FG001|Treatment I Period|Lost to Follow-up|0|||
42146045|NCT00264147|75954970|FG002|Treatment I Period|Lost to Follow-up|0|||
42146046|NCT00264147|75954971|FG003|Treatment I Period|Lost to Follow-up|1|||
42146047|NCT00264147|75954972|FG004|Treatment I Period|Lost to Follow-up|1|||
42146048|NCT00264147|75954973|FG005|Treatment I Period|Lost to Follow-up|0|||
42146049|NCT00264147|75954968|FG000|Treatment I Period|Protocol Violation|2|||
42039406|NCT00879814|75847680|FG001|Overall Study|Withdrawal by Subject|1|||
42039407|NCT00879814|75847681|FG002|Overall Study|Withdrawal by Subject|1|||
42039408|NCT00879814|75847682|FG003|Overall Study|Withdrawal by Subject|2|||
42039409|NCT00879814|75847679|FG000|Overall Study|Physician Decision|0|||
42039410|NCT00879814|75847680|FG001|Overall Study|Physician Decision|0|||
42039411|NCT00879814|75847681|FG002|Overall Study|Physician Decision|1|||
42039412|NCT00879814|75847682|FG003|Overall Study|Physician Decision|0|||
42039413|NCT00879814|75847679|FG000|Overall Study|Other|0|||
42039414|NCT00879814|75847680|FG001|Overall Study|Other|0|||
42146050|NCT00264147|75954969|FG001|Treatment I Period|Protocol Violation|2|||
42146051|NCT00264147|75954970|FG002|Treatment I Period|Protocol Violation|0|||
42146052|NCT00264147|75954971|FG003|Treatment I Period|Protocol Violation|0|||
42146053|NCT00264147|75954972|FG004|Treatment I Period|Protocol Violation|0|||
42039415|NCT00879814|75847681|FG002|Overall Study|Other|1|||
42146054|NCT00264147|75954973|FG005|Treatment I Period|Protocol Violation|0|||
42146055|NCT00264147|75954968|FG000|Treatment I Period|Withdrawal by Subject|2|||
42277189|NCT02458313|76108796|FG000|Overall Study|Excluded for motion during MRI|1|||
42277190|NCT02458313|76108797|FG001|Overall Study|Excluded for motion during MRI|2|||
42277191|NCT01328431|76108814|FG000|Baseline|Protocol Violation|0|||
42277192|NCT01328431|76108815|FG001|Baseline|Protocol Violation|2|||
42277193|NCT01328431|76108814|FG000|1 Month (1M)|Lost to Follow-up|55|||
42277194|NCT01328431|76108815|FG001|1 Month (1M)|Lost to Follow-up|58|||
42277195|NCT01328431|76108814|FG000|3 Month (3M)|Death|2|||
42277196|NCT01328431|76108815|FG001|3 Month (3M)|Death|2|||
42277197|NCT01328431|76108814|FG000|3 Month (3M)|Lost to Follow-up|75|||
42277198|NCT01328431|76108815|FG001|3 Month (3M)|Lost to Follow-up|70|||
42277199|NCT01328431|76108814|FG000|12 Month (12M)|Death|2|||
42277200|NCT01328431|76108815|FG001|12 Month (12M)|Death|6|||
42277201|NCT01328431|76108814|FG000|12 Month (12M)|Lost to Follow-up|82|||
42277202|NCT01328431|76108815|FG001|12 Month (12M)|Lost to Follow-up|91|||
42277203|NCT00893789|76108825|FG000|Overall Study|Withdrawal by Subject|3|||
42277204|NCT00893789|76108826|FG001|Overall Study|Withdrawal by Subject|1|||
42277205|NCT00893789|76108827|FG002|Overall Study|Withdrawal by Subject|3|||
42277206|NCT00893789|76108828|FG003|Overall Study|Withdrawal by Subject|1|||
42039416|NCT00879814|75847682|FG003|Overall Study|Other|0|||
42039417|NCT01132664|75847697|FG000|Phase lb|Adverse Event|0|||
42351130|NCT01517373|76191012|FG005|Treatment Period|Withdrawal by Subject|3|||
42351131|NCT01517373|76191007|FG000|Treatment Period|Other|0|||
42351132|NCT01517373|76191008|FG001|Treatment Period|Other|0|||
42351133|NCT01517373|76191009|FG002|Treatment Period|Other|0|||
42351134|NCT01517373|76191010|FG003|Treatment Period|Other|0|||
42351135|NCT01517373|76191011|FG004|Treatment Period|Other|1|||
42351136|NCT01517373|76191012|FG005|Treatment Period|Other|0|||
42351137|NCT01517373|76191007|FG000|Treatment Period|Protocol Violation|0|||
42351138|NCT01517373|76191008|FG001|Treatment Period|Protocol Violation|0|||
42351139|NCT01517373|76191009|FG002|Treatment Period|Protocol Violation|0|||
42277207|NCT00893789|76108825|FG000|Overall Study|Noncompliance With Study Drug|1|||
42039418|NCT01132664|75847698|FG001|Phase lb|Adverse Event|1|||
42039419|NCT01132664|75847699|FG002|Phase lb|Adverse Event|0|||
42039420|NCT01132664|75847700|FG003|Phase lb|Adverse Event|0|||
42039421|NCT01132664|75847701|FG004|Phase lb|Adverse Event|0|||
42039422|NCT01132664|75847697|FG000|Phase lb|Withdrawal by Subject|1|||
42039423|NCT01132664|75847698|FG001|Phase lb|Withdrawal by Subject|2|||
42039424|NCT01132664|75847699|FG002|Phase lb|Withdrawal by Subject|0|||
42039425|NCT01132664|75847700|FG003|Phase lb|Withdrawal by Subject|0|||
42039426|NCT01132664|75847701|FG004|Phase lb|Withdrawal by Subject|0|||
42039427|NCT01132664|75847697|FG000|Phase lb|Disease Progression|4|||
42277208|NCT00893789|76108826|FG001|Overall Study|Noncompliance With Study Drug|0|||
42277209|NCT00893789|76108827|FG002|Overall Study|Noncompliance With Study Drug|1|||
42351140|NCT01517373|76191010|FG003|Treatment Period|Protocol Violation|0|||
42351141|NCT01517373|76191011|FG004|Treatment Period|Protocol Violation|1|||
42351142|NCT01517373|76191012|FG005|Treatment Period|Protocol Violation|0|||
42351143|NCT01517373|76191007|FG000|Treatment Period|Lack of Efficacy|0|||
42351144|NCT01517373|76191008|FG001|Treatment Period|Lack of Efficacy|1|||
42039428|NCT01132664|75847698|FG001|Phase lb|Disease Progression|9|||
42039429|NCT01132664|75847699|FG002|Phase lb|Disease Progression|0|||
42039430|NCT01132664|75847700|FG003|Phase lb|Disease Progression|0|||
42039431|NCT01132664|75847701|FG004|Phase lb|Disease Progression|0|||
42039432|NCT01132664|75847697|FG000|Phase ll|Death|0|||
42039433|NCT01132664|75847698|FG001|Phase ll|Death|0|||
42039434|NCT01132664|75847699|FG002|Phase ll|Death|2|||
42039435|NCT01132664|75847700|FG003|Phase ll|Death|0|||
42039436|NCT01132664|75847701|FG004|Phase ll|Death|0|||
42039437|NCT01132664|75847697|FG000|Phase ll|Adverse Event|0|||
42146056|NCT00264147|75954969|FG001|Treatment I Period|Withdrawal by Subject|0|||
42039438|NCT01132664|75847698|FG001|Phase ll|Adverse Event|0|||
42039439|NCT01132664|75847699|FG002|Phase ll|Adverse Event|10|||
42039440|NCT01132664|75847700|FG003|Phase ll|Adverse Event|0|||
42277210|NCT00893789|76108828|FG003|Overall Study|Noncompliance With Study Drug|2|||
42277211|NCT00893789|76108825|FG000|Overall Study|Noncompliance With Study Procedures|1|||
42277212|NCT00893789|76108826|FG001|Overall Study|Noncompliance With Study Procedures|0|||
42277213|NCT00893789|76108827|FG002|Overall Study|Noncompliance With Study Procedures|0|||
42039441|NCT01132664|75847701|FG004|Phase ll|Adverse Event|0|||
42039442|NCT01132664|75847697|FG000|Phase ll|Withdrawal by Subject|0|||
42039443|NCT01132664|75847698|FG001|Phase ll|Withdrawal by Subject|0|||
42277214|NCT00893789|76108828|FG003|Overall Study|Noncompliance With Study Procedures|0|||
42277215|NCT00893789|76108825|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
42351145|NCT01517373|76191009|FG002|Treatment Period|Lack of Efficacy|1|||
42351146|NCT01517373|76191010|FG003|Treatment Period|Lack of Efficacy|3|||
42351147|NCT01517373|76191011|FG004|Treatment Period|Lack of Efficacy|2|||
42351148|NCT01517373|76191012|FG005|Treatment Period|Lack of Efficacy|0|||
42277216|NCT00893789|76108826|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
42277217|NCT00893789|76108827|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
42277218|NCT00893789|76108828|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
42277219|NCT00893789|76108825|FG000|Overall Study|Adverse Event|0|||
42277220|NCT00893789|76108826|FG001|Overall Study|Adverse Event|2|||
42277221|NCT00893789|76108827|FG002|Overall Study|Adverse Event|1|||
42277222|NCT00893789|76108828|FG003|Overall Study|Adverse Event|5|||
42277223|NCT00893789|76108825|FG000|Overall Study|Protocol Violation|0|||
42277224|NCT00893789|76108826|FG001|Overall Study|Protocol Violation|1|||
42277225|NCT00893789|76108827|FG002|Overall Study|Protocol Violation|1|||
42277226|NCT00893789|76108828|FG003|Overall Study|Protocol Violation|4|||
42277227|NCT00893789|76108825|FG000|Overall Study|Lost to Follow-up|0|||
42277228|NCT00893789|76108826|FG001|Overall Study|Lost to Follow-up|0|||
42277229|NCT00893789|76108827|FG002|Overall Study|Lost to Follow-up|0|||
42277230|NCT00893789|76108828|FG003|Overall Study|Lost to Follow-up|1|||
42277231|NCT02164864|76108841|FG000|Overall Study|Trial disease worsening|7|||
42277232|NCT02164864|76108842|FG001|Overall Study|Trial disease worsening|5|||
42277233|NCT02164864|76108843|FG002|Overall Study|Trial disease worsening|1|||
42277234|NCT02164864|76108841|FG000|Overall Study|Other pre-existing disease worsening|6|||
42277235|NCT02164864|76108842|FG001|Overall Study|Other pre-existing disease worsening|4|||
42277236|NCT02164864|76108843|FG002|Overall Study|Other pre-existing disease worsening|9|||
42277237|NCT02164864|76108841|FG000|Overall Study|Other Adverse Event (AE)|52|||
42277238|NCT02164864|76108842|FG001|Overall Study|Other Adverse Event (AE)|32|||
42277239|NCT02164864|76108843|FG002|Overall Study|Other Adverse Event (AE)|49|||
42277240|NCT02164864|76108841|FG000|Overall Study|Protocol Violation|2|||
42277241|NCT02164864|76108842|FG001|Overall Study|Protocol Violation|4|||
42277242|NCT02164864|76108843|FG002|Overall Study|Protocol Violation|1|||
42277243|NCT02164864|76108841|FG000|Overall Study|Lost to Follow-up|4|||
42277244|NCT02164864|76108842|FG001|Overall Study|Lost to Follow-up|3|||
42277245|NCT02164864|76108843|FG002|Overall Study|Lost to Follow-up|2|||
42277246|NCT02164864|76108841|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
42277247|NCT02164864|76108842|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
42146057|NCT00264147|75954970|FG002|Treatment I Period|Withdrawal by Subject|0|||
42146058|NCT00264147|75954971|FG003|Treatment I Period|Withdrawal by Subject|2|||
42146059|NCT00264147|75954972|FG004|Treatment I Period|Withdrawal by Subject|2|||
42146060|NCT00264147|75954973|FG005|Treatment I Period|Withdrawal by Subject|0|||
42277248|NCT02164864|76108843|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
42277249|NCT02164864|76108841|FG000|Overall Study|Other than stated|3|||
42277250|NCT02164864|76108842|FG001|Overall Study|Other than stated|4|||
42277251|NCT02164864|76108843|FG002|Overall Study|Other than stated|14|||
42277252|NCT02419807|76108854|FG000|Overall Study|Withdrawal by Subject|4|||
42277253|NCT02419807|76108854|FG000|Overall Study|Physician Decision|1|||
42277254|NCT02419807|76108854|FG000|Overall Study|Protocol Violation|5|||
42277255|NCT03857867|76108858|FG000|Overall Study|Physician Decision|1|||
42277256|NCT01628926|76108866|FG000|Overall Study|Adverse Event|13|||
42277257|NCT01628926|76108867|FG001|Overall Study|Adverse Event|11|||
42277258|NCT01628926|76108868|FG002|Overall Study|Adverse Event|9|||
42277259|NCT01628926|76108866|FG000|Overall Study|Lack of Efficacy|2|||
42277260|NCT01628926|76108867|FG001|Overall Study|Lack of Efficacy|1|||
42277261|NCT01628926|76108868|FG002|Overall Study|Lack of Efficacy|5|||
42277262|NCT01628926|76108866|FG000|Overall Study|Withdrawal by Subject|6|||
42277263|NCT01628926|76108867|FG001|Overall Study|Withdrawal by Subject|4|||
42277264|NCT01628926|76108868|FG002|Overall Study|Withdrawal by Subject|2|||
42277265|NCT01628926|76108866|FG000|Overall Study|Protocol Violation|0|||
42277266|NCT01628926|76108867|FG001|Overall Study|Protocol Violation|1|||
42277267|NCT01628926|76108868|FG002|Overall Study|Protocol Violation|0|||
42277268|NCT01628926|76108866|FG000|Overall Study|Discontinuation criteria|3|||
42277269|NCT01628926|76108867|FG001|Overall Study|Discontinuation criteria|4|||
42277270|NCT01628926|76108868|FG002|Overall Study|Discontinuation criteria|0|||
42146061|NCT00264147|75954968|FG000|Treatment I Period|Patient out of town for an extended time|0|||
42146062|NCT00264147|75954969|FG001|Treatment I Period|Patient out of town for an extended time|1|||
42146063|NCT00264147|75954970|FG002|Treatment I Period|Patient out of town for an extended time|0|||
42146064|NCT00264147|75954971|FG003|Treatment I Period|Patient out of town for an extended time|0|||
42146065|NCT00264147|75954972|FG004|Treatment I Period|Patient out of town for an extended time|0|||
42146066|NCT00264147|75954973|FG005|Treatment I Period|Patient out of town for an extended time|0|||
42277271|NCT01628926|76108866|FG000|Overall Study|Physician Decision|2|||
42277272|NCT01628926|76108867|FG001|Overall Study|Physician Decision|2|||
42277273|NCT01628926|76108868|FG002|Overall Study|Physician Decision|1|||
42277274|NCT01628848|76108879|FG000|Overall Study|Adverse Event|9|||
42277275|NCT01628848|76108880|FG001|Overall Study|Adverse Event|7|||
42277276|NCT01628848|76108879|FG000|Overall Study|Lack of Efficacy|0|||
42277277|NCT01628848|76108880|FG001|Overall Study|Lack of Efficacy|4|||
42277278|NCT01628848|76108879|FG000|Overall Study|Withdrawal by Subject|0|||
42277279|NCT01628848|76108880|FG001|Overall Study|Withdrawal by Subject|2|||
42277280|NCT01628848|76108879|FG000|Overall Study|Physician Decision|3|||
42277281|NCT01628848|76108880|FG001|Overall Study|Physician Decision|1|||
42146067|NCT00264147|75954968|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
42146068|NCT00264147|75954969|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
42146069|NCT00264147|75954970|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
42146070|NCT00264147|75954971|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
42146071|NCT00264147|75954972|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
42146072|NCT00264147|75954973|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
42146073|NCT00264147|75954968|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
42146074|NCT00264147|75954969|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
42146075|NCT00264147|75954970|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
42146076|NCT00264147|75954971|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
42146077|NCT00264147|75954972|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
42146078|NCT00264147|75954973|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
42146079|NCT00264147|75954968|FG000|Treatment II Period|Adverse Event|0|||
42146080|NCT00264147|75954969|FG001|Treatment II Period|Adverse Event|0|||
42146081|NCT00264147|75954970|FG002|Treatment II Period|Adverse Event|0|||
42146082|NCT00264147|75954971|FG003|Treatment II Period|Adverse Event|0|||
42146083|NCT00264147|75954972|FG004|Treatment II Period|Adverse Event|9|||
42146084|NCT00264147|75954973|FG005|Treatment II Period|Adverse Event|9|||
42146085|NCT00264147|75954968|FG000|Treatment II Period|Laboratory Adverse Event|0|||
42146086|NCT00264147|75954969|FG001|Treatment II Period|Laboratory Adverse Event|0|||
42146087|NCT00264147|75954970|FG002|Treatment II Period|Laboratory Adverse Event|0|||
42146088|NCT00264147|75954971|FG003|Treatment II Period|Laboratory Adverse Event|0|||
42146089|NCT00264147|75954972|FG004|Treatment II Period|Laboratory Adverse Event|0|||
42146090|NCT00264147|75954973|FG005|Treatment II Period|Laboratory Adverse Event|1|||
42146091|NCT00264147|75954968|FG000|Treatment II Period|Lack of Efficacy|0|||
42146092|NCT00264147|75954969|FG001|Treatment II Period|Lack of Efficacy|0|||
42146093|NCT00264147|75954970|FG002|Treatment II Period|Lack of Efficacy|0|||
42146094|NCT00264147|75954971|FG003|Treatment II Period|Lack of Efficacy|0|||
42146095|NCT00264147|75954972|FG004|Treatment II Period|Lack of Efficacy|20|||
42146096|NCT00264147|75954973|FG005|Treatment II Period|Lack of Efficacy|19|||
42146097|NCT00264147|75954968|FG000|Treatment II Period|Lost to Follow-up|0|||
42146098|NCT00264147|75954969|FG001|Treatment II Period|Lost to Follow-up|0|||
42146099|NCT00264147|75954970|FG002|Treatment II Period|Lost to Follow-up|0|||
42146100|NCT00264147|75954971|FG003|Treatment II Period|Lost to Follow-up|0|||
42146101|NCT00264147|75954972|FG004|Treatment II Period|Lost to Follow-up|1|||
42146102|NCT00264147|75954973|FG005|Treatment II Period|Lost to Follow-up|1|||
42146103|NCT00264147|75954968|FG000|Treatment II Period|Withdrawal by Subject|0|||
42146104|NCT00264147|75954969|FG001|Treatment II Period|Withdrawal by Subject|0|||
42146105|NCT00264147|75954970|FG002|Treatment II Period|Withdrawal by Subject|0|||
42146106|NCT00264147|75954971|FG003|Treatment II Period|Withdrawal by Subject|0|||
42146107|NCT00264147|75954972|FG004|Treatment II Period|Withdrawal by Subject|3|||
42146108|NCT00264147|75954973|FG005|Treatment II Period|Withdrawal by Subject|2|||
42146109|NCT00264147|75954968|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
42146110|NCT00264147|75954969|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
42146111|NCT00264147|75954970|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
42146112|NCT00264147|75954971|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
42146113|NCT00264147|75954972|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
42146114|NCT00264147|75954973|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
42146115|NCT00263757|75954989|FG000|Overall Study|Withdrawal by Subject|5|||
42146116|NCT00263757|75954990|FG001|Overall Study|Withdrawal by Subject|4|||
42146117|NCT00263757|75954989|FG000|Overall Study|Screen failure|0|||
42146118|NCT00263757|75954990|FG001|Overall Study|Screen failure|1|||
42146119|NCT00263757|75954989|FG000|Overall Study|Adverse Event|3|||
42146120|NCT00263757|75954990|FG001|Overall Study|Adverse Event|3|||
42146121|NCT00263211|75954998|FG000|Overall Study|Death|1|||
42146122|NCT00263211|75954999|FG001|Overall Study|Death|0|||
42146123|NCT00263211|75954998|FG000|Overall Study|Withdrawal by Subject|3|||
42146124|NCT00263211|75954999|FG001|Overall Study|Withdrawal by Subject|0|||
42146125|NCT00263211|75954998|FG000|Overall Study|Protocol Violation|1|||
42146126|NCT00263211|75954999|FG001|Overall Study|Protocol Violation|0|||
42146127|NCT00263211|75954998|FG000|Overall Study|Disease Progression|0|||
42146128|NCT00263211|75954999|FG001|Overall Study|Disease Progression|1|||
42146129|NCT00248625|75955010|FG000|Overall Study|Withdrawal by Subject|0|||
42146130|NCT00248625|75955011|FG001|Overall Study|Withdrawal by Subject|2|||
42146131|NCT00262821|75955019|FG000|Overall Study|Ineligible - wrong stage|0|||
42146132|NCT00262821|75955020|FG001|Overall Study|Ineligible - wrong stage|3|||
42146133|NCT00262821|75955019|FG000|Overall Study|Ineligible - wrong cell type|2|||
42277282|NCT02164318|76108890|FG000|Overall Study|Withdrawal by Subject|0|||
42146134|NCT00262821|75955020|FG001|Overall Study|Ineligible - wrong cell type|2|||
42146135|NCT00262821|75955019|FG000|Overall Study|Ineligible - wrong primary|0|||
42146136|NCT00262821|75955020|FG001|Overall Study|Ineligible - wrong primary|1|||
42146137|NCT00262821|75955019|FG000|Overall Study|Ineligible - inadequate pathology|1|||
42146138|NCT00262821|75955020|FG001|Overall Study|Ineligible - inadequate pathology|3|||
42146139|NCT00262821|75955019|FG000|Overall Study|Ineligible - elevated creatinine|0|||
42146140|NCT00262821|75955020|FG001|Overall Study|Ineligible - elevated creatinine|2|||
42146141|NCT00262821|75955019|FG000|Overall Study|Ineligible - required test not done|1|||
42146142|NCT00262821|75955020|FG001|Overall Study|Ineligible - required test not done|4|||
42146143|NCT00262821|75955019|FG000|Overall Study|Inevaluable - inadequate data|0|||
42277283|NCT02164318|76108891|FG001|Overall Study|Withdrawal by Subject|1|||
42277284|NCT02164318|76108892|FG002|Overall Study|Withdrawal by Subject|0|||
42277285|NCT02164318|76108893|FG003|Overall Study|Withdrawal by Subject|1|||
42277286|NCT03436199|76108906|FG000|Overall Study|Adverse Event|15|||
42277287|NCT03436199|76108907|FG001|Overall Study|Adverse Event|40|||
42277288|NCT03436199|76108908|FG002|Overall Study|Adverse Event|7|||
42277289|NCT03436199|76108906|FG000|Overall Study|Withdrawal by Subject|4|||
42277290|NCT03436199|76108907|FG001|Overall Study|Withdrawal by Subject|10|||
42277291|NCT03436199|76108908|FG002|Overall Study|Withdrawal by Subject|3|||
42277292|NCT03436199|76108906|FG000|Overall Study|Lost to Follow-up|1|||
42277293|NCT03436199|76108907|FG001|Overall Study|Lost to Follow-up|0|||
42039444|NCT01132664|75847699|FG002|Phase ll|Withdrawal by Subject|3|||
42039445|NCT01132664|75847700|FG003|Phase ll|Withdrawal by Subject|0|||
42039446|NCT01132664|75847701|FG004|Phase ll|Withdrawal by Subject|0|||
42039447|NCT01132664|75847697|FG000|Phase ll|Disease progression|0|||
42039448|NCT01132664|75847698|FG001|Phase ll|Disease progression|0|||
42039449|NCT01132664|75847699|FG002|Phase ll|Disease progression|35|||
42039450|NCT01132664|75847700|FG003|Phase ll|Disease progression|0|||
42039451|NCT01132664|75847701|FG004|Phase ll|Disease progression|0|||
42039452|NCT01132664|75847697|FG000|BM Cohort|Disease progression|0|||
42039453|NCT01132664|75847698|FG001|BM Cohort|Disease progression|0|||
42039454|NCT01132664|75847699|FG002|BM Cohort|Disease progression|0|||
42039455|NCT01132664|75847700|FG003|BM Cohort|Disease progression|3|||
42039456|NCT01132664|75847701|FG004|BM Cohort|Disease progression|4|||
42039457|NCT01132664|75847697|FG000|BM Cohort|Adverse Event|0|||
42039458|NCT01132664|75847698|FG001|BM Cohort|Adverse Event|0|||
42039459|NCT01132664|75847699|FG002|BM Cohort|Adverse Event|0|||
42039460|NCT01132664|75847700|FG003|BM Cohort|Adverse Event|0|||
42039461|NCT01132664|75847701|FG004|BM Cohort|Adverse Event|1|||
42039462|NCT01132664|75847697|FG000|BM Cohort|Withdrawal by Subject|0|||
42039463|NCT01132664|75847698|FG001|BM Cohort|Withdrawal by Subject|0|||
42039464|NCT01132664|75847699|FG002|BM Cohort|Withdrawal by Subject|0|||
42039465|NCT01132664|75847700|FG003|BM Cohort|Withdrawal by Subject|0|||
42039466|NCT01132664|75847701|FG004|BM Cohort|Withdrawal by Subject|1|||
42039467|NCT00591409|75847723|FG000|Overall Study|Not Treated|0|||
42039468|NCT00591409|75847724|FG001|Overall Study|Not Treated|0|||
42039469|NCT00591409|75847725|FG002|Overall Study|Not Treated|0|||
42039470|NCT00591409|75847726|FG003|Overall Study|Not Treated|0|||
42039471|NCT00591409|75847727|FG004|Overall Study|Not Treated|1|||
42039472|NCT00591409|75847728|FG005|Overall Study|Not Treated|0|||
42039473|NCT00591409|75847729|FG006|Overall Study|Not Treated|0|||
42039474|NCT00591409|75847730|FG007|Overall Study|Not Treated|0|||
42039475|NCT00591409|75847731|FG008|Overall Study|Not Treated|0|||
42039476|NCT00591409|75847732|FG009|Overall Study|Not Treated|1|||
42039477|NCT01078805|75847754|FG000|Overall Study|Clinically significant abnormal lab|5|||
42039478|NCT01078805|75847754|FG000|Overall Study|Death|134|||
42039479|NCT01078805|75847754|FG000|Overall Study|Lost to Follow-up|676|||
42039480|NCT01078805|75847754|FG000|Overall Study|Physician Decision|169|||
42039481|NCT01078805|75847754|FG000|Overall Study|Serious adverse event|26|||
42039482|NCT01078805|75847754|FG000|Overall Study|Sponsor decision|46|||
42039483|NCT01078805|75847754|FG000|Overall Study|Withdrawal by Subject|739|||
42039484|NCT01078805|75847754|FG000|Overall Study|Other|173|||
42039485|NCT01078805|75847754|FG000|Overall Study|Didn't take study drug|82|||
42039486|NCT00820027|75847762|FG000|Overall Study|Adverse Event|15|||
42039487|NCT00820027|75847763|FG001|Overall Study|Adverse Event|8|||
42039488|NCT00820027|75847764|FG002|Overall Study|Adverse Event|10|||
42039489|NCT00820027|75847765|FG003|Overall Study|Adverse Event|5|||
42039490|NCT00820027|75847762|FG000|Overall Study|Lack of Efficacy|2|||
42039491|NCT00820027|75847763|FG001|Overall Study|Lack of Efficacy|1|||
42039492|NCT00820027|75847764|FG002|Overall Study|Lack of Efficacy|2|||
42277294|NCT03436199|76108908|FG002|Overall Study|Lost to Follow-up|2|||
42277295|NCT03436199|76108906|FG000|Overall Study|Protocol Violation|1|||
42277296|NCT03436199|76108907|FG001|Overall Study|Protocol Violation|1|||
42039493|NCT00820027|75847765|FG003|Overall Study|Lack of Efficacy|2|||
42039494|NCT00820027|75847762|FG000|Overall Study|Physician Decision|0|||
42039495|NCT00820027|75847763|FG001|Overall Study|Physician Decision|1|||
42039496|NCT00820027|75847764|FG002|Overall Study|Physician Decision|1|||
42039497|NCT00820027|75847765|FG003|Overall Study|Physician Decision|0|||
42039498|NCT00820027|75847762|FG000|Overall Study|Protocol Violation|3|||
42039499|NCT00820027|75847763|FG001|Overall Study|Protocol Violation|0|||
42039500|NCT00820027|75847764|FG002|Overall Study|Protocol Violation|4|||
42039501|NCT00820027|75847765|FG003|Overall Study|Protocol Violation|0|||
42039502|NCT00820027|75847762|FG000|Overall Study|Withdrawal by Subject|6|||
42277297|NCT03436199|76108908|FG002|Overall Study|Protocol Violation|0|||
42146144|NCT00262821|75955020|FG001|Overall Study|Inevaluable - inadequate data|4|||
42146145|NCT00262743|75955028|FG000|Overall Study|Adverse Event|0|||
42146146|NCT00262743|75955029|FG001|Overall Study|Adverse Event|9|||
42146147|NCT00262743|75955028|FG000|Overall Study|Disease progression|0|||
42146148|NCT00262743|75955029|FG001|Overall Study|Disease progression|3|||
42146149|NCT00262119|75955036|FG000|Overall Study|Lost to Follow-up|38|||
42146150|NCT00262119|75955037|FG001|Overall Study|Lost to Follow-up|51|||
42146151|NCT00262119|75955038|FG002|Overall Study|Lost to Follow-up|42|||
42146152|NCT00262119|75955036|FG000|Overall Study|Death|20|||
42146153|NCT00262119|75955037|FG001|Overall Study|Death|19|||
42146154|NCT00262119|75955038|FG002|Overall Study|Death|16|||
42146155|NCT00170950|75955048|FG000|Overall Study|Death|236|||
42146156|NCT00170950|75955049|FG001|Overall Study|Death|274|||
42146157|NCT00170950|75955048|FG000|Overall Study|Withdrawal by Subject|496|||
42146158|NCT00170950|75955049|FG001|Overall Study|Withdrawal by Subject|498|||
42146159|NCT00170950|75955048|FG000|Overall Study|Lost to Follow-up|134|||
42146160|NCT00170950|75955049|FG001|Overall Study|Lost to Follow-up|115|||
42146161|NCT00170950|75955048|FG000|Overall Study|Missing|2|||
42146162|NCT00170950|75955049|FG001|Overall Study|Missing|1|||
42146163|NCT00170950|75955048|FG000|Overall Study|Termination Data Not Recorded|17|||
42146164|NCT00170950|75955049|FG001|Overall Study|Termination Data Not Recorded|22|||
42146165|NCT00239577|75955059|FG000|Primary Phase|Adverse Event|0|||
42146166|NCT00239577|75955060|FG001|Primary Phase|Adverse Event|0|||
42146167|NCT00239577|75955061|FG002|Primary Phase|Adverse Event|1|||
42146168|NCT00239577|75955062|FG003|Primary Phase|Adverse Event|0|||
42146169|NCT00239577|75955059|FG000|Primary Phase|Other|5|||
42146170|NCT00239577|75955060|FG001|Primary Phase|Other|3|||
42146171|NCT00239577|75955061|FG002|Primary Phase|Other|2|||
42146172|NCT00239577|75955062|FG003|Primary Phase|Other|0|||
42146173|NCT00262041|75955078|FG000|Overall Study|Withdrawal by Subject|0|||
42146174|NCT00262041|75955079|FG001|Overall Study|Withdrawal by Subject|3|||
42146175|NCT00262041|75955080|FG002|Overall Study|Withdrawal by Subject|1|||
42146176|NCT00262041|75955078|FG000|Overall Study|Lost to Follow-up|1|||
42146177|NCT00262041|75955079|FG001|Overall Study|Lost to Follow-up|1|||
42146178|NCT00262041|75955080|FG002|Overall Study|Lost to Follow-up|5|||
42146179|NCT00262041|75955078|FG000|Overall Study|Unable to classify|1|||
42146180|NCT00262041|75955079|FG001|Overall Study|Unable to classify|0|||
42146181|NCT00262041|75955080|FG002|Overall Study|Unable to classify|0|||
42146182|NCT00208767|75955096|FG000|Overall Study|Adverse Event|9|||
42146183|NCT00208767|75955097|FG001|Overall Study|Adverse Event|1|||
42146184|NCT00208767|75955096|FG000|Overall Study|Withdrawal by Subject|14|||
42146185|NCT00208767|75955097|FG001|Overall Study|Withdrawal by Subject|3|||
42146186|NCT00208767|75955096|FG000|Overall Study|Death|1|||
42146187|NCT00208767|75955097|FG001|Overall Study|Death|0|||
42146188|NCT00208767|75955096|FG000|Overall Study|Lost to Follow-up|3|||
42146189|NCT00208767|75955097|FG001|Overall Study|Lost to Follow-up|3|||
42146190|NCT00390806|75955105|FG000|Overall Study|Lost to Follow-up|7|||
42146191|NCT00390806|75955106|FG001|Overall Study|Lost to Follow-up|6|||
42146192|NCT00390806|75955105|FG000|Overall Study|Protocol Violation|2|||
42146193|NCT00390806|75955106|FG001|Overall Study|Protocol Violation|2|||
42146194|NCT00390806|75955105|FG000|Overall Study|Withdrawal by Subject|12|||
42146195|NCT00390806|75955106|FG001|Overall Study|Withdrawal by Subject|15|||
42146196|NCT00390806|75955105|FG000|Overall Study|Investigator Decision|4|||
42146197|NCT00390806|75955106|FG001|Overall Study|Investigator Decision|6|||
42146198|NCT00390806|75955105|FG000|Overall Study|Death|1|||
42146199|NCT00390806|75955106|FG001|Overall Study|Death|0|||
42146200|NCT00390806|75955105|FG000|Overall Study|Physician Decision|0|||
42146201|NCT00390806|75955106|FG001|Overall Study|Physician Decision|1|||
42146202|NCT00390806|75955105|FG000|Overall Study|Ongoing|4|||
42146203|NCT00390806|75955106|FG001|Overall Study|Ongoing|2|||
42146204|NCT00390572|75955114|FG000|Overall Study|Lost to Follow-up|8|||
42146205|NCT00390572|75955115|FG001|Overall Study|Lost to Follow-up|4|||
42146206|NCT00390572|75955114|FG000|Overall Study|health condition|0|||
42146207|NCT00390572|75955115|FG001|Overall Study|health condition|1|||
42146208|NCT00390416|75955125|FG000|Overall Study|Withdrawal by Subject|1|||
42351149|NCT01517373|76191007|FG000|Treatment Period|Medication error without AEs|0|||
42146209|NCT00390416|75955125|FG000|Overall Study|Not treated|3|||
42146210|NCT00261495|75955131|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
42146211|NCT00261495|75955132|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
42146212|NCT00261495|75955131|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
42146213|NCT00261495|75955132|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
42146214|NCT00261495|75955131|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
42146215|NCT00261495|75955132|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
42146216|NCT00261495|75955131|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
42146217|NCT00261495|75955132|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
42146218|NCT00261495|75955131|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
42146219|NCT00261495|75955132|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
42146220|NCT00261495|75955131|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
42146221|NCT00261495|75955132|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
42146222|NCT00261495|75955131|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
42146223|NCT00261495|75955132|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
42146224|NCT00261495|75955131|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
42146225|NCT00261495|75955132|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
42146226|NCT00261495|75955131|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
42146227|NCT00261495|75955132|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
42146228|NCT00261495|75955131|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
42146229|NCT00261495|75955132|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
42146230|NCT00261495|75955131|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
42146231|NCT00261495|75955132|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
42146232|NCT00261495|75955131|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
42146233|NCT00261495|75955132|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
42146234|NCT00261495|75955131|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
42146235|NCT00261495|75955132|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
42146236|NCT00261495|75955131|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
42146237|NCT00261495|75955132|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
42146238|NCT00261495|75955131|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
42146239|NCT00261495|75955132|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
42146240|NCT00261495|75955131|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
42146241|NCT00261495|75955132|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
42146242|NCT00261495|75955131|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
42146243|NCT00261495|75955132|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
42146244|NCT00261495|75955131|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
42146245|NCT00261495|75955132|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
42146246|NCT00261495|75955131|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
42146247|NCT00261495|75955132|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
42146248|NCT00261495|75955131|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
42146249|NCT00261495|75955132|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
42146250|NCT00261495|75955131|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
42146251|NCT00261495|75955132|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
42146252|NCT00168844|75955141|FG000|Overall Study|Adverse Event|31|||
42146253|NCT00168844|75955142|FG001|Overall Study|Adverse Event|32|||
42146254|NCT00168844|75955143|FG002|Overall Study|Adverse Event|48|||
42146255|NCT00168844|75955141|FG000|Overall Study|Lost to Follow-up|4|||
42146256|NCT00168844|75955142|FG001|Overall Study|Lost to Follow-up|5|||
42146257|NCT00168844|75955143|FG002|Overall Study|Lost to Follow-up|11|||
42146258|NCT00168844|75955141|FG000|Overall Study|Withdrawal by Subject|12|||
42146259|NCT00168844|75955142|FG001|Overall Study|Withdrawal by Subject|9|||
42146260|NCT00168844|75955143|FG002|Overall Study|Withdrawal by Subject|19|||
42146261|NCT00168844|75955141|FG000|Overall Study|Protocol Violation|2|||
42146262|NCT00168844|75955142|FG001|Overall Study|Protocol Violation|2|||
42146263|NCT00168844|75955143|FG002|Overall Study|Protocol Violation|4|||
42146264|NCT00168844|75955141|FG000|Overall Study|Other|6|||
42146265|NCT00168844|75955142|FG001|Overall Study|Other|7|||
42146266|NCT00168844|75955143|FG002|Overall Study|Other|9|||
42146267|NCT00365456|75955151|FG000|Trial Period I (12 Months)|Adverse Event|84|||
42146268|NCT00365456|75955152|FG001|Trial Period I (12 Months)|Adverse Event|0|||
42146269|NCT00365456|75955151|FG000|Trial Period I (12 Months)|Non-compliance|3|||
42146270|NCT00365456|75955152|FG001|Trial Period I (12 Months)|Non-compliance|0|||
42146271|NCT00365456|75955151|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
42146272|NCT00365456|75955152|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
42146273|NCT00365456|75955151|FG000|Trial Period I (12 Months)|Other|11|||
42146274|NCT00365456|75955152|FG001|Trial Period I (12 Months)|Other|0|||
42146275|NCT00365456|75955151|FG000|Trial Period II (12 Months)|Adverse Event|0|||
42146276|NCT00365456|75955152|FG001|Trial Period II (12 Months)|Adverse Event|6|||
42146277|NCT00365456|75955151|FG000|Trial Period II (12 Months)|Non-compliance|0|||
42146278|NCT00365456|75955152|FG001|Trial Period II (12 Months)|Non-compliance|2|||
42146279|NCT00365456|75955151|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
42146280|NCT00365456|75955152|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
42146281|NCT00365456|75955151|FG000|Trial Period II (12 Months)|Other|0|||
42146282|NCT00365456|75955152|FG001|Trial Period II (12 Months)|Other|1|||
42146283|NCT00365456|75955151|FG000|Trial Period III (12 Months)|Adverse Event|13|||
42146284|NCT00365456|75955152|FG001|Trial Period III (12 Months)|Adverse Event|3|||
42146285|NCT00365456|75955151|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
42146286|NCT00365456|75955152|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
42146287|NCT00365456|75955151|FG000|Trial Period III (12 Months)|Other|1|||
42146288|NCT00365456|75955152|FG001|Trial Period III (12 Months)|Other|1|||
42146289|NCT00147238|75955158|FG000|Overall Study|Inevaluable|8|||
42146290|NCT00206427|75955162|FG000|Overall Study|Adverse Event|2|||
42146291|NCT00146848|75955169|FG000|Pre-randomization|Death|19|||
42146292|NCT00146848|75955170|FG001|Pre-randomization|Death|0|||
42146293|NCT00146848|75955171|FG002|Pre-randomization|Death|0|||
42146294|NCT00146848|75955169|FG000|Pre-randomization|Lost to Follow-up|70|||
42146295|NCT00146848|75955170|FG001|Pre-randomization|Lost to Follow-up|0|||
42146296|NCT00146848|75955171|FG002|Pre-randomization|Lost to Follow-up|0|||
42146297|NCT00146848|75955169|FG000|Pre-randomization|Physician Decision|8|||
42146298|NCT00146848|75955170|FG001|Pre-randomization|Physician Decision|0|||
42146299|NCT00146848|75955171|FG002|Pre-randomization|Physician Decision|0|||
42146300|NCT00146848|75955169|FG000|Pre-randomization|Protocol Violation|172|||
42146301|NCT00146848|75955170|FG001|Pre-randomization|Protocol Violation|0|||
42146302|NCT00146848|75955171|FG002|Pre-randomization|Protocol Violation|0|||
42146303|NCT00146848|75955169|FG000|Pre-randomization|Withdrawal by Subject|40|||
42277298|NCT03436199|76108906|FG000|Overall Study|Physician Decision|0|||
42277299|NCT03436199|76108907|FG001|Overall Study|Physician Decision|1|||
42277300|NCT03436199|76108908|FG002|Overall Study|Physician Decision|0|||
42277301|NCT03436199|76108906|FG000|Overall Study|Could not return to clinic|1|||
42277302|NCT03436199|76108907|FG001|Overall Study|Could not return to clinic|0|||
42277303|NCT03436199|76108908|FG002|Overall Study|Could not return to clinic|0|||
42146304|NCT00146848|75955170|FG001|Pre-randomization|Withdrawal by Subject|0|||
42146305|NCT00146848|75955171|FG002|Pre-randomization|Withdrawal by Subject|0|||
42146306|NCT00146848|75955169|FG000|Post-randomization|Lost to Follow-up|12|||
42146307|NCT00146848|75955170|FG001|Post-randomization|Lost to Follow-up|15|||
42146308|NCT00146848|75955171|FG002|Post-randomization|Lost to Follow-up|12|||
42146309|NCT00146848|75955169|FG000|Post-randomization|Withdrawn|26|||
42146310|NCT00146848|75955170|FG001|Post-randomization|Withdrawn|32|||
42146311|NCT00146848|75955171|FG002|Post-randomization|Withdrawn|27|||
42146312|NCT00205881|75955179|FG000|Overall Study|Withdrawal by Subject|16|||
42146313|NCT00365378|75955186|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
42146314|NCT00365378|75955187|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
42146315|NCT00365378|75955188|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
42146316|NCT00365378|75955186|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
42146317|NCT00365378|75955187|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
42039503|NCT00820027|75847763|FG001|Overall Study|Withdrawal by Subject|4|||
42146318|NCT00365378|75955188|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
42146319|NCT00365378|75955186|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
42146320|NCT00365378|75955187|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
42146321|NCT00365378|75955188|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
42146322|NCT00365378|75955186|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
42146323|NCT00365378|75955187|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
42146324|NCT00365378|75955188|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
42146325|NCT00365378|75955186|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
42146326|NCT00365378|75955187|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
42146327|NCT00365378|75955188|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
42146328|NCT00365378|75955186|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
42146329|NCT00365378|75955187|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
42146330|NCT00365378|75955188|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
42146331|NCT00365378|75955186|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
42146332|NCT00365378|75955187|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
42146333|NCT00365378|75955188|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
42146334|NCT00365378|75955186|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
42146335|NCT00365378|75955187|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
42146336|NCT00365378|75955188|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
42146337|NCT00365378|75955186|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
42277304|NCT03436199|76108906|FG000|Overall Study|Withdrawn per physician|0|||
42277305|NCT03436199|76108907|FG001|Overall Study|Withdrawn per physician|1|||
42277306|NCT03436199|76108908|FG002|Overall Study|Withdrawn per physician|0|||
42146338|NCT00365378|75955187|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
42146339|NCT00365378|75955188|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
42277307|NCT02131636|76108918|FG000|Overall Study|Personal Reasons|4|||
42146340|NCT00365378|75955186|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
42277308|NCT02131636|76108919|FG001|Overall Study|Personal Reasons|4|||
42277309|NCT02131636|76108918|FG000|Overall Study|Lost to Follow-up|4|||
42146341|NCT00365378|75955187|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
42277310|NCT02131636|76108919|FG001|Overall Study|Lost to Follow-up|0|||
42277311|NCT02131636|76108918|FG000|Overall Study|Adverse Event|4|||
42146342|NCT00365378|75955188|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
42146343|NCT00365378|75955186|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
42146344|NCT00365378|75955187|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
42146345|NCT00365378|75955188|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
42146346|NCT00365378|75955186|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
42146347|NCT00365378|75955187|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
42146348|NCT00365378|75955188|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
42146349|NCT00365378|75955186|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
42146350|NCT00365378|75955187|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
42146351|NCT00365378|75955188|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
42146352|NCT00365378|75955186|FG000|Extension|Adverse Event|0|||
42146353|NCT00365378|75955187|FG001|Extension|Adverse Event|0|||
42146354|NCT00365378|75955188|FG002|Extension|Adverse Event|1|||
42146355|NCT00365378|75955186|FG000|Extension|Moved|0|||
42146356|NCT00365378|75955187|FG001|Extension|Moved|0|||
42146357|NCT00365378|75955188|FG002|Extension|Moved|8|||
42146358|NCT00365378|75955186|FG000|Extension|Lost to Follow-up|0|||
42146359|NCT00365378|75955187|FG001|Extension|Lost to Follow-up|0|||
42146360|NCT00365378|75955188|FG002|Extension|Lost to Follow-up|57|||
42146361|NCT00365378|75955186|FG000|Extension|Protocol Violation|0|||
42146362|NCT00365378|75955187|FG001|Extension|Protocol Violation|0|||
42146363|NCT00365378|75955188|FG002|Extension|Protocol Violation|2|||
42146364|NCT00365378|75955186|FG000|Extension|Withdrawal by Subject|0|||
42146365|NCT00365378|75955187|FG001|Extension|Withdrawal by Subject|0|||
42146366|NCT00365378|75955188|FG002|Extension|Withdrawal by Subject|98|||
42146367|NCT00365378|75955186|FG000|Extension|Other|0|||
42146368|NCT00365378|75955187|FG001|Extension|Other|0|||
42146369|NCT00365378|75955188|FG002|Extension|Other|31|||
42146370|NCT00389324|75955195|FG000|Run-In Phase|Adverse Event|1|||
42146371|NCT00389324|75955195|FG000|Run-In Phase|Lost to Follow-up|1|||
42146372|NCT00389324|75955195|FG000|Run-In Phase|Withdrawal by Subject|1|||
42146373|NCT00389324|75955195|FG000|Subcutaneous Phase|Adverse Event|2|||
42146374|NCT00389324|75955195|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
42146375|NCT00389324|75955195|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
42146376|NCT00389324|75955195|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
42146377|NCT00365300|75955204|FG000|Open-label Phase|Adverse Event|4|||
42146378|NCT00365300|75955205|FG001|Open-label Phase|Adverse Event|0|||
42146379|NCT00365300|75955204|FG000|Open-label Phase|Failed to Return|1|||
42146380|NCT00365300|75955205|FG001|Open-label Phase|Failed to Return|0|||
42146381|NCT00365300|75955204|FG000|Open-label Phase|Physician Decision|1|||
42146382|NCT00365300|75955205|FG001|Open-label Phase|Physician Decision|0|||
42146383|NCT00365300|75955204|FG000|Open-label Phase|Noncompliance|9|||
42146384|NCT00365300|75955205|FG001|Open-label Phase|Noncompliance|0|||
42146385|NCT00365300|75955204|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
42277312|NCT02131636|76108919|FG001|Overall Study|Adverse Event|1|||
42277313|NCT02131324|76108927|FG000|Overall Study|Withdrawal by Subject|1|||
42277314|NCT02131324|76108928|FG001|Overall Study|Withdrawal by Subject|2|||
42277315|NCT02131324|76108927|FG000|Overall Study|Lost to Follow-up|1|||
42277316|NCT02131324|76108928|FG001|Overall Study|Lost to Follow-up|1|||
42277317|NCT02734693|76108937|FG000|Overall Study|Adverse Event|1|||
42277318|NCT02734693|76108938|FG001|Overall Study|Adverse Event|3|||
42277319|NCT02734693|76108939|FG002|Overall Study|Adverse Event|3|||
42277320|NCT02734693|76108937|FG000|Overall Study|Lack of Efficacy|1|||
42277321|NCT02734693|76108938|FG001|Overall Study|Lack of Efficacy|0|||
42277322|NCT02734693|76108939|FG002|Overall Study|Lack of Efficacy|0|||
42277323|NCT02734693|76108937|FG000|Overall Study|Lost to Follow-up|2|||
42277324|NCT02734693|76108938|FG001|Overall Study|Lost to Follow-up|0|||
42277325|NCT02734693|76108939|FG002|Overall Study|Lost to Follow-up|0|||
42277326|NCT02734693|76108937|FG000|Overall Study|Protocol Violation|1|||
42277327|NCT02734693|76108938|FG001|Overall Study|Protocol Violation|0|||
42277328|NCT02734693|76108939|FG002|Overall Study|Protocol Violation|0|||
42277329|NCT02734693|76108937|FG000|Overall Study|Withdrawal by Subject|1|||
42277330|NCT02734693|76108938|FG001|Overall Study|Withdrawal by Subject|0|||
42277331|NCT02734693|76108939|FG002|Overall Study|Withdrawal by Subject|0|||
42277332|NCT02193880|76108947|FG000|Overall Study|patients did not collect enough HPC|3|||
42277333|NCT01378325|76108953|FG000|Overall Study|Protocol Violation|0|||
42277334|NCT01378325|76108954|FG001|Overall Study|Protocol Violation|1|||
42277335|NCT01093573|76108963|FG000|Overall Study|Physician Decision|0|||
42351150|NCT01517373|76191008|FG001|Treatment Period|Medication error without AEs|0|||
42146386|NCT00365300|75955205|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
42146387|NCT00365300|75955204|FG000|Open-label Phase|Protocol Violation|1|||
42146388|NCT00365300|75955205|FG001|Open-label Phase|Protocol Violation|0|||
42146389|NCT00365300|75955204|FG000|Open-label Phase|Lack of Efficacy|1|||
42146390|NCT00365300|75955205|FG001|Open-label Phase|Lack of Efficacy|0|||
42146391|NCT00365300|75955204|FG000|Open-label Phase|Patient skipped open label phase|1|||
42277336|NCT01093573|76108964|FG001|Overall Study|Physician Decision|0|||
42146392|NCT00365300|75955205|FG001|Open-label Phase|Patient skipped open label phase|0|||
42146393|NCT00365300|75955204|FG000|Double-blind Phase|Failed to return|1|||
42146394|NCT00365300|75955205|FG001|Double-blind Phase|Failed to return|0|||
42146395|NCT00365300|75955204|FG000|Double-blind Phase|Noncompliance|1|||
42146396|NCT00365300|75955205|FG001|Double-blind Phase|Noncompliance|1|||
42146397|NCT00365300|75955204|FG000|Double-blind Phase|Withdrawal by Subject|0|||
42146398|NCT00365300|75955205|FG001|Double-blind Phase|Withdrawal by Subject|1|||
42146399|NCT00365300|75955204|FG000|Double-blind Phase|Protocol Violation|3|||
42146400|NCT00365300|75955205|FG001|Double-blind Phase|Protocol Violation|1|||
42146401|NCT00365300|75955204|FG000|Double-blind Phase|Lack of Efficacy|6|||
42146402|NCT00365300|75955205|FG001|Double-blind Phase|Lack of Efficacy|6|||
42146403|NCT00370292|75955216|FG000|Overall Study|Disease Progression|4|||
42146404|NCT00370292|75955216|FG000|Overall Study|Adverse Event|7|||
42146405|NCT00370292|75955216|FG000|Overall Study|Physician Decision|2|||
42146406|NCT00369824|75955233|FG000|Overall Study|Adverse Event|0|||
42146407|NCT00369824|75955234|FG001|Overall Study|Adverse Event|2|||
42146408|NCT00369824|75955235|FG002|Overall Study|Adverse Event|0|||
42146409|NCT00369824|75955236|FG003|Overall Study|Adverse Event|0|||
42146410|NCT00369824|75955237|FG004|Overall Study|Adverse Event|1|||
42146411|NCT00369824|75955238|FG005|Overall Study|Adverse Event|0|||
42146412|NCT00369824|75955233|FG000|Overall Study|Protocol Violation|0|||
42146413|NCT00369824|75955234|FG001|Overall Study|Protocol Violation|1|||
42146414|NCT00369824|75955235|FG002|Overall Study|Protocol Violation|0|||
42146415|NCT00369824|75955236|FG003|Overall Study|Protocol Violation|1|||
42146416|NCT00369824|75955237|FG004|Overall Study|Protocol Violation|1|||
42146417|NCT00369824|75955238|FG005|Overall Study|Protocol Violation|0|||
42146418|NCT00369824|75955233|FG000|Overall Study|Withdrawal by Subject|9|||
42146419|NCT00369824|75955234|FG001|Overall Study|Withdrawal by Subject|5|||
42146420|NCT00369824|75955235|FG002|Overall Study|Withdrawal by Subject|5|||
42146421|NCT00369824|75955236|FG003|Overall Study|Withdrawal by Subject|4|||
42146422|NCT00369824|75955237|FG004|Overall Study|Withdrawal by Subject|6|||
42146423|NCT00369824|75955238|FG005|Overall Study|Withdrawal by Subject|2|||
42146424|NCT00369824|75955233|FG000|Overall Study|Lost to Follow-up|6|||
42146425|NCT00369824|75955234|FG001|Overall Study|Lost to Follow-up|11|||
42146426|NCT00369824|75955235|FG002|Overall Study|Lost to Follow-up|7|||
42146427|NCT00369824|75955236|FG003|Overall Study|Lost to Follow-up|8|||
42146428|NCT00369824|75955237|FG004|Overall Study|Lost to Follow-up|9|||
42146429|NCT00369824|75955238|FG005|Overall Study|Lost to Follow-up|6|||
42146430|NCT00369824|75955233|FG000|Overall Study|Other|0|||
42146431|NCT00369824|75955234|FG001|Overall Study|Other|0|||
42146432|NCT00369824|75955235|FG002|Overall Study|Other|0|||
42146433|NCT00369824|75955236|FG003|Overall Study|Other|2|||
42146434|NCT00369824|75955237|FG004|Overall Study|Other|1|||
42146435|NCT00369824|75955238|FG005|Overall Study|Other|3|||
42146436|NCT00369668|75955255|FG000|Overall Study|Lack of Efficacy|4|||
42146437|NCT00369668|75955256|FG001|Overall Study|Lack of Efficacy|5|||
42146438|NCT00369668|75955257|FG002|Overall Study|Lack of Efficacy|7|||
42146439|NCT00388154|75955268|FG000|Overall Study|Withdrawal by Subject|1|||
42146440|NCT00387764|75955272|FG000|Overall Study|Adverse Event|12|||
42146441|NCT00387764|75955272|FG000|Overall Study|Withdrawal by Subject|8|||
42146442|NCT00387764|75955272|FG000|Overall Study|Sponsor Terminated Study|1|||
42146443|NCT00387764|75955272|FG000|Overall Study|Physician Decision|1|||
42146444|NCT00387764|75955272|FG000|Overall Study|Other|2|||
42146445|NCT00387764|75955272|FG000|Overall Study|Death|7|||
42146446|NCT00386360|75955278|FG000|Overall Study|Adverse Event|4|||
42146447|NCT00386360|75955279|FG001|Overall Study|Adverse Event|2|||
42277337|NCT01093573|76108965|FG002|Overall Study|Physician Decision|1|||
42277338|NCT01093573|76108963|FG000|Overall Study|Insurance Denied|0|||
42277339|NCT01093573|76108964|FG001|Overall Study|Insurance Denied|0|||
42277340|NCT01093573|76108965|FG002|Overall Study|Insurance Denied|1|||
42277341|NCT02733367|76108993|FG000|Overall Study|Withdrawal by Subject|6|||
42277342|NCT03688555|76109000|FG000|Treatment Period|Adverse Event|0|||
42277343|NCT03688555|76109001|FG001|Treatment Period|Adverse Event|0|||
42277344|NCT03688555|76109002|FG002|Treatment Period|Adverse Event|1|||
42277345|NCT01328951|76109044|FG000|Overall Study|Disease Progression|17|||
42277346|NCT01328951|76109045|FG001|Overall Study|Disease Progression|14|||
42012625|NCT01194219|75819477|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
42146448|NCT00386360|75955278|FG000|Overall Study|Physician Decision|2|||
42146449|NCT00386360|75955279|FG001|Overall Study|Physician Decision|2|||
42277347|NCT01328951|76109044|FG000|Overall Study|Adverse Event|2|||
42277348|NCT01328951|76109045|FG001|Overall Study|Adverse Event|0|||
42277349|NCT01328951|76109044|FG000|Overall Study|Death|243|||
42012626|NCT01194219|75819478|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
42146450|NCT00386360|75955278|FG000|Overall Study|Lost to Follow-up|0|||
42146451|NCT00386360|75955279|FG001|Overall Study|Lost to Follow-up|2|||
42146452|NCT00386360|75955278|FG000|Overall Study|Protocol Violation|0|||
42146453|NCT00386360|75955279|FG001|Overall Study|Protocol Violation|3|||
42146454|NCT00386360|75955278|FG000|Overall Study|Withdrawal by Subject|3|||
42277350|NCT01328951|76109045|FG001|Overall Study|Death|258|||
42277351|NCT01328951|76109044|FG000|Overall Study|Lost to Follow-up|6|||
42146455|NCT00386360|75955279|FG001|Overall Study|Withdrawal by Subject|6|||
42146456|NCT00386360|75955278|FG000|Overall Study|Did not take any study medication|0|||
42146457|NCT00386360|75955279|FG001|Overall Study|Did not take any study medication|2|||
42277352|NCT01328951|76109045|FG001|Overall Study|Lost to Follow-up|7|||
42277353|NCT01328951|76109044|FG000|Overall Study|Withdrawal by Subject|6|||
42277354|NCT01328951|76109045|FG001|Overall Study|Withdrawal by Subject|6|||
42277355|NCT01328951|76109044|FG000|Overall Study|Study Closed by the Sponsor|36|||
42277356|NCT01328951|76109045|FG001|Overall Study|Study Closed by the Sponsor|31|||
42277357|NCT01328951|76109044|FG000|Overall Study|Other|11|||
42277358|NCT01328951|76109045|FG001|Overall Study|Other|6|||
42277359|NCT02611817|76109058|FG000|Open-label Induction Phase|Reason not Specified|9|||
42277360|NCT02611817|76109059|FG001|Open-label Induction Phase|Reason not Specified|0|||
42277361|NCT02611817|76109060|FG002|Open-label Induction Phase|Reason not Specified|0|||
42277362|NCT02611817|76109058|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
42277363|NCT02611817|76109059|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
42277364|NCT02611817|76109060|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
42277365|NCT02611817|76109058|FG000|Open-label Induction Phase|Pregnancy|1|||
42277366|NCT02611817|76109059|FG001|Open-label Induction Phase|Pregnancy|0|||
42277367|NCT02611817|76109060|FG002|Open-label Induction Phase|Pregnancy|0|||
42277368|NCT02611817|76109058|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
42277369|NCT02611817|76109059|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
42277370|NCT02611817|76109060|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
42277371|NCT02611817|76109058|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
42277372|NCT02611817|76109059|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
42277373|NCT02611817|76109060|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
42277374|NCT02611817|76109058|FG000|Open-label Induction Phase|Protocol Violation|5|||
42277375|NCT02611817|76109059|FG001|Open-label Induction Phase|Protocol Violation|0|||
42277376|NCT02611817|76109060|FG002|Open-label Induction Phase|Protocol Violation|0|||
42277377|NCT02611817|76109058|FG000|Open-label Induction Phase|Adverse Event|16|||
42277378|NCT02611817|76109059|FG001|Open-label Induction Phase|Adverse Event|0|||
42277379|NCT02611817|76109060|FG002|Open-label Induction Phase|Adverse Event|0|||
42277380|NCT02611817|76109058|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
42277381|NCT02611817|76109059|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
42277382|NCT02611817|76109060|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
42277383|NCT02611817|76109058|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
42277384|NCT02611817|76109059|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
42277385|NCT02611817|76109060|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
42277386|NCT02611817|76109058|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
42277387|NCT02611817|76109059|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
42277388|NCT02611817|76109060|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
42277389|NCT02611817|76109058|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
42277390|NCT02611817|76109059|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
42277391|NCT02611817|76109060|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
42277392|NCT02611817|76109058|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
42277393|NCT02611817|76109059|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
42277394|NCT02611817|76109060|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
42277395|NCT02611817|76109058|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
42277396|NCT02611817|76109059|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
42277397|NCT02611817|76109060|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
42277398|NCT02611817|76109058|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
42277399|NCT02611817|76109059|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
42012627|NCT01194219|75819479|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
42277400|NCT02611817|76109060|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
42277401|NCT02735915|76109067|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
42277402|NCT02735915|76109067|FG000|Overall Study|Withdrawal following SAE|2|||
42277403|NCT02735915|76109067|FG000|Overall Study|Withdrawal by Subject|1|||
42277404|NCT02557139|76109076|FG000|Overall Study|Significant liver elevation|1|||
42351151|NCT01517373|76191009|FG002|Treatment Period|Medication error without AEs|2|||
42012628|NCT01194219|75819480|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
42012629|NCT01194219|75819481|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
42012630|NCT01194219|75819482|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
42146458|NCT00369278|75955287|FG000|Overall Study|Adverse Event|14|||
42146459|NCT00369278|75955288|FG001|Overall Study|Adverse Event|11|||
42146460|NCT00369278|75955287|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
42277405|NCT02557139|76109077|FG001|Overall Study|Significant liver elevation|0|||
42277406|NCT02557139|76109078|FG002|Overall Study|Significant liver elevation|1|||
42277407|NCT02557139|76109076|FG000|Overall Study|Withdrawal by Subject|1|||
42277408|NCT02557139|76109077|FG001|Overall Study|Withdrawal by Subject|0|||
42277409|NCT02557139|76109078|FG002|Overall Study|Withdrawal by Subject|0|||
42277410|NCT02557139|76109076|FG000|Overall Study|Illness of prohibited medication|0|||
42012631|NCT01194219|75819483|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
42146461|NCT00369278|75955288|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
42146462|NCT00369278|75955287|FG000|Overall Study|Protocol Violation|2|||
42146463|NCT00369278|75955288|FG001|Overall Study|Protocol Violation|1|||
42146464|NCT00369278|75955287|FG000|Overall Study|Withdrawal by Subject|2|||
42146465|NCT00369278|75955288|FG001|Overall Study|Withdrawal by Subject|2|||
42146466|NCT00369278|75955287|FG000|Overall Study|Lost to Follow-up|1|||
42146467|NCT00369278|75955288|FG001|Overall Study|Lost to Follow-up|0|||
42146468|NCT00369278|75955287|FG000|Overall Study|Graft loss|1|||
42146469|NCT00369278|75955288|FG001|Overall Study|Graft loss|2|||
42146470|NCT00529373|75955296|FG000|Base Study|Adverse Event|525|||
42146471|NCT00529373|75955297|FG001|Base Study|Adverse Event|470|||
42146472|NCT00529373|75955296|FG000|Base Study|Lack of Efficacy|16|||
42146473|NCT00529373|75955297|FG001|Base Study|Lack of Efficacy|75|||
42146474|NCT00529373|75955296|FG000|Base Study|Lost to Follow-up|221|||
42146475|NCT00529373|75955297|FG001|Base Study|Lost to Follow-up|208|||
42146476|NCT00529373|75955296|FG000|Base Study|Other Protocol Specified Criteria|19|||
42146477|NCT00529373|75955297|FG001|Base Study|Other Protocol Specified Criteria|20|||
42146478|NCT00529373|75955296|FG000|Base Study|Physician Decision|60|||
42146479|NCT00529373|75955297|FG001|Base Study|Physician Decision|52|||
42146480|NCT00529373|75955296|FG000|Base Study|Protocol Violation|48|||
42277411|NCT02557139|76109077|FG001|Overall Study|Illness of prohibited medication|0|||
42039504|NCT00820027|75847764|FG002|Overall Study|Withdrawal by Subject|4|||
42039505|NCT00820027|75847765|FG003|Overall Study|Withdrawal by Subject|6|||
42039506|NCT01076153|75847776|FG000|Overall Study|Symptoms improved/resolved|10|||
42039507|NCT01076153|75847776|FG000|Overall Study|Adverse Event|1|||
42039508|NCT01076075|75847786|FG000|Overall Study|Adverse Event|3|||
42039509|NCT01076075|75847787|FG001|Overall Study|Adverse Event|9|||
42039510|NCT01076075|75847786|FG000|Overall Study|Lack of Efficacy|5|||
42039511|NCT01076075|75847787|FG001|Overall Study|Lack of Efficacy|4|||
42039512|NCT01076075|75847786|FG000|Overall Study|Lost to Follow-up|6|||
42039513|NCT01076075|75847787|FG001|Overall Study|Lost to Follow-up|5|||
42039514|NCT01076075|75847786|FG000|Overall Study|other|19|||
42039515|NCT01076075|75847787|FG001|Overall Study|other|9|||
42039516|NCT01076075|75847786|FG000|Overall Study|Protocol Violation|0|||
42039517|NCT01076075|75847787|FG001|Overall Study|Protocol Violation|1|||
42039518|NCT01076075|75847786|FG000|Overall Study|Withdrawal by Subject|8|||
42039519|NCT01076075|75847787|FG001|Overall Study|Withdrawal by Subject|19|||
42039520|NCT01075763|75847798|FG000|Overall Study|Lost to Follow-up|2|||
42039521|NCT01075763|75847799|FG001|Overall Study|Lost to Follow-up|1|||
42039522|NCT01075763|75847798|FG000|Overall Study|Lack of Efficacy|0|||
42039523|NCT01075763|75847799|FG001|Overall Study|Lack of Efficacy|1|||
42039524|NCT01075763|75847798|FG000|Overall Study|Withdrawal by Subject|2|||
42039525|NCT01075763|75847799|FG001|Overall Study|Withdrawal by Subject|2|||
42039526|NCT00881530|75847811|FG000|Overall Study|Adverse Event|5|||
42039527|NCT00881530|75847812|FG001|Overall Study|Adverse Event|1|||
42039528|NCT00881530|75847813|FG002|Overall Study|Adverse Event|1|||
42039529|NCT00881530|75847814|FG003|Overall Study|Adverse Event|4|||
42039530|NCT00881530|75847815|FG004|Overall Study|Adverse Event|10|||
42039531|NCT00881530|75847816|FG005|Overall Study|Adverse Event|2|||
42039532|NCT00881530|75847811|FG000|Overall Study|Lack of Efficacy|1|||
42039533|NCT00881530|75847812|FG001|Overall Study|Lack of Efficacy|0|||
42039534|NCT00881530|75847813|FG002|Overall Study|Lack of Efficacy|0|||
42039535|NCT00881530|75847814|FG003|Overall Study|Lack of Efficacy|0|||
42039536|NCT00881530|75847815|FG004|Overall Study|Lack of Efficacy|1|||
42039537|NCT00881530|75847816|FG005|Overall Study|Lack of Efficacy|1|||
42039538|NCT00881530|75847811|FG000|Overall Study|Not compliant with the protocol|0|||
42039539|NCT00881530|75847812|FG001|Overall Study|Not compliant with the protocol|0|||
42039540|NCT00881530|75847813|FG002|Overall Study|Not compliant with the protocol|0|||
42039541|NCT00881530|75847814|FG003|Overall Study|Not compliant with the protocol|0|||
42039542|NCT00881530|75847815|FG004|Overall Study|Not compliant with the protocol|2|||
42039543|NCT00881530|75847816|FG005|Overall Study|Not compliant with the protocol|0|||
42039544|NCT00881530|75847811|FG000|Overall Study|Lost to Follow-up|0|||
42039545|NCT00881530|75847812|FG001|Overall Study|Lost to Follow-up|1|||
42039546|NCT00881530|75847813|FG002|Overall Study|Lost to Follow-up|1|||
42039547|NCT00881530|75847814|FG003|Overall Study|Lost to Follow-up|3|||
42039548|NCT00881530|75847815|FG004|Overall Study|Lost to Follow-up|1|||
42039549|NCT00881530|75847816|FG005|Overall Study|Lost to Follow-up|0|||
42146481|NCT00529373|75955297|FG001|Base Study|Protocol Violation|38|||
42146482|NCT00529373|75955296|FG000|Base Study|Withdrawal by Subject|1062|||
42146483|NCT00529373|75955297|FG001|Base Study|Withdrawal by Subject|967|||
42277412|NCT02557139|76109078|FG002|Overall Study|Illness of prohibited medication|1|||
42039550|NCT00881530|75847811|FG000|Overall Study|Refused to continue medication|7|||
42039551|NCT00881530|75847812|FG001|Overall Study|Refused to continue medication|2|||
42146484|NCT00529373|75955296|FG000|Base Study|Did not continue into Extension|1795|||
42146485|NCT00529373|75955297|FG001|Base Study|Did not continue into Extension|2238|||
42039552|NCT00881530|75847813|FG002|Overall Study|Refused to continue medication|1|||
42039553|NCT00881530|75847814|FG003|Overall Study|Refused to continue medication|2|||
42146486|NCT00529373|75955296|FG000|First Extension Study|Adverse Event|162|||
42146487|NCT00529373|75955297|FG001|First Extension Study|Adverse Event|142|||
42146488|NCT00529373|75955296|FG000|First Extension Study|Lack of Efficacy|65|||
42146489|NCT00529373|75955297|FG001|First Extension Study|Lack of Efficacy|427|||
42146490|NCT00529373|75955296|FG000|First Extension Study|Lost to Follow-up|41|||
42146491|NCT00529373|75955297|FG001|First Extension Study|Lost to Follow-up|37|||
42277413|NCT01328717|76109095|FG000|Overall Study|Adverse Event|1|||
42277414|NCT01677741|76109107|FG000|Overall Study|Death|0|||
42277415|NCT01677741|76109108|FG001|Overall Study|Death|0|||
42277416|NCT01677741|76109109|FG002|Overall Study|Death|0|||
42277417|NCT01677741|76109110|FG003|Overall Study|Death|1|||
42277418|NCT01677741|76109111|FG004|Overall Study|Death|0|||
42277419|NCT01677741|76109112|FG005|Overall Study|Death|1|||
42277420|NCT01677741|76109113|FG006|Overall Study|Death|0|||
42277421|NCT01677741|76109114|FG007|Overall Study|Death|0|||
42277422|NCT01677741|76109107|FG000|Overall Study|Withdrawal by Subject|2|||
42277423|NCT01677741|76109108|FG001|Overall Study|Withdrawal by Subject|7|||
42277424|NCT01677741|76109109|FG002|Overall Study|Withdrawal by Subject|5|||
42277425|NCT01677741|76109110|FG003|Overall Study|Withdrawal by Subject|4|||
42277426|NCT01677741|76109111|FG004|Overall Study|Withdrawal by Subject|11|||
42277427|NCT01677741|76109112|FG005|Overall Study|Withdrawal by Subject|20|||
42277428|NCT01677741|76109113|FG006|Overall Study|Withdrawal by Subject|4|||
42277429|NCT01677741|76109114|FG007|Overall Study|Withdrawal by Subject|2|||
42277430|NCT01677741|76109107|FG000|Overall Study|Enrolled in a rollover study|0|||
42277431|NCT01677741|76109108|FG001|Overall Study|Enrolled in a rollover study|3|||
42277432|NCT01677741|76109109|FG002|Overall Study|Enrolled in a rollover study|2|||
42277433|NCT01677741|76109110|FG003|Overall Study|Enrolled in a rollover study|1|||
42277434|NCT01677741|76109111|FG004|Overall Study|Enrolled in a rollover study|6|||
42277435|NCT01677741|76109112|FG005|Overall Study|Enrolled in a rollover study|6|||
42277436|NCT01677741|76109113|FG006|Overall Study|Enrolled in a rollover study|7|||
42277437|NCT01677741|76109114|FG007|Overall Study|Enrolled in a rollover study|0|||
42277438|NCT01677741|76109107|FG000|Overall Study|Progressive disease|1|||
42277439|NCT01677741|76109108|FG001|Overall Study|Progressive disease|0|||
42277440|NCT01677741|76109109|FG002|Overall Study|Progressive disease|1|||
42277441|NCT01677741|76109110|FG003|Overall Study|Progressive disease|0|||
42277442|NCT01677741|76109111|FG004|Overall Study|Progressive disease|0|||
42277443|NCT01677741|76109112|FG005|Overall Study|Progressive disease|1|||
42277444|NCT01677741|76109113|FG006|Overall Study|Progressive disease|0|||
42277445|NCT01677741|76109114|FG007|Overall Study|Progressive disease|0|||
42277446|NCT01677507|76109166|FG000|Initial Assignment|Adverse Event|0|||
42277447|NCT01677507|76109167|FG001|Initial Assignment|Adverse Event|1|||
42277448|NCT01677507|76109166|FG000|Initial Assignment|Protocol Violation|0|||
42277449|NCT01677507|76109167|FG001|Initial Assignment|Protocol Violation|1|||
42277450|NCT01677507|76109166|FG000|Second Assigment|Withdrawal by Subject|2|||
42277451|NCT01677507|76109167|FG001|Second Assigment|Withdrawal by Subject|2|||
42277452|NCT01677507|76109166|FG000|Second Assigment|Adverse Event|1|||
42277453|NCT01677507|76109167|FG001|Second Assigment|Adverse Event|3|||
42277454|NCT02732951|76109186|FG000|Overall Study|Other than listed|1|||
42277455|NCT02732951|76109187|FG001|Overall Study|Other than listed|0|||
42277456|NCT02732951|76109186|FG000|Overall Study|Lost to Follow-up|0|||
42277457|NCT02732951|76109187|FG001|Overall Study|Lost to Follow-up|1|||
42277458|NCT02732951|76109186|FG000|Overall Study|Adverse Event|4|||
42277459|NCT02732951|76109187|FG001|Overall Study|Adverse Event|4|||
42277460|NCT02732951|76109186|FG000|Overall Study|Protocol Violation|0|||
42277461|NCT02732951|76109187|FG001|Overall Study|Protocol Violation|1|||
42277462|NCT01377233|76109198|FG000|Open-label|Adverse Event|1|||
42351152|NCT01517373|76191010|FG003|Treatment Period|Medication error without AEs|1|||
42351153|NCT01517373|76191011|FG004|Treatment Period|Medication error without AEs|0|||
42277463|NCT01377233|76109199|FG001|Open-label|Adverse Event|0|||
42277464|NCT01377233|76109200|FG002|Open-label|Adverse Event|0|||
42277465|NCT01377233|76109201|FG003|Open-label|Adverse Event|0|||
42277466|NCT01377233|76109202|FG004|Open-label|Adverse Event|0|||
42146492|NCT00529373|75955296|FG000|First Extension Study|Other|27|||
42277467|NCT01377233|76109198|FG000|Open-label|Withdrawal by Subject|3|||
42277468|NCT01377233|76109199|FG001|Open-label|Withdrawal by Subject|0|||
42277469|NCT01377233|76109200|FG002|Open-label|Withdrawal by Subject|0|||
42277470|NCT01377233|76109201|FG003|Open-label|Withdrawal by Subject|0|||
42277471|NCT01377233|76109202|FG004|Open-label|Withdrawal by Subject|0|||
42277472|NCT01377233|76109198|FG000|Double-blind|Adverse Event|0|||
42277473|NCT01377233|76109199|FG001|Double-blind|Adverse Event|1|||
42277474|NCT01377233|76109200|FG002|Double-blind|Adverse Event|2|||
42277475|NCT01377233|76109201|FG003|Double-blind|Adverse Event|2|||
42277476|NCT01377233|76109202|FG004|Double-blind|Adverse Event|0|||
42277477|NCT01377233|76109198|FG000|Double-blind|Protocol Violation|0|||
42277478|NCT01377233|76109199|FG001|Double-blind|Protocol Violation|0|||
42277479|NCT01377233|76109200|FG002|Double-blind|Protocol Violation|0|||
42277480|NCT01377233|76109201|FG003|Double-blind|Protocol Violation|0|||
42277481|NCT01377233|76109202|FG004|Double-blind|Protocol Violation|1|||
42146493|NCT00529373|75955297|FG001|First Extension Study|Other|47|||
42146494|NCT00529373|75955296|FG000|First Extension Study|Physician Decision|50|||
42146495|NCT00529373|75955297|FG001|First Extension Study|Physician Decision|45|||
42146496|NCT00529373|75955296|FG000|First Extension Study|Protocol Violation|16|||
42146497|NCT00529373|75955297|FG001|First Extension Study|Protocol Violation|13|||
42146498|NCT00529373|75955296|FG000|First Extension Study|Withdrawal by Subject|296|||
42146499|NCT00529373|75955297|FG001|First Extension Study|Withdrawal by Subject|287|||
42146500|NCT00529373|75955296|FG000|First Extension Study|Disposition record non-existing|0|||
42146501|NCT00529373|75955297|FG001|First Extension Study|Disposition record non-existing|1|||
42146502|NCT00529373|75955296|FG000|First Extension Study|Discontinued after 5 years completion|208|||
42146503|NCT00529373|75955297|FG001|First Extension Study|Discontinued after 5 years completion|346|||
42146504|NCT00529373|75955296|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
42146505|NCT00529373|75955297|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
42146506|NCT00529373|75955296|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
42146507|NCT00529373|75955297|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
42146508|NCT00529373|75955296|FG000|Second Extension Study|Adverse Event|101|||
42146509|NCT00529373|75955297|FG001|Second Extension Study|Adverse Event|51|||
42146510|NCT00529373|75955296|FG000|Second Extension Study|Lack of Efficacy|7|||
42146511|NCT00529373|75955297|FG001|Second Extension Study|Lack of Efficacy|15|||
42146512|NCT00529373|75955296|FG000|Second Extension Study|Lost to Follow-up|18|||
42146513|NCT00529373|75955297|FG001|Second Extension Study|Lost to Follow-up|12|||
42146514|NCT00529373|75955296|FG000|Second Extension Study|Other|7|||
42146515|NCT00529373|75955297|FG001|Second Extension Study|Other|12|||
42146516|NCT00529373|75955296|FG000|Second Extension Study|Physician Decision|63|||
42146517|NCT00529373|75955297|FG001|Second Extension Study|Physician Decision|26|||
42146518|NCT00529373|75955296|FG000|Second Extension Study|Protocol Violation|2|||
42146519|NCT00529373|75955297|FG001|Second Extension Study|Protocol Violation|1|||
42146520|NCT00529373|75955296|FG000|Second Extension Study|Withdrawal by Subject|97|||
42146521|NCT00529373|75955297|FG001|Second Extension Study|Withdrawal by Subject|75|||
42146522|NCT00529373|75955296|FG000|Second Extension Study|Status Missing|5|||
42146523|NCT00529373|75955297|FG001|Second Extension Study|Status Missing|5|||
42146524|NCT00369122|75955311|FG000|Overall Study|Ineligible|10|||
42146525|NCT00369122|75955311|FG000|Overall Study|No protocol treatment|1|||
42146526|NCT03687125|75955317|FG000|Overall Study|Progressive Disease|2|||
42146527|NCT03687125|75955318|FG001|Overall Study|Progressive Disease|1|||
42146528|NCT03687125|75955317|FG000|Overall Study|Protocol Violation|1|||
42146529|NCT03687125|75955318|FG001|Overall Study|Protocol Violation|0|||
42146530|NCT03872843|75955328|FG000|Overall Study|Lost to Follow-up|5|||
42146531|NCT03872843|75955329|FG001|Overall Study|Lost to Follow-up|7|||
42146532|NCT00146770|75955337|FG000|Overall Study|Adverse Event|2|||
42146533|NCT00146770|75955338|FG001|Overall Study|Adverse Event|0|||
42146534|NCT00146770|75955337|FG000|Overall Study|Pregnancy|1|||
42146535|NCT00146770|75955338|FG001|Overall Study|Pregnancy|0|||
42146536|NCT00146770|75955337|FG000|Overall Study|Withdrawal by Subject|2|||
42146537|NCT00146770|75955338|FG001|Overall Study|Withdrawal by Subject|0|||
42146538|NCT03874013|75955346|FG000|Overall Study|Adverse Event|0|||
42146539|NCT03874013|75955347|FG001|Overall Study|Adverse Event|1|||
42146540|NCT00168064|75955355|FG000|Overall Study|Adverse Event|26|||
42146541|NCT00168064|75955356|FG001|Overall Study|Adverse Event|22|||
42146542|NCT00168064|75955355|FG000|Overall Study|Withdrawal by Subject|3|||
42146543|NCT00168064|75955356|FG001|Overall Study|Withdrawal by Subject|4|||
42146544|NCT00168064|75955355|FG000|Overall Study|Lack of Efficacy|4|||
42146545|NCT00168064|75955356|FG001|Overall Study|Lack of Efficacy|4|||
42146546|NCT00168064|75955355|FG000|Overall Study|Lost to Follow-up|4|||
42146547|NCT00168064|75955356|FG001|Overall Study|Lost to Follow-up|3|||
42146548|NCT00168064|75955355|FG000|Overall Study|Non-compliance|2|||
42146549|NCT00168064|75955356|FG001|Overall Study|Non-compliance|3|||
42146550|NCT00168064|75955355|FG000|Overall Study|Concurrent Illness|4|||
42146551|NCT00168064|75955356|FG001|Overall Study|Concurrent Illness|3|||
42146552|NCT00168064|75955355|FG000|Overall Study|Subject's Best interest|2|||
42146553|NCT00168064|75955356|FG001|Overall Study|Subject's Best interest|2|||
42146554|NCT00168064|75955355|FG000|Overall Study|Various|4|||
42039554|NCT00881530|75847815|FG004|Overall Study|Refused to continue medication|0|||
42146555|NCT00168064|75955356|FG001|Overall Study|Various|3|||
42146556|NCT00166114|75955366|FG000|Overall Study|Protocol Violation|2|||
42146557|NCT00166114|75955367|FG001|Overall Study|Protocol Violation|1|||
42146558|NCT00166114|75955366|FG000|Overall Study|Withdrawal by Subject|10|||
42146559|NCT00166114|75955367|FG001|Overall Study|Withdrawal by Subject|4|||
42146560|NCT00166114|75955366|FG000|Overall Study|Adverse Event|2|||
42146561|NCT00166114|75955367|FG001|Overall Study|Adverse Event|1|||
42146562|NCT03686969|75955375|FG000|Overall Study|Study terminated|1|||
42146563|NCT03686969|75955376|FG001|Overall Study|Study terminated|0|||
42146564|NCT00145600|75955386|FG000|Overall Study|Death|1|||
42146565|NCT00145600|75955387|FG001|Overall Study|Death|2|||
42146566|NCT00145600|75955388|FG002|Overall Study|Death|2|||
42146567|NCT00145600|75955389|FG003|Overall Study|Death|6|||
42146568|NCT00145600|75955386|FG000|Overall Study|Ineligible|3|||
42146569|NCT00145600|75955387|FG001|Overall Study|Ineligible|0|||
42146570|NCT00145600|75955388|FG002|Overall Study|Ineligible|1|||
42146571|NCT00145600|75955389|FG003|Overall Study|Ineligible|5|||
42146572|NCT00145600|75955386|FG000|Overall Study|Lost to Follow-up|2|||
42146573|NCT00145600|75955387|FG001|Overall Study|Lost to Follow-up|6|||
42146574|NCT00145600|75955388|FG002|Overall Study|Lost to Follow-up|2|||
42146575|NCT00145600|75955389|FG003|Overall Study|Lost to Follow-up|4|||
42146576|NCT00145600|75955386|FG000|Overall Study|Noncompliance|1|||
42146577|NCT00145600|75955387|FG001|Overall Study|Noncompliance|0|||
42146578|NCT00145600|75955388|FG002|Overall Study|Noncompliance|0|||
42146579|NCT00145600|75955389|FG003|Overall Study|Noncompliance|0|||
42146580|NCT00145600|75955386|FG000|Overall Study|Withdrawal by Subject|1|||
42146581|NCT00145600|75955387|FG001|Overall Study|Withdrawal by Subject|2|||
42146582|NCT00145600|75955388|FG002|Overall Study|Withdrawal by Subject|0|||
42146583|NCT00145600|75955389|FG003|Overall Study|Withdrawal by Subject|1|||
42146584|NCT00129376|75955413|FG000|Overall Study|Adverse Event|1|||
42146585|NCT00129376|75955413|FG000|Overall Study|Lack of Efficacy|1|||
42146586|NCT00129220|75955420|FG000|Study Period II|Adverse Event|9|||
42146587|NCT00129220|75955421|FG001|Study Period II|Adverse Event|5|||
42146588|NCT00129220|75955422|FG002|Study Period II|Adverse Event|7|||
42146589|NCT00129220|75955420|FG000|Study Period II|Lack of Efficacy|15|||
42146590|NCT00129220|75955421|FG001|Study Period II|Lack of Efficacy|1|||
42146591|NCT00129220|75955422|FG002|Study Period II|Lack of Efficacy|28|||
42146592|NCT00129220|75955420|FG000|Study Period II|Entry Criteria Not Met|2|||
42146593|NCT00129220|75955421|FG001|Study Period II|Entry Criteria Not Met|0|||
42146594|NCT00129220|75955422|FG002|Study Period II|Entry Criteria Not Met|2|||
42146595|NCT00129220|75955420|FG000|Study Period II|Protocol Violation|4|||
42146596|NCT00129220|75955421|FG001|Study Period II|Protocol Violation|2|||
42146597|NCT00129220|75955422|FG002|Study Period II|Protocol Violation|1|||
42146598|NCT00129220|75955420|FG000|Study Period II|Physician Decision|0|||
42146599|NCT00129220|75955421|FG001|Study Period II|Physician Decision|1|||
42146600|NCT00129220|75955422|FG002|Study Period II|Physician Decision|0|||
42146601|NCT00129220|75955420|FG000|Study Period II|Withdrawal by Subject|1|||
42146602|NCT00129220|75955421|FG001|Study Period II|Withdrawal by Subject|3|||
42146603|NCT00129220|75955422|FG002|Study Period II|Withdrawal by Subject|4|||
42146604|NCT00129220|75955420|FG000|Study Period II|Reason Not Specified|2|||
42146605|NCT00129220|75955421|FG001|Study Period II|Reason Not Specified|0|||
42146606|NCT00129220|75955422|FG002|Study Period II|Reason Not Specified|5|||
42146607|NCT00129220|75955420|FG000|Study Period III|Adverse Event|1|||
42146608|NCT00129220|75955421|FG001|Study Period III|Adverse Event|0|||
42146609|NCT00129220|75955422|FG002|Study Period III|Adverse Event|3|||
42146610|NCT00129220|75955420|FG000|Study Period III|Protocol Violation|1|||
42146611|NCT00129220|75955421|FG001|Study Period III|Protocol Violation|1|||
42146612|NCT00129220|75955422|FG002|Study Period III|Protocol Violation|2|||
42146613|NCT00129220|75955420|FG000|Study Period III|Withdrawal by Subject|1|||
42277482|NCT01377233|76109198|FG000|Double-blind|Withdrawal by Subject|0|||
42277483|NCT01377233|76109199|FG001|Double-blind|Withdrawal by Subject|0|||
42277484|NCT01377233|76109200|FG002|Double-blind|Withdrawal by Subject|0|||
42277485|NCT01377233|76109201|FG003|Double-blind|Withdrawal by Subject|1|||
42277486|NCT01377233|76109202|FG004|Double-blind|Withdrawal by Subject|0|||
42277487|NCT01377233|76109198|FG000|Double-blind|Administrative or other|0|||
42277488|NCT01377233|76109199|FG001|Double-blind|Administrative or other|0|||
42277489|NCT01377233|76109200|FG002|Double-blind|Administrative or other|0|||
42277490|NCT01377233|76109201|FG003|Double-blind|Administrative or other|1|||
42277491|NCT01377233|76109202|FG004|Double-blind|Administrative or other|1|||
42277492|NCT03248531|76109221|FG000|Overall Study|Adverse Event|0|||
42146614|NCT00129220|75955421|FG001|Study Period III|Withdrawal by Subject|0|||
42146615|NCT00129220|75955422|FG002|Study Period III|Withdrawal by Subject|3|||
42277493|NCT03248531|76109222|FG001|Overall Study|Adverse Event|0|||
42012632|NCT01194219|75819484|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
42012633|NCT01194219|75819475|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
42012634|NCT01194219|75819476|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
42012635|NCT01194219|75819477|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
42146616|NCT00129220|75955420|FG000|Study Period III|Sponsor Decision|1|||
42146617|NCT00129220|75955421|FG001|Study Period III|Sponsor Decision|0|||
42146618|NCT00129220|75955422|FG002|Study Period III|Sponsor Decision|0|||
42146619|NCT00129220|75955420|FG000|Study Period III|Reason Not Specified|9|||
42146620|NCT00129220|75955421|FG001|Study Period III|Reason Not Specified|0|||
42146621|NCT00129220|75955422|FG002|Study Period III|Reason Not Specified|2|||
42146622|NCT00128830|75955442|FG000|Overall Study|Adverse Event|10|||
42146623|NCT00128830|75955442|FG000|Overall Study|Withdrawal by Subject|14|||
42146624|NCT00128830|75955442|FG000|Overall Study|Lost to Follow-up|4|||
42146625|NCT00128830|75955442|FG000|Overall Study|Reached a virologic endpoint|29|||
42277494|NCT03248531|76109223|FG002|Overall Study|Adverse Event|1|||
42277495|NCT03248531|76109221|FG000|Overall Study|Lost to Follow-up|1|||
42277496|NCT03248531|76109222|FG001|Overall Study|Lost to Follow-up|0|||
42277497|NCT03248531|76109223|FG002|Overall Study|Lost to Follow-up|5|||
42277498|NCT03248531|76109221|FG000|Overall Study|Withdrawal by Subject|3|||
42277499|NCT03248531|76109222|FG001|Overall Study|Withdrawal by Subject|3|||
42277500|NCT03248531|76109223|FG002|Overall Study|Withdrawal by Subject|2|||
42277501|NCT03248531|76109221|FG000|Overall Study|Sponsor Request|0|||
42277502|NCT03248531|76109222|FG001|Overall Study|Sponsor Request|2|||
42277503|NCT03248531|76109223|FG002|Overall Study|Sponsor Request|0|||
42277504|NCT02656329|76109240|FG000|Overall Study|Lost to Follow-up|2|||
42277505|NCT02656329|76109241|FG001|Overall Study|Lost to Follow-up|3|||
42277506|NCT02656329|76109240|FG000|Overall Study|Withdrawal by Subject|7|||
42277507|NCT02656329|76109241|FG001|Overall Study|Withdrawal by Subject|6|||
42277508|NCT02656329|76109240|FG000|Overall Study|Study termination by Sponsor|150|||
42277509|NCT02656329|76109241|FG001|Overall Study|Study termination by Sponsor|142|||
42277510|NCT02656329|76109240|FG000|Overall Study|Other than specified above|5|||
42277511|NCT02656329|76109241|FG001|Overall Study|Other than specified above|6|||
42277512|NCT02712905|76109266|FG000|Monotherapy|Death|2|||
42277513|NCT02712905|76109267|FG001|Monotherapy|Death|5|||
42277514|NCT02712905|76109268|FG002|Monotherapy|Death|0|||
42277515|NCT02712905|76109269|FG003|Monotherapy|Death|3|||
42277516|NCT02712905|76109270|FG004|Monotherapy|Death|15|||
42277517|NCT02712905|76109271|FG005|Monotherapy|Death|1|||
42277518|NCT02712905|76109272|FG006|Monotherapy|Death|3|||
42277519|NCT02712905|76109273|FG007|Monotherapy|Death|3|||
42277520|NCT02712905|76109274|FG008|Monotherapy|Death|0|||
42277521|NCT02712905|76109275|FG009|Monotherapy|Death|27|||
42277522|NCT02712905|76109276|FG010|Monotherapy|Death|2|||
42277523|NCT02712905|76109277|FG011|Monotherapy|Death|5|||
42277524|NCT02712905|76109278|FG012|Monotherapy|Death|0|||
42277525|NCT02712905|76109279|FG013|Monotherapy|Death|0|||
42277526|NCT02712905|76109280|FG014|Monotherapy|Death|0|||
42277527|NCT02712905|76109281|FG015|Monotherapy|Death|0|||
42277528|NCT02712905|76109282|FG016|Monotherapy|Death|0|||
42277529|NCT02712905|76109283|FG017|Monotherapy|Death|0|||
42277530|NCT02712905|76109266|FG000|Monotherapy|Lost to Follow-up|0|||
42277531|NCT02712905|76109267|FG001|Monotherapy|Lost to Follow-up|1|||
42277532|NCT02712905|76109268|FG002|Monotherapy|Lost to Follow-up|0|||
42351154|NCT01517373|76191012|FG005|Treatment Period|Medication error without AEs|2|||
42277533|NCT02712905|76109269|FG003|Monotherapy|Lost to Follow-up|1|||
42277534|NCT02712905|76109270|FG004|Monotherapy|Lost to Follow-up|0|||
42277535|NCT02712905|76109271|FG005|Monotherapy|Lost to Follow-up|0|||
42351155|NCT01517295|76191027|FG000|Overall Study|Physician Decision|1|||
42351156|NCT01517295|76191028|FG001|Overall Study|Physician Decision|0|||
42351157|NCT01541865|76191034|FG000|Overall Study|Lost to Follow-up|11|||
42351158|NCT01541865|76191034|FG000|Overall Study|Withdrawal by Subject|9|||
42351159|NCT01541865|76191034|FG000|Overall Study|Adverse Event|1|||
42351160|NCT01541865|76191034|FG000|Overall Study|Protocol Violation|1|||
42351161|NCT01541397|76191040|FG000|Overall Study|Study ended prior to data collection|4|||
42351162|NCT01541397|76191041|FG001|Overall Study|Study ended prior to data collection|2|||
42351163|NCT01548417|76191049|FG000|Overall Study|Withdrawal by Subject|0|||
42351164|NCT01548417|76191050|FG001|Overall Study|Withdrawal by Subject|2|||
42351165|NCT01546857|76191058|FG000|Overall Study|Withdrawal by Subject|2|||
42351166|NCT01546857|76191059|FG001|Overall Study|Withdrawal by Subject|3|||
42351167|NCT01540851|76191068|FG000|Overall Study|Lost to Follow-up|14|||
42351168|NCT01540851|76191069|FG001|Overall Study|Lost to Follow-up|15|||
42351169|NCT01540851|76191068|FG000|Overall Study|Withdrawal by Subject|7|||
42351170|NCT01540851|76191069|FG001|Overall Study|Withdrawal by Subject|3|||
42351171|NCT01516749|76191077|FG000|Active Therapy|Lost to Follow-up|1|||
42351172|NCT01516749|76191077|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
42351173|NCT01516437|76191085|FG000|Overall Study|Reason not specified|0|||
42351174|NCT01516437|76191086|FG001|Overall Study|Reason not specified|0|||
42351175|NCT01516437|76191087|FG002|Overall Study|Reason not specified|1|||
42351176|NCT01516437|76191088|FG003|Overall Study|Reason not specified|1|||
42277536|NCT02712905|76109272|FG006|Monotherapy|Lost to Follow-up|0|||
42277537|NCT02712905|76109273|FG007|Monotherapy|Lost to Follow-up|0|||
42277538|NCT02712905|76109274|FG008|Monotherapy|Lost to Follow-up|0|||
42277539|NCT02712905|76109275|FG009|Monotherapy|Lost to Follow-up|2|||
42277540|NCT02712905|76109276|FG010|Monotherapy|Lost to Follow-up|0|||
42277541|NCT02712905|76109277|FG011|Monotherapy|Lost to Follow-up|0|||
42277542|NCT02712905|76109278|FG012|Monotherapy|Lost to Follow-up|0|||
42351177|NCT01515423|76191102|FG000|Open Label Phase|Adverse Event|57|||
42351178|NCT01515423|76191103|FG001|Open Label Phase|Adverse Event|0|||
42351179|NCT01515423|76191104|FG002|Open Label Phase|Adverse Event|0|||
42351180|NCT01515423|76191102|FG000|Open Label Phase|Death|2|||
42277543|NCT02712905|76109279|FG013|Monotherapy|Lost to Follow-up|0|||
42277544|NCT02712905|76109280|FG014|Monotherapy|Lost to Follow-up|0|||
42277545|NCT02712905|76109281|FG015|Monotherapy|Lost to Follow-up|0|||
42277546|NCT02712905|76109282|FG016|Monotherapy|Lost to Follow-up|0|||
42277547|NCT02712905|76109283|FG017|Monotherapy|Lost to Follow-up|0|||
42277548|NCT02712905|76109266|FG000|Monotherapy|Physician Decision|1|||
42351181|NCT01515423|76191103|FG001|Open Label Phase|Death|0|||
42351182|NCT01515423|76191104|FG002|Open Label Phase|Death|0|||
42351183|NCT01515423|76191102|FG000|Open Label Phase|Lack of Efficacy|117|||
42277549|NCT02712905|76109267|FG001|Monotherapy|Physician Decision|0|||
42277550|NCT02712905|76109268|FG002|Monotherapy|Physician Decision|0|||
42277551|NCT02712905|76109269|FG003|Monotherapy|Physician Decision|1|||
42277552|NCT02712905|76109270|FG004|Monotherapy|Physician Decision|0|||
42277553|NCT02712905|76109271|FG005|Monotherapy|Physician Decision|0|||
42277554|NCT02712905|76109272|FG006|Monotherapy|Physician Decision|0|||
42277555|NCT02712905|76109273|FG007|Monotherapy|Physician Decision|0|||
42277556|NCT02712905|76109274|FG008|Monotherapy|Physician Decision|0|||
42277557|NCT02712905|76109275|FG009|Monotherapy|Physician Decision|1|||
42277558|NCT02712905|76109276|FG010|Monotherapy|Physician Decision|0|||
42277559|NCT02712905|76109277|FG011|Monotherapy|Physician Decision|0|||
42277560|NCT02712905|76109278|FG012|Monotherapy|Physician Decision|0|||
42277561|NCT02712905|76109279|FG013|Monotherapy|Physician Decision|0|||
42277562|NCT02712905|76109280|FG014|Monotherapy|Physician Decision|0|||
42277563|NCT02712905|76109281|FG015|Monotherapy|Physician Decision|0|||
42277564|NCT02712905|76109282|FG016|Monotherapy|Physician Decision|0|||
42277565|NCT02712905|76109283|FG017|Monotherapy|Physician Decision|0|||
42277566|NCT02712905|76109266|FG000|Monotherapy|Study Terminated by Sponsor|0|||
42277567|NCT02712905|76109267|FG001|Monotherapy|Study Terminated by Sponsor|0|||
42277568|NCT02712905|76109268|FG002|Monotherapy|Study Terminated by Sponsor|0|||
42277569|NCT02712905|76109269|FG003|Monotherapy|Study Terminated by Sponsor|0|||
42277570|NCT02712905|76109270|FG004|Monotherapy|Study Terminated by Sponsor|1|||
42277571|NCT02712905|76109271|FG005|Monotherapy|Study Terminated by Sponsor|0|||
42277572|NCT02712905|76109272|FG006|Monotherapy|Study Terminated by Sponsor|0|||
42277573|NCT02712905|76109273|FG007|Monotherapy|Study Terminated by Sponsor|0|||
42277574|NCT02712905|76109274|FG008|Monotherapy|Study Terminated by Sponsor|0|||
42277575|NCT02712905|76109275|FG009|Monotherapy|Study Terminated by Sponsor|2|||
42277576|NCT02712905|76109276|FG010|Monotherapy|Study Terminated by Sponsor|0|||
42277577|NCT02712905|76109277|FG011|Monotherapy|Study Terminated by Sponsor|0|||
42277578|NCT02712905|76109278|FG012|Monotherapy|Study Terminated by Sponsor|0|||
42277579|NCT02712905|76109279|FG013|Monotherapy|Study Terminated by Sponsor|0|||
42277580|NCT02712905|76109280|FG014|Monotherapy|Study Terminated by Sponsor|0|||
42277581|NCT02712905|76109281|FG015|Monotherapy|Study Terminated by Sponsor|0|||
42277582|NCT02712905|76109282|FG016|Monotherapy|Study Terminated by Sponsor|0|||
42277583|NCT02712905|76109283|FG017|Monotherapy|Study Terminated by Sponsor|0|||
42277584|NCT02712905|76109266|FG000|Monotherapy|Withdrawal by Subject|0|||
42277585|NCT02712905|76109267|FG001|Monotherapy|Withdrawal by Subject|0|||
42277586|NCT02712905|76109268|FG002|Monotherapy|Withdrawal by Subject|1|||
42277587|NCT02712905|76109269|FG003|Monotherapy|Withdrawal by Subject|0|||
42277588|NCT02712905|76109270|FG004|Monotherapy|Withdrawal by Subject|2|||
42277589|NCT02712905|76109271|FG005|Monotherapy|Withdrawal by Subject|0|||
42277590|NCT02712905|76109272|FG006|Monotherapy|Withdrawal by Subject|0|||
42277591|NCT02712905|76109273|FG007|Monotherapy|Withdrawal by Subject|0|||
42277592|NCT02712905|76109274|FG008|Monotherapy|Withdrawal by Subject|0|||
42146626|NCT00128830|75955442|FG000|Overall Study|Non-compliant|4|||
42146627|NCT00128830|75955442|FG000|Overall Study|Discontinued or ineligible for study|2|||
42146628|NCT00128830|75955442|FG000|Overall Study|Other|9|||
42146629|NCT03686033|75955448|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
42277593|NCT02712905|76109275|FG009|Monotherapy|Withdrawal by Subject|4|||
42277594|NCT02712905|76109276|FG010|Monotherapy|Withdrawal by Subject|1|||
42277595|NCT02712905|76109277|FG011|Monotherapy|Withdrawal by Subject|2|||
42277596|NCT02712905|76109278|FG012|Monotherapy|Withdrawal by Subject|0|||
42277597|NCT02712905|76109279|FG013|Monotherapy|Withdrawal by Subject|0|||
42277598|NCT02712905|76109280|FG014|Monotherapy|Withdrawal by Subject|0|||
42277599|NCT02712905|76109281|FG015|Monotherapy|Withdrawal by Subject|0|||
42277600|NCT02712905|76109282|FG016|Monotherapy|Withdrawal by Subject|0|||
42277601|NCT02712905|76109283|FG017|Monotherapy|Withdrawal by Subject|0|||
42277602|NCT02712905|76109266|FG000|Monotherapy|Started New Cancer Drug|0|||
42277603|NCT02712905|76109267|FG001|Monotherapy|Started New Cancer Drug|0|||
42277604|NCT02712905|76109268|FG002|Monotherapy|Started New Cancer Drug|0|||
42277605|NCT02712905|76109269|FG003|Monotherapy|Started New Cancer Drug|0|||
42277606|NCT02712905|76109270|FG004|Monotherapy|Started New Cancer Drug|0|||
42277607|NCT02712905|76109271|FG005|Monotherapy|Started New Cancer Drug|1|||
42012636|NCT01194219|75819478|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
42146630|NCT03686033|75955449|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
42146631|NCT03686033|75955450|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
42146632|NCT03686033|75955451|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
42146633|NCT03686033|75955452|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
42277608|NCT02712905|76109272|FG006|Monotherapy|Started New Cancer Drug|0|||
42277609|NCT02712905|76109273|FG007|Monotherapy|Started New Cancer Drug|0|||
42277610|NCT02712905|76109274|FG008|Monotherapy|Started New Cancer Drug|0|||
42277611|NCT02712905|76109275|FG009|Monotherapy|Started New Cancer Drug|0|||
42277612|NCT02712905|76109276|FG010|Monotherapy|Started New Cancer Drug|0|||
42277613|NCT02712905|76109277|FG011|Monotherapy|Started New Cancer Drug|0|||
42277614|NCT02712905|76109278|FG012|Monotherapy|Started New Cancer Drug|0|||
42146634|NCT03686033|75955453|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
42146635|NCT00128206|75955469|FG000|Overall Study|Lost to Follow-up|137|||
42277615|NCT02712905|76109279|FG013|Monotherapy|Started New Cancer Drug|0|||
42146636|NCT00128206|75955470|FG001|Overall Study|Lost to Follow-up|118|||
42146637|NCT00128206|75955469|FG000|Overall Study|Adverse Event|0|||
42146638|NCT00128206|75955470|FG001|Overall Study|Adverse Event|2|||
42146639|NCT03685643|75955478|FG000|Overall Study|Lost to Follow-up|14|||
42146640|NCT03685643|75955479|FG001|Overall Study|Lost to Follow-up|22|||
42146641|NCT03823378|75955491|FG000|Overall Study|Adverse Event|2|||
42146642|NCT03823378|75955492|FG001|Overall Study|Adverse Event|2|||
42146643|NCT03823378|75955493|FG002|Overall Study|Adverse Event|0|||
42146644|NCT03823378|75955494|FG003|Overall Study|Adverse Event|0|||
42146645|NCT03823378|75955495|FG004|Overall Study|Adverse Event|0|||
42146646|NCT03823378|75955496|FG005|Overall Study|Adverse Event|0|||
42146647|NCT03823378|75955491|FG000|Overall Study|Lost to Follow-up|0|||
42146648|NCT03823378|75955492|FG001|Overall Study|Lost to Follow-up|1|||
42146649|NCT03823378|75955493|FG002|Overall Study|Lost to Follow-up|0|||
42146650|NCT03823378|75955494|FG003|Overall Study|Lost to Follow-up|0|||
42146651|NCT03823378|75955495|FG004|Overall Study|Lost to Follow-up|1|||
42146652|NCT03823378|75955496|FG005|Overall Study|Lost to Follow-up|0|||
42146653|NCT03823378|75955491|FG000|Overall Study|Withdrawal by Subject|0|||
42146654|NCT03823378|75955492|FG001|Overall Study|Withdrawal by Subject|1|||
42146655|NCT03823378|75955493|FG002|Overall Study|Withdrawal by Subject|4|||
42146656|NCT03823378|75955494|FG003|Overall Study|Withdrawal by Subject|2|||
42146657|NCT03823378|75955495|FG004|Overall Study|Withdrawal by Subject|0|||
42146658|NCT03823378|75955496|FG005|Overall Study|Withdrawal by Subject|1|||
42146659|NCT03823378|75955491|FG000|Overall Study|Other, not specified|19|||
42146660|NCT03823378|75955492|FG001|Overall Study|Other, not specified|12|||
42146661|NCT03823378|75955493|FG002|Overall Study|Other, not specified|6|||
42146662|NCT03823378|75955494|FG003|Overall Study|Other, not specified|8|||
42146663|NCT03823378|75955495|FG004|Overall Study|Other, not specified|17|||
42277616|NCT02712905|76109280|FG014|Monotherapy|Started New Cancer Drug|0|||
42277617|NCT02712905|76109281|FG015|Monotherapy|Started New Cancer Drug|0|||
42277618|NCT02712905|76109282|FG016|Monotherapy|Started New Cancer Drug|0|||
42277619|NCT02712905|76109283|FG017|Monotherapy|Started New Cancer Drug|0|||
42277620|NCT02712905|76109266|FG000|Monotherapy|Adverse Event|0|||
42277621|NCT02712905|76109267|FG001|Monotherapy|Adverse Event|0|||
42277622|NCT02712905|76109268|FG002|Monotherapy|Adverse Event|0|||
42277623|NCT02712905|76109269|FG003|Monotherapy|Adverse Event|0|||
42277624|NCT02712905|76109270|FG004|Monotherapy|Adverse Event|0|||
42277625|NCT02712905|76109271|FG005|Monotherapy|Adverse Event|0|||
42277626|NCT02712905|76109272|FG006|Monotherapy|Adverse Event|0|||
42277627|NCT02712905|76109273|FG007|Monotherapy|Adverse Event|0|||
42277628|NCT02712905|76109274|FG008|Monotherapy|Adverse Event|1|||
42277629|NCT02712905|76109275|FG009|Monotherapy|Adverse Event|0|||
42277630|NCT02712905|76109276|FG010|Monotherapy|Adverse Event|0|||
42277631|NCT02712905|76109277|FG011|Monotherapy|Adverse Event|0|||
42277632|NCT02712905|76109278|FG012|Monotherapy|Adverse Event|0|||
42277633|NCT02712905|76109279|FG013|Monotherapy|Adverse Event|0|||
42277634|NCT02712905|76109280|FG014|Monotherapy|Adverse Event|0|||
42277635|NCT02712905|76109281|FG015|Monotherapy|Adverse Event|0|||
42277636|NCT02712905|76109282|FG016|Monotherapy|Adverse Event|0|||
42277637|NCT02712905|76109283|FG017|Monotherapy|Adverse Event|0|||
42277638|NCT02712905|76109266|FG000|Combination Therapy|Death|0|||
42277639|NCT02712905|76109267|FG001|Combination Therapy|Death|0|||
42277640|NCT02712905|76109268|FG002|Combination Therapy|Death|0|||
42277641|NCT02712905|76109269|FG003|Combination Therapy|Death|0|||
42277642|NCT02712905|76109270|FG004|Combination Therapy|Death|0|||
42277643|NCT02712905|76109271|FG005|Combination Therapy|Death|0|||
42277644|NCT02712905|76109272|FG006|Combination Therapy|Death|0|||
42277645|NCT02712905|76109273|FG007|Combination Therapy|Death|0|||
42277646|NCT02712905|76109274|FG008|Combination Therapy|Death|0|||
42277647|NCT02712905|76109275|FG009|Combination Therapy|Death|0|||
42277648|NCT02712905|76109276|FG010|Combination Therapy|Death|0|||
42146664|NCT03823378|75955496|FG005|Overall Study|Other, not specified|7|||
42146665|NCT00142792|75955513|FG000|Overall Study|Death|0|||
42146666|NCT00142792|75955514|FG001|Overall Study|Death|0|||
42146667|NCT00142792|75955515|FG002|Overall Study|Death|1|||
42277649|NCT02712905|76109277|FG011|Combination Therapy|Death|0|||
42277650|NCT02712905|76109278|FG012|Combination Therapy|Death|5|||
42277651|NCT02712905|76109279|FG013|Combination Therapy|Death|6|||
42277652|NCT02712905|76109280|FG014|Combination Therapy|Death|1|||
42277653|NCT02712905|76109281|FG015|Combination Therapy|Death|3|||
42351184|NCT01515423|76191103|FG001|Open Label Phase|Lack of Efficacy|0|||
42146668|NCT00142792|75955513|FG000|Overall Study|Withdrawal by Subject|3|||
42146669|NCT00142792|75955514|FG001|Overall Study|Withdrawal by Subject|2|||
42146670|NCT00142792|75955515|FG002|Overall Study|Withdrawal by Subject|3|||
42146671|NCT00142792|75955513|FG000|Overall Study|Lost to Follow-up|8|||
42146672|NCT00142792|75955514|FG001|Overall Study|Lost to Follow-up|11|||
42146673|NCT00142792|75955515|FG002|Overall Study|Lost to Follow-up|7|||
42146674|NCT00142792|75955513|FG000|Overall Study|No category|1|||
42277654|NCT02712905|76109282|FG016|Combination Therapy|Death|1|||
42277655|NCT02712905|76109283|FG017|Combination Therapy|Death|3|||
42277656|NCT02712905|76109266|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
42277657|NCT02712905|76109267|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
42351185|NCT01515423|76191104|FG002|Open Label Phase|Lack of Efficacy|0|||
42146675|NCT00142792|75955514|FG001|Overall Study|No category|2|||
42146676|NCT00142792|75955515|FG002|Overall Study|No category|1|||
42146677|NCT00141778|75955526|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
42146678|NCT00141778|75955527|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
42146679|NCT00141778|75955528|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
42146680|NCT00141778|75955526|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
42146681|NCT00141778|75955527|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
42146682|NCT00141778|75955528|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
42146683|NCT00141778|75955526|FG000|Started Study Medication|Withdrawal by Subject|0|||
42146684|NCT00141778|75955527|FG001|Started Study Medication|Withdrawal by Subject|2|||
42146685|NCT00141778|75955528|FG002|Started Study Medication|Withdrawal by Subject|0|||
42146686|NCT00141778|75955526|FG000|Started Study Medication|Difficulty Swallowing|0|||
42146687|NCT00141778|75955527|FG001|Started Study Medication|Difficulty Swallowing|1|||
42146688|NCT00141778|75955528|FG002|Started Study Medication|Difficulty Swallowing|0|||
42146689|NCT00141778|75955526|FG000|Started Study Medication|Chest Discomfort|0|||
42146690|NCT00141778|75955527|FG001|Started Study Medication|Chest Discomfort|0|||
42146691|NCT00141778|75955528|FG002|Started Study Medication|Chest Discomfort|1|||
42146692|NCT00127660|75955540|FG000|Overall Study|Protocol Violation|3|||
42146693|NCT00127660|75955541|FG001|Overall Study|Protocol Violation|3|||
42146694|NCT00127660|75955542|FG002|Overall Study|Protocol Violation|5|||
42146695|NCT00127660|75955543|FG003|Overall Study|Protocol Violation|0|||
42146696|NCT03817528|75955553|FG000|Overall Study|Withdrawal by Subject|1|||
42146697|NCT03817528|75955553|FG000|Overall Study|Adverse Event|2|||
42146698|NCT00115336|75955559|FG000|Overall Study|Hospital discharge before study drug|0|||
42146699|NCT00115336|75955560|FG001|Overall Study|Hospital discharge before study drug|1|||
42146700|NCT00205803|75955570|FG000|Infant Series|Lost to Follow-up|10|||
42146701|NCT00205803|75955571|FG001|Infant Series|Lost to Follow-up|4|||
42146702|NCT00205803|75955570|FG000|Infant Series|Withdrawal by Subject|2|||
42146703|NCT00205803|75955571|FG001|Infant Series|Withdrawal by Subject|5|||
42146704|NCT00205803|75955570|FG000|Infant Series|Physician Decision|3|||
42146705|NCT00205803|75955571|FG001|Infant Series|Physician Decision|1|||
42146706|NCT00205803|75955570|FG000|Infant Series|Protocol Violation|1|||
42146707|NCT00205803|75955571|FG001|Infant Series|Protocol Violation|0|||
42146708|NCT00205803|75955570|FG000|Infant Series|Lost Kaiser coverage|0|||
42146709|NCT00205803|75955571|FG001|Infant Series|Lost Kaiser coverage|1|||
42146710|NCT00205803|75955570|FG000|Infant Series|Non-compliant|1|||
42146711|NCT00205803|75955571|FG001|Infant Series|Non-compliant|0|||
42146712|NCT00205803|75955570|FG000|Infant Series|Sponsor request|1|||
42146713|NCT00205803|75955571|FG001|Infant Series|Sponsor request|0|||
42146714|NCT00205803|75955570|FG000|After Infant Series|Adverse Event|1|||
42146715|NCT00205803|75955571|FG001|After Infant Series|Adverse Event|1|||
42146716|NCT00205803|75955570|FG000|After Infant Series|Protocol Violation|1|||
42146717|NCT00205803|75955571|FG001|After Infant Series|Protocol Violation|1|||
42146718|NCT00205803|75955570|FG000|After Infant Series|Lost to Follow-up|2|||
42146719|NCT00205803|75955571|FG001|After Infant Series|Lost to Follow-up|1|||
42146720|NCT00205803|75955570|FG000|After Infant Series|Physician Decision|3|||
42146721|NCT00205803|75955571|FG001|After Infant Series|Physician Decision|2|||
42146722|NCT00205803|75955570|FG000|After Infant Series|Withdrawal by Subject|1|||
42146723|NCT00205803|75955571|FG001|After Infant Series|Withdrawal by Subject|4|||
42146724|NCT00205803|75955570|FG000|After Infant Series|Other|10|||
42146725|NCT00205803|75955571|FG001|After Infant Series|Other|4|||
42146726|NCT00205803|75955570|FG000|Toddler Dose|Lost to Follow-up|2|||
42146727|NCT00205803|75955571|FG001|Toddler Dose|Lost to Follow-up|3|||
42146728|NCT00127192|75955600|FG000|Overall Study|Adverse Event|0|||
42146729|NCT00127192|75955601|FG001|Overall Study|Adverse Event|1|||
42146730|NCT00127192|75955602|FG002|Overall Study|Adverse Event|1|||
42146731|NCT00127192|75955603|FG003|Overall Study|Adverse Event|1|||
42012637|NCT01194219|75819479|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
42146732|NCT00127192|75955604|FG004|Overall Study|Adverse Event|0|||
42146733|NCT00127192|75955600|FG000|Overall Study|Lack of Efficacy|2|||
42146734|NCT00127192|75955601|FG001|Overall Study|Lack of Efficacy|0|||
42146735|NCT00127192|75955602|FG002|Overall Study|Lack of Efficacy|0|||
42146736|NCT00127192|75955603|FG003|Overall Study|Lack of Efficacy|0|||
42146737|NCT00127192|75955604|FG004|Overall Study|Lack of Efficacy|2|||
42146738|NCT00127192|75955600|FG000|Overall Study|Withdrawal by Subject|0|||
42146739|NCT00127192|75955601|FG001|Overall Study|Withdrawal by Subject|0|||
42146740|NCT00127192|75955602|FG002|Overall Study|Withdrawal by Subject|1|||
42146741|NCT00127192|75955603|FG003|Overall Study|Withdrawal by Subject|0|||
42012638|NCT01194219|75819480|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
42146742|NCT00127192|75955604|FG004|Overall Study|Withdrawal by Subject|3|||
42012639|NCT01194219|75819481|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
42146743|NCT00127192|75955600|FG000|Overall Study|Adverse event in pre-treatment period|1|||
42146744|NCT00127192|75955601|FG001|Overall Study|Adverse event in pre-treatment period|0|||
42146745|NCT00127192|75955602|FG002|Overall Study|Adverse event in pre-treatment period|0|||
42012640|NCT01194219|75819482|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
42146746|NCT00127192|75955603|FG003|Overall Study|Adverse event in pre-treatment period|0|||
42146747|NCT00127192|75955604|FG004|Overall Study|Adverse event in pre-treatment period|0|||
42146748|NCT00205179|75955618|FG000|Overall Study|Death|0|||
42146749|NCT00205179|75955619|FG001|Overall Study|Death|2|||
42146750|NCT00205179|75955618|FG000|Overall Study|Physician Decision|1|||
42146751|NCT00205179|75955619|FG001|Overall Study|Physician Decision|1|||
42146752|NCT00205179|75955618|FG000|Overall Study|Adverse Event|1|||
42146753|NCT00205179|75955619|FG001|Overall Study|Adverse Event|1|||
42146754|NCT00127036|75955628|FG000|Overall Study|Insufficient Data for Analysis|6|||
42146755|NCT00127036|75955629|FG001|Overall Study|Insufficient Data for Analysis|11|||
42146756|NCT00127036|75955628|FG000|Overall Study|Screen Failure|2|||
42146757|NCT00127036|75955629|FG001|Overall Study|Screen Failure|0|||
42146758|NCT00259857|75955637|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
42146759|NCT00259857|75955638|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
42146760|NCT00259857|75955637|FG000|24 Months Treatment|Lost to Follow-up|0|||
42146761|NCT00259857|75955638|FG001|24 Months Treatment|Lost to Follow-up|3|||
42146762|NCT00203307|75955646|FG000|First Intervention|Adverse Event|2|||
42146763|NCT00203307|75955647|FG001|First Intervention|Adverse Event|0|||
42146764|NCT00126568|75955653|FG000|Overall Study|Death|2|||
42146765|NCT00114634|75955658|FG000|Overall Study|failure to return forms|3|||
42146766|NCT00202839|75955666|FG000|Overall Study|Adverse Event|1|||
42146767|NCT00202839|75955667|FG001|Overall Study|Adverse Event|5|||
42146768|NCT00202839|75955666|FG000|Overall Study|Physician Decision|12|||
42146769|NCT00202839|75955667|FG001|Overall Study|Physician Decision|0|||
42146770|NCT00202839|75955666|FG000|Overall Study|Withdrawal by Subject|6|||
42146771|NCT00202839|75955667|FG001|Overall Study|Withdrawal by Subject|2|||
42146772|NCT00202839|75955666|FG000|Overall Study|Protocol Violation|2|||
42146773|NCT00202839|75955667|FG001|Overall Study|Protocol Violation|1|||
42146774|NCT00202839|75955666|FG000|Overall Study|Lost to Follow-up|3|||
42146775|NCT00202839|75955667|FG001|Overall Study|Lost to Follow-up|2|||
42146776|NCT00201201|75955675|FG000|Overall Study|Death|0|||
42146777|NCT00201201|75955676|FG001|Overall Study|Death|2|||
42146778|NCT00201201|75955675|FG000|Overall Study|Withdrawal by Subject|5|||
42146779|NCT00201201|75955676|FG001|Overall Study|Withdrawal by Subject|5|||
42146780|NCT00126490|75955682|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
42146781|NCT00346632|75955688|FG000|Overall Study|Progressive Disease|2|||
42146782|NCT00346632|75955689|FG001|Overall Study|Progressive Disease|2|||
42146783|NCT00346632|75955690|FG002|Overall Study|Progressive Disease|4|||
42146784|NCT00346632|75955691|FG003|Overall Study|Progressive Disease|3|||
42146785|NCT00346632|75955692|FG004|Overall Study|Progressive Disease|3|||
42146786|NCT00346632|75955693|FG005|Overall Study|Progressive Disease|1|||
42146787|NCT00346632|75955694|FG006|Overall Study|Progressive Disease|2|||
42146788|NCT00346632|75955695|FG007|Overall Study|Progressive Disease|2|||
42146789|NCT00346632|75955696|FG008|Overall Study|Progressive Disease|2|||
42146790|NCT00346632|75955697|FG009|Overall Study|Progressive Disease|2|||
42146791|NCT00346632|75955688|FG000|Overall Study|Adverse Event|0|||
42146792|NCT00346632|75955689|FG001|Overall Study|Adverse Event|0|||
42146793|NCT00346632|75955690|FG002|Overall Study|Adverse Event|0|||
42146794|NCT00346632|75955691|FG003|Overall Study|Adverse Event|0|||
42146795|NCT00346632|75955692|FG004|Overall Study|Adverse Event|1|||
42146796|NCT00346632|75955693|FG005|Overall Study|Adverse Event|1|||
42146797|NCT00346632|75955694|FG006|Overall Study|Adverse Event|1|||
42146798|NCT00346632|75955695|FG007|Overall Study|Adverse Event|0|||
42146799|NCT00346632|75955696|FG008|Overall Study|Adverse Event|0|||
42146800|NCT00346632|75955697|FG009|Overall Study|Adverse Event|0|||
42146801|NCT00346632|75955688|FG000|Overall Study|Death|0|||
42146802|NCT00346632|75955689|FG001|Overall Study|Death|0|||
42146803|NCT00346632|75955690|FG002|Overall Study|Death|1|||
42146804|NCT00346632|75955691|FG003|Overall Study|Death|0|||
42146805|NCT00346632|75955692|FG004|Overall Study|Death|0|||
42146806|NCT00346632|75955693|FG005|Overall Study|Death|0|||
42146807|NCT00346632|75955694|FG006|Overall Study|Death|0|||
42277658|NCT02712905|76109268|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
42277659|NCT02712905|76109269|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
42277660|NCT02712905|76109270|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
42277661|NCT02712905|76109271|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
42277662|NCT02712905|76109272|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
42277663|NCT02712905|76109273|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
42277664|NCT02712905|76109274|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
42146808|NCT00346632|75955695|FG007|Overall Study|Death|0|||
42146809|NCT00346632|75955696|FG008|Overall Study|Death|0|||
42146810|NCT00346632|75955697|FG009|Overall Study|Death|0|||
42146811|NCT00346632|75955688|FG000|Overall Study|Protocol Violation|0|||
42146812|NCT00346632|75955689|FG001|Overall Study|Protocol Violation|0|||
42146813|NCT00346632|75955690|FG002|Overall Study|Protocol Violation|0|||
42146814|NCT00346632|75955691|FG003|Overall Study|Protocol Violation|0|||
42146815|NCT00346632|75955692|FG004|Overall Study|Protocol Violation|0|||
42146816|NCT00346632|75955693|FG005|Overall Study|Protocol Violation|0|||
42277665|NCT02712905|76109275|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
42146817|NCT00346632|75955694|FG006|Overall Study|Protocol Violation|1|||
42146818|NCT00346632|75955695|FG007|Overall Study|Protocol Violation|0|||
42146819|NCT00346632|75955696|FG008|Overall Study|Protocol Violation|0|||
42146820|NCT00346632|75955697|FG009|Overall Study|Protocol Violation|0|||
42146821|NCT00346632|75955688|FG000|Overall Study|Withdrawal by Subject|0|||
42146822|NCT00346632|75955689|FG001|Overall Study|Withdrawal by Subject|0|||
42146823|NCT00346632|75955690|FG002|Overall Study|Withdrawal by Subject|0|||
42146824|NCT00346632|75955691|FG003|Overall Study|Withdrawal by Subject|0|||
42146825|NCT00346632|75955692|FG004|Overall Study|Withdrawal by Subject|0|||
42146826|NCT00346632|75955693|FG005|Overall Study|Withdrawal by Subject|0|||
42146827|NCT00346632|75955694|FG006|Overall Study|Withdrawal by Subject|1|||
42146828|NCT00346632|75955695|FG007|Overall Study|Withdrawal by Subject|0|||
42146829|NCT00346632|75955696|FG008|Overall Study|Withdrawal by Subject|0|||
42146830|NCT00346632|75955697|FG009|Overall Study|Withdrawal by Subject|0|||
42039555|NCT00881530|75847816|FG005|Overall Study|Refused to continue medication|0|||
42039556|NCT00881530|75847811|FG000|Overall Study|Other reason not defined above|1|||
42146831|NCT00346632|75955688|FG000|Overall Study|Switched to alternative treatment|0|||
42146832|NCT00346632|75955689|FG001|Overall Study|Switched to alternative treatment|0|||
42146833|NCT00346632|75955690|FG002|Overall Study|Switched to alternative treatment|1|||
42146834|NCT00346632|75955691|FG003|Overall Study|Switched to alternative treatment|0|||
42146835|NCT00346632|75955692|FG004|Overall Study|Switched to alternative treatment|0|||
42146836|NCT00346632|75955693|FG005|Overall Study|Switched to alternative treatment|0|||
42146837|NCT00346632|75955694|FG006|Overall Study|Switched to alternative treatment|0|||
42146838|NCT00346632|75955695|FG007|Overall Study|Switched to alternative treatment|0|||
42146839|NCT00346632|75955696|FG008|Overall Study|Switched to alternative treatment|0|||
42146840|NCT00346632|75955697|FG009|Overall Study|Switched to alternative treatment|0|||
42146841|NCT00346632|75955688|FG000|Overall Study|Not Stated|1|||
42146842|NCT00346632|75955689|FG001|Overall Study|Not Stated|1|||
42146843|NCT00346632|75955690|FG002|Overall Study|Not Stated|0|||
42146844|NCT00346632|75955691|FG003|Overall Study|Not Stated|0|||
42146845|NCT00346632|75955692|FG004|Overall Study|Not Stated|0|||
42146846|NCT00346632|75955693|FG005|Overall Study|Not Stated|0|||
42146847|NCT00346632|75955694|FG006|Overall Study|Not Stated|0|||
42146848|NCT00346632|75955695|FG007|Overall Study|Not Stated|2|||
42146849|NCT00346632|75955696|FG008|Overall Study|Not Stated|2|||
42146850|NCT00346632|75955697|FG009|Overall Study|Not Stated|1|||
42146851|NCT00200967|75955761|FG000|First Treatment Period|Withdrawal by Subject|5|||
42146852|NCT00200967|75955762|FG001|First Treatment Period|Withdrawal by Subject|1|||
42146853|NCT00200967|75955761|FG000|First Treatment Period|Pregnancy|1|||
42146854|NCT00200967|75955762|FG001|First Treatment Period|Pregnancy|0|||
42146855|NCT00200967|75955761|FG000|Wash-out Period|Lost to Follow-up|0|||
42146856|NCT00200967|75955762|FG001|Wash-out Period|Lost to Follow-up|1|||
42146857|NCT00200967|75955761|FG000|Second Treatment Period|Withdrawal by Subject|1|||
42146858|NCT00200967|75955762|FG001|Second Treatment Period|Withdrawal by Subject|2|||
42146859|NCT00200967|75955761|FG000|Run-out Period|Lost to Follow-up|1|||
42146860|NCT00200967|75955762|FG001|Run-out Period|Lost to Follow-up|0|||
42146861|NCT00354432|75955772|FG000|Overall Study|Adverse Event|3|||
42277666|NCT02712905|76109276|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
42277667|NCT02712905|76109277|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
42039557|NCT00881530|75847812|FG001|Overall Study|Other reason not defined above|1|||
42039558|NCT00881530|75847813|FG002|Overall Study|Other reason not defined above|2|||
42039559|NCT00881530|75847814|FG003|Overall Study|Other reason not defined above|0|||
42039560|NCT00881530|75847815|FG004|Overall Study|Other reason not defined above|0|||
42039561|NCT00881530|75847816|FG005|Overall Study|Other reason not defined above|2|||
42039562|NCT01075685|75847832|FG000|Overall Study|Protocol Violation|9|||
42039563|NCT01075685|75847833|FG001|Overall Study|Protocol Violation|1|||
42039564|NCT01075685|75847832|FG000|Overall Study|Withdrawal by Subject|20|||
42039565|NCT01075685|75847833|FG001|Overall Study|Withdrawal by Subject|5|||
42039566|NCT01075685|75847832|FG000|Overall Study|Lost to Follow-up|563|||
42039567|NCT01075685|75847833|FG001|Overall Study|Lost to Follow-up|220|||
42039568|NCT01075217|75847841|FG000|Overall Study|Adverse Event|1|||
42039569|NCT01075217|75847842|FG001|Overall Study|Adverse Event|1|||
42039570|NCT01075217|75847841|FG000|Overall Study|Physician Decision|1|||
42039571|NCT01075217|75847842|FG001|Overall Study|Physician Decision|0|||
42039572|NCT01078571|75847856|FG000|Overall Study|Adverse Event|36|||
42146862|NCT00354432|75955773|FG001|Overall Study|Adverse Event|1|||
42146863|NCT00354432|75955774|FG002|Overall Study|Adverse Event|5|||
42146864|NCT00354432|75955775|FG003|Overall Study|Adverse Event|5|||
42146865|NCT00354432|75955772|FG000|Overall Study|Off/Toxicity|3|||
42146866|NCT00354432|75955773|FG001|Overall Study|Off/Toxicity|7|||
42146867|NCT00354432|75955774|FG002|Overall Study|Off/Toxicity|5|||
42146868|NCT00354432|75955775|FG003|Overall Study|Off/Toxicity|5|||
42146869|NCT00140140|75955788|FG000|Overall Study|Unacceptable toxicity|1|||
42146870|NCT00140140|75955789|FG001|Overall Study|Unacceptable toxicity|1|||
42146871|NCT00140140|75955790|FG002|Overall Study|Unacceptable toxicity|2|||
42039573|NCT01078571|75847856|FG000|Overall Study|Lack of effectiveness|36|||
42039574|NCT01078571|75847856|FG000|Overall Study|Reason not reported|21|||
42146872|NCT00140140|75955788|FG000|Overall Study|Physician Decision|1|||
42146873|NCT00140140|75955789|FG001|Overall Study|Physician Decision|1|||
42146874|NCT00140140|75955790|FG002|Overall Study|Physician Decision|0|||
42146875|NCT00346398|75955799|FG000|Overall Study|Lost to Follow-up|3|||
42146876|NCT00346398|75955800|FG001|Overall Study|Lost to Follow-up|0|||
42146877|NCT00346398|75955799|FG000|Overall Study|Withdrawal by Subject|0|||
42146878|NCT00346398|75955800|FG001|Overall Study|Withdrawal by Subject|2|||
42146879|NCT00346164|75955810|FG000|Overall Study|Adverse Event|0|||
42146880|NCT00346164|75955811|FG001|Overall Study|Adverse Event|0|||
42146881|NCT00346164|75955812|FG002|Overall Study|Adverse Event|0|||
42146882|NCT00346164|75955813|FG003|Overall Study|Adverse Event|1|||
42146883|NCT00346164|75955810|FG000|Overall Study|Lack of Efficacy|0|||
42146884|NCT00346164|75955811|FG001|Overall Study|Lack of Efficacy|1|||
42146885|NCT00346164|75955812|FG002|Overall Study|Lack of Efficacy|7|||
42146886|NCT00346164|75955813|FG003|Overall Study|Lack of Efficacy|25|||
42146887|NCT00346164|75955810|FG000|Overall Study|Physician Decision|0|||
42146888|NCT00346164|75955811|FG001|Overall Study|Physician Decision|1|||
42146889|NCT00346164|75955812|FG002|Overall Study|Physician Decision|2|||
42146890|NCT00346164|75955813|FG003|Overall Study|Physician Decision|27|||
42146891|NCT00346164|75955810|FG000|Overall Study|Protocol Violation|6|||
42146892|NCT00346164|75955811|FG001|Overall Study|Protocol Violation|2|||
42146893|NCT00346164|75955812|FG002|Overall Study|Protocol Violation|10|||
42146894|NCT00346164|75955813|FG003|Overall Study|Protocol Violation|4|||
42146895|NCT00346164|75955810|FG000|Overall Study|Withdrawal by Subject|0|||
42146896|NCT00346164|75955811|FG001|Overall Study|Withdrawal by Subject|0|||
42146897|NCT00346164|75955812|FG002|Overall Study|Withdrawal by Subject|2|||
42146898|NCT00346164|75955813|FG003|Overall Study|Withdrawal by Subject|0|||
42146899|NCT00346164|75955810|FG000|Overall Study|Ineligible|11|||
42146900|NCT00346164|75955811|FG001|Overall Study|Ineligible|2|||
42146901|NCT00346164|75955812|FG002|Overall Study|Ineligible|2|||
42146902|NCT00346164|75955813|FG003|Overall Study|Ineligible|23|||
42146903|NCT00346164|75955810|FG000|Overall Study|Refusal of further protocol therapy|0|||
42146904|NCT00346164|75955811|FG001|Overall Study|Refusal of further protocol therapy|1|||
42146905|NCT00346164|75955812|FG002|Overall Study|Refusal of further protocol therapy|3|||
42146906|NCT00346164|75955813|FG003|Overall Study|Refusal of further protocol therapy|15|||
42146907|NCT00346164|75955810|FG000|Overall Study|Inability to start week 16 tx on time|0|||
42146908|NCT00346164|75955811|FG001|Overall Study|Inability to start week 16 tx on time|0|||
42146909|NCT00346164|75955812|FG002|Overall Study|Inability to start week 16 tx on time|0|||
42146910|NCT00346164|75955813|FG003|Overall Study|Inability to start week 16 tx on time|11|||
42146911|NCT00114244|75955841|FG000|Overall Study|Adverse Event|2|||
42146912|NCT00114244|75955842|FG001|Overall Study|Adverse Event|5|||
42146913|NCT00114244|75955841|FG000|Overall Study|Withdrawal by Subject|0|||
42146914|NCT00114244|75955842|FG001|Overall Study|Withdrawal by Subject|2|||
42146915|NCT00138658|75955848|FG000|Overall Study|Adverse Event|23|||
42146916|NCT00138658|75955848|FG000|Overall Study|Death|1|||
42146917|NCT00138658|75955848|FG000|Overall Study|Disease Progression|21|||
42146918|NCT00138658|75955848|FG000|Overall Study|Physician Decision|11|||
42277668|NCT02712905|76109278|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
42277669|NCT02712905|76109279|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
42277670|NCT02712905|76109280|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
42277671|NCT02712905|76109281|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
42277672|NCT02712905|76109282|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
42277673|NCT02712905|76109283|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
42277674|NCT02712905|76109266|FG000|Combination Therapy|Withdrawal by Subject|0|||
42277675|NCT02712905|76109267|FG001|Combination Therapy|Withdrawal by Subject|0|||
42277676|NCT02712905|76109268|FG002|Combination Therapy|Withdrawal by Subject|0|||
42012641|NCT01194219|75819483|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
42277677|NCT02712905|76109269|FG003|Combination Therapy|Withdrawal by Subject|0|||
42351186|NCT01515423|76191102|FG000|Open Label Phase|Lost to Follow-up|21|||
42351187|NCT01515423|76191103|FG001|Open Label Phase|Lost to Follow-up|0|||
42146919|NCT00138658|75955848|FG000|Overall Study|Withdrawal by Subject|5|||
42146920|NCT00337662|75955857|FG000|Study Period II|Lost to Follow-up|0|||
42146921|NCT00337662|75955858|FG001|Study Period II|Lost to Follow-up|0|||
42146922|NCT00337662|75955859|FG002|Study Period II|Lost to Follow-up|0|||
42146923|NCT00337662|75955860|FG003|Study Period II|Lost to Follow-up|35|||
42146924|NCT00337662|75955857|FG000|Study Period II|Withdrawal by Subject|0|||
42146925|NCT00337662|75955858|FG001|Study Period II|Withdrawal by Subject|0|||
42012642|NCT01194219|75819484|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
42146926|NCT00337662|75955859|FG002|Study Period II|Withdrawal by Subject|0|||
42146927|NCT00337662|75955860|FG003|Study Period II|Withdrawal by Subject|20|||
42146928|NCT00337662|75955857|FG000|Study Period II|Adverse Event|0|||
42146929|NCT00337662|75955858|FG001|Study Period II|Adverse Event|0|||
42146930|NCT00337662|75955859|FG002|Study Period II|Adverse Event|0|||
42146931|NCT00337662|75955860|FG003|Study Period II|Adverse Event|16|||
42146932|NCT00337662|75955857|FG000|Study Period II|Physician Decision|0|||
42146933|NCT00337662|75955858|FG001|Study Period II|Physician Decision|0|||
42146934|NCT00337662|75955859|FG002|Study Period II|Physician Decision|0|||
42146935|NCT00337662|75955860|FG003|Study Period II|Physician Decision|13|||
42146936|NCT00337662|75955857|FG000|Study Period II|Entry Criteria Not Met|0|||
42146937|NCT00337662|75955858|FG001|Study Period II|Entry Criteria Not Met|0|||
42146938|NCT00337662|75955859|FG002|Study Period II|Entry Criteria Not Met|0|||
42146939|NCT00337662|75955860|FG003|Study Period II|Entry Criteria Not Met|6|||
42146940|NCT00337662|75955857|FG000|Study Period II|Protocol Violation|0|||
42146941|NCT00337662|75955858|FG001|Study Period II|Protocol Violation|0|||
42146942|NCT00337662|75955859|FG002|Study Period II|Protocol Violation|0|||
42146943|NCT00337662|75955860|FG003|Study Period II|Protocol Violation|6|||
42146944|NCT00337662|75955857|FG000|Study Period II|Lack of Efficacy|0|||
42146945|NCT00337662|75955858|FG001|Study Period II|Lack of Efficacy|0|||
42146946|NCT00337662|75955859|FG002|Study Period II|Lack of Efficacy|0|||
42146947|NCT00337662|75955860|FG003|Study Period II|Lack of Efficacy|7|||
42146948|NCT00337662|75955857|FG000|Study Period II|Sponsor Decision|0|||
42146949|NCT00337662|75955858|FG001|Study Period II|Sponsor Decision|0|||
42146950|NCT00337662|75955859|FG002|Study Period II|Sponsor Decision|0|||
42146951|NCT00337662|75955860|FG003|Study Period II|Sponsor Decision|2|||
42146952|NCT00337662|75955857|FG000|Study Period II|Parent/Caregiver Decision|0|||
42146953|NCT00337662|75955858|FG001|Study Period II|Parent/Caregiver Decision|0|||
42146954|NCT00337662|75955859|FG002|Study Period II|Parent/Caregiver Decision|0|||
42146955|NCT00337662|75955860|FG003|Study Period II|Parent/Caregiver Decision|1|||
42146956|NCT00337662|75955857|FG000|Study Period III|Lost to Follow-up|14|||
42146957|NCT00337662|75955858|FG001|Study Period III|Lost to Follow-up|16|||
42146958|NCT00337662|75955859|FG002|Study Period III|Lost to Follow-up|14|||
42146959|NCT00337662|75955860|FG003|Study Period III|Lost to Follow-up|0|||
42146960|NCT00337662|75955857|FG000|Study Period III|Withdrawal by Subject|18|||
42146961|NCT00337662|75955858|FG001|Study Period III|Withdrawal by Subject|14|||
42146962|NCT00337662|75955859|FG002|Study Period III|Withdrawal by Subject|12|||
42146963|NCT00337662|75955860|FG003|Study Period III|Withdrawal by Subject|0|||
42146964|NCT00337662|75955857|FG000|Study Period III|Adverse Event|9|||
42146965|NCT00337662|75955858|FG001|Study Period III|Adverse Event|10|||
42146966|NCT00337662|75955859|FG002|Study Period III|Adverse Event|8|||
42146967|NCT00337662|75955860|FG003|Study Period III|Adverse Event|0|||
42146968|NCT00337662|75955857|FG000|Study Period III|Protocol Violation|3|||
42146969|NCT00337662|75955858|FG001|Study Period III|Protocol Violation|8|||
42146970|NCT00337662|75955859|FG002|Study Period III|Protocol Violation|2|||
42146971|NCT00337662|75955860|FG003|Study Period III|Protocol Violation|0|||
42146972|NCT00337662|75955857|FG000|Study Period III|Physician Decision|6|||
42146973|NCT00337662|75955858|FG001|Study Period III|Physician Decision|5|||
42146974|NCT00337662|75955859|FG002|Study Period III|Physician Decision|0|||
42146975|NCT00337662|75955860|FG003|Study Period III|Physician Decision|0|||
42146976|NCT00337662|75955857|FG000|Study Period III|Entry Criteria Not Met|4|||
42146977|NCT00337662|75955858|FG001|Study Period III|Entry Criteria Not Met|1|||
42146978|NCT00337662|75955859|FG002|Study Period III|Entry Criteria Not Met|3|||
42146979|NCT00337662|75955860|FG003|Study Period III|Entry Criteria Not Met|0|||
42146980|NCT00337662|75955857|FG000|Study Period III|Lack of Efficacy|4|||
42146981|NCT00337662|75955858|FG001|Study Period III|Lack of Efficacy|4|||
42146982|NCT00337662|75955859|FG002|Study Period III|Lack of Efficacy|2|||
42146983|NCT00337662|75955860|FG003|Study Period III|Lack of Efficacy|0|||
42146984|NCT00337662|75955857|FG000|Study Period III|Parent/Caregiver Decision|0|||
42146985|NCT00337662|75955858|FG001|Study Period III|Parent/Caregiver Decision|0|||
42146986|NCT00337662|75955859|FG002|Study Period III|Parent/Caregiver Decision|2|||
42146987|NCT00337662|75955860|FG003|Study Period III|Parent/Caregiver Decision|0|||
42146988|NCT00337662|75955857|FG000|Study Period III|Sponsor Decision|1|||
42146989|NCT00337662|75955858|FG001|Study Period III|Sponsor Decision|0|||
42146990|NCT00337662|75955859|FG002|Study Period III|Sponsor Decision|1|||
42146991|NCT00337662|75955860|FG003|Study Period III|Sponsor Decision|0|||
42146992|NCT00337662|75955857|FG000|Study Period III|Clinical Relapse|1|||
42146993|NCT00337662|75955858|FG001|Study Period III|Clinical Relapse|0|||
42146994|NCT00337662|75955859|FG002|Study Period III|Clinical Relapse|0|||
42146995|NCT00337662|75955860|FG003|Study Period III|Clinical Relapse|0|||
42146996|NCT00138424|75955875|FG000|Overall Study|Physician Decision|0|||
42146997|NCT00138424|75955876|FG001|Overall Study|Physician Decision|1|||
42146998|NCT00138424|75955877|FG002|Overall Study|Physician Decision|0|||
42146999|NCT00138424|75955878|FG003|Overall Study|Physician Decision|0|||
42147000|NCT00368966|75955892|FG000|Infant Series|Withdrawal by Subject|11|||
42147001|NCT00368966|75955893|FG001|Infant Series|Withdrawal by Subject|6|||
42147002|NCT00368966|75955892|FG000|Infant Series|Protocol Violation|2|||
42147003|NCT00368966|75955893|FG001|Infant Series|Protocol Violation|1|||
42147004|NCT00368966|75955892|FG000|Infant Series|Lost to Follow-up|2|||
42147005|NCT00368966|75955893|FG001|Infant Series|Lost to Follow-up|0|||
42147006|NCT00368966|75955892|FG000|Infant Series|Randomization error|0|||
42147007|NCT00368966|75955893|FG001|Infant Series|Randomization error|1|||
42147008|NCT00368966|75955892|FG000|Infant Series|Failed to meet eligibility criteria|0|||
42147009|NCT00368966|75955893|FG001|Infant Series|Failed to meet eligibility criteria|1|||
42147010|NCT00368966|75955892|FG000|Infant Series|Adverse Event|0|||
42147011|NCT00368966|75955893|FG001|Infant Series|Adverse Event|1|||
42147012|NCT00368966|75955892|FG000|Infant Series|Failed to return|1|||
42147013|NCT00368966|75955893|FG001|Infant Series|Failed to return|0|||
42147014|NCT00368966|75955892|FG000|After Infant|Failed to return|3|||
42147015|NCT00368966|75955893|FG001|After Infant|Failed to return|1|||
42147016|NCT00368966|75955892|FG000|After Infant|Adverse Event|1|||
42147017|NCT00368966|75955893|FG001|After Infant|Adverse Event|2|||
42147018|NCT00368966|75955892|FG000|After Infant|Withdrawal by Subject|1|||
42147019|NCT00368966|75955893|FG001|After Infant|Withdrawal by Subject|1|||
42147020|NCT00368966|75955892|FG000|After Infant|Death|1|||
42147021|NCT00368966|75955893|FG001|After Infant|Death|0|||
42147022|NCT00368966|75955892|FG000|After Infant|Lost to Follow-up|0|||
42147023|NCT00368966|75955893|FG001|After Infant|Lost to Follow-up|1|||
42147024|NCT00368966|75955892|FG000|Toddler Dose|Withdrawal by Subject|1|||
42147025|NCT00368966|75955893|FG001|Toddler Dose|Withdrawal by Subject|1|||
42147026|NCT00368966|75955892|FG000|Toddler Dose|Lost to Follow-up|0|||
42147027|NCT00368966|75955893|FG001|Toddler Dose|Lost to Follow-up|2|||
42147028|NCT00114166|75955926|FG000|Overall Study|Wrong primary|0|||
42147029|NCT00114166|75955927|FG001|Overall Study|Wrong primary|1|||
42147030|NCT00125242|75955937|FG000|Overall Study|did not qualify|7|||
42147031|NCT00125242|75955938|FG001|Overall Study|did not qualify|2|||
42147032|NCT00337428|75955945|FG000|Overall Study|Withdrawal by Subject|1|||
42147033|NCT00337428|75955946|FG001|Overall Study|Withdrawal by Subject|2|||
42147034|NCT00337428|75955945|FG000|Overall Study|Lack of Time|1|||
42147035|NCT00337428|75955946|FG001|Overall Study|Lack of Time|1|||
42147036|NCT00337428|75955945|FG000|Overall Study|Unwilling to Continue|1|||
42147037|NCT00337428|75955946|FG001|Overall Study|Unwilling to Continue|0|||
42147038|NCT00337428|75955945|FG000|Overall Study|Anorexia|1|||
42147039|NCT00337428|75955946|FG001|Overall Study|Anorexia|0|||
42147040|NCT00235989|75955956|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
42147041|NCT00235989|75955957|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
42147042|NCT00235989|75955958|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
42277678|NCT02712905|76109270|FG004|Combination Therapy|Withdrawal by Subject|0|||
42277679|NCT02712905|76109271|FG005|Combination Therapy|Withdrawal by Subject|0|||
42277680|NCT02712905|76109272|FG006|Combination Therapy|Withdrawal by Subject|0|||
42277681|NCT02712905|76109273|FG007|Combination Therapy|Withdrawal by Subject|0|||
42277682|NCT02712905|76109274|FG008|Combination Therapy|Withdrawal by Subject|0|||
42277683|NCT02712905|76109275|FG009|Combination Therapy|Withdrawal by Subject|0|||
42277684|NCT02712905|76109276|FG010|Combination Therapy|Withdrawal by Subject|0|||
42277685|NCT02712905|76109277|FG011|Combination Therapy|Withdrawal by Subject|0|||
42277686|NCT02712905|76109278|FG012|Combination Therapy|Withdrawal by Subject|0|||
42277687|NCT02712905|76109279|FG013|Combination Therapy|Withdrawal by Subject|0|||
42277688|NCT02712905|76109280|FG014|Combination Therapy|Withdrawal by Subject|0|||
42277689|NCT02712905|76109281|FG015|Combination Therapy|Withdrawal by Subject|1|||
42277690|NCT02712905|76109282|FG016|Combination Therapy|Withdrawal by Subject|0|||
42277691|NCT02712905|76109283|FG017|Combination Therapy|Withdrawal by Subject|2|||
42277692|NCT02712905|76109266|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277693|NCT02712905|76109267|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277694|NCT02712905|76109268|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277695|NCT02712905|76109269|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42147043|NCT00235989|75955959|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
42277696|NCT02712905|76109270|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42147044|NCT00235989|75955960|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
42147045|NCT00235989|75955961|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
42147046|NCT00235989|75955956|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
42147047|NCT00235989|75955957|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
42147048|NCT00235989|75955958|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
42147049|NCT00235989|75955959|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
42147050|NCT00235989|75955960|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
42147051|NCT00235989|75955961|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
42147052|NCT00235989|75955956|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
42147053|NCT00235989|75955957|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
42147054|NCT00235989|75955958|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
42147055|NCT00235989|75955959|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
42147056|NCT00235989|75955960|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
42147057|NCT00235989|75955961|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
42147058|NCT00235989|75955956|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
42147059|NCT00235989|75955957|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
42147060|NCT00235989|75955958|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
42147061|NCT00235989|75955959|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
42147062|NCT00235989|75955960|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
42147063|NCT00235989|75955961|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
42147064|NCT00235989|75955956|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
42147065|NCT00235989|75955957|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
42147066|NCT00235989|75955958|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
42147067|NCT00235989|75955959|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
42147068|NCT00235989|75955960|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
42147069|NCT00235989|75955961|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
42147070|NCT00113386|75955973|FG000|Overall Study|Withdrawal by Subject|1|||
42147071|NCT00113386|75955974|FG001|Overall Study|Withdrawal by Subject|0|||
42147072|NCT00113386|75955973|FG000|Overall Study|Physician Decision|0|||
42147073|NCT00113386|75955974|FG001|Overall Study|Physician Decision|1|||
42147074|NCT00113386|75955973|FG000|Overall Study|Toxicity|3|||
42147075|NCT00113386|75955974|FG001|Overall Study|Toxicity|0|||
42147076|NCT00113386|75955973|FG000|Overall Study|Ineligible|1|||
42147077|NCT00113386|75955974|FG001|Overall Study|Ineligible|2|||
42147078|NCT00113386|75955973|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
42147079|NCT00113386|75955974|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
42147080|NCT00353262|75955980|FG000|Overall Study|Adverse Event|8|||
42147081|NCT00353262|75955980|FG000|Overall Study|Withdrawal by Subject|2|||
42147082|NCT00353262|75955980|FG000|Overall Study|Insufficient Therapeutic Response|13|||
42147083|NCT00353262|75955980|FG000|Overall Study|Progression|1|||
42147084|NCT00353262|75955980|FG000|Overall Study|Surgery|4|||
42147085|NCT00353262|75955980|FG000|Overall Study|Break from Chemotherapy|1|||
42147086|NCT00337272|75955986|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
42147087|NCT00337272|75955987|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
42147088|NCT00337272|75955986|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
42147089|NCT00337272|75955987|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
42147090|NCT00337272|75955986|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
42147091|NCT00337272|75955987|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
42147092|NCT00337272|75955986|FG000|Treatment Period|Non-compliance|1|||
42147093|NCT00337272|75955987|FG001|Treatment Period|Non-compliance|1|||
42147094|NCT00337272|75955986|FG000|Treatment Period|Withdrawal by Subject|0|||
42147095|NCT00337272|75955987|FG001|Treatment Period|Withdrawal by Subject|1|||
42147096|NCT00337272|75955986|FG000|Withdrawal Period|Non-compliance|0|||
42147097|NCT00337272|75955987|FG001|Withdrawal Period|Non-compliance|1|||
42147098|NCT00125164|75955997|FG000|Overall Study|Adverse Event|0|||
42147099|NCT00125164|75955998|FG001|Overall Study|Adverse Event|0|||
42147100|NCT00125164|75955999|FG002|Overall Study|Adverse Event|2|||
42147101|NCT00125164|75956000|FG003|Overall Study|Adverse Event|4|||
42147102|NCT00125164|75955997|FG000|Overall Study|Lost to Follow-up|0|||
42147103|NCT00125164|75955998|FG001|Overall Study|Lost to Follow-up|0|||
42147104|NCT00125164|75955999|FG002|Overall Study|Lost to Follow-up|1|||
42147105|NCT00125164|75956000|FG003|Overall Study|Lost to Follow-up|1|||
42147106|NCT00125164|75955997|FG000|Overall Study|Withdrawal by Subject|2|||
42147107|NCT00125164|75955998|FG001|Overall Study|Withdrawal by Subject|0|||
42147108|NCT00125164|75955999|FG002|Overall Study|Withdrawal by Subject|1|||
42147109|NCT00125164|75956000|FG003|Overall Study|Withdrawal by Subject|1|||
42147110|NCT00136318|75956012|FG000|Overall Study|Adverse Event|5|||
42147111|NCT00136318|75956013|FG001|Overall Study|Adverse Event|5|||
42147112|NCT00136318|75956012|FG000|Overall Study|Withdrawal by Subject|2|||
42147113|NCT00136318|75956013|FG001|Overall Study|Withdrawal by Subject|2|||
42147114|NCT00136084|75956022|FG000|Overall Study|Death|12|||
42147115|NCT00136084|75956023|FG001|Overall Study|Death|5|||
42147116|NCT00136084|75956022|FG000|Overall Study|Unacceptable toxicity|8|||
42147117|NCT00136084|75956023|FG001|Overall Study|Unacceptable toxicity|11|||
42147118|NCT00136084|75956022|FG000|Overall Study|Relapse|20|||
42147119|NCT00136084|75956023|FG001|Overall Study|Relapse|23|||
42147120|NCT00136084|75956022|FG000|Overall Study|Lost to Follow-up|2|||
42147121|NCT00136084|75956023|FG001|Overall Study|Lost to Follow-up|0|||
42147122|NCT00136084|75956022|FG000|Overall Study|No Response|1|||
42147123|NCT00136084|75956023|FG001|Overall Study|No Response|2|||
42147124|NCT00136084|75956022|FG000|Overall Study|Withdrawal by Subject|5|||
42147125|NCT00136084|75956023|FG001|Overall Study|Withdrawal by Subject|1|||
42147126|NCT00364832|75956044|FG000|Core Period|Early Withdrawals|2|||
42147127|NCT00364832|75956045|FG001|Core Period|Early Withdrawals|2|||
42147128|NCT00364832|75956046|FG002|Core Period|Early Withdrawals|1|||
42147129|NCT00364832|75956047|FG003|Core Period|Early Withdrawals|1|||
42147130|NCT00364832|75956048|FG004|Core Period|Early Withdrawals|0|||
42147131|NCT00364832|75956049|FG005|Core Period|Early Withdrawals|0|||
42147132|NCT00364832|75956050|FG006|Core Period|Early Withdrawals|4|||
42147133|NCT00364832|75956051|FG007|Core Period|Early Withdrawals|1|||
42147134|NCT00364832|75956052|FG008|Core Period|Early Withdrawals|0|||
42147135|NCT00364832|75956053|FG009|Core Period|Early Withdrawals|0|||
42147136|NCT00364832|75956054|FG010|Core Period|Early Withdrawals|0|||
42147137|NCT00364832|75956055|FG011|Core Period|Early Withdrawals|0|||
42147138|NCT00364832|75956044|FG000|Extension Year 1|Early Withdrawals|0|||
42147139|NCT00364832|75956045|FG001|Extension Year 1|Early Withdrawals|0|||
42147140|NCT00364832|75956046|FG002|Extension Year 1|Early Withdrawals|0|||
42147141|NCT00364832|75956047|FG003|Extension Year 1|Early Withdrawals|0|||
42147142|NCT00364832|75956048|FG004|Extension Year 1|Early Withdrawals|0|||
42147143|NCT00364832|75956049|FG005|Extension Year 1|Early Withdrawals|0|||
42147144|NCT00364832|75956050|FG006|Extension Year 1|Early Withdrawals|0|||
42147145|NCT00364832|75956051|FG007|Extension Year 1|Early Withdrawals|0|||
42147146|NCT00364832|75956052|FG008|Extension Year 1|Early Withdrawals|0|||
42147147|NCT00364832|75956053|FG009|Extension Year 1|Early Withdrawals|4|||
42147148|NCT00364832|75956054|FG010|Extension Year 1|Early Withdrawals|2|||
42147149|NCT00364832|75956055|FG011|Extension Year 1|Early Withdrawals|10|||
42147150|NCT00364832|75956044|FG000|Extension Year 2|Early Withdrawals|0|||
42147151|NCT00364832|75956045|FG001|Extension Year 2|Early Withdrawals|0|||
42147152|NCT00364832|75956046|FG002|Extension Year 2|Early Withdrawals|0|||
42147153|NCT00364832|75956047|FG003|Extension Year 2|Early Withdrawals|0|||
42147154|NCT00364832|75956048|FG004|Extension Year 2|Early Withdrawals|0|||
42147155|NCT00364832|75956049|FG005|Extension Year 2|Early Withdrawals|0|||
42147156|NCT00364832|75956050|FG006|Extension Year 2|Early Withdrawals|0|||
42147157|NCT00364832|75956051|FG007|Extension Year 2|Early Withdrawals|0|||
42147158|NCT00364832|75956052|FG008|Extension Year 2|Early Withdrawals|0|||
42147159|NCT00364832|75956053|FG009|Extension Year 2|Early Withdrawals|5|||
42147160|NCT00364832|75956054|FG010|Extension Year 2|Early Withdrawals|5|||
42147161|NCT00364832|75956055|FG011|Extension Year 2|Early Withdrawals|3|||
42147162|NCT00235755|75956075|FG000|4-Week Titration Phase|Adverse Event|6|||
42147163|NCT00235755|75956076|FG001|4-Week Titration Phase|Adverse Event|14|||
42147164|NCT00235755|75956077|FG002|4-Week Titration Phase|Adverse Event|20|||
42147165|NCT00235755|75956075|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
42147166|NCT00235755|75956076|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
42012643|NCT01194219|75819475|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
42012644|NCT01194219|75819476|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
42147167|NCT00235755|75956077|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
42147168|NCT00235755|75956075|FG000|4-Week Titration Phase|Protocol Violation|2|||
42147169|NCT00235755|75956076|FG001|4-Week Titration Phase|Protocol Violation|2|||
42147170|NCT00235755|75956077|FG002|4-Week Titration Phase|Protocol Violation|1|||
42147171|NCT00235755|75956075|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
42147172|NCT00235755|75956076|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
42147173|NCT00235755|75956077|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
42147174|NCT00235755|75956075|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
42147175|NCT00235755|75956076|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
42147176|NCT00235755|75956077|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
42147177|NCT00235755|75956075|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
42147178|NCT00235755|75956076|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
42147179|NCT00235755|75956077|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
42147180|NCT00235755|75956075|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
42147181|NCT00235755|75956076|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
42147182|NCT00235755|75956077|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
42147183|NCT00235755|75956075|FG000|12-Week Maintenance Phase|Adverse Event|8|||
42147184|NCT00235755|75956076|FG001|12-Week Maintenance Phase|Adverse Event|12|||
42147185|NCT00235755|75956077|FG002|12-Week Maintenance Phase|Adverse Event|26|||
42147186|NCT00235755|75956075|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
42147187|NCT00235755|75956076|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
42147188|NCT00235755|75956077|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
42147189|NCT00235755|75956075|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
42147190|NCT00235755|75956076|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
42147191|NCT00235755|75956077|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
42147192|NCT00235755|75956075|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
42147193|NCT00235755|75956076|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
42147194|NCT00235755|75956077|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
42012645|NCT01194219|75819477|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
42012646|NCT01194219|75819478|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
42147195|NCT00235755|75956075|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
42147196|NCT00235755|75956076|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
42147197|NCT00235755|75956077|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
42147198|NCT00235755|75956075|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
42147199|NCT00235755|75956076|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
42147200|NCT00235755|75956077|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
42147201|NCT00337194|75956102|FG000|Overall Study|Adverse Event|5|||
42147202|NCT00337194|75956103|FG001|Overall Study|Adverse Event|1|||
42147203|NCT00337194|75956102|FG000|Overall Study|Death|2|||
42147204|NCT00337194|75956103|FG001|Overall Study|Death|0|||
42147205|NCT00337194|75956102|FG000|Overall Study|Withdrawal by Subject|1|||
42147206|NCT00337194|75956103|FG001|Overall Study|Withdrawal by Subject|0|||
42147207|NCT00337194|75956102|FG000|Overall Study|Disease progression|1|||
42147208|NCT00337194|75956103|FG001|Overall Study|Disease progression|2|||
42147209|NCT00337194|75956102|FG000|Overall Study|Subsequent non-protocol therapy|3|||
42147210|NCT00337194|75956103|FG001|Overall Study|Subsequent non-protocol therapy|1|||
42147211|NCT03826914|75956113|FG000|Overall Study|Withdrawal by Subject|1|||
42147212|NCT03826914|75956114|FG001|Overall Study|Withdrawal by Subject|1|||
42147213|NCT00385736|75956125|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
42147214|NCT00385736|75956126|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
42147215|NCT00385736|75956127|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
42147216|NCT00385736|75956125|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
42147217|NCT00385736|75956126|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
42147218|NCT00385736|75956127|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
42147219|NCT00385736|75956125|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
42147220|NCT00385736|75956126|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
42147221|NCT00385736|75956127|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
42147222|NCT00385736|75956125|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
42147223|NCT00385736|75956126|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
42147224|NCT00385736|75956127|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
42147225|NCT00385736|75956125|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
42147226|NCT00385736|75956126|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
42147227|NCT00385736|75956127|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
42147228|NCT00385736|75956125|FG000|Efficacy Analysis Set - Induction|Other|0|||
42147229|NCT00385736|75956126|FG001|Efficacy Analysis Set - Induction|Other|0|||
42277697|NCT02712905|76109271|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277698|NCT02712905|76109272|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277699|NCT02712905|76109273|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277700|NCT02712905|76109274|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277701|NCT02712905|76109275|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277702|NCT02712905|76109276|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277703|NCT02712905|76109277|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277704|NCT02712905|76109278|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277705|NCT02712905|76109279|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277706|NCT02712905|76109280|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277707|NCT02712905|76109281|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
42277708|NCT02712905|76109282|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277709|NCT02712905|76109283|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
42277710|NCT03776357|76109321|FG000|Overall Study|Lost to Follow-up|3|||
42277711|NCT04520997|76109327|FG000|Overall Study|Lost to Follow-up|1|||
42277712|NCT04520997|76109328|FG001|Overall Study|Lost to Follow-up|1|||
42277713|NCT04520997|76109327|FG000|Overall Study|Withdrawal by Subject|1|||
42277714|NCT04520997|76109328|FG001|Overall Study|Withdrawal by Subject|0|||
42277715|NCT04520997|76109327|FG000|Overall Study|Not Treated|0|||
42277716|NCT04520997|76109328|FG001|Overall Study|Not Treated|1|||
42277717|NCT02734433|76109339|FG000|Overall Study|Disease progression|1|||
42277718|NCT02734433|76109340|FG001|Overall Study|Disease progression|5|||
42277719|NCT02734433|76109339|FG000|Overall Study|Clinical progression|0|||
42277720|NCT02734433|76109340|FG001|Overall Study|Clinical progression|1|||
42277721|NCT02734433|76109339|FG000|Overall Study|Withdrawal by Subject|1|||
42277722|NCT02734433|76109340|FG001|Overall Study|Withdrawal by Subject|2|||
42277723|NCT02452424|76109366|FG000|Overall Study|Death|2|||
42277724|NCT02452424|76109367|FG001|Overall Study|Death|2|||
42277725|NCT02452424|76109368|FG002|Overall Study|Death|2|||
42277726|NCT02452424|76109369|FG003|Overall Study|Death|6|||
42351188|NCT01515423|76191104|FG002|Open Label Phase|Lost to Follow-up|0|||
42351189|NCT01515423|76191102|FG000|Open Label Phase|Withdrawal by Subject|118|||
42147230|NCT00385736|75956127|FG002|Efficacy Analysis Set - Induction|Other|1|||
42147231|NCT00385736|75956125|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
42277727|NCT02452424|76109370|FG004|Overall Study|Death|2|||
42277728|NCT02452424|76109371|FG005|Overall Study|Death|0|||
42277729|NCT02452424|76109372|FG006|Overall Study|Death|5|||
42277730|NCT02452424|76109373|FG007|Overall Study|Death|1|||
42277731|NCT02452424|76109374|FG008|Overall Study|Death|3|||
42277732|NCT02452424|76109375|FG009|Overall Study|Death|1|||
42277733|NCT02452424|76109376|FG010|Overall Study|Death|0|||
42277734|NCT02452424|76109366|FG000|Overall Study|Lost to Follow-up|0|||
42277735|NCT02452424|76109367|FG001|Overall Study|Lost to Follow-up|1|||
42277736|NCT02452424|76109368|FG002|Overall Study|Lost to Follow-up|1|||
42277737|NCT02452424|76109369|FG003|Overall Study|Lost to Follow-up|0|||
42277738|NCT02452424|76109370|FG004|Overall Study|Lost to Follow-up|0|||
42277739|NCT02452424|76109371|FG005|Overall Study|Lost to Follow-up|0|||
42277740|NCT02452424|76109372|FG006|Overall Study|Lost to Follow-up|0|||
42277741|NCT02452424|76109373|FG007|Overall Study|Lost to Follow-up|0|||
42277742|NCT02452424|76109374|FG008|Overall Study|Lost to Follow-up|0|||
42277743|NCT02452424|76109375|FG009|Overall Study|Lost to Follow-up|0|||
42277744|NCT02452424|76109376|FG010|Overall Study|Lost to Follow-up|0|||
42277745|NCT02452424|76109366|FG000|Overall Study|Withdrawal by Subject|0|||
42277746|NCT02452424|76109367|FG001|Overall Study|Withdrawal by Subject|0|||
42277747|NCT02452424|76109368|FG002|Overall Study|Withdrawal by Subject|3|||
42277748|NCT02452424|76109369|FG003|Overall Study|Withdrawal by Subject|2|||
42277749|NCT02452424|76109370|FG004|Overall Study|Withdrawal by Subject|0|||
42277750|NCT02452424|76109371|FG005|Overall Study|Withdrawal by Subject|0|||
42277751|NCT02452424|76109372|FG006|Overall Study|Withdrawal by Subject|1|||
42277752|NCT02452424|76109373|FG007|Overall Study|Withdrawal by Subject|0|||
42277753|NCT02452424|76109374|FG008|Overall Study|Withdrawal by Subject|1|||
42277754|NCT02452424|76109375|FG009|Overall Study|Withdrawal by Subject|1|||
42277755|NCT02452424|76109376|FG010|Overall Study|Withdrawal by Subject|0|||
42277756|NCT02452424|76109366|FG000|Overall Study|Other|0|||
42277757|NCT02452424|76109367|FG001|Overall Study|Other|0|||
42277758|NCT02452424|76109368|FG002|Overall Study|Other|1|||
42277759|NCT02452424|76109369|FG003|Overall Study|Other|0|||
42277760|NCT02452424|76109370|FG004|Overall Study|Other|0|||
42277761|NCT02452424|76109371|FG005|Overall Study|Other|1|||
42277762|NCT02452424|76109372|FG006|Overall Study|Other|4|||
42277763|NCT02452424|76109373|FG007|Overall Study|Other|3|||
42277764|NCT02452424|76109374|FG008|Overall Study|Other|0|||
42277765|NCT02452424|76109375|FG009|Overall Study|Other|0|||
42277766|NCT02452424|76109376|FG010|Overall Study|Other|1|||
42277767|NCT02452424|76109366|FG000|Overall Study|Progressive disease (per RECIST)|0|||
42277768|NCT02452424|76109367|FG001|Overall Study|Progressive disease (per RECIST)|0|||
42277769|NCT02452424|76109368|FG002|Overall Study|Progressive disease (per RECIST)|0|||
42277770|NCT02452424|76109369|FG003|Overall Study|Progressive disease (per RECIST)|0|||
42277771|NCT02452424|76109370|FG004|Overall Study|Progressive disease (per RECIST)|0|||
42277772|NCT02452424|76109371|FG005|Overall Study|Progressive disease (per RECIST)|0|||
42277773|NCT02452424|76109372|FG006|Overall Study|Progressive disease (per RECIST)|0|||
42277774|NCT02452424|76109373|FG007|Overall Study|Progressive disease (per RECIST)|0|||
42277775|NCT02452424|76109374|FG008|Overall Study|Progressive disease (per RECIST)|2|||
42277776|NCT02452424|76109375|FG009|Overall Study|Progressive disease (per RECIST)|0|||
42277777|NCT02452424|76109376|FG010|Overall Study|Progressive disease (per RECIST)|0|||
42147232|NCT00385736|75956126|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
42147233|NCT00385736|75956127|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
42147234|NCT00385736|75956125|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
42147235|NCT00385736|75956126|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
42147236|NCT00385736|75956127|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
42147237|NCT00385736|75956125|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
42147238|NCT00385736|75956126|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
42277778|NCT02452424|76109366|FG000|Overall Study|Adverse Event|0|||
42277779|NCT02452424|76109367|FG001|Overall Study|Adverse Event|0|||
42277780|NCT02452424|76109368|FG002|Overall Study|Adverse Event|0|||
42277781|NCT02452424|76109369|FG003|Overall Study|Adverse Event|0|||
42277782|NCT02452424|76109370|FG004|Overall Study|Adverse Event|0|||
42351190|NCT01515423|76191103|FG001|Open Label Phase|Withdrawal by Subject|0|||
42277783|NCT02452424|76109371|FG005|Overall Study|Adverse Event|0|||
42277784|NCT02452424|76109372|FG006|Overall Study|Adverse Event|0|||
42277785|NCT02452424|76109373|FG007|Overall Study|Adverse Event|0|||
42277786|NCT02452424|76109374|FG008|Overall Study|Adverse Event|0|||
42277787|NCT02452424|76109375|FG009|Overall Study|Adverse Event|0|||
42277788|NCT02452424|76109376|FG010|Overall Study|Adverse Event|1|||
42277789|NCT02419508|76109404|FG000|Overall Study|Adverse Event|9|||
42277790|NCT02419508|76109405|FG001|Overall Study|Adverse Event|3|||
42277791|NCT02419508|76109404|FG000|Overall Study|Withdrawal by Subject|1|||
42277792|NCT02419508|76109405|FG001|Overall Study|Withdrawal by Subject|0|||
42277793|NCT02419508|76109404|FG000|Overall Study|Other - Reason not specified|0|||
42277794|NCT02419508|76109405|FG001|Overall Study|Other - Reason not specified|1|||
42277795|NCT01328249|76109413|FG000|Overall Study|Adverse Event|3|||
42277796|NCT01328249|76109414|FG001|Overall Study|Adverse Event|0|||
42147239|NCT00385736|75956127|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
42147240|NCT00385736|75956125|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
42147241|NCT00385736|75956126|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
42147242|NCT00385736|75956127|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
42147243|NCT00385736|75956125|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
42147244|NCT00385736|75956126|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
42147245|NCT00385736|75956127|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
42147246|NCT00385736|75956125|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
42147247|NCT00385736|75956126|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
42147248|NCT00385736|75956127|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
42147249|NCT00385736|75956125|FG000|Safety Analysis Set|Adverse Event|23|||
42147250|NCT00385736|75956126|FG001|Safety Analysis Set|Adverse Event|15|||
42147251|NCT00385736|75956127|FG002|Safety Analysis Set|Adverse Event|23|||
42147252|NCT00385736|75956125|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
42147253|NCT00385736|75956126|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
42147254|NCT00385736|75956127|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
42147255|NCT00385736|75956125|FG000|Safety Analysis Set|Lost to Follow-up|0|||
42147256|NCT00385736|75956126|FG001|Safety Analysis Set|Lost to Follow-up|2|||
42147257|NCT00385736|75956127|FG002|Safety Analysis Set|Lost to Follow-up|2|||
42147258|NCT00385736|75956125|FG000|Safety Analysis Set|Lack of Efficacy|38|||
42147259|NCT00385736|75956126|FG001|Safety Analysis Set|Lack of Efficacy|16|||
42147260|NCT00385736|75956127|FG002|Safety Analysis Set|Lack of Efficacy|31|||
42147261|NCT00385736|75956125|FG000|Safety Analysis Set|Protocol Violation|2|||
42147262|NCT00385736|75956126|FG001|Safety Analysis Set|Protocol Violation|1|||
42147263|NCT00385736|75956127|FG002|Safety Analysis Set|Protocol Violation|6|||
42147264|NCT00385736|75956125|FG000|Safety Analysis Set|Other|1|||
42147265|NCT00385736|75956126|FG001|Safety Analysis Set|Other|4|||
42147266|NCT00385736|75956127|FG002|Safety Analysis Set|Other|4|||
42147267|NCT00195819|75956138|FG000|Double-Blind|Withdrawal by Subject|1|||
42147268|NCT00195819|75956139|FG001|Double-Blind|Withdrawal by Subject|0|||
42147269|NCT00195819|75956138|FG000|Double-Blind|Moved|1|||
42147270|NCT00195819|75956139|FG001|Double-Blind|Moved|0|||
42147271|NCT00195819|75956138|FG000|Open-label|Adverse Event|0|||
42147272|NCT00195819|75956139|FG001|Open-label|Adverse Event|9|||
42147273|NCT00195819|75956138|FG000|Open-label|Lack of Efficacy|0|||
42147274|NCT00195819|75956139|FG001|Open-label|Lack of Efficacy|2|||
42147275|NCT00195819|75956138|FG000|Open-label|Pregnancy|0|||
42147276|NCT00195819|75956139|FG001|Open-label|Pregnancy|1|||
42147277|NCT00195819|75956138|FG000|Open-label|Protocol Violation|0|||
42147278|NCT00195819|75956139|FG001|Open-label|Protocol Violation|2|||
42147279|NCT00195819|75956138|FG000|Open-label|Moved|0|||
42147280|NCT00195819|75956139|FG001|Open-label|Moved|1|||
42147281|NCT00195819|75956138|FG000|Open-label|Withdrawal by Subject|0|||
42147282|NCT00195819|75956139|FG001|Open-label|Withdrawal by Subject|5|||
42147283|NCT00527735|75956154|FG000|Overall Study|Disease progression|47|||
42147284|NCT00527735|75956155|FG001|Overall Study|Disease progression|61|||
42147285|NCT00527735|75956156|FG002|Overall Study|Disease progression|53|||
42147286|NCT00527735|75956154|FG000|Overall Study|Death|23|||
42147287|NCT00527735|75956155|FG001|Overall Study|Death|13|||
42147288|NCT00527735|75956156|FG002|Overall Study|Death|15|||
42147289|NCT00527735|75956154|FG000|Overall Study|Completed treatment in treatment phase|14|||
42147290|NCT00527735|75956155|FG001|Overall Study|Completed treatment in treatment phase|13|||
42147291|NCT00527735|75956156|FG002|Overall Study|Completed treatment in treatment phase|18|||
42147292|NCT00527735|75956154|FG000|Overall Study|Adverse Event|10|||
42147293|NCT00527735|75956155|FG001|Overall Study|Adverse Event|6|||
42147294|NCT00527735|75956156|FG002|Overall Study|Adverse Event|7|||
42147295|NCT00527735|75956154|FG000|Overall Study|Not identified|5|||
42147296|NCT00527735|75956155|FG001|Overall Study|Not identified|5|||
42147297|NCT00527735|75956156|FG002|Overall Study|Not identified|5|||
42147298|NCT00527735|75956154|FG000|Overall Study|Withdrawal by Subject|5|||
42147299|NCT00527735|75956155|FG001|Overall Study|Withdrawal by Subject|4|||
42147300|NCT00527735|75956156|FG002|Overall Study|Withdrawal by Subject|3|||
42147301|NCT00527735|75956154|FG000|Overall Study|No longer met study criteria|2|||
42147302|NCT00527735|75956155|FG001|Overall Study|No longer met study criteria|2|||
42147303|NCT00527735|75956156|FG002|Overall Study|No longer met study criteria|1|||
42147304|NCT00527735|75956154|FG000|Overall Study|Lost to Follow-up|0|||
42147305|NCT00527735|75956155|FG001|Overall Study|Lost to Follow-up|0|||
42147306|NCT00527735|75956156|FG002|Overall Study|Lost to Follow-up|3|||
42147307|NCT00527735|75956154|FG000|Overall Study|Poor compliance or noncompliance|0|||
42147308|NCT00527735|75956155|FG001|Overall Study|Poor compliance or noncompliance|1|||
42147309|NCT00527735|75956156|FG002|Overall Study|Poor compliance or noncompliance|1|||
42147310|NCT00527735|75956154|FG000|Overall Study|Completed treatment during maintenance|2|||
42147311|NCT00527735|75956155|FG001|Overall Study|Completed treatment during maintenance|2|||
42147312|NCT00527735|75956156|FG002|Overall Study|Completed treatment during maintenance|1|||
42147313|NCT00336492|75956179|FG000|Overall Study|Adverse Event|4|||
42147314|NCT00336492|75956180|FG001|Overall Study|Adverse Event|3|||
42147315|NCT00336492|75956181|FG002|Overall Study|Adverse Event|6|||
42147316|NCT00336492|75956179|FG000|Overall Study|Lack of Efficacy|6|||
42147317|NCT00336492|75956180|FG001|Overall Study|Lack of Efficacy|1|||
42147318|NCT00336492|75956181|FG002|Overall Study|Lack of Efficacy|4|||
42147319|NCT00336492|75956179|FG000|Overall Study|Other|5|||
42147320|NCT00336492|75956180|FG001|Overall Study|Other|0|||
42147321|NCT00336492|75956181|FG002|Overall Study|Other|1|||
42147322|NCT00194025|75956189|FG000|Overall Study|Adverse Event|1|||
42147323|NCT00194025|75956189|FG000|Overall Study|non-adherence with study medication|4|||
42147324|NCT00368108|75956196|FG000|Overall Study|Adverse Event|38|||
42147325|NCT00368108|75956197|FG001|Overall Study|Adverse Event|26|||
42147326|NCT00368108|75956198|FG002|Overall Study|Adverse Event|44|||
42147327|NCT00368108|75956196|FG000|Overall Study|Abnormal Laboratory Value|0|||
42147328|NCT00368108|75956197|FG001|Overall Study|Abnormal Laboratory Value|0|||
42147329|NCT00368108|75956198|FG002|Overall Study|Abnormal Laboratory Value|3|||
42147330|NCT00368108|75956196|FG000|Overall Study|Protocol Violation|5|||
42147331|NCT00368108|75956197|FG001|Overall Study|Protocol Violation|9|||
42147332|NCT00368108|75956198|FG002|Overall Study|Protocol Violation|9|||
42147333|NCT00368108|75956196|FG000|Overall Study|Withdrawal by Subject|9|||
42147334|NCT00368108|75956197|FG001|Overall Study|Withdrawal by Subject|3|||
42147335|NCT00368108|75956198|FG002|Overall Study|Withdrawal by Subject|5|||
42147336|NCT00368108|75956196|FG000|Overall Study|Lack of Efficacy|7|||
42147337|NCT00368108|75956197|FG001|Overall Study|Lack of Efficacy|8|||
42147338|NCT00368108|75956198|FG002|Overall Study|Lack of Efficacy|5|||
42147339|NCT00368108|75956196|FG000|Overall Study|Physician Decision|2|||
42147340|NCT00368108|75956197|FG001|Overall Study|Physician Decision|0|||
42147341|NCT00368108|75956198|FG002|Overall Study|Physician Decision|1|||
42147342|NCT00368108|75956196|FG000|Overall Study|Other|3|||
42147343|NCT00368108|75956197|FG001|Overall Study|Other|7|||
42147344|NCT00368108|75956198|FG002|Overall Study|Other|1|||
42147345|NCT00364130|75956208|FG000|Intervention Period|Lost to Follow-up|4|||
42147346|NCT00364130|75956209|FG001|Intervention Period|Lost to Follow-up|3|||
42147347|NCT00364130|75956208|FG000|Intervention Period|Pregnancy|1|||
42147348|NCT00364130|75956209|FG001|Intervention Period|Pregnancy|0|||
42147349|NCT00364130|75956208|FG000|Intervention Period|Withdrawal by Subject|4|||
42147350|NCT00364130|75956209|FG001|Intervention Period|Withdrawal by Subject|5|||
42147351|NCT00364130|75956208|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
42147352|NCT00364130|75956209|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
42147353|NCT00521339|75956217|FG000|Treatment Phase|Adverse Event|2|||
42147354|NCT00521339|75956218|FG001|Treatment Phase|Adverse Event|0|||
42147355|NCT00521339|75956219|FG002|Treatment Phase|Adverse Event|0|||
42147356|NCT00521339|75956217|FG000|Treatment Phase|Intolerability to study drug|2|||
42147357|NCT00521339|75956218|FG001|Treatment Phase|Intolerability to study drug|0|||
42147358|NCT00521339|75956219|FG002|Treatment Phase|Intolerability to study drug|0|||
42147359|NCT00521339|75956217|FG000|Treatment Phase|Lack of Efficacy|3|||
42147360|NCT00521339|75956218|FG001|Treatment Phase|Lack of Efficacy|0|||
42147361|NCT00521339|75956219|FG002|Treatment Phase|Lack of Efficacy|0|||
42147362|NCT00521339|75956217|FG000|Treatment Phase|Withdrawal by Subject|3|||
42147363|NCT00521339|75956218|FG001|Treatment Phase|Withdrawal by Subject|0|||
42147364|NCT00521339|75956219|FG002|Treatment Phase|Withdrawal by Subject|0|||
42147365|NCT00521339|75956217|FG000|Treatment Phase|Lost to Follow-up|1|||
42147366|NCT00521339|75956218|FG001|Treatment Phase|Lost to Follow-up|0|||
42147367|NCT00521339|75956219|FG002|Treatment Phase|Lost to Follow-up|0|||
42147368|NCT00521339|75956217|FG000|Treatment Phase|Protocol Violation|1|||
42147369|NCT00521339|75956218|FG001|Treatment Phase|Protocol Violation|0|||
42147370|NCT00521339|75956219|FG002|Treatment Phase|Protocol Violation|0|||
42277797|NCT01328249|76109413|FG000|Overall Study|Disease progression|1|||
42277798|NCT01328249|76109414|FG001|Overall Study|Disease progression|0|||
42277799|NCT01328249|76109413|FG000|Overall Study|Withdrawal by Subject|1|||
42277800|NCT01328249|76109414|FG001|Overall Study|Withdrawal by Subject|1|||
42277801|NCT01328249|76109413|FG000|Overall Study|Moved before end of treatment visit|1|||
42147371|NCT00521339|75956217|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
42147372|NCT00521339|75956218|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
42147373|NCT00521339|75956219|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
42147374|NCT00521339|75956217|FG000|Treatment Extension Phase|Death|0|||
42147375|NCT00521339|75956218|FG001|Treatment Extension Phase|Death|0|||
42147376|NCT00521339|75956219|FG002|Treatment Extension Phase|Death|1|||
42147377|NCT00363896|75956242|FG000|Overall Study|Withdrawal by Subject|29|||
42147378|NCT00363896|75956243|FG001|Overall Study|Withdrawal by Subject|16|||
42147379|NCT00363896|75956242|FG000|Overall Study|Adverse Event|24|||
42147380|NCT00363896|75956243|FG001|Overall Study|Adverse Event|13|||
42277802|NCT01328249|76109414|FG001|Overall Study|Moved before end of treatment visit|0|||
42147381|NCT00363896|75956242|FG000|Overall Study|COPD exacerbation|13|||
42147382|NCT00363896|75956243|FG001|Overall Study|COPD exacerbation|7|||
42147383|NCT00363896|75956242|FG000|Overall Study|Lack of Efficacy|12|||
42147384|NCT00363896|75956243|FG001|Overall Study|Lack of Efficacy|8|||
42147385|NCT00363896|75956242|FG000|Overall Study|Protocol Violation|6|||
42147386|NCT00363896|75956243|FG001|Overall Study|Protocol Violation|1|||
42147387|NCT00363896|75956242|FG000|Overall Study|Lost to Follow-up|3|||
42147388|NCT00363896|75956243|FG001|Overall Study|Lost to Follow-up|0|||
42147389|NCT00363896|75956242|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
42147390|NCT00363896|75956243|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
42147391|NCT00363896|75956242|FG000|Overall Study|Other|1|||
42147392|NCT00363896|75956243|FG001|Overall Study|Other|2|||
42147393|NCT00527423|75956252|FG000|Overall Study|Protocol Violation|1|||
42147394|NCT00527423|75956252|FG000|Overall Study|Adverse Event|5|||
42147395|NCT00527423|75956252|FG000|Overall Study|Physician Decision|4|||
42147396|NCT00527423|75956252|FG000|Overall Study|Withdrawal by Subject|10|||
42147397|NCT00527423|75956252|FG000|Overall Study|Lost to Follow-up|4|||
42147398|NCT00527423|75956252|FG000|Overall Study|OTHER|4|||
42147399|NCT00527423|75956252|FG000|Overall Study|Death|9|||
42147400|NCT00527111|75956260|FG000|Overall Study|Adverse Event|14|||
42147401|NCT00527111|75956261|FG001|Overall Study|Adverse Event|13|||
42147402|NCT00527111|75956260|FG000|Overall Study|Death|0|||
42147403|NCT00527111|75956261|FG001|Overall Study|Death|1|||
42147404|NCT00527111|75956260|FG000|Overall Study|Investigator Request|2|||
42147405|NCT00527111|75956261|FG001|Overall Study|Investigator Request|1|||
42147406|NCT00527111|75956260|FG000|Overall Study|Patient Request|2|||
42147407|NCT00527111|75956261|FG001|Overall Study|Patient Request|5|||
42147408|NCT00527111|75956260|FG000|Overall Study|Other|2|||
42147409|NCT00527111|75956261|FG001|Overall Study|Other|2|||
42147410|NCT00384956|75956267|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
42147411|NCT00367640|75956275|FG000|Overall Study|Adverse Event|3|||
42147412|NCT00367640|75956276|FG001|Overall Study|Adverse Event|6|||
42147413|NCT00367640|75956277|FG002|Overall Study|Adverse Event|8|||
42147414|NCT00367640|75956278|FG003|Overall Study|Adverse Event|0|||
42147415|NCT00367640|75956275|FG000|Overall Study|Withdrawal by Subject|8|||
42147416|NCT00367640|75956276|FG001|Overall Study|Withdrawal by Subject|11|||
42147417|NCT00367640|75956277|FG002|Overall Study|Withdrawal by Subject|8|||
42147418|NCT00367640|75956278|FG003|Overall Study|Withdrawal by Subject|6|||
42147419|NCT00367640|75956275|FG000|Overall Study|Any other reason not above-mentioned|7|||
42147420|NCT00367640|75956276|FG001|Overall Study|Any other reason not above-mentioned|5|||
42147421|NCT00367640|75956277|FG002|Overall Study|Any other reason not above-mentioned|3|||
42147422|NCT00367640|75956278|FG003|Overall Study|Any other reason not above-mentioned|4|||
42147423|NCT00367484|75956288|FG000|Overall Study|Adverse Event|7|||
42147424|NCT00367484|75956288|FG000|Overall Study|Withdrew informed consent|5|||
42147425|NCT00367484|75956288|FG000|Overall Study|Travel to USA|1|||
42147426|NCT00367484|75956288|FG000|Overall Study|Lost to Follow-up|1|||
42147427|NCT00367484|75956288|FG000|Overall Study|Protocol Violation|1|||
42147428|NCT00367484|75956288|FG000|Overall Study|The choice of the patient|1|||
42147429|NCT00367484|75956288|FG000|Overall Study|Lack of Efficacy|1|||
42147430|NCT00526799|75956294|FG000|Overall Study|Withdrawal by Subject|1|||
42147431|NCT00526799|75956295|FG001|Overall Study|Withdrawal by Subject|0|||
42147432|NCT00526799|75956294|FG000|Overall Study|Intercurrent Complicating Disease|0|||
42147433|NCT00526799|75956295|FG001|Overall Study|Intercurrent Complicating Disease|1|||
42147434|NCT00526331|75956301|FG000|Overall Study|Sponsor Termination|55|||
42147435|NCT00520481|75956307|FG000|Overall Study|Adverse Event|4|||
42147436|NCT00520481|75956308|FG001|Overall Study|Adverse Event|1|||
42147437|NCT00520481|75956307|FG000|Overall Study|Withdrawal by Subject|3|||
42147438|NCT00520481|75956308|FG001|Overall Study|Withdrawal by Subject|0|||
42147439|NCT00520403|75956316|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
42147440|NCT00520403|75956316|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
42147441|NCT00520403|75956316|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
42147442|NCT00520403|75956316|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
42012647|NCT01194219|75819479|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
42012648|NCT01194219|75819480|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
42012649|NCT01194219|75819481|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
42147443|NCT00520403|75956316|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
42147444|NCT00520403|75956316|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
42147445|NCT00520403|75956316|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
42147446|NCT00520403|75956316|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
42147447|NCT00520013|75956323|FG000|Overall Study|Withdrawal by Subject|0|||
42147448|NCT00520013|75956324|FG001|Overall Study|Withdrawal by Subject|0|||
42147449|NCT00520013|75956325|FG002|Overall Study|Withdrawal by Subject|1|||
42147450|NCT00520013|75956323|FG000|Overall Study|Adverse Event|2|||
42147451|NCT00520013|75956324|FG001|Overall Study|Adverse Event|10|||
42147452|NCT00520013|75956325|FG002|Overall Study|Adverse Event|7|||
42147453|NCT00520013|75956323|FG000|Overall Study|Progressive Disease|7|||
42147454|NCT00520013|75956324|FG001|Overall Study|Progressive Disease|3|||
42147455|NCT00520013|75956325|FG002|Overall Study|Progressive Disease|0|||
42147456|NCT00520013|75956323|FG000|Overall Study|Clinical Progression|3|||
42147457|NCT00520013|75956324|FG001|Overall Study|Clinical Progression|1|||
42147458|NCT00520013|75956325|FG002|Overall Study|Clinical Progression|0|||
42147459|NCT00520013|75956323|FG000|Overall Study|Death|0|||
42147460|NCT00520013|75956324|FG001|Overall Study|Death|1|||
42147461|NCT00520013|75956325|FG002|Overall Study|Death|0|||
42147462|NCT00520013|75956323|FG000|Overall Study|Physician Decision|0|||
42147463|NCT00520013|75956324|FG001|Overall Study|Physician Decision|0|||
42147464|NCT00520013|75956325|FG002|Overall Study|Physician Decision|3|||
42147465|NCT00519779|75956333|FG000|Overall Study|Withdrawal by Subject|0|||
42147466|NCT00519779|75956334|FG001|Overall Study|Withdrawal by Subject|1|||
42147467|NCT00526097|75956342|FG000|Overall Study|Adverse Event|6|||
42147468|NCT00526097|75956343|FG001|Overall Study|Adverse Event|44|||
42147469|NCT00526097|75956342|FG000|Overall Study|Protocol Violation|4|||
42147470|NCT00526097|75956343|FG001|Overall Study|Protocol Violation|10|||
42147471|NCT00526097|75956342|FG000|Overall Study|Withdrawal by Subject|3|||
42147472|NCT00526097|75956343|FG001|Overall Study|Withdrawal by Subject|1|||
42147473|NCT00526097|75956342|FG000|Overall Study|Other|2|||
42147474|NCT00526097|75956343|FG001|Overall Study|Other|1|||
42147475|NCT00525785|75956349|FG000|Overall Study|Withdrawal by Subject|1|||
42147476|NCT00525785|75956349|FG000|Overall Study|Lack of Efficacy|1|||
42147477|NCT00525785|75956349|FG000|Overall Study|Physician Decision|1|||
42147478|NCT00525161|75956353|FG000|Overall Study|Adverse Event|1|||
42147479|NCT00524771|75956359|FG000|Overall Study|Protocol Violation|220|||
42147480|NCT00524771|75956360|FG001|Overall Study|Protocol Violation|585|||
42147481|NCT00135694|75956370|FG000|Overall Study|Adverse Event|17|||
42147482|NCT00135694|75956371|FG001|Overall Study|Adverse Event|4|||
42147483|NCT00135694|75956372|FG002|Overall Study|Adverse Event|0|||
42147484|NCT00135694|75956370|FG000|Overall Study|Death|14|||
42147485|NCT00135694|75956371|FG001|Overall Study|Death|1|||
42147486|NCT00135694|75956372|FG002|Overall Study|Death|2|||
42147487|NCT00135694|75956370|FG000|Overall Study|Lost to Follow-up|8|||
42147488|NCT00135694|75956371|FG001|Overall Study|Lost to Follow-up|7|||
42147489|NCT00135694|75956372|FG002|Overall Study|Lost to Follow-up|1|||
42147490|NCT00135694|75956370|FG000|Overall Study|Withdrawal by Subject|41|||
42147491|NCT00135694|75956371|FG001|Overall Study|Withdrawal by Subject|7|||
42147492|NCT00135694|75956372|FG002|Overall Study|Withdrawal by Subject|4|||
42147493|NCT00135694|75956370|FG000|Overall Study|Protocol Violation|19|||
42147494|NCT00135694|75956371|FG001|Overall Study|Protocol Violation|1|||
42147495|NCT00135694|75956372|FG002|Overall Study|Protocol Violation|0|||
42147496|NCT00135694|75956370|FG000|Overall Study|Hepatitis C related reasons|39|||
42147497|NCT00135694|75956371|FG001|Overall Study|Hepatitis C related reasons|1|||
42147498|NCT00135694|75956372|FG002|Overall Study|Hepatitis C related reasons|0|||
42147499|NCT00135694|75956370|FG000|Overall Study|Ineligible for Random assignment|42|||
42147500|NCT00135694|75956371|FG001|Overall Study|Ineligible for Random assignment|0|||
42147501|NCT00135694|75956372|FG002|Overall Study|Ineligible for Random assignment|0|||
42147502|NCT00524459|75956380|FG000|Overall Study|Withdrawal by Subject|1|||
42147503|NCT00524459|75956380|FG000|Overall Study|Other|1|||
42147504|NCT00519623|75956384|FG000|Overall Study|Adverse Event|1|||
42147505|NCT00519077|75956388|FG000|Overall Study|Death|6|||
42147506|NCT00519077|75956388|FG000|Overall Study|Other|2|||
42147507|NCT00124618|75956392|FG000|Overall Study|Ineligible|1|||
42147508|NCT00124462|75956398|FG000|Overall Study|Lost to Follow-up|3|||
42147509|NCT00124462|75956399|FG001|Overall Study|Lost to Follow-up|3|||
42147510|NCT00124462|75956398|FG000|Overall Study|Physician Decision|3|||
42147511|NCT00124462|75956399|FG001|Overall Study|Physician Decision|4|||
42147512|NCT00124462|75956398|FG000|Overall Study|Withdrawal by Subject|4|||
42147513|NCT00124462|75956399|FG001|Overall Study|Withdrawal by Subject|5|||
42147514|NCT00124462|75956398|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
42147515|NCT00124462|75956399|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
42351191|NCT01515423|76191104|FG002|Open Label Phase|Withdrawal by Subject|0|||
42039575|NCT01078571|75847856|FG000|Overall Study|Withdrawal by Subject|12|||
42039576|NCT01078571|75847856|FG000|Overall Study|Lost to Follow-up|8|||
42039577|NCT01078571|75847856|FG000|Overall Study|Protocol Violation|2|||
42039578|NCT00977106|75847867|FG000|Overall Study|Adverse Event|5|||
42039579|NCT00977106|75847868|FG001|Overall Study|Adverse Event|6|||
42039580|NCT00977106|75847867|FG000|Overall Study|Withdrawal by Subject|2|||
42039581|NCT00977106|75847868|FG001|Overall Study|Withdrawal by Subject|2|||
42039582|NCT00977106|75847867|FG000|Overall Study|Lack of Efficacy|2|||
42039583|NCT00977106|75847868|FG001|Overall Study|Lack of Efficacy|2|||
42039584|NCT00977106|75847867|FG000|Overall Study|Protocol Violation|0|||
42039585|NCT00977106|75847868|FG001|Overall Study|Protocol Violation|1|||
42039586|NCT00977106|75847867|FG000|Overall Study|Other|1|||
42147516|NCT00124072|75956409|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
42147517|NCT00124072|75956410|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
42147518|NCT00124072|75956411|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
42147519|NCT00124072|75956412|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
42147520|NCT00124072|75956409|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
42147521|NCT00124072|75956410|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
42147522|NCT00124072|75956411|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
42039587|NCT00977106|75847868|FG001|Overall Study|Other|0|||
42039588|NCT01077713|75847878|FG000|Overall Study|Withdrawal by Subject|1|||
42351192|NCT01515423|76191102|FG000|Open Label Phase|excluded from DB Phase|70|||
42039589|NCT01077713|75847879|FG001|Overall Study|Withdrawal by Subject|2|||
42039590|NCT01077713|75847878|FG000|Overall Study|Progressive Disease (PD)|0|||
42039591|NCT01077713|75847879|FG001|Overall Study|Progressive Disease (PD)|1|||
42039592|NCT01077713|75847878|FG000|Overall Study|Death|28|||
42039593|NCT01077713|75847879|FG001|Overall Study|Death|29|||
42039594|NCT01077713|75847878|FG000|Overall Study|Lost to Follow-up|1|||
42039595|NCT01077713|75847879|FG001|Overall Study|Lost to Follow-up|1|||
42039596|NCT01077713|75847878|FG000|Overall Study|Adverse Event|2|||
42039597|NCT01077713|75847879|FG001|Overall Study|Adverse Event|1|||
42039598|NCT01077713|75847878|FG000|Overall Study|Other|4|||
42039599|NCT01077713|75847879|FG001|Overall Study|Other|2|||
42039600|NCT00813709|75847888|FG000|Double Blind Period|Adverse Event|4|||
42039601|NCT00813709|75847889|FG001|Double Blind Period|Adverse Event|1|||
42039602|NCT00813709|75847890|FG002|Double Blind Period|Adverse Event|4|||
42039603|NCT00813709|75847891|FG003|Double Blind Period|Adverse Event|0|||
42039604|NCT00813709|75847892|FG004|Double Blind Period|Adverse Event|0|||
42039605|NCT00813709|75847893|FG005|Double Blind Period|Adverse Event|0|||
42039606|NCT00813709|75847888|FG000|Double Blind Period|Lost to Follow-up|3|||
42039607|NCT00813709|75847889|FG001|Double Blind Period|Lost to Follow-up|2|||
42039608|NCT00813709|75847890|FG002|Double Blind Period|Lost to Follow-up|2|||
42039609|NCT00813709|75847891|FG003|Double Blind Period|Lost to Follow-up|0|||
42039610|NCT00813709|75847892|FG004|Double Blind Period|Lost to Follow-up|0|||
42039611|NCT00813709|75847893|FG005|Double Blind Period|Lost to Follow-up|0|||
42039612|NCT00813709|75847888|FG000|Double Blind Period|Switched to open label phase|9|||
42039613|NCT00813709|75847889|FG001|Double Blind Period|Switched to open label phase|26|||
42039614|NCT00813709|75847890|FG002|Double Blind Period|Switched to open label phase|18|||
42039615|NCT00813709|75847891|FG003|Double Blind Period|Switched to open label phase|0|||
42039616|NCT00813709|75847892|FG004|Double Blind Period|Switched to open label phase|0|||
42277803|NCT01328249|76109413|FG000|Overall Study|Subject choice|1|||
42277804|NCT01328249|76109414|FG001|Overall Study|Subject choice|1|||
42277805|NCT01328249|76109413|FG000|Overall Study|Protocol Violation|0|||
42277806|NCT01328249|76109414|FG001|Overall Study|Protocol Violation|1|||
42277807|NCT01651052|76109422|FG000|Overall Study|Death|21|||
42277808|NCT01651052|76109422|FG000|Overall Study|Explant|1|||
42277809|NCT01651052|76109422|FG000|Overall Study|Withdrawal by Subject|1|||
42351193|NCT01515423|76191103|FG001|Open Label Phase|excluded from DB Phase|0|||
42351194|NCT01515423|76191104|FG002|Open Label Phase|excluded from DB Phase|0|||
42351195|NCT01515423|76191102|FG000|Open Label Phase|Other|28|||
42351196|NCT01515423|76191103|FG001|Open Label Phase|Other|0|||
42277810|NCT01651052|76109422|FG000|Overall Study|Lost to Follow-up|3|||
42277811|NCT02388074|76109426|FG000|Overall Study|Lost in Transit|2|||
42277812|NCT02388074|76109426|FG000|Overall Study|Sample Not Returned|1|||
42277813|NCT01602549|76109432|FG000|Overall Study|Protocol Violation|0|||
42277814|NCT01602549|76109433|FG001|Overall Study|Protocol Violation|1|||
42277815|NCT01602549|76109432|FG000|Overall Study|Withdrawal by Subject|1|||
42277816|NCT01602549|76109433|FG001|Overall Study|Withdrawal by Subject|0|||
42277817|NCT02427464|76109443|FG000|Overall Study|Adverse Event|6|||
42277818|NCT02427464|76109444|FG001|Overall Study|Adverse Event|1|||
42039617|NCT00813709|75847893|FG005|Double Blind Period|Switched to open label phase|0|||
42039618|NCT00813709|75847888|FG000|Double Blind Period|Randomized but not treated|1|||
42039619|NCT00813709|75847889|FG001|Double Blind Period|Randomized but not treated|3|||
42039620|NCT00813709|75847890|FG002|Double Blind Period|Randomized but not treated|1|||
42039621|NCT00813709|75847891|FG003|Double Blind Period|Randomized but not treated|0|||
42039622|NCT00813709|75847892|FG004|Double Blind Period|Randomized but not treated|0|||
42039623|NCT00813709|75847893|FG005|Double Blind Period|Randomized but not treated|0|||
42147523|NCT00124072|75956412|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
42147524|NCT00124072|75956409|FG000|Overall Study|Death|499|||
42277819|NCT02427464|76109443|FG000|Overall Study|Lost to Follow-up|16|||
42277820|NCT02427464|76109444|FG001|Overall Study|Lost to Follow-up|5|||
42277821|NCT02427464|76109443|FG000|Overall Study|Physician Decision|2|||
42277822|NCT02427464|76109444|FG001|Overall Study|Physician Decision|0|||
42277823|NCT02427464|76109443|FG000|Overall Study|Withdrawal by Subject|10|||
42351197|NCT01515423|76191104|FG002|Open Label Phase|Other|0|||
42277824|NCT02427464|76109444|FG001|Overall Study|Withdrawal by Subject|8|||
42039624|NCT00813709|75847888|FG000|Double Blind Period|Other|14|||
42039625|NCT00813709|75847889|FG001|Double Blind Period|Other|9|||
42039626|NCT00813709|75847890|FG002|Double Blind Period|Other|6|||
42039627|NCT00813709|75847891|FG003|Double Blind Period|Other|0|||
42039628|NCT00813709|75847892|FG004|Double Blind Period|Other|0|||
42147525|NCT00124072|75956410|FG001|Overall Study|Death|484|||
42277825|NCT02427464|76109443|FG000|Overall Study|Noncompliance|16|||
42277826|NCT02427464|76109444|FG001|Overall Study|Noncompliance|10|||
42277827|NCT02426918|76109453|FG000|Overall Study|Adverse Event|2|||
42039629|NCT00813709|75847893|FG005|Double Blind Period|Other|0|||
42277828|NCT02426918|76109454|FG001|Overall Study|Adverse Event|2|||
42351198|NCT01515423|76191102|FG000|DOUBLE BLIND|Adverse Event|0|||
42147526|NCT00124072|75956411|FG002|Overall Study|Death|471|||
42147527|NCT00124072|75956412|FG003|Overall Study|Death|480|||
42147528|NCT00362648|75956426|FG000|Overall Study|Adverse Event|12|||
42147529|NCT00362648|75956427|FG001|Overall Study|Adverse Event|21|||
42147530|NCT00362648|75956428|FG002|Overall Study|Adverse Event|1|||
42147531|NCT00362648|75956429|FG003|Overall Study|Adverse Event|0|||
42147532|NCT00362648|75956426|FG000|Overall Study|Lost to Follow-up|62|||
42147533|NCT00362648|75956427|FG001|Overall Study|Lost to Follow-up|69|||
42147534|NCT00362648|75956428|FG002|Overall Study|Lost to Follow-up|4|||
42147535|NCT00362648|75956429|FG003|Overall Study|Lost to Follow-up|3|||
42147536|NCT00362648|75956426|FG000|Overall Study|Protocol Violation|4|||
42147537|NCT00362648|75956427|FG001|Overall Study|Protocol Violation|2|||
42147538|NCT00362648|75956428|FG002|Overall Study|Protocol Violation|2|||
42147539|NCT00362648|75956429|FG003|Overall Study|Protocol Violation|2|||
42147540|NCT00362648|75956426|FG000|Overall Study|Withdrawal by Subject|48|||
42147541|NCT00362648|75956427|FG001|Overall Study|Withdrawal by Subject|42|||
42147542|NCT00362648|75956428|FG002|Overall Study|Withdrawal by Subject|2|||
42147543|NCT00362648|75956429|FG003|Overall Study|Withdrawal by Subject|6|||
42147544|NCT00524303|75956446|FG000|Overall Study|Lost to Follow-up|6|||
42147545|NCT00524303|75956447|FG001|Overall Study|Lost to Follow-up|0|||
42147546|NCT00524303|75956448|FG002|Overall Study|Lost to Follow-up|3|||
42147547|NCT00524303|75956446|FG000|Overall Study|Protocol Violation|0|||
42147548|NCT00524303|75956447|FG001|Overall Study|Protocol Violation|1|||
42147549|NCT00524303|75956448|FG002|Overall Study|Protocol Violation|1|||
42147550|NCT00524303|75956446|FG000|Overall Study|Withdrawal by Subject|3|||
42147551|NCT00524303|75956447|FG001|Overall Study|Withdrawal by Subject|0|||
42147552|NCT00524303|75956448|FG002|Overall Study|Withdrawal by Subject|4|||
42147553|NCT00524303|75956446|FG000|Overall Study|Death|0|||
42147554|NCT00524303|75956447|FG001|Overall Study|Death|2|||
42147555|NCT00524303|75956448|FG002|Overall Study|Death|3|||
42147556|NCT00524303|75956446|FG000|Overall Study|Adverse Event|1|||
42147557|NCT00524303|75956447|FG001|Overall Study|Adverse Event|2|||
42147558|NCT00524303|75956448|FG002|Overall Study|Adverse Event|3|||
42147559|NCT00524303|75956446|FG000|Overall Study|Did not Complete Study Dosing|1|||
42147560|NCT00524303|75956447|FG001|Overall Study|Did not Complete Study Dosing|0|||
42147561|NCT00524303|75956448|FG002|Overall Study|Did not Complete Study Dosing|0|||
42147562|NCT00524303|75956446|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
42147563|NCT00524303|75956447|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
42147564|NCT00524303|75956448|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
42147565|NCT00524303|75956446|FG000|Overall Study|Disease Progression|0|||
42147566|NCT00524303|75956447|FG001|Overall Study|Disease Progression|4|||
42147567|NCT00524303|75956448|FG002|Overall Study|Disease Progression|1|||
42147568|NCT00524303|75956446|FG000|Overall Study|Disease Recurrence|0|||
42147569|NCT00524303|75956447|FG001|Overall Study|Disease Recurrence|1|||
42147570|NCT00524303|75956448|FG002|Overall Study|Disease Recurrence|0|||
42147571|NCT00524303|75956446|FG000|Overall Study|Sponsor Request|0|||
42147572|NCT00524303|75956447|FG001|Overall Study|Sponsor Request|0|||
42147573|NCT00524303|75956448|FG002|Overall Study|Sponsor Request|1|||
42147574|NCT00524303|75956446|FG000|Overall Study|Physician Decision|0|||
42147575|NCT00524303|75956447|FG001|Overall Study|Physician Decision|0|||
42147576|NCT00524303|75956448|FG002|Overall Study|Physician Decision|1|||
42147577|NCT00524303|75956446|FG000|Overall Study|Completed 5 years|0|||
42147578|NCT00524303|75956447|FG001|Overall Study|Completed 5 years|0|||
42147579|NCT00524303|75956448|FG002|Overall Study|Completed 5 years|1|||
42147580|NCT00335556|75956465|FG000|Overall Study|Death|0|||
42147581|NCT00335556|75956466|FG001|Overall Study|Death|5|||
42147582|NCT00335556|75956467|FG002|Overall Study|Death|0|||
42147583|NCT00335556|75956468|FG003|Overall Study|Death|0|||
42147584|NCT00335556|75956469|FG004|Overall Study|Death|1|||
42147585|NCT00335556|75956470|FG005|Overall Study|Death|0|||
42147586|NCT00335556|75956465|FG000|Overall Study|Lack of Efficacy|0|||
42147587|NCT00335556|75956466|FG001|Overall Study|Lack of Efficacy|19|||
42147588|NCT00335556|75956467|FG002|Overall Study|Lack of Efficacy|3|||
42147589|NCT00335556|75956468|FG003|Overall Study|Lack of Efficacy|3|||
42277829|NCT02426918|76109455|FG002|Overall Study|Adverse Event|0|||
42277830|NCT02426918|76109453|FG000|Overall Study|Physician Decision|1|||
42277831|NCT02426918|76109454|FG001|Overall Study|Physician Decision|1|||
42277832|NCT02426918|76109455|FG002|Overall Study|Physician Decision|1|||
42277833|NCT02426918|76109453|FG000|Overall Study|Withdrawal by Subject|5|||
42147590|NCT00335556|75956469|FG004|Overall Study|Lack of Efficacy|0|||
42147591|NCT00335556|75956470|FG005|Overall Study|Lack of Efficacy|1|||
42147592|NCT00335556|75956465|FG000|Overall Study|Physician Decision|0|||
42147593|NCT00335556|75956466|FG001|Overall Study|Physician Decision|6|||
42147594|NCT00335556|75956467|FG002|Overall Study|Physician Decision|2|||
42147595|NCT00335556|75956468|FG003|Overall Study|Physician Decision|1|||
42147596|NCT00335556|75956469|FG004|Overall Study|Physician Decision|0|||
42147597|NCT00335556|75956470|FG005|Overall Study|Physician Decision|0|||
42147598|NCT00335556|75956465|FG000|Overall Study|Ineligible|2|||
42147599|NCT00335556|75956466|FG001|Overall Study|Ineligible|0|||
42147600|NCT00335556|75956467|FG002|Overall Study|Ineligible|0|||
42147601|NCT00335556|75956468|FG003|Overall Study|Ineligible|0|||
42147602|NCT00335556|75956469|FG004|Overall Study|Ineligible|0|||
42147603|NCT00335556|75956470|FG005|Overall Study|Ineligible|0|||
42147604|NCT00335556|75956465|FG000|Overall Study|Refusal of further protocol therapy|0|||
42147605|NCT00335556|75956466|FG001|Overall Study|Refusal of further protocol therapy|4|||
42147606|NCT00335556|75956467|FG002|Overall Study|Refusal of further protocol therapy|0|||
42147607|NCT00335556|75956468|FG003|Overall Study|Refusal of further protocol therapy|1|||
42147608|NCT00335556|75956469|FG004|Overall Study|Refusal of further protocol therapy|0|||
42147609|NCT00335556|75956470|FG005|Overall Study|Refusal of further protocol therapy|0|||
42147610|NCT00518687|75956491|FG000|Overall Study|Adverse Event|201|||
42147611|NCT00518687|75956492|FG001|Overall Study|Adverse Event|177|||
42147612|NCT00518687|75956491|FG000|Overall Study|Lost to Follow-up|144|||
42147613|NCT00518687|75956492|FG001|Overall Study|Lost to Follow-up|155|||
42147614|NCT00518687|75956491|FG000|Overall Study|Physician Decision|42|||
42147615|NCT00518687|75956492|FG001|Overall Study|Physician Decision|48|||
42147616|NCT00518687|75956491|FG000|Overall Study|Progressive disease|2|||
42147617|NCT00518687|75956492|FG001|Overall Study|Progressive disease|2|||
42147618|NCT00518687|75956491|FG000|Overall Study|Protocol Violation|8|||
42147619|NCT00518687|75956492|FG001|Overall Study|Protocol Violation|10|||
42147620|NCT00518687|75956491|FG000|Overall Study|Study terminated by sponsor|930|||
42147621|NCT00518687|75956492|FG001|Overall Study|Study terminated by sponsor|918|||
42147622|NCT00518687|75956491|FG000|Overall Study|Withdrawal by Subject|110|||
42147623|NCT00518687|75956492|FG001|Overall Study|Withdrawal by Subject|110|||
42147624|NCT00134056|75956500|FG000|Randomization|Not eligible for assigned treatment|22|||
42147625|NCT00134056|75956501|FG001|Randomization|Not eligible for assigned treatment|20|||
42147626|NCT00134056|75956500|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
42147627|NCT00134056|75956501|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
42147628|NCT00134056|75956500|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
42147629|NCT00134056|75956501|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
42147630|NCT00134056|75956500|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
42147631|NCT00134056|75956501|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
42147632|NCT00134056|75956500|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
42147633|NCT00134056|75956501|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
42147634|NCT00518531|75956512|FG000|Treatment Period 1|Adverse Event|5|||
42147635|NCT00518531|75956513|FG001|Treatment Period 1|Adverse Event|0|||
42147636|NCT00518531|75956512|FG000|Treatment Period 1|Lost to Follow-up|5|||
42147637|NCT00518531|75956513|FG001|Treatment Period 1|Lost to Follow-up|3|||
42147638|NCT00518531|75956512|FG000|Treatment Period 1|Physician Decision|1|||
42147639|NCT00518531|75956513|FG001|Treatment Period 1|Physician Decision|0|||
42147640|NCT00518531|75956512|FG000|Treatment Period 1|Protocol Violation|2|||
42147641|NCT00518531|75956513|FG001|Treatment Period 1|Protocol Violation|0|||
42147642|NCT00518531|75956512|FG000|Treatment Period 1|Withdrawal by Subject|4|||
42147643|NCT00518531|75956513|FG001|Treatment Period 1|Withdrawal by Subject|6|||
42147644|NCT00518531|75956512|FG000|Treatment Period 1|Early crossover|1|||
42147645|NCT00518531|75956513|FG001|Treatment Period 1|Early crossover|3|||
42147646|NCT00518531|75956512|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42147647|NCT00518531|75956513|FG001|Treatment Period 2|Withdrawal by Subject|8|||
42147648|NCT00518531|75956512|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
42147649|NCT00518531|75956513|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
42147650|NCT00518531|75956512|FG000|Treatment Period 2|Adverse Event|1|||
42147651|NCT00518531|75956513|FG001|Treatment Period 2|Adverse Event|7|||
42147652|NCT00518531|75956512|FG000|Treatment Period 2|Protocol-specified criteria|0|||
42147653|NCT00518531|75956513|FG001|Treatment Period 2|Protocol-specified criteria|1|||
42147654|NCT00518531|75956512|FG000|Treatment Period 2|Non-compliance|1|||
42147655|NCT00518531|75956513|FG001|Treatment Period 2|Non-compliance|2|||
42147656|NCT00351468|75956521|FG000|Overall Study|Adverse Event|42|||
42147657|NCT00351468|75956521|FG000|Overall Study|Withdrawal by Subject|39|||
42147658|NCT00351468|75956521|FG000|Overall Study|Various -follow up w clinical team|39|||
42147659|NCT00351468|75956521|FG000|Overall Study|Lack of Efficacy|32|||
42277834|NCT02426918|76109454|FG001|Overall Study|Withdrawal by Subject|5|||
42277835|NCT02426918|76109455|FG002|Overall Study|Withdrawal by Subject|4|||
42277836|NCT02426918|76109453|FG000|Overall Study|Other|9|||
42277837|NCT02426918|76109454|FG001|Overall Study|Other|11|||
42277838|NCT02426918|76109455|FG002|Overall Study|Other|9|||
42147660|NCT00351468|75956521|FG000|Overall Study|Non-compliance|8|||
42147661|NCT00351468|75956521|FG000|Overall Study|Lost to Follow-up|4|||
42147662|NCT00351468|75956521|FG000|Overall Study|Protocol Violation|3|||
42147663|NCT00523991|75956528|FG000|Overall Study|Adverse Event|6|||
42147664|NCT00523991|75956529|FG001|Overall Study|Adverse Event|5|||
42147665|NCT00523991|75956528|FG000|Overall Study|Protocol Violation|1|||
42277839|NCT02387840|76109469|FG000|Overall Study|Death|0|||
42277840|NCT02387840|76109470|FG001|Overall Study|Death|0|||
42147666|NCT00523991|75956529|FG001|Overall Study|Protocol Violation|4|||
42147667|NCT00523991|75956528|FG000|Overall Study|Lost to Follow-up|4|||
42147668|NCT00523991|75956529|FG001|Overall Study|Lost to Follow-up|1|||
42147669|NCT00523991|75956528|FG000|Overall Study|Withdrawal by Subject|7|||
42147670|NCT00523991|75956529|FG001|Overall Study|Withdrawal by Subject|17|||
42147671|NCT00523991|75956528|FG000|Overall Study|Other reason (not specified)|3|||
42147672|NCT00523991|75956529|FG001|Overall Study|Other reason (not specified)|0|||
42147673|NCT00350844|75956535|FG000|Overall Study|Lost to Follow-up|1|||
42147674|NCT00345540|75956539|FG000|Overall Study|Withdrawal by Subject|1|||
42147675|NCT00335322|75956546|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
42147676|NCT00335322|75956547|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
42147677|NCT00335322|75956548|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
42147678|NCT00523367|75956559|FG000|Overall Study|19 screen failures|19|||
42147679|NCT00523367|75956559|FG000|Overall Study|4 Withdrawn by PI|4|||
42147680|NCT03755765|75956566|FG000|Overall Study|Withdrawal by Subject|2|||
42147681|NCT03755765|75956567|FG001|Overall Study|Withdrawal by Subject|4|||
42147682|NCT03755765|75956568|FG002|Overall Study|Withdrawal by Subject|4|||
42147683|NCT00344448|75956576|FG000|Screening|Withdrawal by Subject|0|||
42147684|NCT00344448|75956577|FG001|Screening|Withdrawal by Subject|1|||
42147685|NCT00344448|75956576|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
42147686|NCT00344448|75956577|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
42147687|NCT00344448|75956576|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
42147688|NCT00344448|75956577|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
42147689|NCT00344448|75956576|FG000|Open Label|Withdrawal by Subject|1|||
42147690|NCT00344448|75956577|FG001|Open Label|Withdrawal by Subject|1|||
42147691|NCT00344448|75956576|FG000|Open Label|Study terminated|1|||
42147692|NCT00344448|75956577|FG001|Open Label|Study terminated|0|||
42147693|NCT00324168|75956585|FG000|Overall Study|Lost to Follow-up|19|||
42147694|NCT00324168|75956586|FG001|Overall Study|Lost to Follow-up|18|||
42147695|NCT00324168|75956585|FG000|Overall Study|Death|3|||
42147696|NCT00324168|75956586|FG001|Overall Study|Death|3|||
42147697|NCT00324168|75956585|FG000|Overall Study|Patient did not visit in f/u window|6|||
42147698|NCT00324168|75956586|FG001|Overall Study|Patient did not visit in f/u window|9|||
42147699|NCT00517829|75956594|FG000|Overall Study|Adverse Event|22|||
42147700|NCT00517829|75956595|FG001|Overall Study|Adverse Event|34|||
42147701|NCT00517829|75956594|FG000|Overall Study|Disease Progression|39|||
42147702|NCT00517829|75956595|FG001|Overall Study|Disease Progression|32|||
42147703|NCT00517829|75956594|FG000|Overall Study|Patient Request|6|||
42147704|NCT00517829|75956595|FG001|Overall Study|Patient Request|5|||
42147705|NCT00517829|75956594|FG000|Overall Study|Investigator Request|5|||
42147706|NCT00517829|75956595|FG001|Overall Study|Investigator Request|3|||
42147707|NCT00517829|75956594|FG000|Overall Study|Other|3|||
42147708|NCT00517829|75956595|FG001|Overall Study|Other|1|||
42147709|NCT00343512|75956601|FG000|Overall Study|Withdrawal by Subject|2|||
42147710|NCT00334542|75956606|FG000|Overall Study|Adverse Event|3|||
42147711|NCT00334542|75956606|FG000|Overall Study|Withdrawal by Subject|1|||
42147712|NCT00334542|75956606|FG000|Overall Study|New cancer diagnosis|1|||
42147713|NCT00112294|75956613|FG000|Overall Study|Still on study|5|||
42147714|NCT00112294|75956614|FG001|Overall Study|Still on study|0|||
42147715|NCT00235443|75956626|FG000|Overall Study|Adverse Event|4|||
42147716|NCT00235443|75956627|FG001|Overall Study|Adverse Event|12|||
42147717|NCT00235443|75956628|FG002|Overall Study|Adverse Event|17|||
42147718|NCT00235443|75956629|FG003|Overall Study|Adverse Event|44|||
42147719|NCT00235443|75956630|FG004|Overall Study|Adverse Event|10|||
42147720|NCT00235443|75956631|FG005|Overall Study|Adverse Event|15|||
42147721|NCT00235443|75956626|FG000|Overall Study|Lack of Efficacy|0|||
42147722|NCT00235443|75956627|FG001|Overall Study|Lack of Efficacy|1|||
42147723|NCT00235443|75956628|FG002|Overall Study|Lack of Efficacy|5|||
42147724|NCT00235443|75956629|FG003|Overall Study|Lack of Efficacy|12|||
42147725|NCT00235443|75956630|FG004|Overall Study|Lack of Efficacy|2|||
42147726|NCT00235443|75956631|FG005|Overall Study|Lack of Efficacy|9|||
42147727|NCT00235443|75956626|FG000|Overall Study|Withdrawal by Subject|3|||
42147728|NCT00235443|75956627|FG001|Overall Study|Withdrawal by Subject|9|||
42147729|NCT00235443|75956628|FG002|Overall Study|Withdrawal by Subject|25|||
42147730|NCT00235443|75956629|FG003|Overall Study|Withdrawal by Subject|24|||
42147731|NCT00235443|75956630|FG004|Overall Study|Withdrawal by Subject|10|||
42147732|NCT00235443|75956631|FG005|Overall Study|Withdrawal by Subject|12|||
42147733|NCT00235443|75956626|FG000|Overall Study|Lost to Follow-up|0|||
42147734|NCT00235443|75956627|FG001|Overall Study|Lost to Follow-up|8|||
42147735|NCT00235443|75956628|FG002|Overall Study|Lost to Follow-up|6|||
42147736|NCT00235443|75956629|FG003|Overall Study|Lost to Follow-up|6|||
42147737|NCT00235443|75956630|FG004|Overall Study|Lost to Follow-up|4|||
42147738|NCT00235443|75956631|FG005|Overall Study|Lost to Follow-up|3|||
42147739|NCT00235443|75956626|FG000|Overall Study|Unsatisfactory compliance|0|||
42147740|NCT00235443|75956627|FG001|Overall Study|Unsatisfactory compliance|2|||
42277841|NCT02387840|76109471|FG002|Overall Study|Death|0|||
42147741|NCT00235443|75956628|FG002|Overall Study|Unsatisfactory compliance|3|||
42147742|NCT00235443|75956629|FG003|Overall Study|Unsatisfactory compliance|4|||
42147743|NCT00235443|75956630|FG004|Overall Study|Unsatisfactory compliance|1|||
42147744|NCT00235443|75956631|FG005|Overall Study|Unsatisfactory compliance|0|||
42147745|NCT00235443|75956626|FG000|Overall Study|Other reasons for premature termination|1|||
42147746|NCT00235443|75956627|FG001|Overall Study|Other reasons for premature termination|6|||
42147747|NCT00235443|75956628|FG002|Overall Study|Other reasons for premature termination|6|||
42147748|NCT00235443|75956629|FG003|Overall Study|Other reasons for premature termination|7|||
42147749|NCT00235443|75956630|FG004|Overall Study|Other reasons for premature termination|3|||
42147750|NCT00235443|75956631|FG005|Overall Study|Other reasons for premature termination|6|||
42147751|NCT00234039|75956647|FG000|Overall Study|Adverse Event|2|||
42147752|NCT00234039|75956647|FG000|Overall Study|Progression/relapse|34|||
42147753|NCT00234039|75956647|FG000|Overall Study|Other - Not Protocol Specified|3|||
42147754|NCT00234039|75956647|FG000|Overall Study|Ineligible|9|||
42147755|NCT00234039|75956647|FG000|Overall Study|No Protocol Treatment Received|2|||
42147756|NCT00323622|75956659|FG000|Overall Study|Other|30|||
42147757|NCT00323622|75956660|FG001|Overall Study|Other|91|||
42147758|NCT00323622|75956661|FG002|Overall Study|Other|4|||
42147759|NCT00323622|75956662|FG003|Overall Study|Other|12|||
42147760|NCT00323622|75956663|FG004|Overall Study|Other|32|||
42147761|NCT00323622|75956664|FG005|Overall Study|Other|74|||
42147762|NCT00323622|75956665|FG006|Overall Study|Other|5|||
42147763|NCT00323622|75956666|FG007|Overall Study|Other|13|||
42147764|NCT00323622|75956659|FG000|Overall Study|Death|1|||
42147765|NCT00323622|75956660|FG001|Overall Study|Death|1|||
42147766|NCT00323622|75956661|FG002|Overall Study|Death|0|||
42147767|NCT00323622|75956662|FG003|Overall Study|Death|0|||
42147768|NCT00323622|75956663|FG004|Overall Study|Death|7|||
42147769|NCT00323622|75956664|FG005|Overall Study|Death|0|||
42147770|NCT00323622|75956665|FG006|Overall Study|Death|0|||
42147771|NCT00323622|75956666|FG007|Overall Study|Death|2|||
42147772|NCT00189423|75956694|FG000|Overall Study|Death|746|||
42147773|NCT00189423|75956695|FG001|Overall Study|Death|747|||
42147774|NCT00189423|75956694|FG000|Overall Study|Withdrawal by Subject|9|||
42147775|NCT00189423|75956695|FG001|Overall Study|Withdrawal by Subject|9|||
42147776|NCT00189423|75956694|FG000|Overall Study|Lost to Follow-up|10|||
42147777|NCT00189423|75956695|FG001|Overall Study|Lost to Follow-up|10|||
42147778|NCT00323310|75956701|FG000|Overall Study|Withdrawal by Subject|1|||
42147779|NCT00323310|75956701|FG000|Overall Study|a parent refused blood draw|1|||
42147780|NCT00323310|75956701|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
42147781|NCT00186537|75956708|FG000|Overall Study|Withdrawal by Subject|4|||
42147782|NCT00186537|75956709|FG001|Overall Study|Withdrawal by Subject|0|||
42147783|NCT00186537|75956710|FG002|Overall Study|Withdrawal by Subject|3|||
42147784|NCT00186537|75956708|FG000|Overall Study|ALT > 1.5 x ULN|3|||
42147785|NCT00186537|75956709|FG001|Overall Study|ALT > 1.5 x ULN|0|||
42147786|NCT00186537|75956710|FG002|Overall Study|ALT > 1.5 x ULN|0|||
42147787|NCT00517751|75956718|FG000|Overall Study|Death|3|||
42147788|NCT00517751|75956718|FG000|Overall Study|Withdrawal by Subject|37|||
42147789|NCT00517751|75956718|FG000|Overall Study|Lost to Follow-up|4|||
42147790|NCT00517751|75956718|FG000|Overall Study|patient not over due|6|||
42147791|NCT00517751|75956718|FG000|Overall Study|Patient not due for visit|76|||
42147792|NCT00517751|75956718|FG000|Overall Study|Missing|3|||
42147793|NCT00322842|75956724|FG000|Overall Study|Withdrawal by Subject|0|||
42147794|NCT00322842|75956725|FG001|Overall Study|Withdrawal by Subject|1|||
42147795|NCT00322842|75956724|FG000|Overall Study|Lost to Follow-up|0|||
42147796|NCT00322842|75956725|FG001|Overall Study|Lost to Follow-up|1|||
42147797|NCT00322842|75956724|FG000|Overall Study|Refused transplant|1|||
42147798|NCT00322842|75956725|FG001|Overall Study|Refused transplant|0|||
42147799|NCT00322842|75956724|FG000|Overall Study|Death|1|||
42147800|NCT00322842|75956725|FG001|Overall Study|Death|0|||
42147801|NCT00255723|75956734|FG000|Overall Study|Adverse Event|1|||
42147802|NCT00255723|75956735|FG001|Overall Study|Adverse Event|1|||
42147803|NCT00255723|75956734|FG000|Overall Study|Death|0|||
42147804|NCT00255723|75956735|FG001|Overall Study|Death|1|||
42147805|NCT00255723|75956734|FG000|Overall Study|Response Data Not Available|1|||
42147806|NCT00255723|75956735|FG001|Overall Study|Response Data Not Available|0|||
42147807|NCT00132808|75956744|FG000|Stratum I|Adverse Event|2|||
42147808|NCT00132808|75956745|FG001|Stratum I|Adverse Event|1|||
42147809|NCT00132808|75956746|FG002|Stratum I|Adverse Event|0|||
42147810|NCT00132808|75956744|FG000|Stratum I|Lost to Follow-up|3|||
42147811|NCT00132808|75956745|FG001|Stratum I|Lost to Follow-up|4|||
42147812|NCT00132808|75956746|FG002|Stratum I|Lost to Follow-up|1|||
42147813|NCT00132808|75956744|FG000|Stratum I|Withdrawal by Subject|4|||
42147814|NCT00132808|75956745|FG001|Stratum I|Withdrawal by Subject|7|||
42147815|NCT00132808|75956746|FG002|Stratum I|Withdrawal by Subject|3|||
42147816|NCT00132808|75956744|FG000|Stratum I|Abnormal test procedure result (s)|0|||
42147817|NCT00132808|75956745|FG001|Stratum I|Abnormal test procedure result (s)|0|||
42147818|NCT00132808|75956746|FG002|Stratum I|Abnormal test procedure result (s)|1|||
42147819|NCT00132808|75956744|FG000|Stratum II|Adverse Event|1|||
42147820|NCT00132808|75956745|FG001|Stratum II|Adverse Event|2|||
42147821|NCT00132808|75956746|FG002|Stratum II|Adverse Event|1|||
42147822|NCT00132808|75956744|FG000|Stratum II|Death|1|||
42147823|NCT00132808|75956745|FG001|Stratum II|Death|0|||
42147824|NCT00132808|75956746|FG002|Stratum II|Death|0|||
42147825|NCT00132808|75956744|FG000|Stratum II|Lost to Follow-up|2|||
42147826|NCT00132808|75956745|FG001|Stratum II|Lost to Follow-up|2|||
42147827|NCT00132808|75956746|FG002|Stratum II|Lost to Follow-up|1|||
42147828|NCT00132808|75956744|FG000|Stratum II|Protocol Violation|0|||
42147829|NCT00132808|75956745|FG001|Stratum II|Protocol Violation|2|||
42147830|NCT00132808|75956746|FG002|Stratum II|Protocol Violation|1|||
42147831|NCT00132808|75956744|FG000|Stratum II|Withdrawal by Subject|4|||
42147832|NCT00132808|75956745|FG001|Stratum II|Withdrawal by Subject|9|||
42147833|NCT00132808|75956746|FG002|Stratum II|Withdrawal by Subject|6|||
42147834|NCT00517361|75956754|FG000|Overall Study|Death|6|||
42147835|NCT00517361|75956754|FG000|Overall Study|The study was terminated|5|||
42147836|NCT00516893|75956758|FG000|Overall Study|Lost to Follow-up|4|||
42147837|NCT00516893|75956758|FG000|Overall Study|Adverse Event|3|||
42147838|NCT00516893|75956758|FG000|Overall Study|Withdrawal by Subject|2|||
42147839|NCT00516893|75956758|FG000|Overall Study|Noncompliance|2|||
42147840|NCT00516893|75956758|FG000|Overall Study|Death|1|||
42147841|NCT00516893|75956758|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
42147842|NCT00516893|75956758|FG000|Overall Study|Relocated|1|||
42147843|NCT00516893|75956758|FG000|Overall Study|Pregnancy|1|||
42147844|NCT00516893|75956758|FG000|Overall Study|Received Medication From Another Study|1|||
42147845|NCT00522431|75956762|FG000|Overall Study|Adverse Event|5|||
42147846|NCT00522431|75956762|FG000|Overall Study|Protocol Violation|2|||
42147847|NCT00522431|75956762|FG000|Overall Study|Withdrawal by Subject|2|||
42147848|NCT00522431|75956762|FG000|Overall Study|Subject non-compliance|1|||
42147849|NCT00522431|75956762|FG000|Overall Study|Other/unknown|1|||
42147850|NCT00185211|75956768|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
42147851|NCT00185211|75956769|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
42147852|NCT00185211|75956768|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
42147853|NCT00185211|75956769|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
42147854|NCT00185211|75956768|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
42147855|NCT00185211|75956769|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
42147856|NCT00185211|75956768|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
42147857|NCT00185211|75956769|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
42147858|NCT00185211|75956768|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
42147859|NCT00185211|75956769|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
42147860|NCT00185211|75956768|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
42147861|NCT00185211|75956769|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
42147862|NCT00185211|75956768|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
42147863|NCT00185211|75956769|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
42147864|NCT00185211|75956768|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
42147865|NCT00185211|75956769|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
42147866|NCT00185211|75956768|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
42147867|NCT00185211|75956769|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
42147868|NCT00185211|75956768|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
42147869|NCT00185211|75956769|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
42147870|NCT00185211|75956768|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
42147871|NCT00185211|75956769|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
42277842|NCT02387840|76109472|FG003|Overall Study|Death|0|||
42277843|NCT02387840|76109473|FG004|Overall Study|Death|0|||
42147872|NCT00185211|75956768|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
42147873|NCT00185211|75956769|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
42147874|NCT00516737|75956778|FG000|Overall Study|Lost to Follow-up|2|||
42147875|NCT00516737|75956779|FG001|Overall Study|Lost to Follow-up|0|||
42147876|NCT00516737|75956778|FG000|Overall Study|Physician Decision|0|||
42277844|NCT02387840|76109474|FG005|Overall Study|Death|1|||
42277845|NCT02387762|76109496|FG000|Overall Study|Withdrawal by Subject|1|||
42277846|NCT02387762|76109497|FG001|Overall Study|Withdrawal by Subject|0|||
42277847|NCT02418182|76109505|FG000|Overall Study|Unable to re-consent|18|||
42147877|NCT00516737|75956779|FG001|Overall Study|Physician Decision|1|||
42147878|NCT00516737|75956778|FG000|Overall Study|Withdrawal by Subject|0|||
42147879|NCT00516737|75956779|FG001|Overall Study|Withdrawal by Subject|1|||
42147880|NCT00516737|75956778|FG000|Overall Study|Lack of Qualifying Event|9|||
42147881|NCT00516737|75956779|FG001|Overall Study|Lack of Qualifying Event|6|||
42147882|NCT00132730|75956789|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
42147883|NCT00132730|75956790|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
42277848|NCT02418182|76109506|FG001|Overall Study|Unable to re-consent|15|||
42277849|NCT02418182|76109505|FG000|Overall Study|Lost to Follow-up|0|||
42277850|NCT02418182|76109506|FG001|Overall Study|Lost to Follow-up|2|||
42147884|NCT00132730|75956791|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
42147885|NCT00132730|75956792|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
42147886|NCT00132730|75956793|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
42147887|NCT00132730|75956794|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
42147888|NCT00132730|75956789|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
42147889|NCT00132730|75956790|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
42147890|NCT00132730|75956791|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
42147891|NCT00132730|75956792|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
42147892|NCT00132730|75956793|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
42147893|NCT00132730|75956794|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
42147894|NCT00132730|75956789|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
42147895|NCT00132730|75956790|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
42147896|NCT00132730|75956791|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
42147897|NCT00132730|75956792|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
42147898|NCT00132730|75956793|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
42147899|NCT00132730|75956794|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
42147900|NCT00132730|75956789|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
42277851|NCT02387372|76109527|FG000|Overall Study|Not Treated|1|||
42277852|NCT02387372|76109528|FG001|Overall Study|Not Treated|0|||
42147901|NCT00132730|75956790|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
42147902|NCT00132730|75956791|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
42147903|NCT00132730|75956792|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
42147904|NCT00132730|75956793|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
42147905|NCT00132730|75956794|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
42147906|NCT00132730|75956789|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
42147907|NCT00132730|75956790|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
42147908|NCT00132730|75956791|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
42147909|NCT00132730|75956792|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
42147910|NCT00132730|75956793|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
42147911|NCT00132730|75956794|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
42147912|NCT00132730|75956789|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
42147913|NCT00132730|75956790|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
42147914|NCT00132730|75956791|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
42147915|NCT00132730|75956792|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
42147916|NCT00132730|75956793|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
42147917|NCT00132730|75956794|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
42147918|NCT00132730|75956789|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
42147919|NCT00132730|75956790|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
42147920|NCT00132730|75956791|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
42147921|NCT00132730|75956792|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
42147922|NCT00132730|75956793|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
42147923|NCT00132730|75956794|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
42147924|NCT00132730|75956789|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
42147925|NCT00132730|75956790|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
42147926|NCT00132730|75956791|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
42147927|NCT00132730|75956792|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
42147928|NCT00132730|75956793|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
42147929|NCT00132730|75956794|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
42147930|NCT00132730|75956789|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
42147931|NCT00132730|75956790|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
42147932|NCT00132730|75956791|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
42147933|NCT00132730|75956792|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
42147934|NCT00132730|75956793|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
42147935|NCT00132730|75956794|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
42147936|NCT00132730|75956789|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
42147937|NCT00132730|75956790|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
42147938|NCT00132730|75956791|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
42147939|NCT00132730|75956792|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
42147940|NCT00132730|75956793|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
42147941|NCT00132730|75956794|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
42147942|NCT00132730|75956789|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
42147943|NCT00132730|75956790|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
42147944|NCT00132730|75956791|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
42147945|NCT00132730|75956792|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
42147946|NCT00132730|75956793|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
42147947|NCT00132730|75956794|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
42147948|NCT00132730|75956789|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
42147949|NCT00132730|75956790|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
42147950|NCT00132730|75956791|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
42147951|NCT00132730|75956792|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
42147952|NCT00132730|75956793|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
42147953|NCT00132730|75956794|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
42012650|NCT01194219|75819482|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
42012651|NCT01194219|75819483|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
42012652|NCT01194219|75819484|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
42012653|NCT01194219|75819475|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
42012654|NCT01194219|75819476|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
42012655|NCT01194219|75819477|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
42012656|NCT01194219|75819478|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
42012657|NCT01194219|75819479|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
42012658|NCT01194219|75819480|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
42147954|NCT00232557|75956810|FG000|Overall Study|Lost to Follow-up|3|||
42147955|NCT00232557|75956811|FG001|Overall Study|Lost to Follow-up|5|||
42147956|NCT00522275|75956817|FG000|Overall Study|Adverse Event|35|||
42147957|NCT00522275|75956817|FG000|Overall Study|Lack of Efficacy|80|||
42147958|NCT00522275|75956817|FG000|Overall Study|Subject withdrew consent|16|||
42147959|NCT00522275|75956817|FG000|Overall Study|Protocol deviation|1|||
42147960|NCT00522275|75956817|FG000|Overall Study|Unsatisfactory compliance|11|||
42147961|NCT00522275|75956817|FG000|Overall Study|Lost to Follow-up|8|||
42147962|NCT00522275|75956817|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
42147963|NCT00522275|75956817|FG000|Overall Study|Other: Subject is pregnant|2|||
42147964|NCT00522275|75956817|FG000|Overall Study|Other: Subject relocated|2|||
42147965|NCT00522275|75956817|FG000|Overall Study|Other: Subject arrested|1|||
42147966|NCT00522275|75956817|FG000|Overall Study|Other: Site / clinic closed|4|||
42147967|NCT00522275|75956817|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
42147968|NCT00522275|75956817|FG000|Overall Study|Other: Sponsor request|2|||
42147969|NCT00522275|75956817|FG000|Overall Study|Other: Subject ran out of medication|1|||
42147970|NCT00522275|75956817|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
42147971|NCT00522041|75956823|FG000|Overall Study|Adverse Event|9|||
42147972|NCT00522041|75956824|FG001|Overall Study|Adverse Event|3|||
42147973|NCT00522041|75956823|FG000|Overall Study|Protocol Violation|2|||
42147974|NCT00522041|75956824|FG001|Overall Study|Protocol Violation|0|||
42147975|NCT00522041|75956823|FG000|Overall Study|Lost to Follow-up|1|||
42147976|NCT00522041|75956824|FG001|Overall Study|Lost to Follow-up|4|||
42147977|NCT00522041|75956823|FG000|Overall Study|Voluntary withdrawal|5|||
42147978|NCT00522041|75956824|FG001|Overall Study|Voluntary withdrawal|4|||
42147979|NCT00522041|75956823|FG000|Overall Study|Did not receive treatment|0|||
42147980|NCT00522041|75956824|FG001|Overall Study|Did not receive treatment|1|||
42147981|NCT00122980|75956833|FG000|Overall Study|Death|0|||
42147982|NCT00122980|75956834|FG001|Overall Study|Death|1|||
42147983|NCT00122980|75956833|FG000|Overall Study|Physician Decision|2|||
42147984|NCT00122980|75956834|FG001|Overall Study|Physician Decision|0|||
42147985|NCT00122980|75956833|FG000|Overall Study|Protocol Violation|5|||
42147986|NCT00122980|75956834|FG001|Overall Study|Protocol Violation|1|||
42147987|NCT00122980|75956833|FG000|Overall Study|Withdrawal by Subject|2|||
42147988|NCT00122980|75956834|FG001|Overall Study|Withdrawal by Subject|3|||
42147989|NCT00122980|75956833|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
42147990|NCT00122980|75956834|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
42147991|NCT00122980|75956833|FG000|Overall Study|Study termination|27|||
42147992|NCT00122980|75956834|FG001|Overall Study|Study termination|35|||
42147993|NCT03868631|75956842|FG000|Baseline to Week 6|Adverse Event|0|||
42147994|NCT03868631|75956843|FG001|Baseline to Week 6|Adverse Event|3|||
42147995|NCT03868631|75956842|FG000|Baseline to Week 6|Protocol Violation|1|||
42147996|NCT03868631|75956843|FG001|Baseline to Week 6|Protocol Violation|1|||
42147997|NCT03868631|75956842|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
42147998|NCT03868631|75956843|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
42147999|NCT03868631|75956842|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
42148000|NCT03868631|75956843|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
42148001|NCT03868631|75956842|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
42148002|NCT03868631|75956843|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
42148003|NCT03868631|75956842|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
42148004|NCT03868631|75956843|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
42148005|NCT05142332|75956851|FG000|Overall Study|Withdrawal by Subject|0|||
42148006|NCT05142332|75956852|FG001|Overall Study|Withdrawal by Subject|1|||
42148007|NCT05142332|75956853|FG002|Overall Study|Withdrawal by Subject|2|||
42148008|NCT05142332|75956854|FG003|Overall Study|Withdrawal by Subject|0|||
42148009|NCT05142332|75956855|FG004|Overall Study|Withdrawal by Subject|0|||
42148010|NCT05142332|75956856|FG005|Overall Study|Withdrawal by Subject|2|||
42148011|NCT05142332|75956857|FG006|Overall Study|Withdrawal by Subject|6|||
42148012|NCT05142332|75956851|FG000|Overall Study|Left ED|3|||
42148013|NCT05142332|75956852|FG001|Overall Study|Left ED|0|||
42012659|NCT01194219|75819481|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
42148014|NCT05142332|75956853|FG002|Overall Study|Left ED|4|||
42148015|NCT05142332|75956854|FG003|Overall Study|Left ED|6|||
42148016|NCT05142332|75956855|FG004|Overall Study|Left ED|1|||
42148017|NCT05142332|75956856|FG005|Overall Study|Left ED|2|||
42148018|NCT05142332|75956857|FG006|Overall Study|Left ED|6|||
42148019|NCT05142332|75956851|FG000|Overall Study|Physician Decision|0|||
42148020|NCT05142332|75956852|FG001|Overall Study|Physician Decision|0|||
42148021|NCT05142332|75956853|FG002|Overall Study|Physician Decision|2|||
42148022|NCT05142332|75956854|FG003|Overall Study|Physician Decision|1|||
42148023|NCT05142332|75956855|FG004|Overall Study|Physician Decision|0|||
42148024|NCT05142332|75956856|FG005|Overall Study|Physician Decision|0|||
42148025|NCT05142332|75956857|FG006|Overall Study|Physician Decision|3|||
42148026|NCT05142332|75956851|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
42012660|NCT01194219|75819482|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
42148027|NCT05142332|75956852|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
42148028|NCT05142332|75956853|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
42148029|NCT05142332|75956854|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
42148030|NCT05142332|75956855|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
42148031|NCT05142332|75956856|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
42148032|NCT05142332|75956857|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
42148033|NCT04556838|75956906|FG000|Overall Study|Withdrawal by Subject|3|||
42148034|NCT04556838|75956907|FG001|Overall Study|Withdrawal by Subject|1|||
42148035|NCT04556838|75956908|FG002|Overall Study|Withdrawal by Subject|2|||
42148036|NCT04556838|75956906|FG000|Overall Study|Adverse Event|0|||
42148037|NCT04556838|75956907|FG001|Overall Study|Adverse Event|1|||
42148038|NCT04556838|75956908|FG002|Overall Study|Adverse Event|1|||
42148039|NCT04556838|75956906|FG000|Overall Study|Lost to Follow-up|0|||
42148040|NCT04556838|75956907|FG001|Overall Study|Lost to Follow-up|0|||
42148041|NCT04556838|75956908|FG002|Overall Study|Lost to Follow-up|2|||
42148042|NCT04556838|75956906|FG000|Overall Study|Subject travel|0|||
42148043|NCT04556838|75956907|FG001|Overall Study|Subject travel|1|||
42148044|NCT04556838|75956908|FG002|Overall Study|Subject travel|0|||
42148045|NCT04556838|75956906|FG000|Overall Study|Physician Decision|1|||
42148046|NCT04556838|75956907|FG001|Overall Study|Physician Decision|0|||
42148047|NCT04556838|75956908|FG002|Overall Study|Physician Decision|0|||
42148048|NCT04523181|75956927|FG000|Overall Study|Withdrawal by Subject|4|||
42148049|NCT04523181|75956928|FG001|Overall Study|Withdrawal by Subject|5|||
42148050|NCT04523181|75956927|FG000|Overall Study|Lost to Follow-up|2|||
42148051|NCT04523181|75956928|FG001|Overall Study|Lost to Follow-up|3|||
42148052|NCT04523181|75956927|FG000|Overall Study|Physician Decision|1|||
42148053|NCT04523181|75956928|FG001|Overall Study|Physician Decision|0|||
42148054|NCT04523181|75956927|FG000|Overall Study|Transferred to external facility.|1|||
42148055|NCT04523181|75956928|FG001|Overall Study|Transferred to external facility.|1|||
42148056|NCT04439799|75956938|FG000|Overall Study|Lost to Follow-up|6|||
42148057|NCT04439799|75956939|FG001|Overall Study|Lost to Follow-up|6|||
42148058|NCT04439799|75956938|FG000|Overall Study|Withdrawal by Subject|2|||
42148059|NCT04439799|75956939|FG001|Overall Study|Withdrawal by Subject|6|||
42148060|NCT04439799|75956938|FG000|Overall Study|Adverse Event|2|||
42148061|NCT04439799|75956939|FG001|Overall Study|Adverse Event|5|||
42148062|NCT04071626|75956971|FG000|Overall Study|Withdrawal by Subject|1|||
42148063|NCT04071626|75956972|FG001|Overall Study|Withdrawal by Subject|1|||
42277853|NCT02426138|76109544|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
42277854|NCT02426138|76109545|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
42277855|NCT02426684|76109558|FG000|Overall Study|Physician Decision|1|||
42277856|NCT02656173|76109564|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
42277857|NCT02656173|76109565|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
42277858|NCT02656173|76109564|FG000|Overall Study|Adverse Event|7|||
42277859|NCT02656173|76109565|FG001|Overall Study|Adverse Event|5|||
42277860|NCT02656173|76109564|FG000|Overall Study|Withdrawal by Subject|1|||
42277861|NCT02656173|76109565|FG001|Overall Study|Withdrawal by Subject|3|||
42277862|NCT02656173|76109564|FG000|Overall Study|Protocol Violation|0|||
42277863|NCT02656173|76109565|FG001|Overall Study|Protocol Violation|1|||
42277864|NCT02656173|76109564|FG000|Overall Study|Miscellaneous|2|||
42277865|NCT02656173|76109565|FG001|Overall Study|Miscellaneous|0|||
42277866|NCT02656017|76109575|FG000|Overall Study|Study burden|3|||
42277867|NCT02656017|76109576|FG001|Overall Study|Study burden|3|||
42277868|NCT02656017|76109575|FG000|Overall Study|Adverse Event|2|||
42277869|NCT02656017|76109576|FG001|Overall Study|Adverse Event|1|||
42277870|NCT02656017|76109575|FG000|Overall Study|Unable/unwilling to take study medication|2|||
42277871|NCT02656017|76109576|FG001|Overall Study|Unable/unwilling to take study medication|1|||
42277872|NCT02656017|76109575|FG000|Overall Study|Began Tolvaptan|1|||
42277873|NCT02656017|76109576|FG001|Overall Study|Began Tolvaptan|1|||
42012661|NCT01194219|75819483|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
42012662|NCT01194219|75819484|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
42012663|NCT01194219|75819475|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
42012664|NCT01194219|75819476|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
42012665|NCT01194219|75819477|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
42012666|NCT01194219|75819478|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
42012667|NCT01194219|75819479|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
42148064|NCT04071626|75956971|FG000|Overall Study|Protocol Violation|0|||
42277874|NCT02656017|76109575|FG000|Overall Study|Withdrawal by Subject|1|||
42148065|NCT04071626|75956972|FG001|Overall Study|Protocol Violation|1|||
42277875|NCT02656017|76109576|FG001|Overall Study|Withdrawal by Subject|0|||
42277876|NCT02657343|76109588|FG000|Overall Study|Death|0|||
42277877|NCT02657343|76109589|FG001|Overall Study|Death|2|||
42277878|NCT02657343|76109590|FG002|Overall Study|Death|0|||
42012668|NCT01194219|75819480|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
42148066|NCT04051008|75956981|FG000|Overall Study|Withdrawal by Subject|2|||
42148067|NCT04051008|75956982|FG001|Overall Study|Withdrawal by Subject|0|||
42148068|NCT04051008|75956983|FG002|Overall Study|Withdrawal by Subject|1|||
42277879|NCT02657343|76109591|FG003|Overall Study|Death|0|||
42277880|NCT02657343|76109592|FG004|Overall Study|Death|0|||
42277881|NCT02657343|76109593|FG005|Overall Study|Death|0|||
42277882|NCT02657343|76109588|FG000|Overall Study|Patient went to hospice|1|||
42148069|NCT03812185|75957005|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
42148070|NCT03789110|75957011|FG000|Overall Study|Adverse Event|2|||
42277883|NCT02657343|76109589|FG001|Overall Study|Patient went to hospice|0|||
42277884|NCT02657343|76109590|FG002|Overall Study|Patient went to hospice|0|||
42277885|NCT02657343|76109591|FG003|Overall Study|Patient went to hospice|0|||
42277886|NCT02657343|76109592|FG004|Overall Study|Patient went to hospice|0|||
42277887|NCT02657343|76109593|FG005|Overall Study|Patient went to hospice|0|||
42277888|NCT02657343|76109588|FG000|Overall Study|Withdrawal by Subject|0|||
42277889|NCT02657343|76109589|FG001|Overall Study|Withdrawal by Subject|0|||
42277890|NCT02657343|76109590|FG002|Overall Study|Withdrawal by Subject|0|||
42277891|NCT02657343|76109591|FG003|Overall Study|Withdrawal by Subject|0|||
42277892|NCT02657343|76109592|FG004|Overall Study|Withdrawal by Subject|1|||
42277893|NCT02657343|76109593|FG005|Overall Study|Withdrawal by Subject|0|||
42277894|NCT02655237|76109609|FG000|Overall Study|Adverse Event|10|||
42277895|NCT02655237|76109610|FG001|Overall Study|Adverse Event|7|||
42277896|NCT02655237|76109609|FG000|Overall Study|Protocol Deviation|2|||
42277897|NCT02655237|76109610|FG001|Overall Study|Protocol Deviation|0|||
42277898|NCT02655237|76109609|FG000|Overall Study|Withdrawal by Participant|1|||
42277899|NCT02655237|76109610|FG001|Overall Study|Withdrawal by Participant|2|||
42277900|NCT02655237|76109609|FG000|Overall Study|Lack of Efficacy|0|||
42277901|NCT02655237|76109610|FG001|Overall Study|Lack of Efficacy|1|||
42277902|NCT02655237|76109609|FG000|Overall Study|Recovery Leading to Surgery|2|||
42277903|NCT02655237|76109610|FG001|Overall Study|Recovery Leading to Surgery|1|||
42277904|NCT02655237|76109609|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
42277905|NCT02655237|76109610|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
42277906|NCT02655237|76109609|FG000|Overall Study|Randomized but Not Treated|1|||
42277907|NCT02655237|76109610|FG001|Overall Study|Randomized but Not Treated|0|||
42277908|NCT02657031|76109618|FG000|Overall Study|Adverse Event|1|||
42277909|NCT02657031|76109619|FG001|Overall Study|Adverse Event|2|||
42277910|NCT04375397|76109647|FG000|Overall Study|Death|1|||
42039630|NCT00813709|75847888|FG000|Open Label Period|Adverse Event|0|||
42039631|NCT00813709|75847889|FG001|Open Label Period|Adverse Event|0|||
42039632|NCT00813709|75847890|FG002|Open Label Period|Adverse Event|0|||
42039633|NCT00813709|75847891|FG003|Open Label Period|Adverse Event|5|||
42039634|NCT00813709|75847892|FG004|Open Label Period|Adverse Event|4|||
42039635|NCT00813709|75847893|FG005|Open Label Period|Adverse Event|3|||
42039636|NCT00813709|75847888|FG000|Open Label Period|Lack of Efficacy|0|||
42039637|NCT00813709|75847889|FG001|Open Label Period|Lack of Efficacy|0|||
42039638|NCT00813709|75847890|FG002|Open Label Period|Lack of Efficacy|0|||
42039639|NCT00813709|75847891|FG003|Open Label Period|Lack of Efficacy|3|||
42039640|NCT00813709|75847892|FG004|Open Label Period|Lack of Efficacy|1|||
42039641|NCT00813709|75847893|FG005|Open Label Period|Lack of Efficacy|1|||
42039642|NCT00813709|75847888|FG000|Open Label Period|Randomized but not treated|0|||
42039643|NCT00813709|75847889|FG001|Open Label Period|Randomized but not treated|0|||
42039644|NCT00813709|75847890|FG002|Open Label Period|Randomized but not treated|0|||
42039645|NCT00813709|75847891|FG003|Open Label Period|Randomized but not treated|1|||
42039646|NCT00813709|75847892|FG004|Open Label Period|Randomized but not treated|0|||
42039647|NCT00813709|75847893|FG005|Open Label Period|Randomized but not treated|1|||
42039648|NCT00813709|75847888|FG000|Open Label Period|Other|0|||
42039649|NCT00813709|75847889|FG001|Open Label Period|Other|0|||
42039650|NCT00813709|75847890|FG002|Open Label Period|Other|0|||
42039651|NCT00813709|75847891|FG003|Open Label Period|Other|11|||
42039652|NCT00813709|75847892|FG004|Open Label Period|Other|5|||
42039653|NCT00813709|75847893|FG005|Open Label Period|Other|6|||
42039654|NCT01077323|75847925|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
42039655|NCT01077323|75847926|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
42039656|NCT01077323|75847927|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
42039657|NCT01077323|75847925|FG000|Overall Study|Dispensing of drug in baseline period|0|||
42039658|NCT01077323|75847926|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
42039659|NCT01077323|75847927|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
42039660|NCT01077323|75847925|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
42277911|NCT04375397|76109648|FG001|Overall Study|Death|1|||
42277912|NCT04375397|76109647|FG000|Overall Study|Withdrew consent|2|||
42277913|NCT04375397|76109648|FG001|Overall Study|Withdrew consent|0|||
42277914|NCT04375397|76109647|FG000|Overall Study|Lost to Follow-up|6|||
42277915|NCT04375397|76109648|FG001|Overall Study|Lost to Follow-up|4|||
42277916|NCT04375397|76109647|FG000|Overall Study|Other, not specified|0|||
42039661|NCT01077323|75847926|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
42148071|NCT03789110|75957011|FG000|Overall Study|Physician Decision|1|||
42277917|NCT04375397|76109648|FG001|Overall Study|Other, not specified|1|||
42277918|NCT02387216|76109656|FG000|Overall Study|Progressive disease|2|||
42277919|NCT02387216|76109657|FG001|Overall Study|Progressive disease|0|||
42277920|NCT02387216|76109656|FG000|Overall Study|Withdrawal by Subject|3|||
42148072|NCT03789110|75957011|FG000|Overall Study|Withdrawal by Subject|2|||
42148073|NCT03789110|75957011|FG000|Overall Study|Lack of Efficacy|22|||
42148074|NCT03789110|75957011|FG000|Overall Study|still on treatment|3|||
42148075|NCT03692910|75957028|FG000|Overall Study|Lost to Follow-up|4|||
42148076|NCT03692910|75957029|FG001|Overall Study|Lost to Follow-up|0|||
42148077|NCT03692910|75957030|FG002|Overall Study|Lost to Follow-up|0|||
42148078|NCT03692910|75957028|FG000|Overall Study|Withdrawal by Subject|2|||
42148079|NCT03692910|75957029|FG001|Overall Study|Withdrawal by Subject|0|||
42148080|NCT03692910|75957030|FG002|Overall Study|Withdrawal by Subject|0|||
42148081|NCT03645863|75957039|FG000|Overall Study|Withdrawal by Subject|1|||
42148082|NCT03645863|75957040|FG001|Overall Study|Withdrawal by Subject|0|||
42148083|NCT03645863|75957041|FG002|Overall Study|Withdrawal by Subject|0|||
42148084|NCT03220776|75957062|FG000|Overall Study|Claustrophobia|0|||
42148085|NCT03220776|75957063|FG001|Overall Study|Claustrophobia|1|||
42012669|NCT01194219|75819481|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
42148086|NCT03220776|75957064|FG002|Overall Study|Claustrophobia|1|||
42148087|NCT03220776|75957065|FG003|Overall Study|Claustrophobia|0|||
42148088|NCT03220776|75957066|FG004|Overall Study|Claustrophobia|1|||
42148089|NCT03220776|75957067|FG005|Overall Study|Claustrophobia|0|||
42148090|NCT03220776|75957062|FG000|Overall Study|MRI Equipment Failure|1|||
42148091|NCT03220776|75957063|FG001|Overall Study|MRI Equipment Failure|0|||
42148092|NCT03220776|75957064|FG002|Overall Study|MRI Equipment Failure|0|||
42148093|NCT03220776|75957065|FG003|Overall Study|MRI Equipment Failure|0|||
42148094|NCT03220776|75957066|FG004|Overall Study|MRI Equipment Failure|0|||
42148095|NCT03220776|75957067|FG005|Overall Study|MRI Equipment Failure|0|||
42148096|NCT03220776|75957062|FG000|Overall Study|Inclimate Weather|0|||
42148097|NCT03220776|75957063|FG001|Overall Study|Inclimate Weather|0|||
42148098|NCT03220776|75957064|FG002|Overall Study|Inclimate Weather|0|||
42148099|NCT03220776|75957065|FG003|Overall Study|Inclimate Weather|0|||
42148100|NCT03220776|75957066|FG004|Overall Study|Inclimate Weather|0|||
42148101|NCT03220776|75957067|FG005|Overall Study|Inclimate Weather|1|||
42148102|NCT03220776|75957062|FG000|Overall Study|Physician Decision|0|||
42148103|NCT03220776|75957063|FG001|Overall Study|Physician Decision|0|||
42148104|NCT03220776|75957064|FG002|Overall Study|Physician Decision|0|||
42148105|NCT03220776|75957065|FG003|Overall Study|Physician Decision|1|||
42148106|NCT03220776|75957066|FG004|Overall Study|Physician Decision|0|||
42148107|NCT03220776|75957067|FG005|Overall Study|Physician Decision|0|||
42148108|NCT03220776|75957062|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
42148109|NCT03220776|75957063|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
42148110|NCT03220776|75957064|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
42148111|NCT03220776|75957065|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
42148112|NCT03220776|75957066|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
42148113|NCT03220776|75957067|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
42148114|NCT03220776|75957062|FG000|Overall Study|Protocol Violation|0|||
42148115|NCT03220776|75957063|FG001|Overall Study|Protocol Violation|0|||
42148116|NCT03220776|75957064|FG002|Overall Study|Protocol Violation|0|||
42148117|NCT03220776|75957065|FG003|Overall Study|Protocol Violation|2|||
42148118|NCT03220776|75957066|FG004|Overall Study|Protocol Violation|0|||
42148119|NCT03220776|75957067|FG005|Overall Study|Protocol Violation|1|||
42148120|NCT03220776|75957062|FG000|Overall Study|Withdrawal by Subject|1|||
42148121|NCT03220776|75957063|FG001|Overall Study|Withdrawal by Subject|0|||
42148122|NCT03220776|75957064|FG002|Overall Study|Withdrawal by Subject|0|||
42148123|NCT03220776|75957065|FG003|Overall Study|Withdrawal by Subject|0|||
42148124|NCT03220776|75957066|FG004|Overall Study|Withdrawal by Subject|0|||
42148125|NCT03220776|75957067|FG005|Overall Study|Withdrawal by Subject|0|||
42148126|NCT03201874|75957077|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
42148127|NCT03201874|75957078|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
42148128|NCT03201874|75957077|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
42148129|NCT03201874|75957078|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
42148130|NCT03006926|75957105|FG000|Overall Study|Adverse Event|0|||
42012670|NCT01194219|75819482|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
42148131|NCT03006926|75957106|FG001|Overall Study|Adverse Event|27|||
42148132|NCT03006926|75957105|FG000|Overall Study|Withdrawal by Subject|0|||
42148133|NCT03006926|75957106|FG001|Overall Study|Withdrawal by Subject|1|||
42148134|NCT03006926|75957105|FG000|Overall Study|Radiological Disease Progression|0|||
42148135|NCT03006926|75957106|FG001|Overall Study|Radiological Disease Progression|52|||
42148136|NCT03006926|75957105|FG000|Overall Study|Clinical Disease Progression|0|||
42277921|NCT02387216|76109657|FG001|Overall Study|Withdrawal by Subject|5|||
42148137|NCT03006926|75957106|FG001|Overall Study|Clinical Disease Progression|10|||
42148138|NCT03006926|75957105|FG000|Overall Study|Other|0|||
42148139|NCT03006926|75957106|FG001|Overall Study|Other|8|||
42148140|NCT02807636|75957122|FG000|Overall Study|Lost to Follow-up|9|||
42148141|NCT02807636|75957123|FG001|Overall Study|Lost to Follow-up|12|||
42148142|NCT02807636|75957124|FG002|Overall Study|Lost to Follow-up|6|||
42148143|NCT02807636|75957122|FG000|Overall Study|Protocol Deviation|2|||
42148144|NCT02807636|75957123|FG001|Overall Study|Protocol Deviation|0|||
42148145|NCT02807636|75957124|FG002|Overall Study|Protocol Deviation|0|||
42148146|NCT02807636|75957122|FG000|Overall Study|Symptomatic Deterioration|0|||
42148147|NCT02807636|75957123|FG001|Overall Study|Symptomatic Deterioration|1|||
42148148|NCT02807636|75957124|FG002|Overall Study|Symptomatic Deterioration|0|||
42277922|NCT02387216|76109656|FG000|Overall Study|Physician Decision|2|||
42277923|NCT02387216|76109657|FG001|Overall Study|Physician Decision|0|||
42277924|NCT02387216|76109656|FG000|Overall Study|Sponsor Decision|28|||
42277925|NCT02387216|76109657|FG001|Overall Study|Sponsor Decision|12|||
42277926|NCT02387216|76109656|FG000|Overall Study|Death|60|||
42277927|NCT02387216|76109657|FG001|Overall Study|Death|23|||
42277928|NCT02387216|76109656|FG000|Overall Study|Other|5|||
42277929|NCT02387216|76109657|FG001|Overall Study|Other|4|||
42277930|NCT02387216|76109656|FG000|Overall Study|Lost to Follow-up|0|||
42277931|NCT02387216|76109657|FG001|Overall Study|Lost to Follow-up|3|||
42277932|NCT02417246|76109665|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
42277933|NCT02417246|76109666|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
42277934|NCT02417246|76109665|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
42277935|NCT02417246|76109666|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
42012671|NCT01194219|75819483|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
42012672|NCT01194219|75819484|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
42012673|NCT01304693|75819512|FG000|Overall Study|Adverse Event|0|||
42012674|NCT01304693|75819513|FG001|Overall Study|Adverse Event|0|||
42012675|NCT01304693|75819514|FG002|Overall Study|Adverse Event|0|||
42012676|NCT01304693|75819515|FG003|Overall Study|Adverse Event|0|||
42012677|NCT01304693|75819516|FG004|Overall Study|Adverse Event|1|||
42012678|NCT01304693|75819512|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
42012679|NCT01304693|75819513|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
42012680|NCT01304693|75819514|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
42012681|NCT01304693|75819515|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
42012682|NCT01304693|75819516|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
42012683|NCT01304147|75819528|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
42012684|NCT01304147|75819529|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
42012685|NCT01303445|75819535|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
42012686|NCT01303445|75819536|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
42012687|NCT01303445|75819535|FG000|Second Intervention (7 Days)|Adverse Event|0|||
42012688|NCT01303445|75819536|FG001|Second Intervention (7 Days)|Adverse Event|2|||
42012689|NCT01303445|75819535|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
42012690|NCT01303445|75819536|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
42012691|NCT01303445|75819535|FG000|Washout (14 Days)|Protocol Violation|1|||
42012692|NCT01303445|75819536|FG001|Washout (14 Days)|Protocol Violation|0|||
42012693|NCT01303445|75819535|FG000|Washout (14 Days)|Lost to Follow-up|0|||
42012694|NCT01303445|75819536|FG001|Washout (14 Days)|Lost to Follow-up|2|||
42012695|NCT01303445|75819535|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
42012696|NCT01303445|75819536|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
42012697|NCT01303445|75819535|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
42012698|NCT01303445|75819536|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
42012699|NCT01188681|75819550|FG000|Overall Study|bladder cancer|0|||
42012700|NCT01188681|75819551|FG001|Overall Study|bladder cancer|0|||
42012701|NCT01188681|75819552|FG002|Overall Study|bladder cancer|1|||
42012702|NCT01188681|75819553|FG003|Overall Study|bladder cancer|0|||
42012703|NCT01188681|75819550|FG000|Overall Study|Withdrawal by Subject|0|||
42012704|NCT01188681|75819551|FG001|Overall Study|Withdrawal by Subject|0|||
42012705|NCT01188681|75819552|FG002|Overall Study|Withdrawal by Subject|0|||
42012706|NCT01188681|75819553|FG003|Overall Study|Withdrawal by Subject|1|||
42012707|NCT01302899|75819569|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
42012708|NCT01302899|75819570|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
42012709|NCT01302899|75819569|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
42012710|NCT01302899|75819570|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
42012711|NCT01187901|75819582|FG000|Overall Study|Protocol Violation|1|||
42012712|NCT01187901|75819583|FG001|Overall Study|Protocol Violation|0|||
42012713|NCT01187901|75819582|FG000|Overall Study|Lost to Follow-up|1|||
42012714|NCT01187901|75819583|FG001|Overall Study|Lost to Follow-up|2|||
42012715|NCT01187901|75819582|FG000|Overall Study|Unrelated Health Reasons|1|||
42012716|NCT01187901|75819583|FG001|Overall Study|Unrelated Health Reasons|2|||
42012717|NCT01187901|75819582|FG000|Overall Study|Suspected Allergic Reaction|1|||
42012718|NCT01187901|75819583|FG001|Overall Study|Suspected Allergic Reaction|1|||
42148149|NCT02807636|75957122|FG000|Overall Study|Withdrawal by Subject|39|||
42277936|NCT02417246|76109665|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
42148150|NCT02807636|75957123|FG001|Overall Study|Withdrawal by Subject|27|||
42148151|NCT02807636|75957124|FG002|Overall Study|Withdrawal by Subject|23|||
42148152|NCT02807636|75957122|FG000|Overall Study|Death|298|||
42148153|NCT02807636|75957123|FG001|Overall Study|Death|327|||
42148154|NCT02807636|75957124|FG002|Overall Study|Death|266|||
42148155|NCT02807636|75957122|FG000|Overall Study|Ongoing in Study|52|||
42148156|NCT02807636|75957123|FG001|Overall Study|Ongoing in Study|84|||
42277937|NCT02417246|76109666|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
42277938|NCT02417246|76109665|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
42277939|NCT02417246|76109666|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
42277940|NCT02424734|76109677|FG000|Overall Study|Treatment stopped to be discharged home|2|||
42277941|NCT02424734|76109678|FG001|Overall Study|Treatment stopped to be discharged home|2|||
42277942|NCT02424734|76109679|FG002|Overall Study|Treatment stopped to be discharged home|0|||
42277943|NCT02424578|76109690|FG000|Overall Study|Withdrawal by Subject|0|||
42277944|NCT02424578|76109691|FG001|Overall Study|Withdrawal by Subject|1|||
42277945|NCT02416934|76109699|FG000|Overall Study|given steroids|1|||
42277946|NCT02416934|76109700|FG001|Overall Study|given steroids|2|||
42277947|NCT02416934|76109699|FG000|Overall Study|Lost to Follow-up|0|||
42277948|NCT02416934|76109700|FG001|Overall Study|Lost to Follow-up|2|||
42148157|NCT02807636|75957124|FG002|Overall Study|Ongoing in Study|67|||
42148158|NCT02684058|75957146|FG000|Treatment Period|Progressive disease|4|||
42148159|NCT02684058|75957147|FG001|Treatment Period|Progressive disease|10|||
42148160|NCT02684058|75957148|FG002|Treatment Period|Progressive disease|19|||
42148161|NCT02684058|75957146|FG000|Treatment Period|Adverse Event|3|||
42148162|NCT02684058|75957147|FG001|Treatment Period|Adverse Event|8|||
42148163|NCT02684058|75957148|FG002|Treatment Period|Adverse Event|1|||
42148164|NCT02684058|75957146|FG000|Treatment Period|Physician Decision|5|||
42148165|NCT02684058|75957147|FG001|Treatment Period|Physician Decision|1|||
42148166|NCT02684058|75957148|FG002|Treatment Period|Physician Decision|2|||
42148167|NCT02684058|75957146|FG000|Treatment Period|New therapy for study indication|1|||
42148168|NCT02684058|75957147|FG001|Treatment Period|New therapy for study indication|0|||
42148169|NCT02684058|75957148|FG002|Treatment Period|New therapy for study indication|0|||
42148170|NCT02684058|75957146|FG000|Treatment Period|Protocol deviation|0|||
42148171|NCT02684058|75957147|FG001|Treatment Period|Protocol deviation|1|||
42148172|NCT02684058|75957148|FG002|Treatment Period|Protocol deviation|0|||
42148173|NCT02684058|75957146|FG000|Treatment Period|Subject/guardian decision|4|||
42148174|NCT02684058|75957147|FG001|Treatment Period|Subject/guardian decision|3|||
42148175|NCT02684058|75957148|FG002|Treatment Period|Subject/guardian decision|0|||
42148176|NCT02684058|75957146|FG000|Treatment Period|Death|0|||
42148177|NCT02684058|75957147|FG001|Treatment Period|Death|0|||
42148178|NCT02684058|75957148|FG002|Treatment Period|Death|2|||
42148179|NCT02684058|75957146|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
42148180|NCT02684058|75957147|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
42148181|NCT02684058|75957148|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
42148182|NCT02684058|75957146|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
42148183|NCT02684058|75957147|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
42148184|NCT02684058|75957148|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
42148185|NCT02684058|75957146|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
42148186|NCT02684058|75957147|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
42148187|NCT02684058|75957148|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
42148188|NCT02684058|75957146|FG000|Post-treatment Efficacy Follow-up|Death|0|||
42148189|NCT02684058|75957147|FG001|Post-treatment Efficacy Follow-up|Death|0|||
42148190|NCT02684058|75957148|FG002|Post-treatment Efficacy Follow-up|Death|3|||
42148191|NCT02684058|75957146|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
42148192|NCT02684058|75957147|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
42148193|NCT02684058|75957148|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
42148194|NCT02684058|75957146|FG000|Post-treatment Survival Follow-up|Death|0|||
42148195|NCT02684058|75957147|FG001|Post-treatment Survival Follow-up|Death|0|||
42148196|NCT02684058|75957148|FG002|Post-treatment Survival Follow-up|Death|7|||
42148197|NCT02684058|75957146|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
42148198|NCT02684058|75957147|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
42277949|NCT02416934|76109699|FG000|Overall Study|Withdrawal by Subject|1|||
42277950|NCT02416934|76109700|FG001|Overall Study|Withdrawal by Subject|0|||
42277951|NCT02416934|76109699|FG000|Overall Study|recruited during continuing renewal proc|0|||
42277952|NCT02416934|76109700|FG001|Overall Study|recruited during continuing renewal proc|1|||
42148199|NCT02684058|75957148|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
42148200|NCT02684058|75957146|FG000|Crossover Treatment Period|Progressive disease|0|||
42148201|NCT02684058|75957147|FG001|Crossover Treatment Period|Progressive disease|1|||
42148202|NCT02684058|75957148|FG002|Crossover Treatment Period|Progressive disease|0|||
42148203|NCT02561273|75957165|FG000|Overall Study|Protocol Violation|1|||
42148204|NCT02561273|75957166|FG001|Overall Study|Protocol Violation|0|||
42277953|NCT02416934|76109699|FG000|Overall Study|Protocol Violation|0|||
42351199|NCT01515423|76191103|FG001|DOUBLE BLIND|Adverse Event|15|||
42351200|NCT01515423|76191104|FG002|DOUBLE BLIND|Adverse Event|13|||
42351201|NCT01515423|76191102|FG000|DOUBLE BLIND|Death|0|||
42277954|NCT02416934|76109700|FG001|Overall Study|Protocol Violation|1|||
42277955|NCT02416934|76109699|FG000|Overall Study|surgery started late|0|||
42277956|NCT02416934|76109700|FG001|Overall Study|surgery started late|1|||
42277957|NCT02416934|76109699|FG000|Overall Study|re-operation|1|||
42277958|NCT02416934|76109700|FG001|Overall Study|re-operation|0|||
42277959|NCT02819635|76109720|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
42277960|NCT02819635|76109721|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
42277961|NCT02819635|76109722|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
42277962|NCT02819635|76109723|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
42277963|NCT02819635|76109724|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
42277964|NCT02819635|76109725|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
42277965|NCT02819635|76109726|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
42277966|NCT02819635|76109727|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
42277967|NCT02819635|76109728|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
42277968|NCT02819635|76109729|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
42277969|NCT02819635|76109730|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
42277970|NCT02819635|76109731|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
42351202|NCT01515423|76191103|FG001|DOUBLE BLIND|Death|1|||
42351203|NCT01515423|76191104|FG002|DOUBLE BLIND|Death|2|||
42351204|NCT01515423|76191102|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
42351205|NCT01515423|76191103|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
42351206|NCT01515423|76191104|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
42351207|NCT01515423|76191102|FG000|DOUBLE BLIND|Pregnancy|0|||
42351208|NCT01515423|76191103|FG001|DOUBLE BLIND|Pregnancy|2|||
42351209|NCT01515423|76191104|FG002|DOUBLE BLIND|Pregnancy|0|||
42351210|NCT01515423|76191102|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
42351211|NCT01515423|76191103|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
42351212|NCT01515423|76191104|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
42351213|NCT01515423|76191102|FG000|DOUBLE BLIND|Other|0|||
42351214|NCT01515423|76191103|FG001|DOUBLE BLIND|Other|6|||
42012719|NCT01187901|75819582|FG000|Overall Study|Adverse Event|3|||
42012720|NCT01187901|75819583|FG001|Overall Study|Adverse Event|0|||
42012721|NCT01187901|75819582|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
42012722|NCT01187901|75819583|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
42012723|NCT01187901|75819582|FG000|Overall Study|Pregnancy|0|||
42012724|NCT01187901|75819583|FG001|Overall Study|Pregnancy|2|||
42012725|NCT01302119|75819591|FG000|Overall Study|Withdrawal by Subject|30|||
42012726|NCT01302119|75819592|FG001|Overall Study|Withdrawal by Subject|20|||
42012727|NCT01302119|75819591|FG000|Overall Study|Lost to Follow-up|10|||
42039662|NCT01077323|75847927|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
42039663|NCT00976950|75847935|FG000|Overall Study|Adverse Event|3|||
42039664|NCT00976950|75847935|FG000|Overall Study|Events with no relationship to Aptivus|3|||
42039665|NCT05570500|75847956|FG000|Overall Study|Lost to Follow-up|7|||
42039666|NCT05570500|75847957|FG001|Overall Study|Lost to Follow-up|5|||
42039667|NCT05466682|75847965|FG000|Overall Study|Withdrawal by Subject|0|||
42039668|NCT05466682|75847966|FG001|Overall Study|Withdrawal by Subject|2|||
42039669|NCT05466682|75847965|FG000|Overall Study|Lost to Follow-up|2|||
42039670|NCT05466682|75847966|FG001|Overall Study|Lost to Follow-up|1|||
42148205|NCT02025010|75957202|FG000|Overall Study|Symptomatic or radiographic progression|36|||
42148206|NCT02025010|75957202|FG000|Overall Study|Adverse Event|6|||
42148207|NCT02025010|75957202|FG000|Overall Study|Physician Decision|7|||
42148208|NCT02025010|75957202|FG000|Overall Study|Withdrawal by Subject|3|||
42148209|NCT02025010|75957202|FG000|Overall Study|Intercurrent illness|3|||
42148210|NCT02025010|75957202|FG000|Overall Study|Patients still on treatment|3|||
42148211|NCT02025010|75957202|FG000|Overall Study|Never initiate the treatment|2|||
42148212|NCT02006576|75957211|FG000|Overall Study|Withdrawal by Subject|4|||
42148213|NCT02006576|75957212|FG001|Overall Study|Withdrawal by Subject|6|||
42148214|NCT02006576|75957213|FG002|Overall Study|Withdrawal by Subject|2|||
42148215|NCT02006576|75957211|FG000|Overall Study|Death|0|||
42148216|NCT02006576|75957212|FG001|Overall Study|Death|0|||
42148217|NCT02006576|75957213|FG002|Overall Study|Death|1|||
42148218|NCT02006576|75957211|FG000|Overall Study|Lost to Follow-up|1|||
42148219|NCT02006576|75957212|FG001|Overall Study|Lost to Follow-up|0|||
42148220|NCT02006576|75957213|FG002|Overall Study|Lost to Follow-up|1|||
42148221|NCT02006576|75957211|FG000|Overall Study|Screen Failure, too sick, other|13|||
42351215|NCT01515423|76191104|FG002|DOUBLE BLIND|Other|12|||
42351216|NCT01515423|76191102|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
42148222|NCT02006576|75957212|FG001|Overall Study|Screen Failure, too sick, other|1|||
42351217|NCT01515423|76191103|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
42351218|NCT01515423|76191104|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
42351219|NCT00637156|76191113|FG000|Overall Study|Withdrawal by Subject|0|||
42148223|NCT02006576|75957213|FG002|Overall Study|Screen Failure, too sick, other|13|||
42148224|NCT01651403|75957223|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
42148225|NCT01651403|75957224|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
42148226|NCT01651403|75957223|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
42148227|NCT01651403|75957224|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
42148228|NCT01651403|75957223|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
42148229|NCT01651403|75957224|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
42148230|NCT01651403|75957223|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
42148231|NCT01651403|75957224|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
42148232|NCT01651403|75957223|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
42148233|NCT01651403|75957224|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
42148234|NCT01651403|75957223|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
42148235|NCT01651403|75957224|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
42148236|NCT01515748|75957237|FG000|Overall Study|Withdrawal by Subject|32|||
42148237|NCT01515748|75957238|FG001|Overall Study|Withdrawal by Subject|41|||
42148238|NCT01515748|75957237|FG000|Overall Study|Lost to Follow-up|2|||
42148239|NCT01515748|75957238|FG001|Overall Study|Lost to Follow-up|4|||
42148240|NCT01515748|75957237|FG000|Overall Study|Other than specified above|5|||
42148241|NCT01515748|75957238|FG001|Overall Study|Other than specified above|10|||
42148242|NCT01309672|75957245|FG000|Overall Study|Lack of Efficacy|20|||
42148243|NCT01309672|75957245|FG000|Overall Study|Other|9|||
42148244|NCT01309672|75957245|FG000|Overall Study|Adverse Event|5|||
42148245|NCT01309672|75957245|FG000|Overall Study|Withdrawal by Subject|3|||
42148246|NCT00340704|75957263|FG000|PK Study|Adverse Event|0|||
42148247|NCT00340704|75957264|FG001|PK Study|Adverse Event|1|||
42148248|NCT00340704|75957265|FG002|PK Study|Adverse Event|0|||
42148249|NCT00340704|75957266|FG003|PK Study|Adverse Event|0|||
42148250|NCT00340704|75957267|FG004|PK Study|Adverse Event|0|||
42148251|NCT00340704|75957268|FG005|PK Study|Adverse Event|0|||
42148252|NCT00340704|75957269|FG006|PK Study|Adverse Event|0|||
42148253|NCT00340704|75957270|FG007|PK Study|Adverse Event|0|||
42148254|NCT00340704|75957271|FG008|PK Study|Adverse Event|0|||
42148255|NCT00340704|75957263|FG000|PK Study|Not treated|0|||
42148256|NCT00340704|75957264|FG001|PK Study|Not treated|0|||
42148257|NCT00340704|75957265|FG002|PK Study|Not treated|1|||
42148258|NCT00340704|75957266|FG003|PK Study|Not treated|0|||
42148259|NCT00340704|75957267|FG004|PK Study|Not treated|0|||
42148260|NCT00340704|75957268|FG005|PK Study|Not treated|0|||
42148261|NCT00340704|75957269|FG006|PK Study|Not treated|0|||
42148262|NCT00340704|75957270|FG007|PK Study|Not treated|0|||
42148263|NCT00340704|75957271|FG008|PK Study|Not treated|0|||
42148264|NCT00340704|75957263|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
42148265|NCT00340704|75957264|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
42148266|NCT00340704|75957265|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
42148267|NCT00340704|75957266|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
42148268|NCT00340704|75957267|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
42148269|NCT00340704|75957268|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
42148270|NCT00340704|75957269|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
42148271|NCT00340704|75957270|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
42148272|NCT00340704|75957271|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
42148273|NCT00340704|75957263|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
42148274|NCT00340704|75957264|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
42148275|NCT00340704|75957265|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
42148276|NCT00340704|75957266|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
42148277|NCT00340704|75957267|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
42148278|NCT00340704|75957268|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
42148279|NCT00340704|75957269|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
42148280|NCT00340704|75957270|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
42148281|NCT00340704|75957271|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
42148282|NCT00340704|75957263|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
42148283|NCT00340704|75957264|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
42148284|NCT00340704|75957265|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
42148285|NCT00340704|75957266|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
42148286|NCT00340704|75957267|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
42148287|NCT00340704|75957268|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
42351220|NCT00637156|76191114|FG001|Overall Study|Withdrawal by Subject|7|||
42148288|NCT00340704|75957269|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
42148289|NCT00340704|75957270|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
42148290|NCT00340704|75957271|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
42148291|NCT00340704|75957263|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
42148292|NCT00340704|75957264|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
42148293|NCT00340704|75957265|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
42148294|NCT00340704|75957266|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
42148295|NCT00340704|75957267|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
42148296|NCT00340704|75957268|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
42148297|NCT00340704|75957269|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
42148298|NCT00340704|75957270|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
42148299|NCT00340704|75957271|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
42148300|NCT00132496|75957299|FG000|Overall Study|Withdrawal by Subject|1|||
42148301|NCT00132496|75957300|FG001|Overall Study|Withdrawal by Subject|2|||
42148302|NCT00132496|75957299|FG000|Overall Study|Physician Decision|1|||
42148303|NCT00132496|75957300|FG001|Overall Study|Physician Decision|0|||
42148304|NCT00231777|75957308|FG000|Overall Study|Lost to Follow-up|3|||
42148305|NCT00231777|75957309|FG001|Overall Study|Lost to Follow-up|0|||
42148306|NCT00231777|75957308|FG000|Overall Study|Other|3|||
42148307|NCT00231777|75957309|FG001|Overall Study|Other|2|||
42148308|NCT00231465|75957315|FG000|Overall Study|Completed only one cycle|1|||
42148309|NCT00231465|75957315|FG000|Overall Study|Did not have follow up CT scans|1|||
42148310|NCT00254397|75957323|FG000|Overall Study|Disease Progression|4|||
42277971|NCT02819635|76109720|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
42277972|NCT02819635|76109721|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
42148311|NCT00254397|75957324|FG001|Overall Study|Disease Progression|1|||
42148312|NCT00254397|75957325|FG002|Overall Study|Disease Progression|16|||
42148313|NCT00254397|75957326|FG003|Overall Study|Disease Progression|23|||
42148314|NCT00254397|75957323|FG000|Overall Study|Non-Compliant|0|||
42148315|NCT00254397|75957324|FG001|Overall Study|Non-Compliant|0|||
42148316|NCT00254397|75957325|FG002|Overall Study|Non-Compliant|0|||
42148317|NCT00254397|75957326|FG003|Overall Study|Non-Compliant|1|||
42148318|NCT00254397|75957323|FG000|Overall Study|Adverse Event|2|||
42148319|NCT00254397|75957324|FG001|Overall Study|Adverse Event|0|||
42148320|NCT00254397|75957325|FG002|Overall Study|Adverse Event|3|||
42148321|NCT00254397|75957326|FG003|Overall Study|Adverse Event|1|||
42148322|NCT00254163|75957337|FG000|Overall Study|Adverse Event|29|||
42148323|NCT00254163|75957338|FG001|Overall Study|Adverse Event|26|||
42148324|NCT00254163|75957337|FG000|Overall Study|Patient request/withdrew consent|6|||
42148325|NCT00254163|75957338|FG001|Overall Study|Patient request/withdrew consent|4|||
42148326|NCT00254163|75957337|FG000|Overall Study|Investigator request|1|||
42148327|NCT00254163|75957338|FG001|Overall Study|Investigator request|3|||
42148328|NCT00254163|75957337|FG000|Overall Study|Failed entry|1|||
42148329|NCT00254163|75957338|FG001|Overall Study|Failed entry|3|||
42148330|NCT00254163|75957337|FG000|Overall Study|Progressive disease|0|||
42148331|NCT00254163|75957338|FG001|Overall Study|Progressive disease|1|||
42148332|NCT00254163|75957337|FG000|Overall Study|Death|0|||
42148333|NCT00254163|75957338|FG001|Overall Study|Death|1|||
42148334|NCT00254163|75957337|FG000|Overall Study|Other|8|||
42148335|NCT00254163|75957338|FG001|Overall Study|Other|8|||
42148336|NCT03869333|75957348|FG000|Overall Study|Lost to Follow-up|1|||
42148337|NCT03869333|75957349|FG001|Overall Study|Lost to Follow-up|0|||
42148338|NCT03869333|75957350|FG002|Overall Study|Lost to Follow-up|0|||
42148339|NCT03869333|75957351|FG003|Overall Study|Lost to Follow-up|0|||
42148340|NCT03869333|75957348|FG000|Overall Study|Pregnancy|1|||
42148341|NCT03869333|75957349|FG001|Overall Study|Pregnancy|0|||
42148342|NCT03869333|75957350|FG002|Overall Study|Pregnancy|0|||
42148343|NCT03869333|75957351|FG003|Overall Study|Pregnancy|0|||
42148344|NCT03869333|75957348|FG000|Overall Study|Physician Decision|0|||
42148345|NCT03869333|75957349|FG001|Overall Study|Physician Decision|1|||
42148346|NCT03869333|75957350|FG002|Overall Study|Physician Decision|0|||
42148347|NCT03869333|75957351|FG003|Overall Study|Physician Decision|0|||
42277973|NCT02819635|76109722|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
42148348|NCT00110890|75957363|FG000|Overall Study|Adverse Event|30|||
42148349|NCT00110890|75957364|FG001|Overall Study|Adverse Event|7|||
42148350|NCT00110890|75957363|FG000|Overall Study|Death|16|||
42148351|NCT00110890|75957364|FG001|Overall Study|Death|9|||
42148352|NCT00110890|75957363|FG000|Overall Study|Lost to Follow-up|3|||
42148353|NCT00110890|75957364|FG001|Overall Study|Lost to Follow-up|1|||
42148354|NCT00110890|75957363|FG000|Overall Study|Physician Decision|4|||
42148355|NCT00110890|75957364|FG001|Overall Study|Physician Decision|5|||
42148356|NCT00110890|75957363|FG000|Overall Study|Withdrawal by Subject|17|||
42148357|NCT00110890|75957364|FG001|Overall Study|Withdrawal by Subject|5|||
42148358|NCT00110890|75957363|FG000|Overall Study|Protocol Deviation|1|||
42148359|NCT00110890|75957364|FG001|Overall Study|Protocol Deviation|0|||
42148360|NCT00110890|75957363|FG000|Overall Study|Noncompliance|10|||
42148361|NCT00110890|75957364|FG001|Overall Study|Noncompliance|0|||
42148362|NCT00110890|75957363|FG000|Overall Study|Kidney Transplant|16|||
42148363|NCT00110890|75957364|FG001|Overall Study|Kidney Transplant|12|||
42148364|NCT00110890|75957363|FG000|Overall Study|Invest. Product Commercially Available|217|||
42148365|NCT00110890|75957364|FG001|Overall Study|Invest. Product Commercially Available|110|||
42148366|NCT00110890|75957363|FG000|Overall Study|Other|34|||
42148367|NCT00110890|75957364|FG001|Overall Study|Other|23|||
42148368|NCT00110890|75957363|FG000|Overall Study|Ineligibility determined|3|||
42148369|NCT00110890|75957364|FG001|Overall Study|Ineligibility determined|0|||
42148370|NCT00110890|75957363|FG000|Overall Study|Requirement for alternative therapy|0|||
42148371|NCT00110890|75957364|FG001|Overall Study|Requirement for alternative therapy|1|||
42148372|NCT00110890|75957363|FG000|Overall Study|Disease progression|0|||
42148373|NCT00110890|75957364|FG001|Overall Study|Disease progression|1|||
42148374|NCT00110890|75957363|FG000|Overall Study|Parathyroidectomy|0|||
42039671|NCT05099640|75847979|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
42148375|NCT00110890|75957364|FG001|Overall Study|Parathyroidectomy|1|||
42148376|NCT00110890|75957363|FG000|Overall Study|Did not enter follow-up phase|10|||
42148377|NCT00110890|75957364|FG001|Overall Study|Did not enter follow-up phase|4|||
42148378|NCT00182637|75957370|FG000|Overall Study|Adverse Event|2|||
42148379|NCT00182637|75957370|FG000|Overall Study|Disease Progression|1|||
42277974|NCT02819635|76109723|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
42277975|NCT02819635|76109724|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
42277976|NCT02819635|76109725|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
42277977|NCT02819635|76109726|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
42277978|NCT02819635|76109727|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
42277979|NCT02819635|76109728|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
42277980|NCT02819635|76109729|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
42277981|NCT02819635|76109730|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
42277982|NCT02819635|76109731|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
42277983|NCT02819635|76109720|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
42277984|NCT02819635|76109721|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
42277985|NCT02819635|76109722|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
42277986|NCT02819635|76109723|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
42277987|NCT02819635|76109724|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
42277988|NCT02819635|76109725|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
42277989|NCT02819635|76109726|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
42277990|NCT02819635|76109727|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
42277991|NCT02819635|76109728|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
42277992|NCT02819635|76109729|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
42277993|NCT02819635|76109730|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
42277994|NCT02819635|76109731|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
42277995|NCT02819635|76109720|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
42277996|NCT02819635|76109721|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
42277997|NCT02819635|76109722|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
42277998|NCT02819635|76109723|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
42277999|NCT02819635|76109724|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
42278000|NCT02819635|76109725|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
42278001|NCT02819635|76109726|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
42278002|NCT02819635|76109727|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
42278003|NCT02819635|76109728|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
42278004|NCT02819635|76109729|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
42278005|NCT02819635|76109730|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
42278006|NCT02819635|76109731|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
42278007|NCT02819635|76109720|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
42278008|NCT02819635|76109721|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
42278009|NCT02819635|76109722|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
42278010|NCT02819635|76109723|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
42278011|NCT02819635|76109724|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
42278012|NCT02819635|76109725|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
42278013|NCT02819635|76109726|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
42278014|NCT02819635|76109727|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
42148380|NCT00182325|75957377|FG000|Overall Study|Lost to Follow-up|7|||
42148381|NCT00182325|75957378|FG001|Overall Study|Lost to Follow-up|7|||
42148382|NCT00182325|75957377|FG000|Overall Study|Miscarriage|5|||
42148383|NCT00182325|75957378|FG001|Overall Study|Miscarriage|3|||
42148384|NCT00182325|75957377|FG000|Overall Study|Did not complete survey|22|||
42148385|NCT00182325|75957378|FG001|Overall Study|Did not complete survey|43|||
42148386|NCT00122278|75957386|FG000|Overall Study|Lost to Follow-up|2|||
42148387|NCT00122278|75957387|FG001|Overall Study|Lost to Follow-up|0|||
42148388|NCT00182091|75957397|FG000|Overall Study|Withdrawal by Subject|1|||
42148389|NCT00182091|75957398|FG001|Overall Study|Withdrawal by Subject|0|||
42148390|NCT00182091|75957399|FG002|Overall Study|Withdrawal by Subject|0|||
42148391|NCT00182091|75957400|FG003|Overall Study|Withdrawal by Subject|0|||
42148392|NCT00181155|75957408|FG000|Overall Study|Physician Decision|1|||
42148393|NCT00181155|75957409|FG001|Overall Study|Physician Decision|0|||
42148394|NCT00181155|75957408|FG000|Overall Study|Withdrawal by Subject|1|||
42148395|NCT00181155|75957409|FG001|Overall Study|Withdrawal by Subject|0|||
42148396|NCT00322452|75957418|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42148397|NCT00322452|75957419|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
42148398|NCT00322452|75957418|FG000|Overall Study|Lost to Follow-up|5|||
42148399|NCT00322452|75957419|FG001|Overall Study|Lost to Follow-up|2|||
42148400|NCT00322452|75957418|FG000|Overall Study|Withdrawal by Subject|19|||
42148401|NCT00322452|75957419|FG001|Overall Study|Withdrawal by Subject|46|||
42148402|NCT00322452|75957418|FG000|Overall Study|Death|223|||
42148403|NCT00322452|75957419|FG001|Overall Study|Death|227|||
42148404|NCT00110812|75957428|FG000|Main Study|Death|0|||
42148405|NCT00110812|75957429|FG001|Main Study|Death|0|||
42148406|NCT00110812|75957430|FG002|Main Study|Death|2|||
42148407|NCT00110812|75957428|FG000|Main Study|Withdrawal by Subject|0|||
42148408|NCT00110812|75957429|FG001|Main Study|Withdrawal by Subject|0|||
42148409|NCT00110812|75957430|FG002|Main Study|Withdrawal by Subject|1|||
42148410|NCT00110812|75957428|FG000|Main Study|Lost to Follow-up|8|||
42148411|NCT00110812|75957429|FG001|Main Study|Lost to Follow-up|11|||
42148412|NCT00110812|75957430|FG002|Main Study|Lost to Follow-up|10|||
42148413|NCT00110812|75957428|FG000|Extended Follow-up|Death|1|||
42148414|NCT00110812|75957429|FG001|Extended Follow-up|Death|0|||
42148415|NCT00110812|75957430|FG002|Extended Follow-up|Death|3|||
42148416|NCT00110812|75957428|FG000|Extended Follow-up|Withdrawal by Subject|0|||
42148417|NCT00110812|75957429|FG001|Extended Follow-up|Withdrawal by Subject|1|||
42148418|NCT00110812|75957430|FG002|Extended Follow-up|Withdrawal by Subject|0|||
42148419|NCT00110812|75957428|FG000|Extended Follow-up|Lost to Follow-up|1|||
42351221|NCT00637156|76191113|FG000|Overall Study|Death|0|||
42039672|NCT05099640|75847980|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
42039673|NCT05099640|75847981|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
42039674|NCT05099640|75847979|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
42039675|NCT05099640|75847980|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
42039676|NCT05099640|75847981|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
42351222|NCT00637156|76191114|FG001|Overall Study|Death|1|||
42039677|NCT05099640|75847979|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
42039678|NCT05099640|75847980|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
42039679|NCT05099640|75847981|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
42039680|NCT05099640|75847979|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
42039681|NCT05099640|75847980|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
42039682|NCT05099640|75847981|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
42039683|NCT05099640|75847979|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
42039684|NCT05099640|75847980|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
42039685|NCT05099640|75847981|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
42039686|NCT05099640|75847979|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
42039687|NCT05099640|75847980|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
42148420|NCT00110812|75957429|FG001|Extended Follow-up|Lost to Follow-up|3|||
42148421|NCT00110812|75957430|FG002|Extended Follow-up|Lost to Follow-up|1|||
42148422|NCT00516269|75957445|FG000|Overall Study|Adverse Event|2|||
42351223|NCT00637156|76191113|FG000|Overall Study|Lost to Follow-up|10|||
42148423|NCT00516269|75957446|FG001|Overall Study|Adverse Event|1|||
42148424|NCT00516269|75957445|FG000|Overall Study|Lost to Follow-up|0|||
42148425|NCT00516269|75957446|FG001|Overall Study|Lost to Follow-up|1|||
42148426|NCT00516269|75957445|FG000|Overall Study|Protocol Violation|0|||
42148427|NCT00516269|75957446|FG001|Overall Study|Protocol Violation|1|||
42148428|NCT00229203|75957454|FG000|Overall Study|Progressive disease|18|||
42148429|NCT00229203|75957455|FG001|Overall Study|Progressive disease|9|||
42148430|NCT00229203|75957454|FG000|Overall Study|Toxicity|6|||
42148431|NCT00229203|75957455|FG001|Overall Study|Toxicity|1|||
42148432|NCT00229203|75957454|FG000|Overall Study|Death|4|||
42148433|NCT00229203|75957455|FG001|Overall Study|Death|2|||
42148434|NCT00229203|75957454|FG000|Overall Study|Other|3|||
42148435|NCT00229203|75957455|FG001|Overall Study|Other|3|||
42148436|NCT00229203|75957454|FG000|Overall Study|Withdrawal by Subject|1|||
42351224|NCT00637156|76191114|FG001|Overall Study|Lost to Follow-up|16|||
42351225|NCT00637000|76191122|FG000|Overall Study|Withdrawal by Subject|4|||
42148437|NCT00229203|75957455|FG001|Overall Study|Withdrawal by Subject|4|||
42148438|NCT00228813|75957461|FG000|Overall Study|Death|4|||
42148439|NCT00322374|75957468|FG000|Starting Dose|Physician Decision|2|||
42148440|NCT00322374|75957469|FG001|Starting Dose|Physician Decision|0|||
42148441|NCT00322374|75957470|FG002|Starting Dose|Physician Decision|0|||
42148442|NCT00322374|75957471|FG003|Starting Dose|Physician Decision|0|||
42148443|NCT00322374|75957468|FG000|Starting Dose|Study Drug Toxicity|4|||
42148444|NCT00322374|75957469|FG001|Starting Dose|Study Drug Toxicity|0|||
42148445|NCT00322374|75957470|FG002|Starting Dose|Study Drug Toxicity|0|||
42148446|NCT00322374|75957471|FG003|Starting Dose|Study Drug Toxicity|0|||
42148447|NCT00322374|75957468|FG000|First Escalation|Documented Disease Progression|0|||
42148448|NCT00322374|75957469|FG001|First Escalation|Documented Disease Progression|6|||
42148449|NCT00322374|75957470|FG002|First Escalation|Documented Disease Progression|0|||
42148450|NCT00322374|75957471|FG003|First Escalation|Documented Disease Progression|0|||
42148451|NCT00322374|75957468|FG000|First Escalation|Physician Decision|0|||
42148452|NCT00322374|75957469|FG001|First Escalation|Physician Decision|12|||
42148453|NCT00322374|75957470|FG002|First Escalation|Physician Decision|0|||
42148454|NCT00322374|75957471|FG003|First Escalation|Physician Decision|0|||
42148455|NCT00322374|75957468|FG000|First Escalation|Study Drug Toxicity|0|||
42148456|NCT00322374|75957469|FG001|First Escalation|Study Drug Toxicity|11|||
42148457|NCT00322374|75957470|FG002|First Escalation|Study Drug Toxicity|0|||
42148458|NCT00322374|75957471|FG003|First Escalation|Study Drug Toxicity|0|||
42148459|NCT00322374|75957468|FG000|First Escalation|Participant Request|0|||
42148460|NCT00322374|75957469|FG001|First Escalation|Participant Request|1|||
42148461|NCT00322374|75957470|FG002|First Escalation|Participant Request|0|||
42148462|NCT00322374|75957471|FG003|First Escalation|Participant Request|0|||
42148463|NCT00322374|75957468|FG000|Second Escalation|Physician Decision|0|||
42148464|NCT00322374|75957469|FG001|Second Escalation|Physician Decision|0|||
42148465|NCT00322374|75957470|FG002|Second Escalation|Physician Decision|5|||
42148466|NCT00322374|75957471|FG003|Second Escalation|Physician Decision|0|||
42148467|NCT00322374|75957468|FG000|Second Escalation|Study Drug Toxicity|0|||
42148468|NCT00322374|75957469|FG001|Second Escalation|Study Drug Toxicity|0|||
42148469|NCT00322374|75957470|FG002|Second Escalation|Study Drug Toxicity|1|||
42148470|NCT00322374|75957471|FG003|Second Escalation|Study Drug Toxicity|0|||
42148471|NCT00174447|75957484|FG000|Overall Study|Adverse Event|19|||
42148472|NCT00174447|75957484|FG000|Overall Study|Withdrawal by Subject|15|||
42148473|NCT00174447|75957484|FG000|Overall Study|Protocol Violation|1|||
42148474|NCT00174447|75957484|FG000|Overall Study|Lack of Efficacy|1|||
42148475|NCT00174447|75957484|FG000|Overall Study|Administrative reason/Other|2|||
42148476|NCT00321984|75957491|FG000|Overall Study|Adverse Event|9|||
42148477|NCT00321984|75957492|FG001|Overall Study|Adverse Event|6|||
42148478|NCT00321984|75957493|FG002|Overall Study|Adverse Event|8|||
42148479|NCT00321984|75957491|FG000|Overall Study|Protocol Violation|0|||
42148480|NCT00321984|75957492|FG001|Overall Study|Protocol Violation|1|||
42148481|NCT00321984|75957493|FG002|Overall Study|Protocol Violation|1|||
42148482|NCT00321984|75957491|FG000|Overall Study|Lost to Follow-up|2|||
42148483|NCT00321984|75957492|FG001|Overall Study|Lost to Follow-up|4|||
42148484|NCT00321984|75957493|FG002|Overall Study|Lost to Follow-up|2|||
42148485|NCT00321984|75957491|FG000|Overall Study|Withdrawal by Subject|8|||
42148486|NCT00321984|75957492|FG001|Overall Study|Withdrawal by Subject|6|||
42148487|NCT00321984|75957493|FG002|Overall Study|Withdrawal by Subject|5|||
42012728|NCT01302119|75819592|FG001|Overall Study|Lost to Follow-up|4|||
42012729|NCT01302119|75819591|FG000|Overall Study|Adverse Event|2|||
42012730|NCT01302119|75819592|FG001|Overall Study|Adverse Event|1|||
42012731|NCT01302119|75819591|FG000|Overall Study|Non-compliance|4|||
42012732|NCT01302119|75819592|FG001|Overall Study|Non-compliance|2|||
42012733|NCT01302119|75819591|FG000|Overall Study|Non-specific|4|||
42012734|NCT01302119|75819592|FG001|Overall Study|Non-specific|1|||
42012735|NCT05038982|75819600|FG000|Overall Study|Withdrawal by Subject|0|||
42012736|NCT05038982|75819601|FG001|Overall Study|Withdrawal by Subject|2|||
42012737|NCT04867785|75819620|FG000|Overall Study|Adverse Event|1|||
42012738|NCT04867785|75819621|FG001|Overall Study|Adverse Event|0|||
42012739|NCT04867785|75819622|FG002|Overall Study|Adverse Event|1|||
42012740|NCT04867785|75819623|FG003|Overall Study|Adverse Event|0|||
42012741|NCT04867785|75819624|FG004|Overall Study|Adverse Event|0|||
42012742|NCT04867785|75819625|FG005|Overall Study|Adverse Event|0|||
42012743|NCT04867785|75819626|FG006|Overall Study|Adverse Event|0|||
42012744|NCT04867785|75819627|FG007|Overall Study|Adverse Event|2|||
42012745|NCT04867785|75819620|FG000|Overall Study|Lost to Follow-up|4|||
42012746|NCT04867785|75819621|FG001|Overall Study|Lost to Follow-up|4|||
42012747|NCT04867785|75819622|FG002|Overall Study|Lost to Follow-up|3|||
42012748|NCT04867785|75819623|FG003|Overall Study|Lost to Follow-up|2|||
42012749|NCT04867785|75819624|FG004|Overall Study|Lost to Follow-up|0|||
42012750|NCT04867785|75819625|FG005|Overall Study|Lost to Follow-up|1|||
42012751|NCT04867785|75819626|FG006|Overall Study|Lost to Follow-up|0|||
42012752|NCT04867785|75819627|FG007|Overall Study|Lost to Follow-up|1|||
42012753|NCT04867785|75819620|FG000|Overall Study|Withdrawal by Subject|6|||
42012754|NCT04867785|75819621|FG001|Overall Study|Withdrawal by Subject|2|||
42012755|NCT04867785|75819622|FG002|Overall Study|Withdrawal by Subject|2|||
42012756|NCT04867785|75819623|FG003|Overall Study|Withdrawal by Subject|1|||
42012757|NCT04867785|75819624|FG004|Overall Study|Withdrawal by Subject|2|||
42012758|NCT04867785|75819625|FG005|Overall Study|Withdrawal by Subject|0|||
42012759|NCT04867785|75819626|FG006|Overall Study|Withdrawal by Subject|2|||
42148488|NCT00321984|75957491|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
42148489|NCT00321984|75957492|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
42148490|NCT00321984|75957493|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
42148491|NCT00321984|75957491|FG000|Overall Study|Lack of Efficacy|3|||
42148492|NCT00321984|75957492|FG001|Overall Study|Lack of Efficacy|1|||
42148493|NCT00321984|75957493|FG002|Overall Study|Lack of Efficacy|3|||
42148494|NCT00321984|75957491|FG000|Overall Study|Noncompliant|0|||
42148495|NCT00321984|75957492|FG001|Overall Study|Noncompliant|0|||
42148496|NCT00321984|75957493|FG002|Overall Study|Noncompliant|2|||
42148497|NCT00321984|75957491|FG000|Overall Study|Pregnancy|0|||
42148498|NCT00321984|75957492|FG001|Overall Study|Pregnancy|1|||
42148499|NCT00321984|75957493|FG002|Overall Study|Pregnancy|0|||
42148500|NCT00321984|75957491|FG000|Overall Study|Per Subject Request|1|||
42148501|NCT00321984|75957492|FG001|Overall Study|Per Subject Request|0|||
42148502|NCT00321984|75957493|FG002|Overall Study|Per Subject Request|0|||
42148503|NCT00321984|75957491|FG000|Overall Study|Per Investigator Request|1|||
42148504|NCT00321984|75957492|FG001|Overall Study|Per Investigator Request|0|||
42148505|NCT00321984|75957493|FG002|Overall Study|Per Investigator Request|0|||
42148506|NCT00321984|75957491|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
42148507|NCT00321984|75957492|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
42148508|NCT00321984|75957493|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
42148509|NCT00515099|75957503|FG000|Overall Study|Lost to Follow-up|0|||
42148510|NCT00515099|75957504|FG001|Overall Study|Lost to Follow-up|4|||
42148511|NCT00515099|75957503|FG000|Overall Study|Withdrawal by Subject|2|||
42148512|NCT00515099|75957504|FG001|Overall Study|Withdrawal by Subject|0|||
42148513|NCT00515099|75957503|FG000|Overall Study|IRB Recommendation|1|||
42148514|NCT00515099|75957504|FG001|Overall Study|IRB Recommendation|0|||
42148515|NCT00110266|75957510|FG000|Overall Study|Adverse Event|27|||
42148516|NCT00110266|75957510|FG000|Overall Study|Abnormal laboratory value|15|||
42148517|NCT00110266|75957510|FG000|Overall Study|Withdrawal by Subject|16|||
42148518|NCT00110266|75957510|FG000|Overall Study|Death|17|||
42148519|NCT00110266|75957510|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
42148520|NCT00110266|75957510|FG000|Overall Study|Participant condition no longer requires study drug|1|||
42148521|NCT00174291|75957517|FG000|Overall Study|Lost to Follow-up|1|||
42148522|NCT00174291|75957518|FG001|Overall Study|Lost to Follow-up|1|||
42148523|NCT00174291|75957517|FG000|Overall Study|Protocol Violation|0|||
42148524|NCT00174291|75957518|FG001|Overall Study|Protocol Violation|2|||
42148525|NCT00174291|75957517|FG000|Overall Study|Study terminated by sponsor|1|||
42148526|NCT00174291|75957518|FG001|Overall Study|Study terminated by sponsor|0|||
42148527|NCT00174291|75957517|FG000|Overall Study|Withdrawal by Subject|3|||
42148528|NCT00174291|75957518|FG001|Overall Study|Withdrawal by Subject|3|||
42148529|NCT00366548|75957526|FG000|Infant Series|Adverse Event|1|||
42148530|NCT00366548|75957527|FG001|Infant Series|Adverse Event|3|||
42148531|NCT00366548|75957526|FG000|Infant Series|Protocol Violation|0|||
42148532|NCT00366548|75957527|FG001|Infant Series|Protocol Violation|1|||
42148533|NCT00366548|75957526|FG000|Infant Series|Withdrawal by Subject|3|||
42148534|NCT00366548|75957527|FG001|Infant Series|Withdrawal by Subject|1|||
42148535|NCT00366548|75957526|FG000|After Infant Series|Withdrawal by Subject|3|||
42148536|NCT00366548|75957527|FG001|After Infant Series|Withdrawal by Subject|1|||
42148537|NCT00366548|75957526|FG000|After Infant Series|Adverse Event|2|||
42148538|NCT00366548|75957527|FG001|After Infant Series|Adverse Event|0|||
42148539|NCT00366548|75957526|FG000|After Infant Series|Lost to Follow-up|1|||
42148540|NCT00366548|75957527|FG001|After Infant Series|Lost to Follow-up|0|||
42148541|NCT00252057|75957553|FG000|Overall Study|Withdrawal by Subject|2|||
42278015|NCT02819635|76109728|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
42278016|NCT02819635|76109729|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
42278017|NCT02819635|76109730|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
42278018|NCT02819635|76109731|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
42278019|NCT02819635|76109720|FG000|Substudy 2, Part 2|Adverse Event|0|||
42148542|NCT00252057|75957554|FG001|Overall Study|Withdrawal by Subject|5|||
42148543|NCT00252057|75957553|FG000|Overall Study|Death|1|||
42148544|NCT00252057|75957554|FG001|Overall Study|Death|2|||
42148545|NCT00252057|75957553|FG000|Overall Study|Participant previously enrolled|0|||
42148546|NCT00252057|75957554|FG001|Overall Study|Participant previously enrolled|1|||
42148547|NCT00132028|75957560|FG000|Overall Study|Adverse Event|7|||
42148548|NCT00132028|75957560|FG000|Overall Study|Death|2|||
42148549|NCT00132028|75957560|FG000|Overall Study|Lack of Efficacy|11|||
42148550|NCT00132028|75957560|FG000|Overall Study|Withdrawal by Subject|2|||
42148551|NCT00132028|75957560|FG000|Overall Study|not eligible|2|||
42148552|NCT00132028|75957560|FG000|Overall Study|Physician Decision|3|||
42148553|NCT00131248|75957564|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
42148554|NCT00131248|75957565|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
42148555|NCT00362414|75957571|FG000|Overall Study|Death|2|||
42148556|NCT00362414|75957571|FG000|Overall Study|Adverse Event|1|||
42148557|NCT00096382|75957580|FG000|Overall Study|Not treated|1|||
42148558|NCT00096382|75957581|FG001|Overall Study|Not treated|0|||
42148559|NCT00096382|75957580|FG000|Overall Study|Death during treatment|1|||
42148560|NCT00096382|75957581|FG001|Overall Study|Death during treatment|0|||
42148561|NCT00359294|75957592|FG000|Overall Study|Progressive disease|1|||
42148562|NCT00359294|75957593|FG001|Overall Study|Progressive disease|1|||
42148563|NCT00359294|75957594|FG002|Overall Study|Progressive disease|2|||
42148564|NCT00359294|75957595|FG003|Overall Study|Progressive disease|3|||
42148565|NCT00359294|75957596|FG004|Overall Study|Progressive disease|2|||
42148566|NCT00359294|75957592|FG000|Overall Study|Withdrawal by Subject|0|||
42148567|NCT00359294|75957593|FG001|Overall Study|Withdrawal by Subject|0|||
42148568|NCT00359294|75957594|FG002|Overall Study|Withdrawal by Subject|0|||
42148569|NCT00359294|75957595|FG003|Overall Study|Withdrawal by Subject|0|||
42148570|NCT00359294|75957596|FG004|Overall Study|Withdrawal by Subject|1|||
42148571|NCT00359294|75957592|FG000|Overall Study|Not treated|0|||
42148572|NCT00359294|75957593|FG001|Overall Study|Not treated|0|||
42148573|NCT00359294|75957594|FG002|Overall Study|Not treated|0|||
42148574|NCT00359294|75957595|FG003|Overall Study|Not treated|1|||
42148575|NCT00359294|75957596|FG004|Overall Study|Not treated|0|||
42148576|NCT00359294|75957592|FG000|Overall Study|Physician Decision|0|||
42148577|NCT00359294|75957593|FG001|Overall Study|Physician Decision|0|||
42148578|NCT00359294|75957594|FG002|Overall Study|Physician Decision|1|||
42148579|NCT00359294|75957595|FG003|Overall Study|Physician Decision|0|||
42148580|NCT00359294|75957596|FG004|Overall Study|Physician Decision|0|||
42148581|NCT00384332|75957606|FG000|Overall Study|Lost to Follow-up|4|||
42148582|NCT00384332|75957607|FG001|Overall Study|Lost to Follow-up|0|||
42148583|NCT00096226|75957615|FG000|Overall Study|Ineligible|2|||
42148584|NCT00096226|75957615|FG000|Overall Study|Protocol treatment not started|1|||
42148585|NCT00105508|75957621|FG000|Overall Study|Prephase Dropout|1|||
42148586|NCT00105508|75957622|FG001|Overall Study|Prephase Dropout|0|||
42148587|NCT00105508|75957621|FG000|Overall Study|Adverse Event|16|||
42148588|NCT00105508|75957622|FG001|Overall Study|Adverse Event|19|||
42278020|NCT02819635|76109721|FG001|Substudy 2, Part 2|Adverse Event|0|||
42278021|NCT02819635|76109722|FG002|Substudy 2, Part 2|Adverse Event|0|||
42278022|NCT02819635|76109723|FG003|Substudy 2, Part 2|Adverse Event|0|||
42278023|NCT02819635|76109724|FG004|Substudy 2, Part 2|Adverse Event|0|||
42278024|NCT02819635|76109725|FG005|Substudy 2, Part 2|Adverse Event|4|||
42278025|NCT02819635|76109726|FG006|Substudy 2, Part 2|Adverse Event|0|||
42278026|NCT02819635|76109727|FG007|Substudy 2, Part 2|Adverse Event|0|||
42278027|NCT02819635|76109728|FG008|Substudy 2, Part 2|Adverse Event|0|||
42278028|NCT02819635|76109729|FG009|Substudy 2, Part 2|Adverse Event|0|||
42278029|NCT02819635|76109730|FG010|Substudy 2, Part 2|Adverse Event|0|||
42278030|NCT02819635|76109731|FG011|Substudy 2, Part 2|Adverse Event|0|||
42278031|NCT02819635|76109720|FG000|Substudy 2, Part 2|Withdrew consent|0|||
42278032|NCT02819635|76109721|FG001|Substudy 2, Part 2|Withdrew consent|0|||
42278033|NCT02819635|76109722|FG002|Substudy 2, Part 2|Withdrew consent|0|||
42278034|NCT02819635|76109723|FG003|Substudy 2, Part 2|Withdrew consent|0|||
42278035|NCT02819635|76109724|FG004|Substudy 2, Part 2|Withdrew consent|0|||
42278036|NCT02819635|76109725|FG005|Substudy 2, Part 2|Withdrew consent|3|||
42278037|NCT02819635|76109726|FG006|Substudy 2, Part 2|Withdrew consent|1|||
42039688|NCT05099640|75847981|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
42148589|NCT00105508|75957621|FG000|Overall Study|Insufficient Efficacy|1|||
42148590|NCT00105508|75957622|FG001|Overall Study|Insufficient Efficacy|0|||
42148591|NCT00105508|75957621|FG000|Overall Study|Withdrawal by Subject|10|||
42148592|NCT00105508|75957622|FG001|Overall Study|Withdrawal by Subject|6|||
42148593|NCT00105508|75957621|FG000|Overall Study|Lost to Follow-up|3|||
42148594|NCT00105508|75957622|FG001|Overall Study|Lost to Follow-up|0|||
42148595|NCT00105508|75957621|FG000|Overall Study|Protocol Violation|1|||
42148596|NCT00105508|75957622|FG001|Overall Study|Protocol Violation|2|||
42148597|NCT00105508|75957621|FG000|Overall Study|Other|8|||
42278038|NCT02819635|76109727|FG007|Substudy 2, Part 2|Withdrew consent|0|||
42278039|NCT02819635|76109728|FG008|Substudy 2, Part 2|Withdrew consent|0|||
42278040|NCT02819635|76109729|FG009|Substudy 2, Part 2|Withdrew consent|0|||
42148598|NCT00105508|75957622|FG001|Overall Study|Other|9|||
42278041|NCT02819635|76109730|FG010|Substudy 2, Part 2|Withdrew consent|0|||
42148599|NCT00105196|75957630|FG000|Overall Study|Lack of Efficacy|2|||
42148600|NCT00105196|75957631|FG001|Overall Study|Lack of Efficacy|3|||
42148601|NCT00105196|75957630|FG000|Overall Study|Adverse Event|11|||
42148602|NCT00105196|75957631|FG001|Overall Study|Adverse Event|3|||
42148603|NCT00105196|75957630|FG000|Overall Study|Withdrawal by Subject|6|||
42148604|NCT00105196|75957631|FG001|Overall Study|Withdrawal by Subject|6|||
42148605|NCT00105196|75957630|FG000|Overall Study|Lost to Follow-up|3|||
42148606|NCT00105196|75957631|FG001|Overall Study|Lost to Follow-up|2|||
42148607|NCT00105196|75957630|FG000|Overall Study|Poor/noncompliance|3|||
42148608|NCT00105196|75957631|FG001|Overall Study|Poor/noncompliance|4|||
42148609|NCT00105196|75957630|FG000|Overall Study|Protocol Violation|5|||
42148610|NCT00105196|75957631|FG001|Overall Study|Protocol Violation|2|||
42148611|NCT00105196|75957630|FG000|Overall Study|pending surgery|0|||
42148612|NCT00105196|75957631|FG001|Overall Study|pending surgery|1|||
42148613|NCT00105196|75957630|FG000|Overall Study|marijuana use|0|||
42148614|NCT00105196|75957631|FG001|Overall Study|marijuana use|1|||
42148615|NCT00105196|75957630|FG000|Overall Study|Subject became unblinded|0|||
42148616|NCT00105196|75957631|FG001|Overall Study|Subject became unblinded|1|||
42148617|NCT03820024|75957639|FG000|Overall Study|Physician Decision|1|||
42148618|NCT03820024|75957640|FG001|Overall Study|Physician Decision|2|||
42148619|NCT03819634|75957646|FG000|Overall Study|Physician Decision|2|||
42148620|NCT00104572|75957653|FG000|Overall Study|Withdrawal by Subject|3|||
42148621|NCT00104572|75957654|FG001|Overall Study|Withdrawal by Subject|3|||
42148622|NCT00104572|75957655|FG002|Overall Study|Withdrawal by Subject|0|||
42148623|NCT00514943|75957665|FG000|Stage 1|Progressive disease|4|||
42148624|NCT00514943|75957666|FG001|Stage 1|Progressive disease|8|||
42148625|NCT00514943|75957665|FG000|Stage 1|Other Adverse Event|16|||
42148626|NCT00514943|75957666|FG001|Stage 1|Other Adverse Event|6|||
42148627|NCT00514943|75957665|FG000|Stage 1|Not treated|1|||
42148628|NCT00514943|75957666|FG001|Stage 1|Not treated|2|||
42148629|NCT00514943|75957665|FG000|Stage 1|Patient refused to continue study meds|8|||
42148630|NCT00514943|75957666|FG001|Stage 1|Patient refused to continue study meds|3|||
42148631|NCT00514943|75957665|FG000|Stage 1|Other than stated above|1|||
42148632|NCT00514943|75957666|FG001|Stage 1|Other than stated above|7|||
42148633|NCT00514943|75957665|FG000|Stage 2|Progressive disease|27|||
42148634|NCT00514943|75957666|FG001|Stage 2|Progressive disease|24|||
42148635|NCT00514943|75957665|FG000|Stage 2|Other Adverse Event|3|||
42148636|NCT00514943|75957666|FG001|Stage 2|Other Adverse Event|10|||
42148637|NCT00514943|75957665|FG000|Stage 2|Patient refused to continue study meds|2|||
42148638|NCT00514943|75957666|FG001|Stage 2|Patient refused to continue study meds|0|||
42148639|NCT00514943|75957665|FG000|Stage 2|Other than stated above|0|||
42148640|NCT00514943|75957666|FG001|Stage 2|Other than stated above|2|||
42148641|NCT03864653|75957687|FG000|Overall Study|Withdrawal by Subject|1|||
42148642|NCT00103402|75957693|FG000|Overall Study|Adverse Event|3|||
42148643|NCT00103402|75957694|FG001|Overall Study|Adverse Event|4|||
42148644|NCT00103402|75957693|FG000|Overall Study|Lost to Follow-up|8|||
42148645|NCT00103402|75957694|FG001|Overall Study|Lost to Follow-up|7|||
42148646|NCT00103402|75957693|FG000|Overall Study|Dissatisfied/No longer interested|6|||
42148647|NCT00103402|75957694|FG001|Overall Study|Dissatisfied/No longer interested|6|||
42148648|NCT00103402|75957693|FG000|Overall Study|Personal constraints/Other|5|||
42148649|NCT00103402|75957694|FG001|Overall Study|Personal constraints/Other|0|||
42148650|NCT03864341|75957700|FG000|Overall Study|Withdrawal by Subject|1|||
42148651|NCT00095836|75957704|FG000|Overall Study|Lost to Follow-up|1|||
42148652|NCT00095836|75957704|FG000|Overall Study|Adverse Event|1|||
42148653|NCT00095836|75957704|FG000|Overall Study|Death|2|||
42148654|NCT00168831|75957711|FG000|Overall Study|Adverse Event|36|||
42012760|NCT04867785|75819627|FG007|Overall Study|Withdrawal by Subject|5|||
42012761|NCT04867785|75819620|FG000|Overall Study|Physician Decision|0|||
42012762|NCT04867785|75819621|FG001|Overall Study|Physician Decision|0|||
42012763|NCT04867785|75819622|FG002|Overall Study|Physician Decision|0|||
42148655|NCT00168831|75957712|FG001|Overall Study|Adverse Event|47|||
42148656|NCT00168831|75957713|FG002|Overall Study|Adverse Event|74|||
42148657|NCT00168831|75957711|FG000|Overall Study|Lost to Follow-up|5|||
42148658|NCT00168831|75957712|FG001|Overall Study|Lost to Follow-up|6|||
42148659|NCT00168831|75957713|FG002|Overall Study|Lost to Follow-up|4|||
42148660|NCT00168831|75957711|FG000|Overall Study|Withdrawal by Subject|7|||
42148661|NCT00168831|75957712|FG001|Overall Study|Withdrawal by Subject|14|||
42148662|NCT00168831|75957713|FG002|Overall Study|Withdrawal by Subject|19|||
42148663|NCT00168831|75957711|FG000|Overall Study|Protocol Violation|6|||
42148664|NCT00168831|75957712|FG001|Overall Study|Protocol Violation|11|||
42012764|NCT04867785|75819623|FG003|Overall Study|Physician Decision|0|||
42012765|NCT04867785|75819624|FG004|Overall Study|Physician Decision|0|||
42148665|NCT00168831|75957713|FG002|Overall Study|Protocol Violation|11|||
42148666|NCT00168831|75957711|FG000|Overall Study|Other|6|||
42148667|NCT00168831|75957712|FG001|Overall Study|Other|3|||
42148668|NCT00168831|75957713|FG002|Overall Study|Other|6|||
42148669|NCT00103012|75957724|FG000|Overall Study|Withdrawal by Subject|2|||
42148670|NCT00103012|75957725|FG001|Overall Study|Withdrawal by Subject|1|||
42148671|NCT00103012|75957726|FG002|Overall Study|Withdrawal by Subject|2|||
42148672|NCT00103012|75957724|FG000|Overall Study|Pregnancy|1|||
42148673|NCT00103012|75957725|FG001|Overall Study|Pregnancy|0|||
42148674|NCT00103012|75957726|FG002|Overall Study|Pregnancy|0|||
42148675|NCT00103012|75957724|FG000|Overall Study|Adverse Event|0|||
42148676|NCT00103012|75957725|FG001|Overall Study|Adverse Event|0|||
42148677|NCT00103012|75957726|FG002|Overall Study|Adverse Event|1|||
42148678|NCT00103012|75957724|FG000|Overall Study|Subject non-compliant with medications|0|||
42148679|NCT00103012|75957725|FG001|Overall Study|Subject non-compliant with medications|0|||
42148680|NCT00103012|75957726|FG002|Overall Study|Subject non-compliant with medications|1|||
42148681|NCT00512135|75957734|FG000|Overall Study|Not Treated|5|||
42148682|NCT00512135|75957734|FG000|Overall Study|Lack of Efficacy|2|||
42148683|NCT00512135|75957734|FG000|Overall Study|Adverse Event|6|||
42148684|NCT00512135|75957734|FG000|Overall Study|Withdrawal by Subject|22|||
42148685|NCT00512135|75957734|FG000|Overall Study|Lost to Follow-up|27|||
42148686|NCT00512135|75957734|FG000|Overall Study|Other|22|||
42148687|NCT00251979|75957741|FG000|Overall Study|Protocol Violation|3|||
42148688|NCT00251979|75957742|FG001|Overall Study|Protocol Violation|5|||
42148689|NCT00251979|75957741|FG000|Overall Study|Adverse Event|11|||
42148690|NCT00251979|75957742|FG001|Overall Study|Adverse Event|17|||
42148691|NCT00251979|75957741|FG000|Overall Study|Withdrawal by Subject|13|||
42148692|NCT00251979|75957742|FG001|Overall Study|Withdrawal by Subject|7|||
42148693|NCT00251979|75957741|FG000|Overall Study|Lost to Follow-up|8|||
42148694|NCT00251979|75957742|FG001|Overall Study|Lost to Follow-up|6|||
42148695|NCT00251979|75957741|FG000|Overall Study|Death|3|||
42148696|NCT00251979|75957742|FG001|Overall Study|Death|5|||
42148697|NCT00511901|75957750|FG000|Overall Study|Withdrawal by Subject|1|||
42148698|NCT00511901|75957751|FG001|Overall Study|Withdrawal by Subject|3|||
42148699|NCT03862625|75957759|FG000|Overall Study|Lost to Follow-up|0|||
42148700|NCT03862625|75957760|FG001|Overall Study|Lost to Follow-up|1|||
42148701|NCT00163215|75957766|FG000|Overall Study|Lack of Efficacy|3|||
42278042|NCT02819635|76109731|FG011|Substudy 2, Part 2|Withdrew consent|0|||
42278043|NCT02819635|76109720|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
42278044|NCT02819635|76109721|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
42278045|NCT02819635|76109722|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
42278046|NCT02819635|76109723|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
42278047|NCT02819635|76109724|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
42278048|NCT02819635|76109725|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
42278049|NCT02819635|76109726|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
42278050|NCT02819635|76109727|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
42278051|NCT02819635|76109728|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
42278052|NCT02819635|76109729|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
42278053|NCT02819635|76109730|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
42278054|NCT02819635|76109731|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
42278055|NCT02819635|76109720|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
42278056|NCT02819635|76109721|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
42278057|NCT02819635|76109722|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
42278058|NCT02819635|76109723|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
42278059|NCT02819635|76109724|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
42278060|NCT02819635|76109725|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
42278061|NCT02819635|76109726|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
42278062|NCT02819635|76109727|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
42278063|NCT02819635|76109728|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
42278064|NCT02819635|76109729|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
42278065|NCT02819635|76109730|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
42278066|NCT02819635|76109731|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
42278067|NCT02819635|76109720|FG000|Substudy 2, Part 2|Other, not specified|0|||
42278068|NCT02819635|76109721|FG001|Substudy 2, Part 2|Other, not specified|0|||
42278069|NCT02819635|76109722|FG002|Substudy 2, Part 2|Other, not specified|0|||
42278070|NCT02819635|76109723|FG003|Substudy 2, Part 2|Other, not specified|0|||
42278071|NCT02819635|76109724|FG004|Substudy 2, Part 2|Other, not specified|0|||
42278072|NCT02819635|76109725|FG005|Substudy 2, Part 2|Other, not specified|4|||
42278073|NCT02819635|76109726|FG006|Substudy 2, Part 2|Other, not specified|8|||
42278074|NCT02819635|76109727|FG007|Substudy 2, Part 2|Other, not specified|0|||
42148702|NCT00163215|75957766|FG000|Overall Study|Withdrawal by Subject|5|||
42148703|NCT00163215|75957766|FG000|Overall Study|Other|7|||
42148704|NCT00228423|75957772|FG000|Overall Study|Adverse Event|2|||
42148705|NCT00228423|75957773|FG001|Overall Study|Adverse Event|5|||
42148706|NCT00228423|75957772|FG000|Overall Study|Withdrawal by Subject|7|||
42148707|NCT00228423|75957773|FG001|Overall Study|Withdrawal by Subject|3|||
42278075|NCT02819635|76109728|FG008|Substudy 2, Part 2|Other, not specified|0|||
42278076|NCT02819635|76109729|FG009|Substudy 2, Part 2|Other, not specified|0|||
42148708|NCT00228423|75957772|FG000|Overall Study|Protocol Violation|1|||
42148709|NCT00228423|75957773|FG001|Overall Study|Protocol Violation|3|||
42148710|NCT00228423|75957772|FG000|Overall Study|Physician Decision|0|||
42148711|NCT00228423|75957773|FG001|Overall Study|Physician Decision|1|||
42148712|NCT00511667|75957781|FG000|Overall Study|Adverse Event|1|||
42148713|NCT00511667|75957782|FG001|Overall Study|Adverse Event|0|||
42148714|NCT00511667|75957781|FG000|Overall Study|Protocol Violation|1|||
42148715|NCT00511667|75957782|FG001|Overall Study|Protocol Violation|1|||
42148716|NCT00511667|75957781|FG000|Overall Study|Withdrawal by Subject|2|||
42148717|NCT00511667|75957782|FG001|Overall Study|Withdrawal by Subject|0|||
42148718|NCT00511667|75957781|FG000|Overall Study|Site terminated|6|||
42148719|NCT00511667|75957782|FG001|Overall Study|Site terminated|1|||
42148720|NCT00511667|75957781|FG000|Overall Study|Other|2|||
42148721|NCT00511667|75957782|FG001|Overall Study|Other|1|||
42148722|NCT00227877|75957798|FG000|Pre-visit Assessment|Technical difficulties|7|||
42148723|NCT00227877|75957799|FG001|Pre-visit Assessment|Technical difficulties|3|||
42148724|NCT00227877|75957800|FG002|Pre-visit Assessment|Technical difficulties|0|||
42148725|NCT00227877|75957801|FG003|Pre-visit Assessment|Technical difficulties|0|||
42148726|NCT00227877|75957798|FG000|Post-visit Checklist|Lost to Follow-up|24|||
42148727|NCT00227877|75957799|FG001|Post-visit Checklist|Lost to Follow-up|13|||
42148728|NCT00227877|75957800|FG002|Post-visit Checklist|Lost to Follow-up|1|||
42148729|NCT00227877|75957801|FG003|Post-visit Checklist|Lost to Follow-up|0|||
42148730|NCT00227877|75957798|FG000|3-months Follow-up|Completed late|135|||
42148731|NCT00227877|75957799|FG001|3-months Follow-up|Completed late|128|||
42148732|NCT00227877|75957800|FG002|3-months Follow-up|Completed late|34|||
42148733|NCT00227877|75957801|FG003|3-months Follow-up|Completed late|8|||
42148734|NCT00227877|75957798|FG000|3-months Follow-up|Lost to Follow-up|178|||
42148735|NCT00227877|75957799|FG001|3-months Follow-up|Lost to Follow-up|139|||
42148736|NCT00227877|75957800|FG002|3-months Follow-up|Lost to Follow-up|18|||
42148737|NCT00227877|75957801|FG003|3-months Follow-up|Lost to Follow-up|13|||
42148738|NCT00227877|75957798|FG000|12-months Follow-up|Completed late|78|||
42148739|NCT00227877|75957799|FG001|12-months Follow-up|Completed late|74|||
42148740|NCT00227877|75957800|FG002|12-months Follow-up|Completed late|1|||
42148741|NCT00227877|75957801|FG003|12-months Follow-up|Completed late|0|||
42148742|NCT00227877|75957798|FG000|12-months Follow-up|Lost to Follow-up|232|||
42148743|NCT00227877|75957799|FG001|12-months Follow-up|Lost to Follow-up|189|||
42148744|NCT00227877|75957800|FG002|12-months Follow-up|Lost to Follow-up|30|||
42148745|NCT00227877|75957801|FG003|12-months Follow-up|Lost to Follow-up|26|||
42148746|NCT00513695|75957813|FG000|Overall Study|Discontinued therapy|2|||
42148747|NCT00513695|75957813|FG000|Overall Study|Progression prior to surgery|3|||
42148748|NCT00162981|75957819|FG000|Overall Study|Adverse Event|2|||
42148749|NCT00162981|75957820|FG001|Overall Study|Adverse Event|5|||
42148750|NCT00162981|75957819|FG000|Overall Study|Withdrawal by Subject|1|||
42148751|NCT00162981|75957820|FG001|Overall Study|Withdrawal by Subject|1|||
42148752|NCT00162981|75957819|FG000|Overall Study|Physician Decision|1|||
42148753|NCT00162981|75957820|FG001|Overall Study|Physician Decision|0|||
42148754|NCT00511433|75957828|FG000|Overall Study|Adverse Event|5|||
42148755|NCT00511433|75957829|FG001|Overall Study|Adverse Event|0|||
42148756|NCT00511433|75957828|FG000|Overall Study|Other Reason|1|||
42148757|NCT00511433|75957829|FG001|Overall Study|Other Reason|1|||
42148758|NCT00099268|75957839|FG000|Overall Study|Withdrawal by Subject|46|||
42148759|NCT00099268|75957840|FG001|Overall Study|Withdrawal by Subject|28|||
42148760|NCT00099268|75957839|FG000|Overall Study|Adverse Event|19|||
42148761|NCT00099268|75957840|FG001|Overall Study|Adverse Event|19|||
42148762|NCT00099268|75957839|FG000|Overall Study|Protocol Violation|9|||
42148763|NCT00099268|75957840|FG001|Overall Study|Protocol Violation|8|||
42148764|NCT00099268|75957839|FG000|Overall Study|Lost to Follow-up|6|||
42148765|NCT00099268|75957840|FG001|Overall Study|Lost to Follow-up|4|||
42148766|NCT00099268|75957839|FG000|Overall Study|Lack of Efficacy|5|||
42148767|NCT00099268|75957840|FG001|Overall Study|Lack of Efficacy|18|||
42148768|NCT00099268|75957839|FG000|Overall Study|Administrative problems|4|||
42148769|NCT00099268|75957840|FG001|Overall Study|Administrative problems|4|||
42148770|NCT00099268|75957839|FG000|Overall Study|Death|3|||
42148771|NCT00099268|75957840|FG001|Overall Study|Death|1|||
42148772|NCT00511355|75957848|FG000|Overall Study|Adverse Event|4|||
42148773|NCT00511355|75957849|FG001|Overall Study|Adverse Event|4|||
42278077|NCT02819635|76109730|FG010|Substudy 2, Part 2|Other, not specified|0|||
42278078|NCT02819635|76109731|FG011|Substudy 2, Part 2|Other, not specified|0|||
42148774|NCT00511355|75957848|FG000|Overall Study|Pregnancy Wish|1|||
42148775|NCT00511355|75957849|FG001|Overall Study|Pregnancy Wish|0|||
42148776|NCT00511355|75957848|FG000|Overall Study|Lost to Follow-up|2|||
42148777|NCT00511355|75957849|FG001|Overall Study|Lost to Follow-up|1|||
42148778|NCT00511355|75957848|FG000|Overall Study|Other Reason|0|||
42148779|NCT00511355|75957849|FG001|Overall Study|Other Reason|1|||
42148780|NCT00511355|75957848|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
42148781|NCT00511355|75957849|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
42148782|NCT00511355|75957848|FG000|Overall Study|Withdrawal of informed consent|0|||
42148783|NCT00511355|75957849|FG001|Overall Study|Withdrawal of informed consent|1|||
42148784|NCT00511355|75957848|FG000|Overall Study|Other reason pre-treatment|0|||
42148785|NCT00511355|75957849|FG001|Overall Study|Other reason pre-treatment|1|||
42278079|NCT02819635|76109720|FG000|Substudy 3|Adverse Event|0|||
42148786|NCT00095212|75957859|FG000|Overall Study|Withdrawal by Subject|1|||
42148787|NCT00095212|75957860|FG001|Overall Study|Withdrawal by Subject|3|||
42148788|NCT00120874|75957868|FG000|Overall Study|Death|0|||
42148789|NCT00120874|75957869|FG001|Overall Study|Death|1|||
42148790|NCT00120406|75957877|FG000|Overall Study|Death|9|||
42148791|NCT00120406|75957878|FG001|Overall Study|Death|4|||
42148792|NCT00120406|75957877|FG000|Overall Study|Withdrawal by Subject|5|||
42148793|NCT00120406|75957878|FG001|Overall Study|Withdrawal by Subject|7|||
42148794|NCT00120406|75957877|FG000|Overall Study|Lost to Follow-up|5|||
42148795|NCT00120406|75957878|FG001|Overall Study|Lost to Follow-up|2|||
42148796|NCT00120406|75957877|FG000|Overall Study|received non-study stent|0|||
42148797|NCT00120406|75957878|FG001|Overall Study|received non-study stent|2|||
42148798|NCT00120406|75957877|FG000|Overall Study|patient moved but has not withdrawn|0|||
42148799|NCT00120406|75957878|FG001|Overall Study|patient moved but has not withdrawn|1|||
42148800|NCT00120250|75957884|FG000|Overall Study|Lost to Follow-up|1|||
42148801|NCT00120250|75957885|FG001|Overall Study|Lost to Follow-up|1|||
42148802|NCT00120250|75957884|FG000|Overall Study|Protocol Violation|0|||
42148803|NCT00120250|75957885|FG001|Overall Study|Protocol Violation|1|||
42148804|NCT00511199|75957894|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
42148805|NCT00511199|75957895|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
42148806|NCT00511199|75957894|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
42148807|NCT00511199|75957895|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
42148808|NCT00511199|75957894|FG000|Overall Study|Withdrawal of Informed Consent|19|||
42148809|NCT00511199|75957895|FG001|Overall Study|Withdrawal of Informed Consent|4|||
42148810|NCT00511199|75957894|FG000|Overall Study|Pregnancy|6|||
42148811|NCT00511199|75957895|FG001|Overall Study|Pregnancy|3|||
42148812|NCT00511199|75957894|FG000|Overall Study|Pregnancy Wish|16|||
42148813|NCT00511199|75957895|FG001|Overall Study|Pregnancy Wish|8|||
42148814|NCT00511199|75957894|FG000|Overall Study|Lost to Follow-up|40|||
42148815|NCT00511199|75957895|FG001|Overall Study|Lost to Follow-up|17|||
42148816|NCT00511199|75957894|FG000|Overall Study|Other Reason|78|||
42148817|NCT00511199|75957895|FG001|Overall Study|Other Reason|37|||
42148818|NCT00384176|75957906|FG000|Overall Study|Death|239|||
42148819|NCT00384176|75957907|FG001|Overall Study|Death|247|||
42148820|NCT00384176|75957908|FG002|Overall Study|Death|105|||
42148821|NCT00384176|75957906|FG000|Overall Study|Withdrawal by Subject|52|||
42148822|NCT00384176|75957907|FG001|Overall Study|Withdrawal by Subject|48|||
42148823|NCT00384176|75957908|FG002|Overall Study|Withdrawal by Subject|22|||
42148824|NCT00384176|75957906|FG000|Overall Study|Lost to Follow-up|16|||
42148825|NCT00384176|75957907|FG001|Overall Study|Lost to Follow-up|18|||
42148826|NCT00384176|75957908|FG002|Overall Study|Lost to Follow-up|4|||
42148827|NCT00384176|75957906|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
42148828|NCT00384176|75957907|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
42148829|NCT00384176|75957908|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
42148830|NCT00384176|75957906|FG000|Overall Study|Longer QTC as Visit 1|1|||
42148831|NCT00384176|75957907|FG001|Overall Study|Longer QTC as Visit 1|0|||
42148832|NCT00384176|75957908|FG002|Overall Study|Longer QTC as Visit 1|0|||
42148833|NCT00384176|75957906|FG000|Overall Study|Toxicity of treatment|1|||
42148834|NCT00384176|75957907|FG001|Overall Study|Toxicity of treatment|0|||
42148835|NCT00384176|75957908|FG002|Overall Study|Toxicity of treatment|0|||
42148836|NCT00384176|75957906|FG000|Overall Study|Did not receive study treatment|0|||
42148837|NCT00384176|75957907|FG001|Overall Study|Did not receive study treatment|1|||
42148838|NCT00384176|75957908|FG002|Overall Study|Did not receive study treatment|1|||
42148839|NCT00384176|75957906|FG000|Overall Study|Physician Decision|0|||
42148840|NCT00384176|75957907|FG001|Overall Study|Physician Decision|2|||
42148841|NCT00384176|75957908|FG002|Overall Study|Physician Decision|0|||
42148842|NCT00384176|75957906|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
42148843|NCT00384176|75957907|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
42148844|NCT00384176|75957908|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
42012766|NCT04867785|75819625|FG005|Overall Study|Physician Decision|0|||
42012767|NCT04867785|75819626|FG006|Overall Study|Physician Decision|0|||
42012768|NCT04867785|75819627|FG007|Overall Study|Physician Decision|1|||
42012769|NCT04867785|75819620|FG000|Overall Study|Inadvertent Enrollment|0|||
42148845|NCT00513305|75957918|FG000|Overall Study|Adverse Event|6|||
42148846|NCT00513305|75957919|FG001|Overall Study|Adverse Event|2|||
42148847|NCT00513305|75957918|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
42148848|NCT00513305|75957919|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
42148849|NCT00513305|75957918|FG000|Overall Study|Lack of Efficacy|8|||
42148850|NCT00513305|75957919|FG001|Overall Study|Lack of Efficacy|13|||
42278080|NCT02819635|76109721|FG001|Substudy 3|Adverse Event|0|||
42012770|NCT04867785|75819621|FG001|Overall Study|Inadvertent Enrollment|0|||
42148851|NCT00513305|75957918|FG000|Overall Study|Withdrawal by Subject|1|||
42148852|NCT00513305|75957919|FG001|Overall Study|Withdrawal by Subject|2|||
42148853|NCT00513305|75957918|FG000|Overall Study|Disease progression|8|||
42012771|NCT04867785|75819622|FG002|Overall Study|Inadvertent Enrollment|0|||
42012772|NCT04867785|75819623|FG003|Overall Study|Inadvertent Enrollment|1|||
42148854|NCT00513305|75957919|FG001|Overall Study|Disease progression|5|||
42148855|NCT00513305|75957918|FG000|Overall Study|Eligible for stem cell transplant|1|||
42148856|NCT00513305|75957919|FG001|Overall Study|Eligible for stem cell transplant|0|||
42148857|NCT00513305|75957918|FG000|Overall Study|Hematologic counts did not recover|1|||
42148858|NCT00513305|75957919|FG001|Overall Study|Hematologic counts did not recover|0|||
42148859|NCT00513305|75957918|FG000|Overall Study|Physician Decision|1|||
42148860|NCT00513305|75957919|FG001|Overall Study|Physician Decision|0|||
42148861|NCT00513305|75957918|FG000|Overall Study|Persistent hypocellularity|0|||
42148862|NCT00513305|75957919|FG001|Overall Study|Persistent hypocellularity|1|||
42148863|NCT00513305|75957918|FG000|Overall Study|Sponsor Decision|0|||
42148864|NCT00513305|75957919|FG001|Overall Study|Sponsor Decision|2|||
42148865|NCT00513071|75957925|FG000|Overall Study|Adverse Event|1|||
42148866|NCT00513071|75957925|FG000|Overall Study|Withdrawal by Subject|1|||
42148867|NCT00513071|75957925|FG000|Overall Study|Physician Decision|3|||
42148868|NCT00510887|75957929|FG000|Overall Study|Lost to Follow-up|1|||
42148869|NCT00358826|75957937|FG000|Core Study|Adverse Event|1|||
42148870|NCT00358826|75957938|FG001|Core Study|Adverse Event|3|||
42148871|NCT00358826|75957939|FG002|Core Study|Adverse Event|1|||
42351226|NCT00637000|76191123|FG001|Overall Study|Withdrawal by Subject|3|||
42351227|NCT01515189|76191131|FG000|Induction|Disease Progression|109|||
42351228|NCT01515189|76191132|FG001|Induction|Disease Progression|155|||
42351229|NCT01515189|76191131|FG000|Induction|Study drug toxicity|86|||
42148872|NCT00358826|75957940|FG003|Core Study|Adverse Event|1|||
42148873|NCT00358826|75957941|FG004|Core Study|Adverse Event|0|||
42148874|NCT00358826|75957942|FG005|Core Study|Adverse Event|0|||
42148875|NCT00358826|75957943|FG006|Core Study|Adverse Event|0|||
42148876|NCT00358826|75957944|FG007|Core Study|Adverse Event|0|||
42148877|NCT00358826|75957937|FG000|Core Study|Withdrawal by Subject|2|||
42148878|NCT00358826|75957938|FG001|Core Study|Withdrawal by Subject|2|||
42148879|NCT00358826|75957939|FG002|Core Study|Withdrawal by Subject|0|||
42148880|NCT00358826|75957940|FG003|Core Study|Withdrawal by Subject|0|||
42148881|NCT00358826|75957941|FG004|Core Study|Withdrawal by Subject|0|||
42148882|NCT00358826|75957942|FG005|Core Study|Withdrawal by Subject|0|||
42148883|NCT00358826|75957943|FG006|Core Study|Withdrawal by Subject|0|||
42148884|NCT00358826|75957944|FG007|Core Study|Withdrawal by Subject|0|||
42148885|NCT00358826|75957937|FG000|Core Study|Lost to Follow-up|0|||
42148886|NCT00358826|75957938|FG001|Core Study|Lost to Follow-up|0|||
42148887|NCT00358826|75957939|FG002|Core Study|Lost to Follow-up|0|||
42148888|NCT00358826|75957940|FG003|Core Study|Lost to Follow-up|1|||
42148889|NCT00358826|75957941|FG004|Core Study|Lost to Follow-up|0|||
42148890|NCT00358826|75957942|FG005|Core Study|Lost to Follow-up|0|||
42148891|NCT00358826|75957943|FG006|Core Study|Lost to Follow-up|0|||
42148892|NCT00358826|75957944|FG007|Core Study|Lost to Follow-up|0|||
42148893|NCT00358826|75957937|FG000|Core Study|Physician Decision|0|||
42148894|NCT00358826|75957938|FG001|Core Study|Physician Decision|0|||
42148895|NCT00358826|75957939|FG002|Core Study|Physician Decision|1|||
42148896|NCT00358826|75957940|FG003|Core Study|Physician Decision|0|||
42148897|NCT00358826|75957941|FG004|Core Study|Physician Decision|0|||
42148898|NCT00358826|75957942|FG005|Core Study|Physician Decision|0|||
42148899|NCT00358826|75957943|FG006|Core Study|Physician Decision|0|||
42148900|NCT00358826|75957944|FG007|Core Study|Physician Decision|0|||
42148901|NCT00358826|75957937|FG000|MDCT Substudy|Adverse Event|0|||
42148902|NCT00358826|75957938|FG001|MDCT Substudy|Adverse Event|0|||
42148903|NCT00358826|75957939|FG002|MDCT Substudy|Adverse Event|0|||
42148904|NCT00358826|75957940|FG003|MDCT Substudy|Adverse Event|0|||
42148905|NCT00358826|75957941|FG004|MDCT Substudy|Adverse Event|1|||
42148906|NCT00358826|75957942|FG005|MDCT Substudy|Adverse Event|0|||
42148907|NCT00358826|75957943|FG006|MDCT Substudy|Adverse Event|0|||
42351230|NCT01515189|76191132|FG001|Induction|Study drug toxicity|36|||
42351231|NCT01515189|76191131|FG000|Induction|Death|24|||
42351232|NCT01515189|76191132|FG001|Induction|Death|17|||
42148908|NCT00358826|75957944|FG007|MDCT Substudy|Adverse Event|0|||
42148909|NCT00358826|75957937|FG000|MDCT Substudy|Lost to Follow-up|0|||
42148910|NCT00358826|75957938|FG001|MDCT Substudy|Lost to Follow-up|0|||
42148911|NCT00358826|75957939|FG002|MDCT Substudy|Lost to Follow-up|0|||
42148912|NCT00358826|75957940|FG003|MDCT Substudy|Lost to Follow-up|0|||
42148913|NCT00358826|75957941|FG004|MDCT Substudy|Lost to Follow-up|0|||
42148914|NCT00358826|75957942|FG005|MDCT Substudy|Lost to Follow-up|1|||
42148915|NCT00358826|75957943|FG006|MDCT Substudy|Lost to Follow-up|0|||
42148916|NCT00358826|75957944|FG007|MDCT Substudy|Lost to Follow-up|0|||
42148917|NCT00358826|75957937|FG000|MDCT Substudy|Withdrawal by Subject|0|||
42148918|NCT00358826|75957938|FG001|MDCT Substudy|Withdrawal by Subject|0|||
42148919|NCT00358826|75957939|FG002|MDCT Substudy|Withdrawal by Subject|0|||
42148920|NCT00358826|75957940|FG003|MDCT Substudy|Withdrawal by Subject|0|||
42351233|NCT01515189|76191131|FG000|Induction|Adverse Event|14|||
42351234|NCT01515189|76191132|FG001|Induction|Adverse Event|9|||
42351235|NCT01515189|76191131|FG000|Induction|Withdrawal by Subject|3|||
42148921|NCT00358826|75957941|FG004|MDCT Substudy|Withdrawal by Subject|0|||
42148922|NCT00358826|75957942|FG005|MDCT Substudy|Withdrawal by Subject|1|||
42148923|NCT00358826|75957943|FG006|MDCT Substudy|Withdrawal by Subject|0|||
42148924|NCT00358826|75957944|FG007|MDCT Substudy|Withdrawal by Subject|0|||
42148925|NCT00510653|75957958|FG000|Overall Study|Withdrawal by Subject|8|||
42148926|NCT00510653|75957958|FG000|Overall Study|Monetary|3|||
42148927|NCT00362336|75957965|FG000|Overall Study|Serious Adverse Event|1|||
42148928|NCT00362336|75957966|FG001|Overall Study|Serious Adverse Event|0|||
42148929|NCT00362336|75957967|FG002|Overall Study|Serious Adverse Event|1|||
42148930|NCT00362336|75957965|FG000|Overall Study|Protocol Violation|0|||
42148931|NCT00362336|75957966|FG001|Overall Study|Protocol Violation|0|||
42148932|NCT00362336|75957967|FG002|Overall Study|Protocol Violation|1|||
42148933|NCT00362336|75957965|FG000|Overall Study|Lost to Follow-up|6|||
42148934|NCT00362336|75957966|FG001|Overall Study|Lost to Follow-up|4|||
42148935|NCT00362336|75957967|FG002|Overall Study|Lost to Follow-up|0|||
42148936|NCT00362336|75957965|FG000|Overall Study|Withdrawal by Subject|3|||
42148937|NCT00362336|75957966|FG001|Overall Study|Withdrawal by Subject|3|||
42148938|NCT00362336|75957967|FG002|Overall Study|Withdrawal by Subject|1|||
42148939|NCT00506285|75957984|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
42148940|NCT00506285|75957985|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
42148941|NCT00506285|75957984|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
42148942|NCT00506285|75957985|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
42148943|NCT00506285|75957984|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
42148944|NCT00506285|75957985|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
42148945|NCT00506285|75957984|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
42148946|NCT00506285|75957985|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
42148947|NCT00506285|75957984|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
42148948|NCT00506285|75957985|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
42148949|NCT00506129|75957993|FG000|Overall Study|Disease Progression/Relapse|15|||
42148950|NCT00506129|75957993|FG000|Overall Study|Death|7|||
42148951|NCT00358670|75957999|FG000|Overall Study|Adverse Event|26|||
42148952|NCT00358670|75958000|FG001|Overall Study|Adverse Event|29|||
42148953|NCT00358670|75957999|FG000|Overall Study|Lack of Efficacy|20|||
42148954|NCT00358670|75958000|FG001|Overall Study|Lack of Efficacy|23|||
42148955|NCT00358670|75957999|FG000|Overall Study|Protocol Violation|6|||
42148956|NCT00358670|75958000|FG001|Overall Study|Protocol Violation|9|||
42148957|NCT00358670|75957999|FG000|Overall Study|Lost to Follow-up|4|||
42148958|NCT00358670|75958000|FG001|Overall Study|Lost to Follow-up|5|||
42148959|NCT00358670|75957999|FG000|Overall Study|Withdrawal by Subject|13|||
42148960|NCT00358670|75958000|FG001|Overall Study|Withdrawal by Subject|24|||
42148961|NCT00358670|75957999|FG000|Overall Study|Protocol Defined Clinical Event|0|||
42148962|NCT00358670|75958000|FG001|Overall Study|Protocol Defined Clinical Event|1|||
42148963|NCT00358670|75957999|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
42148964|NCT00358670|75958000|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
42148965|NCT00358670|75957999|FG000|Overall Study|Administrative|153|||
42148966|NCT00358670|75958000|FG001|Overall Study|Administrative|125|||
42148967|NCT00505661|75958006|FG000|Overall Study|Not Eligible|4|||
42148968|NCT00383786|75958012|FG000|Overall Study|Protocol Violation|2|||
42148969|NCT00383786|75958013|FG001|Overall Study|Protocol Violation|6|||
42148970|NCT00383786|75958012|FG000|Overall Study|Withdrawal by Subject|2|||
42148971|NCT00383786|75958013|FG001|Overall Study|Withdrawal by Subject|5|||
42148972|NCT00383786|75958012|FG000|Overall Study|Physician Decision|0|||
42148973|NCT00383786|75958013|FG001|Overall Study|Physician Decision|1|||
42148974|NCT00383708|75958019|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
42148975|NCT00383708|75958019|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
42148976|NCT00383708|75958019|FG000|Run-in Period|Protocol Violation|4|||
42148977|NCT00383708|75958019|FG000|Run-in Period|Adverse Event|2|||
42148978|NCT00383708|75958019|FG000|Run-in Period|Claustrophobia|1|||
42148979|NCT00383708|75958019|FG000|Co-administration Period|Adverse Event|5|||
42148980|NCT00504881|75958026|FG000|Overall Study|Lack of Efficacy|1|||
42148981|NCT00504881|75958027|FG001|Overall Study|Lack of Efficacy|5|||
42148982|NCT00504881|75958026|FG000|Overall Study|Lost to Follow-up|0|||
42148983|NCT00504881|75958027|FG001|Overall Study|Lost to Follow-up|2|||
42148984|NCT00504881|75958026|FG000|Overall Study|Withdrawal by Subject|1|||
42148985|NCT00504881|75958027|FG001|Overall Study|Withdrawal by Subject|4|||
42039689|NCT05020665|75847993|FG000|Overall Study|Study terminated by Sponsor|5|||
42148986|NCT00504881|75958026|FG000|Overall Study|Non-Compliance|1|||
42148987|NCT00504881|75958027|FG001|Overall Study|Non-Compliance|0|||
42148988|NCT00504881|75958026|FG000|Overall Study|No Birth Control|0|||
42148989|NCT00504881|75958027|FG001|Overall Study|No Birth Control|1|||
42148990|NCT00504881|75958026|FG000|Overall Study|Safety Visit not performed|0|||
42148991|NCT00504881|75958027|FG001|Overall Study|Safety Visit not performed|1|||
42148992|NCT00504881|75958026|FG000|Overall Study|AE, serious fatal|0|||
42148993|NCT00504881|75958027|FG001|Overall Study|AE, serious fatal|1|||
42148994|NCT00504881|75958026|FG000|Overall Study|SAE, non-fatal|2|||
42148995|NCT00504881|75958027|FG001|Overall Study|SAE, non-fatal|6|||
42148996|NCT00504881|75958026|FG000|Overall Study|AE, non-serious non-fatal|4|||
42148997|NCT00504881|75958027|FG001|Overall Study|AE, non-serious non-fatal|14|||
42148998|NCT00504881|75958026|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
42148999|NCT00504881|75958027|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
42149000|NCT00504881|75958026|FG000|Overall Study|AE of unknown type|1|||
42149001|NCT00504881|75958027|FG001|Overall Study|AE of unknown type|0|||
42149002|NCT00504725|75958037|FG000|Overall Study|Protocol Violation|1|||
42149003|NCT00504725|75958038|FG001|Overall Study|Protocol Violation|0|||
42149004|NCT00383240|75958048|FG000|Overall Study|Adverse Event|4|||
42149005|NCT00383240|75958049|FG001|Overall Study|Adverse Event|6|||
42149006|NCT00383240|75958050|FG002|Overall Study|Adverse Event|9|||
42149007|NCT00383240|75958051|FG003|Overall Study|Adverse Event|7|||
42149008|NCT00383240|75958048|FG000|Overall Study|Treatment Failure|8|||
42149009|NCT00383240|75958049|FG001|Overall Study|Treatment Failure|13|||
42149010|NCT00383240|75958050|FG002|Overall Study|Treatment Failure|47|||
42149011|NCT00383240|75958051|FG003|Overall Study|Treatment Failure|46|||
42149012|NCT00383240|75958048|FG000|Overall Study|Lost to Follow-up|3|||
42149013|NCT00383240|75958049|FG001|Overall Study|Lost to Follow-up|0|||
42149014|NCT00383240|75958050|FG002|Overall Study|Lost to Follow-up|0|||
42149015|NCT00383240|75958051|FG003|Overall Study|Lost to Follow-up|2|||
42149016|NCT00383240|75958048|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
42149017|NCT00383240|75958049|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
42149018|NCT00383240|75958050|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
42149019|NCT00383240|75958051|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
42149020|NCT00383240|75958048|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
42149021|NCT00383240|75958049|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
42149022|NCT00383240|75958050|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
42149023|NCT00383240|75958051|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
42149024|NCT00383240|75958048|FG000|Overall Study|Protocol Violation|4|||
42149025|NCT00383240|75958049|FG001|Overall Study|Protocol Violation|5|||
42149026|NCT00383240|75958050|FG002|Overall Study|Protocol Violation|9|||
42149027|NCT00383240|75958051|FG003|Overall Study|Protocol Violation|6|||
42149028|NCT00383240|75958048|FG000|Overall Study|Did not meet protocol eligibility|9|||
42149029|NCT00383240|75958049|FG001|Overall Study|Did not meet protocol eligibility|4|||
42149030|NCT00383240|75958050|FG002|Overall Study|Did not meet protocol eligibility|9|||
42149031|NCT00383240|75958051|FG003|Overall Study|Did not meet protocol eligibility|3|||
42149032|NCT00383240|75958048|FG000|Overall Study|Administrative|1|||
42149033|NCT00383240|75958049|FG001|Overall Study|Administrative|1|||
42149034|NCT00383240|75958050|FG002|Overall Study|Administrative|0|||
42149035|NCT00383240|75958051|FG003|Overall Study|Administrative|0|||
42149036|NCT00362180|75958071|FG000|Treated Period|Withdrawal by Subject|1|||
42149037|NCT00362180|75958072|FG001|Treated Period|Withdrawal by Subject|0|||
42149038|NCT00362180|75958073|FG002|Treated Period|Withdrawal by Subject|0|||
42149039|NCT00362180|75958074|FG003|Treated Period|Withdrawal by Subject|0|||
42149040|NCT00362180|75958075|FG004|Treated Period|Withdrawal by Subject|0|||
42012773|NCT04867785|75819624|FG004|Overall Study|Inadvertent Enrollment|1|||
42012774|NCT04867785|75819625|FG005|Overall Study|Inadvertent Enrollment|0|||
42012775|NCT04867785|75819626|FG006|Overall Study|Inadvertent Enrollment|0|||
42012776|NCT04867785|75819627|FG007|Overall Study|Inadvertent Enrollment|1|||
42012777|NCT04867785|75819620|FG000|Overall Study|Eligibility Criteria Not Met|0|||
42012778|NCT04867785|75819621|FG001|Overall Study|Eligibility Criteria Not Met|0|||
42149041|NCT00362180|75958076|FG005|Treated Period|Withdrawal by Subject|0|||
42149042|NCT00362180|75958077|FG006|Treated Period|Withdrawal by Subject|0|||
42149043|NCT00362180|75958078|FG007|Treated Period|Withdrawal by Subject|0|||
42149044|NCT00362180|75958079|FG008|Treated Period|Withdrawal by Subject|0|||
42278081|NCT02819635|76109722|FG002|Substudy 3|Adverse Event|0|||
42278082|NCT02819635|76109723|FG003|Substudy 3|Adverse Event|0|||
42278083|NCT02819635|76109724|FG004|Substudy 3|Adverse Event|0|||
42012779|NCT04867785|75819622|FG002|Overall Study|Eligibility Criteria Not Met|0|||
42149045|NCT00362180|75958071|FG000|Treated Period|Adverse Event|0|||
42149046|NCT00362180|75958072|FG001|Treated Period|Adverse Event|0|||
42149047|NCT00362180|75958073|FG002|Treated Period|Adverse Event|0|||
42149048|NCT00362180|75958074|FG003|Treated Period|Adverse Event|0|||
42149049|NCT00362180|75958075|FG004|Treated Period|Adverse Event|0|||
42149050|NCT00362180|75958076|FG005|Treated Period|Adverse Event|1|||
42149051|NCT00362180|75958077|FG006|Treated Period|Adverse Event|0|||
42149052|NCT00362180|75958078|FG007|Treated Period|Adverse Event|1|||
42149053|NCT00362180|75958079|FG008|Treated Period|Adverse Event|0|||
42149054|NCT00383162|75958097|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
42149055|NCT00383162|75958098|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
42149056|NCT00383162|75958097|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
42149057|NCT00383162|75958098|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
42149058|NCT00383162|75958097|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
42149059|NCT00383162|75958098|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
42149060|NCT00383162|75958097|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
42149061|NCT00383162|75958098|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
42149062|NCT00383162|75958097|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
42149063|NCT00383162|75958098|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
42149064|NCT00383162|75958097|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
42149065|NCT00383162|75958098|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
42149066|NCT00383162|75958097|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
42149067|NCT00383162|75958098|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
42149068|NCT00383162|75958097|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
42149069|NCT00383162|75958098|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
42149070|NCT00383162|75958097|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
42149071|NCT00383162|75958098|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
42149072|NCT00358436|75958106|FG000|Overall Study|Adverse Event|29|||
42149073|NCT00358436|75958107|FG001|Overall Study|Adverse Event|13|||
42149074|NCT00358436|75958106|FG000|Overall Study|Lack of Efficacy|34|||
42149075|NCT00358436|75958107|FG001|Overall Study|Lack of Efficacy|36|||
42149076|NCT00358436|75958106|FG000|Overall Study|Lost to Follow-up|11|||
42149077|NCT00358436|75958107|FG001|Overall Study|Lost to Follow-up|6|||
42149078|NCT00358436|75958106|FG000|Overall Study|Protocol Violation|8|||
42149079|NCT00358436|75958107|FG001|Overall Study|Protocol Violation|3|||
42149080|NCT00358436|75958106|FG000|Overall Study|Withdrawal by Subject|40|||
42149081|NCT00358436|75958107|FG001|Overall Study|Withdrawal by Subject|17|||
42149082|NCT00358436|75958106|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
42149083|NCT00358436|75958107|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
42149084|NCT00358436|75958106|FG000|Overall Study|COPD exacerbation|22|||
42149085|NCT00358436|75958107|FG001|Overall Study|COPD exacerbation|10|||
42149086|NCT00358436|75958106|FG000|Overall Study|Other|6|||
42149087|NCT00358436|75958107|FG001|Overall Study|Other|1|||
42149088|NCT00383084|75958117|FG000|Overall Study|Withdrawal by Subject|12|||
42149089|NCT00383084|75958118|FG001|Overall Study|Withdrawal by Subject|10|||
42149090|NCT00361634|75958124|FG000|Overall Study|Lost to Follow-up|1|||
42149091|NCT00361634|75958124|FG000|Overall Study|Withdrawal by Subject|1|||
42149092|NCT00357968|75958130|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
42149093|NCT00357968|75958131|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
42149094|NCT00357968|75958130|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
42149095|NCT00357968|75958131|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
42149096|NCT00357656|75958154|FG000|Overall Study|Other, No surgery performed|0|||
42149097|NCT00357656|75958155|FG001|Overall Study|Other, No surgery performed|3|||
42149098|NCT00357500|75958173|FG000|Overall Study|Adverse Event|3|||
42149099|NCT00357500|75958173|FG000|Overall Study|Withdrawal by Subject|5|||
42149100|NCT00357500|75958173|FG000|Overall Study|Progressive Disease|65|||
42149101|NCT00357500|75958173|FG000|Overall Study|Not Started Protocol Therapy|4|||
42149102|NCT00357110|75958179|FG000|Overall Study|Early study termination|5|||
42149103|NCT00357110|75958180|FG001|Overall Study|Early study termination|5|||
42149104|NCT00098722|75958189|FG000|Double Blind Phase|Adverse Event|7|||
42149105|NCT00098722|75958190|FG001|Double Blind Phase|Adverse Event|7|||
42149106|NCT00098722|75958191|FG002|Double Blind Phase|Adverse Event|3|||
42149107|NCT00098722|75958192|FG003|Double Blind Phase|Adverse Event|0|||
42149108|NCT00098722|75958193|FG004|Double Blind Phase|Adverse Event|0|||
42149109|NCT00098722|75958194|FG005|Double Blind Phase|Adverse Event|0|||
42039690|NCT05020665|75847994|FG001|Overall Study|Study terminated by Sponsor|4|||
42149110|NCT00098722|75958195|FG006|Double Blind Phase|Adverse Event|0|||
42149111|NCT00098722|75958189|FG000|Double Blind Phase|Death|2|||
42149112|NCT00098722|75958190|FG001|Double Blind Phase|Death|5|||
42149113|NCT00098722|75958191|FG002|Double Blind Phase|Death|0|||
42149114|NCT00098722|75958192|FG003|Double Blind Phase|Death|0|||
42039691|NCT05020665|75847993|FG000|Overall Study|Death|2|||
42039692|NCT05020665|75847994|FG001|Overall Study|Death|1|||
42149115|NCT00098722|75958193|FG004|Double Blind Phase|Death|0|||
42149116|NCT00098722|75958194|FG005|Double Blind Phase|Death|0|||
42039693|NCT05020665|75847993|FG000|Overall Study|Physician Decision|0|||
42149117|NCT00098722|75958195|FG006|Double Blind Phase|Death|0|||
42149118|NCT00098722|75958189|FG000|Double Blind Phase|Lack of Efficacy|21|||
42149119|NCT00098722|75958190|FG001|Double Blind Phase|Lack of Efficacy|23|||
42149120|NCT00098722|75958191|FG002|Double Blind Phase|Lack of Efficacy|15|||
42149121|NCT00098722|75958192|FG003|Double Blind Phase|Lack of Efficacy|0|||
42149122|NCT00098722|75958193|FG004|Double Blind Phase|Lack of Efficacy|0|||
42149123|NCT00098722|75958194|FG005|Double Blind Phase|Lack of Efficacy|0|||
42149124|NCT00098722|75958195|FG006|Double Blind Phase|Lack of Efficacy|0|||
42149125|NCT00098722|75958189|FG000|Double Blind Phase|Participant defaulted|16|||
42149126|NCT00098722|75958190|FG001|Double Blind Phase|Participant defaulted|11|||
42149127|NCT00098722|75958191|FG002|Double Blind Phase|Participant defaulted|9|||
42149128|NCT00098722|75958192|FG003|Double Blind Phase|Participant defaulted|0|||
42149129|NCT00098722|75958193|FG004|Double Blind Phase|Participant defaulted|0|||
42149130|NCT00098722|75958194|FG005|Double Blind Phase|Participant defaulted|0|||
42149131|NCT00098722|75958195|FG006|Double Blind Phase|Participant defaulted|0|||
42149132|NCT00098722|75958189|FG000|Double Blind Phase|Pregnancy|1|||
42149133|NCT00098722|75958190|FG001|Double Blind Phase|Pregnancy|0|||
42149134|NCT00098722|75958191|FG002|Double Blind Phase|Pregnancy|0|||
42149135|NCT00098722|75958192|FG003|Double Blind Phase|Pregnancy|0|||
42149136|NCT00098722|75958193|FG004|Double Blind Phase|Pregnancy|0|||
42149137|NCT00098722|75958194|FG005|Double Blind Phase|Pregnancy|0|||
42149138|NCT00098722|75958195|FG006|Double Blind Phase|Pregnancy|0|||
42149139|NCT00098722|75958189|FG000|Double Blind Phase|Randomized, not treated|4|||
42149140|NCT00098722|75958190|FG001|Double Blind Phase|Randomized, not treated|3|||
42149141|NCT00098722|75958191|FG002|Double Blind Phase|Randomized, not treated|3|||
42149142|NCT00098722|75958192|FG003|Double Blind Phase|Randomized, not treated|0|||
42149143|NCT00098722|75958193|FG004|Double Blind Phase|Randomized, not treated|0|||
42149144|NCT00098722|75958194|FG005|Double Blind Phase|Randomized, not treated|0|||
42149145|NCT00098722|75958195|FG006|Double Blind Phase|Randomized, not treated|0|||
42149146|NCT00098722|75958189|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
42149147|NCT00098722|75958190|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
42149148|NCT00098722|75958191|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
42149149|NCT00098722|75958192|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
42149150|NCT00098722|75958193|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
42149151|NCT00098722|75958194|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
42149152|NCT00098722|75958195|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
42149153|NCT00098722|75958189|FG000|Double Blind Phase|Other|7|||
42149154|NCT00098722|75958190|FG001|Double Blind Phase|Other|8|||
42149155|NCT00098722|75958191|FG002|Double Blind Phase|Other|7|||
42149156|NCT00098722|75958192|FG003|Double Blind Phase|Other|0|||
42149157|NCT00098722|75958193|FG004|Double Blind Phase|Other|0|||
42149158|NCT00098722|75958194|FG005|Double Blind Phase|Other|0|||
42149159|NCT00098722|75958195|FG006|Double Blind Phase|Other|0|||
42149160|NCT00098722|75958189|FG000|Open Label Phase|Adverse Event|0|||
42149161|NCT00098722|75958190|FG001|Open Label Phase|Adverse Event|0|||
42149162|NCT00098722|75958191|FG002|Open Label Phase|Adverse Event|0|||
42149163|NCT00098722|75958192|FG003|Open Label Phase|Adverse Event|5|||
42149164|NCT00098722|75958193|FG004|Open Label Phase|Adverse Event|0|||
42149165|NCT00098722|75958194|FG005|Open Label Phase|Adverse Event|0|||
42149166|NCT00098722|75958195|FG006|Open Label Phase|Adverse Event|0|||
42149167|NCT00098722|75958189|FG000|Open Label Phase|Death|0|||
42149168|NCT00098722|75958190|FG001|Open Label Phase|Death|0|||
42149169|NCT00098722|75958191|FG002|Open Label Phase|Death|0|||
42012780|NCT04867785|75819623|FG003|Overall Study|Eligibility Criteria Not Met|0|||
42149170|NCT00098722|75958192|FG003|Open Label Phase|Death|2|||
42149171|NCT00098722|75958193|FG004|Open Label Phase|Death|0|||
42149172|NCT00098722|75958194|FG005|Open Label Phase|Death|0|||
42149173|NCT00098722|75958195|FG006|Open Label Phase|Death|0|||
42149174|NCT00098722|75958189|FG000|Open Label Phase|Lack of Efficacy|0|||
42149175|NCT00098722|75958190|FG001|Open Label Phase|Lack of Efficacy|0|||
42351236|NCT01515189|76191132|FG001|Induction|Withdrawal by Subject|9|||
42012781|NCT04867785|75819624|FG004|Overall Study|Eligibility Criteria Not Met|0|||
42012782|NCT04867785|75819625|FG005|Overall Study|Eligibility Criteria Not Met|0|||
42012783|NCT04867785|75819626|FG006|Overall Study|Eligibility Criteria Not Met|0|||
42012784|NCT04867785|75819627|FG007|Overall Study|Eligibility Criteria Not Met|1|||
42149176|NCT00098722|75958191|FG002|Open Label Phase|Lack of Efficacy|0|||
42149177|NCT00098722|75958192|FG003|Open Label Phase|Lack of Efficacy|8|||
42149178|NCT00098722|75958193|FG004|Open Label Phase|Lack of Efficacy|0|||
42149179|NCT00098722|75958194|FG005|Open Label Phase|Lack of Efficacy|0|||
42149180|NCT00098722|75958195|FG006|Open Label Phase|Lack of Efficacy|0|||
42351237|NCT01515189|76191131|FG000|Induction|No longer meets study criteria|0|||
42012785|NCT04541004|75819654|FG000|Overall Study|Adverse Event|2|||
42012786|NCT04091646|75819661|FG000|Overall Study|Adverse Event|2|||
42012787|NCT04091646|75819662|FG001|Overall Study|Adverse Event|1|||
42149181|NCT00098722|75958189|FG000|Open Label Phase|Pregnancy|0|||
42149182|NCT00098722|75958190|FG001|Open Label Phase|Pregnancy|0|||
42149183|NCT00098722|75958191|FG002|Open Label Phase|Pregnancy|0|||
42149184|NCT00098722|75958192|FG003|Open Label Phase|Pregnancy|1|||
42149185|NCT00098722|75958193|FG004|Open Label Phase|Pregnancy|0|||
42149186|NCT00098722|75958194|FG005|Open Label Phase|Pregnancy|0|||
42149187|NCT00098722|75958195|FG006|Open Label Phase|Pregnancy|0|||
42149188|NCT00098722|75958189|FG000|Open Label Phase|Participant defaulted|0|||
42149189|NCT00098722|75958190|FG001|Open Label Phase|Participant defaulted|0|||
42149190|NCT00098722|75958191|FG002|Open Label Phase|Participant defaulted|0|||
42149191|NCT00098722|75958192|FG003|Open Label Phase|Participant defaulted|18|||
42149192|NCT00098722|75958193|FG004|Open Label Phase|Participant defaulted|0|||
42149193|NCT00098722|75958194|FG005|Open Label Phase|Participant defaulted|0|||
42149194|NCT00098722|75958195|FG006|Open Label Phase|Participant defaulted|0|||
42149195|NCT00098722|75958189|FG000|Open Label Phase|Ongoing at cut-off date|0|||
42149196|NCT00098722|75958190|FG001|Open Label Phase|Ongoing at cut-off date|0|||
42149197|NCT00098722|75958191|FG002|Open Label Phase|Ongoing at cut-off date|0|||
42149198|NCT00098722|75958192|FG003|Open Label Phase|Ongoing at cut-off date|220|||
42149199|NCT00098722|75958193|FG004|Open Label Phase|Ongoing at cut-off date|50|||
42149200|NCT00098722|75958194|FG005|Open Label Phase|Ongoing at cut-off date|0|||
42149201|NCT00098722|75958195|FG006|Open Label Phase|Ongoing at cut-off date|0|||
42149202|NCT00098722|75958189|FG000|Open Label Phase|Other|0|||
42149203|NCT00098722|75958190|FG001|Open Label Phase|Other|0|||
42149204|NCT00098722|75958191|FG002|Open Label Phase|Other|0|||
42149205|NCT00098722|75958192|FG003|Open Label Phase|Other|18|||
42149206|NCT00098722|75958193|FG004|Open Label Phase|Other|0|||
42149207|NCT00098722|75958194|FG005|Open Label Phase|Other|0|||
42149208|NCT00098722|75958195|FG006|Open Label Phase|Other|0|||
42149209|NCT00098722|75958189|FG000|Observation Phase|Death|0|||
42149210|NCT00098722|75958190|FG001|Observation Phase|Death|0|||
42149211|NCT00098722|75958191|FG002|Observation Phase|Death|0|||
42149212|NCT00098722|75958192|FG003|Observation Phase|Death|0|||
42149213|NCT00098722|75958193|FG004|Observation Phase|Death|0|||
42149214|NCT00098722|75958194|FG005|Observation Phase|Death|5|||
42149215|NCT00098722|75958195|FG006|Observation Phase|Death|3|||
42149216|NCT00098722|75958189|FG000|Observation Phase|Lack of Efficacy|0|||
42149217|NCT00098722|75958190|FG001|Observation Phase|Lack of Efficacy|0|||
42149218|NCT00098722|75958191|FG002|Observation Phase|Lack of Efficacy|0|||
42149219|NCT00098722|75958192|FG003|Observation Phase|Lack of Efficacy|0|||
42149220|NCT00098722|75958193|FG004|Observation Phase|Lack of Efficacy|0|||
42149221|NCT00098722|75958194|FG005|Observation Phase|Lack of Efficacy|2|||
42149222|NCT00098722|75958195|FG006|Observation Phase|Lack of Efficacy|0|||
42149223|NCT00098722|75958189|FG000|Observation Phase|Participant defaulted|0|||
42149224|NCT00098722|75958190|FG001|Observation Phase|Participant defaulted|0|||
42149225|NCT00098722|75958191|FG002|Observation Phase|Participant defaulted|0|||
42149226|NCT00098722|75958192|FG003|Observation Phase|Participant defaulted|0|||
42149227|NCT00098722|75958193|FG004|Observation Phase|Participant defaulted|0|||
42149228|NCT00098722|75958194|FG005|Observation Phase|Participant defaulted|17|||
42149229|NCT00098722|75958195|FG006|Observation Phase|Participant defaulted|4|||
42149230|NCT00098722|75958189|FG000|Observation Phase|Other|0|||
42149231|NCT00098722|75958190|FG001|Observation Phase|Other|0|||
42149232|NCT00098722|75958191|FG002|Observation Phase|Other|0|||
42149233|NCT00098722|75958192|FG003|Observation Phase|Other|0|||
42149234|NCT00098722|75958193|FG004|Observation Phase|Other|0|||
42149235|NCT00098722|75958194|FG005|Observation Phase|Other|21|||
42149236|NCT00098722|75958195|FG006|Observation Phase|Other|10|||
42149237|NCT00098254|75958207|FG000|Overall Study|Adverse Event|2|||
42149238|NCT00098254|75958207|FG000|Overall Study|Death|1|||
42149239|NCT00095056|75958213|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
42149240|NCT00095056|75958214|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
42149241|NCT00095056|75958213|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
42149242|NCT00095056|75958214|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
42149243|NCT00095056|75958213|FG000|Phase A (Weeks 0-12)|Death|1|||
42149244|NCT00095056|75958214|FG001|Phase A (Weeks 0-12)|Death|0|||
42149245|NCT00095056|75958213|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
42149246|NCT00095056|75958214|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
42278084|NCT02819635|76109725|FG005|Substudy 3|Adverse Event|0|||
42012788|NCT04091646|75819661|FG000|Overall Study|Lost to Follow-up|6|||
42012789|NCT04091646|75819662|FG001|Overall Study|Lost to Follow-up|2|||
42149247|NCT00095056|75958213|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
42149248|NCT00095056|75958214|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
42149249|NCT00095056|75958213|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
42278085|NCT02819635|76109726|FG006|Substudy 3|Adverse Event|0|||
42149250|NCT00095056|75958214|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
42149251|NCT00095056|75958213|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
42149252|NCT00095056|75958214|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
42149253|NCT00095056|75958213|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
42012790|NCT04091646|75819661|FG000|Overall Study|Protocol Violation|0|||
42012791|NCT04091646|75819662|FG001|Overall Study|Protocol Violation|1|||
42149254|NCT00095056|75958214|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
42149255|NCT00095056|75958213|FG000|Phase B (Weeks 12-54)|Death|3|||
42149256|NCT00095056|75958214|FG001|Phase B (Weeks 12-54)|Death|1|||
42149257|NCT00095056|75958213|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
42149258|NCT00095056|75958214|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
42149259|NCT00095056|75958213|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
42149260|NCT00095056|75958214|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
42039694|NCT05020665|75847994|FG001|Overall Study|Physician Decision|1|||
42039695|NCT05020665|75847993|FG000|Overall Study|Withdrawal by Subject|0|||
42039696|NCT05020665|75847994|FG001|Overall Study|Withdrawal by Subject|1|||
42149261|NCT00098020|75958220|FG000|Overall Study|Adverse Event|2|||
42149262|NCT00098020|75958220|FG000|Overall Study|Lost to Follow-up|1|||
42149263|NCT00098020|75958220|FG000|Overall Study|elevated liver enzymes|1|||
42149264|NCT00098020|75958220|FG000|Overall Study|Low urine PCR|1|||
42149265|NCT00098020|75958220|FG000|Overall Study|Low epidermal growth factor receptor|1|||
42149266|NCT00381680|75958226|FG000|Overall Study|Adverse Event|9|||
42149267|NCT00381680|75958227|FG001|Overall Study|Adverse Event|3|||
42149268|NCT00381680|75958226|FG000|Overall Study|Death|10|||
42149269|NCT00381680|75958227|FG001|Overall Study|Death|7|||
42149270|NCT00381680|75958226|FG000|Overall Study|Lost to Follow-up|3|||
42149271|NCT00381680|75958227|FG001|Overall Study|Lost to Follow-up|2|||
42149272|NCT00381680|75958226|FG000|Overall Study|Physician Decision|25|||
42149273|NCT00381680|75958227|FG001|Overall Study|Physician Decision|6|||
42149274|NCT00381680|75958226|FG000|Overall Study|Withdrawal by Subject|3|||
42149275|NCT00381680|75958227|FG001|Overall Study|Withdrawal by Subject|1|||
42149276|NCT00381680|75958226|FG000|Overall Study|Entry onto another COG Trial|1|||
42149277|NCT00381680|75958227|FG001|Overall Study|Entry onto another COG Trial|2|||
42149278|NCT00381680|75958226|FG000|Overall Study|Alternative Therapy|11|||
42149279|NCT00381680|75958227|FG001|Overall Study|Alternative Therapy|5|||
42149280|NCT00381680|75958226|FG000|Overall Study|Secondary Malignancy|3|||
42149281|NCT00381680|75958227|FG001|Overall Study|Secondary Malignancy|0|||
42149282|NCT00381680|75958226|FG000|Overall Study|Delay initiation|1|||
42149283|NCT00381680|75958227|FG001|Overall Study|Delay initiation|0|||
42149284|NCT00381680|75958226|FG000|Overall Study|Stem Cell Transplant|26|||
42278086|NCT02819635|76109727|FG007|Substudy 3|Adverse Event|0|||
42278087|NCT02819635|76109728|FG008|Substudy 3|Adverse Event|32|||
42278088|NCT02819635|76109729|FG009|Substudy 3|Adverse Event|3|||
42278089|NCT02819635|76109730|FG010|Substudy 3|Adverse Event|12|||
42278090|NCT02819635|76109731|FG011|Substudy 3|Adverse Event|18|||
42039697|NCT05020665|75847993|FG000|Overall Study|Reason not specified|1|||
42039698|NCT05020665|75847994|FG001|Overall Study|Reason not specified|0|||
42039699|NCT04869787|75848003|FG000|Screening|Physician Decision|1|||
42039700|NCT04869787|75848003|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
42039701|NCT04854057|75848009|FG000|Overall Study|Adverse Event|0|||
42039702|NCT04854057|75848010|FG001|Overall Study|Adverse Event|1|||
42039703|NCT04639258|75848039|FG000|Overall Study|Screen failure|5|||
42039704|NCT04639258|75848039|FG000|Overall Study|Physician Decision|2|||
42039705|NCT04639258|75848039|FG000|Overall Study|Early study termination|3|||
42039706|NCT04639258|75848039|FG000|Overall Study|Withdrawal by Subject|1|||
42039707|NCT04568122|75848061|FG000|Overall Study|Lost to Follow-up|48|||
42039708|NCT04568122|75848062|FG001|Overall Study|Lost to Follow-up|44|||
42039709|NCT04568122|75848063|FG002|Overall Study|Lost to Follow-up|4|||
42039710|NCT04568122|75848064|FG003|Overall Study|Lost to Follow-up|0|||
42039711|NCT04568122|75848065|FG004|Overall Study|Lost to Follow-up|0|||
42039712|NCT04533815|75848081|FG000|Overall Study|Adverse Event|2|||
42039713|NCT04533815|75848081|FG000|Overall Study|Site withdrew|5|||
42039714|NCT04447755|75848092|FG000|Overall Study|Death|8|||
42039715|NCT04447755|75848093|FG001|Overall Study|Death|14|||
42039716|NCT04447755|75848094|FG002|Overall Study|Death|8|||
42039717|NCT04447755|75848095|FG003|Overall Study|Death|9|||
42039718|NCT04447755|75848096|FG004|Overall Study|Death|7|||
42039719|NCT04447755|75848097|FG005|Overall Study|Death|7|||
42039720|NCT04447755|75848098|FG006|Overall Study|Death|40|||
42278091|NCT02819635|76109720|FG000|Substudy 3|Withdrew consent|0|||
42039721|NCT04447755|75848092|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42039722|NCT04447755|75848093|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
42149285|NCT00381680|75958227|FG001|Overall Study|Stem Cell Transplant|10|||
42149286|NCT00381680|75958226|FG000|Overall Study|Relapse|18|||
42149287|NCT00381680|75958227|FG001|Overall Study|Relapse|9|||
42149288|NCT00381680|75958226|FG000|Overall Study|Induction Failure|4|||
42149289|NCT00381680|75958227|FG001|Overall Study|Induction Failure|1|||
42149290|NCT00381680|75958226|FG000|Overall Study|Progression|1|||
42149291|NCT00381680|75958227|FG001|Overall Study|Progression|1|||
42149292|NCT00381680|75958226|FG000|Overall Study|Other not otherwise specified|7|||
42149293|NCT00381680|75958227|FG001|Overall Study|Other not otherwise specified|2|||
42149294|NCT00381680|75958226|FG000|Overall Study|Ineligible|3|||
42278092|NCT02819635|76109721|FG001|Substudy 3|Withdrew consent|0|||
42039723|NCT04447755|75848094|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
42039724|NCT04447755|75848095|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
42149295|NCT00381680|75958227|FG001|Overall Study|Ineligible|1|||
42278093|NCT02819635|76109722|FG002|Substudy 3|Withdrew consent|0|||
42149296|NCT00360698|75958239|FG000|Run-In|Physician Decision|0|||
42149297|NCT00360698|75958240|FG001|Run-In|Physician Decision|1|||
42149298|NCT00360698|75958239|FG000|Run-In|Withdrawal by Subject|0|||
42149299|NCT00360698|75958240|FG001|Run-In|Withdrawal by Subject|2|||
42149300|NCT00360698|75958239|FG000|Run-In|Non compliance with treatment procedure|0|||
42149301|NCT00360698|75958240|FG001|Run-In|Non compliance with treatment procedure|1|||
42149302|NCT00360698|75958239|FG000|Run-In|Sponsor request|0|||
42149303|NCT00360698|75958240|FG001|Run-In|Sponsor request|2|||
42149304|NCT00360698|75958239|FG000|Run-In|Patient did not meet inclusion criteria|0|||
42149305|NCT00360698|75958240|FG001|Run-In|Patient did not meet inclusion criteria|1|||
42149306|NCT00360698|75958239|FG000|Run-In|Patient personal reasons|0|||
42149307|NCT00360698|75958240|FG001|Run-In|Patient personal reasons|2|||
42149308|NCT00360698|75958239|FG000|Run-In|Need of insulin with meals|0|||
42149309|NCT00360698|75958240|FG001|Run-In|Need of insulin with meals|1|||
42149310|NCT00360698|75958239|FG000|Treatment Period|Non compliance with treatment procedure|1|||
42149311|NCT00360698|75958240|FG001|Treatment Period|Non compliance with treatment procedure|0|||
42149312|NCT00360698|75958239|FG000|Treatment Period|Early termination by error|0|||
42149313|NCT00360698|75958240|FG001|Treatment Period|Early termination by error|1|||
42149314|NCT00380978|75958248|FG000|Overall Study|Refused allocated intervention|0|||
42149315|NCT00380978|75958249|FG001|Overall Study|Refused allocated intervention|6|||
42149316|NCT00380978|75958248|FG000|Overall Study|Wrong study envelope|0|||
42149317|NCT00380978|75958249|FG001|Overall Study|Wrong study envelope|2|||
42149318|NCT00380978|75958248|FG000|Overall Study|Allocation prior to analgesia request|1|||
42149319|NCT00380978|75958249|FG001|Overall Study|Allocation prior to analgesia request|2|||
42149320|NCT00380978|75958248|FG000|Overall Study|Parous patient|1|||
42149321|NCT00380978|75958249|FG001|Overall Study|Parous patient|0|||
42149322|NCT00162123|75958263|FG000|Overall Study|Disease progression|27|||
42149323|NCT00162123|75958264|FG001|Overall Study|Disease progression|19|||
42149324|NCT00162123|75958265|FG002|Overall Study|Disease progression|10|||
42149325|NCT00162123|75958266|FG003|Overall Study|Disease progression|4|||
42149326|NCT00162123|75958267|FG004|Overall Study|Disease progression|8|||
42149327|NCT00162123|75958268|FG005|Overall Study|Disease progression|3|||
42149328|NCT00162123|75958269|FG006|Overall Study|Disease progression|1|||
42149329|NCT00162123|75958270|FG007|Overall Study|Disease progression|0|||
42149330|NCT00162123|75958263|FG000|Overall Study|Study drug toxicity|6|||
42149331|NCT00162123|75958264|FG001|Overall Study|Study drug toxicity|1|||
42149332|NCT00162123|75958265|FG002|Overall Study|Study drug toxicity|5|||
42149333|NCT00162123|75958266|FG003|Overall Study|Study drug toxicity|0|||
42149334|NCT00162123|75958267|FG004|Overall Study|Study drug toxicity|4|||
42149335|NCT00162123|75958268|FG005|Overall Study|Study drug toxicity|1|||
42149336|NCT00162123|75958269|FG006|Overall Study|Study drug toxicity|1|||
42149337|NCT00162123|75958270|FG007|Overall Study|Study drug toxicity|0|||
42149338|NCT00162123|75958263|FG000|Overall Study|Death|3|||
42149339|NCT00162123|75958264|FG001|Overall Study|Death|3|||
42149340|NCT00162123|75958265|FG002|Overall Study|Death|1|||
42149341|NCT00162123|75958266|FG003|Overall Study|Death|1|||
42149342|NCT00162123|75958267|FG004|Overall Study|Death|1|||
42149343|NCT00162123|75958268|FG005|Overall Study|Death|1|||
42149344|NCT00162123|75958269|FG006|Overall Study|Death|0|||
42149345|NCT00162123|75958270|FG007|Overall Study|Death|0|||
42149346|NCT00162123|75958263|FG000|Overall Study|Withdrawal by Subject|2|||
42149347|NCT00162123|75958264|FG001|Overall Study|Withdrawal by Subject|0|||
42149348|NCT00162123|75958265|FG002|Overall Study|Withdrawal by Subject|2|||
42149349|NCT00162123|75958266|FG003|Overall Study|Withdrawal by Subject|1|||
42149350|NCT00162123|75958267|FG004|Overall Study|Withdrawal by Subject|1|||
42149351|NCT00162123|75958268|FG005|Overall Study|Withdrawal by Subject|2|||
42149352|NCT00162123|75958269|FG006|Overall Study|Withdrawal by Subject|1|||
42149353|NCT00162123|75958270|FG007|Overall Study|Withdrawal by Subject|0|||
42149354|NCT00162123|75958263|FG000|Overall Study|Deterioration without progression|2|||
42278094|NCT02819635|76109723|FG003|Substudy 3|Withdrew consent|0|||
42012792|NCT04091646|75819661|FG000|Overall Study|Withdrawal by Subject|4|||
42149355|NCT00162123|75958264|FG001|Overall Study|Deterioration without progression|2|||
42278095|NCT02819635|76109724|FG004|Substudy 3|Withdrew consent|0|||
42012793|NCT04091646|75819662|FG001|Overall Study|Withdrawal by Subject|1|||
42149356|NCT00162123|75958265|FG002|Overall Study|Deterioration without progression|3|||
42149357|NCT00162123|75958266|FG003|Overall Study|Deterioration without progression|0|||
42149358|NCT00162123|75958267|FG004|Overall Study|Deterioration without progression|1|||
42149359|NCT00162123|75958268|FG005|Overall Study|Deterioration without progression|0|||
42149360|NCT00162123|75958269|FG006|Overall Study|Deterioration without progression|0|||
42149361|NCT00162123|75958270|FG007|Overall Study|Deterioration without progression|0|||
42149362|NCT00162123|75958263|FG000|Overall Study|Adverse Event|1|||
42149363|NCT00162123|75958264|FG001|Overall Study|Adverse Event|2|||
42149364|NCT00162123|75958265|FG002|Overall Study|Adverse Event|0|||
42149365|NCT00162123|75958266|FG003|Overall Study|Adverse Event|2|||
42149366|NCT00162123|75958267|FG004|Overall Study|Adverse Event|1|||
42149367|NCT00162123|75958268|FG005|Overall Study|Adverse Event|0|||
42012794|NCT04091646|75819661|FG000|Overall Study|Participant Incarcerated|1|||
42149368|NCT00162123|75958269|FG006|Overall Study|Adverse Event|0|||
42149369|NCT00162123|75958270|FG007|Overall Study|Adverse Event|0|||
42149370|NCT00162123|75958263|FG000|Overall Study|Not specified (before treatment)|2|||
42149371|NCT00162123|75958264|FG001|Overall Study|Not specified (before treatment)|0|||
42149372|NCT00162123|75958265|FG002|Overall Study|Not specified (before treatment)|0|||
42149373|NCT00162123|75958266|FG003|Overall Study|Not specified (before treatment)|0|||
42149374|NCT00162123|75958267|FG004|Overall Study|Not specified (before treatment)|12|||
42149375|NCT00162123|75958268|FG005|Overall Study|Not specified (before treatment)|1|||
42149376|NCT00162123|75958269|FG006|Overall Study|Not specified (before treatment)|0|||
42149377|NCT00162123|75958270|FG007|Overall Study|Not specified (before treatment)|0|||
42149378|NCT00162123|75958263|FG000|Overall Study|Not specified (after start of treatment)|0|||
42149379|NCT00162123|75958264|FG001|Overall Study|Not specified (after start of treatment)|0|||
42149380|NCT00162123|75958265|FG002|Overall Study|Not specified (after start of treatment)|0|||
42149381|NCT00162123|75958266|FG003|Overall Study|Not specified (after start of treatment)|0|||
42149382|NCT00162123|75958267|FG004|Overall Study|Not specified (after start of treatment)|3|||
42149383|NCT00162123|75958268|FG005|Overall Study|Not specified (after start of treatment)|0|||
42149384|NCT00162123|75958269|FG006|Overall Study|Not specified (after start of treatment)|0|||
42149385|NCT00162123|75958270|FG007|Overall Study|Not specified (after start of treatment)|0|||
42149386|NCT00162123|75958263|FG000|Overall Study|Physician Decision|1|||
42149387|NCT00162123|75958264|FG001|Overall Study|Physician Decision|2|||
42149388|NCT00162123|75958265|FG002|Overall Study|Physician Decision|0|||
42149389|NCT00162123|75958266|FG003|Overall Study|Physician Decision|0|||
42149390|NCT00162123|75958267|FG004|Overall Study|Physician Decision|0|||
42149391|NCT00162123|75958268|FG005|Overall Study|Physician Decision|1|||
42149392|NCT00162123|75958269|FG006|Overall Study|Physician Decision|1|||
42149393|NCT00162123|75958270|FG007|Overall Study|Physician Decision|0|||
42149394|NCT00162123|75958263|FG000|Overall Study|Tumor assessment only (not treated)|0|||
42149395|NCT00162123|75958264|FG001|Overall Study|Tumor assessment only (not treated)|0|||
42149396|NCT00162123|75958265|FG002|Overall Study|Tumor assessment only (not treated)|0|||
42149397|NCT00162123|75958266|FG003|Overall Study|Tumor assessment only (not treated)|0|||
42149398|NCT00162123|75958267|FG004|Overall Study|Tumor assessment only (not treated)|0|||
42149399|NCT00162123|75958268|FG005|Overall Study|Tumor assessment only (not treated)|0|||
42149400|NCT00162123|75958269|FG006|Overall Study|Tumor assessment only (not treated)|0|||
42149401|NCT00162123|75958270|FG007|Overall Study|Tumor assessment only (not treated)|1|||
42149402|NCT00162123|75958263|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
42149403|NCT00162123|75958264|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
42149404|NCT00162123|75958265|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
42149405|NCT00162123|75958266|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
42149406|NCT00162123|75958267|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
42149407|NCT00162123|75958268|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
42149408|NCT00162123|75958269|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
42149409|NCT00162123|75958270|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
42149410|NCT00227721|75958289|FG000|Overall Study|On study, but never treated.|1|||
42149411|NCT00226941|75958297|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
42149412|NCT00226941|75958298|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
42149413|NCT00226941|75958299|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
42149414|NCT00226941|75958300|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
42149415|NCT00226941|75958297|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
42149416|NCT00226941|75958298|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
42149417|NCT00226941|75958299|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
42149418|NCT00226941|75958300|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
42149419|NCT00356408|75958320|FG000|Overall Study|Adverse Event|9|||
42149420|NCT00356408|75958320|FG000|Overall Study|Lack of Efficacy|36|||
42149421|NCT00356408|75958320|FG000|Overall Study|Lost to Follow-up|2|||
42149422|NCT00356408|75958320|FG000|Overall Study|Withdrawal by Subject|6|||
42149423|NCT00356408|75958320|FG000|Overall Study|Other: Principal investigator discretion|3|||
42149424|NCT00356408|75958320|FG000|Overall Study|Other: Sponsor request|1|||
42149425|NCT00356408|75958320|FG000|Overall Study|Other: Azathioprine stopped|1|||
42149426|NCT00356408|75958320|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
42149427|NCT00356408|75958320|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
42149428|NCT00509795|75958335|FG000|Overall Study|Adverse Event|4|||
42278096|NCT02819635|76109725|FG005|Substudy 3|Withdrew consent|0|||
42278097|NCT02819635|76109726|FG006|Substudy 3|Withdrew consent|0|||
42149429|NCT00509795|75958336|FG001|Overall Study|Adverse Event|3|||
42149430|NCT00509795|75958337|FG002|Overall Study|Adverse Event|5|||
42149431|NCT00509795|75958338|FG003|Overall Study|Adverse Event|4|||
42149432|NCT00509795|75958335|FG000|Overall Study|Death|3|||
42149433|NCT00509795|75958336|FG001|Overall Study|Death|1|||
42149434|NCT00509795|75958337|FG002|Overall Study|Death|2|||
42149435|NCT00509795|75958338|FG003|Overall Study|Death|7|||
42149436|NCT00509795|75958335|FG000|Overall Study|Lack of Efficacy|0|||
42149437|NCT00509795|75958336|FG001|Overall Study|Lack of Efficacy|0|||
42149438|NCT00509795|75958337|FG002|Overall Study|Lack of Efficacy|2|||
42149439|NCT00509795|75958338|FG003|Overall Study|Lack of Efficacy|2|||
42149440|NCT00509795|75958335|FG000|Overall Study|Lost to Follow-up|1|||
42149441|NCT00509795|75958336|FG001|Overall Study|Lost to Follow-up|2|||
42149442|NCT00509795|75958337|FG002|Overall Study|Lost to Follow-up|4|||
42149443|NCT00509795|75958338|FG003|Overall Study|Lost to Follow-up|4|||
42149444|NCT00509795|75958335|FG000|Overall Study|OTHER|1|||
42149445|NCT00509795|75958336|FG001|Overall Study|OTHER|0|||
42149446|NCT00509795|75958337|FG002|Overall Study|OTHER|4|||
42149447|NCT00509795|75958338|FG003|Overall Study|OTHER|1|||
42039725|NCT04447755|75848096|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
42039726|NCT04447755|75848097|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
42039727|NCT04447755|75848098|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
42039728|NCT04447755|75848092|FG000|Overall Study|Ongoing in Study|1|||
42039729|NCT04447755|75848093|FG001|Overall Study|Ongoing in Study|2|||
42039730|NCT04447755|75848094|FG002|Overall Study|Ongoing in Study|0|||
42039731|NCT04447755|75848095|FG003|Overall Study|Ongoing in Study|0|||
42039732|NCT04447755|75848096|FG004|Overall Study|Ongoing in Study|2|||
42039733|NCT04447755|75848097|FG005|Overall Study|Ongoing in Study|2|||
42039734|NCT04447755|75848098|FG006|Overall Study|Ongoing in Study|26|||
42039735|NCT04060680|75848133|FG000|Overall Study|Unsuccessful implant|17|||
42039736|NCT04060680|75848133|FG000|Overall Study|Adverse Event|3|||
42039737|NCT04060680|75848133|FG000|Overall Study|Death|2|||
42039738|NCT04060680|75848133|FG000|Overall Study|Study product no longer in use|1|||
42039739|NCT04060680|75848133|FG000|Overall Study|Withdrawal by Subject|1|||
42039740|NCT03981614|75848141|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
42039741|NCT03981614|75848142|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
42039742|NCT03981614|75848143|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
42039743|NCT03965689|75848154|FG000|Overall Study|Too sick to get study intervention|2|||
42039744|NCT03918629|75848173|FG000|Overall Study|Adverse Event|19|||
42039745|NCT03918629|75848174|FG001|Overall Study|Adverse Event|20|||
42039746|NCT03918629|75848173|FG000|Overall Study|Death|14|||
42039747|NCT03918629|75848174|FG001|Overall Study|Death|7|||
42039748|NCT03918629|75848173|FG000|Overall Study|Lost to Follow-up|36|||
42039749|NCT03918629|75848174|FG001|Overall Study|Lost to Follow-up|28|||
42039750|NCT03918629|75848173|FG000|Overall Study|Physician Decision|1|||
42039751|NCT03918629|75848174|FG001|Overall Study|Physician Decision|0|||
42039752|NCT03918629|75848173|FG000|Overall Study|Protocol Violation|7|||
42039753|NCT03918629|75848174|FG001|Overall Study|Protocol Violation|4|||
42039754|NCT03918629|75848173|FG000|Overall Study|Withdrawal by Subject|47|||
42039755|NCT03918629|75848174|FG001|Overall Study|Withdrawal by Subject|47|||
42039756|NCT03918629|75848173|FG000|Overall Study|Other|7|||
42039757|NCT03918629|75848174|FG001|Overall Study|Other|11|||
42039758|NCT03918629|75848173|FG000|Overall Study|Randomized but not vaccinated|2|||
42039759|NCT03918629|75848174|FG001|Overall Study|Randomized but not vaccinated|1|||
42039760|NCT03713593|75848186|FG000|Overall Study|Participants Ongoing|140|||
42039761|NCT03713593|75848187|FG001|Overall Study|Participants Ongoing|114|||
42039762|NCT03713593|75848186|FG000|Overall Study|Withdrawal by Subject|3|||
42039763|NCT03713593|75848187|FG001|Overall Study|Withdrawal by Subject|6|||
42039764|NCT03713593|75848186|FG000|Overall Study|Death|252|||
42039765|NCT03713593|75848187|FG001|Overall Study|Death|279|||
42039766|NCT03585270|75848195|FG000|Overall Study|Withdrawal by Subject|2|||
42039767|NCT03585270|75848196|FG001|Overall Study|Withdrawal by Subject|6|||
42039768|NCT03585270|75848195|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
42149448|NCT00509795|75958335|FG000|Overall Study|Protocol Violation|3|||
42149449|NCT00509795|75958336|FG001|Overall Study|Protocol Violation|0|||
42149450|NCT00509795|75958337|FG002|Overall Study|Protocol Violation|3|||
42149451|NCT00509795|75958338|FG003|Overall Study|Protocol Violation|1|||
42351238|NCT01515189|76191132|FG001|Induction|No longer meets study criteria|2|||
42012795|NCT04091646|75819662|FG001|Overall Study|Participant Incarcerated|0|||
42012796|NCT04040933|75819674|FG000|Overall Study|Protocol Violation|1|||
42012797|NCT04040933|75819674|FG000|Overall Study|Withdrawal by Subject|2|||
42012798|NCT03995355|75819687|FG000|Overall Study|Adverse Event|1|||
42012799|NCT03995355|75819688|FG001|Overall Study|Adverse Event|0|||
42012800|NCT03995355|75819687|FG000|Overall Study|Withdrawal by Subject|1|||
42012801|NCT03995355|75819688|FG001|Overall Study|Withdrawal by Subject|0|||
42039769|NCT03585270|75848196|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
42039770|NCT03585270|75848195|FG000|Overall Study|Adverse Event|5|||
42039771|NCT03585270|75848196|FG001|Overall Study|Adverse Event|2|||
42039772|NCT03585270|75848195|FG000|Overall Study|Lost to Follow-up|1|||
42149452|NCT00509795|75958335|FG000|Overall Study|Withdrawal by Subject|10|||
42149453|NCT00509795|75958336|FG001|Overall Study|Withdrawal by Subject|5|||
42149454|NCT00509795|75958337|FG002|Overall Study|Withdrawal by Subject|7|||
42012802|NCT03995355|75819687|FG000|Overall Study|Scheduling Issues|0|||
42012803|NCT03995355|75819688|FG001|Overall Study|Scheduling Issues|1|||
42039773|NCT03585270|75848196|FG001|Overall Study|Lost to Follow-up|4|||
42039774|NCT03585270|75848195|FG000|Overall Study|Death|5|||
42149455|NCT00509795|75958338|FG003|Overall Study|Withdrawal by Subject|8|||
42149456|NCT00165789|75958353|FG000|Overall Study|Adverse Event|0|||
42149457|NCT00165789|75958354|FG001|Overall Study|Adverse Event|3|||
42149458|NCT00165789|75958355|FG002|Overall Study|Adverse Event|0|||
42149459|NCT00165789|75958356|FG003|Overall Study|Adverse Event|12|||
42149460|NCT00165789|75958353|FG000|Overall Study|Withdrawal by Subject|0|||
42149461|NCT00165789|75958354|FG001|Overall Study|Withdrawal by Subject|1|||
42149462|NCT00165789|75958355|FG002|Overall Study|Withdrawal by Subject|1|||
42149463|NCT00165789|75958356|FG003|Overall Study|Withdrawal by Subject|2|||
42149464|NCT00504257|75958366|FG000|Overall Study|Withdrawal by Subject|2|||
42149465|NCT00504257|75958366|FG000|Overall Study|ineligible histology|2|||
42149466|NCT00509093|75958370|FG000|Overall Study|Adverse Event|10|||
42149467|NCT00509093|75958370|FG000|Overall Study|Disease Progression|9|||
42149468|NCT00509093|75958370|FG000|Overall Study|Transformed into MDS|1|||
42149469|NCT00509093|75958370|FG000|Overall Study|Withdrawal by Subject|3|||
42149470|NCT00509093|75958370|FG000|Overall Study|Physician Decision|1|||
42149471|NCT00160641|75958374|FG000|Overall Study|Adverse Event|102|||
42149472|NCT00160641|75958374|FG000|Overall Study|Withdrawal by Subject|87|||
42149473|NCT00160641|75958374|FG000|Overall Study|Lost to Follow-up|8|||
42149474|NCT00160641|75958374|FG000|Overall Study|Lack of Efficacy|12|||
42149475|NCT00160641|75958374|FG000|Overall Study|Protocol Violation|3|||
42149476|NCT00160641|75958374|FG000|Overall Study|Other|9|||
42149477|NCT00493025|75958378|FG000|Overall Study|Physician Decision|19|||
42149478|NCT00160563|75958386|FG000|Overall Study|Adverse Event|1|||
42149479|NCT00160563|75958387|FG001|Overall Study|Adverse Event|1|||
42149480|NCT00160563|75958388|FG002|Overall Study|Adverse Event|1|||
42149481|NCT00160563|75958386|FG000|Overall Study|Lost to Follow-up|1|||
42149482|NCT00160563|75958387|FG001|Overall Study|Lost to Follow-up|1|||
42149483|NCT00160563|75958388|FG002|Overall Study|Lost to Follow-up|2|||
42149484|NCT00160563|75958386|FG000|Overall Study|Protocol Violation|0|||
42149485|NCT00160563|75958387|FG001|Overall Study|Protocol Violation|0|||
42149486|NCT00160563|75958388|FG002|Overall Study|Protocol Violation|3|||
42149487|NCT00160563|75958386|FG000|Overall Study|Withdrawal by Subject|1|||
42149488|NCT00160563|75958387|FG001|Overall Study|Withdrawal by Subject|2|||
42149489|NCT00160563|75958388|FG002|Overall Study|Withdrawal by Subject|3|||
42149490|NCT00160563|75958386|FG000|Overall Study|Other (listed in the study report)|48|||
42149491|NCT00160563|75958387|FG001|Overall Study|Other (listed in the study report)|40|||
42149492|NCT00160563|75958388|FG002|Overall Study|Other (listed in the study report)|81|||
42149493|NCT00160563|75958386|FG000|Overall Study|Missing reason|0|||
42149494|NCT00160563|75958387|FG001|Overall Study|Missing reason|1|||
42149495|NCT00160563|75958388|FG002|Overall Study|Missing reason|0|||
42149496|NCT00380744|75958404|FG000|Overall Study|Death|0|||
42149497|NCT00380744|75958405|FG001|Overall Study|Death|0|||
42149498|NCT00380744|75958406|FG002|Overall Study|Death|0|||
42149499|NCT00380744|75958407|FG003|Overall Study|Death|0|||
42149500|NCT00380744|75958408|FG004|Overall Study|Death|0|||
42149501|NCT00380744|75958409|FG005|Overall Study|Death|0|||
42149502|NCT00380744|75958410|FG006|Overall Study|Death|1|||
42149503|NCT00380744|75958404|FG000|Overall Study|Withdrawal by Subject|1|||
42149504|NCT00380744|75958405|FG001|Overall Study|Withdrawal by Subject|0|||
42149505|NCT00380744|75958406|FG002|Overall Study|Withdrawal by Subject|0|||
42149506|NCT00380744|75958407|FG003|Overall Study|Withdrawal by Subject|0|||
42149507|NCT00380744|75958408|FG004|Overall Study|Withdrawal by Subject|0|||
42149508|NCT00380744|75958409|FG005|Overall Study|Withdrawal by Subject|0|||
42149509|NCT00380744|75958410|FG006|Overall Study|Withdrawal by Subject|0|||
42149510|NCT00380588|75958429|FG000|Overall Study|Unequivocal Disease Progression|25|||
42149511|NCT00380588|75958430|FG001|Overall Study|Unequivocal Disease Progression|34|||
42149512|NCT00380588|75958429|FG000|Overall Study|Next Cycle Not Started|4|||
42149513|NCT00380588|75958430|FG001|Overall Study|Next Cycle Not Started|0|||
42149514|NCT00380588|75958429|FG000|Overall Study|Adverse Event|7|||
42149515|NCT00380588|75958430|FG001|Overall Study|Adverse Event|3|||
42278098|NCT02819635|76109727|FG007|Substudy 3|Withdrew consent|0|||
42012804|NCT03933397|75819696|FG000|Overall Study|No emergency department visit|65|||
42012805|NCT03933397|75819697|FG001|Overall Study|No emergency department visit|71|||
42012806|NCT03933397|75819696|FG000|Overall Study|Missed emergency department visit|25|||
42012807|NCT03933397|75819697|FG001|Overall Study|Missed emergency department visit|30|||
42278099|NCT02819635|76109728|FG008|Substudy 3|Withdrew consent|11|||
42278100|NCT02819635|76109729|FG009|Substudy 3|Withdrew consent|1|||
42039775|NCT03585270|75848196|FG001|Overall Study|Death|3|||
42149516|NCT00380588|75958429|FG000|Overall Study|Withdrawal by Subject|1|||
42149517|NCT00380588|75958430|FG001|Overall Study|Withdrawal by Subject|3|||
42149518|NCT00380588|75958429|FG000|Overall Study|Physician Decision|2|||
42149519|NCT00380588|75958430|FG001|Overall Study|Physician Decision|0|||
42149520|NCT00379808|75958436|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
42149521|NCT00379808|75958437|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
42149522|NCT00355784|75958446|FG000|Overall Study|Withdrawal by Subject|0|||
42149523|NCT00355784|75958447|FG001|Overall Study|Withdrawal by Subject|0|||
42149524|NCT00355784|75958448|FG002|Overall Study|Withdrawal by Subject|2|||
42149525|NCT00355472|75958457|FG000|Overall Study|Physician Decision|1|||
42149526|NCT00492557|75958471|FG000|Overall Study|Subject request|12|||
42149527|NCT00492557|75958472|FG001|Overall Study|Subject request|11|||
42149528|NCT00492557|75958471|FG000|Overall Study|Protocol Violation|7|||
42149529|NCT00492557|75958472|FG001|Overall Study|Protocol Violation|8|||
42149530|NCT00492557|75958471|FG000|Overall Study|Other|2|||
42149531|NCT00492557|75958472|FG001|Overall Study|Other|2|||
42149532|NCT00492557|75958471|FG000|Overall Study|Death|1|||
42149533|NCT00492557|75958472|FG001|Overall Study|Death|1|||
42149534|NCT00492557|75958471|FG000|Overall Study|Adverse Event|1|||
42149535|NCT00492557|75958472|FG001|Overall Study|Adverse Event|0|||
42149536|NCT00492557|75958471|FG000|Overall Study|Failed to return|1|||
42149537|NCT00492557|75958472|FG001|Overall Study|Failed to return|0|||
42149538|NCT00492557|75958471|FG000|Overall Study|Lost to Follow-up|0|||
42149539|NCT00492557|75958472|FG001|Overall Study|Lost to Follow-up|1|||
42149540|NCT00508391|75958483|FG000|First Treatment|Withdrawal by Subject|6|||
42149541|NCT00508391|75958484|FG001|First Treatment|Withdrawal by Subject|3|||
42149542|NCT00508391|75958483|FG000|Second Treatment|Withdrawal by Subject|2|||
42149543|NCT00508391|75958484|FG001|Second Treatment|Withdrawal by Subject|0|||
42149544|NCT00508157|75958494|FG000|Overall Study|Adverse Event|0|||
42149545|NCT00508157|75958495|FG001|Overall Study|Adverse Event|1|||
42149546|NCT00508157|75958494|FG000|Overall Study|Subject Withdrew Consent|1|||
42149547|NCT00508157|75958495|FG001|Overall Study|Subject Withdrew Consent|0|||
42149548|NCT00508157|75958494|FG000|Overall Study|Lost to Follow-up|1|||
42149549|NCT00508157|75958495|FG001|Overall Study|Lost to Follow-up|0|||
42149550|NCT00508157|75958494|FG000|Overall Study|Subject no longer met study criteria|0|||
42149551|NCT00508157|75958495|FG001|Overall Study|Subject no longer met study criteria|1|||
42149552|NCT00508157|75958494|FG000|Overall Study|Other known cause|0|||
42149553|NCT00508157|75958495|FG001|Overall Study|Other known cause|1|||
42149554|NCT00378560|75958503|FG000|Overall Study|Adverse Event|1|||
42149555|NCT00378560|75958504|FG001|Overall Study|Adverse Event|0|||
42149556|NCT00378560|75958503|FG000|Overall Study|Lost to Follow-up|24|||
42149557|NCT00378560|75958504|FG001|Overall Study|Lost to Follow-up|29|||
42149558|NCT00378560|75958503|FG000|Overall Study|Protocol Violation|2|||
42149559|NCT00378560|75958504|FG001|Overall Study|Protocol Violation|0|||
42149560|NCT00378560|75958503|FG000|Overall Study|Withdrawal by Subject|17|||
42149561|NCT00378560|75958504|FG001|Overall Study|Withdrawal by Subject|21|||
42149562|NCT00378560|75958503|FG000|Overall Study|Moved|4|||
42149563|NCT00378560|75958504|FG001|Overall Study|Moved|3|||
42149564|NCT00378560|75958503|FG000|Overall Study|Pregnancy|7|||
42149565|NCT00378560|75958504|FG001|Overall Study|Pregnancy|5|||
42149566|NCT00378560|75958503|FG000|Overall Study|Laboratory test values abnormal|1|||
42149567|NCT00378560|75958504|FG001|Overall Study|Laboratory test values abnormal|0|||
42149568|NCT00508001|75958513|FG000|Overall Study|Adverse Event|2|||
42149569|NCT00508001|75958514|FG001|Overall Study|Adverse Event|0|||
42149570|NCT00508001|75958515|FG002|Overall Study|Adverse Event|4|||
42149571|NCT00508001|75958513|FG000|Overall Study|condition under investigation worsened|13|||
42149572|NCT00508001|75958514|FG001|Overall Study|condition under investigation worsened|7|||
42149573|NCT00508001|75958515|FG002|Overall Study|condition under investigation worsened|1|||
42149574|NCT00508001|75958513|FG000|Overall Study|Death|0|||
42149575|NCT00508001|75958514|FG001|Overall Study|Death|1|||
42149576|NCT00508001|75958515|FG002|Overall Study|Death|1|||
42149577|NCT00508001|75958513|FG000|Overall Study|Withdrawal by Subject|4|||
42149578|NCT00508001|75958514|FG001|Overall Study|Withdrawal by Subject|4|||
42149579|NCT00508001|75958515|FG002|Overall Study|Withdrawal by Subject|1|||
42149580|NCT00507689|75958526|FG000|Pre-Randomization Period|Adverse Event|1|||
42149581|NCT00507689|75958527|FG001|Pre-Randomization Period|Adverse Event|0|||
42149582|NCT00507689|75958526|FG000|Pre-Randomization Period|Physician Decision|1|||
42149583|NCT00507689|75958527|FG001|Pre-Randomization Period|Physician Decision|0|||
42149584|NCT00507689|75958526|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
42149585|NCT00507689|75958527|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
42149586|NCT00507689|75958526|FG000|Randomized Period|Adverse Event|1|||
42278101|NCT02819635|76109730|FG010|Substudy 3|Withdrew consent|4|||
42012808|NCT03933397|75819696|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
42012809|NCT03933397|75819697|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
42149587|NCT00507689|75958527|FG001|Randomized Period|Adverse Event|1|||
42149588|NCT00507689|75958526|FG000|Randomized Period|Withdrawal by Subject|0|||
42149589|NCT00507689|75958527|FG001|Randomized Period|Withdrawal by Subject|1|||
42012810|NCT03933397|75819696|FG000|Overall Study|Withdrawal by Subject|1|||
42012811|NCT03933397|75819697|FG001|Overall Study|Withdrawal by Subject|0|||
42149590|NCT00491387|75958534|FG000|Overall Study|study terminated|20|||
42149591|NCT00491075|75958538|FG000|Overall Study|Withdrawal by Subject|1|||
42149592|NCT00491075|75958538|FG000|Overall Study|Physician Decision|1|||
42149593|NCT00507455|75958545|FG000|Overall Study|Adverse Event|3|||
42149594|NCT00507455|75958546|FG001|Overall Study|Adverse Event|3|||
42149595|NCT00507455|75958547|FG002|Overall Study|Adverse Event|6|||
42149596|NCT00507455|75958545|FG000|Overall Study|Withdrawal by Subject|2|||
42149597|NCT00507455|75958546|FG001|Overall Study|Withdrawal by Subject|1|||
42149598|NCT00507455|75958547|FG002|Overall Study|Withdrawal by Subject|2|||
42149599|NCT00507455|75958545|FG000|Overall Study|Protocol Violation|4|||
42149600|NCT00507455|75958546|FG001|Overall Study|Protocol Violation|1|||
42149601|NCT00507455|75958547|FG002|Overall Study|Protocol Violation|1|||
42149602|NCT00507455|75958545|FG000|Overall Study|Lost to Follow-up|2|||
42149603|NCT00507455|75958546|FG001|Overall Study|Lost to Follow-up|0|||
42149604|NCT00507455|75958547|FG002|Overall Study|Lost to Follow-up|2|||
42149605|NCT00507455|75958545|FG000|Overall Study|Lack of Efficacy|0|||
42149606|NCT00507455|75958546|FG001|Overall Study|Lack of Efficacy|1|||
42149607|NCT00507455|75958547|FG002|Overall Study|Lack of Efficacy|0|||
42149608|NCT00507455|75958545|FG000|Overall Study|Other - miscellaneous reason|1|||
42149609|NCT00507455|75958546|FG001|Overall Study|Other - miscellaneous reason|0|||
42149610|NCT00507455|75958547|FG002|Overall Study|Other - miscellaneous reason|1|||
42149611|NCT00506831|75958555|FG000|Overall Study|Death|1|||
42149612|NCT00506831|75958555|FG000|Overall Study|Withdrawal by Subject|1|||
42149613|NCT00506753|75958561|FG000|Overall Study|Lost to Follow-up|21|||
42149614|NCT00506753|75958562|FG001|Overall Study|Lost to Follow-up|15|||
42149615|NCT00490919|75958570|FG000|Open-label Run-in Period|Adverse Event|239|||
42149616|NCT00490919|75958571|FG001|Open-label Run-in Period|Adverse Event|0|||
42149617|NCT00490919|75958572|FG002|Open-label Run-in Period|Adverse Event|0|||
42149618|NCT00490919|75958570|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
42149619|NCT00490919|75958571|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
42149620|NCT00490919|75958572|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
42149621|NCT00490919|75958570|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
42149622|NCT00490919|75958571|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
42149623|NCT00490919|75958572|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
42149624|NCT00490919|75958570|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
42149625|NCT00490919|75958571|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
42149626|NCT00490919|75958572|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
42149627|NCT00490919|75958570|FG000|Open-label Run-in Period|Administrative|40|||
42149628|NCT00490919|75958571|FG001|Open-label Run-in Period|Administrative|0|||
42149629|NCT00490919|75958572|FG002|Open-label Run-in Period|Administrative|0|||
42149630|NCT00490919|75958570|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
42149631|NCT00490919|75958571|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
42149632|NCT00490919|75958572|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
42149633|NCT00490919|75958570|FG000|Double-blind Phase|Adverse Event|0|||
42149634|NCT00490919|75958571|FG001|Double-blind Phase|Adverse Event|40|||
42149635|NCT00490919|75958572|FG002|Double-blind Phase|Adverse Event|20|||
42149636|NCT00490919|75958570|FG000|Double-blind Phase|Withdrawal by Subject|0|||
42149637|NCT00490919|75958571|FG001|Double-blind Phase|Withdrawal by Subject|10|||
42149638|NCT00490919|75958572|FG002|Double-blind Phase|Withdrawal by Subject|11|||
42149639|NCT00490919|75958570|FG000|Double-blind Phase|Lost to Follow-up|0|||
42149640|NCT00490919|75958571|FG001|Double-blind Phase|Lost to Follow-up|8|||
42149641|NCT00490919|75958572|FG002|Double-blind Phase|Lost to Follow-up|11|||
42149642|NCT00490919|75958570|FG000|Double-blind Phase|Lack of Efficacy|0|||
42149643|NCT00490919|75958571|FG001|Double-blind Phase|Lack of Efficacy|22|||
42149644|NCT00490919|75958572|FG002|Double-blind Phase|Lack of Efficacy|36|||
42149645|NCT00490919|75958570|FG000|Double-blind Phase|Administrative|0|||
42149646|NCT00490919|75958571|FG001|Double-blind Phase|Administrative|6|||
42149647|NCT00490919|75958572|FG002|Double-blind Phase|Administrative|6|||
42149648|NCT00503867|75958579|FG000|Overall Study|Lost to Follow-up|1|||
42149649|NCT00503867|75958579|FG000|Overall Study|Adverse Event|1|||
42149650|NCT00503399|75958585|FG000|Overall Study|Death|2|||
42149651|NCT00503399|75958586|FG001|Overall Study|Death|1|||
42149652|NCT00503399|75958585|FG000|Overall Study|Protocol Violation|1|||
42278102|NCT02819635|76109731|FG011|Substudy 3|Withdrew consent|9|||
42278103|NCT02819635|76109720|FG000|Substudy 3|Lost to Follow-up|0|||
42278104|NCT02819635|76109721|FG001|Substudy 3|Lost to Follow-up|0|||
42278105|NCT02819635|76109722|FG002|Substudy 3|Lost to Follow-up|0|||
42278106|NCT02819635|76109723|FG003|Substudy 3|Lost to Follow-up|0|||
42012812|NCT03933397|75819696|FG000|Overall Study|Physician Decision|1|||
42012813|NCT03933397|75819697|FG001|Overall Study|Physician Decision|1|||
42012814|NCT03933397|75819696|FG000|Overall Study|missing pain score|1|||
42012815|NCT03933397|75819697|FG001|Overall Study|missing pain score|1|||
42012816|NCT03933397|75819696|FG000|Overall Study|Confirmed COVID-19|1|||
42012817|NCT03933397|75819697|FG001|Overall Study|Confirmed COVID-19|2|||
42012818|NCT03624881|75819738|FG000|Overall Study|Screen Failure|14|||
42149653|NCT00503399|75958586|FG001|Overall Study|Protocol Violation|0|||
42149654|NCT00503399|75958585|FG000|Overall Study|Withdrawal by Subject|4|||
42149655|NCT00503399|75958586|FG001|Overall Study|Withdrawal by Subject|2|||
42149656|NCT00503399|75958585|FG000|Overall Study|Adverse Event|0|||
42149657|NCT00503399|75958586|FG001|Overall Study|Adverse Event|3|||
42149658|NCT00503399|75958585|FG000|Overall Study|Lost to Follow-up|0|||
42149659|NCT00503399|75958586|FG001|Overall Study|Lost to Follow-up|2|||
42149660|NCT00506519|75958595|FG000|Overall Study|Death|4|||
42149661|NCT00506519|75958596|FG001|Overall Study|Death|6|||
42149662|NCT00506519|75958597|FG002|Overall Study|Death|0|||
42149663|NCT00506519|75958595|FG000|Overall Study|Adverse Event|1|||
42149664|NCT00506519|75958596|FG001|Overall Study|Adverse Event|0|||
42149665|NCT00506519|75958597|FG002|Overall Study|Adverse Event|0|||
42149666|NCT00503009|75958611|FG000|Overall Study|Protocol Violation|1|||
42149667|NCT00503009|75958612|FG001|Overall Study|Protocol Violation|0|||
42149668|NCT00503009|75958613|FG002|Overall Study|Protocol Violation|1|||
42149669|NCT00503009|75958611|FG000|Overall Study|Withdrawal by Subject|0|||
42149670|NCT00503009|75958612|FG001|Overall Study|Withdrawal by Subject|1|||
42149671|NCT00503009|75958613|FG002|Overall Study|Withdrawal by Subject|1|||
42149672|NCT00503009|75958611|FG000|Overall Study|Physician Decision|0|||
42149673|NCT00503009|75958612|FG001|Overall Study|Physician Decision|1|||
42149674|NCT00503009|75958613|FG002|Overall Study|Physician Decision|1|||
42149675|NCT00160251|75958627|FG000|Prior to Amendment 2|Adverse Event|2|||
42149676|NCT00160251|75958628|FG001|Prior to Amendment 2|Adverse Event|1|||
42149677|NCT00160251|75958629|FG002|Prior to Amendment 2|Adverse Event|3|||
42149678|NCT00160251|75958630|FG003|Prior to Amendment 2|Adverse Event|1|||
42149679|NCT00160251|75958631|FG004|Prior to Amendment 2|Adverse Event|1|||
42149680|NCT00160251|75958632|FG005|Prior to Amendment 2|Adverse Event|1|||
42149681|NCT00160251|75958633|FG006|Prior to Amendment 2|Adverse Event|1|||
42149682|NCT00160251|75958634|FG007|Prior to Amendment 2|Adverse Event|0|||
42149683|NCT00160251|75958627|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
42149684|NCT00160251|75958628|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
42149685|NCT00160251|75958629|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
42149686|NCT00160251|75958630|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
42149687|NCT00160251|75958631|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
42149688|NCT00160251|75958632|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
42149689|NCT00160251|75958633|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
42149690|NCT00160251|75958634|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
42149691|NCT00160251|75958627|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
42149692|NCT00160251|75958628|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
42149693|NCT00160251|75958629|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
42149694|NCT00160251|75958630|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
42149695|NCT00160251|75958631|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
42149696|NCT00160251|75958632|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
42149697|NCT00160251|75958633|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
42149698|NCT00160251|75958634|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
42149699|NCT00160251|75958627|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
42149700|NCT00160251|75958628|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
42149701|NCT00160251|75958629|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
42149702|NCT00160251|75958630|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
42149703|NCT00160251|75958631|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
42149704|NCT00160251|75958632|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
42149705|NCT00160251|75958633|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
42149706|NCT00160251|75958634|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
42149707|NCT00160251|75958627|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
42149708|NCT00160251|75958628|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
42149709|NCT00160251|75958629|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
42149710|NCT00160251|75958630|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
42149711|NCT00160251|75958631|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
42149712|NCT00160251|75958632|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
42149713|NCT00160251|75958633|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
42149714|NCT00160251|75958634|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
42149715|NCT00160251|75958627|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
42149716|NCT00160251|75958628|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
42149717|NCT00160251|75958629|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
42149718|NCT00160251|75958630|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
42149719|NCT00160251|75958631|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
42149720|NCT00160251|75958632|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
42149721|NCT00160251|75958633|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
42149722|NCT00160251|75958634|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
42351239|NCT01515189|76191131|FG000|Induction|Lost to Follow-up|1|||
42351240|NCT01515189|76191132|FG001|Induction|Lost to Follow-up|0|||
42039776|NCT03585270|75848195|FG000|Overall Study|Other reasons|2|||
42039777|NCT03585270|75848196|FG001|Overall Study|Other reasons|2|||
42039778|NCT03499249|75848204|FG000|Overall Study|Physician Decision|1|||
42039779|NCT03138499|75848210|FG000|Overall Study|Lost to Follow-up|1|||
42149723|NCT00160251|75958627|FG000|Post-amendment 2|Adverse Event|0|||
42149724|NCT00160251|75958628|FG001|Post-amendment 2|Adverse Event|0|||
42149725|NCT00160251|75958629|FG002|Post-amendment 2|Adverse Event|0|||
42149726|NCT00160251|75958630|FG003|Post-amendment 2|Adverse Event|0|||
42149727|NCT00160251|75958631|FG004|Post-amendment 2|Adverse Event|0|||
42149728|NCT00160251|75958632|FG005|Post-amendment 2|Adverse Event|0|||
42149729|NCT00160251|75958633|FG006|Post-amendment 2|Adverse Event|0|||
42149730|NCT00160251|75958634|FG007|Post-amendment 2|Adverse Event|20|||
42149731|NCT00160251|75958627|FG000|Post-amendment 2|Lack of Efficacy|0|||
42149732|NCT00160251|75958628|FG001|Post-amendment 2|Lack of Efficacy|0|||
42149733|NCT00160251|75958629|FG002|Post-amendment 2|Lack of Efficacy|0|||
42149734|NCT00160251|75958630|FG003|Post-amendment 2|Lack of Efficacy|0|||
42149735|NCT00160251|75958631|FG004|Post-amendment 2|Lack of Efficacy|0|||
42149736|NCT00160251|75958632|FG005|Post-amendment 2|Lack of Efficacy|0|||
42149737|NCT00160251|75958633|FG006|Post-amendment 2|Lack of Efficacy|0|||
42149738|NCT00160251|75958634|FG007|Post-amendment 2|Lack of Efficacy|24|||
42149739|NCT00160251|75958627|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
42149740|NCT00160251|75958628|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
42149741|NCT00160251|75958629|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
42149742|NCT00160251|75958630|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
42149743|NCT00160251|75958631|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
42149744|NCT00160251|75958632|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
42149745|NCT00160251|75958633|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
42149746|NCT00160251|75958634|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
42149747|NCT00506441|75958691|FG000|Period 1; Open-label Period|Adverse Event|21|||
42149748|NCT00506441|75958692|FG001|Period 1; Open-label Period|Adverse Event|0|||
42149749|NCT00506441|75958691|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
42149750|NCT00506441|75958692|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
42149751|NCT00506441|75958691|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
42149752|NCT00506441|75958692|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
42149753|NCT00506441|75958691|FG000|Period 1; Open-label Period|Physician Decision|5|||
42149754|NCT00506441|75958692|FG001|Period 1; Open-label Period|Physician Decision|0|||
42149755|NCT00506441|75958691|FG000|Period 1; Open-label Period|Protocol Violation|9|||
42149756|NCT00506441|75958692|FG001|Period 1; Open-label Period|Protocol Violation|0|||
42149757|NCT00506441|75958691|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
42149758|NCT00506441|75958692|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
42149759|NCT00506441|75958691|FG000|Period 1; Open-label Period|Other Reasons|13|||
42149760|NCT00506441|75958692|FG001|Period 1; Open-label Period|Other Reasons|0|||
42149761|NCT00506441|75958691|FG000|Period 2; Double-blind Period|Adverse Event|0|||
42149762|NCT00506441|75958692|FG001|Period 2; Double-blind Period|Adverse Event|1|||
42149763|NCT00506441|75958691|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
42149764|NCT00506441|75958692|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
42149765|NCT00506441|75958691|FG000|Period 2; Double-blind Period|Physician Decision|1|||
42149766|NCT00506441|75958692|FG001|Period 2; Double-blind Period|Physician Decision|1|||
42149767|NCT00506441|75958691|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
42149768|NCT00506441|75958692|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
42149769|NCT00506441|75958691|FG000|Period 2; Double-blind Period|Other Reason|1|||
42149770|NCT00506441|75958692|FG001|Period 2; Double-blind Period|Other Reason|1|||
42149771|NCT00378014|75958719|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
42149772|NCT00378014|75958720|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
42149773|NCT00378014|75958719|FG000|Core (Randomization to Month 11)|Graft loss|1|||
42149774|NCT00378014|75958720|FG001|Core (Randomization to Month 11)|Graft loss|2|||
42149775|NCT00378014|75958719|FG000|Core (Randomization to Month 11)|Death|5|||
42149776|NCT00378014|75958720|FG001|Core (Randomization to Month 11)|Death|3|||
42149777|NCT00378014|75958719|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
42149778|NCT00378014|75958720|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
42149779|NCT00378014|75958719|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
42149780|NCT00378014|75958720|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
42039780|NCT03138499|75848211|FG001|Overall Study|Lost to Follow-up|0|||
42149781|NCT00378014|75958719|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
42149782|NCT00378014|75958720|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
42149783|NCT00378014|75958719|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
42149784|NCT00378014|75958720|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
42149785|NCT00378014|75958719|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
42149786|NCT00378014|75958720|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
42149787|NCT00378014|75958719|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
42149788|NCT00378014|75958720|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
42149789|NCT00378014|75958719|FG000|Extension (Month 12 to Month 59)|Death|1|||
42149790|NCT00378014|75958720|FG001|Extension (Month 12 to Month 59)|Death|2|||
42149791|NCT00378014|75958719|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
42149792|NCT00378014|75958720|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
42149793|NCT00378014|75958719|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
42149794|NCT00378014|75958720|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
42039781|NCT03138499|75848210|FG000|Overall Study|Participants withdrew consent|1|||
42039782|NCT03138499|75848211|FG001|Overall Study|Participants withdrew consent|0|||
42039783|NCT03138499|75848210|FG000|Overall Study|Participant discontinued study before treatment|0|||
42039784|NCT03138499|75848211|FG001|Overall Study|Participant discontinued study before treatment|1|||
42149795|NCT00378014|75958719|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
42149796|NCT00378014|75958720|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
42149797|NCT00378014|75958719|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
42149798|NCT00378014|75958720|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
42149799|NCT00485303|75958728|FG000|Overall Study|Adverse Event|5|||
42149800|NCT00485303|75958728|FG000|Overall Study|Progressive Disease|44|||
42149801|NCT00485303|75958728|FG000|Overall Study|Other|3|||
42149802|NCT00485303|75958728|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
42149803|NCT00485303|75958728|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
42149804|NCT00490841|75958732|FG000|Overall Study|Death|5|||
42149805|NCT00490841|75958732|FG000|Overall Study|Withdrawal by Subject|4|||
42149806|NCT00490841|75958732|FG000|Overall Study|Lost to Follow-up|1|||
42149807|NCT00490841|75958732|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
42149808|NCT00377858|75958739|FG000|Overall Study|Withdrawal by Subject|12|||
42149809|NCT00377858|75958740|FG001|Overall Study|Withdrawal by Subject|11|||
42149810|NCT00377858|75958739|FG000|Overall Study|Lost to Follow-up|6|||
42149811|NCT00377858|75958740|FG001|Overall Study|Lost to Follow-up|1|||
42149812|NCT00377858|75958739|FG000|Overall Study|Physician Decision|5|||
42149813|NCT00377858|75958740|FG001|Overall Study|Physician Decision|5|||
42149814|NCT00377858|75958739|FG000|Overall Study|Protocol Violation|3|||
42149815|NCT00377858|75958740|FG001|Overall Study|Protocol Violation|4|||
42039785|NCT03138499|75848210|FG000|Overall Study|Disease Progression|2|||
42039786|NCT03138499|75848211|FG001|Overall Study|Disease Progression|6|||
42039787|NCT03138499|75848210|FG000|Overall Study|Study drug toxicity|2|||
42039788|NCT03138499|75848211|FG001|Overall Study|Study drug toxicity|2|||
42039789|NCT03138499|75848210|FG000|Overall Study|Participant request to discontinue study treatment|1|||
42039790|NCT03138499|75848211|FG001|Overall Study|Participant request to discontinue study treatment|1|||
42149816|NCT00377858|75958739|FG000|Overall Study|Adverse Event|2|||
42149817|NCT00377858|75958740|FG001|Overall Study|Adverse Event|1|||
42149818|NCT00377858|75958739|FG000|Overall Study|Entry Criteria Not Met|2|||
42149819|NCT00377858|75958740|FG001|Overall Study|Entry Criteria Not Met|0|||
42149820|NCT00377858|75958739|FG000|Overall Study|Sponsor Decision|1|||
42149821|NCT00377858|75958740|FG001|Overall Study|Sponsor Decision|2|||
42149822|NCT00377858|75958739|FG000|Overall Study|Death|0|||
42149823|NCT00377858|75958740|FG001|Overall Study|Death|3|||
42149824|NCT00502775|75958749|FG000|Overall Study|Adverse Event|1|||
42149825|NCT00502775|75958750|FG001|Overall Study|Adverse Event|2|||
42149826|NCT00502775|75958751|FG002|Overall Study|Adverse Event|1|||
42149827|NCT00502775|75958749|FG000|Overall Study|Protocol Violation|1|||
42149828|NCT00502775|75958750|FG001|Overall Study|Protocol Violation|5|||
42149829|NCT00502775|75958751|FG002|Overall Study|Protocol Violation|2|||
42149830|NCT00502775|75958749|FG000|Overall Study|Withdrawal by Subject|1|||
42149831|NCT00502775|75958750|FG001|Overall Study|Withdrawal by Subject|1|||
42149832|NCT00502775|75958751|FG002|Overall Study|Withdrawal by Subject|2|||
42149833|NCT00502775|75958749|FG000|Overall Study|Sponsor Terminated Study|1|||
42149834|NCT00502775|75958750|FG001|Overall Study|Sponsor Terminated Study|0|||
42149835|NCT00502775|75958751|FG002|Overall Study|Sponsor Terminated Study|1|||
42149836|NCT00502775|75958749|FG000|Overall Study|Non-compliance with eDiary|4|||
42149837|NCT00502775|75958750|FG001|Overall Study|Non-compliance with eDiary|1|||
42149838|NCT00502775|75958751|FG002|Overall Study|Non-compliance with eDiary|1|||
42149839|NCT00502775|75958749|FG000|Overall Study|Subject unable to swallow capsule|1|||
42149840|NCT00502775|75958750|FG001|Overall Study|Subject unable to swallow capsule|0|||
42149841|NCT00502775|75958751|FG002|Overall Study|Subject unable to swallow capsule|1|||
42149842|NCT00502775|75958749|FG000|Overall Study|Logpad compliance <80%|1|||
42149843|NCT00502775|75958750|FG001|Overall Study|Logpad compliance <80%|0|||
42149844|NCT00502775|75958751|FG002|Overall Study|Logpad compliance <80%|0|||
42149845|NCT00502775|75958749|FG000|Overall Study|Randomized in error|0|||
42149846|NCT00502775|75958750|FG001|Overall Study|Randomized in error|1|||
42149847|NCT00502775|75958751|FG002|Overall Study|Randomized in error|1|||
42149848|NCT00502775|75958749|FG000|Overall Study|Non-compliance|0|||
42149849|NCT00502775|75958750|FG001|Overall Study|Non-compliance|2|||
42149850|NCT00502775|75958751|FG002|Overall Study|Non-compliance|2|||
42149851|NCT00502775|75958749|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
42149852|NCT00502775|75958750|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
42039791|NCT03138499|75848210|FG000|Overall Study|Other reasons|2|||
42039792|NCT03138499|75848211|FG001|Overall Study|Other reasons|0|||
42039793|NCT03136185|75848227|FG000|Overall Study|Adverse Event|0|||
42149853|NCT00502775|75958751|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
42149854|NCT00502775|75958749|FG000|Overall Study|Declining pollen counts|0|||
42149855|NCT00502775|75958750|FG001|Overall Study|Declining pollen counts|1|||
42149856|NCT00502775|75958751|FG002|Overall Study|Declining pollen counts|1|||
42149857|NCT00502775|75958749|FG000|Overall Study|Subject in jail|0|||
42149858|NCT00502775|75958750|FG001|Overall Study|Subject in jail|1|||
42149859|NCT00502775|75958751|FG002|Overall Study|Subject in jail|0|||
42149860|NCT00502775|75958749|FG000|Overall Study|Subject took disallowed drug|0|||
42039794|NCT03136185|75848228|FG001|Overall Study|Adverse Event|1|||
42149861|NCT00502775|75958750|FG001|Overall Study|Subject took disallowed drug|0|||
42149862|NCT00502775|75958751|FG002|Overall Study|Subject took disallowed drug|1|||
42149863|NCT00502697|75958761|FG000|Overall Study|Withdrawal by Subject|3|||
42149864|NCT00502697|75958762|FG001|Overall Study|Withdrawal by Subject|1|||
42149865|NCT00502697|75958761|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
42149866|NCT00502697|75958762|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
42149867|NCT00502697|75958761|FG000|Overall Study|found not to meet eligibility criteria|3|||
42149868|NCT00502697|75958762|FG001|Overall Study|found not to meet eligibility criteria|4|||
42149869|NCT00502697|75958761|FG000|Overall Study|did not meet assignment criteria|4|||
42149870|NCT00502697|75958762|FG001|Overall Study|did not meet assignment criteria|2|||
42149871|NCT00485069|75958770|FG000|Overall Study|Adverse Event|10|||
42149872|NCT00485069|75958771|FG001|Overall Study|Adverse Event|4|||
42149873|NCT00485069|75958770|FG000|Overall Study|Lack of Efficacy|2|||
42149874|NCT00485069|75958771|FG001|Overall Study|Lack of Efficacy|1|||
42149875|NCT00485069|75958770|FG000|Overall Study|Protocol Violation|0|||
42149876|NCT00485069|75958771|FG001|Overall Study|Protocol Violation|1|||
42149877|NCT00485069|75958770|FG000|Overall Study|Withdrawal by Subject|6|||
42149878|NCT00485069|75958771|FG001|Overall Study|Withdrawal by Subject|6|||
42149879|NCT00355082|75958786|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
42149880|NCT00355082|75958787|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
42149881|NCT00355082|75958788|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
42149882|NCT00355082|75958786|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
42149883|NCT00355082|75958787|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
42149884|NCT00355082|75958788|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
42149885|NCT00355082|75958786|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
42149886|NCT00355082|75958787|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
42149887|NCT00355082|75958788|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
42149888|NCT00355082|75958786|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
42278107|NCT02819635|76109724|FG004|Substudy 3|Lost to Follow-up|0|||
42278108|NCT02819635|76109725|FG005|Substudy 3|Lost to Follow-up|0|||
42351241|NCT01515189|76191131|FG000|Induction|Other|0|||
42351242|NCT01515189|76191132|FG001|Induction|Other|4|||
42351243|NCT01515189|76191131|FG000|First Re-Induction Phase|Disease progression|6|||
42351244|NCT01515189|76191132|FG001|First Re-Induction Phase|Disease progression|14|||
42278109|NCT02819635|76109726|FG006|Substudy 3|Lost to Follow-up|0|||
42278110|NCT02819635|76109727|FG007|Substudy 3|Lost to Follow-up|0|||
42278111|NCT02819635|76109728|FG008|Substudy 3|Lost to Follow-up|1|||
42278112|NCT02819635|76109729|FG009|Substudy 3|Lost to Follow-up|0|||
42278113|NCT02819635|76109730|FG010|Substudy 3|Lost to Follow-up|1|||
42278114|NCT02819635|76109731|FG011|Substudy 3|Lost to Follow-up|1|||
42278115|NCT02819635|76109720|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
42278116|NCT02819635|76109721|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
42278117|NCT02819635|76109722|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
42278118|NCT02819635|76109723|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
42278119|NCT02819635|76109724|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
42278120|NCT02819635|76109725|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
42278121|NCT02819635|76109726|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
42278122|NCT02819635|76109727|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
42278123|NCT02819635|76109728|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
42278124|NCT02819635|76109729|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
42278125|NCT02819635|76109730|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
42278126|NCT02819635|76109731|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
42278127|NCT02819635|76109720|FG000|Substudy 3|Other, not specified|0|||
42278128|NCT02819635|76109721|FG001|Substudy 3|Other, not specified|0|||
42278129|NCT02819635|76109722|FG002|Substudy 3|Other, not specified|0|||
42278130|NCT02819635|76109723|FG003|Substudy 3|Other, not specified|0|||
42278131|NCT02819635|76109724|FG004|Substudy 3|Other, not specified|0|||
42278132|NCT02819635|76109725|FG005|Substudy 3|Other, not specified|0|||
42278133|NCT02819635|76109726|FG006|Substudy 3|Other, not specified|0|||
42278134|NCT02819635|76109727|FG007|Substudy 3|Other, not specified|0|||
42278135|NCT02819635|76109728|FG008|Substudy 3|Other, not specified|202|||
42278136|NCT02819635|76109729|FG009|Substudy 3|Other, not specified|5|||
42278137|NCT02819635|76109730|FG010|Substudy 3|Other, not specified|89|||
42278138|NCT02819635|76109731|FG011|Substudy 3|Other, not specified|39|||
42278139|NCT02424344|76109766|FG000|Overall Study|Lack of Efficacy|0|||
42278140|NCT02424344|76109767|FG001|Overall Study|Lack of Efficacy|1|||
42278141|NCT02424344|76109766|FG000|Overall Study|Withdrawal by Subject|2|||
42278142|NCT02424344|76109767|FG001|Overall Study|Withdrawal by Subject|1|||
42278143|NCT02424344|76109766|FG000|Overall Study|Lost to Follow-up|1|||
42278144|NCT02424344|76109767|FG001|Overall Study|Lost to Follow-up|0|||
42278145|NCT02424344|76109766|FG000|Overall Study|Adverse Event|4|||
42278146|NCT02424344|76109767|FG001|Overall Study|Adverse Event|8|||
42278147|NCT02423798|76109773|FG000|Overall Study|Withdrawal by Subject|3|||
42278148|NCT02383940|76109796|FG000|Overall Study|Adverse Event|1|||
42351245|NCT01515189|76191131|FG000|First Re-Induction Phase|Study drug toxicity|5|||
42351246|NCT01515189|76191132|FG001|First Re-Induction Phase|Study drug toxicity|0|||
42351247|NCT01515189|76191131|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
42351248|NCT01515189|76191132|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
42351249|NCT01515189|76191131|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
42351250|NCT01515189|76191132|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
42351251|NCT01515189|76191131|FG000|First Re-Induction Phase|Other|1|||
42149889|NCT00355082|75958787|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
42149890|NCT00355082|75958788|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
42149891|NCT00355082|75958786|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
42149892|NCT00355082|75958787|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
42149893|NCT00355082|75958788|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
42149894|NCT00355082|75958786|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
42149895|NCT00355082|75958787|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
42149896|NCT00355082|75958788|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
42149897|NCT00355082|75958786|FG000|Continuation Phase|Adverse Event|2|||
42149898|NCT00355082|75958787|FG001|Continuation Phase|Adverse Event|0|||
42149899|NCT00355082|75958788|FG002|Continuation Phase|Adverse Event|1|||
42149900|NCT00355082|75958786|FG000|Continuation Phase|Lost to Follow-up|2|||
42149901|NCT00355082|75958787|FG001|Continuation Phase|Lost to Follow-up|0|||
42149902|NCT00355082|75958788|FG002|Continuation Phase|Lost to Follow-up|1|||
42149903|NCT00355082|75958786|FG000|Continuation Phase|Protocol Violation|1|||
42149904|NCT00355082|75958787|FG001|Continuation Phase|Protocol Violation|0|||
42149905|NCT00355082|75958788|FG002|Continuation Phase|Protocol Violation|1|||
42149906|NCT00355082|75958786|FG000|Continuation Phase|Withdrawal by Subject|4|||
42149907|NCT00355082|75958787|FG001|Continuation Phase|Withdrawal by Subject|0|||
42149908|NCT00355082|75958788|FG002|Continuation Phase|Withdrawal by Subject|0|||
42149909|NCT00355082|75958786|FG000|Continuation Phase|Lack of Efficacy|5|||
42149910|NCT00355082|75958787|FG001|Continuation Phase|Lack of Efficacy|0|||
42149911|NCT00355082|75958788|FG002|Continuation Phase|Lack of Efficacy|0|||
42149912|NCT00355082|75958786|FG000|Continuation Phase|Site Closed by Sponsor|8|||
42149913|NCT00355082|75958787|FG001|Continuation Phase|Site Closed by Sponsor|0|||
42149914|NCT00355082|75958788|FG002|Continuation Phase|Site Closed by Sponsor|0|||
42149915|NCT00355082|75958786|FG000|Continuation Phase|Scheduling Error|1|||
42149916|NCT00355082|75958787|FG001|Continuation Phase|Scheduling Error|0|||
42149917|NCT00355082|75958788|FG002|Continuation Phase|Scheduling Error|0|||
42149918|NCT00355082|75958786|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
42149919|NCT00355082|75958787|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
42149920|NCT00355082|75958788|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
42149921|NCT00502307|75958799|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
42149922|NCT00502307|75958800|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
42149923|NCT00502307|75958801|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
42149924|NCT00502307|75958799|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
42149925|NCT00502307|75958800|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
42149926|NCT00502307|75958801|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
42149927|NCT00502307|75958799|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
42149928|NCT00502307|75958800|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
42149929|NCT00502307|75958801|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
42149930|NCT00502307|75958799|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
42149931|NCT00502307|75958800|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
42149932|NCT00502307|75958801|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
42149933|NCT00502307|75958799|FG000|Maintenance Period|Progressive disease|80|||
42149934|NCT00502307|75958800|FG001|Maintenance Period|Progressive disease|0|||
42149935|NCT00502307|75958801|FG002|Maintenance Period|Progressive disease|0|||
42149936|NCT00502307|75958799|FG000|Maintenance Period|Discontinued due to other reasons|68|||
42149937|NCT00502307|75958800|FG001|Maintenance Period|Discontinued due to other reasons|0|||
42149938|NCT00502307|75958801|FG002|Maintenance Period|Discontinued due to other reasons|0|||
42149939|NCT00484679|75958818|FG000|Overall Study|Withdrawal by Subject|3|||
42149940|NCT00377312|75958824|FG000|Overall Study|Adverse Event|1|||
42149941|NCT00377312|75958825|FG001|Overall Study|Adverse Event|1|||
42149942|NCT00377234|75958833|FG000|Overall Study|Adverse Event|14|||
42149943|NCT00377234|75958834|FG001|Overall Study|Adverse Event|17|||
42149944|NCT00377234|75958833|FG000|Overall Study|Withdrawal by Subject|11|||
42149945|NCT00377234|75958834|FG001|Overall Study|Withdrawal by Subject|9|||
42149946|NCT00377234|75958833|FG000|Overall Study|Lost to Follow-up|4|||
42351252|NCT01515189|76191132|FG001|First Re-Induction Phase|Other|0|||
42012819|NCT03624881|75819739|FG001|Overall Study|Screen Failure|0|||
42012820|NCT03624881|75819738|FG000|Overall Study|No Catheter Inserted|6|||
42012821|NCT03624881|75819739|FG001|Overall Study|No Catheter Inserted|1|||
42012822|NCT03624881|75819738|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
42149947|NCT00377234|75958834|FG001|Overall Study|Lost to Follow-up|2|||
42149948|NCT00377234|75958833|FG000|Overall Study|Administrative|2|||
42149949|NCT00377234|75958834|FG001|Overall Study|Administrative|1|||
42149950|NCT00377234|75958833|FG000|Overall Study|Not assigned|3|||
42149951|NCT00377234|75958834|FG001|Overall Study|Not assigned|2|||
42149952|NCT00377156|75958848|FG000|Overall Study|Death|23|||
42149953|NCT00377156|75958849|FG001|Overall Study|Death|19|||
42351253|NCT01546623|76191140|FG000|Overall Study|Adverse Event|2|||
42149954|NCT00377156|75958848|FG000|Overall Study|Withdrawal by Subject|16|||
42149955|NCT00377156|75958849|FG001|Overall Study|Withdrawal by Subject|24|||
42149956|NCT00377156|75958848|FG000|Overall Study|Had follow-up <90 d|3|||
42149957|NCT00377156|75958849|FG001|Overall Study|Had follow-up <90 d|6|||
42149958|NCT00377156|75958848|FG000|Overall Study|Cancellation|1|||
42149959|NCT00377156|75958849|FG001|Overall Study|Cancellation|0|||
42149960|NCT00377156|75958848|FG000|Overall Study|Refused testing|0|||
42149961|NCT00377156|75958849|FG001|Overall Study|Refused testing|1|||
42149962|NCT00377156|75958848|FG000|Overall Study|Ineligible|0|||
42149963|NCT00377156|75958849|FG001|Overall Study|Ineligible|1|||
42149964|NCT00377156|75958848|FG000|Overall Study|Disability or language problem|0|||
42149965|NCT00377156|75958849|FG001|Overall Study|Disability or language problem|1|||
42149966|NCT00377156|75958848|FG000|Overall Study|Other|5|||
42149967|NCT00377156|75958849|FG001|Overall Study|Other|2|||
42149968|NCT00376688|75958857|FG000|Overall Study|Adverse Event|3|||
42149969|NCT00376688|75958857|FG000|Overall Study|Death|1|||
42149970|NCT00376532|75958863|FG000|Overall Study|Lack sufficient blood sample|6|||
42149971|NCT00376532|75958864|FG001|Overall Study|Lack sufficient blood sample|6|||
42149972|NCT00376220|75958872|FG000|Overall Study|Lost to Follow-up|7|||
42149973|NCT00376220|75958873|FG001|Overall Study|Lost to Follow-up|10|||
42149974|NCT00376220|75958872|FG000|Overall Study|Withdrawal by Subject|3|||
42149975|NCT00376220|75958873|FG001|Overall Study|Withdrawal by Subject|2|||
42149976|NCT00375752|75958881|FG000|Overall Study|Lack of Efficacy|4|||
42149977|NCT00375752|75958882|FG001|Overall Study|Lack of Efficacy|4|||
42149978|NCT00375752|75958881|FG000|Overall Study|Adverse Event|1|||
42149979|NCT00375752|75958882|FG001|Overall Study|Adverse Event|6|||
42149980|NCT00375752|75958881|FG000|Overall Study|Withdrawal by Subject|6|||
42149981|NCT00375752|75958882|FG001|Overall Study|Withdrawal by Subject|1|||
42149982|NCT00375752|75958881|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
42149983|NCT00375752|75958882|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
42149984|NCT00375752|75958881|FG000|Overall Study|Protocol Violation|0|||
42149985|NCT00375752|75958882|FG001|Overall Study|Protocol Violation|2|||
42149986|NCT00375752|75958881|FG000|Overall Study|Administrative Problems|0|||
42149987|NCT00375752|75958882|FG001|Overall Study|Administrative Problems|1|||
42149988|NCT00484289|75958891|FG000|Long Term Phase|Adverse Event|1|||
42149989|NCT00484289|75958892|FG001|Long Term Phase|Adverse Event|17|||
42149990|NCT00484289|75958893|FG002|Long Term Phase|Adverse Event|5|||
42149991|NCT00484289|75958891|FG000|Long Term Phase|Withdrawal by Subject|0|||
42149992|NCT00484289|75958892|FG001|Long Term Phase|Withdrawal by Subject|7|||
42149993|NCT00484289|75958893|FG002|Long Term Phase|Withdrawal by Subject|6|||
42149994|NCT00484289|75958891|FG000|Long Term Phase|Inadequate response|2|||
42149995|NCT00484289|75958892|FG001|Long Term Phase|Inadequate response|7|||
42149996|NCT00484289|75958893|FG002|Long Term Phase|Inadequate response|4|||
42149997|NCT00484289|75958891|FG000|Long Term Phase|Other Reason|0|||
42149998|NCT00484289|75958892|FG001|Long Term Phase|Other Reason|5|||
42149999|NCT00484289|75958893|FG002|Long Term Phase|Other Reason|1|||
42150000|NCT00484289|75958891|FG000|Post Marketing Phase|Adverse Event|0|||
42150001|NCT00484289|75958892|FG001|Post Marketing Phase|Adverse Event|1|||
42150002|NCT00484289|75958893|FG002|Post Marketing Phase|Adverse Event|0|||
42150003|NCT00490529|75958902|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
42150004|NCT00490529|75958902|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
42150005|NCT00490529|75958902|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
42150006|NCT00490529|75958902|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
42150007|NCT00490529|75958902|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
42150008|NCT00490529|75958902|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
42150009|NCT00333840|75958908|FG000|First-line Treatment Period|Adverse Event|38|||
42150010|NCT00333840|75958909|FG001|First-line Treatment Period|Adverse Event|37|||
42150011|NCT00333840|75958910|FG002|First-line Treatment Period|Adverse Event|0|||
42150012|NCT00333840|75958911|FG003|First-line Treatment Period|Adverse Event|0|||
42012823|NCT03624881|75819739|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
42012824|NCT03624881|75819738|FG000|Overall Study|Death|2|||
42278149|NCT02383940|76109797|FG001|Overall Study|Adverse Event|0|||
42012825|NCT03624881|75819739|FG001|Overall Study|Death|0|||
42012826|NCT03624881|75819738|FG000|Overall Study|Lost to Follow-up|10|||
42150013|NCT00333840|75958908|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
42150014|NCT00333840|75958909|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
42150015|NCT00333840|75958910|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
42150016|NCT00333840|75958911|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
42150017|NCT00333840|75958908|FG000|First-line Treatment Period|Abnormal procedure|2|||
42150018|NCT00333840|75958909|FG001|First-line Treatment Period|Abnormal procedure|0|||
42150019|NCT00333840|75958910|FG002|First-line Treatment Period|Abnormal procedure|0|||
42150020|NCT00333840|75958911|FG003|First-line Treatment Period|Abnormal procedure|0|||
42150021|NCT00333840|75958908|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
42150022|NCT00333840|75958909|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
42150023|NCT00333840|75958910|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
42150024|NCT00333840|75958911|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
42150025|NCT00333840|75958908|FG000|First-line Treatment Period|No longer required study drug|21|||
42150026|NCT00333840|75958909|FG001|First-line Treatment Period|No longer required study drug|8|||
42150027|NCT00333840|75958910|FG002|First-line Treatment Period|No longer required study drug|0|||
42150028|NCT00333840|75958911|FG003|First-line Treatment Period|No longer required study drug|0|||
42150029|NCT00333840|75958908|FG000|First-line Treatment Period|Protocol Violation|17|||
42150030|NCT00333840|75958909|FG001|First-line Treatment Period|Protocol Violation|17|||
42150031|NCT00333840|75958910|FG002|First-line Treatment Period|Protocol Violation|0|||
42150032|NCT00333840|75958911|FG003|First-line Treatment Period|Protocol Violation|0|||
42150033|NCT00333840|75958908|FG000|First-line Treatment Period|Subject withdrew consent|57|||
42150034|NCT00333840|75958909|FG001|First-line Treatment Period|Subject withdrew consent|77|||
42150035|NCT00333840|75958910|FG002|First-line Treatment Period|Subject withdrew consent|0|||
42150036|NCT00333840|75958911|FG003|First-line Treatment Period|Subject withdrew consent|0|||
42150037|NCT00333840|75958908|FG000|First-line Treatment Period|Lost to Follow-up|15|||
42150038|NCT00333840|75958909|FG001|First-line Treatment Period|Lost to Follow-up|6|||
42150039|NCT00333840|75958910|FG002|First-line Treatment Period|Lost to Follow-up|0|||
42150040|NCT00333840|75958911|FG003|First-line Treatment Period|Lost to Follow-up|0|||
42150041|NCT00333840|75958908|FG000|First-line Treatment Period|Administrative problems|12|||
42150042|NCT00333840|75958909|FG001|First-line Treatment Period|Administrative problems|6|||
42150043|NCT00333840|75958910|FG002|First-line Treatment Period|Administrative problems|0|||
42150044|NCT00333840|75958911|FG003|First-line Treatment Period|Administrative problems|0|||
42150045|NCT00333840|75958908|FG000|First-line Treatment Period|Death|19|||
42150046|NCT00333840|75958909|FG001|First-line Treatment Period|Death|2|||
42150047|NCT00333840|75958910|FG002|First-line Treatment Period|Death|0|||
42150048|NCT00333840|75958911|FG003|First-line Treatment Period|Death|0|||
42150049|NCT00333840|75958908|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
42150050|NCT00333840|75958909|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
42150051|NCT00333840|75958910|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
42150052|NCT00333840|75958911|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
42150053|NCT00333840|75958908|FG000|Second-line Treatment Period|Adverse Event|0|||
42150054|NCT00333840|75958909|FG001|Second-line Treatment Period|Adverse Event|0|||
42150055|NCT00333840|75958910|FG002|Second-line Treatment Period|Adverse Event|3|||
42150056|NCT00333840|75958911|FG003|Second-line Treatment Period|Adverse Event|34|||
42150057|NCT00333840|75958908|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
42150058|NCT00333840|75958909|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
42150059|NCT00333840|75958910|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
42150060|NCT00333840|75958911|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
42150061|NCT00333840|75958908|FG000|Second-line Treatment Period|Abnormal procedure|0|||
42150062|NCT00333840|75958909|FG001|Second-line Treatment Period|Abnormal procedure|0|||
42150063|NCT00333840|75958910|FG002|Second-line Treatment Period|Abnormal procedure|0|||
42150064|NCT00333840|75958911|FG003|Second-line Treatment Period|Abnormal procedure|1|||
42150065|NCT00333840|75958908|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
42150066|NCT00333840|75958909|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
42150067|NCT00333840|75958910|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
42150068|NCT00333840|75958911|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
42150069|NCT00333840|75958908|FG000|Second-line Treatment Period|No longer required study drug|0|||
42150070|NCT00333840|75958909|FG001|Second-line Treatment Period|No longer required study drug|0|||
42150071|NCT00333840|75958910|FG002|Second-line Treatment Period|No longer required study drug|1|||
42150072|NCT00333840|75958911|FG003|Second-line Treatment Period|No longer required study drug|14|||
42150073|NCT00333840|75958908|FG000|Second-line Treatment Period|Protocol Violation|0|||
42150074|NCT00333840|75958909|FG001|Second-line Treatment Period|Protocol Violation|0|||
42150075|NCT00333840|75958910|FG002|Second-line Treatment Period|Protocol Violation|1|||
42150076|NCT00333840|75958911|FG003|Second-line Treatment Period|Protocol Violation|10|||
42150077|NCT00333840|75958908|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
42150078|NCT00333840|75958909|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
42150079|NCT00333840|75958910|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
42150080|NCT00333840|75958911|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
42150081|NCT00333840|75958908|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
42351254|NCT01546623|76191141|FG001|Overall Study|Adverse Event|3|||
42351255|NCT01546623|76191140|FG000|Overall Study|Major Protocol Deviation|1|||
42150082|NCT00333840|75958909|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
42150083|NCT00333840|75958910|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
42351256|NCT01546623|76191141|FG001|Overall Study|Major Protocol Deviation|1|||
42150084|NCT00333840|75958911|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
42150085|NCT00333840|75958908|FG000|Second-line Treatment Period|Administrative problems|0|||
42150086|NCT00333840|75958909|FG001|Second-line Treatment Period|Administrative problems|0|||
42150087|NCT00333840|75958910|FG002|Second-line Treatment Period|Administrative problems|0|||
42150088|NCT00333840|75958911|FG003|Second-line Treatment Period|Administrative problems|7|||
42150089|NCT00333840|75958908|FG000|Second-line Treatment Period|Death|0|||
42150090|NCT00333840|75958909|FG001|Second-line Treatment Period|Death|0|||
42150091|NCT00333840|75958910|FG002|Second-line Treatment Period|Death|0|||
42150092|NCT00333840|75958911|FG003|Second-line Treatment Period|Death|9|||
42150093|NCT00490451|75958927|FG000|Overall Study|Adverse Event|3|||
42150094|NCT00490451|75958928|FG001|Overall Study|Adverse Event|3|||
42150095|NCT00490451|75958927|FG000|Overall Study|Death|3|||
42150096|NCT00490451|75958928|FG001|Overall Study|Death|1|||
42150097|NCT00490451|75958927|FG000|Overall Study|Withdrawal by Subject|2|||
42150098|NCT00490451|75958928|FG001|Overall Study|Withdrawal by Subject|0|||
42150099|NCT00490451|75958927|FG000|Overall Study|Investigator Decision|1|||
42150100|NCT00490451|75958928|FG001|Overall Study|Investigator Decision|0|||
42150101|NCT00490451|75958927|FG000|Overall Study|Protocol Violation|1|||
42150102|NCT00490451|75958928|FG001|Overall Study|Protocol Violation|0|||
42150103|NCT00490451|75958927|FG000|Overall Study|Progressive Disease|53|||
42150104|NCT00490451|75958928|FG001|Overall Study|Progressive Disease|34|||
42150105|NCT00321906|75958936|FG000|Overall Study|Adverse Event|36|||
42150106|NCT00321906|75958937|FG001|Overall Study|Adverse Event|44|||
42150107|NCT00321906|75958936|FG000|Overall Study|Death|9|||
42150108|NCT00321906|75958937|FG001|Overall Study|Death|6|||
42150109|NCT00321906|75958936|FG000|Overall Study|Lost to Follow-up|1|||
42150110|NCT00321906|75958937|FG001|Overall Study|Lost to Follow-up|2|||
42150111|NCT00321906|75958936|FG000|Overall Study|Withdrawal by Subject|0|||
42150112|NCT00321906|75958937|FG001|Overall Study|Withdrawal by Subject|4|||
42150113|NCT00339144|75958946|FG000|Overall Study|Disease progression|5|||
42150114|NCT00339144|75958947|FG001|Overall Study|Disease progression|2|||
42150115|NCT00339144|75958948|FG002|Overall Study|Disease progression|2|||
42150116|NCT00339144|75958946|FG000|Overall Study|Study drug toxicity|3|||
42150117|NCT00339144|75958947|FG001|Overall Study|Study drug toxicity|1|||
42150118|NCT00339144|75958948|FG002|Overall Study|Study drug toxicity|1|||
42150119|NCT00339144|75958946|FG000|Overall Study|Participant's request to discontinuation|1|||
42150120|NCT00339144|75958947|FG001|Overall Study|Participant's request to discontinuation|0|||
42150121|NCT00339144|75958948|FG002|Overall Study|Participant's request to discontinuation|1|||
42150122|NCT00321828|75958957|FG000|Overall Study|Ineligible|3|||
42150123|NCT00321828|75958957|FG000|Overall Study|No follow up data|1|||
42150124|NCT00333138|75958964|FG000|Core Study (6 Months)|Adverse Event|4|||
42150125|NCT00333138|75958965|FG001|Core Study (6 Months)|Adverse Event|5|||
42150126|NCT00333138|75958966|FG002|Core Study (6 Months)|Adverse Event|8|||
42150127|NCT00333138|75958964|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
42150128|NCT00333138|75958965|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
42150129|NCT00333138|75958966|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
42150130|NCT00333138|75958964|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
42150131|NCT00333138|75958965|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
42150132|NCT00333138|75958966|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
42150133|NCT00333138|75958964|FG000|Core Study (6 Months)|Protocol Violation|1|||
42150134|NCT00333138|75958965|FG001|Core Study (6 Months)|Protocol Violation|0|||
42150135|NCT00333138|75958966|FG002|Core Study (6 Months)|Protocol Violation|1|||
42150136|NCT00333138|75958964|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
42150137|NCT00333138|75958965|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
42150138|NCT00333138|75958966|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
42150139|NCT00333138|75958964|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
42150140|NCT00333138|75958965|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
42150141|NCT00333138|75958966|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
42150142|NCT00333138|75958964|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
42150143|NCT00333138|75958965|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
42150144|NCT00333138|75958966|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
42150145|NCT00333138|75958964|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
42351257|NCT01546623|76191140|FG000|Overall Study|High Prostate specific antigen|2|||
42351258|NCT01546623|76191141|FG001|Overall Study|High Prostate specific antigen|1|||
42150146|NCT00333138|75958965|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
42150147|NCT00333138|75958966|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
42150148|NCT00333138|75958964|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
42150149|NCT00333138|75958965|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
42150150|NCT00333138|75958966|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
42150151|NCT00333138|75958964|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
42150152|NCT00333138|75958965|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
42150153|NCT00333138|75958966|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
42150154|NCT00333138|75958964|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
42150155|NCT00333138|75958965|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
42351259|NCT01546623|76191140|FG000|Overall Study|Did Not Receive Study Drug|1|||
42150156|NCT00333138|75958966|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
42150157|NCT00333138|75958964|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
42150158|NCT00333138|75958965|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
42150159|NCT00333138|75958966|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
42150160|NCT00333138|75958964|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
42150161|NCT00333138|75958965|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
42150162|NCT00333138|75958966|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
42150163|NCT00333138|75958964|FG000|Extension Study (Month6 to End of Study)|Death|0|||
42150164|NCT00333138|75958965|FG001|Extension Study (Month6 to End of Study)|Death|1|||
42150165|NCT00333138|75958966|FG002|Extension Study (Month6 to End of Study)|Death|0|||
42150166|NCT00332202|75958978|FG000|Overall Study|Adverse Event|72|||
42150167|NCT00332202|75958979|FG001|Overall Study|Adverse Event|28|||
42012827|NCT03624881|75819739|FG001|Overall Study|Lost to Follow-up|4|||
42150168|NCT00332202|75958978|FG000|Overall Study|Lost to Follow-up|2|||
42150169|NCT00332202|75958979|FG001|Overall Study|Lost to Follow-up|1|||
42012828|NCT03624881|75819738|FG000|Overall Study|Withdrawal by Subject|12|||
42150170|NCT00332202|75958978|FG000|Overall Study|Physician Decision|6|||
42150171|NCT00332202|75958979|FG001|Overall Study|Physician Decision|8|||
42150172|NCT00332202|75958978|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
42150173|NCT00332202|75958979|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
42150174|NCT00332202|75958978|FG000|Overall Study|Protocol Violation|7|||
42150175|NCT00332202|75958979|FG001|Overall Study|Protocol Violation|2|||
42150176|NCT00332202|75958978|FG000|Overall Study|Sponsor Decision|1|||
42150177|NCT00332202|75958979|FG001|Overall Study|Sponsor Decision|2|||
42150178|NCT00332202|75958978|FG000|Overall Study|Withdrawal by Subject|36|||
42150179|NCT00332202|75958979|FG001|Overall Study|Withdrawal by Subject|17|||
42150180|NCT00332202|75958978|FG000|Overall Study|Progressive Disease|106|||
42150181|NCT00332202|75958979|FG001|Overall Study|Progressive Disease|60|||
42150182|NCT00332202|75958978|FG000|Overall Study|Death|5|||
42150183|NCT00332202|75958979|FG001|Overall Study|Death|2|||
42150184|NCT00331422|75958994|FG000|Overall Study|Did not receive entire study regimen|5|||
42150185|NCT00331344|75958999|FG000|Phase I|Adverse Event|0|||
42150186|NCT00331344|75959000|FG001|Phase I|Adverse Event|0|||
42150187|NCT00331344|75959001|FG002|Phase I|Adverse Event|0|||
42150188|NCT00331344|75959002|FG003|Phase I|Adverse Event|1|||
42150189|NCT00331344|75959003|FG004|Phase I|Adverse Event|2|||
42150190|NCT00331344|75959004|FG005|Phase I|Adverse Event|2|||
42150191|NCT00331344|75959005|FG006|Phase I|Adverse Event|0|||
42150192|NCT00331344|75959006|FG007|Phase I|Adverse Event|1|||
42150193|NCT00331344|75959007|FG008|Phase I|Adverse Event|0|||
42150194|NCT00331344|75958999|FG000|Phase II|Death|0|||
42150195|NCT00331344|75959000|FG001|Phase II|Death|0|||
42150196|NCT00331344|75959001|FG002|Phase II|Death|0|||
42150197|NCT00331344|75959002|FG003|Phase II|Death|0|||
42150198|NCT00331344|75959003|FG004|Phase II|Death|0|||
42150199|NCT00331344|75959004|FG005|Phase II|Death|0|||
42150200|NCT00331344|75959005|FG006|Phase II|Death|0|||
42150201|NCT00331344|75959006|FG007|Phase II|Death|0|||
42150202|NCT00331344|75959007|FG008|Phase II|Death|4|||
42150203|NCT00321672|75959024|FG000|Overall Study|Withdrawal by Subject|5|||
42150204|NCT00321672|75959025|FG001|Overall Study|Withdrawal by Subject|1|||
42150205|NCT00321672|75959026|FG002|Overall Study|Withdrawal by Subject|2|||
42150206|NCT00321672|75959027|FG003|Overall Study|Withdrawal by Subject|0|||
42150207|NCT00321672|75959024|FG000|Overall Study|Noncompliance|1|||
42150208|NCT00321672|75959025|FG001|Overall Study|Noncompliance|2|||
42150209|NCT00321672|75959026|FG002|Overall Study|Noncompliance|1|||
42150210|NCT00321672|75959027|FG003|Overall Study|Noncompliance|0|||
42150211|NCT00321672|75959024|FG000|Overall Study|Adverse Event|1|||
42150212|NCT00321672|75959025|FG001|Overall Study|Adverse Event|1|||
42150213|NCT00321672|75959026|FG002|Overall Study|Adverse Event|0|||
42150214|NCT00321672|75959027|FG003|Overall Study|Adverse Event|0|||
42150215|NCT00321672|75959024|FG000|Overall Study|Lack of Efficacy|1|||
42150216|NCT00321672|75959025|FG001|Overall Study|Lack of Efficacy|1|||
42150217|NCT00321672|75959026|FG002|Overall Study|Lack of Efficacy|0|||
42150218|NCT00321672|75959027|FG003|Overall Study|Lack of Efficacy|0|||
42150219|NCT00321672|75959024|FG000|Overall Study|Lost to Follow-up|2|||
42150220|NCT00321672|75959025|FG001|Overall Study|Lost to Follow-up|0|||
42150221|NCT00321672|75959026|FG002|Overall Study|Lost to Follow-up|4|||
42150222|NCT00321672|75959027|FG003|Overall Study|Lost to Follow-up|2|||
42150223|NCT00321672|75959024|FG000|Overall Study|Death|1|||
42150224|NCT00321672|75959025|FG001|Overall Study|Death|0|||
42150225|NCT00321672|75959026|FG002|Overall Study|Death|0|||
42150226|NCT00321672|75959027|FG003|Overall Study|Death|0|||
42150227|NCT00321672|75959024|FG000|Overall Study|Too far to travel for visits|1|||
42150228|NCT00321672|75959025|FG001|Overall Study|Too far to travel for visits|0|||
42150229|NCT00321672|75959026|FG002|Overall Study|Too far to travel for visits|0|||
42150230|NCT00321672|75959027|FG003|Overall Study|Too far to travel for visits|0|||
42150231|NCT00321672|75959024|FG000|Overall Study|Incarcerated|0|||
42150232|NCT00321672|75959025|FG001|Overall Study|Incarcerated|0|||
42150233|NCT00321672|75959026|FG002|Overall Study|Incarcerated|2|||
42150234|NCT00321672|75959027|FG003|Overall Study|Incarcerated|0|||
42150235|NCT00321672|75959024|FG000|Overall Study|Moved out of state|0|||
42150236|NCT00321672|75959025|FG001|Overall Study|Moved out of state|1|||
42150237|NCT00321672|75959026|FG002|Overall Study|Moved out of state|1|||
42150238|NCT00321672|75959027|FG003|Overall Study|Moved out of state|0|||
42150239|NCT00321672|75959024|FG000|Overall Study|Protocol Violation|0|||
42150240|NCT00321672|75959025|FG001|Overall Study|Protocol Violation|0|||
42150241|NCT00321672|75959026|FG002|Overall Study|Protocol Violation|1|||
42150242|NCT00321672|75959027|FG003|Overall Study|Protocol Violation|0|||
42150243|NCT00321672|75959024|FG000|Overall Study|Diagnosis of testicular cancer|0|||
42150244|NCT00321672|75959025|FG001|Overall Study|Diagnosis of testicular cancer|1|||
42150245|NCT00321672|75959026|FG002|Overall Study|Diagnosis of testicular cancer|0|||
42150246|NCT00321672|75959027|FG003|Overall Study|Diagnosis of testicular cancer|0|||
42150247|NCT00321672|75959024|FG000|Overall Study|Extensive travel required for new job|0|||
42150248|NCT00321672|75959025|FG001|Overall Study|Extensive travel required for new job|1|||
42150249|NCT00321672|75959026|FG002|Overall Study|Extensive travel required for new job|0|||
42150250|NCT00321672|75959027|FG003|Overall Study|Extensive travel required for new job|0|||
42150251|NCT00321048|75959043|FG000|Overall Study|Withdrawal by Subject|6|||
42150252|NCT00321048|75959044|FG001|Overall Study|Withdrawal by Subject|8|||
42150253|NCT00330174|75959052|FG000|Overall Study|Withdrawal by Subject|7|||
42150254|NCT00330174|75959053|FG001|Overall Study|Withdrawal by Subject|7|||
42150255|NCT00330174|75959052|FG000|Overall Study|Lost to Follow-up|4|||
42150256|NCT00330174|75959053|FG001|Overall Study|Lost to Follow-up|1|||
42150257|NCT00330174|75959052|FG000|Overall Study|Clinical deterioration|1|||
42150258|NCT00330174|75959053|FG001|Overall Study|Clinical deterioration|2|||
42150259|NCT00330174|75959052|FG000|Overall Study|Excessive missed visits|3|||
42150260|NCT00330174|75959053|FG001|Overall Study|Excessive missed visits|8|||
42150261|NCT00330174|75959052|FG000|Overall Study|Miscellaneous reasons|7|||
42150262|NCT00330174|75959053|FG001|Overall Study|Miscellaneous reasons|1|||
42150263|NCT00320424|75959059|FG000|Overall Study|Adverse Event|3|||
42150264|NCT00320424|75959059|FG000|Overall Study|Other|3|||
42150265|NCT00338286|75959065|FG000|Overall Study|Withdrawal by Subject|50|||
42150266|NCT00338286|75959066|FG001|Overall Study|Withdrawal by Subject|54|||
42012829|NCT03624881|75819739|FG001|Overall Study|Withdrawal by Subject|1|||
42012830|NCT03428997|75819762|FG000|Overall Study|Sponsor decision.|1|||
42039795|NCT03136185|75848229|FG002|Overall Study|Adverse Event|3|||
42039796|NCT03136185|75848230|FG003|Overall Study|Adverse Event|1|||
42039797|NCT03136185|75848231|FG004|Overall Study|Adverse Event|2|||
42039798|NCT03136185|75848232|FG005|Overall Study|Adverse Event|2|||
42039799|NCT03136185|75848233|FG006|Overall Study|Adverse Event|5|||
42039800|NCT03136185|75848234|FG007|Overall Study|Adverse Event|1|||
42039801|NCT03136185|75848235|FG008|Overall Study|Adverse Event|1|||
42039802|NCT03136185|75848227|FG000|Overall Study|Death|0|||
42039803|NCT03136185|75848228|FG001|Overall Study|Death|0|||
42039804|NCT03136185|75848229|FG002|Overall Study|Death|0|||
42039805|NCT03136185|75848230|FG003|Overall Study|Death|1|||
42039806|NCT03136185|75848231|FG004|Overall Study|Death|1|||
42039807|NCT03136185|75848232|FG005|Overall Study|Death|0|||
42039808|NCT03136185|75848233|FG006|Overall Study|Death|1|||
42150267|NCT00338286|75959065|FG000|Overall Study|Lost to Follow-up|80|||
42150268|NCT00338286|75959066|FG001|Overall Study|Lost to Follow-up|66|||
42012831|NCT03428997|75819762|FG000|Overall Study|Withdrawal by Subject|3|||
42012832|NCT03428997|75819762|FG000|Overall Study|Lost to Follow-up|4|||
42012833|NCT03118674|75819795|FG000|Overall Study|Lost to Follow-up|2|||
42012834|NCT03118674|75819795|FG000|Overall Study|Screen Faliure|8|||
42012835|NCT03118674|75819795|FG000|Overall Study|Withdrawal by Subject|5|||
42012836|NCT03069352|75819801|FG000|Overall Study|Ongoing|12|||
42012837|NCT03069352|75819802|FG001|Overall Study|Ongoing|40|||
42012838|NCT02993523|75819813|FG000|Overall Study|Withdrew Consent|0|||
42012839|NCT02993523|75819814|FG001|Overall Study|Withdrew Consent|0|||
42012840|NCT02993523|75819815|FG002|Overall Study|Withdrew Consent|2|||
42012841|NCT02993523|75819816|FG003|Overall Study|Withdrew Consent|9|||
42012842|NCT02993523|75819817|FG004|Overall Study|Withdrew Consent|0|||
42012843|NCT02993523|75819813|FG000|Overall Study|Lost to Follow-up|0|||
42012844|NCT02993523|75819814|FG001|Overall Study|Lost to Follow-up|0|||
42012845|NCT02993523|75819815|FG002|Overall Study|Lost to Follow-up|3|||
42012846|NCT02993523|75819816|FG003|Overall Study|Lost to Follow-up|6|||
42012847|NCT02993523|75819817|FG004|Overall Study|Lost to Follow-up|0|||
42012848|NCT02993523|75819813|FG000|Overall Study|Death|1|||
42012849|NCT02993523|75819814|FG001|Overall Study|Death|1|||
42012850|NCT02993523|75819815|FG002|Overall Study|Death|138|||
42012851|NCT02993523|75819816|FG003|Overall Study|Death|222|||
42012852|NCT02993523|75819817|FG004|Overall Study|Death|6|||
42012853|NCT02993523|75819813|FG000|Overall Study|Reason not Specified|0|||
42012854|NCT02993523|75819814|FG001|Overall Study|Reason not Specified|0|||
42012855|NCT02993523|75819815|FG002|Overall Study|Reason not Specified|1|||
42012856|NCT02993523|75819816|FG003|Overall Study|Reason not Specified|1|||
42012857|NCT02993523|75819817|FG004|Overall Study|Reason not Specified|0|||
42150269|NCT00338286|75959065|FG000|Overall Study|Other|103|||
42039809|NCT03136185|75848234|FG007|Overall Study|Death|0|||
42039810|NCT03136185|75848235|FG008|Overall Study|Death|0|||
42039811|NCT03136185|75848227|FG000|Overall Study|Physician Decision|3|||
42150270|NCT00338286|75959066|FG001|Overall Study|Other|93|||
42150271|NCT00329784|75959076|FG000|Overall Study|Lost to Follow-up|0|||
42150272|NCT00329784|75959077|FG001|Overall Study|Lost to Follow-up|1|||
42150273|NCT00329784|75959078|FG002|Overall Study|Lost to Follow-up|0|||
42150274|NCT00329784|75959079|FG003|Overall Study|Lost to Follow-up|0|||
42150275|NCT00329784|75959076|FG000|Overall Study|Withdrawal by Subject|4|||
42150276|NCT00329784|75959077|FG001|Overall Study|Withdrawal by Subject|2|||
42150277|NCT00329784|75959078|FG002|Overall Study|Withdrawal by Subject|0|||
42150278|NCT00329784|75959079|FG003|Overall Study|Withdrawal by Subject|0|||
42150279|NCT00329784|75959076|FG000|Overall Study|Other|1|||
42150280|NCT00329784|75959077|FG001|Overall Study|Other|2|||
42150281|NCT00329784|75959078|FG002|Overall Study|Other|0|||
42150282|NCT00329784|75959079|FG003|Overall Study|Other|0|||
42150283|NCT00337818|75959094|FG000|Overall Study|Lost to Follow-up|289|||
42150284|NCT00337818|75959095|FG001|Overall Study|Lost to Follow-up|91|||
42150285|NCT00337818|75959096|FG002|Overall Study|Lost to Follow-up|107|||
42150286|NCT00329550|75959107|FG000|Overall Study|Adverse Event|3|||
42150287|NCT00329550|75959108|FG001|Overall Study|Adverse Event|4|||
42150288|NCT00329550|75959109|FG002|Overall Study|Adverse Event|2|||
42150289|NCT00329550|75959107|FG000|Overall Study|Withdrawal of Consent|1|||
42150290|NCT00329550|75959108|FG001|Overall Study|Withdrawal of Consent|0|||
42150291|NCT00329550|75959109|FG002|Overall Study|Withdrawal of Consent|1|||
42150292|NCT00329550|75959107|FG000|Overall Study|Due to Relocation|0|||
42150293|NCT00329550|75959108|FG001|Overall Study|Due to Relocation|0|||
42150294|NCT00329550|75959109|FG002|Overall Study|Due to Relocation|1|||
42150295|NCT00375674|75959121|FG000|Overall Study|Other|26|||
42150296|NCT00375674|75959122|FG001|Overall Study|Other|18|||
42150297|NCT00375674|75959121|FG000|Overall Study|Death|67|||
42150298|NCT00375674|75959122|FG001|Overall Study|Death|76|||
42150299|NCT00375674|75959121|FG000|Overall Study|Participants refused further follow-up|31|||
42150300|NCT00375674|75959122|FG001|Overall Study|Participants refused further follow-up|30|||
42150301|NCT00375674|75959121|FG000|Overall Study|Lost to Follow-up|17|||
42150302|NCT00375674|75959122|FG001|Overall Study|Lost to Follow-up|15|||
42150303|NCT00375674|75959121|FG000|Overall Study|Enrolled but not treated|3|||
42150304|NCT00375674|75959122|FG001|Overall Study|Enrolled but not treated|2|||
42150305|NCT00350402|75959130|FG000|Overall Study|Lost to Follow-up|1|||
42150306|NCT00350402|75959131|FG001|Overall Study|Lost to Follow-up|1|||
42150307|NCT00320190|75959145|FG000|First 12 Months|Completed but did not enter extension|5|||
42150308|NCT00320190|75959146|FG001|First 12 Months|Completed but did not enter extension|3|||
42150309|NCT00320190|75959145|FG000|First 12 Months|Sponsor terminated study|2|||
42150310|NCT00320190|75959146|FG001|First 12 Months|Sponsor terminated study|2|||
42150311|NCT00320190|75959145|FG000|First 12 Months|Lost to Follow-up|0|||
42150312|NCT00320190|75959146|FG001|First 12 Months|Lost to Follow-up|1|||
42150313|NCT00320190|75959145|FG000|First 12 Months|Enrollment failure|0|||
42150314|NCT00320190|75959146|FG001|First 12 Months|Enrollment failure|1|||
42150315|NCT00320190|75959145|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
42150316|NCT00320190|75959146|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
42150317|NCT00320190|75959145|FG000|First 12 Months|Investigator request|0|||
42150318|NCT00320190|75959146|FG001|First 12 Months|Investigator request|1|||
42150319|NCT00320190|75959145|FG000|First 12 Months|Study drug toxicity|0|||
42150320|NCT00320190|75959146|FG001|First 12 Months|Study drug toxicity|1|||
42150321|NCT00320190|75959145|FG000|First 12 Months|Withdrawal by Subject|0|||
42150322|NCT00320190|75959146|FG001|First 12 Months|Withdrawal by Subject|1|||
42150323|NCT00320190|75959145|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
42150324|NCT00320190|75959146|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
42150325|NCT00320190|75959145|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
42150326|NCT00320190|75959146|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
42150327|NCT00320190|75959145|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
42150328|NCT00320190|75959146|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
42150329|NCT00320112|75959154|FG000|Overall Study|Lost to Follow-up|3|||
42150330|NCT00320112|75959155|FG001|Overall Study|Lost to Follow-up|4|||
42150331|NCT00320112|75959154|FG000|Overall Study|Withdrawal by Subject|3|||
42150332|NCT00320112|75959155|FG001|Overall Study|Withdrawal by Subject|0|||
42150333|NCT00320112|75959154|FG000|Overall Study|Death|2|||
42012858|NCT02795429|75819830|FG000|Overall Study|Adverse Event|1|||
42012859|NCT02795429|75819831|FG001|Overall Study|Adverse Event|2|||
42150334|NCT00320112|75959155|FG001|Overall Study|Death|1|||
42150335|NCT00319956|75959169|FG000|Overall Study|Death|20|||
42150336|NCT00319956|75959170|FG001|Overall Study|Death|24|||
42150337|NCT00349622|75959178|FG000|Overall Study|Death|168|||
42150338|NCT00349622|75959179|FG001|Overall Study|Death|86|||
42150339|NCT00349622|75959178|FG000|Overall Study|Lost to Follow-up|5|||
42150340|NCT00349622|75959179|FG001|Overall Study|Lost to Follow-up|1|||
42150341|NCT00349622|75959178|FG000|Overall Study|Withdrawal by Subject|5|||
42150342|NCT00349622|75959179|FG001|Overall Study|Withdrawal by Subject|9|||
42150343|NCT00354614|75959185|FG000|Overall Study|Lack of Efficacy|28|||
42150344|NCT00360308|75959192|FG000|Overall Study|Adverse Event|15|||
42150345|NCT00360308|75959193|FG001|Overall Study|Adverse Event|14|||
42150346|NCT00360308|75959194|FG002|Overall Study|Adverse Event|25|||
42150347|NCT00360308|75959192|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
42150348|NCT00360308|75959193|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
42150349|NCT00360308|75959194|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
42150350|NCT00360308|75959192|FG000|Overall Study|Protocol Violation|2|||
42150351|NCT00360308|75959193|FG001|Overall Study|Protocol Violation|1|||
42150352|NCT00360308|75959194|FG002|Overall Study|Protocol Violation|2|||
42150353|NCT00360308|75959192|FG000|Overall Study|Withdrawal by Subject|11|||
42150354|NCT00360308|75959193|FG001|Overall Study|Withdrawal by Subject|7|||
42150355|NCT00360308|75959194|FG002|Overall Study|Withdrawal by Subject|14|||
42150356|NCT00360308|75959192|FG000|Overall Study|Lack of Efficacy|3|||
42150357|NCT00360308|75959193|FG001|Overall Study|Lack of Efficacy|0|||
42150358|NCT00360308|75959194|FG002|Overall Study|Lack of Efficacy|2|||
42150359|NCT00360308|75959192|FG000|Overall Study|Other|2|||
42150360|NCT00360308|75959193|FG001|Overall Study|Other|1|||
42150361|NCT00360308|75959194|FG002|Overall Study|Other|1|||
42150362|NCT00360308|75959192|FG000|Overall Study|Study termination by sponsor|43|||
42150363|NCT00360308|75959193|FG001|Overall Study|Study termination by sponsor|55|||
42150364|NCT00360308|75959194|FG002|Overall Study|Study termination by sponsor|44|||
42150365|NCT00348686|75959206|FG000|Overall Study|Withdrawal by Subject|45|||
42150366|NCT00348686|75959206|FG000|Overall Study|Adverse Event|5|||
42150367|NCT00348686|75959206|FG000|Overall Study|Protocol Violation|6|||
42150368|NCT00348686|75959206|FG000|Overall Study|Lost to Follow-up|2|||
42150369|NCT00348686|75959206|FG000|Overall Study|Multiple Reasons|8|||
42150370|NCT00360230|75959217|FG000|Overall Study|Withdrawal by Subject|1|||
42150371|NCT00360230|75959218|FG001|Overall Study|Withdrawal by Subject|1|||
42150372|NCT00360230|75959219|FG002|Overall Study|Withdrawal by Subject|0|||
42150373|NCT00360230|75959220|FG003|Overall Study|Withdrawal by Subject|1|||
42150374|NCT00360230|75959221|FG004|Overall Study|Withdrawal by Subject|1|||
42150375|NCT00360230|75959222|FG005|Overall Study|Withdrawal by Subject|1|||
42150376|NCT00360230|75959223|FG006|Overall Study|Withdrawal by Subject|0|||
42150377|NCT00360230|75959217|FG000|Overall Study|Migrated|4|||
42150378|NCT00360230|75959218|FG001|Overall Study|Migrated|1|||
42150379|NCT00360230|75959219|FG002|Overall Study|Migrated|3|||
42150380|NCT00360230|75959220|FG003|Overall Study|Migrated|1|||
42150381|NCT00360230|75959221|FG004|Overall Study|Migrated|4|||
42150382|NCT00360230|75959222|FG005|Overall Study|Migrated|1|||
42150383|NCT00360230|75959223|FG006|Overall Study|Migrated|1|||
42012860|NCT02795429|75819832|FG002|Overall Study|Adverse Event|1|||
42012861|NCT02795429|75819833|FG003|Overall Study|Adverse Event|2|||
42012862|NCT02795429|75819834|FG004|Overall Study|Adverse Event|1|||
42012863|NCT02795429|75819830|FG000|Overall Study|Death|1|||
42012864|NCT02795429|75819831|FG001|Overall Study|Death|0|||
42012865|NCT02795429|75819832|FG002|Overall Study|Death|1|||
42012866|NCT02795429|75819833|FG003|Overall Study|Death|2|||
42012867|NCT02795429|75819834|FG004|Overall Study|Death|1|||
42012868|NCT02795429|75819830|FG000|Overall Study|Physician Decision|0|||
42012869|NCT02795429|75819831|FG001|Overall Study|Physician Decision|0|||
42012870|NCT02795429|75819832|FG002|Overall Study|Physician Decision|2|||
42012871|NCT02795429|75819833|FG003|Overall Study|Physician Decision|1|||
42012872|NCT02795429|75819834|FG004|Overall Study|Physician Decision|5|||
42012873|NCT02795429|75819830|FG000|Overall Study|Progressive disease|3|||
42012874|NCT02795429|75819831|FG001|Overall Study|Progressive disease|7|||
42012875|NCT02795429|75819832|FG002|Overall Study|Progressive disease|6|||
42012876|NCT02795429|75819833|FG003|Overall Study|Progressive disease|26|||
42012877|NCT02795429|75819834|FG004|Overall Study|Progressive disease|20|||
42012878|NCT02795429|75819830|FG000|Overall Study|Subject/guardian decision|1|||
42012879|NCT02795429|75819831|FG001|Overall Study|Subject/guardian decision|1|||
42012880|NCT02795429|75819832|FG002|Overall Study|Subject/guardian decision|1|||
42012881|NCT02795429|75819833|FG003|Overall Study|Subject/guardian decision|1|||
42039812|NCT03136185|75848228|FG001|Overall Study|Physician Decision|1|||
42150384|NCT00360230|75959217|FG000|Overall Study|Other|1|||
42150385|NCT00360230|75959218|FG001|Overall Study|Other|0|||
42012882|NCT02795429|75819834|FG004|Overall Study|Subject/guardian decision|3|||
42012883|NCT02652949|75819857|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
42012884|NCT02652949|75819857|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
42012885|NCT02652949|75819857|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
42012886|NCT02652949|75819857|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
42150386|NCT00360230|75959219|FG002|Overall Study|Other|0|||
42150387|NCT00360230|75959220|FG003|Overall Study|Other|0|||
42150388|NCT00360230|75959221|FG004|Overall Study|Other|0|||
42150389|NCT00360230|75959222|FG005|Overall Study|Other|0|||
42150390|NCT00360230|75959223|FG006|Overall Study|Other|0|||
42150391|NCT00360230|75959217|FG000|Overall Study|Protocol Violation|0|||
42150392|NCT00360230|75959218|FG001|Overall Study|Protocol Violation|0|||
42150393|NCT00360230|75959219|FG002|Overall Study|Protocol Violation|0|||
42012887|NCT02652949|75819857|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
42012888|NCT02652949|75819857|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
42150394|NCT00360230|75959220|FG003|Overall Study|Protocol Violation|0|||
42150395|NCT00360230|75959221|FG004|Overall Study|Protocol Violation|0|||
42150396|NCT00360230|75959222|FG005|Overall Study|Protocol Violation|1|||
42150397|NCT00360230|75959223|FG006|Overall Study|Protocol Violation|0|||
42150398|NCT00360230|75959217|FG000|Overall Study|Death|0|||
42150399|NCT00360230|75959218|FG001|Overall Study|Death|1|||
42150400|NCT00360230|75959219|FG002|Overall Study|Death|0|||
42150401|NCT00360230|75959220|FG003|Overall Study|Death|0|||
42150402|NCT00360230|75959221|FG004|Overall Study|Death|0|||
42150403|NCT00360230|75959222|FG005|Overall Study|Death|1|||
42150404|NCT00360230|75959223|FG006|Overall Study|Death|1|||
42150405|NCT00348374|75959243|FG000|Overall Study|Adverse Event|1|||
42150406|NCT00348374|75959244|FG001|Overall Study|Adverse Event|4|||
42150407|NCT00348374|75959243|FG000|Overall Study|Lost to Follow-up|1|||
42150408|NCT00348374|75959244|FG001|Overall Study|Lost to Follow-up|3|||
42150409|NCT00348374|75959243|FG000|Overall Study|Withdrawal by Subject|5|||
42150410|NCT00348374|75959244|FG001|Overall Study|Withdrawal by Subject|5|||
42150411|NCT00348374|75959243|FG000|Overall Study|Other|11|||
42150412|NCT00348374|75959244|FG001|Overall Study|Other|12|||
42150413|NCT00348374|75959243|FG000|Overall Study|ongoing at date of cutoff|1|||
42150414|NCT00348374|75959244|FG001|Overall Study|ongoing at date of cutoff|1|||
42012889|NCT02652949|75819857|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
42012890|NCT02652949|75819857|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
42039813|NCT03136185|75848229|FG002|Overall Study|Physician Decision|1|||
42039814|NCT03136185|75848230|FG003|Overall Study|Physician Decision|2|||
42150415|NCT00348374|75959243|FG000|Overall Study|randomized but did not receive treatment|0|||
42150416|NCT00348374|75959244|FG001|Overall Study|randomized but did not receive treatment|7|||
42150417|NCT00353366|75959251|FG000|Overall Study|Adverse Event|8|||
42278150|NCT02383940|76109796|FG000|Overall Study|Lost to Follow-up|2|||
42012891|NCT02652949|75819857|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
42012892|NCT02652949|75819857|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
42012893|NCT02652949|75819857|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
42012894|NCT02652949|75819857|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
42012895|NCT02652949|75819857|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
42012896|NCT02652949|75819857|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
42012897|NCT02652949|75819857|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
42039815|NCT03136185|75848231|FG004|Overall Study|Physician Decision|1|||
42012898|NCT02632344|75819868|FG000|Overall Study|Adverse Event|3|||
42150418|NCT00353366|75959251|FG000|Overall Study|Protocol Violation|12|||
42150419|NCT00353366|75959251|FG000|Overall Study|Withdrawal by Subject|12|||
42150420|NCT00353366|75959251|FG000|Overall Study|Lost to Follow-up|92|||
42150421|NCT00353366|75959251|FG000|Overall Study|Other|19|||
42150422|NCT00352664|75959257|FG000|Overall Study|Withdrawal by Subject|7|||
42150423|NCT00352664|75959258|FG001|Overall Study|Withdrawal by Subject|0|||
42150424|NCT00490139|75959268|FG000|Overall Study|Death|106|||
42150425|NCT00490139|75959269|FG001|Overall Study|Death|119|||
42150426|NCT00490139|75959270|FG002|Overall Study|Death|168|||
42150427|NCT00490139|75959271|FG003|Overall Study|Death|135|||
42150428|NCT00490139|75959268|FG000|Overall Study|Lost to Follow-up|56|||
42150429|NCT00490139|75959269|FG001|Overall Study|Lost to Follow-up|46|||
42150430|NCT00490139|75959270|FG002|Overall Study|Lost to Follow-up|58|||
42150431|NCT00490139|75959271|FG003|Overall Study|Lost to Follow-up|56|||
42150432|NCT00490139|75959268|FG000|Overall Study|Participant Withdrew Consent|146|||
42150433|NCT00490139|75959269|FG001|Overall Study|Participant Withdrew Consent|110|||
42150434|NCT00490139|75959270|FG002|Overall Study|Participant Withdrew Consent|208|||
42150435|NCT00490139|75959271|FG003|Overall Study|Participant Withdrew Consent|116|||
42150436|NCT00348140|75959286|FG000|Overall Study|Adverse Event|46|||
42150437|NCT00348140|75959287|FG001|Overall Study|Adverse Event|49|||
42150438|NCT00348140|75959288|FG002|Overall Study|Adverse Event|78|||
42150439|NCT00348140|75959286|FG000|Overall Study|Lost to Follow-up|4|||
42150440|NCT00348140|75959287|FG001|Overall Study|Lost to Follow-up|4|||
42150441|NCT00348140|75959288|FG002|Overall Study|Lost to Follow-up|4|||
42150442|NCT00348140|75959286|FG000|Overall Study|Protocol Violation|12|||
42150443|NCT00348140|75959287|FG001|Overall Study|Protocol Violation|13|||
42150444|NCT00348140|75959288|FG002|Overall Study|Protocol Violation|14|||
42150445|NCT00348140|75959286|FG000|Overall Study|Withdrawal by Subject|32|||
42150446|NCT00348140|75959287|FG001|Overall Study|Withdrawal by Subject|40|||
42150447|NCT00348140|75959288|FG002|Overall Study|Withdrawal by Subject|40|||
42150448|NCT00348140|75959286|FG000|Overall Study|Non-compliance|8|||
42150449|NCT00348140|75959287|FG001|Overall Study|Non-compliance|13|||
42150450|NCT00348140|75959288|FG002|Overall Study|Non-compliance|5|||
42150451|NCT00348140|75959286|FG000|Overall Study|Participant at risk due to study drug|2|||
42150452|NCT00348140|75959287|FG001|Overall Study|Participant at risk due to study drug|0|||
42150453|NCT00348140|75959288|FG002|Overall Study|Participant at risk due to study drug|0|||
42150454|NCT00348140|75959286|FG000|Overall Study|Conditional medication increased dose|1|||
42150455|NCT00348140|75959287|FG001|Overall Study|Conditional medication increased dose|0|||
42150456|NCT00348140|75959288|FG002|Overall Study|Conditional medication increased dose|0|||
42150457|NCT00348140|75959286|FG000|Overall Study|Caregiver related|4|||
42150458|NCT00348140|75959287|FG001|Overall Study|Caregiver related|7|||
42012899|NCT02632344|75819868|FG000|Overall Study|Lack of Efficacy|3|||
42150459|NCT00348140|75959288|FG002|Overall Study|Caregiver related|3|||
42150460|NCT00348140|75959286|FG000|Overall Study|Participant hospitalised|3|||
42150461|NCT00348140|75959287|FG001|Overall Study|Participant hospitalised|0|||
42150462|NCT00348140|75959288|FG002|Overall Study|Participant hospitalised|0|||
42150463|NCT00348140|75959286|FG000|Overall Study|Efficacy related|1|||
42150464|NCT00348140|75959287|FG001|Overall Study|Efficacy related|1|||
42278151|NCT02383940|76109797|FG001|Overall Study|Lost to Follow-up|2|||
42150465|NCT00348140|75959288|FG002|Overall Study|Efficacy related|0|||
42278152|NCT02383940|76109796|FG000|Overall Study|Physician Decision|2|||
42012900|NCT02632344|75819868|FG000|Overall Study|Withdrawal by Subject|2|||
42150466|NCT00348140|75959286|FG000|Overall Study|Administration related|3|||
42150467|NCT00348140|75959287|FG001|Overall Study|Administration related|1|||
42150468|NCT00348140|75959288|FG002|Overall Study|Administration related|1|||
42150469|NCT00348140|75959286|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
42150470|NCT00348140|75959287|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
42278153|NCT02383940|76109797|FG001|Overall Study|Physician Decision|0|||
42278154|NCT02383940|76109796|FG000|Overall Study|Withdrawal by Subject|1|||
42278155|NCT02383940|76109797|FG001|Overall Study|Withdrawal by Subject|1|||
42278156|NCT02383940|76109796|FG000|Overall Study|Randomized but not treated|2|||
42278157|NCT02383940|76109797|FG001|Overall Study|Randomized but not treated|0|||
42278158|NCT02383940|76109796|FG000|Overall Study|Other than specified above|1|||
42278159|NCT02383940|76109797|FG001|Overall Study|Other than specified above|0|||
42278160|NCT02383862|76109805|FG000|3 Month Follow up|Lost to Follow-up|23|||
42278161|NCT02383862|76109806|FG001|3 Month Follow up|Lost to Follow-up|21|||
42278162|NCT02383472|76109821|FG000|Overall Study|Withdrawal by Subject|1|||
42278163|NCT02383472|76109822|FG001|Overall Study|Withdrawal by Subject|1|||
42278164|NCT02234323|76109830|FG000|All Enrolled|Not Treated: Completed study in database|2|||
42278165|NCT02234323|76109830|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
42278166|NCT02234323|76109830|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
42278167|NCT02234323|76109830|FG000|All Treated|Death|1|||
42278168|NCT02234323|76109830|FG000|All Treated|Physician Decision|5|||
42278169|NCT02234323|76109830|FG000|All Treated|Lack of Efficacy|3|||
42012901|NCT02625324|75819872|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
42012902|NCT02625324|75819872|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
42012903|NCT02625324|75819872|FG000|6-Month Follow-up Subject Accountability|Death|5|||
42012904|NCT02625324|75819872|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
42012905|NCT02625324|75819872|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
42012906|NCT02625324|75819872|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
42012907|NCT02625324|75819872|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
42012908|NCT02625324|75819872|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
42012909|NCT02625324|75819872|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
42012910|NCT02625324|75819872|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
42012911|NCT02625324|75819872|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
42012912|NCT02625324|75819872|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
42012913|NCT02625324|75819872|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
42012914|NCT02625324|75819872|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
42012915|NCT02625324|75819872|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
42012916|NCT02213328|75819908|FG000|Overall Study|Withdrawal by Subject|10|||
42012917|NCT02213328|75819908|FG000|Overall Study|Physician Decision|2|||
42012918|NCT02213328|75819908|FG000|Overall Study|Lost to Follow-up|16|||
42012919|NCT02085408|75819937|FG000|Step 1: Induction|Disease Progression|19|||
42012920|NCT02085408|75819938|FG001|Step 1: Induction|Disease Progression|19|||
42012921|NCT02085408|75819937|FG000|Step 1: Induction|Adverse Event|18|||
42012922|NCT02085408|75819938|FG001|Step 1: Induction|Adverse Event|17|||
42012923|NCT02085408|75819937|FG000|Step 1: Induction|Death|33|||
42012924|NCT02085408|75819938|FG001|Step 1: Induction|Death|30|||
42012925|NCT02085408|75819937|FG000|Step 1: Induction|Withdrawal by Subject|16|||
42012926|NCT02085408|75819938|FG001|Step 1: Induction|Withdrawal by Subject|8|||
42012927|NCT02085408|75819937|FG000|Step 1: Induction|Alternative Therapy|15|||
42012928|NCT02085408|75819938|FG001|Step 1: Induction|Alternative Therapy|19|||
42012929|NCT02085408|75819937|FG000|Step 1: Induction|Complicating Disease|2|||
42012930|NCT02085408|75819938|FG001|Step 1: Induction|Complicating Disease|3|||
42012931|NCT02085408|75819937|FG000|Step 1: Induction|Other|27|||
42012932|NCT02085408|75819938|FG001|Step 1: Induction|Other|39|||
42012933|NCT02085408|75819937|FG000|Step 1: Induction|Never started treatment|6|||
42012934|NCT02085408|75819938|FG001|Step 1: Induction|Never started treatment|4|||
42012935|NCT02085408|75819937|FG000|Step 2: Consolidation|Disease Progression|5|||
42278170|NCT02234323|76109830|FG000|All Treated|Exceeded lab value limit|2|||
42278171|NCT02234323|76109830|FG000|All Treated|Other|7|||
42278172|NCT02414828|76109840|FG000|Overall Study|Lost to Follow-up|0|||
42278173|NCT02414828|76109841|FG001|Overall Study|Lost to Follow-up|1|||
42012936|NCT02085408|75819938|FG001|Step 2: Consolidation|Disease Progression|20|||
42012937|NCT02085408|75819937|FG000|Step 2: Consolidation|Adverse Event|9|||
42012938|NCT02085408|75819938|FG001|Step 2: Consolidation|Adverse Event|8|||
42012939|NCT02085408|75819937|FG000|Step 2: Consolidation|Death|4|||
42012940|NCT02085408|75819938|FG001|Step 2: Consolidation|Death|3|||
42012941|NCT02085408|75819937|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
42012942|NCT02085408|75819938|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
42012943|NCT02085408|75819937|FG000|Step 2: Consolidation|Alternative Therapy|9|||
42012944|NCT02085408|75819938|FG001|Step 2: Consolidation|Alternative Therapy|3|||
42012945|NCT02085408|75819937|FG000|Step 2: Consolidation|Complicating Disease|0|||
42039816|NCT03136185|75848232|FG005|Overall Study|Physician Decision|2|||
42278174|NCT02414828|76109842|FG002|Overall Study|Lost to Follow-up|1|||
42150471|NCT00348140|75959288|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
42278175|NCT02414828|76109843|FG003|Overall Study|Lost to Follow-up|2|||
42150472|NCT00348140|75959286|FG000|Overall Study|Participant unwell|1|||
42150473|NCT00348140|75959287|FG001|Overall Study|Participant unwell|0|||
42150474|NCT00348140|75959288|FG002|Overall Study|Participant unwell|0|||
42150475|NCT00348140|75959286|FG000|Overall Study|Screen failure|1|||
42150476|NCT00348140|75959287|FG001|Overall Study|Screen failure|0|||
42150477|NCT00348140|75959288|FG002|Overall Study|Screen failure|0|||
42150478|NCT00348140|75959286|FG000|Overall Study|Investigator decided to discontinue|4|||
42150479|NCT00348140|75959287|FG001|Overall Study|Investigator decided to discontinue|1|||
42150480|NCT00348140|75959288|FG002|Overall Study|Investigator decided to discontinue|4|||
42150481|NCT00348140|75959286|FG000|Overall Study|Decided to discontinue on their own|1|||
42150482|NCT00348140|75959287|FG001|Overall Study|Decided to discontinue on their own|4|||
42150483|NCT00348140|75959288|FG002|Overall Study|Decided to discontinue on their own|1|||
42150484|NCT00348140|75959286|FG000|Overall Study|Use of prohibited drug|1|||
42150485|NCT00348140|75959287|FG001|Overall Study|Use of prohibited drug|0|||
42150486|NCT00348140|75959288|FG002|Overall Study|Use of prohibited drug|2|||
42150487|NCT00348140|75959286|FG000|Overall Study|Disease progression|1|||
42150488|NCT00348140|75959287|FG001|Overall Study|Disease progression|2|||
42150489|NCT00348140|75959288|FG002|Overall Study|Disease progression|5|||
42150490|NCT00348140|75959286|FG000|Overall Study|Increased risk of cardiac infarction|0|||
42150491|NCT00348140|75959287|FG001|Overall Study|Increased risk of cardiac infarction|1|||
42150492|NCT00348140|75959288|FG002|Overall Study|Increased risk of cardiac infarction|0|||
42150493|NCT00348140|75959286|FG000|Overall Study|Serious adverse event|0|||
42150494|NCT00348140|75959287|FG001|Overall Study|Serious adverse event|1|||
42150495|NCT00348140|75959288|FG002|Overall Study|Serious adverse event|0|||
42150496|NCT00348140|75959286|FG000|Overall Study|Abnormal ECG|0|||
42150497|NCT00348140|75959287|FG001|Overall Study|Abnormal ECG|1|||
42150498|NCT00348140|75959288|FG002|Overall Study|Abnormal ECG|3|||
42150499|NCT00348140|75959286|FG000|Overall Study|Participant died|0|||
42150500|NCT00348140|75959287|FG001|Overall Study|Participant died|1|||
42150501|NCT00348140|75959288|FG002|Overall Study|Participant died|0|||
42150502|NCT00348140|75959286|FG000|Overall Study|Exclusion criteria met|0|||
42150503|NCT00348140|75959287|FG001|Overall Study|Exclusion criteria met|0|||
42150504|NCT00348140|75959288|FG002|Overall Study|Exclusion criteria met|1|||
42150505|NCT00348140|75959286|FG000|Overall Study|Memory declined|0|||
42150506|NCT00348140|75959287|FG001|Overall Study|Memory declined|0|||
42150507|NCT00348140|75959288|FG002|Overall Study|Memory declined|1|||
42150508|NCT00490061|75959297|FG000|Overall Study|Physician Decision|1|||
42150509|NCT00483119|75959303|FG000|Overall Study|Adverse Event|0|||
42150510|NCT00483119|75959304|FG001|Overall Study|Adverse Event|1|||
42150511|NCT00483119|75959303|FG000|Overall Study|Physician Decision|1|||
42150512|NCT00483119|75959304|FG001|Overall Study|Physician Decision|0|||
42150513|NCT00483041|75959312|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
42150514|NCT00483041|75959313|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
42150515|NCT00501293|75959321|FG000|Optimization Period|Enrolled in error|1|||
42150516|NCT00501293|75959322|FG001|Optimization Period|Enrolled in error|0|||
42150517|NCT00501293|75959321|FG000|Maintenance Period|Withdrawal by Subject|14|||
42150518|NCT00501293|75959322|FG001|Maintenance Period|Withdrawal by Subject|13|||
42150519|NCT00501293|75959321|FG000|Maintenance Period|Lost to Follow-up|12|||
42150520|NCT00501293|75959322|FG001|Maintenance Period|Lost to Follow-up|7|||
42150521|NCT00501293|75959321|FG000|Maintenance Period|Adverse Event|6|||
42150522|NCT00501293|75959322|FG001|Maintenance Period|Adverse Event|6|||
42150523|NCT00501293|75959321|FG000|Maintenance Period|Protocol Violation|2|||
42150524|NCT00501293|75959322|FG001|Maintenance Period|Protocol Violation|1|||
42278176|NCT02413346|76109856|FG000|Overall Study|Adverse Event|6|||
42278177|NCT02413346|76109857|FG001|Overall Study|Adverse Event|6|||
42278178|NCT02413346|76109856|FG000|Overall Study|Withdrawal by Subject|30|||
42150525|NCT00501293|75959321|FG000|Maintenance Period|Lack of Efficacy|4|||
42150526|NCT00501293|75959322|FG001|Maintenance Period|Lack of Efficacy|1|||
42150527|NCT00501293|75959321|FG000|Maintenance Period|Noncompliant with study medication|5|||
42150528|NCT00501293|75959322|FG001|Maintenance Period|Noncompliant with study medication|0|||
42150529|NCT00501293|75959321|FG000|Maintenance Period|Went into rehabilitation|1|||
42150530|NCT00501293|75959322|FG001|Maintenance Period|Went into rehabilitation|0|||
42150531|NCT00501293|75959321|FG000|Maintenance Period|Would not wear patch|1|||
42150532|NCT00501293|75959322|FG001|Maintenance Period|Would not wear patch|0|||
42150533|NCT00501293|75959321|FG000|Maintenance Period|Application site reaction|1|||
42278179|NCT02413346|76109857|FG001|Overall Study|Withdrawal by Subject|40|||
42150534|NCT00501293|75959322|FG001|Maintenance Period|Application site reaction|0|||
42150535|NCT00482729|75959331|FG000|Overall Study|Adverse Event|29|||
42150536|NCT00482729|75959332|FG001|Overall Study|Adverse Event|33|||
42150537|NCT00482729|75959331|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
42150538|NCT00482729|75959332|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
42150539|NCT00482729|75959331|FG000|Overall Study|Hyperglycemia Criteria|7|||
42150540|NCT00482729|75959332|FG001|Overall Study|Hyperglycemia Criteria|5|||
42150541|NCT00482729|75959331|FG000|Overall Study|Lack of Efficacy|4|||
42150542|NCT00482729|75959332|FG001|Overall Study|Lack of Efficacy|16|||
42150543|NCT00482729|75959331|FG000|Overall Study|Lost to Follow-up|86|||
42150544|NCT00482729|75959332|FG001|Overall Study|Lost to Follow-up|66|||
42150545|NCT00482729|75959331|FG000|Overall Study|Physician Decision|10|||
42150546|NCT00482729|75959332|FG001|Overall Study|Physician Decision|7|||
42150547|NCT00482729|75959331|FG000|Overall Study|Pregnancy|4|||
42150548|NCT00482729|75959332|FG001|Overall Study|Pregnancy|2|||
42150549|NCT00482729|75959331|FG000|Overall Study|Protocol Violation|10|||
42150550|NCT00482729|75959332|FG001|Overall Study|Protocol Violation|18|||
42150551|NCT00482729|75959331|FG000|Overall Study|Withdrawal by Subject|67|||
42150552|NCT00482729|75959332|FG001|Overall Study|Withdrawal by Subject|69|||
42150553|NCT00359762|75959340|FG000|Period II|Adverse Event|17|||
42150554|NCT00359762|75959341|FG001|Period II|Adverse Event|0|||
42150555|NCT00359762|75959342|FG002|Period II|Adverse Event|0|||
42150556|NCT00359762|75959343|FG003|Period II|Adverse Event|0|||
42150557|NCT00359762|75959344|FG004|Period II|Adverse Event|49|||
42150558|NCT00359762|75959340|FG000|Period II|Protocol Violation|18|||
42150559|NCT00359762|75959341|FG001|Period II|Protocol Violation|0|||
42150560|NCT00359762|75959342|FG002|Period II|Protocol Violation|0|||
42150561|NCT00359762|75959343|FG003|Period II|Protocol Violation|0|||
42150562|NCT00359762|75959344|FG004|Period II|Protocol Violation|11|||
42150563|NCT00359762|75959340|FG000|Period II|Physician Decision|17|||
42150564|NCT00359762|75959341|FG001|Period II|Physician Decision|0|||
42150565|NCT00359762|75959342|FG002|Period II|Physician Decision|0|||
42150566|NCT00359762|75959343|FG003|Period II|Physician Decision|0|||
42150567|NCT00359762|75959344|FG004|Period II|Physician Decision|23|||
42150568|NCT00359762|75959340|FG000|Period II|Death|2|||
42150569|NCT00359762|75959341|FG001|Period II|Death|0|||
42150570|NCT00359762|75959342|FG002|Period II|Death|0|||
42150571|NCT00359762|75959343|FG003|Period II|Death|0|||
42150572|NCT00359762|75959344|FG004|Period II|Death|4|||
42150573|NCT00359762|75959340|FG000|Period II|Lack of Efficacy|11|||
42150574|NCT00359762|75959341|FG001|Period II|Lack of Efficacy|0|||
42150575|NCT00359762|75959342|FG002|Period II|Lack of Efficacy|0|||
42150576|NCT00359762|75959343|FG003|Period II|Lack of Efficacy|0|||
42150577|NCT00359762|75959344|FG004|Period II|Lack of Efficacy|8|||
42150578|NCT00359762|75959340|FG000|Period II|Lost to follow up|5|||
42150579|NCT00359762|75959341|FG001|Period II|Lost to follow up|0|||
42150580|NCT00359762|75959342|FG002|Period II|Lost to follow up|0|||
42150581|NCT00359762|75959343|FG003|Period II|Lost to follow up|0|||
42150582|NCT00359762|75959344|FG004|Period II|Lost to follow up|5|||
42150583|NCT00359762|75959340|FG000|Period II|Entry Criteria Not Met|8|||
42150584|NCT00359762|75959341|FG001|Period II|Entry Criteria Not Met|0|||
42150585|NCT00359762|75959342|FG002|Period II|Entry Criteria Not Met|0|||
42150586|NCT00359762|75959343|FG003|Period II|Entry Criteria Not Met|0|||
42150587|NCT00359762|75959344|FG004|Period II|Entry Criteria Not Met|4|||
42150588|NCT00359762|75959340|FG000|Period II|Subject Decision|50|||
42150589|NCT00359762|75959341|FG001|Period II|Subject Decision|0|||
42150590|NCT00359762|75959342|FG002|Period II|Subject Decision|0|||
42150591|NCT00359762|75959343|FG003|Period II|Subject Decision|0|||
42150592|NCT00359762|75959344|FG004|Period II|Subject Decision|70|||
42150593|NCT00359762|75959340|FG000|Period III|Protocol Violation|0|||
42150594|NCT00359762|75959341|FG001|Period III|Protocol Violation|5|||
42150595|NCT00359762|75959342|FG002|Period III|Protocol Violation|3|||
42150596|NCT00359762|75959343|FG003|Period III|Protocol Violation|8|||
42150597|NCT00359762|75959344|FG004|Period III|Protocol Violation|0|||
42150598|NCT00359762|75959340|FG000|Period III|Adverse Event|0|||
42150599|NCT00359762|75959341|FG001|Period III|Adverse Event|3|||
42150600|NCT00359762|75959342|FG002|Period III|Adverse Event|4|||
42150601|NCT00359762|75959343|FG003|Period III|Adverse Event|10|||
42150602|NCT00359762|75959344|FG004|Period III|Adverse Event|0|||
42150603|NCT00359762|75959340|FG000|Period III|Physician Decision|0|||
42150604|NCT00359762|75959341|FG001|Period III|Physician Decision|5|||
42150605|NCT00359762|75959342|FG002|Period III|Physician Decision|9|||
42150606|NCT00359762|75959343|FG003|Period III|Physician Decision|15|||
42150607|NCT00359762|75959344|FG004|Period III|Physician Decision|0|||
42150608|NCT00359762|75959340|FG000|Period III|Lack of Efficacy|0|||
42150609|NCT00359762|75959341|FG001|Period III|Lack of Efficacy|7|||
42150610|NCT00359762|75959342|FG002|Period III|Lack of Efficacy|5|||
42150611|NCT00359762|75959343|FG003|Period III|Lack of Efficacy|9|||
42150612|NCT00359762|75959344|FG004|Period III|Lack of Efficacy|0|||
42150613|NCT00359762|75959340|FG000|Period III|Lost to follow up|0|||
42150614|NCT00359762|75959341|FG001|Period III|Lost to follow up|1|||
42150615|NCT00359762|75959342|FG002|Period III|Lost to follow up|1|||
42150616|NCT00359762|75959343|FG003|Period III|Lost to follow up|2|||
42150617|NCT00359762|75959344|FG004|Period III|Lost to follow up|0|||
42150618|NCT00359762|75959340|FG000|Period III|Entry Criteria Not Met|0|||
42150619|NCT00359762|75959341|FG001|Period III|Entry Criteria Not Met|1|||
42150620|NCT00359762|75959342|FG002|Period III|Entry Criteria Not Met|0|||
42150621|NCT00359762|75959343|FG003|Period III|Entry Criteria Not Met|1|||
42150622|NCT00359762|75959344|FG004|Period III|Entry Criteria Not Met|0|||
42150623|NCT00359762|75959340|FG000|Period III|Subject Decision|0|||
42150624|NCT00359762|75959341|FG001|Period III|Subject Decision|7|||
42150625|NCT00359762|75959342|FG002|Period III|Subject Decision|8|||
42150626|NCT00359762|75959343|FG003|Period III|Subject Decision|20|||
42150627|NCT00359762|75959344|FG004|Period III|Subject Decision|0|||
42150628|NCT00347438|75959358|FG000|Overall Study|Withdrawal by Subject|1|||
42150629|NCT00347438|75959358|FG000|Overall Study|Physician Decision|1|||
42150630|NCT00329238|75959364|FG000|Overall Study|Adverse Event|147|||
42150631|NCT00329238|75959365|FG001|Overall Study|Adverse Event|129|||
42150632|NCT00329238|75959364|FG000|Overall Study|Protocol Violation|23|||
42150633|NCT00329238|75959365|FG001|Overall Study|Protocol Violation|34|||
42150634|NCT00329238|75959364|FG000|Overall Study|Lost to Follow-up|2|||
42150635|NCT00329238|75959365|FG001|Overall Study|Lost to Follow-up|6|||
42150636|NCT00329238|75959364|FG000|Overall Study|Withdrawal by Subject|64|||
42150637|NCT00329238|75959365|FG001|Overall Study|Withdrawal by Subject|58|||
42150638|NCT00329238|75959364|FG000|Overall Study|Other reason (not specified)|40|||
42150639|NCT00329238|75959365|FG001|Overall Study|Other reason (not specified)|54|||
42150640|NCT00329160|75959373|FG000|Overall Study|Adverse Event|27|||
42150641|NCT00329160|75959373|FG000|Overall Study|Withdrawal by Subject|13|||
42150642|NCT00329160|75959373|FG000|Overall Study|Protocol Violation|2|||
42150643|NCT00329160|75959373|FG000|Overall Study|Did not Receive Study Drug|1|||
42150644|NCT00329160|75959373|FG000|Overall Study|Incomplete IVUS|45|||
42150645|NCT00328926|75959380|FG000|Overall Study|Pregnancy|2|||
42150646|NCT00328926|75959381|FG001|Overall Study|Pregnancy|1|||
42150647|NCT00328926|75959382|FG002|Overall Study|Pregnancy|0|||
42150648|NCT00328926|75959380|FG000|Overall Study|Lost to Follow-up|0|||
42150649|NCT00328926|75959381|FG001|Overall Study|Lost to Follow-up|1|||
42150650|NCT00328926|75959382|FG002|Overall Study|Lost to Follow-up|0|||
42150651|NCT00328926|75959380|FG000|Overall Study|Death|0|||
42150652|NCT00328926|75959381|FG001|Overall Study|Death|0|||
42150653|NCT00328926|75959382|FG002|Overall Study|Death|1|||
42150654|NCT00328926|75959380|FG000|Overall Study|In vitro fertilization treatment|0|||
42150655|NCT00328926|75959381|FG001|Overall Study|In vitro fertilization treatment|0|||
42150656|NCT00328926|75959382|FG002|Overall Study|In vitro fertilization treatment|1|||
42150657|NCT00328926|75959380|FG000|Overall Study|Lack of ovarian response|0|||
42150658|NCT00328926|75959381|FG001|Overall Study|Lack of ovarian response|1|||
42150659|NCT00328926|75959382|FG002|Overall Study|Lack of ovarian response|0|||
42150660|NCT00319254|75959390|FG000|Overall Study|Withdrawal by Subject|4|||
42150661|NCT00319254|75959390|FG000|Overall Study|Death|46|||
42150662|NCT00319254|75959390|FG000|Overall Study|Lost to Follow-up|2|||
42150663|NCT00319254|75959390|FG000|Overall Study|Enrolled, Not Treated|2|||
42150664|NCT00319098|75959398|FG000|Overall Study|Serious adverse event|3|||
42150665|NCT00319098|75959399|FG001|Overall Study|Serious adverse event|0|||
42150666|NCT00319098|75959398|FG000|Overall Study|Adverse Event|20|||
42150667|NCT00319098|75959399|FG001|Overall Study|Adverse Event|1|||
42150668|NCT00319098|75959398|FG000|Overall Study|Withdrawal by Subject|37|||
42150669|NCT00319098|75959399|FG001|Overall Study|Withdrawal by Subject|8|||
42150670|NCT00319098|75959398|FG000|Overall Study|Migrated/moved from study area|2|||
42150671|NCT00319098|75959399|FG001|Overall Study|Migrated/moved from study area|1|||
42150672|NCT00319098|75959398|FG000|Overall Study|Lost to Follow-up|37|||
42012946|NCT02085408|75819938|FG001|Step 2: Consolidation|Complicating Disease|2|||
42012947|NCT02085408|75819937|FG000|Step 2: Consolidation|Other|6|||
42012948|NCT02085408|75819938|FG001|Step 2: Consolidation|Other|6|||
42012949|NCT02085408|75819937|FG000|Step 2: Consolidation|Never started treatment|4|||
42150673|NCT00319098|75959399|FG001|Overall Study|Lost to Follow-up|13|||
42150674|NCT00319098|75959398|FG000|Overall Study|Others|33|||
42150675|NCT00319098|75959399|FG001|Overall Study|Others|8|||
42150676|NCT00319098|75959398|FG000|Overall Study|Protocol Violation|3|||
42150677|NCT00319098|75959399|FG001|Overall Study|Protocol Violation|1|||
42150678|NCT00347360|75959424|FG000|Overall Study|Adverse Event|1|||
42150679|NCT00347360|75959425|FG001|Overall Study|Adverse Event|2|||
42150680|NCT00347360|75959426|FG002|Overall Study|Adverse Event|0|||
42150681|NCT00347360|75959427|FG003|Overall Study|Adverse Event|4|||
42150682|NCT00347360|75959428|FG004|Overall Study|Adverse Event|1|||
42150683|NCT00347360|75959429|FG005|Overall Study|Adverse Event|2|||
42150684|NCT00347360|75959430|FG006|Overall Study|Adverse Event|2|||
42150685|NCT00347360|75959431|FG007|Overall Study|Adverse Event|0|||
42150686|NCT00347360|75959432|FG008|Overall Study|Adverse Event|2|||
42150687|NCT00347360|75959433|FG009|Overall Study|Adverse Event|3|||
42150688|NCT00347360|75959434|FG010|Overall Study|Adverse Event|3|||
42150689|NCT00347360|75959435|FG011|Overall Study|Adverse Event|1|||
42150690|NCT00347360|75959436|FG012|Overall Study|Adverse Event|3|||
42150691|NCT00347360|75959437|FG013|Overall Study|Adverse Event|2|||
42150692|NCT00347360|75959438|FG014|Overall Study|Adverse Event|2|||
42150693|NCT00347360|75959424|FG000|Overall Study|Lost to Follow-up|0|||
42150694|NCT00347360|75959425|FG001|Overall Study|Lost to Follow-up|0|||
42150695|NCT00347360|75959426|FG002|Overall Study|Lost to Follow-up|0|||
42150696|NCT00347360|75959427|FG003|Overall Study|Lost to Follow-up|2|||
42150697|NCT00347360|75959428|FG004|Overall Study|Lost to Follow-up|1|||
42150698|NCT00347360|75959429|FG005|Overall Study|Lost to Follow-up|1|||
42150699|NCT00347360|75959430|FG006|Overall Study|Lost to Follow-up|0|||
42150700|NCT00347360|75959431|FG007|Overall Study|Lost to Follow-up|1|||
42150701|NCT00347360|75959432|FG008|Overall Study|Lost to Follow-up|1|||
42150702|NCT00347360|75959433|FG009|Overall Study|Lost to Follow-up|2|||
42150703|NCT00347360|75959434|FG010|Overall Study|Lost to Follow-up|0|||
42150704|NCT00347360|75959435|FG011|Overall Study|Lost to Follow-up|0|||
42150705|NCT00347360|75959436|FG012|Overall Study|Lost to Follow-up|1|||
42150706|NCT00347360|75959437|FG013|Overall Study|Lost to Follow-up|0|||
42150707|NCT00347360|75959438|FG014|Overall Study|Lost to Follow-up|0|||
42012950|NCT02085408|75819938|FG001|Step 2: Consolidation|Never started treatment|3|||
42012951|NCT02085408|75819937|FG000|Step 3: Maintenance|Disease Progression|13|||
42012952|NCT02085408|75819938|FG001|Step 3: Maintenance|Disease Progression|11|||
42012953|NCT02085408|75819937|FG000|Step 3: Maintenance|Adverse Event|2|||
42012954|NCT02085408|75819938|FG001|Step 3: Maintenance|Adverse Event|4|||
42012955|NCT02085408|75819937|FG000|Step 3: Maintenance|Death|1|||
42012956|NCT02085408|75819938|FG001|Step 3: Maintenance|Death|2|||
42012957|NCT02085408|75819937|FG000|Step 3: Maintenance|Alternative Therapy|1|||
42012958|NCT02085408|75819938|FG001|Step 3: Maintenance|Alternative Therapy|1|||
42012959|NCT02085408|75819937|FG000|Step 3: Maintenance|Complicating Disease|0|||
42039817|NCT03136185|75848233|FG006|Overall Study|Physician Decision|1|||
42039818|NCT03136185|75848234|FG007|Overall Study|Physician Decision|0|||
42039819|NCT03136185|75848235|FG008|Overall Study|Physician Decision|1|||
42039820|NCT03136185|75848227|FG000|Overall Study|Protocol Defined Disease Progression|0|||
42039821|NCT03136185|75848228|FG001|Overall Study|Protocol Defined Disease Progression|0|||
42039822|NCT03136185|75848229|FG002|Overall Study|Protocol Defined Disease Progression|1|||
42150708|NCT00347360|75959424|FG000|Overall Study|Protocol Violation|2|||
42150709|NCT00347360|75959425|FG001|Overall Study|Protocol Violation|3|||
42150710|NCT00347360|75959426|FG002|Overall Study|Protocol Violation|1|||
42150711|NCT00347360|75959427|FG003|Overall Study|Protocol Violation|2|||
42150712|NCT00347360|75959428|FG004|Overall Study|Protocol Violation|1|||
42150713|NCT00347360|75959429|FG005|Overall Study|Protocol Violation|2|||
42012960|NCT02085408|75819938|FG001|Step 3: Maintenance|Complicating Disease|1|||
42039823|NCT03136185|75848230|FG003|Overall Study|Protocol Defined Disease Progression|0|||
42039824|NCT03136185|75848231|FG004|Overall Study|Protocol Defined Disease Progression|0|||
42039825|NCT03136185|75848232|FG005|Overall Study|Protocol Defined Disease Progression|1|||
42039826|NCT03136185|75848233|FG006|Overall Study|Protocol Defined Disease Progression|0|||
42039827|NCT03136185|75848234|FG007|Overall Study|Protocol Defined Disease Progression|1|||
42039828|NCT03136185|75848235|FG008|Overall Study|Protocol Defined Disease Progression|1|||
42039829|NCT03136185|75848227|FG000|Overall Study|Withdrawal by Subject|1|||
42039830|NCT03136185|75848228|FG001|Overall Study|Withdrawal by Subject|0|||
42039831|NCT03136185|75848229|FG002|Overall Study|Withdrawal by Subject|1|||
42039832|NCT03136185|75848230|FG003|Overall Study|Withdrawal by Subject|1|||
42039833|NCT03136185|75848231|FG004|Overall Study|Withdrawal by Subject|1|||
42039834|NCT03136185|75848232|FG005|Overall Study|Withdrawal by Subject|1|||
42039835|NCT03136185|75848233|FG006|Overall Study|Withdrawal by Subject|2|||
42039836|NCT03136185|75848234|FG007|Overall Study|Withdrawal by Subject|3|||
42039837|NCT03136185|75848235|FG008|Overall Study|Withdrawal by Subject|3|||
42039838|NCT03136185|75848227|FG000|Overall Study|Not Reported|4|||
42039839|NCT03136185|75848228|FG001|Overall Study|Not Reported|1|||
42039840|NCT03136185|75848229|FG002|Overall Study|Not Reported|0|||
42150714|NCT00347360|75959430|FG006|Overall Study|Protocol Violation|0|||
42039841|NCT03136185|75848230|FG003|Overall Study|Not Reported|1|||
42039842|NCT03136185|75848231|FG004|Overall Study|Not Reported|0|||
42150715|NCT00347360|75959431|FG007|Overall Study|Protocol Violation|0|||
42150716|NCT00347360|75959432|FG008|Overall Study|Protocol Violation|1|||
42150717|NCT00347360|75959433|FG009|Overall Study|Protocol Violation|2|||
42150718|NCT00347360|75959434|FG010|Overall Study|Protocol Violation|0|||
42150719|NCT00347360|75959435|FG011|Overall Study|Protocol Violation|0|||
42150720|NCT00347360|75959436|FG012|Overall Study|Protocol Violation|0|||
42150721|NCT00347360|75959437|FG013|Overall Study|Protocol Violation|1|||
42150722|NCT00347360|75959438|FG014|Overall Study|Protocol Violation|0|||
42150723|NCT00347360|75959424|FG000|Overall Study|Withdrawal by Subject|0|||
42012961|NCT02085408|75819937|FG000|Step 3: Maintenance|Other|3|||
42012962|NCT02085408|75819938|FG001|Step 3: Maintenance|Other|2|||
42012963|NCT02085408|75819937|FG000|Step 3: Maintenance|Never started treatment|5|||
42150724|NCT00347360|75959425|FG001|Overall Study|Withdrawal by Subject|1|||
42150725|NCT00347360|75959426|FG002|Overall Study|Withdrawal by Subject|2|||
42150726|NCT00347360|75959427|FG003|Overall Study|Withdrawal by Subject|4|||
42150727|NCT00347360|75959428|FG004|Overall Study|Withdrawal by Subject|1|||
42150728|NCT00347360|75959429|FG005|Overall Study|Withdrawal by Subject|2|||
42150729|NCT00347360|75959430|FG006|Overall Study|Withdrawal by Subject|1|||
42150730|NCT00347360|75959431|FG007|Overall Study|Withdrawal by Subject|1|||
42150731|NCT00347360|75959432|FG008|Overall Study|Withdrawal by Subject|1|||
42150732|NCT00347360|75959433|FG009|Overall Study|Withdrawal by Subject|1|||
42150733|NCT00347360|75959434|FG010|Overall Study|Withdrawal by Subject|0|||
42150734|NCT00347360|75959435|FG011|Overall Study|Withdrawal by Subject|3|||
42150735|NCT00347360|75959436|FG012|Overall Study|Withdrawal by Subject|4|||
42150736|NCT00347360|75959437|FG013|Overall Study|Withdrawal by Subject|2|||
42150737|NCT00347360|75959438|FG014|Overall Study|Withdrawal by Subject|1|||
42150738|NCT00347360|75959424|FG000|Overall Study|Lack of Efficacy|1|||
42150739|NCT00347360|75959425|FG001|Overall Study|Lack of Efficacy|1|||
42150740|NCT00347360|75959426|FG002|Overall Study|Lack of Efficacy|3|||
42150741|NCT00347360|75959427|FG003|Overall Study|Lack of Efficacy|1|||
42150742|NCT00347360|75959428|FG004|Overall Study|Lack of Efficacy|0|||
42150743|NCT00347360|75959429|FG005|Overall Study|Lack of Efficacy|1|||
42150744|NCT00347360|75959430|FG006|Overall Study|Lack of Efficacy|0|||
42150745|NCT00347360|75959431|FG007|Overall Study|Lack of Efficacy|1|||
42150746|NCT00347360|75959432|FG008|Overall Study|Lack of Efficacy|1|||
42150747|NCT00347360|75959433|FG009|Overall Study|Lack of Efficacy|0|||
42150748|NCT00347360|75959434|FG010|Overall Study|Lack of Efficacy|0|||
42150749|NCT00347360|75959435|FG011|Overall Study|Lack of Efficacy|0|||
42150750|NCT00347360|75959436|FG012|Overall Study|Lack of Efficacy|0|||
42150751|NCT00347360|75959437|FG013|Overall Study|Lack of Efficacy|0|||
42150752|NCT00347360|75959438|FG014|Overall Study|Lack of Efficacy|0|||
42150753|NCT00347360|75959424|FG000|Overall Study|Reason not listed/blank|1|||
42039843|NCT03136185|75848232|FG005|Overall Study|Not Reported|2|||
42039844|NCT03136185|75848233|FG006|Overall Study|Not Reported|1|||
42039845|NCT03136185|75848234|FG007|Overall Study|Not Reported|1|||
42039846|NCT03136185|75848235|FG008|Overall Study|Not Reported|0|||
42039847|NCT03125902|75848264|FG000|Overall Study|Death|52|||
42039848|NCT03125902|75848265|FG001|Overall Study|Death|123|||
42039849|NCT03125902|75848264|FG000|Overall Study|Lost to Follow-up|1|||
42039850|NCT03125902|75848265|FG001|Overall Study|Lost to Follow-up|0|||
42039851|NCT03125902|75848264|FG000|Overall Study|Mastectomy|0|||
42039852|NCT03125902|75848265|FG001|Overall Study|Mastectomy|1|||
42150754|NCT00347360|75959425|FG001|Overall Study|Reason not listed/blank|0|||
42150755|NCT00347360|75959426|FG002|Overall Study|Reason not listed/blank|0|||
42150756|NCT00347360|75959427|FG003|Overall Study|Reason not listed/blank|0|||
42150757|NCT00347360|75959428|FG004|Overall Study|Reason not listed/blank|0|||
42150758|NCT00347360|75959429|FG005|Overall Study|Reason not listed/blank|0|||
42150759|NCT00347360|75959430|FG006|Overall Study|Reason not listed/blank|1|||
42150760|NCT00347360|75959431|FG007|Overall Study|Reason not listed/blank|0|||
42150761|NCT00347360|75959432|FG008|Overall Study|Reason not listed/blank|0|||
42150762|NCT00347360|75959433|FG009|Overall Study|Reason not listed/blank|0|||
42150763|NCT00347360|75959434|FG010|Overall Study|Reason not listed/blank|0|||
42150764|NCT00347360|75959435|FG011|Overall Study|Reason not listed/blank|0|||
42150765|NCT00347360|75959436|FG012|Overall Study|Reason not listed/blank|0|||
42150766|NCT00347360|75959437|FG013|Overall Study|Reason not listed/blank|1|||
42150767|NCT00347360|75959438|FG014|Overall Study|Reason not listed/blank|0|||
42150768|NCT00347360|75959424|FG000|Overall Study|Per sponsors instruction|0|||
42150769|NCT00347360|75959425|FG001|Overall Study|Per sponsors instruction|1|||
42150770|NCT00347360|75959426|FG002|Overall Study|Per sponsors instruction|0|||
42150771|NCT00347360|75959427|FG003|Overall Study|Per sponsors instruction|0|||
42150772|NCT00347360|75959428|FG004|Overall Study|Per sponsors instruction|0|||
42150773|NCT00347360|75959429|FG005|Overall Study|Per sponsors instruction|0|||
42150774|NCT00347360|75959430|FG006|Overall Study|Per sponsors instruction|0|||
42150775|NCT00347360|75959431|FG007|Overall Study|Per sponsors instruction|0|||
42150776|NCT00347360|75959432|FG008|Overall Study|Per sponsors instruction|0|||
42150777|NCT00347360|75959433|FG009|Overall Study|Per sponsors instruction|0|||
42150778|NCT00347360|75959434|FG010|Overall Study|Per sponsors instruction|0|||
42150779|NCT00347360|75959435|FG011|Overall Study|Per sponsors instruction|0|||
42150780|NCT00347360|75959436|FG012|Overall Study|Per sponsors instruction|0|||
42150781|NCT00347360|75959437|FG013|Overall Study|Per sponsors instruction|0|||
42150782|NCT00347360|75959438|FG014|Overall Study|Per sponsors instruction|0|||
42150783|NCT00347360|75959424|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
42150784|NCT00347360|75959425|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
42150785|NCT00347360|75959426|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
42150786|NCT00347360|75959427|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
42150787|NCT00347360|75959428|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
42150788|NCT00347360|75959429|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
42150789|NCT00347360|75959430|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
42039853|NCT03125902|75848264|FG000|Overall Study|Physician Decision|1|||
42039854|NCT03125902|75848265|FG001|Overall Study|Physician Decision|0|||
42150790|NCT00347360|75959431|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
42150791|NCT00347360|75959432|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
42150792|NCT00347360|75959433|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
42150793|NCT00347360|75959434|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
42150794|NCT00347360|75959435|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
42150795|NCT00347360|75959436|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
42150796|NCT00347360|75959437|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
42150797|NCT00347360|75959438|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
42150798|NCT00347360|75959424|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
42150799|NCT00347360|75959425|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
42150800|NCT00347360|75959426|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
42150801|NCT00347360|75959427|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
42150802|NCT00347360|75959428|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
42150803|NCT00347360|75959429|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
42150804|NCT00347360|75959430|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
42150805|NCT00347360|75959431|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
42150806|NCT00347360|75959432|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
42150807|NCT00347360|75959433|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
42150808|NCT00347360|75959434|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
42150809|NCT00347360|75959435|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
42150810|NCT00347360|75959436|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
42150811|NCT00347360|75959437|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
42150812|NCT00347360|75959438|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
42150813|NCT00347360|75959424|FG000|Overall Study|Abnormal lab values|0|||
42150814|NCT00347360|75959425|FG001|Overall Study|Abnormal lab values|0|||
42150815|NCT00347360|75959426|FG002|Overall Study|Abnormal lab values|0|||
42150816|NCT00347360|75959427|FG003|Overall Study|Abnormal lab values|0|||
42150817|NCT00347360|75959428|FG004|Overall Study|Abnormal lab values|0|||
42150818|NCT00347360|75959429|FG005|Overall Study|Abnormal lab values|0|||
42150819|NCT00347360|75959430|FG006|Overall Study|Abnormal lab values|1|||
42150820|NCT00347360|75959431|FG007|Overall Study|Abnormal lab values|0|||
42150821|NCT00347360|75959432|FG008|Overall Study|Abnormal lab values|0|||
42150822|NCT00347360|75959433|FG009|Overall Study|Abnormal lab values|0|||
42150823|NCT00347360|75959434|FG010|Overall Study|Abnormal lab values|0|||
42150824|NCT00347360|75959435|FG011|Overall Study|Abnormal lab values|0|||
42150825|NCT00347360|75959436|FG012|Overall Study|Abnormal lab values|0|||
42150826|NCT00347360|75959437|FG013|Overall Study|Abnormal lab values|0|||
42150827|NCT00347360|75959438|FG014|Overall Study|Abnormal lab values|0|||
42150828|NCT00347360|75959424|FG000|Overall Study|PI recommended early withdrawal|0|||
42150829|NCT00347360|75959425|FG001|Overall Study|PI recommended early withdrawal|0|||
42150830|NCT00347360|75959426|FG002|Overall Study|PI recommended early withdrawal|0|||
42150831|NCT00347360|75959427|FG003|Overall Study|PI recommended early withdrawal|0|||
42150832|NCT00347360|75959428|FG004|Overall Study|PI recommended early withdrawal|0|||
42150833|NCT00347360|75959429|FG005|Overall Study|PI recommended early withdrawal|0|||
42150834|NCT00347360|75959430|FG006|Overall Study|PI recommended early withdrawal|0|||
42150835|NCT00347360|75959431|FG007|Overall Study|PI recommended early withdrawal|0|||
42150836|NCT00347360|75959432|FG008|Overall Study|PI recommended early withdrawal|0|||
42150837|NCT00347360|75959433|FG009|Overall Study|PI recommended early withdrawal|1|||
42150838|NCT00347360|75959434|FG010|Overall Study|PI recommended early withdrawal|0|||
42150839|NCT00347360|75959435|FG011|Overall Study|PI recommended early withdrawal|0|||
42150840|NCT00347360|75959436|FG012|Overall Study|PI recommended early withdrawal|0|||
42150841|NCT00347360|75959437|FG013|Overall Study|PI recommended early withdrawal|0|||
42150842|NCT00347360|75959438|FG014|Overall Study|PI recommended early withdrawal|0|||
42150843|NCT00347360|75959424|FG000|Overall Study|Did not meet criteria before ABPM|0|||
42150844|NCT00347360|75959425|FG001|Overall Study|Did not meet criteria before ABPM|0|||
42150845|NCT00347360|75959426|FG002|Overall Study|Did not meet criteria before ABPM|0|||
42150846|NCT00347360|75959427|FG003|Overall Study|Did not meet criteria before ABPM|0|||
42150847|NCT00347360|75959428|FG004|Overall Study|Did not meet criteria before ABPM|0|||
42150848|NCT00347360|75959429|FG005|Overall Study|Did not meet criteria before ABPM|0|||
42150849|NCT00347360|75959430|FG006|Overall Study|Did not meet criteria before ABPM|0|||
42150850|NCT00347360|75959431|FG007|Overall Study|Did not meet criteria before ABPM|0|||
42278180|NCT02413346|76109856|FG000|Overall Study|Lost to Follow-up|17|||
42150851|NCT00347360|75959432|FG008|Overall Study|Did not meet criteria before ABPM|0|||
42150852|NCT00347360|75959433|FG009|Overall Study|Did not meet criteria before ABPM|0|||
42150853|NCT00347360|75959434|FG010|Overall Study|Did not meet criteria before ABPM|1|||
42150854|NCT00347360|75959435|FG011|Overall Study|Did not meet criteria before ABPM|0|||
42150855|NCT00347360|75959436|FG012|Overall Study|Did not meet criteria before ABPM|0|||
42150856|NCT00347360|75959437|FG013|Overall Study|Did not meet criteria before ABPM|0|||
42150857|NCT00347360|75959438|FG014|Overall Study|Did not meet criteria before ABPM|0|||
42150858|NCT00347360|75959424|FG000|Overall Study|Randomized in error|0|||
42150859|NCT00347360|75959425|FG001|Overall Study|Randomized in error|0|||
42150860|NCT00347360|75959426|FG002|Overall Study|Randomized in error|0|||
42150861|NCT00347360|75959427|FG003|Overall Study|Randomized in error|0|||
42150862|NCT00347360|75959428|FG004|Overall Study|Randomized in error|0|||
42150863|NCT00347360|75959429|FG005|Overall Study|Randomized in error|0|||
42150864|NCT00347360|75959430|FG006|Overall Study|Randomized in error|0|||
42150865|NCT00347360|75959431|FG007|Overall Study|Randomized in error|0|||
42150866|NCT00347360|75959432|FG008|Overall Study|Randomized in error|0|||
42150867|NCT00347360|75959433|FG009|Overall Study|Randomized in error|0|||
42150868|NCT00347360|75959434|FG010|Overall Study|Randomized in error|0|||
42150869|NCT00347360|75959435|FG011|Overall Study|Randomized in error|1|||
42150870|NCT00347360|75959436|FG012|Overall Study|Randomized in error|0|||
42150871|NCT00347360|75959437|FG013|Overall Study|Randomized in error|0|||
42150872|NCT00347360|75959438|FG014|Overall Study|Randomized in error|0|||
42150873|NCT00347360|75959424|FG000|Overall Study|Failed inclusion criteria #4|0|||
42150874|NCT00347360|75959425|FG001|Overall Study|Failed inclusion criteria #4|0|||
42150875|NCT00347360|75959426|FG002|Overall Study|Failed inclusion criteria #4|0|||
42150876|NCT00347360|75959427|FG003|Overall Study|Failed inclusion criteria #4|0|||
42150877|NCT00347360|75959428|FG004|Overall Study|Failed inclusion criteria #4|0|||
42150878|NCT00347360|75959429|FG005|Overall Study|Failed inclusion criteria #4|0|||
42150879|NCT00347360|75959430|FG006|Overall Study|Failed inclusion criteria #4|0|||
42150880|NCT00347360|75959431|FG007|Overall Study|Failed inclusion criteria #4|0|||
42150881|NCT00347360|75959432|FG008|Overall Study|Failed inclusion criteria #4|0|||
42150882|NCT00347360|75959433|FG009|Overall Study|Failed inclusion criteria #4|0|||
42150883|NCT00347360|75959434|FG010|Overall Study|Failed inclusion criteria #4|0|||
42150884|NCT00347360|75959435|FG011|Overall Study|Failed inclusion criteria #4|1|||
42150885|NCT00347360|75959436|FG012|Overall Study|Failed inclusion criteria #4|0|||
42150886|NCT00347360|75959437|FG013|Overall Study|Failed inclusion criteria #4|0|||
42150887|NCT00347360|75959438|FG014|Overall Study|Failed inclusion criteria #4|0|||
42150888|NCT00347360|75959424|FG000|Overall Study|Prolonged duration between visits|0|||
42150889|NCT00347360|75959425|FG001|Overall Study|Prolonged duration between visits|0|||
42150890|NCT00347360|75959426|FG002|Overall Study|Prolonged duration between visits|0|||
42150891|NCT00347360|75959427|FG003|Overall Study|Prolonged duration between visits|0|||
42150892|NCT00347360|75959428|FG004|Overall Study|Prolonged duration between visits|0|||
42150893|NCT00347360|75959429|FG005|Overall Study|Prolonged duration between visits|0|||
42150894|NCT00347360|75959430|FG006|Overall Study|Prolonged duration between visits|0|||
42150895|NCT00347360|75959431|FG007|Overall Study|Prolonged duration between visits|0|||
42150896|NCT00347360|75959432|FG008|Overall Study|Prolonged duration between visits|0|||
42150897|NCT00347360|75959433|FG009|Overall Study|Prolonged duration between visits|0|||
42150898|NCT00347360|75959434|FG010|Overall Study|Prolonged duration between visits|0|||
42150899|NCT00347360|75959435|FG011|Overall Study|Prolonged duration between visits|0|||
42150900|NCT00347360|75959436|FG012|Overall Study|Prolonged duration between visits|1|||
42150901|NCT00347360|75959437|FG013|Overall Study|Prolonged duration between visits|0|||
42150902|NCT00347360|75959438|FG014|Overall Study|Prolonged duration between visits|0|||
42150903|NCT00347360|75959424|FG000|Overall Study|Subject left town, ran out of study drug|0|||
42150904|NCT00347360|75959425|FG001|Overall Study|Subject left town, ran out of study drug|0|||
42150905|NCT00347360|75959426|FG002|Overall Study|Subject left town, ran out of study drug|0|||
42150906|NCT00347360|75959427|FG003|Overall Study|Subject left town, ran out of study drug|0|||
42150907|NCT00347360|75959428|FG004|Overall Study|Subject left town, ran out of study drug|0|||
42150908|NCT00347360|75959429|FG005|Overall Study|Subject left town, ran out of study drug|0|||
42150909|NCT00347360|75959430|FG006|Overall Study|Subject left town, ran out of study drug|0|||
42150910|NCT00347360|75959431|FG007|Overall Study|Subject left town, ran out of study drug|0|||
42150911|NCT00347360|75959432|FG008|Overall Study|Subject left town, ran out of study drug|0|||
42150912|NCT00347360|75959433|FG009|Overall Study|Subject left town, ran out of study drug|0|||
42150913|NCT00347360|75959434|FG010|Overall Study|Subject left town, ran out of study drug|0|||
42150914|NCT00347360|75959435|FG011|Overall Study|Subject left town, ran out of study drug|0|||
42150915|NCT00347360|75959436|FG012|Overall Study|Subject left town, ran out of study drug|0|||
42150916|NCT00347360|75959437|FG013|Overall Study|Subject left town, ran out of study drug|1|||
42150917|NCT00347360|75959438|FG014|Overall Study|Subject left town, ran out of study drug|0|||
42150918|NCT00347360|75959424|FG000|Overall Study|Subject refuse to sign updated consent|0|||
42150919|NCT00347360|75959425|FG001|Overall Study|Subject refuse to sign updated consent|0|||
42150920|NCT00347360|75959426|FG002|Overall Study|Subject refuse to sign updated consent|0|||
42150921|NCT00347360|75959427|FG003|Overall Study|Subject refuse to sign updated consent|0|||
42150922|NCT00347360|75959428|FG004|Overall Study|Subject refuse to sign updated consent|0|||
42150923|NCT00347360|75959429|FG005|Overall Study|Subject refuse to sign updated consent|0|||
42150924|NCT00347360|75959430|FG006|Overall Study|Subject refuse to sign updated consent|0|||
42150925|NCT00347360|75959431|FG007|Overall Study|Subject refuse to sign updated consent|0|||
42150926|NCT00347360|75959432|FG008|Overall Study|Subject refuse to sign updated consent|0|||
42150927|NCT00347360|75959433|FG009|Overall Study|Subject refuse to sign updated consent|0|||
42150928|NCT00347360|75959434|FG010|Overall Study|Subject refuse to sign updated consent|0|||
42150929|NCT00347360|75959435|FG011|Overall Study|Subject refuse to sign updated consent|0|||
42150930|NCT00347360|75959436|FG012|Overall Study|Subject refuse to sign updated consent|0|||
42150931|NCT00347360|75959437|FG013|Overall Study|Subject refuse to sign updated consent|0|||
42150932|NCT00347360|75959438|FG014|Overall Study|Subject refuse to sign updated consent|1|||
42150933|NCT00347360|75959424|FG000|Overall Study|Visits conflicted with new job|0|||
42150934|NCT00347360|75959425|FG001|Overall Study|Visits conflicted with new job|0|||
42150935|NCT00347360|75959426|FG002|Overall Study|Visits conflicted with new job|0|||
42150936|NCT00347360|75959427|FG003|Overall Study|Visits conflicted with new job|0|||
42150937|NCT00347360|75959428|FG004|Overall Study|Visits conflicted with new job|0|||
42150938|NCT00347360|75959429|FG005|Overall Study|Visits conflicted with new job|0|||
42150939|NCT00347360|75959430|FG006|Overall Study|Visits conflicted with new job|1|||
42150940|NCT00347360|75959431|FG007|Overall Study|Visits conflicted with new job|0|||
42150941|NCT00347360|75959432|FG008|Overall Study|Visits conflicted with new job|0|||
42150942|NCT00347360|75959433|FG009|Overall Study|Visits conflicted with new job|0|||
42150943|NCT00347360|75959434|FG010|Overall Study|Visits conflicted with new job|0|||
42150944|NCT00347360|75959435|FG011|Overall Study|Visits conflicted with new job|0|||
42150945|NCT00347360|75959436|FG012|Overall Study|Visits conflicted with new job|0|||
42150946|NCT00347360|75959437|FG013|Overall Study|Visits conflicted with new job|0|||
42150947|NCT00347360|75959438|FG014|Overall Study|Visits conflicted with new job|0|||
42150948|NCT00319020|75959472|FG000|Overall Study|Death|2|||
42150949|NCT00319020|75959473|FG001|Overall Study|Death|2|||
42150950|NCT00319020|75959472|FG000|Overall Study|Withdrawal by Subject|4|||
42150951|NCT00319020|75959473|FG001|Overall Study|Withdrawal by Subject|1|||
42150952|NCT00319020|75959472|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
42150953|NCT00319020|75959473|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
42150954|NCT00319020|75959472|FG000|Overall Study|Administrative reason|0|||
42150955|NCT00319020|75959473|FG001|Overall Study|Administrative reason|5|||
42150956|NCT00319020|75959472|FG000|Overall Study|Disease progression|0|||
42150957|NCT00319020|75959473|FG001|Overall Study|Disease progression|2|||
42150958|NCT00319020|75959472|FG000|Overall Study|Transplant|0|||
42150959|NCT00319020|75959473|FG001|Overall Study|Transplant|1|||
42150960|NCT00319020|75959472|FG000|Overall Study|Treatment failure|0|||
42150961|NCT00319020|75959473|FG001|Overall Study|Treatment failure|1|||
42150962|NCT00319020|75959472|FG000|Overall Study|Adverse Event|0|||
42150963|NCT00319020|75959473|FG001|Overall Study|Adverse Event|1|||
42150964|NCT00352118|75959481|FG000|Overall Study|Physician Decision|4|||
42150965|NCT00318474|75959487|FG000|Overall Study|Adverse Event|1|||
42150966|NCT00318474|75959488|FG001|Overall Study|Adverse Event|1|||
42150967|NCT00318474|75959487|FG000|Overall Study|Lost to Follow-up|0|||
42150968|NCT00318474|75959488|FG001|Overall Study|Lost to Follow-up|1|||
42150969|NCT00318474|75959487|FG000|Overall Study|Pregnancy|0|||
42150970|NCT00318474|75959488|FG001|Overall Study|Pregnancy|2|||
42150971|NCT00318474|75959487|FG000|Overall Study|Protocol Violation|1|||
42150972|NCT00318474|75959488|FG001|Overall Study|Protocol Violation|0|||
42150973|NCT00318474|75959487|FG000|Overall Study|Withdrawal by Subject|3|||
42150974|NCT00318474|75959488|FG001|Overall Study|Withdrawal by Subject|2|||
42150975|NCT00318474|75959487|FG000|Overall Study|Fall in GFR|3|||
42150976|NCT00318474|75959488|FG001|Overall Study|Fall in GFR|3|||
42150977|NCT00318474|75959487|FG000|Overall Study|Post-therapy hyperflycemia|0|||
42150978|NCT00318474|75959488|FG001|Overall Study|Post-therapy hyperflycemia|1|||
42150979|NCT00318474|75959487|FG000|Overall Study|Trial terminated|10|||
42150980|NCT00318474|75959488|FG001|Overall Study|Trial terminated|7|||
42150981|NCT00350870|75959498|FG000|Overall Study|Withdrawal by Subject|21|||
42150982|NCT00350870|75959499|FG001|Overall Study|Withdrawal by Subject|17|||
42150983|NCT00350870|75959500|FG002|Overall Study|Withdrawal by Subject|15|||
42150984|NCT00350870|75959501|FG003|Overall Study|Withdrawal by Subject|14|||
42150985|NCT00350870|75959498|FG000|Overall Study|Physician Decision|1|||
42150986|NCT00350870|75959499|FG001|Overall Study|Physician Decision|0|||
42150987|NCT00350870|75959500|FG002|Overall Study|Physician Decision|1|||
42150988|NCT00350870|75959501|FG003|Overall Study|Physician Decision|1|||
42150989|NCT00350792|75959511|FG000|Overall Study|Adverse Event|11|||
42150990|NCT00350792|75959511|FG000|Overall Study|Death from Study Disease|1|||
42150991|NCT00350792|75959511|FG000|Overall Study|Death from Study Drug Toxicity|1|||
42278181|NCT02413346|76109857|FG001|Overall Study|Lost to Follow-up|21|||
42278182|NCT02413346|76109856|FG000|Overall Study|Protocol Violation|2|||
42150992|NCT00350792|75959511|FG000|Overall Study|Death Not Study Drug Related|2|||
42150993|NCT00350792|75959511|FG000|Overall Study|Protocol Violation|1|||
42150994|NCT00350792|75959511|FG000|Overall Study|Withdrawal by Subject|4|||
42150995|NCT00350792|75959511|FG000|Overall Study|Physician Decision|2|||
42150996|NCT00350792|75959511|FG000|Overall Study|Lack of Efficacy|11|||
42150997|NCT00317772|75959519|FG000|Overall Study|Adverse Event|0|||
42150998|NCT00317772|75959520|FG001|Overall Study|Adverse Event|0|||
42150999|NCT00317772|75959521|FG002|Overall Study|Adverse Event|0|||
42151000|NCT00317772|75959522|FG003|Overall Study|Adverse Event|2|||
42151001|NCT00317772|75959519|FG000|Overall Study|Disease Progression|2|||
42151002|NCT00317772|75959520|FG001|Overall Study|Disease Progression|2|||
42151003|NCT00317772|75959521|FG002|Overall Study|Disease Progression|1|||
42151004|NCT00317772|75959522|FG003|Overall Study|Disease Progression|7|||
42151005|NCT00350636|75959535|FG000|Overall Study|Adverse Event|19|||
42151006|NCT00350636|75959536|FG001|Overall Study|Adverse Event|13|||
42151007|NCT00350636|75959535|FG000|Overall Study|Protocol Violation|1|||
42151008|NCT00350636|75959536|FG001|Overall Study|Protocol Violation|3|||
42151009|NCT00350636|75959535|FG000|Overall Study|Withdrawal by Subject|13|||
42151010|NCT00350636|75959536|FG001|Overall Study|Withdrawal by Subject|17|||
42151011|NCT00350636|75959535|FG000|Overall Study|Lost to Follow-up|9|||
42151012|NCT00350636|75959536|FG001|Overall Study|Lost to Follow-up|8|||
42151013|NCT00350636|75959535|FG000|Overall Study|Physician Decision|0|||
42151014|NCT00350636|75959536|FG001|Overall Study|Physician Decision|2|||
42151015|NCT00350636|75959535|FG000|Overall Study|Other|1|||
42151016|NCT00350636|75959536|FG001|Overall Study|Other|2|||
42151017|NCT00346268|75959544|FG000|Overall Study|Adverse Event|1|||
42151018|NCT00346268|75959545|FG001|Overall Study|Adverse Event|0|||
42151019|NCT00346268|75959544|FG000|Overall Study|Protocol Violation|1|||
42151020|NCT00346268|75959545|FG001|Overall Study|Protocol Violation|0|||
42151021|NCT00346268|75959544|FG000|Overall Study|Participant refused|0|||
42151022|NCT00346268|75959545|FG001|Overall Study|Participant refused|3|||
42151023|NCT00327444|75959553|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
42151024|NCT00327444|75959554|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
42151025|NCT00327444|75959553|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
42151026|NCT00327444|75959554|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
42151027|NCT00327444|75959553|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
42151028|NCT00327444|75959554|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
42151029|NCT00327444|75959553|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
42151030|NCT00327444|75959554|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
42151031|NCT00327444|75959553|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
42151032|NCT00327444|75959554|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
42151033|NCT00327444|75959553|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
42151034|NCT00327444|75959554|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
42151035|NCT00327444|75959553|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
42151036|NCT00327444|75959554|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
42151037|NCT00327444|75959553|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
42151038|NCT00327444|75959554|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
42151039|NCT00337610|75959564|FG000|Overall Study|Adverse Event|2|||
42151040|NCT00337610|75959565|FG001|Overall Study|Adverse Event|2|||
42151041|NCT00337610|75959564|FG000|Overall Study|Death|0|||
42151042|NCT00337610|75959565|FG001|Overall Study|Death|1|||
42151043|NCT00337610|75959564|FG000|Overall Study|Lack of Efficacy|6|||
42151044|NCT00337610|75959565|FG001|Overall Study|Lack of Efficacy|3|||
42151045|NCT00337610|75959564|FG000|Overall Study|Lost to Follow-up|3|||
42151046|NCT00337610|75959565|FG001|Overall Study|Lost to Follow-up|3|||
42151047|NCT00337610|75959564|FG000|Overall Study|Withdrawal by Subject|6|||
42151048|NCT00337610|75959565|FG001|Overall Study|Withdrawal by Subject|5|||
42151049|NCT00316914|75959573|FG000|Overall Study|Withdrawal by Subject|5|||
42151050|NCT00316914|75959574|FG001|Overall Study|Withdrawal by Subject|3|||
42278183|NCT02413346|76109857|FG001|Overall Study|Protocol Violation|0|||
42278184|NCT02413346|76109856|FG000|Overall Study|Other Miscellaneous Reasons|4|||
42278185|NCT02413346|76109857|FG001|Overall Study|Other Miscellaneous Reasons|3|||
42278186|NCT03390101|76109870|FG000|Weeks 0-12|Withdrawal by Subject|0|||
42278187|NCT03390101|76109871|FG001|Weeks 0-12|Withdrawal by Subject|1|||
42278188|NCT03390101|76109872|FG002|Weeks 0-12|Withdrawal by Subject|1|||
42278189|NCT03390101|76109870|FG000|Weeks 0-12|Lost to Follow-up|0|||
42278190|NCT03390101|76109871|FG001|Weeks 0-12|Lost to Follow-up|1|||
42278191|NCT03390101|76109872|FG002|Weeks 0-12|Lost to Follow-up|0|||
42278192|NCT03390101|76109870|FG000|Weeks 12-54|Withdrawal by Subject|0|||
42278193|NCT03390101|76109871|FG001|Weeks 12-54|Withdrawal by Subject|3|||
42278194|NCT03390101|76109872|FG002|Weeks 12-54|Withdrawal by Subject|1|||
42278195|NCT03390101|76109870|FG000|Weeks 12-54|Pregnancy|1|||
42278196|NCT03390101|76109871|FG001|Weeks 12-54|Pregnancy|0|||
42351260|NCT01546623|76191141|FG001|Overall Study|Did Not Receive Study Drug|1|||
42151051|NCT00316914|75959573|FG000|Overall Study|Adverse Event|8|||
42151052|NCT00316914|75959574|FG001|Overall Study|Adverse Event|7|||
42151053|NCT00316914|75959573|FG000|Overall Study|Other Problems|6|||
42151054|NCT00316914|75959574|FG001|Overall Study|Other Problems|11|||
42151055|NCT00316914|75959573|FG000|Overall Study|Missing end of treatment documentation|14|||
42151056|NCT00316914|75959574|FG001|Overall Study|Missing end of treatment documentation|15|||
42151057|NCT00336284|75959582|FG000|Overall Study|Death|52|||
42151058|NCT00336284|75959583|FG001|Overall Study|Death|26|||
42151059|NCT00336284|75959582|FG000|Overall Study|Lost to Follow-up|82|||
42151060|NCT00336284|75959583|FG001|Overall Study|Lost to Follow-up|61|||
42151061|NCT00336284|75959582|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
42278197|NCT03390101|76109872|FG002|Weeks 12-54|Pregnancy|0|||
42278198|NCT03390101|76109870|FG000|Weeks 12-54|Adverse Event|2|||
42151062|NCT00336284|75959583|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
42151063|NCT00316602|75959591|FG000|Overall Study|Withdrawal by Subject|3|||
42151064|NCT00316602|75959592|FG001|Overall Study|Withdrawal by Subject|2|||
42151065|NCT00316602|75959591|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
42151066|NCT00316602|75959592|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
42151067|NCT00316602|75959591|FG000|Overall Study|Adverse Event|1|||
42151068|NCT00316602|75959592|FG001|Overall Study|Adverse Event|0|||
42151069|NCT00316602|75959591|FG000|Overall Study|Other|3|||
42012964|NCT02085408|75819938|FG001|Step 3: Maintenance|Never started treatment|1|||
42012965|NCT01475786|75819956|FG000|Overall Study|Adverse Event|0|||
42012966|NCT01475786|75819957|FG001|Overall Study|Adverse Event|1|||
42012967|NCT01475786|75819958|FG002|Overall Study|Adverse Event|0|||
42012968|NCT01475786|75819956|FG000|Overall Study|Lost to Follow-up|1|||
42151070|NCT00316602|75959592|FG001|Overall Study|Other|6|||
42151071|NCT00335972|75959600|FG000|Overall Study|not given treatments|0|||
42151072|NCT00335972|75959601|FG001|Overall Study|not given treatments|3|||
42151073|NCT00346034|75959607|FG000|Overall Study|Adverse Event|34|||
42151074|NCT00346034|75959607|FG000|Overall Study|Lack of Efficacy|8|||
42151075|NCT00346034|75959607|FG000|Overall Study|Withdrawal by Subject|13|||
42151076|NCT00346034|75959607|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
42151077|NCT00346034|75959607|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
42151078|NCT00345878|75959613|FG000|Overall Study|Adverse Event|1|||
42151079|NCT00345878|75959614|FG001|Overall Study|Adverse Event|0|||
42151080|NCT00345878|75959613|FG000|Overall Study|Lost to Follow-up|2|||
42151081|NCT00345878|75959614|FG001|Overall Study|Lost to Follow-up|1|||
42151082|NCT00345878|75959613|FG000|Overall Study|Other|1|||
42151083|NCT00345878|75959614|FG001|Overall Study|Other|0|||
42151084|NCT00335738|75959622|FG000|Overall Study|Physician Decision|6|||
42151085|NCT00335738|75959623|FG001|Overall Study|Physician Decision|0|||
42151086|NCT00335738|75959622|FG000|Overall Study|Withdrawal by Subject|2|||
42151087|NCT00335738|75959623|FG001|Overall Study|Withdrawal by Subject|0|||
42151088|NCT00335738|75959622|FG000|Overall Study|Ineligible|3|||
42151089|NCT00335738|75959623|FG001|Overall Study|Ineligible|4|||
42151090|NCT00334958|75959641|FG000|Overall Study|Medication Noncompliance|0|||
42151091|NCT00334958|75959642|FG001|Overall Study|Medication Noncompliance|3|||
42151092|NCT00334958|75959641|FG000|Overall Study|Protocol Violation|2|||
42151093|NCT00334958|75959642|FG001|Overall Study|Protocol Violation|2|||
42151094|NCT00334958|75959641|FG000|Overall Study|Request of the investigator or sponsor|0|||
42151095|NCT00334958|75959642|FG001|Overall Study|Request of the investigator or sponsor|1|||
42151096|NCT00334958|75959641|FG000|Overall Study|Withdrawal by Subject|7|||
42151097|NCT00334958|75959642|FG001|Overall Study|Withdrawal by Subject|4|||
42151098|NCT00334958|75959641|FG000|Overall Study|Adverse Event|27|||
42151099|NCT00334958|75959642|FG001|Overall Study|Adverse Event|12|||
42151100|NCT00334958|75959641|FG000|Overall Study|Other|1|||
42151101|NCT00334958|75959642|FG001|Overall Study|Other|2|||
42151102|NCT00326898|75959651|FG000|Overall Study|Disease progression|52|||
42151103|NCT00326898|75959652|FG001|Overall Study|Disease progression|54|||
42151104|NCT00326898|75959653|FG002|Overall Study|Disease progression|102|||
42151105|NCT00326898|75959651|FG000|Overall Study|Adverse Event|124|||
42151106|NCT00326898|75959652|FG001|Overall Study|Adverse Event|128|||
42151107|NCT00326898|75959653|FG002|Overall Study|Adverse Event|33|||
42151108|NCT00326898|75959651|FG000|Overall Study|Death|2|||
42151109|NCT00326898|75959652|FG001|Overall Study|Death|0|||
42151110|NCT00326898|75959653|FG002|Overall Study|Death|0|||
42151111|NCT00326898|75959651|FG000|Overall Study|Withdrawal by Subject|134|||
42151112|NCT00326898|75959652|FG001|Overall Study|Withdrawal by Subject|128|||
42151113|NCT00326898|75959653|FG002|Overall Study|Withdrawal by Subject|32|||
42151114|NCT00326898|75959651|FG000|Overall Study|Alternative therapy|1|||
42151115|NCT00326898|75959652|FG001|Overall Study|Alternative therapy|0|||
42151116|NCT00326898|75959653|FG002|Overall Study|Alternative therapy|0|||
42278199|NCT03390101|76109871|FG001|Weeks 12-54|Adverse Event|1|||
42012969|NCT01475786|75819957|FG001|Overall Study|Lost to Follow-up|2|||
42012970|NCT01475786|75819958|FG002|Overall Study|Lost to Follow-up|1|||
42012971|NCT01475786|75819956|FG000|Overall Study|Withdrawal by Subject|0|||
42151117|NCT00326898|75959651|FG000|Overall Study|Other complicating disease|5|||
42151118|NCT00326898|75959652|FG001|Overall Study|Other complicating disease|5|||
42151119|NCT00326898|75959653|FG002|Overall Study|Other complicating disease|4|||
42151120|NCT00326898|75959651|FG000|Overall Study|Other/Missing/Unknown|33|||
42151121|NCT00326898|75959652|FG001|Overall Study|Other/Missing/Unknown|28|||
42012972|NCT01475786|75819957|FG001|Overall Study|Withdrawal by Subject|1|||
42151122|NCT00326898|75959653|FG002|Overall Study|Other/Missing/Unknown|32|||
42151123|NCT00326118|75959663|FG000|Active Phase|Withdrawal by Subject|4|||
42151124|NCT00326118|75959664|FG001|Active Phase|Withdrawal by Subject|1|||
42151125|NCT00334802|75959673|FG000|Overall Study|Progressive Disease|2|||
42151126|NCT00334802|75959674|FG001|Overall Study|Progressive Disease|24|||
42151127|NCT00334802|75959673|FG000|Overall Study|Toxicity|1|||
42151128|NCT00334802|75959674|FG001|Overall Study|Toxicity|5|||
42278200|NCT03390101|76109872|FG002|Weeks 12-54|Adverse Event|1|||
42151129|NCT00334802|75959673|FG000|Overall Study|Lack of Efficacy|1|||
42151130|NCT00334802|75959674|FG001|Overall Study|Lack of Efficacy|3|||
42151131|NCT00334802|75959673|FG000|Overall Study|Patient Condition Aggrevated|1|||
42151132|NCT00334802|75959674|FG001|Overall Study|Patient Condition Aggrevated|0|||
42151133|NCT00334802|75959673|FG000|Overall Study|Physician Decision|1|||
42151134|NCT00334802|75959674|FG001|Overall Study|Physician Decision|0|||
42151135|NCT00334802|75959673|FG000|Overall Study|Withdrawal by Subject|0|||
42151136|NCT00334802|75959674|FG001|Overall Study|Withdrawal by Subject|4|||
42151137|NCT00334802|75959673|FG000|Overall Study|Adverse Event|0|||
42151138|NCT00334802|75959674|FG001|Overall Study|Adverse Event|3|||
42151139|NCT00334802|75959673|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
42151140|NCT00334802|75959674|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
42151141|NCT00307164|75959685|FG000|Overall Study|Death|1|||
42151142|NCT00307164|75959686|FG001|Overall Study|Death|0|||
42151143|NCT00307164|75959685|FG000|Overall Study|Severe debilitation, unable to continue|1|||
42151144|NCT00307164|75959686|FG001|Overall Study|Severe debilitation, unable to continue|0|||
42151145|NCT00307164|75959685|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
42151146|NCT00307164|75959686|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
42151147|NCT00307164|75959685|FG000|Overall Study|Withdrawal by Subject|1|||
42151148|NCT00307164|75959686|FG001|Overall Study|Withdrawal by Subject|8|||
42151149|NCT00307164|75959685|FG000|Overall Study|Not compliant with requirements|4|||
42151150|NCT00307164|75959686|FG001|Overall Study|Not compliant with requirements|4|||
42151151|NCT00307164|75959685|FG000|Overall Study|Lost to Follow-up|6|||
42151152|NCT00307164|75959686|FG001|Overall Study|Lost to Follow-up|1|||
42151153|NCT03827564|75959694|FG000|Overall Study|Discontinued due to Study Termination|1|||
42151154|NCT03827564|75959695|FG001|Overall Study|Discontinued due to Study Termination|0|||
42151155|NCT00307086|75959701|FG000|Overall Study|ineligible|5|||
42151156|NCT00325416|75959707|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
42151157|NCT00325416|75959708|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
42151158|NCT00325416|75959707|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
42151159|NCT00325416|75959708|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
42151160|NCT00325416|75959707|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
42151161|NCT00325416|75959708|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
42151162|NCT00325416|75959707|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
42151163|NCT00325416|75959708|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
42151164|NCT00325416|75959707|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
42151165|NCT00325416|75959708|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
42151166|NCT00325416|75959707|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
42151167|NCT00325416|75959708|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
42151168|NCT00314808|75959714|FG000|Overall Study|Disease Progression without AE|4|||
42151169|NCT00314808|75959714|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
42151170|NCT00314574|75959720|FG000|Overall Study|Death|3|||
42151171|NCT00314574|75959721|FG001|Overall Study|Death|0|||
42151172|NCT00314574|75959720|FG000|Overall Study|Adverse Event|11|||
42151173|NCT00314574|75959721|FG001|Overall Study|Adverse Event|16|||
42151174|NCT00314574|75959720|FG000|Overall Study|Lost to Follow-up|19|||
42151175|NCT00314574|75959721|FG001|Overall Study|Lost to Follow-up|25|||
42151176|NCT00314574|75959720|FG000|Overall Study|Withdrawal by Subject|33|||
42151177|NCT00314574|75959721|FG001|Overall Study|Withdrawal by Subject|22|||
42151178|NCT00314574|75959720|FG000|Overall Study|Physician Decision|22|||
42151179|NCT00314574|75959721|FG001|Overall Study|Physician Decision|15|||
42151180|NCT00314574|75959720|FG000|Overall Study|Pregnancy|6|||
42151181|NCT00314574|75959721|FG001|Overall Study|Pregnancy|4|||
42151182|NCT00314574|75959720|FG000|Overall Study|Data unknown at database lock|0|||
42151183|NCT00314574|75959721|FG001|Overall Study|Data unknown at database lock|1|||
42151184|NCT00314340|75959727|FG000|Overall Study|lost interest|1|||
42151185|NCT00306852|75959735|FG000|Overall Study|Death|14|||
42151186|NCT00306852|75959736|FG001|Overall Study|Death|14|||
42151187|NCT00306852|75959735|FG000|Overall Study|Lost to Follow-up|15|||
42351261|NCT01546155|76191147|FG000|Overall Study|could not tolerate long scan duration|3|||
42151188|NCT00306852|75959736|FG001|Overall Study|Lost to Follow-up|24|||
42151189|NCT00314262|75959742|FG000|Overall Study|Adverse Event|2|||
42151190|NCT00314262|75959742|FG000|Overall Study|Withdrawal by Subject|2|||
42151191|NCT00314262|75959742|FG000|Overall Study|Physician Decision|1|||
42151192|NCT00333866|75959750|FG000|Overall Study|Adverse Event|23|||
42151193|NCT00333866|75959751|FG001|Overall Study|Adverse Event|37|||
42151194|NCT00333866|75959752|FG002|Overall Study|Adverse Event|38|||
42039855|NCT03125902|75848264|FG000|Overall Study|Withdrawal by Subject|13|||
42151195|NCT00333866|75959753|FG003|Overall Study|Adverse Event|47|||
42151196|NCT00333866|75959750|FG000|Overall Study|Other|3|||
42151197|NCT00333866|75959751|FG001|Overall Study|Other|2|||
42151198|NCT00333866|75959752|FG002|Overall Study|Other|2|||
42151199|NCT00333866|75959753|FG003|Overall Study|Other|2|||
42151200|NCT00333866|75959750|FG000|Overall Study|Lack of Efficacy|8|||
42151201|NCT00333866|75959751|FG001|Overall Study|Lack of Efficacy|6|||
42151202|NCT00333866|75959752|FG002|Overall Study|Lack of Efficacy|3|||
42151203|NCT00333866|75959753|FG003|Overall Study|Lack of Efficacy|5|||
42151204|NCT00333866|75959750|FG000|Overall Study|Lost to Follow-up|1|||
42151205|NCT00333866|75959751|FG001|Overall Study|Lost to Follow-up|2|||
42151206|NCT00333866|75959752|FG002|Overall Study|Lost to Follow-up|2|||
42151207|NCT00333866|75959753|FG003|Overall Study|Lost to Follow-up|2|||
42151208|NCT00333866|75959750|FG000|Overall Study|Withdrawal by Subject|8|||
42151209|NCT00333866|75959751|FG001|Overall Study|Withdrawal by Subject|14|||
42151210|NCT00333866|75959752|FG002|Overall Study|Withdrawal by Subject|4|||
42151211|NCT00333866|75959753|FG003|Overall Study|Withdrawal by Subject|9|||
42151212|NCT00333866|75959750|FG000|Overall Study|Randomized but not Treated|5|||
42151213|NCT00333866|75959751|FG001|Overall Study|Randomized but not Treated|3|||
42151214|NCT00333866|75959752|FG002|Overall Study|Randomized but not Treated|2|||
42151215|NCT00333866|75959753|FG003|Overall Study|Randomized but not Treated|1|||
42151216|NCT00324740|75959763|FG000|Overall Study|Withdrawal by Subject|1|||
42151217|NCT00324740|75959764|FG001|Overall Study|Withdrawal by Subject|0|||
42151218|NCT00324740|75959765|FG002|Overall Study|Withdrawal by Subject|1|||
42151219|NCT00333788|75959772|FG000|Overall Study|Adverse Event|44|||
42151220|NCT00333788|75959772|FG000|Overall Study|Lack of Efficacy|80|||
42151221|NCT00333788|75959772|FG000|Overall Study|Lost to Follow-up|2|||
42151222|NCT00333788|75959772|FG000|Overall Study|Withdrawal by Subject|24|||
42151223|NCT00333788|75959772|FG000|Overall Study|Other: Non-compliance|2|||
42151224|NCT00333788|75959772|FG000|Overall Study|Other: Moved|2|||
42151225|NCT00333788|75959772|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
42151226|NCT00333788|75959772|FG000|Overall Study|Other: Investigator decision|1|||
42151227|NCT00333788|75959772|FG000|Overall Study|Other: Quality of life concern|1|||
42151228|NCT00333788|75959772|FG000|Overall Study|Other: Sponsor decision|1|||
42151229|NCT00333788|75959772|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
42151230|NCT00333788|75959772|FG000|Overall Study|Other: Medical monitor decision|1|||
42151231|NCT00333788|75959772|FG000|Overall Study|Other: Physician decision|1|||
42151232|NCT00333788|75959772|FG000|Overall Study|Other: Signed consent for another study|1|||
42151233|NCT00324116|75959776|FG000|Overall Study|Adverse Event|5|||
42151234|NCT00324116|75959776|FG000|Overall Study|Lack of Efficacy|17|||
42151235|NCT00324116|75959776|FG000|Overall Study|Withdrawal by Subject|5|||
42151236|NCT00324116|75959776|FG000|Overall Study|Other|5|||
42151237|NCT00332696|75959782|FG000|Overall Study|Death|24|||
42151238|NCT00332696|75959783|FG001|Overall Study|Death|14|||
42151239|NCT00332696|75959782|FG000|Overall Study|Insufficient therapeutic effect|4|||
42151240|NCT00332696|75959783|FG001|Overall Study|Insufficient therapeutic effect|11|||
42151241|NCT00332696|75959782|FG000|Overall Study|Adverse Event|1|||
42151242|NCT00332696|75959783|FG001|Overall Study|Adverse Event|2|||
42151243|NCT00332696|75959782|FG000|Overall Study|Condition does not justify treatment|0|||
42151244|NCT00332696|75959783|FG001|Overall Study|Condition does not justify treatment|2|||
42151245|NCT00332696|75959782|FG000|Overall Study|Lost to Follow-up|0|||
42151246|NCT00332696|75959783|FG001|Overall Study|Lost to Follow-up|1|||
42151247|NCT00332696|75959782|FG000|Overall Study|Withdrawal by Subject|1|||
42151248|NCT00332696|75959783|FG001|Overall Study|Withdrawal by Subject|0|||
42151249|NCT00313716|75959795|FG000|Overall Study|Death|3|||
42151250|NCT00313716|75959796|FG001|Overall Study|Death|2|||
42151251|NCT00313716|75959797|FG002|Overall Study|Death|9|||
42151252|NCT00313716|75959798|FG003|Overall Study|Death|3|||
42151253|NCT00313716|75959799|FG004|Overall Study|Death|5|||
42151254|NCT00313716|75959800|FG005|Overall Study|Death|9|||
42151255|NCT00313716|75959795|FG000|Overall Study|Lost to Follow-up|2|||
42151256|NCT00313716|75959796|FG001|Overall Study|Lost to Follow-up|5|||
42151257|NCT00313716|75959797|FG002|Overall Study|Lost to Follow-up|2|||
42151258|NCT00313716|75959798|FG003|Overall Study|Lost to Follow-up|1|||
42151259|NCT00313716|75959799|FG004|Overall Study|Lost to Follow-up|0|||
42151260|NCT00313716|75959800|FG005|Overall Study|Lost to Follow-up|4|||
42151261|NCT00313716|75959795|FG000|Overall Study|Withdrawal by Subject|0|||
42151262|NCT00313716|75959796|FG001|Overall Study|Withdrawal by Subject|1|||
42151263|NCT00313716|75959797|FG002|Overall Study|Withdrawal by Subject|1|||
42151264|NCT00313716|75959798|FG003|Overall Study|Withdrawal by Subject|0|||
42039856|NCT03125902|75848265|FG001|Overall Study|Withdrawal by Subject|25|||
42151265|NCT00313716|75959799|FG004|Overall Study|Withdrawal by Subject|1|||
42151266|NCT00313716|75959800|FG005|Overall Study|Withdrawal by Subject|0|||
42039857|NCT03125902|75848264|FG000|Overall Study|Study is ongoing|153|||
42151267|NCT00313170|75959821|FG000|Overall Study|Death|2|||
42151268|NCT00313170|75959822|FG001|Overall Study|Death|4|||
42151269|NCT00313170|75959823|FG002|Overall Study|Death|2|||
42151270|NCT00313170|75959821|FG000|Overall Study|Adverse Event|1|||
42151271|NCT00313170|75959822|FG001|Overall Study|Adverse Event|2|||
42151272|NCT00313170|75959823|FG002|Overall Study|Adverse Event|0|||
42151273|NCT00313170|75959821|FG000|Overall Study|Disease progression|31|||
42151274|NCT00313170|75959822|FG001|Overall Study|Disease progression|26|||
42151275|NCT00313170|75959823|FG002|Overall Study|Disease progression|27|||
42151276|NCT00313170|75959821|FG000|Overall Study|Withdrawal by Subject|1|||
42151277|NCT00313170|75959822|FG001|Overall Study|Withdrawal by Subject|0|||
42151278|NCT00313170|75959823|FG002|Overall Study|Withdrawal by Subject|1|||
42151279|NCT00313170|75959821|FG000|Overall Study|Incorrect enrollment|0|||
42151280|NCT00313170|75959822|FG001|Overall Study|Incorrect enrollment|2|||
42151281|NCT00313170|75959823|FG002|Overall Study|Incorrect enrollment|1|||
42151282|NCT00313170|75959821|FG000|Overall Study|Lost to Follow-up|0|||
42151283|NCT00313170|75959822|FG001|Overall Study|Lost to Follow-up|0|||
42278201|NCT02732639|76109880|FG000|Overall Study|Lost to Follow-up|1|||
42278202|NCT02732561|76109886|FG000|Overall Study|Lost to Follow-up|1|||
42278203|NCT02732561|76109887|FG001|Overall Study|Lost to Follow-up|1|||
42278204|NCT02732561|76109886|FG000|Overall Study|Withdrawal by Subject|1|||
42278205|NCT02732561|76109887|FG001|Overall Study|Withdrawal by Subject|0|||
42278206|NCT02412878|76109895|FG000|Overall Study|Withdrawal by Subject|19|||
42278207|NCT02412878|76109896|FG001|Overall Study|Withdrawal by Subject|10|||
42278208|NCT02412878|76109895|FG000|Overall Study|Lost to Follow-up|2|||
42278209|NCT02412878|76109896|FG001|Overall Study|Lost to Follow-up|3|||
42278210|NCT02380742|76109904|FG000|Overall Study|Withdrawal by Subject|1|||
42278211|NCT02380742|76109905|FG001|Overall Study|Withdrawal by Subject|0|||
42278212|NCT02922725|76109914|FG000|Overall Study|Withdrawal by Subject|1|||
42278213|NCT02922725|76109915|FG001|Overall Study|Withdrawal by Subject|0|||
42278214|NCT02922725|76109916|FG002|Overall Study|Withdrawal by Subject|0|||
42278215|NCT02805257|76109925|FG000|Overall Study|Lost to Follow-up|7|||
42278216|NCT02805257|76109926|FG001|Overall Study|Lost to Follow-up|6|||
42278217|NCT02805257|76109925|FG000|Overall Study|Death|0|||
42278218|NCT02805257|76109926|FG001|Overall Study|Death|1|||
42278219|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
42278220|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
42278221|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
42278222|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
42278223|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
42278224|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
42278225|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
42278226|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
42278227|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
42278228|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
42278229|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
42278230|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
42278231|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
42278232|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
42278233|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
42278234|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
42278235|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
42278236|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
42278237|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
42278238|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
42278239|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
42278240|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
42278241|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
42278242|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
42278243|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
42278244|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
42278245|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
42278246|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
42278247|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
42278248|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
42278249|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
42278250|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
42278251|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
42278252|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
42278253|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
42278254|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
42278255|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
42278256|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
42278257|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
42278258|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
42278259|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
42351262|NCT00636610|76191153|FG000|Overall Study|Adverse Event|4|||
42351263|NCT00636610|76191154|FG001|Overall Study|Adverse Event|4|||
42151284|NCT00313170|75959823|FG002|Overall Study|Lost to Follow-up|1|||
42278260|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
42151285|NCT00313170|75959821|FG000|Overall Study|Progression (investigators opinion)|1|||
42151286|NCT00313170|75959822|FG001|Overall Study|Progression (investigators opinion)|0|||
42151287|NCT00313170|75959823|FG002|Overall Study|Progression (investigators opinion)|0|||
42151288|NCT00332462|75959832|FG000|Overall Study|Adverse Event|5|||
42151289|NCT00332462|75959832|FG000|Overall Study|Abnormal Lab Value|1|||
42151290|NCT00332462|75959832|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
42151291|NCT00332462|75959832|FG000|Overall Study|no longer requires study drug|1|||
42151292|NCT00332462|75959832|FG000|Overall Study|Death|3|||
42151293|NCT00332462|75959832|FG000|Overall Study|Graft Loss|2|||
42151294|NCT00324038|75959841|FG000|Overall Study|Adverse Event|38|||
42151295|NCT00324038|75959842|FG001|Overall Study|Adverse Event|23|||
42151296|NCT00324038|75959841|FG000|Overall Study|Lack of Efficacy|5|||
42151297|NCT00324038|75959842|FG001|Overall Study|Lack of Efficacy|13|||
42151298|NCT00324038|75959841|FG000|Overall Study|Lost to Follow-up|0|||
42151299|NCT00324038|75959842|FG001|Overall Study|Lost to Follow-up|2|||
42151300|NCT00324038|75959841|FG000|Overall Study|Other|6|||
42151301|NCT00324038|75959842|FG001|Overall Study|Other|13|||
42151302|NCT00159861|75959850|FG000|Core Study - 16 Weeks|Death|3|||
42151303|NCT00159861|75959851|FG001|Core Study - 16 Weeks|Death|0|||
42151304|NCT00159861|75959850|FG000|Core Study - 16 Weeks|Adverse Event|12|||
42151305|NCT00159861|75959851|FG001|Core Study - 16 Weeks|Adverse Event|6|||
42151306|NCT00159861|75959850|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
42151307|NCT00159861|75959851|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
42151308|NCT00159861|75959850|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
42151309|NCT00159861|75959851|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
42151310|NCT00159861|75959850|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
42151311|NCT00159861|75959851|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
42151312|NCT00159861|75959850|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
42151313|NCT00159861|75959851|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
42151314|NCT00159861|75959850|FG000|Extension Study - up to 3 Years|Death|24|||
42151315|NCT00159861|75959851|FG001|Extension Study - up to 3 Years|Death|28|||
42151316|NCT00159861|75959850|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
42151317|NCT00159861|75959851|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
42151318|NCT00159861|75959850|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
42151319|NCT00159861|75959851|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
42151320|NCT00159861|75959850|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
42151321|NCT00159861|75959851|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
42151322|NCT00159861|75959850|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
42151323|NCT00159861|75959851|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
42151324|NCT00331760|75959864|FG000|Overall Study|Ineligible / no protocol treatment|15|||
42151325|NCT00331760|75959865|FG001|Overall Study|Ineligible / no protocol treatment|8|||
42151326|NCT00225147|75959876|FG000|Open-label Phase|Lost to Follow-up|0|||
42151327|NCT00225147|75959877|FG001|Open-label Phase|Lost to Follow-up|0|||
42151328|NCT00225147|75959878|FG002|Open-label Phase|Lost to Follow-up|0|||
42151329|NCT00225147|75959879|FG003|Open-label Phase|Lost to Follow-up|4|||
42151330|NCT00225147|75959876|FG000|Open-label Phase|Withdrawal by Subject|0|||
42151331|NCT00225147|75959877|FG001|Open-label Phase|Withdrawal by Subject|0|||
42151332|NCT00225147|75959878|FG002|Open-label Phase|Withdrawal by Subject|0|||
42151333|NCT00225147|75959879|FG003|Open-label Phase|Withdrawal by Subject|6|||
42151334|NCT00313014|75959894|FG000|Overall Study|Withdrawal by Subject|11|||
42151335|NCT00313014|75959895|FG001|Overall Study|Withdrawal by Subject|7|||
42151336|NCT00313014|75959896|FG002|Overall Study|Withdrawal by Subject|5|||
42151337|NCT00313014|75959894|FG000|Overall Study|Adverse Event|14|||
42151338|NCT00313014|75959895|FG001|Overall Study|Adverse Event|29|||
42151339|NCT00313014|75959896|FG002|Overall Study|Adverse Event|16|||
42151340|NCT00313014|75959894|FG000|Overall Study|Lost to Follow-up|7|||
42151341|NCT00313014|75959895|FG001|Overall Study|Lost to Follow-up|6|||
42151342|NCT00313014|75959896|FG002|Overall Study|Lost to Follow-up|10|||
42151343|NCT00313014|75959894|FG000|Overall Study|Administrative|9|||
42151344|NCT00313014|75959895|FG001|Overall Study|Administrative|6|||
42151345|NCT00313014|75959896|FG002|Overall Study|Administrative|14|||
42151346|NCT00313014|75959894|FG000|Overall Study|Lack of Efficacy|52|||
42278261|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
42012973|NCT01475786|75819958|FG002|Overall Study|Withdrawal by Subject|1|||
42012974|NCT01475786|75819956|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
42151347|NCT00313014|75959895|FG001|Overall Study|Lack of Efficacy|25|||
42151348|NCT00313014|75959896|FG002|Overall Study|Lack of Efficacy|16|||
42151349|NCT00157209|75959907|FG000|Overall Study|Ongoing at data cut-off|10|||
42151350|NCT00157209|75959908|FG001|Overall Study|Ongoing at data cut-off|0|||
42151351|NCT00312858|75959916|FG000|Overall Study|Adverse Event|0|||
42151352|NCT00312858|75959917|FG001|Overall Study|Adverse Event|1|||
42151353|NCT00312858|75959916|FG000|Overall Study|Lost to Follow-up|25|||
42151354|NCT00312858|75959917|FG001|Overall Study|Lost to Follow-up|42|||
42151355|NCT00312858|75959916|FG000|Overall Study|Protocol Violation|3|||
42151356|NCT00312858|75959917|FG001|Overall Study|Protocol Violation|8|||
42151357|NCT00312858|75959916|FG000|Overall Study|Withdraw by Participant|20|||
42151358|NCT00312858|75959917|FG001|Overall Study|Withdraw by Participant|20|||
42151359|NCT00312858|75959916|FG000|Overall Study|Participant Moved|11|||
42151360|NCT00312858|75959917|FG001|Overall Study|Participant Moved|10|||
42151361|NCT00312858|75959916|FG000|Overall Study|Other|9|||
42151362|NCT00312858|75959917|FG001|Overall Study|Other|12|||
42151363|NCT00312702|75959926|FG000|Immunization Phase|Lost to Follow-up|0|||
42151364|NCT00312702|75959927|FG001|Immunization Phase|Lost to Follow-up|1|||
42151365|NCT00312702|75959928|FG002|Immunization Phase|Lost to Follow-up|0|||
42151366|NCT00156819|75959939|FG000|Overall Study|Lost to Follow-up|1|||
42151367|NCT00156819|75959940|FG001|Overall Study|Lost to Follow-up|1|||
42151368|NCT00156819|75959941|FG002|Overall Study|Lost to Follow-up|3|||
42151369|NCT03825042|75959951|FG000|Overall Study|Adverse Event|1|||
42151370|NCT03825042|75959952|FG001|Overall Study|Adverse Event|0|||
42151371|NCT03825042|75959951|FG000|Overall Study|Withdrawal by Subject|1|||
42151372|NCT03825042|75959952|FG001|Overall Study|Withdrawal by Subject|0|||
42151373|NCT00129987|75959960|FG000|1st Educational Session|Withdrawal by Subject|141|||
42151374|NCT00129987|75959961|FG001|1st Educational Session|Withdrawal by Subject|109|||
42151375|NCT00129987|75959960|FG000|1 Year|Withdrawal by Subject|32|||
42151376|NCT00129987|75959961|FG001|1 Year|Withdrawal by Subject|21|||
42151377|NCT00224133|75959967|FG000|Overall Study|Adverse Event|93|||
42151378|NCT00224133|75959967|FG000|Overall Study|Protocol Violation|6|||
42151379|NCT00224133|75959967|FG000|Overall Study|Withdrawal by Subject|33|||
42151380|NCT00224133|75959967|FG000|Overall Study|Lack of Efficacy|58|||
42151381|NCT00224133|75959967|FG000|Overall Study|Lost to Follow-up|21|||
42151382|NCT00224133|75959967|FG000|Overall Study|Physician Decision|1|||
42151383|NCT00224133|75959967|FG000|Overall Study|Other|14|||
42151384|NCT00224055|75959973|FG000|Overall Study|Adverse Event|9|||
42151385|NCT00224055|75959974|FG001|Overall Study|Adverse Event|3|||
42151386|NCT00224055|75959973|FG000|Overall Study|Lost to Follow-up|1|||
42151387|NCT00224055|75959974|FG001|Overall Study|Lost to Follow-up|2|||
42151388|NCT00224055|75959973|FG000|Overall Study|Protocol Violation|1|||
42151389|NCT00224055|75959974|FG001|Overall Study|Protocol Violation|1|||
42151390|NCT00224055|75959973|FG000|Overall Study|Inclusion Violation|3|||
42151391|NCT00224055|75959974|FG001|Overall Study|Inclusion Violation|6|||
42151392|NCT00224055|75959973|FG000|Overall Study|Withdrawal by Subject|0|||
42151393|NCT00224055|75959974|FG001|Overall Study|Withdrawal by Subject|2|||
42151394|NCT00224055|75959973|FG000|Overall Study|Other|1|||
42151395|NCT00224055|75959974|FG001|Overall Study|Other|0|||
42151396|NCT00150345|75959982|FG000|Overall Study|Death|5|||
42151397|NCT00150345|75959983|FG001|Overall Study|Death|2|||
42151398|NCT00150345|75959982|FG000|Overall Study|Adverse Event|8|||
42151399|NCT00150345|75959983|FG001|Overall Study|Adverse Event|6|||
42151400|NCT00150345|75959982|FG000|Overall Study|Lack of Efficacy|5|||
42151401|NCT00150345|75959983|FG001|Overall Study|Lack of Efficacy|4|||
42151402|NCT00150345|75959982|FG000|Overall Study|Withdrawal by Subject|3|||
42151403|NCT00150345|75959983|FG001|Overall Study|Withdrawal by Subject|4|||
42151404|NCT00150345|75959982|FG000|Overall Study|Laboratory abnormality|1|||
42151405|NCT00150345|75959983|FG001|Overall Study|Laboratory abnormality|2|||
42151406|NCT00150345|75959982|FG000|Overall Study|Other|12|||
42151407|NCT00150345|75959983|FG001|Overall Study|Other|14|||
42151408|NCT00223977|75959993|FG000|Overall Study|Adverse Event|7|||
42151409|NCT00223977|75959994|FG001|Overall Study|Adverse Event|10|||
42151410|NCT00223977|75959995|FG002|Overall Study|Adverse Event|0|||
42151411|NCT00223977|75959993|FG000|Overall Study|Protocol Violation|0|||
42278262|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
42278263|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
42278264|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
42039858|NCT03125902|75848265|FG001|Overall Study|Study is ongoing|282|||
42039859|NCT02985957|75848288|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
42039860|NCT02985957|75848289|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
42039861|NCT02985957|75848290|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
42039862|NCT02985957|75848291|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
42039863|NCT02985957|75848292|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
42039864|NCT02985957|75848293|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
42039865|NCT02985957|75848294|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
42039866|NCT02985957|75848288|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
42039867|NCT02985957|75848289|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
42039868|NCT02985957|75848290|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
42039869|NCT02985957|75848291|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
42039870|NCT02985957|75848292|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
42151412|NCT00223977|75959994|FG001|Overall Study|Protocol Violation|0|||
42151413|NCT00223977|75959995|FG002|Overall Study|Protocol Violation|1|||
42151414|NCT00223977|75959993|FG000|Overall Study|Withdrawal by Subject|1|||
42151415|NCT00223977|75959994|FG001|Overall Study|Withdrawal by Subject|1|||
42151416|NCT00223977|75959995|FG002|Overall Study|Withdrawal by Subject|2|||
42151417|NCT00223977|75959993|FG000|Overall Study|Other|1|||
42151418|NCT00223977|75959994|FG001|Overall Study|Other|0|||
42151419|NCT00223977|75959995|FG002|Overall Study|Other|0|||
42151420|NCT00148941|75960007|FG000|Overall Study|Lost to Follow-up|17|||
42151421|NCT00148941|75960008|FG001|Overall Study|Lost to Follow-up|24|||
42151422|NCT00148941|75960009|FG002|Overall Study|Lost to Follow-up|18|||
42151423|NCT00148941|75960010|FG003|Overall Study|Lost to Follow-up|22|||
42151424|NCT00148941|75960007|FG000|Overall Study|Withdrawal by Subject|1|||
42151425|NCT00148941|75960008|FG001|Overall Study|Withdrawal by Subject|0|||
42151426|NCT00148941|75960009|FG002|Overall Study|Withdrawal by Subject|1|||
42151427|NCT00148941|75960010|FG003|Overall Study|Withdrawal by Subject|0|||
42151428|NCT00148941|75960007|FG000|Overall Study|Other|0|||
42151429|NCT00148941|75960008|FG001|Overall Study|Other|0|||
42151430|NCT00148941|75960009|FG002|Overall Study|Other|1|||
42151431|NCT00148941|75960010|FG003|Overall Study|Other|2|||
42151432|NCT00148317|75960020|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
42151433|NCT00148317|75960020|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
42151434|NCT00148317|75960020|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
42151435|NCT00323882|75960032|FG000|Overall Study|Adverse Event|2|||
42151436|NCT00323882|75960033|FG001|Overall Study|Adverse Event|1|||
42151437|NCT00323882|75960034|FG002|Overall Study|Adverse Event|1|||
42151438|NCT00323882|75960035|FG003|Overall Study|Adverse Event|1|||
42151439|NCT00323882|75960036|FG004|Overall Study|Adverse Event|3|||
42151440|NCT00323882|75960032|FG000|Overall Study|Disease Progression|6|||
42151441|NCT00323882|75960033|FG001|Overall Study|Disease Progression|4|||
42151442|NCT00323882|75960034|FG002|Overall Study|Disease Progression|10|||
42151443|NCT00323882|75960035|FG003|Overall Study|Disease Progression|5|||
42151444|NCT00323882|75960036|FG004|Overall Study|Disease Progression|22|||
42151445|NCT00323882|75960032|FG000|Overall Study|Death|0|||
42151446|NCT00323882|75960033|FG001|Overall Study|Death|1|||
42151447|NCT00323882|75960034|FG002|Overall Study|Death|1|||
42151448|NCT00323882|75960035|FG003|Overall Study|Death|0|||
42151449|NCT00323882|75960036|FG004|Overall Study|Death|5|||
42151450|NCT00323882|75960032|FG000|Overall Study|Lost to Follow-up|0|||
42151451|NCT00323882|75960033|FG001|Overall Study|Lost to Follow-up|0|||
42151452|NCT00323882|75960034|FG002|Overall Study|Lost to Follow-up|1|||
42151453|NCT00323882|75960035|FG003|Overall Study|Lost to Follow-up|0|||
42151454|NCT00323882|75960036|FG004|Overall Study|Lost to Follow-up|1|||
42151455|NCT00323882|75960032|FG000|Overall Study|Other|0|||
42151456|NCT00323882|75960033|FG001|Overall Study|Other|0|||
42151457|NCT00323882|75960034|FG002|Overall Study|Other|0|||
42151458|NCT00323882|75960035|FG003|Overall Study|Other|1|||
42151459|NCT00323882|75960036|FG004|Overall Study|Other|1|||
42151460|NCT00331682|75960057|FG000|Overall Study|Adverse Event|1|||
42151461|NCT00323492|75960063|FG000|Study Phase 1|Adverse Event|2|||
42151462|NCT00323492|75960064|FG001|Study Phase 1|Adverse Event|0|||
42151463|NCT00323492|75960065|FG002|Study Phase 1|Adverse Event|0|||
42151464|NCT00323492|75960063|FG000|Study Phase 2|Adverse Event|1|||
42151465|NCT00323492|75960064|FG001|Study Phase 2|Adverse Event|0|||
42151466|NCT00323492|75960065|FG002|Study Phase 2|Adverse Event|0|||
42151467|NCT00323492|75960063|FG000|Study Phase 2|Physician Decision|1|||
42151468|NCT00323492|75960064|FG001|Study Phase 2|Physician Decision|0|||
42151469|NCT00323492|75960065|FG002|Study Phase 2|Physician Decision|0|||
42151470|NCT00323492|75960063|FG000|Study Phase 2|Lost to Follow-up|1|||
42151471|NCT00323492|75960064|FG001|Study Phase 2|Lost to Follow-up|0|||
42151472|NCT00323492|75960065|FG002|Study Phase 2|Lost to Follow-up|0|||
42151473|NCT00323492|75960063|FG000|Study Phase 2|Withdrawal by Subject|0|||
42151474|NCT00323492|75960064|FG001|Study Phase 2|Withdrawal by Subject|1|||
42151475|NCT00323492|75960065|FG002|Study Phase 2|Withdrawal by Subject|0|||
42151476|NCT00323492|75960063|FG000|Study Phase 2|Noncompliance with study schedule|0|||
42151477|NCT00323492|75960064|FG001|Study Phase 2|Noncompliance with study schedule|0|||
42151478|NCT00323492|75960065|FG002|Study Phase 2|Noncompliance with study schedule|1|||
42151479|NCT00323492|75960063|FG000|Study Phase 2|Protocol Violation|1|||
42151480|NCT00323492|75960064|FG001|Study Phase 2|Protocol Violation|0|||
42151481|NCT00323492|75960065|FG002|Study Phase 2|Protocol Violation|0|||
42151482|NCT00331136|75960076|FG000|Overall Study|Adverse Event|3|||
42151483|NCT00331136|75960077|FG001|Overall Study|Adverse Event|5|||
42151484|NCT00331136|75960078|FG002|Overall Study|Adverse Event|0|||
42151485|NCT00331136|75960079|FG003|Overall Study|Adverse Event|1|||
42278265|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
42151486|NCT00331136|75960076|FG000|Overall Study|Withdrawal by Subject|0|||
42151487|NCT00331136|75960077|FG001|Overall Study|Withdrawal by Subject|1|||
42151488|NCT00331136|75960078|FG002|Overall Study|Withdrawal by Subject|0|||
42151489|NCT00331136|75960079|FG003|Overall Study|Withdrawal by Subject|0|||
42151490|NCT00331136|75960076|FG000|Overall Study|Lost to Follow-up|0|||
42151491|NCT00331136|75960077|FG001|Overall Study|Lost to Follow-up|1|||
42151492|NCT00331136|75960078|FG002|Overall Study|Lost to Follow-up|0|||
42151493|NCT00331136|75960079|FG003|Overall Study|Lost to Follow-up|0|||
42151494|NCT00331136|75960076|FG000|Overall Study|Protocol Violation|1|||
42151495|NCT00331136|75960077|FG001|Overall Study|Protocol Violation|0|||
42151496|NCT00331136|75960078|FG002|Overall Study|Protocol Violation|0|||
42151497|NCT00331136|75960079|FG003|Overall Study|Protocol Violation|0|||
42151498|NCT00331136|75960076|FG000|Overall Study|Not treated|1|||
42151499|NCT00331136|75960077|FG001|Overall Study|Not treated|0|||
42151500|NCT00331136|75960078|FG002|Overall Study|Not treated|0|||
42151501|NCT00331136|75960079|FG003|Overall Study|Not treated|0|||
42151502|NCT00323414|75960091|FG000|Overall Study|Withdrawal by Subject|0|||
42151503|NCT00323414|75960092|FG001|Overall Study|Withdrawal by Subject|1|||
42151504|NCT00330668|75960098|FG000|BID Dosing Period|Adverse Event|1|||
42151505|NCT00330668|75960098|FG000|BID Dosing Period|Lost to Follow-up|7|||
42151506|NCT00330668|75960098|FG000|BID Dosing Period|Non-Compliance|5|||
42151507|NCT00330668|75960098|FG000|BID Dosing Period|Withdrawal by Subject|19|||
42151508|NCT00330668|75960098|FG000|BID Dosing Period|Sponsor's decision|1|||
42151509|NCT00330668|75960098|FG000|BID Dosing Period|Other|3|||
42151510|NCT00330668|75960098|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
42151511|NCT00330668|75960098|FG000|QD Dosing Period|Other|1|||
42151512|NCT00330668|75960098|FG000|QD Dosing Period|Withdrawal by Subject|1|||
42151513|NCT00330668|75960098|FG000|QD Dosing Period|Lost to Follow-up|2|||
42151514|NCT00306384|75960105|FG000|Overall Study|Adverse Event|103|||
42151515|NCT00306384|75960106|FG001|Overall Study|Adverse Event|87|||
42151516|NCT00306384|75960107|FG002|Overall Study|Adverse Event|40|||
42151517|NCT00306384|75960105|FG000|Overall Study|Major protocol deviation|43|||
42151518|NCT00306384|75960106|FG001|Overall Study|Major protocol deviation|51|||
42151519|NCT00306384|75960107|FG002|Overall Study|Major protocol deviation|18|||
42151520|NCT00306384|75960105|FG000|Overall Study|Lost to Follow-up|57|||
42151521|NCT00306384|75960106|FG001|Overall Study|Lost to Follow-up|41|||
42151522|NCT00306384|75960107|FG002|Overall Study|Lost to Follow-up|35|||
42151523|NCT00306384|75960105|FG000|Overall Study|Voluntary withdrawal|199|||
42151524|NCT00306384|75960106|FG001|Overall Study|Voluntary withdrawal|187|||
42151525|NCT00306384|75960107|FG002|Overall Study|Voluntary withdrawal|91|||
42151526|NCT00306384|75960105|FG000|Overall Study|Study termination|1|||
42151527|NCT00306384|75960106|FG001|Overall Study|Study termination|0|||
42151528|NCT00306384|75960107|FG002|Overall Study|Study termination|1|||
42151529|NCT00306384|75960105|FG000|Overall Study|Pregnancy|3|||
42151530|NCT00306384|75960106|FG001|Overall Study|Pregnancy|1|||
42151531|NCT00306384|75960107|FG002|Overall Study|Pregnancy|1|||
42151532|NCT00306384|75960105|FG000|Overall Study|Lack of Efficacy|26|||
42151533|NCT00306384|75960106|FG001|Overall Study|Lack of Efficacy|40|||
42151534|NCT00306384|75960107|FG002|Overall Study|Lack of Efficacy|38|||
42151535|NCT00306384|75960105|FG000|Overall Study|Investigator discretion|28|||
42151536|NCT00306384|75960106|FG001|Overall Study|Investigator discretion|31|||
42151537|NCT00306384|75960107|FG002|Overall Study|Investigator discretion|21|||
42151538|NCT00306384|75960105|FG000|Overall Study|Other|80|||
42151539|NCT00306384|75960106|FG001|Overall Study|Other|70|||
42151540|NCT00306384|75960107|FG002|Overall Study|Other|32|||
42151541|NCT00306384|75960105|FG000|Overall Study|Site closure|2|||
42151542|NCT00306384|75960106|FG001|Overall Study|Site closure|0|||
42151543|NCT00306384|75960107|FG002|Overall Study|Site closure|0|||
42151544|NCT00305604|75960117|FG000|Overall Study|Adverse Event|6|||
42151545|NCT00305604|75960118|FG001|Overall Study|Adverse Event|3|||
42151546|NCT00305604|75960117|FG000|Overall Study|Lack of Efficacy|11|||
42151547|NCT00305604|75960118|FG001|Overall Study|Lack of Efficacy|18|||
42151548|NCT00305604|75960117|FG000|Overall Study|Lost to Follow-up|0|||
42151549|NCT00305604|75960118|FG001|Overall Study|Lost to Follow-up|4|||
42151550|NCT00305604|75960117|FG000|Overall Study|Protocol Violation|2|||
42151551|NCT00305604|75960118|FG001|Overall Study|Protocol Violation|1|||
42151552|NCT00305604|75960117|FG000|Overall Study|Withdrawal by Subject|12|||
42151553|NCT00305604|75960118|FG001|Overall Study|Withdrawal by Subject|21|||
42151554|NCT00305604|75960117|FG000|Overall Study|Patient moved|1|||
42151555|NCT00305604|75960118|FG001|Overall Study|Patient moved|0|||
42151556|NCT00501059|75960126|FG000|Overall Study|Protocol Violation|80|||
42151557|NCT00501059|75960127|FG001|Overall Study|Protocol Violation|69|||
42151558|NCT00501059|75960126|FG000|Overall Study|Death|140|||
42151559|NCT00501059|75960127|FG001|Overall Study|Death|137|||
42151560|NCT00501059|75960126|FG000|Overall Study|Other|236|||
42151561|NCT00501059|75960127|FG001|Overall Study|Other|239|||
42151562|NCT00501059|75960126|FG000|Overall Study|Missing end-of-study page|91|||
42151563|NCT00501059|75960127|FG001|Overall Study|Missing end-of-study page|92|||
42278266|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
42151564|NCT00501059|75960126|FG000|Overall Study|Clinical endpoint reached|110|||
42151565|NCT00501059|75960127|FG001|Overall Study|Clinical endpoint reached|123|||
42151566|NCT00501059|75960126|FG000|Overall Study|Insufficient therapeutic effect|4|||
42151567|NCT00501059|75960127|FG001|Overall Study|Insufficient therapeutic effect|5|||
42278267|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
42278268|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
42151568|NCT00501059|75960126|FG000|Overall Study|Consent withdrawn by subject|817|||
42151569|NCT00501059|75960127|FG001|Overall Study|Consent withdrawn by subject|873|||
42151570|NCT00501059|75960126|FG000|Overall Study|Non-compliant with study treatment|23|||
42151571|NCT00501059|75960127|FG001|Overall Study|Non-compliant with study treatment|16|||
42151572|NCT00501059|75960126|FG000|Overall Study|Reason not given|3|||
42151573|NCT00501059|75960127|FG001|Overall Study|Reason not given|1|||
42151574|NCT00501059|75960126|FG000|Overall Study|Adverse Event|129|||
42151575|NCT00501059|75960127|FG001|Overall Study|Adverse Event|122|||
42151576|NCT00501059|75960126|FG000|Overall Study|Lost to Follow-up|210|||
42151577|NCT00501059|75960127|FG001|Overall Study|Lost to Follow-up|198|||
42151578|NCT00501059|75960126|FG000|Overall Study|Not treated|25|||
42151579|NCT00501059|75960127|FG001|Overall Study|Not treated|17|||
42151580|NCT00344318|75960139|FG000|Overall Study|Adverse Event|0|||
42151581|NCT00344318|75960140|FG001|Overall Study|Adverse Event|3|||
42151582|NCT00344318|75960141|FG002|Overall Study|Adverse Event|0|||
42151583|NCT00344318|75960142|FG003|Overall Study|Adverse Event|1|||
42151584|NCT00344318|75960139|FG000|Overall Study|Withdrawal by Subject|2|||
42151585|NCT00344318|75960140|FG001|Overall Study|Withdrawal by Subject|2|||
42151586|NCT00344318|75960141|FG002|Overall Study|Withdrawal by Subject|0|||
42151587|NCT00344318|75960142|FG003|Overall Study|Withdrawal by Subject|2|||
42151588|NCT00344318|75960139|FG000|Overall Study|Lost to Follow-up|2|||
42151589|NCT00344318|75960140|FG001|Overall Study|Lost to Follow-up|0|||
42151590|NCT00344318|75960141|FG002|Overall Study|Lost to Follow-up|1|||
42151591|NCT00344318|75960142|FG003|Overall Study|Lost to Follow-up|0|||
42151592|NCT00323258|75960156|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
42151593|NCT00323258|75960157|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
42151594|NCT00323258|75960156|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
42151595|NCT00323258|75960157|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
42151596|NCT00323258|75960156|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
42151597|NCT00323258|75960157|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
42151598|NCT00323258|75960156|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
42151599|NCT00323258|75960157|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
42151600|NCT00323258|75960156|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
42151601|NCT00323258|75960157|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
42151602|NCT00323258|75960156|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
42151603|NCT00323258|75960157|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
42151604|NCT00323258|75960156|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
42151605|NCT00323258|75960157|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
42151606|NCT00322868|75960163|FG000|Overall Study|disease progression|1|||
42151607|NCT00322712|75960168|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
42151608|NCT00343382|75960175|FG000|Overall Study|Adverse Event|2|||
42151609|NCT00343382|75960176|FG001|Overall Study|Adverse Event|10|||
42151610|NCT00343382|75960177|FG002|Overall Study|Adverse Event|7|||
42151611|NCT00343382|75960175|FG000|Overall Study|Withdrawal by Subject|1|||
42151612|NCT00343382|75960176|FG001|Overall Study|Withdrawal by Subject|2|||
42151613|NCT00343382|75960177|FG002|Overall Study|Withdrawal by Subject|6|||
42151614|NCT00343382|75960175|FG000|Overall Study|Other Reason Not Specified|1|||
42151615|NCT00343382|75960176|FG001|Overall Study|Other Reason Not Specified|2|||
42151616|NCT00343382|75960177|FG002|Overall Study|Other Reason Not Specified|4|||
42151617|NCT00481871|75960190|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
42151618|NCT00481871|75960191|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
42151619|NCT00481871|75960192|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
42151620|NCT00481871|75960193|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
42151621|NCT00481871|75960194|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
42151622|NCT00329420|75960205|FG000|Re-induction Phase|Lack of Efficacy|0|||
42151623|NCT00329420|75960206|FG001|Re-induction Phase|Lack of Efficacy|1|||
42151624|NCT00329420|75960207|FG002|Re-induction Phase|Lack of Efficacy|0|||
42151625|NCT00329420|75960205|FG000|Re-induction Phase|Withdrawal of Consent|0|||
42151626|NCT00329420|75960206|FG001|Re-induction Phase|Withdrawal of Consent|0|||
42151627|NCT00329420|75960207|FG002|Re-induction Phase|Withdrawal of Consent|1|||
42151628|NCT00329420|75960205|FG000|Re-induction Phase|Did not respond to re-induction|6|||
42151629|NCT00329420|75960206|FG001|Re-induction Phase|Did not respond to re-induction|5|||
42151630|NCT00329420|75960207|FG002|Re-induction Phase|Did not respond to re-induction|7|||
42151631|NCT00329420|75960205|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
42151632|NCT00329420|75960206|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
42151633|NCT00329420|75960207|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
42151634|NCT00329420|75960205|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
42151635|NCT00329420|75960206|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
42151636|NCT00329420|75960207|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
42151637|NCT00329420|75960205|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
42151638|NCT00329420|75960206|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
42151639|NCT00329420|75960207|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
42151640|NCT00329108|75960219|FG000|Overall Study|Adverse Event|2|||
42151641|NCT00329108|75960220|FG001|Overall Study|Adverse Event|2|||
42151642|NCT00329108|75960219|FG000|Overall Study|Lack of Efficacy|3|||
42151643|NCT00329108|75960220|FG001|Overall Study|Lack of Efficacy|3|||
42151644|NCT00329108|75960219|FG000|Overall Study|Withdrawal by Subject|0|||
42151645|NCT00329108|75960220|FG001|Overall Study|Withdrawal by Subject|2|||
42151646|NCT00329108|75960219|FG000|Overall Study|symptomatic deterioration|1|||
42151647|NCT00329108|75960220|FG001|Overall Study|symptomatic deterioration|1|||
42151648|NCT00329108|75960219|FG000|Overall Study|Subject no longer willing to participate|2|||
42151649|NCT00329108|75960220|FG001|Overall Study|Subject no longer willing to participate|2|||
42151650|NCT00329108|75960219|FG000|Overall Study|study terminated by sponsor|1|||
42151651|NCT00329108|75960220|FG001|Overall Study|study terminated by sponsor|0|||
42151652|NCT00329108|75960219|FG000|Overall Study|withdrew patient after SAE resolved|1|||
42151653|NCT00329108|75960220|FG001|Overall Study|withdrew patient after SAE resolved|0|||
42151654|NCT00329108|75960219|FG000|Overall Study|Protocol Violation|0|||
42151655|NCT00329108|75960220|FG001|Overall Study|Protocol Violation|2|||
42151656|NCT00329030|75960228|FG000|Overall Study|Withdrawal by Subject|1|||
42151657|NCT00329030|75960229|FG001|Overall Study|Withdrawal by Subject|3|||
42151658|NCT00329030|75960228|FG000|Overall Study|Progressive Disease|6|||
42151659|NCT00329030|75960229|FG001|Overall Study|Progressive Disease|2|||
42151660|NCT00329030|75960228|FG000|Overall Study|Ineligible Pathology|1|||
42151661|NCT00329030|75960229|FG001|Overall Study|Ineligible Pathology|1|||
42151662|NCT00328562|75960235|FG000|Overall Study|Disease progression|1|||
42151663|NCT00328172|75960244|FG000|Overall Study|Adverse Event|3|||
42151664|NCT00328172|75960245|FG001|Overall Study|Adverse Event|2|||
42151665|NCT00328172|75960246|FG002|Overall Study|Adverse Event|1|||
42151666|NCT00328172|75960247|FG003|Overall Study|Adverse Event|2|||
42151667|NCT00328172|75960248|FG004|Overall Study|Adverse Event|1|||
42151668|NCT00328172|75960244|FG000|Overall Study|Protocol Violation|0|||
42151669|NCT00328172|75960245|FG001|Overall Study|Protocol Violation|1|||
42151670|NCT00328172|75960246|FG002|Overall Study|Protocol Violation|1|||
42151671|NCT00328172|75960247|FG003|Overall Study|Protocol Violation|0|||
42151672|NCT00328172|75960248|FG004|Overall Study|Protocol Violation|0|||
42151673|NCT00328172|75960244|FG000|Overall Study|Lost to Follow-up|1|||
42151674|NCT00328172|75960245|FG001|Overall Study|Lost to Follow-up|1|||
42151675|NCT00328172|75960246|FG002|Overall Study|Lost to Follow-up|2|||
42151676|NCT00328172|75960247|FG003|Overall Study|Lost to Follow-up|1|||
42151677|NCT00328172|75960248|FG004|Overall Study|Lost to Follow-up|1|||
42151678|NCT00328172|75960244|FG000|Overall Study|Withdrawal by Subject|1|||
42151679|NCT00328172|75960245|FG001|Overall Study|Withdrawal by Subject|1|||
42151680|NCT00328172|75960246|FG002|Overall Study|Withdrawal by Subject|1|||
42151681|NCT00328172|75960247|FG003|Overall Study|Withdrawal by Subject|6|||
42151682|NCT00328172|75960248|FG004|Overall Study|Withdrawal by Subject|0|||
42151683|NCT00328172|75960244|FG000|Overall Study|Lack of Efficacy|14|||
42151684|NCT00328172|75960245|FG001|Overall Study|Lack of Efficacy|9|||
42151685|NCT00328172|75960246|FG002|Overall Study|Lack of Efficacy|4|||
42151686|NCT00328172|75960247|FG003|Overall Study|Lack of Efficacy|4|||
42151687|NCT00328172|75960248|FG004|Overall Study|Lack of Efficacy|3|||
42151688|NCT00328172|75960244|FG000|Overall Study|Other reason (not specified)|3|||
42151689|NCT00328172|75960245|FG001|Overall Study|Other reason (not specified)|0|||
42151690|NCT00328172|75960246|FG002|Overall Study|Other reason (not specified)|1|||
42151691|NCT00328172|75960247|FG003|Overall Study|Other reason (not specified)|0|||
42151692|NCT00328172|75960248|FG004|Overall Study|Other reason (not specified)|0|||
42151693|NCT00328094|75960262|FG000|Overall Study|Physician Decision|3|||
42151694|NCT00328094|75960263|FG001|Overall Study|Physician Decision|3|||
42151695|NCT00500903|75960272|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
42151696|NCT00500903|75960273|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
42151697|NCT00500903|75960274|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
42151698|NCT00500903|75960272|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
42151699|NCT00500903|75960273|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
42151700|NCT00500903|75960274|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
42151701|NCT00500903|75960272|FG000|Overall Study|Progressive Disease|41|||
42151702|NCT00500903|75960273|FG001|Overall Study|Progressive Disease|2|||
42151703|NCT00500903|75960274|FG002|Overall Study|Progressive Disease|15|||
42151704|NCT00500903|75960272|FG000|Overall Study|Patient Declined Further Treatment|0|||
42151705|NCT00500903|75960273|FG001|Overall Study|Patient Declined Further Treatment|0|||
42151706|NCT00500903|75960274|FG002|Overall Study|Patient Declined Further Treatment|3|||
42151707|NCT00500903|75960272|FG000|Overall Study|Symptomatic Deterioration|2|||
42151708|NCT00500903|75960273|FG001|Overall Study|Symptomatic Deterioration|0|||
42151709|NCT00500903|75960274|FG002|Overall Study|Symptomatic Deterioration|0|||
42151710|NCT00500903|75960272|FG000|Overall Study|Reason Not Specified|10|||
42151711|NCT00500903|75960273|FG001|Overall Study|Reason Not Specified|0|||
42151712|NCT00500903|75960274|FG002|Overall Study|Reason Not Specified|2|||
42151713|NCT00295932|75960323|FG000|Overall Study|Not Treated|0|||
42151714|NCT00295932|75960324|FG001|Overall Study|Not Treated|0|||
42151715|NCT00295932|75960325|FG002|Overall Study|Not Treated|0|||
42151716|NCT00295932|75960326|FG003|Overall Study|Not Treated|0|||
42151717|NCT00295932|75960327|FG004|Overall Study|Not Treated|0|||
42151718|NCT00295932|75960328|FG005|Overall Study|Not Treated|0|||
42151719|NCT00295932|75960329|FG006|Overall Study|Not Treated|0|||
42151720|NCT00295932|75960330|FG007|Overall Study|Not Treated|0|||
42151721|NCT00295932|75960331|FG008|Overall Study|Not Treated|0|||
42151722|NCT00295932|75960332|FG009|Overall Study|Not Treated|0|||
42151723|NCT00295932|75960333|FG010|Overall Study|Not Treated|1|||
42151724|NCT00305448|75960362|FG000|Overall Study|Protocol Violation|0|||
42151725|NCT00305448|75960363|FG001|Overall Study|Protocol Violation|1|||
42151726|NCT00305448|75960364|FG002|Overall Study|Protocol Violation|0|||
42151727|NCT00305448|75960362|FG000|Overall Study|Withdrawal by Subject|2|||
42151728|NCT00305448|75960363|FG001|Overall Study|Withdrawal by Subject|0|||
42151729|NCT00305448|75960364|FG002|Overall Study|Withdrawal by Subject|1|||
42151730|NCT00305448|75960362|FG000|Overall Study|Adverse Event|1|||
42151731|NCT00305448|75960363|FG001|Overall Study|Adverse Event|0|||
42151732|NCT00305448|75960364|FG002|Overall Study|Adverse Event|1|||
42151733|NCT00305448|75960362|FG000|Overall Study|Disease Progression|27|||
42151734|NCT00305448|75960363|FG001|Overall Study|Disease Progression|31|||
42151735|NCT00305448|75960364|FG002|Overall Study|Disease Progression|28|||
42151736|NCT00305448|75960362|FG000|Overall Study|Subjective Disease Progression|1|||
42151737|NCT00305448|75960363|FG001|Overall Study|Subjective Disease Progression|2|||
42151738|NCT00305448|75960364|FG002|Overall Study|Subjective Disease Progression|2|||
42151739|NCT00305448|75960362|FG000|Overall Study|Tumor Marker Elevation|0|||
42151740|NCT00305448|75960363|FG001|Overall Study|Tumor Marker Elevation|0|||
42151741|NCT00305448|75960364|FG002|Overall Study|Tumor Marker Elevation|1|||
42151742|NCT00305058|75960375|FG000|Overall Study|Participant too young|1|||
42151743|NCT00305058|75960376|FG001|Overall Study|Participant too young|0|||
42278269|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
42278270|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
42278271|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
42278272|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
42278273|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
42278274|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
42278275|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
42278276|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
42278277|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
42278278|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
42278279|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
42278280|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
42278281|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
42278282|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
42278283|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
42278284|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
42278285|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
42278286|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
42278287|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
42278288|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
42278289|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
42278290|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
42278291|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
42278292|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
42278293|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
42278294|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
42278295|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
42278296|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
42278297|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
42278298|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
42278299|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
42278300|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
42278301|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
42278302|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
42278303|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
42278304|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
42278305|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
42278306|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
42278307|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
42278308|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
42151744|NCT00305058|75960375|FG000|Overall Study|Missing data collection instrument|3|||
42151745|NCT00305058|75960376|FG001|Overall Study|Missing data collection instrument|2|||
42151746|NCT00305058|75960375|FG000|Overall Study|Missing outcome data|3|||
42151747|NCT00305058|75960376|FG001|Overall Study|Missing outcome data|2|||
42151748|NCT00295854|75960385|FG000|Overall Study|Adverse Event|7|||
42151749|NCT00295854|75960386|FG001|Overall Study|Adverse Event|7|||
42151750|NCT00295854|75960387|FG002|Overall Study|Adverse Event|6|||
42151751|NCT00295854|75960385|FG000|Overall Study|Protocol Violation|1|||
42151752|NCT00295854|75960386|FG001|Overall Study|Protocol Violation|1|||
42151753|NCT00295854|75960387|FG002|Overall Study|Protocol Violation|1|||
42151754|NCT00295854|75960385|FG000|Overall Study|Lost to Follow-up|2|||
42151755|NCT00295854|75960386|FG001|Overall Study|Lost to Follow-up|0|||
42151756|NCT00295854|75960387|FG002|Overall Study|Lost to Follow-up|1|||
42151757|NCT00295854|75960385|FG000|Overall Study|Withdrawal by Subject|3|||
42151758|NCT00295854|75960386|FG001|Overall Study|Withdrawal by Subject|7|||
42151759|NCT00295854|75960387|FG002|Overall Study|Withdrawal by Subject|4|||
42151760|NCT00295854|75960385|FG000|Overall Study|did not continue to meet criteria|1|||
42151761|NCT00295854|75960386|FG001|Overall Study|did not continue to meet criteria|1|||
42151762|NCT00295854|75960387|FG002|Overall Study|did not continue to meet criteria|2|||
42151763|NCT00295854|75960385|FG000|Overall Study|required a prohibited medication|1|||
42151764|NCT00295854|75960386|FG001|Overall Study|required a prohibited medication|0|||
42151765|NCT00295854|75960387|FG002|Overall Study|required a prohibited medication|0|||
42151766|NCT00295854|75960385|FG000|Overall Study|Other|3|||
42151767|NCT00295854|75960386|FG001|Overall Study|Other|5|||
42151768|NCT00295854|75960387|FG002|Overall Study|Other|1|||
42151769|NCT00327470|75960397|FG000|Overall Study|Randomized, but not treated|0|||
42151770|NCT00327470|75960398|FG001|Overall Study|Randomized, but not treated|2|||
42151771|NCT00327470|75960397|FG000|Overall Study|Adverse Event|9|||
42151772|NCT00327470|75960398|FG001|Overall Study|Adverse Event|14|||
42151773|NCT00327470|75960397|FG000|Overall Study|Lack of Efficacy|7|||
42151774|NCT00327470|75960398|FG001|Overall Study|Lack of Efficacy|19|||
42151775|NCT00327470|75960397|FG000|Overall Study|Other|5|||
42151776|NCT00327470|75960398|FG001|Overall Study|Other|9|||
42151777|NCT00327470|75960397|FG000|Overall Study|Lost to Follow-up|1|||
42151778|NCT00327470|75960398|FG001|Overall Study|Lost to Follow-up|3|||
42151779|NCT00327470|75960397|FG000|Overall Study|Withdrawal by Subject|6|||
42151780|NCT00327470|75960398|FG001|Overall Study|Withdrawal by Subject|12|||
42151781|NCT00327470|75960397|FG000|Overall Study|Death|1|||
42151782|NCT00327470|75960398|FG001|Overall Study|Death|4|||
42151783|NCT00322556|75960404|FG000|Overall Study|Adverse Event|1|||
42151784|NCT00322556|75960404|FG000|Overall Study|Withdrawal by Subject|1|||
42151785|NCT00322556|75960404|FG000|Overall Study|Lost to Follow-up|3|||
42151786|NCT00322556|75960404|FG000|Overall Study|Other Reason|7|||
42151787|NCT00321932|75960413|FG000|Overall Study|Death|3|||
42151788|NCT00321932|75960414|FG001|Overall Study|Death|6|||
42151789|NCT00321932|75960413|FG000|Overall Study|Withdrawal by Subject|3|||
42151790|NCT00321932|75960414|FG001|Overall Study|Withdrawal by Subject|6|||
42151791|NCT00321932|75960413|FG000|Overall Study|Early relapse|2|||
42151792|NCT00321932|75960414|FG001|Overall Study|Early relapse|8|||
42151793|NCT00321932|75960413|FG000|Overall Study|Missing data|2|||
42151794|NCT00321932|75960414|FG001|Overall Study|Missing data|1|||
42151795|NCT00326612|75960423|FG000|Overall Study|They did not have a seizure requiring tx|129|||
42151796|NCT00326612|75960424|FG001|Overall Study|They did not have a seizure requiring tx|137|||
42151797|NCT00325130|75960436|FG000|Overall Study|Lost to Follow-up|6|||
42151798|NCT00325130|75960437|FG001|Overall Study|Lost to Follow-up|14|||
42151799|NCT00325130|75960436|FG000|Overall Study|Withdrawal by Subject|12|||
42151800|NCT00325130|75960437|FG001|Overall Study|Withdrawal by Subject|14|||
42151801|NCT00325130|75960436|FG000|Overall Study|Protocol Deviation|0|||
42151802|NCT00325130|75960437|FG001|Overall Study|Protocol Deviation|1|||
42151803|NCT00325130|75960436|FG000|Overall Study|Moved|0|||
42151804|NCT00325130|75960437|FG001|Overall Study|Moved|1|||
42151805|NCT00325130|75960436|FG000|Overall Study|Patient Discontinued for Other|1|||
42151806|NCT00325130|75960437|FG001|Overall Study|Patient Discontinued for Other|0|||
42151807|NCT00321854|75960445|FG000|Overall Study|Adverse Event|41|||
42151808|NCT00321854|75960446|FG001|Overall Study|Adverse Event|43|||
42151809|NCT00321854|75960445|FG000|Overall Study|Lack of Efficacy|9|||
42151810|NCT00321854|75960446|FG001|Overall Study|Lack of Efficacy|14|||
42151811|NCT00321854|75960445|FG000|Overall Study|Protocol Violation|6|||
42151812|NCT00321854|75960446|FG001|Overall Study|Protocol Violation|5|||
42151813|NCT00321854|75960445|FG000|Overall Study|Lost to Follow-up|0|||
42151814|NCT00321854|75960446|FG001|Overall Study|Lost to Follow-up|2|||
42151815|NCT00321854|75960445|FG000|Overall Study|Withdrawal by Subject|6|||
42151816|NCT00321854|75960446|FG001|Overall Study|Withdrawal by Subject|17|||
42151817|NCT00321854|75960445|FG000|Overall Study|Other|1|||
42278309|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
42278310|NCT01791595|76109939|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
42151818|NCT00321854|75960446|FG001|Overall Study|Other|1|||
42151819|NCT00310388|75960454|FG000|Primary Reporting Phase|Adverse Event|101|||
42151820|NCT00310388|75960455|FG001|Primary Reporting Phase|Adverse Event|0|||
42151821|NCT00310388|75960454|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
42151822|NCT00310388|75960455|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
42151823|NCT00310388|75960454|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
42151824|NCT00310388|75960455|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
42151825|NCT00310388|75960454|FG000|Primary Reporting Phase|Protocol Violation|10|||
42151826|NCT00310388|75960455|FG001|Primary Reporting Phase|Protocol Violation|0|||
42151827|NCT00310388|75960454|FG000|Primary Reporting Phase|Pregnancy|3|||
42151828|NCT00310388|75960455|FG001|Primary Reporting Phase|Pregnancy|0|||
42151829|NCT00310388|75960454|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
42151830|NCT00310388|75960455|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
42151831|NCT00310388|75960454|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
42151832|NCT00310388|75960455|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
42151833|NCT00310388|75960454|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
42151834|NCT00310388|75960455|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
42151835|NCT00310388|75960454|FG000|Primary Reporting Phase|Physician Decision|2|||
42151836|NCT00310388|75960455|FG001|Primary Reporting Phase|Physician Decision|0|||
42151837|NCT00310388|75960454|FG000|Primary Reporting Phase|Request of the sponsor|19|||
42151838|NCT00310388|75960455|FG001|Primary Reporting Phase|Request of the sponsor|0|||
42151839|NCT00310388|75960454|FG000|Primary Reporting Phase|Failed to return|8|||
42151840|NCT00310388|75960455|FG001|Primary Reporting Phase|Failed to return|0|||
42151841|NCT00310388|75960454|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
42151842|NCT00310388|75960455|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
42151843|NCT00310388|75960454|FG000|Primary Reporting Phase|Participant request|2|||
42151844|NCT00310388|75960455|FG001|Primary Reporting Phase|Participant request|0|||
42151845|NCT00310388|75960454|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
42151846|NCT00310388|75960455|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
42151847|NCT00310388|75960454|FG000|Primary Reporting Phase|Discontinuation of study|1|||
42151848|NCT00310388|75960455|FG001|Primary Reporting Phase|Discontinuation of study|0|||
42151849|NCT00310388|75960454|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
42151850|NCT00310388|75960455|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
42151851|NCT00310388|75960454|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
42151852|NCT00310388|75960455|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
42151853|NCT00310388|75960454|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
42151854|NCT00310388|75960455|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
42151855|NCT00310388|75960454|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
42151856|NCT00310388|75960455|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
42151857|NCT00310388|75960454|FG000|Primary Reporting Phase|Participant passed away|1|||
42151858|NCT00310388|75960455|FG001|Primary Reporting Phase|Participant passed away|0|||
42151859|NCT00310388|75960454|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
42151860|NCT00310388|75960455|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
42151861|NCT00310388|75960454|FG000|Primary Reporting Phase|Missing|1|||
42151862|NCT00310388|75960455|FG001|Primary Reporting Phase|Missing|0|||
42151863|NCT00310388|75960454|FG000|Primary Reporting Phase|Other|1|||
42151864|NCT00310388|75960455|FG001|Primary Reporting Phase|Other|0|||
42151865|NCT00310388|75960454|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
42151866|NCT00310388|75960455|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
42151867|NCT00310388|75960454|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
42151868|NCT00310388|75960455|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
42151869|NCT00310388|75960454|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
42151870|NCT00310388|75960455|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
42151871|NCT00310388|75960454|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
42151872|NCT00310388|75960455|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
42151873|NCT00500357|75960460|FG000|Overall Study|Death|1|||
42151874|NCT00309842|75960475|FG000|Overall Study|Lost to Follow-up|1|||
42151875|NCT00325754|75960481|FG000|Overall Study|Adverse Event|4|||
42151876|NCT00325754|75960482|FG001|Overall Study|Adverse Event|1|||
42151877|NCT00499889|75960488|FG000|Overall Study|Infection prior to treatment|1|||
42151878|NCT00309608|75960497|FG000|Overall Study|Adverse Event|1|||
42151879|NCT00309608|75960498|FG001|Overall Study|Adverse Event|5|||
42151880|NCT00309608|75960499|FG002|Overall Study|Adverse Event|3|||
42151881|NCT00309608|75960500|FG003|Overall Study|Adverse Event|2|||
42151882|NCT00309608|75960501|FG004|Overall Study|Adverse Event|3|||
42151883|NCT00309608|75960497|FG000|Overall Study|Protocol Violation|2|||
42151884|NCT00309608|75960498|FG001|Overall Study|Protocol Violation|0|||
42151885|NCT00309608|75960499|FG002|Overall Study|Protocol Violation|0|||
42151886|NCT00309608|75960500|FG003|Overall Study|Protocol Violation|0|||
42151887|NCT00309608|75960501|FG004|Overall Study|Protocol Violation|0|||
42151888|NCT00309608|75960497|FG000|Overall Study|Lost to Follow-up|0|||
42151889|NCT00309608|75960498|FG001|Overall Study|Lost to Follow-up|0|||
42151890|NCT00309608|75960499|FG002|Overall Study|Lost to Follow-up|2|||
42151891|NCT00309608|75960500|FG003|Overall Study|Lost to Follow-up|0|||
42351264|NCT00636610|76191153|FG000|Overall Study|Death|6|||
42151892|NCT00309608|75960501|FG004|Overall Study|Lost to Follow-up|1|||
42151893|NCT00309608|75960497|FG000|Overall Study|Withdrawal by Subject|1|||
42151894|NCT00309608|75960498|FG001|Overall Study|Withdrawal by Subject|4|||
42151895|NCT00309608|75960499|FG002|Overall Study|Withdrawal by Subject|2|||
42151896|NCT00309608|75960500|FG003|Overall Study|Withdrawal by Subject|0|||
42151897|NCT00309608|75960501|FG004|Overall Study|Withdrawal by Subject|0|||
42151898|NCT00309608|75960497|FG000|Overall Study|Other incl. Lack of efficacy|10|||
42151899|NCT00309608|75960498|FG001|Overall Study|Other incl. Lack of efficacy|4|||
42151900|NCT00309608|75960499|FG002|Overall Study|Other incl. Lack of efficacy|3|||
42151901|NCT00309608|75960500|FG003|Overall Study|Other incl. Lack of efficacy|4|||
42151902|NCT00309608|75960501|FG004|Overall Study|Other incl. Lack of efficacy|0|||
42151903|NCT00309452|75960515|FG000|Overall Study|Withdrawal by Subject|3|||
42151904|NCT00309452|75960516|FG001|Overall Study|Withdrawal by Subject|0|||
42151905|NCT00308750|75960525|FG000|Overall Study|Adverse Event|9|||
42151906|NCT00308750|75960526|FG001|Overall Study|Adverse Event|9|||
42151907|NCT00308750|75960527|FG002|Overall Study|Adverse Event|13|||
42151908|NCT00308750|75960525|FG000|Overall Study|Withdrawal by Subject|6|||
42151909|NCT00308750|75960526|FG001|Overall Study|Withdrawal by Subject|2|||
42151910|NCT00308750|75960527|FG002|Overall Study|Withdrawal by Subject|3|||
42151911|NCT00308750|75960525|FG000|Overall Study|Physician Decision|3|||
42151912|NCT00308750|75960526|FG001|Overall Study|Physician Decision|4|||
42151913|NCT00308750|75960527|FG002|Overall Study|Physician Decision|3|||
42151914|NCT00308750|75960525|FG000|Overall Study|Sponsor Decision|1|||
42151915|NCT00308750|75960526|FG001|Overall Study|Sponsor Decision|0|||
42151916|NCT00308750|75960527|FG002|Overall Study|Sponsor Decision|0|||
42151917|NCT00308750|75960525|FG000|Overall Study|Disease Progression|47|||
42151918|NCT00308750|75960526|FG001|Overall Study|Disease Progression|24|||
42151919|NCT00308750|75960527|FG002|Overall Study|Disease Progression|28|||
42151920|NCT00308750|75960525|FG000|Overall Study|Unrelated Complication|3|||
42151921|NCT00308750|75960526|FG001|Overall Study|Unrelated Complication|0|||
42151922|NCT00308750|75960527|FG002|Overall Study|Unrelated Complication|1|||
42151923|NCT00308750|75960525|FG000|Overall Study|Death|1|||
42151924|NCT00308750|75960526|FG001|Overall Study|Death|0|||
42151925|NCT00308750|75960527|FG002|Overall Study|Death|1|||
42151926|NCT00308750|75960525|FG000|Overall Study|Protocol Violation|1|||
42151927|NCT00308750|75960526|FG001|Overall Study|Protocol Violation|0|||
42151928|NCT00308750|75960527|FG002|Overall Study|Protocol Violation|0|||
42151929|NCT00308750|75960525|FG000|Overall Study|New Primary Disease Identified|1|||
42151930|NCT00308750|75960526|FG001|Overall Study|New Primary Disease Identified|1|||
42151931|NCT00308750|75960527|FG002|Overall Study|New Primary Disease Identified|0|||
42151932|NCT00489359|75960538|FG000|Overall Study|Death|0|||
42151933|NCT00489359|75960539|FG001|Overall Study|Death|2|||
42151934|NCT00489359|75960538|FG000|Overall Study|Progressive Disease|5|||
42151935|NCT00489359|75960539|FG001|Overall Study|Progressive Disease|6|||
42151936|NCT00489359|75960538|FG000|Overall Study|Lost to Follow-up|1|||
42151937|NCT00489359|75960539|FG001|Overall Study|Lost to Follow-up|0|||
42151938|NCT00489359|75960538|FG000|Overall Study|Withdrawal by Subject|1|||
42151939|NCT00489359|75960539|FG001|Overall Study|Withdrawal by Subject|5|||
42151940|NCT00489359|75960538|FG000|Overall Study|Adverse Event|0|||
42151941|NCT00489359|75960539|FG001|Overall Study|Adverse Event|16|||
42151942|NCT00481247|75960552|FG000|Overall Study|Death|0|||
42151943|NCT00481247|75960553|FG001|Overall Study|Death|1|||
42151944|NCT00481247|75960552|FG000|Overall Study|Disease progression|18|||
42151945|NCT00481247|75960553|FG001|Overall Study|Disease progression|22|||
42151946|NCT00481247|75960552|FG000|Overall Study|Intolerance|42|||
42151947|NCT00481247|75960553|FG001|Overall Study|Intolerance|17|||
42151948|NCT00481247|75960552|FG000|Overall Study|Treatment failure|10|||
42151949|NCT00481247|75960553|FG001|Overall Study|Treatment failure|14|||
42151950|NCT00481247|75960552|FG000|Overall Study|AE unrelated to study drug|13|||
42151951|NCT00481247|75960553|FG001|Overall Study|AE unrelated to study drug|4|||
42151952|NCT00481247|75960552|FG000|Overall Study|Withdrawal by Subject|8|||
42151953|NCT00481247|75960553|FG001|Overall Study|Withdrawal by Subject|13|||
42039871|NCT02985957|75848293|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
42151954|NCT00481247|75960552|FG000|Overall Study|Pregnancy|2|||
42151955|NCT00481247|75960553|FG001|Overall Study|Pregnancy|1|||
42151956|NCT00481247|75960552|FG000|Overall Study|Lost to Follow-up|1|||
42151957|NCT00481247|75960553|FG001|Overall Study|Lost to Follow-up|2|||
42151958|NCT00481247|75960552|FG000|Overall Study|Poor compliance/noncompliance|1|||
42151959|NCT00481247|75960553|FG001|Overall Study|Poor compliance/noncompliance|7|||
42151960|NCT00481247|75960552|FG000|Overall Study|Administrative reason by sponsor|157|||
42151961|NCT00481247|75960553|FG001|Overall Study|Administrative reason by sponsor|162|||
42151962|NCT00481247|75960552|FG000|Overall Study|Varied|6|||
42151963|NCT00481247|75960553|FG001|Overall Study|Varied|15|||
42151964|NCT00481247|75960552|FG000|Overall Study|Did not receive treatment|1|||
42151965|NCT00481247|75960553|FG001|Overall Study|Did not receive treatment|2|||
42151966|NCT00480857|75960559|FG000|Overall Study|Lack of Efficacy|2|||
42151967|NCT00480779|75960565|FG000|Overall Study|Other|2|||
42151968|NCT00480779|75960566|FG001|Overall Study|Other|0|||
42151969|NCT00480779|75960565|FG000|Overall Study|Job and Health-related|0|||
42151970|NCT00480779|75960566|FG001|Overall Study|Job and Health-related|3|||
42151971|NCT00499031|75960572|FG000|Overall Study|Improper pre-protocol treatment|1|||
42151972|NCT00499031|75960572|FG000|Overall Study|Required test not done|1|||
42151973|NCT00499031|75960572|FG000|Overall Study|Never treated|1|||
42151974|NCT00498797|75960578|FG000|Overall Study|Withdrawal by Subject|4|||
42151975|NCT00498797|75960579|FG001|Overall Study|Withdrawal by Subject|2|||
42151976|NCT00498797|75960578|FG000|Overall Study|Adverse Event|12|||
42151977|NCT00498797|75960579|FG001|Overall Study|Adverse Event|5|||
42151978|NCT00498797|75960578|FG000|Overall Study|Condition under investigation worsened|19|||
42151979|NCT00498797|75960579|FG001|Overall Study|Condition under investigation worsened|21|||
42151980|NCT00498797|75960578|FG000|Overall Study|Other|3|||
42151981|NCT00498797|75960579|FG001|Overall Study|Other|1|||
42151982|NCT00498485|75960587|FG000|Overall Study|Adverse Event|1|||
42151983|NCT00498485|75960588|FG001|Overall Study|Adverse Event|5|||
42151984|NCT00480077|75960598|FG000|Overall Study|Death|19|||
42151985|NCT00480077|75960599|FG001|Overall Study|Death|15|||
42151986|NCT00480077|75960598|FG000|Overall Study|early exit|12|||
42151987|NCT00480077|75960599|FG001|Overall Study|early exit|11|||
42151988|NCT00498173|75960607|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
42151989|NCT00498173|75960608|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
42151990|NCT00498173|75960609|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
42151991|NCT00295620|75960619|FG000|Overall Study|Lost to Follow-up|9|||
42151992|NCT00295620|75960620|FG001|Overall Study|Lost to Follow-up|5|||
42151993|NCT00295620|75960619|FG000|Overall Study|Withdrawal by Subject|37|||
42151994|NCT00295620|75960620|FG001|Overall Study|Withdrawal by Subject|50|||
42151995|NCT00295620|75960619|FG000|Overall Study|Death|206|||
42151996|NCT00295620|75960620|FG001|Overall Study|Death|207|||
42151997|NCT00295620|75960619|FG000|Overall Study|Other reasons|10|||
42151998|NCT00295620|75960620|FG001|Overall Study|Other reasons|9|||
42151999|NCT00295620|75960619|FG000|Overall Study|Discontinuation by sponsor|580|||
42152000|NCT00295620|75960620|FG001|Overall Study|Discontinuation by sponsor|593|||
42152001|NCT00295620|75960619|FG000|Overall Study|Protocol Violation|30|||
42152002|NCT00295620|75960620|FG001|Overall Study|Protocol Violation|32|||
42152003|NCT00310440|75960628|FG000|Overall Study|Lost to Follow-up|17|||
42152004|NCT00310440|75960629|FG001|Overall Study|Lost to Follow-up|8|||
42152005|NCT00310440|75960628|FG000|Overall Study|Withdrawal by Subject|2|||
42152006|NCT00310440|75960629|FG001|Overall Study|Withdrawal by Subject|1|||
42152007|NCT00310440|75960628|FG000|Overall Study|Missed 12 Month Visit|7|||
42152008|NCT00310440|75960629|FG001|Overall Study|Missed 12 Month Visit|4|||
42152009|NCT00304356|75960635|FG000|Nitazoxanide|Physician Decision|5|||
42152010|NCT00304356|75960635|FG000|Nitazoxanide|Physician Decision|1|||
42152011|NCT00304356|75960635|FG000|Nitazoxanide|number is 0|1|||
42152012|NCT00304356|75960635|FG000|Nitazoxanide|Physician Decision|1|||
42152013|NCT00304356|75960635|FG000|Nitazoxanide|Physician Decision|1|||
42152014|NCT00304356|75960635|FG000|Nitazoxanide|Physician Decision|1|||
42152015|NCT00321620|75960641|FG000|Overall Study|Death|269|||
42152016|NCT00321620|75960642|FG001|Overall Study|Death|294|||
42152017|NCT00321620|75960641|FG000|Overall Study|Withdrawal by Subject|164|||
42152018|NCT00321620|75960642|FG001|Overall Study|Withdrawal by Subject|147|||
42152019|NCT00321620|75960641|FG000|Overall Study|Disease progression|113|||
42152020|NCT00321620|75960642|FG001|Overall Study|Disease progression|117|||
42278311|NCT01791595|76109940|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
42152021|NCT00321620|75960641|FG000|Overall Study|Adverse Event|43|||
42152022|NCT00321620|75960642|FG001|Overall Study|Adverse Event|56|||
42152023|NCT00321620|75960641|FG000|Overall Study|Lost to Follow-up|13|||
42152024|NCT00321620|75960642|FG001|Overall Study|Lost to Follow-up|9|||
42152025|NCT00321620|75960641|FG000|Overall Study|Physician Decision|4|||
42152026|NCT00321620|75960642|FG001|Overall Study|Physician Decision|1|||
42152027|NCT00321620|75960641|FG000|Overall Study|Noncompliance|14|||
42152028|NCT00321620|75960642|FG001|Overall Study|Noncompliance|7|||
42152029|NCT00321620|75960641|FG000|Overall Study|Protocol deviation|4|||
42152030|NCT00321620|75960642|FG001|Overall Study|Protocol deviation|3|||
42152031|NCT00321620|75960641|FG000|Overall Study|Ineligibility determined|2|||
42152032|NCT00321620|75960642|FG001|Overall Study|Ineligibility determined|3|||
42152033|NCT00321620|75960641|FG000|Overall Study|Participant request|75|||
42152034|NCT00321620|75960642|FG001|Overall Study|Participant request|52|||
42152035|NCT00321620|75960641|FG000|Overall Study|Other|42|||
42152036|NCT00321620|75960642|FG001|Overall Study|Other|33|||
42152037|NCT00304278|75960648|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
42152038|NCT00304278|75960648|FG000|Overall Study|PT had medical condition preventing TX|1|||
42152039|NCT00291018|75960655|FG000|Overall Study|Not Consented or Declined PAS|12|||
42152040|NCT00291018|75960656|FG001|Overall Study|Not Consented or Declined PAS|15|||
42152041|NCT00291018|75960657|FG002|Overall Study|Not Consented or Declined PAS|15|||
42152042|NCT00291018|75960655|FG000|Overall Study|Death|3|||
42152043|NCT00291018|75960656|FG001|Overall Study|Death|3|||
42152044|NCT00291018|75960657|FG002|Overall Study|Death|4|||
42152045|NCT00291018|75960655|FG000|Overall Study|Withdrawal by Subject|2|||
42152046|NCT00291018|75960656|FG001|Overall Study|Withdrawal by Subject|8|||
42152047|NCT00291018|75960657|FG002|Overall Study|Withdrawal by Subject|1|||
42152048|NCT00291018|75960655|FG000|Overall Study|Failures|5|||
42152049|NCT00291018|75960656|FG001|Overall Study|Failures|12|||
42152050|NCT00291018|75960657|FG002|Overall Study|Failures|5|||
42152051|NCT00291018|75960655|FG000|Overall Study|Lost to Follow-up|3|||
42152052|NCT00291018|75960656|FG001|Overall Study|Lost to Follow-up|4|||
42152053|NCT00291018|75960657|FG002|Overall Study|Lost to Follow-up|18|||
42152054|NCT00320606|75960668|FG000|Overall Study|Adverse Event|1|||
42152055|NCT00320606|75960668|FG000|Overall Study|Protocol Violation|1|||
42152056|NCT00320606|75960668|FG000|Overall Study|Withdrawal by Subject|1|||
42152057|NCT00307736|75960673|FG000|Overall Study|Adverse Event|0|||
42152058|NCT00307736|75960674|FG001|Overall Study|Adverse Event|0|||
42152059|NCT00307736|75960675|FG002|Overall Study|Adverse Event|1|||
42152060|NCT00307736|75960676|FG003|Overall Study|Adverse Event|3|||
42152061|NCT00307736|75960673|FG000|Overall Study|Withdrawal by Subject|0|||
42152062|NCT00307736|75960674|FG001|Overall Study|Withdrawal by Subject|0|||
42152063|NCT00307736|75960675|FG002|Overall Study|Withdrawal by Subject|2|||
42152064|NCT00307736|75960676|FG003|Overall Study|Withdrawal by Subject|0|||
42152065|NCT00320528|75960690|FG000|Study Period II|Adverse Event|3|||
42152066|NCT00320528|75960691|FG001|Study Period II|Adverse Event|4|||
42152067|NCT00320528|75960692|FG002|Study Period II|Adverse Event|8|||
42152068|NCT00320528|75960690|FG000|Study Period II|Parent/Caregiver Decision|8|||
42152069|NCT00320528|75960691|FG001|Study Period II|Parent/Caregiver Decision|3|||
42152070|NCT00320528|75960692|FG002|Study Period II|Parent/Caregiver Decision|11|||
42152071|NCT00320528|75960690|FG000|Study Period II|Withdrawal by Subject|0|||
42152072|NCT00320528|75960691|FG001|Study Period II|Withdrawal by Subject|1|||
42152073|NCT00320528|75960692|FG002|Study Period II|Withdrawal by Subject|1|||
42152074|NCT00320528|75960690|FG000|Study Period II|Entry Criteria Exclusion|0|||
42152075|NCT00320528|75960691|FG001|Study Period II|Entry Criteria Exclusion|2|||
42152076|NCT00320528|75960692|FG002|Study Period II|Entry Criteria Exclusion|2|||
42152077|NCT00320528|75960690|FG000|Study Period III|Adverse Event|1|||
42152078|NCT00320528|75960691|FG001|Study Period III|Adverse Event|0|||
42152079|NCT00320528|75960692|FG002|Study Period III|Adverse Event|0|||
42152080|NCT00320528|75960690|FG000|Study Period III|Lost to Follow-up|1|||
42152081|NCT00320528|75960691|FG001|Study Period III|Lost to Follow-up|0|||
42152082|NCT00320528|75960692|FG002|Study Period III|Lost to Follow-up|0|||
42152083|NCT00320528|75960690|FG000|Study Period III|Withdrawal by Subject|1|||
42152084|NCT00320528|75960691|FG001|Study Period III|Withdrawal by Subject|1|||
42152085|NCT00320528|75960692|FG002|Study Period III|Withdrawal by Subject|2|||
42278312|NCT01791595|76109941|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
42152086|NCT00320528|75960690|FG000|Study Period III|Lack of Efficacy|2|||
42152087|NCT00320528|75960691|FG001|Study Period III|Lack of Efficacy|0|||
42152088|NCT00320528|75960692|FG002|Study Period III|Lack of Efficacy|0|||
42152089|NCT00320528|75960690|FG000|Study Period III|Parent/Caregiver Decision|14|||
42152090|NCT00320528|75960691|FG001|Study Period III|Parent/Caregiver Decision|3|||
42152091|NCT00320528|75960692|FG002|Study Period III|Parent/Caregiver Decision|11|||
42152092|NCT00320528|75960690|FG000|Study Period III|Protocol Violation|0|||
42152093|NCT00320528|75960691|FG001|Study Period III|Protocol Violation|1|||
42152094|NCT00320528|75960692|FG002|Study Period III|Protocol Violation|0|||
42152095|NCT00320528|75960690|FG000|Study Period III|Physician Decision|0|||
42152096|NCT00320528|75960691|FG001|Study Period III|Physician Decision|1|||
42152097|NCT00320528|75960692|FG002|Study Period III|Physician Decision|2|||
42152098|NCT00320528|75960690|FG000|Study Period III|Sponsor Decision|0|||
42152099|NCT00320528|75960691|FG001|Study Period III|Sponsor Decision|0|||
42152100|NCT00320528|75960692|FG002|Study Period III|Sponsor Decision|1|||
42152101|NCT00320528|75960690|FG000|Study Period III|Atomoxetine Commercially Available|68|||
42152102|NCT00320528|75960691|FG001|Study Period III|Atomoxetine Commercially Available|25|||
42351265|NCT00636610|76191154|FG001|Overall Study|Death|3|||
42351266|NCT00636610|76191153|FG000|Overall Study|Physician decision to withdraw patient|15|||
42351267|NCT00636610|76191154|FG001|Overall Study|Physician decision to withdraw patient|9|||
42351268|NCT00636610|76191153|FG000|Overall Study|Subject decision to withdraw|15|||
42351269|NCT00636610|76191154|FG001|Overall Study|Subject decision to withdraw|11|||
42351270|NCT00636610|76191153|FG000|Overall Study|Disease progression - radiographic|41|||
42152103|NCT00320528|75960692|FG002|Study Period III|Atomoxetine Commercially Available|90|||
42152104|NCT00320372|75960703|FG000|Overall Study|Physician Decision|4|||
42152105|NCT00320372|75960704|FG001|Overall Study|Physician Decision|7|||
42152106|NCT00320372|75960703|FG000|Overall Study|Death|7|||
42152107|NCT00320372|75960704|FG001|Overall Study|Death|8|||
42152108|NCT00320372|75960703|FG000|Overall Study|Withdrawal by Subject|55|||
42152109|NCT00320372|75960704|FG001|Overall Study|Withdrawal by Subject|37|||
42152110|NCT00320372|75960703|FG000|Overall Study|Non-Compliance|40|||
42152111|NCT00320372|75960704|FG001|Overall Study|Non-Compliance|39|||
42152112|NCT00320372|75960703|FG000|Overall Study|Did not Meet (I/E)|3|||
42152113|NCT00320372|75960704|FG001|Overall Study|Did not Meet (I/E)|1|||
42152114|NCT00320372|75960703|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
42152115|NCT00320372|75960704|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
42152116|NCT00294762|75960720|FG000|Overall Study|Did not receive study treatment|3|||
42152117|NCT00294762|75960721|FG001|Overall Study|Did not receive study treatment|3|||
42152118|NCT00294684|75960729|FG000|Overall Study|Lost to Follow-up|5|||
42152119|NCT00294684|75960730|FG001|Overall Study|Lost to Follow-up|8|||
42152120|NCT00307034|75960738|FG000|Overall Study|Adverse Event|1|||
42152121|NCT00307034|75960739|FG001|Overall Study|Adverse Event|2|||
42152122|NCT00307034|75960738|FG000|Overall Study|Withdrawal by Subject|1|||
42152123|NCT00307034|75960739|FG001|Overall Study|Withdrawal by Subject|2|||
42152124|NCT00307034|75960738|FG000|Overall Study|Lost to Follow-up|0|||
42152125|NCT00307034|75960739|FG001|Overall Study|Lost to Follow-up|3|||
42152126|NCT00320216|75960750|FG000|Overall Study|Adverse Event|0|||
42152127|NCT00320216|75960751|FG001|Overall Study|Adverse Event|6|||
42152128|NCT00320216|75960752|FG002|Overall Study|Adverse Event|0|||
42152129|NCT00320216|75960753|FG003|Overall Study|Adverse Event|2|||
42152130|NCT00320216|75960754|FG004|Overall Study|Adverse Event|2|||
42278313|NCT01791595|76109942|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
42278314|NCT01791595|76109943|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
42278315|NCT01791595|76109944|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
42278316|NCT01791595|76109945|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
42278317|NCT01791595|76109939|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
42278318|NCT01791595|76109940|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
42278319|NCT01791595|76109941|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
42278320|NCT01791595|76109942|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
42278321|NCT01791595|76109943|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
42278322|NCT01791595|76109944|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
42351271|NCT00636610|76191154|FG001|Overall Study|Disease progression - radiographic|51|||
42152131|NCT00320216|75960750|FG000|Overall Study|Lack of Efficacy|6|||
42152132|NCT00320216|75960751|FG001|Overall Study|Lack of Efficacy|2|||
42152133|NCT00320216|75960752|FG002|Overall Study|Lack of Efficacy|1|||
42152134|NCT00320216|75960753|FG003|Overall Study|Lack of Efficacy|0|||
42152135|NCT00320216|75960754|FG004|Overall Study|Lack of Efficacy|1|||
42152136|NCT00320216|75960750|FG000|Overall Study|Lost to Follow-up|3|||
42152137|NCT00320216|75960751|FG001|Overall Study|Lost to Follow-up|0|||
42152138|NCT00320216|75960752|FG002|Overall Study|Lost to Follow-up|0|||
42152139|NCT00320216|75960753|FG003|Overall Study|Lost to Follow-up|0|||
42152140|NCT00320216|75960754|FG004|Overall Study|Lost to Follow-up|0|||
42152141|NCT00320216|75960750|FG000|Overall Study|Other|7|||
42152142|NCT00320216|75960751|FG001|Overall Study|Other|2|||
42152143|NCT00320216|75960752|FG002|Overall Study|Other|5|||
42152144|NCT00320216|75960753|FG003|Overall Study|Other|1|||
42152145|NCT00320216|75960754|FG004|Overall Study|Other|3|||
42152146|NCT00290706|75960775|FG000|Overall Study|Withdrawal by Subject|2|||
42152147|NCT00290706|75960776|FG001|Overall Study|Withdrawal by Subject|0|||
42152148|NCT00290706|75960777|FG002|Overall Study|Withdrawal by Subject|0|||
42152149|NCT00290706|75960778|FG003|Overall Study|Withdrawal by Subject|0|||
42152150|NCT00290706|75960775|FG000|Overall Study|Progressive Disease|3|||
42152151|NCT00290706|75960776|FG001|Overall Study|Progressive Disease|5|||
42152152|NCT00290706|75960777|FG002|Overall Study|Progressive Disease|4|||
42152153|NCT00290706|75960778|FG003|Overall Study|Progressive Disease|10|||
42152154|NCT00290706|75960775|FG000|Overall Study|Adverse Event|0|||
42152155|NCT00290706|75960776|FG001|Overall Study|Adverse Event|1|||
42152156|NCT00290706|75960777|FG002|Overall Study|Adverse Event|2|||
42152157|NCT00290706|75960778|FG003|Overall Study|Adverse Event|0|||
42152158|NCT00290706|75960775|FG000|Overall Study|Receive auto transplant or radiation|0|||
42152159|NCT00290706|75960776|FG001|Overall Study|Receive auto transplant or radiation|0|||
42152160|NCT00290706|75960777|FG002|Overall Study|Receive auto transplant or radiation|0|||
42152161|NCT00290706|75960778|FG003|Overall Study|Receive auto transplant or radiation|1|||
42152162|NCT00290706|75960775|FG000|Overall Study|Physician Decision|0|||
42152163|NCT00290706|75960776|FG001|Overall Study|Physician Decision|0|||
42152164|NCT00290706|75960777|FG002|Overall Study|Physician Decision|0|||
42152165|NCT00290706|75960778|FG003|Overall Study|Physician Decision|1|||
42152166|NCT00303186|75960789|FG000|Overall Study|Other|52|||
42152167|NCT00294060|75960793|FG000|Overall Study|Death|225|||
42152168|NCT00294060|75960793|FG000|Overall Study|Other|59|||
42152169|NCT00294060|75960793|FG000|Overall Study|Lost to Follow-up|55|||
42152170|NCT00294060|75960793|FG000|Overall Study|Withdrawal by Subject|11|||
42152171|NCT00294060|75960793|FG000|Overall Study|Physician Decision|797|||
42152172|NCT00294060|75960793|FG000|Overall Study|Medical condition|3|||
42152173|NCT00294060|75960793|FG000|Overall Study|Device explanted/not replaced|23|||
42152174|NCT00303108|75960800|FG000|Overall Study|Adverse Event|5|||
42152175|NCT00303108|75960801|FG001|Overall Study|Adverse Event|6|||
42152176|NCT00303108|75960802|FG002|Overall Study|Adverse Event|7|||
42152177|NCT00303108|75960800|FG000|Overall Study|Patient Request|4|||
42152178|NCT00303108|75960801|FG001|Overall Study|Patient Request|2|||
42152179|NCT00303108|75960802|FG002|Overall Study|Patient Request|8|||
42152180|NCT00303108|75960800|FG000|Overall Study|Failed Entry|1|||
42152181|NCT00303108|75960801|FG001|Overall Study|Failed Entry|0|||
42152182|NCT00303108|75960802|FG002|Overall Study|Failed Entry|1|||
42152183|NCT00303108|75960800|FG000|Overall Study|ineligible|2|||
42152184|NCT00303108|75960801|FG001|Overall Study|ineligible|1|||
42152185|NCT00303108|75960802|FG002|Overall Study|ineligible|0|||
42152186|NCT00302952|75960811|FG000|Overall Study|Physician Decision|1|||
42152187|NCT00302952|75960812|FG001|Overall Study|Physician Decision|1|||
42152188|NCT00302952|75960811|FG000|Overall Study|Withdrawal by Subject|2|||
42152189|NCT00302952|75960812|FG001|Overall Study|Withdrawal by Subject|3|||
42278323|NCT01791595|76109945|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
42278324|NCT01791595|76109939|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
42278325|NCT01791595|76109940|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
42278326|NCT01791595|76109941|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
42278327|NCT01791595|76109942|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
42278328|NCT01791595|76109943|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
42278329|NCT01791595|76109944|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
42278330|NCT01791595|76109945|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
42278331|NCT01791595|76109939|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
42278332|NCT01791595|76109940|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
42278333|NCT01791595|76109941|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
42278334|NCT01791595|76109942|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
42278335|NCT01791595|76109943|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
42278336|NCT01791595|76109944|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
42278337|NCT01791595|76109945|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
42278338|NCT01791595|76109939|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
42278339|NCT01791595|76109940|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
42012975|NCT01475786|75819957|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
42152190|NCT00302952|75960811|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
42152191|NCT00302952|75960812|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
42152192|NCT00302718|75960822|FG000|Overall Study|Participant left the hospital|1|||
42152193|NCT00302718|75960823|FG001|Overall Study|Participant left the hospital|0|||
42278340|NCT01791595|76109941|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
42351272|NCT00636610|76191153|FG000|Overall Study|Disease progression - clinical|8|||
42152194|NCT00302718|75960824|FG002|Overall Study|Participant left the hospital|0|||
42152195|NCT00302718|75960825|FG003|Overall Study|Participant left the hospital|1|||
42152196|NCT00302718|75960822|FG000|Overall Study|Withdrawal by Subject|0|||
42152197|NCT00302718|75960823|FG001|Overall Study|Withdrawal by Subject|1|||
42152198|NCT00302718|75960824|FG002|Overall Study|Withdrawal by Subject|0|||
42152199|NCT00302718|75960825|FG003|Overall Study|Withdrawal by Subject|0|||
42152200|NCT00302718|75960822|FG000|Overall Study|Participant left primary care setting|0|||
42152201|NCT00302718|75960823|FG001|Overall Study|Participant left primary care setting|0|||
42152202|NCT00302718|75960824|FG002|Overall Study|Participant left primary care setting|2|||
42152203|NCT00302718|75960825|FG003|Overall Study|Participant left primary care setting|1|||
42152204|NCT00302328|75960843|FG000|Overall Study|Physician Decision|0|||
42152205|NCT00302328|75960844|FG001|Overall Study|Physician Decision|1|||
42152206|NCT00302328|75960845|FG002|Overall Study|Physician Decision|0|||
42152207|NCT00301080|75960856|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
42152208|NCT00301080|75960857|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
42152209|NCT00301080|75960858|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
42152210|NCT00301080|75960859|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
42152211|NCT00301080|75960860|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
42152212|NCT00290238|75960871|FG000|Overall Study|Study terminated|27|||
42152213|NCT00290238|75960872|FG001|Overall Study|Study terminated|27|||
42152214|NCT00290238|75960871|FG000|Overall Study|Lost to Follow-up|0|||
42152215|NCT00290238|75960872|FG001|Overall Study|Lost to Follow-up|1|||
42152216|NCT00290238|75960871|FG000|Overall Study|Withdrawal by Subject|15|||
42152217|NCT00290238|75960872|FG001|Overall Study|Withdrawal by Subject|13|||
42152218|NCT00289848|75960880|FG000|Overall Study|Adverse Event|6|||
42152219|NCT00289848|75960881|FG001|Overall Study|Adverse Event|4|||
42152220|NCT00289848|75960880|FG000|Overall Study|Death|1|||
42152221|NCT00289848|75960881|FG001|Overall Study|Death|0|||
42152222|NCT00289848|75960880|FG000|Overall Study|Lack of Efficacy|20|||
42152223|NCT00289848|75960881|FG001|Overall Study|Lack of Efficacy|24|||
42152224|NCT00289848|75960880|FG000|Overall Study|Lost to Follow-up|3|||
42152225|NCT00289848|75960881|FG001|Overall Study|Lost to Follow-up|1|||
42152226|NCT00289848|75960880|FG000|Overall Study|Protocol Violation|5|||
42039872|NCT02985957|75848294|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
42039873|NCT02985957|75848288|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
42039874|NCT02985957|75848289|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
42039875|NCT02985957|75848290|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
42039876|NCT02985957|75848291|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
42039877|NCT02985957|75848292|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
42039878|NCT02985957|75848293|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
42039879|NCT02985957|75848294|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
42039880|NCT02985957|75848288|FG000|Treatment Period|Death|0|||
42039881|NCT02985957|75848289|FG001|Treatment Period|Death|0|||
42039882|NCT02985957|75848290|FG002|Treatment Period|Death|0|||
42039883|NCT02985957|75848291|FG003|Treatment Period|Death|0|||
42039884|NCT02985957|75848292|FG004|Treatment Period|Death|1|||
42039885|NCT02985957|75848293|FG005|Treatment Period|Death|0|||
42039886|NCT02985957|75848294|FG006|Treatment Period|Death|0|||
42152227|NCT00289848|75960881|FG001|Overall Study|Protocol Violation|2|||
42152228|NCT00289848|75960880|FG000|Overall Study|Withdrawal by Subject|5|||
42152229|NCT00289848|75960881|FG001|Overall Study|Withdrawal by Subject|11|||
42152230|NCT00289848|75960880|FG000|Overall Study|Patient Moved|6|||
42152231|NCT00289848|75960881|FG001|Overall Study|Patient Moved|2|||
42152232|NCT00289848|75960880|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
42152233|NCT00289848|75960881|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
42152234|NCT00289770|75960887|FG000|Year 15|Withdrawal by Subject|1|||
42152235|NCT00289536|75960891|FG000|Period 3|Lost to Follow-up|0|||
42152236|NCT00289536|75960892|FG001|Period 3|Lost to Follow-up|0|||
42152237|NCT00289536|75960893|FG002|Period 3|Lost to Follow-up|1|||
42152238|NCT00289458|75960902|FG000|Overall Study|Death|1|||
42152239|NCT00289458|75960903|FG001|Overall Study|Death|0|||
42152240|NCT00289458|75960904|FG002|Overall Study|Death|0|||
42152241|NCT00289458|75960902|FG000|Overall Study|Physician Decision|3|||
42278341|NCT01791595|76109942|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
42039887|NCT02985957|75848288|FG000|Treatment Period|Participant withdrew consent|0|||
42039888|NCT02985957|75848289|FG001|Treatment Period|Participant withdrew consent|0|||
42039889|NCT02985957|75848290|FG002|Treatment Period|Participant withdrew consent|0|||
42039890|NCT02985957|75848291|FG003|Treatment Period|Participant withdrew consent|1|||
42039891|NCT02985957|75848292|FG004|Treatment Period|Participant withdrew consent|3|||
42039892|NCT02985957|75848293|FG005|Treatment Period|Participant withdrew consent|0|||
42039893|NCT02985957|75848294|FG006|Treatment Period|Participant withdrew consent|1|||
42152242|NCT00289458|75960903|FG001|Overall Study|Physician Decision|4|||
42152243|NCT00289458|75960904|FG002|Overall Study|Physician Decision|2|||
42152244|NCT00289458|75960902|FG000|Overall Study|Withdrawal by Subject|2|||
42152245|NCT00289458|75960903|FG001|Overall Study|Withdrawal by Subject|2|||
42152246|NCT00289458|75960904|FG002|Overall Study|Withdrawal by Subject|4|||
42152247|NCT00288912|75960915|FG000|Overall Study|Developed exclusion criterion|4|||
42152248|NCT00288912|75960916|FG001|Overall Study|Developed exclusion criterion|6|||
42152249|NCT00288912|75960917|FG002|Overall Study|Developed exclusion criterion|7|||
42152250|NCT00288912|75960915|FG000|Overall Study|Lost to Follow-up|9|||
42152251|NCT00288912|75960916|FG001|Overall Study|Lost to Follow-up|6|||
42152252|NCT00288912|75960917|FG002|Overall Study|Lost to Follow-up|9|||
42152253|NCT00288912|75960915|FG000|Overall Study|Withdrawal by Subject|4|||
42152254|NCT00288912|75960916|FG001|Overall Study|Withdrawal by Subject|5|||
42152255|NCT00288912|75960917|FG002|Overall Study|Withdrawal by Subject|12|||
42152256|NCT00305864|75960929|FG000|Overall Study|Ineligible / No protocol treatment|0|||
42152257|NCT00305864|75960930|FG001|Overall Study|Ineligible / No protocol treatment|1|||
42152258|NCT00305864|75960931|FG002|Overall Study|Ineligible / No protocol treatment|1|||
42152259|NCT00305864|75960932|FG003|Overall Study|Ineligible / No protocol treatment|13|||
42152260|NCT00295880|75960942|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
42152261|NCT00295880|75960942|FG000|Overall Study|Unit randomization did not occur|1|||
42152262|NCT00319982|75960948|FG000|Overall Study|Withdrawal by Subject|1|||
42152263|NCT00319982|75960949|FG001|Overall Study|Withdrawal by Subject|0|||
42152264|NCT00319592|75960957|FG000|Overall Study|Protocol Violation|1|||
42152265|NCT00319592|75960958|FG001|Overall Study|Protocol Violation|0|||
42152266|NCT00319592|75960957|FG000|Overall Study|Physician Decision|0|||
42152267|NCT00319592|75960958|FG001|Overall Study|Physician Decision|1|||
42152268|NCT00295490|75960968|FG000|Overall Study|Protocol Violation|0|||
42152269|NCT00295490|75960969|FG001|Overall Study|Protocol Violation|0|||
42152270|NCT00295490|75960970|FG002|Overall Study|Protocol Violation|3|||
42152271|NCT00295490|75960971|FG003|Overall Study|Protocol Violation|3|||
42152272|NCT00295490|75960968|FG000|Overall Study|Withdrawal by Subject|0|||
42152273|NCT00295490|75960969|FG001|Overall Study|Withdrawal by Subject|2|||
42152274|NCT00295490|75960970|FG002|Overall Study|Withdrawal by Subject|0|||
42152275|NCT00295490|75960971|FG003|Overall Study|Withdrawal by Subject|1|||
42152276|NCT00295490|75960968|FG000|Overall Study|Lost to Follow-up|0|||
42152277|NCT00295490|75960969|FG001|Overall Study|Lost to Follow-up|0|||
42152278|NCT00295490|75960970|FG002|Overall Study|Lost to Follow-up|1|||
42152279|NCT00295490|75960971|FG003|Overall Study|Lost to Follow-up|0|||
42152280|NCT00295490|75960968|FG000|Overall Study|Adverse Event|1|||
42152281|NCT00295490|75960969|FG001|Overall Study|Adverse Event|0|||
42152282|NCT00295490|75960970|FG002|Overall Study|Adverse Event|0|||
42152283|NCT00295490|75960971|FG003|Overall Study|Adverse Event|0|||
42152284|NCT00295490|75960968|FG000|Overall Study|Other|0|||
42152285|NCT00295490|75960969|FG001|Overall Study|Other|2|||
42152286|NCT00295490|75960970|FG002|Overall Study|Other|0|||
42152287|NCT00295490|75960971|FG003|Overall Study|Other|1|||
42152288|NCT00305006|75960983|FG000|Overall Study|Withdrawal by Subject|1|||
42152289|NCT00305006|75960984|FG001|Overall Study|Withdrawal by Subject|0|||
42152290|NCT00305006|75960983|FG000|Overall Study|Failure to complete pretest|0|||
42152291|NCT00305006|75960984|FG001|Overall Study|Failure to complete pretest|1|||
42152292|NCT00319436|75960992|FG000|Overall Study|Withdrawal by Subject|6|||
42152293|NCT00319436|75960993|FG001|Overall Study|Withdrawal by Subject|7|||
42152294|NCT00319046|75960999|FG000|Overall Study|withdrawal of subject's consent|7|||
42152295|NCT00319046|75960999|FG000|Overall Study|administrative reason|1|||
42152296|NCT00303602|75961005|FG000|Overall Study|Adverse Event|2|||
42152297|NCT00303602|75961006|FG001|Overall Study|Adverse Event|2|||
42152298|NCT00303602|75961005|FG000|Overall Study|Withdrawal by Subject|5|||
42152299|NCT00303602|75961006|FG001|Overall Study|Withdrawal by Subject|6|||
42152300|NCT00303602|75961005|FG000|Overall Study|Lost to Follow-up|5|||
42152301|NCT00303602|75961006|FG001|Overall Study|Lost to Follow-up|2|||
42152302|NCT00303602|75961005|FG000|Overall Study|Protocol entry criteria not met|2|||
42152303|NCT00303602|75961006|FG001|Overall Study|Protocol entry criteria not met|2|||
42278342|NCT01791595|76109943|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
42351273|NCT00636610|76191154|FG001|Overall Study|Disease progression - clinical|3|||
42012976|NCT01475786|75819958|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
42012977|NCT01290692|75819966|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
42012978|NCT00700882|75820002|FG000|Overall Study|Never received treatment|6|||
42012979|NCT00700882|75820002|FG000|Overall Study|Ineligible|2|||
42152304|NCT00303602|75961005|FG000|Overall Study|Physician Decision|2|||
42152305|NCT00303602|75961006|FG001|Overall Study|Physician Decision|1|||
42152306|NCT00303602|75961005|FG000|Overall Study|Noncompliance|2|||
42152307|NCT00303602|75961006|FG001|Overall Study|Noncompliance|2|||
42152308|NCT00303602|75961005|FG000|Overall Study|Protocol Violation|1|||
42152309|NCT00303602|75961006|FG001|Overall Study|Protocol Violation|0|||
42152310|NCT00299130|75961015|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
42152311|NCT00299130|75961016|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
42152312|NCT00299130|75961017|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
42152313|NCT00299130|75961015|FG000|Treatment Period (up to 5 Years)|Death|1|||
42152314|NCT00299130|75961016|FG001|Treatment Period (up to 5 Years)|Death|3|||
42152315|NCT00299130|75961017|FG002|Treatment Period (up to 5 Years)|Death|1|||
42152316|NCT00299130|75961015|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
42152317|NCT00299130|75961016|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
42152318|NCT00299130|75961017|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
42152319|NCT00299130|75961015|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
42152320|NCT00299130|75961016|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
42152321|NCT00299130|75961017|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
42152322|NCT00299130|75961015|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
42152323|NCT00299130|75961016|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
42152324|NCT00299130|75961017|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
42152325|NCT00299130|75961015|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
42152326|NCT00299130|75961016|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
42152327|NCT00299130|75961017|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
42152328|NCT00299130|75961015|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
42152329|NCT00299130|75961016|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
42152330|NCT00299130|75961017|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
42152331|NCT00299130|75961015|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
42152332|NCT00299130|75961016|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
42152333|NCT00299130|75961017|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
42152334|NCT00299130|75961015|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
42152335|NCT00299130|75961016|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
42152336|NCT00299130|75961017|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
42278343|NCT01791595|76109944|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
42278344|NCT01791595|76109945|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
42039894|NCT02985957|75848288|FG000|Treatment Period|Lost to Follow-up|0|||
42278345|NCT01559363|76109998|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
42278346|NCT01559363|76109999|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
42278347|NCT01559363|76110000|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
42278348|NCT01559363|76110001|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
42278349|NCT01559363|76110002|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
42278350|NCT01559363|76110003|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
42039895|NCT02985957|75848289|FG001|Treatment Period|Lost to Follow-up|0|||
42039896|NCT02985957|75848290|FG002|Treatment Period|Lost to Follow-up|0|||
42152337|NCT00299130|75961015|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
42152338|NCT00299130|75961016|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
42152339|NCT00299130|75961017|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
42152340|NCT00299130|75961015|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
42152341|NCT00299130|75961016|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
42152342|NCT00299130|75961017|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
42152343|NCT00299130|75961015|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
42152344|NCT00299130|75961016|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
42278351|NCT01559363|76109998|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
42039897|NCT02985957|75848291|FG003|Treatment Period|Lost to Follow-up|0|||
42039898|NCT02985957|75848292|FG004|Treatment Period|Lost to Follow-up|1|||
42039899|NCT02985957|75848293|FG005|Treatment Period|Lost to Follow-up|0|||
42039900|NCT02985957|75848294|FG006|Treatment Period|Lost to Follow-up|0|||
42039901|NCT02985957|75848288|FG000|Treatment Period|Other reasons|0|||
42039902|NCT02985957|75848289|FG001|Treatment Period|Other reasons|0|||
42039903|NCT02985957|75848290|FG002|Treatment Period|Other reasons|1|||
42039904|NCT02985957|75848291|FG003|Treatment Period|Other reasons|3|||
42278352|NCT01559363|76109999|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
42278353|NCT01559363|76110000|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
42278354|NCT01559363|76110001|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
42278355|NCT01559363|76110002|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
42278356|NCT01559363|76110003|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
42278357|NCT01559363|76109998|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
42278358|NCT01559363|76109999|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
42278359|NCT01559363|76110000|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
42278360|NCT01559363|76110001|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
42012980|NCT00700882|75820002|FG000|Overall Study|No KIT mutation|51|||
42012981|NCT00666835|75820040|FG000|Overall Study|Withdrawal by Subject|5|||
42012982|NCT00666835|75820041|FG001|Overall Study|Withdrawal by Subject|2|||
42012983|NCT00666835|75820040|FG000|Overall Study|Lack of Efficacy|0|||
42152345|NCT00299130|75961017|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
42152346|NCT00299130|75961015|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
42152347|NCT00299130|75961016|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
42012984|NCT00666835|75820041|FG001|Overall Study|Lack of Efficacy|1|||
42152348|NCT00299130|75961017|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
42152349|NCT00299130|75961015|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
42152350|NCT00299130|75961016|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
42152351|NCT00299130|75961017|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
42152352|NCT00299130|75961015|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
42152353|NCT00299130|75961016|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
42152354|NCT00299130|75961017|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
42152355|NCT00299130|75961015|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
42152356|NCT00299130|75961016|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
42152357|NCT00299130|75961017|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
42152358|NCT00299130|75961015|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
42152359|NCT00299130|75961016|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
42152360|NCT00299130|75961017|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
42152361|NCT00288054|75961032|FG000|Overall Study|Protocol Violation|2|||
42152362|NCT00288054|75961032|FG000|Overall Study|Lack of Efficacy|16|||
42152363|NCT00288054|75961032|FG000|Overall Study|Adverse Event|3|||
42152364|NCT00288054|75961032|FG000|Overall Study|Withdrawal by Subject|1|||
42152365|NCT00288054|75961032|FG000|Overall Study|Not protocol specified|2|||
42152366|NCT00287586|75961040|FG000|Overall Study|Withdrew Consent|19|||
42012985|NCT00666835|75820040|FG000|Overall Study|Incl./excl. not fulfilled|7|||
42152367|NCT00287586|75961041|FG001|Overall Study|Withdrew Consent|30|||
42152368|NCT00287586|75961040|FG000|Overall Study|Lost to Follow-up|5|||
42152369|NCT00287586|75961041|FG001|Overall Study|Lost to Follow-up|4|||
42152370|NCT00287586|75961040|FG000|Overall Study|Death|2|||
42152371|NCT00287586|75961041|FG001|Overall Study|Death|3|||
42152372|NCT00287586|75961040|FG000|Overall Study|Elevated Hematocrit|3|||
42152373|NCT00287586|75961041|FG001|Overall Study|Elevated Hematocrit|0|||
42152374|NCT00287586|75961040|FG000|Overall Study|Rash|3|||
42152375|NCT00287586|75961041|FG001|Overall Study|Rash|0|||
42152376|NCT00287586|75961040|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
42152377|NCT00287586|75961041|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
42152378|NCT00287586|75961040|FG000|Overall Study|Stroke|2|||
42152379|NCT00287586|75961041|FG001|Overall Study|Stroke|0|||
42152380|NCT00287586|75961040|FG000|Overall Study|Myocardial Infarction|1|||
42152381|NCT00287586|75961041|FG001|Overall Study|Myocardial Infarction|0|||
42152382|NCT00287586|75961040|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
42152383|NCT00287586|75961041|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
42152384|NCT00287586|75961040|FG000|Overall Study|Cognitive Impairment|1|||
42152385|NCT00287586|75961041|FG001|Overall Study|Cognitive Impairment|0|||
42152386|NCT00287586|75961040|FG000|Overall Study|Pancreatic Cancer|1|||
42152387|NCT00287586|75961041|FG001|Overall Study|Pancreatic Cancer|3|||
42152388|NCT00287586|75961040|FG000|Overall Study|Sleep Apnea|1|||
42152389|NCT00287586|75961041|FG001|Overall Study|Sleep Apnea|0|||
42152390|NCT00287586|75961040|FG000|Overall Study|Shoulder Pain|1|||
42152391|NCT00287586|75961041|FG001|Overall Study|Shoulder Pain|0|||
42152392|NCT00287586|75961040|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
42152393|NCT00287586|75961041|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
42152394|NCT00287586|75961040|FG000|Overall Study|Nonadherence|1|||
42152395|NCT00287586|75961041|FG001|Overall Study|Nonadherence|1|||
42152396|NCT00287586|75961040|FG000|Overall Study|Enrolled in Another Study|1|||
42152397|NCT00287586|75961041|FG001|Overall Study|Enrolled in Another Study|0|||
42152398|NCT00287586|75961040|FG000|Overall Study|Major Depression|0|||
42152399|NCT00287586|75961041|FG001|Overall Study|Major Depression|2|||
42152400|NCT00287586|75961040|FG000|Overall Study|Lung Cancer|0|||
42152401|NCT00287586|75961041|FG001|Overall Study|Lung Cancer|2|||
42152402|NCT00287586|75961040|FG000|Overall Study|Elevated IPSS Score|0|||
42152403|NCT00287586|75961041|FG001|Overall Study|Elevated IPSS Score|1|||
42152404|NCT00287586|75961040|FG000|Overall Study|Retroperitoneal Cancer|0|||
42152405|NCT00287586|75961041|FG001|Overall Study|Retroperitoneal Cancer|1|||
42152406|NCT00287586|75961040|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
42152407|NCT00287586|75961041|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
42152408|NCT00287586|75961040|FG000|Overall Study|Mood Swings and Irritability|0|||
42152409|NCT00287586|75961041|FG001|Overall Study|Mood Swings and Irritability|1|||
42152410|NCT00287586|75961040|FG000|Overall Study|Bradycardia|0|||
42152411|NCT00287586|75961041|FG001|Overall Study|Bradycardia|1|||
42152412|NCT00287586|75961040|FG000|Overall Study|Itchy Swollen Eyes|0|||
42152413|NCT00287586|75961041|FG001|Overall Study|Itchy Swollen Eyes|1|||
42152414|NCT00287586|75961040|FG000|Overall Study|Recurrent Melanoma|0|||
42152415|NCT00287586|75961041|FG001|Overall Study|Recurrent Melanoma|1|||
42152416|NCT00287118|75961047|FG000|Overall Study|Adverse Event|30|||
42152417|NCT00287118|75961047|FG000|Overall Study|Death|1|||
42152418|NCT00287118|75961047|FG000|Overall Study|Lack of Efficacy|11|||
42152419|NCT00287118|75961047|FG000|Overall Study|Lost to Follow-up|1|||
42152420|NCT00287118|75961047|FG000|Overall Study|Protocol Violation|2|||
42152421|NCT00287118|75961047|FG000|Overall Study|Other|7|||
42152422|NCT00293202|75961053|FG000|Overall Study|Withdrawal by Subject|1|||
42152423|NCT00293202|75961054|FG001|Overall Study|Withdrawal by Subject|2|||
42152424|NCT00293202|75961053|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
42152425|NCT00293202|75961054|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
42152426|NCT00293202|75961053|FG000|Overall Study|on-hold due to fistula maturation time|1|||
42152427|NCT00293202|75961054|FG001|Overall Study|on-hold due to fistula maturation time|0|||
42039905|NCT02985957|75848292|FG004|Treatment Period|Other reasons|6|||
42039906|NCT02985957|75848293|FG005|Treatment Period|Other reasons|0|||
42039907|NCT02985957|75848294|FG006|Treatment Period|Other reasons|1|||
42039908|NCT02985957|75848288|FG000|Treatment Period|Not reported|0|||
42039909|NCT02985957|75848289|FG001|Treatment Period|Not reported|1|||
42039910|NCT02985957|75848290|FG002|Treatment Period|Not reported|2|||
42039911|NCT02985957|75848291|FG003|Treatment Period|Not reported|5|||
42039912|NCT02985957|75848292|FG004|Treatment Period|Not reported|0|||
42039913|NCT02985957|75848293|FG005|Treatment Period|Not reported|0|||
42039914|NCT02985957|75848294|FG006|Treatment Period|Not reported|0|||
42039915|NCT02985957|75848288|FG000|Treatment Period|Maximum clinical benefit|0|||
42039916|NCT02985957|75848289|FG001|Treatment Period|Maximum clinical benefit|0|||
42039917|NCT02985957|75848290|FG002|Treatment Period|Maximum clinical benefit|1|||
42039918|NCT02985957|75848291|FG003|Treatment Period|Maximum clinical benefit|1|||
42039919|NCT02985957|75848292|FG004|Treatment Period|Maximum clinical benefit|0|||
42039920|NCT02985957|75848293|FG005|Treatment Period|Maximum clinical benefit|0|||
42039921|NCT02985957|75848294|FG006|Treatment Period|Maximum clinical benefit|2|||
42152428|NCT00298896|75961064|FG000|Overall Study|Death|3|||
42152429|NCT00298896|75961064|FG000|Overall Study|Physician Decision|2|||
42152430|NCT00298896|75961064|FG000|Overall Study|Intercurrent Illness|1|||
42152431|NCT00298896|75961064|FG000|Overall Study|Disease Progression|41|||
42152432|NCT00298896|75961064|FG000|Overall Study|Withdrawal by Subject|2|||
42152433|NCT00298896|75961064|FG000|Overall Study|Assigned to treatment in error|1|||
42152434|NCT00286494|75961071|FG000|Overall Study|Hyperglycemic rescue|12|||
42152435|NCT00286494|75961072|FG001|Overall Study|Hyperglycemic rescue|19|||
42039922|NCT02985957|75848288|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
42039923|NCT02985957|75848289|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
42039924|NCT02985957|75848290|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
42039925|NCT02985957|75848291|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
42039926|NCT02985957|75848292|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
42039927|NCT02985957|75848293|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
42039928|NCT02985957|75848294|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
42039929|NCT02985957|75848288|FG000|Treatment Period|Study drug toxicity|1|||
42039930|NCT02985957|75848289|FG001|Treatment Period|Study drug toxicity|23|||
42039931|NCT02985957|75848290|FG002|Treatment Period|Study drug toxicity|20|||
42039932|NCT02985957|75848291|FG003|Treatment Period|Study drug toxicity|11|||
42039933|NCT02985957|75848292|FG004|Treatment Period|Study drug toxicity|19|||
42039934|NCT02985957|75848293|FG005|Treatment Period|Study drug toxicity|3|||
42039935|NCT02985957|75848294|FG006|Treatment Period|Study drug toxicity|5|||
42039936|NCT02985957|75848288|FG000|Treatment Period|Disease progression|0|||
42039937|NCT02985957|75848289|FG001|Treatment Period|Disease progression|16|||
42039938|NCT02985957|75848290|FG002|Treatment Period|Disease progression|20|||
42039939|NCT02985957|75848291|FG003|Treatment Period|Disease progression|39|||
42039940|NCT02985957|75848292|FG004|Treatment Period|Disease progression|29|||
42039941|NCT02985957|75848293|FG005|Treatment Period|Disease progression|11|||
42039942|NCT02985957|75848294|FG006|Treatment Period|Disease progression|28|||
42039943|NCT02985957|75848288|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
42039944|NCT02985957|75848289|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
42039945|NCT02985957|75848290|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
42039946|NCT02985957|75848291|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
42039947|NCT02985957|75848292|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
42039948|NCT02985957|75848293|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
42039949|NCT02985957|75848294|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
42039950|NCT02985957|75848288|FG000|Treatment Period|Poor/Non-Compliance|0|||
42039951|NCT02985957|75848289|FG001|Treatment Period|Poor/Non-Compliance|0|||
42039952|NCT02985957|75848290|FG002|Treatment Period|Poor/Non-Compliance|0|||
42039953|NCT02985957|75848291|FG003|Treatment Period|Poor/Non-Compliance|0|||
42039954|NCT02985957|75848292|FG004|Treatment Period|Poor/Non-Compliance|1|||
42039955|NCT02985957|75848293|FG005|Treatment Period|Poor/Non-Compliance|1|||
42152436|NCT00286494|75961073|FG002|Overall Study|Hyperglycemic rescue|18|||
42152437|NCT00286494|75961071|FG000|Overall Study|Withdrawal by Subject|2|||
42152438|NCT00286494|75961072|FG001|Overall Study|Withdrawal by Subject|10|||
42152439|NCT00286494|75961073|FG002|Overall Study|Withdrawal by Subject|9|||
42152440|NCT00286494|75961071|FG000|Overall Study|Adverse Event|3|||
42152441|NCT00286494|75961072|FG001|Overall Study|Adverse Event|8|||
42152442|NCT00286494|75961073|FG002|Overall Study|Adverse Event|6|||
42152443|NCT00286494|75961071|FG000|Overall Study|Physician Decision|5|||
42152444|NCT00286494|75961072|FG001|Overall Study|Physician Decision|5|||
42152445|NCT00286494|75961073|FG002|Overall Study|Physician Decision|1|||
42152446|NCT00286494|75961071|FG000|Overall Study|Lost to Follow-up|3|||
42152447|NCT00286494|75961072|FG001|Overall Study|Lost to Follow-up|1|||
42152448|NCT00286494|75961073|FG002|Overall Study|Lost to Follow-up|3|||
42152449|NCT00286494|75961071|FG000|Overall Study|Protocol Violation|1|||
42152450|NCT00286494|75961072|FG001|Overall Study|Protocol Violation|1|||
42152451|NCT00286494|75961073|FG002|Overall Study|Protocol Violation|2|||
42152452|NCT00298740|75961081|FG000|Overall Study|Lack of Efficacy|6|||
42152453|NCT00298740|75961081|FG000|Overall Study|Withdrawal by Subject|3|||
42152454|NCT00285012|75961087|FG000|Assigned to Study Treatment (Tx)|Other|2|||
42152455|NCT00285012|75961088|FG001|Assigned to Study Treatment (Tx)|Other|3|||
42152456|NCT00285012|75961087|FG000|Received Study Tx|Death|2|||
42152457|NCT00285012|75961088|FG001|Received Study Tx|Death|1|||
42152458|NCT00285012|75961087|FG000|Received Study Tx|Adverse Event|5|||
42152459|NCT00285012|75961088|FG001|Received Study Tx|Adverse Event|11|||
42152460|NCT00285012|75961087|FG000|Received Study Tx|Lack of Efficacy|0|||
42152461|NCT00285012|75961088|FG001|Received Study Tx|Lack of Efficacy|3|||
42152462|NCT00285012|75961087|FG000|Received Study Tx|Lost to Follow-up|29|||
42152463|NCT00285012|75961088|FG001|Received Study Tx|Lost to Follow-up|31|||
42152464|NCT00285012|75961087|FG000|Received Study Tx|Withdrawal by Subject|31|||
42152465|NCT00285012|75961088|FG001|Received Study Tx|Withdrawal by Subject|43|||
42152466|NCT00285012|75961087|FG000|Received Study Tx|Other|5|||
42152467|NCT00285012|75961088|FG001|Received Study Tx|Other|5|||
42152468|NCT00284934|75961096|FG000|Overall Study|Adverse Event|1|||
42152469|NCT00284934|75961097|FG001|Overall Study|Adverse Event|2|||
42152470|NCT00284934|75961096|FG000|Overall Study|Other reasons|3|||
42152471|NCT00284934|75961097|FG001|Overall Study|Other reasons|1|||
42152472|NCT00284856|75961106|FG000|Overall Study|Adverse Event|3|||
42152473|NCT00284856|75961107|FG001|Overall Study|Adverse Event|3|||
42152474|NCT00284856|75961108|FG002|Overall Study|Adverse Event|3|||
42152475|NCT00284856|75961106|FG000|Overall Study|Lack of Efficacy|2|||
42152476|NCT00284856|75961107|FG001|Overall Study|Lack of Efficacy|1|||
42152477|NCT00284856|75961108|FG002|Overall Study|Lack of Efficacy|8|||
42152478|NCT00284856|75961106|FG000|Overall Study|Lost to Follow-up|25|||
42152479|NCT00284856|75961107|FG001|Overall Study|Lost to Follow-up|21|||
42152480|NCT00284856|75961108|FG002|Overall Study|Lost to Follow-up|22|||
42152481|NCT00284856|75961106|FG000|Overall Study|Protocol Violation|5|||
42152482|NCT00284856|75961107|FG001|Overall Study|Protocol Violation|4|||
42152483|NCT00284856|75961108|FG002|Overall Study|Protocol Violation|5|||
42152484|NCT00284856|75961106|FG000|Overall Study|Withdrawal by Subject|12|||
42152485|NCT00284856|75961107|FG001|Overall Study|Withdrawal by Subject|16|||
42152486|NCT00284856|75961108|FG002|Overall Study|Withdrawal by Subject|18|||
42152487|NCT00284856|75961106|FG000|Overall Study|Other|4|||
42152488|NCT00284856|75961107|FG001|Overall Study|Other|5|||
42152489|NCT00284856|75961108|FG002|Overall Study|Other|4|||
42152490|NCT00298272|75961118|FG000|Double-blind Phase|Adverse Event|2|||
42152491|NCT00298272|75961119|FG001|Double-blind Phase|Adverse Event|0|||
42152492|NCT00298272|75961118|FG000|Double-blind Phase|Failure to Return|2|||
42152493|NCT00298272|75961119|FG001|Double-blind Phase|Failure to Return|0|||
42152494|NCT00298272|75961118|FG000|Double-blind Phase|Protocol Violation|2|||
42152495|NCT00298272|75961119|FG001|Double-blind Phase|Protocol Violation|0|||
42152496|NCT00298272|75961118|FG000|Double-blind Phase|Withdrawal by Subject|2|||
42152497|NCT00298272|75961119|FG001|Double-blind Phase|Withdrawal by Subject|0|||
42152498|NCT00298272|75961118|FG000|Open Label Retreatment Phase|Adverse Event|1|||
42152499|NCT00298272|75961119|FG001|Open Label Retreatment Phase|Adverse Event|2|||
42152500|NCT00298272|75961118|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
42152501|NCT00298272|75961119|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
42152502|NCT00298272|75961118|FG000|Open Label Retreatment Phase|Failure to Return|1|||
42152503|NCT00298272|75961119|FG001|Open Label Retreatment Phase|Failure to Return|0|||
42152504|NCT00298272|75961118|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
42152505|NCT00298272|75961119|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
42152506|NCT00298272|75961118|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
42152507|NCT00298272|75961119|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
42152508|NCT00298272|75961118|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
42152509|NCT00298272|75961119|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
42152510|NCT00298272|75961118|FG000|Safety Follow-up Phase|Failure to Return|1|||
42152511|NCT00298272|75961119|FG001|Safety Follow-up Phase|Failure to Return|1|||
42152512|NCT00298272|75961118|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
42152513|NCT00298272|75961119|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
42152514|NCT00298272|75961118|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
42152515|NCT00298272|75961119|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
42152516|NCT00283842|75961133|FG000|Overall Study|Adverse Event|8|||
42152517|NCT00283842|75961134|FG001|Overall Study|Adverse Event|7|||
42152518|NCT00283842|75961135|FG002|Overall Study|Adverse Event|21|||
42152519|NCT00283842|75961136|FG003|Overall Study|Adverse Event|21|||
42152520|NCT00283842|75961137|FG004|Overall Study|Adverse Event|5|||
42152521|NCT00283842|75961133|FG000|Overall Study|Protocol Violation|1|||
42152522|NCT00283842|75961134|FG001|Overall Study|Protocol Violation|5|||
42152523|NCT00283842|75961135|FG002|Overall Study|Protocol Violation|4|||
42152524|NCT00283842|75961136|FG003|Overall Study|Protocol Violation|0|||
42152525|NCT00283842|75961137|FG004|Overall Study|Protocol Violation|0|||
42152526|NCT00283842|75961133|FG000|Overall Study|Protocol deviation|0|||
42152527|NCT00283842|75961134|FG001|Overall Study|Protocol deviation|0|||
42152528|NCT00283842|75961135|FG002|Overall Study|Protocol deviation|0|||
42152529|NCT00283842|75961136|FG003|Overall Study|Protocol deviation|0|||
42152530|NCT00283842|75961137|FG004|Overall Study|Protocol deviation|2|||
42152531|NCT00283842|75961133|FG000|Overall Study|Withdrawal by Subject|2|||
42152532|NCT00283842|75961134|FG001|Overall Study|Withdrawal by Subject|1|||
42278361|NCT01559363|76110002|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
42278362|NCT01559363|76110003|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
42278363|NCT01559363|76109998|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
42278364|NCT01559363|76109999|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
42351274|NCT00636610|76191153|FG000|Overall Study|Reason for discontinuation not available|3|||
42152533|NCT00283842|75961135|FG002|Overall Study|Withdrawal by Subject|1|||
42152534|NCT00283842|75961136|FG003|Overall Study|Withdrawal by Subject|5|||
42152535|NCT00283842|75961137|FG004|Overall Study|Withdrawal by Subject|4|||
42152536|NCT00283842|75961133|FG000|Overall Study|Lack of Efficacy|1|||
42152537|NCT00283842|75961134|FG001|Overall Study|Lack of Efficacy|3|||
42152538|NCT00283842|75961135|FG002|Overall Study|Lack of Efficacy|1|||
42152539|NCT00283842|75961136|FG003|Overall Study|Lack of Efficacy|0|||
42152540|NCT00283842|75961137|FG004|Overall Study|Lack of Efficacy|3|||
42152541|NCT00283842|75961133|FG000|Overall Study|Lost to Follow-up|0|||
42152542|NCT00283842|75961134|FG001|Overall Study|Lost to Follow-up|2|||
42152543|NCT00283842|75961135|FG002|Overall Study|Lost to Follow-up|4|||
42152544|NCT00283842|75961136|FG003|Overall Study|Lost to Follow-up|1|||
42152545|NCT00283842|75961137|FG004|Overall Study|Lost to Follow-up|1|||
42152546|NCT00298038|75961151|FG000|Overall Study|Lost to Follow-up|0|||
42152547|NCT00298038|75961152|FG001|Overall Study|Lost to Follow-up|1|||
42152548|NCT00298038|75961151|FG000|Overall Study|Liver Transplant|0|||
42152549|NCT00298038|75961152|FG001|Overall Study|Liver Transplant|1|||
42152550|NCT00298038|75961151|FG000|Overall Study|Protocol Violation|1|||
42152551|NCT00298038|75961152|FG001|Overall Study|Protocol Violation|3|||
42152552|NCT00298038|75961151|FG000|Overall Study|Death|6|||
42152553|NCT00298038|75961152|FG001|Overall Study|Death|3|||
42152554|NCT00298038|75961151|FG000|Overall Study|Withdrawal by Subject|6|||
42152555|NCT00298038|75961152|FG001|Overall Study|Withdrawal by Subject|9|||
42152556|NCT00298038|75961151|FG000|Overall Study|Adverse Event|8|||
42152557|NCT00298038|75961152|FG001|Overall Study|Adverse Event|7|||
42152558|NCT00298038|75961151|FG000|Overall Study|Breakthrough overt HE episode|28|||
42152559|NCT00298038|75961152|FG001|Overall Study|Breakthrough overt HE episode|69|||
42152560|NCT00298038|75961151|FG000|Overall Study|Noncompliance|1|||
42152561|NCT00298038|75961152|FG001|Overall Study|Noncompliance|0|||
42152562|NCT00298038|75961151|FG000|Overall Study|Cocaine Abuse|1|||
42152563|NCT00298038|75961152|FG001|Overall Study|Cocaine Abuse|0|||
42152564|NCT00298038|75961151|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
42152565|NCT00298038|75961152|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
42152566|NCT00283686|75961162|FG000|Overall Study|Death|1|||
42152567|NCT00283686|75961163|FG001|Overall Study|Death|1|||
42152568|NCT00283686|75961164|FG002|Overall Study|Death|1|||
42152569|NCT00283686|75961165|FG003|Overall Study|Death|0|||
42152570|NCT00283686|75961162|FG000|Overall Study|Lost to Follow-up|21|||
42152571|NCT00283686|75961163|FG001|Overall Study|Lost to Follow-up|31|||
42152572|NCT00283686|75961164|FG002|Overall Study|Lost to Follow-up|26|||
42152573|NCT00283686|75961165|FG003|Overall Study|Lost to Follow-up|20|||
42152574|NCT00283686|75961162|FG000|Overall Study|Less than full participation|7|||
42152575|NCT00283686|75961163|FG001|Overall Study|Less than full participation|9|||
42152576|NCT00283686|75961164|FG002|Overall Study|Less than full participation|6|||
42152577|NCT00283686|75961165|FG003|Overall Study|Less than full participation|12|||
42152578|NCT00297882|75961177|FG000|Day 14|Lack of Efficacy|12|||
42152579|NCT00297882|75961178|FG001|Day 14|Lack of Efficacy|49|||
42152580|NCT00297882|75961177|FG000|Day 28|Lost to Follow-up|13|||
42152581|NCT00297882|75961178|FG001|Day 28|Lost to Follow-up|23|||
42152582|NCT00297882|75961177|FG000|Day 28|Lack of Efficacy|3|||
42152583|NCT00297882|75961178|FG001|Day 28|Lack of Efficacy|0|||
42152584|NCT00297648|75961186|FG000|Overall Study|Adverse Event|13|||
42152585|NCT00297648|75961186|FG000|Overall Study|Lack of Efficacy|18|||
42152586|NCT00297648|75961186|FG000|Overall Study|Lost to Follow-up|1|||
42152587|NCT00297648|75961186|FG000|Overall Study|Withdrawal by Subject|3|||
42152588|NCT00297648|75961186|FG000|Overall Study|Other: Incompliance|1|||
42152589|NCT00283296|75961190|FG000|Overall Study|in-home trial not completed|5|||
42152590|NCT00297492|75961198|FG000|Set Quit Date|Lost to Follow-up|7|||
42152591|NCT00297492|75961199|FG001|Set Quit Date|Lost to Follow-up|13|||
42152592|NCT00297492|75961200|FG002|Set Quit Date|Lost to Follow-up|5|||
42152593|NCT00297492|75961198|FG000|6 Month Follow-up|Lost to Follow-up|63|||
42152594|NCT00297492|75961199|FG001|6 Month Follow-up|Lost to Follow-up|49|||
42152595|NCT00297492|75961200|FG002|6 Month Follow-up|Lost to Follow-up|27|||
42152596|NCT00297258|75961208|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
42039956|NCT02985957|75848294|FG006|Treatment Period|Poor/Non-Compliance|0|||
42039957|NCT02985957|75848288|FG000|Treatment Period|Continuing in Treatment Period|0|||
42152597|NCT00297258|75961208|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
42152598|NCT00297258|75961208|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
42152599|NCT00297258|75961208|FG000|Overall Study|Intercurrent Illness|3|||
42152600|NCT00297258|75961208|FG000|Overall Study|Intercurrent Death|2|||
42152601|NCT00297258|75961208|FG000|Overall Study|Deteriorization of General Condition|1|||
42152602|NCT00297258|75961208|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
42152603|NCT00297258|75961208|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
42152604|NCT00297258|75961208|FG000|Overall Study|Switch to Commercial Treatment|1|||
42152605|NCT00297258|75961208|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
42039958|NCT02985957|75848289|FG001|Treatment Period|Continuing in Treatment Period|1|||
42152606|NCT00496769|75961217|FG000|Double Blind|>=1 reason assigned per patient|558|||
42039959|NCT02985957|75848290|FG002|Treatment Period|Continuing in Treatment Period|0|||
42152607|NCT00496769|75961218|FG001|Double Blind|>=1 reason assigned per patient|649|||
42152608|NCT00496769|75961219|FG002|Double Blind|>=1 reason assigned per patient|0|||
42152609|NCT00496769|75961217|FG000|Open Label|>=1 reason assigned per patient|0|||
42152610|NCT00496769|75961218|FG001|Open Label|>=1 reason assigned per patient|0|||
42152611|NCT00496769|75961219|FG002|Open Label|>=1 reason assigned per patient|1011|||
42152612|NCT00478673|75961228|FG000|30-Days Post-Procedure|Death|2|||
42152613|NCT00478673|75961228|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
42152614|NCT00478673|75961228|FG000|30-Days Post-Procedure|Missed Visit|7|||
42152615|NCT00478673|75961228|FG000|12-Months Post-Procedure|Death|23|||
42152616|NCT00478673|75961228|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
42152617|NCT00478673|75961228|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
42152618|NCT00478673|75961228|FG000|12-Months Post-Procedure|Missed Visit|25|||
42152619|NCT00478673|75961228|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
42152620|NCT00488345|75961235|FG000|Overall Study|Adverse Event|0|||
42152621|NCT00488345|75961236|FG001|Overall Study|Adverse Event|1|||
42152622|NCT00488345|75961237|FG002|Overall Study|Adverse Event|1|||
42152623|NCT00488345|75961235|FG000|Overall Study|Unable to administer antibiotics at home|0|||
42152624|NCT00488345|75961236|FG001|Overall Study|Unable to administer antibiotics at home|1|||
42152625|NCT00488345|75961237|FG002|Overall Study|Unable to administer antibiotics at home|0|||
42039960|NCT02985957|75848291|FG003|Treatment Period|Continuing in Treatment Period|4|||
42039961|NCT02985957|75848292|FG004|Treatment Period|Continuing in Treatment Period|4|||
42039962|NCT02985957|75848293|FG005|Treatment Period|Continuing in Treatment Period|0|||
42039963|NCT02985957|75848294|FG006|Treatment Period|Continuing in Treatment Period|0|||
42039964|NCT02915523|75848320|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
42039965|NCT02915523|75848321|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
42039966|NCT02915523|75848322|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
42039967|NCT02915523|75848323|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
42039968|NCT02915523|75848320|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
42039969|NCT02915523|75848321|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
42152626|NCT00488345|75961235|FG000|Overall Study|Institutional Review Board review|0|||
42152627|NCT00488345|75961236|FG001|Overall Study|Institutional Review Board review|0|||
42152628|NCT00488345|75961237|FG002|Overall Study|Institutional Review Board review|1|||
42152629|NCT00488345|75961235|FG000|Overall Study|Surgical team recommendation|0|||
42152630|NCT00488345|75961236|FG001|Overall Study|Surgical team recommendation|1|||
42152631|NCT00488345|75961237|FG002|Overall Study|Surgical team recommendation|0|||
42152632|NCT00488345|75961235|FG000|Overall Study|Parent/legal guardian request|0|||
42152633|NCT00488345|75961236|FG001|Overall Study|Parent/legal guardian request|1|||
42152634|NCT00488345|75961237|FG002|Overall Study|Parent/legal guardian request|1|||
42152635|NCT00283062|75961250|FG000|Overall Study|Did not receive any study medication|5|||
42152636|NCT00283062|75961251|FG001|Overall Study|Did not receive any study medication|4|||
42152637|NCT00283062|75961252|FG002|Overall Study|Did not receive any study medication|36|||
42152638|NCT00283062|75961253|FG003|Overall Study|Did not receive any study medication|45|||
42152639|NCT00283062|75961250|FG000|Overall Study|Adverse Event|2|||
42152640|NCT00283062|75961251|FG001|Overall Study|Adverse Event|0|||
42152641|NCT00283062|75961252|FG002|Overall Study|Adverse Event|1|||
42152642|NCT00283062|75961253|FG003|Overall Study|Adverse Event|0|||
42152643|NCT00283062|75961250|FG000|Overall Study|Lost to Follow-up|1|||
42152644|NCT00283062|75961251|FG001|Overall Study|Lost to Follow-up|0|||
42152645|NCT00283062|75961252|FG002|Overall Study|Lost to Follow-up|1|||
42152646|NCT00283062|75961253|FG003|Overall Study|Lost to Follow-up|0|||
42152647|NCT00283062|75961250|FG000|Overall Study|Progressive disease|0|||
42152648|NCT00283062|75961251|FG001|Overall Study|Progressive disease|0|||
42152649|NCT00283062|75961252|FG002|Overall Study|Progressive disease|1|||
42152650|NCT00283062|75961253|FG003|Overall Study|Progressive disease|0|||
42152651|NCT00283062|75961250|FG000|Overall Study|Participant did not wish to continue|3|||
42152652|NCT00283062|75961251|FG001|Overall Study|Participant did not wish to continue|2|||
42152653|NCT00283062|75961252|FG002|Overall Study|Participant did not wish to continue|1|||
42152654|NCT00283062|75961253|FG003|Overall Study|Participant did not wish to continue|0|||
42152655|NCT00283062|75961250|FG000|Overall Study|Undefined|0|||
42152656|NCT00283062|75961251|FG001|Overall Study|Undefined|1|||
42152657|NCT00283062|75961252|FG002|Overall Study|Undefined|1|||
42152658|NCT00283062|75961253|FG003|Overall Study|Undefined|4|||
42152659|NCT00283062|75961250|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
42152660|NCT00283062|75961251|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
42152661|NCT00283062|75961252|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
42152662|NCT00283062|75961253|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
42152663|NCT00282984|75961265|FG000|Overall Study|Death|2|||
42152664|NCT00282984|75961266|FG001|Overall Study|Death|5|||
42152665|NCT00282984|75961265|FG000|Overall Study|Adverse Event|8|||
42152666|NCT00282984|75961266|FG001|Overall Study|Adverse Event|5|||
42152667|NCT00282984|75961265|FG000|Overall Study|Lack of Efficacy|0|||
42152668|NCT00282984|75961266|FG001|Overall Study|Lack of Efficacy|2|||
42152669|NCT00282984|75961265|FG000|Overall Study|Lost to Follow-up|14|||
42278365|NCT01559363|76110000|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
42278366|NCT01559363|76110001|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
42278367|NCT01559363|76110002|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
42278368|NCT01559363|76110003|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
42278369|NCT01559363|76109998|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
42152670|NCT00282984|75961266|FG001|Overall Study|Lost to Follow-up|10|||
42152671|NCT00282984|75961265|FG000|Overall Study|Withdrawal by Participant|22|||
42152672|NCT00282984|75961266|FG001|Overall Study|Withdrawal by Participant|34|||
42152673|NCT00282984|75961265|FG000|Overall Study|Participant stopped study medication|2|||
42152674|NCT00282984|75961266|FG001|Overall Study|Participant stopped study medication|2|||
42152675|NCT00282984|75961265|FG000|Overall Study|Participant only allowed phone follow-up|0|||
42152676|NCT00282984|75961266|FG001|Overall Study|Participant only allowed phone follow-up|1|||
42152677|NCT00282984|75961265|FG000|Overall Study|Participant used antipsychosis meds|0|||
42152678|NCT00282984|75961266|FG001|Overall Study|Participant used antipsychosis meds|1|||
42152679|NCT00282984|75961265|FG000|Overall Study|lack of motivation|1|||
42152680|NCT00282984|75961266|FG001|Overall Study|lack of motivation|0|||
42152681|NCT00282984|75961265|FG000|Overall Study|in prison|0|||
42152682|NCT00282984|75961266|FG001|Overall Study|in prison|1|||
42152683|NCT00282984|75961265|FG000|Overall Study|Protocol Violation|2|||
42152684|NCT00282984|75961266|FG001|Overall Study|Protocol Violation|0|||
42152685|NCT00282438|75961274|FG000|Overall Study|Lack of Efficacy|1|||
42152686|NCT00282438|75961275|FG001|Overall Study|Lack of Efficacy|0|||
42152687|NCT00282438|75961274|FG000|Overall Study|Death|0|||
42152688|NCT00282438|75961275|FG001|Overall Study|Death|1|||
42152689|NCT00296400|75961284|FG000|Overall Study|Adverse Event|7|||
42152690|NCT00296400|75961285|FG001|Overall Study|Adverse Event|7|||
42152691|NCT00296400|75961286|FG002|Overall Study|Adverse Event|7|||
42152692|NCT00296400|75961284|FG000|Overall Study|Withdrawal by Subject|5|||
42152693|NCT00296400|75961285|FG001|Overall Study|Withdrawal by Subject|6|||
42152694|NCT00296400|75961286|FG002|Overall Study|Withdrawal by Subject|2|||
42152695|NCT00296400|75961284|FG000|Overall Study|Incorrect enrollment|2|||
42152696|NCT00296400|75961285|FG001|Overall Study|Incorrect enrollment|0|||
42152697|NCT00296400|75961286|FG002|Overall Study|Incorrect enrollment|0|||
42152698|NCT00296400|75961284|FG000|Overall Study|Protocol Violation|1|||
42152699|NCT00296400|75961285|FG001|Overall Study|Protocol Violation|1|||
42152700|NCT00296400|75961286|FG002|Overall Study|Protocol Violation|1|||
42152701|NCT00296400|75961284|FG000|Overall Study|Lost to Follow-up|1|||
42152702|NCT00296400|75961285|FG001|Overall Study|Lost to Follow-up|1|||
42152703|NCT00296400|75961286|FG002|Overall Study|Lost to Follow-up|2|||
42152704|NCT00296400|75961284|FG000|Overall Study|Study specific discontinuation criteria|0|||
42152705|NCT00296400|75961285|FG001|Overall Study|Study specific discontinuation criteria|0|||
42152706|NCT00296400|75961286|FG002|Overall Study|Study specific discontinuation criteria|1|||
42152707|NCT00296400|75961284|FG000|Overall Study|Visit 10 was performed earlier|0|||
42152708|NCT00296400|75961285|FG001|Overall Study|Visit 10 was performed earlier|1|||
42152709|NCT00296400|75961286|FG002|Overall Study|Visit 10 was performed earlier|0|||
42152710|NCT00296400|75961284|FG000|Overall Study|Pregnancy|1|||
42152711|NCT00296400|75961285|FG001|Overall Study|Pregnancy|2|||
42152712|NCT00296400|75961286|FG002|Overall Study|Pregnancy|0|||
42152713|NCT00296244|75961299|FG000|Overall Study|Underwent retransplant|0|||
42152714|NCT00296244|75961300|FG001|Overall Study|Underwent retransplant|1|||
42152715|NCT00274716|75961317|FG000|Phase A|Other non-reported reason|4|||
42152716|NCT00274716|75961318|FG001|Phase A|Other non-reported reason|2|||
42152717|NCT00274716|75961319|FG002|Phase A|Other non-reported reason|1|||
42152718|NCT00274716|75961320|FG003|Phase A|Other non-reported reason|2|||
42152719|NCT00274716|75961321|FG004|Phase A|Other non-reported reason|0|||
42152720|NCT00274716|75961322|FG005|Phase A|Other non-reported reason|1|||
42152721|NCT00274716|75961317|FG000|Phase A|Participant moved|0|||
42152722|NCT00274716|75961318|FG001|Phase A|Participant moved|0|||
42152723|NCT00274716|75961319|FG002|Phase A|Participant moved|1|||
42152724|NCT00274716|75961320|FG003|Phase A|Participant moved|0|||
42152725|NCT00274716|75961321|FG004|Phase A|Participant moved|0|||
42152726|NCT00274716|75961322|FG005|Phase A|Participant moved|1|||
42152727|NCT00274716|75961317|FG000|Phase A|Site Terminated|0|||
42152728|NCT00274716|75961318|FG001|Phase A|Site Terminated|0|||
42152729|NCT00274716|75961319|FG002|Phase A|Site Terminated|0|||
42152730|NCT00274716|75961320|FG003|Phase A|Site Terminated|1|||
42152731|NCT00274716|75961321|FG004|Phase A|Site Terminated|0|||
42152732|NCT00274716|75961322|FG005|Phase A|Site Terminated|0|||
42152733|NCT00274716|75961317|FG000|Phase A|Protocol Violation|1|||
42152734|NCT00274716|75961318|FG001|Phase A|Protocol Violation|0|||
42152735|NCT00274716|75961319|FG002|Phase A|Protocol Violation|0|||
42152736|NCT00274716|75961320|FG003|Phase A|Protocol Violation|1|||
42152737|NCT00274716|75961321|FG004|Phase A|Protocol Violation|0|||
42152738|NCT00274716|75961322|FG005|Phase A|Protocol Violation|0|||
42152739|NCT00274716|75961317|FG000|Phase A|Met criteria for discontinuation|1|||
42152740|NCT00274716|75961318|FG001|Phase A|Met criteria for discontinuation|1|||
42152741|NCT00274716|75961319|FG002|Phase A|Met criteria for discontinuation|0|||
42152742|NCT00274716|75961320|FG003|Phase A|Met criteria for discontinuation|0|||
42152743|NCT00274716|75961321|FG004|Phase A|Met criteria for discontinuation|0|||
42152744|NCT00274716|75961322|FG005|Phase A|Met criteria for discontinuation|0|||
42152745|NCT00274716|75961317|FG000|Phase A|Withdrawal by Subject|2|||
42152746|NCT00274716|75961318|FG001|Phase A|Withdrawal by Subject|2|||
42152747|NCT00274716|75961319|FG002|Phase A|Withdrawal by Subject|1|||
42152748|NCT00274716|75961320|FG003|Phase A|Withdrawal by Subject|3|||
42152749|NCT00274716|75961321|FG004|Phase A|Withdrawal by Subject|0|||
42152750|NCT00274716|75961322|FG005|Phase A|Withdrawal by Subject|1|||
42152751|NCT00274716|75961317|FG000|Phase A|Adverse Event|2|||
42039970|NCT02915523|75848322|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
42039971|NCT02915523|75848323|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
42039972|NCT02915523|75848320|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
42039973|NCT02915523|75848321|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
42039974|NCT02915523|75848322|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
42039975|NCT02915523|75848323|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
42039976|NCT02915523|75848320|FG000|Expansion Phase (Phase 2)|Death|0|||
42039977|NCT02915523|75848321|FG001|Expansion Phase (Phase 2)|Death|0|||
42039978|NCT02915523|75848322|FG002|Expansion Phase (Phase 2)|Death|26|||
42039979|NCT02915523|75848323|FG003|Expansion Phase (Phase 2)|Death|53|||
42039980|NCT02915523|75848320|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
42039981|NCT02915523|75848321|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
42039982|NCT02915523|75848322|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
42039983|NCT02915523|75848323|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
42039984|NCT02915523|75848320|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
42039985|NCT02915523|75848321|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
42039986|NCT02915523|75848322|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
42039987|NCT02915523|75848323|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
42039988|NCT02915523|75848320|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
42039989|NCT02915523|75848321|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
42039990|NCT02915523|75848322|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
42039991|NCT02915523|75848323|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
42039992|NCT02890355|75848337|FG000|Overall Study|Adverse Event|5|||
42039993|NCT02890355|75848338|FG001|Overall Study|Adverse Event|5|||
42039994|NCT02890355|75848337|FG000|Overall Study|Refusal unrelated to adverse event|5|||
42039995|NCT02890355|75848338|FG001|Overall Study|Refusal unrelated to adverse event|10|||
42039996|NCT02890355|75848337|FG000|Overall Study|Progression/relapse|46|||
42152752|NCT00274716|75961318|FG001|Phase A|Adverse Event|3|||
42152753|NCT00274716|75961319|FG002|Phase A|Adverse Event|3|||
42152754|NCT00274716|75961320|FG003|Phase A|Adverse Event|0|||
42152755|NCT00274716|75961321|FG004|Phase A|Adverse Event|2|||
42152756|NCT00274716|75961322|FG005|Phase A|Adverse Event|0|||
42152757|NCT00274716|75961317|FG000|Phase A|Completed but did not enter Phase B|1|||
42152758|NCT00274716|75961318|FG001|Phase A|Completed but did not enter Phase B|2|||
42152759|NCT00274716|75961319|FG002|Phase A|Completed but did not enter Phase B|2|||
42152760|NCT00274716|75961320|FG003|Phase A|Completed but did not enter Phase B|2|||
42152761|NCT00274716|75961321|FG004|Phase A|Completed but did not enter Phase B|1|||
42152762|NCT00274716|75961322|FG005|Phase A|Completed but did not enter Phase B|1|||
42152763|NCT00274716|75961317|FG000|Phase B|Adverse Event|0|||
42152764|NCT00274716|75961318|FG001|Phase B|Adverse Event|0|||
42152765|NCT00274716|75961319|FG002|Phase B|Adverse Event|2|||
42152766|NCT00274716|75961320|FG003|Phase B|Adverse Event|0|||
42152767|NCT00274716|75961321|FG004|Phase B|Adverse Event|0|||
42152768|NCT00274716|75961322|FG005|Phase B|Adverse Event|1|||
42152769|NCT00274716|75961317|FG000|Phase B|Protocol Violation|0|||
42152770|NCT00274716|75961318|FG001|Phase B|Protocol Violation|2|||
42152771|NCT00274716|75961319|FG002|Phase B|Protocol Violation|0|||
42039997|NCT02890355|75848338|FG001|Overall Study|Progression/relapse|39|||
42039998|NCT02890355|75848337|FG000|Overall Study|Not protocol specified|3|||
42039999|NCT02890355|75848338|FG001|Overall Study|Not protocol specified|4|||
42040000|NCT02844816|75848348|FG000|Overall Study|No protocol treatment received|5|||
42040001|NCT02844816|75848349|FG001|Overall Study|No protocol treatment received|1|||
42040002|NCT02844816|75848348|FG000|Overall Study|Ineligible|22|||
42040003|NCT02844816|75848349|FG001|Overall Study|Ineligible|15|||
42040004|NCT02844816|75848348|FG000|Overall Study|Participant refusal|5|||
42040005|NCT02844816|75848349|FG001|Overall Study|Participant refusal|5|||
42040006|NCT02844816|75848348|FG000|Overall Study|Adverse Event|5|||
42040007|NCT02844816|75848349|FG001|Overall Study|Adverse Event|4|||
42040008|NCT02844816|75848348|FG000|Overall Study|Death|0|||
42040009|NCT02844816|75848349|FG001|Overall Study|Death|1|||
42040010|NCT02844816|75848348|FG000|Overall Study|Disease progression/recurrence|50|||
42040011|NCT02844816|75848349|FG001|Overall Study|Disease progression/recurrence|24|||
42040012|NCT02844816|75848348|FG000|Overall Study|Physician Decision|1|||
42040013|NCT02844816|75848349|FG001|Overall Study|Physician Decision|1|||
42040014|NCT02581930|75848365|FG000|Overall Study|Withdrawal by Subject|1|||
42040015|NCT02581930|75848365|FG000|Overall Study|patient declined further treatment|1|||
42040016|NCT02513563|75848378|FG000|Overall Study|Death|4|||
42152772|NCT00274716|75961320|FG003|Phase B|Protocol Violation|0|||
42152773|NCT00274716|75961321|FG004|Phase B|Protocol Violation|0|||
42152774|NCT00274716|75961322|FG005|Phase B|Protocol Violation|0|||
42040017|NCT02513563|75848378|FG000|Overall Study|Withdrawal by Subject|4|||
42040018|NCT02513563|75848378|FG000|Overall Study|Physician Decision|1|||
42040019|NCT02466971|75848393|FG000|Overall Study|eligible and never treated|14|||
42040020|NCT02466971|75848394|FG001|Overall Study|eligible and never treated|20|||
42040021|NCT02466971|75848393|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
42152775|NCT00274716|75961317|FG000|Phase B|Withdrawal by Subject|0|||
42152776|NCT00274716|75961318|FG001|Phase B|Withdrawal by Subject|1|||
42152777|NCT00274716|75961319|FG002|Phase B|Withdrawal by Subject|0|||
42278370|NCT01559363|76109999|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
42040022|NCT02466971|75848394|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
42040023|NCT02466971|75848393|FG000|Overall Study|ineligible and treated|1|||
42040024|NCT02466971|75848394|FG001|Overall Study|ineligible and treated|0|||
42040025|NCT02466971|75848393|FG000|Overall Study|ineligible and never treated|0|||
42040026|NCT02466971|75848394|FG001|Overall Study|ineligible and never treated|1|||
42040027|NCT02443545|75848400|FG000|Overall Study|Adverse Event|1|||
42040028|NCT02443545|75848401|FG001|Overall Study|Adverse Event|1|||
42040029|NCT02443545|75848400|FG000|Overall Study|Lost to Follow-up|0|||
42040030|NCT02443545|75848401|FG001|Overall Study|Lost to Follow-up|2|||
42040031|NCT02443545|75848400|FG000|Overall Study|Physician Decision|3|||
42040032|NCT02443545|75848401|FG001|Overall Study|Physician Decision|0|||
42040033|NCT02443545|75848400|FG000|Overall Study|Protocol Violation|8|||
42040034|NCT02443545|75848401|FG001|Overall Study|Protocol Violation|1|||
42040035|NCT02443545|75848400|FG000|Overall Study|Pregnancy|1|||
42278371|NCT01559363|76110000|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
42278372|NCT01559363|76110001|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
42278373|NCT01559363|76110002|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
42278374|NCT01559363|76110003|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
42278375|NCT01559363|76109998|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
42278376|NCT01559363|76109999|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
42278377|NCT01559363|76110000|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
42278378|NCT01559363|76110001|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
42278379|NCT01559363|76110002|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
42278380|NCT01559363|76110003|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
42278381|NCT01559363|76109998|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
42278382|NCT01559363|76109999|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
42278383|NCT01559363|76110000|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
42278384|NCT01559363|76110001|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
42278385|NCT01559363|76110002|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
42278386|NCT01559363|76110003|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
42278387|NCT02732327|76110025|FG000|Overall Study|Protocol Violation|0|||
42278388|NCT02732327|76110026|FG001|Overall Study|Protocol Violation|1|||
42278389|NCT03179605|76110032|FG000|Overall Study|Withdrawal by Subject|1|||
42278390|NCT02412722|76110042|FG000|Overall Study|Adverse Event|0|||
42278391|NCT02412722|76110043|FG001|Overall Study|Adverse Event|2|||
42278392|NCT02412722|76110044|FG002|Overall Study|Adverse Event|0|||
42278393|NCT02412722|76110045|FG003|Overall Study|Adverse Event|3|||
42278394|NCT02412722|76110046|FG004|Overall Study|Adverse Event|0|||
42278395|NCT02412722|76110047|FG005|Overall Study|Adverse Event|3|||
42278396|NCT02412722|76110042|FG000|Overall Study|Progressive Disease|6|||
42278397|NCT02412722|76110043|FG001|Overall Study|Progressive Disease|4|||
42278398|NCT02412722|76110044|FG002|Overall Study|Progressive Disease|4|||
42278399|NCT02412722|76110045|FG003|Overall Study|Progressive Disease|9|||
42278400|NCT02412722|76110046|FG004|Overall Study|Progressive Disease|3|||
42278401|NCT02412722|76110047|FG005|Overall Study|Progressive Disease|3|||
42278402|NCT02412722|76110042|FG000|Overall Study|Withdrawal by Subject|2|||
42278403|NCT02412722|76110043|FG001|Overall Study|Withdrawal by Subject|0|||
42351275|NCT00636610|76191154|FG001|Overall Study|Reason for discontinuation not available|2|||
42351276|NCT00635050|76191162|FG000|Overall Study|Withdrawal by Subject|1|||
42351277|NCT00634504|76191171|FG000|Overall Study|Protocol Violation|1|||
42040036|NCT02443545|75848401|FG001|Overall Study|Pregnancy|1|||
42040037|NCT02443545|75848400|FG000|Overall Study|Withdrawal by Subject|6|||
42040038|NCT02443545|75848401|FG001|Overall Study|Withdrawal by Subject|3|||
42040039|NCT02443545|75848400|FG000|Overall Study|Termination of study|20|||
42040040|NCT02443545|75848401|FG001|Overall Study|Termination of study|11|||
42040041|NCT02388906|75848424|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
42040042|NCT02388906|75848425|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
42040043|NCT02388906|75848424|FG000|Treatment Period|Disease progression|121|||
42040044|NCT02388906|75848425|FG001|Treatment Period|Disease progression|101|||
42040045|NCT02388906|75848424|FG000|Treatment Period|Study drug toxicity|41|||
42040046|NCT02388906|75848425|FG001|Treatment Period|Study drug toxicity|208|||
42040047|NCT02388906|75848424|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
42278404|NCT02412722|76110044|FG002|Overall Study|Withdrawal by Subject|1|||
42278405|NCT02412722|76110045|FG003|Overall Study|Withdrawal by Subject|2|||
42278406|NCT02412722|76110046|FG004|Overall Study|Withdrawal by Subject|1|||
42278407|NCT02412722|76110047|FG005|Overall Study|Withdrawal by Subject|1|||
42278408|NCT02412722|76110042|FG000|Overall Study|Lost to Follow-up|0|||
42278409|NCT02412722|76110043|FG001|Overall Study|Lost to Follow-up|0|||
42278410|NCT02412722|76110044|FG002|Overall Study|Lost to Follow-up|0|||
42278411|NCT02412722|76110045|FG003|Overall Study|Lost to Follow-up|0|||
42278412|NCT02412722|76110046|FG004|Overall Study|Lost to Follow-up|1|||
42278413|NCT02412722|76110047|FG005|Overall Study|Lost to Follow-up|0|||
42278414|NCT02412722|76110042|FG000|Overall Study|Received drug in run-in and discontinued|0|||
42278415|NCT02412722|76110043|FG001|Overall Study|Received drug in run-in and discontinued|2|||
42040048|NCT02388906|75848425|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
42040049|NCT02388906|75848424|FG000|Treatment Period|Participant request to stop treatment|5|||
42040050|NCT02388906|75848425|FG001|Treatment Period|Participant request to stop treatment|9|||
42040051|NCT02388906|75848424|FG000|Treatment Period|Participant withdrew consent|2|||
42040052|NCT02388906|75848425|FG001|Treatment Period|Participant withdrew consent|3|||
42040053|NCT02388906|75848424|FG000|Treatment Period|Poor/non-compliance|0|||
42040054|NCT02388906|75848425|FG001|Treatment Period|Poor/non-compliance|1|||
42040055|NCT02388906|75848424|FG000|Treatment Period|Participant no longer meets study criteria|0|||
42040056|NCT02388906|75848425|FG001|Treatment Period|Participant no longer meets study criteria|1|||
42040057|NCT02388906|75848424|FG000|Treatment Period|Other reasons|3|||
42040058|NCT02388906|75848425|FG001|Treatment Period|Other reasons|3|||
42040059|NCT02375555|75848431|FG000|Induction Period|Adverse Event|7|||
42040060|NCT02375555|75848431|FG000|Induction Period|Withdrawal by Subject|2|||
42040061|NCT02375555|75848431|FG000|Induction Period|Other|1|||
42152778|NCT00274716|75961320|FG003|Phase B|Withdrawal by Subject|0|||
42152779|NCT00274716|75961321|FG004|Phase B|Withdrawal by Subject|0|||
42152780|NCT00274716|75961322|FG005|Phase B|Withdrawal by Subject|0|||
42152781|NCT00274716|75961317|FG000|Phase B|Participant moved|1|||
42152782|NCT00274716|75961318|FG001|Phase B|Participant moved|0|||
42152783|NCT00274716|75961319|FG002|Phase B|Participant moved|0|||
42152784|NCT00274716|75961320|FG003|Phase B|Participant moved|0|||
42152785|NCT00274716|75961321|FG004|Phase B|Participant moved|0|||
42152786|NCT00274716|75961322|FG005|Phase B|Participant moved|0|||
42152787|NCT00274716|75961317|FG000|Phase B|Other non-reported reason|0|||
42152788|NCT00274716|75961318|FG001|Phase B|Other non-reported reason|0|||
42152789|NCT00274716|75961319|FG002|Phase B|Other non-reported reason|1|||
42152790|NCT00274716|75961320|FG003|Phase B|Other non-reported reason|1|||
42152791|NCT00274716|75961321|FG004|Phase B|Other non-reported reason|0|||
42152792|NCT00274716|75961322|FG005|Phase B|Other non-reported reason|0|||
42152793|NCT00274716|75961317|FG000|Phase B|Lost to Follow-up|0|||
42152794|NCT00274716|75961318|FG001|Phase B|Lost to Follow-up|1|||
42152795|NCT00274716|75961319|FG002|Phase B|Lost to Follow-up|0|||
42152796|NCT00274716|75961320|FG003|Phase B|Lost to Follow-up|0|||
42152797|NCT00274716|75961321|FG004|Phase B|Lost to Follow-up|0|||
42152798|NCT00274716|75961322|FG005|Phase B|Lost to Follow-up|0|||
42152799|NCT00282048|75961340|FG000|Overall Study|Lack of Efficacy|30|||
42152800|NCT00282048|75961340|FG000|Overall Study|Adverse Event|22|||
42152801|NCT00282048|75961340|FG000|Overall Study|Withdrawal by Subject|1|||
42152802|NCT00282048|75961340|FG000|Overall Study|Other|8|||
42278416|NCT02412722|76110044|FG002|Overall Study|Received drug in run-in and discontinued|0|||
42278417|NCT02412722|76110045|FG003|Overall Study|Received drug in run-in and discontinued|0|||
42278418|NCT02412722|76110046|FG004|Overall Study|Received drug in run-in and discontinued|0|||
42351278|NCT00634504|76191172|FG001|Overall Study|Protocol Violation|0|||
42278419|NCT02412722|76110047|FG005|Overall Study|Received drug in run-in and discontinued|0|||
42152803|NCT00282048|75961340|FG000|Overall Study|Ongoing|1|||
42278420|NCT02412722|76110042|FG000|Overall Study|Reason not Specified|3|||
42278421|NCT02412722|76110043|FG001|Overall Study|Reason not Specified|0|||
42152804|NCT00474539|75961346|FG000|Infant Series|Withdrawal by Subject|3|||
42152805|NCT00474539|75961347|FG001|Infant Series|Withdrawal by Subject|4|||
42152806|NCT00474539|75961346|FG000|Infant Series|Randomization error|5|||
42152807|NCT00474539|75961347|FG001|Infant Series|Randomization error|0|||
42152808|NCT00474539|75961346|FG000|Infant Series|Lost to Follow-up|2|||
42152809|NCT00474539|75961347|FG001|Infant Series|Lost to Follow-up|1|||
42152810|NCT00474539|75961346|FG000|Infant Series|Protocol Violation|0|||
42152811|NCT00474539|75961347|FG001|Infant Series|Protocol Violation|1|||
42152812|NCT00474539|75961346|FG000|After Infant Series|Lost to Follow-up|3|||
42152813|NCT00474539|75961347|FG001|After Infant Series|Lost to Follow-up|0|||
42152814|NCT00474539|75961346|FG000|After Infant Series|Withdrawal by Subject|1|||
42152815|NCT00474539|75961347|FG001|After Infant Series|Withdrawal by Subject|0|||
42152816|NCT00474539|75961346|FG000|Toddler Dose|Protocol Violation|1|||
42152817|NCT00474539|75961347|FG001|Toddler Dose|Protocol Violation|0|||
42152818|NCT00281580|75961394|FG000|Overall Study|Adverse Event|2|||
42152819|NCT00281580|75961395|FG001|Overall Study|Adverse Event|0|||
42152820|NCT00281580|75961396|FG002|Overall Study|Adverse Event|2|||
42152821|NCT00281580|75961397|FG003|Overall Study|Adverse Event|4|||
42152822|NCT00281580|75961398|FG004|Overall Study|Adverse Event|1|||
42152823|NCT00281580|75961399|FG005|Overall Study|Adverse Event|0|||
42152824|NCT00281580|75961400|FG006|Overall Study|Adverse Event|1|||
42152825|NCT00281580|75961401|FG007|Overall Study|Adverse Event|0|||
42152826|NCT00281580|75961402|FG008|Overall Study|Adverse Event|1|||
42152827|NCT00281580|75961403|FG009|Overall Study|Adverse Event|6|||
42152828|NCT00281580|75961404|FG010|Overall Study|Adverse Event|0|||
42152829|NCT00281580|75961405|FG011|Overall Study|Adverse Event|5|||
42152830|NCT00281580|75961406|FG012|Overall Study|Adverse Event|8|||
42152831|NCT00281580|75961407|FG013|Overall Study|Adverse Event|2|||
42152832|NCT00281580|75961408|FG014|Overall Study|Adverse Event|3|||
42152833|NCT00281580|75961409|FG015|Overall Study|Adverse Event|3|||
42152834|NCT00281580|75961394|FG000|Overall Study|Protocol Violation|0|||
42152835|NCT00281580|75961395|FG001|Overall Study|Protocol Violation|0|||
42152836|NCT00281580|75961396|FG002|Overall Study|Protocol Violation|1|||
42152837|NCT00281580|75961397|FG003|Overall Study|Protocol Violation|1|||
42152838|NCT00281580|75961398|FG004|Overall Study|Protocol Violation|0|||
42152839|NCT00281580|75961399|FG005|Overall Study|Protocol Violation|0|||
42152840|NCT00281580|75961400|FG006|Overall Study|Protocol Violation|1|||
42152841|NCT00281580|75961401|FG007|Overall Study|Protocol Violation|0|||
42152842|NCT00281580|75961402|FG008|Overall Study|Protocol Violation|2|||
42152843|NCT00281580|75961403|FG009|Overall Study|Protocol Violation|0|||
42152844|NCT00281580|75961404|FG010|Overall Study|Protocol Violation|1|||
42152845|NCT00281580|75961405|FG011|Overall Study|Protocol Violation|2|||
42152846|NCT00281580|75961406|FG012|Overall Study|Protocol Violation|0|||
42152847|NCT00281580|75961407|FG013|Overall Study|Protocol Violation|1|||
42152848|NCT00281580|75961408|FG014|Overall Study|Protocol Violation|1|||
42152849|NCT00281580|75961409|FG015|Overall Study|Protocol Violation|3|||
42152850|NCT00281580|75961394|FG000|Overall Study|Withdrawal by Subject|3|||
42152851|NCT00281580|75961395|FG001|Overall Study|Withdrawal by Subject|0|||
42152852|NCT00281580|75961396|FG002|Overall Study|Withdrawal by Subject|1|||
42152853|NCT00281580|75961397|FG003|Overall Study|Withdrawal by Subject|1|||
42152854|NCT00281580|75961398|FG004|Overall Study|Withdrawal by Subject|1|||
42152855|NCT00281580|75961399|FG005|Overall Study|Withdrawal by Subject|2|||
42152856|NCT00281580|75961400|FG006|Overall Study|Withdrawal by Subject|2|||
42152857|NCT00281580|75961401|FG007|Overall Study|Withdrawal by Subject|0|||
42152858|NCT00281580|75961402|FG008|Overall Study|Withdrawal by Subject|1|||
42152859|NCT00281580|75961403|FG009|Overall Study|Withdrawal by Subject|4|||
42152860|NCT00281580|75961404|FG010|Overall Study|Withdrawal by Subject|1|||
42152861|NCT00281580|75961405|FG011|Overall Study|Withdrawal by Subject|1|||
42152862|NCT00281580|75961406|FG012|Overall Study|Withdrawal by Subject|2|||
42152863|NCT00281580|75961407|FG013|Overall Study|Withdrawal by Subject|2|||
42152864|NCT00281580|75961408|FG014|Overall Study|Withdrawal by Subject|1|||
42152865|NCT00281580|75961409|FG015|Overall Study|Withdrawal by Subject|5|||
42152866|NCT00281580|75961394|FG000|Overall Study|Lack of Efficacy|2|||
42152867|NCT00281580|75961395|FG001|Overall Study|Lack of Efficacy|1|||
42152868|NCT00281580|75961396|FG002|Overall Study|Lack of Efficacy|1|||
42152869|NCT00281580|75961397|FG003|Overall Study|Lack of Efficacy|6|||
42152870|NCT00281580|75961398|FG004|Overall Study|Lack of Efficacy|2|||
42152871|NCT00281580|75961399|FG005|Overall Study|Lack of Efficacy|0|||
42152872|NCT00281580|75961400|FG006|Overall Study|Lack of Efficacy|0|||
42278422|NCT02412722|76110044|FG002|Overall Study|Reason not Specified|2|||
42278423|NCT02412722|76110045|FG003|Overall Study|Reason not Specified|1|||
42152873|NCT00281580|75961401|FG007|Overall Study|Lack of Efficacy|0|||
42278424|NCT02412722|76110046|FG004|Overall Study|Reason not Specified|2|||
42152874|NCT00281580|75961402|FG008|Overall Study|Lack of Efficacy|0|||
42152875|NCT00281580|75961403|FG009|Overall Study|Lack of Efficacy|0|||
42152876|NCT00281580|75961404|FG010|Overall Study|Lack of Efficacy|0|||
42152877|NCT00281580|75961405|FG011|Overall Study|Lack of Efficacy|1|||
42152878|NCT00281580|75961406|FG012|Overall Study|Lack of Efficacy|0|||
42152879|NCT00281580|75961407|FG013|Overall Study|Lack of Efficacy|2|||
42152880|NCT00281580|75961408|FG014|Overall Study|Lack of Efficacy|1|||
42152881|NCT00281580|75961409|FG015|Overall Study|Lack of Efficacy|0|||
42152882|NCT00281580|75961394|FG000|Overall Study|Lost to Follow-up|0|||
42152883|NCT00281580|75961395|FG001|Overall Study|Lost to Follow-up|0|||
42152884|NCT00281580|75961396|FG002|Overall Study|Lost to Follow-up|0|||
42152885|NCT00281580|75961397|FG003|Overall Study|Lost to Follow-up|3|||
42152886|NCT00281580|75961398|FG004|Overall Study|Lost to Follow-up|0|||
42040062|NCT02375555|75848431|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
42040063|NCT02375555|75848431|FG000|Maintenance Period|Adverse Event|2|||
42040064|NCT02375555|75848431|FG000|Maintenance Period|Withdrawal by Subject|4|||
42040065|NCT02375555|75848431|FG000|Maintenance Period|Death|1|||
42040066|NCT02375555|75848431|FG000|Maintenance Period|Disease Progression|5|||
42040067|NCT02375555|75848431|FG000|Maintenance Period|Patient Non-compliance|1|||
42040068|NCT02375555|75848431|FG000|Maintenance Period|Still on maintenance|16|||
42040069|NCT02367040|75848439|FG000|Overall Study|Lost to Follow-up|1|||
42040070|NCT02367040|75848440|FG001|Overall Study|Lost to Follow-up|1|||
42040071|NCT02367040|75848439|FG000|Overall Study|Lack of Efficacy|1|||
42040072|NCT02367040|75848440|FG001|Overall Study|Lack of Efficacy|0|||
42040073|NCT02367040|75848439|FG000|Overall Study|Additional primary malignancy|0|||
42040074|NCT02367040|75848440|FG001|Overall Study|Additional primary malignancy|1|||
42040075|NCT02367040|75848439|FG000|Overall Study|AE not associated with clinical disease progression|114|||
42040076|NCT02367040|75848440|FG001|Overall Study|AE not associated with clinical disease progression|11|||
42040077|NCT02367040|75848439|FG000|Overall Study|AE associated with clinical disease progression|1|||
42278425|NCT02412722|76110047|FG005|Overall Study|Reason not Specified|6|||
42278426|NCT03074695|76110083|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
42278427|NCT03074695|76110084|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
42278428|NCT03074695|76110083|FG000|Overall Study|Research staff not available|1|||
42278429|NCT03074695|76110084|FG001|Overall Study|Research staff not available|2|||
42278430|NCT03074695|76110083|FG000|Overall Study|Did not receive neuraxial block|2|||
42278431|NCT03074695|76110084|FG001|Overall Study|Did not receive neuraxial block|2|||
42278432|NCT03469999|76110090|FG000|Overall Study|Lost to Follow-up|2|||
42278433|NCT02379728|76110097|FG000|Overall Study|Lost to Follow-up|1|||
42278434|NCT02379728|76110098|FG001|Overall Study|Lost to Follow-up|0|||
42278435|NCT02379728|76110099|FG002|Overall Study|Lost to Follow-up|3|||
42278436|NCT02379728|76110100|FG003|Overall Study|Lost to Follow-up|0|||
42278437|NCT02379728|76110097|FG000|Overall Study|Withdrawal by Subject|5|||
42278438|NCT02379728|76110098|FG001|Overall Study|Withdrawal by Subject|0|||
42278439|NCT02379728|76110099|FG002|Overall Study|Withdrawal by Subject|5|||
42278440|NCT02379728|76110100|FG003|Overall Study|Withdrawal by Subject|3|||
42278441|NCT02379728|76110097|FG000|Overall Study|Protocol Violation|0|||
42278442|NCT02379728|76110098|FG001|Overall Study|Protocol Violation|0|||
42278443|NCT02379728|76110099|FG002|Overall Study|Protocol Violation|2|||
42278444|NCT02379728|76110100|FG003|Overall Study|Protocol Violation|0|||
42278445|NCT03463993|76110111|FG000|Overall Study|Lost to Follow-up|7|||
42278446|NCT03463993|76110112|FG001|Overall Study|Lost to Follow-up|8|||
42278447|NCT03463993|76110111|FG000|Overall Study|Withdrawal by Subject|2|||
42278448|NCT03463993|76110112|FG001|Overall Study|Withdrawal by Subject|0|||
42278449|NCT03463993|76110111|FG000|Overall Study|Protocol Violation|4|||
42278450|NCT03463993|76110112|FG001|Overall Study|Protocol Violation|1|||
42278451|NCT03463993|76110111|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
42278452|NCT03463993|76110112|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
42278453|NCT03463993|76110111|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
42278454|NCT03463993|76110112|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
42351279|NCT00634114|76191181|FG000|Overall Study|Adverse Event|6|||
42040078|NCT02367040|75848440|FG001|Overall Study|AE associated with clinical disease progression|3|||
42040079|NCT02367040|75848439|FG000|Overall Study|Physician Decision|2|||
42040080|NCT02367040|75848440|FG001|Overall Study|Physician Decision|8|||
42278455|NCT02412488|76110127|FG000|Overall Study|Lost to Follow-up|10|||
42278456|NCT02412488|76110127|FG000|Overall Study|Withdrawal by Subject|5|||
42278457|NCT02412488|76110127|FG000|Overall Study|Physician Decision|1|||
42278458|NCT02412488|76110127|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
42278459|NCT02412488|76110127|FG000|Overall Study|Reveal LINQ explant|1|||
42278460|NCT02378480|76110133|FG000|Overall Study|Physician Decision|1|||
42278461|NCT02378480|76110134|FG001|Overall Study|Physician Decision|1|||
42278462|NCT02378480|76110133|FG000|Overall Study|Death|1|||
42278463|NCT02378480|76110134|FG001|Overall Study|Death|2|||
42278464|NCT02378480|76110133|FG000|Overall Study|Randomized, but Not Treated|6|||
42278465|NCT02378480|76110134|FG001|Overall Study|Randomized, but Not Treated|4|||
42278466|NCT02378480|76110133|FG000|Overall Study|Adverse Event|0|||
42278467|NCT02378480|76110134|FG001|Overall Study|Adverse Event|1|||
42351280|NCT00634114|76191182|FG001|Overall Study|Adverse Event|8|||
42351281|NCT00634114|76191183|FG002|Overall Study|Adverse Event|3|||
42040081|NCT02367040|75848439|FG000|Overall Study|Non-compliance with study drug|1|||
42152887|NCT00281580|75961399|FG005|Overall Study|Lost to Follow-up|1|||
42152888|NCT00281580|75961400|FG006|Overall Study|Lost to Follow-up|0|||
42278468|NCT02378480|76110133|FG000|Overall Study|Missed EOT/PTE Visit|1|||
42278469|NCT02378480|76110134|FG001|Overall Study|Missed EOT/PTE Visit|2|||
42351282|NCT00634114|76191181|FG000|Overall Study|Withdrawal by Subject|9|||
42040082|NCT02367040|75848440|FG001|Overall Study|Non-compliance with study drug|0|||
42040083|NCT02367040|75848439|FG000|Overall Study|Failure to meet continuation criteria|1|||
42040084|NCT02367040|75848440|FG001|Overall Study|Failure to meet continuation criteria|0|||
42040085|NCT02367040|75848439|FG000|Overall Study|Switching to other therapy|2|||
42040086|NCT02367040|75848440|FG001|Overall Study|Switching to other therapy|0|||
42040087|NCT02367040|75848439|FG000|Overall Study|Withdrawal by Subject|46|||
42040088|NCT02367040|75848440|FG001|Overall Study|Withdrawal by Subject|16|||
42040089|NCT02367040|75848439|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
42040090|NCT02367040|75848440|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
42040091|NCT02367040|75848439|FG000|Overall Study|Patient decision|39|||
42040092|NCT02367040|75848440|FG001|Overall Study|Patient decision|14|||
42040093|NCT02367040|75848439|FG000|Overall Study|Required procedure failed|1|||
42152889|NCT00281580|75961401|FG007|Overall Study|Lost to Follow-up|1|||
42152890|NCT00281580|75961402|FG008|Overall Study|Lost to Follow-up|2|||
42152891|NCT00281580|75961403|FG009|Overall Study|Lost to Follow-up|1|||
42152892|NCT00281580|75961404|FG010|Overall Study|Lost to Follow-up|1|||
42152893|NCT00281580|75961405|FG011|Overall Study|Lost to Follow-up|0|||
42152894|NCT00281580|75961406|FG012|Overall Study|Lost to Follow-up|1|||
42152895|NCT00281580|75961407|FG013|Overall Study|Lost to Follow-up|0|||
42152896|NCT00281580|75961408|FG014|Overall Study|Lost to Follow-up|0|||
42152897|NCT00281580|75961409|FG015|Overall Study|Lost to Follow-up|0|||
42152898|NCT00281580|75961394|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
42152899|NCT00281580|75961395|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
42152900|NCT00281580|75961396|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
42152901|NCT00281580|75961397|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
42152902|NCT00281580|75961398|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
42152903|NCT00281580|75961399|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
42152904|NCT00281580|75961400|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
42152905|NCT00281580|75961401|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
42152906|NCT00281580|75961402|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
42152907|NCT00281580|75961403|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
42152908|NCT00281580|75961404|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
42152909|NCT00281580|75961405|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
42152910|NCT00281580|75961406|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
42152911|NCT00281580|75961407|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
42152912|NCT00281580|75961408|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
42152913|NCT00281580|75961409|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
42152914|NCT00495755|75961478|FG000|Overall Study|Adverse Event|3|||
42152915|NCT00495677|75961490|FG000|Stage 1 (25 Days)|Adverse Event|0|||
42351283|NCT00634114|76191182|FG001|Overall Study|Withdrawal by Subject|6|||
42351284|NCT00634114|76191183|FG002|Overall Study|Withdrawal by Subject|11|||
42351285|NCT00634114|76191181|FG000|Overall Study|Lost to Follow-up|0|||
42351286|NCT00634114|76191182|FG001|Overall Study|Lost to Follow-up|0|||
42351287|NCT00634114|76191183|FG002|Overall Study|Lost to Follow-up|1|||
42351288|NCT00634114|76191181|FG000|Overall Study|Protocol Violation|3|||
42351289|NCT00634114|76191182|FG001|Overall Study|Protocol Violation|3|||
42351290|NCT00634114|76191183|FG002|Overall Study|Protocol Violation|1|||
42351291|NCT00634114|76191181|FG000|Overall Study|Pregnancy|1|||
42351292|NCT00634114|76191182|FG001|Overall Study|Pregnancy|0|||
42351293|NCT00634114|76191183|FG002|Overall Study|Pregnancy|0|||
42012986|NCT00666835|75820041|FG001|Overall Study|Incl./excl. not fulfilled|2|||
42012987|NCT00666835|75820040|FG000|Overall Study|Adverse Event|7|||
42012988|NCT00666835|75820041|FG001|Overall Study|Adverse Event|6|||
42012989|NCT00666835|75820040|FG000|Overall Study|Protocol Violation|2|||
42012990|NCT00666835|75820041|FG001|Overall Study|Protocol Violation|0|||
42012991|NCT00666835|75820040|FG000|Overall Study|Death|15|||
42012992|NCT00666835|75820041|FG001|Overall Study|Death|4|||
42012993|NCT00666835|75820040|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
42012994|NCT00666835|75820041|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
42012995|NCT00666835|75820040|FG000|Overall Study|Hemoglobulin concentration|4|||
42012996|NCT00666835|75820041|FG001|Overall Study|Hemoglobulin concentration|3|||
42012997|NCT00666835|75820040|FG000|Overall Study|Planned operation|2|||
42012998|NCT00666835|75820041|FG001|Overall Study|Planned operation|0|||
42012999|NCT00666835|75820040|FG000|Overall Study|Physician Decision|1|||
42013000|NCT00666835|75820041|FG001|Overall Study|Physician Decision|2|||
42013001|NCT00551759|75820048|FG000|Overall Study|Adverse Event|7|||
42013002|NCT00551759|75820048|FG000|Overall Study|Death|5|||
42013003|NCT00551759|75820048|FG000|Overall Study|Ineligible|1|||
42013004|NCT00335140|75820052|FG000|Overall Study|Ineligible|1|||
42013005|NCT00304239|75820058|FG000|Overall Study|Protocol Deviations/Violations|15|||
42013006|NCT00304239|75820059|FG001|Overall Study|Protocol Deviations/Violations|0|||
42013007|NCT00304239|75820058|FG000|Overall Study|Adverse Event|2|||
42013008|NCT00304239|75820059|FG001|Overall Study|Adverse Event|0|||
42013009|NCT00101283|75820067|FG000|Overall Study|Withdrawal by Subject|0|||
42040094|NCT02367040|75848440|FG001|Overall Study|Required procedure failed|0|||
42152916|NCT00495677|75961491|FG001|Stage 1 (25 Days)|Adverse Event|0|||
42152917|NCT00495677|75961492|FG002|Stage 1 (25 Days)|Adverse Event|1|||
42152918|NCT00495677|75961493|FG003|Stage 1 (25 Days)|Adverse Event|0|||
42152919|NCT00495677|75961494|FG004|Stage 1 (25 Days)|Adverse Event|0|||
42152920|NCT00495677|75961495|FG005|Stage 1 (25 Days)|Adverse Event|0|||
42152921|NCT00495677|75961496|FG006|Stage 1 (25 Days)|Adverse Event|0|||
42152922|NCT00495521|75961514|FG000|Overall Study|Physician Decision|0|||
42152923|NCT00495521|75961515|FG001|Overall Study|Physician Decision|1|||
42152924|NCT00273858|75961521|FG000|Overall Study|Not completed 24 month observation time|334|||
42152925|NCT00273858|75961521|FG000|Overall Study|Lost to Follow-up|101|||
42152926|NCT00273858|75961521|FG000|Overall Study|Withdrawal by Subject|21|||
42152927|NCT00273858|75961521|FG000|Overall Study|Adverse Event|81|||
42152928|NCT00494507|75961529|FG000|Double-Blind Phase|Adverse Event|2|||
42152929|NCT00494507|75961530|FG001|Double-Blind Phase|Adverse Event|0|||
42152930|NCT00494507|75961531|FG002|Double-Blind Phase|Adverse Event|1|||
42152931|NCT00494507|75961532|FG003|Double-Blind Phase|Adverse Event|0|||
42152932|NCT00494507|75961529|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
42152933|NCT00494507|75961530|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
42152934|NCT00494507|75961531|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
42152935|NCT00494507|75961532|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
42152936|NCT00494507|75961529|FG000|Double-Blind Phase|Subject Non-compliance|0|||
42152937|NCT00494507|75961530|FG001|Double-Blind Phase|Subject Non-compliance|0|||
42152938|NCT00494507|75961531|FG002|Double-Blind Phase|Subject Non-compliance|1|||
42152939|NCT00494507|75961532|FG003|Double-Blind Phase|Subject Non-compliance|0|||
42152940|NCT00494507|75961529|FG000|Double-Blind Phase|Negative DNA test|0|||
42152941|NCT00494507|75961530|FG001|Double-Blind Phase|Negative DNA test|0|||
42152942|NCT00494507|75961531|FG002|Double-Blind Phase|Negative DNA test|0|||
42152943|NCT00494507|75961532|FG003|Double-Blind Phase|Negative DNA test|1|||
42152944|NCT00494507|75961529|FG000|Open-Label Phase|Adverse Event|0|||
42152945|NCT00494507|75961530|FG001|Open-Label Phase|Adverse Event|1|||
42152946|NCT00494507|75961531|FG002|Open-Label Phase|Adverse Event|5|||
42152947|NCT00494507|75961532|FG003|Open-Label Phase|Adverse Event|3|||
42152948|NCT00494507|75961529|FG000|Open-Label Phase|Worsening Disease|0|||
42152949|NCT00494507|75961530|FG001|Open-Label Phase|Worsening Disease|0|||
42152950|NCT00494507|75961531|FG002|Open-Label Phase|Worsening Disease|0|||
42152951|NCT00494507|75961532|FG003|Open-Label Phase|Worsening Disease|2|||
42152952|NCT00292188|75961554|FG000|Single-Blind|Adverse Event|14|||
42152953|NCT00292188|75961555|FG001|Single-Blind|Adverse Event|0|||
42152954|NCT00292188|75961556|FG002|Single-Blind|Adverse Event|0|||
42152955|NCT00292188|75961554|FG000|Single-Blind|Lack of Efficacy|2|||
42152956|NCT00292188|75961555|FG001|Single-Blind|Lack of Efficacy|0|||
42152957|NCT00292188|75961556|FG002|Single-Blind|Lack of Efficacy|0|||
42152958|NCT00292188|75961554|FG000|Single-Blind|Laboratory Abnormality|5|||
42152959|NCT00292188|75961555|FG001|Single-Blind|Laboratory Abnormality|0|||
42152960|NCT00292188|75961556|FG002|Single-Blind|Laboratory Abnormality|0|||
42152961|NCT00292188|75961554|FG000|Single-Blind|Lost to Follow-up|3|||
42152962|NCT00292188|75961555|FG001|Single-Blind|Lost to Follow-up|0|||
42152963|NCT00292188|75961556|FG002|Single-Blind|Lost to Follow-up|0|||
42152964|NCT00292188|75961554|FG000|Single-Blind|Other|77|||
42152965|NCT00292188|75961555|FG001|Single-Blind|Other|0|||
42152966|NCT00292188|75961556|FG002|Single-Blind|Other|0|||
42152967|NCT00292188|75961554|FG000|Single-Blind|Withdrawal by Subject|12|||
42152968|NCT00292188|75961555|FG001|Single-Blind|Withdrawal by Subject|0|||
42152969|NCT00292188|75961556|FG002|Single-Blind|Withdrawal by Subject|0|||
42152970|NCT00292188|75961554|FG000|Single-Blind|Did not receive treatment|1|||
42152971|NCT00292188|75961555|FG001|Single-Blind|Did not receive treatment|0|||
42152972|NCT00292188|75961556|FG002|Single-Blind|Did not receive treatment|0|||
42152973|NCT00292188|75961554|FG000|Double-Blind|Adverse Event|0|||
42152974|NCT00292188|75961555|FG001|Double-Blind|Adverse Event|25|||
42152975|NCT00292188|75961556|FG002|Double-Blind|Adverse Event|9|||
42152976|NCT00292188|75961554|FG000|Double-Blind|Lack of Efficacy|0|||
42152977|NCT00292188|75961555|FG001|Double-Blind|Lack of Efficacy|2|||
42152978|NCT00292188|75961556|FG002|Double-Blind|Lack of Efficacy|12|||
42152979|NCT00292188|75961554|FG000|Double-Blind|Lost to Follow-up|0|||
42152980|NCT00292188|75961555|FG001|Double-Blind|Lost to Follow-up|1|||
42152981|NCT00292188|75961556|FG002|Double-Blind|Lost to Follow-up|0|||
42152982|NCT00292188|75961554|FG000|Double-Blind|Other|0|||
42152983|NCT00292188|75961555|FG001|Double-Blind|Other|3|||
42152984|NCT00292188|75961556|FG002|Double-Blind|Other|4|||
42152985|NCT00292188|75961554|FG000|Double-Blind|Withdrawal by Subject|0|||
42152986|NCT00292188|75961555|FG001|Double-Blind|Withdrawal by Subject|0|||
42152987|NCT00292188|75961556|FG002|Double-Blind|Withdrawal by Subject|3|||
42152988|NCT00292188|75961554|FG000|Double-Blind|Laboratory Abnormality|0|||
42152989|NCT00292188|75961555|FG001|Double-Blind|Laboratory Abnormality|0|||
42152990|NCT00292188|75961556|FG002|Double-Blind|Laboratory Abnormality|1|||
42152991|NCT00272844|75961563|FG000|Overall Study|Withdrawal by Subject|5|||
42152992|NCT00271596|75961569|FG000|Overall Study|Protocol Violation|1|||
42152993|NCT00271596|75961570|FG001|Overall Study|Protocol Violation|0|||
42152994|NCT00271596|75961569|FG000|Overall Study|Withdrawal by Subject|0|||
42152995|NCT00271596|75961570|FG001|Overall Study|Withdrawal by Subject|1|||
42152996|NCT00291642|75961581|FG000|Overall Study|Adverse Event|1|||
42152997|NCT00291642|75961582|FG001|Overall Study|Adverse Event|0|||
42152998|NCT00291642|75961583|FG002|Overall Study|Adverse Event|1|||
42152999|NCT00291642|75961584|FG003|Overall Study|Adverse Event|0|||
42153000|NCT00291642|75961585|FG004|Overall Study|Adverse Event|1|||
42153001|NCT00291642|75961581|FG000|Overall Study|Patient missed visit|0|||
42153002|NCT00291642|75961582|FG001|Overall Study|Patient missed visit|0|||
42153003|NCT00291642|75961583|FG002|Overall Study|Patient missed visit|1|||
42153004|NCT00291642|75961584|FG003|Overall Study|Patient missed visit|0|||
42153005|NCT00291642|75961585|FG004|Overall Study|Patient missed visit|0|||
42153006|NCT00291642|75961581|FG000|Overall Study|Intake of prohibited medication|1|||
42153007|NCT00291642|75961582|FG001|Overall Study|Intake of prohibited medication|0|||
42153008|NCT00291642|75961583|FG002|Overall Study|Intake of prohibited medication|0|||
42153009|NCT00291642|75961584|FG003|Overall Study|Intake of prohibited medication|0|||
42153010|NCT00291642|75961585|FG004|Overall Study|Intake of prohibited medication|0|||
42153011|NCT00280566|75961599|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
42153012|NCT00280566|75961600|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
42153013|NCT00280566|75961601|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
42153014|NCT00280566|75961599|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
42153015|NCT00280566|75961600|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
42153016|NCT00280566|75961601|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
42153017|NCT00280566|75961599|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
42153018|NCT00280566|75961600|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
42153019|NCT00280566|75961601|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
42153020|NCT00280566|75961599|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
42153021|NCT00280566|75961600|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
42153022|NCT00280566|75961601|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
42153023|NCT00280566|75961599|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
42153024|NCT00280566|75961600|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
42153025|NCT00280566|75961601|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
42153026|NCT00280566|75961599|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
42153027|NCT00280566|75961600|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
42153028|NCT00280566|75961601|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
42153029|NCT00280566|75961599|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
42153030|NCT00280566|75961600|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
42040095|NCT02367040|75848439|FG000|Overall Study|Randomized by mistake with study treatment|1|||
42040096|NCT02367040|75848440|FG001|Overall Study|Randomized by mistake with study treatment|0|||
42153031|NCT00280566|75961601|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
42153032|NCT00280566|75961599|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
42153033|NCT00280566|75961600|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
42153034|NCT00280566|75961601|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
42153035|NCT00280566|75961599|FG000|Period 2 Double Blind|Adverse Event|0|||
42153036|NCT00280566|75961600|FG001|Period 2 Double Blind|Adverse Event|11|||
42153037|NCT00280566|75961601|FG002|Period 2 Double Blind|Adverse Event|15|||
42153038|NCT00280566|75961599|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
42153039|NCT00280566|75961600|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
42153040|NCT00280566|75961601|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
42153041|NCT00280566|75961599|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
42278470|NCT02378480|76110133|FG000|Overall Study|Withdrawal by Subject|9|||
42278471|NCT02378480|76110134|FG001|Overall Study|Withdrawal by Subject|4|||
42278472|NCT02378480|76110133|FG000|Overall Study|Lost to Follow-up|10|||
42278473|NCT02378480|76110134|FG001|Overall Study|Lost to Follow-up|18|||
42153042|NCT00280566|75961600|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
42153043|NCT00280566|75961601|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
42153044|NCT00280566|75961599|FG000|Period 2 Double Blind|miscellaneous|0|||
42153045|NCT00280566|75961600|FG001|Period 2 Double Blind|miscellaneous|10|||
42153046|NCT00280566|75961601|FG002|Period 2 Double Blind|miscellaneous|5|||
42153047|NCT00270894|75961608|FG000|Overall Study|Adverse Event|1|||
42153048|NCT00270894|75961608|FG000|Overall Study|Withdrawal by Subject|1|||
42153049|NCT00317642|75961614|FG000|Overall Study|Not Received Either Study Drug|1|||
42153050|NCT00317642|75961615|FG001|Overall Study|Not Received Either Study Drug|3|||
42153051|NCT00317642|75961614|FG000|Overall Study|Physician Decision|15|||
42153052|NCT00317642|75961615|FG001|Overall Study|Physician Decision|7|||
42153053|NCT00317642|75961614|FG000|Overall Study|Participant declined treatment|14|||
42153054|NCT00317642|75961615|FG001|Overall Study|Participant declined treatment|3|||
42153055|NCT00317642|75961614|FG000|Overall Study|Adverse Event|17|||
42153056|NCT00317642|75961615|FG001|Overall Study|Adverse Event|5|||
42153057|NCT00317642|75961614|FG000|Overall Study|Treatment Failure|56|||
42153058|NCT00317642|75961615|FG001|Overall Study|Treatment Failure|102|||
42153059|NCT00317642|75961614|FG000|Overall Study|Disease Recurrence|1|||
42153060|NCT00317642|75961615|FG001|Overall Study|Disease Recurrence|2|||
42278474|NCT02411396|76110140|FG000|Overall Study|Lost to Follow-up|31|||
42278475|NCT02411396|76110140|FG000|Overall Study|Death|10|||
42278476|NCT02345252|76110161|FG000|Double-Blind Phase|Adverse Event|2|||
42278477|NCT02345252|76110162|FG001|Double-Blind Phase|Adverse Event|3|||
42153061|NCT00317642|75961614|FG000|Overall Study|Death|14|||
42153062|NCT00317642|75961615|FG001|Overall Study|Death|7|||
42153063|NCT00317642|75961614|FG000|Overall Study|Not Continue to Consolidation|2|||
42153064|NCT00317642|75961615|FG001|Overall Study|Not Continue to Consolidation|0|||
42153065|NCT00317642|75961614|FG000|Overall Study|Withdrawal by Subject|0|||
42153066|NCT00317642|75961615|FG001|Overall Study|Withdrawal by Subject|1|||
42153067|NCT00317642|75961614|FG000|Overall Study|Referred For Transplantation|1|||
42153068|NCT00317642|75961615|FG001|Overall Study|Referred For Transplantation|0|||
42153069|NCT00317642|75961614|FG000|Overall Study|AML Not Centrally Confirmed|1|||
42153070|NCT00317642|75961615|FG001|Overall Study|AML Not Centrally Confirmed|5|||
42153071|NCT00295022|75961631|FG000|Overall Study|Adverse Event|1|||
42153072|NCT00295022|75961632|FG001|Overall Study|Adverse Event|1|||
42153073|NCT00295022|75961633|FG002|Overall Study|Adverse Event|2|||
42153074|NCT00295022|75961631|FG000|Overall Study|Lost to Follow-up|0|||
42153075|NCT00295022|75961632|FG001|Overall Study|Lost to Follow-up|0|||
42153076|NCT00295022|75961633|FG002|Overall Study|Lost to Follow-up|1|||
42153077|NCT00295022|75961631|FG000|Overall Study|Withdrawal by Subject|0|||
42153078|NCT00295022|75961632|FG001|Overall Study|Withdrawal by Subject|0|||
42153079|NCT00295022|75961633|FG002|Overall Study|Withdrawal by Subject|2|||
42153080|NCT00303446|75961645|FG000|Overall Study|Withdrawal by Subject|2|||
42153081|NCT00303446|75961646|FG001|Overall Study|Withdrawal by Subject|2|||
42153082|NCT00303446|75961645|FG000|Overall Study|Death|0|||
42153083|NCT00303446|75961646|FG001|Overall Study|Death|1|||
42153084|NCT00303446|75961645|FG000|Overall Study|Physician Decision|0|||
42153085|NCT00303446|75961646|FG001|Overall Study|Physician Decision|1|||
42153086|NCT00316706|75961654|FG000|Overall Study|Lost to Follow-up|38|||
42153087|NCT00316706|75961655|FG001|Overall Study|Lost to Follow-up|48|||
42153088|NCT00291486|75961666|FG000|Overall Study|Adverse Event|0|||
42153089|NCT00291486|75961667|FG001|Overall Study|Adverse Event|3|||
42153090|NCT00291486|75961668|FG002|Overall Study|Adverse Event|0|||
42153091|NCT00291486|75961669|FG003|Overall Study|Adverse Event|1|||
42153092|NCT00291486|75961670|FG004|Overall Study|Adverse Event|0|||
42153093|NCT00291486|75961666|FG000|Overall Study|Withdrawal by Subject|0|||
42153094|NCT00291486|75961667|FG001|Overall Study|Withdrawal by Subject|0|||
42278478|NCT02345252|76110161|FG000|Double-Blind Phase|Death|1|||
42278479|NCT02345252|76110162|FG001|Double-Blind Phase|Death|2|||
42278480|NCT02345252|76110161|FG000|Double-Blind Phase|Lack of Efficacy|1|||
42278481|NCT02345252|76110162|FG001|Double-Blind Phase|Lack of Efficacy|0|||
42278482|NCT02345252|76110161|FG000|Double-Blind Phase|Investigator's Discretion|4|||
42278483|NCT02345252|76110162|FG001|Double-Blind Phase|Investigator's Discretion|6|||
42278484|NCT02345252|76110161|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
42278485|NCT02345252|76110162|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
42153095|NCT00291486|75961668|FG002|Overall Study|Withdrawal by Subject|0|||
42278486|NCT02345252|76110161|FG000|Double-Blind Phase|Protocol Violation|2|||
42153096|NCT00291486|75961669|FG003|Overall Study|Withdrawal by Subject|0|||
42153097|NCT00291486|75961670|FG004|Overall Study|Withdrawal by Subject|1|||
42278487|NCT02345252|76110162|FG001|Double-Blind Phase|Protocol Violation|1|||
42278488|NCT02345252|76110161|FG000|Double-Blind Phase|Withdrew Consent|21|||
42153098|NCT00291486|75961666|FG000|Overall Study|Disease progression|1|||
42153099|NCT00291486|75961667|FG001|Overall Study|Disease progression|0|||
42153100|NCT00291486|75961668|FG002|Overall Study|Disease progression|1|||
42153101|NCT00291486|75961669|FG003|Overall Study|Disease progression|0|||
42153102|NCT00291486|75961670|FG004|Overall Study|Disease progression|0|||
42153103|NCT00301964|75961691|FG000|Overall Study|Second primary|2|||
42153104|NCT00301964|75961691|FG000|Overall Study|Wrong primary|1|||
42153105|NCT00301964|75961691|FG000|Overall Study|Inadequate pathology|1|||
42153106|NCT00268242|75961701|FG000|Overall Study|Death|1|||
42153107|NCT00294554|75961707|FG000|Overall Study|Lack of Efficacy|0|||
42153108|NCT00294554|75961708|FG001|Overall Study|Lack of Efficacy|1|||
42153109|NCT00294554|75961707|FG000|Overall Study|Physician Decision|0|||
42153110|NCT00294554|75961708|FG001|Overall Study|Physician Decision|1|||
42153111|NCT00294398|75961716|FG000|Overall Study|Lost to Follow-up|21|||
42153112|NCT00294398|75961717|FG001|Overall Study|Lost to Follow-up|26|||
42153113|NCT00279708|75961725|FG000|Overall Study|Withdrawal by Subject|2|||
42153114|NCT00279708|75961726|FG001|Overall Study|Withdrawal by Subject|3|||
42153115|NCT00279708|75961725|FG000|Overall Study|Adverse Event|1|||
42153116|NCT00279708|75961726|FG001|Overall Study|Adverse Event|1|||
42153117|NCT00299702|75961734|FG000|Overall Study|Death|1|||
42153118|NCT00299702|75961735|FG001|Overall Study|Death|0|||
42153119|NCT00299702|75961734|FG000|Overall Study|Adverse Event|0|||
42153120|NCT00299702|75961735|FG001|Overall Study|Adverse Event|4|||
42153121|NCT00299702|75961734|FG000|Overall Study|Lost to Follow-up|18|||
42153122|NCT00299702|75961735|FG001|Overall Study|Lost to Follow-up|10|||
42153123|NCT00299702|75961734|FG000|Overall Study|Withdrawal by Subject|25|||
42153124|NCT00299702|75961735|FG001|Overall Study|Withdrawal by Subject|23|||
42153125|NCT00299702|75961734|FG000|Overall Study|Pregnancy|0|||
42153126|NCT00299702|75961735|FG001|Overall Study|Pregnancy|1|||
42153127|NCT00299702|75961734|FG000|Overall Study|Insufficient Response|4|||
42153128|NCT00299702|75961735|FG001|Overall Study|Insufficient Response|3|||
42153129|NCT00299702|75961734|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
42153130|NCT00299702|75961735|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
42153131|NCT00291330|75961743|FG000|Overall Study|Adverse Event|47|||
42153132|NCT00291330|75961744|FG001|Overall Study|Adverse Event|40|||
42153133|NCT00291330|75961743|FG000|Overall Study|Protocol Violation|13|||
42153134|NCT00291330|75961744|FG001|Overall Study|Protocol Violation|20|||
42153135|NCT00291330|75961743|FG000|Overall Study|Lost to Follow-up|16|||
42153136|NCT00291330|75961744|FG001|Overall Study|Lost to Follow-up|11|||
42153137|NCT00291330|75961743|FG000|Overall Study|Withdrawal by Subject|22|||
42153138|NCT00291330|75961744|FG001|Overall Study|Withdrawal by Subject|25|||
42153139|NCT00291330|75961743|FG000|Overall Study|Other|3|||
42153140|NCT00291330|75961744|FG001|Overall Study|Other|1|||
42153141|NCT00267150|75961750|FG000|Overall Study|Adverse Event|1|||
42153142|NCT00278148|75961754|FG000|Phase II - Expansion Phase|Disease progression|0|||
42153143|NCT00278148|75961755|FG001|Phase II - Expansion Phase|Disease progression|0|||
42153144|NCT00278148|75961756|FG002|Phase II - Expansion Phase|Disease progression|4|||
42153145|NCT00278148|75961754|FG000|Phase II - Expansion Phase|Adverse Event|0|||
42153146|NCT00278148|75961755|FG001|Phase II - Expansion Phase|Adverse Event|0|||
42153147|NCT00278148|75961756|FG002|Phase II - Expansion Phase|Adverse Event|2|||
42153148|NCT00299546|75961766|FG000|Overall Study|Death|3|||
42153149|NCT00299546|75961767|FG001|Overall Study|Death|2|||
42153150|NCT00299546|75961768|FG002|Overall Study|Death|0|||
42153151|NCT00299546|75961766|FG000|Overall Study|Lost to Follow-up|2|||
42278489|NCT02345252|76110162|FG001|Double-Blind Phase|Withdrew Consent|23|||
42278490|NCT02345252|76110161|FG000|Double-Blind Phase|Lost to Follow-up|8|||
42278491|NCT02345252|76110162|FG001|Double-Blind Phase|Lost to Follow-up|10|||
42278492|NCT02345252|76110161|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
42278493|NCT02345252|76110162|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
42278494|NCT01239797|76110172|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
42278495|NCT01239797|76110173|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
42278496|NCT01239797|76110172|FG000|Randomized Participants|Participant withdrew consent|1|||
42278497|NCT01239797|76110173|FG001|Randomized Participants|Participant withdrew consent|7|||
42278498|NCT01239797|76110172|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
42153152|NCT00299546|75961767|FG001|Overall Study|Lost to Follow-up|2|||
42153153|NCT00299546|75961768|FG002|Overall Study|Lost to Follow-up|5|||
42153154|NCT00299546|75961766|FG000|Overall Study|Adverse Event|37|||
42153155|NCT00299546|75961767|FG001|Overall Study|Adverse Event|22|||
42153156|NCT00299546|75961768|FG002|Overall Study|Adverse Event|27|||
42153157|NCT00299546|75961766|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
42153158|NCT00299546|75961767|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
42153159|NCT00299546|75961768|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
42153160|NCT00299546|75961766|FG000|Overall Study|Other|24|||
42153161|NCT00299546|75961767|FG001|Overall Study|Other|26|||
42153162|NCT00299546|75961768|FG002|Overall Study|Other|19|||
42153163|NCT00299546|75961766|FG000|Overall Study|Not treated|0|||
42153164|NCT00299546|75961767|FG001|Overall Study|Not treated|1|||
42153165|NCT00299546|75961768|FG002|Overall Study|Not treated|1|||
42278499|NCT01239797|76110173|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
42278500|NCT01239797|76110172|FG000|Treated Participants|Disease progression|185|||
42278501|NCT01239797|76110173|FG001|Treated Participants|Disease progression|185|||
42278502|NCT01239797|76110172|FG000|Treated Participants|Study drug toxicity|39|||
42278503|NCT01239797|76110173|FG001|Treated Participants|Study drug toxicity|45|||
42153166|NCT00299156|75961780|FG000|Period 2 (Randomized)|Screen Failure|0|||
42153167|NCT00299156|75961781|FG001|Period 2 (Randomized)|Screen Failure|1|||
42153168|NCT00299156|75961782|FG002|Period 2 (Randomized)|Screen Failure|0|||
42153169|NCT00277212|75961790|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
42153170|NCT00277212|75961791|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
42153171|NCT00277212|75961792|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
42153172|NCT00277212|75961790|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
42153173|NCT00277212|75961791|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
42153174|NCT00277212|75961792|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
42153175|NCT00277212|75961790|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
42153176|NCT00277212|75961791|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
42153177|NCT00277212|75961792|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
42153178|NCT00277212|75961790|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
42153179|NCT00277212|75961791|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
42153180|NCT00277212|75961792|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
42153181|NCT00277212|75961790|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
42153182|NCT00277212|75961791|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
42153183|NCT00277212|75961792|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
42153184|NCT00277212|75961790|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
42153185|NCT00277212|75961791|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
42153186|NCT00277212|75961792|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
42153187|NCT00277212|75961790|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
42153188|NCT00277212|75961791|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
42153189|NCT00277212|75961792|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
42153190|NCT00277212|75961790|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
42153191|NCT00277212|75961791|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
42153192|NCT00277212|75961792|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
42153193|NCT00277212|75961790|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
42153194|NCT00277212|75961791|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
42153195|NCT00277212|75961792|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
42153196|NCT00277212|75961790|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
42153197|NCT00277212|75961791|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
42153198|NCT00277212|75961792|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
42153199|NCT00277212|75961790|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
42153200|NCT00277212|75961791|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
42153201|NCT00277212|75961792|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
42153202|NCT00277212|75961790|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
42153203|NCT00277212|75961791|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
42153204|NCT00277212|75961792|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
42153205|NCT00277212|75961790|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
42153206|NCT00277212|75961791|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
42153207|NCT00277212|75961792|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
42153208|NCT00277212|75961790|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
42153209|NCT00277212|75961791|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
42153210|NCT00277212|75961792|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
42153211|NCT00277212|75961790|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
42153212|NCT00277212|75961791|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
42153213|NCT00277212|75961792|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
42153214|NCT00277212|75961790|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
42278504|NCT01239797|76110172|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
42278505|NCT01239797|76110173|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
42278506|NCT01239797|76110172|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
42278507|NCT01239797|76110173|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
42278508|NCT01239797|76110172|FG000|Treated Participants|Administrative reason by sponsor|13|||
42278509|NCT01239797|76110173|FG001|Treated Participants|Administrative reason by sponsor|4|||
42278510|NCT01239797|76110172|FG000|Treated Participants|Other reasons|14|||
42278511|NCT01239797|76110173|FG001|Treated Participants|Other reasons|14|||
42153215|NCT00277212|75961791|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
42153216|NCT00277212|75961792|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
42278512|NCT01239797|76110172|FG000|Treated Participants|Participant withdrew consent|6|||
42278513|NCT01239797|76110173|FG001|Treated Participants|Participant withdrew consent|11|||
42351294|NCT00634114|76191181|FG000|Overall Study|Incorrect enrolment|0|||
42153217|NCT00277212|75961790|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
42153218|NCT00277212|75961791|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
42153219|NCT00277212|75961792|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
42153220|NCT00277212|75961790|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
42153221|NCT00277212|75961791|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
42153222|NCT00277212|75961792|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
42153223|NCT00276744|75961800|FG000|PART A|Reason unknown|98|||
42153224|NCT00251316|75961806|FG000|Overall Study|Physician Decision|2|||
42153225|NCT00251316|75961807|FG001|Overall Study|Physician Decision|3|||
42153226|NCT00293462|75961816|FG000|Overall Study|Withdrawal by Subject|4|||
42153227|NCT00293462|75961817|FG001|Overall Study|Withdrawal by Subject|3|||
42153228|NCT00293462|75961818|FG002|Overall Study|Withdrawal by Subject|8|||
42153229|NCT00293462|75961816|FG000|Overall Study|Death|1|||
42153230|NCT00293462|75961817|FG001|Overall Study|Death|0|||
42153231|NCT00293462|75961818|FG002|Overall Study|Death|0|||
42153232|NCT00293462|75961816|FG000|Overall Study|Lost to Follow-up|0|||
42153233|NCT00293462|75961817|FG001|Overall Study|Lost to Follow-up|1|||
42153234|NCT00293462|75961818|FG002|Overall Study|Lost to Follow-up|0|||
42153235|NCT00293462|75961816|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
42153236|NCT00293462|75961817|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
42153237|NCT00293462|75961818|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
42153238|NCT00293462|75961816|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
42153239|NCT00293462|75961817|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
42153240|NCT00293462|75961818|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
42153241|NCT00293462|75961816|FG000|Overall Study|Refuse Radiation Treatment|1|||
42153242|NCT00293462|75961817|FG001|Overall Study|Refuse Radiation Treatment|0|||
42153243|NCT00293462|75961818|FG002|Overall Study|Refuse Radiation Treatment|0|||
42153244|NCT00293462|75961816|FG000|Overall Study|No Show|0|||
42153245|NCT00293462|75961817|FG001|Overall Study|No Show|0|||
42153246|NCT00293462|75961818|FG002|Overall Study|No Show|1|||
42153247|NCT00293462|75961816|FG000|Overall Study|Went back to his home country|0|||
42153248|NCT00293462|75961817|FG001|Overall Study|Went back to his home country|0|||
42153249|NCT00293462|75961818|FG002|Overall Study|Went back to his home country|1|||
42153250|NCT00293462|75961816|FG000|Overall Study|Blood clot after chemotherapy|0|||
42153251|NCT00293462|75961817|FG001|Overall Study|Blood clot after chemotherapy|0|||
42153252|NCT00293462|75961818|FG002|Overall Study|Blood clot after chemotherapy|1|||
42153253|NCT00293462|75961816|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
42153254|NCT00293462|75961817|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
42153255|NCT00293462|75961818|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
42153256|NCT00293462|75961816|FG000|Overall Study|Possible Tracheostomy leakage|0|||
42153257|NCT00293462|75961817|FG001|Overall Study|Possible Tracheostomy leakage|1|||
42153258|NCT00293462|75961818|FG002|Overall Study|Possible Tracheostomy leakage|0|||
42153259|NCT00293462|75961816|FG000|Overall Study|Low radiation dose in oral cavity|0|||
42153260|NCT00293462|75961817|FG001|Overall Study|Low radiation dose in oral cavity|1|||
42153261|NCT00293462|75961818|FG002|Overall Study|Low radiation dose in oral cavity|0|||
42153262|NCT00293462|75961816|FG000|Overall Study|Physician Decision|0|||
42153263|NCT00293462|75961817|FG001|Overall Study|Physician Decision|1|||
42153264|NCT00293462|75961818|FG002|Overall Study|Physician Decision|0|||
42153265|NCT00316082|75961831|FG000|Overall Study|Lack of Efficacy|2|||
42153266|NCT00316082|75961832|FG001|Overall Study|Lack of Efficacy|3|||
42153267|NCT00316082|75961833|FG002|Overall Study|Lack of Efficacy|3|||
42153268|NCT00316082|75961834|FG003|Overall Study|Lack of Efficacy|4|||
42153269|NCT00316082|75961835|FG004|Overall Study|Lack of Efficacy|6|||
42153270|NCT00316082|75961831|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
42153271|NCT00316082|75961832|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
42153272|NCT00316082|75961833|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
42153273|NCT00316082|75961834|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
42153274|NCT00316082|75961835|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
42153275|NCT00316082|75961831|FG000|Overall Study|Lost to Follow-up|7|||
42153276|NCT00316082|75961832|FG001|Overall Study|Lost to Follow-up|6|||
42153277|NCT00316082|75961833|FG002|Overall Study|Lost to Follow-up|7|||
42153278|NCT00316082|75961834|FG003|Overall Study|Lost to Follow-up|8|||
42153279|NCT00316082|75961835|FG004|Overall Study|Lost to Follow-up|6|||
42153280|NCT00316082|75961831|FG000|Overall Study|Poor/noncompliance|6|||
42153281|NCT00316082|75961832|FG001|Overall Study|Poor/noncompliance|1|||
42153282|NCT00316082|75961833|FG002|Overall Study|Poor/noncompliance|4|||
42153283|NCT00316082|75961834|FG003|Overall Study|Poor/noncompliance|1|||
42153284|NCT00316082|75961835|FG004|Overall Study|Poor/noncompliance|4|||
42153285|NCT00316082|75961831|FG000|Overall Study|Adverse Event|4|||
42153286|NCT00316082|75961832|FG001|Overall Study|Adverse Event|2|||
42153287|NCT00316082|75961833|FG002|Overall Study|Adverse Event|5|||
42153288|NCT00316082|75961834|FG003|Overall Study|Adverse Event|1|||
42153289|NCT00316082|75961835|FG004|Overall Study|Adverse Event|3|||
42153290|NCT00316082|75961831|FG000|Overall Study|Subject no longer meets study criteria|3|||
42278514|NCT01239797|76110172|FG000|Treated Participants|Death|1|||
42153291|NCT00316082|75961832|FG001|Overall Study|Subject no longer meets study criteria|1|||
42153292|NCT00316082|75961833|FG002|Overall Study|Subject no longer meets study criteria|2|||
42153293|NCT00316082|75961834|FG003|Overall Study|Subject no longer meets study criteria|2|||
42153294|NCT00316082|75961835|FG004|Overall Study|Subject no longer meets study criteria|1|||
42153295|NCT00316082|75961831|FG000|Overall Study|Physician Decision|1|||
42153296|NCT00316082|75961832|FG001|Overall Study|Physician Decision|1|||
42153297|NCT00316082|75961833|FG002|Overall Study|Physician Decision|2|||
42153298|NCT00316082|75961834|FG003|Overall Study|Physician Decision|1|||
42153299|NCT00316082|75961835|FG004|Overall Study|Physician Decision|1|||
42153300|NCT00316082|75961831|FG000|Overall Study|Death|0|||
42153301|NCT00316082|75961832|FG001|Overall Study|Death|0|||
42153302|NCT00316082|75961833|FG002|Overall Study|Death|1|||
42153303|NCT00316082|75961834|FG003|Overall Study|Death|0|||
42153304|NCT00316082|75961835|FG004|Overall Study|Death|0|||
42153305|NCT00316082|75961831|FG000|Overall Study|Administrative reason by sponsor|0|||
42153306|NCT00316082|75961832|FG001|Overall Study|Administrative reason by sponsor|0|||
42153307|NCT00316082|75961833|FG002|Overall Study|Administrative reason by sponsor|1|||
42153308|NCT00316082|75961834|FG003|Overall Study|Administrative reason by sponsor|0|||
42153309|NCT00316082|75961835|FG004|Overall Study|Administrative reason by sponsor|0|||
42153310|NCT00316004|75961854|FG000|Overall Study|Subject was not given study fluid.|14|||
42153311|NCT00316004|75961855|FG001|Overall Study|Subject was not given study fluid.|14|||
42153312|NCT00316004|75961856|FG002|Overall Study|Subject was not given study fluid.|21|||
42278515|NCT01239797|76110173|FG001|Treated Participants|Death|1|||
42278516|NCT01239797|76110172|FG000|Treated Participants|Participant no longer meets study criteria|1|||
42278517|NCT01239797|76110173|FG001|Treated Participants|Participant no longer meets study criteria|1|||
42278518|NCT01239797|76110172|FG000|Treated Participants|Poor/non-compliance|0|||
42278519|NCT01239797|76110173|FG001|Treated Participants|Poor/non-compliance|1|||
42278520|NCT01092143|76110184|FG000|Overall Study|Adverse Event|10|||
42278521|NCT01092143|76110185|FG001|Overall Study|Adverse Event|5|||
42278522|NCT01092143|76110186|FG002|Overall Study|Adverse Event|1|||
42278523|NCT01092143|76110187|FG003|Overall Study|Adverse Event|4|||
42278524|NCT01092143|76110188|FG004|Overall Study|Adverse Event|3|||
42013010|NCT00101283|75820068|FG001|Overall Study|Withdrawal by Subject|1|||
42013011|NCT00101283|75820067|FG000|Overall Study|Insurance Refusal|0|||
42013012|NCT00101283|75820068|FG001|Overall Study|Insurance Refusal|1|||
42013013|NCT00101283|75820067|FG000|Overall Study|Prostate Cancer Recurrence|0|||
42013014|NCT00101283|75820068|FG001|Overall Study|Prostate Cancer Recurrence|1|||
42013015|NCT01302041|75820074|FG000|Overall Study|Death|5|||
42013016|NCT01302041|75820074|FG000|Overall Study|Withdrawal by Subject|4|||
42013017|NCT01302041|75820074|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
42013018|NCT01302041|75820074|FG000|Overall Study|Other-Miscellaneous Reason|2|||
42153313|NCT00298766|75961864|FG000|Overall Study|Adverse Event|18|||
42153314|NCT00298766|75961864|FG000|Overall Study|Death|2|||
42351295|NCT00634114|76191182|FG001|Overall Study|Incorrect enrolment|1|||
42153315|NCT00298766|75961864|FG000|Overall Study|Withdrawal by Subject|9|||
42278525|NCT01092143|76110184|FG000|Overall Study|Lost to Follow-up|1|||
42278526|NCT01092143|76110185|FG001|Overall Study|Lost to Follow-up|0|||
42278527|NCT01092143|76110186|FG002|Overall Study|Lost to Follow-up|1|||
42013019|NCT01301729|75820079|FG000|Overall Study|Withdrawal by Subject|2|||
42013020|NCT01301729|75820079|FG000|Overall Study|Participant did not Return for Treatment|1|||
42153316|NCT00298766|75961864|FG000|Overall Study|Treatment ongoing|4|||
42153317|NCT00298766|75961864|FG000|Overall Study|Progression of amyloid markers|4|||
42153318|NCT00298766|75961864|FG000|Overall Study|Deterioration in KPS and organ function|1|||
42153319|NCT00298766|75961864|FG000|Overall Study|Subjects overall condition deterioration|4|||
42153320|NCT00298766|75961864|FG000|Overall Study|Other|4|||
42153321|NCT00315458|75961870|FG000|Overall Study|Administrative|0|||
42153322|NCT00315458|75961871|FG001|Overall Study|Administrative|3|||
42153323|NCT00315458|75961872|FG002|Overall Study|Administrative|8|||
42153324|NCT00315458|75961873|FG003|Overall Study|Administrative|21|||
42153325|NCT00315458|75961870|FG000|Overall Study|Adverse Event|2|||
42153326|NCT00315458|75961871|FG001|Overall Study|Adverse Event|4|||
42153327|NCT00315458|75961872|FG002|Overall Study|Adverse Event|23|||
42153328|NCT00315458|75961873|FG003|Overall Study|Adverse Event|3|||
42153329|NCT00315458|75961870|FG000|Overall Study|Lost to Follow-up|1|||
42153330|NCT00315458|75961871|FG001|Overall Study|Lost to Follow-up|2|||
42153331|NCT00315458|75961872|FG002|Overall Study|Lost to Follow-up|0|||
42153332|NCT00315458|75961873|FG003|Overall Study|Lost to Follow-up|2|||
42153333|NCT00315458|75961870|FG000|Overall Study|Withdrawal by Subject|0|||
42153334|NCT00315458|75961871|FG001|Overall Study|Withdrawal by Subject|3|||
42153335|NCT00315458|75961872|FG002|Overall Study|Withdrawal by Subject|0|||
42153336|NCT00315458|75961873|FG003|Overall Study|Withdrawal by Subject|2|||
42153337|NCT00315458|75961870|FG000|Overall Study|Lack of Efficacy|0|||
42153338|NCT00315458|75961871|FG001|Overall Study|Lack of Efficacy|0|||
42153339|NCT00315458|75961872|FG002|Overall Study|Lack of Efficacy|20|||
42153340|NCT00315458|75961873|FG003|Overall Study|Lack of Efficacy|1|||
42153341|NCT00315458|75961870|FG000|Overall Study|Did not qualify|0|||
42278528|NCT01092143|76110187|FG003|Overall Study|Lost to Follow-up|0|||
42278529|NCT01092143|76110188|FG004|Overall Study|Lost to Follow-up|0|||
42278530|NCT01092143|76110184|FG000|Overall Study|Consent withdrawn|2|||
42278531|NCT01092143|76110185|FG001|Overall Study|Consent withdrawn|1|||
42278532|NCT01092143|76110186|FG002|Overall Study|Consent withdrawn|0|||
42278533|NCT01092143|76110187|FG003|Overall Study|Consent withdrawn|1|||
42278534|NCT01092143|76110188|FG004|Overall Study|Consent withdrawn|3|||
42153342|NCT00315458|75961871|FG001|Overall Study|Did not qualify|0|||
42153343|NCT00315458|75961872|FG002|Overall Study|Did not qualify|1|||
42278535|NCT01092143|76110184|FG000|Overall Study|Not treated|0|||
42278536|NCT01092143|76110185|FG001|Overall Study|Not treated|0|||
42153344|NCT00315458|75961873|FG003|Overall Study|Did not qualify|0|||
42153345|NCT00293384|75961883|FG000|Overall Study|Non-compliance|2|||
42153346|NCT00293384|75961883|FG000|Overall Study|Missed dosage/study drug|1|||
42278537|NCT01092143|76110186|FG002|Overall Study|Not treated|1|||
42278538|NCT01092143|76110187|FG003|Overall Study|Not treated|0|||
42278539|NCT01092143|76110188|FG004|Overall Study|Not treated|0|||
42278540|NCT01092143|76110184|FG000|Overall Study|did not reversibility criteria|0|||
42278541|NCT01092143|76110185|FG001|Overall Study|did not reversibility criteria|0|||
42278542|NCT01092143|76110186|FG002|Overall Study|did not reversibility criteria|1|||
42278543|NCT01092143|76110187|FG003|Overall Study|did not reversibility criteria|0|||
42278544|NCT01092143|76110188|FG004|Overall Study|did not reversibility criteria|0|||
42278545|NCT01092143|76110184|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
42153347|NCT00293384|75961883|FG000|Overall Study|Ineligible|2|||
42153348|NCT00297830|75961890|FG000|6 Month Visit|Death|1|||
42040097|NCT02367040|75848439|FG000|Overall Study|Protocol Violation|1|||
42153349|NCT00297830|75961891|FG001|6 Month Visit|Death|0|||
42153350|NCT00297830|75961892|FG002|6 Month Visit|Death|2|||
42153351|NCT00297830|75961890|FG000|6 Month Visit|Withdrawal by Subject|2|||
42153352|NCT00297830|75961891|FG001|6 Month Visit|Withdrawal by Subject|1|||
42153353|NCT00297830|75961892|FG002|6 Month Visit|Withdrawal by Subject|1|||
42278546|NCT01092143|76110185|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
42278547|NCT01092143|76110186|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
42278548|NCT01092143|76110187|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
42351296|NCT00634114|76191183|FG002|Overall Study|Incorrect enrolment|0|||
42013021|NCT01301729|75820079|FG000|Overall Study|Violated Selection Criteria|1|||
42351297|NCT00634114|76191181|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
42351298|NCT00634114|76191182|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
42351299|NCT00634114|76191183|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
42351300|NCT00634114|76191181|FG000|Overall Study|Difficult to continue|3|||
42351301|NCT00634114|76191182|FG001|Overall Study|Difficult to continue|1|||
42351302|NCT00634114|76191183|FG002|Overall Study|Difficult to continue|1|||
42351303|NCT00634114|76191181|FG000|Overall Study|Other reason|1|||
42351304|NCT00634114|76191182|FG001|Overall Study|Other reason|1|||
42013022|NCT01187043|75820089|FG000|Overall Study|Adverse Event|0|||
42153354|NCT00297830|75961890|FG000|6 Month Visit|Adverse Event|0|||
42153355|NCT00297830|75961891|FG001|6 Month Visit|Adverse Event|1|||
42153356|NCT00297830|75961892|FG002|6 Month Visit|Adverse Event|0|||
42153357|NCT00297830|75961890|FG000|12 Month Visit|Lost to Follow-up|1|||
42153358|NCT00297830|75961891|FG001|12 Month Visit|Lost to Follow-up|0|||
42153359|NCT00297830|75961892|FG002|12 Month Visit|Lost to Follow-up|0|||
42153360|NCT00297830|75961890|FG000|12 Month Visit|Adverse Event|0|||
42153361|NCT00297830|75961891|FG001|12 Month Visit|Adverse Event|3|||
42153362|NCT00297830|75961892|FG002|12 Month Visit|Adverse Event|0|||
42153363|NCT00297830|75961890|FG000|12 Month Visit|Withdrawal by Subject|0|||
42153364|NCT00297830|75961891|FG001|12 Month Visit|Withdrawal by Subject|3|||
42153365|NCT00297830|75961892|FG002|12 Month Visit|Withdrawal by Subject|0|||
42153366|NCT00296816|75961902|FG000|Overall Study|Disease Progression|37|||
42153367|NCT00296816|75961902|FG000|Overall Study|Adverse Event|18|||
42153368|NCT00296816|75961902|FG000|Overall Study|Investigator/Participant request|5|||
42153369|NCT00296816|75961902|FG000|Overall Study|Non-compliance|1|||
42153370|NCT00296816|75961902|FG000|Overall Study|Missing for end of treatment|4|||
42153371|NCT00296816|75961902|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
42153372|NCT00296816|75961902|FG000|Overall Study|Poor performance status|1|||
42153373|NCT00296816|75961902|FG000|Overall Study|Relocation to Florida|1|||
42153374|NCT00296816|75961902|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
42153375|NCT00296816|75961902|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
42153376|NCT00296816|75961902|FG000|Overall Study|Neuropathy/patient preference|1|||
42153377|NCT00296816|75961902|FG000|Overall Study|Proteinuria|1|||
42153378|NCT00296816|75961902|FG000|Overall Study|ineligibility due to radiation treatment|1|||
42153379|NCT00314132|75961908|FG000|Overall Study|Lost to Follow-up|3|||
42153380|NCT00314132|75961909|FG001|Overall Study|Lost to Follow-up|13|||
42153381|NCT00314132|75961908|FG000|Overall Study|Withdrawal by Subject|3|||
42153382|NCT00314132|75961909|FG001|Overall Study|Withdrawal by Subject|5|||
42153383|NCT00314132|75961908|FG000|Overall Study|Adverse Event|1|||
42153384|NCT00314132|75961909|FG001|Overall Study|Adverse Event|0|||
42153385|NCT00314132|75961908|FG000|Overall Study|Physician Decision|1|||
42153386|NCT00314132|75961909|FG001|Overall Study|Physician Decision|0|||
42153387|NCT00117988|75961917|FG000|Overall Study|Death|3|||
42153388|NCT00117988|75961917|FG000|Overall Study|Adverse Event|1|||
42153389|NCT00117676|75961923|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
42153390|NCT00117676|75961924|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
42153391|NCT00117676|75961923|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
42153392|NCT00117676|75961924|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
42153393|NCT00117676|75961923|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
42153394|NCT00117676|75961924|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
42351305|NCT00634114|76191183|FG002|Overall Study|Other reason|1|||
42351306|NCT00634036|76191193|FG000|Overall Study|Lost to Follow-up|1|||
42351307|NCT00634036|76191194|FG001|Overall Study|Lost to Follow-up|1|||
42013023|NCT01187043|75820090|FG001|Overall Study|Adverse Event|0|||
42013024|NCT01187043|75820091|FG002|Overall Study|Adverse Event|0|||
42153395|NCT00117676|75961923|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
42153396|NCT00117676|75961924|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
42153397|NCT00117676|75961923|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
42153398|NCT00117676|75961924|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
42351308|NCT00634036|76191193|FG000|Overall Study|Withdrawal by Subject|1|||
42153399|NCT00117676|75961923|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
42013025|NCT01187043|75820092|FG003|Overall Study|Adverse Event|0|||
42153400|NCT00117676|75961924|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
42351309|NCT00634036|76191194|FG001|Overall Study|Withdrawal by Subject|1|||
42351310|NCT01545375|76191202|FG000|Overall Study|Adverse Event|2|||
42351311|NCT01545375|76191203|FG001|Overall Study|Adverse Event|1|||
42153401|NCT00117676|75961923|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
42153402|NCT00117676|75961924|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
42153403|NCT00117676|75961923|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
42153404|NCT00117676|75961924|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
42153405|NCT00117676|75961923|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
42153406|NCT00117676|75961924|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
42153407|NCT00117676|75961923|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
42153408|NCT00117676|75961924|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
42153409|NCT00117676|75961923|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
42153410|NCT00117676|75961924|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
42153411|NCT00117676|75961923|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
42153412|NCT00117676|75961924|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
42153413|NCT00117676|75961923|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
42153414|NCT00117676|75961924|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
42153415|NCT00117676|75961923|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
42153416|NCT00117676|75961924|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
42153417|NCT00117676|75961923|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
42153418|NCT00117676|75961924|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
42153419|NCT00117676|75961923|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
42153420|NCT00117676|75961924|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
42153421|NCT00117676|75961923|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
42153422|NCT00117676|75961924|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
42153423|NCT00117676|75961923|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
42153424|NCT00117676|75961924|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
42153425|NCT00117676|75961923|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
42153426|NCT00117676|75961924|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
42153427|NCT00117676|75961923|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
42153428|NCT00117676|75961924|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
42153429|NCT00117676|75961923|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
42153430|NCT00117676|75961924|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
42153431|NCT00117676|75961923|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
42153432|NCT00117676|75961924|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
42153433|NCT00117676|75961923|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
42153434|NCT00117676|75961924|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
42153435|NCT00117676|75961923|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
42153436|NCT00117676|75961924|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
42153437|NCT00117676|75961923|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
42153438|NCT00117676|75961924|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
42153439|NCT00117676|75961923|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
42153440|NCT00117676|75961924|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
42153441|NCT00117676|75961923|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
42153442|NCT00117676|75961924|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
42153443|NCT00117676|75961923|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
42153444|NCT00117676|75961924|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
42153445|NCT00117676|75961923|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
42153446|NCT00117676|75961924|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
42153447|NCT00117676|75961923|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
42153448|NCT00117676|75961924|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
42153449|NCT00117676|75961923|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
42153450|NCT00117676|75961924|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
42153451|NCT00117676|75961923|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
42153452|NCT00117676|75961924|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
42153453|NCT00117676|75961923|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
42153454|NCT00117676|75961924|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
42153455|NCT00117676|75961923|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
42153456|NCT00117676|75961924|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
42153457|NCT00117676|75961923|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
42153458|NCT00117676|75961924|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
42153459|NCT00251004|75961938|FG000|Overall Study|Withdrawal by Subject|23|||
42153460|NCT00251004|75961939|FG001|Overall Study|Withdrawal by Subject|16|||
42040098|NCT02367040|75848440|FG001|Overall Study|Protocol Violation|0|||
42040099|NCT02367040|75848439|FG000|Overall Study|Progressive disease - radiological progression|51|||
42040100|NCT02367040|75848440|FG001|Overall Study|Progressive disease - radiological progression|78|||
42153461|NCT00251004|75961940|FG002|Overall Study|Withdrawal by Subject|14|||
42153462|NCT00251004|75961938|FG000|Overall Study|Death|9|||
42153463|NCT00251004|75961939|FG001|Overall Study|Death|10|||
42153464|NCT00251004|75961940|FG002|Overall Study|Death|8|||
42153465|NCT00251004|75961938|FG000|Overall Study|Lost to Follow-up|1|||
42153466|NCT00251004|75961939|FG001|Overall Study|Lost to Follow-up|2|||
42153467|NCT00251004|75961940|FG002|Overall Study|Lost to Follow-up|1|||
42153468|NCT00251004|75961938|FG000|Overall Study|Graft Loss|12|||
42153469|NCT00251004|75961939|FG001|Overall Study|Graft Loss|13|||
42153470|NCT00251004|75961940|FG002|Overall Study|Graft Loss|8|||
42153471|NCT00275340|75961950|FG000|Overall Study|Lost to Follow-up|2|||
42153472|NCT00275340|75961951|FG001|Overall Study|Lost to Follow-up|4|||
42153473|NCT00275262|75961957|FG000|Overall Study|Adverse Event|2|||
42153474|NCT00275262|75961958|FG001|Overall Study|Adverse Event|0|||
42153475|NCT00275262|75961957|FG000|Overall Study|Disease progression|2|||
42153476|NCT00275262|75961958|FG001|Overall Study|Disease progression|5|||
42153477|NCT00275262|75961957|FG000|Overall Study|Lost to Follow-up|0|||
42153478|NCT00275262|75961958|FG001|Overall Study|Lost to Follow-up|2|||
42153479|NCT00275262|75961957|FG000|Overall Study|Protocol Violation|0|||
42153480|NCT00275262|75961958|FG001|Overall Study|Protocol Violation|2|||
42153481|NCT00275262|75961957|FG000|Overall Study|Death|1|||
42153482|NCT00275262|75961958|FG001|Overall Study|Death|0|||
42153483|NCT00275262|75961957|FG000|Overall Study|Started Chemotherapy|1|||
42153484|NCT00275262|75961958|FG001|Overall Study|Started Chemotherapy|0|||
42153485|NCT00275028|75961964|FG000|Overall Study|Withdrew consent before treatment began|1|||
42153486|NCT00275028|75961964|FG000|Overall Study|Withdrawal by Subject|5|||
42153487|NCT00275028|75961964|FG000|Overall Study|Adverse Event|9|||
42153488|NCT00275028|75961964|FG000|Overall Study|Progressive Disease|30|||
42153489|NCT00275028|75961964|FG000|Overall Study|Physician Decision|2|||
42153490|NCT00471497|75961971|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
42153491|NCT00471497|75961972|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
42153492|NCT00471497|75961973|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
42153493|NCT00471497|75961971|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
42153494|NCT00471497|75961972|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
42153495|NCT00471497|75961973|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
42153496|NCT00471497|75961971|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
42153497|NCT00471497|75961972|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
42153498|NCT00471497|75961973|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
42153499|NCT00471497|75961971|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
42153500|NCT00471497|75961972|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
42153501|NCT00471497|75961973|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
42153502|NCT00471497|75961971|FG000|Core Treatment Phase|Lost to Follow-up|6|||
42153503|NCT00471497|75961972|FG001|Core Treatment Phase|Lost to Follow-up|6|||
42153504|NCT00471497|75961973|FG002|Core Treatment Phase|Lost to Follow-up|3|||
42153505|NCT00471497|75961971|FG000|Core Treatment Phase|Death|3|||
42153506|NCT00471497|75961972|FG001|Core Treatment Phase|Death|9|||
42153507|NCT00471497|75961973|FG002|Core Treatment Phase|Death|3|||
42153508|NCT00471497|75961971|FG000|Core Treatment Phase|Disease Progression|10|||
42153509|NCT00471497|75961972|FG001|Core Treatment Phase|Disease Progression|2|||
42153510|NCT00471497|75961973|FG002|Core Treatment Phase|Disease Progression|4|||
42153511|NCT00471497|75961971|FG000|Core Treatment Phase|Protocol Violation|6|||
42153512|NCT00471497|75961972|FG001|Core Treatment Phase|Protocol Violation|15|||
42153513|NCT00471497|75961973|FG002|Core Treatment Phase|Protocol Violation|11|||
42153514|NCT00471497|75961971|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
42153515|NCT00471497|75961972|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
42153516|NCT00471497|75961973|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
42153517|NCT00471497|75961971|FG000|Core Treatment Phase|Administrative problems|14|||
42153518|NCT00471497|75961972|FG001|Core Treatment Phase|Administrative problems|14|||
42153519|NCT00471497|75961973|FG002|Core Treatment Phase|Administrative problems|12|||
42153520|NCT00471497|75961971|FG000|Core Treatment Phase|Adverse Event|43|||
42153521|NCT00471497|75961972|FG001|Core Treatment Phase|Adverse Event|53|||
42153522|NCT00471497|75961973|FG002|Core Treatment Phase|Adverse Event|89|||
42153523|NCT00471497|75961971|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
42153524|NCT00471497|75961972|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
42153525|NCT00471497|75961973|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
42153526|NCT00471497|75961971|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
42153527|NCT00471497|75961972|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
42153528|NCT00471497|75961973|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
42153529|NCT00471497|75961971|FG000|Extension Phase|Adverse Event|9|||
42153530|NCT00471497|75961972|FG001|Extension Phase|Adverse Event|5|||
42153531|NCT00471497|75961973|FG002|Extension Phase|Adverse Event|1|||
42153532|NCT00471497|75961971|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
42153533|NCT00471497|75961972|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
42351312|NCT01545375|76191202|FG000|Overall Study|Lost to Follow-up|34|||
42153534|NCT00471497|75961973|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
42153535|NCT00471497|75961971|FG000|Extension Phase|Withdrawal by Subject|3|||
42153536|NCT00471497|75961972|FG001|Extension Phase|Withdrawal by Subject|1|||
42153537|NCT00471497|75961973|FG002|Extension Phase|Withdrawal by Subject|0|||
42153538|NCT00471497|75961971|FG000|Extension Phase|Lost to Follow-up|2|||
42153539|NCT00471497|75961972|FG001|Extension Phase|Lost to Follow-up|0|||
42153540|NCT00471497|75961973|FG002|Extension Phase|Lost to Follow-up|0|||
42153541|NCT00471497|75961971|FG000|Extension Phase|Death|1|||
42153542|NCT00471497|75961972|FG001|Extension Phase|Death|0|||
42153543|NCT00471497|75961973|FG002|Extension Phase|Death|0|||
42153544|NCT00471497|75961971|FG000|Extension Phase|Disease progression|2|||
42153545|NCT00471497|75961972|FG001|Extension Phase|Disease progression|0|||
42153546|NCT00471497|75961973|FG002|Extension Phase|Disease progression|0|||
42153547|NCT00471497|75961971|FG000|Extension Phase|Protocol Violation|2|||
42153548|NCT00471497|75961972|FG001|Extension Phase|Protocol Violation|2|||
42153549|NCT00471497|75961973|FG002|Extension Phase|Protocol Violation|0|||
42153550|NCT00493649|75961984|FG000|Overall Study|Adverse Event|44|||
42153551|NCT00493649|75961984|FG000|Overall Study|Patient Request|21|||
42153552|NCT00493649|75961984|FG000|Overall Study|Investigator Request|2|||
42153553|NCT00493649|75961984|FG000|Overall Study|Disease Progression|1|||
42153554|NCT00493649|75961984|FG000|Overall Study|Lost to Follow-up|1|||
42153555|NCT00493649|75961984|FG000|Overall Study|Other|13|||
42153556|NCT00471107|75961994|FG000|Overall Study|Technical problems/data loss|3|||
42153557|NCT00471107|75961995|FG001|Overall Study|Technical problems/data loss|1|||
42153558|NCT00471107|75961996|FG002|Overall Study|Technical problems/data loss|3|||
42153559|NCT00488033|75962006|FG000|Overall Study|Withdrawal by Subject|1|||
42153560|NCT00488033|75962007|FG001|Overall Study|Withdrawal by Subject|0|||
42153561|NCT00117598|75962016|FG000|Prior to Treatment Cross Over|Death|40|||
42153562|NCT00117598|75962017|FG001|Prior to Treatment Cross Over|Death|41|||
42153563|NCT00117598|75962018|FG002|Prior to Treatment Cross Over|Death|37|||
42153564|NCT00117598|75962019|FG003|Prior to Treatment Cross Over|Death|0|||
42153565|NCT00117598|75962020|FG004|Prior to Treatment Cross Over|Death|0|||
42153566|NCT00117598|75962016|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
42153567|NCT00117598|75962017|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
42153568|NCT00117598|75962018|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
42153569|NCT00117598|75962019|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
42153570|NCT00117598|75962020|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
42153571|NCT00117598|75962016|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
42153572|NCT00117598|75962017|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
42153573|NCT00117598|75962018|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
42153574|NCT00117598|75962019|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
42153575|NCT00117598|75962020|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
42153576|NCT00117598|75962016|FG000|Prior to Treatment Cross Over|Other|15|||
42153577|NCT00117598|75962017|FG001|Prior to Treatment Cross Over|Other|9|||
42351313|NCT01545375|76191203|FG001|Overall Study|Lost to Follow-up|31|||
42351314|NCT01545375|76191202|FG000|Overall Study|Protocol Violation|3|||
42013026|NCT01187043|75820093|FG004|Overall Study|Adverse Event|1|||
42040101|NCT02367040|75848439|FG000|Overall Study|Progressive disease - clinical progression|6|||
42040102|NCT02367040|75848440|FG001|Overall Study|Progressive disease - clinical progression|6|||
42013027|NCT01187043|75820089|FG000|Overall Study|Unable to make scheduled visits|1|||
42013028|NCT01187043|75820090|FG001|Overall Study|Unable to make scheduled visits|0|||
42013029|NCT01187043|75820091|FG002|Overall Study|Unable to make scheduled visits|4|||
42013030|NCT01187043|75820092|FG003|Overall Study|Unable to make scheduled visits|0|||
42013031|NCT01187043|75820093|FG004|Overall Study|Unable to make scheduled visits|1|||
42013032|NCT01186809|75820105|FG000|Overall Study|Death|30|||
42013033|NCT01186419|75820111|FG000|Overall Study|Withdrawal by Subject|5|||
42013034|NCT01186419|75820112|FG001|Overall Study|Withdrawal by Subject|3|||
42013035|NCT01186419|75820111|FG000|Overall Study|Adverse Event|1|||
42013036|NCT01186419|75820112|FG001|Overall Study|Adverse Event|2|||
42013037|NCT01186419|75820111|FG000|Overall Study|Physician Decision|0|||
42013038|NCT01186419|75820112|FG001|Overall Study|Physician Decision|3|||
42013039|NCT01186419|75820111|FG000|Overall Study|Other|1|||
42013040|NCT01186419|75820112|FG001|Overall Study|Other|1|||
42013041|NCT01301027|75820119|FG000|Overall Study|Physician Decision|2|||
42013042|NCT01301027|75820120|FG001|Overall Study|Physician Decision|0|||
42013043|NCT01301027|75820119|FG000|Overall Study|Withdrawal by Subject|2|||
42153578|NCT00117598|75962018|FG002|Prior to Treatment Cross Over|Other|9|||
42153579|NCT00117598|75962019|FG003|Prior to Treatment Cross Over|Other|0|||
42153580|NCT00117598|75962020|FG004|Prior to Treatment Cross Over|Other|0|||
42153581|NCT00117598|75962016|FG000|After Treament Cross Over|Death|0|||
42153582|NCT00117598|75962017|FG001|After Treament Cross Over|Death|0|||
42153583|NCT00117598|75962018|FG002|After Treament Cross Over|Death|0|||
42153584|NCT00117598|75962019|FG003|After Treament Cross Over|Death|1|||
42153585|NCT00117598|75962020|FG004|After Treament Cross Over|Death|2|||
42153586|NCT00117598|75962016|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
42153587|NCT00117598|75962017|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
42153588|NCT00117598|75962018|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
42153589|NCT00117598|75962019|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
42153590|NCT00117598|75962020|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
42153591|NCT00117598|75962016|FG000|After Treament Cross Over|Other|0|||
42153592|NCT00117598|75962017|FG001|After Treament Cross Over|Other|0|||
42153593|NCT00117598|75962018|FG002|After Treament Cross Over|Other|0|||
42153594|NCT00117598|75962019|FG003|After Treament Cross Over|Other|1|||
42153595|NCT00117598|75962020|FG004|After Treament Cross Over|Other|2|||
42153596|NCT00469859|75962032|FG000|Overall Study|Inevaluable|0|||
42153597|NCT00469859|75962033|FG001|Overall Study|Inevaluable|2|||
42153598|NCT00093808|75962039|FG000|Overall Study|Cancel participation before receiving tx|1|||
42153599|NCT00093808|75962039|FG000|Overall Study|Protocol Violation|1|||
42153600|NCT00469079|75962046|FG000|Overall Study|Lack of Efficacy|3|||
42153601|NCT00469079|75962047|FG001|Overall Study|Lack of Efficacy|8|||
42153602|NCT00469079|75962048|FG002|Overall Study|Lack of Efficacy|5|||
42153603|NCT00469079|75962046|FG000|Overall Study|Adverse Event|1|||
42153604|NCT00469079|75962047|FG001|Overall Study|Adverse Event|3|||
42153605|NCT00469079|75962048|FG002|Overall Study|Adverse Event|2|||
42153606|NCT00469079|75962046|FG000|Overall Study|Lost to Follow-up|4|||
42013044|NCT01301027|75820120|FG001|Overall Study|Withdrawal by Subject|3|||
42013045|NCT01301027|75820119|FG000|Overall Study|Adverse Event|0|||
42013046|NCT01301027|75820120|FG001|Overall Study|Adverse Event|2|||
42013047|NCT01301027|75820119|FG000|Overall Study|Fracture|1|||
42013048|NCT01301027|75820120|FG001|Overall Study|Fracture|3|||
42013049|NCT01301027|75820119|FG000|Overall Study|Transplant|0|||
42013050|NCT01301027|75820120|FG001|Overall Study|Transplant|2|||
42013051|NCT01301027|75820119|FG000|Overall Study|Volume Overload|3|||
42013052|NCT01301027|75820120|FG001|Overall Study|Volume Overload|0|||
42013053|NCT01185639|75820126|FG000|Overall Study|Progressed and didn't receive therapy|2|||
42013054|NCT01185561|75820132|FG000|Overall Study|Lost to Follow-up|0|||
42013055|NCT01185561|75820133|FG001|Overall Study|Lost to Follow-up|4|||
42040103|NCT02367040|75848439|FG000|Overall Study|Drug not administered|3|||
42040104|NCT02367040|75848440|FG001|Overall Study|Drug not administered|2|||
42040105|NCT02367040|75848439|FG000|Overall Study|Progressive disease|0|||
42040106|NCT02367040|75848440|FG001|Overall Study|Progressive disease|1|||
42040107|NCT02367040|75848439|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
42040108|NCT02367040|75848440|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
42040109|NCT02367040|75848439|FG000|Overall Study|Death|2|||
42040110|NCT02367040|75848440|FG001|Overall Study|Death|0|||
42040111|NCT02306161|75848457|FG000|Overall Study|Death|1|||
42040112|NCT02306161|75848458|FG001|Overall Study|Death|3|||
42040113|NCT02306161|75848457|FG000|Overall Study|Lack of Efficacy|20|||
42040114|NCT02306161|75848458|FG001|Overall Study|Lack of Efficacy|43|||
42040115|NCT02306161|75848457|FG000|Overall Study|Physician Decision|30|||
42040116|NCT02306161|75848458|FG001|Overall Study|Physician Decision|18|||
42040117|NCT02306161|75848457|FG000|Overall Study|Withdrawal by Subject|4|||
42040118|NCT02306161|75848458|FG001|Overall Study|Withdrawal by Subject|0|||
42040119|NCT02306161|75848457|FG000|Overall Study|Ineligible|9|||
42040120|NCT02306161|75848458|FG001|Overall Study|Ineligible|5|||
42040121|NCT02152982|75848473|FG000|Overall Study|Ineligible|4|||
42040122|NCT02152982|75848474|FG001|Overall Study|Ineligible|4|||
42040123|NCT02152982|75848473|FG000|Overall Study|Did not start treatment|12|||
42040124|NCT02152982|75848474|FG001|Overall Study|Did not start treatment|6|||
42040125|NCT01928394|75848566|FG000|Treatment Period|Disease progression|17|||
42040126|NCT01928394|75848567|FG001|Treatment Period|Disease progression|2|||
42040127|NCT01928394|75848568|FG002|Treatment Period|Disease progression|12|||
42040128|NCT01928394|75848569|FG003|Treatment Period|Disease progression|48|||
42040129|NCT01928394|75848570|FG004|Treatment Period|Disease progression|3|||
42040130|NCT01928394|75848571|FG005|Treatment Period|Disease progression|25|||
42040131|NCT01928394|75848572|FG006|Treatment Period|Disease progression|38|||
42040132|NCT01928394|75848573|FG007|Treatment Period|Disease progression|16|||
42040133|NCT01928394|75848574|FG008|Treatment Period|Disease progression|3|||
42040134|NCT01928394|75848575|FG009|Treatment Period|Disease progression|11|||
42040135|NCT01928394|75848576|FG010|Treatment Period|Disease progression|22|||
42040136|NCT01928394|75848577|FG011|Treatment Period|Disease progression|73|||
42040137|NCT01928394|75848578|FG012|Treatment Period|Disease progression|38|||
42040138|NCT01928394|75848579|FG013|Treatment Period|Disease progression|118|||
42153607|NCT00469079|75962047|FG001|Overall Study|Lost to Follow-up|8|||
42153608|NCT00469079|75962048|FG002|Overall Study|Lost to Follow-up|10|||
42153609|NCT00469079|75962046|FG000|Overall Study|Withdrawal by Subject|1|||
42153610|NCT00469079|75962047|FG001|Overall Study|Withdrawal by Subject|2|||
42153611|NCT00469079|75962048|FG002|Overall Study|Withdrawal by Subject|2|||
42153612|NCT00469079|75962046|FG000|Overall Study|Ineligible|0|||
42153613|NCT00469079|75962047|FG001|Overall Study|Ineligible|1|||
42153614|NCT00469079|75962048|FG002|Overall Study|Ineligible|0|||
42278549|NCT01092143|76110188|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
42278550|NCT01092143|76110184|FG000|Overall Study|Ineligible patient|1|||
42278551|NCT01092143|76110185|FG001|Overall Study|Ineligible patient|0|||
42278552|NCT01092143|76110186|FG002|Overall Study|Ineligible patient|0|||
42278553|NCT01092143|76110187|FG003|Overall Study|Ineligible patient|0|||
42278554|NCT01092143|76110188|FG004|Overall Study|Ineligible patient|0|||
42278555|NCT01092143|76110184|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
42278556|NCT01092143|76110185|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
42278557|NCT01092143|76110186|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
42278558|NCT01092143|76110187|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
42278559|NCT01092143|76110188|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
42278560|NCT01092143|76110184|FG000|Overall Study|Patient travel|0|||
42278561|NCT01092143|76110185|FG001|Overall Study|Patient travel|0|||
42278562|NCT01092143|76110186|FG002|Overall Study|Patient travel|0|||
42278563|NCT01092143|76110187|FG003|Overall Study|Patient travel|0|||
42278564|NCT01092143|76110188|FG004|Overall Study|Patient travel|1|||
42278565|NCT01092143|76110184|FG000|Overall Study|Non compliance with study medication|0|||
42278566|NCT01092143|76110185|FG001|Overall Study|Non compliance with study medication|0|||
42278567|NCT01092143|76110186|FG002|Overall Study|Non compliance with study medication|0|||
42278568|NCT01092143|76110187|FG003|Overall Study|Non compliance with study medication|0|||
42278569|NCT01092143|76110188|FG004|Overall Study|Non compliance with study medication|1|||
42278570|NCT01092143|76110184|FG000|Overall Study|Randomized by mistake|0|||
42153615|NCT00093496|75962064|FG000|Overall Study|Protocol Violation|1|||
42153616|NCT00093496|75962065|FG001|Overall Study|Protocol Violation|3|||
42153617|NCT00117286|75962072|FG000|Overall Study|Adverse Event|12|||
42153618|NCT00117286|75962073|FG001|Overall Study|Adverse Event|6|||
42153619|NCT00117286|75962072|FG000|Overall Study|Lost to Follow-up|2|||
42153620|NCT00117286|75962073|FG001|Overall Study|Lost to Follow-up|0|||
42153621|NCT00117286|75962072|FG000|Overall Study|Protocol Violation|3|||
42153622|NCT00117286|75962073|FG001|Overall Study|Protocol Violation|3|||
42153623|NCT00117286|75962072|FG000|Overall Study|Withdrawal by Subject|6|||
42153624|NCT00117286|75962073|FG001|Overall Study|Withdrawal by Subject|2|||
42153625|NCT00117286|75962072|FG000|Overall Study|Physician Decision|3|||
42153626|NCT00117286|75962073|FG001|Overall Study|Physician Decision|7|||
42153627|NCT00117286|75962072|FG000|Overall Study|Lack of Efficacy|2|||
42153628|NCT00117286|75962073|FG001|Overall Study|Lack of Efficacy|1|||
42153629|NCT00117286|75962072|FG000|Overall Study|Research site closing|0|||
42153630|NCT00117286|75962073|FG001|Overall Study|Research site closing|2|||
42153631|NCT00265122|75962085|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
42153632|NCT00265122|75962086|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
42153633|NCT00265122|75962087|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
42153634|NCT00265122|75962088|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
42153635|NCT00265122|75962089|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
42153636|NCT00265122|75962090|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
42153637|NCT00265122|75962085|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
42153638|NCT00265122|75962086|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
42153639|NCT00265122|75962087|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
42153640|NCT00265122|75962088|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
42153641|NCT00265122|75962089|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
42153642|NCT00265122|75962090|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
42153643|NCT00265122|75962085|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
42153644|NCT00265122|75962086|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
42153645|NCT00265122|75962087|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
42153646|NCT00265122|75962088|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
42153647|NCT00265122|75962089|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
42153648|NCT00265122|75962090|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
42278571|NCT01092143|76110185|FG001|Overall Study|Randomized by mistake|0|||
42153649|NCT00265122|75962085|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
42153650|NCT00265122|75962086|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
42153651|NCT00265122|75962087|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
42153652|NCT00265122|75962088|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
42153653|NCT00265122|75962089|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
42153654|NCT00265122|75962090|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
42278572|NCT01092143|76110186|FG002|Overall Study|Randomized by mistake|0|||
42153655|NCT00265122|75962085|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
42153656|NCT00265122|75962086|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
42153657|NCT00265122|75962087|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
42153658|NCT00265122|75962088|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
42153659|NCT00265122|75962089|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
42278573|NCT01092143|76110187|FG003|Overall Study|Randomized by mistake|1|||
42153660|NCT00265122|75962090|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
42153661|NCT00265122|75962085|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
42153662|NCT00265122|75962086|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
42153663|NCT00265122|75962087|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
42153664|NCT00265122|75962088|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
42153665|NCT00265122|75962089|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
42153666|NCT00265122|75962090|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
42153667|NCT00116584|75962111|FG000|Overall Study|Withdrawal by Subject|1|||
42153668|NCT00116584|75962112|FG001|Overall Study|Withdrawal by Subject|0|||
42153669|NCT00116584|75962111|FG000|Overall Study|Protocol Violation|1|||
42153670|NCT00116584|75962112|FG001|Overall Study|Protocol Violation|1|||
42153671|NCT00096538|75962118|FG000|Overall Study|Withdrawal by Subject|1|||
42153672|NCT00239928|75962122|FG000|Overall Study|Lack of Efficacy|1|||
42153673|NCT00239928|75962122|FG000|Overall Study|Adverse Event|4|||
42153674|NCT00239928|75962122|FG000|Overall Study|Not need to continue study|3|||
42153675|NCT00239928|75962122|FG000|Overall Study|Withdrawal by Subject|2|||
42153676|NCT00116428|75962128|FG000|Overall Study|Withdrawal by Subject|2|||
42153677|NCT00116428|75962129|FG001|Overall Study|Withdrawal by Subject|5|||
42153678|NCT00116428|75962128|FG000|Overall Study|Did not meet inclusion criteria|1|||
42153679|NCT00116428|75962129|FG001|Overall Study|Did not meet inclusion criteria|0|||
42153680|NCT00468845|75962141|FG000|Overall Study|Adverse Event|9|||
42153681|NCT00468845|75962142|FG001|Overall Study|Adverse Event|14|||
42153682|NCT00468845|75962143|FG002|Overall Study|Adverse Event|11|||
42153683|NCT00468845|75962141|FG000|Overall Study|Lost to Follow-up|2|||
42153684|NCT00468845|75962142|FG001|Overall Study|Lost to Follow-up|1|||
42153685|NCT00468845|75962143|FG002|Overall Study|Lost to Follow-up|2|||
42153686|NCT00468845|75962141|FG000|Overall Study|Other|4|||
42153687|NCT00468845|75962142|FG001|Overall Study|Other|9|||
42153688|NCT00468845|75962143|FG002|Overall Study|Other|5|||
42153689|NCT00468845|75962141|FG000|Overall Study|No longer willing to participate|5|||
42153690|NCT00468845|75962142|FG001|Overall Study|No longer willing to participate|6|||
42153691|NCT00468845|75962143|FG002|Overall Study|No longer willing to participate|10|||
42153692|NCT00468845|75962141|FG000|Overall Study|Randomized, not treated|1|||
42153693|NCT00468845|75962142|FG001|Overall Study|Randomized, not treated|4|||
42153694|NCT00468845|75962143|FG002|Overall Study|Randomized, not treated|2|||
42153695|NCT00468299|75962153|FG000|Overall Study|Withdrawal by Subject|0|||
42153696|NCT00468299|75962154|FG001|Overall Study|Withdrawal by Subject|1|||
42153697|NCT00468143|75962162|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
42153698|NCT00468143|75962163|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
42153699|NCT00468143|75962162|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
42153700|NCT00468143|75962163|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
42153701|NCT00467831|75962169|FG000|Overall Study|Death|2|||
42153702|NCT00467831|75962169|FG000|Overall Study|Withdrawal by Subject|1|||
42153703|NCT00467753|75962175|FG000|Overall Study|Lost to Follow-up|1|||
42153704|NCT00467753|75962176|FG001|Overall Study|Lost to Follow-up|2|||
42153705|NCT00467753|75962175|FG000|Overall Study|Adverse Event|2|||
42153706|NCT00467753|75962176|FG001|Overall Study|Adverse Event|0|||
42153707|NCT00467597|75962190|FG000|Overall Study|Withdrawal by Subject|2|||
42153708|NCT00467597|75962191|FG001|Overall Study|Withdrawal by Subject|0|||
42153709|NCT00115804|75962201|FG000|Overall Study|Adverse Event|2|||
42153710|NCT00467519|75962209|FG000|Overall Study|Protocol Violation|8|||
42153711|NCT00467519|75962210|FG001|Overall Study|Protocol Violation|4|||
42278574|NCT01092143|76110188|FG004|Overall Study|Randomized by mistake|0|||
42278575|NCT01092143|76110184|FG000|Overall Study|Pregnancy|0|||
42278576|NCT01092143|76110185|FG001|Overall Study|Pregnancy|0|||
42278577|NCT01092143|76110186|FG002|Overall Study|Pregnancy|0|||
42278578|NCT01092143|76110187|FG003|Overall Study|Pregnancy|1|||
42040139|NCT01928394|75848580|FG014|Treatment Period|Disease progression|59|||
42040140|NCT01928394|75848581|FG015|Treatment Period|Disease progression|1|||
42040141|NCT01928394|75848582|FG016|Treatment Period|Disease progression|43|||
42040142|NCT01928394|75848583|FG017|Treatment Period|Disease progression|56|||
42040143|NCT01928394|75848584|FG018|Treatment Period|Disease progression|50|||
42040144|NCT01928394|75848585|FG019|Treatment Period|Disease progression|71|||
42040145|NCT01928394|75848586|FG020|Treatment Period|Disease progression|30|||
42153712|NCT00467519|75962209|FG000|Overall Study|Lost to Follow-up|2|||
42153713|NCT00467519|75962210|FG001|Overall Study|Lost to Follow-up|9|||
42153714|NCT00467519|75962209|FG000|Overall Study|Withdrawal by Subject|4|||
42153715|NCT00467519|75962210|FG001|Overall Study|Withdrawal by Subject|10|||
42153716|NCT00264810|75962218|FG000|Baseline|Withdrawal by Subject|10|||
42153717|NCT00264810|75962219|FG001|Baseline|Withdrawal by Subject|10|||
42153718|NCT00264810|75962218|FG000|Baseline|Physician Decision|7|||
42153719|NCT00264810|75962219|FG001|Baseline|Physician Decision|8|||
42153720|NCT00264810|75962218|FG000|Baseline|Subject Compliance Failure|3|||
42278579|NCT01092143|76110188|FG004|Overall Study|Pregnancy|0|||
42278580|NCT02377466|76110202|FG000|Overall Study|Other: Randomized and not treated|0|||
42040146|NCT01928394|75848587|FG021|Treatment Period|Disease progression|31|||
42153721|NCT00264810|75962219|FG001|Baseline|Subject Compliance Failure|3|||
42278581|NCT02377466|76110203|FG001|Overall Study|Other: Randomized and not treated|2|||
42040147|NCT01928394|75848588|FG022|Treatment Period|Disease progression|31|||
42040148|NCT01928394|75848566|FG000|Treatment Period|Study drug toxicity|1|||
42040149|NCT01928394|75848567|FG001|Treatment Period|Study drug toxicity|1|||
42040150|NCT01928394|75848568|FG002|Treatment Period|Study drug toxicity|3|||
42153722|NCT00264810|75962218|FG000|Baseline|Insufficient Seizure Frequency|2|||
42153723|NCT00264810|75962219|FG001|Baseline|Insufficient Seizure Frequency|2|||
42153724|NCT00264810|75962218|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
42153725|NCT00264810|75962219|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
42153726|NCT00264810|75962218|FG000|Baseline|Other|0|||
42153727|NCT00264810|75962219|FG001|Baseline|Other|1|||
42153728|NCT00264810|75962218|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
42153729|NCT00264810|75962219|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
42153730|NCT00264810|75962218|FG000|Stimulation Optimization Period|Death|0|||
42153731|NCT00264810|75962219|FG001|Stimulation Optimization Period|Death|1|||
42153732|NCT00264810|75962218|FG000|Blinded Evaluation Period|Explant due to infection|1|||
42153733|NCT00264810|75962219|FG001|Blinded Evaluation Period|Explant due to infection|1|||
42153734|NCT00264810|75962218|FG000|Open Label Evaluation Period|Explant due to infection|1|||
42153735|NCT00264810|75962219|FG001|Open Label Evaluation Period|Explant due to infection|1|||
42153736|NCT00264810|75962218|FG000|Open Label Evaluation Period|Death|3|||
42153737|NCT00264810|75962219|FG001|Open Label Evaluation Period|Death|2|||
42153738|NCT00264810|75962218|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
42153739|NCT00264810|75962219|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
42153740|NCT00467363|75962229|FG000|Overall Study|Lost to Follow-up|80|||
42153741|NCT00467363|75962230|FG001|Overall Study|Lost to Follow-up|70|||
42153742|NCT00091390|75962236|FG000|Overall Study|Protocol Violation|1|||
42153743|NCT00091390|75962236|FG000|Overall Study|No protocol treatment|3|||
42153744|NCT00239226|75962244|FG000|Overall Study|permAF during stabilization period|0|||
42153745|NCT00239226|75962245|FG001|Overall Study|permAF during stabilization period|0|||
42153746|NCT00239226|75962246|FG002|Overall Study|permAF during stabilization period|0|||
42153747|NCT00239226|75962247|FG003|Overall Study|permAF during stabilization period|3|||
42153748|NCT00239226|75962244|FG000|Overall Study|Lost to Follow-up|1|||
42153749|NCT00239226|75962245|FG001|Overall Study|Lost to Follow-up|0|||
42153750|NCT00239226|75962246|FG002|Overall Study|Lost to Follow-up|1|||
42153751|NCT00239226|75962247|FG003|Overall Study|Lost to Follow-up|0|||
42153752|NCT00467285|75962259|FG000|Overall Study|Lost to Follow-up|4|||
42153753|NCT00467285|75962260|FG001|Overall Study|Lost to Follow-up|4|||
42153754|NCT00264576|75962270|FG000|Overall Study|Lost to Follow-up|1|||
42153755|NCT00264576|75962271|FG001|Overall Study|Lost to Follow-up|1|||
42153756|NCT00466505|75962278|FG000|Overall Study|disease progression|13|||
42278582|NCT00950989|76110220|FG000|Overall Study|Death|0|||
42278583|NCT00950989|76110221|FG001|Overall Study|Death|0|||
42278584|NCT00950989|76110222|FG002|Overall Study|Death|1|||
42278585|NCT00950989|76110223|FG003|Overall Study|Death|0|||
42278586|NCT00950989|76110220|FG000|Overall Study|Administrative Decision|0|||
42278587|NCT00950989|76110221|FG001|Overall Study|Administrative Decision|1|||
42278588|NCT00950989|76110222|FG002|Overall Study|Administrative Decision|0|||
42278589|NCT00950989|76110223|FG003|Overall Study|Administrative Decision|0|||
42278590|NCT00950989|76110220|FG000|Overall Study|Disease Progression|0|||
42013056|NCT01185561|75820132|FG000|Overall Study|Withdrawal by Subject|2|||
42013057|NCT01185561|75820133|FG001|Overall Study|Withdrawal by Subject|8|||
42013058|NCT01185249|75820139|FG000|Overall Study|Patients discharged or change in status|42|||
42013059|NCT01184859|75820149|FG000|Period 1: Single Dose|Insufficient urine production|0|||
42013060|NCT01184859|75820150|FG001|Period 1: Single Dose|Insufficient urine production|1|||
42013061|NCT01184859|75820151|FG002|Period 1: Single Dose|Insufficient urine production|0|||
42013062|NCT01184859|75820152|FG003|Period 1: Single Dose|Insufficient urine production|0|||
42040151|NCT01928394|75848569|FG003|Treatment Period|Study drug toxicity|3|||
42040152|NCT01928394|75848570|FG004|Treatment Period|Study drug toxicity|0|||
42040153|NCT01928394|75848571|FG005|Treatment Period|Study drug toxicity|9|||
42153757|NCT00466505|75962278|FG000|Overall Study|Adverse Event|4|||
42153758|NCT00467051|75962282|FG000|Overall Study|Adverse Event|2|||
42153759|NCT00264498|75962289|FG000|Randomized Treatment|Death|0|||
42153760|NCT00264498|75962290|FG001|Randomized Treatment|Death|3|||
42153761|NCT00264498|75962289|FG000|Randomized Treatment|Withdrawal by Subject|0|||
42013063|NCT01184859|75820153|FG004|Period 1: Single Dose|Insufficient urine production|0|||
42153762|NCT00264498|75962290|FG001|Randomized Treatment|Withdrawal by Subject|1|||
42278591|NCT00950989|76110221|FG001|Overall Study|Disease Progression|0|||
42278592|NCT00950989|76110222|FG002|Overall Study|Disease Progression|1|||
42153763|NCT00264498|75962289|FG000|Randomized Treatment|Objective disease Progression|13|||
42153764|NCT00264498|75962290|FG001|Randomized Treatment|Objective disease Progression|14|||
42153765|NCT00264498|75962289|FG000|Randomized Treatment|Physician Decision|1|||
42153766|NCT00264498|75962290|FG001|Randomized Treatment|Physician Decision|0|||
42153767|NCT00264498|75962289|FG000|Randomized Treatment|Incorrectly randomized|1|||
42153768|NCT00264498|75962290|FG001|Randomized Treatment|Incorrectly randomized|0|||
42153769|NCT00264498|75962289|FG000|Randomized Treatment|Study Closure|1|||
42153770|NCT00264498|75962290|FG001|Randomized Treatment|Study Closure|0|||
42153771|NCT00264498|75962289|FG000|Randomized Treatment|Protocol Violation|1|||
42153772|NCT00264498|75962290|FG001|Randomized Treatment|Protocol Violation|0|||
42153773|NCT00264498|75962289|FG000|Crossover Treatment|Death|1|||
42153774|NCT00264498|75962290|FG001|Crossover Treatment|Death|3|||
42153775|NCT00264498|75962289|FG000|Crossover Treatment|Objective disease progression|4|||
42153776|NCT00264498|75962290|FG001|Crossover Treatment|Objective disease progression|5|||
42153777|NCT00264498|75962289|FG000|Crossover Treatment|Study closure|0|||
42153778|NCT00264498|75962290|FG001|Crossover Treatment|Study closure|1|||
42153779|NCT00264498|75962289|FG000|Crossover Treatment|Withdrawal by Subject|1|||
42153780|NCT00264498|75962290|FG001|Crossover Treatment|Withdrawal by Subject|0|||
42153781|NCT00466193|75962298|FG000|Overall Study|Adverse Event|0|||
42153782|NCT00466193|75962299|FG001|Overall Study|Adverse Event|1|||
42153783|NCT00466193|75962298|FG000|Overall Study|Lost to Follow-up|2|||
42153784|NCT00466193|75962299|FG001|Overall Study|Lost to Follow-up|4|||
42153785|NCT00466193|75962298|FG000|Overall Study|Physician Decision|1|||
42153786|NCT00466193|75962299|FG001|Overall Study|Physician Decision|0|||
42153787|NCT00466193|75962298|FG000|Overall Study|Protocol Violation|1|||
42153788|NCT00466193|75962299|FG001|Overall Study|Protocol Violation|1|||
42153789|NCT00466193|75962298|FG000|Overall Study|Withdrawal by Subject|7|||
42153790|NCT00466193|75962299|FG001|Overall Study|Withdrawal by Subject|2|||
42153791|NCT00466193|75962298|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
42153792|NCT00466193|75962299|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
42153793|NCT00263562|75962307|FG000|Overall Study|Protocol Violation|3|||
42153794|NCT00263562|75962308|FG001|Overall Study|Protocol Violation|0|||
42153795|NCT00454181|75962318|FG000|Overall Study|Adverse Event|1|||
42153796|NCT00454181|75962319|FG001|Overall Study|Adverse Event|1|||
42153797|NCT00454181|75962318|FG000|Overall Study|Lost to Follow-up|11|||
42153798|NCT00454181|75962319|FG001|Overall Study|Lost to Follow-up|1|||
42153799|NCT00454181|75962318|FG000|Overall Study|Protocol Violation|1|||
42153800|NCT00454181|75962319|FG001|Overall Study|Protocol Violation|1|||
42153801|NCT00454181|75962318|FG000|Overall Study|Withdrawal by Subject|2|||
42153802|NCT00454181|75962319|FG001|Overall Study|Withdrawal by Subject|0|||
42153803|NCT00237744|75962328|FG000|Overall Study|Withdrawal by Subject|3|||
42153804|NCT00237744|75962329|FG001|Overall Study|Withdrawal by Subject|1|||
42153805|NCT00237744|75962330|FG002|Overall Study|Withdrawal by Subject|0|||
42153806|NCT00237042|75962344|FG000|Treatment|Became ineligible post-randomization|0|||
42153807|NCT00237042|75962345|FG001|Treatment|Became ineligible post-randomization|1|||
42153808|NCT00237042|75962346|FG002|Treatment|Became ineligible post-randomization|16|||
42153809|NCT00237042|75962344|FG000|Treatment|Moved out of state|1|||
42153810|NCT00237042|75962345|FG001|Treatment|Moved out of state|1|||
42153811|NCT00237042|75962346|FG002|Treatment|Moved out of state|1|||
42153812|NCT00237042|75962344|FG000|Treatment|Completed no treatment|5|||
42153813|NCT00237042|75962345|FG001|Treatment|Completed no treatment|5|||
42153814|NCT00237042|75962346|FG002|Treatment|Completed no treatment|21|||
42153815|NCT00237042|75962344|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
42153816|NCT00237042|75962345|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
42153817|NCT00237042|75962346|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
42153818|NCT00237042|75962344|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
42153819|NCT00237042|75962345|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
42153820|NCT00237042|75962346|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
42153821|NCT00465647|75962358|FG000|Overall Study|Administrative|2|||
42153822|NCT00465647|75962359|FG001|Overall Study|Administrative|2|||
42153823|NCT00465647|75962360|FG002|Overall Study|Administrative|3|||
42153824|NCT00465647|75962361|FG003|Overall Study|Administrative|2|||
42153825|NCT00465647|75962358|FG000|Overall Study|Adverse Event|2|||
42153826|NCT00465647|75962359|FG001|Overall Study|Adverse Event|0|||
42153827|NCT00465647|75962360|FG002|Overall Study|Adverse Event|3|||
42153828|NCT00465647|75962361|FG003|Overall Study|Adverse Event|2|||
42153829|NCT00465647|75962358|FG000|Overall Study|Withdrawal by Subject|1|||
42153830|NCT00465647|75962359|FG001|Overall Study|Withdrawal by Subject|2|||
42153831|NCT00465647|75962360|FG002|Overall Study|Withdrawal by Subject|2|||
42153832|NCT00465647|75962361|FG003|Overall Study|Withdrawal by Subject|7|||
42153833|NCT00465647|75962358|FG000|Overall Study|"The other reasons included loss of IV"|8|||
42153834|NCT00465647|75962359|FG001|Overall Study|"The other reasons included loss of IV"|4|||
42153835|NCT00465647|75962360|FG002|Overall Study|"The other reasons included loss of IV"|3|||
42153836|NCT00465647|75962361|FG003|Overall Study|"The other reasons included loss of IV"|2|||
42153837|NCT00465569|75962383|FG000|Overall Study|persistent eczema during dose escalation|1|||
42153838|NCT00465569|75962384|FG001|Overall Study|persistent eczema during dose escalation|0|||
42153839|NCT00090766|75962393|FG000|Overall Study|Nephrectomy Planned|0|||
42153840|NCT00090766|75962394|FG001|Overall Study|Nephrectomy Planned|0|||
42153841|NCT00090766|75962395|FG002|Overall Study|Nephrectomy Planned|1|||
42153842|NCT00090766|75962393|FG000|Overall Study|Death|1|||
42153843|NCT00090766|75962394|FG001|Overall Study|Death|0|||
42153844|NCT00090766|75962395|FG002|Overall Study|Death|0|||
42278593|NCT00950989|76110223|FG003|Overall Study|Disease Progression|0|||
42278594|NCT00950989|76110220|FG000|Overall Study|Withdrawal by Subject|2|||
42278595|NCT00950989|76110221|FG001|Overall Study|Withdrawal by Subject|1|||
42278596|NCT00950989|76110222|FG002|Overall Study|Withdrawal by Subject|0|||
42278597|NCT00950989|76110223|FG003|Overall Study|Withdrawal by Subject|0|||
42278598|NCT00950989|76110220|FG000|Overall Study|Adverse Event|2|||
42278599|NCT00950989|76110221|FG001|Overall Study|Adverse Event|1|||
42278600|NCT00950989|76110222|FG002|Overall Study|Adverse Event|1|||
42278601|NCT00950989|76110223|FG003|Overall Study|Adverse Event|0|||
42278602|NCT00593567|76110238|FG000|Overall Study|Adverse Event|2|||
42278603|NCT00593567|76110239|FG001|Overall Study|Adverse Event|0|||
42278604|NCT00593567|76110238|FG000|Overall Study|Physician Decision|2|||
42278605|NCT00593567|76110239|FG001|Overall Study|Physician Decision|0|||
42278606|NCT00593567|76110238|FG000|Overall Study|Protocol Violation|13|||
42278607|NCT00593567|76110239|FG001|Overall Study|Protocol Violation|7|||
42278608|NCT00593567|76110238|FG000|Overall Study|Lack of Efficacy|2|||
42153845|NCT00090766|75962393|FG000|Overall Study|Admin|0|||
42153846|NCT00090766|75962394|FG001|Overall Study|Admin|2|||
42153847|NCT00090766|75962395|FG002|Overall Study|Admin|0|||
42153848|NCT00090766|75962393|FG000|Overall Study|Lost to Follow-up|2|||
42153849|NCT00090766|75962394|FG001|Overall Study|Lost to Follow-up|0|||
42153850|NCT00090766|75962395|FG002|Overall Study|Lost to Follow-up|2|||
42153851|NCT00465179|75962405|FG000|Overall Study|Adverse Event|4|||
42153852|NCT00465179|75962405|FG000|Overall Study|Withdrawal by Subject|2|||
42153853|NCT00465179|75962405|FG000|Overall Study|Progression of Disease|47|||
42153854|NCT00465101|75962409|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
42153855|NCT00465101|75962409|FG000|Overall Study|Change in health precluded follow up|4|||
42153856|NCT00465101|75962409|FG000|Overall Study|Did not meet study criteria|4|||
42153857|NCT00465101|75962409|FG000|Overall Study|Lost to Follow-up|5|||
42153858|NCT00465101|75962409|FG000|Overall Study|Other|6|||
42278609|NCT00593567|76110239|FG001|Overall Study|Lack of Efficacy|1|||
42278610|NCT00593567|76110238|FG000|Overall Study|Withdrawal by Subject|1|||
42278611|NCT00593567|76110239|FG001|Overall Study|Withdrawal by Subject|2|||
42153859|NCT00465101|75962409|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
42153860|NCT00465101|75962409|FG000|Overall Study|Patient postponed procedure|1|||
42153861|NCT00465101|75962409|FG000|Overall Study|Site closed due to IRB expiration|1|||
42153862|NCT00465101|75962409|FG000|Overall Study|Unable to obtain IRB approval|1|||
42153863|NCT00465101|75962409|FG000|Overall Study|Death|3|||
42153864|NCT00465101|75962409|FG000|Overall Study|Withdrawal by Subject|25|||
42153865|NCT00465101|75962409|FG000|Overall Study|Physician Decision|1|||
42153866|NCT00465101|75962409|FG000|Overall Study|Withdrew consent prior to procedure|3|||
42153867|NCT00084136|75962438|FG000|PI Comparison|Death|10|||
42153868|NCT00084136|75962439|FG001|PI Comparison|Death|9|||
42153869|NCT00084136|75962440|FG002|PI Comparison|Death|0|||
42153870|NCT00084136|75962438|FG000|PI Comparison|Lost to Follow-up|11|||
42153871|NCT00084136|75962439|FG001|PI Comparison|Lost to Follow-up|8|||
42153872|NCT00084136|75962440|FG002|PI Comparison|Lost to Follow-up|0|||
42153873|NCT00084136|75962438|FG000|PI Comparison|Withdrawal by Subject|33|||
42153874|NCT00084136|75962439|FG001|PI Comparison|Withdrawal by Subject|30|||
42153875|NCT00084136|75962440|FG002|PI Comparison|Withdrawal by Subject|0|||
42153876|NCT00084136|75962438|FG000|PI Comparison|Clinic site closed|1|||
42153877|NCT00084136|75962439|FG001|PI Comparison|Clinic site closed|0|||
42278612|NCT02411084|76110247|FG000|Overall Study|Lack of Efficacy|6|||
42278613|NCT02411084|76110248|FG001|Overall Study|Lack of Efficacy|3|||
42153878|NCT00084136|75962440|FG002|PI Comparison|Clinic site closed|0|||
42153879|NCT00084136|75962438|FG000|NRTI Comparison|Death|20|||
42153880|NCT00084136|75962439|FG001|NRTI Comparison|Death|0|||
42153881|NCT00084136|75962440|FG002|NRTI Comparison|Death|18|||
42153882|NCT00084136|75962438|FG000|NRTI Comparison|Lost to Follow-up|14|||
42153883|NCT00084136|75962439|FG001|NRTI Comparison|Lost to Follow-up|0|||
42153884|NCT00084136|75962440|FG002|NRTI Comparison|Lost to Follow-up|12|||
42153885|NCT00084136|75962438|FG000|NRTI Comparison|Withdrawal by Subject|54|||
42153886|NCT00084136|75962439|FG001|NRTI Comparison|Withdrawal by Subject|0|||
42153887|NCT00084136|75962440|FG002|NRTI Comparison|Withdrawal by Subject|38|||
42278614|NCT02411084|76110247|FG000|Overall Study|Death|5|||
42278615|NCT02411084|76110248|FG001|Overall Study|Death|4|||
42278616|NCT02411084|76110247|FG000|Overall Study|Adverse Event|2|||
42278617|NCT02411084|76110248|FG001|Overall Study|Adverse Event|1|||
42153888|NCT00084136|75962438|FG000|NRTI Comparison|Clinic site closed|12|||
42153889|NCT00084136|75962439|FG001|NRTI Comparison|Clinic site closed|0|||
42153890|NCT00084136|75962440|FG002|NRTI Comparison|Clinic site closed|14|||
42153891|NCT00084136|75962438|FG000|NRTI Comparison|Not reason above|1|||
42153892|NCT00084136|75962439|FG001|NRTI Comparison|Not reason above|0|||
42153893|NCT00084136|75962440|FG002|NRTI Comparison|Not reason above|0|||
42153894|NCT03812380|75962451|FG000|Overall Study|Protocol Violation|3|||
42153895|NCT03812380|75962452|FG001|Overall Study|Protocol Violation|3|||
42153896|NCT03812380|75962451|FG000|Overall Study|Withdrawal by Subject|5|||
42153897|NCT03812380|75962452|FG001|Overall Study|Withdrawal by Subject|4|||
42153898|NCT03812380|75962451|FG000|Overall Study|Early termination of study|14|||
42153899|NCT03812380|75962452|FG001|Overall Study|Early termination of study|14|||
42153900|NCT00464945|75962460|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
42153901|NCT00464945|75962461|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
42153902|NCT00464945|75962460|FG000|Infant Series|Protocol Violation|1|||
42153903|NCT00464945|75962461|FG001|Infant Series|Protocol Violation|0|||
42153904|NCT00464945|75962460|FG000|Infant Series|Lost to Follow-up|1|||
42153905|NCT00464945|75962461|FG001|Infant Series|Lost to Follow-up|0|||
42153906|NCT00464945|75962460|FG000|After Infant Series|Withdrawal by Subject|0|||
42153907|NCT00464945|75962461|FG001|After Infant Series|Withdrawal by Subject|2|||
42153908|NCT00464945|75962460|FG000|Toddler Dose|Lost to Follow-up|0|||
42153909|NCT00464945|75962461|FG001|Toddler Dose|Lost to Follow-up|1|||
42153910|NCT00464087|75962486|FG000|Overall Study|No PCI per inclusion criteria|0|||
42153911|NCT00464087|75962487|FG001|Overall Study|No PCI per inclusion criteria|0|||
42153912|NCT00464087|75962488|FG002|Overall Study|No PCI per inclusion criteria|29|||
42153913|NCT00452699|75962498|FG000|Overall Study|Adverse Event|10|||
42153914|NCT00452699|75962499|FG001|Overall Study|Adverse Event|3|||
42153915|NCT00452699|75962498|FG000|Overall Study|Lack of Efficacy|6|||
42153916|NCT00452699|75962499|FG001|Overall Study|Lack of Efficacy|4|||
42153917|NCT00452699|75962498|FG000|Overall Study|Lost to Follow-up|6|||
42153918|NCT00452699|75962499|FG001|Overall Study|Lost to Follow-up|9|||
42153919|NCT00452699|75962498|FG000|Overall Study|Protocol Violation|21|||
42153920|NCT00452699|75962499|FG001|Overall Study|Protocol Violation|25|||
42153921|NCT00452699|75962498|FG000|Overall Study|Withdrawal by Subject|26|||
42153922|NCT00452699|75962499|FG001|Overall Study|Withdrawal by Subject|25|||
42153923|NCT00452699|75962498|FG000|Overall Study|Other|12|||
42153924|NCT00452699|75962499|FG001|Overall Study|Other|7|||
42153925|NCT00069784|75962507|FG000|Overall Study|Adverse Event|105|||
42153926|NCT00069784|75962508|FG001|Overall Study|Adverse Event|0|||
42153927|NCT00069784|75962507|FG000|Overall Study|Withdrawal by Subject|1090|||
42153928|NCT00069784|75962508|FG001|Overall Study|Withdrawal by Subject|0|||
42153929|NCT00069784|75962507|FG000|Overall Study|Other|17|||
42153930|NCT00069784|75962508|FG001|Overall Study|Other|0|||
42153931|NCT03811834|75962514|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
42153932|NCT00090610|75962529|FG000|Overall Study|Withdrawal by Subject|1|||
42153933|NCT00090610|75962530|FG001|Overall Study|Withdrawal by Subject|1|||
42153934|NCT00463385|75962540|FG000|Overall Study|Other|4|||
42153935|NCT00463385|75962541|FG001|Overall Study|Other|3|||
42153936|NCT00463385|75962542|FG002|Overall Study|Other|6|||
42153937|NCT00463385|75962543|FG003|Overall Study|Other|4|||
42153938|NCT00463385|75962540|FG000|Overall Study|Adverse Event|5|||
42153939|NCT00463385|75962541|FG001|Overall Study|Adverse Event|8|||
42153940|NCT00463385|75962542|FG002|Overall Study|Adverse Event|4|||
42153941|NCT00463385|75962543|FG003|Overall Study|Adverse Event|2|||
42153942|NCT00463385|75962540|FG000|Overall Study|Lack of Efficacy|6|||
42153943|NCT00463385|75962541|FG001|Overall Study|Lack of Efficacy|6|||
42153944|NCT00463385|75962542|FG002|Overall Study|Lack of Efficacy|7|||
42153945|NCT00463385|75962543|FG003|Overall Study|Lack of Efficacy|9|||
42153946|NCT00463385|75962540|FG000|Overall Study|Withdrawal by Subject|3|||
42153947|NCT00463385|75962541|FG001|Overall Study|Withdrawal by Subject|3|||
42153948|NCT00463385|75962542|FG002|Overall Study|Withdrawal by Subject|3|||
42153949|NCT00463385|75962543|FG003|Overall Study|Withdrawal by Subject|4|||
42153950|NCT00463385|75962540|FG000|Overall Study|Lost to Follow-up|0|||
42278618|NCT02411084|76110247|FG000|Overall Study|Other reasons|0|||
42153951|NCT00463385|75962541|FG001|Overall Study|Lost to Follow-up|0|||
42153952|NCT00463385|75962542|FG002|Overall Study|Lost to Follow-up|0|||
42153953|NCT00463385|75962543|FG003|Overall Study|Lost to Follow-up|1|||
42153954|NCT00463385|75962540|FG000|Overall Study|Death|2|||
42153955|NCT00463385|75962541|FG001|Overall Study|Death|1|||
42153956|NCT00463385|75962542|FG002|Overall Study|Death|2|||
42153957|NCT00463385|75962543|FG003|Overall Study|Death|0|||
42153958|NCT00463385|75962540|FG000|Overall Study|Missing|2|||
42153959|NCT00463385|75962541|FG001|Overall Study|Missing|0|||
42153960|NCT00463385|75962542|FG002|Overall Study|Missing|0|||
42153961|NCT00463385|75962543|FG003|Overall Study|Missing|2|||
42153962|NCT00463385|75962540|FG000|Overall Study|1 participant received commercial drug|0|||
42153963|NCT00463385|75962541|FG001|Overall Study|1 participant received commercial drug|1|||
42153964|NCT00463385|75962542|FG002|Overall Study|1 participant received commercial drug|0|||
42153965|NCT00463385|75962543|FG003|Overall Study|1 participant received commercial drug|0|||
42153966|NCT00463229|75962563|FG000|Overall Study|Lost to Follow-up|5|||
42153967|NCT00463229|75962564|FG001|Overall Study|Lost to Follow-up|7|||
42153968|NCT00463229|75962563|FG000|Overall Study|Death|4|||
42153969|NCT00463229|75962564|FG001|Overall Study|Death|3|||
42153970|NCT03839693|75962574|FG000|Overall Study|Lost to Follow-up|0|||
42153971|NCT03839693|75962575|FG001|Overall Study|Lost to Follow-up|2|||
42153972|NCT03839693|75962576|FG002|Overall Study|Lost to Follow-up|2|||
42153973|NCT03839693|75962574|FG000|Overall Study|Withdrawal by Subject|1|||
42278619|NCT02411084|76110248|FG001|Overall Study|Other reasons|5|||
42013064|NCT01184859|75820149|FG000|Period 1: Single Dose|Protocol Violation|0|||
42013065|NCT01184859|75820150|FG001|Period 1: Single Dose|Protocol Violation|1|||
42013066|NCT01184859|75820151|FG002|Period 1: Single Dose|Protocol Violation|0|||
42013067|NCT01184859|75820152|FG003|Period 1: Single Dose|Protocol Violation|0|||
42013068|NCT01184859|75820153|FG004|Period 1: Single Dose|Protocol Violation|0|||
42013069|NCT01184859|75820149|FG000|Period 1: Single Dose|Adverse Event|0|||
42013070|NCT01184859|75820150|FG001|Period 1: Single Dose|Adverse Event|0|||
42013071|NCT01184859|75820151|FG002|Period 1: Single Dose|Adverse Event|0|||
42013072|NCT01184859|75820152|FG003|Period 1: Single Dose|Adverse Event|0|||
42013073|NCT01184859|75820153|FG004|Period 1: Single Dose|Adverse Event|1|||
42013074|NCT01184859|75820149|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
42013075|NCT01184859|75820150|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
42013076|NCT01184859|75820151|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
42013077|NCT01184859|75820152|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
42013078|NCT01184859|75820153|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
42013079|NCT01184859|75820149|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
42013080|NCT01184859|75820150|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
42013081|NCT01184859|75820151|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
42013082|NCT01184859|75820152|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
42013083|NCT01184859|75820153|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
42013084|NCT01184079|75820172|FG000|Overall Study|Lost to Follow-up|14|||
42013085|NCT01184079|75820173|FG001|Overall Study|Lost to Follow-up|2|||
42013086|NCT01190865|75820181|FG000|Overall Study|Withdrawal by Subject|1|||
42013087|NCT01190865|75820181|FG000|Overall Study|Non-compliance|2|||
42013088|NCT01190475|75820188|FG000|Overall Study|Withdrawal by Subject|0|||
42013089|NCT01190475|75820189|FG001|Overall Study|Withdrawal by Subject|0|||
42013090|NCT01190475|75820190|FG002|Overall Study|Withdrawal by Subject|1|||
42013091|NCT01289990|75820213|FG000|Overall Study|Death|0|||
42013092|NCT01289990|75820214|FG001|Overall Study|Death|0|||
42013093|NCT01289990|75820215|FG002|Overall Study|Death|0|||
42013094|NCT01289990|75820216|FG003|Overall Study|Death|1|||
42013095|NCT01289990|75820217|FG004|Overall Study|Death|2|||
42013096|NCT01289990|75820218|FG005|Overall Study|Death|1|||
42013097|NCT01289990|75820219|FG006|Overall Study|Death|0|||
42013098|NCT01289990|75820220|FG007|Overall Study|Death|0|||
42013099|NCT01289990|75820221|FG008|Overall Study|Death|0|||
42013100|NCT01289990|75820222|FG009|Overall Study|Death|0|||
42013101|NCT01289990|75820223|FG010|Overall Study|Death|0|||
42013102|NCT01289990|75820224|FG011|Overall Study|Death|1|||
42013103|NCT01289990|75820225|FG012|Overall Study|Death|0|||
42013104|NCT01289990|75820213|FG000|Overall Study|Lost to Follow-up|3|||
42013105|NCT01289990|75820214|FG001|Overall Study|Lost to Follow-up|2|||
42013106|NCT01289990|75820215|FG002|Overall Study|Lost to Follow-up|5|||
42013107|NCT01289990|75820216|FG003|Overall Study|Lost to Follow-up|5|||
42013108|NCT01289990|75820217|FG004|Overall Study|Lost to Follow-up|3|||
42013109|NCT01289990|75820218|FG005|Overall Study|Lost to Follow-up|4|||
42013110|NCT01289990|75820219|FG006|Overall Study|Lost to Follow-up|2|||
42013111|NCT01289990|75820220|FG007|Overall Study|Lost to Follow-up|2|||
42013112|NCT01289990|75820221|FG008|Overall Study|Lost to Follow-up|1|||
42013113|NCT01289990|75820222|FG009|Overall Study|Lost to Follow-up|4|||
42013114|NCT01289990|75820223|FG010|Overall Study|Lost to Follow-up|2|||
42013115|NCT01289990|75820224|FG011|Overall Study|Lost to Follow-up|1|||
42013116|NCT01289990|75820225|FG012|Overall Study|Lost to Follow-up|2|||
42013117|NCT01289990|75820213|FG000|Overall Study|Withdrawal by Subject|15|||
42013118|NCT01289990|75820214|FG001|Overall Study|Withdrawal by Subject|14|||
42013119|NCT01289990|75820215|FG002|Overall Study|Withdrawal by Subject|12|||
42013120|NCT01289990|75820216|FG003|Overall Study|Withdrawal by Subject|13|||
42013121|NCT01289990|75820217|FG004|Overall Study|Withdrawal by Subject|8|||
42013122|NCT01289990|75820218|FG005|Overall Study|Withdrawal by Subject|7|||
42013123|NCT01289990|75820219|FG006|Overall Study|Withdrawal by Subject|13|||
42013124|NCT01289990|75820220|FG007|Overall Study|Withdrawal by Subject|9|||
42013125|NCT01289990|75820221|FG008|Overall Study|Withdrawal by Subject|12|||
42013126|NCT01289990|75820222|FG009|Overall Study|Withdrawal by Subject|13|||
42013127|NCT01289990|75820223|FG010|Overall Study|Withdrawal by Subject|11|||
42153974|NCT03839693|75962575|FG001|Overall Study|Withdrawal by Subject|0|||
42153975|NCT03839693|75962576|FG002|Overall Study|Withdrawal by Subject|2|||
42013128|NCT01289990|75820224|FG011|Overall Study|Withdrawal by Subject|13|||
42013129|NCT01289990|75820225|FG012|Overall Study|Withdrawal by Subject|16|||
42153976|NCT03839693|75962574|FG000|Overall Study|subject moved out of the area|1|||
42153977|NCT03839693|75962575|FG001|Overall Study|subject moved out of the area|0|||
42153978|NCT03839693|75962576|FG002|Overall Study|subject moved out of the area|0|||
42153979|NCT00068692|75962589|FG000|Step 1: Registration|Disese progression/relapse|5|||
42153980|NCT00068692|75962590|FG001|Step 1: Registration|Disese progression/relapse|0|||
42153981|NCT00068692|75962591|FG002|Step 1: Registration|Disese progression/relapse|0|||
42153982|NCT00068692|75962592|FG003|Step 1: Registration|Disese progression/relapse|0|||
42153983|NCT00068692|75962593|FG004|Step 1: Registration|Disese progression/relapse|0|||
42153984|NCT00068692|75962594|FG005|Step 1: Registration|Disese progression/relapse|0|||
42153985|NCT00068692|75962595|FG006|Step 1: Registration|Disese progression/relapse|0|||
42153986|NCT00068692|75962596|FG007|Step 1: Registration|Disese progression/relapse|0|||
42153987|NCT00068692|75962589|FG000|Step 1: Registration|Adverse Event|7|||
42153988|NCT00068692|75962590|FG001|Step 1: Registration|Adverse Event|0|||
42153989|NCT00068692|75962591|FG002|Step 1: Registration|Adverse Event|0|||
42153990|NCT00068692|75962592|FG003|Step 1: Registration|Adverse Event|0|||
42153991|NCT00068692|75962593|FG004|Step 1: Registration|Adverse Event|0|||
42153992|NCT00068692|75962594|FG005|Step 1: Registration|Adverse Event|0|||
42013130|NCT01289990|75820213|FG000|Overall Study|discontinued in preceding trial|18|||
42013131|NCT01289990|75820214|FG001|Overall Study|discontinued in preceding trial|20|||
42013132|NCT01289990|75820215|FG002|Overall Study|discontinued in preceding trial|41|||
42013133|NCT01289990|75820216|FG003|Overall Study|discontinued in preceding trial|17|||
42013134|NCT01289990|75820217|FG004|Overall Study|discontinued in preceding trial|11|||
42013135|NCT01289990|75820218|FG005|Overall Study|discontinued in preceding trial|12|||
42013136|NCT01289990|75820219|FG006|Overall Study|discontinued in preceding trial|18|||
42013137|NCT01289990|75820220|FG007|Overall Study|discontinued in preceding trial|8|||
42013138|NCT01289990|75820221|FG008|Overall Study|discontinued in preceding trial|17|||
42013139|NCT01289990|75820222|FG009|Overall Study|discontinued in preceding trial|21|||
42013140|NCT01289990|75820223|FG010|Overall Study|discontinued in preceding trial|17|||
42013141|NCT01289990|75820224|FG011|Overall Study|discontinued in preceding trial|17|||
42013142|NCT01289990|75820225|FG012|Overall Study|discontinued in preceding trial|24|||
42013143|NCT01289990|75820213|FG000|Overall Study|did not continue in extension|41|||
42013144|NCT01289990|75820214|FG001|Overall Study|did not continue in extension|45|||
42013145|NCT01289990|75820215|FG002|Overall Study|did not continue in extension|51|||
42013146|NCT01289990|75820216|FG003|Overall Study|did not continue in extension|51|||
42013147|NCT01289990|75820217|FG004|Overall Study|did not continue in extension|48|||
42013148|NCT01289990|75820218|FG005|Overall Study|did not continue in extension|50|||
42153993|NCT00068692|75962595|FG006|Step 1: Registration|Adverse Event|0|||
42153994|NCT00068692|75962596|FG007|Step 1: Registration|Adverse Event|0|||
42153995|NCT00068692|75962589|FG000|Step 1: Registration|Death|1|||
42153996|NCT00068692|75962590|FG001|Step 1: Registration|Death|0|||
42153997|NCT00068692|75962591|FG002|Step 1: Registration|Death|0|||
42153998|NCT00068692|75962592|FG003|Step 1: Registration|Death|0|||
42153999|NCT00068692|75962593|FG004|Step 1: Registration|Death|0|||
42154000|NCT00068692|75962594|FG005|Step 1: Registration|Death|0|||
42154001|NCT00068692|75962595|FG006|Step 1: Registration|Death|0|||
42154002|NCT00068692|75962596|FG007|Step 1: Registration|Death|0|||
42154003|NCT00068692|75962589|FG000|Step 1: Registration|Withdrawal by Subject|11|||
42154004|NCT00068692|75962590|FG001|Step 1: Registration|Withdrawal by Subject|0|||
42154005|NCT00068692|75962591|FG002|Step 1: Registration|Withdrawal by Subject|0|||
42154006|NCT00068692|75962592|FG003|Step 1: Registration|Withdrawal by Subject|0|||
42154007|NCT00068692|75962593|FG004|Step 1: Registration|Withdrawal by Subject|0|||
42154008|NCT00068692|75962594|FG005|Step 1: Registration|Withdrawal by Subject|0|||
42154009|NCT00068692|75962595|FG006|Step 1: Registration|Withdrawal by Subject|0|||
42154010|NCT00068692|75962596|FG007|Step 1: Registration|Withdrawal by Subject|0|||
42154011|NCT00068692|75962589|FG000|Step 1: Registration|Alternative therapy|2|||
42154012|NCT00068692|75962590|FG001|Step 1: Registration|Alternative therapy|0|||
42278620|NCT01602315|76110261|FG000|Overall Study|Protocol Violation|0|||
42278621|NCT01602315|76110262|FG001|Overall Study|Protocol Violation|0|||
42278622|NCT01602315|76110263|FG002|Overall Study|Protocol Violation|0|||
42013149|NCT01289990|75820219|FG006|Overall Study|did not continue in extension|54|||
42013150|NCT01289990|75820220|FG007|Overall Study|did not continue in extension|36|||
42013151|NCT01289990|75820221|FG008|Overall Study|did not continue in extension|44|||
42013152|NCT01289990|75820222|FG009|Overall Study|did not continue in extension|48|||
42013153|NCT01289990|75820223|FG010|Overall Study|did not continue in extension|45|||
42013154|NCT01289990|75820224|FG011|Overall Study|did not continue in extension|34|||
42013155|NCT01289990|75820225|FG012|Overall Study|did not continue in extension|56|||
42013156|NCT01289990|75820213|FG000|Overall Study|Not treated|0|||
42154013|NCT00068692|75962591|FG002|Step 1: Registration|Alternative therapy|0|||
42154014|NCT00068692|75962592|FG003|Step 1: Registration|Alternative therapy|0|||
42154015|NCT00068692|75962593|FG004|Step 1: Registration|Alternative therapy|0|||
42154016|NCT00068692|75962594|FG005|Step 1: Registration|Alternative therapy|0|||
42154017|NCT00068692|75962595|FG006|Step 1: Registration|Alternative therapy|0|||
42154018|NCT00068692|75962596|FG007|Step 1: Registration|Alternative therapy|0|||
42278623|NCT01602315|76110264|FG003|Overall Study|Protocol Violation|0|||
42154019|NCT00068692|75962589|FG000|Step 1: Registration|Complicating disease|2|||
42154020|NCT00068692|75962590|FG001|Step 1: Registration|Complicating disease|0|||
42154021|NCT00068692|75962591|FG002|Step 1: Registration|Complicating disease|0|||
42154022|NCT00068692|75962592|FG003|Step 1: Registration|Complicating disease|0|||
42154023|NCT00068692|75962593|FG004|Step 1: Registration|Complicating disease|0|||
42154024|NCT00068692|75962594|FG005|Step 1: Registration|Complicating disease|0|||
42154025|NCT00068692|75962595|FG006|Step 1: Registration|Complicating disease|0|||
42154026|NCT00068692|75962596|FG007|Step 1: Registration|Complicating disease|0|||
42154027|NCT00068692|75962589|FG000|Step 1: Registration|Protocol Violation|1|||
42154028|NCT00068692|75962590|FG001|Step 1: Registration|Protocol Violation|0|||
42154029|NCT00068692|75962591|FG002|Step 1: Registration|Protocol Violation|0|||
42154030|NCT00068692|75962592|FG003|Step 1: Registration|Protocol Violation|0|||
42154031|NCT00068692|75962593|FG004|Step 1: Registration|Protocol Violation|0|||
42154032|NCT00068692|75962594|FG005|Step 1: Registration|Protocol Violation|0|||
42154033|NCT00068692|75962595|FG006|Step 1: Registration|Protocol Violation|0|||
42154034|NCT00068692|75962596|FG007|Step 1: Registration|Protocol Violation|0|||
42154035|NCT00068692|75962589|FG000|Step 1: Registration|Not eligible|6|||
42154036|NCT00068692|75962590|FG001|Step 1: Registration|Not eligible|0|||
42154037|NCT00068692|75962591|FG002|Step 1: Registration|Not eligible|0|||
42154038|NCT00068692|75962592|FG003|Step 1: Registration|Not eligible|0|||
42154039|NCT00068692|75962593|FG004|Step 1: Registration|Not eligible|0|||
42154040|NCT00068692|75962594|FG005|Step 1: Registration|Not eligible|0|||
42154041|NCT00068692|75962595|FG006|Step 1: Registration|Not eligible|0|||
42154042|NCT00068692|75962596|FG007|Step 1: Registration|Not eligible|0|||
42154043|NCT00068692|75962589|FG000|Step 1: Registration|Other|2|||
42154044|NCT00068692|75962590|FG001|Step 1: Registration|Other|0|||
42154045|NCT00068692|75962591|FG002|Step 1: Registration|Other|0|||
42154046|NCT00068692|75962592|FG003|Step 1: Registration|Other|0|||
42154047|NCT00068692|75962593|FG004|Step 1: Registration|Other|0|||
42154048|NCT00068692|75962594|FG005|Step 1: Registration|Other|0|||
42154049|NCT00068692|75962595|FG006|Step 1: Registration|Other|0|||
42154050|NCT00068692|75962596|FG007|Step 1: Registration|Other|0|||
42154051|NCT00068692|75962589|FG000|Step 1: Registration|Not start protocol therapy|3|||
42154052|NCT00068692|75962590|FG001|Step 1: Registration|Not start protocol therapy|0|||
42278624|NCT01602315|76110265|FG004|Overall Study|Protocol Violation|0|||
42278625|NCT01602315|76110266|FG005|Overall Study|Protocol Violation|1|||
42278626|NCT01602315|76110267|FG006|Overall Study|Protocol Violation|0|||
42278627|NCT01602315|76110261|FG000|Overall Study|Physician Decision|2|||
42278628|NCT01602315|76110262|FG001|Overall Study|Physician Decision|0|||
42278629|NCT01602315|76110263|FG002|Overall Study|Physician Decision|0|||
42278630|NCT01602315|76110264|FG003|Overall Study|Physician Decision|0|||
42278631|NCT01602315|76110265|FG004|Overall Study|Physician Decision|2|||
42278632|NCT01602315|76110266|FG005|Overall Study|Physician Decision|1|||
42278633|NCT01602315|76110267|FG006|Overall Study|Physician Decision|1|||
42278634|NCT01602315|76110261|FG000|Overall Study|Disease progression|6|||
42278635|NCT01602315|76110262|FG001|Overall Study|Disease progression|3|||
42013157|NCT01289990|75820214|FG001|Overall Study|Not treated|0|||
42013158|NCT01289990|75820215|FG002|Overall Study|Not treated|0|||
42154053|NCT00068692|75962591|FG002|Step 1: Registration|Not start protocol therapy|0|||
42154054|NCT00068692|75962592|FG003|Step 1: Registration|Not start protocol therapy|0|||
42154055|NCT00068692|75962593|FG004|Step 1: Registration|Not start protocol therapy|0|||
42154056|NCT00068692|75962594|FG005|Step 1: Registration|Not start protocol therapy|0|||
42154057|NCT00068692|75962595|FG006|Step 1: Registration|Not start protocol therapy|0|||
42154058|NCT00068692|75962596|FG007|Step 1: Registration|Not start protocol therapy|0|||
42154059|NCT00068692|75962589|FG000|Step 1: Registration|Registered but not randomized|0|||
42154060|NCT00068692|75962590|FG001|Step 1: Registration|Registered but not randomized|1|||
42154061|NCT00068692|75962591|FG002|Step 1: Registration|Registered but not randomized|0|||
42154062|NCT00068692|75962592|FG003|Step 1: Registration|Registered but not randomized|0|||
42278636|NCT01602315|76110263|FG002|Overall Study|Disease progression|10|||
42278637|NCT01602315|76110264|FG003|Overall Study|Disease progression|1|||
42278638|NCT01602315|76110265|FG004|Overall Study|Disease progression|41|||
42278639|NCT01602315|76110266|FG005|Overall Study|Disease progression|12|||
42351315|NCT01545375|76191203|FG001|Overall Study|Protocol Violation|3|||
42278640|NCT01602315|76110267|FG006|Overall Study|Disease progression|15|||
42351316|NCT01545375|76191202|FG000|Overall Study|Withdrawal by Subject|58|||
42351317|NCT01545375|76191203|FG001|Overall Study|Withdrawal by Subject|55|||
42351318|NCT01539837|76191212|FG000|Overall Study|reduce neutrophil level|0|||
42013159|NCT01289990|75820216|FG003|Overall Study|Not treated|0|||
42013160|NCT01289990|75820217|FG004|Overall Study|Not treated|0|||
42013161|NCT01289990|75820218|FG005|Overall Study|Not treated|0|||
42154063|NCT00068692|75962593|FG004|Step 1: Registration|Registered but not randomized|0|||
42154064|NCT00068692|75962594|FG005|Step 1: Registration|Registered but not randomized|0|||
42154065|NCT00068692|75962595|FG006|Step 1: Registration|Registered but not randomized|0|||
42013162|NCT01289990|75820219|FG006|Overall Study|Not treated|1|||
42154066|NCT00068692|75962596|FG007|Step 1: Registration|Registered but not randomized|0|||
42278641|NCT01602315|76110261|FG000|Overall Study|Death|1|||
42278642|NCT01602315|76110262|FG001|Overall Study|Death|1|||
42154067|NCT00068692|75962589|FG000|Step 2: Randomization|Disesae progression/replase|0|||
42154068|NCT00068692|75962590|FG001|Step 2: Randomization|Disesae progression/replase|0|||
42154069|NCT00068692|75962591|FG002|Step 2: Randomization|Disesae progression/replase|1|||
42154070|NCT00068692|75962592|FG003|Step 2: Randomization|Disesae progression/replase|1|||
42154071|NCT00068692|75962593|FG004|Step 2: Randomization|Disesae progression/replase|0|||
42154072|NCT00068692|75962594|FG005|Step 2: Randomization|Disesae progression/replase|0|||
42154073|NCT00068692|75962595|FG006|Step 2: Randomization|Disesae progression/replase|0|||
42154074|NCT00068692|75962596|FG007|Step 2: Randomization|Disesae progression/replase|0|||
42154075|NCT00068692|75962589|FG000|Step 2: Randomization|Adverse Event|0|||
42154076|NCT00068692|75962590|FG001|Step 2: Randomization|Adverse Event|0|||
42154077|NCT00068692|75962591|FG002|Step 2: Randomization|Adverse Event|4|||
42154078|NCT00068692|75962592|FG003|Step 2: Randomization|Adverse Event|2|||
42154079|NCT00068692|75962593|FG004|Step 2: Randomization|Adverse Event|2|||
42154080|NCT00068692|75962594|FG005|Step 2: Randomization|Adverse Event|3|||
42154081|NCT00068692|75962595|FG006|Step 2: Randomization|Adverse Event|4|||
42154082|NCT00068692|75962596|FG007|Step 2: Randomization|Adverse Event|4|||
42154083|NCT00068692|75962589|FG000|Step 2: Randomization|Death|0|||
42154084|NCT00068692|75962590|FG001|Step 2: Randomization|Death|0|||
42154085|NCT00068692|75962591|FG002|Step 2: Randomization|Death|0|||
42154086|NCT00068692|75962592|FG003|Step 2: Randomization|Death|0|||
42154087|NCT00068692|75962593|FG004|Step 2: Randomization|Death|1|||
42154088|NCT00068692|75962594|FG005|Step 2: Randomization|Death|0|||
42154089|NCT00068692|75962595|FG006|Step 2: Randomization|Death|0|||
42154090|NCT00068692|75962596|FG007|Step 2: Randomization|Death|1|||
42154091|NCT00068692|75962589|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
42154092|NCT00068692|75962590|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
42154093|NCT00068692|75962591|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
42154094|NCT00068692|75962592|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
42154095|NCT00068692|75962593|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
42278643|NCT01602315|76110263|FG002|Overall Study|Death|1|||
42278644|NCT01602315|76110264|FG003|Overall Study|Death|1|||
42154096|NCT00068692|75962594|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
42154097|NCT00068692|75962595|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
42154098|NCT00068692|75962596|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
42154099|NCT00068692|75962589|FG000|Step 2: Randomization|alternative therapy|0|||
42154100|NCT00068692|75962590|FG001|Step 2: Randomization|alternative therapy|0|||
42154101|NCT00068692|75962591|FG002|Step 2: Randomization|alternative therapy|0|||
42154102|NCT00068692|75962592|FG003|Step 2: Randomization|alternative therapy|1|||
42154103|NCT00068692|75962593|FG004|Step 2: Randomization|alternative therapy|1|||
42154104|NCT00068692|75962594|FG005|Step 2: Randomization|alternative therapy|0|||
42154105|NCT00068692|75962595|FG006|Step 2: Randomization|alternative therapy|0|||
42154106|NCT00068692|75962596|FG007|Step 2: Randomization|alternative therapy|0|||
42154107|NCT00068692|75962589|FG000|Step 2: Randomization|Physician Decision|0|||
42154108|NCT00068692|75962590|FG001|Step 2: Randomization|Physician Decision|0|||
42154109|NCT00068692|75962591|FG002|Step 2: Randomization|Physician Decision|0|||
42154110|NCT00068692|75962592|FG003|Step 2: Randomization|Physician Decision|1|||
42154111|NCT00068692|75962593|FG004|Step 2: Randomization|Physician Decision|1|||
42154112|NCT00068692|75962594|FG005|Step 2: Randomization|Physician Decision|0|||
42154113|NCT00068692|75962595|FG006|Step 2: Randomization|Physician Decision|0|||
42154114|NCT00068692|75962596|FG007|Step 2: Randomization|Physician Decision|0|||
42154115|NCT00068692|75962589|FG000|Step 2: Randomization|Other|0|||
42154116|NCT00068692|75962590|FG001|Step 2: Randomization|Other|0|||
42154117|NCT00068692|75962591|FG002|Step 2: Randomization|Other|0|||
42154118|NCT00068692|75962592|FG003|Step 2: Randomization|Other|1|||
42154119|NCT00068692|75962593|FG004|Step 2: Randomization|Other|0|||
42154120|NCT00068692|75962594|FG005|Step 2: Randomization|Other|1|||
42154121|NCT00068692|75962595|FG006|Step 2: Randomization|Other|0|||
42154122|NCT00068692|75962596|FG007|Step 2: Randomization|Other|0|||
42154123|NCT00068692|75962589|FG000|Step 2: Randomization|never start protocol therapy|0|||
42154124|NCT00068692|75962590|FG001|Step 2: Randomization|never start protocol therapy|0|||
42154125|NCT00068692|75962591|FG002|Step 2: Randomization|never start protocol therapy|1|||
42154126|NCT00068692|75962592|FG003|Step 2: Randomization|never start protocol therapy|0|||
42154127|NCT00068692|75962593|FG004|Step 2: Randomization|never start protocol therapy|1|||
42351319|NCT01539837|76191213|FG001|Overall Study|reduce neutrophil level|1|||
42154128|NCT00068692|75962594|FG005|Step 2: Randomization|never start protocol therapy|0|||
42154129|NCT00068692|75962595|FG006|Step 2: Randomization|never start protocol therapy|0|||
42154130|NCT00068692|75962596|FG007|Step 2: Randomization|never start protocol therapy|0|||
42154131|NCT00463151|75962613|FG000|Overall Study|Adverse Event|0|||
42154132|NCT00463151|75962614|FG001|Overall Study|Adverse Event|0|||
42154133|NCT00463151|75962615|FG002|Overall Study|Adverse Event|1|||
42154134|NCT00463151|75962616|FG003|Overall Study|Adverse Event|0|||
42154135|NCT00463151|75962613|FG000|Overall Study|Lack of Efficacy|2|||
42154136|NCT00463151|75962614|FG001|Overall Study|Lack of Efficacy|5|||
42278645|NCT01602315|76110265|FG004|Overall Study|Death|7|||
42154137|NCT00463151|75962615|FG002|Overall Study|Lack of Efficacy|2|||
42154138|NCT00463151|75962616|FG003|Overall Study|Lack of Efficacy|5|||
42154139|NCT00463151|75962613|FG000|Overall Study|Protocol Violation|0|||
42154140|NCT00463151|75962614|FG001|Overall Study|Protocol Violation|0|||
42154141|NCT00463151|75962615|FG002|Overall Study|Protocol Violation|0|||
42154142|NCT00463151|75962616|FG003|Overall Study|Protocol Violation|1|||
42154143|NCT00463151|75962613|FG000|Overall Study|Withdrawal by Subject|0|||
42154144|NCT00463151|75962614|FG001|Overall Study|Withdrawal by Subject|0|||
42154145|NCT00463151|75962615|FG002|Overall Study|Withdrawal by Subject|0|||
42154146|NCT00463151|75962616|FG003|Overall Study|Withdrawal by Subject|1|||
42154147|NCT00068380|75962626|FG000|Overall Study|Withdrawal by Subject|3|||
42154148|NCT00068380|75962626|FG000|Overall Study|Adverse Event|2|||
42154149|NCT00067990|75962632|FG000|Overall Study|Death|5|||
42154150|NCT00067990|75962633|FG001|Overall Study|Death|7|||
42154151|NCT00067990|75962632|FG000|Overall Study|ESRD, Non IF/TA|1|||
42154152|NCT00067990|75962633|FG001|Overall Study|ESRD, Non IF/TA|3|||
42154153|NCT00067990|75962632|FG000|Overall Study|Withdrawal by Subject|4|||
42154154|NCT00067990|75962633|FG001|Overall Study|Withdrawal by Subject|12|||
42154155|NCT00090220|75962641|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
42154156|NCT00090220|75962642|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
42154157|NCT00090220|75962643|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
42154158|NCT00090220|75962644|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
42154159|NCT00090220|75962645|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
42154160|NCT00090220|75962646|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
42154161|NCT00090220|75962641|FG000|Base Study Vaccination Period|Adverse Event|6|||
42154162|NCT00090220|75962642|FG001|Base Study Vaccination Period|Adverse Event|1|||
42154163|NCT00090220|75962643|FG002|Base Study Vaccination Period|Adverse Event|0|||
42154164|NCT00090220|75962644|FG003|Base Study Vaccination Period|Adverse Event|0|||
42154165|NCT00090220|75962645|FG004|Base Study Vaccination Period|Adverse Event|0|||
42154166|NCT00090220|75962646|FG005|Base Study Vaccination Period|Adverse Event|0|||
42154167|NCT00090220|75962641|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
42154168|NCT00090220|75962642|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
42154169|NCT00090220|75962643|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
42154170|NCT00090220|75962644|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
42154171|NCT00090220|75962645|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
42154172|NCT00090220|75962646|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
42154173|NCT00090220|75962641|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
42154174|NCT00090220|75962642|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
42154175|NCT00090220|75962643|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
42154176|NCT00090220|75962644|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
42154177|NCT00090220|75962645|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
42154178|NCT00090220|75962646|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
42154179|NCT00090220|75962641|FG000|Base Study Vaccination Period|Patient Moved|6|||
42154180|NCT00090220|75962642|FG001|Base Study Vaccination Period|Patient Moved|2|||
42154181|NCT00090220|75962643|FG002|Base Study Vaccination Period|Patient Moved|0|||
42154182|NCT00090220|75962644|FG003|Base Study Vaccination Period|Patient Moved|0|||
42154183|NCT00090220|75962645|FG004|Base Study Vaccination Period|Patient Moved|0|||
42154184|NCT00090220|75962646|FG005|Base Study Vaccination Period|Patient Moved|0|||
42154185|NCT00090220|75962641|FG000|Base Study Vaccination Period|Other|4|||
42154186|NCT00090220|75962642|FG001|Base Study Vaccination Period|Other|4|||
42154187|NCT00090220|75962643|FG002|Base Study Vaccination Period|Other|0|||
42154188|NCT00090220|75962644|FG003|Base Study Vaccination Period|Other|0|||
42278646|NCT01602315|76110266|FG005|Overall Study|Death|2|||
42278647|NCT01602315|76110267|FG006|Overall Study|Death|2|||
42278648|NCT01602315|76110261|FG000|Overall Study|Withdrawal by Subject|2|||
42154189|NCT00090220|75962645|FG004|Base Study Vaccination Period|Other|0|||
42154190|NCT00090220|75962646|FG005|Base Study Vaccination Period|Other|0|||
42154191|NCT00090220|75962641|FG000|Base Study Follow-up Period|Adverse Event|6|||
42154192|NCT00090220|75962642|FG001|Base Study Follow-up Period|Adverse Event|1|||
42154193|NCT00090220|75962643|FG002|Base Study Follow-up Period|Adverse Event|0|||
42154194|NCT00090220|75962644|FG003|Base Study Follow-up Period|Adverse Event|0|||
42154195|NCT00090220|75962645|FG004|Base Study Follow-up Period|Adverse Event|0|||
42154196|NCT00090220|75962646|FG005|Base Study Follow-up Period|Adverse Event|0|||
42013163|NCT01289990|75820220|FG007|Overall Study|Not treated|0|||
42013164|NCT01289990|75820221|FG008|Overall Study|Not treated|1|||
42013165|NCT01289990|75820222|FG009|Overall Study|Not treated|0|||
42013166|NCT01289990|75820223|FG010|Overall Study|Not treated|1|||
42013167|NCT01289990|75820224|FG011|Overall Study|Not treated|2|||
42013168|NCT01289990|75820225|FG012|Overall Study|Not treated|0|||
42013169|NCT01190007|75820253|FG000|Overall Study|Withdrawal by Subject|4|||
42013170|NCT01190007|75820253|FG000|Overall Study|Adverse Event|8|||
42013171|NCT01190007|75820253|FG000|Overall Study|Difficulty of visit for complications|1|||
42013172|NCT01190007|75820253|FG000|Overall Study|Participant was arrested|1|||
42013173|NCT01189461|75820257|FG000|Overall Study|Lack of Efficacy|13|||
42013174|NCT01189461|75820257|FG000|Overall Study|Lost to Follow-up|1|||
42013175|NCT01189461|75820257|FG000|Overall Study|Withdrawal by Subject|6|||
42013176|NCT01189461|75820257|FG000|Overall Study|Protocol Violation|1|||
42013177|NCT01189461|75820257|FG000|Overall Study|Adverse Event|2|||
42013178|NCT01189461|75820257|FG000|Overall Study|Did not meet entrance criteria|3|||
42013179|NCT01189461|75820257|FG000|Overall Study|Other|8|||
42013180|NCT01189227|75820263|FG000|Overall Study|Study terminated due to low accrual|6|||
42013181|NCT01189227|75820264|FG001|Overall Study|Study terminated due to low accrual|3|||
42013182|NCT01300247|75820272|FG000|Overall Study|Death|1|||
42013183|NCT01300247|75820273|FG001|Overall Study|Death|1|||
42013184|NCT01300247|75820272|FG000|Overall Study|Lost to Follow-up|2|||
42013185|NCT01300247|75820273|FG001|Overall Study|Lost to Follow-up|0|||
42013186|NCT01300247|75820272|FG000|Overall Study|Withdrawal by Subject|1|||
42013187|NCT01300247|75820273|FG001|Overall Study|Withdrawal by Subject|0|||
42013188|NCT01300247|75820272|FG000|Overall Study|Non-Compliance|0|||
42013189|NCT01300247|75820273|FG001|Overall Study|Non-Compliance|1|||
42013190|NCT01289678|75820279|FG000|Overall Study|Physician Decision|6|||
42013191|NCT01289210|75820283|FG000|Overall Study|Adverse Event|1|||
42013192|NCT01183221|75820289|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
42013193|NCT01183221|75820290|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
42013194|NCT01183143|75820296|FG000|Overall Study|Protocol Violation|115|||
42013195|NCT01183143|75820296|FG000|Overall Study|Withdrawal by Subject|19|||
42013196|NCT01183143|75820296|FG000|Overall Study|Subject Questionnaires not returned|5|||
42040154|NCT01928394|75848572|FG006|Treatment Period|Study drug toxicity|7|||
42040155|NCT01928394|75848573|FG007|Treatment Period|Study drug toxicity|1|||
42154197|NCT00090220|75962641|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
42154198|NCT00090220|75962642|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
42154199|NCT00090220|75962643|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
42278649|NCT01602315|76110262|FG001|Overall Study|Withdrawal by Subject|0|||
42278650|NCT01602315|76110263|FG002|Overall Study|Withdrawal by Subject|2|||
42278651|NCT01602315|76110264|FG003|Overall Study|Withdrawal by Subject|0|||
42278652|NCT01602315|76110265|FG004|Overall Study|Withdrawal by Subject|6|||
42278653|NCT01602315|76110266|FG005|Overall Study|Withdrawal by Subject|0|||
42278654|NCT01602315|76110267|FG006|Overall Study|Withdrawal by Subject|1|||
42278655|NCT01602315|76110261|FG000|Overall Study|Adverse Event|5|||
42278656|NCT01602315|76110262|FG001|Overall Study|Adverse Event|1|||
42351320|NCT01539837|76191214|FG002|Overall Study|reduce neutrophil level|1|||
42013197|NCT01183143|75820296|FG000|Overall Study|Subjects enrolled, but not treated|11|||
42154200|NCT00090220|75962644|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
42154201|NCT00090220|75962645|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
42154202|NCT00090220|75962646|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
42154203|NCT00090220|75962641|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
42040156|NCT01928394|75848574|FG008|Treatment Period|Study drug toxicity|0|||
42154204|NCT00090220|75962642|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
42154205|NCT00090220|75962643|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
42154206|NCT00090220|75962644|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
42154207|NCT00090220|75962645|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
42154208|NCT00090220|75962646|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
42154209|NCT00090220|75962641|FG000|Base Study Follow-up Period|Patient Moved|20|||
42154210|NCT00090220|75962642|FG001|Base Study Follow-up Period|Patient Moved|28|||
42154211|NCT00090220|75962643|FG002|Base Study Follow-up Period|Patient Moved|0|||
42040157|NCT01928394|75848575|FG009|Treatment Period|Study drug toxicity|5|||
42040158|NCT01928394|75848576|FG010|Treatment Period|Study drug toxicity|2|||
42040159|NCT01928394|75848577|FG011|Treatment Period|Study drug toxicity|3|||
42040160|NCT01928394|75848578|FG012|Treatment Period|Study drug toxicity|7|||
42278657|NCT01602315|76110263|FG002|Overall Study|Adverse Event|5|||
42013198|NCT01183065|75820300|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
42040161|NCT01928394|75848579|FG013|Treatment Period|Study drug toxicity|5|||
42040162|NCT01928394|75848580|FG014|Treatment Period|Study drug toxicity|12|||
42040163|NCT01928394|75848581|FG015|Treatment Period|Study drug toxicity|0|||
42040164|NCT01928394|75848582|FG016|Treatment Period|Study drug toxicity|3|||
42040165|NCT01928394|75848583|FG017|Treatment Period|Study drug toxicity|3|||
42040166|NCT01928394|75848584|FG018|Treatment Period|Study drug toxicity|12|||
42040167|NCT01928394|75848585|FG019|Treatment Period|Study drug toxicity|15|||
42040168|NCT01928394|75848586|FG020|Treatment Period|Study drug toxicity|4|||
42040169|NCT01928394|75848587|FG021|Treatment Period|Study drug toxicity|7|||
42040170|NCT01928394|75848588|FG022|Treatment Period|Study drug toxicity|4|||
42040171|NCT01928394|75848566|FG000|Treatment Period|AE unrelated to study drug|0|||
42040172|NCT01928394|75848567|FG001|Treatment Period|AE unrelated to study drug|0|||
42040173|NCT01928394|75848568|FG002|Treatment Period|AE unrelated to study drug|2|||
42154212|NCT00090220|75962644|FG003|Base Study Follow-up Period|Patient Moved|0|||
42154213|NCT00090220|75962645|FG004|Base Study Follow-up Period|Patient Moved|0|||
42154214|NCT00090220|75962646|FG005|Base Study Follow-up Period|Patient Moved|0|||
42154215|NCT00090220|75962641|FG000|Base Study Follow-up Period|Other|19|||
42154216|NCT00090220|75962642|FG001|Base Study Follow-up Period|Other|21|||
42154217|NCT00090220|75962643|FG002|Base Study Follow-up Period|Other|0|||
42154218|NCT00090220|75962644|FG003|Base Study Follow-up Period|Other|0|||
42154219|NCT00090220|75962645|FG004|Base Study Follow-up Period|Other|0|||
42154220|NCT00090220|75962646|FG005|Base Study Follow-up Period|Other|0|||
42154221|NCT00090220|75962641|FG000|Extension 1 (EXT1)|Adverse Event|0|||
42154222|NCT00090220|75962642|FG001|Extension 1 (EXT1)|Adverse Event|0|||
42154223|NCT00090220|75962643|FG002|Extension 1 (EXT1)|Adverse Event|4|||
42154224|NCT00090220|75962644|FG003|Extension 1 (EXT1)|Adverse Event|0|||
42154225|NCT00090220|75962645|FG004|Extension 1 (EXT1)|Adverse Event|0|||
42154226|NCT00090220|75962646|FG005|Extension 1 (EXT1)|Adverse Event|0|||
42154227|NCT00090220|75962641|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
42154228|NCT00090220|75962642|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
42154229|NCT00090220|75962643|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
42154230|NCT00090220|75962644|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
42154231|NCT00090220|75962645|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
42154232|NCT00090220|75962646|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
42154233|NCT00090220|75962641|FG000|Extension 1 (EXT1)|Moved|0|||
42154234|NCT00090220|75962642|FG001|Extension 1 (EXT1)|Moved|0|||
42154235|NCT00090220|75962643|FG002|Extension 1 (EXT1)|Moved|2|||
42154236|NCT00090220|75962644|FG003|Extension 1 (EXT1)|Moved|1|||
42154237|NCT00090220|75962645|FG004|Extension 1 (EXT1)|Moved|0|||
42154238|NCT00090220|75962646|FG005|Extension 1 (EXT1)|Moved|0|||
42154239|NCT00090220|75962641|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
42154240|NCT00090220|75962642|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
42154241|NCT00090220|75962643|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
42154242|NCT00090220|75962644|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
42154243|NCT00090220|75962645|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
42154244|NCT00090220|75962646|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
42154245|NCT00090220|75962641|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
42154246|NCT00090220|75962642|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
42154247|NCT00090220|75962643|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
42154248|NCT00090220|75962644|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
42154249|NCT00090220|75962645|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
42154250|NCT00090220|75962646|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
42154251|NCT00090220|75962641|FG000|Extension 1 (EXT1)|Other reason|0|||
42154252|NCT00090220|75962642|FG001|Extension 1 (EXT1)|Other reason|0|||
42154253|NCT00090220|75962643|FG002|Extension 1 (EXT1)|Other reason|2|||
42154254|NCT00090220|75962644|FG003|Extension 1 (EXT1)|Other reason|0|||
42154255|NCT00090220|75962645|FG004|Extension 1 (EXT1)|Other reason|0|||
42154256|NCT00090220|75962646|FG005|Extension 1 (EXT1)|Other reason|0|||
42154257|NCT00090220|75962641|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
42154258|NCT00090220|75962642|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
42154259|NCT00090220|75962643|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
42154260|NCT00090220|75962644|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
42154261|NCT00090220|75962645|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
42154262|NCT00090220|75962646|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
42154263|NCT00090220|75962641|FG000|Long-term Follow-up (EXT2)|Death|0|||
42040174|NCT01928394|75848569|FG003|Treatment Period|AE unrelated to study drug|3|||
42154264|NCT00090220|75962642|FG001|Long-term Follow-up (EXT2)|Death|0|||
42154265|NCT00090220|75962643|FG002|Long-term Follow-up (EXT2)|Death|0|||
42154266|NCT00090220|75962644|FG003|Long-term Follow-up (EXT2)|Death|0|||
42154267|NCT00090220|75962645|FG004|Long-term Follow-up (EXT2)|Death|1|||
42154268|NCT00090220|75962646|FG005|Long-term Follow-up (EXT2)|Death|1|||
42154269|NCT00090220|75962641|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
42154270|NCT00090220|75962642|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
42154271|NCT00090220|75962643|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
42154272|NCT00090220|75962644|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
42154273|NCT00090220|75962645|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
42154274|NCT00090220|75962646|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
42154275|NCT00090220|75962641|FG000|Long-term Follow-up (EXT2)|Other|0|||
42154276|NCT00090220|75962642|FG001|Long-term Follow-up (EXT2)|Other|0|||
42154277|NCT00090220|75962643|FG002|Long-term Follow-up (EXT2)|Other|0|||
42154278|NCT00090220|75962644|FG003|Long-term Follow-up (EXT2)|Other|0|||
42154279|NCT00090220|75962645|FG004|Long-term Follow-up (EXT2)|Other|1|||
42154280|NCT00090220|75962646|FG005|Long-term Follow-up (EXT2)|Other|0|||
42154281|NCT00263328|75962666|FG000|Overall Study|Death|0|||
42154282|NCT00263328|75962667|FG001|Overall Study|Death|0|||
42154283|NCT00263328|75962668|FG002|Overall Study|Death|1|||
42154284|NCT00263328|75962666|FG000|Overall Study|Lost to Follow-up|1|||
42154285|NCT00263328|75962667|FG001|Overall Study|Lost to Follow-up|1|||
42154286|NCT00263328|75962668|FG002|Overall Study|Lost to Follow-up|0|||
42154287|NCT00263328|75962666|FG000|Overall Study|Withdrawal by Subject|3|||
42154288|NCT00263328|75962667|FG001|Overall Study|Withdrawal by Subject|0|||
42154289|NCT00263328|75962668|FG002|Overall Study|Withdrawal by Subject|1|||
42154290|NCT00263328|75962666|FG000|Overall Study|Other|3|||
42154291|NCT00263328|75962667|FG001|Overall Study|Other|0|||
42154292|NCT00263328|75962668|FG002|Overall Study|Other|1|||
42154293|NCT00263328|75962666|FG000|Overall Study|Adverse Event|1|||
42154294|NCT00263328|75962667|FG001|Overall Study|Adverse Event|1|||
42154295|NCT00263328|75962668|FG002|Overall Study|Adverse Event|4|||
42154296|NCT00262860|75962678|FG000|Overall Study|Adverse Event|2|||
42154297|NCT00236184|75962684|FG000|Overall Study|Adverse Event|5|||
42154298|NCT00236184|75962685|FG001|Overall Study|Adverse Event|2|||
42154299|NCT00236184|75962684|FG000|Overall Study|Lack of Efficacy|0|||
42154300|NCT00236184|75962685|FG001|Overall Study|Lack of Efficacy|1|||
42154301|NCT00236184|75962684|FG000|Overall Study|Lost to Follow-up|3|||
42040175|NCT01928394|75848570|FG004|Treatment Period|AE unrelated to study drug|0|||
42040176|NCT01928394|75848571|FG005|Treatment Period|AE unrelated to study drug|5|||
42040177|NCT01928394|75848572|FG006|Treatment Period|AE unrelated to study drug|1|||
42040178|NCT01928394|75848573|FG007|Treatment Period|AE unrelated to study drug|0|||
42278658|NCT01602315|76110264|FG003|Overall Study|Adverse Event|4|||
42278659|NCT01602315|76110265|FG004|Overall Study|Adverse Event|15|||
42278660|NCT01602315|76110266|FG005|Overall Study|Adverse Event|3|||
42278661|NCT01602315|76110267|FG006|Overall Study|Adverse Event|9|||
42278662|NCT01602315|76110261|FG000|Overall Study|Subject/guardian decision|0|||
42278663|NCT01602315|76110262|FG001|Overall Study|Subject/guardian decision|0|||
42278664|NCT01602315|76110263|FG002|Overall Study|Subject/guardian decision|0|||
42278665|NCT01602315|76110264|FG003|Overall Study|Subject/guardian decision|0|||
42278666|NCT01602315|76110265|FG004|Overall Study|Subject/guardian decision|0|||
42278667|NCT01602315|76110266|FG005|Overall Study|Subject/guardian decision|0|||
42278668|NCT01602315|76110267|FG006|Overall Study|Subject/guardian decision|1|||
42278669|NCT01602315|76110261|FG000|Overall Study|Cross-over patients to combo treatment|0|||
42278670|NCT01602315|76110262|FG001|Overall Study|Cross-over patients to combo treatment|0|||
42278671|NCT01602315|76110263|FG002|Overall Study|Cross-over patients to combo treatment|0|||
42278672|NCT01602315|76110264|FG003|Overall Study|Cross-over patients to combo treatment|0|||
42278673|NCT01602315|76110265|FG004|Overall Study|Cross-over patients to combo treatment|0|||
42278674|NCT01602315|76110266|FG005|Overall Study|Cross-over patients to combo treatment|16|||
42278675|NCT01602315|76110267|FG006|Overall Study|Cross-over patients to combo treatment|0|||
42278676|NCT02344004|76110314|FG000|Overall Study|Adverse Event|11|||
42278677|NCT02344004|76110315|FG001|Overall Study|Adverse Event|1|||
42278678|NCT02344004|76110314|FG000|Overall Study|Death|9|||
42278679|NCT02344004|76110315|FG001|Overall Study|Death|7|||
42278680|NCT02344004|76110314|FG000|Overall Study|Physician Decision|4|||
42278681|NCT02344004|76110315|FG001|Overall Study|Physician Decision|1|||
42278682|NCT02344004|76110314|FG000|Overall Study|Withdrawal by Subject|22|||
42278683|NCT02344004|76110315|FG001|Overall Study|Withdrawal by Subject|5|||
42278684|NCT02344004|76110314|FG000|Overall Study|Rescue Medication|2|||
42278685|NCT02344004|76110315|FG001|Overall Study|Rescue Medication|0|||
42040179|NCT01928394|75848574|FG008|Treatment Period|AE unrelated to study drug|0|||
42040180|NCT01928394|75848575|FG009|Treatment Period|AE unrelated to study drug|2|||
42278686|NCT02344004|76110314|FG000|Overall Study|Other Not Specified|12|||
42278687|NCT02344004|76110315|FG001|Overall Study|Other Not Specified|0|||
42278688|NCT02344004|76110314|FG000|Overall Study|Protocol Violation|1|||
42278689|NCT02344004|76110315|FG001|Overall Study|Protocol Violation|0|||
42040181|NCT01928394|75848576|FG010|Treatment Period|AE unrelated to study drug|0|||
42278690|NCT01328093|76110324|FG000|Double-Blind Phase|Adverse Event|78|||
42278691|NCT01328093|76110325|FG001|Double-Blind Phase|Adverse Event|15|||
42040182|NCT01928394|75848577|FG011|Treatment Period|AE unrelated to study drug|12|||
42278692|NCT01328093|76110324|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
42351321|NCT01539837|76191212|FG000|Overall Study|bad compliance|0|||
42040183|NCT01928394|75848578|FG012|Treatment Period|AE unrelated to study drug|6|||
42154302|NCT00236184|75962685|FG001|Overall Study|Lost to Follow-up|4|||
42154303|NCT00236184|75962684|FG000|Overall Study|Physician Decision|1|||
42154304|NCT00236184|75962685|FG001|Overall Study|Physician Decision|1|||
42154305|NCT00236184|75962684|FG000|Overall Study|Withdrawal by Subject|3|||
42278693|NCT01328093|76110325|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
42351322|NCT01539837|76191213|FG001|Overall Study|bad compliance|0|||
42040184|NCT01928394|75848579|FG013|Treatment Period|AE unrelated to study drug|13|||
42154306|NCT00236184|75962685|FG001|Overall Study|Withdrawal by Subject|0|||
42154307|NCT00236184|75962684|FG000|Overall Study|Protocol Violation|3|||
42154308|NCT00236184|75962685|FG001|Overall Study|Protocol Violation|0|||
42154309|NCT00236184|75962684|FG000|Overall Study|non-compliance with study drug|2|||
42154310|NCT00236184|75962685|FG001|Overall Study|non-compliance with study drug|1|||
42154311|NCT00236184|75962684|FG000|Overall Study|other|1|||
42154312|NCT00236184|75962685|FG001|Overall Study|other|2|||
42154313|NCT00296504|75962699|FG000|Interim Analysis|Withdrawal by Subject|8|||
42154314|NCT00296504|75962700|FG001|Interim Analysis|Withdrawal by Subject|0|||
42154315|NCT00296504|75962701|FG002|Interim Analysis|Withdrawal by Subject|12|||
42154316|NCT00296504|75962702|FG003|Interim Analysis|Withdrawal by Subject|0|||
42154317|NCT00296504|75962703|FG004|Interim Analysis|Withdrawal by Subject|5|||
42154318|NCT00296504|75962704|FG005|Interim Analysis|Withdrawal by Subject|5|||
42154319|NCT00296504|75962705|FG006|Interim Analysis|Withdrawal by Subject|9|||
42154320|NCT00296504|75962706|FG007|Interim Analysis|Withdrawal by Subject|3|||
42154321|NCT00296504|75962707|FG008|Interim Analysis|Withdrawal by Subject|0|||
42154322|NCT00296504|75962699|FG000|Interim Analysis|Lost to Follow-up|13|||
42154323|NCT00296504|75962700|FG001|Interim Analysis|Lost to Follow-up|3|||
42154324|NCT00296504|75962701|FG002|Interim Analysis|Lost to Follow-up|26|||
42154325|NCT00296504|75962702|FG003|Interim Analysis|Lost to Follow-up|8|||
42154326|NCT00296504|75962703|FG004|Interim Analysis|Lost to Follow-up|14|||
42154327|NCT00296504|75962704|FG005|Interim Analysis|Lost to Follow-up|4|||
42154328|NCT00296504|75962705|FG006|Interim Analysis|Lost to Follow-up|11|||
42154329|NCT00296504|75962706|FG007|Interim Analysis|Lost to Follow-up|4|||
42154330|NCT00296504|75962707|FG008|Interim Analysis|Lost to Follow-up|0|||
42154331|NCT00296504|75962699|FG000|Interim Analysis|Clinical Progression|1|||
42154332|NCT00296504|75962700|FG001|Interim Analysis|Clinical Progression|0|||
42154333|NCT00296504|75962701|FG002|Interim Analysis|Clinical Progression|1|||
42154334|NCT00296504|75962702|FG003|Interim Analysis|Clinical Progression|1|||
42154335|NCT00296504|75962703|FG004|Interim Analysis|Clinical Progression|0|||
42154336|NCT00296504|75962704|FG005|Interim Analysis|Clinical Progression|2|||
42154337|NCT00296504|75962705|FG006|Interim Analysis|Clinical Progression|1|||
42154338|NCT00296504|75962706|FG007|Interim Analysis|Clinical Progression|2|||
42154339|NCT00296504|75962707|FG008|Interim Analysis|Clinical Progression|0|||
42154340|NCT00296504|75962699|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
42154341|NCT00296504|75962700|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
42154342|NCT00296504|75962701|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
42154343|NCT00296504|75962702|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
42154344|NCT00296504|75962703|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
42154345|NCT00296504|75962704|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
42154346|NCT00296504|75962705|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
42154347|NCT00296504|75962706|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
42154348|NCT00296504|75962707|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
42154349|NCT00296504|75962699|FG000|Interim Analysis|Adverse Event|0|||
42154350|NCT00296504|75962700|FG001|Interim Analysis|Adverse Event|0|||
42154351|NCT00296504|75962701|FG002|Interim Analysis|Adverse Event|13|||
42154352|NCT00296504|75962702|FG003|Interim Analysis|Adverse Event|4|||
42154353|NCT00296504|75962703|FG004|Interim Analysis|Adverse Event|6|||
42154354|NCT00296504|75962704|FG005|Interim Analysis|Adverse Event|3|||
42154355|NCT00296504|75962705|FG006|Interim Analysis|Adverse Event|4|||
42154356|NCT00296504|75962706|FG007|Interim Analysis|Adverse Event|5|||
42154357|NCT00296504|75962707|FG008|Interim Analysis|Adverse Event|0|||
42154358|NCT00296504|75962699|FG000|Interim Analysis|Protocol Violation|0|||
42154359|NCT00296504|75962700|FG001|Interim Analysis|Protocol Violation|0|||
42154360|NCT00296504|75962701|FG002|Interim Analysis|Protocol Violation|2|||
42154361|NCT00296504|75962702|FG003|Interim Analysis|Protocol Violation|0|||
42154362|NCT00296504|75962703|FG004|Interim Analysis|Protocol Violation|1|||
42154363|NCT00296504|75962704|FG005|Interim Analysis|Protocol Violation|0|||
42154364|NCT00296504|75962705|FG006|Interim Analysis|Protocol Violation|0|||
42154365|NCT00296504|75962706|FG007|Interim Analysis|Protocol Violation|1|||
42154366|NCT00296504|75962707|FG008|Interim Analysis|Protocol Violation|0|||
42154367|NCT00296504|75962699|FG000|Interim Analysis|Insufficient CD4 Response|0|||
42154368|NCT00296504|75962700|FG001|Interim Analysis|Insufficient CD4 Response|0|||
42154369|NCT00296504|75962701|FG002|Interim Analysis|Insufficient CD4 Response|0|||
42154370|NCT00296504|75962702|FG003|Interim Analysis|Insufficient CD4 Response|0|||
42154371|NCT00296504|75962703|FG004|Interim Analysis|Insufficient CD4 Response|1|||
42154372|NCT00296504|75962704|FG005|Interim Analysis|Insufficient CD4 Response|1|||
42154373|NCT00296504|75962705|FG006|Interim Analysis|Insufficient CD4 Response|0|||
42154374|NCT00296504|75962706|FG007|Interim Analysis|Insufficient CD4 Response|0|||
42154375|NCT00296504|75962707|FG008|Interim Analysis|Insufficient CD4 Response|0|||
42040185|NCT01928394|75848580|FG014|Treatment Period|AE unrelated to study drug|6|||
42351323|NCT01539837|76191214|FG002|Overall Study|bad compliance|1|||
42013199|NCT01182441|75820306|FG000|Overall Study|Patient Still in Follow-up|152|||
42013200|NCT01182441|75820307|FG001|Overall Study|Patient Still in Follow-up|72|||
42013201|NCT01182441|75820306|FG000|Overall Study|Death|37|||
42013202|NCT01182441|75820307|FG001|Overall Study|Death|25|||
42013203|NCT01182441|75820306|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
42013204|NCT01182441|75820307|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
42013205|NCT01182441|75820306|FG000|Overall Study|Lost to Follow-up|5|||
42013206|NCT01182441|75820307|FG001|Overall Study|Lost to Follow-up|8|||
42013207|NCT01182441|75820306|FG000|Overall Study|Withdrawal by Subject|6|||
42013208|NCT01182441|75820307|FG001|Overall Study|Withdrawal by Subject|13|||
42013209|NCT01182441|75820306|FG000|Overall Study|Implant Not Attempted|4|||
42013210|NCT01182441|75820307|FG001|Overall Study|Implant Not Attempted|0|||
42013211|NCT01182441|75820306|FG000|Overall Study|Adverse Event|2|||
42013212|NCT01182441|75820307|FG001|Overall Study|Adverse Event|0|||
42013213|NCT01182441|75820306|FG000|Overall Study|Physician Decision|1|||
42013214|NCT01182441|75820307|FG001|Overall Study|Physician Decision|1|||
42013215|NCT01182285|75820313|FG000|First Intervention Week 1-10|Disease progression|1|||
42013216|NCT01182285|75820314|FG001|First Intervention Week 1-10|Disease progression|0|||
42013217|NCT01182285|75820315|FG002|First Intervention Week 1-10|Disease progression|0|||
42013218|NCT01182285|75820313|FG000|First Intervention Week 1-10|Adverse Event|1|||
42013219|NCT01182285|75820314|FG001|First Intervention Week 1-10|Adverse Event|0|||
42013220|NCT01182285|75820315|FG002|First Intervention Week 1-10|Adverse Event|0|||
42013221|NCT01182285|75820313|FG000|First Intervention Week 1-10|Non-compliance|1|||
42013222|NCT01182285|75820314|FG001|First Intervention Week 1-10|Non-compliance|0|||
42013223|NCT01182285|75820315|FG002|First Intervention Week 1-10|Non-compliance|0|||
42013224|NCT01182285|75820313|FG000|Third Intervention Week 11-52|Disease Progression|0|||
42013225|NCT01182285|75820314|FG001|Third Intervention Week 11-52|Disease Progression|0|||
42013226|NCT01182285|75820315|FG002|Third Intervention Week 11-52|Disease Progression|6|||
42013227|NCT01182285|75820313|FG000|Third Intervention Week 11-52|Other|0|||
42013228|NCT01182285|75820314|FG001|Third Intervention Week 11-52|Other|0|||
42013229|NCT01182285|75820315|FG002|Third Intervention Week 11-52|Other|2|||
42013230|NCT01182207|75820324|FG000|First Intervention|Positive Hepatitis Results|0|||
42013231|NCT01182207|75820325|FG001|First Intervention|Positive Hepatitis Results|1|||
42013232|NCT01182207|75820324|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
42013233|NCT01182207|75820325|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
42013234|NCT01181895|75820334|FG000|Overall Study|Adverse Event|3|||
42013235|NCT01181895|75820335|FG001|Overall Study|Adverse Event|1|||
42013236|NCT01181895|75820336|FG002|Overall Study|Adverse Event|1|||
42013237|NCT01181895|75820334|FG000|Overall Study|Lack of Efficacy|8|||
42013238|NCT01181895|75820335|FG001|Overall Study|Lack of Efficacy|9|||
42013239|NCT01181895|75820336|FG002|Overall Study|Lack of Efficacy|9|||
42013240|NCT01181895|75820334|FG000|Overall Study|Protocol Violation|2|||
42013241|NCT01181895|75820335|FG001|Overall Study|Protocol Violation|1|||
42013242|NCT01181895|75820336|FG002|Overall Study|Protocol Violation|0|||
42013243|NCT01181895|75820334|FG000|Overall Study|Lost to Follow-up|0|||
42013244|NCT01181895|75820335|FG001|Overall Study|Lost to Follow-up|1|||
42013245|NCT01181895|75820336|FG002|Overall Study|Lost to Follow-up|2|||
42013246|NCT01181895|75820334|FG000|Overall Study|Investigator Discretion|1|||
42013247|NCT01181895|75820335|FG001|Overall Study|Investigator Discretion|2|||
42013248|NCT01181895|75820336|FG002|Overall Study|Investigator Discretion|1|||
42013249|NCT01181895|75820334|FG000|Overall Study|Withdrawal by Subject|3|||
42013250|NCT01181895|75820335|FG001|Overall Study|Withdrawal by Subject|0|||
42013251|NCT01181895|75820336|FG002|Overall Study|Withdrawal by Subject|5|||
42013252|NCT01181271|75820344|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
42013253|NCT01181271|75820344|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
42013254|NCT01181271|75820344|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
42013255|NCT01181271|75820344|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
42013256|NCT01180647|75820350|FG000|Overall Study|Lost to Follow-up|5|||
42013257|NCT01180647|75820351|FG001|Overall Study|Lost to Follow-up|6|||
42013258|NCT00969553|75820366|FG000|Overall Study|Progressive disease (PD)|2|||
42013259|NCT00969553|75820367|FG001|Overall Study|Progressive disease (PD)|2|||
42013260|NCT00969553|75820368|FG002|Overall Study|Progressive disease (PD)|6|||
42013261|NCT00969553|75820369|FG003|Overall Study|Progressive disease (PD)|9|||
42013262|NCT00969553|75820370|FG004|Overall Study|Progressive disease (PD)|2|||
42154376|NCT00296504|75962699|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
42154377|NCT00296504|75962700|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
42154378|NCT00296504|75962701|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
42154379|NCT00296504|75962702|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
42154380|NCT00296504|75962703|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
42154381|NCT00296504|75962704|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
42154382|NCT00296504|75962705|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
42154383|NCT00296504|75962706|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
42154384|NCT00296504|75962707|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
42154385|NCT00296504|75962699|FG000|Interim Analysis|Pregnancy|4|||
42154386|NCT00296504|75962700|FG001|Interim Analysis|Pregnancy|1|||
42154387|NCT00296504|75962701|FG002|Interim Analysis|Pregnancy|4|||
42154388|NCT00296504|75962702|FG003|Interim Analysis|Pregnancy|2|||
42154389|NCT00296504|75962703|FG004|Interim Analysis|Pregnancy|0|||
42154390|NCT00296504|75962704|FG005|Interim Analysis|Pregnancy|1|||
42154391|NCT00296504|75962705|FG006|Interim Analysis|Pregnancy|1|||
42154392|NCT00296504|75962706|FG007|Interim Analysis|Pregnancy|1|||
42154393|NCT00296504|75962707|FG008|Interim Analysis|Pregnancy|0|||
42154394|NCT00296504|75962699|FG000|Interim Analysis|Death|1|||
42154395|NCT00296504|75962700|FG001|Interim Analysis|Death|0|||
42154396|NCT00296504|75962701|FG002|Interim Analysis|Death|3|||
42154397|NCT00296504|75962702|FG003|Interim Analysis|Death|0|||
42154398|NCT00296504|75962703|FG004|Interim Analysis|Death|0|||
42154399|NCT00296504|75962704|FG005|Interim Analysis|Death|0|||
42154400|NCT00296504|75962705|FG006|Interim Analysis|Death|0|||
42154401|NCT00296504|75962706|FG007|Interim Analysis|Death|0|||
42154402|NCT00296504|75962707|FG008|Interim Analysis|Death|0|||
42154403|NCT00296504|75962699|FG000|Interim Analysis|Participant Non-compliant|0|||
42154404|NCT00296504|75962700|FG001|Interim Analysis|Participant Non-compliant|1|||
42154405|NCT00296504|75962701|FG002|Interim Analysis|Participant Non-compliant|2|||
42013263|NCT00969553|75820371|FG005|Overall Study|Progressive disease (PD)|4|||
42013264|NCT00969553|75820372|FG006|Overall Study|Progressive disease (PD)|2|||
42013265|NCT00969553|75820373|FG007|Overall Study|Progressive disease (PD)|12|||
42013266|NCT00969553|75820374|FG008|Overall Study|Progressive disease (PD)|3|||
42013267|NCT00969553|75820366|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
42013268|NCT00969553|75820367|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
42013269|NCT00969553|75820368|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
42013270|NCT00969553|75820369|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
42040186|NCT01928394|75848581|FG015|Treatment Period|AE unrelated to study drug|1|||
42154406|NCT00296504|75962702|FG003|Interim Analysis|Participant Non-compliant|1|||
42154407|NCT00296504|75962703|FG004|Interim Analysis|Participant Non-compliant|1|||
42154408|NCT00296504|75962704|FG005|Interim Analysis|Participant Non-compliant|3|||
42154409|NCT00296504|75962705|FG006|Interim Analysis|Participant Non-compliant|6|||
42154410|NCT00296504|75962706|FG007|Interim Analysis|Participant Non-compliant|2|||
42154411|NCT00296504|75962707|FG008|Interim Analysis|Participant Non-compliant|0|||
42154412|NCT00296504|75962699|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
42013271|NCT00969553|75820370|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
42154413|NCT00296504|75962700|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
42154414|NCT00296504|75962701|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
42154415|NCT00296504|75962702|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
42154416|NCT00296504|75962703|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
42154417|NCT00296504|75962704|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
42154418|NCT00296504|75962705|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
42154419|NCT00296504|75962706|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
42154420|NCT00296504|75962707|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
42154421|NCT00296504|75962699|FG000|Interim Analysis|To Simplify Treatment|0|||
42154422|NCT00296504|75962700|FG001|Interim Analysis|To Simplify Treatment|0|||
42154423|NCT00296504|75962701|FG002|Interim Analysis|To Simplify Treatment|1|||
42154424|NCT00296504|75962702|FG003|Interim Analysis|To Simplify Treatment|0|||
42154425|NCT00296504|75962703|FG004|Interim Analysis|To Simplify Treatment|0|||
42154426|NCT00296504|75962704|FG005|Interim Analysis|To Simplify Treatment|0|||
42154427|NCT00296504|75962705|FG006|Interim Analysis|To Simplify Treatment|2|||
42154428|NCT00296504|75962706|FG007|Interim Analysis|To Simplify Treatment|0|||
42351324|NCT01539759|76191224|FG000|Overall Study|Lost to Follow-up|6|||
42351325|NCT01539759|76191225|FG001|Overall Study|Lost to Follow-up|8|||
42351326|NCT00633022|76191234|FG000|Overall Study|Adverse Event|1|||
42351327|NCT00633022|76191235|FG001|Overall Study|Adverse Event|0|||
42154429|NCT00296504|75962707|FG008|Interim Analysis|To Simplify Treatment|0|||
42154430|NCT00296504|75962699|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
42154431|NCT00296504|75962700|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
42154432|NCT00296504|75962701|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
42154433|NCT00296504|75962702|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
42154434|NCT00296504|75962703|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
42154435|NCT00296504|75962704|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
42154436|NCT00296504|75962705|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
42154437|NCT00296504|75962706|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
42154438|NCT00296504|75962707|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
42154439|NCT00296504|75962699|FG000|Interim Analysis|Participant Moved|1|||
42154440|NCT00296504|75962700|FG001|Interim Analysis|Participant Moved|0|||
42154441|NCT00296504|75962701|FG002|Interim Analysis|Participant Moved|1|||
42154442|NCT00296504|75962702|FG003|Interim Analysis|Participant Moved|0|||
42154443|NCT00296504|75962703|FG004|Interim Analysis|Participant Moved|0|||
42154444|NCT00296504|75962704|FG005|Interim Analysis|Participant Moved|1|||
42154445|NCT00296504|75962705|FG006|Interim Analysis|Participant Moved|1|||
42154446|NCT00296504|75962706|FG007|Interim Analysis|Participant Moved|0|||
42154447|NCT00296504|75962707|FG008|Interim Analysis|Participant Moved|0|||
42154448|NCT00296504|75962699|FG000|Interim Analysis|Participant Was Incarcerated|2|||
42154449|NCT00296504|75962700|FG001|Interim Analysis|Participant Was Incarcerated|0|||
42154450|NCT00296504|75962701|FG002|Interim Analysis|Participant Was Incarcerated|1|||
42154451|NCT00296504|75962702|FG003|Interim Analysis|Participant Was Incarcerated|0|||
42351328|NCT00633022|76191236|FG002|Overall Study|Adverse Event|5|||
42351329|NCT00633022|76191234|FG000|Overall Study|Physician Decision|0|||
42351330|NCT00633022|76191235|FG001|Overall Study|Physician Decision|1|||
42013272|NCT00969553|75820371|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
42154452|NCT00296504|75962703|FG004|Interim Analysis|Participant Was Incarcerated|0|||
42154453|NCT00296504|75962704|FG005|Interim Analysis|Participant Was Incarcerated|0|||
42154454|NCT00296504|75962705|FG006|Interim Analysis|Participant Was Incarcerated|0|||
42154455|NCT00296504|75962706|FG007|Interim Analysis|Participant Was Incarcerated|0|||
42154456|NCT00296504|75962707|FG008|Interim Analysis|Participant Was Incarcerated|0|||
42154457|NCT00296504|75962699|FG000|Interim Analysis|Resistance to FPV|0|||
42154458|NCT00296504|75962700|FG001|Interim Analysis|Resistance to FPV|0|||
42154459|NCT00296504|75962701|FG002|Interim Analysis|Resistance to FPV|1|||
42154460|NCT00296504|75962702|FG003|Interim Analysis|Resistance to FPV|0|||
42154461|NCT00296504|75962703|FG004|Interim Analysis|Resistance to FPV|0|||
42154462|NCT00296504|75962704|FG005|Interim Analysis|Resistance to FPV|0|||
42154463|NCT00296504|75962705|FG006|Interim Analysis|Resistance to FPV|0|||
42154464|NCT00296504|75962706|FG007|Interim Analysis|Resistance to FPV|0|||
42154465|NCT00296504|75962707|FG008|Interim Analysis|Resistance to FPV|0|||
42154466|NCT00296504|75962699|FG000|Interim Analysis|Physician Decision|0|||
42154467|NCT00296504|75962700|FG001|Interim Analysis|Physician Decision|0|||
42154468|NCT00296504|75962701|FG002|Interim Analysis|Physician Decision|1|||
42154469|NCT00296504|75962702|FG003|Interim Analysis|Physician Decision|0|||
42351331|NCT00633022|76191236|FG002|Overall Study|Physician Decision|0|||
42154470|NCT00296504|75962703|FG004|Interim Analysis|Physician Decision|0|||
42154471|NCT00296504|75962704|FG005|Interim Analysis|Physician Decision|0|||
42154472|NCT00296504|75962705|FG006|Interim Analysis|Physician Decision|0|||
42154473|NCT00296504|75962706|FG007|Interim Analysis|Physician Decision|0|||
42351332|NCT00630994|76191244|FG000|Overall Study|Adverse Event|1|||
42351333|NCT00630994|76191244|FG000|Overall Study|Disease Progression|1|||
42154474|NCT00296504|75962707|FG008|Interim Analysis|Physician Decision|0|||
42278694|NCT01328093|76110324|FG000|Double-Blind Phase|Lost to Follow-up|39|||
42278695|NCT01328093|76110325|FG001|Double-Blind Phase|Lost to Follow-up|14|||
42040187|NCT01928394|75848582|FG016|Treatment Period|AE unrelated to study drug|1|||
42040188|NCT01928394|75848583|FG017|Treatment Period|AE unrelated to study drug|6|||
42154475|NCT00296504|75962699|FG000|Interim Analysis|Principle Investigator Discretion|2|||
42154476|NCT00296504|75962700|FG001|Interim Analysis|Principle Investigator Discretion|0|||
42278696|NCT01328093|76110324|FG000|Double-Blind Phase|Protocol Violation|30|||
42278697|NCT01328093|76110325|FG001|Double-Blind Phase|Protocol Violation|10|||
42278698|NCT01328093|76110324|FG000|Double-Blind Phase|Lack of Efficacy|55|||
42278699|NCT01328093|76110325|FG001|Double-Blind Phase|Lack of Efficacy|13|||
42278700|NCT01328093|76110324|FG000|Double-Blind Phase|Sponsor Decision|17|||
42154477|NCT00296504|75962701|FG002|Interim Analysis|Principle Investigator Discretion|1|||
42154478|NCT00296504|75962702|FG003|Interim Analysis|Principle Investigator Discretion|1|||
42154479|NCT00296504|75962703|FG004|Interim Analysis|Principle Investigator Discretion|0|||
42154480|NCT00296504|75962704|FG005|Interim Analysis|Principle Investigator Discretion|0|||
42154481|NCT00296504|75962705|FG006|Interim Analysis|Principle Investigator Discretion|0|||
42154482|NCT00296504|75962706|FG007|Interim Analysis|Principle Investigator Discretion|0|||
42154483|NCT00296504|75962707|FG008|Interim Analysis|Principle Investigator Discretion|0|||
42154484|NCT00296504|75962699|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
42154485|NCT00296504|75962700|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
42154486|NCT00296504|75962701|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
42154487|NCT00296504|75962702|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
42154488|NCT00296504|75962703|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
42154489|NCT00296504|75962704|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
42154490|NCT00296504|75962705|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
42154491|NCT00296504|75962706|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
42278701|NCT01328093|76110325|FG001|Double-Blind Phase|Sponsor Decision|3|||
42278702|NCT01328093|76110324|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
42154492|NCT00296504|75962707|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
42154493|NCT00296504|75962699|FG000|Interim Analysis|Non-adherence|2|||
42154494|NCT00296504|75962700|FG001|Interim Analysis|Non-adherence|0|||
42154495|NCT00296504|75962701|FG002|Interim Analysis|Non-adherence|0|||
42154496|NCT00296504|75962702|FG003|Interim Analysis|Non-adherence|0|||
42154497|NCT00296504|75962703|FG004|Interim Analysis|Non-adherence|1|||
42154498|NCT00296504|75962704|FG005|Interim Analysis|Non-adherence|0|||
42154499|NCT00296504|75962705|FG006|Interim Analysis|Non-adherence|0|||
42154500|NCT00296504|75962706|FG007|Interim Analysis|Non-adherence|1|||
42154501|NCT00296504|75962707|FG008|Interim Analysis|Non-adherence|0|||
42154502|NCT00296504|75962699|FG000|Interim Analysis|Site Closing|1|||
42154503|NCT00296504|75962700|FG001|Interim Analysis|Site Closing|0|||
42154504|NCT00296504|75962701|FG002|Interim Analysis|Site Closing|0|||
42154505|NCT00296504|75962702|FG003|Interim Analysis|Site Closing|0|||
42154506|NCT00296504|75962703|FG004|Interim Analysis|Site Closing|0|||
42154507|NCT00296504|75962704|FG005|Interim Analysis|Site Closing|1|||
42154508|NCT00296504|75962705|FG006|Interim Analysis|Site Closing|2|||
42154509|NCT00296504|75962706|FG007|Interim Analysis|Site Closing|0|||
42154510|NCT00296504|75962707|FG008|Interim Analysis|Site Closing|0|||
42154511|NCT00296504|75962699|FG000|Interim Analysis|Lack of Personnel at Site|1|||
42154512|NCT00296504|75962700|FG001|Interim Analysis|Lack of Personnel at Site|0|||
42154513|NCT00296504|75962701|FG002|Interim Analysis|Lack of Personnel at Site|0|||
42154514|NCT00296504|75962702|FG003|Interim Analysis|Lack of Personnel at Site|0|||
42154515|NCT00296504|75962703|FG004|Interim Analysis|Lack of Personnel at Site|0|||
42154516|NCT00296504|75962704|FG005|Interim Analysis|Lack of Personnel at Site|0|||
42154517|NCT00296504|75962705|FG006|Interim Analysis|Lack of Personnel at Site|0|||
42154518|NCT00296504|75962706|FG007|Interim Analysis|Lack of Personnel at Site|0|||
42278703|NCT01328093|76110325|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
42040189|NCT01928394|75848584|FG018|Treatment Period|AE unrelated to study drug|3|||
42154519|NCT00296504|75962707|FG008|Interim Analysis|Lack of Personnel at Site|0|||
42154520|NCT00296504|75962699|FG000|Interim Analysis|Missed Schedule Date|1|||
42154521|NCT00296504|75962700|FG001|Interim Analysis|Missed Schedule Date|0|||
42154522|NCT00296504|75962701|FG002|Interim Analysis|Missed Schedule Date|0|||
42154523|NCT00296504|75962702|FG003|Interim Analysis|Missed Schedule Date|0|||
42154524|NCT00296504|75962703|FG004|Interim Analysis|Missed Schedule Date|0|||
42278704|NCT01328093|76110324|FG000|Double-Blind Phase|Scheduling conflict|8|||
42278705|NCT01328093|76110325|FG001|Double-Blind Phase|Scheduling conflict|3|||
42351334|NCT00630994|76191244|FG000|Overall Study|Lack of Efficacy|1|||
42154525|NCT00296504|75962704|FG005|Interim Analysis|Missed Schedule Date|0|||
42154526|NCT00296504|75962705|FG006|Interim Analysis|Missed Schedule Date|0|||
42154527|NCT00296504|75962706|FG007|Interim Analysis|Missed Schedule Date|0|||
42154528|NCT00296504|75962707|FG008|Interim Analysis|Missed Schedule Date|0|||
42154529|NCT00296504|75962699|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
42154530|NCT00296504|75962700|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
42154531|NCT00296504|75962701|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
42154532|NCT00296504|75962702|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
42154533|NCT00296504|75962703|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
42154534|NCT00296504|75962704|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
42154535|NCT00296504|75962705|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
42154536|NCT00296504|75962706|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
42154537|NCT00296504|75962707|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
42154538|NCT00296504|75962699|FG000|Interim Analysis|Participant Stopped|0|||
42154539|NCT00296504|75962700|FG001|Interim Analysis|Participant Stopped|0|||
42154540|NCT00296504|75962701|FG002|Interim Analysis|Participant Stopped|0|||
42154541|NCT00296504|75962702|FG003|Interim Analysis|Participant Stopped|0|||
42154542|NCT00296504|75962703|FG004|Interim Analysis|Participant Stopped|1|||
42154543|NCT00296504|75962704|FG005|Interim Analysis|Participant Stopped|0|||
42154544|NCT00296504|75962705|FG006|Interim Analysis|Participant Stopped|0|||
42154545|NCT00296504|75962706|FG007|Interim Analysis|Participant Stopped|0|||
42154546|NCT00296504|75962707|FG008|Interim Analysis|Participant Stopped|0|||
42154547|NCT00296504|75962699|FG000|Interim Analysis|Physician and Participant Decision|0|||
42154548|NCT00296504|75962700|FG001|Interim Analysis|Physician and Participant Decision|0|||
42154549|NCT00296504|75962701|FG002|Interim Analysis|Physician and Participant Decision|0|||
42154550|NCT00296504|75962702|FG003|Interim Analysis|Physician and Participant Decision|0|||
42154551|NCT00296504|75962703|FG004|Interim Analysis|Physician and Participant Decision|0|||
42154552|NCT00296504|75962704|FG005|Interim Analysis|Physician and Participant Decision|1|||
42154553|NCT00296504|75962705|FG006|Interim Analysis|Physician and Participant Decision|0|||
42154554|NCT00296504|75962706|FG007|Interim Analysis|Physician and Participant Decision|0|||
42154555|NCT00296504|75962707|FG008|Interim Analysis|Physician and Participant Decision|0|||
42154556|NCT00296504|75962699|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
42013273|NCT00969553|75820372|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
42013274|NCT00969553|75820373|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
42154557|NCT00296504|75962700|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
42154558|NCT00296504|75962701|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
42040190|NCT01928394|75848585|FG019|Treatment Period|AE unrelated to study drug|5|||
42040191|NCT01928394|75848586|FG020|Treatment Period|AE unrelated to study drug|1|||
42040192|NCT01928394|75848587|FG021|Treatment Period|AE unrelated to study drug|1|||
42040193|NCT01928394|75848588|FG022|Treatment Period|AE unrelated to study drug|0|||
42040194|NCT01928394|75848566|FG000|Treatment Period|Participant request to stop therapy|0|||
42040195|NCT01928394|75848567|FG001|Treatment Period|Participant request to stop therapy|0|||
42154559|NCT00296504|75962702|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
42154560|NCT00296504|75962703|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
42154561|NCT00296504|75962704|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
42154562|NCT00296504|75962705|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
42154563|NCT00296504|75962706|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
42154564|NCT00296504|75962707|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
42154565|NCT00296504|75962699|FG000|Interim Analysis|Study Ended|0|||
42154566|NCT00296504|75962700|FG001|Interim Analysis|Study Ended|0|||
42154567|NCT00296504|75962701|FG002|Interim Analysis|Study Ended|0|||
42154568|NCT00296504|75962702|FG003|Interim Analysis|Study Ended|0|||
42154569|NCT00296504|75962703|FG004|Interim Analysis|Study Ended|0|||
42278706|NCT01328093|76110324|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
42278707|NCT01328093|76110325|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
42278708|NCT01328093|76110324|FG000|Double-Blind Phase|Death|1|||
42278709|NCT01328093|76110325|FG001|Double-Blind Phase|Death|0|||
42278710|NCT01328093|76110324|FG000|Open-Label Phase|Sponsor Decision|98|||
42278711|NCT01328093|76110325|FG001|Open-Label Phase|Sponsor Decision|34|||
42278712|NCT01328093|76110324|FG000|Open-Label Phase|Protocol Violation|8|||
42278713|NCT01328093|76110325|FG001|Open-Label Phase|Protocol Violation|3|||
42278714|NCT01328093|76110324|FG000|Open-Label Phase|Lost to Follow-up|10|||
42278715|NCT01328093|76110325|FG001|Open-Label Phase|Lost to Follow-up|1|||
42278716|NCT01328093|76110324|FG000|Open-Label Phase|Adverse Event|10|||
42278717|NCT01328093|76110325|FG001|Open-Label Phase|Adverse Event|4|||
42278718|NCT01328093|76110324|FG000|Open-Label Phase|Lack of Efficacy|5|||
42278719|NCT01328093|76110325|FG001|Open-Label Phase|Lack of Efficacy|6|||
42278720|NCT01328093|76110324|FG000|Open-Label Phase|Withdrawal by Subject|4|||
42154570|NCT00296504|75962704|FG005|Interim Analysis|Study Ended|0|||
42154571|NCT00296504|75962705|FG006|Interim Analysis|Study Ended|1|||
42154572|NCT00296504|75962706|FG007|Interim Analysis|Study Ended|0|||
42154573|NCT00296504|75962707|FG008|Interim Analysis|Study Ended|0|||
42154574|NCT00296504|75962699|FG000|Interim Analysis|Participant Needed Interferon|0|||
42154575|NCT00296504|75962700|FG001|Interim Analysis|Participant Needed Interferon|0|||
42154576|NCT00296504|75962701|FG002|Interim Analysis|Participant Needed Interferon|0|||
42154577|NCT00296504|75962702|FG003|Interim Analysis|Participant Needed Interferon|0|||
42154578|NCT00296504|75962703|FG004|Interim Analysis|Participant Needed Interferon|0|||
42154579|NCT00296504|75962704|FG005|Interim Analysis|Participant Needed Interferon|0|||
42154580|NCT00296504|75962705|FG006|Interim Analysis|Participant Needed Interferon|0|||
42154581|NCT00296504|75962706|FG007|Interim Analysis|Participant Needed Interferon|1|||
42154582|NCT00296504|75962707|FG008|Interim Analysis|Participant Needed Interferon|0|||
42154583|NCT00296504|75962699|FG000|Interim Analysis|Ongoing|32|||
42154584|NCT00296504|75962700|FG001|Interim Analysis|Ongoing|12|||
42154585|NCT00296504|75962701|FG002|Interim Analysis|Ongoing|16|||
42154586|NCT00296504|75962702|FG003|Interim Analysis|Ongoing|22|||
42278721|NCT01328093|76110325|FG001|Open-Label Phase|Withdrawal by Subject|1|||
42278722|NCT01328093|76110324|FG000|Open-Label Phase|Scheduling conflict|2|||
42278723|NCT01328093|76110325|FG001|Open-Label Phase|Scheduling conflict|1|||
42278724|NCT01328093|76110324|FG000|Open-Label Phase|Subject is moving or has moved|2|||
42278725|NCT01328093|76110325|FG001|Open-Label Phase|Subject is moving or has moved|0|||
42278726|NCT01328093|76110324|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
42013275|NCT00969553|75820374|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
42154587|NCT00296504|75962703|FG004|Interim Analysis|Ongoing|0|||
42154588|NCT00296504|75962704|FG005|Interim Analysis|Ongoing|0|||
42154589|NCT00296504|75962705|FG006|Interim Analysis|Ongoing|30|||
42154590|NCT00296504|75962706|FG007|Interim Analysis|Ongoing|1|||
42154591|NCT00296504|75962707|FG008|Interim Analysis|Ongoing|0|||
42154592|NCT00296504|75962699|FG000|Final Analysis|Withdrawal by Subject|0|||
42154593|NCT00296504|75962700|FG001|Final Analysis|Withdrawal by Subject|0|||
42154594|NCT00296504|75962701|FG002|Final Analysis|Withdrawal by Subject|0|||
42278727|NCT01328093|76110325|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
42013276|NCT00969553|75820366|FG000|Overall Study|Other Adverse Event|0|||
42013277|NCT00969553|75820367|FG001|Overall Study|Other Adverse Event|0|||
42013278|NCT00969553|75820368|FG002|Overall Study|Other Adverse Event|0|||
42013279|NCT00969553|75820369|FG003|Overall Study|Other Adverse Event|1|||
42013280|NCT00969553|75820370|FG004|Overall Study|Other Adverse Event|0|||
42013281|NCT00969553|75820371|FG005|Overall Study|Other Adverse Event|0|||
42013282|NCT00969553|75820372|FG006|Overall Study|Other Adverse Event|1|||
42013283|NCT00969553|75820373|FG007|Overall Study|Other Adverse Event|0|||
42154595|NCT00296504|75962702|FG003|Final Analysis|Withdrawal by Subject|0|||
42154596|NCT00296504|75962703|FG004|Final Analysis|Withdrawal by Subject|0|||
42154597|NCT00296504|75962704|FG005|Final Analysis|Withdrawal by Subject|0|||
42154598|NCT00296504|75962705|FG006|Final Analysis|Withdrawal by Subject|0|||
42154599|NCT00296504|75962706|FG007|Final Analysis|Withdrawal by Subject|0|||
42154600|NCT00296504|75962707|FG008|Final Analysis|Withdrawal by Subject|1|||
42154601|NCT00296504|75962699|FG000|Final Analysis|Lost to Follow-up|0|||
42154602|NCT00296504|75962700|FG001|Final Analysis|Lost to Follow-up|0|||
42154603|NCT00296504|75962701|FG002|Final Analysis|Lost to Follow-up|0|||
42154604|NCT00296504|75962702|FG003|Final Analysis|Lost to Follow-up|0|||
42154605|NCT00296504|75962703|FG004|Final Analysis|Lost to Follow-up|0|||
42154606|NCT00296504|75962704|FG005|Final Analysis|Lost to Follow-up|0|||
42154607|NCT00296504|75962705|FG006|Final Analysis|Lost to Follow-up|0|||
42154608|NCT00296504|75962706|FG007|Final Analysis|Lost to Follow-up|0|||
42154609|NCT00296504|75962707|FG008|Final Analysis|Lost to Follow-up|5|||
42154610|NCT00296504|75962699|FG000|Final Analysis|Insufficient Viral Load Response|0|||
42154611|NCT00296504|75962700|FG001|Final Analysis|Insufficient Viral Load Response|0|||
42154612|NCT00296504|75962701|FG002|Final Analysis|Insufficient Viral Load Response|0|||
42154613|NCT00296504|75962702|FG003|Final Analysis|Insufficient Viral Load Response|0|||
42013284|NCT00969553|75820374|FG008|Overall Study|Other Adverse Event|0|||
42013285|NCT00969553|75820366|FG000|Overall Study|Refused cont. medication|1|||
42013286|NCT00969553|75820367|FG001|Overall Study|Refused cont. medication|1|||
42013287|NCT00969553|75820368|FG002|Overall Study|Refused cont. medication|0|||
42013288|NCT00969553|75820369|FG003|Overall Study|Refused cont. medication|2|||
42013289|NCT00969553|75820370|FG004|Overall Study|Refused cont. medication|0|||
42013290|NCT00969553|75820371|FG005|Overall Study|Refused cont. medication|0|||
42013291|NCT00969553|75820372|FG006|Overall Study|Refused cont. medication|0|||
42013292|NCT00969553|75820373|FG007|Overall Study|Refused cont. medication|1|||
42013293|NCT00969553|75820374|FG008|Overall Study|Refused cont. medication|0|||
42013294|NCT00969553|75820366|FG000|Overall Study|Not specified above|0|||
42013295|NCT00969553|75820367|FG001|Overall Study|Not specified above|0|||
42013296|NCT00969553|75820368|FG002|Overall Study|Not specified above|0|||
42013297|NCT00969553|75820369|FG003|Overall Study|Not specified above|4|||
42013298|NCT00969553|75820370|FG004|Overall Study|Not specified above|0|||
42013299|NCT00969553|75820371|FG005|Overall Study|Not specified above|0|||
42013300|NCT00969553|75820372|FG006|Overall Study|Not specified above|1|||
42040196|NCT01928394|75848568|FG002|Treatment Period|Participant request to stop therapy|0|||
42154614|NCT00296504|75962703|FG004|Final Analysis|Insufficient Viral Load Response|0|||
42154615|NCT00296504|75962704|FG005|Final Analysis|Insufficient Viral Load Response|0|||
42154616|NCT00296504|75962705|FG006|Final Analysis|Insufficient Viral Load Response|0|||
42154617|NCT00296504|75962706|FG007|Final Analysis|Insufficient Viral Load Response|0|||
42154618|NCT00296504|75962707|FG008|Final Analysis|Insufficient Viral Load Response|6|||
42154619|NCT00296504|75962699|FG000|Final Analysis|Adverse Event|0|||
42154620|NCT00296504|75962700|FG001|Final Analysis|Adverse Event|0|||
42154621|NCT00296504|75962701|FG002|Final Analysis|Adverse Event|0|||
42154622|NCT00296504|75962702|FG003|Final Analysis|Adverse Event|0|||
42154623|NCT00296504|75962703|FG004|Final Analysis|Adverse Event|0|||
42154624|NCT00296504|75962704|FG005|Final Analysis|Adverse Event|0|||
42154625|NCT00296504|75962705|FG006|Final Analysis|Adverse Event|0|||
42154626|NCT00296504|75962706|FG007|Final Analysis|Adverse Event|0|||
42278728|NCT02654145|76110332|FG000|Overall Study|Lack of Efficacy|1|||
42278729|NCT02654145|76110332|FG000|Overall Study|Protocol Violation|1|||
42278730|NCT02654145|76110332|FG000|Overall Study|Withdrawal by Subject|5|||
42278731|NCT01111565|76110336|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
42154627|NCT00296504|75962707|FG008|Final Analysis|Adverse Event|2|||
42154628|NCT00296504|75962699|FG000|Final Analysis|Pregnancy|0|||
42154629|NCT00296504|75962700|FG001|Final Analysis|Pregnancy|0|||
42278732|NCT01111565|76110337|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
42278733|NCT01111565|76110338|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
42278734|NCT01111565|76110339|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
42278735|NCT01111565|76110340|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
42013301|NCT00969553|75820373|FG007|Overall Study|Not specified above|1|||
42013302|NCT00969553|75820374|FG008|Overall Study|Not specified above|0|||
42013303|NCT01179477|75820402|FG000|Overall Study|Death|542|||
42013304|NCT01179477|75820402|FG000|Overall Study|Unsuccessful implant|80|||
42013305|NCT01179477|75820402|FG000|Overall Study|Non-death withdrawal|438|||
42040197|NCT01928394|75848569|FG003|Treatment Period|Participant request to stop therapy|0|||
42040198|NCT01928394|75848570|FG004|Treatment Period|Participant request to stop therapy|0|||
42013306|NCT01179477|75820402|FG000|Overall Study|Did not complete final visit|27|||
42013307|NCT01179399|75820406|FG000|Overall Study|Adverse Event|1|||
42013308|NCT01179399|75820406|FG000|Overall Study|Lack of Efficacy|30|||
42040199|NCT01928394|75848571|FG005|Treatment Period|Participant request to stop therapy|3|||
42154630|NCT00296504|75962701|FG002|Final Analysis|Pregnancy|0|||
42154631|NCT00296504|75962702|FG003|Final Analysis|Pregnancy|0|||
42013309|NCT01179399|75820406|FG000|Overall Study|Withdrawal by Subject|1|||
42154632|NCT00296504|75962703|FG004|Final Analysis|Pregnancy|0|||
42154633|NCT00296504|75962704|FG005|Final Analysis|Pregnancy|0|||
42278736|NCT01111565|76110336|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
42278737|NCT01111565|76110337|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
42278738|NCT01111565|76110338|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
42278739|NCT01111565|76110339|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
42278740|NCT01111565|76110340|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
42278741|NCT01111565|76110336|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
42278742|NCT01111565|76110337|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
42278743|NCT01111565|76110338|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
42278744|NCT01111565|76110339|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
42278745|NCT01111565|76110340|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
42278746|NCT01111565|76110336|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
42040200|NCT01928394|75848572|FG006|Treatment Period|Participant request to stop therapy|3|||
42040201|NCT01928394|75848573|FG007|Treatment Period|Participant request to stop therapy|0|||
42040202|NCT01928394|75848574|FG008|Treatment Period|Participant request to stop therapy|0|||
42040203|NCT01928394|75848575|FG009|Treatment Period|Participant request to stop therapy|0|||
42040204|NCT01928394|75848576|FG010|Treatment Period|Participant request to stop therapy|3|||
42040205|NCT01928394|75848577|FG011|Treatment Period|Participant request to stop therapy|2|||
42040206|NCT01928394|75848578|FG012|Treatment Period|Participant request to stop therapy|1|||
42040207|NCT01928394|75848579|FG013|Treatment Period|Participant request to stop therapy|2|||
42040208|NCT01928394|75848580|FG014|Treatment Period|Participant request to stop therapy|4|||
42040209|NCT01928394|75848581|FG015|Treatment Period|Participant request to stop therapy|0|||
42154634|NCT00296504|75962705|FG006|Final Analysis|Pregnancy|0|||
42154635|NCT00296504|75962706|FG007|Final Analysis|Pregnancy|0|||
42154636|NCT00296504|75962707|FG008|Final Analysis|Pregnancy|4|||
42154637|NCT00296504|75962699|FG000|Final Analysis|Tuberculosis|0|||
42154638|NCT00296504|75962700|FG001|Final Analysis|Tuberculosis|0|||
42154639|NCT00296504|75962701|FG002|Final Analysis|Tuberculosis|0|||
42154640|NCT00296504|75962702|FG003|Final Analysis|Tuberculosis|0|||
42154641|NCT00296504|75962703|FG004|Final Analysis|Tuberculosis|0|||
42154642|NCT00296504|75962704|FG005|Final Analysis|Tuberculosis|0|||
42154643|NCT00296504|75962705|FG006|Final Analysis|Tuberculosis|0|||
42154644|NCT00296504|75962706|FG007|Final Analysis|Tuberculosis|0|||
42154645|NCT00296504|75962707|FG008|Final Analysis|Tuberculosis|1|||
42154646|NCT00296504|75962699|FG000|Final Analysis|Participant Moved to Another Country|0|||
42154647|NCT00296504|75962700|FG001|Final Analysis|Participant Moved to Another Country|0|||
42154648|NCT00296504|75962701|FG002|Final Analysis|Participant Moved to Another Country|0|||
42154649|NCT00296504|75962702|FG003|Final Analysis|Participant Moved to Another Country|0|||
42154650|NCT00296504|75962703|FG004|Final Analysis|Participant Moved to Another Country|0|||
42154651|NCT00296504|75962704|FG005|Final Analysis|Participant Moved to Another Country|0|||
42154652|NCT00296504|75962705|FG006|Final Analysis|Participant Moved to Another Country|0|||
42154653|NCT00296504|75962706|FG007|Final Analysis|Participant Moved to Another Country|0|||
42154654|NCT00296504|75962707|FG008|Final Analysis|Participant Moved to Another Country|1|||
42154655|NCT00296504|75962699|FG000|Final Analysis|Poor Adherence|0|||
42154656|NCT00296504|75962700|FG001|Final Analysis|Poor Adherence|0|||
42154657|NCT00296504|75962701|FG002|Final Analysis|Poor Adherence|0|||
42154658|NCT00296504|75962702|FG003|Final Analysis|Poor Adherence|0|||
42154659|NCT00296504|75962703|FG004|Final Analysis|Poor Adherence|0|||
42154660|NCT00296504|75962704|FG005|Final Analysis|Poor Adherence|0|||
42154661|NCT00296504|75962705|FG006|Final Analysis|Poor Adherence|0|||
42154662|NCT00296504|75962706|FG007|Final Analysis|Poor Adherence|0|||
42154663|NCT00296504|75962707|FG008|Final Analysis|Poor Adherence|1|||
42154664|NCT00313820|75962734|FG000|Assigned to Treatment|Other|1|||
42154665|NCT00313820|75962735|FG001|Assigned to Treatment|Other|0|||
42154666|NCT00313820|75962734|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
42154667|NCT00313820|75962735|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
42154668|NCT00313820|75962734|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
42154669|NCT00313820|75962735|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
42154670|NCT00313820|75962734|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
42154671|NCT00313820|75962735|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
42278747|NCT01111565|76110337|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
42278748|NCT01111565|76110338|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
42278749|NCT01111565|76110339|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
42040210|NCT01928394|75848582|FG016|Treatment Period|Participant request to stop therapy|1|||
42154672|NCT00313820|75962734|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
42154673|NCT00313820|75962735|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
42154674|NCT00313820|75962734|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
42154675|NCT00313820|75962735|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
42154676|NCT00462761|75962741|FG000|Overall Study|Adverse Event|6|||
42154677|NCT00462761|75962741|FG000|Overall Study|Withdrawal by Subject|9|||
42154678|NCT00462761|75962741|FG000|Overall Study|Physician Decision|5|||
42154679|NCT00462761|75962741|FG000|Overall Study|Disease progression|43|||
42154680|NCT00462761|75962741|FG000|Overall Study|Death|12|||
42154681|NCT00462761|75962741|FG000|Overall Study|Other|1|||
42154682|NCT00235872|75962773|FG000|Overall Study|Adverse Event|34|||
42154683|NCT00235872|75962773|FG000|Overall Study|Death|1|||
42154684|NCT00235872|75962773|FG000|Overall Study|Lost to Follow-up|1|||
42154685|NCT00235872|75962773|FG000|Overall Study|Withdrawal by Subject|50|||
42154686|NCT00235872|75962773|FG000|Overall Study|Administrative reason|61|||
42154687|NCT00461981|75962779|FG000|Overall Study|Lost to Follow-up|9|||
42154688|NCT00461981|75962780|FG001|Overall Study|Lost to Follow-up|6|||
42154689|NCT00461981|75962779|FG000|Overall Study|Withdrawal by Subject|2|||
42154690|NCT00461981|75962780|FG001|Overall Study|Withdrawal by Subject|3|||
42154691|NCT00296036|75962788|FG000|Overall Study|Withdrawal by Subject|1|||
42154692|NCT00296036|75962789|FG001|Overall Study|Withdrawal by Subject|0|||
42154693|NCT00296036|75962790|FG002|Overall Study|Withdrawal by Subject|2|||
42154694|NCT00296036|75962791|FG003|Overall Study|Withdrawal by Subject|1|||
42154695|NCT00296036|75962792|FG004|Overall Study|Withdrawal by Subject|2|||
42154696|NCT00296036|75962793|FG005|Overall Study|Withdrawal by Subject|1|||
42154697|NCT00296036|75962788|FG000|Overall Study|Protocol Violation|0|||
42154698|NCT00296036|75962789|FG001|Overall Study|Protocol Violation|0|||
42154699|NCT00296036|75962790|FG002|Overall Study|Protocol Violation|0|||
42154700|NCT00296036|75962791|FG003|Overall Study|Protocol Violation|0|||
42154701|NCT00296036|75962792|FG004|Overall Study|Protocol Violation|0|||
42154702|NCT00296036|75962793|FG005|Overall Study|Protocol Violation|3|||
42154703|NCT00089674|75962812|FG000|Overall Study|Physician Decision|4|||
42154704|NCT00089674|75962813|FG001|Overall Study|Physician Decision|2|||
42154705|NCT00089674|75962812|FG000|Overall Study|Adverse Event|23|||
42154706|NCT00089674|75962813|FG001|Overall Study|Adverse Event|29|||
42154707|NCT00089674|75962812|FG000|Overall Study|Withdrawal by Subject|143|||
42154708|NCT00089674|75962813|FG001|Overall Study|Withdrawal by Subject|127|||
42154709|NCT00089674|75962812|FG000|Overall Study|Death|43|||
42154710|NCT00089674|75962813|FG001|Overall Study|Death|43|||
42154711|NCT00089674|75962812|FG000|Overall Study|Disease progression|21|||
42154712|NCT00089674|75962813|FG001|Overall Study|Disease progression|23|||
42154713|NCT00089674|75962812|FG000|Overall Study|Ineligibility determined|8|||
42154714|NCT00089674|75962813|FG001|Overall Study|Ineligibility determined|10|||
42154715|NCT00089674|75962812|FG000|Overall Study|Lost to Follow-up|21|||
42154716|NCT00089674|75962813|FG001|Overall Study|Lost to Follow-up|17|||
42154717|NCT00089674|75962812|FG000|Overall Study|Noncompliance|7|||
42154718|NCT00089674|75962813|FG001|Overall Study|Noncompliance|3|||
42154719|NCT00089674|75962812|FG000|Overall Study|Other|5|||
42154720|NCT00089674|75962813|FG001|Overall Study|Other|9|||
42154721|NCT00089674|75962812|FG000|Overall Study|Requirement for alternative therapy|14|||
42154722|NCT00089674|75962813|FG001|Overall Study|Requirement for alternative therapy|4|||
42154723|NCT00313586|75962823|FG000|Overall Study|Disease progression|14|||
42154724|NCT00313586|75962824|FG001|Overall Study|Disease progression|19|||
42154725|NCT00313586|75962825|FG002|Overall Study|Disease progression|10|||
42154726|NCT00313586|75962826|FG003|Overall Study|Disease progression|3|||
42154727|NCT00313586|75962823|FG000|Overall Study|Adverse Event|12|||
42154728|NCT00313586|75962824|FG001|Overall Study|Adverse Event|18|||
42154729|NCT00313586|75962825|FG002|Overall Study|Adverse Event|3|||
42154730|NCT00313586|75962826|FG003|Overall Study|Adverse Event|10|||
42154731|NCT00313586|75962823|FG000|Overall Study|Death|11|||
42154732|NCT00313586|75962824|FG001|Overall Study|Death|8|||
42154733|NCT00313586|75962825|FG002|Overall Study|Death|1|||
42154734|NCT00313586|75962826|FG003|Overall Study|Death|7|||
42154735|NCT00313586|75962823|FG000|Overall Study|Withdrawal by Subject|13|||
42154736|NCT00313586|75962824|FG001|Overall Study|Withdrawal by Subject|6|||
42154737|NCT00313586|75962825|FG002|Overall Study|Withdrawal by Subject|6|||
42154738|NCT00313586|75962826|FG003|Overall Study|Withdrawal by Subject|2|||
42154739|NCT00313586|75962823|FG000|Overall Study|Alternative therapy|3|||
42154740|NCT00313586|75962824|FG001|Overall Study|Alternative therapy|6|||
42154741|NCT00313586|75962825|FG002|Overall Study|Alternative therapy|2|||
42154742|NCT00313586|75962826|FG003|Overall Study|Alternative therapy|0|||
42154743|NCT00313586|75962823|FG000|Overall Study|Other complicating disease|2|||
42154744|NCT00313586|75962824|FG001|Overall Study|Other complicating disease|2|||
42154745|NCT00313586|75962825|FG002|Overall Study|Other complicating disease|0|||
42154746|NCT00313586|75962826|FG003|Overall Study|Other complicating disease|0|||
42154747|NCT00313586|75962823|FG000|Overall Study|Did not achieve HI-major/better response|10|||
42154748|NCT00313586|75962824|FG001|Overall Study|Did not achieve HI-major/better response|7|||
42154749|NCT00313586|75962825|FG002|Overall Study|Did not achieve HI-major/better response|2|||
42154750|NCT00313586|75962826|FG003|Overall Study|Did not achieve HI-major/better response|1|||
42154751|NCT00313586|75962823|FG000|Overall Study|Physician Decision|2|||
42154752|NCT00313586|75962824|FG001|Overall Study|Physician Decision|1|||
42154753|NCT00313586|75962825|FG002|Overall Study|Physician Decision|0|||
42154754|NCT00313586|75962826|FG003|Overall Study|Physician Decision|0|||
42154755|NCT00313586|75962823|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
42154756|NCT00313586|75962824|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
42154757|NCT00313586|75962825|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
42154758|NCT00313586|75962826|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
42154759|NCT00313586|75962823|FG000|Overall Study|Lost insurance|0|||
42154760|NCT00313586|75962824|FG001|Overall Study|Lost insurance|1|||
42154761|NCT00313586|75962825|FG002|Overall Study|Lost insurance|0|||
42154762|NCT00313586|75962826|FG003|Overall Study|Lost insurance|0|||
42154763|NCT00313586|75962823|FG000|Overall Study|Moved|0|||
42154764|NCT00313586|75962824|FG001|Overall Study|Moved|1|||
42154765|NCT00313586|75962825|FG002|Overall Study|Moved|0|||
42154766|NCT00313586|75962826|FG003|Overall Study|Moved|0|||
42154767|NCT00313586|75962823|FG000|Overall Study|Death before starting treatment|1|||
42154768|NCT00313586|75962824|FG001|Overall Study|Death before starting treatment|0|||
42154769|NCT00313586|75962825|FG002|Overall Study|Death before starting treatment|0|||
42154770|NCT00313586|75962826|FG003|Overall Study|Death before starting treatment|0|||
42154771|NCT00312572|75962836|FG000|Overall Study|Adverse Event|10|||
42154772|NCT00312572|75962837|FG001|Overall Study|Adverse Event|16|||
42154773|NCT00312572|75962836|FG000|Overall Study|Lost to Follow-up|1|||
42154774|NCT00312572|75962837|FG001|Overall Study|Lost to Follow-up|1|||
42154775|NCT00312572|75962836|FG000|Overall Study|Administrative|4|||
42154776|NCT00312572|75962837|FG001|Overall Study|Administrative|2|||
42154777|NCT00312572|75962836|FG000|Overall Study|Lack of Efficacy|1|||
42154778|NCT00312572|75962837|FG001|Overall Study|Lack of Efficacy|2|||
42154779|NCT00290888|75962847|FG000|Overall Study|Physician Decision|3|||
42154780|NCT00290888|75962848|FG001|Overall Study|Physician Decision|1|||
42154781|NCT00290732|75962857|FG000|Overall Study|Inability to instill drug intraductally.|0|||
42154782|NCT00290732|75962858|FG001|Overall Study|Inability to instill drug intraductally.|1|||
42154783|NCT00290732|75962859|FG002|Overall Study|Inability to instill drug intraductally.|1|||
42154784|NCT00290732|75962860|FG003|Overall Study|Inability to instill drug intraductally.|0|||
42154785|NCT00290732|75962861|FG004|Overall Study|Inability to instill drug intraductally.|0|||
42154786|NCT00312494|75962877|FG000|Overall Study|Randomized; not treated with study drug|9|||
42154787|NCT00312494|75962878|FG001|Overall Study|Randomized; not treated with study drug|10|||
42154788|NCT00312494|75962879|FG002|Overall Study|Randomized; not treated with study drug|5|||
42154789|NCT00312494|75962877|FG000|Overall Study|Adverse Event|33|||
42154790|NCT00312494|75962878|FG001|Overall Study|Adverse Event|15|||
42154791|NCT00312494|75962879|FG002|Overall Study|Adverse Event|11|||
42154792|NCT00312494|75962877|FG000|Overall Study|Lack of Efficacy|4|||
42154793|NCT00312494|75962878|FG001|Overall Study|Lack of Efficacy|6|||
42154794|NCT00312494|75962879|FG002|Overall Study|Lack of Efficacy|8|||
42154795|NCT00312494|75962877|FG000|Overall Study|Laboratory abnormality|1|||
42154796|NCT00312494|75962878|FG001|Overall Study|Laboratory abnormality|0|||
42154797|NCT00312494|75962879|FG002|Overall Study|Laboratory abnormality|0|||
42154798|NCT00312494|75962877|FG000|Overall Study|Lost to Follow-up|8|||
42154799|NCT00312494|75962878|FG001|Overall Study|Lost to Follow-up|8|||
42154800|NCT00312494|75962879|FG002|Overall Study|Lost to Follow-up|8|||
42154801|NCT00312494|75962877|FG000|Overall Study|Withdrawal by Subject|6|||
42154802|NCT00312494|75962878|FG001|Overall Study|Withdrawal by Subject|9|||
42154803|NCT00312494|75962879|FG002|Overall Study|Withdrawal by Subject|10|||
42154804|NCT00312494|75962877|FG000|Overall Study|Other|10|||
42154805|NCT00312494|75962878|FG001|Overall Study|Other|10|||
42154806|NCT00312494|75962879|FG002|Overall Study|Other|1|||
42154807|NCT00312338|75962889|FG000|Overall Study|Adverse Event|7|||
42154808|NCT00312338|75962890|FG001|Overall Study|Adverse Event|2|||
42154809|NCT00312338|75962889|FG000|Overall Study|Lost to Follow-up|9|||
42154810|NCT00312338|75962890|FG001|Overall Study|Lost to Follow-up|1|||
42154811|NCT00312338|75962889|FG000|Overall Study|Withdrawal by Subject|4|||
42154812|NCT00312338|75962890|FG001|Overall Study|Withdrawal by Subject|0|||
42154813|NCT00312338|75962889|FG000|Overall Study|Subsequent infection|2|||
42154814|NCT00312338|75962890|FG001|Overall Study|Subsequent infection|0|||
42154815|NCT00290498|75962898|FG000|Overall Study|Death|2|||
42154816|NCT00290498|75962899|FG001|Overall Study|Death|0|||
42154817|NCT00290498|75962898|FG000|Overall Study|Physician Decision|1|||
42154818|NCT00290498|75962899|FG001|Overall Study|Physician Decision|0|||
42154819|NCT00290498|75962898|FG000|Overall Study|Withdrawal by Subject|1|||
42154820|NCT00290498|75962899|FG001|Overall Study|Withdrawal by Subject|0|||
42154821|NCT00290498|75962898|FG000|Overall Study|Ineligible|3|||
42278750|NCT01111565|76110340|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
42278751|NCT01111565|76110336|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
42278752|NCT01111565|76110337|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
42154822|NCT00290498|75962899|FG001|Overall Study|Ineligible|0|||
42154823|NCT00290498|75962898|FG000|Overall Study|Non-Compliance|1|||
42154824|NCT00290498|75962899|FG001|Overall Study|Non-Compliance|0|||
42154825|NCT00451451|75962910|FG000|Overall Study|Adverse Event|11|||
42154826|NCT00451451|75962911|FG001|Overall Study|Adverse Event|21|||
42154827|NCT00451451|75962912|FG002|Overall Study|Adverse Event|26|||
42154828|NCT00451451|75962913|FG003|Overall Study|Adverse Event|10|||
42154829|NCT00451451|75962910|FG000|Overall Study|Lost to Follow-up|11|||
42154830|NCT00451451|75962911|FG001|Overall Study|Lost to Follow-up|9|||
42278753|NCT01111565|76110338|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
42154831|NCT00451451|75962912|FG002|Overall Study|Lost to Follow-up|8|||
42278754|NCT01111565|76110339|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
42154832|NCT00451451|75962913|FG003|Overall Study|Lost to Follow-up|11|||
42154833|NCT00451451|75962910|FG000|Overall Study|Consent Withdrawn|14|||
42154834|NCT00451451|75962911|FG001|Overall Study|Consent Withdrawn|9|||
42154835|NCT00451451|75962912|FG002|Overall Study|Consent Withdrawn|17|||
42154836|NCT00451451|75962913|FG003|Overall Study|Consent Withdrawn|17|||
42154837|NCT00451451|75962910|FG000|Overall Study|Investigator Decision|6|||
42154838|NCT00451451|75962911|FG001|Overall Study|Investigator Decision|2|||
42154839|NCT00451451|75962912|FG002|Overall Study|Investigator Decision|1|||
42154840|NCT00451451|75962913|FG003|Overall Study|Investigator Decision|2|||
42154841|NCT00451451|75962910|FG000|Overall Study|Subject Non-Compliance|8|||
42154842|NCT00451451|75962911|FG001|Overall Study|Subject Non-Compliance|4|||
42154843|NCT00451451|75962912|FG002|Overall Study|Subject Non-Compliance|3|||
42154844|NCT00451451|75962913|FG003|Overall Study|Subject Non-Compliance|3|||
42154845|NCT00451451|75962910|FG000|Overall Study|Death|1|||
42154846|NCT00451451|75962911|FG001|Overall Study|Death|0|||
42154847|NCT00451451|75962912|FG002|Overall Study|Death|0|||
42154848|NCT00451451|75962913|FG003|Overall Study|Death|1|||
42154849|NCT00451451|75962910|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
42154850|NCT00451451|75962911|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
42154851|NCT00451451|75962912|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
42154852|NCT00451451|75962913|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
42154853|NCT03824912|75962928|FG000|Overall Study|Lost to Follow-up|18|||
42154854|NCT03824912|75962929|FG001|Overall Study|Lost to Follow-up|15|||
42154855|NCT03824912|75962930|FG002|Overall Study|Lost to Follow-up|8|||
42154856|NCT03824912|75962928|FG000|Overall Study|Negative Baseline Culture Result|118|||
42154857|NCT03824912|75962929|FG001|Overall Study|Negative Baseline Culture Result|112|||
42154858|NCT03824912|75962930|FG002|Overall Study|Negative Baseline Culture Result|57|||
42154859|NCT03824912|75962928|FG000|Overall Study|Non-Compliance with Study Drug|0|||
42154860|NCT03824912|75962929|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42154861|NCT03824912|75962930|FG002|Overall Study|Non-Compliance with Study Drug|1|||
42154862|NCT03824912|75962928|FG000|Overall Study|Protocol Violation|1|||
42154863|NCT03824912|75962929|FG001|Overall Study|Protocol Violation|4|||
42154864|NCT03824912|75962930|FG002|Overall Study|Protocol Violation|1|||
42154865|NCT03824912|75962928|FG000|Overall Study|Withdrawal by Subject|3|||
42154866|NCT03824912|75962929|FG001|Overall Study|Withdrawal by Subject|2|||
42154867|NCT03824912|75962930|FG002|Overall Study|Withdrawal by Subject|1|||
42154868|NCT03824912|75962928|FG000|Overall Study|Participation in another study|0|||
42154869|NCT03824912|75962929|FG001|Overall Study|Participation in another study|1|||
42154870|NCT03824912|75962930|FG002|Overall Study|Participation in another study|0|||
42154871|NCT00461123|75962940|FG000|Overall Study|Adverse Event|1|||
42154872|NCT00461123|75962941|FG001|Overall Study|Adverse Event|0|||
42154873|NCT00461123|75962940|FG000|Overall Study|Lost to Follow-up|1|||
42154874|NCT00461123|75962941|FG001|Overall Study|Lost to Follow-up|1|||
42154875|NCT00461123|75962940|FG000|Overall Study|Protocol Violation|3|||
42154876|NCT00461123|75962941|FG001|Overall Study|Protocol Violation|2|||
42154877|NCT00461123|75962940|FG000|Overall Study|Withdrawal by Subject|1|||
42154878|NCT00461123|75962941|FG001|Overall Study|Withdrawal by Subject|3|||
42154879|NCT00290342|75962949|FG000|Overall Study|Other|0|||
42154880|NCT00290342|75962950|FG001|Overall Study|Other|1|||
42154881|NCT00290342|75962949|FG000|Overall Study|Withdrawal by Subject|6|||
42154882|NCT00290342|75962950|FG001|Overall Study|Withdrawal by Subject|4|||
42154883|NCT00290342|75962949|FG000|Overall Study|Lost to Follow-up|1|||
42154884|NCT00290342|75962950|FG001|Overall Study|Lost to Follow-up|0|||
42154885|NCT00460811|75962961|FG000|Overall Study|Adverse Event|4|||
42154886|NCT00460811|75962962|FG001|Overall Study|Adverse Event|6|||
42154887|NCT00460811|75962963|FG002|Overall Study|Adverse Event|3|||
42154888|NCT00460811|75962964|FG003|Overall Study|Adverse Event|10|||
42154889|NCT00460811|75962965|FG004|Overall Study|Adverse Event|2|||
42154890|NCT00460811|75962961|FG000|Overall Study|Noncompliance|1|||
42154891|NCT00460811|75962962|FG001|Overall Study|Noncompliance|0|||
42154892|NCT00460811|75962963|FG002|Overall Study|Noncompliance|0|||
42154893|NCT00460811|75962964|FG003|Overall Study|Noncompliance|2|||
42154894|NCT00460811|75962965|FG004|Overall Study|Noncompliance|1|||
42154895|NCT00460811|75962961|FG000|Overall Study|Withdrawal by Subject|7|||
42154896|NCT00460811|75962962|FG001|Overall Study|Withdrawal by Subject|7|||
42351335|NCT00630994|76191244|FG000|Overall Study|Other|1|||
42154897|NCT00460811|75962963|FG002|Overall Study|Withdrawal by Subject|6|||
42154898|NCT00460811|75962964|FG003|Overall Study|Withdrawal by Subject|3|||
42154899|NCT00460811|75962965|FG004|Overall Study|Withdrawal by Subject|11|||
42154900|NCT00460811|75962961|FG000|Overall Study|Physician Decision|1|||
42154901|NCT00460811|75962962|FG001|Overall Study|Physician Decision|0|||
42154902|NCT00460811|75962963|FG002|Overall Study|Physician Decision|0|||
42154903|NCT00460811|75962964|FG003|Overall Study|Physician Decision|0|||
42154904|NCT00460811|75962965|FG004|Overall Study|Physician Decision|0|||
42154905|NCT00460811|75962961|FG000|Overall Study|Lost to Follow-up|3|||
42154906|NCT00460811|75962962|FG001|Overall Study|Lost to Follow-up|2|||
42154907|NCT00460811|75962963|FG002|Overall Study|Lost to Follow-up|5|||
42154908|NCT00460811|75962964|FG003|Overall Study|Lost to Follow-up|3|||
42154909|NCT00460811|75962965|FG004|Overall Study|Lost to Follow-up|6|||
42154910|NCT00290186|75962984|FG000|Overall Study|Adverse Event|1|||
42154911|NCT00290186|75962985|FG001|Overall Study|Adverse Event|1|||
42154912|NCT00290186|75962984|FG000|Overall Study|Lost to Follow-up|3|||
42154913|NCT00290186|75962985|FG001|Overall Study|Lost to Follow-up|2|||
42154914|NCT00290186|75962984|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
42154915|NCT00290186|75962985|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
42154916|NCT00290186|75962984|FG000|Overall Study|Withdrawal by Subject|0|||
42154917|NCT00290186|75962985|FG001|Overall Study|Withdrawal by Subject|1|||
42154918|NCT00460655|75962995|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
42154919|NCT00460655|75962996|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
42154920|NCT00460655|75962997|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
42154921|NCT00460655|75962998|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
42154922|NCT00460655|75962995|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
42154923|NCT00460655|75962996|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
42154924|NCT00460655|75962997|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
42154925|NCT00460655|75962998|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
42154926|NCT00460655|75962995|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
42154927|NCT00460655|75962996|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
42154928|NCT00460655|75962997|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
42154929|NCT00460655|75962998|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
42154930|NCT00460655|75962995|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
42154931|NCT00460655|75962996|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
42154932|NCT00460655|75962997|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
42154933|NCT00460655|75962998|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
42154934|NCT00460655|75962995|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
42154935|NCT00460655|75962996|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
42154936|NCT00460655|75962997|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
42154937|NCT00460655|75962998|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
42154938|NCT00460655|75962995|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
42154939|NCT00460655|75962996|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
42154940|NCT00460655|75962997|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
42154941|NCT00460655|75962998|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
42154942|NCT00460577|75963010|FG000|Overall Study|Protocol Violation|2|||
42154943|NCT00460577|75963011|FG001|Overall Study|Protocol Violation|6|||
42154944|NCT00289016|75963017|FG000|Overall Study|Disease Progression|29|||
42154945|NCT00289016|75963017|FG000|Overall Study|Death|2|||
42154946|NCT00289016|75963017|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
42154947|NCT00289016|75963017|FG000|Overall Study|Withdrawal by Subject|2|||
42154948|NCT00289016|75963017|FG000|Overall Study|Adverse Event|1|||
42154949|NCT00289016|75963017|FG000|Overall Study|Other|1|||
42154950|NCT00288860|75963023|FG000|Overall Study|Did not complete intake|4|||
42154951|NCT00288860|75963024|FG001|Overall Study|Did not complete intake|8|||
42154952|NCT00288860|75963023|FG000|Overall Study|Death|4|||
42154953|NCT00288860|75963024|FG001|Overall Study|Death|3|||
42154954|NCT00288860|75963023|FG000|Overall Study|Withdrawal by Subject|20|||
42154955|NCT00288860|75963024|FG001|Overall Study|Withdrawal by Subject|15|||
42154956|NCT00288860|75963023|FG000|Overall Study|Lost to Follow-up|74|||
42154957|NCT00288860|75963024|FG001|Overall Study|Lost to Follow-up|71|||
42154958|NCT00288704|75963036|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
42154959|NCT00288704|75963037|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
42154960|NCT00288704|75963038|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
42154961|NCT00288704|75963036|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
42154962|NCT00288704|75963037|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
42154963|NCT00288704|75963038|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
42154964|NCT00288704|75963036|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
42154965|NCT00288704|75963037|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
42154966|NCT00288704|75963038|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
42154967|NCT00288704|75963036|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
42154968|NCT00288704|75963037|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
42154969|NCT00288704|75963038|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
42154970|NCT00288704|75963036|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
42154971|NCT00288704|75963037|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
42154972|NCT00288704|75963038|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
42154973|NCT00288704|75963036|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
42154974|NCT00288704|75963037|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
42154975|NCT00288704|75963038|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
42351336|NCT00630838|76191250|FG000|Overall Study|Death|0|||
42154976|NCT00288704|75963036|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
42154977|NCT00288704|75963037|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
42154978|NCT00288704|75963038|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
42154979|NCT00288626|75963045|FG000|Overall Study|Death|3|||
42154980|NCT00288626|75963045|FG000|Overall Study|Withdrawal by Subject|4|||
42154981|NCT00087490|75963053|FG000|Overall Study|Death|6|||
42154982|NCT00087490|75963054|FG001|Overall Study|Death|4|||
42154983|NCT00087490|75963053|FG000|Overall Study|Adverse Event|3|||
42154984|NCT00087490|75963054|FG001|Overall Study|Adverse Event|8|||
42154985|NCT00087490|75963053|FG000|Overall Study|Lack of Efficacy|0|||
42351337|NCT00630838|76191251|FG001|Overall Study|Death|1|||
42154986|NCT00087490|75963054|FG001|Overall Study|Lack of Efficacy|2|||
42154987|NCT00087490|75963053|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
42154988|NCT00087490|75963054|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
42154989|NCT00087490|75963053|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
42154990|NCT00087490|75963054|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
42154991|NCT00087490|75963053|FG000|Overall Study|Randomized but not treated|7|||
42154992|NCT00087490|75963054|FG001|Overall Study|Randomized but not treated|18|||
42154993|NCT00087178|75963062|FG000|Overall Study|No follow up data|5|||
42154994|NCT00087178|75963063|FG001|Overall Study|No follow up data|15|||
42154995|NCT00087178|75963062|FG000|Overall Study|No clinical assessment|1|||
42154996|NCT00087178|75963063|FG001|Overall Study|No clinical assessment|2|||
42154997|NCT00087178|75963062|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
42154998|NCT00087178|75963063|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
42154999|NCT00288080|75963071|FG000|Overall Study|Withdrawal by Subject|1|||
42155000|NCT00288080|75963072|FG001|Overall Study|Withdrawal by Subject|3|||
42155001|NCT00288080|75963071|FG000|Overall Study|Protocol Violation|25|||
42155002|NCT00288080|75963072|FG001|Overall Study|Protocol Violation|20|||
42155003|NCT00287690|75963080|FG000|Overall Study|Protocol Violation|20|||
42155004|NCT00287690|75963081|FG001|Overall Study|Protocol Violation|26|||
42155005|NCT00286754|75963090|FG000|Overall Study|Adverse Event|2|||
42155006|NCT00286754|75963091|FG001|Overall Study|Adverse Event|2|||
42155007|NCT00286754|75963092|FG002|Overall Study|Adverse Event|3|||
42155008|NCT00286754|75963090|FG000|Overall Study|Withdrawal by Subject|6|||
42155009|NCT00286754|75963091|FG001|Overall Study|Withdrawal by Subject|2|||
42155010|NCT00286754|75963092|FG002|Overall Study|Withdrawal by Subject|0|||
42155011|NCT00286754|75963090|FG000|Overall Study|Lost to Follow-up|12|||
42155012|NCT00286754|75963091|FG001|Overall Study|Lost to Follow-up|14|||
42155013|NCT00286754|75963092|FG002|Overall Study|Lost to Follow-up|6|||
42155014|NCT00286754|75963090|FG000|Overall Study|Moved out of state|0|||
42155015|NCT00286754|75963091|FG001|Overall Study|Moved out of state|0|||
42155016|NCT00286754|75963092|FG002|Overall Study|Moved out of state|1|||
42155017|NCT00066742|75963106|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
42155018|NCT00066742|75963106|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
42155019|NCT00066742|75963106|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
42155020|NCT00066742|75963106|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
42155021|NCT00066742|75963106|FG000|Induction Chemoradiotherapy|Ineligible|3|||
42155022|NCT00066742|75963106|FG000|Consolidation Chemotherapy|not protocol specified|1|||
42155023|NCT00066742|75963106|FG000|Consolidation Chemotherapy|Ineligible|2|||
42278755|NCT01111565|76110340|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
42278756|NCT01111565|76110336|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
42278757|NCT01111565|76110337|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
42278758|NCT01111565|76110338|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
42278759|NCT01111565|76110339|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
42278760|NCT01111565|76110340|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
42013310|NCT01178853|75820412|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
42013311|NCT01178853|75820413|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
42013312|NCT01178853|75820412|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
42013313|NCT01178853|75820413|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
42013314|NCT01178853|75820412|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
42013315|NCT01178853|75820413|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
42155024|NCT00460265|75963114|FG000|Overall Study|Lost to Follow-up|14|||
42155025|NCT00460265|75963115|FG001|Overall Study|Lost to Follow-up|15|||
42155026|NCT00460265|75963114|FG000|Overall Study|Physician Decision|1|||
42155027|NCT00460265|75963115|FG001|Overall Study|Physician Decision|2|||
42155028|NCT00460265|75963114|FG000|Overall Study|Withdrawal by Subject|10|||
42155029|NCT00460265|75963115|FG001|Overall Study|Withdrawal by Subject|25|||
42155030|NCT00460265|75963114|FG000|Overall Study|Ongoing|60|||
42155031|NCT00460265|75963115|FG001|Overall Study|Ongoing|47|||
42155032|NCT00460109|75963121|FG000|Overall Study|Death|1|||
42155033|NCT00065260|75963127|FG000|Overall Study|Death|0|||
42155034|NCT00065260|75963128|FG001|Overall Study|Death|1|||
42278761|NCT01111565|76110336|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
42155035|NCT00460031|75963134|FG000|Overall Study|Adverse Event|5|||
42278762|NCT01111565|76110337|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
42155036|NCT00460031|75963134|FG000|Overall Study|Withdrawal by Subject|5|||
42155037|NCT00460031|75963134|FG000|Overall Study|Death|1|||
42155038|NCT00451217|75963142|FG000|Overall Study|Lost to Follow-up|0|||
42155039|NCT00451217|75963143|FG001|Overall Study|Lost to Follow-up|1|||
42155040|NCT00451217|75963144|FG002|Overall Study|Lost to Follow-up|1|||
42155041|NCT00451217|75963145|FG003|Overall Study|Lost to Follow-up|1|||
42155042|NCT00451217|75963142|FG000|Overall Study|Withdrawal by Subject|1|||
42155043|NCT00451217|75963143|FG001|Overall Study|Withdrawal by Subject|0|||
42155044|NCT00451217|75963144|FG002|Overall Study|Withdrawal by Subject|0|||
42155045|NCT00451217|75963145|FG003|Overall Study|Withdrawal by Subject|0|||
42155046|NCT00451217|75963142|FG000|Overall Study|Not Treated|1|||
42155047|NCT00451217|75963143|FG001|Overall Study|Not Treated|1|||
42155048|NCT00451217|75963144|FG002|Overall Study|Not Treated|3|||
42155049|NCT00451217|75963145|FG003|Overall Study|Not Treated|4|||
42155050|NCT00459953|75963157|FG000|Overall Study|not analyzed-household member in study|1|||
42155051|NCT00459953|75963158|FG001|Overall Study|not analyzed-household member in study|1|||
42155052|NCT00459875|75963164|FG000|Overall Study|Ineligible participant|1|||
42155053|NCT00459875|75963164|FG000|Overall Study|Adverse Event|2|||
42155054|NCT00311402|75963170|FG000|Overall Study|Adverse Event|118|||
42155055|NCT00311402|75963171|FG001|Overall Study|Adverse Event|105|||
42155056|NCT00311402|75963170|FG000|Overall Study|Lost to Follow-up|0|||
42155057|NCT00311402|75963171|FG001|Overall Study|Lost to Follow-up|3|||
42155058|NCT00311402|75963170|FG000|Overall Study|Withdrawal by Subject|17|||
42155059|NCT00311402|75963171|FG001|Overall Study|Withdrawal by Subject|18|||
42013316|NCT01178853|75820412|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
42013317|NCT01178853|75820413|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
42013318|NCT01178853|75820412|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
42013319|NCT01178853|75820413|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
42013320|NCT01178385|75820421|FG000|Overall Study|Withdrawal by Subject|2|||
42013321|NCT01178385|75820422|FG001|Overall Study|Withdrawal by Subject|0|||
42013322|NCT01288976|75820431|FG000|Overall Study|Withdrawal by Subject|58|||
42013323|NCT01288976|75820432|FG001|Overall Study|Withdrawal by Subject|12|||
42278763|NCT01111565|76110338|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
42278764|NCT01111565|76110339|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
42278765|NCT01111565|76110340|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
42278766|NCT01111565|76110336|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
42278767|NCT01111565|76110337|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
42278768|NCT01111565|76110338|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
42278769|NCT01111565|76110339|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
42278770|NCT01111565|76110340|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
42278771|NCT01111565|76110336|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
42278772|NCT01111565|76110337|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
42278773|NCT01111565|76110338|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
42278774|NCT01111565|76110339|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
42278775|NCT01111565|76110340|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
42278776|NCT01111565|76110336|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
42278777|NCT01111565|76110337|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
42278778|NCT01111565|76110338|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
42278779|NCT01111565|76110339|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
42278780|NCT01111565|76110340|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
42278781|NCT01111565|76110336|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
42278782|NCT01111565|76110337|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
42278783|NCT01111565|76110338|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
42278784|NCT01111565|76110339|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
42278785|NCT01111565|76110340|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
42278786|NCT01111565|76110336|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
42278787|NCT01111565|76110337|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
42278788|NCT01111565|76110338|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
42278789|NCT01111565|76110339|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
42278790|NCT01111565|76110340|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
42278791|NCT02343458|76110354|FG000|Overall Study|Adverse Event|15|||
42278792|NCT02343458|76110355|FG001|Overall Study|Adverse Event|14|||
42013324|NCT01288976|75820433|FG002|Overall Study|Withdrawal by Subject|9|||
42013325|NCT01288976|75820431|FG000|Overall Study|Death|98|||
42155060|NCT00311402|75963170|FG000|Overall Study|Lack of Efficacy|58|||
42155061|NCT00311402|75963171|FG001|Overall Study|Lack of Efficacy|42|||
42155062|NCT00311402|75963170|FG000|Overall Study|Protocol Violation|7|||
42155063|NCT00311402|75963171|FG001|Overall Study|Protocol Violation|6|||
42278793|NCT02343458|76110356|FG002|Overall Study|Adverse Event|15|||
42155064|NCT00311402|75963170|FG000|Overall Study|IRB's rejection etc.|10|||
42155065|NCT00311402|75963171|FG001|Overall Study|IRB's rejection etc.|3|||
42155066|NCT00450749|75963180|FG000|Overall Study|Withdrawal by Subject|0|||
42155067|NCT00450749|75963181|FG001|Overall Study|Withdrawal by Subject|0|||
42155068|NCT00450749|75963182|FG002|Overall Study|Withdrawal by Subject|2|||
42155069|NCT00450749|75963180|FG000|Overall Study|Noncompliant|0|||
42155070|NCT00450749|75963181|FG001|Overall Study|Noncompliant|1|||
42155071|NCT00450749|75963182|FG002|Overall Study|Noncompliant|0|||
42155072|NCT00292370|75963193|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
42155073|NCT00292370|75963194|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
42155074|NCT00292370|75963195|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
42155075|NCT00292370|75963193|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
42155076|NCT00292370|75963194|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
42155077|NCT00292370|75963195|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
42155078|NCT00292370|75963193|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
42155079|NCT00292370|75963194|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
42155080|NCT00292370|75963195|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
42155081|NCT00292370|75963193|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
42155082|NCT00292370|75963194|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
42155083|NCT00292370|75963195|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
42155084|NCT00292370|75963193|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
42155085|NCT00292370|75963194|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
42155086|NCT00292370|75963195|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
42155087|NCT00292370|75963193|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
42155088|NCT00292370|75963194|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
42155089|NCT00292370|75963195|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
42155090|NCT00065182|75963204|FG000|Overall Study|Adverse Event|24|||
42155091|NCT00065182|75963205|FG001|Overall Study|Adverse Event|17|||
42155092|NCT00065182|75963204|FG000|Overall Study|Lost to Follow-up|0|||
42155093|NCT00065182|75963205|FG001|Overall Study|Lost to Follow-up|4|||
42155094|NCT00065182|75963204|FG000|Overall Study|Protocol Violation|3|||
42155095|NCT00065182|75963205|FG001|Overall Study|Protocol Violation|4|||
42155096|NCT00065182|75963204|FG000|Overall Study|Serious adverse events (SAE)|1|||
42155097|NCT00065182|75963205|FG001|Overall Study|Serious adverse events (SAE)|0|||
42155098|NCT00065182|75963204|FG000|Overall Study|Sponsor Decision|11|||
42155099|NCT00065182|75963205|FG001|Overall Study|Sponsor Decision|7|||
42155100|NCT00065182|75963204|FG000|Overall Study|Withdrawal by Subject|8|||
42155101|NCT00065182|75963205|FG001|Overall Study|Withdrawal by Subject|3|||
42155102|NCT00065182|75963204|FG000|Overall Study|No clinical benefit|1|||
42155103|NCT00065182|75963205|FG001|Overall Study|No clinical benefit|0|||
42155104|NCT00065182|75963204|FG000|Overall Study|Death|0|||
42155105|NCT00065182|75963205|FG001|Overall Study|Death|1|||
42155106|NCT00065182|75963204|FG000|Overall Study|Decline in Status|0|||
42155107|NCT00065182|75963205|FG001|Overall Study|Decline in Status|1|||
42155108|NCT00064792|75963213|FG000|Overall Study|Withdrawal by Subject|2|||
42155109|NCT00064792|75963214|FG001|Overall Study|Withdrawal by Subject|0|||
42155110|NCT00064792|75963213|FG000|Overall Study|Adverse Event|3|||
42155111|NCT00064792|75963214|FG001|Overall Study|Adverse Event|0|||
42155112|NCT00450437|75963222|FG000|Overall Study|Withdrawal by Subject|10|||
42155113|NCT00450437|75963223|FG001|Overall Study|Withdrawal by Subject|2|||
42155114|NCT00450437|75963224|FG002|Overall Study|Withdrawal by Subject|0|||
42155115|NCT00450437|75963225|FG003|Overall Study|Withdrawal by Subject|1|||
42155116|NCT00450437|75963222|FG000|Overall Study|Lost to Follow-up|31|||
42278794|NCT02343458|76110357|FG003|Overall Study|Adverse Event|3|||
42278795|NCT02343458|76110354|FG000|Overall Study|Lack of Efficacy|3|||
42013326|NCT01288976|75820432|FG001|Overall Study|Death|6|||
42013327|NCT01288976|75820433|FG002|Overall Study|Death|4|||
42013328|NCT01288976|75820431|FG000|Overall Study|Data unavailable|22|||
42013329|NCT01288976|75820432|FG001|Overall Study|Data unavailable|9|||
42013330|NCT01288976|75820433|FG002|Overall Study|Data unavailable|7|||
42155117|NCT00450437|75963223|FG001|Overall Study|Lost to Follow-up|12|||
42155118|NCT00450437|75963224|FG002|Overall Study|Lost to Follow-up|19|||
42155119|NCT00450437|75963225|FG003|Overall Study|Lost to Follow-up|9|||
42155120|NCT00450437|75963222|FG000|Overall Study|Protocol Violation|0|||
42155121|NCT00450437|75963223|FG001|Overall Study|Protocol Violation|1|||
42155122|NCT00450437|75963224|FG002|Overall Study|Protocol Violation|0|||
42155123|NCT00450437|75963225|FG003|Overall Study|Protocol Violation|1|||
42155124|NCT00450437|75963222|FG000|Overall Study|Inappropriate enrollment|4|||
42155125|NCT00450437|75963223|FG001|Overall Study|Inappropriate enrollment|1|||
42155126|NCT00450437|75963224|FG002|Overall Study|Inappropriate enrollment|3|||
42155127|NCT00450437|75963225|FG003|Overall Study|Inappropriate enrollment|0|||
42155128|NCT00450437|75963222|FG000|Overall Study|Administrative reason|0|||
42155129|NCT00450437|75963223|FG001|Overall Study|Administrative reason|0|||
42155130|NCT00450437|75963224|FG002|Overall Study|Administrative reason|1|||
42155131|NCT00450437|75963225|FG003|Overall Study|Administrative reason|0|||
42155132|NCT00450437|75963222|FG000|Overall Study|Unable to Classify|1|||
42155133|NCT00450437|75963223|FG001|Overall Study|Unable to Classify|0|||
42155134|NCT00450437|75963224|FG002|Overall Study|Unable to Classify|1|||
42155135|NCT00450437|75963225|FG003|Overall Study|Unable to Classify|0|||
42155136|NCT00286442|75963242|FG000|Overall Study|Hyperglycemic Rescue|19|||
42278796|NCT02343458|76110355|FG001|Overall Study|Lack of Efficacy|8|||
42278797|NCT02343458|76110356|FG002|Overall Study|Lack of Efficacy|4|||
42278798|NCT02343458|76110357|FG003|Overall Study|Lack of Efficacy|8|||
42278799|NCT02343458|76110354|FG000|Overall Study|Withdrawal by Subject|18|||
42278800|NCT02343458|76110355|FG001|Overall Study|Withdrawal by Subject|17|||
42278801|NCT02343458|76110356|FG002|Overall Study|Withdrawal by Subject|23|||
42278802|NCT02343458|76110357|FG003|Overall Study|Withdrawal by Subject|14|||
42278803|NCT02343458|76110354|FG000|Overall Study|Physician Decision|1|||
42278804|NCT02343458|76110355|FG001|Overall Study|Physician Decision|4|||
42155137|NCT00286442|75963243|FG001|Overall Study|Hyperglycemic Rescue|17|||
42155138|NCT00286442|75963244|FG002|Overall Study|Hyperglycemic Rescue|25|||
42155139|NCT00286442|75963242|FG000|Overall Study|Adverse Event|7|||
42155140|NCT00286442|75963243|FG001|Overall Study|Adverse Event|6|||
42155141|NCT00286442|75963244|FG002|Overall Study|Adverse Event|1|||
42155142|NCT00286442|75963242|FG000|Overall Study|Protocol Violation|2|||
42155143|NCT00286442|75963243|FG001|Overall Study|Protocol Violation|4|||
42155144|NCT00286442|75963244|FG002|Overall Study|Protocol Violation|2|||
42155145|NCT00286442|75963242|FG000|Overall Study|Lost to Follow-up|5|||
42155146|NCT00286442|75963243|FG001|Overall Study|Lost to Follow-up|2|||
42155147|NCT00286442|75963244|FG002|Overall Study|Lost to Follow-up|1|||
42155148|NCT00286442|75963242|FG000|Overall Study|Physician Decision|1|||
42155149|NCT00286442|75963243|FG001|Overall Study|Physician Decision|1|||
42155150|NCT00286442|75963244|FG002|Overall Study|Physician Decision|1|||
42155151|NCT00286442|75963242|FG000|Overall Study|Administrative Error|1|||
42155152|NCT00286442|75963243|FG001|Overall Study|Administrative Error|1|||
42155153|NCT00286442|75963244|FG002|Overall Study|Administrative Error|0|||
42155154|NCT00286442|75963242|FG000|Overall Study|Withdrawal by Subject|2|||
42278805|NCT02343458|76110356|FG002|Overall Study|Physician Decision|2|||
42278806|NCT02343458|76110357|FG003|Overall Study|Physician Decision|2|||
42155155|NCT00286442|75963243|FG001|Overall Study|Withdrawal by Subject|14|||
42155156|NCT00286442|75963244|FG002|Overall Study|Withdrawal by Subject|2|||
42155157|NCT00063934|75963252|FG000|Overall Study|Ineligible|1|||
42155158|NCT00458783|75963258|FG000|Overall Study|Protocol Violation|1228|||
42155159|NCT00458783|75963259|FG001|Overall Study|Protocol Violation|1220|||
42155160|NCT00063154|75963265|FG000|Overall Study|Disease progression|27|||
42155161|NCT00063154|75963265|FG000|Overall Study|Adverse Event|2|||
42155162|NCT00063154|75963265|FG000|Overall Study|Physician Decision|10|||
42155163|NCT00063154|75963265|FG000|Overall Study|Death|3|||
42155164|NCT00063154|75963265|FG000|Overall Study|Reason unspecified|1|||
42155165|NCT00063154|75963265|FG000|Overall Study|Did not receive treatment|8|||
42155166|NCT00311168|75963271|FG000|First Intervention|Withdrawal by Subject|2|||
42155167|NCT00311168|75963272|FG001|First Intervention|Withdrawal by Subject|2|||
42155168|NCT00311168|75963271|FG000|First Intervention|Lost to Follow-up|1|||
42155169|NCT00311168|75963272|FG001|First Intervention|Lost to Follow-up|1|||
42155170|NCT00311168|75963271|FG000|First Intervention|Protocol Violation|1|||
42155171|NCT00311168|75963272|FG001|First Intervention|Protocol Violation|1|||
42155172|NCT00311168|75963271|FG000|First Intervention|Adverse Event|1|||
42155173|NCT00311168|75963272|FG001|First Intervention|Adverse Event|0|||
42155174|NCT00311168|75963271|FG000|First Intervention|Other|2|||
42155175|NCT00311168|75963272|FG001|First Intervention|Other|2|||
42155176|NCT00311168|75963271|FG000|Second Intervention|Lost to Follow-up|9|||
42155177|NCT00311168|75963272|FG001|Second Intervention|Lost to Follow-up|2|||
42155178|NCT00311168|75963271|FG000|Second Intervention|Withdrawal by Subject|0|||
42278807|NCT02343458|76110354|FG000|Overall Study|Lost to Follow-up|5|||
42278808|NCT02343458|76110355|FG001|Overall Study|Lost to Follow-up|5|||
42278809|NCT02343458|76110356|FG002|Overall Study|Lost to Follow-up|3|||
42278810|NCT02343458|76110357|FG003|Overall Study|Lost to Follow-up|1|||
42278811|NCT02343458|76110354|FG000|Overall Study|Protocol Violation|2|||
42278812|NCT02343458|76110355|FG001|Overall Study|Protocol Violation|5|||
42155179|NCT00311168|75963272|FG001|Second Intervention|Withdrawal by Subject|1|||
42155180|NCT00311168|75963271|FG000|Second Intervention|Other|1|||
42155181|NCT00311168|75963272|FG001|Second Intervention|Other|1|||
42278813|NCT02343458|76110356|FG002|Overall Study|Protocol Violation|2|||
42278814|NCT02343458|76110357|FG003|Overall Study|Protocol Violation|2|||
42278815|NCT02343458|76110354|FG000|Overall Study|Protocol Specified Criteria|17|||
42155182|NCT00458705|75963280|FG000|Overall Study|Adverse Event|4|||
42155183|NCT00458705|75963280|FG000|Overall Study|Not Treated|1|||
42278816|NCT02343458|76110355|FG001|Overall Study|Protocol Specified Criteria|13|||
42155184|NCT00062374|75963284|FG000|Overall Study|Not treated|12|||
42155185|NCT00285818|75963290|FG000|Overall Study|Withdrawal by Subject|3|||
42155186|NCT00285818|75963291|FG001|Overall Study|Withdrawal by Subject|2|||
42155187|NCT00285818|75963290|FG000|Overall Study|Lost to Follow-up|1|||
42155188|NCT00285818|75963291|FG001|Overall Study|Lost to Follow-up|0|||
42155189|NCT04761627|75963395|FG000|Run-in Period|Death|1|||
42155190|NCT04761627|75963396|FG001|Run-in Period|Death|0|||
42278817|NCT02343458|76110356|FG002|Overall Study|Protocol Specified Criteria|14|||
42155191|NCT04761627|75963397|FG002|Run-in Period|Death|0|||
42155192|NCT04761627|75963395|FG000|Run-in Period|Required alternative therapy|2|||
42155193|NCT04761627|75963396|FG001|Run-in Period|Required alternative therapy|0|||
42155194|NCT04761627|75963397|FG002|Run-in Period|Required alternative therapy|0|||
42155195|NCT04761627|75963395|FG000|Run-in Period|Lost to Follow-up|2|||
42155196|NCT04761627|75963396|FG001|Run-in Period|Lost to Follow-up|0|||
42155197|NCT04761627|75963397|FG002|Run-in Period|Lost to Follow-up|0|||
42155198|NCT04761627|75963395|FG000|Run-in Period|Protocol Violation|3|||
42155199|NCT04761627|75963396|FG001|Run-in Period|Protocol Violation|0|||
42155200|NCT04761627|75963397|FG002|Run-in Period|Protocol Violation|0|||
42155201|NCT04761627|75963395|FG000|Run-in Period|Abnormal liver function|1|||
42155202|NCT04761627|75963396|FG001|Run-in Period|Abnormal liver function|0|||
42155203|NCT04761627|75963397|FG002|Run-in Period|Abnormal liver function|0|||
42155204|NCT04761627|75963395|FG000|Run-in Period|Adverse Event|6|||
42155205|NCT04761627|75963396|FG001|Run-in Period|Adverse Event|0|||
42155206|NCT04761627|75963397|FG002|Run-in Period|Adverse Event|0|||
42155207|NCT04761627|75963395|FG000|Run-in Period|Withdrawal by Subject|7|||
42155208|NCT04761627|75963396|FG001|Run-in Period|Withdrawal by Subject|0|||
42155209|NCT04761627|75963397|FG002|Run-in Period|Withdrawal by Subject|0|||
42155210|NCT04761627|75963395|FG000|Run-in Period|Did not meet PASI 50|15|||
42155211|NCT04761627|75963396|FG001|Run-in Period|Did not meet PASI 50|0|||
42155212|NCT04761627|75963397|FG002|Run-in Period|Did not meet PASI 50|0|||
42155213|NCT04761627|75963395|FG000|Run-in Period|Study site closure|2|||
42155214|NCT04761627|75963396|FG001|Run-in Period|Study site closure|0|||
42155215|NCT04761627|75963397|FG002|Run-in Period|Study site closure|0|||
42155216|NCT04761627|75963395|FG000|Run-in Period|Pregnancy|2|||
42155217|NCT04761627|75963396|FG001|Run-in Period|Pregnancy|0|||
42155218|NCT04761627|75963397|FG002|Run-in Period|Pregnancy|0|||
42155219|NCT04761627|75963395|FG000|Post-randomization Period|Military service|0|||
42155220|NCT04761627|75963396|FG001|Post-randomization Period|Military service|1|||
42155221|NCT04761627|75963397|FG002|Post-randomization Period|Military service|0|||
42155222|NCT04761627|75963395|FG000|Post-randomization Period|Adverse Event|0|||
42155223|NCT04761627|75963396|FG001|Post-randomization Period|Adverse Event|4|||
42155224|NCT04761627|75963397|FG002|Post-randomization Period|Adverse Event|2|||
42155225|NCT04761627|75963395|FG000|Post-randomization Period|Lost to Follow-up|0|||
42155226|NCT04761627|75963396|FG001|Post-randomization Period|Lost to Follow-up|6|||
42155227|NCT04761627|75963397|FG002|Post-randomization Period|Lost to Follow-up|6|||
42155228|NCT04761627|75963395|FG000|Post-randomization Period|Withdrawal by Subject|0|||
42155229|NCT04761627|75963396|FG001|Post-randomization Period|Withdrawal by Subject|7|||
42155230|NCT04761627|75963397|FG002|Post-randomization Period|Withdrawal by Subject|6|||
42155231|NCT04761627|75963395|FG000|Post-randomization Period|Pregnancy|0|||
42155232|NCT04761627|75963396|FG001|Post-randomization Period|Pregnancy|0|||
42155233|NCT04761627|75963397|FG002|Post-randomization Period|Pregnancy|1|||
42155234|NCT04761627|75963395|FG000|Post-randomization Period|Study site closure|0|||
42155235|NCT04761627|75963396|FG001|Post-randomization Period|Study site closure|0|||
42155236|NCT04761627|75963397|FG002|Post-randomization Period|Study site closure|1|||
42155237|NCT04761627|75963395|FG000|Post-randomization Period|Family planning|0|||
42155238|NCT04761627|75963396|FG001|Post-randomization Period|Family planning|1|||
42155239|NCT04761627|75963397|FG002|Post-randomization Period|Family planning|0|||
42155240|NCT04621786|75963414|FG000|Overall Study|Lost to Follow-up|9|||
42155241|NCT04621786|75963414|FG000|Overall Study|Protocol Violation|3|||
42155242|NCT04533438|75963420|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
42155243|NCT04533438|75963421|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
42155244|NCT04025710|75963442|FG000|Overall Study|Death|3|||
42155245|NCT04025710|75963442|FG000|Overall Study|Lost to Follow-up|5|||
42155246|NCT04025710|75963442|FG000|Overall Study|Withdrawal by Subject|1|||
42155247|NCT04025710|75963442|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
42155248|NCT04025710|75963442|FG000|Overall Study|Drop-out according to protocol|34|||
42155249|NCT03474107|75963521|FG000|Overall Study|Adverse Event|42|||
42155250|NCT03474107|75963522|FG001|Overall Study|Adverse Event|46|||
42155251|NCT03474107|75963521|FG000|Overall Study|Death|2|||
42155252|NCT03474107|75963522|FG001|Overall Study|Death|2|||
42155253|NCT03474107|75963521|FG000|Overall Study|Lost to Follow-up|0|||
42155254|NCT03474107|75963522|FG001|Overall Study|Lost to Follow-up|1|||
42155255|NCT03474107|75963521|FG000|Overall Study|Progressive Disease|177|||
42278818|NCT02343458|76110357|FG003|Overall Study|Protocol Specified Criteria|8|||
42278819|NCT01328041|76110380|FG000|Overall Study|Adverse Event|7|||
42155256|NCT03474107|75963522|FG001|Overall Study|Progressive Disease|180|||
42155257|NCT03474107|75963521|FG000|Overall Study|Protocol Violation|1|||
42155258|NCT03474107|75963522|FG001|Overall Study|Protocol Violation|1|||
42155259|NCT03474107|75963521|FG000|Overall Study|Withdrawal by Subject|15|||
42155260|NCT03474107|75963522|FG001|Overall Study|Withdrawal by Subject|27|||
42155261|NCT03474107|75963521|FG000|Overall Study|Physician Decision|7|||
42155262|NCT03474107|75963522|FG001|Overall Study|Physician Decision|22|||
42155263|NCT03474107|75963521|FG000|Overall Study|Miscellaneous|1|||
42155264|NCT03474107|75963522|FG001|Overall Study|Miscellaneous|6|||
42278820|NCT01328041|76110380|FG000|Overall Study|Lack of Efficacy|27|||
42155265|NCT03147287|75963531|FG000|Overall Study|Randomized Not Treated|2|||
42155266|NCT03147287|75963532|FG001|Overall Study|Randomized Not Treated|1|||
42155267|NCT03147287|75963533|FG002|Overall Study|Randomized Not Treated|1|||
42155268|NCT03147287|75963531|FG000|Overall Study|Progressive Disease RECIST|31|||
42155269|NCT03147287|75963532|FG001|Overall Study|Progressive Disease RECIST|72|||
42155270|NCT03147287|75963533|FG002|Overall Study|Progressive Disease RECIST|32|||
42155271|NCT03147287|75963531|FG000|Overall Study|Progressive Disease not RECIST|13|||
42155272|NCT03147287|75963532|FG001|Overall Study|Progressive Disease not RECIST|21|||
42155273|NCT03147287|75963533|FG002|Overall Study|Progressive Disease not RECIST|13|||
42155274|NCT03147287|75963531|FG000|Overall Study|Physician Decision|1|||
42155275|NCT03147287|75963532|FG001|Overall Study|Physician Decision|2|||
42155276|NCT03147287|75963533|FG002|Overall Study|Physician Decision|1|||
42155277|NCT03147287|75963531|FG000|Overall Study|Intercurrent illness|0|||
42155278|NCT03147287|75963532|FG001|Overall Study|Intercurrent illness|1|||
42155279|NCT03147287|75963533|FG002|Overall Study|Intercurrent illness|0|||
42155280|NCT03147287|75963531|FG000|Overall Study|Withdrawal by Subject|2|||
42155281|NCT03147287|75963532|FG001|Overall Study|Withdrawal by Subject|3|||
42155282|NCT03147287|75963533|FG002|Overall Study|Withdrawal by Subject|2|||
42155283|NCT03147287|75963531|FG000|Overall Study|Patient Non-Compliance|0|||
42155284|NCT03147287|75963532|FG001|Overall Study|Patient Non-Compliance|2|||
42155285|NCT03147287|75963533|FG002|Overall Study|Patient Non-Compliance|0|||
42155286|NCT03147287|75963531|FG000|Overall Study|Patient moved|0|||
42155287|NCT03147287|75963532|FG001|Overall Study|Patient moved|1|||
42155288|NCT03147287|75963533|FG002|Overall Study|Patient moved|0|||
42155289|NCT03147287|75963531|FG000|Overall Study|Arm A crossover without PD|1|||
42155290|NCT03147287|75963532|FG001|Overall Study|Arm A crossover without PD|0|||
42155291|NCT03147287|75963533|FG002|Overall Study|Arm A crossover without PD|0|||
42155292|NCT03147287|75963531|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
42155293|NCT03147287|75963532|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
42155294|NCT03147287|75963533|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
42155295|NCT02865135|75963544|FG000|Overall Study|Death|0|||
42155296|NCT02865135|75963545|FG001|Overall Study|Death|1|||
42155297|NCT02865135|75963546|FG002|Overall Study|Death|0|||
42155298|NCT02865135|75963544|FG000|Overall Study|Progression|6|||
42155299|NCT02865135|75963545|FG001|Overall Study|Progression|2|||
42155300|NCT02865135|75963546|FG002|Overall Study|Progression|2|||
42155301|NCT02709720|75963564|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
42155302|NCT02709720|75963564|FG000|Overall Study|Protocol Violation|1|||
42155303|NCT02709720|75963564|FG000|Overall Study|Not take study medication|1|||
42155304|NCT02652260|75963570|FG000|Overall Study|Pregnancy|0|||
42155305|NCT02652260|75963571|FG001|Overall Study|Pregnancy|1|||
42155306|NCT02652260|75963570|FG000|Overall Study|Withdrawal by Subject|0|||
42155307|NCT02652260|75963571|FG001|Overall Study|Withdrawal by Subject|1|||
42155308|NCT02364557|75963599|FG000|Overall Study|Protocol Violation|3|||
42155309|NCT02364557|75963600|FG001|Overall Study|Protocol Violation|1|||
42155310|NCT01774487|75963615|FG000|Overall Study|Did not tolerate taste|4|||
42155311|NCT01774487|75963616|FG001|Overall Study|Did not tolerate taste|4|||
42155312|NCT00905645|75963654|FG000|Overall Study|Death (not device related)|10|||
42155313|NCT00905645|75963655|FG001|Overall Study|Death (not device related)|4|||
42155314|NCT00905645|75963656|FG002|Overall Study|Death (not device related)|15|||
42155315|NCT00905645|75963657|FG003|Overall Study|Death (not device related)|8|||
42155316|NCT00905645|75963654|FG000|Overall Study|Explantation of study device(s)|78|||
42155317|NCT00905645|75963655|FG001|Overall Study|Explantation of study device(s)|47|||
42155318|NCT00905645|75963656|FG002|Overall Study|Explantation of study device(s)|28|||
42155319|NCT00905645|75963657|FG003|Overall Study|Explantation of study device(s)|21|||
42155320|NCT00905645|75963654|FG000|Overall Study|Subject Request|41|||
42278821|NCT01328041|76110380|FG000|Overall Study|Protocol Violation|7|||
42278822|NCT01328041|76110380|FG000|Overall Study|Lost to Follow-up|7|||
42155321|NCT00905645|75963655|FG001|Overall Study|Subject Request|17|||
42155322|NCT00905645|75963656|FG002|Overall Study|Subject Request|13|||
42155323|NCT00905645|75963657|FG003|Overall Study|Subject Request|11|||
42278823|NCT01328041|76110380|FG000|Overall Study|Physician Decision|2|||
42278824|NCT01328041|76110380|FG000|Overall Study|Withdrawal by Subject|7|||
42278825|NCT02410772|76110387|FG000|Overall Study|Death|3|||
42278826|NCT02410772|76110388|FG001|Overall Study|Death|4|||
42155324|NCT00905645|75963654|FG000|Overall Study|Lost to Follow-up|299|||
42155325|NCT00905645|75963655|FG001|Overall Study|Lost to Follow-up|103|||
42155326|NCT00905645|75963656|FG002|Overall Study|Lost to Follow-up|51|||
42155327|NCT00905645|75963657|FG003|Overall Study|Lost to Follow-up|12|||
42155328|NCT00285584|75963669|FG000|Month 3|Lost to Follow-up|3|||
42155329|NCT00285584|75963670|FG001|Month 3|Lost to Follow-up|3|||
42155330|NCT00285584|75963669|FG000|Month 3|Withdrawal by Subject|1|||
42155331|NCT00285584|75963670|FG001|Month 3|Withdrawal by Subject|0|||
42155332|NCT00285584|75963669|FG000|Month 6|Lost to Follow-up|0|||
42155333|NCT00285584|75963670|FG001|Month 6|Lost to Follow-up|1|||
42278827|NCT02410772|76110389|FG002|Overall Study|Death|8|||
42155334|NCT03807700|75963682|FG000|Overall Study|Withdrawal by Subject|2|||
42155335|NCT03807700|75963683|FG001|Overall Study|Withdrawal by Subject|1|||
42155336|NCT00291668|75963693|FG000|Overall Study|Lack of Efficacy|1|||
42155337|NCT00291668|75963694|FG001|Overall Study|Lack of Efficacy|0|||
42155338|NCT00291668|75963695|FG002|Overall Study|Lack of Efficacy|0|||
42155339|NCT00291668|75963693|FG000|Overall Study|SAE, non-fatal|1|||
42155340|NCT00291668|75963694|FG001|Overall Study|SAE, non-fatal|1|||
42155341|NCT00291668|75963695|FG002|Overall Study|SAE, non-fatal|1|||
42155342|NCT00291668|75963693|FG000|Overall Study|AE, non-serious non-fatal|1|||
42155343|NCT00291668|75963694|FG001|Overall Study|AE, non-serious non-fatal|0|||
42155344|NCT00291668|75963695|FG002|Overall Study|AE, non-serious non-fatal|0|||
42155345|NCT00291668|75963693|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
42155346|NCT00291668|75963694|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
42155347|NCT00291668|75963695|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
42155348|NCT00458393|75963705|FG000|Overall Study|Withdrawal by Subject|67|||
42155349|NCT00458393|75963706|FG001|Overall Study|Withdrawal by Subject|80|||
42155350|NCT00458393|75963705|FG000|Overall Study|Physician Decision|31|||
42155351|NCT00458393|75963706|FG001|Overall Study|Physician Decision|22|||
42155352|NCT00458393|75963705|FG000|Overall Study|Relocated|77|||
42155353|NCT00458393|75963706|FG001|Overall Study|Relocated|81|||
42155354|NCT00458393|75963705|FG000|Overall Study|Lost to Follow-up|115|||
42155355|NCT00458393|75963706|FG001|Overall Study|Lost to Follow-up|92|||
42155356|NCT00458393|75963705|FG000|Overall Study|Sites marked other on the form.|19|||
42155357|NCT00458393|75963706|FG001|Overall Study|Sites marked other on the form.|20|||
42155358|NCT00310856|75963717|FG000|Overall Study|Withdrawal by Subject|2|||
42155359|NCT00310856|75963718|FG001|Overall Study|Withdrawal by Subject|2|||
42155360|NCT00310856|75963719|FG002|Overall Study|Withdrawal by Subject|2|||
42155361|NCT00310856|75963717|FG000|Overall Study|Lost to Follow-up|1|||
42155362|NCT00310856|75963718|FG001|Overall Study|Lost to Follow-up|2|||
42155363|NCT00310856|75963719|FG002|Overall Study|Lost to Follow-up|6|||
42155364|NCT00310856|75963717|FG000|Overall Study|Inappropriate enrollment|1|||
42155365|NCT00310856|75963718|FG001|Overall Study|Inappropriate enrollment|1|||
42155366|NCT00310856|75963719|FG002|Overall Study|Inappropriate enrollment|0|||
42155367|NCT00310856|75963717|FG000|Overall Study|Unable to classify|1|||
42155368|NCT00310856|75963718|FG001|Overall Study|Unable to classify|0|||
42155369|NCT00310856|75963719|FG002|Overall Study|Unable to classify|0|||
42155370|NCT00283712|75963730|FG000|Overall Study|Death|0|||
42155371|NCT00283712|75963731|FG001|Overall Study|Death|1|||
42155372|NCT00048724|75963739|FG000|Overall Study|Adverse Event|53|||
42155373|NCT00048724|75963740|FG001|Overall Study|Adverse Event|12|||
42155374|NCT00048724|75963739|FG000|Overall Study|Withdrawal by Subject|34|||
42155375|NCT00048724|75963740|FG001|Overall Study|Withdrawal by Subject|54|||
42155376|NCT00048724|75963739|FG000|Overall Study|Lost to Follow-up|5|||
42155377|NCT00048724|75963740|FG001|Overall Study|Lost to Follow-up|5|||
42155378|NCT00048724|75963739|FG000|Overall Study|Protocol-defined Clinical Event|17|||
42155379|NCT00048724|75963740|FG001|Overall Study|Protocol-defined Clinical Event|32|||
42155380|NCT00048724|75963739|FG000|Overall Study|Noncompliance With Protocol|4|||
42155381|NCT00048724|75963740|FG001|Overall Study|Noncompliance With Protocol|12|||
42155382|NCT00048724|75963739|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
42155383|NCT00048724|75963740|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
42155384|NCT00048724|75963739|FG000|Overall Study|Administrative|1|||
42155385|NCT00048724|75963740|FG001|Overall Study|Administrative|1|||
42155386|NCT00449033|75963748|FG000|Treatment Period|Adverse Event|117|||
42155387|NCT00449033|75963749|FG001|Treatment Period|Adverse Event|83|||
42155388|NCT00449033|75963748|FG000|Treatment Period|Death|21|||
42155389|NCT00449033|75963749|FG001|Treatment Period|Death|12|||
42155390|NCT00449033|75963748|FG000|Treatment Period|Lost to Follow-up|0|||
42155391|NCT00449033|75963749|FG001|Treatment Period|Lost to Follow-up|2|||
42155392|NCT00449033|75963748|FG000|Treatment Period|Physician Decision|4|||
42155393|NCT00449033|75963749|FG001|Treatment Period|Physician Decision|5|||
42155394|NCT00449033|75963748|FG000|Treatment Period|Protocol Violation|8|||
42155395|NCT00449033|75963749|FG001|Treatment Period|Protocol Violation|7|||
42155396|NCT00449033|75963748|FG000|Treatment Period|Disease Progression|231|||
42155397|NCT00449033|75963749|FG001|Treatment Period|Disease Progression|288|||
42155398|NCT00449033|75963748|FG000|Treatment Period|Consent Withdrawn|36|||
42155399|NCT00449033|75963749|FG001|Treatment Period|Consent Withdrawn|20|||
42155400|NCT00449033|75963748|FG000|Treatment Period|Amended Protocol Criteria|22|||
42155401|NCT00449033|75963749|FG001|Treatment Period|Amended Protocol Criteria|18|||
42155402|NCT00449033|75963748|FG000|Treatment Period|Non-compliance|7|||
42155403|NCT00449033|75963749|FG001|Treatment Period|Non-compliance|8|||
42155404|NCT00449033|75963748|FG000|Treatment Period|Second Malignancy|0|||
42155405|NCT00449033|75963749|FG001|Treatment Period|Second Malignancy|1|||
42155406|NCT00449033|75963748|FG000|Treatment Period|Reason Missing|0|||
42155407|NCT00449033|75963749|FG001|Treatment Period|Reason Missing|4|||
42155408|NCT00449033|75963748|FG000|Treatment Period|Treatment Ongoing|6|||
42155409|NCT00449033|75963749|FG001|Treatment Period|Treatment Ongoing|4|||
42155410|NCT00449033|75963748|FG000|Follow-up Period|Death|299|||
42155411|NCT00449033|75963749|FG001|Follow-up Period|Death|311|||
42155412|NCT00449033|75963748|FG000|Follow-up Period|Lost to Follow-up|6|||
42155413|NCT00449033|75963749|FG001|Follow-up Period|Lost to Follow-up|10|||
42155414|NCT00449033|75963748|FG000|Follow-up Period|Reason Missing|120|||
42155415|NCT00449033|75963749|FG001|Follow-up Period|Reason Missing|113|||
42155416|NCT00448019|75963755|FG000|Overall Study|Withdrawal by Subject|3|||
42155417|NCT00448019|75963755|FG000|Overall Study|Disease progression|1|||
42155418|NCT00448019|75963755|FG000|Overall Study|Death|2|||
42155419|NCT00448019|75963755|FG000|Overall Study|Insurance Issues|1|||
42155420|NCT00457691|75963761|FG000|Overall Study|Adverse Event|4|||
42155421|NCT00457691|75963762|FG001|Overall Study|Adverse Event|1|||
42155422|NCT00457691|75963761|FG000|Overall Study|Death|163|||
42155423|NCT00457691|75963762|FG001|Overall Study|Death|148|||
42155424|NCT00457691|75963761|FG000|Overall Study|Protocol Violation|1|||
42155425|NCT00457691|75963762|FG001|Overall Study|Protocol Violation|3|||
42155426|NCT00457691|75963761|FG000|Overall Study|Lost to Follow-up|23|||
42155427|NCT00457691|75963762|FG001|Overall Study|Lost to Follow-up|14|||
42155428|NCT00457691|75963761|FG000|Overall Study|Study terminated by Sponsor|1|||
42155429|NCT00457691|75963762|FG001|Overall Study|Study terminated by Sponsor|1|||
42155430|NCT00457691|75963761|FG000|Overall Study|Subject refused (reason other than AE)|14|||
42155431|NCT00457691|75963762|FG001|Overall Study|Subject refused (reason other than AE)|19|||
42155432|NCT00457691|75963761|FG000|Overall Study|Disease progression, study terminated|180|||
42155433|NCT00457691|75963762|FG001|Overall Study|Disease progression, study terminated|196|||
42155434|NCT00457301|75963770|FG000|Overall Study|Withdrawal by Subject|3|||
42155435|NCT00457301|75963771|FG001|Overall Study|Withdrawal by Subject|3|||
42155436|NCT00457301|75963770|FG000|Overall Study|Censored out of the study|15|||
42155437|NCT00457301|75963771|FG001|Overall Study|Censored out of the study|14|||
42155438|NCT00457301|75963770|FG000|Overall Study|Death|5|||
42155439|NCT00457301|75963771|FG001|Overall Study|Death|7|||
42155440|NCT00456755|75963779|FG000|Overall Study|Lost to Follow-up|2|||
42155441|NCT00456755|75963780|FG001|Overall Study|Lost to Follow-up|1|||
42155442|NCT00447005|75963786|FG000|Overall Study|Adverse Event|1|||
42155443|NCT00447005|75963786|FG000|Overall Study|Lack of Efficacy|11|||
42155444|NCT00446849|75963790|FG000|Acute Phase|Lack of Efficacy|64|||
42155445|NCT00446849|75963790|FG000|Acute Phase|Protocol Violation|10|||
42155446|NCT00446849|75963790|FG000|Acute Phase|Consent withdrawn|4|||
42155447|NCT00446849|75963790|FG000|Acute Phase|Lost to Follow-up|2|||
42155448|NCT00446849|75963790|FG000|Acute Phase|Physician Decision|1|||
42155449|NCT00446849|75963790|FG000|Acute Phase|noncompliance|1|||
42155450|NCT00446849|75963790|FG000|Maintenance Phase|Lack of Efficacy|40|||
42155451|NCT00446849|75963790|FG000|Maintenance Phase|Protocol Violation|7|||
42155452|NCT00446849|75963790|FG000|Maintenance Phase|Adverse Event|6|||
42155453|NCT00446849|75963790|FG000|Maintenance Phase|Consent withdrawn|5|||
42155454|NCT00446849|75963790|FG000|Maintenance Phase|Lost to Follow-up|3|||
42155455|NCT00446849|75963790|FG000|Maintenance Phase|Pregnancy|1|||
42278828|NCT02410772|76110387|FG000|Overall Study|Lost to Follow-up|31|||
42278829|NCT02410772|76110388|FG001|Overall Study|Lost to Follow-up|23|||
42278830|NCT02410772|76110389|FG002|Overall Study|Lost to Follow-up|22|||
42278831|NCT02410772|76110387|FG000|Overall Study|Pregnancy|8|||
42278832|NCT02410772|76110388|FG001|Overall Study|Pregnancy|4|||
42278833|NCT02410772|76110389|FG002|Overall Study|Pregnancy|5|||
42278834|NCT02410772|76110387|FG000|Overall Study|Protocol Violation|8|||
42278835|NCT02410772|76110388|FG001|Overall Study|Protocol Violation|8|||
42278836|NCT02410772|76110389|FG002|Overall Study|Protocol Violation|4|||
42278837|NCT02410772|76110387|FG000|Overall Study|Baseline Drug Resistance|49|||
42278838|NCT02410772|76110388|FG001|Overall Study|Baseline Drug Resistance|40|||
42278839|NCT02410772|76110389|FG002|Overall Study|Baseline Drug Resistance|51|||
42278840|NCT02410772|76110387|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
42278841|NCT02410772|76110388|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
42278842|NCT02410772|76110389|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
42278843|NCT02410772|76110387|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
42278844|NCT02410772|76110388|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
42278845|NCT02410772|76110389|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
42351338|NCT00630838|76191250|FG000|Overall Study|Lost to Follow-up|0|||
42155456|NCT00446849|75963790|FG000|Maintenance Phase|noncompliance|2|||
42155457|NCT00446849|75963790|FG000|Maintenance Phase|prohibited medication use|2|||
42155458|NCT00446849|75963790|FG000|Maintenance Phase|antibiotic use|1|||
42155459|NCT00446849|75963790|FG000|Maintenance Phase|study closure|1|||
42155460|NCT00446849|75963790|FG000|Maintenance Phase|hydrocodone use|1|||
42155461|NCT00446849|75963790|FG000|Maintenance Phase|concomitant medication use|1|||
42155462|NCT00446459|75963795|FG000|8 Months|Protocol Violation|12|||
42155463|NCT00446459|75963795|FG000|12 Months|Protocol Violation|4|||
42155464|NCT00446459|75963795|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
42155465|NCT00456599|75963799|FG000|Overall Study|Non-compliance|1|||
42155466|NCT00456599|75963799|FG000|Overall Study|Withdrawal by Subject|2|||
42155467|NCT00456521|75963805|FG000|Overall Study|Adverse Event|150|||
42155468|NCT00456521|75963806|FG001|Overall Study|Adverse Event|25|||
42155469|NCT00456521|75963805|FG000|Overall Study|Withdrawal by Subject|43|||
42155470|NCT00456521|75963806|FG001|Overall Study|Withdrawal by Subject|24|||
42155471|NCT00456521|75963805|FG000|Overall Study|Lost to Follow-up|22|||
42155472|NCT00456521|75963806|FG001|Overall Study|Lost to Follow-up|17|||
42155473|NCT00456521|75963805|FG000|Overall Study|Lack of Efficacy|3|||
42155474|NCT00456521|75963806|FG001|Overall Study|Lack of Efficacy|6|||
42155475|NCT00456521|75963805|FG000|Overall Study|Protocol Violation|4|||
42155476|NCT00456521|75963806|FG001|Overall Study|Protocol Violation|0|||
42155477|NCT00456521|75963805|FG000|Overall Study|Pregnancy|1|||
42155478|NCT00456521|75963806|FG001|Overall Study|Pregnancy|1|||
42155479|NCT00456521|75963805|FG000|Overall Study|Drug non-compliance, moved, other|26|||
42155480|NCT00456521|75963806|FG001|Overall Study|Drug non-compliance, moved, other|11|||
42155481|NCT00456365|75963815|FG000|Overall Study|Lost to Follow-up|1|||
42155482|NCT00456365|75963816|FG001|Overall Study|Lost to Follow-up|3|||
42155483|NCT00456365|75963815|FG000|Overall Study|Withdrawal by Subject|4|||
42155484|NCT00456365|75963816|FG001|Overall Study|Withdrawal by Subject|7|||
42155485|NCT00456365|75963815|FG000|Overall Study|Pregnancy|1|||
42155486|NCT00456365|75963816|FG001|Overall Study|Pregnancy|1|||
42278846|NCT01648790|76110406|FG000|Treatment 3|Withdrawal by Subject|0|||
42278847|NCT01648790|76110407|FG001|Treatment 3|Withdrawal by Subject|0|||
42351339|NCT00630838|76191251|FG001|Overall Study|Lost to Follow-up|1|||
42278848|NCT01648790|76110408|FG002|Treatment 3|Withdrawal by Subject|0|||
42278849|NCT01648790|76110409|FG003|Treatment 3|Withdrawal by Subject|1|||
42278850|NCT01648790|76110410|FG004|Treatment 3|Withdrawal by Subject|0|||
42155487|NCT00456365|75963815|FG000|Overall Study|oncologic diagnosis|1|||
42155488|NCT00456365|75963816|FG001|Overall Study|oncologic diagnosis|1|||
42155489|NCT00455741|75963826|FG000|Overall Study|Physician Decision|0|||
42155490|NCT00455741|75963827|FG001|Overall Study|Physician Decision|1|||
42155491|NCT00445679|75963847|FG000|Overall Study|Adverse Event|22|||
42155492|NCT00445679|75963848|FG001|Overall Study|Adverse Event|12|||
42155493|NCT00445679|75963849|FG002|Overall Study|Adverse Event|30|||
42155494|NCT00445679|75963850|FG003|Overall Study|Adverse Event|19|||
42155495|NCT00445679|75963847|FG000|Overall Study|Failed to return|1|||
42155496|NCT00445679|75963848|FG001|Overall Study|Failed to return|3|||
42155497|NCT00445679|75963849|FG002|Overall Study|Failed to return|2|||
42155498|NCT00445679|75963850|FG003|Overall Study|Failed to return|2|||
42155499|NCT00445679|75963847|FG000|Overall Study|Physician Decision|0|||
42155500|NCT00445679|75963848|FG001|Overall Study|Physician Decision|0|||
42155501|NCT00445679|75963849|FG002|Overall Study|Physician Decision|1|||
42155502|NCT00445679|75963850|FG003|Overall Study|Physician Decision|0|||
42155503|NCT00445679|75963847|FG000|Overall Study|Lost to Follow-up|10|||
42155504|NCT00445679|75963848|FG001|Overall Study|Lost to Follow-up|6|||
42155505|NCT00445679|75963849|FG002|Overall Study|Lost to Follow-up|6|||
42155506|NCT00445679|75963850|FG003|Overall Study|Lost to Follow-up|5|||
42155507|NCT00445679|75963847|FG000|Overall Study|Compliance|3|||
42155508|NCT00445679|75963848|FG001|Overall Study|Compliance|2|||
42155509|NCT00445679|75963849|FG002|Overall Study|Compliance|1|||
42155510|NCT00445679|75963850|FG003|Overall Study|Compliance|2|||
42155511|NCT00445679|75963847|FG000|Overall Study|Withdrawal of Informed Consent|0|||
42155512|NCT00445679|75963848|FG001|Overall Study|Withdrawal of Informed Consent|0|||
42155513|NCT00445679|75963849|FG002|Overall Study|Withdrawal of Informed Consent|1|||
42155514|NCT00445679|75963850|FG003|Overall Study|Withdrawal of Informed Consent|0|||
42155515|NCT00445679|75963847|FG000|Overall Study|Protocol Violation|2|||
42155516|NCT00445679|75963848|FG001|Overall Study|Protocol Violation|3|||
42155517|NCT00445679|75963849|FG002|Overall Study|Protocol Violation|3|||
42155518|NCT00445679|75963850|FG003|Overall Study|Protocol Violation|1|||
42155519|NCT00445679|75963847|FG000|Overall Study|Withdrawal by Subject|8|||
42155520|NCT00445679|75963848|FG001|Overall Study|Withdrawal by Subject|14|||
42155521|NCT00445679|75963849|FG002|Overall Study|Withdrawal by Subject|20|||
42278851|NCT01936857|76110433|FG000|Overall Study|Sent to prison or 06 center|11|||
42278852|NCT01936857|76110434|FG001|Overall Study|Sent to prison or 06 center|12|||
42155522|NCT00445679|75963850|FG003|Overall Study|Withdrawal by Subject|18|||
42155523|NCT00445679|75963847|FG000|Overall Study|Lack of Efficacy|2|||
42155524|NCT00445679|75963848|FG001|Overall Study|Lack of Efficacy|6|||
42155525|NCT00445679|75963849|FG002|Overall Study|Lack of Efficacy|2|||
42155526|NCT00445679|75963850|FG003|Overall Study|Lack of Efficacy|0|||
42155527|NCT00455429|75963864|FG000|Overall Study|Study Terminated by Sponsor|0|||
42155528|NCT00455429|75963865|FG001|Overall Study|Study Terminated by Sponsor|0|||
42155529|NCT00455429|75963866|FG002|Overall Study|Study Terminated by Sponsor|0|||
42155530|NCT00455429|75963867|FG003|Overall Study|Study Terminated by Sponsor|3|||
42155531|NCT00455429|75963864|FG000|Overall Study|Lost to Follow-up|1|||
42155532|NCT00455429|75963865|FG001|Overall Study|Lost to Follow-up|0|||
42155533|NCT00455429|75963866|FG002|Overall Study|Lost to Follow-up|0|||
42155534|NCT00455429|75963867|FG003|Overall Study|Lost to Follow-up|3|||
42155535|NCT00455429|75963864|FG000|Overall Study|Withdrawal by Subject|0|||
42155536|NCT00455429|75963865|FG001|Overall Study|Withdrawal by Subject|1|||
42155537|NCT00455429|75963866|FG002|Overall Study|Withdrawal by Subject|1|||
42155538|NCT00455429|75963867|FG003|Overall Study|Withdrawal by Subject|0|||
42155539|NCT00455429|75963864|FG000|Overall Study|Lack of Efficacy|0|||
42155540|NCT00455429|75963865|FG001|Overall Study|Lack of Efficacy|1|||
42155541|NCT00455429|75963866|FG002|Overall Study|Lack of Efficacy|0|||
42155542|NCT00455429|75963867|FG003|Overall Study|Lack of Efficacy|1|||
42155543|NCT00455429|75963864|FG000|Overall Study|Adverse Event|0|||
42155544|NCT00455429|75963865|FG001|Overall Study|Adverse Event|1|||
42155545|NCT00455429|75963866|FG002|Overall Study|Adverse Event|0|||
42155546|NCT00455429|75963867|FG003|Overall Study|Adverse Event|3|||
42155547|NCT00455429|75963864|FG000|Overall Study|Randomly assigned but not treated|0|||
42155548|NCT00455429|75963865|FG001|Overall Study|Randomly assigned but not treated|0|||
42155549|NCT00455429|75963866|FG002|Overall Study|Randomly assigned but not treated|0|||
42155550|NCT00455429|75963867|FG003|Overall Study|Randomly assigned but not treated|2|||
42155551|NCT00455429|75963864|FG000|Overall Study|Personal Reason|1|||
42155552|NCT00455429|75963865|FG001|Overall Study|Personal Reason|0|||
42155553|NCT00455429|75963866|FG002|Overall Study|Personal Reason|0|||
42155554|NCT00455429|75963867|FG003|Overall Study|Personal Reason|0|||
42155555|NCT00455429|75963864|FG000|Overall Study|Non-compliance|0|||
42155556|NCT00455429|75963865|FG001|Overall Study|Non-compliance|0|||
42155557|NCT00455429|75963866|FG002|Overall Study|Non-compliance|0|||
42155558|NCT00455429|75963867|FG003|Overall Study|Non-compliance|1|||
42278853|NCT01936857|76110433|FG000|Overall Study|Lost to Follow-up|10|||
42040211|NCT01928394|75848583|FG017|Treatment Period|Participant request to stop therapy|3|||
42155559|NCT00455429|75963864|FG000|Overall Study|Other|0|||
42155560|NCT00455429|75963865|FG001|Overall Study|Other|2|||
42155561|NCT00455429|75963866|FG002|Overall Study|Other|0|||
42155562|NCT00455429|75963867|FG003|Overall Study|Other|1|||
42155563|NCT00445601|75963882|FG000|Overall Study|Withdrawal by Subject|11|||
42155564|NCT00445601|75963883|FG001|Overall Study|Withdrawal by Subject|11|||
42155565|NCT00445601|75963882|FG000|Overall Study|TURBT Complication|12|||
42155566|NCT00445601|75963883|FG001|Overall Study|TURBT Complication|8|||
42155567|NCT00445601|75963882|FG000|Overall Study|Incorrect Disease Status|6|||
42155568|NCT00445601|75963883|FG001|Overall Study|Incorrect Disease Status|6|||
42155569|NCT00445601|75963882|FG000|Overall Study|Drug Delivery Issue|2|||
42155570|NCT00445601|75963883|FG001|Overall Study|Drug Delivery Issue|2|||
42155571|NCT00445601|75963882|FG000|Overall Study|Adverse Event|2|||
42155572|NCT00445601|75963883|FG001|Overall Study|Adverse Event|0|||
42155573|NCT00445601|75963882|FG000|Overall Study|Death prior to TURBT|0|||
42155574|NCT00445601|75963883|FG001|Overall Study|Death prior to TURBT|1|||
42155575|NCT00444587|75963895|FG000|Overall Study|Death|2|||
42155576|NCT00444587|75963896|FG001|Overall Study|Death|1|||
42155577|NCT00444587|75963895|FG000|Overall Study|Progression of the disease|73|||
42155578|NCT00444587|75963896|FG001|Overall Study|Progression of the disease|8|||
42155579|NCT00444587|75963895|FG000|Overall Study|Refused treatment/did not cooperate|4|||
42155580|NCT00444587|75963896|FG001|Overall Study|Refused treatment/did not cooperate|1|||
42155581|NCT00444587|75963895|FG000|Overall Study|Investigator decision|3|||
42155582|NCT00444587|75963896|FG001|Overall Study|Investigator decision|0|||
42155583|NCT00444587|75963895|FG000|Overall Study|Protocol Violation|1|||
42155584|NCT00444587|75963896|FG001|Overall Study|Protocol Violation|0|||
42155585|NCT00444587|75963895|FG000|Overall Study|Missing|0|||
42155586|NCT00444587|75963896|FG001|Overall Study|Missing|5|||
42155587|NCT00455195|75963906|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
42155588|NCT00455195|75963907|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
42155589|NCT00455195|75963906|FG000|Double-blind Study AGLU02704|Death|1|||
42155590|NCT00455195|75963907|FG001|Double-blind Study AGLU02704|Death|0|||
42155591|NCT00455195|75963906|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
42155592|NCT00455195|75963907|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
42155593|NCT00455195|75963906|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
42155594|NCT00455195|75963907|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
42155595|NCT00235716|75963917|FG000|Overall Study|Death|26|||
42155596|NCT00235716|75963918|FG001|Overall Study|Death|39|||
42155597|NCT00235716|75963919|FG002|Overall Study|Death|32|||
42155598|NCT00235716|75963920|FG003|Overall Study|Death|31|||
42155599|NCT00235716|75963917|FG000|Overall Study|Withdrawal by Subject|23|||
42155600|NCT00235716|75963918|FG001|Overall Study|Withdrawal by Subject|19|||
42155601|NCT00235716|75963919|FG002|Overall Study|Withdrawal by Subject|17|||
42155602|NCT00235716|75963920|FG003|Overall Study|Withdrawal by Subject|18|||
42155603|NCT00235716|75963917|FG000|Overall Study|Lost to Follow-up|12|||
42155604|NCT00235716|75963918|FG001|Overall Study|Lost to Follow-up|7|||
42155605|NCT00235716|75963919|FG002|Overall Study|Lost to Follow-up|14|||
42155606|NCT00235716|75963920|FG003|Overall Study|Lost to Follow-up|10|||
42155607|NCT00235716|75963917|FG000|Overall Study|Adverse Event|1|||
42155608|NCT00235716|75963918|FG001|Overall Study|Adverse Event|1|||
42155609|NCT00235716|75963919|FG002|Overall Study|Adverse Event|1|||
42155610|NCT00235716|75963920|FG003|Overall Study|Adverse Event|0|||
42155611|NCT00235716|75963917|FG000|Overall Study|Physician Decision|0|||
42155612|NCT00235716|75963918|FG001|Overall Study|Physician Decision|1|||
42155613|NCT00235716|75963919|FG002|Overall Study|Physician Decision|1|||
42155614|NCT00235716|75963920|FG003|Overall Study|Physician Decision|3|||
42155615|NCT00274742|75963936|FG000|Overall Study|Adverse Event|0|||
42155616|NCT00274742|75963937|FG001|Overall Study|Adverse Event|4|||
42155617|NCT00274742|75963938|FG002|Overall Study|Adverse Event|1|||
42155618|NCT00274742|75963939|FG003|Overall Study|Adverse Event|4|||
42155619|NCT00274742|75963940|FG004|Overall Study|Adverse Event|12|||
42155620|NCT00274742|75963941|FG005|Overall Study|Adverse Event|3|||
42155621|NCT00274742|75963936|FG000|Overall Study|Lost to Follow-up|0|||
42155622|NCT00274742|75963937|FG001|Overall Study|Lost to Follow-up|0|||
42155623|NCT00274742|75963938|FG002|Overall Study|Lost to Follow-up|0|||
42155624|NCT00274742|75963939|FG003|Overall Study|Lost to Follow-up|0|||
42155625|NCT00274742|75963940|FG004|Overall Study|Lost to Follow-up|1|||
42155626|NCT00274742|75963941|FG005|Overall Study|Lost to Follow-up|0|||
42155627|NCT00274742|75963936|FG000|Overall Study|End of Study|0|||
42155628|NCT00274742|75963937|FG001|Overall Study|End of Study|0|||
42155629|NCT00274742|75963938|FG002|Overall Study|End of Study|0|||
42155630|NCT00274742|75963939|FG003|Overall Study|End of Study|1|||
42155631|NCT00274742|75963940|FG004|Overall Study|End of Study|0|||
42155632|NCT00274742|75963941|FG005|Overall Study|End of Study|0|||
42155633|NCT00274742|75963936|FG000|Overall Study|Disease Progression|0|||
42155634|NCT00274742|75963937|FG001|Overall Study|Disease Progression|1|||
42155635|NCT00274742|75963938|FG002|Overall Study|Disease Progression|1|||
42155636|NCT00274742|75963939|FG003|Overall Study|Disease Progression|0|||
42155637|NCT00274742|75963940|FG004|Overall Study|Disease Progression|1|||
42155638|NCT00274742|75963941|FG005|Overall Study|Disease Progression|0|||
42155639|NCT00274742|75963936|FG000|Overall Study|Other|0|||
42155640|NCT00274742|75963937|FG001|Overall Study|Other|3|||
42155641|NCT00274742|75963938|FG002|Overall Study|Other|0|||
42155642|NCT00274742|75963939|FG003|Overall Study|Other|0|||
42155643|NCT00274742|75963940|FG004|Overall Study|Other|2|||
42155644|NCT00274742|75963941|FG005|Overall Study|Other|0|||
42155645|NCT00262314|75963961|FG000|Overall Study|Changing physicians|38|||
42155646|NCT00262314|75963961|FG000|Overall Study|Death|12|||
42155647|NCT00262314|75963961|FG000|Overall Study|Patient's decision|92|||
42155648|NCT00262314|75963961|FG000|Overall Study|Other|95|||
42155649|NCT00262314|75963961|FG000|Overall Study|Lost to Follow-up|70|||
42155650|NCT00262314|75963961|FG000|Overall Study|Administrative withdrawal|30|||
42155651|NCT00283400|75963969|FG000|Overall Study|Withdrawal by Subject|1|||
42155652|NCT00283400|75963970|FG001|Overall Study|Withdrawal by Subject|1|||
42155653|NCT00283400|75963971|FG002|Overall Study|Withdrawal by Subject|0|||
42155654|NCT00283400|75963972|FG003|Overall Study|Withdrawal by Subject|0|||
42155655|NCT00283400|75963969|FG000|Overall Study|Death|1|||
42155656|NCT00283400|75963970|FG001|Overall Study|Death|0|||
42155657|NCT00283400|75963971|FG002|Overall Study|Death|1|||
42155658|NCT00283400|75963972|FG003|Overall Study|Death|0|||
42155659|NCT00444275|75963985|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
42155660|NCT00444275|75963986|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
42155661|NCT00444275|75963987|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
42155662|NCT00444275|75963988|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
42155663|NCT00444275|75963989|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
42155664|NCT00444275|75963985|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
42155665|NCT00444275|75963986|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
42155666|NCT00444275|75963987|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
42155667|NCT00444275|75963988|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
42155668|NCT00444275|75963989|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
42155669|NCT00444275|75963985|FG000|Maintenance Treatment Phase|Adverse Event|0|||
42155670|NCT00444275|75963986|FG001|Maintenance Treatment Phase|Adverse Event|0|||
42155671|NCT00444275|75963987|FG002|Maintenance Treatment Phase|Adverse Event|3|||
42155672|NCT00444275|75963988|FG003|Maintenance Treatment Phase|Adverse Event|2|||
42155673|NCT00444275|75963989|FG004|Maintenance Treatment Phase|Adverse Event|13|||
42155674|NCT00444275|75963985|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
42155675|NCT00444275|75963986|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
42155676|NCT00444275|75963987|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
42155677|NCT00444275|75963988|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
42155678|NCT00444275|75963989|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
42155679|NCT00444275|75963985|FG000|Maintenance Treatment Phase|Patient's wish|0|||
42155680|NCT00444275|75963986|FG001|Maintenance Treatment Phase|Patient's wish|0|||
42155681|NCT00444275|75963987|FG002|Maintenance Treatment Phase|Patient's wish|19|||
42155682|NCT00444275|75963988|FG003|Maintenance Treatment Phase|Patient's wish|9|||
42155683|NCT00444275|75963989|FG004|Maintenance Treatment Phase|Patient's wish|20|||
42155684|NCT00444275|75963985|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
42155685|NCT00444275|75963986|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
42155686|NCT00444275|75963987|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
42155687|NCT00444275|75963988|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
42155688|NCT00444275|75963989|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
42155689|NCT00444275|75963985|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
42155690|NCT00444275|75963986|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
42155691|NCT00444275|75963987|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
42155692|NCT00444275|75963988|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
42155693|NCT00444275|75963989|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
42155694|NCT00454805|75964006|FG000|Overall Study|Withdrawal by Subject|9|||
42155695|NCT00454805|75964007|FG001|Overall Study|Withdrawal by Subject|2|||
42155696|NCT00454805|75964006|FG000|Overall Study|Death|0|||
42155697|NCT00454805|75964007|FG001|Overall Study|Death|2|||
42155698|NCT00454805|75964006|FG000|Overall Study|Disease progression|16|||
42155699|NCT00454805|75964007|FG001|Overall Study|Disease progression|19|||
42155700|NCT00454805|75964006|FG000|Overall Study|In order to begin radiotherapy|1|||
42155701|NCT00454805|75964007|FG001|Overall Study|In order to begin radiotherapy|0|||
42155702|NCT00283244|75964016|FG000|Overall Study|Adverse Event|0|||
42155703|NCT00283244|75964017|FG001|Overall Study|Adverse Event|8|||
42155704|NCT00283244|75964018|FG002|Overall Study|Adverse Event|11|||
42155705|NCT00283244|75964016|FG000|Overall Study|Death|4|||
42155706|NCT00283244|75964017|FG001|Overall Study|Death|3|||
42155707|NCT00283244|75964018|FG002|Overall Study|Death|2|||
42155708|NCT00283244|75964016|FG000|Overall Study|Lack of Efficacy|8|||
42155709|NCT00283244|75964017|FG001|Overall Study|Lack of Efficacy|32|||
42155710|NCT00283244|75964018|FG002|Overall Study|Lack of Efficacy|26|||
42155711|NCT00283244|75964016|FG000|Overall Study|Withdrawal by Subject|1|||
42155712|NCT00283244|75964017|FG001|Overall Study|Withdrawal by Subject|2|||
42155713|NCT00283244|75964018|FG002|Overall Study|Withdrawal by Subject|2|||
42155714|NCT00283244|75964016|FG000|Overall Study|Physician Decision|0|||
42155715|NCT00283244|75964017|FG001|Overall Study|Physician Decision|0|||
42155716|NCT00283244|75964018|FG002|Overall Study|Physician Decision|1|||
42155717|NCT00283244|75964016|FG000|Overall Study|Medical illness (other complicating dz)|4|||
42155718|NCT00283244|75964017|FG001|Overall Study|Medical illness (other complicating dz)|3|||
42155719|NCT00283244|75964018|FG002|Overall Study|Medical illness (other complicating dz)|6|||
42155720|NCT00283244|75964016|FG000|Overall Study|Clinical deterioration|1|||
42155721|NCT00283244|75964017|FG001|Overall Study|Clinical deterioration|3|||
42155722|NCT00283244|75964018|FG002|Overall Study|Clinical deterioration|3|||
42155723|NCT00282464|75964029|FG000|Overall Study|Adverse Event|26|||
42278854|NCT01936857|76110434|FG001|Overall Study|Lost to Follow-up|7|||
42278855|NCT01936857|76110433|FG000|Overall Study|Death|7|||
42278856|NCT01936857|76110434|FG001|Overall Study|Death|3|||
42278857|NCT01936857|76110433|FG000|Overall Study|Moved|2|||
42278858|NCT01936857|76110434|FG001|Overall Study|Moved|1|||
42278859|NCT01936857|76110433|FG000|Overall Study|Withdrawal by Subject|1|||
42278860|NCT01936857|76110434|FG001|Overall Study|Withdrawal by Subject|0|||
42278861|NCT01936857|76110433|FG000|Overall Study|Side effect of medication|1|||
42278862|NCT01936857|76110434|FG001|Overall Study|Side effect of medication|0|||
42278863|NCT01936857|76110433|FG000|Overall Study|Other|2|||
42278864|NCT01936857|76110434|FG001|Overall Study|Other|2|||
42278865|NCT01602224|76110443|FG000|Overall Study|Adverse Event|0|||
42155724|NCT00282464|75964030|FG001|Overall Study|Adverse Event|20|||
42155725|NCT00282464|75964029|FG000|Overall Study|Lack of Efficacy|8|||
42155726|NCT00282464|75964030|FG001|Overall Study|Lack of Efficacy|8|||
42155727|NCT00282464|75964029|FG000|Overall Study|Lost to Follow-up|10|||
42155728|NCT00282464|75964030|FG001|Overall Study|Lost to Follow-up|10|||
42155729|NCT00282464|75964029|FG000|Overall Study|Withdrawal by Subject|24|||
42155730|NCT00282464|75964030|FG001|Overall Study|Withdrawal by Subject|10|||
42155731|NCT00282464|75964029|FG000|Overall Study|laboratory abnormality|1|||
42155732|NCT00282464|75964030|FG001|Overall Study|laboratory abnormality|2|||
42155733|NCT00282464|75964029|FG000|Overall Study|Protocol Violation|0|||
42278866|NCT01602224|76110444|FG001|Overall Study|Adverse Event|1|||
42278867|NCT01602224|76110445|FG002|Overall Study|Adverse Event|0|||
42278868|NCT01602224|76110443|FG000|Overall Study|Investigator Decison|1|||
42278869|NCT01602224|76110444|FG001|Overall Study|Investigator Decison|0|||
42278870|NCT01602224|76110445|FG002|Overall Study|Investigator Decison|0|||
42278871|NCT01602224|76110443|FG000|Overall Study|Lost to Follow-up|0|||
42278872|NCT01602224|76110444|FG001|Overall Study|Lost to Follow-up|0|||
42278873|NCT01602224|76110445|FG002|Overall Study|Lost to Follow-up|1|||
42155734|NCT00282464|75964030|FG001|Overall Study|Protocol Violation|7|||
42155735|NCT00282464|75964029|FG000|Overall Study|Patient moved|1|||
42278874|NCT01602224|76110443|FG000|Overall Study|Protocol Violation|0|||
42278875|NCT01602224|76110444|FG001|Overall Study|Protocol Violation|1|||
42278876|NCT01602224|76110445|FG002|Overall Study|Protocol Violation|0|||
42278877|NCT01602224|76110443|FG000|Overall Study|Sponsor Decision|2|||
42278878|NCT01602224|76110444|FG001|Overall Study|Sponsor Decision|3|||
42278879|NCT01602224|76110445|FG002|Overall Study|Sponsor Decision|2|||
42278880|NCT01602224|76110443|FG000|Overall Study|Withdrawal by Subject|5|||
42278881|NCT01602224|76110444|FG001|Overall Study|Withdrawal by Subject|3|||
42278882|NCT01602224|76110445|FG002|Overall Study|Withdrawal by Subject|3|||
42278883|NCT04498247|76110463|FG000|Overall Study|Lost to Follow-up|0|||
42278884|NCT04498247|76110464|FG001|Overall Study|Lost to Follow-up|0|||
42278885|NCT04498247|76110465|FG002|Overall Study|Lost to Follow-up|0|||
42278886|NCT04498247|76110466|FG003|Overall Study|Lost to Follow-up|1|||
42278887|NCT04498247|76110467|FG004|Overall Study|Lost to Follow-up|0|||
42278888|NCT04498247|76110468|FG005|Overall Study|Lost to Follow-up|0|||
42155736|NCT00282464|75964030|FG001|Overall Study|Patient moved|0|||
42155737|NCT00282464|75964029|FG000|Overall Study|patient non-compliant|3|||
42155738|NCT00282464|75964030|FG001|Overall Study|patient non-compliant|0|||
42155739|NCT00282464|75964029|FG000|Overall Study|patient no show|0|||
42155740|NCT00282464|75964030|FG001|Overall Study|patient no show|1|||
42155741|NCT00282464|75964029|FG000|Overall Study|patient incarcerated|0|||
42155742|NCT00282464|75964030|FG001|Overall Study|patient incarcerated|1|||
42155743|NCT00282464|75964029|FG000|Overall Study|family crisis|0|||
42155744|NCT00282464|75964030|FG001|Overall Study|family crisis|1|||
42155745|NCT00282464|75964029|FG000|Overall Study|dispensed wrong kit|0|||
42155746|NCT00282464|75964030|FG001|Overall Study|dispensed wrong kit|1|||
42155747|NCT00282464|75964029|FG000|Overall Study|dropped due to missed visits|0|||
42155748|NCT00282464|75964030|FG001|Overall Study|dropped due to missed visits|1|||
42155749|NCT00273182|75964036|FG000|Overall Study|Death|450|||
42155750|NCT00273182|75964036|FG000|Overall Study|Lost to Follow-up|88|||
42155751|NCT00273182|75964036|FG000|Overall Study|Withdrawal by Subject|257|||
42155752|NCT00273182|75964036|FG000|Overall Study|Device/System Explant|154|||
42155753|NCT00273182|75964036|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
42155754|NCT00209274|75964043|FG000|Overall Study|Missed visit|3|||
42155755|NCT00209274|75964044|FG001|Overall Study|Missed visit|2|||
42155756|NCT00209274|75964043|FG000|Overall Study|Death|32|||
42155757|NCT00209274|75964044|FG001|Overall Study|Death|15|||
42155758|NCT00209274|75964043|FG000|Overall Study|Withdrawal by Subject|30|||
42155759|NCT00209274|75964044|FG001|Overall Study|Withdrawal by Subject|15|||
42155760|NCT00209274|75964043|FG000|Overall Study|Randomized not treated (RNT)|6|||
42155761|NCT00209274|75964044|FG001|Overall Study|Randomized not treated (RNT)|15|||
42155762|NCT03841331|75964052|FG000|Overall Study|Withdrawal by Subject|4|||
42278889|NCT04498247|76110469|FG006|Overall Study|Lost to Follow-up|0|||
42278890|NCT04498247|76110470|FG007|Overall Study|Lost to Follow-up|0|||
42278891|NCT04498247|76110463|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
42278892|NCT04498247|76110464|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
42278893|NCT04498247|76110465|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
42278894|NCT04498247|76110466|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
42278895|NCT04498247|76110467|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
42278896|NCT04498247|76110468|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
42278897|NCT04498247|76110469|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
42278898|NCT04498247|76110470|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
42278899|NCT04498247|76110463|FG000|Overall Study|Withdrawal by Subject|0|||
42278900|NCT04498247|76110464|FG001|Overall Study|Withdrawal by Subject|8|||
42278901|NCT04498247|76110465|FG002|Overall Study|Withdrawal by Subject|0|||
42278902|NCT04498247|76110466|FG003|Overall Study|Withdrawal by Subject|7|||
42278903|NCT04498247|76110467|FG004|Overall Study|Withdrawal by Subject|0|||
42278904|NCT04498247|76110468|FG005|Overall Study|Withdrawal by Subject|0|||
42278905|NCT04498247|76110469|FG006|Overall Study|Withdrawal by Subject|1|||
42278906|NCT04498247|76110470|FG007|Overall Study|Withdrawal by Subject|0|||
42278907|NCT04498247|76110463|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
42278908|NCT04498247|76110464|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
42278909|NCT04498247|76110465|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
42278910|NCT04498247|76110466|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
42278911|NCT04498247|76110467|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
42278912|NCT04498247|76110468|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
42278913|NCT04498247|76110469|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
42278914|NCT04498247|76110470|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
42278915|NCT03887117|76110498|FG000|Overall Study|Discontinued prematurely|0|||
42278916|NCT03887117|76110499|FG001|Overall Study|Discontinued prematurely|1|||
42278917|NCT03887117|76110500|FG002|Overall Study|Discontinued prematurely|1|||
42278918|NCT03887117|76110501|FG003|Overall Study|Discontinued prematurely|2|||
42278919|NCT04038385|76110522|FG000|Overall Study|Completed baseline assessment only|7|||
42278920|NCT04038385|76110523|FG001|Overall Study|Completed baseline assessment only|4|||
42278921|NCT04038385|76110522|FG000|Overall Study|Moved out of area|4|||
42278922|NCT04038385|76110523|FG001|Overall Study|Moved out of area|2|||
42278923|NCT04038385|76110522|FG000|Overall Study|Discontinued study involvement|6|||
42278924|NCT04038385|76110523|FG001|Overall Study|Discontinued study involvement|1|||
42278925|NCT00783263|76110533|FG000|Overall Study|Adverse Event|3|||
42278926|NCT00783263|76110534|FG001|Overall Study|Adverse Event|0|||
42155763|NCT03841331|75964053|FG001|Overall Study|Withdrawal by Subject|9|||
42155764|NCT03841331|75964052|FG000|Overall Study|Lost to Follow-up|5|||
42155765|NCT03841331|75964053|FG001|Overall Study|Lost to Follow-up|1|||
42155766|NCT00262080|75964062|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
42155767|NCT00262080|75964063|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
42155768|NCT00262080|75964064|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
42155769|NCT00262080|75964062|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
42278927|NCT00783263|76110535|FG002|Overall Study|Adverse Event|2|||
42278928|NCT00783263|76110536|FG003|Overall Study|Adverse Event|1|||
42155770|NCT00262080|75964063|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
42155771|NCT00262080|75964064|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
42155772|NCT00262080|75964062|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
42155773|NCT00262080|75964063|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
42155774|NCT00262080|75964064|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
42155775|NCT00262080|75964062|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
42155776|NCT00262080|75964063|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
42155777|NCT00262080|75964064|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
42155778|NCT00262080|75964062|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
42278929|NCT00783263|76110533|FG000|Overall Study|Lost to Follow-up|1|||
42278930|NCT00783263|76110534|FG001|Overall Study|Lost to Follow-up|1|||
42278931|NCT00783263|76110535|FG002|Overall Study|Lost to Follow-up|0|||
42278932|NCT00783263|76110536|FG003|Overall Study|Lost to Follow-up|0|||
42278933|NCT00783263|76110533|FG000|Overall Study|Withdrawal by Subject|0|||
42278934|NCT00783263|76110534|FG001|Overall Study|Withdrawal by Subject|1|||
42278935|NCT00783263|76110535|FG002|Overall Study|Withdrawal by Subject|1|||
42278936|NCT00783263|76110536|FG003|Overall Study|Withdrawal by Subject|2|||
42278937|NCT03987919|76110563|FG000|Overall Study|Adverse Event|1|||
42278938|NCT03987919|76110564|FG001|Overall Study|Adverse Event|4|||
42278939|NCT03987919|76110565|FG002|Overall Study|Adverse Event|1|||
42278940|NCT03987919|76110566|FG003|Overall Study|Adverse Event|3|||
42278941|NCT03987919|76110563|FG000|Overall Study|Death|4|||
42278942|NCT03987919|76110564|FG001|Overall Study|Death|4|||
42351340|NCT00630058|76191261|FG000|Overall Study|Adverse Event|1|||
42278943|NCT03987919|76110565|FG002|Overall Study|Death|4|||
42278944|NCT03987919|76110566|FG003|Overall Study|Death|1|||
42278945|NCT03987919|76110563|FG000|Overall Study|Lost to Follow-up|5|||
42278946|NCT03987919|76110564|FG001|Overall Study|Lost to Follow-up|6|||
42278947|NCT03987919|76110565|FG002|Overall Study|Lost to Follow-up|8|||
42278948|NCT03987919|76110566|FG003|Overall Study|Lost to Follow-up|12|||
42155779|NCT00262080|75964063|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
42155780|NCT00262080|75964064|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
42155781|NCT00262080|75964062|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
42155782|NCT00262080|75964063|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
42155783|NCT00262080|75964064|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
42155784|NCT00282308|75964074|FG000|Treatment Period|Lost to Follow-up|1|||
42155785|NCT00282308|75964075|FG001|Treatment Period|Lost to Follow-up|0|||
42155786|NCT00282308|75964076|FG002|Treatment Period|Lost to Follow-up|0|||
42155787|NCT00282308|75964074|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
42155788|NCT00282308|75964075|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
42155789|NCT00282308|75964076|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
42155790|NCT00282308|75964074|FG000|Treatment Period|Adverse Event|0|||
42155791|NCT00282308|75964075|FG001|Treatment Period|Adverse Event|2|||
42155792|NCT00282308|75964076|FG002|Treatment Period|Adverse Event|0|||
42155793|NCT00282308|75964074|FG000|Treatment Period|Not Treated with Study Drug|1|||
42155794|NCT00282308|75964075|FG001|Treatment Period|Not Treated with Study Drug|0|||
42155795|NCT00282308|75964076|FG002|Treatment Period|Not Treated with Study Drug|0|||
42155796|NCT00282308|75964074|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
42155797|NCT00282308|75964075|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
42155798|NCT00282308|75964076|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
42155799|NCT00282308|75964074|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
42155800|NCT00282308|75964075|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
42155801|NCT00282308|75964076|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
42155802|NCT00282308|75964074|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
42155803|NCT00282308|75964075|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
42155804|NCT00282308|75964076|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
42155805|NCT00282308|75964074|FG000|Safety Follow-up Period|Adverse Event|0|||
42155806|NCT00282308|75964075|FG001|Safety Follow-up Period|Adverse Event|0|||
42155807|NCT00282308|75964076|FG002|Safety Follow-up Period|Adverse Event|1|||
42155808|NCT00282308|75964074|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
42155809|NCT00282308|75964075|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
42155810|NCT00282308|75964076|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
42155811|NCT00282308|75964074|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
42155812|NCT00282308|75964075|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
42155813|NCT00282308|75964076|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
42155814|NCT00282308|75964074|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
42155815|NCT00282308|75964075|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
42155816|NCT00282308|75964076|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
42155817|NCT00282152|75964088|FG000|Overall Study|Withdrawal by Subject|1|||
42155818|NCT00282152|75964089|FG001|Overall Study|Withdrawal by Subject|0|||
42155819|NCT00281840|75964096|FG000|Overall Study|Adverse Event|12|||
42155820|NCT00281840|75964096|FG000|Overall Study|Physician Decision|6|||
42155821|NCT00281840|75964096|FG000|Overall Study|Withdrawal by Subject|3|||
42155822|NCT00281840|75964096|FG000|Overall Study|Disease Progression|2|||
42155823|NCT00281840|75964096|FG000|Overall Study|exceed maximum delay in treatment|1|||
42155824|NCT00281840|75964096|FG000|Overall Study|Complicating Disease|1|||
42155825|NCT00281684|75964105|FG000|Overall Study|Lost to Follow-up|0|||
42155826|NCT00281684|75964106|FG001|Overall Study|Lost to Follow-up|0|||
42155827|NCT00281684|75964107|FG002|Overall Study|Lost to Follow-up|1|||
42155828|NCT00281684|75964108|FG003|Overall Study|Lost to Follow-up|0|||
42155829|NCT00281684|75964105|FG000|Overall Study|Withdrawal by Subject|1|||
42155830|NCT00281684|75964106|FG001|Overall Study|Withdrawal by Subject|0|||
42155831|NCT00281684|75964107|FG002|Overall Study|Withdrawal by Subject|0|||
42155832|NCT00281684|75964108|FG003|Overall Study|Withdrawal by Subject|0|||
42155833|NCT00272792|75964122|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
42155834|NCT00272792|75964123|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
42155835|NCT00272792|75964122|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
42155836|NCT00272792|75964123|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
42155837|NCT00272792|75964122|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
42155838|NCT00272792|75964123|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
42278949|NCT03987919|76110563|FG000|Overall Study|Physician Decision|0|||
42278950|NCT03987919|76110564|FG001|Overall Study|Physician Decision|2|||
42155839|NCT00272792|75964122|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
42155840|NCT00272792|75964123|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
42155841|NCT00048568|75964131|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
42155842|NCT00048568|75964132|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
42278951|NCT03987919|76110565|FG002|Overall Study|Physician Decision|0|||
42278952|NCT03987919|76110566|FG003|Overall Study|Physician Decision|4|||
42278953|NCT03987919|76110563|FG000|Overall Study|Pregnancy|1|||
42278954|NCT03987919|76110564|FG001|Overall Study|Pregnancy|0|||
42278955|NCT03987919|76110565|FG002|Overall Study|Pregnancy|1|||
42278956|NCT03987919|76110566|FG003|Overall Study|Pregnancy|1|||
42278957|NCT03987919|76110563|FG000|Overall Study|Protocol Violation|0|||
42278958|NCT03987919|76110564|FG001|Overall Study|Protocol Violation|1|||
42278959|NCT03987919|76110565|FG002|Overall Study|Protocol Violation|0|||
42278960|NCT03987919|76110566|FG003|Overall Study|Protocol Violation|0|||
42278961|NCT03987919|76110563|FG000|Overall Study|Site terminated by Sponsor|0|||
42278962|NCT03987919|76110564|FG001|Overall Study|Site terminated by Sponsor|0|||
42278963|NCT03987919|76110565|FG002|Overall Study|Site terminated by Sponsor|0|||
42278964|NCT03987919|76110566|FG003|Overall Study|Site terminated by Sponsor|1|||
42278965|NCT03987919|76110563|FG000|Overall Study|Withdrawal by Subject|7|||
42278966|NCT03987919|76110564|FG001|Overall Study|Withdrawal by Subject|7|||
42278967|NCT03987919|76110565|FG002|Overall Study|Withdrawal by Subject|8|||
42278968|NCT03987919|76110566|FG003|Overall Study|Withdrawal by Subject|4|||
42278969|NCT03987919|76110563|FG000|Overall Study|Other - as reported by the investigator|1|||
42278970|NCT03987919|76110564|FG001|Overall Study|Other - as reported by the investigator|3|||
42278971|NCT03987919|76110565|FG002|Overall Study|Other - as reported by the investigator|2|||
42278972|NCT03987919|76110566|FG003|Overall Study|Other - as reported by the investigator|0|||
42155843|NCT00048568|75964133|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
42155844|NCT00048568|75964131|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
42155845|NCT00048568|75964132|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
42155846|NCT00048568|75964133|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
42155847|NCT00048568|75964131|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
42155848|NCT00048568|75964132|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
42278973|NCT00535405|76110586|FG000|Overall Study|Adverse Event|6|||
42278974|NCT00535405|76110587|FG001|Overall Study|Adverse Event|8|||
42155849|NCT00048568|75964133|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
42155850|NCT00048568|75964131|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
42155851|NCT00048568|75964132|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
42155852|NCT00048568|75964133|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
42155853|NCT00048568|75964131|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
42278975|NCT00535405|76110588|FG002|Overall Study|Adverse Event|3|||
42155854|NCT00048568|75964132|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
42278976|NCT00535405|76110589|FG003|Overall Study|Adverse Event|8|||
42278977|NCT00535405|76110590|FG004|Overall Study|Adverse Event|6|||
42278978|NCT00535405|76110586|FG000|Overall Study|Lost to Follow-up|1|||
42278979|NCT00535405|76110587|FG001|Overall Study|Lost to Follow-up|3|||
42278980|NCT00535405|76110588|FG002|Overall Study|Lost to Follow-up|3|||
42278981|NCT00535405|76110589|FG003|Overall Study|Lost to Follow-up|2|||
42278982|NCT00535405|76110590|FG004|Overall Study|Lost to Follow-up|1|||
42278983|NCT00535405|76110586|FG000|Overall Study|Physician Decision|3|||
42278984|NCT00535405|76110587|FG001|Overall Study|Physician Decision|2|||
42155855|NCT00048568|75964133|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
42155856|NCT00048568|75964131|FG000|Double-Blind Period Days 170 to 365|Death|1|||
42155857|NCT00048568|75964132|FG001|Double-Blind Period Days 170 to 365|Death|1|||
42155858|NCT00048568|75964133|FG002|Double-Blind Period Days 170 to 365|Death|0|||
42155859|NCT00048568|75964131|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
42155860|NCT00048568|75964132|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
42155861|NCT00048568|75964133|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
42155862|NCT00048568|75964131|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
42155863|NCT00048568|75964132|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
42155864|NCT00048568|75964133|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
42155865|NCT00048568|75964131|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
42155866|NCT00048568|75964132|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
42155867|NCT00048568|75964133|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
42155868|NCT00048568|75964131|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
42155869|NCT00048568|75964132|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
42155870|NCT00048568|75964133|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
42155871|NCT00048568|75964131|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
42278985|NCT00535405|76110588|FG002|Overall Study|Physician Decision|0|||
42278986|NCT00535405|76110589|FG003|Overall Study|Physician Decision|1|||
42278987|NCT00535405|76110590|FG004|Overall Study|Physician Decision|1|||
42278988|NCT00535405|76110586|FG000|Overall Study|Protocol Violation|2|||
42278989|NCT00535405|76110587|FG001|Overall Study|Protocol Violation|2|||
42278990|NCT00535405|76110588|FG002|Overall Study|Protocol Violation|2|||
42278991|NCT00535405|76110589|FG003|Overall Study|Protocol Violation|1|||
42278992|NCT00535405|76110590|FG004|Overall Study|Protocol Violation|0|||
42278993|NCT00535405|76110586|FG000|Overall Study|Withdrawal by Subject|5|||
42278994|NCT00535405|76110587|FG001|Overall Study|Withdrawal by Subject|11|||
42278995|NCT00535405|76110588|FG002|Overall Study|Withdrawal by Subject|10|||
42351341|NCT00630058|76191262|FG001|Overall Study|Adverse Event|1|||
42155872|NCT00048568|75964132|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
42155873|NCT00048568|75964133|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
42155874|NCT00048568|75964131|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
42155875|NCT00048568|75964132|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
42155876|NCT00048568|75964133|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
42155877|NCT00048568|75964131|FG000|Open-Label Period|Death|0|||
42155878|NCT00048568|75964132|FG001|Open-Label Period|Death|0|||
42155879|NCT00048568|75964133|FG002|Open-Label Period|Death|13|||
42155880|NCT00048568|75964131|FG000|Open-Label Period|Adverse Event|0|||
42155881|NCT00048568|75964132|FG001|Open-Label Period|Adverse Event|0|||
42155882|NCT00048568|75964133|FG002|Open-Label Period|Adverse Event|49|||
42155883|NCT00048568|75964131|FG000|Open-Label Period|Lack of Efficacy|0|||
42155884|NCT00048568|75964132|FG001|Open-Label Period|Lack of Efficacy|0|||
42155885|NCT00048568|75964133|FG002|Open-Label Period|Lack of Efficacy|32|||
42155886|NCT00048568|75964131|FG000|Open-Label Period|Withdrawal by Subject|0|||
42155887|NCT00048568|75964132|FG001|Open-Label Period|Withdrawal by Subject|0|||
42155888|NCT00048568|75964133|FG002|Open-Label Period|Withdrawal by Subject|26|||
42155889|NCT00048568|75964131|FG000|Open-Label Period|Pregnancy|0|||
42155890|NCT00048568|75964132|FG001|Open-Label Period|Pregnancy|0|||
42155891|NCT00048568|75964133|FG002|Open-Label Period|Pregnancy|5|||
42155892|NCT00048568|75964131|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
42155893|NCT00048568|75964132|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
42155894|NCT00048568|75964133|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
42155895|NCT00048568|75964131|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
42155896|NCT00048568|75964132|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
42155897|NCT00048568|75964133|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
42155898|NCT00048568|75964131|FG000|Open-Label Period|Unknown Reasons|0|||
42155899|NCT00048568|75964132|FG001|Open-Label Period|Unknown Reasons|0|||
42155900|NCT00048568|75964133|FG002|Open-Label Period|Unknown Reasons|25|||
42155901|NCT00048568|75964131|FG000|Open-Label Period|Lost to Follow-up|0|||
42155902|NCT00048568|75964132|FG001|Open-Label Period|Lost to Follow-up|0|||
42155903|NCT00048568|75964133|FG002|Open-Label Period|Lost to Follow-up|7|||
42155904|NCT00262002|75964161|FG000|Overall Study|Adverse Event|2|||
42155905|NCT00262002|75964162|FG001|Overall Study|Adverse Event|1|||
42155906|NCT00262002|75964163|FG002|Overall Study|Adverse Event|0|||
42155907|NCT00262002|75964164|FG003|Overall Study|Adverse Event|0|||
42155908|NCT00262002|75964165|FG004|Overall Study|Adverse Event|0|||
42155909|NCT00262002|75964166|FG005|Overall Study|Adverse Event|1|||
42155910|NCT00262002|75964167|FG006|Overall Study|Adverse Event|0|||
42155911|NCT00262002|75964161|FG000|Overall Study|Withdrawal by Subject|4|||
42155912|NCT00262002|75964162|FG001|Overall Study|Withdrawal by Subject|2|||
42155913|NCT00262002|75964163|FG002|Overall Study|Withdrawal by Subject|0|||
42155914|NCT00262002|75964164|FG003|Overall Study|Withdrawal by Subject|1|||
42155915|NCT00262002|75964165|FG004|Overall Study|Withdrawal by Subject|2|||
42155916|NCT00262002|75964166|FG005|Overall Study|Withdrawal by Subject|2|||
42155917|NCT00262002|75964167|FG006|Overall Study|Withdrawal by Subject|2|||
42155918|NCT00262002|75964161|FG000|Overall Study|Lost to Follow-up|2|||
42155919|NCT00262002|75964162|FG001|Overall Study|Lost to Follow-up|0|||
42155920|NCT00262002|75964163|FG002|Overall Study|Lost to Follow-up|0|||
42155921|NCT00262002|75964164|FG003|Overall Study|Lost to Follow-up|2|||
42155922|NCT00262002|75964165|FG004|Overall Study|Lost to Follow-up|0|||
42155923|NCT00262002|75964166|FG005|Overall Study|Lost to Follow-up|1|||
42155924|NCT00262002|75964167|FG006|Overall Study|Lost to Follow-up|0|||
42155925|NCT00262002|75964161|FG000|Overall Study|Inapropriate enrollment|0|||
42155926|NCT00262002|75964162|FG001|Overall Study|Inapropriate enrollment|1|||
42155927|NCT00262002|75964163|FG002|Overall Study|Inapropriate enrollment|0|||
42155928|NCT00262002|75964164|FG003|Overall Study|Inapropriate enrollment|0|||
42155929|NCT00262002|75964165|FG004|Overall Study|Inapropriate enrollment|0|||
42155930|NCT00262002|75964166|FG005|Overall Study|Inapropriate enrollment|0|||
42155931|NCT00262002|75964167|FG006|Overall Study|Inapropriate enrollment|0|||
42155932|NCT00262002|75964161|FG000|Overall Study|Protocol Violation|3|||
42155933|NCT00262002|75964162|FG001|Overall Study|Protocol Violation|2|||
42155934|NCT00262002|75964163|FG002|Overall Study|Protocol Violation|0|||
42155935|NCT00262002|75964164|FG003|Overall Study|Protocol Violation|2|||
42278996|NCT00535405|76110589|FG003|Overall Study|Withdrawal by Subject|10|||
42278997|NCT00535405|76110590|FG004|Overall Study|Withdrawal by Subject|8|||
42278998|NCT00271817|76110605|FG000|Part 1|Adverse Event|68|||
42155936|NCT00262002|75964165|FG004|Overall Study|Protocol Violation|5|||
42155937|NCT00262002|75964166|FG005|Overall Study|Protocol Violation|3|||
42155938|NCT00262002|75964167|FG006|Overall Study|Protocol Violation|2|||
42155939|NCT00262002|75964161|FG000|Overall Study|Unable to classify|0|||
42155940|NCT00262002|75964162|FG001|Overall Study|Unable to classify|0|||
42155941|NCT00262002|75964163|FG002|Overall Study|Unable to classify|0|||
42278999|NCT00271817|76110606|FG001|Part 1|Adverse Event|25|||
42155942|NCT00262002|75964164|FG003|Overall Study|Unable to classify|0|||
42155943|NCT00262002|75964165|FG004|Overall Study|Unable to classify|0|||
42155944|NCT00262002|75964166|FG005|Overall Study|Unable to classify|0|||
42155945|NCT00262002|75964167|FG006|Overall Study|Unable to classify|2|||
42155946|NCT00281528|75964235|FG000|Overall Study|Progressive Disease|28|||
42155947|NCT00281528|75964236|FG001|Overall Study|Progressive Disease|18|||
42155948|NCT00281528|75964237|FG002|Overall Study|Progressive Disease|27|||
42155949|NCT00281528|75964235|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
42155950|NCT00281528|75964236|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
42155951|NCT00281528|75964237|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
42155952|NCT00281528|75964235|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
42155953|NCT00281528|75964236|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
42155954|NCT00281528|75964237|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
42155955|NCT00281528|75964235|FG000|Overall Study|Physician Decision|11|||
42155956|NCT00281528|75964236|FG001|Overall Study|Physician Decision|4|||
42155957|NCT00281528|75964237|FG002|Overall Study|Physician Decision|5|||
42155958|NCT00281528|75964235|FG000|Overall Study|Protocol Violation|1|||
42155959|NCT00281528|75964236|FG001|Overall Study|Protocol Violation|0|||
42155960|NCT00281528|75964237|FG002|Overall Study|Protocol Violation|1|||
42155961|NCT00281528|75964235|FG000|Overall Study|Withdrawal by Subject|5|||
42155962|NCT00281528|75964236|FG001|Overall Study|Withdrawal by Subject|5|||
42155963|NCT00281528|75964237|FG002|Overall Study|Withdrawal by Subject|7|||
42155964|NCT00281528|75964235|FG000|Overall Study|Other|6|||
42155965|NCT00281528|75964236|FG001|Overall Study|Other|3|||
42155966|NCT00281528|75964237|FG002|Overall Study|Other|5|||
42155967|NCT00280748|75964245|FG000|Overall Study|Decline in performance|3|||
42155968|NCT00280748|75964245|FG000|Overall Study|Extra-cranial disease progression|1|||
42155969|NCT00271856|75964251|FG000|Overall Study|Withdrawal by Subject|1|||
42155970|NCT00271856|75964252|FG001|Overall Study|Withdrawal by Subject|7|||
42155971|NCT00271856|75964251|FG000|Overall Study|Lost to Follow-up|10|||
42155972|NCT00271856|75964252|FG001|Overall Study|Lost to Follow-up|11|||
42155973|NCT00061048|75964258|FG000|Overall Study|Adverse Event|2|||
42155974|NCT00061048|75964258|FG000|Overall Study|disease progression|20|||
42155975|NCT00270998|75964265|FG000|3 Month Follow-up|Adverse Event|1|||
42155976|NCT00270998|75964266|FG001|3 Month Follow-up|Adverse Event|0|||
42155977|NCT00270998|75964267|FG002|3 Month Follow-up|Adverse Event|0|||
42155978|NCT00270998|75964265|FG000|3 Month Follow-up|Lack of Efficacy|1|||
42155979|NCT00270998|75964266|FG001|3 Month Follow-up|Lack of Efficacy|2|||
42155980|NCT00270998|75964267|FG002|3 Month Follow-up|Lack of Efficacy|1|||
42155981|NCT00270998|75964265|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
42155982|NCT00270998|75964266|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
42155983|NCT00270998|75964267|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
42155984|NCT00270998|75964265|FG000|3 Month Follow-up|Pessary did not fit|12|||
42155985|NCT00270998|75964266|FG001|3 Month Follow-up|Pessary did not fit|0|||
42155986|NCT00270998|75964267|FG002|3 Month Follow-up|Pessary did not fit|0|||
42155987|NCT00270998|75964265|FG000|3 Month Follow-up|Personal/family health|1|||
42155988|NCT00270998|75964266|FG001|3 Month Follow-up|Personal/family health|1|||
42155989|NCT00270998|75964267|FG002|3 Month Follow-up|Personal/family health|0|||
42155990|NCT00270998|75964265|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
42155991|NCT00270998|75964266|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
42155992|NCT00270998|75964267|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
42155993|NCT00270998|75964265|FG000|12 Month Follow-up|Lack of Efficacy|5|||
42155994|NCT00270998|75964266|FG001|12 Month Follow-up|Lack of Efficacy|4|||
42155995|NCT00270998|75964267|FG002|12 Month Follow-up|Lack of Efficacy|3|||
42155996|NCT00270998|75964265|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
42155997|NCT00270998|75964266|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
42155998|NCT00270998|75964267|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
42155999|NCT00270998|75964265|FG000|12 Month Follow-up|Pessary did not fit|1|||
42156000|NCT00270998|75964266|FG001|12 Month Follow-up|Pessary did not fit|0|||
42156001|NCT00270998|75964267|FG002|12 Month Follow-up|Pessary did not fit|0|||
42156002|NCT00270998|75964265|FG000|12 Month Follow-up|Personal/family health|0|||
42040212|NCT01928394|75848584|FG018|Treatment Period|Participant request to stop therapy|1|||
42156003|NCT00270998|75964266|FG001|12 Month Follow-up|Personal/family health|5|||
42351342|NCT00630058|76191261|FG000|Overall Study|Withdrawal by Subject|0|||
42040213|NCT01928394|75848585|FG019|Treatment Period|Participant request to stop therapy|1|||
42040214|NCT01928394|75848586|FG020|Treatment Period|Participant request to stop therapy|3|||
42040215|NCT01928394|75848587|FG021|Treatment Period|Participant request to stop therapy|1|||
42156004|NCT00270998|75964267|FG002|12 Month Follow-up|Personal/family health|1|||
42156005|NCT00270998|75964265|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
42156006|NCT00270998|75964266|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
42156007|NCT00270998|75964267|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
42156008|NCT00279812|75964283|FG000|Overall Study|Protocol Violation|1|||
42156009|NCT00279812|75964284|FG001|Overall Study|Protocol Violation|1|||
42156010|NCT00279812|75964285|FG002|Overall Study|Protocol Violation|0|||
42156011|NCT00279812|75964286|FG003|Overall Study|Protocol Violation|0|||
42156012|NCT00279812|75964287|FG004|Overall Study|Protocol Violation|1|||
42156013|NCT00279812|75964288|FG005|Overall Study|Protocol Violation|0|||
42156014|NCT00279812|75964283|FG000|Overall Study|Withdrawal by Subject|0|||
42156015|NCT00279812|75964284|FG001|Overall Study|Withdrawal by Subject|4|||
42156016|NCT00279812|75964285|FG002|Overall Study|Withdrawal by Subject|2|||
42156017|NCT00279812|75964286|FG003|Overall Study|Withdrawal by Subject|0|||
42156018|NCT00279812|75964287|FG004|Overall Study|Withdrawal by Subject|0|||
42156019|NCT00279812|75964288|FG005|Overall Study|Withdrawal by Subject|0|||
42156020|NCT00279812|75964283|FG000|Overall Study|Adverse Event|0|||
42156021|NCT00279812|75964284|FG001|Overall Study|Adverse Event|1|||
42156022|NCT00279812|75964285|FG002|Overall Study|Adverse Event|1|||
42156023|NCT00279812|75964286|FG003|Overall Study|Adverse Event|0|||
42156024|NCT00279812|75964287|FG004|Overall Study|Adverse Event|2|||
42156025|NCT00279812|75964288|FG005|Overall Study|Adverse Event|1|||
42156026|NCT00207714|75964307|FG000|Overall Study|Adverse Event|6|||
42156027|NCT00207714|75964308|FG001|Overall Study|Adverse Event|2|||
42156028|NCT00207714|75964309|FG002|Overall Study|Adverse Event|4|||
42156029|NCT00207714|75964310|FG003|Overall Study|Adverse Event|3|||
42156030|NCT00207714|75964311|FG004|Overall Study|Adverse Event|1|||
42156031|NCT00207714|75964307|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
42156032|NCT00207714|75964308|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
42156033|NCT00207714|75964309|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
42156034|NCT00207714|75964310|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
42156035|NCT00207714|75964311|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
42156036|NCT00207714|75964307|FG000|Overall Study|Other|3|||
42156037|NCT00207714|75964308|FG001|Overall Study|Other|2|||
42156038|NCT00207714|75964309|FG002|Overall Study|Other|5|||
42156039|NCT00207714|75964310|FG003|Overall Study|Other|1|||
42156040|NCT00207714|75964311|FG004|Overall Study|Other|0|||
42156041|NCT00207090|75964330|FG000|Overall Study|Study drug toxicity|3|||
42156042|NCT00207090|75964330|FG000|Overall Study|Chest wall mass larger|1|||
42156043|NCT00207090|75964330|FG000|Overall Study|Disease progression/relapse|2|||
42156044|NCT00207090|75964330|FG000|Overall Study|Physician Decision|1|||
42156045|NCT00059332|75964341|FG000|Overall Study|Withdrawal by Subject|2|||
42156046|NCT00059332|75964342|FG001|Overall Study|Withdrawal by Subject|1|||
42156047|NCT00059332|75964341|FG000|Overall Study|Lost to Follow-up|1|||
42156048|NCT00059332|75964342|FG001|Overall Study|Lost to Follow-up|1|||
42156049|NCT00233454|75964348|FG000|Overall Study|Death|6|||
42156050|NCT00047320|75964352|FG000|Overall Study|Lack of Efficacy|8|||
42156051|NCT00047320|75964352|FG000|Overall Study|Lost to Follow-up|1|||
42156052|NCT00047320|75964352|FG000|Overall Study|Physician Decision|8|||
42156053|NCT00047320|75964352|FG000|Overall Study|Withdrawal by Subject|9|||
42156054|NCT00047320|75964352|FG000|Overall Study|Ineligible|2|||
42156055|NCT00233064|75964358|FG000|Overall Study|Lost to Follow-up|7|||
42156056|NCT00233064|75964359|FG001|Overall Study|Lost to Follow-up|7|||
42156057|NCT00233064|75964358|FG000|Overall Study|Withdrawal by Subject|5|||
42156058|NCT00233064|75964359|FG001|Overall Study|Withdrawal by Subject|3|||
42156059|NCT00233064|75964358|FG000|Overall Study|Death|0|||
42156060|NCT00233064|75964359|FG001|Overall Study|Death|1|||
42156061|NCT00233064|75964358|FG000|Overall Study|Relocation|0|||
42156062|NCT00233064|75964359|FG001|Overall Study|Relocation|1|||
42156063|NCT00233064|75964358|FG000|Overall Study|Protocol Violation|1|||
42156064|NCT00233064|75964359|FG001|Overall Study|Protocol Violation|0|||
42156065|NCT00233064|75964358|FG000|Overall Study|Moved to Dom. Republic|1|||
42156066|NCT00233064|75964359|FG001|Overall Study|Moved to Dom. Republic|0|||
42156067|NCT00268892|75964369|FG000|Overall Study|Adverse Event|14|||
42156068|NCT00268892|75964370|FG001|Overall Study|Adverse Event|17|||
42156069|NCT00268892|75964371|FG002|Overall Study|Adverse Event|20|||
42156070|NCT00268892|75964369|FG000|Overall Study|Lack of Efficacy|1|||
42156071|NCT00268892|75964370|FG001|Overall Study|Lack of Efficacy|3|||
42156072|NCT00268892|75964371|FG002|Overall Study|Lack of Efficacy|0|||
42156073|NCT00268892|75964369|FG000|Overall Study|Withdrawal by Subject|14|||
42156074|NCT00268892|75964370|FG001|Overall Study|Withdrawal by Subject|15|||
42156075|NCT00268892|75964371|FG002|Overall Study|Withdrawal by Subject|13|||
42156076|NCT00268892|75964369|FG000|Overall Study|Physician Decision|0|||
42279000|NCT00271817|76110607|FG002|Part 1|Adverse Event|156|||
42156077|NCT00268892|75964370|FG001|Overall Study|Physician Decision|1|||
42156078|NCT00268892|75964371|FG002|Overall Study|Physician Decision|0|||
42156079|NCT00268892|75964369|FG000|Overall Study|Lost to Follow-up|5|||
42156080|NCT00268892|75964370|FG001|Overall Study|Lost to Follow-up|2|||
42156081|NCT00268892|75964371|FG002|Overall Study|Lost to Follow-up|4|||
42156082|NCT00268892|75964369|FG000|Overall Study|Protocol Violation|0|||
42279001|NCT00271817|76110605|FG000|Part 1|Lost to Follow-up|6|||
42156083|NCT00268892|75964370|FG001|Overall Study|Protocol Violation|1|||
42156084|NCT00268892|75964371|FG002|Overall Study|Protocol Violation|0|||
42156085|NCT00268892|75964369|FG000|Overall Study|Disease Progression|1|||
42156086|NCT00268892|75964370|FG001|Overall Study|Disease Progression|1|||
42156087|NCT00268892|75964371|FG002|Overall Study|Disease Progression|0|||
42156088|NCT00268892|75964369|FG000|Overall Study|Trial Site Closed|4|||
42156089|NCT00268892|75964370|FG001|Overall Study|Trial Site Closed|2|||
42156090|NCT00268892|75964371|FG002|Overall Study|Trial Site Closed|2|||
42156091|NCT00206076|75964381|FG000|Overall Study|Physician Decision|2|||
42156092|NCT00206076|75964382|FG001|Overall Study|Physician Decision|0|||
42156093|NCT00206076|75964381|FG000|Overall Study|Withdrawal by Subject|1|||
42279002|NCT00271817|76110606|FG001|Part 1|Lost to Follow-up|8|||
42279003|NCT00271817|76110607|FG002|Part 1|Lost to Follow-up|24|||
42279004|NCT00271817|76110605|FG000|Part 1|Protocol Violation|5|||
42279005|NCT00271817|76110606|FG001|Part 1|Protocol Violation|4|||
42279006|NCT00271817|76110607|FG002|Part 1|Protocol Violation|7|||
42156094|NCT00206076|75964382|FG001|Overall Study|Withdrawal by Subject|1|||
42156095|NCT00278954|75964390|FG000|Overall Study|Adverse Event|3|||
42156096|NCT00278954|75964390|FG000|Overall Study|Lost to Follow-up|1|||
42156097|NCT00278954|75964390|FG000|Overall Study|Withdrawal by Subject|1|||
42156098|NCT00278564|75964394|FG000|Overall Study|Lack of Efficacy|4|||
42156099|NCT00268346|75964400|FG000|Overall Study|Adverse Event|0|||
42156100|NCT00268346|75964401|FG001|Overall Study|Adverse Event|1|||
42156101|NCT00268346|75964400|FG000|Overall Study|Death|0|||
42156102|NCT00268346|75964401|FG001|Overall Study|Death|1|||
42156103|NCT00268346|75964400|FG000|Overall Study|Withdrawal by Subject|0|||
42156104|NCT00268346|75964401|FG001|Overall Study|Withdrawal by Subject|1|||
42156105|NCT00203892|75964410|FG000|Overall Study|Physician Decision|1|||
42156106|NCT00203892|75964411|FG001|Overall Study|Physician Decision|2|||
42156107|NCT00203892|75964412|FG002|Overall Study|Physician Decision|0|||
42156108|NCT00203892|75964410|FG000|Overall Study|Death|1|||
42156109|NCT00203892|75964411|FG001|Overall Study|Death|0|||
42156110|NCT00203892|75964412|FG002|Overall Study|Death|0|||
42156111|NCT00250718|75964420|FG000|Overall Study|Death|1|||
42156112|NCT00250718|75964420|FG000|Overall Study|Adverse Event|1|||
42156113|NCT00250718|75964420|FG000|Overall Study|Withdrawal by Subject|1|||
42156114|NCT00276614|75964424|FG000|Overall Study|Progression of disease under study|3|||
42156115|NCT00276458|75964430|FG000|Overall Study|Adverse Event|0|||
42156116|NCT00276458|75964431|FG001|Overall Study|Adverse Event|2|||
42156117|NCT00276458|75964430|FG000|Overall Study|Lost to Follow-up|2|||
42156118|NCT00276458|75964431|FG001|Overall Study|Lost to Follow-up|2|||
42156119|NCT00276458|75964430|FG000|Overall Study|Protocol Violation|4|||
42156120|NCT00276458|75964431|FG001|Overall Study|Protocol Violation|3|||
42156121|NCT00276380|75964439|FG000|Overall Study|Adverse Event|5|||
42156122|NCT00276380|75964440|FG001|Overall Study|Adverse Event|3|||
42156123|NCT00276380|75964439|FG000|Overall Study|Lost to Follow-up|1|||
42156124|NCT00276380|75964440|FG001|Overall Study|Lost to Follow-up|1|||
42156125|NCT00276380|75964439|FG000|Overall Study|Withdrawal by Subject|3|||
42156126|NCT00276380|75964440|FG001|Overall Study|Withdrawal by Subject|6|||
42156127|NCT00276380|75964439|FG000|Overall Study|Death|5|||
42156128|NCT00276380|75964440|FG001|Overall Study|Death|3|||
42156129|NCT00276380|75964439|FG000|Overall Study|Abnormal aPPT Levels|0|||
42156130|NCT00276380|75964440|FG001|Overall Study|Abnormal aPPT Levels|1|||
42156131|NCT00267956|75964449|FG000|Controlled Period|Adverse Event|4|||
42156132|NCT00267956|75964450|FG001|Controlled Period|Adverse Event|1|||
42156133|NCT00267956|75964451|FG002|Controlled Period|Adverse Event|0|||
42156134|NCT00267956|75964452|FG003|Controlled Period|Adverse Event|0|||
42156135|NCT00267956|75964449|FG000|Controlled Period|Lack of Efficacy|4|||
42156136|NCT00267956|75964450|FG001|Controlled Period|Lack of Efficacy|2|||
42156137|NCT00267956|75964451|FG002|Controlled Period|Lack of Efficacy|0|||
42156138|NCT00267956|75964452|FG003|Controlled Period|Lack of Efficacy|0|||
42156139|NCT00267956|75964449|FG000|Controlled Period|Lost to Follow-up|2|||
42156140|NCT00267956|75964450|FG001|Controlled Period|Lost to Follow-up|0|||
42156141|NCT00267956|75964451|FG002|Controlled Period|Lost to Follow-up|0|||
42156142|NCT00267956|75964452|FG003|Controlled Period|Lost to Follow-up|0|||
42156143|NCT00267956|75964449|FG000|Controlled Period|Withdrew consent|3|||
42156144|NCT00267956|75964450|FG001|Controlled Period|Withdrew consent|1|||
42156145|NCT00267956|75964451|FG002|Controlled Period|Withdrew consent|0|||
42156146|NCT00267956|75964452|FG003|Controlled Period|Withdrew consent|0|||
42156147|NCT00267956|75964449|FG000|After Controlled Period|Adverse Event|0|||
42156148|NCT00267956|75964450|FG001|After Controlled Period|Adverse Event|0|||
42156149|NCT00267956|75964451|FG002|After Controlled Period|Adverse Event|2|||
42156150|NCT00267956|75964452|FG003|After Controlled Period|Adverse Event|1|||
42156151|NCT00267956|75964449|FG000|After Controlled Period|Lack of Efficacy|0|||
42156152|NCT00267956|75964450|FG001|After Controlled Period|Lack of Efficacy|0|||
42279007|NCT00271817|76110605|FG000|Part 1|Patient Moved|3|||
42156153|NCT00267956|75964451|FG002|After Controlled Period|Lack of Efficacy|1|||
42156154|NCT00267956|75964452|FG003|After Controlled Period|Lack of Efficacy|1|||
42156155|NCT00267956|75964449|FG000|After Controlled Period|Lost to Follow-up|0|||
42156156|NCT00267956|75964450|FG001|After Controlled Period|Lost to Follow-up|0|||
42156157|NCT00267956|75964451|FG002|After Controlled Period|Lost to Follow-up|1|||
42156158|NCT00267956|75964452|FG003|After Controlled Period|Lost to Follow-up|0|||
42156159|NCT00267956|75964449|FG000|After Controlled Period|Withdrew consent|0|||
42156160|NCT00267956|75964450|FG001|After Controlled Period|Withdrew consent|0|||
42156161|NCT00267956|75964451|FG002|After Controlled Period|Withdrew consent|1|||
42351343|NCT00630058|76191262|FG001|Overall Study|Withdrawal by Subject|1|||
42156162|NCT00267956|75964452|FG003|After Controlled Period|Withdrew consent|0|||
42156163|NCT00267488|75964460|FG000|Overall Study|Sponsor Terminated Study|9|||
42156164|NCT00267488|75964460|FG000|Overall Study|Protocol Violation|1|||
42156165|NCT00267488|75964460|FG000|Overall Study|Other (Disease Progression)|1|||
42156166|NCT00058552|75964466|FG000|Overall Study|Died prior to receiving treatment|4|||
42156167|NCT00058552|75964467|FG001|Overall Study|Died prior to receiving treatment|2|||
42156168|NCT00058552|75964466|FG000|Overall Study|Disease progression|52|||
42156169|NCT00058552|75964467|FG001|Overall Study|Disease progression|44|||
42156170|NCT00058552|75964466|FG000|Overall Study|Adverse Event|4|||
42156171|NCT00058552|75964467|FG001|Overall Study|Adverse Event|2|||
42156172|NCT00058552|75964466|FG000|Overall Study|Withdrawal by Subject|3|||
42156173|NCT00058552|75964467|FG001|Overall Study|Withdrawal by Subject|5|||
42156174|NCT00058552|75964466|FG000|Overall Study|Physician Decision|2|||
42156175|NCT00058552|75964467|FG001|Overall Study|Physician Decision|5|||
42156176|NCT00058552|75964466|FG000|Overall Study|Clinical disease progression|0|||
42156177|NCT00058552|75964467|FG001|Overall Study|Clinical disease progression|4|||
42156178|NCT00044512|75964475|FG000|Follow Up|Lost to Follow-up|2|||
42156179|NCT03805438|75964479|FG000|Overall Study|Lack of Efficacy|1|||
42156180|NCT03805438|75964479|FG000|Overall Study|Protocol Violation|1|||
42156181|NCT05369806|75964492|FG000|Overall Study|Lost to Follow-up|1|||
42156182|NCT05195528|75964503|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
42156183|NCT05195528|75964504|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
42156184|NCT05195528|75964505|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
42156185|NCT05195528|75964506|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
42156186|NCT05195528|75964507|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
42156187|NCT05195528|75964503|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
42156188|NCT05195528|75964504|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
42156189|NCT05195528|75964505|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
42156190|NCT05195528|75964506|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
42156191|NCT05195528|75964507|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
42156192|NCT05195528|75964503|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
42156193|NCT05195528|75964504|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
42156194|NCT05195528|75964505|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
42156195|NCT05195528|75964506|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
42156196|NCT05195528|75964507|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
42156197|NCT05195528|75964503|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
42156198|NCT05195528|75964504|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
42156199|NCT05195528|75964505|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
42156200|NCT05195528|75964506|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
42156201|NCT05195528|75964507|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
42156202|NCT05195528|75964503|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
42156203|NCT05195528|75964504|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
42156204|NCT05195528|75964505|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
42156205|NCT05195528|75964506|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
42156206|NCT05195528|75964507|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
42156207|NCT05195528|75964503|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
42156208|NCT05195528|75964504|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
42156209|NCT05195528|75964505|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
42156210|NCT05195528|75964506|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
42156211|NCT05195528|75964507|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
42156212|NCT05195528|75964503|FG000|Placebo-controlled Treatment Period|Other|0|||
42156213|NCT05195528|75964504|FG001|Placebo-controlled Treatment Period|Other|0|||
42156214|NCT05195528|75964505|FG002|Placebo-controlled Treatment Period|Other|1|||
42156215|NCT05195528|75964506|FG003|Placebo-controlled Treatment Period|Other|0|||
42156216|NCT05195528|75964507|FG004|Placebo-controlled Treatment Period|Other|0|||
42156217|NCT05195528|75964503|FG000|Extension Period|PTE or AE or SAE|0|||
42156218|NCT05195528|75964504|FG001|Extension Period|PTE or AE or SAE|4|||
42156219|NCT05195528|75964505|FG002|Extension Period|PTE or AE or SAE|5|||
42156220|NCT05195528|75964506|FG003|Extension Period|PTE or AE or SAE|4|||
42156221|NCT05195528|75964507|FG004|Extension Period|PTE or AE or SAE|4|||
42156222|NCT05195528|75964503|FG000|Extension Period|Protocol Violation|0|||
42156223|NCT05195528|75964504|FG001|Extension Period|Protocol Violation|2|||
42156224|NCT05195528|75964505|FG002|Extension Period|Protocol Violation|1|||
42156225|NCT05195528|75964506|FG003|Extension Period|Protocol Violation|0|||
42279008|NCT00271817|76110606|FG001|Part 1|Patient Moved|1|||
42013331|NCT00970489|75820441|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
42156226|NCT05195528|75964507|FG004|Extension Period|Protocol Violation|1|||
42279009|NCT00271817|76110607|FG002|Part 1|Patient Moved|5|||
42013332|NCT00970489|75820442|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
42156227|NCT05195528|75964503|FG000|Extension Period|Lost to Follow-up|0|||
42156228|NCT05195528|75964504|FG001|Extension Period|Lost to Follow-up|6|||
42156229|NCT05195528|75964505|FG002|Extension Period|Lost to Follow-up|13|||
42156230|NCT05195528|75964506|FG003|Extension Period|Lost to Follow-up|3|||
42156231|NCT05195528|75964507|FG004|Extension Period|Lost to Follow-up|7|||
42156232|NCT05195528|75964503|FG000|Extension Period|Withdrawal by Subject|0|||
42156233|NCT05195528|75964504|FG001|Extension Period|Withdrawal by Subject|12|||
42156234|NCT05195528|75964505|FG002|Extension Period|Withdrawal by Subject|9|||
42156235|NCT05195528|75964506|FG003|Extension Period|Withdrawal by Subject|6|||
42156236|NCT05195528|75964507|FG004|Extension Period|Withdrawal by Subject|5|||
42156237|NCT05195528|75964503|FG000|Extension Period|Lack of Efficacy|0|||
42156238|NCT05195528|75964504|FG001|Extension Period|Lack of Efficacy|3|||
42156239|NCT05195528|75964505|FG002|Extension Period|Lack of Efficacy|0|||
42156240|NCT05195528|75964506|FG003|Extension Period|Lack of Efficacy|0|||
42156241|NCT05195528|75964507|FG004|Extension Period|Lack of Efficacy|2|||
42156242|NCT05195528|75964503|FG000|Extension Period|Not Treated|0|||
42156243|NCT05195528|75964504|FG001|Extension Period|Not Treated|0|||
42156244|NCT05195528|75964505|FG002|Extension Period|Not Treated|2|||
42156245|NCT05195528|75964506|FG003|Extension Period|Not Treated|3|||
42156246|NCT05195528|75964507|FG004|Extension Period|Not Treated|0|||
42156247|NCT05195528|75964503|FG000|Extension Period|Other|0|||
42156248|NCT05195528|75964504|FG001|Extension Period|Other|1|||
42156249|NCT05195528|75964505|FG002|Extension Period|Other|1|||
42156250|NCT05195528|75964506|FG003|Extension Period|Other|0|||
42156251|NCT05195528|75964507|FG004|Extension Period|Other|0|||
42156252|NCT05135156|75964521|FG000|Overall Study|Lost to Follow-up|0|||
42279010|NCT00271817|76110605|FG000|Part 1|Withdrawal by Subject|23|||
42279011|NCT00271817|76110606|FG001|Part 1|Withdrawal by Subject|17|||
42156253|NCT05135156|75964522|FG001|Overall Study|Lost to Follow-up|0|||
42156254|NCT05135156|75964523|FG002|Overall Study|Lost to Follow-up|2|||
42156255|NCT04956666|75964530|FG000|Overall Study|Adverse Event|18|||
42156256|NCT04956666|75964530|FG000|Overall Study|Physician Decision|5|||
42156257|NCT04738318|75964536|FG000|Overall Study|Protocol Violation|1|||
42156258|NCT04738318|75964537|FG001|Overall Study|Protocol Violation|0|||
42156259|NCT04726709|75964545|FG000|Overall Study|Withdrawal by Subject|2|||
42156260|NCT04726709|75964546|FG001|Overall Study|Withdrawal by Subject|2|||
42156261|NCT04684420|75964559|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
42156262|NCT04684420|75964560|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
42156263|NCT04684420|75964561|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
42156264|NCT04684420|75964562|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
42156265|NCT04684420|75964559|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
42156266|NCT04684420|75964560|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
42156267|NCT04684420|75964561|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
42156268|NCT04684420|75964562|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
42156269|NCT04352101|75964575|FG000|Overall Study|Physician Decision|2|||
42156270|NCT04352101|75964576|FG001|Overall Study|Physician Decision|1|||
42156271|NCT04208087|75964587|FG000|Overall Study|Adverse Event|1|||
42156272|NCT04208087|75964588|FG001|Overall Study|Adverse Event|0|||
42156273|NCT04208087|75964589|FG002|Overall Study|Adverse Event|0|||
42156274|NCT04208087|75964590|FG003|Overall Study|Adverse Event|0|||
42156275|NCT04208087|75964591|FG004|Overall Study|Adverse Event|0|||
42156276|NCT04208087|75964587|FG000|Overall Study|Withdrawal by Subject|0|||
42156277|NCT04208087|75964588|FG001|Overall Study|Withdrawal by Subject|0|||
42156278|NCT04208087|75964589|FG002|Overall Study|Withdrawal by Subject|1|||
42279012|NCT00271817|76110607|FG002|Part 1|Withdrawal by Subject|45|||
42279013|NCT00271817|76110605|FG000|Part 1|LDL < 50 mg/dL|1|||
42279014|NCT00271817|76110606|FG001|Part 1|LDL < 50 mg/dL|4|||
42279015|NCT00271817|76110607|FG002|Part 1|LDL < 50 mg/dL|48|||
42279016|NCT00271817|76110605|FG000|Part 2|Adverse Event|0|||
42013333|NCT00968617|75820448|FG000|Overall Study|Study terminated by sponsor|6|||
42013334|NCT00968539|75820454|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
42013335|NCT00968539|75820455|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
42156279|NCT04208087|75964590|FG003|Overall Study|Withdrawal by Subject|0|||
42156280|NCT04208087|75964591|FG004|Overall Study|Withdrawal by Subject|0|||
42156281|NCT04208087|75964587|FG000|Overall Study|Other|0|||
42279017|NCT00271817|76110606|FG001|Part 2|Adverse Event|17|||
42156282|NCT04208087|75964588|FG001|Overall Study|Other|0|||
42156283|NCT04208087|75964589|FG002|Overall Study|Other|0|||
42156284|NCT04208087|75964590|FG003|Overall Study|Other|0|||
42156285|NCT04208087|75964591|FG004|Overall Study|Other|1|||
42156286|NCT04140227|75964611|FG000|Overall Study|Withdrawal by Subject|26|||
42156287|NCT04140227|75964611|FG000|Overall Study|Lost to Follow-up|8|||
42156288|NCT04140227|75964611|FG000|Overall Study|Adverse Event|8|||
42156289|NCT04140227|75964611|FG000|Overall Study|Death|1|||
42156290|NCT04140227|75964611|FG000|Overall Study|Other|3|||
42156291|NCT04140227|75964611|FG000|Overall Study|Protocol Violation|2|||
42156292|NCT03782259|75964617|FG000|Overall Study|Lost to Follow-up|1|||
42279018|NCT00271817|76110607|FG002|Part 2|Adverse Event|33|||
42279019|NCT00271817|76110605|FG000|Part 2|Lack of Efficacy|0|||
42156293|NCT03782259|75964618|FG001|Overall Study|Lost to Follow-up|1|||
42156294|NCT03782259|75964617|FG000|Overall Study|Moved out of state|0|||
42156295|NCT03782259|75964618|FG001|Overall Study|Moved out of state|2|||
42156296|NCT03782259|75964617|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
42156297|NCT03782259|75964618|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
42156298|NCT03782259|75964617|FG000|Overall Study|Subject discontinued intervention|1|||
42156299|NCT03782259|75964618|FG001|Overall Study|Subject discontinued intervention|0|||
42156300|NCT03743194|75964631|FG000|Overall Study|Protocol Violation|7|||
42156301|NCT03743194|75964632|FG001|Overall Study|Protocol Violation|7|||
42156302|NCT03743194|75964631|FG000|Overall Study|Physician Decision|0|||
42156303|NCT03743194|75964632|FG001|Overall Study|Physician Decision|2|||
42156304|NCT03461146|75964647|FG000|Overall Study|Adverse Event|2|||
42156305|NCT03461146|75964647|FG000|Overall Study|Physician Decision|1|||
42156306|NCT03460704|75964653|FG000|Overall Study|Withdrawal by Subject|11|||
42279020|NCT00271817|76110606|FG001|Part 2|Lack of Efficacy|1|||
42279021|NCT00271817|76110607|FG002|Part 2|Lack of Efficacy|6|||
42279022|NCT00271817|76110605|FG000|Part 2|Lost to Follow-up|0|||
42279023|NCT00271817|76110606|FG001|Part 2|Lost to Follow-up|6|||
42156307|NCT03460704|75964654|FG001|Overall Study|Withdrawal by Subject|14|||
42156308|NCT03460704|75964653|FG000|Overall Study|Study terminated by the Sponsor|29|||
42156309|NCT03460704|75964654|FG001|Overall Study|Study terminated by the Sponsor|19|||
42156310|NCT03460704|75964653|FG000|Overall Study|Adverse Event|10|||
42156311|NCT03460704|75964654|FG001|Overall Study|Adverse Event|5|||
42156312|NCT03460704|75964653|FG000|Overall Study|Death|3|||
42156313|NCT03460704|75964654|FG001|Overall Study|Death|2|||
42156314|NCT03460704|75964653|FG000|Overall Study|Non-Compliance with Study Drug|3|||
42279024|NCT00271817|76110607|FG002|Part 2|Lost to Follow-up|18|||
42279025|NCT00271817|76110605|FG000|Part 2|Protocol Violation|0|||
42279026|NCT00271817|76110606|FG001|Part 2|Protocol Violation|3|||
42279027|NCT00271817|76110607|FG002|Part 2|Protocol Violation|5|||
42279028|NCT00271817|76110605|FG000|Part 2|Patient Moved|0|||
42279029|NCT00271817|76110606|FG001|Part 2|Patient Moved|0|||
42279030|NCT00271817|76110607|FG002|Part 2|Patient Moved|5|||
42279031|NCT00271817|76110605|FG000|Part 2|Withdrawal by Subject|0|||
42279032|NCT00271817|76110606|FG001|Part 2|Withdrawal by Subject|2|||
42279033|NCT00271817|76110607|FG002|Part 2|Withdrawal by Subject|13|||
42279034|NCT00271817|76110605|FG000|Part 2|LDL < 50 mg/dL|0|||
42279035|NCT00271817|76110606|FG001|Part 2|LDL < 50 mg/dL|3|||
42279036|NCT00271817|76110607|FG002|Part 2|LDL < 50 mg/dL|4|||
42279037|NCT02731157|76110619|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
42279038|NCT03268811|76110627|FG000|Overall Study|Adverse Event|0|||
42279039|NCT03268811|76110628|FG001|Overall Study|Adverse Event|1|||
42279040|NCT02732015|76110637|FG000|Overall Study|Lost to Follow-up|0|||
42279041|NCT02732015|76110638|FG001|Overall Study|Lost to Follow-up|1|||
42279042|NCT01441115|76110658|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
42279043|NCT02006147|76110669|FG000|Overall Study|Protocol Violation|1|||
42279044|NCT02006147|76110670|FG001|Overall Study|Protocol Violation|1|||
42279045|NCT02006147|76110671|FG002|Overall Study|Protocol Violation|0|||
42279046|NCT02006147|76110672|FG003|Overall Study|Protocol Violation|0|||
42279047|NCT02006147|76110669|FG000|Overall Study|Withdrawal by Subject|0|||
42279048|NCT02006147|76110670|FG001|Overall Study|Withdrawal by Subject|1|||
42279049|NCT02006147|76110671|FG002|Overall Study|Withdrawal by Subject|0|||
42279050|NCT02006147|76110672|FG003|Overall Study|Withdrawal by Subject|0|||
42279051|NCT02006147|76110669|FG000|Overall Study|Withdrawal by Sponsor|1|||
42279052|NCT02006147|76110670|FG001|Overall Study|Withdrawal by Sponsor|0|||
42279053|NCT02006147|76110671|FG002|Overall Study|Withdrawal by Sponsor|0|||
42279054|NCT02006147|76110672|FG003|Overall Study|Withdrawal by Sponsor|0|||
42279055|NCT02732119|76110683|FG000|Phase I|Adverse Event|1|||
42279056|NCT02732119|76110684|FG001|Phase I|Adverse Event|3|||
42279057|NCT02732119|76110685|FG002|Phase I|Adverse Event|1|||
42013336|NCT00976573|75820464|FG000|Overall Study|Ineligible|0|||
42279058|NCT02732119|76110686|FG003|Phase I|Adverse Event|0|||
42279059|NCT02732119|76110687|FG004|Phase I|Adverse Event|0|||
42279060|NCT02732119|76110683|FG000|Phase I|Progressive disease|7|||
42279061|NCT02732119|76110684|FG001|Phase I|Progressive disease|3|||
42279062|NCT02732119|76110685|FG002|Phase I|Progressive disease|2|||
42279063|NCT02732119|76110686|FG003|Phase I|Progressive disease|0|||
42279064|NCT02732119|76110687|FG004|Phase I|Progressive disease|0|||
42279065|NCT02732119|76110683|FG000|Phase I|Protocol deviation|0|||
42156315|NCT03460704|75964654|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42156316|NCT03460704|75964653|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
42156317|NCT03460704|75964654|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
42156318|NCT03460704|75964653|FG000|Overall Study|Other|2|||
42156319|NCT03460704|75964654|FG001|Overall Study|Other|1|||
42279066|NCT02732119|76110684|FG001|Phase I|Protocol deviation|1|||
42279067|NCT02732119|76110685|FG002|Phase I|Protocol deviation|0|||
42279068|NCT02732119|76110686|FG003|Phase I|Protocol deviation|0|||
42279069|NCT02732119|76110687|FG004|Phase I|Protocol deviation|0|||
42279070|NCT02732119|76110683|FG000|Phase I|Physician Decision|0|||
42279071|NCT02732119|76110684|FG001|Phase I|Physician Decision|3|||
42156320|NCT03430843|75964662|FG000|Overall Study|Death|233|||
42156321|NCT03430843|75964663|FG001|Overall Study|Death|233|||
42156322|NCT03430843|75964662|FG000|Overall Study|Sponsor Decision|17|||
42156323|NCT03430843|75964663|FG001|Overall Study|Sponsor Decision|6|||
42156324|NCT03430843|75964662|FG000|Overall Study|Withdrawal by Subject|5|||
42156325|NCT03430843|75964663|FG001|Overall Study|Withdrawal by Subject|14|||
42156326|NCT03430843|75964662|FG000|Overall Study|Lost to Follow-up|1|||
42156327|NCT03430843|75964663|FG001|Overall Study|Lost to Follow-up|3|||
42156328|NCT03382600|75964680|FG000|Overall Study|Adverse Event|3|||
42156329|NCT03382600|75964681|FG001|Overall Study|Adverse Event|3|||
42156330|NCT03382600|75964680|FG000|Overall Study|Clinical Disease Progression|2|||
42156331|NCT03382600|75964681|FG001|Overall Study|Clinical Disease Progression|4|||
42156332|NCT03382600|75964680|FG000|Overall Study|Radiological Progression|40|||
42156333|NCT03382600|75964681|FG001|Overall Study|Radiological Progression|31|||
42156334|NCT03382600|75964680|FG000|Overall Study|Withdrawal by Subject|0|||
42156335|NCT03382600|75964681|FG001|Overall Study|Withdrawal by Subject|1|||
42156336|NCT03382600|75964680|FG000|Overall Study|Other|9|||
42156337|NCT03382600|75964681|FG001|Overall Study|Other|7|||
42156338|NCT03207009|75964696|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
42156339|NCT02759861|75964700|FG000|Overall Study|Death|1|||
42156340|NCT02141074|75964730|FG000|Pre-prophylaxis|Adverse Event|3|||
42156341|NCT02141074|75964731|FG001|Pre-prophylaxis|Adverse Event|0|||
42156342|NCT02141074|75964730|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
42156343|NCT02141074|75964731|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
42156344|NCT02141074|75964730|FG000|Prophylaxis|Adverse Event|0|||
42156345|NCT02141074|75964731|FG001|Prophylaxis|Adverse Event|4|||
42156346|NCT02141074|75964730|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
42156347|NCT02141074|75964731|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
42156348|NCT02141074|75964730|FG000|Prophylaxis|Withdrawal by Subject|0|||
42156349|NCT02141074|75964731|FG001|Prophylaxis|Withdrawal by Subject|1|||
42156350|NCT01524705|75964741|FG000|Overall Study|Adverse Event|2|||
42156351|NCT01524705|75964742|FG001|Overall Study|Adverse Event|0|||
42156352|NCT01524705|75964741|FG000|Overall Study|Death|1|||
42156353|NCT01524705|75964742|FG001|Overall Study|Death|0|||
42156354|NCT01524705|75964741|FG000|Overall Study|Lost to Follow-up|0|||
42156355|NCT01524705|75964742|FG001|Overall Study|Lost to Follow-up|1|||
42156356|NCT01524705|75964741|FG000|Overall Study|Withdrawal by Subject|0|||
42156357|NCT01524705|75964742|FG001|Overall Study|Withdrawal by Subject|1|||
42156358|NCT01524705|75964741|FG000|Overall Study|Pancreatic Cancer|0|||
42040216|NCT01928394|75848588|FG022|Treatment Period|Participant request to stop therapy|3|||
42156359|NCT01524705|75964742|FG001|Overall Study|Pancreatic Cancer|1|||
42156360|NCT01072539|75964754|FG000|Overall Study|Treated prior to the Site Initiation|1|||
42156361|NCT01072539|75964754|FG000|Overall Study|Protocol Violation|2|||
42156362|NCT00147537|75964762|FG000|Phase 1b|Death|0|||
42156363|NCT00147537|75964763|FG001|Phase 1b|Death|1|||
42156364|NCT00147537|75964764|FG002|Phase 1b|Death|2|||
42156365|NCT00147537|75964765|FG003|Phase 1b|Death|1|||
42156366|NCT00147537|75964766|FG004|Phase 1b|Death|2|||
42279072|NCT02732119|76110685|FG002|Phase I|Physician Decision|4|||
42279073|NCT02732119|76110686|FG003|Phase I|Physician Decision|0|||
42279074|NCT02732119|76110687|FG004|Phase I|Physician Decision|0|||
42279075|NCT02732119|76110683|FG000|Phase II|Adverse Event|0|||
42279076|NCT02732119|76110684|FG001|Phase II|Adverse Event|0|||
42279077|NCT02732119|76110685|FG002|Phase II|Adverse Event|0|||
42013337|NCT00976573|75820465|FG001|Overall Study|Ineligible|1|||
42013338|NCT00976573|75820464|FG000|Overall Study|Cancel prior to receiving treatment|4|||
42013339|NCT00976573|75820465|FG001|Overall Study|Cancel prior to receiving treatment|2|||
42013340|NCT00976495|75820474|FG000|Overall Study|Withdrawal by Subject|0|||
42013341|NCT00976495|75820475|FG001|Overall Study|Withdrawal by Subject|1|||
42013342|NCT00976495|75820476|FG002|Overall Study|Withdrawal by Subject|0|||
42013343|NCT01288430|75820494|FG000|Part 1|Progressive disease|2|||
42013344|NCT01288430|75820495|FG001|Part 1|Progressive disease|1|||
42013345|NCT01288430|75820496|FG002|Part 1|Progressive disease|1|||
42013346|NCT01288430|75820497|FG003|Part 1|Progressive disease|6|||
42013347|NCT01288430|75820498|FG004|Part 1|Progressive disease|2|||
42013348|NCT01288430|75820499|FG005|Part 1|Progressive disease|4|||
42156367|NCT00147537|75964767|FG005|Phase 1b|Death|2|||
42156368|NCT00147537|75964768|FG006|Phase 1b|Death|1|||
42156369|NCT00147537|75964769|FG007|Phase 1b|Death|3|||
42156370|NCT00147537|75964770|FG008|Phase 1b|Death|9|||
42156371|NCT00147537|75964771|FG009|Phase 1b|Death|0|||
42156372|NCT00147537|75964772|FG010|Phase 1b|Death|0|||
42156373|NCT00147537|75964762|FG000|Phase 1b|Lost to Follow-up|2|||
42156374|NCT00147537|75964763|FG001|Phase 1b|Lost to Follow-up|1|||
42156375|NCT00147537|75964764|FG002|Phase 1b|Lost to Follow-up|0|||
42156376|NCT00147537|75964765|FG003|Phase 1b|Lost to Follow-up|0|||
42156377|NCT00147537|75964766|FG004|Phase 1b|Lost to Follow-up|0|||
42156378|NCT00147537|75964767|FG005|Phase 1b|Lost to Follow-up|0|||
42279078|NCT02732119|76110686|FG003|Phase II|Adverse Event|3|||
42279079|NCT02732119|76110687|FG004|Phase II|Adverse Event|3|||
42279080|NCT02732119|76110683|FG000|Phase II|Death|0|||
42279081|NCT02732119|76110684|FG001|Phase II|Death|0|||
42279082|NCT02732119|76110685|FG002|Phase II|Death|0|||
42279083|NCT02732119|76110686|FG003|Phase II|Death|1|||
42279084|NCT02732119|76110687|FG004|Phase II|Death|0|||
42156379|NCT00147537|75964768|FG006|Phase 1b|Lost to Follow-up|2|||
42156380|NCT00147537|75964769|FG007|Phase 1b|Lost to Follow-up|0|||
42279085|NCT02732119|76110683|FG000|Phase II|Progressive dissease|0|||
42156381|NCT00147537|75964770|FG008|Phase 1b|Lost to Follow-up|1|||
42156382|NCT00147537|75964771|FG009|Phase 1b|Lost to Follow-up|0|||
42156383|NCT00147537|75964772|FG010|Phase 1b|Lost to Follow-up|0|||
42156384|NCT00147537|75964762|FG000|Phase 1b|Other|0|||
42156385|NCT00147537|75964763|FG001|Phase 1b|Other|0|||
42156386|NCT00147537|75964764|FG002|Phase 1b|Other|2|||
42156387|NCT00147537|75964765|FG003|Phase 1b|Other|1|||
42156388|NCT00147537|75964766|FG004|Phase 1b|Other|1|||
42156389|NCT00147537|75964767|FG005|Phase 1b|Other|1|||
42156390|NCT00147537|75964768|FG006|Phase 1b|Other|14|||
42156391|NCT00147537|75964769|FG007|Phase 1b|Other|4|||
42156392|NCT00147537|75964770|FG008|Phase 1b|Other|4|||
42156393|NCT00147537|75964771|FG009|Phase 1b|Other|0|||
42156394|NCT00147537|75964772|FG010|Phase 1b|Other|0|||
42156395|NCT00147537|75964762|FG000|Phase 1b|Withdrawal by Subject|0|||
42156396|NCT00147537|75964763|FG001|Phase 1b|Withdrawal by Subject|0|||
42156397|NCT00147537|75964764|FG002|Phase 1b|Withdrawal by Subject|0|||
42156398|NCT00147537|75964765|FG003|Phase 1b|Withdrawal by Subject|0|||
42156399|NCT00147537|75964766|FG004|Phase 1b|Withdrawal by Subject|0|||
42156400|NCT00147537|75964767|FG005|Phase 1b|Withdrawal by Subject|0|||
42156401|NCT00147537|75964768|FG006|Phase 1b|Withdrawal by Subject|0|||
42156402|NCT00147537|75964769|FG007|Phase 1b|Withdrawal by Subject|0|||
42156403|NCT00147537|75964770|FG008|Phase 1b|Withdrawal by Subject|2|||
42156404|NCT00147537|75964771|FG009|Phase 1b|Withdrawal by Subject|0|||
42156405|NCT00147537|75964772|FG010|Phase 1b|Withdrawal by Subject|0|||
42156406|NCT00147537|75964762|FG000|Phase 1b|Randomized but not treated|0|||
42156407|NCT00147537|75964763|FG001|Phase 1b|Randomized but not treated|0|||
42013349|NCT01288430|75820500|FG006|Part 1|Progressive disease|2|||
42156408|NCT00147537|75964764|FG002|Phase 1b|Randomized but not treated|0|||
42156409|NCT00147537|75964765|FG003|Phase 1b|Randomized but not treated|0|||
42156410|NCT00147537|75964766|FG004|Phase 1b|Randomized but not treated|0|||
42156411|NCT00147537|75964767|FG005|Phase 1b|Randomized but not treated|0|||
42156412|NCT00147537|75964768|FG006|Phase 1b|Randomized but not treated|1|||
42156413|NCT00147537|75964769|FG007|Phase 1b|Randomized but not treated|0|||
42156414|NCT00147537|75964770|FG008|Phase 1b|Randomized but not treated|1|||
42156415|NCT00147537|75964771|FG009|Phase 1b|Randomized but not treated|0|||
42156416|NCT00147537|75964772|FG010|Phase 1b|Randomized but not treated|0|||
42156417|NCT00147537|75964762|FG000|Phase 2|Death|0|||
42279086|NCT02732119|76110684|FG001|Phase II|Progressive dissease|0|||
42279087|NCT02732119|76110685|FG002|Phase II|Progressive dissease|0|||
42279088|NCT02732119|76110686|FG003|Phase II|Progressive dissease|30|||
42013350|NCT01288430|75820501|FG007|Part 1|Progressive disease|0|||
42156418|NCT00147537|75964763|FG001|Phase 2|Death|0|||
42156419|NCT00147537|75964764|FG002|Phase 2|Death|0|||
42156420|NCT00147537|75964765|FG003|Phase 2|Death|0|||
42156421|NCT00147537|75964766|FG004|Phase 2|Death|0|||
42156422|NCT00147537|75964767|FG005|Phase 2|Death|0|||
42156423|NCT00147537|75964768|FG006|Phase 2|Death|0|||
42156424|NCT00147537|75964769|FG007|Phase 2|Death|0|||
42156425|NCT00147537|75964770|FG008|Phase 2|Death|0|||
42156426|NCT00147537|75964771|FG009|Phase 2|Death|85|||
42156427|NCT00147537|75964772|FG010|Phase 2|Death|31|||
42156428|NCT00147537|75964762|FG000|Phase 2|Lost to Follow-up|0|||
42156429|NCT00147537|75964763|FG001|Phase 2|Lost to Follow-up|0|||
42156430|NCT00147537|75964764|FG002|Phase 2|Lost to Follow-up|0|||
42279089|NCT02732119|76110687|FG004|Phase II|Progressive dissease|23|||
42351344|NCT00630058|76191261|FG000|Overall Study|stopping criteria|3|||
42156431|NCT00147537|75964765|FG003|Phase 2|Lost to Follow-up|0|||
42156432|NCT00147537|75964766|FG004|Phase 2|Lost to Follow-up|0|||
42156433|NCT00147537|75964767|FG005|Phase 2|Lost to Follow-up|0|||
42156434|NCT00147537|75964768|FG006|Phase 2|Lost to Follow-up|0|||
42156435|NCT00147537|75964769|FG007|Phase 2|Lost to Follow-up|0|||
42156436|NCT00147537|75964770|FG008|Phase 2|Lost to Follow-up|0|||
42156437|NCT00147537|75964771|FG009|Phase 2|Lost to Follow-up|12|||
42156438|NCT00147537|75964772|FG010|Phase 2|Lost to Follow-up|4|||
42156439|NCT00147537|75964762|FG000|Phase 2|Other|0|||
42156440|NCT00147537|75964763|FG001|Phase 2|Other|0|||
42156441|NCT00147537|75964764|FG002|Phase 2|Other|0|||
42156442|NCT00147537|75964765|FG003|Phase 2|Other|0|||
42156443|NCT00147537|75964766|FG004|Phase 2|Other|0|||
42156444|NCT00147537|75964767|FG005|Phase 2|Other|0|||
42156445|NCT00147537|75964768|FG006|Phase 2|Other|0|||
42156446|NCT00147537|75964769|FG007|Phase 2|Other|0|||
42156447|NCT00147537|75964770|FG008|Phase 2|Other|0|||
42156448|NCT00147537|75964771|FG009|Phase 2|Other|47|||
42156449|NCT00147537|75964772|FG010|Phase 2|Other|12|||
42156450|NCT00147537|75964762|FG000|Phase 2|Withdrawal by Subject|0|||
42156451|NCT00147537|75964763|FG001|Phase 2|Withdrawal by Subject|0|||
42156452|NCT00147537|75964764|FG002|Phase 2|Withdrawal by Subject|0|||
42156453|NCT00147537|75964765|FG003|Phase 2|Withdrawal by Subject|0|||
42156454|NCT00147537|75964766|FG004|Phase 2|Withdrawal by Subject|0|||
42156455|NCT00147537|75964767|FG005|Phase 2|Withdrawal by Subject|0|||
42156456|NCT00147537|75964768|FG006|Phase 2|Withdrawal by Subject|0|||
42156457|NCT00147537|75964769|FG007|Phase 2|Withdrawal by Subject|0|||
42156458|NCT00147537|75964770|FG008|Phase 2|Withdrawal by Subject|0|||
42156459|NCT00147537|75964771|FG009|Phase 2|Withdrawal by Subject|16|||
42156460|NCT00147537|75964772|FG010|Phase 2|Withdrawal by Subject|4|||
42156461|NCT00147537|75964762|FG000|Phase 2|Randomized but not treated|0|||
42156462|NCT00147537|75964763|FG001|Phase 2|Randomized but not treated|0|||
42156463|NCT00147537|75964764|FG002|Phase 2|Randomized but not treated|0|||
42156464|NCT00147537|75964765|FG003|Phase 2|Randomized but not treated|0|||
42156465|NCT00147537|75964766|FG004|Phase 2|Randomized but not treated|0|||
42156466|NCT00147537|75964767|FG005|Phase 2|Randomized but not treated|0|||
42156467|NCT00147537|75964768|FG006|Phase 2|Randomized but not treated|0|||
42156468|NCT00147537|75964769|FG007|Phase 2|Randomized but not treated|0|||
42156469|NCT00147537|75964770|FG008|Phase 2|Randomized but not treated|0|||
42156470|NCT00147537|75964771|FG009|Phase 2|Randomized but not treated|1|||
42156471|NCT00147537|75964772|FG010|Phase 2|Randomized but not treated|1|||
42156472|NCT00222729|75964817|FG000|Overall Study|Adverse Event|3|||
42156473|NCT00147225|75964827|FG000|Overall Study|Withdrawal by Subject|1|||
42156474|NCT00147225|75964828|FG001|Overall Study|Withdrawal by Subject|0|||
42156475|NCT00147225|75964829|FG002|Overall Study|Withdrawal by Subject|1|||
42156476|NCT00147225|75964830|FG003|Overall Study|Withdrawal by Subject|0|||
42156477|NCT00147225|75964831|FG004|Overall Study|Withdrawal by Subject|0|||
42156478|NCT00147225|75964832|FG005|Overall Study|Withdrawal by Subject|1|||
42156479|NCT00147225|75964827|FG000|Overall Study|Adverse Event|0|||
42156480|NCT00147225|75964828|FG001|Overall Study|Adverse Event|0|||
42156481|NCT00147225|75964829|FG002|Overall Study|Adverse Event|1|||
42156482|NCT00147225|75964830|FG003|Overall Study|Adverse Event|1|||
42156483|NCT00147225|75964831|FG004|Overall Study|Adverse Event|0|||
42156484|NCT00147225|75964832|FG005|Overall Study|Adverse Event|0|||
42156485|NCT00147225|75964827|FG000|Overall Study|Screen Failure|0|||
42156486|NCT00147225|75964828|FG001|Overall Study|Screen Failure|0|||
42156487|NCT00147225|75964829|FG002|Overall Study|Screen Failure|0|||
42156488|NCT00147225|75964830|FG003|Overall Study|Screen Failure|0|||
42156489|NCT00147225|75964831|FG004|Overall Study|Screen Failure|1|||
42156490|NCT00147225|75964832|FG005|Overall Study|Screen Failure|0|||
42156491|NCT00147225|75964827|FG000|Overall Study|Chemotherapy Changed|0|||
42156492|NCT00147225|75964828|FG001|Overall Study|Chemotherapy Changed|0|||
42279090|NCT02732119|76110683|FG000|Phase II|Study terminated by sponsor|0|||
42156493|NCT00147225|75964829|FG002|Overall Study|Chemotherapy Changed|0|||
42156494|NCT00147225|75964830|FG003|Overall Study|Chemotherapy Changed|0|||
42156495|NCT00147225|75964831|FG004|Overall Study|Chemotherapy Changed|0|||
42156496|NCT00147225|75964832|FG005|Overall Study|Chemotherapy Changed|1|||
42156497|NCT00222105|75964846|FG000|Overall Study|Removed due to wrong diagnosis|1|||
42156498|NCT00222105|75964846|FG000|Overall Study|Withdrawal by Subject|1|||
42156499|NCT00222105|75964846|FG000|Overall Study|Adverse Event|8|||
42156500|NCT00222105|75964846|FG000|Overall Study|Treatment delays|2|||
42156501|NCT00222105|75964846|FG000|Overall Study|Death|2|||
42156502|NCT00146757|75964850|FG000|Overall Study|Death|1|||
42156503|NCT00146757|75964851|FG001|Overall Study|Death|0|||
42156504|NCT00146757|75964850|FG000|Overall Study|Adverse Event|1|||
42156505|NCT00146757|75964851|FG001|Overall Study|Adverse Event|0|||
42156506|NCT00267098|75964865|FG000|Overall Study|Death|0|||
42156507|NCT00267098|75964866|FG001|Overall Study|Death|0|||
42156508|NCT00267098|75964867|FG002|Overall Study|Death|57|||
42156509|NCT00267098|75964868|FG003|Overall Study|Death|66|||
42156510|NCT00267098|75964869|FG004|Overall Study|Death|14|||
42156511|NCT00267098|75964870|FG005|Overall Study|Death|23|||
42156512|NCT00267098|75964871|FG006|Overall Study|Death|28|||
42156513|NCT00267098|75964872|FG007|Overall Study|Death|9|||
42156514|NCT00267098|75964865|FG000|Overall Study|Lost to Follow-up|0|||
42156515|NCT00267098|75964866|FG001|Overall Study|Lost to Follow-up|0|||
42156516|NCT00267098|75964867|FG002|Overall Study|Lost to Follow-up|6|||
42156517|NCT00267098|75964868|FG003|Overall Study|Lost to Follow-up|5|||
42156518|NCT00267098|75964869|FG004|Overall Study|Lost to Follow-up|2|||
42156519|NCT00267098|75964870|FG005|Overall Study|Lost to Follow-up|3|||
42156520|NCT00267098|75964871|FG006|Overall Study|Lost to Follow-up|1|||
42156521|NCT00267098|75964872|FG007|Overall Study|Lost to Follow-up|1|||
42156522|NCT00267098|75964865|FG000|Overall Study|Withdrawal by Subject|8|||
42156523|NCT00267098|75964866|FG001|Overall Study|Withdrawal by Subject|0|||
42156524|NCT00267098|75964867|FG002|Overall Study|Withdrawal by Subject|24|||
42156525|NCT00267098|75964868|FG003|Overall Study|Withdrawal by Subject|21|||
42156526|NCT00267098|75964869|FG004|Overall Study|Withdrawal by Subject|12|||
42156527|NCT00267098|75964870|FG005|Overall Study|Withdrawal by Subject|9|||
42156528|NCT00267098|75964871|FG006|Overall Study|Withdrawal by Subject|12|||
42156529|NCT00267098|75964872|FG007|Overall Study|Withdrawal by Subject|5|||
42156530|NCT00267098|75964865|FG000|Overall Study|Physician Decision|5|||
42156531|NCT00267098|75964866|FG001|Overall Study|Physician Decision|0|||
42156532|NCT00267098|75964867|FG002|Overall Study|Physician Decision|7|||
42156533|NCT00267098|75964868|FG003|Overall Study|Physician Decision|11|||
42156534|NCT00267098|75964869|FG004|Overall Study|Physician Decision|5|||
42156535|NCT00267098|75964870|FG005|Overall Study|Physician Decision|4|||
42156536|NCT00267098|75964871|FG006|Overall Study|Physician Decision|3|||
42156537|NCT00267098|75964872|FG007|Overall Study|Physician Decision|0|||
42156538|NCT00267098|75964865|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
42013351|NCT01288430|75820502|FG008|Part 1|Progressive disease|0|||
42013352|NCT01288430|75820503|FG009|Part 1|Progressive disease|0|||
42013353|NCT01288430|75820494|FG000|Part 1|Clinical disease progression|0|||
42013354|NCT01288430|75820495|FG001|Part 1|Clinical disease progression|0|||
42013355|NCT01288430|75820496|FG002|Part 1|Clinical disease progression|1|||
42013356|NCT01288430|75820497|FG003|Part 1|Clinical disease progression|0|||
42013357|NCT01288430|75820498|FG004|Part 1|Clinical disease progression|0|||
42156539|NCT00267098|75964866|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42156540|NCT00267098|75964867|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42156541|NCT00267098|75964868|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42156542|NCT00267098|75964869|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
42156543|NCT00267098|75964870|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42156544|NCT00267098|75964871|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42156545|NCT00267098|75964872|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42156546|NCT00267098|75964865|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
42156547|NCT00267098|75964866|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
42156548|NCT00267098|75964867|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
42156549|NCT00267098|75964868|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
42156550|NCT00267098|75964869|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
42156551|NCT00267098|75964870|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
42279091|NCT02732119|76110684|FG001|Phase II|Study terminated by sponsor|0|||
42279092|NCT02732119|76110685|FG002|Phase II|Study terminated by sponsor|0|||
42279093|NCT02732119|76110686|FG003|Phase II|Study terminated by sponsor|2|||
42279094|NCT02732119|76110687|FG004|Phase II|Study terminated by sponsor|2|||
42013358|NCT01288430|75820499|FG005|Part 1|Clinical disease progression|2|||
42013359|NCT01288430|75820500|FG006|Part 1|Clinical disease progression|2|||
42013360|NCT01288430|75820501|FG007|Part 1|Clinical disease progression|0|||
42013361|NCT01288430|75820502|FG008|Part 1|Clinical disease progression|0|||
42013362|NCT01288430|75820503|FG009|Part 1|Clinical disease progression|0|||
42013363|NCT01288430|75820494|FG000|Part 1|Death due to disease progression|0|||
42013364|NCT01288430|75820495|FG001|Part 1|Death due to disease progression|0|||
42013365|NCT01288430|75820496|FG002|Part 1|Death due to disease progression|0|||
42013366|NCT01288430|75820497|FG003|Part 1|Death due to disease progression|0|||
42013367|NCT01288430|75820498|FG004|Part 1|Death due to disease progression|1|||
42013368|NCT01288430|75820499|FG005|Part 1|Death due to disease progression|0|||
42279095|NCT02732119|76110683|FG000|Phase II|Other|0|||
42279096|NCT02732119|76110684|FG001|Phase II|Other|0|||
42013369|NCT01288430|75820500|FG006|Part 1|Death due to disease progression|0|||
42040217|NCT01928394|75848566|FG000|Treatment Period|Participant withdrew consent|0|||
42156552|NCT00267098|75964871|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
42156553|NCT00267098|75964872|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
42156554|NCT00267098|75964865|FG000|Overall Study|Site closure|0|||
42156555|NCT00267098|75964866|FG001|Overall Study|Site closure|0|||
42156556|NCT00267098|75964867|FG002|Overall Study|Site closure|0|||
42156557|NCT00267098|75964868|FG003|Overall Study|Site closure|1|||
42156558|NCT00267098|75964869|FG004|Overall Study|Site closure|0|||
42279097|NCT02732119|76110685|FG002|Phase II|Other|0|||
42279098|NCT02732119|76110686|FG003|Phase II|Other|2|||
42351345|NCT00630058|76191262|FG001|Overall Study|stopping criteria|2|||
42351346|NCT01925794|76191268|FG000|180 Days|Death|2|||
42351347|NCT01925794|76191268|FG000|180 Days|Withdrawal by Subject|2|||
42351348|NCT01925794|76191268|FG000|270 Days|Death|2|||
42351349|NCT01925794|76191268|FG000|270 Days|Protocol Violation|3|||
42351350|NCT00989950|76191280|FG000|Randomized Phase|Protocol Violation|1|||
42351351|NCT00989950|76191281|FG001|Randomized Phase|Protocol Violation|0|||
42279099|NCT02732119|76110687|FG004|Phase II|Other|0|||
42279100|NCT02732119|76110683|FG000|Phase II|Physician Decision|0|||
42279101|NCT02732119|76110684|FG001|Phase II|Physician Decision|0|||
42279102|NCT02732119|76110685|FG002|Phase II|Physician Decision|0|||
42279103|NCT02732119|76110686|FG003|Phase II|Physician Decision|8|||
42279104|NCT02732119|76110687|FG004|Phase II|Physician Decision|5|||
42279105|NCT03252925|76110710|FG000|Overall Study|Withdrawal by Subject|1|||
42279106|NCT03252925|76110711|FG001|Overall Study|Withdrawal by Subject|0|||
42279107|NCT03252925|76110710|FG000|Overall Study|Protocol Violation|6|||
42279108|NCT03252925|76110711|FG001|Overall Study|Protocol Violation|0|||
42351352|NCT00989950|76191282|FG002|Randomized Phase|Protocol Violation|0|||
42351353|NCT00989950|76191283|FG003|Randomized Phase|Protocol Violation|0|||
42351354|NCT00989950|76191280|FG000|Randomized Phase|Adverse Event|0|||
42351355|NCT00989950|76191281|FG001|Randomized Phase|Adverse Event|1|||
42013370|NCT01288430|75820501|FG007|Part 1|Death due to disease progression|0|||
42013371|NCT01288430|75820502|FG008|Part 1|Death due to disease progression|0|||
42013372|NCT01288430|75820503|FG009|Part 1|Death due to disease progression|0|||
42013373|NCT01288430|75820494|FG000|Part 1|Adverse Event|0|||
42013374|NCT01288430|75820495|FG001|Part 1|Adverse Event|0|||
42156559|NCT00267098|75964870|FG005|Overall Study|Site closure|1|||
42156560|NCT00267098|75964871|FG006|Overall Study|Site closure|1|||
42156561|NCT00267098|75964872|FG007|Overall Study|Site closure|0|||
42156562|NCT00267098|75964865|FG000|Overall Study|Explanted Medtronic device|0|||
42156563|NCT00267098|75964866|FG001|Overall Study|Explanted Medtronic device|0|||
42156564|NCT00267098|75964867|FG002|Overall Study|Explanted Medtronic device|0|||
42156565|NCT00267098|75964868|FG003|Overall Study|Explanted Medtronic device|1|||
42156566|NCT00267098|75964869|FG004|Overall Study|Explanted Medtronic device|0|||
42156567|NCT00267098|75964870|FG005|Overall Study|Explanted Medtronic device|0|||
42156568|NCT00267098|75964871|FG006|Overall Study|Explanted Medtronic device|0|||
42156569|NCT00267098|75964872|FG007|Overall Study|Explanted Medtronic device|0|||
42156570|NCT00267098|75964865|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
42156571|NCT00267098|75964866|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
42156572|NCT00267098|75964867|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
42156573|NCT00267098|75964868|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
42156574|NCT00267098|75964869|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
42156575|NCT00267098|75964870|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
42156576|NCT00267098|75964871|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
42156577|NCT00267098|75964872|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
42156578|NCT00267098|75964865|FG000|Overall Study|Subject listed for heart transplant|0|||
42156579|NCT00267098|75964866|FG001|Overall Study|Subject listed for heart transplant|0|||
42156580|NCT00267098|75964867|FG002|Overall Study|Subject listed for heart transplant|0|||
42156581|NCT00267098|75964868|FG003|Overall Study|Subject listed for heart transplant|0|||
42156582|NCT00267098|75964869|FG004|Overall Study|Subject listed for heart transplant|0|||
42156583|NCT00267098|75964870|FG005|Overall Study|Subject listed for heart transplant|0|||
42156584|NCT00267098|75964871|FG006|Overall Study|Subject listed for heart transplant|1|||
42156585|NCT00267098|75964872|FG007|Overall Study|Subject listed for heart transplant|0|||
42156586|NCT00267098|75964865|FG000|Overall Study|Sponsor withdrew subject|0|||
42156587|NCT00267098|75964866|FG001|Overall Study|Sponsor withdrew subject|0|||
42156588|NCT00267098|75964867|FG002|Overall Study|Sponsor withdrew subject|0|||
42279109|NCT03252925|76110710|FG000|Overall Study|Adverse Event|1|||
42156589|NCT00267098|75964868|FG003|Overall Study|Sponsor withdrew subject|1|||
42156590|NCT00267098|75964869|FG004|Overall Study|Sponsor withdrew subject|0|||
42279110|NCT03252925|76110711|FG001|Overall Study|Adverse Event|0|||
42351356|NCT00989950|76191282|FG002|Randomized Phase|Adverse Event|0|||
42351357|NCT00989950|76191283|FG003|Randomized Phase|Adverse Event|0|||
42351358|NCT01905943|76191293|FG000|Overall Study|Withdrawal of consent|90|||
42351359|NCT01905943|76191293|FG000|Overall Study|Lost to Follow-up|16|||
42351360|NCT01905943|76191293|FG000|Overall Study|Investigator discretion|7|||
42351361|NCT01905943|76191293|FG000|Overall Study|Death|186|||
42013375|NCT01288430|75820496|FG002|Part 1|Adverse Event|3|||
42156591|NCT00267098|75964870|FG005|Overall Study|Sponsor withdrew subject|0|||
42156592|NCT00267098|75964871|FG006|Overall Study|Sponsor withdrew subject|0|||
42156593|NCT00267098|75964872|FG007|Overall Study|Sponsor withdrew subject|0|||
42156594|NCT00247676|75964895|FG000|Overall Study|Death|5|||
42156595|NCT00247676|75964895|FG000|Overall Study|Adverse Event|11|||
42279111|NCT03252925|76110710|FG000|Overall Study|Lost to Follow-up|6|||
42351362|NCT01905943|76191293|FG000|Overall Study|Adverse Event|3|||
42351363|NCT01905943|76191293|FG000|Overall Study|Other|12|||
42351364|NCT01905553|76191314|FG000|Period 2|Adverse Event|1|||
42351365|NCT01905553|76191315|FG001|Period 2|Adverse Event|0|||
42279112|NCT03252925|76110711|FG001|Overall Study|Lost to Follow-up|6|||
42279113|NCT01327885|76110719|FG000|Overall Study|Disease progression-according to RECIST|173|||
42279114|NCT01327885|76110720|FG001|Overall Study|Disease progression-according to RECIST|165|||
42279115|NCT01327885|76110719|FG000|Overall Study|Clinical progression|24|||
42279116|NCT01327885|76110720|FG001|Overall Study|Clinical progression|27|||
42279117|NCT01327885|76110719|FG000|Overall Study|Adverse Event|14|||
42279118|NCT01327885|76110720|FG001|Overall Study|Adverse Event|10|||
42279119|NCT01327885|76110719|FG000|Overall Study|Subject choice|5|||
42279120|NCT01327885|76110720|FG001|Overall Study|Subject choice|10|||
42279121|NCT01327885|76110719|FG000|Overall Study|Other|8|||
42279122|NCT01327885|76110720|FG001|Overall Study|Other|6|||
42279123|NCT01327885|76110719|FG000|Overall Study|Withdrawal of consent from study|3|||
42279124|NCT01327885|76110720|FG001|Overall Study|Withdrawal of consent from study|4|||
42279125|NCT01327885|76110719|FG000|Overall Study|Not treated|1|||
42279126|NCT01327885|76110720|FG001|Overall Study|Not treated|1|||
42279127|NCT01327885|76110719|FG000|Overall Study|Administrative decision|0|||
42279128|NCT01327885|76110720|FG001|Overall Study|Administrative decision|1|||
42279129|NCT03420781|76110738|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
42279130|NCT03420781|76110739|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
42279131|NCT03420781|76110740|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
42279132|NCT03420781|76110741|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
42279133|NCT03420781|76110742|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
42279134|NCT03420781|76110738|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
42279135|NCT03420781|76110739|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
42279136|NCT03420781|76110740|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
42279137|NCT03420781|76110741|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
42279138|NCT03420781|76110742|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
42279139|NCT03420781|76110738|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
42279140|NCT03420781|76110739|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
42279141|NCT03420781|76110740|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
42279142|NCT03420781|76110741|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
42279143|NCT03420781|76110742|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
42279144|NCT03420781|76110738|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
42279145|NCT03420781|76110739|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
42279146|NCT03420781|76110740|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
42279147|NCT03420781|76110741|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
42279148|NCT03420781|76110742|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
42279149|NCT03420781|76110738|FG000|Treatment Period (40 Weeks)|Death|2|||
42279150|NCT03420781|76110739|FG001|Treatment Period (40 Weeks)|Death|2|||
42279151|NCT03420781|76110740|FG002|Treatment Period (40 Weeks)|Death|0|||
42279152|NCT03420781|76110741|FG003|Treatment Period (40 Weeks)|Death|0|||
42279153|NCT03420781|76110742|FG004|Treatment Period (40 Weeks)|Death|0|||
42279154|NCT03420781|76110738|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
42279155|NCT03420781|76110739|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
42279156|NCT03420781|76110740|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
42279157|NCT03420781|76110741|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
42279158|NCT03420781|76110742|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
42279159|NCT03420781|76110738|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
42279160|NCT03420781|76110739|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
42279161|NCT03420781|76110740|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
42279162|NCT03420781|76110741|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
42279163|NCT03420781|76110742|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
42279164|NCT03420781|76110738|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
42279165|NCT03420781|76110739|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
42279166|NCT03420781|76110740|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
42279167|NCT03420781|76110741|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
42279168|NCT03420781|76110742|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
42279169|NCT03420781|76110738|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
42279170|NCT03420781|76110739|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
42279171|NCT03420781|76110740|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
42279172|NCT03420781|76110741|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
42013376|NCT01288430|75820497|FG003|Part 1|Adverse Event|1|||
42013377|NCT01288430|75820498|FG004|Part 1|Adverse Event|0|||
42279173|NCT03420781|76110742|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
42279174|NCT03420781|76110738|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
42279175|NCT03420781|76110739|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
42279176|NCT03420781|76110740|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
42279177|NCT03420781|76110741|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
42279178|NCT03420781|76110742|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
42279179|NCT03420781|76110738|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
42279180|NCT03420781|76110739|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
42351366|NCT01929031|76191325|FG000|Overall Study|Adverse Event|3|||
42279181|NCT03420781|76110740|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
42279182|NCT03420781|76110741|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
42279183|NCT03420781|76110742|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
42279184|NCT03420781|76110738|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
42279185|NCT03420781|76110739|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
42279186|NCT03420781|76110740|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
42279187|NCT03420781|76110741|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
42156596|NCT00247676|75964895|FG000|Overall Study|Lack of Efficacy|15|||
42156597|NCT00247676|75964895|FG000|Overall Study|Other|3|||
42156598|NCT00247676|75964895|FG000|Overall Study|Withdrawal by Subject|2|||
42156599|NCT00267020|75964901|FG000|Overall Study|Adverse Event|22|||
42156600|NCT00267020|75964902|FG001|Overall Study|Adverse Event|5|||
42156601|NCT00267020|75964901|FG000|Overall Study|Death|2|||
42156602|NCT00267020|75964902|FG001|Overall Study|Death|1|||
42156603|NCT00267020|75964901|FG000|Overall Study|Withdrawal by Subject|17|||
42156604|NCT00267020|75964902|FG001|Overall Study|Withdrawal by Subject|7|||
42156605|NCT00267020|75964901|FG000|Overall Study|Physician Decision|3|||
42156606|NCT00267020|75964902|FG001|Overall Study|Physician Decision|2|||
42156607|NCT00267020|75964901|FG000|Overall Study|Disease Progression|39|||
42156608|NCT00267020|75964902|FG001|Overall Study|Disease Progression|25|||
42156609|NCT00267020|75964901|FG000|Overall Study|Unrelated Complication|1|||
42156610|NCT00267020|75964902|FG001|Overall Study|Unrelated Complication|1|||
42156611|NCT00267020|75964901|FG000|Overall Study|Sponsor Request|1|||
42156612|NCT00267020|75964902|FG001|Overall Study|Sponsor Request|0|||
42156613|NCT00267020|75964901|FG000|Overall Study|Other|1|||
42156614|NCT00267020|75964902|FG001|Overall Study|Other|2|||
42156615|NCT00242216|75964910|FG000|Overall Study|Lost to Follow-up|12|||
42156616|NCT00242216|75964911|FG001|Overall Study|Lost to Follow-up|17|||
42156617|NCT00242216|75964910|FG000|Overall Study|Death|4|||
42156618|NCT00242216|75964911|FG001|Overall Study|Death|2|||
42156619|NCT00242216|75964910|FG000|Overall Study|Lack of Efficacy|1|||
42156620|NCT00242216|75964911|FG001|Overall Study|Lack of Efficacy|2|||
42156621|NCT00242216|75964910|FG000|Overall Study|no medicaiton dispensed|1|||
42156622|NCT00242216|75964911|FG001|Overall Study|no medicaiton dispensed|1|||
42156623|NCT00240110|75964919|FG000|Overall Study|Lost to Follow-up|6|||
42156624|NCT00240110|75964920|FG001|Overall Study|Lost to Follow-up|7|||
42156625|NCT00239720|75964930|FG000|Overall Study|Adverse Event|1|||
42156626|NCT00239720|75964931|FG001|Overall Study|Adverse Event|0|||
42156627|NCT00239720|75964930|FG000|Overall Study|Lost to Follow-up|0|||
42156628|NCT00239720|75964931|FG001|Overall Study|Lost to Follow-up|1|||
42156629|NCT00266864|75964939|FG000|Overall Study|Lost to Follow-up|4|||
42156630|NCT00266864|75964940|FG001|Overall Study|Lost to Follow-up|1|||
42156631|NCT00266864|75964939|FG000|Overall Study|Withdrawal by Subject|1|||
42156632|NCT00266864|75964940|FG001|Overall Study|Withdrawal by Subject|1|||
42156633|NCT00266708|75964948|FG000|Overall Study|No renal function|1|||
42156634|NCT00266708|75964949|FG001|Overall Study|No renal function|1|||
42156635|NCT00266708|75964948|FG000|Overall Study|Refused biopsy|3|||
42156636|NCT00266708|75964949|FG001|Overall Study|Refused biopsy|6|||
42156637|NCT00266708|75964948|FG000|Overall Study|Asthma|0|||
42156638|NCT00266708|75964949|FG001|Overall Study|Asthma|2|||
42156639|NCT00266630|75964957|FG000|Overall Study|Adverse Event|8|||
42156640|NCT00266630|75964958|FG001|Overall Study|Adverse Event|6|||
42156641|NCT00266630|75964957|FG000|Overall Study|Lack of Efficacy|1|||
42156642|NCT00266630|75964958|FG001|Overall Study|Lack of Efficacy|4|||
42279188|NCT03420781|76110742|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
42279189|NCT03420781|76110738|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
42351367|NCT01929031|76191326|FG001|Overall Study|Adverse Event|1|||
42156643|NCT00266630|75964957|FG000|Overall Study|Entry Criteria not met|1|||
42156644|NCT00266630|75964958|FG001|Overall Study|Entry Criteria not met|0|||
42156645|NCT00266630|75964957|FG000|Overall Study|Protocol Violation|1|||
42156646|NCT00266630|75964958|FG001|Overall Study|Protocol Violation|3|||
42156647|NCT00266630|75964957|FG000|Overall Study|Physician Decision|1|||
42156648|NCT00266630|75964958|FG001|Overall Study|Physician Decision|2|||
42156649|NCT00266630|75964957|FG000|Overall Study|Withdrawal by Subject|10|||
42156650|NCT00266630|75964958|FG001|Overall Study|Withdrawal by Subject|2|||
42156651|NCT00266630|75964957|FG000|Overall Study|Lost to Follow-up|1|||
42156652|NCT00266630|75964958|FG001|Overall Study|Lost to Follow-up|0|||
42156653|NCT00266630|75964957|FG000|Overall Study|Other|19|||
42156654|NCT00266630|75964958|FG001|Overall Study|Other|11|||
42156655|NCT00129129|75964969|FG000|Primary Phase|Adverse Event|2|||
42156656|NCT00129129|75964970|FG001|Primary Phase|Adverse Event|1|||
42156657|NCT00129129|75964971|FG002|Primary Phase|Adverse Event|0|||
42156658|NCT00129129|75964972|FG003|Primary Phase|Adverse Event|0|||
42156659|NCT00129129|75964973|FG004|Primary Phase|Adverse Event|0|||
42156660|NCT00129129|75964969|FG000|Primary Phase|Withdrawal by Subject|12|||
42156661|NCT00129129|75964970|FG001|Primary Phase|Withdrawal by Subject|10|||
42156662|NCT00129129|75964971|FG002|Primary Phase|Withdrawal by Subject|0|||
42156663|NCT00129129|75964972|FG003|Primary Phase|Withdrawal by Subject|0|||
42156664|NCT00129129|75964973|FG004|Primary Phase|Withdrawal by Subject|0|||
42156665|NCT00129129|75964969|FG000|Primary Phase|Migration from study area|1|||
42156666|NCT00129129|75964970|FG001|Primary Phase|Migration from study area|3|||
42279190|NCT03420781|76110739|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
42279191|NCT03420781|76110740|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
42156667|NCT00129129|75964971|FG002|Primary Phase|Migration from study area|0|||
42156668|NCT00129129|75964972|FG003|Primary Phase|Migration from study area|0|||
42156669|NCT00129129|75964973|FG004|Primary Phase|Migration from study area|0|||
42156670|NCT00129129|75964969|FG000|Primary Phase|Lost to Follow-up|8|||
42156671|NCT00129129|75964970|FG001|Primary Phase|Lost to Follow-up|6|||
42156672|NCT00129129|75964971|FG002|Primary Phase|Lost to Follow-up|0|||
42156673|NCT00129129|75964972|FG003|Primary Phase|Lost to Follow-up|0|||
42156674|NCT00129129|75964973|FG004|Primary Phase|Lost to Follow-up|0|||
42156675|NCT00129129|75964969|FG000|Primary Phase|Other|2|||
42156676|NCT00129129|75964970|FG001|Primary Phase|Other|5|||
42156677|NCT00129129|75964971|FG002|Primary Phase|Other|0|||
42156678|NCT00129129|75964972|FG003|Primary Phase|Other|0|||
42279192|NCT03420781|76110741|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
42279193|NCT03420781|76110742|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
42279194|NCT03269695|76110760|FG000|Overall Study|Adverse Event|2|||
42279195|NCT03269695|76110761|FG001|Overall Study|Adverse Event|1|||
42279196|NCT03269695|76110760|FG000|Overall Study|Lack of Efficacy|0|||
42279197|NCT03269695|76110761|FG001|Overall Study|Lack of Efficacy|1|||
42156679|NCT00129129|75964973|FG004|Primary Phase|Other|0|||
42156680|NCT00129129|75964969|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
42156681|NCT00129129|75964970|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
42156682|NCT00129129|75964971|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
42156683|NCT00129129|75964972|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
42156684|NCT00129129|75964973|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
42156685|NCT00129129|75964969|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
42156686|NCT00129129|75964970|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
42156687|NCT00129129|75964971|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
42156688|NCT00129129|75964972|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
42156689|NCT00129129|75964973|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
42156690|NCT00129129|75964969|FG000|Fourth Dose Phase|Migration from study area|0|||
42156691|NCT00129129|75964970|FG001|Fourth Dose Phase|Migration from study area|0|||
42156692|NCT00129129|75964971|FG002|Fourth Dose Phase|Migration from study area|0|||
42156693|NCT00129129|75964972|FG003|Fourth Dose Phase|Migration from study area|0|||
42156694|NCT00129129|75964973|FG004|Fourth Dose Phase|Migration from study area|2|||
42156695|NCT00129129|75964969|FG000|Fourth Dose Phase|Other|0|||
42156696|NCT00129129|75964970|FG001|Fourth Dose Phase|Other|0|||
42156697|NCT00129129|75964971|FG002|Fourth Dose Phase|Other|0|||
42156698|NCT00129129|75964972|FG003|Fourth Dose Phase|Other|1|||
42156699|NCT00129129|75964973|FG004|Fourth Dose Phase|Other|1|||
42156700|NCT00129129|75964969|FG000|Fourth Dose Phase|Protocol Violation|0|||
42156701|NCT00129129|75964970|FG001|Fourth Dose Phase|Protocol Violation|0|||
42156702|NCT00129129|75964971|FG002|Fourth Dose Phase|Protocol Violation|0|||
42156703|NCT00129129|75964972|FG003|Fourth Dose Phase|Protocol Violation|1|||
42156704|NCT00129129|75964973|FG004|Fourth Dose Phase|Protocol Violation|0|||
42156705|NCT00221403|75964996|FG000|Overall Study|Protocol Violation|1|||
42156706|NCT00221403|75964997|FG001|Overall Study|Protocol Violation|0|||
42279198|NCT03269695|76110760|FG000|Overall Study|Withdrawal by Subject|0|||
42279199|NCT03269695|76110761|FG001|Overall Study|Withdrawal by Subject|1|||
42279200|NCT00462943|76110771|FG000|Overall Study|Failure to achieve a response|5|||
42279201|NCT00462943|76110772|FG001|Overall Study|Failure to achieve a response|5|||
42279202|NCT00462943|76110773|FG002|Overall Study|Failure to achieve a response|1|||
42279203|NCT00462943|76110771|FG000|Overall Study|Adverse Event|6|||
42279204|NCT00462943|76110772|FG001|Overall Study|Adverse Event|4|||
42013378|NCT01288430|75820499|FG005|Part 1|Adverse Event|0|||
42351368|NCT01929031|76191327|FG002|Overall Study|Adverse Event|1|||
42351369|NCT01929031|76191328|FG003|Overall Study|Adverse Event|0|||
42351370|NCT01929031|76191329|FG004|Overall Study|Adverse Event|0|||
42351371|NCT01929031|76191330|FG005|Overall Study|Adverse Event|0|||
42351372|NCT01929031|76191325|FG000|Overall Study|Protocol Violation|1|||
42013379|NCT01288430|75820500|FG006|Part 1|Adverse Event|2|||
42351373|NCT01929031|76191326|FG001|Overall Study|Protocol Violation|0|||
42156707|NCT00221403|75964998|FG002|Overall Study|Protocol Violation|0|||
42156708|NCT00221403|75964996|FG000|Overall Study|Physician Decision|1|||
42156709|NCT00221403|75964997|FG001|Overall Study|Physician Decision|0|||
42156710|NCT00221403|75964998|FG002|Overall Study|Physician Decision|0|||
42156711|NCT00221403|75964996|FG000|Overall Study|Withdrawal by Subject|0|||
42156712|NCT00221403|75964997|FG001|Overall Study|Withdrawal by Subject|3|||
42156713|NCT00221403|75964998|FG002|Overall Study|Withdrawal by Subject|0|||
42156714|NCT00221403|75964996|FG000|Overall Study|Lack of Efficacy|0|||
42156715|NCT00221403|75964997|FG001|Overall Study|Lack of Efficacy|1|||
42156716|NCT00221403|75964998|FG002|Overall Study|Lack of Efficacy|0|||
42156717|NCT00221403|75964996|FG000|Overall Study|Adverse Event|0|||
42156718|NCT00221403|75964997|FG001|Overall Study|Adverse Event|1|||
42156719|NCT00221403|75964998|FG002|Overall Study|Adverse Event|0|||
42156720|NCT00145977|75965008|FG000|Overall Study|Lack of Efficacy|0|||
42156721|NCT00145977|75965009|FG001|Overall Study|Lack of Efficacy|4|||
42156722|NCT00145977|75965008|FG000|Overall Study|Lost to Follow-up|1|||
42156723|NCT00145977|75965009|FG001|Overall Study|Lost to Follow-up|0|||
42156724|NCT00145977|75965008|FG000|Overall Study|Withdrawal by Subject|1|||
42156725|NCT00145977|75965009|FG001|Overall Study|Withdrawal by Subject|0|||
42156726|NCT00238238|75965018|FG000|Overall Study|Withdrawal by Subject|0|||
42156727|NCT00238238|75965019|FG001|Overall Study|Withdrawal by Subject|3|||
42156728|NCT00238238|75965020|FG002|Overall Study|Withdrawal by Subject|0|||
42156729|NCT00128661|75965030|FG000|Overall Study|Adverse Event|14|||
42156730|NCT00128661|75965031|FG001|Overall Study|Adverse Event|11|||
42156731|NCT00128661|75965030|FG000|Overall Study|Lost to Follow-up|10|||
42156732|NCT00128661|75965031|FG001|Overall Study|Lost to Follow-up|7|||
42156733|NCT00128661|75965030|FG000|Overall Study|Withdrawal by Subject|243|||
42156734|NCT00128661|75965031|FG001|Overall Study|Withdrawal by Subject|232|||
42156735|NCT00128661|75965030|FG000|Overall Study|Other|7|||
42156736|NCT00128661|75965031|FG001|Overall Study|Other|8|||
42156737|NCT00145509|75965039|FG000|Overall Study|Adverse Event|10|||
42156738|NCT00145509|75965040|FG001|Overall Study|Adverse Event|3|||
42156739|NCT00145509|75965039|FG000|Overall Study|Lack of Efficacy|3|||
42156740|NCT00145509|75965040|FG001|Overall Study|Lack of Efficacy|1|||
42156741|NCT00145509|75965039|FG000|Overall Study|Lost to Follow-up|5|||
42156742|NCT00145509|75965040|FG001|Overall Study|Lost to Follow-up|9|||
42156743|NCT00145509|75965039|FG000|Overall Study|Withdrew Consent|2|||
42156744|NCT00145509|75965040|FG001|Overall Study|Withdrew Consent|7|||
42156745|NCT00145509|75965039|FG000|Overall Study|Reason not provided|2|||
42156746|NCT00145509|75965040|FG001|Overall Study|Reason not provided|1|||
42156747|NCT00145119|75965046|FG000|Overall Study|Death|45|||
42156748|NCT00220779|75965053|FG000|Overall Study|Adverse Event|1|||
42156749|NCT00220779|75965054|FG001|Overall Study|Adverse Event|0|||
42156750|NCT00220779|75965055|FG002|Overall Study|Adverse Event|0|||
42156751|NCT00220779|75965053|FG000|Overall Study|Withdrawal by Subject|1|||
42156752|NCT00220779|75965054|FG001|Overall Study|Withdrawal by Subject|4|||
42156753|NCT00220779|75965055|FG002|Overall Study|Withdrawal by Subject|1|||
42156754|NCT00220779|75965053|FG000|Overall Study|Non-compliance|1|||
42156755|NCT00220779|75965054|FG001|Overall Study|Non-compliance|0|||
42156756|NCT00220779|75965055|FG002|Overall Study|Non-compliance|0|||
42156757|NCT00220779|75965053|FG000|Overall Study|Too time consuming|1|||
42156758|NCT00220779|75965054|FG001|Overall Study|Too time consuming|0|||
42156759|NCT00220779|75965055|FG002|Overall Study|Too time consuming|0|||
42156760|NCT00220779|75965053|FG000|Overall Study|Pregnancy|0|||
42156761|NCT00220779|75965054|FG001|Overall Study|Pregnancy|0|||
42156762|NCT00220779|75965055|FG002|Overall Study|Pregnancy|2|||
42156763|NCT00220779|75965053|FG000|Overall Study|Lack of Efficacy|3|||
42156764|NCT00220779|75965054|FG001|Overall Study|Lack of Efficacy|0|||
42156765|NCT00220779|75965055|FG002|Overall Study|Lack of Efficacy|1|||
42156766|NCT00207740|75965067|FG000|Overall Study|Adverse Event|4|||
42156767|NCT00207740|75965068|FG001|Overall Study|Adverse Event|14|||
42156768|NCT00207740|75965069|FG002|Overall Study|Adverse Event|14|||
42156769|NCT00207740|75965070|FG003|Overall Study|Adverse Event|11|||
42156770|NCT00207740|75965067|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42279205|NCT00462943|76110773|FG002|Overall Study|Adverse Event|1|||
42279206|NCT00462943|76110771|FG000|Overall Study|Protocol Violation|1|||
42279207|NCT00462943|76110772|FG001|Overall Study|Protocol Violation|0|||
42156771|NCT00207740|75965068|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42156772|NCT00207740|75965069|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
42156773|NCT00207740|75965070|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
42156774|NCT00207740|75965067|FG000|Overall Study|Lost to Follow-up|0|||
42156775|NCT00207740|75965068|FG001|Overall Study|Lost to Follow-up|2|||
42156776|NCT00207740|75965069|FG002|Overall Study|Lost to Follow-up|1|||
42156777|NCT00207740|75965070|FG003|Overall Study|Lost to Follow-up|1|||
42156778|NCT00207740|75965067|FG000|Overall Study|Death|0|||
42156779|NCT00207740|75965068|FG001|Overall Study|Death|0|||
42156780|NCT00207740|75965069|FG002|Overall Study|Death|0|||
42156781|NCT00207740|75965070|FG003|Overall Study|Death|1|||
42156782|NCT00207740|75965067|FG000|Overall Study|Sponsor Directive|22|||
42156783|NCT00207740|75965068|FG001|Overall Study|Sponsor Directive|15|||
42156784|NCT00207740|75965069|FG002|Overall Study|Sponsor Directive|16|||
42156785|NCT00207740|75965070|FG003|Overall Study|Sponsor Directive|21|||
42156786|NCT00207740|75965067|FG000|Overall Study|Other|2|||
42156787|NCT00207740|75965068|FG001|Overall Study|Other|10|||
42156788|NCT00207740|75965069|FG002|Overall Study|Other|7|||
42156789|NCT00207740|75965070|FG003|Overall Study|Other|5|||
42156790|NCT00265382|75965084|FG000|Overall Study|Adverse Event|21|||
42156791|NCT00265382|75965084|FG000|Overall Study|Laboratory Abnormality|1|||
42156792|NCT00265382|75965084|FG000|Overall Study|Lost to Follow-up|3|||
42279208|NCT00462943|76110773|FG002|Overall Study|Protocol Violation|0|||
42279209|NCT00462943|76110771|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
42279210|NCT00462943|76110772|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
42279211|NCT00462943|76110773|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
42279212|NCT00462943|76110771|FG000|Overall Study|Disease Progression|15|||
42279213|NCT00462943|76110772|FG001|Overall Study|Disease Progression|15|||
42279214|NCT00462943|76110773|FG002|Overall Study|Disease Progression|9|||
42279215|NCT00462943|76110771|FG000|Overall Study|Death|5|||
42279216|NCT00462943|76110772|FG001|Overall Study|Death|2|||
42279217|NCT00462943|76110773|FG002|Overall Study|Death|7|||
42279218|NCT00462943|76110771|FG000|Overall Study|Stem Cell Transplant|1|||
42279219|NCT00462943|76110772|FG001|Overall Study|Stem Cell Transplant|1|||
42279220|NCT00462943|76110773|FG002|Overall Study|Stem Cell Transplant|0|||
42351374|NCT01929031|76191327|FG002|Overall Study|Protocol Violation|0|||
42013380|NCT01288430|75820501|FG007|Part 1|Adverse Event|0|||
42013381|NCT01288430|75820502|FG008|Part 1|Adverse Event|0|||
42156793|NCT00265382|75965084|FG000|Overall Study|Lack of Efficacy|6|||
42156794|NCT00265382|75965084|FG000|Overall Study|Miscellaneous|6|||
42156795|NCT00265382|75965084|FG000|Overall Study|Withdrawal by Subject|13|||
42156796|NCT00265382|75965084|FG000|Overall Study|Study terminated by sponsor|94|||
42156797|NCT00265382|75965084|FG000|Overall Study|Death|1|||
42156798|NCT00206726|75965088|FG000|Overall Study|Delayed recovery of blood counts|1|||
42156799|NCT00206726|75965088|FG000|Overall Study|Progressive disease or relapsed disease|18|||
42156800|NCT00206726|75965088|FG000|Overall Study|Placed on new protocol|1|||
42156801|NCT00206726|75965088|FG000|Overall Study|Bone marrow transplant|1|||
42156802|NCT00206726|75965088|FG000|Overall Study|Adverse Event|17|||
42156803|NCT00206726|75965088|FG000|Overall Study|Death|4|||
42156804|NCT00206726|75965088|FG000|Overall Study|Protocol Violation|1|||
42156805|NCT00206726|75965088|FG000|Overall Study|Withdrawal by Subject|8|||
42156806|NCT00237692|75965096|FG000|Overall Study|Lost to Follow-up|9|||
42013382|NCT01288430|75820503|FG009|Part 1|Adverse Event|0|||
42013383|NCT01288430|75820494|FG000|Part 1|Other|0|||
42156807|NCT00237692|75965097|FG001|Overall Study|Lost to Follow-up|3|||
42156808|NCT00237692|75965098|FG002|Overall Study|Lost to Follow-up|5|||
42156809|NCT00237692|75965099|FG003|Overall Study|Lost to Follow-up|3|||
42156810|NCT00237692|75965096|FG000|Overall Study|Death|1|||
42156811|NCT00237692|75965097|FG001|Overall Study|Death|2|||
42156812|NCT00237692|75965098|FG002|Overall Study|Death|2|||
42156813|NCT00237692|75965099|FG003|Overall Study|Death|3|||
42156814|NCT00237692|75965096|FG000|Overall Study|Excluded - did not meet criteria|4|||
42156815|NCT00237692|75965097|FG001|Overall Study|Excluded - did not meet criteria|3|||
42156816|NCT00237692|75965098|FG002|Overall Study|Excluded - did not meet criteria|5|||
42156817|NCT00237692|75965099|FG003|Overall Study|Excluded - did not meet criteria|9|||
42156818|NCT00237692|75965096|FG000|Overall Study|Withdrawal by Subject|4|||
42156819|NCT00237692|75965097|FG001|Overall Study|Withdrawal by Subject|6|||
42156820|NCT00237692|75965098|FG002|Overall Study|Withdrawal by Subject|10|||
42156821|NCT00237692|75965099|FG003|Overall Study|Withdrawal by Subject|4|||
42156822|NCT00237458|75965109|FG000|Overall Study|Lack of Efficacy|1|||
42156823|NCT00237458|75965109|FG000|Overall Study|Adverse Event|1|||
42156824|NCT00237458|75965109|FG000|Overall Study|Withdrawal by Subject|1|||
42156825|NCT00265148|75965115|FG000|Overall Study|Adverse Event|2|||
42156826|NCT00265148|75965116|FG001|Overall Study|Adverse Event|2|||
42156827|NCT00265148|75965115|FG000|Overall Study|Lack of Efficacy|0|||
42156828|NCT00265148|75965116|FG001|Overall Study|Lack of Efficacy|2|||
42156829|NCT00265148|75965115|FG000|Overall Study|Protocol Violation|3|||
42279221|NCT00462943|76110771|FG000|Overall Study|Bone Marrow Transplant|1|||
42013384|NCT01288430|75820495|FG001|Part 1|Other|2|||
42013385|NCT01288430|75820496|FG002|Part 1|Other|0|||
42013386|NCT01288430|75820497|FG003|Part 1|Other|0|||
42156830|NCT00265148|75965116|FG001|Overall Study|Protocol Violation|2|||
42156831|NCT00265148|75965115|FG000|Overall Study|Lost to Follow-up|0|||
42156832|NCT00265148|75965116|FG001|Overall Study|Lost to Follow-up|1|||
42156833|NCT00265148|75965115|FG000|Overall Study|Withdrawal by Subject|2|||
42156834|NCT00265148|75965116|FG001|Overall Study|Withdrawal by Subject|1|||
42156835|NCT00265148|75965115|FG000|Overall Study|Physician Decision|1|||
42156836|NCT00265148|75965116|FG001|Overall Study|Physician Decision|0|||
42156837|NCT00265148|75965115|FG000|Overall Study|Increasing frailty|0|||
42279222|NCT00462943|76110772|FG001|Overall Study|Bone Marrow Transplant|0|||
42279223|NCT00462943|76110773|FG002|Overall Study|Bone Marrow Transplant|0|||
42351375|NCT01929031|76191328|FG003|Overall Study|Protocol Violation|0|||
42013387|NCT01288430|75820498|FG004|Part 1|Other|0|||
42013388|NCT01288430|75820499|FG005|Part 1|Other|0|||
42156838|NCT00265148|75965116|FG001|Overall Study|Increasing frailty|1|||
42156839|NCT00265148|75965115|FG000|Overall Study|Subject chose to change of the dose|1|||
42156840|NCT00265148|75965116|FG001|Overall Study|Subject chose to change of the dose|0|||
42156841|NCT00043186|75965132|FG000|Overall Study|Physician Decision|0|||
42156842|NCT00043186|75965133|FG001|Overall Study|Physician Decision|0|||
42156843|NCT00043186|75965134|FG002|Overall Study|Physician Decision|3|||
42156844|NCT00043186|75965135|FG003|Overall Study|Physician Decision|0|||
42156845|NCT00043186|75965136|FG004|Overall Study|Physician Decision|1|||
42156846|NCT00043186|75965137|FG005|Overall Study|Physician Decision|0|||
42156847|NCT00043186|75965138|FG006|Overall Study|Physician Decision|0|||
42156848|NCT00043186|75965139|FG007|Overall Study|Physician Decision|1|||
42156849|NCT00043186|75965140|FG008|Overall Study|Physician Decision|1|||
42156850|NCT00043186|75965132|FG000|Overall Study|Adverse Event|2|||
42156851|NCT00043186|75965133|FG001|Overall Study|Adverse Event|2|||
42156852|NCT00043186|75965134|FG002|Overall Study|Adverse Event|2|||
42156853|NCT00043186|75965135|FG003|Overall Study|Adverse Event|3|||
42156854|NCT00043186|75965136|FG004|Overall Study|Adverse Event|2|||
42156855|NCT00043186|75965137|FG005|Overall Study|Adverse Event|1|||
42156856|NCT00043186|75965138|FG006|Overall Study|Adverse Event|2|||
42156857|NCT00043186|75965139|FG007|Overall Study|Adverse Event|1|||
42156858|NCT00043186|75965140|FG008|Overall Study|Adverse Event|3|||
42156859|NCT00043186|75965132|FG000|Overall Study|Withdrawal by Subject|11|||
42156860|NCT00043186|75965133|FG001|Overall Study|Withdrawal by Subject|8|||
42156861|NCT00043186|75965134|FG002|Overall Study|Withdrawal by Subject|11|||
42156862|NCT00043186|75965135|FG003|Overall Study|Withdrawal by Subject|13|||
42156863|NCT00043186|75965136|FG004|Overall Study|Withdrawal by Subject|14|||
42156864|NCT00043186|75965137|FG005|Overall Study|Withdrawal by Subject|6|||
42156865|NCT00043186|75965138|FG006|Overall Study|Withdrawal by Subject|12|||
42156866|NCT00043186|75965139|FG007|Overall Study|Withdrawal by Subject|9|||
42156867|NCT00043186|75965140|FG008|Overall Study|Withdrawal by Subject|10|||
42156868|NCT00043186|75965132|FG000|Overall Study|Death|0|||
42156869|NCT00043186|75965133|FG001|Overall Study|Death|0|||
42156870|NCT00043186|75965134|FG002|Overall Study|Death|1|||
42156871|NCT00043186|75965135|FG003|Overall Study|Death|0|||
42156872|NCT00043186|75965136|FG004|Overall Study|Death|0|||
42156873|NCT00043186|75965137|FG005|Overall Study|Death|0|||
42156874|NCT00043186|75965138|FG006|Overall Study|Death|2|||
42156875|NCT00043186|75965139|FG007|Overall Study|Death|0|||
42156876|NCT00043186|75965140|FG008|Overall Study|Death|0|||
42156877|NCT00043186|75965132|FG000|Overall Study|Disease progression|1|||
42156878|NCT00043186|75965133|FG001|Overall Study|Disease progression|0|||
42156879|NCT00043186|75965134|FG002|Overall Study|Disease progression|0|||
42279224|NCT00462943|76110771|FG000|Overall Study|Required Lymphocyte Infusion|1|||
42279225|NCT00462943|76110772|FG001|Overall Study|Required Lymphocyte Infusion|0|||
42279226|NCT00462943|76110773|FG002|Overall Study|Required Lymphocyte Infusion|0|||
42279227|NCT00462943|76110771|FG000|Overall Study|Transplant - not specified|1|||
42279228|NCT00462943|76110772|FG001|Overall Study|Transplant - not specified|0|||
42279229|NCT00462943|76110773|FG002|Overall Study|Transplant - not specified|1|||
42279230|NCT00462943|76110771|FG000|Overall Study|Physician Decision|1|||
42279231|NCT00462943|76110772|FG001|Overall Study|Physician Decision|0|||
42279232|NCT00462943|76110773|FG002|Overall Study|Physician Decision|0|||
42279233|NCT00462943|76110771|FG000|Overall Study|Withdrawal by Subject|0|||
42279234|NCT00462943|76110772|FG001|Overall Study|Withdrawal by Subject|1|||
42279235|NCT00462943|76110773|FG002|Overall Study|Withdrawal by Subject|0|||
42279236|NCT02730793|76110797|FG000|Overall Study|Physician Decision|0|||
42279237|NCT02730793|76110798|FG001|Overall Study|Physician Decision|1|||
42279238|NCT02730793|76110797|FG000|Overall Study|Withdrawal by Subject|0|||
42279239|NCT02730793|76110798|FG001|Overall Study|Withdrawal by Subject|1|||
42279240|NCT02855125|76110806|FG000|Overall Study|Withdrawal by Subject|2|||
42279241|NCT02855125|76110807|FG001|Overall Study|Withdrawal by Subject|2|||
42279242|NCT02855125|76110806|FG000|Overall Study|Clinical Disease Progression|5|||
42279243|NCT02855125|76110807|FG001|Overall Study|Clinical Disease Progression|4|||
42279244|NCT02855125|76110806|FG000|Overall Study|Radiologic Disease Progression|36|||
42279245|NCT02855125|76110807|FG001|Overall Study|Radiologic Disease Progression|39|||
42279246|NCT02855125|76110806|FG000|Overall Study|Adverse Event|11|||
42279247|NCT02855125|76110807|FG001|Overall Study|Adverse Event|7|||
42156880|NCT00043186|75965135|FG003|Overall Study|Disease progression|3|||
42156881|NCT00043186|75965136|FG004|Overall Study|Disease progression|0|||
42156882|NCT00043186|75965137|FG005|Overall Study|Disease progression|0|||
42156883|NCT00043186|75965138|FG006|Overall Study|Disease progression|0|||
42156884|NCT00043186|75965139|FG007|Overall Study|Disease progression|4|||
42156885|NCT00043186|75965140|FG008|Overall Study|Disease progression|0|||
42156886|NCT00043186|75965132|FG000|Overall Study|Ineligibility determined|0|||
42156887|NCT00043186|75965133|FG001|Overall Study|Ineligibility determined|0|||
42279248|NCT02855125|76110806|FG000|Overall Study|Physician Decision|1|||
42279249|NCT02855125|76110807|FG001|Overall Study|Physician Decision|0|||
42279250|NCT02855125|76110806|FG000|Overall Study|On Treatment|9|||
42279251|NCT02855125|76110807|FG001|Overall Study|On Treatment|11|||
42279252|NCT02855125|76110806|FG000|Overall Study|Randomized but not treated|0|||
42279253|NCT02855125|76110807|FG001|Overall Study|Randomized but not treated|1|||
42156888|NCT00043186|75965134|FG002|Overall Study|Ineligibility determined|0|||
42156889|NCT00043186|75965135|FG003|Overall Study|Ineligibility determined|0|||
42156890|NCT00043186|75965136|FG004|Overall Study|Ineligibility determined|0|||
42156891|NCT00043186|75965137|FG005|Overall Study|Ineligibility determined|0|||
42279254|NCT02730871|76110830|FG000|Overall Study|Adverse Event|6|||
42279255|NCT02730871|76110831|FG001|Overall Study|Adverse Event|0|||
42279256|NCT03376789|76110839|FG000|Overall Study|Withdrawal by Subject|3|||
42279257|NCT03376789|76110840|FG001|Overall Study|Withdrawal by Subject|5|||
42279258|NCT03376789|76110839|FG000|Overall Study|Protocol Violation|0|||
42279259|NCT03376789|76110840|FG001|Overall Study|Protocol Violation|1|||
42279260|NCT03376789|76110839|FG000|Overall Study|Adverse Event|0|||
42279261|NCT03376789|76110840|FG001|Overall Study|Adverse Event|1|||
42279262|NCT03376789|76110839|FG000|Overall Study|Lost to Follow-up|1|||
42279263|NCT03376789|76110840|FG001|Overall Study|Lost to Follow-up|1|||
42279264|NCT03376789|76110839|FG000|Overall Study|Per sponsor due to noncompliance|1|||
42279265|NCT03376789|76110840|FG001|Overall Study|Per sponsor due to noncompliance|0|||
42279266|NCT03376789|76110839|FG000|Overall Study|Subject off study medication|0|||
42279267|NCT03376789|76110840|FG001|Overall Study|Subject off study medication|1|||
42279268|NCT04032093|76110856|FG000|Overall Study|Lost to Follow-up|7|||
42279269|NCT04032093|76110857|FG001|Overall Study|Lost to Follow-up|7|||
42279270|NCT04032093|76110858|FG002|Overall Study|Lost to Follow-up|6|||
42279271|NCT04032093|76110859|FG003|Overall Study|Lost to Follow-up|10|||
42279272|NCT04032093|76110860|FG004|Overall Study|Lost to Follow-up|13|||
42279273|NCT04032093|76110861|FG005|Overall Study|Lost to Follow-up|7|||
42279274|NCT04032093|76110862|FG006|Overall Study|Lost to Follow-up|7|||
42279275|NCT04032093|76110863|FG007|Overall Study|Lost to Follow-up|5|||
42279276|NCT04032093|76110864|FG008|Overall Study|Lost to Follow-up|9|||
42279277|NCT04032093|76110865|FG009|Overall Study|Lost to Follow-up|12|||
42279278|NCT04032093|76110856|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
42279279|NCT04032093|76110857|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
42279280|NCT04032093|76110858|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
42279281|NCT04032093|76110859|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
42279282|NCT04032093|76110860|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
42279283|NCT04032093|76110861|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
42279284|NCT04032093|76110862|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
42279285|NCT04032093|76110863|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
42279286|NCT04032093|76110864|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
42279287|NCT04032093|76110865|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
42279288|NCT04032093|76110856|FG000|Overall Study|Other|1|||
42279289|NCT04032093|76110857|FG001|Overall Study|Other|0|||
42279290|NCT04032093|76110858|FG002|Overall Study|Other|0|||
42279291|NCT04032093|76110859|FG003|Overall Study|Other|1|||
42279292|NCT04032093|76110860|FG004|Overall Study|Other|1|||
42279293|NCT04032093|76110861|FG005|Overall Study|Other|0|||
42279294|NCT04032093|76110862|FG006|Overall Study|Other|0|||
42279295|NCT04032093|76110863|FG007|Overall Study|Other|0|||
42279296|NCT04032093|76110864|FG008|Overall Study|Other|0|||
42279297|NCT04032093|76110865|FG009|Overall Study|Other|1|||
42279298|NCT04032093|76110856|FG000|Overall Study|Withdrawal by Subject|1|||
42279299|NCT04032093|76110857|FG001|Overall Study|Withdrawal by Subject|3|||
42279300|NCT04032093|76110858|FG002|Overall Study|Withdrawal by Subject|2|||
42279301|NCT04032093|76110859|FG003|Overall Study|Withdrawal by Subject|2|||
42279302|NCT04032093|76110860|FG004|Overall Study|Withdrawal by Subject|3|||
42279303|NCT04032093|76110861|FG005|Overall Study|Withdrawal by Subject|0|||
42279304|NCT04032093|76110862|FG006|Overall Study|Withdrawal by Subject|0|||
42279305|NCT04032093|76110863|FG007|Overall Study|Withdrawal by Subject|0|||
42279306|NCT04032093|76110864|FG008|Overall Study|Withdrawal by Subject|0|||
42279307|NCT04032093|76110865|FG009|Overall Study|Withdrawal by Subject|0|||
42279308|NCT04032093|76110856|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42279309|NCT04032093|76110857|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
42279310|NCT04032093|76110858|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
42279311|NCT04032093|76110859|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
42279312|NCT04032093|76110860|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
42279313|NCT04032093|76110861|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
42279314|NCT04032093|76110862|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
42279315|NCT04032093|76110863|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
42040218|NCT01928394|75848567|FG001|Treatment Period|Participant withdrew consent|0|||
42279316|NCT04032093|76110864|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
42279317|NCT04032093|76110865|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
42279318|NCT04032093|76110856|FG000|Overall Study|Adverse Event|0|||
42279319|NCT04032093|76110857|FG001|Overall Study|Adverse Event|0|||
42279320|NCT04032093|76110858|FG002|Overall Study|Adverse Event|0|||
42279321|NCT04032093|76110859|FG003|Overall Study|Adverse Event|0|||
42279322|NCT04032093|76110860|FG004|Overall Study|Adverse Event|0|||
42279323|NCT04032093|76110861|FG005|Overall Study|Adverse Event|0|||
42279324|NCT04032093|76110862|FG006|Overall Study|Adverse Event|0|||
42279325|NCT04032093|76110863|FG007|Overall Study|Adverse Event|0|||
42279326|NCT04032093|76110864|FG008|Overall Study|Adverse Event|0|||
42279327|NCT04032093|76110865|FG009|Overall Study|Adverse Event|1|||
42279328|NCT04032093|76110856|FG000|Overall Study|Physician Decision|0|||
42279329|NCT04032093|76110857|FG001|Overall Study|Physician Decision|0|||
42279330|NCT04032093|76110858|FG002|Overall Study|Physician Decision|0|||
42279331|NCT04032093|76110859|FG003|Overall Study|Physician Decision|0|||
42279332|NCT04032093|76110860|FG004|Overall Study|Physician Decision|0|||
42279333|NCT04032093|76110861|FG005|Overall Study|Physician Decision|1|||
42279334|NCT04032093|76110862|FG006|Overall Study|Physician Decision|0|||
42279335|NCT04032093|76110863|FG007|Overall Study|Physician Decision|0|||
42279336|NCT04032093|76110864|FG008|Overall Study|Physician Decision|0|||
42279337|NCT04032093|76110865|FG009|Overall Study|Physician Decision|0|||
42279338|NCT01675167|76110889|FG000|Open-label Titration Phase|Adverse Event|81|||
42279339|NCT01675167|76110890|FG001|Open-label Titration Phase|Adverse Event|0|||
42279340|NCT01675167|76110891|FG002|Open-label Titration Phase|Adverse Event|0|||
42279341|NCT01675167|76110889|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
42279342|NCT01675167|76110890|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
42279343|NCT01675167|76110891|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
42279344|NCT01675167|76110889|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
42279345|NCT01675167|76110890|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
42279346|NCT01675167|76110891|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
42279347|NCT01675167|76110889|FG000|Open-label Titration Phase|Protocol Violation|43|||
42279348|NCT01675167|76110890|FG001|Open-label Titration Phase|Protocol Violation|0|||
42279349|NCT01675167|76110891|FG002|Open-label Titration Phase|Protocol Violation|0|||
42279350|NCT01675167|76110889|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
42279351|NCT01675167|76110890|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
42279352|NCT01675167|76110891|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
42279353|NCT01675167|76110889|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
42013389|NCT01288430|75820500|FG006|Part 1|Other|1|||
42013390|NCT01288430|75820501|FG007|Part 1|Other|0|||
42013391|NCT01288430|75820502|FG008|Part 1|Other|0|||
42013392|NCT01288430|75820503|FG009|Part 1|Other|0|||
42013393|NCT01288430|75820494|FG000|Part 2|Progressive disease|0|||
42013394|NCT01288430|75820495|FG001|Part 2|Progressive disease|0|||
42013395|NCT01288430|75820496|FG002|Part 2|Progressive disease|0|||
42013396|NCT01288430|75820497|FG003|Part 2|Progressive disease|0|||
42013397|NCT01288430|75820498|FG004|Part 2|Progressive disease|0|||
42013398|NCT01288430|75820499|FG005|Part 2|Progressive disease|0|||
42013399|NCT01288430|75820500|FG006|Part 2|Progressive disease|0|||
42013400|NCT01288430|75820501|FG007|Part 2|Progressive disease|8|||
42013401|NCT01288430|75820502|FG008|Part 2|Progressive disease|7|||
42013402|NCT01288430|75820503|FG009|Part 2|Progressive disease|2|||
42013403|NCT01288430|75820494|FG000|Part 2|Clinical disease progression|0|||
42013404|NCT01288430|75820495|FG001|Part 2|Clinical disease progression|0|||
42013405|NCT01288430|75820496|FG002|Part 2|Clinical disease progression|0|||
42013406|NCT01288430|75820497|FG003|Part 2|Clinical disease progression|0|||
42156892|NCT00043186|75965138|FG006|Overall Study|Ineligibility determined|0|||
42156893|NCT00043186|75965139|FG007|Overall Study|Ineligibility determined|0|||
42156894|NCT00043186|75965140|FG008|Overall Study|Ineligibility determined|1|||
42156895|NCT00043186|75965132|FG000|Overall Study|Lost to Follow-up|3|||
42156896|NCT00043186|75965133|FG001|Overall Study|Lost to Follow-up|5|||
42156897|NCT00043186|75965134|FG002|Overall Study|Lost to Follow-up|1|||
42156898|NCT00043186|75965135|FG003|Overall Study|Lost to Follow-up|1|||
42156899|NCT00043186|75965136|FG004|Overall Study|Lost to Follow-up|1|||
42156900|NCT00043186|75965137|FG005|Overall Study|Lost to Follow-up|1|||
42156901|NCT00043186|75965138|FG006|Overall Study|Lost to Follow-up|1|||
42156902|NCT00043186|75965139|FG007|Overall Study|Lost to Follow-up|1|||
42156903|NCT00043186|75965140|FG008|Overall Study|Lost to Follow-up|2|||
42156904|NCT00043186|75965132|FG000|Overall Study|Noncompliance|0|||
42156905|NCT00043186|75965133|FG001|Overall Study|Noncompliance|0|||
42156906|NCT00043186|75965134|FG002|Overall Study|Noncompliance|1|||
42156907|NCT00043186|75965135|FG003|Overall Study|Noncompliance|1|||
42156908|NCT00043186|75965136|FG004|Overall Study|Noncompliance|0|||
42013407|NCT01288430|75820498|FG004|Part 2|Clinical disease progression|0|||
42013408|NCT01288430|75820499|FG005|Part 2|Clinical disease progression|0|||
42156909|NCT00043186|75965137|FG005|Overall Study|Noncompliance|0|||
42156910|NCT00043186|75965138|FG006|Overall Study|Noncompliance|0|||
42156911|NCT00043186|75965139|FG007|Overall Study|Noncompliance|0|||
42279354|NCT01675167|76110890|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
42279355|NCT01675167|76110891|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
42279356|NCT01675167|76110889|FG000|Open-label Titration Phase|Other|55|||
42279357|NCT01675167|76110890|FG001|Open-label Titration Phase|Other|0|||
42279358|NCT01675167|76110891|FG002|Open-label Titration Phase|Other|0|||
42279359|NCT01675167|76110889|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
42013409|NCT01288430|75820500|FG006|Part 2|Clinical disease progression|0|||
42156912|NCT00043186|75965140|FG008|Overall Study|Noncompliance|0|||
42156913|NCT00043186|75965132|FG000|Overall Study|Other|0|||
42156914|NCT00043186|75965133|FG001|Overall Study|Other|0|||
42156915|NCT00043186|75965134|FG002|Overall Study|Other|1|||
42156916|NCT00043186|75965135|FG003|Overall Study|Other|1|||
42156917|NCT00043186|75965136|FG004|Overall Study|Other|0|||
42156918|NCT00043186|75965137|FG005|Overall Study|Other|0|||
42156919|NCT00043186|75965138|FG006|Overall Study|Other|0|||
42156920|NCT00043186|75965139|FG007|Overall Study|Other|0|||
42156921|NCT00043186|75965140|FG008|Overall Study|Other|0|||
42156922|NCT00041470|75965161|FG000|Overall Study|Loss of Funding|38|||
42156923|NCT00206102|75965167|FG000|Overall Study|Adverse Event|119|||
42156924|NCT00206102|75965168|FG001|Overall Study|Adverse Event|82|||
42156925|NCT00206102|75965167|FG000|Overall Study|Protocol Violation|0|||
42156926|NCT00206102|75965168|FG001|Overall Study|Protocol Violation|2|||
42156927|NCT00206102|75965167|FG000|Overall Study|Lack of therapeutic response|16|||
42156928|NCT00206102|75965168|FG001|Overall Study|Lack of therapeutic response|11|||
42156929|NCT00206102|75965167|FG000|Overall Study|Lost to Follow-up|95|||
42156930|NCT00206102|75965168|FG001|Overall Study|Lost to Follow-up|66|||
42156931|NCT00206102|75965167|FG000|Overall Study|Withdrawal by Subject|118|||
42156932|NCT00206102|75965168|FG001|Overall Study|Withdrawal by Subject|101|||
42156933|NCT00206102|75965167|FG000|Overall Study|Study-specific discontinuation criteria|18|||
42156934|NCT00206102|75965168|FG001|Overall Study|Study-specific discontinuation criteria|17|||
42156935|NCT00206102|75965167|FG000|Overall Study|None of those categories|42|||
42156936|NCT00206102|75965168|FG001|Overall Study|None of those categories|36|||
42156937|NCT00041080|75965176|FG000|Overall Study|Adverse Event|21|||
42156938|NCT00041080|75965177|FG001|Overall Study|Adverse Event|1|||
42156939|NCT00041080|75965176|FG000|Overall Study|Withdrawal by Subject|6|||
42156940|NCT00041080|75965177|FG001|Overall Study|Withdrawal by Subject|6|||
42156941|NCT00041080|75965176|FG000|Overall Study|Concommitant Illness/Other|1|||
42156942|NCT00041080|75965177|FG001|Overall Study|Concommitant Illness/Other|2|||
42156943|NCT00041080|75965176|FG000|Overall Study|Did not start therapy|1|||
42156944|NCT00041080|75965177|FG001|Overall Study|Did not start therapy|1|||
42156945|NCT00041080|75965176|FG000|Overall Study|Ineligible|1|||
42156946|NCT00041080|75965177|FG001|Overall Study|Ineligible|0|||
42156947|NCT00205712|75965185|FG000|Overall Study|Lost to Follow-up|0|||
42156948|NCT00205712|75965186|FG001|Overall Study|Lost to Follow-up|1|||
42156949|NCT00203294|75965196|FG000|Overall Study|Withdrawal by Subject|8|||
42156950|NCT00203294|75965197|FG001|Overall Study|Withdrawal by Subject|13|||
42156951|NCT00264290|75965205|FG000|Intervention (8 Weeks)|Adverse Event|1|||
42156952|NCT00264290|75965206|FG001|Intervention (8 Weeks)|Adverse Event|0|||
42156953|NCT00234494|75965216|FG000|Overall Study|Protocol Violation|2|||
42156954|NCT00234104|75965224|FG000|Overall Study|Adverse Event|4|||
42156955|NCT00234104|75965225|FG001|Overall Study|Adverse Event|0|||
42156956|NCT00234104|75965226|FG002|Overall Study|Adverse Event|3|||
42156957|NCT00234104|75965227|FG003|Overall Study|Adverse Event|5|||
42156958|NCT00234104|75965224|FG000|Overall Study|Protocol Violation|0|||
42156959|NCT00234104|75965225|FG001|Overall Study|Protocol Violation|0|||
42156960|NCT00234104|75965226|FG002|Overall Study|Protocol Violation|0|||
42156961|NCT00234104|75965227|FG003|Overall Study|Protocol Violation|1|||
42156962|NCT00234104|75965224|FG000|Overall Study|Physician Decision|0|||
42156963|NCT00234104|75965225|FG001|Overall Study|Physician Decision|1|||
42156964|NCT00234104|75965226|FG002|Overall Study|Physician Decision|2|||
42156965|NCT00234104|75965227|FG003|Overall Study|Physician Decision|2|||
42156966|NCT00263666|75965239|FG000|Overall Study|Adverse Event|6|||
42156967|NCT00263666|75965240|FG001|Overall Study|Adverse Event|8|||
42156968|NCT00263666|75965239|FG000|Overall Study|Lost to Follow-up|1|||
42156969|NCT00263666|75965240|FG001|Overall Study|Lost to Follow-up|2|||
42156970|NCT00263666|75965239|FG000|Overall Study|Withdrawal by Subject|0|||
42156971|NCT00263666|75965240|FG001|Overall Study|Withdrawal by Subject|1|||
42156972|NCT00195338|75965246|FG000|Overall Study|Lost to Follow-up|2|||
42156973|NCT00195338|75965246|FG000|Overall Study|Adverse Event|5|||
42156974|NCT00195338|75965246|FG000|Overall Study|Lack of Efficacy|1|||
42156975|NCT00195338|75965246|FG000|Overall Study|Early closure of the site|4|||
42156976|NCT00035932|75965253|FG000|Overall Study|Adverse Event|10|||
42156977|NCT00035932|75965254|FG001|Overall Study|Adverse Event|9|||
42156978|NCT00035932|75965255|FG002|Overall Study|Adverse Event|9|||
42156979|NCT00035932|75965253|FG000|Overall Study|Death|0|||
42156980|NCT00035932|75965254|FG001|Overall Study|Death|0|||
42156981|NCT00035932|75965255|FG002|Overall Study|Death|1|||
42156982|NCT00035932|75965253|FG000|Overall Study|Disease Progression / Relapse|1|||
42156983|NCT00035932|75965254|FG001|Overall Study|Disease Progression / Relapse|1|||
42156984|NCT00035932|75965255|FG002|Overall Study|Disease Progression / Relapse|0|||
42156985|NCT00035932|75965253|FG000|Overall Study|Lost to Follow-up|4|||
42156986|NCT00035932|75965254|FG001|Overall Study|Lost to Follow-up|4|||
42156987|NCT00035932|75965255|FG002|Overall Study|Lost to Follow-up|3|||
42156988|NCT00035932|75965253|FG000|Overall Study|Noncompliance|6|||
42156989|NCT00035932|75965254|FG001|Overall Study|Noncompliance|7|||
42156990|NCT00035932|75965255|FG002|Overall Study|Noncompliance|6|||
42156991|NCT00035932|75965253|FG000|Overall Study|Protocol Violation While on Study|0|||
42156992|NCT00035932|75965254|FG001|Overall Study|Protocol Violation While on Study|1|||
42156993|NCT00035932|75965255|FG002|Overall Study|Protocol Violation While on Study|2|||
42156994|NCT00035932|75965253|FG000|Overall Study|Withdrawal by Subject|1|||
42156995|NCT00035932|75965254|FG001|Overall Study|Withdrawal by Subject|5|||
42156996|NCT00035932|75965255|FG002|Overall Study|Withdrawal by Subject|0|||
42156997|NCT00035932|75965253|FG000|Overall Study|Study Termination by Sponsor|1|||
42156998|NCT00035932|75965254|FG001|Overall Study|Study Termination by Sponsor|0|||
42156999|NCT00035932|75965255|FG002|Overall Study|Study Termination by Sponsor|0|||
42157000|NCT00035932|75965253|FG000|Overall Study|Lack of Efficacy|33|||
42157001|NCT00035932|75965254|FG001|Overall Study|Lack of Efficacy|33|||
42157002|NCT00035932|75965255|FG002|Overall Study|Lack of Efficacy|28|||
42157003|NCT00022516|75965270|FG000|Overall Study|Adverse Event|0|||
42157004|NCT00022516|75965271|FG001|Overall Study|Adverse Event|59|||
42157005|NCT00022516|75965270|FG000|Overall Study|Lack of Efficacy|0|||
42157006|NCT00022516|75965271|FG001|Overall Study|Lack of Efficacy|27|||
42157007|NCT00022516|75965270|FG000|Overall Study|Physician Decision|0|||
42157008|NCT00022516|75965271|FG001|Overall Study|Physician Decision|1|||
42157009|NCT00022516|75965270|FG000|Overall Study|Protocol Violation|1|||
42157010|NCT00022516|75965271|FG001|Overall Study|Protocol Violation|3|||
42157011|NCT00022516|75965270|FG000|Overall Study|Withdrawal by Subject|2|||
42157012|NCT00022516|75965271|FG001|Overall Study|Withdrawal by Subject|113|||
42157013|NCT00022516|75965270|FG000|Overall Study|Incomplete documentation|0|||
42157014|NCT00022516|75965271|FG001|Overall Study|Incomplete documentation|27|||
42157015|NCT00033514|75965279|FG000|Overall Study|Lost to Follow-up|1|||
42157016|NCT00033514|75965280|FG001|Overall Study|Lost to Follow-up|1|||
42157017|NCT00033514|75965279|FG000|Overall Study|Withdrawal by Subject|0|||
42157018|NCT00033514|75965280|FG001|Overall Study|Withdrawal by Subject|3|||
42157019|NCT00006916|75965287|FG000|Overall Study|Device not inserted|4|||
42157020|NCT00006916|75965287|FG000|Overall Study|Complication of device insertion|1|||
42157021|NCT00454649|75965301|FG000|Overall Study|Lack of Efficacy|2|||
42279360|NCT01675167|76110890|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
42279361|NCT01675167|76110891|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
42279362|NCT01675167|76110889|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
42279363|NCT01675167|76110890|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
42157022|NCT00454649|75965302|FG001|Overall Study|Lack of Efficacy|2|||
42279364|NCT01675167|76110891|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
42279365|NCT01675167|76110889|FG000|Double-blind Treatment Phase|Adverse Event|0|||
42279366|NCT01675167|76110890|FG001|Double-blind Treatment Phase|Adverse Event|5|||
42279367|NCT01675167|76110891|FG002|Double-blind Treatment Phase|Adverse Event|13|||
42279368|NCT01675167|76110889|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
42279369|NCT01675167|76110890|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
42279370|NCT01675167|76110891|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
42279371|NCT01675167|76110889|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
42279372|NCT01675167|76110890|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
42157023|NCT00454649|75965303|FG002|Overall Study|Lack of Efficacy|10|||
42279373|NCT01675167|76110891|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
42157024|NCT00454649|75965304|FG003|Overall Study|Lack of Efficacy|3|||
42279374|NCT01675167|76110889|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
42157025|NCT00454649|75965305|FG004|Overall Study|Lack of Efficacy|0|||
42157026|NCT00454649|75965306|FG005|Overall Study|Lack of Efficacy|4|||
42157027|NCT00454649|75965307|FG006|Overall Study|Lack of Efficacy|5|||
42157028|NCT00454649|75965308|FG007|Overall Study|Lack of Efficacy|13|||
42157029|NCT00454649|75965309|FG008|Overall Study|Lack of Efficacy|10|||
42157030|NCT00454649|75965310|FG009|Overall Study|Lack of Efficacy|2|||
42157031|NCT00454649|75965301|FG000|Overall Study|Adverse Event|0|||
42157032|NCT00454649|75965302|FG001|Overall Study|Adverse Event|1|||
42157033|NCT00454649|75965303|FG002|Overall Study|Adverse Event|3|||
42157034|NCT00454649|75965304|FG003|Overall Study|Adverse Event|0|||
42157035|NCT00454649|75965305|FG004|Overall Study|Adverse Event|1|||
42157036|NCT00454649|75965306|FG005|Overall Study|Adverse Event|2|||
42157037|NCT00454649|75965307|FG006|Overall Study|Adverse Event|3|||
42157038|NCT00454649|75965308|FG007|Overall Study|Adverse Event|4|||
42157039|NCT00454649|75965309|FG008|Overall Study|Adverse Event|6|||
42157040|NCT00454649|75965310|FG009|Overall Study|Adverse Event|2|||
42157041|NCT00454649|75965301|FG000|Overall Study|Lost to Follow-up|0|||
42157042|NCT00454649|75965302|FG001|Overall Study|Lost to Follow-up|0|||
42279375|NCT01675167|76110890|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
42279376|NCT01675167|76110891|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
42157043|NCT00454649|75965303|FG002|Overall Study|Lost to Follow-up|1|||
42157044|NCT00454649|75965304|FG003|Overall Study|Lost to Follow-up|0|||
42157045|NCT00454649|75965305|FG004|Overall Study|Lost to Follow-up|0|||
42157046|NCT00454649|75965306|FG005|Overall Study|Lost to Follow-up|0|||
42157047|NCT00454649|75965307|FG006|Overall Study|Lost to Follow-up|1|||
42157048|NCT00454649|75965308|FG007|Overall Study|Lost to Follow-up|0|||
42157049|NCT00454649|75965309|FG008|Overall Study|Lost to Follow-up|0|||
42157050|NCT00454649|75965310|FG009|Overall Study|Lost to Follow-up|0|||
42157051|NCT00454649|75965301|FG000|Overall Study|Other|1|||
42157052|NCT00454649|75965302|FG001|Overall Study|Other|1|||
42157053|NCT00454649|75965303|FG002|Overall Study|Other|5|||
42157054|NCT00454649|75965304|FG003|Overall Study|Other|3|||
42157055|NCT00454649|75965305|FG004|Overall Study|Other|0|||
42157056|NCT00454649|75965306|FG005|Overall Study|Other|0|||
42157057|NCT00454649|75965307|FG006|Overall Study|Other|0|||
42157058|NCT00454649|75965308|FG007|Overall Study|Other|0|||
42157059|NCT00454649|75965309|FG008|Overall Study|Other|3|||
42157060|NCT00454649|75965310|FG009|Overall Study|Other|1|||
42157061|NCT00454649|75965301|FG000|Overall Study|Withdrawal by Subject|0|||
42157062|NCT00454649|75965302|FG001|Overall Study|Withdrawal by Subject|0|||
42157063|NCT00454649|75965303|FG002|Overall Study|Withdrawal by Subject|0|||
42157064|NCT00454649|75965304|FG003|Overall Study|Withdrawal by Subject|0|||
42157065|NCT00454649|75965305|FG004|Overall Study|Withdrawal by Subject|0|||
42157066|NCT00454649|75965306|FG005|Overall Study|Withdrawal by Subject|1|||
42157067|NCT00454649|75965307|FG006|Overall Study|Withdrawal by Subject|0|||
42157068|NCT00454649|75965308|FG007|Overall Study|Withdrawal by Subject|2|||
42157069|NCT00454649|75965309|FG008|Overall Study|Withdrawal by Subject|1|||
42157070|NCT00454649|75965310|FG009|Overall Study|Withdrawal by Subject|0|||
42157071|NCT00454571|75965353|FG000|Overall Study|Adverse Event|2|||
42157072|NCT00454571|75965354|FG001|Overall Study|Adverse Event|0|||
42157073|NCT00454571|75965353|FG000|Overall Study|Physician Decision|0|||
42157074|NCT00454571|75965354|FG001|Overall Study|Physician Decision|1|||
42157075|NCT00454571|75965353|FG000|Overall Study|Protocol Violation|1|||
42157076|NCT00454571|75965354|FG001|Overall Study|Protocol Violation|0|||
42157077|NCT00454571|75965353|FG000|Overall Study|Withdrawal by Subject|10|||
42157078|NCT00454571|75965354|FG001|Overall Study|Withdrawal by Subject|5|||
42157079|NCT03837743|75965360|FG000|Overall Study|Adverse Event|1|||
42157080|NCT03837743|75965360|FG000|Overall Study|Withdrawal by Subject|2|||
42157081|NCT03836729|75965368|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
42157082|NCT00443729|75965378|FG000|Overall Study|Never Treated|0|||
42157083|NCT00443729|75965379|FG001|Overall Study|Never Treated|1|||
42157084|NCT00443729|75965378|FG000|Overall Study|Lack of Efficacy|4|||
42157085|NCT00443729|75965379|FG001|Overall Study|Lack of Efficacy|2|||
42157086|NCT00443729|75965378|FG000|Overall Study|Lost to Follow-up|0|||
42157087|NCT00443729|75965379|FG001|Overall Study|Lost to Follow-up|1|||
42157088|NCT00443729|75965378|FG000|Overall Study|Physician Decision|2|||
42157089|NCT00443729|75965379|FG001|Overall Study|Physician Decision|1|||
42279377|NCT01675167|76110889|FG000|Double-blind Treatment Phase|Other|0|||
42279378|NCT01675167|76110890|FG001|Double-blind Treatment Phase|Other|7|||
42279379|NCT01675167|76110891|FG002|Double-blind Treatment Phase|Other|5|||
42351376|NCT01929031|76191329|FG004|Overall Study|Protocol Violation|0|||
42157090|NCT00443729|75965378|FG000|Overall Study|Protocol Violation|1|||
42157091|NCT00443729|75965379|FG001|Overall Study|Protocol Violation|1|||
42157092|NCT00443729|75965378|FG000|Overall Study|Withdrawal by Subject|3|||
42157093|NCT00443729|75965379|FG001|Overall Study|Withdrawal by Subject|1|||
42157094|NCT00443651|75965387|FG000|Overall Study|Death|1|||
42157095|NCT00443651|75965388|FG001|Overall Study|Death|5|||
42157096|NCT00443651|75965387|FG000|Overall Study|Adverse Event|5|||
42157097|NCT00443651|75965388|FG001|Overall Study|Adverse Event|6|||
42157098|NCT00443651|75965387|FG000|Overall Study|Lost to Follow-up|18|||
42157099|NCT00443651|75965388|FG001|Overall Study|Lost to Follow-up|12|||
42157100|NCT00443651|75965387|FG000|Overall Study|Patient's/Guardian's Decision|58|||
42157101|NCT00443651|75965388|FG001|Overall Study|Patient's/Guardian's Decision|30|||
42157102|NCT00443651|75965387|FG000|Overall Study|Physician Decision|13|||
42279380|NCT01675011|76110901|FG000|Overall Study|Trial terminated by Sponsor|3|||
42157103|NCT00443651|75965388|FG001|Overall Study|Physician Decision|4|||
42157104|NCT00443651|75965387|FG000|Overall Study|Pregnancy|0|||
42157105|NCT00443651|75965388|FG001|Overall Study|Pregnancy|1|||
42157106|NCT00443261|75965394|FG000|Overall Study|Death|1|||
42157107|NCT00439517|75965400|FG000|Overall Study|Subject on treatment|1|||
42157108|NCT00439517|75965401|FG001|Overall Study|Subject on treatment|0|||
42157109|NCT00439517|75965400|FG000|Overall Study|Subject in survival follow-up|1|||
42157110|NCT00439517|75965401|FG001|Overall Study|Subject in survival follow-up|0|||
42157111|NCT00438815|75965407|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
42157112|NCT00438815|75965407|FG000|Overall Study|3-month follow-up no longer required|12|||
42157113|NCT00438815|75965407|FG000|Overall Study|Noncompliance with protocol requirements|9|||
42157114|NCT00438815|75965407|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
42157115|NCT00438815|75965407|FG000|Overall Study|Lost to Follow-up|6|||
42157116|NCT00438815|75965407|FG000|Overall Study|Withdrawal by Subject|6|||
42157117|NCT00438815|75965407|FG000|Overall Study|Death|1|||
42157118|NCT00438659|75965413|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
42157119|NCT00438659|75965414|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
42157120|NCT00438659|75965413|FG000|Overall Study|Cancel|5|||
42157121|NCT00438659|75965414|FG001|Overall Study|Cancel|2|||
42157122|NCT00437645|75965423|FG000|Overall Study|Adverse Event|15|||
42157123|NCT00437645|75965424|FG001|Overall Study|Adverse Event|84|||
42157124|NCT00437645|75965423|FG000|Overall Study|Withdrawal by Subject|10|||
42157125|NCT00437645|75965424|FG001|Overall Study|Withdrawal by Subject|22|||
42157126|NCT00437645|75965423|FG000|Overall Study|Protocol Violation|3|||
42157127|NCT00437645|75965424|FG001|Overall Study|Protocol Violation|3|||
42157128|NCT00437645|75965423|FG000|Overall Study|Lost to Follow-up|2|||
42157129|NCT00437645|75965424|FG001|Overall Study|Lost to Follow-up|3|||
42279381|NCT01675011|76110902|FG001|Overall Study|Trial terminated by Sponsor|1|||
42279382|NCT04109547|76110930|FG000|Overall Study|Withdrawal by Subject|3|||
42279383|NCT04109547|76110931|FG001|Overall Study|Withdrawal by Subject|2|||
42279384|NCT04109547|76110932|FG002|Overall Study|Withdrawal by Subject|6|||
42279385|NCT04109547|76110933|FG003|Overall Study|Withdrawal by Subject|6|||
42279386|NCT04109547|76110930|FG000|Overall Study|Lost to Follow-up|0|||
42157130|NCT00437645|75965423|FG000|Overall Study|Administrative problems|2|||
42157131|NCT00437645|75965424|FG001|Overall Study|Administrative problems|1|||
42157132|NCT00437645|75965423|FG000|Overall Study|Lack of Efficacy|2|||
42157133|NCT00437645|75965424|FG001|Overall Study|Lack of Efficacy|1|||
42157134|NCT00437645|75965423|FG000|Overall Study|Condition no longer requires study drug|1|||
42157135|NCT00437645|75965424|FG001|Overall Study|Condition no longer requires study drug|1|||
42157136|NCT00437489|75965432|FG000|Overall Study|Study terminated by sponsor|23|||
42157137|NCT00437489|75965433|FG001|Overall Study|Study terminated by sponsor|21|||
42157138|NCT00437489|75965432|FG000|Overall Study|Lost to Follow-up|0|||
42157139|NCT00437489|75965433|FG001|Overall Study|Lost to Follow-up|1|||
42157140|NCT00442559|75965441|FG000|Overall Study|Lost to Follow-up|32|||
42157141|NCT00442559|75965442|FG001|Overall Study|Lost to Follow-up|34|||
42157142|NCT00442559|75965441|FG000|Overall Study|Protocol Violation|1|||
42157143|NCT00442559|75965442|FG001|Overall Study|Protocol Violation|1|||
42157144|NCT00442559|75965441|FG000|Overall Study|Withdrawal by Subject|1|||
42157145|NCT00442559|75965442|FG001|Overall Study|Withdrawal by Subject|0|||
42157146|NCT00441701|75965464|FG000|Overall Study|Adverse Event|3|||
42157147|NCT00441701|75965465|FG001|Overall Study|Adverse Event|2|||
42157148|NCT00441701|75965466|FG002|Overall Study|Adverse Event|1|||
42157149|NCT00441701|75965467|FG003|Overall Study|Adverse Event|0|||
42157150|NCT00441701|75965468|FG004|Overall Study|Adverse Event|2|||
42157151|NCT00441701|75965469|FG005|Overall Study|Adverse Event|2|||
42157152|NCT00441701|75965470|FG006|Overall Study|Adverse Event|0|||
42157153|NCT00441701|75965471|FG007|Overall Study|Adverse Event|0|||
42157154|NCT00441701|75965472|FG008|Overall Study|Adverse Event|0|||
42157155|NCT00441701|75965473|FG009|Overall Study|Adverse Event|0|||
42157156|NCT00441701|75965464|FG000|Overall Study|Lack of Efficacy|2|||
42157157|NCT00441701|75965465|FG001|Overall Study|Lack of Efficacy|0|||
42157158|NCT00441701|75965466|FG002|Overall Study|Lack of Efficacy|2|||
42157159|NCT00441701|75965467|FG003|Overall Study|Lack of Efficacy|2|||
42279387|NCT04109547|76110931|FG001|Overall Study|Lost to Follow-up|0|||
42279388|NCT04109547|76110932|FG002|Overall Study|Lost to Follow-up|0|||
42279389|NCT04109547|76110933|FG003|Overall Study|Lost to Follow-up|1|||
42279390|NCT04109547|76110930|FG000|Overall Study|Physician Decision|1|||
42279391|NCT04109547|76110931|FG001|Overall Study|Physician Decision|2|||
42157160|NCT00441701|75965468|FG004|Overall Study|Lack of Efficacy|0|||
42157161|NCT00441701|75965469|FG005|Overall Study|Lack of Efficacy|1|||
42157162|NCT00441701|75965470|FG006|Overall Study|Lack of Efficacy|0|||
42157163|NCT00441701|75965471|FG007|Overall Study|Lack of Efficacy|0|||
42157164|NCT00441701|75965472|FG008|Overall Study|Lack of Efficacy|0|||
42157165|NCT00441701|75965473|FG009|Overall Study|Lack of Efficacy|0|||
42157166|NCT00441701|75965464|FG000|Overall Study|Withdrawal by Subject|0|||
42157167|NCT00441701|75965465|FG001|Overall Study|Withdrawal by Subject|2|||
42279392|NCT04109547|76110932|FG002|Overall Study|Physician Decision|0|||
42279393|NCT04109547|76110933|FG003|Overall Study|Physician Decision|0|||
42157168|NCT00441701|75965466|FG002|Overall Study|Withdrawal by Subject|1|||
42157169|NCT00441701|75965467|FG003|Overall Study|Withdrawal by Subject|1|||
42157170|NCT00441701|75965468|FG004|Overall Study|Withdrawal by Subject|0|||
42157171|NCT00441701|75965469|FG005|Overall Study|Withdrawal by Subject|0|||
42157172|NCT00441701|75965470|FG006|Overall Study|Withdrawal by Subject|0|||
42157173|NCT00441701|75965471|FG007|Overall Study|Withdrawal by Subject|0|||
42157174|NCT00441701|75965472|FG008|Overall Study|Withdrawal by Subject|0|||
42157175|NCT00441701|75965473|FG009|Overall Study|Withdrawal by Subject|0|||
42157176|NCT00441545|75965491|FG000|First Intervention|Adverse Event|6|||
42157177|NCT00441545|75965492|FG001|First Intervention|Adverse Event|5|||
42157178|NCT00441545|75965491|FG000|First Intervention|Protocol Violation|2|||
42157179|NCT00441545|75965492|FG001|First Intervention|Protocol Violation|2|||
42157180|NCT00441545|75965491|FG000|First Intervention|Withdrawal by Subject|3|||
42157181|NCT00441545|75965492|FG001|First Intervention|Withdrawal by Subject|3|||
42157182|NCT00441545|75965491|FG000|First Intervention|Kidney transplant|1|||
42157183|NCT00441545|75965492|FG001|First Intervention|Kidney transplant|1|||
42157184|NCT00441545|75965491|FG000|First Intervention|Lack of Efficacy|2|||
42157185|NCT00441545|75965492|FG001|First Intervention|Lack of Efficacy|0|||
42157186|NCT00441545|75965491|FG000|First Intervention|Subject exceeded safety criteria|0|||
42157187|NCT00441545|75965492|FG001|First Intervention|Subject exceeded safety criteria|1|||
42157188|NCT00441545|75965491|FG000|First Intervention|Subject met an exclusionary criteria|1|||
42157189|NCT00441545|75965492|FG001|First Intervention|Subject met an exclusionary criteria|0|||
42157190|NCT00441545|75965491|FG000|First Intervention|Extended hospitalization|1|||
42157191|NCT00441545|75965492|FG001|First Intervention|Extended hospitalization|0|||
42157192|NCT00441545|75965491|FG000|First Intervention|Site error|1|||
42157193|NCT00441545|75965492|FG001|First Intervention|Site error|0|||
42157194|NCT00441545|75965491|FG000|First Intervention|Sponsor's request|1|||
42157195|NCT00441545|75965492|FG001|First Intervention|Sponsor's request|0|||
42157196|NCT00441545|75965491|FG000|Second Intervention|Adverse Event|5|||
42157197|NCT00441545|75965492|FG001|Second Intervention|Adverse Event|2|||
42157198|NCT00441545|75965491|FG000|Second Intervention|Protocol Violation|4|||
42157199|NCT00441545|75965492|FG001|Second Intervention|Protocol Violation|1|||
42157200|NCT00441545|75965491|FG000|Second Intervention|Withdrawal by Subject|1|||
42157201|NCT00441545|75965492|FG001|Second Intervention|Withdrawal by Subject|1|||
42157202|NCT00441545|75965491|FG000|Second Intervention|Kidney Transplant|1|||
42157203|NCT00441545|75965492|FG001|Second Intervention|Kidney Transplant|1|||
42157204|NCT00441545|75965491|FG000|Second Intervention|Lack of Efficacy|0|||
42157205|NCT00441545|75965492|FG001|Second Intervention|Lack of Efficacy|1|||
42157206|NCT00441545|75965491|FG000|Second Intervention|Subject exceeded safety criteria|1|||
42157207|NCT00441545|75965492|FG001|Second Intervention|Subject exceeded safety criteria|0|||
42157208|NCT00441545|75965491|FG000|Second Intervention|Subject moved|0|||
42157209|NCT00441545|75965492|FG001|Second Intervention|Subject moved|1|||
42157210|NCT00436553|75965501|FG000|Overall Study|Adverse Event|4|||
42157211|NCT00436553|75965502|FG001|Overall Study|Adverse Event|3|||
42157212|NCT00436553|75965503|FG002|Overall Study|Adverse Event|4|||
42157213|NCT00436553|75965501|FG000|Overall Study|Death|3|||
42157214|NCT00436553|75965502|FG001|Overall Study|Death|1|||
42157215|NCT00436553|75965503|FG002|Overall Study|Death|3|||
42157216|NCT00436553|75965501|FG000|Overall Study|Lost to Follow-up|0|||
42157217|NCT00436553|75965502|FG001|Overall Study|Lost to Follow-up|2|||
42157218|NCT00436553|75965503|FG002|Overall Study|Lost to Follow-up|0|||
42157219|NCT00436553|75965501|FG000|Overall Study|Protocol Violation|1|||
42157220|NCT00436553|75965502|FG001|Overall Study|Protocol Violation|0|||
42157221|NCT00436553|75965503|FG002|Overall Study|Protocol Violation|0|||
42157222|NCT00436553|75965501|FG000|Overall Study|Withdrawal by Subject|5|||
42157223|NCT00436553|75965502|FG001|Overall Study|Withdrawal by Subject|6|||
42157224|NCT00436553|75965503|FG002|Overall Study|Withdrawal by Subject|3|||
42157225|NCT00441467|75965511|FG000|Overall Study|Adverse Event|6|||
42157226|NCT00441467|75965511|FG000|Overall Study|Withdrawal by Subject|3|||
42157227|NCT00441467|75965511|FG000|Overall Study|Progressive disease|9|||
42157228|NCT00436163|75965515|FG000|Overall Study|Lost to Follow-up|2|||
42157229|NCT00436163|75965515|FG000|Overall Study|Adverse Event|1|||
42157230|NCT00006604|75965527|FG000|Overall Study|Met study objective - no further FU|1|||
42157231|NCT00006604|75965528|FG001|Overall Study|Met study objective - no further FU|0|||
42157232|NCT00006604|75965529|FG002|Overall Study|Met study objective - no further FU|0|||
42157233|NCT00006604|75965530|FG003|Overall Study|Met study objective - no further FU|0|||
42157234|NCT00006604|75965531|FG004|Overall Study|Met study objective - no further FU|0|||
42157235|NCT00006604|75965532|FG005|Overall Study|Met study objective - no further FU|0|||
42157236|NCT00006604|75965533|FG006|Overall Study|Met study objective - no further FU|0|||
42157237|NCT00006604|75965534|FG007|Overall Study|Met study objective - no further FU|0|||
42157238|NCT00006604|75965535|FG008|Overall Study|Met study objective - no further FU|0|||
42157239|NCT00006604|75965536|FG009|Overall Study|Met study objective - no further FU|0|||
42157240|NCT00006604|75965537|FG010|Overall Study|Met study objective - no further FU|0|||
42157241|NCT00006604|75965538|FG011|Overall Study|Met study objective - no further FU|0|||
42279394|NCT02649231|76110956|FG000|Overall Study|Adverse Event|0|||
42157242|NCT00006604|75965539|FG012|Overall Study|Met study objective - no further FU|0|||
42157243|NCT00006604|75965540|FG013|Overall Study|Met study objective - no further FU|0|||
42157244|NCT00006604|75965541|FG014|Overall Study|Met study objective - no further FU|1|||
42157245|NCT00006604|75965542|FG015|Overall Study|Met study objective - no further FU|1|||
42157246|NCT00006604|75965543|FG016|Overall Study|Met study objective - no further FU|0|||
42157247|NCT00006604|75965527|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
42157248|NCT00006604|75965528|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
42157249|NCT00006604|75965529|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
42157250|NCT00006604|75965530|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
42157251|NCT00006604|75965531|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
42157252|NCT00006604|75965532|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
42157253|NCT00006604|75965533|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
42157254|NCT00006604|75965534|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
42157255|NCT00006604|75965535|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
42157256|NCT00006604|75965536|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
42157257|NCT00006604|75965537|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
42157258|NCT00006604|75965538|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
42157259|NCT00006604|75965539|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
42157260|NCT00006604|75965540|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
42157261|NCT00006604|75965541|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
42157262|NCT00006604|75965542|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
42157263|NCT00006604|75965543|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
42157264|NCT00006604|75965527|FG000|Overall Study|Death|0|||
42157265|NCT00006604|75965528|FG001|Overall Study|Death|0|||
42157266|NCT00006604|75965529|FG002|Overall Study|Death|0|||
42157267|NCT00006604|75965530|FG003|Overall Study|Death|0|||
42279395|NCT02649231|76110957|FG001|Overall Study|Adverse Event|0|||
42279396|NCT02649231|76110958|FG002|Overall Study|Adverse Event|0|||
42279397|NCT02649231|76110959|FG003|Overall Study|Adverse Event|1|||
42279398|NCT02649231|76110956|FG000|Overall Study|Lost to Follow-up|2|||
42279399|NCT02649231|76110957|FG001|Overall Study|Lost to Follow-up|1|||
42279400|NCT02649231|76110958|FG002|Overall Study|Lost to Follow-up|1|||
42279401|NCT02649231|76110959|FG003|Overall Study|Lost to Follow-up|0|||
42279402|NCT02649231|76110956|FG000|Overall Study|Withdrawal by Subject|0|||
42279403|NCT02649231|76110957|FG001|Overall Study|Withdrawal by Subject|1|||
42351377|NCT01929031|76191330|FG005|Overall Study|Protocol Violation|1|||
42351378|NCT01929031|76191325|FG000|Overall Study|Reason other than specified above|0|||
42351379|NCT01929031|76191326|FG001|Overall Study|Reason other than specified above|1|||
42157268|NCT00006604|75965531|FG004|Overall Study|Death|0|||
42157269|NCT00006604|75965532|FG005|Overall Study|Death|0|||
42157270|NCT00006604|75965533|FG006|Overall Study|Death|0|||
42157271|NCT00006604|75965534|FG007|Overall Study|Death|0|||
42157272|NCT00006604|75965535|FG008|Overall Study|Death|0|||
42157273|NCT00006604|75965536|FG009|Overall Study|Death|1|||
42157274|NCT00006604|75965537|FG010|Overall Study|Death|1|||
42157275|NCT00006604|75965538|FG011|Overall Study|Death|1|||
42157276|NCT00006604|75965539|FG012|Overall Study|Death|0|||
42157277|NCT00006604|75965540|FG013|Overall Study|Death|0|||
42157278|NCT00006604|75965541|FG014|Overall Study|Death|0|||
42157279|NCT00006604|75965542|FG015|Overall Study|Death|0|||
42157280|NCT00006604|75965543|FG016|Overall Study|Death|0|||
42157281|NCT00006604|75965527|FG000|Overall Study|Severe debilitation, unable to continue|0|||
42157282|NCT00006604|75965528|FG001|Overall Study|Severe debilitation, unable to continue|0|||
42157283|NCT00006604|75965529|FG002|Overall Study|Severe debilitation, unable to continue|0|||
42157284|NCT00006604|75965530|FG003|Overall Study|Severe debilitation, unable to continue|0|||
42157285|NCT00006604|75965531|FG004|Overall Study|Severe debilitation, unable to continue|0|||
42157286|NCT00006604|75965532|FG005|Overall Study|Severe debilitation, unable to continue|0|||
42157287|NCT00006604|75965533|FG006|Overall Study|Severe debilitation, unable to continue|3|||
42157288|NCT00006604|75965534|FG007|Overall Study|Severe debilitation, unable to continue|0|||
42157289|NCT00006604|75965535|FG008|Overall Study|Severe debilitation, unable to continue|0|||
42157290|NCT00006604|75965536|FG009|Overall Study|Severe debilitation, unable to continue|5|||
42279404|NCT02649231|76110958|FG002|Overall Study|Withdrawal by Subject|0|||
42157291|NCT00006604|75965537|FG010|Overall Study|Severe debilitation, unable to continue|0|||
42157292|NCT00006604|75965538|FG011|Overall Study|Severe debilitation, unable to continue|2|||
42157293|NCT00006604|75965539|FG012|Overall Study|Severe debilitation, unable to continue|1|||
42157294|NCT00006604|75965540|FG013|Overall Study|Severe debilitation, unable to continue|0|||
42157295|NCT00006604|75965541|FG014|Overall Study|Severe debilitation, unable to continue|2|||
42157296|NCT00006604|75965542|FG015|Overall Study|Severe debilitation, unable to continue|0|||
42157297|NCT00006604|75965543|FG016|Overall Study|Severe debilitation, unable to continue|0|||
42279405|NCT02649231|76110959|FG003|Overall Study|Withdrawal by Subject|1|||
42351380|NCT01929031|76191327|FG002|Overall Study|Reason other than specified above|0|||
42351381|NCT01929031|76191328|FG003|Overall Study|Reason other than specified above|0|||
42157298|NCT00006604|75965527|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
42157299|NCT00006604|75965528|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
42157300|NCT00006604|75965529|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
42157301|NCT00006604|75965530|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
42157302|NCT00006604|75965531|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
42157303|NCT00006604|75965532|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
42157304|NCT00006604|75965533|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
42157305|NCT00006604|75965534|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
42157306|NCT00006604|75965535|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
42157307|NCT00006604|75965536|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
42157308|NCT00006604|75965537|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
42157309|NCT00006604|75965538|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
42157310|NCT00006604|75965539|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
42157311|NCT00006604|75965540|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
42157312|NCT00006604|75965541|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
42157313|NCT00006604|75965542|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
42157314|NCT00006604|75965543|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
42157315|NCT00006604|75965527|FG000|Overall Study|Site closing|0|||
42157316|NCT00006604|75965528|FG001|Overall Study|Site closing|0|||
42157317|NCT00006604|75965529|FG002|Overall Study|Site closing|1|||
42157318|NCT00006604|75965530|FG003|Overall Study|Site closing|1|||
42157319|NCT00006604|75965531|FG004|Overall Study|Site closing|0|||
42157320|NCT00006604|75965532|FG005|Overall Study|Site closing|0|||
42157321|NCT00006604|75965533|FG006|Overall Study|Site closing|0|||
42157322|NCT00006604|75965534|FG007|Overall Study|Site closing|1|||
42157323|NCT00006604|75965535|FG008|Overall Study|Site closing|0|||
42157324|NCT00006604|75965536|FG009|Overall Study|Site closing|0|||
42157325|NCT00006604|75965537|FG010|Overall Study|Site closing|0|||
42157326|NCT00006604|75965538|FG011|Overall Study|Site closing|1|||
42157327|NCT00006604|75965539|FG012|Overall Study|Site closing|1|||
42157328|NCT00006604|75965540|FG013|Overall Study|Site closing|1|||
42157329|NCT00006604|75965541|FG014|Overall Study|Site closing|0|||
42157330|NCT00006604|75965542|FG015|Overall Study|Site closing|0|||
42157331|NCT00006604|75965543|FG016|Overall Study|Site closing|1|||
42157332|NCT00006604|75965527|FG000|Overall Study|Withdrawal by Subject|1|||
42157333|NCT00006604|75965528|FG001|Overall Study|Withdrawal by Subject|0|||
42157334|NCT00006604|75965529|FG002|Overall Study|Withdrawal by Subject|2|||
42157335|NCT00006604|75965530|FG003|Overall Study|Withdrawal by Subject|0|||
42157336|NCT00006604|75965531|FG004|Overall Study|Withdrawal by Subject|1|||
42157337|NCT00006604|75965532|FG005|Overall Study|Withdrawal by Subject|2|||
42157338|NCT00006604|75965533|FG006|Overall Study|Withdrawal by Subject|2|||
42157339|NCT00006604|75965534|FG007|Overall Study|Withdrawal by Subject|0|||
42157340|NCT00006604|75965535|FG008|Overall Study|Withdrawal by Subject|1|||
42157341|NCT00006604|75965536|FG009|Overall Study|Withdrawal by Subject|3|||
42157342|NCT00006604|75965537|FG010|Overall Study|Withdrawal by Subject|2|||
42157343|NCT00006604|75965538|FG011|Overall Study|Withdrawal by Subject|0|||
42157344|NCT00006604|75965539|FG012|Overall Study|Withdrawal by Subject|1|||
42157345|NCT00006604|75965540|FG013|Overall Study|Withdrawal by Subject|2|||
42157346|NCT00006604|75965541|FG014|Overall Study|Withdrawal by Subject|1|||
42157347|NCT00006604|75965542|FG015|Overall Study|Withdrawal by Subject|0|||
42157348|NCT00006604|75965543|FG016|Overall Study|Withdrawal by Subject|1|||
42157349|NCT00006604|75965527|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
42157350|NCT00006604|75965528|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
42157351|NCT00006604|75965529|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
42157352|NCT00006604|75965530|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
42157353|NCT00006604|75965531|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
42157354|NCT00006604|75965532|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
42157355|NCT00006604|75965533|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
42157356|NCT00006604|75965534|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
42157357|NCT00006604|75965535|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
42157358|NCT00006604|75965536|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
42157359|NCT00006604|75965537|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
42157360|NCT00006604|75965538|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
42157361|NCT00006604|75965539|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
42157362|NCT00006604|75965540|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
42157363|NCT00006604|75965541|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
42157364|NCT00006604|75965542|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
42157365|NCT00006604|75965543|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
42157366|NCT00006604|75965527|FG000|Overall Study|Lost to Follow-up|0|||
42157367|NCT00006604|75965528|FG001|Overall Study|Lost to Follow-up|0|||
42157368|NCT00006604|75965529|FG002|Overall Study|Lost to Follow-up|0|||
42157369|NCT00006604|75965530|FG003|Overall Study|Lost to Follow-up|0|||
42157370|NCT00006604|75965531|FG004|Overall Study|Lost to Follow-up|0|||
42157371|NCT00006604|75965532|FG005|Overall Study|Lost to Follow-up|0|||
42157372|NCT00006604|75965533|FG006|Overall Study|Lost to Follow-up|0|||
42157373|NCT00006604|75965534|FG007|Overall Study|Lost to Follow-up|1|||
42157374|NCT00006604|75965535|FG008|Overall Study|Lost to Follow-up|0|||
42157375|NCT00006604|75965536|FG009|Overall Study|Lost to Follow-up|2|||
42279406|NCT02649231|76110956|FG000|Overall Study|Protocol Violation|2|||
42157376|NCT00006604|75965537|FG010|Overall Study|Lost to Follow-up|0|||
42157377|NCT00006604|75965538|FG011|Overall Study|Lost to Follow-up|0|||
42157378|NCT00006604|75965539|FG012|Overall Study|Lost to Follow-up|0|||
42157379|NCT00006604|75965540|FG013|Overall Study|Lost to Follow-up|0|||
42157380|NCT00006604|75965541|FG014|Overall Study|Lost to Follow-up|0|||
42279407|NCT02649231|76110957|FG001|Overall Study|Protocol Violation|1|||
42279408|NCT02649231|76110958|FG002|Overall Study|Protocol Violation|1|||
42157381|NCT00006604|75965542|FG015|Overall Study|Lost to Follow-up|1|||
42157382|NCT00006604|75965543|FG016|Overall Study|Lost to Follow-up|3|||
42279409|NCT02649231|76110959|FG003|Overall Study|Protocol Violation|0|||
42279410|NCT01376245|76110973|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
42279411|NCT01376245|76110974|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
42279412|NCT01376245|76110975|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
42279413|NCT01376245|76110976|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
42279414|NCT01376245|76110977|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
42279415|NCT01376245|76110973|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
42279416|NCT01376245|76110974|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
42279417|NCT01376245|76110975|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
42279418|NCT01376245|76110976|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
42279419|NCT01376245|76110977|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
42279420|NCT01376245|76110973|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
42157383|NCT00006604|75965527|FG000|Overall Study|Other Reason|0|||
42157384|NCT00006604|75965528|FG001|Overall Study|Other Reason|0|||
42157385|NCT00006604|75965529|FG002|Overall Study|Other Reason|0|||
42157386|NCT00006604|75965530|FG003|Overall Study|Other Reason|0|||
42157387|NCT00006604|75965531|FG004|Overall Study|Other Reason|0|||
42157388|NCT00006604|75965532|FG005|Overall Study|Other Reason|1|||
42157389|NCT00006604|75965533|FG006|Overall Study|Other Reason|0|||
42157390|NCT00006604|75965534|FG007|Overall Study|Other Reason|0|||
42157391|NCT00006604|75965535|FG008|Overall Study|Other Reason|0|||
42157392|NCT00006604|75965536|FG009|Overall Study|Other Reason|1|||
42157393|NCT00006604|75965537|FG010|Overall Study|Other Reason|0|||
42157394|NCT00006604|75965538|FG011|Overall Study|Other Reason|0|||
42157395|NCT00006604|75965539|FG012|Overall Study|Other Reason|0|||
42157396|NCT00006604|75965540|FG013|Overall Study|Other Reason|0|||
42157397|NCT00006604|75965541|FG014|Overall Study|Other Reason|0|||
42157398|NCT00006604|75965542|FG015|Overall Study|Other Reason|0|||
42157399|NCT00006604|75965543|FG016|Overall Study|Other Reason|0|||
42157400|NCT00436007|75965569|FG000|Overall Study|Withdrawal by Subject|5|||
42157401|NCT00436007|75965570|FG001|Overall Study|Withdrawal by Subject|3|||
42157402|NCT00436007|75965571|FG002|Overall Study|Withdrawal by Subject|4|||
42157403|NCT00436007|75965569|FG000|Overall Study|Lost to Follow-up|14|||
42157404|NCT00436007|75965570|FG001|Overall Study|Lost to Follow-up|10|||
42157405|NCT00436007|75965571|FG002|Overall Study|Lost to Follow-up|13|||
42157406|NCT00436007|75965569|FG000|Overall Study|Physician Decision|0|||
42157407|NCT00436007|75965570|FG001|Overall Study|Physician Decision|0|||
42157408|NCT00436007|75965571|FG002|Overall Study|Physician Decision|2|||
42157409|NCT00436007|75965569|FG000|Overall Study|Death|0|||
42157410|NCT00436007|75965570|FG001|Overall Study|Death|1|||
42157411|NCT00436007|75965571|FG002|Overall Study|Death|3|||
42157412|NCT00436007|75965569|FG000|Overall Study|Other|0|||
42157413|NCT00436007|75965570|FG001|Overall Study|Other|0|||
42157414|NCT00436007|75965571|FG002|Overall Study|Other|1|||
42157415|NCT00435461|75965587|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
42157416|NCT00435461|75965588|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
42157417|NCT00435461|75965589|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
42157418|NCT00435461|75965587|FG000|Overall Study|Protocol Violation|6|||
42157419|NCT00435461|75965588|FG001|Overall Study|Protocol Violation|9|||
42157420|NCT00435461|75965589|FG002|Overall Study|Protocol Violation|10|||
42157421|NCT00435461|75965587|FG000|Overall Study|Participant randomized(inadequate score)|1|||
42157422|NCT00435461|75965588|FG001|Overall Study|Participant randomized(inadequate score)|0|||
42157423|NCT00435461|75965589|FG002|Overall Study|Participant randomized(inadequate score)|0|||
42157424|NCT00435461|75965587|FG000|Overall Study|Compliance less than 80 percent|1|||
42157425|NCT00435461|75965588|FG001|Overall Study|Compliance less than 80 percent|0|||
42157426|NCT00435461|75965589|FG002|Overall Study|Compliance less than 80 percent|0|||
42157427|NCT00435461|75965587|FG000|Overall Study|In error, two study medications switched|1|||
42040219|NCT01928394|75848568|FG002|Treatment Period|Participant withdrew consent|1|||
42157428|NCT00435461|75965588|FG001|Overall Study|In error, two study medications switched|0|||
42157429|NCT00435461|75965589|FG002|Overall Study|In error, two study medications switched|0|||
42157430|NCT00435461|75965587|FG000|Overall Study|Lack of Efficacy|2|||
42157431|NCT00435461|75965588|FG001|Overall Study|Lack of Efficacy|1|||
42157432|NCT00435461|75965589|FG002|Overall Study|Lack of Efficacy|0|||
42157433|NCT00435461|75965587|FG000|Overall Study|Withdrawal by Subject|1|||
42040220|NCT01928394|75848569|FG003|Treatment Period|Participant withdrew consent|1|||
42157434|NCT00435461|75965588|FG001|Overall Study|Withdrawal by Subject|0|||
42157435|NCT00435461|75965589|FG002|Overall Study|Withdrawal by Subject|2|||
42157436|NCT00435461|75965587|FG000|Overall Study|Randomized in error|1|||
42157437|NCT00435461|75965588|FG001|Overall Study|Randomized in error|0|||
42157438|NCT00435461|75965589|FG002|Overall Study|Randomized in error|0|||
42157439|NCT00435461|75965587|FG000|Overall Study|Participant could not tolerate symptoms|0|||
42157440|NCT00435461|75965588|FG001|Overall Study|Participant could not tolerate symptoms|0|||
42157441|NCT00435461|75965589|FG002|Overall Study|Participant could not tolerate symptoms|1|||
42157442|NCT00435461|75965587|FG000|Overall Study|Participant could not swallow capsule|0|||
42157443|NCT00435461|75965588|FG001|Overall Study|Participant could not swallow capsule|0|||
42157444|NCT00435461|75965589|FG002|Overall Study|Participant could not swallow capsule|1|||
42157445|NCT00435461|75965587|FG000|Overall Study|Pregnancy|2|||
42157446|NCT00435461|75965588|FG001|Overall Study|Pregnancy|0|||
42157447|NCT00435461|75965589|FG002|Overall Study|Pregnancy|0|||
42157448|NCT00435461|75965587|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
42157449|NCT00435461|75965588|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
42157450|NCT00435461|75965589|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
42157451|NCT00435461|75965587|FG000|Overall Study|Participant ended study one day early|1|||
42157452|NCT00435461|75965588|FG001|Overall Study|Participant ended study one day early|0|||
42157453|NCT00435461|75965589|FG002|Overall Study|Participant ended study one day early|0|||
42157454|NCT00435461|75965587|FG000|Overall Study|Noncompliance with study requirements|1|||
42157455|NCT00435461|75965588|FG001|Overall Study|Noncompliance with study requirements|1|||
42157456|NCT00435461|75965589|FG002|Overall Study|Noncompliance with study requirements|1|||
42157457|NCT00435461|75965587|FG000|Overall Study|Adverse Event|1|||
42157458|NCT00435461|75965588|FG001|Overall Study|Adverse Event|2|||
42157459|NCT00435461|75965589|FG002|Overall Study|Adverse Event|6|||
42157460|NCT00435461|75965587|FG000|Overall Study|Non-Compliance of diary|2|||
42157461|NCT00435461|75965588|FG001|Overall Study|Non-Compliance of diary|0|||
42157462|NCT00435461|75965589|FG002|Overall Study|Non-Compliance of diary|1|||
42157463|NCT00435461|75965587|FG000|Overall Study|Lost to Follow-up|1|||
42157464|NCT00435461|75965588|FG001|Overall Study|Lost to Follow-up|1|||
42157465|NCT00435461|75965589|FG002|Overall Study|Lost to Follow-up|2|||
42157466|NCT00434759|75965599|FG000|Overall Study|Lack of Efficacy|5|||
42157467|NCT00434759|75965600|FG001|Overall Study|Lack of Efficacy|4|||
42157468|NCT00434759|75965599|FG000|Overall Study|Withdrawal by Subject|17|||
42157469|NCT00434759|75965600|FG001|Overall Study|Withdrawal by Subject|1|||
42157470|NCT00434759|75965599|FG000|Overall Study|family affairs|2|||
42157471|NCT00434759|75965600|FG001|Overall Study|family affairs|0|||
42157472|NCT00440999|75965610|FG000|Overall Study|Adverse Event|0|||
42157473|NCT00440999|75965611|FG001|Overall Study|Adverse Event|2|||
42157474|NCT00440999|75965610|FG000|Overall Study|Lack of Efficacy|6|||
42157475|NCT00440999|75965611|FG001|Overall Study|Lack of Efficacy|7|||
42157476|NCT00440999|75965610|FG000|Overall Study|Lost to Follow-up|19|||
42157477|NCT00440999|75965611|FG001|Overall Study|Lost to Follow-up|12|||
42157478|NCT00440999|75965610|FG000|Overall Study|Protocol Violation|1|||
42157479|NCT00440999|75965611|FG001|Overall Study|Protocol Violation|0|||
42157480|NCT00440999|75965610|FG000|Overall Study|Withdrawal by Subject|2|||
42157481|NCT00440999|75965611|FG001|Overall Study|Withdrawal by Subject|5|||
42157482|NCT00440999|75965610|FG000|Overall Study|Subjets missed the visit|1|||
42157483|NCT00440999|75965611|FG001|Overall Study|Subjets missed the visit|0|||
42157484|NCT00440999|75965610|FG000|Overall Study|Mixed infection at entry|1|||
42157485|NCT00440999|75965611|FG001|Overall Study|Mixed infection at entry|0|||
42157486|NCT00440999|75965610|FG000|Overall Study|P. falciparum malaria|5|||
42157487|NCT00440999|75965611|FG001|Overall Study|P. falciparum malaria|14|||
42157488|NCT00440999|75965610|FG000|Overall Study|Subj left hosp without inform staff|0|||
42157489|NCT00440999|75965611|FG001|Overall Study|Subj left hosp without inform staff|1|||
42157490|NCT00434213|75965619|FG000|Overall Study|Adverse Event|12|||
42157491|NCT00434213|75965619|FG000|Overall Study|Lack of Efficacy|9|||
42157492|NCT00434213|75965619|FG000|Overall Study|Lost to Follow-up|14|||
42157493|NCT00434213|75965619|FG000|Overall Study|Withdrawal by Subject|7|||
42157494|NCT00434213|75965619|FG000|Overall Study|Protocol Violation|3|||
42157495|NCT00434213|75965619|FG000|Overall Study|Unable to comply with study visit window|2|||
42157496|NCT00434213|75965619|FG000|Overall Study|Application site reaction|1|||
42157497|NCT00434213|75965619|FG000|Overall Study|Non-compliant to study schedule|1|||
42157498|NCT00006184|75965625|FG000|Overall Study|Death|1|||
42157499|NCT00006184|75965626|FG001|Overall Study|Death|0|||
42157500|NCT00434057|75965632|FG000|Overall Study|Withdrawal by Subject|1|||
42157501|NCT00433199|75965638|FG000|Double-Blind Period|Adverse Event|0|||
42157502|NCT00433199|75965639|FG001|Double-Blind Period|Adverse Event|25|||
42157503|NCT00433199|75965638|FG000|Double-Blind Period|Lack of Efficacy|0|||
42157504|NCT00433199|75965639|FG001|Double-Blind Period|Lack of Efficacy|2|||
42157505|NCT00433199|75965638|FG000|Double-Blind Period|Lost to Follow-up|2|||
42157506|NCT00433199|75965639|FG001|Double-Blind Period|Lost to Follow-up|5|||
42157507|NCT00433199|75965638|FG000|Double-Blind Period|Withdrawal by Subject|8|||
42157508|NCT00433199|75965639|FG001|Double-Blind Period|Withdrawal by Subject|19|||
42157509|NCT00433199|75965638|FG000|Double-Blind Period|Protocol Violation|1|||
42157510|NCT00433199|75965639|FG001|Double-Blind Period|Protocol Violation|10|||
42157511|NCT00433199|75965638|FG000|Double-Blind Period|Administrative|1|||
42157512|NCT00433199|75965639|FG001|Double-Blind Period|Administrative|5|||
42157513|NCT00433199|75965638|FG000|Open-Label Period|Adverse Event|0|||
42157514|NCT00433199|75965639|FG001|Open-Label Period|Adverse Event|19|||
42157515|NCT00433199|75965638|FG000|Open-Label Period|Lack of Efficacy|0|||
42157516|NCT00433199|75965639|FG001|Open-Label Period|Lack of Efficacy|2|||
42157517|NCT00433199|75965638|FG000|Open-Label Period|Lost to Follow-up|0|||
42157518|NCT00433199|75965639|FG001|Open-Label Period|Lost to Follow-up|3|||
42157519|NCT00433199|75965638|FG000|Open-Label Period|Withdrawal by Subject|0|||
42157520|NCT00433199|75965639|FG001|Open-Label Period|Withdrawal by Subject|7|||
42157521|NCT00433199|75965638|FG000|Open-Label Period|Protocol Violation|0|||
42157522|NCT00433199|75965639|FG001|Open-Label Period|Protocol Violation|2|||
42157523|NCT00433199|75965638|FG000|Open-Label Period|Administrative|0|||
42157524|NCT00433199|75965639|FG001|Open-Label Period|Administrative|1|||
42157525|NCT00005908|75965650|FG000|Overall Study|Withdrawal by Subject|1|||
42157526|NCT00005908|75965651|FG001|Overall Study|Withdrawal by Subject|0|||
42157527|NCT00432965|75965662|FG000|Overall Study|Lost to Follow-up|22|||
42157528|NCT00432965|75965663|FG001|Overall Study|Lost to Follow-up|19|||
42157529|NCT00432965|75965662|FG000|Overall Study|Withdrawal by Subject|13|||
42157530|NCT00432965|75965663|FG001|Overall Study|Withdrawal by Subject|13|||
42157531|NCT00432965|75965662|FG000|Overall Study|Physician Decision|14|||
42157532|NCT00432965|75965663|FG001|Overall Study|Physician Decision|13|||
42157533|NCT00432965|75965662|FG000|Overall Study|Lack of Efficacy|8|||
42279421|NCT01376245|76110974|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
42279422|NCT01376245|76110975|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
42279423|NCT01376245|76110976|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
42279424|NCT01376245|76110977|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
42279425|NCT01376245|76110973|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
42279426|NCT01376245|76110974|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
42279427|NCT01376245|76110975|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
42279428|NCT01376245|76110976|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
42279429|NCT01376245|76110977|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
42279430|NCT01376245|76110973|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
42279431|NCT01376245|76110974|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
42279432|NCT01376245|76110975|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
42279433|NCT01376245|76110976|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
42279434|NCT01376245|76110977|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
42279435|NCT01376245|76110973|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
42279436|NCT01376245|76110974|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
42279437|NCT01376245|76110975|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
42279438|NCT01376245|76110976|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
42279439|NCT01376245|76110977|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
42279440|NCT01376245|76110973|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
42279441|NCT01376245|76110974|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
42279442|NCT01376245|76110975|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
42279443|NCT01376245|76110976|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
42279444|NCT01376245|76110977|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
42013410|NCT01288430|75820501|FG007|Part 2|Clinical disease progression|2|||
42013411|NCT01288430|75820502|FG008|Part 2|Clinical disease progression|0|||
42013412|NCT01288430|75820503|FG009|Part 2|Clinical disease progression|0|||
42157534|NCT00432965|75965663|FG001|Overall Study|Lack of Efficacy|13|||
42013413|NCT01288430|75820494|FG000|Part 2|Withdrawal by Subject|0|||
42157535|NCT00432965|75965662|FG000|Overall Study|Non-compliance|7|||
42157536|NCT00432965|75965663|FG001|Overall Study|Non-compliance|0|||
42157537|NCT00432965|75965662|FG000|Overall Study|Adverse Event|22|||
42157538|NCT00432965|75965663|FG001|Overall Study|Adverse Event|19|||
42157539|NCT00432965|75965662|FG000|Overall Study|Death|3|||
42157540|NCT00432965|75965663|FG001|Overall Study|Death|4|||
42157541|NCT00432965|75965662|FG000|Overall Study|Exclusionary Methods|1|||
42157542|NCT00432965|75965663|FG001|Overall Study|Exclusionary Methods|2|||
42157543|NCT00432965|75965662|FG000|Overall Study|Incomplete Data|4|||
42157544|NCT00432965|75965663|FG001|Overall Study|Incomplete Data|3|||
42157545|NCT00440297|75965671|FG000|Overall Study|Adverse Event|8|||
42157546|NCT00440297|75965672|FG001|Overall Study|Adverse Event|5|||
42013414|NCT01288430|75820495|FG001|Part 2|Withdrawal by Subject|0|||
42013415|NCT01288430|75820496|FG002|Part 2|Withdrawal by Subject|0|||
42013416|NCT01288430|75820497|FG003|Part 2|Withdrawal by Subject|0|||
42013417|NCT01288430|75820498|FG004|Part 2|Withdrawal by Subject|0|||
42013418|NCT01288430|75820499|FG005|Part 2|Withdrawal by Subject|0|||
42013419|NCT01288430|75820500|FG006|Part 2|Withdrawal by Subject|0|||
42013420|NCT01288430|75820501|FG007|Part 2|Withdrawal by Subject|1|||
42013421|NCT01288430|75820502|FG008|Part 2|Withdrawal by Subject|4|||
42013422|NCT01288430|75820503|FG009|Part 2|Withdrawal by Subject|0|||
42013423|NCT01288430|75820494|FG000|Part 2|Adverse Event|0|||
42013424|NCT01288430|75820495|FG001|Part 2|Adverse Event|0|||
42013425|NCT01288430|75820496|FG002|Part 2|Adverse Event|0|||
42013426|NCT01288430|75820497|FG003|Part 2|Adverse Event|0|||
42013427|NCT01288430|75820498|FG004|Part 2|Adverse Event|0|||
42013428|NCT01288430|75820499|FG005|Part 2|Adverse Event|0|||
42279445|NCT01376245|76110973|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
42279446|NCT01376245|76110974|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
42279447|NCT01376245|76110975|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
42279448|NCT01376245|76110976|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
42279449|NCT01376245|76110977|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
42013429|NCT01288430|75820500|FG006|Part 2|Adverse Event|0|||
42013430|NCT01288430|75820501|FG007|Part 2|Adverse Event|1|||
42013431|NCT01288430|75820502|FG008|Part 2|Adverse Event|1|||
42013432|NCT01288430|75820503|FG009|Part 2|Adverse Event|0|||
42013433|NCT01288430|75820494|FG000|Part 2|Other|0|||
42013434|NCT01288430|75820495|FG001|Part 2|Other|0|||
42013435|NCT01288430|75820496|FG002|Part 2|Other|0|||
42013436|NCT01288430|75820497|FG003|Part 2|Other|0|||
42013437|NCT01288430|75820498|FG004|Part 2|Other|0|||
42013438|NCT01288430|75820499|FG005|Part 2|Other|0|||
42013439|NCT01288430|75820500|FG006|Part 2|Other|0|||
42013440|NCT01288430|75820501|FG007|Part 2|Other|0|||
42013441|NCT01288430|75820502|FG008|Part 2|Other|0|||
42013442|NCT01288430|75820503|FG009|Part 2|Other|1|||
42013443|NCT01287416|75820532|FG000|Pre-post Training|Withdrawal by Subject|17|||
42013444|NCT01287416|75820533|FG001|Pre-post Training|Withdrawal by Subject|24|||
42157547|NCT00440297|75965671|FG000|Overall Study|Lost to Follow-up|1|||
42157548|NCT00440297|75965672|FG001|Overall Study|Lost to Follow-up|0|||
42157549|NCT00440297|75965671|FG000|Overall Study|Physician Decision|1|||
42157550|NCT00440297|75965672|FG001|Overall Study|Physician Decision|0|||
42157551|NCT00440297|75965671|FG000|Overall Study|Protocol Violation|11|||
42157552|NCT00440297|75965672|FG001|Overall Study|Protocol Violation|7|||
42157553|NCT00440297|75965671|FG000|Overall Study|Withdrawal by Subject|1|||
42157554|NCT00440297|75965672|FG001|Overall Study|Withdrawal by Subject|6|||
42157555|NCT00440297|75965671|FG000|Overall Study|Randomized by mistake|1|||
42157556|NCT00440297|75965672|FG001|Overall Study|Randomized by mistake|0|||
42157557|NCT00432809|75965681|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
42157558|NCT00432809|75965682|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
42157559|NCT00432809|75965683|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
42157560|NCT00432809|75965681|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
42157561|NCT00432809|75965682|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
42157562|NCT00432809|75965683|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
42279450|NCT01376245|76110973|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
42279451|NCT01376245|76110974|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
42279452|NCT01376245|76110975|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
42013445|NCT01287416|75820532|FG000|Pre-post Training|Lost to Follow-up|5|||
42013446|NCT01287416|75820533|FG001|Pre-post Training|Lost to Follow-up|1|||
42157563|NCT00431951|75965695|FG000|Overall Study|Inability to follow study procedures|1|||
42013447|NCT01287416|75820532|FG000|6 Month Follow-up|Lost to Follow-up|3|||
42013448|NCT01287416|75820533|FG001|6 Month Follow-up|Lost to Follow-up|2|||
42013449|NCT00998296|75820550|FG000|Overall Study|Progressive disease|0|||
42013450|NCT00998296|75820551|FG001|Overall Study|Progressive disease|1|||
42013451|NCT00998296|75820552|FG002|Overall Study|Progressive disease|0|||
42013452|NCT00998296|75820553|FG003|Overall Study|Progressive disease|0|||
42013453|NCT00998296|75820554|FG004|Overall Study|Progressive disease|0|||
42157564|NCT00431951|75965696|FG001|Overall Study|Inability to follow study procedures|0|||
42157565|NCT00431951|75965697|FG002|Overall Study|Inability to follow study procedures|1|||
42157566|NCT00431951|75965698|FG003|Overall Study|Inability to follow study procedures|2|||
42157567|NCT00431951|75965695|FG000|Overall Study|Lost to Follow-up|0|||
42157568|NCT00431951|75965696|FG001|Overall Study|Lost to Follow-up|1|||
42157569|NCT00431951|75965697|FG002|Overall Study|Lost to Follow-up|0|||
42157570|NCT00431951|75965698|FG003|Overall Study|Lost to Follow-up|0|||
42157571|NCT00431951|75965695|FG000|Overall Study|Withdrawal by Subject|0|||
42157572|NCT00431951|75965696|FG001|Overall Study|Withdrawal by Subject|1|||
42157573|NCT00431951|75965697|FG002|Overall Study|Withdrawal by Subject|0|||
42157574|NCT00431951|75965698|FG003|Overall Study|Withdrawal by Subject|0|||
42279453|NCT01376245|76110976|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
42279454|NCT01376245|76110977|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
42279455|NCT01376245|76110973|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
42279456|NCT01376245|76110974|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
42279457|NCT01376245|76110975|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
42279458|NCT01376245|76110976|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
42279459|NCT01376245|76110977|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
42279460|NCT01376245|76110973|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
42279461|NCT01376245|76110974|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
42279462|NCT01376245|76110975|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
42279463|NCT01376245|76110976|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
42279464|NCT01376245|76110977|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
42279465|NCT01376245|76110973|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
42279466|NCT01376245|76110974|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
42279467|NCT01376245|76110975|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
42279468|NCT01376245|76110976|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
42351382|NCT01929031|76191329|FG004|Overall Study|Reason other than specified above|1|||
42351383|NCT01929031|76191330|FG005|Overall Study|Reason other than specified above|0|||
42351384|NCT00989092|76191342|FG000|Overall Study|Physician Decision|9|||
42351385|NCT00989092|76191343|FG001|Overall Study|Physician Decision|6|||
42040221|NCT01928394|75848570|FG004|Treatment Period|Participant withdrew consent|0|||
42157575|NCT00431951|75965695|FG000|Overall Study|Adverse Event|0|||
42157576|NCT00431951|75965696|FG001|Overall Study|Adverse Event|0|||
42157577|NCT00431951|75965697|FG002|Overall Study|Adverse Event|1|||
42157578|NCT00431951|75965698|FG003|Overall Study|Adverse Event|0|||
42157579|NCT00004978|75965714|FG000|Overall Study|Death|107|||
42157580|NCT00004978|75965715|FG001|Overall Study|Death|116|||
42157581|NCT00004978|75965714|FG000|Overall Study|Lost to Follow-up|101|||
42157582|NCT00004978|75965715|FG001|Overall Study|Lost to Follow-up|108|||
42157583|NCT00004978|75965714|FG000|Overall Study|Withdrawal by Subject|17|||
42157584|NCT00004978|75965715|FG001|Overall Study|Withdrawal by Subject|26|||
42157585|NCT00004978|75965714|FG000|Overall Study|site closure - not in analysis cohort|19|||
42157586|NCT00004978|75965715|FG001|Overall Study|site closure - not in analysis cohort|20|||
42157587|NCT00430937|75965723|FG000|Overall Study|Adverse Event|3|||
42157588|NCT00430937|75965724|FG001|Overall Study|Adverse Event|8|||
42040222|NCT01928394|75848571|FG005|Treatment Period|Participant withdrew consent|1|||
42040223|NCT01928394|75848572|FG006|Treatment Period|Participant withdrew consent|0|||
42040224|NCT01928394|75848573|FG007|Treatment Period|Participant withdrew consent|1|||
42157589|NCT00430937|75965723|FG000|Overall Study|Death|0|||
42157590|NCT00430937|75965724|FG001|Overall Study|Death|1|||
42157591|NCT00430937|75965723|FG000|Overall Study|Lost to Follow-up|6|||
42157592|NCT00430937|75965724|FG001|Overall Study|Lost to Follow-up|6|||
42157593|NCT00430937|75965723|FG000|Overall Study|Withdrawal by Subject|5|||
42157594|NCT00430937|75965724|FG001|Overall Study|Withdrawal by Subject|2|||
42157595|NCT00430937|75965723|FG000|Overall Study|Protocol Violation|3|||
42157596|NCT00430937|75965724|FG001|Overall Study|Protocol Violation|2|||
42157597|NCT00430937|75965723|FG000|Overall Study|Lack of Efficacy|6|||
42157598|NCT00430937|75965724|FG001|Overall Study|Lack of Efficacy|5|||
42157599|NCT00430937|75965723|FG000|Overall Study|Inappropriate enrollment|2|||
42157600|NCT00430937|75965724|FG001|Overall Study|Inappropriate enrollment|1|||
42157601|NCT00430937|75965723|FG000|Overall Study|Administrative reasons|1|||
42157602|NCT00430937|75965724|FG001|Overall Study|Administrative reasons|0|||
42157603|NCT00430937|75965723|FG000|Overall Study|Protocol discontinuation criteria met|1|||
42157604|NCT00430937|75965724|FG001|Overall Study|Protocol discontinuation criteria met|2|||
42157605|NCT00430937|75965723|FG000|Overall Study|Unable to classify|0|||
42157606|NCT00430937|75965724|FG001|Overall Study|Unable to classify|1|||
42157607|NCT00004888|75965732|FG000|Overall Study|Adverse Event|5|||
42157608|NCT00004888|75965733|FG001|Overall Study|Adverse Event|10|||
42157609|NCT00004888|75965732|FG000|Overall Study|Withdrawal by Subject|0|||
42279469|NCT01376245|76110977|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
42279470|NCT01674621|76110992|FG000|Overall Study|Adverse Event|3|||
42279471|NCT01674621|76110993|FG001|Overall Study|Adverse Event|2|||
42279472|NCT01674621|76110994|FG002|Overall Study|Adverse Event|5|||
42279473|NCT01674621|76110995|FG003|Overall Study|Adverse Event|5|||
42279474|NCT01674621|76110996|FG004|Overall Study|Adverse Event|1|||
42279475|NCT01674621|76110992|FG000|Overall Study|Inability to Complete Study Procedures|0|||
42157610|NCT00004888|75965733|FG001|Overall Study|Withdrawal by Subject|3|||
42157611|NCT00004888|75965732|FG000|Overall Study|Physician Decision|1|||
42157612|NCT00004888|75965733|FG001|Overall Study|Physician Decision|1|||
42157613|NCT00004888|75965732|FG000|Overall Study|Progressive Disease|4|||
42157614|NCT00004888|75965733|FG001|Overall Study|Progressive Disease|9|||
42157615|NCT00004888|75965732|FG000|Overall Study|Death without progressive disease|0|||
42157616|NCT00004888|75965733|FG001|Overall Study|Death without progressive disease|1|||
42157617|NCT00004888|75965732|FG000|Overall Study|Toxic death|1|||
42157618|NCT00004888|75965733|FG001|Overall Study|Toxic death|0|||
42157619|NCT00004732|75965741|FG000|Overall Study|Withdrawal by Subject|36|||
42157620|NCT00004732|75965742|FG001|Overall Study|Withdrawal by Subject|64|||
42157621|NCT00004732|75965741|FG000|Overall Study|Lost to Follow-up|33|||
42157622|NCT00004732|75965742|FG001|Overall Study|Lost to Follow-up|47|||
42157623|NCT00430781|75965753|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
42157624|NCT00430781|75965754|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
42157625|NCT00430781|75965755|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
42157626|NCT00430781|75965753|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
42157627|NCT00430781|75965754|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
42157628|NCT00430781|75965755|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
42157629|NCT00430781|75965753|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
42157630|NCT00430781|75965754|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
42157631|NCT00430781|75965755|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
42157632|NCT00430781|75965753|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
42157633|NCT00430781|75965754|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
42157634|NCT00430781|75965755|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
42157635|NCT00430781|75965753|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
42157636|NCT00430781|75965754|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
42157637|NCT00430781|75965755|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
42157638|NCT00430781|75965753|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
42157639|NCT00430781|75965754|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
42157640|NCT00430781|75965755|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
42157641|NCT00430781|75965753|FG000|Interim Analysis; 11 February 2008|Death|0|||
42157642|NCT00430781|75965754|FG001|Interim Analysis; 11 February 2008|Death|1|||
42157643|NCT00430781|75965755|FG002|Interim Analysis; 11 February 2008|Death|0|||
42157644|NCT00430781|75965753|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
42157645|NCT00430781|75965754|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
42279476|NCT01674621|76110993|FG001|Overall Study|Inability to Complete Study Procedures|0|||
42279477|NCT01674621|76110994|FG002|Overall Study|Inability to Complete Study Procedures|0|||
42279478|NCT01674621|76110995|FG003|Overall Study|Inability to Complete Study Procedures|0|||
42279479|NCT01674621|76110996|FG004|Overall Study|Inability to Complete Study Procedures|2|||
42279480|NCT01674621|76110992|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
42279481|NCT01674621|76110993|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
42279482|NCT01674621|76110994|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
42279483|NCT01674621|76110995|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
42279484|NCT01674621|76110996|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
42279485|NCT01674621|76110992|FG000|Overall Study|Withdrawal by Subject|2|||
42279486|NCT01674621|76110993|FG001|Overall Study|Withdrawal by Subject|5|||
42279487|NCT01674621|76110994|FG002|Overall Study|Withdrawal by Subject|2|||
42279488|NCT01674621|76110995|FG003|Overall Study|Withdrawal by Subject|0|||
42279489|NCT01674621|76110996|FG004|Overall Study|Withdrawal by Subject|1|||
42279490|NCT01674621|76110992|FG000|Overall Study|Other than specified|0|||
42279491|NCT01674621|76110993|FG001|Overall Study|Other than specified|1|||
42279492|NCT01674621|76110994|FG002|Overall Study|Other than specified|0|||
42157646|NCT00430781|75965755|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
42157647|NCT00430781|75965753|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
42157648|NCT00430781|75965754|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
42157649|NCT00430781|75965755|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
42157650|NCT00430781|75965753|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
42157651|NCT00430781|75965754|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
42157652|NCT00430781|75965755|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
42157653|NCT00430781|75965753|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
42157654|NCT00430781|75965754|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
42157655|NCT00430781|75965755|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
42157656|NCT00430781|75965753|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
42157657|NCT00430781|75965754|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
42157658|NCT00430781|75965755|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
42157659|NCT00430781|75965753|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
42157660|NCT00430781|75965754|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
42157661|NCT00430781|75965755|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
42157662|NCT00430781|75965753|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
42157663|NCT00430781|75965754|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
42157664|NCT00430781|75965755|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
42157665|NCT00430781|75965753|FG000|Final Analysis; 31 July 2008|Other|0|||
42157666|NCT00430781|75965754|FG001|Final Analysis; 31 July 2008|Other|1|||
42157667|NCT00430781|75965755|FG002|Final Analysis; 31 July 2008|Other|0|||
42157668|NCT00430781|75965753|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
42157669|NCT00430781|75965754|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
42157670|NCT00430781|75965755|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
42157671|NCT00430781|75965753|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
42157672|NCT00430781|75965754|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
42157673|NCT00430781|75965755|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
42157674|NCT00430781|75965753|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
42157675|NCT00430781|75965754|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
42157676|NCT00430781|75965755|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
42157677|NCT00430781|75965753|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
42157678|NCT00430781|75965754|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
42157679|NCT00430781|75965755|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
42157680|NCT00430781|75965753|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
42157681|NCT00430781|75965754|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
42157682|NCT00430781|75965755|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
42157683|NCT00430781|75965753|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
42157684|NCT00430781|75965754|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
42157685|NCT00430781|75965755|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
42157686|NCT00430781|75965753|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
42157687|NCT00430781|75965754|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
42157688|NCT00430781|75965755|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
42157689|NCT00429299|75965769|FG000|Overall Study|Disease Progression|1|||
42157690|NCT00429299|75965770|FG001|Overall Study|Disease Progression|1|||
42157691|NCT00429299|75965771|FG002|Overall Study|Disease Progression|0|||
42157692|NCT00429299|75965769|FG000|Overall Study|Adverse Event|2|||
42157693|NCT00429299|75965770|FG001|Overall Study|Adverse Event|5|||
42157694|NCT00429299|75965771|FG002|Overall Study|Adverse Event|1|||
42157695|NCT00429299|75965769|FG000|Overall Study|Protocol Violation|1|||
42157696|NCT00429299|75965770|FG001|Overall Study|Protocol Violation|0|||
42157697|NCT00429299|75965771|FG002|Overall Study|Protocol Violation|0|||
42157698|NCT00429299|75965769|FG000|Overall Study|Withdrawal by Subject|0|||
42157699|NCT00429299|75965770|FG001|Overall Study|Withdrawal by Subject|1|||
42157700|NCT00429299|75965771|FG002|Overall Study|Withdrawal by Subject|3|||
42157701|NCT00428597|75965781|FG000|Overall Study|Randomized but not treated|3|||
42157702|NCT00428597|75965782|FG001|Overall Study|Randomized but not treated|3|||
42157703|NCT00428597|75965781|FG000|Overall Study|Objective Progression or Relapse|19|||
42157704|NCT00428597|75965782|FG001|Overall Study|Objective Progression or Relapse|47|||
42157705|NCT00428597|75965781|FG000|Overall Study|Study Terminated by Sponsor|41|||
42157706|NCT00428597|75965782|FG001|Overall Study|Study Terminated by Sponsor|16|||
42157707|NCT00428597|75965781|FG000|Overall Study|Adverse Event|15|||
42157708|NCT00428597|75965782|FG001|Overall Study|Adverse Event|7|||
42157709|NCT00428597|75965781|FG000|Overall Study|Global Deterioration of Health Status|1|||
42157710|NCT00428597|75965782|FG001|Overall Study|Global Deterioration of Health Status|5|||
42157711|NCT00428597|75965781|FG000|Overall Study|Protocol Violation|2|||
42157712|NCT00428597|75965782|FG001|Overall Study|Protocol Violation|1|||
42157713|NCT00428597|75965781|FG000|Overall Study|Withdrawal by Subject|2|||
42157714|NCT00428597|75965782|FG001|Overall Study|Withdrawal by Subject|1|||
42157715|NCT00428597|75965781|FG000|Overall Study|Other|1|||
42157716|NCT00428597|75965782|FG001|Overall Study|Other|1|||
42157717|NCT00428597|75965781|FG000|Overall Study|Lost to Follow-up|0|||
42157718|NCT00428597|75965782|FG001|Overall Study|Lost to Follow-up|1|||
42157719|NCT00428597|75965781|FG000|Overall Study|Pregnancy|1|||
42157720|NCT00428597|75965782|FG001|Overall Study|Pregnancy|0|||
42157721|NCT00428597|75965781|FG000|Overall Study|Death|1|||
42157722|NCT00428597|75965782|FG001|Overall Study|Death|3|||
42157723|NCT00428441|75965788|FG000|Overall Study|Lost to Follow-up|1|||
42157724|NCT00144339|75965794|FG000|Overall Study|Adverse Event|746|||
42157725|NCT00144339|75965795|FG001|Overall Study|Adverse Event|627|||
42157726|NCT00144339|75965794|FG000|Overall Study|Protocol Violation|75|||
42157727|NCT00144339|75965795|FG001|Overall Study|Protocol Violation|48|||
42157728|NCT00144339|75965794|FG000|Overall Study|Withdrawal by Subject|403|||
42157729|NCT00144339|75965795|FG001|Overall Study|Withdrawal by Subject|300|||
42157730|NCT00144339|75965794|FG000|Overall Study|Lost to Follow-up|76|||
42157731|NCT00144339|75965795|FG001|Overall Study|Lost to Follow-up|64|||
42157732|NCT00144339|75965794|FG000|Overall Study|Other|58|||
42157733|NCT00144339|75965795|FG001|Overall Study|Other|60|||
42157734|NCT00144027|75965803|FG000|Overall Study|Lost to Follow-up|1|||
42157735|NCT00144027|75965804|FG001|Overall Study|Lost to Follow-up|3|||
42157736|NCT00144027|75965803|FG000|Overall Study|Withdrawal by Subject|2|||
42157737|NCT00144027|75965804|FG001|Overall Study|Withdrawal by Subject|2|||
42157738|NCT00144027|75965803|FG000|Overall Study|did not complete baseline assessment|0|||
42157739|NCT00144027|75965804|FG001|Overall Study|did not complete baseline assessment|6|||
42157740|NCT00127803|75965814|FG000|Overall Study|Adverse Event|2|||
42157741|NCT00127803|75965815|FG001|Overall Study|Adverse Event|0|||
42157742|NCT00127803|75965816|FG002|Overall Study|Adverse Event|0|||
42157743|NCT00127803|75965817|FG003|Overall Study|Adverse Event|0|||
42157744|NCT00127803|75965814|FG000|Overall Study|Withdrawal by Subject|1|||
42157745|NCT00127803|75965815|FG001|Overall Study|Withdrawal by Subject|0|||
42157746|NCT00127803|75965816|FG002|Overall Study|Withdrawal by Subject|0|||
42157747|NCT00127803|75965817|FG003|Overall Study|Withdrawal by Subject|0|||
42157748|NCT00127803|75965814|FG000|Overall Study|Lost to Follow-up|0|||
42157749|NCT00127803|75965815|FG001|Overall Study|Lost to Follow-up|0|||
42157750|NCT00127803|75965816|FG002|Overall Study|Lost to Follow-up|0|||
42157751|NCT00127803|75965817|FG003|Overall Study|Lost to Follow-up|1|||
42157752|NCT00127413|75965831|FG000|Overall Study|Lost to Follow-up|6|||
42157753|NCT00127413|75965832|FG001|Overall Study|Lost to Follow-up|4|||
42157754|NCT00127413|75965833|FG002|Overall Study|Lost to Follow-up|8|||
42157755|NCT00127413|75965834|FG003|Overall Study|Lost to Follow-up|2|||
42157756|NCT00143403|75965846|FG000|Overall Study|Adverse Event|3|||
42157757|NCT00143403|75965847|FG001|Overall Study|Adverse Event|8|||
42157758|NCT00143403|75965846|FG000|Overall Study|Death|1|||
42157759|NCT00143403|75965847|FG001|Overall Study|Death|0|||
42157760|NCT00143403|75965846|FG000|Overall Study|Withdrawal by Subject|3|||
42157761|NCT00143403|75965847|FG001|Overall Study|Withdrawal by Subject|12|||
42157762|NCT00143403|75965846|FG000|Overall Study|Relapse|15|||
42157763|NCT00143403|75965847|FG001|Overall Study|Relapse|7|||
42157764|NCT00143403|75965846|FG000|Overall Study|Protocol Violation|2|||
42157765|NCT00143403|75965847|FG001|Overall Study|Protocol Violation|2|||
42157766|NCT00143403|75965846|FG000|Overall Study|specified by site|4|||
42157767|NCT00143403|75965847|FG001|Overall Study|specified by site|9|||
42157768|NCT00143403|75965846|FG000|Overall Study|Randomized Not Treated|7|||
42157769|NCT00143403|75965847|FG001|Overall Study|Randomized Not Treated|8|||
42157770|NCT00220701|75965855|FG000|Overall Study|Lost to Follow-up|5|||
42157771|NCT00220701|75965856|FG001|Overall Study|Lost to Follow-up|4|||
42157772|NCT00127101|75965868|FG000|Base Protocol|Adverse Event|0|||
42157773|NCT00127101|75965869|FG001|Base Protocol|Adverse Event|2|||
42157774|NCT00127101|75965870|FG002|Base Protocol|Adverse Event|1|||
42157775|NCT00127101|75965871|FG003|Base Protocol|Adverse Event|0|||
42157776|NCT00127101|75965872|FG004|Base Protocol|Adverse Event|0|||
42157777|NCT00127101|75965873|FG005|Base Protocol|Adverse Event|0|||
42157778|NCT00127101|75965868|FG000|Base Protocol|Lack of Efficacy|1|||
42157779|NCT00127101|75965869|FG001|Base Protocol|Lack of Efficacy|0|||
42351386|NCT00989092|76191342|FG000|Overall Study|Adverse Event|20|||
42351387|NCT00989092|76191343|FG001|Overall Study|Adverse Event|1|||
42351388|NCT00989092|76191342|FG000|Overall Study|Chemotherapy initiated|12|||
42157780|NCT00127101|75965870|FG002|Base Protocol|Lack of Efficacy|0|||
42157781|NCT00127101|75965871|FG003|Base Protocol|Lack of Efficacy|0|||
42351389|NCT00989092|76191343|FG001|Overall Study|Chemotherapy initiated|4|||
42351390|NCT00989092|76191342|FG000|Overall Study|Withdrawal by Subject|17|||
42157782|NCT00127101|75965872|FG004|Base Protocol|Lack of Efficacy|2|||
42157783|NCT00127101|75965873|FG005|Base Protocol|Lack of Efficacy|0|||
42157784|NCT00127101|75965868|FG000|Base Protocol|Withdrawal by Subject|1|||
42157785|NCT00127101|75965869|FG001|Base Protocol|Withdrawal by Subject|2|||
42157786|NCT00127101|75965870|FG002|Base Protocol|Withdrawal by Subject|1|||
42157787|NCT00127101|75965871|FG003|Base Protocol|Withdrawal by Subject|0|||
42157788|NCT00127101|75965872|FG004|Base Protocol|Withdrawal by Subject|0|||
42157789|NCT00127101|75965873|FG005|Base Protocol|Withdrawal by Subject|1|||
42157790|NCT00127101|75965868|FG000|Continuation Phase|Adverse Event|0|||
42157791|NCT00127101|75965869|FG001|Continuation Phase|Adverse Event|0|||
42157792|NCT00127101|75965870|FG002|Continuation Phase|Adverse Event|0|||
42157793|NCT00127101|75965871|FG003|Continuation Phase|Adverse Event|0|||
42351391|NCT00989092|76191343|FG001|Overall Study|Withdrawal by Subject|9|||
42157794|NCT00127101|75965872|FG004|Continuation Phase|Adverse Event|1|||
42157795|NCT00127101|75965873|FG005|Continuation Phase|Adverse Event|1|||
42157796|NCT00127101|75965868|FG000|Continuation Phase|Lack of Efficacy|0|||
42157797|NCT00127101|75965869|FG001|Continuation Phase|Lack of Efficacy|0|||
42157798|NCT00127101|75965870|FG002|Continuation Phase|Lack of Efficacy|0|||
42157799|NCT00127101|75965871|FG003|Continuation Phase|Lack of Efficacy|0|||
42157800|NCT00127101|75965872|FG004|Continuation Phase|Lack of Efficacy|0|||
42157801|NCT00127101|75965873|FG005|Continuation Phase|Lack of Efficacy|1|||
42157802|NCT00127101|75965868|FG000|Continuation Phase|Withdrawal by Subject|0|||
42157803|NCT00127101|75965869|FG001|Continuation Phase|Withdrawal by Subject|0|||
42157804|NCT00127101|75965870|FG002|Continuation Phase|Withdrawal by Subject|1|||
42157805|NCT00127101|75965871|FG003|Continuation Phase|Withdrawal by Subject|0|||
42157806|NCT00127101|75965872|FG004|Continuation Phase|Withdrawal by Subject|2|||
42157807|NCT00127101|75965873|FG005|Continuation Phase|Withdrawal by Subject|1|||
42157808|NCT00126555|75965887|FG000|Overall Study|Withdrawal by Subject|1|||
42157809|NCT00126555|75965887|FG000|Overall Study|Adverse Event|2|||
42157810|NCT00126555|75965887|FG000|Overall Study|Progressive Disease|3|||
42157811|NCT00004228|75965910|FG000|Overall Study|Adverse Event|0|||
42157812|NCT00004228|75965911|FG001|Overall Study|Adverse Event|1|||
42157813|NCT00004228|75965912|FG002|Overall Study|Adverse Event|0|||
42157814|NCT00004228|75965913|FG003|Overall Study|Adverse Event|0|||
42157815|NCT00004228|75965914|FG004|Overall Study|Adverse Event|1|||
42157816|NCT00004228|75965915|FG005|Overall Study|Adverse Event|0|||
42157817|NCT00004228|75965916|FG006|Overall Study|Adverse Event|0|||
42157818|NCT00004228|75965910|FG000|Overall Study|Death|0|||
42157819|NCT00004228|75965911|FG001|Overall Study|Death|1|||
42157820|NCT00004228|75965912|FG002|Overall Study|Death|2|||
42157821|NCT00004228|75965913|FG003|Overall Study|Death|0|||
42157822|NCT00004228|75965914|FG004|Overall Study|Death|1|||
42157823|NCT00004228|75965915|FG005|Overall Study|Death|0|||
42157824|NCT00004228|75965916|FG006|Overall Study|Death|0|||
42157825|NCT00004228|75965910|FG000|Overall Study|Lack of Efficacy|1|||
42157826|NCT00004228|75965911|FG001|Overall Study|Lack of Efficacy|6|||
42157827|NCT00004228|75965912|FG002|Overall Study|Lack of Efficacy|5|||
42157828|NCT00004228|75965913|FG003|Overall Study|Lack of Efficacy|3|||
42157829|NCT00004228|75965914|FG004|Overall Study|Lack of Efficacy|9|||
42157830|NCT00004228|75965915|FG005|Overall Study|Lack of Efficacy|8|||
42157831|NCT00004228|75965916|FG006|Overall Study|Lack of Efficacy|4|||
42157832|NCT00004228|75965910|FG000|Overall Study|Lost to Follow-up|0|||
42157833|NCT00004228|75965911|FG001|Overall Study|Lost to Follow-up|0|||
42157834|NCT00004228|75965912|FG002|Overall Study|Lost to Follow-up|1|||
42157835|NCT00004228|75965913|FG003|Overall Study|Lost to Follow-up|0|||
42157836|NCT00004228|75965914|FG004|Overall Study|Lost to Follow-up|0|||
42157837|NCT00004228|75965915|FG005|Overall Study|Lost to Follow-up|0|||
42157838|NCT00004228|75965916|FG006|Overall Study|Lost to Follow-up|0|||
42157839|NCT00004228|75965910|FG000|Overall Study|Physician Decision|1|||
42157840|NCT00004228|75965911|FG001|Overall Study|Physician Decision|0|||
42157841|NCT00004228|75965912|FG002|Overall Study|Physician Decision|3|||
42157842|NCT00004228|75965913|FG003|Overall Study|Physician Decision|2|||
42157843|NCT00004228|75965914|FG004|Overall Study|Physician Decision|1|||
42157844|NCT00004228|75965915|FG005|Overall Study|Physician Decision|1|||
42157845|NCT00004228|75965916|FG006|Overall Study|Physician Decision|1|||
42157846|NCT00004228|75965910|FG000|Overall Study|Protocol Violation|0|||
42157847|NCT00004228|75965911|FG001|Overall Study|Protocol Violation|5|||
42157848|NCT00004228|75965912|FG002|Overall Study|Protocol Violation|2|||
42157849|NCT00004228|75965913|FG003|Overall Study|Protocol Violation|1|||
42157850|NCT00004228|75965914|FG004|Overall Study|Protocol Violation|1|||
42279493|NCT01674621|76110995|FG003|Overall Study|Other than specified|0|||
42279494|NCT01674621|76110996|FG004|Overall Study|Other than specified|2|||
42279495|NCT02730169|76111013|FG000|Overall Study|Protocol Violation|1|||
42279496|NCT02730169|76111014|FG001|Overall Study|Protocol Violation|0|||
42279497|NCT02730169|76111015|FG002|Overall Study|Protocol Violation|0|||
42157851|NCT00004228|75965915|FG005|Overall Study|Protocol Violation|2|||
42157852|NCT00004228|75965916|FG006|Overall Study|Protocol Violation|0|||
42279498|NCT02730169|76111016|FG003|Overall Study|Protocol Violation|1|||
42279499|NCT02730169|76111013|FG000|Overall Study|Adverse Event|2|||
42157853|NCT00004228|75965910|FG000|Overall Study|Withdrawal by Subject|3|||
42157854|NCT00004228|75965911|FG001|Overall Study|Withdrawal by Subject|0|||
42157855|NCT00004228|75965912|FG002|Overall Study|Withdrawal by Subject|1|||
42157856|NCT00004228|75965913|FG003|Overall Study|Withdrawal by Subject|0|||
42157857|NCT00004228|75965914|FG004|Overall Study|Withdrawal by Subject|2|||
42157858|NCT00004228|75965915|FG005|Overall Study|Withdrawal by Subject|1|||
42157859|NCT00004228|75965916|FG006|Overall Study|Withdrawal by Subject|2|||
42157860|NCT00004228|75965910|FG000|Overall Study|Other|0|||
42157861|NCT00004228|75965911|FG001|Overall Study|Other|0|||
42157862|NCT00004228|75965912|FG002|Overall Study|Other|1|||
42157863|NCT00004228|75965913|FG003|Overall Study|Other|0|||
42279500|NCT02730169|76111014|FG001|Overall Study|Adverse Event|3|||
42157864|NCT00004228|75965914|FG004|Overall Study|Other|0|||
42157865|NCT00004228|75965915|FG005|Overall Study|Other|0|||
42157866|NCT00004228|75965916|FG006|Overall Study|Other|0|||
42279501|NCT02730169|76111015|FG002|Overall Study|Adverse Event|3|||
42279502|NCT02730169|76111016|FG003|Overall Study|Adverse Event|0|||
42157867|NCT00004228|75965910|FG000|Overall Study|ineligible|4|||
42157868|NCT00004228|75965911|FG001|Overall Study|ineligible|2|||
42157869|NCT00004228|75965912|FG002|Overall Study|ineligible|4|||
42157870|NCT00004228|75965913|FG003|Overall Study|ineligible|1|||
42157871|NCT00004228|75965914|FG004|Overall Study|ineligible|1|||
42157872|NCT00004228|75965915|FG005|Overall Study|ineligible|2|||
42157873|NCT00004228|75965916|FG006|Overall Study|ineligible|5|||
42157874|NCT00003526|75965933|FG000|Overall Study|Not evaluable|6|||
42157875|NCT00195260|75965939|FG000|Part 1: Dose Escalation|Adverse Event|0|||
42157876|NCT00195260|75965940|FG001|Part 1: Dose Escalation|Adverse Event|1|||
42157877|NCT00195260|75965941|FG002|Part 1: Dose Escalation|Adverse Event|0|||
42157878|NCT00195260|75965942|FG003|Part 1: Dose Escalation|Adverse Event|1|||
42157879|NCT00195260|75965943|FG004|Part 1: Dose Escalation|Adverse Event|1|||
42157880|NCT00195260|75965944|FG005|Part 1: Dose Escalation|Adverse Event|0|||
42157881|NCT00195260|75965945|FG006|Part 1: Dose Escalation|Adverse Event|3|||
42157882|NCT00195260|75965946|FG007|Part 1: Dose Escalation|Adverse Event|0|||
42157883|NCT00195260|75965947|FG008|Part 1: Dose Escalation|Adverse Event|0|||
42157884|NCT00195260|75965948|FG009|Part 1: Dose Escalation|Adverse Event|0|||
42157885|NCT00195260|75965949|FG010|Part 1: Dose Escalation|Adverse Event|0|||
42157886|NCT00195260|75965939|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
42157887|NCT00195260|75965940|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
42157888|NCT00195260|75965941|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
42157889|NCT00195260|75965942|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
42157890|NCT00195260|75965943|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
42157891|NCT00195260|75965944|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
42157892|NCT00195260|75965945|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
42157893|NCT00195260|75965946|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
42157894|NCT00195260|75965947|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
42157895|NCT00195260|75965948|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
42157896|NCT00195260|75965949|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
42157897|NCT00195260|75965939|FG000|Part 1: Dose Escalation|Death|0|||
42157898|NCT00195260|75965940|FG001|Part 1: Dose Escalation|Death|0|||
42157899|NCT00195260|75965941|FG002|Part 1: Dose Escalation|Death|0|||
42157900|NCT00195260|75965942|FG003|Part 1: Dose Escalation|Death|0|||
42157901|NCT00195260|75965943|FG004|Part 1: Dose Escalation|Death|0|||
42157902|NCT00195260|75965944|FG005|Part 1: Dose Escalation|Death|0|||
42157903|NCT00195260|75965945|FG006|Part 1: Dose Escalation|Death|0|||
42157904|NCT00195260|75965946|FG007|Part 1: Dose Escalation|Death|1|||
42157905|NCT00195260|75965947|FG008|Part 1: Dose Escalation|Death|0|||
42157906|NCT00195260|75965948|FG009|Part 1: Dose Escalation|Death|0|||
42157907|NCT00195260|75965949|FG010|Part 1: Dose Escalation|Death|0|||
42157908|NCT00195260|75965939|FG000|Part 1: Dose Escalation|Disease Progression|3|||
42157909|NCT00195260|75965940|FG001|Part 1: Dose Escalation|Disease Progression|2|||
42157910|NCT00195260|75965941|FG002|Part 1: Dose Escalation|Disease Progression|5|||
42157911|NCT00195260|75965942|FG003|Part 1: Dose Escalation|Disease Progression|6|||
42157912|NCT00195260|75965943|FG004|Part 1: Dose Escalation|Disease Progression|4|||
42157913|NCT00195260|75965944|FG005|Part 1: Dose Escalation|Disease Progression|6|||
42157914|NCT00195260|75965945|FG006|Part 1: Dose Escalation|Disease Progression|7|||
42157915|NCT00195260|75965946|FG007|Part 1: Dose Escalation|Disease Progression|4|||
42157916|NCT00195260|75965947|FG008|Part 1: Dose Escalation|Disease Progression|0|||
42157917|NCT00195260|75965948|FG009|Part 1: Dose Escalation|Disease Progression|0|||
42157918|NCT00195260|75965949|FG010|Part 1: Dose Escalation|Disease Progression|0|||
42157919|NCT00195260|75965939|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
42157920|NCT00195260|75965940|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
42157921|NCT00195260|75965941|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
42157922|NCT00195260|75965942|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
42157923|NCT00195260|75965943|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
42279503|NCT02730169|76111013|FG000|Overall Study|Adverse Event of Special Interest|0|||
42279504|NCT02730169|76111014|FG001|Overall Study|Adverse Event of Special Interest|1|||
42157924|NCT00195260|75965944|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
42157925|NCT00195260|75965945|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
42157926|NCT00195260|75965946|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
42157927|NCT00195260|75965947|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
42157928|NCT00195260|75965948|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
42157929|NCT00195260|75965949|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
42157930|NCT00195260|75965939|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
42157931|NCT00195260|75965940|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
42157932|NCT00195260|75965941|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
42157933|NCT00195260|75965942|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
42279505|NCT02730169|76111015|FG002|Overall Study|Adverse Event of Special Interest|2|||
42279506|NCT02730169|76111016|FG003|Overall Study|Adverse Event of Special Interest|0|||
42157934|NCT00195260|75965943|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
42157935|NCT00195260|75965944|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
42157936|NCT00195260|75965945|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
42157937|NCT00195260|75965946|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
42157938|NCT00195260|75965947|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
42157939|NCT00195260|75965948|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
42157940|NCT00195260|75965949|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
42157941|NCT00195260|75965939|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
42157942|NCT00195260|75965940|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
42279507|NCT02730169|76111013|FG000|Overall Study|Withdrawal by Subject|6|||
42279508|NCT02730169|76111014|FG001|Overall Study|Withdrawal by Subject|11|||
42279509|NCT02730169|76111015|FG002|Overall Study|Withdrawal by Subject|6|||
42279510|NCT02730169|76111016|FG003|Overall Study|Withdrawal by Subject|8|||
42279511|NCT02730169|76111013|FG000|Overall Study|Lost to Follow-up|5|||
42279512|NCT02730169|76111014|FG001|Overall Study|Lost to Follow-up|6|||
42279513|NCT02730169|76111015|FG002|Overall Study|Lost to Follow-up|5|||
42279514|NCT02730169|76111016|FG003|Overall Study|Lost to Follow-up|6|||
42279515|NCT02730169|76111013|FG000|Overall Study|Other|0|||
42279516|NCT02730169|76111014|FG001|Overall Study|Other|0|||
42279517|NCT02730169|76111015|FG002|Overall Study|Other|1|||
42279518|NCT02730169|76111016|FG003|Overall Study|Other|1|||
42157943|NCT00195260|75965941|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
42157944|NCT00195260|75965942|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
42157945|NCT00195260|75965943|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
42157946|NCT00195260|75965944|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
42157947|NCT00195260|75965945|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
42351392|NCT00989092|76191342|FG000|Overall Study|Death|14|||
42351393|NCT00989092|76191343|FG001|Overall Study|Death|2|||
42351394|NCT00989092|76191342|FG000|Overall Study|Ineligibility determined|3|||
42157948|NCT00195260|75965946|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
42157949|NCT00195260|75965947|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
42157950|NCT00195260|75965948|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
42157951|NCT00195260|75965949|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
42157952|NCT00195260|75965939|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
42157953|NCT00195260|75965940|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
42157954|NCT00195260|75965941|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
42157955|NCT00195260|75965942|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
42157956|NCT00195260|75965943|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
42157957|NCT00195260|75965944|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
42157958|NCT00195260|75965945|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
42157959|NCT00195260|75965946|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
42157960|NCT00195260|75965947|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
42157961|NCT00195260|75965948|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
42279519|NCT02648217|76111028|FG000|Overall Study|Adverse Event|0|||
42279520|NCT02648217|76111029|FG001|Overall Study|Adverse Event|1|||
42279521|NCT02648217|76111028|FG000|Overall Study|Lost to Follow-up|1|||
42279522|NCT02648217|76111029|FG001|Overall Study|Lost to Follow-up|1|||
42279523|NCT02648217|76111028|FG000|Overall Study|Withdrawal by Subject|4|||
42279524|NCT02648217|76111029|FG001|Overall Study|Withdrawal by Subject|3|||
42279525|NCT02648217|76111028|FG000|Overall Study|Unclassified|5|||
42279526|NCT02648217|76111029|FG001|Overall Study|Unclassified|0|||
42279527|NCT00709735|76111037|FG000|Overall Study|Lost to Follow-up|1|||
42279528|NCT00709735|76111038|FG001|Overall Study|Lost to Follow-up|1|||
42279529|NCT00709735|76111037|FG000|Overall Study|Relapse into Opioid Abuse|0|||
42279530|NCT00709735|76111038|FG001|Overall Study|Relapse into Opioid Abuse|1|||
42279531|NCT00709735|76111037|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
42279532|NCT00709735|76111038|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
42279533|NCT02647905|76111044|FG000|Overall Study|Lost to Follow-up|1|||
42279534|NCT02647905|76111044|FG000|Overall Study|Withdrawal by Subject|2|||
42279535|NCT04185909|76111057|FG000|Overall Study|Lost to Follow-up|1|||
42279536|NCT04076943|76111061|FG000|Overall Study|Withdrawal by Subject|12|||
42279537|NCT04076943|76111061|FG000|Overall Study|Adverse Event|1|||
42351395|NCT00989092|76191343|FG001|Overall Study|Ineligibility determined|3|||
42351396|NCT00989092|76191342|FG000|Overall Study|Lost to Follow-up|6|||
42279538|NCT04076943|76111061|FG000|Overall Study|Progressive Disease|2|||
42279539|NCT04076943|76111061|FG000|Overall Study|Death|13|||
42279540|NCT04076943|76111061|FG000|Overall Study|Other than specified|6|||
42013454|NCT00998296|75820555|FG005|Overall Study|Progressive disease|0|||
42279541|NCT00708643|76111067|FG000|Overall Study|Adverse Event|0|||
42157962|NCT00195260|75965949|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
42157963|NCT00195260|75965939|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
42157964|NCT00195260|75965940|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
42157965|NCT00195260|75965941|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
42157966|NCT00195260|75965942|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
42157967|NCT00195260|75965943|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
42157968|NCT00195260|75965944|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
42157969|NCT00195260|75965945|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
42157970|NCT00195260|75965946|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
42157971|NCT00195260|75965947|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
42157972|NCT00195260|75965948|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
42157973|NCT00195260|75965949|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
42157974|NCT00031486|75965979|FG000|Overall Study|Adverse Event|1|||
42157975|NCT00031486|75965980|FG001|Overall Study|Adverse Event|0|||
42157976|NCT00031486|75965979|FG000|Overall Study|Lost to Follow-up|0|||
42157977|NCT00031486|75965980|FG001|Overall Study|Lost to Follow-up|1|||
42157978|NCT00031486|75965979|FG000|Overall Study|Withdrawal by Subject|3|||
42157979|NCT00031486|75965980|FG001|Overall Study|Withdrawal by Subject|2|||
42157980|NCT00031486|75965979|FG000|Overall Study|Death|0|||
42157981|NCT00031486|75965980|FG001|Overall Study|Death|3|||
42157982|NCT00031486|75965979|FG000|Overall Study|Non-compliant|0|||
42157983|NCT00031486|75965980|FG001|Overall Study|Non-compliant|4|||
42157984|NCT00031486|75965979|FG000|Overall Study|Did not meet eligibility requirement|2|||
42157985|NCT00031486|75965980|FG001|Overall Study|Did not meet eligibility requirement|1|||
42157986|NCT00031486|75965979|FG000|Overall Study|Other|1|||
42157987|NCT00031486|75965980|FG001|Overall Study|Other|1|||
42157988|NCT00003508|75965988|FG000|Overall Study|Not evaluable|5|||
42157989|NCT00003472|75965992|FG000|Overall Study|Not evaluable|3|||
42157990|NCT00003298|75965996|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
42157991|NCT00003298|75965996|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
42279542|NCT00708643|76111068|FG001|Overall Study|Adverse Event|1|||
42279543|NCT05425563|76111121|FG000|Overall Study|Withdrawal by Subject|17|||
42279544|NCT05097963|76111131|FG000|Overall Study|Protocol Violation|13|||
42279545|NCT05097963|76111131|FG000|Overall Study|Withdrawal by Subject|21|||
42279546|NCT04529096|76111146|FG000|Overall Study|Adverse Event|6|||
42279547|NCT04529096|76111147|FG001|Overall Study|Adverse Event|1|||
42279548|NCT04529096|76111146|FG000|Overall Study|Lack of Efficacy|1|||
42279549|NCT04529096|76111147|FG001|Overall Study|Lack of Efficacy|0|||
42279550|NCT04529096|76111146|FG000|Overall Study|Lost to Follow-up|1|||
42279551|NCT04529096|76111147|FG001|Overall Study|Lost to Follow-up|1|||
42279552|NCT04529096|76111146|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42279553|NCT04529096|76111147|FG001|Overall Study|Non-Compliance With Study Drug|1|||
42279554|NCT04529096|76111146|FG000|Overall Study|Physician Decision|1|||
42279555|NCT04529096|76111147|FG001|Overall Study|Physician Decision|3|||
42279556|NCT04529096|76111146|FG000|Overall Study|Withdrawal by Subject|5|||
42279557|NCT04529096|76111147|FG001|Overall Study|Withdrawal by Subject|0|||
42279558|NCT04442503|76111155|FG000|Overall Study|Adverse Event|1|||
42279559|NCT04442503|76111156|FG001|Overall Study|Adverse Event|1|||
42279560|NCT04442503|76111155|FG000|Overall Study|Lost to Follow-up|8|||
42279561|NCT04442503|76111156|FG001|Overall Study|Lost to Follow-up|6|||
42279562|NCT04442503|76111155|FG000|Overall Study|Physician Decision|0|||
42279563|NCT04442503|76111156|FG001|Overall Study|Physician Decision|2|||
42279564|NCT04442503|76111155|FG000|Overall Study|Withdrawal by Subject|3|||
42279565|NCT04442503|76111156|FG001|Overall Study|Withdrawal by Subject|4|||
42279566|NCT04442503|76111155|FG000|Overall Study|Reason not Specified|0|||
42279567|NCT04442503|76111156|FG001|Overall Study|Reason not Specified|1|||
42279568|NCT04442503|76111155|FG000|Overall Study|Randomized but not Treated|3|||
42279569|NCT04442503|76111156|FG001|Overall Study|Randomized but not Treated|1|||
42279570|NCT04109976|76111169|FG000|Overall Study|Withdrawal by Subject|1|||
42279571|NCT04109976|76111170|FG001|Overall Study|Withdrawal by Subject|0|||
42279572|NCT04068519|76111176|FG000|Dose Verification|Death|15|||
42279573|NCT04068519|76111176|FG000|Dose Verification|Withdrawal by Subject|1|||
42013455|NCT00998296|75820556|FG006|Overall Study|Progressive disease|1|||
42013456|NCT00998296|75820557|FG007|Overall Study|Progressive disease|0|||
42013457|NCT00998296|75820558|FG008|Overall Study|Progressive disease|0|||
42013458|NCT00998296|75820559|FG009|Overall Study|Progressive disease|14|||
42157992|NCT00003298|75965996|FG000|Surgery|Unresectable at surgery|3|||
42279574|NCT04068519|76111176|FG000|Pharmacokinetic Sub-study|Death|35|||
42279575|NCT04068519|76111176|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
42279576|NCT04068519|76111176|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
42279577|NCT04068519|76111176|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
42279578|NCT04068519|76111176|FG000|Indication Expansion|Death|152|||
42279579|NCT04068519|76111176|FG000|Indication Expansion|Withdrawal by Subject|10|||
42279580|NCT04068519|76111176|FG000|Indication Expansion|Lost to Follow-up|7|||
42279581|NCT03810365|76111203|FG000|Overall Study|Lost to Follow-up|2|||
42157993|NCT00003298|75965996|FG000|Surgery|Progression before surgery|2|||
42279582|NCT03810365|76111204|FG001|Overall Study|Lost to Follow-up|1|||
42279583|NCT03810365|76111203|FG000|Overall Study|Withdrawal by Subject|4|||
42279584|NCT03810365|76111204|FG001|Overall Study|Withdrawal by Subject|3|||
42279585|NCT03810365|76111203|FG000|Overall Study|referred for Sleep apnea|0|||
42279586|NCT03810365|76111204|FG001|Overall Study|referred for Sleep apnea|3|||
42279587|NCT03605758|76111221|FG000|Overall Study|Lost to Follow-up|2|||
42279588|NCT03605758|76111222|FG001|Overall Study|Lost to Follow-up|1|||
42279589|NCT03605758|76111221|FG000|Overall Study|Illness|0|||
42279590|NCT03605758|76111222|FG001|Overall Study|Illness|1|||
42279591|NCT03605758|76111221|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
42279592|NCT03605758|76111222|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
42279593|NCT03016975|76111236|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
42279594|NCT03016975|76111237|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
42279595|NCT03016975|76111238|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
42279596|NCT03016975|76111236|FG000|At 6 Months Follow-up|Death|2|||
42279597|NCT03016975|76111237|FG001|At 6 Months Follow-up|Death|0|||
42279598|NCT03016975|76111238|FG002|At 6 Months Follow-up|Death|0|||
42351397|NCT00989092|76191343|FG001|Overall Study|Lost to Follow-up|2|||
42157994|NCT00003298|75965996|FG000|Surgery|Unevaluable and off study|2|||
42157995|NCT00003298|75965996|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
42157996|NCT00003298|75965996|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
42157997|NCT00003298|75965996|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
42157998|NCT00003298|75965996|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
42157999|NCT00003298|75965996|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
42158000|NCT00003298|75965996|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
42158001|NCT00003298|75965996|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
42158002|NCT00003298|75965996|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
42158003|NCT00003298|75965996|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
42158004|NCT00003298|75965996|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
42158005|NCT00002842|75966001|FG000|Overall Study|ineligible for surgical resection|27|||
42158006|NCT00143247|75966005|FG000|Overall Study|Death|8|||
42158007|NCT00143247|75966005|FG000|Overall Study|Adverse Event|19|||
42158008|NCT00143247|75966005|FG000|Overall Study|Lack of Efficacy|3|||
42158009|NCT00143247|75966005|FG000|Overall Study|Withdrawal by Subject|55|||
42158010|NCT00143247|75966005|FG000|Overall Study|Study terminated by sponsor|31|||
42158011|NCT00143247|75966005|FG000|Overall Study|Protocol Violation|15|||
42158012|NCT00143247|75966005|FG000|Overall Study|Lost to Follow-up|12|||
42158013|NCT00143247|75966005|FG000|Overall Study|following inaccurate lab adverse event|1|||
42158014|NCT00143247|75966005|FG000|Overall Study|Other|12|||
42158015|NCT00125853|75966009|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
42158016|NCT00125853|75966010|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
42158017|NCT00219141|75966019|FG000|Overall Study|Adverse Event|4|||
42158018|NCT00219141|75966020|FG001|Overall Study|Adverse Event|10|||
42158019|NCT00219141|75966021|FG002|Overall Study|Adverse Event|5|||
42158020|NCT00219141|75966019|FG000|Overall Study|Lack of Efficacy|3|||
42158021|NCT00219141|75966020|FG001|Overall Study|Lack of Efficacy|2|||
42158022|NCT00219141|75966021|FG002|Overall Study|Lack of Efficacy|0|||
42158023|NCT00219141|75966019|FG000|Overall Study|Administrative problems|0|||
42158024|NCT00219141|75966020|FG001|Overall Study|Administrative problems|1|||
42158025|NCT00219141|75966021|FG002|Overall Study|Administrative problems|0|||
42158026|NCT00219141|75966019|FG000|Overall Study|Lost to Follow-up|2|||
42158027|NCT00219141|75966020|FG001|Overall Study|Lost to Follow-up|4|||
42158028|NCT00219141|75966021|FG002|Overall Study|Lost to Follow-up|1|||
42158029|NCT00219141|75966019|FG000|Overall Study|Protocol Violation|3|||
42158030|NCT00219141|75966020|FG001|Overall Study|Protocol Violation|1|||
42158031|NCT00219141|75966021|FG002|Overall Study|Protocol Violation|1|||
42158032|NCT00219141|75966019|FG000|Overall Study|Withdrawal by Subject|1|||
42158033|NCT00219141|75966020|FG001|Overall Study|Withdrawal by Subject|3|||
42279599|NCT03016975|76111236|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
42351398|NCT00989092|76191342|FG000|Overall Study|Other|3|||
42351399|NCT00989092|76191343|FG001|Overall Study|Other|1|||
42351400|NCT00989092|76191342|FG000|Overall Study|Protocol deviation|2|||
42351401|NCT00989092|76191343|FG001|Overall Study|Protocol deviation|0|||
42013459|NCT00998296|75820560|FG010|Overall Study|Progressive disease|5|||
42158034|NCT00219141|75966021|FG002|Overall Study|Withdrawal by Subject|5|||
42158035|NCT00219141|75966019|FG000|Overall Study|Condition no longer requires study drug|1|||
42279600|NCT03016975|76111237|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
42279601|NCT03016975|76111238|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
42158036|NCT00219141|75966020|FG001|Overall Study|Condition no longer requires study drug|0|||
42158037|NCT00219141|75966021|FG002|Overall Study|Condition no longer requires study drug|0|||
42279602|NCT03016975|76111236|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
42351402|NCT00989092|76191342|FG000|Overall Study|Erythropoietin therapy initiated|2|||
42158038|NCT00142935|75966032|FG000|Overall Study|Other reason|1|||
42158039|NCT00142935|75966033|FG001|Overall Study|Other reason|1|||
42158040|NCT00142935|75966034|FG002|Overall Study|Other reason|1|||
42158041|NCT00142935|75966032|FG000|Overall Study|Lost to Follow-up|2|||
42158042|NCT00142935|75966033|FG001|Overall Study|Lost to Follow-up|5|||
42158043|NCT00142935|75966034|FG002|Overall Study|Lost to Follow-up|5|||
42158044|NCT00142935|75966032|FG000|Overall Study|Death|0|||
42158045|NCT00142935|75966033|FG001|Overall Study|Death|2|||
42158046|NCT00142935|75966034|FG002|Overall Study|Death|1|||
42158047|NCT00233948|75966048|FG000|Overall Study|Adverse Event|1|||
42158048|NCT00233948|75966049|FG001|Overall Study|Adverse Event|0|||
42158049|NCT00233948|75966050|FG002|Overall Study|Adverse Event|0|||
42158050|NCT00233948|75966051|FG003|Overall Study|Adverse Event|0|||
42158051|NCT00233948|75966052|FG004|Overall Study|Adverse Event|0|||
42158052|NCT00233948|75966053|FG005|Overall Study|Adverse Event|0|||
42158053|NCT00233480|75966070|FG000|Overall Study|Underwent status II heart transplant|0|||
42158054|NCT00233480|75966071|FG001|Overall Study|Underwent status II heart transplant|1|||
42158055|NCT03801928|75966085|FG000|Overall Study|Adverse Event|1|||
42158056|NCT03801928|75966086|FG001|Overall Study|Adverse Event|0|||
42158057|NCT03801928|75966087|FG002|Overall Study|Adverse Event|1|||
42158058|NCT03801928|75966088|FG003|Overall Study|Adverse Event|2|||
42158059|NCT03801928|75966089|FG004|Overall Study|Adverse Event|0|||
42158060|NCT03801928|75966090|FG005|Overall Study|Adverse Event|2|||
42158061|NCT03801928|75966085|FG000|Overall Study|Lack of Efficacy|0|||
42158062|NCT03801928|75966086|FG001|Overall Study|Lack of Efficacy|0|||
42158063|NCT03801928|75966087|FG002|Overall Study|Lack of Efficacy|1|||
42158064|NCT03801928|75966088|FG003|Overall Study|Lack of Efficacy|0|||
42158065|NCT03801928|75966089|FG004|Overall Study|Lack of Efficacy|0|||
42158066|NCT03801928|75966090|FG005|Overall Study|Lack of Efficacy|0|||
42158067|NCT03801928|75966085|FG000|Overall Study|Lost to Follow-up|5|||
42158068|NCT03801928|75966086|FG001|Overall Study|Lost to Follow-up|1|||
42158069|NCT03801928|75966087|FG002|Overall Study|Lost to Follow-up|1|||
42158070|NCT03801928|75966088|FG003|Overall Study|Lost to Follow-up|4|||
42158071|NCT03801928|75966089|FG004|Overall Study|Lost to Follow-up|4|||
42158072|NCT03801928|75966090|FG005|Overall Study|Lost to Follow-up|2|||
42158073|NCT03801928|75966085|FG000|Overall Study|Withdrawal by Subject|0|||
42158074|NCT03801928|75966086|FG001|Overall Study|Withdrawal by Subject|0|||
42279603|NCT03016975|76111237|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
42279604|NCT03016975|76111238|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
42279605|NCT03016975|76111236|FG000|At 6 Months Follow-up|Aborted implant|1|||
42279606|NCT03016975|76111237|FG001|At 6 Months Follow-up|Aborted implant|0|||
42279607|NCT03016975|76111238|FG002|At 6 Months Follow-up|Aborted implant|0|||
42279608|NCT03016975|76111236|FG000|At 2 Year Follow-up|Death|1|||
42279609|NCT03016975|76111237|FG001|At 2 Year Follow-up|Death|0|||
42279610|NCT03016975|76111238|FG002|At 2 Year Follow-up|Death|0|||
42279611|NCT03016975|76111236|FG000|At 3 Year Follow-up|Death|1|||
42279612|NCT03016975|76111237|FG001|At 3 Year Follow-up|Death|0|||
42279613|NCT03016975|76111238|FG002|At 3 Year Follow-up|Death|0|||
42158075|NCT03801928|75966087|FG002|Overall Study|Withdrawal by Subject|2|||
42158076|NCT03801928|75966088|FG003|Overall Study|Withdrawal by Subject|1|||
42158077|NCT03801928|75966089|FG004|Overall Study|Withdrawal by Subject|0|||
42158078|NCT03801928|75966090|FG005|Overall Study|Withdrawal by Subject|0|||
42158079|NCT03801928|75966085|FG000|Overall Study|Other|0|||
42158080|NCT03801928|75966086|FG001|Overall Study|Other|2|||
42158081|NCT03801928|75966087|FG002|Overall Study|Other|0|||
42158082|NCT03801928|75966088|FG003|Overall Study|Other|1|||
42158083|NCT03801928|75966089|FG004|Overall Study|Other|0|||
42158084|NCT03801928|75966090|FG005|Overall Study|Other|1|||
42158085|NCT00263588|75966109|FG000|Overall Study|Death|54|||
42158086|NCT00263588|75966110|FG001|Overall Study|Death|90|||
42158087|NCT00263588|75966109|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
42279614|NCT03016975|76111236|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
42279615|NCT03016975|76111237|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
42279616|NCT03016975|76111238|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
42279617|NCT03016975|76111236|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
42351403|NCT00989092|76191343|FG001|Overall Study|Erythropoietin therapy initiated|0|||
42351404|NCT00989092|76191342|FG000|Overall Study|Did not receive study drug|2|||
42158088|NCT00263588|75966110|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
42158089|NCT00263588|75966109|FG000|Overall Study|Lost to Follow-up|7|||
42158090|NCT00263588|75966110|FG001|Overall Study|Lost to Follow-up|10|||
42158091|NCT00263588|75966109|FG000|Overall Study|Withdrawal by Subject|3|||
42158092|NCT00263588|75966110|FG001|Overall Study|Withdrawal by Subject|4|||
42158093|NCT00263588|75966109|FG000|Overall Study|Protocol Violation|0|||
42158094|NCT00263588|75966110|FG001|Overall Study|Protocol Violation|1|||
42158095|NCT00263588|75966109|FG000|Overall Study|Investigator decision|7|||
42158096|NCT00263588|75966110|FG001|Overall Study|Investigator decision|15|||
42158097|NCT00263588|75966109|FG000|Overall Study|Sponsor terminated study|0|||
42158098|NCT00263588|75966110|FG001|Overall Study|Sponsor terminated study|1|||
42158099|NCT00213135|75966120|FG000|Overall Study|Adverse Event|9|||
42158100|NCT00213135|75966121|FG001|Overall Study|Adverse Event|5|||
42158101|NCT00213135|75966122|FG002|Overall Study|Adverse Event|5|||
42279618|NCT03016975|76111237|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
42158102|NCT00213135|75966120|FG000|Overall Study|Lost to Follow-up|11|||
42158103|NCT00213135|75966121|FG001|Overall Study|Lost to Follow-up|8|||
42158104|NCT00213135|75966122|FG002|Overall Study|Lost to Follow-up|4|||
42158105|NCT00213135|75966120|FG000|Overall Study|Protocol Violation|4|||
42158106|NCT00213135|75966121|FG001|Overall Study|Protocol Violation|4|||
42158107|NCT00213135|75966122|FG002|Overall Study|Protocol Violation|10|||
42158108|NCT00213135|75966120|FG000|Overall Study|Death|1|||
42158109|NCT00213135|75966121|FG001|Overall Study|Death|1|||
42158110|NCT00213135|75966122|FG002|Overall Study|Death|2|||
42158111|NCT00213135|75966120|FG000|Overall Study|Disease progression|4|||
42158112|NCT00213135|75966121|FG001|Overall Study|Disease progression|5|||
42158113|NCT00213135|75966122|FG002|Overall Study|Disease progression|21|||
42158114|NCT00213135|75966120|FG000|Overall Study|Other|21|||
42158115|NCT00213135|75966121|FG001|Overall Study|Other|12|||
42158116|NCT00213135|75966122|FG002|Overall Study|Other|15|||
42158117|NCT00077974|75966130|FG000|Overall Study|Adverse Event|22|||
42158118|NCT00077974|75966130|FG000|Overall Study|Protocol Violation|1|||
42158119|NCT00077974|75966130|FG000|Overall Study|Withdrawal by Subject|3|||
42158120|NCT00077974|75966130|FG000|Overall Study|Lack of Efficacy|76|||
42158121|NCT00077974|75966130|FG000|Overall Study|Decision of Sponsor|2|||
42279619|NCT03016975|76111238|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
42279620|NCT02911792|76111261|FG000|Overall Study|Lost to Follow-up|3|||
42279621|NCT02911792|76111262|FG001|Overall Study|Lost to Follow-up|3|||
42279622|NCT02911792|76111263|FG002|Overall Study|Lost to Follow-up|3|||
42279623|NCT02911792|76111264|FG003|Overall Study|Lost to Follow-up|3|||
42279624|NCT02152995|76111309|FG000|Overall Study|Withdrawal by Subject|1|||
42279625|NCT02152995|76111310|FG001|Overall Study|Withdrawal by Subject|0|||
42279626|NCT01867606|76111324|FG000|Overall Study|Withdrawal by Subject|10|||
42158122|NCT00124917|75966134|FG000|Overall Study|Physician Decision|3|||
42158123|NCT00141921|75966139|FG000|Overall Study|Remain on Study|28|||
42158124|NCT00141921|75966139|FG000|Overall Study|Withdrawal by Subject|42|||
42158125|NCT00141921|75966139|FG000|Overall Study|Lost to Follow-up|19|||
42158126|NCT00141921|75966139|FG000|Overall Study|Noncompliance|17|||
42158127|NCT00141921|75966139|FG000|Overall Study|Disease Progression|7|||
42158128|NCT00141921|75966139|FG000|Overall Study|Protocol Deviation|7|||
42158129|NCT00141921|75966139|FG000|Overall Study|Adverse Event|5|||
42158130|NCT00141921|75966139|FG000|Overall Study|Administrative Decision|2|||
42158131|NCT00141921|75966139|FG000|Overall Study|Pregnancy|4|||
42279627|NCT01867606|76111325|FG001|Overall Study|Withdrawal by Subject|14|||
42279628|NCT01867606|76111324|FG000|Overall Study|Protocol Violation|0|||
42279629|NCT01867606|76111325|FG001|Overall Study|Protocol Violation|1|||
42279630|NCT01828112|76111339|FG000|Overall Study|Adverse Event|6|||
42158132|NCT00141921|75966139|FG000|Overall Study|Ineligibility Determined|2|||
42158133|NCT00141921|75966139|FG000|Overall Study|Other|8|||
42158134|NCT00029146|75966145|FG000|Overall Study|Lost to Follow-up|2|||
42158135|NCT00029146|75966146|FG001|Overall Study|Lost to Follow-up|1|||
42158136|NCT00026494|75966156|FG000|Overall Study|Withdrawal by Subject|1|||
42158137|NCT00026494|75966157|FG001|Overall Study|Withdrawal by Subject|0|||
42158138|NCT00026494|75966158|FG002|Overall Study|Withdrawal by Subject|1|||
42158139|NCT00026494|75966159|FG003|Overall Study|Withdrawal by Subject|0|||
42158140|NCT00026494|75966156|FG000|Overall Study|Patient non-compliance|1|||
42158141|NCT00026494|75966157|FG001|Overall Study|Patient non-compliance|0|||
42158142|NCT00026494|75966158|FG002|Overall Study|Patient non-compliance|0|||
42158143|NCT00026494|75966159|FG003|Overall Study|Patient non-compliance|0|||
42158144|NCT00026494|75966156|FG000|Overall Study|Patient not treated|0|||
42158145|NCT00026494|75966157|FG001|Overall Study|Patient not treated|0|||
42158146|NCT00026494|75966158|FG002|Overall Study|Patient not treated|2|||
42158147|NCT00026494|75966159|FG003|Overall Study|Patient not treated|0|||
42279631|NCT01828112|76111340|FG001|Overall Study|Adverse Event|8|||
42013460|NCT00998296|75820550|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
42013461|NCT00998296|75820551|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
42013462|NCT00998296|75820552|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
42158148|NCT00026494|75966156|FG000|Overall Study|Clinical progression|0|||
42158149|NCT00026494|75966157|FG001|Overall Study|Clinical progression|0|||
42158150|NCT00026494|75966158|FG002|Overall Study|Clinical progression|3|||
42158151|NCT00026494|75966159|FG003|Overall Study|Clinical progression|0|||
42158152|NCT00023764|75966169|FG000|Overall Study|Other|1|||
42158153|NCT00023764|75966169|FG000|Overall Study|Adverse Event|4|||
42158154|NCT00023764|75966169|FG000|Overall Study|Withdrawal by Subject|1|||
42158155|NCT00023764|75966169|FG000|Overall Study|Progression of disease|6|||
42279632|NCT01828112|76111339|FG000|Overall Study|Death|9|||
42279633|NCT01828112|76111340|FG001|Overall Study|Death|5|||
42158156|NCT00023764|75966169|FG000|Overall Study|patient received other treatment|1|||
42158157|NCT00023764|75966169|FG000|Overall Study|delay in obtaining staging images|1|||
42158158|NCT00189488|75966176|FG000|Overall Study|Ineligibility determined|1|||
42158159|NCT00189488|75966177|FG001|Overall Study|Ineligibility determined|0|||
42158160|NCT00189488|75966176|FG000|Overall Study|Protocol deviation|2|||
42279634|NCT01828112|76111339|FG000|Overall Study|Physician Decision|5|||
42279635|NCT01828112|76111340|FG001|Overall Study|Physician Decision|5|||
42279636|NCT01828112|76111339|FG000|Overall Study|Progressive disease|56|||
42279637|NCT01828112|76111340|FG001|Overall Study|Progressive disease|82|||
42279638|NCT01828112|76111339|FG000|Overall Study|Subject/guardian decision|6|||
42279639|NCT01828112|76111340|FG001|Overall Study|Subject/guardian decision|8|||
42279640|NCT01740427|76111348|FG000|Overall Study|Ongoing|45|||
42279641|NCT01740427|76111349|FG001|Overall Study|Ongoing|5|||
42279642|NCT01740427|76111348|FG000|Overall Study|Objective Progression or Relapse|281|||
42158161|NCT00189488|75966177|FG001|Overall Study|Protocol deviation|1|||
42158162|NCT00189488|75966176|FG000|Overall Study|Adverse Event|2|||
42158163|NCT00189488|75966177|FG001|Overall Study|Adverse Event|1|||
42158164|NCT00189488|75966176|FG000|Overall Study|Withdrawal by Subject|2|||
42158165|NCT00189488|75966177|FG001|Overall Study|Withdrawal by Subject|6|||
42158166|NCT00189488|75966176|FG000|Overall Study|Disease progression|2|||
42158167|NCT00189488|75966177|FG001|Overall Study|Disease progression|4|||
42158168|NCT00189488|75966176|FG000|Overall Study|Administrative Decision|0|||
42158169|NCT00189488|75966177|FG001|Overall Study|Administrative Decision|2|||
42158170|NCT00189488|75966176|FG000|Overall Study|Death|5|||
42158171|NCT00189488|75966177|FG001|Overall Study|Death|8|||
42158172|NCT00189488|75966176|FG000|Overall Study|Other|1|||
42158173|NCT00189488|75966177|FG001|Overall Study|Other|0|||
42158174|NCT00233402|75966186|FG000|Overall Study|No pathology data|12|||
42158175|NCT00233402|75966187|FG001|Overall Study|No pathology data|9|||
42158176|NCT00233402|75966186|FG000|Overall Study|No Ta/T1|89|||
42158177|NCT00233402|75966187|FG001|Overall Study|No Ta/T1|94|||
42158178|NCT00233402|75966186|FG000|Overall Study|Lost to follow up etc|3|||
42158179|NCT00233402|75966187|FG001|Overall Study|Lost to follow up etc|21|||
42158180|NCT00233324|75966199|FG000|Main Study|Death|68|||
42158181|NCT00233324|75966200|FG001|Main Study|Death|60|||
42158182|NCT00233324|75966201|FG002|Main Study|Death|62|||
42158183|NCT00233324|75966202|FG003|Main Study|Death|47|||
42158184|NCT00233324|75966199|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
42158185|NCT00233324|75966200|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
42158186|NCT00233324|75966201|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
42158187|NCT00233324|75966202|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
42158188|NCT00233324|75966199|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
42158189|NCT00233324|75966200|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
42158190|NCT00233324|75966201|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
42158191|NCT00233324|75966202|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
42158192|NCT00023452|75966221|FG000|Overall Study|Ineligible for Study|163|||
42158193|NCT00023452|75966222|FG001|Overall Study|Ineligible for Study|159|||
42158194|NCT00023452|75966221|FG000|Overall Study|Out of Window|129|||
42158195|NCT00023452|75966222|FG001|Overall Study|Out of Window|69|||
42158196|NCT00023452|75966221|FG000|Overall Study|Death|2|||
42158197|NCT00023452|75966222|FG001|Overall Study|Death|0|||
42158198|NCT00023452|75966221|FG000|Overall Study|Withdrawal by Subject|66|||
42279643|NCT01740427|76111349|FG001|Overall Study|Objective Progression or Relapse|171|||
42279644|NCT01740427|76111348|FG000|Overall Study|Adverse Event|31|||
42279645|NCT01740427|76111349|FG001|Overall Study|Adverse Event|9|||
42279646|NCT01740427|76111348|FG000|Overall Study|Global Deterioration of Health Status|28|||
42279647|NCT01740427|76111349|FG001|Overall Study|Global Deterioration of Health Status|12|||
42279648|NCT01740427|76111348|FG000|Overall Study|Participant Refused Continued Treatment|26|||
42279649|NCT01740427|76111349|FG001|Overall Study|Participant Refused Continued Treatment|15|||
42279650|NCT01740427|76111348|FG000|Overall Study|Unspecified reasons|15|||
42279651|NCT01740427|76111349|FG001|Overall Study|Unspecified reasons|4|||
42279652|NCT01740427|76111348|FG000|Overall Study|Death|10|||
42279653|NCT01740427|76111349|FG001|Overall Study|Death|3|||
42158199|NCT00023452|75966222|FG001|Overall Study|Withdrawal by Subject|54|||
42158200|NCT00023452|75966221|FG000|Overall Study|Adverse Event|139|||
42158201|NCT00023452|75966222|FG001|Overall Study|Adverse Event|196|||
42158202|NCT00023452|75966221|FG000|Overall Study|Lost to Follow-up|293|||
42158203|NCT00023452|75966222|FG001|Overall Study|Lost to Follow-up|60|||
42158204|NCT00023452|75966221|FG000|Overall Study|Physician Decision|49|||
42158205|NCT00023452|75966222|FG001|Overall Study|Physician Decision|21|||
42158206|NCT00023452|75966221|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
42158207|NCT00023452|75966222|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
42279654|NCT01740427|76111348|FG000|Overall Study|Protocol Violation|5|||
42279655|NCT01740427|76111349|FG001|Overall Study|Protocol Violation|3|||
42158208|NCT00023452|75966221|FG000|Overall Study|Pregnant|53|||
42279656|NCT01740427|76111348|FG000|Overall Study|Lost to Follow-up|2|||
42279657|NCT01740427|76111349|FG001|Overall Study|Lost to Follow-up|0|||
42279658|NCT01740427|76111348|FG000|Overall Study|Site Terminated by Sponsor|1|||
42279659|NCT01740427|76111349|FG001|Overall Study|Site Terminated by Sponsor|0|||
42279660|NCT01657682|76111358|FG000|Overall Study|Lost to Follow-up|1|||
42279661|NCT01657682|76111359|FG001|Overall Study|Lost to Follow-up|0|||
42279662|NCT01657682|76111360|FG002|Overall Study|Lost to Follow-up|0|||
42279663|NCT01657682|76111358|FG000|Overall Study|Withdrawal by Subject|0|||
42279664|NCT01657682|76111359|FG001|Overall Study|Withdrawal by Subject|1|||
42279665|NCT01657682|76111360|FG002|Overall Study|Withdrawal by Subject|1|||
42279666|NCT01657682|76111358|FG000|Overall Study|Adverse Event|0|||
42279667|NCT01657682|76111359|FG001|Overall Study|Adverse Event|1|||
42279668|NCT01657682|76111360|FG002|Overall Study|Adverse Event|0|||
42279669|NCT01556243|76111380|FG000|Overall Study|Ineligible|34|||
42279670|NCT01556243|76111380|FG000|Overall Study|Converted to mastectomy|14|||
42158209|NCT00023452|75966222|FG001|Overall Study|Pregnant|20|||
42158210|NCT00023452|75966221|FG000|Overall Study|Other|204|||
42158211|NCT00023452|75966222|FG001|Overall Study|Other|69|||
42158212|NCT00022672|75966234|FG000|Main Phase: 24 Months|Adverse Event|6|||
42158213|NCT00022672|75966235|FG001|Main Phase: 24 Months|Adverse Event|0|||
42158214|NCT00022672|75966234|FG000|Main Phase: 24 Months|Death|0|||
42158215|NCT00022672|75966235|FG001|Main Phase: 24 Months|Death|3|||
42158216|NCT00022672|75966234|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
42158217|NCT00022672|75966235|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
42158218|NCT00022672|75966234|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
42158219|NCT00022672|75966235|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
42158220|NCT00022672|75966234|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
42158221|NCT00022672|75966235|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
42158222|NCT00022672|75966234|FG000|Main Phase: 24 Months|Refused Treatment|3|||
42158223|NCT00022672|75966235|FG001|Main Phase: 24 Months|Refused Treatment|4|||
42158224|NCT00022672|75966234|FG000|Main Phase: 24 Months|Failure to Return|1|||
42158225|NCT00022672|75966235|FG001|Main Phase: 24 Months|Failure to Return|1|||
42158226|NCT00022672|75966234|FG000|Main Phase: 24 Months|Other|1|||
42158227|NCT00022672|75966235|FG001|Main Phase: 24 Months|Other|0|||
42158228|NCT00022672|75966234|FG000|Extension Phase|Adverse Event|1|||
42158229|NCT00022672|75966235|FG001|Extension Phase|Adverse Event|3|||
42158230|NCT00022672|75966234|FG000|Extension Phase|Death|0|||
42279671|NCT01556243|76111380|FG000|Overall Study|Unable to achieve negative margins|2|||
42279672|NCT01556243|76111380|FG000|Overall Study|Withdrawal by Subject|16|||
42279673|NCT00819156|76111425|FG000|Overall Study|Adverse Event|1|||
42279674|NCT00819156|76111426|FG001|Overall Study|Adverse Event|4|||
42158231|NCT00022672|75966235|FG001|Extension Phase|Death|1|||
42158232|NCT00022672|75966234|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
42279675|NCT00819156|76111427|FG002|Overall Study|Adverse Event|2|||
42279676|NCT00819156|76111428|FG003|Overall Study|Adverse Event|1|||
42158233|NCT00022672|75966235|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
42158234|NCT00022672|75966234|FG000|Extension Phase|Refused Treatment|0|||
42158235|NCT00022672|75966235|FG001|Extension Phase|Refused Treatment|2|||
42158236|NCT00022672|75966234|FG000|Extension Phase|Other|1|||
42158237|NCT00022672|75966235|FG001|Extension Phase|Other|1|||
42158238|NCT00076804|75966244|FG000|Overall Study|Death|9|||
42158239|NCT00076804|75966245|FG001|Overall Study|Death|20|||
42158240|NCT00076804|75966244|FG000|Overall Study|Lost to Follow-up|9|||
42158241|NCT00076804|75966245|FG001|Overall Study|Lost to Follow-up|9|||
42158242|NCT00076804|75966244|FG000|Overall Study|Withdrawal by Subject|10|||
42158243|NCT00076804|75966245|FG001|Overall Study|Withdrawal by Subject|8|||
42158244|NCT00076804|75966244|FG000|Overall Study|Early study Closure|32|||
42158245|NCT00076804|75966245|FG001|Overall Study|Early study Closure|32|||
42158246|NCT00141453|75966253|FG000|Overall Study|Protocol Violation|6|||
42158247|NCT00141453|75966254|FG001|Overall Study|Protocol Violation|5|||
42158248|NCT00076570|75966262|FG000|Overall Study|Drug intolerance|8|||
42158249|NCT00076570|75966263|FG001|Overall Study|Drug intolerance|8|||
42158250|NCT00124449|75966271|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
42158251|NCT00124449|75966272|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
42158252|NCT00124449|75966271|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
42158253|NCT00124449|75966272|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
42158254|NCT00124449|75966271|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
42158255|NCT00124449|75966272|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
42158256|NCT00124449|75966271|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
42158257|NCT00124449|75966272|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
42158258|NCT00124449|75966271|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
42158259|NCT00124449|75966272|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
42158260|NCT00124449|75966271|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
42158261|NCT00124449|75966272|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
42158262|NCT00124449|75966271|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
42158263|NCT00124449|75966272|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
42279677|NCT00819156|76111429|FG004|Overall Study|Adverse Event|2|||
42279678|NCT00819156|76111430|FG005|Overall Study|Adverse Event|3|||
42279679|NCT00819156|76111425|FG000|Overall Study|Withdrawal by Subject|0|||
42279680|NCT00819156|76111426|FG001|Overall Study|Withdrawal by Subject|3|||
42279681|NCT00819156|76111427|FG002|Overall Study|Withdrawal by Subject|2|||
42279682|NCT00819156|76111428|FG003|Overall Study|Withdrawal by Subject|0|||
42279683|NCT00819156|76111429|FG004|Overall Study|Withdrawal by Subject|1|||
42279684|NCT00819156|76111430|FG005|Overall Study|Withdrawal by Subject|0|||
42279685|NCT00819156|76111425|FG000|Overall Study|Protocol Violation|1|||
42279686|NCT00819156|76111426|FG001|Overall Study|Protocol Violation|0|||
42279687|NCT00819156|76111427|FG002|Overall Study|Protocol Violation|1|||
42279688|NCT00819156|76111428|FG003|Overall Study|Protocol Violation|0|||
42279689|NCT00819156|76111429|FG004|Overall Study|Protocol Violation|0|||
42279690|NCT00819156|76111430|FG005|Overall Study|Protocol Violation|1|||
42279691|NCT00819156|76111425|FG000|Overall Study|Lost to Follow-up|0|||
42279692|NCT00819156|76111426|FG001|Overall Study|Lost to Follow-up|1|||
42279693|NCT00819156|76111427|FG002|Overall Study|Lost to Follow-up|0|||
42279694|NCT00819156|76111428|FG003|Overall Study|Lost to Follow-up|0|||
42279695|NCT00819156|76111429|FG004|Overall Study|Lost to Follow-up|0|||
42279696|NCT00819156|76111430|FG005|Overall Study|Lost to Follow-up|2|||
42279697|NCT00819156|76111425|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
42279698|NCT00819156|76111426|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
42279699|NCT00819156|76111427|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
42279700|NCT00819156|76111428|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
42279701|NCT00819156|76111429|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
42279702|NCT00819156|76111430|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
42279703|NCT00819156|76111425|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
42279704|NCT00819156|76111426|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
42279705|NCT00819156|76111427|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
42279706|NCT00819156|76111428|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
42279707|NCT00819156|76111429|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
42279708|NCT00819156|76111430|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
42158264|NCT00124449|75966271|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
42279709|NCT00819156|76111425|FG000|Overall Study|Prostate-specific antigen progression|0|||
42040225|NCT01928394|75848574|FG008|Treatment Period|Participant withdrew consent|0|||
42279710|NCT00819156|76111426|FG001|Overall Study|Prostate-specific antigen progression|0|||
42279711|NCT00819156|76111427|FG002|Overall Study|Prostate-specific antigen progression|0|||
42279712|NCT00819156|76111428|FG003|Overall Study|Prostate-specific antigen progression|0|||
42279713|NCT00819156|76111429|FG004|Overall Study|Prostate-specific antigen progression|1|||
42279714|NCT00819156|76111430|FG005|Overall Study|Prostate-specific antigen progression|0|||
42279715|NCT00818623|76111460|FG000|Overall Study|Adverse Event|1|||
42158265|NCT00124449|75966272|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
42158266|NCT00124449|75966271|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
42158267|NCT00124449|75966272|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
42158268|NCT00124449|75966271|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
42158269|NCT00124449|75966272|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
42158270|NCT00124449|75966271|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
42158271|NCT00124449|75966272|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
42158272|NCT00124449|75966271|FG000|18-Month Untreated Observation Period|Relocated|1|||
42158273|NCT00124449|75966272|FG001|18-Month Untreated Observation Period|Relocated|0|||
42158274|NCT00076336|75966281|FG000|Overall Study|Death|13|||
42158275|NCT00076336|75966282|FG001|Overall Study|Death|17|||
42158276|NCT00076336|75966281|FG000|Overall Study|Adverse Event|4|||
42158277|NCT00076336|75966282|FG001|Overall Study|Adverse Event|4|||
42158278|NCT00076336|75966281|FG000|Overall Study|Lost to Follow-up|4|||
42158279|NCT00076336|75966282|FG001|Overall Study|Lost to Follow-up|4|||
42158280|NCT00076336|75966281|FG000|Overall Study|Non-Compliance|2|||
42158281|NCT00076336|75966282|FG001|Overall Study|Non-Compliance|0|||
42158282|NCT00076336|75966281|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
42158283|NCT00076336|75966282|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
42158284|NCT00076336|75966281|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
42158285|NCT00076336|75966282|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
42158286|NCT00076336|75966281|FG000|Overall Study|Liver Transplantation|3|||
42158287|NCT00076336|75966282|FG001|Overall Study|Liver Transplantation|3|||
42158288|NCT00076336|75966281|FG000|Overall Study|Virologic Breakthrough|14|||
42158289|NCT00076336|75966282|FG001|Overall Study|Virologic Breakthrough|16|||
42158290|NCT00076336|75966281|FG000|Overall Study|Treatment failure|4|||
42158291|NCT00076336|75966282|FG001|Overall Study|Treatment failure|5|||
42158292|NCT00185588|75966292|FG000|Overall Study|Adverse Event|3|||
42158293|NCT00185588|75966293|FG001|Overall Study|Adverse Event|1|||
42158294|NCT00185588|75966294|FG002|Overall Study|Adverse Event|4|||
42158295|NCT00185588|75966295|FG003|Overall Study|Adverse Event|2|||
42158296|NCT00185588|75966292|FG000|Overall Study|Lost to Follow-up|0|||
42158297|NCT00185588|75966293|FG001|Overall Study|Lost to Follow-up|0|||
42158298|NCT00185588|75966294|FG002|Overall Study|Lost to Follow-up|1|||
42158299|NCT00185588|75966295|FG003|Overall Study|Lost to Follow-up|2|||
42158300|NCT00185588|75966292|FG000|Overall Study|Withdrawal by Subject|0|||
42158301|NCT00185588|75966293|FG001|Overall Study|Withdrawal by Subject|1|||
42158302|NCT00185588|75966294|FG002|Overall Study|Withdrawal by Subject|0|||
42158303|NCT00185588|75966295|FG003|Overall Study|Withdrawal by Subject|0|||
42158304|NCT00185588|75966292|FG000|Overall Study|Physician Decision|0|||
42158305|NCT00185588|75966293|FG001|Overall Study|Physician Decision|0|||
42158306|NCT00185588|75966294|FG002|Overall Study|Physician Decision|1|||
42158307|NCT00185588|75966295|FG003|Overall Study|Physician Decision|0|||
42158308|NCT00232544|75966307|FG000|Overall Study|Lost to Follow-up|20|||
42158309|NCT00232544|75966308|FG001|Overall Study|Lost to Follow-up|15|||
42158310|NCT00231842|75966314|FG000|Overall Study|Withdrawal by Subject|3|||
42158311|NCT00231842|75966314|FG000|Overall Study|Did not complete the last 3 cycle|8|||
42158312|NCT00076102|75966319|FG000|Overall Study|Clinical progression|1|||
42158313|NCT00076102|75966319|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
42158314|NCT00076102|75966319|FG000|Overall Study|plexiform neurofibroma surgery|1|||
42158315|NCT00076102|75966319|FG000|Overall Study|refusal of further therapy|2|||
42158316|NCT00231062|75966333|FG000|Overall Study|Physician Decision|6|||
42158317|NCT00184028|75966337|FG000|Overall Study|Death|1|||
42158318|NCT00184028|75966337|FG000|Overall Study|Lack of Efficacy|4|||
42158319|NCT00184028|75966337|FG000|Overall Study|Adverse Event|2|||
42158320|NCT00184028|75966337|FG000|Overall Study|Withdrawal by Subject|1|||
42158321|NCT00184028|75966337|FG000|Overall Study|Non-compliance|2|||
42158322|NCT00183872|75966342|FG000|Overall Study|Death|3|||
42158323|NCT00183872|75966342|FG000|Overall Study|Adverse Event|9|||
42158324|NCT00183872|75966342|FG000|Overall Study|Withdrawal by Subject|2|||
42158325|NCT00183872|75966342|FG000|Overall Study|Drug delayed more than 28 days|2|||
42158326|NCT03815175|75966346|FG000|Overall Study|Subject Lost to Follow-up|6|||
42158327|NCT03815175|75966346|FG000|Overall Study|Subject Withdrew Consent|48|||
42158328|NCT03815175|75966346|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
42158329|NCT03815175|75966346|FG000|Overall Study|Death|86|||
42158330|NCT03815175|75966346|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
42158331|NCT03815175|75966346|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
42158332|NCT03815175|75966346|FG000|Overall Study|Other Status Change Reason|1|||
42158333|NCT03815175|75966346|FG000|Overall Study|Missed Visit|12|||
42158334|NCT00262028|75966359|FG000|Overall Study|Withdrawal by Subject|6|||
42158335|NCT00262028|75966360|FG001|Overall Study|Withdrawal by Subject|3|||
42158336|NCT00262028|75966361|FG002|Overall Study|Withdrawal by Subject|6|||
42158337|NCT00262028|75966362|FG003|Overall Study|Withdrawal by Subject|5|||
42158338|NCT00262028|75966363|FG004|Overall Study|Withdrawal by Subject|2|||
42158339|NCT00262028|75966364|FG005|Overall Study|Withdrawal by Subject|3|||
42158340|NCT00262028|75966365|FG006|Overall Study|Withdrawal by Subject|5|||
42158341|NCT00262028|75966366|FG007|Overall Study|Withdrawal by Subject|7|||
42158342|NCT00262028|75966367|FG008|Overall Study|Withdrawal by Subject|2|||
42158343|NCT00262028|75966359|FG000|Overall Study|Lost to Follow-up|7|||
42158344|NCT00262028|75966360|FG001|Overall Study|Lost to Follow-up|7|||
42158345|NCT00262028|75966361|FG002|Overall Study|Lost to Follow-up|5|||
42158346|NCT00262028|75966362|FG003|Overall Study|Lost to Follow-up|5|||
42158347|NCT00262028|75966363|FG004|Overall Study|Lost to Follow-up|4|||
42158348|NCT00262028|75966364|FG005|Overall Study|Lost to Follow-up|3|||
42158349|NCT00262028|75966365|FG006|Overall Study|Lost to Follow-up|3|||
42158350|NCT00262028|75966366|FG007|Overall Study|Lost to Follow-up|5|||
42158351|NCT00262028|75966367|FG008|Overall Study|Lost to Follow-up|6|||
42158352|NCT00262028|75966359|FG000|Overall Study|Administrative Reason|11|||
42158353|NCT00262028|75966360|FG001|Overall Study|Administrative Reason|14|||
42158354|NCT00262028|75966361|FG002|Overall Study|Administrative Reason|9|||
42158355|NCT00262028|75966362|FG003|Overall Study|Administrative Reason|12|||
42158356|NCT00262028|75966363|FG004|Overall Study|Administrative Reason|6|||
42158357|NCT00262028|75966364|FG005|Overall Study|Administrative Reason|7|||
42158358|NCT00262028|75966365|FG006|Overall Study|Administrative Reason|4|||
42158359|NCT00262028|75966366|FG007|Overall Study|Administrative Reason|6|||
42158360|NCT00262028|75966367|FG008|Overall Study|Administrative Reason|10|||
42158361|NCT00262028|75966359|FG000|Overall Study|Protocol Violation|0|||
42158362|NCT00262028|75966360|FG001|Overall Study|Protocol Violation|0|||
42158363|NCT00262028|75966361|FG002|Overall Study|Protocol Violation|0|||
42158364|NCT00262028|75966362|FG003|Overall Study|Protocol Violation|1|||
42158365|NCT00262028|75966363|FG004|Overall Study|Protocol Violation|0|||
42158366|NCT00262028|75966364|FG005|Overall Study|Protocol Violation|0|||
42158367|NCT00262028|75966365|FG006|Overall Study|Protocol Violation|0|||
42158368|NCT00262028|75966366|FG007|Overall Study|Protocol Violation|0|||
42158369|NCT00262028|75966367|FG008|Overall Study|Protocol Violation|0|||
42158370|NCT00262028|75966359|FG000|Overall Study|Unable to classify|0|||
42158371|NCT00262028|75966360|FG001|Overall Study|Unable to classify|3|||
42158372|NCT00262028|75966361|FG002|Overall Study|Unable to classify|0|||
42158373|NCT00262028|75966362|FG003|Overall Study|Unable to classify|0|||
42158374|NCT00262028|75966363|FG004|Overall Study|Unable to classify|0|||
42158375|NCT00262028|75966364|FG005|Overall Study|Unable to classify|0|||
42158376|NCT00262028|75966365|FG006|Overall Study|Unable to classify|0|||
42158377|NCT00262028|75966366|FG007|Overall Study|Unable to classify|0|||
42158378|NCT00262028|75966367|FG008|Overall Study|Unable to classify|1|||
42158379|NCT00183248|75966411|FG000|Overall Study|Lost to Follow-up|0|||
42158380|NCT00183248|75966412|FG001|Overall Study|Lost to Follow-up|1|||
42158381|NCT00183248|75966411|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
42158382|NCT00183248|75966412|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
42158383|NCT00183170|75966420|FG000|First Intervention|Did not complete study|1|||
42158384|NCT00183170|75966421|FG001|First Intervention|Did not complete study|0|||
42158385|NCT00183170|75966420|FG000|First Intervention|Did not meet targeted BrAC|1|||
42158386|NCT00183170|75966421|FG001|First Intervention|Did not meet targeted BrAC|0|||
42158387|NCT00183170|75966420|FG000|Washout 1 Week|Did not complete study|6|||
42158388|NCT00183170|75966421|FG001|Washout 1 Week|Did not complete study|8|||
42158389|NCT00183170|75966420|FG000|Second Intervention|Did not complete study|1|||
42158390|NCT00183170|75966421|FG001|Second Intervention|Did not complete study|0|||
42158391|NCT00183170|75966420|FG000|Second Intervention|Did not meet targeted BrAC|0|||
42158392|NCT00183170|75966421|FG001|Second Intervention|Did not meet targeted BrAC|2|||
42158393|NCT00230282|75966427|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
42158394|NCT00230282|75966427|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
42158395|NCT00230282|75966427|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
42158396|NCT00230282|75966427|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
42158397|NCT00261950|75966431|FG000|Overall Study|Lost to Follow-up|2|||
42158398|NCT00261950|75966431|FG000|Overall Study|Death|6|||
42158399|NCT00261950|75966431|FG000|Overall Study|Withdrawal by Subject|5|||
42158400|NCT00261950|75966431|FG000|Overall Study|Other|1|||
42158401|NCT00261950|75966431|FG000|Overall Study|Physician Decision|1|||
42158402|NCT00261950|75966431|FG000|Overall Study|Protocol specified Criteria|11|||
42158403|NCT00230048|75966437|FG000|Overall Study|Lost to Follow-up|13|||
42158404|NCT00230048|75966438|FG001|Overall Study|Lost to Follow-up|18|||
42158405|NCT00229658|75966448|FG000|Overall Study|Administrative|2|||
42158406|NCT00229658|75966449|FG001|Overall Study|Administrative|1|||
42158407|NCT00229658|75966448|FG000|Overall Study|Investigator decision|13|||
42158408|NCT00229658|75966449|FG001|Overall Study|Investigator decision|10|||
42158409|NCT00229658|75966448|FG000|Overall Study|Other|80|||
42158410|NCT00229658|75966449|FG001|Overall Study|Other|60|||
42158411|NCT00229658|75966448|FG000|Overall Study|Lost to Follow-up|82|||
42158412|NCT00229658|75966449|FG001|Overall Study|Lost to Follow-up|55|||
42158413|NCT00229658|75966448|FG000|Overall Study|Serious Adverse Event|2|||
42158414|NCT00229658|75966449|FG001|Overall Study|Serious Adverse Event|2|||
42158415|NCT00229658|75966448|FG000|Overall Study|Withdrawal of consent|46|||
42158416|NCT00229658|75966449|FG001|Overall Study|Withdrawal of consent|39|||
42158417|NCT00182078|75966457|FG000|Overall Study|Withdrawal by Subject|1|||
42158418|NCT00182078|75966458|FG001|Overall Study|Withdrawal by Subject|0|||
42158419|NCT00181844|75966464|FG000|Signed Consent|Withdrawal by Subject|5|||
42158420|NCT00181844|75966464|FG000|Signed Consent|Did not meet entrance criteria|7|||
42158421|NCT00181844|75966464|FG000|Exposed to Study Medication|Adverse Event|10|||
42158422|NCT00181844|75966464|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
42158423|NCT00181844|75966464|FG000|Exposed to Study Medication|Non-compliance|2|||
42158424|NCT00181844|75966464|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
42158425|NCT00181844|75966464|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
42158426|NCT00181766|75966468|FG000|Overall Study|Lost to Follow-up|6|||
42158427|NCT00181766|75966468|FG000|Overall Study|Adverse Event|4|||
42158428|NCT00181766|75966468|FG000|Overall Study|non-compliance|2|||
42158429|NCT00180674|75966472|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
42158430|NCT00180674|75966472|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
42158431|NCT00076024|75966483|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
42158432|NCT00076024|75966484|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
42158433|NCT00076024|75966485|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
42158434|NCT00076024|75966486|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
42158435|NCT00076024|75966483|FG000|Phase 1, Lead-in|Adverse Event|1|||
42158436|NCT00076024|75966484|FG001|Phase 1, Lead-in|Adverse Event|0|||
42158437|NCT00076024|75966485|FG002|Phase 1, Lead-in|Adverse Event|0|||
42158438|NCT00076024|75966486|FG003|Phase 1, Lead-in|Adverse Event|0|||
42158439|NCT00076024|75966483|FG000|Phase 1, Lead-in|Clinical progression|1|||
42158440|NCT00076024|75966484|FG001|Phase 1, Lead-in|Clinical progression|0|||
42158441|NCT00076024|75966485|FG002|Phase 1, Lead-in|Clinical progression|0|||
42158442|NCT00076024|75966486|FG003|Phase 1, Lead-in|Clinical progression|0|||
42158443|NCT00076024|75966483|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
42158444|NCT00076024|75966484|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
42158445|NCT00076024|75966485|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
42158446|NCT00076024|75966486|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
42158447|NCT00076024|75966483|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
42158448|NCT00076024|75966484|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
42158449|NCT00076024|75966485|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
42158450|NCT00076024|75966486|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
42158451|NCT00076024|75966483|FG000|Phase 2, Double-blind|Adverse Event|0|||
42158452|NCT00076024|75966484|FG001|Phase 2, Double-blind|Adverse Event|25|||
42158453|NCT00076024|75966485|FG002|Phase 2, Double-blind|Adverse Event|6|||
42158454|NCT00076024|75966486|FG003|Phase 2, Double-blind|Adverse Event|0|||
42158455|NCT00076024|75966483|FG000|Phase 2, Double-blind|Un-specified|0|||
42158456|NCT00076024|75966484|FG001|Phase 2, Double-blind|Un-specified|14|||
42158457|NCT00076024|75966485|FG002|Phase 2, Double-blind|Un-specified|6|||
42158458|NCT00076024|75966486|FG003|Phase 2, Double-blind|Un-specified|0|||
42158459|NCT00076024|75966483|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
42158460|NCT00076024|75966484|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
42158461|NCT00076024|75966485|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
42158462|NCT00076024|75966486|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
42158463|NCT00076024|75966483|FG000|Phase 2, Open-label|Adverse Event|0|||
42158464|NCT00076024|75966484|FG001|Phase 2, Open-label|Adverse Event|0|||
42158465|NCT00076024|75966485|FG002|Phase 2, Open-label|Adverse Event|0|||
42158466|NCT00076024|75966486|FG003|Phase 2, Open-label|Adverse Event|2|||
42158467|NCT00076024|75966483|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
42158468|NCT00076024|75966484|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
42158469|NCT00076024|75966485|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
42158470|NCT00076024|75966486|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
42158471|NCT00076024|75966483|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
42158472|NCT00076024|75966484|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
42158473|NCT00076024|75966485|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
42158474|NCT00076024|75966486|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
42158475|NCT00076024|75966483|FG000|Phase 2, Open-label|Other|0|||
42158476|NCT00076024|75966484|FG001|Phase 2, Open-label|Other|0|||
42158477|NCT00076024|75966485|FG002|Phase 2, Open-label|Other|0|||
42158478|NCT00076024|75966486|FG003|Phase 2, Open-label|Other|2|||
42158479|NCT00075478|75966497|FG000|Overall Study|not eligible|1|||
42158480|NCT00075478|75966498|FG001|Overall Study|not eligible|0|||
42158481|NCT00075478|75966497|FG000|Overall Study|Physician Decision|0|||
42158482|NCT00075478|75966498|FG001|Overall Study|Physician Decision|1|||
42158483|NCT00175916|75966504|FG000|Overall Study|Death|19|||
42158484|NCT00175916|75966504|FG000|Overall Study|Adverse Event|81|||
42158485|NCT00175916|75966504|FG000|Overall Study|Lack of Efficacy|354|||
42158486|NCT00175916|75966504|FG000|Overall Study|Lost to Follow-up|17|||
42158487|NCT00175916|75966504|FG000|Overall Study|Subject Choice|98|||
42158488|NCT00175916|75966504|FG000|Overall Study|Lack of compliance|8|||
42158489|NCT00175916|75966504|FG000|Overall Study|Patient cannot record seizures|1|||
42158490|NCT00175916|75966504|FG000|Overall Study|Sponsor decision|17|||
42158491|NCT00175916|75966504|FG000|Overall Study|Vigabatrin intake|1|||
42158492|NCT00175916|75966504|FG000|Overall Study|Suicidal behaviour|1|||
42158493|NCT00175916|75966504|FG000|Overall Study|Withdrawal by Subject|1|||
42158494|NCT00175916|75966504|FG000|Overall Study|Seizure - free|4|||
42158495|NCT00175916|75966504|FG000|Overall Study|Administrative reason|1|||
42158496|NCT00175916|75966504|FG000|Overall Study|Pregnancy|1|||
42158497|NCT00175916|75966504|FG000|Overall Study|Patient's request|2|||
42158498|NCT00175916|75966504|FG000|Overall Study|Treating physiciant's choice|1|||
42158499|NCT00175916|75966504|FG000|Overall Study|Moved overseas|1|||
42158500|NCT00175916|75966504|FG000|Overall Study|Loss of job and economic burden|1|||
42158501|NCT00175916|75966504|FG000|Overall Study|Site was closed|9|||
42158502|NCT00175916|75966504|FG000|Overall Study|Patient went to prison|1|||
42158503|NCT00075400|75966509|FG000|Overall Study|Ineligible: wrong primary|1|||
42158504|NCT00075400|75966509|FG000|Overall Study|Never treated|2|||
42158505|NCT00228566|75966518|FG000|Overall Study|Adverse Event|31|||
42158506|NCT00228566|75966518|FG000|Overall Study|Lack of Efficacy|14|||
42158507|NCT00228566|75966518|FG000|Overall Study|Lost to Follow-up|16|||
42158508|NCT00228566|75966518|FG000|Overall Study|Physician Decision|5|||
42158509|NCT00228566|75966518|FG000|Overall Study|Withdrawal by Subject|4|||
42158510|NCT00228566|75966518|FG000|Overall Study|Miscellaneous|1|||
42158511|NCT00074152|75966524|FG000|Overall Study|Death|21|||
42158512|NCT00074152|75966525|FG001|Overall Study|Death|9|||
42158513|NCT00074152|75966524|FG000|Overall Study|Lack of Efficacy|34|||
42158514|NCT00074152|75966525|FG001|Overall Study|Lack of Efficacy|24|||
42158515|NCT00261846|75966541|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
42158516|NCT00261846|75966542|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
42158517|NCT00261846|75966543|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
42158518|NCT00261846|75966544|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
42158519|NCT00261846|75966545|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
42158520|NCT00261846|75966546|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
42158521|NCT00261846|75966547|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
42158522|NCT00261846|75966548|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
42158523|NCT00261846|75966549|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
42158524|NCT00261846|75966550|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
42158525|NCT00261846|75966551|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
42158526|NCT00261846|75966552|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
42158527|NCT00261846|75966541|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
42158528|NCT00261846|75966542|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
42158529|NCT00261846|75966543|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
42158530|NCT00261846|75966544|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
42158531|NCT00261846|75966545|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
42158532|NCT00261846|75966546|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
42158533|NCT00261846|75966547|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
42158534|NCT00261846|75966548|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
42158535|NCT00261846|75966549|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
42158536|NCT00261846|75966550|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
42158537|NCT00261846|75966551|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
42158538|NCT00261846|75966552|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
42158539|NCT00261846|75966541|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
42158540|NCT00261846|75966542|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
42158541|NCT00261846|75966543|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
42158542|NCT00261846|75966544|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
42158543|NCT00261846|75966545|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
42158544|NCT00261846|75966546|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
42158545|NCT00261846|75966547|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
42158546|NCT00261846|75966548|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
42158547|NCT00261846|75966549|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
42158548|NCT00261846|75966550|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
42158549|NCT00261846|75966551|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
42158550|NCT00261846|75966552|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
42158551|NCT00261846|75966541|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
42158552|NCT00261846|75966542|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
42158553|NCT00261846|75966543|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
42158554|NCT00261846|75966544|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
42158555|NCT00261846|75966545|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
42158556|NCT00261846|75966546|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
42158557|NCT00261846|75966547|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
42158558|NCT00261846|75966548|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
42158559|NCT00261846|75966549|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
42158560|NCT00261846|75966550|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
42158561|NCT00261846|75966551|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
42158562|NCT00261846|75966552|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
42158563|NCT00261846|75966541|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
42158564|NCT00261846|75966542|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
42158565|NCT00261846|75966543|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
42158566|NCT00261846|75966544|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
42158567|NCT00261846|75966545|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
42158568|NCT00261846|75966546|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
42158569|NCT00261846|75966547|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
42158570|NCT00261846|75966548|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
42158571|NCT00261846|75966549|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
42158572|NCT00261846|75966550|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
42158573|NCT00261846|75966551|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
42158574|NCT00261846|75966552|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
42158575|NCT00261846|75966541|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
42158576|NCT00261846|75966542|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
42158577|NCT00261846|75966543|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
42158578|NCT00261846|75966544|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
42158579|NCT00261846|75966545|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
42158580|NCT00261846|75966546|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
42158581|NCT00261846|75966547|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
42158582|NCT00261846|75966548|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
42158583|NCT00261846|75966549|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
42158584|NCT00261846|75966550|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
42158585|NCT00261846|75966551|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
42158586|NCT00261846|75966552|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
42158587|NCT00261846|75966541|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
42158588|NCT00261846|75966542|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
42158589|NCT00261846|75966543|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
42158590|NCT00261846|75966544|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
42158591|NCT00261846|75966545|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
42158592|NCT00261846|75966546|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
42158593|NCT00261846|75966547|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
42158594|NCT00261846|75966548|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
42158595|NCT00261846|75966549|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
42158596|NCT00261846|75966550|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
42158597|NCT00261846|75966551|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
42158598|NCT00261846|75966552|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
42158599|NCT00169442|75966597|FG000|Overall Study|Withdrawal by Subject|0|||
42158600|NCT00169442|75966598|FG001|Overall Study|Withdrawal by Subject|0|||
42158601|NCT00169442|75966599|FG002|Overall Study|Withdrawal by Subject|1|||
42158602|NCT00169442|75966600|FG003|Overall Study|Withdrawal by Subject|0|||
42158603|NCT00169442|75966601|FG004|Overall Study|Withdrawal by Subject|0|||
42158604|NCT00169442|75966602|FG005|Overall Study|Withdrawal by Subject|0|||
42158605|NCT00169442|75966597|FG000|Overall Study|Migrated/moved from study area|0|||
42158606|NCT00169442|75966598|FG001|Overall Study|Migrated/moved from study area|0|||
42158607|NCT00169442|75966599|FG002|Overall Study|Migrated/moved from study area|0|||
42158608|NCT00169442|75966600|FG003|Overall Study|Migrated/moved from study area|0|||
42158609|NCT00169442|75966601|FG004|Overall Study|Migrated/moved from study area|0|||
42158610|NCT00169442|75966602|FG005|Overall Study|Migrated/moved from study area|2|||
42158611|NCT00169442|75966597|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
42158612|NCT00169442|75966598|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
42158613|NCT00169442|75966599|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
42158614|NCT00169442|75966600|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
42158615|NCT00169442|75966601|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
42158616|NCT00169442|75966602|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
42158617|NCT00169442|75966597|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
42158618|NCT00169442|75966598|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
42158619|NCT00169442|75966599|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
42158620|NCT00169442|75966600|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
42158621|NCT00169442|75966601|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
42158622|NCT00169442|75966602|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
42158623|NCT00261716|75966620|FG000|Overall Study|Withdrawal by Subject|6|||
42158624|NCT00261716|75966621|FG001|Overall Study|Withdrawal by Subject|8|||
42158625|NCT00261716|75966620|FG000|Overall Study|Lost to Follow-up|0|||
42158626|NCT00261716|75966621|FG001|Overall Study|Lost to Follow-up|2|||
42158627|NCT03809104|75966631|FG000|Overall Study|Withdrawal by Subject|3|||
42158628|NCT00203502|75966635|FG000|Overall Study|Death|1|||
42158629|NCT03799198|75966641|FG000|Overall Study|Lost to Follow-up|4|||
42158630|NCT03799198|75966642|FG001|Overall Study|Lost to Follow-up|8|||
42158631|NCT03799198|75966641|FG000|Overall Study|Death|0|||
42158632|NCT03799198|75966642|FG001|Overall Study|Death|1|||
42158633|NCT00232596|75966650|FG000|6-Week Titration Phase|Adverse Event|6|||
42158634|NCT00232596|75966651|FG001|6-Week Titration Phase|Adverse Event|19|||
42158635|NCT00232596|75966650|FG000|6-Week Titration Phase|Failed to Return|2|||
42158636|NCT00232596|75966651|FG001|6-Week Titration Phase|Failed to Return|1|||
42158637|NCT00232596|75966650|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
42158638|NCT00232596|75966651|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
42158639|NCT00232596|75966650|FG000|6-Week Titration Phase|Protocol Violation|1|||
42158640|NCT00232596|75966651|FG001|6-Week Titration Phase|Protocol Violation|3|||
42158641|NCT00232596|75966650|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
42158642|NCT00232596|75966651|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
42158643|NCT00232596|75966650|FG000|6-Week Titration Phase|Other|3|||
42158644|NCT00232596|75966651|FG001|6-Week Titration Phase|Other|3|||
42158645|NCT00232596|75966650|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
42158646|NCT00232596|75966651|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
42158647|NCT00232596|75966650|FG000|12-Week Maintenance Phase|Adverse Event|7|||
42158648|NCT00232596|75966651|FG001|12-Week Maintenance Phase|Adverse Event|22|||
42158649|NCT00232596|75966650|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
42158650|NCT00232596|75966651|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
42158651|NCT00232596|75966650|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
42158652|NCT00232596|75966651|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
42158653|NCT00232596|75966650|FG000|12-Week Maintenance Phase|Other|1|||
42158654|NCT00232596|75966651|FG001|12-Week Maintenance Phase|Other|3|||
42158655|NCT00073918|75966669|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
42158656|NCT00073918|75966669|FG000|Overall Study|Rapid disease progression|2|||
42158657|NCT00073918|75966669|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
42158658|NCT00231894|75966675|FG000|Overall Study|Withdrawal by Subject|1|||
42158659|NCT00231894|75966676|FG001|Overall Study|Withdrawal by Subject|1|||
42158660|NCT00203424|75966688|FG000|Treatment Period|Withdrawal by Subject|4|||
42158661|NCT00203424|75966688|FG000|Treatment Period|Adverse Event|5|||
42158662|NCT00203424|75966688|FG000|Treatment Period|progressive disease|2|||
42158663|NCT00203424|75966688|FG000|Follow-up Period|Withdrawal by Subject|1|||
42158664|NCT00203424|75966688|FG000|Follow-up Period|progressive disease|4|||
42158665|NCT00203424|75966688|FG000|Follow-up Period|Lost to Follow-up|1|||
42158666|NCT00203268|75966692|FG000|Early Treatment|only treated one headache|2|||
42158667|NCT00203268|75966692|FG000|Early Treatment|Lost to Follow-up|1|||
42158668|NCT00203268|75966692|FG000|Early Treatment|Withdrawal by Subject|1|||
42158669|NCT00168818|75966701|FG000|Overall Study|Adverse Event|23|||
42158670|NCT00168818|75966702|FG001|Overall Study|Adverse Event|29|||
42158671|NCT00168818|75966703|FG002|Overall Study|Adverse Event|31|||
42158672|NCT00168818|75966701|FG000|Overall Study|Protocol Violation|16|||
42158673|NCT00168818|75966702|FG001|Overall Study|Protocol Violation|11|||
42158674|NCT00168818|75966703|FG002|Overall Study|Protocol Violation|11|||
42158675|NCT00168818|75966701|FG000|Overall Study|Lost to Follow-up|13|||
42158676|NCT00168818|75966702|FG001|Overall Study|Lost to Follow-up|4|||
42158677|NCT00168818|75966703|FG002|Overall Study|Lost to Follow-up|15|||
42158678|NCT00168818|75966701|FG000|Overall Study|Withdrawal by Subject|43|||
42158679|NCT00168818|75966702|FG001|Overall Study|Withdrawal by Subject|41|||
42158680|NCT00168818|75966703|FG002|Overall Study|Withdrawal by Subject|37|||
42158681|NCT00168818|75966701|FG000|Overall Study|Other|22|||
42158682|NCT00168818|75966702|FG001|Overall Study|Other|24|||
42158683|NCT00168818|75966703|FG002|Overall Study|Other|30|||
42158684|NCT00168818|75966701|FG000|Treatment|Adverse Event|77|||
42158685|NCT00168818|75966702|FG001|Treatment|Adverse Event|89|||
42158686|NCT00168818|75966703|FG002|Treatment|Adverse Event|68|||
42158687|NCT00168818|75966701|FG000|Treatment|Protocol Violation|8|||
42158688|NCT00168818|75966702|FG001|Treatment|Protocol Violation|11|||
42158689|NCT00168818|75966703|FG002|Treatment|Protocol Violation|11|||
42040226|NCT01928394|75848575|FG009|Treatment Period|Participant withdrew consent|0|||
42158690|NCT00168818|75966701|FG000|Treatment|Lost to Follow-up|0|||
42158691|NCT00168818|75966702|FG001|Treatment|Lost to Follow-up|2|||
42158692|NCT00168818|75966703|FG002|Treatment|Lost to Follow-up|1|||
42158693|NCT00168818|75966701|FG000|Treatment|Withdrawal by Subject|25|||
42158694|NCT00168818|75966702|FG001|Treatment|Withdrawal by Subject|20|||
42158695|NCT00168818|75966703|FG002|Treatment|Withdrawal by Subject|22|||
42158696|NCT00168818|75966701|FG000|Treatment|Other|23|||
42158697|NCT00168818|75966702|FG001|Treatment|Other|29|||
42158698|NCT00168818|75966703|FG002|Treatment|Other|31|||
42158699|NCT00260832|75966713|FG000|Overall Study|Adverse Event|26|||
42158700|NCT00260832|75966714|FG001|Overall Study|Adverse Event|19|||
42158701|NCT00260832|75966713|FG000|Overall Study|Progression|116|||
42158702|NCT00260832|75966714|FG001|Overall Study|Progression|96|||
42158703|NCT00260832|75966713|FG000|Overall Study|Withdrawal by Subject|15|||
42158704|NCT00260832|75966714|FG001|Overall Study|Withdrawal by Subject|17|||
42158705|NCT00260832|75966713|FG000|Overall Study|Physician Decision|15|||
42158706|NCT00260832|75966714|FG001|Overall Study|Physician Decision|9|||
42158707|NCT00260832|75966713|FG000|Overall Study|Death|43|||
42158708|NCT00260832|75966714|FG001|Overall Study|Death|62|||
42158709|NCT00260832|75966713|FG000|Overall Study|Other|10|||
42158710|NCT00260832|75966714|FG001|Overall Study|Other|7|||
42158711|NCT00260832|75966713|FG000|Overall Study|Protocol Violation|3|||
42158712|NCT00260832|75966714|FG001|Overall Study|Protocol Violation|1|||
42158713|NCT00168038|75966720|FG000|Overall Study|Adverse Event|1|||
42158714|NCT00168038|75966720|FG000|Overall Study|Therapy failure|1|||
42158715|NCT00167414|75966724|FG000|Overall Study|Death|10|||
42158716|NCT00166712|75966730|FG000|Overall Study|Death|0|||
42158717|NCT00166712|75966731|FG001|Overall Study|Death|1|||
42158718|NCT00166712|75966730|FG000|Overall Study|Adverse Event|1|||
42158719|NCT00166712|75966731|FG001|Overall Study|Adverse Event|0|||
42158720|NCT00166712|75966730|FG000|Overall Study|Withdrawal by Subject|1|||
42158721|NCT00166712|75966731|FG001|Overall Study|Withdrawal by Subject|2|||
42158722|NCT00166712|75966730|FG000|Overall Study|Physician Decision|0|||
42158723|NCT00166712|75966731|FG001|Overall Study|Physician Decision|2|||
42158724|NCT00073528|75966743|FG000|Overall Study|Death|488|||
42158725|NCT00073528|75966744|FG001|Overall Study|Death|473|||
42158726|NCT00073528|75966743|FG000|Overall Study|Lost to Follow-up|52|||
42158727|NCT00073528|75966744|FG001|Overall Study|Lost to Follow-up|45|||
42158728|NCT00073528|75966743|FG000|Overall Study|Withdrawal by Subject|50|||
42158729|NCT00073528|75966744|FG001|Overall Study|Withdrawal by Subject|45|||
42158730|NCT00073528|75966743|FG000|Overall Study|Study terminated by Sponsor|10|||
42158731|NCT00073528|75966744|FG001|Overall Study|Study terminated by Sponsor|29|||
42158732|NCT00073528|75966743|FG000|Overall Study|Other|18|||
42158733|NCT00073528|75966744|FG001|Overall Study|Other|19|||
42158734|NCT00073528|75966743|FG000|Overall Study|Other|9|||
42158735|NCT00073528|75966744|FG001|Overall Study|Other|12|||
42158736|NCT00073528|75966743|FG000|Overall Study|Protocol Violation|3|||
42158737|NCT00073528|75966744|FG001|Overall Study|Protocol Violation|5|||
42279716|NCT00818623|76111461|FG001|Overall Study|Adverse Event|0|||
42279717|NCT00818623|76111462|FG002|Overall Study|Adverse Event|1|||
42279718|NCT00818623|76111463|FG003|Overall Study|Adverse Event|0|||
42279719|NCT00818623|76111464|FG004|Overall Study|Adverse Event|0|||
42279720|NCT00818623|76111465|FG005|Overall Study|Adverse Event|1|||
42279721|NCT00818623|76111466|FG006|Overall Study|Adverse Event|0|||
42279722|NCT00818623|76111467|FG007|Overall Study|Adverse Event|0|||
42279723|NCT00818623|76111460|FG000|Overall Study|Bad prostate specific antigen response|0|||
42279724|NCT00818623|76111461|FG001|Overall Study|Bad prostate specific antigen response|3|||
42279725|NCT00818623|76111462|FG002|Overall Study|Bad prostate specific antigen response|2|||
42279726|NCT00818623|76111463|FG003|Overall Study|Bad prostate specific antigen response|5|||
42279727|NCT00818623|76111464|FG004|Overall Study|Bad prostate specific antigen response|0|||
42279728|NCT00818623|76111465|FG005|Overall Study|Bad prostate specific antigen response|1|||
42158738|NCT03801148|75966754|FG000|Period 1 (2 Days)|Adverse Event|1|||
42279729|NCT00818623|76111466|FG006|Overall Study|Bad prostate specific antigen response|0|||
42279730|NCT00818623|76111467|FG007|Overall Study|Bad prostate specific antigen response|0|||
42279731|NCT00818623|76111460|FG000|Overall Study|Withdrawal by Subject|0|||
42279732|NCT00818623|76111461|FG001|Overall Study|Withdrawal by Subject|1|||
42279733|NCT00818623|76111462|FG002|Overall Study|Withdrawal by Subject|1|||
42158739|NCT03801148|75966755|FG001|Period 1 (2 Days)|Adverse Event|1|||
42279734|NCT00818623|76111463|FG003|Overall Study|Withdrawal by Subject|0|||
42158740|NCT03801148|75966756|FG002|Period 1 (2 Days)|Adverse Event|0|||
42158741|NCT03801148|75966757|FG003|Period 1 (2 Days)|Adverse Event|0|||
42158742|NCT03801148|75966754|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
42158743|NCT03801148|75966755|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
42158744|NCT03801148|75966756|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
42158745|NCT03801148|75966757|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
42158746|NCT03801148|75966754|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
42158747|NCT03801148|75966755|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
42158748|NCT03801148|75966756|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
42279735|NCT00818623|76111464|FG004|Overall Study|Withdrawal by Subject|0|||
42279736|NCT00818623|76111465|FG005|Overall Study|Withdrawal by Subject|1|||
42279737|NCT00818623|76111466|FG006|Overall Study|Withdrawal by Subject|1|||
42279738|NCT00818623|76111467|FG007|Overall Study|Withdrawal by Subject|1|||
42279739|NCT00818623|76111460|FG000|Overall Study|Protocol Violation|1|||
42279740|NCT00818623|76111461|FG001|Overall Study|Protocol Violation|0|||
42279741|NCT00818623|76111462|FG002|Overall Study|Protocol Violation|0|||
42158749|NCT03801148|75966757|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
42158750|NCT03801148|75966754|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
42158751|NCT03801148|75966755|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
42158752|NCT03801148|75966756|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
42158753|NCT03801148|75966757|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
42158754|NCT00072280|75966769|FG000|Treatment|Found ineligible|1|||
42158755|NCT00072280|75966770|FG001|Treatment|Found ineligible|2|||
42158756|NCT00072280|75966769|FG000|Follow-up|Early termination of study|2|||
42158757|NCT00072280|75966770|FG001|Follow-up|Early termination of study|2|||
42158758|NCT00071812|75966779|FG000|24-Week Double-Blind Period|Adverse Event|2|||
42158759|NCT00071812|75966780|FG001|24-Week Double-Blind Period|Adverse Event|3|||
42158760|NCT00071812|75966781|FG002|24-Week Double-Blind Period|Adverse Event|4|||
42158761|NCT00071812|75966782|FG003|24-Week Double-Blind Period|Adverse Event|4|||
42158762|NCT00071812|75966779|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
42158763|NCT00071812|75966780|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
42158764|NCT00071812|75966781|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
42158765|NCT00071812|75966782|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
42158766|NCT00071812|75966779|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
42158767|NCT00071812|75966780|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
42158768|NCT00071812|75966781|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
42158769|NCT00071812|75966782|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
42158770|NCT00071812|75966779|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
42158771|NCT00071812|75966780|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
42158772|NCT00071812|75966781|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
42158773|NCT00071812|75966782|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
42158774|NCT00071812|75966779|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
42158775|NCT00071812|75966780|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
42158776|NCT00071812|75966781|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
42158777|NCT00071812|75966782|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
42158778|NCT00071812|75966779|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
42158779|NCT00071812|75966780|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
42158780|NCT00071812|75966781|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
42158781|NCT00071812|75966782|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
42158782|NCT00071812|75966779|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
42158783|NCT00071812|75966780|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
42158784|NCT00071812|75966781|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
42158785|NCT00071812|75966782|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
42158786|NCT00071812|75966779|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
42158787|NCT00071812|75966780|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
42158788|NCT00071812|75966781|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
42158789|NCT00071812|75966782|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
42158790|NCT00071812|75966779|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
42158791|NCT00071812|75966780|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
42158792|NCT00071812|75966781|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
42158793|NCT00071812|75966782|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
42158794|NCT00071812|75966779|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
42158795|NCT00071812|75966780|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
42158796|NCT00071812|75966781|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
42158797|NCT00071812|75966782|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
42158798|NCT00071110|75966796|FG000|Overall Study|Protocol Violation|0|||
42158799|NCT00071110|75966797|FG001|Overall Study|Protocol Violation|4|||
42158800|NCT00071032|75966805|FG000|Overall Study|Lost to Follow-up|1|||
42158801|NCT00071032|75966806|FG001|Overall Study|Lost to Follow-up|1|||
42158802|NCT00071032|75966805|FG000|Overall Study|Withdrawal by Subject|8|||
42279742|NCT00818623|76111463|FG003|Overall Study|Protocol Violation|0|||
42279743|NCT00818623|76111464|FG004|Overall Study|Protocol Violation|1|||
42158803|NCT00071032|75966806|FG001|Overall Study|Withdrawal by Subject|6|||
42158804|NCT00071032|75966805|FG000|Overall Study|Missing Primary Outcome|0|||
42158805|NCT00071032|75966806|FG001|Overall Study|Missing Primary Outcome|1|||
42158806|NCT00259610|75966817|FG000|Overall Study|Withdrawal by Subject|33|||
42158807|NCT00259610|75966818|FG001|Overall Study|Withdrawal by Subject|25|||
42279744|NCT00818623|76111465|FG005|Overall Study|Protocol Violation|0|||
42279745|NCT00818623|76111466|FG006|Overall Study|Protocol Violation|1|||
42279746|NCT00818623|76111467|FG007|Overall Study|Protocol Violation|0|||
42158808|NCT00259610|75966819|FG002|Overall Study|Withdrawal by Subject|29|||
42158809|NCT00259610|75966820|FG003|Overall Study|Withdrawal by Subject|19|||
42158810|NCT00259610|75966817|FG000|Overall Study|Lost to Follow-up|19|||
42158811|NCT00259610|75966818|FG001|Overall Study|Lost to Follow-up|8|||
42158812|NCT00259610|75966819|FG002|Overall Study|Lost to Follow-up|18|||
42158813|NCT00259610|75966820|FG003|Overall Study|Lost to Follow-up|15|||
42158814|NCT00259610|75966817|FG000|Overall Study|Physician Decision|6|||
42158815|NCT00259610|75966818|FG001|Overall Study|Physician Decision|4|||
42158816|NCT00259610|75966819|FG002|Overall Study|Physician Decision|7|||
42158817|NCT00259610|75966820|FG003|Overall Study|Physician Decision|2|||
42158818|NCT00259610|75966817|FG000|Overall Study|Death|1|||
42158819|NCT00259610|75966818|FG001|Overall Study|Death|1|||
42158820|NCT00259610|75966819|FG002|Overall Study|Death|2|||
42158821|NCT00259610|75966820|FG003|Overall Study|Death|0|||
42158822|NCT00259610|75966817|FG000|Overall Study|non medical reason|6|||
42158823|NCT00259610|75966818|FG001|Overall Study|non medical reason|2|||
42158824|NCT00259610|75966819|FG002|Overall Study|non medical reason|10|||
42158825|NCT00259610|75966820|FG003|Overall Study|non medical reason|3|||
42158826|NCT00259610|75966817|FG000|Overall Study|Adverse Event|3|||
42158827|NCT00259610|75966818|FG001|Overall Study|Adverse Event|4|||
42158828|NCT00259610|75966819|FG002|Overall Study|Adverse Event|5|||
42158829|NCT00259610|75966820|FG003|Overall Study|Adverse Event|2|||
42158830|NCT00259610|75966817|FG000|Overall Study|Serious Adverse Event|8|||
42158831|NCT00259610|75966818|FG001|Overall Study|Serious Adverse Event|2|||
42158832|NCT00259610|75966819|FG002|Overall Study|Serious Adverse Event|2|||
42158833|NCT00259610|75966820|FG003|Overall Study|Serious Adverse Event|2|||
42158834|NCT00165776|75966834|FG000|Overall Study|Lack of Efficacy|0|||
42158835|NCT00165776|75966835|FG001|Overall Study|Lack of Efficacy|0|||
42158836|NCT00165776|75966836|FG002|Overall Study|Lack of Efficacy|0|||
42158837|NCT00165776|75966837|FG003|Overall Study|Lack of Efficacy|1|||
42158838|NCT00165776|75966834|FG000|Overall Study|Withdrawal by Subject|4|||
42158839|NCT00165776|75966835|FG001|Overall Study|Withdrawal by Subject|1|||
42158840|NCT00165776|75966836|FG002|Overall Study|Withdrawal by Subject|2|||
42158841|NCT00165776|75966837|FG003|Overall Study|Withdrawal by Subject|0|||
42158842|NCT00165776|75966834|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
42158843|NCT00165776|75966835|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
42158844|NCT00165776|75966836|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
42158845|NCT00165776|75966837|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
42158846|NCT00165698|75966849|FG000|Overall Study|Adverse Event|2|||
42158847|NCT00165698|75966850|FG001|Overall Study|Adverse Event|10|||
42158848|NCT00165698|75966849|FG000|Overall Study|Lost to Follow-up|2|||
42158849|NCT00165698|75966850|FG001|Overall Study|Lost to Follow-up|2|||
42158850|NCT00165698|75966849|FG000|Overall Study|Withdrawal by Subject|2|||
42158851|NCT00165698|75966850|FG001|Overall Study|Withdrawal by Subject|1|||
42158852|NCT00165698|75966849|FG000|Overall Study|Protocol Violation|1|||
42158853|NCT00165698|75966850|FG001|Overall Study|Protocol Violation|0|||
42158854|NCT00165698|75966849|FG000|Overall Study|Not Taken/Lost the medicine|1|||
42158855|NCT00165698|75966850|FG001|Overall Study|Not Taken/Lost the medicine|2|||
42158856|NCT00225758|75966856|FG000|Overall Study|Adverse Event|4|||
42158857|NCT00259298|75966862|FG000|Overall Study|Withdrawal by Subject|1|||
42158858|NCT00259298|75966862|FG000|Overall Study|Physician Decision|2|||
42158859|NCT03789292|75966868|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
42158860|NCT03789292|75966869|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
42158861|NCT03789292|75966870|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
42158862|NCT03789292|75966868|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
42158863|NCT03789292|75966869|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
42279747|NCT00818623|76111460|FG000|Overall Study|Need of additional treatment|0|||
42279748|NCT00818623|76111461|FG001|Overall Study|Need of additional treatment|0|||
42279749|NCT00818623|76111462|FG002|Overall Study|Need of additional treatment|0|||
42279750|NCT00818623|76111463|FG003|Overall Study|Need of additional treatment|0|||
42279751|NCT00818623|76111464|FG004|Overall Study|Need of additional treatment|1|||
42279752|NCT00818623|76111465|FG005|Overall Study|Need of additional treatment|0|||
42158864|NCT03789292|75966870|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
42158865|NCT03789292|75966868|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
42158866|NCT03789292|75966869|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
42158867|NCT03789292|75966870|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
42158868|NCT03789292|75966868|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
42158869|NCT03789292|75966869|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
42158870|NCT03789292|75966870|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
42158871|NCT03789292|75966868|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
42158872|NCT03789292|75966869|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
42158873|NCT03789292|75966870|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
42158874|NCT03789292|75966868|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
42158875|NCT03789292|75966869|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
42279753|NCT00818623|76111466|FG006|Overall Study|Need of additional treatment|0|||
42279754|NCT00818623|76111467|FG007|Overall Study|Need of additional treatment|0|||
42279755|NCT00818623|76111460|FG000|Overall Study|Lack of trial drug at site|0|||
42279756|NCT00818623|76111461|FG001|Overall Study|Lack of trial drug at site|0|||
42279757|NCT00818623|76111462|FG002|Overall Study|Lack of trial drug at site|0|||
42279758|NCT00818623|76111463|FG003|Overall Study|Lack of trial drug at site|0|||
42279759|NCT00818623|76111464|FG004|Overall Study|Lack of trial drug at site|2|||
42279760|NCT00818623|76111465|FG005|Overall Study|Lack of trial drug at site|0|||
42279761|NCT00818623|76111466|FG006|Overall Study|Lack of trial drug at site|1|||
42279762|NCT00818623|76111467|FG007|Overall Study|Lack of trial drug at site|0|||
42158876|NCT03789292|75966870|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
42158877|NCT03789292|75966868|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
42158878|NCT03789292|75966869|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
42158879|NCT03789292|75966870|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
42158880|NCT03789292|75966868|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
42158881|NCT03789292|75966869|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
42279763|NCT00818623|76111460|FG000|Overall Study|Disease progression|0|||
42158882|NCT03789292|75966870|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
42158883|NCT03789292|75966868|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
42158884|NCT03789292|75966869|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
42158885|NCT03789292|75966870|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
42158886|NCT03789292|75966868|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
42158887|NCT03789292|75966869|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
42158888|NCT03789292|75966870|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
42158889|NCT03789292|75966868|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
42158890|NCT03789292|75966869|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
42158891|NCT03789292|75966870|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
42158892|NCT03789292|75966868|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
42158893|NCT03789292|75966869|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
42158894|NCT03789292|75966870|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
42158895|NCT03789292|75966868|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
42158896|NCT03789292|75966869|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
42158897|NCT03789292|75966870|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
42158898|NCT03781336|75966886|FG000|Overall Study|Withdrawal by Subject|2|||
42279764|NCT00818623|76111461|FG001|Overall Study|Disease progression|0|||
42279765|NCT00818623|76111462|FG002|Overall Study|Disease progression|0|||
42279766|NCT00818623|76111463|FG003|Overall Study|Disease progression|0|||
42279767|NCT00818623|76111464|FG004|Overall Study|Disease progression|0|||
42279768|NCT00818623|76111465|FG005|Overall Study|Disease progression|0|||
42279769|NCT00818623|76111466|FG006|Overall Study|Disease progression|1|||
42279770|NCT00818623|76111467|FG007|Overall Study|Disease progression|0|||
42279771|NCT01285557|76111495|FG000|Overall Study|Death|173|||
42279772|NCT01285557|76111496|FG001|Overall Study|Death|90|||
42279773|NCT01285557|76111495|FG000|Overall Study|Lost to Follow-up|6|||
42279774|NCT01285557|76111496|FG001|Overall Study|Lost to Follow-up|2|||
42279775|NCT01285557|76111495|FG000|Overall Study|Withdrew Consent|6|||
42279776|NCT01285557|76111496|FG001|Overall Study|Withdrew Consent|1|||
42279777|NCT01285557|76111495|FG000|Overall Study|Sponsor Study Termination|23|||
42279778|NCT01285557|76111496|FG001|Overall Study|Sponsor Study Termination|13|||
42279779|NCT01285557|76111495|FG000|Overall Study|Randomized but not treated|1|||
42279780|NCT01285557|76111496|FG001|Overall Study|Randomized but not treated|1|||
42279781|NCT01285557|76111495|FG000|Overall Study|Study follow-up ongoing|28|||
42279782|NCT01285557|76111496|FG001|Overall Study|Study follow-up ongoing|14|||
42279783|NCT01285557|76111495|FG000|Overall Study|Sponsor Decision|2|||
42279784|NCT01285557|76111496|FG001|Overall Study|Sponsor Decision|1|||
42279785|NCT01376167|76111558|FG000|Overall Study|Lost to Follow-up|2|||
42279786|NCT01376167|76111559|FG001|Overall Study|Lost to Follow-up|4|||
42279787|NCT01376167|76111560|FG002|Overall Study|Lost to Follow-up|2|||
42279788|NCT01376167|76111558|FG000|Overall Study|Physician Decision|1|||
42279789|NCT01376167|76111559|FG001|Overall Study|Physician Decision|1|||
42279790|NCT01376167|76111560|FG002|Overall Study|Physician Decision|0|||
42279791|NCT01376167|76111558|FG000|Overall Study|Withdrawal by Subject|1|||
42279792|NCT01376167|76111559|FG001|Overall Study|Withdrawal by Subject|5|||
42279793|NCT01376167|76111560|FG002|Overall Study|Withdrawal by Subject|4|||
42279794|NCT02647281|76111580|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
42279795|NCT02647281|76111581|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
42279796|NCT02647281|76111582|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
42279797|NCT02647281|76111583|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
42158899|NCT03781336|75966887|FG001|Overall Study|Withdrawal by Subject|2|||
42158900|NCT03780400|75966893|FG000|Overall Study|Lost to Follow-up|5|||
42158901|NCT03780400|75966893|FG000|Overall Study|Withdrawal by Subject|2|||
42158902|NCT03780244|75966899|FG000|Overall Study|Lost to Follow-up|1|||
42158903|NCT03780244|75966900|FG001|Overall Study|Lost to Follow-up|0|||
42158904|NCT03785548|75966908|FG000|Overall Study|age > 80|1|||
42158905|NCT03785548|75966909|FG001|Overall Study|age > 80|0|||
42158906|NCT03785548|75966908|FG000|Overall Study|no Postop queries|1|||
42158907|NCT03785548|75966909|FG001|Overall Study|no Postop queries|0|||
42158908|NCT00141297|75966917|FG000|Overall Study|Adverse Event|0|||
42158909|NCT00141297|75966918|FG001|Overall Study|Adverse Event|0|||
42158910|NCT00141297|75966919|FG002|Overall Study|Adverse Event|1|||
42158911|NCT00141297|75966920|FG003|Overall Study|Adverse Event|0|||
42158912|NCT00141297|75966921|FG004|Overall Study|Adverse Event|1|||
42158913|NCT00141297|75966922|FG005|Overall Study|Adverse Event|1|||
42158914|NCT00141297|75966923|FG006|Overall Study|Adverse Event|0|||
42158915|NCT00141297|75966924|FG007|Overall Study|Adverse Event|1|||
42158916|NCT00141297|75966925|FG008|Overall Study|Adverse Event|1|||
42158917|NCT00141297|75966926|FG009|Overall Study|Adverse Event|0|||
42158918|NCT00141297|75966917|FG000|Overall Study|Death|1|||
42158919|NCT00141297|75966918|FG001|Overall Study|Death|0|||
42158920|NCT00141297|75966919|FG002|Overall Study|Death|0|||
42158921|NCT00141297|75966920|FG003|Overall Study|Death|0|||
42158922|NCT00141297|75966921|FG004|Overall Study|Death|0|||
42158923|NCT00141297|75966922|FG005|Overall Study|Death|0|||
42158924|NCT00141297|75966923|FG006|Overall Study|Death|0|||
42158925|NCT00141297|75966924|FG007|Overall Study|Death|0|||
42158926|NCT00141297|75966925|FG008|Overall Study|Death|1|||
42158927|NCT00141297|75966926|FG009|Overall Study|Death|0|||
42158928|NCT00141297|75966917|FG000|Overall Study|Withdrawal by Subject|0|||
42158929|NCT00141297|75966918|FG001|Overall Study|Withdrawal by Subject|0|||
42158930|NCT00141297|75966919|FG002|Overall Study|Withdrawal by Subject|0|||
42158931|NCT00141297|75966920|FG003|Overall Study|Withdrawal by Subject|0|||
42158932|NCT00141297|75966921|FG004|Overall Study|Withdrawal by Subject|0|||
42158933|NCT00141297|75966922|FG005|Overall Study|Withdrawal by Subject|0|||
42158934|NCT00141297|75966923|FG006|Overall Study|Withdrawal by Subject|0|||
42158935|NCT00141297|75966924|FG007|Overall Study|Withdrawal by Subject|0|||
42158936|NCT00141297|75966925|FG008|Overall Study|Withdrawal by Subject|1|||
42158937|NCT00141297|75966926|FG009|Overall Study|Withdrawal by Subject|0|||
42158938|NCT00141297|75966917|FG000|Overall Study|Other|0|||
42158939|NCT00141297|75966918|FG001|Overall Study|Other|0|||
42158940|NCT00141297|75966919|FG002|Overall Study|Other|0|||
42158941|NCT00141297|75966920|FG003|Overall Study|Other|1|||
42158942|NCT00141297|75966921|FG004|Overall Study|Other|5|||
42158943|NCT00141297|75966922|FG005|Overall Study|Other|0|||
42158944|NCT00141297|75966923|FG006|Overall Study|Other|0|||
42158945|NCT00141297|75966924|FG007|Overall Study|Other|0|||
42158946|NCT00141297|75966925|FG008|Overall Study|Other|2|||
42158947|NCT00141297|75966926|FG009|Overall Study|Other|0|||
42158948|NCT00141297|75966917|FG000|Overall Study|Progressive Disease|2|||
42158949|NCT00141297|75966918|FG001|Overall Study|Progressive Disease|3|||
42279798|NCT02647281|76111584|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
42279799|NCT02647281|76111585|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
42279800|NCT02647281|76111586|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
42279801|NCT02647281|76111587|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
42279802|NCT02647281|76111588|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
42013463|NCT00998296|75820553|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
42013464|NCT00998296|75820554|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
42013465|NCT00998296|75820555|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
42013466|NCT00998296|75820556|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
42013467|NCT00998296|75820557|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
42013468|NCT00998296|75820558|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
42158950|NCT00141297|75966919|FG002|Overall Study|Progressive Disease|6|||
42158951|NCT00141297|75966920|FG003|Overall Study|Progressive Disease|2|||
42158952|NCT00141297|75966921|FG004|Overall Study|Progressive Disease|15|||
42158953|NCT00141297|75966922|FG005|Overall Study|Progressive Disease|2|||
42158954|NCT00141297|75966923|FG006|Overall Study|Progressive Disease|3|||
42158955|NCT00141297|75966924|FG007|Overall Study|Progressive Disease|3|||
42158956|NCT00141297|75966925|FG008|Overall Study|Progressive Disease|15|||
42158957|NCT00141297|75966926|FG009|Overall Study|Progressive Disease|6|||
42158958|NCT00141297|75966917|FG000|Overall Study|Transitioned|0|||
42158959|NCT00141297|75966918|FG001|Overall Study|Transitioned|0|||
42158960|NCT00141297|75966919|FG002|Overall Study|Transitioned|0|||
42158961|NCT00141297|75966920|FG003|Overall Study|Transitioned|0|||
42158962|NCT00141297|75966921|FG004|Overall Study|Transitioned|1|||
42158963|NCT00141297|75966922|FG005|Overall Study|Transitioned|0|||
42158964|NCT00141297|75966923|FG006|Overall Study|Transitioned|0|||
42158965|NCT00141297|75966924|FG007|Overall Study|Transitioned|0|||
42158966|NCT00141297|75966925|FG008|Overall Study|Transitioned|0|||
42013469|NCT00998296|75820559|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
42013470|NCT00998296|75820560|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
42013471|NCT00998296|75820550|FG000|Overall Study|Other adverse event|0|||
42013472|NCT00998296|75820551|FG001|Overall Study|Other adverse event|0|||
42158967|NCT00141297|75966926|FG009|Overall Study|Transitioned|0|||
42158968|NCT00141219|75966961|FG000|Overall Study|Protocol violations|5|||
42158969|NCT00141219|75966962|FG001|Overall Study|Protocol violations|4|||
42158970|NCT00141219|75966961|FG000|Overall Study|Adverse Event|8|||
42158971|NCT00141219|75966962|FG001|Overall Study|Adverse Event|6|||
42158972|NCT00141219|75966961|FG000|Overall Study|Lack of Efficacy|5|||
42158973|NCT00141219|75966962|FG001|Overall Study|Lack of Efficacy|4|||
42158974|NCT00141219|75966961|FG000|Overall Study|Withdrawal by Subject|6|||
42158975|NCT00141219|75966962|FG001|Overall Study|Withdrawal by Subject|2|||
42158976|NCT00162266|75966971|FG000|Double-Blind Period|Adverse Event|5|||
42158977|NCT00162266|75966972|FG001|Double-Blind Period|Adverse Event|9|||
42158978|NCT00162266|75966973|FG002|Double-Blind Period|Adverse Event|11|||
42158979|NCT00162266|75966974|FG003|Double-Blind Period|Adverse Event|0|||
42158980|NCT00162266|75966971|FG000|Double-Blind Period|Death|0|||
42158981|NCT00162266|75966972|FG001|Double-Blind Period|Death|1|||
42158982|NCT00162266|75966973|FG002|Double-Blind Period|Death|0|||
42158983|NCT00162266|75966974|FG003|Double-Blind Period|Death|0|||
42158984|NCT00162266|75966971|FG000|Double-Blind Period|Lost to Follow-up|1|||
42158985|NCT00162266|75966972|FG001|Double-Blind Period|Lost to Follow-up|2|||
42158986|NCT00162266|75966973|FG002|Double-Blind Period|Lost to Follow-up|0|||
42158987|NCT00162266|75966974|FG003|Double-Blind Period|Lost to Follow-up|0|||
42158988|NCT00162266|75966971|FG000|Double-Blind Period|Other Reason|1|||
42158989|NCT00162266|75966972|FG001|Double-Blind Period|Other Reason|0|||
42158990|NCT00162266|75966973|FG002|Double-Blind Period|Other Reason|1|||
42158991|NCT00162266|75966974|FG003|Double-Blind Period|Other Reason|0|||
42158992|NCT00162266|75966971|FG000|Double-Blind Period|Lack of Efficacy|13|||
42158993|NCT00162266|75966972|FG001|Double-Blind Period|Lack of Efficacy|17|||
42158994|NCT00162266|75966973|FG002|Double-Blind Period|Lack of Efficacy|30|||
42158995|NCT00162266|75966974|FG003|Double-Blind Period|Lack of Efficacy|0|||
42158996|NCT00162266|75966971|FG000|Double-Blind Period|Withdrawal by Subject|5|||
42158997|NCT00162266|75966972|FG001|Double-Blind Period|Withdrawal by Subject|2|||
42158998|NCT00162266|75966973|FG002|Double-Blind Period|Withdrawal by Subject|6|||
42158999|NCT00162266|75966974|FG003|Double-Blind Period|Withdrawal by Subject|0|||
42159000|NCT00162266|75966971|FG000|Open-Label Period|Death|0|||
42159001|NCT00162266|75966972|FG001|Open-Label Period|Death|0|||
42159002|NCT00162266|75966973|FG002|Open-Label Period|Death|0|||
42159003|NCT00162266|75966974|FG003|Open-Label Period|Death|7|||
42159004|NCT00162266|75966971|FG000|Open-Label Period|Adverse Event|0|||
42159005|NCT00162266|75966972|FG001|Open-Label Period|Adverse Event|0|||
42159006|NCT00162266|75966973|FG002|Open-Label Period|Adverse Event|0|||
42159007|NCT00162266|75966974|FG003|Open-Label Period|Adverse Event|46|||
42159008|NCT00162266|75966971|FG000|Open-Label Period|Lack of Efficacy|0|||
42159009|NCT00162266|75966972|FG001|Open-Label Period|Lack of Efficacy|0|||
42159010|NCT00162266|75966973|FG002|Open-Label Period|Lack of Efficacy|0|||
42159011|NCT00162266|75966974|FG003|Open-Label Period|Lack of Efficacy|26|||
42159012|NCT00162266|75966971|FG000|Open-Label Period|Lost to Follow-up|0|||
42159013|NCT00162266|75966972|FG001|Open-Label Period|Lost to Follow-up|0|||
42159014|NCT00162266|75966973|FG002|Open-Label Period|Lost to Follow-up|0|||
42159015|NCT00162266|75966974|FG003|Open-Label Period|Lost to Follow-up|3|||
42159016|NCT00162266|75966971|FG000|Open-Label Period|Withdrawal by Subject|0|||
42159017|NCT00162266|75966972|FG001|Open-Label Period|Withdrawal by Subject|0|||
42159018|NCT00162266|75966973|FG002|Open-Label Period|Withdrawal by Subject|0|||
42159019|NCT00162266|75966974|FG003|Open-Label Period|Withdrawal by Subject|31|||
42159020|NCT00162266|75966971|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
42159021|NCT00162266|75966972|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
42159022|NCT00162266|75966973|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
42159023|NCT00162266|75966974|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
42159024|NCT00162266|75966971|FG000|Open-Label Period|Other Reasons|0|||
42013473|NCT00998296|75820552|FG002|Overall Study|Other adverse event|0|||
42013474|NCT00998296|75820553|FG003|Overall Study|Other adverse event|0|||
42159025|NCT00162266|75966972|FG001|Open-Label Period|Other Reasons|0|||
42159026|NCT00162266|75966973|FG002|Open-Label Period|Other Reasons|0|||
42159027|NCT00162266|75966974|FG003|Open-Label Period|Other Reasons|15|||
42159028|NCT00225212|75967026|FG000|Overall Study|Disease progression|2|||
42159029|NCT00225212|75967026|FG000|Overall Study|Death|1|||
42159030|NCT00225212|75967026|FG000|Overall Study|Adverse Event|2|||
42159031|NCT00225212|75967026|FG000|Overall Study|Intercurrent illness|1|||
42159032|NCT00162032|75967032|FG000|Overall Study|Lost to Follow-up|4|||
42159033|NCT00162032|75967033|FG001|Overall Study|Lost to Follow-up|2|||
42159034|NCT00162032|75967032|FG000|Overall Study|Reason not specified|1|||
42159035|NCT00162032|75967033|FG001|Overall Study|Reason not specified|0|||
42159036|NCT00258674|75967047|FG000|Overall Study|Death|32|||
42013475|NCT00998296|75820554|FG004|Overall Study|Other adverse event|1|||
42159037|NCT00258674|75967048|FG001|Overall Study|Death|53|||
42159038|NCT00258674|75967049|FG002|Overall Study|Death|34|||
42159039|NCT00258440|75967060|FG000|Overall Study|Withdrawal by Subject|0|||
42159040|NCT00258440|75967061|FG001|Overall Study|Withdrawal by Subject|0|||
42159041|NCT00258440|75967062|FG002|Overall Study|Withdrawal by Subject|1|||
42159042|NCT00224120|75967072|FG000|Overall Study|Adverse Event|10|||
42159043|NCT00224120|75967073|FG001|Overall Study|Adverse Event|4|||
42159044|NCT00224120|75967072|FG000|Overall Study|Protocol Violation|1|||
42159045|NCT00224120|75967073|FG001|Overall Study|Protocol Violation|0|||
42159046|NCT00224120|75967072|FG000|Overall Study|Withdrawal by Subject|5|||
42159047|NCT00224120|75967073|FG001|Overall Study|Withdrawal by Subject|10|||
42159048|NCT00224120|75967072|FG000|Overall Study|Lack of Efficacy|0|||
42159049|NCT00224120|75967073|FG001|Overall Study|Lack of Efficacy|2|||
42159050|NCT00224120|75967072|FG000|Overall Study|Lost to Follow-up|2|||
42159051|NCT00224120|75967073|FG001|Overall Study|Lost to Follow-up|3|||
42159052|NCT00224120|75967072|FG000|Overall Study|Other|4|||
42159053|NCT00224120|75967073|FG001|Overall Study|Other|5|||
42159054|NCT00257660|75967081|FG000|Overall Study|Lack of Efficacy|5|||
42159055|NCT00257660|75967082|FG001|Overall Study|Lack of Efficacy|23|||
42159056|NCT00257660|75967081|FG000|Overall Study|Withdrawal by Subject|2|||
42159057|NCT00257660|75967082|FG001|Overall Study|Withdrawal by Subject|0|||
42159058|NCT00257660|75967081|FG000|Overall Study|Lost to Follow-up|1|||
42159059|NCT00257660|75967082|FG001|Overall Study|Lost to Follow-up|0|||
42159060|NCT00257660|75967081|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
42159061|NCT00257660|75967082|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
42159062|NCT00257660|75967081|FG000|Overall Study|No longer wanted to do blood draws|1|||
42159063|NCT00257660|75967082|FG001|Overall Study|No longer wanted to do blood draws|0|||
42159064|NCT00224042|75967090|FG000|Overall Study|Adverse Event|2|||
42159065|NCT00224042|75967091|FG001|Overall Study|Adverse Event|1|||
42159066|NCT00224042|75967090|FG000|Overall Study|Protocol Violation|0|||
42159067|NCT00224042|75967091|FG001|Overall Study|Protocol Violation|1|||
42159068|NCT00224042|75967090|FG000|Overall Study|Physician Decision|0|||
42159069|NCT00224042|75967091|FG001|Overall Study|Physician Decision|1|||
42159070|NCT00224042|75967090|FG000|Overall Study|Did not meet lab incusion criteria|2|||
42159071|NCT00224042|75967091|FG001|Overall Study|Did not meet lab incusion criteria|3|||
42159072|NCT00224042|75967090|FG000|Overall Study|Other|2|||
42159073|NCT00224042|75967091|FG001|Overall Study|Other|0|||
42159074|NCT00160706|75967097|FG000|Overall Study|Adverse Event|53|||
42159075|NCT00160706|75967097|FG000|Overall Study|Adverse Event and Other Reason|105|||
42159076|NCT00160706|75967097|FG000|Overall Study|Protocol Violation|3|||
42159077|NCT00160706|75967097|FG000|Overall Study|Withdrawal by Subject|41|||
42159078|NCT00160706|75967097|FG000|Overall Study|Withdrawal by Subject and Other|12|||
42159079|NCT00160706|75967097|FG000|Overall Study|Physician Decision|10|||
42159080|NCT00160706|75967097|FG000|Overall Study|Physician Decision and Other|3|||
42159081|NCT00160706|75967097|FG000|Overall Study|Lost to Follow-up|4|||
42159082|NCT00160706|75967097|FG000|Overall Study|Lost to Follow-up and Other|1|||
42159083|NCT00160706|75967097|FG000|Overall Study|Lack of Efficacy|42|||
42159084|NCT00160706|75967097|FG000|Overall Study|Lack of Efficacy and Other|1|||
42159085|NCT00160706|75967097|FG000|Overall Study|Other Reason|11|||
42159086|NCT00257192|75967103|FG000|Overall Study|Adverse Event|21|||
42159087|NCT00257192|75967104|FG001|Overall Study|Adverse Event|10|||
42159088|NCT00257192|75967103|FG000|Overall Study|Laboratory abnormality|1|||
42159089|NCT00257192|75967104|FG001|Overall Study|Laboratory abnormality|1|||
42159090|NCT00257192|75967103|FG000|Overall Study|Lost to Follow-up|3|||
42159091|NCT00257192|75967104|FG001|Overall Study|Lost to Follow-up|3|||
42159092|NCT00257192|75967103|FG000|Overall Study|Insufficient clinical response|18|||
42159093|NCT00257192|75967104|FG001|Overall Study|Insufficient clinical response|18|||
42159094|NCT00257192|75967103|FG000|Overall Study|Withdrawal by Subject|14|||
42159095|NCT00257192|75967104|FG001|Overall Study|Withdrawal by Subject|2|||
42159096|NCT00257192|75967103|FG000|Overall Study|Randomized but not treated|0|||
42159097|NCT00257192|75967104|FG001|Overall Study|Randomized but not treated|1|||
42159098|NCT00257192|75967103|FG000|Overall Study|Study terminated by sponsor|1|||
42159099|NCT00257192|75967104|FG001|Overall Study|Study terminated by sponsor|0|||
42159100|NCT00257192|75967103|FG000|Overall Study|Miscellaneous|0|||
42159101|NCT00257192|75967104|FG001|Overall Study|Miscellaneous|4|||
42159102|NCT00256724|75967112|FG000|Overall Study|Physician Decision|2|||
42159103|NCT00256724|75967113|FG001|Overall Study|Physician Decision|5|||
42159104|NCT00256724|75967112|FG000|Overall Study|Protocol Violation|3|||
42159105|NCT00256724|75967113|FG001|Overall Study|Protocol Violation|3|||
42159106|NCT00157820|75967122|FG000|Randomized|Physician Decision|4|||
42159107|NCT00157820|75967123|FG001|Randomized|Physician Decision|2|||
42159108|NCT00157820|75967124|FG002|Randomized|Physician Decision|3|||
42159109|NCT00157820|75967122|FG000|Randomized|Withdrawal by Subject|1|||
42159110|NCT00157820|75967123|FG001|Randomized|Withdrawal by Subject|2|||
42159111|NCT00157820|75967124|FG002|Randomized|Withdrawal by Subject|3|||
42159112|NCT00157820|75967122|FG000|Randomized|Protocol Violation|2|||
42159113|NCT00157820|75967123|FG001|Randomized|Protocol Violation|1|||
42159114|NCT00157820|75967124|FG002|Randomized|Protocol Violation|2|||
42159115|NCT00157820|75967122|FG000|1st 8 Month|Death|7|||
42159116|NCT00157820|75967123|FG001|1st 8 Month|Death|8|||
42159117|NCT00157820|75967124|FG002|1st 8 Month|Death|3|||
42159118|NCT00157820|75967122|FG000|1st 8 Month|Lost to Follow-up|1|||
42159119|NCT00157820|75967123|FG001|1st 8 Month|Lost to Follow-up|2|||
42159120|NCT00157820|75967124|FG002|1st 8 Month|Lost to Follow-up|1|||
42159121|NCT00157820|75967122|FG000|1st 8 Month|Premature cross-over|0|||
42159122|NCT00157820|75967123|FG001|1st 8 Month|Premature cross-over|2|||
42159123|NCT00157820|75967124|FG002|1st 8 Month|Premature cross-over|2|||
42159124|NCT00157820|75967122|FG000|2nd 8 Months|Death|3|||
42159125|NCT00157820|75967123|FG001|2nd 8 Months|Death|1|||
42159126|NCT00157820|75967124|FG002|2nd 8 Months|Death|3|||
42159127|NCT00157820|75967122|FG000|2nd 8 Months|Lost to Follow-up|1|||
42159128|NCT00157820|75967123|FG001|2nd 8 Months|Lost to Follow-up|5|||
42159129|NCT00157820|75967124|FG002|2nd 8 Months|Lost to Follow-up|2|||
42159130|NCT00157820|75967122|FG000|2nd 8 Months|Premature cross-over|1|||
42159131|NCT00157820|75967123|FG001|2nd 8 Months|Premature cross-over|7|||
42159132|NCT00157820|75967124|FG002|2nd 8 Months|Premature cross-over|9|||
42159133|NCT00223808|75967136|FG000|Overall Study|<5 hrs therapy before discharge|3|||
42159134|NCT00223808|75967137|FG001|Overall Study|<5 hrs therapy before discharge|5|||
42159135|NCT00223808|75967138|FG002|Overall Study|<5 hrs therapy before discharge|5|||
42159136|NCT00154310|75967148|FG000|Overall Study|Adverse Event|19|||
42159137|NCT00154310|75967149|FG001|Overall Study|Adverse Event|9|||
42159138|NCT00154310|75967148|FG000|Overall Study|Lack of Efficacy|5|||
42159139|NCT00154310|75967149|FG001|Overall Study|Lack of Efficacy|4|||
42159140|NCT00154310|75967148|FG000|Overall Study|Protocol Violation|4|||
42159141|NCT00154310|75967149|FG001|Overall Study|Protocol Violation|2|||
42159142|NCT00154310|75967148|FG000|Overall Study|Withdrawal by Subject|9|||
42159143|NCT00154310|75967149|FG001|Overall Study|Withdrawal by Subject|3|||
42159144|NCT00154310|75967148|FG000|Overall Study|Lost to Follow-up|0|||
42159145|NCT00154310|75967149|FG001|Overall Study|Lost to Follow-up|8|||
42159146|NCT00154310|75967148|FG000|Overall Study|Administrative problems|0|||
42159147|NCT00154310|75967149|FG001|Overall Study|Administrative problems|1|||
42159148|NCT00154310|75967148|FG000|Overall Study|Death|0|||
42159149|NCT00154310|75967149|FG001|Overall Study|Death|1|||
42159150|NCT03771352|75967155|FG000|Overall Study|Screen failure|2|||
42159151|NCT03771352|75967155|FG000|Overall Study|Withdrawal by Subject|2|||
42159152|NCT03770728|75967163|FG000|Overall Study|Adverse Event|1|||
42159153|NCT03770728|75967164|FG001|Overall Study|Adverse Event|0|||
42159154|NCT03770728|75967165|FG002|Overall Study|Adverse Event|1|||
42159155|NCT03770728|75967166|FG003|Overall Study|Adverse Event|0|||
42159156|NCT03770728|75967163|FG000|Overall Study|Poor compliance to protocol|0|||
42159157|NCT03770728|75967164|FG001|Overall Study|Poor compliance to protocol|0|||
42159158|NCT03770728|75967165|FG002|Overall Study|Poor compliance to protocol|1|||
42159159|NCT03770728|75967166|FG003|Overall Study|Poor compliance to protocol|0|||
42159160|NCT03770728|75967163|FG000|Overall Study|Withdrawal by Subject|13|||
42159161|NCT03770728|75967164|FG001|Overall Study|Withdrawal by Subject|8|||
42159162|NCT03770728|75967165|FG002|Overall Study|Withdrawal by Subject|9|||
42159163|NCT03770728|75967166|FG003|Overall Study|Withdrawal by Subject|13|||
42159164|NCT03770728|75967163|FG000|Overall Study|Other than specified|24|||
42159165|NCT03770728|75967164|FG001|Overall Study|Other than specified|23|||
42159166|NCT03770728|75967165|FG002|Overall Study|Other than specified|21|||
42159167|NCT03770728|75967166|FG003|Overall Study|Other than specified|22|||
42159168|NCT03769090|75967181|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
42159169|NCT03769090|75967182|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
42159170|NCT03769090|75967183|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
42159171|NCT03769090|75967181|FG000|Overall Study|Withdrawal by Subject|52|||
42159172|NCT03769090|75967182|FG001|Overall Study|Withdrawal by Subject|62|||
42159173|NCT03769090|75967183|FG002|Overall Study|Withdrawal by Subject|74|||
42159174|NCT03769090|75967181|FG000|Overall Study|Death|4|||
42013476|NCT00998296|75820555|FG005|Overall Study|Other adverse event|0|||
42013477|NCT00998296|75820556|FG006|Overall Study|Other adverse event|0|||
42013478|NCT00998296|75820557|FG007|Overall Study|Other adverse event|0|||
42013479|NCT00998296|75820558|FG008|Overall Study|Other adverse event|0|||
42159175|NCT03769090|75967182|FG001|Overall Study|Death|2|||
42159176|NCT03769090|75967183|FG002|Overall Study|Death|2|||
42159177|NCT03769090|75967181|FG000|Overall Study|Adverse Event|7|||
42159178|NCT03769090|75967182|FG001|Overall Study|Adverse Event|7|||
42159179|NCT03769090|75967183|FG002|Overall Study|Adverse Event|8|||
42159180|NCT03769090|75967181|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
42159181|NCT03769090|75967182|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
42159182|NCT03769090|75967183|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
42159183|NCT03769090|75967181|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
42159184|NCT03769090|75967182|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
42159185|NCT03769090|75967183|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
42159186|NCT03769090|75967181|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
42159187|NCT03769090|75967182|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
42159188|NCT03769090|75967183|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
42159189|NCT03769090|75967181|FG000|Overall Study|Protocol Violation|5|||
42159190|NCT03769090|75967182|FG001|Overall Study|Protocol Violation|6|||
42159191|NCT03769090|75967183|FG002|Overall Study|Protocol Violation|8|||
42159192|NCT03769090|75967181|FG000|Overall Study|Pregnancy|1|||
42159193|NCT03769090|75967182|FG001|Overall Study|Pregnancy|0|||
42159194|NCT03769090|75967183|FG002|Overall Study|Pregnancy|3|||
42159195|NCT03769090|75967181|FG000|Overall Study|Lost to Follow-up|19|||
42159196|NCT03769090|75967182|FG001|Overall Study|Lost to Follow-up|25|||
42159197|NCT03769090|75967183|FG002|Overall Study|Lost to Follow-up|21|||
42159198|NCT03769090|75967181|FG000|Overall Study|Condition under investigation worsened|2|||
42159199|NCT03769090|75967182|FG001|Overall Study|Condition under investigation worsened|0|||
42159200|NCT03769090|75967183|FG002|Overall Study|Condition under investigation worsened|1|||
42159201|NCT03769090|75967181|FG000|Overall Study|Lack of Efficacy|1|||
42159202|NCT03769090|75967182|FG001|Overall Study|Lack of Efficacy|2|||
42159203|NCT03769090|75967183|FG002|Overall Study|Lack of Efficacy|2|||
42159204|NCT03769090|75967181|FG000|Overall Study|Other reasons|8|||
42159205|NCT03769090|75967182|FG001|Overall Study|Other reasons|12|||
42159206|NCT03769090|75967183|FG002|Overall Study|Other reasons|15|||
42159207|NCT03559270|75967207|FG000|Overall Study|Adverse Event|6|||
42159208|NCT03559270|75967208|FG001|Overall Study|Adverse Event|5|||
42159209|NCT03559270|75967209|FG002|Overall Study|Adverse Event|3|||
42159210|NCT03559270|75967210|FG003|Overall Study|Adverse Event|0|||
42159211|NCT03559270|75967207|FG000|Overall Study|Lack of Efficacy|34|||
42159212|NCT03559270|75967208|FG001|Overall Study|Lack of Efficacy|52|||
42159213|NCT03559270|75967209|FG002|Overall Study|Lack of Efficacy|37|||
42159214|NCT03559270|75967210|FG003|Overall Study|Lack of Efficacy|2|||
42159215|NCT03559270|75967207|FG000|Overall Study|Death|0|||
42159216|NCT03559270|75967208|FG001|Overall Study|Death|2|||
42159217|NCT03559270|75967209|FG002|Overall Study|Death|0|||
42159218|NCT03559270|75967210|FG003|Overall Study|Death|0|||
42159219|NCT03559270|75967207|FG000|Overall Study|Lost to Follow-up|16|||
42159220|NCT03559270|75967208|FG001|Overall Study|Lost to Follow-up|4|||
42159221|NCT03559270|75967209|FG002|Overall Study|Lost to Follow-up|12|||
42159222|NCT03559270|75967210|FG003|Overall Study|Lost to Follow-up|3|||
42159223|NCT03559270|75967207|FG000|Overall Study|Sponsor Decision|38|||
42159224|NCT03559270|75967208|FG001|Overall Study|Sponsor Decision|31|||
42159225|NCT03559270|75967209|FG002|Overall Study|Sponsor Decision|35|||
42159226|NCT03559270|75967210|FG003|Overall Study|Sponsor Decision|18|||
42159227|NCT03559270|75967207|FG000|Overall Study|Withdrawal by Subject|19|||
42159228|NCT03559270|75967208|FG001|Overall Study|Withdrawal by Subject|21|||
42159229|NCT03559270|75967209|FG002|Overall Study|Withdrawal by Subject|18|||
42159230|NCT03559270|75967210|FG003|Overall Study|Withdrawal by Subject|7|||
42159231|NCT03559270|75967207|FG000|Overall Study|Physician Decision|3|||
42159232|NCT03559270|75967208|FG001|Overall Study|Physician Decision|2|||
42159233|NCT03559270|75967209|FG002|Overall Study|Physician Decision|1|||
42159234|NCT03559270|75967210|FG003|Overall Study|Physician Decision|0|||
42159235|NCT03559270|75967207|FG000|Overall Study|Pregnancy|0|||
42159236|NCT03559270|75967208|FG001|Overall Study|Pregnancy|1|||
42159237|NCT03559270|75967209|FG002|Overall Study|Pregnancy|0|||
42159238|NCT03559270|75967210|FG003|Overall Study|Pregnancy|0|||
42159239|NCT03559270|75967207|FG000|Overall Study|Protocol Violation|1|||
42159240|NCT03559270|75967208|FG001|Overall Study|Protocol Violation|0|||
42159241|NCT03559270|75967209|FG002|Overall Study|Protocol Violation|2|||
42159242|NCT03559270|75967210|FG003|Overall Study|Protocol Violation|0|||
42159243|NCT00114777|75967265|FG000|Randomization to Month 36|Death|10|||
42159244|NCT00114777|75967266|FG001|Randomization to Month 36|Death|4|||
42159245|NCT00114777|75967267|FG002|Randomization to Month 36|Death|3|||
42279803|NCT02729545|76111619|FG000|Overall Study|Pregnancy|1|||
42279804|NCT02729545|76111620|FG001|Overall Study|Pregnancy|1|||
42279805|NCT02729545|76111619|FG000|Overall Study|Lost to Follow-up|0|||
42279806|NCT02729545|76111620|FG001|Overall Study|Lost to Follow-up|1|||
42159246|NCT00114777|75967265|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
42159247|NCT00114777|75967266|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
42159248|NCT00114777|75967267|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
42159249|NCT00114777|75967265|FG000|Randomization to Month 36|Lack of Efficacy|19|||
42159250|NCT00114777|75967266|FG001|Randomization to Month 36|Lack of Efficacy|15|||
42159251|NCT00114777|75967267|FG002|Randomization to Month 36|Lack of Efficacy|17|||
42159252|NCT00114777|75967265|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
42159253|NCT00114777|75967266|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
42159254|NCT00114777|75967267|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
42159255|NCT00114777|75967265|FG000|Randomization to Month 36|Adverse Event|34|||
42159256|NCT00114777|75967266|FG001|Randomization to Month 36|Adverse Event|35|||
42159257|NCT00114777|75967267|FG002|Randomization to Month 36|Adverse Event|44|||
42159258|NCT00114777|75967265|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
42159259|NCT00114777|75967266|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
42279807|NCT02729545|76111619|FG000|Overall Study|Withdrawal by Subject|2|||
42279808|NCT02729545|76111620|FG001|Overall Study|Withdrawal by Subject|3|||
42159260|NCT00114777|75967267|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
42159261|NCT00114777|75967265|FG000|Randomization to Month 36|Other|9|||
42159262|NCT00114777|75967266|FG001|Randomization to Month 36|Other|3|||
42159263|NCT00114777|75967267|FG002|Randomization to Month 36|Other|12|||
42159264|NCT00114777|75967265|FG000|Long-Term Extension to Month 84|Death|8|||
42159265|NCT00114777|75967266|FG001|Long-Term Extension to Month 84|Death|13|||
42159266|NCT00114777|75967267|FG002|Long-Term Extension to Month 84|Death|7|||
42159267|NCT00114777|75967265|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
42159268|NCT00114777|75967266|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
42159269|NCT00114777|75967267|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
42159270|NCT00114777|75967265|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
42159271|NCT00114777|75967266|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
42159272|NCT00114777|75967267|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
42159273|NCT00114777|75967265|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
42159274|NCT00114777|75967266|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
42159275|NCT00114777|75967267|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
42159276|NCT00114777|75967265|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
42159277|NCT00114777|75967266|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
42159278|NCT00114777|75967267|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
42159279|NCT00114777|75967265|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
42159280|NCT00114777|75967266|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
42159281|NCT00114777|75967267|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
42159282|NCT00114777|75967265|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
42159283|NCT00114777|75967266|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
42159284|NCT00114777|75967267|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
42159285|NCT00114777|75967265|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
42159286|NCT00114777|75967266|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
42159287|NCT00114777|75967267|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
42159288|NCT00114777|75967265|FG000|Long-Term Extension to Month 84|Other|2|||
42159289|NCT00114777|75967266|FG001|Long-Term Extension to Month 84|Other|0|||
42159290|NCT00114777|75967267|FG002|Long-Term Extension to Month 84|Other|2|||
42159291|NCT00139737|75967276|FG000|Overall Study|Withdrawal by Subject|190|||
42159292|NCT00139737|75967276|FG000|Overall Study|Adverse Event|58|||
42159293|NCT00139737|75967276|FG000|Overall Study|Lack of Efficacy|40|||
42159294|NCT00139737|75967276|FG000|Overall Study|Lost to Follow-up|8|||
42159295|NCT00139737|75967276|FG000|Overall Study|Death|3|||
42159296|NCT00139737|75967276|FG000|Overall Study|Laboratory Abnormality|2|||
42159297|NCT00139737|75967276|FG000|Overall Study|Protocol Violation|18|||
42159298|NCT00139737|75967276|FG000|Overall Study|Withdrew During Screening Phase|8|||
42159299|NCT00139737|75967276|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
42159300|NCT00139737|75967276|FG000|Overall Study|Screened, Not Treated|13|||
42159301|NCT00122187|75967282|FG000|Overall Study|Withdrew because of resource limitations|2|||
42159302|NCT00122187|75967283|FG001|Overall Study|Withdrew because of resource limitations|2|||
42159303|NCT00139659|75967293|FG000|Overall Study|Adverse Event|12|||
42159304|NCT00139659|75967294|FG001|Overall Study|Adverse Event|1|||
42159305|NCT00139659|75967293|FG000|Overall Study|Lack of Efficacy|1|||
42159306|NCT00139659|75967294|FG001|Overall Study|Lack of Efficacy|1|||
42159307|NCT00139659|75967293|FG000|Overall Study|Lost to Follow-up|7|||
42159308|NCT00139659|75967294|FG001|Overall Study|Lost to Follow-up|3|||
42159309|NCT00139659|75967293|FG000|Overall Study|Reason not Specified|6|||
42159310|NCT00139659|75967294|FG001|Overall Study|Reason not Specified|3|||
42159311|NCT00139659|75967293|FG000|Overall Study|Withdrawal by Subject|14|||
42279809|NCT01376089|76111628|FG000|Overall Study|Patient received no contrast media|3|||
42279810|NCT01376089|76111629|FG001|Overall Study|Patient received no contrast media|4|||
42279811|NCT00706849|76111641|FG000|Treatment Period|Adverse Event|0|||
42279812|NCT00706849|76111642|FG001|Treatment Period|Adverse Event|9|||
42279813|NCT00706849|76111641|FG000|Treatment Period|Other|0|||
42279814|NCT00706849|76111642|FG001|Treatment Period|Other|1|||
42279815|NCT00706849|76111641|FG000|Follow-up Period|Withdrawal by Subject|0|||
42279816|NCT00706849|76111642|FG001|Follow-up Period|Withdrawal by Subject|2|||
42279817|NCT00706849|76111641|FG000|Follow-up Period|Protocol non-compliance|0|||
42279818|NCT00706849|76111642|FG001|Follow-up Period|Protocol non-compliance|1|||
42159312|NCT00139659|75967294|FG001|Overall Study|Withdrawal by Subject|10|||
42159313|NCT00137631|75967306|FG000|Overall Study|Lost to Follow-up|37|||
42159314|NCT00137631|75967307|FG001|Overall Study|Lost to Follow-up|41|||
42159315|NCT00114231|75967315|FG000|Overall Study|No consent|2|||
42159316|NCT00114231|75967316|FG001|Overall Study|No consent|0|||
42159317|NCT00114231|75967315|FG000|Overall Study|QARC requirement not met|1|||
42159318|NCT00114231|75967316|FG001|Overall Study|QARC requirement not met|0|||
42159319|NCT00114231|75967315|FG000|Overall Study|Suspected metastatic disease|1|||
42159320|NCT00114231|75967316|FG001|Overall Study|Suspected metastatic disease|0|||
42159321|NCT00114231|75967315|FG000|Overall Study|No adenocarcinoma|1|||
42159322|NCT00114231|75967316|FG001|Overall Study|No adenocarcinoma|0|||
42279819|NCT00707161|76111648|FG000|Overall Study|Physician Decision|6|||
42159323|NCT00114231|75967315|FG000|Overall Study|Low creatinine clearance|0|||
42159324|NCT00114231|75967316|FG001|Overall Study|Low creatinine clearance|1|||
42279820|NCT02130466|76111666|FG000|Overall Study|Death|4|||
42279821|NCT02130466|76111667|FG001|Overall Study|Death|1|||
42279822|NCT02130466|76111668|FG002|Overall Study|Death|1|||
42279823|NCT02130466|76111669|FG003|Overall Study|Death|3|||
42279824|NCT02130466|76111670|FG004|Overall Study|Death|2|||
42279825|NCT02130466|76111671|FG005|Overall Study|Death|30|||
42279826|NCT02130466|76111672|FG006|Overall Study|Death|45|||
42279827|NCT02130466|76111673|FG007|Overall Study|Death|2|||
42159325|NCT00114231|75967315|FG000|Overall Study|Tumor size > 4cm|1|||
42159326|NCT00114231|75967316|FG001|Overall Study|Tumor size > 4cm|0|||
42159327|NCT00114231|75967315|FG000|Overall Study|Tumor fixed on digital exam|0|||
42159328|NCT00114231|75967316|FG001|Overall Study|Tumor fixed on digital exam|1|||
42159329|NCT00114231|75967315|FG000|Overall Study|No Absolute Neutrophil Count|2|||
42159330|NCT00114231|75967316|FG001|Overall Study|No Absolute Neutrophil Count|0|||
42159331|NCT00114231|75967315|FG000|Overall Study|Biopsy done after registration|1|||
42159332|NCT00114231|75967316|FG001|Overall Study|Biopsy done after registration|0|||
42159333|NCT00113919|75967321|FG000|Overall Study|Physician Decision|8|||
42159334|NCT00113919|75967321|FG000|Overall Study|Death|6|||
42159335|NCT00113841|75967327|FG000|Overall Study|Disease progression|0|||
42159336|NCT00113841|75967328|FG001|Overall Study|Disease progression|2|||
42159337|NCT00113841|75967327|FG000|Overall Study|Non-compliant|1|||
42159338|NCT00113841|75967328|FG001|Overall Study|Non-compliant|0|||
42159339|NCT00113607|75967336|FG000|Overall Study|Adverse Event|40|||
42159340|NCT00113607|75967337|FG001|Overall Study|Adverse Event|71|||
42159341|NCT00113607|75967336|FG000|Overall Study|Death|8|||
42159342|NCT00113607|75967337|FG001|Overall Study|Death|8|||
42159343|NCT00113607|75967336|FG000|Overall Study|Withdrawal by Subject|50|||
42159344|NCT00113607|75967337|FG001|Overall Study|Withdrawal by Subject|58|||
42159345|NCT00113607|75967336|FG000|Overall Study|Lost to Follow-up|0|||
42159346|NCT00113607|75967337|FG001|Overall Study|Lost to Follow-up|2|||
42159347|NCT00113607|75967336|FG000|Overall Study|Disease Progression|180|||
42159348|NCT00113607|75967337|FG001|Overall Study|Disease Progression|142|||
42159349|NCT00113607|75967336|FG000|Overall Study|Complete Response (Confirmed)|14|||
42159350|NCT00113607|75967337|FG001|Overall Study|Complete Response (Confirmed)|24|||
42159351|NCT00113607|75967336|FG000|Overall Study|Other|43|||
42159352|NCT00113607|75967337|FG001|Overall Study|Other|32|||
42159353|NCT00113529|75967344|FG000|Overall Study|Adverse Event|4|||
42159354|NCT00113529|75967344|FG000|Overall Study|Lack of Efficacy|20|||
42159355|NCT00113529|75967344|FG000|Overall Study|Decision of sponsor|6|||
42159356|NCT00113529|75967344|FG000|Overall Study|Withdrawal by Subject|4|||
42159357|NCT00134901|75967350|FG000|Overall Study|Lost to Follow-up|5|||
42159358|NCT00134901|75967351|FG001|Overall Study|Lost to Follow-up|5|||
42159359|NCT00134901|75967350|FG000|Overall Study|discontinued intervention|12|||
42279828|NCT02130466|76111674|FG008|Overall Study|Death|3|||
42279829|NCT02130466|76111675|FG009|Overall Study|Death|4|||
42279830|NCT02130466|76111676|FG010|Overall Study|Death|5|||
42279831|NCT02130466|76111677|FG011|Overall Study|Death|3|||
42279832|NCT02130466|76111678|FG012|Overall Study|Death|11|||
42159360|NCT00134901|75967351|FG001|Overall Study|discontinued intervention|10|||
42159361|NCT00122109|75967361|FG000|Overall Study|Did not meet criteria|6|||
42159362|NCT00122109|75967362|FG001|Overall Study|Did not meet criteria|7|||
42159363|NCT00113373|75967371|FG000|Overall Study|Ineligible: wrong primary|1|||
42159364|NCT00113373|75967371|FG000|Overall Study|Ineligible: second primary|1|||
42159365|NCT00113373|75967371|FG000|Overall Study|Never Treated|1|||
42159366|NCT00113295|75967382|FG000|Overall Study|Adverse Event|4|||
42159367|NCT00113295|75967383|FG001|Overall Study|Adverse Event|1|||
42159368|NCT00113295|75967382|FG000|Overall Study|Unrelated Medical Illness|1|||
42279833|NCT02130466|76111679|FG013|Overall Study|Death|7|||
42279834|NCT02130466|76111666|FG000|Overall Study|Lost to Follow-up|1|||
42279835|NCT02130466|76111667|FG001|Overall Study|Lost to Follow-up|0|||
42279836|NCT02130466|76111668|FG002|Overall Study|Lost to Follow-up|0|||
42159369|NCT00113295|75967383|FG001|Overall Study|Unrelated Medical Illness|0|||
42279837|NCT02130466|76111669|FG003|Overall Study|Lost to Follow-up|0|||
42351405|NCT00989092|76191343|FG001|Overall Study|Did not receive study drug|0|||
42351406|NCT00988858|76191350|FG000|Overall Study|Adverse Event|7|||
42159370|NCT00112905|75967391|FG000|Overall Study|Adverse Event|4|||
42159371|NCT00112905|75967391|FG000|Overall Study|Death|1|||
42159372|NCT00112905|75967391|FG000|Overall Study|Ineligibility|5|||
42159373|NCT00112905|75967391|FG000|Overall Study|Alternative treatment|1|||
42159374|NCT00112905|75967391|FG000|Overall Study|performance status was deteiorating|1|||
42159375|NCT00427895|75967399|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
42159376|NCT00427895|75967400|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
42159377|NCT00427895|75967401|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
42279838|NCT02130466|76111670|FG004|Overall Study|Lost to Follow-up|0|||
42279839|NCT02130466|76111671|FG005|Overall Study|Lost to Follow-up|1|||
42279840|NCT02130466|76111672|FG006|Overall Study|Lost to Follow-up|0|||
42279841|NCT02130466|76111673|FG007|Overall Study|Lost to Follow-up|0|||
42159378|NCT00427895|75967402|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
42159379|NCT00427895|75967403|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
42159380|NCT00427895|75967404|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
42159381|NCT00427895|75967405|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
42159382|NCT00427895|75967406|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
42159383|NCT00427895|75967399|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
42159384|NCT00427895|75967400|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
42159385|NCT00427895|75967401|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
42159386|NCT00427895|75967402|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
42159387|NCT00427895|75967403|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
42159388|NCT00427895|75967404|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
42159389|NCT00427895|75967405|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
42159390|NCT00427895|75967406|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
42159391|NCT00427895|75967399|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
42159392|NCT00427895|75967400|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
42159393|NCT00427895|75967401|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
42159394|NCT00427895|75967402|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
42159395|NCT00427895|75967403|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
42159396|NCT00427895|75967404|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
42159397|NCT00427895|75967405|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
42159398|NCT00427895|75967406|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
42159399|NCT00427895|75967399|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
42159400|NCT00427895|75967400|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
42159401|NCT00427895|75967401|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
42159402|NCT00427895|75967402|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
42159403|NCT00427895|75967403|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
42159404|NCT00427895|75967404|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
42159405|NCT00427895|75967405|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
42159406|NCT00427895|75967406|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
42159407|NCT00427895|75967399|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
42159408|NCT00427895|75967400|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
42159409|NCT00427895|75967401|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
42159410|NCT00427895|75967402|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
42159411|NCT00427895|75967403|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
42159412|NCT00427895|75967404|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
42159413|NCT00427895|75967405|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
42159414|NCT00427895|75967406|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
42159415|NCT00427895|75967399|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
42159416|NCT00427895|75967400|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
42159417|NCT00427895|75967401|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
42159418|NCT00427895|75967402|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
42159419|NCT00427895|75967403|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
42159420|NCT00427895|75967404|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
42159421|NCT00427895|75967405|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
42159422|NCT00427895|75967406|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
42159423|NCT00427895|75967399|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
42159424|NCT00427895|75967400|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
42159425|NCT00427895|75967401|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
42159426|NCT00427895|75967402|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
42159427|NCT00427895|75967403|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
42159428|NCT00427895|75967404|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
42159429|NCT00427895|75967405|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
42159430|NCT00427895|75967406|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
42159431|NCT00427895|75967399|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
42159432|NCT00427895|75967400|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
42159433|NCT00427895|75967401|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
42159434|NCT00427895|75967402|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
42040227|NCT01928394|75848576|FG010|Treatment Period|Participant withdrew consent|1|||
42159435|NCT00427895|75967403|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
42159436|NCT00427895|75967404|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
42159437|NCT00427895|75967405|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
42159438|NCT00427895|75967406|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
42159439|NCT00427895|75967399|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
42159440|NCT00427895|75967400|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
42159441|NCT00427895|75967401|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
42159442|NCT00427895|75967402|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
42159443|NCT00427895|75967403|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
42351407|NCT00988858|76191350|FG000|Overall Study|Death|1|||
42351408|NCT00988858|76191350|FG000|Overall Study|Physician Decision|1|||
42159444|NCT00427895|75967404|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
42159445|NCT00427895|75967405|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
42159446|NCT00427895|75967406|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
42159447|NCT00427895|75967399|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
42159448|NCT00427895|75967400|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
42159449|NCT00427895|75967401|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
42159450|NCT00427895|75967402|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
42159451|NCT00427895|75967403|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
42159452|NCT00427895|75967404|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
42159453|NCT00427895|75967405|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
42159454|NCT00427895|75967406|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
42159455|NCT00427895|75967399|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
42159456|NCT00427895|75967400|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
42159457|NCT00427895|75967401|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
42159458|NCT00427895|75967402|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
42159459|NCT00427895|75967403|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
42159460|NCT00427895|75967404|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
42159461|NCT00427895|75967405|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
42159462|NCT00427895|75967406|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
42159463|NCT00427895|75967399|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
42159464|NCT00427895|75967400|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
42159465|NCT00427895|75967401|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
42159466|NCT00427895|75967402|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
42159467|NCT00427895|75967403|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
42159468|NCT00427895|75967404|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
42159469|NCT00427895|75967405|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
42159470|NCT00427895|75967406|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
42159471|NCT00427895|75967399|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
42159472|NCT00427895|75967400|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
42159473|NCT00427895|75967401|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
42159474|NCT00427895|75967402|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
42159475|NCT00427895|75967403|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
42159476|NCT00427895|75967404|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
42159477|NCT00427895|75967405|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
42159478|NCT00427895|75967406|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
42159479|NCT00427895|75967399|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
42159480|NCT00427895|75967400|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
42159481|NCT00427895|75967401|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
42159482|NCT00427895|75967402|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
42159483|NCT00427895|75967403|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
42159484|NCT00427895|75967404|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
42159485|NCT00427895|75967405|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
42159486|NCT00427895|75967406|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
42159487|NCT00427895|75967399|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
42159488|NCT00427895|75967400|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
42279842|NCT02130466|76111674|FG008|Overall Study|Lost to Follow-up|0|||
42279843|NCT02130466|76111675|FG009|Overall Study|Lost to Follow-up|0|||
42279844|NCT02130466|76111676|FG010|Overall Study|Lost to Follow-up|0|||
42040228|NCT01928394|75848577|FG011|Treatment Period|Participant withdrew consent|1|||
42040229|NCT01928394|75848578|FG012|Treatment Period|Participant withdrew consent|1|||
42040230|NCT01928394|75848579|FG013|Treatment Period|Participant withdrew consent|0|||
42040231|NCT01928394|75848580|FG014|Treatment Period|Participant withdrew consent|2|||
42040232|NCT01928394|75848581|FG015|Treatment Period|Participant withdrew consent|0|||
42040233|NCT01928394|75848582|FG016|Treatment Period|Participant withdrew consent|2|||
42040234|NCT01928394|75848583|FG017|Treatment Period|Participant withdrew consent|1|||
42040235|NCT01928394|75848584|FG018|Treatment Period|Participant withdrew consent|1|||
42040236|NCT01928394|75848585|FG019|Treatment Period|Participant withdrew consent|1|||
42159489|NCT00427895|75967401|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
42279845|NCT02130466|76111677|FG011|Overall Study|Lost to Follow-up|0|||
42279846|NCT02130466|76111678|FG012|Overall Study|Lost to Follow-up|1|||
42279847|NCT02130466|76111679|FG013|Overall Study|Lost to Follow-up|0|||
42279848|NCT02130466|76111666|FG000|Overall Study|Physician Decision|0|||
42279849|NCT02130466|76111667|FG001|Overall Study|Physician Decision|0|||
42159490|NCT00427895|75967402|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
42159491|NCT00427895|75967403|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
42159492|NCT00427895|75967404|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
42159493|NCT00427895|75967405|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
42159494|NCT00427895|75967406|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
42279850|NCT02130466|76111668|FG002|Overall Study|Physician Decision|0|||
42040237|NCT01928394|75848586|FG020|Treatment Period|Participant withdrew consent|0|||
42159495|NCT00427895|75967399|FG000|Vax 1/Year 1 Follow-up|Death|1|||
42159496|NCT00427895|75967400|FG001|Vax 1/Year 1 Follow-up|Death|0|||
42159497|NCT00427895|75967401|FG002|Vax 1/Year 1 Follow-up|Death|0|||
42159498|NCT00427895|75967402|FG003|Vax 1/Year 1 Follow-up|Death|0|||
42159499|NCT00427895|75967403|FG004|Vax 1/Year 1 Follow-up|Death|0|||
42159500|NCT00427895|75967404|FG005|Vax 1/Year 1 Follow-up|Death|0|||
42159501|NCT00427895|75967405|FG006|Vax 1/Year 1 Follow-up|Death|0|||
42159502|NCT00427895|75967406|FG007|Vax 1/Year 1 Follow-up|Death|0|||
42159503|NCT00427895|75967399|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
42159504|NCT00427895|75967400|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
42159505|NCT00427895|75967401|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
42159506|NCT00427895|75967402|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
42159507|NCT00427895|75967403|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
42159508|NCT00427895|75967404|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
42159509|NCT00427895|75967405|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
42159510|NCT00427895|75967406|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
42159511|NCT00427895|75967399|FG000|Vax 1/Year 1 Follow-up|Other|0|||
42159512|NCT00427895|75967400|FG001|Vax 1/Year 1 Follow-up|Other|0|||
42159513|NCT00427895|75967401|FG002|Vax 1/Year 1 Follow-up|Other|0|||
42159514|NCT00427895|75967402|FG003|Vax 1/Year 1 Follow-up|Other|2|||
42159515|NCT00427895|75967403|FG004|Vax 1/Year 1 Follow-up|Other|0|||
42159516|NCT00427895|75967404|FG005|Vax 1/Year 1 Follow-up|Other|0|||
42159517|NCT00427895|75967405|FG006|Vax 1/Year 1 Follow-up|Other|0|||
42159518|NCT00427895|75967406|FG007|Vax 1/Year 1 Follow-up|Other|0|||
42159519|NCT00427895|75967399|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
42159520|NCT00427895|75967400|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
42159521|NCT00427895|75967401|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
42159522|NCT00427895|75967402|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
42159523|NCT00427895|75967403|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
42159524|NCT00427895|75967404|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
42159525|NCT00427895|75967405|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
42159526|NCT00427895|75967406|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
42159527|NCT00425945|75967447|FG000|Overall Study|Concern about Supplement|2|||
42159528|NCT00425945|75967448|FG001|Overall Study|Concern about Supplement|0|||
42159529|NCT00425945|75967447|FG000|Overall Study|Inconvenience|0|||
42159530|NCT00425945|75967448|FG001|Overall Study|Inconvenience|2|||
42159531|NCT00425945|75967447|FG000|Overall Study|Lost to Follow-up|0|||
42159532|NCT00425945|75967448|FG001|Overall Study|Lost to Follow-up|2|||
42159533|NCT00425945|75967447|FG000|Overall Study|Began hypertension medication|1|||
42159534|NCT00425945|75967448|FG001|Overall Study|Began hypertension medication|0|||
42159535|NCT00425945|75967447|FG000|Overall Study|Began cancer treatments|1|||
42159536|NCT00425945|75967448|FG001|Overall Study|Began cancer treatments|0|||
42159537|NCT00425945|75967447|FG000|Overall Study|Moved from area|0|||
42159538|NCT00425945|75967448|FG001|Overall Study|Moved from area|1|||
42159539|NCT00416195|75967458|FG000|Overall Study|Adverse Event|1|||
42159540|NCT00416195|75967459|FG001|Overall Study|Adverse Event|2|||
42159541|NCT00416195|75967458|FG000|Overall Study|Protocol Violation|1|||
42159542|NCT00416195|75967459|FG001|Overall Study|Protocol Violation|1|||
42159543|NCT00416195|75967458|FG000|Overall Study|Other|0|||
42159544|NCT00416195|75967459|FG001|Overall Study|Other|1|||
42159545|NCT00121641|75967469|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
42159546|NCT00121641|75967470|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
42159547|NCT00121641|75967471|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
42159548|NCT00121641|75967472|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
42159549|NCT00121641|75967473|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
42159550|NCT00121641|75967469|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
42159551|NCT00121641|75967470|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
42159552|NCT00121641|75967471|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
42159553|NCT00121641|75967472|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
42159554|NCT00121641|75967473|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
42159555|NCT00121641|75967469|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
42159556|NCT00121641|75967470|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
42159557|NCT00121641|75967471|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
42159558|NCT00121641|75967472|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
42159559|NCT00121641|75967473|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
42159560|NCT00121641|75967469|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
42159561|NCT00121641|75967470|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
42159562|NCT00121641|75967471|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
42159563|NCT00121641|75967472|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
42159564|NCT00121641|75967473|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
42159565|NCT00121641|75967469|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
42159566|NCT00121641|75967470|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
42159567|NCT00121641|75967471|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
42159568|NCT00121641|75967472|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
42159569|NCT00121641|75967473|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
42159570|NCT00121641|75967469|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
42159571|NCT00121641|75967470|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
42159572|NCT00121641|75967471|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
42159573|NCT00121641|75967472|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
42159574|NCT00121641|75967473|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
42159575|NCT00121641|75967469|FG000|24-week Short-term Treatment Period|Other Reason|1|||
42159576|NCT00121641|75967470|FG001|24-week Short-term Treatment Period|Other Reason|0|||
42159577|NCT00121641|75967471|FG002|24-week Short-term Treatment Period|Other Reason|0|||
42159578|NCT00121641|75967472|FG003|24-week Short-term Treatment Period|Other Reason|0|||
42159579|NCT00121641|75967473|FG004|24-week Short-term Treatment Period|Other Reason|0|||
42159580|NCT00121641|75967469|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
42159581|NCT00121641|75967470|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
42159582|NCT00121641|75967471|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
42159583|NCT00121641|75967472|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
42159584|NCT00121641|75967473|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
42159585|NCT00121641|75967469|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
42159586|NCT00121641|75967470|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
42159587|NCT00121641|75967471|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
42159588|NCT00121641|75967472|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
42159589|NCT00121641|75967473|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
42159590|NCT00121641|75967469|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
42159591|NCT00121641|75967470|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
42159592|NCT00121641|75967471|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
42279851|NCT02130466|76111669|FG003|Overall Study|Physician Decision|0|||
42279852|NCT02130466|76111670|FG004|Overall Study|Physician Decision|0|||
42279853|NCT02130466|76111671|FG005|Overall Study|Physician Decision|1|||
42159593|NCT00121641|75967472|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
42159594|NCT00121641|75967473|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
42159595|NCT00121641|75967469|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
42159596|NCT00121641|75967470|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
42159597|NCT00121641|75967471|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
42159598|NCT00121641|75967472|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
42159599|NCT00121641|75967473|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
42159600|NCT00121641|75967469|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
42159601|NCT00121641|75967470|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
42159602|NCT00121641|75967471|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
42159603|NCT00121641|75967472|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
42159604|NCT00121641|75967473|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
42159605|NCT00121641|75967469|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
42159606|NCT00121641|75967470|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
42159607|NCT00121641|75967471|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
42159608|NCT00121641|75967472|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
42159609|NCT00121641|75967473|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
42159610|NCT00121641|75967469|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
42159611|NCT00121641|75967470|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
42159612|NCT00121641|75967471|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
42159613|NCT00121641|75967472|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
42159614|NCT00121641|75967473|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
42159615|NCT00121641|75967469|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
42159616|NCT00121641|75967470|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
42159617|NCT00121641|75967471|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
42159618|NCT00121641|75967472|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
42159619|NCT00121641|75967473|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
42159620|NCT00121641|75967469|FG000|48-month Short Term + Long Term Period|Death|0|||
42159621|NCT00121641|75967470|FG001|48-month Short Term + Long Term Period|Death|0|||
42159622|NCT00121641|75967471|FG002|48-month Short Term + Long Term Period|Death|0|||
42159623|NCT00121641|75967472|FG003|48-month Short Term + Long Term Period|Death|1|||
42159624|NCT00121641|75967473|FG004|48-month Short Term + Long Term Period|Death|0|||
42159625|NCT00121641|75967469|FG000|48-month Short Term + Long Term Period|Missing|0|||
42159626|NCT00121641|75967470|FG001|48-month Short Term + Long Term Period|Missing|0|||
42159627|NCT00121641|75967471|FG002|48-month Short Term + Long Term Period|Missing|1|||
42159628|NCT00121641|75967472|FG003|48-month Short Term + Long Term Period|Missing|0|||
42159629|NCT00121641|75967473|FG004|48-month Short Term + Long Term Period|Missing|0|||
42159630|NCT00121641|75967469|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
42159631|NCT00121641|75967470|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
42159632|NCT00121641|75967471|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
42159633|NCT00121641|75967472|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
42159634|NCT00121641|75967473|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
42159635|NCT00425555|75967489|FG000|Overall Study|Withdrawal by Subject|11|||
42159636|NCT00425555|75967490|FG001|Overall Study|Withdrawal by Subject|8|||
42159637|NCT00425555|75967489|FG000|Overall Study|Lost to Follow-up|0|||
42159638|NCT00425555|75967490|FG001|Overall Study|Lost to Follow-up|1|||
42159639|NCT00425555|75967489|FG000|Overall Study|Administrative problems|3|||
42159640|NCT00425555|75967490|FG001|Overall Study|Administrative problems|0|||
42159641|NCT00425555|75967489|FG000|Overall Study|Death|1|||
42159642|NCT00425555|75967490|FG001|Overall Study|Death|2|||
42159643|NCT00425555|75967489|FG000|Overall Study|New cancer therapy|2|||
42159644|NCT00425555|75967490|FG001|Overall Study|New cancer therapy|1|||
42159645|NCT00425555|75967489|FG000|Overall Study|Disease progression|36|||
42159646|NCT00425555|75967490|FG001|Overall Study|Disease progression|33|||
42159647|NCT00425555|75967489|FG000|Overall Study|Adverse Event|25|||
42159648|NCT00425555|75967490|FG001|Overall Study|Adverse Event|15|||
42159649|NCT00425555|75967489|FG000|Overall Study|Protocol Violation|1|||
42159650|NCT00425555|75967490|FG001|Overall Study|Protocol Violation|0|||
42159651|NCT00424775|75967499|FG000|Overall Study|Adverse Event|2|||
42159652|NCT00424775|75967500|FG001|Overall Study|Adverse Event|0|||
42159653|NCT00424775|75967499|FG000|Overall Study|Lack of Efficacy|1|||
42159654|NCT00424775|75967500|FG001|Overall Study|Lack of Efficacy|0|||
42159655|NCT00121485|75967506|FG000|Overall Study|Not implanted|1|||
42159656|NCT00121485|75967507|FG001|Overall Study|Not implanted|5|||
42159657|NCT00121485|75967506|FG000|Overall Study|Crossover|0|||
42159658|NCT00121485|75967507|FG001|Overall Study|Crossover|2|||
42159659|NCT01763866|75967538|FG000|Overall Study|Withdrawal by Subject|2|||
42279854|NCT02130466|76111672|FG006|Overall Study|Physician Decision|1|||
42279855|NCT02130466|76111673|FG007|Overall Study|Physician Decision|0|||
42279856|NCT02130466|76111674|FG008|Overall Study|Physician Decision|0|||
42159660|NCT01763866|75967539|FG001|Overall Study|Withdrawal by Subject|1|||
42159661|NCT01763866|75967540|FG002|Overall Study|Withdrawal by Subject|4|||
42013480|NCT00998296|75820559|FG009|Overall Study|Other adverse event|1|||
42279857|NCT02130466|76111675|FG009|Overall Study|Physician Decision|0|||
42279858|NCT02130466|76111676|FG010|Overall Study|Physician Decision|0|||
42159662|NCT01763866|75967541|FG003|Overall Study|Withdrawal by Subject|0|||
42159663|NCT01763866|75967542|FG004|Overall Study|Withdrawal by Subject|0|||
42159664|NCT01763866|75967543|FG005|Overall Study|Withdrawal by Subject|3|||
42159665|NCT01763866|75967544|FG006|Overall Study|Withdrawal by Subject|4|||
42159666|NCT01763866|75967545|FG007|Overall Study|Withdrawal by Subject|0|||
42159667|NCT01763866|75967546|FG008|Overall Study|Withdrawal by Subject|1|||
42159668|NCT01763866|75967547|FG009|Overall Study|Withdrawal by Subject|1|||
42159669|NCT01763866|75967548|FG010|Overall Study|Withdrawal by Subject|2|||
42159670|NCT01763866|75967549|FG011|Overall Study|Withdrawal by Subject|2|||
42159671|NCT01763866|75967550|FG012|Overall Study|Withdrawal by Subject|2|||
42159672|NCT01763866|75967551|FG013|Overall Study|Withdrawal by Subject|0|||
42159673|NCT01763866|75967552|FG014|Overall Study|Withdrawal by Subject|6|||
42159674|NCT01763866|75967553|FG015|Overall Study|Withdrawal by Subject|3|||
42159675|NCT01763866|75967554|FG016|Overall Study|Withdrawal by Subject|0|||
42159676|NCT01763866|75967555|FG017|Overall Study|Withdrawal by Subject|1|||
42159677|NCT01763866|75967556|FG018|Overall Study|Withdrawal by Subject|1|||
42159678|NCT01763866|75967557|FG019|Overall Study|Withdrawal by Subject|1|||
42159679|NCT01763866|75967558|FG020|Overall Study|Withdrawal by Subject|2|||
42159680|NCT01763866|75967559|FG021|Overall Study|Withdrawal by Subject|1|||
42159681|NCT01763866|75967560|FG022|Overall Study|Withdrawal by Subject|2|||
42159682|NCT01763866|75967561|FG023|Overall Study|Withdrawal by Subject|1|||
42159683|NCT01763866|75967538|FG000|Overall Study|Decision by sponsor|0|||
42159684|NCT01763866|75967539|FG001|Overall Study|Decision by sponsor|0|||
42159685|NCT01763866|75967540|FG002|Overall Study|Decision by sponsor|1|||
42159686|NCT01763866|75967541|FG003|Overall Study|Decision by sponsor|0|||
42159687|NCT01763866|75967542|FG004|Overall Study|Decision by sponsor|2|||
42159688|NCT01763866|75967543|FG005|Overall Study|Decision by sponsor|0|||
42159689|NCT01763866|75967544|FG006|Overall Study|Decision by sponsor|2|||
42159690|NCT01763866|75967545|FG007|Overall Study|Decision by sponsor|0|||
42159691|NCT01763866|75967546|FG008|Overall Study|Decision by sponsor|2|||
42159692|NCT01763866|75967547|FG009|Overall Study|Decision by sponsor|0|||
42159693|NCT01763866|75967548|FG010|Overall Study|Decision by sponsor|6|||
42159694|NCT01763866|75967549|FG011|Overall Study|Decision by sponsor|0|||
42159695|NCT01763866|75967550|FG012|Overall Study|Decision by sponsor|1|||
42159696|NCT01763866|75967551|FG013|Overall Study|Decision by sponsor|0|||
42159697|NCT01763866|75967552|FG014|Overall Study|Decision by sponsor|5|||
42159698|NCT01763866|75967553|FG015|Overall Study|Decision by sponsor|0|||
42159699|NCT01763866|75967554|FG016|Overall Study|Decision by sponsor|0|||
42159700|NCT01763866|75967555|FG017|Overall Study|Decision by sponsor|0|||
42279859|NCT02130466|76111677|FG011|Overall Study|Physician Decision|0|||
42279860|NCT02130466|76111678|FG012|Overall Study|Physician Decision|0|||
42279861|NCT02130466|76111679|FG013|Overall Study|Physician Decision|0|||
42279862|NCT02130466|76111666|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
42279863|NCT02130466|76111667|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
42279864|NCT02130466|76111668|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
42279865|NCT02130466|76111669|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
42279866|NCT02130466|76111670|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
42279867|NCT02130466|76111671|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
42279868|NCT02130466|76111672|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
42279869|NCT02130466|76111673|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
42279870|NCT02130466|76111674|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
42279871|NCT02130466|76111675|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
42279872|NCT02130466|76111676|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
42279873|NCT02130466|76111677|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
42279874|NCT02130466|76111678|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
42279875|NCT02130466|76111679|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
42279876|NCT02130466|76111666|FG000|Overall Study|Withdrawal by Subject|1|||
42279877|NCT02130466|76111667|FG001|Overall Study|Withdrawal by Subject|0|||
42279878|NCT02130466|76111668|FG002|Overall Study|Withdrawal by Subject|0|||
42279879|NCT02130466|76111669|FG003|Overall Study|Withdrawal by Subject|0|||
42279880|NCT02130466|76111670|FG004|Overall Study|Withdrawal by Subject|0|||
42279881|NCT02130466|76111671|FG005|Overall Study|Withdrawal by Subject|1|||
42279882|NCT02130466|76111672|FG006|Overall Study|Withdrawal by Subject|0|||
42279883|NCT02130466|76111673|FG007|Overall Study|Withdrawal by Subject|0|||
42279884|NCT02130466|76111674|FG008|Overall Study|Withdrawal by Subject|1|||
42279885|NCT02130466|76111675|FG009|Overall Study|Withdrawal by Subject|0|||
42159701|NCT01763866|75967556|FG018|Overall Study|Decision by sponsor|4|||
42159702|NCT01763866|75967557|FG019|Overall Study|Decision by sponsor|0|||
42159703|NCT01763866|75967558|FG020|Overall Study|Decision by sponsor|2|||
42159704|NCT01763866|75967559|FG021|Overall Study|Decision by sponsor|0|||
42159705|NCT01763866|75967560|FG022|Overall Study|Decision by sponsor|1|||
42159706|NCT01763866|75967561|FG023|Overall Study|Decision by sponsor|0|||
42159707|NCT01763866|75967538|FG000|Overall Study|Lost to Follow-up|0|||
42159708|NCT01763866|75967539|FG001|Overall Study|Lost to Follow-up|0|||
42159709|NCT01763866|75967540|FG002|Overall Study|Lost to Follow-up|0|||
42159710|NCT01763866|75967541|FG003|Overall Study|Lost to Follow-up|0|||
42159711|NCT01763866|75967542|FG004|Overall Study|Lost to Follow-up|0|||
42159712|NCT01763866|75967543|FG005|Overall Study|Lost to Follow-up|0|||
42159713|NCT01763866|75967544|FG006|Overall Study|Lost to Follow-up|1|||
42159714|NCT01763866|75967545|FG007|Overall Study|Lost to Follow-up|0|||
42159715|NCT01763866|75967546|FG008|Overall Study|Lost to Follow-up|0|||
42159716|NCT01763866|75967547|FG009|Overall Study|Lost to Follow-up|0|||
42159717|NCT01763866|75967548|FG010|Overall Study|Lost to Follow-up|0|||
42279886|NCT02130466|76111676|FG010|Overall Study|Withdrawal by Subject|0|||
42279887|NCT02130466|76111677|FG011|Overall Study|Withdrawal by Subject|0|||
42279888|NCT02130466|76111678|FG012|Overall Study|Withdrawal by Subject|0|||
42279889|NCT02130466|76111679|FG013|Overall Study|Withdrawal by Subject|0|||
42279890|NCT02163538|76111728|FG000|Overall Study|Protocol Violation|1|||
42279891|NCT02163538|76111729|FG001|Overall Study|Protocol Violation|0|||
42279892|NCT02163538|76111728|FG000|Overall Study|Physician Decision|0|||
42279893|NCT02163538|76111729|FG001|Overall Study|Physician Decision|1|||
42279894|NCT02163226|76111737|FG000|Overall Study|Death|2|||
42279895|NCT02163226|76111738|FG001|Overall Study|Death|1|||
42279896|NCT02163226|76111737|FG000|Overall Study|Withdrawal by Subject|5|||
42279897|NCT02163226|76111738|FG001|Overall Study|Withdrawal by Subject|2|||
42279898|NCT02163226|76111737|FG000|Overall Study|Returned home, local radiotherapy|3|||
42279899|NCT02163226|76111738|FG001|Overall Study|Returned home, local radiotherapy|0|||
42279900|NCT02163226|76111737|FG000|Overall Study|Repeat imaging showed no disease|2|||
42279901|NCT02163226|76111738|FG001|Overall Study|Repeat imaging showed no disease|0|||
42279902|NCT02163226|76111737|FG000|Overall Study|Incomplete radiotherapy|3|||
42279903|NCT02163226|76111738|FG001|Overall Study|Incomplete radiotherapy|0|||
42279904|NCT02163226|76111737|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
42279905|NCT02163226|76111738|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
42279906|NCT02163226|76111737|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
42279907|NCT02163226|76111738|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
42279908|NCT02163226|76111737|FG000|Overall Study|ineligible|0|||
42279909|NCT02163226|76111738|FG001|Overall Study|ineligible|3|||
42279910|NCT02193178|76111744|FG000|Overall Study|Lost to Follow-up|1|||
42279911|NCT02193178|76111744|FG000|Overall Study|Dry eyes|1|||
42279912|NCT02129608|76111765|FG000|Overall Study|Lost to Follow-up|0|||
42279913|NCT02129608|76111766|FG001|Overall Study|Lost to Follow-up|1|||
42279914|NCT02129608|76111767|FG002|Overall Study|Lost to Follow-up|1|||
42279915|NCT02129608|76111765|FG000|Overall Study|Withdrawal by Subject|0|||
42279916|NCT02129608|76111766|FG001|Overall Study|Withdrawal by Subject|0|||
42279917|NCT02129608|76111767|FG002|Overall Study|Withdrawal by Subject|2|||
42279918|NCT01631188|76111775|FG000|Overall Study|Physician Decision|75|||
42279919|NCT02129062|76111779|FG000|Overall Study|Death|1|||
42279920|NCT02129062|76111779|FG000|Overall Study|Disease Progression|2|||
42279921|NCT02162758|76111785|FG000|Overall Study|Study termination|0|||
42279922|NCT02162758|76111786|FG001|Overall Study|Study termination|1|||
42279923|NCT02192164|76111792|FG000|Overall Study|Other|8|||
42279924|NCT02192164|76111792|FG000|Overall Study|Withdrawal by Subject|1|||
42279925|NCT02192164|76111792|FG000|Overall Study|Physician Decision|4|||
42279926|NCT02192164|76111792|FG000|Overall Study|Did not meet the exclusion criteria|1|||
42279927|NCT02191618|76111799|FG000|Overall Study|Withdrawal by Subject|3|||
42351409|NCT00988858|76191350|FG000|Overall Study|Sponsor Decision|1|||
42351410|NCT00986986|76191356|FG000|Overall Study|Lost to Follow-up|0|||
42351411|NCT00986986|76191357|FG001|Overall Study|Lost to Follow-up|1|||
42351412|NCT01904773|76191364|FG000|Screen|Screen failure|3|||
42351413|NCT01904773|76191365|FG001|Screen|Screen failure|0|||
42159718|NCT01763866|75967549|FG011|Overall Study|Lost to Follow-up|0|||
42159719|NCT01763866|75967550|FG012|Overall Study|Lost to Follow-up|1|||
42279928|NCT02191618|76111799|FG000|Overall Study|Missed Visit|4|||
42279929|NCT02646891|76111813|FG000|Overall Study|Adverse Event|0|||
42279930|NCT02646891|76111814|FG001|Overall Study|Adverse Event|1|||
42279931|NCT02646891|76111815|FG002|Overall Study|Adverse Event|0|||
42279932|NCT02646891|76111816|FG003|Overall Study|Adverse Event|0|||
42279933|NCT02646891|76111817|FG004|Overall Study|Adverse Event|0|||
42279934|NCT02646891|76111818|FG005|Overall Study|Adverse Event|0|||
42279935|NCT02646891|76111819|FG006|Overall Study|Adverse Event|0|||
42351414|NCT01904773|76191366|FG002|Screen|Screen failure|0|||
42279936|NCT02646891|76111820|FG007|Overall Study|Adverse Event|0|||
42351415|NCT01904773|76191367|FG003|Screen|Screen failure|0|||
42279937|NCT02646891|76111821|FG008|Overall Study|Adverse Event|0|||
42279938|NCT02646891|76111822|FG009|Overall Study|Adverse Event|0|||
42279939|NCT02646891|76111813|FG000|Overall Study|Lost to Follow-up|0|||
42279940|NCT02646891|76111814|FG001|Overall Study|Lost to Follow-up|0|||
42159720|NCT01763866|75967551|FG013|Overall Study|Lost to Follow-up|0|||
42159721|NCT01763866|75967552|FG014|Overall Study|Lost to Follow-up|1|||
42159722|NCT01763866|75967553|FG015|Overall Study|Lost to Follow-up|0|||
42159723|NCT01763866|75967554|FG016|Overall Study|Lost to Follow-up|0|||
42159724|NCT01763866|75967555|FG017|Overall Study|Lost to Follow-up|0|||
42159725|NCT01763866|75967556|FG018|Overall Study|Lost to Follow-up|1|||
42159726|NCT01763866|75967557|FG019|Overall Study|Lost to Follow-up|1|||
42159727|NCT01763866|75967558|FG020|Overall Study|Lost to Follow-up|0|||
42159728|NCT01763866|75967559|FG021|Overall Study|Lost to Follow-up|0|||
42159729|NCT01763866|75967560|FG022|Overall Study|Lost to Follow-up|0|||
42159730|NCT01763866|75967561|FG023|Overall Study|Lost to Follow-up|1|||
42159731|NCT01763866|75967538|FG000|Overall Study|Death|0|||
42159732|NCT01763866|75967539|FG001|Overall Study|Death|0|||
42159733|NCT01763866|75967540|FG002|Overall Study|Death|0|||
42159734|NCT01763866|75967541|FG003|Overall Study|Death|0|||
42159735|NCT01763866|75967542|FG004|Overall Study|Death|0|||
42159736|NCT01763866|75967543|FG005|Overall Study|Death|0|||
42279941|NCT02646891|76111815|FG002|Overall Study|Lost to Follow-up|0|||
42279942|NCT02646891|76111816|FG003|Overall Study|Lost to Follow-up|0|||
42159737|NCT01763866|75967544|FG006|Overall Study|Death|0|||
42159738|NCT01763866|75967545|FG007|Overall Study|Death|0|||
42159739|NCT01763866|75967546|FG008|Overall Study|Death|0|||
42159740|NCT01763866|75967547|FG009|Overall Study|Death|0|||
42159741|NCT01763866|75967548|FG010|Overall Study|Death|0|||
42159742|NCT01763866|75967549|FG011|Overall Study|Death|0|||
42159743|NCT01763866|75967550|FG012|Overall Study|Death|0|||
42159744|NCT01763866|75967551|FG013|Overall Study|Death|0|||
42159745|NCT01763866|75967552|FG014|Overall Study|Death|0|||
42159746|NCT01763866|75967553|FG015|Overall Study|Death|0|||
42159747|NCT01763866|75967554|FG016|Overall Study|Death|1|||
42159748|NCT01763866|75967555|FG017|Overall Study|Death|0|||
42279943|NCT02646891|76111817|FG004|Overall Study|Lost to Follow-up|0|||
42279944|NCT02646891|76111818|FG005|Overall Study|Lost to Follow-up|0|||
42279945|NCT02646891|76111819|FG006|Overall Study|Lost to Follow-up|2|||
42279946|NCT02646891|76111820|FG007|Overall Study|Lost to Follow-up|2|||
42279947|NCT02646891|76111821|FG008|Overall Study|Lost to Follow-up|2|||
42279948|NCT02646891|76111822|FG009|Overall Study|Lost to Follow-up|2|||
42279949|NCT02646891|76111813|FG000|Overall Study|Protocol Violation|0|||
42279950|NCT02646891|76111814|FG001|Overall Study|Protocol Violation|0|||
42279951|NCT02646891|76111815|FG002|Overall Study|Protocol Violation|0|||
42279952|NCT02646891|76111816|FG003|Overall Study|Protocol Violation|0|||
42279953|NCT02646891|76111817|FG004|Overall Study|Protocol Violation|0|||
42159749|NCT01763866|75967556|FG018|Overall Study|Death|0|||
42159750|NCT01763866|75967557|FG019|Overall Study|Death|0|||
42159751|NCT01763866|75967558|FG020|Overall Study|Death|0|||
42159752|NCT01763866|75967559|FG021|Overall Study|Death|0|||
42159753|NCT01763866|75967560|FG022|Overall Study|Death|0|||
42279954|NCT02646891|76111818|FG005|Overall Study|Protocol Violation|0|||
42279955|NCT02646891|76111819|FG006|Overall Study|Protocol Violation|1|||
42279956|NCT02646891|76111820|FG007|Overall Study|Protocol Violation|1|||
42279957|NCT02646891|76111821|FG008|Overall Study|Protocol Violation|0|||
42279958|NCT02646891|76111822|FG009|Overall Study|Protocol Violation|0|||
42279959|NCT02646891|76111813|FG000|Overall Study|Withdrawal by Subject|2|||
42279960|NCT02646891|76111814|FG001|Overall Study|Withdrawal by Subject|0|||
42279961|NCT02646891|76111815|FG002|Overall Study|Withdrawal by Subject|1|||
42279962|NCT02646891|76111816|FG003|Overall Study|Withdrawal by Subject|0|||
42159754|NCT01763866|75967561|FG023|Overall Study|Death|0|||
42159755|NCT00132873|75967611|FG000|Overall Study|Adverse Event|3|||
42159756|NCT00132873|75967611|FG000|Overall Study|Lost to Follow-up|1|||
42159757|NCT00132873|75967611|FG000|Overall Study|Lack of Efficacy|1|||
42159758|NCT00132873|75967611|FG000|Overall Study|Withdrawal by Subject|3|||
42279963|NCT02646891|76111817|FG004|Overall Study|Withdrawal by Subject|0|||
42279964|NCT02646891|76111818|FG005|Overall Study|Withdrawal by Subject|0|||
42279965|NCT02646891|76111819|FG006|Overall Study|Withdrawal by Subject|5|||
42279966|NCT02646891|76111820|FG007|Overall Study|Withdrawal by Subject|9|||
42279967|NCT02646891|76111821|FG008|Overall Study|Withdrawal by Subject|7|||
42279968|NCT02646891|76111822|FG009|Overall Study|Withdrawal by Subject|3|||
42159759|NCT00132873|75967611|FG000|Overall Study|Planned Pregnancy|1|||
42159760|NCT00120627|75967617|FG000|Overall Study|Withdrawal by Subject|5|||
42279969|NCT02646891|76111813|FG000|Overall Study|Death|0|||
42279970|NCT02646891|76111814|FG001|Overall Study|Death|0|||
42279971|NCT02646891|76111815|FG002|Overall Study|Death|0|||
42279972|NCT02646891|76111816|FG003|Overall Study|Death|0|||
42159761|NCT00120627|75967618|FG001|Overall Study|Withdrawal by Subject|5|||
42159762|NCT03762616|75967633|FG000|Overall Study|Protocol Violation|2|||
42159763|NCT04246996|75967641|FG000|Overall Study|Physician Decision|1|||
42159764|NCT04246996|75967642|FG001|Overall Study|Physician Decision|1|||
42279973|NCT02646891|76111817|FG004|Overall Study|Death|0|||
42279974|NCT02646891|76111818|FG005|Overall Study|Death|0|||
42279975|NCT02646891|76111819|FG006|Overall Study|Death|1|||
42279976|NCT02646891|76111820|FG007|Overall Study|Death|1|||
42279977|NCT02646891|76111821|FG008|Overall Study|Death|1|||
42279978|NCT02646891|76111822|FG009|Overall Study|Death|0|||
42279979|NCT02646423|76111858|FG000|Overall Study|Adverse Event|5|||
42279980|NCT02646423|76111859|FG001|Overall Study|Adverse Event|7|||
42279981|NCT02646423|76111858|FG000|Overall Study|Ineligible|2|||
42279982|NCT02646423|76111859|FG001|Overall Study|Ineligible|1|||
42279983|NCT02647359|76111895|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
42279984|NCT02647359|76111896|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
42279985|NCT02647359|76111895|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
42279986|NCT02647359|76111896|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
42279987|NCT02647359|76111895|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
42279988|NCT02647359|76111896|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
42279989|NCT02647359|76111895|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
42279990|NCT02647359|76111896|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
42279991|NCT02647359|76111895|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
42279992|NCT02647359|76111896|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
42279993|NCT02647359|76111895|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
42279994|NCT02647359|76111896|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
42279995|NCT02645409|76111908|FG000|Overall Study|Withdrawal by Subject|3|||
42279996|NCT02645409|76111909|FG001|Overall Study|Withdrawal by Subject|0|||
42279997|NCT02645409|76111908|FG000|Overall Study|Physician Decision|1|||
42279998|NCT02645409|76111909|FG001|Overall Study|Physician Decision|0|||
42279999|NCT01597479|76111916|FG000|Overall Study|Protocol Violation|1|||
42280000|NCT01597479|76111917|FG001|Overall Study|Protocol Violation|0|||
42159765|NCT04246996|75967641|FG000|Overall Study|Did not meet eligibility criteria|1|||
42159766|NCT04246996|75967642|FG001|Overall Study|Did not meet eligibility criteria|4|||
42159767|NCT00424463|75967651|FG000|Overall Study|Adverse Event|2|||
42159768|NCT00424463|75967652|FG001|Overall Study|Adverse Event|3|||
42159769|NCT00424463|75967653|FG002|Overall Study|Adverse Event|2|||
42159770|NCT00424463|75967651|FG000|Overall Study|Physician Decision|0|||
42159771|NCT00424463|75967652|FG001|Overall Study|Physician Decision|2|||
42159772|NCT00424463|75967653|FG002|Overall Study|Physician Decision|2|||
42159773|NCT00424463|75967651|FG000|Overall Study|Withdrawal by Subject|4|||
42159774|NCT00424463|75967652|FG001|Overall Study|Withdrawal by Subject|2|||
42159775|NCT00424463|75967653|FG002|Overall Study|Withdrawal by Subject|5|||
42159776|NCT00424463|75967651|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
42159777|NCT00424463|75967652|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
42159778|NCT00424463|75967653|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
42159779|NCT00424463|75967651|FG000|Overall Study|Patient's convenience|0|||
42159780|NCT00424463|75967652|FG001|Overall Study|Patient's convenience|0|||
42159781|NCT00424463|75967653|FG002|Overall Study|Patient's convenience|1|||
42159782|NCT00424385|75967661|FG000|Cohort 0|Withdrawal by Subject|5|||
42159783|NCT00424385|75967661|FG000|Cohort 0|Physician Decision|1|||
42159784|NCT00424385|75967661|FG000|Cohort 1|Withdrawal by Subject|1|||
42159785|NCT00423917|75967667|FG000|Overall Study|Cancel|2|||
42159786|NCT00423917|75967667|FG000|Overall Study|Ineligible|1|||
42159787|NCT00845026|75967673|FG000|Study Period III|Adverse Event|23|||
42159788|NCT00845026|75967674|FG001|Study Period III|Adverse Event|19|||
42159789|NCT00845026|75967673|FG000|Study Period III|Perceived lack of efficacy|27|||
42159790|NCT00845026|75967674|FG001|Study Period III|Perceived lack of efficacy|15|||
42159791|NCT00845026|75967673|FG000|Study Period III|Withdrawal by Subject|19|||
42159792|NCT00845026|75967674|FG001|Study Period III|Withdrawal by Subject|15|||
42159793|NCT00845026|75967673|FG000|Study Period III|Entry Criteria not met|8|||
42159794|NCT00845026|75967674|FG001|Study Period III|Entry Criteria not met|11|||
42159795|NCT00845026|75967673|FG000|Study Period III|Lost to Follow-up|4|||
42159796|NCT00845026|75967674|FG001|Study Period III|Lost to Follow-up|5|||
42159797|NCT00845026|75967673|FG000|Study Period III|Protocol Violation|8|||
42159798|NCT00845026|75967674|FG001|Study Period III|Protocol Violation|1|||
42159799|NCT00845026|75967673|FG000|Study Period III|Scheduled conflict|3|||
42159800|NCT00845026|75967674|FG001|Study Period III|Scheduled conflict|1|||
42040238|NCT01928394|75848587|FG021|Treatment Period|Participant withdrew consent|2|||
42280001|NCT01597479|76111916|FG000|Overall Study|Lost to Follow-up|1|||
42280002|NCT01597479|76111917|FG001|Overall Study|Lost to Follow-up|0|||
42280003|NCT04248465|76111926|FG000|Randomized-Controlled Period|Death|12|||
42351416|NCT01904773|76191368|FG004|Screen|Screen failure|0|||
42159801|NCT00845026|75967673|FG000|Study Period III|Subject is moving or has moved|2|||
42159802|NCT00845026|75967674|FG001|Study Period III|Subject is moving or has moved|4|||
42159803|NCT00845026|75967673|FG000|Study Period III|Transportation issues|1|||
42280004|NCT04248465|76111927|FG001|Randomized-Controlled Period|Death|5|||
42280005|NCT04248465|76111926|FG000|Randomized-Controlled Period|Adverse Event|2|||
42351417|NCT01904773|76191369|FG005|Screen|Screen failure|0|||
42159804|NCT00845026|75967674|FG001|Study Period III|Transportation issues|1|||
42159805|NCT00845026|75967673|FG000|Study Period IV|Adverse Event|4|||
42159806|NCT00845026|75967674|FG001|Study Period IV|Adverse Event|0|||
42159807|NCT00845026|75967673|FG000|Study Period IV|Perceived lack of efficacy|2|||
42159808|NCT00845026|75967674|FG001|Study Period IV|Perceived lack of efficacy|1|||
42159809|NCT00845026|75967673|FG000|Study Period IV|Protocol Violation|3|||
42159810|NCT00845026|75967674|FG001|Study Period IV|Protocol Violation|1|||
42159811|NCT00845026|75967673|FG000|Study Period IV|Lost to Follow-up|1|||
42159812|NCT00845026|75967674|FG001|Study Period IV|Lost to Follow-up|0|||
42159813|NCT00845026|75967673|FG000|Study Period IV|Withdrawal by Subject|4|||
42159814|NCT00845026|75967674|FG001|Study Period IV|Withdrawal by Subject|1|||
42159815|NCT00845026|75967673|FG000|Study Period IV|Entry Criteria Not Met|1|||
42159816|NCT00845026|75967674|FG001|Study Period IV|Entry Criteria Not Met|0|||
42159817|NCT00845026|75967673|FG000|Study Period IV|Subject is moving or has moved|0|||
42159818|NCT00845026|75967674|FG001|Study Period IV|Subject is moving or has moved|1|||
42159819|NCT00845026|75967673|FG000|Study Period IV|Scheduling conflict|1|||
42159820|NCT00845026|75967674|FG001|Study Period IV|Scheduling conflict|0|||
42159821|NCT00691678|75967682|FG000|Overall Study|Adverse Event|5|||
42159822|NCT00691678|75967682|FG000|Overall Study|life events, pain|11|||
42159823|NCT00423605|75967686|FG000|Overall Study|Adverse Event|129|||
42159824|NCT00423605|75967686|FG000|Overall Study|Withdrawal by Subject|36|||
42159825|NCT00423605|75967686|FG000|Overall Study|Lost to Follow-up|15|||
42159826|NCT00423605|75967686|FG000|Overall Study|Lack of Efficacy|38|||
42159827|NCT00423605|75967686|FG000|Overall Study|Sponsor Decision|3|||
42159828|NCT00423605|75967686|FG000|Overall Study|Physician Decision|8|||
42159829|NCT00423605|75967686|FG000|Overall Study|Protocol Violation|7|||
42159830|NCT00423605|75967686|FG000|Overall Study|Not one of the pre-specified options|5|||
42159831|NCT00423449|75967690|FG000|Overall Study|Clinical Adverse Event|1|||
42159832|NCT00423449|75967691|FG001|Overall Study|Clinical Adverse Event|0|||
42159833|NCT00423449|75967692|FG002|Overall Study|Clinical Adverse Event|1|||
42159834|NCT00423449|75967693|FG003|Overall Study|Clinical Adverse Event|8|||
42159835|NCT00423449|75967694|FG004|Overall Study|Clinical Adverse Event|2|||
42159836|NCT00423449|75967690|FG000|Overall Study|Death|1|||
42159837|NCT00423449|75967691|FG001|Overall Study|Death|0|||
42159838|NCT00423449|75967692|FG002|Overall Study|Death|2|||
42159839|NCT00423449|75967693|FG003|Overall Study|Death|1|||
42159840|NCT00423449|75967694|FG004|Overall Study|Death|1|||
42159841|NCT00423449|75967690|FG000|Overall Study|Progressive Disease|1|||
42159842|NCT00423449|75967691|FG001|Overall Study|Progressive Disease|3|||
42159843|NCT00423449|75967692|FG002|Overall Study|Progressive Disease|8|||
42159844|NCT00423449|75967693|FG003|Overall Study|Progressive Disease|11|||
42159845|NCT00423449|75967694|FG004|Overall Study|Progressive Disease|4|||
42159846|NCT00423449|75967690|FG000|Overall Study|Laboratory Adverse Event|0|||
42159847|NCT00423449|75967691|FG001|Overall Study|Laboratory Adverse Event|1|||
42159848|NCT00423449|75967692|FG002|Overall Study|Laboratory Adverse Event|2|||
42159849|NCT00423449|75967693|FG003|Overall Study|Laboratory Adverse Event|0|||
42159850|NCT00423449|75967694|FG004|Overall Study|Laboratory Adverse Event|0|||
42159851|NCT00423449|75967690|FG000|Overall Study|Other|0|||
42159852|NCT00423449|75967691|FG001|Overall Study|Other|0|||
42159853|NCT00423449|75967692|FG002|Overall Study|Other|0|||
42159854|NCT00423449|75967693|FG003|Overall Study|Other|1|||
42159855|NCT00423449|75967694|FG004|Overall Study|Other|0|||
42159856|NCT00423449|75967690|FG000|Overall Study|Protocol Violation|0|||
42159857|NCT00423449|75967691|FG001|Overall Study|Protocol Violation|0|||
42159858|NCT00423449|75967692|FG002|Overall Study|Protocol Violation|2|||
42159859|NCT00423449|75967693|FG003|Overall Study|Protocol Violation|1|||
42159860|NCT00423449|75967694|FG004|Overall Study|Protocol Violation|0|||
42280006|NCT04248465|76111927|FG001|Randomized-Controlled Period|Adverse Event|0|||
42280007|NCT04248465|76111926|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
42280008|NCT04248465|76111927|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
42280009|NCT04248465|76111926|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
42159861|NCT00423293|75967707|FG000|Overall Study|Ineligible / No protocol treatment|11|||
42159862|NCT00423137|75967715|FG000|Overall Study|Lost to Follow-up|0|||
42159863|NCT00423137|75967716|FG001|Overall Study|Lost to Follow-up|0|||
42159864|NCT00423137|75967717|FG002|Overall Study|Lost to Follow-up|1|||
42159865|NCT00423137|75967718|FG003|Overall Study|Lost to Follow-up|0|||
42159866|NCT00423137|75967715|FG000|Overall Study|Protocol Violation|0|||
42159867|NCT00423137|75967716|FG001|Overall Study|Protocol Violation|0|||
42159868|NCT00423137|75967717|FG002|Overall Study|Protocol Violation|0|||
42159869|NCT00423137|75967718|FG003|Overall Study|Protocol Violation|1|||
42280010|NCT04248465|76111927|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
42159870|NCT00423137|75967715|FG000|Overall Study|Adverse Event Study disease worse|1|||
42159871|NCT00423137|75967716|FG001|Overall Study|Adverse Event Study disease worse|0|||
42159872|NCT00423137|75967717|FG002|Overall Study|Adverse Event Study disease worse|3|||
42159873|NCT00423137|75967718|FG003|Overall Study|Adverse Event Study disease worse|1|||
42159874|NCT00423137|75967715|FG000|Overall Study|Adverse Event Other|0|||
42280011|NCT04248465|76111926|FG000|Randomized-Controlled Period|Physician Decision|1|||
42280012|NCT04248465|76111927|FG001|Randomized-Controlled Period|Physician Decision|1|||
42280013|NCT04248465|76111926|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
42280014|NCT04248465|76111927|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
42280015|NCT04248465|76111926|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
42280016|NCT04248465|76111927|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
42280017|NCT04248465|76111926|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
42280018|NCT04248465|76111927|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
42280019|NCT02643693|76111935|FG000|Overall Study|Physician Decision|0|||
42280020|NCT02643693|76111936|FG001|Overall Study|Physician Decision|1|||
42280021|NCT02643693|76111937|FG002|Overall Study|Physician Decision|0|||
42280022|NCT02643693|76111938|FG003|Overall Study|Physician Decision|0|||
42040239|NCT01928394|75848588|FG022|Treatment Period|Participant withdrew consent|0|||
42159875|NCT00423137|75967716|FG001|Overall Study|Adverse Event Other|0|||
42159876|NCT00423137|75967717|FG002|Overall Study|Adverse Event Other|2|||
42040240|NCT01928394|75848566|FG000|Treatment Period|Poor/non-compliance|0|||
42040241|NCT01928394|75848567|FG001|Treatment Period|Poor/non-compliance|0|||
42040242|NCT01928394|75848568|FG002|Treatment Period|Poor/non-compliance|0|||
42040243|NCT01928394|75848569|FG003|Treatment Period|Poor/non-compliance|1|||
42040244|NCT01928394|75848570|FG004|Treatment Period|Poor/non-compliance|0|||
42040245|NCT01928394|75848571|FG005|Treatment Period|Poor/non-compliance|0|||
42040246|NCT01928394|75848572|FG006|Treatment Period|Poor/non-compliance|0|||
42040247|NCT01928394|75848573|FG007|Treatment Period|Poor/non-compliance|0|||
42040248|NCT01928394|75848574|FG008|Treatment Period|Poor/non-compliance|0|||
42040249|NCT01928394|75848575|FG009|Treatment Period|Poor/non-compliance|0|||
42040250|NCT01928394|75848576|FG010|Treatment Period|Poor/non-compliance|0|||
42040251|NCT01928394|75848577|FG011|Treatment Period|Poor/non-compliance|0|||
42040252|NCT01928394|75848578|FG012|Treatment Period|Poor/non-compliance|1|||
42040253|NCT01928394|75848579|FG013|Treatment Period|Poor/non-compliance|0|||
42040254|NCT01928394|75848580|FG014|Treatment Period|Poor/non-compliance|1|||
42040255|NCT01928394|75848581|FG015|Treatment Period|Poor/non-compliance|0|||
42040256|NCT01928394|75848582|FG016|Treatment Period|Poor/non-compliance|0|||
42040257|NCT01928394|75848583|FG017|Treatment Period|Poor/non-compliance|1|||
42040258|NCT01928394|75848584|FG018|Treatment Period|Poor/non-compliance|0|||
42040259|NCT01928394|75848585|FG019|Treatment Period|Poor/non-compliance|1|||
42040260|NCT01928394|75848586|FG020|Treatment Period|Poor/non-compliance|0|||
42040261|NCT01928394|75848587|FG021|Treatment Period|Poor/non-compliance|0|||
42040262|NCT01928394|75848588|FG022|Treatment Period|Poor/non-compliance|0|||
42040263|NCT01928394|75848566|FG000|Treatment Period|other reason|0|||
42040264|NCT01928394|75848567|FG001|Treatment Period|other reason|0|||
42040265|NCT01928394|75848568|FG002|Treatment Period|other reason|0|||
42040266|NCT01928394|75848569|FG003|Treatment Period|other reason|0|||
42040267|NCT01928394|75848570|FG004|Treatment Period|other reason|0|||
42040268|NCT01928394|75848571|FG005|Treatment Period|other reason|0|||
42040269|NCT01928394|75848572|FG006|Treatment Period|other reason|0|||
42040270|NCT01928394|75848573|FG007|Treatment Period|other reason|0|||
42040271|NCT01928394|75848574|FG008|Treatment Period|other reason|0|||
42040272|NCT01928394|75848575|FG009|Treatment Period|other reason|0|||
42040273|NCT01928394|75848576|FG010|Treatment Period|other reason|1|||
42040274|NCT01928394|75848577|FG011|Treatment Period|other reason|1|||
42040275|NCT01928394|75848578|FG012|Treatment Period|other reason|1|||
42040276|NCT01928394|75848579|FG013|Treatment Period|other reason|0|||
42040277|NCT01928394|75848580|FG014|Treatment Period|other reason|1|||
42040278|NCT01928394|75848581|FG015|Treatment Period|other reason|0|||
42040279|NCT01928394|75848582|FG016|Treatment Period|other reason|0|||
42040280|NCT01928394|75848583|FG017|Treatment Period|other reason|0|||
42040281|NCT01928394|75848584|FG018|Treatment Period|other reason|2|||
42040282|NCT01928394|75848585|FG019|Treatment Period|other reason|2|||
42040283|NCT01928394|75848586|FG020|Treatment Period|other reason|0|||
42040284|NCT01928394|75848587|FG021|Treatment Period|other reason|0|||
42159877|NCT00423137|75967718|FG003|Overall Study|Adverse Event Other|0|||
42159878|NCT00422903|75967733|FG000|Overall Study|Disease Progression|3|||
42159879|NCT00422903|75967734|FG001|Overall Study|Disease Progression|1|||
42280023|NCT02643693|76111939|FG004|Overall Study|Physician Decision|0|||
42351418|NCT01904773|76191370|FG006|Screen|Screen failure|0|||
42040285|NCT01928394|75848588|FG022|Treatment Period|other reason|0|||
42040286|NCT01928394|75848566|FG000|Treatment Period|Maximum clinical benefit|0|||
42159880|NCT00422903|75967733|FG000|Overall Study|Adverse Event|0|||
42280024|NCT02643693|76111940|FG005|Overall Study|Physician Decision|0|||
42040287|NCT01928394|75848567|FG001|Treatment Period|Maximum clinical benefit|0|||
42040288|NCT01928394|75848568|FG002|Treatment Period|Maximum clinical benefit|0|||
42040289|NCT01928394|75848569|FG003|Treatment Period|Maximum clinical benefit|0|||
42040290|NCT01928394|75848570|FG004|Treatment Period|Maximum clinical benefit|0|||
42040291|NCT01928394|75848571|FG005|Treatment Period|Maximum clinical benefit|0|||
42040292|NCT01928394|75848572|FG006|Treatment Period|Maximum clinical benefit|0|||
42280025|NCT02643693|76111935|FG000|Overall Study|Withdrawal by Subject|0|||
42159881|NCT00422903|75967734|FG001|Overall Study|Adverse Event|2|||
42159882|NCT00422903|75967733|FG000|Overall Study|Informed Consent Withdrawn|1|||
42159883|NCT00422903|75967734|FG001|Overall Study|Informed Consent Withdrawn|2|||
42159884|NCT00422669|75967743|FG000|Overall Study|The study was terminated early.|98|||
42159885|NCT00422669|75967744|FG001|Overall Study|The study was terminated early.|100|||
42159886|NCT00422669|75967745|FG002|Overall Study|The study was terminated early.|7|||
42159887|NCT00422591|75967751|FG000|Overall Study|Physician Decision|4|||
42159888|NCT00422591|75967751|FG000|Overall Study|Withdrawal by Subject|2|||
42159889|NCT00422513|75967757|FG000|Overall Study|Lack of Efficacy|4|||
42159890|NCT00422513|75967758|FG001|Overall Study|Lack of Efficacy|5|||
42159891|NCT00422513|75967757|FG000|Overall Study|Protocol Violation|23|||
42159892|NCT00422513|75967758|FG001|Overall Study|Protocol Violation|7|||
42159893|NCT00422513|75967757|FG000|Overall Study|Refused Treatment|4|||
42159894|NCT00422513|75967758|FG001|Overall Study|Refused Treatment|2|||
42159895|NCT00422513|75967757|FG000|Overall Study|Withdrawal by Subject|2|||
42159896|NCT00422513|75967758|FG001|Overall Study|Withdrawal by Subject|1|||
42159897|NCT00422513|75967757|FG000|Overall Study|early termination of the study|67|||
42159898|NCT00422513|75967758|FG001|Overall Study|early termination of the study|80|||
42159899|NCT00422513|75967757|FG000|Overall Study|Adverse Event|4|||
42159900|NCT00422513|75967758|FG001|Overall Study|Adverse Event|4|||
42159901|NCT00422513|75967757|FG000|Overall Study|Death|3|||
42159902|NCT00422513|75967758|FG001|Overall Study|Death|7|||
42159903|NCT00202878|75967766|FG000|Overall Study|Death|964|||
42159904|NCT00202878|75967767|FG001|Overall Study|Death|968|||
42159905|NCT00202878|75967766|FG000|Overall Study|Only Vital Status Known|357|||
42159906|NCT00202878|75967767|FG001|Overall Study|Only Vital Status Known|356|||
42159907|NCT00202878|75967766|FG000|Overall Study|Lost to Follow-up|44|||
42159908|NCT00202878|75967767|FG001|Overall Study|Lost to Follow-up|49|||
42159909|NCT00202878|75967766|FG000|Overall Study|Site Closure|39|||
42159910|NCT00202878|75967767|FG001|Overall Study|Site Closure|36|||
42159911|NCT00202878|75967766|FG000|Overall Study|Withdrawal by Subject|795|||
42159912|NCT00202878|75967767|FG001|Overall Study|Withdrawal by Subject|808|||
42159913|NCT00414011|75967773|FG000|Overall Study|Physician Decision|3|||
42159914|NCT00414011|75967773|FG000|Overall Study|Withdrawal by Subject|2|||
42159915|NCT00231816|75967780|FG000|Overall Study|Adverse Event|1|||
42159916|NCT00231816|75967781|FG001|Overall Study|Adverse Event|0|||
42159917|NCT00231816|75967780|FG000|Overall Study|Lost to Follow-up|8|||
42159918|NCT00231816|75967781|FG001|Overall Study|Lost to Follow-up|5|||
42159919|NCT00231816|75967780|FG000|Overall Study|Protocol Violation|2|||
42159920|NCT00231816|75967781|FG001|Overall Study|Protocol Violation|3|||
42159921|NCT00231816|75967780|FG000|Overall Study|Withdrawal by Subject|3|||
42159922|NCT00231816|75967781|FG001|Overall Study|Withdrawal by Subject|3|||
42159923|NCT00231816|75967780|FG000|Overall Study|Other|2|||
42159924|NCT00231816|75967781|FG001|Overall Study|Other|1|||
42159925|NCT00260208|75967790|FG000|Overall Study|Subject withdrew consent|11|||
42159926|NCT00260208|75967791|FG001|Overall Study|Subject withdrew consent|7|||
42159927|NCT00260208|75967790|FG000|Overall Study|Lost to Follow-up|6|||
42159928|NCT00260208|75967791|FG001|Overall Study|Lost to Follow-up|1|||
42159929|NCT00260208|75967790|FG000|Overall Study|Death|12|||
42159930|NCT00260208|75967791|FG001|Overall Study|Death|10|||
42159931|NCT00260208|75967790|FG000|Overall Study|Missing|18|||
42159932|NCT00260208|75967791|FG001|Overall Study|Missing|16|||
42159933|NCT00202644|75967799|FG000|Overall Study|Adverse Event|12|||
42159934|NCT00202644|75967800|FG001|Overall Study|Adverse Event|13|||
42159935|NCT00202644|75967799|FG000|Overall Study|Withdrawal by Subject|8|||
42159936|NCT00202644|75967800|FG001|Overall Study|Withdrawal by Subject|6|||
42159937|NCT00202644|75967799|FG000|Overall Study|Lack of Efficacy|6|||
42159938|NCT00202644|75967800|FG001|Overall Study|Lack of Efficacy|6|||
42159939|NCT00202644|75967799|FG000|Overall Study|Lost to Follow-up|0|||
42159940|NCT00202644|75967800|FG001|Overall Study|Lost to Follow-up|1|||
42159941|NCT00202644|75967799|FG000|Overall Study|Other|9|||
42159942|NCT00202644|75967800|FG001|Overall Study|Other|1|||
42351419|NCT01904773|76191371|FG007|Screen|Screen failure|0|||
42159943|NCT01235962|75967810|FG000|Overall Study|Withdrawal by Subject|20|||
42159944|NCT01235962|75967811|FG001|Overall Study|Withdrawal by Subject|19|||
42159945|NCT01235962|75967812|FG002|Overall Study|Withdrawal by Subject|62|||
42159946|NCT01235962|75967813|FG003|Overall Study|Withdrawal by Subject|49|||
42159947|NCT01235962|75967810|FG000|Overall Study|Lost to Follow-up|21|||
42159948|NCT01235962|75967811|FG001|Overall Study|Lost to Follow-up|16|||
42159949|NCT01235962|75967812|FG002|Overall Study|Lost to Follow-up|47|||
42159950|NCT01235962|75967813|FG003|Overall Study|Lost to Follow-up|32|||
42159951|NCT01235962|75967810|FG000|Overall Study|Physician Decision|5|||
42159952|NCT01235962|75967811|FG001|Overall Study|Physician Decision|0|||
42159953|NCT01235962|75967812|FG002|Overall Study|Physician Decision|9|||
42159954|NCT01235962|75967813|FG003|Overall Study|Physician Decision|5|||
42159955|NCT00259740|75967833|FG000|Overall Study|Physician Decision|1|||
42159956|NCT00259740|75967834|FG001|Overall Study|Physician Decision|1|||
42159957|NCT00259740|75967833|FG000|Overall Study|Adverse Event|0|||
42159958|NCT00259740|75967834|FG001|Overall Study|Adverse Event|2|||
42159959|NCT00259740|75967833|FG000|Overall Study|Withdrawal by Subject|2|||
42351420|NCT01904773|76191372|FG008|Screen|Screen failure|0|||
42159960|NCT00259740|75967834|FG001|Overall Study|Withdrawal by Subject|6|||
42159961|NCT00259740|75967833|FG000|Overall Study|Death|1|||
42159962|NCT00259740|75967834|FG001|Overall Study|Death|1|||
42159963|NCT00259740|75967833|FG000|Overall Study|Disease progression|19|||
42159964|NCT00259740|75967834|FG001|Overall Study|Disease progression|36|||
42159965|NCT00259740|75967833|FG000|Overall Study|Ongoing|17|||
42159966|NCT00259740|75967834|FG001|Overall Study|Ongoing|3|||
42280026|NCT02643693|76111936|FG001|Overall Study|Withdrawal by Subject|1|||
42280027|NCT02643693|76111937|FG002|Overall Study|Withdrawal by Subject|0|||
42280028|NCT02643693|76111938|FG003|Overall Study|Withdrawal by Subject|0|||
42280029|NCT02643693|76111939|FG004|Overall Study|Withdrawal by Subject|0|||
42280030|NCT02643693|76111940|FG005|Overall Study|Withdrawal by Subject|0|||
42280031|NCT02643693|76111935|FG000|Overall Study|Protocol Adherence Issues|2|||
42280032|NCT02643693|76111936|FG001|Overall Study|Protocol Adherence Issues|0|||
42280033|NCT02643693|76111937|FG002|Overall Study|Protocol Adherence Issues|1|||
42280034|NCT02643693|76111938|FG003|Overall Study|Protocol Adherence Issues|0|||
42280035|NCT02643693|76111939|FG004|Overall Study|Protocol Adherence Issues|0|||
42159967|NCT00259740|75967833|FG000|Overall Study|Other|3|||
42159968|NCT00259740|75967834|FG001|Overall Study|Other|0|||
42159969|NCT00259740|75967833|FG000|Overall Study|Requirement for alternative therapy|0|||
42159970|NCT00259740|75967834|FG001|Overall Study|Requirement for alternative therapy|4|||
42159971|NCT00201006|75967843|FG000|Overall Study|Withdrawal by Subject|7|||
42159972|NCT00201006|75967844|FG001|Overall Study|Withdrawal by Subject|2|||
42159973|NCT00201006|75967845|FG002|Overall Study|Withdrawal by Subject|3|||
42159974|NCT00201006|75967843|FG000|Overall Study|Adverse Event|1|||
42159975|NCT00201006|75967844|FG001|Overall Study|Adverse Event|0|||
42159976|NCT00201006|75967845|FG002|Overall Study|Adverse Event|1|||
42159977|NCT00200850|75967856|FG000|Overall Study|relocation|1|||
42159978|NCT00200850|75967857|FG001|Overall Study|relocation|0|||
42159979|NCT00200850|75967858|FG002|Overall Study|relocation|1|||
42159980|NCT00200850|75967856|FG000|Overall Study|too busy|1|||
42159981|NCT00200850|75967857|FG001|Overall Study|too busy|0|||
42159982|NCT00200850|75967858|FG002|Overall Study|too busy|0|||
42159983|NCT00200850|75967856|FG000|Overall Study|Pregnancy|0|||
42159984|NCT00200850|75967857|FG001|Overall Study|Pregnancy|0|||
42159985|NCT00200850|75967858|FG002|Overall Study|Pregnancy|1|||
42280036|NCT02643693|76111940|FG005|Overall Study|Protocol Adherence Issues|1|||
42280037|NCT02726113|76111950|FG000|Total Enrollment|Physician Decision|0|||
42280038|NCT02726113|76111951|FG001|Total Enrollment|Physician Decision|1|||
42351421|NCT01904773|76191364|FG000|Screen|Withdrawal by Subject|1|||
42351422|NCT01904773|76191365|FG001|Screen|Withdrawal by Subject|0|||
42351423|NCT01904773|76191366|FG002|Screen|Withdrawal by Subject|0|||
42351424|NCT01904773|76191367|FG003|Screen|Withdrawal by Subject|0|||
42159986|NCT00200850|75967856|FG000|Overall Study|Poor adherence|0|||
42159987|NCT00200850|75967857|FG001|Overall Study|Poor adherence|0|||
42159988|NCT00200850|75967858|FG002|Overall Study|Poor adherence|1|||
42159989|NCT00200850|75967856|FG000|Overall Study|optic neuritis|0|||
42159990|NCT00200850|75967857|FG001|Overall Study|optic neuritis|0|||
42159991|NCT00200850|75967858|FG002|Overall Study|optic neuritis|1|||
42159992|NCT00200850|75967856|FG000|Overall Study|Adverse Event|1|||
42159993|NCT00200850|75967857|FG001|Overall Study|Adverse Event|1|||
42159994|NCT00200850|75967858|FG002|Overall Study|Adverse Event|2|||
42159995|NCT03812224|75967868|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
42159996|NCT03812224|75967869|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
42159997|NCT03812224|75967868|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
42159998|NCT03812224|75967869|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
42159999|NCT03812224|75967868|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
42160000|NCT03812224|75967869|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
42160001|NCT03812224|75967868|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
42351425|NCT01904773|76191368|FG004|Screen|Withdrawal by Subject|0|||
42351426|NCT01904773|76191369|FG005|Screen|Withdrawal by Subject|0|||
42351427|NCT01904773|76191370|FG006|Screen|Withdrawal by Subject|0|||
42351428|NCT01904773|76191371|FG007|Screen|Withdrawal by Subject|0|||
42160002|NCT03812224|75967869|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
42160003|NCT00231114|75967878|FG000|Randomized|Withdrawal by Subject|6|||
42160004|NCT00231114|75967879|FG001|Randomized|Withdrawal by Subject|3|||
42351429|NCT01904773|76191372|FG008|Screen|Withdrawal by Subject|0|||
42351430|NCT01904773|76191364|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
42351431|NCT01904773|76191365|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
42351432|NCT01904773|76191366|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
42160005|NCT00231114|75967878|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
42160006|NCT00231114|75967879|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
42160007|NCT00231114|75967878|FG000|Post-Treatment Period|Lost to Follow-up|6|||
42160008|NCT00231114|75967879|FG001|Post-Treatment Period|Lost to Follow-up|1|||
42160009|NCT00231114|75967878|FG000|Post-Treatment Period|Physician Decision|1|||
42160010|NCT00231114|75967879|FG001|Post-Treatment Period|Physician Decision|0|||
42351433|NCT01904773|76191367|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
42160011|NCT00231114|75967878|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
42160012|NCT00231114|75967879|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
42160013|NCT03543046|75967889|FG000|Overall Study|Adverse Event|1|||
42160014|NCT03543046|75967890|FG001|Overall Study|Adverse Event|1|||
42160015|NCT03543046|75967889|FG000|Overall Study|Physician Decision|1|||
42160016|NCT03543046|75967890|FG001|Overall Study|Physician Decision|1|||
42160017|NCT03543046|75967889|FG000|Overall Study|Protocol Violation|1|||
42160018|NCT03543046|75967890|FG001|Overall Study|Protocol Violation|0|||
42160019|NCT00259272|75967909|FG000|Overall Study|Adverse Event|2|||
42160020|NCT00259272|75967910|FG001|Overall Study|Adverse Event|1|||
42160021|NCT00259272|75967911|FG002|Overall Study|Adverse Event|0|||
42160022|NCT00259272|75967912|FG003|Overall Study|Adverse Event|3|||
42160023|NCT00259272|75967909|FG000|Overall Study|Lack of Efficacy|5|||
42160024|NCT00259272|75967910|FG001|Overall Study|Lack of Efficacy|1|||
42160025|NCT00259272|75967911|FG002|Overall Study|Lack of Efficacy|2|||
42160026|NCT00259272|75967912|FG003|Overall Study|Lack of Efficacy|6|||
42160027|NCT00259272|75967909|FG000|Overall Study|Physician Decision|1|||
42160028|NCT00259272|75967910|FG001|Overall Study|Physician Decision|2|||
42160029|NCT00259272|75967911|FG002|Overall Study|Physician Decision|1|||
42160030|NCT00259272|75967912|FG003|Overall Study|Physician Decision|3|||
42160031|NCT00259272|75967909|FG000|Overall Study|Protocol Violation|2|||
42160032|NCT00259272|75967910|FG001|Overall Study|Protocol Violation|0|||
42160033|NCT00259272|75967911|FG002|Overall Study|Protocol Violation|0|||
42160034|NCT00259272|75967912|FG003|Overall Study|Protocol Violation|1|||
42160035|NCT00259272|75967909|FG000|Overall Study|Sponsor Decision|0|||
42160036|NCT00259272|75967910|FG001|Overall Study|Sponsor Decision|1|||
42160037|NCT00259272|75967911|FG002|Overall Study|Sponsor Decision|0|||
42160038|NCT00259272|75967912|FG003|Overall Study|Sponsor Decision|0|||
42160039|NCT00259272|75967909|FG000|Overall Study|Withdrawal by Subject|4|||
42160040|NCT00259272|75967910|FG001|Overall Study|Withdrawal by Subject|2|||
42160041|NCT00259272|75967911|FG002|Overall Study|Withdrawal by Subject|2|||
42160042|NCT00259272|75967912|FG003|Overall Study|Withdrawal by Subject|7|||
42160043|NCT00259272|75967909|FG000|Overall Study|Lost to Follow-up|1|||
42160044|NCT00259272|75967910|FG001|Overall Study|Lost to Follow-up|0|||
42160045|NCT00259272|75967911|FG002|Overall Study|Lost to Follow-up|0|||
42160046|NCT00259272|75967912|FG003|Overall Study|Lost to Follow-up|1|||
42160047|NCT00421889|75967945|FG000|Overall Study|Adverse Event|1|||
42160048|NCT00421889|75967946|FG001|Overall Study|Adverse Event|0|||
42160049|NCT00421889|75967947|FG002|Overall Study|Adverse Event|1|||
42160050|NCT00421889|75967948|FG003|Overall Study|Adverse Event|1|||
42160051|NCT00421889|75967949|FG004|Overall Study|Adverse Event|1|||
42160052|NCT00421889|75967950|FG005|Overall Study|Adverse Event|4|||
42160053|NCT00421889|75967951|FG006|Overall Study|Adverse Event|1|||
42160054|NCT00421889|75967952|FG007|Overall Study|Adverse Event|0|||
42160055|NCT00421889|75967953|FG008|Overall Study|Adverse Event|2|||
42160056|NCT00421889|75967945|FG000|Overall Study|Withdrawal by Subject|1|||
42160057|NCT00421889|75967946|FG001|Overall Study|Withdrawal by Subject|3|||
42160058|NCT00421889|75967947|FG002|Overall Study|Withdrawal by Subject|0|||
42160059|NCT00421889|75967948|FG003|Overall Study|Withdrawal by Subject|0|||
42160060|NCT00421889|75967949|FG004|Overall Study|Withdrawal by Subject|2|||
42160061|NCT00421889|75967950|FG005|Overall Study|Withdrawal by Subject|0|||
42160062|NCT00421889|75967951|FG006|Overall Study|Withdrawal by Subject|0|||
42160063|NCT00421889|75967952|FG007|Overall Study|Withdrawal by Subject|0|||
42160064|NCT00421889|75967953|FG008|Overall Study|Withdrawal by Subject|0|||
42160065|NCT00421889|75967945|FG000|Overall Study|Death|0|||
42160066|NCT00421889|75967946|FG001|Overall Study|Death|0|||
42160067|NCT00421889|75967947|FG002|Overall Study|Death|0|||
42160068|NCT00421889|75967948|FG003|Overall Study|Death|0|||
42160069|NCT00421889|75967949|FG004|Overall Study|Death|1|||
42160070|NCT00421889|75967950|FG005|Overall Study|Death|1|||
42160071|NCT00421889|75967951|FG006|Overall Study|Death|0|||
42160072|NCT00421889|75967952|FG007|Overall Study|Death|0|||
42280039|NCT02726113|76111950|FG000|Total Enrollment|Protocol Violation|1|||
42280040|NCT02726113|76111951|FG001|Total Enrollment|Protocol Violation|0|||
42280041|NCT02726113|76111950|FG000|Total Enrollment|Withdrawal by Subject|2|||
42280042|NCT02726113|76111951|FG001|Total Enrollment|Withdrawal by Subject|1|||
42280043|NCT02726113|76111950|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
42280044|NCT02726113|76111951|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
42280045|NCT02726113|76111950|FG000|Genomic Analysis|Protocol Violation|1|||
42280046|NCT02726113|76111951|FG001|Genomic Analysis|Protocol Violation|0|||
42160073|NCT00421889|75967953|FG008|Overall Study|Death|0|||
42160074|NCT00421889|75967945|FG000|Overall Study|Progressive disease|3|||
42160075|NCT00421889|75967946|FG001|Overall Study|Progressive disease|2|||
42160076|NCT00421889|75967947|FG002|Overall Study|Progressive disease|2|||
42160077|NCT00421889|75967948|FG003|Overall Study|Progressive disease|3|||
42160078|NCT00421889|75967949|FG004|Overall Study|Progressive disease|2|||
42160079|NCT00421889|75967950|FG005|Overall Study|Progressive disease|21|||
42160080|NCT00421889|75967951|FG006|Overall Study|Progressive disease|3|||
42160081|NCT00421889|75967952|FG007|Overall Study|Progressive disease|1|||
42160082|NCT00421889|75967953|FG008|Overall Study|Progressive disease|5|||
42160083|NCT00421889|75967945|FG000|Overall Study|Patient/Investigator request|0|||
42160084|NCT00421889|75967946|FG001|Overall Study|Patient/Investigator request|0|||
42160085|NCT00421889|75967947|FG002|Overall Study|Patient/Investigator request|0|||
42160086|NCT00421889|75967948|FG003|Overall Study|Patient/Investigator request|0|||
42160087|NCT00421889|75967949|FG004|Overall Study|Patient/Investigator request|0|||
42160088|NCT00421889|75967950|FG005|Overall Study|Patient/Investigator request|9|||
42160089|NCT00421889|75967951|FG006|Overall Study|Patient/Investigator request|0|||
42160090|NCT00421889|75967952|FG007|Overall Study|Patient/Investigator request|1|||
42160091|NCT00421889|75967953|FG008|Overall Study|Patient/Investigator request|3|||
42160092|NCT00421889|75967945|FG000|Overall Study|Lost to Follow-up|0|||
42160093|NCT00421889|75967946|FG001|Overall Study|Lost to Follow-up|0|||
42160094|NCT00421889|75967947|FG002|Overall Study|Lost to Follow-up|0|||
42160095|NCT00421889|75967948|FG003|Overall Study|Lost to Follow-up|0|||
42013481|NCT00998296|75820560|FG010|Overall Study|Other adverse event|2|||
42160096|NCT00421889|75967949|FG004|Overall Study|Lost to Follow-up|0|||
42160097|NCT00421889|75967950|FG005|Overall Study|Lost to Follow-up|0|||
42160098|NCT00421889|75967951|FG006|Overall Study|Lost to Follow-up|0|||
42160099|NCT00421889|75967952|FG007|Overall Study|Lost to Follow-up|0|||
42160100|NCT00421889|75967953|FG008|Overall Study|Lost to Follow-up|1|||
42160101|NCT00421733|75967980|FG000|Overall Study|Adverse Event|4|||
42160102|NCT00421733|75967981|FG001|Overall Study|Adverse Event|9|||
42160103|NCT00421733|75967982|FG002|Overall Study|Adverse Event|2|||
42160104|NCT00421733|75967980|FG000|Overall Study|Lost to Follow-up|1|||
42160105|NCT00421733|75967981|FG001|Overall Study|Lost to Follow-up|2|||
42160106|NCT00421733|75967982|FG002|Overall Study|Lost to Follow-up|4|||
42160107|NCT00421733|75967980|FG000|Overall Study|Withdrawal by Subject|1|||
42160108|NCT00421733|75967981|FG001|Overall Study|Withdrawal by Subject|2|||
42160109|NCT00421733|75967982|FG002|Overall Study|Withdrawal by Subject|7|||
42160110|NCT00421733|75967980|FG000|Overall Study|Death|0|||
42160111|NCT00421733|75967981|FG001|Overall Study|Death|3|||
42160112|NCT00421733|75967982|FG002|Overall Study|Death|0|||
42160113|NCT00421733|75967980|FG000|Overall Study|Required dialysis|1|||
42160114|NCT00421733|75967981|FG001|Overall Study|Required dialysis|0|||
42160115|NCT00421733|75967982|FG002|Overall Study|Required dialysis|0|||
42160116|NCT00421733|75967980|FG000|Overall Study|Administrative|2|||
42160117|NCT00421733|75967981|FG001|Overall Study|Administrative|0|||
42160118|NCT00421733|75967982|FG002|Overall Study|Administrative|0|||
42160119|NCT00421733|75967980|FG000|Overall Study|Did not satisfy entry criteria|1|||
42160120|NCT00421733|75967981|FG001|Overall Study|Did not satisfy entry criteria|3|||
42160121|NCT00421733|75967982|FG002|Overall Study|Did not satisfy entry criteria|2|||
42160122|NCT00421733|75967980|FG000|Overall Study|Sponsor request|1|||
42160123|NCT00421733|75967981|FG001|Overall Study|Sponsor request|0|||
42160124|NCT00421733|75967982|FG002|Overall Study|Sponsor request|3|||
42160125|NCT00421733|75967980|FG000|Overall Study|Protocol deviation|4|||
42160126|NCT00421733|75967981|FG001|Overall Study|Protocol deviation|7|||
42160127|NCT00421733|75967982|FG002|Overall Study|Protocol deviation|2|||
42160128|NCT00421343|75967994|FG000|Overall Study|Death|1|||
42160129|NCT00421343|75967994|FG000|Overall Study|Withdrawal by Subject|2|||
42160130|NCT00421343|75967994|FG000|Overall Study|Lost to Follow-up|3|||
42160131|NCT00230178|75968001|FG000|Overall Study|Adverse Event|1|||
42160132|NCT00230178|75968002|FG001|Overall Study|Adverse Event|5|||
42160133|NCT00230178|75968003|FG002|Overall Study|Adverse Event|2|||
42160134|NCT00230178|75968001|FG000|Overall Study|Withdrawal by Subject|0|||
42160135|NCT00230178|75968002|FG001|Overall Study|Withdrawal by Subject|0|||
42160136|NCT00230178|75968003|FG002|Overall Study|Withdrawal by Subject|1|||
42160137|NCT00230178|75968001|FG000|Overall Study|Various other reasons|3|||
42160138|NCT00230178|75968002|FG001|Overall Study|Various other reasons|2|||
42160139|NCT00230178|75968003|FG002|Overall Study|Various other reasons|4|||
42160140|NCT00413777|75968013|FG000|Fixed-dose Period|Lost to Follow-up|1|||
42160141|NCT00413777|75968014|FG001|Fixed-dose Period|Lost to Follow-up|1|||
42160142|NCT00413777|75968013|FG000|Fixed-dose Period|Adverse Event|2|||
42160143|NCT00413777|75968014|FG001|Fixed-dose Period|Adverse Event|1|||
42160144|NCT00413777|75968013|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
42160145|NCT00413777|75968014|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
42160146|NCT00413777|75968013|FG000|Fixed-dose Period|Withdrew Consent|0|||
42160147|NCT00413777|75968014|FG001|Fixed-dose Period|Withdrew Consent|1|||
42160148|NCT00197028|75968022|FG000|Overall Study|Adverse Event|2|||
42160149|NCT00197028|75968023|FG001|Overall Study|Adverse Event|2|||
42160150|NCT00197028|75968022|FG000|Overall Study|Protocol Violation|2|||
42160151|NCT00197028|75968023|FG001|Overall Study|Protocol Violation|1|||
42160152|NCT00197028|75968022|FG000|Overall Study|Withdrawal by Subject|8|||
42160153|NCT00197028|75968023|FG001|Overall Study|Withdrawal by Subject|12|||
42160154|NCT00197028|75968022|FG000|Overall Study|Lost to Follow-up|1|||
42160155|NCT00197028|75968023|FG001|Overall Study|Lost to Follow-up|0|||
42160156|NCT00197028|75968022|FG000|Overall Study|Other|3|||
42160157|NCT00197028|75968023|FG001|Overall Study|Other|6|||
42160158|NCT00420641|75968032|FG000|Overall Study|Adverse Event|3|||
42160159|NCT00420641|75968033|FG001|Overall Study|Adverse Event|25|||
42160160|NCT00420641|75968034|FG002|Overall Study|Adverse Event|10|||
42160161|NCT00420641|75968032|FG000|Overall Study|Lost to Follow-up|2|||
42160162|NCT00420641|75968033|FG001|Overall Study|Lost to Follow-up|4|||
42160163|NCT00420641|75968034|FG002|Overall Study|Lost to Follow-up|2|||
42160164|NCT00420641|75968032|FG000|Overall Study|Protocol Violation|8|||
42160165|NCT00420641|75968033|FG001|Overall Study|Protocol Violation|8|||
42160166|NCT00420641|75968034|FG002|Overall Study|Protocol Violation|7|||
42160167|NCT00420641|75968032|FG000|Overall Study|Withdrawal by Subject|15|||
42160168|NCT00420641|75968033|FG001|Overall Study|Withdrawal by Subject|21|||
42160169|NCT00420641|75968034|FG002|Overall Study|Withdrawal by Subject|14|||
42160170|NCT00420641|75968032|FG000|Overall Study|Lack of Efficacy|6|||
42160171|NCT00420641|75968033|FG001|Overall Study|Lack of Efficacy|5|||
42160172|NCT00420641|75968034|FG002|Overall Study|Lack of Efficacy|4|||
42160173|NCT00420641|75968032|FG000|Overall Study|Non-compliance|7|||
42160174|NCT00420641|75968033|FG001|Overall Study|Non-compliance|5|||
42160175|NCT00420641|75968034|FG002|Overall Study|Non-compliance|4|||
42160176|NCT00420641|75968032|FG000|Overall Study|Other|4|||
42160177|NCT00420641|75968033|FG001|Overall Study|Other|4|||
42160178|NCT00420641|75968034|FG002|Overall Study|Other|3|||
42160179|NCT00257556|75968044|FG000|Overall Study|Adverse Event|1|||
42160180|NCT00257556|75968045|FG001|Overall Study|Adverse Event|4|||
42160181|NCT00257556|75968044|FG000|Overall Study|Physician Decision|6|||
42160182|NCT00257556|75968045|FG001|Overall Study|Physician Decision|0|||
42160183|NCT00257556|75968044|FG000|Overall Study|Did not meet hCG criterion|3|||
42160184|NCT00257556|75968045|FG001|Overall Study|Did not meet hCG criterion|0|||
42160185|NCT00257556|75968044|FG000|Overall Study|other reason|4|||
42160186|NCT00257556|75968045|FG001|Overall Study|other reason|6|||
42160187|NCT00228384|75968053|FG000|Overall Study|Death|9|||
42160188|NCT00228384|75968054|FG001|Overall Study|Death|3|||
42160189|NCT00228384|75968053|FG000|Overall Study|Lost to Follow-up|6|||
42160190|NCT00228384|75968054|FG001|Overall Study|Lost to Follow-up|10|||
42160191|NCT00228384|75968053|FG000|Overall Study|Surgical Intervention (bypass)|5|||
42160192|NCT00228384|75968054|FG001|Overall Study|Surgical Intervention (bypass)|5|||
42160193|NCT00228384|75968053|FG000|Overall Study|Withdrawal by Subject|9|||
42160194|NCT00228384|75968054|FG001|Overall Study|Withdrawal by Subject|10|||
42160195|NCT00228384|75968053|FG000|Overall Study|Physician Decision|0|||
42160196|NCT00228384|75968054|FG001|Overall Study|Physician Decision|1|||
42160197|NCT00257166|75968062|FG000|Overall Study|Adverse Event|18|||
42160198|NCT00257166|75968063|FG001|Overall Study|Adverse Event|13|||
42160199|NCT00257166|75968062|FG000|Overall Study|Laboratory abnormality|1|||
42160200|NCT00257166|75968063|FG001|Overall Study|Laboratory abnormality|0|||
42160201|NCT00257166|75968062|FG000|Overall Study|Lost to Follow-up|8|||
42160202|NCT00257166|75968063|FG001|Overall Study|Lost to Follow-up|1|||
42160203|NCT00257166|75968062|FG000|Overall Study|Withdrawal by Subject|9|||
42160204|NCT00257166|75968063|FG001|Overall Study|Withdrawal by Subject|2|||
42160205|NCT00257166|75968062|FG000|Overall Study|Other|16|||
42160206|NCT00257166|75968063|FG001|Overall Study|Other|21|||
42280047|NCT02726113|76111950|FG000|Genomic Analysis|Withdrawal by Subject|2|||
42280048|NCT02726113|76111951|FG001|Genomic Analysis|Withdrawal by Subject|1|||
42280049|NCT02726113|76111950|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
42160207|NCT00257166|75968062|FG000|Overall Study|Randomized, but not treated|1|||
42160208|NCT00257166|75968063|FG001|Overall Study|Randomized, but not treated|0|||
42160209|NCT00227370|75968071|FG000|Overall Study|Withdrawal by Subject|1|||
42160210|NCT00227370|75968072|FG001|Overall Study|Withdrawal by Subject|2|||
42160211|NCT00227370|75968071|FG000|Overall Study|Death|3|||
42160212|NCT00227370|75968072|FG001|Overall Study|Death|4|||
42280050|NCT02726113|76111951|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
42280051|NCT01361919|76111969|FG000|Overall Study|technical issues|10|||
42160213|NCT00227370|75968071|FG000|Overall Study|Adverse Event|6|||
42160214|NCT00227370|75968072|FG001|Overall Study|Adverse Event|11|||
42160215|NCT00227370|75968071|FG000|Overall Study|Physician Decision|9|||
42160216|NCT00227370|75968072|FG001|Overall Study|Physician Decision|6|||
42160217|NCT00227370|75968071|FG000|Overall Study|Other reasons|2|||
42160218|NCT00227370|75968072|FG001|Overall Study|Other reasons|1|||
42160219|NCT00191100|75968080|FG000|Overall Study|Adverse Event|18|||
42160220|NCT00191100|75968081|FG001|Overall Study|Adverse Event|1|||
42160221|NCT00191100|75968080|FG000|Overall Study|Lost to Follow-up|2|||
42280052|NCT01361919|76111970|FG001|Overall Study|technical issues|12|||
42280053|NCT01361919|76111971|FG002|Overall Study|technical issues|10|||
42160222|NCT00191100|75968081|FG001|Overall Study|Lost to Follow-up|0|||
42160223|NCT00191100|75968080|FG000|Overall Study|Patient Moved|0|||
42160224|NCT00191100|75968081|FG001|Overall Study|Patient Moved|1|||
42160225|NCT00191100|75968080|FG000|Overall Study|Withdrawal by Subject|9|||
42160226|NCT00191100|75968081|FG001|Overall Study|Withdrawal by Subject|3|||
42160227|NCT00191100|75968080|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
42160228|NCT00191100|75968081|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
42160229|NCT00191100|75968080|FG000|Overall Study|Clinical Relapse|2|||
42160230|NCT00191100|75968081|FG001|Overall Study|Clinical Relapse|1|||
42160231|NCT00191100|75968080|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
42040293|NCT01928394|75848573|FG007|Treatment Period|Maximum clinical benefit|0|||
42040294|NCT01928394|75848574|FG008|Treatment Period|Maximum clinical benefit|0|||
42040295|NCT01928394|75848575|FG009|Treatment Period|Maximum clinical benefit|0|||
42040296|NCT01928394|75848576|FG010|Treatment Period|Maximum clinical benefit|1|||
42040297|NCT01928394|75848577|FG011|Treatment Period|Maximum clinical benefit|1|||
42040298|NCT01928394|75848578|FG012|Treatment Period|Maximum clinical benefit|0|||
42040299|NCT01928394|75848579|FG013|Treatment Period|Maximum clinical benefit|0|||
42040300|NCT01928394|75848580|FG014|Treatment Period|Maximum clinical benefit|1|||
42040301|NCT01928394|75848581|FG015|Treatment Period|Maximum clinical benefit|0|||
42040302|NCT01928394|75848582|FG016|Treatment Period|Maximum clinical benefit|0|||
42040303|NCT01928394|75848583|FG017|Treatment Period|Maximum clinical benefit|1|||
42040304|NCT01928394|75848584|FG018|Treatment Period|Maximum clinical benefit|1|||
42040305|NCT01928394|75848585|FG019|Treatment Period|Maximum clinical benefit|0|||
42040306|NCT01928394|75848586|FG020|Treatment Period|Maximum clinical benefit|2|||
42040307|NCT01928394|75848587|FG021|Treatment Period|Maximum clinical benefit|0|||
42040308|NCT01928394|75848588|FG022|Treatment Period|Maximum clinical benefit|0|||
42040309|NCT01928394|75848566|FG000|Treatment Period|Lost to Follow-up|0|||
42040310|NCT01928394|75848567|FG001|Treatment Period|Lost to Follow-up|0|||
42040311|NCT01928394|75848568|FG002|Treatment Period|Lost to Follow-up|0|||
42040312|NCT01928394|75848569|FG003|Treatment Period|Lost to Follow-up|0|||
42040313|NCT01928394|75848570|FG004|Treatment Period|Lost to Follow-up|0|||
42040314|NCT01928394|75848571|FG005|Treatment Period|Lost to Follow-up|0|||
42040315|NCT01928394|75848572|FG006|Treatment Period|Lost to Follow-up|0|||
42040316|NCT01928394|75848573|FG007|Treatment Period|Lost to Follow-up|0|||
42040317|NCT01928394|75848574|FG008|Treatment Period|Lost to Follow-up|0|||
42040318|NCT01928394|75848575|FG009|Treatment Period|Lost to Follow-up|0|||
42040319|NCT01928394|75848576|FG010|Treatment Period|Lost to Follow-up|0|||
42040320|NCT01928394|75848577|FG011|Treatment Period|Lost to Follow-up|0|||
42040321|NCT01928394|75848578|FG012|Treatment Period|Lost to Follow-up|0|||
42040322|NCT01928394|75848579|FG013|Treatment Period|Lost to Follow-up|0|||
42040323|NCT01928394|75848580|FG014|Treatment Period|Lost to Follow-up|0|||
42040324|NCT01928394|75848581|FG015|Treatment Period|Lost to Follow-up|0|||
42040325|NCT01928394|75848582|FG016|Treatment Period|Lost to Follow-up|0|||
42040326|NCT01928394|75848583|FG017|Treatment Period|Lost to Follow-up|0|||
42040327|NCT01928394|75848584|FG018|Treatment Period|Lost to Follow-up|0|||
42040328|NCT01928394|75848585|FG019|Treatment Period|Lost to Follow-up|0|||
42040329|NCT01928394|75848586|FG020|Treatment Period|Lost to Follow-up|0|||
42040330|NCT01928394|75848587|FG021|Treatment Period|Lost to Follow-up|0|||
42040331|NCT01928394|75848588|FG022|Treatment Period|Lost to Follow-up|1|||
42040332|NCT01928394|75848566|FG000|Treatment Period|Death|0|||
42040333|NCT01928394|75848567|FG001|Treatment Period|Death|0|||
42040334|NCT01928394|75848568|FG002|Treatment Period|Death|0|||
42040335|NCT01928394|75848569|FG003|Treatment Period|Death|0|||
42160232|NCT00191100|75968081|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
42160233|NCT00191100|75968080|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
42160234|NCT00191100|75968081|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
42160235|NCT00191100|75968080|FG000|Overall Study|Physician Decision|3|||
42280054|NCT02642679|76111979|FG000|Overall Study|Withdrawal by Subject|1|||
42280055|NCT02642679|76111979|FG000|Overall Study|Physician Decision|1|||
42280056|NCT02642679|76111979|FG000|Overall Study|Physician Decision|1|||
42280057|NCT00705523|76111985|FG000|Overall Study|Lost to Follow-up|2|||
42280058|NCT00705523|76111986|FG001|Overall Study|Lost to Follow-up|3|||
42280059|NCT02725411|76111995|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
42280060|NCT02725411|76111996|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
42280061|NCT02725411|76111997|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
42280062|NCT02725411|76111995|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
42280063|NCT02725411|76111996|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
42280064|NCT02725411|76111997|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
42280065|NCT02725411|76111995|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
42280066|NCT02725411|76111996|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
42040336|NCT01928394|75848570|FG004|Treatment Period|Death|0|||
42040337|NCT01928394|75848571|FG005|Treatment Period|Death|0|||
42040338|NCT01928394|75848572|FG006|Treatment Period|Death|0|||
42040339|NCT01928394|75848573|FG007|Treatment Period|Death|0|||
42280067|NCT02725411|76111997|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
42040340|NCT01928394|75848574|FG008|Treatment Period|Death|0|||
42280068|NCT02725411|76111995|FG000|Treatment Period (56 Weeks)|Other|1|||
42040341|NCT01928394|75848575|FG009|Treatment Period|Death|0|||
42040342|NCT01928394|75848576|FG010|Treatment Period|Death|0|||
42040343|NCT01928394|75848577|FG011|Treatment Period|Death|0|||
42040344|NCT01928394|75848578|FG012|Treatment Period|Death|0|||
42040345|NCT01928394|75848579|FG013|Treatment Period|Death|1|||
42040346|NCT01928394|75848580|FG014|Treatment Period|Death|2|||
42280069|NCT02725411|76111996|FG001|Treatment Period (56 Weeks)|Other|4|||
42280070|NCT02725411|76111997|FG002|Treatment Period (56 Weeks)|Other|5|||
42280071|NCT02725411|76111995|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
42280072|NCT02725411|76111996|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
42280073|NCT02725411|76111997|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
42280074|NCT02725411|76111995|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
42280075|NCT02725411|76111996|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
42280076|NCT02725411|76111997|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
42280077|NCT02725411|76111995|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
42280078|NCT02725411|76111996|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
42280079|NCT02725411|76111997|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
42280080|NCT02725411|76111995|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
42160236|NCT00191100|75968081|FG001|Overall Study|Physician Decision|1|||
42160237|NCT00191100|75968080|FG000|Overall Study|Death from Study Drug Toxicity|2|||
42160238|NCT00191100|75968081|FG001|Overall Study|Death from Study Drug Toxicity|0|||
42160239|NCT00191100|75968080|FG000|Overall Study|Protocol Violation|1|||
42160240|NCT00191100|75968081|FG001|Overall Study|Protocol Violation|1|||
42160241|NCT00191100|75968080|FG000|Overall Study|Death from Other Cause|1|||
42160242|NCT00191100|75968081|FG001|Overall Study|Death from Other Cause|0|||
42160243|NCT00191100|75968080|FG000|Overall Study|Reason Not Specified|0|||
42160244|NCT00191100|75968081|FG001|Overall Study|Reason Not Specified|1|||
42160245|NCT00189540|75968089|FG000|Overall Study|Withdrawal by Subject|3|||
42160246|NCT00189540|75968090|FG001|Overall Study|Withdrawal by Subject|0|||
42160247|NCT00189540|75968089|FG000|Overall Study|Death|4|||
42160248|NCT00189540|75968090|FG001|Overall Study|Death|1|||
42160249|NCT00257010|75968096|FG000|Overall Study|Lack of Efficacy|11|||
42160250|NCT00257010|75968096|FG000|Overall Study|Lost to Follow-up|53|||
42160251|NCT00257010|75968096|FG000|Overall Study|Withdrawal by Subject|34|||
42160252|NCT00257010|75968096|FG000|Overall Study|Adverse Event|10|||
42160253|NCT00257010|75968096|FG000|Overall Study|various|11|||
42160254|NCT00257010|75968096|FG000|Overall Study|no headache reported|9|||
42160255|NCT00256854|75968106|FG000|Overall Study|Withdrawal by Subject|2|||
42160256|NCT00256854|75968107|FG001|Overall Study|Withdrawal by Subject|3|||
42160257|NCT00256854|75968108|FG002|Overall Study|Withdrawal by Subject|0|||
42160258|NCT00256854|75968109|FG003|Overall Study|Withdrawal by Subject|0|||
42160259|NCT00256854|75968110|FG004|Overall Study|Withdrawal by Subject|0|||
42160260|NCT00256854|75968111|FG005|Overall Study|Withdrawal by Subject|0|||
42160261|NCT00256854|75968106|FG000|Overall Study|Lack of Efficacy|1|||
42160262|NCT00256854|75968107|FG001|Overall Study|Lack of Efficacy|0|||
42160263|NCT00256854|75968108|FG002|Overall Study|Lack of Efficacy|0|||
42160264|NCT00256854|75968109|FG003|Overall Study|Lack of Efficacy|0|||
42160265|NCT00256854|75968110|FG004|Overall Study|Lack of Efficacy|0|||
42280081|NCT02725411|76111996|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
42280082|NCT02725411|76111997|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
42280083|NCT02725411|76111995|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
42280084|NCT02725411|76111996|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
42280085|NCT02725411|76111997|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
42280086|NCT02725411|76111995|FG000|Follow-up Period (24 Weeks)|Other|1|||
42280087|NCT02725411|76111996|FG001|Follow-up Period (24 Weeks)|Other|4|||
42280088|NCT02725411|76111997|FG002|Follow-up Period (24 Weeks)|Other|2|||
42280089|NCT02725411|76111995|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
42280090|NCT02725411|76111996|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
42280091|NCT02725411|76111997|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
42280092|NCT02190604|76112033|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280093|NCT02190604|76112034|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280094|NCT02190604|76112035|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280095|NCT02190604|76112036|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280096|NCT02190604|76112037|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42013482|NCT00998296|75820550|FG000|Overall Study|Refused to continue taking trial med.|0|||
42013483|NCT00998296|75820551|FG001|Overall Study|Refused to continue taking trial med.|0|||
42013484|NCT00998296|75820552|FG002|Overall Study|Refused to continue taking trial med.|0|||
42013485|NCT00998296|75820553|FG003|Overall Study|Refused to continue taking trial med.|0|||
42013486|NCT00998296|75820554|FG004|Overall Study|Refused to continue taking trial med.|0|||
42013487|NCT00998296|75820555|FG005|Overall Study|Refused to continue taking trial med.|0|||
42013488|NCT00998296|75820556|FG006|Overall Study|Refused to continue taking trial med.|0|||
42013489|NCT00998296|75820557|FG007|Overall Study|Refused to continue taking trial med.|0|||
42160266|NCT00256854|75968111|FG005|Overall Study|Lack of Efficacy|0|||
42160267|NCT00256854|75968106|FG000|Overall Study|Protocol Violation|0|||
42160268|NCT00256854|75968107|FG001|Overall Study|Protocol Violation|1|||
42160269|NCT00256854|75968108|FG002|Overall Study|Protocol Violation|1|||
42280097|NCT02190604|76112038|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280098|NCT02190604|76112039|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280099|NCT02190604|76112040|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280100|NCT02190604|76112041|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280101|NCT02190604|76112042|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280102|NCT02190604|76112043|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280103|NCT02190604|76112044|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280104|NCT02190604|76112045|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280105|NCT02190604|76112046|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42160270|NCT00256854|75968109|FG003|Overall Study|Protocol Violation|1|||
42160271|NCT00256854|75968110|FG004|Overall Study|Protocol Violation|0|||
42160272|NCT00256854|75968111|FG005|Overall Study|Protocol Violation|0|||
42160273|NCT00256854|75968106|FG000|Overall Study|Adverse Event|0|||
42280106|NCT02190604|76112047|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
42280107|NCT02190604|76112048|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280108|NCT02190604|76112049|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280109|NCT02190604|76112050|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42280110|NCT02190604|76112051|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
42160274|NCT00256854|75968107|FG001|Overall Study|Adverse Event|0|||
42160275|NCT00256854|75968108|FG002|Overall Study|Adverse Event|2|||
42160276|NCT00256854|75968109|FG003|Overall Study|Adverse Event|2|||
42160277|NCT00256854|75968110|FG004|Overall Study|Adverse Event|0|||
42160278|NCT00256854|75968111|FG005|Overall Study|Adverse Event|1|||
42160279|NCT00256854|75968106|FG000|Overall Study|Not compliant with the study drug|0|||
42160280|NCT00256854|75968107|FG001|Overall Study|Not compliant with the study drug|0|||
42160281|NCT00256854|75968108|FG002|Overall Study|Not compliant with the study drug|0|||
42160282|NCT00256854|75968109|FG003|Overall Study|Not compliant with the study drug|0|||
42160283|NCT00256854|75968110|FG004|Overall Study|Not compliant with the study drug|1|||
42160284|NCT00256854|75968111|FG005|Overall Study|Not compliant with the study drug|0|||
42160285|NCT00189462|75968128|FG000|Overall Study|Lack of Efficacy|5|||
42160286|NCT00189462|75968129|FG001|Overall Study|Lack of Efficacy|1|||
42160287|NCT00189462|75968128|FG000|Overall Study|Lost to Follow-up|18|||
42160288|NCT00189462|75968129|FG001|Overall Study|Lost to Follow-up|20|||
42160289|NCT00256698|75968137|FG000|Overall Study|Withdrawal by Subject|7|||
42280111|NCT02190604|76112033|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42160290|NCT00256698|75968138|FG001|Overall Study|Withdrawal by Subject|7|||
42160291|NCT00256698|75968137|FG000|Overall Study|Adverse Event|13|||
42280112|NCT02190604|76112034|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280113|NCT02190604|76112035|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280114|NCT02190604|76112036|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280115|NCT02190604|76112037|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42160292|NCT00256698|75968138|FG001|Overall Study|Adverse Event|6|||
42160293|NCT00256698|75968137|FG000|Overall Study|Protocol Violation|6|||
42160294|NCT00256698|75968138|FG001|Overall Study|Protocol Violation|5|||
42160295|NCT00256698|75968137|FG000|Overall Study|Lost to Follow-up|1|||
42160296|NCT00256698|75968138|FG001|Overall Study|Lost to Follow-up|3|||
42160297|NCT00256698|75968137|FG000|Overall Study|disease progression|97|||
42160298|NCT00256698|75968138|FG001|Overall Study|disease progression|105|||
42160299|NCT00256698|75968137|FG000|Overall Study|still ongoing at data cut-off|41|||
42160300|NCT00256698|75968138|FG001|Overall Study|still ongoing at data cut-off|46|||
42160301|NCT00256698|75968137|FG000|Overall Study|withdrawn due to osteoporosis|1|||
42160302|NCT00256698|75968138|FG001|Overall Study|withdrawn due to osteoporosis|0|||
42160303|NCT00256698|75968137|FG000|Overall Study|Prematurely Discontinued|1|||
42160304|NCT00256698|75968138|FG001|Overall Study|Prematurely Discontinued|0|||
42160305|NCT00189306|75968144|FG000|Treatment Period|Withdrawal by Subject|2|||
42160306|NCT00189306|75968144|FG000|Treatment Period|Adverse Event|2|||
42160307|NCT00189306|75968144|FG000|Treatment Period|Protocol Violation|1|||
42160308|NCT00189306|75968144|FG000|Posttreatment Period|Death|1|||
42160309|NCT00189306|75968144|FG000|Posttreatment Period|Withdrawal by Subject|2|||
42160310|NCT00189306|75968144|FG000|Posttreatment Period|Noncompliance|1|||
42160311|NCT00189306|75968144|FG000|Posttreatment Period|Target lesion excised|1|||
42160312|NCT00189306|75968144|FG000|Posttreatment Period|Protocol Violation|1|||
42160313|NCT00189306|75968144|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
42160314|NCT00189306|75968144|FG000|Posttreatment Period|Local skin reaction/sign|1|||
42160315|NCT00189306|75968144|FG000|Long-Term Follow-up|Adverse Event|2|||
42160316|NCT00189306|75968144|FG000|Long-Term Follow-up|Death|4|||
42160317|NCT00189306|75968144|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
42160318|NCT00189306|75968144|FG000|Long-Term Follow-up|Intercurrent disease|2|||
42160319|NCT00189306|75968144|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
42160320|NCT00189306|75968144|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
42160321|NCT00187278|75968150|FG000|Overall Study|Protocol Violation|10|||
42160322|NCT00187278|75968151|FG001|Overall Study|Protocol Violation|13|||
42160323|NCT00256308|75968159|FG000|Overall Study|Death|2|||
42160324|NCT00255840|75968165|FG000|Overall Study|Lost to Follow-up|10|||
42160325|NCT00255840|75968166|FG001|Overall Study|Lost to Follow-up|14|||
42160326|NCT00255840|75968165|FG000|Overall Study|Discontinued intervention|53|||
42160327|NCT00255840|75968166|FG001|Overall Study|Discontinued intervention|56|||
42160328|NCT00224874|75968176|FG000|Overall Study|Withdrawal by Subject|0|||
42160329|NCT00224874|75968177|FG001|Overall Study|Withdrawal by Subject|0|||
42160330|NCT00224874|75968178|FG002|Overall Study|Withdrawal by Subject|1|||
42160331|NCT00224874|75968179|FG003|Overall Study|Withdrawal by Subject|0|||
42160332|NCT00186186|75968189|FG000|Overall Study|Lack of Efficacy|3|||
42160333|NCT00186186|75968189|FG000|Overall Study|Withdrawal by Subject|3|||
42160334|NCT00186186|75968189|FG000|Overall Study|Not reported as to reason|2|||
42160335|NCT00185640|75968194|FG000|Overall Study|Not Eligible|4|||
42160336|NCT00185640|75968194|FG000|Overall Study|Withdrawal by Subject|3|||
42160337|NCT00185640|75968194|FG000|Overall Study|Death|138|||
42160338|NCT03760666|75968201|FG000|Overall Study|Adverse Event|2|||
42160339|NCT03760666|75968202|FG001|Overall Study|Adverse Event|4|||
42160340|NCT03760666|75968203|FG002|Overall Study|Adverse Event|1|||
42160341|NCT03760666|75968201|FG000|Overall Study|AML Disease Progression|3|||
42160342|NCT03760666|75968202|FG001|Overall Study|AML Disease Progression|3|||
42160343|NCT03760666|75968203|FG002|Overall Study|AML Disease Progression|0|||
42160344|NCT03760666|75968201|FG000|Overall Study|Physician Decision|0|||
42160345|NCT03760666|75968202|FG001|Overall Study|Physician Decision|3|||
42160346|NCT03760666|75968203|FG002|Overall Study|Physician Decision|0|||
42160347|NCT03760666|75968201|FG000|Overall Study|Withdrawal by Subject|0|||
42160348|NCT03760666|75968202|FG001|Overall Study|Withdrawal by Subject|1|||
42160349|NCT03760666|75968203|FG002|Overall Study|Withdrawal by Subject|0|||
42160350|NCT03760510|75968216|FG000|Overall Study|Not ventilated for 24 hours|105|||
42160351|NCT03760510|75968217|FG001|Overall Study|Not ventilated for 24 hours|97|||
42160352|NCT00224484|75968226|FG000|Overall Study|Serious Adverse Event|1|||
42160353|NCT00224484|75968227|FG001|Overall Study|Serious Adverse Event|1|||
42013490|NCT00998296|75820558|FG008|Overall Study|Refused to continue taking trial med.|0|||
42013491|NCT00998296|75820559|FG009|Overall Study|Refused to continue taking trial med.|2|||
42160354|NCT00224484|75968228|FG002|Overall Study|Serious Adverse Event|0|||
42160355|NCT00224484|75968226|FG000|Overall Study|Non-Serious Adverse Event|5|||
42160356|NCT00224484|75968227|FG001|Overall Study|Non-Serious Adverse Event|7|||
42160357|NCT00224484|75968228|FG002|Overall Study|Non-Serious Adverse Event|3|||
42160358|NCT00224484|75968226|FG000|Overall Study|Protocol Violation|2|||
42160359|NCT00224484|75968227|FG001|Overall Study|Protocol Violation|2|||
42160360|NCT00224484|75968228|FG002|Overall Study|Protocol Violation|0|||
42160361|NCT00224484|75968226|FG000|Overall Study|Withdrawal by Subject|49|||
42160362|NCT00224484|75968227|FG001|Overall Study|Withdrawal by Subject|18|||
42160363|NCT00224484|75968228|FG002|Overall Study|Withdrawal by Subject|16|||
42160364|NCT00224484|75968226|FG000|Overall Study|Migrated/moved from study area|18|||
42160365|NCT00224484|75968227|FG001|Overall Study|Migrated/moved from study area|5|||
42160366|NCT00224484|75968228|FG002|Overall Study|Migrated/moved from study area|5|||
42160367|NCT00224484|75968226|FG000|Overall Study|Lost to Follow-up|66|||
42160368|NCT00224484|75968227|FG001|Overall Study|Lost to Follow-up|28|||
42160369|NCT00224484|75968228|FG002|Overall Study|Lost to Follow-up|36|||
42160370|NCT00224484|75968226|FG000|Overall Study|Reason not specified|5|||
42160371|NCT00224484|75968227|FG001|Overall Study|Reason not specified|4|||
42160372|NCT00224484|75968228|FG002|Overall Study|Reason not specified|2|||
42160373|NCT00254982|75968241|FG000|Overall Study|Other|2|||
42160374|NCT00254982|75968242|FG001|Overall Study|Other|1|||
42160375|NCT00254982|75968241|FG000|Overall Study|Lack of Efficacy|5|||
42160376|NCT00254982|75968242|FG001|Overall Study|Lack of Efficacy|3|||
42160377|NCT00254982|75968241|FG000|Overall Study|Lost to Follow-up|5|||
42160378|NCT00254982|75968242|FG001|Overall Study|Lost to Follow-up|3|||
42160379|NCT00254982|75968241|FG000|Overall Study|Adverse Event|18|||
42160380|NCT00254982|75968242|FG001|Overall Study|Adverse Event|16|||
42160381|NCT00254982|75968241|FG000|Overall Study|Withdrawal by Subject|1|||
42160382|NCT00254982|75968242|FG001|Overall Study|Withdrawal by Subject|1|||
42160383|NCT00254982|75968241|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
42160384|NCT00254982|75968242|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
42160385|NCT00254982|75968241|FG000|Overall Study|Protocol deviation|1|||
42160386|NCT00254982|75968242|FG001|Overall Study|Protocol deviation|1|||
42160387|NCT00254982|75968241|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
42160388|NCT00254982|75968242|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
42160389|NCT00254982|75968241|FG000|Overall Study|Malignancy|0|||
42160390|NCT00254982|75968242|FG001|Overall Study|Malignancy|2|||
42160391|NCT00254982|75968241|FG000|Overall Study|Opportunistic infection|1|||
42160392|NCT00254982|75968242|FG001|Overall Study|Opportunistic infection|0|||
42160393|NCT00254982|75968241|FG000|Overall Study|Abnormal liver function tests|2|||
42160394|NCT00254982|75968242|FG001|Overall Study|Abnormal liver function tests|1|||
42160395|NCT03759340|75968248|FG000|Overall Study|Adverse Event|2|||
42160396|NCT03759340|75968248|FG000|Overall Study|Lost to Follow-up|1|||
42160397|NCT03759340|75968248|FG000|Overall Study|Withdrawal by Subject|15|||
42160398|NCT03759340|75968248|FG000|Overall Study|Study Terminated by Sponsor|38|||
42160399|NCT00224016|75968254|FG000|Titration Period|Withdrawal by Subject|0|||
42160400|NCT00224016|75968255|FG001|Titration Period|Withdrawal by Subject|1|||
42160401|NCT00224016|75968254|FG000|Titration Period|Lost to Follow-up|1|||
42160402|NCT00224016|75968255|FG001|Titration Period|Lost to Follow-up|0|||
42160403|NCT00224016|75968254|FG000|Maintenance Period|Withdrawal by Subject|2|||
42160404|NCT00224016|75968255|FG001|Maintenance Period|Withdrawal by Subject|0|||
42160405|NCT00224016|75968254|FG000|Maintenance Period|Lost to Follow-up|0|||
42160406|NCT00224016|75968255|FG001|Maintenance Period|Lost to Follow-up|1|||
42160407|NCT03757234|75968266|FG000|Overall Study|Adverse Event|0|||
42160408|NCT03757234|75968267|FG001|Overall Study|Adverse Event|0|||
42160409|NCT03757234|75968268|FG002|Overall Study|Adverse Event|0|||
42160410|NCT03757234|75968269|FG003|Overall Study|Adverse Event|0|||
42013492|NCT00998296|75820560|FG010|Overall Study|Refused to continue taking trial med.|0|||
42160411|NCT03757234|75968270|FG004|Overall Study|Adverse Event|1|||
42160412|NCT03757234|75968266|FG000|Overall Study|Lost to Follow-up|1|||
42160413|NCT03757234|75968267|FG001|Overall Study|Lost to Follow-up|0|||
42160414|NCT03757234|75968268|FG002|Overall Study|Lost to Follow-up|0|||
42160415|NCT03757234|75968269|FG003|Overall Study|Lost to Follow-up|0|||
42160416|NCT03757234|75968270|FG004|Overall Study|Lost to Follow-up|1|||
42160417|NCT03757234|75968266|FG000|Overall Study|Withdrawal by Subject|1|||
42160418|NCT03757234|75968267|FG001|Overall Study|Withdrawal by Subject|1|||
42160419|NCT03757234|75968268|FG002|Overall Study|Withdrawal by Subject|0|||
42160420|NCT03757234|75968269|FG003|Overall Study|Withdrawal by Subject|1|||
42160421|NCT03757234|75968270|FG004|Overall Study|Withdrawal by Subject|2|||
42160422|NCT03757234|75968266|FG000|Overall Study|Other|1|||
42160423|NCT03757234|75968267|FG001|Overall Study|Other|1|||
42013493|NCT00998296|75820550|FG000|Overall Study|Reason other than those specified above|0|||
42013494|NCT00998296|75820551|FG001|Overall Study|Reason other than those specified above|0|||
42013495|NCT00998296|75820552|FG002|Overall Study|Reason other than those specified above|0|||
42013496|NCT00998296|75820553|FG003|Overall Study|Reason other than those specified above|0|||
42160424|NCT03757234|75968268|FG002|Overall Study|Other|0|||
42013497|NCT00998296|75820554|FG004|Overall Study|Reason other than those specified above|0|||
42013498|NCT00998296|75820555|FG005|Overall Study|Reason other than those specified above|0|||
42160425|NCT03757234|75968269|FG003|Overall Study|Other|0|||
42160426|NCT03757234|75968270|FG004|Overall Study|Other|0|||
42160427|NCT00223080|75968284|FG000|Overall Study|Withdrawal by Subject|253|||
42160428|NCT00223080|75968285|FG001|Overall Study|Withdrawal by Subject|232|||
42160429|NCT00223080|75968284|FG000|Overall Study|Required contraindicated med|0|||
42160430|NCT00223080|75968285|FG001|Overall Study|Required contraindicated med|1|||
42160431|NCT00223080|75968284|FG000|Overall Study|Non-compliant|7|||
42160432|NCT00223080|75968285|FG001|Overall Study|Non-compliant|7|||
42160433|NCT00223080|75968284|FG000|Overall Study|Moved from study area|37|||
42160434|NCT00223080|75968285|FG001|Overall Study|Moved from study area|47|||
42160435|NCT00223080|75968284|FG000|Overall Study|Lost to Follow-up|259|||
42160436|NCT00223080|75968285|FG001|Overall Study|Lost to Follow-up|284|||
42160437|NCT00223080|75968284|FG000|Overall Study|Death|85|||
42160438|NCT00223080|75968285|FG001|Overall Study|Death|74|||
42160439|NCT00223080|75968284|FG000|Overall Study|Other|14|||
42160440|NCT00223080|75968285|FG001|Overall Study|Other|11|||
42160441|NCT00223080|75968284|FG000|Overall Study|Reason not provided|141|||
42160442|NCT00223080|75968285|FG001|Overall Study|Reason not provided|140|||
42160443|NCT00223080|75968284|FG000|Overall Study|Adverse Event|0|||
42160444|NCT00223080|75968285|FG001|Overall Study|Adverse Event|1|||
42160445|NCT00220740|75968293|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
42160446|NCT00220740|75968294|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
42160447|NCT00220740|75968293|FG000|Efficacy Period|Adverse Event|1|||
42160448|NCT00220740|75968294|FG001|Efficacy Period|Adverse Event|1|||
42160449|NCT00220740|75968293|FG000|Efficacy Period|Withdrawal by Subject|1|||
42160450|NCT00220740|75968294|FG001|Efficacy Period|Withdrawal by Subject|0|||
42160451|NCT00220740|75968293|FG000|Efficacy Period|Protocol Violation|1|||
42160452|NCT00220740|75968294|FG001|Efficacy Period|Protocol Violation|0|||
42160453|NCT00220740|75968293|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
42160454|NCT00220740|75968294|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
42160455|NCT00184002|75968302|FG000|Overall Study|Adverse Event|9|||
42160456|NCT00184002|75968302|FG000|Overall Study|Death|3|||
42160457|NCT00184002|75968302|FG000|Overall Study|Physician Decision|1|||
42160458|NCT00184002|75968302|FG000|Overall Study|Withdrawal by Subject|4|||
42160459|NCT00165672|75968308|FG000|Overall Study|Adverse Event|0|||
42160460|NCT00165672|75968309|FG001|Overall Study|Adverse Event|1|||
42160461|NCT00180414|75968317|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
42160462|NCT00180414|75968318|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
42160463|NCT00174252|75968324|FG000|Overall Study|Protocol Violation|2|||
42160464|NCT00169104|75968332|FG000|Overall Study|Withdrawal by Subject|2|||
42160465|NCT00169104|75968333|FG001|Overall Study|Withdrawal by Subject|0|||
42160466|NCT00169104|75968332|FG000|Overall Study|Protocol Violation|0|||
42160467|NCT00169104|75968333|FG001|Overall Study|Protocol Violation|1|||
42160468|NCT00169104|75968332|FG000|Overall Study|Physician Decision|0|||
42160469|NCT00169104|75968333|FG001|Overall Study|Physician Decision|1|||
42160470|NCT00163020|75968342|FG000|Overall Study|Lost to Follow-up|0|||
42160471|NCT00163020|75968343|FG001|Overall Study|Lost to Follow-up|2|||
42160472|NCT00252720|75968353|FG000|Overall Study|Withdrawal by Subject|95|||
42160473|NCT00252720|75968354|FG001|Overall Study|Withdrawal by Subject|97|||
42160474|NCT00252720|75968353|FG000|Overall Study|Death|7|||
42160475|NCT00252720|75968354|FG001|Overall Study|Death|8|||
42160476|NCT00252720|75968353|FG000|Overall Study|Moving|23|||
42160477|NCT00252720|75968354|FG001|Overall Study|Moving|42|||
42160478|NCT00252720|75968353|FG000|Overall Study|Mainly patients lost to follow-up|7|||
42160479|NCT00252720|75968354|FG001|Overall Study|Mainly patients lost to follow-up|18|||
42160480|NCT00167778|75968360|FG000|Overall Study|Withdrawal by Subject|1|||
42160481|NCT00167310|75968367|FG000|Overall Study|Protocol Violation|5|||
42160482|NCT00167310|75968368|FG001|Overall Study|Protocol Violation|3|||
42160483|NCT00167310|75968367|FG000|Overall Study|Withdrawal by Subject|3|||
42160484|NCT00167310|75968368|FG001|Overall Study|Withdrawal by Subject|7|||
42160485|NCT03754582|75968374|FG000|Treatment Phase|Adverse Event|0|||
42160486|NCT03754582|75968375|FG001|Treatment Phase|Adverse Event|1|||
42160487|NCT03754582|75968376|FG002|Treatment Phase|Adverse Event|0|||
42160488|NCT03754582|75968374|FG000|Follow-up Phase|Other|0|||
42160489|NCT03754582|75968375|FG001|Follow-up Phase|Other|0|||
42160490|NCT03754582|75968376|FG002|Follow-up Phase|Other|1|||
42160491|NCT00161616|75968394|FG000|Overall Study|Withdrawal by Subject|6|||
42160492|NCT00161616|75968395|FG001|Overall Study|Withdrawal by Subject|5|||
42160493|NCT00161616|75968394|FG000|Overall Study|Physician Decision|1|||
42160494|NCT00161616|75968395|FG001|Overall Study|Physician Decision|0|||
42160495|NCT00161616|75968394|FG000|Overall Study|Death|1|||
42160496|NCT00161616|75968395|FG001|Overall Study|Death|1|||
42160497|NCT00161616|75968394|FG000|Overall Study|Lost to Follow-up|17|||
42160498|NCT00161616|75968395|FG001|Overall Study|Lost to Follow-up|13|||
42160499|NCT00161616|75968394|FG000|Overall Study|Protocol deviation|1|||
42160500|NCT00161616|75968395|FG001|Overall Study|Protocol deviation|0|||
42160501|NCT00252564|75968403|FG000|Overall Study|Adverse Event|17|||
42160502|NCT00252564|75968404|FG001|Overall Study|Adverse Event|13|||
42160503|NCT00252564|75968403|FG000|Overall Study|Unrelated Complication|2|||
42160504|NCT00252564|75968404|FG001|Overall Study|Unrelated Complication|1|||
42160505|NCT00252564|75968403|FG000|Overall Study|Disease Progression|14|||
42160506|NCT00252564|75968404|FG001|Overall Study|Disease Progression|20|||
42160507|NCT00252564|75968403|FG000|Overall Study|Death|0|||
42160508|NCT00252564|75968404|FG001|Overall Study|Death|3|||
42160509|NCT00252564|75968403|FG000|Overall Study|Physician Decision|1|||
42160510|NCT00252564|75968404|FG001|Overall Study|Physician Decision|0|||
42160511|NCT00252564|75968403|FG000|Overall Study|Lost to Follow-up|1|||
42160512|NCT00252564|75968404|FG001|Overall Study|Lost to Follow-up|0|||
42160513|NCT00252564|75968403|FG000|Overall Study|Patient Request|4|||
42160514|NCT00252564|75968404|FG001|Overall Study|Patient Request|5|||
42160515|NCT00252564|75968403|FG000|Overall Study|Withdrawal by Subject|0|||
42160516|NCT00252564|75968404|FG001|Overall Study|Withdrawal by Subject|2|||
42160517|NCT00166296|75968412|FG000|Overall Study|Withdrawal by Subject|1|||
42160518|NCT00166296|75968413|FG001|Overall Study|Withdrawal by Subject|3|||
42160519|NCT00166296|75968412|FG000|Overall Study|Adverse Event|2|||
42160520|NCT00166296|75968413|FG001|Overall Study|Adverse Event|4|||
42160521|NCT00166296|75968412|FG000|Overall Study|Lost to Follow-up|4|||
42160522|NCT00166296|75968413|FG001|Overall Study|Lost to Follow-up|2|||
42160523|NCT00252174|75968422|FG000|Overall Study|Withdrawal by Subject|0|||
42160524|NCT00252174|75968423|FG001|Overall Study|Withdrawal by Subject|1|||
42160525|NCT00252174|75968424|FG002|Overall Study|Withdrawal by Subject|0|||
42160526|NCT00165984|75968432|FG000|Overall Study|Death|15|||
42160527|NCT00160524|75968439|FG000|Overall Study|Adverse Event|119|||
42160528|NCT00160524|75968439|FG000|Overall Study|Adverse Event and Other|94|||
42160529|NCT00160524|75968439|FG000|Overall Study|Protocol Violation|16|||
42160530|NCT00160524|75968439|FG000|Overall Study|Protocol Violation and Other|2|||
42160531|NCT00160524|75968439|FG000|Overall Study|Withdrawal by Subject|141|||
42160532|NCT00160524|75968439|FG000|Overall Study|Withdrawal by Subject and Other|17|||
42160533|NCT00160524|75968439|FG000|Overall Study|Physician Decision|27|||
42160534|NCT00160524|75968439|FG000|Overall Study|Physician Decision and Other|6|||
42160535|NCT00160524|75968439|FG000|Overall Study|Lost to Follow-up|13|||
42160536|NCT00160524|75968439|FG000|Overall Study|Lost to Follow-up and Other|1|||
42160537|NCT00160524|75968439|FG000|Overall Study|Lack of Efficacy|21|||
42160538|NCT00160524|75968439|FG000|Overall Study|Lack of Efficacy and Other|1|||
42160539|NCT00160524|75968439|FG000|Overall Study|Other|20|||
42160540|NCT00159822|75968443|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
42160541|NCT00159822|75968443|FG000|Voriconazole Treatment Period|Adverse Event|9|||
42160542|NCT00159822|75968443|FG000|Voriconazole Treatment Period|Death|4|||
42160543|NCT00159822|75968443|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
42160544|NCT00159822|75968443|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
42160545|NCT00159822|75968443|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
42160546|NCT00159822|75968443|FG000|Post-treatment Follow-up Period|Death|1|||
42160547|NCT00159822|75968443|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
42160548|NCT00159822|75968443|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
42160549|NCT00158262|75968449|FG000|Overall Study|Lost to Follow-up|1|||
42160550|NCT00158262|75968450|FG001|Overall Study|Lost to Follow-up|1|||
42160551|NCT00157950|75968458|FG000|Overall Study|Death|1|||
42160552|NCT00157950|75968459|FG001|Overall Study|Death|0|||
42160553|NCT03745768|75968467|FG000|Overall Study|discontinued study|2|||
42160554|NCT03745768|75968468|FG001|Overall Study|discontinued study|0|||
42160555|NCT03745222|75968477|FG000|Overall Study|Withdrawal by Subject|0|||
42160556|NCT03745222|75968478|FG001|Overall Study|Withdrawal by Subject|1|||
42160557|NCT03745222|75968479|FG002|Overall Study|Withdrawal by Subject|0|||
42160558|NCT03743038|75968487|FG000|Overall Study|Physician Decision|1|||
42160559|NCT00153816|75968499|FG000|Overall Study|Death|6|||
42160560|NCT00153816|75968500|FG001|Overall Study|Death|5|||
42160561|NCT00153816|75968501|FG002|Overall Study|Death|4|||
42160562|NCT00153816|75968502|FG003|Overall Study|Death|6|||
42160563|NCT00153816|75968503|FG004|Overall Study|Death|0|||
42160564|NCT00153816|75968504|FG005|Overall Study|Death|2|||
42160565|NCT00153816|75968499|FG000|Overall Study|Lost to Follow-up|7|||
42160566|NCT00153816|75968500|FG001|Overall Study|Lost to Follow-up|8|||
42160567|NCT00153816|75968501|FG002|Overall Study|Lost to Follow-up|5|||
42160568|NCT00153816|75968502|FG003|Overall Study|Lost to Follow-up|8|||
42280116|NCT02190604|76112038|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280117|NCT02190604|76112039|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280118|NCT02190604|76112040|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280119|NCT02190604|76112041|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280120|NCT02190604|76112042|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280121|NCT02190604|76112043|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280122|NCT02190604|76112044|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280123|NCT02190604|76112045|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280124|NCT02190604|76112046|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
42160569|NCT00153816|75968503|FG004|Overall Study|Lost to Follow-up|7|||
42160570|NCT00153816|75968504|FG005|Overall Study|Lost to Follow-up|9|||
42280125|NCT02190604|76112047|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280126|NCT02190604|76112048|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42160571|NCT00153816|75968499|FG000|Overall Study|Withdrawal by Subject|9|||
42160572|NCT00153816|75968500|FG001|Overall Study|Withdrawal by Subject|9|||
42160573|NCT00153816|75968501|FG002|Overall Study|Withdrawal by Subject|9|||
42160574|NCT00153816|75968502|FG003|Overall Study|Withdrawal by Subject|4|||
42160575|NCT00153816|75968503|FG004|Overall Study|Withdrawal by Subject|1|||
42160576|NCT00153816|75968504|FG005|Overall Study|Withdrawal by Subject|5|||
42160577|NCT00153816|75968499|FG000|Overall Study|Follow-up exam not done|8|||
42160578|NCT00153816|75968500|FG001|Overall Study|Follow-up exam not done|7|||
42160579|NCT00153816|75968501|FG002|Overall Study|Follow-up exam not done|11|||
42160580|NCT00153816|75968502|FG003|Overall Study|Follow-up exam not done|10|||
42160581|NCT00153816|75968503|FG004|Overall Study|Follow-up exam not done|8|||
42160582|NCT00153816|75968504|FG005|Overall Study|Follow-up exam not done|9|||
42160583|NCT00153816|75968499|FG000|Overall Study|Follow-up exam done, histology missing|2|||
42160584|NCT00153816|75968500|FG001|Overall Study|Follow-up exam done, histology missing|3|||
42160585|NCT00153816|75968501|FG002|Overall Study|Follow-up exam done, histology missing|3|||
42160586|NCT00153816|75968502|FG003|Overall Study|Follow-up exam done, histology missing|3|||
42160587|NCT00153816|75968503|FG004|Overall Study|Follow-up exam done, histology missing|1|||
42160588|NCT00153816|75968504|FG005|Overall Study|Follow-up exam done, histology missing|2|||
42160589|NCT00151476|75968521|FG000|FAP Identified Subjects|Protocol Violation|0|||
42160590|NCT00151476|75968522|FG001|FAP Identified Subjects|Protocol Violation|1|||
42160591|NCT00151476|75968521|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
42160592|NCT00151476|75968522|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
42160593|NCT00151476|75968521|FG000|FAP Analyzed Subjects|Other study participation|0|||
42160594|NCT00151476|75968522|FG001|FAP Analyzed Subjects|Other study participation|1|||
42160595|NCT00149994|75968531|FG000|Overall Study|Administrative problems:|1|||
42160596|NCT00149994|75968532|FG001|Overall Study|Administrative problems:|0|||
42160597|NCT00149994|75968531|FG000|Overall Study|Protocol Violation|0|||
42160598|NCT00149994|75968532|FG001|Overall Study|Protocol Violation|1|||
42160599|NCT00149214|75968540|FG000|Overall Study|Adverse Event|12|||
42160600|NCT00149214|75968541|FG001|Overall Study|Adverse Event|9|||
42160601|NCT00149214|75968540|FG000|Overall Study|Withdrawal by Subject|4|||
42160602|NCT00149214|75968541|FG001|Overall Study|Withdrawal by Subject|1|||
42160603|NCT00149214|75968540|FG000|Overall Study|Physician Decision|3|||
42160604|NCT00149214|75968541|FG001|Overall Study|Physician Decision|3|||
42160605|NCT00149214|75968540|FG000|Overall Study|Sponsor Decision|0|||
42160606|NCT00149214|75968541|FG001|Overall Study|Sponsor Decision|1|||
42160607|NCT00149214|75968540|FG000|Overall Study|Progressive Disease|7|||
42160608|NCT00149214|75968541|FG001|Overall Study|Progressive Disease|3|||
42160609|NCT00114972|75968558|FG000|Overall Study|Withdrawal by Subject|40|||
42160610|NCT00114972|75968559|FG001|Overall Study|Withdrawal by Subject|7|||
42160611|NCT00114972|75968558|FG000|Overall Study|Lost to Follow-up|8|||
42280127|NCT02190604|76112049|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280128|NCT02190604|76112050|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280129|NCT02190604|76112051|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
42280130|NCT02127970|76112110|FG000|Overall Study|Adverse Event|2|||
42280131|NCT02127970|76112111|FG001|Overall Study|Adverse Event|1|||
42280132|NCT02127970|76112110|FG000|Overall Study|Death|1|||
42013499|NCT00998296|75820556|FG006|Overall Study|Reason other than those specified above|0|||
42013500|NCT00998296|75820557|FG007|Overall Study|Reason other than those specified above|0|||
42013501|NCT00998296|75820558|FG008|Overall Study|Reason other than those specified above|0|||
42013502|NCT00998296|75820559|FG009|Overall Study|Reason other than those specified above|1|||
42013503|NCT00998296|75820560|FG010|Overall Study|Reason other than those specified above|0|||
42013504|NCT01178073|75820592|FG000|Overall Study|Adverse Event|34|||
42160612|NCT00114972|75968559|FG001|Overall Study|Lost to Follow-up|5|||
42280133|NCT02127970|76112111|FG001|Overall Study|Death|1|||
42280134|NCT02127970|76112110|FG000|Overall Study|Lost to Follow-up|14|||
42280135|NCT02127970|76112111|FG001|Overall Study|Lost to Follow-up|14|||
42280136|NCT02127970|76112110|FG000|Overall Study|Reason not Specified|4|||
42280137|NCT02127970|76112111|FG001|Overall Study|Reason not Specified|7|||
42280138|NCT02127970|76112110|FG000|Overall Study|Pregnancy|0|||
42280139|NCT02127970|76112111|FG001|Overall Study|Pregnancy|1|||
42280140|NCT02127970|76112110|FG000|Overall Study|Subject Withdrew Consent|5|||
42280141|NCT02127970|76112111|FG001|Overall Study|Subject Withdrew Consent|3|||
42280142|NCT03549871|76112119|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
42280143|NCT03549871|76112120|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
42280144|NCT03549871|76112119|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
42280145|NCT03549871|76112120|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
42280146|NCT03549871|76112119|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
42280147|NCT03549871|76112120|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
42280148|NCT03549871|76112119|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
42280149|NCT03549871|76112120|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
42280150|NCT03549871|76112119|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
42280151|NCT03549871|76112120|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
42280152|NCT03549871|76112119|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
42160613|NCT00129402|75968567|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
42160614|NCT00129402|75968568|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
42160615|NCT00129402|75968569|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
42160616|NCT00129402|75968570|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
42160617|NCT00129402|75968571|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
42160618|NCT00129402|75968572|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
42160619|NCT00129402|75968573|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
42160620|NCT00129402|75968567|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
42160621|NCT00129402|75968568|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
42280153|NCT03549871|76112120|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
42160622|NCT00129402|75968569|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
42160623|NCT00129402|75968570|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
42160624|NCT00129402|75968571|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
42160625|NCT00129402|75968572|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
42160626|NCT00129402|75968573|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
42160627|NCT00129402|75968567|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
42160628|NCT00129402|75968568|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
42160629|NCT00129402|75968569|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
42160630|NCT00129402|75968570|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
42160631|NCT00129402|75968571|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
42160632|NCT00129402|75968572|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
42160633|NCT00129402|75968573|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
42160634|NCT00129402|75968567|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
42160635|NCT00129402|75968568|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
42160636|NCT00129402|75968569|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
42160637|NCT00129402|75968570|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
42160638|NCT00129402|75968571|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
42351434|NCT01904773|76191368|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
42351435|NCT01904773|76191369|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
42351436|NCT01904773|76191370|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
42351437|NCT01904773|76191371|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
42351438|NCT01904773|76191372|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
42351439|NCT01904773|76191364|FG000|First Intervention|Adverse Event|0|||
42351440|NCT01904773|76191365|FG001|First Intervention|Adverse Event|0|||
42351441|NCT01904773|76191366|FG002|First Intervention|Adverse Event|0|||
42351442|NCT01904773|76191367|FG003|First Intervention|Adverse Event|0|||
42351443|NCT01904773|76191368|FG004|First Intervention|Adverse Event|0|||
42351444|NCT01904773|76191369|FG005|First Intervention|Adverse Event|0|||
42351445|NCT01904773|76191370|FG006|First Intervention|Adverse Event|1|||
42351446|NCT01904773|76191371|FG007|First Intervention|Adverse Event|0|||
42351447|NCT01904773|76191372|FG008|First Intervention|Adverse Event|0|||
42351448|NCT01904773|76191364|FG000|Placebo Washout First Intervention|Condition worsened|0|||
42351449|NCT01904773|76191365|FG001|Placebo Washout First Intervention|Condition worsened|1|||
42280154|NCT03549871|76112119|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
42280155|NCT03549871|76112120|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
42280156|NCT03549871|76112119|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
42280157|NCT03549871|76112120|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
42280158|NCT03549871|76112119|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
42160639|NCT00129402|75968572|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
42280159|NCT03549871|76112120|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
42351450|NCT01904773|76191366|FG002|Placebo Washout First Intervention|Condition worsened|0|||
42351451|NCT01904773|76191367|FG003|Placebo Washout First Intervention|Condition worsened|0|||
42160640|NCT00129402|75968573|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
42160641|NCT00129402|75968567|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
42160642|NCT00129402|75968568|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
42160643|NCT00129402|75968569|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
42160644|NCT00129402|75968570|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
42160645|NCT00129402|75968571|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
42160646|NCT00129402|75968572|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
42160647|NCT00129402|75968573|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
42160648|NCT00129402|75968567|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
42160649|NCT00129402|75968568|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
42160650|NCT00129402|75968569|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
42160651|NCT00129402|75968570|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
42160652|NCT00129402|75968571|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
42160653|NCT00129402|75968572|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
42160654|NCT00129402|75968573|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
42160655|NCT00129402|75968567|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
42160656|NCT00129402|75968568|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
42160657|NCT00129402|75968569|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
42160658|NCT00129402|75968570|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
42160659|NCT00129402|75968571|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
42160660|NCT00129402|75968572|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
42160661|NCT00129402|75968573|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
42160662|NCT00129402|75968567|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
42160663|NCT00129402|75968568|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
42160664|NCT00129402|75968569|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
42160665|NCT00129402|75968570|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
42160666|NCT00129402|75968571|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
42040347|NCT01928394|75848581|FG015|Treatment Period|Death|0|||
42040348|NCT01928394|75848582|FG016|Treatment Period|Death|0|||
42040349|NCT01928394|75848583|FG017|Treatment Period|Death|0|||
42040350|NCT01928394|75848584|FG018|Treatment Period|Death|0|||
42040351|NCT01928394|75848585|FG019|Treatment Period|Death|0|||
42160667|NCT00129402|75968572|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
42160668|NCT00129402|75968573|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
42160669|NCT00129402|75968567|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
42160670|NCT00129402|75968568|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
42160671|NCT00129402|75968569|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
42160672|NCT00129402|75968570|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
42160673|NCT00129402|75968571|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
42160674|NCT00129402|75968572|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
42160675|NCT00129402|75968573|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
42160676|NCT00129402|75968567|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
42160677|NCT00129402|75968568|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
42160678|NCT00129402|75968569|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
42160679|NCT00129402|75968570|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
42160680|NCT00129402|75968571|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
42160681|NCT00129402|75968572|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
42160682|NCT00129402|75968573|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
42160683|NCT00129402|75968567|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
42040352|NCT01928394|75848586|FG020|Treatment Period|Death|0|||
42160684|NCT00129402|75968568|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
42160685|NCT00129402|75968569|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
42160686|NCT00129402|75968570|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
42160687|NCT00129402|75968571|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
42160688|NCT00129402|75968572|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
42160689|NCT00129402|75968573|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
42160690|NCT00129402|75968567|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
42160691|NCT00129402|75968568|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
42160692|NCT00129402|75968569|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
42160693|NCT00129402|75968570|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
42160694|NCT00129402|75968571|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
42160695|NCT00129402|75968572|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
42160696|NCT00129402|75968573|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
42160697|NCT00129402|75968567|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
42160698|NCT00129402|75968568|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
42160699|NCT00129402|75968569|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
42160700|NCT00129402|75968570|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
42280160|NCT03549871|76112119|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
42040353|NCT01928394|75848587|FG021|Treatment Period|Death|0|||
42040354|NCT01928394|75848588|FG022|Treatment Period|Death|0|||
42040355|NCT01928394|75848566|FG000|Follow-up Period|Participant withdrew consent|3|||
42040356|NCT01928394|75848567|FG001|Follow-up Period|Participant withdrew consent|0|||
42040357|NCT01928394|75848568|FG002|Follow-up Period|Participant withdrew consent|1|||
42040358|NCT01928394|75848569|FG003|Follow-up Period|Participant withdrew consent|4|||
42040359|NCT01928394|75848570|FG004|Follow-up Period|Participant withdrew consent|0|||
42040360|NCT01928394|75848571|FG005|Follow-up Period|Participant withdrew consent|2|||
42040361|NCT01928394|75848572|FG006|Follow-up Period|Participant withdrew consent|5|||
42040362|NCT01928394|75848573|FG007|Follow-up Period|Participant withdrew consent|1|||
42040363|NCT01928394|75848574|FG008|Follow-up Period|Participant withdrew consent|0|||
42040364|NCT01928394|75848575|FG009|Follow-up Period|Participant withdrew consent|0|||
42040365|NCT01928394|75848576|FG010|Follow-up Period|Participant withdrew consent|5|||
42040366|NCT01928394|75848577|FG011|Follow-up Period|Participant withdrew consent|8|||
42040367|NCT01928394|75848578|FG012|Follow-up Period|Participant withdrew consent|2|||
42040368|NCT01928394|75848579|FG013|Follow-up Period|Participant withdrew consent|12|||
42040369|NCT01928394|75848580|FG014|Follow-up Period|Participant withdrew consent|7|||
42040370|NCT01928394|75848581|FG015|Follow-up Period|Participant withdrew consent|0|||
42040371|NCT01928394|75848582|FG016|Follow-up Period|Participant withdrew consent|5|||
42040372|NCT01928394|75848583|FG017|Follow-up Period|Participant withdrew consent|3|||
42040373|NCT01928394|75848584|FG018|Follow-up Period|Participant withdrew consent|2|||
42040374|NCT01928394|75848585|FG019|Follow-up Period|Participant withdrew consent|7|||
42040375|NCT01928394|75848586|FG020|Follow-up Period|Participant withdrew consent|4|||
42040376|NCT01928394|75848587|FG021|Follow-up Period|Participant withdrew consent|6|||
42040377|NCT01928394|75848588|FG022|Follow-up Period|Participant withdrew consent|2|||
42280161|NCT03549871|76112120|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
42040378|NCT01928394|75848566|FG000|Follow-up Period|Death|0|||
42013505|NCT01178073|75820593|FG001|Overall Study|Adverse Event|27|||
42160701|NCT00129402|75968571|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
42160702|NCT00129402|75968572|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
42160703|NCT00129402|75968573|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
42160704|NCT03739528|75968583|FG000|Overall Study|Not treated|8|||
42160705|NCT03739528|75968584|FG001|Overall Study|Not treated|12|||
42160706|NCT03739528|75968583|FG000|Overall Study|Treatment and study discontinued|6|||
42160707|NCT03739528|75968584|FG001|Overall Study|Treatment and study discontinued|2|||
42160708|NCT03739528|75968583|FG000|Overall Study|Treatment discontinued + study completed|1|||
42160709|NCT03739528|75968584|FG001|Overall Study|Treatment discontinued + study completed|3|||
42160710|NCT00114738|75968593|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
42160711|NCT00114738|75968594|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
42160712|NCT00114738|75968595|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
42160713|NCT00114738|75968593|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
42160714|NCT00114738|75968594|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
42160715|NCT00114738|75968595|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
42160716|NCT00114738|75968593|FG000|Screening for Randomization|Neuropathy|17|||
42160717|NCT00114738|75968594|FG001|Screening for Randomization|Neuropathy|0|||
42160718|NCT00114738|75968595|FG002|Screening for Randomization|Neuropathy|0|||
42160719|NCT00114738|75968593|FG000|Screening for Randomization|Progressive disease|2|||
42160720|NCT00114738|75968594|FG001|Screening for Randomization|Progressive disease|0|||
42160721|NCT00114738|75968595|FG002|Screening for Randomization|Progressive disease|0|||
42160722|NCT00114738|75968593|FG000|Screening for Randomization|CNS Hemorrhage|1|||
42160723|NCT00114738|75968594|FG001|Screening for Randomization|CNS Hemorrhage|0|||
42160724|NCT00114738|75968595|FG002|Screening for Randomization|CNS Hemorrhage|0|||
42160725|NCT00114738|75968593|FG000|Screening for Randomization|Other|1|||
42160726|NCT00114738|75968594|FG001|Screening for Randomization|Other|0|||
42160727|NCT00114738|75968595|FG002|Screening for Randomization|Other|0|||
42280162|NCT03549871|76112119|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
42280163|NCT03549871|76112120|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
42280164|NCT00705367|76112143|FG000|Long-term Extension Period|Adverse Event|2|||
42280165|NCT00705367|76112144|FG001|Long-term Extension Period|Adverse Event|0|||
42280166|NCT00705367|76112143|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
42280167|NCT00705367|76112144|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
42280168|NCT00705367|76112143|FG000|Long-term Extension Period|Lack of Efficacy|1|||
42280169|NCT00705367|76112144|FG001|Long-term Extension Period|Lack of Efficacy|0|||
42280170|NCT00705367|76112143|FG000|Long-term Extension Period|No longer met study criteria|1|||
42280171|NCT00705367|76112144|FG001|Long-term Extension Period|No longer met study criteria|0|||
42280172|NCT00705367|76112143|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
42280173|NCT00705367|76112144|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
42280174|NCT00705289|76112152|FG000|Overall Study|Subject or treating physician's choice|131|||
42280175|NCT00703963|76112175|FG000|Overall Study|Withdrawal by Subject|7|||
42280176|NCT00703963|76112176|FG001|Overall Study|Withdrawal by Subject|13|||
42280177|NCT00703963|76112175|FG000|Overall Study|Physician Decision|0|||
42160728|NCT00148122|75968602|FG000|Overall Study|Withdrawal by Subject|2|||
42160729|NCT00147498|75968610|FG000|Overall Study|Adverse Event|1|||
42160730|NCT00147498|75968611|FG001|Overall Study|Adverse Event|6|||
42160731|NCT00147498|75968612|FG002|Overall Study|Adverse Event|7|||
42160732|NCT00147498|75968613|FG003|Overall Study|Adverse Event|3|||
42160733|NCT00147498|75968610|FG000|Overall Study|Lack of Efficacy|1|||
42160734|NCT00147498|75968611|FG001|Overall Study|Lack of Efficacy|1|||
42160735|NCT00147498|75968612|FG002|Overall Study|Lack of Efficacy|1|||
42160736|NCT00147498|75968613|FG003|Overall Study|Lack of Efficacy|8|||
42160737|NCT00147498|75968610|FG000|Overall Study|Laboratory abnormality|0|||
42160738|NCT00147498|75968611|FG001|Overall Study|Laboratory abnormality|0|||
42160739|NCT00147498|75968612|FG002|Overall Study|Laboratory abnormality|2|||
42160740|NCT00147498|75968613|FG003|Overall Study|Laboratory abnormality|0|||
42160741|NCT00147498|75968610|FG000|Overall Study|Participant defaulted|0|||
42160742|NCT00147498|75968611|FG001|Overall Study|Participant defaulted|1|||
42160743|NCT00147498|75968612|FG002|Overall Study|Participant defaulted|4|||
42160744|NCT00147498|75968613|FG003|Overall Study|Participant defaulted|3|||
42160745|NCT00147498|75968610|FG000|Overall Study|Other|1|||
42280178|NCT00703963|76112176|FG001|Overall Study|Physician Decision|1|||
42280179|NCT02721355|76112184|FG000|Overall Study|Lost to Follow-up|6|||
42280180|NCT02721355|76112185|FG001|Overall Study|Lost to Follow-up|1|||
42280181|NCT02733991|76112193|FG000|Overall Study|Adverse Event|1|||
42013506|NCT01178073|75820594|FG002|Overall Study|Adverse Event|24|||
42160746|NCT00147498|75968611|FG001|Overall Study|Other|1|||
42160747|NCT00147498|75968612|FG002|Overall Study|Other|3|||
42160748|NCT00147498|75968613|FG003|Overall Study|Other|3|||
42160749|NCT00113568|75968623|FG000|Overall Study|Adverse Event|97|||
42160750|NCT00113568|75968623|FG000|Overall Study|Death|1|||
42160751|NCT00113568|75968623|FG000|Overall Study|Lack of Efficacy|30|||
42160752|NCT00113568|75968623|FG000|Overall Study|Lost to Follow-up|156|||
42160753|NCT00113568|75968623|FG000|Overall Study|Protocol Violation|32|||
42160754|NCT00113568|75968623|FG000|Overall Study|Withdrawal by Subject|117|||
42160755|NCT00113568|75968623|FG000|Overall Study|Other|112|||
42160756|NCT00113490|75968629|FG000|Overall Study|Withdrawal by Subject|1|||
42160757|NCT00113490|75968630|FG001|Overall Study|Withdrawal by Subject|3|||
42160758|NCT00113490|75968629|FG000|Overall Study|Lost to Follow-up|1|||
42160759|NCT00113490|75968630|FG001|Overall Study|Lost to Follow-up|0|||
42160760|NCT00146640|75968638|FG000|Overall Study|Adverse Event|12|||
42160761|NCT00146640|75968639|FG001|Overall Study|Adverse Event|10|||
42160762|NCT00146640|75968638|FG000|Overall Study|Medical Reasons|3|||
42160763|NCT00146640|75968639|FG001|Overall Study|Medical Reasons|0|||
42160764|NCT00146640|75968638|FG000|Overall Study|Non-Medical Reasons|8|||
42160765|NCT00146640|75968639|FG001|Overall Study|Non-Medical Reasons|4|||
42160766|NCT00146328|75968657|FG000|Overall Study|Adverse Event|39|||
42160767|NCT00146328|75968658|FG001|Overall Study|Adverse Event|48|||
42160768|NCT00146328|75968659|FG002|Overall Study|Adverse Event|79|||
42160769|NCT00146328|75968657|FG000|Overall Study|Protocol Violation|11|||
42160770|NCT00146328|75968658|FG001|Overall Study|Protocol Violation|6|||
42160771|NCT00146328|75968659|FG002|Overall Study|Protocol Violation|12|||
42160772|NCT00146328|75968657|FG000|Overall Study|Lost to Follow-up|7|||
42160773|NCT00146328|75968658|FG001|Overall Study|Lost to Follow-up|4|||
42160774|NCT00146328|75968659|FG002|Overall Study|Lost to Follow-up|7|||
42160775|NCT00146328|75968657|FG000|Overall Study|Withdrawal by Subject|16|||
42160776|NCT00146328|75968658|FG001|Overall Study|Withdrawal by Subject|16|||
42160777|NCT00146328|75968659|FG002|Overall Study|Withdrawal by Subject|22|||
42160778|NCT00146328|75968657|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
42160779|NCT00146328|75968658|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
42160780|NCT00146328|75968659|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
42160781|NCT00146328|75968657|FG000|Overall Study|Trial ended/site closed|8|||
42160782|NCT00146328|75968658|FG001|Overall Study|Trial ended/site closed|2|||
42160783|NCT00146328|75968659|FG002|Overall Study|Trial ended/site closed|19|||
42160784|NCT00146328|75968657|FG000|Overall Study|Patient decision to end|0|||
42160785|NCT00146328|75968658|FG001|Overall Study|Patient decision to end|1|||
42160786|NCT00146328|75968659|FG002|Overall Study|Patient decision to end|6|||
42160787|NCT00146328|75968657|FG000|Overall Study|Enroll into other trial|2|||
42160788|NCT00146328|75968658|FG001|Overall Study|Enroll into other trial|4|||
42160789|NCT00146328|75968659|FG002|Overall Study|Enroll into other trial|2|||
42160790|NCT00146328|75968657|FG000|Overall Study|Death|0|||
42160791|NCT00146328|75968658|FG001|Overall Study|Death|1|||
42160792|NCT00146328|75968659|FG002|Overall Study|Death|1|||
42160793|NCT00146328|75968657|FG000|Overall Study|Moved|2|||
42160794|NCT00146328|75968658|FG001|Overall Study|Moved|0|||
42160795|NCT00146328|75968659|FG002|Overall Study|Moved|0|||
42160796|NCT00146328|75968657|FG000|Overall Study|Interaction with other medication|2|||
42160797|NCT00146328|75968658|FG001|Overall Study|Interaction with other medication|0|||
42160798|NCT00146328|75968659|FG002|Overall Study|Interaction with other medication|1|||
42160799|NCT03733444|75968670|FG000|Overall Study|Adverse Event|8|||
42160800|NCT03733444|75968671|FG001|Overall Study|Adverse Event|10|||
42160801|NCT03733444|75968672|FG002|Overall Study|Adverse Event|5|||
42160802|NCT03733444|75968670|FG000|Overall Study|Death|20|||
42160803|NCT03733444|75968671|FG001|Overall Study|Death|19|||
42160804|NCT03733444|75968672|FG002|Overall Study|Death|11|||
42040379|NCT01928394|75848567|FG001|Follow-up Period|Death|0|||
42040380|NCT01928394|75848568|FG002|Follow-up Period|Death|2|||
42040381|NCT01928394|75848569|FG003|Follow-up Period|Death|6|||
42040382|NCT01928394|75848570|FG004|Follow-up Period|Death|0|||
42040383|NCT01928394|75848571|FG005|Follow-up Period|Death|6|||
42040384|NCT01928394|75848572|FG006|Follow-up Period|Death|6|||
42040385|NCT01928394|75848573|FG007|Follow-up Period|Death|2|||
42040386|NCT01928394|75848574|FG008|Follow-up Period|Death|1|||
42040387|NCT01928394|75848575|FG009|Follow-up Period|Death|2|||
42040388|NCT01928394|75848576|FG010|Follow-up Period|Death|4|||
42040389|NCT01928394|75848577|FG011|Follow-up Period|Death|12|||
42040390|NCT01928394|75848578|FG012|Follow-up Period|Death|11|||
42040391|NCT01928394|75848579|FG013|Follow-up Period|Death|25|||
42040392|NCT01928394|75848580|FG014|Follow-up Period|Death|18|||
42040393|NCT01928394|75848581|FG015|Follow-up Period|Death|0|||
42040394|NCT01928394|75848582|FG016|Follow-up Period|Death|6|||
42040395|NCT01928394|75848583|FG017|Follow-up Period|Death|5|||
42160805|NCT03733444|75968670|FG000|Overall Study|Lost to Follow-up|3|||
42160806|NCT03733444|75968671|FG001|Overall Study|Lost to Follow-up|0|||
42160807|NCT03733444|75968672|FG002|Overall Study|Lost to Follow-up|1|||
42160808|NCT03733444|75968670|FG000|Overall Study|Lack of Efficacy|0|||
42160809|NCT03733444|75968671|FG001|Overall Study|Lack of Efficacy|1|||
42160810|NCT03733444|75968672|FG002|Overall Study|Lack of Efficacy|1|||
42040396|NCT01928394|75848584|FG018|Follow-up Period|Death|13|||
42040397|NCT01928394|75848585|FG019|Follow-up Period|Death|13|||
42160811|NCT03733444|75968670|FG000|Overall Study|Physician Decision|2|||
42160812|NCT03733444|75968671|FG001|Overall Study|Physician Decision|1|||
42160813|NCT03733444|75968672|FG002|Overall Study|Physician Decision|0|||
42040398|NCT01928394|75848586|FG020|Follow-up Period|Death|5|||
42040399|NCT01928394|75848587|FG021|Follow-up Period|Death|3|||
42040400|NCT01928394|75848588|FG022|Follow-up Period|Death|2|||
42040401|NCT01928394|75848566|FG000|Follow-up Period|other reason|0|||
42040402|NCT01928394|75848567|FG001|Follow-up Period|other reason|0|||
42040403|NCT01928394|75848568|FG002|Follow-up Period|other reason|0|||
42160814|NCT03733444|75968670|FG000|Overall Study|Protocol Violation|2|||
42160815|NCT03733444|75968671|FG001|Overall Study|Protocol Violation|1|||
42160816|NCT03733444|75968672|FG002|Overall Study|Protocol Violation|0|||
42160817|NCT03733444|75968670|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
42160818|NCT03733444|75968671|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
42160819|NCT03733444|75968672|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
42160820|NCT03733444|75968670|FG000|Overall Study|Study Terminated by Sponsor|203|||
42160821|NCT03733444|75968671|FG001|Overall Study|Study Terminated by Sponsor|209|||
42160822|NCT03733444|75968672|FG002|Overall Study|Study Terminated by Sponsor|221|||
42160823|NCT03733444|75968670|FG000|Overall Study|Withdrawal by Subject|19|||
42160824|NCT03733444|75968671|FG001|Overall Study|Withdrawal by Subject|18|||
42160825|NCT03733444|75968672|FG002|Overall Study|Withdrawal by Subject|16|||
42160826|NCT03733444|75968670|FG000|Overall Study|Miscellaneous|1|||
42160827|NCT03733444|75968671|FG001|Overall Study|Miscellaneous|0|||
42160828|NCT03733444|75968672|FG002|Overall Study|Miscellaneous|1|||
42160829|NCT03733444|75968670|FG000|Overall Study|Not Treated|1|||
42160830|NCT03733444|75968671|FG001|Overall Study|Not Treated|2|||
42160831|NCT03733444|75968672|FG002|Overall Study|Not Treated|1|||
42160832|NCT03731182|75968692|FG000|Overall Study|Lost to Follow-up|2|||
42160833|NCT03731182|75968693|FG001|Overall Study|Lost to Follow-up|0|||
42160834|NCT03731182|75968692|FG000|Overall Study|Physician Decision|1|||
42160835|NCT03731182|75968693|FG001|Overall Study|Physician Decision|0|||
42160836|NCT03731182|75968692|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
42160837|NCT03731182|75968693|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
42160838|NCT03730012|75968702|FG000|Overall Study|Adverse Event|0|||
42160839|NCT03730012|75968703|FG001|Overall Study|Adverse Event|1|||
42160840|NCT03730012|75968702|FG000|Overall Study|Lack of Efficacy|1|||
42160841|NCT03730012|75968703|FG001|Overall Study|Lack of Efficacy|5|||
42160842|NCT03730012|75968702|FG000|Overall Study|Withdrawal by Subject|0|||
42280182|NCT02733991|76112194|FG001|Overall Study|Adverse Event|0|||
42280183|NCT02733991|76112193|FG000|Overall Study|Withdrawal by Subject|0|||
42280184|NCT02733991|76112194|FG001|Overall Study|Withdrawal by Subject|5|||
42280185|NCT00702949|76112203|FG000|Overall Study|Refusal|3|||
42280186|NCT00702949|76112204|FG001|Overall Study|Refusal|2|||
42160843|NCT03730012|75968703|FG001|Overall Study|Withdrawal by Subject|1|||
42160844|NCT03730012|75968702|FG000|Overall Study|Miscellaneous|2|||
42160845|NCT03730012|75968703|FG001|Overall Study|Miscellaneous|1|||
42160846|NCT03728140|75968714|FG000|Overall Study|Abnormal embryo transfer operation|10|||
42160847|NCT03728140|75968715|FG001|Overall Study|Abnormal embryo transfer operation|7|||
42160848|NCT03725722|75968740|FG000|Overall Study|Lack of Efficacy|2|||
42160849|NCT03725722|75968741|FG001|Overall Study|Lack of Efficacy|1|||
42160850|NCT03725722|75968742|FG002|Overall Study|Lack of Efficacy|2|||
42160851|NCT03725722|75968743|FG003|Overall Study|Lack of Efficacy|0|||
42160852|NCT03725722|75968744|FG004|Overall Study|Lack of Efficacy|2|||
42160853|NCT03725722|75968740|FG000|Overall Study|Adverse Event|2|||
42280187|NCT00702949|76112205|FG002|Overall Study|Refusal|2|||
42280188|NCT00702949|76112203|FG000|Overall Study|Adverse Event|1|||
42280189|NCT00702949|76112204|FG001|Overall Study|Adverse Event|6|||
42160854|NCT03725722|75968741|FG001|Overall Study|Adverse Event|2|||
42280190|NCT00702949|76112205|FG002|Overall Study|Adverse Event|3|||
42280191|NCT00702949|76112203|FG000|Overall Study|Other Medical Reason/unknown|1|||
42351452|NCT01904773|76191368|FG004|Placebo Washout First Intervention|Condition worsened|0|||
42160855|NCT03725722|75968742|FG002|Overall Study|Adverse Event|1|||
42160856|NCT03725722|75968743|FG003|Overall Study|Adverse Event|0|||
42160857|NCT03725722|75968744|FG004|Overall Study|Adverse Event|6|||
42160858|NCT03725722|75968740|FG000|Overall Study|Withdrawal by Subject|4|||
42160859|NCT03725722|75968741|FG001|Overall Study|Withdrawal by Subject|1|||
42160860|NCT03725722|75968742|FG002|Overall Study|Withdrawal by Subject|0|||
42160861|NCT03725722|75968743|FG003|Overall Study|Withdrawal by Subject|4|||
42160862|NCT03725722|75968744|FG004|Overall Study|Withdrawal by Subject|4|||
42160863|NCT03725722|75968740|FG000|Overall Study|Lost to Follow-up|3|||
42160864|NCT03725722|75968741|FG001|Overall Study|Lost to Follow-up|1|||
42160865|NCT03725722|75968742|FG002|Overall Study|Lost to Follow-up|2|||
42160866|NCT03725722|75968743|FG003|Overall Study|Lost to Follow-up|2|||
42160867|NCT03725722|75968744|FG004|Overall Study|Lost to Follow-up|1|||
42160868|NCT03725722|75968740|FG000|Overall Study|Personal reasons|0|||
42160869|NCT03725722|75968741|FG001|Overall Study|Personal reasons|0|||
42040404|NCT01928394|75848569|FG003|Follow-up Period|other reason|0|||
42040405|NCT01928394|75848570|FG004|Follow-up Period|other reason|0|||
42160870|NCT03725722|75968742|FG002|Overall Study|Personal reasons|1|||
42160871|NCT03725722|75968743|FG003|Overall Study|Personal reasons|0|||
42160872|NCT03725722|75968744|FG004|Overall Study|Personal reasons|1|||
42160873|NCT03725722|75968740|FG000|Overall Study|COVID-19 situation|0|||
42160874|NCT03725722|75968741|FG001|Overall Study|COVID-19 situation|1|||
42160875|NCT03725722|75968742|FG002|Overall Study|COVID-19 situation|0|||
42160876|NCT03725722|75968743|FG003|Overall Study|COVID-19 situation|0|||
42160877|NCT03725722|75968744|FG004|Overall Study|COVID-19 situation|0|||
42160878|NCT02966314|75968758|FG000|Overall Study|Lost to Follow-up|1|||
42160879|NCT02966314|75968759|FG001|Overall Study|Lost to Follow-up|0|||
42160880|NCT03723070|75968765|FG000|Overall Study|Lost to Follow-up|2|||
42160881|NCT03723070|75968765|FG000|Overall Study|Physician Decision|1|||
42160882|NCT03723070|75968765|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
42160883|NCT03722524|75968773|FG000|Overall Study|Protocol Violation|86|||
42160884|NCT03722524|75968773|FG000|Overall Study|Adverse Event|7|||
42160885|NCT03722524|75968773|FG000|Overall Study|Lost to Follow-up|1|||
42160886|NCT03722524|75968773|FG000|Overall Study|Reason is not stated|1|||
42160887|NCT03722524|75968773|FG000|Overall Study|Physician Decision|1|||
42160888|NCT03722524|75968773|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
42160889|NCT03722446|75968779|FG000|Overall Study|Protocol Violation|15|||
42160890|NCT03722446|75968780|FG001|Overall Study|Protocol Violation|2|||
42160891|NCT00146172|75968794|FG000|Overall Study|Adverse Event|0|||
42160892|NCT00146172|75968795|FG001|Overall Study|Adverse Event|0|||
42160893|NCT00146172|75968796|FG002|Overall Study|Adverse Event|1|||
42160894|NCT00146172|75968797|FG003|Overall Study|Adverse Event|1|||
42160895|NCT00146172|75968798|FG004|Overall Study|Adverse Event|0|||
42160896|NCT00146172|75968799|FG005|Overall Study|Adverse Event|2|||
42160897|NCT00146172|75968800|FG006|Overall Study|Adverse Event|3|||
42160898|NCT00146172|75968801|FG007|Overall Study|Adverse Event|10|||
42160899|NCT00146172|75968794|FG000|Overall Study|Lost to Follow-up|0|||
42160900|NCT00146172|75968795|FG001|Overall Study|Lost to Follow-up|0|||
42160901|NCT00146172|75968796|FG002|Overall Study|Lost to Follow-up|0|||
42160902|NCT00146172|75968797|FG003|Overall Study|Lost to Follow-up|0|||
42160903|NCT00146172|75968798|FG004|Overall Study|Lost to Follow-up|0|||
42160904|NCT00146172|75968799|FG005|Overall Study|Lost to Follow-up|0|||
42160905|NCT00146172|75968800|FG006|Overall Study|Lost to Follow-up|0|||
42160906|NCT00146172|75968801|FG007|Overall Study|Lost to Follow-up|1|||
42280192|NCT00702949|76112204|FG001|Overall Study|Other Medical Reason/unknown|1|||
42160907|NCT00146172|75968794|FG000|Overall Study|Disease Progression|2|||
42160908|NCT00146172|75968795|FG001|Overall Study|Disease Progression|4|||
42160909|NCT00146172|75968796|FG002|Overall Study|Disease Progression|2|||
42160910|NCT00146172|75968797|FG003|Overall Study|Disease Progression|5|||
42160911|NCT00146172|75968798|FG004|Overall Study|Disease Progression|2|||
42160912|NCT00146172|75968799|FG005|Overall Study|Disease Progression|2|||
42160913|NCT00146172|75968800|FG006|Overall Study|Disease Progression|1|||
42160914|NCT00146172|75968801|FG007|Overall Study|Disease Progression|22|||
42160915|NCT00146172|75968794|FG000|Overall Study|Death|0|||
42160916|NCT00146172|75968795|FG001|Overall Study|Death|0|||
42160917|NCT00146172|75968796|FG002|Overall Study|Death|0|||
42160918|NCT00146172|75968797|FG003|Overall Study|Death|0|||
42160919|NCT00146172|75968798|FG004|Overall Study|Death|0|||
42160920|NCT00146172|75968799|FG005|Overall Study|Death|0|||
42160921|NCT00146172|75968800|FG006|Overall Study|Death|1|||
42160922|NCT00146172|75968801|FG007|Overall Study|Death|0|||
42160923|NCT00146172|75968794|FG000|Overall Study|Physician Decision|0|||
42160924|NCT00146172|75968795|FG001|Overall Study|Physician Decision|0|||
42160925|NCT00146172|75968796|FG002|Overall Study|Physician Decision|0|||
42160926|NCT00146172|75968797|FG003|Overall Study|Physician Decision|0|||
42160927|NCT00146172|75968798|FG004|Overall Study|Physician Decision|0|||
42160928|NCT00146172|75968799|FG005|Overall Study|Physician Decision|0|||
42160929|NCT00146172|75968800|FG006|Overall Study|Physician Decision|0|||
42160930|NCT00146172|75968801|FG007|Overall Study|Physician Decision|1|||
42280193|NCT00702949|76112205|FG002|Overall Study|Other Medical Reason/unknown|3|||
42280194|NCT00702715|76112217|FG000|Overall Study|Lost to Follow-up|1|||
42280195|NCT00702715|76112218|FG001|Overall Study|Lost to Follow-up|0|||
42160931|NCT00146172|75968794|FG000|Overall Study|Withdrawal by Subject|0|||
42160932|NCT00146172|75968795|FG001|Overall Study|Withdrawal by Subject|0|||
42160933|NCT00146172|75968796|FG002|Overall Study|Withdrawal by Subject|0|||
42160934|NCT00146172|75968797|FG003|Overall Study|Withdrawal by Subject|0|||
42280196|NCT00702403|76112224|FG000|From Consent to Engraftment|Progressive leukemia|6|||
42160935|NCT00146172|75968798|FG004|Overall Study|Withdrawal by Subject|0|||
42160936|NCT00146172|75968799|FG005|Overall Study|Withdrawal by Subject|1|||
42160937|NCT00146172|75968800|FG006|Overall Study|Withdrawal by Subject|1|||
42160938|NCT00146172|75968801|FG007|Overall Study|Withdrawal by Subject|4|||
42160939|NCT00146172|75968794|FG000|Overall Study|Symptomatic Deterioration|1|||
42160940|NCT00146172|75968795|FG001|Overall Study|Symptomatic Deterioration|0|||
42160941|NCT00146172|75968796|FG002|Overall Study|Symptomatic Deterioration|1|||
42160942|NCT00146172|75968797|FG003|Overall Study|Symptomatic Deterioration|0|||
42160943|NCT00146172|75968798|FG004|Overall Study|Symptomatic Deterioration|1|||
42160944|NCT00146172|75968799|FG005|Overall Study|Symptomatic Deterioration|2|||
42160945|NCT00146172|75968800|FG006|Overall Study|Symptomatic Deterioration|0|||
42160946|NCT00146172|75968801|FG007|Overall Study|Symptomatic Deterioration|2|||
42160947|NCT00145626|75968829|FG000|Overall Study|Did not have NK infusions|2|||
42160948|NCT00145626|75968829|FG000|Overall Study|Turned 2 years old before treatment|1|||
42160949|NCT00145626|75968829|FG000|Overall Study|Death|1|||
42160950|NCT00145626|75968829|FG000|Overall Study|Withdrawal by Subject|1|||
42160951|NCT00153062|75968853|FG000|Overall Study|Death|360|||
42160952|NCT00153062|75968854|FG001|Overall Study|Death|352|||
42160953|NCT00153062|75968855|FG002|Overall Study|Death|369|||
42160954|NCT00153062|75968856|FG003|Overall Study|Death|365|||
42160955|NCT00153062|75968853|FG000|Overall Study|Withdrawal by Subject|14|||
42160956|NCT00153062|75968854|FG001|Overall Study|Withdrawal by Subject|30|||
42160957|NCT00153062|75968855|FG002|Overall Study|Withdrawal by Subject|27|||
42160958|NCT00153062|75968856|FG003|Overall Study|Withdrawal by Subject|28|||
42040406|NCT01928394|75848571|FG005|Follow-up Period|other reason|0|||
42040407|NCT01928394|75848572|FG006|Follow-up Period|other reason|1|||
42040408|NCT01928394|75848573|FG007|Follow-up Period|other reason|3|||
42040409|NCT01928394|75848574|FG008|Follow-up Period|other reason|0|||
42040410|NCT01928394|75848575|FG009|Follow-up Period|other reason|0|||
42040411|NCT01928394|75848576|FG010|Follow-up Period|other reason|2|||
42040412|NCT01928394|75848577|FG011|Follow-up Period|other reason|1|||
42040413|NCT01928394|75848578|FG012|Follow-up Period|other reason|0|||
42040414|NCT01928394|75848579|FG013|Follow-up Period|other reason|1|||
42040415|NCT01928394|75848580|FG014|Follow-up Period|other reason|4|||
42160959|NCT00153062|75968853|FG000|Overall Study|Lost to Follow-up|12|||
42160960|NCT00153062|75968854|FG001|Overall Study|Lost to Follow-up|20|||
42160961|NCT00153062|75968855|FG002|Overall Study|Lost to Follow-up|15|||
42160962|NCT00153062|75968856|FG003|Overall Study|Lost to Follow-up|16|||
42160963|NCT00153062|75968853|FG000|Overall Study|Adverse Event|0|||
42160964|NCT00153062|75968854|FG001|Overall Study|Adverse Event|1|||
42160965|NCT00153062|75968855|FG002|Overall Study|Adverse Event|1|||
42160966|NCT00153062|75968856|FG003|Overall Study|Adverse Event|0|||
42160967|NCT00153062|75968853|FG000|Overall Study|Protocol Violation|0|||
42160968|NCT00153062|75968854|FG001|Overall Study|Protocol Violation|2|||
42160969|NCT00153062|75968855|FG002|Overall Study|Protocol Violation|1|||
42160970|NCT00153062|75968856|FG003|Overall Study|Protocol Violation|1|||
42160971|NCT00153062|75968853|FG000|Overall Study|No disposition data available|1|||
42160972|NCT00153062|75968854|FG001|Overall Study|No disposition data available|1|||
42160973|NCT00153062|75968855|FG002|Overall Study|No disposition data available|1|||
42160974|NCT00153062|75968856|FG003|Overall Study|No disposition data available|1|||
42160975|NCT00153062|75968853|FG000|Overall Study|Other|0|||
42160976|NCT00153062|75968854|FG001|Overall Study|Other|0|||
42160977|NCT00153062|75968855|FG002|Overall Study|Other|1|||
42160978|NCT00153062|75968856|FG003|Overall Study|Other|0|||
42160979|NCT00145470|75968868|FG000|Overall Study|Adverse Event|19|||
42160980|NCT00145470|75968869|FG001|Overall Study|Adverse Event|25|||
42160981|NCT00145470|75968868|FG000|Overall Study|Lack of Efficacy|27|||
42160982|NCT00145470|75968869|FG001|Overall Study|Lack of Efficacy|13|||
42160983|NCT00145470|75968868|FG000|Overall Study|Withdrawal by Subject|36|||
42280197|NCT00702403|76112224|FG000|From Consent to Engraftment|Critically ill|2|||
42280198|NCT00702403|76112224|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
42280199|NCT00702403|76112224|FG000|From Consent to Engraftment|Myocardial infarction|1|||
42280200|NCT00702403|76112224|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
42160984|NCT00145470|75968869|FG001|Overall Study|Withdrawal by Subject|34|||
42160985|NCT00145470|75968868|FG000|Overall Study|Lost to Follow-up|21|||
42160986|NCT00145470|75968869|FG001|Overall Study|Lost to Follow-up|17|||
42280201|NCT00702403|76112224|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
42160987|NCT00145470|75968868|FG000|Overall Study|Reason Not Reported|9|||
42280202|NCT00702403|76112224|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
42040416|NCT01928394|75848581|FG015|Follow-up Period|other reason|0|||
42160988|NCT00145470|75968869|FG001|Overall Study|Reason Not Reported|9|||
42160989|NCT00152516|75968875|FG000|Overall Study|Adverse Event|18|||
42040417|NCT01928394|75848582|FG016|Follow-up Period|other reason|2|||
42040418|NCT01928394|75848583|FG017|Follow-up Period|other reason|0|||
42160990|NCT00152516|75968875|FG000|Overall Study|Lack and Loss of Efficacy|30|||
42160991|NCT00152516|75968875|FG000|Overall Study|Lost to Follow-up|5|||
42160992|NCT00152516|75968875|FG000|Overall Study|Withdrawal by Subject|8|||
42160993|NCT00152516|75968875|FG000|Overall Study|Protocol Violation|3|||
42160994|NCT00152516|75968875|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
42160995|NCT00152516|75968875|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
42160996|NCT00152516|75968875|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
42160997|NCT00152516|75968875|FG000|Overall Study|Other: Non-Compliance|2|||
42160998|NCT00152516|75968875|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
42160999|NCT00152516|75968875|FG000|Overall Study|Other: Moved Out Of State|1|||
42161000|NCT00152516|75968875|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
42161001|NCT00152516|75968875|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
42161002|NCT00145158|75968881|FG000|Overall Study|premature withdrawal|2|||
42161003|NCT00145158|75968882|FG001|Overall Study|premature withdrawal|3|||
42161004|NCT00150800|75968889|FG000|Overall Study|Adverse Event|89|||
42161005|NCT00150800|75968889|FG000|Overall Study|Death|18|||
42161006|NCT00150800|75968889|FG000|Overall Study|Lack of Efficacy|166|||
42161007|NCT00150800|75968889|FG000|Overall Study|Lost to Follow-up|58|||
42161008|NCT00150800|75968889|FG000|Overall Study|Subject's choice|90|||
42161009|NCT00150800|75968889|FG000|Overall Study|No compliance|18|||
42161010|NCT00150800|75968889|FG000|Overall Study|IP misshandling|1|||
42161011|NCT00150800|75968889|FG000|Overall Study|Site closure|24|||
42161012|NCT00150800|75968889|FG000|Overall Study|Protocol non-adherence|2|||
42161013|NCT00150800|75968889|FG000|Overall Study|Nobody to accompany patient|1|||
42013507|NCT01178073|75820592|FG000|Overall Study|Protocol Violation|1|||
42013508|NCT01178073|75820593|FG001|Overall Study|Protocol Violation|1|||
42013509|NCT01178073|75820594|FG002|Overall Study|Protocol Violation|1|||
42013510|NCT01178073|75820592|FG000|Overall Study|Lost to Follow-up|2|||
42161014|NCT00150800|75968889|FG000|Overall Study|Distance too long for patient|1|||
42161015|NCT00150800|75968889|FG000|Overall Study|Neurosurgery|2|||
42161016|NCT00150800|75968889|FG000|Overall Study|BRV monotherapy|1|||
42161017|NCT00150800|75968889|FG000|Overall Study|Visit refusal|3|||
42161018|NCT00150800|75968889|FG000|Overall Study|Sponsor's request|2|||
42161019|NCT00150800|75968889|FG000|Overall Study|Generalized Epilepsy|1|||
42161020|NCT00150800|75968889|FG000|Overall Study|Moved from area/country|8|||
42161021|NCT00150800|75968889|FG000|Overall Study|PI retiring|2|||
42161022|NCT00150800|75968889|FG000|Overall Study|PI leaving site|2|||
42161023|NCT00150800|75968889|FG000|Overall Study|Patient insurance|1|||
42161024|NCT00150800|75968889|FG000|Overall Study|Surgical intervention|4|||
42161025|NCT00150800|75968889|FG000|Overall Study|Pregnancy planned|1|||
42161026|NCT00150800|75968889|FG000|Overall Study|PI discontinuation request|1|||
42161027|NCT00144300|75968896|FG000|Overall Study|Adverse Event|18|||
42161028|NCT00144300|75968897|FG001|Overall Study|Adverse Event|16|||
42351453|NCT01904773|76191369|FG005|Placebo Washout First Intervention|Condition worsened|0|||
42351454|NCT01904773|76191370|FG006|Placebo Washout First Intervention|Condition worsened|0|||
42351455|NCT01904773|76191371|FG007|Placebo Washout First Intervention|Condition worsened|0|||
42351456|NCT01904773|76191372|FG008|Placebo Washout First Intervention|Condition worsened|0|||
42351457|NCT01904773|76191364|FG000|Fifth Intervention|Adverse Event|0|||
42351458|NCT01904773|76191365|FG001|Fifth Intervention|Adverse Event|0|||
42351459|NCT01904773|76191366|FG002|Fifth Intervention|Adverse Event|0|||
42351460|NCT01904773|76191367|FG003|Fifth Intervention|Adverse Event|0|||
42351461|NCT01904773|76191368|FG004|Fifth Intervention|Adverse Event|0|||
42161029|NCT00144300|75968896|FG000|Overall Study|Protocol Violation|1|||
42161030|NCT00144300|75968897|FG001|Overall Study|Protocol Violation|3|||
42161031|NCT00144300|75968896|FG000|Overall Study|Lost to Follow-up|3|||
42161032|NCT00144300|75968897|FG001|Overall Study|Lost to Follow-up|0|||
42161033|NCT00144300|75968896|FG000|Overall Study|Withdrawal by Subject|6|||
42161034|NCT00144300|75968897|FG001|Overall Study|Withdrawal by Subject|6|||
42161035|NCT00144300|75968896|FG000|Overall Study|Other reason (not specified)|1|||
42161036|NCT00144300|75968897|FG001|Overall Study|Other reason (not specified)|3|||
42161037|NCT00149630|75968905|FG000|Overall Study|Incarceration|2|||
42161038|NCT00149630|75968906|FG001|Overall Study|Incarceration|0|||
42161039|NCT00149630|75968905|FG000|Overall Study|Treatment Programs|4|||
42161040|NCT00149630|75968906|FG001|Overall Study|Treatment Programs|5|||
42161041|NCT00149630|75968905|FG000|Overall Study|Adverse Event|2|||
42013511|NCT01178073|75820593|FG001|Overall Study|Lost to Follow-up|0|||
42161042|NCT00149630|75968906|FG001|Overall Study|Adverse Event|0|||
42161043|NCT00127842|75968916|FG000|Overall Study|Adverse Event|15|||
42161044|NCT00127842|75968916|FG000|Overall Study|Withdrawal by Subject|3|||
42161045|NCT00127842|75968916|FG000|Overall Study|Lost to Follow-up|1|||
42161046|NCT00127842|75968916|FG000|Overall Study|Lack of Efficacy|12|||
42161047|NCT00127842|75968916|FG000|Overall Study|Noncompliance|2|||
42161048|NCT00127842|75968916|FG000|Overall Study|Protocol Violation|1|||
42161049|NCT00127842|75968916|FG000|Overall Study|Other|5|||
42013512|NCT01178073|75820594|FG002|Overall Study|Lost to Follow-up|3|||
42161050|NCT03720652|75968922|FG000|Overall Study|Withdrawal by Subject|2|||
42161051|NCT03720652|75968923|FG001|Overall Study|Withdrawal by Subject|7|||
42161052|NCT03720652|75968922|FG000|Overall Study|Lost to Follow-up|0|||
42161053|NCT03720652|75968923|FG001|Overall Study|Lost to Follow-up|4|||
42161054|NCT00112866|75968933|FG000|Overall Study|Protocol Violation|1|||
42161055|NCT00112866|75968934|FG001|Overall Study|Protocol Violation|0|||
42161056|NCT00112866|75968933|FG000|Overall Study|did not start treatment post-op|1|||
42351462|NCT01904773|76191369|FG005|Fifth Intervention|Adverse Event|0|||
42013513|NCT01178073|75820592|FG000|Overall Study|Physician Decision|14|||
42351463|NCT01904773|76191370|FG006|Fifth Intervention|Adverse Event|0|||
42351464|NCT01904773|76191371|FG007|Fifth Intervention|Adverse Event|1|||
42161057|NCT00112866|75968934|FG001|Overall Study|did not start treatment post-op|2|||
42161058|NCT00127608|75968948|FG000|Overall Study|VZV DNA negative|1|||
42161059|NCT00149396|75968952|FG000|Overall Study|Death|15|||
42161060|NCT00149396|75968952|FG000|Overall Study|Withdrawal by Subject|1|||
42161061|NCT00149396|75968952|FG000|Overall Study|Subject noncompliance|2|||
42161062|NCT00149396|75968952|FG000|Overall Study|other treatment|5|||
42161063|NCT00223496|75968963|FG000|Overall Study|screen failure|9|||
42161064|NCT00223496|75968963|FG000|Overall Study|Lost to Follow-up|4|||
42161065|NCT00223496|75968963|FG000|Overall Study|Lack of Efficacy|6|||
42161066|NCT00223496|75968963|FG000|Overall Study|Withdrawal by Subject|1|||
42161067|NCT00223496|75968963|FG000|Overall Study|Physician Decision|2|||
42161068|NCT00255944|75968969|FG000|Overall Study|Lost to Follow-up|797|||
42161069|NCT00255944|75968970|FG001|Overall Study|Lost to Follow-up|834|||
42161070|NCT00143598|75968978|FG000|Overall Study|Lost to Follow-up|23|||
42161071|NCT00143598|75968979|FG001|Overall Study|Lost to Follow-up|21|||
42161072|NCT00143598|75968978|FG000|Overall Study|Withdrawal by Subject|33|||
42161073|NCT00143598|75968979|FG001|Overall Study|Withdrawal by Subject|37|||
42161074|NCT00143598|75968978|FG000|Overall Study|Death|36|||
42161075|NCT00143598|75968979|FG001|Overall Study|Death|36|||
42161076|NCT00126672|75968985|FG000|Overall Study|Adverse Event|4|||
42161077|NCT00126672|75968985|FG000|Overall Study|Lost to Follow-up|4|||
42280203|NCT00702403|76112224|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
42280204|NCT00702403|76112224|FG000|From Engraftment to Study Completion|Non-compliance|2|||
42280205|NCT00702403|76112224|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
42280206|NCT00702403|76112224|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
42280207|NCT00702403|76112224|FG000|From Engraftment to Study Completion|Suicide|1|||
42280208|NCT00702403|76112224|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
42280209|NCT00702403|76112224|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
42280210|NCT00702403|76112224|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
42280211|NCT00702325|76112233|FG000|Overall Study|Adverse Event|1|||
42280212|NCT00702325|76112234|FG001|Overall Study|Adverse Event|0|||
42280213|NCT00702325|76112233|FG000|Overall Study|Withdrawal by Subject|7|||
42280214|NCT00702325|76112234|FG001|Overall Study|Withdrawal by Subject|7|||
42280215|NCT00702325|76112233|FG000|Overall Study|Lost to Follow-up|3|||
42280216|NCT00702325|76112234|FG001|Overall Study|Lost to Follow-up|4|||
42280217|NCT00702325|76112233|FG000|Overall Study|Incorrect enrollment|5|||
42280218|NCT00702325|76112234|FG001|Overall Study|Incorrect enrollment|7|||
42280219|NCT00702325|76112233|FG000|Overall Study|Developed study discontinuation criteria|18|||
42280220|NCT00702325|76112234|FG001|Overall Study|Developed study discontinuation criteria|28|||
42280221|NCT00702325|76112233|FG000|Overall Study|Severe noncompliance to protocol|3|||
42280222|NCT00702325|76112234|FG001|Overall Study|Severe noncompliance to protocol|3|||
42280223|NCT00702325|76112233|FG000|Overall Study|Termination due to lab results|1|||
42280224|NCT00702325|76112234|FG001|Overall Study|Termination due to lab results|0|||
42280225|NCT00702325|76112233|FG000|Overall Study|Didn't follow study medication dosage|0|||
42280226|NCT00702325|76112234|FG001|Overall Study|Didn't follow study medication dosage|2|||
42280227|NCT00702325|76112233|FG000|Overall Study|Withdrew consent|0|||
42280228|NCT00702325|76112234|FG001|Overall Study|Withdrew consent|1|||
42280229|NCT00702325|76112233|FG000|Overall Study|Incorrectly Discontinued|0|||
42280230|NCT00702325|76112234|FG001|Overall Study|Incorrectly Discontinued|1|||
42280231|NCT02719171|76112245|FG000|Overall Study|Adverse Event|1|||
42280232|NCT02719171|76112246|FG001|Overall Study|Adverse Event|2|||
42280233|NCT02719171|76112247|FG002|Overall Study|Adverse Event|0|||
42280234|NCT02719171|76112248|FG003|Overall Study|Adverse Event|0|||
42280235|NCT02719171|76112249|FG004|Overall Study|Adverse Event|2|||
42280236|NCT02719171|76112245|FG000|Overall Study|Lost to Follow-up|0|||
42280237|NCT02719171|76112246|FG001|Overall Study|Lost to Follow-up|0|||
42351465|NCT01904773|76191372|FG008|Fifth Intervention|Adverse Event|0|||
42351466|NCT01904773|76191364|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
42351467|NCT01904773|76191365|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
42351468|NCT01904773|76191366|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
42161078|NCT00145574|75968992|FG000|Double Blind|Adverse Event|0|||
42351469|NCT01904773|76191367|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
42351470|NCT01904773|76191368|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
42351471|NCT01904773|76191369|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
42351472|NCT01904773|76191370|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
42351473|NCT01904773|76191371|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
42351474|NCT01904773|76191372|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
42161079|NCT00145574|75968993|FG001|Double Blind|Adverse Event|3|||
42161080|NCT00145574|75968994|FG002|Double Blind|Adverse Event|1|||
42161081|NCT00145574|75968992|FG000|Double Blind|Withdrawal by Subject|1|||
42161082|NCT00145574|75968993|FG001|Double Blind|Withdrawal by Subject|1|||
42161083|NCT00145574|75968994|FG002|Double Blind|Withdrawal by Subject|1|||
42161084|NCT00145574|75968992|FG000|Double Blind|required restricted medicine|0|||
42161085|NCT00145574|75968993|FG001|Double Blind|required restricted medicine|1|||
42161086|NCT00145574|75968994|FG002|Double Blind|required restricted medicine|0|||
42161087|NCT00145574|75968992|FG000|Open Label Long-term Extension|Adverse Event|0|||
42161088|NCT00145574|75968993|FG001|Open Label Long-term Extension|Adverse Event|0|||
42161089|NCT00145574|75968994|FG002|Open Label Long-term Extension|Adverse Event|5|||
42161090|NCT00145574|75968992|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
42161091|NCT00145574|75968993|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
42161092|NCT00145574|75968994|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
42161093|NCT00145574|75968992|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
42161094|NCT00145574|75968993|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
42161095|NCT00145574|75968994|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
42161096|NCT00145574|75968992|FG000|Open Label Long-term Extension|required restricted medicine|0|||
42161097|NCT00145574|75968993|FG001|Open Label Long-term Extension|required restricted medicine|0|||
42161098|NCT00145574|75968994|FG002|Open Label Long-term Extension|required restricted medicine|1|||
42161099|NCT00145496|75969009|FG000|Overall Study|Adverse Event|42|||
42161100|NCT00145496|75969010|FG001|Overall Study|Adverse Event|30|||
42161101|NCT00145496|75969009|FG000|Overall Study|Lack of Efficacy|12|||
42161102|NCT00145496|75969010|FG001|Overall Study|Lack of Efficacy|7|||
42161103|NCT00145496|75969009|FG000|Overall Study|Withdrawal by Subject|32|||
42161104|NCT00145496|75969010|FG001|Overall Study|Withdrawal by Subject|26|||
42161105|NCT00145496|75969009|FG000|Overall Study|Lost to Follow-up|12|||
42161106|NCT00145496|75969010|FG001|Overall Study|Lost to Follow-up|5|||
42161107|NCT00145496|75969009|FG000|Overall Study|Other|25|||
42161108|NCT00145496|75969010|FG001|Overall Study|Other|13|||
42161109|NCT00255164|75969019|FG000|Overall Study|Adverse Event|10|||
42161110|NCT00255164|75969020|FG001|Overall Study|Adverse Event|6|||
42161111|NCT00255164|75969021|FG002|Overall Study|Adverse Event|9|||
42161112|NCT00255164|75969019|FG000|Overall Study|Lost to Follow-up|4|||
42161113|NCT00255164|75969020|FG001|Overall Study|Lost to Follow-up|3|||
42161114|NCT00255164|75969021|FG002|Overall Study|Lost to Follow-up|4|||
42161115|NCT00255164|75969019|FG000|Overall Study|Withdrawal by Subject|18|||
42161116|NCT00255164|75969020|FG001|Overall Study|Withdrawal by Subject|17|||
42161117|NCT00255164|75969021|FG002|Overall Study|Withdrawal by Subject|8|||
42161118|NCT00255164|75969019|FG000|Overall Study|Noncompliance|0|||
42161119|NCT00255164|75969020|FG001|Overall Study|Noncompliance|1|||
42161120|NCT00255164|75969021|FG002|Overall Study|Noncompliance|2|||
42161121|NCT00255164|75969019|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
42161122|NCT00255164|75969020|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
42161123|NCT00255164|75969021|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
42161124|NCT00255164|75969019|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
42280238|NCT02719171|76112247|FG002|Overall Study|Lost to Follow-up|1|||
42280239|NCT02719171|76112248|FG003|Overall Study|Lost to Follow-up|0|||
42280240|NCT02719171|76112249|FG004|Overall Study|Lost to Follow-up|0|||
42280241|NCT02719171|76112245|FG000|Overall Study|Subject Withdrawal|0|||
42280242|NCT02719171|76112246|FG001|Overall Study|Subject Withdrawal|2|||
42280243|NCT02719171|76112247|FG002|Overall Study|Subject Withdrawal|2|||
42280244|NCT02719171|76112248|FG003|Overall Study|Subject Withdrawal|1|||
42280245|NCT02719171|76112249|FG004|Overall Study|Subject Withdrawal|0|||
42280246|NCT02719171|76112245|FG000|Overall Study|Other|0|||
42280247|NCT02719171|76112246|FG001|Overall Study|Other|0|||
42013514|NCT01178073|75820593|FG001|Overall Study|Physician Decision|10|||
42161125|NCT00255164|75969020|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
42161126|NCT00255164|75969021|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
42161127|NCT00255164|75969019|FG000|Overall Study|Possible Barrett's Esophagus|1|||
42280248|NCT02719171|76112247|FG002|Overall Study|Other|0|||
42351475|NCT01928719|76191386|FG000|Overall Study|Lost to Follow-up|26|||
42351476|NCT01928719|76191387|FG001|Overall Study|Lost to Follow-up|11|||
42351477|NCT01928719|76191386|FG000|Overall Study|Withdrawal by Subject|22|||
42351478|NCT01928719|76191387|FG001|Overall Study|Withdrawal by Subject|7|||
42351479|NCT01928719|76191386|FG000|Overall Study|Protocol Violation|3|||
42161128|NCT00255164|75969020|FG001|Overall Study|Possible Barrett's Esophagus|3|||
42161129|NCT00255164|75969021|FG002|Overall Study|Possible Barrett's Esophagus|8|||
42161130|NCT00255164|75969019|FG000|Overall Study|Esophageal Stricture|0|||
42161131|NCT00255164|75969020|FG001|Overall Study|Esophageal Stricture|0|||
42161132|NCT00255164|75969021|FG002|Overall Study|Esophageal Stricture|1|||
42161133|NCT00255164|75969019|FG000|Overall Study|Therapeutic Failure|11|||
42161134|NCT00255164|75969020|FG001|Overall Study|Therapeutic Failure|2|||
42161135|NCT00255164|75969021|FG002|Overall Study|Therapeutic Failure|3|||
42280249|NCT02719171|76112248|FG003|Overall Study|Other|1|||
42280250|NCT02719171|76112249|FG004|Overall Study|Other|0|||
42161136|NCT00126594|75969031|FG000|Overall Study|Ineligible|2|||
42280251|NCT02718625|76112266|FG000|Overall Study|Adverse Event|0|||
42280252|NCT02718625|76112267|FG001|Overall Study|Adverse Event|1|||
42351480|NCT01928719|76191387|FG001|Overall Study|Protocol Violation|1|||
42161137|NCT00126594|75969032|FG001|Overall Study|Ineligible|0|||
42161138|NCT00126594|75969031|FG000|Overall Study|Withdrawal by Subject|0|||
42161139|NCT00126594|75969032|FG001|Overall Study|Withdrawal by Subject|4|||
42161140|NCT00126594|75969031|FG000|Overall Study|Physician Decision|1|||
42161141|NCT00126594|75969032|FG001|Overall Study|Physician Decision|3|||
42161142|NCT00126594|75969031|FG000|Overall Study|Adverse Event|7|||
42161143|NCT00126594|75969032|FG001|Overall Study|Adverse Event|5|||
42161144|NCT00126594|75969031|FG000|Overall Study|Non-compliance|0|||
42161145|NCT00126594|75969032|FG001|Overall Study|Non-compliance|1|||
42161146|NCT00126594|75969031|FG000|Overall Study|Disease Progression|29|||
42161147|NCT00126594|75969032|FG001|Overall Study|Disease Progression|24|||
42161148|NCT00126438|75969041|FG000|Overall Study|Withdrawal due to adverse event|1|||
42161149|NCT00126438|75969042|FG001|Overall Study|Withdrawal due to adverse event|0|||
42161150|NCT00126438|75969041|FG000|Overall Study|Lost to Follow-up|22|||
42161151|NCT00126438|75969042|FG001|Overall Study|Lost to Follow-up|0|||
42161152|NCT00126438|75969041|FG000|Overall Study|Protocol Violation|8|||
42161153|NCT00126438|75969042|FG001|Overall Study|Protocol Violation|8|||
42161154|NCT00126438|75969041|FG000|Overall Study|Withdrawal by Subject|3|||
42161155|NCT00126438|75969042|FG001|Overall Study|Withdrawal by Subject|2|||
42161156|NCT00142584|75969050|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
42161157|NCT00142584|75969051|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
42161158|NCT00142584|75969050|FG000|Overall Study|Withdrawal by Subject|30|||
42161159|NCT00142584|75969051|FG001|Overall Study|Withdrawal by Subject|16|||
42161160|NCT00142584|75969050|FG000|Overall Study|Lost to Follow-up|22|||
42161161|NCT00142584|75969051|FG001|Overall Study|Lost to Follow-up|12|||
42161162|NCT00142584|75969050|FG000|Overall Study|Adverse Event|14|||
42161163|NCT00142584|75969051|FG001|Overall Study|Adverse Event|5|||
42161164|NCT00142584|75969050|FG000|Overall Study|Protocol Violation|4|||
42161165|NCT00142584|75969051|FG001|Overall Study|Protocol Violation|7|||
42161166|NCT00142584|75969050|FG000|Overall Study|Treatment Failure|2|||
42161167|NCT00142584|75969051|FG001|Overall Study|Treatment Failure|0|||
42161168|NCT00126126|75969061|FG000|Overall Study|Lost to Follow-up|0|||
42161169|NCT00126126|75969062|FG001|Overall Study|Lost to Follow-up|2|||
42161170|NCT00125268|75969070|FG000|Overall Study|Withdrawal by Subject|1|||
42161171|NCT00125268|75969071|FG001|Overall Study|Withdrawal by Subject|1|||
42161172|NCT00125190|75969077|FG000|Overall Study|Subject/Parent Decision|7|||
42161173|NCT00125190|75969077|FG000|Overall Study|Non-compliance|2|||
42161174|NCT00125190|75969077|FG000|Overall Study|Adverse Event|1|||
42161175|NCT00125190|75969077|FG000|Overall Study|Other|1|||
42161176|NCT00125190|75969077|FG000|Overall Study|Lost to Follow-up|4|||
42161177|NCT00141726|75969082|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
42161178|NCT00111228|75969089|FG000|Overall Study|Withdrawal by Subject|5|||
42161179|NCT00111228|75969090|FG001|Overall Study|Withdrawal by Subject|1|||
42161180|NCT00111228|75969091|FG002|Overall Study|Withdrawal by Subject|0|||
42280253|NCT02718625|76112266|FG000|Overall Study|Termination of Study by Sponsor|0|||
42280254|NCT02718625|76112267|FG001|Overall Study|Termination of Study by Sponsor|1|||
42280255|NCT02716987|76112279|FG000|Overall Study|Ligand synthesis failure|0|||
42280256|NCT02716987|76112280|FG001|Overall Study|Ligand synthesis failure|0|||
42280257|NCT02716987|76112281|FG002|Overall Study|Ligand synthesis failure|1|||
42280258|NCT02716987|76112282|FG003|Overall Study|Ligand synthesis failure|0|||
42280259|NCT02716987|76112283|FG004|Overall Study|Ligand synthesis failure|0|||
42280260|NCT02716987|76112284|FG005|Overall Study|Ligand synthesis failure|0|||
42280261|NCT02716987|76112279|FG000|Overall Study|Withdrawal by Subject|0|||
42280262|NCT02716987|76112280|FG001|Overall Study|Withdrawal by Subject|0|||
42280263|NCT02716987|76112281|FG002|Overall Study|Withdrawal by Subject|0|||
42280264|NCT02716987|76112282|FG003|Overall Study|Withdrawal by Subject|0|||
42280265|NCT02716987|76112283|FG004|Overall Study|Withdrawal by Subject|1|||
42161181|NCT00110994|75969101|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
42161182|NCT00110994|75969102|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
42280266|NCT02716987|76112284|FG005|Overall Study|Withdrawal by Subject|1|||
42280267|NCT00701779|76112309|FG000|Overall Study|Adverse Event|6|||
42280268|NCT00701779|76112309|FG000|Overall Study|Lost to Follow-up|1|||
42280269|NCT00701779|76112309|FG000|Overall Study|Withdrawal by Subject|2|||
42040419|NCT01928394|75848584|FG018|Follow-up Period|other reason|1|||
42161183|NCT00110994|75969101|FG000|Double-blind (DB) Treatment|Death|1|||
42161184|NCT00110994|75969102|FG001|Double-blind (DB) Treatment|Death|0|||
42161185|NCT00110994|75969101|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
42161186|NCT00110994|75969102|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
42280270|NCT03707977|76112332|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
42280271|NCT03707977|76112333|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
42351481|NCT01928719|76191386|FG000|Overall Study|Adverse Event|1|||
42351482|NCT01928719|76191387|FG001|Overall Study|Adverse Event|0|||
42351483|NCT00986674|76191398|FG000|Overall Study|Lack of Efficacy|28|||
42351484|NCT00986674|76191399|FG001|Overall Study|Lack of Efficacy|25|||
42161187|NCT00110994|75969101|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
42161188|NCT00110994|75969102|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
42161189|NCT00110994|75969101|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
42161190|NCT00110994|75969102|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
42161191|NCT00110994|75969101|FG000|Double-blind (DB) Treatment|other reasons|2|||
42161192|NCT00110994|75969102|FG001|Double-blind (DB) Treatment|other reasons|3|||
42161193|NCT00110994|75969101|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
42161194|NCT00110994|75969102|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
42161195|NCT00110994|75969101|FG000|Active Follow-up|Other reasons|0|||
42161196|NCT00110994|75969102|FG001|Active Follow-up|Other reasons|2|||
42161197|NCT00110994|75969101|FG000|Long Term Follow-up|Death|19|||
42161198|NCT00110994|75969102|FG001|Long Term Follow-up|Death|17|||
42161199|NCT00144170|75969110|FG000|Overall Study|Adverse Event|84|||
42161200|NCT00144170|75969111|FG001|Overall Study|Adverse Event|41|||
42161201|NCT00144170|75969110|FG000|Overall Study|Protocol Violation|23|||
42161202|NCT00144170|75969111|FG001|Overall Study|Protocol Violation|16|||
42161203|NCT00144170|75969110|FG000|Overall Study|Lost to Follow-up|5|||
42161204|NCT00144170|75969111|FG001|Overall Study|Lost to Follow-up|10|||
42161205|NCT00144170|75969110|FG000|Overall Study|Withdrawal by Subject|29|||
42161206|NCT00144170|75969111|FG001|Overall Study|Withdrawal by Subject|13|||
42161207|NCT00144170|75969110|FG000|Overall Study|Other reason not defined above|211|||
42161208|NCT00144170|75969111|FG001|Overall Study|Other reason not defined above|316|||
42161209|NCT00255086|75969119|FG000|Overall Study|Adverse Event|1|||
42161210|NCT00255086|75969120|FG001|Overall Study|Adverse Event|1|||
42161211|NCT00255086|75969119|FG000|Overall Study|Protocol Violation|1|||
42161212|NCT00255086|75969120|FG001|Overall Study|Protocol Violation|1|||
42161213|NCT00110214|75969129|FG000|Overall Study|Never started treatment|21|||
42161214|NCT00110214|75969130|FG001|Overall Study|Never started treatment|20|||
42161215|NCT00110214|75969129|FG000|Overall Study|Disease progression or death|260|||
42161216|NCT00110214|75969130|FG001|Overall Study|Disease progression or death|151|||
42161217|NCT00110214|75969129|FG000|Overall Study|Adverse Event|115|||
42161218|NCT00110214|75969130|FG001|Overall Study|Adverse Event|192|||
42161219|NCT00110214|75969129|FG000|Overall Study|Refused further treatment|52|||
42280272|NCT03707977|76112334|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
42280273|NCT03707977|76112332|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
42351485|NCT00986674|76191400|FG002|Overall Study|Lack of Efficacy|23|||
42351486|NCT00986674|76191398|FG000|Overall Study|Adverse Event|4|||
42351487|NCT00986674|76191399|FG001|Overall Study|Adverse Event|8|||
42351488|NCT00986674|76191400|FG002|Overall Study|Adverse Event|9|||
42161220|NCT00110214|75969130|FG001|Overall Study|Refused further treatment|65|||
42161221|NCT00110214|75969129|FG000|Overall Study|Other (not specified)|61|||
42161222|NCT00110214|75969130|FG001|Overall Study|Other (not specified)|75|||
42161223|NCT00124020|75969138|FG000|Overall Study|Death|67|||
42161224|NCT00124020|75969139|FG001|Overall Study|Death|71|||
42161225|NCT00124020|75969138|FG000|Overall Study|Withdrawal by Subject|13|||
42161226|NCT00124020|75969139|FG001|Overall Study|Withdrawal by Subject|11|||
42161227|NCT00124020|75969138|FG000|Overall Study|Lost to Follow-up|5|||
42161228|NCT00124020|75969139|FG001|Overall Study|Lost to Follow-up|8|||
42161229|NCT00124020|75969138|FG000|Overall Study|Other|1|||
42161230|NCT00124020|75969139|FG001|Overall Study|Other|1|||
42161231|NCT00124020|75969138|FG000|Overall Study|Transfer to another hospital|2|||
42161232|NCT00124020|75969139|FG001|Overall Study|Transfer to another hospital|0|||
42161233|NCT00215540|75969148|FG000|Overall Study|Withdrew from study medication|1|||
42161234|NCT00215540|75969149|FG001|Overall Study|Withdrew from study medication|0|||
42161235|NCT00215540|75969150|FG002|Overall Study|Withdrew from study medication|0|||
42161236|NCT00143390|75969160|FG000|Overall Study|Death|2|||
42161237|NCT00143390|75969161|FG001|Overall Study|Death|0|||
42161238|NCT00143390|75969160|FG000|Overall Study|Not meeting entry criteria|2|||
42280274|NCT03707977|76112333|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
42280275|NCT03707977|76112334|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
42280276|NCT03332095|76112350|FG000|Overall Study|Lost to Follow-up|1|||
42280277|NCT03332095|76112351|FG001|Overall Study|Lost to Follow-up|0|||
42280278|NCT03332095|76112350|FG000|Overall Study|Pregnancy|0|||
42280279|NCT03332095|76112351|FG001|Overall Study|Pregnancy|1|||
42351489|NCT00986674|76191398|FG000|Overall Study|Death|5|||
42351490|NCT00986674|76191399|FG001|Overall Study|Death|0|||
42351491|NCT00986674|76191400|FG002|Overall Study|Death|4|||
42161239|NCT00143390|75969161|FG001|Overall Study|Not meeting entry criteria|5|||
42161240|NCT00143390|75969160|FG000|Overall Study|Withdrawal by Subject|4|||
42280280|NCT02764489|76112358|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
42280281|NCT02764489|76112359|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
42351492|NCT00986674|76191398|FG000|Overall Study|Withdrawal by Subject|6|||
42161241|NCT00143390|75969161|FG001|Overall Study|Withdrawal by Subject|4|||
42040420|NCT01928394|75848585|FG019|Follow-up Period|other reason|1|||
42161242|NCT00143390|75969160|FG000|Overall Study|Progressive disease|119|||
42161243|NCT00143390|75969161|FG001|Overall Study|Progressive disease|115|||
42161244|NCT00143390|75969160|FG000|Overall Study|Protocol Violation|2|||
42161245|NCT00143390|75969161|FG001|Overall Study|Protocol Violation|0|||
42161246|NCT00143390|75969160|FG000|Overall Study|Study termination|10|||
42280282|NCT02764489|76112358|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
42280283|NCT02764489|76112359|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
42280284|NCT02764489|76112358|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
42280285|NCT02764489|76112359|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
42280286|NCT02764489|76112358|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
42280287|NCT02764489|76112359|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
42280288|NCT02001623|76112384|FG000|Overall Study|Disease Progression|2|||
42280289|NCT02001623|76112385|FG001|Overall Study|Disease Progression|2|||
42280290|NCT02001623|76112386|FG002|Overall Study|Disease Progression|3|||
42280291|NCT02001623|76112387|FG003|Overall Study|Disease Progression|2|||
42280292|NCT02001623|76112388|FG004|Overall Study|Disease Progression|3|||
42280293|NCT02001623|76112389|FG005|Overall Study|Disease Progression|2|||
42280294|NCT02001623|76112390|FG006|Overall Study|Disease Progression|3|||
42280295|NCT02001623|76112391|FG007|Overall Study|Disease Progression|3|||
42280296|NCT02001623|76112392|FG008|Overall Study|Disease Progression|7|||
42280297|NCT02001623|76112393|FG009|Overall Study|Disease Progression|40|||
42280298|NCT02001623|76112394|FG010|Overall Study|Disease Progression|5|||
42280299|NCT02001623|76112395|FG011|Overall Study|Disease Progression|9|||
42280300|NCT02001623|76112396|FG012|Overall Study|Disease Progression|9|||
42280301|NCT02001623|76112397|FG013|Overall Study|Disease Progression|20|||
42280302|NCT02001623|76112398|FG014|Overall Study|Disease Progression|9|||
42280303|NCT02001623|76112384|FG000|Overall Study|Physician Decision|0|||
42280304|NCT02001623|76112385|FG001|Overall Study|Physician Decision|0|||
42280305|NCT02001623|76112386|FG002|Overall Study|Physician Decision|0|||
42280306|NCT02001623|76112387|FG003|Overall Study|Physician Decision|0|||
42280307|NCT02001623|76112388|FG004|Overall Study|Physician Decision|0|||
42280308|NCT02001623|76112389|FG005|Overall Study|Physician Decision|0|||
42280309|NCT02001623|76112390|FG006|Overall Study|Physician Decision|0|||
42280310|NCT02001623|76112391|FG007|Overall Study|Physician Decision|0|||
42280311|NCT02001623|76112392|FG008|Overall Study|Physician Decision|3|||
42280312|NCT02001623|76112393|FG009|Overall Study|Physician Decision|2|||
42280313|NCT02001623|76112394|FG010|Overall Study|Physician Decision|3|||
42280314|NCT02001623|76112395|FG011|Overall Study|Physician Decision|3|||
42280315|NCT02001623|76112396|FG012|Overall Study|Physician Decision|1|||
42280316|NCT02001623|76112397|FG013|Overall Study|Physician Decision|2|||
42280317|NCT02001623|76112398|FG014|Overall Study|Physician Decision|1|||
42280318|NCT02001623|76112384|FG000|Overall Study|Death|0|||
42280319|NCT02001623|76112385|FG001|Overall Study|Death|1|||
42280320|NCT02001623|76112386|FG002|Overall Study|Death|0|||
42280321|NCT02001623|76112387|FG003|Overall Study|Death|0|||
42280322|NCT02001623|76112388|FG004|Overall Study|Death|0|||
42280323|NCT02001623|76112389|FG005|Overall Study|Death|0|||
42280324|NCT02001623|76112390|FG006|Overall Study|Death|0|||
42280325|NCT02001623|76112391|FG007|Overall Study|Death|0|||
42280326|NCT02001623|76112392|FG008|Overall Study|Death|0|||
42280327|NCT02001623|76112393|FG009|Overall Study|Death|0|||
42280328|NCT02001623|76112394|FG010|Overall Study|Death|0|||
42280329|NCT02001623|76112395|FG011|Overall Study|Death|0|||
42280330|NCT02001623|76112396|FG012|Overall Study|Death|0|||
42280331|NCT02001623|76112397|FG013|Overall Study|Death|0|||
42280332|NCT02001623|76112398|FG014|Overall Study|Death|0|||
42280333|NCT02001623|76112384|FG000|Overall Study|Adverse Event|0|||
42280334|NCT02001623|76112385|FG001|Overall Study|Adverse Event|0|||
42280335|NCT02001623|76112386|FG002|Overall Study|Adverse Event|0|||
42280336|NCT02001623|76112387|FG003|Overall Study|Adverse Event|0|||
42280337|NCT02001623|76112388|FG004|Overall Study|Adverse Event|0|||
42280338|NCT02001623|76112389|FG005|Overall Study|Adverse Event|1|||
42351493|NCT00986674|76191399|FG001|Overall Study|Withdrawal by Subject|2|||
42351494|NCT00986674|76191400|FG002|Overall Study|Withdrawal by Subject|1|||
42013515|NCT01178073|75820594|FG002|Overall Study|Physician Decision|10|||
42013516|NCT01178073|75820592|FG000|Overall Study|Withdrawal by Subject|10|||
42013517|NCT01178073|75820593|FG001|Overall Study|Withdrawal by Subject|6|||
42013518|NCT01178073|75820594|FG002|Overall Study|Withdrawal by Subject|8|||
42013519|NCT01178073|75820592|FG000|Overall Study|Missing Completion Status|1|||
42013520|NCT01178073|75820593|FG001|Overall Study|Missing Completion Status|0|||
42013521|NCT01178073|75820594|FG002|Overall Study|Missing Completion Status|0|||
42013522|NCT00997984|75820606|FG000|Overall Study|Adverse Event|1|||
42280339|NCT02001623|76112390|FG006|Overall Study|Adverse Event|0|||
42351495|NCT00986674|76191398|FG000|Overall Study|alternative therapy|0|||
42351496|NCT00986674|76191399|FG001|Overall Study|alternative therapy|0|||
42351497|NCT00986674|76191400|FG002|Overall Study|alternative therapy|1|||
42013523|NCT00997984|75820607|FG001|Overall Study|Adverse Event|8|||
42280340|NCT02001623|76112391|FG007|Overall Study|Adverse Event|3|||
42280341|NCT02001623|76112392|FG008|Overall Study|Adverse Event|4|||
42280342|NCT02001623|76112393|FG009|Overall Study|Adverse Event|6|||
42280343|NCT02001623|76112394|FG010|Overall Study|Adverse Event|4|||
42280344|NCT02001623|76112395|FG011|Overall Study|Adverse Event|0|||
42280345|NCT02001623|76112396|FG012|Overall Study|Adverse Event|3|||
42280346|NCT02001623|76112397|FG013|Overall Study|Adverse Event|5|||
42280347|NCT02001623|76112398|FG014|Overall Study|Adverse Event|6|||
42161247|NCT00143390|75969161|FG001|Overall Study|Study termination|15|||
42161248|NCT00143390|75969160|FG000|Overall Study|Adverse Event|9|||
42161249|NCT00143390|75969161|FG001|Overall Study|Adverse Event|8|||
42161250|NCT00143390|75969160|FG000|Overall Study|Other|1|||
42161251|NCT00143390|75969161|FG001|Overall Study|Other|2|||
42161252|NCT00141102|75969169|FG000|Overall Study|Adverse Event|233|||
42161253|NCT00141102|75969170|FG001|Overall Study|Adverse Event|305|||
42161254|NCT00141102|75969169|FG000|Overall Study|Laboratory Abnormality|9|||
42161255|NCT00141102|75969170|FG001|Overall Study|Laboratory Abnormality|33|||
42161256|NCT00141102|75969169|FG000|Overall Study|Lack of Efficacy|21|||
42161257|NCT00141102|75969170|FG001|Overall Study|Lack of Efficacy|26|||
42161258|NCT00141102|75969169|FG000|Overall Study|Lost to Follow-up|29|||
42161259|NCT00141102|75969170|FG001|Overall Study|Lost to Follow-up|32|||
42161260|NCT00141102|75969169|FG000|Overall Study|Other|87|||
42161261|NCT00141102|75969170|FG001|Overall Study|Other|76|||
42161262|NCT00141102|75969169|FG000|Overall Study|Withdrawal by Subject|112|||
42161263|NCT00141102|75969170|FG001|Overall Study|Withdrawal by Subject|142|||
42161264|NCT00141102|75969169|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
42161265|NCT00141102|75969170|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
42161266|NCT00141102|75969169|FG000|Overall Study|Death|2|||
42161267|NCT00141102|75969170|FG001|Overall Study|Death|2|||
42161268|NCT00255008|75969181|FG000|Overall Study|Adverse Event|1|||
42161269|NCT00255008|75969182|FG001|Overall Study|Adverse Event|1|||
42161270|NCT00255008|75969183|FG002|Overall Study|Adverse Event|2|||
42161271|NCT00255008|75969184|FG003|Overall Study|Adverse Event|0|||
42161272|NCT00255008|75969181|FG000|Overall Study|Lost to Follow-up|1|||
42161273|NCT00255008|75969182|FG001|Overall Study|Lost to Follow-up|0|||
42161274|NCT00255008|75969183|FG002|Overall Study|Lost to Follow-up|1|||
42161275|NCT00255008|75969184|FG003|Overall Study|Lost to Follow-up|2|||
42161276|NCT00255008|75969181|FG000|Overall Study|Did not meet viral reduction criteria|4|||
42161277|NCT00255008|75969182|FG001|Overall Study|Did not meet viral reduction criteria|5|||
42161278|NCT00255008|75969183|FG002|Overall Study|Did not meet viral reduction criteria|0|||
42161279|NCT00255008|75969184|FG003|Overall Study|Did not meet viral reduction criteria|1|||
42161280|NCT00255008|75969181|FG000|Overall Study|Withdrew consent|0|||
42161281|NCT00255008|75969182|FG001|Overall Study|Withdrew consent|0|||
42161282|NCT00255008|75969183|FG002|Overall Study|Withdrew consent|2|||
42161283|NCT00255008|75969184|FG003|Overall Study|Withdrew consent|0|||
42161284|NCT00255008|75969181|FG000|Overall Study|Sponsor request|18|||
42161285|NCT00255008|75969182|FG001|Overall Study|Sponsor request|3|||
42161286|NCT00255008|75969183|FG002|Overall Study|Sponsor request|8|||
42161287|NCT00255008|75969184|FG003|Overall Study|Sponsor request|17|||
42161288|NCT00255008|75969181|FG000|Overall Study|Adverse lab experience|1|||
42161289|NCT00255008|75969182|FG001|Overall Study|Adverse lab experience|0|||
42161290|NCT00255008|75969183|FG002|Overall Study|Adverse lab experience|0|||
42161291|NCT00255008|75969184|FG003|Overall Study|Adverse lab experience|0|||
42161292|NCT00255008|75969181|FG000|Overall Study|Other|7|||
42161293|NCT00255008|75969182|FG001|Overall Study|Other|0|||
42161294|NCT00255008|75969183|FG002|Overall Study|Other|3|||
42161295|NCT00255008|75969184|FG003|Overall Study|Other|2|||
42161296|NCT03714022|75969196|FG000|Overall Study|Adverse Event|1|||
42161297|NCT03714022|75969197|FG001|Overall Study|Adverse Event|0|||
42161298|NCT03714022|75969196|FG000|Overall Study|Consent withdrawal|0|||
42161299|NCT03714022|75969197|FG001|Overall Study|Consent withdrawal|1|||
42161300|NCT03714022|75969196|FG000|Overall Study|Lost to Follow-up|3|||
42161301|NCT03714022|75969197|FG001|Overall Study|Lost to Follow-up|2|||
42161302|NCT00143312|75969203|FG000|Overall Study|Death|11|||
42161303|NCT00143312|75969203|FG000|Overall Study|Adverse Event|2|||
42161304|NCT00143312|75969203|FG000|Overall Study|Lost to Follow-up|1|||
42161305|NCT00143312|75969203|FG000|Overall Study|Other|1|||
42161306|NCT00143312|75969203|FG000|Overall Study|Withdrawal by Subject|1|||
42161307|NCT00254540|75969209|FG000|Overall Study|Adverse Event|6|||
42161308|NCT00254540|75969210|FG001|Overall Study|Adverse Event|7|||
42013524|NCT00997984|75820608|FG002|Overall Study|Adverse Event|8|||
42161309|NCT00254540|75969209|FG000|Overall Study|Lack of Efficacy|13|||
42161310|NCT00254540|75969210|FG001|Overall Study|Lack of Efficacy|13|||
42161311|NCT00254540|75969209|FG000|Overall Study|Death|0|||
42161312|NCT00254540|75969210|FG001|Overall Study|Death|1|||
42161313|NCT00254540|75969209|FG000|Overall Study|Laboratory Test Abnormality|0|||
42161314|NCT00254540|75969210|FG001|Overall Study|Laboratory Test Abnormality|1|||
42161315|NCT00139776|75969236|FG000|Period I|Did not enter Period II|575|||
42161316|NCT00139776|75969237|FG001|Period I|Did not enter Period II|0|||
42161317|NCT00139776|75969238|FG002|Period I|Did not enter Period II|0|||
42161318|NCT00139776|75969239|FG003|Period I|Did not enter Period II|0|||
42161319|NCT00139776|75969236|FG000|Period II|Not Randomized into Period III|0|||
42161320|NCT00139776|75969237|FG001|Period II|Not Randomized into Period III|322|||
42161321|NCT00139776|75969238|FG002|Period II|Not Randomized into Period III|0|||
42161322|NCT00139776|75969239|FG003|Period II|Not Randomized into Period III|0|||
42161323|NCT00139776|75969236|FG000|Period III|Adverse Event|0|||
42161324|NCT00139776|75969237|FG001|Period III|Adverse Event|0|||
42161325|NCT00139776|75969238|FG002|Period III|Adverse Event|22|||
42161326|NCT00139776|75969239|FG003|Period III|Adverse Event|23|||
42161327|NCT00139776|75969236|FG000|Period III|Other|0|||
42161328|NCT00139776|75969237|FG001|Period III|Other|0|||
42161329|NCT00139776|75969238|FG002|Period III|Other|23|||
42161330|NCT00139776|75969239|FG003|Period III|Other|34|||
42161331|NCT00139776|75969236|FG000|Period III|Lack of Efficacy|0|||
42161332|NCT00139776|75969237|FG001|Period III|Lack of Efficacy|0|||
42161333|NCT00139776|75969238|FG002|Period III|Lack of Efficacy|10|||
42161334|NCT00139776|75969239|FG003|Period III|Lack of Efficacy|24|||
42161335|NCT00139776|75969236|FG000|Period III|Lost to Follow-up|0|||
42161336|NCT00139776|75969237|FG001|Period III|Lost to Follow-up|0|||
42161337|NCT00139776|75969238|FG002|Period III|Lost to Follow-up|5|||
42161338|NCT00139776|75969239|FG003|Period III|Lost to Follow-up|4|||
42161339|NCT00139776|75969236|FG000|Period III|Withdrawal by Subject|0|||
42161340|NCT00139776|75969237|FG001|Period III|Withdrawal by Subject|0|||
42161341|NCT00139776|75969238|FG002|Period III|Withdrawal by Subject|16|||
42161342|NCT00139776|75969239|FG003|Period III|Withdrawal by Subject|21|||
42161343|NCT00413699|75969248|FG000|Initial Period|Death|25|||
42280348|NCT02001623|76112384|FG000|Overall Study|Other - Miscellaneous|0|||
42280349|NCT02001623|76112385|FG001|Overall Study|Other - Miscellaneous|0|||
42280350|NCT02001623|76112386|FG002|Overall Study|Other - Miscellaneous|0|||
42280351|NCT02001623|76112387|FG003|Overall Study|Other - Miscellaneous|0|||
42280352|NCT02001623|76112388|FG004|Overall Study|Other - Miscellaneous|0|||
42280353|NCT02001623|76112389|FG005|Overall Study|Other - Miscellaneous|0|||
42280354|NCT02001623|76112390|FG006|Overall Study|Other - Miscellaneous|0|||
42280355|NCT02001623|76112391|FG007|Overall Study|Other - Miscellaneous|0|||
42280356|NCT02001623|76112392|FG008|Overall Study|Other - Miscellaneous|0|||
42280357|NCT02001623|76112393|FG009|Overall Study|Other - Miscellaneous|1|||
42280358|NCT02001623|76112394|FG010|Overall Study|Other - Miscellaneous|0|||
42280359|NCT02001623|76112395|FG011|Overall Study|Other - Miscellaneous|0|||
42280360|NCT02001623|76112396|FG012|Overall Study|Other - Miscellaneous|0|||
42280361|NCT02001623|76112397|FG013|Overall Study|Other - Miscellaneous|1|||
42280362|NCT02001623|76112398|FG014|Overall Study|Other - Miscellaneous|0|||
42280363|NCT02001623|76112384|FG000|Overall Study|Withdrawal by Subject|1|||
42280364|NCT02001623|76112385|FG001|Overall Study|Withdrawal by Subject|0|||
42280365|NCT02001623|76112386|FG002|Overall Study|Withdrawal by Subject|0|||
42280366|NCT02001623|76112387|FG003|Overall Study|Withdrawal by Subject|0|||
42280367|NCT02001623|76112388|FG004|Overall Study|Withdrawal by Subject|0|||
42280368|NCT02001623|76112389|FG005|Overall Study|Withdrawal by Subject|0|||
42280369|NCT02001623|76112390|FG006|Overall Study|Withdrawal by Subject|0|||
42013525|NCT00997984|75820606|FG000|Overall Study|Protocol Violation|1|||
42161344|NCT00413699|75969249|FG001|Initial Period|Death|30|||
42161345|NCT00413699|75969250|FG002|Initial Period|Death|0|||
42161346|NCT00413699|75969248|FG000|Initial Period|Lack of Efficacy|59|||
42280370|NCT02001623|76112391|FG007|Overall Study|Withdrawal by Subject|0|||
42280371|NCT02001623|76112392|FG008|Overall Study|Withdrawal by Subject|1|||
42280372|NCT02001623|76112393|FG009|Overall Study|Withdrawal by Subject|3|||
42280373|NCT02001623|76112394|FG010|Overall Study|Withdrawal by Subject|2|||
42280374|NCT02001623|76112395|FG011|Overall Study|Withdrawal by Subject|2|||
42280375|NCT02001623|76112396|FG012|Overall Study|Withdrawal by Subject|1|||
42013526|NCT00997984|75820607|FG001|Overall Study|Protocol Violation|3|||
42013527|NCT00997984|75820608|FG002|Overall Study|Protocol Violation|0|||
42013528|NCT00997984|75820606|FG000|Overall Study|Withdrawal by Subject|6|||
42013529|NCT00997984|75820607|FG001|Overall Study|Withdrawal by Subject|9|||
42013530|NCT00997984|75820608|FG002|Overall Study|Withdrawal by Subject|5|||
42013531|NCT00997984|75820606|FG000|Overall Study|Lost to Follow-up|8|||
42013532|NCT00997984|75820607|FG001|Overall Study|Lost to Follow-up|5|||
42013533|NCT00997984|75820608|FG002|Overall Study|Lost to Follow-up|4|||
42013534|NCT00997984|75820606|FG000|Overall Study|Lack of Efficacy|20|||
42013535|NCT00997984|75820607|FG001|Overall Study|Lack of Efficacy|6|||
42013536|NCT00997984|75820608|FG002|Overall Study|Lack of Efficacy|3|||
42013537|NCT00997984|75820606|FG000|Overall Study|Met exclusion criteria|1|||
42013538|NCT00997984|75820607|FG001|Overall Study|Met exclusion criteria|0|||
42013539|NCT00997984|75820608|FG002|Overall Study|Met exclusion criteria|0|||
42013540|NCT00997984|75820606|FG000|Overall Study|non-compliance|0|||
42161347|NCT00413699|75969249|FG001|Initial Period|Lack of Efficacy|115|||
42161348|NCT00413699|75969250|FG002|Initial Period|Lack of Efficacy|0|||
42161349|NCT00413699|75969248|FG000|Initial Period|Lost to Follow-up|31|||
42351498|NCT00986674|76191398|FG000|Overall Study|not start protocol therapy|4|||
42013541|NCT00997984|75820607|FG001|Overall Study|non-compliance|2|||
42013542|NCT00997984|75820608|FG002|Overall Study|non-compliance|3|||
42161350|NCT00413699|75969249|FG001|Initial Period|Lost to Follow-up|101|||
42161351|NCT00413699|75969250|FG002|Initial Period|Lost to Follow-up|0|||
42161352|NCT00413699|75969248|FG000|Initial Period|Protocol Violation|38|||
42161353|NCT00413699|75969249|FG001|Initial Period|Protocol Violation|89|||
42161354|NCT00413699|75969250|FG002|Initial Period|Protocol Violation|0|||
42280376|NCT02001623|76112397|FG013|Overall Study|Withdrawal by Subject|5|||
42280377|NCT02001623|76112398|FG014|Overall Study|Withdrawal by Subject|2|||
42161355|NCT00413699|75969248|FG000|Initial Period|Pregnancy|10|||
42161356|NCT00413699|75969249|FG001|Initial Period|Pregnancy|8|||
42161357|NCT00413699|75969250|FG002|Initial Period|Pregnancy|0|||
42161358|NCT00413699|75969248|FG000|Initial Period|Did not meet entrance criteria|2|||
42161359|NCT00413699|75969249|FG001|Initial Period|Did not meet entrance criteria|2|||
42161360|NCT00413699|75969250|FG002|Initial Period|Did not meet entrance criteria|0|||
42161361|NCT00413699|75969248|FG000|Initial Period|Medication error without adverse event|0|||
42161362|NCT00413699|75969249|FG001|Initial Period|Medication error without adverse event|1|||
42161363|NCT00413699|75969250|FG002|Initial Period|Medication error without adverse event|0|||
42161364|NCT00413699|75969248|FG000|Initial Period|Study terminated by Sponsor|0|||
42161365|NCT00413699|75969249|FG001|Initial Period|Study terminated by Sponsor|1|||
42161366|NCT00413699|75969250|FG002|Initial Period|Study terminated by Sponsor|0|||
42161367|NCT00413699|75969248|FG000|Initial Period|Other|67|||
42161368|NCT00413699|75969249|FG001|Initial Period|Other|211|||
42161369|NCT00413699|75969250|FG002|Initial Period|Other|0|||
42161370|NCT00413699|75969248|FG000|Initial Period|Adverse event related to study drug|178|||
42161371|NCT00413699|75969249|FG001|Initial Period|Adverse event related to study drug|527|||
42161372|NCT00413699|75969250|FG002|Initial Period|Adverse event related to study drug|0|||
42161373|NCT00413699|75969248|FG000|Initial Period|Adverse event not related to study drug|113|||
42161374|NCT00413699|75969249|FG001|Initial Period|Adverse event not related to study drug|248|||
42161375|NCT00413699|75969250|FG002|Initial Period|Adverse event not related to study drug|0|||
42161376|NCT00413699|75969248|FG000|Initial Period|Missing end of study page|0|||
42161377|NCT00413699|75969249|FG001|Initial Period|Missing end of study page|4|||
42280378|NCT02001623|76112384|FG000|Overall Study|Lost to Follow-up|0|||
42280379|NCT02001623|76112385|FG001|Overall Study|Lost to Follow-up|0|||
42280380|NCT02001623|76112386|FG002|Overall Study|Lost to Follow-up|0|||
42280381|NCT02001623|76112387|FG003|Overall Study|Lost to Follow-up|0|||
42280382|NCT02001623|76112388|FG004|Overall Study|Lost to Follow-up|0|||
42280383|NCT02001623|76112389|FG005|Overall Study|Lost to Follow-up|0|||
42280384|NCT02001623|76112390|FG006|Overall Study|Lost to Follow-up|0|||
42280385|NCT02001623|76112391|FG007|Overall Study|Lost to Follow-up|0|||
42280386|NCT02001623|76112392|FG008|Overall Study|Lost to Follow-up|0|||
42280387|NCT02001623|76112393|FG009|Overall Study|Lost to Follow-up|1|||
42280388|NCT02001623|76112394|FG010|Overall Study|Lost to Follow-up|0|||
42280389|NCT02001623|76112395|FG011|Overall Study|Lost to Follow-up|0|||
42280390|NCT02001623|76112396|FG012|Overall Study|Lost to Follow-up|0|||
42280391|NCT02001623|76112397|FG013|Overall Study|Lost to Follow-up|0|||
42351499|NCT00986674|76191399|FG001|Overall Study|not start protocol therapy|3|||
42161378|NCT00413699|75969250|FG002|Initial Period|Missing end of study page|0|||
42161379|NCT00413699|75969248|FG000|Initial Period|No longer willing to participate|116|||
42161380|NCT00413699|75969249|FG001|Initial Period|No longer willing to participate|368|||
42161381|NCT00413699|75969250|FG002|Initial Period|No longer willing to participate|0|||
42161382|NCT00413699|75969248|FG000|Extension Period|No Longer Willing to Participate|0|||
42161383|NCT00413699|75969249|FG001|Extension Period|No Longer Willing to Participate|0|||
42161384|NCT00413699|75969250|FG002|Extension Period|No Longer Willing to Participate|2|||
42161385|NCT00413699|75969248|FG000|Extension Period|Protocol Violation|0|||
42161386|NCT00413699|75969249|FG001|Extension Period|Protocol Violation|0|||
42161387|NCT00413699|75969250|FG002|Extension Period|Protocol Violation|1|||
42161388|NCT00413699|75969248|FG000|Extension Period|Adverse Event|0|||
42161389|NCT00413699|75969249|FG001|Extension Period|Adverse Event|0|||
42161390|NCT00413699|75969250|FG002|Extension Period|Adverse Event|2|||
42161391|NCT03713320|75969278|FG000|Randomized Period|Adverse Event|1|||
42161392|NCT03713320|75969279|FG001|Randomized Period|Adverse Event|5|||
42161393|NCT03713320|75969280|FG002|Randomized Period|Adverse Event|0|||
42161394|NCT03713320|75969278|FG000|Randomized Period|Physician Decision|1|||
42161395|NCT03713320|75969279|FG001|Randomized Period|Physician Decision|1|||
42161396|NCT03713320|75969280|FG002|Randomized Period|Physician Decision|0|||
42161397|NCT03713320|75969278|FG000|Randomized Period|Withdrawal by Subject|4|||
42161398|NCT03713320|75969279|FG001|Randomized Period|Withdrawal by Subject|0|||
42161399|NCT03713320|75969280|FG002|Randomized Period|Withdrawal by Subject|0|||
42161400|NCT03713320|75969278|FG000|Randomized Period|Participant decision|3|||
42161401|NCT03713320|75969279|FG001|Randomized Period|Participant decision|1|||
42280392|NCT02001623|76112398|FG014|Overall Study|Lost to Follow-up|0|||
42351500|NCT00986674|76191400|FG002|Overall Study|not start protocol therapy|1|||
42351501|NCT00986674|76191398|FG000|Overall Study|unknown/not specify|0|||
42161402|NCT03713320|75969280|FG002|Randomized Period|Participant decision|0|||
42161403|NCT03713320|75969278|FG000|Randomized Period|Study terminated by sponsor|6|||
42280393|NCT02001623|76112384|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
42161404|NCT03713320|75969279|FG001|Randomized Period|Study terminated by sponsor|3|||
42161405|NCT03713320|75969280|FG002|Randomized Period|Study terminated by sponsor|0|||
42161406|NCT03713320|75969278|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
42280394|NCT02001623|76112385|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
42280395|NCT02001623|76112386|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
42161407|NCT03713320|75969279|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
42161408|NCT03713320|75969280|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
42161409|NCT03713320|75969278|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
42351502|NCT00986674|76191399|FG001|Overall Study|unknown/not specify|7|||
42351503|NCT00986674|76191400|FG002|Overall Study|unknown/not specify|9|||
42351504|NCT00986440|76191410|FG000|Overall Study|Progressive disease|27|||
42351505|NCT00986440|76191411|FG001|Overall Study|Progressive disease|37|||
42351506|NCT00986440|76191410|FG000|Overall Study|Serious adverse event or adverse event|9|||
42351507|NCT00986440|76191411|FG001|Overall Study|Serious adverse event or adverse event|2|||
42351508|NCT00986440|76191410|FG000|Overall Study|Withdrawal by Subject|1|||
42351509|NCT00986440|76191411|FG001|Overall Study|Withdrawal by Subject|2|||
42161410|NCT03713320|75969279|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
42161411|NCT03713320|75969280|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
42161412|NCT03712930|75969287|FG000|Overall Study|Death|7|||
42161413|NCT03712930|75969287|FG000|Overall Study|Physician Decision|1|||
42161414|NCT03712930|75969287|FG000|Overall Study|Study Terminated by Sponsor|3|||
42161415|NCT03712930|75969287|FG000|Overall Study|Progressive Disease|2|||
42161416|NCT00420407|75969293|FG000|Overall Study|Lost to Follow-up|0|||
42161417|NCT00420407|75969294|FG001|Overall Study|Lost to Follow-up|3|||
42161418|NCT00420407|75969293|FG000|Overall Study|Physician Decision|2|||
42161419|NCT00420407|75969294|FG001|Overall Study|Physician Decision|1|||
42161420|NCT00420407|75969293|FG000|Overall Study|subject identified as detainee|1|||
42161421|NCT00420407|75969294|FG001|Overall Study|subject identified as detainee|0|||
42280396|NCT02001623|76112387|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
42280397|NCT02001623|76112388|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
42280398|NCT02001623|76112389|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
42280399|NCT02001623|76112390|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
42280400|NCT02001623|76112391|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
42351510|NCT00986440|76191410|FG000|Overall Study|Screen failure (not dosed)|4|||
42351511|NCT00986440|76191411|FG001|Overall Study|Screen failure (not dosed)|2|||
42351512|NCT01904383|76191417|FG000|Overall Study|CRF not collected|117|||
42351513|NCT01904383|76191417|FG000|Overall Study|Reason not listed|147|||
42351514|NCT01904383|76191417|FG000|Overall Study|Lost to Follow-up|674|||
42351515|NCT01904383|76191417|FG000|Overall Study|Lack of Efficacy|370|||
42351516|NCT01904383|76191417|FG000|Overall Study|Improvement|141|||
42351517|NCT01904383|76191417|FG000|Overall Study|Adverse Event|271|||
42351518|NCT01904383|76191417|FG000|Overall Study|No patient visit after entry|54|||
42013543|NCT00997984|75820606|FG000|Overall Study|Wrong medication dispensed|0|||
42161422|NCT00420407|75969293|FG000|Overall Study|subject identified as Jehovah's witness|1|||
42161423|NCT00420407|75969294|FG001|Overall Study|subject identified as Jehovah's witness|0|||
42161424|NCT00420407|75969293|FG000|Overall Study|Withdrawal by Subject|0|||
42161425|NCT00420407|75969294|FG001|Overall Study|Withdrawal by Subject|2|||
42161426|NCT00420095|75969303|FG000|Overall Study|Adverse Event|1|||
42161427|NCT00420095|75969304|FG001|Overall Study|Adverse Event|0|||
42161428|NCT00420095|75969303|FG000|Overall Study|Protocol Violation|1|||
42161429|NCT00420095|75969304|FG001|Overall Study|Protocol Violation|1|||
42161430|NCT00420095|75969303|FG000|Overall Study|Lost to Follow-up|1|||
42161431|NCT00420095|75969304|FG001|Overall Study|Lost to Follow-up|0|||
42161432|NCT00419393|75969310|FG000|Overall Study|Adverse Event|5|||
42161433|NCT00419393|75969310|FG000|Overall Study|Protocol Violation|5|||
42161434|NCT00419393|75969310|FG000|Overall Study|Withdrawal by Subject|7|||
42161435|NCT00419393|75969310|FG000|Overall Study|Other: Sponsor request|3|||
42161436|NCT00419393|75969310|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
42161437|NCT00419393|75969310|FG000|Overall Study|Other: Site closure|1|||
42161438|NCT00419393|75969310|FG000|Overall Study|Other: Other health problems|1|||
42161439|NCT00419393|75969310|FG000|Overall Study|Other: Investigator decision|1|||
42161440|NCT00419159|75969316|FG000|Overall Study|Adverse Event|7|||
42161441|NCT00419159|75969317|FG001|Overall Study|Adverse Event|15|||
42161442|NCT00419159|75969316|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42161443|NCT00419159|75969317|FG001|Overall Study|Abnormal laboratory value(s)|2|||
42161444|NCT00419159|75969316|FG000|Overall Study|Subject's no longer requires study drug|0|||
42161445|NCT00419159|75969317|FG001|Overall Study|Subject's no longer requires study drug|1|||
42161446|NCT00419159|75969316|FG000|Overall Study|Protocol Violation|1|||
42161447|NCT00419159|75969317|FG001|Overall Study|Protocol Violation|0|||
42161448|NCT00419159|75969316|FG000|Overall Study|Withdrawal by Subject|10|||
42161449|NCT00419159|75969317|FG001|Overall Study|Withdrawal by Subject|3|||
42161450|NCT00419159|75969316|FG000|Overall Study|Lost to Follow-up|0|||
42161451|NCT00419159|75969317|FG001|Overall Study|Lost to Follow-up|1|||
42161452|NCT00419159|75969316|FG000|Overall Study|Death|2|||
42280401|NCT02001623|76112392|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
42280402|NCT02001623|76112393|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
42280403|NCT02001623|76112394|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
42161453|NCT00419159|75969317|FG001|Overall Study|Death|2|||
42280404|NCT02001623|76112395|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
42351519|NCT01904149|76191427|FG000|Overall Study|Adverse Event|3|||
42161454|NCT00419159|75969316|FG000|Overall Study|Disease progression|79|||
42161455|NCT00419159|75969317|FG001|Overall Study|Disease progression|76|||
42161456|NCT03717064|75969331|FG000|Period 2|Adverse Event|1|||
42161457|NCT03716050|75969343|FG000|Overall Study|Lost to Follow-up|0|||
42161458|NCT03716050|75969344|FG001|Overall Study|Lost to Follow-up|0|||
42161459|NCT03716050|75969345|FG002|Overall Study|Lost to Follow-up|1|||
42161460|NCT03716050|75969346|FG003|Overall Study|Lost to Follow-up|0|||
42161461|NCT03716050|75969347|FG004|Overall Study|Lost to Follow-up|0|||
42161462|NCT03716050|75969348|FG005|Overall Study|Lost to Follow-up|0|||
42161463|NCT03716050|75969349|FG006|Overall Study|Lost to Follow-up|0|||
42161464|NCT03716050|75969350|FG007|Overall Study|Lost to Follow-up|0|||
42161465|NCT03716050|75969343|FG000|Overall Study|Physician Decision|0|||
42161466|NCT03716050|75969344|FG001|Overall Study|Physician Decision|0|||
42040421|NCT01928394|75848586|FG020|Follow-up Period|other reason|0|||
42040422|NCT01928394|75848587|FG021|Follow-up Period|other reason|0|||
42040423|NCT01928394|75848588|FG022|Follow-up Period|other reason|1|||
42040424|NCT01928394|75848566|FG000|Follow-up Period|Lost to Follow-up|0|||
42040425|NCT01928394|75848567|FG001|Follow-up Period|Lost to Follow-up|0|||
42040426|NCT01928394|75848568|FG002|Follow-up Period|Lost to Follow-up|0|||
42040427|NCT01928394|75848569|FG003|Follow-up Period|Lost to Follow-up|0|||
42040428|NCT01928394|75848570|FG004|Follow-up Period|Lost to Follow-up|0|||
42040429|NCT01928394|75848571|FG005|Follow-up Period|Lost to Follow-up|0|||
42040430|NCT01928394|75848572|FG006|Follow-up Period|Lost to Follow-up|0|||
42040431|NCT01928394|75848573|FG007|Follow-up Period|Lost to Follow-up|0|||
42040432|NCT01928394|75848574|FG008|Follow-up Period|Lost to Follow-up|0|||
42040433|NCT01928394|75848575|FG009|Follow-up Period|Lost to Follow-up|0|||
42040434|NCT01928394|75848576|FG010|Follow-up Period|Lost to Follow-up|0|||
42040435|NCT01928394|75848577|FG011|Follow-up Period|Lost to Follow-up|1|||
42040436|NCT01928394|75848578|FG012|Follow-up Period|Lost to Follow-up|1|||
42161467|NCT03716050|75969345|FG002|Overall Study|Physician Decision|0|||
42161468|NCT03716050|75969346|FG003|Overall Study|Physician Decision|1|||
42161469|NCT03716050|75969347|FG004|Overall Study|Physician Decision|0|||
42161470|NCT03716050|75969348|FG005|Overall Study|Physician Decision|0|||
42161471|NCT03716050|75969349|FG006|Overall Study|Physician Decision|0|||
42161472|NCT03716050|75969350|FG007|Overall Study|Physician Decision|0|||
42161473|NCT03716050|75969343|FG000|Overall Study|Protocol Violation|0|||
42161474|NCT03716050|75969344|FG001|Overall Study|Protocol Violation|0|||
42161475|NCT03716050|75969345|FG002|Overall Study|Protocol Violation|0|||
42161476|NCT03716050|75969346|FG003|Overall Study|Protocol Violation|1|||
42161477|NCT03716050|75969347|FG004|Overall Study|Protocol Violation|0|||
42161478|NCT03716050|75969348|FG005|Overall Study|Protocol Violation|0|||
42161479|NCT03716050|75969349|FG006|Overall Study|Protocol Violation|0|||
42161480|NCT03716050|75969350|FG007|Overall Study|Protocol Violation|2|||
42161481|NCT00413231|75969367|FG000|0 to 30-day Post Treatment|Death|5|||
42161482|NCT00413231|75969367|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
42161483|NCT00413231|75969367|FG000|30-day to 365-day Post Treatment|Death|13|||
42161484|NCT00413231|75969367|FG000|365-day to 60-month Post Treatment|Death|36|||
42161485|NCT00413231|75969367|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
42161486|NCT00413231|75969367|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
42161487|NCT00413231|75969367|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
42161488|NCT00413153|75969387|FG000|Overall Study|Withdrawal by Subject|1|||
42280405|NCT02001623|76112396|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
42280406|NCT02001623|76112397|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
42280407|NCT02001623|76112398|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
42280408|NCT02001623|76112384|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
42280409|NCT02001623|76112385|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
42280410|NCT02001623|76112386|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
42280411|NCT02001623|76112387|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
42280412|NCT02001623|76112388|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
42351520|NCT01904149|76191428|FG001|Overall Study|Adverse Event|4|||
42040437|NCT01928394|75848579|FG013|Follow-up Period|Lost to Follow-up|0|||
42040438|NCT01928394|75848580|FG014|Follow-up Period|Lost to Follow-up|1|||
42040439|NCT01928394|75848581|FG015|Follow-up Period|Lost to Follow-up|0|||
42040440|NCT01928394|75848582|FG016|Follow-up Period|Lost to Follow-up|1|||
42040441|NCT01928394|75848583|FG017|Follow-up Period|Lost to Follow-up|0|||
42040442|NCT01928394|75848584|FG018|Follow-up Period|Lost to Follow-up|0|||
42161489|NCT00413153|75969388|FG001|Overall Study|Withdrawal by Subject|1|||
42161490|NCT00413153|75969387|FG000|Overall Study|Adverse Event|1|||
42161491|NCT00413153|75969388|FG001|Overall Study|Adverse Event|0|||
42161492|NCT00412607|75969394|FG000|Overall Study|Withdrawal by Subject|9|||
42161493|NCT00412607|75969394|FG000|Overall Study|Lost to Follow-up|19|||
42161494|NCT00412607|75969394|FG000|Overall Study|Death|61|||
42280413|NCT02001623|76112389|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
42280414|NCT02001623|76112390|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
42280415|NCT02001623|76112391|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
42280416|NCT02001623|76112392|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
42280417|NCT02001623|76112393|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
42280418|NCT02001623|76112394|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
42280419|NCT02001623|76112395|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
42161495|NCT00412607|75969394|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
42161496|NCT00419003|75969403|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
42161497|NCT00419003|75969404|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
42161498|NCT00419003|75969403|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
42351521|NCT01904149|76191429|FG002|Overall Study|Adverse Event|0|||
42351522|NCT01904149|76191430|FG003|Overall Study|Adverse Event|1|||
42351523|NCT01904149|76191431|FG004|Overall Study|Adverse Event|1|||
42351524|NCT01904149|76191432|FG005|Overall Study|Adverse Event|2|||
42351525|NCT01904149|76191427|FG000|Overall Study|Lack of Efficacy|0|||
42351526|NCT01904149|76191428|FG001|Overall Study|Lack of Efficacy|3|||
42351527|NCT01904149|76191429|FG002|Overall Study|Lack of Efficacy|1|||
42351528|NCT01904149|76191430|FG003|Overall Study|Lack of Efficacy|3|||
42161499|NCT00419003|75969404|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
42161500|NCT00418691|75969416|FG000|Overall Study|Lost to Follow-up|1|||
42161501|NCT00418691|75969417|FG001|Overall Study|Lost to Follow-up|2|||
42161502|NCT00418691|75969418|FG002|Overall Study|Lost to Follow-up|3|||
42161503|NCT00418691|75969416|FG000|Overall Study|Started new medication voiding entry|0|||
42161504|NCT00418691|75969417|FG001|Overall Study|Started new medication voiding entry|0|||
42161505|NCT00418691|75969418|FG002|Overall Study|Started new medication voiding entry|1|||
42161506|NCT00418691|75969416|FG000|Overall Study|Progressive Disease|1|||
42161507|NCT00418691|75969417|FG001|Overall Study|Progressive Disease|0|||
42161508|NCT00418691|75969418|FG002|Overall Study|Progressive Disease|1|||
42161509|NCT00412373|75969428|FG000|Overall Study|Adverse Event|8|||
42161510|NCT00412373|75969429|FG001|Overall Study|Adverse Event|13|||
42161511|NCT00412373|75969428|FG000|Overall Study|Lack of Efficacy|16|||
42161512|NCT00412373|75969429|FG001|Overall Study|Lack of Efficacy|22|||
42161513|NCT00412373|75969428|FG000|Overall Study|Lost to Follow-up|7|||
42161514|NCT00412373|75969429|FG001|Overall Study|Lost to Follow-up|13|||
42161515|NCT00412373|75969428|FG000|Overall Study|Withdrawal by Subject|8|||
42161516|NCT00412373|75969429|FG001|Overall Study|Withdrawal by Subject|27|||
42161517|NCT00412373|75969428|FG000|Overall Study|Other|2|||
42161518|NCT00412373|75969429|FG001|Overall Study|Other|2|||
42161519|NCT00418379|75969438|FG000|Year 1|Adverse Event|9|||
42161520|NCT00418379|75969439|FG001|Year 1|Adverse Event|15|||
42161521|NCT00418379|75969440|FG002|Year 1|Adverse Event|3|||
42161522|NCT00418379|75969438|FG000|Year 1|Withdrawal by Subject|7|||
42161523|NCT00418379|75969439|FG001|Year 1|Withdrawal by Subject|8|||
42161524|NCT00418379|75969440|FG002|Year 1|Withdrawal by Subject|5|||
42161525|NCT00418379|75969438|FG000|Year 1|Any other reason not above-mentioned|2|||
42161526|NCT00418379|75969439|FG001|Year 1|Any other reason not above-mentioned|5|||
42161527|NCT00418379|75969440|FG002|Year 1|Any other reason not above-mentioned|7|||
42161528|NCT00418379|75969438|FG000|Year 2|Adverse Event|5|||
42280420|NCT02001623|76112396|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
42280421|NCT02001623|76112397|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
42161529|NCT00418379|75969439|FG001|Year 2|Adverse Event|2|||
42161530|NCT00418379|75969440|FG002|Year 2|Adverse Event|1|||
42280422|NCT02001623|76112398|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
42161531|NCT00418379|75969438|FG000|Year 2|Withdrawal by Subject|1|||
42161532|NCT00418379|75969439|FG001|Year 2|Withdrawal by Subject|1|||
42161533|NCT00418379|75969440|FG002|Year 2|Withdrawal by Subject|3|||
42280423|NCT02713867|76112449|FG000|Randomization|Other Reason|2|||
42280424|NCT02713867|76112450|FG001|Randomization|Other Reason|1|||
42351529|NCT01904149|76191431|FG004|Overall Study|Lack of Efficacy|3|||
42351530|NCT01904149|76191432|FG005|Overall Study|Lack of Efficacy|1|||
42351531|NCT01904149|76191427|FG000|Overall Study|Withdrawal by Subject|1|||
42351532|NCT01904149|76191428|FG001|Overall Study|Withdrawal by Subject|3|||
42351533|NCT01904149|76191429|FG002|Overall Study|Withdrawal by Subject|1|||
42351534|NCT01904149|76191430|FG003|Overall Study|Withdrawal by Subject|0|||
42351535|NCT01904149|76191431|FG004|Overall Study|Withdrawal by Subject|1|||
42013544|NCT00997984|75820607|FG001|Overall Study|Wrong medication dispensed|1|||
42013545|NCT00997984|75820608|FG002|Overall Study|Wrong medication dispensed|0|||
42161534|NCT00418379|75969438|FG000|Year 2|Any other reason not above-mentioned|2|||
42161535|NCT00418379|75969439|FG001|Year 2|Any other reason not above-mentioned|1|||
42161536|NCT00418379|75969440|FG002|Year 2|Any other reason not above-mentioned|6|||
42161537|NCT00418379|75969438|FG000|Year 3|Withdrawal by Subject|1|||
42161538|NCT00418379|75969439|FG001|Year 3|Withdrawal by Subject|1|||
42280425|NCT02713867|76112449|FG000|Randomization|Participant Withdrew consent|0|||
42280426|NCT02713867|76112450|FG001|Randomization|Participant Withdrew consent|2|||
42351536|NCT01904149|76191432|FG005|Overall Study|Withdrawal by Subject|0|||
42351537|NCT01904149|76191427|FG000|Overall Study|Protocol Violation|0|||
42161539|NCT00418379|75969440|FG002|Year 3|Withdrawal by Subject|2|||
42161540|NCT00418379|75969438|FG000|Year 3|Any other reason not above-mentioned|2|||
42161541|NCT00418379|75969439|FG001|Year 3|Any other reason not above-mentioned|1|||
42161542|NCT00418379|75969440|FG002|Year 3|Any other reason not above-mentioned|1|||
42161543|NCT00418379|75969438|FG000|Year 4|Adverse Event|0|||
42161544|NCT00418379|75969439|FG001|Year 4|Adverse Event|1|||
42161545|NCT00418379|75969440|FG002|Year 4|Adverse Event|0|||
42161546|NCT00418379|75969438|FG000|Year 4|Withdrawal by Subject|2|||
42161547|NCT00418379|75969439|FG001|Year 4|Withdrawal by Subject|3|||
42161548|NCT00418379|75969440|FG002|Year 4|Withdrawal by Subject|2|||
42161549|NCT00418379|75969438|FG000|Year 4|Any other reason not above-mentioned|1|||
42161550|NCT00418379|75969439|FG001|Year 4|Any other reason not above-mentioned|1|||
42161551|NCT00418379|75969440|FG002|Year 4|Any other reason not above-mentioned|0|||
42161552|NCT00418379|75969438|FG000|Year 5|Adverse Event|0|||
42161553|NCT00418379|75969439|FG001|Year 5|Adverse Event|1|||
42161554|NCT00418379|75969440|FG002|Year 5|Adverse Event|0|||
42161555|NCT00418379|75969438|FG000|Year 5|Any other reason not above-mentioned|2|||
42161556|NCT00418379|75969439|FG001|Year 5|Any other reason not above-mentioned|4|||
42161557|NCT00418379|75969440|FG002|Year 5|Any other reason not above-mentioned|3|||
42161558|NCT00418145|75969448|FG000|Overall Study|study terminated|6|||
42161559|NCT00417989|75969456|FG000|Overall Study|Withdrawal by Subject|13|||
42161560|NCT00417989|75969457|FG001|Overall Study|Withdrawal by Subject|13|||
42161561|NCT00417989|75969456|FG000|Overall Study|Lost to Follow-up|1|||
42161562|NCT00417989|75969457|FG001|Overall Study|Lost to Follow-up|6|||
42161563|NCT00417989|75969456|FG000|Overall Study|Protocol Violation|1|||
42161564|NCT00417989|75969457|FG001|Overall Study|Protocol Violation|0|||
42161565|NCT00417989|75969456|FG000|Overall Study|Death|0|||
42161566|NCT00417989|75969457|FG001|Overall Study|Death|1|||
42161567|NCT00417989|75969456|FG000|Overall Study|Physician Decision|5|||
42161568|NCT00417989|75969457|FG001|Overall Study|Physician Decision|2|||
42161569|NCT00412217|75969467|FG000|Overall Study|Insufficient Data Available|8|||
42161570|NCT00412217|75969468|FG001|Overall Study|Insufficient Data Available|3|||
42161571|NCT00412217|75969467|FG000|Overall Study|Death|5|||
42161572|NCT00412217|75969468|FG001|Overall Study|Death|4|||
42161573|NCT00412217|75969467|FG000|Overall Study|Disease Progression|2|||
42161574|NCT00412217|75969468|FG001|Overall Study|Disease Progression|3|||
42161575|NCT00412217|75969467|FG000|Overall Study|Investigator Decision|1|||
42161576|NCT00412217|75969468|FG001|Overall Study|Investigator Decision|0|||
42161577|NCT00412217|75969467|FG000|Overall Study|Withdrawal by Subject|2|||
42161578|NCT00412217|75969468|FG001|Overall Study|Withdrawal by Subject|0|||
42161579|NCT00412217|75969467|FG000|Overall Study|Lost to Follow-up|1|||
42161580|NCT00412217|75969468|FG001|Overall Study|Lost to Follow-up|4|||
42161581|NCT00412217|75969467|FG000|Overall Study|Study Terminated by Sponsor|26|||
42161582|NCT00412217|75969468|FG001|Overall Study|Study Terminated by Sponsor|33|||
42161583|NCT00412217|75969467|FG000|Overall Study|Other|1|||
42161584|NCT00412217|75969468|FG001|Overall Study|Other|1|||
42161585|NCT05000164|75969474|FG000|Overall Study|Adverse Event|1|||
42161586|NCT05000164|75969474|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
42161587|NCT05000164|75969474|FG000|Overall Study|Lens Discomfort|3|||
42161588|NCT05000164|75969474|FG000|Overall Study|Withdrew Consent during Study|2|||
42161589|NCT05000164|75969474|FG000|Overall Study|Subject Withdrawn by PI|2|||
42161590|NCT05000164|75969474|FG000|Overall Study|Other Fractured Test Article|1|||
42161591|NCT00123474|75969482|FG000|Randomized to Treatment|Randomized, never treated|1|||
42161592|NCT00123474|75969483|FG001|Randomized to Treatment|Randomized, never treated|4|||
42161593|NCT00123474|75969484|FG002|Randomized to Treatment|Randomized, never treated|2|||
42161594|NCT00123474|75969485|FG003|Randomized to Treatment|Randomized, never treated|1|||
42161595|NCT00123474|75969482|FG000|As Treated at Study Closure|not reported when site closed|1|||
42161596|NCT00123474|75969483|FG001|As Treated at Study Closure|not reported when site closed|0|||
42161597|NCT00123474|75969484|FG002|As Treated at Study Closure|not reported when site closed|1|||
42161598|NCT00123474|75969485|FG003|As Treated at Study Closure|not reported when site closed|0|||
42161599|NCT00123474|75969482|FG000|As Treated at Study Closure|Adverse Event|10|||
42161600|NCT00123474|75969483|FG001|As Treated at Study Closure|Adverse Event|4|||
42161601|NCT00123474|75969484|FG002|As Treated at Study Closure|Adverse Event|10|||
42161602|NCT00123474|75969485|FG003|As Treated at Study Closure|Adverse Event|8|||
42161603|NCT00123474|75969482|FG000|As Treated at Study Closure|Disease Progression|35|||
42161604|NCT00123474|75969483|FG001|As Treated at Study Closure|Disease Progression|42|||
42161605|NCT00123474|75969484|FG002|As Treated at Study Closure|Disease Progression|29|||
42161606|NCT00123474|75969485|FG003|As Treated at Study Closure|Disease Progression|27|||
42161607|NCT00123474|75969482|FG000|As Treated at Study Closure|Investigator Request|12|||
42040443|NCT01928394|75848585|FG019|Follow-up Period|Lost to Follow-up|0|||
42161608|NCT00123474|75969483|FG001|As Treated at Study Closure|Investigator Request|6|||
42161609|NCT00123474|75969484|FG002|As Treated at Study Closure|Investigator Request|7|||
42161610|NCT00123474|75969485|FG003|As Treated at Study Closure|Investigator Request|5|||
42161611|NCT00123474|75969482|FG000|As Treated at Study Closure|non-specified|54|||
42161612|NCT00123474|75969483|FG001|As Treated at Study Closure|non-specified|47|||
42161613|NCT00123474|75969484|FG002|As Treated at Study Closure|non-specified|57|||
42161614|NCT00123474|75969485|FG003|As Treated at Study Closure|non-specified|60|||
42161615|NCT00123474|75969482|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
42161616|NCT00123474|75969483|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
42161617|NCT00123474|75969484|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
42161618|NCT00123474|75969485|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
42161619|NCT00123474|75969482|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
42161620|NCT00123474|75969483|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
42161621|NCT00123474|75969484|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
42161622|NCT00123474|75969485|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
42161623|NCT00142298|75969526|FG000|Overall Study|Adverse Event|10|||
42161624|NCT00142298|75969527|FG001|Overall Study|Adverse Event|10|||
42161625|NCT00142298|75969528|FG002|Overall Study|Adverse Event|1|||
42161626|NCT00142298|75969529|FG003|Overall Study|Adverse Event|5|||
42161627|NCT00142298|75969530|FG004|Overall Study|Adverse Event|2|||
42161628|NCT00142298|75969531|FG005|Overall Study|Adverse Event|2|||
42161629|NCT00142298|75969532|FG006|Overall Study|Adverse Event|0|||
42161630|NCT00142298|75969533|FG007|Overall Study|Adverse Event|0|||
42161631|NCT00142298|75969534|FG008|Overall Study|Adverse Event|0|||
42161632|NCT00142298|75969535|FG009|Overall Study|Adverse Event|0|||
42161633|NCT00142298|75969526|FG000|Overall Study|Clinical disease progression|1|||
42161634|NCT00142298|75969527|FG001|Overall Study|Clinical disease progression|0|||
42161635|NCT00142298|75969528|FG002|Overall Study|Clinical disease progression|0|||
42161636|NCT00142298|75969529|FG003|Overall Study|Clinical disease progression|0|||
42161637|NCT00142298|75969530|FG004|Overall Study|Clinical disease progression|0|||
42161638|NCT00142298|75969531|FG005|Overall Study|Clinical disease progression|0|||
42161639|NCT00142298|75969532|FG006|Overall Study|Clinical disease progression|0|||
42161640|NCT00142298|75969533|FG007|Overall Study|Clinical disease progression|0|||
42161641|NCT00142298|75969534|FG008|Overall Study|Clinical disease progression|0|||
42161642|NCT00142298|75969535|FG009|Overall Study|Clinical disease progression|0|||
42161643|NCT00142298|75969526|FG000|Overall Study|Death|1|||
42161644|NCT00142298|75969527|FG001|Overall Study|Death|1|||
42161645|NCT00142298|75969528|FG002|Overall Study|Death|1|||
42161646|NCT00142298|75969529|FG003|Overall Study|Death|0|||
42161647|NCT00142298|75969530|FG004|Overall Study|Death|0|||
42161648|NCT00142298|75969531|FG005|Overall Study|Death|6|||
42161649|NCT00142298|75969532|FG006|Overall Study|Death|0|||
42161650|NCT00142298|75969533|FG007|Overall Study|Death|0|||
42161651|NCT00142298|75969534|FG008|Overall Study|Death|0|||
42161652|NCT00142298|75969535|FG009|Overall Study|Death|0|||
42161653|NCT00142298|75969526|FG000|Overall Study|Lack of Efficacy|44|||
42161654|NCT00142298|75969527|FG001|Overall Study|Lack of Efficacy|62|||
42161655|NCT00142298|75969528|FG002|Overall Study|Lack of Efficacy|9|||
42161656|NCT00142298|75969529|FG003|Overall Study|Lack of Efficacy|12|||
42161657|NCT00142298|75969530|FG004|Overall Study|Lack of Efficacy|1|||
42161658|NCT00142298|75969531|FG005|Overall Study|Lack of Efficacy|0|||
42161659|NCT00142298|75969532|FG006|Overall Study|Lack of Efficacy|0|||
42161660|NCT00142298|75969533|FG007|Overall Study|Lack of Efficacy|1|||
42161661|NCT00142298|75969534|FG008|Overall Study|Lack of Efficacy|0|||
42161662|NCT00142298|75969535|FG009|Overall Study|Lack of Efficacy|0|||
42161663|NCT00142298|75969526|FG000|Overall Study|Non-compliance|15|||
42161664|NCT00142298|75969527|FG001|Overall Study|Non-compliance|13|||
42161665|NCT00142298|75969528|FG002|Overall Study|Non-compliance|0|||
42161666|NCT00142298|75969529|FG003|Overall Study|Non-compliance|6|||
42161667|NCT00142298|75969530|FG004|Overall Study|Non-compliance|1|||
42161668|NCT00142298|75969531|FG005|Overall Study|Non-compliance|0|||
42161669|NCT00142298|75969532|FG006|Overall Study|Non-compliance|0|||
42161670|NCT00142298|75969533|FG007|Overall Study|Non-compliance|3|||
42161671|NCT00142298|75969534|FG008|Overall Study|Non-compliance|3|||
42161672|NCT00142298|75969535|FG009|Overall Study|Non-compliance|0|||
42280427|NCT02713867|76112449|FG000|Treatment Period|Other Reasons|22|||
42280428|NCT02713867|76112450|FG001|Treatment Period|Other Reasons|28|||
42280429|NCT02713867|76112449|FG000|Treatment Period|Administrative reason by sponsor|21|||
42280430|NCT02713867|76112450|FG001|Treatment Period|Administrative reason by sponsor|16|||
42280431|NCT02713867|76112449|FG000|Treatment Period|No longer meets study criteria|2|||
42280432|NCT02713867|76112450|FG001|Treatment Period|No longer meets study criteria|1|||
42280433|NCT02713867|76112449|FG000|Treatment Period|Poor/Non Compliance|1|||
42280434|NCT02713867|76112450|FG001|Treatment Period|Poor/Non Compliance|0|||
42280435|NCT02713867|76112449|FG000|Treatment Period|Maximum Clinical Benefit|5|||
42280436|NCT02713867|76112450|FG001|Treatment Period|Maximum Clinical Benefit|6|||
42280437|NCT02713867|76112449|FG000|Treatment Period|Withdrew consent|3|||
42280438|NCT02713867|76112450|FG001|Treatment Period|Withdrew consent|6|||
42280439|NCT02713867|76112449|FG000|Treatment Period|Requested to Discontinue|8|||
42161673|NCT00142298|75969526|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
42161674|NCT00142298|75969527|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
42161675|NCT00142298|75969528|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
42161676|NCT00142298|75969529|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
42280440|NCT02713867|76112450|FG001|Treatment Period|Requested to Discontinue|8|||
42280441|NCT02713867|76112449|FG000|Treatment Period|AE unrelated to Study Drug|11|||
42280442|NCT02713867|76112450|FG001|Treatment Period|AE unrelated to Study Drug|10|||
42280443|NCT02713867|76112449|FG000|Treatment Period|Death|7|||
42280444|NCT02713867|76112450|FG001|Treatment Period|Death|3|||
42280445|NCT02713867|76112449|FG000|Treatment Period|Study Drug Toxicity|16|||
42280446|NCT02713867|76112450|FG001|Treatment Period|Study Drug Toxicity|19|||
42280447|NCT02713867|76112449|FG000|Treatment Period|Disease Progression|82|||
42280448|NCT02713867|76112450|FG001|Treatment Period|Disease Progression|83|||
42280449|NCT02730455|76112459|FG000|Overall Study|Death|5|||
42280450|NCT02730455|76112460|FG001|Overall Study|Death|6|||
42280451|NCT02730455|76112461|FG002|Overall Study|Death|4|||
42280452|NCT02730455|76112459|FG000|Overall Study|Consent withdrawn|2|||
42280453|NCT02730455|76112460|FG001|Overall Study|Consent withdrawn|4|||
42280454|NCT02730455|76112461|FG002|Overall Study|Consent withdrawn|1|||
42280455|NCT02730455|76112459|FG000|Overall Study|Lost to Follow-up|3|||
42280456|NCT02730455|76112460|FG001|Overall Study|Lost to Follow-up|1|||
42280457|NCT02730455|76112461|FG002|Overall Study|Lost to Follow-up|4|||
42280458|NCT02730455|76112459|FG000|Overall Study|Other|1|||
42280459|NCT02730455|76112460|FG001|Overall Study|Other|1|||
42280460|NCT02730455|76112461|FG002|Overall Study|Other|2|||
42161677|NCT00142298|75969530|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
42161678|NCT00142298|75969531|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
42161679|NCT00142298|75969532|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
42161680|NCT00142298|75969533|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
42161681|NCT00142298|75969534|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
42161682|NCT00142298|75969535|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
42161683|NCT00142298|75969526|FG000|Overall Study|Pregnancy|4|||
42161684|NCT00142298|75969527|FG001|Overall Study|Pregnancy|4|||
42161685|NCT00142298|75969528|FG002|Overall Study|Pregnancy|2|||
42161686|NCT00142298|75969529|FG003|Overall Study|Pregnancy|3|||
42161687|NCT00142298|75969530|FG004|Overall Study|Pregnancy|0|||
42161688|NCT00142298|75969531|FG005|Overall Study|Pregnancy|0|||
42161689|NCT00142298|75969532|FG006|Overall Study|Pregnancy|0|||
42161690|NCT00142298|75969533|FG007|Overall Study|Pregnancy|0|||
42161691|NCT00142298|75969534|FG008|Overall Study|Pregnancy|1|||
42161692|NCT00142298|75969535|FG009|Overall Study|Pregnancy|0|||
42161693|NCT00142298|75969526|FG000|Overall Study|Virologic breakthrough|19|||
42161694|NCT00142298|75969527|FG001|Overall Study|Virologic breakthrough|23|||
42161695|NCT00142298|75969528|FG002|Overall Study|Virologic breakthrough|9|||
42161696|NCT00142298|75969529|FG003|Overall Study|Virologic breakthrough|7|||
42161697|NCT00142298|75969530|FG004|Overall Study|Virologic breakthrough|2|||
42161698|NCT00142298|75969531|FG005|Overall Study|Virologic breakthrough|3|||
42161699|NCT00142298|75969532|FG006|Overall Study|Virologic breakthrough|3|||
42161700|NCT00142298|75969533|FG007|Overall Study|Virologic breakthrough|0|||
42161701|NCT00142298|75969534|FG008|Overall Study|Virologic breakthrough|0|||
42161702|NCT00142298|75969535|FG009|Overall Study|Virologic breakthrough|0|||
42161703|NCT00142298|75969526|FG000|Overall Study|Other- not specified|0|||
42161704|NCT00142298|75969527|FG001|Overall Study|Other- not specified|3|||
42161705|NCT00142298|75969528|FG002|Overall Study|Other- not specified|0|||
42161706|NCT00142298|75969529|FG003|Overall Study|Other- not specified|1|||
42161707|NCT00142298|75969530|FG004|Overall Study|Other- not specified|0|||
42161708|NCT00142298|75969531|FG005|Overall Study|Other- not specified|0|||
42161709|NCT00142298|75969532|FG006|Overall Study|Other- not specified|0|||
42280461|NCT02730455|76112459|FG000|Overall Study|Other|2|||
42280462|NCT02730455|76112460|FG001|Overall Study|Other|2|||
42280463|NCT02730455|76112461|FG002|Overall Study|Other|0|||
42280464|NCT04440449|76112471|FG000|Overall Study|Lost to Follow-up|2|||
42280465|NCT04440449|76112472|FG001|Overall Study|Lost to Follow-up|0|||
42280466|NCT00701311|76112479|FG000|Overall Study|Lack of Efficacy|3|||
42280467|NCT00701311|76112479|FG000|Overall Study|Adverse Event|3|||
42280468|NCT00701311|76112479|FG000|Overall Study|Withdrawal by Subject|2|||
42280469|NCT02730377|76112485|FG000|Overall Study|Other|5|||
42280470|NCT02730377|76112486|FG001|Overall Study|Other|4|||
42280471|NCT02730377|76112485|FG000|Overall Study|Death|1|||
42280472|NCT02730377|76112486|FG001|Overall Study|Death|8|||
42280473|NCT02730377|76112485|FG000|Overall Study|Inadequate glycaemic control|368|||
42280474|NCT02730377|76112486|FG001|Overall Study|Inadequate glycaemic control|473|||
42280475|NCT02730377|76112485|FG000|Overall Study|Adverse Event|79|||
42280476|NCT02730377|76112486|FG001|Overall Study|Adverse Event|41|||
42280477|NCT02730377|76112485|FG000|Overall Study|Protocol Violation|23|||
42280478|NCT02730377|76112486|FG001|Overall Study|Protocol Violation|30|||
42280479|NCT02730377|76112485|FG000|Overall Study|Lack of Efficacy|4|||
42161710|NCT00142298|75969533|FG007|Overall Study|Other- not specified|0|||
42161711|NCT00142298|75969534|FG008|Overall Study|Other- not specified|0|||
42161712|NCT00142298|75969535|FG009|Overall Study|Other- not specified|0|||
42161713|NCT00142298|75969526|FG000|Overall Study|Lost to Follow-up|0|||
42161714|NCT00142298|75969527|FG001|Overall Study|Lost to Follow-up|0|||
42161715|NCT00142298|75969528|FG002|Overall Study|Lost to Follow-up|0|||
42161716|NCT00142298|75969529|FG003|Overall Study|Lost to Follow-up|0|||
42161717|NCT00142298|75969530|FG004|Overall Study|Lost to Follow-up|0|||
42161718|NCT00142298|75969531|FG005|Overall Study|Lost to Follow-up|0|||
42161719|NCT00142298|75969532|FG006|Overall Study|Lost to Follow-up|2|||
42161720|NCT00142298|75969533|FG007|Overall Study|Lost to Follow-up|0|||
42161721|NCT00142298|75969534|FG008|Overall Study|Lost to Follow-up|0|||
42161722|NCT00142298|75969535|FG009|Overall Study|Lost to Follow-up|0|||
42161723|NCT00142298|75969526|FG000|Overall Study|Treatment Failure|0|||
42161724|NCT00142298|75969527|FG001|Overall Study|Treatment Failure|0|||
42161725|NCT00142298|75969528|FG002|Overall Study|Treatment Failure|0|||
42161726|NCT00142298|75969529|FG003|Overall Study|Treatment Failure|0|||
42161727|NCT00142298|75969530|FG004|Overall Study|Treatment Failure|0|||
42161728|NCT00142298|75969531|FG005|Overall Study|Treatment Failure|2|||
42161729|NCT00142298|75969532|FG006|Overall Study|Treatment Failure|2|||
42161730|NCT00142298|75969533|FG007|Overall Study|Treatment Failure|0|||
42161731|NCT00142298|75969534|FG008|Overall Study|Treatment Failure|0|||
42161732|NCT00142298|75969535|FG009|Overall Study|Treatment Failure|0|||
42161733|NCT03709654|75969559|FG000|Overall Study|Lost to Follow-up|1|||
42161734|NCT03709654|75969560|FG001|Overall Study|Lost to Follow-up|1|||
42161735|NCT03709654|75969559|FG000|Overall Study|Withdrawal by Subject|1|||
42161736|NCT03709654|75969560|FG001|Overall Study|Withdrawal by Subject|1|||
42161737|NCT03709654|75969559|FG000|Overall Study|Adverse Event|1|||
42161738|NCT03709654|75969560|FG001|Overall Study|Adverse Event|0|||
42161739|NCT00412061|75969568|FG000|Double Blind Phase|Disease Progression|101|||
42161740|NCT00412061|75969569|FG001|Double Blind Phase|Disease Progression|154|||
42161741|NCT00412061|75969568|FG000|Double Blind Phase|Adverse Event|61|||
42161742|NCT00412061|75969569|FG001|Double Blind Phase|Adverse Event|16|||
42161743|NCT00412061|75969568|FG000|Double Blind Phase|Final Primary Analysis|26|||
42161744|NCT00412061|75969569|FG001|Double Blind Phase|Final Primary Analysis|14|||
42161745|NCT00412061|75969568|FG000|Double Blind Phase|Withdrawal by Subject|18|||
42161746|NCT00412061|75969569|FG001|Double Blind Phase|Withdrawal by Subject|20|||
42161747|NCT00412061|75969568|FG000|Double Blind Phase|Death|6|||
42161748|NCT00412061|75969569|FG001|Double Blind Phase|Death|3|||
42161749|NCT00412061|75969568|FG000|Double Blind Phase|Protocol Violation|3|||
42161750|NCT00412061|75969569|FG001|Double Blind Phase|Protocol Violation|4|||
42161751|NCT00412061|75969568|FG000|Double Blind Phase|New Cander Therapy|1|||
42161752|NCT00412061|75969569|FG001|Double Blind Phase|New Cander Therapy|1|||
42161753|NCT00412061|75969568|FG000|Double Blind Phase|Lost to Follow-up|0|||
42161754|NCT00412061|75969569|FG001|Double Blind Phase|Lost to Follow-up|1|||
42161755|NCT00412061|75969568|FG000|Open Label Phase|Disease Progression|0|||
42161756|NCT00412061|75969569|FG001|Open Label Phase|Disease Progression|86|||
42161757|NCT00412061|75969568|FG000|Open Label Phase|Adverse Event|0|||
42161758|NCT00412061|75969569|FG001|Open Label Phase|Adverse Event|46|||
42161759|NCT00412061|75969568|FG000|Open Label Phase|Withdrawal by Subject|0|||
42161760|NCT00412061|75969569|FG001|Open Label Phase|Withdrawal by Subject|15|||
42161761|NCT00412061|75969568|FG000|Open Label Phase|Administrative Problems|0|||
42161762|NCT00412061|75969569|FG001|Open Label Phase|Administrative Problems|13|||
42161763|NCT00412061|75969568|FG000|Open Label Phase|Death|0|||
42161764|NCT00412061|75969569|FG001|Open Label Phase|Death|7|||
42161765|NCT00412061|75969568|FG000|Open Label Phase|Lost to Follow-up|0|||
42161766|NCT00412061|75969569|FG001|Open Label Phase|Lost to Follow-up|2|||
42161767|NCT00412061|75969568|FG000|Open Label Phase|New Cancer Therapy|0|||
42161768|NCT00412061|75969569|FG001|Open Label Phase|New Cancer Therapy|1|||
42161769|NCT00411671|75969587|FG000|Overall Study|Adverse Event|15|||
42161770|NCT00411671|75969587|FG000|Overall Study|Death|2|||
42161771|NCT00411671|75969587|FG000|Overall Study|Lost to Follow-up|3|||
42161772|NCT03835481|75969596|FG000|Double-blind Period|Other not stated below|0|||
42161773|NCT03835481|75969597|FG001|Double-blind Period|Other not stated below|0|||
42040444|NCT01928394|75848586|FG020|Follow-up Period|Lost to Follow-up|0|||
42040445|NCT01928394|75848587|FG021|Follow-up Period|Lost to Follow-up|0|||
42161774|NCT03835481|75969598|FG002|Double-blind Period|Other not stated below|0|||
42040446|NCT01928394|75848588|FG022|Follow-up Period|Lost to Follow-up|1|||
42161775|NCT03835481|75969599|FG003|Double-blind Period|Other not stated below|1|||
42161776|NCT03835481|75969600|FG004|Double-blind Period|Other not stated below|1|||
42161777|NCT03835481|75969596|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
42161778|NCT03835481|75969597|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
42161779|NCT03835481|75969598|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
42161780|NCT03835481|75969599|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
42161781|NCT03835481|75969600|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
42161782|NCT03835481|75969596|FG000|Double-blind Period|Withdrawal by Subject|0|||
42040447|NCT01886872|75848639|FG000|Overall Study|Ineligible|7|||
42161783|NCT03835481|75969597|FG001|Double-blind Period|Withdrawal by Subject|0|||
42161784|NCT03835481|75969598|FG002|Double-blind Period|Withdrawal by Subject|1|||
42161785|NCT03835481|75969599|FG003|Double-blind Period|Withdrawal by Subject|0|||
42161786|NCT03835481|75969600|FG004|Double-blind Period|Withdrawal by Subject|5|||
42161787|NCT03835481|75969596|FG000|Double-blind Period|Lost to Follow-up|0|||
42161788|NCT03835481|75969597|FG001|Double-blind Period|Lost to Follow-up|0|||
42161789|NCT03835481|75969598|FG002|Double-blind Period|Lost to Follow-up|0|||
42161790|NCT03835481|75969599|FG003|Double-blind Period|Lost to Follow-up|1|||
42161791|NCT03835481|75969600|FG004|Double-blind Period|Lost to Follow-up|0|||
42161792|NCT03835481|75969596|FG000|Double-blind Period|Protocol Violation|0|||
42161793|NCT03835481|75969597|FG001|Double-blind Period|Protocol Violation|2|||
42161794|NCT03835481|75969598|FG002|Double-blind Period|Protocol Violation|0|||
42161795|NCT03835481|75969599|FG003|Double-blind Period|Protocol Violation|1|||
42161796|NCT03835481|75969600|FG004|Double-blind Period|Protocol Violation|0|||
42161797|NCT03835481|75969596|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
42161798|NCT03835481|75969597|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
42161799|NCT03835481|75969598|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
42161800|NCT03835481|75969599|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
42161801|NCT03835481|75969600|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
42161802|NCT03835481|75969596|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
42161803|NCT03835481|75969597|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
42161804|NCT03835481|75969598|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
42161805|NCT03835481|75969599|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
42161806|NCT03835481|75969600|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
42161807|NCT03835481|75969596|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
42161808|NCT03835481|75969597|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
42161809|NCT03835481|75969598|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
42161810|NCT03835481|75969599|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
42161811|NCT03835481|75969600|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
42161812|NCT03835481|75969596|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
42161813|NCT03835481|75969597|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
42161814|NCT03835481|75969598|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
42161815|NCT03835481|75969599|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
42161816|NCT03835481|75969600|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
42161817|NCT03835481|75969596|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
42161818|NCT03835481|75969597|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
42280480|NCT02730377|76112486|FG001|Overall Study|Lack of Efficacy|13|||
42280481|NCT02730377|76112485|FG000|Overall Study|Pregnancy|0|||
42280482|NCT02730377|76112486|FG001|Overall Study|Pregnancy|1|||
42280483|NCT02730377|76112485|FG000|Overall Study|Withdrawal by Subject|45|||
42013546|NCT00997984|75820606|FG000|Overall Study|Suicidal ideation|0|||
42161819|NCT03835481|75969598|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
42161820|NCT03835481|75969599|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
42161821|NCT03835481|75969600|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
42161822|NCT03835481|75969596|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
42161823|NCT03835481|75969597|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
42161824|NCT03835481|75969598|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
42161825|NCT03835481|75969599|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
42161826|NCT03835481|75969600|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
42161827|NCT03709576|75969647|FG000|Overall Study|progression prior to enrollment|1|||
42161828|NCT00122460|75969654|FG000|Overall Study|investigational study phase ongoing|7|||
42013547|NCT00997984|75820607|FG001|Overall Study|Suicidal ideation|0|||
42161829|NCT00122460|75969655|FG001|Overall Study|investigational study phase ongoing|1|||
42161830|NCT00137436|75969661|FG000|Overall Study|Adverse Event|13|||
42161831|NCT00137436|75969661|FG000|Overall Study|Death|2|||
42013548|NCT00997984|75820608|FG002|Overall Study|Suicidal ideation|1|||
42013549|NCT00997984|75820606|FG000|Overall Study|Work schedule|0|||
42013550|NCT00997984|75820607|FG001|Overall Study|Work schedule|0|||
42013551|NCT00997984|75820608|FG002|Overall Study|Work schedule|2|||
42013552|NCT01177293|75820618|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
42013553|NCT01177293|75820619|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
42013554|NCT01177137|75820628|FG000|Overall Study|Withdrawal by Subject|10|||
42013555|NCT01177137|75820629|FG001|Overall Study|Withdrawal by Subject|10|||
42013556|NCT01177137|75820630|FG002|Overall Study|Withdrawal by Subject|2|||
42013557|NCT01177059|75820641|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
42040448|NCT01886872|75848640|FG001|Overall Study|Ineligible|4|||
42280484|NCT02730377|76112486|FG001|Overall Study|Withdrawal by Subject|42|||
42013558|NCT01177059|75820641|FG000|Overall Study|Withdrew consent|2|||
42013559|NCT01177059|75820641|FG000|Overall Study|Lost to Follow-up|18|||
42013560|NCT01176513|75820645|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
42040449|NCT01886872|75848641|FG002|Overall Study|Ineligible|12|||
42040450|NCT01864018|75848652|FG000|Overall Study|Ineligible|3|||
42040451|NCT01864018|75848653|FG001|Overall Study|Ineligible|1|||
42040452|NCT01856192|75848666|FG000|Overall Study|Adverse Event|12|||
42040453|NCT01856192|75848667|FG001|Overall Study|Adverse Event|4|||
42040454|NCT01856192|75848666|FG000|Overall Study|Alternative therapy|0|||
42040455|NCT01856192|75848667|FG001|Overall Study|Alternative therapy|3|||
42040456|NCT01856192|75848666|FG000|Overall Study|Death|3|||
42040457|NCT01856192|75848667|FG001|Overall Study|Death|5|||
42040458|NCT01856192|75848666|FG000|Overall Study|Lack of Efficacy|0|||
42040459|NCT01856192|75848667|FG001|Overall Study|Lack of Efficacy|5|||
42040460|NCT01856192|75848666|FG000|Overall Study|Withdrawal by Subject|1|||
42040461|NCT01856192|75848667|FG001|Overall Study|Withdrawal by Subject|1|||
42040462|NCT01856192|75848666|FG000|Overall Study|Other diseases|1|||
42040463|NCT01856192|75848667|FG001|Overall Study|Other diseases|0|||
42040464|NCT01856192|75848666|FG000|Overall Study|Never started treatment|7|||
42040465|NCT01856192|75848667|FG001|Overall Study|Never started treatment|5|||
42040466|NCT01856192|75848666|FG000|Overall Study|Path ineligible|20|||
42040467|NCT01856192|75848667|FG001|Overall Study|Path ineligible|34|||
42040468|NCT01856192|75848666|FG000|Overall Study|Non-path ineligible|2|||
42040469|NCT01856192|75848667|FG001|Overall Study|Non-path ineligible|2|||
42040470|NCT01856192|75848666|FG000|Overall Study|Physician Decision|1|||
42040471|NCT01856192|75848667|FG001|Overall Study|Physician Decision|1|||
42040472|NCT01856192|75848666|FG000|Overall Study|Suspicion of progressive disease|1|||
42040473|NCT01856192|75848667|FG001|Overall Study|Suspicion of progressive disease|0|||
42040474|NCT01856192|75848666|FG000|Overall Study|Non-compliance|1|||
42040475|NCT01856192|75848667|FG001|Overall Study|Non-compliance|0|||
42040476|NCT01850108|75848673|FG000|Overall Study|Lost to Follow-up|4|||
42040477|NCT01850108|75848673|FG000|Overall Study|Not eligible|1|||
42040478|NCT01850108|75848673|FG000|Overall Study|Failed engraftment|2|||
42040479|NCT01850108|75848673|FG000|Overall Study|Physician Decision|1|||
42040480|NCT01844505|75848682|FG000|Overall Study|Disease progression|170|||
42040481|NCT01844505|75848683|FG001|Overall Study|Disease progression|88|||
42040482|NCT01844505|75848684|FG002|Overall Study|Disease progression|224|||
42040483|NCT01844505|75848682|FG000|Overall Study|Study drug toxicity|40|||
42040484|NCT01844505|75848683|FG001|Overall Study|Study drug toxicity|131|||
42040485|NCT01844505|75848684|FG002|Overall Study|Study drug toxicity|50|||
42040486|NCT01844505|75848682|FG000|Overall Study|Death|1|||
42040487|NCT01844505|75848683|FG001|Overall Study|Death|3|||
42161832|NCT00137436|75969661|FG000|Overall Study|Lack of Efficacy|17|||
42161833|NCT00137436|75969661|FG000|Overall Study|Withdrawal by Subject|6|||
42161834|NCT00137436|75969661|FG000|Overall Study|Other|5|||
42161835|NCT03834623|75969667|FG000|Overall Study|Progression|0|||
42161836|NCT03834623|75969668|FG001|Overall Study|Progression|1|||
42161837|NCT00410813|75969676|FG000|Overall Study|Adverse Event|6|||
42161838|NCT00410813|75969677|FG001|Overall Study|Adverse Event|11|||
42161839|NCT00410813|75969676|FG000|Overall Study|Progression|32|||
42161840|NCT00410813|75969677|FG001|Overall Study|Progression|21|||
42161841|NCT00410813|75969676|FG000|Overall Study|Not protocol specified|3|||
42161842|NCT00410813|75969677|FG001|Overall Study|Not protocol specified|4|||
42161843|NCT00410813|75969676|FG000|Overall Study|Ineligible|2|||
42161844|NCT00410813|75969677|FG001|Overall Study|Ineligible|4|||
42161845|NCT00410813|75969676|FG000|Overall Study|Death|0|||
42161846|NCT00410813|75969677|FG001|Overall Study|Death|2|||
42161847|NCT00405821|75969708|FG000|Overall Study|Death|5|||
42161848|NCT00405821|75969709|FG001|Overall Study|Death|7|||
42161849|NCT00405821|75969708|FG000|Overall Study|Lost to Follow-up|7|||
42161850|NCT00405821|75969709|FG001|Overall Study|Lost to Follow-up|7|||
42280485|NCT02730377|76112485|FG000|Overall Study|Lost to Follow-up|25|||
42161851|NCT00405821|75969708|FG000|Overall Study|Protocol Violation|1|||
42161852|NCT00405821|75969709|FG001|Overall Study|Protocol Violation|0|||
42040488|NCT01844505|75848684|FG002|Overall Study|Death|1|||
42040489|NCT01844505|75848682|FG000|Overall Study|Adverse event unrelated to study drug|7|||
42040490|NCT01844505|75848683|FG001|Overall Study|Adverse event unrelated to study drug|15|||
42040491|NCT01844505|75848684|FG002|Overall Study|Adverse event unrelated to study drug|6|||
42040492|NCT01844505|75848682|FG000|Overall Study|Subject request discontinue treatment|17|||
42161853|NCT00405821|75969708|FG000|Overall Study|initiated ART|9|||
42161854|NCT00405821|75969709|FG001|Overall Study|initiated ART|8|||
42161855|NCT01446016|75969715|FG000|Overall Study|Lost to Follow-up|3|||
42161856|NCT01446016|75969715|FG000|Overall Study|Withdrawal by Subject|1|||
42280486|NCT02730377|76112486|FG001|Overall Study|Lost to Follow-up|21|||
42040493|NCT01844505|75848683|FG001|Overall Study|Subject request discontinue treatment|14|||
42040494|NCT01844505|75848684|FG002|Overall Study|Subject request discontinue treatment|8|||
42040495|NCT01844505|75848682|FG000|Overall Study|Withdrawal by Subject|0|||
42040496|NCT01844505|75848683|FG001|Overall Study|Withdrawal by Subject|3|||
42040497|NCT01844505|75848684|FG002|Overall Study|Withdrawal by Subject|0|||
42040498|NCT01844505|75848682|FG000|Overall Study|Lost to Follow-up|1|||
42040499|NCT01844505|75848683|FG001|Overall Study|Lost to Follow-up|0|||
42161857|NCT01446016|75969715|FG000|Overall Study|Toxicity|3|||
42161858|NCT00137046|75969721|FG000|Overall Study|Death|2|||
42161859|NCT00137046|75969722|FG001|Overall Study|Death|1|||
42161860|NCT00137046|75969721|FG000|Overall Study|Adverse Event|16|||
42161861|NCT00137046|75969722|FG001|Overall Study|Adverse Event|5|||
42161862|NCT00137046|75969721|FG000|Overall Study|Laboratory Abnormality|2|||
42161863|NCT00137046|75969722|FG001|Overall Study|Laboratory Abnormality|0|||
42161864|NCT00137046|75969721|FG000|Overall Study|Lack of Efficacy|13|||
42161865|NCT00137046|75969722|FG001|Overall Study|Lack of Efficacy|1|||
42161866|NCT00137046|75969721|FG000|Overall Study|Lost to Follow-up|8|||
42161867|NCT00137046|75969722|FG001|Overall Study|Lost to Follow-up|24|||
42161868|NCT00137046|75969721|FG000|Overall Study|Other|23|||
42161869|NCT00137046|75969722|FG001|Overall Study|Other|19|||
42280487|NCT02714569|76112503|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
42280488|NCT02714569|76112504|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
42280489|NCT02714569|76112505|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
42280490|NCT02714569|76112506|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
42280491|NCT02714569|76112507|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
42280492|NCT02714569|76112508|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
42280493|NCT02714569|76112509|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
42280494|NCT02714569|76112510|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
42280495|NCT02714569|76112511|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
42280496|NCT02714569|76112512|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
42280497|NCT02714569|76112513|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
42280498|NCT02714569|76112503|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
42280499|NCT02714569|76112504|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
42280500|NCT02714569|76112505|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
42280501|NCT02714569|76112506|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
42280502|NCT02714569|76112507|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
42280503|NCT02714569|76112508|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
42280504|NCT02714569|76112509|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
42351538|NCT01904149|76191428|FG001|Overall Study|Protocol Violation|1|||
42351539|NCT01904149|76191429|FG002|Overall Study|Protocol Violation|0|||
42351540|NCT01904149|76191430|FG003|Overall Study|Protocol Violation|0|||
42351541|NCT01904149|76191431|FG004|Overall Study|Protocol Violation|0|||
42351542|NCT01904149|76191432|FG005|Overall Study|Protocol Violation|0|||
42351543|NCT01904149|76191427|FG000|Overall Study|non compliance with study drug|1|||
42351544|NCT01904149|76191428|FG001|Overall Study|non compliance with study drug|0|||
42351545|NCT01904149|76191429|FG002|Overall Study|non compliance with study drug|0|||
42351546|NCT01904149|76191430|FG003|Overall Study|non compliance with study drug|0|||
42351547|NCT01904149|76191431|FG004|Overall Study|non compliance with study drug|0|||
42013561|NCT01299389|75820651|FG000|Double-blind|Adverse Event|45|||
42013562|NCT01299389|75820652|FG001|Double-blind|Adverse Event|27|||
42013563|NCT01299389|75820653|FG002|Double-blind|Adverse Event|0|||
42013564|NCT01299389|75820654|FG003|Double-blind|Adverse Event|0|||
42013565|NCT01299389|75820651|FG000|Double-blind|Lack of Efficacy|45|||
42013566|NCT01299389|75820652|FG001|Double-blind|Lack of Efficacy|21|||
42013567|NCT01299389|75820653|FG002|Double-blind|Lack of Efficacy|0|||
42013568|NCT01299389|75820654|FG003|Double-blind|Lack of Efficacy|0|||
42040500|NCT01844505|75848684|FG002|Overall Study|Lost to Follow-up|0|||
42040501|NCT01844505|75848682|FG000|Overall Study|Maximum clinical benefit|8|||
42040502|NCT01844505|75848683|FG001|Overall Study|Maximum clinical benefit|11|||
42040503|NCT01844505|75848684|FG002|Overall Study|Maximum clinical benefit|2|||
42040504|NCT01844505|75848682|FG000|Overall Study|Poor/non-compliance|1|||
42040505|NCT01844505|75848683|FG001|Overall Study|Poor/non-compliance|1|||
42040506|NCT01844505|75848684|FG002|Overall Study|Poor/non-compliance|1|||
42040507|NCT01844505|75848682|FG000|Overall Study|Subject no longer meets criteria|0|||
42040508|NCT01844505|75848683|FG001|Overall Study|Subject no longer meets criteria|1|||
42040509|NCT01844505|75848684|FG002|Overall Study|Subject no longer meets criteria|0|||
42040510|NCT01844505|75848682|FG000|Overall Study|Other Reasons|4|||
42013569|NCT01299389|75820651|FG000|Double-blind|Lost to Follow-up|2|||
42013570|NCT01299389|75820652|FG001|Double-blind|Lost to Follow-up|1|||
42013571|NCT01299389|75820653|FG002|Double-blind|Lost to Follow-up|0|||
42013572|NCT01299389|75820654|FG003|Double-blind|Lost to Follow-up|0|||
42013573|NCT01299389|75820651|FG000|Double-blind|Withdrawal by Subject|16|||
42013574|NCT01299389|75820652|FG001|Double-blind|Withdrawal by Subject|13|||
42013575|NCT01299389|75820653|FG002|Double-blind|Withdrawal by Subject|0|||
42013576|NCT01299389|75820654|FG003|Double-blind|Withdrawal by Subject|0|||
42013577|NCT01299389|75820651|FG000|Double-blind|Other|1|||
42013578|NCT01299389|75820652|FG001|Double-blind|Other|1|||
42013579|NCT01299389|75820653|FG002|Double-blind|Other|0|||
42040511|NCT01844505|75848683|FG001|Overall Study|Other Reasons|2|||
42040512|NCT01844505|75848684|FG002|Overall Study|Other Reasons|2|||
42161870|NCT00137046|75969721|FG000|Overall Study|Withdrawal by Subject|33|||
42013580|NCT01299389|75820654|FG003|Double-blind|Other|0|||
42013581|NCT01299389|75820651|FG000|Double-blind|"fail to meet study population criteria"|0|||
42161871|NCT00137046|75969722|FG001|Overall Study|Withdrawal by Subject|42|||
42280505|NCT02714569|76112510|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
42040513|NCT01844505|75848682|FG000|Overall Study|Not Reported|0|||
42040514|NCT01844505|75848683|FG001|Overall Study|Not Reported|0|||
42040515|NCT01844505|75848684|FG002|Overall Study|Not Reported|1|||
42040516|NCT01796171|75848706|FG000|Enrolled|Death|0|||
42040517|NCT01796171|75848707|FG001|Enrolled|Death|0|||
42040518|NCT01796171|75848708|FG002|Enrolled|Death|0|||
42040519|NCT01796171|75848709|FG003|Enrolled|Death|0|||
42040520|NCT01796171|75848710|FG004|Enrolled|Death|0|||
42040521|NCT01796171|75848711|FG005|Enrolled|Death|0|||
42040522|NCT01796171|75848712|FG006|Enrolled|Death|0|||
42040523|NCT01796171|75848713|FG007|Enrolled|Death|0|||
42040524|NCT01796171|75848714|FG008|Enrolled|Death|0|||
42040525|NCT01796171|75848715|FG009|Enrolled|Death|0|||
42161872|NCT00137046|75969721|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
42161873|NCT00137046|75969722|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
42161874|NCT00137046|75969721|FG000|Overall Study|Withdrew prior to study treatment|1|||
42161875|NCT00137046|75969722|FG001|Overall Study|Withdrew prior to study treatment|1|||
42161876|NCT00122382|75969734|FG000|Double-Blind Study|Adverse Event|9|||
42161877|NCT00122382|75969735|FG001|Double-Blind Study|Adverse Event|11|||
42161878|NCT00122382|75969736|FG002|Double-Blind Study|Adverse Event|0|||
42161879|NCT00122382|75969734|FG000|Double-Blind Study|Death|2|||
42161880|NCT00122382|75969735|FG001|Double-Blind Study|Death|2|||
42161881|NCT00122382|75969736|FG002|Double-Blind Study|Death|0|||
42161882|NCT00122382|75969734|FG000|Double-Blind Study|Lack of Efficacy|0|||
42161883|NCT00122382|75969735|FG001|Double-Blind Study|Lack of Efficacy|8|||
42161884|NCT00122382|75969736|FG002|Double-Blind Study|Lack of Efficacy|0|||
42161885|NCT00122382|75969734|FG000|Double-Blind Study|Lost to Follow-up|2|||
42161886|NCT00122382|75969735|FG001|Double-Blind Study|Lost to Follow-up|1|||
42161887|NCT00122382|75969736|FG002|Double-Blind Study|Lost to Follow-up|0|||
42161888|NCT00122382|75969734|FG000|Double-Blind Study|Pregnancy|2|||
42161889|NCT00122382|75969735|FG001|Double-Blind Study|Pregnancy|0|||
42161890|NCT00122382|75969736|FG002|Double-Blind Study|Pregnancy|0|||
42040526|NCT01796171|75848716|FG010|Enrolled|Death|0|||
42040527|NCT01796171|75848717|FG011|Enrolled|Death|0|||
42040528|NCT01796171|75848718|FG012|Enrolled|Death|0|||
42040529|NCT01796171|75848719|FG013|Enrolled|Death|0|||
42040530|NCT01796171|75848720|FG014|Enrolled|Death|1|||
42040531|NCT01796171|75848706|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
42161891|NCT00122382|75969734|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
42161892|NCT00122382|75969735|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
42161893|NCT00122382|75969736|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
42161894|NCT00122382|75969734|FG000|Double-Blind Study|Withdrawal of Consent|7|||
42161895|NCT00122382|75969735|FG001|Double-Blind Study|Withdrawal of Consent|3|||
42161896|NCT00122382|75969736|FG002|Double-Blind Study|Withdrawal of Consent|0|||
42161897|NCT00122382|75969734|FG000|Double-Blind Study|Protocol Violation|1|||
42161898|NCT00122382|75969735|FG001|Double-Blind Study|Protocol Violation|0|||
42161899|NCT00122382|75969736|FG002|Double-Blind Study|Protocol Violation|0|||
42161900|NCT00122382|75969734|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
42161901|NCT00122382|75969735|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
42161902|NCT00122382|75969736|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
42161903|NCT00122382|75969734|FG000|Double-Blind Study|Randomized but not treated|0|||
42161904|NCT00122382|75969735|FG001|Double-Blind Study|Randomized but not treated|2|||
42161905|NCT00122382|75969736|FG002|Double-Blind Study|Randomized but not treated|0|||
42161906|NCT00122382|75969734|FG000|Open-Label Study|Adverse Event|0|||
42161907|NCT00122382|75969735|FG001|Open-Label Study|Adverse Event|0|||
42161908|NCT00122382|75969736|FG002|Open-Label Study|Adverse Event|11|||
42161909|NCT00122382|75969734|FG000|Open-Label Study|Death|0|||
42280506|NCT02714569|76112511|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
42280507|NCT02714569|76112512|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
42280508|NCT02714569|76112513|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
42013582|NCT01299389|75820652|FG001|Double-blind|"fail to meet study population criteria"|1|||
42013583|NCT01299389|75820653|FG002|Double-blind|"fail to meet study population criteria"|0|||
42013584|NCT01299389|75820654|FG003|Double-blind|"fail to meet study population criteria"|0|||
42013585|NCT01299389|75820651|FG000|Post-observational|Other|0|||
42013586|NCT01299389|75820652|FG001|Post-observational|Other|0|||
42013587|NCT01299389|75820653|FG002|Post-observational|Other|12|||
42013588|NCT01299389|75820654|FG003|Post-observational|Other|6|||
42013589|NCT01298999|75820665|FG000|Overall Study|Physician Decision|0|||
42013590|NCT01298999|75820666|FG001|Overall Study|Physician Decision|1|||
42013591|NCT01298999|75820665|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
42040532|NCT01796171|75848707|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
42040533|NCT01796171|75848708|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
42040534|NCT01796171|75848709|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
42040535|NCT01796171|75848710|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
42040536|NCT01796171|75848711|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
42040537|NCT01796171|75848712|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
42161910|NCT00122382|75969735|FG001|Open-Label Study|Death|0|||
42161911|NCT00122382|75969736|FG002|Open-Label Study|Death|2|||
42161912|NCT00122382|75969734|FG000|Open-Label Study|Lack of Efficacy|0|||
42161913|NCT00122382|75969735|FG001|Open-Label Study|Lack of Efficacy|0|||
42161914|NCT00122382|75969736|FG002|Open-Label Study|Lack of Efficacy|3|||
42161915|NCT00122382|75969734|FG000|Open-Label Study|Lost to Follow-up|0|||
42161916|NCT00122382|75969735|FG001|Open-Label Study|Lost to Follow-up|0|||
42161917|NCT00122382|75969736|FG002|Open-Label Study|Lost to Follow-up|3|||
42161918|NCT00122382|75969734|FG000|Open-Label Study|Pregnancy|0|||
42161919|NCT00122382|75969735|FG001|Open-Label Study|Pregnancy|0|||
42161920|NCT00122382|75969736|FG002|Open-Label Study|Pregnancy|2|||
42161921|NCT00122382|75969734|FG000|Open-Label Study|Poor/Non-Compliance|0|||
42161922|NCT00122382|75969735|FG001|Open-Label Study|Poor/Non-Compliance|0|||
42161923|NCT00122382|75969736|FG002|Open-Label Study|Poor/Non-Compliance|1|||
42161924|NCT00122382|75969734|FG000|Open-Label Study|Withdrawal of Consent|0|||
42161925|NCT00122382|75969735|FG001|Open-Label Study|Withdrawal of Consent|0|||
42161926|NCT00122382|75969736|FG002|Open-Label Study|Withdrawal of Consent|4|||
42161927|NCT01028716|75969754|FG000|Overall Study|Physician Decision|1|||
42161928|NCT00106704|75969761|FG000|Overall Study|Adverse Event|10|||
42161929|NCT00106704|75969762|FG001|Overall Study|Adverse Event|7|||
42161930|NCT00106704|75969761|FG000|Overall Study|Death|2|||
42161931|NCT00106704|75969762|FG001|Overall Study|Death|1|||
42161932|NCT00106704|75969761|FG000|Overall Study|Lack of Efficacy|67|||
42161933|NCT00106704|75969762|FG001|Overall Study|Lack of Efficacy|69|||
42161934|NCT00106704|75969761|FG000|Overall Study|Lost to Follow-up|7|||
42161935|NCT00106704|75969762|FG001|Overall Study|Lost to Follow-up|3|||
42161936|NCT00106704|75969761|FG000|Overall Study|Pregnancy|1|||
42161937|NCT00106704|75969762|FG001|Overall Study|Pregnancy|0|||
42161938|NCT00106704|75969761|FG000|Overall Study|Protocol Violation|4|||
42161939|NCT00106704|75969762|FG001|Overall Study|Protocol Violation|7|||
42161940|NCT00106704|75969761|FG000|Overall Study|Withdrawal by Subject|14|||
42161941|NCT00106704|75969762|FG001|Overall Study|Withdrawal by Subject|21|||
42161942|NCT00106704|75969761|FG000|Overall Study|Patient moved|1|||
42161943|NCT00106704|75969762|FG001|Overall Study|Patient moved|0|||
42161944|NCT00106704|75969761|FG000|Overall Study|Site terminated|0|||
42161945|NCT00106704|75969762|FG001|Overall Study|Site terminated|1|||
42161946|NCT00106704|75969761|FG000|Overall Study|Planned major surgery|1|||
42161947|NCT00106704|75969762|FG001|Overall Study|Planned major surgery|0|||
42161948|NCT00106704|75969761|FG000|Overall Study|Patient Received Glycemic Medication|22|||
42161949|NCT00106704|75969762|FG001|Overall Study|Patient Received Glycemic Medication|41|||
42161950|NCT00106704|75969761|FG000|Overall Study|Unable to re-enter US|1|||
42161951|NCT00106704|75969762|FG001|Overall Study|Unable to re-enter US|0|||
42161952|NCT00106704|75969761|FG000|Overall Study|Laboratory test|1|||
42161953|NCT00106704|75969762|FG001|Overall Study|Laboratory test|1|||
42161954|NCT00105066|75969770|FG000|Overall Study|Adverse Event|2|||
42161955|NCT00105066|75969771|FG001|Overall Study|Adverse Event|5|||
42161956|NCT00104520|75969779|FG000|Overall Study|Unrelated adverse event|34|||
42161957|NCT00104520|75969780|FG001|Overall Study|Unrelated adverse event|47|||
42161958|NCT00104520|75969779|FG000|Overall Study|Study drug intolerance|0|||
42161959|NCT00104520|75969780|FG001|Overall Study|Study drug intolerance|1|||
42161960|NCT00104520|75969779|FG000|Overall Study|Related adverse event|13|||
42161961|NCT00104520|75969780|FG001|Overall Study|Related adverse event|15|||
42161962|NCT00104520|75969779|FG000|Overall Study|Lost to Follow-up|1|||
42161963|NCT00104520|75969780|FG001|Overall Study|Lost to Follow-up|0|||
42161964|NCT00104520|75969779|FG000|Overall Study|Noncompliance|0|||
42161965|NCT00104520|75969780|FG001|Overall Study|Noncompliance|2|||
42161966|NCT00104520|75969779|FG000|Overall Study|Personal/administrative|1|||
42161967|NCT00104520|75969780|FG001|Overall Study|Personal/administrative|1|||
42161968|NCT00104520|75969779|FG000|Overall Study|Other|1|||
42280509|NCT02714569|76112503|FG000|Part A Third Intervention|Adverse Event|0|||
42280510|NCT02714569|76112504|FG001|Part A Third Intervention|Adverse Event|0|||
42280511|NCT02714569|76112505|FG002|Part A Third Intervention|Adverse Event|1|||
42280512|NCT02714569|76112506|FG003|Part A Third Intervention|Adverse Event|0|||
42280513|NCT02714569|76112507|FG004|Part A Third Intervention|Adverse Event|0|||
42280514|NCT02714569|76112508|FG005|Part A Third Intervention|Adverse Event|0|||
42280515|NCT02714569|76112509|FG006|Part A Third Intervention|Adverse Event|0|||
42161969|NCT00104520|75969780|FG001|Overall Study|Other|5|||
42161970|NCT00135330|75969789|FG000|Overall Study|Adverse Event|2|||
42280516|NCT02714569|76112510|FG007|Part A Third Intervention|Adverse Event|0|||
42280517|NCT02714569|76112511|FG008|Part A Third Intervention|Adverse Event|0|||
42161971|NCT00135330|75969790|FG001|Overall Study|Adverse Event|5|||
42161972|NCT00135330|75969791|FG002|Overall Study|Adverse Event|1|||
42161973|NCT00135330|75969789|FG000|Overall Study|Lost to Follow-up|0|||
42161974|NCT00135330|75969790|FG001|Overall Study|Lost to Follow-up|2|||
42280518|NCT02714569|76112512|FG009|Part A Third Intervention|Adverse Event|0|||
42280519|NCT02714569|76112513|FG010|Part A Third Intervention|Adverse Event|0|||
42161975|NCT00135330|75969791|FG002|Overall Study|Lost to Follow-up|3|||
42161976|NCT00135330|75969789|FG000|Overall Study|Physician Decision|1|||
42161977|NCT00135330|75969790|FG001|Overall Study|Physician Decision|1|||
42161978|NCT00135330|75969791|FG002|Overall Study|Physician Decision|0|||
42161979|NCT00135330|75969789|FG000|Overall Study|Protocol Violation|4|||
42161980|NCT00135330|75969790|FG001|Overall Study|Protocol Violation|3|||
42161981|NCT00135330|75969791|FG002|Overall Study|Protocol Violation|3|||
42161982|NCT00135330|75969789|FG000|Overall Study|Patient Decision|5|||
42161983|NCT00135330|75969790|FG001|Overall Study|Patient Decision|1|||
42161984|NCT00135330|75969791|FG002|Overall Study|Patient Decision|4|||
42161985|NCT00135330|75969789|FG000|Overall Study|Sponsor Decision|0|||
42161986|NCT00135330|75969790|FG001|Overall Study|Sponsor Decision|1|||
42161987|NCT00135330|75969791|FG002|Overall Study|Sponsor Decision|0|||
42161988|NCT00134784|75969803|FG000|Overall Study|Withdrawal by Subject|2|||
42161989|NCT00134784|75969804|FG001|Overall Study|Withdrawal by Subject|2|||
42161990|NCT00134784|75969805|FG002|Overall Study|Withdrawal by Subject|2|||
42161991|NCT00134784|75969806|FG003|Overall Study|Withdrawal by Subject|1|||
42161992|NCT00134082|75969813|FG000|Overall Study|Adverse Event|2|||
42161993|NCT00134082|75969813|FG000|Overall Study|Death|1|||
42161994|NCT03703336|75969819|FG000|Overall Study|Parent withdrew consent|29|||
42161995|NCT03703336|75969820|FG001|Overall Study|Parent withdrew consent|8|||
42161996|NCT03703336|75969819|FG000|Overall Study|Migration|3|||
42161997|NCT03703336|75969820|FG001|Overall Study|Migration|3|||
42161998|NCT03703336|75969819|FG000|Overall Study|Protocol Violation|3|||
42161999|NCT03703336|75969820|FG001|Overall Study|Protocol Violation|1|||
42162000|NCT03703336|75969819|FG000|Overall Study|Physician Decision|2|||
42162001|NCT03703336|75969820|FG001|Overall Study|Physician Decision|0|||
42162002|NCT03703336|75969819|FG000|Overall Study|Adverse Event|0|||
42162003|NCT03703336|75969820|FG001|Overall Study|Adverse Event|2|||
42162004|NCT03703336|75969819|FG000|Overall Study|Lost to Follow-up|1|||
42162005|NCT03703336|75969820|FG001|Overall Study|Lost to Follow-up|0|||
42162006|NCT03702166|75969826|FG000|Overall Study|Lost to Follow-up|1|||
42162007|NCT03702166|75969826|FG000|Overall Study|Withdrawal by Subject|1|||
42162008|NCT00132678|75969833|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
42162009|NCT00132678|75969834|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
42162010|NCT00132678|75969835|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
42162011|NCT00132678|75969833|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
42162012|NCT00132678|75969834|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
42162013|NCT00132678|75969835|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
42162014|NCT00132678|75969833|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
42162015|NCT00132678|75969834|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
42162016|NCT00132678|75969835|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
42162017|NCT00132678|75969833|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
42162018|NCT00132678|75969834|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
42162019|NCT00132678|75969835|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
42162020|NCT00132678|75969833|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
42162021|NCT00132678|75969834|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
42162022|NCT00132678|75969835|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
42162023|NCT00132678|75969833|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
42162024|NCT00132678|75969834|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
42162025|NCT00132678|75969835|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
42162026|NCT00132678|75969833|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
42162027|NCT00132678|75969834|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
42162028|NCT00132678|75969835|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
42162029|NCT00132678|75969833|FG000|Period III (Open-Label Stabilization)|Death|2|||
42162030|NCT00132678|75969834|FG001|Period III (Open-Label Stabilization)|Death|0|||
42162031|NCT00132678|75969835|FG002|Period III (Open-Label Stabilization)|Death|0|||
42162032|NCT00132678|75969833|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
42162033|NCT00132678|75969834|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
42162034|NCT00132678|75969835|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
42162035|NCT00132678|75969833|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
42162036|NCT00132678|75969834|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
42162037|NCT00132678|75969835|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
42162038|NCT00132678|75969833|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
42162039|NCT00132678|75969834|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
42162040|NCT00132678|75969835|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
42162041|NCT00132678|75969833|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
42162042|NCT00132678|75969834|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
42162043|NCT00132678|75969835|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
42162044|NCT00132678|75969833|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
42162045|NCT00132678|75969834|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
42162046|NCT00132678|75969835|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
42162047|NCT00132678|75969833|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
42162048|NCT00132678|75969834|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
42162049|NCT00132678|75969835|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
42162050|NCT00132678|75969833|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
42162051|NCT00132678|75969834|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
42162052|NCT00132678|75969835|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
42162053|NCT00132678|75969833|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
42162054|NCT00132678|75969834|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
42162055|NCT00132678|75969835|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
42162056|NCT00132678|75969833|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
42162057|NCT00132678|75969834|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
42162058|NCT00132678|75969835|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
42162059|NCT00132678|75969833|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
42162060|NCT00132678|75969834|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
42162061|NCT00132678|75969835|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
42162062|NCT00132678|75969833|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
42162063|NCT00132678|75969834|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
42162064|NCT00132678|75969835|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
42162065|NCT00132678|75969833|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
42162066|NCT00132678|75969834|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
42162067|NCT00132678|75969835|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
42162068|NCT00132678|75969833|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
42162069|NCT00132678|75969834|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
42162070|NCT00132678|75969835|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
42162071|NCT00132678|75969833|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
42162072|NCT00132678|75969834|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
42162073|NCT00132678|75969835|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
42162074|NCT00132678|75969833|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
42162075|NCT00132678|75969834|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
42162076|NCT00132678|75969835|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
42162077|NCT00101868|75969845|FG000|Overall Study|Death|10|||
42162078|NCT00101868|75969846|FG001|Overall Study|Death|10|||
42162079|NCT00101868|75969845|FG000|Overall Study|Withdrawal by Subject|8|||
42351548|NCT01904149|76191432|FG005|Overall Study|non compliance with study drug|0|||
42351549|NCT00986362|76191450|FG000|Overall Study|Death|2|||
42351550|NCT00986362|76191451|FG001|Overall Study|Death|0|||
42351551|NCT00986362|76191450|FG000|Overall Study|Lost to Follow-up|0|||
42351552|NCT00986362|76191451|FG001|Overall Study|Lost to Follow-up|1|||
42351553|NCT01890421|76191457|FG000|Overall Study|Adverse Event|1|||
42351554|NCT01890421|76191457|FG000|Overall Study|Other reason|10|||
42351555|NCT00985738|76191463|FG000|Overall Study|Study closed prematurely|8|||
42351556|NCT00985738|76191464|FG001|Overall Study|Study closed prematurely|8|||
42351557|NCT01928485|76191472|FG000|Overall Study|Physician Decision|0|||
42162080|NCT00101868|75969846|FG001|Overall Study|Withdrawal by Subject|9|||
42162081|NCT00101868|75969845|FG000|Overall Study|Protocol Violation|3|||
42162082|NCT00101868|75969846|FG001|Overall Study|Protocol Violation|0|||
42162083|NCT00101868|75969845|FG000|Overall Study|Lost to Follow-up|8|||
42162084|NCT00101868|75969846|FG001|Overall Study|Lost to Follow-up|13|||
42162085|NCT00101400|75969854|FG000|Survival Follow-Up|Alive|7|||
42162086|NCT03821064|75969858|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
42162087|NCT00141518|75969865|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
42162088|NCT00141518|75969866|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
42162089|NCT00141518|75969867|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
42162090|NCT00141518|75969865|FG000|Overall Study|Adverse Event|7|||
42162091|NCT00141518|75969866|FG001|Overall Study|Adverse Event|5|||
42162092|NCT00141518|75969867|FG002|Overall Study|Adverse Event|2|||
42162093|NCT00141518|75969865|FG000|Overall Study|Withdrawal by Subject|2|||
42162094|NCT00141518|75969866|FG001|Overall Study|Withdrawal by Subject|0|||
42162095|NCT00141518|75969867|FG002|Overall Study|Withdrawal by Subject|2|||
42162096|NCT00141518|75969865|FG000|Overall Study|Protocol Violation|1|||
42162097|NCT00141518|75969866|FG001|Overall Study|Protocol Violation|1|||
42162098|NCT00141518|75969867|FG002|Overall Study|Protocol Violation|2|||
42162099|NCT00141518|75969865|FG000|Overall Study|Lack of Efficacy|5|||
42162100|NCT00141518|75969866|FG001|Overall Study|Lack of Efficacy|0|||
42162101|NCT00141518|75969867|FG002|Overall Study|Lack of Efficacy|0|||
42351558|NCT01928485|76191473|FG001|Overall Study|Physician Decision|1|||
42351559|NCT00985504|76191481|FG000|Acute Treatment Period|Adverse Event|3|||
42351560|NCT00985504|76191482|FG001|Acute Treatment Period|Adverse Event|4|||
42162102|NCT00253448|75969877|FG000|Overall Study|Withdrawal by Subject|1|||
42162103|NCT00098748|75969884|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
42162104|NCT00098748|75969885|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
42162105|NCT00098748|75969886|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
42162106|NCT00098748|75969884|FG000|Received Study Treatment|Death|2|||
42162107|NCT00098748|75969885|FG001|Received Study Treatment|Death|1|||
42162108|NCT00098748|75969886|FG002|Received Study Treatment|Death|2|||
42162109|NCT00098748|75969884|FG000|Received Study Treatment|Adverse Event|1|||
42162110|NCT00098748|75969885|FG001|Received Study Treatment|Adverse Event|2|||
42162111|NCT00098748|75969886|FG002|Received Study Treatment|Adverse Event|5|||
42162112|NCT00098748|75969884|FG000|Received Study Treatment|Lack of Efficacy|40|||
42162113|NCT00098748|75969885|FG001|Received Study Treatment|Lack of Efficacy|27|||
42162114|NCT00098748|75969886|FG002|Received Study Treatment|Lack of Efficacy|27|||
42162115|NCT00098748|75969884|FG000|Received Study Treatment|Other|2|||
42162116|NCT00098748|75969885|FG001|Received Study Treatment|Other|2|||
42162117|NCT00098748|75969886|FG002|Received Study Treatment|Other|6|||
42162118|NCT00098748|75969884|FG000|Received Study Treatment|Subject defaulted|3|||
42162119|NCT00098748|75969885|FG001|Received Study Treatment|Subject defaulted|4|||
42162120|NCT00098748|75969886|FG002|Received Study Treatment|Subject defaulted|4|||
42162121|NCT00098748|75969884|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
42162122|NCT00098748|75969885|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
42162123|NCT00098748|75969886|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
42162124|NCT00098748|75969884|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
42162125|NCT00098748|75969885|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
42162126|NCT00098748|75969886|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
42162127|NCT00098748|75969884|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
42162128|NCT00098748|75969885|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
42162129|NCT00098748|75969886|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
42162130|NCT00098748|75969884|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
42162131|NCT00098748|75969885|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
42162132|NCT00098748|75969886|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
42162133|NCT00098748|75969884|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
42162134|NCT00098748|75969885|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
42162135|NCT00098748|75969886|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
42162136|NCT00130520|75969894|FG000|Overall Study|Adverse Event|11|||
42162137|NCT00130520|75969894|FG000|Overall Study|Death|1|||
42162138|NCT00130520|75969894|FG000|Overall Study|Physician Decision|1|||
42162139|NCT00130520|75969894|FG000|Overall Study|Withdrawal by Subject|1|||
42162140|NCT00130520|75969894|FG000|Overall Study|Disease Progression|23|||
42162141|NCT00130520|75969894|FG000|Overall Study|Protocol non-compliance|1|||
42162142|NCT00130520|75969894|FG000|Overall Study|Did not meet re-treatment criteria|1|||
42162143|NCT00132132|75969900|FG000|Overall Study|Lost to Follow-up|7|||
42162144|NCT00132132|75969901|FG001|Overall Study|Lost to Follow-up|2|||
42162145|NCT00130442|75969909|FG000|Overall Study|Withdrawal by Subject|0|||
42162146|NCT00130442|75969910|FG001|Overall Study|Withdrawal by Subject|1|||
42162147|NCT00130442|75969909|FG000|Overall Study|did not meet criteria|1|||
42162148|NCT00130442|75969910|FG001|Overall Study|did not meet criteria|1|||
42162149|NCT00130208|75969920|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
42162150|NCT00130208|75969921|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
42162151|NCT00130208|75969920|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
42162152|NCT00130208|75969921|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
42162153|NCT00130208|75969920|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
42162154|NCT00130208|75969921|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
42162155|NCT00130208|75969920|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
42162156|NCT00130208|75969921|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
42162157|NCT00130208|75969920|FG000|Maintenance Period (26 Weeks)|Other|1|||
42162158|NCT00130208|75969921|FG001|Maintenance Period (26 Weeks)|Other|1|||
42162159|NCT00130208|75969920|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
42162160|NCT00130208|75969921|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
42162161|NCT00130208|75969920|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
42162162|NCT00130208|75969921|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
42162163|NCT00130208|75969920|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
42162164|NCT00130208|75969921|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
42162165|NCT00130208|75969920|FG000|Washout Period (8 Weeks)|Other|1|||
42162166|NCT00130208|75969921|FG001|Washout Period (8 Weeks)|Other|1|||
42162167|NCT00253370|75969927|FG000|Overall Study|Adverse Event|18|||
42162168|NCT00253370|75969927|FG000|Overall Study|Disease progression|13|||
42162169|NCT00253370|75969927|FG000|Overall Study|Death|2|||
42162170|NCT00253370|75969927|FG000|Overall Study|Withdrawal by Subject|6|||
42162171|NCT00253370|75969927|FG000|Overall Study|Non-protocol therapy|1|||
42162172|NCT00253370|75969927|FG000|Overall Study|Physician Decision|1|||
42162173|NCT00253370|75969927|FG000|Overall Study|Protocol Violation|1|||
42162174|NCT00253370|75969927|FG000|Overall Study|Abdominal pain due to disease|1|||
42162175|NCT00140426|75969934|FG000|Overall Study|Withdrawal by Subject|0|||
42162176|NCT00140426|75969935|FG001|Overall Study|Withdrawal by Subject|3|||
42162177|NCT00121134|75969950|FG000|Overall Study|Progression of Disease|5|||
42162178|NCT00121134|75969951|FG001|Overall Study|Progression of Disease|3|||
42162179|NCT00121134|75969952|FG002|Overall Study|Progression of Disease|4|||
42162180|NCT00121134|75969953|FG003|Overall Study|Progression of Disease|2|||
42162181|NCT00121134|75969950|FG000|Overall Study|Toxicity|4|||
42162182|NCT00121134|75969951|FG001|Overall Study|Toxicity|7|||
42162183|NCT00121134|75969952|FG002|Overall Study|Toxicity|13|||
42162184|NCT00121134|75969953|FG003|Overall Study|Toxicity|5|||
42162185|NCT00121134|75969950|FG000|Overall Study|Physician Decision|6|||
42162186|NCT00121134|75969951|FG001|Overall Study|Physician Decision|4|||
42162187|NCT00121134|75969952|FG002|Overall Study|Physician Decision|4|||
42162188|NCT00121134|75969953|FG003|Overall Study|Physician Decision|1|||
42162189|NCT00121134|75969950|FG000|Overall Study|Treatment Delay|1|||
42162190|NCT00121134|75969951|FG001|Overall Study|Treatment Delay|0|||
42162191|NCT00121134|75969952|FG002|Overall Study|Treatment Delay|0|||
42162192|NCT00121134|75969953|FG003|Overall Study|Treatment Delay|0|||
42162193|NCT00121134|75969950|FG000|Overall Study|Intercurrent Illness|0|||
42162194|NCT00121134|75969951|FG001|Overall Study|Intercurrent Illness|0|||
42162195|NCT00121134|75969952|FG002|Overall Study|Intercurrent Illness|0|||
42162196|NCT00121134|75969953|FG003|Overall Study|Intercurrent Illness|1|||
42162197|NCT00121134|75969950|FG000|Overall Study|Patient Personal Reasons|0|||
42162198|NCT00121134|75969951|FG001|Overall Study|Patient Personal Reasons|1|||
42162199|NCT00121134|75969952|FG002|Overall Study|Patient Personal Reasons|0|||
42162200|NCT00121134|75969953|FG003|Overall Study|Patient Personal Reasons|0|||
42162201|NCT00119262|75969965|FG000|Overall Study|Lack of Efficacy|0|||
42162202|NCT00119262|75969966|FG001|Overall Study|Lack of Efficacy|3|||
42162203|NCT00119262|75969965|FG000|Overall Study|Withdrawal by Subject|12|||
42162204|NCT00119262|75969966|FG001|Overall Study|Withdrawal by Subject|11|||
42162205|NCT00119262|75969965|FG000|Overall Study|Adverse Event|33|||
42162206|NCT00119262|75969966|FG001|Overall Study|Adverse Event|35|||
42162207|NCT00119262|75969965|FG000|Overall Study|other disease|0|||
42162208|NCT00119262|75969966|FG001|Overall Study|other disease|2|||
42162209|NCT00119262|75969965|FG000|Overall Study|ineligble|1|||
42162210|NCT00119262|75969966|FG001|Overall Study|ineligble|2|||
42162211|NCT00119262|75969965|FG000|Overall Study|others|0|||
42162212|NCT00119262|75969966|FG001|Overall Study|others|5|||
42162213|NCT03703882|75969974|FG000|Overall Study|Adverse Event|1|||
42162214|NCT03703882|75969975|FG001|Overall Study|Adverse Event|0|||
42162215|NCT03703882|75969974|FG000|Overall Study|Lost to Follow-up|0|||
42162216|NCT03703882|75969975|FG001|Overall Study|Lost to Follow-up|2|||
42162217|NCT03703882|75969974|FG000|Overall Study|Non-compliance with study drug|0|||
42162218|NCT03703882|75969975|FG001|Overall Study|Non-compliance with study drug|1|||
42162219|NCT03703882|75969974|FG000|Overall Study|Physician Decision|0|||
42162220|NCT03703882|75969975|FG001|Overall Study|Physician Decision|1|||
42162221|NCT03703882|75969974|FG000|Overall Study|Progressive disease|1|||
42162222|NCT03703882|75969975|FG001|Overall Study|Progressive disease|0|||
42280520|NCT02714569|76112503|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
42280521|NCT02714569|76112504|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
42280522|NCT02714569|76112505|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
42280523|NCT02714569|76112506|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
42280524|NCT02714569|76112507|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
42280525|NCT02714569|76112508|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
42280526|NCT02714569|76112509|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
42280527|NCT02714569|76112510|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
42280528|NCT02714569|76112511|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
42280529|NCT02714569|76112512|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
42351561|NCT00985504|76191481|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
42162223|NCT03703882|75969974|FG000|Overall Study|Withdrawal by parent/guardian|1|||
42162224|NCT03703882|75969975|FG001|Overall Study|Withdrawal by parent/guardian|0|||
42162225|NCT03703882|75969974|FG000|Overall Study|Starting another treatment|0|||
42162226|NCT03703882|75969975|FG001|Overall Study|Starting another treatment|1|||
42162227|NCT03703882|75969974|FG000|Overall Study|noncompliance with study procedures|0|||
42162228|NCT03703882|75969975|FG001|Overall Study|noncompliance with study procedures|1|||
42351562|NCT00985504|76191482|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
42162229|NCT00131664|75969984|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
42162230|NCT00131664|75969985|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
42162231|NCT00131664|75969986|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
42162232|NCT00131664|75969987|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
42162233|NCT00131664|75969988|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
42162234|NCT00131664|75969989|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
42162235|NCT00131664|75969984|FG000|First Period (First 6 Months)|Death|0|||
42162236|NCT00131664|75969985|FG001|First Period (First 6 Months)|Death|1|||
42162237|NCT00131664|75969986|FG002|First Period (First 6 Months)|Death|0|||
42162238|NCT00131664|75969987|FG003|First Period (First 6 Months)|Death|0|||
42162239|NCT00131664|75969988|FG004|First Period (First 6 Months)|Death|0|||
42162240|NCT00131664|75969989|FG005|First Period (First 6 Months)|Death|0|||
42162241|NCT00131664|75969984|FG000|First Period (First 6 Months)|Protocol Violation|2|||
42162242|NCT00131664|75969985|FG001|First Period (First 6 Months)|Protocol Violation|2|||
42162243|NCT00131664|75969986|FG002|First Period (First 6 Months)|Protocol Violation|1|||
42162244|NCT00131664|75969987|FG003|First Period (First 6 Months)|Protocol Violation|0|||
42162245|NCT00131664|75969988|FG004|First Period (First 6 Months)|Protocol Violation|0|||
42162246|NCT00131664|75969989|FG005|First Period (First 6 Months)|Protocol Violation|0|||
42162247|NCT00131664|75969984|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
42162248|NCT00131664|75969985|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
42162249|NCT00131664|75969986|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
42162250|NCT00131664|75969987|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
42162251|NCT00131664|75969988|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
42162252|NCT00131664|75969989|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
42162253|NCT00131664|75969984|FG000|First Period (First 6 Months)|Adverse Event|9|||
42162254|NCT00131664|75969985|FG001|First Period (First 6 Months)|Adverse Event|4|||
42162255|NCT00131664|75969986|FG002|First Period (First 6 Months)|Adverse Event|5|||
42162256|NCT00131664|75969987|FG003|First Period (First 6 Months)|Adverse Event|0|||
42162257|NCT00131664|75969988|FG004|First Period (First 6 Months)|Adverse Event|0|||
42162258|NCT00131664|75969989|FG005|First Period (First 6 Months)|Adverse Event|0|||
42162259|NCT00131664|75969984|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
42162260|NCT00131664|75969985|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
42280530|NCT02714569|76112513|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
42280531|NCT02714569|76112503|FG000|Part B (Overall)|Lost to Follow-up|0|||
42280532|NCT02714569|76112504|FG001|Part B (Overall)|Lost to Follow-up|0|||
42280533|NCT02714569|76112505|FG002|Part B (Overall)|Lost to Follow-up|0|||
42162261|NCT00131664|75969986|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
42162262|NCT00131664|75969987|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
42162263|NCT00131664|75969988|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
42162264|NCT00131664|75969989|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
42162265|NCT00131664|75969984|FG000|First Period (First 6 Months)|Administrative reasons|2|||
42162266|NCT00131664|75969985|FG001|First Period (First 6 Months)|Administrative reasons|0|||
42162267|NCT00131664|75969986|FG002|First Period (First 6 Months)|Administrative reasons|5|||
42162268|NCT00131664|75969987|FG003|First Period (First 6 Months)|Administrative reasons|0|||
42162269|NCT00131664|75969988|FG004|First Period (First 6 Months)|Administrative reasons|0|||
42162270|NCT00131664|75969989|FG005|First Period (First 6 Months)|Administrative reasons|0|||
42162271|NCT00131664|75969984|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
42162272|NCT00131664|75969985|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
42162273|NCT00131664|75969986|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
42162274|NCT00131664|75969987|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
42162275|NCT00131664|75969988|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
42162276|NCT00131664|75969989|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
42162277|NCT00131664|75969984|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
42162278|NCT00131664|75969985|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
42162279|NCT00131664|75969986|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
42162280|NCT00131664|75969987|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
42162281|NCT00131664|75969988|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
42162282|NCT00131664|75969989|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
42162283|NCT00131664|75969984|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
42162284|NCT00131664|75969985|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
42280534|NCT02714569|76112506|FG003|Part B (Overall)|Lost to Follow-up|0|||
42280535|NCT02714569|76112507|FG004|Part B (Overall)|Lost to Follow-up|0|||
42280536|NCT02714569|76112508|FG005|Part B (Overall)|Lost to Follow-up|0|||
42280537|NCT02714569|76112509|FG006|Part B (Overall)|Lost to Follow-up|1|||
42280538|NCT02714569|76112510|FG007|Part B (Overall)|Lost to Follow-up|0|||
42280539|NCT02714569|76112511|FG008|Part B (Overall)|Lost to Follow-up|0|||
42280540|NCT02714569|76112512|FG009|Part B (Overall)|Lost to Follow-up|0|||
42280541|NCT02714569|76112513|FG010|Part B (Overall)|Lost to Follow-up|0|||
42280542|NCT02714569|76112503|FG000|Part B (Overall)|Withdrawal by Subject|0|||
42280543|NCT02714569|76112504|FG001|Part B (Overall)|Withdrawal by Subject|0|||
42280544|NCT02714569|76112505|FG002|Part B (Overall)|Withdrawal by Subject|0|||
42280545|NCT02714569|76112506|FG003|Part B (Overall)|Withdrawal by Subject|0|||
42280546|NCT02714569|76112507|FG004|Part B (Overall)|Withdrawal by Subject|0|||
42280547|NCT02714569|76112508|FG005|Part B (Overall)|Withdrawal by Subject|0|||
42280548|NCT02714569|76112509|FG006|Part B (Overall)|Withdrawal by Subject|0|||
42280549|NCT02714569|76112510|FG007|Part B (Overall)|Withdrawal by Subject|1|||
42040538|NCT01796171|75848713|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
42040539|NCT01796171|75848714|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
42162285|NCT00131664|75969986|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
42162286|NCT00131664|75969987|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
42162287|NCT00131664|75969988|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
42162288|NCT00131664|75969989|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
42162289|NCT00131664|75969984|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
42162290|NCT00131664|75969985|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
42162291|NCT00131664|75969986|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
42162292|NCT00131664|75969987|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
42162293|NCT00131664|75969988|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
42162294|NCT00131664|75969989|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
42162295|NCT00131664|75969984|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
42162296|NCT00131664|75969985|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
42162297|NCT00131664|75969986|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
42162298|NCT00131664|75969987|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
42162299|NCT00131664|75969988|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
42162300|NCT00131664|75969989|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
42162301|NCT00131664|75969984|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
42162302|NCT00131664|75969985|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
42013592|NCT01298999|75820666|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
42013593|NCT01007032|75820676|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
42013594|NCT01007032|75820677|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
42013595|NCT01007032|75820678|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
42013596|NCT01007032|75820679|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
42013597|NCT01007032|75820676|FG000|Overall Study|Withdrawal by Subject|0|||
42013598|NCT01007032|75820677|FG001|Overall Study|Withdrawal by Subject|0|||
42013599|NCT01007032|75820678|FG002|Overall Study|Withdrawal by Subject|0|||
42013600|NCT01007032|75820679|FG003|Overall Study|Withdrawal by Subject|1|||
42013601|NCT00976027|75820696|FG000|Overall Study|Serious Adverse Event|36|||
42013602|NCT00976027|75820697|FG001|Overall Study|Serious Adverse Event|17|||
42013603|NCT00976027|75820696|FG000|Overall Study|Adverse Event|0|||
42013604|NCT00976027|75820697|FG001|Overall Study|Adverse Event|2|||
42013605|NCT00976027|75820696|FG000|Overall Study|Protocol Violation|60|||
42013606|NCT00976027|75820697|FG001|Overall Study|Protocol Violation|27|||
42040540|NCT01796171|75848715|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
42162303|NCT00131664|75969986|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
42162304|NCT00131664|75969987|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
42162305|NCT00131664|75969988|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
42162306|NCT00131664|75969989|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
42162307|NCT00131508|75970002|FG000|Overall Study|Disease progression|0|||
42162308|NCT00131508|75970003|FG001|Overall Study|Disease progression|2|||
42162309|NCT00131508|75970002|FG000|Overall Study|Non-Compliance|2|||
42162310|NCT00131508|75970003|FG001|Overall Study|Non-Compliance|4|||
42162311|NCT00131508|75970002|FG000|Overall Study|Withdrawal by Subject|1|||
42162312|NCT00131508|75970003|FG001|Overall Study|Withdrawal by Subject|2|||
42162313|NCT05050318|75970012|FG000|Overall Study|Protocol Deviation|1|||
42162314|NCT05050318|75970013|FG001|Overall Study|Protocol Deviation|0|||
42162315|NCT05050318|75970014|FG002|Overall Study|Protocol Deviation|0|||
42162316|NCT03699124|75970025|FG000|Overall Study|Adverse Event|6|||
42162317|NCT03699124|75970026|FG001|Overall Study|Adverse Event|5|||
42162318|NCT03699124|75970027|FG002|Overall Study|Adverse Event|2|||
42162319|NCT03699124|75970025|FG000|Overall Study|Death|0|||
42162320|NCT03699124|75970026|FG001|Overall Study|Death|2|||
42162321|NCT03699124|75970027|FG002|Overall Study|Death|0|||
42162322|NCT03699124|75970025|FG000|Overall Study|Lost to Follow-up|20|||
42162323|NCT03699124|75970026|FG001|Overall Study|Lost to Follow-up|16|||
42162324|NCT03699124|75970027|FG002|Overall Study|Lost to Follow-up|15|||
42162325|NCT03699124|75970025|FG000|Overall Study|Protocol Violation|1|||
42280550|NCT02714569|76112511|FG008|Part B (Overall)|Withdrawal by Subject|0|||
42280551|NCT02714569|76112512|FG009|Part B (Overall)|Withdrawal by Subject|1|||
42280552|NCT02714569|76112513|FG010|Part B (Overall)|Withdrawal by Subject|0|||
42280553|NCT02714569|76112503|FG000|Part B (Overall)|Adverse Event|0|||
42280554|NCT02714569|76112504|FG001|Part B (Overall)|Adverse Event|0|||
42280555|NCT02714569|76112505|FG002|Part B (Overall)|Adverse Event|0|||
42280556|NCT02714569|76112506|FG003|Part B (Overall)|Adverse Event|0|||
42280557|NCT02714569|76112507|FG004|Part B (Overall)|Adverse Event|0|||
42280558|NCT02714569|76112508|FG005|Part B (Overall)|Adverse Event|0|||
42280559|NCT02714569|76112509|FG006|Part B (Overall)|Adverse Event|0|||
42280560|NCT02714569|76112510|FG007|Part B (Overall)|Adverse Event|0|||
42280561|NCT02714569|76112511|FG008|Part B (Overall)|Adverse Event|0|||
42280562|NCT02714569|76112512|FG009|Part B (Overall)|Adverse Event|1|||
42280563|NCT02714569|76112513|FG010|Part B (Overall)|Adverse Event|0|||
42280564|NCT02713789|76112576|FG000|Overall Study|Lost to Follow-up|0|||
42280565|NCT02713789|76112577|FG001|Overall Study|Lost to Follow-up|1|||
42280566|NCT02713789|76112578|FG002|Overall Study|Lost to Follow-up|1|||
42280567|NCT04445051|76112588|FG000|Overall Study|Adverse Event|0|||
42280568|NCT04445051|76112589|FG001|Overall Study|Adverse Event|0|||
42280569|NCT04445051|76112590|FG002|Overall Study|Adverse Event|1|||
42280570|NCT04445051|76112591|FG003|Overall Study|Adverse Event|0|||
42280571|NCT04445051|76112592|FG004|Overall Study|Adverse Event|0|||
42280572|NCT04445051|76112593|FG005|Overall Study|Adverse Event|0|||
42280573|NCT04086121|76112607|FG000|Overall Study|Other than listed|8|||
42280574|NCT04086121|76112607|FG000|Overall Study|Withdrawal by Subject|3|||
42280575|NCT04086121|76112607|FG000|Overall Study|Lost to Follow-up|2|||
42013607|NCT00976027|75820696|FG000|Overall Study|Lost to Follow-up|208|||
42013608|NCT00976027|75820697|FG001|Overall Study|Lost to Follow-up|103|||
42013609|NCT00976027|75820696|FG000|Overall Study|Withdrawal by Subject|107|||
42013610|NCT00976027|75820697|FG001|Overall Study|Withdrawal by Subject|66|||
42013611|NCT01298765|75820703|FG000|Titration Period|Adverse Event|26|||
42013612|NCT01298765|75820703|FG000|Titration Period|Death|1|||
42013613|NCT01298765|75820703|FG000|Titration Period|Lack of Efficacy|21|||
42162326|NCT03699124|75970026|FG001|Overall Study|Protocol Violation|0|||
42280576|NCT04086121|76112607|FG000|Overall Study|Adverse Event|1|||
42013614|NCT01298765|75820703|FG000|Titration Period|Lost to Follow-up|9|||
42013615|NCT01298765|75820703|FG000|Titration Period|Physician Decision|1|||
42013616|NCT01298765|75820703|FG000|Titration Period|Withdrawal by Subject|10|||
42162327|NCT03699124|75970027|FG002|Overall Study|Protocol Violation|0|||
42280577|NCT02729909|76112614|FG000|Overall Study|Lost to Follow-up|0|||
42013617|NCT01298765|75820703|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
42162328|NCT03699124|75970025|FG000|Overall Study|Withdrawal by Subject|13|||
42162329|NCT03699124|75970026|FG001|Overall Study|Withdrawal by Subject|14|||
42162330|NCT03699124|75970027|FG002|Overall Study|Withdrawal by Subject|13|||
42280578|NCT02729909|76112615|FG001|Overall Study|Lost to Follow-up|1|||
42280579|NCT02729909|76112614|FG000|Overall Study|Lack of Efficacy|0|||
42280580|NCT02729909|76112615|FG001|Overall Study|Lack of Efficacy|2|||
42280581|NCT02729909|76112614|FG000|Overall Study|Significant Protocol Deviation|0|||
42280582|NCT02729909|76112615|FG001|Overall Study|Significant Protocol Deviation|2|||
42280583|NCT02729909|76112614|FG000|Overall Study|Voluntary Withdrawal|1|||
42280584|NCT02729909|76112615|FG001|Overall Study|Voluntary Withdrawal|0|||
42280585|NCT02713243|76112623|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
42280586|NCT02713243|76112624|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
42280587|NCT02713243|76112623|FG000|Overall Study|Administrative problems|0|||
42280588|NCT02713243|76112624|FG001|Overall Study|Administrative problems|1|||
42280589|NCT02713243|76112623|FG000|Overall Study|Protocol deviation|0|||
42280590|NCT02713243|76112624|FG001|Overall Study|Protocol deviation|1|||
42280591|NCT03434041|76112632|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
42280592|NCT03434041|76112633|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
42280593|NCT03434041|76112632|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
42280594|NCT03434041|76112633|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
42280595|NCT03434041|76112632|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
42162331|NCT03699124|75970025|FG000|Overall Study|Other reasons|5|||
42162332|NCT03699124|75970026|FG001|Overall Study|Other reasons|3|||
42162333|NCT03699124|75970027|FG002|Overall Study|Other reasons|10|||
42162334|NCT05002972|75970035|FG000|Overall Study|Withdrawal by Subject|2|||
42162335|NCT04651114|75970039|FG000|Overall Study|Withdrawal by Subject|8|||
42162336|NCT04980040|75970043|FG000|Overall Study|Violated the Inclusion Criteria|260|||
42162337|NCT04980040|75970043|FG000|Overall Study|Violated the Administration & Dosage|225|||
42162338|NCT04980040|75970043|FG000|Overall Study|Lost to Safety-Follow-up|4|||
42162339|NCT04980040|75970043|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
42162340|NCT00131352|75970049|FG000|Initial Treatment Period|Adverse Event|1|||
42162341|NCT00131352|75970050|FG001|Initial Treatment Period|Adverse Event|3|||
42162342|NCT00131352|75970049|FG000|Initial Treatment Period|Non-compliant|1|||
42162343|NCT00131352|75970050|FG001|Initial Treatment Period|Non-compliant|2|||
42162344|NCT00131352|75970049|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
42162345|NCT00131352|75970050|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
42162346|NCT00131352|75970049|FG000|Initial Treatment Period|Lack of Efficacy|6|||
42162347|NCT00131352|75970050|FG001|Initial Treatment Period|Lack of Efficacy|4|||
42162348|NCT00131352|75970049|FG000|Initial Treatment Period|Other|0|||
42280596|NCT03434041|76112633|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
42280597|NCT03434041|76112632|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
42280598|NCT03434041|76112633|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
42280599|NCT03434041|76112632|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
42280600|NCT03434041|76112633|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
42280601|NCT03434041|76112632|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
42013618|NCT01298765|75820703|FG000|Long-Term Treatment Period|Adverse Event|19|||
42013619|NCT01298765|75820703|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
42162349|NCT00131352|75970050|FG001|Initial Treatment Period|Other|2|||
42162350|NCT00131352|75970049|FG000|Repeat Treatment Period|Adverse Event|1|||
42280602|NCT03434041|76112633|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
42280603|NCT03434041|76112632|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
42280604|NCT03434041|76112633|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
42162351|NCT00131352|75970050|FG001|Repeat Treatment Period|Adverse Event|0|||
42162352|NCT00131352|75970049|FG000|Repeat Treatment Period|Other|1|||
42162353|NCT00131352|75970050|FG001|Repeat Treatment Period|Other|0|||
42162354|NCT04633642|75970060|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
42162355|NCT04633642|75970061|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
42162356|NCT00136916|75970069|FG000|Overall Study|Never received study treatment|3|||
42162357|NCT00136916|75970070|FG001|Overall Study|Never received study treatment|5|||
42162358|NCT00136916|75970069|FG000|Overall Study|Death|1|||
42280605|NCT03434041|76112632|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
42280606|NCT03434041|76112633|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
42280607|NCT03434041|76112632|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
42280608|NCT03434041|76112633|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
42280609|NCT03434041|76112632|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
42280610|NCT03434041|76112633|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
42162359|NCT00136916|75970070|FG001|Overall Study|Death|3|||
42162360|NCT00136916|75970069|FG000|Overall Study|Adverse Event|27|||
42162361|NCT00136916|75970070|FG001|Overall Study|Adverse Event|8|||
42162362|NCT00136916|75970069|FG000|Overall Study|Laboratory abnormality|0|||
42162363|NCT00136916|75970070|FG001|Overall Study|Laboratory abnormality|1|||
42162364|NCT00136916|75970069|FG000|Overall Study|Lack of Efficacy|13|||
42280611|NCT03434041|76112632|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
42280612|NCT03434041|76112633|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
42280613|NCT00708461|76112648|FG000|Overall Study|Lost to Follow-up|18|||
42280614|NCT00708461|76112649|FG001|Overall Study|Lost to Follow-up|11|||
42280615|NCT00708461|76112648|FG000|Overall Study|Withdrawal by Subject|8|||
42280616|NCT00708461|76112649|FG001|Overall Study|Withdrawal by Subject|9|||
42280617|NCT00708461|76112648|FG000|Overall Study|left workforce|115|||
42280618|NCT00708461|76112649|FG001|Overall Study|left workforce|180|||
42280619|NCT00700999|76112657|FG000|Overall Study|Lost to Follow-up|7|||
42280620|NCT00700999|76112658|FG001|Overall Study|Lost to Follow-up|7|||
42280621|NCT00700999|76112657|FG000|Overall Study|Excluded - did not meet study criteria|0|||
42280622|NCT00700999|76112658|FG001|Overall Study|Excluded - did not meet study criteria|1|||
42280623|NCT00700999|76112657|FG000|Overall Study|Withdrawal by Subject|8|||
42280624|NCT00700999|76112658|FG001|Overall Study|Withdrawal by Subject|1|||
42280625|NCT02729831|76112668|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
42280626|NCT02729831|76112669|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
42040541|NCT01796171|75848716|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
42040542|NCT01796171|75848717|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
42040543|NCT01796171|75848718|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
42040544|NCT01796171|75848719|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
42040545|NCT01796171|75848720|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
42040546|NCT01796171|75848706|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42040547|NCT01796171|75848707|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42040548|NCT01796171|75848708|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42040549|NCT01796171|75848709|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42162365|NCT00136916|75970070|FG001|Overall Study|Lack of Efficacy|3|||
42162366|NCT00136916|75970069|FG000|Overall Study|Lost to Follow-up|12|||
42162367|NCT00136916|75970070|FG001|Overall Study|Lost to Follow-up|14|||
42162368|NCT00136916|75970069|FG000|Overall Study|Withdrawal by Subject|44|||
42162369|NCT00136916|75970070|FG001|Overall Study|Withdrawal by Subject|46|||
42162370|NCT00136916|75970069|FG000|Overall Study|Other|22|||
42162371|NCT00136916|75970070|FG001|Overall Study|Other|24|||
42162372|NCT00136916|75970069|FG000|Overall Study|Discontinued in follow up period|3|||
42162373|NCT00136916|75970070|FG001|Overall Study|Discontinued in follow up period|0|||
42162374|NCT04633564|75970080|FG000|Period 1|Adverse Event|28|||
42162375|NCT04633564|75970081|FG001|Period 1|Adverse Event|19|||
42162376|NCT04633564|75970080|FG000|Period 1|Death|8|||
42162377|NCT04633564|75970081|FG001|Period 1|Death|7|||
42162378|NCT04633564|75970080|FG000|Period 1|Lost to Follow-up|3|||
42162379|NCT04633564|75970081|FG001|Period 1|Lost to Follow-up|5|||
42162380|NCT04633564|75970080|FG000|Period 1|Physician Decision|4|||
42162381|NCT04633564|75970081|FG001|Period 1|Physician Decision|12|||
42280627|NCT02729831|76112670|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
42280628|NCT02729831|76112671|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
42280629|NCT02729831|76112668|FG000|1 Week Post-visit|Lost to Follow-up|43|||
42162382|NCT04633564|75970080|FG000|Period 1|Protocol Violation|0|||
42280630|NCT02729831|76112669|FG001|1 Week Post-visit|Lost to Follow-up|40|||
42280631|NCT02729831|76112670|FG002|1 Week Post-visit|Lost to Follow-up|38|||
42040550|NCT01796171|75848710|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42162383|NCT04633564|75970081|FG001|Period 1|Protocol Violation|1|||
42162384|NCT04633564|75970080|FG000|Period 1|Withdrawal by Subject|10|||
42162385|NCT04633564|75970081|FG001|Period 1|Withdrawal by Subject|8|||
42351563|NCT00985504|76191481|FG000|Acute Treatment Period|Protocol Violation|2|||
42162386|NCT04633564|75970080|FG000|Period 1|Progressive disease|47|||
42162387|NCT04633564|75970081|FG001|Period 1|Progressive disease|51|||
42162388|NCT04633564|75970080|FG000|Period 1|Terminated by Sponsor|8|||
42162389|NCT04633564|75970081|FG001|Period 1|Terminated by Sponsor|6|||
42162390|NCT04633564|75970080|FG000|Period 2|Adverse Event|3|||
42162391|NCT04633564|75970081|FG001|Period 2|Adverse Event|4|||
42162392|NCT04633564|75970080|FG000|Period 2|Death|0|||
42162393|NCT04633564|75970081|FG001|Period 2|Death|2|||
42162394|NCT04633564|75970080|FG000|Period 2|Lost to Follow-up|0|||
42162395|NCT04633564|75970081|FG001|Period 2|Lost to Follow-up|1|||
42162396|NCT04633564|75970080|FG000|Period 2|Physician Decision|2|||
42162397|NCT04633564|75970081|FG001|Period 2|Physician Decision|4|||
42162398|NCT04633564|75970080|FG000|Period 2|Withdrawal by Subject|5|||
42162399|NCT04633564|75970081|FG001|Period 2|Withdrawal by Subject|1|||
42162400|NCT04633564|75970080|FG000|Period 2|Progressive Disease|74|||
42162401|NCT04633564|75970081|FG001|Period 2|Progressive Disease|82|||
42162402|NCT04633564|75970080|FG000|Period 2|Terminated by Sponsor|9|||
42162403|NCT04633564|75970081|FG001|Period 2|Terminated by Sponsor|3|||
42162404|NCT04960228|75970089|FG000|Overall Study|Withdrawal by Subject|216|||
42162405|NCT04960228|75970090|FG001|Overall Study|Withdrawal by Subject|35|||
42162406|NCT04960228|75970089|FG000|Overall Study|Failed attention check|69|||
42162407|NCT04960228|75970090|FG001|Overall Study|Failed attention check|148|||
42162408|NCT04960228|75970089|FG000|Overall Study|Flagged for response quality by Dynata|3|||
42162409|NCT04960228|75970090|FG001|Overall Study|Flagged for response quality by Dynata|3|||
42162410|NCT04619992|75970098|FG000|Overall Study|Withdrawal by Subject|1|||
42162411|NCT04619992|75970099|FG001|Overall Study|Withdrawal by Subject|0|||
42162412|NCT00136604|75970110|FG000|Overall Study|Lost to Follow-up|1|||
42162413|NCT00136604|75970111|FG001|Overall Study|Lost to Follow-up|0|||
42162414|NCT00136604|75970112|FG002|Overall Study|Lost to Follow-up|0|||
42162415|NCT00136604|75970113|FG003|Overall Study|Lost to Follow-up|0|||
42162416|NCT00136604|75970114|FG004|Overall Study|Lost to Follow-up|1|||
42162417|NCT00136604|75970110|FG000|Overall Study|Migrated/moved from study area|0|||
42162418|NCT00136604|75970111|FG001|Overall Study|Migrated/moved from study area|1|||
42162419|NCT00136604|75970112|FG002|Overall Study|Migrated/moved from study area|0|||
42280632|NCT02729831|76112671|FG003|1 Week Post-visit|Lost to Follow-up|36|||
42280633|NCT02729831|76112668|FG000|6 Month Follow-up|Lost to Follow-up|54|||
42280634|NCT02729831|76112669|FG001|6 Month Follow-up|Lost to Follow-up|51|||
42280635|NCT02729831|76112670|FG002|6 Month Follow-up|Lost to Follow-up|48|||
42280636|NCT02729831|76112671|FG003|6 Month Follow-up|Lost to Follow-up|42|||
42280637|NCT02729831|76112668|FG000|6 Month Follow-up|Death|1|||
42280638|NCT02729831|76112669|FG001|6 Month Follow-up|Death|3|||
42280639|NCT02729831|76112670|FG002|6 Month Follow-up|Death|0|||
42280640|NCT02729831|76112671|FG003|6 Month Follow-up|Death|1|||
42280641|NCT02729753|76112683|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
42280642|NCT02729753|76112684|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
42280643|NCT00709319|76112693|FG000|Overall Study|Death|4|||
42280644|NCT00709319|76112693|FG000|Overall Study|Withdrawal by Subject|2|||
42280645|NCT02729051|76112738|FG000|Overall Study|Adverse Event|21|||
42280646|NCT02729051|76112739|FG001|Overall Study|Adverse Event|11|||
42280647|NCT02729051|76112738|FG000|Overall Study|Lack of Efficacy|1|||
42280648|NCT02729051|76112739|FG001|Overall Study|Lack of Efficacy|1|||
42280649|NCT02729051|76112738|FG000|Overall Study|Lost to Follow-up|1|||
42280650|NCT02729051|76112739|FG001|Overall Study|Lost to Follow-up|2|||
42280651|NCT02729051|76112738|FG000|Overall Study|Physician Decision|1|||
42013620|NCT01298765|75820703|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
42162420|NCT00136604|75970113|FG003|Overall Study|Migrated/moved from study area|0|||
42162421|NCT00136604|75970114|FG004|Overall Study|Migrated/moved from study area|0|||
42162422|NCT00135512|75970130|FG000|Overall Study|Adverse Event|56|||
42162423|NCT00135512|75970130|FG000|Overall Study|Lack of Efficacy|25|||
42162424|NCT00135512|75970130|FG000|Overall Study|Other|42|||
42280652|NCT02729051|76112739|FG001|Overall Study|Physician Decision|1|||
42280653|NCT02729051|76112738|FG000|Overall Study|Withdrawal by Subject|6|||
42280654|NCT02729051|76112739|FG001|Overall Study|Withdrawal by Subject|17|||
42280655|NCT00707993|76112747|FG000|Overall Study|Adverse Event|16|||
42280656|NCT00707993|76112748|FG001|Overall Study|Adverse Event|20|||
42351564|NCT00985504|76191482|FG001|Acute Treatment Period|Protocol Violation|0|||
42013621|NCT01298765|75820703|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
42013622|NCT01298765|75820703|FG000|Long-Term Treatment Period|Physician Decision|1|||
42013623|NCT01298765|75820703|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
42013624|NCT00997438|75820710|FG000|Overall Study|Blood draw difficulty|2|||
42013625|NCT00997438|75820711|FG001|Overall Study|Blood draw difficulty|0|||
42013626|NCT00997438|75820712|FG002|Overall Study|Blood draw difficulty|1|||
42280657|NCT00707993|76112747|FG000|Overall Study|Protocol Violation|4|||
42280658|NCT00707993|76112748|FG001|Overall Study|Protocol Violation|7|||
42280659|NCT00707993|76112747|FG000|Overall Study|Lost to Follow-up|0|||
42280660|NCT00707993|76112748|FG001|Overall Study|Lost to Follow-up|4|||
42280661|NCT00707993|76112747|FG000|Overall Study|Withdrawal by Subject|12|||
42162425|NCT00130728|75970136|FG000|Overall Study|Death|258|||
42162426|NCT00130728|75970137|FG001|Overall Study|Death|258|||
42162427|NCT00130728|75970136|FG000|Overall Study|Lost to Follow-up|4|||
42162428|NCT00130728|75970137|FG001|Overall Study|Lost to Follow-up|0|||
42162429|NCT00130728|75970136|FG000|Overall Study|Withdrawal by Subject|0|||
42162430|NCT00130728|75970137|FG001|Overall Study|Withdrawal by Subject|2|||
42162431|NCT00129974|75970143|FG000|Overall Study|Other|1|||
42162432|NCT04947436|75970150|FG000|Overall Study|Lost to Follow-up|3|||
42162433|NCT04947436|75970151|FG001|Overall Study|Lost to Follow-up|7|||
42162434|NCT04947436|75970152|FG002|Overall Study|Lost to Follow-up|5|||
42162435|NCT04947436|75970150|FG000|Overall Study|Death|1|||
42162436|NCT04947436|75970151|FG001|Overall Study|Death|1|||
42162437|NCT04947436|75970152|FG002|Overall Study|Death|1|||
42162438|NCT00119106|75970162|FG000|Overall Study|HIV infected at baseline|179|||
42162439|NCT00119106|75970163|FG001|Overall Study|HIV infected at baseline|178|||
42162440|NCT00135356|75970179|FG000|Overall Study|Adverse Event|6|||
42162441|NCT00135356|75970180|FG001|Overall Study|Adverse Event|2|||
42162442|NCT00135356|75970179|FG000|Overall Study|Lack of Efficacy|2|||
42162443|NCT00135356|75970180|FG001|Overall Study|Lack of Efficacy|0|||
42280662|NCT00707993|76112748|FG001|Overall Study|Withdrawal by Subject|16|||
42280663|NCT00707993|76112747|FG000|Overall Study|Hyperglycemic Rescue|55|||
42280664|NCT00707993|76112748|FG001|Overall Study|Hyperglycemic Rescue|47|||
42280665|NCT00707993|76112747|FG000|Overall Study|Other|2|||
42280666|NCT00707993|76112748|FG001|Overall Study|Other|0|||
42280667|NCT00708227|76112758|FG000|Overall Study|Physician Decision|0|||
42280668|NCT00708227|76112759|FG001|Overall Study|Physician Decision|3|||
42280669|NCT00708227|76112760|FG002|Overall Study|Physician Decision|1|||
42280670|NCT00708227|76112761|FG003|Overall Study|Physician Decision|2|||
42280671|NCT00708227|76112758|FG000|Overall Study|Withdrawal by Subject|1|||
42280672|NCT00708227|76112759|FG001|Overall Study|Withdrawal by Subject|2|||
42280673|NCT00708227|76112760|FG002|Overall Study|Withdrawal by Subject|0|||
42280674|NCT00708227|76112761|FG003|Overall Study|Withdrawal by Subject|1|||
42280675|NCT02425891|76112793|FG000|Overall Study|Death|333|||
42280676|NCT02425891|76112794|FG001|Overall Study|Death|314|||
42280677|NCT02425891|76112793|FG000|Overall Study|Lost to Follow-up|4|||
42280678|NCT02425891|76112794|FG001|Overall Study|Lost to Follow-up|6|||
42280679|NCT02425891|76112793|FG000|Overall Study|Non-Compliance|1|||
42280680|NCT02425891|76112794|FG001|Overall Study|Non-Compliance|1|||
42280681|NCT02425891|76112793|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
42280682|NCT02425891|76112794|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
42040551|NCT01796171|75848711|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42040552|NCT01796171|75848712|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42040553|NCT01796171|75848713|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42162444|NCT00135356|75970179|FG000|Overall Study|Lost to Follow-up|3|||
42162445|NCT00135356|75970180|FG001|Overall Study|Lost to Follow-up|1|||
42162446|NCT00135356|75970179|FG000|Overall Study|Surgery for abdominal fat|1|||
42162447|NCT00135356|75970180|FG001|Overall Study|Surgery for abdominal fat|0|||
42162448|NCT00135356|75970179|FG000|Overall Study|Change in antiviral regimen|0|||
42040554|NCT01796171|75848714|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42040555|NCT01796171|75848715|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42040556|NCT01796171|75848716|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42040557|NCT01796171|75848717|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42040558|NCT01796171|75848718|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42040559|NCT01796171|75848719|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
42040560|NCT01796171|75848720|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
42040561|NCT01796171|75848706|FG000|Treatment Period With Betalutin|Progressive disease|0|||
42040562|NCT01796171|75848707|FG001|Treatment Period With Betalutin|Progressive disease|1|||
42280683|NCT02425891|76112793|FG000|Overall Study|Physician Decision|0|||
42280684|NCT02425891|76112794|FG001|Overall Study|Physician Decision|1|||
42280685|NCT02425891|76112793|FG000|Overall Study|Protocol Violation|1|||
42280686|NCT02425891|76112794|FG001|Overall Study|Protocol Violation|1|||
42280687|NCT02425891|76112793|FG000|Overall Study|Study Terminated By Sponsor|85|||
42280688|NCT02425891|76112794|FG001|Overall Study|Study Terminated By Sponsor|95|||
42040563|NCT01796171|75848708|FG002|Treatment Period With Betalutin|Progressive disease|0|||
42040564|NCT01796171|75848709|FG003|Treatment Period With Betalutin|Progressive disease|0|||
42162449|NCT00135356|75970180|FG001|Overall Study|Change in antiviral regimen|1|||
42162450|NCT00135356|75970179|FG000|Overall Study|Poor/noncompliance|1|||
42162451|NCT00135356|75970180|FG001|Overall Study|Poor/noncompliance|1|||
42162452|NCT00135356|75970179|FG000|Overall Study|No longer meets study criteria|2|||
42280689|NCT02425891|76112793|FG000|Overall Study|Withdrawal by Subject|27|||
42280690|NCT02425891|76112794|FG001|Overall Study|Withdrawal by Subject|32|||
42280691|NCT03241225|76112804|FG000|Overall Study|Lost to Follow-up|2|||
42280692|NCT03241225|76112805|FG001|Overall Study|Lost to Follow-up|1|||
42280693|NCT03241225|76112804|FG000|Overall Study|Protocol Violation|4|||
42280694|NCT03241225|76112805|FG001|Overall Study|Protocol Violation|1|||
42280695|NCT03241225|76112804|FG000|Overall Study|Withdrawal by Subject|1|||
42280696|NCT03241225|76112805|FG001|Overall Study|Withdrawal by Subject|0|||
42013627|NCT00997438|75820710|FG000|Overall Study|Withdrawal by Subject|1|||
42013628|NCT00997438|75820711|FG001|Overall Study|Withdrawal by Subject|1|||
42013629|NCT00997438|75820712|FG002|Overall Study|Withdrawal by Subject|0|||
42013630|NCT00997438|75820710|FG000|Overall Study|Exclusion criteria at visit 1|2|||
42013631|NCT00997438|75820711|FG001|Overall Study|Exclusion criteria at visit 1|2|||
42013632|NCT00997438|75820712|FG002|Overall Study|Exclusion criteria at visit 1|3|||
42013633|NCT00997126|75820723|FG000|Overall Study|Physician Decision|7|||
42013634|NCT00997126|75820724|FG001|Overall Study|Physician Decision|11|||
42040565|NCT01796171|75848710|FG004|Treatment Period With Betalutin|Progressive disease|0|||
42162453|NCT00135356|75970180|FG001|Overall Study|No longer meets study criteria|0|||
42162454|NCT00135356|75970179|FG000|Overall Study|Withdrawal by Subject|2|||
42162455|NCT00135356|75970180|FG001|Overall Study|Withdrawal by Subject|4|||
42162456|NCT00118716|75970188|FG000|Overall Study|Adverse Event|2|||
42162457|NCT00118716|75970189|FG001|Overall Study|Adverse Event|7|||
42162458|NCT00118716|75970188|FG000|Overall Study|Protocol Violation|5|||
42162459|NCT00118716|75970189|FG001|Overall Study|Protocol Violation|4|||
42162460|NCT00118716|75970188|FG000|Overall Study|Withdrawal by Subject|0|||
42162461|NCT00118716|75970189|FG001|Overall Study|Withdrawal by Subject|1|||
42162462|NCT00118716|75970188|FG000|Overall Study|Exacerbation|2|||
42162463|NCT00118716|75970189|FG001|Overall Study|Exacerbation|2|||
42162464|NCT00118716|75970188|FG000|Overall Study|Discontinued by sponsor|1|||
42162465|NCT00118716|75970189|FG001|Overall Study|Discontinued by sponsor|1|||
42162466|NCT00118716|75970188|FG000|Overall Study|Non-compliance|1|||
42162467|NCT00118716|75970189|FG001|Overall Study|Non-compliance|3|||
42162468|NCT00118716|75970188|FG000|Overall Study|misrandomized|1|||
42162469|NCT00118716|75970189|FG001|Overall Study|misrandomized|1|||
42162470|NCT00118716|75970188|FG000|Overall Study|Expired drug use|1|||
42162471|NCT00118716|75970189|FG001|Overall Study|Expired drug use|2|||
42162472|NCT00118716|75970188|FG000|Overall Study|Investigator discretion|0|||
42162473|NCT00118716|75970189|FG001|Overall Study|Investigator discretion|1|||
42162474|NCT04584346|75970197|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
42162475|NCT04584346|75970198|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
42162476|NCT00118482|75970208|FG000|Overall Study|Lost to Follow-up|7|||
42162477|NCT00118482|75970209|FG001|Overall Study|Lost to Follow-up|7|||
42162478|NCT00118482|75970208|FG000|Overall Study|Withdrawal by Subject|23|||
42162479|NCT00118482|75970209|FG001|Overall Study|Withdrawal by Subject|22|||
42162480|NCT00129272|75970217|FG000|Overall Study|Lost to Follow-up|12|||
42162481|NCT00129272|75970218|FG001|Overall Study|Lost to Follow-up|11|||
42162482|NCT00129272|75970217|FG000|Overall Study|Withdrawal by Subject|5|||
42040566|NCT01796171|75848711|FG005|Treatment Period With Betalutin|Progressive disease|0|||
42040567|NCT01796171|75848712|FG006|Treatment Period With Betalutin|Progressive disease|0|||
42040568|NCT01796171|75848713|FG007|Treatment Period With Betalutin|Progressive disease|0|||
42162483|NCT00129272|75970218|FG001|Overall Study|Withdrawal by Subject|11|||
42162484|NCT04899232|75970227|FG000|Screening Period|Physician Decision|1|||
42162485|NCT04899232|75970228|FG001|Screening Period|Physician Decision|0|||
42162486|NCT04899232|75970229|FG002|Screening Period|Physician Decision|0|||
42162487|NCT04899232|75970227|FG000|Screening Period|Withdrawal by Subject|1|||
42162488|NCT04899232|75970228|FG001|Screening Period|Withdrawal by Subject|0|||
42040569|NCT01796171|75848714|FG008|Treatment Period With Betalutin|Progressive disease|0|||
42040570|NCT01796171|75848715|FG009|Treatment Period With Betalutin|Progressive disease|0|||
42040571|NCT01796171|75848716|FG010|Treatment Period With Betalutin|Progressive disease|0|||
42040572|NCT01796171|75848717|FG011|Treatment Period With Betalutin|Progressive disease|0|||
42040573|NCT01796171|75848718|FG012|Treatment Period With Betalutin|Progressive disease|0|||
42040574|NCT01796171|75848719|FG013|Treatment Period With Betalutin|Progressive disease|0|||
42040575|NCT01796171|75848720|FG014|Treatment Period With Betalutin|Progressive disease|0|||
42040576|NCT01796171|75848706|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42162489|NCT04899232|75970229|FG002|Screening Period|Withdrawal by Subject|0|||
42162490|NCT04899232|75970227|FG000|Screening Period|Participant discharged before receiving intervention|3|||
42162491|NCT04899232|75970228|FG001|Screening Period|Participant discharged before receiving intervention|0|||
42162492|NCT04899232|75970229|FG002|Screening Period|Participant discharged before receiving intervention|0|||
42162493|NCT04559698|75970248|FG000|Overall Study|Lost to Follow-up|14|||
42162494|NCT04559698|75970249|FG001|Overall Study|Lost to Follow-up|15|||
42162495|NCT04559698|75970248|FG000|Overall Study|Withdrawal by Subject|0|||
42162496|NCT04559698|75970249|FG001|Overall Study|Withdrawal by Subject|1|||
42162497|NCT00133952|75970257|FG000|Overall Study|Adverse Event|1|||
42162498|NCT00133952|75970258|FG001|Overall Study|Adverse Event|2|||
42162499|NCT00133952|75970257|FG000|Overall Study|Death|3|||
42162500|NCT00133952|75970258|FG001|Overall Study|Death|2|||
42162501|NCT00133952|75970257|FG000|Overall Study|Lost to Follow-up|9|||
42162502|NCT00133952|75970258|FG001|Overall Study|Lost to Follow-up|14|||
42162503|NCT00133952|75970257|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
42162504|NCT00133952|75970258|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
42162505|NCT00133952|75970257|FG000|Overall Study|Protocol Violation|1|||
42162506|NCT00133952|75970258|FG001|Overall Study|Protocol Violation|1|||
42162507|NCT00133952|75970257|FG000|Overall Study|Withdrawal by Subject|20|||
42162508|NCT00133952|75970258|FG001|Overall Study|Withdrawal by Subject|4|||
42162509|NCT00133952|75970257|FG000|Overall Study|Physician Decision|4|||
42162510|NCT00133952|75970258|FG001|Overall Study|Physician Decision|3|||
42162511|NCT00133952|75970257|FG000|Overall Study|Sponsor Decision|0|||
42162512|NCT00133952|75970258|FG001|Overall Study|Sponsor Decision|1|||
42162513|NCT00118092|75970264|FG000|Overall Study|Withdrawal by Subject|1|||
42162514|NCT00118092|75970264|FG000|Overall Study|Protocol Violation|1|||
42162515|NCT04555096|75970271|FG000|Overall Study|Death|4|||
42162516|NCT04555096|75970272|FG001|Overall Study|Death|4|||
42162517|NCT04555096|75970271|FG000|Overall Study|Withdrawal by Subject|1|||
42162518|NCT04555096|75970272|FG001|Overall Study|Withdrawal by Subject|0|||
42162519|NCT04555096|75970271|FG000|Overall Study|Other|0|||
42162520|NCT04555096|75970272|FG001|Overall Study|Other|1|||
42162521|NCT00097500|75970280|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
42162522|NCT00097500|75970281|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
42162523|NCT00097500|75970280|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
42162524|NCT00097500|75970281|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
42162525|NCT00097500|75970280|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
42162526|NCT00097500|75970281|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
42162527|NCT00097500|75970280|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
42162528|NCT00097500|75970281|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
42162529|NCT00097500|75970280|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
42162530|NCT00097500|75970281|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
42162531|NCT00097500|75970280|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
42162532|NCT00097500|75970281|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
42162533|NCT00097500|75970280|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
42162534|NCT00097500|75970281|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
42162535|NCT04551898|75970291|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
42162536|NCT04551898|75970292|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
42162537|NCT04551898|75970293|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
42162538|NCT04551898|75970294|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
42162539|NCT04551898|75970291|FG000|Overall Study|Withdrawal by Subject|5|||
42162540|NCT04551898|75970292|FG001|Overall Study|Withdrawal by Subject|1|||
42280697|NCT01597245|76112815|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
42280698|NCT01597245|76112816|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
42280699|NCT01597245|76112817|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
42280700|NCT01597245|76112818|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
42280701|NCT01597245|76112819|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42162541|NCT04551898|75970293|FG002|Overall Study|Withdrawal by Subject|2|||
42162542|NCT04551898|75970294|FG003|Overall Study|Withdrawal by Subject|2|||
42162543|NCT04551898|75970291|FG000|Overall Study|Lost to Follow-up|2|||
42162544|NCT04551898|75970292|FG001|Overall Study|Lost to Follow-up|1|||
42162545|NCT04551898|75970293|FG002|Overall Study|Lost to Follow-up|2|||
42162546|NCT04551898|75970294|FG003|Overall Study|Lost to Follow-up|2|||
42162547|NCT04551898|75970291|FG000|Overall Study|Death|1|||
42162548|NCT04551898|75970292|FG001|Overall Study|Death|0|||
42162549|NCT04551898|75970293|FG002|Overall Study|Death|0|||
42162550|NCT04551898|75970294|FG003|Overall Study|Death|0|||
42162551|NCT04551898|75970291|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
42162552|NCT04551898|75970292|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
42162553|NCT04551898|75970293|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
42162554|NCT04551898|75970294|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
42162555|NCT04849780|75970312|FG000|Period 1|Covid-19 Related|1|||
42162556|NCT04849780|75970313|FG001|Period 1|Covid-19 Related|0|||
42280702|NCT01597245|76112820|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280703|NCT01597245|76112821|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280704|NCT01597245|76112822|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42162557|NCT04849780|75970312|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
42162558|NCT04849780|75970313|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
42280705|NCT01597245|76112823|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42162559|NCT04849780|75970312|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
42162560|NCT04849780|75970313|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
42162561|NCT04823494|75970327|FG000|Overall Study|Programming software malfunction.|1|||
42162562|NCT04823494|75970328|FG001|Overall Study|Programming software malfunction.|0|||
42162563|NCT04823494|75970327|FG000|Overall Study|Withdrawal by Subject|1|||
42162564|NCT04823494|75970328|FG001|Overall Study|Withdrawal by Subject|0|||
42162565|NCT04823494|75970327|FG000|Overall Study|Devices lost|0|||
42162566|NCT04823494|75970328|FG001|Overall Study|Devices lost|1|||
42162567|NCT04542694|75970338|FG000|Overall Study|The need for prohibited therapy|2|||
42162568|NCT04542694|75970339|FG001|Overall Study|The need for prohibited therapy|0|||
42162569|NCT04542694|75970338|FG000|Overall Study|Adverse Event|1|||
42162570|NCT04542694|75970339|FG001|Overall Study|Adverse Event|0|||
42162571|NCT04542694|75970338|FG000|Overall Study|Protocol Violation|1|||
42162572|NCT04542694|75970339|FG001|Overall Study|Protocol Violation|0|||
42162573|NCT00117312|75970349|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
42162574|NCT00117312|75970350|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
42162575|NCT00117312|75970351|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
42162576|NCT00117312|75970352|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
42162577|NCT00117312|75970349|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
42162578|NCT00117312|75970350|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
42162579|NCT00117312|75970351|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
42162580|NCT00117312|75970352|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
42162581|NCT00117312|75970349|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
42162582|NCT00117312|75970350|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
42162583|NCT00117312|75970351|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
42162584|NCT00117312|75970352|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
42162585|NCT00117312|75970349|FG000|Overall Study|Other|0|||
42162586|NCT00117312|75970350|FG001|Overall Study|Other|1|||
42162587|NCT00117312|75970351|FG002|Overall Study|Other|3|||
42162588|NCT00117312|75970352|FG003|Overall Study|Other|1|||
42162589|NCT00117312|75970349|FG000|Overall Study|Patient choice|0|||
42162590|NCT00117312|75970350|FG001|Overall Study|Patient choice|0|||
42162591|NCT00117312|75970351|FG002|Overall Study|Patient choice|2|||
42162592|NCT00117312|75970352|FG003|Overall Study|Patient choice|1|||
42162593|NCT00117312|75970349|FG000|Overall Study|Adverse Event|0|||
42162594|NCT00117312|75970350|FG001|Overall Study|Adverse Event|2|||
42162595|NCT00117312|75970351|FG002|Overall Study|Adverse Event|0|||
42162596|NCT00117312|75970352|FG003|Overall Study|Adverse Event|0|||
42162597|NCT00117312|75970349|FG000|Overall Study|Protocol Violation|0|||
42162598|NCT00117312|75970350|FG001|Overall Study|Protocol Violation|1|||
42162599|NCT00117312|75970351|FG002|Overall Study|Protocol Violation|3|||
42162600|NCT00117312|75970352|FG003|Overall Study|Protocol Violation|0|||
42162601|NCT00117312|75970349|FG000|Overall Study|PSA decrease <=50%|0|||
42162602|NCT00117312|75970350|FG001|Overall Study|PSA decrease <=50%|2|||
42280706|NCT01597245|76112824|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280707|NCT01597245|76112825|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280708|NCT01597245|76112826|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280709|NCT01597245|76112827|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42162603|NCT00117312|75970351|FG002|Overall Study|PSA decrease <=50%|2|||
42162604|NCT00117312|75970352|FG003|Overall Study|PSA decrease <=50%|4|||
42162605|NCT00117312|75970349|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
42162606|NCT00117312|75970350|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
42162607|NCT00117312|75970351|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
42162608|NCT00117312|75970352|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
42162609|NCT00117312|75970349|FG000|Overall Study|Hepatic abnormality|0|||
42162610|NCT00117312|75970350|FG001|Overall Study|Hepatic abnormality|1|||
42162611|NCT00117312|75970351|FG002|Overall Study|Hepatic abnormality|0|||
42162612|NCT00117312|75970352|FG003|Overall Study|Hepatic abnormality|1|||
42162613|NCT00117312|75970349|FG000|Overall Study|Withdrawal by Subject|0|||
42162614|NCT00117312|75970350|FG001|Overall Study|Withdrawal by Subject|2|||
42162615|NCT00117312|75970351|FG002|Overall Study|Withdrawal by Subject|0|||
42162616|NCT00117312|75970352|FG003|Overall Study|Withdrawal by Subject|0|||
42162617|NCT00129116|75970367|FG000|Primary Phase|Lost to Follow-up|1|||
42280710|NCT01597245|76112828|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280711|NCT01597245|76112829|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280712|NCT01597245|76112830|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280713|NCT01597245|76112831|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280714|NCT01597245|76112832|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42162618|NCT00129116|75970368|FG001|Primary Phase|Lost to Follow-up|1|||
42162619|NCT00129116|75970369|FG002|Primary Phase|Lost to Follow-up|0|||
42162620|NCT00129116|75970370|FG003|Primary Phase|Lost to Follow-up|1|||
42162621|NCT00129116|75970371|FG004|Primary Phase|Lost to Follow-up|1|||
42162622|NCT00129116|75970367|FG000|Primary Phase|Protocol Violation|0|||
42162623|NCT00129116|75970368|FG001|Primary Phase|Protocol Violation|1|||
42162624|NCT00129116|75970369|FG002|Primary Phase|Protocol Violation|0|||
42162625|NCT00129116|75970370|FG003|Primary Phase|Protocol Violation|0|||
42162626|NCT00129116|75970371|FG004|Primary Phase|Protocol Violation|0|||
42162627|NCT00129116|75970367|FG000|Primary Phase|Adverse Event|1|||
42162628|NCT00129116|75970368|FG001|Primary Phase|Adverse Event|1|||
42280715|NCT01597245|76112833|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280716|NCT01597245|76112834|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280717|NCT01597245|76112835|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
42280718|NCT01597245|76112815|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
42280719|NCT01597245|76112816|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
42280720|NCT01597245|76112817|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
42280721|NCT01597245|76112818|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
42280722|NCT01597245|76112819|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280723|NCT01597245|76112820|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280724|NCT01597245|76112821|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280725|NCT01597245|76112822|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280726|NCT01597245|76112823|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42351565|NCT00985504|76191481|FG000|Acute Treatment Period|Sponsor Decision|0|||
42351566|NCT00985504|76191482|FG001|Acute Treatment Period|Sponsor Decision|1|||
42351567|NCT00985504|76191481|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
42351568|NCT00985504|76191482|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
42351569|NCT00985504|76191481|FG000|Optimization Period|Adverse Event|7|||
42351570|NCT00985504|76191482|FG001|Optimization Period|Adverse Event|9|||
42162629|NCT00129116|75970369|FG002|Primary Phase|Adverse Event|0|||
42162630|NCT00129116|75970370|FG003|Primary Phase|Adverse Event|0|||
42162631|NCT00129116|75970371|FG004|Primary Phase|Adverse Event|0|||
42162632|NCT00129116|75970367|FG000|Primary Phase|Withdrawal by Subject|0|||
42162633|NCT00129116|75970368|FG001|Primary Phase|Withdrawal by Subject|1|||
42162634|NCT00129116|75970369|FG002|Primary Phase|Withdrawal by Subject|0|||
42162635|NCT00129116|75970370|FG003|Primary Phase|Withdrawal by Subject|0|||
42280727|NCT01597245|76112824|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280728|NCT01597245|76112825|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280729|NCT01597245|76112826|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280730|NCT01597245|76112827|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280731|NCT01597245|76112828|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280732|NCT01597245|76112829|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280733|NCT01597245|76112830|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280734|NCT01597245|76112831|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280735|NCT01597245|76112832|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280736|NCT01597245|76112833|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280737|NCT01597245|76112834|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280738|NCT01597245|76112835|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
42280739|NCT01597245|76112815|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
42280740|NCT01597245|76112816|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
42280741|NCT01597245|76112817|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
42280742|NCT01597245|76112818|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
42280743|NCT01597245|76112819|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280744|NCT01597245|76112820|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280745|NCT01597245|76112821|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280746|NCT01597245|76112822|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42162636|NCT00129116|75970371|FG004|Primary Phase|Withdrawal by Subject|0|||
42162637|NCT00129116|75970367|FG000|Primary Phase|Other|0|||
42162638|NCT00129116|75970368|FG001|Primary Phase|Other|0|||
42162639|NCT00129116|75970369|FG002|Primary Phase|Other|1|||
42162640|NCT00129116|75970370|FG003|Primary Phase|Other|0|||
42162641|NCT00129116|75970371|FG004|Primary Phase|Other|0|||
42162642|NCT00129116|75970367|FG000|Booster Phase|Lost to Follow-up|2|||
42162643|NCT00129116|75970368|FG001|Booster Phase|Lost to Follow-up|0|||
42162644|NCT00129116|75970369|FG002|Booster Phase|Lost to Follow-up|0|||
42162645|NCT00129116|75970370|FG003|Booster Phase|Lost to Follow-up|0|||
42280747|NCT01597245|76112823|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280748|NCT01597245|76112824|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280749|NCT01597245|76112825|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280750|NCT01597245|76112826|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280751|NCT01597245|76112827|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42351571|NCT00985504|76191481|FG000|Optimization Period|Death|0|||
42351572|NCT00985504|76191482|FG001|Optimization Period|Death|1|||
42162646|NCT00129116|75970371|FG004|Booster Phase|Lost to Follow-up|1|||
42162647|NCT00117156|75970383|FG000|Overall Study|Adverse Event|9|||
42351573|NCT00985504|76191481|FG000|Optimization Period|Lack of Efficacy|5|||
42162648|NCT00117156|75970383|FG000|Overall Study|Physician Decision|1|||
42162649|NCT00117156|75970383|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
42162650|NCT00096954|75970389|FG000|Overall Study|Adverse Event|3|||
42162651|NCT00096954|75970390|FG001|Overall Study|Adverse Event|1|||
42162652|NCT00096954|75970389|FG000|Overall Study|Withdrawal by Subject|9|||
42162653|NCT00096954|75970390|FG001|Overall Study|Withdrawal by Subject|8|||
42162654|NCT00096954|75970389|FG000|Overall Study|Physician Decision|1|||
42162655|NCT00096954|75970390|FG001|Overall Study|Physician Decision|1|||
42162656|NCT00096954|75970389|FG000|Overall Study|Sponsors Decision|1|||
42162657|NCT00096954|75970390|FG001|Overall Study|Sponsors Decision|1|||
42162658|NCT00096954|75970389|FG000|Overall Study|Pregnancy|1|||
42162659|NCT00096954|75970390|FG001|Overall Study|Pregnancy|1|||
42162660|NCT00096954|75970389|FG000|Overall Study|Initiation of immunotherapy|1|||
42162661|NCT00096954|75970390|FG001|Overall Study|Initiation of immunotherapy|0|||
42162662|NCT00096954|75970389|FG000|Overall Study|Non-compliance|0|||
42162663|NCT00096954|75970390|FG001|Overall Study|Non-compliance|3|||
42162664|NCT00096954|75970389|FG000|Overall Study|Lost to Follow-up|8|||
42162665|NCT00096954|75970390|FG001|Overall Study|Lost to Follow-up|5|||
42162666|NCT00096486|75970400|FG000|Overall Study|Withdrawal by Subject|0|||
42162667|NCT00096486|75970401|FG001|Overall Study|Withdrawal by Subject|0|||
42162668|NCT00096486|75970402|FG002|Overall Study|Withdrawal by Subject|1|||
42162669|NCT00096486|75970403|FG003|Overall Study|Withdrawal by Subject|1|||
42162670|NCT00096486|75970400|FG000|Overall Study|Not Treated|0|||
42162671|NCT00096486|75970401|FG001|Overall Study|Not Treated|0|||
42162672|NCT00096486|75970402|FG002|Overall Study|Not Treated|1|||
42162673|NCT00096486|75970403|FG003|Overall Study|Not Treated|1|||
42162674|NCT00116844|75970415|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
42162675|NCT00116844|75970416|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
42162676|NCT00116844|75970415|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
42162677|NCT00116844|75970416|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
42162678|NCT00116844|75970415|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
42162679|NCT00116844|75970416|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
42162680|NCT00116844|75970415|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
42162681|NCT00116844|75970416|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
42162682|NCT00116844|75970415|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
42162683|NCT00116844|75970416|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
42162684|NCT00116844|75970415|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
42162685|NCT00116844|75970416|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
42162686|NCT00116844|75970415|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
42162687|NCT00116844|75970416|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
42162688|NCT00116844|75970415|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
42162689|NCT00116844|75970416|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
42162690|NCT00116844|75970415|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
42162691|NCT00116844|75970416|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
42162692|NCT00128492|75970424|FG000|Overall Study|AE unrelated to study|2|||
42162693|NCT00128492|75970425|FG001|Overall Study|AE unrelated to study|9|||
42162694|NCT00128492|75970424|FG000|Overall Study|Study drug intolerance (AE)|2|||
42162695|NCT00128492|75970425|FG001|Overall Study|Study drug intolerance (AE)|8|||
42162696|NCT00128492|75970424|FG000|Overall Study|AE related to study|1|||
42162697|NCT00128492|75970425|FG001|Overall Study|AE related to study|4|||
42162698|NCT00128492|75970424|FG000|Overall Study|Death|1|||
42162699|NCT00128492|75970425|FG001|Overall Study|Death|0|||
42162700|NCT00128492|75970424|FG000|Overall Study|Lost to Follow-up|1|||
42162701|NCT00128492|75970425|FG001|Overall Study|Lost to Follow-up|5|||
42162702|NCT00128492|75970424|FG000|Overall Study|Noncompliance|0|||
42162703|NCT00128492|75970425|FG001|Overall Study|Noncompliance|5|||
42162704|NCT00128492|75970424|FG000|Overall Study|Personal or administrative|10|||
42351574|NCT00985504|76191482|FG001|Optimization Period|Lack of Efficacy|3|||
42351575|NCT00985504|76191481|FG000|Optimization Period|Lost to Follow-up|0|||
42351576|NCT00985504|76191482|FG001|Optimization Period|Lost to Follow-up|1|||
42351577|NCT00985504|76191481|FG000|Optimization Period|Physician Decision|1|||
42351578|NCT00985504|76191482|FG001|Optimization Period|Physician Decision|0|||
42351579|NCT00985504|76191481|FG000|Optimization Period|Protocol Violation|3|||
42351580|NCT00985504|76191482|FG001|Optimization Period|Protocol Violation|1|||
42351581|NCT00985504|76191481|FG000|Optimization Period|Withdrawal by Subject|10|||
42351582|NCT00985504|76191482|FG001|Optimization Period|Withdrawal by Subject|8|||
42351583|NCT00985426|76191490|FG000|Overall Study|Adverse Event|0|||
42162705|NCT00128492|75970425|FG001|Overall Study|Personal or administrative|22|||
42162706|NCT00128492|75970424|FG000|Overall Study|Withdrawal by Subject|3|||
42162707|NCT00128492|75970425|FG001|Overall Study|Withdrawal by Subject|5|||
42351584|NCT00985426|76191491|FG001|Overall Study|Adverse Event|1|||
42162708|NCT00128492|75970424|FG000|Overall Study|Pregnancy|0|||
42162709|NCT00128492|75970425|FG001|Overall Study|Pregnancy|1|||
42162710|NCT00132314|75970433|FG000|Overall Study|Lost to Follow-up|70|||
42351585|NCT00985426|76191490|FG000|Overall Study|Subject Non-Compliance|3|||
42162711|NCT00132314|75970434|FG001|Overall Study|Lost to Follow-up|62|||
42162712|NCT00132314|75970433|FG000|Overall Study|Lacked SSN|1|||
42351586|NCT00985426|76191491|FG001|Overall Study|Subject Non-Compliance|3|||
42351587|NCT00985426|76191490|FG000|Overall Study|Withdrawal by Subject|12|||
42162713|NCT00132314|75970434|FG001|Overall Study|Lacked SSN|3|||
42162714|NCT00132314|75970433|FG000|Overall Study|Refused intervention at baseline|2|||
42162715|NCT00132314|75970434|FG001|Overall Study|Refused intervention at baseline|7|||
42162716|NCT04539262|75970448|FG000|Overall Study|Adverse Event|0|||
42162717|NCT04539262|75970449|FG001|Overall Study|Adverse Event|0|||
42162718|NCT04539262|75970450|FG002|Overall Study|Adverse Event|1|||
42162719|NCT04539262|75970451|FG003|Overall Study|Adverse Event|0|||
42162720|NCT04539262|75970452|FG004|Overall Study|Adverse Event|0|||
42162721|NCT04539262|75970453|FG005|Overall Study|Adverse Event|0|||
42162722|NCT04539262|75970454|FG006|Overall Study|Adverse Event|0|||
42162723|NCT04539262|75970455|FG007|Overall Study|Adverse Event|0|||
42162724|NCT04539262|75970448|FG000|Overall Study|Withdrew Consent|0|||
42162725|NCT04539262|75970449|FG001|Overall Study|Withdrew Consent|0|||
42162726|NCT04539262|75970450|FG002|Overall Study|Withdrew Consent|0|||
42162727|NCT04539262|75970451|FG003|Overall Study|Withdrew Consent|1|||
42162728|NCT04539262|75970452|FG004|Overall Study|Withdrew Consent|0|||
42162729|NCT04539262|75970453|FG005|Overall Study|Withdrew Consent|0|||
42162730|NCT04539262|75970454|FG006|Overall Study|Withdrew Consent|0|||
42162731|NCT04539262|75970455|FG007|Overall Study|Withdrew Consent|0|||
42162732|NCT04539262|75970448|FG000|Overall Study|Randomized, Not treated|0|||
42162733|NCT04539262|75970449|FG001|Overall Study|Randomized, Not treated|1|||
42162734|NCT04539262|75970450|FG002|Overall Study|Randomized, Not treated|0|||
42162735|NCT04539262|75970451|FG003|Overall Study|Randomized, Not treated|0|||
42162736|NCT04539262|75970452|FG004|Overall Study|Randomized, Not treated|0|||
42162737|NCT04539262|75970453|FG005|Overall Study|Randomized, Not treated|0|||
42162738|NCT04539262|75970454|FG006|Overall Study|Randomized, Not treated|1|||
42162739|NCT04539262|75970455|FG007|Overall Study|Randomized, Not treated|0|||
42162740|NCT03702010|75970478|FG000|Follow-up (30days)|Lack of Efficacy|2|||
42162741|NCT03702010|75970479|FG001|Follow-up (30days)|Lack of Efficacy|2|||
42162742|NCT04538170|75970493|FG000|Overall Study|Withdrawal by Subject|104|||
42162743|NCT04538170|75970494|FG001|Overall Study|Withdrawal by Subject|210|||
42162744|NCT04537234|75970506|FG000|Overall Study|Withdrawal by Subject|2|||
42162745|NCT04537234|75970507|FG001|Overall Study|Withdrawal by Subject|0|||
42162746|NCT04537078|75970515|FG000|Overall Study|Protocol Violation|3|||
42162747|NCT04537078|75970516|FG001|Overall Study|Protocol Violation|2|||
42162748|NCT04537078|75970515|FG000|Overall Study|Lost to Follow-up|1|||
42162749|NCT04537078|75970516|FG001|Overall Study|Lost to Follow-up|0|||
42162750|NCT04537078|75970515|FG000|Overall Study|Withdrawal by Subject|0|||
42162751|NCT04537078|75970516|FG001|Overall Study|Withdrawal by Subject|1|||
42162752|NCT04532164|75970529|FG000|Overall Study|Adverse Event|1|||
42162753|NCT04532164|75970529|FG000|Overall Study|Protocol Violation|5|||
42280752|NCT01597245|76112828|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280753|NCT01597245|76112829|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280754|NCT01597245|76112830|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280755|NCT01597245|76112831|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280756|NCT01597245|76112832|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280757|NCT01597245|76112833|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280758|NCT01597245|76112834|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280759|NCT01597245|76112835|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
42280760|NCT01597245|76112815|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
42280761|NCT01597245|76112816|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
42280762|NCT01597245|76112817|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
42280763|NCT01597245|76112818|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280764|NCT01597245|76112819|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280765|NCT01597245|76112820|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280766|NCT01597245|76112821|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280767|NCT01597245|76112822|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280768|NCT01597245|76112823|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280769|NCT01597245|76112824|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280770|NCT01597245|76112825|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280771|NCT01597245|76112826|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280772|NCT01597245|76112827|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280773|NCT01597245|76112828|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280774|NCT01597245|76112829|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42162754|NCT04532164|75970529|FG000|Overall Study|Lost to Follow-up|1|||
42162755|NCT04532164|75970529|FG000|Overall Study|Found to be Ineligible|3|||
42162756|NCT04532164|75970529|FG000|Overall Study|Withdrawal by Subject|14|||
42162757|NCT00116688|75970536|FG000|Overall Study|Protocol deviation|1|||
42162758|NCT00116688|75970537|FG001|Overall Study|Protocol deviation|0|||
42162759|NCT00116688|75970536|FG000|Overall Study|Noncompliance|3|||
42280775|NCT01597245|76112830|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42162760|NCT00116688|75970537|FG001|Overall Study|Noncompliance|1|||
42162761|NCT00116688|75970536|FG000|Overall Study|Adverse Event|11|||
42162762|NCT00116688|75970537|FG001|Overall Study|Adverse Event|0|||
42280776|NCT01597245|76112831|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280777|NCT01597245|76112832|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280778|NCT01597245|76112833|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280779|NCT01597245|76112834|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280780|NCT01597245|76112835|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
42280781|NCT01597245|76112815|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
42280782|NCT01597245|76112816|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280783|NCT01597245|76112817|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280784|NCT01597245|76112818|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
42280785|NCT01597245|76112819|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280786|NCT01597245|76112820|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280787|NCT01597245|76112821|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280788|NCT01597245|76112822|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280789|NCT01597245|76112823|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280790|NCT01597245|76112824|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42013635|NCT01000636|75820730|FG000|Overall Study|Withdrawal by Subject|1|||
42013636|NCT01000636|75820730|FG000|Overall Study|Adverse Event|1|||
42280791|NCT01597245|76112825|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280792|NCT01597245|76112826|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280793|NCT01597245|76112827|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280794|NCT01597245|76112828|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280795|NCT01597245|76112829|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280796|NCT01597245|76112830|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280797|NCT01597245|76112831|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280798|NCT01597245|76112832|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280799|NCT01597245|76112833|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280800|NCT01597245|76112834|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280801|NCT01597245|76112835|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
42280802|NCT01597245|76112815|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
42280803|NCT01597245|76112816|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
42280804|NCT01597245|76112817|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
42280805|NCT01597245|76112818|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280806|NCT01597245|76112819|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280807|NCT01597245|76112820|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42351588|NCT00985426|76191491|FG001|Overall Study|Withdrawal by Subject|16|||
42162763|NCT00116688|75970536|FG000|Overall Study|Withdrawal by Subject|26|||
42162764|NCT00116688|75970537|FG001|Overall Study|Withdrawal by Subject|2|||
42162765|NCT00116688|75970536|FG000|Overall Study|Requirement for alternative therapy|11|||
42162766|NCT00116688|75970537|FG001|Overall Study|Requirement for alternative therapy|1|||
42162767|NCT00116688|75970536|FG000|Overall Study|Physician Decision|7|||
42162768|NCT00116688|75970537|FG001|Overall Study|Physician Decision|0|||
42162769|NCT00116688|75970536|FG000|Overall Study|Lost to Follow-up|3|||
42162770|NCT00116688|75970537|FG001|Overall Study|Lost to Follow-up|0|||
42162771|NCT00116688|75970536|FG000|Overall Study|Death|15|||
42162772|NCT00116688|75970537|FG001|Overall Study|Death|0|||
42162773|NCT00116688|75970536|FG000|Overall Study|Protocol-specified criteria|3|||
42162774|NCT00116688|75970537|FG001|Overall Study|Protocol-specified criteria|0|||
42162775|NCT00116688|75970536|FG000|Overall Study|Pregnancy|1|||
42162776|NCT00116688|75970537|FG001|Overall Study|Pregnancy|0|||
42162777|NCT00116688|75970536|FG000|Overall Study|Other|11|||
42162778|NCT00116688|75970537|FG001|Overall Study|Other|0|||
42162779|NCT04531540|75970543|FG000|Overall Study|Adverse Event|1|||
42162780|NCT04531540|75970543|FG000|Overall Study|Protocol Violation|3|||
42162781|NCT04531540|75970543|FG000|Overall Study|Withdrawal by Subject|4|||
42162782|NCT04531540|75970543|FG000|Overall Study|Found to be Ineligible|1|||
42162783|NCT04799782|75970547|FG000|Washout|Physician Decision|2|||
42162784|NCT04799782|75970548|FG001|Washout|Physician Decision|0|||
42162785|NCT04799782|75970547|FG000|Washout|Withdrawal by Subject|0|||
42162786|NCT04799782|75970548|FG001|Washout|Withdrawal by Subject|2|||
42162787|NCT04799782|75970547|FG000|Washout|Lost to Follow-up|0|||
42162788|NCT04799782|75970548|FG001|Washout|Lost to Follow-up|1|||
42162789|NCT03697252|75970556|FG000|Overall Study|Adverse Event|3|||
42162790|NCT03697252|75970557|FG001|Overall Study|Adverse Event|2|||
42162791|NCT03697252|75970556|FG000|Overall Study|Withdrawal by Subject|14|||
42162792|NCT03697252|75970557|FG001|Overall Study|Withdrawal by Subject|14|||
42162793|NCT03697252|75970556|FG000|Overall Study|Lost to Follow-up|0|||
42351589|NCT00985426|76191490|FG000|Overall Study|Lost to Follow-up|8|||
42351590|NCT00985426|76191491|FG001|Overall Study|Lost to Follow-up|10|||
42351591|NCT00985426|76191490|FG000|Overall Study|Death|7|||
42351592|NCT00985426|76191491|FG001|Overall Study|Death|3|||
42162794|NCT03697252|75970557|FG001|Overall Study|Lost to Follow-up|1|||
42013637|NCT00965419|75820734|FG000|Open Label Treatment for Responders|Adverse Event|33|||
42162795|NCT03697252|75970556|FG000|Overall Study|Physician Decision|1|||
42162796|NCT03697252|75970557|FG001|Overall Study|Physician Decision|1|||
42162797|NCT03697252|75970556|FG000|Overall Study|Other|0|||
42162798|NCT03697252|75970557|FG001|Overall Study|Other|1|||
42162799|NCT03701074|75970565|FG000|Overall Study|Physician Decision|1|||
42162800|NCT03701074|75970566|FG001|Overall Study|Physician Decision|0|||
42162801|NCT04728802|75970574|FG000|Overall Study|Withdrawal by Subject|4|||
42162802|NCT04728802|75970575|FG001|Overall Study|Withdrawal by Subject|20|||
42162803|NCT04728802|75970574|FG000|Overall Study|Physician Decision|7|||
42162804|NCT04728802|75970575|FG001|Overall Study|Physician Decision|7|||
42162805|NCT04728802|75970574|FG000|Overall Study|Protocol Violation|10|||
42162806|NCT04728802|75970575|FG001|Overall Study|Protocol Violation|4|||
42162807|NCT04728802|75970574|FG000|Overall Study|Transfer|1|||
42162808|NCT04728802|75970575|FG001|Overall Study|Transfer|0|||
42162809|NCT04728802|75970574|FG000|Overall Study|Death|4|||
42162810|NCT04728802|75970575|FG001|Overall Study|Death|5|||
42162811|NCT04728802|75970574|FG000|Overall Study|Other|3|||
42162812|NCT04728802|75970575|FG001|Overall Study|Other|0|||
42162813|NCT04715932|75970583|FG000|Overall Study|Lost to Follow-up|1|||
42162814|NCT04715932|75970584|FG001|Overall Study|Lost to Follow-up|0|||
42162815|NCT00130832|75970592|FG000|Overall Study|Adverse Event|1|||
42162816|NCT00130832|75970593|FG001|Overall Study|Adverse Event|1|||
42162817|NCT00130832|75970592|FG000|Overall Study|Lost to Follow-up|1|||
42162818|NCT00130832|75970593|FG001|Overall Study|Lost to Follow-up|2|||
42162819|NCT00130832|75970592|FG000|Overall Study|Protocol Violation|6|||
42162820|NCT00130832|75970593|FG001|Overall Study|Protocol Violation|8|||
42162821|NCT00130832|75970592|FG000|Overall Study|Withdrawal by Subject|6|||
42162822|NCT00130832|75970593|FG001|Overall Study|Withdrawal by Subject|1|||
42162823|NCT00130832|75970592|FG000|Overall Study|Moved|2|||
42162824|NCT00130832|75970593|FG001|Overall Study|Moved|2|||
42162825|NCT00130832|75970592|FG000|Overall Study|Other|0|||
42162826|NCT00130832|75970593|FG001|Overall Study|Other|3|||
42162827|NCT00096018|75970601|FG000|Overall Study|Became Ineligible (not treated)|0|||
42162828|NCT00096018|75970602|FG001|Overall Study|Became Ineligible (not treated)|3|||
42162829|NCT00096018|75970601|FG000|Overall Study|Miscellaneous (not treated)|0|||
42162830|NCT00096018|75970602|FG001|Overall Study|Miscellaneous (not treated)|2|||
42162831|NCT00096018|75970601|FG000|Overall Study|Adverse Event|0|||
42162832|NCT00096018|75970602|FG001|Overall Study|Adverse Event|5|||
42162833|NCT00096018|75970601|FG000|Overall Study|Death|0|||
42162834|NCT00096018|75970602|FG001|Overall Study|Death|1|||
42162835|NCT00096018|75970601|FG000|Overall Study|Withdrawal by Subject|0|||
42162836|NCT00096018|75970602|FG001|Overall Study|Withdrawal by Subject|2|||
42162837|NCT00096018|75970601|FG000|Overall Study|Miscellaneous|2|||
42162838|NCT00096018|75970602|FG001|Overall Study|Miscellaneous|1|||
42162839|NCT04713748|75970608|FG000|Overall Study|Not enough kits allocated|35|||
42162840|NCT04702984|75970612|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
42162841|NCT04701658|75970618|FG000|Overall Study|Lost to Follow-up|6|||
42162842|NCT00128102|75970624|FG000|Overall Study|Site Discontinued|3|||
42162843|NCT00128102|75970625|FG001|Overall Study|Site Discontinued|6|||
42162844|NCT00128102|75970624|FG000|Overall Study|Other|0|||
42162845|NCT00128102|75970625|FG001|Overall Study|Other|1|||
42162846|NCT00128102|75970624|FG000|Overall Study|Progressive Disease|255|||
42162847|NCT00128102|75970625|FG001|Overall Study|Progressive Disease|285|||
42280808|NCT01597245|76112821|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280809|NCT01597245|76112822|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280810|NCT01597245|76112823|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280811|NCT01597245|76112824|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280812|NCT01597245|76112825|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280813|NCT01597245|76112826|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280814|NCT01597245|76112827|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42162848|NCT00128102|75970624|FG000|Overall Study|Adverse Event|34|||
42162849|NCT00128102|75970625|FG001|Overall Study|Adverse Event|11|||
42162850|NCT00128102|75970624|FG000|Overall Study|Death|12|||
42162851|NCT00128102|75970625|FG001|Overall Study|Death|13|||
42280815|NCT01597245|76112828|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280816|NCT01597245|76112829|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42351593|NCT00985426|76191490|FG000|Overall Study|Protocol Violation|2|||
42351594|NCT00985426|76191491|FG001|Overall Study|Protocol Violation|0|||
42351595|NCT00985426|76191490|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
42162852|NCT00128102|75970624|FG000|Overall Study|Physician Decision|3|||
42162853|NCT00128102|75970625|FG001|Overall Study|Physician Decision|3|||
42162854|NCT00128102|75970624|FG000|Overall Study|Withdrawal by Subject|19|||
42162855|NCT00128102|75970625|FG001|Overall Study|Withdrawal by Subject|11|||
42162856|NCT00128102|75970624|FG000|Overall Study|Protocol Violation|2|||
42162857|NCT00128102|75970625|FG001|Overall Study|Protocol Violation|2|||
42162858|NCT04668274|75970631|FG000|Part 1 Study Period 1|Adverse Event|3|||
42162859|NCT04668274|75970632|FG001|Part 1 Study Period 1|Adverse Event|0|||
42162860|NCT04668274|75970633|FG002|Part 1 Study Period 1|Adverse Event|0|||
42162861|NCT04668274|75970634|FG003|Part 1 Study Period 1|Adverse Event|0|||
42162862|NCT04668274|75970631|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
42162863|NCT04668274|75970632|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
42162864|NCT04668274|75970633|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
42162865|NCT04668274|75970634|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
42162866|NCT04668274|75970631|FG000|Part 1 Study Period 2|Other|0|||
42162867|NCT04668274|75970632|FG001|Part 1 Study Period 2|Other|1|||
42162868|NCT04668274|75970633|FG002|Part 1 Study Period 2|Other|0|||
42162869|NCT04668274|75970634|FG003|Part 1 Study Period 2|Other|0|||
42162870|NCT04668274|75970631|FG000|Part 1 Study Period 3|Adverse Event|0|||
42162871|NCT04668274|75970632|FG001|Part 1 Study Period 3|Adverse Event|0|||
42162872|NCT04668274|75970633|FG002|Part 1 Study Period 3|Adverse Event|1|||
42162873|NCT04668274|75970634|FG003|Part 1 Study Period 3|Adverse Event|0|||
42162874|NCT04668274|75970631|FG000|Part 1 Study Period 3|Other|0|||
42162875|NCT04668274|75970632|FG001|Part 1 Study Period 3|Other|0|||
42162876|NCT04668274|75970633|FG002|Part 1 Study Period 3|Other|2|||
42162877|NCT04668274|75970634|FG003|Part 1 Study Period 3|Other|0|||
42162878|NCT04668274|75970631|FG000|Part 2 Study Period 4|Other|0|||
42162879|NCT04668274|75970632|FG001|Part 2 Study Period 4|Other|0|||
42162880|NCT04668274|75970633|FG002|Part 2 Study Period 4|Other|0|||
42162881|NCT04668274|75970634|FG003|Part 2 Study Period 4|Other|1|||
42162882|NCT04406194|75970649|FG000|Period 1|Withdrawal by Subject|0|||
42162883|NCT04406194|75970650|FG001|Period 1|Withdrawal by Subject|1|||
42162884|NCT03822884|75970665|FG000|Overall Study|Withdrawal by Subject|0|||
42162885|NCT03822884|75970666|FG001|Overall Study|Withdrawal by Subject|0|||
42162886|NCT03822884|75970667|FG002|Overall Study|Withdrawal by Subject|0|||
42162887|NCT03822884|75970668|FG003|Overall Study|Withdrawal by Subject|0|||
42162888|NCT03822884|75970669|FG004|Overall Study|Withdrawal by Subject|1|||
42162889|NCT03822884|75970670|FG005|Overall Study|Withdrawal by Subject|0|||
42162890|NCT03822416|75970680|FG000|Overall Study|Lost to Follow-up|1|||
42162891|NCT03822416|75970681|FG001|Overall Study|Lost to Follow-up|0|||
42162892|NCT03822416|75970680|FG000|Overall Study|Withdrawal by Subject|0|||
42162893|NCT03822416|75970681|FG001|Overall Study|Withdrawal by Subject|1|||
42162894|NCT04405570|75970691|FG000|Overall Study|Adverse Event|0|||
42162895|NCT04405570|75970692|FG001|Overall Study|Adverse Event|1|||
42162896|NCT04405570|75970693|FG002|Overall Study|Adverse Event|1|||
42162897|NCT04405570|75970694|FG003|Overall Study|Adverse Event|1|||
42162898|NCT04405570|75970691|FG000|Overall Study|Lost to Follow-up|0|||
42162899|NCT04405570|75970692|FG001|Overall Study|Lost to Follow-up|1|||
42162900|NCT04405570|75970693|FG002|Overall Study|Lost to Follow-up|0|||
42162901|NCT04405570|75970694|FG003|Overall Study|Lost to Follow-up|0|||
42162902|NCT04405570|75970691|FG000|Overall Study|Physician Decision|0|||
42162903|NCT04405570|75970692|FG001|Overall Study|Physician Decision|0|||
42162904|NCT04405570|75970693|FG002|Overall Study|Physician Decision|1|||
42162905|NCT04405570|75970694|FG003|Overall Study|Physician Decision|0|||
42280817|NCT01597245|76112830|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280818|NCT01597245|76112831|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280819|NCT01597245|76112832|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280820|NCT01597245|76112833|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280821|NCT01597245|76112834|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42280822|NCT01597245|76112835|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
42351596|NCT00985426|76191491|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
42162906|NCT04405570|75970691|FG000|Overall Study|Withdrawal by Subject|0|||
42162907|NCT04405570|75970692|FG001|Overall Study|Withdrawal by Subject|1|||
42162908|NCT04405570|75970693|FG002|Overall Study|Withdrawal by Subject|1|||
42162909|NCT04405570|75970694|FG003|Overall Study|Withdrawal by Subject|0|||
42162910|NCT04405570|75970691|FG000|Overall Study|Randomized not dosed|0|||
42162911|NCT04405570|75970692|FG001|Overall Study|Randomized not dosed|2|||
42162912|NCT04405570|75970693|FG002|Overall Study|Randomized not dosed|0|||
42162913|NCT04405570|75970694|FG003|Overall Study|Randomized not dosed|0|||
42162914|NCT00127712|75970709|FG000|Overall Study|Adverse Event|3|||
42162915|NCT00127712|75970710|FG001|Overall Study|Adverse Event|0|||
42162916|NCT00127712|75970709|FG000|Overall Study|Lack of GI access to continue|2|||
42162917|NCT00127712|75970710|FG001|Overall Study|Lack of GI access to continue|0|||
42162918|NCT04404010|75970718|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
42162919|NCT04404010|75970719|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
42162920|NCT04401202|75970729|FG000|Overall Study|Lost to Follow-up|2|||
42162921|NCT04401202|75970730|FG001|Overall Study|Lost to Follow-up|2|||
42162922|NCT04401202|75970729|FG000|Overall Study|Adverse Event|0|||
42162923|NCT04401202|75970730|FG001|Overall Study|Adverse Event|1|||
42162924|NCT04401202|75970729|FG000|Overall Study|Hospitalized|4|||
42280823|NCT01597245|76112815|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280824|NCT01597245|76112816|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280825|NCT01597245|76112817|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42162925|NCT04401202|75970730|FG001|Overall Study|Hospitalized|1|||
42162926|NCT00096356|75970739|FG000|Overall Study|Adverse Event|11|||
42162927|NCT00096356|75970740|FG001|Overall Study|Adverse Event|9|||
42162928|NCT00096356|75970739|FG000|Overall Study|Physician Decision|5|||
42162929|NCT00096356|75970740|FG001|Overall Study|Physician Decision|3|||
42162930|NCT00096356|75970739|FG000|Overall Study|Withdrawal by Subject|17|||
42162931|NCT00096356|75970740|FG001|Overall Study|Withdrawal by Subject|23|||
42162932|NCT00096356|75970739|FG000|Overall Study|Lack of Efficacy|1|||
42162933|NCT00096356|75970740|FG001|Overall Study|Lack of Efficacy|0|||
42162934|NCT00096356|75970739|FG000|Overall Study|multiple reasons|10|||
42162935|NCT00096356|75970740|FG001|Overall Study|multiple reasons|18|||
42162936|NCT04358068|75970749|FG000|Overall Study|Did not initiate study treatment|2|||
42162937|NCT04358068|75970750|FG001|Overall Study|Did not initiate study treatment|2|||
42162938|NCT03694210|75970756|FG000|Overall Study|Death|1|||
42162939|NCT03694210|75970756|FG000|Overall Study|Screen Failure|7|||
42162940|NCT04339972|75970764|FG000|Overall Study|Scheduling Issues|3|||
42162941|NCT04339972|75970765|FG001|Overall Study|Scheduling Issues|3|||
42162942|NCT04339972|75970764|FG000|Overall Study|dropout|1|||
42162943|NCT04339972|75970765|FG001|Overall Study|dropout|1|||
42162944|NCT04339972|75970764|FG000|Overall Study|Technical issues|1|||
42162945|NCT04339972|75970765|FG001|Overall Study|Technical issues|0|||
42162946|NCT04339972|75970764|FG000|Overall Study|Claustraphobia|0|||
42280826|NCT01597245|76112818|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280827|NCT01597245|76112819|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42162947|NCT04339972|75970765|FG001|Overall Study|Claustraphobia|1|||
42280828|NCT01597245|76112820|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
42280829|NCT01597245|76112821|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
42280830|NCT01597245|76112822|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280831|NCT01597245|76112823|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280832|NCT01597245|76112824|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280833|NCT01597245|76112825|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280834|NCT01597245|76112826|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280835|NCT01597245|76112827|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280836|NCT01597245|76112828|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280837|NCT01597245|76112829|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280838|NCT01597245|76112830|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280839|NCT01597245|76112831|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280840|NCT01597245|76112832|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280841|NCT01597245|76112833|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280842|NCT01597245|76112834|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280843|NCT01597245|76112835|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
42280844|NCT01597245|76112815|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280845|NCT01597245|76112816|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280846|NCT01597245|76112817|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280847|NCT01597245|76112818|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280848|NCT01597245|76112819|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
42280849|NCT01597245|76112820|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
42280850|NCT01597245|76112821|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
42162948|NCT00096278|75970773|FG000|Overall Study|No follow-up data|15|||
42162949|NCT00096278|75970774|FG001|Overall Study|No follow-up data|18|||
42162950|NCT00096278|75970773|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
42162951|NCT00096278|75970774|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
42162952|NCT00095940|75970789|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
42162953|NCT00095940|75970790|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
42162954|NCT00095940|75970791|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
42162955|NCT00095940|75970792|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
42162956|NCT00095940|75970793|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
42162957|NCT00095940|75970794|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
42162958|NCT00095940|75970795|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
42280851|NCT01597245|76112822|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
42162959|NCT00095940|75970796|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
42162960|NCT00095940|75970797|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
42162961|NCT00095940|75970789|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
42162962|NCT00095940|75970790|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
42162963|NCT00095940|75970791|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
42280852|NCT01597245|76112823|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42013638|NCT00965419|75820734|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
42162964|NCT00095940|75970792|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
42162965|NCT00095940|75970793|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
42162966|NCT00095940|75970794|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
42162967|NCT00095940|75970795|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
42162968|NCT00095940|75970796|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
42162969|NCT00095940|75970797|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
42162970|NCT00095940|75970789|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
42162971|NCT00095940|75970790|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
42162972|NCT00095940|75970791|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
42162973|NCT00095940|75970792|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
42162974|NCT00095940|75970793|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
42013639|NCT00965419|75820734|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
42013640|NCT00965419|75820734|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
42013641|NCT00965419|75820734|FG000|Open Label Treatment for Responders|Physician Decision|6|||
42013642|NCT00965419|75820734|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
42013643|NCT00965419|75820734|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
42013644|NCT00965419|75820734|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
42013645|NCT00965419|75820734|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
42013646|NCT00965419|75820734|FG000|Follow-up Phase|Adverse Event|9|||
42013647|NCT00965419|75820734|FG000|Follow-up Phase|Protocol Violation|4|||
42013648|NCT00965419|75820734|FG000|Follow-up Phase|Withdrawal by Subject|8|||
42013649|NCT00965419|75820734|FG000|Follow-up Phase|Physician Decision|4|||
42013650|NCT00965419|75820734|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
42013651|NCT00965419|75820734|FG000|Follow-up Phase|Lack of Efficacy|28|||
42013652|NCT01000480|75820739|FG000|Induction Phase|Adverse Event|2|||
42013653|NCT01000480|75820739|FG000|Induction Phase|Lost to Follow-up|1|||
42013654|NCT01000480|75820739|FG000|Induction Phase|Physician Decision|1|||
42013655|NCT01000480|75820739|FG000|Induction Phase|Entry Criteria Not Met|3|||
42013656|NCT01000480|75820739|FG000|Concurrent Therapy Phase|Adverse Event|4|||
42013657|NCT01000480|75820739|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
42013658|NCT01000480|75820739|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
42013659|NCT01000480|75820739|FG000|Concurrent Therapy Phase|Physician Decision|1|||
42013660|NCT00965341|75820745|FG000|Overall Study|Withdrew consent|1|||
42013661|NCT00965341|75820746|FG001|Overall Study|Withdrew consent|5|||
42013662|NCT00965341|75820745|FG000|Overall Study|Lost to Follow-up|1|||
42013663|NCT00965341|75820746|FG001|Overall Study|Lost to Follow-up|0|||
42013664|NCT00965341|75820745|FG000|Overall Study|Transportation issues|4|||
42013665|NCT00965341|75820746|FG001|Overall Study|Transportation issues|3|||
42013666|NCT01175811|75820754|FG000|Overall Study|Adverse Event|1|||
42013667|NCT01175811|75820755|FG001|Overall Study|Adverse Event|1|||
42013668|NCT01175811|75820754|FG000|Overall Study|Entry criteria not met|3|||
42013669|NCT01175811|75820755|FG001|Overall Study|Entry criteria not met|1|||
42013670|NCT01175811|75820754|FG000|Overall Study|Lack of Efficacy|1|||
42013671|NCT01175811|75820755|FG001|Overall Study|Lack of Efficacy|0|||
42280853|NCT01597245|76112824|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
42280854|NCT01597245|76112825|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280855|NCT01597245|76112826|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280856|NCT01597245|76112827|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280857|NCT01597245|76112828|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42013672|NCT01175811|75820754|FG000|Overall Study|Lost to Follow-up|3|||
42013673|NCT01175811|75820755|FG001|Overall Study|Lost to Follow-up|2|||
42013674|NCT01175811|75820754|FG000|Overall Study|Physician Decision|1|||
42013675|NCT01175811|75820755|FG001|Overall Study|Physician Decision|1|||
42013676|NCT01175811|75820754|FG000|Overall Study|Protocol Violation|1|||
42013677|NCT01175811|75820755|FG001|Overall Study|Protocol Violation|2|||
42013678|NCT01175811|75820754|FG000|Overall Study|Withdrawal by Subject|6|||
42013679|NCT01175811|75820755|FG001|Overall Study|Withdrawal by Subject|7|||
42013680|NCT00965263|75820763|FG000|Overall Study|Physician Decision|2|||
42013681|NCT00965263|75820764|FG001|Overall Study|Physician Decision|0|||
42013682|NCT00965263|75820763|FG000|Overall Study|Family emergency|0|||
42013683|NCT00965263|75820764|FG001|Overall Study|Family emergency|1|||
42013684|NCT00965263|75820763|FG000|Overall Study|Protocol Violation|0|||
42013685|NCT00965263|75820764|FG001|Overall Study|Protocol Violation|2|||
42013686|NCT00965185|75820790|FG000|Overall Study|Lost to Follow-up|2|||
42013687|NCT00965185|75820791|FG001|Overall Study|Lost to Follow-up|0|||
42040577|NCT01796171|75848707|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42162975|NCT00095940|75970794|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
42162976|NCT00095940|75970795|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
42162977|NCT00095940|75970796|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
42280858|NCT01597245|76112829|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280859|NCT01597245|76112830|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280860|NCT01597245|76112831|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42013688|NCT00965185|75820790|FG000|Overall Study|Withdrawal by Subject|0|||
42013689|NCT00965185|75820791|FG001|Overall Study|Withdrawal by Subject|1|||
42013690|NCT01174563|75820799|FG000|Overall Study|Progressive Disease|45|||
42013691|NCT01174563|75820799|FG000|Overall Study|Death|5|||
42013692|NCT01174563|75820799|FG000|Overall Study|Investigator's Discretion|5|||
42162978|NCT00095940|75970797|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
42162979|NCT00114218|75970815|FG000|Overall Study|Wrong Cell Type|2|||
42162980|NCT00114218|75970815|FG000|Overall Study|Wrong Primary|1|||
42162981|NCT00114218|75970815|FG000|Overall Study|Never Treated|1|||
42162982|NCT00095628|75970819|FG000|Overall Study|Disease progression prior to treatment|1|||
42162983|NCT04380142|75970825|FG000|LD/CD Stabilization Period|Adverse Event|3|||
42162984|NCT04380142|75970826|FG001|LD/CD Stabilization Period|Adverse Event|0|||
42162985|NCT04380142|75970827|FG002|LD/CD Stabilization Period|Adverse Event|0|||
42162986|NCT04380142|75970825|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
42162987|NCT04380142|75970826|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
42162988|NCT04380142|75970827|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
42162989|NCT04380142|75970825|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
42162990|NCT04380142|75970826|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
42162991|NCT04380142|75970827|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
42162992|NCT04380142|75970825|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
42162993|NCT04380142|75970826|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
42162994|NCT04380142|75970827|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
42162995|NCT04380142|75970825|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
42162996|NCT04380142|75970826|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
42162997|NCT04380142|75970827|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
42162998|NCT04380142|75970825|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
42162999|NCT04380142|75970826|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
42163000|NCT04380142|75970827|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
42163001|NCT04380142|75970825|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42163002|NCT04380142|75970826|FG001|Double-Blind Treatment Period|Adverse Event|1|||
42163003|NCT04380142|75970827|FG002|Double-Blind Treatment Period|Adverse Event|14|||
42163004|NCT04380142|75970825|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
42163005|NCT04380142|75970826|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
42163006|NCT04380142|75970827|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
42163007|NCT04380142|75970825|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
42163008|NCT04380142|75970826|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
42163009|NCT04380142|75970827|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
42163010|NCT04380142|75970825|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
42163011|NCT04380142|75970826|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
42163012|NCT04380142|75970827|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
42163013|NCT04380142|75970825|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
42163014|NCT04380142|75970826|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
42163015|NCT04380142|75970827|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
42163016|NCT04380142|75970825|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
42163017|NCT04380142|75970826|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
42163018|NCT04380142|75970827|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
42163019|NCT04335136|75970837|FG000|Overall Study|Death|8|||
42163020|NCT04335136|75970838|FG001|Overall Study|Death|4|||
42163021|NCT04335136|75970837|FG000|Overall Study|Lost to Follow-up|2|||
42163022|NCT04335136|75970838|FG001|Overall Study|Lost to Follow-up|0|||
42163023|NCT04335136|75970837|FG000|Overall Study|Protocol Violation|1|||
42163024|NCT04335136|75970838|FG001|Overall Study|Protocol Violation|0|||
42163025|NCT04335136|75970837|FG000|Overall Study|Withdrawal by Subject|1|||
42280861|NCT01597245|76112832|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280862|NCT01597245|76112833|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42013693|NCT01174563|75820799|FG000|Overall Study|Participant Withdrew Consent|3|||
42013694|NCT01174563|75820799|FG000|Overall Study|Rash Adverse Event|1|||
42013695|NCT01174563|75820799|FG000|Overall Study|Sponsor's decision|1|||
42013696|NCT01298531|75820805|FG000|Overall Study|Lack of Efficacy|0|||
42013697|NCT01298531|75820806|FG001|Overall Study|Lack of Efficacy|1|||
42013698|NCT01298531|75820805|FG000|Overall Study|Lost to Follow-up|2|||
42013699|NCT01298531|75820806|FG001|Overall Study|Lost to Follow-up|0|||
42013700|NCT01298531|75820805|FG000|Overall Study|Protocol Violation|1|||
42013701|NCT01298531|75820806|FG001|Overall Study|Protocol Violation|1|||
42013702|NCT01298531|75820805|FG000|Overall Study|Adverse Event|4|||
42013703|NCT01298531|75820806|FG001|Overall Study|Adverse Event|3|||
42013704|NCT01298531|75820805|FG000|Overall Study|Does not meet entrance criteria|0|||
42013705|NCT01298531|75820806|FG001|Overall Study|Does not meet entrance criteria|1|||
42013706|NCT01298531|75820805|FG000|Overall Study|Other|2|||
42013707|NCT01298531|75820806|FG001|Overall Study|Other|1|||
42280863|NCT01597245|76112834|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280864|NCT01597245|76112835|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
42280865|NCT01597245|76112815|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280866|NCT01597245|76112816|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280867|NCT01597245|76112817|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280868|NCT01597245|76112818|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280869|NCT01597245|76112819|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42013708|NCT01174173|75820813|FG000|Overall Study|drug-drug interaction|1|||
42013709|NCT00964795|75820818|FG000|Overall Study|Withdrawal by Subject|79|||
42013710|NCT00964795|75820818|FG000|Overall Study|Adverse Event|12|||
42013711|NCT00964795|75820818|FG000|Overall Study|Death|14|||
42013712|NCT00964795|75820818|FG000|Overall Study|Lost to Follow-up|7|||
42013713|NCT00964795|75820818|FG000|Overall Study|Termination of Study by Sponsor|169|||
42013714|NCT00964795|75820818|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
42013715|NCT00964795|75820818|FG000|Overall Study|Other|23|||
42013716|NCT01173471|75820827|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42013717|NCT01173471|75820828|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
42013718|NCT01173471|75820829|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
42351597|NCT00985192|76191497|FG000|Overall Study|Withdrawal by Subject|1|||
42013719|NCT01173471|75820830|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
42013720|NCT01173471|75820827|FG000|Overall Study|Condition under investigation worsened|2|||
42013721|NCT01173471|75820828|FG001|Overall Study|Condition under investigation worsened|0|||
42013722|NCT01173471|75820829|FG002|Overall Study|Condition under investigation worsened|0|||
42013723|NCT01173471|75820830|FG003|Overall Study|Condition under investigation worsened|0|||
42013724|NCT01173471|75820827|FG000|Overall Study|Lost to Follow-up|0|||
42280870|NCT01597245|76112820|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
42280871|NCT01597245|76112821|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280872|NCT01597245|76112822|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280873|NCT01597245|76112823|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
42280874|NCT01597245|76112824|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280875|NCT01597245|76112825|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
42280876|NCT01597245|76112826|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
42280877|NCT01597245|76112827|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
42280878|NCT01597245|76112828|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280879|NCT01597245|76112829|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280880|NCT01597245|76112830|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280881|NCT01597245|76112831|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280882|NCT01597245|76112832|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280883|NCT01597245|76112833|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280884|NCT01597245|76112834|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280885|NCT01597245|76112835|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
42280886|NCT01597245|76112815|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280887|NCT01597245|76112816|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280888|NCT01597245|76112817|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280889|NCT01597245|76112818|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280890|NCT01597245|76112819|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
42280891|NCT01597245|76112820|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
42280892|NCT01597245|76112821|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
42280893|NCT01597245|76112822|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
42280894|NCT01597245|76112823|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
42351598|NCT00985192|76191497|FG000|Overall Study|Disease Progression|1|||
42351599|NCT00985192|76191497|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
42013725|NCT01173471|75820828|FG001|Overall Study|Lost to Follow-up|0|||
42013726|NCT01173471|75820829|FG002|Overall Study|Lost to Follow-up|1|||
42013727|NCT01173471|75820830|FG003|Overall Study|Lost to Follow-up|0|||
42013728|NCT01173471|75820827|FG000|Overall Study|Reason given as Other|0|||
42013729|NCT01173471|75820828|FG001|Overall Study|Reason given as Other|0|||
42013730|NCT01173471|75820829|FG002|Overall Study|Reason given as Other|1|||
42013731|NCT01173471|75820830|FG003|Overall Study|Reason given as Other|0|||
42280895|NCT01597245|76112824|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
42280896|NCT01597245|76112825|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
42280897|NCT01597245|76112826|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
42280898|NCT01597245|76112827|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
42280899|NCT01597245|76112828|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280900|NCT01597245|76112829|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280901|NCT01597245|76112830|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280902|NCT01597245|76112831|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280903|NCT01597245|76112832|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280904|NCT01597245|76112833|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280905|NCT01597245|76112834|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280906|NCT01597245|76112835|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
42280907|NCT01597245|76112815|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280908|NCT01597245|76112816|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280909|NCT01597245|76112817|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280910|NCT01597245|76112818|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280911|NCT01597245|76112819|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
42280912|NCT01597245|76112820|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
42280913|NCT01597245|76112821|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
42280914|NCT01597245|76112822|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280915|NCT01597245|76112823|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
42280916|NCT01597245|76112824|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
42280917|NCT01597245|76112825|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
42280918|NCT01597245|76112826|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
42280919|NCT01597245|76112827|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
42280920|NCT01597245|76112828|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280921|NCT01597245|76112829|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280922|NCT01597245|76112830|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280923|NCT01597245|76112831|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280924|NCT01597245|76112832|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280925|NCT01597245|76112833|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280926|NCT01597245|76112834|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280927|NCT01597245|76112835|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
42280928|NCT01597245|76112815|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280929|NCT01597245|76112816|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280930|NCT01597245|76112817|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42351600|NCT00985114|76191503|FG000|Overall Study|Adverse Event|1|||
42351601|NCT00985114|76191504|FG001|Overall Study|Adverse Event|0|||
42351602|NCT00985114|76191503|FG000|Overall Study|Withdrawal by Subject|0|||
42351603|NCT00985114|76191504|FG001|Overall Study|Withdrawal by Subject|2|||
42351604|NCT00984568|76191512|FG000|Overall Study|Withdrawal by Subject|1|||
42351605|NCT00984568|76191513|FG001|Overall Study|Withdrawal by Subject|2|||
42351606|NCT00984568|76191512|FG000|Overall Study|Lack of Efficacy|2|||
42163026|NCT04335136|75970838|FG001|Overall Study|Withdrawal by Subject|1|||
42163027|NCT04335136|75970837|FG000|Overall Study|Health-threatening condition|0|||
42163028|NCT04335136|75970838|FG001|Overall Study|Health-threatening condition|1|||
42163029|NCT04335136|75970837|FG000|Overall Study|Adverse Event|0|||
42163030|NCT04335136|75970838|FG001|Overall Study|Adverse Event|1|||
42163031|NCT04335136|75970837|FG000|Overall Study|Erroneously randomized|2|||
42163032|NCT04335136|75970838|FG001|Overall Study|Erroneously randomized|0|||
42163033|NCT04171414|75970844|FG000|Overall Study|Death|1|||
42163034|NCT04171414|75970844|FG000|Overall Study|Withdrawal by Subject|1|||
42163035|NCT04167670|75970851|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
42163036|NCT04167670|75970852|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
42163037|NCT04167670|75970853|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
42163038|NCT04167670|75970851|FG000|Overall Study|Significant protocol deviation|3|||
42163039|NCT04167670|75970852|FG001|Overall Study|Significant protocol deviation|1|||
42351607|NCT00984568|76191513|FG001|Overall Study|Lack of Efficacy|0|||
42351608|NCT00984568|76191512|FG000|Overall Study|Adverse Event|2|||
42351609|NCT00984568|76191513|FG001|Overall Study|Adverse Event|0|||
42351610|NCT00984568|76191512|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
42351611|NCT00984568|76191513|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
42351612|NCT00984568|76191512|FG000|Overall Study|Lost to Follow-up|0|||
42351613|NCT00984568|76191513|FG001|Overall Study|Lost to Follow-up|1|||
42351614|NCT00984568|76191512|FG000|Overall Study|Opportunistic Infection|1|||
42163040|NCT04167670|75970853|FG002|Overall Study|Significant protocol deviation|0|||
42163041|NCT04167670|75970851|FG000|Overall Study|Lost to Follow-up|0|||
42163042|NCT04167670|75970852|FG001|Overall Study|Lost to Follow-up|3|||
42163043|NCT04167670|75970853|FG002|Overall Study|Lost to Follow-up|3|||
42163044|NCT04167670|75970851|FG000|Overall Study|Voluntary Withdrawal|0|||
42163045|NCT04167670|75970852|FG001|Overall Study|Voluntary Withdrawal|1|||
42163046|NCT04167670|75970853|FG002|Overall Study|Voluntary Withdrawal|1|||
42163047|NCT04167670|75970851|FG000|Overall Study|Withdrawal of Consent|4|||
42163048|NCT04167670|75970852|FG001|Overall Study|Withdrawal of Consent|1|||
42163049|NCT04167670|75970853|FG002|Overall Study|Withdrawal of Consent|3|||
42163050|NCT04167670|75970851|FG000|Overall Study|Miscellaneous|7|||
42163051|NCT04167670|75970852|FG001|Overall Study|Miscellaneous|5|||
42163052|NCT04167670|75970853|FG002|Overall Study|Miscellaneous|3|||
42163053|NCT00113516|75970861|FG000|Part 1|Adverse Event|6|||
42163054|NCT00113516|75970862|FG001|Part 1|Adverse Event|0|||
42163055|NCT00113516|75970861|FG000|Part 1|Death|3|||
42163056|NCT00113516|75970862|FG001|Part 1|Death|0|||
42163057|NCT00113516|75970861|FG000|Part 1|Other|3|||
42163058|NCT00113516|75970862|FG001|Part 1|Other|0|||
42280931|NCT01597245|76112818|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280932|NCT01597245|76112819|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
42280933|NCT01597245|76112820|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280934|NCT01597245|76112821|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280935|NCT01597245|76112822|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280936|NCT01597245|76112823|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
42163059|NCT00113516|75970861|FG000|Part 1|Withdrawal by Subject|2|||
42163060|NCT00113516|75970862|FG001|Part 1|Withdrawal by Subject|0|||
42163061|NCT00113516|75970861|FG000|Part 1|Lack of Efficacy|2|||
42163062|NCT00113516|75970862|FG001|Part 1|Lack of Efficacy|0|||
42163063|NCT00113516|75970861|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
42163064|NCT00113516|75970862|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
42163065|NCT00113516|75970861|FG000|Part 1|Laboratory Abnormality|1|||
42163066|NCT00113516|75970862|FG001|Part 1|Laboratory Abnormality|0|||
42163067|NCT00113516|75970861|FG000|Part 1|Ongoing|1|||
42163068|NCT00113516|75970862|FG001|Part 1|Ongoing|0|||
42163069|NCT00113516|75970861|FG000|Part 1|Missing|65|||
42163070|NCT00113516|75970862|FG001|Part 1|Missing|0|||
42163071|NCT00113516|75970861|FG000|Part 2|Adverse Event|0|||
42163072|NCT00113516|75970862|FG001|Part 2|Adverse Event|16|||
42163073|NCT00113516|75970861|FG000|Part 2|Death|0|||
42163074|NCT00113516|75970862|FG001|Part 2|Death|5|||
42163075|NCT00113516|75970861|FG000|Part 2|Lack of Efficacy|0|||
42163076|NCT00113516|75970862|FG001|Part 2|Lack of Efficacy|37|||
42163077|NCT00113516|75970861|FG000|Part 2|Withdrawal by Subject|0|||
42163078|NCT00113516|75970862|FG001|Part 2|Withdrawal by Subject|3|||
42163079|NCT00113516|75970861|FG000|Part 2|Other|0|||
42163080|NCT00113516|75970862|FG001|Part 2|Other|3|||
42163081|NCT00113516|75970861|FG000|Part 2|Laboratory Abnormality|0|||
42163082|NCT00113516|75970862|FG001|Part 2|Laboratory Abnormality|1|||
42163083|NCT00113516|75970861|FG000|Part 2|Ongoing|0|||
42163084|NCT00113516|75970862|FG001|Part 2|Ongoing|1|||
42163085|NCT04140292|75970883|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
42163086|NCT04140292|75970884|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
42163087|NCT04138810|75970893|FG000|Overall Study|Withdrawal by Subject|0|||
42163088|NCT04138810|75970894|FG001|Overall Study|Withdrawal by Subject|1|||
42280937|NCT01597245|76112824|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
42163089|NCT04138810|75970893|FG000|Overall Study|Subject cancelled surgery|1|||
42163090|NCT04138810|75970894|FG001|Overall Study|Subject cancelled surgery|0|||
42163091|NCT00127166|75970902|FG000|Period I|Protocol Violation|0|||
42163092|NCT00127166|75970903|FG001|Period I|Protocol Violation|2|||
42163093|NCT00127166|75970902|FG000|Period I|Withdrawal by Subject|2|||
42280938|NCT01597245|76112825|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
42280939|NCT01597245|76112826|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280940|NCT01597245|76112827|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
42163094|NCT00127166|75970903|FG001|Period I|Withdrawal by Subject|0|||
42163095|NCT00127166|75970902|FG000|Period I|Patient did not meet inclusion criteria|1|||
42163096|NCT00127166|75970903|FG001|Period I|Patient did not meet inclusion criteria|0|||
42163097|NCT00127166|75970902|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
42163098|NCT00127166|75970903|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
42163099|NCT00127166|75970902|FG000|Period II|Withdrawal by Subject|2|||
42163100|NCT00127166|75970903|FG001|Period II|Withdrawal by Subject|0|||
42163101|NCT00127166|75970902|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
42163102|NCT00127166|75970903|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
42163103|NCT00125138|75970913|FG000|Overall Study|Adverse Event|1|||
42163104|NCT00125138|75970914|FG001|Overall Study|Adverse Event|0|||
42163105|NCT00125138|75970915|FG002|Overall Study|Adverse Event|3|||
42163106|NCT00125138|75970916|FG003|Overall Study|Adverse Event|2|||
42163107|NCT00125138|75970913|FG000|Overall Study|Withdrawal by Subject|2|||
42163108|NCT00125138|75970914|FG001|Overall Study|Withdrawal by Subject|3|||
42280941|NCT01597245|76112828|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280942|NCT01597245|76112829|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280943|NCT01597245|76112830|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280944|NCT01597245|76112831|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280945|NCT01597245|76112832|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280946|NCT01597245|76112833|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42163109|NCT00125138|75970915|FG002|Overall Study|Withdrawal by Subject|1|||
42163110|NCT00125138|75970916|FG003|Overall Study|Withdrawal by Subject|1|||
42163111|NCT00125138|75970913|FG000|Overall Study|Lack of Efficacy|0|||
42163112|NCT00125138|75970914|FG001|Overall Study|Lack of Efficacy|0|||
42163113|NCT00125138|75970915|FG002|Overall Study|Lack of Efficacy|0|||
42163114|NCT00125138|75970916|FG003|Overall Study|Lack of Efficacy|1|||
42163115|NCT00125138|75970913|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
42163116|NCT00125138|75970914|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
42163117|NCT00125138|75970915|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
42163118|NCT00125138|75970916|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
42163119|NCT04132336|75970933|FG000|Overall Study|Investigator Decision|0|||
42163120|NCT04132336|75970934|FG001|Overall Study|Investigator Decision|1|||
42163121|NCT04132336|75970935|FG002|Overall Study|Investigator Decision|0|||
42163122|NCT04132336|75970936|FG003|Overall Study|Investigator Decision|0|||
42163123|NCT04132336|75970937|FG004|Overall Study|Investigator Decision|0|||
42163124|NCT04132336|75970938|FG005|Overall Study|Investigator Decision|0|||
42163125|NCT04132336|75970939|FG006|Overall Study|Investigator Decision|0|||
42163126|NCT04131556|75970955|FG000|Overall Study|Adverse Event|1|||
42163127|NCT04131556|75970955|FG000|Overall Study|Withdrawal by Subject|1|||
42163128|NCT04295356|75970964|FG000|Overall Study|Physician Decision|1|||
42163129|NCT04295356|75970965|FG001|Overall Study|Physician Decision|0|||
42163130|NCT04295356|75970964|FG000|Overall Study|Lost to Follow-up|0|||
42163131|NCT04295356|75970965|FG001|Overall Study|Lost to Follow-up|3|||
42163132|NCT04295356|75970964|FG000|Overall Study|Protocol Violation|0|||
42163133|NCT04295356|75970965|FG001|Overall Study|Protocol Violation|1|||
42163134|NCT03691948|75970973|FG000|Overall Study|Lost to Follow-up|1|||
42163135|NCT03691948|75970974|FG001|Overall Study|Lost to Follow-up|3|||
42163136|NCT04126174|75970981|FG000|Overall Study|Lost to Follow-up|3|||
42163137|NCT04126174|75970982|FG001|Overall Study|Lost to Follow-up|3|||
42163138|NCT04124926|75970990|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
42163139|NCT04124926|75970991|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
42163140|NCT04124926|75970992|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
42163141|NCT04124926|75970993|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
42163142|NCT04124926|75970994|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
42163143|NCT04124926|75970990|FG000|Healing Phase|Protocol Violation|0|||
42163144|NCT04124926|75970991|FG001|Healing Phase|Protocol Violation|1|||
42163145|NCT04124926|75970992|FG002|Healing Phase|Protocol Violation|0|||
42163146|NCT04124926|75970993|FG003|Healing Phase|Protocol Violation|0|||
42163147|NCT04124926|75970994|FG004|Healing Phase|Protocol Violation|0|||
42163148|NCT04124926|75970990|FG000|Healing Phase|Lost to Follow-up|5|||
42163149|NCT04124926|75970991|FG001|Healing Phase|Lost to Follow-up|4|||
42163150|NCT04124926|75970992|FG002|Healing Phase|Lost to Follow-up|0|||
42163151|NCT04124926|75970993|FG003|Healing Phase|Lost to Follow-up|0|||
42163152|NCT04124926|75970994|FG004|Healing Phase|Lost to Follow-up|0|||
42163153|NCT04124926|75970990|FG000|Healing Phase|Voluntary Withdrawal|10|||
42163154|NCT04124926|75970991|FG001|Healing Phase|Voluntary Withdrawal|7|||
42280947|NCT01597245|76112834|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280948|NCT01597245|76112835|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
42280949|NCT01597245|76112815|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280950|NCT01597245|76112816|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280951|NCT01597245|76112817|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280952|NCT01597245|76112818|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280953|NCT01597245|76112819|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
42280954|NCT01597245|76112820|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
42280955|NCT01597245|76112821|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
42013732|NCT01172847|75820840|FG000|Overall Study|Withdrawal by Subject|3|||
42013733|NCT00966355|75820853|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
42163155|NCT04124926|75970992|FG002|Healing Phase|Voluntary Withdrawal|0|||
42163156|NCT04124926|75970993|FG003|Healing Phase|Voluntary Withdrawal|0|||
42163157|NCT04124926|75970994|FG004|Healing Phase|Voluntary Withdrawal|0|||
42163158|NCT04124926|75970990|FG000|Healing Phase|Withdrawal of Consent|5|||
42163159|NCT04124926|75970991|FG001|Healing Phase|Withdrawal of Consent|3|||
42163160|NCT04124926|75970992|FG002|Healing Phase|Withdrawal of Consent|0|||
42163161|NCT04124926|75970993|FG003|Healing Phase|Withdrawal of Consent|0|||
42163162|NCT04124926|75970994|FG004|Healing Phase|Withdrawal of Consent|0|||
42163163|NCT04124926|75970990|FG000|Healing Phase|Miscellaneous|8|||
42280956|NCT01597245|76112822|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280957|NCT01597245|76112823|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
42280958|NCT01597245|76112824|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
42280959|NCT01597245|76112825|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
42280960|NCT01597245|76112826|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
42280961|NCT01597245|76112827|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
42280962|NCT01597245|76112828|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280963|NCT01597245|76112829|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280964|NCT01597245|76112830|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280965|NCT01597245|76112831|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280966|NCT01597245|76112832|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280967|NCT01597245|76112833|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42163164|NCT04124926|75970991|FG001|Healing Phase|Miscellaneous|7|||
42163165|NCT04124926|75970992|FG002|Healing Phase|Miscellaneous|0|||
42280968|NCT01597245|76112834|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280969|NCT01597245|76112835|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
42280970|NCT01597245|76112815|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42013734|NCT00966355|75820854|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
42163166|NCT04124926|75970993|FG003|Healing Phase|Miscellaneous|0|||
42163167|NCT04124926|75970994|FG004|Healing Phase|Miscellaneous|0|||
42280971|NCT01597245|76112816|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280972|NCT01597245|76112817|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280973|NCT01597245|76112818|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280974|NCT01597245|76112819|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280975|NCT01597245|76112820|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
42280976|NCT01597245|76112821|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280977|NCT01597245|76112822|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280978|NCT01597245|76112823|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
42280979|NCT01597245|76112824|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
42280980|NCT01597245|76112825|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
42280981|NCT01597245|76112826|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
42280982|NCT01597245|76112827|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280983|NCT01597245|76112828|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280984|NCT01597245|76112829|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280985|NCT01597245|76112830|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280986|NCT01597245|76112831|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280987|NCT01597245|76112832|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280988|NCT01597245|76112833|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280989|NCT01597245|76112834|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280990|NCT01597245|76112835|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
42280991|NCT01597245|76112815|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42280992|NCT01597245|76112816|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42280993|NCT01597245|76112817|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42280994|NCT01597245|76112818|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42280995|NCT01597245|76112819|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42280996|NCT01597245|76112820|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42280997|NCT01597245|76112821|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42351615|NCT00984568|76191513|FG001|Overall Study|Opportunistic Infection|0|||
42351616|NCT00984568|76191512|FG000|Overall Study|Unknown Reason|1|||
42351617|NCT00984568|76191513|FG001|Overall Study|Unknown Reason|3|||
42351618|NCT00984256|76191521|FG000|Overall Study|Withdrawal by Subject|0|||
42351619|NCT00984256|76191522|FG001|Overall Study|Withdrawal by Subject|1|||
42351620|NCT00984022|76191539|FG000|Overall Study|Lost to Follow-up|10|||
42351621|NCT00984022|76191540|FG001|Overall Study|Lost to Follow-up|14|||
42351622|NCT01890265|76191552|FG000|Overall Study|Other (Unspecified reason)|0|||
42351623|NCT01890265|76191553|FG001|Overall Study|Other (Unspecified reason)|1|||
42351624|NCT01890265|76191554|FG002|Overall Study|Other (Unspecified reason)|0|||
42351625|NCT01890265|76191555|FG003|Overall Study|Other (Unspecified reason)|0|||
42351626|NCT01890265|76191556|FG004|Overall Study|Other (Unspecified reason)|0|||
42351627|NCT01890265|76191557|FG005|Overall Study|Other (Unspecified reason)|0|||
42351628|NCT01890265|76191552|FG000|Overall Study|Progressive disease|6|||
42013735|NCT00966355|75820855|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
42163168|NCT04124926|75970990|FG000|Healing Phase|Randomized but not Treated|0|||
42163169|NCT04124926|75970991|FG001|Healing Phase|Randomized but not Treated|3|||
42280998|NCT01597245|76112822|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42280999|NCT01597245|76112823|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42351629|NCT01890265|76191553|FG001|Overall Study|Progressive disease|6|||
42351630|NCT01890265|76191554|FG002|Overall Study|Progressive disease|0|||
42281000|NCT01597245|76112824|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42281001|NCT01597245|76112825|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
42163170|NCT04124926|75970992|FG002|Healing Phase|Randomized but not Treated|0|||
42163171|NCT04124926|75970993|FG003|Healing Phase|Randomized but not Treated|0|||
42163172|NCT04124926|75970994|FG004|Healing Phase|Randomized but not Treated|0|||
42163173|NCT04124926|75970990|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
42163174|NCT04124926|75970991|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
42163175|NCT04124926|75970992|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
42163176|NCT04124926|75970993|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
42163177|NCT04124926|75970994|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
42163178|NCT04124926|75970990|FG000|Maintenance Phase|Protocol Violation|0|||
42163179|NCT04124926|75970991|FG001|Maintenance Phase|Protocol Violation|0|||
42163180|NCT04124926|75970992|FG002|Maintenance Phase|Protocol Violation|3|||
42163181|NCT04124926|75970993|FG003|Maintenance Phase|Protocol Violation|0|||
42163182|NCT04124926|75970994|FG004|Maintenance Phase|Protocol Violation|0|||
42163183|NCT04124926|75970990|FG000|Maintenance Phase|Lost to Follow-up|0|||
42163184|NCT04124926|75970991|FG001|Maintenance Phase|Lost to Follow-up|0|||
42163185|NCT04124926|75970992|FG002|Maintenance Phase|Lost to Follow-up|7|||
42163186|NCT04124926|75970993|FG003|Maintenance Phase|Lost to Follow-up|8|||
42281002|NCT01597245|76112826|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42281003|NCT01597245|76112827|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42281004|NCT01597245|76112828|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42163187|NCT04124926|75970994|FG004|Maintenance Phase|Lost to Follow-up|9|||
42163188|NCT04124926|75970990|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
42163189|NCT04124926|75970991|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
42163190|NCT04124926|75970992|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
42163191|NCT04124926|75970993|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
42163192|NCT04124926|75970994|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
42163193|NCT04124926|75970990|FG000|Maintenance Phase|Pregnancy|0|||
42163194|NCT04124926|75970991|FG001|Maintenance Phase|Pregnancy|0|||
42163195|NCT04124926|75970992|FG002|Maintenance Phase|Pregnancy|0|||
42163196|NCT04124926|75970993|FG003|Maintenance Phase|Pregnancy|1|||
42163197|NCT04124926|75970994|FG004|Maintenance Phase|Pregnancy|0|||
42163198|NCT04124926|75970990|FG000|Maintenance Phase|Lack of Efficacy|0|||
42163199|NCT04124926|75970991|FG001|Maintenance Phase|Lack of Efficacy|0|||
42163200|NCT04124926|75970992|FG002|Maintenance Phase|Lack of Efficacy|0|||
42163201|NCT04124926|75970993|FG003|Maintenance Phase|Lack of Efficacy|0|||
42163202|NCT04124926|75970994|FG004|Maintenance Phase|Lack of Efficacy|1|||
42163203|NCT04124926|75970990|FG000|Maintenance Phase|Withdrawal of Consent|0|||
42163204|NCT04124926|75970991|FG001|Maintenance Phase|Withdrawal of Consent|0|||
42163205|NCT04124926|75970992|FG002|Maintenance Phase|Withdrawal of Consent|5|||
42163206|NCT04124926|75970993|FG003|Maintenance Phase|Withdrawal of Consent|5|||
42163207|NCT04124926|75970994|FG004|Maintenance Phase|Withdrawal of Consent|5|||
42163208|NCT04124926|75970990|FG000|Maintenance Phase|Miscellaneous|0|||
42163209|NCT04124926|75970991|FG001|Maintenance Phase|Miscellaneous|0|||
42163210|NCT04124926|75970992|FG002|Maintenance Phase|Miscellaneous|1|||
42163211|NCT04124926|75970993|FG003|Maintenance Phase|Miscellaneous|2|||
42163212|NCT04124926|75970994|FG004|Maintenance Phase|Miscellaneous|4|||
42163213|NCT04124926|75970990|FG000|Maintenance Phase|Randomized but not Treated|0|||
42163214|NCT04124926|75970991|FG001|Maintenance Phase|Randomized but not Treated|0|||
42163215|NCT04124926|75970992|FG002|Maintenance Phase|Randomized but not Treated|2|||
42163216|NCT04124926|75970993|FG003|Maintenance Phase|Randomized but not Treated|2|||
42163217|NCT04124926|75970994|FG004|Maintenance Phase|Randomized but not Treated|0|||
42163218|NCT04274686|75971006|FG000|Overall Study|Physician Decision|1|||
42163219|NCT04274686|75971007|FG001|Overall Study|Physician Decision|0|||
42163220|NCT04113694|75971015|FG000|Overall Study|Adverse Event|2|||
42163221|NCT04113694|75971015|FG000|Overall Study|Lost to Follow-up|2|||
42163222|NCT04113694|75971015|FG000|Overall Study|Withdrawal by Subject|6|||
42163223|NCT04113694|75971015|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
42163224|NCT04105972|75971024|FG000|Overall Study|Adverse Event|2|||
42163225|NCT04105972|75971025|FG001|Overall Study|Adverse Event|1|||
42163226|NCT04102540|75971031|FG000|Overall Study|Withdrawn by PI|2|||
42163227|NCT04102540|75971031|FG000|Overall Study|Lost to Follow-up|6|||
42163228|NCT00124982|75971037|FG000|Short-term Period|Death|1|||
42163229|NCT00124982|75971038|FG001|Short-term Period|Death|1|||
42163230|NCT00124982|75971039|FG002|Short-term Period|Death|0|||
42163231|NCT00124982|75971037|FG000|Short-term Period|Adverse Event|17|||
42163232|NCT00124982|75971038|FG001|Short-term Period|Adverse Event|22|||
42163233|NCT00124982|75971039|FG002|Short-term Period|Adverse Event|0|||
42163234|NCT00124982|75971037|FG000|Short-term Period|Lack of Efficacy|32|||
42163235|NCT00124982|75971038|FG001|Short-term Period|Lack of Efficacy|73|||
42163236|NCT00124982|75971039|FG002|Short-term Period|Lack of Efficacy|0|||
42163237|NCT00124982|75971037|FG000|Short-term Period|Lost to Follow-up|8|||
42163238|NCT00124982|75971038|FG001|Short-term Period|Lost to Follow-up|5|||
42163239|NCT00124982|75971039|FG002|Short-term Period|Lost to Follow-up|0|||
42163240|NCT00124982|75971037|FG000|Short-term Period|Withdrawal of Consent|7|||
42163241|NCT00124982|75971038|FG001|Short-term Period|Withdrawal of Consent|9|||
42163242|NCT00124982|75971039|FG002|Short-term Period|Withdrawal of Consent|0|||
42163243|NCT00124982|75971037|FG000|Short-term Period|Poor/Non-compliance|3|||
42163244|NCT00124982|75971038|FG001|Short-term Period|Poor/Non-compliance|1|||
42163245|NCT00124982|75971039|FG002|Short-term Period|Poor/Non-compliance|0|||
42163246|NCT00124982|75971037|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
42163247|NCT00124982|75971038|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
42163248|NCT00124982|75971039|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
42163249|NCT00124982|75971037|FG000|Short-term Period|Participant Decision|1|||
42163250|NCT00124982|75971038|FG001|Short-term Period|Participant Decision|0|||
42163251|NCT00124982|75971039|FG002|Short-term Period|Participant Decision|0|||
42163252|NCT00124982|75971037|FG000|Short-term Period|Participant Chose Own Doctor|0|||
42163253|NCT00124982|75971038|FG001|Short-term Period|Participant Chose Own Doctor|1|||
42163254|NCT00124982|75971039|FG002|Short-term Period|Participant Chose Own Doctor|0|||
42163255|NCT00124982|75971037|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
42163256|NCT00124982|75971038|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
42163257|NCT00124982|75971039|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
42163258|NCT00124982|75971037|FG000|Short-term Period|Participant Had Lymphopenia|1|||
42163259|NCT00124982|75971038|FG001|Short-term Period|Participant Had Lymphopenia|0|||
42163260|NCT00124982|75971039|FG002|Short-term Period|Participant Had Lymphopenia|0|||
42163261|NCT00124982|75971037|FG000|Long-term Period|Death|0|||
42163262|NCT00124982|75971038|FG001|Long-term Period|Death|0|||
42163263|NCT00124982|75971039|FG002|Long-term Period|Death|1|||
42163264|NCT00124982|75971037|FG000|Long-term Period|Adverse Event|0|||
42163265|NCT00124982|75971038|FG001|Long-term Period|Adverse Event|0|||
42163266|NCT00124982|75971039|FG002|Long-term Period|Adverse Event|17|||
42163267|NCT00124982|75971037|FG000|Long-term Period|Lack of Efficacy|0|||
42163268|NCT00124982|75971038|FG001|Long-term Period|Lack of Efficacy|0|||
42281005|NCT01597245|76112829|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42281006|NCT01597245|76112830|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42281007|NCT01597245|76112831|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42281008|NCT01597245|76112832|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42163269|NCT00124982|75971039|FG002|Long-term Period|Lack of Efficacy|46|||
42163270|NCT00124982|75971037|FG000|Long-term Period|Lost to Follow-up|0|||
42281009|NCT01597245|76112833|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42281010|NCT01597245|76112834|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42281011|NCT01597245|76112835|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
42281012|NCT01597245|76112815|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281013|NCT01597245|76112816|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42163271|NCT00124982|75971038|FG001|Long-term Period|Lost to Follow-up|0|||
42163272|NCT00124982|75971039|FG002|Long-term Period|Lost to Follow-up|4|||
42163273|NCT00124982|75971037|FG000|Long-term Period|Withdrawal by Subject|0|||
42163274|NCT00124982|75971038|FG001|Long-term Period|Withdrawal by Subject|0|||
42163275|NCT00124982|75971039|FG002|Long-term Period|Withdrawal by Subject|16|||
42163276|NCT00124982|75971037|FG000|Long-term Period|Pregnancy|0|||
42163277|NCT00124982|75971038|FG001|Long-term Period|Pregnancy|0|||
42163278|NCT00124982|75971039|FG002|Long-term Period|Pregnancy|1|||
42281014|NCT01597245|76112817|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281015|NCT01597245|76112818|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281016|NCT01597245|76112819|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281017|NCT01597245|76112820|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281018|NCT01597245|76112821|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281019|NCT01597245|76112822|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281020|NCT01597245|76112823|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281021|NCT01597245|76112824|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281022|NCT01597245|76112825|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281023|NCT01597245|76112826|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42013736|NCT00966355|75820853|FG000|Overall Study|newly diagnosed advanced HCC|11|||
42013737|NCT00966355|75820854|FG001|Overall Study|newly diagnosed advanced HCC|12|||
42013738|NCT00966355|75820855|FG002|Overall Study|newly diagnosed advanced HCC|10|||
42163279|NCT00124982|75971037|FG000|Long-term Period|Poor/Non-compliance|0|||
42163280|NCT00124982|75971038|FG001|Long-term Period|Poor/Non-compliance|0|||
42163281|NCT00124982|75971039|FG002|Long-term Period|Poor/Non-compliance|2|||
42163282|NCT00124982|75971037|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
42163283|NCT00124982|75971038|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
42163284|NCT00124982|75971039|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
42163285|NCT00124982|75971037|FG000|Long-term Period|Neurologist Recommendation|0|||
42163286|NCT00124982|75971038|FG001|Long-term Period|Neurologist Recommendation|0|||
42163287|NCT00124982|75971039|FG002|Long-term Period|Neurologist Recommendation|1|||
42163288|NCT04263142|75971053|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
42163289|NCT04263142|75971054|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
42163290|NCT04263142|75971055|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
42163291|NCT04263142|75971056|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
42163292|NCT04263142|75971057|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
42163293|NCT04263142|75971053|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
42163294|NCT04263142|75971054|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
42163295|NCT04263142|75971055|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
42163296|NCT04263142|75971056|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
42163297|NCT04263142|75971057|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
42163298|NCT04095286|75971070|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
42163299|NCT04095286|75971071|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
42163300|NCT04095286|75971072|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
42163301|NCT04095286|75971073|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
42163302|NCT04095286|75971074|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
42163303|NCT04095286|75971075|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
42163304|NCT04095286|75971070|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
42163305|NCT04095286|75971071|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
42163306|NCT04095286|75971072|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
42163307|NCT04095286|75971073|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
42163308|NCT04095286|75971074|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
42163309|NCT04095286|75971075|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
42163310|NCT04095286|75971070|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
42163311|NCT04095286|75971071|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
42163312|NCT04095286|75971072|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
42163313|NCT04095286|75971073|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
42163314|NCT04095286|75971074|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
42163315|NCT04095286|75971075|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
42163316|NCT04095286|75971070|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
42163317|NCT04095286|75971071|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
42281024|NCT01597245|76112827|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281025|NCT01597245|76112828|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
42281026|NCT01597245|76112829|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
42281027|NCT01597245|76112830|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
42281028|NCT01597245|76112831|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281029|NCT01597245|76112832|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281030|NCT01597245|76112833|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281031|NCT01597245|76112834|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281032|NCT01597245|76112835|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
42281033|NCT01597245|76112815|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281034|NCT01597245|76112816|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281035|NCT01597245|76112817|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281036|NCT01597245|76112818|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281037|NCT01597245|76112819|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281038|NCT01597245|76112820|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281039|NCT01597245|76112821|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281040|NCT01597245|76112822|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281041|NCT01597245|76112823|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281042|NCT01597245|76112824|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281043|NCT01597245|76112825|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281044|NCT01597245|76112826|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281045|NCT01597245|76112827|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281046|NCT01597245|76112828|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
42013739|NCT00966355|75820853|FG000|Overall Study|Lost to Follow-up|5|||
42013740|NCT00966355|75820854|FG001|Overall Study|Lost to Follow-up|4|||
42013741|NCT00966355|75820855|FG002|Overall Study|Lost to Follow-up|3|||
42013742|NCT01172535|75820863|FG000|Overall Study|Death|3|||
42013743|NCT01172535|75820863|FG000|Overall Study|Withdrawal by Subject|2|||
42013744|NCT01172535|75820863|FG000|Overall Study|Lost to Follow-up|1|||
42013745|NCT01172535|75820863|FG000|Overall Study|Ineligible at study entry|1|||
42013746|NCT01172535|75820863|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
42163318|NCT04095286|75971072|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
42013747|NCT00966277|75820872|FG000|Overall Study|Withdrawal by Subject|3|||
42013748|NCT00966277|75820873|FG001|Overall Study|Withdrawal by Subject|0|||
42163319|NCT04095286|75971073|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
42013749|NCT00966277|75820872|FG000|Overall Study|Ineligible|1|||
42013750|NCT00966277|75820873|FG001|Overall Study|Ineligible|3|||
42013751|NCT00966277|75820872|FG000|Overall Study|Treatment Plan Changed|0|||
42013752|NCT00966277|75820873|FG001|Overall Study|Treatment Plan Changed|1|||
42013753|NCT01298141|75820879|FG000|Overall Study|Adverse Event|3|||
42013754|NCT01298141|75820879|FG000|Overall Study|Refusal of Required Study Procedures|1|||
42013755|NCT01298141|75820879|FG000|Overall Study|Withdrawal by Subject|6|||
42013756|NCT01298141|75820879|FG000|Overall Study|Termination of Study by the Investigator|5|||
42013757|NCT01298141|75820879|FG000|Overall Study|Other|5|||
42013758|NCT01298141|75820879|FG000|Overall Study|Lost to Follow-up|1|||
42013759|NCT01298141|75820879|FG000|Overall Study|Death|6|||
42013760|NCT01298141|75820879|FG000|Overall Study|Not treated|4|||
42013761|NCT01171989|75820886|FG000|Overall Study|Lost to Follow-up|0|||
42013762|NCT01171989|75820887|FG001|Overall Study|Lost to Follow-up|0|||
42013763|NCT01171989|75820888|FG002|Overall Study|Lost to Follow-up|1|||
42281047|NCT01597245|76112829|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
42281048|NCT01597245|76112830|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
42281049|NCT01597245|76112831|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281050|NCT01597245|76112832|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42013764|NCT01297517|75820899|FG000|Overall Study|Adverse Event|21|||
42163320|NCT04095286|75971074|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
42163321|NCT04095286|75971075|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
42163322|NCT04095286|75971070|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
42163323|NCT04095286|75971071|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
42163324|NCT04095286|75971072|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
42163325|NCT04095286|75971073|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
42163326|NCT04095286|75971074|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
42163327|NCT04095286|75971075|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
42163328|NCT04093414|75971085|FG000|3 Month Follow up|Physician Decision|0|||
42163329|NCT04093414|75971086|FG001|3 Month Follow up|Physician Decision|1|||
42163330|NCT04093414|75971085|FG000|6month Follow up|Physician Decision|1|||
42163331|NCT04093414|75971086|FG001|6month Follow up|Physician Decision|3|||
42163332|NCT04093258|75971092|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
42163333|NCT04093258|75971093|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
42163334|NCT04253236|75971101|FG000|Overall Study|Adverse Event|1|||
42163335|NCT04253236|75971102|FG001|Overall Study|Adverse Event|0|||
42163336|NCT04253236|75971101|FG000|Overall Study|Safety Concerns|1|||
42163337|NCT04253236|75971102|FG001|Overall Study|Safety Concerns|0|||
42163338|NCT04253236|75971101|FG000|Overall Study|Study Terminated by Sponsor|1|||
42163339|NCT04253236|75971102|FG001|Overall Study|Study Terminated by Sponsor|0|||
42163340|NCT04087720|75971108|FG000|Overall Study|Withdrawal by Subject|2|||
42163341|NCT04087720|75971108|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
42163342|NCT04086472|75971117|FG000|Overall Study|Lost to Follow-up|1|||
42163343|NCT04086472|75971118|FG001|Overall Study|Lost to Follow-up|0|||
42163344|NCT04086472|75971119|FG002|Overall Study|Lost to Follow-up|0|||
42163345|NCT04086472|75971120|FG003|Overall Study|Lost to Follow-up|0|||
42163346|NCT04086472|75971121|FG004|Overall Study|Lost to Follow-up|1|||
42163347|NCT04086472|75971117|FG000|Overall Study|Physician Decision|0|||
42163348|NCT04086472|75971118|FG001|Overall Study|Physician Decision|1|||
42163349|NCT04086472|75971119|FG002|Overall Study|Physician Decision|1|||
42163350|NCT04086472|75971120|FG003|Overall Study|Physician Decision|0|||
42163351|NCT04086472|75971121|FG004|Overall Study|Physician Decision|0|||
42163352|NCT04086472|75971117|FG000|Overall Study|Withdrawal by Subject|1|||
42163353|NCT04086472|75971118|FG001|Overall Study|Withdrawal by Subject|1|||
42163354|NCT04086472|75971119|FG002|Overall Study|Withdrawal by Subject|1|||
42163355|NCT04086472|75971120|FG003|Overall Study|Withdrawal by Subject|0|||
42281051|NCT01597245|76112833|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281052|NCT01597245|76112834|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281053|NCT01597245|76112835|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
42281054|NCT01597245|76112815|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281055|NCT01597245|76112816|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281056|NCT01597245|76112817|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281057|NCT01597245|76112818|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42163356|NCT04086472|75971121|FG004|Overall Study|Withdrawal by Subject|0|||
42013765|NCT01297517|75820900|FG001|Overall Study|Adverse Event|7|||
42013766|NCT01297517|75820901|FG002|Overall Study|Adverse Event|16|||
42013767|NCT01297517|75820899|FG000|Overall Study|Lost to Follow-up|1|||
42013768|NCT01297517|75820900|FG001|Overall Study|Lost to Follow-up|0|||
42163357|NCT04086472|75971117|FG000|Overall Study|Various reasons|2|||
42163358|NCT04086472|75971118|FG001|Overall Study|Various reasons|0|||
42013769|NCT01297517|75820901|FG002|Overall Study|Lost to Follow-up|1|||
42013770|NCT01297517|75820899|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
42013771|NCT01297517|75820900|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
42281058|NCT01597245|76112819|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281059|NCT01597245|76112820|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281060|NCT01597245|76112821|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281061|NCT01597245|76112822|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281062|NCT01597245|76112823|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281063|NCT01597245|76112824|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281064|NCT01597245|76112825|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281065|NCT01597245|76112826|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281066|NCT01597245|76112827|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281067|NCT01597245|76112828|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281068|NCT01597245|76112829|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
42281069|NCT01597245|76112830|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
42281070|NCT01597245|76112831|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281071|NCT01597245|76112832|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42163359|NCT04086472|75971119|FG002|Overall Study|Various reasons|0|||
42163360|NCT04086472|75971120|FG003|Overall Study|Various reasons|3|||
42163361|NCT04086472|75971121|FG004|Overall Study|Various reasons|1|||
42163362|NCT04249336|75971137|FG000|Overall Study|Lost to Follow-up|3|||
42163363|NCT04249336|75971138|FG001|Overall Study|Lost to Follow-up|3|||
42163364|NCT04249336|75971139|FG002|Overall Study|Lost to Follow-up|3|||
42163365|NCT04249336|75971140|FG003|Overall Study|Lost to Follow-up|3|||
42163366|NCT04245202|75971152|FG000|Overall Study|Lack of Efficacy|10|||
42163367|NCT04245202|75971153|FG001|Overall Study|Lack of Efficacy|1|||
42163368|NCT04079842|75971160|FG000|Overall Study|Request of subject|2|||
42163369|NCT04079842|75971160|FG000|Overall Study|Unable to draw Arterial samples|1|||
42163370|NCT04078126|75971164|FG000|Washout|Study put on hold due to COVID-19|0|||
42163371|NCT04078126|75971165|FG001|Washout|Study put on hold due to COVID-19|2|||
42163372|NCT04078126|75971164|FG000|Period 2|Study put on hold due to COVID-19|1|||
42163373|NCT04078126|75971165|FG001|Period 2|Study put on hold due to COVID-19|1|||
42163374|NCT04073368|75971175|FG000|Overall Study|Adverse Event|2|||
42163375|NCT04073368|75971176|FG001|Overall Study|Adverse Event|0|||
42163376|NCT04073368|75971177|FG002|Overall Study|Adverse Event|1|||
42163377|NCT04073368|75971178|FG003|Overall Study|Adverse Event|1|||
42163378|NCT04073368|75971175|FG000|Overall Study|Withdrawal by Subject|2|||
42163379|NCT04073368|75971176|FG001|Overall Study|Withdrawal by Subject|2|||
42163380|NCT04073368|75971177|FG002|Overall Study|Withdrawal by Subject|1|||
42163381|NCT04073368|75971178|FG003|Overall Study|Withdrawal by Subject|1|||
42163382|NCT04073368|75971175|FG000|Overall Study|Lost to Follow-up|1|||
42163383|NCT04073368|75971176|FG001|Overall Study|Lost to Follow-up|1|||
42163384|NCT04073368|75971177|FG002|Overall Study|Lost to Follow-up|1|||
42163385|NCT04073368|75971178|FG003|Overall Study|Lost to Follow-up|0|||
42163386|NCT04073368|75971175|FG000|Overall Study|Protocol Violation|0|||
42163387|NCT04073368|75971176|FG001|Overall Study|Protocol Violation|1|||
42163388|NCT04073368|75971177|FG002|Overall Study|Protocol Violation|0|||
42163389|NCT04073368|75971178|FG003|Overall Study|Protocol Violation|0|||
42163390|NCT04073368|75971175|FG000|Overall Study|Subject noncompliance|7|||
42163391|NCT04073368|75971176|FG001|Overall Study|Subject noncompliance|4|||
42163392|NCT04073368|75971177|FG002|Overall Study|Subject noncompliance|0|||
42163393|NCT04073368|75971178|FG003|Overall Study|Subject noncompliance|0|||
42163394|NCT04380688|75971190|FG000|Overall Study|Death|2|||
42163395|NCT04380688|75971191|FG001|Overall Study|Death|2|||
42163396|NCT04380688|75971190|FG000|Overall Study|Lost to Follow-up|2|||
42163397|NCT04380688|75971191|FG001|Overall Study|Lost to Follow-up|4|||
42163398|NCT04380688|75971190|FG000|Overall Study|Withdrawal by Subject|3|||
42163399|NCT04380688|75971191|FG001|Overall Study|Withdrawal by Subject|3|||
42163400|NCT00124748|75971199|FG000|Overall Study|Adverse Event|8|||
42163401|NCT00124748|75971200|FG001|Overall Study|Adverse Event|39|||
42163402|NCT00124748|75971199|FG000|Overall Study|Abnormal laboratory Value|2|||
42163403|NCT00124748|75971200|FG001|Overall Study|Abnormal laboratory Value|2|||
42163404|NCT00124748|75971199|FG000|Overall Study|Abnormal Procedure|0|||
42163405|NCT00124748|75971200|FG001|Overall Study|Abnormal Procedure|1|||
42163406|NCT00124748|75971199|FG000|Overall Study|Lack of Efficacy|20|||
42163407|NCT00124748|75971200|FG001|Overall Study|Lack of Efficacy|41|||
42163408|NCT00124748|75971199|FG000|Overall Study|No longer requires study drug|1|||
42281072|NCT01597245|76112833|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281073|NCT01597245|76112834|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42163409|NCT00124748|75971200|FG001|Overall Study|No longer requires study drug|1|||
42163410|NCT00124748|75971199|FG000|Overall Study|Protocol Violation|3|||
42163411|NCT00124748|75971200|FG001|Overall Study|Protocol Violation|1|||
42163412|NCT00124748|75971199|FG000|Overall Study|Withdrawal by Subject|5|||
42163413|NCT00124748|75971200|FG001|Overall Study|Withdrawal by Subject|15|||
42163414|NCT00124748|75971199|FG000|Overall Study|Lost to Follow-up|2|||
42163415|NCT00124748|75971200|FG001|Overall Study|Lost to Follow-up|7|||
42163416|NCT00124748|75971199|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
42163417|NCT00124748|75971200|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
42163418|NCT00124748|75971199|FG000|Overall Study|Death|1|||
42013772|NCT01297517|75820901|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
42013773|NCT01297517|75820899|FG000|Overall Study|Noncompliance|1|||
42163419|NCT00124748|75971200|FG001|Overall Study|Death|3|||
42163420|NCT04070326|75971208|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
42163421|NCT04070326|75971209|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
42163422|NCT03689452|75971219|FG000|Overall Study|Lost to Follow-up|1|||
42163423|NCT03689452|75971220|FG001|Overall Study|Lost to Follow-up|1|||
42163424|NCT04067050|75971228|FG000|One Month|Lost to Follow-up|4|||
42163425|NCT04067050|75971229|FG001|One Month|Lost to Follow-up|0|||
42163426|NCT04067050|75971228|FG000|Two Month|Lost to Follow-up|1|||
42163427|NCT04067050|75971229|FG001|Two Month|Lost to Follow-up|0|||
42163428|NCT04067050|75971228|FG000|Two Month|Adverse Event|1|||
42163429|NCT04067050|75971229|FG001|Two Month|Adverse Event|0|||
42163430|NCT04060654|75971235|FG000|Overall Study|Withdrawal by Subject|1|||
42163431|NCT04060654|75971235|FG000|Overall Study|Lost to Follow-up|5|||
42163432|NCT00096200|75971242|FG000|Overall Study|Adverse Event|0|||
42163433|NCT00096200|75971243|FG001|Overall Study|Adverse Event|4|||
42163434|NCT00096200|75971244|FG002|Overall Study|Adverse Event|0|||
42163435|NCT00096200|75971242|FG000|Overall Study|Withdrawal by Subject|1|||
42163436|NCT00096200|75971243|FG001|Overall Study|Withdrawal by Subject|2|||
42163437|NCT00096200|75971244|FG002|Overall Study|Withdrawal by Subject|0|||
42163438|NCT00096200|75971242|FG000|Overall Study|Ineligible pathology|0|||
42163439|NCT00096200|75971243|FG001|Overall Study|Ineligible pathology|1|||
42163440|NCT00096200|75971244|FG002|Overall Study|Ineligible pathology|0|||
42163441|NCT04059094|75971257|FG000|Overall Study|Adverse Event|0|||
42163442|NCT04059094|75971258|FG001|Overall Study|Adverse Event|0|||
42163443|NCT04059094|75971259|FG002|Overall Study|Adverse Event|0|||
42163444|NCT04059094|75971260|FG003|Overall Study|Adverse Event|0|||
42163445|NCT04059094|75971261|FG004|Overall Study|Adverse Event|1|||
42163446|NCT04059094|75971257|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
42163447|NCT04059094|75971258|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
42163448|NCT04059094|75971259|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
42163449|NCT04059094|75971260|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
42163450|NCT04059094|75971261|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
42163451|NCT00096044|75971277|FG000|Overall Study|Withdrawal by Subject|9|||
42163452|NCT00096044|75971277|FG000|Overall Study|Adverse Event|21|||
42163453|NCT00096044|75971277|FG000|Overall Study|Disease Progression|4|||
42163454|NCT03689374|75971283|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
42163455|NCT03689374|75971284|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
42163456|NCT03689374|75971285|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
42163457|NCT03689374|75971283|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
42163458|NCT03689374|75971284|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
42163459|NCT03689374|75971285|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
42163460|NCT03689374|75971283|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
42163461|NCT03689374|75971284|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
42163462|NCT03689374|75971285|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
42163463|NCT03689374|75971283|FG000|Treatment Period (Week 0 to 52)|Death|0|||
42163464|NCT03689374|75971284|FG001|Treatment Period (Week 0 to 52)|Death|11|||
42163465|NCT03689374|75971285|FG002|Treatment Period (Week 0 to 52)|Death|1|||
42163466|NCT00123734|75971291|FG000|Overall Study|Death|3|||
42163467|NCT00123734|75971291|FG000|Overall Study|Lost to Follow-up|3|||
42163468|NCT00123734|75971291|FG000|Overall Study|Dropout|1|||
42163469|NCT00123734|75971291|FG000|Overall Study|Withdrawal by Subject|1|||
42163470|NCT00112736|75971301|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
42163471|NCT00112736|75971302|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
42163472|NCT00123422|75971317|FG000|Overall Study|Physician Decision|2|||
42163473|NCT00123422|75971318|FG001|Overall Study|Physician Decision|2|||
42163474|NCT00123422|75971319|FG002|Overall Study|Physician Decision|6|||
42163475|NCT00123422|75971317|FG000|Overall Study|Withdrawal by Subject|1|||
42013774|NCT01297517|75820900|FG001|Overall Study|Noncompliance|0|||
42013775|NCT01297517|75820901|FG002|Overall Study|Noncompliance|0|||
42013776|NCT01297517|75820899|FG000|Overall Study|Protocol Violation|1|||
42013777|NCT01297517|75820900|FG001|Overall Study|Protocol Violation|1|||
42163476|NCT00123422|75971318|FG001|Overall Study|Withdrawal by Subject|2|||
42163477|NCT00123422|75971319|FG002|Overall Study|Withdrawal by Subject|2|||
42163478|NCT00123422|75971317|FG000|Overall Study|Lost to Follow-up|1|||
42163479|NCT00123422|75971318|FG001|Overall Study|Lost to Follow-up|2|||
42163480|NCT00123422|75971319|FG002|Overall Study|Lost to Follow-up|2|||
42163481|NCT04052620|75971329|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
42013778|NCT01297517|75820901|FG002|Overall Study|Protocol Violation|1|||
42013779|NCT01297517|75820899|FG000|Overall Study|Inadequate Control of IOP|1|||
42163482|NCT04052620|75971330|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
42163483|NCT04052620|75971329|FG000|Overall Study|Withdrawal by Subject|1|||
42163484|NCT04052620|75971330|FG001|Overall Study|Withdrawal by Subject|0|||
42163485|NCT04052620|75971329|FG000|Overall Study|Lost to Follow-up|1|||
42163486|NCT04052620|75971330|FG001|Overall Study|Lost to Follow-up|1|||
42163487|NCT04052620|75971329|FG000|Overall Study|Adverse Event|1|||
42163488|NCT04052620|75971330|FG001|Overall Study|Adverse Event|0|||
42163489|NCT04052620|75971329|FG000|Overall Study|Subject did not meet study Criteria|0|||
42163490|NCT04052620|75971330|FG001|Overall Study|Subject did not meet study Criteria|1|||
42163491|NCT04052620|75971329|FG000|Overall Study|Screened failure, randomized by mistake|0|||
42163492|NCT04052620|75971330|FG001|Overall Study|Screened failure, randomized by mistake|1|||
42163493|NCT04052620|75971329|FG000|Overall Study|Personal reasons|2|||
42163494|NCT04052620|75971330|FG001|Overall Study|Personal reasons|4|||
42163495|NCT04052620|75971329|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
42163496|NCT04052620|75971330|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
42163497|NCT00112580|75971338|FG000|Overall Study|Adverse Event|1|||
42163498|NCT00112580|75971339|FG001|Overall Study|Adverse Event|2|||
42163499|NCT00112580|75971338|FG000|Overall Study|Disease progression|5|||
42163500|NCT00112580|75971339|FG001|Overall Study|Disease progression|16|||
42163501|NCT00112580|75971338|FG000|Overall Study|Participant withdrew consent|2|||
42163502|NCT00112580|75971339|FG001|Overall Study|Participant withdrew consent|1|||
42163503|NCT04238650|75971346|FG000|Overall Study|Withdrawal by Subject|0|||
42163504|NCT04238650|75971347|FG001|Overall Study|Withdrawal by Subject|1|||
42163505|NCT00095576|75971355|FG000|Overall Study|Adverse Event|5|||
42163506|NCT00095576|75971356|FG001|Overall Study|Adverse Event|3|||
42163507|NCT00095576|75971355|FG000|Overall Study|Lost to Follow-up|233|||
42163508|NCT00095576|75971356|FG001|Overall Study|Lost to Follow-up|229|||
42163509|NCT00095576|75971355|FG000|Overall Study|Protocol Violation|1|||
42163510|NCT00095576|75971356|FG001|Overall Study|Protocol Violation|0|||
42163511|NCT00095576|75971355|FG000|Overall Study|Withdrawal by Subject|34|||
42163512|NCT00095576|75971356|FG001|Overall Study|Withdrawal by Subject|47|||
42163513|NCT00095576|75971355|FG000|Overall Study|Option to switch to a rollover study|1097|||
42281074|NCT01597245|76112835|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
42281075|NCT01597245|76112815|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281076|NCT01597245|76112816|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281077|NCT01597245|76112817|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281078|NCT01597245|76112818|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281079|NCT01597245|76112819|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281080|NCT01597245|76112820|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281081|NCT01597245|76112821|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281082|NCT01597245|76112822|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281083|NCT01597245|76112823|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281084|NCT01597245|76112824|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281085|NCT01597245|76112825|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281086|NCT01597245|76112826|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42163514|NCT00095576|75971356|FG001|Overall Study|Option to switch to a rollover study|1099|||
42163515|NCT00095576|75971355|FG000|Overall Study|Site terminated|75|||
42163516|NCT00095576|75971356|FG001|Overall Study|Site terminated|67|||
42163517|NCT00095576|75971355|FG000|Overall Study|Subject moved|30|||
42163518|NCT00095576|75971356|FG001|Overall Study|Subject moved|36|||
42163519|NCT04049578|75971362|FG000|Overall Study|Physician Decision|1|||
42163520|NCT04044352|75971366|FG000|Overall Study|Lost to Follow-up|9|||
42163521|NCT04044352|75971366|FG000|Overall Study|Withdrawal by Subject|2|||
42163522|NCT04043962|75971371|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
42163523|NCT04043962|75971371|FG000|Post-Treatment|Withdrawal by Subject|5|||
42281087|NCT01597245|76112827|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281088|NCT01597245|76112828|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42163524|NCT04043962|75971371|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
42281089|NCT01597245|76112829|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
42281090|NCT01597245|76112830|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
42281091|NCT01597245|76112831|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281092|NCT01597245|76112832|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281093|NCT01597245|76112833|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281094|NCT01597245|76112834|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42281095|NCT01597245|76112835|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
42163525|NCT04043728|75971378|FG000|Overall Study|Lost to Follow-up|1|||
42163526|NCT04043728|75971379|FG001|Overall Study|Lost to Follow-up|2|||
42163527|NCT04043728|75971380|FG002|Overall Study|Lost to Follow-up|0|||
42163528|NCT04043416|75971390|FG000|Washout|Change in health condition|0|||
42163529|NCT04043416|75971391|FG001|Washout|Change in health condition|1|||
42163530|NCT00095498|75971403|FG000|Overall Study|Physician Decision|9|||
42163531|NCT00095498|75971404|FG001|Overall Study|Physician Decision|10|||
42163532|NCT00095498|75971405|FG002|Overall Study|Physician Decision|8|||
42163533|NCT00095498|75971403|FG000|Overall Study|Adverse Event|1|||
42163534|NCT00095498|75971404|FG001|Overall Study|Adverse Event|0|||
42163535|NCT00095498|75971405|FG002|Overall Study|Adverse Event|1|||
42163536|NCT00095498|75971403|FG000|Overall Study|Withdrawal by Subject|15|||
42163537|NCT00095498|75971404|FG001|Overall Study|Withdrawal by Subject|16|||
42163538|NCT00095498|75971405|FG002|Overall Study|Withdrawal by Subject|15|||
42163539|NCT00095498|75971403|FG000|Overall Study|Disease progression|0|||
42163540|NCT00095498|75971404|FG001|Overall Study|Disease progression|1|||
42163541|NCT00095498|75971405|FG002|Overall Study|Disease progression|1|||
42163542|NCT00095498|75971403|FG000|Overall Study|Ineligibility determined|3|||
42163543|NCT00095498|75971404|FG001|Overall Study|Ineligibility determined|0|||
42163544|NCT00095498|75971405|FG002|Overall Study|Ineligibility determined|2|||
42163545|NCT00095498|75971403|FG000|Overall Study|Lost to Follow-up|1|||
42163546|NCT00095498|75971404|FG001|Overall Study|Lost to Follow-up|1|||
42163547|NCT00095498|75971405|FG002|Overall Study|Lost to Follow-up|2|||
42163548|NCT00095498|75971403|FG000|Overall Study|Noncompliance|1|||
42163549|NCT00095498|75971404|FG001|Overall Study|Noncompliance|0|||
42163550|NCT00095498|75971405|FG002|Overall Study|Noncompliance|1|||
42163551|NCT00095498|75971403|FG000|Overall Study|Other|6|||
42163552|NCT00095498|75971404|FG001|Overall Study|Other|7|||
42163553|NCT00095498|75971405|FG002|Overall Study|Other|6|||
42163554|NCT00095498|75971403|FG000|Overall Study|Protocol Violation|0|||
42163555|NCT00095498|75971404|FG001|Overall Study|Protocol Violation|0|||
42163556|NCT00095498|75971405|FG002|Overall Study|Protocol Violation|1|||
42163557|NCT00095498|75971403|FG000|Overall Study|Requirement for alternative therapy|1|||
42163558|NCT00095498|75971404|FG001|Overall Study|Requirement for alternative therapy|0|||
42281096|NCT01597245|76112815|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281097|NCT01597245|76112816|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281098|NCT01597245|76112817|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281099|NCT01597245|76112818|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281100|NCT01597245|76112819|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281101|NCT01597245|76112820|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281102|NCT01597245|76112821|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281103|NCT01597245|76112822|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281104|NCT01597245|76112823|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281105|NCT01597245|76112824|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281106|NCT01597245|76112825|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281107|NCT01597245|76112826|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281108|NCT01597245|76112827|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281109|NCT01597245|76112828|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
42163559|NCT00095498|75971405|FG002|Overall Study|Requirement for alternative therapy|2|||
42281110|NCT01597245|76112829|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
42281111|NCT01597245|76112830|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
42281112|NCT01597245|76112831|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281113|NCT01597245|76112832|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42163560|NCT04237792|75971419|FG000|Treatment (Day 1)|Adverse Event|1|||
42163561|NCT04237792|75971420|FG001|Treatment (Day 1)|Adverse Event|0|||
42163562|NCT04237792|75971421|FG002|Treatment (Day 1)|Adverse Event|0|||
42163563|NCT04237792|75971422|FG003|Treatment (Day 1)|Adverse Event|0|||
42163564|NCT04237792|75971423|FG004|Treatment (Day 1)|Adverse Event|1|||
42163565|NCT04237792|75971424|FG005|Treatment (Day 1)|Adverse Event|1|||
42163566|NCT04237792|75971419|FG000|Treatment (Day 1)|Other|0|||
42163567|NCT04237792|75971420|FG001|Treatment (Day 1)|Other|0|||
42163568|NCT04237792|75971421|FG002|Treatment (Day 1)|Other|1|||
42163569|NCT04237792|75971422|FG003|Treatment (Day 1)|Other|0|||
42163570|NCT04237792|75971423|FG004|Treatment (Day 1)|Other|0|||
42163571|NCT04237792|75971424|FG005|Treatment (Day 1)|Other|1|||
42163572|NCT04237792|75971419|FG000|Treatment (Day 1)|Not treated|1|||
42163573|NCT04237792|75971420|FG001|Treatment (Day 1)|Not treated|1|||
42163574|NCT04237792|75971421|FG002|Treatment (Day 1)|Not treated|2|||
42163575|NCT04237792|75971422|FG003|Treatment (Day 1)|Not treated|1|||
42163576|NCT04237792|75971423|FG004|Treatment (Day 1)|Not treated|0|||
42163577|NCT04237792|75971424|FG005|Treatment (Day 1)|Not treated|1|||
42163578|NCT00122954|75971455|FG000|Overall Study|Withdrawal by Subject|2|||
42163579|NCT00122954|75971456|FG001|Overall Study|Withdrawal by Subject|2|||
42163580|NCT00122954|75971455|FG000|Overall Study|Protocol Violation|0|||
42163581|NCT00122954|75971456|FG001|Overall Study|Protocol Violation|1|||
42163582|NCT04491994|75971464|FG000|Overall Study|Withdrawal by Subject|10|||
42163583|NCT04491994|75971465|FG001|Overall Study|Withdrawal by Subject|5|||
42163584|NCT04491994|75971464|FG000|Overall Study|developed fever > 3 days|4|||
42163585|NCT04491994|75971465|FG001|Overall Study|developed fever > 3 days|1|||
42163586|NCT04491994|75971464|FG000|Overall Study|Protocol Violation|11|||
42163587|NCT04491994|75971465|FG001|Overall Study|Protocol Violation|2|||
42163588|NCT04491994|75971464|FG000|Overall Study|Lost to Follow-up|4|||
42163589|NCT04491994|75971465|FG001|Overall Study|Lost to Follow-up|3|||
42163590|NCT04041700|75971471|FG000|Overall Study|Pregnancy|1|||
42281114|NCT01597245|76112833|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281115|NCT01597245|76112834|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281116|NCT01597245|76112835|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
42281117|NCT01597245|76112815|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281118|NCT01597245|76112816|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281119|NCT01597245|76112817|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281120|NCT01597245|76112818|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281121|NCT01597245|76112819|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281122|NCT01597245|76112820|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281123|NCT01597245|76112821|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281124|NCT01597245|76112822|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281125|NCT01597245|76112823|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281126|NCT01597245|76112824|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281127|NCT01597245|76112825|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281128|NCT01597245|76112826|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281129|NCT01597245|76112827|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281130|NCT01597245|76112828|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281131|NCT01597245|76112829|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
42281132|NCT01597245|76112830|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
42281133|NCT01597245|76112831|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281134|NCT01597245|76112832|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281135|NCT01597245|76112833|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
42351631|NCT01890265|76191555|FG003|Overall Study|Progressive disease|0|||
42351632|NCT01890265|76191556|FG004|Overall Study|Progressive disease|0|||
42351633|NCT01890265|76191557|FG005|Overall Study|Progressive disease|0|||
42351634|NCT01890265|76191552|FG000|Overall Study|Adverse Event|2|||
42351635|NCT01890265|76191553|FG001|Overall Study|Adverse Event|1|||
42351636|NCT01890265|76191554|FG002|Overall Study|Adverse Event|0|||
42013780|NCT01297517|75820900|FG001|Overall Study|Inadequate Control of IOP|1|||
42013781|NCT01297517|75820901|FG002|Overall Study|Inadequate Control of IOP|2|||
42013782|NCT01171677|75820911|FG000|Overall Study|Withdrawal by Subject|0|||
42163591|NCT04041700|75971471|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
42163592|NCT04227340|75971477|FG000|Overall Study|Withdrawal by Subject|3|||
42163593|NCT04033432|75971484|FG000|Overall Study|Progressive Disease|8|||
42163594|NCT04033432|75971484|FG000|Overall Study|Adverse Event|4|||
42163595|NCT04033432|75971484|FG000|Overall Study|Death|1|||
42163596|NCT04223830|75971489|FG000|Overall Study|Lost to Follow-up|9|||
42163597|NCT04223830|75971489|FG000|Overall Study|Adverse Event|1|||
42163598|NCT04032652|75971496|FG000|Overall Study|The study was terminated and the PI has|1|||
42163599|NCT04032652|75971497|FG001|Overall Study|The study was terminated and the PI has|1|||
42163600|NCT04031404|75971503|FG000|Baseline|Lost to Follow-up|0|||
42163601|NCT04031404|75971504|FG001|Baseline|Lost to Follow-up|1|||
42163602|NCT04031404|75971503|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
42163603|NCT04031404|75971504|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
42163604|NCT04031404|75971503|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
42163605|NCT04031404|75971504|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
42163606|NCT04031404|75971503|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
42163607|NCT04031404|75971504|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
42163608|NCT04031404|75971503|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
42163609|NCT04031404|75971504|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
42163610|NCT04476784|75971520|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
42163611|NCT04476784|75971521|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
42163612|NCT04026568|75971532|FG000|Overall Study|study terminated|0|||
42163613|NCT04026568|75971533|FG001|Overall Study|study terminated|1|||
42163614|NCT04025632|75971541|FG000|Overall Study|Adverse Event|1|||
42163615|NCT04025632|75971542|FG001|Overall Study|Adverse Event|1|||
42163616|NCT04025632|75971541|FG000|Overall Study|Withdrawal by Subject|1|||
42163617|NCT04025632|75971542|FG001|Overall Study|Withdrawal by Subject|1|||
42163618|NCT04025632|75971541|FG000|Overall Study|Study Terminated by Sponsor|10|||
42013783|NCT01171677|75820912|FG001|Overall Study|Withdrawal by Subject|3|||
42013784|NCT01171677|75820911|FG000|Overall Study|Adverse Event|1|||
42013785|NCT01171677|75820912|FG001|Overall Study|Adverse Event|0|||
42013786|NCT01171677|75820911|FG000|Overall Study|completed <70% IntenSati classes|5|||
42281136|NCT01597245|76112834|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
42281137|NCT01597245|76112835|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
42351637|NCT01890265|76191555|FG003|Overall Study|Adverse Event|0|||
42351638|NCT01890265|76191556|FG004|Overall Study|Adverse Event|0|||
42351639|NCT01890265|76191557|FG005|Overall Study|Adverse Event|0|||
42013787|NCT01171677|75820912|FG001|Overall Study|completed <70% IntenSati classes|0|||
42013788|NCT01171521|75820918|FG000|Overall Study|Lost to Follow-up|5|||
42013789|NCT01171521|75820918|FG000|Overall Study|screen failure|1|||
42163619|NCT04025632|75971542|FG001|Overall Study|Study Terminated by Sponsor|9|||
42163620|NCT04025632|75971541|FG000|Overall Study|Physician Decision|3|||
42163621|NCT04025632|75971542|FG001|Overall Study|Physician Decision|1|||
42163622|NCT04024228|75971553|FG000|Overall Study|Adverse Event|1|||
42163623|NCT04024228|75971554|FG001|Overall Study|Adverse Event|0|||
42163624|NCT04024228|75971553|FG000|Overall Study|Protocol Deviation|0|||
42163625|NCT04024228|75971554|FG001|Overall Study|Protocol Deviation|2|||
42163626|NCT04024228|75971553|FG000|Overall Study|Withdrawal by Subject|3|||
42163627|NCT04024228|75971554|FG001|Overall Study|Withdrawal by Subject|4|||
42163628|NCT04023994|75971568|FG000|Overall Study|Lost to Follow-up|0|||
42163629|NCT04023994|75971569|FG001|Overall Study|Lost to Follow-up|1|||
42163630|NCT04023994|75971570|FG002|Overall Study|Lost to Follow-up|2|||
42163631|NCT04023994|75971571|FG003|Overall Study|Lost to Follow-up|0|||
42163632|NCT04023994|75971572|FG004|Overall Study|Lost to Follow-up|0|||
42163633|NCT04023994|75971573|FG005|Overall Study|Lost to Follow-up|0|||
42281138|NCT01597245|76112815|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281139|NCT01597245|76112816|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281140|NCT01597245|76112817|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281141|NCT01597245|76112818|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281142|NCT01597245|76112819|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281143|NCT01597245|76112820|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281144|NCT01597245|76112821|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281145|NCT01597245|76112822|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281146|NCT01597245|76112823|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281147|NCT01597245|76112824|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281148|NCT01597245|76112825|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281149|NCT01597245|76112826|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281150|NCT01597245|76112827|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281151|NCT01597245|76112828|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281152|NCT01597245|76112829|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
42281153|NCT01597245|76112830|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
42281154|NCT01597245|76112831|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281155|NCT01597245|76112832|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281156|NCT01597245|76112833|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281157|NCT01597245|76112834|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281158|NCT01597245|76112835|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
42281159|NCT01597245|76112815|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281160|NCT01597245|76112816|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281161|NCT01597245|76112817|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281162|NCT01597245|76112818|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281163|NCT01597245|76112819|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281164|NCT01597245|76112820|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281165|NCT01597245|76112821|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281166|NCT01597245|76112822|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42351640|NCT01890265|76191552|FG000|Overall Study|Death|2|||
42351641|NCT01890265|76191553|FG001|Overall Study|Death|3|||
42351642|NCT01890265|76191554|FG002|Overall Study|Death|1|||
42351643|NCT01890265|76191555|FG003|Overall Study|Death|0|||
42351644|NCT01890265|76191556|FG004|Overall Study|Death|0|||
42351645|NCT01890265|76191557|FG005|Overall Study|Death|0|||
42351646|NCT01890265|76191552|FG000|Overall Study|Withdrawal by Subject|0|||
42351647|NCT01890265|76191553|FG001|Overall Study|Withdrawal by Subject|2|||
42351648|NCT01890265|76191554|FG002|Overall Study|Withdrawal by Subject|3|||
42351649|NCT01890265|76191555|FG003|Overall Study|Withdrawal by Subject|0|||
42351650|NCT01890265|76191556|FG004|Overall Study|Withdrawal by Subject|2|||
42351651|NCT01890265|76191557|FG005|Overall Study|Withdrawal by Subject|0|||
42351652|NCT01928329|76191578|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
42351653|NCT01928329|76191579|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
42351654|NCT01928329|76191578|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
42163634|NCT04023994|75971568|FG000|Overall Study|Withdrawal by Subject|0|||
42163635|NCT04023994|75971569|FG001|Overall Study|Withdrawal by Subject|0|||
42163636|NCT04023994|75971570|FG002|Overall Study|Withdrawal by Subject|0|||
42163637|NCT04023994|75971571|FG003|Overall Study|Withdrawal by Subject|1|||
42163638|NCT04023994|75971572|FG004|Overall Study|Withdrawal by Subject|0|||
42163639|NCT04023994|75971573|FG005|Overall Study|Withdrawal by Subject|0|||
42163640|NCT04023682|75971592|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
42163641|NCT04018612|75971603|FG000|Overall Study|Withdrawal by Subject|1|||
42351655|NCT01928329|76191579|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
42351656|NCT01928329|76191578|FG000|Overall Study|Adverse Event|5|||
42351657|NCT01928329|76191579|FG001|Overall Study|Adverse Event|3|||
42351658|NCT01928329|76191578|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
42163642|NCT04018612|75971604|FG001|Overall Study|Withdrawal by Subject|0|||
42163643|NCT04018612|75971605|FG002|Overall Study|Withdrawal by Subject|1|||
42163644|NCT04209400|75971615|FG000|Overall Study|Withdrawal by Subject|0|||
42163645|NCT04209400|75971616|FG001|Overall Study|Withdrawal by Subject|1|||
42163646|NCT04207840|75971622|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
42163647|NCT04207840|75971623|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
42163648|NCT04207840|75971624|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
42163649|NCT04207840|75971622|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
42163650|NCT04207840|75971623|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
42163651|NCT04207840|75971624|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
42163652|NCT04006366|75971632|FG000|Overall Study|Withdrawal by Subject|1|||
42163653|NCT04191148|75971638|FG000|Overall Study|Withdrawal by Subject|1|||
42163654|NCT04191148|75971639|FG001|Overall Study|Withdrawal by Subject|0|||
42163655|NCT04191148|75971638|FG000|Overall Study|Adverse Event|1|||
42163656|NCT04191148|75971639|FG001|Overall Study|Adverse Event|0|||
42163657|NCT04004260|75971649|FG000|Overall Study|Withdrawal by Subject|7|||
42163658|NCT04004260|75971650|FG001|Overall Study|Withdrawal by Subject|3|||
42163659|NCT04004260|75971649|FG000|Overall Study|Lost to Follow-up|22|||
42163660|NCT04004260|75971650|FG001|Overall Study|Lost to Follow-up|12|||
42163661|NCT04004260|75971649|FG000|Overall Study|Did not engage in intervention|13|||
42163662|NCT04004260|75971650|FG001|Overall Study|Did not engage in intervention|17|||
42163663|NCT04470622|75971658|FG000|Overall Study|Withdrawal by Subject|0|||
42163664|NCT04470622|75971659|FG001|Overall Study|Withdrawal by Subject|1|||
42163665|NCT04470622|75971658|FG000|Overall Study|Screen Failure|0|||
42163666|NCT04470622|75971659|FG001|Overall Study|Screen Failure|1|||
42163667|NCT04470622|75971658|FG000|Overall Study|Death|0|||
42163668|NCT04470622|75971659|FG001|Overall Study|Death|1|||
42163669|NCT04465630|75971665|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
42163670|NCT04465630|75971665|FG000|Overall Study|Screen failure|8|||
42163671|NCT04465630|75971665|FG000|Overall Study|Baseline failure|16|||
42163672|NCT04182880|75971672|FG000|Overall Study|Pregnancy|1|||
42163673|NCT04182880|75971673|FG001|Overall Study|Pregnancy|0|||
42163674|NCT04465396|75971683|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
42163675|NCT04465396|75971684|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
42281167|NCT01597245|76112823|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281168|NCT01597245|76112824|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281169|NCT01597245|76112825|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281170|NCT01597245|76112826|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281171|NCT01597245|76112827|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281172|NCT01597245|76112828|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281173|NCT01597245|76112829|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
42281174|NCT01597245|76112830|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
42281175|NCT01597245|76112831|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281176|NCT01597245|76112832|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281177|NCT01597245|76112833|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281178|NCT01597245|76112834|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281179|NCT01597245|76112835|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
42281180|NCT01597245|76112815|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281181|NCT01597245|76112816|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281182|NCT01597245|76112817|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281183|NCT01597245|76112818|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281184|NCT01597245|76112819|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281185|NCT01597245|76112820|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42163676|NCT04465396|75971685|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
42163677|NCT04465396|75971686|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
42163678|NCT03999892|75971711|FG000|Overall Study|Lost to Follow-up|1|||
42163679|NCT03996694|75971715|FG000|First Washout (7 Days)|positive urine drug screen|0|||
42163680|NCT03996694|75971716|FG001|First Washout (7 Days)|positive urine drug screen|0|||
42163681|NCT03996694|75971717|FG002|First Washout (7 Days)|positive urine drug screen|1|||
42163682|NCT03996694|75971718|FG003|First Washout (7 Days)|positive urine drug screen|0|||
42163683|NCT03996694|75971719|FG004|First Washout (7 Days)|positive urine drug screen|0|||
42013790|NCT01296347|75820924|FG000|Allocation|Withdrawal by Subject|1|||
42163684|NCT03996694|75971720|FG005|First Washout (7 Days)|positive urine drug screen|0|||
42163685|NCT03996694|75971715|FG000|First Washout (7 Days)|Adverse Event|0|||
42163686|NCT03996694|75971716|FG001|First Washout (7 Days)|Adverse Event|1|||
42163687|NCT03996694|75971717|FG002|First Washout (7 Days)|Adverse Event|0|||
42163688|NCT03996694|75971718|FG003|First Washout (7 Days)|Adverse Event|0|||
42163689|NCT03996694|75971719|FG004|First Washout (7 Days)|Adverse Event|0|||
42163690|NCT03996694|75971720|FG005|First Washout (7 Days)|Adverse Event|0|||
42013791|NCT01296347|75820925|FG001|Allocation|Withdrawal by Subject|2|||
42013792|NCT01296347|75820924|FG000|Allocation|Lack of Efficacy|1|||
42163691|NCT03996694|75971715|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
42281186|NCT01597245|76112821|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42163692|NCT03996694|75971716|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
42163693|NCT03996694|75971717|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
42163694|NCT03996694|75971718|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
42163695|NCT03996694|75971719|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
42163696|NCT03996694|75971720|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
42163697|NCT03996694|75971715|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
42163698|NCT03996694|75971716|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
42163699|NCT03996694|75971717|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
42163700|NCT03996694|75971718|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
42163701|NCT03996694|75971719|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
42163702|NCT03996694|75971720|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
42163703|NCT04179838|75971736|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
42163704|NCT04179838|75971737|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
42163705|NCT04179838|75971736|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
42163706|NCT04179838|75971737|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
42163707|NCT03994120|75971745|FG000|Overall Study|Lost to Follow-up|3|||
42163708|NCT03994120|75971746|FG001|Overall Study|Lost to Follow-up|1|||
42163709|NCT04178590|75971752|FG000|Overall Study|Pregnancy|1|||
42163710|NCT04178590|75971752|FG000|Overall Study|Lost to Follow-up|1|||
42163711|NCT04175392|75971780|FG000|Overall Study|Withdrawal by Subject|3|||
42163712|NCT04175392|75971781|FG001|Overall Study|Withdrawal by Subject|2|||
42163713|NCT03986866|75971789|FG000|Overall Study|Withdrawal by Subject|0|||
42163714|NCT03986866|75971790|FG001|Overall Study|Withdrawal by Subject|3|||
42163715|NCT03986866|75971789|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
42163716|NCT03986866|75971790|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
42163717|NCT03980938|75971798|FG000|Treatment Period 1|Study Terminated|1|||
42163718|NCT03980938|75971799|FG001|Treatment Period 1|Study Terminated|1|||
42163719|NCT03980938|75971798|FG000|Treatment Period 2|Study Terminated|2|||
42163720|NCT03980938|75971799|FG001|Treatment Period 2|Study Terminated|2|||
42163721|NCT03656692|75971805|FG000|Overall Study|Worsening of disease activity|2|||
42163722|NCT03656692|75971805|FG000|Overall Study|Physician Decision|1|||
42163723|NCT04439266|75971809|FG000|Overall Study|Ineligible|1|||
42163724|NCT04439266|75971809|FG000|Overall Study|Adverse Event|1|||
42163725|NCT04439266|75971809|FG000|Overall Study|Death|1|||
42163726|NCT04439266|75971809|FG000|Overall Study|Disease progression|1|||
42163727|NCT04439266|75971809|FG000|Overall Study|Still on treatment|1|||
42163728|NCT03682120|75971817|FG000|Overall Study|Lost to Follow-up|11|||
42163729|NCT03682120|75971818|FG001|Overall Study|Lost to Follow-up|4|||
42163730|NCT03682120|75971819|FG002|Overall Study|Lost to Follow-up|5|||
42163731|NCT03682120|75971820|FG003|Overall Study|Lost to Follow-up|2|||
42163732|NCT03682120|75971817|FG000|Overall Study|Physician Decision|1|||
42163733|NCT03682120|75971818|FG001|Overall Study|Physician Decision|0|||
42163734|NCT03682120|75971819|FG002|Overall Study|Physician Decision|0|||
42163735|NCT03682120|75971820|FG003|Overall Study|Physician Decision|0|||
42163736|NCT03682120|75971817|FG000|Overall Study|Withdrawal by Subject|1|||
42163737|NCT03682120|75971818|FG001|Overall Study|Withdrawal by Subject|2|||
42163738|NCT03682120|75971819|FG002|Overall Study|Withdrawal by Subject|3|||
42163739|NCT03682120|75971820|FG003|Overall Study|Withdrawal by Subject|0|||
42163740|NCT03682120|75971817|FG000|Overall Study|Death|0|||
42163741|NCT03682120|75971818|FG001|Overall Study|Death|1|||
42163742|NCT03682120|75971819|FG002|Overall Study|Death|0|||
42163743|NCT03682120|75971820|FG003|Overall Study|Death|0|||
42163744|NCT03682120|75971817|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
42163745|NCT03682120|75971818|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
42163746|NCT03682120|75971819|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
42163747|NCT03682120|75971820|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
42163748|NCT04428502|75971832|FG000|Overall Study|Did not meet entrance criteria|14|||
42163749|NCT04428424|75971837|FG000|Overall Study|Does not meet entrance criteria|132|||
42163750|NCT04428424|75971837|FG000|Overall Study|Lost to Follow-up|115|||
42163751|NCT03655756|75971841|FG000|Overall Study|Death|1|||
42163752|NCT00095238|75971847|FG000|Overall Study|Lack of Efficacy|9|||
42163753|NCT00095238|75971848|FG001|Overall Study|Lack of Efficacy|9|||
42163754|NCT00095238|75971847|FG000|Overall Study|Adverse Event|331|||
42163755|NCT00095238|75971848|FG001|Overall Study|Adverse Event|287|||
42013793|NCT01296347|75820925|FG001|Allocation|Lack of Efficacy|2|||
42013794|NCT01296347|75820924|FG000|Allocation|not received infusion|1|||
42163756|NCT00095238|75971847|FG000|Overall Study|Subject Withdrew Consent|208|||
42163757|NCT00095238|75971848|FG001|Overall Study|Subject Withdrew Consent|223|||
42163758|NCT00095238|75971847|FG000|Overall Study|Death|154|||
42163759|NCT00095238|75971848|FG001|Overall Study|Death|170|||
42281187|NCT01597245|76112822|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42013795|NCT01296347|75820925|FG001|Allocation|not received infusion|0|||
42163760|NCT00095238|75971847|FG000|Overall Study|Lost to Follow-up|19|||
42163761|NCT00095238|75971848|FG001|Overall Study|Lost to Follow-up|24|||
42163762|NCT00095238|75971847|FG000|Overall Study|Noncompliance|44|||
42163763|NCT00095238|75971848|FG001|Overall Study|Noncompliance|45|||
42163764|NCT00095238|75971847|FG000|Overall Study|No longer met study criteria|4|||
42163765|NCT00095238|75971848|FG001|Overall Study|No longer met study criteria|5|||
42163766|NCT00095238|75971847|FG000|Overall Study|Study terminated by sponsor|0|||
42163767|NCT00095238|75971848|FG001|Overall Study|Study terminated by sponsor|1|||
42163768|NCT00095238|75971847|FG000|Overall Study|Missing|1|||
42163769|NCT00095238|75971848|FG001|Overall Study|Missing|0|||
42163770|NCT00095238|75971847|FG000|Overall Study|Other Reasons|87|||
42163771|NCT00095238|75971848|FG001|Overall Study|Other Reasons|88|||
42163772|NCT00082368|75971886|FG000|Overall Study|Not treated-pt had poor IV access|1|||
42163773|NCT00094770|75971892|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
42163774|NCT00094770|75971893|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
42163775|NCT00094770|75971892|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
42163776|NCT00094770|75971893|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
42163777|NCT00094770|75971892|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
42163778|NCT00094770|75971893|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
42163779|NCT00094770|75971892|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
42163780|NCT00094770|75971893|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
42163781|NCT00094770|75971892|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
42163782|NCT00094770|75971893|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
42163783|NCT00094770|75971892|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
42163784|NCT00094770|75971893|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
42163785|NCT00094770|75971892|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
42163786|NCT00094770|75971893|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
42163787|NCT00094770|75971892|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
42163788|NCT00094770|75971893|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
42163789|NCT00094770|75971892|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
42163790|NCT00094770|75971893|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
42163791|NCT00094770|75971892|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
42163792|NCT00094770|75971893|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
42281188|NCT01597245|76112823|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281189|NCT01597245|76112824|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281190|NCT01597245|76112825|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281191|NCT01597245|76112826|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281192|NCT01597245|76112827|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281193|NCT01597245|76112828|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42163793|NCT00094770|75971892|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
42163794|NCT00094770|75971893|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
42163795|NCT00094770|75971892|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
42163796|NCT00094770|75971893|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
42163797|NCT00094770|75971892|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
42163798|NCT00094770|75971893|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
42163799|NCT00094770|75971892|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
42163800|NCT00094770|75971893|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
42163801|NCT00094770|75971892|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
42163802|NCT00094770|75971893|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
42163803|NCT00094770|75971892|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
42163804|NCT00094770|75971893|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
42163805|NCT00094770|75971892|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
42163806|NCT00094770|75971893|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
42163807|NCT00094770|75971892|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
42163808|NCT00094770|75971893|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
42163809|NCT00069576|75971901|FG000|Original Trial|Lost to Follow-up|25|||
42163810|NCT00069576|75971902|FG001|Original Trial|Lost to Follow-up|33|||
42163811|NCT00069576|75971901|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
42163812|NCT00069576|75971902|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
42163813|NCT00069264|75971908|FG000|Overall Study|Adverse Event|3|||
42163814|NCT00069264|75971908|FG000|Overall Study|Progressive Disease|23|||
42163815|NCT00069264|75971908|FG000|Overall Study|Withdrawal by Subject|3|||
42281194|NCT01597245|76112829|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
42013796|NCT01296347|75820924|FG000|6 Week Follow up|Death|0|||
42013797|NCT01296347|75820925|FG001|6 Week Follow up|Death|1|||
42013798|NCT01296347|75820924|FG000|3 Month Follow up|Death|1|||
42013799|NCT01296347|75820925|FG001|3 Month Follow up|Death|0|||
42013800|NCT01296347|75820924|FG000|3 Month Follow up|Lost to Follow-up|0|||
42281195|NCT01597245|76112830|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
42281196|NCT01597245|76112831|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281197|NCT01597245|76112832|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42281198|NCT01597245|76112833|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42013801|NCT01296347|75820925|FG001|3 Month Follow up|Lost to Follow-up|1|||
42013802|NCT01296347|75820924|FG000|6 Month Follow up|Death|2|||
42013803|NCT01296347|75820925|FG001|6 Month Follow up|Death|1|||
42163816|NCT00069264|75971908|FG000|Overall Study|Discon Therapy|3|||
42163817|NCT00069108|75971914|FG000|Overall Study|Withdrawal by Subject|5|||
42163818|NCT00069108|75971915|FG001|Overall Study|Withdrawal by Subject|9|||
42163819|NCT00069108|75971914|FG000|Overall Study|Adverse Event|64|||
42163820|NCT00069108|75971915|FG001|Overall Study|Adverse Event|42|||
42163821|NCT00069108|75971914|FG000|Overall Study|Death|6|||
42163822|NCT00069108|75971915|FG001|Overall Study|Death|6|||
42163823|NCT00069108|75971914|FG000|Overall Study|Administration|15|||
42163824|NCT00069108|75971915|FG001|Overall Study|Administration|4|||
42163825|NCT00069108|75971914|FG000|Overall Study|Insufficient therapy|117|||
42163826|NCT00069108|75971915|FG001|Overall Study|Insufficient therapy|144|||
42163827|NCT00069108|75971914|FG000|Overall Study|Violation criteria|1|||
42163828|NCT00069108|75971915|FG001|Overall Study|Violation criteria|4|||
42163829|NCT00069108|75971914|FG000|Overall Study|Refused treatment|5|||
42163830|NCT00069108|75971915|FG001|Overall Study|Refused treatment|10|||
42163831|NCT00094536|75971922|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
42163832|NCT00094536|75971922|FG000|Treatment and Follow-up|Adverse Event|4|||
42163833|NCT00094536|75971922|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
42163834|NCT00094536|75971922|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
42163835|NCT00094536|75971922|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
42163836|NCT00094536|75971922|FG000|Treatment and Follow-up|Subject non-compliance|9|||
42163837|NCT00094536|75971922|FG000|Treatment and Follow-up|Unable to attend visits|1|||
42163838|NCT00405587|75971930|FG000|Overall Study|Death|0|||
42163839|NCT00405587|75971931|FG001|Overall Study|Death|0|||
42163840|NCT00405587|75971932|FG002|Overall Study|Death|0|||
42163841|NCT00405587|75971933|FG003|Overall Study|Death|1|||
42163842|NCT00405587|75971930|FG000|Overall Study|Disease Progression|22|||
42163843|NCT00405587|75971931|FG001|Overall Study|Disease Progression|23|||
42163844|NCT00405587|75971932|FG002|Overall Study|Disease Progression|21|||
42163845|NCT00405587|75971933|FG003|Overall Study|Disease Progression|17|||
42163846|NCT00405587|75971930|FG000|Overall Study|Physician Decision|3|||
42163847|NCT00405587|75971931|FG001|Overall Study|Physician Decision|2|||
42163848|NCT00405587|75971932|FG002|Overall Study|Physician Decision|0|||
42163849|NCT00405587|75971933|FG003|Overall Study|Physician Decision|0|||
42163850|NCT00405587|75971930|FG000|Overall Study|Adverse Event|1|||
42163851|NCT00405587|75971931|FG001|Overall Study|Adverse Event|0|||
42163852|NCT00405587|75971932|FG002|Overall Study|Adverse Event|0|||
42163853|NCT00405587|75971933|FG003|Overall Study|Adverse Event|0|||
42163854|NCT00405587|75971930|FG000|Overall Study|Lost to Follow-up|0|||
42163855|NCT00405587|75971931|FG001|Overall Study|Lost to Follow-up|1|||
42163856|NCT00405587|75971932|FG002|Overall Study|Lost to Follow-up|1|||
42163857|NCT00405587|75971933|FG003|Overall Study|Lost to Follow-up|0|||
42163858|NCT00405587|75971930|FG000|Overall Study|Radiation induced necrosis|0|||
42163859|NCT00405587|75971931|FG001|Overall Study|Radiation induced necrosis|1|||
42163860|NCT00405587|75971932|FG002|Overall Study|Radiation induced necrosis|0|||
42163861|NCT00405587|75971933|FG003|Overall Study|Radiation induced necrosis|0|||
42163862|NCT00405587|75971930|FG000|Overall Study|Withdrawal by Subject|0|||
42163863|NCT00405587|75971931|FG001|Overall Study|Withdrawal by Subject|0|||
42163864|NCT00405587|75971932|FG002|Overall Study|Withdrawal by Subject|0|||
42163865|NCT00405587|75971933|FG003|Overall Study|Withdrawal by Subject|2|||
42163866|NCT00405587|75971930|FG000|Overall Study|Participant not dosed|0|||
42163867|NCT00405587|75971931|FG001|Overall Study|Participant not dosed|1|||
42163868|NCT00405587|75971932|FG002|Overall Study|Participant not dosed|0|||
42163869|NCT00405587|75971933|FG003|Overall Study|Participant not dosed|0|||
42163870|NCT00405275|75971971|FG000|Overall Study|Death|1|||
42163871|NCT00405275|75971972|FG001|Overall Study|Death|0|||
42163872|NCT00405275|75971971|FG000|Overall Study|Lost to Follow-up|5|||
42163873|NCT00405275|75971972|FG001|Overall Study|Lost to Follow-up|1|||
42163874|NCT00405275|75971971|FG000|Overall Study|Withdrawal by Subject|7|||
42163875|NCT00405275|75971972|FG001|Overall Study|Withdrawal by Subject|9|||
42163876|NCT00405275|75971971|FG000|Overall Study|Unwilling to continue|10|||
42163877|NCT00405275|75971972|FG001|Overall Study|Unwilling to continue|9|||
42163878|NCT00404651|75971982|FG000|Overall Study|Serious Adverse Event|0|||
42163879|NCT00404651|75971983|FG001|Overall Study|Serious Adverse Event|0|||
42163880|NCT00404651|75971984|FG002|Overall Study|Serious Adverse Event|2|||
42163881|NCT00404651|75971985|FG003|Overall Study|Serious Adverse Event|0|||
42163882|NCT00404651|75971982|FG000|Overall Study|Protocol Violation|10|||
42163883|NCT00404651|75971983|FG001|Overall Study|Protocol Violation|5|||
42163884|NCT00404651|75971984|FG002|Overall Study|Protocol Violation|14|||
42163885|NCT00404651|75971985|FG003|Overall Study|Protocol Violation|5|||
42281199|NCT01597245|76112834|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42163886|NCT00404651|75971982|FG000|Overall Study|Lost to Follow-up|15|||
42281200|NCT01597245|76112835|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
42163887|NCT00404651|75971983|FG001|Overall Study|Lost to Follow-up|11|||
42163888|NCT00404651|75971984|FG002|Overall Study|Lost to Follow-up|13|||
42163889|NCT00404651|75971985|FG003|Overall Study|Lost to Follow-up|10|||
42163890|NCT00404651|75971982|FG000|Overall Study|Withdrawal by Subject|14|||
42163891|NCT00404651|75971983|FG001|Overall Study|Withdrawal by Subject|12|||
42163892|NCT00404651|75971984|FG002|Overall Study|Withdrawal by Subject|16|||
42163893|NCT00404651|75971985|FG003|Overall Study|Withdrawal by Subject|6|||
42163894|NCT00404495|75971997|FG000|Overall Study|Death|37|||
42163895|NCT00404495|75971998|FG001|Overall Study|Death|11|||
42163896|NCT00404495|75971997|FG000|Overall Study|Lost to Follow-up|5|||
42163897|NCT00404495|75971998|FG001|Overall Study|Lost to Follow-up|0|||
42163898|NCT00404495|75971997|FG000|Overall Study|Other|1|||
42163899|NCT00404495|75971998|FG001|Overall Study|Other|0|||
42163900|NCT00404495|75971997|FG000|Overall Study|Withdrawal by Subject|1|||
42163901|NCT00404495|75971998|FG001|Overall Study|Withdrawal by Subject|0|||
42163902|NCT00409409|75972006|FG000|Overall Study|Adverse Event|7|||
42163903|NCT00409409|75972007|FG001|Overall Study|Adverse Event|2|||
42163904|NCT00409409|75972006|FG000|Overall Study|Withdrawal by Subject|1|||
42163905|NCT00409409|75972007|FG001|Overall Study|Withdrawal by Subject|1|||
42163906|NCT00409409|75972006|FG000|Overall Study|Any other reason not above-mentioned|0|||
42163907|NCT00409409|75972007|FG001|Overall Study|Any other reason not above-mentioned|1|||
42281201|NCT01597245|76112815|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281202|NCT01597245|76112816|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281203|NCT01597245|76112817|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281204|NCT01597245|76112818|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281205|NCT01597245|76112819|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281206|NCT01597245|76112820|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281207|NCT01597245|76112821|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281208|NCT01597245|76112822|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281209|NCT01597245|76112823|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281210|NCT01597245|76112824|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281211|NCT01597245|76112825|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281212|NCT01597245|76112826|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42013804|NCT01296347|75820924|FG000|6 Month Follow up|Lost to Follow-up|0|||
42281213|NCT01597245|76112827|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42013805|NCT01296347|75820925|FG001|6 Month Follow up|Lost to Follow-up|1|||
42013806|NCT01296347|75820924|FG000|12 Month Follow up|Lost to Follow-up|3|||
42163908|NCT00409331|75972013|FG000|Overall Study|Physician Decision|1|||
42163909|NCT00409175|75972019|FG000|Overall Study|Adverse Event|4|||
42163910|NCT00409175|75972020|FG001|Overall Study|Adverse Event|3|||
42163911|NCT00409175|75972019|FG000|Overall Study|Withdrawal by Subject|1|||
42163912|NCT00409175|75972020|FG001|Overall Study|Withdrawal by Subject|2|||
42163913|NCT00409175|75972019|FG000|Overall Study|Negative genotype|0|||
42163914|NCT00409175|75972020|FG001|Overall Study|Negative genotype|1|||
42163915|NCT00409175|75972019|FG000|Overall Study|Liver transplantation|13|||
42163916|NCT00409175|75972020|FG001|Overall Study|Liver transplantation|13|||
42163917|NCT00408629|75972028|FG000|Overall Study|Adverse Event|13|||
42163918|NCT00408629|75972029|FG001|Overall Study|Adverse Event|27|||
42163919|NCT00408629|75972028|FG000|Overall Study|Withdrawal by Subject|8|||
42163920|NCT00408629|75972029|FG001|Overall Study|Withdrawal by Subject|4|||
42163921|NCT00408629|75972028|FG000|Overall Study|Lost to Follow-up|1|||
42163922|NCT00408629|75972029|FG001|Overall Study|Lost to Follow-up|1|||
42163923|NCT00408629|75972028|FG000|Overall Study|Lack of Efficacy|63|||
42163924|NCT00408629|75972029|FG001|Overall Study|Lack of Efficacy|73|||
42163925|NCT00408629|75972028|FG000|Overall Study|Protocol Violation|1|||
42163926|NCT00408629|75972029|FG001|Overall Study|Protocol Violation|5|||
42163927|NCT00408629|75972028|FG000|Overall Study|Miscellaneous|11|||
42163928|NCT00408629|75972029|FG001|Overall Study|Miscellaneous|15|||
42163929|NCT00408317|75972036|FG000|First Intervention Period|Adverse Event|0|||
42163930|NCT00408317|75972037|FG001|First Intervention Period|Adverse Event|1|||
42163931|NCT00408317|75972036|FG000|Second Intervention Period|Adverse Event|2|||
42163932|NCT00408317|75972037|FG001|Second Intervention Period|Adverse Event|0|||
42163933|NCT00408317|75972036|FG000|Second Intervention Period|Protocol Violation|0|||
42163934|NCT00408317|75972037|FG001|Second Intervention Period|Protocol Violation|1|||
42163935|NCT00408317|75972036|FG000|Second Intervention Period|Withdrawal of consent|0|||
42163936|NCT00408317|75972037|FG001|Second Intervention Period|Withdrawal of consent|1|||
42163937|NCT00112502|75972051|FG000|Overall Study|Withdrawal by Subject|0|||
42163938|NCT00112502|75972052|FG001|Overall Study|Withdrawal by Subject|1|||
42163939|NCT00112502|75972053|FG002|Overall Study|Withdrawal by Subject|1|||
42163940|NCT00112502|75972054|FG003|Overall Study|Withdrawal by Subject|4|||
42163941|NCT00112502|75972055|FG004|Overall Study|Withdrawal by Subject|2|||
42163942|NCT00112502|75972056|FG005|Overall Study|Withdrawal by Subject|5|||
42163943|NCT00112502|75972057|FG006|Overall Study|Withdrawal by Subject|3|||
42163944|NCT00112502|75972058|FG007|Overall Study|Withdrawal by Subject|7|||
42163945|NCT03822182|75972089|FG000|Overall Study|Protocol Violation|0|||
42163946|NCT03822182|75972090|FG001|Overall Study|Protocol Violation|1|||
42163947|NCT03822182|75972091|FG002|Overall Study|Protocol Violation|1|||
42163948|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
42281214|NCT01597245|76112828|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
42281215|NCT01597245|76112829|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42163949|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
42163950|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
42163951|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
42163952|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
42163953|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
42163954|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
42163955|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
42163956|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
42163957|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
42163958|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
42163959|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
42163960|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
42163961|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
42163962|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
42163963|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
42163964|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
42163965|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
42163966|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
42163967|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
42163968|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
42163969|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
42281216|NCT01597245|76112830|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42163970|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
42163971|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
42163972|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
42163973|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
42281217|NCT01597245|76112831|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42163974|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
42163975|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
42163976|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
42163977|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
42163978|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
42163979|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
42281218|NCT01597245|76112832|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281219|NCT01597245|76112833|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281220|NCT01597245|76112834|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281221|NCT01597245|76112835|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
42281222|NCT01597245|76112815|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281223|NCT01597245|76112816|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281224|NCT01597245|76112817|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42163980|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
42163981|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
42163982|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
42163983|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
42163984|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
42163985|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
42163986|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
42163987|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
42163988|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
42163989|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
42163990|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
42163991|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
42163992|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
42163993|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
42163994|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
42163995|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
42163996|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
42163997|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
42163998|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
42163999|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
42281225|NCT01597245|76112818|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281226|NCT01597245|76112819|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281227|NCT01597245|76112820|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281228|NCT01597245|76112821|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281229|NCT01597245|76112822|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281230|NCT01597245|76112823|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281231|NCT01597245|76112824|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281232|NCT01597245|76112825|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281233|NCT01597245|76112826|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281234|NCT01597245|76112827|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281235|NCT01597245|76112828|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281236|NCT01597245|76112829|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281237|NCT01597245|76112830|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
42281238|NCT01597245|76112831|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
42281239|NCT01597245|76112832|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
42281240|NCT01597245|76112833|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
42281241|NCT01597245|76112834|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
42281242|NCT01597245|76112835|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
42281243|NCT01597245|76112815|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281244|NCT01597245|76112816|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281245|NCT01597245|76112817|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281246|NCT01597245|76112818|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281247|NCT01597245|76112819|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281248|NCT01597245|76112820|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281249|NCT01597245|76112821|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281250|NCT01597245|76112822|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281251|NCT01597245|76112823|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281252|NCT01597245|76112824|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281253|NCT01597245|76112825|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281254|NCT01597245|76112826|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281255|NCT01597245|76112827|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281256|NCT01597245|76112828|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281257|NCT01597245|76112829|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281258|NCT01597245|76112830|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42281259|NCT01597245|76112831|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
42164000|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
42164001|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
42164002|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
42164003|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
42164004|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
42164005|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
42164006|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
42164007|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
42164008|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
42164009|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
42164010|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
42164011|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
42164012|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
42164013|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
42164014|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
42164015|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
42164016|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
42164017|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
42164018|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
42164019|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
42164020|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
42164021|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
42164022|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
42164023|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
42164024|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
42164025|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
42164026|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
42164027|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
42164028|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
42164029|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
42164030|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
42164031|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
42164032|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
42164033|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
42164034|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
42164035|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
42164036|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
42164037|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
42164038|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
42164039|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
42164040|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
42164041|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
42164042|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
42164043|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
42164044|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
42164045|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
42164046|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
42164047|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
42164048|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
42164049|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
42164050|NCT00111800|75972106|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
42164051|NCT00111800|75972107|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
42164052|NCT00111800|75972108|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
42164053|NCT00111800|75972109|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
42164054|NCT00111800|75972110|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
42164055|NCT00111800|75972111|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
42164056|NCT00111800|75972106|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
42164057|NCT00111800|75972107|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
42013807|NCT01296347|75820925|FG001|12 Month Follow up|Lost to Follow-up|1|||
42013808|NCT01296347|75820924|FG000|12 Month Follow up|Death|1|||
42013809|NCT01296347|75820925|FG001|12 Month Follow up|Death|1|||
42164058|NCT00111800|75972108|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
42164059|NCT00111800|75972109|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
42164060|NCT00111800|75972110|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
42164061|NCT00111800|75972111|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
42164062|NCT00111800|75972106|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
42164063|NCT00111800|75972107|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
42164064|NCT00111800|75972108|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
42164065|NCT00111800|75972109|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
42164066|NCT00111800|75972110|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
42164067|NCT00111800|75972111|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
42164068|NCT00111800|75972106|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
42164069|NCT00111800|75972107|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
42164070|NCT00111800|75972108|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
42281260|NCT01597245|76112832|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
42281261|NCT01597245|76112833|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
42281262|NCT01597245|76112834|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
42281263|NCT01597245|76112835|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
42281264|NCT01597245|76112815|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281265|NCT01597245|76112816|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281266|NCT01597245|76112817|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281267|NCT01597245|76112818|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281268|NCT01597245|76112819|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281269|NCT01597245|76112820|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281270|NCT01597245|76112821|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281271|NCT01597245|76112822|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281272|NCT01597245|76112823|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281273|NCT01597245|76112824|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281274|NCT01597245|76112825|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281275|NCT01597245|76112826|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281276|NCT01597245|76112827|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281277|NCT01597245|76112828|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281278|NCT01597245|76112829|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281279|NCT01597245|76112830|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281280|NCT01597245|76112831|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
42013810|NCT01296347|75820924|FG000|12 Month Follow up|Withdrawal by Subject|0|||
42164071|NCT00111800|75972109|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
42164072|NCT00111800|75972110|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
42164073|NCT00111800|75972111|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
42164074|NCT00111800|75972106|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
42164075|NCT00111800|75972107|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
42164076|NCT00111800|75972108|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
42164077|NCT00111800|75972109|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
42164078|NCT00111800|75972110|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
42164079|NCT00111800|75972111|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
42164080|NCT00111800|75972106|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
42164081|NCT00111800|75972107|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
42164082|NCT00111800|75972108|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
42164083|NCT00111800|75972109|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
42164084|NCT00111800|75972110|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
42164085|NCT00111800|75972111|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
42164086|NCT00111800|75972106|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
42164087|NCT00111800|75972107|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
42164088|NCT00111800|75972108|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
42164089|NCT00111800|75972109|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
42164090|NCT00111800|75972110|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
42164091|NCT00111800|75972111|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
42164092|NCT00111800|75972106|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
42164093|NCT00111800|75972107|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
42164094|NCT00111800|75972108|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
42164095|NCT00111800|75972109|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
42281281|NCT01597245|76112832|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42281282|NCT01597245|76112833|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
42013811|NCT01296347|75820925|FG001|12 Month Follow up|Withdrawal by Subject|1|||
42164096|NCT00111800|75972110|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
42164097|NCT00111800|75972111|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
42164098|NCT00111800|75972106|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
42164099|NCT00111800|75972107|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
42164100|NCT00111800|75972108|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
42164101|NCT00111800|75972109|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
42164102|NCT00111800|75972110|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
42164103|NCT00111800|75972111|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
42164104|NCT00094328|75972134|FG000|Overall Study|Lost to Follow-up|1|||
42164105|NCT00094172|75972140|FG000|Overall Study|Adverse Event|0|||
42164106|NCT00094172|75972141|FG001|Overall Study|Adverse Event|1|||
42164107|NCT00094172|75972140|FG000|Overall Study|Lost to Follow-up|2|||
42164108|NCT00094172|75972141|FG001|Overall Study|Lost to Follow-up|0|||
42164109|NCT00094172|75972140|FG000|Overall Study|Protocol Violation|0|||
42164110|NCT00094172|75972141|FG001|Overall Study|Protocol Violation|1|||
42164111|NCT00094172|75972140|FG000|Overall Study|Withdrawal by Subject|10|||
42164112|NCT00094172|75972141|FG001|Overall Study|Withdrawal by Subject|5|||
42164113|NCT00094172|75972140|FG000|Overall Study|Primary endpoint met.|1|||
42164114|NCT00094172|75972141|FG001|Overall Study|Primary endpoint met.|0|||
42164115|NCT00094172|75972140|FG000|Overall Study|Started other MS therapy due to disease|1|||
42164116|NCT00094172|75972141|FG001|Overall Study|Started other MS therapy due to disease|0|||
42164117|NCT00094094|75972147|FG000|Overall Study|Death|2|||
42164118|NCT00094094|75972147|FG000|Overall Study|Lack of Efficacy|23|||
42164119|NCT00094094|75972147|FG000|Overall Study|Adverse Event|7|||
42164120|NCT00110396|75972151|FG000|Overall Study|Adverse Event|15|||
42164121|NCT00110396|75972151|FG000|Overall Study|Lost to Follow-up|1|||
42164122|NCT00110396|75972151|FG000|Overall Study|Administration of plasmapheresis|1|||
42164123|NCT00110396|75972151|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
42164124|NCT00110396|75972151|FG000|Overall Study|Lack of Efficacy|1|||
42164125|NCT00110396|75972151|FG000|Overall Study|Decided not to continue treatment|1|||
42164126|NCT00110396|75972151|FG000|Overall Study|Patient non-compliance|1|||
42164127|NCT00110396|75972151|FG000|Overall Study|Patient refused to continue|1|||
42164128|NCT00110396|75972151|FG000|Overall Study|Patient refused to participate|1|||
42164129|NCT00110396|75972151|FG000|Overall Study|Patient will|1|||
42164130|NCT00110396|75972151|FG000|Overall Study|Patient's decision|1|||
42164131|NCT00110396|75972151|FG000|Overall Study|Participation in MS vaccine study|1|||
42164132|NCT00110396|75972151|FG000|Overall Study|Pregnancy|1|||
42164133|NCT00110396|75972151|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
42164134|NCT00110396|75972151|FG000|Overall Study|Protocol Violation|2|||
42164135|NCT00110396|75972151|FG000|Overall Study|Patient refused to come back|1|||
42164136|NCT00110396|75972151|FG000|Overall Study|The patient has refused|2|||
42164137|NCT00110396|75972151|FG000|Overall Study|The patient has refused to visit site|1|||
42164138|NCT00110396|75972151|FG000|Overall Study|Patient is to be administered copaxone|1|||
42164139|NCT03819218|75972155|FG000|Overall Study|Protocol Violation|1|||
42164140|NCT00093470|75972161|FG000|Overall Study|Disease progression|39|||
42164141|NCT00093470|75972162|FG001|Overall Study|Disease progression|0|||
42164142|NCT00093470|75972161|FG000|Overall Study|Adverse Event|15|||
42164143|NCT00093470|75972162|FG001|Overall Study|Adverse Event|0|||
42164144|NCT00093470|75972161|FG000|Overall Study|Death|2|||
42164145|NCT00093470|75972162|FG001|Overall Study|Death|0|||
42281283|NCT01597245|76112834|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
42281284|NCT01597245|76112835|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
42281285|NCT01597245|76112815|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281286|NCT01597245|76112816|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281287|NCT01597245|76112817|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281288|NCT01597245|76112818|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281289|NCT01597245|76112819|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281290|NCT01597245|76112820|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281291|NCT01597245|76112821|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281292|NCT01597245|76112822|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281293|NCT01597245|76112823|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42164146|NCT00093470|75972161|FG000|Overall Study|Withdrawal by Subject|8|||
42164147|NCT00093470|75972162|FG001|Overall Study|Withdrawal by Subject|0|||
42164148|NCT00093470|75972161|FG000|Overall Study|Alternative therapy|2|||
42164149|NCT00093470|75972162|FG001|Overall Study|Alternative therapy|0|||
42164150|NCT00093470|75972161|FG000|Overall Study|Other complicating disease|3|||
42164151|NCT00093470|75972162|FG001|Overall Study|Other complicating disease|0|||
42164152|NCT00093470|75972161|FG000|Overall Study|Physician Decision|2|||
42164153|NCT00093470|75972162|FG001|Overall Study|Physician Decision|0|||
42164154|NCT00093470|75972161|FG000|Overall Study|Never started treatment|1|||
42164155|NCT00093470|75972162|FG001|Overall Study|Never started treatment|0|||
42164156|NCT00093470|75972161|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
42164157|NCT00093470|75972162|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
42164158|NCT00407537|75972170|FG000|Overall Study|Death|5|||
42164159|NCT00407537|75972171|FG001|Overall Study|Death|2|||
42164160|NCT00407537|75972170|FG000|Overall Study|Adverse Event|36|||
42164161|NCT00407537|75972171|FG001|Overall Study|Adverse Event|0|||
42164162|NCT00407537|75972170|FG000|Overall Study|Lost to Follow-up|12|||
42164163|NCT00407537|75972171|FG001|Overall Study|Lost to Follow-up|19|||
42164164|NCT00407537|75972170|FG000|Overall Study|Other|6|||
42164165|NCT00407537|75972171|FG001|Overall Study|Other|7|||
42164166|NCT00407537|75972170|FG000|Overall Study|Withdrawal by Subject|34|||
42164167|NCT00407537|75972171|FG001|Overall Study|Withdrawal by Subject|16|||
42164168|NCT00094458|75972180|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
42164169|NCT00094458|75972181|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
42164170|NCT00094458|75972182|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
42164171|NCT00094458|75972183|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
42164172|NCT00094458|75972184|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
42164173|NCT00094458|75972185|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
42164174|NCT00094458|75972180|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
42281294|NCT01597245|76112824|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281295|NCT01597245|76112825|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281296|NCT01597245|76112826|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281297|NCT01597245|76112827|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281298|NCT01597245|76112828|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281299|NCT01597245|76112829|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281300|NCT01597245|76112830|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281301|NCT01597245|76112831|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281302|NCT01597245|76112832|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
42281303|NCT01597245|76112833|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
42281304|NCT01597245|76112834|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
42281305|NCT01597245|76112835|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
42281306|NCT01597245|76112815|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281307|NCT01597245|76112816|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281308|NCT01597245|76112817|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281309|NCT01597245|76112818|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281310|NCT01597245|76112819|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281311|NCT01597245|76112820|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281312|NCT01597245|76112821|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281313|NCT01597245|76112822|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281314|NCT01597245|76112823|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281315|NCT01597245|76112824|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281316|NCT01597245|76112825|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281317|NCT01597245|76112826|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281318|NCT01597245|76112827|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281319|NCT01597245|76112828|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281320|NCT01597245|76112829|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281321|NCT01597245|76112830|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281322|NCT01597245|76112831|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
42281323|NCT01597245|76112832|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281324|NCT01597245|76112833|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
42281325|NCT01597245|76112834|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
42281326|NCT01597245|76112835|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
42281327|NCT01597245|76112815|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281328|NCT01597245|76112816|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281329|NCT01597245|76112817|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281330|NCT01597245|76112818|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281331|NCT01597245|76112819|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281332|NCT01597245|76112820|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281333|NCT01597245|76112821|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281334|NCT01597245|76112822|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281335|NCT01597245|76112823|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42164175|NCT00094458|75972181|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
42281336|NCT01597245|76112824|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281337|NCT01597245|76112825|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281338|NCT01597245|76112826|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281339|NCT01597245|76112827|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42164176|NCT00094458|75972182|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
42164177|NCT00094458|75972183|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
42164178|NCT00094458|75972184|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
42164179|NCT00094458|75972185|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
42164180|NCT00094458|75972180|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
42164181|NCT00094458|75972181|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
42164182|NCT00094458|75972182|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
42164183|NCT00094458|75972183|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
42281340|NCT01597245|76112828|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281341|NCT01597245|76112829|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281342|NCT01597245|76112830|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281343|NCT01597245|76112831|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
42281344|NCT01597245|76112832|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281345|NCT01597245|76112833|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
42281346|NCT01597245|76112834|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
42281347|NCT01597245|76112835|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
42281348|NCT01597245|76112815|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281349|NCT01597245|76112816|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281350|NCT01597245|76112817|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281351|NCT01597245|76112818|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281352|NCT01597245|76112819|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281353|NCT01597245|76112820|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281354|NCT01597245|76112821|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281355|NCT01597245|76112822|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42164184|NCT00094458|75972184|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
42164185|NCT00094458|75972185|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
42164186|NCT00094458|75972180|FG000|Main Study: Through Week 30|Adverse Event|38|||
42164187|NCT00094458|75972181|FG001|Main Study: Through Week 30|Adverse Event|20|||
42164188|NCT00094458|75972182|FG002|Main Study: Through Week 30|Adverse Event|28|||
42164189|NCT00094458|75972183|FG003|Main Study: Through Week 30|Adverse Event|0|||
42164190|NCT00094458|75972184|FG004|Main Study: Through Week 30|Adverse Event|0|||
42164191|NCT00094458|75972185|FG005|Main Study: Through Week 30|Adverse Event|0|||
42164192|NCT00094458|75972180|FG000|Main Study: Through Week 30|Death|1|||
42164193|NCT00094458|75972181|FG001|Main Study: Through Week 30|Death|0|||
42164194|NCT00094458|75972182|FG002|Main Study: Through Week 30|Death|0|||
42164195|NCT00094458|75972183|FG003|Main Study: Through Week 30|Death|0|||
42164196|NCT00094458|75972184|FG004|Main Study: Through Week 30|Death|0|||
42164197|NCT00094458|75972185|FG005|Main Study: Through Week 30|Death|0|||
42164198|NCT00094458|75972180|FG000|Main Study: Through Week 30|Other|19|||
42164199|NCT00094458|75972181|FG001|Main Study: Through Week 30|Other|16|||
42164200|NCT00094458|75972182|FG002|Main Study: Through Week 30|Other|9|||
42164201|NCT00094458|75972183|FG003|Main Study: Through Week 30|Other|0|||
42164202|NCT00094458|75972184|FG004|Main Study: Through Week 30|Other|0|||
42164203|NCT00094458|75972185|FG005|Main Study: Through Week 30|Other|0|||
42164204|NCT00094458|75972180|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
42164205|NCT00094458|75972181|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
42164206|NCT00094458|75972182|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
42164207|NCT00094458|75972183|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
42281356|NCT01597245|76112823|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281357|NCT01597245|76112824|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281358|NCT01597245|76112825|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281359|NCT01597245|76112826|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281360|NCT01597245|76112827|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281361|NCT01597245|76112828|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281362|NCT01597245|76112829|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281363|NCT01597245|76112830|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42164208|NCT00094458|75972184|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
42164209|NCT00094458|75972185|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
42164210|NCT00094458|75972180|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
42040578|NCT01796171|75848708|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42040579|NCT01796171|75848709|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42040580|NCT01796171|75848710|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42040581|NCT01796171|75848711|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42040582|NCT01796171|75848712|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42164211|NCT00094458|75972181|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
42164212|NCT00094458|75972182|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
42164213|NCT00094458|75972183|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
42164214|NCT00094458|75972184|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
42164215|NCT00094458|75972185|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
42164216|NCT00094458|75972180|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
42164217|NCT00094458|75972181|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
42164218|NCT00094458|75972182|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
42164219|NCT00094458|75972183|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
42164220|NCT00094458|75972184|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
42164221|NCT00094458|75972185|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
42164222|NCT00094458|75972180|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
42164223|NCT00094458|75972181|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
42164224|NCT00094458|75972182|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
42164225|NCT00094458|75972183|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
42164226|NCT00094458|75972184|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
42164227|NCT00094458|75972185|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
42164228|NCT00094458|75972180|FG000|OLE: Open-Label Extension|Adverse Event|0|||
42164229|NCT00094458|75972181|FG001|OLE: Open-Label Extension|Adverse Event|0|||
42164230|NCT00094458|75972182|FG002|OLE: Open-Label Extension|Adverse Event|0|||
42164231|NCT00094458|75972183|FG003|OLE: Open-Label Extension|Adverse Event|0|||
42164232|NCT00094458|75972184|FG004|OLE: Open-Label Extension|Adverse Event|3|||
42164233|NCT00094458|75972185|FG005|OLE: Open-Label Extension|Adverse Event|4|||
42164234|NCT00094458|75972180|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
42164235|NCT00094458|75972181|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
42164236|NCT00094458|75972182|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
42164237|NCT00094458|75972183|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
42164238|NCT00094458|75972184|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
42164239|NCT00094458|75972185|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
42164240|NCT00094458|75972180|FG000|OLE: Open-Label Extension|Patient decision|0|||
42164241|NCT00094458|75972181|FG001|OLE: Open-Label Extension|Patient decision|0|||
42013812|NCT01296035|75820934|FG000|Overall Study|Withdrawal by Subject|1|||
42013813|NCT01294787|75820938|FG000|Period 1|Adverse Event|0|||
42164242|NCT00094458|75972182|FG002|OLE: Open-Label Extension|Patient decision|0|||
42164243|NCT00094458|75972183|FG003|OLE: Open-Label Extension|Patient decision|0|||
42164244|NCT00094458|75972184|FG004|OLE: Open-Label Extension|Patient decision|1|||
42164245|NCT00094458|75972185|FG005|OLE: Open-Label Extension|Patient decision|0|||
42164246|NCT00406367|75972201|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
42164247|NCT00406367|75972202|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
42164248|NCT00406367|75972201|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
42164249|NCT00406367|75972202|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
42164250|NCT00406367|75972201|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
42164251|NCT00406367|75972202|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
42164252|NCT00406367|75972201|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
42164253|NCT00406367|75972202|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
42164254|NCT00406367|75972201|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
42164255|NCT00406367|75972202|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
42164256|NCT00406367|75972201|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
42164257|NCT00406367|75972202|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
42164258|NCT00406367|75972201|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
42164259|NCT00406367|75972202|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
42164260|NCT00406367|75972201|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
42164261|NCT00406367|75972202|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
42164262|NCT00406367|75972201|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
42164263|NCT00406367|75972202|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
42013814|NCT01294787|75820939|FG001|Period 1|Adverse Event|0|||
42164264|NCT00406367|75972201|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
42164265|NCT00406367|75972202|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
42281364|NCT01597245|76112831|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
42281365|NCT01597245|76112832|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42013815|NCT01294787|75820940|FG002|Period 1|Adverse Event|0|||
42013816|NCT01294787|75820941|FG003|Period 1|Adverse Event|0|||
42013817|NCT01294787|75820942|FG004|Period 1|Adverse Event|1|||
42013818|NCT01294787|75820943|FG005|Period 1|Adverse Event|0|||
42013819|NCT01294787|75820938|FG000|Period 1|Withdrawal by Subject|0|||
42013820|NCT01294787|75820939|FG001|Period 1|Withdrawal by Subject|0|||
42013821|NCT01294787|75820940|FG002|Period 1|Withdrawal by Subject|0|||
42013822|NCT01294787|75820941|FG003|Period 1|Withdrawal by Subject|1|||
42013823|NCT01294787|75820942|FG004|Period 1|Withdrawal by Subject|1|||
42164266|NCT00406367|75972201|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
42164267|NCT00406367|75972202|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
42164268|NCT00406367|75972201|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
42164269|NCT00406367|75972202|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
42164270|NCT00394589|75972211|FG000|Overall Study|Adverse Event|2|||
42164271|NCT00394589|75972212|FG001|Overall Study|Adverse Event|1|||
42164272|NCT00394589|75972213|FG002|Overall Study|Adverse Event|2|||
42164273|NCT00394589|75972211|FG000|Overall Study|Lack of Efficacy|2|||
42164274|NCT00394589|75972212|FG001|Overall Study|Lack of Efficacy|2|||
42164275|NCT00394589|75972213|FG002|Overall Study|Lack of Efficacy|3|||
42164276|NCT00394589|75972211|FG000|Overall Study|Protocol Violation|4|||
42164277|NCT00394589|75972212|FG001|Overall Study|Protocol Violation|0|||
42164278|NCT00394589|75972213|FG002|Overall Study|Protocol Violation|2|||
42164279|NCT00068406|75972221|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
42164280|NCT00068406|75972221|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
42164281|NCT00403559|75972227|FG000|Overall Study|Adverse Event|0|||
42164282|NCT00403559|75972228|FG001|Overall Study|Adverse Event|1|||
42164283|NCT00403559|75972227|FG000|Overall Study|Lost to Follow-up|3|||
42164284|NCT00403559|75972228|FG001|Overall Study|Lost to Follow-up|3|||
42164285|NCT00403559|75972227|FG000|Overall Study|Withdrawal by Subject|1|||
42164286|NCT00403559|75972228|FG001|Overall Study|Withdrawal by Subject|0|||
42164287|NCT00403481|75972236|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
42164288|NCT00403481|75972236|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
42164289|NCT00403481|75972236|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
42164290|NCT00403481|75972236|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
42164291|NCT00403481|75972236|FG000|Olm 40 mg|Adverse Event|2|||
42164292|NCT00403481|75972236|FG000|Olm 40 mg|Protocol Violation|1|||
42164293|NCT00403481|75972236|FG000|Olm 40 mg|Withdrawal by Subject|1|||
42164294|NCT00403481|75972236|FG000|Olm 40 mg|Other|1|||
42164295|NCT00403481|75972236|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
42164296|NCT00403481|75972236|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
42164297|NCT00403481|75972236|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
42164298|NCT00403481|75972236|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
42164299|NCT00403481|75972236|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
42164300|NCT00403481|75972236|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
42164301|NCT00402779|75972245|FG000|Overall Study|Screen Failure|77|||
42164302|NCT00402779|75972246|FG001|Overall Study|Screen Failure|76|||
42164303|NCT00394433|75972252|FG000|Overall Study|Adverse Event|2|||
42281366|NCT01597245|76112833|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281367|NCT01597245|76112834|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
42281368|NCT01597245|76112835|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
42281369|NCT01597245|76112815|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281370|NCT01597245|76112816|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281371|NCT01597245|76112817|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281372|NCT01597245|76112818|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281373|NCT01597245|76112819|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281374|NCT01597245|76112820|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281375|NCT01597245|76112821|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281376|NCT01597245|76112822|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281377|NCT01597245|76112823|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281378|NCT01597245|76112824|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281379|NCT01597245|76112825|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281380|NCT01597245|76112826|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281381|NCT01597245|76112827|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281382|NCT01597245|76112828|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281383|NCT01597245|76112829|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281384|NCT01597245|76112830|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281385|NCT01597245|76112831|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
42281386|NCT01597245|76112832|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281387|NCT01597245|76112833|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281388|NCT01597245|76112834|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
42281389|NCT01597245|76112835|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
42281390|NCT01597245|76112815|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42164304|NCT00394433|75972252|FG000|Overall Study|Alternative Therapy|1|||
42164305|NCT00092534|75972258|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
42281391|NCT01597245|76112816|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42164306|NCT00092534|75972259|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
42164307|NCT00092534|75972260|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
42164308|NCT00092534|75972261|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
42281392|NCT01597245|76112817|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281393|NCT01597245|76112818|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281394|NCT01597245|76112819|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281395|NCT01597245|76112820|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281396|NCT01597245|76112821|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281397|NCT01597245|76112822|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281398|NCT01597245|76112823|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281399|NCT01597245|76112824|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281400|NCT01597245|76112825|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42164309|NCT00092534|75972262|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
42164310|NCT00092534|75972258|FG000|Base Study Vaccination Period|Adverse Event|3|||
42164311|NCT00092534|75972259|FG001|Base Study Vaccination Period|Adverse Event|1|||
42164312|NCT00092534|75972260|FG002|Base Study Vaccination Period|Adverse Event|0|||
42164313|NCT00092534|75972261|FG003|Base Study Vaccination Period|Adverse Event|0|||
42164314|NCT00092534|75972262|FG004|Base Study Vaccination Period|Adverse Event|0|||
42164315|NCT00092534|75972258|FG000|Base Study Vaccination Period|Death|5|||
42164316|NCT00092534|75972259|FG001|Base Study Vaccination Period|Death|4|||
42164317|NCT00092534|75972260|FG002|Base Study Vaccination Period|Death|0|||
42164318|NCT00092534|75972261|FG003|Base Study Vaccination Period|Death|0|||
42164319|NCT00092534|75972262|FG004|Base Study Vaccination Period|Death|0|||
42164320|NCT00092534|75972258|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
42164321|NCT00092534|75972259|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
42164322|NCT00092534|75972260|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
42164323|NCT00092534|75972261|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
42164324|NCT00092534|75972262|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
42164325|NCT00092534|75972258|FG000|Base Study Vaccination Period|Physician Decision|1|||
42164326|NCT00092534|75972259|FG001|Base Study Vaccination Period|Physician Decision|0|||
42164327|NCT00092534|75972260|FG002|Base Study Vaccination Period|Physician Decision|0|||
42164328|NCT00092534|75972261|FG003|Base Study Vaccination Period|Physician Decision|0|||
42164329|NCT00092534|75972262|FG004|Base Study Vaccination Period|Physician Decision|0|||
42164330|NCT00092534|75972258|FG000|Base Study Vaccination Period|Pregnancy|9|||
42164331|NCT00092534|75972259|FG001|Base Study Vaccination Period|Pregnancy|7|||
42164332|NCT00092534|75972260|FG002|Base Study Vaccination Period|Pregnancy|0|||
42164333|NCT00092534|75972261|FG003|Base Study Vaccination Period|Pregnancy|0|||
42164334|NCT00092534|75972262|FG004|Base Study Vaccination Period|Pregnancy|0|||
42164335|NCT00092534|75972258|FG000|Base Study Vaccination Period|Protocol Violation|2|||
42013824|NCT01294787|75820943|FG005|Period 1|Withdrawal by Subject|1|||
42013825|NCT01294787|75820938|FG000|Period 1|Administrative problem|0|||
42013826|NCT01294787|75820939|FG001|Period 1|Administrative problem|0|||
42013827|NCT01294787|75820940|FG002|Period 1|Administrative problem|1|||
42013828|NCT01294787|75820941|FG003|Period 1|Administrative problem|0|||
42013829|NCT01294787|75820942|FG004|Period 1|Administrative problem|0|||
42013830|NCT01294787|75820943|FG005|Period 1|Administrative problem|1|||
42013831|NCT01294787|75820938|FG000|Period 2|Adverse Event|0|||
42013832|NCT01294787|75820939|FG001|Period 2|Adverse Event|3|||
42013833|NCT01294787|75820940|FG002|Period 2|Adverse Event|0|||
42013834|NCT01294787|75820941|FG003|Period 2|Adverse Event|1|||
42013835|NCT01294787|75820942|FG004|Period 2|Adverse Event|0|||
42013836|NCT01294787|75820943|FG005|Period 2|Adverse Event|0|||
42013837|NCT01294787|75820938|FG000|Period 2|No longer needs study drug|0|||
42013838|NCT01294787|75820939|FG001|Period 2|No longer needs study drug|0|||
42013839|NCT01294787|75820940|FG002|Period 2|No longer needs study drug|0|||
42013840|NCT01294787|75820941|FG003|Period 2|No longer needs study drug|1|||
42013841|NCT01294787|75820942|FG004|Period 2|No longer needs study drug|0|||
42013842|NCT01294787|75820943|FG005|Period 2|No longer needs study drug|0|||
42013843|NCT01294787|75820938|FG000|Period 3|Adverse Event|0|||
42013844|NCT01294787|75820939|FG001|Period 3|Adverse Event|0|||
42013845|NCT01294787|75820940|FG002|Period 3|Adverse Event|0|||
42013846|NCT01294787|75820941|FG003|Period 3|Adverse Event|0|||
42013847|NCT01294787|75820942|FG004|Period 3|Adverse Event|1|||
42013848|NCT01294787|75820943|FG005|Period 3|Adverse Event|0|||
42013849|NCT01294553|75820954|FG000|Overall Study|Duplicated Participants|1|||
42013850|NCT01294553|75820954|FG000|Overall Study|Protocol Violation|268|||
42013851|NCT01294397|75820959|FG000|Overall Study|Withdrawal by Subject|1|||
42013852|NCT01294397|75820959|FG000|Overall Study|Administrative Decision|1|||
42013853|NCT01293695|75820967|FG000|Overall Study|Withdrawal by Subject|7|||
42013854|NCT01293695|75820968|FG001|Overall Study|Withdrawal by Subject|1|||
42013855|NCT01293695|75820967|FG000|Overall Study|Lost to Follow-up|8|||
42013856|NCT01293695|75820968|FG001|Overall Study|Lost to Follow-up|6|||
42013857|NCT01293539|75820977|FG000|Overall Study|Physician Decision|1|||
42164336|NCT00092534|75972259|FG001|Base Study Vaccination Period|Protocol Violation|1|||
42164337|NCT00092534|75972260|FG002|Base Study Vaccination Period|Protocol Violation|0|||
42164338|NCT00092534|75972261|FG003|Base Study Vaccination Period|Protocol Violation|0|||
42164339|NCT00092534|75972262|FG004|Base Study Vaccination Period|Protocol Violation|0|||
42164340|NCT00092534|75972258|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
42164341|NCT00092534|75972259|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
42164342|NCT00092534|75972260|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
42164343|NCT00092534|75972261|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
42164344|NCT00092534|75972262|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
42164345|NCT00092534|75972258|FG000|Base Study Vaccination Period|Moved|14|||
42164346|NCT00092534|75972259|FG001|Base Study Vaccination Period|Moved|12|||
42164347|NCT00092534|75972260|FG002|Base Study Vaccination Period|Moved|0|||
42164348|NCT00092534|75972261|FG003|Base Study Vaccination Period|Moved|0|||
42164349|NCT00092534|75972262|FG004|Base Study Vaccination Period|Moved|0|||
42164350|NCT00092534|75972258|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
42164351|NCT00092534|75972259|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
42164352|NCT00092534|75972260|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
42164353|NCT00092534|75972261|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
42164354|NCT00092534|75972262|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
42164355|NCT00092534|75972258|FG000|Base Study Vaccination Period|Travel|1|||
42164356|NCT00092534|75972259|FG001|Base Study Vaccination Period|Travel|0|||
42164357|NCT00092534|75972260|FG002|Base Study Vaccination Period|Travel|0|||
42164358|NCT00092534|75972261|FG003|Base Study Vaccination Period|Travel|0|||
42013858|NCT01292837|75820981|FG000|Overall Study|Adverse Event|1|||
42013859|NCT01292837|75820981|FG000|Overall Study|Further treatment determined|1|||
42013860|NCT00965731|75820987|FG000|Overall Study|Death|0|||
42013861|NCT00965731|75820988|FG001|Overall Study|Death|4|||
42013862|NCT00965731|75820987|FG000|Overall Study|Withdrawal by Subject|0|||
42013863|NCT00965731|75820988|FG001|Overall Study|Withdrawal by Subject|1|||
42013864|NCT00965731|75820987|FG000|Overall Study|Other|7|||
42013865|NCT00965731|75820988|FG001|Overall Study|Other|15|||
42013866|NCT00965575|75821001|FG000|Overall Study|subject unwillingness to swallow study c|1|||
42013867|NCT00965575|75821002|FG001|Overall Study|subject unwillingness to swallow study c|0|||
42013868|NCT00965497|75821010|FG000|Overall Study|Physician Decision|1|||
42013869|NCT00963937|75821017|FG000|Overall Study|Protocol Violation|1|||
42013870|NCT00963937|75821018|FG001|Overall Study|Protocol Violation|1|||
42013871|NCT00963937|75821019|FG002|Overall Study|Protocol Violation|0|||
42013872|NCT00963937|75821017|FG000|Overall Study|Physician Decision|18|||
42013873|NCT00963937|75821018|FG001|Overall Study|Physician Decision|10|||
42013874|NCT00963937|75821019|FG002|Overall Study|Physician Decision|4|||
42013875|NCT01170663|75821032|FG000|Overall Study|Lost to Follow-up|3|||
42013876|NCT01170663|75821033|FG001|Overall Study|Lost to Follow-up|9|||
42013877|NCT01170663|75821032|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
42013878|NCT01170663|75821033|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
42013879|NCT01170273|75821041|FG000|Overall Study|Lost to Follow-up|6|||
42013880|NCT01170273|75821042|FG001|Overall Study|Lost to Follow-up|8|||
42013881|NCT01170273|75821041|FG000|Overall Study|Protocol Violation|1|||
42013882|NCT01170273|75821042|FG001|Overall Study|Protocol Violation|0|||
42013883|NCT01170273|75821041|FG000|Overall Study|Death|1|||
42013884|NCT01170273|75821042|FG001|Overall Study|Death|0|||
42013885|NCT01170273|75821041|FG000|Overall Study|Adverse Event|0|||
42013886|NCT01170273|75821042|FG001|Overall Study|Adverse Event|1|||
42013887|NCT01170039|75821050|FG000|Overall Study|Withdrawal by Subject|5|||
42013888|NCT01170039|75821051|FG001|Overall Study|Withdrawal by Subject|3|||
42013889|NCT01170039|75821050|FG000|Overall Study|Lack of funding, drug not available|3|||
42013890|NCT01170039|75821051|FG001|Overall Study|Lack of funding, drug not available|3|||
42013891|NCT01169649|75821057|FG000|Overall Study|Patient Not Treated|3|||
42013892|NCT01169493|75821067|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
42013893|NCT01169493|75821068|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
42013894|NCT01169493|75821069|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
42013895|NCT01169493|75821070|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
42013896|NCT01169493|75821071|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
42040583|NCT01796171|75848713|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42040584|NCT01796171|75848714|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
42040585|NCT01796171|75848715|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42040586|NCT01796171|75848716|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
42040587|NCT01796171|75848717|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
42040588|NCT01796171|75848718|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42040589|NCT01796171|75848719|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42040590|NCT01796171|75848720|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
42040591|NCT01796171|75848706|FG000|Treatment Period With Betalutin|Physician Decision|0|||
42040592|NCT01796171|75848707|FG001|Treatment Period With Betalutin|Physician Decision|0|||
42164359|NCT00092534|75972262|FG004|Base Study Vaccination Period|Travel|0|||
42164360|NCT00092534|75972258|FG000|Base Study Vaccination Period|Site Closed|0|||
42164361|NCT00092534|75972259|FG001|Base Study Vaccination Period|Site Closed|1|||
42164362|NCT00092534|75972260|FG002|Base Study Vaccination Period|Site Closed|0|||
42164363|NCT00092534|75972261|FG003|Base Study Vaccination Period|Site Closed|0|||
42164364|NCT00092534|75972262|FG004|Base Study Vaccination Period|Site Closed|0|||
42013897|NCT01169493|75821072|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
42013898|NCT01169493|75821067|FG000|Period 3 (6 Months)|Adverse Event|0|||
42013899|NCT01169493|75821068|FG001|Period 3 (6 Months)|Adverse Event|1|||
42013900|NCT01169493|75821069|FG002|Period 3 (6 Months)|Adverse Event|0|||
42013901|NCT01169493|75821070|FG003|Period 3 (6 Months)|Adverse Event|0|||
42013902|NCT01169493|75821071|FG004|Period 3 (6 Months)|Adverse Event|0|||
42013903|NCT01169493|75821072|FG005|Period 3 (6 Months)|Adverse Event|0|||
42013904|NCT01169493|75821067|FG000|Period 3 (6 Months)|Physician Decision|0|||
42013905|NCT01169493|75821068|FG001|Period 3 (6 Months)|Physician Decision|1|||
42013906|NCT01169493|75821069|FG002|Period 3 (6 Months)|Physician Decision|1|||
42013907|NCT01169493|75821070|FG003|Period 3 (6 Months)|Physician Decision|0|||
42013908|NCT01169493|75821071|FG004|Period 3 (6 Months)|Physician Decision|0|||
42013909|NCT01169493|75821072|FG005|Period 3 (6 Months)|Physician Decision|0|||
42013910|NCT01287104|75821084|FG000|Overall Study|Patient developed progressive disease|1|||
42013911|NCT01287104|75821085|FG001|Overall Study|Patient developed progressive disease|1|||
42013912|NCT01287104|75821086|FG002|Overall Study|Patient developed progressive disease|3|||
42013913|NCT01287104|75821087|FG003|Overall Study|Patient developed progressive disease|2|||
42164365|NCT00092534|75972258|FG000|Base Study Follow-Up Period|Adverse Event|2|||
42164366|NCT00092534|75972259|FG001|Base Study Follow-Up Period|Adverse Event|4|||
42164367|NCT00092534|75972260|FG002|Base Study Follow-Up Period|Adverse Event|0|||
42164368|NCT00092534|75972261|FG003|Base Study Follow-Up Period|Adverse Event|0|||
42164369|NCT00092534|75972262|FG004|Base Study Follow-Up Period|Adverse Event|0|||
42164370|NCT00092534|75972258|FG000|Base Study Follow-Up Period|Death|2|||
42164371|NCT00092534|75972259|FG001|Base Study Follow-Up Period|Death|1|||
42164372|NCT00092534|75972260|FG002|Base Study Follow-Up Period|Death|0|||
42164373|NCT00092534|75972261|FG003|Base Study Follow-Up Period|Death|0|||
42164374|NCT00092534|75972262|FG004|Base Study Follow-Up Period|Death|0|||
42164375|NCT00092534|75972258|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
42164376|NCT00092534|75972259|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
42164377|NCT00092534|75972260|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
42164378|NCT00092534|75972261|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
42164379|NCT00092534|75972262|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
42164380|NCT00092534|75972258|FG000|Base Study Follow-Up Period|Pregnancy|6|||
42164381|NCT00092534|75972259|FG001|Base Study Follow-Up Period|Pregnancy|10|||
42164382|NCT00092534|75972260|FG002|Base Study Follow-Up Period|Pregnancy|0|||
42164383|NCT00092534|75972261|FG003|Base Study Follow-Up Period|Pregnancy|0|||
42164384|NCT00092534|75972262|FG004|Base Study Follow-Up Period|Pregnancy|0|||
42164385|NCT00092534|75972258|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
42164386|NCT00092534|75972259|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
42164387|NCT00092534|75972260|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
42164388|NCT00092534|75972261|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
42164389|NCT00092534|75972262|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
42164390|NCT00092534|75972258|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
42164391|NCT00092534|75972259|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
42164392|NCT00092534|75972260|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
42164393|NCT00092534|75972261|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
42164394|NCT00092534|75972262|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
42164395|NCT00092534|75972258|FG000|Base Study Follow-Up Period|Moved|62|||
42164396|NCT00092534|75972259|FG001|Base Study Follow-Up Period|Moved|58|||
42164397|NCT00092534|75972260|FG002|Base Study Follow-Up Period|Moved|0|||
42164398|NCT00092534|75972261|FG003|Base Study Follow-Up Period|Moved|0|||
42164399|NCT00092534|75972262|FG004|Base Study Follow-Up Period|Moved|0|||
42164400|NCT00092534|75972258|FG000|Base Study Follow-Up Period|Travel|10|||
42164401|NCT00092534|75972259|FG001|Base Study Follow-Up Period|Travel|7|||
42164402|NCT00092534|75972260|FG002|Base Study Follow-Up Period|Travel|0|||
42164403|NCT00092534|75972261|FG003|Base Study Follow-Up Period|Travel|0|||
42164404|NCT00092534|75972262|FG004|Base Study Follow-Up Period|Travel|0|||
42164405|NCT00092534|75972258|FG000|Base Study Follow-Up Period|Site Closed|0|||
42013914|NCT01287104|75821084|FG000|Overall Study|Donor anaphylaxis|0|||
42164406|NCT00092534|75972259|FG001|Base Study Follow-Up Period|Site Closed|2|||
42164407|NCT00092534|75972260|FG002|Base Study Follow-Up Period|Site Closed|0|||
42013915|NCT01287104|75821085|FG001|Overall Study|Donor anaphylaxis|1|||
42164408|NCT00092534|75972261|FG003|Base Study Follow-Up Period|Site Closed|0|||
42351659|NCT01928329|76191579|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
42013916|NCT01287104|75821086|FG002|Overall Study|Donor anaphylaxis|0|||
42013917|NCT01287104|75821087|FG003|Overall Study|Donor anaphylaxis|1|||
42013918|NCT01287104|75821084|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
42164409|NCT00092534|75972262|FG004|Base Study Follow-Up Period|Site Closed|0|||
42164410|NCT00092534|75972258|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
42164411|NCT00092534|75972259|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
42164412|NCT00092534|75972260|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
42164413|NCT00092534|75972261|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
42164414|NCT00092534|75972262|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
42164415|NCT00092534|75972258|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
42164416|NCT00092534|75972259|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
42164417|NCT00092534|75972260|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
42164418|NCT00092534|75972261|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
42164419|NCT00092534|75972262|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
42164420|NCT00092534|75972258|FG000|Base Study EXT|Lost to Follow-up|0|||
42164421|NCT00092534|75972259|FG001|Base Study EXT|Lost to Follow-up|0|||
42164422|NCT00092534|75972260|FG002|Base Study EXT|Lost to Follow-up|41|||
42164423|NCT00092534|75972261|FG003|Base Study EXT|Lost to Follow-up|0|||
42164424|NCT00092534|75972262|FG004|Base Study EXT|Lost to Follow-up|0|||
42164425|NCT00092534|75972258|FG000|Base Study EXT|Physician Decision|0|||
42164426|NCT00092534|75972259|FG001|Base Study EXT|Physician Decision|0|||
42164427|NCT00092534|75972260|FG002|Base Study EXT|Physician Decision|1|||
42164428|NCT00092534|75972261|FG003|Base Study EXT|Physician Decision|0|||
42164429|NCT00092534|75972262|FG004|Base Study EXT|Physician Decision|0|||
42164430|NCT00092534|75972258|FG000|Base Study EXT|Pregnancy|0|||
42164431|NCT00092534|75972259|FG001|Base Study EXT|Pregnancy|0|||
42164432|NCT00092534|75972260|FG002|Base Study EXT|Pregnancy|12|||
42164433|NCT00092534|75972261|FG003|Base Study EXT|Pregnancy|0|||
42164434|NCT00092534|75972262|FG004|Base Study EXT|Pregnancy|0|||
42164435|NCT00092534|75972258|FG000|Base Study EXT|Withdrawal by Subject|0|||
42164436|NCT00092534|75972259|FG001|Base Study EXT|Withdrawal by Subject|0|||
42164437|NCT00092534|75972260|FG002|Base Study EXT|Withdrawal by Subject|18|||
42164438|NCT00092534|75972261|FG003|Base Study EXT|Withdrawal by Subject|0|||
42164439|NCT00092534|75972262|FG004|Base Study EXT|Withdrawal by Subject|0|||
42164440|NCT00092534|75972258|FG000|Base Study EXT|Participant moved|0|||
42164441|NCT00092534|75972259|FG001|Base Study EXT|Participant moved|0|||
42164442|NCT00092534|75972260|FG002|Base Study EXT|Participant moved|6|||
42164443|NCT00092534|75972261|FG003|Base Study EXT|Participant moved|0|||
42164444|NCT00092534|75972262|FG004|Base Study EXT|Participant moved|0|||
42164445|NCT00092534|75972258|FG000|Base Study EXT|Travel|0|||
42164446|NCT00092534|75972259|FG001|Base Study EXT|Travel|0|||
42164447|NCT00092534|75972260|FG002|Base Study EXT|Travel|2|||
42164448|NCT00092534|75972261|FG003|Base Study EXT|Travel|0|||
42164449|NCT00092534|75972262|FG004|Base Study EXT|Travel|0|||
42164450|NCT00092534|75972258|FG000|Base Study EXT|Site closed|0|||
42164451|NCT00092534|75972259|FG001|Base Study EXT|Site closed|0|||
42164452|NCT00092534|75972260|FG002|Base Study EXT|Site closed|21|||
42164453|NCT00092534|75972261|FG003|Base Study EXT|Site closed|0|||
42164454|NCT00092534|75972262|FG004|Base Study EXT|Site closed|0|||
42164455|NCT00092534|75972258|FG000|Base Study EXT|Study ended|0|||
42164456|NCT00092534|75972259|FG001|Base Study EXT|Study ended|0|||
42164457|NCT00092534|75972260|FG002|Base Study EXT|Study ended|29|||
42164458|NCT00092534|75972261|FG003|Base Study EXT|Study ended|0|||
42164459|NCT00092534|75972262|FG004|Base Study EXT|Study ended|0|||
42164460|NCT00092534|75972258|FG000|Base Study EXT|Protocol Violation|0|||
42164461|NCT00092534|75972259|FG001|Base Study EXT|Protocol Violation|0|||
42164462|NCT00092534|75972260|FG002|Base Study EXT|Protocol Violation|15|||
42164463|NCT00092534|75972261|FG003|Base Study EXT|Protocol Violation|0|||
42164464|NCT00092534|75972262|FG004|Base Study EXT|Protocol Violation|0|||
42164465|NCT00092534|75972258|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
42164466|NCT00092534|75972259|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
42164467|NCT00092534|75972260|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
42164468|NCT00092534|75972261|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
42164469|NCT00092534|75972262|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
42164470|NCT00068250|75972275|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
42164471|NCT00068250|75972276|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
42164472|NCT00068250|75972277|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
42164473|NCT00068250|75972278|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
42164474|NCT00393887|75972288|FG000|Overall Study|Physician Decision|5|||
42164475|NCT00393887|75972289|FG001|Overall Study|Physician Decision|0|||
42164476|NCT00393887|75972288|FG000|Overall Study|Lost to Follow-up|11|||
42164477|NCT00393887|75972289|FG001|Overall Study|Lost to Follow-up|9|||
42164478|NCT00393029|75972297|FG000|Overall Study|Not treated|0|||
42164479|NCT00393029|75972298|FG001|Overall Study|Not treated|1|||
42164480|NCT00402233|75972309|FG000|Overall Study|Adverse Event|1|||
42164481|NCT00402233|75972310|FG001|Overall Study|Adverse Event|7|||
42164482|NCT00402233|75972311|FG002|Overall Study|Adverse Event|9|||
42164483|NCT00402233|75972312|FG003|Overall Study|Adverse Event|9|||
42164484|NCT00402233|75972309|FG000|Overall Study|Protocol Violation|0|||
42164485|NCT00402233|75972310|FG001|Overall Study|Protocol Violation|1|||
42164486|NCT00402233|75972311|FG002|Overall Study|Protocol Violation|0|||
42164487|NCT00402233|75972312|FG003|Overall Study|Protocol Violation|0|||
42164488|NCT00402233|75972309|FG000|Overall Study|Withdrawal by Subject|2|||
42164489|NCT00402233|75972310|FG001|Overall Study|Withdrawal by Subject|1|||
42164490|NCT00402233|75972311|FG002|Overall Study|Withdrawal by Subject|2|||
42164491|NCT00402233|75972312|FG003|Overall Study|Withdrawal by Subject|2|||
42164492|NCT00402233|75972309|FG000|Overall Study|Worsening of disease under study|2|||
42164493|NCT00402233|75972310|FG001|Overall Study|Worsening of disease under study|0|||
42164494|NCT00402233|75972311|FG002|Overall Study|Worsening of disease under study|0|||
42164495|NCT00402233|75972312|FG003|Overall Study|Worsening of disease under study|0|||
42164496|NCT00402233|75972309|FG000|Overall Study|Worsening of other pre-existing disease|0|||
42164497|NCT00402233|75972310|FG001|Overall Study|Worsening of other pre-existing disease|1|||
42164498|NCT00402233|75972311|FG002|Overall Study|Worsening of other pre-existing disease|0|||
42164499|NCT00402233|75972312|FG003|Overall Study|Worsening of other pre-existing disease|0|||
42164500|NCT00092456|75972326|FG000|Overall Study|Adverse Event|0|||
42164501|NCT00092456|75972327|FG001|Overall Study|Adverse Event|0|||
42164502|NCT00092456|75972328|FG002|Overall Study|Adverse Event|1|||
42164503|NCT00092456|75972329|FG003|Overall Study|Adverse Event|1|||
42164504|NCT00092456|75972326|FG000|Overall Study|Lost to Follow-up|2|||
42164505|NCT00092456|75972327|FG001|Overall Study|Lost to Follow-up|2|||
42164506|NCT00092456|75972328|FG002|Overall Study|Lost to Follow-up|1|||
42164507|NCT00092456|75972329|FG003|Overall Study|Lost to Follow-up|2|||
42164508|NCT00092456|75972326|FG000|Overall Study|Protocol Violation|5|||
42013919|NCT01287104|75821085|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
42013920|NCT01287104|75821086|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
42164509|NCT00092456|75972327|FG001|Overall Study|Protocol Violation|7|||
42164510|NCT00092456|75972328|FG002|Overall Study|Protocol Violation|8|||
42164511|NCT00092456|75972329|FG003|Overall Study|Protocol Violation|6|||
42164512|NCT00092456|75972326|FG000|Overall Study|Withdrawal by Subject|13|||
42013921|NCT01287104|75821087|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
42013922|NCT01287104|75821084|FG000|Overall Study|Low donor chimerism|0|||
42013923|NCT01287104|75821085|FG001|Overall Study|Low donor chimerism|1|||
42013924|NCT01287104|75821086|FG002|Overall Study|Low donor chimerism|0|||
42013925|NCT01287104|75821087|FG003|Overall Study|Low donor chimerism|0|||
42013926|NCT01287104|75821084|FG000|Overall Study|NK cells did not meet release criteria|0|||
42013927|NCT01287104|75821085|FG001|Overall Study|NK cells did not meet release criteria|1|||
42013928|NCT01287104|75821086|FG002|Overall Study|NK cells did not meet release criteria|0|||
42013929|NCT01287104|75821087|FG003|Overall Study|NK cells did not meet release criteria|0|||
42013930|NCT01286558|75821106|FG000|Overall Study|Adverse Event|1|||
42013931|NCT01286558|75821107|FG001|Overall Study|Adverse Event|1|||
42013932|NCT01286558|75821106|FG000|Overall Study|Withdrawal by Subject|0|||
42013933|NCT01286558|75821107|FG001|Overall Study|Withdrawal by Subject|1|||
42013934|NCT01169103|75821115|FG000|Overall Study|Lost to Follow-up|3|||
42013935|NCT01169103|75821116|FG001|Overall Study|Lost to Follow-up|3|||
42013936|NCT01169103|75821115|FG000|Overall Study|Withdrawal by Subject|3|||
42013937|NCT01169103|75821116|FG001|Overall Study|Withdrawal by Subject|1|||
42013938|NCT01286480|75821124|FG000|Overall Study|Withdrawal by Subject|5|||
42013939|NCT01286480|75821125|FG001|Overall Study|Withdrawal by Subject|3|||
42013940|NCT01286168|75821131|FG000|Overall Study|Withdrawal by Subject|1|||
42164513|NCT00092456|75972327|FG001|Overall Study|Withdrawal by Subject|5|||
42164514|NCT00092456|75972328|FG002|Overall Study|Withdrawal by Subject|16|||
42164515|NCT00092456|75972329|FG003|Overall Study|Withdrawal by Subject|6|||
42164516|NCT00092456|75972326|FG000|Overall Study|Moved|1|||
42164517|NCT00092456|75972327|FG001|Overall Study|Moved|1|||
42013941|NCT01286168|75821131|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
42013942|NCT01286012|75821138|FG000|Overall Study|Adverse Event|3|||
42013943|NCT01286012|75821139|FG001|Overall Study|Adverse Event|3|||
42013944|NCT01286012|75821138|FG000|Overall Study|Death|2|||
42013945|NCT01286012|75821139|FG001|Overall Study|Death|3|||
42013946|NCT01286012|75821138|FG000|Overall Study|Protocol Violation|1|||
42013947|NCT01286012|75821139|FG001|Overall Study|Protocol Violation|1|||
42013948|NCT01286012|75821138|FG000|Overall Study|Withdrawal by Subject|4|||
42013949|NCT01286012|75821139|FG001|Overall Study|Withdrawal by Subject|4|||
42013950|NCT01286012|75821138|FG000|Overall Study|Physician Decision|2|||
42013951|NCT01286012|75821139|FG001|Overall Study|Physician Decision|0|||
42013952|NCT01286012|75821138|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
42013953|NCT01286012|75821139|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
42013954|NCT00963547|75821150|FG000|Overall Study|Adverse Event|0|||
42013955|NCT00963547|75821151|FG001|Overall Study|Adverse Event|1|||
42013956|NCT00963547|75821152|FG002|Overall Study|Adverse Event|0|||
42164518|NCT00092456|75972328|FG002|Overall Study|Moved|0|||
42164519|NCT00092456|75972329|FG003|Overall Study|Moved|1|||
42164520|NCT00092456|75972326|FG000|Overall Study|Other|4|||
42164521|NCT00092456|75972327|FG001|Overall Study|Other|2|||
42164522|NCT00092456|75972328|FG002|Overall Study|Other|3|||
42164523|NCT00092456|75972329|FG003|Overall Study|Other|0|||
42164524|NCT00067470|75972341|FG000|Overall Study|Withdrawal by Subject|0|||
42164525|NCT00067470|75972342|FG001|Overall Study|Withdrawal by Subject|1|||
42164526|NCT00401843|75972351|FG000|Overall Study|Achieved Complete Response|1|||
42013957|NCT00963547|75821153|FG003|Overall Study|Adverse Event|1|||
42013958|NCT00963547|75821154|FG004|Overall Study|Adverse Event|0|||
42013959|NCT00963547|75821155|FG005|Overall Study|Adverse Event|0|||
42013960|NCT00963547|75821156|FG006|Overall Study|Adverse Event|0|||
42013961|NCT00963547|75821150|FG000|Overall Study|Physician Decision|1|||
42013962|NCT00963547|75821151|FG001|Overall Study|Physician Decision|1|||
42013963|NCT00963547|75821152|FG002|Overall Study|Physician Decision|0|||
42013964|NCT00963547|75821153|FG003|Overall Study|Physician Decision|0|||
42013965|NCT00963547|75821154|FG004|Overall Study|Physician Decision|0|||
42013966|NCT00963547|75821155|FG005|Overall Study|Physician Decision|0|||
42013967|NCT00963547|75821156|FG006|Overall Study|Physician Decision|0|||
42013968|NCT00963547|75821150|FG000|Overall Study|Progressive Disease|3|||
42013969|NCT00963547|75821151|FG001|Overall Study|Progressive Disease|8|||
42013970|NCT00963547|75821152|FG002|Overall Study|Progressive Disease|9|||
42013971|NCT00963547|75821153|FG003|Overall Study|Progressive Disease|5|||
42013972|NCT00963547|75821154|FG004|Overall Study|Progressive Disease|0|||
42013973|NCT00963547|75821155|FG005|Overall Study|Progressive Disease|0|||
42013974|NCT00963547|75821156|FG006|Overall Study|Progressive Disease|0|||
42013975|NCT00963547|75821150|FG000|Overall Study|Withdrawal by Subject|0|||
42013976|NCT00963547|75821151|FG001|Overall Study|Withdrawal by Subject|0|||
42013977|NCT00963547|75821152|FG002|Overall Study|Withdrawal by Subject|3|||
42013978|NCT00963547|75821153|FG003|Overall Study|Withdrawal by Subject|0|||
42013979|NCT00963547|75821154|FG004|Overall Study|Withdrawal by Subject|0|||
42013980|NCT00963547|75821155|FG005|Overall Study|Withdrawal by Subject|0|||
42164527|NCT00401843|75972352|FG001|Overall Study|Achieved Complete Response|5|||
42013981|NCT00963547|75821156|FG006|Overall Study|Withdrawal by Subject|0|||
42013982|NCT00963547|75821150|FG000|Overall Study|Reason Unknown|0|||
42013983|NCT00963547|75821151|FG001|Overall Study|Reason Unknown|1|||
42013984|NCT00963547|75821152|FG002|Overall Study|Reason Unknown|0|||
42013985|NCT00963547|75821153|FG003|Overall Study|Reason Unknown|0|||
42013986|NCT00963547|75821154|FG004|Overall Study|Reason Unknown|0|||
42013987|NCT00963547|75821155|FG005|Overall Study|Reason Unknown|0|||
42013988|NCT00963547|75821156|FG006|Overall Study|Reason Unknown|0|||
42013989|NCT01285310|75821172|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
42351660|NCT01928329|76191578|FG000|Overall Study|Withdrawal by Subject|1|||
42351661|NCT01928329|76191579|FG001|Overall Study|Withdrawal by Subject|5|||
42351662|NCT01928329|76191578|FG000|Overall Study|Physician Decision|1|||
42351663|NCT01928329|76191579|FG001|Overall Study|Physician Decision|1|||
42351664|NCT01890109|76191587|FG000|Overall Study|Withdrawal by Subject|0|||
42351665|NCT01890109|76191588|FG001|Overall Study|Withdrawal by Subject|3|||
42351666|NCT01890109|76191587|FG000|Overall Study|Lost to Follow-up|1|||
42351667|NCT01890109|76191588|FG001|Overall Study|Lost to Follow-up|2|||
42351668|NCT00982930|76191595|FG000|Overall Study|Adverse Event|1|||
42351669|NCT00982930|76191595|FG000|Overall Study|Withdrawal by Subject|1|||
42351670|NCT00982930|76191595|FG000|Overall Study|Administrative Problems|2|||
42351671|NCT00981682|76191599|FG000|Overall Study|Adverse Event|48|||
42351672|NCT00981682|76191599|FG000|Overall Study|Withdrawal by Subject|52|||
42351673|NCT00981682|76191599|FG000|Overall Study|Lost to Follow-up|14|||
42351674|NCT00981682|76191599|FG000|Overall Study|Lack of Efficacy|13|||
42351675|NCT00981682|76191599|FG000|Overall Study|Protocol Violation|6|||
42351676|NCT00981682|76191599|FG000|Overall Study|administrative|9|||
42351677|NCT01903993|76191605|FG000|Overall Study|Death|118|||
42351678|NCT01903993|76191606|FG001|Overall Study|Death|121|||
42013990|NCT01285310|75821173|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
42013991|NCT01285310|75821174|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
42351679|NCT01903993|76191605|FG000|Overall Study|Withdrawal by Subject|15|||
42351680|NCT01903993|76191606|FG001|Overall Study|Withdrawal by Subject|4|||
42351681|NCT01903993|76191605|FG000|Overall Study|Lost to Follow-up|2|||
42351682|NCT01903993|76191606|FG001|Overall Study|Lost to Follow-up|3|||
42351683|NCT01903993|76191605|FG000|Overall Study|Study Terminated by Sponsor|8|||
42164528|NCT00401843|75972353|FG002|Overall Study|Achieved Complete Response|11|||
42013992|NCT01285310|75821175|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
42013993|NCT01285310|75821176|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
42013994|NCT01285310|75821172|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
42013995|NCT01285310|75821173|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
42013996|NCT01285310|75821174|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
42013997|NCT01285310|75821175|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
42013998|NCT01285310|75821176|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
42013999|NCT01285310|75821172|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
42351684|NCT01903993|76191606|FG001|Overall Study|Study Terminated by Sponsor|14|||
42351685|NCT01903993|76191605|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
42351686|NCT01903993|76191606|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
42351687|NCT00981292|76191619|FG000|Day 1|Protocol Violation|1|||
42164529|NCT00401843|75972351|FG000|Overall Study|Adverse Event|7|||
42164530|NCT00401843|75972352|FG001|Overall Study|Adverse Event|26|||
42164531|NCT00401843|75972353|FG002|Overall Study|Adverse Event|27|||
42164532|NCT00401843|75972351|FG000|Overall Study|Death|0|||
42164533|NCT00401843|75972352|FG001|Overall Study|Death|8|||
42164534|NCT00401843|75972353|FG002|Overall Study|Death|10|||
42164535|NCT00401843|75972351|FG000|Overall Study|Disease progression|10|||
42164536|NCT00401843|75972352|FG001|Overall Study|Disease progression|60|||
42164537|NCT00401843|75972353|FG002|Overall Study|Disease progression|49|||
42164538|NCT00401843|75972351|FG000|Overall Study|End of Study|1|||
42164539|NCT00401843|75972352|FG001|Overall Study|End of Study|1|||
42164540|NCT00401843|75972353|FG002|Overall Study|End of Study|2|||
42164541|NCT00401843|75972351|FG000|Overall Study|Lost to Follow-up|0|||
42164542|NCT00401843|75972352|FG001|Overall Study|Lost to Follow-up|0|||
42164543|NCT00401843|75972353|FG002|Overall Study|Lost to Follow-up|2|||
42164544|NCT00401843|75972351|FG000|Overall Study|Other Unspecified|0|||
42164545|NCT00401843|75972352|FG001|Overall Study|Other Unspecified|3|||
42164546|NCT00401843|75972353|FG002|Overall Study|Other Unspecified|5|||
42164547|NCT00401843|75972351|FG000|Overall Study|Physician Decision|0|||
42164548|NCT00401843|75972352|FG001|Overall Study|Physician Decision|16|||
42164549|NCT00401843|75972353|FG002|Overall Study|Physician Decision|10|||
42351688|NCT00981292|76191620|FG001|Day 1|Protocol Violation|0|||
42351689|NCT00981292|76191621|FG002|Day 1|Protocol Violation|0|||
42351690|NCT00981292|76191622|FG003|Day 1|Protocol Violation|0|||
42351691|NCT00981292|76191623|FG004|Day 1|Protocol Violation|0|||
42014000|NCT01285310|75821173|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
42164550|NCT00401843|75972351|FG000|Overall Study|Protocol Violation|0|||
42164551|NCT00401843|75972352|FG001|Overall Study|Protocol Violation|0|||
42164552|NCT00401843|75972353|FG002|Overall Study|Protocol Violation|1|||
42164553|NCT00401843|75972351|FG000|Overall Study|Withdrawal by Subject|1|||
42164554|NCT00401843|75972352|FG001|Overall Study|Withdrawal by Subject|5|||
42164555|NCT00401843|75972353|FG002|Overall Study|Withdrawal by Subject|5|||
42164556|NCT00401843|75972351|FG000|Overall Study|Withdrawal of consent to study agent|1|||
42164557|NCT00401843|75972352|FG001|Overall Study|Withdrawal of consent to study agent|15|||
42164558|NCT00401843|75972353|FG002|Overall Study|Withdrawal of consent to study agent|17|||
42164559|NCT00401843|75972351|FG000|Overall Study|Randomized but not Treated|0|||
42164560|NCT00401843|75972352|FG001|Overall Study|Randomized but not Treated|2|||
42164561|NCT00401843|75972353|FG002|Overall Study|Randomized but not Treated|3|||
42164562|NCT00401843|75972351|FG000|Overall Study|Received incorrect treatment|0|||
42164563|NCT00401843|75972352|FG001|Overall Study|Received incorrect treatment|3|||
42164564|NCT00401843|75972353|FG002|Overall Study|Received incorrect treatment|0|||
42164565|NCT00401531|75972365|FG000|Overall Study|Adverse Event|2|||
42014001|NCT01285310|75821174|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
42014002|NCT01285310|75821175|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
42014003|NCT01285310|75821176|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
42014004|NCT01285310|75821172|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
42014005|NCT01285310|75821173|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
42014006|NCT01285310|75821174|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
42014007|NCT01285310|75821175|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
42014008|NCT01285310|75821176|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
42014009|NCT01285310|75821172|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
42164566|NCT00401531|75972366|FG001|Overall Study|Adverse Event|0|||
42164567|NCT00401531|75972365|FG000|Overall Study|Protocol Violation|3|||
42014010|NCT01285310|75821173|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
42014011|NCT01285310|75821174|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
42164568|NCT00401531|75972366|FG001|Overall Study|Protocol Violation|7|||
42351692|NCT00981292|76191624|FG005|Day 1|Protocol Violation|2|||
42164569|NCT00401531|75972365|FG000|Overall Study|Lost to Follow-up|1|||
42164570|NCT00401531|75972366|FG001|Overall Study|Lost to Follow-up|1|||
42164571|NCT00401531|75972365|FG000|Overall Study|Withdrawal by Subject|3|||
42164572|NCT00401531|75972366|FG001|Overall Study|Withdrawal by Subject|2|||
42164573|NCT00401375|75972375|FG000|Overall Study|Protocol Violation|2|||
42164574|NCT00401375|75972376|FG001|Overall Study|Protocol Violation|2|||
42164575|NCT00401375|75972377|FG002|Overall Study|Protocol Violation|1|||
42351693|NCT00981292|76191619|FG000|Day 2|Protocol Violation|2|||
42351694|NCT00981292|76191620|FG001|Day 2|Protocol Violation|0|||
42351695|NCT00981292|76191621|FG002|Day 2|Protocol Violation|0|||
42351696|NCT00981292|76191622|FG003|Day 2|Protocol Violation|0|||
42164576|NCT00401375|75972375|FG000|Overall Study|Adverse Event|6|||
42164577|NCT00401375|75972376|FG001|Overall Study|Adverse Event|11|||
42164578|NCT00401375|75972377|FG002|Overall Study|Adverse Event|10|||
42164579|NCT00401375|75972375|FG000|Overall Study|Withdrawal by Subject|9|||
42164580|NCT00401375|75972376|FG001|Overall Study|Withdrawal by Subject|7|||
42351697|NCT00981292|76191623|FG004|Day 2|Protocol Violation|0|||
42014012|NCT01285310|75821175|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
42014013|NCT01285310|75821176|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
42014014|NCT01285310|75821172|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
42014015|NCT01285310|75821173|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
42014016|NCT01285310|75821174|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
42014017|NCT01285310|75821175|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
42014018|NCT01285310|75821176|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
42014019|NCT01285310|75821172|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
42014020|NCT01285310|75821173|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
42014021|NCT01285310|75821174|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
42014022|NCT01285310|75821175|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
42014023|NCT01285310|75821176|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
42014024|NCT01285310|75821172|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
42014025|NCT01285310|75821173|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
42014026|NCT01285310|75821174|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
42014027|NCT01285310|75821175|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
42014028|NCT01285310|75821176|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
42014029|NCT01285310|75821172|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
42014030|NCT01285310|75821173|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
42014031|NCT01285310|75821174|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
42014032|NCT01285310|75821175|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
42014033|NCT01285310|75821176|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
42014034|NCT01285310|75821172|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
42014035|NCT01285310|75821173|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
42014036|NCT01285310|75821174|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
42014037|NCT01285310|75821175|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
42164581|NCT00401375|75972377|FG002|Overall Study|Withdrawal by Subject|7|||
42164582|NCT00401375|75972375|FG000|Overall Study|Lost to Follow-up|0|||
42164583|NCT00401375|75972376|FG001|Overall Study|Lost to Follow-up|1|||
42164584|NCT00401375|75972377|FG002|Overall Study|Lost to Follow-up|1|||
42164585|NCT00401375|75972375|FG000|Overall Study|Other than specified|2|||
42164586|NCT00401375|75972376|FG001|Overall Study|Other than specified|1|||
42164587|NCT00401375|75972377|FG002|Overall Study|Other than specified|3|||
42164588|NCT00401375|75972375|FG000|Overall Study|Randomized but not treated|3|||
42164589|NCT00401375|75972376|FG001|Overall Study|Randomized but not treated|3|||
42164590|NCT00401375|75972377|FG002|Overall Study|Randomized but not treated|3|||
42164591|NCT00400985|75972385|FG000|Overall Study|Withdrawal by Subject|5|||
42164592|NCT00400985|75972385|FG000|Overall Study|system modification|8|||
42164593|NCT00400985|75972385|FG000|Overall Study|Death|30|||
42164594|NCT00400985|75972385|FG000|Overall Study|Lost to Follow-up|9|||
42164595|NCT00400517|75972389|FG000|Overall Study|Withdrawal by Subject|1|||
42164596|NCT00400517|75972389|FG000|Overall Study|Physician Decision|1|||
42164597|NCT00392171|75972393|FG000|Overall Study|Did not meet inclusion criteria|4|||
42014038|NCT01285310|75821176|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
42014039|NCT01285310|75821172|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
42014040|NCT01285310|75821173|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
42014041|NCT01285310|75821174|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
42014042|NCT01285310|75821175|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
42014043|NCT01285310|75821176|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
42014044|NCT01285310|75821172|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
42014045|NCT01285310|75821173|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
42014046|NCT01285310|75821174|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
42014047|NCT01285310|75821175|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
42014048|NCT01285310|75821176|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
42014049|NCT01254630|75821218|FG000|Overall Study|Adverse Event|36|||
42014050|NCT01254630|75821219|FG001|Overall Study|Adverse Event|15|||
42014051|NCT01254630|75821220|FG002|Overall Study|Adverse Event|40|||
42014052|NCT01254630|75821221|FG003|Overall Study|Adverse Event|8|||
42014053|NCT01254630|75821218|FG000|Overall Study|Death|461|||
42014054|NCT01254630|75821219|FG001|Overall Study|Death|151|||
42351698|NCT00981292|76191624|FG005|Day 2|Protocol Violation|0|||
42164598|NCT00392171|75972393|FG000|Overall Study|Disease progression|101|||
42164599|NCT00391625|75972397|FG000|Month 14|Withdrawal by Subject|1|||
42164600|NCT00391625|75972397|FG000|Month 50|Physician Decision|1|||
42164601|NCT00091832|75972430|FG000|Overall Study|Physician Decision|1|||
42164602|NCT00091832|75972431|FG001|Overall Study|Physician Decision|0|||
42014055|NCT01254630|75821220|FG002|Overall Study|Death|478|||
42014056|NCT01254630|75821221|FG003|Overall Study|Death|139|||
42014057|NCT01254630|75821218|FG000|Overall Study|Lost to Follow-up|80|||
42014058|NCT01254630|75821219|FG001|Overall Study|Lost to Follow-up|26|||
42164603|NCT00091832|75972432|FG002|Overall Study|Physician Decision|0|||
42164604|NCT00091832|75972433|FG003|Overall Study|Physician Decision|0|||
42164605|NCT00091832|75972434|FG004|Overall Study|Physician Decision|0|||
42164606|NCT00091832|75972435|FG005|Overall Study|Physician Decision|0|||
42164607|NCT00091832|75972430|FG000|Overall Study|Adverse Event|0|||
42164608|NCT00091832|75972431|FG001|Overall Study|Adverse Event|0|||
42164609|NCT00091832|75972432|FG002|Overall Study|Adverse Event|0|||
42164610|NCT00091832|75972433|FG003|Overall Study|Adverse Event|1|||
42164611|NCT00091832|75972434|FG004|Overall Study|Adverse Event|3|||
42164612|NCT00091832|75972435|FG005|Overall Study|Adverse Event|0|||
42164613|NCT00091832|75972430|FG000|Overall Study|Withdrawal by Subject|4|||
42164614|NCT00091832|75972431|FG001|Overall Study|Withdrawal by Subject|5|||
42164615|NCT00091832|75972432|FG002|Overall Study|Withdrawal by Subject|0|||
42164616|NCT00091832|75972433|FG003|Overall Study|Withdrawal by Subject|1|||
42164617|NCT00091832|75972434|FG004|Overall Study|Withdrawal by Subject|3|||
42164618|NCT00091832|75972435|FG005|Overall Study|Withdrawal by Subject|1|||
42164619|NCT00091832|75972430|FG000|Overall Study|Death|6|||
42164620|NCT00091832|75972431|FG001|Overall Study|Death|4|||
42164621|NCT00091832|75972432|FG002|Overall Study|Death|5|||
42164622|NCT00091832|75972433|FG003|Overall Study|Death|8|||
42164623|NCT00091832|75972434|FG004|Overall Study|Death|5|||
42164624|NCT00091832|75972435|FG005|Overall Study|Death|6|||
42164625|NCT00091832|75972430|FG000|Overall Study|Disease Progression|2|||
42014059|NCT01254630|75821220|FG002|Overall Study|Lost to Follow-up|89|||
42014060|NCT01254630|75821221|FG003|Overall Study|Lost to Follow-up|32|||
42014061|NCT01254630|75821218|FG000|Overall Study|Physician Decision|24|||
42014062|NCT01254630|75821219|FG001|Overall Study|Physician Decision|8|||
42014063|NCT01254630|75821220|FG002|Overall Study|Physician Decision|16|||
42014064|NCT01254630|75821221|FG003|Overall Study|Physician Decision|7|||
42014065|NCT01254630|75821218|FG000|Overall Study|Withdrawal by Subject|201|||
42014066|NCT01254630|75821219|FG001|Overall Study|Withdrawal by Subject|94|||
42014067|NCT01254630|75821220|FG002|Overall Study|Withdrawal by Subject|188|||
42014068|NCT01254630|75821221|FG003|Overall Study|Withdrawal by Subject|89|||
42014069|NCT01254630|75821218|FG000|Overall Study|Study terminated by sponsor|0|||
42014070|NCT01254630|75821219|FG001|Overall Study|Study terminated by sponsor|994|||
42014071|NCT01254630|75821220|FG002|Overall Study|Study terminated by sponsor|0|||
42014072|NCT01254630|75821221|FG003|Overall Study|Study terminated by sponsor|1010|||
42014073|NCT01254630|75821218|FG000|Overall Study|Status not recorded|0|||
42014074|NCT01254630|75821219|FG001|Overall Study|Status not recorded|0|||
42014075|NCT01254630|75821220|FG002|Overall Study|Status not recorded|1|||
42014076|NCT01254630|75821221|FG003|Overall Study|Status not recorded|0|||
42014077|NCT01284140|75821231|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
42014078|NCT01284140|75821232|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
42014079|NCT01284140|75821231|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
42014080|NCT01284140|75821232|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
42014081|NCT01254318|75821238|FG000|Overall Study|Lost to Follow-up|5|||
42014082|NCT01254318|75821238|FG000|Overall Study|Death|47|||
42014083|NCT01284062|75821246|FG000|Overall Study|Adverse Event|4|||
42014084|NCT01284062|75821247|FG001|Overall Study|Adverse Event|5|||
42014085|NCT01284062|75821248|FG002|Overall Study|Adverse Event|0|||
42014086|NCT01284062|75821249|FG003|Overall Study|Adverse Event|5|||
42014087|NCT01284062|75821246|FG000|Overall Study|Lack of Efficacy|3|||
42014088|NCT01284062|75821247|FG001|Overall Study|Lack of Efficacy|2|||
42014089|NCT01284062|75821248|FG002|Overall Study|Lack of Efficacy|2|||
42014090|NCT01284062|75821249|FG003|Overall Study|Lack of Efficacy|1|||
42014091|NCT01284062|75821246|FG000|Overall Study|Medication error without adverse event|0|||
42014092|NCT01284062|75821247|FG001|Overall Study|Medication error without adverse event|0|||
42014093|NCT01284062|75821248|FG002|Overall Study|Medication error without adverse event|1|||
42014094|NCT01284062|75821249|FG003|Overall Study|Medication error without adverse event|0|||
42014095|NCT01284062|75821246|FG000|Overall Study|Protocol Violation|1|||
42014096|NCT01284062|75821247|FG001|Overall Study|Protocol Violation|0|||
42014097|NCT01284062|75821248|FG002|Overall Study|Protocol Violation|0|||
42014098|NCT01284062|75821249|FG003|Overall Study|Protocol Violation|2|||
42014099|NCT01284062|75821246|FG000|Overall Study|Withdrawal by Subject|3|||
42014100|NCT01284062|75821247|FG001|Overall Study|Withdrawal by Subject|1|||
42014101|NCT01284062|75821248|FG002|Overall Study|Withdrawal by Subject|2|||
42014102|NCT01284062|75821249|FG003|Overall Study|Withdrawal by Subject|5|||
42014103|NCT01284062|75821246|FG000|Overall Study|Other|0|||
42014104|NCT01284062|75821247|FG001|Overall Study|Other|0|||
42014105|NCT01284062|75821248|FG002|Overall Study|Other|0|||
42014106|NCT01284062|75821249|FG003|Overall Study|Other|1|||
42014107|NCT01284062|75821246|FG000|Overall Study|Site Closed|0|||
42014108|NCT01284062|75821247|FG001|Overall Study|Site Closed|0|||
42014109|NCT01284062|75821248|FG002|Overall Study|Site Closed|1|||
42014110|NCT01284062|75821249|FG003|Overall Study|Site Closed|0|||
42164626|NCT00091832|75972431|FG001|Overall Study|Disease Progression|0|||
42164627|NCT00091832|75972432|FG002|Overall Study|Disease Progression|0|||
42164628|NCT00091832|75972433|FG003|Overall Study|Disease Progression|1|||
42164629|NCT00091832|75972434|FG004|Overall Study|Disease Progression|1|||
42164630|NCT00091832|75972435|FG005|Overall Study|Disease Progression|2|||
42164631|NCT00091832|75972430|FG000|Overall Study|Ineligibility Determined|0|||
42164632|NCT00091832|75972431|FG001|Overall Study|Ineligibility Determined|0|||
42164633|NCT00091832|75972432|FG002|Overall Study|Ineligibility Determined|1|||
42164634|NCT00091832|75972433|FG003|Overall Study|Ineligibility Determined|0|||
42164635|NCT00091832|75972434|FG004|Overall Study|Ineligibility Determined|1|||
42164636|NCT00091832|75972435|FG005|Overall Study|Ineligibility Determined|0|||
42164637|NCT00091832|75972430|FG000|Overall Study|Lost to Follow-up|1|||
42164638|NCT00091832|75972431|FG001|Overall Study|Lost to Follow-up|0|||
42164639|NCT00091832|75972432|FG002|Overall Study|Lost to Follow-up|3|||
42164640|NCT00091832|75972433|FG003|Overall Study|Lost to Follow-up|3|||
42164641|NCT00091832|75972434|FG004|Overall Study|Lost to Follow-up|2|||
42164642|NCT00091832|75972435|FG005|Overall Study|Lost to Follow-up|1|||
42164643|NCT00091832|75972430|FG000|Overall Study|Noncompliance|0|||
42164644|NCT00091832|75972431|FG001|Overall Study|Noncompliance|1|||
42164645|NCT00091832|75972432|FG002|Overall Study|Noncompliance|0|||
42164646|NCT00091832|75972433|FG003|Overall Study|Noncompliance|0|||
42164647|NCT00091832|75972434|FG004|Overall Study|Noncompliance|0|||
42164648|NCT00091832|75972435|FG005|Overall Study|Noncompliance|0|||
42164649|NCT00091832|75972430|FG000|Overall Study|Other|0|||
42164650|NCT00091832|75972431|FG001|Overall Study|Other|1|||
42164651|NCT00091832|75972432|FG002|Overall Study|Other|2|||
42164652|NCT00091832|75972433|FG003|Overall Study|Other|0|||
42164653|NCT00091832|75972434|FG004|Overall Study|Other|0|||
42164654|NCT00091832|75972435|FG005|Overall Study|Other|0|||
42164655|NCT00091832|75972430|FG000|Overall Study|Protocol Violation|0|||
42164656|NCT00091832|75972431|FG001|Overall Study|Protocol Violation|0|||
42164657|NCT00091832|75972432|FG002|Overall Study|Protocol Violation|1|||
42164658|NCT00091832|75972433|FG003|Overall Study|Protocol Violation|0|||
42164659|NCT00091832|75972434|FG004|Overall Study|Protocol Violation|0|||
42164660|NCT00091832|75972435|FG005|Overall Study|Protocol Violation|1|||
42164661|NCT00391391|75972453|FG000|Overall Study|Adverse Event|0|||
42164662|NCT00391391|75972454|FG001|Overall Study|Adverse Event|0|||
42164663|NCT00391391|75972455|FG002|Overall Study|Adverse Event|0|||
42164664|NCT00391391|75972456|FG003|Overall Study|Adverse Event|1|||
42164665|NCT00391391|75972453|FG000|Overall Study|Lost to Follow-up|1|||
42164666|NCT00391391|75972454|FG001|Overall Study|Lost to Follow-up|3|||
42164667|NCT00391391|75972455|FG002|Overall Study|Lost to Follow-up|7|||
42164668|NCT00391391|75972456|FG003|Overall Study|Lost to Follow-up|4|||
42164669|NCT00391391|75972453|FG000|Overall Study|Protocol Violation|2|||
42164670|NCT00391391|75972454|FG001|Overall Study|Protocol Violation|3|||
42164671|NCT00391391|75972455|FG002|Overall Study|Protocol Violation|6|||
42164672|NCT00391391|75972456|FG003|Overall Study|Protocol Violation|7|||
42164673|NCT00391391|75972453|FG000|Overall Study|Withdrawal by Subject|6|||
42164674|NCT00391391|75972454|FG001|Overall Study|Withdrawal by Subject|4|||
42164675|NCT00391391|75972455|FG002|Overall Study|Withdrawal by Subject|10|||
42164676|NCT00391391|75972456|FG003|Overall Study|Withdrawal by Subject|7|||
42164677|NCT00091442|75972468|FG000|Overall Study|Progressive Disease|220|||
42164678|NCT00091442|75972469|FG001|Overall Study|Progressive Disease|189|||
42164679|NCT00091442|75972468|FG000|Overall Study|Physician Decision|61|||
42164680|NCT00091442|75972469|FG001|Overall Study|Physician Decision|58|||
42164681|NCT00091442|75972468|FG000|Overall Study|Withdrawal by Subject|38|||
42164682|NCT00091442|75972469|FG001|Overall Study|Withdrawal by Subject|46|||
42164683|NCT00091442|75972468|FG000|Overall Study|Adverse Event|29|||
42164684|NCT00091442|75972469|FG001|Overall Study|Adverse Event|48|||
42164685|NCT00091442|75972468|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
42164686|NCT00091442|75972469|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
42164687|NCT00091442|75972468|FG000|Overall Study|Death|9|||
42164688|NCT00091442|75972469|FG001|Overall Study|Death|7|||
42014111|NCT01253304|75821266|FG000|Overall Study|Adverse Event|0|||
42014112|NCT01253304|75821267|FG001|Overall Study|Adverse Event|0|||
42014113|NCT01253304|75821268|FG002|Overall Study|Adverse Event|0|||
42014114|NCT01253304|75821269|FG003|Overall Study|Adverse Event|1|||
42014115|NCT01253226|75821284|FG000|Overall Study|Adverse Event|0|||
42164689|NCT00091442|75972468|FG000|Overall Study|Lost to Follow-up|1|||
42164690|NCT00091442|75972469|FG001|Overall Study|Lost to Follow-up|3|||
42164691|NCT00091442|75972468|FG000|Overall Study|Other|2|||
42164692|NCT00091442|75972469|FG001|Overall Study|Other|6|||
42164693|NCT00390689|75972478|FG000|Overall Study|Adverse Event|2|||
42164694|NCT00390689|75972479|FG001|Overall Study|Adverse Event|5|||
42164695|NCT00390689|75972480|FG002|Overall Study|Adverse Event|2|||
42164696|NCT00390689|75972478|FG000|Overall Study|Lack of Efficacy|0|||
42164697|NCT00390689|75972479|FG001|Overall Study|Lack of Efficacy|0|||
42164698|NCT00390689|75972480|FG002|Overall Study|Lack of Efficacy|1|||
42164699|NCT00390689|75972478|FG000|Overall Study|Protocol Violation|1|||
42164700|NCT00390689|75972479|FG001|Overall Study|Protocol Violation|0|||
42164701|NCT00390689|75972480|FG002|Overall Study|Protocol Violation|0|||
42164702|NCT00390689|75972478|FG000|Overall Study|Investigator's judgement|2|||
42164703|NCT00390689|75972479|FG001|Overall Study|Investigator's judgement|0|||
42164704|NCT00390689|75972480|FG002|Overall Study|Investigator's judgement|0|||
42164705|NCT00121238|75972497|FG000|Overall Study|disease progression before intervention|1|||
42164706|NCT00121238|75972497|FG000|Overall Study|Protocol Violation|2|||
42164707|NCT00390455|75972503|FG000|Overall Study|Adverse Event|17|||
42164708|NCT00390455|75972504|FG001|Overall Study|Adverse Event|3|||
42164709|NCT00390455|75972503|FG000|Overall Study|Withdrawal by Subject|8|||
42164710|NCT00390455|75972504|FG001|Overall Study|Withdrawal by Subject|8|||
42164711|NCT00390455|75972503|FG000|Overall Study|Alternate Treatment|0|||
42164712|NCT00390455|75972504|FG001|Overall Study|Alternate Treatment|1|||
42164713|NCT00390455|75972503|FG000|Overall Study|Other Medical Reasons|7|||
42164714|NCT00390455|75972504|FG001|Overall Study|Other Medical Reasons|11|||
42164715|NCT03812510|75972510|FG000|Overall Study|Lost to Follow-up|39|||
42164716|NCT03812510|75972510|FG000|Overall Study|Withdrawal by Subject|42|||
42164717|NCT03812510|75972510|FG000|Overall Study|Physician Decision|2|||
42164718|NCT03812510|75972510|FG000|Overall Study|Study Terminated by Sponsor|9|||
42164719|NCT03812510|75972510|FG000|Overall Study|Did Not Start Study Medication|55|||
42164720|NCT03812510|75972510|FG000|Overall Study|Adverse Event|5|||
42164721|NCT00390299|75972520|FG000|Overall Study|Cancellation|1|||
42164722|NCT00390299|75972521|FG001|Overall Study|Cancellation|0|||
42164723|NCT00390299|75972522|FG002|Overall Study|Cancellation|0|||
42164724|NCT00390299|75972523|FG003|Overall Study|Cancellation|0|||
42164725|NCT00390299|75972524|FG004|Overall Study|Cancellation|0|||
42164726|NCT00119678|75972540|FG000|Double-blind Treatment Period|Death|1|||
42164727|NCT00119678|75972541|FG001|Double-blind Treatment Period|Death|0|||
42164728|NCT00119678|75972540|FG000|Double-blind Treatment Period|Adverse Event|7|||
42164729|NCT00119678|75972541|FG001|Double-blind Treatment Period|Adverse Event|1|||
42164730|NCT00119678|75972540|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
42014116|NCT01253226|75821285|FG001|Overall Study|Adverse Event|0|||
42014117|NCT01253226|75821286|FG002|Overall Study|Adverse Event|1|||
42014118|NCT01253226|75821287|FG003|Overall Study|Adverse Event|0|||
42164731|NCT00119678|75972541|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
42014119|NCT01253226|75821288|FG004|Overall Study|Adverse Event|0|||
42014120|NCT01253226|75821284|FG000|Overall Study|Death|0|||
42014121|NCT01253226|75821285|FG001|Overall Study|Death|1|||
42014122|NCT01253226|75821286|FG002|Overall Study|Death|0|||
42014123|NCT01253226|75821287|FG003|Overall Study|Death|0|||
42014124|NCT01253226|75821288|FG004|Overall Study|Death|0|||
42014125|NCT01253226|75821284|FG000|Overall Study|Physician Decision|0|||
42014126|NCT01253226|75821285|FG001|Overall Study|Physician Decision|0|||
42014127|NCT01253226|75821286|FG002|Overall Study|Physician Decision|0|||
42014128|NCT01253226|75821287|FG003|Overall Study|Physician Decision|0|||
42014129|NCT01253226|75821288|FG004|Overall Study|Physician Decision|2|||
42014130|NCT01253226|75821284|FG000|Overall Study|Withdrawal by Subject|0|||
42014131|NCT01253226|75821285|FG001|Overall Study|Withdrawal by Subject|0|||
42014132|NCT01253226|75821286|FG002|Overall Study|Withdrawal by Subject|0|||
42014133|NCT01253226|75821287|FG003|Overall Study|Withdrawal by Subject|1|||
42014134|NCT01253226|75821288|FG004|Overall Study|Withdrawal by Subject|0|||
42164732|NCT00119678|75972540|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
42351699|NCT00981292|76191619|FG000|Day 3|Protocol Violation|0|||
42351700|NCT00981292|76191620|FG001|Day 3|Protocol Violation|0|||
42351701|NCT00981292|76191621|FG002|Day 3|Protocol Violation|0|||
42351702|NCT00981292|76191622|FG003|Day 3|Protocol Violation|0|||
42351703|NCT00981292|76191623|FG004|Day 3|Protocol Violation|0|||
42351704|NCT00981292|76191624|FG005|Day 3|Protocol Violation|1|||
42351705|NCT00980044|76191639|FG000|Overall Study|Withdrawal by Subject|5|||
42351706|NCT00980044|76191640|FG001|Overall Study|Withdrawal by Subject|7|||
42351707|NCT00980044|76191641|FG002|Overall Study|Withdrawal by Subject|3|||
42351708|NCT00980044|76191639|FG000|Overall Study|Protocol Violation|0|||
42351709|NCT00980044|76191640|FG001|Overall Study|Protocol Violation|0|||
42351710|NCT00980044|76191641|FG002|Overall Study|Protocol Violation|2|||
42164733|NCT00119678|75972541|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
42164734|NCT00119678|75972540|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
42164735|NCT00119678|75972541|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
42351711|NCT01903837|76191656|FG000|Part A|Withdrawal by Subject|4|||
42164736|NCT00119678|75972540|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
42164737|NCT00119678|75972541|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
42164738|NCT00119678|75972540|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
42164739|NCT00119678|75972541|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
42164740|NCT00119678|75972540|FG000|Double-blind Treatment Period|Pregnancy|0|||
42164741|NCT00119678|75972541|FG001|Double-blind Treatment Period|Pregnancy|2|||
42164742|NCT00119678|75972540|FG000|Double-blind Treatment Period|Not treated|1|||
42164743|NCT00119678|75972541|FG001|Double-blind Treatment Period|Not treated|2|||
42164744|NCT00119678|75972540|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
42164745|NCT00119678|75972541|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
42164746|NCT00119678|75972540|FG000|Open-label Treatment Period|Death|1|||
42164747|NCT00119678|75972541|FG001|Open-label Treatment Period|Death|0|||
42164748|NCT00119678|75972540|FG000|Open-label Treatment Period|Adverse Event|3|||
42164749|NCT00119678|75972541|FG001|Open-label Treatment Period|Adverse Event|0|||
42164750|NCT00119678|75972540|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
42164751|NCT00119678|75972541|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
42164752|NCT00119678|75972540|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
42164753|NCT00119678|75972541|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
42164754|NCT00119678|75972540|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
42164755|NCT00119678|75972541|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
42164756|NCT00119678|75972540|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
42164757|NCT00119678|75972541|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
42164758|NCT00119678|75972540|FG000|Open-label Treatment Period|Pregnancy|1|||
42164759|NCT00119678|75972541|FG001|Open-label Treatment Period|Pregnancy|0|||
42164760|NCT00119678|75972540|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
42164761|NCT00119678|75972541|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
42164762|NCT00110084|75972549|FG000|Overall Study|Adverse Event|9|||
42164763|NCT00110084|75972549|FG000|Overall Study|Death|1|||
42164764|NCT00110084|75972549|FG000|Overall Study|Patient Refusal|10|||
42164765|NCT00110084|75972549|FG000|Overall Study|Alternate Therapy|5|||
42164766|NCT00110084|75972549|FG000|Overall Study|Intercurrent Illness|1|||
42164767|NCT00110084|75972549|FG000|Overall Study|Other|2|||
42164768|NCT00390221|75972556|FG000|Overall Study|Lost to Follow-up|0|||
42164769|NCT00390221|75972557|FG001|Overall Study|Lost to Follow-up|3|||
42164770|NCT00390221|75972558|FG002|Overall Study|Lost to Follow-up|0|||
42164771|NCT00390221|75972556|FG000|Overall Study|Adverse Event|1|||
42164772|NCT00390221|75972557|FG001|Overall Study|Adverse Event|4|||
42164773|NCT00390221|75972558|FG002|Overall Study|Adverse Event|3|||
42164774|NCT00390221|75972556|FG000|Overall Study|Investigator Decision|0|||
42164775|NCT00390221|75972557|FG001|Overall Study|Investigator Decision|0|||
42164776|NCT00390221|75972558|FG002|Overall Study|Investigator Decision|1|||
42164777|NCT00390221|75972556|FG000|Overall Study|Withdrawal by Subject|13|||
42014135|NCT01252290|75821300|FG000|Overall Study|Withdrawal by Subject|1|||
42351712|NCT01903837|76191657|FG001|Part A|Withdrawal by Subject|9|||
42014136|NCT01252134|75821304|FG000|Period 1, 8 Hours|Personal Reasons|0|||
42014137|NCT01252134|75821305|FG001|Period 1, 8 Hours|Personal Reasons|1|||
42014138|NCT01252134|75821306|FG002|Period 1, 8 Hours|Personal Reasons|1|||
42014139|NCT01252134|75821307|FG003|Period 1, 8 Hours|Personal Reasons|0|||
42014140|NCT01252134|75821308|FG004|Period 1, 8 Hours|Personal Reasons|0|||
42014141|NCT01252134|75821309|FG005|Period 1, 8 Hours|Personal Reasons|0|||
42014142|NCT01251744|75821319|FG000|Overall Study|Lost to Follow-up|1|||
42014143|NCT01251744|75821320|FG001|Overall Study|Lost to Follow-up|0|||
42014144|NCT01251354|75821333|FG000|Overall Study|Adverse Event|1|||
42014145|NCT01251354|75821333|FG000|Overall Study|Investigator's Decision|1|||
42164778|NCT00390221|75972557|FG001|Overall Study|Withdrawal by Subject|9|||
42164779|NCT00390221|75972558|FG002|Overall Study|Withdrawal by Subject|7|||
42164780|NCT00390221|75972556|FG000|Overall Study|Subject Non-compliance|1|||
42164781|NCT00390221|75972557|FG001|Overall Study|Subject Non-compliance|0|||
42164782|NCT00390221|75972558|FG002|Overall Study|Subject Non-compliance|2|||
42164783|NCT00390221|75972556|FG000|Overall Study|Other|3|||
42164784|NCT00390221|75972557|FG001|Overall Study|Other|4|||
42164785|NCT00390221|75972558|FG002|Overall Study|Other|2|||
42164786|NCT00389831|75972569|FG000|Overall Study|Lack of Efficacy|0|||
42164787|NCT00389831|75972570|FG001|Overall Study|Lack of Efficacy|2|||
42164788|NCT00389831|75972569|FG000|Overall Study|Did not receive treatment.|0|||
42164789|NCT00389831|75972570|FG001|Overall Study|Did not receive treatment.|2|||
42164790|NCT00389831|75972569|FG000|Overall Study|Other reasons|0|||
42164791|NCT00389831|75972570|FG001|Overall Study|Other reasons|2|||
42164792|NCT00389831|75972569|FG000|Overall Study|Lost to Follow-up|0|||
42164793|NCT00389831|75972570|FG001|Overall Study|Lost to Follow-up|1|||
42164794|NCT00389597|75972592|FG000|Overall Study|Lost to Follow-up|8|||
42164795|NCT00389597|75972593|FG001|Overall Study|Lost to Follow-up|6|||
42164796|NCT00389597|75972594|FG002|Overall Study|Lost to Follow-up|4|||
42164797|NCT00389597|75972595|FG003|Overall Study|Lost to Follow-up|6|||
42164798|NCT00389519|75972609|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
42164799|NCT00389519|75972610|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
42164800|NCT00389519|75972611|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
42164801|NCT00389519|75972612|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
42164802|NCT00389519|75972609|FG000|Placebo Run-In|Withdrawal by Subject|19|||
42164803|NCT00389519|75972610|FG001|Placebo Run-In|Withdrawal by Subject|0|||
42164804|NCT00389519|75972611|FG002|Placebo Run-In|Withdrawal by Subject|0|||
42164805|NCT00389519|75972612|FG003|Placebo Run-In|Withdrawal by Subject|0|||
42164806|NCT00389519|75972609|FG000|Placebo Run-In|Reason not specified|40|||
42164807|NCT00389519|75972610|FG001|Placebo Run-In|Reason not specified|0|||
42164808|NCT00389519|75972611|FG002|Placebo Run-In|Reason not specified|0|||
42164809|NCT00389519|75972612|FG003|Placebo Run-In|Reason not specified|0|||
42164810|NCT00389519|75972609|FG000|Randomized|Did not receive study drug|2|||
42164811|NCT00389519|75972610|FG001|Randomized|Did not receive study drug|0|||
42164812|NCT00389519|75972611|FG002|Randomized|Did not receive study drug|0|||
42164813|NCT00389519|75972612|FG003|Randomized|Did not receive study drug|0|||
42164814|NCT00389519|75972609|FG000|Treated|Adverse Event|1|||
42164815|NCT00389519|75972610|FG001|Treated|Adverse Event|0|||
42164816|NCT00389519|75972611|FG002|Treated|Adverse Event|0|||
42164817|NCT00389519|75972612|FG003|Treated|Adverse Event|2|||
42164818|NCT00389519|75972609|FG000|Treated|Reason not specified|1|||
42164819|NCT00389519|75972610|FG001|Treated|Reason not specified|1|||
42164820|NCT00389519|75972611|FG002|Treated|Reason not specified|0|||
42164821|NCT00389519|75972612|FG003|Treated|Reason not specified|2|||
42164822|NCT00389441|75972622|FG000|Overall Study|Adverse Event|7|||
42164823|NCT00389441|75972622|FG000|Overall Study|Death|4|||
42014146|NCT01251354|75821333|FG000|Overall Study|Disease Progression|4|||
42040593|NCT01796171|75848708|FG002|Treatment Period With Betalutin|Physician Decision|0|||
42040594|NCT01796171|75848709|FG003|Treatment Period With Betalutin|Physician Decision|0|||
42164824|NCT00389441|75972622|FG000|Overall Study|Lost to Follow-up|2|||
42164825|NCT00389441|75972622|FG000|Overall Study|Withdrawal by Subject|4|||
42164826|NCT00389441|75972622|FG000|Overall Study|Physician Decision|1|||
42164827|NCT00389441|75972622|FG000|Overall Study|Protocol Violation|1|||
42164828|NCT00389441|75972622|FG000|Overall Study|Global deterioration of health status|4|||
42164829|NCT00389441|75972622|FG000|Overall Study|Objective progression or relapse|26|||
42164830|NCT00389441|75972622|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
42164831|NCT00389441|75972622|FG000|Overall Study|Clinical progression|1|||
42164832|NCT00118898|75972630|FG000|Overall Study|Death|6|||
42164833|NCT00118898|75972631|FG001|Overall Study|Death|11|||
42164834|NCT00118898|75972632|FG002|Overall Study|Death|6|||
42164835|NCT00118898|75972633|FG003|Overall Study|Death|8|||
42164836|NCT00118898|75972630|FG000|Overall Study|Lost to Follow-up|26|||
42164837|NCT00118898|75972631|FG001|Overall Study|Lost to Follow-up|34|||
42164838|NCT00118898|75972632|FG002|Overall Study|Lost to Follow-up|33|||
42164839|NCT00118898|75972633|FG003|Overall Study|Lost to Follow-up|33|||
42164840|NCT00118898|75972630|FG000|Overall Study|Withdrawal by Subject|10|||
42164841|NCT00118898|75972631|FG001|Overall Study|Withdrawal by Subject|5|||
42164842|NCT00118898|75972632|FG002|Overall Study|Withdrawal by Subject|8|||
42164843|NCT00118898|75972633|FG003|Overall Study|Withdrawal by Subject|8|||
42164844|NCT00118898|75972630|FG000|Overall Study|Site Closure|33|||
42164845|NCT00118898|75972631|FG001|Overall Study|Site Closure|31|||
42014147|NCT01251276|75821339|FG000|Overall Study|Protocol Violation|1|||
42014148|NCT01251276|75821340|FG001|Overall Study|Protocol Violation|0|||
42164846|NCT00118898|75972632|FG002|Overall Study|Site Closure|28|||
42164847|NCT00118898|75972633|FG003|Overall Study|Site Closure|37|||
42164848|NCT00118898|75972630|FG000|Overall Study|Severe debilitation|1|||
42164849|NCT00118898|75972631|FG001|Overall Study|Severe debilitation|4|||
42164850|NCT00118898|75972632|FG002|Overall Study|Severe debilitation|6|||
42164851|NCT00118898|75972633|FG003|Overall Study|Severe debilitation|4|||
42164852|NCT00118898|75972630|FG000|Overall Study|Not compliant with requirements|11|||
42164853|NCT00118898|75972631|FG001|Overall Study|Not compliant with requirements|13|||
42164854|NCT00118898|75972632|FG002|Overall Study|Not compliant with requirements|11|||
42164855|NCT00118898|75972633|FG003|Overall Study|Not compliant with requirements|11|||
42164856|NCT00118898|75972630|FG000|Overall Study|Not able to get to clinic|34|||
42164857|NCT00118898|75972631|FG001|Overall Study|Not able to get to clinic|43|||
42014149|NCT01251276|75821339|FG000|Overall Study|Lost to Follow-up|0|||
42014150|NCT01251276|75821340|FG001|Overall Study|Lost to Follow-up|1|||
42014151|NCT01251120|75821348|FG000|Overall Study|Lack of Efficacy|0|||
42014152|NCT01251120|75821349|FG001|Overall Study|Lack of Efficacy|1|||
42014153|NCT01250418|75821357|FG000|Overall Study|monitor data failure|1|||
42014154|NCT01250418|75821358|FG001|Overall Study|monitor data failure|1|||
42014155|NCT01292603|75821369|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
42014156|NCT01292603|75821370|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
42014157|NCT01292603|75821371|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
42014158|NCT01292603|75821372|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
42014159|NCT01292603|75821373|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
42014160|NCT01292603|75821374|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
42014161|NCT01292603|75821369|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
42014162|NCT01292603|75821370|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
42014163|NCT01292603|75821371|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
42014164|NCT01292603|75821372|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
42040595|NCT01796171|75848710|FG004|Treatment Period With Betalutin|Physician Decision|0|||
42164858|NCT00118898|75972632|FG002|Overall Study|Not able to get to clinic|31|||
42164859|NCT00118898|75972633|FG003|Overall Study|Not able to get to clinic|40|||
42164860|NCT00118430|75972646|FG000|Overall Study|Withdrawal by Subject|6|||
42164861|NCT00118430|75972647|FG001|Overall Study|Withdrawal by Subject|2|||
42164862|NCT00118430|75972648|FG002|Overall Study|Withdrawal by Subject|0|||
42164863|NCT00118430|75972646|FG000|Overall Study|Lost to Follow-up|15|||
42164864|NCT00118430|75972647|FG001|Overall Study|Lost to Follow-up|22|||
42164865|NCT00118430|75972648|FG002|Overall Study|Lost to Follow-up|28|||
42164866|NCT00090584|75972657|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
42164867|NCT00090584|75972658|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
42164868|NCT00090584|75972657|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
42164869|NCT00090584|75972658|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
42014165|NCT01292603|75821373|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
42164870|NCT03670810|75972678|FG000|Main Study|Adverse Event|37|||
42164871|NCT03670810|75972679|FG001|Main Study|Adverse Event|38|||
42164872|NCT03670810|75972680|FG002|Main Study|Adverse Event|3|||
42164873|NCT03670810|75972681|FG003|Main Study|Adverse Event|4|||
42164874|NCT03670810|75972682|FG004|Main Study|Adverse Event|4|||
42164875|NCT03670810|75972683|FG005|Main Study|Adverse Event|5|||
42164876|NCT03670810|75972684|FG006|Main Study|Adverse Event|0|||
42164877|NCT03670810|75972685|FG007|Main Study|Adverse Event|0|||
42164878|NCT03670810|75972686|FG008|Main Study|Adverse Event|0|||
42164879|NCT03670810|75972678|FG000|Main Study|Lack of Efficacy|8|||
42164880|NCT03670810|75972679|FG001|Main Study|Lack of Efficacy|9|||
42164881|NCT03670810|75972680|FG002|Main Study|Lack of Efficacy|3|||
42164882|NCT03670810|75972681|FG003|Main Study|Lack of Efficacy|4|||
42164883|NCT03670810|75972682|FG004|Main Study|Lack of Efficacy|0|||
42164884|NCT03670810|75972683|FG005|Main Study|Lack of Efficacy|0|||
42164885|NCT03670810|75972684|FG006|Main Study|Lack of Efficacy|0|||
42164886|NCT03670810|75972685|FG007|Main Study|Lack of Efficacy|0|||
42164887|NCT03670810|75972686|FG008|Main Study|Lack of Efficacy|0|||
42164888|NCT03670810|75972678|FG000|Main Study|Lost to Follow-up|9|||
42164889|NCT03670810|75972679|FG001|Main Study|Lost to Follow-up|7|||
42164890|NCT03670810|75972680|FG002|Main Study|Lost to Follow-up|4|||
42164891|NCT03670810|75972681|FG003|Main Study|Lost to Follow-up|6|||
42164892|NCT03670810|75972682|FG004|Main Study|Lost to Follow-up|1|||
42164893|NCT03670810|75972683|FG005|Main Study|Lost to Follow-up|0|||
42164894|NCT03670810|75972684|FG006|Main Study|Lost to Follow-up|0|||
42164895|NCT03670810|75972685|FG007|Main Study|Lost to Follow-up|0|||
42164896|NCT03670810|75972686|FG008|Main Study|Lost to Follow-up|0|||
42164897|NCT03670810|75972678|FG000|Main Study|Non-compliance with Study Drug|0|||
42164898|NCT03670810|75972679|FG001|Main Study|Non-compliance with Study Drug|2|||
42164899|NCT03670810|75972680|FG002|Main Study|Non-compliance with Study Drug|3|||
42164900|NCT03670810|75972681|FG003|Main Study|Non-compliance with Study Drug|0|||
42164901|NCT03670810|75972682|FG004|Main Study|Non-compliance with Study Drug|0|||
42164902|NCT03670810|75972683|FG005|Main Study|Non-compliance with Study Drug|0|||
42164903|NCT03670810|75972684|FG006|Main Study|Non-compliance with Study Drug|0|||
42164904|NCT03670810|75972685|FG007|Main Study|Non-compliance with Study Drug|1|||
42164905|NCT03670810|75972686|FG008|Main Study|Non-compliance with Study Drug|0|||
42164906|NCT03670810|75972678|FG000|Main Study|Physician Decision|3|||
42164907|NCT03670810|75972679|FG001|Main Study|Physician Decision|0|||
42164908|NCT03670810|75972680|FG002|Main Study|Physician Decision|1|||
42164909|NCT03670810|75972681|FG003|Main Study|Physician Decision|0|||
42164910|NCT03670810|75972682|FG004|Main Study|Physician Decision|0|||
42164911|NCT03670810|75972683|FG005|Main Study|Physician Decision|0|||
42164912|NCT03670810|75972684|FG006|Main Study|Physician Decision|1|||
42164913|NCT03670810|75972685|FG007|Main Study|Physician Decision|1|||
42164914|NCT03670810|75972686|FG008|Main Study|Physician Decision|0|||
42164915|NCT03670810|75972678|FG000|Main Study|Pregnancy|1|||
42164916|NCT03670810|75972679|FG001|Main Study|Pregnancy|2|||
42164917|NCT03670810|75972680|FG002|Main Study|Pregnancy|0|||
42164918|NCT03670810|75972681|FG003|Main Study|Pregnancy|0|||
42164919|NCT03670810|75972682|FG004|Main Study|Pregnancy|0|||
42164920|NCT03670810|75972683|FG005|Main Study|Pregnancy|0|||
42164921|NCT03670810|75972684|FG006|Main Study|Pregnancy|0|||
42164922|NCT03670810|75972685|FG007|Main Study|Pregnancy|0|||
42164923|NCT03670810|75972686|FG008|Main Study|Pregnancy|0|||
42164924|NCT03670810|75972678|FG000|Main Study|Protocol Deviation|2|||
42164925|NCT03670810|75972679|FG001|Main Study|Protocol Deviation|12|||
42164926|NCT03670810|75972680|FG002|Main Study|Protocol Deviation|8|||
42014166|NCT01292603|75821374|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
42014167|NCT01292603|75821369|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
42014168|NCT01292603|75821370|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
42014169|NCT01292603|75821371|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
42014170|NCT01292603|75821372|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
42164927|NCT03670810|75972681|FG003|Main Study|Protocol Deviation|4|||
42164928|NCT03670810|75972682|FG004|Main Study|Protocol Deviation|0|||
42164929|NCT03670810|75972683|FG005|Main Study|Protocol Deviation|0|||
42164930|NCT03670810|75972684|FG006|Main Study|Protocol Deviation|0|||
42164931|NCT03670810|75972685|FG007|Main Study|Protocol Deviation|0|||
42164932|NCT03670810|75972686|FG008|Main Study|Protocol Deviation|0|||
42164933|NCT03670810|75972678|FG000|Main Study|Withdrawal by Subject|21|||
42164934|NCT03670810|75972679|FG001|Main Study|Withdrawal by Subject|21|||
42164935|NCT03670810|75972680|FG002|Main Study|Withdrawal by Subject|8|||
42164936|NCT03670810|75972681|FG003|Main Study|Withdrawal by Subject|9|||
42164937|NCT03670810|75972682|FG004|Main Study|Withdrawal by Subject|5|||
42164938|NCT03670810|75972683|FG005|Main Study|Withdrawal by Subject|2|||
42164939|NCT03670810|75972684|FG006|Main Study|Withdrawal by Subject|1|||
42164940|NCT03670810|75972685|FG007|Main Study|Withdrawal by Subject|1|||
42164941|NCT03670810|75972686|FG008|Main Study|Withdrawal by Subject|0|||
42164942|NCT03670810|75972678|FG000|Main Study|Participant did not want to take the three other treatments|1|||
42164943|NCT03670810|75972679|FG001|Main Study|Participant did not want to take the three other treatments|0|||
42164944|NCT03670810|75972680|FG002|Main Study|Participant did not want to take the three other treatments|0|||
42164945|NCT03670810|75972681|FG003|Main Study|Participant did not want to take the three other treatments|0|||
42164946|NCT03670810|75972682|FG004|Main Study|Participant did not want to take the three other treatments|0|||
42164947|NCT03670810|75972683|FG005|Main Study|Participant did not want to take the three other treatments|0|||
42164948|NCT03670810|75972684|FG006|Main Study|Participant did not want to take the three other treatments|0|||
42164949|NCT03670810|75972685|FG007|Main Study|Participant did not want to take the three other treatments|0|||
42164950|NCT03670810|75972686|FG008|Main Study|Participant did not want to take the three other treatments|0|||
42164951|NCT03670810|75972678|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
42164952|NCT03670810|75972679|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
42164953|NCT03670810|75972680|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
42164954|NCT03670810|75972681|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
42164955|NCT03670810|75972682|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
42164956|NCT03670810|75972683|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
42164957|NCT03670810|75972684|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
42164958|NCT03670810|75972685|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
42164959|NCT03670810|75972686|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
42164960|NCT03670810|75972678|FG000|Main Study|Travel and Coronavirus issues|0|||
42164961|NCT03670810|75972679|FG001|Main Study|Travel and Coronavirus issues|0|||
42164962|NCT03670810|75972680|FG002|Main Study|Travel and Coronavirus issues|0|||
42164963|NCT03670810|75972681|FG003|Main Study|Travel and Coronavirus issues|1|||
42164964|NCT03670810|75972682|FG004|Main Study|Travel and Coronavirus issues|0|||
42164965|NCT03670810|75972683|FG005|Main Study|Travel and Coronavirus issues|0|||
42164966|NCT03670810|75972684|FG006|Main Study|Travel and Coronavirus issues|0|||
42164967|NCT03670810|75972685|FG007|Main Study|Travel and Coronavirus issues|0|||
42164968|NCT03670810|75972686|FG008|Main Study|Travel and Coronavirus issues|0|||
42164969|NCT03670810|75972678|FG000|Open Label Extension|Protocol Deviation|0|||
42164970|NCT03670810|75972679|FG001|Open Label Extension|Protocol Deviation|0|||
42164971|NCT03670810|75972680|FG002|Open Label Extension|Protocol Deviation|0|||
42164972|NCT03670810|75972681|FG003|Open Label Extension|Protocol Deviation|0|||
42164973|NCT03670810|75972682|FG004|Open Label Extension|Protocol Deviation|0|||
42164974|NCT03670810|75972683|FG005|Open Label Extension|Protocol Deviation|0|||
42164975|NCT03670810|75972684|FG006|Open Label Extension|Protocol Deviation|0|||
42164976|NCT03670810|75972685|FG007|Open Label Extension|Protocol Deviation|0|||
42164977|NCT03670810|75972686|FG008|Open Label Extension|Protocol Deviation|5|||
42164978|NCT03670810|75972678|FG000|Open Label Extension|Death|0|||
42164979|NCT03670810|75972679|FG001|Open Label Extension|Death|0|||
42164980|NCT03670810|75972680|FG002|Open Label Extension|Death|0|||
42164981|NCT03670810|75972681|FG003|Open Label Extension|Death|0|||
42164982|NCT03670810|75972682|FG004|Open Label Extension|Death|0|||
42164983|NCT03670810|75972683|FG005|Open Label Extension|Death|0|||
42164984|NCT03670810|75972684|FG006|Open Label Extension|Death|0|||
42164985|NCT03670810|75972685|FG007|Open Label Extension|Death|0|||
42164986|NCT03670810|75972686|FG008|Open Label Extension|Death|1|||
42164987|NCT03670810|75972678|FG000|Open Label Extension|COVID-19|0|||
42014171|NCT01292603|75821373|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
42014172|NCT01292603|75821374|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
42014173|NCT01292603|75821369|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
42014174|NCT01292603|75821370|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
42040596|NCT01796171|75848711|FG005|Treatment Period With Betalutin|Physician Decision|0|||
42040597|NCT01796171|75848712|FG006|Treatment Period With Betalutin|Physician Decision|0|||
42040598|NCT01796171|75848713|FG007|Treatment Period With Betalutin|Physician Decision|0|||
42040599|NCT01796171|75848714|FG008|Treatment Period With Betalutin|Physician Decision|0|||
42040600|NCT01796171|75848715|FG009|Treatment Period With Betalutin|Physician Decision|0|||
42014175|NCT01292603|75821371|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
42014176|NCT01292603|75821372|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
42014177|NCT01292603|75821373|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
42014178|NCT01292603|75821374|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
42014179|NCT01292603|75821369|FG000|Part 1: Regular Follow-Up Period|Death|3|||
42014180|NCT01292603|75821370|FG001|Part 1: Regular Follow-Up Period|Death|1|||
42014181|NCT01292603|75821371|FG002|Part 1: Regular Follow-Up Period|Death|3|||
42014182|NCT01292603|75821372|FG003|Part 1: Regular Follow-Up Period|Death|1|||
42014183|NCT01292603|75821373|FG004|Part 1: Regular Follow-Up Period|Death|0|||
42014184|NCT01292603|75821374|FG005|Part 1: Regular Follow-Up Period|Death|0|||
42014185|NCT01292603|75821369|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
42164988|NCT03670810|75972679|FG001|Open Label Extension|COVID-19|0|||
42164989|NCT03670810|75972680|FG002|Open Label Extension|COVID-19|0|||
42164990|NCT03670810|75972681|FG003|Open Label Extension|COVID-19|0|||
42164991|NCT03670810|75972682|FG004|Open Label Extension|COVID-19|0|||
42164992|NCT03670810|75972683|FG005|Open Label Extension|COVID-19|0|||
42351713|NCT01903837|76191658|FG002|Part A|Withdrawal by Subject|8|||
42014186|NCT01292603|75821370|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
42014187|NCT01292603|75821371|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
42014188|NCT01292603|75821372|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
42014189|NCT01292603|75821373|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
42351714|NCT01903837|76191659|FG003|Part A|Withdrawal by Subject|5|||
42351715|NCT01903837|76191656|FG000|Part A|Adverse Event|3|||
42351716|NCT01903837|76191657|FG001|Part A|Adverse Event|6|||
42351717|NCT01903837|76191658|FG002|Part A|Adverse Event|9|||
42351718|NCT01903837|76191659|FG003|Part A|Adverse Event|6|||
42351719|NCT01903837|76191656|FG000|Part A|Lost to Follow-up|9|||
42351720|NCT01903837|76191657|FG001|Part A|Lost to Follow-up|7|||
42351721|NCT01903837|76191658|FG002|Part A|Lost to Follow-up|7|||
42351722|NCT01903837|76191659|FG003|Part A|Lost to Follow-up|2|||
42351723|NCT01903837|76191656|FG000|Part A|Non-compliance with study drug|1|||
42351724|NCT01903837|76191657|FG001|Part A|Non-compliance with study drug|4|||
42351725|NCT01903837|76191658|FG002|Part A|Non-compliance with study drug|4|||
42351726|NCT01903837|76191659|FG003|Part A|Non-compliance with study drug|0|||
42351727|NCT01903837|76191656|FG000|Part A|Physician Decision|1|||
42351728|NCT01903837|76191657|FG001|Part A|Physician Decision|1|||
42351729|NCT01903837|76191658|FG002|Part A|Physician Decision|0|||
42351730|NCT01903837|76191659|FG003|Part A|Physician Decision|0|||
42351731|NCT01903837|76191656|FG000|Part A|Protocol Violation|1|||
42351732|NCT01903837|76191657|FG001|Part A|Protocol Violation|1|||
42351733|NCT01903837|76191658|FG002|Part A|Protocol Violation|0|||
42351734|NCT01903837|76191659|FG003|Part A|Protocol Violation|0|||
42351735|NCT01903837|76191656|FG000|Part B|Lost to Follow-up|0|||
42351736|NCT01903837|76191657|FG001|Part B|Lost to Follow-up|3|||
42351737|NCT01903837|76191658|FG002|Part B|Lost to Follow-up|3|||
42351738|NCT01903837|76191659|FG003|Part B|Lost to Follow-up|4|||
42351739|NCT01903837|76191656|FG000|Part B|Withdrawal by Subject|1|||
42351740|NCT01903837|76191657|FG001|Part B|Withdrawal by Subject|2|||
42351741|NCT01903837|76191658|FG002|Part B|Withdrawal by Subject|0|||
42351742|NCT01903837|76191659|FG003|Part B|Withdrawal by Subject|3|||
42351743|NCT01903837|76191656|FG000|Part B|Adverse Event|3|||
42351744|NCT01903837|76191657|FG001|Part B|Adverse Event|0|||
42351745|NCT01903837|76191658|FG002|Part B|Adverse Event|2|||
42351746|NCT01903837|76191659|FG003|Part B|Adverse Event|0|||
42351747|NCT01903837|76191656|FG000|Part B|Non-compliance with study drug|2|||
42351748|NCT01903837|76191657|FG001|Part B|Non-compliance with study drug|0|||
42351749|NCT01903837|76191658|FG002|Part B|Non-compliance with study drug|0|||
42351750|NCT01903837|76191659|FG003|Part B|Non-compliance with study drug|1|||
42351751|NCT01903837|76191656|FG000|Part B|Incarceration|2|||
42351752|NCT01903837|76191657|FG001|Part B|Incarceration|0|||
42351753|NCT01903837|76191658|FG002|Part B|Incarceration|0|||
42351754|NCT01903837|76191659|FG003|Part B|Incarceration|1|||
42351755|NCT01903837|76191656|FG000|Part B|Physician Decision|1|||
42351756|NCT01903837|76191657|FG001|Part B|Physician Decision|0|||
42351757|NCT01903837|76191658|FG002|Part B|Physician Decision|0|||
42351758|NCT01903837|76191659|FG003|Part B|Physician Decision|2|||
42351759|NCT01903837|76191656|FG000|Part B|Lack of Efficacy|0|||
42351760|NCT01903837|76191657|FG001|Part B|Lack of Efficacy|1|||
42351761|NCT01903837|76191658|FG002|Part B|Lack of Efficacy|0|||
42351762|NCT01903837|76191659|FG003|Part B|Lack of Efficacy|0|||
42351763|NCT01903525|76191692|FG000|Overall Study|Lost to Follow-up|5|||
42351764|NCT01903525|76191693|FG001|Overall Study|Lost to Follow-up|9|||
42351765|NCT01903525|76191692|FG000|Overall Study|Adverse Event|0|||
42351766|NCT01903525|76191693|FG001|Overall Study|Adverse Event|1|||
42351767|NCT00981526|76191701|FG000|Overall Study|Withdrawal by Subject|0|||
42351768|NCT00981526|76191702|FG001|Overall Study|Withdrawal by Subject|2|||
42351769|NCT00981526|76191701|FG000|Overall Study|Physician Decision|4|||
42351770|NCT00981526|76191702|FG001|Overall Study|Physician Decision|4|||
42351771|NCT01927861|76191712|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
42351772|NCT01927861|76191713|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
42351773|NCT01927861|76191712|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
42351774|NCT01927861|76191713|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
42351775|NCT01927627|76191719|FG000|Overall Study|Adverse Event|3|||
42351776|NCT01927627|76191719|FG000|Overall Study|Lack of Efficacy|1|||
42351777|NCT01927627|76191719|FG000|Overall Study|Financial Concerns|1|||
42351778|NCT01889251|76191725|FG000|Overall Study|Adverse Event|1|||
42351779|NCT01889251|76191726|FG001|Overall Study|Adverse Event|0|||
42351780|NCT01616563|76191732|FG000|Overall Study|Lost to Follow-up|40|||
42351781|NCT01616173|76191740|FG000|Overall Study|Lost to Follow-up|0|||
42351782|NCT01616173|76191741|FG001|Overall Study|Lost to Follow-up|2|||
42351783|NCT01616173|76191742|FG002|Overall Study|Lost to Follow-up|0|||
42351784|NCT01544595|76191756|FG000|Status at Week 68|Adverse Event|3|||
42351785|NCT01544595|76191757|FG001|Status at Week 68|Adverse Event|2|||
42351786|NCT01544595|76191758|FG002|Status at Week 68|Adverse Event|1|||
42351787|NCT01544595|76191759|FG003|Status at Week 68|Adverse Event|0|||
42351788|NCT01544595|76191760|FG004|Status at Week 68|Adverse Event|0|||
42351789|NCT01544595|76191761|FG005|Status at Week 68|Adverse Event|0|||
42351790|NCT01544595|76191756|FG000|Status at Week 68|Lack of Efficacy|1|||
42351791|NCT01544595|76191757|FG001|Status at Week 68|Lack of Efficacy|0|||
42351792|NCT01544595|76191758|FG002|Status at Week 68|Lack of Efficacy|0|||
42281401|NCT01597245|76112826|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281402|NCT01597245|76112827|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281403|NCT01597245|76112828|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281404|NCT01597245|76112829|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281405|NCT01597245|76112830|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281406|NCT01597245|76112831|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42164993|NCT03670810|75972684|FG006|Open Label Extension|COVID-19|0|||
42164994|NCT03670810|75972685|FG007|Open Label Extension|COVID-19|0|||
42164995|NCT03670810|75972686|FG008|Open Label Extension|COVID-19|1|||
42164996|NCT03670810|75972678|FG000|Open Label Extension|Lack of Efficacy|0|||
42164997|NCT03670810|75972679|FG001|Open Label Extension|Lack of Efficacy|0|||
42164998|NCT03670810|75972680|FG002|Open Label Extension|Lack of Efficacy|0|||
42281407|NCT01597245|76112832|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281408|NCT01597245|76112833|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281409|NCT01597245|76112834|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
42281410|NCT01597245|76112835|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
42281411|NCT00707057|76112870|FG000|Overall Study|Withdrawal by Subject|8|||
42281412|NCT00707057|76112871|FG001|Overall Study|Withdrawal by Subject|3|||
42281413|NCT00707057|76112870|FG000|Overall Study|Dosed incorrectly|0|||
42281414|NCT00707057|76112871|FG001|Overall Study|Dosed incorrectly|1|||
42281415|NCT02639247|76112879|FG000|Overall Study|Lost to Follow-up|2|||
42281416|NCT02639247|76112880|FG001|Overall Study|Lost to Follow-up|1|||
42281417|NCT02639247|76112879|FG000|Overall Study|Death|2|||
42281418|NCT02639247|76112880|FG001|Overall Study|Death|0|||
42281419|NCT02639247|76112879|FG000|Overall Study|Withdrew Consent|0|||
42281420|NCT02639247|76112880|FG001|Overall Study|Withdrew Consent|1|||
42281421|NCT02639247|76112879|FG000|Overall Study|Protocol Violation|1|||
42281422|NCT02639247|76112880|FG001|Overall Study|Protocol Violation|0|||
42281423|NCT00706901|76112889|FG000|Overall Study|Lost to Follow-up|2|||
42281424|NCT00706901|76112890|FG001|Overall Study|Lost to Follow-up|3|||
42281425|NCT00706901|76112891|FG002|Overall Study|Lost to Follow-up|2|||
42281426|NCT00706901|76112889|FG000|Overall Study|Withdrawal by Subject|4|||
42281427|NCT00706901|76112890|FG001|Overall Study|Withdrawal by Subject|2|||
42281428|NCT00706901|76112891|FG002|Overall Study|Withdrawal by Subject|5|||
42281429|NCT00706901|76112889|FG000|Overall Study|In Jail|1|||
42281430|NCT00706901|76112890|FG001|Overall Study|In Jail|0|||
42281431|NCT00706901|76112891|FG002|Overall Study|In Jail|1|||
42281432|NCT00706901|76112889|FG000|Overall Study|Death|1|||
42281433|NCT00706901|76112890|FG001|Overall Study|Death|0|||
42281434|NCT00706901|76112891|FG002|Overall Study|Death|0|||
42281435|NCT05274217|76112902|FG000|Overall Study|Study terminated.|11|||
42281436|NCT05274217|76112903|FG001|Overall Study|Study terminated.|0|||
42281437|NCT05070546|76112915|FG000|Overall Study|Death|0|||
42281438|NCT05070546|76112916|FG001|Overall Study|Death|0|||
42281439|NCT05070546|76112917|FG002|Overall Study|Death|0|||
42281440|NCT05070546|76112918|FG003|Overall Study|Death|0|||
42281441|NCT05070546|76112919|FG004|Overall Study|Death|0|||
42281442|NCT05070546|76112920|FG005|Overall Study|Death|1|||
42281443|NCT05070546|76112915|FG000|Overall Study|Lost to Follow-up|8|||
42281444|NCT05070546|76112916|FG001|Overall Study|Lost to Follow-up|2|||
42281445|NCT05070546|76112917|FG002|Overall Study|Lost to Follow-up|7|||
42281446|NCT05070546|76112918|FG003|Overall Study|Lost to Follow-up|1|||
42281447|NCT05070546|76112919|FG004|Overall Study|Lost to Follow-up|2|||
42281448|NCT05070546|76112920|FG005|Overall Study|Lost to Follow-up|0|||
42164999|NCT03670810|75972681|FG003|Open Label Extension|Lack of Efficacy|0|||
42165000|NCT03670810|75972682|FG004|Open Label Extension|Lack of Efficacy|0|||
42281449|NCT05070546|76112915|FG000|Overall Study|Withdrawal by Subject|1|||
42281450|NCT05070546|76112916|FG001|Overall Study|Withdrawal by Subject|1|||
42165001|NCT03670810|75972683|FG005|Open Label Extension|Lack of Efficacy|0|||
42165002|NCT03670810|75972684|FG006|Open Label Extension|Lack of Efficacy|0|||
42165003|NCT03670810|75972685|FG007|Open Label Extension|Lack of Efficacy|0|||
42165004|NCT03670810|75972686|FG008|Open Label Extension|Lack of Efficacy|39|||
42165005|NCT03670810|75972678|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
42165006|NCT03670810|75972679|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
42165007|NCT03670810|75972680|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
42165008|NCT03670810|75972681|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
42165009|NCT03670810|75972682|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
42165010|NCT03670810|75972683|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
42165011|NCT03670810|75972684|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
42165012|NCT03670810|75972685|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
42165013|NCT03670810|75972686|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
42165014|NCT03670810|75972678|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
42165015|NCT03670810|75972679|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
42165016|NCT03670810|75972680|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
42165017|NCT03670810|75972681|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
42165018|NCT03670810|75972682|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
42165019|NCT03670810|75972683|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
42165020|NCT03670810|75972684|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
42165021|NCT03670810|75972685|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
42165022|NCT03670810|75972686|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
42165023|NCT03670810|75972678|FG000|Open Label Extension|Withdrawal by Subject|0|||
42165024|NCT03670810|75972679|FG001|Open Label Extension|Withdrawal by Subject|0|||
42165025|NCT03670810|75972680|FG002|Open Label Extension|Withdrawal by Subject|0|||
42165026|NCT03670810|75972681|FG003|Open Label Extension|Withdrawal by Subject|0|||
42165027|NCT03670810|75972682|FG004|Open Label Extension|Withdrawal by Subject|0|||
42165028|NCT03670810|75972683|FG005|Open Label Extension|Withdrawal by Subject|0|||
42165029|NCT03670810|75972684|FG006|Open Label Extension|Withdrawal by Subject|0|||
42165030|NCT03670810|75972685|FG007|Open Label Extension|Withdrawal by Subject|0|||
42165031|NCT03670810|75972686|FG008|Open Label Extension|Withdrawal by Subject|46|||
42165032|NCT03670810|75972678|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
42165033|NCT03670810|75972679|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
42165034|NCT03670810|75972680|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
42165035|NCT03670810|75972681|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
42165036|NCT03670810|75972682|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
42165037|NCT03670810|75972683|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
42165038|NCT03670810|75972684|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
42165039|NCT03670810|75972685|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
42165040|NCT03670810|75972686|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
42165041|NCT03670810|75972678|FG000|Open Label Extension|Physician Decision|0|||
42165042|NCT03670810|75972679|FG001|Open Label Extension|Physician Decision|0|||
42165043|NCT03670810|75972680|FG002|Open Label Extension|Physician Decision|0|||
42165044|NCT03670810|75972681|FG003|Open Label Extension|Physician Decision|0|||
42165045|NCT03670810|75972682|FG004|Open Label Extension|Physician Decision|0|||
42165046|NCT03670810|75972683|FG005|Open Label Extension|Physician Decision|0|||
42165047|NCT03670810|75972684|FG006|Open Label Extension|Physician Decision|0|||
42165048|NCT03670810|75972685|FG007|Open Label Extension|Physician Decision|0|||
42165049|NCT03670810|75972686|FG008|Open Label Extension|Physician Decision|2|||
42165050|NCT03670810|75972678|FG000|Open Label Extension|Non-compliance with study drug|0|||
42165051|NCT03670810|75972679|FG001|Open Label Extension|Non-compliance with study drug|0|||
42165052|NCT03670810|75972680|FG002|Open Label Extension|Non-compliance with study drug|0|||
42165053|NCT03670810|75972681|FG003|Open Label Extension|Non-compliance with study drug|0|||
42165054|NCT03670810|75972682|FG004|Open Label Extension|Non-compliance with study drug|0|||
42165055|NCT03670810|75972683|FG005|Open Label Extension|Non-compliance with study drug|0|||
42165056|NCT03670810|75972684|FG006|Open Label Extension|Non-compliance with study drug|0|||
42165057|NCT03670810|75972685|FG007|Open Label Extension|Non-compliance with study drug|0|||
42165058|NCT03670810|75972686|FG008|Open Label Extension|Non-compliance with study drug|5|||
42165059|NCT03670810|75972678|FG000|Open Label Extension|Pregnancy|0|||
42165060|NCT03670810|75972679|FG001|Open Label Extension|Pregnancy|0|||
42165061|NCT03670810|75972680|FG002|Open Label Extension|Pregnancy|0|||
42165062|NCT03670810|75972681|FG003|Open Label Extension|Pregnancy|0|||
42165063|NCT03670810|75972682|FG004|Open Label Extension|Pregnancy|0|||
42165064|NCT03670810|75972683|FG005|Open Label Extension|Pregnancy|0|||
42165065|NCT03670810|75972684|FG006|Open Label Extension|Pregnancy|0|||
42165066|NCT03670810|75972685|FG007|Open Label Extension|Pregnancy|0|||
42165067|NCT03670810|75972686|FG008|Open Label Extension|Pregnancy|3|||
42165068|NCT03670810|75972678|FG000|Open Label Extension|Adverse Event|0|||
42165069|NCT03670810|75972679|FG001|Open Label Extension|Adverse Event|0|||
42165070|NCT03670810|75972680|FG002|Open Label Extension|Adverse Event|0|||
42165071|NCT03670810|75972681|FG003|Open Label Extension|Adverse Event|0|||
42165072|NCT03670810|75972682|FG004|Open Label Extension|Adverse Event|0|||
42165073|NCT03670810|75972683|FG005|Open Label Extension|Adverse Event|0|||
42165074|NCT03670810|75972684|FG006|Open Label Extension|Adverse Event|0|||
42165075|NCT03670810|75972685|FG007|Open Label Extension|Adverse Event|0|||
42165076|NCT03670810|75972686|FG008|Open Label Extension|Adverse Event|24|||
42165077|NCT03670810|75972678|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
42165078|NCT03670810|75972679|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
42165079|NCT03670810|75972680|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
42165080|NCT03670810|75972681|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
42165081|NCT03670810|75972682|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
42165082|NCT03670810|75972683|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
42165083|NCT03670810|75972684|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
42165084|NCT03670810|75972685|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
42165085|NCT03670810|75972686|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
42165086|NCT03670810|75972678|FG000|Open Label Extension|Lost to Follow-up|0|||
42165087|NCT03670810|75972679|FG001|Open Label Extension|Lost to Follow-up|0|||
42165088|NCT03670810|75972680|FG002|Open Label Extension|Lost to Follow-up|0|||
42165089|NCT03670810|75972681|FG003|Open Label Extension|Lost to Follow-up|0|||
42165090|NCT03670810|75972682|FG004|Open Label Extension|Lost to Follow-up|0|||
42165091|NCT03670810|75972683|FG005|Open Label Extension|Lost to Follow-up|0|||
42165092|NCT03670810|75972684|FG006|Open Label Extension|Lost to Follow-up|0|||
42165093|NCT03670810|75972685|FG007|Open Label Extension|Lost to Follow-up|0|||
42165094|NCT03670810|75972686|FG008|Open Label Extension|Lost to Follow-up|23|||
42165095|NCT00089648|75972700|FG000|Overall Study|Adverse Event|7|||
42165096|NCT00089648|75972700|FG000|Overall Study|Withdrawal by Subject|1|||
42165097|NCT00089648|75972700|FG000|Overall Study|Lack of Efficacy|33|||
42165098|NCT00118040|75972707|FG000|Overall Study|Adverse Event|0|||
42165099|NCT00118040|75972708|FG001|Overall Study|Adverse Event|1|||
42165100|NCT00118040|75972709|FG002|Overall Study|Adverse Event|0|||
42165101|NCT00118040|75972707|FG000|Overall Study|Withdrawal by Subject|0|||
42165102|NCT00118040|75972708|FG001|Overall Study|Withdrawal by Subject|0|||
42165103|NCT00118040|75972709|FG002|Overall Study|Withdrawal by Subject|2|||
42014190|NCT01292603|75821374|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
42014191|NCT01292603|75821369|FG000|Part 2: Dose Confirmation Period|Death|0|||
42014192|NCT01292603|75821370|FG001|Part 2: Dose Confirmation Period|Death|0|||
42165104|NCT00118040|75972707|FG000|Overall Study|Medical Contraindication|0|||
42281451|NCT05070546|76112917|FG002|Overall Study|Withdrawal by Subject|3|||
42281452|NCT05070546|76112918|FG003|Overall Study|Withdrawal by Subject|0|||
42281453|NCT05070546|76112919|FG004|Overall Study|Withdrawal by Subject|0|||
42281454|NCT05070546|76112920|FG005|Overall Study|Withdrawal by Subject|0|||
42281455|NCT05070546|76112915|FG000|Overall Study|Other|0|||
42281456|NCT05070546|76112916|FG001|Overall Study|Other|0|||
42281457|NCT05070546|76112917|FG002|Overall Study|Other|0|||
42281458|NCT05070546|76112918|FG003|Overall Study|Other|0|||
42281459|NCT05070546|76112919|FG004|Overall Study|Other|3|||
42281460|NCT05070546|76112920|FG005|Overall Study|Other|0|||
42281461|NCT05070546|76112915|FG000|Overall Study|Randomized but not vaccinated|1|||
42281462|NCT05070546|76112916|FG001|Overall Study|Randomized but not vaccinated|0|||
42281463|NCT05070546|76112917|FG002|Overall Study|Randomized but not vaccinated|1|||
42165105|NCT00118040|75972708|FG001|Overall Study|Medical Contraindication|0|||
42281464|NCT05070546|76112918|FG003|Overall Study|Randomized but not vaccinated|1|||
42281465|NCT05070546|76112919|FG004|Overall Study|Randomized but not vaccinated|3|||
42014193|NCT01292603|75821371|FG002|Part 2: Dose Confirmation Period|Death|0|||
42165106|NCT00118040|75972709|FG002|Overall Study|Medical Contraindication|1|||
42281466|NCT05070546|76112920|FG005|Overall Study|Randomized but not vaccinated|0|||
42281467|NCT05032950|76112939|FG000|Overall Study|Adverse Event|0|||
42165107|NCT00118040|75972707|FG000|Overall Study|Non-Compliant Participant|1|||
42281468|NCT05032950|76112940|FG001|Overall Study|Adverse Event|0|||
42281469|NCT05032950|76112941|FG002|Overall Study|Adverse Event|1|||
42014194|NCT01292603|75821372|FG003|Part 2: Dose Confirmation Period|Death|0|||
42165108|NCT00118040|75972708|FG001|Overall Study|Non-Compliant Participant|1|||
42165109|NCT00118040|75972709|FG002|Overall Study|Non-Compliant Participant|2|||
42165110|NCT00118040|75972707|FG000|Overall Study|Other|0|||
42165111|NCT00118040|75972708|FG001|Overall Study|Other|0|||
42165112|NCT00118040|75972709|FG002|Overall Study|Other|1|||
42165113|NCT00389207|75972725|FG000|Overall Study|Adverse Event|26|||
42165114|NCT00389207|75972726|FG001|Overall Study|Adverse Event|32|||
42165115|NCT00389207|75972727|FG002|Overall Study|Adverse Event|10|||
42165116|NCT00389207|75972725|FG000|Overall Study|Protocol Violation|3|||
42014195|NCT01292603|75821373|FG004|Part 2: Dose Confirmation Period|Death|1|||
42014196|NCT01292603|75821374|FG005|Part 2: Dose Confirmation Period|Death|0|||
42014197|NCT01292603|75821369|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
42014198|NCT01292603|75821370|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
42014199|NCT01292603|75821371|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
42014200|NCT01292603|75821372|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
42165117|NCT00389207|75972726|FG001|Overall Study|Protocol Violation|1|||
42165118|NCT00389207|75972727|FG002|Overall Study|Protocol Violation|4|||
42165119|NCT00389207|75972725|FG000|Overall Study|Lost to Follow-up|12|||
42165120|NCT00389207|75972726|FG001|Overall Study|Lost to Follow-up|9|||
42165121|NCT00389207|75972727|FG002|Overall Study|Lost to Follow-up|7|||
42165122|NCT00389207|75972725|FG000|Overall Study|Withdrawal by Subject|5|||
42165123|NCT00389207|75972726|FG001|Overall Study|Withdrawal by Subject|7|||
42165124|NCT00389207|75972727|FG002|Overall Study|Withdrawal by Subject|11|||
42165125|NCT00389207|75972725|FG000|Overall Study|Other|17|||
42165126|NCT00389207|75972726|FG001|Overall Study|Other|23|||
42165127|NCT00389207|75972727|FG002|Overall Study|Other|9|||
42165128|NCT00388973|75972742|FG000|Overall Study|Adverse Event|16|||
42165129|NCT00388973|75972743|FG001|Overall Study|Adverse Event|6|||
42165130|NCT00388973|75972742|FG000|Overall Study|Lack of Efficacy|1|||
42165131|NCT00388973|75972743|FG001|Overall Study|Lack of Efficacy|12|||
42165132|NCT00388973|75972742|FG000|Overall Study|Protocol Violation|3|||
42165133|NCT00388973|75972743|FG001|Overall Study|Protocol Violation|0|||
42165134|NCT00388973|75972742|FG000|Overall Study|Withdrawal by Subject|14|||
42165135|NCT00388973|75972743|FG001|Overall Study|Withdrawal by Subject|17|||
42165136|NCT00388973|75972742|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
42165137|NCT00388973|75972743|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
42165138|NCT00388973|75972742|FG000|Overall Study|Did not complete 61 days of treatment|5|||
42165139|NCT00388973|75972743|FG001|Overall Study|Did not complete 61 days of treatment|4|||
42165140|NCT00388973|75972742|FG000|Overall Study|Left region|0|||
42165141|NCT00388973|75972743|FG001|Overall Study|Left region|1|||
42165142|NCT00388973|75972742|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
42165143|NCT00388973|75972743|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
42165144|NCT00388583|75972751|FG000|Overall Study|Protocol Violation|1|||
42165145|NCT00388583|75972752|FG001|Overall Study|Protocol Violation|0|||
42165146|NCT00388583|75972751|FG000|Overall Study|Withdrawal by Subject|3|||
42165147|NCT00388583|75972752|FG001|Overall Study|Withdrawal by Subject|3|||
42165148|NCT00388583|75972751|FG000|Overall Study|Serious Adverse Event|2|||
42165149|NCT00388583|75972752|FG001|Overall Study|Serious Adverse Event|0|||
42165150|NCT00388583|75972751|FG000|Overall Study|Did not receive vaccine|0|||
42165151|NCT00388583|75972752|FG001|Overall Study|Did not receive vaccine|1|||
42165152|NCT00117572|75972760|FG000|Overall Study|Site withdrew before starting treatment|2|||
42165153|NCT00117572|75972761|FG001|Overall Study|Site withdrew before starting treatment|3|||
42165154|NCT00117572|75972760|FG000|Overall Study|Withdrawal by Subject|3|||
42165155|NCT00117572|75972761|FG001|Overall Study|Withdrawal by Subject|3|||
42165156|NCT00117572|75972760|FG000|Overall Study|Protocol Violation|1|||
42165157|NCT00117572|75972761|FG001|Overall Study|Protocol Violation|0|||
42165158|NCT00388505|75972769|FG000|Overall Study|Adverse Event or Death|43|||
42165159|NCT00388505|75972770|FG001|Overall Study|Adverse Event or Death|17|||
42165160|NCT00388505|75972769|FG000|Overall Study|Withdrawal by Subject|24|||
42165161|NCT00388505|75972770|FG001|Overall Study|Withdrawal by Subject|9|||
42165162|NCT00388505|75972769|FG000|Overall Study|Lost to Follow-up|5|||
42165163|NCT00388505|75972770|FG001|Overall Study|Lost to Follow-up|3|||
42165164|NCT00388505|75972769|FG000|Overall Study|Inappropriate Enrollment|0|||
42014201|NCT01292603|75821373|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
42014202|NCT01292603|75821374|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
42014203|NCT01292603|75821369|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
42165165|NCT00388505|75972770|FG001|Overall Study|Inappropriate Enrollment|1|||
42165166|NCT00388505|75972769|FG000|Overall Study|Administrative Reason|1|||
42165167|NCT00388505|75972770|FG001|Overall Study|Administrative Reason|0|||
42165168|NCT00388505|75972769|FG000|Overall Study|Protocol Violation|6|||
42014204|NCT01292603|75821370|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
42165169|NCT00388505|75972770|FG001|Overall Study|Protocol Violation|5|||
42165170|NCT00388505|75972769|FG000|Overall Study|Unable to classify|4|||
42165171|NCT00388505|75972770|FG001|Overall Study|Unable to classify|3|||
42165172|NCT00388349|75972776|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
42165173|NCT00388349|75972777|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
42165174|NCT00117338|75972787|FG000|Overall Study|Adverse Event|0|||
42165175|NCT00117338|75972788|FG001|Overall Study|Adverse Event|1|||
42165176|NCT00117338|75972787|FG000|Overall Study|Protocol Violation|3|||
42165177|NCT00117338|75972788|FG001|Overall Study|Protocol Violation|2|||
42165178|NCT00117338|75972787|FG000|Overall Study|Withdrawal by Subject|1|||
42165179|NCT00117338|75972788|FG001|Overall Study|Withdrawal by Subject|0|||
42165180|NCT00117338|75972787|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
42014205|NCT01292603|75821371|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
42165181|NCT00117338|75972788|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
42165182|NCT00117338|75972787|FG000|Overall Study|Lack of Efficacy|0|||
42165183|NCT00117338|75972788|FG001|Overall Study|Lack of Efficacy|1|||
42165184|NCT00388037|75972794|FG000|Overall Study|Protocol Violation|1|||
42165185|NCT00387881|75972800|FG000|Overall Study|Lost to Follow-up|23|||
42165186|NCT00387881|75972801|FG001|Overall Study|Lost to Follow-up|23|||
42165187|NCT00387881|75972800|FG000|Overall Study|Protocol Violation|2|||
42165188|NCT00387881|75972801|FG001|Overall Study|Protocol Violation|12|||
42165189|NCT00387881|75972800|FG000|Overall Study|Withdrawal by Subject|15|||
42165190|NCT00387881|75972801|FG001|Overall Study|Withdrawal by Subject|18|||
42165191|NCT00387881|75972800|FG000|Overall Study|Sponsor terminated Study|0|||
42165192|NCT00387881|75972801|FG001|Overall Study|Sponsor terminated Study|1|||
42165193|NCT00387881|75972800|FG000|Overall Study|Not eligible|6|||
42165194|NCT00387881|75972801|FG001|Overall Study|Not eligible|7|||
42165195|NCT00387881|75972800|FG000|Overall Study|No opportunity to treat headache|32|||
42165196|NCT00387881|75972801|FG001|Overall Study|No opportunity to treat headache|34|||
42165197|NCT00387881|75972800|FG000|Overall Study|Not otherwise specified|11|||
42165198|NCT00387881|75972801|FG001|Overall Study|Not otherwise specified|7|||
42165199|NCT00084656|75972810|FG000|Overall Study|Other reasons|0|||
42165200|NCT00084656|75972811|FG001|Overall Study|Other reasons|12|||
42165201|NCT00084656|75972812|FG002|Overall Study|Other reasons|11|||
42165202|NCT00084656|75972810|FG000|Overall Study|Withdrawal by Subject|15|||
42165203|NCT00084656|75972811|FG001|Overall Study|Withdrawal by Subject|4|||
42165204|NCT00084656|75972812|FG002|Overall Study|Withdrawal by Subject|4|||
42165205|NCT00084656|75972810|FG000|Overall Study|Disease relapse|0|||
42165206|NCT00084656|75972811|FG001|Overall Study|Disease relapse|9|||
42165207|NCT00084656|75972812|FG002|Overall Study|Disease relapse|10|||
42165208|NCT00084656|75972810|FG000|Overall Study|Disease progression|9|||
42165209|NCT00084656|75972811|FG001|Overall Study|Disease progression|0|||
42165210|NCT00084656|75972812|FG002|Overall Study|Disease progression|0|||
42165211|NCT00084656|75972810|FG000|Overall Study|Lost to Follow-up|1|||
42165212|NCT00084656|75972811|FG001|Overall Study|Lost to Follow-up|0|||
42165213|NCT00084656|75972812|FG002|Overall Study|Lost to Follow-up|1|||
42165214|NCT00387725|75972826|FG000|Overall Study|Adverse Event|0|||
42165215|NCT00387725|75972827|FG001|Overall Study|Adverse Event|0|||
42165216|NCT00387725|75972828|FG002|Overall Study|Adverse Event|0|||
42165217|NCT00387725|75972829|FG003|Overall Study|Adverse Event|1|||
42165218|NCT00387725|75972826|FG000|Overall Study|Protocol Violation|0|||
42165219|NCT00387725|75972827|FG001|Overall Study|Protocol Violation|1|||
42165220|NCT00387725|75972828|FG002|Overall Study|Protocol Violation|0|||
42165221|NCT00387725|75972829|FG003|Overall Study|Protocol Violation|0|||
42165222|NCT00387725|75972826|FG000|Overall Study|Withdrawal by Subject|1|||
42165223|NCT00387725|75972827|FG001|Overall Study|Withdrawal by Subject|0|||
42165224|NCT00387725|75972828|FG002|Overall Study|Withdrawal by Subject|1|||
42165225|NCT00387725|75972829|FG003|Overall Study|Withdrawal by Subject|0|||
42165226|NCT00387725|75972826|FG000|Overall Study|Parent/legal guardian request|0|||
42165227|NCT00387725|75972827|FG001|Overall Study|Parent/legal guardian request|0|||
42165228|NCT00387725|75972828|FG002|Overall Study|Parent/legal guardian request|1|||
42165229|NCT00387725|75972829|FG003|Overall Study|Parent/legal guardian request|1|||
42165230|NCT00102596|75972839|FG000|Part A|Screen failures|6|||
42165231|NCT00102596|75972840|FG001|Part A|Screen failures|0|||
42165232|NCT00102596|75972839|FG000|Part A|Adverse Event|1|||
42165233|NCT00102596|75972840|FG001|Part A|Adverse Event|0|||
42165234|NCT00387647|75972847|FG000|Overall Study|Death|18|||
42165235|NCT00386009|75972853|FG000|Overall Study|Adverse Event|0|||
42165236|NCT00386009|75972854|FG001|Overall Study|Adverse Event|2|||
42165237|NCT00386009|75972853|FG000|Overall Study|Death|1|||
42165238|NCT00386009|75972854|FG001|Overall Study|Death|0|||
42165239|NCT00386009|75972853|FG000|Overall Study|Entry Criteria Not Met|0|||
42165240|NCT00386009|75972854|FG001|Overall Study|Entry Criteria Not Met|2|||
42165241|NCT00386009|75972853|FG000|Overall Study|Lost to Follow-up|1|||
42165242|NCT00386009|75972854|FG001|Overall Study|Lost to Follow-up|1|||
42165243|NCT00386009|75972853|FG000|Overall Study|Protocol Violation|1|||
42165244|NCT00386009|75972854|FG001|Overall Study|Protocol Violation|0|||
42165245|NCT00386009|75972853|FG000|Overall Study|Sponsor Decision|1|||
42165246|NCT00386009|75972854|FG001|Overall Study|Sponsor Decision|1|||
42165247|NCT00386009|75972853|FG000|Overall Study|Withdrawal by Subject|5|||
42165248|NCT00386009|75972854|FG001|Overall Study|Withdrawal by Subject|4|||
42165249|NCT00373685|75972862|FG000|Overall Study|Death|2|||
42165250|NCT00373685|75972863|FG001|Overall Study|Death|1|||
42281470|NCT05032950|76112942|FG003|Overall Study|Adverse Event|1|||
42165251|NCT00373685|75972862|FG000|Overall Study|Adverse Event|278|||
42165252|NCT00373685|75972863|FG001|Overall Study|Adverse Event|253|||
42165253|NCT00373685|75972862|FG000|Overall Study|Insufficient clinical response|169|||
42165254|NCT00373685|75972863|FG001|Overall Study|Insufficient clinical response|119|||
42165255|NCT00373685|75972862|FG000|Overall Study|Did not meet entrance criteria|167|||
42165256|NCT00373685|75972863|FG001|Overall Study|Did not meet entrance criteria|184|||
42281471|NCT05032950|76112943|FG004|Overall Study|Adverse Event|0|||
42165257|NCT00373685|75972862|FG000|Overall Study|Lost to follow up|83|||
42165258|NCT00373685|75972863|FG001|Overall Study|Lost to follow up|103|||
42165259|NCT00373685|75972862|FG000|Overall Study|No longer willing to participate|337|||
42165260|NCT00373685|75972863|FG001|Overall Study|No longer willing to participate|352|||
42165261|NCT00373685|75972862|FG000|Overall Study|Other|149|||
42165262|NCT00373685|75972863|FG001|Overall Study|Other|146|||
42165263|NCT00373685|75972862|FG000|Overall Study|Protocol Violation|191|||
42165264|NCT00373685|75972863|FG001|Overall Study|Protocol Violation|182|||
42165265|NCT00373685|75972862|FG000|Overall Study|Final Status Unknown|12|||
42165266|NCT00373685|75972863|FG001|Overall Study|Final Status Unknown|4|||
42165267|NCT00373685|75972862|FG000|Overall Study|Randomized, not treated|51|||
42165268|NCT00373685|75972863|FG001|Overall Study|Randomized, not treated|77|||
42165269|NCT00373529|75972869|FG000|Overall Study|Physician Decision|19|||
42165270|NCT00373529|75972869|FG000|Overall Study|Withdrawal by Subject|7|||
42165271|NCT00373529|75972869|FG000|Overall Study|Adverse Event|7|||
42165272|NCT00373529|75972869|FG000|Overall Study|Treatment failure|36|||
42165273|NCT00373529|75972869|FG000|Overall Study|Disease recurrence|10|||
42165274|NCT00373529|75972869|FG000|Overall Study|Death|16|||
42165275|NCT00373529|75972869|FG000|Overall Study|Need for treatment prohibited by study|1|||
42165276|NCT00373529|75972869|FG000|Overall Study|Other|8|||
42165277|NCT00373529|75972869|FG000|Overall Study|Failed independent confirmation of AML|3|||
42165278|NCT00373529|75972869|FG000|Overall Study|Consent violation|1|||
42281472|NCT05032950|76112944|FG005|Overall Study|Adverse Event|0|||
42281473|NCT04776161|76112964|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
42281474|NCT04776161|76112965|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
42281475|NCT04776161|76112966|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
42281476|NCT04776161|76112964|FG000|Overall Study|Withdrawal by Subject|1|||
42281477|NCT04776161|76112965|FG001|Overall Study|Withdrawal by Subject|0|||
42281478|NCT04776161|76112966|FG002|Overall Study|Withdrawal by Subject|1|||
42281479|NCT04776161|76112964|FG000|Overall Study|Adverse Event|0|||
42281480|NCT04776161|76112965|FG001|Overall Study|Adverse Event|1|||
42281481|NCT04776161|76112966|FG002|Overall Study|Adverse Event|1|||
42281482|NCT04268823|76112980|FG000|Overall Study|Adverse Event|1|||
42281483|NCT04268823|76112981|FG001|Overall Study|Adverse Event|0|||
42281484|NCT04268823|76112980|FG000|Overall Study|Participant Decision|1|||
42281485|NCT04268823|76112981|FG001|Overall Study|Participant Decision|0|||
42281486|NCT04226495|76112990|FG000|Overall Study|Withdrawal by Subject|3|||
42281487|NCT04226495|76112991|FG001|Overall Study|Withdrawal by Subject|3|||
42281488|NCT04226495|76112990|FG000|Overall Study|PI discretion|2|||
42281489|NCT04226495|76112991|FG001|Overall Study|PI discretion|4|||
42281490|NCT04060212|76112997|FG000|Overall Study|Withdrawal by Subject|7|||
42281491|NCT04007991|76113003|FG000|Overall Study|Withdrawal by Subject|1|||
42281492|NCT04007991|76113004|FG001|Overall Study|Withdrawal by Subject|1|||
42281493|NCT04007991|76113003|FG000|Overall Study|Physician Decision|1|||
42281494|NCT04007991|76113004|FG001|Overall Study|Physician Decision|1|||
42281495|NCT04007991|76113003|FG000|Overall Study|Non-compliance with Study Drug|0|||
42281496|NCT04007991|76113004|FG001|Overall Study|Non-compliance with Study Drug|1|||
42014206|NCT01292603|75821372|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
42014207|NCT01292603|75821373|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
42014208|NCT01292603|75821374|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
42014209|NCT01292603|75821369|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
42014210|NCT01292603|75821370|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
42014211|NCT01292603|75821371|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
42014212|NCT01292603|75821372|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
42014213|NCT01292603|75821373|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
42165279|NCT00373295|75972873|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
42165280|NCT00373295|75972874|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
42165281|NCT00373295|75972875|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
42165282|NCT00373295|75972876|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
42165283|NCT00373295|75972877|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
42165284|NCT00373295|75972878|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
42165285|NCT00385541|75972888|FG000|Overall Study|severe pain, clinician requested unblind|0|||
42165286|NCT00385541|75972889|FG001|Overall Study|severe pain, clinician requested unblind|1|||
42165287|NCT00392015|75972901|FG000|Overall Study|Lost to Follow-up|2|||
42165288|NCT00392015|75972902|FG001|Overall Study|Lost to Follow-up|0|||
42165289|NCT00392015|75972903|FG002|Overall Study|Lost to Follow-up|2|||
42165290|NCT00392015|75972904|FG003|Overall Study|Lost to Follow-up|1|||
42165291|NCT00392015|75972905|FG004|Overall Study|Lost to Follow-up|1|||
42165292|NCT00392015|75972906|FG005|Overall Study|Lost to Follow-up|0|||
42014214|NCT01292603|75821374|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
42014215|NCT01292603|75821369|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
42014216|NCT01292603|75821370|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
42165293|NCT00392015|75972901|FG000|Overall Study|Withdrawal by Subject|0|||
42165294|NCT00392015|75972902|FG001|Overall Study|Withdrawal by Subject|0|||
42165295|NCT00392015|75972903|FG002|Overall Study|Withdrawal by Subject|2|||
42165296|NCT00392015|75972904|FG003|Overall Study|Withdrawal by Subject|0|||
42165297|NCT00392015|75972905|FG004|Overall Study|Withdrawal by Subject|0|||
42165298|NCT00392015|75972906|FG005|Overall Study|Withdrawal by Subject|0|||
42165299|NCT00392015|75972901|FG000|Overall Study|Adverse Event|0|||
42014217|NCT01292603|75821371|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
42014218|NCT01292603|75821372|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
42165300|NCT00392015|75972902|FG001|Overall Study|Adverse Event|0|||
42281497|NCT04007991|76113003|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
42281498|NCT04007991|76113004|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
42281499|NCT04007991|76113003|FG000|Overall Study|Adverse event, non-fatal|5|||
42281500|NCT04007991|76113004|FG001|Overall Study|Adverse event, non-fatal|0|||
42281501|NCT04007991|76113003|FG000|Overall Study|Lost to Follow-up|2|||
42281502|NCT04007991|76113004|FG001|Overall Study|Lost to Follow-up|1|||
42281503|NCT03935217|76113025|FG000|Overall Study|Adverse Event|1|||
42281504|NCT03935217|76113026|FG001|Overall Study|Adverse Event|0|||
42281505|NCT03935217|76113025|FG000|Overall Study|Lost to Follow-up|0|||
42281506|NCT03935217|76113026|FG001|Overall Study|Lost to Follow-up|1|||
42281507|NCT03935217|76113025|FG000|Overall Study|Withdrawal by Subject|0|||
42281508|NCT03935217|76113026|FG001|Overall Study|Withdrawal by Subject|2|||
42281509|NCT03806933|76113040|FG000|Main Period|Physician Decision|0|||
42281510|NCT03806933|76113041|FG001|Main Period|Physician Decision|0|||
42281511|NCT03806933|76113042|FG002|Main Period|Physician Decision|0|||
42281512|NCT03806933|76113043|FG003|Main Period|Physician Decision|1|||
42281513|NCT03806933|76113040|FG000|Main Period|Pregnancy|0|||
42281514|NCT03806933|76113041|FG001|Main Period|Pregnancy|0|||
42281515|NCT03806933|76113042|FG002|Main Period|Pregnancy|1|||
42281516|NCT03806933|76113043|FG003|Main Period|Pregnancy|0|||
42281517|NCT03806933|76113040|FG000|Main Period|Withdrawal by Subject|2|||
42281518|NCT03806933|76113041|FG001|Main Period|Withdrawal by Subject|1|||
42281519|NCT03806933|76113042|FG002|Main Period|Withdrawal by Subject|1|||
42281520|NCT03806933|76113043|FG003|Main Period|Withdrawal by Subject|2|||
42281521|NCT03806933|76113040|FG000|Main Period|Lost to Follow-up|2|||
42281522|NCT03806933|76113041|FG001|Main Period|Lost to Follow-up|2|||
42281523|NCT03806933|76113042|FG002|Main Period|Lost to Follow-up|0|||
42281524|NCT03806933|76113043|FG003|Main Period|Lost to Follow-up|0|||
42281525|NCT03806933|76113040|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
42281526|NCT03806933|76113041|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
42281527|NCT03806933|76113042|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
42281528|NCT03806933|76113043|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
42281529|NCT03590613|76113074|FG000|Period 2, 4 Days|Physician Decision|0|||
42281530|NCT03590613|76113075|FG001|Period 2, 4 Days|Physician Decision|0|||
42281531|NCT03590613|76113076|FG002|Period 2, 4 Days|Physician Decision|0|||
42281532|NCT03590613|76113077|FG003|Period 2, 4 Days|Physician Decision|1|||
42281533|NCT02689258|76113118|FG000|Overall Study|Subject Non-Compliance|0|||
42281534|NCT02689258|76113119|FG001|Overall Study|Subject Non-Compliance|1|||
42281535|NCT02689258|76113120|FG002|Overall Study|Subject Non-Compliance|0|||
42281536|NCT02689258|76113121|FG003|Overall Study|Subject Non-Compliance|0|||
42281537|NCT02689258|76113122|FG004|Overall Study|Subject Non-Compliance|0|||
42281538|NCT02689258|76113123|FG005|Overall Study|Subject Non-Compliance|0|||
42281539|NCT02689258|76113124|FG006|Overall Study|Subject Non-Compliance|0|||
42281540|NCT02689258|76113125|FG007|Overall Study|Subject Non-Compliance|0|||
42281541|NCT02689258|76113126|FG008|Overall Study|Subject Non-Compliance|0|||
42281542|NCT02689258|76113127|FG009|Overall Study|Subject Non-Compliance|0|||
42281543|NCT02689258|76113128|FG010|Overall Study|Subject Non-Compliance|0|||
42281544|NCT02689258|76113129|FG011|Overall Study|Subject Non-Compliance|0|||
42281545|NCT02689258|76113118|FG000|Overall Study|Subject Refusal to Continue|0|||
42281546|NCT02689258|76113119|FG001|Overall Study|Subject Refusal to Continue|1|||
42281547|NCT02689258|76113120|FG002|Overall Study|Subject Refusal to Continue|0|||
42281548|NCT02689258|76113121|FG003|Overall Study|Subject Refusal to Continue|0|||
42281549|NCT02689258|76113122|FG004|Overall Study|Subject Refusal to Continue|0|||
42165301|NCT00392015|75972903|FG002|Overall Study|Adverse Event|0|||
42281550|NCT02689258|76113123|FG005|Overall Study|Subject Refusal to Continue|0|||
42281551|NCT02689258|76113124|FG006|Overall Study|Subject Refusal to Continue|0|||
42281552|NCT02689258|76113125|FG007|Overall Study|Subject Refusal to Continue|0|||
42281553|NCT02689258|76113126|FG008|Overall Study|Subject Refusal to Continue|1|||
42281554|NCT02689258|76113127|FG009|Overall Study|Subject Refusal to Continue|0|||
42281555|NCT02689258|76113128|FG010|Overall Study|Subject Refusal to Continue|0|||
42281556|NCT02689258|76113129|FG011|Overall Study|Subject Refusal to Continue|1|||
42165302|NCT00392015|75972904|FG003|Overall Study|Adverse Event|0|||
42281557|NCT02689258|76113118|FG000|Overall Study|Other|0|||
42281558|NCT02689258|76113119|FG001|Overall Study|Other|2|||
42281559|NCT02689258|76113120|FG002|Overall Study|Other|0|||
42281560|NCT02689258|76113121|FG003|Overall Study|Other|0|||
42281561|NCT02689258|76113122|FG004|Overall Study|Other|1|||
42165303|NCT00392015|75972905|FG004|Overall Study|Adverse Event|1|||
42281562|NCT02689258|76113123|FG005|Overall Study|Other|0|||
42165304|NCT00392015|75972906|FG005|Overall Study|Adverse Event|0|||
42165305|NCT00392015|75972901|FG000|Overall Study|Previous trial recipient|0|||
42165306|NCT00392015|75972902|FG001|Overall Study|Previous trial recipient|0|||
42165307|NCT00392015|75972903|FG002|Overall Study|Previous trial recipient|0|||
42165308|NCT00392015|75972904|FG003|Overall Study|Previous trial recipient|0|||
42165309|NCT00392015|75972905|FG004|Overall Study|Previous trial recipient|1|||
42165310|NCT00392015|75972906|FG005|Overall Study|Previous trial recipient|0|||
42165311|NCT00094302|75972927|FG000|Overall Study|Lost to Follow-up|43|||
42165312|NCT00094302|75972928|FG001|Overall Study|Lost to Follow-up|41|||
42165313|NCT00094302|75972927|FG000|Overall Study|Physician Decision|5|||
42165314|NCT00094302|75972928|FG001|Overall Study|Physician Decision|8|||
42165315|NCT00094302|75972927|FG000|Overall Study|Withdrawal by Subject|103|||
42165316|NCT00094302|75972928|FG001|Overall Study|Withdrawal by Subject|111|||
42165317|NCT00094302|75972927|FG000|Overall Study|Death|266|||
42165318|NCT00094302|75972928|FG001|Overall Study|Death|246|||
42165319|NCT00372905|75972934|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
42165320|NCT00372905|75972935|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
42165321|NCT00372905|75972936|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
42165322|NCT00372905|75972937|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
42165323|NCT00372905|75972934|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
42165324|NCT00372905|75972935|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
42165325|NCT00372905|75972936|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
42165326|NCT00372905|75972937|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
42165327|NCT00372905|75972934|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
42165328|NCT00372905|75972935|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
42165329|NCT00372905|75972936|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
42165330|NCT00372905|75972937|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
42165331|NCT00372905|75972934|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
42165332|NCT00372905|75972935|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
42165333|NCT00372905|75972936|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
42165334|NCT00372905|75972937|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
42165335|NCT00372905|75972934|FG000|Follow up Until Relapse or Progression|Study closed|0|||
42165336|NCT00372905|75972935|FG001|Follow up Until Relapse or Progression|Study closed|0|||
42165337|NCT00372905|75972936|FG002|Follow up Until Relapse or Progression|Study closed|0|||
42165338|NCT00372905|75972937|FG003|Follow up Until Relapse or Progression|Study closed|3|||
42165339|NCT00372905|75972934|FG000|Follow up Until Relapse or Progression|Other|0|||
42165340|NCT00372905|75972935|FG001|Follow up Until Relapse or Progression|Other|1|||
42281563|NCT02689258|76113124|FG006|Overall Study|Other|0|||
42281564|NCT02689258|76113125|FG007|Overall Study|Other|0|||
42281565|NCT02689258|76113126|FG008|Overall Study|Other|1|||
42281566|NCT02689258|76113127|FG009|Overall Study|Other|0|||
42281567|NCT02689258|76113128|FG010|Overall Study|Other|0|||
42281568|NCT02689258|76113129|FG011|Overall Study|Other|0|||
42281569|NCT02685735|76113152|FG000|Overall Study|Missing construct or pain data|23|||
42281570|NCT02685735|76113153|FG001|Overall Study|Missing construct or pain data|22|||
42281571|NCT02606136|76113178|FG000|Overall Study|Participant/Legal Guardian Decision|5|||
42281572|NCT02606136|76113178|FG000|Overall Study|Withdrawal by Subject|1|||
42281573|NCT02292706|76113204|FG000|Overall Study|Lost to Follow-up|20|||
42281574|NCT02292706|76113205|FG001|Overall Study|Lost to Follow-up|44|||
42281575|NCT02292706|76113206|FG002|Overall Study|Lost to Follow-up|24|||
42281576|NCT02292706|76113207|FG003|Overall Study|Lost to Follow-up|61|||
42165341|NCT00372905|75972936|FG002|Follow up Until Relapse or Progression|Other|0|||
42281577|NCT02292706|76113208|FG004|Overall Study|Lost to Follow-up|21|||
42281578|NCT02292706|76113209|FG005|Overall Study|Lost to Follow-up|52|||
42281579|NCT02292706|76113210|FG006|Overall Study|Lost to Follow-up|25|||
42281580|NCT02292706|76113211|FG007|Overall Study|Lost to Follow-up|0|||
42281581|NCT02292706|76113204|FG000|Overall Study|Withdrew consent|15|||
42281582|NCT02292706|76113205|FG001|Overall Study|Withdrew consent|56|||
42281583|NCT02292706|76113206|FG002|Overall Study|Withdrew consent|43|||
42351793|NCT01544595|76191759|FG003|Status at Week 68|Lack of Efficacy|0|||
42351794|NCT01544595|76191760|FG004|Status at Week 68|Lack of Efficacy|0|||
42351795|NCT01544595|76191761|FG005|Status at Week 68|Lack of Efficacy|0|||
42351796|NCT01544595|76191756|FG000|Status at Week 68|Lost to Follow-up|1|||
42281584|NCT02292706|76113207|FG003|Overall Study|Withdrew consent|36|||
42281585|NCT02292706|76113208|FG004|Overall Study|Withdrew consent|13|||
42351797|NCT01544595|76191757|FG001|Status at Week 68|Lost to Follow-up|1|||
42014219|NCT01292603|75821373|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
42165342|NCT00372905|75972937|FG003|Follow up Until Relapse or Progression|Other|0|||
42165343|NCT00384839|75972947|FG000|Overall Study|Adverse Event|4|||
42165344|NCT00384839|75972947|FG000|Overall Study|Investigator Request|1|||
42351798|NCT01544595|76191758|FG002|Status at Week 68|Lost to Follow-up|0|||
42165345|NCT00384839|75972947|FG000|Overall Study|Patient Request|1|||
42165346|NCT00384839|75972947|FG000|Overall Study|Ineligible|2|||
42281586|NCT02292706|76113209|FG005|Overall Study|Withdrew consent|51|||
42281587|NCT02292706|76113210|FG006|Overall Study|Withdrew consent|20|||
42281588|NCT02292706|76113211|FG007|Overall Study|Withdrew consent|0|||
42281589|NCT02292706|76113204|FG000|Overall Study|Death|3|||
42281590|NCT02292706|76113205|FG001|Overall Study|Death|11|||
42281591|NCT02292706|76113206|FG002|Overall Study|Death|16|||
42281592|NCT02292706|76113207|FG003|Overall Study|Death|22|||
42281593|NCT02292706|76113208|FG004|Overall Study|Death|8|||
42281594|NCT02292706|76113209|FG005|Overall Study|Death|17|||
42281595|NCT02292706|76113210|FG006|Overall Study|Death|3|||
42281596|NCT02292706|76113211|FG007|Overall Study|Death|0|||
42281597|NCT02292706|76113204|FG000|Overall Study|Study terminated by sponsor|0|||
42281598|NCT02292706|76113205|FG001|Overall Study|Study terminated by sponsor|9|||
42281599|NCT02292706|76113206|FG002|Overall Study|Study terminated by sponsor|4|||
42281600|NCT02292706|76113207|FG003|Overall Study|Study terminated by sponsor|21|||
42281601|NCT02292706|76113208|FG004|Overall Study|Study terminated by sponsor|11|||
42281602|NCT02292706|76113209|FG005|Overall Study|Study terminated by sponsor|13|||
42281603|NCT02292706|76113210|FG006|Overall Study|Study terminated by sponsor|3|||
42281604|NCT02292706|76113211|FG007|Overall Study|Study terminated by sponsor|0|||
42281605|NCT02292706|76113204|FG000|Overall Study|Investigator's discretion|4|||
42281606|NCT02292706|76113205|FG001|Overall Study|Investigator's discretion|9|||
42281607|NCT02292706|76113206|FG002|Overall Study|Investigator's discretion|7|||
42281608|NCT02292706|76113207|FG003|Overall Study|Investigator's discretion|11|||
42281609|NCT02292706|76113208|FG004|Overall Study|Investigator's discretion|4|||
42281610|NCT02292706|76113209|FG005|Overall Study|Investigator's discretion|10|||
42281611|NCT02292706|76113210|FG006|Overall Study|Investigator's discretion|1|||
42281612|NCT02292706|76113211|FG007|Overall Study|Investigator's discretion|0|||
42281613|NCT02292706|76113204|FG000|Overall Study|Liver transplant|1|||
42281614|NCT02292706|76113205|FG001|Overall Study|Liver transplant|1|||
42281615|NCT02292706|76113206|FG002|Overall Study|Liver transplant|11|||
42281616|NCT02292706|76113207|FG003|Overall Study|Liver transplant|16|||
42281617|NCT02292706|76113208|FG004|Overall Study|Liver transplant|5|||
42281618|NCT02292706|76113209|FG005|Overall Study|Liver transplant|6|||
42281619|NCT02292706|76113210|FG006|Overall Study|Liver transplant|5|||
42281620|NCT02292706|76113211|FG007|Overall Study|Liver transplant|0|||
42281621|NCT02292706|76113204|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
42281622|NCT02292706|76113205|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
42281623|NCT02292706|76113206|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
42281624|NCT02292706|76113207|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
42281625|NCT02292706|76113208|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
42281626|NCT02292706|76113209|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
42281627|NCT02292706|76113210|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
42281628|NCT02292706|76113211|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
42281629|NCT02292706|76113204|FG000|Overall Study|Subject terminated by sponsor|1|||
42281630|NCT02292706|76113205|FG001|Overall Study|Subject terminated by sponsor|0|||
42281631|NCT02292706|76113206|FG002|Overall Study|Subject terminated by sponsor|0|||
42281632|NCT02292706|76113207|FG003|Overall Study|Subject terminated by sponsor|2|||
42281633|NCT02292706|76113208|FG004|Overall Study|Subject terminated by sponsor|1|||
42351799|NCT01544595|76191759|FG003|Status at Week 68|Lost to Follow-up|0|||
42351800|NCT01544595|76191760|FG004|Status at Week 68|Lost to Follow-up|0|||
42351801|NCT01544595|76191761|FG005|Status at Week 68|Lost to Follow-up|0|||
42351802|NCT01544595|76191756|FG000|Status at Week 68|Non-compliance with study treatment|1|||
42351803|NCT01544595|76191757|FG001|Status at Week 68|Non-compliance with study treatment|0|||
42351804|NCT01544595|76191758|FG002|Status at Week 68|Non-compliance with study treatment|0|||
42351805|NCT01544595|76191759|FG003|Status at Week 68|Non-compliance with study treatment|1|||
42351806|NCT01544595|76191760|FG004|Status at Week 68|Non-compliance with study treatment|0|||
42281634|NCT02292706|76113209|FG005|Overall Study|Subject terminated by sponsor|0|||
42351807|NCT01544595|76191761|FG005|Status at Week 68|Non-compliance with study treatment|0|||
42351808|NCT01544595|76191756|FG000|Status at Week 68|Protocol Violation|2|||
42351809|NCT01544595|76191757|FG001|Status at Week 68|Protocol Violation|0|||
42351810|NCT01544595|76191758|FG002|Status at Week 68|Protocol Violation|1|||
42165347|NCT00384293|75972953|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
42165348|NCT00384293|75972954|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
42281635|NCT02292706|76113210|FG006|Overall Study|Subject terminated by sponsor|0|||
42281636|NCT02292706|76113211|FG007|Overall Study|Subject terminated by sponsor|0|||
42281637|NCT02292706|76113204|FG000|Overall Study|Missing|0|||
42281638|NCT02292706|76113205|FG001|Overall Study|Missing|0|||
42281639|NCT02292706|76113206|FG002|Overall Study|Missing|1|||
42351811|NCT01544595|76191759|FG003|Status at Week 68|Protocol Violation|1|||
42165349|NCT00384293|75972955|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
42165350|NCT00384293|75972953|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
42165351|NCT00384293|75972954|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
42165352|NCT00384293|75972955|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
42165353|NCT00384293|75972953|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
42165354|NCT00384293|75972954|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
42165355|NCT00384293|75972955|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
42165356|NCT00384293|75972953|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
42165357|NCT00384293|75972954|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
42165358|NCT00384293|75972955|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
42165359|NCT00384293|75972953|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
42165360|NCT00384293|75972954|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
42165361|NCT00384293|75972955|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
42165362|NCT00384293|75972953|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
42165363|NCT00384293|75972954|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
42165364|NCT00384293|75972955|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
42165365|NCT00384293|75972953|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
42165366|NCT00384293|75972954|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
42165367|NCT00384293|75972955|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
42165368|NCT00384293|75972953|FG000|Post-randomization Period|Adverse Event|0|||
42165369|NCT00384293|75972954|FG001|Post-randomization Period|Adverse Event|23|||
42165370|NCT00384293|75972955|FG002|Post-randomization Period|Adverse Event|7|||
42165371|NCT00384293|75972953|FG000|Post-randomization Period|Lost to Follow-up|0|||
42165372|NCT00384293|75972954|FG001|Post-randomization Period|Lost to Follow-up|2|||
42165373|NCT00384293|75972955|FG002|Post-randomization Period|Lost to Follow-up|1|||
42165374|NCT00384293|75972953|FG000|Post-randomization Period|Protocol Violation|0|||
42165375|NCT00384293|75972954|FG001|Post-randomization Period|Protocol Violation|1|||
42165376|NCT00384293|75972955|FG002|Post-randomization Period|Protocol Violation|0|||
42165377|NCT00384293|75972953|FG000|Post-randomization Period|Withdrawal by Subject|0|||
42165378|NCT00384293|75972954|FG001|Post-randomization Period|Withdrawal by Subject|8|||
42165379|NCT00384293|75972955|FG002|Post-randomization Period|Withdrawal by Subject|6|||
42165380|NCT00384293|75972953|FG000|Post-randomization Period|Trial Termination|0|||
42165381|NCT00384293|75972954|FG001|Post-randomization Period|Trial Termination|180|||
42165382|NCT00384293|75972955|FG002|Post-randomization Period|Trial Termination|204|||
42165383|NCT00384293|75972953|FG000|Post-randomization Period|Patient Randomized in Error|0|||
42165384|NCT00384293|75972954|FG001|Post-randomization Period|Patient Randomized in Error|0|||
42165385|NCT00384293|75972955|FG002|Post-randomization Period|Patient Randomized in Error|1|||
42165386|NCT00067002|75972965|FG000|Overall Study|Early Death|1|||
42165387|NCT00067002|75972966|FG001|Overall Study|Early Death|2|||
42165388|NCT00067002|75972965|FG000|Overall Study|Delayed|1|||
42165389|NCT00067002|75972966|FG001|Overall Study|Delayed|1|||
42165390|NCT00067002|75972965|FG000|Overall Study|Graft Failure|5|||
42165391|NCT00067002|75972966|FG001|Overall Study|Graft Failure|6|||
42165392|NCT00091572|75972974|FG000|Overall Study|Lost to Follow-up|1|||
42165393|NCT00091572|75972975|FG001|Overall Study|Lost to Follow-up|1|||
42165394|NCT00091572|75972974|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
42165395|NCT00091572|75972975|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
42165396|NCT00091572|75972974|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
42165397|NCT00091572|75972975|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
42165398|NCT00091572|75972974|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
42281640|NCT02292706|76113207|FG003|Overall Study|Missing|1|||
42281641|NCT02292706|76113208|FG004|Overall Study|Missing|0|||
42281642|NCT02292706|76113209|FG005|Overall Study|Missing|1|||
42281643|NCT02292706|76113210|FG006|Overall Study|Missing|0|||
42281644|NCT02292706|76113211|FG007|Overall Study|Missing|0|||
42281645|NCT02292706|76113204|FG000|Overall Study|Virologic relapse or reinfection|1|||
42281646|NCT02292706|76113205|FG001|Overall Study|Virologic relapse or reinfection|0|||
42281647|NCT02292706|76113206|FG002|Overall Study|Virologic relapse or reinfection|0|||
42281648|NCT02292706|76113207|FG003|Overall Study|Virologic relapse or reinfection|1|||
42281649|NCT02292706|76113208|FG004|Overall Study|Virologic relapse or reinfection|0|||
42281650|NCT02292706|76113209|FG005|Overall Study|Virologic relapse or reinfection|1|||
42281651|NCT02292706|76113210|FG006|Overall Study|Virologic relapse or reinfection|0|||
42165399|NCT00091572|75972975|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
42165400|NCT00091572|75972974|FG000|Overall Study|Other Reason|6|||
42165401|NCT00091572|75972975|FG001|Overall Study|Other Reason|13|||
42165402|NCT00091572|75972974|FG000|Overall Study|Ongoing (still on treatment)|8|||
42165403|NCT00091572|75972975|FG001|Overall Study|Ongoing (still on treatment)|12|||
42165404|NCT00091572|75972974|FG000|Overall Study|Major Protocol Violation|2|||
42165405|NCT00091572|75972975|FG001|Overall Study|Major Protocol Violation|0|||
42165406|NCT00091572|75972974|FG000|Overall Study|Toxicity (Related AE)|53|||
42165407|NCT00091572|75972975|FG001|Overall Study|Toxicity (Related AE)|9|||
42165408|NCT00084266|75972983|FG000|Overall Study|Death|42|||
42014220|NCT01292603|75821374|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
42165409|NCT00084266|75972984|FG001|Overall Study|Death|39|||
42165410|NCT00084266|75972983|FG000|Overall Study|Adverse Event|8|||
42165411|NCT00084266|75972984|FG001|Overall Study|Adverse Event|5|||
42165412|NCT00084266|75972983|FG000|Overall Study|Lack of Efficacy|2|||
42165413|NCT00084266|75972984|FG001|Overall Study|Lack of Efficacy|4|||
42014221|NCT01292603|75821369|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
42165414|NCT00084266|75972983|FG000|Overall Study|Lost to Follow-up|5|||
42165415|NCT00084266|75972984|FG001|Overall Study|Lost to Follow-up|3|||
42165416|NCT00084266|75972983|FG000|Overall Study|Participant not willing to participate|3|||
42165417|NCT00084266|75972984|FG001|Overall Study|Participant not willing to participate|8|||
42165418|NCT00084266|75972983|FG000|Overall Study|Other|360|||
42165419|NCT00084266|75972984|FG001|Overall Study|Other|344|||
42165420|NCT00084266|75972983|FG000|Overall Study|Randomized not treated|21|||
42165421|NCT00084266|75972984|FG001|Overall Study|Randomized not treated|20|||
42165422|NCT00091026|75972992|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
42165423|NCT00091026|75972993|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
42165424|NCT00091026|75972992|FG000|Overall Study|Patient withdrew and never received trea|0|||
42165425|NCT00091026|75972993|FG001|Overall Study|Patient withdrew and never received trea|2|||
42165426|NCT00091026|75972992|FG000|Overall Study|Unknown-never received treatment|0|||
42165427|NCT00091026|75972993|FG001|Overall Study|Unknown-never received treatment|1|||
42165428|NCT00116558|75973002|FG000|Overall Study|Death|11|||
42165429|NCT00116558|75973003|FG001|Overall Study|Death|5|||
42165430|NCT00116558|75973004|FG002|Overall Study|Death|3|||
42165431|NCT00116558|75973002|FG000|Overall Study|Withdrawal by Subject|17|||
42165432|NCT00116558|75973003|FG001|Overall Study|Withdrawal by Subject|3|||
42165433|NCT00116558|75973004|FG002|Overall Study|Withdrawal by Subject|12|||
42165434|NCT00116558|75973002|FG000|Overall Study|disease progression|3|||
42165435|NCT00116558|75973003|FG001|Overall Study|disease progression|7|||
42165436|NCT00116558|75973004|FG002|Overall Study|disease progression|18|||
42165437|NCT00116168|75973015|FG000|Overall Study|Lost to Follow-up|6|||
42165438|NCT00116168|75973016|FG001|Overall Study|Lost to Follow-up|5|||
42165439|NCT00116168|75973017|FG002|Overall Study|Lost to Follow-up|0|||
42165440|NCT00116168|75973018|FG003|Overall Study|Lost to Follow-up|0|||
42165441|NCT00115934|75973030|FG000|Overall Study|Lost to Follow-up|1|||
42165442|NCT00115934|75973031|FG001|Overall Study|Lost to Follow-up|0|||
42165443|NCT00115934|75973030|FG000|Overall Study|Did not receive intervention|3|||
42165444|NCT00115934|75973031|FG001|Overall Study|Did not receive intervention|2|||
42165445|NCT00115778|75973037|FG000|Overall Study|Withdrawal by Subject|0|||
42165446|NCT00115778|75973038|FG001|Overall Study|Withdrawal by Subject|1|||
42165447|NCT00100178|75973047|FG000|Overall Study|Lost to Follow-up|0|||
42165448|NCT00100178|75973048|FG001|Overall Study|Lost to Follow-up|6|||
42165449|NCT00100178|75973049|FG002|Overall Study|Lost to Follow-up|5|||
42165450|NCT00100178|75973047|FG000|Overall Study|Adverse Event|2|||
42165451|NCT00100178|75973048|FG001|Overall Study|Adverse Event|2|||
42165452|NCT00100178|75973049|FG002|Overall Study|Adverse Event|1|||
42165453|NCT00100178|75973047|FG000|Overall Study|Withdrawal by Subject|1|||
42165454|NCT00100178|75973048|FG001|Overall Study|Withdrawal by Subject|1|||
42165455|NCT00100178|75973049|FG002|Overall Study|Withdrawal by Subject|1|||
42165456|NCT00100178|75973047|FG000|Overall Study|Physician Decision|6|||
42165457|NCT00100178|75973048|FG001|Overall Study|Physician Decision|1|||
42281652|NCT02292706|76113211|FG007|Overall Study|Virologic relapse or reinfection|0|||
42281653|NCT01930539|76113235|FG000|Overall Study|Withdrawal by Subject|2|||
42281654|NCT01930539|76113236|FG001|Overall Study|Withdrawal by Subject|2|||
42281655|NCT01459068|76113244|FG000|Overall Study|Withdrawal by Subject|8|||
42281656|NCT01459068|76113245|FG001|Overall Study|Withdrawal by Subject|18|||
42281657|NCT01459068|76113244|FG000|Overall Study|Lost to Follow-up|31|||
42281658|NCT01459068|76113245|FG001|Overall Study|Lost to Follow-up|15|||
42165458|NCT00100178|75973049|FG002|Overall Study|Physician Decision|3|||
42165459|NCT00099632|75973063|FG000|Overall Study|Lost to Follow-up|1|||
42281659|NCT01459068|76113244|FG000|Overall Study|Death|0|||
42281660|NCT01459068|76113245|FG001|Overall Study|Death|1|||
42281661|NCT01216202|76113253|FG000|Overall Study|Withdrawal by Subject|8|||
42165460|NCT00099632|75973064|FG001|Overall Study|Lost to Follow-up|0|||
42165461|NCT00099632|75973065|FG002|Overall Study|Lost to Follow-up|3|||
42165462|NCT00099632|75973066|FG003|Overall Study|Lost to Follow-up|1|||
42165463|NCT00099632|75973067|FG004|Overall Study|Lost to Follow-up|1|||
42165464|NCT00099632|75973068|FG005|Overall Study|Lost to Follow-up|0|||
42165465|NCT00099632|75973063|FG000|Overall Study|Withdrawal by Subject|0|||
42165466|NCT00099632|75973064|FG001|Overall Study|Withdrawal by Subject|1|||
42165467|NCT00099632|75973065|FG002|Overall Study|Withdrawal by Subject|0|||
42165468|NCT00099632|75973066|FG003|Overall Study|Withdrawal by Subject|0|||
42165469|NCT00099632|75973067|FG004|Overall Study|Withdrawal by Subject|0|||
42165470|NCT00099632|75973068|FG005|Overall Study|Withdrawal by Subject|1|||
42165471|NCT00099632|75973063|FG000|Overall Study|Protocol Violation|0|||
42165472|NCT00099632|75973064|FG001|Overall Study|Protocol Violation|0|||
42165473|NCT00099632|75973065|FG002|Overall Study|Protocol Violation|0|||
42165474|NCT00099632|75973066|FG003|Overall Study|Protocol Violation|0|||
42165475|NCT00099632|75973067|FG004|Overall Study|Protocol Violation|0|||
42165476|NCT00099632|75973068|FG005|Overall Study|Protocol Violation|1|||
42165477|NCT00098774|75973082|FG000|Overall Study|Adverse Event|2|||
42165478|NCT00098774|75973082|FG000|Overall Study|Disease Progression|9|||
42165479|NCT00098774|75973082|FG000|Overall Study|Withdrawal by Subject|1|||
42165480|NCT00098774|75973082|FG000|Overall Study|Failed (to respond) during induction|4|||
42165481|NCT00098774|75973082|FG000|Overall Study|Physician Decision|2|||
42165482|NCT00384059|75973088|FG000|Infant Series|Not consented|2|||
42165483|NCT00384059|75973089|FG001|Infant Series|Not consented|6|||
42165484|NCT00384059|75973088|FG000|Infant Series|Withdrawal by Subject|2|||
42165485|NCT00384059|75973089|FG001|Infant Series|Withdrawal by Subject|2|||
42165486|NCT00384059|75973088|FG000|Infant Series|Adverse Event|1|||
42165487|NCT00384059|75973089|FG001|Infant Series|Adverse Event|2|||
42165488|NCT00384059|75973088|FG000|Infant Series|Protocol Violation|1|||
42165489|NCT00384059|75973089|FG001|Infant Series|Protocol Violation|2|||
42165490|NCT00384059|75973088|FG000|Infant Series|Lost to Follow-up|0|||
42165491|NCT00384059|75973089|FG001|Infant Series|Lost to Follow-up|1|||
42165492|NCT00384059|75973088|FG000|After Infant Series|Protocol Violation|2|||
42165493|NCT00384059|75973089|FG001|After Infant Series|Protocol Violation|3|||
42165494|NCT00384059|75973088|FG000|After Infant Series|Withdrawal by Subject|2|||
42165495|NCT00384059|75973089|FG001|After Infant Series|Withdrawal by Subject|2|||
42165496|NCT00384059|75973088|FG000|After Infant Series|Failed to Return|0|||
42165497|NCT00384059|75973089|FG001|After Infant Series|Failed to Return|2|||
42165498|NCT00384059|75973088|FG000|After Infant Series|Adverse Event|0|||
42165499|NCT00384059|75973089|FG001|After Infant Series|Adverse Event|1|||
42165500|NCT00384059|75973088|FG000|After Infant Series|Physician Decision|0|||
42165501|NCT00384059|75973089|FG001|After Infant Series|Physician Decision|1|||
42165502|NCT00384059|75973088|FG000|After Infant Series|Lost to Follow-up|0|||
42165503|NCT00384059|75973089|FG001|After Infant Series|Lost to Follow-up|1|||
42165504|NCT00384059|75973088|FG000|Toddler Dose|Lost to Follow-up|1|||
42165505|NCT00384059|75973089|FG001|Toddler Dose|Lost to Follow-up|1|||
42165506|NCT00384059|75973088|FG000|Toddler Dose|Failed to return|0|||
42165507|NCT00384059|75973089|FG001|Toddler Dose|Failed to return|1|||
42165508|NCT00383123|75973118|FG000|Overall Study|Adverse Event|1|||
42165509|NCT00383123|75973119|FG001|Overall Study|Adverse Event|0|||
42165510|NCT00383123|75973118|FG000|Overall Study|Lost to Follow-up|68|||
42165511|NCT00383123|75973119|FG001|Overall Study|Lost to Follow-up|61|||
42165512|NCT00383123|75973118|FG000|Overall Study|Protocol Violation|5|||
42165513|NCT00383123|75973119|FG001|Overall Study|Protocol Violation|1|||
42165514|NCT00383123|75973118|FG000|Overall Study|Withdrawal by Subject|27|||
42165515|NCT00383123|75973119|FG001|Overall Study|Withdrawal by Subject|18|||
42165516|NCT00383123|75973118|FG000|Overall Study|Other reason|10|||
42165517|NCT00383123|75973119|FG001|Overall Study|Other reason|6|||
42165518|NCT00382967|75973127|FG000|Overall Study|Protocol Violation|1|||
42165519|NCT00382967|75973128|FG001|Overall Study|Protocol Violation|1|||
42165520|NCT00858364|75973136|FG000|Overall Study|Administrative Decision|3|||
42165521|NCT00858364|75973137|FG001|Overall Study|Administrative Decision|2|||
42165522|NCT00858364|75973136|FG000|Overall Study|Adverse Event|5|||
42165523|NCT00858364|75973137|FG001|Overall Study|Adverse Event|2|||
42165524|NCT00858364|75973136|FG000|Overall Study|Withdrawal by Subject|44|||
42165525|NCT00858364|75973137|FG001|Overall Study|Withdrawal by Subject|118|||
42165526|NCT00858364|75973136|FG000|Overall Study|Ineligibility Determined|1|||
42165527|NCT00858364|75973137|FG001|Overall Study|Ineligibility Determined|10|||
42165528|NCT00858364|75973136|FG000|Overall Study|Lost to Follow-up|24|||
42165529|NCT00858364|75973137|FG001|Overall Study|Lost to Follow-up|54|||
42165530|NCT00858364|75973136|FG000|Overall Study|Noncompliance|3|||
42165531|NCT00858364|75973137|FG001|Overall Study|Noncompliance|4|||
42165532|NCT00858364|75973136|FG000|Overall Study|Protocol Deviation|0|||
42165533|NCT00858364|75973137|FG001|Overall Study|Protocol Deviation|2|||
42165534|NCT00858364|75973136|FG000|Overall Study|Other|9|||
42165535|NCT00858364|75973137|FG001|Overall Study|Other|17|||
42165536|NCT00858364|75973136|FG000|Overall Study|Missing|1|||
42165537|NCT00858364|75973137|FG001|Overall Study|Missing|1|||
42165538|NCT00858364|75973136|FG000|Overall Study|Still on-study|114|||
42165539|NCT00858364|75973137|FG001|Overall Study|Still on-study|247|||
42165540|NCT00382733|75973143|FG000|Overall Study|Withdrawal by Subject|0|||
42165541|NCT00382733|75973144|FG001|Overall Study|Withdrawal by Subject|1|||
42165542|NCT00382733|75973145|FG002|Overall Study|Withdrawal by Subject|0|||
42165543|NCT00382733|75973146|FG003|Overall Study|Withdrawal by Subject|0|||
42165544|NCT00382733|75973147|FG004|Overall Study|Withdrawal by Subject|0|||
42165545|NCT03631732|75973162|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
42165546|NCT03631732|75973163|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
42165547|NCT03631732|75973162|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
42165548|NCT03631732|75973163|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
42165549|NCT03631732|75973162|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
42165550|NCT03631732|75973163|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
42165551|NCT03631732|75973162|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
42165552|NCT03631732|75973163|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
42165553|NCT03631732|75973162|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
42165554|NCT03631732|75973163|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
42165555|NCT03631732|75973162|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
42165556|NCT03631732|75973163|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
42165557|NCT03631732|75973162|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
42165558|NCT03631732|75973163|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
42165559|NCT03631732|75973162|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
42165560|NCT03631732|75973163|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
42165561|NCT03631732|75973162|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
42165562|NCT03631732|75973163|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
42165563|NCT03631732|75973162|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
42165564|NCT03631732|75973163|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
42165565|NCT03630016|75973173|FG000|Overall Study|Poor Sensor Placement|1|||
42165566|NCT03628924|75973180|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
42165567|NCT03628924|75973181|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
42165568|NCT03628924|75973182|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
42165569|NCT03628924|75973183|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
42165570|NCT03628924|75973184|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
42165571|NCT03628924|75973185|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
42165572|NCT03628924|75973186|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
42165573|NCT03628924|75973180|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
42165574|NCT03628924|75973181|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
42165575|NCT03628924|75973182|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
42165576|NCT03628924|75973183|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
42165577|NCT03628924|75973184|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
42165578|NCT03628924|75973185|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
42165579|NCT03628924|75973186|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
42165580|NCT03628924|75973180|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
42165581|NCT03628924|75973181|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
42165582|NCT03628924|75973182|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
42165583|NCT03628924|75973183|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
42165584|NCT03628924|75973184|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
42014222|NCT01292603|75821370|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
42014223|NCT01292603|75821371|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
42014224|NCT01292603|75821372|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
42014225|NCT01292603|75821373|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
42014226|NCT01292603|75821374|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
42014227|NCT01292603|75821369|FG000|Part 2: Regular Follow-Up|Death|0|||
42014228|NCT01292603|75821370|FG001|Part 2: Regular Follow-Up|Death|0|||
42014229|NCT01292603|75821371|FG002|Part 2: Regular Follow-Up|Death|0|||
42014230|NCT01292603|75821372|FG003|Part 2: Regular Follow-Up|Death|0|||
42014231|NCT01292603|75821373|FG004|Part 2: Regular Follow-Up|Death|6|||
42014232|NCT01292603|75821374|FG005|Part 2: Regular Follow-Up|Death|3|||
42040601|NCT01796171|75848716|FG010|Treatment Period With Betalutin|Physician Decision|5|||
42014233|NCT01292603|75821369|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
42040602|NCT01796171|75848717|FG011|Treatment Period With Betalutin|Physician Decision|1|||
42165585|NCT03628924|75973185|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
42165586|NCT03628924|75973186|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
42165587|NCT03628924|75973180|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
42165588|NCT03628924|75973181|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
42165589|NCT03628924|75973182|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
42165590|NCT03628924|75973183|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
42165591|NCT03628924|75973184|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
42165592|NCT03628924|75973185|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
42165593|NCT03628924|75973186|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
42165594|NCT03628924|75973180|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
42165595|NCT03628924|75973181|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
42165596|NCT03628924|75973182|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
42165597|NCT03628924|75973183|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
42165598|NCT03628924|75973184|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
42165599|NCT03628924|75973185|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
42165600|NCT03628924|75973186|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
42165601|NCT03628924|75973180|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
42165602|NCT03628924|75973181|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
42165603|NCT03628924|75973182|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
42165604|NCT03628924|75973183|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
42165605|NCT03628924|75973184|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
42165606|NCT03628924|75973185|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
42165607|NCT03628924|75973186|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
42165608|NCT03628924|75973180|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
42165609|NCT03628924|75973181|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
42165610|NCT03628924|75973182|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
42165611|NCT03628924|75973183|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
42165612|NCT03628924|75973184|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
42165613|NCT03628924|75973185|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
42165614|NCT03628924|75973186|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
42165615|NCT03628924|75973180|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
42165616|NCT03628924|75973181|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
42165617|NCT03628924|75973182|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
42165618|NCT03628924|75973183|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
42165619|NCT03628924|75973184|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
42165620|NCT03628924|75973185|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
42165621|NCT03628924|75973186|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
42165622|NCT03628924|75973180|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
42165623|NCT03628924|75973181|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
42165624|NCT03628924|75973182|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
42165625|NCT03628924|75973183|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
42165626|NCT03628924|75973184|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
42165627|NCT03628924|75973185|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
42165628|NCT03628924|75973186|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
42165629|NCT03628924|75973180|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
42165630|NCT03628924|75973181|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
42165631|NCT03628924|75973182|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
42165632|NCT03628924|75973183|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
42165633|NCT03628924|75973184|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
42165634|NCT03628924|75973185|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
42165635|NCT03628924|75973186|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
42165636|NCT03627832|75973200|FG000|Overall Study|Withdrawal by Subject|10|||
42281662|NCT01216202|76113254|FG001|Overall Study|Withdrawal by Subject|0|||
42281663|NCT01216202|76113253|FG000|Overall Study|Death|0|||
42281664|NCT01216202|76113254|FG001|Overall Study|Death|2|||
42281665|NCT01216202|76113253|FG000|Overall Study|Lost to Follow-up|14|||
42281666|NCT01216202|76113254|FG001|Overall Study|Lost to Follow-up|0|||
42281667|NCT01186016|76113264|FG000|Overall Study|Withdrawal by Subject|46|||
42281668|NCT01186016|76113265|FG001|Overall Study|Withdrawal by Subject|29|||
42281669|NCT01113749|76113273|FG000|Overall Study|Lost to Follow-up|1|||
42281670|NCT01113749|76113274|FG001|Overall Study|Lost to Follow-up|2|||
42281671|NCT01060384|76113280|FG000|Overall Study|Withdrawal by Subject|0|||
42281672|NCT01060384|76113281|FG001|Overall Study|Withdrawal by Subject|1|||
42351812|NCT01544595|76191760|FG004|Status at Week 68|Protocol Violation|0|||
42351813|NCT01544595|76191761|FG005|Status at Week 68|Protocol Violation|0|||
42014234|NCT01292603|75821370|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
42165637|NCT03627832|75973201|FG001|Overall Study|Withdrawal by Subject|1|||
42165638|NCT00112437|75973212|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
42165639|NCT00112437|75973213|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
42165640|NCT00112437|75973214|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
42165641|NCT00112437|75973215|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
42165642|NCT00112437|75973216|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
42165643|NCT00112437|75973217|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165644|NCT00112437|75973218|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165645|NCT00112437|75973219|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165646|NCT00112437|75973220|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165647|NCT00112437|75973221|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165648|NCT00112437|75973222|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165649|NCT00112437|75973223|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165650|NCT00112437|75973224|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165651|NCT00112437|75973225|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165652|NCT00112437|75973226|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165653|NCT00112437|75973227|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165654|NCT00112437|75973228|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165655|NCT00112437|75973229|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165656|NCT00112437|75973230|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165657|NCT00112437|75973231|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165658|NCT00112437|75973232|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165659|NCT00112437|75973233|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165660|NCT00112437|75973234|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165661|NCT00112437|75973235|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165662|NCT00112437|75973236|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165663|NCT00112437|75973237|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
42165664|NCT00112437|75973212|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165665|NCT00112437|75973213|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
42165666|NCT00112437|75973214|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165667|NCT00112437|75973215|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165668|NCT00112437|75973216|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165669|NCT00112437|75973217|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165670|NCT00112437|75973218|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165671|NCT00112437|75973219|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165672|NCT00112437|75973220|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165673|NCT00112437|75973221|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165674|NCT00112437|75973222|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165675|NCT00112437|75973223|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165676|NCT00112437|75973224|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42281673|NCT01060384|76113282|FG002|Overall Study|Withdrawal by Subject|0|||
42281674|NCT01060384|76113283|FG003|Overall Study|Withdrawal by Subject|0|||
42281675|NCT01060384|76113284|FG004|Overall Study|Withdrawal by Subject|0|||
42281676|NCT01060384|76113280|FG000|Overall Study|Death|0|||
42281677|NCT01060384|76113281|FG001|Overall Study|Death|0|||
42281678|NCT01060384|76113282|FG002|Overall Study|Death|0|||
42281679|NCT01060384|76113283|FG003|Overall Study|Death|0|||
42281680|NCT01060384|76113284|FG004|Overall Study|Death|1|||
42281681|NCT01060384|76113280|FG000|Overall Study|Intercurrent illness|0|||
42281682|NCT01060384|76113281|FG001|Overall Study|Intercurrent illness|0|||
42281683|NCT01060384|76113282|FG002|Overall Study|Intercurrent illness|0|||
42165677|NCT00112437|75973225|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165678|NCT00112437|75973226|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165679|NCT00112437|75973227|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42281684|NCT01060384|76113283|FG003|Overall Study|Intercurrent illness|0|||
42281685|NCT01060384|76113284|FG004|Overall Study|Intercurrent illness|1|||
42014235|NCT01292603|75821371|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
42014236|NCT01292603|75821372|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
42165680|NCT00112437|75973228|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165681|NCT00112437|75973229|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165682|NCT00112437|75973230|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165683|NCT00112437|75973231|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165684|NCT00112437|75973232|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165685|NCT00112437|75973233|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165686|NCT00112437|75973234|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165687|NCT00112437|75973235|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165688|NCT00112437|75973236|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42281686|NCT00580047|76113307|FG000|Overall Study|Lost to Follow-up|1|||
42281687|NCT00580047|76113308|FG001|Overall Study|Lost to Follow-up|1|||
42281688|NCT00580047|76113309|FG002|Overall Study|Lost to Follow-up|0|||
42281689|NCT00580047|76113307|FG000|Overall Study|Withdrawal by Subject|1|||
42281690|NCT00580047|76113308|FG001|Overall Study|Withdrawal by Subject|1|||
42281691|NCT00580047|76113309|FG002|Overall Study|Withdrawal by Subject|2|||
42281692|NCT00580047|76113307|FG000|Overall Study|Withdrawal by Subject|1|||
42281693|NCT00580047|76113308|FG001|Overall Study|Withdrawal by Subject|0|||
42281694|NCT00580047|76113309|FG002|Overall Study|Withdrawal by Subject|0|||
42281695|NCT00561340|76113322|FG000|Overall Study|refused to drink pediasure|6|||
42281696|NCT00561340|76113323|FG001|Overall Study|refused to drink pediasure|0|||
42281697|NCT00292045|76113329|FG000|Core Study (Through Week 13)|Adverse Event|1|||
42281698|NCT00292045|76113329|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
42281699|NCT00084799|76113335|FG000|Overall Study|Disease Progression|1|||
42281700|NCT00084799|76113336|FG001|Overall Study|Disease Progression|0|||
42281701|NCT00072410|76113344|FG000|Overall Study|Progressive disease|0|||
42281702|NCT00072410|76113345|FG001|Overall Study|Progressive disease|3|||
42281703|NCT00066729|76113351|FG000|Overall Study|Lost to Follow-up|1|||
42281704|NCT00066729|76113351|FG000|Overall Study|Disease progression|1|||
42281705|NCT00006046|76113369|FG000|Overall Study|Adverse Event|3|||
42281706|NCT00006046|76113370|FG001|Overall Study|Adverse Event|0|||
42281707|NCT00006046|76113371|FG002|Overall Study|Adverse Event|0|||
42281708|NCT00006046|76113372|FG003|Overall Study|Adverse Event|0|||
42281709|NCT00006046|76113373|FG004|Overall Study|Adverse Event|0|||
42281710|NCT00006046|76113369|FG000|Overall Study|Disease Progression|2|||
42281711|NCT00006046|76113370|FG001|Overall Study|Disease Progression|0|||
42281712|NCT00006046|76113371|FG002|Overall Study|Disease Progression|0|||
42281713|NCT00006046|76113372|FG003|Overall Study|Disease Progression|0|||
42281714|NCT00006046|76113373|FG004|Overall Study|Disease Progression|0|||
42281715|NCT00003102|76113388|FG000|Overall Study|Physician Decision|1|||
42281716|NCT00003102|76113389|FG001|Overall Study|Physician Decision|1|||
42281717|NCT00003102|76113390|FG002|Overall Study|Physician Decision|0|||
42281718|NCT00003102|76113388|FG000|Overall Study|Progressive Disease|0|||
42281719|NCT00003102|76113389|FG001|Overall Study|Progressive Disease|1|||
42281720|NCT00003102|76113390|FG002|Overall Study|Progressive Disease|0|||
42281721|NCT00003102|76113388|FG000|Overall Study|Adverse Event|0|||
42281722|NCT00003102|76113389|FG001|Overall Study|Adverse Event|1|||
42281723|NCT00003102|76113390|FG002|Overall Study|Adverse Event|1|||
42281724|NCT00003102|76113388|FG000|Overall Study|Death|0|||
42281725|NCT00003102|76113389|FG001|Overall Study|Death|0|||
42281726|NCT00003102|76113390|FG002|Overall Study|Death|1|||
42281727|NCT01673373|76113398|FG000|Overall Study|Death|2|||
42281728|NCT01236547|76113407|FG000|Overall Study|Protocol Violation|0|||
42281729|NCT01236547|76113408|FG001|Overall Study|Protocol Violation|1|||
42281730|NCT01236547|76113409|FG002|Overall Study|Protocol Violation|1|||
42281731|NCT01236547|76113410|FG003|Overall Study|Protocol Violation|6|||
42281732|NCT01236547|76113411|FG004|Overall Study|Protocol Violation|12|||
42281733|NCT02167945|76113424|FG000|Overall Study|Adverse Event|16|||
42014237|NCT01292603|75821373|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
42165689|NCT00112437|75973237|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
42165690|NCT00112437|75973212|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165691|NCT00112437|75973213|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
42165692|NCT00112437|75973214|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165693|NCT00112437|75973215|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165694|NCT00112437|75973216|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165695|NCT00112437|75973217|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165696|NCT00112437|75973218|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165697|NCT00112437|75973219|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165698|NCT00112437|75973220|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165699|NCT00112437|75973221|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165700|NCT00112437|75973222|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165701|NCT00112437|75973223|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165702|NCT00112437|75973224|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165703|NCT00112437|75973225|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165704|NCT00112437|75973226|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165705|NCT00112437|75973227|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165706|NCT00112437|75973228|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165707|NCT00112437|75973229|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42281734|NCT02167945|76113424|FG000|Overall Study|Withdrew Consent|42|||
42281735|NCT02167945|76113424|FG000|Overall Study|Lost to Follow-up|122|||
42281736|NCT02167945|76113424|FG000|Overall Study|COVID-19 logistical restrictions|6|||
42165708|NCT00112437|75973230|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165709|NCT00112437|75973231|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42281737|NCT02167945|76113424|FG000|Overall Study|Other, not specified|63|||
42281738|NCT01375075|76113442|FG000|Overall Study|Adverse Event|0|||
42281739|NCT01375075|76113443|FG001|Overall Study|Adverse Event|0|||
42281740|NCT01375075|76113444|FG002|Overall Study|Adverse Event|3|||
42281741|NCT01375075|76113445|FG003|Overall Study|Adverse Event|1|||
42281742|NCT01375075|76113446|FG004|Overall Study|Adverse Event|0|||
42281743|NCT01375075|76113447|FG005|Overall Study|Adverse Event|1|||
42281744|NCT01375075|76113442|FG000|Overall Study|Entry Criterion Not Met|1|||
42281745|NCT01375075|76113443|FG001|Overall Study|Entry Criterion Not Met|0|||
42281746|NCT01375075|76113444|FG002|Overall Study|Entry Criterion Not Met|0|||
42281747|NCT01375075|76113445|FG003|Overall Study|Entry Criterion Not Met|0|||
42281748|NCT01375075|76113446|FG004|Overall Study|Entry Criterion Not Met|0|||
42281749|NCT01375075|76113447|FG005|Overall Study|Entry Criterion Not Met|1|||
42281750|NCT01375075|76113442|FG000|Overall Study|Withdrawal by Subject|0|||
42281751|NCT01375075|76113443|FG001|Overall Study|Withdrawal by Subject|1|||
42281752|NCT01375075|76113444|FG002|Overall Study|Withdrawal by Subject|0|||
42281753|NCT01375075|76113445|FG003|Overall Study|Withdrawal by Subject|0|||
42281754|NCT01375075|76113446|FG004|Overall Study|Withdrawal by Subject|0|||
42281755|NCT01375075|76113447|FG005|Overall Study|Withdrawal by Subject|1|||
42281756|NCT00706433|76113469|FG000|Overall Study|Lost to Follow-up|3|||
42281757|NCT00706433|76113470|FG001|Overall Study|Lost to Follow-up|1|||
42281758|NCT00706433|76113471|FG002|Overall Study|Lost to Follow-up|6|||
42281759|NCT00706433|76113472|FG003|Overall Study|Lost to Follow-up|0|||
42281760|NCT00706433|76113469|FG000|Overall Study|Withdrawal by Subject|1|||
42281761|NCT00706433|76113470|FG001|Overall Study|Withdrawal by Subject|2|||
42281762|NCT00706433|76113471|FG002|Overall Study|Withdrawal by Subject|3|||
42281763|NCT00706433|76113472|FG003|Overall Study|Withdrawal by Subject|1|||
42281764|NCT00706433|76113469|FG000|Overall Study|Adverse Event|0|||
42281765|NCT00706433|76113470|FG001|Overall Study|Adverse Event|0|||
42281766|NCT00706433|76113471|FG002|Overall Study|Adverse Event|1|||
42281767|NCT00706433|76113472|FG003|Overall Study|Adverse Event|0|||
42281768|NCT00706433|76113469|FG000|Overall Study|Protocol Violation|1|||
42281769|NCT00706433|76113470|FG001|Overall Study|Protocol Violation|0|||
42281770|NCT00706433|76113471|FG002|Overall Study|Protocol Violation|0|||
42281771|NCT00706433|76113472|FG003|Overall Study|Protocol Violation|0|||
42281772|NCT00706433|76113469|FG000|Overall Study|new job|0|||
42281773|NCT00706433|76113470|FG001|Overall Study|new job|0|||
42281774|NCT00706433|76113471|FG002|Overall Study|new job|0|||
42281775|NCT00706433|76113472|FG003|Overall Study|new job|1|||
42281776|NCT02638623|76113484|FG000|Overall Study|Surgery timing|5|||
42281777|NCT02638623|76113485|FG001|Overall Study|Surgery timing|6|||
42281778|NCT02638623|76113484|FG000|Overall Study|Not given intervention|2|||
42281779|NCT02638623|76113485|FG001|Overall Study|Not given intervention|0|||
42281780|NCT02637141|76113494|FG000|Overall Study|Adverse Event|1|||
42281781|NCT02637141|76113495|FG001|Overall Study|Adverse Event|1|||
42281782|NCT02637141|76113496|FG002|Overall Study|Adverse Event|0|||
42281783|NCT02637141|76113494|FG000|Overall Study|Withdrawal by Subject|1|||
42281784|NCT02637141|76113495|FG001|Overall Study|Withdrawal by Subject|1|||
42281785|NCT02637141|76113496|FG002|Overall Study|Withdrawal by Subject|1|||
42281786|NCT02637063|76113507|FG000|Overall Study|Lost to Follow-up|3|||
42281787|NCT02637063|76113508|FG001|Overall Study|Lost to Follow-up|2|||
42281788|NCT02637063|76113509|FG002|Overall Study|Lost to Follow-up|3|||
42281789|NCT02637063|76113507|FG000|Overall Study|Withdrawal by Subject|2|||
42281790|NCT02637063|76113508|FG001|Overall Study|Withdrawal by Subject|2|||
42281791|NCT02637063|76113509|FG002|Overall Study|Withdrawal by Subject|3|||
42281792|NCT02635737|76113517|FG000|Overall Study|Protocol Violation|1|||
42281793|NCT02636907|76113521|FG000|Autoinjector Assessment Period|Adverse Event|2|||
42281794|NCT02636907|76113521|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
42281795|NCT02636907|76113521|FG000|Extension Phase|Adverse Event|2|||
42281796|NCT02636907|76113521|FG000|Extension Phase|Withdrawal by Subject|4|||
42281797|NCT02636907|76113521|FG000|Extension Phase|Physician Decision|1|||
42281798|NCT02636907|76113521|FG000|Extension Phase|Lost to Follow-up|2|||
42281799|NCT02636907|76113521|FG000|Extension Phase|Lack of Efficacy|1|||
42281800|NCT01374919|76113525|FG000|Overall Study|Withdrawal by Subject|2|||
42281801|NCT02726945|76113536|FG000|Overall Study|Withdrawal by Subject|0|||
42281802|NCT02726945|76113537|FG001|Overall Study|Withdrawal by Subject|0|||
42014238|NCT01292603|75821374|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
42014239|NCT01292603|75821369|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
42281803|NCT02726945|76113538|FG002|Overall Study|Withdrawal by Subject|1|||
42281804|NCT02726945|76113536|FG000|Overall Study|Elected to have total knee replacement|0|||
42281805|NCT02726945|76113537|FG001|Overall Study|Elected to have total knee replacement|1|||
42281806|NCT02726945|76113538|FG002|Overall Study|Elected to have total knee replacement|0|||
42281807|NCT02635347|76113548|FG000|Overall Study|Failed screening|20|||
42281808|NCT02635347|76113549|FG001|Overall Study|Failed screening|7|||
42281809|NCT02726399|76113569|FG000|Overall Study|Participant Non-Compliance|1|||
42281810|NCT02726399|76113569|FG000|Overall Study|Adverse Event|2|||
42281811|NCT02726399|76113569|FG000|Overall Study|Progression of disease|4|||
42281812|NCT02634801|76113576|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
42281813|NCT02634801|76113577|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
42281814|NCT02634801|76113578|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
42281815|NCT02634801|76113576|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
42281816|NCT02634801|76113577|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
42014240|NCT01292603|75821370|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
42281817|NCT02634801|76113578|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
42281818|NCT02634801|76113576|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
42281819|NCT02634801|76113577|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
42281820|NCT02634801|76113578|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
42281821|NCT02634801|76113576|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
42281822|NCT02634801|76113577|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
42281823|NCT02634801|76113578|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
42281824|NCT02634801|76113576|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
42281825|NCT02634801|76113577|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
42281826|NCT02634801|76113578|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
42281827|NCT02634801|76113576|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
42281828|NCT02634801|76113577|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
42281829|NCT02634801|76113578|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
42281830|NCT02634801|76113576|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
42281831|NCT02634801|76113577|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
42281832|NCT02634801|76113578|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
42281833|NCT02634801|76113576|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
42281834|NCT02634801|76113577|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
42281835|NCT02634801|76113578|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
42281836|NCT02634801|76113576|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
42281837|NCT02634801|76113577|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
42281838|NCT02634801|76113578|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
42281839|NCT02634801|76113576|FG000|Follow-up Period|Lost to Follow-up|3|||
42281840|NCT02634801|76113577|FG001|Follow-up Period|Lost to Follow-up|1|||
42281841|NCT02634801|76113578|FG002|Follow-up Period|Lost to Follow-up|2|||
42281842|NCT02634801|76113576|FG000|Follow-up Period|Physician Decision|0|||
42281843|NCT02634801|76113577|FG001|Follow-up Period|Physician Decision|0|||
42351814|NCT01544595|76191756|FG000|Status at Week 68|Technical problems|1|||
42165710|NCT00112437|75973232|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165711|NCT00112437|75973233|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165712|NCT00112437|75973234|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165713|NCT00112437|75973235|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165714|NCT00112437|75973236|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165715|NCT00112437|75973237|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
42165716|NCT00112437|75973212|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
42165717|NCT00112437|75973213|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165718|NCT00112437|75973214|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
42165719|NCT00112437|75973215|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
42165720|NCT00112437|75973216|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
42165721|NCT00112437|75973217|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165722|NCT00112437|75973218|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165723|NCT00112437|75973219|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165724|NCT00112437|75973220|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165725|NCT00112437|75973221|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165726|NCT00112437|75973222|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165727|NCT00112437|75973223|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165728|NCT00112437|75973224|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165729|NCT00112437|75973225|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165730|NCT00112437|75973226|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165731|NCT00112437|75973227|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165732|NCT00112437|75973228|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165733|NCT00112437|75973229|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165734|NCT00112437|75973230|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165735|NCT00112437|75973231|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165736|NCT00112437|75973232|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165737|NCT00112437|75973233|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165738|NCT00112437|75973234|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165739|NCT00112437|75973235|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165740|NCT00112437|75973236|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42165741|NCT00112437|75973237|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
42281844|NCT02634801|76113578|FG002|Follow-up Period|Physician Decision|1|||
42351815|NCT01544595|76191757|FG001|Status at Week 68|Technical problems|0|||
42351816|NCT01544595|76191758|FG002|Status at Week 68|Technical problems|0|||
42281845|NCT02634801|76113576|FG000|Follow-up Period|Withdrawal by Subject|1|||
42281846|NCT02634801|76113577|FG001|Follow-up Period|Withdrawal by Subject|2|||
42281847|NCT02634801|76113578|FG002|Follow-up Period|Withdrawal by Subject|5|||
42351817|NCT01544595|76191759|FG003|Status at Week 68|Technical problems|1|||
42165742|NCT00112437|75973212|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
42165743|NCT00112437|75973213|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
42165744|NCT00112437|75973214|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
42165745|NCT00112437|75973215|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
42165746|NCT00112437|75973216|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
42165747|NCT00112437|75973217|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165748|NCT00112437|75973218|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165749|NCT00112437|75973219|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165750|NCT00112437|75973220|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165751|NCT00112437|75973221|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165752|NCT00112437|75973222|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165753|NCT00112437|75973223|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165754|NCT00112437|75973224|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165755|NCT00112437|75973225|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165756|NCT00112437|75973226|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165757|NCT00112437|75973227|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165758|NCT00112437|75973228|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165759|NCT00112437|75973229|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165760|NCT00112437|75973230|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165761|NCT00112437|75973231|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165762|NCT00112437|75973232|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42040603|NCT01796171|75848718|FG012|Treatment Period With Betalutin|Physician Decision|1|||
42040604|NCT01796171|75848719|FG013|Treatment Period With Betalutin|Physician Decision|0|||
42040605|NCT01796171|75848720|FG014|Treatment Period With Betalutin|Physician Decision|0|||
42040606|NCT01796171|75848706|FG000|Treatment Period With Betalutin|Death|0|||
42040607|NCT01796171|75848707|FG001|Treatment Period With Betalutin|Death|0|||
42165763|NCT00112437|75973233|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165764|NCT00112437|75973234|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165765|NCT00112437|75973235|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165766|NCT00112437|75973236|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165767|NCT00112437|75973237|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
42165768|NCT00112437|75973212|FG000|Year 1 (12-Month Base Study)|moved|0|||
42165769|NCT00112437|75973213|FG001|Year 1 (12-Month Base Study)|moved|1|||
42165770|NCT00112437|75973214|FG002|Year 1 (12-Month Base Study)|moved|1|||
42165771|NCT00112437|75973215|FG003|Year 1 (12-Month Base Study)|moved|0|||
42165772|NCT00112437|75973216|FG004|Year 1 (12-Month Base Study)|moved|0|||
42165773|NCT00112437|75973217|FG005|Year 1 (12-Month Base Study)|moved|0|||
42165774|NCT00112437|75973218|FG006|Year 1 (12-Month Base Study)|moved|0|||
42165775|NCT00112437|75973219|FG007|Year 1 (12-Month Base Study)|moved|0|||
42165776|NCT00112437|75973220|FG008|Year 1 (12-Month Base Study)|moved|0|||
42165777|NCT00112437|75973221|FG009|Year 1 (12-Month Base Study)|moved|0|||
42165778|NCT00112437|75973222|FG010|Year 1 (12-Month Base Study)|moved|0|||
42165779|NCT00112437|75973223|FG011|Year 1 (12-Month Base Study)|moved|0|||
42165780|NCT00112437|75973224|FG012|Year 1 (12-Month Base Study)|moved|0|||
42165781|NCT00112437|75973225|FG013|Year 1 (12-Month Base Study)|moved|0|||
42165782|NCT00112437|75973226|FG014|Year 1 (12-Month Base Study)|moved|0|||
42165783|NCT00112437|75973227|FG015|Year 1 (12-Month Base Study)|moved|0|||
42165784|NCT00112437|75973228|FG016|Year 1 (12-Month Base Study)|moved|0|||
42165785|NCT00112437|75973229|FG017|Year 1 (12-Month Base Study)|moved|0|||
42165786|NCT00112437|75973230|FG018|Year 1 (12-Month Base Study)|moved|0|||
42165787|NCT00112437|75973231|FG019|Year 1 (12-Month Base Study)|moved|0|||
42165788|NCT00112437|75973232|FG020|Year 1 (12-Month Base Study)|moved|0|||
42165789|NCT00112437|75973233|FG021|Year 1 (12-Month Base Study)|moved|0|||
42165790|NCT00112437|75973234|FG022|Year 1 (12-Month Base Study)|moved|0|||
42165791|NCT00112437|75973235|FG023|Year 1 (12-Month Base Study)|moved|0|||
42165792|NCT00112437|75973236|FG024|Year 1 (12-Month Base Study)|moved|0|||
42165793|NCT00112437|75973237|FG025|Year 1 (12-Month Base Study)|moved|0|||
42165794|NCT00112437|75973212|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165795|NCT00112437|75973213|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165796|NCT00112437|75973214|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165797|NCT00112437|75973215|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
42165798|NCT00112437|75973216|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165799|NCT00112437|75973217|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165800|NCT00112437|75973218|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165801|NCT00112437|75973219|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165802|NCT00112437|75973220|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165803|NCT00112437|75973221|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165804|NCT00112437|75973222|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165805|NCT00112437|75973223|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165806|NCT00112437|75973224|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165807|NCT00112437|75973225|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165808|NCT00112437|75973226|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165809|NCT00112437|75973227|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42281848|NCT02634801|76113576|FG000|Follow-up Period|Adverse Event|1|||
42281849|NCT02634801|76113577|FG001|Follow-up Period|Adverse Event|5|||
42281850|NCT02634801|76113578|FG002|Follow-up Period|Adverse Event|0|||
42281851|NCT02724839|76113593|FG000|Overall Study|Withdrawal by Subject|1|||
42281852|NCT02724839|76113594|FG001|Overall Study|Withdrawal by Subject|1|||
42281853|NCT02724839|76113595|FG002|Overall Study|Withdrawal by Subject|0|||
42281854|NCT02724839|76113593|FG000|Overall Study|Lost to Follow-up|0|||
42281855|NCT02724839|76113594|FG001|Overall Study|Lost to Follow-up|3|||
42281856|NCT02724839|76113595|FG002|Overall Study|Lost to Follow-up|2|||
42281857|NCT02724839|76113593|FG000|Overall Study|Physician Decision|0|||
42281858|NCT02724839|76113594|FG001|Overall Study|Physician Decision|0|||
42281859|NCT02724839|76113595|FG002|Overall Study|Physician Decision|3|||
42281860|NCT01375751|76113613|FG000|Overall Study|Other|0|||
42351818|NCT01544595|76191760|FG004|Status at Week 68|Technical problems|0|||
42351819|NCT01544595|76191761|FG005|Status at Week 68|Technical problems|0|||
42351820|NCT01544595|76191756|FG000|Status at Week 68|Withdrawal by Subject|0|||
42014241|NCT01292603|75821371|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
42014242|NCT01292603|75821372|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
42165810|NCT00112437|75973228|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165811|NCT00112437|75973229|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165812|NCT00112437|75973230|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42281861|NCT01375751|76113614|FG001|Overall Study|Other|1|||
42281862|NCT01375751|76113615|FG002|Overall Study|Other|0|||
42281863|NCT00705575|76113625|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42281864|NCT00705575|76113626|FG001|Overall Study|Abnormal laboratory value(s)|3|||
42351821|NCT01544595|76191757|FG001|Status at Week 68|Withdrawal by Subject|1|||
42281865|NCT00705575|76113625|FG000|Overall Study|Abnormal test procedure result(s)|2|||
42281866|NCT00705575|76113626|FG001|Overall Study|Abnormal test procedure result(s)|12|||
42165813|NCT00112437|75973231|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165814|NCT00112437|75973232|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165815|NCT00112437|75973233|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165816|NCT00112437|75973234|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165817|NCT00112437|75973235|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165818|NCT00112437|75973236|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165819|NCT00112437|75973237|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
42165820|NCT00112437|75973212|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165821|NCT00112437|75973213|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165822|NCT00112437|75973214|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165823|NCT00112437|75973215|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165824|NCT00112437|75973216|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
42281867|NCT00705575|76113625|FG000|Overall Study|Adverse Event|11|||
42281868|NCT00705575|76113626|FG001|Overall Study|Adverse Event|15|||
42281869|NCT00705575|76113625|FG000|Overall Study|Lost to Follow-up|3|||
42281870|NCT00705575|76113626|FG001|Overall Study|Lost to Follow-up|4|||
42281871|NCT00705575|76113625|FG000|Overall Study|Protocol Violation|2|||
42165825|NCT00112437|75973217|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165826|NCT00112437|75973218|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165827|NCT00112437|75973219|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165828|NCT00112437|75973220|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165829|NCT00112437|75973221|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165830|NCT00112437|75973222|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165831|NCT00112437|75973223|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165832|NCT00112437|75973224|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165833|NCT00112437|75973225|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165834|NCT00112437|75973226|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165835|NCT00112437|75973227|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165836|NCT00112437|75973228|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165837|NCT00112437|75973229|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165838|NCT00112437|75973230|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165839|NCT00112437|75973231|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165840|NCT00112437|75973232|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165841|NCT00112437|75973233|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165842|NCT00112437|75973234|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165843|NCT00112437|75973235|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165844|NCT00112437|75973236|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165845|NCT00112437|75973237|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
42165846|NCT00112437|75973212|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
42165847|NCT00112437|75973213|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
42281872|NCT00705575|76113626|FG001|Overall Study|Protocol Violation|2|||
42165848|NCT00112437|75973214|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
42165849|NCT00112437|75973215|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
42165850|NCT00112437|75973216|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
42165851|NCT00112437|75973217|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
42165852|NCT00112437|75973218|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
42165853|NCT00112437|75973219|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
42165854|NCT00112437|75973220|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
42165855|NCT00112437|75973221|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
42165856|NCT00112437|75973222|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
42165857|NCT00112437|75973223|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
42165858|NCT00112437|75973224|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
42165859|NCT00112437|75973225|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
42165860|NCT00112437|75973226|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
42165861|NCT00112437|75973227|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
42165862|NCT00112437|75973228|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
42165863|NCT00112437|75973229|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
42165864|NCT00112437|75973230|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
42165865|NCT00112437|75973231|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
42165866|NCT00112437|75973232|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
42281873|NCT00705575|76113625|FG000|Overall Study|Withdrawal by Subject|5|||
42281874|NCT00705575|76113626|FG001|Overall Study|Withdrawal by Subject|10|||
42281875|NCT02636595|76113632|FG000|Overall Study|Lost to Follow-up|1|||
42281876|NCT02636595|76113632|FG000|Overall Study|Other|1|||
42281877|NCT02636361|76113636|FG000|Period 4|Physician Decision|0|||
42281878|NCT02636361|76113637|FG001|Period 4|Physician Decision|0|||
42281879|NCT02636361|76113638|FG002|Period 4|Physician Decision|0|||
42281880|NCT02636361|76113639|FG003|Period 4|Physician Decision|1|||
42281881|NCT02636361|76113640|FG004|Period 4|Physician Decision|0|||
42281882|NCT02636283|76113656|FG000|Overall Study|Adverse Event|2|||
42281883|NCT02636283|76113657|FG001|Overall Study|Adverse Event|0|||
42281884|NCT02636283|76113656|FG000|Overall Study|Trial Terminated Prematurely|0|||
42281885|NCT02636283|76113657|FG001|Overall Study|Trial Terminated Prematurely|3|||
42281886|NCT04430855|76113665|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
42281887|NCT04430855|76113666|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
42281888|NCT04430855|76113665|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
42281889|NCT04430855|76113666|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
42281890|NCT04430855|76113665|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
42281891|NCT04430855|76113666|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
42281892|NCT04430855|76113665|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
42281893|NCT04430855|76113666|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
42281894|NCT04430855|76113665|FG000|Period 1 (Weeks 1-12)|Other|0|||
42281895|NCT04430855|76113666|FG001|Period 1 (Weeks 1-12)|Other|1|||
42281896|NCT04430855|76113665|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
42281897|NCT04430855|76113666|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
42281898|NCT04430855|76113665|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
42281899|NCT04430855|76113666|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
42281900|NCT04430855|76113665|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
42281901|NCT04430855|76113666|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
42281902|NCT01375673|76113676|FG000|Overall Study|Withdrawal by Subject|0|||
42281903|NCT01375673|76113677|FG001|Overall Study|Withdrawal by Subject|1|||
42281904|NCT02723591|76113685|FG000|Overall Study|Adverse Event|48|||
42281905|NCT02723591|76113686|FG001|Overall Study|Adverse Event|40|||
42281906|NCT02723591|76113685|FG000|Overall Study|Death|2|||
42281907|NCT02723591|76113686|FG001|Overall Study|Death|2|||
42281908|NCT02723591|76113685|FG000|Overall Study|Lack of Efficacy|4|||
42281909|NCT02723591|76113686|FG001|Overall Study|Lack of Efficacy|3|||
42281910|NCT02723591|76113685|FG000|Overall Study|Lost to Follow-up|1|||
42281911|NCT02723591|76113686|FG001|Overall Study|Lost to Follow-up|7|||
42281912|NCT02723591|76113685|FG000|Overall Study|Protocol Violation|20|||
42281913|NCT02723591|76113686|FG001|Overall Study|Protocol Violation|23|||
42165867|NCT00112437|75973233|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
42165868|NCT00112437|75973234|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
42281914|NCT02723591|76113685|FG000|Overall Study|Withdrawal by Subject|4|||
42281915|NCT02723591|76113686|FG001|Overall Study|Withdrawal by Subject|8|||
42281916|NCT02723591|76113685|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
42281917|NCT02723591|76113686|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
42281918|NCT02723591|76113685|FG000|Overall Study|Miscellaneous|5|||
42281919|NCT02723591|76113686|FG001|Overall Study|Miscellaneous|6|||
42165869|NCT00112437|75973235|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
42165870|NCT00112437|75973236|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
42165871|NCT00112437|75973237|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
42165872|NCT00112437|75973212|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165873|NCT00112437|75973213|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42281920|NCT00705341|76113694|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
42281921|NCT00705341|76113695|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
42351822|NCT01544595|76191758|FG002|Status at Week 68|Withdrawal by Subject|1|||
42165874|NCT00112437|75973214|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165875|NCT00112437|75973215|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165876|NCT00112437|75973216|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165877|NCT00112437|75973217|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
42165878|NCT00112437|75973218|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
42165879|NCT00112437|75973219|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165880|NCT00112437|75973220|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165881|NCT00112437|75973221|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
42165882|NCT00112437|75973222|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165883|NCT00112437|75973223|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165884|NCT00112437|75973224|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42281922|NCT00705341|76113696|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
42281923|NCT00705341|76113697|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
42281924|NCT00705341|76113694|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
42281925|NCT00705341|76113695|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
42281926|NCT00705341|76113696|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
42281927|NCT00705341|76113697|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
42281928|NCT02723201|76113708|FG000|Second Intervention Period|Protocol Violation|1|||
42281929|NCT02723201|76113709|FG001|Second Intervention Period|Protocol Violation|0|||
42281930|NCT02723201|76113710|FG002|Second Intervention Period|Protocol Violation|0|||
42281931|NCT02723201|76113708|FG000|Second Intervention Period|Adverse Event|1|||
42281932|NCT02723201|76113709|FG001|Second Intervention Period|Adverse Event|0|||
42281933|NCT02723201|76113710|FG002|Second Intervention Period|Adverse Event|0|||
42281934|NCT03846479|76113724|FG000|Overall Study|Death|8|||
42281935|NCT03846479|76113724|FG000|Overall Study|Lost to Follow-up|1|||
42281936|NCT00705263|76113728|FG000|Overall Study|Withdrawal by Subject|2|||
42281937|NCT00704405|76113746|FG000|Overall Study (NC Population)|Adverse Event|1|||
42281938|NCT00704405|76113747|FG001|Overall Study (NC Population)|Adverse Event|0|||
42281939|NCT00704405|76113748|FG002|Overall Study (NC Population)|Adverse Event|0|||
42281940|NCT00704405|76113749|FG003|Overall Study (NC Population)|Adverse Event|0|||
42281941|NCT00704405|76113750|FG004|Overall Study (NC Population)|Adverse Event|0|||
42281942|NCT00704405|76113746|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
42281943|NCT00704405|76113747|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
42281944|NCT00704405|76113748|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
42281945|NCT00704405|76113749|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
42281946|NCT00704405|76113750|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
42281947|NCT00704405|76113746|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
42281948|NCT00704405|76113747|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
42281949|NCT00704405|76113748|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
42281950|NCT00704405|76113749|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
42281951|NCT00704405|76113750|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
42281952|NCT00704405|76113746|FG000|Overall Study (NC Population)|Other|0|||
42281953|NCT00704405|76113747|FG001|Overall Study (NC Population)|Other|0|||
42281954|NCT00704405|76113748|FG002|Overall Study (NC Population)|Other|0|||
42281955|NCT00704405|76113749|FG003|Overall Study (NC Population)|Other|0|||
42281956|NCT00704405|76113750|FG004|Overall Study (NC Population)|Other|1|||
42281957|NCT00704405|76113746|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
42281958|NCT00704405|76113747|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
42281959|NCT00704405|76113748|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
42281960|NCT00704405|76113749|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
42281961|NCT00704405|76113750|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
42281962|NCT00704405|76113746|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
42281963|NCT00704405|76113747|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
42281964|NCT00704405|76113748|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
42281965|NCT00704405|76113749|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
42281966|NCT00704405|76113750|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
42281967|NCT01534481|76113770|FG000|Overall Study|Lost to Follow-up|29|||
42281968|NCT01534481|76113771|FG001|Overall Study|Lost to Follow-up|24|||
42281969|NCT01534481|76113770|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
42281970|NCT01534481|76113771|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
42281971|NCT00704171|76113779|FG000|Overall Study|Withdrawal by Subject|1|||
42281972|NCT00704171|76113780|FG001|Overall Study|Withdrawal by Subject|0|||
42281973|NCT00703781|76113788|FG000|Overall Study|Withdrawal by Subject|1|||
42281974|NCT00703781|76113789|FG001|Overall Study|Withdrawal by Subject|2|||
42165885|NCT00112437|75973225|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165886|NCT00112437|75973226|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42281975|NCT00703781|76113788|FG000|Overall Study|Cancelled surgery|1|||
42281976|NCT00703781|76113789|FG001|Overall Study|Cancelled surgery|0|||
42281977|NCT00703157|76113797|FG000|Overall Study|Lost to Follow-up|0|||
42165887|NCT00112437|75973227|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165888|NCT00112437|75973228|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165889|NCT00112437|75973229|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165890|NCT00112437|75973230|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165891|NCT00112437|75973231|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165892|NCT00112437|75973232|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165893|NCT00112437|75973233|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165894|NCT00112437|75973234|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165895|NCT00112437|75973235|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165896|NCT00112437|75973236|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165897|NCT00112437|75973237|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
42165898|NCT00112437|75973212|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165899|NCT00112437|75973213|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165900|NCT00112437|75973214|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165901|NCT00112437|75973215|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165902|NCT00112437|75973216|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165903|NCT00112437|75973217|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165904|NCT00112437|75973218|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165905|NCT00112437|75973219|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165906|NCT00112437|75973220|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
42165907|NCT00112437|75973221|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165908|NCT00112437|75973222|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165909|NCT00112437|75973223|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165910|NCT00112437|75973224|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165911|NCT00112437|75973225|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165912|NCT00112437|75973226|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165913|NCT00112437|75973227|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165914|NCT00112437|75973228|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165915|NCT00112437|75973229|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165916|NCT00112437|75973230|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165917|NCT00112437|75973231|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165918|NCT00112437|75973232|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165919|NCT00112437|75973233|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165920|NCT00112437|75973234|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165921|NCT00112437|75973235|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165922|NCT00112437|75973236|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165923|NCT00112437|75973237|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
42165924|NCT00112437|75973212|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165925|NCT00112437|75973213|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165926|NCT00112437|75973214|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165927|NCT00112437|75973215|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165928|NCT00112437|75973216|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165929|NCT00112437|75973217|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165930|NCT00112437|75973218|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165931|NCT00112437|75973219|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165932|NCT00112437|75973220|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
42165933|NCT00112437|75973221|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165934|NCT00112437|75973222|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165935|NCT00112437|75973223|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165936|NCT00112437|75973224|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165937|NCT00112437|75973225|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165938|NCT00112437|75973226|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165939|NCT00112437|75973227|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165940|NCT00112437|75973228|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165941|NCT00112437|75973229|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
42014243|NCT01292603|75821373|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
42014244|NCT01292603|75821374|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
42014245|NCT01292603|75821369|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
42014246|NCT01292603|75821370|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
42014247|NCT01292603|75821371|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
42014248|NCT01292603|75821372|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
42014249|NCT01292603|75821373|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
42014250|NCT01292603|75821374|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
42014251|NCT01292603|75821369|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
42014252|NCT01292603|75821370|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
42014253|NCT01292603|75821371|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
42165942|NCT00112437|75973230|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165943|NCT00112437|75973231|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165944|NCT00112437|75973232|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
42014254|NCT01292603|75821372|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
42165945|NCT00112437|75973233|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165946|NCT00112437|75973234|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165947|NCT00112437|75973235|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165948|NCT00112437|75973236|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165949|NCT00112437|75973237|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
42165950|NCT00112437|75973212|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165951|NCT00112437|75973213|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165952|NCT00112437|75973214|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165953|NCT00112437|75973215|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165954|NCT00112437|75973216|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165955|NCT00112437|75973217|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
42165956|NCT00112437|75973218|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
42165957|NCT00112437|75973219|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
42165958|NCT00112437|75973220|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
42165959|NCT00112437|75973221|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
42165960|NCT00112437|75973222|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165961|NCT00112437|75973223|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165962|NCT00112437|75973224|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165963|NCT00112437|75973225|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165964|NCT00112437|75973226|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165965|NCT00112437|75973227|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165966|NCT00112437|75973228|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165967|NCT00112437|75973229|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165968|NCT00112437|75973230|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165969|NCT00112437|75973231|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165970|NCT00112437|75973232|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165971|NCT00112437|75973233|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165972|NCT00112437|75973234|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165973|NCT00112437|75973235|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165974|NCT00112437|75973236|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165975|NCT00112437|75973237|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
42165976|NCT00112437|75973212|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165977|NCT00112437|75973213|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165978|NCT00112437|75973214|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165979|NCT00112437|75973215|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165980|NCT00112437|75973216|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165981|NCT00112437|75973217|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165982|NCT00112437|75973218|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165983|NCT00112437|75973219|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165984|NCT00112437|75973220|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165985|NCT00112437|75973221|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
42165986|NCT00112437|75973222|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165987|NCT00112437|75973223|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165988|NCT00112437|75973224|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165989|NCT00112437|75973225|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165990|NCT00112437|75973226|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42281978|NCT00703157|76113798|FG001|Overall Study|Lost to Follow-up|1|||
42281979|NCT00703157|76113797|FG000|Overall Study|source data permanently lost/ other|4|||
42281980|NCT00703157|76113798|FG001|Overall Study|source data permanently lost/ other|1|||
42281981|NCT03307967|76113806|FG000|Overall Study|Lost to Follow-up|4|||
42281982|NCT02722967|76113813|FG000|Overall Study|Adverse Event|1|||
42281983|NCT02722967|76113814|FG001|Overall Study|Adverse Event|0|||
42281984|NCT02722967|76113815|FG002|Overall Study|Adverse Event|0|||
42281985|NCT02722967|76113813|FG000|Overall Study|Lost to Follow-up|0|||
42281986|NCT02722967|76113814|FG001|Overall Study|Lost to Follow-up|1|||
42281987|NCT02722967|76113815|FG002|Overall Study|Lost to Follow-up|0|||
42281988|NCT02722967|76113813|FG000|Overall Study|Non-compliance with patch wearing|2|||
42281989|NCT02722967|76113814|FG001|Overall Study|Non-compliance with patch wearing|1|||
42351823|NCT01544595|76191759|FG003|Status at Week 68|Withdrawal by Subject|2|||
42351824|NCT01544595|76191760|FG004|Status at Week 68|Withdrawal by Subject|0|||
42351825|NCT01544595|76191761|FG005|Status at Week 68|Withdrawal by Subject|0|||
42165991|NCT00112437|75973227|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165992|NCT00112437|75973228|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165993|NCT00112437|75973229|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165994|NCT00112437|75973230|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165995|NCT00112437|75973231|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165996|NCT00112437|75973232|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165997|NCT00112437|75973233|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42281990|NCT02722967|76113815|FG002|Overall Study|Non-compliance with patch wearing|1|||
42281991|NCT02722967|76113813|FG000|Overall Study|Withdrawal by Subject|1|||
42281992|NCT02722967|76113814|FG001|Overall Study|Withdrawal by Subject|0|||
42281993|NCT02722967|76113815|FG002|Overall Study|Withdrawal by Subject|1|||
42281994|NCT02722967|76113813|FG000|Overall Study|Physician Decision|1|||
42281995|NCT02722967|76113814|FG001|Overall Study|Physician Decision|0|||
42281996|NCT02722967|76113815|FG002|Overall Study|Physician Decision|0|||
42281997|NCT02722967|76113813|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
42281998|NCT02722967|76113814|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
42281999|NCT02722967|76113815|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
42282000|NCT02722499|76113826|FG000|Overall Study|Lost to Follow-up|2|||
42282001|NCT02722499|76113827|FG001|Overall Study|Lost to Follow-up|0|||
42282002|NCT02722499|76113828|FG002|Overall Study|Lost to Follow-up|1|||
42282003|NCT02721875|76113838|FG000|Overall Study|Progressive disease/relapse|1|||
42282004|NCT02721875|76113839|FG001|Overall Study|Progressive disease/relapse|0|||
42282005|NCT02721251|76113848|FG000|Overall Study|Withdrawal by Subject|8|||
42282006|NCT02721251|76113849|FG001|Overall Study|Withdrawal by Subject|7|||
42282007|NCT02721251|76113850|FG002|Overall Study|Withdrawal by Subject|9|||
42282008|NCT02721251|76113848|FG000|Overall Study|poor adherence|2|||
42282009|NCT02721251|76113849|FG001|Overall Study|poor adherence|2|||
42282010|NCT02721251|76113850|FG002|Overall Study|poor adherence|2|||
42282011|NCT00702221|76113861|FG000|Overall Study|Adverse Event|4|||
42282012|NCT00702221|76113862|FG001|Overall Study|Adverse Event|3|||
42282013|NCT00702143|76113871|FG000|Overall Study|Lost to Follow-up|0|||
42282014|NCT00702143|76113872|FG001|Overall Study|Lost to Follow-up|0|||
42282015|NCT00702143|76113873|FG002|Overall Study|Lost to Follow-up|1|||
42282016|NCT00702923|76113879|FG000|Overall Study|Adverse Event|1|||
42282017|NCT02633787|76113884|FG000|Overall Study|Withdrawal by Subject|1|||
42282018|NCT02719691|76113895|FG000|Overall Study|Physician Decision|0|||
42282019|NCT02719691|76113896|FG001|Overall Study|Physician Decision|0|||
42282020|NCT02719691|76113897|FG002|Overall Study|Physician Decision|1|||
42282021|NCT02719691|76113898|FG003|Overall Study|Physician Decision|0|||
42282022|NCT02719691|76113899|FG004|Overall Study|Physician Decision|0|||
42165998|NCT00112437|75973234|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42165999|NCT00112437|75973235|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42166000|NCT00112437|75973236|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42166001|NCT00112437|75973237|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
42166002|NCT00112437|75973212|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166003|NCT00112437|75973213|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166004|NCT00112437|75973214|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166005|NCT00112437|75973215|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166006|NCT00112437|75973216|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166007|NCT00112437|75973217|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166008|NCT00112437|75973218|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166009|NCT00112437|75973219|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166010|NCT00112437|75973220|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166011|NCT00112437|75973221|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
42166012|NCT00112437|75973222|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166013|NCT00112437|75973223|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166014|NCT00112437|75973224|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166015|NCT00112437|75973225|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
42282023|NCT02719691|76113900|FG005|Overall Study|Physician Decision|0|||
42282024|NCT02719691|76113901|FG006|Overall Study|Physician Decision|0|||
42282025|NCT02719691|76113895|FG000|Overall Study|Withdrawal by Subject|0|||
42282026|NCT02719691|76113896|FG001|Overall Study|Withdrawal by Subject|0|||
42282027|NCT02719691|76113897|FG002|Overall Study|Withdrawal by Subject|0|||
42282028|NCT02719691|76113898|FG003|Overall Study|Withdrawal by Subject|0|||
42282029|NCT02719691|76113899|FG004|Overall Study|Withdrawal by Subject|0|||
42282030|NCT02719691|76113900|FG005|Overall Study|Withdrawal by Subject|1|||
42282031|NCT02719691|76113901|FG006|Overall Study|Withdrawal by Subject|0|||
42282032|NCT02720081|76113920|FG000|Overall Study|Adverse Event|0|||
42282033|NCT02720081|76113921|FG001|Overall Study|Adverse Event|3|||
42282034|NCT02720081|76113920|FG000|Overall Study|Protocol Violation|4|||
42282035|NCT02720081|76113921|FG001|Overall Study|Protocol Violation|1|||
42282036|NCT04248933|76113927|FG000|Overall Study|Lost to Follow-up|9|||
42166016|NCT00112437|75973226|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
42282037|NCT04248933|76113927|FG000|Overall Study|Withdrawal by Subject|2|||
42282038|NCT02718131|76113933|FG000|Overall Study|Withdrawal by Subject|1|||
42282039|NCT02718131|76113934|FG001|Overall Study|Withdrawal by Subject|0|||
42282040|NCT02718131|76113933|FG000|Overall Study|Adverse Event|1|||
42282041|NCT02718131|76113934|FG001|Overall Study|Adverse Event|0|||
42282042|NCT02718131|76113933|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
42282043|NCT02718131|76113934|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
42282044|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
42282045|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
42282046|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
42282047|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
42282048|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
42282049|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
42282050|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
42282051|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
42282052|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
42282053|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
42282054|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
42282055|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
42282056|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
42282057|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
42282058|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
42282059|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
42282060|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
42282061|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
42282062|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
42282063|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
42282064|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
42282065|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
42282066|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
42282067|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
42282068|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
42282069|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
42282070|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
42282071|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
42282072|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
42282073|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
42282074|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
42282075|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
42282076|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
42282077|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
42282078|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
42282079|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
42282080|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
42282081|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
42282082|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
42282083|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
42282084|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
42282085|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
42351826|NCT01544595|76191756|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
42351827|NCT01544595|76191757|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
42351828|NCT01544595|76191758|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
42351829|NCT01544595|76191759|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
42351830|NCT01544595|76191760|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
42014255|NCT01292603|75821373|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
42166017|NCT00112437|75973227|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166018|NCT00112437|75973228|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166019|NCT00112437|75973229|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166020|NCT00112437|75973230|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166021|NCT00112437|75973231|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166022|NCT00112437|75973232|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166023|NCT00112437|75973233|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166024|NCT00112437|75973234|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166025|NCT00112437|75973235|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166026|NCT00112437|75973236|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
42166027|NCT00112437|75973237|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
42282086|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
42282087|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
42282088|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
42351831|NCT01544595|76191761|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
42166028|NCT00112437|75973212|FG000|Year 2 (12-Month Extension)|Moved|0|||
42166029|NCT00112437|75973213|FG001|Year 2 (12-Month Extension)|Moved|0|||
42166030|NCT00112437|75973214|FG002|Year 2 (12-Month Extension)|Moved|0|||
42166031|NCT00112437|75973215|FG003|Year 2 (12-Month Extension)|Moved|0|||
42166032|NCT00112437|75973216|FG004|Year 2 (12-Month Extension)|Moved|0|||
42166033|NCT00112437|75973217|FG005|Year 2 (12-Month Extension)|Moved|0|||
42166034|NCT00112437|75973218|FG006|Year 2 (12-Month Extension)|Moved|0|||
42166035|NCT00112437|75973219|FG007|Year 2 (12-Month Extension)|Moved|0|||
42166036|NCT00112437|75973220|FG008|Year 2 (12-Month Extension)|Moved|0|||
42166037|NCT00112437|75973221|FG009|Year 2 (12-Month Extension)|Moved|1|||
42166038|NCT00112437|75973222|FG010|Year 2 (12-Month Extension)|Moved|0|||
42166039|NCT00112437|75973223|FG011|Year 2 (12-Month Extension)|Moved|0|||
42166040|NCT00112437|75973224|FG012|Year 2 (12-Month Extension)|Moved|0|||
42166041|NCT00112437|75973225|FG013|Year 2 (12-Month Extension)|Moved|0|||
42166042|NCT00112437|75973226|FG014|Year 2 (12-Month Extension)|Moved|0|||
42166043|NCT00112437|75973227|FG015|Year 2 (12-Month Extension)|Moved|0|||
42166044|NCT00112437|75973228|FG016|Year 2 (12-Month Extension)|Moved|0|||
42166045|NCT00112437|75973229|FG017|Year 2 (12-Month Extension)|Moved|0|||
42166046|NCT00112437|75973230|FG018|Year 2 (12-Month Extension)|Moved|0|||
42166047|NCT00112437|75973231|FG019|Year 2 (12-Month Extension)|Moved|0|||
42166048|NCT00112437|75973232|FG020|Year 2 (12-Month Extension)|Moved|0|||
42166049|NCT00112437|75973233|FG021|Year 2 (12-Month Extension)|Moved|0|||
42166050|NCT00112437|75973234|FG022|Year 2 (12-Month Extension)|Moved|0|||
42166051|NCT00112437|75973235|FG023|Year 2 (12-Month Extension)|Moved|0|||
42282089|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
42282090|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
42282091|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
42282092|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
42282093|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
42166052|NCT00112437|75973236|FG024|Year 2 (12-Month Extension)|Moved|0|||
42166053|NCT00112437|75973237|FG025|Year 2 (12-Month Extension)|Moved|0|||
42166054|NCT00112437|75973212|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
42166055|NCT00112437|75973213|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
42166056|NCT00112437|75973214|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
42166057|NCT00112437|75973215|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
42166058|NCT00112437|75973216|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
42166059|NCT00112437|75973217|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
42166060|NCT00112437|75973218|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
42166061|NCT00112437|75973219|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
42282094|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
42282095|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
42282096|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
42282097|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
42282098|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
42282099|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
42282100|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
42282101|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
42282102|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
42282103|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
42282104|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
42282105|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
42282106|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
42282107|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
42282108|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
42282109|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
42282110|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
42282111|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
42282112|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
42282113|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
42282114|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
42282115|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
42282116|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
42282117|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
42351832|NCT01544595|76191756|FG000|Status at Week 156|Withdrawal by Subject|9|||
42351833|NCT01544595|76191757|FG001|Status at Week 156|Withdrawal by Subject|10|||
42166062|NCT00112437|75973220|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
42166063|NCT00112437|75973221|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
42166064|NCT00112437|75973222|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
42166065|NCT00112437|75973223|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
42166066|NCT00112437|75973224|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
42166067|NCT00112437|75973225|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
42282118|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
42282119|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
42282120|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
42282121|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
42282122|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
42282123|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
42282124|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
42282125|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
42282126|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
42282127|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
42282128|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
42282129|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
42282130|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
42282131|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
42282132|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
42282133|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
42282134|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
42282135|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
42282136|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
42282137|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
42282138|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
42282139|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
42282140|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
42282141|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
42282142|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
42282143|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
42282144|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
42351834|NCT01544595|76191758|FG002|Status at Week 156|Withdrawal by Subject|4|||
42351835|NCT01544595|76191759|FG003|Status at Week 156|Withdrawal by Subject|9|||
42351836|NCT01544595|76191760|FG004|Status at Week 156|Withdrawal by Subject|20|||
42351837|NCT01544595|76191761|FG005|Status at Week 156|Withdrawal by Subject|6|||
42351838|NCT01544595|76191756|FG000|Status at Week 156|Adverse Event|9|||
42351839|NCT01544595|76191757|FG001|Status at Week 156|Adverse Event|11|||
42351840|NCT01544595|76191758|FG002|Status at Week 156|Adverse Event|1|||
42351841|NCT01544595|76191759|FG003|Status at Week 156|Adverse Event|3|||
42351842|NCT01544595|76191760|FG004|Status at Week 156|Adverse Event|4|||
42351843|NCT01544595|76191761|FG005|Status at Week 156|Adverse Event|2|||
42351844|NCT01544595|76191756|FG000|Status at Week 156|Lost to Follow-up|4|||
42351845|NCT01544595|76191757|FG001|Status at Week 156|Lost to Follow-up|4|||
42351846|NCT01544595|76191758|FG002|Status at Week 156|Lost to Follow-up|0|||
42351847|NCT01544595|76191759|FG003|Status at Week 156|Lost to Follow-up|1|||
42351848|NCT01544595|76191760|FG004|Status at Week 156|Lost to Follow-up|4|||
42351849|NCT01544595|76191761|FG005|Status at Week 156|Lost to Follow-up|1|||
42351850|NCT01544595|76191756|FG000|Status at Week 156|Non-compliance with study treatement|0|||
42351851|NCT01544595|76191757|FG001|Status at Week 156|Non-compliance with study treatement|1|||
42351852|NCT01544595|76191758|FG002|Status at Week 156|Non-compliance with study treatement|0|||
42351853|NCT01544595|76191759|FG003|Status at Week 156|Non-compliance with study treatement|1|||
42351854|NCT01544595|76191760|FG004|Status at Week 156|Non-compliance with study treatement|0|||
42351855|NCT01544595|76191761|FG005|Status at Week 156|Non-compliance with study treatement|1|||
42351856|NCT01544595|76191756|FG000|Status at Week 156|Physician Decision|0|||
42351857|NCT01544595|76191757|FG001|Status at Week 156|Physician Decision|3|||
42351858|NCT01544595|76191758|FG002|Status at Week 156|Physician Decision|1|||
42351859|NCT01544595|76191759|FG003|Status at Week 156|Physician Decision|0|||
42351860|NCT01544595|76191760|FG004|Status at Week 156|Physician Decision|0|||
42351861|NCT01544595|76191761|FG005|Status at Week 156|Physician Decision|0|||
42351862|NCT01544595|76191756|FG000|Status at Week 156|Pregnancy|2|||
42351863|NCT01544595|76191757|FG001|Status at Week 156|Pregnancy|3|||
42351864|NCT01544595|76191758|FG002|Status at Week 156|Pregnancy|0|||
42166068|NCT00112437|75973226|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
42166069|NCT00112437|75973227|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
42166070|NCT00112437|75973228|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
42166071|NCT00112437|75973229|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
42166072|NCT00112437|75973230|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
42166073|NCT00112437|75973231|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
42166074|NCT00112437|75973232|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
42166075|NCT00112437|75973233|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
42014256|NCT01292603|75821374|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
42166076|NCT00112437|75973234|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
42282145|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
42282146|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
42166077|NCT00112437|75973235|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
42166078|NCT00112437|75973236|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
42166079|NCT00112437|75973237|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
42166080|NCT00112437|75973212|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166081|NCT00112437|75973213|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166082|NCT00112437|75973214|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166083|NCT00112437|75973215|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166084|NCT00112437|75973216|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166085|NCT00112437|75973217|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166086|NCT00112437|75973218|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166087|NCT00112437|75973219|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166088|NCT00112437|75973220|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166089|NCT00112437|75973221|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166090|NCT00112437|75973222|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166091|NCT00112437|75973223|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
42166092|NCT00112437|75973224|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166093|NCT00112437|75973225|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
42014257|NCT01292603|75821369|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
42014258|NCT01292603|75821370|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
42166094|NCT00112437|75973226|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166095|NCT00112437|75973227|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
42166096|NCT00112437|75973228|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166097|NCT00112437|75973229|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166098|NCT00112437|75973230|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
42166099|NCT00112437|75973231|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166100|NCT00112437|75973232|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166101|NCT00112437|75973233|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166102|NCT00112437|75973234|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166103|NCT00112437|75973235|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166104|NCT00112437|75973236|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166105|NCT00112437|75973237|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
42166106|NCT00112437|75973212|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166107|NCT00112437|75973213|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166108|NCT00112437|75973214|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166109|NCT00112437|75973215|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166110|NCT00112437|75973216|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166111|NCT00112437|75973217|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166112|NCT00112437|75973218|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166113|NCT00112437|75973219|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166114|NCT00112437|75973220|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166115|NCT00112437|75973221|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166116|NCT00112437|75973222|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166117|NCT00112437|75973223|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166118|NCT00112437|75973224|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166119|NCT00112437|75973225|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166120|NCT00112437|75973226|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166121|NCT00112437|75973227|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
42166122|NCT00112437|75973228|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166123|NCT00112437|75973229|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166124|NCT00112437|75973230|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42282147|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
42282148|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
42282149|NCT02717195|76113969|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
42282150|NCT02717195|76113970|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
42282151|NCT02717195|76113971|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
42282152|NCT02717195|76113972|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
42282153|NCT02717195|76113973|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
42282154|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
42282155|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
42282156|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
42282157|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
42282158|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
42166125|NCT00112437|75973231|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166126|NCT00112437|75973232|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166127|NCT00112437|75973233|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166128|NCT00112437|75973234|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42282159|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
42282160|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
42282161|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
42282162|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
42282163|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
42282164|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
42282165|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
42282166|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
42282167|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
42282168|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
42166129|NCT00112437|75973235|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166130|NCT00112437|75973236|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166131|NCT00112437|75973237|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
42166132|NCT00112437|75973212|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166133|NCT00112437|75973213|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166134|NCT00112437|75973214|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166135|NCT00112437|75973215|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166136|NCT00112437|75973216|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166137|NCT00112437|75973217|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
42014259|NCT01292603|75821371|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
42014260|NCT01292603|75821372|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
42166138|NCT00112437|75973218|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166139|NCT00112437|75973219|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166140|NCT00112437|75973220|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166141|NCT00112437|75973221|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166142|NCT00112437|75973222|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166143|NCT00112437|75973223|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166144|NCT00112437|75973224|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166145|NCT00112437|75973225|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166146|NCT00112437|75973226|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166147|NCT00112437|75973227|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
42166148|NCT00112437|75973228|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166149|NCT00112437|75973229|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166150|NCT00112437|75973230|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166151|NCT00112437|75973231|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166152|NCT00112437|75973232|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166153|NCT00112437|75973233|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166154|NCT00112437|75973234|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166155|NCT00112437|75973235|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166156|NCT00112437|75973236|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166157|NCT00112437|75973237|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
42166158|NCT00112437|75973212|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166159|NCT00112437|75973213|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166160|NCT00112437|75973214|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166161|NCT00112437|75973215|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166162|NCT00112437|75973216|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166163|NCT00112437|75973217|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166164|NCT00112437|75973218|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166165|NCT00112437|75973219|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166166|NCT00112437|75973220|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166167|NCT00112437|75973221|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166168|NCT00112437|75973222|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166169|NCT00112437|75973223|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
42166170|NCT00112437|75973224|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166171|NCT00112437|75973225|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166172|NCT00112437|75973226|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
42282169|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
42282170|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
42282171|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
42282172|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
42282173|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
42282174|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
42351865|NCT01544595|76191759|FG003|Status at Week 156|Pregnancy|0|||
42351866|NCT01544595|76191760|FG004|Status at Week 156|Pregnancy|0|||
42014261|NCT01292603|75821373|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
42166173|NCT00112437|75973227|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166174|NCT00112437|75973228|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166175|NCT00112437|75973229|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42282175|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
42282176|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
42282177|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
42282178|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
42282179|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
42282180|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
42282181|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
42282182|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
42282183|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
42282184|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
42282185|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
42282186|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
42282187|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
42282188|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
42282189|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
42282190|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
42282191|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
42166176|NCT00112437|75973230|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166177|NCT00112437|75973231|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166178|NCT00112437|75973232|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166179|NCT00112437|75973233|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42282192|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
42282193|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
42282194|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
42282195|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
42282196|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
42282197|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
42282198|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
42282199|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
42282200|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
42282201|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
42282202|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
42282203|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
42282204|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
42282205|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
42282206|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
42282207|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
42282208|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
42282209|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
42282210|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
42282211|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
42282212|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
42282213|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
42282214|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
42282215|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
42282216|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
42282217|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
42282218|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
42282219|NCT02717195|76113969|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
42282220|NCT02717195|76113970|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
42282221|NCT02717195|76113971|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
42282222|NCT02717195|76113972|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
42282223|NCT02717195|76113973|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
42282224|NCT00701441|76113988|FG000|Overall Study|failure in cpap compliance|0|||
42351867|NCT01544595|76191761|FG005|Status at Week 156|Pregnancy|0|||
42351868|NCT01544595|76191756|FG000|Status at Week 156|Protocol Violation|3|||
42166180|NCT00112437|75973234|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166181|NCT00112437|75973235|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42282225|NCT00701441|76113989|FG001|Overall Study|failure in cpap compliance|4|||
42282226|NCT02628873|76114001|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
42282227|NCT02628873|76114002|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
42282228|NCT02628873|76114001|FG000|Second Test (1 Hour)|Physician Decision|1|||
42282229|NCT02628873|76114002|FG001|Second Test (1 Hour)|Physician Decision|0|||
42282230|NCT02629965|76114012|FG000|Period 1|Adverse Event|1|||
42282231|NCT02629965|76114013|FG001|Period 1|Adverse Event|0|||
42282232|NCT02629965|76114012|FG000|Period 1|Unexpected worsening of disease|2|||
42166182|NCT00112437|75973236|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166183|NCT00112437|75973237|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
42166184|NCT00112437|75973212|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166185|NCT00112437|75973213|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166186|NCT00112437|75973214|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166187|NCT00112437|75973215|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166188|NCT00112437|75973216|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166189|NCT00112437|75973217|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166190|NCT00112437|75973218|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166191|NCT00112437|75973219|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166192|NCT00112437|75973220|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166193|NCT00112437|75973221|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166194|NCT00112437|75973222|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
42166195|NCT00112437|75973223|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
42166196|NCT00112437|75973224|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166197|NCT00112437|75973225|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166198|NCT00112437|75973226|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166199|NCT00112437|75973227|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166200|NCT00112437|75973228|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42282233|NCT02629965|76114013|FG001|Period 1|Unexpected worsening of disease|0|||
42282234|NCT02629965|76114012|FG000|Period 1|Other than listed above|1|||
42282235|NCT02629965|76114013|FG001|Period 1|Other than listed above|2|||
42166201|NCT00112437|75973229|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166202|NCT00112437|75973230|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166203|NCT00112437|75973231|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166204|NCT00112437|75973232|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166205|NCT00112437|75973233|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166206|NCT00112437|75973234|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42282236|NCT02629965|76114012|FG000|Period 2|Adverse Event|1|||
42282237|NCT02629965|76114013|FG001|Period 2|Adverse Event|0|||
42282238|NCT01671111|76114019|FG000|Overall Study|Adverse Event|2|||
42282239|NCT01671111|76114019|FG000|Overall Study|Lack of Efficacy|1|||
42282240|NCT01671111|76114019|FG000|Overall Study|Withdrawal by Subject|2|||
42282241|NCT01671111|76114019|FG000|Overall Study|Physician Decision|1|||
42282242|NCT01671111|76114019|FG000|Overall Study|Other|24|||
42282243|NCT01671345|76114025|FG000|Overall Study|Lost to Follow-up|10|||
42282244|NCT01671345|76114026|FG001|Overall Study|Lost to Follow-up|6|||
42282245|NCT01671345|76114025|FG000|Overall Study|visit with non-participating physician|3|||
42282246|NCT01671345|76114026|FG001|Overall Study|visit with non-participating physician|3|||
42282247|NCT02487095|76114045|FG000|Dose Expansion|Unable to scan/restage participant|0|||
42166207|NCT00112437|75973235|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166208|NCT00112437|75973236|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166209|NCT00112437|75973237|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
42166210|NCT00112437|75973212|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166211|NCT00112437|75973213|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166212|NCT00112437|75973214|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166213|NCT00112437|75973215|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166214|NCT00112437|75973216|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166215|NCT00112437|75973217|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166216|NCT00112437|75973218|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166217|NCT00112437|75973219|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166218|NCT00112437|75973220|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166219|NCT00112437|75973221|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166220|NCT00112437|75973222|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166221|NCT00112437|75973223|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166222|NCT00112437|75973224|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166223|NCT00112437|75973225|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166224|NCT00112437|75973226|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166225|NCT00112437|75973227|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166226|NCT00112437|75973228|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42351869|NCT01544595|76191757|FG001|Status at Week 156|Protocol Violation|1|||
42166227|NCT00112437|75973229|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166228|NCT00112437|75973230|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166229|NCT00112437|75973231|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42282248|NCT02487095|76114046|FG001|Dose Expansion|Unable to scan/restage participant|0|||
42282249|NCT02487095|76114047|FG002|Dose Expansion|Unable to scan/restage participant|0|||
42282250|NCT02487095|76114048|FG003|Dose Expansion|Unable to scan/restage participant|0|||
42166230|NCT00112437|75973232|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
42166231|NCT00112437|75973233|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
42166232|NCT00112437|75973234|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166233|NCT00112437|75973235|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166234|NCT00112437|75973236|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166235|NCT00112437|75973237|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
42166236|NCT00112437|75973212|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166237|NCT00112437|75973213|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166238|NCT00112437|75973214|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166239|NCT00112437|75973215|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166240|NCT00112437|75973216|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166241|NCT00112437|75973217|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166242|NCT00112437|75973218|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166243|NCT00112437|75973219|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166244|NCT00112437|75973220|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166245|NCT00112437|75973221|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166246|NCT00112437|75973222|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166247|NCT00112437|75973223|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166248|NCT00112437|75973224|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166249|NCT00112437|75973225|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166250|NCT00112437|75973226|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166251|NCT00112437|75973227|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166252|NCT00112437|75973228|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166253|NCT00112437|75973229|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166254|NCT00112437|75973230|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166255|NCT00112437|75973231|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166256|NCT00112437|75973232|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
42166257|NCT00112437|75973233|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166258|NCT00112437|75973234|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166259|NCT00112437|75973235|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166260|NCT00112437|75973236|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166261|NCT00112437|75973237|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
42166262|NCT00112437|75973212|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166263|NCT00112437|75973213|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166264|NCT00112437|75973214|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166265|NCT00112437|75973215|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166266|NCT00112437|75973216|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166267|NCT00112437|75973217|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166268|NCT00112437|75973218|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166269|NCT00112437|75973219|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166270|NCT00112437|75973220|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166271|NCT00112437|75973221|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166272|NCT00112437|75973222|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166273|NCT00112437|75973223|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166274|NCT00112437|75973224|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166275|NCT00112437|75973225|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166276|NCT00112437|75973226|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166277|NCT00112437|75973227|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42282251|NCT02487095|76114049|FG004|Dose Expansion|Unable to scan/restage participant|1|||
42282252|NCT03855137|76114072|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
42282253|NCT03855137|76114073|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
42282254|NCT03855137|76114074|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
42282255|NCT03855137|76114072|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
42282256|NCT03855137|76114073|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
42282257|NCT03855137|76114074|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
42040608|NCT01796171|75848708|FG002|Treatment Period With Betalutin|Death|0|||
42040609|NCT01796171|75848709|FG003|Treatment Period With Betalutin|Death|0|||
42040610|NCT01796171|75848710|FG004|Treatment Period With Betalutin|Death|0|||
42282258|NCT03855137|76114072|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
42351870|NCT01544595|76191758|FG002|Status at Week 156|Protocol Violation|2|||
42351871|NCT01544595|76191759|FG003|Status at Week 156|Protocol Violation|2|||
42282259|NCT03855137|76114073|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
42282260|NCT03855137|76114074|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
42282261|NCT03855137|76114072|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
42282262|NCT03855137|76114073|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
42282263|NCT03855137|76114074|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
42282264|NCT03855137|76114072|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
42282265|NCT03855137|76114073|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
42282266|NCT03855137|76114074|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
42282267|NCT03855137|76114072|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
42282268|NCT03855137|76114073|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
42282269|NCT03855137|76114074|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
42282270|NCT03855137|76114072|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
42282271|NCT03855137|76114073|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
42282272|NCT03855137|76114074|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
42282273|NCT03855137|76114072|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
42282274|NCT03855137|76114073|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
42282275|NCT03855137|76114074|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
42282276|NCT03855137|76114072|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
42282277|NCT03855137|76114073|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
42282278|NCT03855137|76114074|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
42166278|NCT00112437|75973228|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166279|NCT00112437|75973229|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166280|NCT00112437|75973230|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166281|NCT00112437|75973231|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166282|NCT00112437|75973232|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166283|NCT00112437|75973233|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
42166284|NCT00112437|75973234|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166285|NCT00112437|75973235|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166286|NCT00112437|75973236|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166287|NCT00112437|75973237|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
42166288|NCT00112437|75973212|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166289|NCT00112437|75973213|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166290|NCT00112437|75973214|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166291|NCT00112437|75973215|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166292|NCT00112437|75973216|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166293|NCT00112437|75973217|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166294|NCT00112437|75973218|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166295|NCT00112437|75973219|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166296|NCT00112437|75973220|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166297|NCT00112437|75973221|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166298|NCT00112437|75973222|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166299|NCT00112437|75973223|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166300|NCT00112437|75973224|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
42282279|NCT03855137|76114072|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
42282280|NCT03855137|76114073|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
42282281|NCT03855137|76114074|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
42282282|NCT00701363|76114096|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
42282283|NCT00701363|76114097|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
42282284|NCT00701363|76114098|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
42282285|NCT00701363|76114099|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
42282286|NCT00701363|76114096|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
42282287|NCT00701363|76114097|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
42282288|NCT00701363|76114098|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
42282289|NCT00701363|76114099|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
42282290|NCT00701363|76114096|FG000|Treatment Phase 1|Adverse Event|7|||
42282291|NCT00701363|76114097|FG001|Treatment Phase 1|Adverse Event|0|||
42282292|NCT00701363|76114098|FG002|Treatment Phase 1|Adverse Event|0|||
42282293|NCT00701363|76114099|FG003|Treatment Phase 1|Adverse Event|0|||
42014262|NCT01292603|75821374|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
42014263|NCT01292603|75821369|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
42166301|NCT00112437|75973225|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166302|NCT00112437|75973226|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166303|NCT00112437|75973227|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
42282294|NCT00701363|76114096|FG000|Treatment Phase 1|Protocol Violation|1|||
42282295|NCT00701363|76114097|FG001|Treatment Phase 1|Protocol Violation|0|||
42282296|NCT00701363|76114098|FG002|Treatment Phase 1|Protocol Violation|0|||
42166304|NCT00112437|75973228|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166305|NCT00112437|75973229|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166306|NCT00112437|75973230|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166307|NCT00112437|75973231|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166308|NCT00112437|75973232|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166309|NCT00112437|75973233|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
42166310|NCT00112437|75973234|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166311|NCT00112437|75973235|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166312|NCT00112437|75973236|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166313|NCT00112437|75973237|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
42166314|NCT00112437|75973212|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166315|NCT00112437|75973213|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166316|NCT00112437|75973214|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166317|NCT00112437|75973215|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166318|NCT00112437|75973216|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166319|NCT00112437|75973217|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166320|NCT00112437|75973218|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166321|NCT00112437|75973219|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166322|NCT00112437|75973220|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166323|NCT00112437|75973221|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166324|NCT00112437|75973222|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166325|NCT00112437|75973223|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166326|NCT00112437|75973224|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166327|NCT00112437|75973225|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166328|NCT00112437|75973226|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166329|NCT00112437|75973227|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166330|NCT00112437|75973228|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166331|NCT00112437|75973229|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166332|NCT00112437|75973230|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166333|NCT00112437|75973231|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166334|NCT00112437|75973232|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
42166335|NCT00112437|75973233|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
42166336|NCT00112437|75973234|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166337|NCT00112437|75973235|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166338|NCT00112437|75973236|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166339|NCT00112437|75973237|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
42166340|NCT00112437|75973212|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166341|NCT00112437|75973213|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166342|NCT00112437|75973214|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166343|NCT00112437|75973215|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166344|NCT00112437|75973216|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166345|NCT00112437|75973217|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166346|NCT00112437|75973218|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166347|NCT00112437|75973219|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166348|NCT00112437|75973220|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166349|NCT00112437|75973221|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166350|NCT00112437|75973222|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166351|NCT00112437|75973223|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166352|NCT00112437|75973224|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166353|NCT00112437|75973225|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166354|NCT00112437|75973226|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166355|NCT00112437|75973227|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166356|NCT00112437|75973228|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42282297|NCT00701363|76114099|FG003|Treatment Phase 1|Protocol Violation|0|||
42282298|NCT00701363|76114096|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
42282299|NCT00701363|76114097|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
42282300|NCT00701363|76114098|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
42166357|NCT00112437|75973229|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166358|NCT00112437|75973230|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166359|NCT00112437|75973231|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166360|NCT00112437|75973232|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166361|NCT00112437|75973233|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166362|NCT00112437|75973234|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
42351872|NCT01544595|76191760|FG004|Status at Week 156|Protocol Violation|0|||
42351873|NCT01544595|76191761|FG005|Status at Week 156|Protocol Violation|0|||
42351874|NCT01544595|76191756|FG000|Status at Week 156|Technical problems|3|||
42351875|NCT01544595|76191757|FG001|Status at Week 156|Technical problems|1|||
42351876|NCT01544595|76191758|FG002|Status at Week 156|Technical problems|0|||
42351877|NCT01544595|76191759|FG003|Status at Week 156|Technical problems|1|||
42351878|NCT01544595|76191760|FG004|Status at Week 156|Technical problems|0|||
42351879|NCT01544595|76191761|FG005|Status at Week 156|Technical problems|0|||
42351880|NCT01544595|76191756|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
42351881|NCT01544595|76191757|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
42351882|NCT01544595|76191758|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
42014264|NCT01292603|75821370|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
42166363|NCT00112437|75973235|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
42166364|NCT00112437|75973236|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
42166365|NCT00112437|75973237|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
42166366|NCT00112437|75973212|FG000|Years 6-10 (60-Month Extension)|Death|0|||
42166367|NCT00112437|75973213|FG001|Years 6-10 (60-Month Extension)|Death|0|||
42166368|NCT00112437|75973214|FG002|Years 6-10 (60-Month Extension)|Death|0|||
42166369|NCT00112437|75973215|FG003|Years 6-10 (60-Month Extension)|Death|0|||
42166370|NCT00112437|75973216|FG004|Years 6-10 (60-Month Extension)|Death|0|||
42166371|NCT00112437|75973217|FG005|Years 6-10 (60-Month Extension)|Death|0|||
42166372|NCT00112437|75973218|FG006|Years 6-10 (60-Month Extension)|Death|0|||
42166373|NCT00112437|75973219|FG007|Years 6-10 (60-Month Extension)|Death|0|||
42166374|NCT00112437|75973220|FG008|Years 6-10 (60-Month Extension)|Death|0|||
42166375|NCT00112437|75973221|FG009|Years 6-10 (60-Month Extension)|Death|0|||
42166376|NCT00112437|75973222|FG010|Years 6-10 (60-Month Extension)|Death|0|||
42166377|NCT00112437|75973223|FG011|Years 6-10 (60-Month Extension)|Death|0|||
42166378|NCT00112437|75973224|FG012|Years 6-10 (60-Month Extension)|Death|0|||
42166379|NCT00112437|75973225|FG013|Years 6-10 (60-Month Extension)|Death|0|||
42166380|NCT00112437|75973226|FG014|Years 6-10 (60-Month Extension)|Death|0|||
42166381|NCT00112437|75973227|FG015|Years 6-10 (60-Month Extension)|Death|0|||
42166382|NCT00112437|75973228|FG016|Years 6-10 (60-Month Extension)|Death|0|||
42166383|NCT00112437|75973229|FG017|Years 6-10 (60-Month Extension)|Death|0|||
42166384|NCT00112437|75973230|FG018|Years 6-10 (60-Month Extension)|Death|0|||
42166385|NCT00112437|75973231|FG019|Years 6-10 (60-Month Extension)|Death|0|||
42166386|NCT00112437|75973232|FG020|Years 6-10 (60-Month Extension)|Death|0|||
42166387|NCT00112437|75973233|FG021|Years 6-10 (60-Month Extension)|Death|0|||
42282301|NCT00701363|76114099|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
42282302|NCT00701363|76114096|FG000|Treatment Phase 1|Lack of Efficacy|1|||
42282303|NCT00701363|76114097|FG001|Treatment Phase 1|Lack of Efficacy|0|||
42282304|NCT00701363|76114098|FG002|Treatment Phase 1|Lack of Efficacy|0|||
42282305|NCT00701363|76114099|FG003|Treatment Phase 1|Lack of Efficacy|0|||
42282306|NCT00701363|76114096|FG000|Treatment Phase 2|Adverse Event|0|||
42282307|NCT00701363|76114097|FG001|Treatment Phase 2|Adverse Event|0|||
42282308|NCT00701363|76114098|FG002|Treatment Phase 2|Adverse Event|1|||
42282309|NCT00701363|76114099|FG003|Treatment Phase 2|Adverse Event|0|||
42282310|NCT00701363|76114096|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
42282311|NCT00701363|76114097|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
42282312|NCT00701363|76114098|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
42282313|NCT00701363|76114099|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
42014265|NCT01292603|75821371|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
42282314|NCT01670877|76114123|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
42282315|NCT01670877|76114124|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
42351883|NCT01544595|76191759|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
42351884|NCT01544595|76191760|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
42014266|NCT01292603|75821372|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
42014267|NCT01292603|75821373|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
42014268|NCT01292603|75821374|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
42014269|NCT01292603|75821369|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
42014270|NCT01292603|75821370|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
42014271|NCT01292603|75821371|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
42014272|NCT01292603|75821372|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
42014273|NCT01292603|75821373|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
42014274|NCT01292603|75821374|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
42014275|NCT01292603|75821369|FG000|Overall Survival Status|Death|3|||
42014276|NCT01292603|75821370|FG001|Overall Survival Status|Death|1|||
42166388|NCT00112437|75973234|FG022|Years 6-10 (60-Month Extension)|Death|0|||
42166389|NCT00112437|75973235|FG023|Years 6-10 (60-Month Extension)|Death|2|||
42166390|NCT00112437|75973236|FG024|Years 6-10 (60-Month Extension)|Death|0|||
42166391|NCT00112437|75973237|FG025|Years 6-10 (60-Month Extension)|Death|0|||
42282316|NCT01670877|76114125|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
42351885|NCT01544595|76191761|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
42014277|NCT01292603|75821371|FG002|Overall Survival Status|Death|3|||
42014278|NCT01292603|75821372|FG003|Overall Survival Status|Death|1|||
42166392|NCT00112437|75973212|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166393|NCT00112437|75973213|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166394|NCT00112437|75973214|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166395|NCT00112437|75973215|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166396|NCT00112437|75973216|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166397|NCT00112437|75973217|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166398|NCT00112437|75973218|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166399|NCT00112437|75973219|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166400|NCT00112437|75973220|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166401|NCT00112437|75973221|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166402|NCT00112437|75973222|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42282317|NCT01670877|76114126|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
42282318|NCT01670877|76114127|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
42282319|NCT01670877|76114128|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
42282320|NCT01670877|76114123|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
42282321|NCT01670877|76114124|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
42282322|NCT01670877|76114125|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
42282323|NCT01670877|76114126|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
42282324|NCT01670877|76114127|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
42282325|NCT01670877|76114128|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
42282326|NCT01670877|76114123|FG000|Part I and Part 2|Grade 2 vomiting|0|||
42166403|NCT00112437|75973223|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166404|NCT00112437|75973224|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166405|NCT00112437|75973225|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166406|NCT00112437|75973226|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166407|NCT00112437|75973227|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166408|NCT00112437|75973228|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166409|NCT00112437|75973229|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166410|NCT00112437|75973230|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166411|NCT00112437|75973231|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166412|NCT00112437|75973232|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166413|NCT00112437|75973233|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166414|NCT00112437|75973234|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166415|NCT00112437|75973235|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166416|NCT00112437|75973236|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
42166417|NCT00112437|75973237|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
42166418|NCT00112437|75973212|FG000|Years 6-10 (60-Month Extension)|Other|0|||
42166419|NCT00112437|75973213|FG001|Years 6-10 (60-Month Extension)|Other|0|||
42166420|NCT00112437|75973214|FG002|Years 6-10 (60-Month Extension)|Other|0|||
42166421|NCT00112437|75973215|FG003|Years 6-10 (60-Month Extension)|Other|0|||
42166422|NCT00112437|75973216|FG004|Years 6-10 (60-Month Extension)|Other|0|||
42166423|NCT00112437|75973217|FG005|Years 6-10 (60-Month Extension)|Other|0|||
42166424|NCT00112437|75973218|FG006|Years 6-10 (60-Month Extension)|Other|0|||
42166425|NCT00112437|75973219|FG007|Years 6-10 (60-Month Extension)|Other|0|||
42166426|NCT00112437|75973220|FG008|Years 6-10 (60-Month Extension)|Other|0|||
42166427|NCT00112437|75973221|FG009|Years 6-10 (60-Month Extension)|Other|0|||
42166428|NCT00112437|75973222|FG010|Years 6-10 (60-Month Extension)|Other|0|||
42166429|NCT00112437|75973223|FG011|Years 6-10 (60-Month Extension)|Other|0|||
42166430|NCT00112437|75973224|FG012|Years 6-10 (60-Month Extension)|Other|0|||
42166431|NCT00112437|75973225|FG013|Years 6-10 (60-Month Extension)|Other|0|||
42166432|NCT00112437|75973226|FG014|Years 6-10 (60-Month Extension)|Other|0|||
42166433|NCT00112437|75973227|FG015|Years 6-10 (60-Month Extension)|Other|0|||
42166434|NCT00112437|75973228|FG016|Years 6-10 (60-Month Extension)|Other|0|||
42166435|NCT00112437|75973229|FG017|Years 6-10 (60-Month Extension)|Other|0|||
42166436|NCT00112437|75973230|FG018|Years 6-10 (60-Month Extension)|Other|0|||
42166437|NCT00112437|75973231|FG019|Years 6-10 (60-Month Extension)|Other|0|||
42166438|NCT00112437|75973232|FG020|Years 6-10 (60-Month Extension)|Other|0|||
42166439|NCT00112437|75973233|FG021|Years 6-10 (60-Month Extension)|Other|0|||
42166440|NCT00112437|75973234|FG022|Years 6-10 (60-Month Extension)|Other|0|||
42166441|NCT00112437|75973235|FG023|Years 6-10 (60-Month Extension)|Other|0|||
42166442|NCT00112437|75973236|FG024|Years 6-10 (60-Month Extension)|Other|1|||
42166443|NCT00112437|75973237|FG025|Years 6-10 (60-Month Extension)|Other|0|||
42166444|NCT00112437|75973212|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166445|NCT00112437|75973213|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166446|NCT00112437|75973214|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166447|NCT00112437|75973215|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166448|NCT00112437|75973216|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166449|NCT00112437|75973217|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166450|NCT00112437|75973218|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166451|NCT00112437|75973219|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166452|NCT00112437|75973220|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166453|NCT00112437|75973221|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166454|NCT00112437|75973222|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166455|NCT00112437|75973223|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166456|NCT00112437|75973224|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166457|NCT00112437|75973225|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166458|NCT00112437|75973226|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166459|NCT00112437|75973227|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166460|NCT00112437|75973228|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166461|NCT00112437|75973229|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166462|NCT00112437|75973230|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166463|NCT00112437|75973231|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166464|NCT00112437|75973232|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42282327|NCT01670877|76114124|FG001|Part I and Part 2|Grade 2 vomiting|0|||
42282328|NCT01670877|76114125|FG002|Part I and Part 2|Grade 2 vomiting|0|||
42166465|NCT00112437|75973233|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166466|NCT00112437|75973234|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166467|NCT00112437|75973235|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
42166468|NCT00112437|75973236|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166469|NCT00112437|75973237|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
42166470|NCT00112437|75973212|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42282329|NCT01670877|76114126|FG003|Part I and Part 2|Grade 2 vomiting|1|||
42166471|NCT00112437|75973213|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166472|NCT00112437|75973214|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166473|NCT00112437|75973215|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166474|NCT00112437|75973216|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166475|NCT00112437|75973217|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166476|NCT00112437|75973218|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166477|NCT00112437|75973219|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166478|NCT00112437|75973220|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166479|NCT00112437|75973221|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166480|NCT00112437|75973222|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166481|NCT00112437|75973223|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166482|NCT00112437|75973224|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166483|NCT00112437|75973225|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166484|NCT00112437|75973226|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166485|NCT00112437|75973227|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166486|NCT00112437|75973228|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166487|NCT00112437|75973229|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166488|NCT00112437|75973230|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166489|NCT00112437|75973231|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166490|NCT00112437|75973232|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166491|NCT00112437|75973233|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166492|NCT00112437|75973234|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
42166493|NCT00112437|75973235|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
42166494|NCT00112437|75973236|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
42166495|NCT00112437|75973237|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
42166496|NCT03653416|75973293|FG000|Overall Study|Protocol Violation|6|||
42166497|NCT03653416|75973294|FG001|Overall Study|Protocol Violation|1|||
42166498|NCT00112359|75973302|FG000|Overall Study|Unrelated adverse event|16|||
42166499|NCT00112359|75973303|FG001|Overall Study|Unrelated adverse event|8|||
42166500|NCT00112359|75973302|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
42166501|NCT00112359|75973303|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
42166502|NCT00112359|75973302|FG000|Overall Study|Related adverse event|5|||
42166503|NCT00112359|75973303|FG001|Overall Study|Related adverse event|3|||
42166504|NCT00112359|75973302|FG000|Overall Study|Lost to Follow-up|0|||
42166505|NCT00112359|75973303|FG001|Overall Study|Lost to Follow-up|1|||
42166506|NCT00112359|75973302|FG000|Overall Study|Personal/administrative|1|||
42166507|NCT00112359|75973303|FG001|Overall Study|Personal/administrative|1|||
42166508|NCT00112359|75973302|FG000|Overall Study|Other|3|||
42166509|NCT00112359|75973303|FG001|Overall Study|Other|0|||
42166510|NCT00119379|75973311|FG000|Overall Study|Adverse Event|4|||
42166511|NCT00119379|75973312|FG001|Overall Study|Adverse Event|1|||
42166512|NCT00118911|75973320|FG000|Overall Study|Withdrawal by Subject|2|||
42166513|NCT00118911|75973321|FG001|Overall Study|Withdrawal by Subject|5|||
42166514|NCT00131937|75973327|FG000|Overall Study|Adverse Event|3|||
42166515|NCT00131937|75973327|FG000|Overall Study|Withdrawal by Subject|2|||
42166516|NCT00131937|75973327|FG000|Overall Study|Physician Decision|1|||
42166517|NCT00131937|75973327|FG000|Overall Study|Disease Progression|7|||
42166518|NCT00131937|75973327|FG000|Overall Study|Alternative therapy|1|||
42166519|NCT00131469|75973333|FG000|Overall Study|Withdrawal by Subject|3|||
42166520|NCT00131469|75973334|FG001|Overall Study|Withdrawal by Subject|4|||
42166521|NCT00131469|75973333|FG000|Overall Study|Protocol Violation|3|||
42166522|NCT00131469|75973334|FG001|Overall Study|Protocol Violation|1|||
42166523|NCT00131469|75973333|FG000|Overall Study|Death|0|||
42166524|NCT00131469|75973334|FG001|Overall Study|Death|1|||
42166525|NCT00131469|75973333|FG000|Overall Study|Lost to Follow-up|0|||
42166526|NCT00131469|75973334|FG001|Overall Study|Lost to Follow-up|1|||
42166527|NCT00131469|75973333|FG000|Overall Study|scan not analyzable|3|||
42166528|NCT00131469|75973334|FG001|Overall Study|scan not analyzable|6|||
42166529|NCT00372593|75973343|FG000|Overall Study|Adverse Event|43|||
42166530|NCT00372593|75973344|FG001|Overall Study|Adverse Event|45|||
42166531|NCT00372593|75973345|FG002|Overall Study|Adverse Event|0|||
42166532|NCT00372593|75973343|FG000|Overall Study|Death|16|||
42166533|NCT00372593|75973344|FG001|Overall Study|Death|20|||
42014279|NCT01292603|75821373|FG004|Overall Survival Status|Death|16|||
42282330|NCT01670877|76114127|FG004|Part I and Part 2|Grade 2 vomiting|0|||
42014280|NCT01292603|75821374|FG005|Overall Survival Status|Death|10|||
42014281|NCT01292057|75821397|FG000|Overall Study|Protocol Violation|1|||
42014282|NCT01292057|75821398|FG001|Overall Study|Protocol Violation|1|||
42014283|NCT01292057|75821397|FG000|Overall Study|Lost to Follow-up|1|||
42166534|NCT00372593|75973345|FG002|Overall Study|Death|1|||
42166535|NCT00372593|75973343|FG000|Overall Study|Lack of Efficacy|82|||
42166536|NCT00372593|75973344|FG001|Overall Study|Lack of Efficacy|71|||
42166537|NCT00372593|75973345|FG002|Overall Study|Lack of Efficacy|2|||
42014284|NCT01292057|75821398|FG001|Overall Study|Lost to Follow-up|1|||
42166538|NCT00372593|75973343|FG000|Overall Study|Lost to Follow-up|1|||
42166539|NCT00372593|75973344|FG001|Overall Study|Lost to Follow-up|0|||
42166540|NCT00372593|75973345|FG002|Overall Study|Lost to Follow-up|0|||
42166541|NCT00372593|75973343|FG000|Overall Study|Physician Decision|42|||
42166542|NCT00372593|75973344|FG001|Overall Study|Physician Decision|41|||
42166543|NCT00372593|75973345|FG002|Overall Study|Physician Decision|0|||
42166544|NCT00372593|75973343|FG000|Overall Study|Ineligible|20|||
42166545|NCT00372593|75973344|FG001|Overall Study|Ineligible|21|||
42166546|NCT00372593|75973345|FG002|Overall Study|Ineligible|1|||
42166547|NCT03666988|75973360|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
42166548|NCT03666988|75973361|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
42166549|NCT03666988|75973362|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
42166550|NCT03666988|75973363|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
42166551|NCT03666988|75973364|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
42166552|NCT03666988|75973365|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
42166553|NCT03666988|75973360|FG000|Part 1 (Up to 28 Months)|Other|0|||
42166554|NCT03666988|75973361|FG001|Part 1 (Up to 28 Months)|Other|1|||
42166555|NCT03666988|75973362|FG002|Part 1 (Up to 28 Months)|Other|1|||
42166556|NCT03666988|75973363|FG003|Part 1 (Up to 28 Months)|Other|0|||
42282331|NCT01670877|76114128|FG005|Part I and Part 2|Grade 2 vomiting|0|||
42282332|NCT01670877|76114123|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
42282333|NCT01670877|76114124|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
42282334|NCT01670877|76114125|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
42282335|NCT01670877|76114126|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
42166557|NCT03666988|75973364|FG004|Part 1 (Up to 28 Months)|Other|0|||
42166558|NCT03666988|75973365|FG005|Part 1 (Up to 28 Months)|Other|0|||
42166559|NCT03666988|75973360|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
42166560|NCT03666988|75973361|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
42166561|NCT03666988|75973362|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
42166562|NCT03666988|75973363|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
42166563|NCT03666988|75973364|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
42166564|NCT03666988|75973365|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
42166565|NCT03666988|75973360|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
42166566|NCT03666988|75973361|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
42166567|NCT03666988|75973362|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
42166568|NCT03666988|75973363|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
42166569|NCT03666988|75973364|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
42166570|NCT03666988|75973365|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
42166571|NCT03666988|75973360|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
42166572|NCT03666988|75973361|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
42166573|NCT03666988|75973362|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
42166574|NCT03666988|75973363|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
42166575|NCT03666988|75973364|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
42166576|NCT03666988|75973365|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
42166577|NCT00382109|75973385|FG000|Overall Study|Adverse Event|3|||
42282336|NCT01670877|76114127|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
42282337|NCT01670877|76114128|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
42282338|NCT01670877|76114123|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
42351886|NCT01544595|76191756|FG000|Status at Week 156|Lack of Efficacy|1|||
42351887|NCT01544595|76191757|FG001|Status at Week 156|Lack of Efficacy|0|||
42351888|NCT01544595|76191758|FG002|Status at Week 156|Lack of Efficacy|1|||
42351889|NCT01544595|76191759|FG003|Status at Week 156|Lack of Efficacy|4|||
42351890|NCT01544595|76191760|FG004|Status at Week 156|Lack of Efficacy|10|||
42351891|NCT01544595|76191761|FG005|Status at Week 156|Lack of Efficacy|5|||
42351892|NCT01539525|76191782|FG000|Overall Study|Lost to Follow-up|19|||
42351893|NCT01539525|76191783|FG001|Overall Study|Lost to Follow-up|12|||
42351894|NCT01539525|76191784|FG002|Overall Study|Lost to Follow-up|11|||
42351895|NCT01539525|76191782|FG000|Overall Study|Withdrawal by Subject|0|||
42351896|NCT01539525|76191783|FG001|Overall Study|Withdrawal by Subject|3|||
42351897|NCT01539525|76191784|FG002|Overall Study|Withdrawal by Subject|2|||
42351898|NCT01539525|76191782|FG000|Overall Study|Protocol Violation|1|||
42166578|NCT00382109|75973386|FG001|Overall Study|Adverse Event|0|||
42166579|NCT00382109|75973385|FG000|Overall Study|Physician Decision|6|||
42166580|NCT00382109|75973386|FG001|Overall Study|Physician Decision|1|||
42166581|NCT00382109|75973385|FG000|Overall Study|Withdrawal by Subject|1|||
42166582|NCT00382109|75973386|FG001|Overall Study|Withdrawal by Subject|0|||
42166583|NCT00382109|75973385|FG000|Overall Study|ineligible|2|||
42282339|NCT01670877|76114124|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
42351899|NCT01539525|76191783|FG001|Overall Study|Protocol Violation|1|||
42166584|NCT00382109|75973386|FG001|Overall Study|ineligible|0|||
42166585|NCT00382109|75973385|FG000|Overall Study|Other|0|||
42166586|NCT00382109|75973386|FG001|Overall Study|Other|2|||
42166587|NCT00382109|75973385|FG000|Overall Study|consent withdrawal|0|||
42166588|NCT00382109|75973386|FG001|Overall Study|consent withdrawal|1|||
42351900|NCT01539525|76191784|FG002|Overall Study|Protocol Violation|4|||
42282340|NCT01670877|76114125|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
42282341|NCT01670877|76114126|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
42282342|NCT01670877|76114127|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
42282343|NCT01670877|76114128|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
42282344|NCT00701129|76114142|FG000|Overall Study|Death|2|||
42282345|NCT01670721|76114146|FG000|Overall Study|Participant's decision|15|||
42166589|NCT03651622|75973398|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
42166590|NCT03651622|75973399|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
42166591|NCT03651622|75973400|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
42166592|NCT03651622|75973398|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
42166593|NCT03651622|75973399|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
42166594|NCT03651622|75973400|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
42166595|NCT03651622|75973398|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
42166596|NCT03651622|75973399|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
42166597|NCT03651622|75973400|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
42166598|NCT03651622|75973398|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
42166599|NCT03651622|75973399|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
42166600|NCT03651622|75973400|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
42166601|NCT03651622|75973398|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
42166602|NCT03651622|75973399|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
42166603|NCT03651622|75973400|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
42166604|NCT00381797|75973413|FG000|Overall Study|Withdrawal by Subject|1|||
42166605|NCT00381797|75973414|FG001|Overall Study|Withdrawal by Subject|1|||
42166606|NCT00381797|75973415|FG002|Overall Study|Withdrawal by Subject|0|||
42166607|NCT00381797|75973416|FG003|Overall Study|Withdrawal by Subject|0|||
42166608|NCT00381797|75973417|FG004|Overall Study|Withdrawal by Subject|2|||
42166609|NCT00381797|75973413|FG000|Overall Study|Ineligible|0|||
42166610|NCT00381797|75973414|FG001|Overall Study|Ineligible|0|||
42166611|NCT00381797|75973415|FG002|Overall Study|Ineligible|0|||
42166612|NCT00381797|75973416|FG003|Overall Study|Ineligible|1|||
42166613|NCT00381797|75973417|FG004|Overall Study|Ineligible|0|||
42166614|NCT03665038|75973453|FG000|Overall Study|Lost to Follow-up|0|||
42166615|NCT03665038|75973454|FG001|Overall Study|Lost to Follow-up|0|||
42166616|NCT03665038|75973455|FG002|Overall Study|Lost to Follow-up|1|||
42166617|NCT03664024|75973465|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
42166618|NCT03664024|75973465|FG000|Overall Study|Lost to Follow-up|2|||
42166619|NCT03664024|75973465|FG000|Overall Study|Withdrawal by Subject|2|||
42166620|NCT03664024|75973465|FG000|Overall Study|Death|80|||
42166621|NCT00381563|75973474|FG000|Overall Study|Withdrawal by Subject|5|||
42166622|NCT00381563|75973475|FG001|Overall Study|Withdrawal by Subject|5|||
42166623|NCT00381563|75973474|FG000|Overall Study|Lost to Follow-up|2|||
42166624|NCT00381563|75973475|FG001|Overall Study|Lost to Follow-up|0|||
42166625|NCT00381563|75973474|FG000|Overall Study|Protocol Violation|0|||
42166626|NCT00381563|75973475|FG001|Overall Study|Protocol Violation|1|||
42166627|NCT03624946|75973482|FG000|Overall Study|Lost to Follow-up|0|||
42166628|NCT03624946|75973483|FG001|Overall Study|Lost to Follow-up|1|||
42282346|NCT01670721|76114146|FG000|Overall Study|Other than specified above|38|||
42282347|NCT02711137|76114165|FG000|Overall Study|Death|1|||
42282348|NCT02711137|76114166|FG001|Overall Study|Death|4|||
42282349|NCT02711137|76114167|FG002|Overall Study|Death|5|||
42282350|NCT02711137|76114168|FG003|Overall Study|Death|5|||
42282351|NCT02711137|76114169|FG004|Overall Study|Death|3|||
42282352|NCT02711137|76114170|FG005|Overall Study|Death|1|||
42351901|NCT01513551|76191798|FG000|Overall Study|Death|0|||
42351902|NCT01513551|76191799|FG001|Overall Study|Death|1|||
42351903|NCT01513551|76191800|FG002|Overall Study|Death|0|||
42351904|NCT01513551|76191798|FG000|Overall Study|Lost to Follow-up|3|||
42351905|NCT01513551|76191799|FG001|Overall Study|Lost to Follow-up|5|||
42351906|NCT01513551|76191800|FG002|Overall Study|Lost to Follow-up|2|||
42351907|NCT01513551|76191798|FG000|Overall Study|Withdrawal by Subject|1|||
42351908|NCT01513551|76191799|FG001|Overall Study|Withdrawal by Subject|0|||
42166629|NCT00381095|75973495|FG000|Overall Study|Death|3|||
42351909|NCT01513551|76191800|FG002|Overall Study|Withdrawal by Subject|2|||
42166630|NCT00381095|75973496|FG001|Overall Study|Death|4|||
42166631|NCT00381095|75973495|FG000|Overall Study|Lack of Efficacy|2|||
42282353|NCT02711137|76114171|FG006|Overall Study|Death|61|||
42351910|NCT01513551|76191798|FG000|Overall Study|Randomized but not vaccinated|0|||
42166632|NCT00381095|75973496|FG001|Overall Study|Lack of Efficacy|4|||
42166633|NCT00381095|75973495|FG000|Overall Study|Other|2|||
42166634|NCT00381095|75973496|FG001|Overall Study|Other|2|||
42166635|NCT00381095|75973495|FG000|Overall Study|Protocol Violation|1|||
42166636|NCT00381095|75973496|FG001|Overall Study|Protocol Violation|1|||
42166637|NCT00381095|75973495|FG000|Overall Study|Withdrawal by Subject|3|||
42166638|NCT00381095|75973496|FG001|Overall Study|Withdrawal by Subject|3|||
42282354|NCT02711137|76114172|FG007|Overall Study|Death|3|||
42282355|NCT02711137|76114173|FG008|Overall Study|Death|0|||
42282356|NCT02711137|76114174|FG009|Overall Study|Death|1|||
42282357|NCT02711137|76114175|FG010|Overall Study|Death|1|||
42282358|NCT02711137|76114176|FG011|Overall Study|Death|1|||
42282359|NCT02711137|76114177|FG012|Overall Study|Death|0|||
42282360|NCT02711137|76114178|FG013|Overall Study|Death|0|||
42282361|NCT02711137|76114179|FG014|Overall Study|Death|0|||
42282362|NCT02711137|76114165|FG000|Overall Study|Study Terminated by Sponsor|0|||
42282363|NCT02711137|76114166|FG001|Overall Study|Study Terminated by Sponsor|0|||
42282364|NCT02711137|76114167|FG002|Overall Study|Study Terminated by Sponsor|1|||
42282365|NCT02711137|76114168|FG003|Overall Study|Study Terminated by Sponsor|0|||
42282366|NCT02711137|76114169|FG004|Overall Study|Study Terminated by Sponsor|0|||
42282367|NCT02711137|76114170|FG005|Overall Study|Study Terminated by Sponsor|0|||
42282368|NCT02711137|76114171|FG006|Overall Study|Study Terminated by Sponsor|1|||
42282369|NCT02711137|76114172|FG007|Overall Study|Study Terminated by Sponsor|0|||
42282370|NCT02711137|76114173|FG008|Overall Study|Study Terminated by Sponsor|0|||
42282371|NCT02711137|76114174|FG009|Overall Study|Study Terminated by Sponsor|0|||
42282372|NCT02711137|76114175|FG010|Overall Study|Study Terminated by Sponsor|0|||
42351911|NCT01513551|76191799|FG001|Overall Study|Randomized but not vaccinated|0|||
42351912|NCT01513551|76191800|FG002|Overall Study|Randomized but not vaccinated|1|||
42351913|NCT01513473|76191810|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
42351914|NCT01513473|76191811|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
42014285|NCT01291277|75821406|FG000|Overall Study|Death|2|||
42014286|NCT01291277|75821407|FG001|Overall Study|Death|2|||
42014287|NCT01291277|75821406|FG000|Overall Study|Lost to Follow-up|3|||
42014288|NCT01291277|75821407|FG001|Overall Study|Lost to Follow-up|1|||
42014289|NCT01290887|75821415|FG000|Overall Study|Adverse Event|6|||
42014290|NCT01290887|75821416|FG001|Overall Study|Adverse Event|11|||
42014291|NCT01290887|75821415|FG000|Overall Study|Lack of Efficacy|4|||
42014292|NCT01290887|75821416|FG001|Overall Study|Lack of Efficacy|5|||
42014293|NCT01290887|75821415|FG000|Overall Study|Withdrawal by Subject|26|||
42014294|NCT01290887|75821416|FG001|Overall Study|Withdrawal by Subject|32|||
42351915|NCT01513473|76191810|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
42351916|NCT01513473|76191811|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
42014295|NCT01290887|75821415|FG000|Overall Study|Protocol Violation|2|||
42014296|NCT01290887|75821416|FG001|Overall Study|Protocol Violation|1|||
42166639|NCT00381095|75973495|FG000|Overall Study|Adverse Event|2|||
42166640|NCT00381095|75973496|FG001|Overall Study|Adverse Event|7|||
42166641|NCT03619174|75973504|FG000|Overall Study|Lost to Follow-up|3|||
42166642|NCT03619174|75973505|FG001|Overall Study|Lost to Follow-up|0|||
42166643|NCT03619174|75973504|FG000|Overall Study|Withdrawal by Subject|4|||
42166644|NCT03619174|75973505|FG001|Overall Study|Withdrawal by Subject|3|||
42166645|NCT03619174|75973504|FG000|Overall Study|Pregnancy|1|||
42166646|NCT03619174|75973505|FG001|Overall Study|Pregnancy|1|||
42166647|NCT03619174|75973504|FG000|Overall Study|Discomfort during treatment|1|||
42166648|NCT03619174|75973505|FG001|Overall Study|Discomfort during treatment|0|||
42166649|NCT00112047|75973513|FG000|Randomized Phase|Lost to Follow-up|26|||
42166650|NCT00112047|75973514|FG001|Randomized Phase|Lost to Follow-up|33|||
42166651|NCT00112047|75973513|FG000|Randomized Phase|Adverse Event|10|||
42166652|NCT00112047|75973514|FG001|Randomized Phase|Adverse Event|10|||
42166653|NCT00112047|75973513|FG000|Randomized Phase|Withrawal of consent|10|||
42166654|NCT00112047|75973514|FG001|Randomized Phase|Withrawal of consent|18|||
42166655|NCT00112047|75973513|FG000|Randomized Phase|Sub-optimal virological response|3|||
42166656|NCT00112047|75973514|FG001|Randomized Phase|Sub-optimal virological response|13|||
42166657|NCT00112047|75973513|FG000|Randomized Phase|Noncompliance|8|||
42166658|NCT00112047|75973514|FG001|Randomized Phase|Noncompliance|4|||
42166659|NCT00112047|75973513|FG000|Randomized Phase|Protocol Violation|2|||
42166660|NCT00112047|75973514|FG001|Randomized Phase|Protocol Violation|0|||
42166661|NCT00112047|75973513|FG000|Randomized Phase|Pregnancy|3|||
42166662|NCT00112047|75973514|FG001|Randomized Phase|Pregnancy|1|||
42166663|NCT00112047|75973513|FG000|Randomized Phase|Death|1|||
42166664|NCT00112047|75973514|FG001|Randomized Phase|Death|3|||
42166665|NCT00112047|75973513|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
42166666|NCT00112047|75973514|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
42282373|NCT02711137|76114176|FG011|Overall Study|Study Terminated by Sponsor|0|||
42351917|NCT01513473|76191810|FG000|Main Trial (26 Weeks)|Unclassified|0|||
42166667|NCT00112047|75973513|FG000|Randomized Phase|Inability to swallow pills|0|||
42166668|NCT00112047|75973514|FG001|Randomized Phase|Inability to swallow pills|1|||
42166669|NCT00112047|75973513|FG000|Randomized Phase|Incarceration|3|||
42166670|NCT00112047|75973514|FG001|Randomized Phase|Incarceration|2|||
42351918|NCT01513473|76191811|FG001|Main Trial (26 Weeks)|Unclassified|2|||
42351919|NCT01513473|76191810|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
42351920|NCT01513473|76191811|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
42014297|NCT01290887|75821415|FG000|Overall Study|Lost to Follow-up|4|||
42014298|NCT01290887|75821416|FG001|Overall Study|Lost to Follow-up|4|||
42351921|NCT01513473|76191810|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
42351922|NCT01513473|76191811|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
42351923|NCT01513317|76191819|FG000|Overall Study|Withdrawal by Subject|15|||
42351924|NCT01513317|76191820|FG001|Overall Study|Withdrawal by Subject|4|||
42351925|NCT01513317|76191819|FG000|Overall Study|Death|1|||
42351926|NCT01513317|76191820|FG001|Overall Study|Death|1|||
42351927|NCT01513317|76191819|FG000|Overall Study|Study terminated by sponsor|18|||
42351928|NCT01513317|76191820|FG001|Overall Study|Study terminated by sponsor|18|||
42351929|NCT01513317|76191819|FG000|Overall Study|Other|0|||
42351930|NCT01513317|76191820|FG001|Overall Study|Other|1|||
42351931|NCT03824392|76191830|FG000|Overall Study|Adverse Event|1|||
42351932|NCT03824392|76191831|FG001|Overall Study|Adverse Event|0|||
42351933|NCT03824392|76191832|FG002|Overall Study|Adverse Event|0|||
42351934|NCT03824392|76191833|FG003|Overall Study|Adverse Event|0|||
42351935|NCT03824392|76191830|FG000|Overall Study|Investigator Decision|0|||
42351936|NCT03824392|76191831|FG001|Overall Study|Investigator Decision|1|||
42351937|NCT03824392|76191832|FG002|Overall Study|Investigator Decision|0|||
42351938|NCT03824392|76191833|FG003|Overall Study|Investigator Decision|0|||
42351939|NCT03824392|76191830|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
42351940|NCT03824392|76191831|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
42351941|NCT03824392|76191832|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
42351942|NCT03824392|76191833|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
42351943|NCT01901653|76191856|FG000|Overall Study|Death|2|||
42351944|NCT01901653|76191857|FG001|Overall Study|Death|1|||
42351945|NCT01901653|76191858|FG002|Overall Study|Death|8|||
42351946|NCT01901653|76191859|FG003|Overall Study|Death|3|||
42351947|NCT01901653|76191860|FG004|Overall Study|Death|2|||
42351948|NCT01901653|76191861|FG005|Overall Study|Death|2|||
42351949|NCT01901653|76191862|FG006|Overall Study|Death|6|||
42351950|NCT01901653|76191863|FG007|Overall Study|Death|9|||
42351951|NCT01901653|76191864|FG008|Overall Study|Death|1|||
42351952|NCT01901653|76191865|FG009|Overall Study|Death|16|||
42351953|NCT01901653|76191866|FG010|Overall Study|Death|2|||
42351954|NCT01901653|76191867|FG011|Overall Study|Death|15|||
42351955|NCT01901653|76191868|FG012|Overall Study|Death|4|||
42351956|NCT01901653|76191856|FG000|Overall Study|Lost to Follow-up|1|||
42351957|NCT01901653|76191857|FG001|Overall Study|Lost to Follow-up|0|||
42351958|NCT01901653|76191858|FG002|Overall Study|Lost to Follow-up|2|||
42014299|NCT01290887|75821415|FG000|Overall Study|Non-compliance to study procedures|0|||
42014300|NCT01290887|75821416|FG001|Overall Study|Non-compliance to study procedures|1|||
42014301|NCT01290887|75821415|FG000|Overall Study|Non-compliance to study medications|1|||
42014302|NCT01290887|75821416|FG001|Overall Study|Non-compliance to study medications|0|||
42014303|NCT01290887|75821415|FG000|Overall Study|Sponsor closure of study|420|||
42014304|NCT01290887|75821416|FG001|Overall Study|Sponsor closure of study|476|||
42014305|NCT01290887|75821415|FG000|Overall Study|Other|3|||
42014306|NCT01290887|75821416|FG001|Overall Study|Other|6|||
42014307|NCT01290731|75821422|FG000|Overall Study|Withdrawal by Subject|1|||
42014308|NCT01290341|75821428|FG000|Overall Study|Protocol Violation|7|||
42014309|NCT01290341|75821429|FG001|Overall Study|Protocol Violation|3|||
42014310|NCT01290341|75821428|FG000|Overall Study|Adverse Event|1|||
42014311|NCT01290341|75821429|FG001|Overall Study|Adverse Event|0|||
42014312|NCT01290341|75821428|FG000|Overall Study|Lost to Follow-up|21|||
42014313|NCT01290341|75821429|FG001|Overall Study|Lost to Follow-up|10|||
42014314|NCT01290341|75821428|FG000|Overall Study|Withdrawal by Subject|19|||
42014315|NCT01290341|75821429|FG001|Overall Study|Withdrawal by Subject|5|||
42014316|NCT01290341|75821428|FG000|Overall Study|Negative baseline culture and others|44|||
42282374|NCT02711137|76114177|FG012|Overall Study|Study Terminated by Sponsor|0|||
42282375|NCT02711137|76114178|FG013|Overall Study|Study Terminated by Sponsor|0|||
42282376|NCT02711137|76114179|FG014|Overall Study|Study Terminated by Sponsor|0|||
42282377|NCT02711137|76114165|FG000|Overall Study|Physician Decision|1|||
42282378|NCT02711137|76114166|FG001|Overall Study|Physician Decision|0|||
42282379|NCT02711137|76114167|FG002|Overall Study|Physician Decision|2|||
42282380|NCT02711137|76114168|FG003|Overall Study|Physician Decision|1|||
42282381|NCT02711137|76114169|FG004|Overall Study|Physician Decision|1|||
42282382|NCT02711137|76114170|FG005|Overall Study|Physician Decision|0|||
42282383|NCT02711137|76114171|FG006|Overall Study|Physician Decision|12|||
42282384|NCT02711137|76114172|FG007|Overall Study|Physician Decision|2|||
42282385|NCT02711137|76114173|FG008|Overall Study|Physician Decision|1|||
42282386|NCT02711137|76114174|FG009|Overall Study|Physician Decision|1|||
42351959|NCT01901653|76191859|FG003|Overall Study|Lost to Follow-up|0|||
42351960|NCT01901653|76191860|FG004|Overall Study|Lost to Follow-up|0|||
42351961|NCT01901653|76191861|FG005|Overall Study|Lost to Follow-up|1|||
42351962|NCT01901653|76191862|FG006|Overall Study|Lost to Follow-up|0|||
42166671|NCT00112047|75973513|FG000|Randomized Phase|Moved out of State|0|||
42166672|NCT00112047|75973514|FG001|Randomized Phase|Moved out of State|1|||
42166673|NCT00112047|75973513|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
42166674|NCT00112047|75973514|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
42166675|NCT00112047|75973513|FG000|Randomized Phase|High Hepatitis B DNA|0|||
42166676|NCT00112047|75973514|FG001|Randomized Phase|High Hepatitis B DNA|1|||
42166677|NCT00112047|75973513|FG000|Atripla Phase|Adverse Event|2|||
42166678|NCT00112047|75973514|FG001|Atripla Phase|Adverse Event|1|||
42166679|NCT00112047|75973513|FG000|Atripla Phase|Lost to Follow-up|5|||
42166680|NCT00112047|75973514|FG001|Atripla Phase|Lost to Follow-up|7|||
42166681|NCT00112047|75973513|FG000|Atripla Phase|Pregnancy|0|||
42166682|NCT00112047|75973514|FG001|Atripla Phase|Pregnancy|1|||
42166683|NCT00112047|75973513|FG000|Atripla Phase|Death|0|||
42166684|NCT00112047|75973514|FG001|Atripla Phase|Death|2|||
42166685|NCT00112047|75973513|FG000|Atripla Phase|Withdrew consent|7|||
42166686|NCT00112047|75973514|FG001|Atripla Phase|Withdrew consent|7|||
42166687|NCT00112047|75973513|FG000|Atripla Phase|Sub-optimal virological response|0|||
42166688|NCT00112047|75973514|FG001|Atripla Phase|Sub-optimal virological response|1|||
42166689|NCT00112047|75973513|FG000|Atripla Phase|Non-compliance|1|||
42166690|NCT00112047|75973514|FG001|Atripla Phase|Non-compliance|0|||
42166691|NCT00112047|75973513|FG000|Atripla Phase|Other|3|||
42166692|NCT00112047|75973514|FG001|Atripla Phase|Other|1|||
42166693|NCT03658876|75973527|FG000|Overall Study|Protocol Violation|3|||
42166694|NCT03658876|75973528|FG001|Overall Study|Protocol Violation|2|||
42166695|NCT03658876|75973527|FG000|Overall Study|Withdrawal by Subject|2|||
42166696|NCT03658876|75973528|FG001|Overall Study|Withdrawal by Subject|0|||
42166697|NCT03658876|75973527|FG000|Overall Study|Death|0|||
42166698|NCT03658876|75973528|FG001|Overall Study|Death|1|||
42166699|NCT03658876|75973527|FG000|Overall Study|Intercurrent illness|6|||
42166700|NCT03658876|75973528|FG001|Overall Study|Intercurrent illness|4|||
42166701|NCT03658876|75973527|FG000|Overall Study|Transplantation/other operation|1|||
42166702|NCT03658876|75973528|FG001|Overall Study|Transplantation/other operation|5|||
42166703|NCT03618628|75973534|FG000|Overall Study|Death|1|||
42166704|NCT03618628|75973534|FG000|Overall Study|Lost to Follow-up|1|||
42014317|NCT01290341|75821429|FG001|Overall Study|Negative baseline culture and others|11|||
42014318|NCT01290263|75821437|FG000|Overall Study|Adverse Event|0|||
42014319|NCT01290263|75821438|FG001|Overall Study|Adverse Event|0|||
42014320|NCT01290263|75821439|FG002|Overall Study|Adverse Event|0|||
42014321|NCT01290263|75821440|FG003|Overall Study|Adverse Event|1|||
42014322|NCT01290263|75821441|FG004|Overall Study|Adverse Event|1|||
42014323|NCT01290263|75821437|FG000|Overall Study|Lack of Efficacy|8|||
42014324|NCT01290263|75821438|FG001|Overall Study|Lack of Efficacy|2|||
42166705|NCT03617770|75973540|FG000|Overall Study|Lost to Follow-up|1|||
42166706|NCT03617770|75973541|FG001|Overall Study|Lost to Follow-up|0|||
42166707|NCT03616600|75973549|FG000|Overall Study|Withdrawal by Subject|1|||
42166708|NCT03616600|75973550|FG001|Overall Study|Withdrawal by Subject|0|||
42166709|NCT00380393|75973559|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
42166710|NCT00380393|75973560|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
42166711|NCT00380393|75973559|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
42166712|NCT00380393|75973560|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
42166713|NCT00380393|75973559|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
42166714|NCT00380393|75973560|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
42166715|NCT00380393|75973559|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
42166716|NCT00380393|75973560|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
42166717|NCT00380393|75973559|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
42166718|NCT00380393|75973560|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
42166719|NCT00380393|75973559|FG000|Month 14|Withdrawal by Subject|9|||
42166720|NCT00380393|75973560|FG001|Month 14|Withdrawal by Subject|7|||
42166721|NCT00380393|75973559|FG000|Month 14|Death|1|||
42166722|NCT00380393|75973560|FG001|Month 14|Death|0|||
42166723|NCT00380393|75973559|FG000|Month 14|Lost to Follow-up|0|||
42014325|NCT01290263|75821439|FG002|Overall Study|Lack of Efficacy|7|||
42014326|NCT01290263|75821440|FG003|Overall Study|Lack of Efficacy|24|||
42014327|NCT01290263|75821441|FG004|Overall Study|Lack of Efficacy|33|||
42166724|NCT00380393|75973560|FG001|Month 14|Lost to Follow-up|1|||
42166725|NCT00380393|75973559|FG000|Month 14|Migrated/moved from study area|39|||
42166726|NCT00380393|75973560|FG001|Month 14|Migrated/moved from study area|42|||
42166727|NCT00380393|75973559|FG000|Month 14|Protocol Violation|2|||
42282387|NCT02711137|76114175|FG010|Overall Study|Physician Decision|3|||
42014328|NCT01290263|75821437|FG000|Overall Study|Withdrawal by Subject|3|||
42014329|NCT01290263|75821438|FG001|Overall Study|Withdrawal by Subject|1|||
42166728|NCT00380393|75973560|FG001|Month 14|Protocol Violation|0|||
42166729|NCT00380393|75973559|FG000|Month 14|Others|6|||
42166730|NCT00380393|75973560|FG001|Month 14|Others|6|||
42166731|NCT00380081|75973572|FG000|Overall Study|Withdrawal by Subject|0|||
42166732|NCT00380081|75973573|FG001|Overall Study|Withdrawal by Subject|0|||
42166733|NCT00380081|75973574|FG002|Overall Study|Withdrawal by Subject|0|||
42282388|NCT02711137|76114176|FG011|Overall Study|Physician Decision|2|||
42166734|NCT00380081|75973575|FG003|Overall Study|Withdrawal by Subject|0|||
42166735|NCT00380081|75973576|FG004|Overall Study|Withdrawal by Subject|1|||
42166736|NCT00380081|75973577|FG005|Overall Study|Withdrawal by Subject|0|||
42166737|NCT00380081|75973572|FG000|Overall Study|Family Emergency|0|||
42166738|NCT00380081|75973573|FG001|Overall Study|Family Emergency|0|||
42166739|NCT00380081|75973574|FG002|Overall Study|Family Emergency|0|||
42166740|NCT00380081|75973575|FG003|Overall Study|Family Emergency|0|||
42166741|NCT00380081|75973576|FG004|Overall Study|Family Emergency|0|||
42166742|NCT00380081|75973577|FG005|Overall Study|Family Emergency|1|||
42166743|NCT03579940|75973596|FG000|Period 2|Withdrawal by Subject|0|||
42166744|NCT03579940|75973597|FG001|Period 2|Withdrawal by Subject|0|||
42166745|NCT03579940|75973598|FG002|Period 2|Withdrawal by Subject|1|||
42166746|NCT03579940|75973599|FG003|Period 2|Withdrawal by Subject|0|||
42166747|NCT03579940|75973600|FG004|Period 2|Withdrawal by Subject|0|||
42166748|NCT03579940|75973601|FG005|Period 2|Withdrawal by Subject|0|||
42166749|NCT03579940|75973602|FG006|Period 2|Withdrawal by Subject|0|||
42166750|NCT03579940|75973603|FG007|Period 2|Withdrawal by Subject|0|||
42166751|NCT03579940|75973604|FG008|Period 2|Withdrawal by Subject|0|||
42166752|NCT03579940|75973605|FG009|Period 2|Withdrawal by Subject|0|||
42166753|NCT03579940|75973606|FG010|Period 2|Withdrawal by Subject|0|||
42166754|NCT00098306|75973641|FG000|Double Blind|Randomized, not treated|9|||
42166755|NCT00098306|75973642|FG001|Double Blind|Randomized, not treated|5|||
42166756|NCT00098306|75973643|FG002|Double Blind|Randomized, not treated|2|||
42166757|NCT00098306|75973644|FG003|Double Blind|Randomized, not treated|0|||
42166758|NCT00098306|75973645|FG004|Double Blind|Randomized, not treated|0|||
42166759|NCT00098306|75973646|FG005|Double Blind|Randomized, not treated|0|||
42166760|NCT00098306|75973647|FG006|Double Blind|Randomized, not treated|0|||
42166761|NCT00098306|75973641|FG000|Double Blind|Ongoing at cut-off date|151|||
42166762|NCT00098306|75973642|FG001|Double Blind|Ongoing at cut-off date|166|||
42166763|NCT00098306|75973643|FG002|Double Blind|Ongoing at cut-off date|72|||
42166764|NCT00098306|75973644|FG003|Double Blind|Ongoing at cut-off date|0|||
42166765|NCT00098306|75973645|FG004|Double Blind|Ongoing at cut-off date|0|||
42166766|NCT00098306|75973646|FG005|Double Blind|Ongoing at cut-off date|0|||
42166767|NCT00098306|75973647|FG006|Double Blind|Ongoing at cut-off date|0|||
42166768|NCT00098306|75973641|FG000|Double Blind|Adverse Event|11|||
42166769|NCT00098306|75973642|FG001|Double Blind|Adverse Event|10|||
42166770|NCT00098306|75973643|FG002|Double Blind|Adverse Event|6|||
42166771|NCT00098306|75973644|FG003|Double Blind|Adverse Event|0|||
42166772|NCT00098306|75973645|FG004|Double Blind|Adverse Event|0|||
42166773|NCT00098306|75973646|FG005|Double Blind|Adverse Event|0|||
42040611|NCT01796171|75848711|FG005|Treatment Period With Betalutin|Death|0|||
42040612|NCT01796171|75848712|FG006|Treatment Period With Betalutin|Death|0|||
42040613|NCT01796171|75848713|FG007|Treatment Period With Betalutin|Death|0|||
42040614|NCT01796171|75848714|FG008|Treatment Period With Betalutin|Death|0|||
42040615|NCT01796171|75848715|FG009|Treatment Period With Betalutin|Death|0|||
42040616|NCT01796171|75848716|FG010|Treatment Period With Betalutin|Death|2|||
42166774|NCT00098306|75973647|FG006|Double Blind|Adverse Event|0|||
42166775|NCT00098306|75973641|FG000|Double Blind|Lack of Efficacy|43|||
42166776|NCT00098306|75973642|FG001|Double Blind|Lack of Efficacy|34|||
42166777|NCT00098306|75973643|FG002|Double Blind|Lack of Efficacy|17|||
42166778|NCT00098306|75973644|FG003|Double Blind|Lack of Efficacy|0|||
42166779|NCT00098306|75973645|FG004|Double Blind|Lack of Efficacy|0|||
42166780|NCT00098306|75973646|FG005|Double Blind|Lack of Efficacy|0|||
42166781|NCT00098306|75973647|FG006|Double Blind|Lack of Efficacy|0|||
42166782|NCT00098306|75973641|FG000|Double Blind|Death|1|||
42166783|NCT00098306|75973642|FG001|Double Blind|Death|4|||
42166784|NCT00098306|75973643|FG002|Double Blind|Death|1|||
42166785|NCT00098306|75973644|FG003|Double Blind|Death|0|||
42166786|NCT00098306|75973645|FG004|Double Blind|Death|0|||
42166787|NCT00098306|75973646|FG005|Double Blind|Death|0|||
42166788|NCT00098306|75973647|FG006|Double Blind|Death|0|||
42166789|NCT00098306|75973641|FG000|Double Blind|Participant defaulted|19|||
42166790|NCT00098306|75973642|FG001|Double Blind|Participant defaulted|18|||
42166791|NCT00098306|75973643|FG002|Double Blind|Participant defaulted|11|||
42166792|NCT00098306|75973644|FG003|Double Blind|Participant defaulted|0|||
42166793|NCT00098306|75973645|FG004|Double Blind|Participant defaulted|0|||
42040617|NCT01796171|75848717|FG011|Treatment Period With Betalutin|Death|0|||
42166794|NCT00098306|75973646|FG005|Double Blind|Participant defaulted|0|||
42166795|NCT00098306|75973647|FG006|Double Blind|Participant defaulted|0|||
42166796|NCT00098306|75973641|FG000|Double Blind|Un-specified|7|||
42166797|NCT00098306|75973642|FG001|Double Blind|Un-specified|3|||
42166798|NCT00098306|75973643|FG002|Double Blind|Un-specified|11|||
42166799|NCT00098306|75973644|FG003|Double Blind|Un-specified|0|||
42166800|NCT00098306|75973645|FG004|Double Blind|Un-specified|0|||
42166801|NCT00098306|75973646|FG005|Double Blind|Un-specified|0|||
42166802|NCT00098306|75973647|FG006|Double Blind|Un-specified|0|||
42166803|NCT00098306|75973641|FG000|Open Label|Lack of Efficacy|0|||
42166804|NCT00098306|75973642|FG001|Open Label|Lack of Efficacy|0|||
42166805|NCT00098306|75973643|FG002|Open Label|Lack of Efficacy|0|||
42166806|NCT00098306|75973644|FG003|Open Label|Lack of Efficacy|13|||
42166807|NCT00098306|75973645|FG004|Open Label|Lack of Efficacy|0|||
42166808|NCT00098306|75973646|FG005|Open Label|Lack of Efficacy|0|||
42166809|NCT00098306|75973647|FG006|Open Label|Lack of Efficacy|0|||
42166810|NCT00098306|75973641|FG000|Open Label|Adverse Event|0|||
42166811|NCT00098306|75973642|FG001|Open Label|Adverse Event|0|||
42166812|NCT00098306|75973643|FG002|Open Label|Adverse Event|0|||
42166813|NCT00098306|75973644|FG003|Open Label|Adverse Event|2|||
42166814|NCT00098306|75973645|FG004|Open Label|Adverse Event|0|||
42166815|NCT00098306|75973646|FG005|Open Label|Adverse Event|0|||
42166816|NCT00098306|75973647|FG006|Open Label|Adverse Event|0|||
42166817|NCT00098306|75973641|FG000|Open Label|Death|0|||
42166818|NCT00098306|75973642|FG001|Open Label|Death|0|||
42166819|NCT00098306|75973643|FG002|Open Label|Death|0|||
42166820|NCT00098306|75973644|FG003|Open Label|Death|4|||
42166821|NCT00098306|75973645|FG004|Open Label|Death|0|||
42166822|NCT00098306|75973646|FG005|Open Label|Death|0|||
42166823|NCT00098306|75973647|FG006|Open Label|Death|0|||
42166824|NCT00098306|75973641|FG000|Open Label|Participant defaulted|0|||
42166825|NCT00098306|75973642|FG001|Open Label|Participant defaulted|0|||
42166826|NCT00098306|75973643|FG002|Open Label|Participant defaulted|0|||
42166827|NCT00098306|75973644|FG003|Open Label|Participant defaulted|24|||
42166828|NCT00098306|75973645|FG004|Open Label|Participant defaulted|0|||
42166829|NCT00098306|75973646|FG005|Open Label|Participant defaulted|0|||
42166830|NCT00098306|75973647|FG006|Open Label|Participant defaulted|0|||
42166831|NCT00098306|75973641|FG000|Open Label|Un-specified|0|||
42166832|NCT00098306|75973642|FG001|Open Label|Un-specified|0|||
42166833|NCT00098306|75973643|FG002|Open Label|Un-specified|0|||
42166834|NCT00098306|75973644|FG003|Open Label|Un-specified|15|||
42166835|NCT00098306|75973645|FG004|Open Label|Un-specified|0|||
42166836|NCT00098306|75973646|FG005|Open Label|Un-specified|0|||
42166837|NCT00098306|75973647|FG006|Open Label|Un-specified|0|||
42166838|NCT00098306|75973641|FG000|Open Label|Ongoing at cut-off date|0|||
42166839|NCT00098306|75973642|FG001|Open Label|Ongoing at cut-off date|0|||
42166840|NCT00098306|75973643|FG002|Open Label|Ongoing at cut-off date|0|||
42166841|NCT00098306|75973644|FG003|Open Label|Ongoing at cut-off date|269|||
42166842|NCT00098306|75973645|FG004|Open Label|Ongoing at cut-off date|62|||
42166843|NCT00098306|75973646|FG005|Open Label|Ongoing at cut-off date|0|||
42166844|NCT00098306|75973647|FG006|Open Label|Ongoing at cut-off date|0|||
42166845|NCT00098306|75973641|FG000|Observational Phase|Death|0|||
42166846|NCT00098306|75973642|FG001|Observational Phase|Death|0|||
42166847|NCT00098306|75973643|FG002|Observational Phase|Death|0|||
42166848|NCT00098306|75973644|FG003|Observational Phase|Death|0|||
42166849|NCT00098306|75973645|FG004|Observational Phase|Death|0|||
42166850|NCT00098306|75973646|FG005|Observational Phase|Death|5|||
42014330|NCT01290263|75821439|FG002|Overall Study|Withdrawal by Subject|0|||
42166851|NCT00098306|75973647|FG006|Observational Phase|Death|4|||
42166852|NCT00098306|75973641|FG000|Observational Phase|Participant defaulted|0|||
42014331|NCT01290263|75821440|FG003|Overall Study|Withdrawal by Subject|1|||
42282389|NCT02711137|76114177|FG012|Overall Study|Physician Decision|1|||
42282390|NCT02711137|76114178|FG013|Overall Study|Physician Decision|1|||
42282391|NCT02711137|76114179|FG014|Overall Study|Physician Decision|2|||
42282392|NCT02711137|76114165|FG000|Overall Study|Other|0|||
42282393|NCT02711137|76114166|FG001|Overall Study|Other|1|||
42282394|NCT02711137|76114167|FG002|Overall Study|Other|0|||
42282395|NCT02711137|76114168|FG003|Overall Study|Other|0|||
42282396|NCT02711137|76114169|FG004|Overall Study|Other|0|||
42282397|NCT02711137|76114170|FG005|Overall Study|Other|0|||
42282398|NCT02711137|76114171|FG006|Overall Study|Other|3|||
42166853|NCT00098306|75973642|FG001|Observational Phase|Participant defaulted|0|||
42166854|NCT00098306|75973643|FG002|Observational Phase|Participant defaulted|0|||
42166855|NCT00098306|75973644|FG003|Observational Phase|Participant defaulted|0|||
42166856|NCT00098306|75973645|FG004|Observational Phase|Participant defaulted|0|||
42282399|NCT02711137|76114172|FG007|Overall Study|Other|0|||
42166857|NCT00098306|75973646|FG005|Observational Phase|Participant defaulted|34|||
42166858|NCT00098306|75973647|FG006|Observational Phase|Participant defaulted|18|||
42282400|NCT02711137|76114173|FG008|Overall Study|Other|0|||
42166859|NCT00098306|75973641|FG000|Observational Phase|Un-specified|0|||
42166860|NCT00098306|75973642|FG001|Observational Phase|Un-specified|0|||
42166861|NCT00098306|75973643|FG002|Observational Phase|Un-specified|0|||
42282401|NCT02711137|76114174|FG009|Overall Study|Other|0|||
42282402|NCT02711137|76114175|FG010|Overall Study|Other|0|||
42166862|NCT00098306|75973644|FG003|Observational Phase|Un-specified|0|||
42166863|NCT00098306|75973645|FG004|Observational Phase|Un-specified|0|||
42166864|NCT00098306|75973646|FG005|Observational Phase|Un-specified|7|||
42166865|NCT00098306|75973647|FG006|Observational Phase|Un-specified|4|||
42166866|NCT03615040|75973662|FG000|Overall Study|Withdrawal by Subject|2|||
42166867|NCT03615040|75973663|FG001|Overall Study|Withdrawal by Subject|1|||
42282403|NCT02711137|76114176|FG011|Overall Study|Other|0|||
42282404|NCT02711137|76114177|FG012|Overall Study|Other|0|||
42166868|NCT03615040|75973662|FG000|Overall Study|Physician Decision|2|||
42166869|NCT03615040|75973663|FG001|Overall Study|Physician Decision|2|||
42166870|NCT03615040|75973662|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
42282405|NCT02711137|76114178|FG013|Overall Study|Other|0|||
42166871|NCT03615040|75973663|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
42166872|NCT03615040|75973662|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
42166873|NCT03615040|75973663|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
42282406|NCT02711137|76114179|FG014|Overall Study|Other|1|||
42282407|NCT02711137|76114165|FG000|Overall Study|Withdrawal by Subject|1|||
42282408|NCT02711137|76114166|FG001|Overall Study|Withdrawal by Subject|0|||
42282409|NCT02711137|76114167|FG002|Overall Study|Withdrawal by Subject|0|||
42282410|NCT02711137|76114168|FG003|Overall Study|Withdrawal by Subject|1|||
42166874|NCT03615040|75973662|FG000|Overall Study|Death|0|||
42166875|NCT03615040|75973663|FG001|Overall Study|Death|2|||
42166876|NCT00068822|75973671|FG000|First Randomized Intervention|Lost to Follow-up|1|||
42166877|NCT00068822|75973672|FG001|First Randomized Intervention|Lost to Follow-up|2|||
42166878|NCT00068588|75973681|FG000|Overall Study|Adverse Event|0|||
42166879|NCT00068588|75973682|FG001|Overall Study|Adverse Event|0|||
42166880|NCT00068588|75973683|FG002|Overall Study|Adverse Event|2|||
42166881|NCT00068588|75973681|FG000|Overall Study|Withdrawal by Subject|0|||
42166882|NCT00068588|75973682|FG001|Overall Study|Withdrawal by Subject|0|||
42166883|NCT00068588|75973683|FG002|Overall Study|Withdrawal by Subject|1|||
42166884|NCT00068588|75973681|FG000|Overall Study|Poor KPS|0|||
42166885|NCT00068588|75973682|FG001|Overall Study|Poor KPS|0|||
42166886|NCT00068588|75973683|FG002|Overall Study|Poor KPS|1|||
42166887|NCT03650452|75973692|FG000|Overall Study|Physician Decision|1|||
42166888|NCT03650452|75973693|FG001|Overall Study|Physician Decision|0|||
42166889|NCT03650452|75973692|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
42166890|NCT03650452|75973693|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
42166891|NCT03650452|75973692|FG000|Overall Study|Adverse Event|3|||
42166892|NCT03650452|75973693|FG001|Overall Study|Adverse Event|4|||
42166893|NCT03650452|75973692|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
42166894|NCT03650452|75973693|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
42166895|NCT03575806|75973701|FG000|Overall Study|Withdrawal by Subject|0|||
42166896|NCT03575806|75973702|FG001|Overall Study|Withdrawal by Subject|2|||
42166897|NCT03575806|75973701|FG000|Overall Study|Protocol Violation|0|||
42166898|NCT03575806|75973702|FG001|Overall Study|Protocol Violation|2|||
42166899|NCT03610048|75973708|FG000|Overall Study|Study terminated by sponsor|84|||
42166900|NCT03610048|75973708|FG000|Overall Study|Adverse Event|32|||
42166901|NCT03610048|75973708|FG000|Overall Study|Withdrawal by Subject|31|||
42166902|NCT03610048|75973708|FG000|Overall Study|Lost to Follow-up|8|||
42166903|NCT03610048|75973708|FG000|Overall Study|Other|4|||
42166904|NCT03610048|75973708|FG000|Overall Study|Physician Decision|1|||
42166905|NCT03610048|75973708|FG000|Overall Study|Pregnancy|1|||
42166906|NCT03608254|75973712|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
42166907|NCT03608254|75973712|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
42166908|NCT03606460|75973718|FG000|Overall Study|Lost to Follow-up|1|||
42166909|NCT03606460|75973719|FG001|Overall Study|Lost to Follow-up|8|||
42166910|NCT03605836|75973730|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
42166911|NCT03605836|75973731|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
42166912|NCT03605836|75973732|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
42166913|NCT03605836|75973733|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
42166914|NCT03605836|75973730|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
42166915|NCT03605836|75973731|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
42166916|NCT03605836|75973732|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
42166917|NCT03605836|75973733|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
42166918|NCT03605836|75973730|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
42166919|NCT03605836|75973731|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
42166920|NCT03605836|75973732|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
42166921|NCT03605836|75973733|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
42166922|NCT03605836|75973730|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
42166923|NCT03605836|75973731|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
42166924|NCT03605836|75973732|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
42166925|NCT03605836|75973733|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
42166926|NCT03605836|75973730|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
42166927|NCT03605836|75973731|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
42166928|NCT03605836|75973732|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
42166929|NCT03605836|75973733|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
42166930|NCT03605836|75973730|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
42166931|NCT03605836|75973731|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
42166932|NCT03605836|75973732|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
42166933|NCT03605836|75973733|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
42166934|NCT03605836|75973730|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
42282411|NCT02711137|76114169|FG004|Overall Study|Withdrawal by Subject|1|||
42282412|NCT02711137|76114170|FG005|Overall Study|Withdrawal by Subject|0|||
42282413|NCT02711137|76114171|FG006|Overall Study|Withdrawal by Subject|7|||
42166935|NCT03605836|75973731|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
42166936|NCT03605836|75973732|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
42166937|NCT03605836|75973733|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
42166938|NCT03605836|75973730|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
42166939|NCT03605836|75973731|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
42166940|NCT03605836|75973732|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
42166941|NCT03605836|75973733|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
42166942|NCT03605836|75973730|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
42166943|NCT03605836|75973731|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
42166944|NCT03605836|75973732|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
42166945|NCT03605836|75973733|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
42166946|NCT03605836|75973730|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
42166947|NCT03605836|75973731|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
42166948|NCT03605836|75973732|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
42166949|NCT03605836|75973733|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
42166950|NCT03605836|75973730|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
42166951|NCT03605836|75973731|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
42166952|NCT03605836|75973732|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
42166953|NCT03605836|75973733|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
42166954|NCT03605836|75973730|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
42166955|NCT03605836|75973731|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
42166956|NCT03605836|75973732|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
42166957|NCT03605836|75973733|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
42166958|NCT03605836|75973730|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
42166959|NCT03605836|75973731|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
42166960|NCT03605836|75973732|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
42166961|NCT03605836|75973733|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
42166962|NCT03605836|75973730|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
42166963|NCT03605836|75973731|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
42166964|NCT03605836|75973732|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
42166965|NCT03605836|75973733|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
42166966|NCT03605836|75973730|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
42166967|NCT03605836|75973731|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
42166968|NCT03605836|75973732|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
42166969|NCT03605836|75973733|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
42166970|NCT03605836|75973730|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
42166971|NCT03605836|75973731|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
42166972|NCT03605836|75973732|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
42166973|NCT03605836|75973733|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
42166974|NCT03605836|75973730|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
42166975|NCT03605836|75973731|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
42166976|NCT03605836|75973732|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
42166977|NCT03605836|75973733|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
42166978|NCT03605836|75973730|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
42166979|NCT03605836|75973731|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
42166980|NCT03605836|75973732|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
42166981|NCT03605836|75973733|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
42166982|NCT03605836|75973730|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
42166983|NCT03605836|75973731|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
42166984|NCT03605836|75973732|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
42166985|NCT03605836|75973733|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
42166986|NCT03605836|75973730|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
42166987|NCT03605836|75973731|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
42166988|NCT03605836|75973732|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
42166989|NCT03605836|75973733|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
42166990|NCT03605836|75973730|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
42166991|NCT03605836|75973731|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
42282414|NCT02711137|76114172|FG007|Overall Study|Withdrawal by Subject|0|||
42282415|NCT02711137|76114173|FG008|Overall Study|Withdrawal by Subject|0|||
42282416|NCT02711137|76114174|FG009|Overall Study|Withdrawal by Subject|0|||
42282417|NCT02711137|76114175|FG010|Overall Study|Withdrawal by Subject|0|||
42282418|NCT02711137|76114176|FG011|Overall Study|Withdrawal by Subject|0|||
42351963|NCT01901653|76191863|FG007|Overall Study|Lost to Follow-up|1|||
42166992|NCT03605836|75973732|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
42166993|NCT03605836|75973733|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
42166994|NCT03605836|75973730|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
42166995|NCT03605836|75973731|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
42166996|NCT03605836|75973732|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
42166997|NCT03605836|75973733|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
42166998|NCT03605680|75973746|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
42166999|NCT03605680|75973747|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
42167000|NCT03605680|75973748|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
42167001|NCT03605680|75973749|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
42167002|NCT03605680|75973746|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
42167003|NCT03605680|75973747|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
42167004|NCT03605680|75973748|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
42167005|NCT03605680|75973749|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
42167006|NCT03605680|75973746|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
42167007|NCT03605680|75973747|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
42167008|NCT03605680|75973748|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
42167009|NCT03605680|75973749|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
42167010|NCT03605680|75973746|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
42167011|NCT03605680|75973747|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
42167012|NCT03605680|75973748|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
42167013|NCT03605680|75973749|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
42167014|NCT03605680|75973746|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
42167015|NCT03605680|75973747|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
42167016|NCT03605680|75973748|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
42167017|NCT03605680|75973749|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
42167018|NCT03605680|75973746|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
42167019|NCT03605680|75973747|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
42167020|NCT03605680|75973748|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
42167021|NCT03605680|75973749|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
42167022|NCT03605680|75973746|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
42167023|NCT03605680|75973747|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
42167024|NCT03605680|75973748|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
42167025|NCT03605680|75973749|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
42167026|NCT03605680|75973746|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
42167027|NCT03605680|75973747|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
42167028|NCT03605680|75973748|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
42167029|NCT03605680|75973749|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
42167030|NCT03605680|75973746|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
42167031|NCT03605680|75973747|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
42167032|NCT03605680|75973748|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
42167033|NCT03605680|75973749|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
42167034|NCT03605680|75973746|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
42167035|NCT03605680|75973747|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
42167036|NCT03605680|75973748|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
42167037|NCT03605680|75973749|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
42167038|NCT03605680|75973746|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
42167039|NCT03605680|75973747|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
42167040|NCT03605680|75973748|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
42167041|NCT03605680|75973749|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
42167042|NCT03605680|75973746|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
42167043|NCT03605680|75973747|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
42167044|NCT03605680|75973748|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
42167045|NCT03605680|75973749|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
42167046|NCT03605680|75973746|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
42167047|NCT03605680|75973747|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
42167048|NCT03605680|75973748|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
42167049|NCT03605680|75973749|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
42167050|NCT03605680|75973746|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
42167051|NCT03605680|75973747|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
42167052|NCT03605680|75973748|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
42167053|NCT03605680|75973749|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
42014332|NCT01290263|75821441|FG004|Overall Study|Withdrawal by Subject|2|||
42167054|NCT03605680|75973746|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
42167055|NCT03605680|75973747|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
42167056|NCT03605680|75973748|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
42167057|NCT03605680|75973749|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
42167058|NCT03605680|75973746|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
42167059|NCT03605680|75973747|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
42167060|NCT03605680|75973748|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
42167061|NCT03605680|75973749|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
42167062|NCT03605680|75973746|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
42167063|NCT03605680|75973747|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
42167064|NCT03605680|75973748|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
42167065|NCT03605680|75973749|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
42167066|NCT03605680|75973746|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
42167067|NCT03605680|75973747|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
42167068|NCT03605680|75973748|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
42167069|NCT03605680|75973749|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
42167070|NCT03605680|75973746|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
42167071|NCT03605680|75973747|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
42167072|NCT03605680|75973748|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
42167073|NCT03605680|75973749|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
42167074|NCT03572218|75973760|FG000|Overall Study|Lost to Follow-up|3|||
42167075|NCT03572218|75973761|FG001|Overall Study|Lost to Follow-up|2|||
42167076|NCT03572218|75973760|FG000|Overall Study|No longer available for study visits|2|||
42167077|NCT03572218|75973761|FG001|Overall Study|No longer available for study visits|1|||
42167078|NCT03572218|75973760|FG000|Overall Study|No longer interested|1|||
42167079|NCT03572218|75973761|FG001|Overall Study|No longer interested|2|||
42167080|NCT00111813|75973767|FG000|Overall Study|Adverse Event|1|||
42167081|NCT00111813|75973768|FG001|Overall Study|Adverse Event|2|||
42167082|NCT00111813|75973769|FG002|Overall Study|Adverse Event|4|||
42167083|NCT00111813|75973770|FG003|Overall Study|Adverse Event|2|||
42167084|NCT00111813|75973771|FG004|Overall Study|Adverse Event|2|||
42167085|NCT00111813|75973772|FG005|Overall Study|Adverse Event|2|||
42167086|NCT00111813|75973767|FG000|Overall Study|Progressive disease|2|||
42167087|NCT00111813|75973768|FG001|Overall Study|Progressive disease|1|||
42167088|NCT00111813|75973769|FG002|Overall Study|Progressive disease|5|||
42167089|NCT00111813|75973770|FG003|Overall Study|Progressive disease|3|||
42167090|NCT00111813|75973771|FG004|Overall Study|Progressive disease|4|||
42167091|NCT00111813|75973772|FG005|Overall Study|Progressive disease|3|||
42167092|NCT00111813|75973767|FG000|Overall Study|Lack of Efficacy|0|||
42167093|NCT00111813|75973768|FG001|Overall Study|Lack of Efficacy|0|||
42167094|NCT00111813|75973769|FG002|Overall Study|Lack of Efficacy|0|||
42167095|NCT00111813|75973770|FG003|Overall Study|Lack of Efficacy|0|||
42167096|NCT00111813|75973771|FG004|Overall Study|Lack of Efficacy|0|||
42167097|NCT00111813|75973772|FG005|Overall Study|Lack of Efficacy|1|||
42167098|NCT00111813|75973767|FG000|Overall Study|Other|0|||
42167099|NCT00111813|75973768|FG001|Overall Study|Other|0|||
42167100|NCT00111813|75973769|FG002|Overall Study|Other|1|||
42167101|NCT00111813|75973770|FG003|Overall Study|Other|0|||
42167102|NCT00111813|75973771|FG004|Overall Study|Other|0|||
42167103|NCT00111813|75973772|FG005|Overall Study|Other|0|||
42167104|NCT00118287|75973787|FG000|Overall Study|Intracranial haemorrhage|1|||
42167105|NCT00118287|75973787|FG000|Overall Study|Muscle pain|1|||
42167106|NCT00130689|75973791|FG000|Overall Study|Progressive Disease|29|||
42167107|NCT00130689|75973791|FG000|Overall Study|Death|1|||
42167108|NCT00130689|75973791|FG000|Overall Study|Clinical Deterioration|4|||
42167109|NCT00130689|75973791|FG000|Overall Study|Withdrawal by Subject|3|||
42167110|NCT00130689|75973791|FG000|Overall Study|Ineligible|6|||
42282419|NCT02711137|76114177|FG012|Overall Study|Withdrawal by Subject|0|||
42282420|NCT02711137|76114178|FG013|Overall Study|Withdrawal by Subject|1|||
42282421|NCT02711137|76114179|FG014|Overall Study|Withdrawal by Subject|0|||
42167111|NCT03605212|75973800|FG000|Treatment Period|Adverse Event|1|||
42167112|NCT03605212|75973801|FG001|Treatment Period|Adverse Event|0|||
42167113|NCT03605212|75973802|FG002|Treatment Period|Adverse Event|0|||
42167114|NCT03605212|75973803|FG003|Treatment Period|Adverse Event|0|||
42167115|NCT03605212|75973804|FG004|Treatment Period|Adverse Event|0|||
42167116|NCT03605212|75973800|FG000|Treatment Period|Physician Decision|0|||
42167117|NCT03605212|75973801|FG001|Treatment Period|Physician Decision|0|||
42167118|NCT03605212|75973802|FG002|Treatment Period|Physician Decision|0|||
42167119|NCT03605212|75973803|FG003|Treatment Period|Physician Decision|0|||
42167120|NCT03605212|75973804|FG004|Treatment Period|Physician Decision|1|||
42167121|NCT03603652|75973817|FG000|Overall Study|Death|2|||
42167122|NCT00117507|75973821|FG000|Overall Study|Adverse Event|4|||
42167123|NCT00117507|75973821|FG000|Overall Study|Abnormal laboratory values|3|||
42167124|NCT00117507|75973821|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42167125|NCT00117507|75973821|FG000|Overall Study|Patient withdrew consent|4|||
42282422|NCT02711137|76114165|FG000|Overall Study|Lost to Follow-up|1|||
42282423|NCT02711137|76114166|FG001|Overall Study|Lost to Follow-up|0|||
42167126|NCT00117507|75973821|FG000|Overall Study|Death|3|||
42167127|NCT03603496|75973828|FG000|Overall Study|Death|19|||
42167128|NCT03603496|75973829|FG001|Overall Study|Death|24|||
42167129|NCT03603496|75973828|FG000|Overall Study|Lost to Follow-up|141|||
42167130|NCT03603496|75973829|FG001|Overall Study|Lost to Follow-up|141|||
42167131|NCT03603496|75973828|FG000|Overall Study|Withdrawal by Subject|26|||
42167132|NCT03603496|75973829|FG001|Overall Study|Withdrawal by Subject|20|||
42167133|NCT03603028|75973835|FG000|Overall Study|Withdrawal by Subject|1|||
42167134|NCT03602482|75973841|FG000|Overall Study|Withdrawal by Subject|6|||
42167135|NCT03602482|75973842|FG001|Overall Study|Withdrawal by Subject|7|||
42167136|NCT03602482|75973843|FG002|Overall Study|Withdrawal by Subject|0|||
42167137|NCT03602482|75973844|FG003|Overall Study|Withdrawal by Subject|0|||
42282424|NCT02711137|76114167|FG002|Overall Study|Lost to Follow-up|0|||
42282425|NCT02711137|76114168|FG003|Overall Study|Lost to Follow-up|0|||
42282426|NCT02711137|76114169|FG004|Overall Study|Lost to Follow-up|0|||
42282427|NCT02711137|76114170|FG005|Overall Study|Lost to Follow-up|0|||
42282428|NCT02711137|76114171|FG006|Overall Study|Lost to Follow-up|2|||
42282429|NCT02711137|76114172|FG007|Overall Study|Lost to Follow-up|0|||
42282430|NCT02711137|76114173|FG008|Overall Study|Lost to Follow-up|0|||
42282431|NCT02711137|76114174|FG009|Overall Study|Lost to Follow-up|0|||
42282432|NCT02711137|76114175|FG010|Overall Study|Lost to Follow-up|0|||
42282433|NCT02711137|76114176|FG011|Overall Study|Lost to Follow-up|0|||
42282434|NCT02711137|76114177|FG012|Overall Study|Lost to Follow-up|0|||
42282435|NCT02711137|76114178|FG013|Overall Study|Lost to Follow-up|0|||
42282436|NCT02711137|76114179|FG014|Overall Study|Lost to Follow-up|0|||
42282437|NCT02710045|76114219|FG000|Overall Study|Death|1|||
42282438|NCT02710045|76114220|FG001|Overall Study|Death|2|||
42282439|NCT02710045|76114221|FG002|Overall Study|Death|0|||
42282440|NCT02710045|76114219|FG000|Overall Study|Withdrawal by Subject|6|||
42282441|NCT02710045|76114220|FG001|Overall Study|Withdrawal by Subject|6|||
42282442|NCT02710045|76114221|FG002|Overall Study|Withdrawal by Subject|2|||
42282443|NCT02710045|76114219|FG000|Overall Study|Protocol Violation|1|||
42282444|NCT02710045|76114220|FG001|Overall Study|Protocol Violation|2|||
42282445|NCT02710045|76114221|FG002|Overall Study|Protocol Violation|3|||
42167138|NCT00096135|75973859|FG000|Overall Study|Physician Decision|20|||
42167139|NCT00096135|75973860|FG001|Overall Study|Physician Decision|4|||
42167140|NCT00096135|75973859|FG000|Overall Study|Refusal of further protocol therapy|4|||
42167141|NCT00096135|75973860|FG001|Overall Study|Refusal of further protocol therapy|1|||
42167142|NCT00096135|75973859|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
42167143|NCT00096135|75973860|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
42167144|NCT00096135|75973859|FG000|Overall Study|Other, specify|15|||
42167145|NCT00096135|75973860|FG001|Overall Study|Other, specify|3|||
42351964|NCT01901653|76191864|FG008|Overall Study|Lost to Follow-up|0|||
42167146|NCT00096135|75973859|FG000|Overall Study|Ineligible|2|||
42167147|NCT00096135|75973860|FG001|Overall Study|Ineligible|0|||
42351965|NCT01901653|76191865|FG009|Overall Study|Lost to Follow-up|0|||
42351966|NCT01901653|76191866|FG010|Overall Study|Lost to Follow-up|0|||
42351967|NCT01901653|76191867|FG011|Overall Study|Lost to Follow-up|0|||
42351968|NCT01901653|76191868|FG012|Overall Study|Lost to Follow-up|0|||
42351969|NCT01901653|76191856|FG000|Overall Study|Withdrawal by Subject|0|||
42351970|NCT01901653|76191857|FG001|Overall Study|Withdrawal by Subject|0|||
42014333|NCT01290263|75821437|FG000|Overall Study|Participant Non-Compliance|0|||
42014334|NCT01290263|75821438|FG001|Overall Study|Participant Non-Compliance|0|||
42167148|NCT00116805|75973868|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
42167149|NCT00116805|75973869|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
42167150|NCT00116805|75973868|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
42167151|NCT00116805|75973869|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
42167152|NCT00116805|75973868|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
42167153|NCT00116805|75973869|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
42167154|NCT00116805|75973868|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
42167155|NCT00116805|75973869|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
42167156|NCT00116805|75973868|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
42167157|NCT00116805|75973869|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
42282446|NCT02710045|76114219|FG000|Overall Study|Lost to Follow-up|3|||
42282447|NCT02710045|76114220|FG001|Overall Study|Lost to Follow-up|6|||
42282448|NCT02710045|76114221|FG002|Overall Study|Lost to Follow-up|7|||
42282449|NCT02710045|76114219|FG000|Overall Study|Physician Decision|0|||
42282450|NCT02710045|76114220|FG001|Overall Study|Physician Decision|0|||
42351971|NCT01901653|76191858|FG002|Overall Study|Withdrawal by Subject|0|||
42014335|NCT01290263|75821439|FG002|Overall Study|Participant Non-Compliance|0|||
42351972|NCT01901653|76191859|FG003|Overall Study|Withdrawal by Subject|0|||
42167158|NCT00116805|75973868|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
42167159|NCT00116805|75973869|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
42167160|NCT00116805|75973868|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
42167161|NCT00116805|75973869|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
42167162|NCT00116805|75973868|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
42167163|NCT00116805|75973869|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
42167164|NCT00116805|75973868|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
42167165|NCT00116805|75973869|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
42167166|NCT00116805|75973868|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
42167167|NCT00116805|75973869|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
42167168|NCT00116805|75973868|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
42167169|NCT00116805|75973869|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
42167170|NCT00116805|75973868|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
42167171|NCT00116805|75973869|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
42167172|NCT00116805|75973868|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
42167173|NCT00116805|75973869|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
42167174|NCT00116805|75973868|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
42167175|NCT00116805|75973869|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
42167176|NCT00116805|75973868|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
42167177|NCT00116805|75973869|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
42167178|NCT00116805|75973868|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
42167179|NCT00116805|75973869|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
42167180|NCT00116805|75973868|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
42167181|NCT00116805|75973869|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
42167182|NCT00116805|75973868|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
42167183|NCT00116805|75973869|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
42167184|NCT00116805|75973868|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
42167185|NCT00116805|75973869|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
42167186|NCT00116805|75973868|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
42167187|NCT00116805|75973869|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
42167188|NCT00116805|75973868|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
42167189|NCT00116805|75973869|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
42167190|NCT00116805|75973868|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
42167191|NCT00116805|75973869|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
42167192|NCT00116805|75973868|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
42167193|NCT00116805|75973869|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
42167194|NCT00116805|75973868|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
42167195|NCT00116805|75973869|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
42167196|NCT00116805|75973868|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
42167197|NCT00116805|75973869|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
42167198|NCT00116805|75973868|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
42167199|NCT00116805|75973869|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
42167200|NCT00116805|75973868|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
42167201|NCT00116805|75973869|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
42167202|NCT00116805|75973868|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
42167203|NCT00116805|75973869|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
42167204|NCT00116805|75973868|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
42167205|NCT00116805|75973869|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
42167206|NCT00116805|75973868|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
42167207|NCT00116805|75973869|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
42167208|NCT00116805|75973868|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
42167209|NCT00116805|75973869|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
42167210|NCT00116805|75973868|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
42167211|NCT00116805|75973869|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
42167212|NCT00116805|75973868|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
42167213|NCT00116805|75973869|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
42167214|NCT00116805|75973868|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
42167215|NCT00116805|75973869|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
42167216|NCT00116805|75973868|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
42167217|NCT00116805|75973869|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
42167218|NCT00116805|75973868|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
42167219|NCT00116805|75973869|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
42167220|NCT00116805|75973868|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
42167221|NCT00116805|75973869|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
42282451|NCT02710045|76114221|FG002|Overall Study|Physician Decision|1|||
42167222|NCT00116805|75973868|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
42167223|NCT00116805|75973869|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
42167224|NCT00116805|75973868|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
42167225|NCT00116805|75973869|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
42167226|NCT00116805|75973868|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
42167227|NCT00116805|75973869|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
42167228|NCT00116805|75973868|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
42167229|NCT00116805|75973869|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
42167230|NCT00116805|75973868|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
42167231|NCT00116805|75973869|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
42167232|NCT00116805|75973868|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
42167233|NCT00116805|75973869|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
42167234|NCT00116805|75973868|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
42167235|NCT00116805|75973869|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
42167236|NCT00116805|75973868|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
42167237|NCT00116805|75973869|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
42167238|NCT00116649|75973884|FG000|Overall Study|Adverse Event|20|||
42167239|NCT00116649|75973884|FG000|Overall Study|Lack of Efficacy|1|||
42167240|NCT00116649|75973884|FG000|Overall Study|Lost to Follow-up|32|||
42167241|NCT00116649|75973884|FG000|Overall Study|Withdrawal by Subject|68|||
42167242|NCT00116649|75973884|FG000|Overall Study|Local Skin Reaction|9|||
42167243|NCT00116649|75973884|FG000|Overall Study|Various Reasons|18|||
42167244|NCT00116649|75973884|FG000|Overall Study|Protocol Specified|7|||
42167245|NCT00083889|75973890|FG000|Overall Study|Adverse Event|76|||
42167246|NCT00083889|75973891|FG001|Overall Study|Adverse Event|86|||
42167247|NCT00083889|75973890|FG000|Overall Study|Protocol Violation|2|||
42167248|NCT00083889|75973891|FG001|Overall Study|Protocol Violation|2|||
42167249|NCT00083889|75973890|FG000|Overall Study|Withdrawal by Subject|22|||
42167250|NCT00083889|75973891|FG001|Overall Study|Withdrawal by Subject|24|||
42167251|NCT00083889|75973890|FG000|Overall Study|Lack of Efficacy|240|||
42167252|NCT00083889|75973891|FG001|Overall Study|Lack of Efficacy|219|||
42167253|NCT00083889|75973890|FG000|Overall Study|Decision of sponsor|32|||
42167254|NCT00083889|75973891|FG001|Overall Study|Decision of sponsor|4|||
42167255|NCT00083889|75973890|FG000|Overall Study|Randomized: did not take study drug|0|||
42167256|NCT00083889|75973891|FG001|Overall Study|Randomized: did not take study drug|15|||
42167257|NCT00083889|75973890|FG000|Overall Study|Completed on marketed sunitinub|3|||
42167258|NCT00083889|75973891|FG001|Overall Study|Completed on marketed sunitinub|0|||
42167259|NCT00083889|75973890|FG000|Overall Study|Crossover to SU011248|0|||
42167260|NCT00083889|75973891|FG001|Overall Study|Crossover to SU011248|25|||
42167261|NCT03572062|75973910|FG000|Overall Study|Adverse Event|0|||
42167262|NCT03572062|75973911|FG001|Overall Study|Adverse Event|0|||
42167263|NCT03572062|75973912|FG002|Overall Study|Adverse Event|0|||
42167264|NCT03572062|75973913|FG003|Overall Study|Adverse Event|0|||
42167265|NCT03572062|75973914|FG004|Overall Study|Adverse Event|0|||
42167266|NCT03572062|75973915|FG005|Overall Study|Adverse Event|0|||
42167267|NCT03572062|75973916|FG006|Overall Study|Adverse Event|0|||
42167268|NCT03572062|75973917|FG007|Overall Study|Adverse Event|0|||
42167269|NCT03572062|75973918|FG008|Overall Study|Adverse Event|1|||
42167270|NCT03572062|75973919|FG009|Overall Study|Adverse Event|3|||
42167271|NCT03572062|75973910|FG000|Overall Study|Death|0|||
42167272|NCT03572062|75973911|FG001|Overall Study|Death|0|||
42167273|NCT03572062|75973912|FG002|Overall Study|Death|0|||
42167274|NCT03572062|75973913|FG003|Overall Study|Death|0|||
42167275|NCT03572062|75973914|FG004|Overall Study|Death|0|||
42167276|NCT03572062|75973915|FG005|Overall Study|Death|1|||
42167277|NCT03572062|75973916|FG006|Overall Study|Death|0|||
42167278|NCT03572062|75973917|FG007|Overall Study|Death|0|||
42167279|NCT03572062|75973918|FG008|Overall Study|Death|0|||
42167280|NCT03572062|75973919|FG009|Overall Study|Death|0|||
42167281|NCT03572062|75973910|FG000|Overall Study|Lost to Follow-up|0|||
42167282|NCT03572062|75973911|FG001|Overall Study|Lost to Follow-up|0|||
42167283|NCT03572062|75973912|FG002|Overall Study|Lost to Follow-up|0|||
42167284|NCT03572062|75973913|FG003|Overall Study|Lost to Follow-up|0|||
42167285|NCT03572062|75973914|FG004|Overall Study|Lost to Follow-up|0|||
42167286|NCT03572062|75973915|FG005|Overall Study|Lost to Follow-up|1|||
42014336|NCT01290263|75821440|FG003|Overall Study|Participant Non-Compliance|1|||
42167287|NCT03572062|75973916|FG006|Overall Study|Lost to Follow-up|1|||
42167288|NCT03572062|75973917|FG007|Overall Study|Lost to Follow-up|0|||
42167289|NCT03572062|75973918|FG008|Overall Study|Lost to Follow-up|0|||
42167290|NCT03572062|75973919|FG009|Overall Study|Lost to Follow-up|0|||
42167291|NCT03572062|75973910|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
42167292|NCT03572062|75973911|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
42167293|NCT03572062|75973912|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
42167294|NCT03572062|75973913|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
42167295|NCT03572062|75973914|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
42167296|NCT03572062|75973915|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
42167297|NCT03572062|75973916|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
42167298|NCT03572062|75973917|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
42167299|NCT03572062|75973918|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
42167300|NCT03572062|75973919|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
42167301|NCT03572062|75973910|FG000|Overall Study|Study Terminated By Sponsor|0|||
42167302|NCT03572062|75973911|FG001|Overall Study|Study Terminated By Sponsor|0|||
42167303|NCT03572062|75973912|FG002|Overall Study|Study Terminated By Sponsor|0|||
42167304|NCT03572062|75973913|FG003|Overall Study|Study Terminated By Sponsor|0|||
42167305|NCT03572062|75973914|FG004|Overall Study|Study Terminated By Sponsor|0|||
42167306|NCT03572062|75973915|FG005|Overall Study|Study Terminated By Sponsor|0|||
42167307|NCT03572062|75973916|FG006|Overall Study|Study Terminated By Sponsor|0|||
42167308|NCT03572062|75973917|FG007|Overall Study|Study Terminated By Sponsor|0|||
42167309|NCT03572062|75973918|FG008|Overall Study|Study Terminated By Sponsor|29|||
42167310|NCT03572062|75973919|FG009|Overall Study|Study Terminated By Sponsor|27|||
42167311|NCT03572062|75973910|FG000|Overall Study|Physician Decision|0|||
42167312|NCT03572062|75973911|FG001|Overall Study|Physician Decision|0|||
42167313|NCT03572062|75973912|FG002|Overall Study|Physician Decision|0|||
42167314|NCT03572062|75973913|FG003|Overall Study|Physician Decision|0|||
42167315|NCT03572062|75973914|FG004|Overall Study|Physician Decision|0|||
42167316|NCT03572062|75973915|FG005|Overall Study|Physician Decision|0|||
42167317|NCT03572062|75973916|FG006|Overall Study|Physician Decision|0|||
42167318|NCT03572062|75973917|FG007|Overall Study|Physician Decision|0|||
42167319|NCT03572062|75973918|FG008|Overall Study|Physician Decision|1|||
42167320|NCT03572062|75973919|FG009|Overall Study|Physician Decision|0|||
42167321|NCT03572062|75973910|FG000|Overall Study|Withdrawal by Subject|0|||
42167322|NCT03572062|75973911|FG001|Overall Study|Withdrawal by Subject|0|||
42167323|NCT03572062|75973912|FG002|Overall Study|Withdrawal by Subject|0|||
42167324|NCT03572062|75973913|FG003|Overall Study|Withdrawal by Subject|0|||
42167325|NCT03572062|75973914|FG004|Overall Study|Withdrawal by Subject|0|||
42167326|NCT03572062|75973915|FG005|Overall Study|Withdrawal by Subject|0|||
42167327|NCT03572062|75973916|FG006|Overall Study|Withdrawal by Subject|0|||
42167328|NCT03572062|75973917|FG007|Overall Study|Withdrawal by Subject|0|||
42167329|NCT03572062|75973918|FG008|Overall Study|Withdrawal by Subject|0|||
42167330|NCT03572062|75973919|FG009|Overall Study|Withdrawal by Subject|1|||
42167331|NCT03572062|75973910|FG000|Overall Study|Randomized But Not Treated|0|||
42167332|NCT03572062|75973911|FG001|Overall Study|Randomized But Not Treated|0|||
42167333|NCT03572062|75973912|FG002|Overall Study|Randomized But Not Treated|0|||
42167334|NCT03572062|75973913|FG003|Overall Study|Randomized But Not Treated|0|||
42167335|NCT03572062|75973914|FG004|Overall Study|Randomized But Not Treated|1|||
42167336|NCT03572062|75973915|FG005|Overall Study|Randomized But Not Treated|2|||
42167337|NCT03572062|75973916|FG006|Overall Study|Randomized But Not Treated|0|||
42167338|NCT03572062|75973917|FG007|Overall Study|Randomized But Not Treated|1|||
42167339|NCT03572062|75973918|FG008|Overall Study|Randomized But Not Treated|0|||
42167340|NCT03572062|75973919|FG009|Overall Study|Randomized But Not Treated|0|||
42167341|NCT03571516|75973941|FG000|Overall Study|Severe diarrhea|1|||
42167342|NCT03571516|75973942|FG001|Overall Study|Severe diarrhea|0|||
42167343|NCT03571516|75973941|FG000|Overall Study|Withdrawal by Subject|0|||
42167344|NCT03571516|75973942|FG001|Overall Study|Withdrawal by Subject|1|||
42167345|NCT03600376|75973950|FG000|Overall Study|Adverse Event|1|||
42167346|NCT03600376|75973951|FG001|Overall Study|Adverse Event|1|||
42167347|NCT03600376|75973950|FG000|Overall Study|Transferred to other facility|1|||
42167348|NCT03600376|75973951|FG001|Overall Study|Transferred to other facility|0|||
42167349|NCT03600376|75973950|FG000|Overall Study|Investigator Decision|0|||
42167350|NCT03600376|75973951|FG001|Overall Study|Investigator Decision|4|||
42167351|NCT03600376|75973950|FG000|Overall Study|Determined to be ineligible for study|0|||
42167352|NCT03600376|75973951|FG001|Overall Study|Determined to be ineligible for study|1|||
42167353|NCT03599362|75973957|FG000|Overall Study|Screen Failure|3|||
42167354|NCT03598036|75973963|FG000|Overall Study|Withdrawal by Subject|1|||
42167355|NCT03598036|75973964|FG001|Overall Study|Withdrawal by Subject|0|||
42167356|NCT00082407|75973974|FG000|Overall Study|Adverse Event|20|||
42167357|NCT00082407|75973975|FG001|Overall Study|Adverse Event|0|||
42167358|NCT00082407|75973974|FG000|Overall Study|Protocol Violation|14|||
42167359|NCT00082407|75973975|FG001|Overall Study|Protocol Violation|12|||
42167360|NCT00082407|75973974|FG000|Overall Study|Patient Decision|13|||
42167361|NCT00082407|75973975|FG001|Overall Study|Patient Decision|6|||
42167362|NCT00082407|75973974|FG000|Overall Study|Physician Decision|5|||
42167363|NCT00082407|75973975|FG001|Overall Study|Physician Decision|3|||
42167364|NCT00082407|75973974|FG000|Overall Study|Loss of Glucose Control|2|||
42167365|NCT00082407|75973975|FG001|Overall Study|Loss of Glucose Control|2|||
42167366|NCT00082407|75973974|FG000|Overall Study|Death|2|||
42167367|NCT00082407|75973975|FG001|Overall Study|Death|1|||
42167368|NCT00082407|75973974|FG000|Overall Study|Lost to Follow-up|0|||
42167369|NCT00082407|75973975|FG001|Overall Study|Lost to Follow-up|3|||
42167370|NCT03643432|75973983|FG000|Overall Study|Lost to Follow-up|1|||
42167371|NCT03643432|75973984|FG001|Overall Study|Lost to Follow-up|0|||
42167372|NCT03810183|75973992|FG000|Overall Study|Study terminated by Sponsor|2|||
42167373|NCT03810183|75973993|FG001|Overall Study|Study terminated by Sponsor|1|||
42167374|NCT03597022|75974003|FG000|Overall Study|Premature termination of the study|7|||
42167375|NCT03597022|75974004|FG001|Overall Study|Premature termination of the study|7|||
42167376|NCT03597022|75974005|FG002|Overall Study|Premature termination of the study|8|||
42167377|NCT03597022|75974003|FG000|Overall Study|Serious adverse event|1|||
42167378|NCT03597022|75974004|FG001|Overall Study|Serious adverse event|1|||
42167379|NCT03597022|75974005|FG002|Overall Study|Serious adverse event|0|||
42167380|NCT03571204|75974016|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
42014337|NCT01290263|75821441|FG004|Overall Study|Participant Non-Compliance|1|||
42014338|NCT01290029|75821449|FG000|Overall Study|Other|2|||
42167381|NCT03571204|75974017|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
42167382|NCT03571204|75974018|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
42167383|NCT03571204|75974016|FG000|Overall Study|Physician Decision|0|||
42167384|NCT03571204|75974017|FG001|Overall Study|Physician Decision|1|||
42167385|NCT03571204|75974018|FG002|Overall Study|Physician Decision|0|||
42167386|NCT03569098|75974030|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
42167387|NCT03569098|75974031|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
42167388|NCT03569098|75974032|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
42167389|NCT03569098|75974030|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
42167390|NCT03569098|75974031|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
42167391|NCT03569098|75974032|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
42167392|NCT03569098|75974030|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
42167393|NCT03569098|75974031|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
42167394|NCT03569098|75974032|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
42167395|NCT03569098|75974030|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
42167396|NCT03569098|75974031|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
42167397|NCT03569098|75974032|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
42167398|NCT03569098|75974030|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
42167399|NCT03569098|75974031|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
42167400|NCT03569098|75974032|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
42167401|NCT03569098|75974030|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
42167402|NCT03569098|75974031|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
42167403|NCT03569098|75974032|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
42167404|NCT03569098|75974030|FG000|Double-Blind Treatment Cycle 1|Other|1|||
42167405|NCT03569098|75974031|FG001|Double-Blind Treatment Cycle 1|Other|0|||
42167406|NCT03569098|75974032|FG002|Double-Blind Treatment Cycle 1|Other|1|||
42167407|NCT03569098|75974030|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
42167408|NCT03569098|75974031|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
42167409|NCT03569098|75974032|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
42167410|NCT03569098|75974030|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
42167411|NCT03569098|75974031|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
42167412|NCT03569098|75974032|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
42167413|NCT03569098|75974030|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
42167414|NCT03569098|75974031|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
42167415|NCT03569098|75974032|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
42282452|NCT02710045|76114219|FG000|Overall Study|Poor Attendance|0|||
42282453|NCT02710045|76114220|FG001|Overall Study|Poor Attendance|1|||
42014339|NCT01289639|75821456|FG000|Overall Study|Lost to Follow-up|1|||
42014340|NCT01289639|75821457|FG001|Overall Study|Lost to Follow-up|0|||
42282454|NCT02710045|76114221|FG002|Overall Study|Poor Attendance|0|||
42282455|NCT02714153|76114229|FG000|Overall Study|Death|1|||
42282456|NCT04369469|76114235|FG000|Overall Study|Lost to Follow-up|2|||
42282457|NCT04369469|76114236|FG001|Overall Study|Lost to Follow-up|4|||
42282458|NCT04369469|76114235|FG000|Overall Study|Physician Decision|2|||
42014341|NCT01289639|75821458|FG002|Overall Study|Lost to Follow-up|0|||
42014342|NCT01289015|75821468|FG000|Overall Study|Protocol Violation|12|||
42282459|NCT04369469|76114236|FG001|Overall Study|Physician Decision|1|||
42282460|NCT04369469|76114235|FG000|Overall Study|Withdrawal by Subject|2|||
42282461|NCT04369469|76114236|FG001|Overall Study|Withdrawal by Subject|3|||
42040618|NCT01796171|75848718|FG012|Treatment Period With Betalutin|Death|0|||
42040619|NCT01796171|75848719|FG013|Treatment Period With Betalutin|Death|0|||
42040620|NCT01796171|75848720|FG014|Treatment Period With Betalutin|Death|0|||
42040621|NCT01796171|75848706|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
42040622|NCT01796171|75848707|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
42040623|NCT01796171|75848708|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
42282462|NCT04369469|76114235|FG000|Overall Study|Adverse Event|1|||
42282463|NCT04369469|76114236|FG001|Overall Study|Adverse Event|0|||
42014343|NCT01289015|75821469|FG001|Overall Study|Protocol Violation|9|||
42014344|NCT01289015|75821468|FG000|Overall Study|Adverse Event|3|||
42014345|NCT01289015|75821469|FG001|Overall Study|Adverse Event|0|||
42014346|NCT01289015|75821468|FG000|Overall Study|Lost to Follow-up|33|||
42014347|NCT01289015|75821469|FG001|Overall Study|Lost to Follow-up|17|||
42282464|NCT04369469|76114235|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
42282465|NCT04369469|76114236|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
42282466|NCT04369469|76114235|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
42282467|NCT04369469|76114236|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
42282468|NCT04369469|76114235|FG000|Overall Study|Unable to Provide Consent|0|||
42282469|NCT04369469|76114236|FG001|Overall Study|Unable to Provide Consent|1|||
42014348|NCT01289015|75821468|FG000|Overall Study|Withdrawal by Subject|17|||
42014349|NCT01289015|75821469|FG001|Overall Study|Withdrawal by Subject|8|||
42014350|NCT01289015|75821468|FG000|Overall Study|Disease progression|1|||
42014351|NCT01289015|75821469|FG001|Overall Study|Disease progression|0|||
42282470|NCT04647383|76114259|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
42282471|NCT04647383|76114260|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
42282472|NCT04647383|76114261|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
42282473|NCT04647383|76114262|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
42282474|NCT01670097|76114274|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
42282475|NCT01670097|76114275|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
42282476|NCT01670097|76114274|FG000|Overall Study|Study burden|1|||
42282477|NCT01670097|76114275|FG001|Overall Study|Study burden|0|||
42282478|NCT01670097|76114274|FG000|Overall Study|COPD exacerbation|0|||
42282479|NCT01670097|76114275|FG001|Overall Study|COPD exacerbation|1|||
42282480|NCT01670097|76114274|FG000|Overall Study|Neutropenia|0|||
42282481|NCT01670097|76114275|FG001|Overall Study|Neutropenia|1|||
42282482|NCT01670097|76114274|FG000|Overall Study|Clinical deterioration|0|||
42282483|NCT01670097|76114275|FG001|Overall Study|Clinical deterioration|1|||
42282484|NCT01670097|76114274|FG000|Overall Study|Disease progression|0|||
42282485|NCT01670097|76114275|FG001|Overall Study|Disease progression|1|||
42282486|NCT01670019|76114283|FG000|Overall Study|Adverse Event|3|||
42282487|NCT01670019|76114284|FG001|Overall Study|Adverse Event|0|||
42282488|NCT01670019|76114283|FG000|Overall Study|Withdrawal by Subject|6|||
42282489|NCT01670019|76114284|FG001|Overall Study|Withdrawal by Subject|0|||
42282490|NCT01669629|76114290|FG000|Period 1|protocol deviation|1|||
42282491|NCT01669629|76114291|FG001|Period 1|protocol deviation|2|||
42282492|NCT00701051|76114299|FG000|Screening|Failed Screening|40|||
42282493|NCT00701051|76114300|FG001|Screening|Failed Screening|0|||
42282494|NCT00701051|76114301|FG002|Screening|Failed Screening|0|||
42282495|NCT00701051|76114299|FG000|Screening|Time conflicts|19|||
42282496|NCT00701051|76114300|FG001|Screening|Time conflicts|0|||
42282497|NCT00701051|76114301|FG002|Screening|Time conflicts|0|||
42282498|NCT00701051|76114299|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
42282499|NCT00701051|76114300|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
42282500|NCT00701051|76114301|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
42014352|NCT01289015|75821468|FG000|Overall Study|Negative baseline culture and others|33|||
42014353|NCT01289015|75821469|FG001|Overall Study|Negative baseline culture and others|20|||
42014354|NCT01288937|75821477|FG000|Overall Study|Adverse Event|1|||
42014355|NCT01288937|75821478|FG001|Overall Study|Adverse Event|0|||
42014356|NCT01288469|75821487|FG000|Overall Study|Adverse Event|4|||
42014357|NCT01288469|75821488|FG001|Overall Study|Adverse Event|1|||
42014358|NCT01288469|75821489|FG002|Overall Study|Adverse Event|1|||
42014359|NCT01288469|75821487|FG000|Overall Study|Poor compliance to protocol|0|||
42014360|NCT01288469|75821488|FG001|Overall Study|Poor compliance to protocol|1|||
42014361|NCT01288469|75821489|FG002|Overall Study|Poor compliance to protocol|0|||
42014362|NCT01288469|75821487|FG000|Overall Study|Participant Moved|1|||
42014363|NCT01288469|75821488|FG001|Overall Study|Participant Moved|0|||
42014364|NCT01288469|75821489|FG002|Overall Study|Participant Moved|0|||
42014365|NCT01288469|75821487|FG000|Overall Study|Consent withdrawn by subject|1|||
42014366|NCT01288469|75821488|FG001|Overall Study|Consent withdrawn by subject|1|||
42014367|NCT01288469|75821489|FG002|Overall Study|Consent withdrawn by subject|1|||
42014368|NCT01288469|75821487|FG000|Overall Study|Exclusion criteria finally met|1|||
42014369|NCT01288469|75821488|FG001|Overall Study|Exclusion criteria finally met|0|||
42014370|NCT01288469|75821489|FG002|Overall Study|Exclusion criteria finally met|0|||
42014371|NCT01288079|75821501|FG000|Overall Study|Withdrawal by Subject|2|||
42014372|NCT01288079|75821502|FG001|Overall Study|Withdrawal by Subject|4|||
42014373|NCT01288079|75821503|FG002|Overall Study|Withdrawal by Subject|1|||
42014374|NCT01288079|75821504|FG003|Overall Study|Withdrawal by Subject|0|||
42014375|NCT01288079|75821501|FG000|Overall Study|Adverse Event|2|||
42014376|NCT01288079|75821502|FG001|Overall Study|Adverse Event|1|||
42014377|NCT01288079|75821503|FG002|Overall Study|Adverse Event|2|||
42014378|NCT01288079|75821504|FG003|Overall Study|Adverse Event|3|||
42014379|NCT01288079|75821501|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
42014380|NCT01288079|75821502|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
42014381|NCT01288079|75821503|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
42014382|NCT01288079|75821504|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
42014383|NCT01288079|75821501|FG000|Overall Study|Condition under Investigation Worsened|0|||
42014384|NCT01288079|75821502|FG001|Overall Study|Condition under Investigation Worsened|0|||
42014385|NCT01288079|75821503|FG002|Overall Study|Condition under Investigation Worsened|0|||
42014386|NCT01288079|75821504|FG003|Overall Study|Condition under Investigation Worsened|1|||
42167416|NCT03569098|75974030|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
42167417|NCT03569098|75974031|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
42167418|NCT03569098|75974032|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
42167419|NCT03569098|75974030|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
42167420|NCT03569098|75974031|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
42167421|NCT03569098|75974032|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
42167422|NCT03569098|75974030|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
42167423|NCT03569098|75974031|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
42167424|NCT03569098|75974032|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
42167425|NCT03568942|75974043|FG000|Overall Study|Family emergency|1|||
42167426|NCT03568942|75974043|FG000|Overall Study|Lost to Follow-up|1|||
42167427|NCT00110019|75974049|FG000|Overall Study|Lack of Efficacy|253|||
42167428|NCT00110019|75974050|FG001|Overall Study|Lack of Efficacy|285|||
42167429|NCT00110019|75974049|FG000|Overall Study|Adverse Event|61|||
42167430|NCT00110019|75974050|FG001|Overall Study|Adverse Event|40|||
42167431|NCT00110019|75974049|FG000|Overall Study|Death|13|||
42167432|NCT00110019|75974050|FG001|Overall Study|Death|15|||
42167433|NCT00110019|75974049|FG000|Overall Study|Withdrawal by Subject|21|||
42167434|NCT00110019|75974050|FG001|Overall Study|Withdrawal by Subject|9|||
42167435|NCT00110019|75974049|FG000|Overall Study|alternative therapy|5|||
42167436|NCT00110019|75974050|FG001|Overall Study|alternative therapy|1|||
42167437|NCT00110019|75974049|FG000|Overall Study|complicating disease|1|||
42167438|NCT00110019|75974050|FG001|Overall Study|complicating disease|1|||
42167439|NCT00110019|75974049|FG000|Overall Study|symptom deterioration|13|||
42167440|NCT00110019|75974050|FG001|Overall Study|symptom deterioration|16|||
42167441|NCT00110019|75974049|FG000|Overall Study|Not start protocol therapy|17|||
42167442|NCT00110019|75974050|FG001|Overall Study|Not start protocol therapy|16|||
42167443|NCT00110019|75974049|FG000|Overall Study|other reasons|22|||
42167444|NCT00110019|75974050|FG001|Overall Study|other reasons|30|||
42167445|NCT03595618|75974060|FG000|Overall Study|Adverse Event|16|||
42014387|NCT01288079|75821501|FG000|Overall Study|Lack of Efficacy|2|||
42014388|NCT01288079|75821502|FG001|Overall Study|Lack of Efficacy|2|||
42014389|NCT01288079|75821503|FG002|Overall Study|Lack of Efficacy|0|||
42014390|NCT01288079|75821504|FG003|Overall Study|Lack of Efficacy|2|||
42014391|NCT01288079|75821501|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
42014392|NCT01288079|75821502|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
42014393|NCT01288079|75821503|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
42167446|NCT03595618|75974061|FG001|Overall Study|Adverse Event|17|||
42167447|NCT03595618|75974062|FG002|Overall Study|Adverse Event|20|||
42167448|NCT03595618|75974063|FG003|Overall Study|Adverse Event|8|||
42167449|NCT03595618|75974060|FG000|Overall Study|Withdrawal by Subject|12|||
42167450|NCT03595618|75974061|FG001|Overall Study|Withdrawal by Subject|14|||
42167451|NCT03595618|75974062|FG002|Overall Study|Withdrawal by Subject|14|||
42167452|NCT03595618|75974063|FG003|Overall Study|Withdrawal by Subject|10|||
42167453|NCT03595618|75974060|FG000|Overall Study|Lost to Follow-up|6|||
42167454|NCT03595618|75974061|FG001|Overall Study|Lost to Follow-up|4|||
42167455|NCT03595618|75974062|FG002|Overall Study|Lost to Follow-up|5|||
42167456|NCT03595618|75974063|FG003|Overall Study|Lost to Follow-up|6|||
42167457|NCT03595618|75974060|FG000|Overall Study|Protocol Violation|2|||
42167458|NCT03595618|75974061|FG001|Overall Study|Protocol Violation|0|||
42167459|NCT03595618|75974062|FG002|Overall Study|Protocol Violation|6|||
42167460|NCT03595618|75974063|FG003|Overall Study|Protocol Violation|2|||
42167461|NCT03595618|75974060|FG000|Overall Study|Physician Decision|0|||
42167462|NCT03595618|75974061|FG001|Overall Study|Physician Decision|0|||
42167463|NCT03595618|75974062|FG002|Overall Study|Physician Decision|1|||
42167464|NCT03595618|75974063|FG003|Overall Study|Physician Decision|2|||
42167465|NCT03595618|75974060|FG000|Overall Study|Miscellaneous|7|||
42167466|NCT03595618|75974061|FG001|Overall Study|Miscellaneous|5|||
42167467|NCT03595618|75974062|FG002|Overall Study|Miscellaneous|10|||
42167468|NCT03595618|75974063|FG003|Overall Study|Miscellaneous|6|||
42167469|NCT02954848|75974075|FG000|Overall Study|Randomized but Not Treated|0|||
42167470|NCT02954848|75974076|FG001|Overall Study|Randomized but Not Treated|1|||
42167471|NCT02954848|75974075|FG000|Overall Study|Adverse Event|2|||
42167472|NCT02954848|75974076|FG001|Overall Study|Adverse Event|3|||
42167473|NCT02954848|75974075|FG000|Overall Study|Withdrawal by Participant|0|||
42167474|NCT02954848|75974076|FG001|Overall Study|Withdrawal by Participant|1|||
42167475|NCT03642262|75974082|FG000|Period 1|Withdrawal by Subject|1|||
42167476|NCT03642262|75974083|FG001|Period 1|Withdrawal by Subject|1|||
42167477|NCT03642262|75974082|FG000|Period 1|Adverse Event|0|||
42167478|NCT03642262|75974083|FG001|Period 1|Adverse Event|1|||
42167479|NCT00109707|75974093|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
42167480|NCT00109707|75974094|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
42167481|NCT00109707|75974095|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
42167482|NCT00109707|75974093|FG000|Overall Study|Abnormal laboratory values|1|||
42167483|NCT00109707|75974094|FG001|Overall Study|Abnormal laboratory values|0|||
42167484|NCT00109707|75974095|FG002|Overall Study|Abnormal laboratory values|0|||
42167485|NCT00109707|75974093|FG000|Overall Study|Administrative problems|2|||
42167486|NCT00109707|75974094|FG001|Overall Study|Administrative problems|0|||
42167487|NCT00109707|75974095|FG002|Overall Study|Administrative problems|1|||
42167488|NCT00109707|75974093|FG000|Overall Study|Adverse Event|10|||
42167489|NCT00109707|75974094|FG001|Overall Study|Adverse Event|2|||
42167490|NCT00109707|75974095|FG002|Overall Study|Adverse Event|3|||
42167491|NCT00109707|75974093|FG000|Overall Study|Death|4|||
42167492|NCT00109707|75974094|FG001|Overall Study|Death|0|||
42167493|NCT00109707|75974095|FG002|Overall Study|Death|0|||
42167494|NCT00109707|75974093|FG000|Overall Study|Disease progression|12|||
42167495|NCT00109707|75974094|FG001|Overall Study|Disease progression|4|||
42167496|NCT00109707|75974095|FG002|Overall Study|Disease progression|3|||
42167497|NCT00109707|75974093|FG000|Overall Study|Lost to Follow-up|3|||
42167498|NCT00109707|75974094|FG001|Overall Study|Lost to Follow-up|0|||
42167499|NCT00109707|75974095|FG002|Overall Study|Lost to Follow-up|0|||
42167500|NCT00109707|75974093|FG000|Overall Study|Protocol Violation|1|||
42167501|NCT00109707|75974094|FG001|Overall Study|Protocol Violation|0|||
42167502|NCT00109707|75974095|FG002|Overall Study|Protocol Violation|0|||
42167503|NCT00109707|75974093|FG000|Overall Study|Patient withdrew consent|6|||
42282501|NCT00700817|76114312|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
42282502|NCT00700817|76114313|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
42282503|NCT00700817|76114314|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
42282504|NCT00700817|76114315|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
42282505|NCT00700817|76114316|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
42167504|NCT00109707|75974094|FG001|Overall Study|Patient withdrew consent|1|||
42167505|NCT00109707|75974095|FG002|Overall Study|Patient withdrew consent|0|||
42167506|NCT00095979|75974107|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
42167507|NCT00082173|75974118|FG000|Overall Study|Withdrawal by Subject|3|||
42167508|NCT00082173|75974119|FG001|Overall Study|Withdrawal by Subject|5|||
42282506|NCT00700817|76114312|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
42282507|NCT00700817|76114313|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
42282508|NCT00700817|76114314|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
42167509|NCT00082173|75974118|FG000|Overall Study|Lost to Follow-up|1|||
42167510|NCT00082173|75974119|FG001|Overall Study|Lost to Follow-up|0|||
42167511|NCT00082173|75974118|FG000|Overall Study|Adverse Event|1|||
42167512|NCT00082173|75974119|FG001|Overall Study|Adverse Event|0|||
42167513|NCT00082173|75974118|FG000|Overall Study|Culture negative or resistant at baselin|5|||
42167514|NCT00082173|75974119|FG001|Overall Study|Culture negative or resistant at baselin|6|||
42282509|NCT00700817|76114315|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
42167515|NCT00108069|75974127|FG000|Overall Study|Never rec'd study drug|0|||
42167516|NCT00108069|75974128|FG001|Overall Study|Never rec'd study drug|1|||
42167517|NCT00108069|75974127|FG000|Overall Study|Adverse Event|1|||
42167518|NCT00108069|75974128|FG001|Overall Study|Adverse Event|1|||
42167519|NCT00108069|75974127|FG000|Overall Study|Withdrawal by Subject|1|||
42167520|NCT00108069|75974128|FG001|Overall Study|Withdrawal by Subject|0|||
42167521|NCT00108069|75974127|FG000|Overall Study|Death|1|||
42167522|NCT00108069|75974128|FG001|Overall Study|Death|0|||
42167523|NCT00108069|75974127|FG000|Overall Study|Progessive disease|27|||
42167524|NCT00108069|75974128|FG001|Overall Study|Progessive disease|11|||
42167525|NCT00079274|75974147|FG000|Overall Study|Withdrawal by Subject|111|||
42167526|NCT00079274|75974148|FG001|Overall Study|Withdrawal by Subject|10|||
42167527|NCT00079274|75974149|FG002|Overall Study|Withdrawal by Subject|12|||
42167528|NCT00079274|75974150|FG003|Overall Study|Withdrawal by Subject|163|||
42167529|NCT00079274|75974151|FG004|Overall Study|Withdrawal by Subject|7|||
42167530|NCT00079274|75974152|FG005|Overall Study|Withdrawal by Subject|8|||
42167531|NCT00079274|75974153|FG006|Overall Study|Withdrawal by Subject|0|||
42167532|NCT00079274|75974147|FG000|Overall Study|Adverse Event|130|||
42167533|NCT00079274|75974148|FG001|Overall Study|Adverse Event|8|||
42167534|NCT00079274|75974149|FG002|Overall Study|Adverse Event|8|||
42167535|NCT00079274|75974150|FG003|Overall Study|Adverse Event|184|||
42167536|NCT00079274|75974151|FG004|Overall Study|Adverse Event|7|||
42167537|NCT00079274|75974152|FG005|Overall Study|Adverse Event|8|||
42167538|NCT00079274|75974153|FG006|Overall Study|Adverse Event|0|||
42167539|NCT00079274|75974147|FG000|Overall Study|Recurrence|21|||
42282510|NCT00700817|76114316|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
42282511|NCT00700817|76114312|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
42282512|NCT00700817|76114313|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
42282513|NCT00700817|76114314|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
42282514|NCT00700817|76114315|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
42282515|NCT00700817|76114316|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
42282516|NCT00700817|76114312|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
42282517|NCT00700817|76114313|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
42014394|NCT01288079|75821504|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
42014395|NCT01288079|75821501|FG000|Overall Study|Lost to Follow-up|1|||
42014396|NCT01288079|75821502|FG001|Overall Study|Lost to Follow-up|1|||
42014397|NCT01288079|75821503|FG002|Overall Study|Lost to Follow-up|1|||
42014398|NCT01288079|75821504|FG003|Overall Study|Lost to Follow-up|0|||
42014399|NCT01288079|75821501|FG000|Overall Study|Other or Study Termination|11|||
42014400|NCT01288079|75821502|FG001|Overall Study|Other or Study Termination|15|||
42014401|NCT01288079|75821503|FG002|Overall Study|Other or Study Termination|14|||
42014402|NCT01288079|75821504|FG003|Overall Study|Other or Study Termination|8|||
42014403|NCT01287221|75821516|FG000|Overall Study|Lack of Perceived Benefit|1|||
42282518|NCT00700817|76114314|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
42282519|NCT00700817|76114315|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
42282520|NCT00700817|76114316|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
42282521|NCT00700817|76114312|FG000|Week 0-26 (Main Period)|Unclassified|14|||
42282522|NCT00700817|76114313|FG001|Week 0-26 (Main Period)|Unclassified|4|||
42282523|NCT00700817|76114314|FG002|Week 0-26 (Main Period)|Unclassified|8|||
42014404|NCT01287221|75821517|FG001|Overall Study|Lack of Perceived Benefit|1|||
42014405|NCT01287221|75821516|FG000|Overall Study|Adverse Event|3|||
42014406|NCT01287221|75821517|FG001|Overall Study|Adverse Event|3|||
42282524|NCT00700817|76114315|FG003|Week 0-26 (Main Period)|Unclassified|0|||
42282525|NCT00700817|76114316|FG004|Week 0-26 (Main Period)|Unclassified|0|||
42282526|NCT00700817|76114312|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
42282527|NCT00700817|76114313|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
42014407|NCT01287221|75821516|FG000|Overall Study|Withdrawal by Subject|0|||
42014408|NCT01287221|75821517|FG001|Overall Study|Withdrawal by Subject|1|||
42014409|NCT01168401|75821534|FG000|Overall Study|Lost to Follow-up|1|||
42014410|NCT01168401|75821535|FG001|Overall Study|Lost to Follow-up|1|||
42014411|NCT01168401|75821536|FG002|Overall Study|Lost to Follow-up|2|||
42014412|NCT01168401|75821537|FG003|Overall Study|Lost to Follow-up|1|||
42014413|NCT01168401|75821538|FG004|Overall Study|Lost to Follow-up|0|||
42014414|NCT01168401|75821539|FG005|Overall Study|Lost to Follow-up|0|||
42014415|NCT01168401|75821540|FG006|Overall Study|Lost to Follow-up|0|||
42014416|NCT01168401|75821541|FG007|Overall Study|Lost to Follow-up|0|||
42014417|NCT01168401|75821542|FG008|Overall Study|Lost to Follow-up|0|||
42014418|NCT01168401|75821543|FG009|Overall Study|Lost to Follow-up|0|||
42014419|NCT01168401|75821544|FG010|Overall Study|Lost to Follow-up|0|||
42014420|NCT01168401|75821534|FG000|Overall Study|Withdrawal by Subject|0|||
42014421|NCT01168401|75821535|FG001|Overall Study|Withdrawal by Subject|0|||
42014422|NCT01168401|75821536|FG002|Overall Study|Withdrawal by Subject|0|||
42282528|NCT00700817|76114314|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
42014423|NCT01168401|75821537|FG003|Overall Study|Withdrawal by Subject|1|||
42167540|NCT00079274|75974148|FG001|Overall Study|Recurrence|0|||
42167541|NCT00079274|75974149|FG002|Overall Study|Recurrence|1|||
42282529|NCT00700817|76114315|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
42167542|NCT00079274|75974150|FG003|Overall Study|Recurrence|15|||
42014424|NCT01168401|75821538|FG004|Overall Study|Withdrawal by Subject|0|||
42014425|NCT01168401|75821539|FG005|Overall Study|Withdrawal by Subject|0|||
42014426|NCT01168401|75821540|FG006|Overall Study|Withdrawal by Subject|0|||
42014427|NCT01168401|75821541|FG007|Overall Study|Withdrawal by Subject|0|||
42014428|NCT01168401|75821542|FG008|Overall Study|Withdrawal by Subject|0|||
42014429|NCT01168401|75821543|FG009|Overall Study|Withdrawal by Subject|0|||
42014430|NCT01168401|75821544|FG010|Overall Study|Withdrawal by Subject|0|||
42014431|NCT01287065|75821568|FG000|Treatment Period 1|Adverse Event|0|||
42014432|NCT01287065|75821569|FG001|Treatment Period 1|Adverse Event|0|||
42014433|NCT01287065|75821570|FG002|Treatment Period 1|Adverse Event|0|||
42014434|NCT01287065|75821571|FG003|Treatment Period 1|Adverse Event|0|||
42014435|NCT01287065|75821572|FG004|Treatment Period 1|Adverse Event|1|||
42167543|NCT00079274|75974151|FG004|Overall Study|Recurrence|0|||
42167544|NCT00079274|75974152|FG005|Overall Study|Recurrence|2|||
42167545|NCT00079274|75974153|FG006|Overall Study|Recurrence|0|||
42167546|NCT00079274|75974147|FG000|Overall Study|Alternate Treatment|6|||
42167547|NCT00079274|75974148|FG001|Overall Study|Alternate Treatment|1|||
42167548|NCT00079274|75974149|FG002|Overall Study|Alternate Treatment|0|||
42167549|NCT00079274|75974150|FG003|Overall Study|Alternate Treatment|3|||
42167550|NCT00079274|75974151|FG004|Overall Study|Alternate Treatment|0|||
42167551|NCT00079274|75974152|FG005|Overall Study|Alternate Treatment|0|||
42167552|NCT00079274|75974153|FG006|Overall Study|Alternate Treatment|0|||
42167553|NCT00079274|75974147|FG000|Overall Study|Other Medical Problems|6|||
42167554|NCT00079274|75974148|FG001|Overall Study|Other Medical Problems|1|||
42167555|NCT00079274|75974149|FG002|Overall Study|Other Medical Problems|0|||
42167556|NCT00079274|75974150|FG003|Overall Study|Other Medical Problems|7|||
42167557|NCT00079274|75974151|FG004|Overall Study|Other Medical Problems|0|||
42167558|NCT00079274|75974152|FG005|Overall Study|Other Medical Problems|0|||
42167559|NCT00079274|75974153|FG006|Overall Study|Other Medical Problems|0|||
42167560|NCT00079274|75974147|FG000|Overall Study|Death|4|||
42167561|NCT00079274|75974148|FG001|Overall Study|Death|0|||
42167562|NCT00079274|75974149|FG002|Overall Study|Death|1|||
42167563|NCT00079274|75974150|FG003|Overall Study|Death|15|||
42167564|NCT00079274|75974151|FG004|Overall Study|Death|0|||
42167565|NCT00079274|75974152|FG005|Overall Study|Death|0|||
42167566|NCT00079274|75974153|FG006|Overall Study|Death|0|||
42167567|NCT00079274|75974147|FG000|Overall Study|Cytogenetic resistance|0|||
42167568|NCT00079274|75974148|FG001|Overall Study|Cytogenetic resistance|0|||
42167569|NCT00079274|75974149|FG002|Overall Study|Cytogenetic resistance|0|||
42167570|NCT00079274|75974150|FG003|Overall Study|Cytogenetic resistance|2|||
42167571|NCT00079274|75974151|FG004|Overall Study|Cytogenetic resistance|0|||
42167572|NCT00079274|75974152|FG005|Overall Study|Cytogenetic resistance|0|||
42167573|NCT00079274|75974153|FG006|Overall Study|Cytogenetic resistance|0|||
42167574|NCT00079274|75974147|FG000|Overall Study|Other|43|||
42167575|NCT00079274|75974148|FG001|Overall Study|Other|7|||
42167576|NCT00079274|75974149|FG002|Overall Study|Other|5|||
42167577|NCT00079274|75974150|FG003|Overall Study|Other|55|||
42167578|NCT00079274|75974151|FG004|Overall Study|Other|1|||
42167579|NCT00079274|75974152|FG005|Overall Study|Other|2|||
42167580|NCT00079274|75974153|FG006|Overall Study|Other|0|||
42167581|NCT00079040|75974166|FG000|Overall Study|Withdrew before treatment|1|||
42167582|NCT00079040|75974166|FG000|Overall Study|Ineligible|1|||
42167583|NCT00078806|75974170|FG000|Part 1A|Adverse Event|2|||
42167584|NCT00078806|75974171|FG001|Part 1A|Adverse Event|0|||
42167585|NCT00078806|75974172|FG002|Part 1A|Adverse Event|0|||
42167586|NCT00078806|75974173|FG003|Part 1A|Adverse Event|0|||
42167587|NCT00078806|75974170|FG000|Part 1A|Lack of Efficacy|7|||
42167588|NCT00078806|75974171|FG001|Part 1A|Lack of Efficacy|0|||
42167589|NCT00078806|75974172|FG002|Part 1A|Lack of Efficacy|0|||
42167590|NCT00078806|75974173|FG003|Part 1A|Lack of Efficacy|0|||
42167591|NCT00078806|75974170|FG000|Part 1A|Other|1|||
42167592|NCT00078806|75974171|FG001|Part 1A|Other|0|||
42167593|NCT00078806|75974172|FG002|Part 1A|Other|0|||
42167594|NCT00078806|75974173|FG003|Part 1A|Other|0|||
42167595|NCT00078806|75974170|FG000|Part 1B|Adverse Event|1|||
42167596|NCT00078806|75974171|FG001|Part 1B|Adverse Event|0|||
42167597|NCT00078806|75974172|FG002|Part 1B|Adverse Event|0|||
42167598|NCT00078806|75974173|FG003|Part 1B|Adverse Event|0|||
42167599|NCT00078806|75974170|FG000|Part 1B|Lack of Efficacy|7|||
42014436|NCT01287065|75821573|FG005|Treatment Period 1|Adverse Event|0|||
42014437|NCT01287065|75821568|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42167600|NCT00078806|75974171|FG001|Part 1B|Lack of Efficacy|0|||
42167601|NCT00078806|75974172|FG002|Part 1B|Lack of Efficacy|0|||
42167602|NCT00078806|75974173|FG003|Part 1B|Lack of Efficacy|0|||
42167603|NCT00078806|75974170|FG000|Part 2|Adverse Event|0|||
42167604|NCT00078806|75974171|FG001|Part 2|Adverse Event|1|||
42167605|NCT00078806|75974172|FG002|Part 2|Adverse Event|0|||
42167606|NCT00078806|75974173|FG003|Part 2|Adverse Event|0|||
42167607|NCT00078338|75974190|FG000|Overall Study|Adverse Event|31|||
42167608|NCT00078338|75974191|FG001|Overall Study|Adverse Event|24|||
42167609|NCT00078338|75974190|FG000|Overall Study|Lost to Follow-up|17|||
42167610|NCT00078338|75974191|FG001|Overall Study|Lost to Follow-up|2|||
42167611|NCT00078338|75974190|FG000|Overall Study|Protocol Violation|2|||
42167612|NCT00078338|75974191|FG001|Overall Study|Protocol Violation|2|||
42167613|NCT00078338|75974190|FG000|Overall Study|Disease Progression|4|||
42167614|NCT00078338|75974191|FG001|Overall Study|Disease Progression|7|||
42167615|NCT00078338|75974190|FG000|Overall Study|Other|28|||
42167616|NCT00078338|75974191|FG001|Overall Study|Other|16|||
42167617|NCT00078338|75974190|FG000|Overall Study|Subjects randomized, but not treated|3|||
42167618|NCT00078338|75974191|FG001|Overall Study|Subjects randomized, but not treated|3|||
42167619|NCT03808688|75974199|FG000|Overall Study|Adverse Event|13|||
42167620|NCT03808688|75974200|FG001|Overall Study|Adverse Event|17|||
42167621|NCT03808688|75974199|FG000|Overall Study|Lack of Efficacy|2|||
42167622|NCT03808688|75974200|FG001|Overall Study|Lack of Efficacy|0|||
42167623|NCT03808688|75974199|FG000|Overall Study|Lost to Follow-up|0|||
42167624|NCT03808688|75974200|FG001|Overall Study|Lost to Follow-up|2|||
42167625|NCT03808688|75974199|FG000|Overall Study|Withdrawal by Subject|1|||
42167626|NCT03808688|75974200|FG001|Overall Study|Withdrawal by Subject|0|||
42167627|NCT03808688|75974199|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
42282530|NCT00700817|76114316|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
42282531|NCT00700817|76114312|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
42167628|NCT03808688|75974200|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
42167629|NCT03808688|75974199|FG000|Overall Study|IOP Too High|1|||
42167630|NCT03808688|75974200|FG001|Overall Study|IOP Too High|1|||
42167631|NCT03808688|75974199|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
42167632|NCT03808688|75974200|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
42167633|NCT03808688|75974199|FG000|Overall Study|Visit Out of Window|0|||
42167634|NCT03808688|75974200|FG001|Overall Study|Visit Out of Window|1|||
42167635|NCT03808688|75974199|FG000|Overall Study|Medication Non-Compliance|0|||
42167636|NCT03808688|75974200|FG001|Overall Study|Medication Non-Compliance|1|||
42167637|NCT03808298|75974208|FG000|Overall Study|Adverse Event|3|||
42167638|NCT03808298|75974208|FG000|Overall Study|Physician Decision|1|||
42167639|NCT03808298|75974208|FG000|Overall Study|Withdrawal by Subject|1|||
42167640|NCT03808298|75974208|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
42167641|NCT00077636|75974239|FG000|Overall Study|Refused Treatment|9|||
42167642|NCT00077636|75974240|FG001|Overall Study|Refused Treatment|31|||
42167643|NCT00077636|75974239|FG000|Overall Study|Admin|3|||
42167644|NCT00077636|75974240|FG001|Overall Study|Admin|3|||
42167645|NCT00077636|75974239|FG000|Overall Study|Withdrawal by Subject|2|||
42167646|NCT00077636|75974240|FG001|Overall Study|Withdrawal by Subject|2|||
42167647|NCT00077636|75974239|FG000|Overall Study|Adverse Event|17|||
42167648|NCT00077636|75974240|FG001|Overall Study|Adverse Event|34|||
42167649|NCT00077636|75974239|FG000|Overall Study|Protocol Violation|0|||
42167650|NCT00077636|75974240|FG001|Overall Study|Protocol Violation|2|||
42167651|NCT00077636|75974239|FG000|Overall Study|Lost to Follow-up|10|||
42167652|NCT00077636|75974240|FG001|Overall Study|Lost to Follow-up|18|||
42167653|NCT00077636|75974239|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
42167654|NCT00077636|75974240|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
42167655|NCT00095199|75974251|FG000|Overall Study|Adverse Event|40|||
42167656|NCT00095199|75974252|FG001|Overall Study|Adverse Event|22|||
42167657|NCT00095199|75974253|FG002|Overall Study|Adverse Event|26|||
42167658|NCT00095199|75974254|FG003|Overall Study|Adverse Event|11|||
42167659|NCT00095199|75974251|FG000|Overall Study|Progressive disease|213|||
42167660|NCT00095199|75974252|FG001|Overall Study|Progressive disease|179|||
42167661|NCT00095199|75974253|FG002|Overall Study|Progressive disease|105|||
42167662|NCT00095199|75974254|FG003|Overall Study|Progressive disease|98|||
42167663|NCT00095199|75974251|FG000|Overall Study|Death|10|||
42167664|NCT00095199|75974252|FG001|Overall Study|Death|6|||
42167665|NCT00095199|75974253|FG002|Overall Study|Death|11|||
42167666|NCT00095199|75974254|FG003|Overall Study|Death|9|||
42167667|NCT00095199|75974251|FG000|Overall Study|Withdrawal by Subject|21|||
42167668|NCT00095199|75974252|FG001|Overall Study|Withdrawal by Subject|16|||
42167669|NCT00095199|75974253|FG002|Overall Study|Withdrawal by Subject|13|||
42167670|NCT00095199|75974254|FG003|Overall Study|Withdrawal by Subject|22|||
42167671|NCT00095199|75974251|FG000|Overall Study|Protocol Violation|4|||
42167672|NCT00095199|75974252|FG001|Overall Study|Protocol Violation|4|||
42167673|NCT00095199|75974253|FG002|Overall Study|Protocol Violation|2|||
42167674|NCT00095199|75974254|FG003|Overall Study|Protocol Violation|0|||
42167675|NCT00095199|75974251|FG000|Overall Study|Liver function test results elevated|0|||
42167676|NCT00095199|75974252|FG001|Overall Study|Liver function test results elevated|0|||
42167677|NCT00095199|75974253|FG002|Overall Study|Liver function test results elevated|1|||
42167678|NCT00095199|75974254|FG003|Overall Study|Liver function test results elevated|1|||
42282532|NCT00700817|76114313|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
42167679|NCT00095199|75974251|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
42167680|NCT00095199|75974252|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
42167681|NCT00095199|75974253|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
42167682|NCT00095199|75974254|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
42167683|NCT00095199|75974251|FG000|Overall Study|Physician Decision|5|||
42167684|NCT00095199|75974252|FG001|Overall Study|Physician Decision|6|||
42167685|NCT00095199|75974253|FG002|Overall Study|Physician Decision|1|||
42167686|NCT00095199|75974254|FG003|Overall Study|Physician Decision|1|||
42167687|NCT00095199|75974251|FG000|Overall Study|Not eligible|1|||
42167688|NCT00095199|75974252|FG001|Overall Study|Not eligible|7|||
42167689|NCT00095199|75974253|FG002|Overall Study|Not eligible|0|||
42167690|NCT00095199|75974254|FG003|Overall Study|Not eligible|1|||
42167691|NCT00095199|75974251|FG000|Overall Study|Started Palliative Radiotherapy|1|||
42167692|NCT00095199|75974252|FG001|Overall Study|Started Palliative Radiotherapy|0|||
42167693|NCT00095199|75974253|FG002|Overall Study|Started Palliative Radiotherapy|0|||
42167694|NCT00095199|75974254|FG003|Overall Study|Started Palliative Radiotherapy|0|||
42167695|NCT00095199|75974251|FG000|Overall Study|Started radiotherapy regimen|0|||
42282533|NCT00700817|76114314|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
42282534|NCT00700817|76114315|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
42282535|NCT00700817|76114316|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
42282536|NCT00700817|76114312|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
42282537|NCT00700817|76114313|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
42282538|NCT00700817|76114314|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
42282539|NCT00700817|76114315|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
42282540|NCT00700817|76114316|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
42282541|NCT00700817|76114312|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
42282542|NCT00700817|76114313|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
42351973|NCT01901653|76191860|FG004|Overall Study|Withdrawal by Subject|0|||
42167696|NCT00095199|75974252|FG001|Overall Study|Started radiotherapy regimen|1|||
42167697|NCT00095199|75974253|FG002|Overall Study|Started radiotherapy regimen|0|||
42167698|NCT00095199|75974254|FG003|Overall Study|Started radiotherapy regimen|0|||
42167699|NCT00095199|75974251|FG000|Overall Study|Primary tumor removed in other surgery|0|||
42167700|NCT00095199|75974252|FG001|Overall Study|Primary tumor removed in other surgery|1|||
42167701|NCT00095199|75974253|FG002|Overall Study|Primary tumor removed in other surgery|0|||
42167702|NCT00095199|75974254|FG003|Overall Study|Primary tumor removed in other surgery|0|||
42167703|NCT00095199|75974251|FG000|Overall Study|Data inadvertently lost by site|1|||
42167704|NCT00095199|75974252|FG001|Overall Study|Data inadvertently lost by site|0|||
42167705|NCT00095199|75974253|FG002|Overall Study|Data inadvertently lost by site|0|||
42167706|NCT00095199|75974254|FG003|Overall Study|Data inadvertently lost by site|0|||
42167707|NCT00075764|75974271|FG000|Overall Study|Adverse Event|5|||
42167708|NCT00075764|75974272|FG001|Overall Study|Adverse Event|12|||
42167709|NCT00075764|75974271|FG000|Overall Study|Death|4|||
42167710|NCT00075764|75974272|FG001|Overall Study|Death|8|||
42167711|NCT00075764|75974271|FG000|Overall Study|Withdrawal by Subject|28|||
42167712|NCT00075764|75974272|FG001|Overall Study|Withdrawal by Subject|18|||
42167713|NCT00075764|75974271|FG000|Overall Study|Progression|269|||
42167714|NCT00075764|75974272|FG001|Overall Study|Progression|274|||
42167715|NCT00075764|75974271|FG000|Overall Study|Still on treatment|8|||
42167716|NCT00075764|75974272|FG001|Overall Study|Still on treatment|15|||
42167717|NCT00075764|75974271|FG000|Overall Study|Delinquent|4|||
42167718|NCT00075764|75974272|FG001|Overall Study|Delinquent|2|||
42167719|NCT00075764|75974271|FG000|Overall Study|Not protocol specified|27|||
42167720|NCT00075764|75974272|FG001|Overall Study|Not protocol specified|19|||
42167721|NCT00075764|75974271|FG000|Overall Study|Under review|0|||
42167722|NCT00075764|75974272|FG001|Overall Study|Under review|1|||
42167723|NCT03568162|75974286|FG000|Overall Study|Adverse Event|0|||
42167724|NCT03568162|75974287|FG001|Overall Study|Adverse Event|1|||
42167725|NCT03568162|75974288|FG002|Overall Study|Adverse Event|2|||
42167726|NCT03568162|75974289|FG003|Overall Study|Adverse Event|0|||
42167727|NCT03568162|75974290|FG004|Overall Study|Adverse Event|0|||
42167728|NCT03568162|75974291|FG005|Overall Study|Adverse Event|1|||
42167729|NCT03568162|75974286|FG000|Overall Study|Death|0|||
42167730|NCT03568162|75974287|FG001|Overall Study|Death|0|||
42167731|NCT03568162|75974288|FG002|Overall Study|Death|0|||
42167732|NCT03568162|75974289|FG003|Overall Study|Death|0|||
42282543|NCT00700817|76114314|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
42351974|NCT01901653|76191861|FG005|Overall Study|Withdrawal by Subject|0|||
42351975|NCT01901653|76191862|FG006|Overall Study|Withdrawal by Subject|1|||
42351976|NCT01901653|76191863|FG007|Overall Study|Withdrawal by Subject|0|||
42167733|NCT03568162|75974290|FG004|Overall Study|Death|1|||
42167734|NCT03568162|75974291|FG005|Overall Study|Death|0|||
42167735|NCT03568162|75974286|FG000|Overall Study|Lost to Follow-up|3|||
42167736|NCT03568162|75974287|FG001|Overall Study|Lost to Follow-up|2|||
42167737|NCT03568162|75974288|FG002|Overall Study|Lost to Follow-up|4|||
42167738|NCT03568162|75974289|FG003|Overall Study|Lost to Follow-up|2|||
42167739|NCT03568162|75974290|FG004|Overall Study|Lost to Follow-up|3|||
42167740|NCT03568162|75974291|FG005|Overall Study|Lost to Follow-up|2|||
42282544|NCT00700817|76114315|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
42282545|NCT00700817|76114316|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
42351977|NCT01901653|76191864|FG008|Overall Study|Withdrawal by Subject|0|||
42167741|NCT03568162|75974286|FG000|Overall Study|Physician Decision|0|||
42351978|NCT01901653|76191865|FG009|Overall Study|Withdrawal by Subject|0|||
42167742|NCT03568162|75974287|FG001|Overall Study|Physician Decision|1|||
42167743|NCT03568162|75974288|FG002|Overall Study|Physician Decision|1|||
42167744|NCT03568162|75974289|FG003|Overall Study|Physician Decision|0|||
42167745|NCT03568162|75974290|FG004|Overall Study|Physician Decision|1|||
42167746|NCT03568162|75974291|FG005|Overall Study|Physician Decision|0|||
42167747|NCT03568162|75974286|FG000|Overall Study|Pregnancy|0|||
42167748|NCT03568162|75974287|FG001|Overall Study|Pregnancy|0|||
42167749|NCT03568162|75974288|FG002|Overall Study|Pregnancy|0|||
42167750|NCT03568162|75974289|FG003|Overall Study|Pregnancy|1|||
42167751|NCT03568162|75974290|FG004|Overall Study|Pregnancy|0|||
42167752|NCT03568162|75974291|FG005|Overall Study|Pregnancy|0|||
42167753|NCT03568162|75974286|FG000|Overall Study|Protocol Violation|1|||
42167754|NCT03568162|75974287|FG001|Overall Study|Protocol Violation|0|||
42167755|NCT03568162|75974288|FG002|Overall Study|Protocol Violation|1|||
42167756|NCT03568162|75974289|FG003|Overall Study|Protocol Violation|1|||
42167757|NCT03568162|75974290|FG004|Overall Study|Protocol Violation|1|||
42167758|NCT03568162|75974291|FG005|Overall Study|Protocol Violation|1|||
42167759|NCT03568162|75974286|FG000|Overall Study|Withdrawal by Subject|15|||
42167760|NCT03568162|75974287|FG001|Overall Study|Withdrawal by Subject|15|||
42167761|NCT03568162|75974288|FG002|Overall Study|Withdrawal by Subject|26|||
42167762|NCT03568162|75974289|FG003|Overall Study|Withdrawal by Subject|22|||
42167763|NCT03568162|75974290|FG004|Overall Study|Withdrawal by Subject|6|||
42167764|NCT03568162|75974291|FG005|Overall Study|Withdrawal by Subject|9|||
42167765|NCT03568162|75974286|FG000|Overall Study|Others|3|||
42167766|NCT03568162|75974287|FG001|Overall Study|Others|4|||
42167767|NCT03568162|75974288|FG002|Overall Study|Others|1|||
42167768|NCT03568162|75974289|FG003|Overall Study|Others|4|||
42167769|NCT03568162|75974290|FG004|Overall Study|Others|2|||
42167770|NCT03568162|75974291|FG005|Overall Study|Others|1|||
42167771|NCT03567616|75974310|FG000|Overall Study|Disease progression|4|||
42167772|NCT03567616|75974310|FG000|Overall Study|Withdrawal by Subject|1|||
42167773|NCT03567616|75974310|FG000|Overall Study|Physician Decision|1|||
42167774|NCT03567616|75974310|FG000|Overall Study|Death|1|||
42167775|NCT03567616|75974310|FG000|Overall Study|Adverse Event|1|||
42167776|NCT03567382|75974319|FG000|Overall Study|Lost to Follow-up|1|||
42167777|NCT03567382|75974320|FG001|Overall Study|Lost to Follow-up|21|||
42167778|NCT03567382|75974321|FG002|Overall Study|Lost to Follow-up|1|||
42167779|NCT03567382|75974322|FG003|Overall Study|Lost to Follow-up|21|||
42167780|NCT03567382|75974319|FG000|Overall Study|Withdrawal by Subject|2|||
42167781|NCT03567382|75974320|FG001|Overall Study|Withdrawal by Subject|14|||
42167782|NCT03567382|75974321|FG002|Overall Study|Withdrawal by Subject|1|||
42167783|NCT03567382|75974322|FG003|Overall Study|Withdrawal by Subject|12|||
42167784|NCT03595384|75974333|FG000|Overall Study|Other time commitments|8|||
42167785|NCT03595384|75974333|FG000|Overall Study|Changes to session time|7|||
42167786|NCT03595384|75974333|FG000|Overall Study|Relocation out of country|1|||
42167787|NCT03591874|75974339|FG000|Overall Study|Adverse Event|4|||
42167788|NCT03591874|75974340|FG001|Overall Study|Adverse Event|0|||
42167789|NCT03591874|75974339|FG000|Overall Study|Withdrawal by Subject|2|||
42167790|NCT03591874|75974340|FG001|Overall Study|Withdrawal by Subject|1|||
42167791|NCT03591874|75974339|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
42167792|NCT03591874|75974340|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
42167793|NCT03591874|75974339|FG000|Overall Study|On Study at Time of Study Termination|12|||
42167794|NCT03591874|75974340|FG001|Overall Study|On Study at Time of Study Termination|6|||
42167795|NCT03566680|75974346|FG000|Overall Study|Pregnancy|1|||
42167796|NCT03566680|75974346|FG000|Overall Study|Lost to Follow-up|13|||
42167797|NCT03566680|75974346|FG000|Overall Study|Withdrawal by Subject|3|||
42167798|NCT00106353|75974352|FG000|Part 1|Disease progression|3|||
42167799|NCT00106353|75974353|FG001|Part 1|Disease progression|4|||
42167800|NCT00106353|75974354|FG002|Part 1|Disease progression|1|||
42167801|NCT00106353|75974355|FG003|Part 1|Disease progression|3|||
42167802|NCT00106353|75974356|FG004|Part 1|Disease progression|0|||
42167803|NCT00106353|75974357|FG005|Part 1|Disease progression|0|||
42167804|NCT00106353|75974358|FG006|Part 1|Disease progression|0|||
42167805|NCT00106353|75974352|FG000|Part 1|Withdrawal by Subject|0|||
42167806|NCT00106353|75974353|FG001|Part 1|Withdrawal by Subject|0|||
42282546|NCT00700817|76114312|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
42282547|NCT00700817|76114313|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
42167807|NCT00106353|75974354|FG002|Part 1|Withdrawal by Subject|1|||
42167808|NCT00106353|75974355|FG003|Part 1|Withdrawal by Subject|2|||
42167809|NCT00106353|75974356|FG004|Part 1|Withdrawal by Subject|0|||
42167810|NCT00106353|75974357|FG005|Part 1|Withdrawal by Subject|0|||
42167811|NCT00106353|75974358|FG006|Part 1|Withdrawal by Subject|0|||
42167812|NCT00106353|75974352|FG000|Part 1|Symptomatic deterioration|0|||
42167813|NCT00106353|75974353|FG001|Part 1|Symptomatic deterioration|0|||
42167814|NCT00106353|75974354|FG002|Part 1|Symptomatic deterioration|1|||
42167815|NCT00106353|75974355|FG003|Part 1|Symptomatic deterioration|0|||
42167816|NCT00106353|75974356|FG004|Part 1|Symptomatic deterioration|0|||
42167817|NCT00106353|75974357|FG005|Part 1|Symptomatic deterioration|0|||
42167818|NCT00106353|75974358|FG006|Part 1|Symptomatic deterioration|0|||
42167819|NCT00106353|75974352|FG000|Part 1|Entered follow-up phase|1|||
42167820|NCT00106353|75974353|FG001|Part 1|Entered follow-up phase|1|||
42167821|NCT00106353|75974354|FG002|Part 1|Entered follow-up phase|0|||
42167822|NCT00106353|75974355|FG003|Part 1|Entered follow-up phase|1|||
42167823|NCT00106353|75974356|FG004|Part 1|Entered follow-up phase|0|||
42167824|NCT00106353|75974357|FG005|Part 1|Entered follow-up phase|0|||
42167825|NCT00106353|75974358|FG006|Part 1|Entered follow-up phase|0|||
42167826|NCT00106353|75974352|FG000|Part 1|Adverse Event|0|||
42167827|NCT00106353|75974353|FG001|Part 1|Adverse Event|0|||
42167828|NCT00106353|75974354|FG002|Part 1|Adverse Event|0|||
42167829|NCT00106353|75974355|FG003|Part 1|Adverse Event|1|||
42167830|NCT00106353|75974356|FG004|Part 1|Adverse Event|0|||
42167831|NCT00106353|75974357|FG005|Part 1|Adverse Event|0|||
42167832|NCT00106353|75974358|FG006|Part 1|Adverse Event|0|||
42167833|NCT00106353|75974352|FG000|Part 2|Disease progression|0|||
42167834|NCT00106353|75974353|FG001|Part 2|Disease progression|0|||
42167835|NCT00106353|75974354|FG002|Part 2|Disease progression|0|||
42167836|NCT00106353|75974355|FG003|Part 2|Disease progression|0|||
42167837|NCT00106353|75974356|FG004|Part 2|Disease progression|8|||
42167838|NCT00106353|75974357|FG005|Part 2|Disease progression|14|||
42167839|NCT00106353|75974358|FG006|Part 2|Disease progression|13|||
42167840|NCT00106353|75974352|FG000|Part 2|Death|0|||
42167841|NCT00106353|75974353|FG001|Part 2|Death|0|||
42167842|NCT00106353|75974354|FG002|Part 2|Death|0|||
42167843|NCT00106353|75974355|FG003|Part 2|Death|0|||
42167844|NCT00106353|75974356|FG004|Part 2|Death|3|||
42167845|NCT00106353|75974357|FG005|Part 2|Death|0|||
42167846|NCT00106353|75974358|FG006|Part 2|Death|1|||
42167847|NCT00106353|75974352|FG000|Part 2|Symptomatic deterioration|0|||
42167848|NCT00106353|75974353|FG001|Part 2|Symptomatic deterioration|0|||
42167849|NCT00106353|75974354|FG002|Part 2|Symptomatic deterioration|0|||
42167850|NCT00106353|75974355|FG003|Part 2|Symptomatic deterioration|0|||
42167851|NCT00106353|75974356|FG004|Part 2|Symptomatic deterioration|3|||
42167852|NCT00106353|75974357|FG005|Part 2|Symptomatic deterioration|0|||
42167853|NCT00106353|75974358|FG006|Part 2|Symptomatic deterioration|0|||
42167854|NCT00106353|75974352|FG000|Part 2|Adverse Event|0|||
42167855|NCT00106353|75974353|FG001|Part 2|Adverse Event|0|||
42167856|NCT00106353|75974354|FG002|Part 2|Adverse Event|0|||
42167857|NCT00106353|75974355|FG003|Part 2|Adverse Event|0|||
42167858|NCT00106353|75974356|FG004|Part 2|Adverse Event|0|||
42167859|NCT00106353|75974357|FG005|Part 2|Adverse Event|2|||
42167860|NCT00106353|75974358|FG006|Part 2|Adverse Event|1|||
42167861|NCT00106353|75974352|FG000|Part 2|Other|0|||
42167862|NCT00106353|75974353|FG001|Part 2|Other|0|||
42167863|NCT00106353|75974354|FG002|Part 2|Other|0|||
42167864|NCT00106353|75974355|FG003|Part 2|Other|0|||
42167865|NCT00106353|75974356|FG004|Part 2|Other|1|||
42167866|NCT00106353|75974357|FG005|Part 2|Other|1|||
42167867|NCT00106353|75974358|FG006|Part 2|Other|1|||
42167868|NCT00106353|75974352|FG000|Part 2|Withdrawal by Subject|0|||
42167869|NCT00106353|75974353|FG001|Part 2|Withdrawal by Subject|0|||
42167870|NCT00106353|75974354|FG002|Part 2|Withdrawal by Subject|0|||
42167871|NCT00106353|75974355|FG003|Part 2|Withdrawal by Subject|0|||
42167872|NCT00106353|75974356|FG004|Part 2|Withdrawal by Subject|1|||
42167873|NCT00106353|75974357|FG005|Part 2|Withdrawal by Subject|0|||
42167874|NCT00106353|75974358|FG006|Part 2|Withdrawal by Subject|0|||
42167875|NCT00106353|75974352|FG000|Part 2|Physician Decision|0|||
42167876|NCT00106353|75974353|FG001|Part 2|Physician Decision|0|||
42167877|NCT00106353|75974354|FG002|Part 2|Physician Decision|0|||
42167878|NCT00106353|75974355|FG003|Part 2|Physician Decision|0|||
42167879|NCT00106353|75974356|FG004|Part 2|Physician Decision|0|||
42167880|NCT00106353|75974357|FG005|Part 2|Physician Decision|1|||
42167881|NCT00106353|75974358|FG006|Part 2|Physician Decision|0|||
42167882|NCT00080301|75974381|FG000|Overall Study|Randomized but Never Treated|5|||
42167883|NCT00080301|75974382|FG001|Overall Study|Randomized but Never Treated|10|||
42167884|NCT00080301|75974381|FG000|Overall Study|Still on Treatment as of CSR date|0|||
42167885|NCT00080301|75974382|FG001|Overall Study|Still on Treatment as of CSR date|1|||
42167886|NCT00079677|75974391|FG000|Overall Study|Adverse Event|5|||
42014438|NCT01287065|75821569|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42014439|NCT01287065|75821570|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42167887|NCT00079677|75974392|FG001|Overall Study|Adverse Event|6|||
42167888|NCT00079677|75974391|FG000|Overall Study|Lack of Efficacy|1|||
42167889|NCT00079677|75974392|FG001|Overall Study|Lack of Efficacy|0|||
42167890|NCT00079677|75974391|FG000|Overall Study|Lost to Follow-up|2|||
42167891|NCT00079677|75974392|FG001|Overall Study|Lost to Follow-up|2|||
42167892|NCT00079677|75974391|FG000|Overall Study|Physician Decision|3|||
42167893|NCT00079677|75974392|FG001|Overall Study|Physician Decision|0|||
42167894|NCT00079677|75974391|FG000|Overall Study|Protocol Violation|2|||
42167895|NCT00079677|75974392|FG001|Overall Study|Protocol Violation|3|||
42167896|NCT00079677|75974391|FG000|Overall Study|Withdrawal by Subject|5|||
42167897|NCT00079677|75974392|FG001|Overall Study|Withdrawal by Subject|3|||
42167898|NCT00079677|75974391|FG000|Overall Study|Miscellaneous|2|||
42167899|NCT00079677|75974392|FG001|Overall Study|Miscellaneous|0|||
42167900|NCT00095121|75974400|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
42167901|NCT00095121|75974401|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
42167902|NCT00095121|75974400|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
42167903|NCT00095121|75974401|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
42167904|NCT00094809|75974419|FG000|Overall Study|Protocol deviation|2|||
42167905|NCT00094809|75974420|FG001|Overall Study|Protocol deviation|2|||
42167906|NCT00094809|75974419|FG000|Overall Study|Noncompliance|1|||
42167907|NCT00094809|75974420|FG001|Overall Study|Noncompliance|0|||
42167908|NCT00094809|75974419|FG000|Overall Study|Adverse Event|3|||
42167909|NCT00094809|75974420|FG001|Overall Study|Adverse Event|1|||
42167910|NCT00094809|75974419|FG000|Overall Study|Withdrawal by Subject|8|||
42167911|NCT00094809|75974420|FG001|Overall Study|Withdrawal by Subject|9|||
42167912|NCT00094809|75974419|FG000|Overall Study|Disease progression|3|||
42167913|NCT00094809|75974420|FG001|Overall Study|Disease progression|3|||
42167914|NCT00094809|75974419|FG000|Overall Study|Physician Decision|3|||
42167915|NCT00094809|75974420|FG001|Overall Study|Physician Decision|5|||
42167916|NCT00094809|75974419|FG000|Overall Study|Lost to Follow-up|6|||
42167917|NCT00094809|75974420|FG001|Overall Study|Lost to Follow-up|6|||
42167918|NCT00094809|75974419|FG000|Overall Study|Death|19|||
42167919|NCT00094809|75974420|FG001|Overall Study|Death|25|||
42167920|NCT00094809|75974419|FG000|Overall Study|Protocol-specified criteria|1|||
42167921|NCT00094809|75974420|FG001|Overall Study|Protocol-specified criteria|1|||
42167922|NCT00094809|75974419|FG000|Overall Study|Other|2|||
42167923|NCT00094809|75974420|FG001|Overall Study|Other|4|||
42167924|NCT00094809|75974419|FG000|Overall Study|Informed consent signed after treatment|1|||
42167925|NCT00094809|75974420|FG001|Overall Study|Informed consent signed after treatment|0|||
42167926|NCT00094809|75974419|FG000|Overall Study|Study drug not received|2|||
42167927|NCT00094809|75974420|FG001|Overall Study|Study drug not received|8|||
42167928|NCT00094809|75974419|FG000|Overall Study|Other|1|||
42167929|NCT00094809|75974420|FG001|Overall Study|Other|1|||
42167930|NCT00075218|75974428|FG000|Double-Blind Treatment|Adverse Event|23|||
42167931|NCT00075218|75974429|FG001|Double-Blind Treatment|Adverse Event|4|||
42167932|NCT00075218|75974430|FG002|Double-Blind Treatment|Adverse Event|0|||
42167933|NCT00075218|75974428|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
42167934|NCT00075218|75974429|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
42167935|NCT00075218|75974430|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
42167936|NCT00075218|75974428|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
42167937|NCT00075218|75974429|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
42167938|NCT00075218|75974430|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
42167939|NCT00075218|75974428|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
42167940|NCT00075218|75974429|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
42167941|NCT00075218|75974430|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
42167942|NCT00075218|75974428|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
42167943|NCT00075218|75974429|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
42167944|NCT00075218|75974430|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
42167945|NCT00075218|75974428|FG000|Double-Blind Treatment|No study medication taken|2|||
42167946|NCT00075218|75974429|FG001|Double-Blind Treatment|No study medication taken|0|||
42167947|NCT00075218|75974430|FG002|Double-Blind Treatment|No study medication taken|0|||
42167948|NCT00075218|75974428|FG000|Open-Label Treatment|Lack of Efficacy|0|||
42167949|NCT00075218|75974429|FG001|Open-Label Treatment|Lack of Efficacy|0|||
42167950|NCT00075218|75974430|FG002|Open-Label Treatment|Lack of Efficacy|174|||
42167951|NCT00075218|75974428|FG000|Open-Label Treatment|Adverse Event|0|||
42167952|NCT00075218|75974429|FG001|Open-Label Treatment|Adverse Event|0|||
42167953|NCT00075218|75974430|FG002|Open-Label Treatment|Adverse Event|51|||
42167954|NCT00075218|75974428|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
42167955|NCT00075218|75974429|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
42167956|NCT00075218|75974430|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
42167957|NCT00075218|75974428|FG000|Open-Label Treatment|Decision of Sponsor|0|||
42167958|NCT00075218|75974429|FG001|Open-Label Treatment|Decision of Sponsor|0|||
42167959|NCT00075218|75974430|FG002|Open-Label Treatment|Decision of Sponsor|8|||
42167960|NCT00075218|75974428|FG000|Open-Label Treatment|Protocol Violation|0|||
42167961|NCT00075218|75974429|FG001|Open-Label Treatment|Protocol Violation|0|||
42167962|NCT00075218|75974430|FG002|Open-Label Treatment|Protocol Violation|1|||
42167963|NCT00075218|75974428|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
42167964|NCT00075218|75974429|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
42167965|NCT00075218|75974430|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
42167966|NCT00094653|75974440|FG000|Overall Study|Death|306|||
42167967|NCT00094653|75974441|FG001|Overall Study|Death|100|||
42167968|NCT00094653|75974442|FG002|Overall Study|Death|119|||
42167969|NCT00094653|75974440|FG000|Overall Study|Subject Withdrew Consent|10|||
42167970|NCT00094653|75974441|FG001|Overall Study|Subject Withdrew Consent|2|||
42167971|NCT00094653|75974442|FG002|Overall Study|Subject Withdrew Consent|3|||
42167972|NCT00094653|75974440|FG000|Overall Study|Other|2|||
42167973|NCT00094653|75974441|FG001|Overall Study|Other|2|||
42167974|NCT00094653|75974442|FG002|Overall Study|Other|2|||
42167975|NCT00094653|75974440|FG000|Overall Study|Lost to Follow-up|3|||
42167976|NCT00094653|75974441|FG001|Overall Study|Lost to Follow-up|2|||
42167977|NCT00094653|75974442|FG002|Overall Study|Lost to Follow-up|1|||
42167978|NCT00094653|75974440|FG000|Overall Study|Protocol Violation|0|||
42167979|NCT00094653|75974441|FG001|Overall Study|Protocol Violation|0|||
42167980|NCT00094653|75974442|FG002|Overall Study|Protocol Violation|1|||
42167981|NCT00104247|75974453|FG000|Overall Study|Withdrawal by Subject|1|||
42282548|NCT00700817|76114314|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
42282549|NCT00700817|76114315|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
42282550|NCT00700817|76114316|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
42282551|NCT00700817|76114312|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
42282552|NCT00700817|76114313|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
42167982|NCT00104247|75974454|FG001|Overall Study|Withdrawal by Subject|0|||
42167983|NCT00104247|75974453|FG000|Overall Study|Noncompliant with dosing|0|||
42167984|NCT00104247|75974454|FG001|Overall Study|Noncompliant with dosing|1|||
42282553|NCT00700817|76114314|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
42282554|NCT00700817|76114315|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
42282555|NCT00700817|76114316|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
42282556|NCT00700817|76114312|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
42282557|NCT00700817|76114313|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
42282558|NCT00700817|76114314|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
42282559|NCT00700817|76114315|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
42282560|NCT00700817|76114316|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
42282561|NCT00700817|76114312|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
42351979|NCT01901653|76191866|FG010|Overall Study|Withdrawal by Subject|0|||
42351980|NCT01901653|76191867|FG011|Overall Study|Withdrawal by Subject|0|||
42040624|NCT01796171|75848709|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
42351981|NCT01901653|76191868|FG012|Overall Study|Withdrawal by Subject|0|||
42040625|NCT01796171|75848710|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
42040626|NCT01796171|75848711|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
42040627|NCT01796171|75848712|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
42167985|NCT03591406|75974462|FG000|Overall Study|Adverse Event|5|||
42167986|NCT03591406|75974463|FG001|Overall Study|Adverse Event|3|||
42167987|NCT03591406|75974462|FG000|Overall Study|Protocol Violation|2|||
42167988|NCT03591406|75974463|FG001|Overall Study|Protocol Violation|1|||
42167989|NCT03591406|75974462|FG000|Overall Study|Withdrawal by Subject|0|||
42167990|NCT03591406|75974463|FG001|Overall Study|Withdrawal by Subject|5|||
42167991|NCT03560986|75974471|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
42167992|NCT03560986|75974472|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
42167993|NCT03560986|75974471|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
42167994|NCT03560986|75974472|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
42167995|NCT03560986|75974471|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
42167996|NCT03560986|75974472|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
42167997|NCT03560986|75974471|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
42167998|NCT03560986|75974472|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
42167999|NCT03560986|75974471|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
42168000|NCT03560986|75974472|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
42168001|NCT03560986|75974471|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
42168002|NCT03560986|75974472|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
42168003|NCT03560986|75974471|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
42168004|NCT03560986|75974472|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
42351982|NCT01901653|76191856|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
42040628|NCT01796171|75848713|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
42040629|NCT01796171|75848714|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
42040630|NCT01796171|75848715|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
42040631|NCT01796171|75848716|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
42040632|NCT01796171|75848717|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
42040633|NCT01796171|75848718|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
42040634|NCT01796171|75848719|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
42040635|NCT01796171|75848720|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
42040636|NCT01796171|75848706|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42040637|NCT01796171|75848707|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42040638|NCT01796171|75848708|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42040639|NCT01796171|75848709|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42040640|NCT01796171|75848710|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42040641|NCT01796171|75848711|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42040642|NCT01796171|75848712|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42040643|NCT01796171|75848713|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42168005|NCT03560518|75974487|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
42168006|NCT03560518|75974488|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
42168007|NCT03560518|75974489|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
42040644|NCT01796171|75848714|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42040645|NCT01796171|75848715|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42040646|NCT01796171|75848716|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
42040647|NCT01796171|75848717|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
42168008|NCT03560518|75974487|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
42168009|NCT03560518|75974488|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
42168010|NCT03560518|75974489|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
42168011|NCT03560518|75974487|FG000|Double Blind Treatment Period|Protocol Violation|1|||
42168012|NCT03560518|75974488|FG001|Double Blind Treatment Period|Protocol Violation|2|||
42168013|NCT03560518|75974489|FG002|Double Blind Treatment Period|Protocol Violation|0|||
42168014|NCT03560518|75974487|FG000|Double Blind Treatment Period|Pregnancy|0|||
42168015|NCT03560518|75974488|FG001|Double Blind Treatment Period|Pregnancy|2|||
42351983|NCT01901653|76191857|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
42351984|NCT01901653|76191858|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
42351985|NCT01901653|76191859|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
42351986|NCT01901653|76191860|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
42351987|NCT01901653|76191861|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
42351988|NCT01901653|76191862|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
42351989|NCT01901653|76191863|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
42351990|NCT01901653|76191864|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
42351991|NCT01901653|76191865|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
42351992|NCT01901653|76191866|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
42351993|NCT01901653|76191867|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
42351994|NCT01901653|76191868|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
42351995|NCT01925989|76191896|FG000|Period 1|Sponsor Decision|1|||
42351996|NCT01925989|76191897|FG001|Period 1|Sponsor Decision|1|||
42351997|NCT01925989|76191898|FG002|Period 1|Sponsor Decision|0|||
42351998|NCT01925989|76191896|FG000|Period 1|Withdrawal by Subject|0|||
42351999|NCT01925989|76191897|FG001|Period 1|Withdrawal by Subject|1|||
42352000|NCT01925989|76191898|FG002|Period 1|Withdrawal by Subject|0|||
42352001|NCT01901419|76191912|FG000|Overall Study|Protocol Violation|2|||
42352002|NCT01901419|76191913|FG001|Overall Study|Protocol Violation|6|||
42352003|NCT01901419|76191912|FG000|Overall Study|unavailable researchers|6|||
42352004|NCT01901419|76191913|FG001|Overall Study|unavailable researchers|3|||
42352005|NCT01901341|76191940|FG000|Overall Study|Adverse Event|4|||
42352006|NCT01901341|76191941|FG001|Overall Study|Adverse Event|2|||
42352007|NCT01901341|76191940|FG000|Overall Study|Lack of Efficacy|0|||
42352008|NCT01901341|76191941|FG001|Overall Study|Lack of Efficacy|2|||
42352009|NCT01901341|76191940|FG000|Overall Study|Lost to Follow-up|0|||
42352010|NCT01901341|76191941|FG001|Overall Study|Lost to Follow-up|1|||
42352011|NCT01901341|76191940|FG000|Overall Study|Protocol Violation|2|||
42352012|NCT01901341|76191941|FG001|Overall Study|Protocol Violation|0|||
42352013|NCT01901341|76191940|FG000|Overall Study|Study Terminated by Sponsor|13|||
42352014|NCT01901341|76191941|FG001|Overall Study|Study Terminated by Sponsor|15|||
42014440|NCT01287065|75821571|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42168016|NCT03560518|75974489|FG002|Double Blind Treatment Period|Pregnancy|0|||
42168017|NCT03560518|75974487|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
42168018|NCT03560518|75974488|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
42168019|NCT03560518|75974489|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
42168020|NCT03560518|75974487|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
42168021|NCT03560518|75974488|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
42168022|NCT03560518|75974489|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
42168023|NCT03560518|75974487|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
42168024|NCT03560518|75974488|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
42168025|NCT03560518|75974489|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
42168026|NCT03560518|75974487|FG000|Double Blind Treatment Period|Adverse Event|0|||
42168027|NCT03560518|75974488|FG001|Double Blind Treatment Period|Adverse Event|3|||
42168028|NCT03560518|75974489|FG002|Double Blind Treatment Period|Adverse Event|1|||
42168029|NCT03560206|75974499|FG000|Overall Study|Lost to Follow-up|19|||
42168030|NCT03560206|75974500|FG001|Overall Study|Lost to Follow-up|11|||
42168031|NCT03560206|75974499|FG000|Overall Study|Withdrawal by Subject|2|||
42168032|NCT03560206|75974500|FG001|Overall Study|Withdrawal by Subject|4|||
42352015|NCT01901341|76191940|FG000|Overall Study|Withdrawal by Subject|1|||
42352016|NCT01901341|76191941|FG001|Overall Study|Withdrawal by Subject|1|||
42352017|NCT01615939|76191950|FG000|Overall Study|Lost to Follow-up|5|||
42014441|NCT01287065|75821572|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42014442|NCT01287065|75821573|FG005|Treatment Period 1|Withdrawal by Subject|1|||
42014443|NCT01167153|75821583|FG000|Overall Study|Non-effective therapy|1|||
42014444|NCT01167153|75821584|FG001|Overall Study|Non-effective therapy|4|||
42014445|NCT01167153|75821583|FG000|Overall Study|AE including clinical laboratory AE|2|||
42014446|NCT01167153|75821584|FG001|Overall Study|AE including clinical laboratory AE|8|||
42014447|NCT01167153|75821583|FG000|Overall Study|Hypotension|1|||
42282562|NCT00700817|76114313|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
42282563|NCT00700817|76114314|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
42282564|NCT00700817|76114315|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
42282565|NCT00700817|76114316|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
42282566|NCT00700817|76114312|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
42282567|NCT00700817|76114313|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
42282568|NCT00700817|76114314|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
42282569|NCT00700817|76114315|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
42282570|NCT00700817|76114316|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
42282571|NCT00700817|76114312|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
42282572|NCT00700817|76114313|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
42282573|NCT00700817|76114314|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
42282574|NCT00700817|76114315|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
42282575|NCT00700817|76114316|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
42282576|NCT02625909|76114328|FG000|Overall Study|Death|2|||
42282577|NCT02625909|76114329|FG001|Overall Study|Death|0|||
42168033|NCT03560206|75974499|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
42168034|NCT03560206|75974500|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
42168035|NCT03560206|75974499|FG000|Overall Study|Busy schedule|14|||
42168036|NCT03560206|75974500|FG001|Overall Study|Busy schedule|2|||
42168037|NCT03560206|75974499|FG000|Overall Study|patients' new health condition such as cancer|10|||
42168038|NCT03560206|75974500|FG001|Overall Study|patients' new health condition such as cancer|1|||
42168039|NCT02892760|75974506|FG000|Overall Study|Withdrawal by Subject|3|||
42168040|NCT03635086|75974515|FG000|Overall Study|Withdrawal of consent|0|||
42168041|NCT03635086|75974516|FG001|Overall Study|Withdrawal of consent|0|||
42168042|NCT03635086|75974517|FG002|Overall Study|Withdrawal of consent|1|||
42168043|NCT03635086|75974518|FG003|Overall Study|Withdrawal of consent|0|||
42168044|NCT03635086|75974519|FG004|Overall Study|Withdrawal of consent|0|||
42168045|NCT03635086|75974515|FG000|Overall Study|Adverse Event|0|||
42168046|NCT03635086|75974516|FG001|Overall Study|Adverse Event|1|||
42168047|NCT03635086|75974517|FG002|Overall Study|Adverse Event|0|||
42168048|NCT03635086|75974518|FG003|Overall Study|Adverse Event|0|||
42168049|NCT03635086|75974519|FG004|Overall Study|Adverse Event|0|||
42168050|NCT03635086|75974515|FG000|Overall Study|Lost to Follow-up|1|||
42168051|NCT03635086|75974516|FG001|Overall Study|Lost to Follow-up|0|||
42168052|NCT03635086|75974517|FG002|Overall Study|Lost to Follow-up|0|||
42168053|NCT03635086|75974518|FG003|Overall Study|Lost to Follow-up|0|||
42168054|NCT03635086|75974519|FG004|Overall Study|Lost to Follow-up|0|||
42168055|NCT03588910|75974534|FG000|Overall Study|Withdrawal by Subject|1|||
42282578|NCT02625909|76114328|FG000|Overall Study|Lost to Follow-up|3|||
42282579|NCT02625909|76114329|FG001|Overall Study|Lost to Follow-up|5|||
42282580|NCT02625909|76114328|FG000|Overall Study|Lack of Efficacy|9|||
42282581|NCT02625909|76114329|FG001|Overall Study|Lack of Efficacy|2|||
42282582|NCT02625909|76114328|FG000|Overall Study|Reinfection|3|||
42282583|NCT02625909|76114329|FG001|Overall Study|Reinfection|2|||
42282584|NCT02623959|76114337|FG000|Overall Study|Progression|0|||
42282585|NCT02623959|76114338|FG001|Overall Study|Progression|1|||
42282586|NCT00700739|76114348|FG000|Overall Study|Lost to Follow-up|4|||
42282587|NCT00700739|76114349|FG001|Overall Study|Lost to Follow-up|4|||
42282588|NCT02623335|76114358|FG000|Overall Study|Death|8|||
42282589|NCT02623335|76114359|FG001|Overall Study|Death|7|||
42282590|NCT02623335|76114358|FG000|Overall Study|Lost to Follow-up|15|||
42282591|NCT02623335|76114359|FG001|Overall Study|Lost to Follow-up|23|||
42282592|NCT02623335|76114358|FG000|Overall Study|Withdrawal by Subject|2|||
42282593|NCT02623335|76114359|FG001|Overall Study|Withdrawal by Subject|5|||
42282594|NCT02623335|76114358|FG000|Overall Study|Protocol Violation|2|||
42282595|NCT02623335|76114359|FG001|Overall Study|Protocol Violation|1|||
42282596|NCT00700427|76114369|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
42282597|NCT00700427|76114370|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
42282598|NCT00700427|76114371|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
42282599|NCT00700427|76114372|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
42282600|NCT00700427|76114373|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
42282601|NCT00700427|76114369|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
42282602|NCT00700427|76114370|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
42282603|NCT00700427|76114371|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
42282604|NCT00700427|76114372|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
42282605|NCT00700427|76114373|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
42168056|NCT03588910|75974535|FG001|Overall Study|Withdrawal by Subject|0|||
42168057|NCT03588910|75974534|FG000|Overall Study|Allergy|2|||
42168058|NCT03588910|75974535|FG001|Overall Study|Allergy|0|||
42282606|NCT00700427|76114369|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
42282607|NCT00700427|76114370|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
42282608|NCT00700427|76114371|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
42168059|NCT03588910|75974534|FG000|Overall Study|Protocol Violation|0|||
42282609|NCT00700427|76114372|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
42282610|NCT00700427|76114373|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
42168060|NCT03588910|75974535|FG001|Overall Study|Protocol Violation|3|||
42168061|NCT03588910|75974534|FG000|Overall Study|Did not complete Day 1 Survey|5|||
42168062|NCT03588910|75974535|FG001|Overall Study|Did not complete Day 1 Survey|10|||
42282611|NCT00700427|76114369|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
42282612|NCT00700427|76114370|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
42282613|NCT00700427|76114371|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
42282614|NCT00700427|76114372|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
42282615|NCT00700427|76114373|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
42282616|NCT00700427|76114369|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
42282617|NCT00700427|76114370|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
42282618|NCT00700427|76114371|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
42282619|NCT00700427|76114372|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
42282620|NCT00700427|76114373|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
42282621|NCT00700427|76114369|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
42282622|NCT00700427|76114370|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
42282623|NCT00700427|76114371|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
42282624|NCT00700427|76114372|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
42282625|NCT00700427|76114373|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
42282626|NCT00700427|76114369|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
42282627|NCT00700427|76114370|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
42282628|NCT00700427|76114371|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
42282629|NCT00700427|76114372|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
42282630|NCT00700427|76114373|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
42282631|NCT00700427|76114369|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
42282632|NCT00700427|76114370|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
42282633|NCT00700427|76114371|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
42282634|NCT00700427|76114372|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
42282635|NCT00700427|76114373|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
42282636|NCT00700427|76114369|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
42282637|NCT00700427|76114370|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
42282638|NCT00700427|76114371|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
42282639|NCT00700427|76114372|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
42282640|NCT00700427|76114373|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
42282641|NCT00700427|76114369|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
42282642|NCT00700427|76114370|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
42352018|NCT01615939|76191951|FG001|Overall Study|Lost to Follow-up|0|||
42168063|NCT03588910|75974534|FG000|Overall Study|Did not complete Day 7 Survey|5|||
42168064|NCT03588910|75974535|FG001|Overall Study|Did not complete Day 7 Survey|2|||
42168065|NCT03587974|75974543|FG000|Overall Study|caregiver demented, care recipient died|3|||
42168066|NCT03587974|75974544|FG001|Overall Study|caregiver demented, care recipient died|3|||
42168067|NCT03587974|75974543|FG000|Overall Study|Withdrawal by Subject|2|||
42168068|NCT03587974|75974544|FG001|Overall Study|Withdrawal by Subject|1|||
42168069|NCT00103857|75974557|FG000|54-Week Base Study|Adverse Event|12|||
42168070|NCT00103857|75974558|FG001|54-Week Base Study|Adverse Event|9|||
42168071|NCT00103857|75974559|FG002|54-Week Base Study|Adverse Event|11|||
42168072|NCT00103857|75974560|FG003|54-Week Base Study|Adverse Event|6|||
42168073|NCT00103857|75974561|FG004|54-Week Base Study|Adverse Event|5|||
42168074|NCT00103857|75974562|FG005|54-Week Base Study|Adverse Event|11|||
42168075|NCT00103857|75974563|FG006|54-Week Base Study|Adverse Event|3|||
42168076|NCT00103857|75974557|FG000|54-Week Base Study|Death|0|||
42168077|NCT00103857|75974558|FG001|54-Week Base Study|Death|0|||
42168078|NCT00103857|75974559|FG002|54-Week Base Study|Death|0|||
42168079|NCT00103857|75974560|FG003|54-Week Base Study|Death|0|||
42168080|NCT00103857|75974561|FG004|54-Week Base Study|Death|1|||
42168081|NCT00103857|75974562|FG005|54-Week Base Study|Death|1|||
42168082|NCT00103857|75974563|FG006|54-Week Base Study|Death|0|||
42168083|NCT00103857|75974557|FG000|54-Week Base Study|Lack of Efficacy|11|||
42168084|NCT00103857|75974558|FG001|54-Week Base Study|Lack of Efficacy|14|||
42168085|NCT00103857|75974559|FG002|54-Week Base Study|Lack of Efficacy|8|||
42168086|NCT00103857|75974560|FG003|54-Week Base Study|Lack of Efficacy|4|||
42168087|NCT00103857|75974561|FG004|54-Week Base Study|Lack of Efficacy|3|||
42168088|NCT00103857|75974562|FG005|54-Week Base Study|Lack of Efficacy|14|||
42168089|NCT00103857|75974563|FG006|54-Week Base Study|Lack of Efficacy|19|||
42168090|NCT00103857|75974557|FG000|54-Week Base Study|Lost to Follow-up|5|||
42168091|NCT00103857|75974558|FG001|54-Week Base Study|Lost to Follow-up|4|||
42168092|NCT00103857|75974559|FG002|54-Week Base Study|Lost to Follow-up|7|||
42168093|NCT00103857|75974560|FG003|54-Week Base Study|Lost to Follow-up|5|||
42168094|NCT00103857|75974561|FG004|54-Week Base Study|Lost to Follow-up|10|||
42168095|NCT00103857|75974562|FG005|54-Week Base Study|Lost to Follow-up|9|||
42168096|NCT00103857|75974563|FG006|54-Week Base Study|Lost to Follow-up|3|||
42168097|NCT00103857|75974557|FG000|54-Week Base Study|Physician Decision|1|||
42168098|NCT00103857|75974558|FG001|54-Week Base Study|Physician Decision|1|||
42168099|NCT00103857|75974559|FG002|54-Week Base Study|Physician Decision|0|||
42168100|NCT00103857|75974560|FG003|54-Week Base Study|Physician Decision|0|||
42168101|NCT00103857|75974561|FG004|54-Week Base Study|Physician Decision|1|||
42168102|NCT00103857|75974562|FG005|54-Week Base Study|Physician Decision|0|||
42014448|NCT01167153|75821584|FG001|Overall Study|Hypotension|0|||
42014449|NCT01167153|75821583|FG000|Overall Study|Lost to Follow-up|7|||
42014450|NCT01167153|75821584|FG001|Overall Study|Lost to Follow-up|9|||
42014451|NCT01167153|75821583|FG000|Overall Study|Non-compliance to concomitant medication|0|||
42014452|NCT01167153|75821584|FG001|Overall Study|Non-compliance to concomitant medication|2|||
42014453|NCT01167153|75821583|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
42014454|NCT01167153|75821584|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
42014455|NCT01167153|75821583|FG000|Overall Study|Withdrawal consent|1|||
42014456|NCT01167153|75821584|FG001|Overall Study|Withdrawal consent|1|||
42014457|NCT01167153|75821583|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
42168103|NCT00103857|75974563|FG006|54-Week Base Study|Physician Decision|0|||
42168104|NCT00103857|75974557|FG000|54-Week Base Study|Pregnancy|1|||
42168105|NCT00103857|75974558|FG001|54-Week Base Study|Pregnancy|0|||
42168106|NCT00103857|75974559|FG002|54-Week Base Study|Pregnancy|0|||
42168107|NCT00103857|75974560|FG003|54-Week Base Study|Pregnancy|0|||
42168108|NCT00103857|75974561|FG004|54-Week Base Study|Pregnancy|1|||
42168109|NCT00103857|75974562|FG005|54-Week Base Study|Pregnancy|0|||
42168110|NCT00103857|75974563|FG006|54-Week Base Study|Pregnancy|1|||
42168111|NCT00103857|75974557|FG000|54-Week Base Study|Protocol Violation|6|||
42168112|NCT00103857|75974558|FG001|54-Week Base Study|Protocol Violation|4|||
42168113|NCT00103857|75974559|FG002|54-Week Base Study|Protocol Violation|2|||
42168114|NCT00103857|75974560|FG003|54-Week Base Study|Protocol Violation|4|||
42168115|NCT00103857|75974561|FG004|54-Week Base Study|Protocol Violation|0|||
42168116|NCT00103857|75974562|FG005|54-Week Base Study|Protocol Violation|3|||
42168117|NCT00103857|75974563|FG006|54-Week Base Study|Protocol Violation|3|||
42168118|NCT00103857|75974557|FG000|54-Week Base Study|Withdrawal by Subject|17|||
42168119|NCT00103857|75974558|FG001|54-Week Base Study|Withdrawal by Subject|16|||
42168120|NCT00103857|75974559|FG002|54-Week Base Study|Withdrawal by Subject|16|||
42168121|NCT00103857|75974560|FG003|54-Week Base Study|Withdrawal by Subject|15|||
42168122|NCT00103857|75974561|FG004|54-Week Base Study|Withdrawal by Subject|10|||
42168123|NCT00103857|75974562|FG005|54-Week Base Study|Withdrawal by Subject|15|||
42168124|NCT00103857|75974563|FG006|54-Week Base Study|Withdrawal by Subject|4|||
42168125|NCT00103857|75974557|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
42168126|NCT00103857|75974558|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
42168127|NCT00103857|75974559|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
42168128|NCT00103857|75974560|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
42168129|NCT00103857|75974561|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
42168130|NCT00103857|75974562|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
42168131|NCT00103857|75974563|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
42168132|NCT00103857|75974557|FG000|54-Week Base Study|patient moved|0|||
42168133|NCT00103857|75974558|FG001|54-Week Base Study|patient moved|1|||
42168134|NCT00103857|75974559|FG002|54-Week Base Study|patient moved|1|||
42168135|NCT00103857|75974560|FG003|54-Week Base Study|patient moved|2|||
42168136|NCT00103857|75974561|FG004|54-Week Base Study|patient moved|3|||
42168137|NCT00103857|75974562|FG005|54-Week Base Study|patient moved|1|||
42168138|NCT00103857|75974563|FG006|54-Week Base Study|patient moved|0|||
42168139|NCT00103857|75974557|FG000|54-Week Base Study|non-compliance with study procedures|1|||
42352019|NCT01901185|76191957|FG000|Overall Study|Withdrawal by Subject|2|||
42014458|NCT01167153|75821584|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
42014459|NCT01166763|75821590|FG000|Overall Study|Withdrawal by Subject|3|||
42014460|NCT01166373|75821598|FG000|Overall Study|Lost to Follow-up|3|||
42014461|NCT01166373|75821599|FG001|Overall Study|Lost to Follow-up|2|||
42014462|NCT01166373|75821600|FG002|Overall Study|Lost to Follow-up|2|||
42014463|NCT01166373|75821601|FG003|Overall Study|Lost to Follow-up|2|||
42014464|NCT01166373|75821598|FG000|Overall Study|Withdrawal by Subject|1|||
42014465|NCT01166373|75821599|FG001|Overall Study|Withdrawal by Subject|2|||
42014466|NCT01166373|75821600|FG002|Overall Study|Withdrawal by Subject|2|||
42014467|NCT01166373|75821601|FG003|Overall Study|Withdrawal by Subject|3|||
42352020|NCT01888003|76191964|FG000|Overall Study|Study Terminated|5|||
42168140|NCT00103857|75974558|FG001|54-Week Base Study|non-compliance with study procedures|2|||
42168141|NCT00103857|75974559|FG002|54-Week Base Study|non-compliance with study procedures|0|||
42168142|NCT00103857|75974560|FG003|54-Week Base Study|non-compliance with study procedures|0|||
42168143|NCT00103857|75974561|FG004|54-Week Base Study|non-compliance with study procedures|0|||
42168144|NCT00103857|75974562|FG005|54-Week Base Study|non-compliance with study procedures|2|||
42168145|NCT00103857|75974563|FG006|54-Week Base Study|non-compliance with study procedures|0|||
42352021|NCT01888003|76191965|FG001|Overall Study|Study Terminated|6|||
42168146|NCT00103857|75974557|FG000|54-Week Base Study|patient incarcerated|0|||
42168147|NCT00103857|75974558|FG001|54-Week Base Study|patient incarcerated|0|||
42168148|NCT00103857|75974559|FG002|54-Week Base Study|patient incarcerated|0|||
42168149|NCT00103857|75974560|FG003|54-Week Base Study|patient incarcerated|0|||
42168150|NCT00103857|75974561|FG004|54-Week Base Study|patient incarcerated|1|||
42168151|NCT00103857|75974562|FG005|54-Week Base Study|patient incarcerated|1|||
42168152|NCT00103857|75974563|FG006|54-Week Base Study|patient incarcerated|0|||
42168153|NCT00103857|75974557|FG000|54-Week Base Study|laboratory reporting error|0|||
42168154|NCT00103857|75974558|FG001|54-Week Base Study|laboratory reporting error|0|||
42168155|NCT00103857|75974559|FG002|54-Week Base Study|laboratory reporting error|0|||
42168156|NCT00103857|75974560|FG003|54-Week Base Study|laboratory reporting error|0|||
42168157|NCT00103857|75974561|FG004|54-Week Base Study|laboratory reporting error|1|||
42168158|NCT00103857|75974562|FG005|54-Week Base Study|laboratory reporting error|0|||
42168159|NCT00103857|75974563|FG006|54-Week Base Study|laboratory reporting error|0|||
42168160|NCT00103857|75974557|FG000|54-Week Base Study|site error|0|||
42168161|NCT00103857|75974558|FG001|54-Week Base Study|site error|0|||
42168162|NCT00103857|75974559|FG002|54-Week Base Study|site error|0|||
42168163|NCT00103857|75974560|FG003|54-Week Base Study|site error|0|||
42168164|NCT00103857|75974561|FG004|54-Week Base Study|site error|0|||
42168165|NCT00103857|75974562|FG005|54-Week Base Study|site error|1|||
42168166|NCT00103857|75974563|FG006|54-Week Base Study|site error|0|||
42168167|NCT00103857|75974557|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
42168168|NCT00103857|75974558|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
42168169|NCT00103857|75974559|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
42168170|NCT00103857|75974560|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
42168171|NCT00103857|75974561|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
42014468|NCT01166373|75821598|FG000|Overall Study|Physician Decision|1|||
42014469|NCT01166373|75821599|FG001|Overall Study|Physician Decision|0|||
42168172|NCT00103857|75974562|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
42168173|NCT00103857|75974563|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
42168174|NCT00103857|75974557|FG000|50-Week Extension Study|Adverse Event|2|||
42168175|NCT00103857|75974558|FG001|50-Week Extension Study|Adverse Event|3|||
42168176|NCT00103857|75974559|FG002|50-Week Extension Study|Adverse Event|2|||
42168177|NCT00103857|75974560|FG003|50-Week Extension Study|Adverse Event|0|||
42168178|NCT00103857|75974561|FG004|50-Week Extension Study|Adverse Event|1|||
42168179|NCT00103857|75974562|FG005|50-Week Extension Study|Adverse Event|1|||
42168180|NCT00103857|75974563|FG006|50-Week Extension Study|Adverse Event|0|||
42168181|NCT00103857|75974557|FG000|50-Week Extension Study|Death|0|||
42168182|NCT00103857|75974558|FG001|50-Week Extension Study|Death|0|||
42168183|NCT00103857|75974559|FG002|50-Week Extension Study|Death|0|||
42168184|NCT00103857|75974560|FG003|50-Week Extension Study|Death|1|||
42168185|NCT00103857|75974561|FG004|50-Week Extension Study|Death|0|||
42168186|NCT00103857|75974562|FG005|50-Week Extension Study|Death|1|||
42168187|NCT00103857|75974563|FG006|50-Week Extension Study|Death|0|||
42168188|NCT00103857|75974557|FG000|50-Week Extension Study|Lack of Efficacy|26|||
42168189|NCT00103857|75974558|FG001|50-Week Extension Study|Lack of Efficacy|15|||
42168190|NCT00103857|75974559|FG002|50-Week Extension Study|Lack of Efficacy|13|||
42168191|NCT00103857|75974560|FG003|50-Week Extension Study|Lack of Efficacy|16|||
42168192|NCT00103857|75974561|FG004|50-Week Extension Study|Lack of Efficacy|8|||
42168193|NCT00103857|75974562|FG005|50-Week Extension Study|Lack of Efficacy|8|||
42168194|NCT00103857|75974563|FG006|50-Week Extension Study|Lack of Efficacy|0|||
42168195|NCT00103857|75974557|FG000|50-Week Extension Study|Lost to Follow-up|4|||
42168196|NCT00103857|75974558|FG001|50-Week Extension Study|Lost to Follow-up|0|||
42168197|NCT00103857|75974559|FG002|50-Week Extension Study|Lost to Follow-up|1|||
42168198|NCT00103857|75974560|FG003|50-Week Extension Study|Lost to Follow-up|4|||
42168199|NCT00103857|75974561|FG004|50-Week Extension Study|Lost to Follow-up|3|||
42168200|NCT00103857|75974562|FG005|50-Week Extension Study|Lost to Follow-up|3|||
42168201|NCT00103857|75974563|FG006|50-Week Extension Study|Lost to Follow-up|0|||
42282643|NCT00700427|76114371|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
42014470|NCT01166373|75821600|FG002|Overall Study|Physician Decision|0|||
42014471|NCT01166373|75821601|FG003|Overall Study|Physician Decision|0|||
42168202|NCT00103857|75974557|FG000|50-Week Extension Study|Physician Decision|0|||
42168203|NCT00103857|75974558|FG001|50-Week Extension Study|Physician Decision|1|||
42282644|NCT00700427|76114372|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
42168204|NCT00103857|75974559|FG002|50-Week Extension Study|Physician Decision|1|||
42168205|NCT00103857|75974560|FG003|50-Week Extension Study|Physician Decision|0|||
42168206|NCT00103857|75974561|FG004|50-Week Extension Study|Physician Decision|0|||
42168207|NCT00103857|75974562|FG005|50-Week Extension Study|Physician Decision|0|||
42168208|NCT00103857|75974563|FG006|50-Week Extension Study|Physician Decision|0|||
42168209|NCT00103857|75974557|FG000|50-Week Extension Study|Pregnancy|0|||
42168210|NCT00103857|75974558|FG001|50-Week Extension Study|Pregnancy|0|||
42168211|NCT00103857|75974559|FG002|50-Week Extension Study|Pregnancy|1|||
42168212|NCT00103857|75974560|FG003|50-Week Extension Study|Pregnancy|0|||
42168213|NCT00103857|75974561|FG004|50-Week Extension Study|Pregnancy|1|||
42168214|NCT00103857|75974562|FG005|50-Week Extension Study|Pregnancy|0|||
42168215|NCT00103857|75974563|FG006|50-Week Extension Study|Pregnancy|0|||
42168216|NCT00103857|75974557|FG000|50-Week Extension Study|Protocol Violation|1|||
42168217|NCT00103857|75974558|FG001|50-Week Extension Study|Protocol Violation|1|||
42168218|NCT00103857|75974559|FG002|50-Week Extension Study|Protocol Violation|1|||
42168219|NCT00103857|75974560|FG003|50-Week Extension Study|Protocol Violation|2|||
42168220|NCT00103857|75974561|FG004|50-Week Extension Study|Protocol Violation|0|||
42168221|NCT00103857|75974562|FG005|50-Week Extension Study|Protocol Violation|1|||
42168222|NCT00103857|75974563|FG006|50-Week Extension Study|Protocol Violation|0|||
42168223|NCT00103857|75974557|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
42168224|NCT00103857|75974558|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
42168225|NCT00103857|75974559|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
42168226|NCT00103857|75974560|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
42168227|NCT00103857|75974561|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
42168228|NCT00103857|75974562|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
42168229|NCT00103857|75974563|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
42168230|NCT00103857|75974557|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
42168231|NCT00103857|75974558|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
42168232|NCT00103857|75974559|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
42168233|NCT00103857|75974560|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
42168234|NCT00103857|75974561|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
42168235|NCT00103857|75974562|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
42168236|NCT00103857|75974563|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
42168237|NCT00103857|75974557|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
42168238|NCT00103857|75974558|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
42168239|NCT00103857|75974559|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
42168240|NCT00103857|75974560|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
42168241|NCT00103857|75974561|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
42168242|NCT00103857|75974562|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
42168243|NCT00103857|75974563|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
42168244|NCT00103857|75974557|FG000|50-Week Extension Study|patient moved|0|||
42168245|NCT00103857|75974558|FG001|50-Week Extension Study|patient moved|0|||
42168246|NCT00103857|75974559|FG002|50-Week Extension Study|patient moved|1|||
42168247|NCT00103857|75974560|FG003|50-Week Extension Study|patient moved|2|||
42168248|NCT00103857|75974561|FG004|50-Week Extension Study|patient moved|0|||
42168249|NCT00103857|75974562|FG005|50-Week Extension Study|patient moved|0|||
42168250|NCT00103857|75974563|FG006|50-Week Extension Study|patient moved|0|||
42168251|NCT00103857|75974557|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
42168252|NCT00103857|75974558|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
42168253|NCT00103857|75974559|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
42168254|NCT00103857|75974560|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
42168255|NCT00103857|75974561|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
42282645|NCT00700427|76114373|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
42282646|NCT00700427|76114369|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
42282647|NCT00700427|76114370|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
42282648|NCT00700427|76114371|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
42282649|NCT00700427|76114372|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
42282650|NCT00700427|76114373|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
42282651|NCT00700427|76114369|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
42282652|NCT00700427|76114370|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
42282653|NCT00700427|76114371|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
42282654|NCT00700427|76114372|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
42282655|NCT00700427|76114373|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
42282656|NCT00700427|76114369|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
42168256|NCT00103857|75974562|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
42168257|NCT00103857|75974563|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
42040648|NCT01796171|75848718|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42168258|NCT00103857|75974557|FG000|50-Week Extension Study|reason unspecified|0|||
42168259|NCT00103857|75974558|FG001|50-Week Extension Study|reason unspecified|0|||
42168260|NCT00103857|75974559|FG002|50-Week Extension Study|reason unspecified|0|||
42168261|NCT00103857|75974560|FG003|50-Week Extension Study|reason unspecified|0|||
42168262|NCT00103857|75974561|FG004|50-Week Extension Study|reason unspecified|1|||
42168263|NCT00103857|75974562|FG005|50-Week Extension Study|reason unspecified|0|||
42168264|NCT00103857|75974563|FG006|50-Week Extension Study|reason unspecified|0|||
42168265|NCT03587584|75974580|FG000|Overall Study|SOC deviations|4|||
42168266|NCT03587584|75974581|FG001|Overall Study|SOC deviations|6|||
42168267|NCT03587584|75974580|FG000|Overall Study|Incomplete data|0|||
42168268|NCT03587584|75974581|FG001|Overall Study|Incomplete data|3|||
42168269|NCT03586726|75974587|FG000|Overall Study|Withdrawal by Subject|1|||
42168270|NCT03586648|75974591|FG000|Period 1|Withdrawal by Subject|0|||
42168271|NCT03586648|75974592|FG001|Period 1|Withdrawal by Subject|1|||
42168272|NCT03586648|75974591|FG000|Period 1|Lost to Follow-up|1|||
42168273|NCT03586648|75974592|FG001|Period 1|Lost to Follow-up|1|||
42168274|NCT03586648|75974591|FG000|Period 1|Adverse Event|1|||
42168275|NCT03586648|75974592|FG001|Period 1|Adverse Event|0|||
42168276|NCT03586648|75974591|FG000|Period 1|Study related symptoms or complaints|2|||
42168277|NCT03586648|75974592|FG001|Period 1|Study related symptoms or complaints|1|||
42168278|NCT03586648|75974591|FG000|Period 1|Physician Decision|0|||
42168279|NCT03586648|75974592|FG001|Period 1|Physician Decision|1|||
42168280|NCT03586648|75974591|FG000|Period 2|Adverse Event|1|||
42168281|NCT03586648|75974592|FG001|Period 2|Adverse Event|0|||
42168282|NCT02892448|75974601|FG000|Overall Study|Screening failure|2|||
42168283|NCT02892448|75974602|FG001|Overall Study|Screening failure|2|||
42168284|NCT02892448|75974603|FG002|Overall Study|Screening failure|1|||
42168285|NCT03585712|75974611|FG000|Treatment Period 1|Protocol Violation|1|||
42168286|NCT03585712|75974612|FG001|Treatment Period 1|Protocol Violation|0|||
42168287|NCT03585712|75974613|FG002|Treatment Period 1|Protocol Violation|0|||
42168288|NCT03585712|75974611|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
42168289|NCT03585712|75974612|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
42168290|NCT03585712|75974613|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
42168291|NCT03585712|75974611|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
42168292|NCT03585712|75974612|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
42168293|NCT03585712|75974613|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
42282657|NCT00700427|76114370|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
42282658|NCT00700427|76114371|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
42282659|NCT00700427|76114372|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
42282660|NCT00700427|76114373|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
42282661|NCT00700427|76114369|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
42282662|NCT00700427|76114370|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
42282663|NCT00700427|76114371|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
42282664|NCT00700427|76114372|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
42282665|NCT00700427|76114373|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
42282666|NCT00700427|76114369|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
42282667|NCT00700427|76114370|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
42282668|NCT00700427|76114371|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
42282669|NCT00700427|76114372|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
42282670|NCT00700427|76114373|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
42282671|NCT00700427|76114369|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
42282672|NCT00700427|76114370|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
42282673|NCT00700427|76114371|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
42282674|NCT00700427|76114372|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
42282675|NCT00700427|76114373|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
42282676|NCT00700427|76114369|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
42282677|NCT00700427|76114370|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
42282678|NCT00700427|76114371|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
42282679|NCT00700427|76114372|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
42282680|NCT00700427|76114373|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
42282681|NCT00700427|76114369|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
42282682|NCT00700427|76114370|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
42282683|NCT00700427|76114371|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
42282684|NCT00700427|76114372|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
42282685|NCT00700427|76114373|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
42282686|NCT00700427|76114369|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
42282687|NCT00700427|76114370|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
42282688|NCT00700427|76114371|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
42282689|NCT00700427|76114372|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
42282690|NCT00700427|76114373|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
42168294|NCT03585712|75974611|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
42168295|NCT03585712|75974612|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
42168296|NCT03585712|75974613|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
42168297|NCT03585244|75974630|FG000|Overall Study|Withdrawal by Subject|15|||
42168298|NCT00074984|75974636|FG000|Overall Study|Death|1|||
42168299|NCT00074984|75974637|FG001|Overall Study|Death|2|||
42282691|NCT00700427|76114369|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
42282692|NCT00700427|76114370|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
42282693|NCT00700427|76114371|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
42282694|NCT00700427|76114372|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
42282695|NCT00700427|76114373|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
42282696|NCT00700427|76114369|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
42282697|NCT00700427|76114370|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
42282698|NCT00700427|76114371|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
42282699|NCT00700427|76114372|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
42282700|NCT00700427|76114373|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
42352022|NCT01888003|76191966|FG002|Overall Study|Study Terminated|40|||
42352023|NCT02775214|76191976|FG000|Overall Study|Withdrawal by Subject|2|||
42040649|NCT01796171|75848719|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42040650|NCT01796171|75848720|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
42040651|NCT01796171|75848706|FG000|Follow-up Period|Start of further anticancer therapy|4|||
42040652|NCT01796171|75848707|FG001|Follow-up Period|Start of further anticancer therapy|25|||
42040653|NCT01796171|75848708|FG002|Follow-up Period|Start of further anticancer therapy|2|||
42040654|NCT01796171|75848709|FG003|Follow-up Period|Start of further anticancer therapy|1|||
42040655|NCT01796171|75848710|FG004|Follow-up Period|Start of further anticancer therapy|2|||
42168300|NCT00074984|75974636|FG000|Overall Study|Withdrawal by Subject|2|||
42168301|NCT00074984|75974637|FG001|Overall Study|Withdrawal by Subject|3|||
42168302|NCT00074984|75974636|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
42168303|NCT00074984|75974637|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
42168304|NCT03583606|75974647|FG000|Overall Study|Lost to Follow-up|0|||
42168305|NCT03583606|75974648|FG001|Overall Study|Lost to Follow-up|1|||
42168306|NCT03583606|75974649|FG002|Overall Study|Lost to Follow-up|0|||
42168307|NCT03583606|75974647|FG000|Overall Study|Ineligible at baseline|1|||
42168308|NCT03583606|75974648|FG001|Overall Study|Ineligible at baseline|0|||
42168309|NCT03583606|75974649|FG002|Overall Study|Ineligible at baseline|0|||
42168310|NCT03583450|75974660|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
42168311|NCT03583450|75974661|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
42168312|NCT03583372|75974673|FG000|Overall Study|Withdrawal by Subject|6|||
42168313|NCT03583372|75974674|FG001|Overall Study|Withdrawal by Subject|11|||
42168314|NCT03583372|75974675|FG002|Overall Study|Withdrawal by Subject|7|||
42168315|NCT03583372|75974676|FG003|Overall Study|Withdrawal by Subject|8|||
42168316|NCT03583372|75974673|FG000|Overall Study|Lost to Follow-up|4|||
42168317|NCT03583372|75974674|FG001|Overall Study|Lost to Follow-up|6|||
42168318|NCT03583372|75974675|FG002|Overall Study|Lost to Follow-up|3|||
42168319|NCT03583372|75974676|FG003|Overall Study|Lost to Follow-up|2|||
42168320|NCT03583372|75974673|FG000|Overall Study|Adverse Event|1|||
42168321|NCT03583372|75974674|FG001|Overall Study|Adverse Event|3|||
42168322|NCT03583372|75974675|FG002|Overall Study|Adverse Event|4|||
42168323|NCT03583372|75974676|FG003|Overall Study|Adverse Event|4|||
42168324|NCT03583372|75974673|FG000|Overall Study|Physician Decision|0|||
42168325|NCT03583372|75974674|FG001|Overall Study|Physician Decision|1|||
42168326|NCT03583372|75974675|FG002|Overall Study|Physician Decision|1|||
42168327|NCT03583372|75974676|FG003|Overall Study|Physician Decision|1|||
42168328|NCT03583372|75974673|FG000|Overall Study|Lack of Efficacy|0|||
42168329|NCT03583372|75974674|FG001|Overall Study|Lack of Efficacy|1|||
42168330|NCT03583372|75974675|FG002|Overall Study|Lack of Efficacy|0|||
42168331|NCT03583372|75974676|FG003|Overall Study|Lack of Efficacy|1|||
42168332|NCT03583372|75974673|FG000|Overall Study|Death|1|||
42168333|NCT03583372|75974674|FG001|Overall Study|Death|0|||
42168334|NCT03583372|75974675|FG002|Overall Study|Death|0|||
42168335|NCT03583372|75974676|FG003|Overall Study|Death|0|||
42168336|NCT03583372|75974673|FG000|Overall Study|Protocol Violation|0|||
42168337|NCT03583372|75974674|FG001|Overall Study|Protocol Violation|1|||
42168338|NCT03583372|75974675|FG002|Overall Study|Protocol Violation|0|||
42168339|NCT03583372|75974676|FG003|Overall Study|Protocol Violation|0|||
42168340|NCT03583372|75974673|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
42168341|NCT03583372|75974674|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
42168342|NCT03583372|75974675|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
42168343|NCT03583372|75974676|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
42168344|NCT03583372|75974673|FG000|Overall Study|Did Not Receive Study Drug|0|||
42168345|NCT03583372|75974674|FG001|Overall Study|Did Not Receive Study Drug|1|||
42168346|NCT03583372|75974675|FG002|Overall Study|Did Not Receive Study Drug|0|||
42352024|NCT02775214|76191977|FG001|Overall Study|Withdrawal by Subject|0|||
42168347|NCT03583372|75974676|FG003|Overall Study|Did Not Receive Study Drug|0|||
42168348|NCT03583372|75974673|FG000|Overall Study|Captured as Other in the Database|1|||
42168349|NCT03583372|75974674|FG001|Overall Study|Captured as Other in the Database|2|||
42168350|NCT03583372|75974675|FG002|Overall Study|Captured as Other in the Database|4|||
42168351|NCT03583372|75974676|FG003|Overall Study|Captured as Other in the Database|1|||
42168352|NCT03582826|75974688|FG000|Overall Study|Lost to Follow-up|39|||
42168353|NCT03582826|75974689|FG001|Overall Study|Lost to Follow-up|0|||
42168354|NCT03582826|75974688|FG000|Overall Study|Withdrawal by Subject|2|||
42168355|NCT03582826|75974689|FG001|Overall Study|Withdrawal by Subject|0|||
42168356|NCT03518008|75974704|FG000|Period 2, Second Week of Wear|Family emergency|0|||
42168357|NCT03518008|75974705|FG001|Period 2, Second Week of Wear|Family emergency|1|||
42168358|NCT03810014|75974715|FG000|Overall Study|Pregnancy|2|||
42168359|NCT03810014|75974716|FG001|Overall Study|Pregnancy|2|||
42168360|NCT03810014|75974717|FG002|Overall Study|Pregnancy|0|||
42168361|NCT03810014|75974718|FG003|Overall Study|Pregnancy|2|||
42168362|NCT04978363|75974739|FG000|Overall Study|Other medical issues unrelated to the study|0|||
42168363|NCT04978363|75974740|FG001|Overall Study|Other medical issues unrelated to the study|0|||
42168364|NCT04978363|75974741|FG002|Overall Study|Other medical issues unrelated to the study|0|||
42168365|NCT04978363|75974742|FG003|Overall Study|Other medical issues unrelated to the study|0|||
42168366|NCT04978363|75974743|FG004|Overall Study|Other medical issues unrelated to the study|1|||
42168367|NCT04978363|75974744|FG005|Overall Study|Other medical issues unrelated to the study|0|||
42168368|NCT04978363|75974745|FG006|Overall Study|Other medical issues unrelated to the study|0|||
42168369|NCT04978363|75974746|FG007|Overall Study|Other medical issues unrelated to the study|0|||
42168370|NCT04978363|75974747|FG008|Overall Study|Other medical issues unrelated to the study|0|||
42168371|NCT04978363|75974748|FG009|Overall Study|Other medical issues unrelated to the study|0|||
42168372|NCT04978363|75974749|FG010|Overall Study|Other medical issues unrelated to the study|0|||
42168373|NCT04978363|75974739|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
42168374|NCT04978363|75974740|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
42168375|NCT04978363|75974741|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
42168376|NCT04978363|75974742|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
42168377|NCT04978363|75974743|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
42168378|NCT04978363|75974744|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
42168379|NCT04978363|75974745|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
42168380|NCT04978363|75974746|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
42168381|NCT04978363|75974747|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
42168382|NCT04978363|75974748|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
42168383|NCT04978363|75974749|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
42168384|NCT04978363|75974739|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
42168385|NCT04978363|75974740|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
42168386|NCT04978363|75974741|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
42168387|NCT04978363|75974742|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
42168388|NCT04978363|75974743|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
42168389|NCT04978363|75974744|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
42168390|NCT04978363|75974745|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
42168391|NCT04978363|75974746|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
42168392|NCT04978363|75974747|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
42168393|NCT04978363|75974748|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
42168394|NCT04978363|75974749|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
42168395|NCT04101422|75974829|FG000|Overall Study|Ineligible|1|||
42168396|NCT04101422|75974830|FG001|Overall Study|Ineligible|0|||
42168397|NCT04101422|75974831|FG002|Overall Study|Ineligible|9|||
42168398|NCT04101422|75974832|FG003|Overall Study|Ineligible|0|||
42168399|NCT04101422|75974829|FG000|Overall Study|Withdrawal by Subject|0|||
42168400|NCT04101422|75974830|FG001|Overall Study|Withdrawal by Subject|0|||
42168401|NCT04101422|75974831|FG002|Overall Study|Withdrawal by Subject|1|||
42168402|NCT04101422|75974832|FG003|Overall Study|Withdrawal by Subject|0|||
42168403|NCT04101422|75974829|FG000|Overall Study|Not attending to the stimuli|0|||
42168404|NCT04101422|75974830|FG001|Overall Study|Not attending to the stimuli|0|||
42168405|NCT04101422|75974831|FG002|Overall Study|Not attending to the stimuli|4|||
42168406|NCT04101422|75974832|FG003|Overall Study|Not attending to the stimuli|0|||
42168407|NCT04101422|75974829|FG000|Overall Study|Did not download app|0|||
42168408|NCT04101422|75974830|FG001|Overall Study|Did not download app|0|||
42168409|NCT04101422|75974831|FG002|Overall Study|Did not download app|0|||
42168410|NCT04101422|75974832|FG003|Overall Study|Did not download app|17|||
42168411|NCT04101422|75974829|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
42168412|NCT04101422|75974830|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
42168413|NCT04101422|75974831|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
42168414|NCT04101422|75974832|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
42168415|NCT03841604|75974844|FG000|Overall Study|Withdrawal by Subject|3|||
42168416|NCT03841604|75974845|FG001|Overall Study|Withdrawal by Subject|1|||
42168417|NCT03841604|75974844|FG000|Overall Study|Adverse Event|4|||
42168418|NCT03841604|75974845|FG001|Overall Study|Adverse Event|2|||
42168419|NCT03841604|75974844|FG000|Overall Study|Physician Decision|1|||
42168420|NCT03841604|75974845|FG001|Overall Study|Physician Decision|0|||
42168421|NCT03541187|75974862|FG000|Overall Study|Lost to Follow-up|2|||
42168422|NCT03541187|75974863|FG001|Overall Study|Lost to Follow-up|6|||
42168423|NCT03541187|75974862|FG000|Overall Study|Pregnancy|0|||
42168424|NCT03541187|75974863|FG001|Overall Study|Pregnancy|1|||
42168425|NCT03541187|75974862|FG000|Overall Study|Withdrawal by Subject|6|||
42168426|NCT03541187|75974863|FG001|Overall Study|Withdrawal by Subject|2|||
42168427|NCT03541187|75974862|FG000|Overall Study|Moved out of town|1|||
42168428|NCT03541187|75974863|FG001|Overall Study|Moved out of town|0|||
42168429|NCT03541187|75974862|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
42168430|NCT03541187|75974863|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
42168431|NCT03541187|75974862|FG000|Overall Study|Did not meet randomization criteria|1|||
42168432|NCT03541187|75974863|FG001|Overall Study|Did not meet randomization criteria|1|||
42168433|NCT03541187|75974862|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
42168434|NCT03541187|75974863|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
42168435|NCT03541187|75974862|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
42168436|NCT03541187|75974863|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
42168437|NCT03240081|75974884|FG000|Overall Study|Withdrawal by Subject|0|||
42168438|NCT03240081|75974885|FG001|Overall Study|Withdrawal by Subject|2|||
42168439|NCT03240081|75974884|FG000|Overall Study|Lost to Follow-up|0|||
42168440|NCT03240081|75974885|FG001|Overall Study|Lost to Follow-up|1|||
42168441|NCT03003520|75974906|FG000|Overall Study|Adverse Event|9|||
42168442|NCT03003520|75974907|FG001|Overall Study|Adverse Event|0|||
42168443|NCT03003520|75974906|FG000|Overall Study|Death|1|||
42168444|NCT03003520|75974907|FG001|Overall Study|Death|0|||
42168445|NCT03003520|75974906|FG000|Overall Study|Other reasons|4|||
42168446|NCT03003520|75974907|FG001|Overall Study|Other reasons|0|||
42168447|NCT03003520|75974906|FG000|Overall Study|Withdrawal by Subject|6|||
42168448|NCT03003520|75974907|FG001|Overall Study|Withdrawal by Subject|0|||
42168449|NCT03003520|75974906|FG000|Overall Study|Progressive disease|9|||
42168450|NCT03003520|75974907|FG001|Overall Study|Progressive disease|1|||
42168451|NCT02958527|75974930|FG000|Overall Study|Not collected CRFs|12|||
42168452|NCT02586025|75974952|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
42168453|NCT02586025|75974953|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
42168454|NCT02586025|75974952|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
42168455|NCT02586025|75974953|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
42168456|NCT02586025|75974952|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
42168457|NCT02586025|75974953|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
42168458|NCT02586025|75974952|FG000|Neoadjuvant Treatment|Death|1|||
42168459|NCT02586025|75974953|FG001|Neoadjuvant Treatment|Death|0|||
42168460|NCT02586025|75974952|FG000|Neoadjuvant Treatment|Adverse Event|1|||
42168461|NCT02586025|75974953|FG001|Neoadjuvant Treatment|Adverse Event|0|||
42168462|NCT02586025|75974952|FG000|Neoadjuvant Treatment|Physician Decision|2|||
42168463|NCT02586025|75974953|FG001|Neoadjuvant Treatment|Physician Decision|1|||
42168464|NCT02586025|75974952|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
42168465|NCT02586025|75974953|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
42168466|NCT02586025|75974952|FG000|Adjuvant Treatment|Recurrent Disease|4|||
42168467|NCT02586025|75974953|FG001|Adjuvant Treatment|Recurrent Disease|5|||
42168468|NCT02586025|75974952|FG000|Adjuvant Treatment|Physician Decision|0|||
42168469|NCT02586025|75974953|FG001|Adjuvant Treatment|Physician Decision|1|||
42168470|NCT02586025|75974952|FG000|Adjuvant Treatment|Pregnancy|1|||
42168471|NCT02586025|75974953|FG001|Adjuvant Treatment|Pregnancy|0|||
42168472|NCT02586025|75974952|FG000|Treatment-Free Follow-Up|Death|11|||
42168473|NCT02586025|75974953|FG001|Treatment-Free Follow-Up|Death|11|||
42168474|NCT02586025|75974952|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
42168475|NCT02586025|75974953|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
42168476|NCT02586025|75974952|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
42168477|NCT02586025|75974953|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
42352025|NCT01925209|76192032|FG000|Treatment Epoch|Physician Decision|1|||
42352026|NCT01925209|76192033|FG001|Treatment Epoch|Physician Decision|0|||
42352027|NCT01925209|76192034|FG002|Treatment Epoch|Physician Decision|0|||
42352028|NCT01925209|76192035|FG003|Treatment Epoch|Physician Decision|0|||
42352029|NCT01925209|76192032|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
42014472|NCT00963235|75821613|FG000|Overall Study|Withdrawal by Subject|22|||
42014473|NCT00963235|75821613|FG000|Overall Study|Lost to Follow-up|14|||
42014474|NCT00963235|75821613|FG000|Overall Study|Failed to return|9|||
42014475|NCT00963235|75821613|FG000|Overall Study|Protocol Violation|7|||
42014476|NCT00963235|75821613|FG000|Overall Study|Adverse Event|5|||
42168478|NCT02586025|75974952|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
42168479|NCT02586025|75974953|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
42168480|NCT02586025|75974952|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
42014477|NCT00963235|75821613|FG000|Overall Study|Physician Decision|2|||
42352030|NCT01925209|76192033|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
42168481|NCT02586025|75974953|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
42168482|NCT01721577|75974971|FG000|Overall Study|Lack of Efficacy|1|||
42168483|NCT01721577|75974972|FG001|Overall Study|Lack of Efficacy|0|||
42168484|NCT01721577|75974971|FG000|Overall Study|Death|1|||
42168485|NCT01721577|75974972|FG001|Overall Study|Death|0|||
42168486|NCT01721577|75974971|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
42168487|NCT01721577|75974972|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
42168488|NCT01721577|75974971|FG000|Overall Study|Adverse Event|0|||
42168489|NCT01721577|75974972|FG001|Overall Study|Adverse Event|2|||
42168490|NCT01411332|75974989|FG000|Enrollment|Protocol Violation|0|||
42168491|NCT01411332|75974990|FG001|Enrollment|Protocol Violation|1|||
42168492|NCT01411332|75974989|FG000|Enrollment|Withdrawal by Subject|0|||
42168493|NCT01411332|75974990|FG001|Enrollment|Withdrawal by Subject|1|||
42168494|NCT01411332|75974989|FG000|Treatment|Lost to Follow-up|1|||
42168495|NCT01411332|75974990|FG001|Treatment|Lost to Follow-up|0|||
42168496|NCT04881747|75975017|FG000|Period 2 Washout|Adverse Event|1|||
42168497|NCT04881747|75975018|FG001|Period 2 Washout|Adverse Event|0|||
42168498|NCT04881747|75975019|FG002|Period 2 Washout|Adverse Event|0|||
42168499|NCT04881747|75975020|FG003|Period 2 Washout|Adverse Event|0|||
42168500|NCT04881747|75975021|FG004|Period 2 Washout|Adverse Event|1|||
42168501|NCT04881747|75975022|FG005|Period 2 Washout|Adverse Event|0|||
42168502|NCT04881747|75975017|FG000|Period 2 Washout|Withdrawal by Subject|1|||
42168503|NCT04881747|75975018|FG001|Period 2 Washout|Withdrawal by Subject|0|||
42168504|NCT04881747|75975019|FG002|Period 2 Washout|Withdrawal by Subject|0|||
42168505|NCT04881747|75975020|FG003|Period 2 Washout|Withdrawal by Subject|1|||
42168506|NCT04881747|75975021|FG004|Period 2 Washout|Withdrawal by Subject|0|||
42168507|NCT04881747|75975022|FG005|Period 2 Washout|Withdrawal by Subject|0|||
42168508|NCT04795622|75975032|FG000|Overall Study|Adverse Event|1|||
42168509|NCT04795622|75975033|FG001|Overall Study|Adverse Event|0|||
42168510|NCT04795622|75975032|FG000|Overall Study|Withdrawal by Subject|3|||
42168511|NCT04795622|75975033|FG001|Overall Study|Withdrawal by Subject|3|||
42168512|NCT04795622|75975032|FG000|Overall Study|Protocol Violation|0|||
42168513|NCT04795622|75975033|FG001|Overall Study|Protocol Violation|2|||
42168514|NCT04795622|75975032|FG000|Overall Study|Lost to Follow-up|2|||
42168515|NCT04795622|75975033|FG001|Overall Study|Lost to Follow-up|3|||
42168516|NCT04795622|75975032|FG000|Overall Study|Other|7|||
42168517|NCT04795622|75975033|FG001|Overall Study|Other|8|||
42168518|NCT04652245|75975054|FG000|Wash-Out Period|Adverse Event|0|||
42168519|NCT04652245|75975055|FG001|Wash-Out Period|Adverse Event|2|||
42168520|NCT04652245|75975054|FG000|Wash-Out Period|Withdrawal by Subject|0|||
42168521|NCT04652245|75975055|FG001|Wash-Out Period|Withdrawal by Subject|2|||
42168522|NCT04405739|75975072|FG000|Overall Study|Adverse Event|0|||
42168523|NCT04405739|75975073|FG001|Overall Study|Adverse Event|1|||
42168524|NCT04405739|75975074|FG002|Overall Study|Adverse Event|0|||
42168525|NCT04405739|75975075|FG003|Overall Study|Adverse Event|0|||
42168526|NCT04405739|75975072|FG000|Overall Study|Lost to Follow-up|0|||
42168527|NCT04405739|75975073|FG001|Overall Study|Lost to Follow-up|2|||
42168528|NCT04405739|75975074|FG002|Overall Study|Lost to Follow-up|1|||
42168529|NCT04405739|75975075|FG003|Overall Study|Lost to Follow-up|3|||
42168530|NCT04405739|75975072|FG000|Overall Study|Withdrawal by Subject|0|||
42168531|NCT04405739|75975073|FG001|Overall Study|Withdrawal by Subject|2|||
42168532|NCT04405739|75975074|FG002|Overall Study|Withdrawal by Subject|1|||
42168533|NCT04405739|75975075|FG003|Overall Study|Withdrawal by Subject|1|||
42168534|NCT04405739|75975072|FG000|Overall Study|Death|0|||
42168535|NCT04405739|75975073|FG001|Overall Study|Death|0|||
42168536|NCT04405739|75975074|FG002|Overall Study|Death|1|||
42282701|NCT00700427|76114369|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
42168537|NCT04405739|75975075|FG003|Overall Study|Death|0|||
42168538|NCT04405739|75975072|FG000|Overall Study|Transferred to rehab|0|||
42168539|NCT04405739|75975073|FG001|Overall Study|Transferred to rehab|0|||
42168540|NCT04405739|75975074|FG002|Overall Study|Transferred to rehab|0|||
42168541|NCT04405739|75975075|FG003|Overall Study|Transferred to rehab|1|||
42168542|NCT04405739|75975072|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
42168543|NCT04405739|75975073|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
42168544|NCT04405739|75975074|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
42282702|NCT00700427|76114370|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
42168545|NCT04405739|75975075|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
42168546|NCT04954326|75975108|FG000|Overall Study|Protocol Violation|0|||
42168547|NCT04954326|75975109|FG001|Overall Study|Protocol Violation|1|||
42168548|NCT04954326|75975108|FG000|Overall Study|Death|0|||
42282703|NCT00700427|76114371|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
42168549|NCT04954326|75975109|FG001|Overall Study|Death|2|||
42168550|NCT04954326|75975108|FG000|Overall Study|Physician Decision|0|||
42168551|NCT04954326|75975109|FG001|Overall Study|Physician Decision|1|||
42168552|NCT04914819|75975117|FG000|Overall Study|Pregnancy|3|||
42168553|NCT04914819|75975118|FG001|Overall Study|Pregnancy|1|||
42168554|NCT04914819|75975117|FG000|Overall Study|Discontinued study|4|||
42168555|NCT04914819|75975118|FG001|Overall Study|Discontinued study|1|||
42168556|NCT04914819|75975117|FG000|Overall Study|Lost to Follow-up|7|||
42168557|NCT04914819|75975118|FG001|Overall Study|Lost to Follow-up|0|||
42168558|NCT04818346|75975133|FG000|24-Week Placebo-Controlled Period|Adverse Event|1|||
42168559|NCT04818346|75975134|FG001|24-Week Placebo-Controlled Period|Adverse Event|2|||
42168560|NCT04818346|75975135|FG002|24-Week Placebo-Controlled Period|Adverse Event|0|||
42168561|NCT04818346|75975136|FG003|24-Week Placebo-Controlled Period|Adverse Event|3|||
42168562|NCT04818346|75975133|FG000|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
42168563|NCT04818346|75975134|FG001|24-Week Placebo-Controlled Period|Lost to Follow-up|2|||
42168564|NCT04818346|75975135|FG002|24-Week Placebo-Controlled Period|Lost to Follow-up|3|||
42168565|NCT04818346|75975136|FG003|24-Week Placebo-Controlled Period|Lost to Follow-up|1|||
42168566|NCT04818346|75975133|FG000|24-Week Placebo-Controlled Period|Physician Decision|1|||
42168567|NCT04818346|75975134|FG001|24-Week Placebo-Controlled Period|Physician Decision|0|||
42168568|NCT04818346|75975135|FG002|24-Week Placebo-Controlled Period|Physician Decision|0|||
42282704|NCT00700427|76114372|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
42282705|NCT00700427|76114373|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
42282706|NCT00700427|76114369|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
42282707|NCT00700427|76114370|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
42282708|NCT00700427|76114371|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
42282709|NCT00700427|76114372|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
42282710|NCT00700427|76114373|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
42282711|NCT00700427|76114369|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
42282712|NCT00700427|76114370|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
42282713|NCT00700427|76114371|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
42282714|NCT00700427|76114372|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
42282715|NCT00700427|76114373|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
42168569|NCT04818346|75975136|FG003|24-Week Placebo-Controlled Period|Physician Decision|0|||
42168570|NCT04818346|75975133|FG000|24-Week Placebo-Controlled Period|Protocol Violation|0|||
42168571|NCT04818346|75975134|FG001|24-Week Placebo-Controlled Period|Protocol Violation|0|||
42168572|NCT04818346|75975135|FG002|24-Week Placebo-Controlled Period|Protocol Violation|1|||
42168573|NCT04818346|75975136|FG003|24-Week Placebo-Controlled Period|Protocol Violation|1|||
42168574|NCT04818346|75975133|FG000|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
42168575|NCT04818346|75975134|FG001|24-Week Placebo-Controlled Period|Withdrawal by Subject|1|||
42168576|NCT04818346|75975135|FG002|24-Week Placebo-Controlled Period|Withdrawal by Subject|6|||
42168577|NCT04818346|75975136|FG003|24-Week Placebo-Controlled Period|Withdrawal by Subject|2|||
42168578|NCT04818346|75975133|FG000|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|1|||
42168579|NCT04818346|75975134|FG001|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
42168580|NCT04818346|75975135|FG002|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
42168581|NCT04818346|75975136|FG003|24-Week Placebo-Controlled Period|Subject Terminated by Sponsor|0|||
42168582|NCT04818346|75975133|FG000|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
42168583|NCT04818346|75975134|FG001|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
42168584|NCT04818346|75975135|FG002|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
42168585|NCT04818346|75975136|FG003|24-Week Placebo-Controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
42168586|NCT04818346|75975133|FG000|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
42168587|NCT04818346|75975134|FG001|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
42168588|NCT04818346|75975135|FG002|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|1|||
42168589|NCT04818346|75975136|FG003|24-Week Placebo-Controlled Period|Use of Prohibited Concomitant Medication|0|||
42168590|NCT04818346|75975133|FG000|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
42168591|NCT04818346|75975134|FG001|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
42168592|NCT04818346|75975135|FG002|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
42168593|NCT04818346|75975136|FG003|24-Week Placebo-Controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
42168594|NCT04723394|75975148|FG000|Overall Study|Adverse Event|0|||
42168595|NCT04723394|75975149|FG001|Overall Study|Adverse Event|3|||
42168596|NCT04723394|75975148|FG000|Overall Study|Death|8|||
42168597|NCT04723394|75975149|FG001|Overall Study|Death|8|||
42168598|NCT04723394|75975148|FG000|Overall Study|Lost to Follow-up|20|||
42168599|NCT04723394|75975149|FG001|Overall Study|Lost to Follow-up|17|||
42168600|NCT04723394|75975148|FG000|Overall Study|Physician Decision|1|||
42168601|NCT04723394|75975149|FG001|Overall Study|Physician Decision|0|||
42168602|NCT04723394|75975148|FG000|Overall Study|Withdrawal by Subject|20|||
42168603|NCT04723394|75975149|FG001|Overall Study|Withdrawal by Subject|34|||
42168604|NCT04723394|75975148|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
42168605|NCT04723394|75975149|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
42168606|NCT04409002|75975159|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
42168607|NCT04289363|75975165|FG000|Overall Study|Lost to Follow-up|14|||
42168608|NCT04289363|75975166|FG001|Overall Study|Lost to Follow-up|0|||
42168609|NCT04235959|75975175|FG000|Overall Study|Protocol Violation|0|||
42168610|NCT04235959|75975176|FG001|Overall Study|Protocol Violation|1|||
42168611|NCT04235959|75975177|FG002|Overall Study|Protocol Violation|0|||
42168612|NCT04235959|75975175|FG000|Overall Study|Adverse Event|1|||
42168613|NCT04235959|75975176|FG001|Overall Study|Adverse Event|0|||
42168614|NCT04235959|75975177|FG002|Overall Study|Adverse Event|0|||
42168615|NCT03525613|75975212|FG000|Overall Study|Adverse Event|11|||
42168616|NCT03525613|75975213|FG001|Overall Study|Adverse Event|8|||
42168617|NCT03525613|75975214|FG002|Overall Study|Adverse Event|3|||
42168618|NCT03525613|75975215|FG003|Overall Study|Adverse Event|3|||
42168619|NCT03525613|75975212|FG000|Overall Study|Lost to Follow-up|4|||
42168620|NCT03525613|75975213|FG001|Overall Study|Lost to Follow-up|5|||
42168621|NCT03525613|75975214|FG002|Overall Study|Lost to Follow-up|3|||
42168622|NCT03525613|75975215|FG003|Overall Study|Lost to Follow-up|2|||
42168623|NCT03525613|75975212|FG000|Overall Study|Physician Decision|0|||
42168624|NCT03525613|75975213|FG001|Overall Study|Physician Decision|1|||
42168625|NCT03525613|75975214|FG002|Overall Study|Physician Decision|0|||
42168626|NCT03525613|75975215|FG003|Overall Study|Physician Decision|1|||
42168627|NCT03525613|75975212|FG000|Overall Study|Consent Withdrawal|25|||
42168628|NCT03525613|75975213|FG001|Overall Study|Consent Withdrawal|16|||
42168629|NCT03525613|75975214|FG002|Overall Study|Consent Withdrawal|12|||
42168630|NCT03525613|75975215|FG003|Overall Study|Consent Withdrawal|9|||
42168631|NCT03525613|75975212|FG000|Overall Study|Death|20|||
42168632|NCT03525613|75975213|FG001|Overall Study|Death|9|||
42168633|NCT03525613|75975214|FG002|Overall Study|Death|7|||
42168634|NCT03525613|75975215|FG003|Overall Study|Death|1|||
42168635|NCT03525613|75975212|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
42168636|NCT03525613|75975213|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
42014478|NCT00963235|75821613|FG000|Overall Study|Other|1|||
42014479|NCT01165281|75821622|FG000|Overall Study|Adverse Event|12|||
42168637|NCT03525613|75975214|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
42168638|NCT03525613|75975215|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
42168639|NCT03500692|75975229|FG000|Overall Study|Death|163|||
42168640|NCT03500692|75975229|FG000|Overall Study|Lost to Follow-up|76|||
42168641|NCT03500692|75975229|FG000|Overall Study|Termination Reasons|3|||
42168642|NCT03404960|75975244|FG000|Overall Study|Adverse Event|0|||
42168643|NCT03404960|75975245|FG001|Overall Study|Adverse Event|2|||
42168644|NCT03404960|75975244|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
42168645|NCT03404960|75975245|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
42168646|NCT03404960|75975244|FG000|Overall Study|Bowel obstruction|0|||
42168647|NCT03404960|75975245|FG001|Overall Study|Bowel obstruction|1|||
42168648|NCT03404960|75975244|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
42168649|NCT03404960|75975245|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
42168650|NCT03264404|75975251|FG000|Overall Study|Death|2|||
42168651|NCT03264404|75975251|FG000|Overall Study|Physician Decision|1|||
42168652|NCT03264404|75975251|FG000|Overall Study|Disease Progression|28|||
42168653|NCT03264404|75975251|FG000|Overall Study|Adverse Event|1|||
42168654|NCT03264404|75975251|FG000|Overall Study|Off study prior to treatment|2|||
42168655|NCT03118570|75975269|FG000|Overall Study|Adverse Event|2|||
42168656|NCT03118570|75975270|FG001|Overall Study|Adverse Event|0|||
42168657|NCT03118570|75975271|FG002|Overall Study|Adverse Event|0|||
42168658|NCT03118570|75975272|FG003|Overall Study|Adverse Event|0|||
42168659|NCT03118570|75975273|FG004|Overall Study|Adverse Event|3|||
42168660|NCT03118570|75975269|FG000|Overall Study|Withdrawal by Subject|0|||
42168661|NCT03118570|75975270|FG001|Overall Study|Withdrawal by Subject|1|||
42168662|NCT03118570|75975271|FG002|Overall Study|Withdrawal by Subject|4|||
42168663|NCT03118570|75975272|FG003|Overall Study|Withdrawal by Subject|0|||
42168664|NCT03118570|75975273|FG004|Overall Study|Withdrawal by Subject|1|||
42168665|NCT03118570|75975269|FG000|Overall Study|Lost to Follow-up|2|||
42168666|NCT03118570|75975270|FG001|Overall Study|Lost to Follow-up|3|||
42168667|NCT03118570|75975271|FG002|Overall Study|Lost to Follow-up|1|||
42168668|NCT03118570|75975272|FG003|Overall Study|Lost to Follow-up|0|||
42168669|NCT03118570|75975273|FG004|Overall Study|Lost to Follow-up|1|||
42168670|NCT03118570|75975269|FG000|Overall Study|Other, Not Specified|1|||
42168671|NCT03118570|75975270|FG001|Overall Study|Other, Not Specified|3|||
42168672|NCT03118570|75975271|FG002|Overall Study|Other, Not Specified|0|||
42168673|NCT03118570|75975272|FG003|Overall Study|Other, Not Specified|0|||
42168674|NCT03118570|75975273|FG004|Overall Study|Other, Not Specified|0|||
42168675|NCT02971683|75975288|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
42168676|NCT02971683|75975289|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
42168677|NCT02971683|75975288|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
42168678|NCT02971683|75975289|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
42168679|NCT02971683|75975288|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
42168680|NCT02971683|75975289|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
42168681|NCT02971683|75975288|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
42168682|NCT02971683|75975289|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
42168683|NCT02971683|75975288|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
42168684|NCT02971683|75975289|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
42168685|NCT02971683|75975288|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
42168686|NCT02971683|75975289|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
42168687|NCT02971683|75975288|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
42168688|NCT02971683|75975289|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
42168689|NCT02971683|75975288|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
42168690|NCT02971683|75975289|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
42168691|NCT02971683|75975288|FG000|Open-Label|Lost to Follow-up|1|||
42168692|NCT02971683|75975289|FG001|Open-Label|Lost to Follow-up|0|||
42168693|NCT02971683|75975288|FG000|Open-Label|Participants withdrew consent|0|||
42168694|NCT02971683|75975289|FG001|Open-Label|Participants withdrew consent|2|||
42168695|NCT02971683|75975288|FG000|Open-Label|Participant request to discontinue study treatment|1|||
42168696|NCT02971683|75975289|FG001|Open-Label|Participant request to discontinue study treatment|0|||
42168697|NCT02971683|75975288|FG000|Open-Label|Lack of Efficacy|2|||
42168698|NCT02971683|75975289|FG001|Open-Label|Lack of Efficacy|0|||
42168699|NCT02971683|75975288|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
42168700|NCT02971683|75975289|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
42168701|NCT02971683|75975288|FG000|Long-Term Open Label|Participant withdrew consent|1|||
42168702|NCT02971683|75975289|FG001|Long-Term Open Label|Participant withdrew consent|0|||
42168703|NCT02971683|75975288|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
42168704|NCT02971683|75975289|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
42168705|NCT02971683|75975288|FG000|Long-Term Open Label|Adverse Event|1|||
42168706|NCT02971683|75975289|FG001|Long-Term Open Label|Adverse Event|2|||
42168707|NCT02971683|75975288|FG000|Long-Term Open Label|Lack of Efficacy|1|||
42168708|NCT02971683|75975289|FG001|Long-Term Open Label|Lack of Efficacy|1|||
42168709|NCT02899299|75975297|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
42168710|NCT02899299|75975298|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
42168711|NCT02899299|75975297|FG000|Pre-treatment|Participant withdrew consent|1|||
42168712|NCT02899299|75975298|FG001|Pre-treatment|Participant withdrew consent|11|||
42168713|NCT02899299|75975297|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
42168714|NCT02899299|75975298|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
42168715|NCT02899299|75975297|FG000|Pre-treatment|Not reported|0|||
42168716|NCT02899299|75975298|FG001|Pre-treatment|Not reported|1|||
42168717|NCT02899299|75975297|FG000|Treatment|Disease Progression|182|||
42168718|NCT02899299|75975298|FG001|Treatment|Disease Progression|44|||
42168719|NCT02899299|75975297|FG000|Treatment|Study Drug Toxicity|59|||
42168720|NCT02899299|75975298|FG001|Treatment|Study Drug Toxicity|24|||
42168721|NCT02899299|75975297|FG000|Treatment|Adverse Event unrelated to Study Drug|12|||
42168722|NCT02899299|75975298|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
42168723|NCT02899299|75975297|FG000|Treatment|Participant request to discontinue Study treatment|4|||
42168724|NCT02899299|75975298|FG001|Treatment|Participant request to discontinue Study treatment|10|||
42168725|NCT02899299|75975297|FG000|Treatment|Participant withdrew consent|6|||
42168726|NCT02899299|75975298|FG001|Treatment|Participant withdrew consent|3|||
42168727|NCT02899299|75975297|FG000|Treatment|Lost to Follow-up|0|||
42168728|NCT02899299|75975298|FG001|Treatment|Lost to Follow-up|1|||
42168729|NCT02899299|75975297|FG000|Treatment|Maximum Clinical Benefit|10|||
42168730|NCT02899299|75975298|FG001|Treatment|Maximum Clinical Benefit|2|||
42168731|NCT02899299|75975297|FG000|Treatment|Poor/Non-compliance|1|||
42168732|NCT02899299|75975298|FG001|Treatment|Poor/Non-compliance|0|||
42168733|NCT02899299|75975297|FG000|Treatment|Participant no longer meets Study criteria|4|||
42168734|NCT02899299|75975298|FG001|Treatment|Participant no longer meets Study criteria|0|||
42168735|NCT02899299|75975297|FG000|Treatment|Administrative reason by Sponsor|2|||
42168736|NCT02899299|75975298|FG001|Treatment|Administrative reason by Sponsor|0|||
42168737|NCT02899299|75975297|FG000|Treatment|Other reasons|11|||
42168738|NCT02899299|75975298|FG001|Treatment|Other reasons|2|||
42168739|NCT02899299|75975297|FG000|Treatment|Not reported: Includes participants who achieved max duration of treatment|4|||
42168740|NCT02899299|75975298|FG001|Treatment|Not reported: Includes participants who achieved max duration of treatment|189|||
42168741|NCT02899195|75975304|FG000|Concurrent Durvalumab|Adverse Event|4|||
42168742|NCT02899195|75975304|FG000|Concurrent Durvalumab|Physician Decision|1|||
42168743|NCT02899195|75975304|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
42168744|NCT02899195|75975304|FG000|Concurrent Durvalumab|Progressive Disease|5|||
42168745|NCT02899195|75975304|FG000|Maintenance Durvalumab|Adverse Event|1|||
42168746|NCT02899195|75975304|FG000|Maintenance Durvalumab|Physician Decision|1|||
42168747|NCT02899195|75975304|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
42168748|NCT02899195|75975304|FG000|Maintenance Durvalumab|Progressive Disease|31|||
42168749|NCT02581943|75975373|FG000|Overall Study|Death|5|||
42168750|NCT02581943|75975374|FG001|Overall Study|Death|2|||
42168751|NCT02581943|75975373|FG000|Overall Study|Disease Progression|12|||
42168752|NCT02581943|75975374|FG001|Overall Study|Disease Progression|15|||
42168753|NCT02581943|75975373|FG000|Overall Study|Withdrawal by Subject|1|||
42168754|NCT02581943|75975374|FG001|Overall Study|Withdrawal by Subject|2|||
42168755|NCT02527200|75975389|FG000|Overall Study|Withdrawal by Subject|3|||
42168756|NCT02527200|75975390|FG001|Overall Study|Withdrawal by Subject|2|||
42168757|NCT02527200|75975391|FG002|Overall Study|Withdrawal by Subject|1|||
42168758|NCT02527200|75975392|FG003|Overall Study|Withdrawal by Subject|0|||
42168759|NCT02527200|75975389|FG000|Overall Study|Unclassified|0|||
42168760|NCT02527200|75975390|FG001|Overall Study|Unclassified|1|||
42168761|NCT02527200|75975391|FG002|Overall Study|Unclassified|0|||
42168762|NCT02527200|75975392|FG003|Overall Study|Unclassified|0|||
42168763|NCT02527200|75975389|FG000|Overall Study|Lost to Follow-up|0|||
42168764|NCT02527200|75975390|FG001|Overall Study|Lost to Follow-up|0|||
42168765|NCT02527200|75975391|FG002|Overall Study|Lost to Follow-up|1|||
42168766|NCT02527200|75975392|FG003|Overall Study|Lost to Follow-up|0|||
42168767|NCT02510040|75975409|FG000|Overall Study|Deemed no longer eligible|18|||
42168768|NCT02510040|75975410|FG001|Overall Study|Deemed no longer eligible|3|||
42168769|NCT02510040|75975411|FG002|Overall Study|Deemed no longer eligible|1|||
42168770|NCT01935089|75975437|FG000|Overall Study|Adverse Event|2|||
42168771|NCT01935089|75975437|FG000|Overall Study|Withdrawal by Subject|1|||
42168772|NCT00571727|75975473|FG000|Overall Study|Did not enter in this study|1|||
42168773|NCT00571727|75975473|FG000|Overall Study|Non-compliance|4|||
42168774|NCT00571727|75975473|FG000|Overall Study|Lost to Follow-up|30|||
42168775|NCT00571727|75975473|FG000|Overall Study|Poor growth|1|||
42168776|NCT00571727|75975473|FG000|Overall Study|Parent/patient decision|2|||
42168777|NCT00571727|75975473|FG000|Overall Study|Participant transferred to commercial drug|14|||
42168778|NCT00571727|75975473|FG000|Overall Study|Unable to provide study drug|6|||
42352031|NCT01925209|76192034|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
42168779|NCT00571727|75975473|FG000|Overall Study|On-treatment at end of study|8|||
42352032|NCT01925209|76192035|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
42282716|NCT00700427|76114369|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
42282717|NCT00700427|76114370|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
42168780|NCT00427349|75975477|FG000|Overall Study|Lack of Efficacy|23|||
42168781|NCT00427349|75975477|FG000|Overall Study|Adverse Event|14|||
42168782|NCT00427349|75975477|FG000|Overall Study|Death|1|||
42168783|NCT00427349|75975477|FG000|Overall Study|Withdrawal by Subject|3|||
42168784|NCT00427349|75975477|FG000|Overall Study|Alternative therapy|1|||
42168785|NCT00427349|75975477|FG000|Overall Study|Other|2|||
42168786|NCT00427349|75975477|FG000|Overall Study|Ineligible|1|||
42168787|NCT00427349|75975477|FG000|Overall Study|Never started therapy|1|||
42168788|NCT00309985|75975483|FG000|Overall Study|Disease progression|12|||
42168789|NCT00309985|75975484|FG001|Overall Study|Disease progression|0|||
42168790|NCT00309985|75975483|FG000|Overall Study|Adverse Event|30|||
42014480|NCT01165281|75821623|FG001|Overall Study|Adverse Event|14|||
42014481|NCT01165281|75821622|FG000|Overall Study|Death|3|||
42014482|NCT01165281|75821623|FG001|Overall Study|Death|4|||
42014483|NCT01165281|75821622|FG000|Overall Study|Lack of Efficacy|4|||
42014484|NCT01165281|75821623|FG001|Overall Study|Lack of Efficacy|1|||
42014485|NCT01165281|75821622|FG000|Overall Study|Lost to Follow-up|0|||
42168791|NCT00309985|75975484|FG001|Overall Study|Adverse Event|0|||
42168792|NCT00309985|75975483|FG000|Overall Study|Death|2|||
42168793|NCT00309985|75975484|FG001|Overall Study|Death|0|||
42168794|NCT00309985|75975483|FG000|Overall Study|Withdrawal by Subject|5|||
42168795|NCT00309985|75975484|FG001|Overall Study|Withdrawal by Subject|1|||
42168796|NCT00309985|75975483|FG000|Overall Study|Physician Decision|3|||
42168797|NCT00309985|75975484|FG001|Overall Study|Physician Decision|0|||
42168798|NCT00309985|75975483|FG000|Overall Study|Never started treatment|7|||
42168799|NCT00309985|75975484|FG001|Overall Study|Never started treatment|0|||
42168800|NCT00309985|75975483|FG000|Overall Study|Complicating disease|1|||
42168801|NCT00309985|75975484|FG001|Overall Study|Complicating disease|0|||
42168802|NCT00309985|75975483|FG000|Overall Study|Non-compliance|1|||
42168803|NCT00309985|75975484|FG001|Overall Study|Non-compliance|0|||
42168804|NCT00309985|75975483|FG000|Overall Study|Chemotherapy discontinued only|1|||
42168805|NCT00309985|75975484|FG001|Overall Study|Chemotherapy discontinued only|0|||
42168806|NCT00098787|75975493|FG000|Overall Study|Never started treatment|3|||
42168807|NCT00098787|75975494|FG001|Overall Study|Never started treatment|2|||
42168808|NCT00098787|75975495|FG002|Overall Study|Never started treatment|1|||
42168809|NCT00098787|75975493|FG000|Overall Study|Ineligible|9|||
42168810|NCT00098787|75975494|FG001|Overall Study|Ineligible|7|||
42168811|NCT00098787|75975495|FG002|Overall Study|Ineligible|3|||
42168812|NCT00098787|75975493|FG000|Overall Study|Disease progression|28|||
42168813|NCT00098787|75975494|FG001|Overall Study|Disease progression|17|||
42168814|NCT00098787|75975495|FG002|Overall Study|Disease progression|23|||
42168815|NCT00098787|75975493|FG000|Overall Study|Adverse Event|8|||
42168816|NCT00098787|75975494|FG001|Overall Study|Adverse Event|17|||
42168817|NCT00098787|75975495|FG002|Overall Study|Adverse Event|8|||
42168818|NCT00098787|75975493|FG000|Overall Study|Death|6|||
42168819|NCT00098787|75975494|FG001|Overall Study|Death|1|||
42168820|NCT00098787|75975495|FG002|Overall Study|Death|0|||
42168821|NCT00098787|75975493|FG000|Overall Study|Withdrawal by Subject|4|||
42168822|NCT00098787|75975494|FG001|Overall Study|Withdrawal by Subject|12|||
42168823|NCT00098787|75975495|FG002|Overall Study|Withdrawal by Subject|6|||
42168824|NCT00098787|75975493|FG000|Overall Study|Alternative therapy|8|||
42168825|NCT00098787|75975494|FG001|Overall Study|Alternative therapy|13|||
42168826|NCT00098787|75975495|FG002|Overall Study|Alternative therapy|13|||
42168827|NCT00098787|75975493|FG000|Overall Study|Other|7|||
42168828|NCT00098787|75975494|FG001|Overall Study|Other|6|||
42282718|NCT00700427|76114371|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
42282719|NCT00700427|76114372|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
42282720|NCT00700427|76114373|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
42282721|NCT00700427|76114369|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
42282722|NCT00700427|76114370|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
42282723|NCT00700427|76114371|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
42282724|NCT00700427|76114372|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
42282725|NCT00700427|76114373|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
42014486|NCT01165281|75821623|FG001|Overall Study|Lost to Follow-up|1|||
42014487|NCT01165281|75821622|FG000|Overall Study|Physician Decision|8|||
42168829|NCT00098787|75975495|FG002|Overall Study|Other|9|||
42168830|NCT00091169|75975505|FG000|Overall Study|Disease progression|3|||
42168831|NCT00091169|75975506|FG001|Overall Study|Disease progression|1|||
42168832|NCT00091169|75975505|FG000|Overall Study|Adverse Event|11|||
42168833|NCT00091169|75975506|FG001|Overall Study|Adverse Event|17|||
42168834|NCT00091169|75975505|FG000|Overall Study|Death|4|||
42168835|NCT00091169|75975506|FG001|Overall Study|Death|1|||
42014488|NCT01165281|75821623|FG001|Overall Study|Physician Decision|1|||
42014489|NCT01165281|75821622|FG000|Overall Study|Protocol Violation|6|||
42168836|NCT00091169|75975505|FG000|Overall Study|Withdrawal by Subject|10|||
42168837|NCT00091169|75975506|FG001|Overall Study|Withdrawal by Subject|13|||
42168838|NCT00091169|75975505|FG000|Overall Study|Other|3|||
42168839|NCT00091169|75975506|FG001|Overall Study|Other|4|||
42168840|NCT00091169|75975505|FG000|Overall Study|Not start protocol therapy|26|||
42168841|NCT00091169|75975506|FG001|Overall Study|Not start protocol therapy|17|||
42168842|NCT00075946|75975518|FG000|Overall Study|Path ineligible: undetermined histology|0|||
42168843|NCT00075946|75975519|FG001|Overall Study|Path ineligible: undetermined histology|0|||
42168844|NCT00075946|75975520|FG002|Overall Study|Path ineligible: undetermined histology|0|||
42168845|NCT00075946|75975521|FG003|Overall Study|Path ineligible: undetermined histology|0|||
42168846|NCT00075946|75975522|FG004|Overall Study|Path ineligible: undetermined histology|6|||
42168847|NCT00075946|75975518|FG000|Overall Study|Did not achieve response after induction|0|||
42168848|NCT00075946|75975519|FG001|Overall Study|Did not achieve response after induction|0|||
42168849|NCT00075946|75975520|FG002|Overall Study|Did not achieve response after induction|0|||
42168850|NCT00075946|75975521|FG003|Overall Study|Did not achieve response after induction|0|||
42168851|NCT00075946|75975522|FG004|Overall Study|Did not achieve response after induction|182|||
42168852|NCT00075946|75975518|FG000|Overall Study|Incorrectly randomized (no response)|5|||
42168853|NCT00075946|75975519|FG001|Overall Study|Incorrectly randomized (no response)|5|||
42168854|NCT00075946|75975520|FG002|Overall Study|Incorrectly randomized (no response)|5|||
42168855|NCT00075946|75975521|FG003|Overall Study|Incorrectly randomized (no response)|1|||
42168856|NCT00075946|75975522|FG004|Overall Study|Incorrectly randomized (no response)|0|||
42168857|NCT00075946|75975518|FG000|Overall Study|Still on treatment at time of analysis|52|||
42168858|NCT00075946|75975519|FG001|Overall Study|Still on treatment at time of analysis|19|||
42168859|NCT00075946|75975520|FG002|Overall Study|Still on treatment at time of analysis|3|||
42168860|NCT00075946|75975521|FG003|Overall Study|Still on treatment at time of analysis|9|||
42168861|NCT00075946|75975522|FG004|Overall Study|Still on treatment at time of analysis|0|||
42168862|NCT00075946|75975518|FG000|Overall Study|Adverse Event|2|||
42168863|NCT00075946|75975519|FG001|Overall Study|Adverse Event|10|||
42168864|NCT00075946|75975520|FG002|Overall Study|Adverse Event|0|||
42168865|NCT00075946|75975521|FG003|Overall Study|Adverse Event|2|||
42168866|NCT00075946|75975522|FG004|Overall Study|Adverse Event|0|||
42168867|NCT00075946|75975518|FG000|Overall Study|Death|0|||
42168868|NCT00075946|75975519|FG001|Overall Study|Death|1|||
42168869|NCT00075946|75975520|FG002|Overall Study|Death|0|||
42168870|NCT00075946|75975521|FG003|Overall Study|Death|0|||
42168871|NCT00075946|75975522|FG004|Overall Study|Death|0|||
42168872|NCT00075946|75975518|FG000|Overall Study|Withdrawal by Subject|23|||
42168873|NCT00075946|75975519|FG001|Overall Study|Withdrawal by Subject|58|||
42168874|NCT00075946|75975520|FG002|Overall Study|Withdrawal by Subject|4|||
42168875|NCT00075946|75975521|FG003|Overall Study|Withdrawal by Subject|9|||
42168876|NCT00075946|75975522|FG004|Overall Study|Withdrawal by Subject|0|||
42168877|NCT00075946|75975518|FG000|Overall Study|Alternative therapy|16|||
42168878|NCT00075946|75975519|FG001|Overall Study|Alternative therapy|2|||
42168879|NCT00075946|75975520|FG002|Overall Study|Alternative therapy|5|||
42168880|NCT00075946|75975521|FG003|Overall Study|Alternative therapy|0|||
42168881|NCT00075946|75975522|FG004|Overall Study|Alternative therapy|0|||
42168882|NCT00075946|75975518|FG000|Overall Study|Other complicating disease|7|||
42168883|NCT00075946|75975519|FG001|Overall Study|Other complicating disease|13|||
42282726|NCT00700427|76114369|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
42282727|NCT00700427|76114370|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
42282728|NCT00700427|76114371|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
42282729|NCT00700427|76114372|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
42040656|NCT01796171|75848711|FG005|Follow-up Period|Start of further anticancer therapy|2|||
42040657|NCT01796171|75848712|FG006|Follow-up Period|Start of further anticancer therapy|1|||
42040658|NCT01796171|75848713|FG007|Follow-up Period|Start of further anticancer therapy|15|||
42040659|NCT01796171|75848714|FG008|Follow-up Period|Start of further anticancer therapy|2|||
42282730|NCT00700427|76114373|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
42282731|NCT00700427|76114369|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
42282732|NCT00700427|76114370|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
42282733|NCT00700427|76114371|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
42282734|NCT00700427|76114372|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
42282735|NCT00700427|76114373|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
42352033|NCT01925209|76192032|FG000|Treatment Epoch|Death|1|||
42352034|NCT01925209|76192033|FG001|Treatment Epoch|Death|0|||
42352035|NCT01925209|76192034|FG002|Treatment Epoch|Death|0|||
42352036|NCT01925209|76192035|FG003|Treatment Epoch|Death|0|||
42352037|NCT01925209|76192032|FG000|Treatment Epoch|Protocol deviation|0|||
42352038|NCT01925209|76192033|FG001|Treatment Epoch|Protocol deviation|0|||
42352039|NCT01925209|76192034|FG002|Treatment Epoch|Protocol deviation|1|||
42168884|NCT00075946|75975520|FG002|Overall Study|Other complicating disease|1|||
42168885|NCT00075946|75975521|FG003|Overall Study|Other complicating disease|4|||
42352040|NCT01925209|76192035|FG003|Treatment Epoch|Protocol deviation|1|||
42168886|NCT00075946|75975522|FG004|Overall Study|Other complicating disease|0|||
42168887|NCT00075946|75975518|FG000|Overall Study|No response to retreatment|23|||
42168888|NCT00075946|75975519|FG001|Overall Study|No response to retreatment|0|||
42168889|NCT00075946|75975520|FG002|Overall Study|No response to retreatment|2|||
42168890|NCT00075946|75975521|FG003|Overall Study|No response to retreatment|0|||
42168891|NCT00075946|75975522|FG004|Overall Study|No response to retreatment|0|||
42168892|NCT00075946|75975518|FG000|Overall Study|Time to progression less than 6 months|15|||
42168893|NCT00075946|75975519|FG001|Overall Study|Time to progression less than 6 months|30|||
42168894|NCT00075946|75975520|FG002|Overall Study|Time to progression less than 6 months|8|||
42168895|NCT00075946|75975521|FG003|Overall Study|Time to progression less than 6 months|3|||
42168896|NCT00075946|75975522|FG004|Overall Study|Time to progression less than 6 months|0|||
42168897|NCT00075946|75975518|FG000|Overall Study|Other|5|||
42168898|NCT00075946|75975519|FG001|Overall Study|Other|13|||
42168899|NCT00075946|75975520|FG002|Overall Study|Other|0|||
42168900|NCT00075946|75975521|FG003|Overall Study|Other|2|||
42168901|NCT00075946|75975522|FG004|Overall Study|Other|0|||
42168902|NCT00057876|75975539|FG000|Overall Study|Adverse Event|8|||
42168903|NCT00057876|75975540|FG001|Overall Study|Adverse Event|8|||
42168904|NCT00057876|75975539|FG000|Overall Study|Death|2|||
42168905|NCT00057876|75975540|FG001|Overall Study|Death|1|||
42168906|NCT00057876|75975539|FG000|Overall Study|Withdrawal by Subject|5|||
42168907|NCT00057876|75975540|FG001|Overall Study|Withdrawal by Subject|6|||
42168908|NCT00057876|75975539|FG000|Overall Study|Lack of Efficacy|10|||
42168909|NCT00057876|75975540|FG001|Overall Study|Lack of Efficacy|8|||
42168910|NCT00057876|75975539|FG000|Overall Study|Ineligible|1|||
42168911|NCT00057876|75975540|FG001|Overall Study|Ineligible|2|||
42168912|NCT00057876|75975539|FG000|Overall Study|other reason|2|||
42168913|NCT00057876|75975540|FG001|Overall Study|other reason|2|||
42168914|NCT00057876|75975539|FG000|Overall Study|other complicating disease|1|||
42168915|NCT00057876|75975540|FG001|Overall Study|other complicating disease|0|||
42168916|NCT00057837|75975548|FG000|Overall Study|Progression/relapse|12|||
42168917|NCT00057837|75975549|FG001|Overall Study|Progression/relapse|14|||
42168918|NCT00057837|75975548|FG000|Overall Study|Adverse Event|2|||
42168919|NCT00057837|75975549|FG001|Overall Study|Adverse Event|12|||
42168920|NCT00057837|75975548|FG000|Overall Study|Death|5|||
42168921|NCT00057837|75975549|FG001|Overall Study|Death|4|||
42168922|NCT00057837|75975548|FG000|Overall Study|Withdrawal by Subject|5|||
42168923|NCT00057837|75975549|FG001|Overall Study|Withdrawal by Subject|3|||
42168924|NCT00057837|75975548|FG000|Overall Study|Alternative therapy|0|||
42168925|NCT00057837|75975549|FG001|Overall Study|Alternative therapy|1|||
42168926|NCT00057837|75975548|FG000|Overall Study|Other complicating disease|2|||
42168927|NCT00057837|75975549|FG001|Overall Study|Other complicating disease|1|||
42168928|NCT00057837|75975548|FG000|Overall Study|Physician Decision|1|||
42168929|NCT00057837|75975549|FG001|Overall Study|Physician Decision|0|||
42168930|NCT00057837|75975548|FG000|Overall Study|Ineligible|3|||
42168931|NCT00057837|75975549|FG001|Overall Study|Ineligible|3|||
42168932|NCT00057837|75975548|FG000|Overall Study|Never started treatment|1|||
42168933|NCT00057837|75975549|FG001|Overall Study|Never started treatment|1|||
42168934|NCT00046930|75975557|FG000|Overall Study|Ineligible|12|||
42168935|NCT00046930|75975558|FG001|Overall Study|Ineligible|4|||
42168936|NCT00042939|75975569|FG000|Overall Study|Adverse Event|6|||
42282736|NCT00700427|76114369|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
42282737|NCT00700427|76114370|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
42282738|NCT00700427|76114371|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
42282739|NCT00700427|76114372|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
42282740|NCT00700427|76114373|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
42282741|NCT00700427|76114369|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
42014490|NCT01165281|75821623|FG001|Overall Study|Protocol Violation|5|||
42014491|NCT01165281|75821622|FG000|Overall Study|Withdrawal by Subject|8|||
42014492|NCT01165281|75821623|FG001|Overall Study|Withdrawal by Subject|7|||
42014493|NCT01165281|75821622|FG000|Overall Study|Noncompliance with Study Drug|1|||
42014494|NCT01165281|75821623|FG001|Overall Study|Noncompliance with Study Drug|4|||
42168937|NCT00042939|75975570|FG001|Overall Study|Adverse Event|7|||
42168938|NCT00042939|75975569|FG000|Overall Study|Death|3|||
42168939|NCT00042939|75975570|FG001|Overall Study|Death|2|||
42168940|NCT00042939|75975569|FG000|Overall Study|Withdrawal by Subject|3|||
42168941|NCT00042939|75975570|FG001|Overall Study|Withdrawal by Subject|4|||
42168942|NCT00042939|75975569|FG000|Overall Study|Other disease|1|||
42168943|NCT00042939|75975570|FG001|Overall Study|Other disease|0|||
42168944|NCT00042939|75975569|FG000|Overall Study|Ineligible|2|||
42168945|NCT00042939|75975570|FG001|Overall Study|Ineligible|2|||
42168946|NCT00042939|75975569|FG000|Overall Study|Deterioration of health|3|||
42168947|NCT00042939|75975570|FG001|Overall Study|Deterioration of health|4|||
42168948|NCT00042939|75975569|FG000|Overall Study|QOL diminished|1|||
42168949|NCT00042939|75975570|FG001|Overall Study|QOL diminished|0|||
42168950|NCT00042939|75975569|FG000|Overall Study|Rising ca 19-9|1|||
42168951|NCT00042939|75975570|FG001|Overall Study|Rising ca 19-9|0|||
42168952|NCT00042939|75975569|FG000|Overall Study|Patient non-compliance|1|||
42168953|NCT00042939|75975570|FG001|Overall Study|Patient non-compliance|0|||
42168954|NCT00042939|75975569|FG000|Overall Study|Still on treatment|1|||
42168955|NCT00042939|75975570|FG001|Overall Study|Still on treatment|0|||
42168956|NCT00042939|75975569|FG000|Overall Study|Treatment break > 4 weeks|0|||
42168957|NCT00042939|75975570|FG001|Overall Study|Treatment break > 4 weeks|1|||
42168958|NCT00042939|75975569|FG000|Overall Study|Did not start treatment|2|||
42168959|NCT00042939|75975570|FG001|Overall Study|Did not start treatment|1|||
42168960|NCT00008385|75975578|FG000|Overall Study|Off treatment reasons not reported|79|||
42168961|NCT00008385|75975579|FG001|Overall Study|Off treatment reasons not reported|70|||
42168962|NCT00008385|75975578|FG000|Overall Study|Progressive disease|52|||
42168963|NCT00008385|75975579|FG001|Overall Study|Progressive disease|117|||
42168964|NCT00008385|75975578|FG000|Overall Study|Adverse Event|8|||
42168965|NCT00008385|75975579|FG001|Overall Study|Adverse Event|20|||
42168966|NCT00008385|75975578|FG000|Overall Study|Death|12|||
42168967|NCT00008385|75975579|FG001|Overall Study|Death|18|||
42168968|NCT00008385|75975578|FG000|Overall Study|Withdrawal by Subject|67|||
42168969|NCT00008385|75975579|FG001|Overall Study|Withdrawal by Subject|157|||
42168970|NCT00008385|75975578|FG000|Overall Study|Start non-protocol therapy|3|||
42168971|NCT00008385|75975579|FG001|Overall Study|Start non-protocol therapy|1|||
42168972|NCT00008385|75975578|FG000|Overall Study|Other complicating disease|17|||
42168973|NCT00008385|75975579|FG001|Overall Study|Other complicating disease|30|||
42168974|NCT00008385|75975578|FG000|Overall Study|Maximum dose reached|0|||
42168975|NCT00008385|75975579|FG001|Overall Study|Maximum dose reached|2|||
42168976|NCT00008385|75975578|FG000|Overall Study|Other|105|||
42014495|NCT01165281|75821622|FG000|Overall Study|Progressive Disease|10|||
42282742|NCT00700427|76114370|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
42282743|NCT00700427|76114371|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
42168977|NCT00008385|75975579|FG001|Overall Study|Other|212|||
42168978|NCT00008385|75975578|FG000|Overall Study|Not start protocol therapy|44|||
42168979|NCT00008385|75975579|FG001|Overall Study|Not start protocol therapy|175|||
42168980|NCT00003907|75975594|FG000|Overall Study|Adverse Event|2|||
42168981|NCT00003907|75975595|FG001|Overall Study|Adverse Event|11|||
42168982|NCT00003907|75975594|FG000|Overall Study|Death|2|||
42168983|NCT00003907|75975595|FG001|Overall Study|Death|0|||
42168984|NCT00003907|75975594|FG000|Overall Study|Withdrawal by Subject|1|||
42168985|NCT00003907|75975595|FG001|Overall Study|Withdrawal by Subject|3|||
42168986|NCT00003907|75975594|FG000|Overall Study|Progressive disease|4|||
42168987|NCT00003907|75975595|FG001|Overall Study|Progressive disease|4|||
42168988|NCT00003907|75975594|FG000|Overall Study|Complicating disease|1|||
42168989|NCT00003907|75975595|FG001|Overall Study|Complicating disease|0|||
42168990|NCT00003907|75975594|FG000|Overall Study|Other|1|||
42168991|NCT00003907|75975595|FG001|Overall Study|Other|3|||
42168992|NCT00003907|75975594|FG000|Overall Study|ineligible or not treated|2|||
42168993|NCT00003907|75975595|FG001|Overall Study|ineligible or not treated|2|||
42168994|NCT04241315|75975603|FG000|Overall Study|Withdrawal by Subject|0|||
42168995|NCT04241315|75975604|FG001|Overall Study|Withdrawal by Subject|1|||
42168996|NCT04225026|75975610|FG000|Overall Study|Withdrawal by Subject|4|||
42168997|NCT04225026|75975610|FG000|Overall Study|Adverse Event|1|||
42168998|NCT04225026|75975610|FG000|Overall Study|Other|1|||
42168999|NCT04225026|75975610|FG000|Overall Study|Death|11|||
42169000|NCT04225026|75975610|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
42169001|NCT03493958|75976016|FG000|Overall Study|Withdrawal by Subject|6|||
42169002|NCT03493958|75976016|FG000|Overall Study|Lost to Follow-up|7|||
42169003|NCT03493958|75976016|FG000|Overall Study|Did not complete all required study procedures|2|||
42169004|NCT03486223|75976022|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
42169005|NCT03486223|75976023|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
42169006|NCT03482024|75976034|FG000|Overall Study|Physician Decision|1|||
42169007|NCT03482024|75976035|FG001|Overall Study|Physician Decision|0|||
42169008|NCT03482024|75976036|FG002|Overall Study|Physician Decision|0|||
42169009|NCT03482024|75976037|FG003|Overall Study|Physician Decision|0|||
42169010|NCT03482024|75976038|FG004|Overall Study|Physician Decision|0|||
42169011|NCT03468309|75976050|FG000|Overall Study|Lost to Follow-up|4|||
42169012|NCT03468309|75976050|FG000|Overall Study|Withdrawal by Subject|2|||
42169013|NCT03423147|75976056|FG000|Overall Study|Lost to Follow-up|5|||
42169014|NCT03423147|75976057|FG001|Overall Study|Lost to Follow-up|8|||
42169015|NCT03423147|75976056|FG000|Overall Study|Withdrawal by Subject|1|||
42169016|NCT03423147|75976057|FG001|Overall Study|Withdrawal by Subject|0|||
42169017|NCT03423147|75976056|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
42169018|NCT03423147|75976057|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
42169019|NCT03423147|75976056|FG000|Overall Study|Age < 18|1|||
42169020|NCT03423147|75976057|FG001|Overall Study|Age < 18|0|||
42169021|NCT03423147|75976056|FG000|Overall Study|No Trial of Labor|0|||
42169022|NCT03423147|75976057|FG001|Overall Study|No Trial of Labor|1|||
42169023|NCT03322631|75976067|FG000|Overall Study|Withdrawal by Subject|0|||
42169024|NCT03322631|75976068|FG001|Overall Study|Withdrawal by Subject|1|||
42169025|NCT03322631|75976069|FG002|Overall Study|Withdrawal by Subject|0|||
42169026|NCT03322631|75976070|FG003|Overall Study|Withdrawal by Subject|0|||
42169027|NCT03322631|75976067|FG000|Overall Study|Adverse Event|0|||
42169028|NCT03322631|75976068|FG001|Overall Study|Adverse Event|0|||
42169029|NCT03322631|75976069|FG002|Overall Study|Adverse Event|1|||
42169030|NCT03322631|75976070|FG003|Overall Study|Adverse Event|0|||
42169031|NCT03018704|75976089|FG000|Overall Study|Lost to Follow-up|1|||
42169032|NCT03018704|75976090|FG001|Overall Study|Lost to Follow-up|1|||
42169033|NCT02663349|75976096|FG000|Overall Study|Withdrawal by Subject|6|||
42169034|NCT02558491|75976100|FG000|First Invention|Withdrawal by Subject|3|||
42169035|NCT02558491|75976101|FG001|First Invention|Withdrawal by Subject|1|||
42169036|NCT02558491|75976100|FG000|First Invention|Data collection issues|1|||
42169037|NCT02558491|75976101|FG001|First Invention|Data collection issues|0|||
42169038|NCT02558491|75976100|FG000|First Invention|Stopping criteria|0|||
42169039|NCT02558491|75976101|FG001|First Invention|Stopping criteria|1|||
42169040|NCT02558491|75976100|FG000|First Invention|Changed parameters during trial|1|||
42169041|NCT02558491|75976101|FG001|First Invention|Changed parameters during trial|0|||
42169042|NCT02558491|75976100|FG000|Second Intervention|Withdrawal by Subject|1|||
42169043|NCT02558491|75976101|FG001|Second Intervention|Withdrawal by Subject|0|||
42169044|NCT02558491|75976100|FG000|Second Intervention|Stopping Criteria|1|||
42169045|NCT02558491|75976101|FG001|Second Intervention|Stopping Criteria|0|||
42169046|NCT02490878|75976110|FG000|Overall Study|deemed ineligible|0|||
42040660|NCT01796171|75848715|FG009|Follow-up Period|Start of further anticancer therapy|0|||
42040661|NCT01796171|75848716|FG010|Follow-up Period|Start of further anticancer therapy|0|||
42040662|NCT01796171|75848717|FG011|Follow-up Period|Start of further anticancer therapy|0|||
42040663|NCT01796171|75848718|FG012|Follow-up Period|Start of further anticancer therapy|0|||
42040664|NCT01796171|75848719|FG013|Follow-up Period|Start of further anticancer therapy|0|||
42040665|NCT01796171|75848720|FG014|Follow-up Period|Start of further anticancer therapy|0|||
42169047|NCT02490878|75976111|FG001|Overall Study|deemed ineligible|1|||
42169048|NCT02490878|75976110|FG000|Overall Study|progression prior to treatment|0|||
42169049|NCT02490878|75976111|FG001|Overall Study|progression prior to treatment|1|||
42169050|NCT02490878|75976110|FG000|Overall Study|only submitted baseline QOL|0|||
42169051|NCT02490878|75976111|FG001|Overall Study|only submitted baseline QOL|1|||
42169052|NCT02421601|75976117|FG000|Overall Study|Adverse Event|4|||
42169053|NCT02421601|75976117|FG000|Overall Study|Lack of Efficacy|5|||
42169054|NCT02421601|75976117|FG000|Overall Study|Physician Decision|1|||
42169055|NCT02421601|75976117|FG000|Overall Study|Withdrawal by Subject|31|||
42169056|NCT02421601|75976117|FG000|Overall Study|Others|41|||
42169057|NCT01934218|75976123|FG000|Double-blind Phase|Adverse Event|8|||
42169058|NCT01934218|75976124|FG001|Double-blind Phase|Adverse Event|8|||
42169059|NCT01934218|75976123|FG000|Double-blind Phase|Lack of Efficacy|6|||
42169060|NCT01934218|75976124|FG001|Double-blind Phase|Lack of Efficacy|7|||
42169061|NCT01934218|75976123|FG000|Double-blind Phase|Lost to Follow-up|7|||
42169062|NCT01934218|75976124|FG001|Double-blind Phase|Lost to Follow-up|14|||
42169063|NCT01934218|75976123|FG000|Double-blind Phase|Physician Decision|1|||
42169064|NCT01934218|75976124|FG001|Double-blind Phase|Physician Decision|2|||
42169065|NCT01934218|75976123|FG000|Double-blind Phase|Protocol Violation|4|||
42169066|NCT01934218|75976124|FG001|Double-blind Phase|Protocol Violation|0|||
42169067|NCT01934218|75976123|FG000|Double-blind Phase|Withdrawal by Subject|16|||
42169068|NCT01934218|75976124|FG001|Double-blind Phase|Withdrawal by Subject|13|||
42169069|NCT01934218|75976123|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
42169070|NCT01934218|75976124|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
42169071|NCT01934218|75976123|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
42169072|NCT01934218|75976124|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
42169073|NCT01934218|75976123|FG000|Open-Label Phase|Adverse Event|2|||
42169074|NCT01934218|75976124|FG001|Open-Label Phase|Adverse Event|4|||
42169075|NCT01934218|75976123|FG000|Open-Label Phase|Lack of Efficacy|1|||
42169076|NCT01934218|75976124|FG001|Open-Label Phase|Lack of Efficacy|4|||
42169077|NCT01934218|75976123|FG000|Open-Label Phase|Lost to Follow-up|4|||
42282744|NCT00700427|76114372|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
42282745|NCT00700427|76114373|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
42282746|NCT00700427|76114369|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
42282747|NCT00700427|76114370|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
42282748|NCT00700427|76114371|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
42282749|NCT00700427|76114372|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
42282750|NCT00700427|76114373|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
42282751|NCT00700427|76114369|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
42169078|NCT01934218|75976124|FG001|Open-Label Phase|Lost to Follow-up|2|||
42169079|NCT01934218|75976123|FG000|Open-Label Phase|Physician Decision|1|||
42169080|NCT01934218|75976124|FG001|Open-Label Phase|Physician Decision|0|||
42169081|NCT01934218|75976123|FG000|Open-Label Phase|Protocol Violation|1|||
42169082|NCT01934218|75976124|FG001|Open-Label Phase|Protocol Violation|0|||
42169083|NCT01934218|75976123|FG000|Open-Label Phase|Withdrawal by Subject|13|||
42169084|NCT01934218|75976124|FG001|Open-Label Phase|Withdrawal by Subject|11|||
42169085|NCT01934218|75976123|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
42169086|NCT01934218|75976124|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
42169087|NCT01934218|75976123|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
42169088|NCT01934218|75976124|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
42169089|NCT01702805|75976132|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
42169090|NCT01702805|75976133|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
42169091|NCT01702805|75976132|FG000|Overall Study|Incomplete Follow-up|18|||
42169092|NCT01702805|75976133|FG001|Overall Study|Incomplete Follow-up|15|||
42169093|NCT01702805|75976132|FG000|Overall Study|Vital Status Assessment Only|40|||
42169094|NCT01702805|75976133|FG001|Overall Study|Vital Status Assessment Only|39|||
42169095|NCT01702805|75976132|FG000|Overall Study|Lost to Follow-up|5|||
42169096|NCT01702805|75976133|FG001|Overall Study|Lost to Follow-up|5|||
42169097|NCT00097370|75976143|FG000|Stage 1|Adverse Event|3|||
42169098|NCT00097370|75976143|FG000|Stage 1|Withdrawal by Subject|1|||
42169099|NCT00097370|75976143|FG000|Stage 1|Lack of Efficacy|2|||
42169100|NCT00097370|75976143|FG000|Stage 2|Adverse Event|5|||
42169101|NCT00097370|75976143|FG000|Stage 2|Withdrawal by Subject|1|||
42169102|NCT00097370|75976143|FG000|Stage 2|Lack of Efficacy|3|||
42169103|NCT00097370|75976143|FG000|Stage 2|Pregnancy|1|||
42169104|NCT00097370|75976143|FG000|Stage 2|Sponsor Terminated Study|2|||
42169105|NCT00097370|75976143|FG000|Stage 2|Lost to Follow-up|1|||
42169106|NCT00097370|75976143|FG000|Stage 3|Adverse Event|2|||
42169107|NCT00097370|75976143|FG000|Stage 3|Withdrawal by Subject|3|||
42169108|NCT00097370|75976143|FG000|Stage 3|Lack of Efficacy|1|||
42169109|NCT00097370|75976143|FG000|Stage 3|Sponsor Terminated Study|52|||
42169110|NCT00097370|75976143|FG000|Stage 3|Lost to Follow-up|1|||
42169111|NCT03515824|75976150|FG000|Overall Study|Death|3|||
42169112|NCT03515824|75976151|FG001|Overall Study|Death|2|||
42169113|NCT03515824|75976152|FG002|Overall Study|Death|6|||
42169114|NCT03515824|75976153|FG003|Overall Study|Death|0|||
42169115|NCT03515824|75976150|FG000|Overall Study|Lost to Follow-up|0|||
42169116|NCT03515824|75976151|FG001|Overall Study|Lost to Follow-up|1|||
42014496|NCT01165281|75821623|FG001|Overall Study|Progressive Disease|14|||
42014497|NCT01165281|75821622|FG000|Overall Study|Other|6|||
42169117|NCT03515824|75976152|FG002|Overall Study|Lost to Follow-up|1|||
42169118|NCT03515824|75976153|FG003|Overall Study|Lost to Follow-up|0|||
42169119|NCT03515824|75976150|FG000|Overall Study|Study terminated by sponsor|0|||
42169120|NCT03515824|75976151|FG001|Overall Study|Study terminated by sponsor|1|||
42169121|NCT03515824|75976152|FG002|Overall Study|Study terminated by sponsor|6|||
42169122|NCT03515824|75976153|FG003|Overall Study|Study terminated by sponsor|0|||
42169123|NCT03515824|75976150|FG000|Overall Study|Status not recorded|0|||
42169124|NCT03515824|75976151|FG001|Overall Study|Status not recorded|0|||
42169125|NCT03515824|75976152|FG002|Overall Study|Status not recorded|2|||
42169126|NCT03515824|75976153|FG003|Overall Study|Status not recorded|0|||
42169127|NCT01089374|75976163|FG000|Overall Study|Lost to Follow-up|3|||
42040666|NCT01796171|75848706|FG000|Follow-up Period|Progressive disease|0|||
42040667|NCT01796171|75848707|FG001|Follow-up Period|Progressive disease|1|||
42040668|NCT01796171|75848708|FG002|Follow-up Period|Progressive disease|0|||
42040669|NCT01796171|75848709|FG003|Follow-up Period|Progressive disease|0|||
42040670|NCT01796171|75848710|FG004|Follow-up Period|Progressive disease|0|||
42169128|NCT01089374|75976164|FG001|Overall Study|Lost to Follow-up|0|||
42169129|NCT01089374|75976163|FG000|Overall Study|Withdrawal by Subject|1|||
42169130|NCT01089374|75976164|FG001|Overall Study|Withdrawal by Subject|0|||
42169131|NCT01089374|75976163|FG000|Overall Study|Study closed early - low accrual|6|||
42169132|NCT01089374|75976164|FG001|Overall Study|Study closed early - low accrual|0|||
42169133|NCT03511378|75976171|FG000|Overall Study|Withdrawal by Subject|2|||
42169134|NCT03511378|75976172|FG001|Overall Study|Withdrawal by Subject|2|||
42169135|NCT03511378|75976171|FG000|Overall Study|Patient not coming or schedule visit|1|||
42169136|NCT03511378|75976172|FG001|Overall Study|Patient not coming or schedule visit|0|||
42169137|NCT03511066|75976181|FG000|Overall Study|Withdrawal by Subject|1|||
42169138|NCT03511066|75976182|FG001|Overall Study|Withdrawal by Subject|2|||
42169139|NCT03511066|75976183|FG002|Overall Study|Withdrawal by Subject|3|||
42169140|NCT03511066|75976181|FG000|Overall Study|Lost to Follow-up|2|||
42169141|NCT03511066|75976182|FG001|Overall Study|Lost to Follow-up|3|||
42169142|NCT03511066|75976183|FG002|Overall Study|Lost to Follow-up|0|||
42169143|NCT03510910|75976193|FG000|Overall Study|Incomplete Survey|2|||
42169144|NCT03510910|75976194|FG001|Overall Study|Incomplete Survey|3|||
42169145|NCT03509350|75976202|FG000|Overall Study|Withdrawal by Subject|0|||
42169146|NCT03509350|75976203|FG001|Overall Study|Withdrawal by Subject|2|||
42169147|NCT03478696|75976211|FG000|Overall Study|Adverse Event|1|||
42169148|NCT03478696|75976212|FG001|Overall Study|Adverse Event|5|||
42169149|NCT03478696|75976211|FG000|Overall Study|Lost to Follow-up|1|||
42169150|NCT03478696|75976212|FG001|Overall Study|Lost to Follow-up|0|||
42040671|NCT01796171|75848711|FG005|Follow-up Period|Progressive disease|0|||
42040672|NCT01796171|75848712|FG006|Follow-up Period|Progressive disease|0|||
42040673|NCT01796171|75848713|FG007|Follow-up Period|Progressive disease|3|||
42040674|NCT01796171|75848714|FG008|Follow-up Period|Progressive disease|0|||
42040675|NCT01796171|75848715|FG009|Follow-up Period|Progressive disease|0|||
42040676|NCT01796171|75848716|FG010|Follow-up Period|Progressive disease|0|||
42040677|NCT01796171|75848717|FG011|Follow-up Period|Progressive disease|0|||
42040678|NCT01796171|75848718|FG012|Follow-up Period|Progressive disease|0|||
42169151|NCT03478696|75976211|FG000|Overall Study|Physician Decision|6|||
42169152|NCT03478696|75976212|FG001|Overall Study|Physician Decision|3|||
42169153|NCT03478696|75976211|FG000|Overall Study|Withdrawal by Subject|9|||
42169154|NCT03478696|75976212|FG001|Overall Study|Withdrawal by Subject|4|||
42169155|NCT03477838|75976218|FG000|Overall Study|Lost to Follow-up|14|||
42169156|NCT00072176|75976224|FG000|Overall Study|Withdrawal by Subject|1|||
42169157|NCT00072176|75976225|FG001|Overall Study|Withdrawal by Subject|0|||
42169158|NCT00072176|75976224|FG000|Overall Study|Protocol Violation|0|||
42169159|NCT00072176|75976225|FG001|Overall Study|Protocol Violation|1|||
42169160|NCT00071396|75976231|FG000|Overall Study|Withdrawal by Subject|1|||
42169161|NCT00071396|75976231|FG000|Overall Study|Physician Decision|2|||
42169162|NCT03473236|75976245|FG000|Overall Study|Withdrawal by Subject|0|||
42169163|NCT03473236|75976246|FG001|Overall Study|Withdrawal by Subject|0|||
42169164|NCT03473236|75976247|FG002|Overall Study|Withdrawal by Subject|0|||
42169165|NCT03473236|75976248|FG003|Overall Study|Withdrawal by Subject|0|||
42169166|NCT03473236|75976249|FG004|Overall Study|Withdrawal by Subject|0|||
42169167|NCT03473236|75976250|FG005|Overall Study|Withdrawal by Subject|1|||
42169168|NCT03473236|75976251|FG006|Overall Study|Withdrawal by Subject|0|||
42169169|NCT03473236|75976252|FG007|Overall Study|Withdrawal by Subject|0|||
42169170|NCT03473236|75976253|FG008|Overall Study|Withdrawal by Subject|1|||
42014498|NCT01165281|75821623|FG001|Overall Study|Other|0|||
42014499|NCT01165203|75821631|FG000|Active Phase|Serious Adverse Event|1|||
42014500|NCT01165203|75821632|FG001|Active Phase|Serious Adverse Event|0|||
42014501|NCT01165203|75821631|FG000|Active Phase|Withdrawal by Subject|2|||
42014502|NCT01165203|75821632|FG001|Active Phase|Withdrawal by Subject|1|||
42014503|NCT01165203|75821631|FG000|Active Phase|Migrated/moved from study area|0|||
42014504|NCT01165203|75821632|FG001|Active Phase|Migrated/moved from study area|1|||
42014505|NCT01165203|75821631|FG000|Active Phase|Lost to Follow-up|2|||
42014506|NCT01165203|75821632|FG001|Active Phase|Lost to Follow-up|0|||
42014507|NCT01165203|75821631|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
42040679|NCT01796171|75848719|FG013|Follow-up Period|Progressive disease|0|||
42169171|NCT03473236|75976254|FG009|Overall Study|Withdrawal by Subject|0|||
42169172|NCT03550378|75976286|FG000|Overall Study|Death|0|||
42169173|NCT03550378|75976287|FG001|Overall Study|Death|1|||
42169174|NCT03472534|75976294|FG000|Overall Study|Withdrawal by Subject|9|||
42169175|NCT03472534|75976294|FG000|Overall Study|Adverse Event|2|||
42014508|NCT01165203|75821632|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
42169176|NCT03549130|75976300|FG000|Overall Study|Adverse Event|0|||
42169177|NCT03549130|75976301|FG001|Overall Study|Adverse Event|1|||
42169178|NCT03549130|75976300|FG000|Overall Study|Lost to Follow-up|0|||
42169179|NCT03549130|75976301|FG001|Overall Study|Lost to Follow-up|1|||
42169180|NCT03470194|75976311|FG000|Overall Study|Lost to Follow-up|11|||
42169181|NCT03470194|75976312|FG001|Overall Study|Lost to Follow-up|17|||
42169182|NCT03469336|75976318|FG000|Overall Study|Adverse Event|1|||
42169183|NCT03469258|75976328|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
42169184|NCT03503188|75976334|FG000|Overall Study|Non eligible in the sub study|0|||
42169185|NCT03503188|75976335|FG001|Overall Study|Non eligible in the sub study|1|||
42169186|NCT03502798|75976343|FG000|Overall Study|equipment failure|0|||
42169187|NCT03502798|75976344|FG001|Overall Study|equipment failure|7|||
42169188|NCT00066170|75976354|FG000|Overall Study|Adverse Event|2|||
42169189|NCT00066170|75976355|FG001|Overall Study|Adverse Event|4|||
42169190|NCT00066170|75976356|FG002|Overall Study|Adverse Event|1|||
42169191|NCT00066170|75976357|FG003|Overall Study|Adverse Event|7|||
42169192|NCT00066170|75976354|FG000|Overall Study|Serious Adverse Event|0|||
42169193|NCT00066170|75976355|FG001|Overall Study|Serious Adverse Event|0|||
42169194|NCT00066170|75976356|FG002|Overall Study|Serious Adverse Event|1|||
42169195|NCT00066170|75976357|FG003|Overall Study|Serious Adverse Event|1|||
42169196|NCT00066170|75976354|FG000|Overall Study|Lost to Follow-up|0|||
42169197|NCT00066170|75976355|FG001|Overall Study|Lost to Follow-up|1|||
42169198|NCT00066170|75976356|FG002|Overall Study|Lost to Follow-up|0|||
42169199|NCT00066170|75976357|FG003|Overall Study|Lost to Follow-up|0|||
42169200|NCT00066170|75976354|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
42169201|NCT00066170|75976355|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
42169202|NCT00066170|75976356|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
42169203|NCT00066170|75976357|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
42169204|NCT00066170|75976354|FG000|Overall Study|Protocol Violation|3|||
42169205|NCT00066170|75976355|FG001|Overall Study|Protocol Violation|0|||
42169206|NCT00066170|75976356|FG002|Overall Study|Protocol Violation|0|||
42169207|NCT00066170|75976357|FG003|Overall Study|Protocol Violation|0|||
42169208|NCT00066170|75976354|FG000|Overall Study|Other|1|||
42169209|NCT00066170|75976355|FG001|Overall Study|Other|5|||
42169210|NCT00066170|75976356|FG002|Overall Study|Other|2|||
42169211|NCT00066170|75976357|FG003|Overall Study|Other|0|||
42169212|NCT00065468|75976370|FG000|Overall Study|Death|172|||
42169213|NCT00065468|75976371|FG001|Overall Study|Death|169|||
42169214|NCT00065468|75976372|FG002|Overall Study|Death|171|||
42169215|NCT00065468|75976370|FG000|Overall Study|Withdrawal by Subject|3|||
42169216|NCT00065468|75976371|FG001|Overall Study|Withdrawal by Subject|4|||
42282752|NCT00700427|76114370|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
42169217|NCT00065468|75976372|FG002|Overall Study|Withdrawal by Subject|5|||
42169218|NCT00065468|75976370|FG000|Overall Study|Lost to Follow-up|5|||
42169219|NCT00065468|75976371|FG001|Overall Study|Lost to Follow-up|3|||
42169220|NCT00065468|75976372|FG002|Overall Study|Lost to Follow-up|2|||
42169221|NCT00065468|75976370|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
42169222|NCT00065468|75976371|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
42014509|NCT01165203|75821631|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
42014510|NCT01165203|75821632|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
42014511|NCT01165203|75821631|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
42014512|NCT01165203|75821632|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
42014513|NCT01165203|75821631|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
42014514|NCT01165203|75821632|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
42014515|NCT01165203|75821631|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
42014516|NCT01165203|75821632|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
42014517|NCT00960661|75821647|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
42014518|NCT00960661|75821648|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
42014519|NCT00960661|75821649|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
42014520|NCT00960661|75821647|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
42014521|NCT00960661|75821648|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
42014522|NCT00960661|75821649|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
42014523|NCT00960661|75821647|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
42014524|NCT00960661|75821648|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
42169223|NCT00065468|75976372|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
42169224|NCT00065468|75976370|FG000|Overall Study|Disease progression|0|||
42169225|NCT00065468|75976371|FG001|Overall Study|Disease progression|0|||
42169226|NCT00065468|75976372|FG002|Overall Study|Disease progression|1|||
42169227|NCT00065468|75976370|FG000|Overall Study|Other|14|||
42169228|NCT00065468|75976371|FG001|Overall Study|Other|24|||
42169229|NCT00065468|75976372|FG002|Overall Study|Other|18|||
42169230|NCT00071006|75976380|FG000|Overall Study|Lack of Efficacy|7|||
42169231|NCT00071006|75976380|FG000|Overall Study|Adverse Event|1|||
42169232|NCT00071006|75976380|FG000|Overall Study|Withdrawal by Subject|1|||
42169233|NCT00071006|75976380|FG000|Overall Study|Other|3|||
42169234|NCT00094575|75976386|FG000|Overall Study|Death|146|||
42169235|NCT00094575|75976387|FG001|Overall Study|Death|146|||
42169236|NCT00057746|75976398|FG000|Overall Study|Withdrawal by Subject|0|||
42169237|NCT00057746|75976399|FG001|Overall Study|Withdrawal by Subject|0|||
42169238|NCT00057746|75976400|FG002|Overall Study|Withdrawal by Subject|1|||
42169239|NCT00094107|75976408|FG000|Overall Study|Lack of Efficacy|23|||
42169240|NCT00094107|75976408|FG000|Overall Study|Death|5|||
42169241|NCT00094107|75976408|FG000|Overall Study|Adverse Event|3|||
42169242|NCT00094107|75976408|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
42169243|NCT00102063|75976415|FG000|Overall Study|Lack of Efficacy|5|||
42169244|NCT00102063|75976416|FG001|Overall Study|Lack of Efficacy|1|||
42169245|NCT00102063|75976417|FG002|Overall Study|Lack of Efficacy|1|||
42169246|NCT00102063|75976415|FG000|Overall Study|Adverse Event|7|||
42169247|NCT00102063|75976416|FG001|Overall Study|Adverse Event|4|||
42169248|NCT00102063|75976417|FG002|Overall Study|Adverse Event|2|||
42169249|NCT00102063|75976415|FG000|Overall Study|Withdrawal by Subject|4|||
42169250|NCT00102063|75976416|FG001|Overall Study|Withdrawal by Subject|12|||
42169251|NCT00102063|75976417|FG002|Overall Study|Withdrawal by Subject|5|||
42169252|NCT00102063|75976415|FG000|Overall Study|Lost to Follow-up|0|||
42169253|NCT00102063|75976416|FG001|Overall Study|Lost to Follow-up|0|||
42169254|NCT00102063|75976417|FG002|Overall Study|Lost to Follow-up|1|||
42169255|NCT00102063|75976415|FG000|Overall Study|Protocol Violation|0|||
42169256|NCT00102063|75976416|FG001|Overall Study|Protocol Violation|1|||
42169257|NCT00102063|75976417|FG002|Overall Study|Protocol Violation|1|||
42169258|NCT00065156|75976425|FG000|Overall Study|Adverse Event|37|||
42169259|NCT00065156|75976425|FG000|Overall Study|Lack of Efficacy|52|||
42169260|NCT00065156|75976425|FG000|Overall Study|Withdrawal by Subject|8|||
42169261|NCT00065156|75976425|FG000|Overall Study|Lost to Follow-up|1|||
42169262|NCT00065156|75976425|FG000|Overall Study|Death|11|||
42169263|NCT00065156|75976425|FG000|Overall Study|Study Closed by Sponsor|2|||
42169264|NCT00065156|75976425|FG000|Overall Study|Disease Progression|7|||
42169265|NCT00065156|75976425|FG000|Overall Study|Investigator Decision|2|||
42169266|NCT00065156|75976425|FG000|Overall Study|Non-Compliance|2|||
42040680|NCT01796171|75848720|FG014|Follow-up Period|Progressive disease|0|||
42040681|NCT01796171|75848706|FG000|Follow-up Period|Physician Decision|0|||
42040682|NCT01796171|75848707|FG001|Follow-up Period|Physician Decision|2|||
42282753|NCT00700427|76114371|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
42282754|NCT00700427|76114372|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
42282755|NCT00700427|76114373|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
42282756|NCT00700427|76114369|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
42282757|NCT00700427|76114370|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
42282758|NCT00700427|76114371|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
42282759|NCT00700427|76114372|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
42282760|NCT00700427|76114373|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
42282761|NCT00700427|76114369|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
42282762|NCT00700427|76114370|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
42282763|NCT00700427|76114371|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
42282764|NCT00700427|76114372|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
42282765|NCT00700427|76114373|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
42169267|NCT00065156|75976425|FG000|Overall Study|Loss of Response|1|||
42169268|NCT00065156|75976425|FG000|Overall Study|Secondary Malign Disease|1|||
42169269|NCT00064298|75976431|FG000|Overall Study|Withdrawal by Subject|2|||
42169270|NCT00064298|75976432|FG001|Overall Study|Withdrawal by Subject|1|||
42169271|NCT00064298|75976431|FG000|Overall Study|Lost to Follow-up|2|||
42169272|NCT00064298|75976432|FG001|Overall Study|Lost to Follow-up|2|||
42169273|NCT00064298|75976431|FG000|Overall Study|Death|0|||
42169274|NCT00064298|75976432|FG001|Overall Study|Death|1|||
42169275|NCT00064298|75976431|FG000|Overall Study|Disease Progression|2|||
42169276|NCT00064298|75976432|FG001|Overall Study|Disease Progression|1|||
42169277|NCT00078819|75976440|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
42169278|NCT00078819|75976441|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
42169279|NCT00078819|75976442|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
42282766|NCT00700427|76114369|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
42282767|NCT00700427|76114370|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
42282768|NCT00700427|76114371|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
42282769|NCT00700427|76114372|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
42169280|NCT00078819|75976443|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
42169281|NCT00078819|75976440|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
42169282|NCT00078819|75976441|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
42169283|NCT00078819|75976442|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
42169284|NCT00078819|75976443|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
42169285|NCT00078819|75976440|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
42169286|NCT00078819|75976441|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
42169287|NCT00078819|75976442|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
42169288|NCT00078819|75976443|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
42169289|NCT00078819|75976440|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
42169290|NCT00078819|75976441|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
42169291|NCT00078819|75976442|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
42169292|NCT00078819|75976443|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
42169293|NCT00078819|75976440|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
42169294|NCT00078819|75976441|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
42169295|NCT00078819|75976442|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
42169296|NCT00078819|75976443|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
42169297|NCT00078819|75976440|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
42169298|NCT00078819|75976441|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
42169299|NCT00078819|75976442|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
42169300|NCT00078819|75976443|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
42169301|NCT00078819|75976440|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
42169302|NCT00078819|75976441|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
42169303|NCT00078819|75976442|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
42169304|NCT00078819|75976443|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
42169305|NCT00078819|75976440|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
42169306|NCT00078819|75976441|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
42169307|NCT00078819|75976442|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
42169308|NCT00078819|75976443|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
42169309|NCT00098865|75976460|FG000|Overall Study|Progressive Disease|6|||
42169310|NCT00098865|75976460|FG000|Overall Study|Adverse Event|2|||
42169311|NCT00098865|75976460|FG000|Overall Study|Alternative Therapy|1|||
42169312|NCT02954458|75976468|FG000|Overall Study|Adverse Event|0|||
42169313|NCT02954458|75976469|FG001|Overall Study|Adverse Event|0|||
42169314|NCT02954458|75976470|FG002|Overall Study|Adverse Event|0|||
42169315|NCT02954458|75976471|FG003|Overall Study|Adverse Event|1|||
42169316|NCT02954458|75976468|FG000|Overall Study|Withdrawal by Subject|0|||
42169317|NCT02954458|75976469|FG001|Overall Study|Withdrawal by Subject|0|||
42169318|NCT02954458|75976470|FG002|Overall Study|Withdrawal by Subject|0|||
42169319|NCT02954458|75976471|FG003|Overall Study|Withdrawal by Subject|1|||
42169320|NCT02954458|75976468|FG000|Overall Study|Physician Decision|0|||
42169321|NCT02954458|75976469|FG001|Overall Study|Physician Decision|0|||
42169322|NCT02954458|75976470|FG002|Overall Study|Physician Decision|1|||
42169323|NCT02954458|75976471|FG003|Overall Study|Physician Decision|1|||
42169324|NCT02954458|75976468|FG000|Overall Study|Lost to Follow-up|1|||
42169325|NCT02954458|75976469|FG001|Overall Study|Lost to Follow-up|0|||
42169326|NCT02954458|75976470|FG002|Overall Study|Lost to Follow-up|0|||
42169327|NCT02954458|75976471|FG003|Overall Study|Lost to Follow-up|1|||
42169328|NCT02954458|75976468|FG000|Overall Study|Death|0|||
42169329|NCT02954458|75976469|FG001|Overall Study|Death|0|||
42169330|NCT02954458|75976470|FG002|Overall Study|Death|0|||
42169331|NCT02954458|75976471|FG003|Overall Study|Death|1|||
42169332|NCT02954458|75976468|FG000|Overall Study|Other|0|||
42169333|NCT02954458|75976469|FG001|Overall Study|Other|0|||
42169334|NCT02954458|75976470|FG002|Overall Study|Other|0|||
42169335|NCT02954458|75976471|FG003|Overall Study|Other|7|||
42282770|NCT00700427|76114373|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
42282771|NCT00700427|76114369|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
42282772|NCT00700427|76114370|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
42282773|NCT00700427|76114371|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
42282774|NCT00700427|76114372|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
42282775|NCT00700427|76114373|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
42352041|NCT01925209|76192032|FG000|Treatment Epoch|Withdrawal by Subject|4|||
42169336|NCT03500224|75976485|FG000|Overall Study|Withdrawal by Subject|2|||
42169337|NCT00077649|75976493|FG000|Overall Study|Adverse Event|5|||
42169338|NCT00077649|75976494|FG001|Overall Study|Adverse Event|1|||
42169339|NCT00077649|75976495|FG002|Overall Study|Adverse Event|7|||
42282776|NCT00700427|76114369|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
42282777|NCT00700427|76114370|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
42169340|NCT00077649|75976496|FG003|Overall Study|Adverse Event|9|||
42169341|NCT00077649|75976493|FG000|Overall Study|Lack of Efficacy|5|||
42169342|NCT00077649|75976494|FG001|Overall Study|Lack of Efficacy|3|||
42169343|NCT00077649|75976495|FG002|Overall Study|Lack of Efficacy|3|||
42169344|NCT00077649|75976496|FG003|Overall Study|Lack of Efficacy|2|||
42169345|NCT00077649|75976493|FG000|Overall Study|Withdrawal by Subject|0|||
42169346|NCT00077649|75976494|FG001|Overall Study|Withdrawal by Subject|1|||
42169347|NCT00077649|75976495|FG002|Overall Study|Withdrawal by Subject|1|||
42169348|NCT00077649|75976496|FG003|Overall Study|Withdrawal by Subject|2|||
42169349|NCT00077649|75976493|FG000|Overall Study|Lost to Follow-up|2|||
42169350|NCT00077649|75976494|FG001|Overall Study|Lost to Follow-up|2|||
42169351|NCT00077649|75976495|FG002|Overall Study|Lost to Follow-up|3|||
42169352|NCT00077649|75976496|FG003|Overall Study|Lost to Follow-up|2|||
42169353|NCT00077649|75976493|FG000|Overall Study|Abnormality of Laboratory Test|1|||
42169354|NCT00077649|75976494|FG001|Overall Study|Abnormality of Laboratory Test|2|||
42169355|NCT00077649|75976495|FG002|Overall Study|Abnormality of Laboratory Test|1|||
42169356|NCT00077649|75976496|FG003|Overall Study|Abnormality of Laboratory Test|2|||
42169357|NCT00077649|75976493|FG000|Overall Study|Randomized but never dosed|1|||
42169358|NCT00077649|75976494|FG001|Overall Study|Randomized but never dosed|0|||
42169359|NCT00077649|75976495|FG002|Overall Study|Randomized but never dosed|0|||
42169360|NCT00077649|75976496|FG003|Overall Study|Randomized but never dosed|0|||
42169361|NCT00038948|75976512|FG000|Overall Study|Adverse Event|131|||
42169362|NCT00038948|75976513|FG001|Overall Study|Adverse Event|43|||
42169363|NCT00038948|75976512|FG000|Overall Study|Lost to Follow-up|4|||
42169364|NCT00038948|75976513|FG001|Overall Study|Lost to Follow-up|4|||
42169365|NCT00038948|75976512|FG000|Overall Study|Nonmedical event|5|||
42169366|NCT00038948|75976513|FG001|Overall Study|Nonmedical event|7|||
42169367|NCT00038948|75976512|FG000|Overall Study|Withdrawal by Subject|23|||
42169368|NCT00038948|75976513|FG001|Overall Study|Withdrawal by Subject|10|||
42169369|NCT00038948|75976512|FG000|Overall Study|Protocol Violation|3|||
42169370|NCT00038948|75976513|FG001|Overall Study|Protocol Violation|7|||
42169371|NCT00038948|75976512|FG000|Overall Study|Lack of Efficacy|3|||
42169372|NCT00038948|75976513|FG001|Overall Study|Lack of Efficacy|6|||
42169373|NCT00054704|75976527|FG000|Overall Study|Lack of Efficacy|2|||
42169374|NCT00054704|75976528|FG001|Overall Study|Lack of Efficacy|3|||
42169375|NCT00054704|75976527|FG000|Overall Study|Adverse Event|3|||
42169376|NCT00054704|75976528|FG001|Overall Study|Adverse Event|1|||
42169377|NCT00054704|75976527|FG000|Overall Study|Lost to Follow-up|0|||
42169378|NCT00054704|75976528|FG001|Overall Study|Lost to Follow-up|1|||
42169379|NCT00031694|75976534|FG000|Overall Study|Adverse Event|12|||
42169380|NCT00031694|75976534|FG000|Overall Study|Death|2|||
42169381|NCT00031694|75976534|FG000|Overall Study|Withdrawal by Subject|5|||
42169382|NCT00093795|75976542|FG000|Overall Study|No follow up data|20|||
42169383|NCT00093795|75976543|FG001|Overall Study|No follow up data|16|||
42169384|NCT00093795|75976544|FG002|Overall Study|No follow up data|17|||
42169385|NCT03467152|75976554|FG000|Overall Study|Adverse Event|4|||
42169386|NCT03467152|75976555|FG001|Overall Study|Adverse Event|5|||
42169387|NCT03467152|75976556|FG002|Overall Study|Adverse Event|0|||
42169388|NCT03467152|75976554|FG000|Overall Study|Subject Choice|1|||
42169389|NCT03467152|75976555|FG001|Overall Study|Subject Choice|3|||
42169390|NCT03467152|75976556|FG002|Overall Study|Subject Choice|0|||
42169391|NCT03467152|75976554|FG000|Overall Study|Lost to Follow-up|1|||
42169392|NCT03467152|75976555|FG001|Overall Study|Lost to Follow-up|0|||
42169393|NCT03467152|75976556|FG002|Overall Study|Lost to Follow-up|0|||
42169394|NCT03467152|75976554|FG000|Overall Study|Withdrawal by Subject|4|||
42169395|NCT03467152|75976555|FG001|Overall Study|Withdrawal by Subject|2|||
42169396|NCT03467152|75976556|FG002|Overall Study|Withdrawal by Subject|0|||
42169397|NCT03467152|75976554|FG000|Overall Study|Others|3|||
42014525|NCT00960661|75821649|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
42014526|NCT00960661|75821647|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
42169398|NCT03467152|75976555|FG001|Overall Study|Others|0|||
42169399|NCT03467152|75976556|FG002|Overall Study|Others|0|||
42169400|NCT03467152|75976554|FG000|Overall Study|Not treated|3|||
42169401|NCT03467152|75976555|FG001|Overall Study|Not treated|1|||
42169402|NCT03467152|75976556|FG002|Overall Study|Not treated|6|||
42169403|NCT03466060|75976565|FG000|Period 1|Test Lens Damage|0|||
42014527|NCT00960661|75821648|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
42169404|NCT03466060|75976566|FG001|Period 1|Test Lens Damage|2|||
42169405|NCT03466060|75976567|FG002|Period 1|Test Lens Damage|0|||
42169406|NCT03466060|75976568|FG003|Period 1|Test Lens Damage|0|||
42169407|NCT03466060|75976569|FG004|Period 1|Test Lens Damage|0|||
42169408|NCT03466060|75976570|FG005|Period 1|Test Lens Damage|0|||
42169409|NCT03466060|75976565|FG000|Period 1|Withdrawal by Subject|0|||
42169410|NCT03466060|75976566|FG001|Period 1|Withdrawal by Subject|0|||
42169411|NCT03466060|75976567|FG002|Period 1|Withdrawal by Subject|2|||
42169412|NCT03466060|75976568|FG003|Period 1|Withdrawal by Subject|0|||
42169413|NCT03466060|75976569|FG004|Period 1|Withdrawal by Subject|0|||
42169414|NCT03466060|75976570|FG005|Period 1|Withdrawal by Subject|0|||
42169415|NCT03466060|75976565|FG000|Period 1|Lost to Follow-up|0|||
42169416|NCT03466060|75976566|FG001|Period 1|Lost to Follow-up|0|||
42169417|NCT03466060|75976567|FG002|Period 1|Lost to Follow-up|0|||
42169418|NCT03466060|75976568|FG003|Period 1|Lost to Follow-up|1|||
42169419|NCT03466060|75976569|FG004|Period 1|Lost to Follow-up|0|||
42169420|NCT03466060|75976570|FG005|Period 1|Lost to Follow-up|0|||
42169421|NCT03466060|75976565|FG000|Period 1|Grade 2 Conjunctivitis|0|||
42169422|NCT03466060|75976566|FG001|Period 1|Grade 2 Conjunctivitis|0|||
42169423|NCT03466060|75976567|FG002|Period 1|Grade 2 Conjunctivitis|1|||
42169424|NCT03466060|75976568|FG003|Period 1|Grade 2 Conjunctivitis|0|||
42169425|NCT03466060|75976569|FG004|Period 1|Grade 2 Conjunctivitis|0|||
42282778|NCT00700427|76114371|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
42282779|NCT00700427|76114372|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
42282780|NCT00700427|76114373|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
42282781|NCT00700427|76114369|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
42282782|NCT00700427|76114370|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
42282783|NCT00700427|76114371|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
42282784|NCT00700427|76114372|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
42282785|NCT00700427|76114373|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
42282786|NCT02128763|76114383|FG000|Overall Study|Death|1|||
42282787|NCT02128763|76114384|FG001|Overall Study|Death|0|||
42282788|NCT02128763|76114383|FG000|Overall Study|Lost to Follow-up|19|||
42282789|NCT02128763|76114384|FG001|Overall Study|Lost to Follow-up|16|||
42282790|NCT02124772|76114406|FG000|Overall Study|Lack of Efficacy|2|||
42282791|NCT02124772|76114407|FG001|Overall Study|Lack of Efficacy|0|||
42282792|NCT02124772|76114408|FG002|Overall Study|Lack of Efficacy|0|||
42282793|NCT02124772|76114409|FG003|Overall Study|Lack of Efficacy|1|||
42282794|NCT02124772|76114410|FG004|Overall Study|Lack of Efficacy|2|||
42282795|NCT02124772|76114411|FG005|Overall Study|Lack of Efficacy|3|||
42282796|NCT02124772|76114412|FG006|Overall Study|Lack of Efficacy|0|||
42282797|NCT02124772|76114413|FG007|Overall Study|Lack of Efficacy|2|||
42282798|NCT02124772|76114414|FG008|Overall Study|Lack of Efficacy|0|||
42282799|NCT02124772|76114415|FG009|Overall Study|Lack of Efficacy|1|||
42282800|NCT02124772|76114416|FG010|Overall Study|Lack of Efficacy|0|||
42282801|NCT02124772|76114417|FG011|Overall Study|Lack of Efficacy|0|||
42282802|NCT02124772|76114418|FG012|Overall Study|Lack of Efficacy|1|||
42282803|NCT02124772|76114406|FG000|Overall Study|Adverse Event|1|||
42282804|NCT02124772|76114407|FG001|Overall Study|Adverse Event|4|||
42282805|NCT02124772|76114408|FG002|Overall Study|Adverse Event|1|||
42282806|NCT02124772|76114409|FG003|Overall Study|Adverse Event|5|||
42282807|NCT02124772|76114410|FG004|Overall Study|Adverse Event|2|||
42352042|NCT01925209|76192033|FG001|Treatment Epoch|Withdrawal by Subject|3|||
42352043|NCT01925209|76192034|FG002|Treatment Epoch|Withdrawal by Subject|3|||
42352044|NCT01925209|76192035|FG003|Treatment Epoch|Withdrawal by Subject|2|||
42352045|NCT01925209|76192032|FG000|Treatment Epoch|Adverse Event|3|||
42352046|NCT01925209|76192033|FG001|Treatment Epoch|Adverse Event|5|||
42352047|NCT01925209|76192034|FG002|Treatment Epoch|Adverse Event|3|||
42352048|NCT01925209|76192035|FG003|Treatment Epoch|Adverse Event|1|||
42352049|NCT01925209|76192032|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
42352050|NCT01925209|76192033|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
42352051|NCT01925209|76192034|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
42352052|NCT01925209|76192035|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
42014528|NCT00960661|75821649|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
42169426|NCT03466060|75976570|FG005|Period 1|Grade 2 Conjunctivitis|0|||
42169427|NCT03466060|75976565|FG000|Period 2|Lens Handling Difficulties|0|||
42169428|NCT03466060|75976566|FG001|Period 2|Lens Handling Difficulties|0|||
42169429|NCT03466060|75976567|FG002|Period 2|Lens Handling Difficulties|1|||
42169430|NCT03466060|75976568|FG003|Period 2|Lens Handling Difficulties|0|||
42282808|NCT02124772|76114411|FG005|Overall Study|Adverse Event|1|||
42282809|NCT02124772|76114412|FG006|Overall Study|Adverse Event|1|||
42282810|NCT02124772|76114413|FG007|Overall Study|Adverse Event|5|||
42282811|NCT02124772|76114414|FG008|Overall Study|Adverse Event|0|||
42282812|NCT02124772|76114415|FG009|Overall Study|Adverse Event|3|||
42282813|NCT02124772|76114416|FG010|Overall Study|Adverse Event|1|||
42282814|NCT02124772|76114417|FG011|Overall Study|Adverse Event|3|||
42282815|NCT02124772|76114418|FG012|Overall Study|Adverse Event|1|||
42282816|NCT02124772|76114406|FG000|Overall Study|Withdrawal consent|0|||
42282817|NCT02124772|76114407|FG001|Overall Study|Withdrawal consent|1|||
42282818|NCT02124772|76114408|FG002|Overall Study|Withdrawal consent|1|||
42282819|NCT02124772|76114409|FG003|Overall Study|Withdrawal consent|1|||
42282820|NCT02124772|76114410|FG004|Overall Study|Withdrawal consent|0|||
42282821|NCT02124772|76114411|FG005|Overall Study|Withdrawal consent|1|||
42282822|NCT02124772|76114412|FG006|Overall Study|Withdrawal consent|1|||
42282823|NCT02124772|76114413|FG007|Overall Study|Withdrawal consent|0|||
42352053|NCT01925209|76192032|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
42352054|NCT01925209|76192033|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
42352055|NCT01925209|76192034|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
42352056|NCT01925209|76192035|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
42352057|NCT01925209|76192032|FG000|Follow-up|Adverse Event|1|||
42282824|NCT02124772|76114414|FG008|Overall Study|Withdrawal consent|0|||
42282825|NCT02124772|76114415|FG009|Overall Study|Withdrawal consent|1|||
42282826|NCT02124772|76114416|FG010|Overall Study|Withdrawal consent|0|||
42282827|NCT02124772|76114417|FG011|Overall Study|Withdrawal consent|1|||
42352058|NCT01925209|76192033|FG001|Follow-up|Adverse Event|4|||
42282828|NCT02124772|76114418|FG012|Overall Study|Withdrawal consent|0|||
42282829|NCT02124772|76114406|FG000|Overall Study|Investigator discretion|0|||
42282830|NCT02124772|76114407|FG001|Overall Study|Investigator discretion|2|||
42282831|NCT02124772|76114408|FG002|Overall Study|Investigator discretion|2|||
42282832|NCT02124772|76114409|FG003|Overall Study|Investigator discretion|1|||
42282833|NCT02124772|76114410|FG004|Overall Study|Investigator discretion|1|||
42282834|NCT02124772|76114411|FG005|Overall Study|Investigator discretion|0|||
42282835|NCT02124772|76114412|FG006|Overall Study|Investigator discretion|1|||
42282836|NCT02124772|76114413|FG007|Overall Study|Investigator discretion|0|||
42282837|NCT02124772|76114414|FG008|Overall Study|Investigator discretion|0|||
42282838|NCT02124772|76114415|FG009|Overall Study|Investigator discretion|1|||
42282839|NCT02124772|76114416|FG010|Overall Study|Investigator discretion|0|||
42282840|NCT02124772|76114417|FG011|Overall Study|Investigator discretion|1|||
42282841|NCT02124772|76114418|FG012|Overall Study|Investigator discretion|0|||
42282842|NCT02124772|76114406|FG000|Overall Study|Progressive disease|0|||
42282843|NCT02124772|76114407|FG001|Overall Study|Progressive disease|0|||
42282844|NCT02124772|76114408|FG002|Overall Study|Progressive disease|0|||
42282845|NCT02124772|76114409|FG003|Overall Study|Progressive disease|0|||
42282846|NCT02124772|76114410|FG004|Overall Study|Progressive disease|0|||
42282847|NCT02124772|76114411|FG005|Overall Study|Progressive disease|0|||
42282848|NCT02124772|76114412|FG006|Overall Study|Progressive disease|1|||
42282849|NCT02124772|76114413|FG007|Overall Study|Progressive disease|1|||
42014529|NCT00960661|75821647|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
42014530|NCT00960661|75821648|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
42014531|NCT00960661|75821649|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
42282850|NCT02124772|76114414|FG008|Overall Study|Progressive disease|0|||
42282851|NCT02124772|76114415|FG009|Overall Study|Progressive disease|0|||
42282852|NCT02124772|76114416|FG010|Overall Study|Progressive disease|0|||
42282853|NCT02124772|76114417|FG011|Overall Study|Progressive disease|0|||
42282854|NCT02124772|76114418|FG012|Overall Study|Progressive disease|0|||
42282855|NCT02124772|76114406|FG000|Overall Study|Other|0|||
42282856|NCT02124772|76114407|FG001|Overall Study|Other|7|||
42282857|NCT02124772|76114408|FG002|Overall Study|Other|2|||
42282858|NCT02124772|76114409|FG003|Overall Study|Other|5|||
42282859|NCT02124772|76114410|FG004|Overall Study|Other|4|||
42282860|NCT02124772|76114411|FG005|Overall Study|Other|3|||
42282861|NCT02124772|76114412|FG006|Overall Study|Other|4|||
42282862|NCT02124772|76114413|FG007|Overall Study|Other|1|||
42282863|NCT02124772|76114414|FG008|Overall Study|Other|1|||
42282864|NCT02124772|76114415|FG009|Overall Study|Other|1|||
42282865|NCT02124772|76114416|FG010|Overall Study|Other|1|||
42282866|NCT02124772|76114417|FG011|Overall Study|Other|1|||
42282867|NCT02124772|76114418|FG012|Overall Study|Other|0|||
42282868|NCT02159482|76114470|FG000|Overall Study|Withdrawal by Subject|2|||
42352059|NCT01925209|76192034|FG002|Follow-up|Adverse Event|0|||
42352060|NCT01925209|76192035|FG003|Follow-up|Adverse Event|1|||
42352061|NCT01925209|76192032|FG000|Follow-up|Physician Decision|0|||
42352062|NCT01925209|76192033|FG001|Follow-up|Physician Decision|0|||
42352063|NCT01925209|76192034|FG002|Follow-up|Physician Decision|1|||
42014532|NCT00960661|75821647|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
42282869|NCT02159482|76114470|FG000|Overall Study|Physician Decision|3|||
42282870|NCT02622321|76114478|FG000|Overall Study|Withdrawal by Subject|2|||
42282871|NCT02622321|76114479|FG001|Overall Study|Withdrawal by Subject|0|||
42282872|NCT02622321|76114480|FG002|Overall Study|Withdrawal by Subject|0|||
42282873|NCT02622321|76114481|FG003|Overall Study|Withdrawal by Subject|0|||
42282874|NCT02622321|76114478|FG000|Overall Study|Death|0|||
42282875|NCT02622321|76114479|FG001|Overall Study|Death|0|||
42282876|NCT02622321|76114480|FG002|Overall Study|Death|1|||
42282877|NCT02622321|76114481|FG003|Overall Study|Death|0|||
42282878|NCT02622321|76114478|FG000|Overall Study|Physician Decision|1|||
42282879|NCT02622321|76114479|FG001|Overall Study|Physician Decision|0|||
42282880|NCT02622321|76114480|FG002|Overall Study|Physician Decision|0|||
42282881|NCT02622321|76114481|FG003|Overall Study|Physician Decision|0|||
42282882|NCT02187172|76114507|FG000|Overall Study|Lost to Follow-up|1|||
42282883|NCT02187172|76114508|FG001|Overall Study|Lost to Follow-up|2|||
42282884|NCT02187172|76114507|FG000|Overall Study|Lack of Efficacy|1|||
42282885|NCT02187172|76114508|FG001|Overall Study|Lack of Efficacy|2|||
42282886|NCT02187172|76114507|FG000|Overall Study|Adverse Event|0|||
42282887|NCT02187172|76114508|FG001|Overall Study|Adverse Event|1|||
42282888|NCT02187172|76114507|FG000|Overall Study|Physician Decision|1|||
42282889|NCT02187172|76114508|FG001|Overall Study|Physician Decision|1|||
42282890|NCT02621931|76114519|FG000|Overall Study|Death|0|||
42282891|NCT02621931|76114520|FG001|Overall Study|Death|1|||
42352064|NCT01925209|76192035|FG003|Follow-up|Physician Decision|0|||
42169431|NCT03466060|75976569|FG004|Period 2|Lens Handling Difficulties|0|||
42169432|NCT03466060|75976570|FG005|Period 2|Lens Handling Difficulties|0|||
42169433|NCT00092547|75976586|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
42169434|NCT00092547|75976587|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
42169435|NCT00092547|75976588|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
42169436|NCT00092547|75976586|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
42169437|NCT00092547|75976587|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
42169438|NCT00092547|75976588|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
42169439|NCT00092547|75976586|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
42169440|NCT00092547|75976587|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
42169441|NCT00092547|75976588|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
42169442|NCT00092547|75976586|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
42169443|NCT00092547|75976587|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
42169444|NCT00092547|75976588|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
42169445|NCT00092547|75976586|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
42169446|NCT00092547|75976587|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
42169447|NCT00092547|75976588|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
42169448|NCT00092547|75976586|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
42169449|NCT00092547|75976587|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
42169450|NCT00092547|75976588|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
42169451|NCT00092547|75976586|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
42169452|NCT00092547|75976587|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
42169453|NCT00092547|75976588|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
42169454|NCT00092547|75976586|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
42169455|NCT00092547|75976587|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
42169456|NCT00092547|75976588|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
42169457|NCT00092547|75976586|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
42169458|NCT00092547|75976587|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
42169459|NCT00092547|75976588|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
42169460|NCT00092547|75976586|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
42169461|NCT00092547|75976587|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
42169462|NCT00092547|75976588|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
42169463|NCT00092547|75976586|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
42169464|NCT00092547|75976587|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
42014533|NCT00960661|75821648|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
42014534|NCT00960661|75821649|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
42169465|NCT00092547|75976588|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
42169466|NCT00092547|75976586|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
42169467|NCT00092547|75976587|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
42169468|NCT00092547|75976588|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
42282892|NCT02621931|76114521|FG002|Overall Study|Death|0|||
42282893|NCT02621931|76114519|FG000|Overall Study|Adverse Event|8|||
42282894|NCT02621931|76114520|FG001|Overall Study|Adverse Event|5|||
42282895|NCT02621931|76114521|FG002|Overall Study|Adverse Event|7|||
42282896|NCT02621931|76114519|FG000|Overall Study|Withdrawal by Subject|12|||
42282897|NCT02621931|76114520|FG001|Overall Study|Withdrawal by Subject|10|||
42282898|NCT02621931|76114521|FG002|Overall Study|Withdrawal by Subject|11|||
42282899|NCT02621931|76114519|FG000|Overall Study|Protocol Violation|2|||
42169469|NCT00092547|75976586|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
42169470|NCT00092547|75976587|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
42169471|NCT00092547|75976588|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
42169472|NCT00092547|75976586|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
42169473|NCT00092547|75976587|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
42169474|NCT00092547|75976588|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
42169475|NCT00092547|75976586|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
42282900|NCT02621931|76114520|FG001|Overall Study|Protocol Violation|2|||
42014535|NCT00960661|75821647|FG000|Interventional Phase|Adverse Event|0|||
42014536|NCT00960661|75821648|FG001|Interventional Phase|Adverse Event|17|||
42014537|NCT00960661|75821649|FG002|Interventional Phase|Adverse Event|8|||
42169476|NCT00092547|75976587|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
42282901|NCT02621931|76114521|FG002|Overall Study|Protocol Violation|2|||
42282902|NCT02621931|76114519|FG000|Overall Study|Pregnancy|2|||
42352065|NCT01925209|76192032|FG000|Follow-up|Non-compliance with study treatment|0|||
42169477|NCT00092547|75976588|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
42169478|NCT00092547|75976586|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
42169479|NCT00092547|75976587|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
42169480|NCT00092547|75976588|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
42169481|NCT00092547|75976586|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
42169482|NCT00092547|75976587|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
42169483|NCT00092547|75976588|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
42169484|NCT00092547|75976586|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
42169485|NCT00092547|75976587|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
42169486|NCT00092547|75976588|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
42169487|NCT00092547|75976586|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
42169488|NCT00092547|75976587|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
42169489|NCT00092547|75976588|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
42169490|NCT00092547|75976586|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
42169491|NCT00092547|75976587|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
42169492|NCT00092547|75976588|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
42169493|NCT00092547|75976586|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
42169494|NCT00092547|75976587|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
42169495|NCT00092547|75976588|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
42169496|NCT03802994|75976604|FG000|Overall Study|Lost to Follow-up|0|||
42169497|NCT03802994|75976605|FG001|Overall Study|Lost to Follow-up|2|||
42169498|NCT03802994|75976606|FG002|Overall Study|Lost to Follow-up|3|||
42169499|NCT03802994|75976607|FG003|Overall Study|Lost to Follow-up|2|||
42169500|NCT03802994|75976608|FG004|Overall Study|Lost to Follow-up|2|||
42169501|NCT03465904|75976633|FG000|Overall Study|Withdrawal by Subject|9|||
42169502|NCT03465904|75976634|FG001|Overall Study|Withdrawal by Subject|5|||
42169503|NCT03465904|75976633|FG000|Overall Study|Lost to Follow-up|10|||
42169504|NCT03465904|75976634|FG001|Overall Study|Lost to Follow-up|9|||
42169505|NCT03465904|75976633|FG000|Overall Study|Protocol Violation|8|||
42169506|NCT03465904|75976634|FG001|Overall Study|Protocol Violation|5|||
42169507|NCT03465904|75976633|FG000|Overall Study|Ineligible for mITT analysis|62|||
42282903|NCT02621931|76114520|FG001|Overall Study|Pregnancy|0|||
42282904|NCT02621931|76114521|FG002|Overall Study|Pregnancy|0|||
42282905|NCT02621931|76114519|FG000|Overall Study|Noncompliance to study procedures|0|||
42169508|NCT03465904|75976634|FG001|Overall Study|Ineligible for mITT analysis|47|||
42169509|NCT03802916|75976642|FG000|Overall Study|Adverse Event|0|||
42169510|NCT03802916|75976643|FG001|Overall Study|Adverse Event|1|||
42169511|NCT03802916|75976642|FG000|Overall Study|Withdrawal by Subject|0|||
42169512|NCT03802916|75976643|FG001|Overall Study|Withdrawal by Subject|1|||
42169513|NCT00076011|75976651|FG000|Overall Study|Death|1|||
42169514|NCT00076011|75976651|FG000|Overall Study|Adverse Event|10|||
42169515|NCT00076011|75976651|FG000|Overall Study|Lack of Efficacy|25|||
42169516|NCT00076011|75976651|FG000|Overall Study|Withdrawal by Subject|1|||
42169517|NCT00076011|75976651|FG000|Overall Study|Study terminated by sponsor|3|||
42169518|NCT00076011|75976651|FG000|Overall Study|Other|11|||
42169519|NCT00076011|75976651|FG000|Overall Study|Ongoing|1|||
42169520|NCT03465436|75976659|FG000|Period 1|Protocol Violation|0|||
42169521|NCT03465436|75976660|FG001|Period 1|Protocol Violation|0|||
42169522|NCT03465436|75976661|FG002|Period 1|Protocol Violation|1|||
42169523|NCT03465436|75976662|FG003|Period 1|Protocol Violation|0|||
42169524|NCT03465436|75976659|FG000|Period 2|Protocol Violation|0|||
42282906|NCT02621931|76114520|FG001|Overall Study|Noncompliance to study procedures|1|||
42282907|NCT02621931|76114521|FG002|Overall Study|Noncompliance to study procedures|2|||
42282908|NCT02621931|76114519|FG000|Overall Study|Lost to Follow-up|8|||
42282909|NCT02621931|76114520|FG001|Overall Study|Lost to Follow-up|7|||
42282910|NCT02621931|76114521|FG002|Overall Study|Lost to Follow-up|10|||
42282911|NCT02621931|76114519|FG000|Overall Study|Lack of Efficacy|0|||
42282912|NCT02621931|76114520|FG001|Overall Study|Lack of Efficacy|0|||
42282913|NCT02621931|76114521|FG002|Overall Study|Lack of Efficacy|1|||
42014538|NCT00960661|75821647|FG000|Interventional Phase|Death|0|||
42014539|NCT00960661|75821648|FG001|Interventional Phase|Death|1|||
42014540|NCT00960661|75821649|FG002|Interventional Phase|Death|0|||
42014541|NCT00960661|75821647|FG000|Interventional Phase|Lost to Follow-up|0|||
42169525|NCT03465436|75976660|FG001|Period 2|Protocol Violation|1|||
42169526|NCT03465436|75976661|FG002|Period 2|Protocol Violation|0|||
42169527|NCT03465436|75976662|FG003|Period 2|Protocol Violation|0|||
42169528|NCT03465436|75976659|FG000|Period 3|Protocol Violation|1|||
42169529|NCT03465436|75976660|FG001|Period 3|Protocol Violation|1|||
42169530|NCT03465436|75976661|FG002|Period 3|Protocol Violation|0|||
42014542|NCT00960661|75821648|FG001|Interventional Phase|Lost to Follow-up|0|||
42169531|NCT03465436|75976662|FG003|Period 3|Protocol Violation|0|||
42169532|NCT03465436|75976659|FG000|Period 4|Protocol Violation|0|||
42282914|NCT02621931|76114519|FG000|Overall Study|Other|1|||
42282915|NCT02621931|76114520|FG001|Overall Study|Other|1|||
42282916|NCT02621931|76114521|FG002|Overall Study|Other|3|||
42169533|NCT03465436|75976660|FG001|Period 4|Protocol Violation|0|||
42169534|NCT03465436|75976661|FG002|Period 4|Protocol Violation|1|||
42169535|NCT03465436|75976662|FG003|Period 4|Protocol Violation|0|||
42169536|NCT00053846|75976676|FG000|Overall Study|Changed mind|8|||
42169537|NCT00053846|75976677|FG001|Overall Study|Changed mind|13|||
42169538|NCT00053846|75976676|FG000|Overall Study|Became too ill|8|||
42169539|NCT00053846|75976677|FG001|Overall Study|Became too ill|7|||
42169540|NCT00053846|75976676|FG000|Overall Study|Expired|5|||
42169541|NCT00053846|75976677|FG001|Overall Study|Expired|0|||
42169542|NCT00053846|75976676|FG000|Overall Study|Became ineligible|3|||
42282917|NCT02621073|76114533|FG000|Overall Study|Lost to Follow-up|0|||
42282918|NCT02621073|76114534|FG001|Overall Study|Lost to Follow-up|1|||
42282919|NCT02621073|76114533|FG000|Overall Study|Physician Decision|3|||
42282920|NCT02621073|76114534|FG001|Overall Study|Physician Decision|2|||
42282921|NCT02158936|76114542|FG000|Overall Study|Study closed/ terminated|57|||
42282922|NCT02158936|76114543|FG001|Overall Study|Study closed/ terminated|77|||
42282923|NCT02158936|76114542|FG000|Overall Study|Azacitidine tx discontinued|53|||
42282924|NCT02158936|76114543|FG001|Overall Study|Azacitidine tx discontinued|46|||
42282925|NCT02158936|76114542|FG000|Overall Study|Adverse Event|39|||
42282926|NCT02158936|76114543|FG001|Overall Study|Adverse Event|24|||
42282927|NCT02158936|76114542|FG000|Overall Study|Withdrawal by Subject|15|||
42282928|NCT02158936|76114543|FG001|Overall Study|Withdrawal by Subject|16|||
42282929|NCT02158936|76114542|FG000|Overall Study|Physician Decision|15|||
42282930|NCT02158936|76114543|FG001|Overall Study|Physician Decision|13|||
42282931|NCT02158936|76114542|FG000|Overall Study|Lost to Follow-up|0|||
42282932|NCT02158936|76114543|FG001|Overall Study|Lost to Follow-up|1|||
42282933|NCT02158546|76114553|FG000|Overall Study|Physician Decision|0|||
42282934|NCT02158546|76114554|FG001|Overall Study|Physician Decision|1|||
42282935|NCT02158546|76114555|FG002|Overall Study|Physician Decision|0|||
42282936|NCT02158546|76114556|FG003|Overall Study|Physician Decision|0|||
42282937|NCT02158546|76114553|FG000|Overall Study|Non-compliance|0|||
42282938|NCT02158546|76114554|FG001|Overall Study|Non-compliance|1|||
42282939|NCT02158546|76114555|FG002|Overall Study|Non-compliance|0|||
42282940|NCT02158546|76114556|FG003|Overall Study|Non-compliance|1|||
42282941|NCT02158546|76114553|FG000|Overall Study|Failure to meet eligibility criteria|0|||
42169543|NCT00053846|75976677|FG001|Overall Study|Became ineligible|1|||
42169544|NCT00053846|75976676|FG000|Overall Study|Did not return data|1|||
42169545|NCT00053846|75976677|FG001|Overall Study|Did not return data|2|||
42169546|NCT00053846|75976676|FG000|Overall Study|Quit due to side effects|1|||
42169547|NCT00053846|75976677|FG001|Overall Study|Quit due to side effects|3|||
42169548|NCT00053846|75976676|FG000|Overall Study|Pills too large|0|||
42169549|NCT00053846|75976677|FG001|Overall Study|Pills too large|1|||
42169550|NCT00090987|75976683|FG000|Overall Study|Adverse Event|5|||
42169551|NCT00090987|75976683|FG000|Overall Study|Lack of Efficacy|7|||
42169552|NCT00090987|75976683|FG000|Overall Study|Withdrawal by Subject|3|||
42169553|NCT00090987|75976683|FG000|Overall Study|alternative therapy|1|||
42169554|NCT00090987|75976683|FG000|Overall Study|Non-compliance|4|||
42169555|NCT00090987|75976683|FG000|Overall Study|Incarcerated|1|||
42169556|NCT03464422|75976687|FG000|Overall Study|Lost to Follow-up|2|||
42169557|NCT03464422|75976687|FG000|Overall Study|Withdrawal by Subject|2|||
42169558|NCT03489304|75976693|FG000|Overall Study|Lost to Follow-up|4|||
42169559|NCT03543358|75976697|FG000|Overall Study|Death|1|||
42169560|NCT03543358|75976698|FG001|Overall Study|Death|0|||
42169561|NCT03543358|75976697|FG000|Overall Study|Disease Progression|1|||
42169562|NCT03543358|75976698|FG001|Overall Study|Disease Progression|0|||
42169563|NCT03543358|75976697|FG000|Overall Study|Parent Study Closure|1|||
42169564|NCT03543358|75976698|FG001|Overall Study|Parent Study Closure|0|||
42169565|NCT03485950|75976704|FG000|Overall Study|Adverse Event|1|||
42169566|NCT03485950|75976705|FG001|Overall Study|Adverse Event|0|||
42282942|NCT02158546|76114554|FG001|Overall Study|Failure to meet eligibility criteria|1|||
42282943|NCT02158546|76114555|FG002|Overall Study|Failure to meet eligibility criteria|0|||
42282944|NCT02158546|76114556|FG003|Overall Study|Failure to meet eligibility criteria|0|||
42040683|NCT01796171|75848708|FG002|Follow-up Period|Physician Decision|0|||
42040684|NCT01796171|75848709|FG003|Follow-up Period|Physician Decision|0|||
42169567|NCT03485950|75976704|FG000|Overall Study|Death|3|||
42169568|NCT03485950|75976705|FG001|Overall Study|Death|2|||
42169569|NCT03485950|75976704|FG000|Overall Study|Withdrawal by Subject|3|||
42169570|NCT03485950|75976705|FG001|Overall Study|Withdrawal by Subject|0|||
42169571|NCT00060944|75976713|FG000|Overall Study|Adverse Event|12|||
42169572|NCT00060944|75976714|FG001|Overall Study|Adverse Event|10|||
42169573|NCT00060944|75976713|FG000|Overall Study|Death|2|||
42169574|NCT00060944|75976714|FG001|Overall Study|Death|3|||
42169575|NCT00060944|75976713|FG000|Overall Study|Withdrawal by Subject|18|||
42169576|NCT00060944|75976714|FG001|Overall Study|Withdrawal by Subject|5|||
42282945|NCT02158546|76114553|FG000|Overall Study|Lack of Efficacy|1|||
42282946|NCT02158546|76114554|FG001|Overall Study|Lack of Efficacy|1|||
42282947|NCT02158546|76114555|FG002|Overall Study|Lack of Efficacy|0|||
42282948|NCT02158546|76114556|FG003|Overall Study|Lack of Efficacy|0|||
42282949|NCT02158546|76114553|FG000|Overall Study|Adverse Event|2|||
42169577|NCT00060944|75976713|FG000|Overall Study|Disease Progression|93|||
42169578|NCT00060944|75976714|FG001|Overall Study|Disease Progression|94|||
42169579|NCT00060944|75976713|FG000|Overall Study|Lost to Follow-up|1|||
42169580|NCT00060944|75976714|FG001|Overall Study|Lost to Follow-up|0|||
42169581|NCT00060944|75976713|FG000|Overall Study|Subject Ineligible To Continue|2|||
42169582|NCT00060944|75976714|FG001|Overall Study|Subject Ineligible To Continue|1|||
42169583|NCT00060944|75976713|FG000|Overall Study|Treatment Switch|0|||
42169584|NCT00060944|75976714|FG001|Overall Study|Treatment Switch|13|||
42169585|NCT00060944|75976713|FG000|Overall Study|Other|2|||
42169586|NCT00060944|75976714|FG001|Overall Study|Other|4|||
42169587|NCT00060944|75976713|FG000|Overall Study|randomized but not treated|6|||
42169588|NCT00060944|75976714|FG001|Overall Study|randomized but not treated|4|||
42169589|NCT03462082|75976720|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
42169590|NCT03462082|75976721|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
42169591|NCT03462082|75976722|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
42169592|NCT03462082|75976723|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
42169593|NCT03462082|75976724|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
42169594|NCT03462082|75976725|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
42169595|NCT03462082|75976726|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
42169596|NCT03462082|75976727|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
42169597|NCT03541252|75976737|FG000|Overall Study|Withdrawal by Subject|1|||
42169598|NCT00031460|75976743|FG000|Overall Study|Lost to Follow-up|0|||
42169599|NCT00031460|75976744|FG001|Overall Study|Lost to Follow-up|1|||
42169600|NCT00031460|75976743|FG000|Overall Study|Withdrawal by Subject|1|||
42169601|NCT00031460|75976744|FG001|Overall Study|Withdrawal by Subject|1|||
42169602|NCT00031460|75976743|FG000|Overall Study|Non-Compliant|1|||
42169603|NCT00031460|75976744|FG001|Overall Study|Non-Compliant|1|||
42169604|NCT00031460|75976743|FG000|Overall Study|Death|0|||
42169605|NCT00031460|75976744|FG001|Overall Study|Death|1|||
42169606|NCT00031460|75976743|FG000|Overall Study|Reactivation of Disease|5|||
42169607|NCT00031460|75976744|FG001|Overall Study|Reactivation of Disease|9|||
42282950|NCT02158546|76114554|FG001|Overall Study|Adverse Event|2|||
42282951|NCT02158546|76114555|FG002|Overall Study|Adverse Event|0|||
42282952|NCT02158546|76114556|FG003|Overall Study|Adverse Event|0|||
42282953|NCT02158546|76114553|FG000|Overall Study|Withdrawal by Subject|6|||
42282954|NCT02158546|76114554|FG001|Overall Study|Withdrawal by Subject|2|||
42282955|NCT02158546|76114555|FG002|Overall Study|Withdrawal by Subject|1|||
42282956|NCT02158546|76114556|FG003|Overall Study|Withdrawal by Subject|0|||
42282957|NCT02158546|76114553|FG000|Overall Study|Lost to Follow-up|5|||
42282958|NCT02158546|76114554|FG001|Overall Study|Lost to Follow-up|4|||
42282959|NCT02158546|76114555|FG002|Overall Study|Lost to Follow-up|0|||
42282960|NCT02158546|76114556|FG003|Overall Study|Lost to Follow-up|1|||
42282961|NCT02158546|76114553|FG000|Overall Study|Site Excluded|5|||
42282962|NCT02158546|76114554|FG001|Overall Study|Site Excluded|5|||
42282963|NCT02158546|76114555|FG002|Overall Study|Site Excluded|3|||
42282964|NCT02158546|76114556|FG003|Overall Study|Site Excluded|4|||
42282965|NCT02123446|76114566|FG000|Washout Period (1 Day)|Physician Decision|1|||
42282966|NCT02123446|76114567|FG001|Washout Period (1 Day)|Physician Decision|0|||
42282967|NCT02123134|76114575|FG000|Overall Study|Withdrawal of consent|3|||
42282968|NCT02123134|76114576|FG001|Overall Study|Withdrawal of consent|2|||
42282969|NCT02123134|76114575|FG000|Overall Study|Administrative decision|0|||
42282970|NCT02123134|76114576|FG001|Overall Study|Administrative decision|1|||
42282971|NCT02185534|76114588|FG000|First Period|Withdrawal by Subject|0|||
42169608|NCT00031460|75976743|FG000|Overall Study|Disruption of blinded drug supply|2|||
42169609|NCT00031460|75976744|FG001|Overall Study|Disruption of blinded drug supply|0|||
42282972|NCT02185534|76114589|FG001|First Period|Withdrawal by Subject|0|||
42282973|NCT02185534|76114590|FG002|First Period|Withdrawal by Subject|0|||
42282974|NCT02185534|76114591|FG003|First Period|Withdrawal by Subject|1|||
42282975|NCT02185534|76114592|FG004|First Period|Withdrawal by Subject|0|||
42282976|NCT02185534|76114593|FG005|First Period|Withdrawal by Subject|0|||
42282977|NCT02185534|76114588|FG000|First Washout Period|Withdrawal by Subject|1|||
42282978|NCT02185534|76114589|FG001|First Washout Period|Withdrawal by Subject|0|||
42282979|NCT02185534|76114590|FG002|First Washout Period|Withdrawal by Subject|0|||
42282980|NCT02185534|76114591|FG003|First Washout Period|Withdrawal by Subject|0|||
42282981|NCT02185534|76114592|FG004|First Washout Period|Withdrawal by Subject|1|||
42282982|NCT02185534|76114593|FG005|First Washout Period|Withdrawal by Subject|0|||
42282983|NCT02185534|76114588|FG000|First Washout Period|Protocol Violation|0|||
42282984|NCT02185534|76114589|FG001|First Washout Period|Protocol Violation|0|||
42169610|NCT00031460|75976743|FG000|Overall Study|Confirmed unevaluable|0|||
42169611|NCT00031460|75976744|FG001|Overall Study|Confirmed unevaluable|1|||
42169612|NCT03540160|75976750|FG000|Overall Study|Protocol Violation|1|||
42169613|NCT03540160|75976750|FG000|Overall Study|Physician Decision|8|||
42169614|NCT03540160|75976750|FG000|Overall Study|Lack of Efficacy|60|||
42169615|NCT03540160|75976750|FG000|Overall Study|Pregnancy|1|||
42169616|NCT03540160|75976750|FG000|Overall Study|Adverse Event|20|||
42169617|NCT03540160|75976750|FG000|Overall Study|Withdrawal by Subject|68|||
42169618|NCT03540160|75976750|FG000|Overall Study|COVID-19|2|||
42169619|NCT03540160|75976750|FG000|Overall Study|Study Closure|10|||
42169620|NCT03540160|75976750|FG000|Overall Study|Lost to Follow-up|18|||
42169621|NCT03540160|75976750|FG000|Overall Study|Sponsor decision|191|||
42169622|NCT03459196|75976754|FG000|Overall Study|Subject didn't receive study catheter|2|||
42169623|NCT03459040|75976758|FG000|Overall Study|Death|8|||
42169624|NCT03459040|75976758|FG000|Overall Study|Withdrawal by Subject|1|||
42169625|NCT03457636|75976763|FG000|Overall Study|Lost to Follow-up|2|||
42169626|NCT03481816|75976769|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
42169627|NCT03481816|75976770|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
42169628|NCT03481816|75976769|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
42169629|NCT03481816|75976770|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
42169630|NCT03481816|75976769|FG000|Dose Expansion|Withdrawal by Subject|0|||
42169631|NCT03481816|75976770|FG001|Dose Expansion|Withdrawal by Subject|2|||
42169632|NCT03481816|75976769|FG000|Dose Expansion|Physician Decision|0|||
42169633|NCT03481816|75976770|FG001|Dose Expansion|Physician Decision|5|||
42169634|NCT03538054|75976778|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
42169635|NCT03538054|75976778|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
42169636|NCT03538054|75976778|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
42169637|NCT03480802|75976786|FG000|Overall Study|Lost to Follow-up|5|||
42169638|NCT03480802|75976787|FG001|Overall Study|Lost to Follow-up|1|||
42169639|NCT03480802|75976786|FG000|Overall Study|Withdrawal by Subject|2|||
42169640|NCT03480802|75976787|FG001|Overall Study|Withdrawal by Subject|1|||
42169641|NCT03480802|75976786|FG000|Overall Study|Relocated|0|||
42169642|NCT03480802|75976787|FG001|Overall Study|Relocated|1|||
42169643|NCT00050960|75976797|FG000|Overall Study|Progressive Disease|137|||
42169644|NCT00050960|75976798|FG001|Overall Study|Progressive Disease|93|||
42169645|NCT00050960|75976797|FG000|Overall Study|Stable Disease|19|||
42169646|NCT00050960|75976798|FG001|Overall Study|Stable Disease|48|||
42169647|NCT00050960|75976797|FG000|Overall Study|Partial Response|14|||
42169648|NCT00050960|75976798|FG001|Overall Study|Partial Response|19|||
42169649|NCT00050960|75976797|FG000|Overall Study|Complete Response|0|||
42169650|NCT00050960|75976798|FG001|Overall Study|Complete Response|2|||
42169651|NCT00050960|75976797|FG000|Overall Study|Adverse Event|62|||
42169652|NCT00050960|75976798|FG001|Overall Study|Adverse Event|61|||
42169653|NCT00050960|75976797|FG000|Overall Study|Lost to Follow-up|0|||
42169654|NCT00050960|75976798|FG001|Overall Study|Lost to Follow-up|1|||
42169655|NCT00050960|75976797|FG000|Overall Study|Withdrawal by Subject|23|||
42169656|NCT00050960|75976798|FG001|Overall Study|Withdrawal by Subject|18|||
42169657|NCT00050960|75976797|FG000|Overall Study|Administrative|31|||
42169658|NCT00050960|75976798|FG001|Overall Study|Administrative|46|||
42169659|NCT00050960|75976797|FG000|Overall Study|Non-compliance|3|||
42169660|NCT00050960|75976798|FG001|Overall Study|Non-compliance|1|||
42169661|NCT00050960|75976797|FG000|Overall Study|Death|13|||
42169662|NCT00050960|75976798|FG001|Overall Study|Death|15|||
42169663|NCT03456856|75976804|FG000|Overall Study|Lost to Follow-up|2|||
42169664|NCT03456856|75976804|FG000|Overall Study|Withdrawal by Subject|1|||
42169665|NCT00058214|75976808|FG000|Overall Study|Adverse Event|1|||
42169666|NCT00097773|75976816|FG000|Overall Study|Lost to Follow-up|2|||
42169667|NCT00097773|75976817|FG001|Overall Study|Lost to Follow-up|2|||
42169668|NCT00097773|75976818|FG002|Overall Study|Lost to Follow-up|0|||
42169669|NCT00097773|75976819|FG003|Overall Study|Lost to Follow-up|1|||
42169670|NCT00097773|75976816|FG000|Overall Study|Physician Decision|2|||
42169671|NCT00097773|75976817|FG001|Overall Study|Physician Decision|2|||
42169672|NCT00097773|75976818|FG002|Overall Study|Physician Decision|3|||
42169673|NCT00097773|75976819|FG003|Overall Study|Physician Decision|1|||
42169674|NCT00097773|75976816|FG000|Overall Study|Withdrawal by Subject|3|||
42169675|NCT00097773|75976817|FG001|Overall Study|Withdrawal by Subject|3|||
42169676|NCT00097773|75976818|FG002|Overall Study|Withdrawal by Subject|3|||
42169677|NCT00097773|75976819|FG003|Overall Study|Withdrawal by Subject|1|||
42169678|NCT00097773|75976816|FG000|Overall Study|Adverse Event|0|||
42169679|NCT00097773|75976817|FG001|Overall Study|Adverse Event|1|||
42169680|NCT00097773|75976818|FG002|Overall Study|Adverse Event|0|||
42169681|NCT00097773|75976819|FG003|Overall Study|Adverse Event|0|||
42169682|NCT00097773|75976816|FG000|Overall Study|Other|1|||
42169683|NCT00097773|75976817|FG001|Overall Study|Other|0|||
42169684|NCT00097773|75976818|FG002|Overall Study|Other|2|||
42169685|NCT00097773|75976819|FG003|Overall Study|Other|0|||
42169686|NCT03480022|75976836|FG000|Overall Study|Pregnancy|2|||
42169687|NCT03480022|75976837|FG001|Overall Study|Pregnancy|0|||
42169688|NCT03480022|75976836|FG000|Overall Study|Adverse Event|6|||
42169689|NCT03480022|75976837|FG001|Overall Study|Adverse Event|0|||
42169690|NCT03480022|75976836|FG000|Overall Study|Lack of Efficacy|0|||
42169691|NCT03480022|75976837|FG001|Overall Study|Lack of Efficacy|2|||
42014543|NCT00960661|75821649|FG002|Interventional Phase|Lost to Follow-up|2|||
42014544|NCT00960661|75821647|FG000|Interventional Phase|entry criteria not met|0|||
42014545|NCT00960661|75821648|FG001|Interventional Phase|entry criteria not met|3|||
42014546|NCT00960661|75821649|FG002|Interventional Phase|entry criteria not met|0|||
42014547|NCT00960661|75821647|FG000|Interventional Phase|Protocol Violation|0|||
42014548|NCT00960661|75821648|FG001|Interventional Phase|Protocol Violation|7|||
42014549|NCT00960661|75821649|FG002|Interventional Phase|Protocol Violation|2|||
42040685|NCT01796171|75848710|FG004|Follow-up Period|Physician Decision|0|||
42040686|NCT01796171|75848711|FG005|Follow-up Period|Physician Decision|0|||
42169692|NCT03480022|75976836|FG000|Overall Study|Physician Decision|0|||
42169693|NCT03480022|75976837|FG001|Overall Study|Physician Decision|1|||
42169694|NCT03480022|75976836|FG000|Overall Study|Withdrawal by Subject|2|||
42169695|NCT03480022|75976837|FG001|Overall Study|Withdrawal by Subject|0|||
42169696|NCT03480022|75976836|FG000|Overall Study|Medication concerns|1|||
42169697|NCT03480022|75976837|FG001|Overall Study|Medication concerns|0|||
42169698|NCT03480022|75976836|FG000|Overall Study|Family member COVID exposure|0|||
42169699|NCT03480022|75976837|FG001|Overall Study|Family member COVID exposure|1|||
42169700|NCT03533608|75976843|FG000|Overall Study|Withdrawal by Subject|3|||
42169701|NCT03533608|75976843|FG000|Overall Study|Physician Decision|2|||
42169702|NCT00049322|75976850|FG000|Overall Study|disease burden|0|||
42169703|NCT00049322|75976851|FG001|Overall Study|disease burden|3|||
42169704|NCT00049322|75976850|FG000|Overall Study|Adverse Event|1|||
42169705|NCT00049322|75976851|FG001|Overall Study|Adverse Event|0|||
42169706|NCT00049322|75976850|FG000|Overall Study|refused angio|0|||
42169707|NCT00049322|75976851|FG001|Overall Study|refused angio|3|||
42169708|NCT03437512|75976861|FG000|Randomized|Withdrawal by Subject|0|||
42169709|NCT03437512|75976862|FG001|Randomized|Withdrawal by Subject|2|||
42169710|NCT03437512|75976861|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
42169711|NCT03437512|75976862|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
42169712|NCT00058058|75976868|FG000|Overall Study|Withdrawal by Subject|4|||
42169713|NCT00058058|75976868|FG000|Overall Study|Ineligible|20|||
42169714|NCT00058058|75976868|FG000|Overall Study|Claustrophobic|5|||
42169715|NCT00058058|75976868|FG000|Overall Study|technical issues|6|||
42169716|NCT00058058|75976868|FG000|Overall Study|Poor positioning, illness,pain|3|||
42169717|NCT03532048|75976875|FG000|Overall Study|Lost to Follow-up|12|||
42169718|NCT03532048|75976876|FG001|Overall Study|Lost to Follow-up|17|||
42169719|NCT03532048|75976875|FG000|Overall Study|Withdrawal by Subject|7|||
42169720|NCT03532048|75976876|FG001|Overall Study|Withdrawal by Subject|0|||
42169721|NCT00008138|75976882|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
42169722|NCT00008138|75976882|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
42169723|NCT00008138|75976882|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
42169724|NCT00008138|75976882|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
42169725|NCT00008138|75976882|FG000|Interval Debulking|Withdrawal by Subject|2|||
42169726|NCT00008138|75976882|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
42169727|NCT00008138|75976882|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
42169728|NCT00008138|75976882|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
42169729|NCT03436732|75976889|FG000|Overall Study|Not treated-enrolled in different study|1|||
42169730|NCT03436732|75976890|FG001|Overall Study|Not treated-enrolled in different study|0|||
42169731|NCT03436732|75976889|FG000|Overall Study|Off study after cycle 1|1|||
42169732|NCT03436732|75976890|FG001|Overall Study|Off study after cycle 1|0|||
42169733|NCT03436732|75976889|FG000|Overall Study|Adverse Event|2|||
42169734|NCT03436732|75976890|FG001|Overall Study|Adverse Event|0|||
42169735|NCT03436732|75976889|FG000|Overall Study|Death|0|||
42169736|NCT03436732|75976890|FG001|Overall Study|Death|1|||
42169737|NCT03436420|75976897|FG000|Overall Study|Lack of Efficacy|3|||
42169738|NCT00027560|75976901|FG000|Overall Study|Withdrawal by Subject|1|||
42169739|NCT03451084|75976911|FG000|Overall Study|Withdrawal by Subject|2|||
42169740|NCT03451084|75976912|FG001|Overall Study|Withdrawal by Subject|1|||
42169741|NCT03451084|75976913|FG002|Overall Study|Withdrawal by Subject|2|||
42169742|NCT03451084|75976914|FG003|Overall Study|Withdrawal by Subject|1|||
42169743|NCT03451084|75976911|FG000|Overall Study|Disease recurrence|0|||
42169744|NCT03451084|75976912|FG001|Overall Study|Disease recurrence|2|||
42169745|NCT03451084|75976913|FG002|Overall Study|Disease recurrence|0|||
42169746|NCT03451084|75976914|FG003|Overall Study|Disease recurrence|0|||
42014550|NCT00960661|75821647|FG000|Interventional Phase|Withdrawal by Subject|0|||
42169747|NCT03451084|75976911|FG000|Overall Study|Lack of Efficacy|0|||
42169748|NCT03451084|75976912|FG001|Overall Study|Lack of Efficacy|3|||
42169749|NCT03451084|75976913|FG002|Overall Study|Lack of Efficacy|0|||
42169750|NCT03451084|75976914|FG003|Overall Study|Lack of Efficacy|1|||
42169751|NCT03451084|75976911|FG000|Overall Study|Death|1|||
42169752|NCT03451084|75976912|FG001|Overall Study|Death|0|||
42169753|NCT03451084|75976913|FG002|Overall Study|Death|2|||
42169754|NCT03451084|75976914|FG003|Overall Study|Death|0|||
42169755|NCT03451084|75976911|FG000|Overall Study|Physician Decision|0|||
42169756|NCT03451084|75976912|FG001|Overall Study|Physician Decision|0|||
42169757|NCT03451084|75976913|FG002|Overall Study|Physician Decision|2|||
42169758|NCT03451084|75976914|FG003|Overall Study|Physician Decision|2|||
42169759|NCT03451084|75976911|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
42169760|NCT03451084|75976912|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
42169761|NCT03451084|75976913|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
42169762|NCT03451084|75976914|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
42169763|NCT03451006|75976926|FG000|Overall Study|Withdrawal by Subject|2|||
42169764|NCT03451006|75976927|FG001|Overall Study|Withdrawal by Subject|2|||
42169765|NCT03450070|75976933|FG000|Overall Study|Withdrawal by Subject|8|||
42169766|NCT03449758|75976937|FG000|Overall Study|Major protocol deviation|1|||
42169767|NCT03449758|75976937|FG000|Overall Study|Treatment inefficacy|5|||
42169768|NCT03449758|75976937|FG000|Overall Study|Adverse Event|9|||
42169769|NCT03449758|75976937|FG000|Overall Study|Consent withdrawal|1|||
42169770|NCT03449758|75976937|FG000|Overall Study|Other unspecified reason|3|||
42169771|NCT03449446|75976949|FG000|Overall Study|Randomized but Never Treated|0|||
42169772|NCT03449446|75976950|FG001|Overall Study|Randomized but Never Treated|0|||
42169773|NCT03449446|75976951|FG002|Overall Study|Randomized but Never Treated|1|||
42169774|NCT03449446|75976952|FG003|Overall Study|Randomized but Never Treated|1|||
42169775|NCT03449446|75976953|FG004|Overall Study|Randomized but Never Treated|1|||
42169776|NCT03449446|75976954|FG005|Overall Study|Randomized but Never Treated|0|||
42282985|NCT02185534|76114590|FG002|First Washout Period|Protocol Violation|0|||
42282986|NCT02185534|76114591|FG003|First Washout Period|Protocol Violation|0|||
42282987|NCT02185534|76114592|FG004|First Washout Period|Protocol Violation|0|||
42282988|NCT02185534|76114593|FG005|First Washout Period|Protocol Violation|1|||
42282989|NCT02121808|76114602|FG000|Overall Study|Technical problem|3|||
42282990|NCT02157376|76114613|FG000|Overall Study|Death|10|||
42282991|NCT02157376|76114614|FG001|Overall Study|Death|4|||
42282992|NCT02157376|76114613|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42282993|NCT02157376|76114614|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
42282994|NCT02157376|76114613|FG000|Overall Study|Withdrawal by Subject|3|||
42282995|NCT02157376|76114614|FG001|Overall Study|Withdrawal by Subject|8|||
42282996|NCT02157376|76114613|FG000|Overall Study|Not treated|8|||
42282997|NCT02157376|76114614|FG001|Overall Study|Not treated|3|||
42282998|NCT02157376|76114613|FG000|Overall Study|Investigator's misjudgement|1|||
42282999|NCT02157376|76114614|FG001|Overall Study|Investigator's misjudgement|2|||
42283000|NCT02157298|76114622|FG000|Overall Study|Adverse Event|1|||
42283001|NCT02157298|76114623|FG001|Overall Study|Adverse Event|0|||
42283002|NCT02157298|76114622|FG000|Overall Study|Subject no longer meets study criteria|1|||
42283003|NCT02157298|76114623|FG001|Overall Study|Subject no longer meets study criteria|2|||
42283004|NCT02157298|76114622|FG000|Overall Study|Poor/Non-compliance|1|||
42283005|NCT02157298|76114623|FG001|Overall Study|Poor/Non-compliance|0|||
42283006|NCT02157298|76114622|FG000|Overall Study|Withdrawal by Subject|1|||
42283007|NCT02157298|76114623|FG001|Overall Study|Withdrawal by Subject|0|||
42283008|NCT02184988|76114629|FG000|Overall Study|Pregnancy|2|||
42283009|NCT02184988|76114629|FG000|Overall Study|Adverse Event|2|||
42283010|NCT02184988|76114629|FG000|Overall Study|moving away/travelling/unable to complet|6|||
42283011|NCT02184988|76114629|FG000|Overall Study|work scheduling issues|4|||
42283012|NCT02184988|76114629|FG000|Overall Study|various other reasons|9|||
42283013|NCT02184988|76114629|FG000|Overall Study|Lost to Follow-up|32|||
42283014|NCT02121262|76114635|FG000|Overall Study|Adverse Event|6|||
42283015|NCT02121262|76114636|FG001|Overall Study|Adverse Event|3|||
42169777|NCT03449446|75976955|FG006|Overall Study|Randomized but Never Treated|0|||
42169778|NCT03449446|75976949|FG000|Overall Study|Unknown Reason|33|||
42169779|NCT03449446|75976950|FG001|Overall Study|Unknown Reason|1|||
42169780|NCT03449446|75976951|FG002|Overall Study|Unknown Reason|1|||
42169781|NCT03449446|75976952|FG003|Overall Study|Unknown Reason|1|||
42169782|NCT03449446|75976953|FG004|Overall Study|Unknown Reason|2|||
42169783|NCT03449446|75976954|FG005|Overall Study|Unknown Reason|2|||
42169784|NCT03449446|75976955|FG006|Overall Study|Unknown Reason|0|||
42169785|NCT03449446|75976949|FG000|Overall Study|Withdrew Consent|1|||
42169786|NCT03449446|75976950|FG001|Overall Study|Withdrew Consent|3|||
42283016|NCT02121262|76114635|FG000|Overall Study|Lack of Efficacy|3|||
42283017|NCT02121262|76114636|FG001|Overall Study|Lack of Efficacy|0|||
42283018|NCT02121262|76114635|FG000|Overall Study|Personal Reasons|19|||
42283019|NCT02121262|76114636|FG001|Overall Study|Personal Reasons|5|||
42283020|NCT02121262|76114635|FG000|Overall Study|Protocol Violation|1|||
42283021|NCT02121262|76114636|FG001|Overall Study|Protocol Violation|1|||
42283022|NCT02121262|76114635|FG000|Overall Study|Participant Dropped-out|0|||
42283023|NCT02121262|76114636|FG001|Overall Study|Participant Dropped-out|1|||
42283024|NCT02121262|76114635|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
42283025|NCT02121262|76114636|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
42283026|NCT02121262|76114635|FG000|Overall Study|Consent Withdrawn|1|||
42283027|NCT02121262|76114636|FG001|Overall Study|Consent Withdrawn|0|||
42283028|NCT02120950|76114644|FG000|Overall Study|Adverse Event|5|||
42283029|NCT02120950|76114645|FG001|Overall Study|Adverse Event|4|||
42283030|NCT02120950|76114646|FG002|Overall Study|Adverse Event|3|||
42283031|NCT02120950|76114644|FG000|Overall Study|Death|3|||
42283032|NCT02120950|76114645|FG001|Overall Study|Death|0|||
42014551|NCT00960661|75821648|FG001|Interventional Phase|Withdrawal by Subject|18|||
42014552|NCT00960661|75821649|FG002|Interventional Phase|Withdrawal by Subject|29|||
42014553|NCT00960661|75821647|FG000|Interventional Phase|Physician Decision|0|||
42283033|NCT02120950|76114646|FG002|Overall Study|Death|1|||
42283034|NCT02120950|76114644|FG000|Overall Study|Withdrawal by Subject|6|||
42283035|NCT02120950|76114645|FG001|Overall Study|Withdrawal by Subject|3|||
42283036|NCT02120950|76114646|FG002|Overall Study|Withdrawal by Subject|2|||
42283037|NCT02120950|76114644|FG000|Overall Study|Protocol Violation|1|||
42352066|NCT01925209|76192033|FG001|Follow-up|Non-compliance with study treatment|0|||
42352067|NCT01925209|76192034|FG002|Follow-up|Non-compliance with study treatment|0|||
42352068|NCT01925209|76192035|FG003|Follow-up|Non-compliance with study treatment|1|||
42352069|NCT01925209|76192032|FG000|Follow-up|Withdrawal by Subject|0|||
42352070|NCT01925209|76192033|FG001|Follow-up|Withdrawal by Subject|2|||
42352071|NCT01925209|76192034|FG002|Follow-up|Withdrawal by Subject|0|||
42352072|NCT01925209|76192035|FG003|Follow-up|Withdrawal by Subject|2|||
42352073|NCT01614925|76192047|FG000|Overall Study|Withdrawal by Subject|1|||
42014554|NCT00960661|75821648|FG001|Interventional Phase|Physician Decision|3|||
42169787|NCT03449446|75976951|FG002|Overall Study|Withdrew Consent|1|||
42169788|NCT03449446|75976952|FG003|Overall Study|Withdrew Consent|4|||
42169789|NCT03449446|75976953|FG004|Overall Study|Withdrew Consent|4|||
42169790|NCT03449446|75976954|FG005|Overall Study|Withdrew Consent|4|||
42283038|NCT02120950|76114645|FG001|Overall Study|Protocol Violation|1|||
42283039|NCT02120950|76114646|FG002|Overall Study|Protocol Violation|7|||
42283040|NCT02120950|76114644|FG000|Overall Study|Other reasons|5|||
42283041|NCT02120950|76114645|FG001|Overall Study|Other reasons|4|||
42283042|NCT02120950|76114646|FG002|Overall Study|Other reasons|1|||
42283043|NCT02120950|76114644|FG000|Overall Study|Lost to Follow-up|0|||
42283044|NCT02120950|76114645|FG001|Overall Study|Lost to Follow-up|2|||
42283045|NCT02120950|76114646|FG002|Overall Study|Lost to Follow-up|1|||
42169791|NCT03449446|75976955|FG006|Overall Study|Withdrew Consent|1|||
42169792|NCT03449446|75976949|FG000|Overall Study|Adverse Event|1|||
42169793|NCT03449446|75976950|FG001|Overall Study|Adverse Event|2|||
42169794|NCT03449446|75976951|FG002|Overall Study|Adverse Event|1|||
42169795|NCT03449446|75976952|FG003|Overall Study|Adverse Event|0|||
42169796|NCT03449446|75976953|FG004|Overall Study|Adverse Event|0|||
42169797|NCT03449446|75976954|FG005|Overall Study|Adverse Event|2|||
42169798|NCT03449446|75976955|FG006|Overall Study|Adverse Event|0|||
42169799|NCT03449446|75976949|FG000|Overall Study|Lost to Follow-up|0|||
42169800|NCT03449446|75976950|FG001|Overall Study|Lost to Follow-up|0|||
42169801|NCT03449446|75976951|FG002|Overall Study|Lost to Follow-up|2|||
42169802|NCT03449446|75976952|FG003|Overall Study|Lost to Follow-up|1|||
42283046|NCT02120794|76114653|FG000|Overall Study|Withdrawal by Subject|43|||
42283047|NCT02120794|76114653|FG000|Overall Study|Adverse Event|10|||
42283048|NCT02120794|76114653|FG000|Overall Study|Physician Decision|4|||
42283049|NCT02120794|76114653|FG000|Overall Study|Due to insurance coverage|1|||
42283050|NCT02184442|76114659|FG000|Overall Study|Death|61|||
42283051|NCT02184442|76114660|FG001|Overall Study|Death|65|||
42169803|NCT03449446|75976953|FG004|Overall Study|Lost to Follow-up|3|||
42169804|NCT03449446|75976954|FG005|Overall Study|Lost to Follow-up|0|||
42169805|NCT03449446|75976955|FG006|Overall Study|Lost to Follow-up|0|||
42169806|NCT03449446|75976949|FG000|Overall Study|Investigator's Discretion|0|||
42169807|NCT03449446|75976950|FG001|Overall Study|Investigator's Discretion|1|||
42169808|NCT03449446|75976951|FG002|Overall Study|Investigator's Discretion|1|||
42169809|NCT03449446|75976952|FG003|Overall Study|Investigator's Discretion|2|||
42169810|NCT03449446|75976953|FG004|Overall Study|Investigator's Discretion|0|||
42169811|NCT03449446|75976954|FG005|Overall Study|Investigator's Discretion|0|||
42169812|NCT03449446|75976955|FG006|Overall Study|Investigator's Discretion|0|||
42169813|NCT03449446|75976949|FG000|Overall Study|Non Compliance with Study Drug|1|||
42169814|NCT03449446|75976950|FG001|Overall Study|Non Compliance with Study Drug|0|||
42169815|NCT03449446|75976951|FG002|Overall Study|Non Compliance with Study Drug|0|||
42169816|NCT03449446|75976952|FG003|Overall Study|Non Compliance with Study Drug|0|||
42169817|NCT03449446|75976953|FG004|Overall Study|Non Compliance with Study Drug|0|||
42169818|NCT03449446|75976954|FG005|Overall Study|Non Compliance with Study Drug|0|||
42169819|NCT03449446|75976955|FG006|Overall Study|Non Compliance with Study Drug|0|||
42283052|NCT02184442|76114659|FG000|Overall Study|Withdrawal by Subject|3|||
42283053|NCT02184442|76114660|FG001|Overall Study|Withdrawal by Subject|11|||
42352074|NCT01614925|76192048|FG001|Overall Study|Withdrawal by Subject|0|||
42352075|NCT01614925|76192047|FG000|Overall Study|Protocol Violation|3|||
42169820|NCT03449446|75976949|FG000|Overall Study|Protocol Violation|0|||
42169821|NCT03449446|75976950|FG001|Overall Study|Protocol Violation|0|||
42014555|NCT00960661|75821649|FG002|Interventional Phase|Physician Decision|5|||
42169822|NCT03449446|75976951|FG002|Overall Study|Protocol Violation|0|||
42169823|NCT03449446|75976952|FG003|Overall Study|Protocol Violation|0|||
42169824|NCT03449446|75976953|FG004|Overall Study|Protocol Violation|1|||
42283054|NCT02155738|76114670|FG000|Overall Study|Missing critical information|1|||
42283055|NCT02155738|76114671|FG001|Overall Study|Missing critical information|0|||
42283056|NCT02155738|76114672|FG002|Overall Study|Missing critical information|0|||
42283057|NCT02155738|76114673|FG003|Overall Study|Missing critical information|1|||
42283058|NCT02181790|76114685|FG000|Overall Study|study terminated|2|||
42283059|NCT02181790|76114686|FG001|Overall Study|study terminated|0|||
42283060|NCT02618967|76114702|FG000|Overall Study|Lost to Follow-up|0|||
42283061|NCT02618967|76114703|FG001|Overall Study|Lost to Follow-up|0|||
42283062|NCT02618967|76114704|FG002|Overall Study|Lost to Follow-up|1|||
42169825|NCT03449446|75976954|FG005|Overall Study|Protocol Violation|1|||
42169826|NCT03449446|75976955|FG006|Overall Study|Protocol Violation|0|||
42169827|NCT03449446|75976949|FG000|Overall Study|Death|0|||
42169828|NCT03449446|75976950|FG001|Overall Study|Death|0|||
42169829|NCT03449446|75976951|FG002|Overall Study|Death|0|||
42169830|NCT03449446|75976952|FG003|Overall Study|Death|0|||
42169831|NCT03449446|75976953|FG004|Overall Study|Death|1|||
42169832|NCT03449446|75976954|FG005|Overall Study|Death|0|||
42169833|NCT03449446|75976955|FG006|Overall Study|Death|0|||
42040687|NCT01796171|75848712|FG006|Follow-up Period|Physician Decision|0|||
42040688|NCT01796171|75848713|FG007|Follow-up Period|Physician Decision|0|||
42040689|NCT01796171|75848714|FG008|Follow-up Period|Physician Decision|0|||
42040690|NCT01796171|75848715|FG009|Follow-up Period|Physician Decision|0|||
42040691|NCT01796171|75848716|FG010|Follow-up Period|Physician Decision|5|||
42040692|NCT01796171|75848717|FG011|Follow-up Period|Physician Decision|0|||
42040693|NCT01796171|75848718|FG012|Follow-up Period|Physician Decision|0|||
42040694|NCT01796171|75848719|FG013|Follow-up Period|Physician Decision|0|||
42040695|NCT01796171|75848720|FG014|Follow-up Period|Physician Decision|0|||
42040696|NCT01796171|75848706|FG000|Follow-up Period|Withdrawal by Subject|0|||
42040697|NCT01796171|75848707|FG001|Follow-up Period|Withdrawal by Subject|1|||
42040698|NCT01796171|75848708|FG002|Follow-up Period|Withdrawal by Subject|0|||
42040699|NCT01796171|75848709|FG003|Follow-up Period|Withdrawal by Subject|0|||
42040700|NCT01796171|75848710|FG004|Follow-up Period|Withdrawal by Subject|0|||
42040701|NCT01796171|75848711|FG005|Follow-up Period|Withdrawal by Subject|1|||
42040702|NCT01796171|75848712|FG006|Follow-up Period|Withdrawal by Subject|0|||
42040703|NCT01796171|75848713|FG007|Follow-up Period|Withdrawal by Subject|0|||
42040704|NCT01796171|75848714|FG008|Follow-up Period|Withdrawal by Subject|0|||
42040705|NCT01796171|75848715|FG009|Follow-up Period|Withdrawal by Subject|0|||
42040706|NCT01796171|75848716|FG010|Follow-up Period|Withdrawal by Subject|3|||
42040707|NCT01796171|75848717|FG011|Follow-up Period|Withdrawal by Subject|1|||
42169834|NCT03449134|75976974|FG000|52-Week Treatment Period|Death|2|||
42169835|NCT03449134|75976975|FG001|52-Week Treatment Period|Death|1|||
42169836|NCT03449134|75976976|FG002|52-Week Treatment Period|Death|0|||
42169837|NCT03449134|75976974|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
42169838|NCT03449134|75976975|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
42169839|NCT03449134|75976976|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
42169840|NCT03449134|75976974|FG000|52-Week Treatment Period|Physician Decision|2|||
42169841|NCT03449134|75976975|FG001|52-Week Treatment Period|Physician Decision|3|||
42169842|NCT03449134|75976976|FG002|52-Week Treatment Period|Physician Decision|3|||
42169843|NCT03449134|75976974|FG000|52-Week Treatment Period|Screen Failure|1|||
42169844|NCT03449134|75976975|FG001|52-Week Treatment Period|Screen Failure|0|||
42169845|NCT03449134|75976976|FG002|52-Week Treatment Period|Screen Failure|1|||
42169846|NCT03449134|75976974|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
42169847|NCT03449134|75976975|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
42169848|NCT03449134|75976976|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
42169849|NCT03449134|75976974|FG000|52-Week Treatment Period|Site Closure|1|||
42169850|NCT03449134|75976975|FG001|52-Week Treatment Period|Site Closure|0|||
42169851|NCT03449134|75976976|FG002|52-Week Treatment Period|Site Closure|0|||
42169852|NCT03529162|75976989|FG000|Overall Study|Lost to Follow-up|2|||
42169853|NCT03529162|75976990|FG001|Overall Study|Lost to Follow-up|2|||
42169854|NCT03447730|75977001|FG000|Overall Study|Adverse Event|0|||
42169855|NCT03447730|75977002|FG001|Overall Study|Adverse Event|2|||
42169856|NCT03447730|75977003|FG002|Overall Study|Adverse Event|0|||
42169857|NCT03429556|75977015|FG000|Overall Study|Lost to Follow-up|0|||
42283063|NCT02618967|76114705|FG003|Overall Study|Lost to Follow-up|0|||
42014556|NCT00960661|75821647|FG000|Interventional Phase|sponsor decision|0|||
42014557|NCT00960661|75821648|FG001|Interventional Phase|sponsor decision|1|||
42014558|NCT00960661|75821649|FG002|Interventional Phase|sponsor decision|0|||
42014559|NCT00960661|75821647|FG000|Interventional Phase|Lack of Efficacy|0|||
42014560|NCT00960661|75821648|FG001|Interventional Phase|Lack of Efficacy|2|||
42014561|NCT00960661|75821649|FG002|Interventional Phase|Lack of Efficacy|0|||
42014562|NCT00960193|75821655|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
42014563|NCT00960115|75821664|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
42014564|NCT00960115|75821665|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
42014565|NCT00959647|75821671|FG000|Overall Study|Adverse Event|2|||
42014566|NCT00959647|75821671|FG000|Overall Study|Progressive disease|6|||
42014567|NCT00959647|75821671|FG000|Overall Study|Study terminated by sponsor|4|||
42014568|NCT00959647|75821671|FG000|Overall Study|Withdrawal by Subject|7|||
42014569|NCT00957931|75821675|FG000|Overall Study|Death|4|||
42014570|NCT00957853|75821682|FG000|Overall Study|Withdrawal by Subject|1|||
42014571|NCT00957853|75821683|FG001|Overall Study|Withdrawal by Subject|0|||
42014572|NCT00957853|75821684|FG002|Overall Study|Withdrawal by Subject|0|||
42169858|NCT03429556|75977016|FG001|Overall Study|Lost to Follow-up|1|||
42169859|NCT03429556|75977017|FG002|Overall Study|Lost to Follow-up|0|||
42169860|NCT03429556|75977018|FG003|Overall Study|Lost to Follow-up|0|||
42169861|NCT03428152|75977030|FG000|Overall Study|Physician Decision|4|||
42283064|NCT02618967|76114706|FG004|Overall Study|Lost to Follow-up|2|||
42169862|NCT03428152|75977031|FG001|Overall Study|Physician Decision|2|||
42169863|NCT03428152|75977030|FG000|Overall Study|Protocol Violation|3|||
42169864|NCT03428152|75977031|FG001|Overall Study|Protocol Violation|5|||
42169865|NCT03428152|75977030|FG000|Overall Study|Lack of Efficacy|0|||
42169866|NCT03428152|75977031|FG001|Overall Study|Lack of Efficacy|4|||
42169867|NCT03444766|75977037|FG000|Overall Study|Other Reasons|2|||
42169868|NCT03444766|75977037|FG000|Overall Study|Participant Withdrew Consent|5|||
42169869|NCT03444766|75977037|FG000|Overall Study|Lost to Follow-up|2|||
42169870|NCT03444766|75977037|FG000|Overall Study|Death|2|||
42169871|NCT03444766|75977037|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
42169872|NCT03444766|75977037|FG000|Overall Study|Disease Progression|49|||
42169873|NCT03426436|75977041|FG000|Overall Study|Incorrect lead placement|12|||
42169874|NCT03426436|75977041|FG000|Overall Study|Withdrawal by Subject|2|||
42169875|NCT03426436|75977041|FG000|Overall Study|Consent issue|1|||
42169876|NCT03426436|75977041|FG000|Overall Study|ECGs not saved|4|||
42169877|NCT03425188|75977045|FG000|Overall Study|Withdrawal by Subject|1|||
42169878|NCT03423238|75977052|FG000|Overall Study|Lost to Follow-up|1|||
42169879|NCT03423238|75977053|FG001|Overall Study|Lost to Follow-up|0|||
42169880|NCT03423238|75977052|FG000|Overall Study|Withdrawal by Subject|1|||
42169881|NCT03423238|75977053|FG001|Overall Study|Withdrawal by Subject|0|||
42169882|NCT02953678|75977060|FG000|Overall Study|Adverse Event|20|||
42169883|NCT02953678|75977060|FG000|Overall Study|Death|7|||
42169884|NCT02953678|75977060|FG000|Overall Study|Physician Decision|23|||
42169885|NCT02953678|75977060|FG000|Overall Study|Progressive Disease of GVHD|7|||
42169886|NCT02953678|75977060|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
42169887|NCT02953678|75977060|FG000|Overall Study|Withdrawal by participant|3|||
42169888|NCT02953678|75977060|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
42169889|NCT02953678|75977060|FG000|Overall Study|Participants were transferred to commercial product.|3|||
42169890|NCT03412084|75977067|FG000|Overall Study|Withdrawal by Subject|2|||
42169891|NCT03412084|75977068|FG001|Overall Study|Withdrawal by Subject|0|||
42169892|NCT03412084|75977067|FG000|Overall Study|Participant moved|1|||
42169893|NCT03412084|75977068|FG001|Overall Study|Participant moved|0|||
42169894|NCT03412084|75977067|FG000|Overall Study|Lost to Follow-up|1|||
42169895|NCT03412084|75977068|FG001|Overall Study|Lost to Follow-up|1|||
42169896|NCT00090753|75977076|FG000|First Treatment Period|Adverse Event|20|||
42169897|NCT00090753|75977077|FG001|First Treatment Period|Adverse Event|8|||
42169898|NCT00090753|75977076|FG000|First Treatment Period|Death|88|||
42169899|NCT00090753|75977077|FG001|First Treatment Period|Death|62|||
42169900|NCT00090753|75977076|FG000|First Treatment Period|Lack of Efficacy|2|||
42169901|NCT00090753|75977077|FG001|First Treatment Period|Lack of Efficacy|1|||
42169902|NCT00090753|75977076|FG000|First Treatment Period|Refused Treatment|32|||
42169903|NCT00090753|75977077|FG001|First Treatment Period|Refused Treatment|25|||
42283065|NCT02618967|76114707|FG005|Overall Study|Lost to Follow-up|0|||
42283066|NCT02618967|76114708|FG006|Overall Study|Lost to Follow-up|0|||
42283067|NCT02618967|76114709|FG007|Overall Study|Lost to Follow-up|0|||
42283068|NCT02618967|76114702|FG000|Overall Study|Withdrawal by Subject|1|||
42283069|NCT02618967|76114703|FG001|Overall Study|Withdrawal by Subject|0|||
42283070|NCT02618967|76114704|FG002|Overall Study|Withdrawal by Subject|0|||
42283071|NCT02618967|76114705|FG003|Overall Study|Withdrawal by Subject|0|||
42283072|NCT02618967|76114706|FG004|Overall Study|Withdrawal by Subject|0|||
42283073|NCT02618967|76114707|FG005|Overall Study|Withdrawal by Subject|0|||
42283074|NCT02618967|76114708|FG006|Overall Study|Withdrawal by Subject|0|||
42283075|NCT02618967|76114709|FG007|Overall Study|Withdrawal by Subject|0|||
42283076|NCT02616783|76114738|FG000|Overall Study|Randomized but Not Treated|1|||
42283077|NCT02616783|76114739|FG001|Overall Study|Randomized but Not Treated|0|||
42352076|NCT01614925|76192048|FG001|Overall Study|Protocol Violation|2|||
42169904|NCT00090753|75977076|FG000|First Treatment Period|Lost to Follow-up|4|||
42169905|NCT00090753|75977077|FG001|First Treatment Period|Lost to Follow-up|4|||
42169906|NCT00090753|75977076|FG000|First Treatment Period|Renal Transplant|70|||
42169907|NCT00090753|75977077|FG001|First Treatment Period|Renal Transplant|50|||
42169908|NCT00090753|75977076|FG000|First Treatment Period|Mircera Commercialization|1|||
42169909|NCT00090753|75977077|FG001|First Treatment Period|Mircera Commercialization|0|||
42169910|NCT00090753|75977076|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
42169911|NCT00090753|75977077|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
42169912|NCT00090753|75977076|FG000|Extended Treatment Period|Adverse Event|11|||
42169913|NCT00090753|75977077|FG001|Extended Treatment Period|Adverse Event|0|||
42169914|NCT00090753|75977076|FG000|Extended Treatment Period|Death|58|||
42169915|NCT00090753|75977077|FG001|Extended Treatment Period|Death|30|||
42169916|NCT00090753|75977076|FG000|Extended Treatment Period|Lack of Efficacy|1|||
42283078|NCT02616783|76114738|FG000|Overall Study|Adverse Event|1|||
42283079|NCT02616783|76114739|FG001|Overall Study|Adverse Event|0|||
42283080|NCT02616783|76114738|FG000|Overall Study|Death|1|||
42283081|NCT02616783|76114739|FG001|Overall Study|Death|0|||
42283082|NCT02616783|76114738|FG000|Overall Study|Non-Compliance with Study Drug|1|||
42283083|NCT02616783|76114739|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42283084|NCT02616783|76114738|FG000|Overall Study|Protocol Violation|1|||
42283085|NCT02616783|76114739|FG001|Overall Study|Protocol Violation|1|||
42283086|NCT02616783|76114738|FG000|Overall Study|Withdrew Consent|1|||
42283087|NCT02616783|76114739|FG001|Overall Study|Withdrew Consent|1|||
42283088|NCT02616393|76114748|FG000|Overall Study|Death|5|||
42283089|NCT02616393|76114749|FG001|Overall Study|Death|12|||
42283090|NCT02616393|76114750|FG002|Overall Study|Death|1|||
42283091|NCT02616393|76114748|FG000|Overall Study|Termination by Sponsor|4|||
42283092|NCT02616393|76114749|FG001|Overall Study|Termination by Sponsor|5|||
42283093|NCT02616393|76114750|FG002|Overall Study|Termination by Sponsor|2|||
42283094|NCT02616393|76114748|FG000|Overall Study|Other|3|||
42283095|NCT02616393|76114749|FG001|Overall Study|Other|0|||
42014573|NCT00957229|75821694|FG000|Study Start|Adverse Event|0|||
42014574|NCT00957229|75821695|FG001|Study Start|Adverse Event|3|||
42169917|NCT00090753|75977077|FG001|Extended Treatment Period|Lack of Efficacy|0|||
42014575|NCT00957229|75821694|FG000|Study Start|Disease Progression|1|||
42014576|NCT00957229|75821695|FG001|Study Start|Disease Progression|0|||
42169918|NCT00090753|75977076|FG000|Extended Treatment Period|Refused Treatment|18|||
42169919|NCT00090753|75977077|FG001|Extended Treatment Period|Refused Treatment|12|||
42169920|NCT00090753|75977076|FG000|Extended Treatment Period|Lost to Follow-up|3|||
42169921|NCT00090753|75977077|FG001|Extended Treatment Period|Lost to Follow-up|1|||
42169922|NCT00090753|75977076|FG000|Extended Treatment Period|Renal Transplant|15|||
42169923|NCT00090753|75977077|FG001|Extended Treatment Period|Renal Transplant|12|||
42169924|NCT00090753|75977076|FG000|Extended Treatment Period|Mircera Commercialization|188|||
42169925|NCT00090753|75977077|FG001|Extended Treatment Period|Mircera Commercialization|93|||
42169926|NCT00090753|75977076|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
42169927|NCT00090753|75977077|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
42169928|NCT00048932|75977085|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
42169929|NCT00048932|75977086|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
42169930|NCT00048932|75977087|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
42169931|NCT00048932|75977085|FG000|Double Blind Period (DB)|Adverse Event|51|||
42169932|NCT00048932|75977086|FG001|Double Blind Period (DB)|Adverse Event|19|||
42169933|NCT00048932|75977087|FG002|Double Blind Period (DB)|Adverse Event|0|||
42169934|NCT00048932|75977085|FG000|Double Blind Period (DB)|Death|5|||
42169935|NCT00048932|75977086|FG001|Double Blind Period (DB)|Death|3|||
42169936|NCT00048932|75977087|FG002|Double Blind Period (DB)|Death|0|||
42169937|NCT00048932|75977085|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
42169938|NCT00048932|75977086|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
42169939|NCT00048932|75977087|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
42169940|NCT00048932|75977085|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
42169941|NCT00048932|75977086|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
42169942|NCT00048932|75977087|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
42169943|NCT00048932|75977085|FG000|Double Blind Period (DB)|Relocation|1|||
42169944|NCT00048932|75977086|FG001|Double Blind Period (DB)|Relocation|0|||
42169945|NCT00048932|75977087|FG002|Double Blind Period (DB)|Relocation|0|||
42169946|NCT00048932|75977085|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
42169947|NCT00048932|75977086|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
42169948|NCT00048932|75977087|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
42169949|NCT00048932|75977085|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
42169950|NCT00048932|75977086|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
42169951|NCT00048932|75977087|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
42169952|NCT00048932|75977085|FG000|Double Blind Period (DB)|Pregnancy|1|||
42169953|NCT00048932|75977086|FG001|Double Blind Period (DB)|Pregnancy|0|||
42169954|NCT00048932|75977087|FG002|Double Blind Period (DB)|Pregnancy|0|||
42169955|NCT00048932|75977085|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
42169956|NCT00048932|75977086|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
42169957|NCT00048932|75977087|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
42169958|NCT00048932|75977085|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
42169959|NCT00048932|75977086|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
42169960|NCT00048932|75977087|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
42169961|NCT00048932|75977085|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
42169962|NCT00048932|75977086|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
42014577|NCT00957229|75821694|FG000|Reallocated to or Continued Vismodegib|Death|1|||
42014578|NCT00957229|75821695|FG001|Reallocated to or Continued Vismodegib|Death|1|||
42169963|NCT00048932|75977087|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
42169964|NCT00048932|75977085|FG000|Open Label Period (OL)|Death|0|||
42169965|NCT00048932|75977086|FG001|Open Label Period (OL)|Death|0|||
42169966|NCT00048932|75977087|FG002|Open Label Period (OL)|Death|25|||
42169967|NCT00048932|75977085|FG000|Open Label Period (OL)|Adverse Event|0|||
42283096|NCT02616393|76114750|FG002|Overall Study|Other|0|||
42283097|NCT02616393|76114748|FG000|Overall Study|Withdrawal by Subject|1|||
42283098|NCT02616393|76114749|FG001|Overall Study|Withdrawal by Subject|1|||
42283099|NCT02616393|76114750|FG002|Overall Study|Withdrawal by Subject|0|||
42283100|NCT02616393|76114748|FG000|Overall Study|Lost to Follow-up|0|||
42014579|NCT00957229|75821694|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
42014580|NCT00957229|75821695|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
42014581|NCT02604511|75821701|FG000|Overall Study|Adverse Event|3|||
42014582|NCT02604511|75821701|FG000|Overall Study|Disease Progression|4|||
42014583|NCT02604511|75821701|FG000|Overall Study|Withdrawal by Subject|3|||
42014584|NCT02604511|75821701|FG000|Overall Study|Participant ineligible|1|||
42014585|NCT02604511|75821701|FG000|Overall Study|Intercurrent illness|1|||
42014586|NCT00956839|75821709|FG000|Overall Study|Lost to Follow-up|3|||
42014587|NCT00956839|75821710|FG001|Overall Study|Lost to Follow-up|0|||
42014588|NCT00956839|75821711|FG002|Overall Study|Lost to Follow-up|3|||
42014589|NCT00956293|75821721|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
42014590|NCT00956293|75821722|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
42014591|NCT00956293|75821723|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
42014592|NCT00956293|75821721|FG000|Main Period (Pre-randomization)|Death|0|||
42014593|NCT00956293|75821722|FG001|Main Period (Pre-randomization)|Death|0|||
42014594|NCT00956293|75821723|FG002|Main Period (Pre-randomization)|Death|1|||
42014595|NCT00956293|75821721|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
42014596|NCT00956293|75821722|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
42014597|NCT00956293|75821723|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
42283101|NCT02616393|76114749|FG001|Overall Study|Lost to Follow-up|2|||
42283102|NCT02616393|76114750|FG002|Overall Study|Lost to Follow-up|0|||
42283103|NCT02155660|76114778|FG000|Overall Study|Other Reason|8|||
42283104|NCT02155660|76114779|FG001|Overall Study|Other Reason|6|||
42283105|NCT02155660|76114780|FG002|Overall Study|Other Reason|10|||
42283106|NCT02155660|76114781|FG003|Overall Study|Other Reason|10|||
42283107|NCT02155660|76114778|FG000|Overall Study|Study-specific withdrawal criteria|0|||
42283108|NCT02155660|76114779|FG001|Overall Study|Study-specific withdrawal criteria|1|||
42283109|NCT02155660|76114780|FG002|Overall Study|Study-specific withdrawal criteria|1|||
42283110|NCT02155660|76114781|FG003|Overall Study|Study-specific withdrawal criteria|1|||
42283111|NCT02155660|76114778|FG000|Overall Study|Severe non-compliance|0|||
42283112|NCT02155660|76114779|FG001|Overall Study|Severe non-compliance|4|||
42283113|NCT02155660|76114780|FG002|Overall Study|Severe non-compliance|0|||
42283114|NCT02155660|76114781|FG003|Overall Study|Severe non-compliance|1|||
42283115|NCT02155660|76114778|FG000|Overall Study|Adverse Event|2|||
42352077|NCT01886833|76192054|FG000|Overall Study|IgA not available from both periods|204|||
42352078|NCT01898923|76192063|FG000|Overall Study|Lack of Efficacy|5|||
42352079|NCT01898923|76192064|FG001|Overall Study|Lack of Efficacy|6|||
42352080|NCT01898923|76192063|FG000|Overall Study|Adverse Event|3|||
42352081|NCT01898923|76192064|FG001|Overall Study|Adverse Event|1|||
42352082|NCT01898923|76192063|FG000|Overall Study|Lost to Follow-up|0|||
42352083|NCT01898923|76192064|FG001|Overall Study|Lost to Follow-up|1|||
42352084|NCT01898923|76192063|FG000|Overall Study|Withdrawal by Subject|4|||
42014598|NCT00956293|75821721|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
42014599|NCT00956293|75821722|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
42014600|NCT00956293|75821723|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
42283116|NCT02155660|76114779|FG001|Overall Study|Adverse Event|6|||
42283117|NCT02155660|76114780|FG002|Overall Study|Adverse Event|3|||
42283118|NCT02155660|76114781|FG003|Overall Study|Adverse Event|1|||
42283119|NCT02155660|76114778|FG000|Overall Study|Lost to Follow-up|3|||
42283120|NCT02155660|76114779|FG001|Overall Study|Lost to Follow-up|6|||
42283121|NCT02155660|76114780|FG002|Overall Study|Lost to Follow-up|5|||
42283122|NCT02155660|76114781|FG003|Overall Study|Lost to Follow-up|8|||
42283123|NCT02155660|76114778|FG000|Overall Study|Death|17|||
42283124|NCT02155660|76114779|FG001|Overall Study|Death|19|||
42283125|NCT02155660|76114780|FG002|Overall Study|Death|17|||
42283126|NCT02155660|76114781|FG003|Overall Study|Death|19|||
42283127|NCT02155660|76114778|FG000|Overall Study|Withdrawal by Subject|28|||
42283128|NCT02155660|76114779|FG001|Overall Study|Withdrawal by Subject|31|||
42283129|NCT02155660|76114780|FG002|Overall Study|Withdrawal by Subject|24|||
42014601|NCT00956293|75821721|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
42014602|NCT00956293|75821722|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
42014603|NCT00956293|75821723|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
42014604|NCT00956293|75821721|FG000|Main Period (Pre-randomization)|Graft loss|0|||
42014605|NCT00956293|75821722|FG001|Main Period (Pre-randomization)|Graft loss|0|||
42283130|NCT02155660|76114781|FG003|Overall Study|Withdrawal by Subject|21|||
42352085|NCT01898923|76192064|FG001|Overall Study|Withdrawal by Subject|7|||
42352086|NCT01898923|76192063|FG000|Overall Study|Physician Decision|3|||
42352087|NCT01898923|76192064|FG001|Overall Study|Physician Decision|4|||
42014606|NCT00956293|75821723|FG002|Main Period (Pre-randomization)|Graft loss|7|||
42014607|NCT00956293|75821721|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
42283131|NCT02119936|76114791|FG000|Overall Study|Lost to Follow-up|10|||
42283132|NCT02181634|76114795|FG000|Overall Study|Lack of Efficacy|33|||
42283133|NCT02181634|76114795|FG000|Overall Study|Adverse Event|17|||
42283134|NCT02181634|76114795|FG000|Overall Study|Physician Decision|8|||
42283135|NCT02181634|76114795|FG000|Overall Study|Withdrawal by Subject|5|||
42014608|NCT00956293|75821722|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
42014609|NCT00956293|75821723|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
42014610|NCT00956293|75821721|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
42014611|NCT00956293|75821722|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
42014612|NCT00956293|75821723|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
42014613|NCT00956293|75821721|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
42014614|NCT00956293|75821722|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
42014615|NCT00956293|75821723|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
42014616|NCT00956293|75821721|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
42014617|NCT00956293|75821722|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
42014618|NCT00956293|75821723|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
42014619|NCT00956293|75821721|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
42169968|NCT00048932|75977086|FG001|Open Label Period (OL)|Adverse Event|0|||
42169969|NCT00048932|75977087|FG002|Open Label Period (OL)|Adverse Event|103|||
42169970|NCT00048932|75977085|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
42169971|NCT00048932|75977086|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
42169972|NCT00048932|75977087|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
42169973|NCT00048932|75977085|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
42169974|NCT00048932|75977086|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
42169975|NCT00048932|75977087|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
42169976|NCT00048932|75977085|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
42169977|NCT00048932|75977086|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
42169978|NCT00048932|75977087|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
42169979|NCT00048932|75977085|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
42169980|NCT00048932|75977086|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
42169981|NCT00048932|75977087|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
42169982|NCT00048932|75977085|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
42169983|NCT00048932|75977086|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
42169984|NCT00048932|75977087|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
42169985|NCT00048932|75977085|FG000|Open Label Period (OL)|Pregnancy|0|||
42169986|NCT00048932|75977086|FG001|Open Label Period (OL)|Pregnancy|0|||
42169987|NCT00048932|75977087|FG002|Open Label Period (OL)|Pregnancy|6|||
42169988|NCT00048932|75977085|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
42283136|NCT02181634|76114795|FG000|Overall Study|Death|2|||
42283137|NCT02181634|76114795|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
42283138|NCT02181634|76114795|FG000|Overall Study|Ineligible|1|||
42283139|NCT02181634|76114795|FG000|Overall Study|Max number of dose reduction|1|||
42283140|NCT02181634|76114795|FG000|Overall Study|Symptomatic progression|1|||
42283141|NCT02181634|76114795|FG000|Overall Study|Patient opted to proceed to surgery|1|||
42283142|NCT01595529|76114801|FG000|Overall Study|Adverse Event|2|||
42283143|NCT01595529|76114802|FG001|Overall Study|Adverse Event|0|||
42283144|NCT01595529|76114801|FG000|Overall Study|Subject Non-Compliant|2|||
42283145|NCT01595529|76114802|FG001|Overall Study|Subject Non-Compliant|0|||
42014620|NCT00956293|75821722|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
42169989|NCT00048932|75977086|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
42169990|NCT00048932|75977087|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
42169991|NCT00048932|75977085|FG000|Open Label Period (OL)|Investigator Retiring|0|||
42169992|NCT00048932|75977086|FG001|Open Label Period (OL)|Investigator Retiring|0|||
42169993|NCT00048932|75977087|FG002|Open Label Period (OL)|Investigator Retiring|2|||
42169994|NCT00048932|75977085|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
42169995|NCT00048932|75977086|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
42169996|NCT00048932|75977087|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
42169997|NCT00048932|75977085|FG000|Open Label Period (OL)|Participant Relocated|0|||
42169998|NCT00048932|75977086|FG001|Open Label Period (OL)|Participant Relocated|0|||
42169999|NCT00048932|75977087|FG002|Open Label Period (OL)|Participant Relocated|6|||
42170000|NCT00048932|75977085|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
42170001|NCT00048932|75977086|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
42170002|NCT00048932|75977087|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
42170003|NCT00048932|75977085|FG000|Open Label Period (OL)|Site Closure|0|||
42170004|NCT00048932|75977086|FG001|Open Label Period (OL)|Site Closure|0|||
42283146|NCT01595529|76114801|FG000|Overall Study|Lost to Follow-up|8|||
42283147|NCT01595529|76114802|FG001|Overall Study|Lost to Follow-up|14|||
42170005|NCT00048932|75977087|FG002|Open Label Period (OL)|Site Closure|3|||
42170006|NCT00048932|75977085|FG000|Open Label Period (OL)|Trial Terminated|0|||
42170007|NCT00048932|75977086|FG001|Open Label Period (OL)|Trial Terminated|0|||
42170008|NCT00048932|75977087|FG002|Open Label Period (OL)|Trial Terminated|1|||
42283148|NCT01595529|76114801|FG000|Overall Study|Protocol Violation|1|||
42283149|NCT01595529|76114802|FG001|Overall Study|Protocol Violation|2|||
42283150|NCT01595529|76114801|FG000|Overall Study|Physician Decision|1|||
42283151|NCT01595529|76114802|FG001|Overall Study|Physician Decision|0|||
42283152|NCT01595529|76114801|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
42283153|NCT01595529|76114802|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
42170009|NCT00048932|75977085|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
42170010|NCT00048932|75977086|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
42170011|NCT00048932|75977087|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
42283154|NCT01595529|76114801|FG000|Overall Study|Administrative Decision|1|||
42283155|NCT01595529|76114802|FG001|Overall Study|Administrative Decision|0|||
42283156|NCT01595529|76114801|FG000|Overall Study|Entry Failure/Screening Failure|6|||
42014621|NCT00956293|75821723|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
42170012|NCT00048932|75977085|FG000|Open Label Period (OL)|Patient Decision|0|||
42170013|NCT00048932|75977086|FG001|Open Label Period (OL)|Patient Decision|0|||
42170014|NCT00048932|75977087|FG002|Open Label Period (OL)|Patient Decision|4|||
42170015|NCT00048932|75977085|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
42170016|NCT00048932|75977086|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
42170017|NCT00048932|75977087|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
42170018|NCT00048932|75977085|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
42170019|NCT00048932|75977086|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
42170020|NCT00048932|75977087|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
42170021|NCT00048932|75977085|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
42170022|NCT00048932|75977086|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
42170023|NCT00048932|75977087|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
42170024|NCT00048932|75977085|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
42170025|NCT00048932|75977086|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
42170026|NCT00048932|75977087|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
42170027|NCT00048932|75977085|FG000|Open Label Period (OL)|Investigator Decision|0|||
42170028|NCT00048932|75977086|FG001|Open Label Period (OL)|Investigator Decision|0|||
42170029|NCT00048932|75977087|FG002|Open Label Period (OL)|Investigator Decision|4|||
42170030|NCT00048932|75977085|FG000|Open Label Period (OL)|Site Staff Issues|0|||
42170031|NCT00048932|75977086|FG001|Open Label Period (OL)|Site Staff Issues|0|||
42170032|NCT00048932|75977087|FG002|Open Label Period (OL)|Site Staff Issues|2|||
42170033|NCT00048932|75977085|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
42170034|NCT00048932|75977086|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
42170035|NCT00048932|75977087|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
42170036|NCT00048932|75977085|FG000|Open Label Period (OL)|Participant Surgery|0|||
42170037|NCT00048932|75977086|FG001|Open Label Period (OL)|Participant Surgery|0|||
42170038|NCT00048932|75977087|FG002|Open Label Period (OL)|Participant Surgery|1|||
42170039|NCT00073983|75977096|FG000|Overall Study|not evaluable|1|||
42170040|NCT03812679|75977102|FG000|Overall Study|Adverse Event|2|||
42170041|NCT03812679|75977102|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
42170042|NCT03812679|75977102|FG000|Overall Study|Renal transplant|1|||
42170043|NCT03812679|75977102|FG000|Overall Study|Withdrawal by Subject|1|||
42170044|NCT03812679|75977102|FG000|Overall Study|Termination of study|2|||
42170045|NCT03812679|75977102|FG000|Overall Study|Water device replacement|1|||
42170046|NCT02952820|75977109|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
42170047|NCT02952820|75977110|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
42170048|NCT02952820|75977111|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
42170049|NCT02952820|75977109|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
42170050|NCT02952820|75977110|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
42170051|NCT02952820|75977111|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
42170052|NCT02952820|75977109|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
42170053|NCT02952820|75977110|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
42170054|NCT02952820|75977111|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
42170055|NCT02952820|75977109|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
42170056|NCT02952820|75977110|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
42170057|NCT02952820|75977111|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
42170058|NCT02952820|75977109|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
42170059|NCT02952820|75977110|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
42170060|NCT02952820|75977111|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
42170061|NCT02952820|75977109|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
42170062|NCT02952820|75977110|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
42170063|NCT02952820|75977111|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
42170064|NCT02952820|75977109|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
42170065|NCT02952820|75977110|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
42283157|NCT01595529|76114802|FG001|Overall Study|Entry Failure/Screening Failure|1|||
42283158|NCT02615145|76114811|FG000|Overall Study|Did Not Start Treatment|0|||
42283159|NCT02615145|76114812|FG001|Overall Study|Did Not Start Treatment|0|||
42014622|NCT00956293|75821721|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
42170066|NCT02952820|75977111|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
42283160|NCT02615145|76114813|FG002|Overall Study|Did Not Start Treatment|1|||
42283161|NCT02615145|76114814|FG003|Overall Study|Did Not Start Treatment|1|||
42283162|NCT02615145|76114811|FG000|Overall Study|Failure to Return|20|||
42283163|NCT02615145|76114812|FG001|Overall Study|Failure to Return|10|||
42283164|NCT02615145|76114813|FG002|Overall Study|Failure to Return|7|||
42283165|NCT02615145|76114814|FG003|Overall Study|Failure to Return|0|||
42283166|NCT02615145|76114811|FG000|Overall Study|Death|2|||
42283167|NCT02615145|76114812|FG001|Overall Study|Death|3|||
42283168|NCT02615145|76114813|FG002|Overall Study|Death|0|||
42283169|NCT02615145|76114814|FG003|Overall Study|Death|0|||
42283170|NCT02615145|76114811|FG000|Overall Study|Other, Not Specified|5|||
42283171|NCT02615145|76114812|FG001|Overall Study|Other, Not Specified|2|||
42283172|NCT02615145|76114813|FG002|Overall Study|Other, Not Specified|0|||
42283173|NCT02615145|76114814|FG003|Overall Study|Other, Not Specified|0|||
42352088|NCT01898923|76192063|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
42170067|NCT02952820|75977109|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
42170068|NCT02952820|75977110|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
42170069|NCT02952820|75977111|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
42170070|NCT02952820|75977109|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
42170071|NCT02952820|75977110|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
42170072|NCT02952820|75977111|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
42170073|NCT02952820|75977109|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
42170074|NCT02952820|75977110|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
42170075|NCT02952820|75977111|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
42170076|NCT02952820|75977109|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
42170077|NCT02952820|75977110|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
42170078|NCT02952820|75977111|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
42170079|NCT02952820|75977109|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
42170080|NCT02952820|75977110|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
42170081|NCT02952820|75977111|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
42170082|NCT02952820|75977109|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
42170083|NCT02952820|75977110|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
42170084|NCT02952820|75977111|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
42170085|NCT02952820|75977109|FG000|Active Treatment Period (6 Months)|Not treated|0|||
42170086|NCT02952820|75977110|FG001|Active Treatment Period (6 Months)|Not treated|0|||
42170087|NCT02952820|75977111|FG002|Active Treatment Period (6 Months)|Not treated|1|||
42170088|NCT00006392|75977126|FG000|Overall Study|Ineligible|11|||
42170089|NCT00006392|75977127|FG001|Overall Study|Ineligible|3|||
42170090|NCT00006392|75977128|FG002|Overall Study|Ineligible|5|||
42170091|NCT00006392|75977129|FG003|Overall Study|Ineligible|5|||
42170092|NCT00006392|75977126|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
42170093|NCT00006392|75977127|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
42170094|NCT00006392|75977128|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
42170095|NCT00006392|75977129|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
42170096|NCT00379769|75977143|FG000|Main Study|Death|57|||
42170097|NCT00379769|75977144|FG001|Main Study|Death|67|||
42170098|NCT00379769|75977145|FG002|Main Study|Death|54|||
42170099|NCT00379769|75977146|FG003|Main Study|Death|72|||
42170100|NCT00379769|75977147|FG004|Main Study|Death|0|||
42170101|NCT00379769|75977148|FG005|Main Study|Death|0|||
42170102|NCT00379769|75977143|FG000|Main Study|Adverse Event|5|||
42170103|NCT00379769|75977144|FG001|Main Study|Adverse Event|8|||
42170104|NCT00379769|75977145|FG002|Main Study|Adverse Event|10|||
42170105|NCT00379769|75977146|FG003|Main Study|Adverse Event|11|||
42170106|NCT00379769|75977147|FG004|Main Study|Adverse Event|0|||
42170107|NCT00379769|75977148|FG005|Main Study|Adverse Event|0|||
42170108|NCT00379769|75977143|FG000|Main Study|Lost to Follow-up|29|||
42170109|NCT00379769|75977144|FG001|Main Study|Lost to Follow-up|29|||
42170110|NCT00379769|75977145|FG002|Main Study|Lost to Follow-up|25|||
42170111|NCT00379769|75977146|FG003|Main Study|Lost to Follow-up|26|||
42170112|NCT00379769|75977147|FG004|Main Study|Lost to Follow-up|0|||
42170113|NCT00379769|75977148|FG005|Main Study|Lost to Follow-up|0|||
42352089|NCT01898923|76192064|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
42170114|NCT00379769|75977143|FG000|Main Study|Withdrawal by Subject|46|||
42170115|NCT00379769|75977144|FG001|Main Study|Withdrawal by Subject|56|||
42170116|NCT00379769|75977145|FG002|Main Study|Withdrawal by Subject|72|||
42170117|NCT00379769|75977146|FG003|Main Study|Withdrawal by Subject|70|||
42283174|NCT02119156|76114843|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
42283175|NCT02119156|76114844|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
42170118|NCT00379769|75977147|FG004|Main Study|Withdrawal by Subject|0|||
42170119|NCT00379769|75977148|FG005|Main Study|Withdrawal by Subject|0|||
42170120|NCT00379769|75977143|FG000|Main Study|Moved to survival status follow-up only|27|||
42170121|NCT00379769|75977144|FG001|Main Study|Moved to survival status follow-up only|25|||
42170122|NCT00379769|75977145|FG002|Main Study|Moved to survival status follow-up only|32|||
42170123|NCT00379769|75977146|FG003|Main Study|Moved to survival status follow-up only|36|||
42283176|NCT02119156|76114845|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
42283177|NCT02119156|76114843|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
42283178|NCT02119156|76114844|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
42014623|NCT00956293|75821722|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
42014624|NCT00956293|75821723|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
42014625|NCT00956293|75821721|FG000|Main Period (Randomization)|Adverse Event|0|||
42014626|NCT00956293|75821722|FG001|Main Period (Randomization)|Adverse Event|15|||
42283179|NCT02119156|76114845|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
42283180|NCT02119156|76114843|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
42283181|NCT02119156|76114844|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
42283182|NCT02119156|76114845|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
42283183|NCT02119156|76114843|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
42283184|NCT02119156|76114844|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
42283185|NCT02119156|76114845|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
42283186|NCT02119156|76114843|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
42283187|NCT02119156|76114844|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
42283188|NCT02119156|76114845|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
42283189|NCT02181556|76114860|FG000|Overall Study|Withdrawal by Subject|1|||
42283190|NCT02614131|76114871|FG000|Overall Study|Withdrawal by Subject|1|||
42283191|NCT02614131|76114872|FG001|Overall Study|Withdrawal by Subject|0|||
42283192|NCT02614131|76114873|FG002|Overall Study|Withdrawal by Subject|0|||
42283193|NCT02614131|76114874|FG003|Overall Study|Withdrawal by Subject|0|||
42283194|NCT02614131|76114875|FG004|Overall Study|Withdrawal by Subject|0|||
42283195|NCT02614131|76114876|FG005|Overall Study|Withdrawal by Subject|0|||
42283196|NCT02614131|76114877|FG006|Overall Study|Withdrawal by Subject|0|||
42283197|NCT02614131|76114871|FG000|Overall Study|Adverse Event|0|||
42283198|NCT02614131|76114872|FG001|Overall Study|Adverse Event|0|||
42283199|NCT02614131|76114873|FG002|Overall Study|Adverse Event|0|||
42283200|NCT02614131|76114874|FG003|Overall Study|Adverse Event|0|||
42283201|NCT02614131|76114875|FG004|Overall Study|Adverse Event|0|||
42283202|NCT02614131|76114876|FG005|Overall Study|Adverse Event|0|||
42283203|NCT02614131|76114877|FG006|Overall Study|Adverse Event|1|||
42283204|NCT05091307|76114903|FG000|Overall Study|Death|0|||
42283205|NCT05091307|76114904|FG001|Overall Study|Death|0|||
42283206|NCT05091307|76114905|FG002|Overall Study|Death|1|||
42283207|NCT05091307|76114906|FG003|Overall Study|Death|0|||
42283208|NCT05091307|76114903|FG000|Overall Study|Lost to Follow-up|33|||
42283209|NCT05091307|76114904|FG001|Overall Study|Lost to Follow-up|33|||
42283210|NCT05091307|76114905|FG002|Overall Study|Lost to Follow-up|2|||
42283211|NCT05091307|76114906|FG003|Overall Study|Lost to Follow-up|0|||
42283212|NCT05091307|76114903|FG000|Overall Study|Physician Decision|1|||
42283213|NCT05091307|76114904|FG001|Overall Study|Physician Decision|0|||
42283214|NCT05091307|76114905|FG002|Overall Study|Physician Decision|0|||
42283215|NCT05091307|76114906|FG003|Overall Study|Physician Decision|0|||
42283216|NCT05091307|76114903|FG000|Overall Study|Protocol Violation|1|||
42283217|NCT05091307|76114904|FG001|Overall Study|Protocol Violation|0|||
42283218|NCT05091307|76114905|FG002|Overall Study|Protocol Violation|0|||
42283219|NCT05091307|76114906|FG003|Overall Study|Protocol Violation|0|||
42283220|NCT05091307|76114903|FG000|Overall Study|Withdrawal by Subject|16|||
42283221|NCT05091307|76114904|FG001|Overall Study|Withdrawal by Subject|16|||
42283222|NCT05091307|76114905|FG002|Overall Study|Withdrawal by Subject|0|||
42352090|NCT01924429|76192072|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
42352091|NCT01924429|76192073|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
42352092|NCT01898299|76192083|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
42352093|NCT01898299|76192084|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
42352094|NCT01886287|76192090|FG000|Overall Study|Radiographic disease progression|1|||
42014627|NCT00956293|75821723|FG002|Main Period (Randomization)|Adverse Event|0|||
42170124|NCT00379769|75977147|FG004|Main Study|Moved to survival status follow-up only|0|||
42283223|NCT05091307|76114906|FG003|Overall Study|Withdrawal by Subject|1|||
42170125|NCT00379769|75977148|FG005|Main Study|Moved to survival status follow-up only|0|||
42283224|NCT05091307|76114903|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
42283225|NCT05091307|76114904|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
42283226|NCT05091307|76114905|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
42283227|NCT05091307|76114906|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
42283228|NCT05091307|76114903|FG000|Overall Study|Initiated Prohibited Medication|1|||
42283229|NCT05091307|76114904|FG001|Overall Study|Initiated Prohibited Medication|0|||
42352095|NCT01886287|76192090|FG000|Overall Study|Clinical progression due to disease|1|||
42014628|NCT00956293|75821721|FG000|Follow-up Period|Follow-up period was terminated.|20|||
42014629|NCT00956293|75821722|FG001|Follow-up Period|Follow-up period was terminated.|32|||
42014630|NCT00956293|75821723|FG002|Follow-up Period|Follow-up period was terminated.|0|||
42014631|NCT00955825|75821731|FG000|Overall Study|Adverse Event|15|||
42014632|NCT00955825|75821732|FG001|Overall Study|Adverse Event|2|||
42014633|NCT00955825|75821731|FG000|Overall Study|Withdrawal by Subject|4|||
42014634|NCT00955825|75821732|FG001|Overall Study|Withdrawal by Subject|6|||
42014635|NCT00955825|75821731|FG000|Overall Study|Any other reason not above-mentioned|7|||
42014636|NCT00955825|75821732|FG001|Overall Study|Any other reason not above-mentioned|9|||
42014637|NCT01164579|75821741|FG000|Overall Study|Lack of Efficacy|0|||
42014638|NCT01164579|75821742|FG001|Overall Study|Lack of Efficacy|0|||
42040708|NCT01796171|75848718|FG012|Follow-up Period|Withdrawal by Subject|0|||
42040709|NCT01796171|75848719|FG013|Follow-up Period|Withdrawal by Subject|0|||
42170126|NCT00379769|75977143|FG000|Main Study|Participant moved|3|||
42170127|NCT00379769|75977144|FG001|Main Study|Participant moved|2|||
42170128|NCT00379769|75977145|FG002|Main Study|Participant moved|3|||
42040710|NCT01796171|75848720|FG014|Follow-up Period|Withdrawal by Subject|0|||
42040711|NCT01796171|75848706|FG000|Follow-up Period|Death|0|||
42040712|NCT01796171|75848707|FG001|Follow-up Period|Death|0|||
42352096|NCT01885195|76192094|FG000|Overall Study|Adverse Event|29|||
42352097|NCT01885195|76192094|FG000|Overall Study|Death|1|||
42352098|NCT01885195|76192094|FG000|Overall Study|Disease Progression|67|||
42352099|NCT01885195|76192094|FG000|Overall Study|Protocol Deviation|2|||
42352100|NCT01885195|76192094|FG000|Overall Study|Physician Decision|3|||
42014639|NCT01164579|75821743|FG002|Overall Study|Lack of Efficacy|6|||
42014640|NCT01164579|75821741|FG000|Overall Study|Lost to Follow-up|1|||
42040713|NCT01796171|75848708|FG002|Follow-up Period|Death|0|||
42040714|NCT01796171|75848709|FG003|Follow-up Period|Death|0|||
42040715|NCT01796171|75848710|FG004|Follow-up Period|Death|0|||
42040716|NCT01796171|75848711|FG005|Follow-up Period|Death|0|||
42170129|NCT00379769|75977146|FG003|Main Study|Participant moved|3|||
42170130|NCT00379769|75977147|FG004|Main Study|Participant moved|0|||
42170131|NCT00379769|75977148|FG005|Main Study|Participant moved|0|||
42170132|NCT00379769|75977143|FG000|Main Study|Poor compliance|3|||
42170133|NCT00379769|75977144|FG001|Main Study|Poor compliance|2|||
42170134|NCT00379769|75977145|FG002|Main Study|Poor compliance|2|||
42170135|NCT00379769|75977146|FG003|Main Study|Poor compliance|1|||
42170136|NCT00379769|75977147|FG004|Main Study|Poor compliance|0|||
42170137|NCT00379769|75977148|FG005|Main Study|Poor compliance|0|||
42170138|NCT00379769|75977143|FG000|Main Study|Prohibited glucose lowering medication|0|||
42170139|NCT00379769|75977144|FG001|Main Study|Prohibited glucose lowering medication|3|||
42170140|NCT00379769|75977145|FG002|Main Study|Prohibited glucose lowering medication|0|||
42170141|NCT00379769|75977146|FG003|Main Study|Prohibited glucose lowering medication|1|||
42170142|NCT00379769|75977147|FG004|Main Study|Prohibited glucose lowering medication|0|||
42170143|NCT00379769|75977148|FG005|Main Study|Prohibited glucose lowering medication|0|||
42170144|NCT00379769|75977143|FG000|Main Study|Site closed|4|||
42170145|NCT00379769|75977144|FG001|Main Study|Site closed|4|||
42170146|NCT00379769|75977145|FG002|Main Study|Site closed|4|||
42170147|NCT00379769|75977146|FG003|Main Study|Site closed|8|||
42170148|NCT00379769|75977147|FG004|Main Study|Site closed|0|||
42170149|NCT00379769|75977148|FG005|Main Study|Site closed|0|||
42170150|NCT00379769|75977143|FG000|Main Study|Entry criteria violation|0|||
42170151|NCT00379769|75977144|FG001|Main Study|Entry criteria violation|0|||
42170152|NCT00379769|75977145|FG002|Main Study|Entry criteria violation|1|||
42170153|NCT00379769|75977146|FG003|Main Study|Entry criteria violation|1|||
42170154|NCT00379769|75977147|FG004|Main Study|Entry criteria violation|0|||
42040717|NCT01796171|75848712|FG006|Follow-up Period|Death|1|||
42040718|NCT01796171|75848713|FG007|Follow-up Period|Death|0|||
42040719|NCT01796171|75848714|FG008|Follow-up Period|Death|0|||
42040720|NCT01796171|75848715|FG009|Follow-up Period|Death|0|||
42040721|NCT01796171|75848716|FG010|Follow-up Period|Death|17|||
42040722|NCT01796171|75848717|FG011|Follow-up Period|Death|9|||
42170155|NCT00379769|75977148|FG005|Main Study|Entry criteria violation|0|||
42170156|NCT00379769|75977143|FG000|Main Study|Participant did not take study drug|0|||
42170157|NCT00379769|75977144|FG001|Main Study|Participant did not take study drug|0|||
42170158|NCT00379769|75977145|FG002|Main Study|Participant did not take study drug|1|||
42170159|NCT00379769|75977146|FG003|Main Study|Participant did not take study drug|0|||
42352101|NCT01885195|76192094|FG000|Overall Study|Patient/guardian decision|8|||
42040723|NCT01796171|75848718|FG012|Follow-up Period|Death|1|||
42040724|NCT01796171|75848719|FG013|Follow-up Period|Death|0|||
42170160|NCT00379769|75977147|FG004|Main Study|Participant did not take study drug|0|||
42040725|NCT01796171|75848720|FG014|Follow-up Period|Death|0|||
42170161|NCT00379769|75977148|FG005|Main Study|Participant did not take study drug|0|||
42170162|NCT00379769|75977143|FG000|Main Study|Physician Decision|2|||
42040726|NCT01796171|75848706|FG000|Follow-up Period|Patient transferred to other hospital|0|||
42040727|NCT01796171|75848707|FG001|Follow-up Period|Patient transferred to other hospital|1|||
42170163|NCT00379769|75977144|FG001|Main Study|Physician Decision|2|||
42170164|NCT00379769|75977145|FG002|Main Study|Physician Decision|1|||
42170165|NCT00379769|75977146|FG003|Main Study|Physician Decision|1|||
42170166|NCT00379769|75977147|FG004|Main Study|Physician Decision|0|||
42170167|NCT00379769|75977148|FG005|Main Study|Physician Decision|0|||
42170168|NCT00379769|75977143|FG000|Main Study|Participant completed study at visit 27|1|||
42170169|NCT00379769|75977144|FG001|Main Study|Participant completed study at visit 27|0|||
42170170|NCT00379769|75977145|FG002|Main Study|Participant completed study at visit 27|0|||
42170171|NCT00379769|75977146|FG003|Main Study|Participant completed study at visit 27|0|||
42170172|NCT00379769|75977147|FG004|Main Study|Participant completed study at visit 27|0|||
42170173|NCT00379769|75977148|FG005|Main Study|Participant completed study at visit 27|0|||
42170174|NCT00379769|75977143|FG000|Main Study|Personal reasons|1|||
42170175|NCT00379769|75977144|FG001|Main Study|Personal reasons|0|||
42170176|NCT00379769|75977145|FG002|Main Study|Personal reasons|0|||
42170177|NCT00379769|75977146|FG003|Main Study|Personal reasons|0|||
42170178|NCT00379769|75977147|FG004|Main Study|Personal reasons|0|||
42170179|NCT00379769|75977148|FG005|Main Study|Personal reasons|0|||
42170180|NCT00379769|75977143|FG000|Main Study|Risk of heart failure|0|||
42170181|NCT00379769|75977144|FG001|Main Study|Risk of heart failure|1|||
42170182|NCT00379769|75977145|FG002|Main Study|Risk of heart failure|0|||
42170183|NCT00379769|75977146|FG003|Main Study|Risk of heart failure|0|||
42170184|NCT00379769|75977147|FG004|Main Study|Risk of heart failure|0|||
42170185|NCT00379769|75977148|FG005|Main Study|Risk of heart failure|0|||
42170186|NCT00379769|75977143|FG000|Main Study|Investigator refused to log temperature|0|||
42170187|NCT00379769|75977144|FG001|Main Study|Investigator refused to log temperature|0|||
42283230|NCT05091307|76114905|FG002|Overall Study|Initiated Prohibited Medication|0|||
42283231|NCT05091307|76114906|FG003|Overall Study|Initiated Prohibited Medication|0|||
42283232|NCT05091307|76114903|FG000|Overall Study|Other|4|||
42283233|NCT05091307|76114904|FG001|Overall Study|Other|4|||
42283234|NCT05091307|76114905|FG002|Overall Study|Other|0|||
42283235|NCT05091307|76114906|FG003|Overall Study|Other|0|||
42283236|NCT05091307|76114903|FG000|Overall Study|Randomized but not vaccinated|0|||
42283237|NCT05091307|76114904|FG001|Overall Study|Randomized but not vaccinated|2|||
42283238|NCT05091307|76114905|FG002|Overall Study|Randomized but not vaccinated|0|||
42283239|NCT05091307|76114906|FG003|Overall Study|Randomized but not vaccinated|0|||
42283240|NCT04930965|76114938|FG000|Overall Study|Lost to Follow-up|7|||
42352102|NCT01896895|76192101|FG000|Double-blind MP|Physician Decision|0|||
42352103|NCT01896895|76192102|FG001|Double-blind MP|Physician Decision|0|||
42352104|NCT01896895|76192103|FG002|Double-blind MP|Physician Decision|1|||
42352105|NCT01896895|76192104|FG003|Double-blind MP|Physician Decision|0|||
42352106|NCT01896895|76192101|FG000|Double-blind MP|Withdrawal by Subject|0|||
42352107|NCT01896895|76192102|FG001|Double-blind MP|Withdrawal by Subject|2|||
42352108|NCT01896895|76192103|FG002|Double-blind MP|Withdrawal by Subject|1|||
42352109|NCT01896895|76192104|FG003|Double-blind MP|Withdrawal by Subject|0|||
42352110|NCT01896895|76192101|FG000|Double-blind MP|Lost to Follow-up|1|||
42352111|NCT01896895|76192102|FG001|Double-blind MP|Lost to Follow-up|0|||
42352112|NCT01896895|76192103|FG002|Double-blind MP|Lost to Follow-up|1|||
42352113|NCT01896895|76192104|FG003|Double-blind MP|Lost to Follow-up|0|||
42352114|NCT01923181|76192140|FG000|Overall Study|Protocol Violation|2|||
42352115|NCT01923181|76192141|FG001|Overall Study|Protocol Violation|2|||
42352116|NCT01923181|76192142|FG002|Overall Study|Protocol Violation|0|||
42352117|NCT01923181|76192143|FG003|Overall Study|Protocol Violation|2|||
42352118|NCT01923181|76192144|FG004|Overall Study|Protocol Violation|2|||
42352119|NCT01923181|76192145|FG005|Overall Study|Protocol Violation|1|||
42352120|NCT01923181|76192146|FG006|Overall Study|Protocol Violation|1|||
42352121|NCT01923181|76192147|FG007|Overall Study|Protocol Violation|2|||
42352122|NCT01923181|76192148|FG008|Overall Study|Protocol Violation|1|||
42352123|NCT01923181|76192140|FG000|Overall Study|Withdrawal by Subject|0|||
42352124|NCT01923181|76192141|FG001|Overall Study|Withdrawal by Subject|1|||
42352125|NCT01923181|76192142|FG002|Overall Study|Withdrawal by Subject|0|||
42352126|NCT01923181|76192143|FG003|Overall Study|Withdrawal by Subject|1|||
42170188|NCT00379769|75977145|FG002|Main Study|Investigator refused to log temperature|1|||
42170189|NCT00379769|75977146|FG003|Main Study|Investigator refused to log temperature|0|||
42170190|NCT00379769|75977147|FG004|Main Study|Investigator refused to log temperature|0|||
42170191|NCT00379769|75977148|FG005|Main Study|Investigator refused to log temperature|0|||
42170192|NCT00379769|75977143|FG000|Main Study|Reason unspecified|0|||
42352127|NCT01923181|76192144|FG004|Overall Study|Withdrawal by Subject|4|||
42352128|NCT01923181|76192145|FG005|Overall Study|Withdrawal by Subject|2|||
42170193|NCT00379769|75977144|FG001|Main Study|Reason unspecified|0|||
42170194|NCT00379769|75977145|FG002|Main Study|Reason unspecified|1|||
42283241|NCT04930965|76114939|FG001|Overall Study|Lost to Follow-up|5|||
42352129|NCT01923181|76192146|FG006|Overall Study|Withdrawal by Subject|4|||
42352130|NCT01923181|76192147|FG007|Overall Study|Withdrawal by Subject|3|||
42352131|NCT01923181|76192148|FG008|Overall Study|Withdrawal by Subject|1|||
42352132|NCT01923181|76192140|FG000|Overall Study|Other|1|||
42352133|NCT01923181|76192141|FG001|Overall Study|Other|0|||
42352134|NCT01923181|76192142|FG002|Overall Study|Other|0|||
42283242|NCT04806334|76114945|FG000|Overall Study|Withdrawal by Subject|1|||
42283243|NCT04740931|76114964|FG000|Overall Study|Ongoing in the Study at the Primary Completion Date|360|||
42283244|NCT04740931|76114965|FG001|Overall Study|Ongoing in the Study at the Primary Completion Date|353|||
42170195|NCT00379769|75977146|FG003|Main Study|Reason unspecified|0|||
42170196|NCT00379769|75977147|FG004|Main Study|Reason unspecified|0|||
42170197|NCT00379769|75977148|FG005|Main Study|Reason unspecified|0|||
42170198|NCT00379769|75977143|FG000|Observational Follow-up|Death|0|||
42170199|NCT00379769|75977144|FG001|Observational Follow-up|Death|0|||
42170200|NCT00379769|75977145|FG002|Observational Follow-up|Death|0|||
42170201|NCT00379769|75977146|FG003|Observational Follow-up|Death|0|||
42170202|NCT00379769|75977147|FG004|Observational Follow-up|Death|78|||
42170203|NCT00379769|75977148|FG005|Observational Follow-up|Death|70|||
42170204|NCT00379769|75977143|FG000|Observational Follow-up|Adverse Event|0|||
42170205|NCT00379769|75977144|FG001|Observational Follow-up|Adverse Event|0|||
42170206|NCT00379769|75977145|FG002|Observational Follow-up|Adverse Event|0|||
42170207|NCT00379769|75977146|FG003|Observational Follow-up|Adverse Event|0|||
42170208|NCT00379769|75977147|FG004|Observational Follow-up|Adverse Event|1|||
42170209|NCT00379769|75977148|FG005|Observational Follow-up|Adverse Event|0|||
42170210|NCT00379769|75977143|FG000|Observational Follow-up|Lost to Follow-up|0|||
42170211|NCT00379769|75977144|FG001|Observational Follow-up|Lost to Follow-up|0|||
42170212|NCT00379769|75977145|FG002|Observational Follow-up|Lost to Follow-up|0|||
42170213|NCT00379769|75977146|FG003|Observational Follow-up|Lost to Follow-up|0|||
42170214|NCT00379769|75977147|FG004|Observational Follow-up|Lost to Follow-up|25|||
42170215|NCT00379769|75977148|FG005|Observational Follow-up|Lost to Follow-up|27|||
42170216|NCT00379769|75977143|FG000|Observational Follow-up|Withdrawal by Subject|0|||
42170217|NCT00379769|75977144|FG001|Observational Follow-up|Withdrawal by Subject|0|||
42170218|NCT00379769|75977145|FG002|Observational Follow-up|Withdrawal by Subject|0|||
42170219|NCT00379769|75977146|FG003|Observational Follow-up|Withdrawal by Subject|0|||
42170220|NCT00379769|75977147|FG004|Observational Follow-up|Withdrawal by Subject|12|||
42170221|NCT00379769|75977148|FG005|Observational Follow-up|Withdrawal by Subject|12|||
42170222|NCT00379769|75977143|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
42283245|NCT04740931|76114964|FG000|Overall Study|Withdrawal by Subject|0|||
42283246|NCT04740931|76114965|FG001|Overall Study|Withdrawal by Subject|4|||
42170223|NCT00379769|75977144|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
42170224|NCT00379769|75977145|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
42170225|NCT00379769|75977146|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
42283247|NCT04740931|76114964|FG000|Overall Study|Death|1|||
42283248|NCT04740931|76114965|FG001|Overall Study|Death|2|||
42170226|NCT00379769|75977147|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
42170227|NCT00379769|75977148|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
42170228|NCT00379769|75977143|FG000|Observational Follow-up|Physician Decision|0|||
42170229|NCT00379769|75977144|FG001|Observational Follow-up|Physician Decision|0|||
42283249|NCT04740931|76114964|FG000|Overall Study|Noncompliance with study drug|2|||
42283250|NCT04740931|76114965|FG001|Overall Study|Noncompliance with study drug|0|||
42283251|NCT04740931|76114964|FG000|Overall Study|Reason Not Specified|2|||
42283252|NCT04740931|76114965|FG001|Overall Study|Reason Not Specified|0|||
42283253|NCT04740931|76114964|FG000|Overall Study|Adverse Event|1|||
42283254|NCT04740931|76114965|FG001|Overall Study|Adverse Event|1|||
42283255|NCT04740931|76114964|FG000|Overall Study|Protocol Violation|0|||
42283256|NCT04740931|76114965|FG001|Overall Study|Protocol Violation|1|||
42283257|NCT04740931|76114964|FG000|Overall Study|Physician Decision|0|||
42283258|NCT04740931|76114965|FG001|Overall Study|Physician Decision|1|||
42283259|NCT04740931|76114964|FG000|Overall Study|Lost to Follow-up|0|||
42283260|NCT04740931|76114965|FG001|Overall Study|Lost to Follow-up|1|||
42283261|NCT04681352|76114971|FG000|Overall Study|Lost to Follow-up|2|||
42283262|NCT04681352|76114971|FG000|Overall Study|Withdrawal by Subject|22|||
42283263|NCT04471428|76114977|FG000|Overall Study|Withdrawal by Subject|29|||
42283264|NCT04471428|76114978|FG001|Overall Study|Withdrawal by Subject|1|||
42283265|NCT04471428|76114977|FG000|Overall Study|Physician Decision|0|||
42014641|NCT01164579|75821742|FG001|Overall Study|Lost to Follow-up|1|||
42170230|NCT00379769|75977145|FG002|Observational Follow-up|Physician Decision|0|||
42170231|NCT00379769|75977146|FG003|Observational Follow-up|Physician Decision|0|||
42170232|NCT00379769|75977147|FG004|Observational Follow-up|Physician Decision|8|||
42283266|NCT04471428|76114978|FG001|Overall Study|Physician Decision|1|||
42283267|NCT04471428|76114977|FG000|Overall Study|Reason Not Specified|0|||
42014642|NCT01164579|75821743|FG002|Overall Study|Lost to Follow-up|0|||
42014643|NCT01164579|75821741|FG000|Overall Study|Withdrawal by Subject|2|||
42014644|NCT01164579|75821742|FG001|Overall Study|Withdrawal by Subject|5|||
42014645|NCT01164579|75821743|FG002|Overall Study|Withdrawal by Subject|3|||
42014646|NCT01164579|75821741|FG000|Overall Study|Protocol Violation|0|||
42014647|NCT01164579|75821742|FG001|Overall Study|Protocol Violation|1|||
42014648|NCT01164579|75821743|FG002|Overall Study|Protocol Violation|2|||
42283268|NCT04471428|76114978|FG001|Overall Study|Reason Not Specified|2|||
42283269|NCT04471428|76114977|FG000|Overall Study|Death|106|||
42014649|NCT01164579|75821741|FG000|Overall Study|Adverse Event|4|||
42170233|NCT00379769|75977148|FG005|Observational Follow-up|Physician Decision|8|||
42170234|NCT00379769|75977143|FG000|Observational Follow-up|Site Closed Early|0|||
42170235|NCT00379769|75977144|FG001|Observational Follow-up|Site Closed Early|0|||
42170236|NCT00379769|75977145|FG002|Observational Follow-up|Site Closed Early|0|||
42170237|NCT00379769|75977146|FG003|Observational Follow-up|Site Closed Early|0|||
42170238|NCT00379769|75977147|FG004|Observational Follow-up|Site Closed Early|6|||
42170239|NCT00379769|75977148|FG005|Observational Follow-up|Site Closed Early|7|||
42170240|NCT00379769|75977143|FG000|Observational Follow-up|Participant Moved|0|||
42170241|NCT00379769|75977144|FG001|Observational Follow-up|Participant Moved|0|||
42170242|NCT00379769|75977145|FG002|Observational Follow-up|Participant Moved|0|||
42170243|NCT00379769|75977146|FG003|Observational Follow-up|Participant Moved|0|||
42170244|NCT00379769|75977147|FG004|Observational Follow-up|Participant Moved|0|||
42170245|NCT00379769|75977148|FG005|Observational Follow-up|Participant Moved|1|||
42170246|NCT00379769|75977143|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
42170247|NCT00379769|75977144|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
42170248|NCT00379769|75977145|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
42170249|NCT00379769|75977146|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
42170250|NCT00379769|75977147|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
42170251|NCT00379769|75977148|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
42170252|NCT00006164|75977177|FG000|Overall Study|Withdrew or lost to follow-up|70|||
42170253|NCT00006164|75977178|FG001|Overall Study|Withdrew or lost to follow-up|81|||
42170254|NCT00378599|75977184|FG000|Overall Study|Adverse Event|38|||
42170255|NCT00378599|75977184|FG000|Overall Study|Protocol Violation|2|||
42170256|NCT00378599|75977184|FG000|Overall Study|Treatment failure|7|||
42170257|NCT00378599|75977184|FG000|Overall Study|Withdrawal by Subject|5|||
42170258|NCT00378209|75977188|FG000|Overall Study|Progressive disease|11|||
42170259|NCT00378209|75977188|FG000|Overall Study|Adverse Event|3|||
42170260|NCT00378209|75977188|FG000|Overall Study|Initiation of non-protocol therapy|3|||
42170261|NCT00378209|75977188|FG000|Overall Study|Physician Decision|3|||
42170262|NCT00378209|75977188|FG000|Overall Study|Death|1|||
42170263|NCT00378209|75977188|FG000|Overall Study|Treatment delay|1|||
42170264|NCT00377819|75977195|FG000|Overall Study|Adverse Event|2|||
42170265|NCT00377819|75977196|FG001|Overall Study|Adverse Event|3|||
42170266|NCT00377819|75977195|FG000|Overall Study|Withdrawal by Subject|10|||
42170267|NCT00377819|75977196|FG001|Overall Study|Withdrawal by Subject|4|||
42170268|NCT00377819|75977195|FG000|Overall Study|Death|0|||
42170269|NCT00377819|75977196|FG001|Overall Study|Death|1|||
42170270|NCT00377819|75977195|FG000|Overall Study|Lost to Follow-up|0|||
42170271|NCT00377819|75977196|FG001|Overall Study|Lost to Follow-up|1|||
42170272|NCT00377819|75977195|FG000|Overall Study|Protocol Violation|1|||
42170273|NCT00377819|75977196|FG001|Overall Study|Protocol Violation|1|||
42170274|NCT03419962|75977202|FG000|Overall Study|Change to other medication|1|||
42170275|NCT03419962|75977202|FG000|Overall Study|Refusal of continuing with trial drug|1|||
42170276|NCT03419962|75977202|FG000|Overall Study|Lost to Follow-up|3|||
42170277|NCT03419962|75977202|FG000|Overall Study|Difficulty in inhaling the doses|1|||
42170278|NCT03419962|75977202|FG000|Overall Study|Missing completion data|31|||
42170279|NCT00377429|75977206|FG000|Overall Study|Withdrawal by Subject|5|||
42283270|NCT04471428|76114978|FG001|Overall Study|Death|114|||
42283271|NCT04471428|76114977|FG000|Overall Study|Ongoing in the study|45|||
42283272|NCT04471428|76114978|FG001|Overall Study|Ongoing in the study|68|||
42283273|NCT04339413|76114996|FG000|Overall Study|Reason Not Specified|2|||
42283274|NCT04339413|76114997|FG001|Overall Study|Reason Not Specified|7|||
42283275|NCT04339413|76114996|FG000|Overall Study|Study Terminated by Sponsor|30|||
42283276|NCT04339413|76114997|FG001|Overall Study|Study Terminated by Sponsor|33|||
42283277|NCT04339413|76114996|FG000|Overall Study|Progressive Disease|9|||
42283278|NCT04339413|76114997|FG001|Overall Study|Progressive Disease|6|||
42170280|NCT00377429|75977206|FG000|Overall Study|Adverse Event|8|||
42170281|NCT00377429|75977206|FG000|Overall Study|Physician Decision|1|||
42283279|NCT04339413|76114996|FG000|Overall Study|Withdrawal by Subject|9|||
42283280|NCT04339413|76114997|FG001|Overall Study|Withdrawal by Subject|10|||
42040728|NCT01796171|75848708|FG002|Follow-up Period|Patient transferred to other hospital|0|||
42040729|NCT01796171|75848709|FG003|Follow-up Period|Patient transferred to other hospital|0|||
42170282|NCT00377429|75977206|FG000|Overall Study|Patient non-compliance|1|||
42170283|NCT00376961|75977210|FG000|Initial Registration|Adverse Event|1|||
42170284|NCT00376961|75977211|FG001|Initial Registration|Adverse Event|0|||
42170285|NCT00376961|75977210|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
42170286|NCT00376961|75977211|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
42170287|NCT00376961|75977210|FG000|Initial Registration|Progression/relapse|1|||
42283281|NCT04339413|76114996|FG000|Overall Study|Physician Decision|3|||
42170288|NCT00376961|75977211|FG001|Initial Registration|Progression/relapse|0|||
42170289|NCT00376961|75977210|FG000|Initial Registration|Ineligible|3|||
42170290|NCT00376961|75977211|FG001|Initial Registration|Ineligible|0|||
42170291|NCT00376961|75977210|FG000|Maintenance|Adverse Event|0|||
42170292|NCT00376961|75977211|FG001|Maintenance|Adverse Event|1|||
42170293|NCT00376961|75977210|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
42170294|NCT00376961|75977211|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
42170295|NCT00376961|75977210|FG000|Maintenance|Progression/relapse|0|||
42283282|NCT04339413|76114997|FG001|Overall Study|Physician Decision|1|||
42283283|NCT04339413|76114996|FG000|Overall Study|Death|2|||
42170296|NCT00376961|75977211|FG001|Maintenance|Progression/relapse|18|||
42170297|NCT00376961|75977210|FG000|Maintenance|Ineligible|0|||
42170298|NCT00376961|75977211|FG001|Maintenance|Ineligible|3|||
42170299|NCT03418324|75977221|FG000|Overall Study|Death|0|||
42170300|NCT03418324|75977222|FG001|Overall Study|Death|1|||
42170301|NCT03418324|75977221|FG000|Overall Study|Physician Decision|1|||
42170302|NCT03418324|75977222|FG001|Overall Study|Physician Decision|1|||
42170303|NCT00376259|75977230|FG000|Overall Study|Sponsor request - study termination|21|||
42283284|NCT04339413|76114997|FG001|Overall Study|Death|0|||
42283285|NCT04339413|76114996|FG000|Overall Study|Adverse Event|3|||
42283286|NCT04339413|76114997|FG001|Overall Study|Adverse Event|0|||
42283287|NCT04327999|76115003|FG000|Overall Study|Protocol Violation|1|||
42283288|NCT04145037|76115013|FG000|Overall Study|Study terminated|2|||
42283289|NCT04145037|76115014|FG001|Overall Study|Study terminated|0|||
42283290|NCT04145037|76115013|FG000|Overall Study|Withdrawal by Subject|1|||
42283291|NCT04145037|76115014|FG001|Overall Study|Withdrawal by Subject|0|||
42283292|NCT04145037|76115013|FG000|Overall Study|Lost to Follow-up|1|||
42283293|NCT04145037|76115014|FG001|Overall Study|Lost to Follow-up|0|||
42283294|NCT04097028|76115022|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
42283295|NCT04097028|76115022|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
42283296|NCT04097028|76115022|FG000|Overall Study|Disease Progression prior to Surgery|2|||
42283297|NCT04097028|76115022|FG000|Overall Study|Adverse Event prior to Surgery|1|||
42283298|NCT03749330|76115041|FG000|Overall Study|Clinicians left work in the CICU|0|||
42283299|NCT03749330|76115042|FG001|Overall Study|Clinicians left work in the CICU|2|||
42283300|NCT03749330|76115043|FG002|Overall Study|Clinicians left work in the CICU|0|||
42283301|NCT03749330|76115044|FG003|Overall Study|Clinicians left work in the CICU|0|||
42283302|NCT03749330|76115045|FG004|Overall Study|Clinicians left work in the CICU|0|||
42283303|NCT03749330|76115046|FG005|Overall Study|Clinicians left work in the CICU|0|||
42283304|NCT03740737|76115068|FG000|Overall Study|Protocol deviation|13|||
42283305|NCT03740737|76115069|FG001|Overall Study|Protocol deviation|0|||
42283306|NCT03740737|76115068|FG000|Overall Study|Adverse Event|2|||
42170304|NCT00376259|75977231|FG001|Overall Study|Sponsor request - study termination|21|||
42170305|NCT00376259|75977230|FG000|Overall Study|Patient request|1|||
42170306|NCT00376259|75977231|FG001|Overall Study|Patient request|0|||
42170307|NCT03410056|75977241|FG000|Overall Study|Decision by Sponsor|0|||
42170308|NCT03410056|75977242|FG001|Overall Study|Decision by Sponsor|0|||
42170309|NCT03410056|75977243|FG002|Overall Study|Decision by Sponsor|3|||
42170310|NCT03410056|75977244|FG003|Overall Study|Decision by Sponsor|0|||
42170311|NCT03410056|75977245|FG004|Overall Study|Decision by Sponsor|0|||
42170312|NCT03410056|75977246|FG005|Overall Study|Decision by Sponsor|0|||
42170313|NCT03410056|75977247|FG006|Overall Study|Decision by Sponsor|0|||
42170314|NCT03410056|75977241|FG000|Overall Study|Withdrawal by Subject|0|||
42170315|NCT03410056|75977242|FG001|Overall Study|Withdrawal by Subject|2|||
42170316|NCT03410056|75977243|FG002|Overall Study|Withdrawal by Subject|5|||
42170317|NCT03410056|75977244|FG003|Overall Study|Withdrawal by Subject|5|||
42170318|NCT03410056|75977245|FG004|Overall Study|Withdrawal by Subject|0|||
42170319|NCT03410056|75977246|FG005|Overall Study|Withdrawal by Subject|0|||
42283307|NCT03740737|76115069|FG001|Overall Study|Adverse Event|0|||
42283308|NCT03740737|76115068|FG000|Overall Study|Lost to Follow-up|1|||
42283309|NCT03740737|76115069|FG001|Overall Study|Lost to Follow-up|0|||
42283310|NCT03740737|76115068|FG000|Overall Study|Randomization failure|1|||
42283311|NCT03740737|76115069|FG001|Overall Study|Randomization failure|0|||
42283312|NCT03740737|76115068|FG000|Overall Study|Participant withdrew consent|1|||
42170320|NCT03410056|75977247|FG006|Overall Study|Withdrawal by Subject|0|||
42170321|NCT03409666|75977265|FG000|Overall Study|Physician Decision|0|||
42170322|NCT03409666|75977266|FG001|Overall Study|Physician Decision|1|||
42170323|NCT03409666|75977265|FG000|Overall Study|Protocol Violation|0|||
42170324|NCT03409666|75977266|FG001|Overall Study|Protocol Violation|3|||
42170325|NCT03440944|75977274|FG000|Overall Study|Physician Decision|1|||
42170326|NCT03440944|75977275|FG001|Overall Study|Physician Decision|0|||
42170327|NCT03440944|75977274|FG000|Overall Study|No Acceptable Vasculature|0|||
42170328|NCT03440944|75977275|FG001|Overall Study|No Acceptable Vasculature|1|||
42170329|NCT00365105|75977284|FG000|Overall Study|Protocol Violation|5|||
42170330|NCT00365105|75977285|FG001|Overall Study|Protocol Violation|8|||
42170331|NCT00399893|75977293|FG000|Overall Study|Withdrawal by Subject|1|||
42170332|NCT00399893|75977294|FG001|Overall Study|Withdrawal by Subject|0|||
42170333|NCT00048542|75977304|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
42170334|NCT00048542|75977305|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
42170335|NCT00048542|75977306|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
42170336|NCT00048542|75977307|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
42170337|NCT00048542|75977308|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
42170338|NCT00048542|75977309|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
42170339|NCT00048542|75977310|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
42170340|NCT00048542|75977311|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
42170341|NCT00048542|75977304|FG000|Double-Blind Phase|Protocol Violation|0|||
42170342|NCT00048542|75977305|FG001|Double-Blind Phase|Protocol Violation|0|||
42170343|NCT00048542|75977306|FG002|Double-Blind Phase|Protocol Violation|1|||
42170344|NCT00048542|75977307|FG003|Double-Blind Phase|Protocol Violation|0|||
42170345|NCT00048542|75977308|FG004|Double-Blind Phase|Protocol Violation|0|||
42170346|NCT00048542|75977309|FG005|Double-Blind Phase|Protocol Violation|0|||
42170347|NCT00048542|75977310|FG006|Double-Blind Phase|Protocol Violation|0|||
42170348|NCT00048542|75977311|FG007|Double-Blind Phase|Protocol Violation|0|||
42170349|NCT00048542|75977304|FG000|Double-Blind Phase|Sponsor request or decision|2|||
42170350|NCT00048542|75977305|FG001|Double-Blind Phase|Sponsor request or decision|0|||
42170351|NCT00048542|75977306|FG002|Double-Blind Phase|Sponsor request or decision|0|||
42170352|NCT00048542|75977307|FG003|Double-Blind Phase|Sponsor request or decision|0|||
42170353|NCT00048542|75977308|FG004|Double-Blind Phase|Sponsor request or decision|0|||
42170354|NCT00048542|75977309|FG005|Double-Blind Phase|Sponsor request or decision|0|||
42170355|NCT00048542|75977310|FG006|Double-Blind Phase|Sponsor request or decision|0|||
42170356|NCT00048542|75977311|FG007|Double-Blind Phase|Sponsor request or decision|0|||
42170357|NCT00048542|75977304|FG000|Double-Blind Phase|Randomized in error|1|||
42170358|NCT00048542|75977305|FG001|Double-Blind Phase|Randomized in error|0|||
42170359|NCT00048542|75977306|FG002|Double-Blind Phase|Randomized in error|0|||
42170360|NCT00048542|75977307|FG003|Double-Blind Phase|Randomized in error|0|||
42170361|NCT00048542|75977308|FG004|Double-Blind Phase|Randomized in error|0|||
42170362|NCT00048542|75977309|FG005|Double-Blind Phase|Randomized in error|0|||
42170363|NCT00048542|75977310|FG006|Double-Blind Phase|Randomized in error|0|||
42170364|NCT00048542|75977311|FG007|Double-Blind Phase|Randomized in error|0|||
42170365|NCT00048542|75977304|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
42170366|NCT00048542|75977305|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
42170367|NCT00048542|75977306|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
42170368|NCT00048542|75977307|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
42170369|NCT00048542|75977308|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
42170370|NCT00048542|75977309|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
42170371|NCT00048542|75977310|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
42170372|NCT00048542|75977311|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
42170373|NCT00048542|75977304|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
42170374|NCT00048542|75977305|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
42170375|NCT00048542|75977306|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
42170376|NCT00048542|75977307|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
42170377|NCT00048542|75977308|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
42170378|NCT00048542|75977309|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
42170379|NCT00048542|75977310|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
42170380|NCT00048542|75977311|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
42170381|NCT00048542|75977304|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
42170382|NCT00048542|75977305|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
42170383|NCT00048542|75977306|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
42170384|NCT00048542|75977307|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
42170385|NCT00048542|75977308|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
42170386|NCT00048542|75977309|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
42170387|NCT00048542|75977310|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
42170388|NCT00048542|75977311|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
42170389|NCT00048542|75977304|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
42170390|NCT00048542|75977305|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
42170391|NCT00048542|75977306|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
42170392|NCT00048542|75977307|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
42170393|NCT00048542|75977308|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
42170394|NCT00048542|75977309|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
42170395|NCT00048542|75977310|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
42170396|NCT00048542|75977311|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
42170397|NCT00048542|75977304|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
42170398|NCT00048542|75977305|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
42170399|NCT00048542|75977306|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
42170400|NCT00048542|75977307|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
42170401|NCT00048542|75977308|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
42170402|NCT00048542|75977309|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
42170403|NCT00048542|75977310|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
42170404|NCT00048542|75977311|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
42170405|NCT00048542|75977304|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
42170406|NCT00048542|75977305|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
42170407|NCT00048542|75977306|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
42170408|NCT00048542|75977307|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
42170409|NCT00048542|75977308|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
42170410|NCT00048542|75977309|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
42170411|NCT00048542|75977310|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
42170412|NCT00048542|75977311|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
42170413|NCT00048542|75977304|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
42170414|NCT00048542|75977305|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
42170415|NCT00048542|75977306|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
42170416|NCT00048542|75977307|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
42170417|NCT00048542|75977308|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
42014650|NCT01164579|75821742|FG001|Overall Study|Adverse Event|2|||
42014651|NCT01164579|75821743|FG002|Overall Study|Adverse Event|5|||
42014652|NCT01164579|75821741|FG000|Overall Study|Reason not specified|1|||
42014653|NCT01164579|75821742|FG001|Overall Study|Reason not specified|0|||
42014654|NCT01164579|75821743|FG002|Overall Study|Reason not specified|0|||
42014655|NCT00958789|75821752|FG000|Overall Study|Death|5|||
42014656|NCT00958789|75821752|FG000|Overall Study|Lost to Follow-up|14|||
42014657|NCT00958789|75821752|FG000|Overall Study|Withdrawal by Subject|17|||
42014658|NCT00958789|75821752|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
42014659|NCT00958789|75821752|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
42014660|NCT00958789|75821752|FG000|Overall Study|Subject terminated|2|||
42014661|NCT00958789|75821752|FG000|Overall Study|Revision|7|||
42014662|NCT02445391|75821763|FG000|Overall Study|No active protocol treatment|3|||
42014663|NCT02445391|75821764|FG001|Overall Study|No active protocol treatment|0|||
42014664|NCT02445391|75821765|FG002|Overall Study|No active protocol treatment|0|||
42170418|NCT00048542|75977309|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
42170419|NCT00048542|75977310|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
42170420|NCT00048542|75977311|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
42170421|NCT00048542|75977304|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
42170422|NCT00048542|75977305|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
42170423|NCT00048542|75977306|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
42170424|NCT00048542|75977307|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
42170425|NCT00048542|75977308|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
42170426|NCT00048542|75977309|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
42170427|NCT00048542|75977310|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
42170428|NCT00048542|75977311|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
42170429|NCT00048542|75977304|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
42283313|NCT03740737|76115069|FG001|Overall Study|Participant withdrew consent|0|||
42283314|NCT03740737|76115068|FG000|Overall Study|Participant withdrew from trial|2|||
42283315|NCT03740737|76115069|FG001|Overall Study|Participant withdrew from trial|1|||
42283316|NCT03738618|76115078|FG000|Overall Study|Protocol deviation|23|||
42283317|NCT03738618|76115079|FG001|Overall Study|Protocol deviation|0|||
42283318|NCT03738618|76115078|FG000|Overall Study|Adverse Event|4|||
42283319|NCT03738618|76115079|FG001|Overall Study|Adverse Event|0|||
42170430|NCT00048542|75977305|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
42170431|NCT00048542|75977306|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
42170432|NCT00048542|75977307|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
42283320|NCT03738618|76115078|FG000|Overall Study|Lost to Follow-up|2|||
42283321|NCT03738618|76115079|FG001|Overall Study|Lost to Follow-up|0|||
42014665|NCT02445391|75821763|FG000|Overall Study|Adverse Event|0|||
42040730|NCT01796171|75848710|FG004|Follow-up Period|Patient transferred to other hospital|0|||
42014666|NCT02445391|75821764|FG001|Overall Study|Adverse Event|21|||
42014667|NCT02445391|75821765|FG002|Overall Study|Adverse Event|12|||
42014668|NCT02445391|75821763|FG000|Overall Study|Alternative therapy|0|||
42014669|NCT02445391|75821764|FG001|Overall Study|Alternative therapy|0|||
42170433|NCT00048542|75977308|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
42170434|NCT00048542|75977309|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
42170435|NCT00048542|75977310|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
42170436|NCT00048542|75977311|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
42170437|NCT00048542|75977304|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
42170438|NCT00048542|75977305|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
42170439|NCT00048542|75977306|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
42170440|NCT00048542|75977307|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
42170441|NCT00048542|75977308|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
42170442|NCT00048542|75977309|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
42170443|NCT00048542|75977310|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
42170444|NCT00048542|75977311|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
42170445|NCT00048542|75977304|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
42170446|NCT00048542|75977305|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
42170447|NCT00048542|75977306|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
42170448|NCT00048542|75977307|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
42170449|NCT00048542|75977308|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
42170450|NCT00048542|75977309|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
42170451|NCT00048542|75977310|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
42170452|NCT00048542|75977311|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
42170453|NCT03814590|75977354|FG000|Overall Study|Adverse Event|0|||
42170454|NCT03814590|75977355|FG001|Overall Study|Adverse Event|0|||
42170455|NCT03814590|75977356|FG002|Overall Study|Adverse Event|0|||
42170456|NCT03814590|75977357|FG003|Overall Study|Adverse Event|0|||
42170457|NCT03814590|75977358|FG004|Overall Study|Adverse Event|0|||
42170458|NCT03814590|75977359|FG005|Overall Study|Adverse Event|1|||
42170459|NCT03814590|75977360|FG006|Overall Study|Adverse Event|1|||
42170460|NCT03814590|75977361|FG007|Overall Study|Adverse Event|1|||
42170461|NCT03814590|75977362|FG008|Overall Study|Adverse Event|0|||
42170462|NCT03814590|75977363|FG009|Overall Study|Adverse Event|0|||
42170463|NCT03814590|75977364|FG010|Overall Study|Adverse Event|1|||
42170464|NCT03814590|75977365|FG011|Overall Study|Adverse Event|0|||
42170465|NCT03814590|75977366|FG012|Overall Study|Adverse Event|3|||
42170466|NCT03814590|75977367|FG013|Overall Study|Adverse Event|0|||
42170467|NCT03814590|75977354|FG000|Overall Study|Lost to Follow-up|0|||
42170468|NCT03814590|75977355|FG001|Overall Study|Lost to Follow-up|2|||
42170469|NCT03814590|75977356|FG002|Overall Study|Lost to Follow-up|1|||
42170470|NCT03814590|75977357|FG003|Overall Study|Lost to Follow-up|0|||
42170471|NCT03814590|75977358|FG004|Overall Study|Lost to Follow-up|1|||
42170472|NCT03814590|75977359|FG005|Overall Study|Lost to Follow-up|1|||
42170473|NCT03814590|75977360|FG006|Overall Study|Lost to Follow-up|1|||
42170474|NCT03814590|75977361|FG007|Overall Study|Lost to Follow-up|1|||
42170475|NCT03814590|75977362|FG008|Overall Study|Lost to Follow-up|0|||
42170476|NCT03814590|75977363|FG009|Overall Study|Lost to Follow-up|0|||
42170477|NCT03814590|75977364|FG010|Overall Study|Lost to Follow-up|1|||
42170478|NCT03814590|75977365|FG011|Overall Study|Lost to Follow-up|0|||
42170479|NCT03814590|75977366|FG012|Overall Study|Lost to Follow-up|0|||
42170480|NCT03814590|75977367|FG013|Overall Study|Lost to Follow-up|1|||
42170481|NCT03814590|75977354|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42170482|NCT03814590|75977355|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42170483|NCT03814590|75977356|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42170484|NCT03814590|75977357|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42170485|NCT03814590|75977358|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42170486|NCT03814590|75977359|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42170487|NCT03814590|75977360|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42170488|NCT03814590|75977361|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42170489|NCT03814590|75977362|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42170490|NCT03814590|75977363|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
42170491|NCT03814590|75977364|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42170492|NCT03814590|75977365|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42283322|NCT03738618|76115078|FG000|Overall Study|Randomization failure|1|||
42283323|NCT03738618|76115079|FG001|Overall Study|Randomization failure|0|||
42283324|NCT03738618|76115078|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
42170493|NCT03814590|75977366|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42170494|NCT03814590|75977367|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
42283325|NCT03738618|76115079|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
42170495|NCT03814590|75977354|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
42170496|NCT03814590|75977355|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
42170497|NCT03814590|75977356|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
42170498|NCT03814590|75977357|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
42170499|NCT03814590|75977358|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
42170500|NCT03814590|75977359|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
42170501|NCT03814590|75977360|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
42170502|NCT03814590|75977361|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
42170503|NCT03814590|75977362|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
42170504|NCT03814590|75977363|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
42170505|NCT03814590|75977364|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
42170506|NCT03814590|75977365|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
42170507|NCT03814590|75977366|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
42170508|NCT03814590|75977367|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
42170509|NCT03814590|75977354|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170510|NCT03814590|75977355|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170511|NCT03814590|75977356|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170512|NCT03814590|75977357|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170513|NCT03814590|75977358|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170514|NCT03814590|75977359|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170515|NCT03814590|75977360|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170516|NCT03814590|75977361|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
42170517|NCT03814590|75977362|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170518|NCT03814590|75977363|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
42170519|NCT03814590|75977364|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170520|NCT03814590|75977365|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170521|NCT03814590|75977366|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170522|NCT03814590|75977367|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42170523|NCT03814590|75977354|FG000|Overall Study|UNKNOWN REASON|0|||
42170524|NCT03814590|75977355|FG001|Overall Study|UNKNOWN REASON|0|||
42170525|NCT03814590|75977356|FG002|Overall Study|UNKNOWN REASON|0|||
42170526|NCT03814590|75977357|FG003|Overall Study|UNKNOWN REASON|0|||
42170527|NCT03814590|75977358|FG004|Overall Study|UNKNOWN REASON|0|||
42170528|NCT03814590|75977359|FG005|Overall Study|UNKNOWN REASON|0|||
42170529|NCT03814590|75977360|FG006|Overall Study|UNKNOWN REASON|0|||
42170530|NCT03814590|75977361|FG007|Overall Study|UNKNOWN REASON|1|||
42170531|NCT03814590|75977362|FG008|Overall Study|UNKNOWN REASON|0|||
42170532|NCT03814590|75977363|FG009|Overall Study|UNKNOWN REASON|0|||
42170533|NCT03814590|75977364|FG010|Overall Study|UNKNOWN REASON|0|||
42170534|NCT03814590|75977365|FG011|Overall Study|UNKNOWN REASON|0|||
42170535|NCT03814590|75977366|FG012|Overall Study|UNKNOWN REASON|0|||
42170536|NCT03814590|75977367|FG013|Overall Study|UNKNOWN REASON|0|||
42170537|NCT00048074|75977410|FG000|Overall Study|Adverse Event|46|||
42170538|NCT00048074|75977411|FG001|Overall Study|Adverse Event|41|||
42170539|NCT00048074|75977412|FG002|Overall Study|Adverse Event|53|||
42170540|NCT00048074|75977410|FG000|Overall Study|Death|3|||
42170541|NCT00048074|75977411|FG001|Overall Study|Death|3|||
42170542|NCT00048074|75977412|FG002|Overall Study|Death|2|||
42170543|NCT00048074|75977410|FG000|Overall Study|Lost to Follow-up|2|||
42170544|NCT00048074|75977411|FG001|Overall Study|Lost to Follow-up|6|||
42170545|NCT00048074|75977412|FG002|Overall Study|Lost to Follow-up|6|||
42170546|NCT00048074|75977410|FG000|Overall Study|Withdrawal by Subject|28|||
42170547|NCT00048074|75977411|FG001|Overall Study|Withdrawal by Subject|30|||
42283326|NCT03738618|76115078|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
42283327|NCT03738618|76115079|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
42283328|NCT03556891|76115087|FG000|Overall Study|Adverse Event|4|||
42283329|NCT03556891|76115087|FG000|Overall Study|MRI Need|3|||
42283330|NCT03556891|76115087|FG000|Overall Study|Device Failure|1|||
42014670|NCT02445391|75821765|FG002|Overall Study|Alternative therapy|1|||
42170548|NCT00048074|75977412|FG002|Overall Study|Withdrawal by Subject|35|||
42170549|NCT00048074|75977410|FG000|Overall Study|Protocol Violation|1|||
42170550|NCT00048074|75977411|FG001|Overall Study|Protocol Violation|3|||
42170551|NCT00048074|75977412|FG002|Overall Study|Protocol Violation|0|||
42170552|NCT00048074|75977410|FG000|Overall Study|Study participation was terminated|0|||
42283331|NCT03556891|76115087|FG000|Overall Study|Death|1|||
42014671|NCT02445391|75821763|FG000|Overall Study|Disease progression|0|||
42283332|NCT03556891|76115087|FG000|Overall Study|Lost to Follow-up|1|||
42283333|NCT03556891|76115087|FG000|Overall Study|Missing at random|1|||
42014672|NCT02445391|75821764|FG001|Overall Study|Disease progression|7|||
42352135|NCT01923181|76192143|FG003|Overall Study|Other|1|||
42014673|NCT02445391|75821765|FG002|Overall Study|Disease progression|22|||
42170553|NCT00048074|75977411|FG001|Overall Study|Study participation was terminated|1|||
42170554|NCT00048074|75977412|FG002|Overall Study|Study participation was terminated|0|||
42170555|NCT00048074|75977410|FG000|Overall Study|Husband ill|0|||
42170556|NCT00048074|75977411|FG001|Overall Study|Husband ill|1|||
42170557|NCT00048074|75977412|FG002|Overall Study|Husband ill|0|||
42170558|NCT00048074|75977410|FG000|Overall Study|Poor compliance|0|||
42170559|NCT00048074|75977411|FG001|Overall Study|Poor compliance|1|||
42170560|NCT00048074|75977412|FG002|Overall Study|Poor compliance|0|||
42170561|NCT00048074|75977410|FG000|Overall Study|Out of station|0|||
42170562|NCT00048074|75977411|FG001|Overall Study|Out of station|1|||
42170563|NCT00048074|75977412|FG002|Overall Study|Out of station|1|||
42170564|NCT00048074|75977410|FG000|Overall Study|Social reasons|1|||
42170565|NCT00048074|75977411|FG001|Overall Study|Social reasons|0|||
42170566|NCT00048074|75977412|FG002|Overall Study|Social reasons|0|||
42170567|NCT03831191|75977424|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
42170568|NCT03831191|75977425|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
42170569|NCT03831191|75977426|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
42170570|NCT03831191|75977427|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
42170571|NCT03831191|75977428|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
42170572|NCT03831191|75977429|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
42170573|NCT03831191|75977430|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
42170574|NCT03831191|75977431|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
42170575|NCT03831191|75977432|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
42170576|NCT03831191|75977433|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
42170577|NCT03831191|75977434|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
42170578|NCT03831191|75977435|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
42170579|NCT03831191|75977436|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
42170580|NCT03831191|75977437|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
42170581|NCT03831191|75977438|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
42170582|NCT03831191|75977424|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
42170583|NCT03831191|75977425|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
42170584|NCT03831191|75977426|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170585|NCT03831191|75977427|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170586|NCT03831191|75977428|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170587|NCT03831191|75977429|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170588|NCT03831191|75977430|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170589|NCT03831191|75977431|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170590|NCT03831191|75977432|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170591|NCT03831191|75977433|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170592|NCT03831191|75977434|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170593|NCT03831191|75977435|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170594|NCT03831191|75977436|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170595|NCT03831191|75977437|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170596|NCT03831191|75977438|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
42170597|NCT03831191|75977424|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
42170598|NCT03831191|75977425|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
42170599|NCT03831191|75977426|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
42170600|NCT03831191|75977427|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
42170601|NCT03831191|75977428|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
42170602|NCT03831191|75977429|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
42170603|NCT03831191|75977430|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
42170604|NCT03831191|75977431|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
42170605|NCT03831191|75977432|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
42170606|NCT03831191|75977433|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
42170607|NCT03831191|75977434|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
42170608|NCT03831191|75977435|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
42170609|NCT03831191|75977436|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
42170610|NCT03831191|75977437|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
42170611|NCT03831191|75977438|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
42170612|NCT03831191|75977424|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
42170613|NCT03831191|75977425|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
42170614|NCT03831191|75977426|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
42170615|NCT03831191|75977427|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
42170616|NCT03831191|75977428|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
42170617|NCT03831191|75977429|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
42170618|NCT03831191|75977430|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
42283334|NCT03556891|76115087|FG000|Overall Study|Missing due to COVID|1|||
42170619|NCT03831191|75977431|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
42170620|NCT03831191|75977432|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
42170621|NCT03831191|75977433|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
42170622|NCT03831191|75977434|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
42170623|NCT03831191|75977435|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
42283335|NCT03556891|76115087|FG000|Overall Study|Protocol Violation|1|||
42170624|NCT03831191|75977436|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
42170625|NCT03831191|75977437|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
42170626|NCT03831191|75977438|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
42170627|NCT03831191|75977424|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
42170628|NCT03831191|75977425|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
42170629|NCT03831191|75977426|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
42170630|NCT03831191|75977427|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
42170631|NCT03831191|75977428|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42170632|NCT03831191|75977429|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42170633|NCT03831191|75977430|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42170634|NCT03831191|75977431|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42170635|NCT03831191|75977432|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42170636|NCT03831191|75977433|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42170637|NCT03831191|75977434|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42170638|NCT03831191|75977435|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42170639|NCT03831191|75977436|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42170640|NCT03831191|75977437|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42170641|NCT03831191|75977438|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
42170642|NCT03831191|75977424|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
42170643|NCT03831191|75977425|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
42170644|NCT03831191|75977426|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
42170645|NCT03831191|75977427|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
42170646|NCT03831191|75977428|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
42170647|NCT03831191|75977429|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
42170648|NCT03831191|75977430|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
42170649|NCT03831191|75977431|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
42170650|NCT03831191|75977432|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
42170651|NCT03831191|75977433|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
42170652|NCT03831191|75977434|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
42170653|NCT03831191|75977435|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
42170654|NCT03831191|75977436|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
42170655|NCT03831191|75977437|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
42170656|NCT03831191|75977438|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
42170657|NCT03831191|75977424|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170658|NCT03831191|75977425|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170659|NCT03831191|75977426|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170660|NCT03831191|75977427|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
42170661|NCT03831191|75977428|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170662|NCT03831191|75977429|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170663|NCT03831191|75977430|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170664|NCT03831191|75977431|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170665|NCT03831191|75977432|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170666|NCT03831191|75977433|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170667|NCT03831191|75977434|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170668|NCT03831191|75977435|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170669|NCT03831191|75977436|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170670|NCT03831191|75977437|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170671|NCT03831191|75977438|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
42170672|NCT03831191|75977424|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
42170673|NCT03831191|75977425|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
42170674|NCT03831191|75977426|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
42170675|NCT03831191|75977427|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
42170676|NCT03831191|75977428|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
42170677|NCT03831191|75977429|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
42170678|NCT03831191|75977430|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
42170679|NCT03831191|75977431|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
42170680|NCT03831191|75977432|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
42170681|NCT03831191|75977433|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
42283336|NCT03484923|76115096|FG000|Overall Study|Adverse Event|3|||
42283337|NCT03484923|76115097|FG001|Overall Study|Adverse Event|3|||
42170682|NCT03831191|75977434|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
42170683|NCT03831191|75977435|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
42170684|NCT03831191|75977436|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
42170685|NCT03831191|75977437|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
42170686|NCT03831191|75977438|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
42170687|NCT03831191|75977424|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170688|NCT03831191|75977425|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170689|NCT03831191|75977426|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170690|NCT03831191|75977427|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170691|NCT03831191|75977428|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170692|NCT03831191|75977429|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170693|NCT03831191|75977430|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170694|NCT03831191|75977431|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170695|NCT03831191|75977432|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170696|NCT03831191|75977433|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170697|NCT03831191|75977434|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170698|NCT03831191|75977435|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170699|NCT03831191|75977436|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170700|NCT03831191|75977437|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
42170701|NCT03831191|75977438|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
42170702|NCT03831191|75977424|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170703|NCT03831191|75977425|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170704|NCT03831191|75977426|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170705|NCT03831191|75977427|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170706|NCT03831191|75977428|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170707|NCT03831191|75977429|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42283338|NCT03484923|76115098|FG002|Overall Study|Adverse Event|5|||
42283339|NCT03484923|76115099|FG003|Overall Study|Adverse Event|11|||
42283340|NCT03484923|76115100|FG004|Overall Study|Adverse Event|1|||
42283341|NCT03484923|76115096|FG000|Overall Study|Death|2|||
42283342|NCT03484923|76115097|FG001|Overall Study|Death|2|||
42283343|NCT03484923|76115098|FG002|Overall Study|Death|3|||
42283344|NCT03484923|76115099|FG003|Overall Study|Death|0|||
42283345|NCT03484923|76115100|FG004|Overall Study|Death|1|||
42283346|NCT03484923|76115096|FG000|Overall Study|Physician Decision|6|||
42283347|NCT03484923|76115097|FG001|Overall Study|Physician Decision|7|||
42170708|NCT03831191|75977430|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170709|NCT03831191|75977431|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170710|NCT03831191|75977432|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170711|NCT03831191|75977433|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170712|NCT03831191|75977434|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170713|NCT03831191|75977435|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170714|NCT03831191|75977436|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170715|NCT03831191|75977437|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
42170716|NCT03831191|75977438|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
42170717|NCT00005906|75977471|FG000|Overall Study|Lack of Efficacy|3|||
42170718|NCT03409276|75977480|FG000|Overall Study|Withdrawal by Subject|0|||
42170719|NCT03409276|75977481|FG001|Overall Study|Withdrawal by Subject|0|||
42170720|NCT03409276|75977482|FG002|Overall Study|Withdrawal by Subject|0|||
42170721|NCT03409276|75977483|FG003|Overall Study|Withdrawal by Subject|0|||
42170722|NCT03409276|75977484|FG004|Overall Study|Withdrawal by Subject|1|||
42170723|NCT03409276|75977480|FG000|Overall Study|Lost to Follow-up|0|||
42170724|NCT03409276|75977481|FG001|Overall Study|Lost to Follow-up|0|||
42170725|NCT03409276|75977482|FG002|Overall Study|Lost to Follow-up|0|||
42170726|NCT03409276|75977483|FG003|Overall Study|Lost to Follow-up|2|||
42170727|NCT03409276|75977484|FG004|Overall Study|Lost to Follow-up|2|||
42170728|NCT00004562|75977502|FG000|Overall Study|Lost to Follow-up|102|||
42170729|NCT00004562|75977503|FG001|Overall Study|Lost to Follow-up|91|||
42283348|NCT03484923|76115098|FG002|Overall Study|Physician Decision|6|||
42283349|NCT03484923|76115099|FG003|Overall Study|Physician Decision|3|||
42283350|NCT03484923|76115100|FG004|Overall Study|Physician Decision|2|||
42283351|NCT03484923|76115096|FG000|Overall Study|Progressive disease|33|||
42283352|NCT03484923|76115097|FG001|Overall Study|Progressive disease|28|||
42352136|NCT01923181|76192144|FG004|Overall Study|Other|0|||
42352137|NCT01923181|76192145|FG005|Overall Study|Other|0|||
42170730|NCT00004412|75977512|FG000|Randomized Period|Moved to Crossover Period|3|||
42170731|NCT00004412|75977513|FG001|Randomized Period|Moved to Crossover Period|0|||
42170732|NCT00004412|75977514|FG002|Randomized Period|Moved to Crossover Period|0|||
42170733|NCT03440320|75977524|FG000|Overall Study|Withdrawal by Subject|0|||
42170734|NCT03440320|75977525|FG001|Overall Study|Withdrawal by Subject|1|||
42170735|NCT00004088|75977533|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
42283353|NCT03484923|76115098|FG002|Overall Study|Progressive disease|26|||
42283354|NCT03484923|76115099|FG003|Overall Study|Progressive disease|30|||
42283355|NCT03484923|76115100|FG004|Overall Study|Progressive disease|16|||
42283356|NCT03484923|76115096|FG000|Overall Study|Subject Decision|1|||
42283357|NCT03484923|76115097|FG001|Overall Study|Subject Decision|3|||
42283358|NCT03484923|76115098|FG002|Overall Study|Subject Decision|3|||
42352138|NCT01923181|76192146|FG006|Overall Study|Other|0|||
42170736|NCT00004088|75977533|FG000|Overall Study|Withdrawal by Subject|1|||
42283359|NCT03484923|76115099|FG003|Overall Study|Subject Decision|0|||
42014674|NCT02445391|75821763|FG000|Overall Study|Complicating disease|0|||
42014675|NCT02445391|75821764|FG001|Overall Study|Complicating disease|2|||
42014676|NCT02445391|75821765|FG002|Overall Study|Complicating disease|1|||
42014677|NCT02445391|75821763|FG000|Overall Study|Withdrawal by Subject|0|||
42014678|NCT02445391|75821764|FG001|Overall Study|Withdrawal by Subject|4|||
42014679|NCT02445391|75821765|FG002|Overall Study|Withdrawal by Subject|9|||
42014680|NCT02445391|75821763|FG000|Overall Study|Financial issue|0|||
42014681|NCT02445391|75821764|FG001|Overall Study|Financial issue|0|||
42014682|NCT02445391|75821765|FG002|Overall Study|Financial issue|2|||
42014683|NCT02445391|75821763|FG000|Overall Study|Still on treatment|0|||
42014684|NCT02445391|75821764|FG001|Overall Study|Still on treatment|7|||
42014685|NCT02445391|75821765|FG002|Overall Study|Still on treatment|16|||
42014686|NCT02445391|75821763|FG000|Overall Study|Not start protocol therapy|0|||
42014687|NCT02445391|75821764|FG001|Overall Study|Not start protocol therapy|12|||
42014688|NCT02445391|75821765|FG002|Overall Study|Not start protocol therapy|9|||
42014689|NCT01246986|75821781|FG000|Overall Study|Lost to Follow-up|0|||
42014690|NCT01246986|75821782|FG001|Overall Study|Lost to Follow-up|1|||
42014691|NCT01246986|75821783|FG002|Overall Study|Lost to Follow-up|3|||
42014692|NCT01246986|75821784|FG003|Overall Study|Lost to Follow-up|0|||
42014693|NCT01246986|75821785|FG004|Overall Study|Lost to Follow-up|0|||
42014694|NCT01246986|75821786|FG005|Overall Study|Lost to Follow-up|1|||
42014695|NCT01246986|75821787|FG006|Overall Study|Lost to Follow-up|0|||
42014696|NCT01246986|75821781|FG000|Overall Study|Withdrawal by Subject|3|||
42014697|NCT01246986|75821782|FG001|Overall Study|Withdrawal by Subject|4|||
42014698|NCT01246986|75821783|FG002|Overall Study|Withdrawal by Subject|3|||
42014699|NCT01246986|75821784|FG003|Overall Study|Withdrawal by Subject|0|||
42014700|NCT01246986|75821785|FG004|Overall Study|Withdrawal by Subject|4|||
42014701|NCT01246986|75821786|FG005|Overall Study|Withdrawal by Subject|0|||
42014702|NCT01246986|75821787|FG006|Overall Study|Withdrawal by Subject|0|||
42014703|NCT01164501|75821821|FG000|Overall Study|Not treated|2|||
42014704|NCT01164501|75821822|FG001|Overall Study|Not treated|0|||
42014705|NCT01164501|75821823|FG002|Overall Study|Not treated|1|||
42014706|NCT01164501|75821821|FG000|Overall Study|Adverse Event|18|||
42014707|NCT01164501|75821822|FG001|Overall Study|Adverse Event|4|||
42014708|NCT01164501|75821823|FG002|Overall Study|Adverse Event|21|||
42283360|NCT03484923|76115100|FG004|Overall Study|Subject Decision|1|||
42283361|NCT03146650|76115179|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
42283362|NCT03146650|76115179|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
42283363|NCT03146650|76115179|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
42283364|NCT03146650|76115179|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
42283365|NCT03146650|76115179|FG000|2 Year Follow-up|Death|11|||
42014709|NCT01164501|75821821|FG000|Overall Study|Lack of Efficacy|0|||
42014710|NCT01164501|75821822|FG001|Overall Study|Lack of Efficacy|0|||
42014711|NCT01164501|75821823|FG002|Overall Study|Lack of Efficacy|1|||
42014712|NCT01164501|75821821|FG000|Overall Study|Non compliant with protocol|1|||
42014713|NCT01164501|75821822|FG001|Overall Study|Non compliant with protocol|1|||
42014714|NCT01164501|75821823|FG002|Overall Study|Non compliant with protocol|4|||
42014715|NCT01164501|75821821|FG000|Overall Study|Lost to Follow-up|3|||
42014716|NCT01164501|75821822|FG001|Overall Study|Lost to Follow-up|0|||
42170737|NCT00004088|75977533|FG000|Overall Study|Protocol Violation|3|||
42170738|NCT00004088|75977533|FG000|Overall Study|Physician Decision|1|||
42283366|NCT03146650|76115179|FG000|2 Year Follow-up|Still in follow-up|7|||
42283367|NCT03146650|76115179|FG000|2 Year Follow-up|Lost to Follow-up|1|||
42283368|NCT03091192|76115185|FG000|Overall Study|Study terminated by sponsor|21|||
42283369|NCT03091192|76115186|FG001|Overall Study|Study terminated by sponsor|14|||
42283370|NCT03091192|76115185|FG000|Overall Study|Death|9|||
42283371|NCT03091192|76115186|FG001|Overall Study|Death|13|||
42283372|NCT03091192|76115185|FG000|Overall Study|Withdrawal by Subject|2|||
42283373|NCT03091192|76115186|FG001|Overall Study|Withdrawal by Subject|0|||
42283374|NCT03091192|76115185|FG000|Overall Study|Lost to Follow-up|1|||
42170739|NCT03439072|75977537|FG000|Overall Study|Withdrawal by Subject|2|||
42170740|NCT03439072|75977538|FG001|Overall Study|Withdrawal by Subject|3|||
42283375|NCT03091192|76115186|FG001|Overall Study|Lost to Follow-up|0|||
42283376|NCT02829723|76115222|FG000|Overall Study|Adverse Event|0|||
42283377|NCT02829723|76115223|FG001|Overall Study|Adverse Event|0|||
42014717|NCT01164501|75821823|FG002|Overall Study|Lost to Follow-up|3|||
42014718|NCT01164501|75821821|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
42014719|NCT01164501|75821822|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
42014720|NCT01164501|75821823|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
42014721|NCT01164501|75821821|FG000|Overall Study|Other reason not defined above|9|||
42014722|NCT01164501|75821822|FG001|Overall Study|Other reason not defined above|1|||
42014723|NCT01164501|75821823|FG002|Overall Study|Other reason not defined above|4|||
42170741|NCT03439072|75977537|FG000|Overall Study|Physician Decision|0|||
42283378|NCT02829723|76115224|FG002|Overall Study|Adverse Event|1|||
42283379|NCT02829723|76115225|FG003|Overall Study|Adverse Event|1|||
42014724|NCT00958711|75821835|FG000|Overall Study|Withdrawal by Subject|0|||
42014725|NCT00958711|75821836|FG001|Overall Study|Withdrawal by Subject|4|||
42014726|NCT00958711|75821835|FG000|Overall Study|Physician Decision|5|||
42014727|NCT00958711|75821836|FG001|Overall Study|Physician Decision|7|||
42170742|NCT03439072|75977538|FG001|Overall Study|Physician Decision|1|||
42170743|NCT00078312|75977544|FG000|Overall Study|Adverse Event|43|||
42170744|NCT00078312|75977544|FG000|Overall Study|Lack of Efficacy|15|||
42170745|NCT00078312|75977544|FG000|Overall Study|Lost to Follow-up|41|||
42170746|NCT00078312|75977544|FG000|Overall Study|Physician Decision|9|||
42170747|NCT00078312|75977544|FG000|Overall Study|Protocol Violation|3|||
42170748|NCT00078312|75977544|FG000|Overall Study|Withdrawal by Subject|33|||
42170749|NCT00078312|75977544|FG000|Overall Study|Miscellaneous|33|||
42170750|NCT00003896|75977548|FG000|Overall Study|Adverse Event|16|||
42170751|NCT00003896|75977548|FG000|Overall Study|Withdrawal by Subject|1|||
42170752|NCT00003896|75977548|FG000|Overall Study|Lack of Efficacy|1|||
42170753|NCT00003896|75977548|FG000|Overall Study|Death|3|||
42170754|NCT00003896|75977548|FG000|Overall Study|not protocol specified|3|||
42170755|NCT00003896|75977548|FG000|Overall Study|ineligible|5|||
42170756|NCT00003830|75977555|FG000|Overall Study|No follow up data|3|||
42170757|NCT00003830|75977556|FG001|Overall Study|No follow up data|0|||
42170758|NCT00003830|75977555|FG000|Overall Study|Sentinel node positive patients|829|||
42170759|NCT00003830|75977556|FG001|Overall Study|Sentinel node positive patients|793|||
42170760|NCT03407482|75977564|FG000|Overall Study|Adverse Event|12|||
42170761|NCT03407482|75977564|FG000|Overall Study|Disease Relapse|1|||
42170762|NCT03407482|75977564|FG000|Overall Study|Lost to Follow-up|1|||
42170763|NCT03407482|75977564|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42170764|NCT03407482|75977564|FG000|Overall Study|Pregnancy|2|||
42170765|NCT03407482|75977564|FG000|Overall Study|Protocol Violation|1|||
42170766|NCT03407482|75977564|FG000|Overall Study|Study Terminated By Sponsor|106|||
42170767|NCT03407482|75977564|FG000|Overall Study|Withdrawal by Subject|6|||
42170768|NCT03407482|75977564|FG000|Overall Study|Data Entry Error|1|||
42170769|NCT00003782|75977571|FG000|Overall Study|No follow up data|30|||
42170770|NCT00003782|75977572|FG001|Overall Study|No follow up data|31|||
42170771|NCT00003782|75977573|FG002|Overall Study|No follow up data|26|||
42170772|NCT03389308|75977581|FG000|Overall Study|Withdrawal by Subject|5|||
42170773|NCT03389308|75977581|FG000|Overall Study|Lost to Follow-up|3|||
42170774|NCT03389308|75977581|FG000|Overall Study|Adverse Event|2|||
42170775|NCT03389308|75977581|FG000|Overall Study|Sponsor Request|2|||
42170776|NCT03407170|75977585|FG000|Overall Study|Adverse Event|1|||
42170777|NCT03406858|75977589|FG000|Overall Study|Failure to receive treatment drug.|1|||
42170778|NCT03406858|75977589|FG000|Overall Study|ineligible|1|||
42170779|NCT03406702|75977593|FG000|Overall Study|Missed Day 27 Dosing|1|||
42170780|NCT00003656|75977611|FG000|Overall Study|Adverse Event|0|||
42170781|NCT00003656|75977612|FG001|Overall Study|Adverse Event|1|||
42170782|NCT00003590|75977619|FG000|Overall Study|Ineligible Patient|1|||
42170783|NCT00003590|75977619|FG000|Overall Study|Adverse Event|7|||
42170784|NCT00003590|75977619|FG000|Overall Study|Withdrawal by Subject|1|||
42170785|NCT00003590|75977619|FG000|Overall Study|Lack of Efficacy|11|||
42170786|NCT00003590|75977619|FG000|Overall Study|Death|1|||
42170787|NCT00003590|75977619|FG000|Overall Study|Physician Decision|1|||
42170788|NCT03416374|75977625|FG000|Between Treatment Period I and II|Other|0|||
42170789|NCT03416374|75977626|FG001|Between Treatment Period I and II|Other|9|||
42170790|NCT03416374|75977625|FG000|Treatment Period II|Lack of Efficacy|3|||
42170791|NCT03416374|75977626|FG001|Treatment Period II|Lack of Efficacy|11|||
42170792|NCT03416374|75977625|FG000|Treatment Period II|Adverse Event|1|||
42170793|NCT03416374|75977626|FG001|Treatment Period II|Adverse Event|4|||
42170794|NCT03416374|75977625|FG000|Treatment Period II|Death|0|||
42170795|NCT03416374|75977626|FG001|Treatment Period II|Death|1|||
42170796|NCT03416374|75977625|FG000|Treatment Period II|Other|0|||
42170797|NCT03416374|75977626|FG001|Treatment Period II|Other|2|||
42170798|NCT03799952|75977637|FG000|Overall Study|Program was too easy, discontinued|1|||
42283380|NCT02829723|76115226|FG004|Overall Study|Adverse Event|0|||
42014728|NCT00958711|75821835|FG000|Overall Study|Lost to Follow-up|4|||
42014729|NCT00958711|75821836|FG001|Overall Study|Lost to Follow-up|1|||
42014730|NCT00958711|75821835|FG000|Overall Study|Other|2|||
42014731|NCT00958711|75821836|FG001|Overall Study|Other|5|||
42170799|NCT03799952|75977638|FG001|Overall Study|Program was too easy, discontinued|0|||
42170800|NCT03799952|75977637|FG000|Overall Study|Lost to Follow-up|0|||
42170801|NCT03799952|75977638|FG001|Overall Study|Lost to Follow-up|2|||
42170802|NCT00077766|75977646|FG000|Overall Study|Adverse Event|1|||
42170803|NCT00077766|75977647|FG001|Overall Study|Adverse Event|1|||
42170804|NCT00077766|75977646|FG000|Overall Study|Withdrawal by Subject|4|||
42014732|NCT00958711|75821835|FG000|Overall Study|Death|1|||
42014733|NCT00958711|75821836|FG001|Overall Study|Death|2|||
42170805|NCT00077766|75977647|FG001|Overall Study|Withdrawal by Subject|3|||
42170806|NCT00077766|75977646|FG000|Overall Study|Death|12|||
42170807|NCT00077766|75977647|FG001|Overall Study|Death|10|||
42170808|NCT00077766|75977646|FG000|Overall Study|Lost to Follow-up|2|||
42170809|NCT00077766|75977647|FG001|Overall Study|Lost to Follow-up|0|||
42170810|NCT00077766|75977646|FG000|Overall Study|Protocol Violation|1|||
42170811|NCT00077766|75977647|FG001|Overall Study|Protocol Violation|0|||
42170812|NCT00077766|75977646|FG000|Overall Study|Kidney Transplantation|9|||
42170813|NCT00077766|75977647|FG001|Overall Study|Kidney Transplantation|5|||
42170814|NCT00077766|75977646|FG000|Overall Study|Transplantation|5|||
42170815|NCT00077766|75977647|FG001|Overall Study|Transplantation|1|||
42170816|NCT00077766|75977646|FG000|Overall Study|Investigators Discretion|1|||
42170817|NCT00077766|75977647|FG001|Overall Study|Investigators Discretion|0|||
42170818|NCT00077766|75977646|FG000|Overall Study|Participant's decision|1|||
42170819|NCT00077766|75977647|FG001|Overall Study|Participant's decision|0|||
42170820|NCT00077766|75977646|FG000|Overall Study|Dialysis Discontinued|1|||
42170821|NCT00077766|75977647|FG001|Overall Study|Dialysis Discontinued|0|||
42170822|NCT00077766|75977646|FG000|Overall Study|Dialysis|0|||
42170823|NCT00077766|75977647|FG001|Overall Study|Dialysis|1|||
42170824|NCT00077766|75977646|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
42170825|NCT00077766|75977647|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
42170826|NCT00077766|75977646|FG000|Overall Study|Started Nocturnal Dialysis|0|||
42170827|NCT00077766|75977647|FG001|Overall Study|Started Nocturnal Dialysis|1|||
42170828|NCT00077766|75977646|FG000|Overall Study|Stop Dialysis|0|||
42170829|NCT00077766|75977647|FG001|Overall Study|Stop Dialysis|1|||
42170830|NCT00077766|75977646|FG000|Overall Study|Participants Vacation|2|||
42170831|NCT00077766|75977647|FG001|Overall Study|Participants Vacation|1|||
42170832|NCT03388138|75977656|FG000|Overall Study|Protocol Violation|1|||
42170833|NCT03388138|75977657|FG001|Overall Study|Protocol Violation|0|||
42170834|NCT02952898|75977666|FG000|Overall Study|Withdrawal by Subject|10|||
42170835|NCT02952898|75977667|FG001|Overall Study|Withdrawal by Subject|8|||
42170836|NCT02952898|75977668|FG002|Overall Study|Withdrawal by Subject|8|||
42170837|NCT02952898|75977666|FG000|Overall Study|Adverse Event|8|||
42170838|NCT02952898|75977667|FG001|Overall Study|Adverse Event|8|||
42170839|NCT02952898|75977668|FG002|Overall Study|Adverse Event|3|||
42170840|NCT02952898|75977666|FG000|Overall Study|Lost to Follow-up|3|||
42170841|NCT02952898|75977667|FG001|Overall Study|Lost to Follow-up|2|||
42170842|NCT02952898|75977668|FG002|Overall Study|Lost to Follow-up|2|||
42283381|NCT02829723|76115227|FG005|Overall Study|Adverse Event|0|||
42283382|NCT02829723|76115228|FG006|Overall Study|Adverse Event|0|||
42283383|NCT02829723|76115229|FG007|Overall Study|Adverse Event|1|||
42283384|NCT02829723|76115230|FG008|Overall Study|Adverse Event|0|||
42283385|NCT02829723|76115231|FG009|Overall Study|Adverse Event|0|||
42283386|NCT02829723|76115232|FG010|Overall Study|Adverse Event|0|||
42283387|NCT02829723|76115233|FG011|Overall Study|Adverse Event|0|||
42283388|NCT02829723|76115234|FG012|Overall Study|Adverse Event|0|||
42283389|NCT02829723|76115235|FG013|Overall Study|Adverse Event|0|||
42283390|NCT02829723|76115236|FG014|Overall Study|Adverse Event|1|||
42283391|NCT02829723|76115237|FG015|Overall Study|Adverse Event|1|||
42283392|NCT02829723|76115238|FG016|Overall Study|Adverse Event|1|||
42283393|NCT02829723|76115239|FG017|Overall Study|Adverse Event|2|||
42283394|NCT02829723|76115240|FG018|Overall Study|Adverse Event|1|||
42283395|NCT02829723|76115241|FG019|Overall Study|Adverse Event|1|||
42283396|NCT02829723|76115242|FG020|Overall Study|Adverse Event|3|||
42283397|NCT02829723|76115243|FG021|Overall Study|Adverse Event|0|||
42283398|NCT02829723|76115244|FG022|Overall Study|Adverse Event|0|||
42283399|NCT02829723|76115245|FG023|Overall Study|Adverse Event|1|||
42283400|NCT02829723|76115246|FG024|Overall Study|Adverse Event|1|||
42283401|NCT02829723|76115247|FG025|Overall Study|Adverse Event|3|||
42283402|NCT02829723|76115248|FG026|Overall Study|Adverse Event|5|||
42283403|NCT02829723|76115222|FG000|Overall Study|Death|1|||
42283404|NCT02829723|76115223|FG001|Overall Study|Death|0|||
42283405|NCT02829723|76115224|FG002|Overall Study|Death|1|||
42283406|NCT02829723|76115225|FG003|Overall Study|Death|1|||
42283407|NCT02829723|76115226|FG004|Overall Study|Death|0|||
42283408|NCT02829723|76115227|FG005|Overall Study|Death|0|||
42170843|NCT02952898|75977666|FG000|Overall Study|Non-compliance with study drug|1|||
42170844|NCT02952898|75977667|FG001|Overall Study|Non-compliance with study drug|1|||
42170845|NCT02952898|75977668|FG002|Overall Study|Non-compliance with study drug|2|||
42170846|NCT00045734|75977676|FG000|Overall Study|Protocol Violation|1|||
42170847|NCT03387046|75977682|FG000|Overall Study|Adverse Event|1|||
42170848|NCT03387046|75977683|FG001|Overall Study|Adverse Event|1|||
42170849|NCT00045110|75977692|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
42170850|NCT00045110|75977693|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
42170851|NCT00045110|75977694|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
42170852|NCT00045110|75977692|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
42170853|NCT00045110|75977693|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
42170854|NCT00045110|75977694|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
42170855|NCT00045110|75977692|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
42170856|NCT00045110|75977693|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
42283409|NCT02829723|76115228|FG006|Overall Study|Death|2|||
42283410|NCT02829723|76115229|FG007|Overall Study|Death|0|||
42283411|NCT02829723|76115230|FG008|Overall Study|Death|1|||
42283412|NCT02829723|76115231|FG009|Overall Study|Death|0|||
42283413|NCT02829723|76115232|FG010|Overall Study|Death|0|||
42283414|NCT02829723|76115233|FG011|Overall Study|Death|0|||
42283415|NCT02829723|76115234|FG012|Overall Study|Death|2|||
42283416|NCT02829723|76115235|FG013|Overall Study|Death|1|||
42170857|NCT00045110|75977694|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
42170858|NCT03353740|75977711|FG000|Overall Study|Images for these participants not viable|52|||
42170859|NCT00003476|75977715|FG000|Overall Study|Not evaluable|1|||
42170860|NCT00003470|75977719|FG000|Overall Study|Not evaluable|6|||
42170861|NCT03386344|75977726|FG000|Overall Study|Adverse Event|6|||
42170862|NCT03386344|75977727|FG001|Overall Study|Adverse Event|3|||
42170863|NCT03386344|75977728|FG002|Overall Study|Adverse Event|1|||
42170864|NCT03386344|75977726|FG000|Overall Study|Poor Compliance to Protocol|0|||
42170865|NCT03386344|75977727|FG001|Overall Study|Poor Compliance to Protocol|1|||
42170866|NCT03386344|75977728|FG002|Overall Study|Poor Compliance to Protocol|0|||
42170867|NCT03386344|75977726|FG000|Overall Study|Study Terminated by Sponsor|101|||
42170868|NCT03386344|75977727|FG001|Overall Study|Study Terminated by Sponsor|102|||
42170869|NCT03386344|75977728|FG002|Overall Study|Study Terminated by Sponsor|106|||
42170870|NCT03386344|75977726|FG000|Overall Study|Lost to Follow-up|3|||
42170871|NCT03386344|75977727|FG001|Overall Study|Lost to Follow-up|2|||
42170872|NCT03386344|75977728|FG002|Overall Study|Lost to Follow-up|1|||
42170873|NCT03386344|75977726|FG000|Overall Study|At the Participant's own Request|7|||
42170874|NCT03386344|75977727|FG001|Overall Study|At the Participant's own Request|7|||
42170875|NCT03386344|75977728|FG002|Overall Study|At the Participant's own Request|8|||
42170876|NCT03386344|75977726|FG000|Overall Study|Reason not Specified|0|||
42170877|NCT03386344|75977727|FG001|Overall Study|Reason not Specified|1|||
42170878|NCT03386344|75977728|FG002|Overall Study|Reason not Specified|0|||
42170879|NCT00399035|75977739|FG000|Overall Study|Death|289|||
42170880|NCT00399035|75977740|FG001|Overall Study|Death|141|||
42170881|NCT00399035|75977741|FG002|Overall Study|Death|234|||
42170882|NCT00399035|75977739|FG000|Overall Study|Lost to Follow-up|2|||
42170883|NCT00399035|75977740|FG001|Overall Study|Lost to Follow-up|1|||
42170884|NCT00399035|75977741|FG002|Overall Study|Lost to Follow-up|5|||
42170885|NCT00399035|75977739|FG000|Overall Study|Withdrawal by Subject|19|||
42170886|NCT00399035|75977740|FG001|Overall Study|Withdrawal by Subject|15|||
42170887|NCT00399035|75977741|FG002|Overall Study|Withdrawal by Subject|12|||
42170888|NCT00399035|75977739|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
42170889|NCT00399035|75977740|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
42170890|NCT00399035|75977741|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
42170891|NCT00399035|75977739|FG000|Overall Study|Severe non-compliance with protocol|2|||
42170892|NCT00399035|75977740|FG001|Overall Study|Severe non-compliance with protocol|1|||
42170893|NCT00399035|75977741|FG002|Overall Study|Severe non-compliance with protocol|0|||
42170894|NCT00073749|75977755|FG000|Overall Study|Disease Progression|2|||
42170895|NCT00073749|75977756|FG001|Overall Study|Disease Progression|0|||
42170896|NCT00073749|75977757|FG002|Overall Study|Disease Progression|3|||
42170897|NCT00073749|75977758|FG003|Overall Study|Disease Progression|2|||
42170898|NCT00073749|75977759|FG004|Overall Study|Disease Progression|3|||
42170899|NCT00073749|75977760|FG005|Overall Study|Disease Progression|1|||
42170900|NCT00073749|75977761|FG006|Overall Study|Disease Progression|3|||
42170901|NCT00073749|75977755|FG000|Overall Study|Death|0|||
42170902|NCT00073749|75977756|FG001|Overall Study|Death|1|||
42170903|NCT00073749|75977757|FG002|Overall Study|Death|1|||
42170904|NCT00073749|75977758|FG003|Overall Study|Death|0|||
42170905|NCT00073749|75977759|FG004|Overall Study|Death|0|||
42170906|NCT00073749|75977760|FG005|Overall Study|Death|0|||
42170907|NCT00073749|75977761|FG006|Overall Study|Death|29|||
42170908|NCT00073749|75977755|FG000|Overall Study|Adverse Event|0|||
42170909|NCT00073749|75977756|FG001|Overall Study|Adverse Event|3|||
42283417|NCT02829723|76115236|FG014|Overall Study|Death|0|||
42283418|NCT02829723|76115237|FG015|Overall Study|Death|0|||
42283419|NCT02829723|76115238|FG016|Overall Study|Death|0|||
42283420|NCT02829723|76115239|FG017|Overall Study|Death|0|||
42170910|NCT00073749|75977757|FG002|Overall Study|Adverse Event|6|||
42170911|NCT00073749|75977758|FG003|Overall Study|Adverse Event|4|||
42283421|NCT02829723|76115240|FG018|Overall Study|Death|0|||
42283422|NCT02829723|76115241|FG019|Overall Study|Death|0|||
42170912|NCT00073749|75977759|FG004|Overall Study|Adverse Event|2|||
42170913|NCT00073749|75977760|FG005|Overall Study|Adverse Event|1|||
42170914|NCT00073749|75977761|FG006|Overall Study|Adverse Event|0|||
42170915|NCT00073749|75977755|FG000|Overall Study|Physician Decision|0|||
42170916|NCT00073749|75977756|FG001|Overall Study|Physician Decision|0|||
42170917|NCT00073749|75977757|FG002|Overall Study|Physician Decision|1|||
42170918|NCT00073749|75977758|FG003|Overall Study|Physician Decision|0|||
42170919|NCT00073749|75977759|FG004|Overall Study|Physician Decision|0|||
42283423|NCT02829723|76115242|FG020|Overall Study|Death|0|||
42170920|NCT00073749|75977760|FG005|Overall Study|Physician Decision|2|||
42170921|NCT00073749|75977761|FG006|Overall Study|Physician Decision|0|||
42170922|NCT00073749|75977755|FG000|Overall Study|Withdrawal by Subject|0|||
42170923|NCT00073749|75977756|FG001|Overall Study|Withdrawal by Subject|1|||
42170924|NCT00073749|75977757|FG002|Overall Study|Withdrawal by Subject|0|||
42170925|NCT00073749|75977758|FG003|Overall Study|Withdrawal by Subject|0|||
42170926|NCT00073749|75977759|FG004|Overall Study|Withdrawal by Subject|1|||
42170927|NCT00073749|75977760|FG005|Overall Study|Withdrawal by Subject|0|||
42014734|NCT00958711|75821835|FG000|Overall Study|Adverse Event|1|||
42170928|NCT00073749|75977761|FG006|Overall Study|Withdrawal by Subject|2|||
42170929|NCT00073749|75977755|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
42170930|NCT00073749|75977756|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
42170931|NCT00073749|75977757|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
42170932|NCT00073749|75977758|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
42170933|NCT00073749|75977759|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
42170934|NCT00073749|75977760|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
42170935|NCT00073749|75977761|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
42170936|NCT00073749|75977755|FG000|Overall Study|Lost to Follow-up|0|||
42170937|NCT00073749|75977756|FG001|Overall Study|Lost to Follow-up|0|||
42170938|NCT00073749|75977757|FG002|Overall Study|Lost to Follow-up|0|||
42170939|NCT00073749|75977758|FG003|Overall Study|Lost to Follow-up|0|||
42170940|NCT00073749|75977759|FG004|Overall Study|Lost to Follow-up|0|||
42170941|NCT00073749|75977760|FG005|Overall Study|Lost to Follow-up|0|||
42170942|NCT00073749|75977761|FG006|Overall Study|Lost to Follow-up|2|||
42170943|NCT00073749|75977755|FG000|Overall Study|Other|0|||
42170944|NCT00073749|75977756|FG001|Overall Study|Other|0|||
42170945|NCT00073749|75977757|FG002|Overall Study|Other|0|||
42170946|NCT00073749|75977758|FG003|Overall Study|Other|0|||
42170947|NCT00073749|75977759|FG004|Overall Study|Other|0|||
42170948|NCT00073749|75977760|FG005|Overall Study|Other|2|||
42170949|NCT00073749|75977761|FG006|Overall Study|Other|0|||
42170950|NCT00398567|75977783|FG000|Overall Study|Disease Progression|3|||
42170951|NCT00398567|75977784|FG001|Overall Study|Disease Progression|4|||
42170952|NCT00398567|75977785|FG002|Overall Study|Disease Progression|27|||
42170953|NCT00398567|75977783|FG000|Overall Study|Withdrawal by Subject|1|||
42170954|NCT00398567|75977784|FG001|Overall Study|Withdrawal by Subject|0|||
42170955|NCT00398567|75977785|FG002|Overall Study|Withdrawal by Subject|4|||
42170956|NCT00398567|75977783|FG000|Overall Study|Adverse Event|0|||
42170957|NCT00398567|75977784|FG001|Overall Study|Adverse Event|0|||
42170958|NCT00398567|75977785|FG002|Overall Study|Adverse Event|2|||
42170959|NCT00398567|75977783|FG000|Overall Study|Protocol Violation|0|||
42170960|NCT00398567|75977784|FG001|Overall Study|Protocol Violation|0|||
42170961|NCT00398567|75977785|FG002|Overall Study|Protocol Violation|1|||
42170962|NCT05249569|75977791|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
42170963|NCT04779879|75977814|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
42170964|NCT04779879|75977815|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
42170965|NCT04779879|75977816|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
42170966|NCT04779879|75977817|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
42170967|NCT04779879|75977818|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
42170968|NCT04779879|75977819|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
42170969|NCT04779879|75977814|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
42170970|NCT04779879|75977815|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
42170971|NCT04779879|75977816|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
42170972|NCT04779879|75977817|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
42170973|NCT04779879|75977818|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
42170974|NCT04779879|75977819|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
42170975|NCT04779879|75977814|FG000|Part C: Up to Week 36|Death|0|||
42170976|NCT04779879|75977815|FG001|Part C: Up to Week 36|Death|0|||
42170977|NCT04779879|75977816|FG002|Part C: Up to Week 36|Death|0|||
42170978|NCT04779879|75977817|FG003|Part C: Up to Week 36|Death|0|||
42170979|NCT04779879|75977818|FG004|Part C: Up to Week 36|Death|0|||
42170980|NCT04779879|75977819|FG005|Part C: Up to Week 36|Death|1|||
42170981|NCT04779879|75977814|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
42170982|NCT04779879|75977815|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
42170983|NCT04779879|75977816|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
42170984|NCT04779879|75977817|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
42014735|NCT00958711|75821836|FG001|Overall Study|Adverse Event|2|||
42170985|NCT04779879|75977818|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
42170986|NCT04779879|75977819|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
42170987|NCT04535167|75977860|FG000|Treatment|Adverse Event|0|||
42170988|NCT04535167|75977861|FG001|Treatment|Adverse Event|0|||
42170989|NCT04535167|75977862|FG002|Treatment|Adverse Event|0|||
42170990|NCT04535167|75977863|FG003|Treatment|Adverse Event|0|||
42170991|NCT04535167|75977864|FG004|Treatment|Adverse Event|0|||
42170992|NCT04535167|75977865|FG005|Treatment|Adverse Event|0|||
42170993|NCT04535167|75977866|FG006|Treatment|Adverse Event|1|||
42170994|NCT04535167|75977860|FG000|Follow-Up|Death|0|||
42170995|NCT04535167|75977861|FG001|Follow-Up|Death|0|||
42170996|NCT04535167|75977862|FG002|Follow-Up|Death|0|||
42352139|NCT01923181|76192147|FG007|Overall Study|Other|0|||
42352140|NCT01923181|76192148|FG008|Overall Study|Other|0|||
42170997|NCT04535167|75977863|FG003|Follow-Up|Death|0|||
42170998|NCT04535167|75977864|FG004|Follow-Up|Death|0|||
42170999|NCT04535167|75977865|FG005|Follow-Up|Death|0|||
42283424|NCT02829723|76115243|FG021|Overall Study|Death|2|||
42283425|NCT02829723|76115244|FG022|Overall Study|Death|0|||
42283426|NCT02829723|76115245|FG023|Overall Study|Death|0|||
42283427|NCT02829723|76115246|FG024|Overall Study|Death|0|||
42283428|NCT02829723|76115247|FG025|Overall Study|Death|1|||
42283429|NCT02829723|76115248|FG026|Overall Study|Death|2|||
42283430|NCT02829723|76115222|FG000|Overall Study|Physician Decision|0|||
42283431|NCT02829723|76115223|FG001|Overall Study|Physician Decision|0|||
42283432|NCT02829723|76115224|FG002|Overall Study|Physician Decision|0|||
42283433|NCT02829723|76115225|FG003|Overall Study|Physician Decision|0|||
42283434|NCT02829723|76115226|FG004|Overall Study|Physician Decision|0|||
42283435|NCT02829723|76115227|FG005|Overall Study|Physician Decision|0|||
42283436|NCT02829723|76115228|FG006|Overall Study|Physician Decision|0|||
42283437|NCT02829723|76115229|FG007|Overall Study|Physician Decision|0|||
42283438|NCT02829723|76115230|FG008|Overall Study|Physician Decision|0|||
42283439|NCT02829723|76115231|FG009|Overall Study|Physician Decision|1|||
42283440|NCT02829723|76115232|FG010|Overall Study|Physician Decision|1|||
42283441|NCT02829723|76115233|FG011|Overall Study|Physician Decision|0|||
42283442|NCT02829723|76115234|FG012|Overall Study|Physician Decision|0|||
42283443|NCT02829723|76115235|FG013|Overall Study|Physician Decision|1|||
42283444|NCT02829723|76115236|FG014|Overall Study|Physician Decision|0|||
42352141|NCT01923181|76192140|FG000|Overall Study|Lost to Follow-up|0|||
42352142|NCT01923181|76192141|FG001|Overall Study|Lost to Follow-up|3|||
42352143|NCT01923181|76192142|FG002|Overall Study|Lost to Follow-up|2|||
42352144|NCT01923181|76192143|FG003|Overall Study|Lost to Follow-up|1|||
42352145|NCT01923181|76192144|FG004|Overall Study|Lost to Follow-up|2|||
42352146|NCT01923181|76192145|FG005|Overall Study|Lost to Follow-up|1|||
42352147|NCT01923181|76192146|FG006|Overall Study|Lost to Follow-up|3|||
42352148|NCT01923181|76192147|FG007|Overall Study|Lost to Follow-up|3|||
42352149|NCT01923181|76192148|FG008|Overall Study|Lost to Follow-up|1|||
42352150|NCT01896271|76192171|FG000|Overall Study|Physician Decision|10|||
42352151|NCT01884571|76192175|FG000|Overall Study|Adverse Event|1|||
42352152|NCT01884571|76192175|FG000|Overall Study|Death|2|||
42352153|NCT01884571|76192175|FG000|Overall Study|Withdrawal by Subject|2|||
42352154|NCT01884571|76192175|FG000|Overall Study|Disease progression|3|||
42352155|NCT01884337|76192181|FG000|Treatment|Adverse Event|2|||
42352156|NCT01884337|76192182|FG001|Treatment|Adverse Event|2|||
42352157|NCT01884337|76192181|FG000|Treatment|Subj. request to discont. treatment|2|||
42352158|NCT01884337|76192182|FG001|Treatment|Subj. request to discont. treatment|0|||
42352159|NCT01884337|76192181|FG000|Follow-up Period|Lost to Follow-up|1|||
42352160|NCT01884337|76192182|FG001|Follow-up Period|Lost to Follow-up|1|||
42352161|NCT01922089|76192190|FG000|Overall Study|Adverse Event|18|||
42352162|NCT01922089|76192191|FG001|Overall Study|Adverse Event|13|||
42352163|NCT01922089|76192190|FG000|Overall Study|Protocol Deviation|10|||
42352164|NCT01922089|76192191|FG001|Overall Study|Protocol Deviation|7|||
42352165|NCT01922089|76192190|FG000|Overall Study|Withdrawal by Subject|3|||
42352166|NCT01922089|76192191|FG001|Overall Study|Withdrawal by Subject|4|||
42352167|NCT01922089|76192190|FG000|Overall Study|administrative problems|4|||
42014736|NCT01163721|75821844|FG000|Overall Study|Adverse Event|5|||
42171000|NCT04535167|75977866|FG006|Follow-Up|Death|1|||
42283445|NCT02829723|76115237|FG015|Overall Study|Physician Decision|0|||
42014737|NCT01163721|75821845|FG001|Overall Study|Adverse Event|6|||
42283446|NCT02829723|76115238|FG016|Overall Study|Physician Decision|2|||
42014738|NCT01163721|75821844|FG000|Overall Study|Withdrawal by Subject|3|||
42014739|NCT01163721|75821845|FG001|Overall Study|Withdrawal by Subject|4|||
42014740|NCT01163721|75821844|FG000|Overall Study|Lost to Follow-up|0|||
42014741|NCT01163721|75821845|FG001|Overall Study|Lost to Follow-up|1|||
42283447|NCT02829723|76115239|FG017|Overall Study|Physician Decision|0|||
42283448|NCT02829723|76115240|FG018|Overall Study|Physician Decision|0|||
42014742|NCT01163721|75821844|FG000|Overall Study|Physician Decision|0|||
42014743|NCT01163721|75821845|FG001|Overall Study|Physician Decision|1|||
42171001|NCT04535167|75977860|FG000|Follow-Up|Lost to Follow-up|0|||
42171002|NCT04535167|75977861|FG001|Follow-Up|Lost to Follow-up|0|||
42171003|NCT04535167|75977862|FG002|Follow-Up|Lost to Follow-up|0|||
42283449|NCT02829723|76115241|FG019|Overall Study|Physician Decision|0|||
42283450|NCT02829723|76115242|FG020|Overall Study|Physician Decision|0|||
42352168|NCT01922089|76192191|FG001|Overall Study|administrative problems|1|||
42352169|NCT01922089|76192190|FG000|Overall Study|Physician Decision|2|||
42352170|NCT01922089|76192191|FG001|Overall Study|Physician Decision|3|||
42352171|NCT01922089|76192190|FG000|Overall Study|Death|2|||
42352172|NCT01922089|76192191|FG001|Overall Study|Death|1|||
42171004|NCT04535167|75977863|FG003|Follow-Up|Lost to Follow-up|1|||
42171005|NCT04535167|75977864|FG004|Follow-Up|Lost to Follow-up|0|||
42171006|NCT04535167|75977865|FG005|Follow-Up|Lost to Follow-up|0|||
42171007|NCT04535167|75977866|FG006|Follow-Up|Lost to Follow-up|0|||
42171008|NCT04223791|75977884|FG000|Overall Study|Lost to Follow-up|0|||
42171009|NCT04223791|75977885|FG001|Overall Study|Lost to Follow-up|4|||
42171010|NCT04223791|75977884|FG000|Overall Study|Physician Decision|5|||
42014744|NCT00958243|75821857|FG000|Overall Study|Withdrawal by Subject|0|||
42171011|NCT04223791|75977885|FG001|Overall Study|Physician Decision|1|||
42171012|NCT04223791|75977884|FG000|Overall Study|Protocol Violation|1|||
42171013|NCT04223791|75977885|FG001|Overall Study|Protocol Violation|1|||
42171014|NCT04223791|75977884|FG000|Overall Study|Withdrawal by Subject|10|||
42171015|NCT04223791|75977885|FG001|Overall Study|Withdrawal by Subject|12|||
42171016|NCT04223791|75977884|FG000|Overall Study|Pregnancy|1|||
42171017|NCT04223791|75977885|FG001|Overall Study|Pregnancy|1|||
42171018|NCT04223791|75977884|FG000|Overall Study|Ongoing in Study|305|||
42171019|NCT04223791|75977885|FG001|Overall Study|Ongoing in Study|302|||
42171020|NCT04115293|75977893|FG000|Overall Study|Adverse Event|0|||
42171021|NCT04115293|75977894|FG001|Overall Study|Adverse Event|2|||
42171022|NCT04115293|75977893|FG000|Overall Study|Withdrawal by Subject|2|||
42171023|NCT04115293|75977894|FG001|Overall Study|Withdrawal by Subject|1|||
42171024|NCT04115293|75977893|FG000|Overall Study|Physician Decision|1|||
42171025|NCT04115293|75977894|FG001|Overall Study|Physician Decision|0|||
42171026|NCT04115293|75977893|FG000|Overall Study|Death|1|||
42171027|NCT04115293|75977894|FG001|Overall Study|Death|1|||
42171028|NCT04035499|75977900|FG000|Overall Study|Death|2|||
42171029|NCT04035499|75977900|FG000|Overall Study|Withdrawal by Subject|1|||
42171030|NCT03915067|75977907|FG000|Overall Study|Adverse Event|0|||
42171031|NCT03915067|75977908|FG001|Overall Study|Adverse Event|0|||
42171032|NCT03915067|75977909|FG002|Overall Study|Adverse Event|1|||
42171033|NCT03915067|75977907|FG000|Overall Study|Withdrawal by Subject|4|||
42171034|NCT03915067|75977908|FG001|Overall Study|Withdrawal by Subject|3|||
42171035|NCT03915067|75977909|FG002|Overall Study|Withdrawal by Subject|0|||
42171036|NCT03915067|75977907|FG000|Overall Study|Lost to Follow-up|3|||
42171037|NCT03915067|75977908|FG001|Overall Study|Lost to Follow-up|2|||
42171038|NCT03915067|75977909|FG002|Overall Study|Lost to Follow-up|0|||
42171039|NCT03915067|75977907|FG000|Overall Study|Protocol Deviation|0|||
42171040|NCT03915067|75977908|FG001|Overall Study|Protocol Deviation|0|||
42171041|NCT03915067|75977909|FG002|Overall Study|Protocol Deviation|1|||
42171042|NCT03915067|75977907|FG000|Overall Study|Covid-19 Related Issues|2|||
42171043|NCT03915067|75977908|FG001|Overall Study|Covid-19 Related Issues|4|||
42352173|NCT01922089|76192190|FG000|Overall Study|Lost to Follow-up|0|||
42352174|NCT01922089|76192191|FG001|Overall Study|Lost to Follow-up|1|||
42352175|NCT01884025|76192199|FG000|Overall Study|Lost to Follow-up|3|||
42352176|NCT01884025|76192200|FG001|Overall Study|Lost to Follow-up|4|||
42352177|NCT01896193|76192210|FG000|Overall Study|Lack of Efficacy|20|||
42352178|NCT01896193|76192211|FG001|Overall Study|Lack of Efficacy|11|||
42352179|NCT01896193|76192210|FG000|Overall Study|Protocol Violation|0|||
42352180|NCT01896193|76192211|FG001|Overall Study|Protocol Violation|1|||
42352181|NCT01896193|76192210|FG000|Overall Study|Withdrew Consent|1|||
42352182|NCT01896193|76192211|FG001|Overall Study|Withdrew Consent|0|||
42352183|NCT01922011|76192221|FG000|Overall Study|Protocol Violation|0|||
42352184|NCT01922011|76192222|FG001|Overall Study|Protocol Violation|1|||
42352185|NCT01922011|76192221|FG000|Overall Study|Physician Decision|0|||
42352186|NCT01922011|76192222|FG001|Overall Study|Physician Decision|1|||
42352187|NCT01922011|76192221|FG000|Overall Study|Parent/Guardian Decision|3|||
42352188|NCT01922011|76192222|FG001|Overall Study|Parent/Guardian Decision|0|||
42352189|NCT01922011|76192221|FG000|Overall Study|Lost to Follow-up|0|||
42352190|NCT01922011|76192222|FG001|Overall Study|Lost to Follow-up|1|||
42352191|NCT01922011|76192221|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
42352192|NCT01922011|76192222|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
42352193|NCT01922011|76192221|FG000|Overall Study|Not Treated|1|||
42352194|NCT01922011|76192222|FG001|Overall Study|Not Treated|0|||
42014745|NCT00958243|75821858|FG001|Overall Study|Withdrawal by Subject|1|||
42014746|NCT00958243|75821859|FG002|Overall Study|Withdrawal by Subject|3|||
42014747|NCT00958243|75821860|FG003|Overall Study|Withdrawal by Subject|1|||
42014748|NCT00958243|75821861|FG004|Overall Study|Withdrawal by Subject|1|||
42171044|NCT03915067|75977909|FG002|Overall Study|Covid-19 Related Issues|4|||
42171045|NCT03915067|75977907|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
42171046|NCT03915067|75977908|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
42171047|NCT03915067|75977909|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
42171048|NCT03654404|75977917|FG000|Overall Study|Death|1|||
42171049|NCT03654404|75977917|FG000|Overall Study|Lost to Follow-up|2|||
42171050|NCT03654404|75977917|FG000|Overall Study|Withdrawal by Subject|5|||
42171051|NCT03447314|75977982|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
42171052|NCT03447314|75977983|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
42171053|NCT03447314|75977984|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
42171054|NCT03447314|75977985|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
42171055|NCT03447314|75977986|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
42171056|NCT03447314|75977987|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
42171057|NCT03447314|75977988|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
42171058|NCT03447314|75977989|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
42171059|NCT03447314|75977990|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
42171060|NCT03447314|75977991|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
42171061|NCT03447314|75977992|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
42171062|NCT03447314|75977993|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
42171063|NCT03447314|75977994|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
42171064|NCT03447314|75977995|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
42171065|NCT03447314|75977996|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
42171066|NCT03447314|75977997|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
42171067|NCT03447314|75977998|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
42171068|NCT03447314|75977999|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
42171069|NCT03447314|75977982|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
42014749|NCT00958243|75821862|FG005|Overall Study|Withdrawal by Subject|5|||
42014750|NCT00958243|75821857|FG000|Overall Study|Lost to Follow-up|2|||
42014751|NCT00958243|75821858|FG001|Overall Study|Lost to Follow-up|5|||
42171070|NCT03447314|75977983|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171071|NCT03447314|75977984|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
42171072|NCT03447314|75977985|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171073|NCT03447314|75977986|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171074|NCT03447314|75977987|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
42171075|NCT03447314|75977988|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
42171076|NCT03447314|75977989|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171077|NCT03447314|75977990|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171078|NCT03447314|75977991|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171079|NCT03447314|75977992|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171080|NCT03447314|75977993|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171081|NCT03447314|75977994|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171082|NCT03447314|75977995|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171083|NCT03447314|75977996|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171084|NCT03447314|75977997|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171085|NCT03447314|75977998|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171086|NCT03447314|75977999|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
42171087|NCT03447314|75977982|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171088|NCT03447314|75977983|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171089|NCT03447314|75977984|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
42171090|NCT03447314|75977985|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171091|NCT03447314|75977986|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171092|NCT03447314|75977987|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171093|NCT03447314|75977988|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171094|NCT03447314|75977989|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171095|NCT03447314|75977990|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171096|NCT03447314|75977991|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171097|NCT03447314|75977992|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171098|NCT03447314|75977993|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171099|NCT03447314|75977994|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171100|NCT03447314|75977995|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171101|NCT03447314|75977996|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171102|NCT03447314|75977997|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171103|NCT03447314|75977998|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171104|NCT03447314|75977999|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
42171105|NCT03447314|75977982|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171106|NCT03447314|75977983|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171107|NCT03447314|75977984|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
42171108|NCT03447314|75977985|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171109|NCT03447314|75977986|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171110|NCT03447314|75977987|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171111|NCT03447314|75977988|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171112|NCT03447314|75977989|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171113|NCT03447314|75977990|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171114|NCT03447314|75977991|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171115|NCT03447314|75977992|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171116|NCT03447314|75977993|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171117|NCT03447314|75977994|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42283451|NCT02829723|76115243|FG021|Overall Study|Physician Decision|0|||
42171118|NCT03447314|75977995|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171119|NCT03447314|75977996|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171120|NCT03447314|75977997|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171121|NCT03447314|75977998|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171122|NCT03447314|75977999|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
42171123|NCT03447314|75977982|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171124|NCT03447314|75977983|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171125|NCT03447314|75977984|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171126|NCT03447314|75977985|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171127|NCT03447314|75977986|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171128|NCT03447314|75977987|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171129|NCT03447314|75977988|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171130|NCT03447314|75977989|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171131|NCT03447314|75977990|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171132|NCT03447314|75977991|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171133|NCT03447314|75977992|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
42171134|NCT03447314|75977993|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171135|NCT03447314|75977994|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171136|NCT03447314|75977995|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171137|NCT03447314|75977996|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171138|NCT03447314|75977997|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171139|NCT03447314|75977998|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171140|NCT03447314|75977999|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
42171141|NCT03447314|75977982|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171142|NCT03447314|75977983|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171143|NCT03447314|75977984|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171144|NCT03447314|75977985|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
42171145|NCT03447314|75977986|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171146|NCT03447314|75977987|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
42283452|NCT02829723|76115244|FG022|Overall Study|Physician Decision|1|||
42283453|NCT02829723|76115245|FG023|Overall Study|Physician Decision|1|||
42283454|NCT02829723|76115246|FG024|Overall Study|Physician Decision|1|||
42283455|NCT02829723|76115247|FG025|Overall Study|Physician Decision|1|||
42283456|NCT02829723|76115248|FG026|Overall Study|Physician Decision|3|||
42283457|NCT02829723|76115222|FG000|Overall Study|Progressive disease|4|||
42283458|NCT02829723|76115223|FG001|Overall Study|Progressive disease|6|||
42283459|NCT02829723|76115224|FG002|Overall Study|Progressive disease|3|||
42283460|NCT02829723|76115225|FG003|Overall Study|Progressive disease|3|||
42283461|NCT02829723|76115226|FG004|Overall Study|Progressive disease|3|||
42283462|NCT02829723|76115227|FG005|Overall Study|Progressive disease|5|||
42283463|NCT02829723|76115228|FG006|Overall Study|Progressive disease|4|||
42352195|NCT01922011|76192221|FG000|Overall Study|Lack of willing home health agency|1|||
42352196|NCT01922011|76192222|FG001|Overall Study|Lack of willing home health agency|0|||
42352197|NCT01922011|76192221|FG000|Overall Study|Randomized in error|1|||
42352198|NCT01922011|76192222|FG001|Overall Study|Randomized in error|0|||
42352199|NCT01883635|76192236|FG000|Overall Study|Withdrawal by Subject|4|||
42352200|NCT01883635|76192237|FG001|Overall Study|Withdrawal by Subject|0|||
42352201|NCT01921387|76192245|FG000|Overall Study|Adverse Event|1|||
42352202|NCT01895335|76192249|FG000|Overall Study|Adverse Event|106|||
42352203|NCT01895335|76192249|FG000|Overall Study|Lack of Efficacy|53|||
42352204|NCT01895335|76192249|FG000|Overall Study|Poor Compliance to Protocol|11|||
42352205|NCT01895335|76192249|FG000|Overall Study|Included But Not treated|1|||
42352206|NCT01895335|76192249|FG000|Overall Study|Other than Specified Above|44|||
42352207|NCT01617655|76192255|FG000|Overall Study|Adverse Event|2|||
42352208|NCT01617655|76192256|FG001|Overall Study|Adverse Event|3|||
42014752|NCT00958243|75821859|FG002|Overall Study|Lost to Follow-up|11|||
42014753|NCT00958243|75821860|FG003|Overall Study|Lost to Follow-up|2|||
42014754|NCT00958243|75821861|FG004|Overall Study|Lost to Follow-up|8|||
42014755|NCT00958243|75821862|FG005|Overall Study|Lost to Follow-up|5|||
42352209|NCT01617655|76192255|FG000|Overall Study|Poor compliance to protocol|1|||
42352210|NCT01617655|76192256|FG001|Overall Study|Poor compliance to protocol|4|||
42352211|NCT01617655|76192255|FG000|Overall Study|Participants moved|0|||
42014756|NCT01241760|75821884|FG000|Overall Study|Adverse Event|1|||
42014757|NCT01241760|75821885|FG001|Overall Study|Adverse Event|0|||
42283464|NCT02829723|76115229|FG007|Overall Study|Progressive disease|6|||
42283465|NCT02829723|76115230|FG008|Overall Study|Progressive disease|8|||
42283466|NCT02829723|76115231|FG009|Overall Study|Progressive disease|4|||
42283467|NCT02829723|76115232|FG010|Overall Study|Progressive disease|9|||
42014758|NCT01241760|75821884|FG000|Overall Study|Lost to Follow-up|18|||
42014759|NCT01241760|75821885|FG001|Overall Study|Lost to Follow-up|22|||
42014760|NCT01241760|75821884|FG000|Overall Study|Withdrawal by Subject|13|||
42014761|NCT01241760|75821885|FG001|Overall Study|Withdrawal by Subject|13|||
42014762|NCT01241760|75821884|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
42014763|NCT01241760|75821885|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
42014764|NCT01241760|75821884|FG000|Overall Study|Other|1|||
42014765|NCT01241760|75821885|FG001|Overall Study|Other|1|||
42283468|NCT02829723|76115233|FG011|Overall Study|Progressive disease|0|||
42283469|NCT02829723|76115234|FG012|Overall Study|Progressive disease|3|||
42014766|NCT00958165|75821892|FG000|Overall Study|Lost to Follow-up|5|||
42014767|NCT00958165|75821892|FG000|Overall Study|Not eligible|9|||
42283470|NCT02829723|76115235|FG013|Overall Study|Progressive disease|4|||
42171147|NCT03447314|75977988|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171148|NCT03447314|75977989|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171149|NCT03447314|75977990|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171150|NCT03447314|75977991|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171151|NCT03447314|75977992|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171152|NCT03447314|75977993|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171153|NCT03447314|75977994|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171154|NCT03447314|75977995|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171155|NCT03447314|75977996|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171156|NCT03447314|75977997|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171157|NCT03447314|75977998|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171158|NCT03447314|75977999|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
42171159|NCT03423121|75978042|FG000|Overall Study|Lost to Follow-up|2|||
42171160|NCT03423121|75978043|FG001|Overall Study|Lost to Follow-up|6|||
42171161|NCT03423121|75978042|FG000|Overall Study|Adverse Event|1|||
42171162|NCT03423121|75978043|FG001|Overall Study|Adverse Event|0|||
42171163|NCT03335475|75978051|FG000|Overall Study|Did not wear accelerometer|4|||
42171164|NCT03335475|75978052|FG001|Overall Study|Did not wear accelerometer|0|||
42283471|NCT02829723|76115236|FG014|Overall Study|Progressive disease|2|||
42283472|NCT02829723|76115237|FG015|Overall Study|Progressive disease|4|||
42283473|NCT02829723|76115238|FG016|Overall Study|Progressive disease|5|||
42014768|NCT00958009|75821896|FG000|Overall Study|Adverse Event|1|||
42014769|NCT00958009|75821896|FG000|Overall Study|Subject found device difficult to use|1|||
42014770|NCT00953407|75821905|FG000|Overall Study|Failed inclusion criteria|1|||
42014771|NCT00953407|75821906|FG001|Overall Study|Failed inclusion criteria|1|||
42014772|NCT00953407|75821907|FG002|Overall Study|Failed inclusion criteria|1|||
42014773|NCT00953407|75821908|FG003|Overall Study|Failed inclusion criteria|1|||
42014774|NCT00953407|75821909|FG004|Overall Study|Failed inclusion criteria|1|||
42014775|NCT00953407|75821905|FG000|Overall Study|Lost to Follow-up|0|||
42014776|NCT00953407|75821906|FG001|Overall Study|Lost to Follow-up|0|||
42014777|NCT00953407|75821907|FG002|Overall Study|Lost to Follow-up|0|||
42014778|NCT00953407|75821908|FG003|Overall Study|Lost to Follow-up|1|||
42014779|NCT00953407|75821909|FG004|Overall Study|Lost to Follow-up|0|||
42014780|NCT00953329|75821921|FG000|Overall Study|Lack of Efficacy|1|||
42014781|NCT00953017|75821929|FG000|Overall Study|DId not show up for colonoscopy|4|||
42014782|NCT00953017|75821930|FG001|Overall Study|DId not show up for colonoscopy|4|||
42352212|NCT01617655|76192256|FG001|Overall Study|Participants moved|4|||
42014783|NCT00953017|75821931|FG002|Overall Study|DId not show up for colonoscopy|5|||
42014784|NCT00953017|75821932|FG003|Overall Study|DId not show up for colonoscopy|4|||
42014785|NCT00953017|75821929|FG000|Overall Study|Incomplete data|1|||
42014786|NCT00953017|75821930|FG001|Overall Study|Incomplete data|1|||
42014787|NCT00953017|75821931|FG002|Overall Study|Incomplete data|0|||
42014788|NCT00953017|75821932|FG003|Overall Study|Incomplete data|0|||
42014789|NCT00953017|75821929|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
42283474|NCT02829723|76115239|FG017|Overall Study|Progressive disease|3|||
42283475|NCT02829723|76115240|FG018|Overall Study|Progressive disease|4|||
42283476|NCT02829723|76115241|FG019|Overall Study|Progressive disease|4|||
42352213|NCT01617655|76192255|FG000|Overall Study|Consent withdrawn by participant|1|||
42014790|NCT00953017|75821930|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
42014791|NCT00953017|75821931|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
42014792|NCT00953017|75821932|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
42014793|NCT00953017|75821929|FG000|Overall Study|Brown stool prior to procedure|0|||
42014794|NCT00953017|75821930|FG001|Overall Study|Brown stool prior to procedure|0|||
42283477|NCT02829723|76115242|FG020|Overall Study|Progressive disease|7|||
42283478|NCT02829723|76115243|FG021|Overall Study|Progressive disease|6|||
42283479|NCT02829723|76115244|FG022|Overall Study|Progressive disease|3|||
42014795|NCT00953017|75821931|FG002|Overall Study|Brown stool prior to procedure|1|||
42283480|NCT02829723|76115245|FG023|Overall Study|Progressive disease|3|||
42283481|NCT02829723|76115246|FG024|Overall Study|Progressive disease|3|||
42283482|NCT02829723|76115247|FG025|Overall Study|Progressive disease|16|||
42283483|NCT02829723|76115248|FG026|Overall Study|Progressive disease|10|||
42283484|NCT02829723|76115222|FG000|Overall Study|Subject/guardian decision|0|||
42352214|NCT01617655|76192256|FG001|Overall Study|Consent withdrawn by participant|1|||
42352215|NCT01617655|76192255|FG000|Overall Study|Last visit outside protocol visit window|1|||
42352216|NCT01617655|76192256|FG001|Overall Study|Last visit outside protocol visit window|10|||
42352217|NCT01617655|76192255|FG000|Overall Study|Site closure|3|||
42352218|NCT01617655|76192256|FG001|Overall Study|Site closure|5|||
42352219|NCT01617655|76192255|FG000|Overall Study|Other than specified above|1|||
42352220|NCT01617655|76192256|FG001|Overall Study|Other than specified above|2|||
42352221|NCT01895101|76192267|FG000|Overall Study|OPCAB procedure|1|||
42352222|NCT01895101|76192268|FG001|Overall Study|OPCAB procedure|1|||
42352223|NCT01895101|76192269|FG002|Overall Study|OPCAB procedure|3|||
42283485|NCT02829723|76115223|FG001|Overall Study|Subject/guardian decision|1|||
42283486|NCT02829723|76115224|FG002|Overall Study|Subject/guardian decision|0|||
42283487|NCT02829723|76115225|FG003|Overall Study|Subject/guardian decision|1|||
42283488|NCT02829723|76115226|FG004|Overall Study|Subject/guardian decision|0|||
42283489|NCT02829723|76115227|FG005|Overall Study|Subject/guardian decision|0|||
42352224|NCT01895101|76192267|FG000|Overall Study|Withdrawal by Subject|0|||
42352225|NCT01895101|76192268|FG001|Overall Study|Withdrawal by Subject|1|||
42352226|NCT01895101|76192269|FG002|Overall Study|Withdrawal by Subject|2|||
42352227|NCT01895101|76192267|FG000|Overall Study|another study, enrolled in other study|0|||
42283490|NCT02829723|76115228|FG006|Overall Study|Subject/guardian decision|0|||
42283491|NCT02829723|76115229|FG007|Overall Study|Subject/guardian decision|1|||
42283492|NCT02829723|76115230|FG008|Overall Study|Subject/guardian decision|0|||
42283493|NCT02829723|76115231|FG009|Overall Study|Subject/guardian decision|0|||
42283494|NCT02829723|76115232|FG010|Overall Study|Subject/guardian decision|0|||
42283495|NCT02829723|76115233|FG011|Overall Study|Subject/guardian decision|0|||
42283496|NCT02829723|76115234|FG012|Overall Study|Subject/guardian decision|0|||
42283497|NCT02829723|76115235|FG013|Overall Study|Subject/guardian decision|0|||
42283498|NCT02829723|76115236|FG014|Overall Study|Subject/guardian decision|1|||
42283499|NCT02829723|76115237|FG015|Overall Study|Subject/guardian decision|0|||
42283500|NCT02829723|76115238|FG016|Overall Study|Subject/guardian decision|1|||
42283501|NCT02829723|76115239|FG017|Overall Study|Subject/guardian decision|0|||
42283502|NCT02829723|76115240|FG018|Overall Study|Subject/guardian decision|1|||
42283503|NCT02829723|76115241|FG019|Overall Study|Subject/guardian decision|0|||
42352228|NCT01895101|76192268|FG001|Overall Study|another study, enrolled in other study|1|||
42352229|NCT01895101|76192269|FG002|Overall Study|another study, enrolled in other study|0|||
42352230|NCT01895101|76192267|FG000|Overall Study|Death|0|||
42352231|NCT01895101|76192268|FG001|Overall Study|Death|1|||
42352232|NCT01895101|76192269|FG002|Overall Study|Death|0|||
42352233|NCT01895101|76192267|FG000|Overall Study|coagulation disorder|0|||
42352234|NCT01895101|76192268|FG001|Overall Study|coagulation disorder|1|||
42283504|NCT02829723|76115242|FG020|Overall Study|Subject/guardian decision|1|||
42283505|NCT02829723|76115243|FG021|Overall Study|Subject/guardian decision|0|||
42283506|NCT02829723|76115244|FG022|Overall Study|Subject/guardian decision|0|||
42283507|NCT02829723|76115245|FG023|Overall Study|Subject/guardian decision|1|||
42283508|NCT02829723|76115246|FG024|Overall Study|Subject/guardian decision|0|||
42283509|NCT02829723|76115247|FG025|Overall Study|Subject/guardian decision|1|||
42283510|NCT02829723|76115248|FG026|Overall Study|Subject/guardian decision|1|||
42283511|NCT02829723|76115222|FG000|Overall Study|Study terminated by sponsor|0|||
42283512|NCT02829723|76115223|FG001|Overall Study|Study terminated by sponsor|0|||
42283513|NCT02829723|76115224|FG002|Overall Study|Study terminated by sponsor|0|||
42283514|NCT02829723|76115225|FG003|Overall Study|Study terminated by sponsor|0|||
42283515|NCT02829723|76115226|FG004|Overall Study|Study terminated by sponsor|0|||
42283516|NCT02829723|76115227|FG005|Overall Study|Study terminated by sponsor|0|||
42283517|NCT02829723|76115228|FG006|Overall Study|Study terminated by sponsor|0|||
42283518|NCT02829723|76115229|FG007|Overall Study|Study terminated by sponsor|0|||
42283519|NCT02829723|76115230|FG008|Overall Study|Study terminated by sponsor|0|||
42283520|NCT02829723|76115231|FG009|Overall Study|Study terminated by sponsor|0|||
42283521|NCT02829723|76115232|FG010|Overall Study|Study terminated by sponsor|0|||
42283522|NCT02829723|76115233|FG011|Overall Study|Study terminated by sponsor|0|||
42283523|NCT02829723|76115234|FG012|Overall Study|Study terminated by sponsor|0|||
42283524|NCT02829723|76115235|FG013|Overall Study|Study terminated by sponsor|0|||
42283525|NCT02829723|76115236|FG014|Overall Study|Study terminated by sponsor|0|||
42283526|NCT02829723|76115237|FG015|Overall Study|Study terminated by sponsor|0|||
42283527|NCT02829723|76115238|FG016|Overall Study|Study terminated by sponsor|0|||
42283528|NCT02829723|76115239|FG017|Overall Study|Study terminated by sponsor|0|||
42352235|NCT01895101|76192269|FG002|Overall Study|coagulation disorder|0|||
42352236|NCT01894477|76192279|FG000|Overall Study|Protocol Violation|0|||
42283529|NCT02829723|76115240|FG018|Overall Study|Study terminated by sponsor|0|||
42283530|NCT02829723|76115241|FG019|Overall Study|Study terminated by sponsor|0|||
42283531|NCT02829723|76115242|FG020|Overall Study|Study terminated by sponsor|0|||
42283532|NCT02829723|76115243|FG021|Overall Study|Study terminated by sponsor|1|||
42283533|NCT02829723|76115244|FG022|Overall Study|Study terminated by sponsor|0|||
42283534|NCT02829723|76115245|FG023|Overall Study|Study terminated by sponsor|0|||
42283535|NCT02829723|76115246|FG024|Overall Study|Study terminated by sponsor|0|||
42283536|NCT02829723|76115247|FG025|Overall Study|Study terminated by sponsor|0|||
42283537|NCT02829723|76115248|FG026|Overall Study|Study terminated by sponsor|0|||
42283538|NCT02815579|76115367|FG000|Overall Study|Non-payment of loan down-payment|16|||
42283539|NCT02815579|76115368|FG001|Overall Study|Non-payment of loan down-payment|0|||
42283540|NCT02815579|76115367|FG000|Overall Study|Withdrawal by Subject|7|||
42283541|NCT02815579|76115368|FG001|Overall Study|Withdrawal by Subject|1|||
42283542|NCT02815579|76115367|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
42283543|NCT02815579|76115368|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
42283544|NCT02815579|76115367|FG000|Overall Study|Lost to Follow-up|7|||
42283545|NCT02815579|76115368|FG001|Overall Study|Lost to Follow-up|4|||
42283546|NCT02815579|76115367|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
42283547|NCT02815579|76115368|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
42283548|NCT02815579|76115367|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
42283549|NCT02815579|76115368|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
42283550|NCT02815579|76115367|FG000|Overall Study|Death|5|||
42283551|NCT02815579|76115368|FG001|Overall Study|Death|4|||
42283552|NCT02815579|76115367|FG000|Overall Study|Imprisoned|0|||
42283553|NCT02815579|76115368|FG001|Overall Study|Imprisoned|2|||
42283554|NCT02815579|76115367|FG000|Overall Study|Did not meet enrollment criteria|0|||
42283555|NCT02815579|76115368|FG001|Overall Study|Did not meet enrollment criteria|1|||
42283556|NCT02722616|76115377|FG000|Overall Study|Sponsor closed study after one month|2|||
42283557|NCT02722616|76115378|FG001|Overall Study|Sponsor closed study after one month|0|||
42283558|NCT02722616|76115379|FG002|Overall Study|Sponsor closed study after one month|0|||
42283559|NCT02658487|76115387|FG000|Overall Study|Death|2|||
42283560|NCT02658487|76115387|FG000|Overall Study|Disease progression|10|||
42283561|NCT02658487|76115387|FG000|Overall Study|Alternative therapy|1|||
42283562|NCT02658487|76115387|FG000|Overall Study|Adverse Event|1|||
42283563|NCT02658487|76115387|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
42283564|NCT02658487|76115387|FG000|Overall Study|Refractory AML|1|||
42283565|NCT02553460|76115401|FG000|Overall Study|Death|3|||
42283566|NCT02553460|76115401|FG000|Overall Study|Withdrawal by Subject|1|||
42283567|NCT02553460|76115401|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
42283568|NCT02553460|76115401|FG000|Overall Study|Relapse or Transplant|14|||
42283569|NCT02553460|76115401|FG000|Overall Study|No response to treatment|2|||
42283570|NCT02553460|76115401|FG000|Overall Study|Still on therapy|7|||
42283571|NCT02553460|76115401|FG000|Overall Study|CAR T cells|1|||
42283572|NCT02453282|76115408|FG000|Overall Study|Death|275|||
42283573|NCT02453282|76115409|FG001|Overall Study|Death|277|||
42283574|NCT02453282|76115410|FG002|Overall Study|Death|296|||
42283575|NCT02453282|76115408|FG000|Overall Study|Lost to Follow-up|1|||
42283576|NCT02453282|76115409|FG001|Overall Study|Lost to Follow-up|0|||
42283577|NCT02453282|76115410|FG002|Overall Study|Lost to Follow-up|2|||
42283578|NCT02453282|76115408|FG000|Overall Study|Withdrawal by Subject|12|||
42283579|NCT02453282|76115409|FG001|Overall Study|Withdrawal by Subject|10|||
42283580|NCT02453282|76115410|FG002|Overall Study|Withdrawal by Subject|11|||
42283581|NCT02453282|76115408|FG000|Overall Study|Participants ongoing at data cut-off|85|||
42283582|NCT02453282|76115409|FG001|Overall Study|Participants ongoing at data cut-off|84|||
42283583|NCT02453282|76115410|FG002|Overall Study|Participants ongoing at data cut-off|62|||
42283584|NCT02453282|76115408|FG000|Overall Study|Other|1|||
42283585|NCT02453282|76115409|FG001|Overall Study|Other|1|||
42283586|NCT02453282|76115410|FG002|Overall Study|Other|1|||
42283587|NCT02296125|76115422|FG000|Overall Study|Withdrawal by Subject|18|||
42283588|NCT02296125|76115423|FG001|Overall Study|Withdrawal by Subject|8|||
42283589|NCT02296125|76115424|FG002|Overall Study|Withdrawal by Subject|6|||
42283590|NCT02296125|76115425|FG003|Overall Study|Withdrawal by Subject|2|||
42283591|NCT02296125|76115422|FG000|Overall Study|Adverse Event|41|||
42283592|NCT02296125|76115423|FG001|Overall Study|Adverse Event|52|||
42283593|NCT02296125|76115424|FG002|Overall Study|Adverse Event|9|||
42283594|NCT02296125|76115425|FG003|Overall Study|Adverse Event|4|||
42283595|NCT02296125|76115422|FG000|Overall Study|Severe non-compliance to protocol|0|||
42014796|NCT00953017|75821932|FG003|Overall Study|Brown stool prior to procedure|0|||
42352237|NCT01894477|76192280|FG001|Overall Study|Protocol Violation|1|||
42014797|NCT00952705|75821945|FG000|Overall Study|Lost to Follow-up|24|||
42014798|NCT00952705|75821946|FG001|Overall Study|Lost to Follow-up|8|||
42283596|NCT02296125|76115423|FG001|Overall Study|Severe non-compliance to protocol|1|||
42283597|NCT02296125|76115424|FG002|Overall Study|Severe non-compliance to protocol|0|||
42283598|NCT02296125|76115425|FG003|Overall Study|Severe non-compliance to protocol|0|||
42283599|NCT02296125|76115422|FG000|Overall Study|Condition under investigation worsened|153|||
42283600|NCT02296125|76115423|FG001|Overall Study|Condition under investigation worsened|199|||
42283601|NCT02296125|76115424|FG002|Overall Study|Condition under investigation worsened|39|||
42283602|NCT02296125|76115425|FG003|Overall Study|Condition under investigation worsened|56|||
42283603|NCT02296125|76115422|FG000|Overall Study|Any reason not specifically recorded|6|||
42283604|NCT02296125|76115423|FG001|Overall Study|Any reason not specifically recorded|4|||
42283605|NCT02296125|76115424|FG002|Overall Study|Any reason not specifically recorded|2|||
42283606|NCT02296125|76115425|FG003|Overall Study|Any reason not specifically recorded|0|||
42283607|NCT02286089|76115440|FG000|Overall Study|Ongoing in Study|1|||
42283608|NCT02286089|76115441|FG001|Overall Study|Ongoing in Study|1|||
42283609|NCT02286089|76115442|FG002|Overall Study|Ongoing in Study|4|||
42283610|NCT02286089|76115443|FG003|Overall Study|Ongoing in Study|10|||
42283611|NCT02286089|76115440|FG000|Overall Study|Withdrawal by Subject|0|||
42283612|NCT02286089|76115441|FG001|Overall Study|Withdrawal by Subject|0|||
42283613|NCT02286089|76115442|FG002|Overall Study|Withdrawal by Subject|2|||
42283614|NCT02286089|76115443|FG003|Overall Study|Withdrawal by Subject|2|||
42283615|NCT02087423|76115456|FG000|Overall Study|Withdrawal by Subject|20|||
42283616|NCT02087423|76115457|FG001|Overall Study|Withdrawal by Subject|20|||
42283617|NCT02087423|76115458|FG002|Overall Study|Withdrawal by Subject|3|||
42283618|NCT02087423|76115456|FG000|Overall Study|Death|68|||
42283619|NCT02087423|76115457|FG001|Overall Study|Death|207|||
42283620|NCT02087423|76115458|FG002|Overall Study|Death|40|||
42283621|NCT02087423|76115456|FG000|Overall Study|Lost to Follow-up|0|||
42283622|NCT02087423|76115457|FG001|Overall Study|Lost to Follow-up|2|||
42283623|NCT02087423|76115458|FG002|Overall Study|Lost to Follow-up|0|||
42283624|NCT02087423|76115456|FG000|Overall Study|Terminated from study at final DCO|23|||
42283625|NCT02087423|76115457|FG001|Overall Study|Terminated from study at final DCO|36|||
42283626|NCT02087423|76115458|FG002|Overall Study|Terminated from study at final DCO|25|||
42283627|NCT01874353|76115470|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
42283628|NCT01874353|76115471|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
42283629|NCT01874353|76115472|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
42283630|NCT01874353|76115473|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
42283631|NCT01874353|76115470|FG000|Overall Study|Lost to Follow-up|2|||
42283632|NCT01874353|76115471|FG001|Overall Study|Lost to Follow-up|2|||
42283633|NCT01874353|76115472|FG002|Overall Study|Lost to Follow-up|2|||
42283634|NCT01874353|76115473|FG003|Overall Study|Lost to Follow-up|0|||
42283635|NCT01874353|76115470|FG000|Overall Study|Death|110|||
42283636|NCT01874353|76115471|FG001|Overall Study|Death|60|||
42283637|NCT01874353|76115472|FG002|Overall Study|Death|13|||
42283638|NCT01874353|76115473|FG003|Overall Study|Death|7|||
42283639|NCT01874353|76115470|FG000|Overall Study|Withdrawal by Subject|13|||
42283640|NCT01874353|76115471|FG001|Overall Study|Withdrawal by Subject|11|||
42283641|NCT01874353|76115472|FG002|Overall Study|Withdrawal by Subject|0|||
42283642|NCT01874353|76115473|FG003|Overall Study|Withdrawal by Subject|0|||
42283643|NCT01802632|76115491|FG000|Overall Study|Death|28|||
42283644|NCT01802632|76115492|FG001|Overall Study|Death|1|||
42283645|NCT01802632|76115493|FG002|Overall Study|Death|38|||
42283646|NCT01802632|76115494|FG003|Overall Study|Death|0|||
42283647|NCT01802632|76115495|FG004|Overall Study|Death|2|||
42283648|NCT01802632|76115496|FG005|Overall Study|Death|0|||
42283649|NCT01802632|76115491|FG000|Overall Study|Withdrawal by Subject|4|||
42283650|NCT01802632|76115492|FG001|Overall Study|Withdrawal by Subject|2|||
42283651|NCT01802632|76115493|FG002|Overall Study|Withdrawal by Subject|7|||
42283652|NCT01802632|76115494|FG003|Overall Study|Withdrawal by Subject|3|||
42283653|NCT01802632|76115495|FG004|Overall Study|Withdrawal by Subject|0|||
42283654|NCT01802632|76115496|FG005|Overall Study|Withdrawal by Subject|1|||
42283655|NCT01802632|76115491|FG000|Overall Study|Objective Disease Progression|1|||
42283656|NCT01802632|76115492|FG001|Overall Study|Objective Disease Progression|12|||
42283657|NCT01802632|76115493|FG002|Overall Study|Objective Disease Progression|104|||
42283658|NCT01802632|76115494|FG003|Overall Study|Objective Disease Progression|6|||
42283659|NCT01802632|76115495|FG004|Overall Study|Objective Disease Progression|4|||
42283660|NCT01802632|76115496|FG005|Overall Study|Objective Disease Progression|4|||
42283661|NCT01802632|76115491|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
42283662|NCT01802632|76115492|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
42283663|NCT01802632|76115493|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
42283664|NCT01802632|76115494|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
42283665|NCT01802632|76115495|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
42283666|NCT01802632|76115496|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
42283667|NCT01802632|76115491|FG000|Overall Study|Other (not specified)|0|||
42283668|NCT01802632|76115492|FG001|Overall Study|Other (not specified)|0|||
42283669|NCT01802632|76115493|FG002|Overall Study|Other (not specified)|7|||
42283670|NCT01802632|76115494|FG003|Overall Study|Other (not specified)|1|||
42283671|NCT01802632|76115495|FG004|Overall Study|Other (not specified)|0|||
42283672|NCT01802632|76115496|FG005|Overall Study|Other (not specified)|1|||
42283673|NCT01782131|76115510|FG000|Overall Study|Death|93|||
42283674|NCT01782131|76115511|FG001|Overall Study|Death|96|||
42283675|NCT01782131|76115510|FG000|Overall Study|Lost to Follow-up|1|||
42283676|NCT01782131|76115511|FG001|Overall Study|Lost to Follow-up|3|||
42283677|NCT01782131|76115510|FG000|Overall Study|Withdrawal by Subject|10|||
42283678|NCT01782131|76115511|FG001|Overall Study|Withdrawal by Subject|10|||
42283679|NCT01782131|76115510|FG000|Overall Study|Randomized but not treated|5|||
42283680|NCT01782131|76115511|FG001|Overall Study|Randomized but not treated|5|||
42283681|NCT01782131|76115510|FG000|Overall Study|Reason not provided|0|||
42352238|NCT01894477|76192279|FG000|Overall Study|protocol changed due SC changed to cord|0|||
42352239|NCT01894477|76192280|FG001|Overall Study|protocol changed due SC changed to cord|1|||
42352240|NCT01894243|76192289|FG000|Overall Study|Adverse Event|0|||
42352241|NCT01894243|76192290|FG001|Overall Study|Adverse Event|1|||
42352242|NCT01894243|76192291|FG002|Overall Study|Adverse Event|2|||
42283682|NCT01782131|76115511|FG001|Overall Study|Reason not provided|1|||
42283683|NCT01903733|76115530|FG000|Overall Study|Death|23|||
42283684|NCT01903733|76115531|FG001|Overall Study|Death|54|||
42283685|NCT01903733|76115532|FG002|Overall Study|Death|30|||
42283686|NCT01903733|76115533|FG003|Overall Study|Death|98|||
42283687|NCT01903733|76115530|FG000|Overall Study|Participant refused further follow-up|35|||
42283688|NCT01903733|76115531|FG001|Overall Study|Participant refused further follow-up|38|||
42283689|NCT01903733|76115532|FG002|Overall Study|Participant refused further follow-up|13|||
42283690|NCT01903733|76115533|FG003|Overall Study|Participant refused further follow-up|9|||
42283691|NCT01903733|76115530|FG000|Overall Study|Lost to Follow-up|18|||
42283692|NCT01903733|76115531|FG001|Overall Study|Lost to Follow-up|19|||
42283693|NCT01903733|76115532|FG002|Overall Study|Lost to Follow-up|6|||
42283694|NCT01903733|76115533|FG003|Overall Study|Lost to Follow-up|9|||
42283695|NCT01903733|76115530|FG000|Overall Study|Other|10|||
42283696|NCT01903733|76115531|FG001|Overall Study|Other|15|||
42283697|NCT01903733|76115532|FG002|Overall Study|Other|12|||
42283698|NCT01903733|76115533|FG003|Overall Study|Other|3|||
42283699|NCT01903733|76115530|FG000|Overall Study|Missing|2|||
42283700|NCT01903733|76115531|FG001|Overall Study|Missing|0|||
42352243|NCT01894243|76192289|FG000|Overall Study|Death|0|||
42352244|NCT01894243|76192290|FG001|Overall Study|Death|0|||
42352245|NCT01894243|76192291|FG002|Overall Study|Death|3|||
42352246|NCT01894243|76192289|FG000|Overall Study|Lack of Efficacy|3|||
42352247|NCT01894243|76192290|FG001|Overall Study|Lack of Efficacy|3|||
42352248|NCT01894243|76192291|FG002|Overall Study|Lack of Efficacy|1|||
42352249|NCT01894243|76192289|FG000|Overall Study|Condition under investigation worsened|8|||
42352250|NCT01894243|76192290|FG001|Overall Study|Condition under investigation worsened|6|||
42352251|NCT01894243|76192291|FG002|Overall Study|Condition under investigation worsened|2|||
42352252|NCT01894243|76192289|FG000|Overall Study|Subject decision|1|||
42352253|NCT01894243|76192290|FG001|Overall Study|Subject decision|0|||
42014799|NCT00952705|75821947|FG002|Overall Study|Lost to Follow-up|9|||
42283701|NCT01903733|76115532|FG002|Overall Study|Missing|0|||
42283702|NCT01903733|76115533|FG003|Overall Study|Missing|0|||
42283703|NCT01903733|76115530|FG000|Overall Study|Investigator request|18|||
42283704|NCT01903733|76115531|FG001|Overall Study|Investigator request|0|||
42283705|NCT01903733|76115532|FG002|Overall Study|Investigator request|0|||
42283706|NCT01903733|76115533|FG003|Overall Study|Investigator request|0|||
42283707|NCT01375205|76115555|FG000|Overall Study|Lost to Follow-up|15|||
42283708|NCT01375205|76115556|FG001|Overall Study|Lost to Follow-up|12|||
42283709|NCT01375205|76115555|FG000|Overall Study|Withdrawal by Subject|6|||
42283710|NCT01375205|76115556|FG001|Overall Study|Withdrawal by Subject|1|||
42283711|NCT00700271|76115564|FG000|Overall Study|Adverse Event|4|||
42283712|NCT00700271|76115565|FG001|Overall Study|Adverse Event|6|||
42283713|NCT00700271|76115564|FG000|Overall Study|Protocol Violation|1|||
42283714|NCT00700271|76115565|FG001|Overall Study|Protocol Violation|0|||
42014800|NCT00952705|75821945|FG000|Overall Study|Withdrawal by Subject|2|||
42014801|NCT00952705|75821946|FG001|Overall Study|Withdrawal by Subject|1|||
42014802|NCT00952705|75821947|FG002|Overall Study|Withdrawal by Subject|1|||
42014803|NCT00952705|75821945|FG000|Overall Study|Death|2|||
42014804|NCT00952705|75821946|FG001|Overall Study|Death|0|||
42014805|NCT00952705|75821947|FG002|Overall Study|Death|0|||
42283715|NCT00700271|76115564|FG000|Overall Study|Administrative Reasons|1|||
42283716|NCT00700271|76115565|FG001|Overall Study|Administrative Reasons|0|||
42283717|NCT00700271|76115564|FG000|Overall Study|Withdrawal by Subject|6|||
42283718|NCT00700271|76115565|FG001|Overall Study|Withdrawal by Subject|4|||
42283719|NCT00700271|76115564|FG000|Overall Study|Lost to Follow-up|2|||
42283720|NCT00700271|76115565|FG001|Overall Study|Lost to Follow-up|2|||
42283721|NCT01375049|76115571|FG000|Overall Study|Adverse Event|2|||
42352254|NCT01894243|76192291|FG002|Overall Study|Subject decision|0|||
42352255|NCT01894243|76192289|FG000|Overall Study|Other|1|||
42352256|NCT01894243|76192290|FG001|Overall Study|Other|0|||
42014806|NCT00952705|75821945|FG000|Overall Study|Incarcerated post dose|5|||
42352257|NCT01894243|76192291|FG002|Overall Study|Other|0|||
42283722|NCT01375049|76115571|FG000|Overall Study|Lost to Follow-up|1|||
42352258|NCT03822832|76192308|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
42352259|NCT03822832|76192309|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
42352260|NCT03822832|76192308|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
42352261|NCT03822832|76192309|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
42352262|NCT03822832|76192308|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
42352263|NCT03822832|76192309|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
42352264|NCT03822832|76192308|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
42352265|NCT03822832|76192309|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
42352266|NCT03822832|76192308|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
42352267|NCT03822832|76192309|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
42352268|NCT03822832|76192308|FG000|Re-allocation|Not re-allocated to open label period|2|||
42352269|NCT03822832|76192309|FG001|Re-allocation|Not re-allocated to open label period|6|||
42352270|NCT03822832|76192308|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
42352271|NCT03822832|76192309|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
42352272|NCT03822832|76192308|FG000|Period 2 - Open Label Period|Adverse Event|0|||
42352273|NCT03822832|76192309|FG001|Period 2 - Open Label Period|Adverse Event|3|||
42352274|NCT01513239|76192319|FG000|Period 1: Main Phase|Adverse Event|1|||
42352275|NCT01513239|76192320|FG001|Period 1: Main Phase|Adverse Event|1|||
42352276|NCT01513239|76192321|FG002|Period 1: Main Phase|Adverse Event|2|||
42352277|NCT01513239|76192322|FG003|Period 1: Main Phase|Adverse Event|0|||
42352278|NCT01513239|76192323|FG004|Period 1: Main Phase|Adverse Event|0|||
42171165|NCT03335475|75978051|FG000|Overall Study|Withdrawal by Subject|0|||
42171166|NCT03335475|75978052|FG001|Overall Study|Withdrawal by Subject|1|||
42171167|NCT03252756|75978060|FG000|Overall Study|Protocol Violation|2|||
42283723|NCT01375049|76115571|FG000|Overall Study|Withdrawal by Subject|2|||
42283724|NCT01375049|76115571|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
42283725|NCT01594749|76115581|FG000|Overall Study|Adverse Event|2|||
42283726|NCT01594749|76115582|FG001|Overall Study|Adverse Event|1|||
42283727|NCT01594749|76115581|FG000|Overall Study|Withdrawal by Subject|2|||
42283728|NCT01594749|76115582|FG001|Overall Study|Withdrawal by Subject|2|||
42283729|NCT01594749|76115581|FG000|Overall Study|Protocol Violation|2|||
42283730|NCT01594749|76115582|FG001|Overall Study|Protocol Violation|0|||
42283731|NCT01594749|76115581|FG000|Overall Study|Physician Decision|1|||
42283732|NCT01594749|76115582|FG001|Overall Study|Physician Decision|1|||
42283733|NCT01594749|76115581|FG000|Overall Study|Non-compliance with Protocol|0|||
42283734|NCT01594749|76115582|FG001|Overall Study|Non-compliance with Protocol|1|||
42283735|NCT01594749|76115581|FG000|Overall Study|Lost to Follow-up|1|||
42283736|NCT01594749|76115582|FG001|Overall Study|Lost to Follow-up|0|||
42171168|NCT03252756|75978061|FG001|Overall Study|Protocol Violation|4|||
42171169|NCT03252756|75978060|FG000|Overall Study|COVID-19 Pandemic|1|||
42171170|NCT03252756|75978061|FG001|Overall Study|COVID-19 Pandemic|1|||
42171171|NCT03252756|75978060|FG000|Overall Study|Study Drug Expiration|0|||
42171172|NCT03252756|75978061|FG001|Overall Study|Study Drug Expiration|1|||
42171173|NCT03164356|75978073|FG000|Overall Study|Lost to Follow-up|1|||
42171174|NCT03164356|75978074|FG001|Overall Study|Lost to Follow-up|1|||
42171175|NCT03164356|75978075|FG002|Overall Study|Lost to Follow-up|2|||
42171176|NCT03164356|75978076|FG003|Overall Study|Lost to Follow-up|1|||
42171177|NCT03164356|75978073|FG000|Overall Study|Physician Decision|0|||
42171178|NCT03164356|75978074|FG001|Overall Study|Physician Decision|0|||
42171179|NCT03164356|75978075|FG002|Overall Study|Physician Decision|3|||
42171180|NCT03164356|75978076|FG003|Overall Study|Physician Decision|0|||
42171181|NCT03164356|75978073|FG000|Overall Study|Protocol Violation|2|||
42171182|NCT03164356|75978074|FG001|Overall Study|Protocol Violation|1|||
42171183|NCT03164356|75978075|FG002|Overall Study|Protocol Violation|0|||
42171184|NCT03164356|75978076|FG003|Overall Study|Protocol Violation|0|||
42171185|NCT03164356|75978073|FG000|Overall Study|Withdrawal by Subject|1|||
42171186|NCT03164356|75978074|FG001|Overall Study|Withdrawal by Subject|0|||
42171187|NCT03164356|75978075|FG002|Overall Study|Withdrawal by Subject|0|||
42171188|NCT03164356|75978076|FG003|Overall Study|Withdrawal by Subject|0|||
42171189|NCT03164356|75978073|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
42171190|NCT03164356|75978074|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
42171191|NCT03164356|75978075|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
42171192|NCT03164356|75978076|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
42171193|NCT03164356|75978073|FG000|Overall Study|Subject Incarcerated|0|||
42171194|NCT03164356|75978074|FG001|Overall Study|Subject Incarcerated|1|||
42283737|NCT01594749|76115581|FG000|Overall Study|Death|9|||
42283738|NCT01594749|76115582|FG001|Overall Study|Death|3|||
42171195|NCT03164356|75978075|FG002|Overall Study|Subject Incarcerated|0|||
42171196|NCT03164356|75978076|FG003|Overall Study|Subject Incarcerated|0|||
42283739|NCT01594749|76115581|FG000|Overall Study|Not Treated|4|||
42352279|NCT01513239|76192324|FG005|Period 1: Main Phase|Adverse Event|0|||
42352280|NCT01513239|76192319|FG000|Period 1: Main Phase|Death|29|||
42352281|NCT01513239|76192320|FG001|Period 1: Main Phase|Death|22|||
42171197|NCT03164356|75978073|FG000|Overall Study|Prosthetist unable to participate|0|||
42171198|NCT03164356|75978074|FG001|Overall Study|Prosthetist unable to participate|2|||
42171199|NCT03164356|75978075|FG002|Overall Study|Prosthetist unable to participate|1|||
42171200|NCT03164356|75978076|FG003|Overall Study|Prosthetist unable to participate|0|||
42171201|NCT01925131|75978111|FG000|Overall Study|Death|0|||
42283740|NCT01594749|76115582|FG001|Overall Study|Not Treated|10|||
42283741|NCT01594749|76115581|FG000|Overall Study|Lost Source Documentation|1|||
42283742|NCT01594749|76115582|FG001|Overall Study|Lost Source Documentation|0|||
42283743|NCT02179918|76115593|FG000|Overall Study|Death|0|||
42283744|NCT02179918|76115594|FG001|Overall Study|Death|0|||
42283745|NCT02179918|76115595|FG002|Overall Study|Death|0|||
42283746|NCT02179918|76115596|FG003|Overall Study|Death|1|||
42283747|NCT02179918|76115597|FG004|Overall Study|Death|0|||
42283748|NCT02179918|76115593|FG000|Overall Study|Lost to Follow-up|0|||
42283749|NCT02179918|76115594|FG001|Overall Study|Lost to Follow-up|0|||
42283750|NCT02179918|76115595|FG002|Overall Study|Lost to Follow-up|1|||
42283751|NCT02179918|76115596|FG003|Overall Study|Lost to Follow-up|0|||
42283752|NCT02179918|76115597|FG004|Overall Study|Lost to Follow-up|0|||
42283753|NCT02179918|76115593|FG000|Overall Study|Progressive Disease|4|||
42283754|NCT02179918|76115594|FG001|Overall Study|Progressive Disease|1|||
42283755|NCT02179918|76115595|FG002|Overall Study|Progressive Disease|1|||
42283756|NCT02179918|76115596|FG003|Overall Study|Progressive Disease|2|||
42283757|NCT02179918|76115597|FG004|Overall Study|Progressive Disease|6|||
42283758|NCT02179918|76115593|FG000|Overall Study|Other|0|||
42283759|NCT02179918|76115594|FG001|Overall Study|Other|1|||
42283760|NCT02179918|76115595|FG002|Overall Study|Other|0|||
42283761|NCT02179918|76115596|FG003|Overall Study|Other|0|||
42283762|NCT02179918|76115597|FG004|Overall Study|Other|1|||
42283763|NCT02179918|76115593|FG000|Overall Study|Subject refused further follow-up|0|||
42283764|NCT02179918|76115594|FG001|Overall Study|Subject refused further follow-up|1|||
42283765|NCT02179918|76115595|FG002|Overall Study|Subject refused further follow-up|0|||
42283766|NCT02179918|76115596|FG003|Overall Study|Subject refused further follow-up|0|||
42283767|NCT02179918|76115597|FG004|Overall Study|Subject refused further follow-up|1|||
42283768|NCT02611479|76115610|FG000|Baseline Enrollment|Exited study|13|||
42283769|NCT02611479|76115610|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
42283770|NCT02611479|76115610|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
42283771|NCT02611479|76115610|FG000|Data Cleaning|No baseline function or pain metrics|2|||
42283772|NCT02153788|76115616|FG000|Overall Study|Physician Decision|2|||
42283773|NCT02153788|76115617|FG001|Overall Study|Physician Decision|1|||
42283774|NCT02153398|76115628|FG000|Overall Study|Withdrawal by Subject|1|||
42283775|NCT02153398|76115629|FG001|Overall Study|Withdrawal by Subject|0|||
42283776|NCT02153398|76115630|FG002|Overall Study|Withdrawal by Subject|0|||
42283777|NCT02153398|76115631|FG003|Overall Study|Withdrawal by Subject|0|||
42283778|NCT02153398|76115632|FG004|Overall Study|Withdrawal by Subject|0|||
42283779|NCT02153398|76115628|FG000|Overall Study|Adverse Event|0|||
42283780|NCT02153398|76115629|FG001|Overall Study|Adverse Event|0|||
42283781|NCT02153398|76115630|FG002|Overall Study|Adverse Event|1|||
42283782|NCT02153398|76115631|FG003|Overall Study|Adverse Event|1|||
42283783|NCT02153398|76115632|FG004|Overall Study|Adverse Event|0|||
42283784|NCT02118766|76115646|FG000|Overall Study|Adverse Event|7|||
42283785|NCT02118766|76115647|FG001|Overall Study|Adverse Event|2|||
42283786|NCT02118766|76115646|FG000|Overall Study|Withdrawal by Subject|3|||
42283787|NCT02118766|76115647|FG001|Overall Study|Withdrawal by Subject|6|||
42283788|NCT02118766|76115646|FG000|Overall Study|Lost to Follow-up|5|||
42283789|NCT02118766|76115647|FG001|Overall Study|Lost to Follow-up|4|||
42283790|NCT02118766|76115646|FG000|Overall Study|Withdrawal by parent/guardian|12|||
42283791|NCT02118766|76115647|FG001|Overall Study|Withdrawal by parent/guardian|18|||
42283792|NCT02118766|76115646|FG000|Overall Study|Other|3|||
42283793|NCT02118766|76115647|FG001|Overall Study|Other|1|||
42352282|NCT01513239|76192321|FG002|Period 1: Main Phase|Death|32|||
42352283|NCT01513239|76192322|FG003|Period 1: Main Phase|Death|0|||
42171202|NCT01925131|75978112|FG001|Overall Study|Death|0|||
42171203|NCT01925131|75978113|FG002|Overall Study|Death|1|||
42171204|NCT01925131|75978114|FG003|Overall Study|Death|0|||
42283794|NCT02614287|76115655|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
42283795|NCT02614287|76115656|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
42283796|NCT02614287|76115655|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
42283797|NCT02614287|76115656|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
42283798|NCT02614287|76115655|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
42283799|NCT02614287|76115656|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
42283800|NCT02614287|76115655|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
42283801|NCT02614287|76115656|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
42283802|NCT02614287|76115655|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
42283803|NCT02614287|76115656|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
42283804|NCT02614287|76115655|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
42283805|NCT02614287|76115656|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
42352284|NCT01513239|76192323|FG004|Period 1: Main Phase|Death|0|||
42283806|NCT02614287|76115655|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
42283807|NCT02614287|76115656|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
42283808|NCT02614287|76115655|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
42283809|NCT02614287|76115656|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
42283810|NCT01374971|76115667|FG000|Overall Study|Withdrawal by Subject|1|||
42283811|NCT02178592|76115673|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
42283812|NCT02178592|76115674|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
42283813|NCT02178592|76115673|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
42283814|NCT02178592|76115674|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
42283815|NCT02178592|76115673|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
42283816|NCT02178592|76115674|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
42283817|NCT02178592|76115673|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
42283818|NCT02178592|76115674|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
42283819|NCT02178592|76115673|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
42283820|NCT02178592|76115674|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
42283821|NCT02178592|76115673|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
42283822|NCT02178592|76115674|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
42283823|NCT02178592|76115673|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
42283824|NCT02178592|76115674|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
42283825|NCT02178592|76115673|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
42283826|NCT02178592|76115674|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
42283827|NCT02178592|76115673|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
42352285|NCT01513239|76192324|FG005|Period 1: Main Phase|Death|0|||
42352286|NCT01513239|76192319|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
42352287|NCT01513239|76192320|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
42352288|NCT01513239|76192321|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
42352289|NCT01513239|76192322|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
42352290|NCT01513239|76192323|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
42352291|NCT01513239|76192324|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
42352292|NCT01513239|76192319|FG000|Period 1: Main Phase|Physician Decision|4|||
42352293|NCT01513239|76192320|FG001|Period 1: Main Phase|Physician Decision|4|||
42352294|NCT01513239|76192321|FG002|Period 1: Main Phase|Physician Decision|4|||
42352295|NCT01513239|76192322|FG003|Period 1: Main Phase|Physician Decision|0|||
42352296|NCT01513239|76192323|FG004|Period 1: Main Phase|Physician Decision|0|||
42352297|NCT01513239|76192324|FG005|Period 1: Main Phase|Physician Decision|0|||
42352298|NCT01513239|76192319|FG000|Period 1: Main Phase|Protocol Violation|2|||
42352299|NCT01513239|76192320|FG001|Period 1: Main Phase|Protocol Violation|2|||
42352300|NCT01513239|76192321|FG002|Period 1: Main Phase|Protocol Violation|2|||
42352301|NCT01513239|76192322|FG003|Period 1: Main Phase|Protocol Violation|0|||
42352302|NCT01513239|76192323|FG004|Period 1: Main Phase|Protocol Violation|0|||
42352303|NCT01513239|76192324|FG005|Period 1: Main Phase|Protocol Violation|0|||
42352304|NCT01513239|76192319|FG000|Period 1: Main Phase|Technical Problems|1|||
42352305|NCT01513239|76192320|FG001|Period 1: Main Phase|Technical Problems|2|||
42352306|NCT01513239|76192321|FG002|Period 1: Main Phase|Technical Problems|0|||
42352307|NCT01513239|76192322|FG003|Period 1: Main Phase|Technical Problems|0|||
42352308|NCT01513239|76192323|FG004|Period 1: Main Phase|Technical Problems|0|||
42352309|NCT01513239|76192324|FG005|Period 1: Main Phase|Technical Problems|0|||
42352310|NCT01513239|76192319|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
42352311|NCT01513239|76192320|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
42352312|NCT01513239|76192321|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
42352313|NCT01513239|76192322|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
42352314|NCT01513239|76192323|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
42352315|NCT01513239|76192324|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
42352316|NCT01513239|76192319|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
42352317|NCT01513239|76192320|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
42352318|NCT01513239|76192321|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
42352319|NCT01513239|76192322|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
42352320|NCT01513239|76192323|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
42352321|NCT01513239|76192324|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
42352322|NCT01513239|76192319|FG000|Period 2: 9 Month Extension Phase|Death|0|||
42352323|NCT01513239|76192320|FG001|Period 2: 9 Month Extension Phase|Death|0|||
42283828|NCT02178592|76115674|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
42283829|NCT02178592|76115673|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
42283830|NCT02178592|76115674|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
42352324|NCT01513239|76192321|FG002|Period 2: 9 Month Extension Phase|Death|0|||
42352325|NCT01513239|76192322|FG003|Period 2: 9 Month Extension Phase|Death|2|||
42352326|NCT01513239|76192323|FG004|Period 2: 9 Month Extension Phase|Death|5|||
42283831|NCT02178592|76115673|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
42352327|NCT01513239|76192324|FG005|Period 2: 9 Month Extension Phase|Death|2|||
42352328|NCT01513239|76192319|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
42283832|NCT02178592|76115674|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
42283833|NCT02178592|76115673|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
42283834|NCT02178592|76115674|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
42283835|NCT02610777|76115685|FG000|Overall Study|Lost to Follow-up|1|||
42283836|NCT02610777|76115686|FG001|Overall Study|Lost to Follow-up|0|||
42283837|NCT02610777|76115685|FG000|Overall Study|Site Terminated by Sponsor|9|||
42283838|NCT02610777|76115686|FG001|Overall Study|Site Terminated by Sponsor|8|||
42283839|NCT02610777|76115685|FG000|Overall Study|Withdrawal by Subject|2|||
42352329|NCT01513239|76192320|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
42352330|NCT01513239|76192321|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
42352331|NCT01513239|76192322|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
42352332|NCT01513239|76192323|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
42352333|NCT01513239|76192324|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
42352334|NCT01513239|76192319|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
42352335|NCT01513239|76192320|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
42352336|NCT01513239|76192321|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
42352337|NCT01513239|76192322|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
42352338|NCT01513239|76192323|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
42352339|NCT01513239|76192324|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
42352340|NCT01513239|76192319|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
42352341|NCT01513239|76192320|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
42352342|NCT01513239|76192321|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
42352343|NCT01513239|76192322|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
42352344|NCT01513239|76192323|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
42171205|NCT01925131|75978115|FG004|Overall Study|Death|0|||
42283840|NCT02610777|76115686|FG001|Overall Study|Withdrawal by Subject|2|||
42283841|NCT02610777|76115685|FG000|Overall Study|Reason not Specified|0|||
42283842|NCT02610777|76115686|FG001|Overall Study|Reason not Specified|1|||
42283843|NCT02610777|76115685|FG000|Overall Study|Death|50|||
42283844|NCT02610777|76115686|FG001|Overall Study|Death|47|||
42283845|NCT01628692|76115700|FG000|Overall Study|Lack of Efficacy|4|||
42283846|NCT01628692|76115701|FG001|Overall Study|Lack of Efficacy|4|||
42283847|NCT01628692|76115702|FG002|Overall Study|Lack of Efficacy|5|||
42283848|NCT01628692|76115703|FG003|Overall Study|Lack of Efficacy|1|||
42283849|NCT01628692|76115704|FG004|Overall Study|Lack of Efficacy|4|||
42283850|NCT01628692|76115705|FG005|Overall Study|Lack of Efficacy|7|||
42283851|NCT01628692|76115700|FG000|Overall Study|Adverse Event|2|||
42283852|NCT01628692|76115701|FG001|Overall Study|Adverse Event|0|||
42283853|NCT01628692|76115702|FG002|Overall Study|Adverse Event|2|||
42283854|NCT01628692|76115703|FG003|Overall Study|Adverse Event|0|||
42283855|NCT01628692|76115704|FG004|Overall Study|Adverse Event|0|||
42283856|NCT01628692|76115705|FG005|Overall Study|Adverse Event|0|||
42283857|NCT01628692|76115700|FG000|Overall Study|Withdrawal by Subject|0|||
42283858|NCT01628692|76115701|FG001|Overall Study|Withdrawal by Subject|1|||
42283859|NCT01628692|76115702|FG002|Overall Study|Withdrawal by Subject|1|||
42283860|NCT01628692|76115703|FG003|Overall Study|Withdrawal by Subject|0|||
42283861|NCT01628692|76115704|FG004|Overall Study|Withdrawal by Subject|0|||
42283862|NCT01628692|76115705|FG005|Overall Study|Withdrawal by Subject|0|||
42283863|NCT01628692|76115700|FG000|Overall Study|Death|0|||
42283864|NCT01628692|76115701|FG001|Overall Study|Death|1|||
42283865|NCT01628692|76115702|FG002|Overall Study|Death|0|||
42283866|NCT01628692|76115703|FG003|Overall Study|Death|0|||
42283867|NCT01628692|76115704|FG004|Overall Study|Death|0|||
42283868|NCT01628692|76115705|FG005|Overall Study|Death|0|||
42283869|NCT01628692|76115700|FG000|Overall Study|Poor compliance/noncompliance|1|||
42283870|NCT01628692|76115701|FG001|Overall Study|Poor compliance/noncompliance|0|||
42283871|NCT01628692|76115702|FG002|Overall Study|Poor compliance/noncompliance|0|||
42283872|NCT01628692|76115703|FG003|Overall Study|Poor compliance/noncompliance|0|||
42283873|NCT01628692|76115704|FG004|Overall Study|Poor compliance/noncompliance|0|||
42283874|NCT01628692|76115705|FG005|Overall Study|Poor compliance/noncompliance|0|||
42283875|NCT01628692|76115700|FG000|Overall Study|Administrative reason by sponsor|0|||
42283876|NCT01628692|76115701|FG001|Overall Study|Administrative reason by sponsor|0|||
42283877|NCT01628692|76115702|FG002|Overall Study|Administrative reason by sponsor|0|||
42283878|NCT01628692|76115703|FG003|Overall Study|Administrative reason by sponsor|0|||
42283879|NCT01628692|76115704|FG004|Overall Study|Administrative reason by sponsor|0|||
42283880|NCT01628692|76115705|FG005|Overall Study|Administrative reason by sponsor|1|||
42283881|NCT01628692|76115700|FG000|Overall Study|Completed 12 Week only|0|||
42283882|NCT01628692|76115701|FG001|Overall Study|Completed 12 Week only|0|||
42283883|NCT01628692|76115702|FG002|Overall Study|Completed 12 Week only|0|||
42283884|NCT01628692|76115703|FG003|Overall Study|Completed 12 Week only|0|||
42283885|NCT01628692|76115704|FG004|Overall Study|Completed 12 Week only|0|||
42283886|NCT01628692|76115705|FG005|Overall Study|Completed 12 Week only|1|||
42283887|NCT02612727|76115724|FG000|Overall Study|Parent request|4|||
42283888|NCT02612727|76115725|FG001|Overall Study|Parent request|1|||
42283889|NCT02612727|76115724|FG000|Overall Study|Needed treatment incompatible with PT|1|||
42283890|NCT02612727|76115725|FG001|Overall Study|Needed treatment incompatible with PT|1|||
42283891|NCT02612727|76115724|FG000|Overall Study|Direct hyperbilirubinemia|0|||
42283892|NCT02612727|76115725|FG001|Overall Study|Direct hyperbilirubinemia|2|||
42283893|NCT01594827|76115733|FG000|Overall Study|Adverse Event|1|||
42283894|NCT01594827|76115734|FG001|Overall Study|Adverse Event|0|||
42283895|NCT01594827|76115733|FG000|Overall Study|Physician Decision|3|||
42283896|NCT01594827|76115734|FG001|Overall Study|Physician Decision|0|||
42283897|NCT02610231|76115742|FG000|Overall Study|Withdrawal by Subject|27|||
42283898|NCT02610231|76115742|FG000|Overall Study|Adverse Event|20|||
42283899|NCT02610231|76115742|FG000|Overall Study|Death|5|||
42283900|NCT02610231|76115742|FG000|Overall Study|Surgery|2|||
42283901|NCT02610231|76115742|FG000|Overall Study|Physician Decision|1|||
42283902|NCT02610231|76115742|FG000|Overall Study|Non Compliance|2|||
42283903|NCT02610231|76115742|FG000|Overall Study|Other|3|||
42283904|NCT02178358|76115752|FG000|Overall Study|Withdrawal by Subject|0|||
42040731|NCT01796171|75848711|FG005|Follow-up Period|Patient transferred to other hospital|0|||
42040732|NCT01796171|75848712|FG006|Follow-up Period|Patient transferred to other hospital|0|||
42283905|NCT02178358|76115753|FG001|Overall Study|Withdrawal by Subject|2|||
42283906|NCT02178358|76115754|FG002|Overall Study|Withdrawal by Subject|2|||
42283907|NCT02178358|76115752|FG000|Overall Study|Lost to Follow-up|1|||
42283908|NCT02178358|76115753|FG001|Overall Study|Lost to Follow-up|0|||
42283909|NCT02178358|76115754|FG002|Overall Study|Lost to Follow-up|0|||
42283910|NCT01598896|76115765|FG000|Overall Study|Withdrawal by Subject|0|||
42283911|NCT01598896|76115766|FG001|Overall Study|Withdrawal by Subject|1|||
42283912|NCT01598896|76115765|FG000|Overall Study|Lack of Efficacy|0|||
42283913|NCT01598896|76115766|FG001|Overall Study|Lack of Efficacy|1|||
42283914|NCT01598662|76115774|FG000|Overall Study|Lost to Follow-up|10|||
42283915|NCT01598662|76115775|FG001|Overall Study|Lost to Follow-up|17|||
42283916|NCT01598662|76115774|FG000|Overall Study|Physician Decision|1|||
42171206|NCT01925131|75978116|FG005|Overall Study|Death|0|||
42171207|NCT01925131|75978111|FG000|Overall Study|Progression/Relapse|1|||
42171208|NCT01925131|75978112|FG001|Overall Study|Progression/Relapse|1|||
42171209|NCT01925131|75978113|FG002|Overall Study|Progression/Relapse|4|||
42171210|NCT01925131|75978114|FG003|Overall Study|Progression/Relapse|0|||
42171211|NCT01925131|75978115|FG004|Overall Study|Progression/Relapse|0|||
42171212|NCT01925131|75978116|FG005|Overall Study|Progression/Relapse|1|||
42171213|NCT01925131|75978111|FG000|Overall Study|Patient Refusal|1|||
42171214|NCT01925131|75978112|FG001|Overall Study|Patient Refusal|0|||
42171215|NCT01925131|75978113|FG002|Overall Study|Patient Refusal|0|||
42171216|NCT01925131|75978114|FG003|Overall Study|Patient Refusal|0|||
42171217|NCT01925131|75978115|FG004|Overall Study|Patient Refusal|0|||
42171218|NCT01925131|75978116|FG005|Overall Study|Patient Refusal|0|||
42283917|NCT01598662|76115775|FG001|Overall Study|Physician Decision|2|||
42283918|NCT01598662|76115774|FG000|Overall Study|IUD expelled before month 6|0|||
42283919|NCT01598662|76115775|FG001|Overall Study|IUD expelled before month 6|2|||
42283920|NCT01629706|76115781|FG000|Phase 1 PureVision|Screen Failure|4|||
42283921|NCT01629706|76115781|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
42283922|NCT01629706|76115781|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
42283923|NCT01629706|76115781|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
42283924|NCT01629706|76115781|FG000|Phase 2 Habitual|Screen Failure|6|||
42283925|NCT01629706|76115781|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
42283926|NCT01629706|76115781|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
42283927|NCT01629706|76115781|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
42283928|NCT01629706|76115781|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
42283929|NCT02153086|76115789|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
42283930|NCT02153086|76115789|FG000|Overall Study|Other|2|||
42283931|NCT02117050|76115793|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
42283932|NCT02728895|76115800|FG000|Overall Study|Other|1|||
42283933|NCT02728895|76115801|FG001|Overall Study|Other|2|||
42283934|NCT02728895|76115800|FG000|Overall Study|Withdrawal by Subject|0|||
42283935|NCT02728895|76115801|FG001|Overall Study|Withdrawal by Subject|3|||
42283936|NCT02606877|76115809|FG000|Overall Study|Adverse Event|3|||
42283937|NCT02606877|76115810|FG001|Overall Study|Adverse Event|0|||
42283938|NCT02606877|76115809|FG000|Overall Study|Non-compliance with protocol|0|||
42283939|NCT02606877|76115810|FG001|Overall Study|Non-compliance with protocol|1|||
42352345|NCT01513239|76192324|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
42352346|NCT01544127|76192339|FG000|Overall Study|Lost to Follow-up|4|||
42352347|NCT01544127|76192340|FG001|Overall Study|Lost to Follow-up|2|||
42352348|NCT01544127|76192341|FG002|Overall Study|Lost to Follow-up|9|||
42352349|NCT01544127|76192339|FG000|Overall Study|Withdrawal by Subject|2|||
42352350|NCT01544127|76192340|FG001|Overall Study|Withdrawal by Subject|2|||
42352351|NCT01544127|76192341|FG002|Overall Study|Withdrawal by Subject|1|||
42352352|NCT01544127|76192339|FG000|Overall Study|Discharged out of catchment area|1|||
42352353|NCT01544127|76192340|FG001|Overall Study|Discharged out of catchment area|1|||
42352354|NCT01544127|76192341|FG002|Overall Study|Discharged out of catchment area|1|||
42352355|NCT01544127|76192339|FG000|Overall Study|Death|1|||
42352356|NCT01544127|76192340|FG001|Overall Study|Death|0|||
42352357|NCT01544127|76192341|FG002|Overall Study|Death|0|||
42352358|NCT01544127|76192339|FG000|Overall Study|Jail or Prison|1|||
42171219|NCT01925131|75978111|FG000|Overall Study|Adverse Event|0|||
42171220|NCT01925131|75978112|FG001|Overall Study|Adverse Event|0|||
42171221|NCT01925131|75978113|FG002|Overall Study|Adverse Event|2|||
42171222|NCT01925131|75978114|FG003|Overall Study|Adverse Event|0|||
42171223|NCT01925131|75978115|FG004|Overall Study|Adverse Event|1|||
42171224|NCT01925131|75978116|FG005|Overall Study|Adverse Event|3|||
42171225|NCT01925131|75978111|FG000|Overall Study|Other - Not Protocol Specified|3|||
42171226|NCT01925131|75978112|FG001|Overall Study|Other - Not Protocol Specified|1|||
42171227|NCT01925131|75978113|FG002|Overall Study|Other - Not Protocol Specified|2|||
42171228|NCT01925131|75978114|FG003|Overall Study|Other - Not Protocol Specified|5|||
42171229|NCT01925131|75978115|FG004|Overall Study|Other - Not Protocol Specified|10|||
42171230|NCT01925131|75978116|FG005|Overall Study|Other - Not Protocol Specified|6|||
42171231|NCT01698918|75978132|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
42171232|NCT01698918|75978132|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
42171233|NCT01698918|75978132|FG000|First Line Treatment (Core+Extension)|Death|2|||
42283940|NCT02606877|76115809|FG000|Overall Study|Other than listed above|1|||
42352359|NCT01544127|76192340|FG001|Overall Study|Jail or Prison|1|||
42352360|NCT01544127|76192341|FG002|Overall Study|Jail or Prison|2|||
42352361|NCT01544127|76192339|FG000|Overall Study|Became Psychotic|1|||
42283941|NCT02606877|76115810|FG001|Overall Study|Other than listed above|0|||
42283942|NCT02606643|76115820|FG000|Overall Study|did not meet inclusion criteria|1|||
42283943|NCT02606643|76115821|FG001|Overall Study|did not meet inclusion criteria|3|||
42352362|NCT01544127|76192340|FG001|Overall Study|Became Psychotic|0|||
42352363|NCT01544127|76192341|FG002|Overall Study|Became Psychotic|0|||
42352364|NCT01544127|76192339|FG000|Overall Study|Researcher withdrew|1|||
42352365|NCT01544127|76192340|FG001|Overall Study|Researcher withdrew|0|||
42352366|NCT01544127|76192341|FG002|Overall Study|Researcher withdrew|0|||
42352367|NCT01544127|76192339|FG000|Overall Study|Went active duty|0|||
42352368|NCT01544127|76192340|FG001|Overall Study|Went active duty|0|||
42352369|NCT01544127|76192341|FG002|Overall Study|Went active duty|1|||
42352370|NCT01512693|76192352|FG000|Overall Study|Withdrawal by Subject|0|||
42352371|NCT01512693|76192353|FG001|Overall Study|Withdrawal by Subject|1|||
42352372|NCT01458340|76192362|FG000|Overall Study|Adverse Event|5|||
42352373|NCT01458340|76192363|FG001|Overall Study|Adverse Event|4|||
42352374|NCT01458340|76192364|FG002|Overall Study|Adverse Event|2|||
42352375|NCT01458340|76192362|FG000|Overall Study|Lost to Follow-up|3|||
42352376|NCT01458340|76192363|FG001|Overall Study|Lost to Follow-up|3|||
42352377|NCT01458340|76192364|FG002|Overall Study|Lost to Follow-up|10|||
42352378|NCT01458340|76192362|FG000|Overall Study|Miscellaneous|0|||
42352379|NCT01458340|76192363|FG001|Overall Study|Miscellaneous|1|||
42352380|NCT01458340|76192364|FG002|Overall Study|Miscellaneous|0|||
42352381|NCT01458340|76192362|FG000|Overall Study|Physician Decision|1|||
42352382|NCT01458340|76192363|FG001|Overall Study|Physician Decision|1|||
42352383|NCT01458340|76192364|FG002|Overall Study|Physician Decision|2|||
42352384|NCT01458340|76192362|FG000|Overall Study|Protocol Violation|6|||
42352385|NCT01458340|76192363|FG001|Overall Study|Protocol Violation|6|||
42352386|NCT01458340|76192364|FG002|Overall Study|Protocol Violation|5|||
42352387|NCT01458340|76192362|FG000|Overall Study|Withdrawal by Subject|12|||
42352388|NCT01458340|76192363|FG001|Overall Study|Withdrawal by Subject|6|||
42352389|NCT01458340|76192364|FG002|Overall Study|Withdrawal by Subject|4|||
42352390|NCT01539291|76192410|FG000|Study GS-US-312-0116|Adverse Event|9|||
42352391|NCT01539291|76192411|FG001|Study GS-US-312-0116|Adverse Event|0|||
42352392|NCT01539291|76192412|FG002|Study GS-US-312-0116|Adverse Event|0|||
42352393|NCT01539291|76192413|FG003|Study GS-US-312-0116|Adverse Event|0|||
42352394|NCT01539291|76192410|FG000|Study GS-US-312-0116|Physician Decision|1|||
42352395|NCT01539291|76192411|FG001|Study GS-US-312-0116|Physician Decision|0|||
42040733|NCT01796171|75848713|FG007|Follow-up Period|Patient transferred to other hospital|0|||
42040734|NCT01796171|75848714|FG008|Follow-up Period|Patient transferred to other hospital|0|||
42040735|NCT01796171|75848715|FG009|Follow-up Period|Patient transferred to other hospital|0|||
42040736|NCT01796171|75848716|FG010|Follow-up Period|Patient transferred to other hospital|0|||
42171234|NCT01698918|75978132|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
42171235|NCT01698918|75978132|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
42171236|NCT01698918|75978132|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
42171237|NCT01698918|75978132|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
42171238|NCT01698918|75978132|FG000|Second Line Treatment (Core+Extension)|Death|1|||
42171239|NCT01698918|75978132|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
42171240|NCT01698918|75978132|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
42171241|NCT01208974|75978145|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
42171242|NCT01208974|75978146|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
42171243|NCT01208974|75978147|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
42171244|NCT01208974|75978148|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
42171245|NCT01208974|75978145|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
42171246|NCT01208974|75978146|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
42171247|NCT01208974|75978147|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
42171248|NCT01208974|75978148|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
42171249|NCT01208974|75978145|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
42171250|NCT01208974|75978146|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
42171251|NCT01208974|75978147|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
42171252|NCT01208974|75978148|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
42171253|NCT00840177|75978158|FG000|Overall Study|Adverse Event|5|||
42171254|NCT00840177|75978159|FG001|Overall Study|Adverse Event|1|||
42171255|NCT00840177|75978160|FG002|Overall Study|Adverse Event|1|||
42171256|NCT00840177|75978158|FG000|Overall Study|Refusal unrelated to adverse events|1|||
42171257|NCT00840177|75978159|FG001|Overall Study|Refusal unrelated to adverse events|0|||
42171258|NCT00840177|75978160|FG002|Overall Study|Refusal unrelated to adverse events|1|||
42352396|NCT01539291|76192412|FG002|Study GS-US-312-0116|Physician Decision|0|||
42352397|NCT01539291|76192413|FG003|Study GS-US-312-0116|Physician Decision|0|||
42352398|NCT01539291|76192410|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
42040737|NCT01796171|75848717|FG011|Follow-up Period|Patient transferred to other hospital|0|||
42352399|NCT01539291|76192411|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
42352400|NCT01539291|76192412|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
42352401|NCT01539291|76192413|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
42352402|NCT01539291|76192410|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
42352403|NCT01539291|76192411|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
42352404|NCT01539291|76192412|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
42352405|NCT01539291|76192413|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
42352406|NCT01539291|76192410|FG000|Study GS-US-312-0116|Other|1|||
42352407|NCT01539291|76192411|FG001|Study GS-US-312-0116|Other|0|||
42352408|NCT01539291|76192412|FG002|Study GS-US-312-0116|Other|0|||
42352409|NCT01539291|76192413|FG003|Study GS-US-312-0116|Other|0|||
42352410|NCT01539291|76192410|FG000|Study GS-US-312-0117|Adverse Event|22|||
42352411|NCT01539291|76192411|FG001|Study GS-US-312-0117|Adverse Event|1|||
42352412|NCT01539291|76192412|FG002|Study GS-US-312-0117|Adverse Event|9|||
42352413|NCT01539291|76192413|FG003|Study GS-US-312-0117|Adverse Event|12|||
42352414|NCT01539291|76192410|FG000|Study GS-US-312-0117|Physician Decision|9|||
42352415|NCT01539291|76192411|FG001|Study GS-US-312-0117|Physician Decision|0|||
42352416|NCT01539291|76192412|FG002|Study GS-US-312-0117|Physician Decision|6|||
42352417|NCT01539291|76192413|FG003|Study GS-US-312-0117|Physician Decision|4|||
42352418|NCT01539291|76192410|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
42352419|NCT01539291|76192411|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
42352420|NCT01539291|76192412|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
42352421|NCT01539291|76192413|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
42352422|NCT01539291|76192410|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
42352423|NCT01539291|76192411|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
42352424|NCT01539291|76192412|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
42352425|NCT01539291|76192413|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
42352426|NCT01539291|76192410|FG000|Study GS-US-312-0117|Other|2|||
42352427|NCT01539291|76192411|FG001|Study GS-US-312-0117|Other|1|||
42352428|NCT01539291|76192412|FG002|Study GS-US-312-0117|Other|1|||
42352429|NCT01539291|76192413|FG003|Study GS-US-312-0117|Other|1|||
42352430|NCT01538199|76192436|FG000|Overall Study|Lost to Follow-up|1|||
42352431|NCT01538199|76192437|FG001|Overall Study|Lost to Follow-up|2|||
42352432|NCT01538199|76192438|FG002|Overall Study|Lost to Follow-up|1|||
42352433|NCT01538199|76192439|FG003|Overall Study|Lost to Follow-up|0|||
42352434|NCT01538199|76192436|FG000|Overall Study|participant did not have time|1|||
42352435|NCT01538199|76192437|FG001|Overall Study|participant did not have time|0|||
42352436|NCT01538199|76192438|FG002|Overall Study|participant did not have time|0|||
42352437|NCT01538199|76192439|FG003|Overall Study|participant did not have time|2|||
42352438|NCT01538199|76192436|FG000|Overall Study|Lack of Efficacy|0|||
42352439|NCT01538199|76192437|FG001|Overall Study|Lack of Efficacy|1|||
42352440|NCT01538199|76192438|FG002|Overall Study|Lack of Efficacy|0|||
42352441|NCT01538199|76192439|FG003|Overall Study|Lack of Efficacy|0|||
42352442|NCT01511445|76192458|FG000|Overall Study|Lost to Follow-up|3|||
42352443|NCT01511445|76192459|FG001|Overall Study|Lost to Follow-up|1|||
42352444|NCT01511445|76192458|FG000|Overall Study|Protocol Violation|1|||
42352445|NCT01511445|76192459|FG001|Overall Study|Protocol Violation|3|||
42171259|NCT00840177|75978158|FG000|Overall Study|Progression/relapse|2|||
42171260|NCT00840177|75978159|FG001|Overall Study|Progression/relapse|0|||
42171261|NCT00840177|75978160|FG002|Overall Study|Progression/relapse|0|||
42171262|NCT00840177|75978158|FG000|Overall Study|Death|4|||
42171263|NCT00840177|75978159|FG001|Overall Study|Death|5|||
42171264|NCT00840177|75978160|FG002|Overall Study|Death|5|||
42171265|NCT00840177|75978158|FG000|Overall Study|not protocol specified|6|||
42171266|NCT00840177|75978159|FG001|Overall Study|not protocol specified|3|||
42171267|NCT00840177|75978160|FG002|Overall Study|not protocol specified|0|||
42171268|NCT00840177|75978158|FG000|Overall Study|Ineligible|0|||
42171269|NCT00840177|75978159|FG001|Overall Study|Ineligible|0|||
42171270|NCT00840177|75978160|FG002|Overall Study|Ineligible|3|||
42171271|NCT00840177|75978158|FG000|Overall Study|Did not start treatment|0|||
42171272|NCT00840177|75978159|FG001|Overall Study|Did not start treatment|0|||
42171273|NCT00840177|75978160|FG002|Overall Study|Did not start treatment|1|||
42171274|NCT01347580|75978170|FG000|Overall Study|Withdrawal by Subject|13|||
42352446|NCT01511445|76192458|FG000|Overall Study|Protocol Violation|1|||
42352447|NCT01511445|76192459|FG001|Overall Study|Protocol Violation|0|||
42014807|NCT00952705|75821946|FG001|Overall Study|Incarcerated post dose|0|||
42014808|NCT00952705|75821947|FG002|Overall Study|Incarcerated post dose|0|||
42171275|NCT01347580|75978171|FG001|Overall Study|Withdrawal by Subject|23|||
42171276|NCT01347580|75978170|FG000|Overall Study|Death|30|||
42171277|NCT01347580|75978171|FG001|Overall Study|Death|19|||
42171278|NCT01347580|75978170|FG000|Overall Study|Protocol Violation|10|||
42352448|NCT01543503|76192467|FG000|Overall Study|Lost to Follow-up|32|||
42014809|NCT00952705|75821945|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
42171279|NCT01347580|75978171|FG001|Overall Study|Protocol Violation|7|||
42171280|NCT01347580|75978170|FG000|Overall Study|Lost to Follow-up|3|||
42352449|NCT01543503|76192468|FG001|Overall Study|Lost to Follow-up|36|||
42352450|NCT01543503|76192467|FG000|Overall Study|Adverse Event|9|||
42352451|NCT01543503|76192468|FG001|Overall Study|Adverse Event|13|||
42352452|NCT01543503|76192467|FG000|Overall Study|Lack of Efficacy|4|||
42014810|NCT00952705|75821946|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
42171281|NCT01347580|75978171|FG001|Overall Study|Lost to Follow-up|1|||
42352453|NCT01543503|76192468|FG001|Overall Study|Lack of Efficacy|16|||
42352454|NCT01543503|76192467|FG000|Overall Study|Participant withdrew informed consent|8|||
42352455|NCT01543503|76192468|FG001|Overall Study|Participant withdrew informed consent|10|||
42352456|NCT01543503|76192467|FG000|Overall Study|Change of jobs|0|||
42352457|NCT01543503|76192468|FG001|Overall Study|Change of jobs|1|||
42352458|NCT01543503|76192467|FG000|Overall Study|Intolerance to the biologic treatment|0|||
42352459|NCT01543503|76192468|FG001|Overall Study|Intolerance to the biologic treatment|1|||
42352460|NCT01543503|76192467|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
42352461|NCT01543503|76192468|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
42352462|NCT01543503|76192467|FG000|Overall Study|Participant did not complete last visit|0|||
42352463|NCT01543503|76192468|FG001|Overall Study|Participant did not complete last visit|2|||
42352464|NCT01543503|76192467|FG000|Overall Study|Refused to continue treatment|7|||
42352465|NCT01543503|76192468|FG001|Overall Study|Refused to continue treatment|0|||
42352466|NCT01543503|76192467|FG000|Overall Study|Incorrect medication received|1|||
42352467|NCT01543503|76192468|FG001|Overall Study|Incorrect medication received|0|||
42352468|NCT01543503|76192467|FG000|Overall Study|Participant moved to another city|2|||
42352469|NCT01543503|76192468|FG001|Overall Study|Participant moved to another city|0|||
42352470|NCT01543503|76192467|FG000|Overall Study|Participant will not return for visits|0|||
42352471|NCT01543503|76192468|FG001|Overall Study|Participant will not return for visits|2|||
42352472|NCT01543503|76192467|FG000|Overall Study|Participant transferred to another city|1|||
42352473|NCT01543503|76192468|FG001|Overall Study|Participant transferred to another city|0|||
42352474|NCT01543503|76192467|FG000|Overall Study|Participant moved to Scotland|1|||
42352475|NCT01543503|76192468|FG001|Overall Study|Participant moved to Scotland|0|||
42352476|NCT01543503|76192467|FG000|Overall Study|Participant decision to stop treatment|1|||
42352477|NCT01543503|76192468|FG001|Overall Study|Participant decision to stop treatment|0|||
42352478|NCT01543503|76192467|FG000|Overall Study|Investigator did not wish to participate|1|||
42352479|NCT01543503|76192468|FG001|Overall Study|Investigator did not wish to participate|1|||
42352480|NCT01543503|76192467|FG000|Overall Study|Participant recruited after closing date|0|||
42352481|NCT01543503|76192468|FG001|Overall Study|Participant recruited after closing date|1|||
42352482|NCT01543503|76192467|FG000|Overall Study|Site stopped participation|5|||
42352483|NCT01543503|76192468|FG001|Overall Study|Site stopped participation|1|||
42352484|NCT01543503|76192467|FG000|Overall Study|Participant did not attend a visit|1|||
42352485|NCT01543503|76192468|FG001|Overall Study|Participant did not attend a visit|0|||
42352486|NCT01543503|76192467|FG000|Overall Study|Moved to other rheumatologic site|0|||
42352487|NCT01543503|76192468|FG001|Overall Study|Moved to other rheumatologic site|1|||
42352488|NCT01543503|76192467|FG000|Overall Study|Participant consented to another study|0|||
42352489|NCT01543503|76192468|FG001|Overall Study|Participant consented to another study|2|||
42352490|NCT01543503|76192467|FG000|Overall Study|Participant went to United States|1|||
42352491|NCT01543503|76192468|FG001|Overall Study|Participant went to United States|0|||
42352492|NCT01543503|76192467|FG000|Overall Study|Screen failure|1|||
42352493|NCT01543503|76192468|FG001|Overall Study|Screen failure|0|||
42352494|NCT01511055|76192474|FG000|Overall Study|Withdrawal by Subject|6|||
42352495|NCT01537887|76192478|FG000|Period 1|Physician Decision|0|||
42352496|NCT01537887|76192479|FG001|Period 1|Physician Decision|0|||
42352497|NCT01537887|76192480|FG002|Period 1|Physician Decision|0|||
42352498|NCT01537887|76192481|FG003|Period 1|Physician Decision|0|||
42352499|NCT01537887|76192482|FG004|Period 1|Physician Decision|1|||
42352500|NCT01537887|76192483|FG005|Period 1|Physician Decision|1|||
42352501|NCT01537887|76192478|FG000|Period 1|Did not receive treatment|0|||
42352502|NCT01537887|76192479|FG001|Period 1|Did not receive treatment|0|||
42352503|NCT01537887|76192480|FG002|Period 1|Did not receive treatment|1|||
42352504|NCT01537887|76192481|FG003|Period 1|Did not receive treatment|0|||
42352505|NCT01537887|76192482|FG004|Period 1|Did not receive treatment|0|||
42352506|NCT01537887|76192483|FG005|Period 1|Did not receive treatment|0|||
42352507|NCT01537887|76192478|FG000|Period 2|Withdrawal by Subject|0|||
42352508|NCT01537887|76192479|FG001|Period 2|Withdrawal by Subject|1|||
42352509|NCT01537887|76192480|FG002|Period 2|Withdrawal by Subject|0|||
42352510|NCT01537887|76192481|FG003|Period 2|Withdrawal by Subject|0|||
42352511|NCT01537887|76192482|FG004|Period 2|Withdrawal by Subject|0|||
42352512|NCT01537887|76192483|FG005|Period 2|Withdrawal by Subject|0|||
42352513|NCT01537887|76192478|FG000|Period 3|Adverse Event|0|||
42040738|NCT01796171|75848718|FG012|Follow-up Period|Patient transferred to other hospital|0|||
42352514|NCT01537887|76192479|FG001|Period 3|Adverse Event|0|||
42352515|NCT01537887|76192480|FG002|Period 3|Adverse Event|1|||
42040739|NCT01796171|75848719|FG013|Follow-up Period|Patient transferred to other hospital|0|||
42040740|NCT01796171|75848720|FG014|Follow-up Period|Patient transferred to other hospital|0|||
42352516|NCT01537887|76192481|FG003|Period 3|Adverse Event|0|||
42352517|NCT01537887|76192482|FG004|Period 3|Adverse Event|0|||
42352518|NCT01537887|76192483|FG005|Period 3|Adverse Event|0|||
42352519|NCT01537887|76192478|FG000|Period 3|Withdrawal by Subject|0|||
42352520|NCT01537887|76192479|FG001|Period 3|Withdrawal by Subject|1|||
42352521|NCT01537887|76192480|FG002|Period 3|Withdrawal by Subject|0|||
42352522|NCT01537887|76192481|FG003|Period 3|Withdrawal by Subject|0|||
42352523|NCT01537887|76192482|FG004|Period 3|Withdrawal by Subject|0|||
42352524|NCT01537887|76192483|FG005|Period 3|Withdrawal by Subject|0|||
42352525|NCT01489527|76192493|FG000|Overall Study|Pregnancy|9|||
42352526|NCT01489527|76192494|FG001|Overall Study|Pregnancy|14|||
42352527|NCT01489527|76192493|FG000|Overall Study|Participant moved|6|||
42352528|NCT01489527|76192494|FG001|Overall Study|Participant moved|7|||
42352529|NCT01489527|76192493|FG000|Overall Study|Withdrawal by Subject|0|||
42352530|NCT01489527|76192494|FG001|Overall Study|Withdrawal by Subject|4|||
42352531|NCT01489527|76192493|FG000|Overall Study|Lost to Follow-up|5|||
42352532|NCT01489527|76192494|FG001|Overall Study|Lost to Follow-up|1|||
42352533|NCT01489527|76192493|FG000|Overall Study|Procedures|1|||
42352534|NCT01489527|76192494|FG001|Overall Study|Procedures|0|||
42352535|NCT01489527|76192493|FG000|Overall Study|Not compliant|1|||
42352536|NCT01489527|76192494|FG001|Overall Study|Not compliant|0|||
42352537|NCT01487577|76192507|FG000|Overall Study|Became ineligible after signing consent|1|||
42352538|NCT01536951|76192513|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
42352539|NCT01536951|76192514|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
42352540|NCT01536951|76192515|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
42352541|NCT01536951|76192516|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
42352542|NCT01536951|76192517|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
42352543|NCT01536951|76192518|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
42352544|NCT01536951|76192519|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
42352545|NCT01536951|76192520|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
42352546|NCT01536951|76192521|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
42352547|NCT01536951|76192513|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
42352548|NCT01536951|76192514|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
42352549|NCT01536951|76192515|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
42352550|NCT01536951|76192516|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
42352551|NCT01536951|76192517|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
42352552|NCT01536951|76192518|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
42352553|NCT01536951|76192519|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
42352554|NCT01536951|76192520|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
42352555|NCT01536951|76192521|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
42352556|NCT01536795|76192546|FG000|Overall Study|Lost to Follow-up|0|||
42352557|NCT01536795|76192547|FG001|Overall Study|Lost to Follow-up|2|||
42352558|NCT01536795|76192546|FG000|Overall Study|Lack of Efficacy|1|||
42352559|NCT01536795|76192547|FG001|Overall Study|Lack of Efficacy|0|||
42352560|NCT01536561|76192557|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
42352561|NCT01536561|76192557|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
42014811|NCT00952705|75821947|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
42283944|NCT02609607|76115852|FG000|Overall Study|Lost to Follow-up|0|||
42283945|NCT02609607|76115853|FG001|Overall Study|Lost to Follow-up|1|||
42283946|NCT02606253|76115862|FG000|Overall Study|Adverse Event|2|||
42283947|NCT02606253|76115863|FG001|Overall Study|Adverse Event|0|||
42283948|NCT02606253|76115864|FG002|Overall Study|Adverse Event|0|||
42283949|NCT02606253|76115862|FG000|Overall Study|Protocol Violation|2|||
42283950|NCT02606253|76115863|FG001|Overall Study|Protocol Violation|1|||
42283951|NCT02606253|76115864|FG002|Overall Study|Protocol Violation|0|||
42283952|NCT02606253|76115862|FG000|Overall Study|Physician Decision|1|||
42283953|NCT02606253|76115863|FG001|Overall Study|Physician Decision|1|||
42283954|NCT02606253|76115864|FG002|Overall Study|Physician Decision|0|||
42283955|NCT02607735|76115874|FG000|Primary Study|Randomized but Never Treated|1|||
42283956|NCT02607735|76115875|FG001|Primary Study|Randomized but Never Treated|0|||
42283957|NCT02607735|76115876|FG002|Primary Study|Randomized but Never Treated|0|||
42283958|NCT02607735|76115874|FG000|Primary Study|Lost to Follow-up|4|||
42283959|NCT02607735|76115875|FG001|Primary Study|Lost to Follow-up|0|||
42014812|NCT00955357|75821961|FG000|Titration Phase|Adverse Event|9|||
42014813|NCT00955357|75821962|FG001|Titration Phase|Adverse Event|46|||
42014814|NCT00955357|75821961|FG000|Titration Phase|Lack of Efficacy|0|||
42014815|NCT00955357|75821962|FG001|Titration Phase|Lack of Efficacy|2|||
42014816|NCT00955357|75821961|FG000|Titration Phase|Protocol Violation|3|||
42014817|NCT00955357|75821962|FG001|Titration Phase|Protocol Violation|7|||
42014818|NCT00955357|75821961|FG000|Titration Phase|Lost to Follow-up|1|||
42283960|NCT02607735|76115876|FG002|Primary Study|Lost to Follow-up|0|||
42283961|NCT02607735|76115874|FG000|Primary Study|Withdrew Consent|2|||
42283962|NCT02607735|76115875|FG001|Primary Study|Withdrew Consent|0|||
42283963|NCT02607735|76115876|FG002|Primary Study|Withdrew Consent|0|||
42352562|NCT01536561|76192557|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
42352563|NCT01536561|76192557|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
42352564|NCT01536561|76192557|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
42352565|NCT01536561|76192557|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
42352566|NCT01536405|76192575|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
42352567|NCT01536405|76192576|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
42352568|NCT01536405|76192575|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
42352569|NCT01536405|76192576|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
42352570|NCT01536405|76192575|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
42352571|NCT01536405|76192576|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
42352572|NCT01536405|76192575|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
42352573|NCT01536405|76192576|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
42352574|NCT01536405|76192575|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
42352575|NCT01536405|76192576|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
42352576|NCT01536405|76192575|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
42352577|NCT01536405|76192576|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
42352578|NCT01536405|76192575|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
42352579|NCT01536405|76192576|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
42352580|NCT01536405|76192575|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
42352581|NCT01536405|76192576|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
42171282|NCT01347580|75978170|FG000|Overall Study|Had other reason|9|||
42171283|NCT01347580|75978171|FG001|Overall Study|Had other reason|6|||
42171284|NCT00398411|75978179|FG000|Overall Study|Death|0|||
42171285|NCT00398411|75978180|FG001|Overall Study|Death|1|||
42171286|NCT03352414|75978188|FG000|Overall Study|Ineligible by operative criteria|12|||
42171287|NCT03352414|75978189|FG001|Overall Study|Ineligible by operative criteria|10|||
42171288|NCT00364793|75978201|FG000|Overall Study|Adverse Event|2|||
42171289|NCT00364793|75978202|FG001|Overall Study|Adverse Event|0|||
42171290|NCT00364793|75978203|FG002|Overall Study|Adverse Event|0|||
42171291|NCT00364793|75978204|FG003|Overall Study|Adverse Event|0|||
42352582|NCT01536405|76192575|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
42352583|NCT01536405|76192576|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
42352584|NCT01536405|76192575|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
42352585|NCT01536405|76192576|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
42171292|NCT00364793|75978201|FG000|Overall Study|Death|1|||
42171293|NCT00364793|75978202|FG001|Overall Study|Death|0|||
42171294|NCT00364793|75978203|FG002|Overall Study|Death|1|||
42171295|NCT00364793|75978204|FG003|Overall Study|Death|0|||
42171296|NCT00364793|75978201|FG000|Overall Study|Lack of Efficacy|3|||
42171297|NCT00364793|75978202|FG001|Overall Study|Lack of Efficacy|3|||
42171298|NCT00364793|75978203|FG002|Overall Study|Lack of Efficacy|1|||
42171299|NCT00364793|75978204|FG003|Overall Study|Lack of Efficacy|1|||
42171300|NCT00364793|75978201|FG000|Overall Study|Lost to Follow-up|1|||
42171301|NCT00364793|75978202|FG001|Overall Study|Lost to Follow-up|0|||
42014819|NCT00955357|75821962|FG001|Titration Phase|Lost to Follow-up|3|||
42014820|NCT00955357|75821961|FG000|Titration Phase|Withdrawal by Subject|3|||
42171302|NCT00364793|75978203|FG002|Overall Study|Lost to Follow-up|2|||
42171303|NCT00364793|75978204|FG003|Overall Study|Lost to Follow-up|0|||
42171304|NCT00364793|75978201|FG000|Overall Study|Poor or non-compliance|1|||
42171305|NCT00364793|75978202|FG001|Overall Study|Poor or non-compliance|1|||
42171306|NCT00364793|75978203|FG002|Overall Study|Poor or non-compliance|0|||
42171307|NCT00364793|75978204|FG003|Overall Study|Poor or non-compliance|1|||
42171308|NCT00364793|75978201|FG000|Overall Study|No longer meets criteria|0|||
42171309|NCT00364793|75978202|FG001|Overall Study|No longer meets criteria|0|||
42171310|NCT00364793|75978203|FG002|Overall Study|No longer meets criteria|0|||
42171311|NCT00364793|75978204|FG003|Overall Study|No longer meets criteria|1|||
42171312|NCT00364793|75978201|FG000|Overall Study|Withdrawal by Subject|0|||
42171313|NCT00364793|75978202|FG001|Overall Study|Withdrawal by Subject|1|||
42171314|NCT00364793|75978203|FG002|Overall Study|Withdrawal by Subject|0|||
42171315|NCT00364793|75978204|FG003|Overall Study|Withdrawal by Subject|0|||
42171316|NCT03351478|75978220|FG000|Overall Study|At the subject's own request|11|||
42171317|NCT03351478|75978221|FG001|Overall Study|At the subject's own request|12|||
42171318|NCT03351478|75978222|FG002|Overall Study|At the subject's own request|5|||
42171319|NCT03351478|75978220|FG000|Overall Study|Adverse Event|1|||
42171320|NCT03351478|75978221|FG001|Overall Study|Adverse Event|2|||
42171321|NCT03351478|75978222|FG002|Overall Study|Adverse Event|1|||
42171322|NCT03351478|75978220|FG000|Overall Study|Poor compliance to protocol|1|||
42171323|NCT03351478|75978221|FG001|Overall Study|Poor compliance to protocol|0|||
42352586|NCT01536405|76192575|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
42352587|NCT01536405|76192576|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
42352588|NCT01536405|76192575|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
42352589|NCT01536405|76192576|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
42352590|NCT01536405|76192575|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
42352591|NCT01536405|76192576|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
42352592|NCT01487265|76192582|FG000|Overall Study|Adverse Event|8|||
42352593|NCT01487265|76192582|FG000|Overall Study|Withdrawal by Subject|5|||
42352594|NCT01487265|76192582|FG000|Overall Study|Disease Progression|21|||
42171324|NCT03351478|75978222|FG002|Overall Study|Poor compliance to protocol|0|||
42171325|NCT03351478|75978220|FG000|Overall Study|Reason not Specified|1|||
42171326|NCT03351478|75978221|FG001|Overall Study|Reason not Specified|3|||
42171327|NCT03351478|75978222|FG002|Overall Study|Reason not Specified|0|||
42171328|NCT03351478|75978220|FG000|Overall Study|Lost to Follow-up|0|||
42171329|NCT03351478|75978221|FG001|Overall Study|Lost to Follow-up|0|||
42171330|NCT03351478|75978222|FG002|Overall Study|Lost to Follow-up|1|||
42171331|NCT00363545|75978232|FG000|Overall Study|Serious Adverse Event|0|||
42171332|NCT00363545|75978233|FG001|Overall Study|Serious Adverse Event|1|||
42171333|NCT00363545|75978232|FG000|Overall Study|Withdrawal by Subject|12|||
42171334|NCT00363545|75978233|FG001|Overall Study|Withdrawal by Subject|15|||
42171335|NCT00363545|75978232|FG000|Overall Study|Migrated/moved from study area|3|||
42171336|NCT00363545|75978233|FG001|Overall Study|Migrated/moved from study area|6|||
42171337|NCT00363545|75978232|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
42171338|NCT00363545|75978233|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
42171339|NCT00363545|75978232|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
42171340|NCT00363545|75978233|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
42171341|NCT00363545|75978232|FG000|Overall Study|Others|1|||
42171342|NCT00363545|75978233|FG001|Overall Study|Others|0|||
42171343|NCT03351244|75978242|FG000|Overall Study|Adverse Event|7|||
42171344|NCT03351244|75978243|FG001|Overall Study|Adverse Event|11|||
42171345|NCT03351244|75978244|FG002|Overall Study|Adverse Event|12|||
42171346|NCT03351244|75978242|FG000|Overall Study|Investigator's decision|0|||
42171347|NCT03351244|75978243|FG001|Overall Study|Investigator's decision|0|||
42171348|NCT03351244|75978244|FG002|Overall Study|Investigator's decision|2|||
42171349|NCT03351244|75978242|FG000|Overall Study|System error|0|||
42171350|NCT03351244|75978243|FG001|Overall Study|System error|0|||
42171351|NCT03351244|75978244|FG002|Overall Study|System error|2|||
42171352|NCT03351244|75978242|FG000|Overall Study|COVID-19 restrictions|3|||
42171353|NCT03351244|75978243|FG001|Overall Study|COVID-19 restrictions|0|||
42171354|NCT03351244|75978244|FG002|Overall Study|COVID-19 restrictions|1|||
42171355|NCT03351244|75978242|FG000|Overall Study|Non-compliance|2|||
42171356|NCT03351244|75978243|FG001|Overall Study|Non-compliance|5|||
42171357|NCT03351244|75978244|FG002|Overall Study|Non-compliance|0|||
42171358|NCT03351244|75978242|FG000|Overall Study|Withdrawal by Subject|11|||
42171359|NCT03351244|75978243|FG001|Overall Study|Withdrawal by Subject|16|||
42171360|NCT03351244|75978244|FG002|Overall Study|Withdrawal by Subject|13|||
42171361|NCT03351244|75978242|FG000|Overall Study|Lost to Follow-up|2|||
42171362|NCT03351244|75978243|FG001|Overall Study|Lost to Follow-up|6|||
42283964|NCT02607735|76115874|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
42283965|NCT02607735|76115875|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
42283966|NCT02607735|76115876|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
42283967|NCT02607735|76115874|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
42283968|NCT02607735|76115875|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
42283969|NCT02607735|76115876|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
42283970|NCT04772313|76115884|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
42283971|NCT04772313|76115884|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
42283972|NCT01668537|76115891|FG000|Overall Study|Request to Discontinue Prematurely|1|||
42352595|NCT01487265|76192582|FG000|Overall Study|Death|2|||
42352596|NCT01487265|76192582|FG000|Overall Study|Still on Treatment|1|||
42014821|NCT00955357|75821962|FG001|Titration Phase|Withdrawal by Subject|5|||
42014822|NCT00955357|75821961|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
42171363|NCT03351244|75978244|FG002|Overall Study|Lost to Follow-up|4|||
42171364|NCT03351244|75978242|FG000|Overall Study|Protocol Violation|2|||
42171365|NCT03351244|75978243|FG001|Overall Study|Protocol Violation|2|||
42171366|NCT03351244|75978244|FG002|Overall Study|Protocol Violation|0|||
42171367|NCT03386032|75978257|FG000|Overall Study|Lack of Efficacy|6|||
42171368|NCT03386032|75978258|FG001|Overall Study|Lack of Efficacy|2|||
42171369|NCT03386032|75978259|FG002|Overall Study|Lack of Efficacy|0|||
42171370|NCT03386032|75978257|FG000|Overall Study|Adverse Event|2|||
42171371|NCT03386032|75978258|FG001|Overall Study|Adverse Event|2|||
42171372|NCT03386032|75978259|FG002|Overall Study|Adverse Event|0|||
42171373|NCT03386032|75978257|FG000|Overall Study|Withdrawal by Subject|1|||
42171374|NCT03386032|75978258|FG001|Overall Study|Withdrawal by Subject|0|||
42171375|NCT03386032|75978259|FG002|Overall Study|Withdrawal by Subject|0|||
42171376|NCT03386032|75978257|FG000|Overall Study|Lost to Follow-up|9|||
42171377|NCT03386032|75978258|FG001|Overall Study|Lost to Follow-up|3|||
42171378|NCT03386032|75978259|FG002|Overall Study|Lost to Follow-up|0|||
42171379|NCT00077610|75978270|FG000|Overall Study|Adverse Event|9|||
42171380|NCT00077610|75978271|FG001|Overall Study|Adverse Event|7|||
42171381|NCT00077610|75978272|FG002|Overall Study|Adverse Event|1|||
42171382|NCT00077610|75978270|FG000|Overall Study|Lost to Follow-up|0|||
42171383|NCT00077610|75978271|FG001|Overall Study|Lost to Follow-up|1|||
42171384|NCT00077610|75978272|FG002|Overall Study|Lost to Follow-up|2|||
42171385|NCT00077610|75978270|FG000|Overall Study|Withdrawal by Subject|4|||
42171386|NCT00077610|75978271|FG001|Overall Study|Withdrawal by Subject|10|||
42171387|NCT00077610|75978272|FG002|Overall Study|Withdrawal by Subject|6|||
42171388|NCT00077610|75978270|FG000|Overall Study|Death|17|||
42171389|NCT00077610|75978271|FG001|Overall Study|Death|13|||
42171390|NCT00077610|75978272|FG002|Overall Study|Death|13|||
42171391|NCT00077610|75978270|FG000|Overall Study|Renal transplant|12|||
42171392|NCT00077610|75978271|FG001|Overall Study|Renal transplant|15|||
42171393|NCT00077610|75978272|FG002|Overall Study|Renal transplant|11|||
42171394|NCT00077610|75978270|FG000|Overall Study|Withdrew from dialysis care|5|||
42171395|NCT00077610|75978271|FG001|Overall Study|Withdrew from dialysis care|0|||
42171396|NCT00077610|75978272|FG002|Overall Study|Withdrew from dialysis care|3|||
42171397|NCT00077610|75978270|FG000|Overall Study|Insufficient Therapeutic Response|1|||
42171398|NCT00077610|75978271|FG001|Overall Study|Insufficient Therapeutic Response|0|||
42171399|NCT00077610|75978272|FG002|Overall Study|Insufficient Therapeutic Response|0|||
42171400|NCT00077610|75978270|FG000|Overall Study|Multiple blood transfusions|0|||
42171401|NCT00077610|75978271|FG001|Overall Study|Multiple blood transfusions|0|||
42171402|NCT00077610|75978272|FG002|Overall Study|Multiple blood transfusions|1|||
42171403|NCT00077610|75978270|FG000|Overall Study|Principal Investigator's decision|1|||
42171404|NCT00077610|75978271|FG001|Overall Study|Principal Investigator's decision|0|||
42171405|NCT00077610|75978272|FG002|Overall Study|Principal Investigator's decision|1|||
42171406|NCT00077610|75978270|FG000|Overall Study|Worsening of health condition|1|||
42171407|NCT00077610|75978271|FG001|Overall Study|Worsening of health condition|1|||
42171408|NCT00077610|75978272|FG002|Overall Study|Worsening of health condition|0|||
42171409|NCT00077610|75978270|FG000|Overall Study|Given Epogen in hospital|1|||
42171410|NCT00077610|75978271|FG001|Overall Study|Given Epogen in hospital|0|||
42171411|NCT00077610|75978272|FG002|Overall Study|Given Epogen in hospital|0|||
42171412|NCT00077610|75978270|FG000|Overall Study|Transferred to other unit|0|||
42171413|NCT00077610|75978271|FG001|Overall Study|Transferred to other unit|0|||
42171414|NCT00077610|75978272|FG002|Overall Study|Transferred to other unit|1|||
42283973|NCT01668537|76115892|FG001|Overall Study|Request to Discontinue Prematurely|1|||
42283974|NCT01668537|76115891|FG000|Overall Study|Subject unwilling/unable to comply|5|||
42283975|NCT01668537|76115892|FG001|Overall Study|Subject unwilling/unable to comply|0|||
42283976|NCT01668537|76115891|FG000|Overall Study|Reason Precludes Participation|1|||
42283977|NCT01668537|76115892|FG001|Overall Study|Reason Precludes Participation|0|||
42283978|NCT01668537|76115891|FG000|Overall Study|Lost to Follow-up|13|||
42352597|NCT01485627|76192588|FG000|Overall Study|Patient withdrew|6|||
42352598|NCT01485627|76192589|FG001|Overall Study|Patient withdrew|5|||
42352599|NCT01485627|76192588|FG000|Overall Study|Patient died|3|||
42352600|NCT01485627|76192589|FG001|Overall Study|Patient died|1|||
42040741|NCT01796171|75848706|FG000|Follow-up Period|Sponsor Decision|0|||
42171415|NCT00077610|75978270|FG000|Overall Study|Transferred to nursing home|0|||
42171416|NCT00077610|75978271|FG001|Overall Study|Transferred to nursing home|0|||
42171417|NCT00077610|75978272|FG002|Overall Study|Transferred to nursing home|1|||
42171418|NCT00077610|75978270|FG000|Overall Study|Transfer to satellite unit|1|||
42171419|NCT00077610|75978271|FG001|Overall Study|Transfer to satellite unit|0|||
42352601|NCT01485627|76192588|FG000|Overall Study|Patient lost to followup|0|||
42352602|NCT01485627|76192589|FG001|Overall Study|Patient lost to followup|1|||
42040742|NCT01796171|75848707|FG001|Follow-up Period|Sponsor Decision|0|||
42283979|NCT01668537|76115892|FG001|Overall Study|Lost to Follow-up|6|||
42283980|NCT01668537|76115891|FG000|Overall Study|Other|2|||
42283981|NCT01668537|76115892|FG001|Overall Study|Other|3|||
42352603|NCT01485627|76192588|FG000|Overall Study|Caregiver withdrew|3|||
42171420|NCT00077610|75978272|FG002|Overall Study|Transfer to satellite unit|0|||
42171421|NCT00077610|75978270|FG000|Overall Study|Transfer to other center for surgery|1|||
42171422|NCT00077610|75978271|FG001|Overall Study|Transfer to other center for surgery|0|||
42171423|NCT00077610|75978272|FG002|Overall Study|Transfer to other center for surgery|0|||
42171424|NCT00077610|75978270|FG000|Overall Study|Change in dialysis modality|1|||
42171425|NCT00077610|75978271|FG001|Overall Study|Change in dialysis modality|0|||
42283982|NCT01668147|76115898|FG000|Overall Study|Withdrawal by Subject|6|||
42283983|NCT02600559|76115915|FG000|Overall Study|Withdrawal by Subject|3|||
42283984|NCT02600559|76115915|FG000|Overall Study|Lost to Follow-up|20|||
42283985|NCT02601573|76115924|FG000|Overall Study|Lost to Follow-up|0|||
42283986|NCT02601573|76115925|FG001|Overall Study|Lost to Follow-up|3|||
42283987|NCT02601573|76115926|FG002|Overall Study|Lost to Follow-up|1|||
42283988|NCT02601573|76115927|FG003|Overall Study|Lost to Follow-up|0|||
42283989|NCT02601573|76115928|FG004|Overall Study|Lost to Follow-up|2|||
42283990|NCT02601573|76115924|FG000|Overall Study|Withdrawal by Subject|0|||
42283991|NCT02601573|76115925|FG001|Overall Study|Withdrawal by Subject|1|||
42283992|NCT02601573|76115926|FG002|Overall Study|Withdrawal by Subject|0|||
42283993|NCT02601573|76115927|FG003|Overall Study|Withdrawal by Subject|1|||
42283994|NCT02601573|76115928|FG004|Overall Study|Withdrawal by Subject|0|||
42283995|NCT02601027|76115942|FG000|Registration to Surgery|Withdrawal by Subject|20|||
42283996|NCT02601027|76115943|FG001|Registration to Surgery|Withdrawal by Subject|10|||
42283997|NCT02600871|76115951|FG000|Overall Study|Lost to Follow-up|13|||
42283998|NCT02600871|76115952|FG001|Overall Study|Lost to Follow-up|10|||
42283999|NCT02598297|76115961|FG000|Overall Study|Study terminated by Sponsor|21|||
42284000|NCT02598297|76115962|FG001|Overall Study|Study terminated by Sponsor|23|||
42284001|NCT02598297|76115961|FG000|Overall Study|Adverse Event|1|||
42284002|NCT02598297|76115962|FG001|Overall Study|Adverse Event|1|||
42284003|NCT02598297|76115961|FG000|Overall Study|Physician Decision|1|||
42284004|NCT02598297|76115962|FG001|Overall Study|Physician Decision|0|||
42284005|NCT02598297|76115961|FG000|Overall Study|Subject/guardian decision|1|||
42352604|NCT01485627|76192589|FG001|Overall Study|Caregiver withdrew|3|||
42352605|NCT01485627|76192588|FG000|Overall Study|Caregiver lost to follow up|11|||
42352606|NCT01485627|76192589|FG001|Overall Study|Caregiver lost to follow up|12|||
42171426|NCT00077610|75978272|FG002|Overall Study|Change in dialysis modality|0|||
42171427|NCT00077610|75978270|FG000|Overall Study|Relocation|0|||
42352607|NCT01485627|76192588|FG000|Overall Study|Caregiver died|1|||
42352608|NCT01485627|76192589|FG001|Overall Study|Caregiver died|0|||
42352609|NCT01485627|76192588|FG000|Overall Study|caregiver was not bereaved|42|||
42352610|NCT01485627|76192589|FG001|Overall Study|caregiver was not bereaved|35|||
42284006|NCT02598297|76115962|FG001|Overall Study|Subject/guardian decision|0|||
42284007|NCT02598297|76115961|FG000|Overall Study|Followed for survival|1|||
42352611|NCT01508325|76192612|FG000|Overall Study|Withdrawal by Subject|8|||
42352612|NCT01508325|76192613|FG001|Overall Study|Withdrawal by Subject|9|||
42352613|NCT01508325|76192612|FG000|Overall Study|Protocol Violation|0|||
42352614|NCT01508325|76192613|FG001|Overall Study|Protocol Violation|3|||
42352615|NCT01508325|76192612|FG000|Overall Study|Physician Decision|2|||
42352616|NCT01508325|76192613|FG001|Overall Study|Physician Decision|1|||
42352617|NCT01508325|76192612|FG000|Overall Study|Adverse Event|1|||
42352618|NCT01508325|76192613|FG001|Overall Study|Adverse Event|0|||
42352619|NCT01508325|76192612|FG000|Overall Study|Lost to Follow-up|5|||
42284008|NCT02598297|76115962|FG001|Overall Study|Followed for survival|0|||
42284009|NCT02596893|76115972|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
42284010|NCT02596893|76115973|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
42352620|NCT01508325|76192613|FG001|Overall Study|Lost to Follow-up|6|||
42284011|NCT02596893|76115974|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
42352621|NCT01508325|76192612|FG000|Overall Study|Other|2|||
42352622|NCT01508325|76192613|FG001|Overall Study|Other|2|||
42352623|NCT01508169|76192621|FG000|Overall Study|Adverse Event|1|||
42040743|NCT01796171|75848708|FG002|Follow-up Period|Sponsor Decision|0|||
42040744|NCT01796171|75848709|FG003|Follow-up Period|Sponsor Decision|0|||
42040745|NCT01796171|75848710|FG004|Follow-up Period|Sponsor Decision|0|||
42040746|NCT01796171|75848711|FG005|Follow-up Period|Sponsor Decision|0|||
42040747|NCT01796171|75848712|FG006|Follow-up Period|Sponsor Decision|0|||
42040748|NCT01796171|75848713|FG007|Follow-up Period|Sponsor Decision|0|||
42284012|NCT02596893|76115975|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
42284013|NCT02596893|76115972|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
42284014|NCT02596893|76115973|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
42284015|NCT02596893|76115974|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
42284016|NCT02596893|76115975|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
42284017|NCT02596893|76115972|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
42284018|NCT02596893|76115973|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
42284019|NCT02596893|76115974|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
42284020|NCT02596893|76115975|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
42284021|NCT02596893|76115972|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
42284022|NCT02596893|76115973|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
42284023|NCT02596893|76115974|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
42284024|NCT02596893|76115975|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
42284025|NCT02596893|76115972|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
42284026|NCT02596893|76115973|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
42284027|NCT02596893|76115974|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
42284028|NCT02596893|76115975|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
42284029|NCT02596893|76115972|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
42284030|NCT02596893|76115973|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
42284031|NCT02596893|76115974|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
42284032|NCT02596893|76115975|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
42284033|NCT02596893|76115972|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
42284034|NCT02596893|76115973|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
42284035|NCT02596893|76115974|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
42284036|NCT02596893|76115975|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
42284037|NCT02596893|76115972|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
42284038|NCT02596893|76115973|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
42284039|NCT02596893|76115974|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
42284040|NCT02596893|76115975|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
42284041|NCT02596893|76115972|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
42284042|NCT02596893|76115973|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
42284043|NCT02596893|76115974|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
42284044|NCT02596893|76115975|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
42284045|NCT02596893|76115972|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
42284046|NCT02596893|76115973|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
42284047|NCT02596893|76115974|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
42284048|NCT02596893|76115975|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
42284049|NCT02596893|76115972|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
42284050|NCT02596893|76115973|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
42284051|NCT02596893|76115974|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
42284052|NCT02596893|76115975|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
42284053|NCT02592447|76115991|FG000|Overall Study|Lost to Follow-up|1|||
42284054|NCT02592447|76115992|FG001|Overall Study|Lost to Follow-up|0|||
42284055|NCT02592447|76115991|FG000|Overall Study|Ineligible after randomization|1|||
42284056|NCT02592447|76115992|FG001|Overall Study|Ineligible after randomization|0|||
42284057|NCT02592447|76115991|FG000|Overall Study|Withdrawal by Subject|0|||
42284058|NCT02592447|76115992|FG001|Overall Study|Withdrawal by Subject|1|||
42284059|NCT02595723|76116001|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
42284060|NCT02595723|76116002|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
42284061|NCT02595723|76116003|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
42284062|NCT02595723|76116001|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
42284063|NCT02595723|76116002|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
42352624|NCT01508169|76192622|FG001|Overall Study|Adverse Event|0|||
42352625|NCT01508169|76192621|FG000|Overall Study|Withdrawal by Subject|1|||
42352626|NCT01508169|76192622|FG001|Overall Study|Withdrawal by Subject|0|||
42352627|NCT01508169|76192621|FG000|Overall Study|Lost to Follow-up|1|||
42352628|NCT01508169|76192622|FG001|Overall Study|Lost to Follow-up|2|||
42284064|NCT02595723|76116003|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
42352629|NCT01536171|76192634|FG000|Overall Study|Withdrawal by Subject|1|||
42352630|NCT01536093|76192641|FG000|Overall Study|Death|1|||
42352631|NCT01536093|76192642|FG001|Overall Study|Death|2|||
42040749|NCT01796171|75848714|FG008|Follow-up Period|Sponsor Decision|0|||
42284065|NCT01667679|76116013|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
42284066|NCT01667679|76116014|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
42284067|NCT01667679|76116013|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
42284068|NCT01667679|76116014|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
42284069|NCT01667679|76116013|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
42284070|NCT01667679|76116014|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
42284071|NCT01667679|76116013|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
42284072|NCT01667679|76116014|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
42284073|NCT01667679|76116013|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
42284074|NCT01667679|76116014|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
42284075|NCT01667679|76116013|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
42284076|NCT01667679|76116014|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
42284077|NCT01667679|76116013|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
42284078|NCT01667679|76116014|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
42284079|NCT01667679|76116013|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
42284080|NCT01667679|76116014|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
42284081|NCT01667679|76116013|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
42284082|NCT01667679|76116014|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
42284083|NCT01667679|76116013|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
42284084|NCT01667679|76116014|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
42284085|NCT01667679|76116013|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
42284086|NCT01667679|76116014|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
42284087|NCT01667679|76116013|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
42284088|NCT01667679|76116014|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
42284089|NCT01667679|76116013|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
42284090|NCT01667679|76116014|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
42284091|NCT01667679|76116013|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
42284092|NCT01667679|76116014|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
42284093|NCT01667679|76116013|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
42284094|NCT01667679|76116014|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
42284095|NCT01667679|76116013|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
42284096|NCT01667679|76116014|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
42284097|NCT01667679|76116013|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
42284098|NCT01667679|76116014|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
42284099|NCT01667679|76116013|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
42284100|NCT01667679|76116014|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
42284101|NCT01667679|76116013|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
42284102|NCT01667679|76116014|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
42284103|NCT01667679|76116013|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
42284104|NCT01667679|76116014|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
42284105|NCT01667679|76116013|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
42284106|NCT01667679|76116014|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
42284107|NCT02597049|76116025|FG000|Overall Study|Lost to Follow-up|0|||
42284108|NCT02597049|76116026|FG001|Overall Study|Lost to Follow-up|3|||
42284109|NCT02597049|76116027|FG002|Overall Study|Lost to Follow-up|2|||
42284110|NCT02597049|76116025|FG000|Overall Study|Withdrawal by Subject|2|||
42284111|NCT02597049|76116026|FG001|Overall Study|Withdrawal by Subject|2|||
42284112|NCT02597049|76116027|FG002|Overall Study|Withdrawal by Subject|1|||
42284113|NCT02597049|76116025|FG000|Overall Study|Adverse Event|2|||
42284114|NCT02597049|76116026|FG001|Overall Study|Adverse Event|0|||
42284115|NCT02597049|76116027|FG002|Overall Study|Adverse Event|0|||
42284116|NCT02597049|76116025|FG000|Overall Study|Death|2|||
42284117|NCT02597049|76116026|FG001|Overall Study|Death|0|||
42284118|NCT02597049|76116027|FG002|Overall Study|Death|0|||
42284119|NCT02597049|76116025|FG000|Overall Study|Noncompliant with Study Visits|1|||
42284120|NCT02597049|76116026|FG001|Overall Study|Noncompliant with Study Visits|0|||
42284121|NCT02597049|76116027|FG002|Overall Study|Noncompliant with Study Visits|0|||
42284122|NCT02594163|76116037|FG000|Treatment Period|Progressive disease|2|||
42284123|NCT02594163|76116038|FG001|Treatment Period|Progressive disease|3|||
42284124|NCT02594163|76116037|FG000|Treatment Period|Adverse Event|1|||
42284125|NCT02594163|76116038|FG001|Treatment Period|Adverse Event|5|||
42284126|NCT02594163|76116037|FG000|Treatment Period|Physician Decision|1|||
42284127|NCT02594163|76116038|FG001|Treatment Period|Physician Decision|3|||
42284128|NCT02594163|76116037|FG000|Treatment Period|Study termination by sponsor|2|||
42284129|NCT02594163|76116038|FG001|Treatment Period|Study termination by sponsor|1|||
42284130|NCT02594163|76116037|FG000|Treatment Period|Other, Non-AE|1|||
42284131|NCT02594163|76116038|FG001|Treatment Period|Other, Non-AE|0|||
42284132|NCT02594163|76116037|FG000|Follow-up Period|Withdrawal by Subject|0|||
42284133|NCT02594163|76116038|FG001|Follow-up Period|Withdrawal by Subject|1|||
42284134|NCT02594163|76116037|FG000|Follow-up Period|Study Termination by Sponsor|6|||
42284135|NCT02594163|76116038|FG001|Follow-up Period|Study Termination by Sponsor|4|||
42284136|NCT02594163|76116037|FG000|Follow-up Period|Lost to Follow-up|1|||
42284137|NCT02594163|76116038|FG001|Follow-up Period|Lost to Follow-up|0|||
42171428|NCT00077610|75978271|FG001|Overall Study|Relocation|8|||
42171429|NCT00077610|75978272|FG002|Overall Study|Relocation|5|||
42171430|NCT00077610|75978270|FG000|Overall Study|Financial issues|0|||
42284138|NCT02594163|76116037|FG000|Follow-up Period|Death|2|||
42284139|NCT02594163|76116038|FG001|Follow-up Period|Death|5|||
42284140|NCT02594163|76116037|FG000|Follow-up Period|Adverse Event|0|||
42284141|NCT02594163|76116038|FG001|Follow-up Period|Adverse Event|1|||
42284142|NCT02594163|76116037|FG000|Follow-up Period|Progressive Disease|2|||
42284143|NCT02594163|76116038|FG001|Follow-up Period|Progressive Disease|0|||
42284144|NCT02594163|76116037|FG000|Follow-up Period|Physician Decision|0|||
42284145|NCT02594163|76116038|FG001|Follow-up Period|Physician Decision|1|||
42284146|NCT02712983|76116053|FG000|Treatment Phase|Adverse Event|3|||
42284147|NCT02712983|76116054|FG001|Treatment Phase|Adverse Event|1|||
42284148|NCT02712983|76116055|FG002|Treatment Phase|Adverse Event|1|||
42284149|NCT02712983|76116056|FG003|Treatment Phase|Adverse Event|4|||
42284150|NCT02712983|76116057|FG004|Treatment Phase|Adverse Event|3|||
42284151|NCT02712983|76116058|FG005|Treatment Phase|Adverse Event|0|||
42284152|NCT02712983|76116059|FG006|Treatment Phase|Adverse Event|6|||
42284153|NCT02712983|76116060|FG007|Treatment Phase|Adverse Event|6|||
42284154|NCT02712983|76116061|FG008|Treatment Phase|Adverse Event|1|||
42284155|NCT02712983|76116053|FG000|Treatment Phase|Protocol Deviation|0|||
42284156|NCT02712983|76116054|FG001|Treatment Phase|Protocol Deviation|0|||
42284157|NCT02712983|76116055|FG002|Treatment Phase|Protocol Deviation|0|||
42284158|NCT02712983|76116056|FG003|Treatment Phase|Protocol Deviation|2|||
42284159|NCT02712983|76116057|FG004|Treatment Phase|Protocol Deviation|0|||
42284160|NCT02712983|76116058|FG005|Treatment Phase|Protocol Deviation|0|||
42284161|NCT02712983|76116059|FG006|Treatment Phase|Protocol Deviation|1|||
42284162|NCT02712983|76116060|FG007|Treatment Phase|Protocol Deviation|0|||
42284163|NCT02712983|76116061|FG008|Treatment Phase|Protocol Deviation|0|||
42284164|NCT02712983|76116053|FG000|Treatment Phase|Technical Problems|0|||
42284165|NCT02712983|76116054|FG001|Treatment Phase|Technical Problems|0|||
42284166|NCT02712983|76116055|FG002|Treatment Phase|Technical Problems|0|||
42284167|NCT02712983|76116056|FG003|Treatment Phase|Technical Problems|0|||
42284168|NCT02712983|76116057|FG004|Treatment Phase|Technical Problems|0|||
42284169|NCT02712983|76116058|FG005|Treatment Phase|Technical Problems|0|||
42284170|NCT02712983|76116059|FG006|Treatment Phase|Technical Problems|1|||
42284171|NCT02712983|76116060|FG007|Treatment Phase|Technical Problems|0|||
42284172|NCT02712983|76116061|FG008|Treatment Phase|Technical Problems|0|||
42284173|NCT02712983|76116053|FG000|Treatment Phase|Physician Decision|0|||
42284174|NCT02712983|76116054|FG001|Treatment Phase|Physician Decision|0|||
42284175|NCT02712983|76116055|FG002|Treatment Phase|Physician Decision|0|||
42284176|NCT02712983|76116056|FG003|Treatment Phase|Physician Decision|0|||
42014823|NCT00955357|75821962|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
42014824|NCT00955357|75821961|FG000|Titration Phase|Study medication not tolerated|0|||
42171431|NCT00077610|75978271|FG001|Overall Study|Financial issues|1|||
42171432|NCT00077610|75978272|FG002|Overall Study|Financial issues|0|||
42171433|NCT00077610|75978270|FG000|Overall Study|Sponsors decision to withdraw|0|||
42171434|NCT00077610|75978271|FG001|Overall Study|Sponsors decision to withdraw|0|||
42171435|NCT00077610|75978272|FG002|Overall Study|Sponsors decision to withdraw|1|||
42171436|NCT03385564|75978289|FG000|Overall Study|Adverse Event|0|||
42171437|NCT03385564|75978290|FG001|Overall Study|Adverse Event|0|||
42171438|NCT03385564|75978291|FG002|Overall Study|Adverse Event|3|||
42171439|NCT03385564|75978292|FG003|Overall Study|Adverse Event|3|||
42171440|NCT03385564|75978289|FG000|Overall Study|Other than listed|0|||
42171441|NCT03385564|75978290|FG001|Overall Study|Other than listed|0|||
42171442|NCT03385564|75978291|FG002|Overall Study|Other than listed|0|||
42171443|NCT03385564|75978292|FG003|Overall Study|Other than listed|5|||
42171444|NCT03385564|75978289|FG000|Overall Study|Withdrawal by Subject|0|||
42014825|NCT00955357|75821962|FG001|Titration Phase|Study medication not tolerated|1|||
42171445|NCT03385564|75978290|FG001|Overall Study|Withdrawal by Subject|1|||
42171446|NCT03385564|75978291|FG002|Overall Study|Withdrawal by Subject|1|||
42171447|NCT03385564|75978292|FG003|Overall Study|Withdrawal by Subject|0|||
42171448|NCT03385564|75978289|FG000|Overall Study|Lack of Efficacy|0|||
42284177|NCT02712983|76116057|FG004|Treatment Phase|Physician Decision|0|||
42284178|NCT02712983|76116058|FG005|Treatment Phase|Physician Decision|0|||
42284179|NCT02712983|76116059|FG006|Treatment Phase|Physician Decision|0|||
42284180|NCT02712983|76116060|FG007|Treatment Phase|Physician Decision|1|||
42284181|NCT02712983|76116061|FG008|Treatment Phase|Physician Decision|1|||
42284182|NCT02712983|76116053|FG000|Treatment Phase|Subject Decision|2|||
42040750|NCT01796171|75848715|FG009|Follow-up Period|Sponsor Decision|0|||
42284183|NCT02712983|76116054|FG001|Treatment Phase|Subject Decision|0|||
42171449|NCT03385564|75978290|FG001|Overall Study|Lack of Efficacy|0|||
42284184|NCT02712983|76116055|FG002|Treatment Phase|Subject Decision|0|||
42284185|NCT02712983|76116056|FG003|Treatment Phase|Subject Decision|2|||
42284186|NCT02712983|76116057|FG004|Treatment Phase|Subject Decision|1|||
42284187|NCT02712983|76116058|FG005|Treatment Phase|Subject Decision|0|||
42284188|NCT02712983|76116059|FG006|Treatment Phase|Subject Decision|1|||
42284189|NCT02712983|76116060|FG007|Treatment Phase|Subject Decision|2|||
42284190|NCT02712983|76116061|FG008|Treatment Phase|Subject Decision|0|||
42284191|NCT02712983|76116053|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
42284192|NCT02712983|76116054|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
42284193|NCT02712983|76116055|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
42284194|NCT02712983|76116056|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
42284195|NCT02712983|76116057|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
42284196|NCT02712983|76116058|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
42284197|NCT02712983|76116059|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
42284198|NCT02712983|76116060|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
42284199|NCT02712983|76116061|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
42284200|NCT02712983|76116053|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
42284201|NCT02712983|76116054|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
42284202|NCT02712983|76116055|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
42284203|NCT02712983|76116056|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
42284204|NCT02712983|76116057|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
42284205|NCT02712983|76116058|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
42284206|NCT02712983|76116059|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
42284207|NCT02712983|76116060|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
42284208|NCT02712983|76116061|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
42284209|NCT02712983|76116053|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
42284210|NCT02712983|76116054|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
42284211|NCT02712983|76116055|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
42284212|NCT02712983|76116056|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
42284213|NCT02712983|76116057|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
42284214|NCT02712983|76116058|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
42284215|NCT02712983|76116059|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
42284216|NCT02712983|76116060|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
42284217|NCT02712983|76116061|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
42284218|NCT02596971|76116084|FG000|Overall Study|Death|5|||
42284219|NCT02596971|76116085|FG001|Overall Study|Death|1|||
42284220|NCT02596971|76116086|FG002|Overall Study|Death|5|||
42284221|NCT02596971|76116084|FG000|Overall Study|Withdrawal by Subject|5|||
42284222|NCT02596971|76116085|FG001|Overall Study|Withdrawal by Subject|1|||
42284223|NCT02596971|76116086|FG002|Overall Study|Withdrawal by Subject|4|||
42284224|NCT02593773|76116097|FG000|Overall Study|Voluntary Withdrawal|3|||
42284225|NCT02593773|76116097|FG000|Overall Study|Study Terminated by Sponsor|31|||
42284226|NCT02593773|76116097|FG000|Overall Study|Death|1|||
42284227|NCT02593539|76116101|FG000|Overall Study|Adverse Event|1|||
42284228|NCT00919763|76116110|FG000|Overall Study|Adverse Event|7|||
42284229|NCT00919763|76116111|FG001|Overall Study|Adverse Event|1|||
42284230|NCT00919763|76116110|FG000|Overall Study|Lost to Follow-up|1|||
42284231|NCT00919763|76116111|FG001|Overall Study|Lost to Follow-up|0|||
42284232|NCT00919763|76116110|FG000|Overall Study|Protocol Violation|1|||
42284233|NCT00919763|76116111|FG001|Overall Study|Protocol Violation|1|||
42284234|NCT00919763|76116110|FG000|Overall Study|Withdrawal by Subject|3|||
42284235|NCT00919763|76116111|FG001|Overall Study|Withdrawal by Subject|1|||
42284236|NCT00919763|76116110|FG000|Overall Study|Non-compliance|0|||
42284237|NCT00919763|76116111|FG001|Overall Study|Non-compliance|1|||
42284238|NCT02593305|76116129|FG000|Post 1|Comparison only group. No intervention.|0|||
42284239|NCT02593305|76116130|FG001|Post 1|Comparison only group. No intervention.|0|||
42284240|NCT02593305|76116131|FG002|Post 1|Comparison only group. No intervention.|10|||
42284241|NCT02593149|76116142|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
42284242|NCT02593149|76116143|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
42284243|NCT02593149|76116142|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
42284244|NCT02593149|76116143|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
42284245|NCT02177812|76116158|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
42284246|NCT02177812|76116159|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
42352632|NCT01536093|76192641|FG000|Overall Study|absence of maternal colostrum|2|||
42352633|NCT01536093|76192642|FG001|Overall Study|absence of maternal colostrum|0|||
42284247|NCT02177812|76116160|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
42352634|NCT01536093|76192641|FG000|Overall Study|Withdrawal by Subject|0|||
42284248|NCT02177812|76116161|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
42284249|NCT02177812|76116162|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
42284250|NCT02177812|76116163|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
42284251|NCT02177812|76116164|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
42352635|NCT01536093|76192642|FG001|Overall Study|Withdrawal by Subject|1|||
42040751|NCT01796171|75848716|FG010|Follow-up Period|Sponsor Decision|40|||
42284252|NCT02177812|76116165|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
42284253|NCT02177812|76116166|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
42284254|NCT02177812|76116158|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
42284255|NCT02177812|76116159|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
42284256|NCT02177812|76116160|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
42284257|NCT02177812|76116161|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
42284258|NCT02177812|76116162|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
42284259|NCT02177812|76116163|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
42284260|NCT02177812|76116164|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
42284261|NCT02177812|76116165|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
42284262|NCT02177812|76116166|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
42284263|NCT02177812|76116158|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
42284264|NCT02177812|76116159|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
42284265|NCT02177812|76116160|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
42284266|NCT02177812|76116161|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
42284267|NCT02177812|76116162|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
42284268|NCT02177812|76116163|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
42284269|NCT02177812|76116164|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
42284270|NCT02177812|76116165|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
42284271|NCT02177812|76116166|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
42284272|NCT01626352|76116210|FG000|Overall Study|Disease Progression|3|||
42284273|NCT01626352|76116210|FG000|Overall Study|Intercurrent Illness|2|||
42284274|NCT01626352|76116210|FG000|Overall Study|Death|2|||
42284275|NCT01626352|76116210|FG000|Overall Study|Withdrawal by Subject|1|||
42284276|NCT01626352|76116210|FG000|Overall Study|Non-Compliance|1|||
42284277|NCT01626352|76116210|FG000|Overall Study|Never Treated|1|||
42284278|NCT01626118|76116221|FG000|Overall Study|Lack of Efficacy|1|||
42284279|NCT01626118|76116222|FG001|Overall Study|Lack of Efficacy|0|||
42284280|NCT01626118|76116223|FG002|Overall Study|Lack of Efficacy|1|||
42284281|NCT01626118|76116224|FG003|Overall Study|Lack of Efficacy|3|||
42284282|NCT01626118|76116221|FG000|Overall Study|Lost to Follow-up|1|||
42284283|NCT01626118|76116222|FG001|Overall Study|Lost to Follow-up|0|||
42284284|NCT01626118|76116223|FG002|Overall Study|Lost to Follow-up|0|||
42284285|NCT01626118|76116224|FG003|Overall Study|Lost to Follow-up|0|||
42284286|NCT01626118|76116221|FG000|Overall Study|Adverse Event|0|||
42284287|NCT01626118|76116222|FG001|Overall Study|Adverse Event|1|||
42284288|NCT01626118|76116223|FG002|Overall Study|Adverse Event|1|||
42284289|NCT01626118|76116224|FG003|Overall Study|Adverse Event|0|||
42284290|NCT01626118|76116221|FG000|Overall Study|Investigator Decision|0|||
42284291|NCT01626118|76116222|FG001|Overall Study|Investigator Decision|1|||
42284292|NCT01626118|76116223|FG002|Overall Study|Investigator Decision|0|||
42284293|NCT01626118|76116224|FG003|Overall Study|Investigator Decision|0|||
42284294|NCT02152384|76116234|FG000|Period 1|Withdrawal by Subject|0|||
42284295|NCT02152384|76116235|FG001|Period 1|Withdrawal by Subject|1|||
42284296|NCT02152384|76116234|FG000|Period 1|Adverse Event|1|||
42284297|NCT02152384|76116235|FG001|Period 1|Adverse Event|1|||
42284298|NCT02177266|76116247|FG000|Overall Study|Adverse Event|0|||
42284299|NCT02177266|76116248|FG001|Overall Study|Adverse Event|1|||
42284300|NCT02177266|76116247|FG000|Overall Study|Withdrawal by Subject|1|||
42284301|NCT02177266|76116248|FG001|Overall Study|Withdrawal by Subject|0|||
42284302|NCT02177032|76116258|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
42284303|NCT02177032|76116259|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
42284304|NCT02177032|76116260|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
42284305|NCT02177032|76116261|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
42284306|NCT02177032|76116258|FG000|Overall Study|Lost to Follow-up|0|||
42284307|NCT02177032|76116259|FG001|Overall Study|Lost to Follow-up|2|||
42284308|NCT02177032|76116260|FG002|Overall Study|Lost to Follow-up|0|||
42284309|NCT02177032|76116261|FG003|Overall Study|Lost to Follow-up|0|||
42284310|NCT02177032|76116258|FG000|Overall Study|OTHER|2|||
42284311|NCT02177032|76116259|FG001|Overall Study|OTHER|0|||
42284312|NCT02177032|76116260|FG002|Overall Study|OTHER|1|||
42284313|NCT02177032|76116261|FG003|Overall Study|OTHER|0|||
42284314|NCT02177032|76116258|FG000|Overall Study|Withdrawal by Subject|1|||
42284315|NCT02177032|76116259|FG001|Overall Study|Withdrawal by Subject|0|||
42284316|NCT02177032|76116260|FG002|Overall Study|Withdrawal by Subject|1|||
42284317|NCT02177032|76116261|FG003|Overall Study|Withdrawal by Subject|0|||
42284318|NCT02176642|76116284|FG000|Overall Study|Withdrawal by Subject|0|||
42284319|NCT02176642|76116285|FG001|Overall Study|Withdrawal by Subject|1|||
42284320|NCT02116660|76116293|FG000|Overall Study|Deteriorating renal function|0|||
42284321|NCT02116660|76116294|FG001|Overall Study|Deteriorating renal function|1|||
42284322|NCT02116660|76116293|FG000|Overall Study|Adverse Event|1|||
42284323|NCT02116660|76116294|FG001|Overall Study|Adverse Event|1|||
42284324|NCT02116660|76116293|FG000|Overall Study|Withdrawal by Subject|0|||
42284325|NCT02116660|76116294|FG001|Overall Study|Withdrawal by Subject|2|||
42284326|NCT02116660|76116293|FG000|Overall Study|Organization reason|1|||
42284327|NCT02116660|76116294|FG001|Overall Study|Organization reason|0|||
42284328|NCT02589405|76116302|FG000|Overall Study|Adverse Event|3|||
42284329|NCT02589405|76116302|FG000|Overall Study|Withdrawal by Subject|1|||
42284330|NCT02176018|76116308|FG000|Overall Study|Adverse Event|0|||
42284331|NCT02176018|76116309|FG001|Overall Study|Adverse Event|2|||
42284332|NCT02176018|76116308|FG000|Overall Study|Lost to Follow-up|3|||
42284333|NCT02176018|76116309|FG001|Overall Study|Lost to Follow-up|1|||
42284334|NCT02176018|76116308|FG000|Overall Study|Protocol Violation|1|||
42171450|NCT03385564|75978291|FG002|Overall Study|Lack of Efficacy|0|||
42171451|NCT03385564|75978292|FG003|Overall Study|Lack of Efficacy|1|||
42171452|NCT03385564|75978289|FG000|Overall Study|Death|0|||
42171453|NCT03385564|75978290|FG001|Overall Study|Death|0|||
42171454|NCT03385564|75978291|FG002|Overall Study|Death|1|||
42171455|NCT03385564|75978292|FG003|Overall Study|Death|0|||
42171456|NCT00066222|75978302|FG000|Overall Study|No protocol treatment received|1|||
42171457|NCT00397943|75978311|FG000|Overall Study|Unspecified reasons|12|||
42171458|NCT00397943|75978312|FG001|Overall Study|Unspecified reasons|9|||
42284335|NCT02176018|76116309|FG001|Overall Study|Protocol Violation|1|||
42284336|NCT02176018|76116308|FG000|Overall Study|Withdrawal by Subject|1|||
42284337|NCT02176018|76116309|FG001|Overall Study|Withdrawal by Subject|2|||
42284338|NCT02116582|76116315|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
42284339|NCT02116582|76116315|FG000|Overall Study|Adverse Event|22|||
42284340|NCT02116582|76116315|FG000|Overall Study|Death|9|||
42284341|NCT02116582|76116315|FG000|Overall Study|Progressive Disease|148|||
42284342|NCT02116582|76116315|FG000|Overall Study|Protocol Violation|3|||
42284343|NCT02116582|76116315|FG000|Overall Study|Withdrawal by Subject|8|||
42284344|NCT02116582|76116315|FG000|Overall Study|Other: Miscellaneous|11|||
42284345|NCT02116582|76116315|FG000|Overall Study|Lost to Follow-up|1|||
42284346|NCT02116582|76116315|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
42284347|NCT02589639|76116322|FG000|Overall Study|Lost to Follow-up|1|||
42284348|NCT02589639|76116323|FG001|Overall Study|Lost to Follow-up|0|||
42284349|NCT02589639|76116324|FG002|Overall Study|Lost to Follow-up|0|||
42171459|NCT00397943|75978313|FG002|Overall Study|Unspecified reasons|0|||
42171460|NCT00397943|75978314|FG003|Overall Study|Unspecified reasons|0|||
42284350|NCT02589639|76116322|FG000|Overall Study|Protocol Violation|1|||
42284351|NCT02589639|76116323|FG001|Overall Study|Protocol Violation|0|||
42284352|NCT02589639|76116324|FG002|Overall Study|Protocol Violation|0|||
42284353|NCT02589639|76116322|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
42284354|NCT02589639|76116323|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
42284355|NCT02589639|76116324|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
42284356|NCT02589639|76116322|FG000|Overall Study|Adverse Event|4|||
42284357|NCT02589639|76116323|FG001|Overall Study|Adverse Event|5|||
42352636|NCT01536015|76192650|FG000|Overall Study|Adverse Event|1|||
42171461|NCT00397943|75978315|FG004|Overall Study|Unspecified reasons|0|||
42171462|NCT00066066|75978330|FG000|Overall Study|Lost to Follow-up|6|||
42284358|NCT02589639|76116324|FG002|Overall Study|Adverse Event|3|||
42284359|NCT02589639|76116322|FG000|Overall Study|Other reason than specified above|1|||
42284360|NCT02589639|76116323|FG001|Overall Study|Other reason than specified above|2|||
42284361|NCT02589639|76116324|FG002|Overall Study|Other reason than specified above|1|||
42284362|NCT02589639|76116322|FG000|Overall Study|Not Treated|0|||
42284363|NCT02589639|76116323|FG001|Overall Study|Not Treated|3|||
42284364|NCT02589639|76116324|FG002|Overall Study|Not Treated|0|||
42284365|NCT02151682|76116334|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
42284366|NCT02151682|76116335|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
42171463|NCT00066066|75978331|FG001|Overall Study|Lost to Follow-up|4|||
42171464|NCT00066066|75978332|FG002|Overall Study|Lost to Follow-up|7|||
42284367|NCT02151682|76116336|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
42284368|NCT02151682|76116337|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
42284369|NCT02151682|76116338|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
42284370|NCT02151682|76116339|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
42284371|NCT02151682|76116334|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
42284372|NCT02151682|76116335|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
42284373|NCT02151682|76116336|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
42284374|NCT02151682|76116337|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
42284375|NCT02151682|76116338|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
42284376|NCT02151682|76116339|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
42171465|NCT00066066|75978333|FG003|Overall Study|Lost to Follow-up|4|||
42284377|NCT02151682|76116334|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
42284378|NCT02151682|76116335|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
42284379|NCT02151682|76116336|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
42284380|NCT02151682|76116337|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
42284381|NCT02151682|76116338|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
42284382|NCT02151682|76116339|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
42284383|NCT02151682|76116334|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
42284384|NCT02151682|76116335|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
42284385|NCT02151682|76116336|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
42284386|NCT02151682|76116337|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
42284387|NCT02151682|76116338|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
42284388|NCT02151682|76116339|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
42284389|NCT02151682|76116334|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
42284390|NCT02151682|76116335|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
42284391|NCT02151682|76116336|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
42284392|NCT02151682|76116337|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
42284393|NCT02151682|76116338|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
42284394|NCT02151682|76116339|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
42014826|NCT00955357|75821961|FG000|Titration Phase|Non compliance to study procedures|0|||
42014827|NCT00955357|75821962|FG001|Titration Phase|Non compliance to study procedures|1|||
42014828|NCT00955357|75821961|FG000|Maintenance Phase|Adverse Event|3|||
42014829|NCT00955357|75821962|FG001|Maintenance Phase|Adverse Event|23|||
42014830|NCT00955357|75821961|FG000|Maintenance Phase|Lack of Efficacy|0|||
42171466|NCT00066066|75978334|FG004|Overall Study|Lost to Follow-up|3|||
42171467|NCT00066066|75978335|FG005|Overall Study|Lost to Follow-up|5|||
42171468|NCT00363467|75978349|FG000|Overall Study|Physician Decision|1|||
42171469|NCT00397631|75978355|FG000|Overall Study|Adverse Event|5|||
42171470|NCT00397631|75978356|FG001|Overall Study|Adverse Event|6|||
42171471|NCT00397631|75978355|FG000|Overall Study|Lack of Efficacy|7|||
42171472|NCT00397631|75978356|FG001|Overall Study|Lack of Efficacy|10|||
42171473|NCT00397631|75978355|FG000|Overall Study|Lost to Follow-up|8|||
42171474|NCT00397631|75978356|FG001|Overall Study|Lost to Follow-up|9|||
42171475|NCT00397631|75978355|FG000|Overall Study|Physician Decision|2|||
42171476|NCT00397631|75978356|FG001|Overall Study|Physician Decision|0|||
42171477|NCT00397631|75978355|FG000|Overall Study|Protocol Violation|0|||
42171478|NCT00397631|75978356|FG001|Overall Study|Protocol Violation|1|||
42171479|NCT00397631|75978355|FG000|Overall Study|Withdrawal by Subject|7|||
42171480|NCT00397631|75978356|FG001|Overall Study|Withdrawal by Subject|14|||
42171481|NCT00397631|75978355|FG000|Overall Study|protocol discontinuation criteria|1|||
42171482|NCT00397631|75978356|FG001|Overall Study|protocol discontinuation criteria|4|||
42171483|NCT00077376|75978362|FG000|Overall Study|Adverse Event|8|||
42171484|NCT00077376|75978362|FG000|Overall Study|Withdrawal by Subject|2|||
42171485|NCT00077376|75978362|FG000|Overall Study|Death|1|||
42171486|NCT00077376|75978362|FG000|Overall Study|Physician Decision|1|||
42171487|NCT00077376|75978362|FG000|Overall Study|Alternative therapy|5|||
42171488|NCT00077376|75978362|FG000|Overall Study|Complicating disease|1|||
42171489|NCT00077376|75978362|FG000|Overall Study|Still on treatment|1|||
42171490|NCT00077376|75978362|FG000|Overall Study|Symptomatic deterioration|1|||
42171491|NCT00077376|75978362|FG000|Overall Study|Surgery|1|||
42284395|NCT02151682|76116334|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
42284396|NCT02151682|76116335|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
42284397|NCT02151682|76116336|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
42171492|NCT00077376|75978362|FG000|Overall Study|Insurance ran out|1|||
42171493|NCT00363311|75978368|FG000|Overall Study|Adverse Event|6|||
42171494|NCT00363311|75978369|FG001|Overall Study|Adverse Event|4|||
42171495|NCT00363311|75978368|FG000|Overall Study|Lost to Follow-up|3|||
42171496|NCT00363311|75978369|FG001|Overall Study|Lost to Follow-up|0|||
42171497|NCT00363311|75978368|FG000|Overall Study|Protocol Violation|1|||
42171498|NCT00363311|75978369|FG001|Overall Study|Protocol Violation|2|||
42171499|NCT00363311|75978368|FG000|Overall Study|Withdrawal by Subject|12|||
42171500|NCT00363311|75978369|FG001|Overall Study|Withdrawal by Subject|6|||
42171501|NCT00363311|75978368|FG000|Overall Study|Physician Decision|1|||
42171502|NCT00363311|75978369|FG001|Overall Study|Physician Decision|1|||
42171503|NCT00363311|75978368|FG000|Overall Study|Sponsor Terminated Study|2|||
42284398|NCT02151682|76116337|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
42284399|NCT02151682|76116338|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
42284400|NCT02151682|76116339|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
42284401|NCT02151682|76116334|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
42284402|NCT02151682|76116335|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
42284403|NCT02151682|76116336|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
42284404|NCT02151682|76116337|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
42284405|NCT02151682|76116338|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
42284406|NCT02151682|76116339|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
42284407|NCT02151682|76116334|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
42284408|NCT02151682|76116335|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
42284409|NCT02151682|76116336|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
42284410|NCT02151682|76116337|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
42284411|NCT02151682|76116338|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
42284412|NCT02151682|76116339|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
42284413|NCT02151682|76116334|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
42284414|NCT02151682|76116335|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
42284415|NCT02151682|76116336|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
42284416|NCT02151682|76116337|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
42284417|NCT02151682|76116338|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
42284418|NCT02151682|76116339|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
42284419|NCT02151682|76116334|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
42284420|NCT02151682|76116335|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
42284421|NCT02151682|76116336|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
42284422|NCT02151682|76116337|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
42284423|NCT02151682|76116338|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
42284424|NCT02151682|76116339|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
42284425|NCT02151682|76116334|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
42040752|NCT01796171|75848717|FG011|Follow-up Period|Sponsor Decision|15|||
42040753|NCT01796171|75848718|FG012|Follow-up Period|Sponsor Decision|7|||
42040754|NCT01796171|75848719|FG013|Follow-up Period|Sponsor Decision|0|||
42040755|NCT01796171|75848720|FG014|Follow-up Period|Sponsor Decision|0|||
42040756|NCT01620944|75848753|FG000|Overall Study|Early termination of Study|2|||
42040757|NCT01620944|75848754|FG001|Overall Study|Early termination of Study|1|||
42040758|NCT01522976|75848763|FG000|Overall Study|Ineligible|4|||
42040759|NCT01522976|75848764|FG001|Overall Study|Ineligible|0|||
42040760|NCT01522976|75848765|FG002|Overall Study|Ineligible|1|||
42040761|NCT01522976|75848763|FG000|Overall Study|Death|7|||
42171504|NCT00363311|75978369|FG001|Overall Study|Sponsor Terminated Study|2|||
42171505|NCT00363311|75978368|FG000|Overall Study|Disease Progression|46|||
42284426|NCT02151682|76116335|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
42284427|NCT02151682|76116336|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
42014831|NCT00955357|75821962|FG001|Maintenance Phase|Lack of Efficacy|4|||
42014832|NCT00955357|75821961|FG000|Maintenance Phase|Protocol Violation|2|||
42014833|NCT00955357|75821962|FG001|Maintenance Phase|Protocol Violation|6|||
42014834|NCT00955357|75821961|FG000|Maintenance Phase|Lost to Follow-up|2|||
42014835|NCT00955357|75821962|FG001|Maintenance Phase|Lost to Follow-up|7|||
42014836|NCT00955357|75821961|FG000|Maintenance Phase|Withdrawal by Subject|4|||
42014837|NCT00955357|75821962|FG001|Maintenance Phase|Withdrawal by Subject|4|||
42014838|NCT00955357|75821961|FG000|Maintenance Phase|Patient moving out of area|0|||
42014839|NCT00955357|75821962|FG001|Maintenance Phase|Patient moving out of area|1|||
42014840|NCT00955357|75821961|FG000|Maintenance Phase|Non compliance to study procedures|1|||
42171506|NCT00363311|75978369|FG001|Overall Study|Disease Progression|26|||
42284428|NCT02151682|76116337|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
42284429|NCT02151682|76116338|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
42284430|NCT02151682|76116339|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
42284431|NCT02151682|76116334|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
42352637|NCT01536015|76192651|FG001|Overall Study|Adverse Event|4|||
42171507|NCT00363311|75978368|FG000|Overall Study|Non-Compliance|1|||
42014841|NCT00955357|75821962|FG001|Maintenance Phase|Non compliance to study procedures|0|||
42040762|NCT01522976|75848764|FG001|Overall Study|Death|6|||
42040763|NCT01522976|75848765|FG002|Overall Study|Death|2|||
42171508|NCT00363311|75978369|FG001|Overall Study|Non-Compliance|1|||
42284432|NCT02151682|76116335|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
42284433|NCT02151682|76116336|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
42284434|NCT02151682|76116337|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
42284435|NCT02151682|76116338|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
42284436|NCT02151682|76116339|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
42284437|NCT02151682|76116334|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
42284438|NCT02151682|76116335|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
42284439|NCT02151682|76116336|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
42284440|NCT02151682|76116337|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
42284441|NCT02151682|76116338|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
42284442|NCT02151682|76116339|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
42352638|NCT01536015|76192650|FG000|Overall Study|Lost to Follow-up|0|||
42014842|NCT00955279|75821971|FG000|Overall Study|Other|0|||
42014843|NCT00955279|75821972|FG001|Overall Study|Other|0|||
42014844|NCT00955279|75821973|FG002|Overall Study|Other|3|||
42014845|NCT00955279|75821971|FG000|Overall Study|Death|1|||
42014846|NCT00955279|75821972|FG001|Overall Study|Death|1|||
42014847|NCT00955279|75821973|FG002|Overall Study|Death|1|||
42014848|NCT00955279|75821971|FG000|Overall Study|Lost to Follow-up|0|||
42014849|NCT00955279|75821972|FG001|Overall Study|Lost to Follow-up|3|||
42014850|NCT00955279|75821973|FG002|Overall Study|Lost to Follow-up|1|||
42014851|NCT00955279|75821971|FG000|Overall Study|Withdrawal by Subject|2|||
42014852|NCT00955279|75821972|FG001|Overall Study|Withdrawal by Subject|0|||
42014853|NCT00955279|75821973|FG002|Overall Study|Withdrawal by Subject|3|||
42014854|NCT00954733|75821981|FG000|Overall Study|blood gas machine did not work|1|||
42014855|NCT00954421|75821985|FG000|Screening|screen failures|3|||
42014856|NCT00954421|75821985|FG000|6 Months of DBS|Withdrawal by Subject|1|||
42014857|NCT00954421|75821985|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
42014858|NCT01241448|75821995|FG000|Overall Study|Adverse Event|1|||
42014859|NCT01241448|75821996|FG001|Overall Study|Adverse Event|0|||
42014860|NCT01241448|75821997|FG002|Overall Study|Adverse Event|2|||
42014861|NCT01241448|75821998|FG003|Overall Study|Adverse Event|2|||
42014862|NCT01241448|75821995|FG000|Overall Study|Lost to Follow-up|2|||
42014863|NCT01241448|75821996|FG001|Overall Study|Lost to Follow-up|1|||
42014864|NCT01241448|75821997|FG002|Overall Study|Lost to Follow-up|1|||
42014865|NCT01241448|75821998|FG003|Overall Study|Lost to Follow-up|1|||
42014866|NCT01241448|75821995|FG000|Overall Study|Physician Decision|0|||
42014867|NCT01241448|75821996|FG001|Overall Study|Physician Decision|2|||
42014868|NCT01241448|75821997|FG002|Overall Study|Physician Decision|0|||
42014869|NCT01241448|75821998|FG003|Overall Study|Physician Decision|0|||
42014870|NCT01241448|75821995|FG000|Overall Study|Protocol Violation|10|||
42014871|NCT01241448|75821996|FG001|Overall Study|Protocol Violation|5|||
42014872|NCT01241448|75821997|FG002|Overall Study|Protocol Violation|3|||
42171509|NCT00363311|75978368|FG000|Overall Study|Participant Refused Biopsy|1|||
42171510|NCT00363311|75978369|FG001|Overall Study|Participant Refused Biopsy|0|||
42171511|NCT00363311|75978368|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
42171512|NCT00363311|75978369|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
42171513|NCT00363311|75978368|FG000|Overall Study|Participant Opted for Treatment|1|||
42171514|NCT00363311|75978369|FG001|Overall Study|Participant Opted for Treatment|0|||
42171515|NCT00363311|75978368|FG000|Overall Study|Participant Moved to Another Country|1|||
42171516|NCT00363311|75978369|FG001|Overall Study|Participant Moved to Another Country|0|||
42171517|NCT00363311|75978368|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
42171518|NCT00363311|75978369|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
42171519|NCT00363311|75978368|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
42171520|NCT00363311|75978369|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
42171521|NCT00363311|75978368|FG000|Overall Study|Participant Moved to Louisiana|0|||
42171522|NCT00363311|75978369|FG001|Overall Study|Participant Moved to Louisiana|1|||
42171523|NCT00362609|75978377|FG000|Overall Study|Withdrawal by Subject|0|||
42171524|NCT00362609|75978378|FG001|Overall Study|Withdrawal by Subject|1|||
42171525|NCT00362609|75978377|FG000|Overall Study|Protocol Violation|0|||
42352639|NCT01536015|76192651|FG001|Overall Study|Lost to Follow-up|1|||
42352640|NCT01536015|76192650|FG000|Overall Study|Inclusion Criterion not met|2|||
42014873|NCT01241448|75821998|FG003|Overall Study|Protocol Violation|6|||
42014874|NCT01241448|75821995|FG000|Overall Study|Sponsor Decision|17|||
42014875|NCT01241448|75821996|FG001|Overall Study|Sponsor Decision|14|||
42171526|NCT00362609|75978378|FG001|Overall Study|Protocol Violation|1|||
42284443|NCT02151682|76116334|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
42014876|NCT01241448|75821997|FG002|Overall Study|Sponsor Decision|12|||
42014877|NCT01241448|75821998|FG003|Overall Study|Sponsor Decision|6|||
42014878|NCT01241448|75821995|FG000|Overall Study|Withdrawal by Subject|4|||
42014879|NCT01241448|75821996|FG001|Overall Study|Withdrawal by Subject|5|||
42171527|NCT00362375|75978386|FG000|Overall Study|Lost to Follow-up|40|||
42171528|NCT00362375|75978387|FG001|Overall Study|Lost to Follow-up|35|||
42014880|NCT01241448|75821997|FG002|Overall Study|Withdrawal by Subject|3|||
42014881|NCT01241448|75821998|FG003|Overall Study|Withdrawal by Subject|6|||
42014882|NCT01241448|75821995|FG000|Overall Study|Excluded due to data integrity issues|3|||
42284444|NCT02151682|76116335|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
42284445|NCT02151682|76116336|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
42284446|NCT02151682|76116337|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
42284447|NCT02151682|76116338|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
42284448|NCT02151682|76116339|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
42352641|NCT01536015|76192651|FG001|Overall Study|Inclusion Criterion not met|0|||
42014883|NCT01241448|75821996|FG001|Overall Study|Excluded due to data integrity issues|2|||
42014884|NCT01241448|75821997|FG002|Overall Study|Excluded due to data integrity issues|2|||
42014885|NCT01241448|75821998|FG003|Overall Study|Excluded due to data integrity issues|2|||
42014886|NCT01240356|75822011|FG000|Overall Study|Withdrawal by Subject|2|||
42014887|NCT01240356|75822012|FG001|Overall Study|Withdrawal by Subject|0|||
42014888|NCT01240356|75822011|FG000|Overall Study|MRI contraindication|1|||
42014889|NCT01240356|75822012|FG001|Overall Study|MRI contraindication|0|||
42014890|NCT01239732|75822021|FG000|Overall Study|Termination of study per protocol|667|||
42014891|NCT01239732|75822021|FG000|Overall Study|Death|226|||
42014892|NCT01239732|75822021|FG000|Overall Study|Withdrawal by Subject|87|||
42014893|NCT01239732|75822021|FG000|Overall Study|Adverse Event|6|||
42014894|NCT01239732|75822021|FG000|Overall Study|Protocol Violation|3|||
42014895|NCT01239732|75822021|FG000|Overall Study|Participant non compliance|5|||
42014896|NCT01239732|75822021|FG000|Overall Study|Study termination by sponsor|2|||
42014897|NCT01239732|75822021|FG000|Overall Study|Investigator's decision|4|||
42014898|NCT01239732|75822021|FG000|Overall Study|Treatment failure|2|||
42014899|NCT01239732|75822021|FG000|Overall Study|Other|19|||
42014900|NCT02227147|75822027|FG000|Controlled Treatment Period|Adverse Event|4|||
42014901|NCT02227147|75822028|FG001|Controlled Treatment Period|Adverse Event|3|||
42014902|NCT02227147|75822027|FG000|Controlled Treatment Period|Other|2|||
42014903|NCT02227147|75822028|FG001|Controlled Treatment Period|Other|0|||
42014904|NCT02227147|75822027|FG000|Follow-up Period|Other|3|||
42014905|NCT02227147|75822028|FG001|Follow-up Period|Other|5|||
42014906|NCT00948025|75822040|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
42014907|NCT00948025|75822041|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
42014908|NCT00948025|75822040|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
42014909|NCT00948025|75822041|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
42014910|NCT00948025|75822040|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
42014911|NCT00948025|75822041|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
42014912|NCT00947011|75822048|FG000|Overall Study|Study was terminated,PI left institution|12|||
42014913|NCT01239342|75822056|FG000|Overall Study|Adverse Event|1|||
42014914|NCT01239342|75822057|FG001|Overall Study|Adverse Event|0|||
42014915|NCT01239342|75822056|FG000|Overall Study|Withdrawal by Subject|1|||
42014916|NCT01239342|75822057|FG001|Overall Study|Withdrawal by Subject|5|||
42014917|NCT01239342|75822056|FG000|Overall Study|Reason Unknown|1|||
42014918|NCT01239342|75822057|FG001|Overall Study|Reason Unknown|1|||
42014919|NCT00946309|75822065|FG000|Overall Study|Protocol Violation|1|||
42014920|NCT00946309|75822066|FG001|Overall Study|Protocol Violation|0|||
42014921|NCT00946309|75822065|FG000|Overall Study|Lost to Follow-up|0|||
42014922|NCT00946309|75822066|FG001|Overall Study|Lost to Follow-up|1|||
42014923|NCT00946309|75822065|FG000|Overall Study|Procedure cancelled/discontinued|0|||
42014924|NCT00946309|75822066|FG001|Overall Study|Procedure cancelled/discontinued|3|||
42014925|NCT01236534|75822075|FG000|Overall Study|Adverse Event|3|||
42014926|NCT01236534|75822076|FG001|Overall Study|Adverse Event|0|||
42014927|NCT01235598|75822084|FG000|Overall Study|Adverse Event|0|||
42014928|NCT01235598|75822085|FG001|Overall Study|Adverse Event|3|||
42014929|NCT01235598|75822084|FG000|Overall Study|Lack of Efficacy|0|||
42014930|NCT01235598|75822085|FG001|Overall Study|Lack of Efficacy|1|||
42014931|NCT01235598|75822084|FG000|Overall Study|Withdrawal by Subject|1|||
42040764|NCT01522976|75848763|FG000|Overall Study|Still on treatment|9|||
42040765|NCT01522976|75848764|FG001|Overall Study|Still on treatment|9|||
42040766|NCT01522976|75848765|FG002|Overall Study|Still on treatment|6|||
42040767|NCT01522976|75848763|FG000|Overall Study|Disease progression|28|||
42040768|NCT01522976|75848764|FG001|Overall Study|Disease progression|30|||
42040769|NCT01522976|75848765|FG002|Overall Study|Disease progression|25|||
42014932|NCT01235598|75822085|FG001|Overall Study|Withdrawal by Subject|0|||
42014933|NCT01235442|75822094|FG000|Overall Study|Lost to Follow-up|12|||
42014934|NCT01235442|75822095|FG001|Overall Study|Lost to Follow-up|10|||
42014935|NCT01235442|75822094|FG000|Overall Study|Death|0|||
42014936|NCT01235442|75822095|FG001|Overall Study|Death|2|||
42014937|NCT01235442|75822094|FG000|Overall Study|Pregnancy|1|||
42014938|NCT01235442|75822095|FG001|Overall Study|Pregnancy|1|||
42284449|NCT02151682|76116334|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
42352642|NCT01536015|76192650|FG000|Overall Study|Study closure|5|||
42014939|NCT01235442|75822094|FG000|Overall Study|Ineligibility determined|5|||
42014940|NCT01235442|75822095|FG001|Overall Study|Ineligibility determined|4|||
42040770|NCT01522976|75848763|FG000|Overall Study|Adverse Event|17|||
42040771|NCT01522976|75848764|FG001|Overall Study|Adverse Event|7|||
42014941|NCT01235442|75822094|FG000|Overall Study|Protocol Violation|3|||
42014942|NCT01235442|75822095|FG001|Overall Study|Protocol Violation|3|||
42014943|NCT01235442|75822094|FG000|Overall Study|Adverse Event|4|||
42014944|NCT01235442|75822095|FG001|Overall Study|Adverse Event|6|||
42014945|NCT01235442|75822094|FG000|Overall Study|Withdrawal by Subject|15|||
42014946|NCT01235442|75822095|FG001|Overall Study|Withdrawal by Subject|9|||
42014947|NCT01235442|75822094|FG000|Overall Study|Lack of Efficacy|1|||
42014948|NCT01235442|75822095|FG001|Overall Study|Lack of Efficacy|3|||
42014949|NCT01235442|75822094|FG000|Overall Study|Noncompliance|1|||
42014950|NCT01235442|75822095|FG001|Overall Study|Noncompliance|2|||
42014951|NCT01235442|75822094|FG000|Overall Study|Administrative decision|1|||
42014952|NCT01235442|75822095|FG001|Overall Study|Administrative decision|2|||
42014953|NCT01235442|75822094|FG000|Overall Study|Other unspecified|1|||
42014954|NCT01235442|75822095|FG001|Overall Study|Other unspecified|2|||
42014955|NCT01163253|75822103|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
42014956|NCT01163253|75822104|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
42014957|NCT01163253|75822103|FG000|Overall Study|Study Terminated by Sponsor|978|||
42014958|NCT01163253|75822104|FG001|Overall Study|Study Terminated by Sponsor|349|||
42014959|NCT01163253|75822103|FG000|Overall Study|Protocol Violation|43|||
42014960|NCT01163253|75822104|FG001|Overall Study|Protocol Violation|12|||
42014961|NCT01163253|75822103|FG000|Overall Study|Withdrawal by Subject|199|||
42014962|NCT01163253|75822104|FG001|Overall Study|Withdrawal by Subject|50|||
42014963|NCT01163253|75822103|FG000|Overall Study|Medication Error|1|||
42014964|NCT01163253|75822104|FG001|Overall Study|Medication Error|0|||
42014965|NCT01163253|75822103|FG000|Overall Study|Lost to Follow-up|125|||
42014966|NCT01163253|75822104|FG001|Overall Study|Lost to Follow-up|23|||
42014967|NCT01163253|75822103|FG000|Overall Study|Insufficient Clinical Response|423|||
42014968|NCT01163253|75822104|FG001|Overall Study|Insufficient Clinical Response|29|||
42014969|NCT01163253|75822103|FG000|Overall Study|Adverse Event|300|||
42014970|NCT01163253|75822104|FG001|Overall Study|Adverse Event|78|||
42014971|NCT01163253|75822103|FG000|Overall Study|Death|17|||
42014972|NCT01163253|75822104|FG001|Overall Study|Death|5|||
42014973|NCT01163253|75822103|FG000|Overall Study|Ongoing|13|||
42014974|NCT01163253|75822104|FG001|Overall Study|Ongoing|4|||
42014975|NCT01163253|75822103|FG000|Overall Study|Other Unspecified|170|||
42014976|NCT01163253|75822104|FG001|Overall Study|Other Unspecified|34|||
42014977|NCT01162863|75822113|FG000|Overall Study|Lack of Efficacy|1|||
42014978|NCT01162863|75822114|FG001|Overall Study|Lack of Efficacy|0|||
42014979|NCT01162863|75822115|FG002|Overall Study|Lack of Efficacy|0|||
42014980|NCT01162863|75822113|FG000|Overall Study|Adverse Event|0|||
42014981|NCT01162863|75822114|FG001|Overall Study|Adverse Event|1|||
42014982|NCT01162863|75822115|FG002|Overall Study|Adverse Event|0|||
42014983|NCT01162473|75822125|FG000|Overall Study|Adverse Event|2|||
42014984|NCT01162473|75822126|FG001|Overall Study|Adverse Event|1|||
42014985|NCT01162473|75822125|FG000|Overall Study|Withdrawal by Subject|0|||
42014986|NCT01162473|75822126|FG001|Overall Study|Withdrawal by Subject|4|||
42014987|NCT01162239|75822136|FG000|Treatment Phase|Withdrawal by Subject|1|||
42014988|NCT01162239|75822137|FG001|Treatment Phase|Withdrawal by Subject|3|||
42014989|NCT01162239|75822138|FG002|Treatment Phase|Withdrawal by Subject|2|||
42014990|NCT01162239|75822139|FG003|Treatment Phase|Withdrawal by Subject|3|||
42014991|NCT01162239|75822136|FG000|Treatment Phase|Death|0|||
42014992|NCT01162239|75822137|FG001|Treatment Phase|Death|0|||
42014993|NCT01162239|75822138|FG002|Treatment Phase|Death|0|||
42014994|NCT01162239|75822139|FG003|Treatment Phase|Death|1|||
42014995|NCT01162239|75822136|FG000|Treatment Phase|Lost to Follow-up|5|||
42014996|NCT01162239|75822137|FG001|Treatment Phase|Lost to Follow-up|4|||
42014997|NCT01162239|75822138|FG002|Treatment Phase|Lost to Follow-up|2|||
42014998|NCT01162239|75822139|FG003|Treatment Phase|Lost to Follow-up|1|||
42014999|NCT01162239|75822136|FG000|Extended Follow-up|Lost to Follow-up|8|||
42015000|NCT01162239|75822137|FG001|Extended Follow-up|Lost to Follow-up|13|||
42015001|NCT01162239|75822138|FG002|Extended Follow-up|Lost to Follow-up|8|||
42015002|NCT01162239|75822139|FG003|Extended Follow-up|Lost to Follow-up|6|||
42040772|NCT01522976|75848765|FG002|Overall Study|Adverse Event|18|||
42015003|NCT01161537|75822150|FG000|Part B|Withdrawal by Subject|2|||
42015004|NCT01234350|75822161|FG000|Overall Study|Adverse Event|277|||
42015005|NCT01234350|75822162|FG001|Overall Study|Adverse Event|92|||
42171529|NCT00362297|75978395|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
42015006|NCT01234350|75822161|FG000|Overall Study|Withdrawal by Subject|61|||
42015007|NCT01234350|75822162|FG001|Overall Study|Withdrawal by Subject|36|||
42040773|NCT01522976|75848763|FG000|Overall Study|Refusal unrelated to adverse event|10|||
42015008|NCT01234350|75822161|FG000|Overall Study|Lost to Follow-up|115|||
42015009|NCT01234350|75822162|FG001|Overall Study|Lost to Follow-up|47|||
42015010|NCT01234350|75822161|FG000|Overall Study|Covers a diverse set of reasons|234|||
42015011|NCT01234350|75822162|FG001|Overall Study|Covers a diverse set of reasons|92|||
42015012|NCT01233258|75822173|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
42015013|NCT01233258|75822174|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
42015014|NCT01233258|75822175|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
42015015|NCT01233258|75822176|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
42015016|NCT01233258|75822177|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
42015017|NCT01233258|75822178|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
42015018|NCT01233258|75822173|FG000|First Intervention (6 Months)|Protocol Violation|0|||
42015019|NCT01233258|75822174|FG001|First Intervention (6 Months)|Protocol Violation|0|||
42015020|NCT01233258|75822175|FG002|First Intervention (6 Months)|Protocol Violation|1|||
42015021|NCT01233258|75822176|FG003|First Intervention (6 Months)|Protocol Violation|0|||
42015022|NCT01233258|75822177|FG004|First Intervention (6 Months)|Protocol Violation|0|||
42015023|NCT01233258|75822178|FG005|First Intervention (6 Months)|Protocol Violation|0|||
42015024|NCT01233258|75822173|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
42015025|NCT01233258|75822174|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
42015026|NCT01233258|75822175|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
42015027|NCT01233258|75822176|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
42015028|NCT01233258|75822177|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
42171530|NCT00362297|75978396|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
42171531|NCT00065442|75978404|FG000|Overall Study|Lost to Follow-up|1|||
42171532|NCT00065442|75978405|FG001|Overall Study|Lost to Follow-up|1|||
42171533|NCT00065442|75978404|FG000|Overall Study|Death|121|||
42352643|NCT01536015|76192651|FG001|Overall Study|Study closure|5|||
42352644|NCT01484691|76192660|FG000|Overall Study|Withdrawal by Subject|1|||
42352645|NCT01484691|76192661|FG001|Overall Study|Withdrawal by Subject|1|||
42352646|NCT01484691|76192662|FG002|Overall Study|Withdrawal by Subject|1|||
42352647|NCT01484691|76192660|FG000|Overall Study|Physician Decision|0|||
42352648|NCT01484691|76192661|FG001|Overall Study|Physician Decision|2|||
42352649|NCT01484691|76192662|FG002|Overall Study|Physician Decision|1|||
42284450|NCT02151682|76116335|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
42284451|NCT02151682|76116336|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
42284452|NCT02151682|76116337|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
42284453|NCT02151682|76116338|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
42284454|NCT02151682|76116339|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
42284455|NCT02151682|76116334|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
42352650|NCT01535235|76192673|FG000|Overall Study|Adverse Event|1|||
42352651|NCT01535235|76192674|FG001|Overall Study|Adverse Event|0|||
42352652|NCT01483599|76192718|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
42352653|NCT01483599|76192719|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
42015029|NCT01233258|75822178|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
42015030|NCT01232868|75822195|FG000|Overall Study|Lost to Follow-up|2|||
42015031|NCT01232868|75822196|FG001|Overall Study|Lost to Follow-up|4|||
42171534|NCT00065442|75978405|FG001|Overall Study|Death|210|||
42284456|NCT02151682|76116335|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
42352654|NCT01483599|76192720|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
42352655|NCT01483599|76192721|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
42284457|NCT02151682|76116336|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
42284458|NCT02151682|76116337|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
42284459|NCT02151682|76116338|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
42284460|NCT02151682|76116339|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
42284461|NCT02151682|76116334|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
42284462|NCT02151682|76116335|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
42284463|NCT02151682|76116336|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
42352656|NCT01483599|76192722|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
42352657|NCT01483599|76192723|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
42352658|NCT01483599|76192724|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
42352659|NCT01483599|76192725|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
42352660|NCT01483599|76192726|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
42352661|NCT01483599|76192727|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
42352662|NCT01483599|76192728|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
42352663|NCT01483599|76192729|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
42352664|NCT01483599|76192730|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
42352665|NCT01483599|76192731|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
42352666|NCT01483599|76192718|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
42352667|NCT01483599|76192719|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
42352668|NCT01483599|76192720|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
42352669|NCT01483599|76192721|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
42015032|NCT01232790|75822202|FG000|Randomization|Withdrawal by Subject|2|||
42284464|NCT02151682|76116337|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
42284465|NCT02151682|76116338|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
42352670|NCT01483599|76192722|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
42352671|NCT01483599|76192723|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
42352672|NCT01483599|76192724|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
42352673|NCT01483599|76192725|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
42015033|NCT01232790|75822203|FG001|Randomization|Withdrawal by Subject|0|||
42284466|NCT02151682|76116339|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
42284467|NCT02151682|76116334|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
42284468|NCT02151682|76116335|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
42015034|NCT01232790|75822202|FG000|Randomization|Protocol Violation|0|||
42284469|NCT02151682|76116336|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
42284470|NCT02151682|76116337|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
42284471|NCT02151682|76116338|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
42284472|NCT02151682|76116339|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
42284473|NCT02174848|76116359|FG000|Overall Study|Adverse Event|2|||
42284474|NCT02174848|76116360|FG001|Overall Study|Adverse Event|1|||
42284475|NCT02174848|76116359|FG000|Overall Study|Withdrawal by Subject|3|||
42284476|NCT02174848|76116360|FG001|Overall Study|Withdrawal by Subject|3|||
42284477|NCT02174848|76116359|FG000|Overall Study|Lost to Follow-up|0|||
42284478|NCT02174848|76116360|FG001|Overall Study|Lost to Follow-up|1|||
42284479|NCT02174848|76116359|FG000|Overall Study|Worsening of disease|1|||
42284480|NCT02174848|76116360|FG001|Overall Study|Worsening of disease|1|||
42284481|NCT02174848|76116359|FG000|Overall Study|Unable to comply with study requirements|1|||
42284482|NCT02174848|76116360|FG001|Overall Study|Unable to comply with study requirements|0|||
42284483|NCT02151058|76116374|FG000|Overall Study|Withdrawal by Subject|1|||
42284484|NCT02151058|76116375|FG001|Overall Study|Withdrawal by Subject|1|||
42284485|NCT02151058|76116376|FG002|Overall Study|Withdrawal by Subject|3|||
42284486|NCT02151058|76116374|FG000|Overall Study|Lost to Follow-up|1|||
42284487|NCT02151058|76116375|FG001|Overall Study|Lost to Follow-up|0|||
42284488|NCT02151058|76116376|FG002|Overall Study|Lost to Follow-up|2|||
42284489|NCT02149810|76116386|FG000|Overall Study|Physician Decision|1|||
42284490|NCT02149810|76116387|FG001|Overall Study|Physician Decision|2|||
42284491|NCT02149810|76116386|FG000|Overall Study|Lost to Follow-up|2|||
42284492|NCT02149810|76116387|FG001|Overall Study|Lost to Follow-up|1|||
42284493|NCT02149810|76116386|FG000|Overall Study|Withdrawal by Subject|5|||
42284494|NCT02149810|76116387|FG001|Overall Study|Withdrawal by Subject|1|||
42284495|NCT02149420|76116396|FG000|Core Study|Administrative problems|0|||
42284496|NCT02149420|76116397|FG001|Core Study|Administrative problems|1|||
42284497|NCT02149420|76116398|FG002|Core Study|Administrative problems|2|||
42352674|NCT01483599|76192726|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
42352675|NCT01483599|76192727|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
42352676|NCT01483599|76192728|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
42352677|NCT01483599|76192729|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
42284498|NCT02149420|76116396|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
42284499|NCT02149420|76116397|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
42284500|NCT02149420|76116398|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
42284501|NCT02149264|76116411|FG000|Overall Study|Withdrawal by Subject|9|||
42352678|NCT01483599|76192730|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
42352679|NCT01483599|76192731|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
42352680|NCT01483599|76192718|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
42352681|NCT01483599|76192719|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352682|NCT01483599|76192720|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352683|NCT01483599|76192721|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352684|NCT01483599|76192722|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352685|NCT01483599|76192723|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352686|NCT01483599|76192724|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352687|NCT01483599|76192725|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352688|NCT01483599|76192726|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352689|NCT01483599|76192727|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352690|NCT01483599|76192728|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352691|NCT01483599|76192729|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352692|NCT01483599|76192730|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352693|NCT01483599|76192731|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
42352694|NCT01483599|76192718|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
42352695|NCT01483599|76192719|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
42352696|NCT01483599|76192720|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
42352697|NCT01483599|76192721|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
42352698|NCT01483599|76192722|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
42352699|NCT01483599|76192723|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
42352700|NCT01483599|76192724|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
42015035|NCT01232790|75822203|FG001|Randomization|Protocol Violation|1|||
42284502|NCT02149264|76116411|FG000|Overall Study|Adverse Event|7|||
42284503|NCT02149264|76116411|FG000|Overall Study|Physician Decision|3|||
42284504|NCT02149264|76116411|FG000|Overall Study|Protocol Violation|1|||
42284505|NCT02115256|76116417|FG000|Overall Study|Withdrawal by Subject|0|||
42284506|NCT02115256|76116418|FG001|Overall Study|Withdrawal by Subject|1|||
42284507|NCT02173054|76116427|FG000|Overall Study|lack of compliance|1|||
42284508|NCT02173054|76116428|FG001|Overall Study|lack of compliance|0|||
42284509|NCT02173054|76116429|FG002|Overall Study|lack of compliance|0|||
42284510|NCT02173054|76116427|FG000|Overall Study|Withdrawal by Subject|0|||
42284511|NCT02173054|76116428|FG001|Overall Study|Withdrawal by Subject|0|||
42284512|NCT02173054|76116429|FG002|Overall Study|Withdrawal by Subject|1|||
42284513|NCT02149108|76116474|FG000|Overall Study|Not treated|1|||
42284514|NCT02149108|76116475|FG001|Overall Study|Not treated|2|||
42284515|NCT02149108|76116474|FG000|Overall Study|Progressive Disease (PD)|324|||
42284516|NCT02149108|76116475|FG001|Overall Study|Progressive Disease (PD)|318|||
42284517|NCT02149108|76116474|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
42284518|NCT02149108|76116475|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
42284519|NCT02149108|76116474|FG000|Overall Study|Other Adverse Event (AE)|8|||
42284520|NCT02149108|76116475|FG001|Overall Study|Other Adverse Event (AE)|18|||
42284521|NCT02149108|76116474|FG000|Overall Study|Other not defined above|0|||
42284522|NCT02149108|76116475|FG001|Overall Study|Other not defined above|2|||
42284523|NCT02149108|76116474|FG000|Overall Study|Refusal to continue trial medication|15|||
42284524|NCT02149108|76116475|FG001|Overall Study|Refusal to continue trial medication|11|||
42284525|NCT02149108|76116474|FG000|Overall Study|Lost to Follow-up|1|||
42284526|NCT02149108|76116475|FG001|Overall Study|Lost to Follow-up|0|||
42284527|NCT02148952|76116483|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
42284528|NCT02148952|76116484|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
42284529|NCT02148952|76116483|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
42284530|NCT02148952|76116484|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
42284531|NCT02148952|76116483|FG000|Follow-Up|Lost to Follow-up|219|||
42284532|NCT02148952|76116484|FG001|Follow-Up|Lost to Follow-up|231|||
42284533|NCT02148952|76116483|FG000|Follow-Up|Withdrawal by Subject|46|||
42284534|NCT02148952|76116484|FG001|Follow-Up|Withdrawal by Subject|48|||
42284535|NCT02148718|76116508|FG000|Overall Study|Protocol Violation|26|||
42284536|NCT02148718|76116508|FG000|Overall Study|Discontinued Study Prematurely|5|||
42284537|NCT02148250|76116512|FG000|Screening|Withdrawal by Subject|5|||
42284538|NCT02148250|76116513|FG001|Screening|Withdrawal by Subject|0|||
42284539|NCT02147626|76116522|FG000|Overall Study|Lost to Follow-up|4|||
42284540|NCT02147626|76116523|FG001|Overall Study|Lost to Follow-up|4|||
42284541|NCT02147626|76116522|FG000|Overall Study|Pregnancy|1|||
42284542|NCT02147626|76116523|FG001|Overall Study|Pregnancy|2|||
42284543|NCT02147626|76116522|FG000|Overall Study|Withdrawal by Subject|0|||
42284544|NCT02147626|76116523|FG001|Overall Study|Withdrawal by Subject|1|||
42284545|NCT02172664|76116529|FG000|Overall Study|Lost to Follow-up|4|||
42284546|NCT02172664|76116530|FG001|Overall Study|Lost to Follow-up|4|||
42284547|NCT02172664|76116529|FG000|Overall Study|Death|1|||
42284548|NCT02172664|76116530|FG001|Overall Study|Death|1|||
42284549|NCT02172664|76116529|FG000|Overall Study|Moved out of area|1|||
42284550|NCT02172664|76116530|FG001|Overall Study|Moved out of area|1|||
42284551|NCT02172040|76116539|FG000|Overall Study|Adverse Event|0|||
42284552|NCT02172040|76116540|FG001|Overall Study|Adverse Event|2|||
42284553|NCT02172040|76116541|FG002|Overall Study|Adverse Event|0|||
42284554|NCT02172040|76116542|FG003|Overall Study|Adverse Event|0|||
42284555|NCT02172040|76116539|FG000|Overall Study|Protocol Violation|0|||
42284556|NCT02172040|76116540|FG001|Overall Study|Protocol Violation|1|||
42284557|NCT02172040|76116541|FG002|Overall Study|Protocol Violation|0|||
42284558|NCT02172040|76116542|FG003|Overall Study|Protocol Violation|0|||
42284559|NCT02172040|76116539|FG000|Overall Study|Withdrawal by Subject|0|||
42284560|NCT02172040|76116540|FG001|Overall Study|Withdrawal by Subject|0|||
42284561|NCT02172040|76116541|FG002|Overall Study|Withdrawal by Subject|1|||
42284562|NCT02172040|76116542|FG003|Overall Study|Withdrawal by Subject|0|||
42284563|NCT02172040|76116539|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
42284564|NCT02172040|76116540|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
42352701|NCT01483599|76192725|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
42352702|NCT01483599|76192726|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
42171535|NCT00065442|75978404|FG000|Overall Study|Withdrawal by Subject|3|||
42171536|NCT00065442|75978405|FG001|Overall Study|Withdrawal by Subject|9|||
42284565|NCT02172040|76116541|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
42171537|NCT00090402|75978414|FG000|Overall Study|Death|1|||
42284566|NCT02172040|76116542|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
42284567|NCT02172040|76116539|FG000|Overall Study|Family emergency abroad|0|||
42284568|NCT02172040|76116540|FG001|Overall Study|Family emergency abroad|0|||
42284569|NCT02172040|76116541|FG002|Overall Study|Family emergency abroad|0|||
42284570|NCT02172040|76116542|FG003|Overall Study|Family emergency abroad|1|||
42284571|NCT02112994|76116568|FG000|Overall Study|Progressive Disease|0|||
42284572|NCT02112994|76116569|FG001|Overall Study|Progressive Disease|0|||
42284573|NCT02112994|76116570|FG002|Overall Study|Progressive Disease|1|||
42284574|NCT02112994|76116568|FG000|Overall Study|Pregnancy|0|||
42284575|NCT02112994|76116569|FG001|Overall Study|Pregnancy|1|||
42284576|NCT02112994|76116570|FG002|Overall Study|Pregnancy|1|||
42284577|NCT02112994|76116568|FG000|Overall Study|Liver Transplant|0|||
42284578|NCT02112994|76116569|FG001|Overall Study|Liver Transplant|1|||
42284579|NCT02112994|76116570|FG002|Overall Study|Liver Transplant|0|||
42284580|NCT02112994|76116568|FG000|Overall Study|Withdrawal by Subject|0|||
42284581|NCT02112994|76116569|FG001|Overall Study|Withdrawal by Subject|0|||
42284582|NCT02112994|76116570|FG002|Overall Study|Withdrawal by Subject|1|||
42284583|NCT02147158|76116588|FG000|Treatment Course 1|Adverse Event|1|||
42284584|NCT02147158|76116589|FG001|Treatment Course 1|Adverse Event|4|||
42284585|NCT02147158|76116590|FG002|Treatment Course 1|Adverse Event|3|||
42284586|NCT02147158|76116591|FG003|Treatment Course 1|Adverse Event|4|||
42284587|NCT02147158|76116592|FG004|Treatment Course 1|Adverse Event|1|||
42284588|NCT02147158|76116593|FG005|Treatment Course 1|Adverse Event|2|||
42284589|NCT02147158|76116588|FG000|Treatment Course 1|Lost to Follow-up|2|||
42284590|NCT02147158|76116589|FG001|Treatment Course 1|Lost to Follow-up|4|||
42284591|NCT02147158|76116590|FG002|Treatment Course 1|Lost to Follow-up|3|||
42284592|NCT02147158|76116591|FG003|Treatment Course 1|Lost to Follow-up|3|||
42284593|NCT02147158|76116592|FG004|Treatment Course 1|Lost to Follow-up|2|||
42284594|NCT02147158|76116593|FG005|Treatment Course 1|Lost to Follow-up|4|||
42284595|NCT02147158|76116588|FG000|Treatment Course 1|Protocol Violation|0|||
42284596|NCT02147158|76116589|FG001|Treatment Course 1|Protocol Violation|0|||
42284597|NCT02147158|76116590|FG002|Treatment Course 1|Protocol Violation|1|||
42284598|NCT02147158|76116591|FG003|Treatment Course 1|Protocol Violation|1|||
42284599|NCT02147158|76116592|FG004|Treatment Course 1|Protocol Violation|0|||
42284600|NCT02147158|76116593|FG005|Treatment Course 1|Protocol Violation|0|||
42284601|NCT02147158|76116588|FG000|Treatment Course 1|Withdrawal of Consent|1|||
42284602|NCT02147158|76116589|FG001|Treatment Course 1|Withdrawal of Consent|1|||
42284603|NCT02147158|76116590|FG002|Treatment Course 1|Withdrawal of Consent|1|||
42284604|NCT02147158|76116591|FG003|Treatment Course 1|Withdrawal of Consent|5|||
42284605|NCT02147158|76116592|FG004|Treatment Course 1|Withdrawal of Consent|3|||
42284606|NCT02147158|76116593|FG005|Treatment Course 1|Withdrawal of Consent|2|||
42284607|NCT02147158|76116588|FG000|Off-Treatment Interval 1|Adverse Event|1|||
42284608|NCT02147158|76116589|FG001|Off-Treatment Interval 1|Adverse Event|0|||
42284609|NCT02147158|76116590|FG002|Off-Treatment Interval 1|Adverse Event|0|||
42284610|NCT02147158|76116591|FG003|Off-Treatment Interval 1|Adverse Event|1|||
42284611|NCT02147158|76116592|FG004|Off-Treatment Interval 1|Adverse Event|0|||
42284612|NCT02147158|76116593|FG005|Off-Treatment Interval 1|Adverse Event|0|||
42284613|NCT02147158|76116588|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
42284614|NCT02147158|76116589|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
42284615|NCT02147158|76116590|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
42284616|NCT02147158|76116591|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
42284617|NCT02147158|76116592|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
42284618|NCT02147158|76116593|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
42284619|NCT02147158|76116588|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
42284620|NCT02147158|76116589|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
42284621|NCT02147158|76116590|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
42284622|NCT02147158|76116591|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
42284623|NCT02147158|76116592|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
42284624|NCT02147158|76116593|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
42284625|NCT02147158|76116588|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
42284626|NCT02147158|76116589|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
42284627|NCT02147158|76116590|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
42284628|NCT02147158|76116591|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
42284629|NCT02147158|76116592|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
42284630|NCT02147158|76116593|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
42284631|NCT02147158|76116588|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
42284632|NCT02147158|76116589|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
42284633|NCT02147158|76116590|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
42284634|NCT02147158|76116591|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
42284635|NCT02147158|76116592|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
42284636|NCT02147158|76116593|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
42284637|NCT02147158|76116588|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
42284638|NCT02147158|76116589|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
42284639|NCT02147158|76116590|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
42284640|NCT02147158|76116591|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
42284641|NCT02147158|76116592|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
42284642|NCT02147158|76116593|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
42284643|NCT02147158|76116588|FG000|Treatment Course 2|Adverse Event|0|||
42284644|NCT02147158|76116589|FG001|Treatment Course 2|Adverse Event|4|||
42284645|NCT02147158|76116590|FG002|Treatment Course 2|Adverse Event|2|||
42284646|NCT02147158|76116591|FG003|Treatment Course 2|Adverse Event|1|||
42284647|NCT02147158|76116592|FG004|Treatment Course 2|Adverse Event|0|||
42284648|NCT02147158|76116593|FG005|Treatment Course 2|Adverse Event|1|||
42284649|NCT02147158|76116588|FG000|Treatment Course 2|Withdrawal of Consent|0|||
42171538|NCT00090402|75978415|FG001|Overall Study|Death|1|||
42171539|NCT00090402|75978416|FG002|Overall Study|Death|0|||
42171540|NCT00090402|75978414|FG000|Overall Study|subject moved|0|||
42171541|NCT00090402|75978415|FG001|Overall Study|subject moved|1|||
42171542|NCT00090402|75978416|FG002|Overall Study|subject moved|0|||
42171543|NCT00090402|75978414|FG000|Overall Study|stopped taking study medication|1|||
42171544|NCT00090402|75978415|FG001|Overall Study|stopped taking study medication|0|||
42284650|NCT02147158|76116589|FG001|Treatment Course 2|Withdrawal of Consent|1|||
42284651|NCT02147158|76116590|FG002|Treatment Course 2|Withdrawal of Consent|2|||
42284652|NCT02147158|76116591|FG003|Treatment Course 2|Withdrawal of Consent|3|||
42284653|NCT02147158|76116592|FG004|Treatment Course 2|Withdrawal of Consent|0|||
42284654|NCT02147158|76116593|FG005|Treatment Course 2|Withdrawal of Consent|0|||
42284655|NCT02147158|76116588|FG000|Treatment Course 2|Lost to Follow-up|1|||
42284656|NCT02147158|76116589|FG001|Treatment Course 2|Lost to Follow-up|0|||
42284657|NCT02147158|76116590|FG002|Treatment Course 2|Lost to Follow-up|1|||
42284658|NCT02147158|76116591|FG003|Treatment Course 2|Lost to Follow-up|1|||
42284659|NCT02147158|76116592|FG004|Treatment Course 2|Lost to Follow-up|0|||
42284660|NCT02147158|76116593|FG005|Treatment Course 2|Lost to Follow-up|1|||
42284661|NCT02147158|76116588|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
42284662|NCT02147158|76116589|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
42284663|NCT02147158|76116590|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
42171545|NCT00090402|75978416|FG002|Overall Study|stopped taking study medication|1|||
42171546|NCT00361283|75978427|FG000|Overall Study|Lost to Follow-up|27|||
42284664|NCT02147158|76116591|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
42284665|NCT02147158|76116592|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
42284666|NCT02147158|76116593|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
42284667|NCT02147158|76116588|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
42284668|NCT02147158|76116589|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
42284669|NCT02147158|76116590|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
42284670|NCT02147158|76116591|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
42284671|NCT02147158|76116592|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
42284672|NCT02147158|76116593|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
42284673|NCT02147158|76116588|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
42284674|NCT02147158|76116589|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
42284675|NCT02147158|76116590|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
42284676|NCT02147158|76116591|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
42284677|NCT02147158|76116592|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
42284678|NCT02147158|76116593|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
42284679|NCT02147158|76116588|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
42284680|NCT02147158|76116589|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
42284681|NCT02147158|76116590|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
42284682|NCT02147158|76116591|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
42284683|NCT02147158|76116592|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
42284684|NCT02147158|76116593|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
42284685|NCT02147158|76116588|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
42284686|NCT02147158|76116589|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
42284687|NCT02147158|76116590|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
42284688|NCT02147158|76116591|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
42284689|NCT02147158|76116592|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
42284690|NCT02147158|76116593|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
42284691|NCT02112448|76116612|FG000|Overall Study|lab values precluding use of ketorolac|2|||
42284692|NCT02112448|76116613|FG001|Overall Study|lab values precluding use of ketorolac|2|||
42284693|NCT02112448|76116612|FG000|Overall Study|Protocol Violation|1|||
42284694|NCT02112448|76116613|FG001|Overall Study|Protocol Violation|2|||
42284695|NCT02112448|76116612|FG000|Overall Study|Physician Decision|4|||
42284696|NCT02112448|76116613|FG001|Overall Study|Physician Decision|6|||
42284697|NCT02112448|76116612|FG000|Overall Study|required heparin so could not use ketoro|1|||
42284698|NCT02112448|76116613|FG001|Overall Study|required heparin so could not use ketoro|0|||
42284699|NCT02171260|76116625|FG000|Overall Study|Death|0|||
42284700|NCT02171260|76116626|FG001|Overall Study|Death|0|||
42284701|NCT02171260|76116627|FG002|Overall Study|Death|0|||
42284702|NCT02171260|76116628|FG003|Overall Study|Death|1|||
42284703|NCT02171260|76116625|FG000|Overall Study|Physician Decision|1|||
42284704|NCT02171260|76116626|FG001|Overall Study|Physician Decision|0|||
42284705|NCT02171260|76116627|FG002|Overall Study|Physician Decision|1|||
42284706|NCT02171260|76116628|FG003|Overall Study|Physician Decision|0|||
42284707|NCT02171260|76116625|FG000|Overall Study|Withdrawal by Subject|1|||
42284708|NCT02171260|76116626|FG001|Overall Study|Withdrawal by Subject|0|||
42284709|NCT02171260|76116627|FG002|Overall Study|Withdrawal by Subject|0|||
42352703|NCT01483599|76192727|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
42352704|NCT01483599|76192728|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
42352705|NCT01483599|76192729|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
42352706|NCT01483599|76192730|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
42352707|NCT01483599|76192731|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
42352708|NCT01483599|76192718|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
42352709|NCT01483599|76192719|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
42352710|NCT01483599|76192720|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
42352711|NCT01483599|76192721|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
42352712|NCT01483599|76192722|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
42352713|NCT01483599|76192723|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
42284710|NCT02171260|76116628|FG003|Overall Study|Withdrawal by Subject|0|||
42284711|NCT02171260|76116625|FG000|Overall Study|Evidence of progressive disease|4|||
42352714|NCT01483599|76192724|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
42171547|NCT00077064|75978433|FG000|Overall Study|Adverse Event|0|||
42284712|NCT02171260|76116626|FG001|Overall Study|Evidence of progressive disease|6|||
42284713|NCT02171260|76116627|FG002|Overall Study|Evidence of progressive disease|4|||
42284714|NCT02171260|76116628|FG003|Overall Study|Evidence of progressive disease|4|||
42284715|NCT02110732|76116646|FG000|Overall Study|Physician Decision|5|||
42352715|NCT01483599|76192725|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
42284716|NCT02110732|76116647|FG001|Overall Study|Physician Decision|2|||
42284717|NCT02110732|76116646|FG000|Overall Study|Lost to Follow-up|1|||
42284718|NCT02110732|76116647|FG001|Overall Study|Lost to Follow-up|1|||
42284719|NCT02109562|76116656|FG000|Overall Study|Insufficient clinical response|2|||
42284720|NCT02109562|76116657|FG001|Overall Study|Insufficient clinical response|0|||
42284721|NCT02109562|76116658|FG002|Overall Study|Insufficient clinical response|4|||
42284722|NCT02109562|76116656|FG000|Overall Study|Adverse Event|0|||
42284723|NCT02109562|76116657|FG001|Overall Study|Adverse Event|2|||
42284724|NCT02109562|76116658|FG002|Overall Study|Adverse Event|3|||
42284725|NCT02109562|76116656|FG000|Overall Study|Lost to Follow-up|1|||
42284726|NCT02109562|76116657|FG001|Overall Study|Lost to Follow-up|0|||
42284727|NCT02109562|76116658|FG002|Overall Study|Lost to Follow-up|1|||
42284728|NCT02109562|76116656|FG000|Overall Study|Protocol Violation|0|||
42015036|NCT01232790|75822202|FG000|Randomization|Physician Decision|0|||
42284729|NCT02109562|76116657|FG001|Overall Study|Protocol Violation|3|||
42284730|NCT02109562|76116658|FG002|Overall Study|Protocol Violation|1|||
42284731|NCT02109562|76116656|FG000|Overall Study|Withdrawal by Subject|20|||
42284732|NCT02109562|76116657|FG001|Overall Study|Withdrawal by Subject|25|||
42284733|NCT02109562|76116658|FG002|Overall Study|Withdrawal by Subject|21|||
42284734|NCT02109562|76116656|FG000|Overall Study|Physician Decision|3|||
42284735|NCT02109562|76116657|FG001|Overall Study|Physician Decision|4|||
42284736|NCT02109562|76116658|FG002|Overall Study|Physician Decision|5|||
42284737|NCT02109484|76116674|FG000|Overall Study|Lost to Follow-up|0|||
42284738|NCT02109484|76116675|FG001|Overall Study|Lost to Follow-up|0|||
42284739|NCT02109484|76116676|FG002|Overall Study|Lost to Follow-up|0|||
42284740|NCT02109484|76116677|FG003|Overall Study|Lost to Follow-up|1|||
42284741|NCT02109484|76116678|FG004|Overall Study|Lost to Follow-up|1|||
42284742|NCT02109484|76116679|FG005|Overall Study|Lost to Follow-up|0|||
42284743|NCT02109484|76116680|FG006|Overall Study|Lost to Follow-up|1|||
42284744|NCT02109484|76116681|FG007|Overall Study|Lost to Follow-up|0|||
42284745|NCT02109484|76116674|FG000|Overall Study|Withdrawal by Subject|0|||
42284746|NCT02109484|76116675|FG001|Overall Study|Withdrawal by Subject|0|||
42284747|NCT02109484|76116676|FG002|Overall Study|Withdrawal by Subject|0|||
42284748|NCT02109484|76116677|FG003|Overall Study|Withdrawal by Subject|0|||
42284749|NCT02109484|76116678|FG004|Overall Study|Withdrawal by Subject|1|||
42284750|NCT02109484|76116679|FG005|Overall Study|Withdrawal by Subject|1|||
42284751|NCT02109484|76116680|FG006|Overall Study|Withdrawal by Subject|1|||
42284752|NCT02109484|76116681|FG007|Overall Study|Withdrawal by Subject|0|||
42284753|NCT02109484|76116674|FG000|Overall Study|Physician Decision|0|||
42284754|NCT02109484|76116675|FG001|Overall Study|Physician Decision|0|||
42284755|NCT02109484|76116676|FG002|Overall Study|Physician Decision|0|||
42352716|NCT01483599|76192726|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
42284756|NCT02109484|76116677|FG003|Overall Study|Physician Decision|0|||
42284757|NCT02109484|76116678|FG004|Overall Study|Physician Decision|2|||
42284758|NCT02109484|76116679|FG005|Overall Study|Physician Decision|0|||
42352717|NCT01483599|76192727|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
42352718|NCT01483599|76192728|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
42352719|NCT01483599|76192729|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
42284759|NCT02109484|76116680|FG006|Overall Study|Physician Decision|0|||
42284760|NCT02109484|76116681|FG007|Overall Study|Physician Decision|0|||
42284761|NCT02109484|76116674|FG000|Overall Study|Death|0|||
42284762|NCT02109484|76116675|FG001|Overall Study|Death|0|||
42284763|NCT02109484|76116676|FG002|Overall Study|Death|0|||
42284764|NCT02109484|76116677|FG003|Overall Study|Death|0|||
42284765|NCT02109484|76116678|FG004|Overall Study|Death|0|||
42284766|NCT02109484|76116679|FG005|Overall Study|Death|0|||
42284767|NCT02109484|76116680|FG006|Overall Study|Death|0|||
42171548|NCT00077064|75978434|FG001|Overall Study|Adverse Event|4|||
42171549|NCT00077064|75978433|FG000|Overall Study|Patient refusal|0|||
42171550|NCT00077064|75978434|FG001|Overall Study|Patient refusal|2|||
42171551|NCT00396383|75978441|FG000|Overall Study|Death|2|||
42171552|NCT00396383|75978441|FG000|Overall Study|Lost to Follow-up|1|||
42171553|NCT00395447|75978447|FG000|Overall Study|Death|37|||
42284768|NCT02109484|76116681|FG007|Overall Study|Death|2|||
42284769|NCT02109484|76116674|FG000|Overall Study|Moved away from study area|0|||
42284770|NCT02109484|76116675|FG001|Overall Study|Moved away from study area|0|||
42284771|NCT02109484|76116676|FG002|Overall Study|Moved away from study area|0|||
42284772|NCT02109484|76116677|FG003|Overall Study|Moved away from study area|0|||
42284773|NCT02109484|76116678|FG004|Overall Study|Moved away from study area|0|||
42284774|NCT02109484|76116679|FG005|Overall Study|Moved away from study area|0|||
42284775|NCT02109484|76116680|FG006|Overall Study|Moved away from study area|1|||
42284776|NCT02109484|76116681|FG007|Overall Study|Moved away from study area|1|||
42284777|NCT02105974|76116718|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
42284778|NCT02105974|76116719|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
42284779|NCT02105974|76116720|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
42284780|NCT02105974|76116718|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
42284781|NCT02105974|76116719|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
42284782|NCT02105974|76116720|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
42284783|NCT02105974|76116718|FG000|2 Week Run-in Period|Adverse Event|6|||
42284784|NCT02105974|76116719|FG001|2 Week Run-in Period|Adverse Event|0|||
42284785|NCT02105974|76116720|FG002|2 Week Run-in Period|Adverse Event|0|||
42284786|NCT02105974|76116718|FG000|2 Week Run-in Period|Study closed/terminated|1|||
42284787|NCT02105974|76116719|FG001|2 Week Run-in Period|Study closed/terminated|0|||
42284788|NCT02105974|76116720|FG002|2 Week Run-in Period|Study closed/terminated|0|||
42284789|NCT02105974|76116718|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
42284790|NCT02105974|76116719|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
42352720|NCT01483599|76192730|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
42284791|NCT02105974|76116720|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
42352721|NCT01483599|76192731|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
42352722|NCT01483599|76192718|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
42352723|NCT01483599|76192719|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
42352724|NCT01483599|76192720|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
42352725|NCT01483599|76192721|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
42352726|NCT01483599|76192722|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
42352727|NCT01483599|76192723|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
42352728|NCT01483599|76192724|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
42352729|NCT01483599|76192725|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
42352730|NCT01483599|76192726|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
42352731|NCT01483599|76192727|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
42352732|NCT01483599|76192728|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
42352733|NCT01483599|76192729|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
42352734|NCT01483599|76192730|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
42352735|NCT01483599|76192731|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
42015037|NCT01232790|75822203|FG001|Randomization|Physician Decision|1|||
42171554|NCT00395447|75978448|FG001|Overall Study|Death|32|||
42171555|NCT00395447|75978447|FG000|Overall Study|Lost to Follow-up|52|||
42284792|NCT02105974|76116718|FG000|2 Week Run-in Period|Withdrew consent|23|||
42284793|NCT02105974|76116719|FG001|2 Week Run-in Period|Withdrew consent|0|||
42284794|NCT02105974|76116720|FG002|2 Week Run-in Period|Withdrew consent|0|||
42284795|NCT02105974|76116718|FG000|2 Week Run-in Period|Investigator discretion|8|||
42284796|NCT02105974|76116719|FG001|2 Week Run-in Period|Investigator discretion|0|||
42284797|NCT02105974|76116720|FG002|2 Week Run-in Period|Investigator discretion|0|||
42284798|NCT02105974|76116718|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
42284799|NCT02105974|76116719|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
42284800|NCT02105974|76116720|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
42284801|NCT02105974|76116718|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
42284802|NCT02105974|76116719|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
42284803|NCT02105974|76116720|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
42284804|NCT02105974|76116718|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
42284805|NCT02105974|76116719|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
42284806|NCT02105974|76116720|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
42284807|NCT02105974|76116718|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
42284808|NCT02105974|76116719|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
42284809|NCT02105974|76116720|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
42284810|NCT02105974|76116718|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
42284811|NCT02105974|76116719|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
42284812|NCT02105974|76116720|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
42015038|NCT01232790|75822202|FG000|Initial Assessment|Withdrawal by Subject|0|||
42171556|NCT00395447|75978448|FG001|Overall Study|Lost to Follow-up|43|||
42171557|NCT00395447|75978447|FG000|Overall Study|Withdrawal by Subject|24|||
42284813|NCT02105974|76116718|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
42284814|NCT02105974|76116719|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
42284815|NCT02105974|76116720|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
42284816|NCT02105974|76116718|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
42284817|NCT02105974|76116719|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
42284818|NCT02105974|76116720|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
42284819|NCT02105662|76116726|FG000|Overall Study|Lost to Follow-up|5|||
42284820|NCT02105662|76116726|FG000|Overall Study|Withdrawal by Subject|1|||
42284821|NCT02143102|76116732|FG000|Overall Study|Lost to Follow-up|11|||
42284822|NCT02143102|76116733|FG001|Overall Study|Lost to Follow-up|0|||
42284823|NCT02143024|76116741|FG000|Overall Study|Lost to Follow-up|1|||
42284824|NCT02143024|76116742|FG001|Overall Study|Lost to Follow-up|1|||
42284825|NCT02143024|76116741|FG000|Overall Study|Withdrawal by Subject|1|||
42284826|NCT02143024|76116742|FG001|Overall Study|Withdrawal by Subject|0|||
42284827|NCT02142712|76116751|FG000|Overall Study|Lost to Follow-up|1|||
42284828|NCT02142712|76116752|FG001|Overall Study|Lost to Follow-up|1|||
42284829|NCT02142712|76116753|FG002|Overall Study|Lost to Follow-up|1|||
42284830|NCT02142712|76116754|FG003|Overall Study|Lost to Follow-up|0|||
42284831|NCT02105272|76116765|FG000|Overall Study|Adverse Event|1|||
42284832|NCT02105272|76116766|FG001|Overall Study|Adverse Event|2|||
42284833|NCT02105272|76116765|FG000|Overall Study|Physician Decision|0|||
42284834|NCT02105272|76116766|FG001|Overall Study|Physician Decision|1|||
42284835|NCT02105272|76116765|FG000|Overall Study|Protocol Violation|2|||
42284836|NCT02105272|76116766|FG001|Overall Study|Protocol Violation|0|||
42284837|NCT02105272|76116765|FG000|Overall Study|Withdrawal by Subject|2|||
42284838|NCT02105272|76116766|FG001|Overall Study|Withdrawal by Subject|0|||
42284839|NCT02141854|76116777|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
42284840|NCT02141854|76116778|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42284841|NCT02141854|76116779|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42284842|NCT02141854|76116780|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42171558|NCT00395447|75978448|FG001|Overall Study|Withdrawal by Subject|19|||
42171559|NCT00395447|75978447|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
42171560|NCT00395447|75978448|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
42171561|NCT03404674|75978460|FG000|Overall Study|Inability to Attend Future Visits|0|||
42171562|NCT03404674|75978461|FG001|Overall Study|Inability to Attend Future Visits|1|||
42171563|NCT03404674|75978462|FG002|Overall Study|Inability to Attend Future Visits|1|||
42171564|NCT03404674|75978463|FG003|Overall Study|Inability to Attend Future Visits|0|||
42171565|NCT03404674|75978464|FG004|Overall Study|Inability to Attend Future Visits|0|||
42171566|NCT03404674|75978465|FG005|Overall Study|Inability to Attend Future Visits|0|||
42171567|NCT03404674|75978460|FG000|Overall Study|Behavioral Problems|0|||
42171568|NCT03404674|75978461|FG001|Overall Study|Behavioral Problems|0|||
42171569|NCT03404674|75978462|FG002|Overall Study|Behavioral Problems|1|||
42171570|NCT03404674|75978463|FG003|Overall Study|Behavioral Problems|0|||
42171571|NCT03404674|75978464|FG004|Overall Study|Behavioral Problems|0|||
42284843|NCT02141854|76116781|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42171572|NCT03404674|75978465|FG005|Overall Study|Behavioral Problems|0|||
42171573|NCT03404674|75978460|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
42171574|NCT03404674|75978461|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
42284844|NCT02141854|76116782|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
42284845|NCT02141854|76116777|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
42284846|NCT02141854|76116778|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42284847|NCT02141854|76116779|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42284848|NCT02141854|76116780|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42284849|NCT02141854|76116781|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42284850|NCT02141854|76116782|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
42284851|NCT02141854|76116777|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
42284852|NCT02141854|76116778|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42284853|NCT02141854|76116779|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42284854|NCT02141854|76116780|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42284855|NCT02141854|76116781|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42284856|NCT02141854|76116782|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
42284857|NCT02141854|76116777|FG000|Run-In Period (Pre-assignment)|Other|14|||
42284858|NCT02141854|76116778|FG001|Run-In Period (Pre-assignment)|Other|0|||
42284859|NCT02141854|76116779|FG002|Run-In Period (Pre-assignment)|Other|0|||
42284860|NCT02141854|76116780|FG003|Run-In Period (Pre-assignment)|Other|0|||
42284861|NCT02141854|76116781|FG004|Run-In Period (Pre-assignment)|Other|0|||
42284862|NCT02141854|76116782|FG005|Run-In Period (Pre-assignment)|Other|0|||
42284863|NCT02141854|76116777|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
42284864|NCT02141854|76116778|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
42284865|NCT02141854|76116779|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
42284866|NCT02141854|76116780|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
42284867|NCT02141854|76116781|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
42284868|NCT02141854|76116782|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
42284869|NCT02141854|76116777|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
42284870|NCT02141854|76116778|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42171575|NCT03404674|75978462|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
42171576|NCT03404674|75978463|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
42171577|NCT03404674|75978464|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
42171578|NCT03404674|75978465|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
42171579|NCT00064662|75978482|FG000|Overall Study|Death|1|||
42171580|NCT00064662|75978483|FG001|Overall Study|Death|1|||
42171581|NCT00064662|75978482|FG000|Overall Study|Lost to Follow-up|57|||
42171582|NCT00064662|75978483|FG001|Overall Study|Lost to Follow-up|44|||
42171583|NCT00064662|75978482|FG000|Overall Study|Withdrawal by Subject|14|||
42171584|NCT00064662|75978483|FG001|Overall Study|Withdrawal by Subject|14|||
42171585|NCT00064662|75978482|FG000|Overall Study|Administratively withdrawn|2|||
42171586|NCT00064662|75978483|FG001|Overall Study|Administratively withdrawn|2|||
42171587|NCT03404518|75978491|FG000|Overall Study|Lost to Follow-up|28|||
42171588|NCT03404518|75978492|FG001|Overall Study|Lost to Follow-up|30|||
42171589|NCT03404518|75978491|FG000|Overall Study|Protocol Violation|13|||
42171590|NCT03404518|75978492|FG001|Overall Study|Protocol Violation|6|||
42171591|NCT03404206|75978501|FG000|Overall Study|Withdrawal by Subject|1|||
42171592|NCT03404206|75978502|FG001|Overall Study|Withdrawal by Subject|1|||
42284871|NCT02141854|76116779|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42284872|NCT02141854|76116780|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42040774|NCT01522976|75848764|FG001|Overall Study|Refusal unrelated to adverse event|13|||
42171593|NCT03404206|75978503|FG002|Overall Study|Withdrawal by Subject|0|||
42171594|NCT03404206|75978501|FG000|Overall Study|Lost to Follow-up|3|||
42171595|NCT03404206|75978502|FG001|Overall Study|Lost to Follow-up|1|||
42284873|NCT02141854|76116781|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42284874|NCT02141854|76116782|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
42284875|NCT02141854|76116777|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
42284876|NCT02141854|76116778|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42284877|NCT02141854|76116779|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42284878|NCT02141854|76116780|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42284879|NCT02141854|76116781|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42284880|NCT02141854|76116782|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
42284881|NCT02141854|76116777|FG000|Treatment Period|Protocol Violation|0|||
42284882|NCT02141854|76116778|FG001|Treatment Period|Protocol Violation|1|||
42284883|NCT02141854|76116779|FG002|Treatment Period|Protocol Violation|0|||
42284884|NCT02141854|76116780|FG003|Treatment Period|Protocol Violation|2|||
42284885|NCT02141854|76116781|FG004|Treatment Period|Protocol Violation|2|||
42284886|NCT02141854|76116782|FG005|Treatment Period|Protocol Violation|1|||
42284887|NCT02141854|76116777|FG000|Treatment Period|Noncompliance|0|||
42015039|NCT01232790|75822203|FG001|Initial Assessment|Withdrawal by Subject|1|||
42171596|NCT03404206|75978503|FG002|Overall Study|Lost to Follow-up|0|||
42284888|NCT02141854|76116778|FG001|Treatment Period|Noncompliance|0|||
42284889|NCT02141854|76116779|FG002|Treatment Period|Noncompliance|0|||
42284890|NCT02141854|76116780|FG003|Treatment Period|Noncompliance|1|||
42284891|NCT02141854|76116781|FG004|Treatment Period|Noncompliance|0|||
42284892|NCT02141854|76116782|FG005|Treatment Period|Noncompliance|0|||
42284893|NCT02141854|76116777|FG000|Treatment Period|Lack of Efficacy|0|||
42284894|NCT02141854|76116778|FG001|Treatment Period|Lack of Efficacy|0|||
42352736|NCT01483599|76192718|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
42352737|NCT01483599|76192719|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
42352738|NCT01483599|76192720|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
42352739|NCT01483599|76192721|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
42352740|NCT01483599|76192722|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
42284895|NCT02141854|76116779|FG002|Treatment Period|Lack of Efficacy|0|||
42284896|NCT02141854|76116780|FG003|Treatment Period|Lack of Efficacy|1|||
42352741|NCT01483599|76192723|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
42352742|NCT01483599|76192724|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
42015040|NCT01232790|75822202|FG000|First Crossover|Withdrawal by Subject|1|||
42015041|NCT01232790|75822203|FG001|First Crossover|Withdrawal by Subject|0|||
42284897|NCT02141854|76116781|FG004|Treatment Period|Lack of Efficacy|1|||
42284898|NCT02141854|76116782|FG005|Treatment Period|Lack of Efficacy|7|||
42284899|NCT02141854|76116777|FG000|Treatment Period|Pregnancy|0|||
42284900|NCT02141854|76116778|FG001|Treatment Period|Pregnancy|1|||
42284901|NCT02141854|76116779|FG002|Treatment Period|Pregnancy|0|||
42284902|NCT02141854|76116780|FG003|Treatment Period|Pregnancy|0|||
42284903|NCT02141854|76116781|FG004|Treatment Period|Pregnancy|0|||
42284904|NCT02141854|76116782|FG005|Treatment Period|Pregnancy|0|||
42284905|NCT02141854|76116777|FG000|Treatment Period|Other|0|||
42284906|NCT02141854|76116778|FG001|Treatment Period|Other|1|||
42284907|NCT02141854|76116779|FG002|Treatment Period|Other|2|||
42284908|NCT02141854|76116780|FG003|Treatment Period|Other|0|||
42284909|NCT02141854|76116781|FG004|Treatment Period|Other|1|||
42284910|NCT02141854|76116782|FG005|Treatment Period|Other|2|||
42284911|NCT02141854|76116777|FG000|Treatment Period|Adverse Event|0|||
42284912|NCT02141854|76116778|FG001|Treatment Period|Adverse Event|2|||
42284913|NCT02141854|76116779|FG002|Treatment Period|Adverse Event|2|||
42284914|NCT02141854|76116780|FG003|Treatment Period|Adverse Event|0|||
42284915|NCT02141854|76116781|FG004|Treatment Period|Adverse Event|2|||
42284916|NCT02141854|76116782|FG005|Treatment Period|Adverse Event|2|||
42284917|NCT02141854|76116777|FG000|Treatment Period|Withdrawal by Subject|0|||
42284918|NCT02141854|76116778|FG001|Treatment Period|Withdrawal by Subject|2|||
42284919|NCT02141854|76116779|FG002|Treatment Period|Withdrawal by Subject|3|||
42284920|NCT02141854|76116780|FG003|Treatment Period|Withdrawal by Subject|3|||
42352743|NCT01483599|76192725|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
42352744|NCT01483599|76192726|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
42352745|NCT01483599|76192727|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
42352746|NCT01483599|76192728|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
42352747|NCT01483599|76192729|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
42352748|NCT01483599|76192730|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
42352749|NCT01483599|76192731|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
42352750|NCT01483599|76192718|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
42352751|NCT01483599|76192719|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
42352752|NCT01483599|76192720|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
42352753|NCT01483599|76192721|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
42352754|NCT01483599|76192722|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
42352755|NCT01483599|76192723|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
42352756|NCT01483599|76192724|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
42352757|NCT01483599|76192725|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
42352758|NCT01483599|76192726|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
42352759|NCT01483599|76192727|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
42352760|NCT01483599|76192728|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
42352761|NCT01483599|76192729|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
42352762|NCT01483599|76192730|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
42352763|NCT01483599|76192731|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
42352764|NCT01483599|76192718|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
42352765|NCT01483599|76192719|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
42352766|NCT01483599|76192720|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
42352767|NCT01483599|76192721|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
42352768|NCT01483599|76192722|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
42352769|NCT01483599|76192723|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
42352770|NCT01483599|76192724|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
42352771|NCT01483599|76192725|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
42284921|NCT02141854|76116781|FG004|Treatment Period|Withdrawal by Subject|4|||
42284922|NCT02141854|76116782|FG005|Treatment Period|Withdrawal by Subject|7|||
42284923|NCT02141854|76116777|FG000|Treatment Period|Disease progression|0|||
42284924|NCT02141854|76116778|FG001|Treatment Period|Disease progression|2|||
42284925|NCT02141854|76116779|FG002|Treatment Period|Disease progression|1|||
42284926|NCT02141854|76116780|FG003|Treatment Period|Disease progression|3|||
42352772|NCT01483599|76192726|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
42284927|NCT02141854|76116781|FG004|Treatment Period|Disease progression|0|||
42284928|NCT02141854|76116782|FG005|Treatment Period|Disease progression|18|||
42284929|NCT02141854|76116777|FG000|Treatment Period|Lost to Follow-up|0|||
42284930|NCT02141854|76116778|FG001|Treatment Period|Lost to Follow-up|1|||
42352773|NCT01483599|76192727|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
42015042|NCT01232790|75822202|FG000|Second Crossover|Withdrawal by Subject|1|||
42284931|NCT02141854|76116779|FG002|Treatment Period|Lost to Follow-up|1|||
42284932|NCT02141854|76116780|FG003|Treatment Period|Lost to Follow-up|1|||
42284933|NCT02141854|76116781|FG004|Treatment Period|Lost to Follow-up|0|||
42284934|NCT02141854|76116782|FG005|Treatment Period|Lost to Follow-up|1|||
42284935|NCT02587221|76116796|FG000|Overall Study|Adverse Event|3|||
42284936|NCT02587221|76116797|FG001|Overall Study|Adverse Event|3|||
42284937|NCT02587221|76116796|FG000|Overall Study|Death|33|||
42284938|NCT02587221|76116797|FG001|Overall Study|Death|34|||
42284939|NCT02587221|76116796|FG000|Overall Study|Withdrawal by Subject|66|||
42284940|NCT02587221|76116797|FG001|Overall Study|Withdrawal by Subject|61|||
42284941|NCT02587221|76116796|FG000|Overall Study|Lost to Follow-up|21|||
42284942|NCT02587221|76116797|FG001|Overall Study|Lost to Follow-up|19|||
42284943|NCT02587221|76116796|FG000|Overall Study|Protocol Violation|6|||
42284944|NCT02587221|76116797|FG001|Overall Study|Protocol Violation|5|||
42284945|NCT02587221|76116796|FG000|Overall Study|Other Reason or Unspecified|2|||
42284946|NCT02587221|76116797|FG001|Overall Study|Other Reason or Unspecified|1|||
42284947|NCT02141620|76116803|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
42284948|NCT02141620|76116804|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
42284949|NCT02106910|76116812|FG000|Overall Study|Lost to Follow-up|1|||
42284950|NCT02106910|76116813|FG001|Overall Study|Lost to Follow-up|1|||
42284951|NCT01664949|76116822|FG000|Overall Study|Adverse Event|11|||
42284952|NCT01664949|76116823|FG001|Overall Study|Adverse Event|12|||
42284953|NCT01664949|76116822|FG000|Overall Study|Lack of Efficacy|1|||
42284954|NCT01664949|76116823|FG001|Overall Study|Lack of Efficacy|1|||
42284955|NCT01664949|76116822|FG000|Overall Study|Lost to Follow-up|1|||
42284956|NCT01664949|76116823|FG001|Overall Study|Lost to Follow-up|2|||
42284957|NCT01664949|76116822|FG000|Overall Study|Personal Reasons|3|||
42284958|NCT01664949|76116823|FG001|Overall Study|Personal Reasons|4|||
42284959|NCT01664949|76116822|FG000|Overall Study|Protocol Violation|5|||
42284960|NCT01664949|76116823|FG001|Overall Study|Protocol Violation|5|||
42284961|NCT01664949|76116822|FG000|Overall Study|Other Miscellaneous Reasons|3|||
42284962|NCT01664949|76116823|FG001|Overall Study|Other Miscellaneous Reasons|1|||
42284963|NCT02587143|76116831|FG000|Overall Study|Adverse Event|1|||
42284964|NCT02587143|76116832|FG001|Overall Study|Adverse Event|0|||
42284965|NCT02106832|76116842|FG000|Overall Study|Adverse Event|1|||
42284966|NCT02106832|76116843|FG001|Overall Study|Adverse Event|2|||
42284967|NCT02106832|76116844|FG002|Overall Study|Adverse Event|3|||
42284968|NCT02106832|76116845|FG003|Overall Study|Adverse Event|0|||
42284969|NCT02106832|76116842|FG000|Overall Study|Death|4|||
42284970|NCT02106832|76116843|FG001|Overall Study|Death|4|||
42284971|NCT02106832|76116844|FG002|Overall Study|Death|1|||
42284972|NCT02106832|76116845|FG003|Overall Study|Death|4|||
42284973|NCT02106832|76116842|FG000|Overall Study|Deterioration of general conditions|0|||
42284974|NCT02106832|76116843|FG001|Overall Study|Deterioration of general conditions|0|||
42284975|NCT02106832|76116844|FG002|Overall Study|Deterioration of general conditions|1|||
42284976|NCT02106832|76116845|FG003|Overall Study|Deterioration of general conditions|0|||
42284977|NCT02106832|76116842|FG000|Overall Study|Lost to Follow-up|0|||
42284978|NCT02106832|76116843|FG001|Overall Study|Lost to Follow-up|1|||
42284979|NCT02106832|76116844|FG002|Overall Study|Lost to Follow-up|1|||
42284980|NCT02106832|76116845|FG003|Overall Study|Lost to Follow-up|3|||
42284981|NCT02106832|76116842|FG000|Overall Study|Physician Decision|1|||
42284982|NCT02106832|76116843|FG001|Overall Study|Physician Decision|0|||
42284983|NCT02106832|76116844|FG002|Overall Study|Physician Decision|0|||
42171597|NCT03403426|75978511|FG000|Overall Study|Death|1|||
42171598|NCT03403426|75978511|FG000|Overall Study|Lost to Follow-up|2|||
42171599|NCT00394901|75978519|FG000|Baseline Phase|Protocol Violation|0|||
42171600|NCT00394901|75978520|FG001|Baseline Phase|Protocol Violation|0|||
42171601|NCT00394901|75978521|FG002|Baseline Phase|Protocol Violation|1|||
42171602|NCT00394901|75978522|FG003|Baseline Phase|Protocol Violation|0|||
42171603|NCT00394901|75978519|FG000|Double-blind Phase|Adverse Event|5|||
42171604|NCT00394901|75978520|FG001|Double-blind Phase|Adverse Event|7|||
42171605|NCT00394901|75978521|FG002|Double-blind Phase|Adverse Event|16|||
42171606|NCT00394901|75978522|FG003|Double-blind Phase|Adverse Event|20|||
42171607|NCT00394901|75978519|FG000|Double-blind Phase|Lack of Efficacy|6|||
42171608|NCT00394901|75978520|FG001|Double-blind Phase|Lack of Efficacy|4|||
42284984|NCT02106832|76116845|FG003|Overall Study|Physician Decision|0|||
42284985|NCT02106832|76116842|FG000|Overall Study|Protocol Violation|0|||
42284986|NCT02106832|76116843|FG001|Overall Study|Protocol Violation|0|||
42284987|NCT02106832|76116844|FG002|Overall Study|Protocol Violation|0|||
42352774|NCT01483599|76192728|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
42171609|NCT00394901|75978521|FG002|Double-blind Phase|Lack of Efficacy|1|||
42171610|NCT00394901|75978522|FG003|Double-blind Phase|Lack of Efficacy|3|||
42171611|NCT00394901|75978519|FG000|Double-blind Phase|Withdrawal by Subject|2|||
42284988|NCT02106832|76116845|FG003|Overall Study|Protocol Violation|1|||
42284989|NCT02106832|76116842|FG000|Overall Study|Withdrawal by Subject|17|||
42284990|NCT02106832|76116843|FG001|Overall Study|Withdrawal by Subject|17|||
42284991|NCT02106832|76116844|FG002|Overall Study|Withdrawal by Subject|10|||
42284992|NCT02106832|76116845|FG003|Overall Study|Withdrawal by Subject|7|||
42284993|NCT02106832|76116842|FG000|Overall Study|Technical problems|0|||
42284994|NCT02106832|76116843|FG001|Overall Study|Technical problems|1|||
42284995|NCT02106832|76116844|FG002|Overall Study|Technical problems|0|||
42284996|NCT02106832|76116845|FG003|Overall Study|Technical problems|0|||
42284997|NCT02106442|76116857|FG000|Overall Study|Case Report Forms Uncollected|7|||
42284998|NCT02106442|76116857|FG000|Overall Study|Protocol Deviation|30|||
42284999|NCT02105116|76116861|FG000|Overall Study|not eligible for step 2 of trial|5|||
42285000|NCT02105116|76116861|FG000|Overall Study|Death|1|||
42285001|NCT02104804|76116867|FG000|Overall Study|Did not take study medication|0|||
42285002|NCT02104804|76116868|FG001|Overall Study|Did not take study medication|1|||
42285003|NCT02104804|76116867|FG000|Overall Study|Study specific discontinuation criteria|6|||
42285004|NCT02104804|76116868|FG001|Overall Study|Study specific discontinuation criteria|1|||
42285005|NCT02104804|76116867|FG000|Overall Study|Other listed|2|||
42285006|NCT02104804|76116868|FG001|Overall Study|Other listed|1|||
42285007|NCT02104804|76116867|FG000|Overall Study|Protocol Violation|0|||
42285008|NCT02104804|76116868|FG001|Overall Study|Protocol Violation|1|||
42285009|NCT02104804|76116867|FG000|Overall Study|Adverse Event|4|||
42285010|NCT02104804|76116868|FG001|Overall Study|Adverse Event|3|||
42285011|NCT02104804|76116867|FG000|Overall Study|Withdrawal by Subject|4|||
42285012|NCT02104804|76116868|FG001|Overall Study|Withdrawal by Subject|12|||
42285013|NCT02075008|76116874|FG000|Overall Study|Technical problems|1|||
42285014|NCT02075008|76116874|FG000|Overall Study|Pregnancy|1|||
42285015|NCT02075008|76116874|FG000|Overall Study|Physician Decision|1|||
42285016|NCT02075008|76116874|FG000|Overall Study|Lost to Follow-up|1|||
42285017|NCT02075008|76116874|FG000|Overall Study|Lack of Efficacy|1|||
42285018|NCT02075008|76116874|FG000|Overall Study|Death|1|||
42285019|NCT02075008|76116874|FG000|Overall Study|Adverse Event|5|||
42285020|NCT02075008|76116874|FG000|Overall Study|Withdrawal by Subject|6|||
42285021|NCT02075008|76116874|FG000|Overall Study|Study terminated by Sponsor|159|||
42285022|NCT01666119|76116905|FG000|Overall Study|Adverse Event|6|||
42285023|NCT01666119|76116905|FG000|Overall Study|Withdrawal by Subject|16|||
42285024|NCT01666119|76116905|FG000|Overall Study|Lost to Follow-up|7|||
42285025|NCT01666119|76116905|FG000|Overall Study|non compliance with study medication, pa|18|||
42285026|NCT01666119|76116905|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
42285027|NCT05128773|76116909|FG000|Overall Study|Sponsor decision to terminate study|3|||
42285028|NCT01665807|76116917|FG000|Overall Study|Withdrawal by Subject|2|||
42285029|NCT01665807|76116918|FG001|Overall Study|Withdrawal by Subject|0|||
42285030|NCT01665807|76116919|FG002|Overall Study|Withdrawal by Subject|1|||
42285031|NCT02584959|76116930|FG000|Period 1|Withdrawn from study|3|||
42285032|NCT02584959|76116931|FG001|Period 1|Withdrawn from study|4|||
42285033|NCT02584959|76116932|FG002|Period 1|Withdrawn from study|0|||
42285034|NCT02584959|76116930|FG000|Period 2|Withdrawn from study|6|||
42285035|NCT02584959|76116931|FG001|Period 2|Withdrawn from study|1|||
42285036|NCT02584959|76116932|FG002|Period 2|Withdrawn from study|2|||
42285037|NCT02584257|76116949|FG000|Period 1|Withdrawal by Subject|0|||
42285038|NCT02584257|76116950|FG001|Period 1|Withdrawal by Subject|0|||
42285039|NCT02584257|76116951|FG002|Period 1|Withdrawal by Subject|0|||
42285040|NCT02584257|76116952|FG003|Period 1|Withdrawal by Subject|0|||
42285041|NCT02584257|76116953|FG004|Period 1|Withdrawal by Subject|0|||
42285042|NCT02584257|76116954|FG005|Period 1|Withdrawal by Subject|0|||
42285043|NCT02584257|76116955|FG006|Period 1|Withdrawal by Subject|1|||
42352775|NCT01483599|76192729|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
42352776|NCT01483599|76192730|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
42352777|NCT01483599|76192731|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
42352778|NCT01483599|76192718|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
42352779|NCT01483599|76192719|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
42352780|NCT01483599|76192720|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
42352781|NCT01483599|76192721|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
42352782|NCT01483599|76192722|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
42352783|NCT01483599|76192723|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
42352784|NCT01483599|76192724|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
42352785|NCT01483599|76192725|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
42285044|NCT02584257|76116956|FG007|Period 1|Withdrawal by Subject|0|||
42285045|NCT02584257|76116957|FG008|Period 1|Withdrawal by Subject|0|||
42285046|NCT02584257|76116949|FG000|Period 2|Physician Decision|1|||
42285047|NCT02584257|76116950|FG001|Period 2|Physician Decision|0|||
42285048|NCT02584257|76116951|FG002|Period 2|Physician Decision|0|||
42285049|NCT02584257|76116952|FG003|Period 2|Physician Decision|0|||
42285050|NCT02584257|76116953|FG004|Period 2|Physician Decision|0|||
42285051|NCT02584257|76116954|FG005|Period 2|Physician Decision|0|||
42285052|NCT02584257|76116955|FG006|Period 2|Physician Decision|0|||
42285053|NCT02584257|76116956|FG007|Period 2|Physician Decision|0|||
42285054|NCT02584257|76116957|FG008|Period 2|Physician Decision|0|||
42285055|NCT02584257|76116949|FG000|Period 2|Adverse Event|0|||
42285056|NCT02584257|76116950|FG001|Period 2|Adverse Event|1|||
42285057|NCT02584257|76116951|FG002|Period 2|Adverse Event|0|||
42285058|NCT02584257|76116952|FG003|Period 2|Adverse Event|0|||
42285059|NCT02584257|76116953|FG004|Period 2|Adverse Event|0|||
42285060|NCT02584257|76116954|FG005|Period 2|Adverse Event|0|||
42285061|NCT02584257|76116955|FG006|Period 2|Adverse Event|0|||
42285062|NCT02584257|76116956|FG007|Period 2|Adverse Event|0|||
42285063|NCT02584257|76116957|FG008|Period 2|Adverse Event|0|||
42285064|NCT02583711|76116972|FG000|Overall Study|Withdrawal by Subject|0|||
42285065|NCT02583711|76116973|FG001|Overall Study|Withdrawal by Subject|10|||
42285066|NCT02583711|76116974|FG002|Overall Study|Withdrawal by Subject|0|||
42285067|NCT02583477|76116986|FG000|Overall Study|Adverse Event|0|||
42285068|NCT02583477|76116987|FG001|Overall Study|Adverse Event|2|||
42285069|NCT02583477|76116986|FG000|Overall Study|Death|1|||
42171612|NCT00394901|75978520|FG001|Double-blind Phase|Withdrawal by Subject|0|||
42171613|NCT00394901|75978521|FG002|Double-blind Phase|Withdrawal by Subject|0|||
42171614|NCT00394901|75978522|FG003|Double-blind Phase|Withdrawal by Subject|0|||
42285070|NCT02583477|76116987|FG001|Overall Study|Death|16|||
42285071|NCT02583477|76116986|FG000|Overall Study|Study terminated|2|||
42285072|NCT02583477|76116987|FG001|Overall Study|Study terminated|2|||
42285073|NCT02583399|76116994|FG000|Overall Study|Able to be discharged|3|||
42285074|NCT02583399|76116994|FG000|Overall Study|Wanted to use a restricted medication|3|||
42285075|NCT02580591|76117002|FG000|Overall Study|Adverse Event|0|||
42285076|NCT02580591|76117003|FG001|Overall Study|Adverse Event|1|||
42285077|NCT02580591|76117004|FG002|Overall Study|Adverse Event|2|||
42285078|NCT02580591|76117005|FG003|Overall Study|Adverse Event|5|||
42285079|NCT02580591|76117002|FG000|Overall Study|Protocol Violation|3|||
42285080|NCT02580591|76117003|FG001|Overall Study|Protocol Violation|2|||
42285081|NCT02580591|76117004|FG002|Overall Study|Protocol Violation|1|||
42352786|NCT01483599|76192726|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
42352787|NCT01483599|76192727|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
42352788|NCT01483599|76192728|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
42352789|NCT01483599|76192729|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
42352790|NCT01483599|76192730|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
42352791|NCT01483599|76192731|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
42352792|NCT01507545|76192807|FG000|Overall Study|Withdrawal by Subject|6|||
42352793|NCT01507545|76192808|FG001|Overall Study|Withdrawal by Subject|2|||
42352794|NCT01507545|76192807|FG000|Overall Study|Lost to Follow-up|1|||
42352795|NCT01507545|76192808|FG001|Overall Study|Lost to Follow-up|0|||
42352796|NCT01507545|76192807|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
42352797|NCT01507545|76192808|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
42352798|NCT01507545|76192807|FG000|Overall Study|Progressive disease|60|||
42352799|NCT01507545|76192808|FG001|Overall Study|Progressive disease|27|||
42352800|NCT01507545|76192807|FG000|Overall Study|Other|6|||
42352801|NCT01507545|76192808|FG001|Overall Study|Other|4|||
42352802|NCT01482819|76192814|FG000|Overall Study|Lost to Follow-up|2|||
42352803|NCT01534533|76192826|FG000|Overall Study|Lost to Follow-up|3|||
42352804|NCT01534533|76192827|FG001|Overall Study|Lost to Follow-up|0|||
42352805|NCT01534533|76192828|FG002|Overall Study|Lost to Follow-up|4|||
42171615|NCT00394901|75978519|FG000|Double-blind Phase|Lost to Follow-up|0|||
42171616|NCT00394901|75978520|FG001|Double-blind Phase|Lost to Follow-up|0|||
42171617|NCT00394901|75978521|FG002|Double-blind Phase|Lost to Follow-up|0|||
42285082|NCT02580591|76117005|FG003|Overall Study|Protocol Violation|1|||
42285083|NCT02580591|76117002|FG000|Overall Study|Lost to Follow-up|5|||
42285084|NCT02580591|76117003|FG001|Overall Study|Lost to Follow-up|3|||
42285085|NCT02580591|76117004|FG002|Overall Study|Lost to Follow-up|3|||
42285086|NCT02580591|76117005|FG003|Overall Study|Lost to Follow-up|1|||
42352806|NCT01534533|76192829|FG003|Overall Study|Lost to Follow-up|3|||
42352807|NCT01534533|76192826|FG000|Overall Study|Withdrawal by Subject|5|||
42285087|NCT02580591|76117002|FG000|Overall Study|Withdrawal by Subject|6|||
42285088|NCT02580591|76117003|FG001|Overall Study|Withdrawal by Subject|1|||
42285089|NCT02580591|76117004|FG002|Overall Study|Withdrawal by Subject|2|||
42285090|NCT02580591|76117005|FG003|Overall Study|Withdrawal by Subject|3|||
42285091|NCT02580591|76117002|FG000|Overall Study|Not treated|1|||
42285092|NCT02580591|76117003|FG001|Overall Study|Not treated|1|||
42285093|NCT02580591|76117004|FG002|Overall Study|Not treated|0|||
42285094|NCT02580591|76117005|FG003|Overall Study|Not treated|0|||
42285095|NCT02580591|76117002|FG000|Overall Study|Other than specified|3|||
42285096|NCT02580591|76117003|FG001|Overall Study|Other than specified|2|||
42285097|NCT02580591|76117004|FG002|Overall Study|Other than specified|5|||
42285098|NCT02580591|76117005|FG003|Overall Study|Other than specified|2|||
42285099|NCT02580357|76117018|FG000|Overall Study|Lost to Follow-up|2|||
42285100|NCT02580357|76117019|FG001|Overall Study|Lost to Follow-up|0|||
42285101|NCT02580357|76117020|FG002|Overall Study|Lost to Follow-up|0|||
42285102|NCT02580357|76117018|FG000|Overall Study|Protocol Violation|1|||
42285103|NCT02580357|76117019|FG001|Overall Study|Protocol Violation|0|||
42285104|NCT02580357|76117020|FG002|Overall Study|Protocol Violation|0|||
42285105|NCT01664091|76117028|FG000|Overall Study|Death|1|||
42285106|NCT01664091|76117028|FG000|Overall Study|Disease Progression|2|||
42285107|NCT01664091|76117028|FG000|Overall Study|Lost to Follow-up|2|||
42285108|NCT01664091|76117028|FG000|Overall Study|Withdrawal by Subject|1|||
42285109|NCT02577315|76117035|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
42285110|NCT02577315|76117036|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
42285111|NCT02711345|76117052|FG000|Overall Study|Adverse Event|0|||
42285112|NCT02711345|76117053|FG001|Overall Study|Adverse Event|0|||
42285113|NCT02711345|76117054|FG002|Overall Study|Adverse Event|0|||
42285114|NCT02711345|76117055|FG003|Overall Study|Adverse Event|1|||
42285115|NCT02711345|76117056|FG004|Overall Study|Adverse Event|1|||
42285116|NCT02711345|76117057|FG005|Overall Study|Adverse Event|2|||
42285117|NCT02711345|76117058|FG006|Overall Study|Adverse Event|1|||
42285118|NCT02711345|76117059|FG007|Overall Study|Adverse Event|0|||
42285119|NCT02711345|76117060|FG008|Overall Study|Adverse Event|0|||
42285120|NCT02711345|76117061|FG009|Overall Study|Adverse Event|2|||
42285121|NCT02711345|76117052|FG000|Overall Study|Physician Decision|0|||
42285122|NCT02711345|76117053|FG001|Overall Study|Physician Decision|0|||
42285123|NCT02711345|76117054|FG002|Overall Study|Physician Decision|1|||
42285124|NCT02711345|76117055|FG003|Overall Study|Physician Decision|0|||
42285125|NCT02711345|76117056|FG004|Overall Study|Physician Decision|0|||
42285126|NCT02711345|76117057|FG005|Overall Study|Physician Decision|0|||
42285127|NCT02711345|76117058|FG006|Overall Study|Physician Decision|0|||
42285128|NCT02711345|76117059|FG007|Overall Study|Physician Decision|0|||
42285129|NCT02711345|76117060|FG008|Overall Study|Physician Decision|1|||
42285130|NCT02711345|76117061|FG009|Overall Study|Physician Decision|0|||
42285131|NCT02711345|76117052|FG000|Overall Study|Progressive disease|1|||
42285132|NCT02711345|76117053|FG001|Overall Study|Progressive disease|3|||
42352808|NCT01534533|76192827|FG001|Overall Study|Withdrawal by Subject|3|||
42352809|NCT01534533|76192828|FG002|Overall Study|Withdrawal by Subject|4|||
42352810|NCT01534533|76192829|FG003|Overall Study|Withdrawal by Subject|1|||
42352811|NCT01506609|76192963|FG000|Overall Study|Adverse Event Related to Progression|0|||
42352812|NCT01506609|76192964|FG001|Overall Study|Adverse Event Related to Progression|0|||
42352813|NCT01506609|76192965|FG002|Overall Study|Adverse Event Related to Progression|0|||
42285133|NCT02711345|76117054|FG002|Overall Study|Progressive disease|5|||
42285134|NCT02711345|76117055|FG003|Overall Study|Progressive disease|3|||
42285135|NCT02711345|76117056|FG004|Overall Study|Progressive disease|7|||
42352814|NCT01506609|76192966|FG003|Overall Study|Adverse Event Related to Progression|3|||
42352815|NCT01506609|76192967|FG004|Overall Study|Adverse Event Related to Progression|7|||
42352816|NCT01506609|76192968|FG005|Overall Study|Adverse Event Related to Progression|3|||
42352817|NCT01506609|76192963|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
42285136|NCT02711345|76117057|FG005|Overall Study|Progressive disease|2|||
42285137|NCT02711345|76117058|FG006|Overall Study|Progressive disease|8|||
42285138|NCT02711345|76117059|FG007|Overall Study|Progressive disease|4|||
42285139|NCT02711345|76117060|FG008|Overall Study|Progressive disease|5|||
42285140|NCT02711345|76117061|FG009|Overall Study|Progressive disease|6|||
42285141|NCT02711345|76117052|FG000|Overall Study|Subject/guardian decision|0|||
42285142|NCT02711345|76117053|FG001|Overall Study|Subject/guardian decision|0|||
42285143|NCT02711345|76117054|FG002|Overall Study|Subject/guardian decision|0|||
42285144|NCT02711345|76117055|FG003|Overall Study|Subject/guardian decision|0|||
42285145|NCT02711345|76117056|FG004|Overall Study|Subject/guardian decision|0|||
42285146|NCT02711345|76117057|FG005|Overall Study|Subject/guardian decision|2|||
42285147|NCT02711345|76117058|FG006|Overall Study|Subject/guardian decision|3|||
42285148|NCT02711345|76117059|FG007|Overall Study|Subject/guardian decision|1|||
42285149|NCT02711345|76117060|FG008|Overall Study|Subject/guardian decision|0|||
42285150|NCT02711345|76117061|FG009|Overall Study|Subject/guardian decision|4|||
42285151|NCT02711345|76117052|FG000|Overall Study|Death|1|||
42285152|NCT02711345|76117053|FG001|Overall Study|Death|0|||
42285153|NCT02711345|76117054|FG002|Overall Study|Death|0|||
42285154|NCT02711345|76117055|FG003|Overall Study|Death|0|||
42285155|NCT02711345|76117056|FG004|Overall Study|Death|0|||
42285156|NCT02711345|76117057|FG005|Overall Study|Death|0|||
42285157|NCT02711345|76117058|FG006|Overall Study|Death|0|||
42285158|NCT02711345|76117059|FG007|Overall Study|Death|1|||
42285159|NCT02711345|76117060|FG008|Overall Study|Death|0|||
42285160|NCT02711345|76117061|FG009|Overall Study|Death|0|||
42285161|NCT02581995|76117098|FG000|Overall Study|Unspecified other|3|||
42285162|NCT02581995|76117098|FG000|Overall Study|Adverse Event|6|||
42285163|NCT02581995|76117098|FG000|Overall Study|Lost to Follow-up|5|||
42285164|NCT02581995|76117098|FG000|Overall Study|Withdrawal by participant|12|||
42285165|NCT02581995|76117098|FG000|Overall Study|Physician Decision|1|||
42285166|NCT02581995|76117098|FG000|Overall Study|Death|4|||
42285167|NCT02577003|76117104|FG000|Overall Study|Adverse Event|2|||
42285168|NCT02577003|76117105|FG001|Overall Study|Adverse Event|4|||
42285169|NCT02577003|76117104|FG000|Overall Study|Withdrawal by Subject|0|||
42285170|NCT02577003|76117105|FG001|Overall Study|Withdrawal by Subject|1|||
42285171|NCT02446899|76117113|FG000|Overall Study|Adverse Event|4|||
42285172|NCT02446899|76117114|FG001|Overall Study|Adverse Event|7|||
42285173|NCT02446899|76117113|FG000|Overall Study|Condition Under Investigation Worsened|1|||
42285174|NCT02446899|76117114|FG001|Overall Study|Condition Under Investigation Worsened|4|||
42285175|NCT02446899|76117113|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
42285176|NCT02446899|76117114|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
42285177|NCT02446899|76117113|FG000|Overall Study|Lack of Efficacy|2|||
42285178|NCT02446899|76117114|FG001|Overall Study|Lack of Efficacy|8|||
42285179|NCT02446899|76117113|FG000|Overall Study|Lost to Follow-up|1|||
42285180|NCT02446899|76117114|FG001|Overall Study|Lost to Follow-up|3|||
42285181|NCT02446899|76117113|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
42285182|NCT02446899|76117114|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
42285183|NCT02446899|76117113|FG000|Overall Study|Withdrawal by Subject|11|||
42285184|NCT02446899|76117114|FG001|Overall Study|Withdrawal by Subject|19|||
42285185|NCT02446899|76117113|FG000|Overall Study|Miscellaneous|5|||
42285186|NCT02446899|76117114|FG001|Overall Study|Miscellaneous|4|||
42285187|NCT02446899|76117113|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
42285188|NCT02446899|76117114|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
42285189|NCT02709785|76117123|FG000|Overall Study|Withdrawal by Subject|1|||
42285190|NCT02709785|76117124|FG001|Overall Study|Withdrawal by Subject|2|||
42285191|NCT02709785|76117125|FG002|Overall Study|Withdrawal by Subject|1|||
42285192|NCT02356887|76117133|FG000|Overall Study|poor compliance|2|||
42285193|NCT01604265|76117145|FG000|Overall Study|Adverse Event|1|||
42285194|NCT01604265|76117146|FG001|Overall Study|Adverse Event|0|||
42285195|NCT01604265|76117145|FG000|Overall Study|Withdrawal by Subject|1|||
42285196|NCT01604265|76117146|FG001|Overall Study|Withdrawal by Subject|0|||
42285197|NCT01664247|76117154|FG000|Overall Study|Adverse Event|5|||
42285198|NCT01664247|76117155|FG001|Overall Study|Adverse Event|3|||
42285199|NCT01664247|76117154|FG000|Overall Study|Protocol Violation|3|||
42285200|NCT01664247|76117155|FG001|Overall Study|Protocol Violation|5|||
42285201|NCT01664247|76117154|FG000|Overall Study|Withdrawal Criteria|1|||
42352818|NCT01506609|76192964|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
42171618|NCT00394901|75978522|FG003|Double-blind Phase|Lost to Follow-up|1|||
42171619|NCT00394901|75978519|FG000|Double-blind Phase|Protocol Violation|0|||
42285202|NCT01664247|76117155|FG001|Overall Study|Withdrawal Criteria|4|||
42285203|NCT01664247|76117154|FG000|Overall Study|Unclassified|5|||
42285204|NCT01664247|76117155|FG001|Overall Study|Unclassified|29|||
42285205|NCT03191903|76117179|FG000|Overall Study|Withdrawal by Subject|6|||
42285206|NCT03191903|76117180|FG001|Overall Study|Withdrawal by Subject|5|||
42285207|NCT03191903|76117181|FG002|Overall Study|Withdrawal by Subject|4|||
42285208|NCT03191903|76117179|FG000|Overall Study|Adverse Event|1|||
42285209|NCT03191903|76117180|FG001|Overall Study|Adverse Event|0|||
42352819|NCT01506609|76192965|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
42285210|NCT03191903|76117181|FG002|Overall Study|Adverse Event|0|||
42285211|NCT02576145|76117196|FG000|Overall Study|Adverse Event|1|||
42285212|NCT02576145|76117197|FG001|Overall Study|Adverse Event|0|||
42285213|NCT02576145|76117196|FG000|Overall Study|Withdrawal by Subject|1|||
42285214|NCT02576145|76117197|FG001|Overall Study|Withdrawal by Subject|0|||
42285215|NCT02576145|76117196|FG000|Overall Study|Acute rejection|1|||
42285216|NCT02576145|76117197|FG001|Overall Study|Acute rejection|0|||
42285217|NCT02576145|76117196|FG000|Overall Study|Tetanus Titers Decreased|0|||
42285218|NCT02576145|76117197|FG001|Overall Study|Tetanus Titers Decreased|1|||
42285219|NCT02576067|76117242|FG000|Overall Study|Death|0|||
42285220|NCT02576067|76117243|FG001|Overall Study|Death|1|||
42285221|NCT02576067|76117242|FG000|Overall Study|Lack of Efficacy|1|||
42285222|NCT02576067|76117243|FG001|Overall Study|Lack of Efficacy|0|||
42285223|NCT02576067|76117242|FG000|Overall Study|Lost to Follow-up|11|||
42285224|NCT02576067|76117243|FG001|Overall Study|Lost to Follow-up|0|||
42285225|NCT02576067|76117242|FG000|Overall Study|Withdrawal by Subject|11|||
42285226|NCT02576067|76117243|FG001|Overall Study|Withdrawal by Subject|2|||
42285227|NCT02576067|76117242|FG000|Overall Study|study closure of main CIRT trial)|0|||
42285228|NCT02576067|76117243|FG001|Overall Study|study closure of main CIRT trial)|8|||
42285229|NCT02576067|76117242|FG000|Overall Study|not randomized, failed run-in|7|||
42285230|NCT02576067|76117243|FG001|Overall Study|not randomized, failed run-in|0|||
42285231|NCT02576067|76117242|FG000|Overall Study|screen failure/ re-enrolled|0|||
42285232|NCT02576067|76117243|FG001|Overall Study|screen failure/ re-enrolled|25|||
42285233|NCT02576067|76117242|FG000|Overall Study|Physician Decision|4|||
42285234|NCT02576067|76117243|FG001|Overall Study|Physician Decision|0|||
42285235|NCT02575911|76117249|FG000|Overall Study|Lost to Follow-up|1|||
42285236|NCT02575833|76117263|FG000|Overall Study|Withdrawal by Subject|0|||
42285237|NCT02575833|76117264|FG001|Overall Study|Withdrawal by Subject|1|||
42285238|NCT02575833|76117263|FG000|Overall Study|Lost to Follow-up|1|||
42285239|NCT02575833|76117264|FG001|Overall Study|Lost to Follow-up|0|||
42285240|NCT02709083|76117270|FG000|Overall Study|Original PI left institution|7|||
42285241|NCT02709005|76117276|FG000|Overall Study|Lost to Follow-up|1|||
42285242|NCT02709005|76117277|FG001|Overall Study|Lost to Follow-up|1|||
42285243|NCT02709005|76117276|FG000|Overall Study|Withdrawal by Subject|3|||
42285244|NCT02709005|76117277|FG001|Overall Study|Withdrawal by Subject|0|||
42285245|NCT02573883|76117285|FG000|Six Month Follow Up|Lost to Follow-up|1|||
42285246|NCT02573883|76117286|FG001|Six Month Follow Up|Lost to Follow-up|0|||
42285247|NCT02573883|76117287|FG002|Six Month Follow Up|Lost to Follow-up|0|||
42285248|NCT02573883|76117288|FG003|Six Month Follow Up|Lost to Follow-up|0|||
42285249|NCT02573883|76117285|FG000|One Year Follow Up|Lost to Follow-up|2|||
42285250|NCT02573883|76117286|FG001|One Year Follow Up|Lost to Follow-up|1|||
42285251|NCT02573883|76117287|FG002|One Year Follow Up|Lost to Follow-up|0|||
42285252|NCT02573883|76117288|FG003|One Year Follow Up|Lost to Follow-up|0|||
42285253|NCT02575365|76117303|FG000|Overall Study|Lost to Follow-up|4|||
42285254|NCT02707991|76117309|FG000|Overall Study|Protocol Violation|1|||
42285255|NCT02707991|76117310|FG001|Overall Study|Protocol Violation|0|||
42285256|NCT02707991|76117309|FG000|Overall Study|Became ineligible|0|||
42285257|NCT02707991|76117310|FG001|Overall Study|Became ineligible|1|||
42285258|NCT02707757|76117318|FG000|Overall Study|Protocol Violation|3|||
42285259|NCT02707757|76117319|FG001|Overall Study|Protocol Violation|2|||
42285260|NCT02707757|76117318|FG000|Overall Study|Withdrawal by Subject|2|||
42285261|NCT02707757|76117319|FG001|Overall Study|Withdrawal by Subject|0|||
42285262|NCT02707757|76117318|FG000|Overall Study|Death|0|||
42285263|NCT02707757|76117319|FG001|Overall Study|Death|1|||
42285264|NCT02707757|76117318|FG000|Overall Study|Adverse Event|6|||
42285265|NCT02707757|76117319|FG001|Overall Study|Adverse Event|4|||
42285266|NCT02707757|76117318|FG000|Overall Study|Renal transplant/elective operation|1|||
42285267|NCT02707757|76117319|FG001|Overall Study|Renal transplant/elective operation|5|||
42285268|NCT02572401|76117329|FG000|Overall Study|Lost to Follow-up|5|||
42285269|NCT02572401|76117330|FG001|Overall Study|Lost to Follow-up|8|||
42285270|NCT02572401|76117331|FG002|Overall Study|Lost to Follow-up|9|||
42285271|NCT02572401|76117332|FG003|Overall Study|Lost to Follow-up|9|||
42285272|NCT02572401|76117329|FG000|Overall Study|Death|0|||
42285273|NCT02572401|76117330|FG001|Overall Study|Death|0|||
42285274|NCT02572401|76117331|FG002|Overall Study|Death|0|||
42015043|NCT01232790|75822203|FG001|Second Crossover|Withdrawal by Subject|2|||
42015044|NCT01232556|75822221|FG000|Overall Study|Withdrawal by Subject|21|||
42171620|NCT00394901|75978520|FG001|Double-blind Phase|Protocol Violation|0|||
42171621|NCT00394901|75978521|FG002|Double-blind Phase|Protocol Violation|0|||
42285275|NCT02572401|76117332|FG003|Overall Study|Death|1|||
42285276|NCT02431325|76117344|FG000|Overall Study|Adverse Event|3|||
42285277|NCT02431325|76117345|FG001|Overall Study|Adverse Event|0|||
42285278|NCT02431325|76117344|FG000|Overall Study|Lost to Follow-up|0|||
42285279|NCT02431325|76117345|FG001|Overall Study|Lost to Follow-up|1|||
42285280|NCT02431325|76117344|FG000|Overall Study|Withdrawal by Subject|1|||
42285281|NCT02431325|76117345|FG001|Overall Study|Withdrawal by Subject|2|||
42285282|NCT02431325|76117344|FG000|Overall Study|Declined to take study medication|1|||
42285283|NCT02431325|76117345|FG001|Overall Study|Declined to take study medication|0|||
42285284|NCT02431325|76117344|FG000|Overall Study|Withdrew before starting study medication|1|||
42171622|NCT00394901|75978522|FG003|Double-blind Phase|Protocol Violation|1|||
42285285|NCT02431325|76117345|FG001|Overall Study|Withdrew before starting study medication|0|||
42285286|NCT02431325|76117344|FG000|Overall Study|Placebo shortage|2|||
42285287|NCT02431325|76117345|FG001|Overall Study|Placebo shortage|0|||
42285288|NCT02103478|76117358|FG000|Overall Study|Adverse Event|0|||
42285289|NCT02103478|76117359|FG001|Overall Study|Adverse Event|0|||
42285290|NCT02103478|76117360|FG002|Overall Study|Adverse Event|1|||
42285291|NCT02103478|76117361|FG003|Overall Study|Adverse Event|1|||
42285292|NCT02103478|76117362|FG004|Overall Study|Adverse Event|2|||
42285293|NCT02103478|76117363|FG005|Overall Study|Adverse Event|1|||
42285294|NCT02103478|76117364|FG006|Overall Study|Adverse Event|0|||
42285295|NCT02103478|76117365|FG007|Overall Study|Adverse Event|0|||
42285296|NCT02103478|76117366|FG008|Overall Study|Adverse Event|0|||
42285297|NCT02103478|76117358|FG000|Overall Study|Death|2|||
42285298|NCT02103478|76117359|FG001|Overall Study|Death|2|||
42285299|NCT02103478|76117360|FG002|Overall Study|Death|1|||
42285300|NCT02103478|76117361|FG003|Overall Study|Death|1|||
42285301|NCT02103478|76117362|FG004|Overall Study|Death|5|||
42352820|NCT01506609|76192966|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
42352821|NCT01506609|76192967|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
42352822|NCT01506609|76192968|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
42352823|NCT01506609|76192963|FG000|Overall Study|Withdrawal by Subject|0|||
42352824|NCT01506609|76192964|FG001|Overall Study|Withdrawal by Subject|0|||
42352825|NCT01506609|76192965|FG002|Overall Study|Withdrawal by Subject|0|||
42352826|NCT01506609|76192966|FG003|Overall Study|Withdrawal by Subject|9|||
42352827|NCT01506609|76192967|FG004|Overall Study|Withdrawal by Subject|7|||
42352828|NCT01506609|76192968|FG005|Overall Study|Withdrawal by Subject|7|||
42352829|NCT01506609|76192963|FG000|Overall Study|Lost to Follow-up|0|||
42352830|NCT01506609|76192964|FG001|Overall Study|Lost to Follow-up|0|||
42352831|NCT01506609|76192965|FG002|Overall Study|Lost to Follow-up|0|||
42352832|NCT01506609|76192966|FG003|Overall Study|Lost to Follow-up|1|||
42352833|NCT01506609|76192967|FG004|Overall Study|Lost to Follow-up|2|||
42352834|NCT01506609|76192968|FG005|Overall Study|Lost to Follow-up|0|||
42352835|NCT01506609|76192963|FG000|Overall Study|Sponsor Discontinued Study|0|||
42352836|NCT01506609|76192964|FG001|Overall Study|Sponsor Discontinued Study|0|||
42352837|NCT01506609|76192965|FG002|Overall Study|Sponsor Discontinued Study|0|||
42352838|NCT01506609|76192966|FG003|Overall Study|Sponsor Discontinued Study|2|||
42352839|NCT01506609|76192967|FG004|Overall Study|Sponsor Discontinued Study|2|||
42352840|NCT01506609|76192968|FG005|Overall Study|Sponsor Discontinued Study|0|||
42352841|NCT01506609|76192963|FG000|Overall Study|Progressive Disease per Protocol|1|||
42352842|NCT01506609|76192964|FG001|Overall Study|Progressive Disease per Protocol|0|||
42352843|NCT01506609|76192965|FG002|Overall Study|Progressive Disease per Protocol|0|||
42352844|NCT01506609|76192966|FG003|Overall Study|Progressive Disease per Protocol|64|||
42352845|NCT01506609|76192967|FG004|Overall Study|Progressive Disease per Protocol|57|||
42352846|NCT01506609|76192968|FG005|Overall Study|Progressive Disease per Protocol|74|||
42352847|NCT01506609|76192963|FG000|Overall Study|Other, Not Specified|0|||
42352848|NCT01506609|76192964|FG001|Overall Study|Other, Not Specified|0|||
42352849|NCT01506609|76192965|FG002|Overall Study|Other, Not Specified|0|||
42352850|NCT01506609|76192966|FG003|Overall Study|Other, Not Specified|10|||
42352851|NCT01506609|76192967|FG004|Overall Study|Other, Not Specified|7|||
42352852|NCT01506609|76192968|FG005|Overall Study|Other, Not Specified|3|||
42352853|NCT01506609|76192963|FG000|Overall Study|Missing / Unknown Reason|1|||
42352854|NCT01506609|76192964|FG001|Overall Study|Missing / Unknown Reason|0|||
42352855|NCT01506609|76192965|FG002|Overall Study|Missing / Unknown Reason|1|||
42352856|NCT01506609|76192966|FG003|Overall Study|Missing / Unknown Reason|4|||
42352857|NCT01506609|76192967|FG004|Overall Study|Missing / Unknown Reason|4|||
42352858|NCT01506609|76192968|FG005|Overall Study|Missing / Unknown Reason|2|||
42352859|NCT01506453|76192992|FG000|Overall Study|Withdrawal prior to treatment|0|||
42352860|NCT01506453|76192993|FG001|Overall Study|Withdrawal prior to treatment|2|||
42352861|NCT01482429|76193001|FG000|Care Usual|Protocol Violation|0|||
42352862|NCT01482429|76193002|FG001|Care Usual|Protocol Violation|172|||
42352863|NCT01482429|76193001|FG000|Care Usual|Lost to Follow-up|0|||
42352864|NCT01482429|76193002|FG001|Care Usual|Lost to Follow-up|1|||
42352865|NCT01482429|76193001|FG000|Protocol|Protocol Violation|275|||
42352866|NCT01482429|76193002|FG001|Protocol|Protocol Violation|0|||
42015045|NCT01232556|75822222|FG001|Overall Study|Withdrawal by Subject|17|||
42352867|NCT01504971|76193008|FG000|Overall Study|Physician Decision|13|||
42015046|NCT01232556|75822221|FG000|Overall Study|Death|97|||
42285302|NCT02103478|76117363|FG005|Overall Study|Death|15|||
42285303|NCT02103478|76117364|FG006|Overall Study|Death|14|||
42285304|NCT02103478|76117365|FG007|Overall Study|Death|10|||
42352868|NCT01479777|76193016|FG000|Overall Study|Physician Decision|2|||
42352869|NCT01479621|76193026|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
42352870|NCT01479621|76193027|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42285305|NCT02103478|76117366|FG008|Overall Study|Death|11|||
42352871|NCT01479621|76193028|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42352872|NCT01479621|76193029|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42352873|NCT01479621|76193030|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42285306|NCT02103478|76117358|FG000|Overall Study|Progressive Disease|2|||
42285307|NCT02103478|76117359|FG001|Overall Study|Progressive Disease|1|||
42285308|NCT02103478|76117360|FG002|Overall Study|Progressive Disease|2|||
42285309|NCT02103478|76117361|FG003|Overall Study|Progressive Disease|0|||
42285310|NCT02103478|76117362|FG004|Overall Study|Progressive Disease|9|||
42285311|NCT02103478|76117363|FG005|Overall Study|Progressive Disease|1|||
42285312|NCT02103478|76117364|FG006|Overall Study|Progressive Disease|2|||
42285313|NCT02103478|76117365|FG007|Overall Study|Progressive Disease|0|||
42285314|NCT02103478|76117366|FG008|Overall Study|Progressive Disease|1|||
42285315|NCT02103478|76117358|FG000|Overall Study|Withdrawal by Subject|2|||
42285316|NCT02103478|76117359|FG001|Overall Study|Withdrawal by Subject|0|||
42285317|NCT02103478|76117360|FG002|Overall Study|Withdrawal by Subject|0|||
42285318|NCT02103478|76117361|FG003|Overall Study|Withdrawal by Subject|4|||
42285319|NCT02103478|76117362|FG004|Overall Study|Withdrawal by Subject|0|||
42285320|NCT02103478|76117363|FG005|Overall Study|Withdrawal by Subject|0|||
42285321|NCT02103478|76117364|FG006|Overall Study|Withdrawal by Subject|1|||
42285322|NCT02103478|76117365|FG007|Overall Study|Withdrawal by Subject|1|||
42352874|NCT01479621|76193031|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42352875|NCT01479621|76193032|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42352876|NCT01479621|76193026|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
42352877|NCT01479621|76193027|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42352878|NCT01479621|76193028|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42352879|NCT01479621|76193029|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42352880|NCT01479621|76193030|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42352881|NCT01479621|76193031|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42352882|NCT01479621|76193032|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42352883|NCT01479621|76193026|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
42352884|NCT01479621|76193027|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42352885|NCT01479621|76193028|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42352886|NCT01479621|76193029|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42352887|NCT01479621|76193030|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42352888|NCT01479621|76193031|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42352889|NCT01479621|76193032|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42352890|NCT01479621|76193026|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
42352891|NCT01479621|76193027|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42352892|NCT01479621|76193028|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42352893|NCT01479621|76193029|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42352894|NCT01479621|76193030|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42352895|NCT01479621|76193031|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42352896|NCT01479621|76193032|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42352897|NCT01479621|76193026|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
42352898|NCT01479621|76193027|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42352899|NCT01479621|76193028|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42352900|NCT01479621|76193029|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42352901|NCT01479621|76193030|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42352902|NCT01479621|76193031|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42352903|NCT01479621|76193032|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42352904|NCT01479621|76193026|FG000|Treatment Period|Adverse Event|0|||
42352905|NCT01479621|76193027|FG001|Treatment Period|Adverse Event|0|||
42352906|NCT01479621|76193028|FG002|Treatment Period|Adverse Event|0|||
42352907|NCT01479621|76193029|FG003|Treatment Period|Adverse Event|0|||
42352908|NCT01479621|76193030|FG004|Treatment Period|Adverse Event|1|||
42352909|NCT01479621|76193031|FG005|Treatment Period|Adverse Event|2|||
42352910|NCT01479621|76193032|FG006|Treatment Period|Adverse Event|2|||
42352911|NCT01479621|76193026|FG000|Treatment Period|Withdrawal by Subject|0|||
42352912|NCT01479621|76193027|FG001|Treatment Period|Withdrawal by Subject|4|||
42352913|NCT01479621|76193028|FG002|Treatment Period|Withdrawal by Subject|2|||
42352914|NCT01479621|76193029|FG003|Treatment Period|Withdrawal by Subject|2|||
42352915|NCT01479621|76193030|FG004|Treatment Period|Withdrawal by Subject|5|||
42352916|NCT01479621|76193031|FG005|Treatment Period|Withdrawal by Subject|5|||
42352917|NCT01479621|76193032|FG006|Treatment Period|Withdrawal by Subject|1|||
42352918|NCT01479621|76193026|FG000|Treatment Period|Physician Decision|0|||
42285323|NCT02103478|76117366|FG008|Overall Study|Withdrawal by Subject|0|||
42285324|NCT02103478|76117358|FG000|Overall Study|Lost to Follow-up|0|||
42285325|NCT02103478|76117359|FG001|Overall Study|Lost to Follow-up|0|||
42352919|NCT01479621|76193027|FG001|Treatment Period|Physician Decision|0|||
42352920|NCT01479621|76193028|FG002|Treatment Period|Physician Decision|0|||
42352921|NCT01479621|76193029|FG003|Treatment Period|Physician Decision|0|||
42352922|NCT01479621|76193030|FG004|Treatment Period|Physician Decision|1|||
42015047|NCT01232556|75822222|FG001|Overall Study|Death|97|||
42285326|NCT02103478|76117360|FG002|Overall Study|Lost to Follow-up|0|||
42285327|NCT02103478|76117361|FG003|Overall Study|Lost to Follow-up|0|||
42285328|NCT02103478|76117362|FG004|Overall Study|Lost to Follow-up|0|||
42285329|NCT02103478|76117363|FG005|Overall Study|Lost to Follow-up|0|||
42285330|NCT02103478|76117364|FG006|Overall Study|Lost to Follow-up|0|||
42285331|NCT02103478|76117365|FG007|Overall Study|Lost to Follow-up|1|||
42285332|NCT02103478|76117366|FG008|Overall Study|Lost to Follow-up|0|||
42285333|NCT02103478|76117358|FG000|Overall Study|Other|1|||
42285334|NCT02103478|76117359|FG001|Overall Study|Other|3|||
42285335|NCT02103478|76117360|FG002|Overall Study|Other|2|||
42285336|NCT02103478|76117361|FG003|Overall Study|Other|0|||
42285337|NCT02103478|76117362|FG004|Overall Study|Other|3|||
42285338|NCT02103478|76117363|FG005|Overall Study|Other|8|||
42285339|NCT02103478|76117364|FG006|Overall Study|Other|8|||
42285340|NCT02103478|76117365|FG007|Overall Study|Other|4|||
42285341|NCT02103478|76117366|FG008|Overall Study|Other|2|||
42285342|NCT02102464|76117398|FG000|Randomized Study|Withdrawal by Subject|0|||
42285343|NCT02102464|76117399|FG001|Randomized Study|Withdrawal by Subject|1|||
42285344|NCT02102464|76117400|FG002|Randomized Study|Withdrawal by Subject|0|||
42285345|NCT02707601|76117411|FG000|Overall Study|Death|0|||
42285346|NCT02707601|76117412|FG001|Overall Study|Death|1|||
42285347|NCT02707601|76117411|FG000|Overall Study|Lack of Efficacy|0|||
42285348|NCT02707601|76117412|FG001|Overall Study|Lack of Efficacy|1|||
42285349|NCT02707601|76117411|FG000|Overall Study|Investigator's Discretion|1|||
42285350|NCT02707601|76117412|FG001|Overall Study|Investigator's Discretion|0|||
42285351|NCT02707601|76117411|FG000|Overall Study|Withdrew Consent|0|||
42285352|NCT02707601|76117412|FG001|Overall Study|Withdrew Consent|1|||
42285353|NCT02707601|76117411|FG000|Overall Study|Lost to Follow-up|1|||
42285354|NCT02707601|76117412|FG001|Overall Study|Lost to Follow-up|1|||
42285355|NCT02707601|76117411|FG000|Overall Study|Participants Randomized but Not Treated|2|||
42285356|NCT02707601|76117412|FG001|Overall Study|Participants Randomized but Not Treated|0|||
42285357|NCT02707055|76117424|FG000|Phase 1|Withdrawal by Subject|1|||
42285358|NCT02707055|76117425|FG001|Phase 1|Withdrawal by Subject|2|||
42285359|NCT02707055|76117424|FG000|Phase 1|Physician Decision|0|||
42285360|NCT02707055|76117425|FG001|Phase 1|Physician Decision|1|||
42285361|NCT02707055|76117424|FG000|Phase 2|Adverse Event|1|||
42285362|NCT02707055|76117425|FG001|Phase 2|Adverse Event|2|||
42285363|NCT02073682|76117433|FG000|Overall Study|Low Creatinine Clearance|1|||
42285364|NCT02073682|76117434|FG001|Overall Study|Low Creatinine Clearance|2|||
42285365|NCT02073682|76117433|FG000|Overall Study|Death|86|||
42285366|NCT02073682|76117434|FG001|Overall Study|Death|100|||
42285367|NCT02073682|76117433|FG000|Overall Study|Cancer Cured|10|||
42285368|NCT02073682|76117434|FG001|Overall Study|Cancer Cured|15|||
42285369|NCT02073682|76117433|FG000|Overall Study|ID: Patient Noncompliance|1|||
42285370|NCT02073682|76117434|FG001|Overall Study|ID: Patient Noncompliance|2|||
42285371|NCT02073682|76117433|FG000|Overall Study|ID: Palliative Treatment Only|10|||
42285372|NCT02073682|76117434|FG001|Overall Study|ID: Palliative Treatment Only|7|||
42285373|NCT02073682|76117433|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
42285374|NCT02073682|76117434|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
42015048|NCT01232556|75822221|FG000|Overall Study|Lost to Follow-up|0|||
42171623|NCT00394901|75978519|FG000|Double-blind Phase|Death|1|||
42171624|NCT00394901|75978520|FG001|Double-blind Phase|Death|0|||
42171625|NCT00394901|75978521|FG002|Double-blind Phase|Death|0|||
42285375|NCT02073682|76117433|FG000|Overall Study|Platelet Count <50,000/mL|1|||
42285376|NCT02073682|76117434|FG001|Overall Study|Platelet Count <50,000/mL|2|||
42285377|NCT02073682|76117433|FG000|Overall Study|Surgery/Medical Procedure|3|||
42285378|NCT02073682|76117434|FG001|Overall Study|Surgery/Medical Procedure|1|||
42285379|NCT02073682|76117433|FG000|Overall Study|Withdrawal by Subject|6|||
42285380|NCT02073682|76117434|FG001|Overall Study|Withdrawal by Subject|8|||
42285381|NCT02073682|76117433|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
42285382|NCT02073682|76117434|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
42285383|NCT02073682|76117433|FG000|Overall Study|Cancer Progression|53|||
42285384|NCT02073682|76117434|FG001|Overall Study|Cancer Progression|33|||
42285385|NCT02073682|76117433|FG000|Overall Study|Protocol Violation|1|||
42285386|NCT02073682|76117434|FG001|Overall Study|Protocol Violation|0|||
42285387|NCT02073682|76117433|FG000|Overall Study|Adverse Event|79|||
42285388|NCT02073682|76117434|FG001|Overall Study|Adverse Event|62|||
42285389|NCT02073682|76117433|FG000|Overall Study|No reason provided|11|||
42285390|NCT02073682|76117434|FG001|Overall Study|No reason provided|9|||
42285391|NCT02073682|76117433|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
42285392|NCT02073682|76117434|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
42285393|NCT02073682|76117433|FG000|Overall Study|Lost to Follow-up|1|||
42285394|NCT02073682|76117434|FG001|Overall Study|Lost to Follow-up|1|||
42285395|NCT02073682|76117433|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
42285396|NCT02073682|76117434|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
42285397|NCT02072980|76117440|FG000|Period 2, Second Wear|Adverse Event|0|||
42285398|NCT02072980|76117441|FG001|Period 2, Second Wear|Adverse Event|1|||
42285399|NCT02706899|76117449|FG000|Overall Study|Withdrawal by Subject|1|||
42285400|NCT02706899|76117450|FG001|Overall Study|Withdrawal by Subject|0|||
42285401|NCT02706899|76117449|FG000|Overall Study|Death|8|||
42285402|NCT02706899|76117450|FG001|Overall Study|Death|0|||
42285403|NCT02706899|76117449|FG000|Overall Study|Study Termination by Sponsor|4|||
42285404|NCT02706899|76117450|FG001|Overall Study|Study Termination by Sponsor|6|||
42285405|NCT02072824|76117459|FG000|Overall Study|Insufficient clinical response|1|||
42285406|NCT02072824|76117460|FG001|Overall Study|Insufficient clinical response|0|||
42285407|NCT02072824|76117461|FG002|Overall Study|Insufficient clinical response|1|||
42285408|NCT02072824|76117459|FG000|Overall Study|No longer willing to participate|1|||
42285409|NCT02072824|76117460|FG001|Overall Study|No longer willing to participate|0|||
42285410|NCT02072824|76117461|FG002|Overall Study|No longer willing to participate|1|||
42285411|NCT02072824|76117459|FG000|Overall Study|Medication error|0|||
42285412|NCT02072824|76117460|FG001|Overall Study|Medication error|1|||
42285413|NCT02072824|76117461|FG002|Overall Study|Medication error|0|||
42285414|NCT02072824|76117459|FG000|Overall Study|Adverse Event|0|||
42285415|NCT02072824|76117460|FG001|Overall Study|Adverse Event|0|||
42285416|NCT02072824|76117461|FG002|Overall Study|Adverse Event|1|||
42285417|NCT02072668|76117469|FG000|Second Intervention|Lost to Follow-up|1|||
42285418|NCT02072668|76117470|FG001|Second Intervention|Lost to Follow-up|0|||
42285419|NCT02140762|76117480|FG000|Overall Study|Adverse Event|1|||
42285420|NCT02140762|76117481|FG001|Overall Study|Adverse Event|1|||
42285421|NCT02140762|76117480|FG000|Overall Study|Lost to Follow-up|9|||
42285422|NCT02140762|76117481|FG001|Overall Study|Lost to Follow-up|5|||
42285423|NCT02140762|76117480|FG000|Overall Study|Protocol Violation|1|||
42285424|NCT02140762|76117481|FG001|Overall Study|Protocol Violation|1|||
42285425|NCT02140762|76117480|FG000|Overall Study|Withdrawal by Subject|6|||
42285426|NCT02140762|76117481|FG001|Overall Study|Withdrawal by Subject|4|||
42285427|NCT02140762|76117480|FG000|Overall Study|Other|0|||
42285428|NCT02140762|76117481|FG001|Overall Study|Other|1|||
42285429|NCT02101294|76117492|FG000|Overall Study|Withdrawal by Subject|5|||
42285430|NCT02101294|76117492|FG000|Overall Study|Lost to Follow-up|6|||
42285431|NCT01598506|76117499|FG000|Overall Study|Withdrawal by Subject|2|||
42285432|NCT02140060|76117510|FG000|Overall Study|Adverse Event|0|||
42285433|NCT02140060|76117511|FG001|Overall Study|Adverse Event|0|||
42285434|NCT02140060|76117512|FG002|Overall Study|Adverse Event|0|||
42285435|NCT02140060|76117513|FG003|Overall Study|Adverse Event|1|||
42285436|NCT02140060|76117514|FG004|Overall Study|Adverse Event|1|||
42285437|NCT02140060|76117515|FG005|Overall Study|Adverse Event|1|||
42285438|NCT02140060|76117510|FG000|Overall Study|Lack of Efficacy|0|||
42285439|NCT02140060|76117511|FG001|Overall Study|Lack of Efficacy|0|||
42285440|NCT02140060|76117512|FG002|Overall Study|Lack of Efficacy|0|||
42285441|NCT02140060|76117513|FG003|Overall Study|Lack of Efficacy|1|||
42285442|NCT02140060|76117514|FG004|Overall Study|Lack of Efficacy|0|||
42285443|NCT02140060|76117515|FG005|Overall Study|Lack of Efficacy|0|||
42285444|NCT02139982|76117540|FG000|Overall Study|Lack of Efficacy|0|||
42285445|NCT02139982|76117541|FG001|Overall Study|Lack of Efficacy|1|||
42285446|NCT02139982|76117542|FG002|Overall Study|Lack of Efficacy|0|||
42285447|NCT02139982|76117543|FG003|Overall Study|Lack of Efficacy|1|||
42285448|NCT02139982|76117544|FG004|Overall Study|Lack of Efficacy|0|||
42285449|NCT02139982|76117545|FG005|Overall Study|Lack of Efficacy|0|||
42285450|NCT02139982|76117546|FG006|Overall Study|Lack of Efficacy|0|||
42285451|NCT02139982|76117547|FG007|Overall Study|Lack of Efficacy|0|||
42285452|NCT02139982|76117548|FG008|Overall Study|Lack of Efficacy|0|||
42015049|NCT01232556|75822222|FG001|Overall Study|Lost to Follow-up|2|||
42285453|NCT02139982|76117549|FG009|Overall Study|Lack of Efficacy|0|||
42285454|NCT02139826|76117571|FG000|Overall Study|Adverse Event|1|||
42285455|NCT02139592|76117581|FG000|Overall Study|Case Report Forms Uncollected|8|||
42285456|NCT02139280|76117587|FG000|Overall Study|No longer eligible|2|||
42285457|NCT02139280|76117588|FG001|Overall Study|No longer eligible|0|||
42285458|NCT02072434|76117596|FG000|Overall Study|Protocol Violation|10|||
42285459|NCT02072434|76117597|FG001|Overall Study|Protocol Violation|9|||
42285460|NCT02072434|76117596|FG000|Overall Study|Physician Decision|5|||
42285461|NCT02072434|76117597|FG001|Overall Study|Physician Decision|10|||
42285462|NCT02072434|76117596|FG000|Overall Study|Adverse event, serious fatal|1|||
42285463|NCT02072434|76117597|FG001|Overall Study|Adverse event, serious fatal|6|||
42285464|NCT02072434|76117596|FG000|Overall Study|Adverse Event|7|||
42285465|NCT02072434|76117597|FG001|Overall Study|Adverse Event|6|||
42285466|NCT02072434|76117596|FG000|Overall Study|Withdrawal by Subject|17|||
42285467|NCT02072434|76117597|FG001|Overall Study|Withdrawal by Subject|29|||
42285468|NCT02072434|76117596|FG000|Overall Study|Other|14|||
42285469|NCT02072434|76117597|FG001|Overall Study|Other|29|||
42285470|NCT02072434|76117596|FG000|Overall Study|Lost to Follow-up|0|||
42285471|NCT02072434|76117597|FG001|Overall Study|Lost to Follow-up|1|||
42285472|NCT02101060|76117605|FG000|Overall Study|Adverse Event|1|||
42285473|NCT02101060|76117606|FG001|Overall Study|Adverse Event|0|||
42285474|NCT02101060|76117605|FG000|Overall Study|Withdrawal by Subject|1|||
42285475|NCT02101060|76117606|FG001|Overall Study|Withdrawal by Subject|1|||
42015050|NCT01232556|75822221|FG000|Overall Study|Terminated by Sponsor|35|||
42285476|NCT02101060|76117605|FG000|Overall Study|Lost to Follow-up|3|||
42285477|NCT02101060|76117606|FG001|Overall Study|Lost to Follow-up|3|||
42285478|NCT02139124|76117617|FG000|Overall Study|Adverse Event|2|||
42285479|NCT02139124|76117618|FG001|Overall Study|Adverse Event|0|||
42285480|NCT02139124|76117619|FG002|Overall Study|Adverse Event|1|||
42285481|NCT02139124|76117620|FG003|Overall Study|Adverse Event|2|||
42285482|NCT02139124|76117621|FG004|Overall Study|Adverse Event|5|||
42285483|NCT02139124|76117617|FG000|Overall Study|Withdrawal by Subject|2|||
42285484|NCT02139124|76117618|FG001|Overall Study|Withdrawal by Subject|2|||
42285485|NCT02139124|76117619|FG002|Overall Study|Withdrawal by Subject|2|||
42352923|NCT01479621|76193031|FG005|Treatment Period|Physician Decision|1|||
42352924|NCT01479621|76193032|FG006|Treatment Period|Physician Decision|0|||
42352925|NCT01479621|76193026|FG000|Treatment Period|Non-compliance to study drug|0|||
42352926|NCT01479621|76193027|FG001|Treatment Period|Non-compliance to study drug|1|||
42352927|NCT01479621|76193028|FG002|Treatment Period|Non-compliance to study drug|0|||
42040775|NCT01522976|75848765|FG002|Overall Study|Refusal unrelated to adverse event|14|||
42040776|NCT01522976|75848763|FG000|Overall Study|Not protocol specified|22|||
42285486|NCT02139124|76117620|FG003|Overall Study|Withdrawal by Subject|2|||
42285487|NCT02139124|76117621|FG004|Overall Study|Withdrawal by Subject|3|||
42285488|NCT02139124|76117617|FG000|Overall Study|Protocol Violation|0|||
42285489|NCT02139124|76117618|FG001|Overall Study|Protocol Violation|0|||
42285490|NCT02139124|76117619|FG002|Overall Study|Protocol Violation|0|||
42285491|NCT02139124|76117620|FG003|Overall Study|Protocol Violation|1|||
42285492|NCT02139124|76117621|FG004|Overall Study|Protocol Violation|1|||
42285493|NCT02139124|76117617|FG000|Overall Study|non-compliant|1|||
42285494|NCT02139124|76117618|FG001|Overall Study|non-compliant|0|||
42285495|NCT02139124|76117619|FG002|Overall Study|non-compliant|0|||
42285496|NCT02139124|76117620|FG003|Overall Study|non-compliant|2|||
42285497|NCT02139124|76117621|FG004|Overall Study|non-compliant|0|||
42285498|NCT02139124|76117617|FG000|Overall Study|incarceration|0|||
42285499|NCT02139124|76117618|FG001|Overall Study|incarceration|0|||
42285500|NCT02139124|76117619|FG002|Overall Study|incarceration|1|||
42285501|NCT02139124|76117620|FG003|Overall Study|incarceration|0|||
42285502|NCT02139124|76117621|FG004|Overall Study|incarceration|0|||
42285503|NCT02139124|76117617|FG000|Overall Study|subject moved|1|||
42285504|NCT02139124|76117618|FG001|Overall Study|subject moved|0|||
42285505|NCT02139124|76117619|FG002|Overall Study|subject moved|0|||
42285506|NCT02139124|76117620|FG003|Overall Study|subject moved|0|||
42285507|NCT02139124|76117621|FG004|Overall Study|subject moved|0|||
42285508|NCT02139124|76117617|FG000|Overall Study|Lost to Follow-up|3|||
42285509|NCT02139124|76117618|FG001|Overall Study|Lost to Follow-up|2|||
42285510|NCT02139124|76117619|FG002|Overall Study|Lost to Follow-up|0|||
42285511|NCT02139124|76117620|FG003|Overall Study|Lost to Follow-up|5|||
42285512|NCT02139124|76117621|FG004|Overall Study|Lost to Follow-up|4|||
42285513|NCT02139046|76117638|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
42285514|NCT02139046|76117639|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
42285515|NCT02139046|76117640|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
42285516|NCT02139046|76117641|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
42285517|NCT02139046|76117642|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
42285518|NCT02139046|76117638|FG000|Overall Study|Major Protocol Deviation|9|||
42285519|NCT02139046|76117639|FG001|Overall Study|Major Protocol Deviation|10|||
42285520|NCT02139046|76117640|FG002|Overall Study|Major Protocol Deviation|16|||
42285521|NCT02139046|76117641|FG003|Overall Study|Major Protocol Deviation|12|||
42285522|NCT02139046|76117642|FG004|Overall Study|Major Protocol Deviation|6|||
42285523|NCT02139046|76117638|FG000|Overall Study|Lost to Follow-up|13|||
42352928|NCT01479621|76193029|FG003|Treatment Period|Non-compliance to study drug|0|||
42015051|NCT01232556|75822222|FG001|Overall Study|Terminated by Sponsor|51|||
42015052|NCT01232556|75822221|FG000|Overall Study|Other|6|||
42015053|NCT01232556|75822222|FG001|Overall Study|Other|4|||
42015054|NCT00946153|75822233|FG000|Phase 2|Adverse Event|0|||
42015055|NCT00946153|75822234|FG001|Phase 2|Adverse Event|0|||
42015056|NCT00946153|75822235|FG002|Phase 2|Adverse Event|0|||
42015057|NCT00946153|75822236|FG003|Phase 2|Adverse Event|0|||
42015058|NCT00946153|75822237|FG004|Phase 2|Adverse Event|6|||
42015059|NCT00946153|75822233|FG000|Phase 2|Need more reduction of dose|0|||
42015060|NCT00946153|75822234|FG001|Phase 2|Need more reduction of dose|0|||
42040777|NCT01522976|75848764|FG001|Overall Study|Not protocol specified|27|||
42040778|NCT01522976|75848765|FG002|Overall Study|Not protocol specified|27|||
42040779|NCT01386385|75848781|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
42352929|NCT01479621|76193030|FG004|Treatment Period|Non-compliance to study drug|0|||
42285524|NCT02139046|76117639|FG001|Overall Study|Lost to Follow-up|16|||
42285525|NCT02139046|76117640|FG002|Overall Study|Lost to Follow-up|16|||
42285526|NCT02139046|76117641|FG003|Overall Study|Lost to Follow-up|18|||
42015061|NCT00946153|75822235|FG002|Phase 2|Need more reduction of dose|0|||
42015062|NCT00946153|75822236|FG003|Phase 2|Need more reduction of dose|0|||
42285527|NCT02139046|76117642|FG004|Overall Study|Lost to Follow-up|13|||
42352930|NCT01479621|76193031|FG005|Treatment Period|Non-compliance to study drug|0|||
42285528|NCT02139046|76117638|FG000|Overall Study|Voluntary Withdrawal|20|||
42285529|NCT02139046|76117639|FG001|Overall Study|Voluntary Withdrawal|8|||
42285530|NCT02139046|76117640|FG002|Overall Study|Voluntary Withdrawal|10|||
42285531|NCT02139046|76117641|FG003|Overall Study|Voluntary Withdrawal|15|||
42285532|NCT02139046|76117642|FG004|Overall Study|Voluntary Withdrawal|16|||
42285533|NCT02139046|76117638|FG000|Overall Study|Lack of Efficacy|0|||
42285534|NCT02139046|76117639|FG001|Overall Study|Lack of Efficacy|1|||
42285535|NCT02139046|76117640|FG002|Overall Study|Lack of Efficacy|2|||
42285536|NCT02139046|76117641|FG003|Overall Study|Lack of Efficacy|1|||
42285537|NCT02139046|76117642|FG004|Overall Study|Lack of Efficacy|2|||
42285538|NCT02139046|76117638|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
42285539|NCT02139046|76117639|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
42285540|NCT02139046|76117640|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
42285541|NCT02139046|76117641|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
42285542|NCT02139046|76117642|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
42285543|NCT02139046|76117638|FG000|Overall Study|Other Miscellaneous Reasons|10|||
42285544|NCT02139046|76117639|FG001|Overall Study|Other Miscellaneous Reasons|9|||
42285545|NCT02139046|76117640|FG002|Overall Study|Other Miscellaneous Reasons|4|||
42285546|NCT02139046|76117641|FG003|Overall Study|Other Miscellaneous Reasons|9|||
42285547|NCT02139046|76117642|FG004|Overall Study|Other Miscellaneous Reasons|12|||
42285548|NCT02138890|76117656|FG000|Overall Study|Adverse Event|1|||
42285549|NCT02138890|76117657|FG001|Overall Study|Adverse Event|0|||
42285550|NCT02100670|76117668|FG000|Overall Study|Adverse Event|10|||
42285551|NCT02100670|76117669|FG001|Overall Study|Adverse Event|3|||
42285552|NCT02100670|76117670|FG002|Overall Study|Adverse Event|3|||
42285553|NCT02100670|76117671|FG003|Overall Study|Adverse Event|0|||
42285554|NCT02100670|76117668|FG000|Overall Study|Lost to Follow-up|1|||
42285555|NCT02100670|76117669|FG001|Overall Study|Lost to Follow-up|0|||
42285556|NCT02100670|76117670|FG002|Overall Study|Lost to Follow-up|0|||
42285557|NCT02100670|76117671|FG003|Overall Study|Lost to Follow-up|0|||
42285558|NCT02100670|76117668|FG000|Overall Study|Protocol Violation|0|||
42285559|NCT02100670|76117669|FG001|Overall Study|Protocol Violation|1|||
42285560|NCT02100670|76117670|FG002|Overall Study|Protocol Violation|0|||
42285561|NCT02100670|76117671|FG003|Overall Study|Protocol Violation|1|||
42285562|NCT02100670|76117668|FG000|Overall Study|Withdrawal of Consent|0|||
42285563|NCT02100670|76117669|FG001|Overall Study|Withdrawal of Consent|1|||
42285564|NCT02100670|76117670|FG002|Overall Study|Withdrawal of Consent|1|||
42285565|NCT02100670|76117671|FG003|Overall Study|Withdrawal of Consent|0|||
42285566|NCT02100670|76117668|FG000|Overall Study|No swelling no pain|1|||
42285567|NCT02100670|76117669|FG001|Overall Study|No swelling no pain|0|||
42285568|NCT02100670|76117670|FG002|Overall Study|No swelling no pain|0|||
42285569|NCT02100670|76117671|FG003|Overall Study|No swelling no pain|0|||
42285570|NCT02100670|76117668|FG000|Overall Study|Poor Efficacy|0|||
42285571|NCT02100670|76117669|FG001|Overall Study|Poor Efficacy|1|||
42285572|NCT02100670|76117670|FG002|Overall Study|Poor Efficacy|0|||
42285573|NCT02100670|76117671|FG003|Overall Study|Poor Efficacy|0|||
42285574|NCT02100670|76117668|FG000|Overall Study|Physician Decision|0|||
42285575|NCT02100670|76117669|FG001|Overall Study|Physician Decision|1|||
42352931|NCT01479621|76193032|FG006|Treatment Period|Non-compliance to study drug|1|||
42352932|NCT01479621|76193026|FG000|Treatment Period|Protocol Violation|0|||
42352933|NCT01479621|76193027|FG001|Treatment Period|Protocol Violation|9|||
42352934|NCT01479621|76193028|FG002|Treatment Period|Protocol Violation|6|||
42352935|NCT01479621|76193029|FG003|Treatment Period|Protocol Violation|5|||
42352936|NCT01479621|76193030|FG004|Treatment Period|Protocol Violation|2|||
42352937|NCT01479621|76193031|FG005|Treatment Period|Protocol Violation|10|||
42285576|NCT02100670|76117670|FG002|Overall Study|Physician Decision|0|||
42352938|NCT01479621|76193032|FG006|Treatment Period|Protocol Violation|6|||
42352939|NCT01479621|76193026|FG000|Treatment Period|Pregnancy|0|||
42285577|NCT02100670|76117671|FG003|Overall Study|Physician Decision|0|||
42015063|NCT00946153|75822237|FG004|Phase 2|Need more reduction of dose|2|||
42285578|NCT02100670|76117668|FG000|Overall Study|Withdrawal by Subject|1|||
42285579|NCT02100670|76117669|FG001|Overall Study|Withdrawal by Subject|0|||
42285580|NCT02100670|76117670|FG002|Overall Study|Withdrawal by Subject|0|||
42285581|NCT02100670|76117671|FG003|Overall Study|Withdrawal by Subject|0|||
42285582|NCT02070484|76117690|FG000|Overall Study|Withdrawal by Subject|1|||
42285583|NCT02070484|76117691|FG001|Overall Study|Withdrawal by Subject|0|||
42285584|NCT02100514|76117699|FG000|Treatment Period|Adverse Event|0|||
42285585|NCT02100514|76117700|FG001|Treatment Period|Adverse Event|5|||
42352940|NCT01479621|76193027|FG001|Treatment Period|Pregnancy|0|||
42015064|NCT00946153|75822233|FG000|Phase 2|Physician Decision|0|||
42015065|NCT00946153|75822234|FG001|Phase 2|Physician Decision|0|||
42285586|NCT02100514|76117701|FG002|Treatment Period|Adverse Event|0|||
42352941|NCT01479621|76193028|FG002|Treatment Period|Pregnancy|2|||
42015066|NCT00946153|75822235|FG002|Phase 2|Physician Decision|0|||
42015067|NCT00946153|75822236|FG003|Phase 2|Physician Decision|0|||
42015068|NCT00946153|75822237|FG004|Phase 2|Physician Decision|1|||
42352942|NCT01479621|76193029|FG003|Treatment Period|Pregnancy|0|||
42171626|NCT00394901|75978522|FG003|Double-blind Phase|Death|0|||
42171627|NCT00394901|75978519|FG000|Double-blind Phase|Subject's Personal Reason|1|||
42171628|NCT00394901|75978520|FG001|Double-blind Phase|Subject's Personal Reason|0|||
42171629|NCT00394901|75978521|FG002|Double-blind Phase|Subject's Personal Reason|0|||
42352943|NCT01479621|76193030|FG004|Treatment Period|Pregnancy|0|||
42352944|NCT01479621|76193031|FG005|Treatment Period|Pregnancy|0|||
42352945|NCT01479621|76193032|FG006|Treatment Period|Pregnancy|0|||
42352946|NCT01479621|76193026|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
42352947|NCT01479621|76193027|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
42352948|NCT01479621|76193028|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
42352949|NCT01479621|76193029|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
42352950|NCT01479621|76193030|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
42352951|NCT01479621|76193031|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
42352952|NCT01479621|76193032|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
42352953|NCT01479621|76193026|FG000|Treatment Period|Lost to Follow-up|0|||
42352954|NCT01479621|76193027|FG001|Treatment Period|Lost to Follow-up|0|||
42352955|NCT01479621|76193028|FG002|Treatment Period|Lost to Follow-up|1|||
42352956|NCT01479621|76193029|FG003|Treatment Period|Lost to Follow-up|0|||
42352957|NCT01479621|76193030|FG004|Treatment Period|Lost to Follow-up|2|||
42352958|NCT01479621|76193031|FG005|Treatment Period|Lost to Follow-up|2|||
42171630|NCT00394901|75978522|FG003|Double-blind Phase|Subject's Personal Reason|1|||
42171631|NCT00394901|75978519|FG000|Double-blind Phase|Lack of Compliance|0|||
42171632|NCT00394901|75978520|FG001|Double-blind Phase|Lack of Compliance|3|||
42171633|NCT00394901|75978521|FG002|Double-blind Phase|Lack of Compliance|0|||
42171634|NCT00394901|75978522|FG003|Double-blind Phase|Lack of Compliance|0|||
42171635|NCT00394901|75978519|FG000|Double-blind Phase|Entry into another study was found|0|||
42171636|NCT00394901|75978520|FG001|Double-blind Phase|Entry into another study was found|0|||
42171637|NCT00394901|75978521|FG002|Double-blind Phase|Entry into another study was found|1|||
42171638|NCT00394901|75978522|FG003|Double-blind Phase|Entry into another study was found|0|||
42171639|NCT00394901|75978519|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
42171640|NCT00394901|75978520|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
42171641|NCT00394901|75978521|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
42171642|NCT00394901|75978522|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
42285587|NCT02100514|76117702|FG003|Treatment Period|Adverse Event|0|||
42285588|NCT02100514|76117703|FG004|Treatment Period|Adverse Event|0|||
42285589|NCT02100514|76117699|FG000|Treatment Period|Death|2|||
42285590|NCT02100514|76117700|FG001|Treatment Period|Death|2|||
42285591|NCT02100514|76117701|FG002|Treatment Period|Death|0|||
42285592|NCT02100514|76117702|FG003|Treatment Period|Death|0|||
42285593|NCT02100514|76117703|FG004|Treatment Period|Death|0|||
42285594|NCT02100514|76117699|FG000|Treatment Period|Lost to Follow-up|5|||
42285595|NCT02100514|76117700|FG001|Treatment Period|Lost to Follow-up|17|||
42285596|NCT02100514|76117701|FG002|Treatment Period|Lost to Follow-up|0|||
42285597|NCT02100514|76117702|FG003|Treatment Period|Lost to Follow-up|0|||
42285598|NCT02100514|76117703|FG004|Treatment Period|Lost to Follow-up|0|||
42285599|NCT02100514|76117699|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
42285600|NCT02100514|76117700|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
42285601|NCT02100514|76117701|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
42285602|NCT02100514|76117702|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
42285603|NCT02100514|76117703|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
42352959|NCT01479621|76193032|FG006|Treatment Period|Lost to Follow-up|1|||
42352960|NCT01479621|76193026|FG000|Treatment Period|Met stopping criteria|0|||
42352961|NCT01479621|76193027|FG001|Treatment Period|Met stopping criteria|8|||
42352962|NCT01479621|76193028|FG002|Treatment Period|Met stopping criteria|7|||
42352963|NCT01479621|76193029|FG003|Treatment Period|Met stopping criteria|4|||
42352964|NCT01479621|76193030|FG004|Treatment Period|Met stopping criteria|9|||
42352965|NCT01479621|76193031|FG005|Treatment Period|Met stopping criteria|20|||
42352966|NCT01479621|76193032|FG006|Treatment Period|Met stopping criteria|6|||
42352967|NCT01479465|76193080|FG000|Overall Study|Disease Progression|9|||
42352968|NCT01479465|76193081|FG001|Overall Study|Disease Progression|61|||
42352969|NCT01479465|76193082|FG002|Overall Study|Disease Progression|65|||
42352970|NCT01479465|76193083|FG003|Overall Study|Disease Progression|70|||
42352971|NCT01479465|76193080|FG000|Overall Study|Study Discontinued by Sponsor|0|||
42352972|NCT01479465|76193081|FG001|Overall Study|Study Discontinued by Sponsor|7|||
42352973|NCT01479465|76193082|FG002|Overall Study|Study Discontinued by Sponsor|5|||
42352974|NCT01479465|76193083|FG003|Overall Study|Study Discontinued by Sponsor|3|||
42285604|NCT02100514|76117699|FG000|Treatment Period|Protocol Violation|1|||
42171643|NCT03349060|75978538|FG000|Overall Study|Adverse Event|9|||
42171644|NCT03349060|75978539|FG001|Overall Study|Adverse Event|9|||
42171645|NCT03349060|75978540|FG002|Overall Study|Adverse Event|7|||
42171646|NCT03349060|75978538|FG000|Overall Study|Lack of Efficacy|1|||
42285605|NCT02100514|76117700|FG001|Treatment Period|Protocol Violation|1|||
42285606|NCT02100514|76117701|FG002|Treatment Period|Protocol Violation|0|||
42285607|NCT02100514|76117702|FG003|Treatment Period|Protocol Violation|0|||
42285608|NCT02100514|76117703|FG004|Treatment Period|Protocol Violation|0|||
42285609|NCT02100514|76117699|FG000|Treatment Period|Withdrawal by Subject|12|||
42285610|NCT02100514|76117700|FG001|Treatment Period|Withdrawal by Subject|37|||
42285611|NCT02100514|76117701|FG002|Treatment Period|Withdrawal by Subject|0|||
42285612|NCT02100514|76117702|FG003|Treatment Period|Withdrawal by Subject|0|||
42285613|NCT02100514|76117703|FG004|Treatment Period|Withdrawal by Subject|0|||
42285614|NCT02100514|76117699|FG000|Treatment Period|Other|9|||
42285615|NCT02100514|76117700|FG001|Treatment Period|Other|11|||
42285616|NCT02100514|76117701|FG002|Treatment Period|Other|0|||
42285617|NCT02100514|76117702|FG003|Treatment Period|Other|0|||
42285618|NCT02100514|76117703|FG004|Treatment Period|Other|0|||
42285619|NCT02100514|76117699|FG000|Extension Period|Withdrew consent|0|||
42285620|NCT02100514|76117700|FG001|Extension Period|Withdrew consent|0|||
42285621|NCT02100514|76117701|FG002|Extension Period|Withdrew consent|2|||
42285622|NCT02100514|76117702|FG003|Extension Period|Withdrew consent|0|||
42285623|NCT02100514|76117703|FG004|Extension Period|Withdrew consent|0|||
42285624|NCT02069392|76117719|FG000|Overall Study|Withdrawal by Subject|4|||
42285625|NCT02069392|76117720|FG001|Overall Study|Withdrawal by Subject|2|||
42285626|NCT02047318|76117728|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
42285627|NCT02047318|76117728|FG000|Core Study Period|Adverse Event|1|||
42285628|NCT02047318|76117728|FG000|Core Study Period|Withdrawal by caregiver|3|||
42285629|NCT02047318|76117728|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
42285630|NCT02100124|76117746|FG000|Overall Study|Lost to Follow-up|5|||
42285631|NCT02100124|76117747|FG001|Overall Study|Lost to Follow-up|11|||
42285632|NCT02100124|76117748|FG002|Overall Study|Lost to Follow-up|3|||
42285633|NCT02100124|76117746|FG000|Overall Study|Withdrawal by Subject|1|||
42285634|NCT02100124|76117747|FG001|Overall Study|Withdrawal by Subject|0|||
42285635|NCT02100124|76117748|FG002|Overall Study|Withdrawal by Subject|0|||
42285636|NCT02068768|76117756|FG000|Overall Study|Lost to Follow-up|5|||
42285637|NCT02068768|76117756|FG000|Overall Study|Early Termination by Sponsor|2|||
42285638|NCT02046616|76117760|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
42171647|NCT03349060|75978539|FG001|Overall Study|Lack of Efficacy|0|||
42171648|NCT03349060|75978540|FG002|Overall Study|Lack of Efficacy|2|||
42171649|NCT03349060|75978538|FG000|Overall Study|Lost to Follow-up|2|||
42171650|NCT03349060|75978539|FG001|Overall Study|Lost to Follow-up|1|||
42285639|NCT02046616|76117760|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
42285640|NCT02046616|76117760|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
42285641|NCT02046616|76117760|FG000|24-Week Treatment Period|Physician Decision|3|||
42285642|NCT02046616|76117760|FG000|24-Week Treatment Period|Other|1|||
42285643|NCT02046616|76117760|FG000|8-Week FU Period|Lost to Follow-up|1|||
42285644|NCT02099344|76117766|FG000|Overall Study|Physician Decision|1|||
42285645|NCT02099344|76117767|FG001|Overall Study|Physician Decision|0|||
42285646|NCT02068222|76117775|FG000|Overall Study|Lost to Follow-up|1|||
42285647|NCT02099110|76117784|FG000|Overall Study|Protocol Violation|2|||
42285648|NCT02099110|76117785|FG001|Overall Study|Protocol Violation|1|||
42285649|NCT02099110|76117786|FG002|Overall Study|Protocol Violation|0|||
42285650|NCT02099110|76117787|FG003|Overall Study|Protocol Violation|3|||
42285651|NCT02099110|76117788|FG004|Overall Study|Protocol Violation|1|||
42171651|NCT03349060|75978540|FG002|Overall Study|Lost to Follow-up|1|||
42171652|NCT03349060|75978538|FG000|Overall Study|Protocol Violation|2|||
42285652|NCT02099110|76117784|FG000|Overall Study|Participant moved|1|||
42352975|NCT01479465|76193080|FG000|Overall Study|Adverse Event|0|||
42352976|NCT01479465|76193081|FG001|Overall Study|Adverse Event|3|||
42352977|NCT01479465|76193082|FG002|Overall Study|Adverse Event|6|||
42285653|NCT02099110|76117785|FG001|Overall Study|Participant moved|1|||
42285654|NCT02099110|76117786|FG002|Overall Study|Participant moved|1|||
42285655|NCT02099110|76117787|FG003|Overall Study|Participant moved|0|||
42285656|NCT02099110|76117788|FG004|Overall Study|Participant moved|2|||
42285657|NCT02099110|76117784|FG000|Overall Study|Withdrawal by Subject|7|||
42285658|NCT02099110|76117785|FG001|Overall Study|Withdrawal by Subject|11|||
42285659|NCT02099110|76117786|FG002|Overall Study|Withdrawal by Subject|13|||
42285660|NCT02099110|76117787|FG003|Overall Study|Withdrawal by Subject|9|||
42352978|NCT01479465|76193083|FG003|Overall Study|Adverse Event|4|||
42352979|NCT01479465|76193080|FG000|Overall Study|Investigator Discretion|1|||
42352980|NCT01479465|76193081|FG001|Overall Study|Investigator Discretion|4|||
42352981|NCT01479465|76193082|FG002|Overall Study|Investigator Discretion|2|||
42352982|NCT01479465|76193083|FG003|Overall Study|Investigator Discretion|4|||
42352983|NCT01479465|76193080|FG000|Overall Study|Subject Request|1|||
42352984|NCT01479465|76193081|FG001|Overall Study|Subject Request|3|||
42352985|NCT01479465|76193082|FG002|Overall Study|Subject Request|4|||
42352986|NCT01479465|76193083|FG003|Overall Study|Subject Request|2|||
42352987|NCT01479465|76193080|FG000|Overall Study|Subject Withdrew Consent|0|||
42352988|NCT01479465|76193081|FG001|Overall Study|Subject Withdrew Consent|5|||
42352989|NCT01479465|76193082|FG002|Overall Study|Subject Withdrew Consent|2|||
42352990|NCT01479465|76193083|FG003|Overall Study|Subject Withdrew Consent|1|||
42352991|NCT01479465|76193080|FG000|Overall Study|Protocol Violation|0|||
42352992|NCT01479465|76193081|FG001|Overall Study|Protocol Violation|1|||
42352993|NCT01479465|76193082|FG002|Overall Study|Protocol Violation|1|||
42352994|NCT01479465|76193083|FG003|Overall Study|Protocol Violation|0|||
42352995|NCT01479465|76193080|FG000|Overall Study|Death|0|||
42352996|NCT01479465|76193081|FG001|Overall Study|Death|0|||
42352997|NCT01479465|76193082|FG002|Overall Study|Death|0|||
42352998|NCT01479465|76193083|FG003|Overall Study|Death|1|||
42352999|NCT01479465|76193080|FG000|Overall Study|Lost to Follow-up|0|||
42353000|NCT01479465|76193081|FG001|Overall Study|Lost to Follow-up|0|||
42353001|NCT01479465|76193082|FG002|Overall Study|Lost to Follow-up|1|||
42353002|NCT01479465|76193083|FG003|Overall Study|Lost to Follow-up|0|||
42353003|NCT01503021|76193137|FG000|Overall Study|Adverse Event|7|||
42353004|NCT01503021|76193138|FG001|Overall Study|Adverse Event|6|||
42353005|NCT01503021|76193137|FG000|Overall Study|Death|0|||
42353006|NCT01503021|76193138|FG001|Overall Study|Death|2|||
42353007|NCT01503021|76193137|FG000|Overall Study|Lost to Follow-up|2|||
42353008|NCT01503021|76193138|FG001|Overall Study|Lost to Follow-up|0|||
42353009|NCT01503021|76193137|FG000|Overall Study|Physician Decision|3|||
42353010|NCT01503021|76193138|FG001|Overall Study|Physician Decision|0|||
42353011|NCT01503021|76193137|FG000|Overall Study|Protocol Violation|1|||
42353012|NCT01503021|76193138|FG001|Overall Study|Protocol Violation|3|||
42353013|NCT01503021|76193137|FG000|Overall Study|Withdrawal by Subject|9|||
42353014|NCT01503021|76193138|FG001|Overall Study|Withdrawal by Subject|8|||
42353015|NCT01503021|76193137|FG000|Overall Study|Moved, received transplant, etc.|5|||
42353016|NCT01503021|76193138|FG001|Overall Study|Moved, received transplant, etc.|7|||
42353017|NCT01531725|76193149|FG000|Overall Study|Protocol Violation|5|||
42353018|NCT01478373|76193153|FG000|Treatment Phase|Protocol Violation|1|||
42353019|NCT01478373|76193153|FG000|Survival Phase|Adverse Event|8|||
42353020|NCT01478373|76193153|FG000|Survival Phase|Protocol Violation|1|||
42353021|NCT01478373|76193153|FG000|Survival Phase|crossover to another study|2|||
42353022|NCT01478373|76193153|FG000|Survival Phase|Progressive Disease|27|||
42353023|NCT01502709|76193159|FG000|Overall Study|Lost to Follow-up|4|||
42353024|NCT01502709|76193160|FG001|Overall Study|Lost to Follow-up|0|||
42353025|NCT01477749|76193167|FG000|Overall Study|Physician Decision|4|||
42353026|NCT01502631|76193197|FG000|Overall Study|Adverse Event|5|||
42353027|NCT01502631|76193198|FG001|Overall Study|Adverse Event|8|||
42353028|NCT01502631|76193197|FG000|Overall Study|Lost to Follow-up|2|||
42353029|NCT01502631|76193198|FG001|Overall Study|Lost to Follow-up|2|||
42353030|NCT01502631|76193197|FG000|Overall Study|Participant withdrew consent|2|||
42353031|NCT01502631|76193198|FG001|Overall Study|Participant withdrew consent|4|||
42353032|NCT01502631|76193197|FG000|Overall Study|Participant non-compliant|1|||
42353033|NCT01502631|76193198|FG001|Overall Study|Participant non-compliant|0|||
42353034|NCT01502631|76193197|FG000|Overall Study|Investigator's decision|0|||
42353035|NCT01502631|76193198|FG001|Overall Study|Investigator's decision|1|||
42353036|NCT01502631|76193197|FG000|Overall Study|Other|10|||
42353037|NCT01502631|76193198|FG001|Overall Study|Other|5|||
42353038|NCT01475721|76193254|FG000|Overall Study|Death|3|||
42353039|NCT01475721|76193255|FG001|Overall Study|Death|6|||
42353040|NCT01475721|76193254|FG000|Overall Study|Withdrawal by Subject|8|||
42353041|NCT01475721|76193255|FG001|Overall Study|Withdrawal by Subject|8|||
42353042|NCT01530087|76193279|FG000|Overall Study|Physician Decision|2|||
42353043|NCT01475487|76193297|FG000|Overall Study|had to leave early for personal reasons|2|||
42285661|NCT02099110|76117788|FG004|Overall Study|Withdrawal by Subject|13|||
42285662|NCT02099110|76117784|FG000|Overall Study|Adverse Event|3|||
42285663|NCT02099110|76117785|FG001|Overall Study|Adverse Event|5|||
42285664|NCT02099110|76117786|FG002|Overall Study|Adverse Event|2|||
42285665|NCT02099110|76117787|FG003|Overall Study|Adverse Event|3|||
42285666|NCT02099110|76117788|FG004|Overall Study|Adverse Event|2|||
42285667|NCT02099110|76117784|FG000|Overall Study|Lost to Follow-up|6|||
42285668|NCT02099110|76117785|FG001|Overall Study|Lost to Follow-up|12|||
42285669|NCT02099110|76117786|FG002|Overall Study|Lost to Follow-up|11|||
42285670|NCT02099110|76117787|FG003|Overall Study|Lost to Follow-up|5|||
42285671|NCT02099110|76117788|FG004|Overall Study|Lost to Follow-up|6|||
42285672|NCT02099110|76117784|FG000|Overall Study|Death|0|||
42285673|NCT02099110|76117785|FG001|Overall Study|Death|1|||
42285674|NCT02099110|76117786|FG002|Overall Study|Death|0|||
42285675|NCT02099110|76117787|FG003|Overall Study|Death|0|||
42353044|NCT01475487|76193298|FG001|Overall Study|had to leave early for personal reasons|1|||
42353045|NCT01475331|76193306|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
42353046|NCT01475331|76193307|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
42353047|NCT01475331|76193306|FG000|Overall Study|excessive main duct communication|1|||
42353048|NCT01475331|76193307|FG001|Overall Study|excessive main duct communication|1|||
42353049|NCT01475331|76193306|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
42353050|NCT01475331|76193307|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
42353051|NCT01475331|76193306|FG000|Overall Study|Sign of malignancy during the procedure|2|||
42285676|NCT02099110|76117788|FG004|Overall Study|Death|0|||
42285677|NCT02099110|76117784|FG000|Overall Study|Screen failure|0|||
42285678|NCT02099110|76117785|FG001|Overall Study|Screen failure|0|||
42285679|NCT02099110|76117786|FG002|Overall Study|Screen failure|0|||
42285680|NCT02099110|76117787|FG003|Overall Study|Screen failure|0|||
42285681|NCT02099110|76117788|FG004|Overall Study|Screen failure|1|||
42285682|NCT02099110|76117784|FG000|Overall Study|Non-compliance with study drug|2|||
42285683|NCT02099110|76117785|FG001|Overall Study|Non-compliance with study drug|0|||
42285684|NCT02099110|76117786|FG002|Overall Study|Non-compliance with study drug|0|||
42285685|NCT02099110|76117787|FG003|Overall Study|Non-compliance with study drug|0|||
42285686|NCT02099110|76117788|FG004|Overall Study|Non-compliance with study drug|1|||
42353052|NCT01475331|76193307|FG001|Overall Study|Sign of malignancy during the procedure|0|||
42353053|NCT01475331|76193306|FG000|Overall Study|cyst found to be prohibitively small|0|||
42285687|NCT02099110|76117784|FG000|Overall Study|Physician Decision|3|||
42285688|NCT02099110|76117785|FG001|Overall Study|Physician Decision|0|||
42285689|NCT02099110|76117786|FG002|Overall Study|Physician Decision|1|||
42285690|NCT02099110|76117787|FG003|Overall Study|Physician Decision|2|||
42285691|NCT02099110|76117788|FG004|Overall Study|Physician Decision|1|||
42285692|NCT02098876|76117802|FG000|Overall Study|Withdrawal by Subject|5|||
42285693|NCT02098876|76117803|FG001|Overall Study|Withdrawal by Subject|5|||
42285694|NCT01624090|76117813|FG000|Overall Study|DLT, taken off therapy|0|||
42285695|NCT01624090|76117814|FG001|Overall Study|DLT, taken off therapy|1|||
42353054|NCT01475331|76193307|FG001|Overall Study|cyst found to be prohibitively small|1|||
42353055|NCT01500213|76193315|FG000|Overall Study|Adverse Event|35|||
42353056|NCT01500213|76193316|FG001|Overall Study|Adverse Event|35|||
42353057|NCT01500213|76193315|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
42353058|NCT01500213|76193316|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
42353059|NCT01500213|76193315|FG000|Overall Study|Withdrawal by Subject|28|||
42015069|NCT00946153|75822233|FG000|Phase 2|14 days washout for recovery due to AE|0|||
42171653|NCT03349060|75978539|FG001|Overall Study|Protocol Violation|2|||
42171654|NCT03349060|75978540|FG002|Overall Study|Protocol Violation|1|||
42171655|NCT03349060|75978538|FG000|Overall Study|Withdrawal by Subject|5|||
42171656|NCT03349060|75978539|FG001|Overall Study|Withdrawal by Subject|3|||
42171657|NCT03349060|75978540|FG002|Overall Study|Withdrawal by Subject|4|||
42171658|NCT03349060|75978538|FG000|Overall Study|Medication error,no linked adverse event|0|||
42285696|NCT01624090|76117815|FG002|Overall Study|DLT, taken off therapy|0|||
42285697|NCT01624090|76117816|FG003|Overall Study|DLT, taken off therapy|0|||
42285698|NCT01624090|76117813|FG000|Overall Study|Withdrew prior to treatment|0|||
42285699|NCT01624090|76117814|FG001|Overall Study|Withdrew prior to treatment|1|||
42285700|NCT01624090|76117815|FG002|Overall Study|Withdrew prior to treatment|0|||
42285701|NCT01624090|76117816|FG003|Overall Study|Withdrew prior to treatment|0|||
42285702|NCT01624090|76117813|FG000|Overall Study|Died on study|0|||
42285703|NCT01624090|76117814|FG001|Overall Study|Died on study|0|||
42285704|NCT01624090|76117815|FG002|Overall Study|Died on study|2|||
42285705|NCT01624090|76117816|FG003|Overall Study|Died on study|0|||
42353060|NCT01500213|76193316|FG001|Overall Study|Withdrawal by Subject|37|||
42285706|NCT01624090|76117813|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
42285707|NCT01624090|76117814|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
42285708|NCT01624090|76117815|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
42015070|NCT00946153|75822234|FG001|Phase 2|14 days washout for recovery due to AE|0|||
42285709|NCT01624090|76117816|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
42285710|NCT01624090|76117813|FG000|Overall Study|Dose escalated|0|||
42171659|NCT03349060|75978539|FG001|Overall Study|Medication error,no linked adverse event|0|||
42171660|NCT03349060|75978540|FG002|Overall Study|Medication error,no linked adverse event|1|||
42171661|NCT03349060|75978538|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
42171662|NCT03349060|75978539|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
42171663|NCT03349060|75978540|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
42171664|NCT03349060|75978538|FG000|Overall Study|Other|2|||
42171665|NCT03349060|75978539|FG001|Overall Study|Other|1|||
42171666|NCT03349060|75978540|FG002|Overall Study|Other|0|||
42171667|NCT03348904|75978551|FG000|Overall Study|Administrative reason by the sponsor|0|||
42285711|NCT01624090|76117814|FG001|Overall Study|Dose escalated|0|||
42285712|NCT01624090|76117815|FG002|Overall Study|Dose escalated|3|||
42285713|NCT01624090|76117816|FG003|Overall Study|Dose escalated|0|||
42285714|NCT02571777|76117831|FG000|Overall Study|Subject/guardian decision|34|||
42285715|NCT02571777|76117832|FG001|Overall Study|Subject/guardian decision|26|||
42353061|NCT01500213|76193315|FG000|Overall Study|Death|7|||
42353062|NCT01500213|76193316|FG001|Overall Study|Death|3|||
42353063|NCT01500213|76193315|FG000|Overall Study|Disease Progression|13|||
42353064|NCT01500213|76193316|FG001|Overall Study|Disease Progression|21|||
42353065|NCT01500213|76193315|FG000|Overall Study|Protocol Violation|19|||
42353066|NCT01500213|76193316|FG001|Overall Study|Protocol Violation|19|||
42353067|NCT01500213|76193315|FG000|Overall Study|Physician Decision|12|||
42353068|NCT01500213|76193316|FG001|Overall Study|Physician Decision|10|||
42353069|NCT01500213|76193315|FG000|Overall Study|Lack of Efficacy|9|||
42353070|NCT01500213|76193316|FG001|Overall Study|Lack of Efficacy|7|||
42353071|NCT01500213|76193315|FG000|Overall Study|Lost to Follow-up|3|||
42353072|NCT01500213|76193316|FG001|Overall Study|Lost to Follow-up|6|||
42353073|NCT01500213|76193315|FG000|Overall Study|Other Reasons|7|||
42040780|NCT01386385|75848782|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
42040781|NCT01386385|75848783|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
42040782|NCT01386385|75848784|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
42353074|NCT01500213|76193316|FG001|Overall Study|Other Reasons|5|||
42353075|NCT01475253|76193346|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
42353076|NCT01475253|76193347|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
42353077|NCT01475253|76193348|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
42353078|NCT01475253|76193349|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
42353079|NCT01475253|76193346|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
42353080|NCT01475253|76193347|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
42353081|NCT01475253|76193348|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
42285716|NCT02571777|76117833|FG002|Overall Study|Subject/guardian decision|26|||
42285717|NCT02571777|76117834|FG003|Overall Study|Subject/guardian decision|25|||
42353082|NCT01475253|76193349|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
42353083|NCT01500135|76193407|FG000|Overall Study|Withdrawal of Consent|4|||
42353084|NCT01500135|76193408|FG001|Overall Study|Withdrawal of Consent|0|||
42353085|NCT01500135|76193407|FG000|Overall Study|Lost to Follow-up|6|||
42353086|NCT01500135|76193408|FG001|Overall Study|Lost to Follow-up|4|||
42353087|NCT01500135|76193407|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
42353088|NCT01500135|76193408|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
42353089|NCT01500135|76193407|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
42353090|NCT01500135|76193408|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
42353091|NCT01500135|76193407|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
42353092|NCT01500135|76193408|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
42353093|NCT01500135|76193407|FG000|Overall Study|Participant was a Safety Concern|1|||
42353094|NCT01500135|76193408|FG001|Overall Study|Participant was a Safety Concern|0|||
42353095|NCT01500135|76193407|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
42285718|NCT02571777|76117835|FG004|Overall Study|Subject/guardian decision|27|||
42285719|NCT02571777|76117831|FG000|Overall Study|Protocol Deviation|2|||
42285720|NCT02571777|76117832|FG001|Overall Study|Protocol Deviation|3|||
42285721|NCT02571777|76117833|FG002|Overall Study|Protocol Deviation|4|||
42285722|NCT02571777|76117834|FG003|Overall Study|Protocol Deviation|8|||
42285723|NCT02571777|76117835|FG004|Overall Study|Protocol Deviation|4|||
42285724|NCT02571777|76117831|FG000|Overall Study|Death|1|||
42285725|NCT02571777|76117832|FG001|Overall Study|Death|1|||
42285726|NCT02571777|76117833|FG002|Overall Study|Death|4|||
42353096|NCT01500135|76193408|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
42353097|NCT01475097|76193420|FG000|Overall Study|Protocol Violation|1|||
42171668|NCT03348904|75978552|FG001|Overall Study|Administrative reason by the sponsor|1|||
42285727|NCT02571777|76117834|FG003|Overall Study|Death|0|||
42353098|NCT01475097|76193421|FG001|Overall Study|Protocol Violation|1|||
42353099|NCT01529385|76193429|FG000|Overall Study|Lost to Follow-up|2|||
42353100|NCT01529385|76193430|FG001|Overall Study|Lost to Follow-up|1|||
42353101|NCT01474551|76193436|FG000|Overall Study|Death|1|||
42285728|NCT02571777|76117835|FG004|Overall Study|Death|0|||
42285729|NCT02571777|76117831|FG000|Overall Study|Lost to Follow-up|1|||
42285730|NCT02571777|76117832|FG001|Overall Study|Lost to Follow-up|1|||
42285731|NCT02571777|76117833|FG002|Overall Study|Lost to Follow-up|2|||
42285732|NCT02571777|76117834|FG003|Overall Study|Lost to Follow-up|0|||
42040783|NCT01386385|75848785|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
42040784|NCT01386385|75848786|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
42285733|NCT02571777|76117835|FG004|Overall Study|Lost to Follow-up|1|||
42285734|NCT02571777|76117831|FG000|Overall Study|Physician Decision|1|||
42285735|NCT02571777|76117832|FG001|Overall Study|Physician Decision|7|||
42285736|NCT02571777|76117833|FG002|Overall Study|Physician Decision|5|||
42285737|NCT02571777|76117834|FG003|Overall Study|Physician Decision|2|||
42285738|NCT02571777|76117835|FG004|Overall Study|Physician Decision|4|||
42285739|NCT02571777|76117831|FG000|Overall Study|Pregnancy|0|||
42285740|NCT02571777|76117832|FG001|Overall Study|Pregnancy|0|||
42285741|NCT02571777|76117833|FG002|Overall Study|Pregnancy|0|||
42285742|NCT02571777|76117834|FG003|Overall Study|Pregnancy|2|||
42285743|NCT02571777|76117835|FG004|Overall Study|Pregnancy|0|||
42285744|NCT02571075|76117849|FG000|Overall Study|Lost to Follow-up|20|||
42285745|NCT02571075|76117850|FG001|Overall Study|Lost to Follow-up|24|||
42285746|NCT02705105|76117864|FG000|Treatment|Objective Disease Progression|1|||
42285747|NCT02705105|76117865|FG001|Treatment|Objective Disease Progression|50|||
42285748|NCT02705105|76117864|FG000|Treatment|Withdrawal by Subject|3|||
42285749|NCT02705105|76117865|FG001|Treatment|Withdrawal by Subject|5|||
42285750|NCT02705105|76117864|FG000|Treatment|Adverse Event|0|||
42285751|NCT02705105|76117865|FG001|Treatment|Adverse Event|17|||
42285752|NCT02705105|76117864|FG000|Treatment|Clinical Disease Progression|0|||
42285753|NCT02705105|76117865|FG001|Treatment|Clinical Disease Progression|32|||
42285754|NCT02705105|76117864|FG000|Treatment|Physician Decision|0|||
42285755|NCT02705105|76117865|FG001|Treatment|Physician Decision|3|||
42285756|NCT02705105|76117864|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
42285757|NCT02705105|76117865|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
42285758|NCT02705105|76117864|FG000|Follow-Up|Death|3|||
42285759|NCT02705105|76117865|FG001|Follow-Up|Death|68|||
42285760|NCT02705105|76117864|FG000|Follow-Up|Withdrawal by Subject|1|||
42285761|NCT02705105|76117865|FG001|Follow-Up|Withdrawal by Subject|14|||
42285762|NCT02705105|76117864|FG000|Follow-Up|Study Terminated|0|||
42285763|NCT02705105|76117865|FG001|Follow-Up|Study Terminated|26|||
42285764|NCT02705105|76117864|FG000|Follow-Up|Discontinued per Amendment 3|0|||
42285765|NCT02705105|76117865|FG001|Follow-Up|Discontinued per Amendment 3|2|||
42285766|NCT02097472|76117891|FG000|Received Vaccination 2|Adverse Event|0|||
42285767|NCT02097472|76117892|FG001|Received Vaccination 2|Adverse Event|0|||
42285768|NCT02097472|76117893|FG002|Received Vaccination 2|Adverse Event|0|||
42353102|NCT01500057|76193471|FG000|Overall Study|Lost to Follow-up|6|||
42353103|NCT01500057|76193472|FG001|Overall Study|Lost to Follow-up|4|||
42353104|NCT01499667|76193490|FG000|Overall Study|administrative problems|4|||
42353105|NCT01499667|76193491|FG001|Overall Study|administrative problems|5|||
42353106|NCT01499667|76193492|FG002|Overall Study|administrative problems|5|||
42353107|NCT01499667|76193490|FG000|Overall Study|Protocol Violation|1|||
42353108|NCT01499667|76193491|FG001|Overall Study|Protocol Violation|3|||
42353109|NCT01499667|76193492|FG002|Overall Study|Protocol Violation|2|||
42353110|NCT01499667|76193490|FG000|Overall Study|Adverse Event|0|||
42353111|NCT01499667|76193491|FG001|Overall Study|Adverse Event|2|||
42353112|NCT01499667|76193492|FG002|Overall Study|Adverse Event|2|||
42353113|NCT01499667|76193490|FG000|Overall Study|Withdrawal by Subject|2|||
42353114|NCT01499667|76193491|FG001|Overall Study|Withdrawal by Subject|1|||
42353115|NCT01499667|76193492|FG002|Overall Study|Withdrawal by Subject|1|||
42353116|NCT01499667|76193490|FG000|Overall Study|Lack of Efficacy|2|||
42353117|NCT01499667|76193491|FG001|Overall Study|Lack of Efficacy|0|||
42353118|NCT01499667|76193492|FG002|Overall Study|Lack of Efficacy|0|||
42353119|NCT01499511|76193502|FG000|Overall Study|Death|1|||
42353120|NCT01499511|76193503|FG001|Overall Study|Death|0|||
42353121|NCT01474317|76193523|FG000|Overall Study|Adverse Event|1|||
42353122|NCT01474317|76193523|FG000|Overall Study|Subject ineligible for study|1|||
42353123|NCT01499355|76193619|FG000|Run-In Period|Study Termination|15|||
42040785|NCT01386385|75848787|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
42040786|NCT01386385|75848788|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
42353124|NCT01499355|76193620|FG001|Run-In Period|Study Termination|0|||
42353125|NCT01499355|76193621|FG002|Run-In Period|Study Termination|0|||
42353126|NCT01499355|76193622|FG003|Run-In Period|Study Termination|0|||
42353127|NCT01499355|76193619|FG000|Run-In Period|Other|3|||
42353128|NCT01499355|76193620|FG001|Run-In Period|Other|0|||
42353129|NCT01499355|76193621|FG002|Run-In Period|Other|0|||
42040787|NCT01386385|75848781|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
42353130|NCT01499355|76193622|FG003|Run-In Period|Other|0|||
42353131|NCT01499355|76193619|FG000|Run-In Period|Death|2|||
42353132|NCT01499355|76193620|FG001|Run-In Period|Death|0|||
42353133|NCT01499355|76193621|FG002|Run-In Period|Death|0|||
42353134|NCT01499355|76193622|FG003|Run-In Period|Death|0|||
42353135|NCT01499355|76193619|FG000|Run-In Period|Investigator Decision|2|||
42285769|NCT02097472|76117894|FG003|Received Vaccination 2|Adverse Event|0|||
42285770|NCT02097472|76117895|FG004|Received Vaccination 2|Adverse Event|0|||
42353136|NCT01499355|76193620|FG001|Run-In Period|Investigator Decision|0|||
42353137|NCT01499355|76193621|FG002|Run-In Period|Investigator Decision|0|||
42353138|NCT01499355|76193622|FG003|Run-In Period|Investigator Decision|0|||
42285771|NCT02097472|76117896|FG005|Received Vaccination 2|Adverse Event|0|||
42285772|NCT02097472|76117897|FG006|Received Vaccination 2|Adverse Event|1|||
42285773|NCT02097472|76117898|FG007|Received Vaccination 2|Adverse Event|0|||
42285774|NCT01623310|76117982|FG000|Overall Study|Adverse Event|21|||
42285775|NCT01623310|76117982|FG000|Overall Study|Lost to Follow-up|18|||
42285776|NCT01623310|76117982|FG000|Overall Study|Lack of Efficacy|6|||
42285777|NCT01623310|76117982|FG000|Overall Study|Protocol Violation|6|||
42285778|NCT01623310|76117982|FG000|Overall Study|Withdrawal by Subject|25|||
42285779|NCT01623310|76117982|FG000|Overall Study|Became potentially child-bearing|1|||
42353139|NCT01499355|76193619|FG000|Run-In Period|Consent Withdrawn|1|||
42353140|NCT01499355|76193620|FG001|Run-In Period|Consent Withdrawn|0|||
42353141|NCT01499355|76193621|FG002|Run-In Period|Consent Withdrawn|0|||
42353142|NCT01499355|76193622|FG003|Run-In Period|Consent Withdrawn|0|||
42353143|NCT01499355|76193619|FG000|Run-In Period|Adverse Event|8|||
42353144|NCT01499355|76193620|FG001|Run-In Period|Adverse Event|0|||
42353145|NCT01499355|76193621|FG002|Run-In Period|Adverse Event|0|||
42353146|NCT01499355|76193622|FG003|Run-In Period|Adverse Event|0|||
42353147|NCT01499355|76193619|FG000|Double-Blind Period|Adverse Event|0|||
42353148|NCT01499355|76193620|FG001|Double-Blind Period|Adverse Event|2|||
42353149|NCT01499355|76193621|FG002|Double-Blind Period|Adverse Event|3|||
42353150|NCT01499355|76193622|FG003|Double-Blind Period|Adverse Event|2|||
42353151|NCT01499355|76193619|FG000|Double-Blind Period|Study Termination|0|||
42353152|NCT01499355|76193620|FG001|Double-Blind Period|Study Termination|18|||
42353153|NCT01499355|76193621|FG002|Double-Blind Period|Study Termination|16|||
42353154|NCT01499355|76193622|FG003|Double-Blind Period|Study Termination|14|||
42353155|NCT01499355|76193619|FG000|Double-Blind Period|Other|0|||
42353156|NCT01499355|76193620|FG001|Double-Blind Period|Other|1|||
42353157|NCT01499355|76193621|FG002|Double-Blind Period|Other|2|||
42353158|NCT01499355|76193622|FG003|Double-Blind Period|Other|2|||
42353159|NCT01499355|76193619|FG000|Double-Blind Period|Death|0|||
42353160|NCT01499355|76193620|FG001|Double-Blind Period|Death|1|||
42353161|NCT01499355|76193621|FG002|Double-Blind Period|Death|0|||
42353162|NCT01499355|76193622|FG003|Double-Blind Period|Death|0|||
42171669|NCT03348904|75978553|FG002|Overall Study|Administrative reason by the sponsor|0|||
42171670|NCT00359021|75978563|FG000|Overall Study|Adverse Event|26|||
42171671|NCT00359021|75978564|FG001|Overall Study|Adverse Event|8|||
42171672|NCT00359021|75978563|FG000|Overall Study|Subject Non-Compliant|1|||
42171673|NCT00359021|75978564|FG001|Overall Study|Subject Non-Compliant|2|||
42171674|NCT00359021|75978563|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
42171675|NCT00359021|75978564|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
42171676|NCT00359021|75978563|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
42171677|NCT00359021|75978564|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
42171678|NCT00359021|75978563|FG000|Overall Study|Withdrawal by Subject|2|||
42171679|NCT00359021|75978564|FG001|Overall Study|Withdrawal by Subject|9|||
42171680|NCT00359021|75978563|FG000|Overall Study|Lost to Follow-up|1|||
42171681|NCT00359021|75978564|FG001|Overall Study|Lost to Follow-up|0|||
42171682|NCT00359021|75978563|FG000|Overall Study|Other|4|||
42171683|NCT00359021|75978564|FG001|Overall Study|Other|1|||
42171684|NCT00359021|75978563|FG000|Overall Study|Pregnancy|1|||
42353163|NCT01499355|76193619|FG000|Double-Blind Period|Investigator Decision|0|||
42353164|NCT01499355|76193620|FG001|Double-Blind Period|Investigator Decision|0|||
42353165|NCT01499355|76193621|FG002|Double-Blind Period|Investigator Decision|3|||
42353166|NCT01499355|76193622|FG003|Double-Blind Period|Investigator Decision|3|||
42353167|NCT01499355|76193619|FG000|Double-Blind Period|Consent Withdrawn|0|||
42171685|NCT00359021|75978564|FG001|Overall Study|Pregnancy|0|||
42171686|NCT00360269|75978574|FG000|Overall Study|Lost to Follow-up|7|||
42171687|NCT00360269|75978575|FG001|Overall Study|Lost to Follow-up|9|||
42285780|NCT01623310|76117982|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
42353168|NCT01499355|76193620|FG001|Double-Blind Period|Consent Withdrawn|0|||
42353169|NCT01499355|76193621|FG002|Double-Blind Period|Consent Withdrawn|1|||
42353170|NCT01499355|76193622|FG003|Double-Blind Period|Consent Withdrawn|2|||
42353171|NCT01499355|76193619|FG000|Double-Blind Period|Lost to Follow-up|0|||
42353172|NCT01499355|76193620|FG001|Double-Blind Period|Lost to Follow-up|1|||
42285781|NCT01623310|76117982|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
42285782|NCT02046226|76117986|FG000|Overall Study|Lost to Follow-up|7|||
42285783|NCT02046148|76117993|FG000|Overall Study|Lost to Follow-up|1|||
42285784|NCT02046148|76117994|FG001|Overall Study|Lost to Follow-up|1|||
42285785|NCT02046148|76117993|FG000|Overall Study|Withdrawal by Subject|0|||
42285786|NCT02046148|76117994|FG001|Overall Study|Withdrawal by Subject|2|||
42285787|NCT02097238|76118000|FG000|Overall Study|Death|1|||
42285788|NCT02097238|76118000|FG000|Overall Study|Physician Decision|1|||
42285789|NCT02097238|76118000|FG000|Overall Study|Progressive Disease|17|||
42285790|NCT02704091|76118007|FG000|Overall Study|Adverse Event|4|||
42285791|NCT02704091|76118008|FG001|Overall Study|Adverse Event|3|||
42285792|NCT02704091|76118007|FG000|Overall Study|Protocol Violation|5|||
42285793|NCT02704091|76118008|FG001|Overall Study|Protocol Violation|3|||
42285794|NCT02704091|76118007|FG000|Overall Study|Consent withdrawn|4|||
42285795|NCT02704091|76118008|FG001|Overall Study|Consent withdrawn|4|||
42285796|NCT02704091|76118007|FG000|Overall Study|Lost to Follow-up|13|||
42285797|NCT02704091|76118008|FG001|Overall Study|Lost to Follow-up|5|||
42285798|NCT02704091|76118007|FG000|Overall Study|Other|2|||
42285799|NCT02704091|76118008|FG001|Overall Study|Other|8|||
42285800|NCT02702609|76118016|FG000|Overall Study|Lost to Follow-up|8|||
42285801|NCT02702609|76118017|FG001|Overall Study|Lost to Follow-up|4|||
42285802|NCT02702609|76118016|FG000|Overall Study|Physician Decision|1|||
42285803|NCT02702609|76118017|FG001|Overall Study|Physician Decision|0|||
42285804|NCT02046070|76118026|FG000|Overall Study|Progressive Disease|18|||
42285805|NCT02046070|76118027|FG001|Overall Study|Progressive Disease|11|||
42285806|NCT02046070|76118028|FG002|Overall Study|Progressive Disease|40|||
42285807|NCT02046070|76118026|FG000|Overall Study|Adverse Event|8|||
42285808|NCT02046070|76118027|FG001|Overall Study|Adverse Event|10|||
42285809|NCT02046070|76118028|FG002|Overall Study|Adverse Event|17|||
42285810|NCT02046070|76118026|FG000|Overall Study|Withdrawal by Subject|1|||
42285811|NCT02046070|76118027|FG001|Overall Study|Withdrawal by Subject|2|||
42285812|NCT02046070|76118028|FG002|Overall Study|Withdrawal by Subject|6|||
42285813|NCT02046070|76118026|FG000|Overall Study|Study Terminated by Sponsor|1|||
42285814|NCT02046070|76118027|FG001|Overall Study|Study Terminated by Sponsor|1|||
42285815|NCT02046070|76118028|FG002|Overall Study|Study Terminated by Sponsor|1|||
42285816|NCT02046070|76118026|FG000|Overall Study|Reason not Specified|4|||
42285817|NCT02046070|76118027|FG001|Overall Study|Reason not Specified|4|||
42285818|NCT02046070|76118028|FG002|Overall Study|Reason not Specified|6|||
42285819|NCT01663857|76118040|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
42285820|NCT01663857|76118041|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
42285821|NCT01663857|76118042|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
42285822|NCT01663857|76118043|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
42285823|NCT01663857|76118040|FG000|Overall Study|Lost to Follow-up|0|||
42285824|NCT01663857|76118041|FG001|Overall Study|Lost to Follow-up|0|||
42285825|NCT01663857|76118042|FG002|Overall Study|Lost to Follow-up|3|||
42285826|NCT01663857|76118043|FG003|Overall Study|Lost to Follow-up|1|||
42285827|NCT02094898|76118059|FG000|Overall Study|Clinical Worsening|2|||
42171688|NCT00360269|75978574|FG000|Overall Study|Physician Decision|1|||
42171689|NCT00360269|75978575|FG001|Overall Study|Physician Decision|2|||
42015071|NCT00946153|75822235|FG002|Phase 2|14 days washout for recovery due to AE|0|||
42171690|NCT00360269|75978574|FG000|Overall Study|Adverse Event|1|||
42171691|NCT00360269|75978575|FG001|Overall Study|Adverse Event|0|||
42171692|NCT00360269|75978574|FG000|Overall Study|Withdrawal by Subject|1|||
42171693|NCT00360269|75978575|FG001|Overall Study|Withdrawal by Subject|1|||
42171694|NCT00076752|75978581|FG000|Overall Study|Death|2|||
42171695|NCT00076752|75978581|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
42171696|NCT03384940|75978589|FG000|Overall Study|Progressive disease|36|||
42171697|NCT03384940|75978590|FG001|Overall Study|Progressive disease|11|||
42171698|NCT03384940|75978591|FG002|Overall Study|Progressive disease|13|||
42171699|NCT03384940|75978589|FG000|Overall Study|Clinical progression|4|||
42171700|NCT03384940|75978590|FG001|Overall Study|Clinical progression|0|||
42171701|NCT03384940|75978591|FG002|Overall Study|Clinical progression|3|||
42285828|NCT02094898|76118059|FG000|Overall Study|Adverse Event|2|||
42171702|NCT03384940|75978589|FG000|Overall Study|Adverse Event|7|||
42171703|NCT03384940|75978590|FG001|Overall Study|Adverse Event|1|||
42171704|NCT03384940|75978591|FG002|Overall Study|Adverse Event|1|||
42171705|NCT03384940|75978589|FG000|Overall Study|Withdrawal by Subject|3|||
42171706|NCT03384940|75978590|FG001|Overall Study|Withdrawal by Subject|1|||
42285829|NCT02094898|76118059|FG000|Overall Study|Lack of Efficacy|1|||
42285830|NCT02045836|76118067|FG000|Overall Study|Adverse Event|4|||
42285831|NCT02045836|76118068|FG001|Overall Study|Adverse Event|4|||
42285832|NCT02045836|76118067|FG000|Overall Study|Withdrawal by Subject|1|||
42285833|NCT02045836|76118068|FG001|Overall Study|Withdrawal by Subject|1|||
42285834|NCT02045836|76118067|FG000|Overall Study|Lost to Follow-up|4|||
42285835|NCT02045836|76118068|FG001|Overall Study|Lost to Follow-up|7|||
42285836|NCT02045836|76118067|FG000|Overall Study|Migrated from study area|0|||
42285837|NCT02045836|76118068|FG001|Overall Study|Migrated from study area|2|||
42285838|NCT02569437|76118077|FG000|Overall Study|Lost to Follow-up|12|||
42285839|NCT02569437|76118078|FG001|Overall Study|Lost to Follow-up|14|||
42285840|NCT02045212|76118086|FG000|Overall Study|Adverse Event|0|||
42285841|NCT02045212|76118087|FG001|Overall Study|Adverse Event|1|||
42285842|NCT02045212|76118086|FG000|Overall Study|Withdrawal by Subject|1|||
42285843|NCT02045212|76118087|FG001|Overall Study|Withdrawal by Subject|0|||
42285844|NCT02045212|76118086|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
42285845|NCT02045212|76118087|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
42285846|NCT02044822|76118097|FG000|Overall Study|Study Terminated by Sponsor|77|||
42285847|NCT02044822|76118097|FG000|Overall Study|Investigator's Discretion|10|||
42285848|NCT02044822|76118097|FG000|Overall Study|Withdrew Consent|3|||
42285849|NCT02044822|76118097|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
42285850|NCT02044822|76118097|FG000|Overall Study|Lost to Follow-up|1|||
42285851|NCT02044510|76118103|FG000|Overall Study|Adverse Event|1|||
42285852|NCT02044510|76118104|FG001|Overall Study|Adverse Event|2|||
42285853|NCT02067676|76118116|FG000|Overall Study|Withdrawal by Subject|1|||
42285854|NCT02067676|76118117|FG001|Overall Study|Withdrawal by Subject|0|||
42285855|NCT02067676|76118118|FG002|Overall Study|Withdrawal by Subject|0|||
42285856|NCT02067676|76118119|FG003|Overall Study|Withdrawal by Subject|0|||
42285857|NCT02067676|76118120|FG004|Overall Study|Withdrawal by Subject|0|||
42285858|NCT02067676|76118121|FG005|Overall Study|Withdrawal by Subject|0|||
42285859|NCT01623154|76118140|FG000|Overall Study|Did not drink Pranactin Citric|4|||
42285860|NCT00702689|76118146|FG000|Overall Study|Withdrawal by Subject|4|||
42285861|NCT00702689|76118146|FG000|Overall Study|Recurrent malignancy|1|||
42285862|NCT00702689|76118146|FG000|Overall Study|Adverse Event|1|||
42285863|NCT02065570|76118152|FG000|Induction Study|Adverse Event|5|||
42285864|NCT02065570|76118153|FG001|Induction Study|Adverse Event|12|||
42285865|NCT02065570|76118154|FG002|Induction Study|Adverse Event|0|||
42285866|NCT02065570|76118155|FG003|Induction Study|Adverse Event|0|||
42285867|NCT02065570|76118152|FG000|Induction Study|Withdrawal by Subject|2|||
42285868|NCT02065570|76118153|FG001|Induction Study|Withdrawal by Subject|3|||
42285869|NCT02065570|76118154|FG002|Induction Study|Withdrawal by Subject|0|||
42285870|NCT02065570|76118155|FG003|Induction Study|Withdrawal by Subject|0|||
42285871|NCT02065570|76118152|FG000|Induction Study|Lost to Follow-up|1|||
42285872|NCT02065570|76118153|FG001|Induction Study|Lost to Follow-up|1|||
42285873|NCT02065570|76118154|FG002|Induction Study|Lost to Follow-up|0|||
42285874|NCT02065570|76118155|FG003|Induction Study|Lost to Follow-up|0|||
42285875|NCT02065570|76118152|FG000|Induction Study|Other, Not Specified|6|||
42285876|NCT02065570|76118153|FG001|Induction Study|Other, Not Specified|5|||
42285877|NCT02065570|76118154|FG002|Induction Study|Other, Not Specified|0|||
42285878|NCT02065570|76118155|FG003|Induction Study|Other, Not Specified|0|||
42285879|NCT02065570|76118152|FG000|Maintenance Study|Adverse Event|0|||
42285880|NCT02065570|76118153|FG001|Maintenance Study|Adverse Event|0|||
42285881|NCT02065570|76118154|FG002|Maintenance Study|Adverse Event|8|||
42285882|NCT02065570|76118155|FG003|Maintenance Study|Adverse Event|8|||
42285883|NCT02065570|76118152|FG000|Maintenance Study|Withdrawal by Subject|0|||
42285884|NCT02065570|76118153|FG001|Maintenance Study|Withdrawal by Subject|0|||
42285885|NCT02065570|76118154|FG002|Maintenance Study|Withdrawal by Subject|1|||
42171707|NCT03384940|75978591|FG002|Overall Study|Withdrawal by Subject|0|||
42171708|NCT03384940|75978589|FG000|Overall Study|Physician Decision|1|||
42171709|NCT03384940|75978590|FG001|Overall Study|Physician Decision|1|||
42171710|NCT03384940|75978591|FG002|Overall Study|Physician Decision|0|||
42171711|NCT03384940|75978589|FG000|Overall Study|Death|2|||
42171712|NCT03384940|75978590|FG001|Overall Study|Death|1|||
42171713|NCT03384940|75978591|FG002|Overall Study|Death|0|||
42171714|NCT03384940|75978589|FG000|Overall Study|Other|0|||
42171715|NCT03384940|75978590|FG001|Overall Study|Other|0|||
42285886|NCT02065570|76118155|FG003|Maintenance Study|Withdrawal by Subject|4|||
42171716|NCT03384940|75978591|FG002|Overall Study|Other|1|||
42171717|NCT00075582|75978601|FG000|Overall Study|Adverse Event|3|||
42285887|NCT02065570|76118152|FG000|Maintenance Study|Lost to Follow-up|0|||
42285888|NCT02065570|76118153|FG001|Maintenance Study|Lost to Follow-up|0|||
42171718|NCT00075582|75978602|FG001|Overall Study|Adverse Event|1|||
42171719|NCT00075582|75978601|FG000|Overall Study|Lack of Efficacy|4|||
42171720|NCT00075582|75978602|FG001|Overall Study|Lack of Efficacy|8|||
42285889|NCT02065570|76118154|FG002|Maintenance Study|Lost to Follow-up|2|||
42353173|NCT01499355|76193621|FG002|Double-Blind Period|Lost to Follow-up|0|||
42285890|NCT02065570|76118155|FG003|Maintenance Study|Lost to Follow-up|2|||
42285891|NCT02065570|76118152|FG000|Maintenance Study|Other, Not Specified|0|||
42171721|NCT00075582|75978601|FG000|Overall Study|Physician Decision|5|||
42171722|NCT00075582|75978602|FG001|Overall Study|Physician Decision|8|||
42171723|NCT00075582|75978601|FG000|Overall Study|Withdrawal by Subject|2|||
42171724|NCT00075582|75978602|FG001|Overall Study|Withdrawal by Subject|2|||
42285892|NCT02065570|76118153|FG001|Maintenance Study|Other, Not Specified|0|||
42285893|NCT02065570|76118154|FG002|Maintenance Study|Other, Not Specified|11|||
42285894|NCT02065570|76118155|FG003|Maintenance Study|Other, Not Specified|5|||
42285895|NCT02566005|76118168|FG000|Overall Study|vaginal bleeding|0|||
42285896|NCT02566005|76118169|FG001|Overall Study|vaginal bleeding|1|||
42285897|NCT02566005|76118168|FG000|Overall Study|received foley|8|||
42285898|NCT02566005|76118169|FG001|Overall Study|received foley|0|||
42285899|NCT02566005|76118168|FG000|Overall Study|did not receive foley|0|||
42285900|NCT02566005|76118169|FG001|Overall Study|did not receive foley|1|||
42285901|NCT02566005|76118168|FG000|Overall Study|labor after randomization|0|||
42285902|NCT02566005|76118169|FG001|Overall Study|labor after randomization|4|||
42285903|NCT02065336|76118187|FG000|Extension Phase|Study Terminated by Sponsor|0|||
42285904|NCT02065336|76118188|FG001|Extension Phase|Study Terminated by Sponsor|0|||
42285905|NCT02065336|76118189|FG002|Extension Phase|Study Terminated by Sponsor|0|||
42285906|NCT02065336|76118190|FG003|Extension Phase|Study Terminated by Sponsor|0|||
42285907|NCT02065336|76118191|FG004|Extension Phase|Study Terminated by Sponsor|0|||
42285908|NCT02065336|76118192|FG005|Extension Phase|Study Terminated by Sponsor|0|||
42285909|NCT02065336|76118193|FG006|Extension Phase|Study Terminated by Sponsor|0|||
42285910|NCT02065336|76118194|FG007|Extension Phase|Study Terminated by Sponsor|0|||
42285911|NCT02065336|76118195|FG008|Extension Phase|Study Terminated by Sponsor|2|||
42285912|NCT02065336|76118196|FG009|Extension Phase|Study Terminated by Sponsor|8|||
42285913|NCT02701985|76118229|FG000|Overall Study|Withdrawal by Subject|1|||
42285914|NCT02701985|76118230|FG001|Overall Study|Withdrawal by Subject|1|||
42285915|NCT02701985|76118229|FG000|Overall Study|Lost to Follow-up|1|||
42285916|NCT02701985|76118230|FG001|Overall Study|Lost to Follow-up|0|||
42285917|NCT02701985|76118229|FG000|Overall Study|Death|1|||
42285918|NCT02701985|76118230|FG001|Overall Study|Death|0|||
42285919|NCT02701985|76118229|FG000|Overall Study|Adverse Event|0|||
42285920|NCT02701985|76118230|FG001|Overall Study|Adverse Event|5|||
42285921|NCT02064868|76118239|FG000|Overall Study|Lost to Follow-up|14|||
42285922|NCT02064868|76118240|FG001|Overall Study|Lost to Follow-up|8|||
42285923|NCT02064868|76118239|FG000|Overall Study|Physician Decision|1|||
42285924|NCT02064868|76118240|FG001|Overall Study|Physician Decision|0|||
42285925|NCT02064868|76118239|FG000|Overall Study|Withdrawal by Subject|14|||
42285926|NCT02064868|76118240|FG001|Overall Study|Withdrawal by Subject|3|||
42285927|NCT02064868|76118239|FG000|Overall Study|Technical Problems or Missing|5|||
42285928|NCT02064868|76118240|FG001|Overall Study|Technical Problems or Missing|2|||
42285929|NCT02064166|76118248|FG000|Overall Study|Adverse Event|1|||
42285930|NCT02064166|76118249|FG001|Overall Study|Adverse Event|0|||
42285931|NCT02565615|76118282|FG000|Overall Study|Death|0|||
42285932|NCT02565615|76118283|FG001|Overall Study|Death|1|||
42285933|NCT02565615|76118284|FG002|Overall Study|Death|0|||
42285934|NCT02565615|76118285|FG003|Overall Study|Death|0|||
42285935|NCT02565615|76118286|FG004|Overall Study|Death|4|||
42285936|NCT02565615|76118282|FG000|Overall Study|Not willing to participate in study|2|||
42285937|NCT02565615|76118283|FG001|Overall Study|Not willing to participate in study|21|||
42285938|NCT02565615|76118284|FG002|Overall Study|Not willing to participate in study|0|||
42285939|NCT02565615|76118285|FG003|Overall Study|Not willing to participate in study|1|||
42285940|NCT02565615|76118286|FG004|Overall Study|Not willing to participate in study|169|||
42285941|NCT02565615|76118282|FG000|Overall Study|Lost to Follow-up|0|||
42171725|NCT00075582|75978601|FG000|Overall Study|Ineligible for study|36|||
42171726|NCT00075582|75978602|FG001|Overall Study|Ineligible for study|16|||
42171727|NCT00063258|75978614|FG000|Overall Study|Physician Decision|2|||
42171728|NCT00063258|75978615|FG001|Overall Study|Physician Decision|0|||
42171729|NCT00063258|75978614|FG000|Overall Study|Lack of Efficacy|2|||
42171730|NCT00063258|75978615|FG001|Overall Study|Lack of Efficacy|0|||
42171731|NCT00088530|75978623|FG000|Overall Study|Progressive/Relapsed Disease|28|||
42171732|NCT00088530|75978624|FG001|Overall Study|Progressive/Relapsed Disease|39|||
42171733|NCT00088530|75978623|FG000|Overall Study|Adverse Event|15|||
42171734|NCT00088530|75978624|FG001|Overall Study|Adverse Event|9|||
42171735|NCT00088530|75978623|FG000|Overall Study|Withdrawal by Subject|2|||
42171736|NCT00088530|75978624|FG001|Overall Study|Withdrawal by Subject|5|||
42171737|NCT00088530|75978623|FG000|Overall Study|Lost to Follow-up|2|||
42171738|NCT00088530|75978624|FG001|Overall Study|Lost to Follow-up|0|||
42171739|NCT00088530|75978623|FG000|Overall Study|Physician Decision|2|||
42171740|NCT00088530|75978624|FG001|Overall Study|Physician Decision|0|||
42171741|NCT00088530|75978623|FG000|Overall Study|Sponsor decision|0|||
42171742|NCT00088530|75978624|FG001|Overall Study|Sponsor decision|1|||
42171743|NCT00088530|75978623|FG000|Overall Study|Patient never treated|1|||
42171744|NCT00088530|75978624|FG001|Overall Study|Patient never treated|0|||
42171745|NCT00359801|75978632|FG000|Overall Study|Lost to Follow-up|72|||
42285942|NCT02565615|76118283|FG001|Overall Study|Lost to Follow-up|4|||
42285943|NCT02565615|76118284|FG002|Overall Study|Lost to Follow-up|0|||
42285944|NCT02565615|76118285|FG003|Overall Study|Lost to Follow-up|1|||
42285945|NCT02565615|76118286|FG004|Overall Study|Lost to Follow-up|765|||
42285946|NCT02565615|76118282|FG000|Overall Study|Not meeting eligibility criteria|0|||
42171746|NCT00359801|75978633|FG001|Overall Study|Lost to Follow-up|58|||
42171747|NCT00359801|75978632|FG000|Overall Study|Withdrawal by Subject|143|||
42171748|NCT00359801|75978633|FG001|Overall Study|Withdrawal by Subject|96|||
42171749|NCT00359801|75978632|FG000|Overall Study|Other|66|||
42171750|NCT00359801|75978633|FG001|Overall Study|Other|46|||
42285947|NCT02565615|76118283|FG001|Overall Study|Not meeting eligibility criteria|7|||
42285948|NCT02565615|76118284|FG002|Overall Study|Not meeting eligibility criteria|0|||
42171751|NCT00359801|75978632|FG000|Overall Study|Final Status Unknown: missing data|7|||
42171752|NCT00359801|75978633|FG001|Overall Study|Final Status Unknown: missing data|4|||
42171753|NCT00359801|75978632|FG000|Overall Study|Sponsor Decision|17|||
42171754|NCT00359801|75978633|FG001|Overall Study|Sponsor Decision|16|||
42171755|NCT00045032|75978642|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
42171756|NCT00045032|75978643|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
42171757|NCT00045032|75978644|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
42171758|NCT00045032|75978642|FG000|Overall Study|Death|22|||
42171759|NCT00045032|75978643|FG001|Overall Study|Death|24|||
42285949|NCT02565615|76118285|FG003|Overall Study|Not meeting eligibility criteria|0|||
42285950|NCT02565615|76118286|FG004|Overall Study|Not meeting eligibility criteria|25|||
42285951|NCT02565615|76118282|FG000|Overall Study|Reason not defined|0|||
42285952|NCT02565615|76118283|FG001|Overall Study|Reason not defined|2|||
42285953|NCT02565615|76118284|FG002|Overall Study|Reason not defined|0|||
42285954|NCT02565615|76118285|FG003|Overall Study|Reason not defined|1|||
42285955|NCT02565615|76118286|FG004|Overall Study|Reason not defined|62|||
42285956|NCT02565615|76118282|FG000|Overall Study|Adverse Event|1|||
42285957|NCT02565615|76118283|FG001|Overall Study|Adverse Event|1|||
42285958|NCT02565615|76118284|FG002|Overall Study|Adverse Event|0|||
42285959|NCT02565615|76118285|FG003|Overall Study|Adverse Event|0|||
42353174|NCT01499355|76193622|FG003|Double-Blind Period|Lost to Follow-up|0|||
42353175|NCT01474239|76193643|FG000|Overall Study|Disease Progression|37|||
42353176|NCT01474239|76193644|FG001|Overall Study|Disease Progression|25|||
42353177|NCT01474239|76193643|FG000|Overall Study|Adverse Event|12|||
42353178|NCT01474239|76193644|FG001|Overall Study|Adverse Event|3|||
42353179|NCT01474239|76193643|FG000|Overall Study|Withdrawal by Subject|1|||
42353180|NCT01474239|76193644|FG001|Overall Study|Withdrawal by Subject|2|||
42040788|NCT01386385|75848782|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
42040789|NCT01386385|75848783|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
42040790|NCT01386385|75848784|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
42040791|NCT01386385|75848785|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
42040792|NCT01386385|75848786|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
42040793|NCT01386385|75848787|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
42040794|NCT01386385|75848788|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
42040795|NCT01386385|75848781|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
42040796|NCT01386385|75848782|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
42040797|NCT01386385|75848783|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
42040798|NCT01386385|75848784|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
42040799|NCT01386385|75848785|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
42040800|NCT01386385|75848786|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
42040801|NCT01386385|75848787|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
42040802|NCT01386385|75848788|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
42040803|NCT01386385|75848781|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
42040804|NCT01386385|75848782|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
42040805|NCT01386385|75848783|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
42040806|NCT01386385|75848784|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
42040807|NCT01386385|75848785|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
42040808|NCT01386385|75848786|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
42040809|NCT01386385|75848787|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
42040810|NCT01386385|75848788|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
42040811|NCT01386385|75848781|FG000|Phase II Concurrent CRT|Adverse Event|0|||
42040812|NCT01386385|75848782|FG001|Phase II Concurrent CRT|Adverse Event|0|||
42171760|NCT00045032|75978644|FG002|Overall Study|Death|17|||
42171761|NCT00045032|75978642|FG000|Overall Study|Insufficient Therapeutic Response|542|||
42171762|NCT00045032|75978643|FG001|Overall Study|Insufficient Therapeutic Response|437|||
42171763|NCT00045032|75978644|FG002|Overall Study|Insufficient Therapeutic Response|445|||
42171764|NCT00045032|75978642|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
42171765|NCT00045032|75978643|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
42171766|NCT00045032|75978644|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
42171767|NCT00045032|75978642|FG000|Overall Study|Other Protocol Violation|2|||
42171768|NCT00045032|75978643|FG001|Overall Study|Other Protocol Violation|0|||
42171769|NCT00045032|75978644|FG002|Overall Study|Other Protocol Violation|1|||
42171770|NCT00045032|75978642|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
42171771|NCT00045032|75978643|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
42171772|NCT00045032|75978644|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
42171773|NCT00045032|75978642|FG000|Overall Study|Failure to Return|57|||
42285960|NCT02565615|76118286|FG004|Overall Study|Adverse Event|9|||
42040813|NCT01386385|75848783|FG002|Phase II Concurrent CRT|Adverse Event|0|||
42040814|NCT01386385|75848784|FG003|Phase II Concurrent CRT|Adverse Event|0|||
42040815|NCT01386385|75848785|FG004|Phase II Concurrent CRT|Adverse Event|0|||
42171774|NCT00045032|75978643|FG001|Overall Study|Failure to Return|62|||
42285961|NCT02565615|76118282|FG000|Overall Study|Untreated|0|||
42353181|NCT01474239|76193643|FG000|Overall Study|Death|1|||
42171775|NCT00045032|75978644|FG002|Overall Study|Failure to Return|61|||
42015072|NCT00946153|75822236|FG003|Phase 2|14 days washout for recovery due to AE|0|||
42015073|NCT00946153|75822237|FG004|Phase 2|14 days washout for recovery due to AE|4|||
42015074|NCT01160289|75822259|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
42015075|NCT01160289|75822260|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
42015076|NCT01160289|75822261|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
42015077|NCT01160289|75822262|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
42015078|NCT01160289|75822263|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
42015079|NCT01160289|75822264|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
42015080|NCT01160289|75822259|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
42015081|NCT01160289|75822260|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
42353182|NCT01474239|76193644|FG001|Overall Study|Death|1|||
42015082|NCT01160289|75822261|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
42015083|NCT01160289|75822262|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
42015084|NCT01160289|75822263|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
42015085|NCT01160289|75822264|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
42015086|NCT01160289|75822259|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
42015087|NCT01160289|75822260|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
42015088|NCT01160289|75822261|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
42015089|NCT01160289|75822262|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
42353183|NCT01474239|76193643|FG000|Overall Study|Clinical Disease Progression|7|||
42353184|NCT01474239|76193644|FG001|Overall Study|Clinical Disease Progression|1|||
42353185|NCT01474239|76193643|FG000|Overall Study|Withdrawal for Economic Reason|1|||
42353186|NCT01474239|76193644|FG001|Overall Study|Withdrawal for Economic Reason|0|||
42353187|NCT01473381|76193654|FG000|Overall Study|Adverse Event|8|||
42015090|NCT01160289|75822263|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
42015091|NCT01160289|75822264|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
42015092|NCT01160289|75822259|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
42015093|NCT01160289|75822260|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
42285962|NCT02565615|76118283|FG001|Overall Study|Untreated|0|||
42285963|NCT02565615|76118284|FG002|Overall Study|Untreated|0|||
42353188|NCT01473381|76193655|FG001|Overall Study|Adverse Event|20|||
42353189|NCT01473381|76193656|FG002|Overall Study|Adverse Event|25|||
42353190|NCT01473381|76193657|FG003|Overall Study|Adverse Event|17|||
42171776|NCT00045032|75978642|FG000|Overall Study|Other|93|||
42285964|NCT02565615|76118285|FG003|Overall Study|Untreated|0|||
42285965|NCT02565615|76118286|FG004|Overall Study|Untreated|567|||
42285966|NCT02701361|76118301|FG000|Overall Study|Lost to Follow-up|5|||
42285967|NCT02701361|76118302|FG001|Overall Study|Lost to Follow-up|2|||
42285968|NCT02701361|76118303|FG002|Overall Study|Lost to Follow-up|1|||
42285969|NCT02701361|76118301|FG000|Overall Study|Withdrawal by Subject|4|||
42285970|NCT02701361|76118302|FG001|Overall Study|Withdrawal by Subject|0|||
42285971|NCT02701361|76118303|FG002|Overall Study|Withdrawal by Subject|0|||
42285972|NCT02701361|76118301|FG000|Overall Study|timed out in rehab center|0|||
42285973|NCT02701361|76118302|FG001|Overall Study|timed out in rehab center|1|||
42285974|NCT02701361|76118303|FG002|Overall Study|timed out in rehab center|0|||
42171777|NCT00045032|75978643|FG001|Overall Study|Other|84|||
42171778|NCT00045032|75978644|FG002|Overall Study|Other|105|||
42171779|NCT00356915|75978657|FG000|Overall Study|Non compliance|1|||
42171780|NCT00356915|75978658|FG001|Overall Study|Non compliance|2|||
42285975|NCT02701361|76118301|FG000|Overall Study|incarceration|0|||
42353191|NCT01473381|76193654|FG000|Overall Study|Insufficient Therapeutic Response|10|||
42171781|NCT00356915|75978659|FG002|Overall Study|Non compliance|1|||
42171782|NCT00356915|75978657|FG000|Overall Study|Protocol Violation|2|||
42015094|NCT01160289|75822261|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
42015095|NCT01160289|75822262|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
42285976|NCT02701361|76118302|FG001|Overall Study|incarceration|0|||
42285977|NCT02701361|76118303|FG002|Overall Study|incarceration|1|||
42015096|NCT01160289|75822263|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
42015097|NCT01160289|75822264|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
42015098|NCT01160289|75822259|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
42285978|NCT01662999|76118328|FG000|Period 3|Withdrawal by Subject|0|||
42353192|NCT01473381|76193655|FG001|Overall Study|Insufficient Therapeutic Response|1|||
42353193|NCT01473381|76193656|FG002|Overall Study|Insufficient Therapeutic Response|2|||
42171783|NCT00356915|75978658|FG001|Overall Study|Protocol Violation|3|||
42171784|NCT00356915|75978659|FG002|Overall Study|Protocol Violation|2|||
42171785|NCT00356915|75978657|FG000|Overall Study|Withdrawal by Subject|14|||
42171786|NCT00356915|75978658|FG001|Overall Study|Withdrawal by Subject|14|||
42285979|NCT01662999|76118329|FG001|Period 3|Withdrawal by Subject|1|||
42353194|NCT01473381|76193657|FG003|Overall Study|Insufficient Therapeutic Response|3|||
42285980|NCT01662999|76118330|FG002|Period 3|Withdrawal by Subject|0|||
42285981|NCT01662999|76118331|FG003|Period 3|Withdrawal by Subject|0|||
42285982|NCT01662999|76118332|FG004|Period 3|Withdrawal by Subject|0|||
42285983|NCT01662999|76118333|FG005|Period 3|Withdrawal by Subject|0|||
42285984|NCT02565381|76118366|FG000|Overall Study|Lost to Follow-up|1|||
42285985|NCT02565381|76118367|FG001|Overall Study|Lost to Follow-up|0|||
42285986|NCT02565381|76118368|FG002|Overall Study|Lost to Follow-up|1|||
42285987|NCT02063854|76118383|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
42285988|NCT02063854|76118384|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
42285989|NCT02063854|76118385|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
42285990|NCT02063854|76118386|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
42285991|NCT02063854|76118387|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
42285992|NCT02063854|76118388|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
42285993|NCT02063854|76118389|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
42285994|NCT02063854|76118383|FG000|Overall Study|Major Protocol Deviation|0|||
42285995|NCT02063854|76118384|FG001|Overall Study|Major Protocol Deviation|0|||
42285996|NCT02063854|76118385|FG002|Overall Study|Major Protocol Deviation|3|||
42285997|NCT02063854|76118386|FG003|Overall Study|Major Protocol Deviation|0|||
42285998|NCT02063854|76118387|FG004|Overall Study|Major Protocol Deviation|0|||
42285999|NCT02063854|76118388|FG005|Overall Study|Major Protocol Deviation|0|||
42286000|NCT02063854|76118389|FG006|Overall Study|Major Protocol Deviation|0|||
42286001|NCT02063854|76118383|FG000|Overall Study|Voluntary Withdrawal|2|||
42353195|NCT01473381|76193654|FG000|Overall Study|Protocol Violation|17|||
42353196|NCT01473381|76193655|FG001|Overall Study|Protocol Violation|23|||
42353197|NCT01473381|76193656|FG002|Overall Study|Protocol Violation|19|||
42353198|NCT01473381|76193657|FG003|Overall Study|Protocol Violation|17|||
42353199|NCT01473381|76193654|FG000|Overall Study|Withdrawal of Consent|20|||
42353200|NCT01473381|76193655|FG001|Overall Study|Withdrawal of Consent|21|||
42353201|NCT01473381|76193656|FG002|Overall Study|Withdrawal of Consent|20|||
42286002|NCT02063854|76118384|FG001|Overall Study|Voluntary Withdrawal|0|||
42286003|NCT02063854|76118385|FG002|Overall Study|Voluntary Withdrawal|8|||
42286004|NCT02063854|76118386|FG003|Overall Study|Voluntary Withdrawal|1|||
42286005|NCT02063854|76118387|FG004|Overall Study|Voluntary Withdrawal|3|||
42286006|NCT02063854|76118388|FG005|Overall Study|Voluntary Withdrawal|6|||
42286007|NCT02063854|76118389|FG006|Overall Study|Voluntary Withdrawal|1|||
42286008|NCT02063854|76118383|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
42286009|NCT02063854|76118384|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
42286010|NCT02063854|76118385|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
42286011|NCT02063854|76118386|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
42286012|NCT02063854|76118387|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
42286013|NCT02063854|76118388|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
42286014|NCT02063854|76118389|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
42286015|NCT02063854|76118383|FG000|Overall Study|Reason Not Specified|1|||
42286016|NCT02063854|76118384|FG001|Overall Study|Reason Not Specified|0|||
42286017|NCT02063854|76118385|FG002|Overall Study|Reason Not Specified|0|||
42286018|NCT02063854|76118386|FG003|Overall Study|Reason Not Specified|0|||
42286019|NCT02063854|76118387|FG004|Overall Study|Reason Not Specified|0|||
42286020|NCT02063854|76118388|FG005|Overall Study|Reason Not Specified|0|||
42353202|NCT01473381|76193657|FG003|Overall Study|Withdrawal of Consent|26|||
42353203|NCT01473381|76193654|FG000|Overall Study|Lost to Follow-up|25|||
42353204|NCT01473381|76193655|FG001|Overall Study|Lost to Follow-up|28|||
42353205|NCT01473381|76193656|FG002|Overall Study|Lost to Follow-up|35|||
42353206|NCT01473381|76193657|FG003|Overall Study|Lost to Follow-up|23|||
42353207|NCT01473381|76193654|FG000|Overall Study|Other Reasons|0|||
42353208|NCT01473381|76193655|FG001|Overall Study|Other Reasons|0|||
42353209|NCT01473381|76193656|FG002|Overall Study|Other Reasons|1|||
42353210|NCT01473381|76193657|FG003|Overall Study|Other Reasons|3|||
42353211|NCT01499277|76193699|FG000|Overall Study|Adverse Event|3|||
42353212|NCT01499277|76193700|FG001|Overall Study|Adverse Event|6|||
42353213|NCT01499277|76193699|FG000|Overall Study|Death|3|||
42353214|NCT01499277|76193700|FG001|Overall Study|Death|2|||
42353215|NCT01499277|76193699|FG000|Overall Study|Lost to Follow-up|15|||
42353216|NCT01499277|76193700|FG001|Overall Study|Lost to Follow-up|8|||
42015099|NCT01160289|75822260|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
42286021|NCT02063854|76118389|FG006|Overall Study|Reason Not Specified|0|||
42353217|NCT01499277|76193699|FG000|Overall Study|Protocol Violation|2|||
42353218|NCT01499277|76193700|FG001|Overall Study|Protocol Violation|3|||
42353219|NCT01499277|76193699|FG000|Overall Study|Withdrawal by Subject|16|||
42353220|NCT01499277|76193700|FG001|Overall Study|Withdrawal by Subject|6|||
42353221|NCT01499277|76193699|FG000|Overall Study|Lack of therapeutic response and other|8|||
42353222|NCT01499277|76193700|FG001|Overall Study|Lack of therapeutic response and other|7|||
42353223|NCT01499199|76193725|FG000|Overall Study|Adverse Event|1|||
42286022|NCT02063854|76118383|FG000|Overall Study|Did Not Receive Study Drug|0|||
42286023|NCT02063854|76118384|FG001|Overall Study|Did Not Receive Study Drug|0|||
42286024|NCT02063854|76118385|FG002|Overall Study|Did Not Receive Study Drug|0|||
42286025|NCT02063854|76118386|FG003|Overall Study|Did Not Receive Study Drug|0|||
42286026|NCT02063854|76118387|FG004|Overall Study|Did Not Receive Study Drug|0|||
42286027|NCT02063854|76118388|FG005|Overall Study|Did Not Receive Study Drug|1|||
42286028|NCT02063854|76118389|FG006|Overall Study|Did Not Receive Study Drug|0|||
42286029|NCT02063698|76118409|FG000|Overall Study|did not complete booklet for days 2-8|1|||
42286030|NCT02063698|76118410|FG001|Overall Study|did not complete booklet for days 2-8|2|||
42286031|NCT04701333|76118418|FG000|Overall Study|Lost to Follow-up|3|||
42286032|NCT04701333|76118419|FG001|Overall Study|Lost to Follow-up|7|||
42286033|NCT04701333|76118418|FG000|Overall Study|Withdrawal by Subject|0|||
42286034|NCT04701333|76118419|FG001|Overall Study|Withdrawal by Subject|1|||
42286035|NCT02062450|76118427|FG000|Overall Study|No follow-up visit|124|||
42286036|NCT02561247|76118435|FG000|Overall Study|Protocol Violation|1|||
42286037|NCT02561247|76118435|FG000|Overall Study|Withdrawal by Subject|1|||
42286038|NCT02561247|76118435|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
42286039|NCT02061592|76118441|FG000|Period 1|Withdrawal by Subject|1|||
42286040|NCT02061592|76118442|FG001|Period 1|Withdrawal by Subject|0|||
42286041|NCT02061592|76118441|FG000|Period 1|Protocol Violation|1|||
42286042|NCT02061592|76118442|FG001|Period 1|Protocol Violation|0|||
42286043|NCT02061592|76118441|FG000|Period 2|Lost to Follow-up|0|||
42286044|NCT02061592|76118442|FG001|Period 2|Lost to Follow-up|1|||
42286045|NCT01663623|76118452|FG000|Overall Study|Adverse Event|3|||
42286046|NCT01663623|76118453|FG001|Overall Study|Adverse Event|7|||
42286047|NCT01663623|76118452|FG000|Overall Study|Lack of Efficacy|5|||
42286048|NCT01663623|76118453|FG001|Overall Study|Lack of Efficacy|6|||
42286049|NCT01663623|76118452|FG000|Overall Study|Protocol Violation|0|||
42286050|NCT01663623|76118453|FG001|Overall Study|Protocol Violation|1|||
42286051|NCT01663623|76118452|FG000|Overall Study|Other-Study closed/terminated|1|||
42286052|NCT01663623|76118453|FG001|Overall Study|Other-Study closed/terminated|1|||
42286053|NCT01663623|76118452|FG000|Overall Study|Physician Decision|1|||
42286054|NCT01663623|76118453|FG001|Overall Study|Physician Decision|4|||
42286055|NCT01663623|76118452|FG000|Overall Study|Withdrawal by Subject|2|||
42286056|NCT01663623|76118453|FG001|Overall Study|Withdrawal by Subject|1|||
42286057|NCT02042950|76118459|FG000|Overall Study|Progressive Disease|4|||
42286058|NCT02042404|76118463|FG000|Overall Study|Death|1|||
42286059|NCT02042404|76118464|FG001|Overall Study|Death|0|||
42286060|NCT02042404|76118463|FG000|Overall Study|Unrelated Adverse Event|3|||
42286061|NCT02042404|76118464|FG001|Overall Study|Unrelated Adverse Event|0|||
42286062|NCT02042404|76118463|FG000|Overall Study|Inability to meet time requirements|1|||
42286063|NCT02042404|76118464|FG001|Overall Study|Inability to meet time requirements|0|||
42286064|NCT02042014|76118471|FG000|Overall Study|Adverse Event|1|||
42286065|NCT02042014|76118471|FG000|Overall Study|Physician Decision|7|||
42286066|NCT02041702|76118477|FG000|Overall Study|Lost to Follow-up|1|||
42286067|NCT02041702|76118478|FG001|Overall Study|Lost to Follow-up|6|||
42286068|NCT02041702|76118477|FG000|Overall Study|Death|4|||
42286069|NCT02041702|76118478|FG001|Overall Study|Death|0|||
42286070|NCT02041702|76118477|FG000|Overall Study|Withdrawal by Subject|4|||
42286071|NCT02041702|76118478|FG001|Overall Study|Withdrawal by Subject|3|||
42286072|NCT02041702|76118477|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
42286073|NCT02041702|76118478|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
42286074|NCT02041702|76118477|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
42286075|NCT02041702|76118478|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
42286076|NCT02565147|76118486|FG000|Overall Study|Withdrawal by Subject|5|||
42286077|NCT02565147|76118487|FG001|Overall Study|Withdrawal by Subject|1|||
42286078|NCT02565147|76118486|FG000|Overall Study|Lost to Follow-up|0|||
42286079|NCT02565147|76118487|FG001|Overall Study|Lost to Follow-up|1|||
42286080|NCT02565147|76118486|FG000|Overall Study|Death|1|||
42286081|NCT02565147|76118487|FG001|Overall Study|Death|1|||
42286082|NCT02061280|76118495|FG000|Overall Study|Protocol Violation|12|||
42286083|NCT02061280|76118496|FG001|Overall Study|Protocol Violation|8|||
42286084|NCT02061280|76118495|FG000|Overall Study|moved out of state|0|||
42286085|NCT02061280|76118496|FG001|Overall Study|moved out of state|1|||
42286086|NCT02061280|76118495|FG000|Overall Study|Withdrawal by Subject|1|||
42286087|NCT02061280|76118496|FG001|Overall Study|Withdrawal by Subject|2|||
42286088|NCT02061280|76118495|FG000|Overall Study|Lost to Follow-up|5|||
42286089|NCT02061280|76118496|FG001|Overall Study|Lost to Follow-up|1|||
42286090|NCT02061202|76118507|FG000|Overall Study|Lost to Follow-up|1|||
42286091|NCT02061202|76118508|FG001|Overall Study|Lost to Follow-up|1|||
42286092|NCT02059408|76118517|FG000|Overall Study|Did not get tested|0|||
42286093|NCT02059408|76118518|FG001|Overall Study|Did not get tested|330|||
42286094|NCT02059408|76118519|FG002|Overall Study|Did not get tested|358|||
42286095|NCT01625338|76118532|FG000|Overall Study|Enrolled but not Treated|0|||
42286096|NCT01625338|76118533|FG001|Overall Study|Enrolled but not Treated|0|||
42286097|NCT01625338|76118534|FG002|Overall Study|Enrolled but not Treated|1|||
42286098|NCT01625338|76118532|FG000|Overall Study|Efficacy Failure|27|||
42286099|NCT01625338|76118533|FG001|Overall Study|Efficacy Failure|39|||
42286100|NCT01625338|76118534|FG002|Overall Study|Efficacy Failure|31|||
42286101|NCT01625338|76118532|FG000|Overall Study|Lost to Follow-up|3|||
42286102|NCT01625338|76118533|FG001|Overall Study|Lost to Follow-up|3|||
42286103|NCT01625338|76118534|FG002|Overall Study|Lost to Follow-up|2|||
42286104|NCT01625338|76118532|FG000|Overall Study|Investigator Decision|0|||
42286105|NCT01625338|76118533|FG001|Overall Study|Investigator Decision|2|||
42286106|NCT01625338|76118534|FG002|Overall Study|Investigator Decision|1|||
42286107|NCT01625338|76118532|FG000|Overall Study|Subject Withdrew Consent|1|||
42286108|NCT01625338|76118533|FG001|Overall Study|Subject Withdrew Consent|0|||
42286109|NCT01625338|76118534|FG002|Overall Study|Subject Withdrew Consent|2|||
42286110|NCT01625338|76118532|FG000|Overall Study|Adverse Event|1|||
42286111|NCT01625338|76118533|FG001|Overall Study|Adverse Event|0|||
42286112|NCT01625338|76118534|FG002|Overall Study|Adverse Event|1|||
42286113|NCT01625338|76118532|FG000|Overall Study|Study Discontinued by Sponsor|0|||
42286114|NCT01625338|76118533|FG001|Overall Study|Study Discontinued by Sponsor|0|||
42286115|NCT01625338|76118534|FG002|Overall Study|Study Discontinued by Sponsor|1|||
42286116|NCT02560623|76118546|FG000|Overall Study|Unable to swallow sponge|0|||
42286117|NCT02560623|76118547|FG001|Overall Study|Unable to swallow sponge|1|||
42286118|NCT02560623|76118548|FG002|Overall Study|Unable to swallow sponge|0|||
42286119|NCT02560623|76118549|FG003|Overall Study|Unable to swallow sponge|0|||
42286120|NCT02560623|76118546|FG000|Overall Study|Intervention prior to sponge administration|0|||
42286121|NCT02560623|76118547|FG001|Overall Study|Intervention prior to sponge administration|1|||
42286122|NCT02560623|76118548|FG002|Overall Study|Intervention prior to sponge administration|0|||
42286123|NCT02560623|76118549|FG003|Overall Study|Intervention prior to sponge administration|0|||
42286124|NCT02560389|76118562|FG000|Overall Study|Lost to Follow-up|1|||
42286125|NCT02560389|76118563|FG001|Overall Study|Lost to Follow-up|2|||
42286126|NCT02560389|76118564|FG002|Overall Study|Lost to Follow-up|2|||
42286127|NCT02560389|76118562|FG000|Overall Study|Tested positive for illicit substance|0|||
42286128|NCT02560389|76118563|FG001|Overall Study|Tested positive for illicit substance|1|||
42286129|NCT02560389|76118564|FG002|Overall Study|Tested positive for illicit substance|0|||
42286130|NCT02564211|76118572|FG000|Overall Study|Adverse Event|4|||
42286131|NCT02093026|76118576|FG000|Overall Study|Adverse Event|26|||
42286132|NCT02093026|76118576|FG000|Overall Study|Death|10|||
42286133|NCT02093026|76118576|FG000|Overall Study|Other|157|||
42286134|NCT02040844|76118584|FG000|Overall Study|Adverse Event|0|||
42286135|NCT02040844|76118585|FG001|Overall Study|Adverse Event|0|||
42286136|NCT02040844|76118586|FG002|Overall Study|Adverse Event|1|||
42286137|NCT02040844|76118584|FG000|Overall Study|Withdrawal by Subject|16|||
42286138|NCT02040844|76118585|FG001|Overall Study|Withdrawal by Subject|22|||
42286139|NCT02040844|76118586|FG002|Overall Study|Withdrawal by Subject|25|||
42286140|NCT02040844|76118584|FG000|Overall Study|Lost to Follow-up|12|||
42286141|NCT02040844|76118585|FG001|Overall Study|Lost to Follow-up|9|||
42286142|NCT02040844|76118586|FG002|Overall Study|Lost to Follow-up|13|||
42286143|NCT02040844|76118584|FG000|Overall Study|Missing|13|||
42286144|NCT02040844|76118585|FG001|Overall Study|Missing|3|||
42286145|NCT02040844|76118586|FG002|Overall Study|Missing|2|||
42015100|NCT01160289|75822261|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
42015101|NCT01160289|75822262|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
42015102|NCT01160289|75822263|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
42286146|NCT02040844|76118584|FG000|Overall Study|Non-specified|8|||
42286147|NCT02040844|76118585|FG001|Overall Study|Non-specified|2|||
42286148|NCT02040844|76118586|FG002|Overall Study|Non-specified|5|||
42286149|NCT02040844|76118584|FG000|Overall Study|Concomitant medication|1|||
42286150|NCT02040844|76118585|FG001|Overall Study|Concomitant medication|3|||
42286151|NCT02040844|76118586|FG002|Overall Study|Concomitant medication|1|||
42286152|NCT02059174|76118594|FG000|Period 1|Withdrawal by Subject|0|||
42286153|NCT02059174|76118595|FG001|Period 1|Withdrawal by Subject|2|||
42286154|NCT02059174|76118594|FG000|Period 2|Withdrawal by Subject|0|||
42286155|NCT02059174|76118595|FG001|Period 2|Withdrawal by Subject|2|||
42286156|NCT02059174|76118594|FG000|Period 2|Protocol Violation|1|||
42286157|NCT02059174|76118595|FG001|Period 2|Protocol Violation|0|||
42286158|NCT02059174|76118594|FG000|Period 3|Physician Decision|1|||
42286159|NCT02059174|76118595|FG001|Period 3|Physician Decision|0|||
42286160|NCT02092324|76118603|FG000|Overall Study|Adverse Event|1|||
42286161|NCT02092324|76118603|FG000|Overall Study|Lack of Efficacy|6|||
42286162|NCT02092324|76118603|FG000|Overall Study|Proceed to Transplant|3|||
42286163|NCT02092324|76118603|FG000|Overall Study|Physician Decision|7|||
42286164|NCT02092324|76118603|FG000|Overall Study|Misdiagnosis|2|||
42286165|NCT02040766|76118615|FG000|Overall Study|Adverse Event|1|||
42286166|NCT02040766|76118616|FG001|Overall Study|Adverse Event|1|||
42286167|NCT02040766|76118617|FG002|Overall Study|Adverse Event|1|||
42286168|NCT02040766|76118618|FG003|Overall Study|Adverse Event|0|||
42286169|NCT02040766|76118619|FG004|Overall Study|Adverse Event|2|||
42286170|NCT02040766|76118615|FG000|Overall Study|Withdrawal by Subject|4|||
42286171|NCT02040766|76118616|FG001|Overall Study|Withdrawal by Subject|3|||
42286172|NCT02040766|76118617|FG002|Overall Study|Withdrawal by Subject|2|||
42286173|NCT02040766|76118618|FG003|Overall Study|Withdrawal by Subject|3|||
42286174|NCT02040766|76118619|FG004|Overall Study|Withdrawal by Subject|2|||
42286175|NCT02040766|76118615|FG000|Overall Study|Non-compliance|0|||
42286176|NCT02040766|76118616|FG001|Overall Study|Non-compliance|1|||
42286177|NCT02040766|76118617|FG002|Overall Study|Non-compliance|0|||
42286178|NCT02040766|76118618|FG003|Overall Study|Non-compliance|0|||
42286179|NCT02040766|76118619|FG004|Overall Study|Non-compliance|0|||
42286180|NCT02040766|76118615|FG000|Overall Study|Protocol Violation|2|||
42286181|NCT02040766|76118616|FG001|Overall Study|Protocol Violation|1|||
42286182|NCT02040766|76118617|FG002|Overall Study|Protocol Violation|2|||
42286183|NCT02040766|76118618|FG003|Overall Study|Protocol Violation|3|||
42286184|NCT02040766|76118619|FG004|Overall Study|Protocol Violation|0|||
42286185|NCT02040766|76118615|FG000|Overall Study|Lost to Follow-up|4|||
42286186|NCT02040766|76118616|FG001|Overall Study|Lost to Follow-up|1|||
42286187|NCT02040766|76118617|FG002|Overall Study|Lost to Follow-up|3|||
42286188|NCT02040766|76118618|FG003|Overall Study|Lost to Follow-up|1|||
42286189|NCT02040766|76118619|FG004|Overall Study|Lost to Follow-up|4|||
42286190|NCT02040766|76118615|FG000|Overall Study|Not reported|1|||
42286191|NCT02040766|76118616|FG001|Overall Study|Not reported|0|||
42286192|NCT02040766|76118617|FG002|Overall Study|Not reported|0|||
42286193|NCT02040766|76118618|FG003|Overall Study|Not reported|0|||
42286194|NCT02040766|76118619|FG004|Overall Study|Not reported|0|||
42286195|NCT02040766|76118615|FG000|Overall Study|Lack of Efficacy|6|||
42286196|NCT02040766|76118616|FG001|Overall Study|Lack of Efficacy|3|||
42286197|NCT02040766|76118617|FG002|Overall Study|Lack of Efficacy|4|||
42286198|NCT02040766|76118618|FG003|Overall Study|Lack of Efficacy|6|||
42286199|NCT02040766|76118619|FG004|Overall Study|Lack of Efficacy|5|||
42286200|NCT02040532|76118632|FG000|Overall Study|Lost to Follow-up|1|||
42286201|NCT02040532|76118632|FG000|Overall Study|Physician Decision|4|||
42286202|NCT02040532|76118632|FG000|Overall Study|Adverse Event|4|||
42286203|NCT02040532|76118632|FG000|Overall Study|Withdrawal by Subject|3|||
42286204|NCT02039908|76118636|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
42286205|NCT02039908|76118637|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
42286206|NCT02039908|76118638|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
42286207|NCT02039908|76118639|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
42286208|NCT02039908|76118636|FG000|Phase 1-Summer|Protocol Violation|6|||
42286209|NCT02039908|76118637|FG001|Phase 1-Summer|Protocol Violation|0|||
42286210|NCT02039908|76118638|FG002|Phase 1-Summer|Protocol Violation|0|||
42286211|NCT02039908|76118639|FG003|Phase 1-Summer|Protocol Violation|0|||
42353224|NCT01499199|76193725|FG000|Overall Study|Lack of Efficacy|1|||
42353225|NCT01499043|76193729|FG000|Overall Study|Progressive disease (radiographic)|2|||
42286212|NCT02039908|76118636|FG000|Phase 2-School Year|Lost to Follow-up|0|||
42286213|NCT02039908|76118637|FG001|Phase 2-School Year|Lost to Follow-up|0|||
42286214|NCT02039908|76118638|FG002|Phase 2-School Year|Lost to Follow-up|1|||
42286215|NCT02039908|76118639|FG003|Phase 2-School Year|Lost to Follow-up|3|||
42015103|NCT01160289|75822264|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
42015104|NCT01160289|75822259|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
42015105|NCT01160289|75822260|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
42015106|NCT01160289|75822261|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
42353226|NCT01499043|76193729|FG000|Overall Study|Progressive disease (clinical)|1|||
42353227|NCT01499043|76193729|FG000|Overall Study|Withdrawal by Subject|2|||
42015107|NCT01160289|75822262|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
42015108|NCT01160289|75822263|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
42015109|NCT01160289|75822264|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
42015110|NCT01160289|75822259|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
42015111|NCT01160289|75822260|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
42015112|NCT01160289|75822261|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
42040816|NCT01386385|75848786|FG005|Phase II Concurrent CRT|Adverse Event|0|||
42286216|NCT02039908|76118636|FG000|Phase 2-School Year|Protocol Violation|0|||
42286217|NCT02039908|76118637|FG001|Phase 2-School Year|Protocol Violation|0|||
42286218|NCT02039908|76118638|FG002|Phase 2-School Year|Protocol Violation|3|||
42286219|NCT02039908|76118639|FG003|Phase 2-School Year|Protocol Violation|0|||
42286220|NCT02039908|76118636|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
42353228|NCT01499043|76193729|FG000|Overall Study|Adverse Event|1|||
42353229|NCT01498887|76193803|FG000|Overall Study|Administrative problems|1|||
42353230|NCT01498887|76193804|FG001|Overall Study|Administrative problems|0|||
42353231|NCT01498887|76193803|FG000|Overall Study|Lost to Follow-up|1|||
42353232|NCT01498887|76193804|FG001|Overall Study|Lost to Follow-up|1|||
42353233|NCT01498887|76193803|FG000|Overall Study|Withdrawal by Subject|1|||
42353234|NCT01498887|76193804|FG001|Overall Study|Withdrawal by Subject|0|||
42353235|NCT01498887|76193803|FG000|Overall Study|Protocol Violation|1|||
42353236|NCT01498887|76193804|FG001|Overall Study|Protocol Violation|3|||
42353237|NCT01498887|76193803|FG000|Overall Study|Lack of Efficacy|5|||
42286221|NCT02039908|76118637|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
42286222|NCT02039908|76118638|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
42286223|NCT02039908|76118639|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
42286224|NCT02058940|76118647|FG000|Overall Study|Discharged from Critical Care Unit|1|||
42286225|NCT02058628|76118653|FG000|Overall Study|Adverse Event|1|||
42286226|NCT02058628|76118654|FG001|Overall Study|Adverse Event|0|||
42286227|NCT02058628|76118653|FG000|Overall Study|Withdrawal by Subject|2|||
42286228|NCT02058628|76118654|FG001|Overall Study|Withdrawal by Subject|2|||
42286229|NCT02058628|76118653|FG000|Overall Study|Lost to Follow-up|2|||
42286230|NCT02058628|76118654|FG001|Overall Study|Lost to Follow-up|4|||
42286231|NCT02058628|76118653|FG000|Overall Study|Not in time schedule|0|||
42286232|NCT02058628|76118654|FG001|Overall Study|Not in time schedule|1|||
42286233|NCT02058628|76118653|FG000|Overall Study|The visit date was not in timeline|0|||
42286234|NCT02058628|76118654|FG001|Overall Study|The visit date was not in timeline|1|||
42286235|NCT02058628|76118653|FG000|Overall Study|A lot of time for study for participant|1|||
42286236|NCT02058628|76118654|FG001|Overall Study|A lot of time for study for participant|0|||
42286237|NCT02058628|76118653|FG000|Overall Study|Non compliance|1|||
42286238|NCT02058628|76118654|FG001|Overall Study|Non compliance|0|||
42286239|NCT02058160|76118665|FG000|Overall Study|Randomized but not treated|2|||
42286240|NCT02058160|76118666|FG001|Overall Study|Randomized but not treated|4|||
42286241|NCT02058160|76118665|FG000|Overall Study|Poor compliance to protocol|4|||
42286242|NCT02058160|76118666|FG001|Overall Study|Poor compliance to protocol|1|||
42286243|NCT02058160|76118665|FG000|Overall Study|Adverse Event|12|||
42286244|NCT02058160|76118666|FG001|Overall Study|Adverse Event|3|||
42286245|NCT02058160|76118665|FG000|Overall Study|Lost to Follow-up|1|||
42286246|NCT02058160|76118666|FG001|Overall Study|Lost to Follow-up|0|||
42286247|NCT02058160|76118665|FG000|Overall Study|Other than specified above|12|||
42286248|NCT02058160|76118666|FG001|Overall Study|Other than specified above|6|||
42286249|NCT02090764|76118674|FG000|Overall Study|Adverse Event|1|||
42353238|NCT01498887|76193804|FG001|Overall Study|Lack of Efficacy|3|||
42353239|NCT01498887|76193803|FG000|Overall Study|Abnormal result from test procedure|1|||
42353240|NCT01498887|76193804|FG001|Overall Study|Abnormal result from test procedure|1|||
42353241|NCT01498887|76193803|FG000|Overall Study|Abnormal laboratory value|2|||
42353242|NCT01498887|76193804|FG001|Overall Study|Abnormal laboratory value|2|||
42353243|NCT01498887|76193803|FG000|Overall Study|Adverse Event|4|||
42353244|NCT01498887|76193804|FG001|Overall Study|Adverse Event|1|||
42353245|NCT01498653|76193813|FG000|Overall Study|Adverse Event|2|||
42353246|NCT01498653|76193814|FG001|Overall Study|Adverse Event|2|||
42353247|NCT01498653|76193813|FG000|Overall Study|Lack of Efficacy|12|||
42353248|NCT01498653|76193814|FG001|Overall Study|Lack of Efficacy|26|||
42353249|NCT01498653|76193813|FG000|Overall Study|Protocol Violation|0|||
42353250|NCT01498653|76193814|FG001|Overall Study|Protocol Violation|4|||
42353251|NCT01498653|76193813|FG000|Overall Study|Lost to Follow-up|1|||
42353252|NCT01498653|76193814|FG001|Overall Study|Lost to Follow-up|0|||
42353253|NCT01498653|76193813|FG000|Overall Study|Physician Decision|2|||
42353254|NCT01498653|76193814|FG001|Overall Study|Physician Decision|0|||
42353255|NCT01498653|76193813|FG000|Overall Study|Withdrawal by Subject|2|||
42353256|NCT01498653|76193814|FG001|Overall Study|Withdrawal by Subject|3|||
42353257|NCT01498575|76193822|FG000|Overall Sample|Withdrawal by Subject|60|||
42353258|NCT01498575|76193823|FG001|Overall Sample|Withdrawal by Subject|14|||
42353259|NCT01498575|76193822|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
42353260|NCT01498575|76193823|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
42353261|NCT01498575|76193822|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
42353262|NCT01498575|76193823|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
42286250|NCT02090764|76118675|FG001|Overall Study|Adverse Event|3|||
42286251|NCT02090764|76118674|FG000|Overall Study|Lack of Efficacy|0|||
42286252|NCT02090764|76118675|FG001|Overall Study|Lack of Efficacy|13|||
42286253|NCT02090764|76118674|FG000|Overall Study|Withdrawal by Subject|2|||
42286254|NCT02090764|76118675|FG001|Overall Study|Withdrawal by Subject|1|||
42286255|NCT02090764|76118674|FG000|Overall Study|Intercurrent illness and other|1|||
42353263|NCT01498185|76193834|FG000|Overall Study|Adverse Event|0|||
42353264|NCT01498185|76193835|FG001|Overall Study|Adverse Event|0|||
42353265|NCT01498185|76193836|FG002|Overall Study|Adverse Event|0|||
42353266|NCT01498185|76193837|FG003|Overall Study|Adverse Event|1|||
42286256|NCT02090764|76118675|FG001|Overall Study|Intercurrent illness and other|1|||
42286257|NCT02090764|76118674|FG000|Overall Study|Lost to Follow-up|2|||
42286258|NCT02090764|76118675|FG001|Overall Study|Lost to Follow-up|2|||
42286259|NCT02057692|76118685|FG000|Overall Study|Adverse Event|1|||
42286260|NCT02057692|76118686|FG001|Overall Study|Adverse Event|0|||
42286261|NCT02057692|76118687|FG002|Overall Study|Adverse Event|0|||
42286262|NCT02057692|76118688|FG003|Overall Study|Adverse Event|0|||
42286263|NCT02057692|76118685|FG000|Overall Study|Lost to Follow-up|0|||
42286264|NCT02057692|76118686|FG001|Overall Study|Lost to Follow-up|0|||
42286265|NCT02057692|76118687|FG002|Overall Study|Lost to Follow-up|0|||
42286266|NCT02057692|76118688|FG003|Overall Study|Lost to Follow-up|1|||
42286267|NCT02038036|76118706|FG000|Core Study|Adverse Event|7|||
42286268|NCT02038036|76118707|FG001|Core Study|Adverse Event|7|||
42286269|NCT02038036|76118706|FG000|Core Study|Death|1|||
42286270|NCT02038036|76118707|FG001|Core Study|Death|1|||
42286271|NCT02038036|76118706|FG000|Core Study|Disease progression|2|||
42286272|NCT02038036|76118707|FG001|Core Study|Disease progression|2|||
42286273|NCT02038036|76118706|FG000|Core Study|Lost to Follow-up|0|||
42286274|NCT02038036|76118707|FG001|Core Study|Lost to Follow-up|1|||
42286275|NCT02038036|76118706|FG000|Core Study|Physician Decision|2|||
42286276|NCT02038036|76118707|FG001|Core Study|Physician Decision|1|||
42286277|NCT02038036|76118706|FG000|Core Study|Subject/guardian decision|0|||
42286278|NCT02038036|76118707|FG001|Core Study|Subject/guardian decision|1|||
42286279|NCT02038036|76118706|FG000|Core Study|Withdrawal by Subject|3|||
42286280|NCT02038036|76118707|FG001|Core Study|Withdrawal by Subject|1|||
42286281|NCT02038036|76118706|FG000|Crossover Period|Withdrawal by Subject|0|||
42286282|NCT02038036|76118707|FG001|Crossover Period|Withdrawal by Subject|3|||
42286283|NCT02038036|76118706|FG000|Crossover Period|Adverse Event|0|||
42286284|NCT02038036|76118707|FG001|Crossover Period|Adverse Event|9|||
42286285|NCT02038036|76118706|FG000|Crossover Period|Death|0|||
42286286|NCT02038036|76118707|FG001|Crossover Period|Death|2|||
42286287|NCT02038036|76118706|FG000|Crossover Period|Disease progression|0|||
42286288|NCT02038036|76118707|FG001|Crossover Period|Disease progression|3|||
42286289|NCT02038036|76118706|FG000|Crossover Period|Lost to Follow-up|0|||
42286290|NCT02038036|76118707|FG001|Crossover Period|Lost to Follow-up|1|||
42286291|NCT02038036|76118706|FG000|Crossover Period|Physician Decision|0|||
42286292|NCT02038036|76118707|FG001|Crossover Period|Physician Decision|2|||
42353267|NCT01498185|76193838|FG004|Overall Study|Adverse Event|0|||
42353268|NCT01498185|76193834|FG000|Overall Study|Withdrawal by Subject|1|||
42286293|NCT02037568|76118718|FG000|Overall Study|Withdrawal by Subject|17|||
42286294|NCT02037568|76118719|FG001|Overall Study|Withdrawal by Subject|24|||
42286295|NCT02037568|76118718|FG000|Overall Study|Lost to Follow-up|16|||
42286296|NCT02037568|76118719|FG001|Overall Study|Lost to Follow-up|13|||
42286297|NCT02037568|76118718|FG000|Overall Study|Screen Failure|3|||
42286298|NCT02037568|76118719|FG001|Overall Study|Screen Failure|1|||
42286299|NCT02037568|76118718|FG000|Overall Study|Patient did not receive transplant|0|||
42286300|NCT02037568|76118719|FG001|Overall Study|Patient did not receive transplant|1|||
42286301|NCT02088034|76118728|FG000|Overall Study|Lost to Follow-up|1|||
42286302|NCT02088034|76118729|FG001|Overall Study|Lost to Follow-up|1|||
42286303|NCT02088034|76118730|FG002|Overall Study|Lost to Follow-up|0|||
42286304|NCT02088034|76118728|FG000|Overall Study|Pregnancy|2|||
42286305|NCT02088034|76118729|FG001|Overall Study|Pregnancy|1|||
42286306|NCT02088034|76118730|FG002|Overall Study|Pregnancy|2|||
42286307|NCT02037256|76118740|FG000|Overall Study|Protocol Violation|0|||
42286308|NCT02037256|76118741|FG001|Overall Study|Protocol Violation|1|||
42286309|NCT02037256|76118740|FG000|Overall Study|Withdrawn prior to Velcade|0|||
42286310|NCT02037256|76118741|FG001|Overall Study|Withdrawn prior to Velcade|2|||
42286311|NCT02035696|76118753|FG000|Overall Study|Lost to Follow-up|0|||
42286312|NCT02035696|76118754|FG001|Overall Study|Lost to Follow-up|3|||
42353269|NCT01498185|76193835|FG001|Overall Study|Withdrawal by Subject|1|||
42353270|NCT01498185|76193836|FG002|Overall Study|Withdrawal by Subject|0|||
42353271|NCT01498185|76193837|FG003|Overall Study|Withdrawal by Subject|2|||
42353272|NCT01498185|76193838|FG004|Overall Study|Withdrawal by Subject|1|||
42353273|NCT01498185|76193834|FG000|Overall Study|No longer met criteria, etc|0|||
42353274|NCT01498185|76193835|FG001|Overall Study|No longer met criteria, etc|0|||
42353275|NCT01498185|76193836|FG002|Overall Study|No longer met criteria, etc|0|||
42353276|NCT01498185|76193837|FG003|Overall Study|No longer met criteria, etc|0|||
42353277|NCT01498185|76193838|FG004|Overall Study|No longer met criteria, etc|2|||
42286313|NCT02035696|76118755|FG002|Overall Study|Lost to Follow-up|1|||
42286314|NCT02035696|76118756|FG003|Overall Study|Lost to Follow-up|2|||
42286315|NCT02035696|76118753|FG000|Overall Study|Withdrawal by Subject|3|||
42286316|NCT02035696|76118754|FG001|Overall Study|Withdrawal by Subject|0|||
42286317|NCT02035696|76118755|FG002|Overall Study|Withdrawal by Subject|2|||
42286318|NCT02035696|76118756|FG003|Overall Study|Withdrawal by Subject|1|||
42286319|NCT02057458|76118770|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
42286320|NCT02057458|76118771|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
42353278|NCT01528605|76193860|FG000|Overall Study|Lost to Follow-up|1|||
42353279|NCT01528605|76193861|FG001|Overall Study|Lost to Follow-up|0|||
42353280|NCT01528605|76193862|FG002|Overall Study|Lost to Follow-up|1|||
42286321|NCT02057458|76118772|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
42286322|NCT02057458|76118770|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
42286323|NCT02057458|76118771|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
42286324|NCT02057458|76118772|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
42286325|NCT02057458|76118770|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
42286326|NCT02057458|76118771|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
42286327|NCT02057458|76118772|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
42286328|NCT02057068|76118804|FG000|Overall Study|Withdrawal by Subject|2|||
42286329|NCT02057068|76118805|FG001|Overall Study|Withdrawal by Subject|2|||
42286330|NCT02057068|76118804|FG000|Overall Study|Caregiver (CG) Health|0|||
42286331|NCT02057068|76118805|FG001|Overall Study|Caregiver (CG) Health|2|||
42286332|NCT02057068|76118804|FG000|Overall Study|Carepartner (CP) Health|4|||
42286333|NCT02057068|76118805|FG001|Overall Study|Carepartner (CP) Health|2|||
42286334|NCT02057068|76118804|FG000|Overall Study|Lost to Follow-up|2|||
42286335|NCT02057068|76118805|FG001|Overall Study|Lost to Follow-up|2|||
42286336|NCT02056834|76118813|FG000|Overall Study|Lost to Follow-up|7|||
42286337|NCT02087176|76118818|FG000|Overall Study|Withdrawal by Subject|1|||
42286338|NCT02087176|76118818|FG000|Overall Study|Death|10|||
42286339|NCT02087176|76118818|FG000|Overall Study|Censored|19|||
42286340|NCT02087176|76118818|FG000|Overall Study|Study Terminated by Sponsor|2|||
42286341|NCT02056288|76118824|FG000|In-Hospital Data|Surgery cancelled|1|||
42286342|NCT02056288|76118825|FG001|In-Hospital Data|Surgery cancelled|0|||
42286343|NCT02056288|76118824|FG000|In-Hospital Data|Protocol Violation|3|||
42286344|NCT02056288|76118825|FG001|In-Hospital Data|Protocol Violation|0|||
42286345|NCT02056288|76118824|FG000|In-Hospital Data|Physician Decision|1|||
42286346|NCT02056288|76118825|FG001|In-Hospital Data|Physician Decision|0|||
42286347|NCT02056288|76118824|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
42286348|NCT02056288|76118825|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
42286349|NCT02086162|76118833|FG000|Overall Study|Withdrawal by Subject|4|||
42286350|NCT02086162|76118834|FG001|Overall Study|Withdrawal by Subject|4|||
42286351|NCT02086162|76118833|FG000|Overall Study|moved|1|||
42353281|NCT01528605|76193863|FG003|Overall Study|Lost to Follow-up|1|||
42353282|NCT01528605|76193864|FG004|Overall Study|Lost to Follow-up|0|||
42353283|NCT01528605|76193865|FG005|Overall Study|Lost to Follow-up|0|||
42353284|NCT01528605|76193860|FG000|Overall Study|Death|1|||
42353285|NCT01528605|76193861|FG001|Overall Study|Death|0|||
42353286|NCT01528605|76193862|FG002|Overall Study|Death|0|||
42353287|NCT01528605|76193863|FG003|Overall Study|Death|0|||
42353288|NCT01528605|76193864|FG004|Overall Study|Death|0|||
42353289|NCT01528605|76193865|FG005|Overall Study|Death|0|||
42353290|NCT01528215|76193881|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
42353291|NCT01528215|76193882|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
42353292|NCT01528215|76193881|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
42353293|NCT01528215|76193882|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
42353294|NCT01528215|76193881|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
42353295|NCT01528215|76193882|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
42353296|NCT01528215|76193881|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
42353297|NCT01528215|76193882|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
42353298|NCT01527357|76193890|FG000|Overall Study|Death|8|||
42353299|NCT01527357|76193891|FG001|Overall Study|Death|2|||
42353300|NCT01527357|76193890|FG000|Overall Study|Lost to Follow-up|6|||
42015113|NCT01160289|75822262|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
42015114|NCT01160289|75822263|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
42286352|NCT02086162|76118834|FG001|Overall Study|moved|1|||
42286353|NCT02086162|76118833|FG000|Overall Study|Lost to Follow-up|4|||
42286354|NCT02086162|76118834|FG001|Overall Study|Lost to Follow-up|2|||
42286355|NCT02086162|76118833|FG000|Overall Study|Death|1|||
42286356|NCT02086162|76118834|FG001|Overall Study|Death|0|||
42353301|NCT01527357|76193891|FG001|Overall Study|Lost to Follow-up|4|||
42353302|NCT01527357|76193890|FG000|Overall Study|Withdrew Consent|1|||
42353303|NCT01527357|76193891|FG001|Overall Study|Withdrew Consent|1|||
42353304|NCT01527357|76193890|FG000|Overall Study|Non-compliance|0|||
42353305|NCT01527357|76193891|FG001|Overall Study|Non-compliance|1|||
42353306|NCT01527357|76193890|FG000|Overall Study|No Day 29 Visit|0|||
42353307|NCT01527357|76193891|FG001|Overall Study|No Day 29 Visit|1|||
42286357|NCT02700815|76118848|FG000|Overall Study|Adverse Event|0|||
42286358|NCT02700815|76118849|FG001|Overall Study|Adverse Event|6|||
42286359|NCT02700815|76118850|FG002|Overall Study|Adverse Event|2|||
42286360|NCT02700815|76118851|FG003|Overall Study|Adverse Event|3|||
42171787|NCT00356915|75978659|FG002|Overall Study|Withdrawal by Subject|10|||
42171788|NCT00356915|75978657|FG000|Overall Study|Lack of Efficacy|0|||
42171789|NCT00356915|75978658|FG001|Overall Study|Lack of Efficacy|0|||
42171790|NCT00356915|75978659|FG002|Overall Study|Lack of Efficacy|3|||
42171791|NCT00356915|75978657|FG000|Overall Study|Lost to Follow-up|27|||
42286361|NCT02700815|76118848|FG000|Overall Study|Lack of Efficacy|0|||
42353308|NCT01527357|76193890|FG000|Overall Study|Did Not Receive Treatment|2|||
42353309|NCT01527357|76193891|FG001|Overall Study|Did Not Receive Treatment|0|||
42353310|NCT01526889|76193910|FG000|Treatment Period|Adverse Event|2|||
42353311|NCT01526889|76193911|FG001|Treatment Period|Adverse Event|0|||
42353312|NCT01526889|76193910|FG000|Treatment Extension Period|Administrative problems|1|||
42353313|NCT01526889|76193911|FG001|Treatment Extension Period|Administrative problems|0|||
42353314|NCT01472835|76193923|FG000|Overall Study|Lost to Follow-up|2|||
42353315|NCT01472835|76193924|FG001|Overall Study|Lost to Follow-up|0|||
42353316|NCT01526733|76193937|FG000|Phase 1|Protocol Violation|1|||
42353317|NCT01526733|76193938|FG001|Phase 1|Protocol Violation|0|||
42353318|NCT01526733|76193937|FG000|Phase 1|Withdrawal by Subject|1|||
42353319|NCT01526733|76193938|FG001|Phase 1|Withdrawal by Subject|1|||
42286362|NCT02700815|76118849|FG001|Overall Study|Lack of Efficacy|0|||
42286363|NCT02700815|76118850|FG002|Overall Study|Lack of Efficacy|1|||
42286364|NCT02700815|76118851|FG003|Overall Study|Lack of Efficacy|2|||
42286365|NCT02700815|76118848|FG000|Overall Study|Lost to Follow-up|1|||
42286366|NCT02700815|76118849|FG001|Overall Study|Lost to Follow-up|0|||
42286367|NCT02700815|76118850|FG002|Overall Study|Lost to Follow-up|0|||
42015115|NCT01160289|75822264|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
42015116|NCT01160289|75822259|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
42286368|NCT02700815|76118851|FG003|Overall Study|Lost to Follow-up|1|||
42286369|NCT02700815|76118848|FG000|Overall Study|Refusal to continue medication|0|||
42286370|NCT02700815|76118849|FG001|Overall Study|Refusal to continue medication|1|||
42286371|NCT02700815|76118850|FG002|Overall Study|Refusal to continue medication|0|||
42171792|NCT00356915|75978658|FG001|Overall Study|Lost to Follow-up|34|||
42286372|NCT02700815|76118851|FG003|Overall Study|Refusal to continue medication|1|||
42286373|NCT02700815|76118848|FG000|Overall Study|Withdrawal by Subject|0|||
42353320|NCT01472757|76193983|FG000|Overall Study|Withdrawal by Subject|1|||
42353321|NCT01472757|76193984|FG001|Overall Study|Withdrawal by Subject|2|||
42286374|NCT02700815|76118849|FG001|Overall Study|Withdrawal by Subject|0|||
42286375|NCT02700815|76118850|FG002|Overall Study|Withdrawal by Subject|1|||
42353322|NCT01472757|76193985|FG002|Overall Study|Withdrawal by Subject|2|||
42353323|NCT01472757|76193986|FG003|Overall Study|Withdrawal by Subject|0|||
42353324|NCT01472757|76193983|FG000|Overall Study|Asthma exacerbation|4|||
42353325|NCT01472757|76193984|FG001|Overall Study|Asthma exacerbation|1|||
42353326|NCT01472757|76193985|FG002|Overall Study|Asthma exacerbation|2|||
42353327|NCT01472757|76193986|FG003|Overall Study|Asthma exacerbation|1|||
42353328|NCT01472757|76193983|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
42353329|NCT01472757|76193984|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
42353330|NCT01472757|76193985|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
42353331|NCT01472757|76193986|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
42353332|NCT01472757|76193983|FG000|Overall Study|Protocol Violation|3|||
42353333|NCT01472757|76193984|FG001|Overall Study|Protocol Violation|2|||
42353334|NCT01472757|76193985|FG002|Overall Study|Protocol Violation|4|||
42353335|NCT01472757|76193986|FG003|Overall Study|Protocol Violation|4|||
42353336|NCT01472757|76193983|FG000|Overall Study|Other reasons|1|||
42353337|NCT01472757|76193984|FG001|Overall Study|Other reasons|0|||
42353338|NCT01472757|76193985|FG002|Overall Study|Other reasons|2|||
42353339|NCT01472757|76193986|FG003|Overall Study|Other reasons|2|||
42353340|NCT01472289|76194005|FG000|Overall Study|Death|2|||
42353341|NCT01525875|76194024|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
42353342|NCT01525875|76194025|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
42353343|NCT01525875|76194024|FG000|Open-label Period|Lost to Follow-up|0|||
42353344|NCT01525875|76194025|FG001|Open-label Period|Lost to Follow-up|2|||
42353345|NCT01525641|76194031|FG000|Overall Study|Case report form not collected|25|||
42353346|NCT01525641|76194031|FG000|Overall Study|No visit since the first visit|16|||
42353347|NCT01525641|76194031|FG000|Overall Study|Adverse Event|73|||
42353348|NCT01525641|76194031|FG000|Overall Study|Lack of Efficacy|24|||
42353349|NCT01525641|76194031|FG000|Overall Study|Improvement|5|||
42353350|NCT01525641|76194031|FG000|Overall Study|Lost to follow-up (relocation)|1|||
42353351|NCT01525641|76194031|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
42353352|NCT01525641|76194031|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
42353353|NCT01525641|76194031|FG000|Overall Study|Other than stated above|7|||
42353354|NCT01496469|76194046|FG000|Overall Study|Adverse Event|1|||
42353355|NCT01496469|76194047|FG001|Overall Study|Adverse Event|0|||
42353356|NCT01496469|76194046|FG000|Overall Study|Protocol Violation|2|||
42353357|NCT01496469|76194047|FG001|Overall Study|Protocol Violation|0|||
42353358|NCT01496469|76194046|FG000|Overall Study|Lost to Follow-up|1|||
42015117|NCT01160289|75822260|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
42353359|NCT01496469|76194047|FG001|Overall Study|Lost to Follow-up|1|||
42353360|NCT01496469|76194046|FG000|Overall Study|Withdrawal by Subject|4|||
42353361|NCT01496469|76194047|FG001|Overall Study|Withdrawal by Subject|4|||
42353362|NCT01496469|76194046|FG000|Overall Study|BP exceeds protocol limits|1|||
42353363|NCT01496469|76194047|FG001|Overall Study|BP exceeds protocol limits|2|||
42353364|NCT01496469|76194046|FG000|Overall Study|Other|1|||
42353365|NCT01496469|76194047|FG001|Overall Study|Other|1|||
42353366|NCT01471353|76194062|FG000|Overall Study|remain on study|3|||
42353367|NCT01525407|76194068|FG000|Overall Study|Change in recipient treatment plan|2|||
42353368|NCT01525407|76194069|FG001|Overall Study|Change in recipient treatment plan|2|||
42353369|NCT01525407|76194068|FG000|Overall Study|Withdrawal by Subject|0|||
42353370|NCT01525407|76194069|FG001|Overall Study|Withdrawal by Subject|1|||
42353371|NCT01525407|76194068|FG000|Overall Study|Transplant was delayed|0|||
42353372|NCT01525407|76194069|FG001|Overall Study|Transplant was delayed|1|||
42353373|NCT01525407|76194068|FG000|Overall Study|Delay in Transplant|1|||
42353374|NCT01525407|76194069|FG001|Overall Study|Delay in Transplant|0|||
42353375|NCT01471197|76194077|FG000|Overall Study|Disease Progression|4|||
42353376|NCT01471197|76194078|FG001|Overall Study|Disease Progression|2|||
42353377|NCT01471197|76194077|FG000|Overall Study|Death|1|||
42015118|NCT01160289|75822261|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
42015119|NCT01160289|75822262|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
42015120|NCT01160289|75822263|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
42015121|NCT01160289|75822264|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
42015122|NCT01160289|75822259|FG000|Post-Randomization Period|Adverse Event|0|||
42015123|NCT01160289|75822260|FG001|Post-Randomization Period|Adverse Event|4|||
42015124|NCT01160289|75822261|FG002|Post-Randomization Period|Adverse Event|4|||
42353378|NCT01471197|76194078|FG001|Overall Study|Death|0|||
42353379|NCT01471197|76194077|FG000|Overall Study|Study Drug Toxicity|1|||
42353380|NCT01471197|76194078|FG001|Overall Study|Study Drug Toxicity|0|||
42353381|NCT01524783|76194112|FG000|Blinded Period|Adverse Event|64|||
42353382|NCT01524783|76194113|FG001|Blinded Period|Adverse Event|7|||
42353383|NCT01524783|76194114|FG002|Blinded Period|Adverse Event|0|||
42353384|NCT01524783|76194112|FG000|Blinded Period|Disease Progression|89|||
42353385|NCT01524783|76194113|FG001|Blinded Period|Disease Progression|75|||
42353386|NCT01524783|76194114|FG002|Blinded Period|Disease Progression|0|||
42353387|NCT01524783|76194112|FG000|Blinded Period|Withdrawal by Subject|19|||
42353388|NCT01524783|76194113|FG001|Blinded Period|Withdrawal by Subject|6|||
42353389|NCT01524783|76194114|FG002|Blinded Period|Withdrawal by Subject|0|||
42353390|NCT01524783|76194112|FG000|Blinded Period|Protocol deviation|2|||
42353391|NCT01524783|76194113|FG001|Blinded Period|Protocol deviation|1|||
42353392|NCT01524783|76194114|FG002|Blinded Period|Protocol deviation|0|||
42353393|NCT01524783|76194112|FG000|Blinded Period|Death|5|||
42353394|NCT01524783|76194113|FG001|Blinded Period|Death|2|||
42353395|NCT01524783|76194114|FG002|Blinded Period|Death|0|||
42353396|NCT01524783|76194112|FG000|Open-label Period|Disease progression|13|||
42353397|NCT01524783|76194113|FG001|Open-label Period|Disease progression|0|||
42353398|NCT01524783|76194114|FG002|Open-label Period|Disease progression|2|||
42353399|NCT01524783|76194112|FG000|Open-label Period|Administrative problems|5|||
42353400|NCT01524783|76194113|FG001|Open-label Period|Administrative problems|0|||
42353401|NCT01524783|76194114|FG002|Open-label Period|Administrative problems|2|||
42353402|NCT01524783|76194112|FG000|Open-label Period|Adverse Event|5|||
42353403|NCT01524783|76194113|FG001|Open-label Period|Adverse Event|0|||
42353404|NCT01524783|76194114|FG002|Open-label Period|Adverse Event|1|||
42353405|NCT01524783|76194112|FG000|Open-label Period|Withdrawal by Subject|2|||
42353406|NCT01524783|76194113|FG001|Open-label Period|Withdrawal by Subject|0|||
42353407|NCT01524783|76194114|FG002|Open-label Period|Withdrawal by Subject|1|||
42353408|NCT01524783|76194112|FG000|Open-label Period|Protocol deviation|1|||
42353409|NCT01524783|76194113|FG001|Open-label Period|Protocol deviation|0|||
42353410|NCT01524783|76194114|FG002|Open-label Period|Protocol deviation|0|||
42353411|NCT01494987|76194128|FG000|Overall Study|Adverse Event|6|||
42353412|NCT01494987|76194129|FG001|Overall Study|Adverse Event|5|||
42353413|NCT01494987|76194128|FG000|Overall Study|Hyperglycemia|6|||
42353414|NCT01494987|76194129|FG001|Overall Study|Hyperglycemia|4|||
42353415|NCT01494987|76194128|FG000|Overall Study|Investigator's Discretion|1|||
42353416|NCT01494987|76194129|FG001|Overall Study|Investigator's Discretion|2|||
42353417|NCT01494987|76194128|FG000|Overall Study|Lost to Follow-up|1|||
42353418|NCT01494987|76194129|FG001|Overall Study|Lost to Follow-up|1|||
42353419|NCT01494987|76194128|FG000|Overall Study|Protocol Violation|3|||
42353420|NCT01494987|76194129|FG001|Overall Study|Protocol Violation|3|||
42353421|NCT01494987|76194128|FG000|Overall Study|Subject Non-Compliance|9|||
42353422|NCT01494987|76194129|FG001|Overall Study|Subject Non-Compliance|10|||
42353423|NCT01494987|76194128|FG000|Overall Study|Subject Withdrew Consent|2|||
42353424|NCT01494987|76194129|FG001|Overall Study|Subject Withdrew Consent|3|||
42353425|NCT01524627|76194137|FG000|Overall Study|Physician Decision|0|||
42353426|NCT01524627|76194138|FG001|Overall Study|Physician Decision|1|||
42353427|NCT01524627|76194137|FG000|Overall Study|Lost to Follow-up|1|||
42353428|NCT01524627|76194138|FG001|Overall Study|Lost to Follow-up|1|||
42353429|NCT01469637|76194146|FG000|First Intervention|Unacceptable behavior|0|||
42353430|NCT01469637|76194147|FG001|First Intervention|Unacceptable behavior|1|||
42353431|NCT01469637|76194146|FG000|Second Intervention|Incarcerated|1|||
42353432|NCT01469637|76194147|FG001|Second Intervention|Incarcerated|0|||
42353433|NCT04842747|76194567|FG000|Overall Study|Withdrawal by Subject|6|||
42353434|NCT04842747|76194568|FG001|Overall Study|Withdrawal by Subject|2|||
42353435|NCT04842747|76194567|FG000|Overall Study|Lost to Follow-up|1|||
42353436|NCT04842747|76194568|FG001|Overall Study|Lost to Follow-up|2|||
42353437|NCT04842747|76194567|FG000|Overall Study|Physician Decision|1|||
42353438|NCT04842747|76194568|FG001|Overall Study|Physician Decision|0|||
42353439|NCT04842747|76194567|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
42353440|NCT04842747|76194568|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
42353441|NCT04810481|76194576|FG000|Overall Study|Disqualified data sets|10|||
42353442|NCT04810481|76194577|FG001|Overall Study|Disqualified data sets|28|||
42353443|NCT04755231|76194596|FG000|Overall Study|Lost to Follow-up|5|||
42353444|NCT04755231|76194596|FG000|Overall Study|Withdrawal by Subject|5|||
42353445|NCT04664400|76194609|FG000|Overall Study|Withdrawal by Subject|2|||
42353446|NCT04657770|76194614|FG000|Overall Study|Withdrawal by Subject|3|||
42353447|NCT04657770|76194614|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
42353448|NCT04496453|76194618|FG000|Overall Study|Lost to Follow-up|6|||
42353449|NCT04440163|76194630|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
42353450|NCT04440163|76194631|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
42353451|NCT04440163|76194632|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
42353452|NCT04440163|76194633|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
42353453|NCT04440163|76194634|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
42353454|NCT04440163|76194635|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
42353455|NCT04440163|76194636|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
42353456|NCT04440163|76194637|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
42353457|NCT04440163|76194630|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
42353458|NCT04440163|76194631|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
42353459|NCT04440163|76194632|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
42353460|NCT04440163|76194633|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
42353461|NCT04440163|76194634|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
42353462|NCT04440163|76194635|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
42353463|NCT04440163|76194636|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
42353464|NCT04440163|76194637|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
42353465|NCT04440163|76194630|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
42353466|NCT04440163|76194631|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
42353467|NCT04440163|76194632|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
42353468|NCT04440163|76194633|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
42353469|NCT04440163|76194634|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
42353470|NCT04440163|76194635|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
42353471|NCT04440163|76194636|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
42353472|NCT04440163|76194637|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
42353473|NCT04440163|76194630|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
42353474|NCT04440163|76194631|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
42353475|NCT04440163|76194632|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
42353476|NCT04440163|76194633|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
42353477|NCT04440163|76194634|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
42353478|NCT04440163|76194635|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
42353479|NCT04440163|76194636|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
42353480|NCT04440163|76194637|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
42353481|NCT04440163|76194630|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
42353482|NCT04440163|76194631|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
42353483|NCT04440163|76194632|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
42353484|NCT04440163|76194633|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
42353485|NCT04440163|76194634|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
42353486|NCT04440163|76194635|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
42353487|NCT04440163|76194636|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
42353488|NCT04440163|76194637|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
42353489|NCT04440163|76194630|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
42353490|NCT04440163|76194631|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
42353491|NCT04440163|76194632|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
42353492|NCT04440163|76194633|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
42353493|NCT04440163|76194634|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
42353494|NCT04440163|76194635|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
42353495|NCT04440163|76194636|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
42353496|NCT04440163|76194637|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
42353497|NCT04440163|76194630|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
42353498|NCT04440163|76194631|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
42353499|NCT04440163|76194632|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
42353500|NCT04440163|76194633|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
42353501|NCT04440163|76194634|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
42353502|NCT04440163|76194635|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
42353503|NCT04440163|76194636|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
42353504|NCT04440163|76194637|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
42353505|NCT04440163|76194630|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
42353506|NCT04440163|76194631|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
42353507|NCT04440163|76194632|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
42353508|NCT04440163|76194633|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
42353509|NCT04440163|76194634|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
42286376|NCT02700815|76118851|FG003|Overall Study|Withdrawal by Subject|0|||
42286377|NCT00708305|76118861|FG000|Period 1|Protocol Violation|1|||
42286378|NCT00708305|76118862|FG001|Period 1|Protocol Violation|0|||
42286379|NCT00708305|76118863|FG002|Period 1|Protocol Violation|1|||
42286380|NCT00708305|76118864|FG003|Period 1|Protocol Violation|0|||
42286381|NCT00708305|76118861|FG000|Period 1|Other Reason|0|||
42286382|NCT00708305|76118862|FG001|Period 1|Other Reason|0|||
42286383|NCT00708305|76118863|FG002|Period 1|Other Reason|0|||
42286384|NCT00708305|76118864|FG003|Period 1|Other Reason|2|||
42286385|NCT00708305|76118861|FG000|Period 2|Lost to Follow-up|0|||
42286386|NCT00708305|76118862|FG001|Period 2|Lost to Follow-up|1|||
42286387|NCT00708305|76118863|FG002|Period 2|Lost to Follow-up|0|||
42286388|NCT00708305|76118864|FG003|Period 2|Lost to Follow-up|0|||
42286389|NCT00708305|76118861|FG000|Period 2|Protocol Violation|0|||
42286390|NCT00708305|76118862|FG001|Period 2|Protocol Violation|1|||
42286391|NCT00708305|76118863|FG002|Period 2|Protocol Violation|0|||
42286392|NCT00708305|76118864|FG003|Period 2|Protocol Violation|0|||
42286393|NCT00708305|76118861|FG000|Period 2|Other Reason|1|||
42286394|NCT00708305|76118862|FG001|Period 2|Other Reason|0|||
42353510|NCT04440163|76194635|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
42353511|NCT04440163|76194636|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
42353512|NCT04440163|76194637|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
42353513|NCT04440163|76194630|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
42353514|NCT04440163|76194631|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
42353515|NCT04440163|76194632|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
42353516|NCT04440163|76194633|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
42353517|NCT04440163|76194634|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
42353518|NCT04440163|76194635|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
42353519|NCT04440163|76194636|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
42353520|NCT04440163|76194637|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
42353521|NCT04440163|76194630|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
42353522|NCT04440163|76194631|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
42353523|NCT04440163|76194632|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
42353524|NCT04440163|76194633|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
42353525|NCT04440163|76194634|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
42353526|NCT04440163|76194635|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
42353527|NCT04440163|76194636|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
42353528|NCT04440163|76194637|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
42353529|NCT04440163|76194630|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
42353530|NCT04440163|76194631|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
42353531|NCT04440163|76194632|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
42353532|NCT04440163|76194633|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
42015125|NCT01160289|75822262|FG003|Post-Randomization Period|Adverse Event|2|||
42286395|NCT00708305|76118863|FG002|Period 2|Other Reason|0|||
42286396|NCT00708305|76118864|FG003|Period 2|Other Reason|1|||
42286397|NCT00708305|76118861|FG000|Period 3|Protocol Violation|0|||
42286398|NCT00708305|76118862|FG001|Period 3|Protocol Violation|2|||
42286399|NCT00708305|76118863|FG002|Period 3|Protocol Violation|0|||
42286400|NCT00708305|76118864|FG003|Period 3|Protocol Violation|0|||
42286401|NCT00708305|76118861|FG000|Period 3|Other Reason|1|||
42286402|NCT00708305|76118862|FG001|Period 3|Other Reason|0|||
42286403|NCT00708305|76118863|FG002|Period 3|Other Reason|0|||
42286404|NCT00708305|76118864|FG003|Period 3|Other Reason|0|||
42286405|NCT02055976|76118886|FG000|Overall Study|Other|0|||
42286406|NCT02055976|76118887|FG001|Overall Study|Other|0|||
42286407|NCT02055976|76118888|FG002|Overall Study|Other|1|||
42286408|NCT02055976|76118889|FG003|Overall Study|Other|0|||
42286409|NCT02055976|76118890|FG004|Overall Study|Other|0|||
42286410|NCT02055976|76118891|FG005|Overall Study|Other|0|||
42286411|NCT02055976|76118892|FG006|Overall Study|Other|0|||
42286412|NCT02055976|76118893|FG007|Overall Study|Other|0|||
42286413|NCT02055976|76118894|FG008|Overall Study|Other|0|||
42286414|NCT02055976|76118886|FG000|Overall Study|Adverse Event|0|||
42286415|NCT02055976|76118887|FG001|Overall Study|Adverse Event|0|||
42286416|NCT02055976|76118888|FG002|Overall Study|Adverse Event|0|||
42286417|NCT02055976|76118889|FG003|Overall Study|Adverse Event|0|||
42286418|NCT02055976|76118890|FG004|Overall Study|Adverse Event|0|||
42286419|NCT02055976|76118891|FG005|Overall Study|Adverse Event|1|||
42286420|NCT02055976|76118892|FG006|Overall Study|Adverse Event|1|||
42286421|NCT02055976|76118893|FG007|Overall Study|Adverse Event|0|||
42286422|NCT02055976|76118894|FG008|Overall Study|Adverse Event|0|||
42286423|NCT02055976|76118886|FG000|Overall Study|Does not meet entrance criteria|0|||
42286424|NCT02055976|76118887|FG001|Overall Study|Does not meet entrance criteria|0|||
42286425|NCT02055976|76118888|FG002|Overall Study|Does not meet entrance criteria|0|||
42286426|NCT02055976|76118889|FG003|Overall Study|Does not meet entrance criteria|0|||
42286427|NCT02055976|76118890|FG004|Overall Study|Does not meet entrance criteria|0|||
42353533|NCT04440163|76194634|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
42353534|NCT04440163|76194635|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
42353535|NCT04440163|76194636|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
42015126|NCT01160289|75822263|FG004|Post-Randomization Period|Adverse Event|0|||
42015127|NCT01160289|75822264|FG005|Post-Randomization Period|Adverse Event|0|||
42286428|NCT02055976|76118891|FG005|Overall Study|Does not meet entrance criteria|0|||
42286429|NCT02055976|76118892|FG006|Overall Study|Does not meet entrance criteria|1|||
42286430|NCT02055976|76118893|FG007|Overall Study|Does not meet entrance criteria|0|||
42286431|NCT02055976|76118894|FG008|Overall Study|Does not meet entrance criteria|0|||
42286432|NCT02055976|76118886|FG000|Overall Study|Lost to Follow-up|0|||
42286433|NCT02055976|76118887|FG001|Overall Study|Lost to Follow-up|0|||
42286434|NCT02055976|76118888|FG002|Overall Study|Lost to Follow-up|0|||
42286435|NCT02055976|76118889|FG003|Overall Study|Lost to Follow-up|1|||
42286436|NCT02055976|76118890|FG004|Overall Study|Lost to Follow-up|0|||
42286437|NCT02055976|76118891|FG005|Overall Study|Lost to Follow-up|0|||
42171793|NCT00356915|75978659|FG002|Overall Study|Lost to Follow-up|14|||
42171794|NCT00356915|75978657|FG000|Overall Study|Administrative Decision|0|||
42171795|NCT00356915|75978658|FG001|Overall Study|Administrative Decision|0|||
42171796|NCT00356915|75978659|FG002|Overall Study|Administrative Decision|1|||
42171797|NCT00356915|75978657|FG000|Overall Study|Physician Decision|0|||
42171798|NCT00356915|75978658|FG001|Overall Study|Physician Decision|2|||
42171799|NCT00356915|75978659|FG002|Overall Study|Physician Decision|0|||
42171800|NCT00356915|75978657|FG000|Overall Study|Adverse Event|21|||
42171801|NCT00356915|75978658|FG001|Overall Study|Adverse Event|31|||
42171802|NCT00356915|75978659|FG002|Overall Study|Adverse Event|8|||
42171803|NCT00356915|75978657|FG000|Overall Study|Miscellaneous reasons|11|||
42171804|NCT00356915|75978658|FG001|Overall Study|Miscellaneous reasons|8|||
42171805|NCT00356915|75978659|FG002|Overall Study|Miscellaneous reasons|3|||
42171806|NCT00356759|75978675|FG000|Overall Study|Death|5|||
42171807|NCT00356759|75978676|FG001|Overall Study|Death|2|||
42171808|NCT00356759|75978675|FG000|Overall Study|Withdrawal by Subject|2|||
42171809|NCT00356759|75978676|FG001|Overall Study|Withdrawal by Subject|2|||
42171810|NCT00356759|75978675|FG000|Overall Study|Adverse Event|1|||
42171811|NCT00356759|75978676|FG001|Overall Study|Adverse Event|3|||
42171812|NCT00356759|75978675|FG000|Overall Study|Lost to Follow-up|1|||
42171813|NCT00356759|75978676|FG001|Overall Study|Lost to Follow-up|1|||
42171814|NCT00356759|75978675|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
42171815|NCT00356759|75978676|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
42171816|NCT03804710|75978684|FG000|Overall Study|Adverse Event|0|||
42171817|NCT03804710|75978685|FG001|Overall Study|Adverse Event|3|||
42171818|NCT03804710|75978684|FG000|Overall Study|Withdrawal by Subject|2|||
42171819|NCT03804710|75978685|FG001|Overall Study|Withdrawal by Subject|1|||
42171820|NCT03804710|75978684|FG000|Overall Study|Other|0|||
42171821|NCT03804710|75978685|FG001|Overall Study|Other|1|||
42171822|NCT00356603|75978697|FG000|Overall Study|Other|6|||
42171823|NCT00356603|75978698|FG001|Overall Study|Other|3|||
42171824|NCT00002558|75978708|FG000|Overall Study|Withdrawal by Subject|0|||
42171825|NCT00002558|75978709|FG001|Overall Study|Withdrawal by Subject|1|||
42171826|NCT00001880|75978715|FG000|Overall Study|Death|14|||
42171827|NCT00043550|75978722|FG000|Overall Study|Withdrawal by Subject|22|||
42171828|NCT00043550|75978723|FG001|Overall Study|Withdrawal by Subject|12|||
42171829|NCT00043550|75978724|FG002|Overall Study|Withdrawal by Subject|20|||
42171830|NCT00041756|75978737|FG000|Overall Study|Adverse Event|4|||
42171831|NCT00041756|75978738|FG001|Overall Study|Adverse Event|10|||
42171832|NCT00041756|75978739|FG002|Overall Study|Adverse Event|6|||
42171833|NCT00041756|75978740|FG003|Overall Study|Adverse Event|11|||
42171834|NCT00041756|75978741|FG004|Overall Study|Adverse Event|34|||
42171835|NCT00041756|75978737|FG000|Overall Study|Protocol Violation|1|||
42171836|NCT00041756|75978738|FG001|Overall Study|Protocol Violation|1|||
42171837|NCT00041756|75978739|FG002|Overall Study|Protocol Violation|2|||
42171838|NCT00041756|75978740|FG003|Overall Study|Protocol Violation|2|||
42171839|NCT00041756|75978741|FG004|Overall Study|Protocol Violation|1|||
42171840|NCT00041756|75978737|FG000|Overall Study|Withdrawal by Subject|3|||
42171841|NCT00041756|75978738|FG001|Overall Study|Withdrawal by Subject|3|||
42171842|NCT00041756|75978739|FG002|Overall Study|Withdrawal by Subject|4|||
42171843|NCT00041756|75978740|FG003|Overall Study|Withdrawal by Subject|2|||
42171844|NCT00041756|75978741|FG004|Overall Study|Withdrawal by Subject|3|||
42171845|NCT00041756|75978737|FG000|Overall Study|Lost to Follow-up|0|||
42171846|NCT00041756|75978738|FG001|Overall Study|Lost to Follow-up|1|||
42171847|NCT00041756|75978739|FG002|Overall Study|Lost to Follow-up|0|||
42171848|NCT00041756|75978740|FG003|Overall Study|Lost to Follow-up|1|||
42171849|NCT00041756|75978741|FG004|Overall Study|Lost to Follow-up|0|||
42171850|NCT00041756|75978737|FG000|Overall Study|Unable to meet protocol criteria|0|||
42171851|NCT00041756|75978738|FG001|Overall Study|Unable to meet protocol criteria|0|||
42171852|NCT00041756|75978739|FG002|Overall Study|Unable to meet protocol criteria|1|||
42286438|NCT02055976|76118892|FG006|Overall Study|Lost to Follow-up|0|||
42286439|NCT02055976|76118893|FG007|Overall Study|Lost to Follow-up|0|||
42286440|NCT02055976|76118894|FG008|Overall Study|Lost to Follow-up|0|||
42286441|NCT02055898|76118923|FG000|First Intervention (5 Days)|Physician Decision|2|||
42171853|NCT00041756|75978740|FG003|Overall Study|Unable to meet protocol criteria|0|||
42171854|NCT00041756|75978741|FG004|Overall Study|Unable to meet protocol criteria|1|||
42171855|NCT00041756|75978737|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
42171856|NCT00041756|75978738|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
42171857|NCT00041756|75978739|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
42171858|NCT00041756|75978740|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
42171859|NCT00041756|75978741|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
42171860|NCT00041132|75978753|FG000|Overall Study|Adverse Event|19|||
42171861|NCT00041132|75978753|FG000|Overall Study|Death|1|||
42171862|NCT00041132|75978753|FG000|Overall Study|Not Eligible|7|||
42171863|NCT00041132|75978753|FG000|Overall Study|Withdrawal by Subject|1|||
42286442|NCT02055898|76118924|FG001|First Intervention (5 Days)|Physician Decision|0|||
42286443|NCT02055898|76118923|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
42286444|NCT02055898|76118924|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
42286445|NCT02564055|76118936|FG000|Overall Study|Adverse Event|1|||
42286446|NCT02564055|76118937|FG001|Overall Study|Adverse Event|0|||
42286447|NCT02564055|76118938|FG002|Overall Study|Adverse Event|4|||
42286448|NCT02564055|76118939|FG003|Overall Study|Adverse Event|1|||
42286449|NCT02564055|76118940|FG004|Overall Study|Adverse Event|4|||
42286450|NCT02564055|76118941|FG005|Overall Study|Adverse Event|1|||
42286451|NCT02564055|76118936|FG000|Overall Study|Protocol Violation|1|||
42286452|NCT02564055|76118937|FG001|Overall Study|Protocol Violation|0|||
42286453|NCT02564055|76118938|FG002|Overall Study|Protocol Violation|0|||
42353536|NCT04440163|76194637|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
42353537|NCT04440163|76194630|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
42353538|NCT04440163|76194631|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
42353539|NCT04440163|76194632|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
42353540|NCT04440163|76194633|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
42353541|NCT04440163|76194634|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
42353542|NCT04440163|76194635|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
42353543|NCT04440163|76194636|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
42286454|NCT02564055|76118939|FG003|Overall Study|Protocol Violation|0|||
42286455|NCT02564055|76118940|FG004|Overall Study|Protocol Violation|0|||
42286456|NCT02564055|76118941|FG005|Overall Study|Protocol Violation|0|||
42286457|NCT02564055|76118936|FG000|Overall Study|Reached stopping criteria|0|||
42286458|NCT02564055|76118937|FG001|Overall Study|Reached stopping criteria|0|||
42286459|NCT02564055|76118938|FG002|Overall Study|Reached stopping criteria|0|||
42286460|NCT02564055|76118939|FG003|Overall Study|Reached stopping criteria|0|||
42286461|NCT02564055|76118940|FG004|Overall Study|Reached stopping criteria|0|||
42286462|NCT02564055|76118941|FG005|Overall Study|Reached stopping criteria|1|||
42286463|NCT02564055|76118936|FG000|Overall Study|Lost to Follow-up|0|||
42286464|NCT02564055|76118937|FG001|Overall Study|Lost to Follow-up|1|||
42286465|NCT02564055|76118938|FG002|Overall Study|Lost to Follow-up|4|||
42286466|NCT02564055|76118939|FG003|Overall Study|Lost to Follow-up|2|||
42286467|NCT02564055|76118940|FG004|Overall Study|Lost to Follow-up|1|||
42286468|NCT02564055|76118941|FG005|Overall Study|Lost to Follow-up|0|||
42286469|NCT02564055|76118936|FG000|Overall Study|Physician Decision|0|||
42286470|NCT02564055|76118937|FG001|Overall Study|Physician Decision|0|||
42286471|NCT02564055|76118938|FG002|Overall Study|Physician Decision|1|||
42286472|NCT02564055|76118939|FG003|Overall Study|Physician Decision|0|||
42286473|NCT02564055|76118940|FG004|Overall Study|Physician Decision|0|||
42286474|NCT02564055|76118941|FG005|Overall Study|Physician Decision|0|||
42286475|NCT02564055|76118936|FG000|Overall Study|Withdrawal by Subject|4|||
42286476|NCT02564055|76118937|FG001|Overall Study|Withdrawal by Subject|4|||
42286477|NCT02564055|76118938|FG002|Overall Study|Withdrawal by Subject|3|||
42286478|NCT02564055|76118939|FG003|Overall Study|Withdrawal by Subject|3|||
42286479|NCT02564055|76118940|FG004|Overall Study|Withdrawal by Subject|10|||
42286480|NCT02564055|76118941|FG005|Overall Study|Withdrawal by Subject|10|||
42286481|NCT02563899|76118959|FG000|Overall Study|Protocol Violation|1|||
42286482|NCT02563899|76118960|FG001|Overall Study|Protocol Violation|0|||
42286483|NCT02563899|76118961|FG002|Overall Study|Protocol Violation|0|||
42286484|NCT02563899|76118962|FG003|Overall Study|Protocol Violation|0|||
42286485|NCT02563899|76118959|FG000|Overall Study|Withdrawal by Subject|0|||
42286486|NCT02563899|76118960|FG001|Overall Study|Withdrawal by Subject|0|||
42286487|NCT02563899|76118961|FG002|Overall Study|Withdrawal by Subject|1|||
42286488|NCT02563899|76118962|FG003|Overall Study|Withdrawal by Subject|0|||
42353544|NCT04440163|76194637|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
42353545|NCT04304508|76194668|FG000|Overall Study|Subject Decision|29|||
42353546|NCT04304508|76194669|FG001|Overall Study|Subject Decision|39|||
42353547|NCT04304508|76194670|FG002|Overall Study|Subject Decision|37|||
42353548|NCT04304508|76194671|FG003|Overall Study|Subject Decision|48|||
42353549|NCT04304508|76194668|FG000|Overall Study|Death|6|||
42353550|NCT04304508|76194669|FG001|Overall Study|Death|1|||
42353551|NCT04304508|76194670|FG002|Overall Study|Death|8|||
42353552|NCT04304508|76194671|FG003|Overall Study|Death|5|||
42353553|NCT04304508|76194668|FG000|Overall Study|Non-compliance With Study Drug|3|||
42353554|NCT04304508|76194669|FG001|Overall Study|Non-compliance With Study Drug|1|||
42353555|NCT04304508|76194670|FG002|Overall Study|Non-compliance With Study Drug|2|||
42353556|NCT04304508|76194671|FG003|Overall Study|Non-compliance With Study Drug|0|||
42353557|NCT04304508|76194668|FG000|Overall Study|Switching To Other Therapy|1|||
42286489|NCT02699099|76118976|FG000|Overall Study|Adverse Event|1|||
42286490|NCT02699099|76118977|FG001|Overall Study|Adverse Event|0|||
42286491|NCT02699099|76118978|FG002|Overall Study|Adverse Event|2|||
42286492|NCT02699099|76118976|FG000|Overall Study|Lost to Follow-up|0|||
42286493|NCT02699099|76118977|FG001|Overall Study|Lost to Follow-up|1|||
42286494|NCT02699099|76118978|FG002|Overall Study|Lost to Follow-up|0|||
42353558|NCT04304508|76194669|FG001|Overall Study|Switching To Other Therapy|1|||
42353559|NCT04304508|76194670|FG002|Overall Study|Switching To Other Therapy|1|||
42353560|NCT04304508|76194671|FG003|Overall Study|Switching To Other Therapy|2|||
42353561|NCT04304508|76194668|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
42353562|NCT04304508|76194669|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
42286495|NCT02699099|76118976|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
42286496|NCT02699099|76118977|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
42286497|NCT02699099|76118978|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
42286498|NCT02698865|76118990|FG000|Overall Study|Other|11|||
42286499|NCT02698865|76118991|FG001|Overall Study|Other|11|||
42353563|NCT04304508|76194670|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
42353564|NCT04304508|76194671|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
42353565|NCT04304508|76194668|FG000|Overall Study|Withdrawal by Subject|7|||
42353566|NCT04304508|76194669|FG001|Overall Study|Withdrawal by Subject|5|||
42353567|NCT04304508|76194670|FG002|Overall Study|Withdrawal by Subject|11|||
42353568|NCT04304508|76194671|FG003|Overall Study|Withdrawal by Subject|6|||
42353569|NCT04304508|76194668|FG000|Overall Study|Logistical Difficulties|2|||
42353570|NCT04304508|76194669|FG001|Overall Study|Logistical Difficulties|2|||
42353571|NCT04304508|76194670|FG002|Overall Study|Logistical Difficulties|3|||
42353572|NCT04304508|76194671|FG003|Overall Study|Logistical Difficulties|2|||
42353573|NCT04304508|76194668|FG000|Overall Study|Missing Information|1|||
42353574|NCT04304508|76194669|FG001|Overall Study|Missing Information|2|||
42353575|NCT04304508|76194670|FG002|Overall Study|Missing Information|1|||
42353576|NCT04304508|76194671|FG003|Overall Study|Missing Information|3|||
42353577|NCT04304508|76194668|FG000|Overall Study|Other|7|||
42353578|NCT04304508|76194669|FG001|Overall Study|Other|6|||
42353579|NCT04304508|76194670|FG002|Overall Study|Other|5|||
42353580|NCT04304508|76194671|FG003|Overall Study|Other|4|||
42353581|NCT04304508|76194668|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
42353582|NCT04304508|76194669|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
42353583|NCT04304508|76194670|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
42353584|NCT04304508|76194671|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
42353585|NCT04304508|76194668|FG000|Overall Study|Physician Decision|3|||
42353586|NCT04304508|76194669|FG001|Overall Study|Physician Decision|4|||
42353587|NCT04304508|76194670|FG002|Overall Study|Physician Decision|9|||
42353588|NCT04304508|76194671|FG003|Overall Study|Physician Decision|7|||
42353589|NCT04304508|76194668|FG000|Overall Study|Study drug never administered|10|||
42353590|NCT04304508|76194669|FG001|Overall Study|Study drug never administered|4|||
42353591|NCT04304508|76194670|FG002|Overall Study|Study drug never administered|4|||
42353592|NCT04304508|76194671|FG003|Overall Study|Study drug never administered|4|||
42353593|NCT04304508|76194668|FG000|Overall Study|Adverse Event|49|||
42353594|NCT04304508|76194669|FG001|Overall Study|Adverse Event|50|||
42353595|NCT04304508|76194670|FG002|Overall Study|Adverse Event|51|||
42353596|NCT04304508|76194671|FG003|Overall Study|Adverse Event|56|||
42353597|NCT04304508|76194668|FG000|Overall Study|Lost to Follow-up|1|||
42353598|NCT04304508|76194669|FG001|Overall Study|Lost to Follow-up|5|||
42353599|NCT04304508|76194670|FG002|Overall Study|Lost to Follow-up|2|||
42353600|NCT04304508|76194671|FG003|Overall Study|Lost to Follow-up|3|||
42353601|NCT04206332|76194700|FG000|Part A|Lost to Follow-up|0|||
42353602|NCT04206332|76194701|FG001|Part A|Lost to Follow-up|1|||
42353603|NCT04206332|76194702|FG002|Part A|Lost to Follow-up|0|||
42353604|NCT04206332|76194703|FG003|Part A|Lost to Follow-up|0|||
42353605|NCT04206332|76194704|FG004|Part A|Lost to Follow-up|0|||
42353606|NCT04206332|76194705|FG005|Part A|Lost to Follow-up|0|||
42286500|NCT02698865|76118990|FG000|Overall Study|Withdrawal by Subject|20|||
42286501|NCT02698865|76118991|FG001|Overall Study|Withdrawal by Subject|16|||
42286502|NCT02698865|76118990|FG000|Overall Study|Physician Decision|0|||
42286503|NCT02698865|76118991|FG001|Overall Study|Physician Decision|4|||
42286504|NCT02698865|76118990|FG000|Overall Study|Lost to Follow-up|4|||
42286505|NCT02698865|76118991|FG001|Overall Study|Lost to Follow-up|2|||
42286506|NCT02698787|76118999|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
42286507|NCT02698787|76119000|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
42286508|NCT02698475|76119007|FG000|Main Study Period|Lack of Efficacy|1|||
42286509|NCT02698475|76119007|FG000|Main Study Period|Protocol Violation|2|||
42286510|NCT02698475|76119007|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
42286511|NCT02698475|76119007|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
42286512|NCT02698475|76119007|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
42286513|NCT02698475|76119007|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
42286514|NCT02698475|76119007|FG000|Long-Term Extension Period|Other|1|||
42286515|NCT02559687|76119014|FG000|Overall Study|Death|112|||
42286516|NCT02559687|76119014|FG000|Overall Study|Sponsor Decision|5|||
42286517|NCT02559687|76119014|FG000|Overall Study|Withdrawal by Subject|4|||
42353607|NCT04206332|76194706|FG006|Part A|Lost to Follow-up|0|||
42353608|NCT04206332|76194707|FG007|Part A|Lost to Follow-up|0|||
42353609|NCT04206332|76194708|FG008|Part A|Lost to Follow-up|0|||
42353610|NCT04206332|76194709|FG009|Part A|Lost to Follow-up|0|||
42353611|NCT04206332|76194710|FG010|Part A|Lost to Follow-up|0|||
42353612|NCT04206332|76194711|FG011|Part A|Lost to Follow-up|0|||
42353613|NCT04206332|76194712|FG012|Part A|Lost to Follow-up|0|||
42353614|NCT04206332|76194713|FG013|Part A|Lost to Follow-up|0|||
42286518|NCT04294719|76119028|FG000|Overall Study|Withdrawal by Subject|1|||
42286519|NCT02703311|76119036|FG000|Overall Study|Death|5|||
42286520|NCT02703311|76119036|FG000|Overall Study|Withdrawal by Subject|3|||
42286521|NCT02697617|76119040|FG000|Overall Study|Withdrawal by Subject|0|||
42286522|NCT02697617|76119041|FG001|Overall Study|Withdrawal by Subject|2|||
42286523|NCT02697617|76119040|FG000|Overall Study|Pregnancy|1|||
42286524|NCT02697617|76119041|FG001|Overall Study|Pregnancy|0|||
42286525|NCT02698241|76119051|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
42286526|NCT02698241|76119051|FG000|Overall Study|Screening not met|7|||
42286527|NCT02698241|76119051|FG000|Overall Study|Withdrawal by Subject|7|||
42286528|NCT02698241|76119051|FG000|Overall Study|Physician Decision|2|||
42286529|NCT02698241|76119051|FG000|Overall Study|Subject underwent system modification|2|||
42286530|NCT02698241|76119051|FG000|Overall Study|Lost to Follow-up|3|||
42286531|NCT02698241|76119051|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
42286532|NCT02698241|76119051|FG000|Overall Study|geographic and licensing issue|1|||
42286533|NCT02698241|76119051|FG000|Overall Study|Death|2|||
42286534|NCT01663233|76119057|FG000|Overall Study|Withdrawal by Subject|3|||
42286535|NCT01663233|76119058|FG001|Overall Study|Withdrawal by Subject|2|||
42286536|NCT01663233|76119057|FG000|Overall Study|Protocol Deviation|1|||
42286537|NCT01663233|76119058|FG001|Overall Study|Protocol Deviation|4|||
42286538|NCT01663233|76119057|FG000|Overall Study|Lost to Follow-up|0|||
42286539|NCT01663233|76119058|FG001|Overall Study|Lost to Follow-up|1|||
42286540|NCT02556255|76119077|FG000|Overall Study|Lost to Follow-up|4|||
42286541|NCT02556801|76119085|FG000|Overall Study|Lost to Follow-up|1|||
42286542|NCT02556801|76119086|FG001|Overall Study|Lost to Follow-up|0|||
42286543|NCT02556801|76119087|FG002|Overall Study|Lost to Follow-up|2|||
42286544|NCT02556801|76119088|FG003|Overall Study|Lost to Follow-up|0|||
42286545|NCT02556801|76119085|FG000|Overall Study|Withdrawal by Subject|1|||
42286546|NCT02556801|76119086|FG001|Overall Study|Withdrawal by Subject|1|||
42286547|NCT02556801|76119087|FG002|Overall Study|Withdrawal by Subject|1|||
42286548|NCT02556801|76119088|FG003|Overall Study|Withdrawal by Subject|0|||
42286549|NCT02556801|76119085|FG000|Overall Study|Protocol Violation|0|||
42286550|NCT02556801|76119086|FG001|Overall Study|Protocol Violation|3|||
42286551|NCT02556801|76119087|FG002|Overall Study|Protocol Violation|1|||
42286552|NCT02556801|76119088|FG003|Overall Study|Protocol Violation|1|||
42286553|NCT02556801|76119085|FG000|Overall Study|Adverse Event|0|||
42286554|NCT02556801|76119086|FG001|Overall Study|Adverse Event|2|||
42286555|NCT02556801|76119087|FG002|Overall Study|Adverse Event|0|||
42286556|NCT02556801|76119088|FG003|Overall Study|Adverse Event|3|||
42286557|NCT02556801|76119085|FG000|Overall Study|Pregnancy|0|||
42286558|NCT02556801|76119086|FG001|Overall Study|Pregnancy|1|||
42286559|NCT02556801|76119087|FG002|Overall Study|Pregnancy|0|||
42286560|NCT02556801|76119088|FG003|Overall Study|Pregnancy|0|||
42286561|NCT02556801|76119085|FG000|Overall Study|Personal reasons patient|0|||
42286562|NCT02556801|76119086|FG001|Overall Study|Personal reasons patient|0|||
42286563|NCT02556801|76119087|FG002|Overall Study|Personal reasons patient|0|||
42286564|NCT02556801|76119088|FG003|Overall Study|Personal reasons patient|1|||
42286565|NCT02556177|76119100|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
42286566|NCT02556177|76119101|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
42286567|NCT02554929|76119109|FG000|Overall Study|Lost to Follow-up|4|||
42286568|NCT02554929|76119110|FG001|Overall Study|Lost to Follow-up|4|||
42286569|NCT02554929|76119109|FG000|Overall Study|Withdrawal by Subject|2|||
42286570|NCT02554929|76119110|FG001|Overall Study|Withdrawal by Subject|8|||
42286571|NCT02697773|76119128|FG000|Overall Study|Adverse Event|2|||
42286572|NCT02697773|76119129|FG001|Overall Study|Adverse Event|1|||
42286573|NCT02697773|76119130|FG002|Overall Study|Adverse Event|2|||
42286574|NCT02697773|76119128|FG000|Overall Study|Death|0|||
42286575|NCT02697773|76119129|FG001|Overall Study|Death|0|||
42286576|NCT02697773|76119130|FG002|Overall Study|Death|2|||
42286577|NCT02697773|76119128|FG000|Overall Study|Lack of Efficacy|4|||
42286578|NCT02697773|76119129|FG001|Overall Study|Lack of Efficacy|6|||
42286579|NCT02697773|76119130|FG002|Overall Study|Lack of Efficacy|6|||
42015128|NCT01160289|75822259|FG000|Post-Randomization Period|Death|0|||
42286580|NCT02697773|76119128|FG000|Overall Study|Lost to Follow-up|5|||
42286581|NCT02697773|76119129|FG001|Overall Study|Lost to Follow-up|5|||
42286582|NCT02697773|76119130|FG002|Overall Study|Lost to Follow-up|7|||
42286583|NCT02697773|76119128|FG000|Overall Study|Other|15|||
42286584|NCT02697773|76119129|FG001|Overall Study|Other|11|||
42286585|NCT02697773|76119130|FG002|Overall Study|Other|10|||
42286586|NCT02697773|76119128|FG000|Overall Study|Protocol Violation|1|||
42286587|NCT02697773|76119129|FG001|Overall Study|Protocol Violation|1|||
42015129|NCT01160289|75822260|FG001|Post-Randomization Period|Death|0|||
42015130|NCT01160289|75822261|FG002|Post-Randomization Period|Death|0|||
42015131|NCT01160289|75822262|FG003|Post-Randomization Period|Death|1|||
42286588|NCT02697773|76119130|FG002|Overall Study|Protocol Violation|0|||
42286589|NCT02697773|76119128|FG000|Overall Study|Withdrawal by Subject|10|||
42286590|NCT02697773|76119129|FG001|Overall Study|Withdrawal by Subject|13|||
42286591|NCT02697773|76119130|FG002|Overall Study|Withdrawal by Subject|13|||
42286592|NCT02697773|76119128|FG000|Overall Study|Randomized but not treated|1|||
42286593|NCT02697773|76119129|FG001|Overall Study|Randomized but not treated|1|||
42286594|NCT02697773|76119130|FG002|Overall Study|Randomized but not treated|0|||
42286595|NCT02693171|76119138|FG000|Overall Study|Adverse Event|1|||
42286596|NCT02693171|76119138|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
42286597|NCT02692703|76119142|FG000|Overall Study|Lost to Follow-up|1|||
42286598|NCT02692703|76119142|FG000|Overall Study|Other|1|||
42286599|NCT02692235|76119148|FG000|Overall Study|Withdrawal by Subject|2|||
42286600|NCT02692235|76119149|FG001|Overall Study|Withdrawal by Subject|1|||
42286601|NCT02692235|76119148|FG000|Overall Study|Adverse Event|1|||
42286602|NCT02692235|76119149|FG001|Overall Study|Adverse Event|2|||
42286603|NCT02552121|76119163|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
42286604|NCT02552121|76119164|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
42286605|NCT02552121|76119165|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
42286606|NCT02552121|76119166|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
42286607|NCT02552121|76119167|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
42353615|NCT04206332|76194714|FG014|Part A|Lost to Follow-up|0|||
42353616|NCT04206332|76194715|FG015|Part A|Lost to Follow-up|0|||
42353617|NCT04206332|76194716|FG016|Part A|Lost to Follow-up|0|||
42353618|NCT04206332|76194700|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353619|NCT04206332|76194701|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353620|NCT04206332|76194702|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42286608|NCT02552121|76119168|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
42286609|NCT02552121|76119169|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
42286610|NCT02552121|76119170|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
42286611|NCT02552121|76119163|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
42286612|NCT02552121|76119164|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
42286613|NCT02552121|76119165|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
42286614|NCT02552121|76119166|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
42286615|NCT02552121|76119167|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
42286616|NCT02552121|76119168|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
42286617|NCT02552121|76119169|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
42286618|NCT02552121|76119170|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
42286619|NCT02552121|76119163|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
42286620|NCT02552121|76119164|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
42353621|NCT04206332|76194703|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353622|NCT04206332|76194704|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353623|NCT04206332|76194705|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
42353624|NCT04206332|76194706|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353625|NCT04206332|76194707|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353626|NCT04206332|76194708|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42286621|NCT02552121|76119165|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
42286622|NCT02552121|76119166|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
42286623|NCT02552121|76119167|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
42286624|NCT02552121|76119168|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
42286625|NCT02552121|76119169|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
42286626|NCT02552121|76119170|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
42286627|NCT02552121|76119163|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
42286628|NCT02552121|76119164|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
42286629|NCT02552121|76119165|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
42286630|NCT02552121|76119166|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
42286631|NCT02552121|76119167|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
42286632|NCT02552121|76119168|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
42286633|NCT02552121|76119169|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
42286634|NCT02552121|76119170|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
42286635|NCT02552121|76119163|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
42015132|NCT01160289|75822263|FG004|Post-Randomization Period|Death|0|||
42015133|NCT01160289|75822264|FG005|Post-Randomization Period|Death|0|||
42015134|NCT01160289|75822259|FG000|Post-Randomization Period|Lack of Efficacy|0|||
42015135|NCT01160289|75822260|FG001|Post-Randomization Period|Lack of Efficacy|1|||
42286636|NCT02552121|76119164|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
42286637|NCT02552121|76119165|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
42286638|NCT02552121|76119166|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
42015136|NCT01160289|75822261|FG002|Post-Randomization Period|Lack of Efficacy|0|||
42286639|NCT02552121|76119167|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
42286640|NCT02552121|76119168|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
42286641|NCT02552121|76119169|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
42286642|NCT02552121|76119170|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
42286643|NCT02552121|76119163|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
42286644|NCT02552121|76119164|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
42286645|NCT02552121|76119165|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
42286646|NCT02552121|76119166|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
42286647|NCT02552121|76119167|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
42286648|NCT02552121|76119168|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
42286649|NCT02552121|76119169|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
42286650|NCT02552121|76119170|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
42286651|NCT02552121|76119163|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
42286652|NCT02552121|76119164|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
42286653|NCT02552121|76119165|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
42286654|NCT02552121|76119166|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
42286655|NCT02552121|76119167|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
42286656|NCT02552121|76119168|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
42286657|NCT02552121|76119169|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
42286658|NCT02552121|76119170|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
42286659|NCT02552121|76119163|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
42286660|NCT02552121|76119164|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
42353627|NCT04206332|76194709|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353628|NCT04206332|76194710|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353629|NCT04206332|76194711|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353630|NCT04206332|76194712|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353631|NCT04206332|76194713|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353632|NCT04206332|76194714|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353633|NCT04206332|76194715|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353634|NCT04206332|76194716|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
42353635|NCT04206332|76194700|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353636|NCT04206332|76194701|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353637|NCT04206332|76194702|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353638|NCT04206332|76194703|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353639|NCT04206332|76194704|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353640|NCT04206332|76194705|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353641|NCT04206332|76194706|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353642|NCT04206332|76194707|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
42353643|NCT04206332|76194708|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353644|NCT04206332|76194709|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353645|NCT04206332|76194710|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
42353646|NCT04206332|76194711|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353647|NCT04206332|76194712|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353648|NCT04206332|76194713|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353649|NCT04206332|76194714|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353650|NCT04206332|76194715|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353651|NCT04206332|76194716|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353652|NCT04206332|76194700|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353653|NCT04206332|76194701|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353654|NCT04206332|76194702|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353655|NCT04206332|76194703|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353656|NCT04206332|76194704|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353657|NCT04206332|76194705|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353658|NCT04206332|76194706|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42171864|NCT00041132|75978753|FG000|Overall Study|Physician Decision|2|||
42171865|NCT00040742|75978761|FG000|Overall Study|Death|0|||
42286661|NCT02552121|76119165|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
42171866|NCT00040742|75978762|FG001|Overall Study|Death|0|||
42286662|NCT02552121|76119166|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
42286663|NCT02552121|76119167|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
42286664|NCT02552121|76119168|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
42286665|NCT02552121|76119169|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
42286666|NCT02552121|76119170|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
42286667|NCT02552121|76119163|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
42286668|NCT02552121|76119164|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
42286669|NCT02552121|76119165|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
42286670|NCT02552121|76119166|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
42286671|NCT02552121|76119167|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
42286672|NCT02552121|76119168|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
42286673|NCT02552121|76119169|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
42286674|NCT02552121|76119170|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
42286675|NCT02552121|76119163|FG000|Part 2: Cohort Expansion|Death|0|||
42286676|NCT02552121|76119164|FG001|Part 2: Cohort Expansion|Death|0|||
42286677|NCT02552121|76119165|FG002|Part 2: Cohort Expansion|Death|1|||
42286678|NCT02552121|76119166|FG003|Part 2: Cohort Expansion|Death|0|||
42286679|NCT02552121|76119167|FG004|Part 2: Cohort Expansion|Death|0|||
42286680|NCT02552121|76119168|FG005|Part 2: Cohort Expansion|Death|0|||
42286681|NCT02552121|76119169|FG006|Part 2: Cohort Expansion|Death|0|||
42286682|NCT02552121|76119170|FG007|Part 2: Cohort Expansion|Death|0|||
42286683|NCT02552355|76119215|FG000|Overall Study|Adverse Event|0|||
42286684|NCT02552355|76119216|FG001|Overall Study|Adverse Event|2|||
42171867|NCT00040742|75978763|FG002|Overall Study|Death|1|||
42171868|NCT00040742|75978764|FG003|Overall Study|Death|0|||
42171869|NCT00040742|75978761|FG000|Overall Study|Adverse Event|15|||
42171870|NCT00040742|75978762|FG001|Overall Study|Adverse Event|16|||
42286685|NCT02552355|76119217|FG002|Overall Study|Adverse Event|2|||
42286686|NCT02552355|76119218|FG003|Overall Study|Adverse Event|0|||
42286687|NCT02552355|76119215|FG000|Overall Study|Withdrawal by Subject|0|||
42286688|NCT02552355|76119216|FG001|Overall Study|Withdrawal by Subject|0|||
42286689|NCT02552355|76119217|FG002|Overall Study|Withdrawal by Subject|0|||
42286690|NCT02552355|76119218|FG003|Overall Study|Withdrawal by Subject|1|||
42286691|NCT02551731|76119228|FG000|Overall Study|Withdrawal by Subject|2|||
42286692|NCT02542605|76119232|FG000|Part B: Challenge Phase|Sponsor decision|1|||
42286693|NCT02542605|76119233|FG001|Part B: Challenge Phase|Sponsor decision|0|||
42286694|NCT02542605|76119234|FG002|Part B: Challenge Phase|Sponsor decision|0|||
42286695|NCT02542605|76119232|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
42286696|NCT02542605|76119233|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
42286697|NCT02542605|76119234|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
42286698|NCT02550873|76119245|FG000|Randomized Double Blind|Adverse Event|3|||
42286699|NCT02550873|76119246|FG001|Randomized Double Blind|Adverse Event|1|||
42286700|NCT02550873|76119247|FG002|Randomized Double Blind|Adverse Event|0|||
42286701|NCT02550873|76119245|FG000|Randomized Double Blind|Disease progression|1|||
42286702|NCT02550873|76119246|FG001|Randomized Double Blind|Disease progression|1|||
42286703|NCT02550873|76119247|FG002|Randomized Double Blind|Disease progression|0|||
42286704|NCT02550873|76119245|FG000|Open Label Extension|Study ongoing|0|||
42286705|NCT02550873|76119246|FG001|Open Label Extension|Study ongoing|0|||
42286706|NCT02550873|76119247|FG002|Open Label Extension|Study ongoing|111|||
42286707|NCT02535741|76119269|FG000|Overall Study|Adverse Event|3|||
42286708|NCT02535741|76119269|FG000|Overall Study|Withdrawal by Subject|9|||
42286709|NCT02535741|76119269|FG000|Overall Study|Lost to Follow-up|10|||
42286710|NCT02535741|76119269|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
42286711|NCT02535741|76119269|FG000|Overall Study|Missing data|6|||
42286712|NCT02550795|76119290|FG000|Overall Study|Physician Decision|0|||
42286713|NCT02550795|76119291|FG001|Overall Study|Physician Decision|1|||
42286714|NCT02550795|76119292|FG002|Overall Study|Physician Decision|0|||
42286715|NCT02541903|76119300|FG000|Overall Study|Death|1|||
42286716|NCT02541669|76119309|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
42286717|NCT02541669|76119310|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
42286718|NCT02541669|76119311|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
42286719|NCT02541669|76119312|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
42286720|NCT02541669|76119313|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
42171871|NCT00040742|75978763|FG002|Overall Study|Adverse Event|21|||
42171872|NCT00040742|75978764|FG003|Overall Study|Adverse Event|9|||
42171873|NCT00040742|75978761|FG000|Overall Study|Withdrawal by Subject|7|||
42286721|NCT02549859|76119324|FG000|Long-term 60 Hz DBS|Study Closed|1|||
42286722|NCT02688647|76119334|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
42286723|NCT02688647|76119335|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
42286724|NCT02688647|76119334|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
42286725|NCT02688647|76119335|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
42353659|NCT04206332|76194707|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42171874|NCT00040742|75978762|FG001|Overall Study|Withdrawal by Subject|15|||
42171875|NCT00040742|75978763|FG002|Overall Study|Withdrawal by Subject|10|||
42286726|NCT02688647|76119334|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
42286727|NCT02688647|76119335|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
42286728|NCT02688647|76119334|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
42286729|NCT02688647|76119335|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
42286730|NCT02688647|76119334|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
42171876|NCT00040742|75978764|FG003|Overall Study|Withdrawal by Subject|13|||
42171877|NCT00040742|75978761|FG000|Overall Study|Chemotoxicity|4|||
42171878|NCT00040742|75978762|FG001|Overall Study|Chemotoxicity|3|||
42171879|NCT00040742|75978763|FG002|Overall Study|Chemotoxicity|5|||
42171880|NCT00040742|75978764|FG003|Overall Study|Chemotoxicity|2|||
42171881|NCT00040742|75978761|FG000|Overall Study|Incomplete Forms|6|||
42171882|NCT00040742|75978762|FG001|Overall Study|Incomplete Forms|10|||
42171883|NCT00040742|75978763|FG002|Overall Study|Incomplete Forms|4|||
42286731|NCT02688647|76119335|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
42286732|NCT02688647|76119334|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
42286733|NCT02688647|76119335|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
42286734|NCT02688647|76119334|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
42286735|NCT02688647|76119335|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
42286736|NCT02687711|76119353|FG000|Overall Study|Adverse Event|89|||
42015137|NCT01160289|75822262|FG003|Post-Randomization Period|Lack of Efficacy|3|||
42015138|NCT01160289|75822263|FG004|Post-Randomization Period|Lack of Efficacy|0|||
42015139|NCT01160289|75822264|FG005|Post-Randomization Period|Lack of Efficacy|0|||
42015140|NCT01160289|75822259|FG000|Post-Randomization Period|Lost to Follow-up|0|||
42015141|NCT01160289|75822260|FG001|Post-Randomization Period|Lost to Follow-up|3|||
42286737|NCT02687711|76119353|FG000|Overall Study|Lack of Efficacy|70|||
42286738|NCT02687711|76119353|FG000|Overall Study|Lost to Follow-up|20|||
42286739|NCT02687711|76119353|FG000|Overall Study|Consent withdrawn|15|||
42286740|NCT02687711|76119353|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
42286741|NCT02687711|76119353|FG000|Overall Study|Too expensive|4|||
42286742|NCT02687711|76119353|FG000|Overall Study|Participant moved abroad|1|||
42015142|NCT01160289|75822261|FG002|Post-Randomization Period|Lost to Follow-up|2|||
42015143|NCT01160289|75822262|FG003|Post-Randomization Period|Lost to Follow-up|5|||
42015144|NCT01160289|75822263|FG004|Post-Randomization Period|Lost to Follow-up|3|||
42015145|NCT01160289|75822264|FG005|Post-Randomization Period|Lost to Follow-up|4|||
42015146|NCT01160289|75822259|FG000|Post-Randomization Period|Physician Decision|0|||
42171884|NCT00040742|75978764|FG003|Overall Study|Incomplete Forms|5|||
42286743|NCT02687711|76119353|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
42286744|NCT02687711|76119353|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
42286745|NCT02687711|76119353|FG000|Overall Study|Disliked taste|1|||
42286746|NCT02687711|76119353|FG000|Overall Study|Low mood|1|||
42286747|NCT02687711|76119353|FG000|Overall Study|Side effects|1|||
42286748|NCT02687711|76119353|FG000|Overall Study|Change of Hospital|1|||
42286749|NCT02687711|76119353|FG000|Overall Study|Liver Encephalopathy|1|||
42286750|NCT02687711|76119353|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
42286751|NCT02687711|76119353|FG000|Overall Study|Withdrawn due to intake interruption|1|||
42353660|NCT04206332|76194708|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353661|NCT04206332|76194709|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353662|NCT04206332|76194710|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353663|NCT04206332|76194711|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353664|NCT04206332|76194712|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353665|NCT04206332|76194713|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42286752|NCT02687711|76119353|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
42171885|NCT00040742|75978761|FG000|Overall Study|Other medical|7|||
42171886|NCT00040742|75978762|FG001|Overall Study|Other medical|5|||
42171887|NCT00040742|75978763|FG002|Overall Study|Other medical|5|||
42171888|NCT00040742|75978764|FG003|Overall Study|Other medical|5|||
42286753|NCT02687711|76119353|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
42286754|NCT02687711|76119353|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
42286755|NCT01662063|76119359|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
42286756|NCT01662063|76119360|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
42286757|NCT01662063|76119361|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
42286758|NCT01662063|76119359|FG000|Overall Study|Lack of Efficacy|1|||
42286759|NCT01662063|76119360|FG001|Overall Study|Lack of Efficacy|6|||
42286760|NCT01662063|76119361|FG002|Overall Study|Lack of Efficacy|0|||
42286761|NCT01662063|76119359|FG000|Overall Study|Lost to Follow-up|0|||
42286762|NCT01662063|76119360|FG001|Overall Study|Lost to Follow-up|4|||
42286763|NCT01662063|76119361|FG002|Overall Study|Lost to Follow-up|0|||
42286764|NCT01662063|76119359|FG000|Overall Study|Protocol Violation|1|||
42286765|NCT01662063|76119360|FG001|Overall Study|Protocol Violation|0|||
42286766|NCT01662063|76119361|FG002|Overall Study|Protocol Violation|0|||
42286767|NCT01662063|76119359|FG000|Overall Study|Withdrawal by Subject|2|||
42286768|NCT01662063|76119360|FG001|Overall Study|Withdrawal by Subject|4|||
42286769|NCT01662063|76119361|FG002|Overall Study|Withdrawal by Subject|1|||
42286770|NCT01662063|76119359|FG000|Overall Study|Physician Decision|0|||
42286771|NCT01662063|76119360|FG001|Overall Study|Physician Decision|2|||
42286772|NCT01662063|76119361|FG002|Overall Study|Physician Decision|0|||
42286773|NCT01662063|76119359|FG000|Overall Study|Other|0|||
42353666|NCT04206332|76194714|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353667|NCT04206332|76194715|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
42353668|NCT04206332|76194716|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
42353669|NCT04206332|76194700|FG000|Part C|Withdrawal by Subject|0|||
42353670|NCT04206332|76194701|FG001|Part C|Withdrawal by Subject|0|||
42353671|NCT04206332|76194702|FG002|Part C|Withdrawal by Subject|0|||
42353672|NCT04206332|76194703|FG003|Part C|Withdrawal by Subject|0|||
42353673|NCT04206332|76194704|FG004|Part C|Withdrawal by Subject|0|||
42353674|NCT04206332|76194705|FG005|Part C|Withdrawal by Subject|0|||
42353675|NCT04206332|76194706|FG006|Part C|Withdrawal by Subject|0|||
42353676|NCT04206332|76194707|FG007|Part C|Withdrawal by Subject|0|||
42353677|NCT04206332|76194708|FG008|Part C|Withdrawal by Subject|0|||
42353678|NCT04206332|76194709|FG009|Part C|Withdrawal by Subject|0|||
42353679|NCT04206332|76194710|FG010|Part C|Withdrawal by Subject|0|||
42353680|NCT04206332|76194711|FG011|Part C|Withdrawal by Subject|0|||
42353681|NCT04206332|76194712|FG012|Part C|Withdrawal by Subject|0|||
42353682|NCT04206332|76194713|FG013|Part C|Withdrawal by Subject|0|||
42353683|NCT04206332|76194714|FG014|Part C|Withdrawal by Subject|2|||
42353684|NCT04206332|76194715|FG015|Part C|Withdrawal by Subject|0|||
42353685|NCT04206332|76194716|FG016|Part C|Withdrawal by Subject|0|||
42353686|NCT03790111|76194799|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
42353687|NCT03780543|76194806|FG000|Overall Study|Adverse Event|1|||
42353688|NCT03780543|76194807|FG001|Overall Study|Adverse Event|0|||
42353689|NCT03780543|76194808|FG002|Overall Study|Adverse Event|2|||
42353690|NCT03780543|76194806|FG000|Overall Study|Lost to Follow-up|2|||
42353691|NCT03780543|76194807|FG001|Overall Study|Lost to Follow-up|0|||
42353692|NCT03780543|76194808|FG002|Overall Study|Lost to Follow-up|1|||
42353693|NCT03780543|76194806|FG000|Overall Study|Study terminated by Sponsor|8|||
42353694|NCT03780543|76194807|FG001|Overall Study|Study terminated by Sponsor|7|||
42353695|NCT03780543|76194808|FG002|Overall Study|Study terminated by Sponsor|13|||
42353696|NCT03780543|76194806|FG000|Overall Study|Withdrawal by Subject|1|||
42353697|NCT03780543|76194807|FG001|Overall Study|Withdrawal by Subject|8|||
42353698|NCT03780543|76194808|FG002|Overall Study|Withdrawal by Subject|1|||
42353699|NCT03780543|76194806|FG000|Overall Study|Noncompliance with study drug|1|||
42353700|NCT03780543|76194807|FG001|Overall Study|Noncompliance with study drug|0|||
42353701|NCT03780543|76194808|FG002|Overall Study|Noncompliance with study drug|0|||
42353702|NCT03745820|76194821|FG000|Overall Study|Adverse Event|0|||
42353703|NCT03745820|76194822|FG001|Overall Study|Adverse Event|3|||
42353704|NCT03745820|76194823|FG002|Overall Study|Adverse Event|2|||
42353705|NCT03745820|76194821|FG000|Overall Study|Non-Compliance with Study Drug|4|||
42353706|NCT03745820|76194822|FG001|Overall Study|Non-Compliance with Study Drug|3|||
42353707|NCT03745820|76194823|FG002|Overall Study|Non-Compliance with Study Drug|0|||
42353708|NCT03745820|76194821|FG000|Overall Study|Withdrawal by Subject|4|||
42353709|NCT03745820|76194822|FG001|Overall Study|Withdrawal by Subject|4|||
42353710|NCT03745820|76194823|FG002|Overall Study|Withdrawal by Subject|4|||
42353711|NCT03745820|76194821|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
42353712|NCT03745820|76194822|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
42353713|NCT03745820|76194823|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
42286774|NCT01662063|76119360|FG001|Overall Study|Other|1|||
42286775|NCT01662063|76119361|FG002|Overall Study|Other|0|||
42286776|NCT02548455|76119369|FG000|Overall Study|Withdrawal by Subject|27|||
42286777|NCT02548455|76119369|FG000|Overall Study|Death|26|||
42286778|NCT02548455|76119369|FG000|Overall Study|Lost to Follow-up|14|||
42353714|NCT03745820|76194821|FG000|Overall Study|Lost to Follow-up|2|||
42286779|NCT02548455|76119369|FG000|Overall Study|Visit not completed|173|||
42286780|NCT02691455|76119375|FG000|Overall Study|Withdrawal by Subject|1|||
42286781|NCT02691455|76119376|FG001|Overall Study|Withdrawal by Subject|2|||
42286782|NCT02691455|76119375|FG000|Overall Study|Lost to Follow-up|15|||
42286783|NCT02691455|76119376|FG001|Overall Study|Lost to Follow-up|15|||
42286784|NCT02534883|76119384|FG000|Overall Study|Early Termination|8|||
42286785|NCT02534883|76119385|FG001|Overall Study|Early Termination|3|||
42286786|NCT02685995|76119393|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
42286787|NCT02685995|76119394|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
42286788|NCT02548143|76119402|FG000|Overall Study|Adverse Event|1|||
42286789|NCT02548143|76119403|FG001|Overall Study|Adverse Event|0|||
42286790|NCT02548143|76119402|FG000|Overall Study|Withdrawal by Subject|0|||
42286791|NCT02548143|76119403|FG001|Overall Study|Withdrawal by Subject|1|||
42286792|NCT02547441|76119411|FG000|Double-Blind Study Period|Adverse Event|4|||
42286793|NCT02547441|76119412|FG001|Double-Blind Study Period|Adverse Event|9|||
42286794|NCT02547441|76119411|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
42286795|NCT02547441|76119412|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
42286796|NCT02547441|76119411|FG000|Double-Blind Study Period|Physician Decision|1|||
42286797|NCT02547441|76119412|FG001|Double-Blind Study Period|Physician Decision|0|||
42286798|NCT02547441|76119411|FG000|Double-Blind Study Period|Protocol Violation|1|||
42286799|NCT02547441|76119412|FG001|Double-Blind Study Period|Protocol Violation|2|||
42286800|NCT02547441|76119411|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
42286801|NCT02547441|76119412|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
42286802|NCT02547441|76119411|FG000|Double-Blind Study Period|Sponsor Decision|1|||
42286803|NCT02547441|76119412|FG001|Double-Blind Study Period|Sponsor Decision|0|||
42286804|NCT02547441|76119411|FG000|Open-Label Study Period|Adverse Event|10|||
42286805|NCT02547441|76119412|FG001|Open-Label Study Period|Adverse Event|11|||
42286806|NCT02547441|76119411|FG000|Open-Label Study Period|Lack of Efficacy|3|||
42286807|NCT02547441|76119412|FG001|Open-Label Study Period|Lack of Efficacy|2|||
42286808|NCT02547441|76119411|FG000|Open-Label Study Period|Lost to Follow-up|7|||
42286809|NCT02547441|76119412|FG001|Open-Label Study Period|Lost to Follow-up|8|||
42286810|NCT02547441|76119411|FG000|Open-Label Study Period|Physician Decision|1|||
42286811|NCT02547441|76119412|FG001|Open-Label Study Period|Physician Decision|0|||
42286812|NCT02547441|76119411|FG000|Open-Label Study Period|Protocol Violation|2|||
42286813|NCT02547441|76119412|FG001|Open-Label Study Period|Protocol Violation|0|||
42286814|NCT02547441|76119411|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
42286815|NCT02547441|76119412|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
42286816|NCT02547441|76119411|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
42286817|NCT02547441|76119412|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
42286818|NCT02540265|76119422|FG000|Overall Study|Lost to Follow-up|0|||
42286819|NCT02540265|76119423|FG001|Overall Study|Lost to Follow-up|0|||
42286820|NCT02540265|76119424|FG002|Overall Study|Lost to Follow-up|1|||
42286821|NCT02547363|76119434|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
42286822|NCT02547363|76119435|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
42286823|NCT02547363|76119434|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
42286824|NCT02547363|76119435|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
42286825|NCT02547363|76119434|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
42286826|NCT02547363|76119435|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
42286827|NCT02547363|76119434|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
42286828|NCT02547363|76119435|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
42286829|NCT02547363|76119434|FG000|12-month Follow-up|Withdrawal by Subject|4|||
42286830|NCT02547363|76119435|FG001|12-month Follow-up|Withdrawal by Subject|3|||
42286831|NCT02547363|76119434|FG000|12-month Follow-up|Lost to Follow-up|4|||
42286832|NCT02547363|76119435|FG001|12-month Follow-up|Lost to Follow-up|1|||
42286833|NCT02547363|76119434|FG000|12-month Follow-up|Lack of Efficacy|1|||
42286834|NCT02547363|76119435|FG001|12-month Follow-up|Lack of Efficacy|1|||
42353715|NCT03745820|76194822|FG001|Overall Study|Lost to Follow-up|0|||
42353716|NCT03745820|76194823|FG002|Overall Study|Lost to Follow-up|3|||
42353717|NCT03745820|76194821|FG000|Overall Study|Reason not Specified|2|||
42015147|NCT01160289|75822260|FG001|Post-Randomization Period|Physician Decision|0|||
42015148|NCT01160289|75822261|FG002|Post-Randomization Period|Physician Decision|1|||
42286835|NCT02547363|76119434|FG000|12-month Follow-up|Other|1|||
42286836|NCT02547363|76119435|FG001|12-month Follow-up|Other|0|||
42286837|NCT02539797|76119443|FG000|Overall Study|Lost to Follow-up|0|||
42286838|NCT02539797|76119444|FG001|Overall Study|Lost to Follow-up|1|||
42286839|NCT02539797|76119445|FG002|Overall Study|Lost to Follow-up|0|||
42286840|NCT02684357|76119456|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
42286841|NCT02684357|76119457|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
42015149|NCT01160289|75822262|FG003|Post-Randomization Period|Physician Decision|0|||
42286842|NCT02684357|76119458|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
42286843|NCT02684357|76119459|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
42286844|NCT02684357|76119460|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
42353718|NCT03745820|76194822|FG001|Overall Study|Reason not Specified|4|||
42286845|NCT02684357|76119461|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
42286846|NCT02684357|76119456|FG000|Part A|Lost to Follow-up|0|||
42286847|NCT02684357|76119457|FG001|Part A|Lost to Follow-up|2|||
42286848|NCT02684357|76119458|FG002|Part A|Lost to Follow-up|2|||
42286849|NCT02684357|76119459|FG003|Part A|Lost to Follow-up|0|||
42286850|NCT02684357|76119460|FG004|Part A|Lost to Follow-up|0|||
42286851|NCT02684357|76119461|FG005|Part A|Lost to Follow-up|0|||
42286852|NCT02684357|76119456|FG000|Part A|Withdrawal by Subject|3|||
42286853|NCT02684357|76119457|FG001|Part A|Withdrawal by Subject|0|||
42286854|NCT02684357|76119458|FG002|Part A|Withdrawal by Subject|0|||
42286855|NCT02684357|76119459|FG003|Part A|Withdrawal by Subject|0|||
42286856|NCT02684357|76119460|FG004|Part A|Withdrawal by Subject|0|||
42286857|NCT02684357|76119461|FG005|Part A|Withdrawal by Subject|0|||
42286858|NCT02684357|76119456|FG000|Part A|Other|0|||
42286859|NCT02684357|76119457|FG001|Part A|Other|1|||
42286860|NCT02684357|76119458|FG002|Part A|Other|0|||
42286861|NCT02684357|76119459|FG003|Part A|Other|0|||
42286862|NCT02684357|76119460|FG004|Part A|Other|0|||
42286863|NCT02684357|76119461|FG005|Part A|Other|0|||
42286864|NCT02684357|76119456|FG000|Part B|Adverse Event (Other)|0|||
42286865|NCT02684357|76119457|FG001|Part B|Adverse Event (Other)|0|||
42286866|NCT02684357|76119458|FG002|Part B|Adverse Event (Other)|0|||
42286867|NCT02684357|76119459|FG003|Part B|Adverse Event (Other)|1|||
42286868|NCT02684357|76119460|FG004|Part B|Adverse Event (Other)|1|||
42286869|NCT02684357|76119461|FG005|Part B|Adverse Event (Other)|1|||
42286870|NCT02684357|76119456|FG000|Part B|Lost to Follow-up|0|||
42286871|NCT02684357|76119457|FG001|Part B|Lost to Follow-up|0|||
42286872|NCT02684357|76119458|FG002|Part B|Lost to Follow-up|0|||
42286873|NCT02684357|76119459|FG003|Part B|Lost to Follow-up|1|||
42286874|NCT02684357|76119460|FG004|Part B|Lost to Follow-up|1|||
42286875|NCT02684357|76119461|FG005|Part B|Lost to Follow-up|7|||
42286876|NCT02684357|76119456|FG000|Part B|Withdrawal by Subject|0|||
42286877|NCT02684357|76119457|FG001|Part B|Withdrawal by Subject|0|||
42286878|NCT02684357|76119458|FG002|Part B|Withdrawal by Subject|0|||
42286879|NCT02684357|76119459|FG003|Part B|Withdrawal by Subject|0|||
42286880|NCT02684357|76119460|FG004|Part B|Withdrawal by Subject|2|||
42286881|NCT02684357|76119461|FG005|Part B|Withdrawal by Subject|4|||
42353719|NCT03745820|76194823|FG002|Overall Study|Reason not Specified|1|||
42353720|NCT03699631|76194831|FG000|Overall Study|Adverse Event|3|||
42353721|NCT03686150|76194841|FG000|Overall Study|Withdrawal by Subject|1|||
42353722|NCT03686150|76194842|FG001|Overall Study|Withdrawal by Subject|1|||
42353723|NCT03686150|76194843|FG002|Overall Study|Withdrawal by Subject|1|||
42353724|NCT03686150|76194844|FG003|Overall Study|Withdrawal by Subject|0|||
42353725|NCT03686150|76194845|FG004|Overall Study|Withdrawal by Subject|1|||
42353726|NCT03686150|76194846|FG005|Overall Study|Withdrawal by Subject|2|||
42353727|NCT03686150|76194841|FG000|Overall Study|Physician Decision|1|||
42353728|NCT03686150|76194842|FG001|Overall Study|Physician Decision|0|||
42353729|NCT03686150|76194843|FG002|Overall Study|Physician Decision|0|||
42353730|NCT03686150|76194844|FG003|Overall Study|Physician Decision|0|||
42353731|NCT03686150|76194845|FG004|Overall Study|Physician Decision|0|||
42353732|NCT03686150|76194846|FG005|Overall Study|Physician Decision|1|||
42353733|NCT03686150|76194841|FG000|Overall Study|Lost to Follow-up|0|||
42353734|NCT03686150|76194842|FG001|Overall Study|Lost to Follow-up|1|||
42353735|NCT03686150|76194843|FG002|Overall Study|Lost to Follow-up|0|||
42353736|NCT03686150|76194844|FG003|Overall Study|Lost to Follow-up|0|||
42353737|NCT03686150|76194845|FG004|Overall Study|Lost to Follow-up|0|||
42353738|NCT03686150|76194846|FG005|Overall Study|Lost to Follow-up|0|||
42353739|NCT03604172|76194859|FG000|Overall Study|Lost to Follow-up|1|||
42353740|NCT03604172|76194860|FG001|Overall Study|Lost to Follow-up|2|||
42353741|NCT03496207|76194869|FG000|Base Study|Adverse Event|0|||
42286882|NCT02684357|76119456|FG000|Part B|Other|0|||
42286883|NCT02684357|76119457|FG001|Part B|Other|0|||
42286884|NCT02684357|76119458|FG002|Part B|Other|0|||
42286885|NCT02684357|76119459|FG003|Part B|Other|1|||
42286886|NCT02684357|76119460|FG004|Part B|Other|0|||
42353742|NCT03496207|76194870|FG001|Base Study|Adverse Event|0|||
42353743|NCT03496207|76194871|FG002|Base Study|Adverse Event|1|||
42286887|NCT02684357|76119461|FG005|Part B|Other|1|||
42286888|NCT02684279|76119474|FG000|Overall Study|Adverse Event|87|||
42353744|NCT03496207|76194872|FG003|Base Study|Adverse Event|1|||
42353745|NCT03496207|76194873|FG004|Base Study|Adverse Event|4|||
42353746|NCT03496207|76194869|FG000|Base Study|Death|0|||
42286889|NCT02684279|76119474|FG000|Overall Study|Lack of Efficacy|4|||
42286890|NCT02684279|76119474|FG000|Overall Study|Lost to Follow-up|61|||
42286891|NCT02684279|76119474|FG000|Overall Study|Protocol Violation|6|||
42286892|NCT02684279|76119474|FG000|Overall Study|Pregnancy|8|||
42286893|NCT02684279|76119474|FG000|Overall Study|Withdrawal by Subject|92|||
42286894|NCT02684279|76119474|FG000|Overall Study|non-compliance with study drug|9|||
42286895|NCT02684279|76119474|FG000|Overall Study|non compliance with study visits|2|||
42286896|NCT02684279|76119474|FG000|Overall Study|subject to have surgery|1|||
42286897|NCT02684279|76119474|FG000|Overall Study|family emergency|1|||
42353747|NCT03496207|76194870|FG001|Base Study|Death|0|||
42353748|NCT03496207|76194871|FG002|Base Study|Death|0|||
42353749|NCT03496207|76194872|FG003|Base Study|Death|0|||
42286898|NCT02684279|76119474|FG000|Overall Study|Site closures|7|||
42286899|NCT02684279|76119474|FG000|Overall Study|Physician Decision|1|||
42286900|NCT02534493|76119478|FG000|Overall Study|Lost to Follow-up|1|||
42286901|NCT02534493|76119478|FG000|Overall Study|Withdrawal by Subject|1|||
42286902|NCT02547129|76119486|FG000|Overall Study|Difficulty with ongoing infection|1|||
42286903|NCT02547129|76119487|FG001|Overall Study|Difficulty with ongoing infection|0|||
42286904|NCT02546193|76119495|FG000|Overall Study|Withdrawal by Subject|2|||
42286905|NCT02546193|76119496|FG001|Overall Study|Withdrawal by Subject|0|||
42286906|NCT02546193|76119497|FG002|Overall Study|Withdrawal by Subject|1|||
42286907|NCT02546193|76119498|FG003|Overall Study|Withdrawal by Subject|0|||
42286908|NCT02546193|76119495|FG000|Overall Study|Not eligible at time of induction|4|||
42286909|NCT02546193|76119496|FG001|Overall Study|Not eligible at time of induction|6|||
42286910|NCT02546193|76119497|FG002|Overall Study|Not eligible at time of induction|1|||
42286911|NCT02546193|76119498|FG003|Overall Study|Not eligible at time of induction|0|||
42286912|NCT02538471|76119504|FG000|Overall Study|Progression of disease|2|||
42286913|NCT01661595|76119512|FG000|Phase 1: Week 0-4|Adverse Event|1|||
42286914|NCT01661595|76119513|FG001|Phase 1: Week 0-4|Adverse Event|0|||
42286915|NCT01661595|76119514|FG002|Phase 1: Week 0-4|Adverse Event|0|||
42286916|NCT01661595|76119515|FG003|Phase 1: Week 0-4|Adverse Event|0|||
42286917|NCT01661595|76119512|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
42286918|NCT01661595|76119513|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
42286919|NCT01661595|76119514|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
42286920|NCT01661595|76119515|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
42286921|NCT02213133|76119535|FG000|Overall Study|Participant discontinued study therapy|2|||
42286922|NCT02213133|76119536|FG001|Overall Study|Participant discontinued study therapy|0|||
42286923|NCT02213133|76119537|FG002|Overall Study|Participant discontinued study therapy|0|||
42286924|NCT02213133|76119535|FG000|Overall Study|Participant withdrew informed consent|2|||
42286925|NCT02213133|76119536|FG001|Overall Study|Participant withdrew informed consent|1|||
42286926|NCT02213133|76119537|FG002|Overall Study|Participant withdrew informed consent|2|||
42286927|NCT02213133|76119535|FG000|Overall Study|Disease progression|11|||
42286928|NCT02213133|76119536|FG001|Overall Study|Disease progression|2|||
42286929|NCT02213133|76119537|FG002|Overall Study|Disease progression|0|||
42286930|NCT02213133|76119535|FG000|Overall Study|Adverse Event (AE)|1|||
42286931|NCT02213133|76119536|FG001|Overall Study|Adverse Event (AE)|0|||
42286932|NCT02213133|76119537|FG002|Overall Study|Adverse Event (AE)|0|||
42286933|NCT02213133|76119535|FG000|Overall Study|Death|16|||
42286934|NCT02213133|76119536|FG001|Overall Study|Death|2|||
42286935|NCT02213133|76119537|FG002|Overall Study|Death|1|||
42286936|NCT02213133|76119535|FG000|Overall Study|Other|5|||
42286937|NCT02213133|76119536|FG001|Overall Study|Other|0|||
42286938|NCT02213133|76119537|FG002|Overall Study|Other|0|||
42286939|NCT02684981|76119549|FG000|Overall Study|Permanently discontinued the treatment|157|||
42286940|NCT02684981|76119550|FG001|Overall Study|Permanently discontinued the treatment|161|||
42286941|NCT02684981|76119551|FG002|Overall Study|Permanently discontinued the treatment|110|||
42286942|NCT02684981|76119549|FG000|Overall Study|Other|83|||
42286943|NCT02684981|76119550|FG001|Overall Study|Other|49|||
42286944|NCT02684981|76119551|FG002|Overall Study|Other|17|||
42286945|NCT02146833|76119565|FG000|Overall Study|Death|10|||
42286946|NCT02146833|76119565|FG000|Overall Study|No longer consented to study treatment|1|||
42286947|NCT02690207|76119569|FG000|Overall Study|Lost to Follow-up|48|||
42286948|NCT02690207|76119569|FG000|Overall Study|Withdrawal by Subject|46|||
42286949|NCT02690207|76119569|FG000|Overall Study|Protocol Violation|2|||
42286950|NCT02690207|76119569|FG000|Overall Study|Serious adverse event|110|||
42286951|NCT02690207|76119569|FG000|Overall Study|Non-serious Adverse Event|18|||
42286952|NCT02690207|76119569|FG000|Overall Study|Migrated/moved from study area|5|||
42286953|NCT02690207|76119569|FG000|Overall Study|Suspected HZ Episode|1|||
42286954|NCT02690207|76119569|FG000|Overall Study|Other reasons for withdrawal|23|||
42286955|NCT02689349|76119575|FG000|Overall Study|Not implanted|4|||
42286956|NCT02689349|76119576|FG001|Overall Study|Not implanted|0|||
42286957|NCT02689349|76119575|FG000|Overall Study|Withdrawal by Subject|9|||
42286958|NCT02689349|76119576|FG001|Overall Study|Withdrawal by Subject|0|||
42286959|NCT02679287|76119587|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
42286960|NCT02679287|76119588|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
42286961|NCT02679287|76119587|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
42286962|NCT02679287|76119588|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
42286963|NCT02679287|76119587|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
42286964|NCT02679287|76119588|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
42286965|NCT02679287|76119587|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
42286966|NCT02679287|76119588|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
42286967|NCT02679287|76119587|FG000|Period 2|Work/Scheduling Conflict|1|||
42286968|NCT02679287|76119588|FG001|Period 2|Work/Scheduling Conflict|0|||
42286969|NCT02679287|76119587|FG000|Period 2|Disliked Mobile System|2|||
42286970|NCT02679287|76119588|FG001|Period 2|Disliked Mobile System|0|||
42286971|NCT02679287|76119587|FG000|Period 3|Work/Scheduling Conflict|0|||
42286972|NCT02679287|76119588|FG001|Period 3|Work/Scheduling Conflict|1|||
42286973|NCT02544633|76119604|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
42286974|NCT02544633|76119605|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
42286975|NCT02544633|76119606|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
42286976|NCT02544633|76119607|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
42286977|NCT02544633|76119604|FG000|Treatment Period|Adverse Event|7|||
42286978|NCT02544633|76119605|FG001|Treatment Period|Adverse Event|4|||
42286979|NCT02544633|76119606|FG002|Treatment Period|Adverse Event|0|||
42286980|NCT02544633|76119607|FG003|Treatment Period|Adverse Event|5|||
42171889|NCT00040664|75978774|FG000|Overall Study|Adverse Event|12|||
42171890|NCT00040664|75978775|FG001|Overall Study|Adverse Event|3|||
42171891|NCT00040664|75978776|FG002|Overall Study|Adverse Event|2|||
42171892|NCT00040664|75978777|FG003|Overall Study|Adverse Event|7|||
42171893|NCT00040664|75978774|FG000|Overall Study|Lack of Efficacy|9|||
42171894|NCT00040664|75978775|FG001|Overall Study|Lack of Efficacy|2|||
42171895|NCT00040664|75978776|FG002|Overall Study|Lack of Efficacy|3|||
42171896|NCT00040664|75978777|FG003|Overall Study|Lack of Efficacy|4|||
42171897|NCT00040664|75978774|FG000|Overall Study|Insufficient CD4 response|1|||
42171898|NCT00040664|75978775|FG001|Overall Study|Insufficient CD4 response|0|||
42286981|NCT02544633|76119604|FG000|Treatment Period|Lack of Efficacy|17|||
42286982|NCT02544633|76119605|FG001|Treatment Period|Lack of Efficacy|11|||
42286983|NCT02544633|76119606|FG002|Treatment Period|Lack of Efficacy|5|||
42286984|NCT02544633|76119607|FG003|Treatment Period|Lack of Efficacy|5|||
42286985|NCT02544633|76119604|FG000|Treatment Period|Global Deterioration of Health|3|||
42286986|NCT02544633|76119605|FG001|Treatment Period|Global Deterioration of Health|3|||
42286987|NCT02544633|76119606|FG002|Treatment Period|Global Deterioration of Health|0|||
42286988|NCT02544633|76119607|FG003|Treatment Period|Global Deterioration of Health|1|||
42286989|NCT02544633|76119604|FG000|Treatment Period|Withdrawal by Subject|1|||
42286990|NCT02544633|76119605|FG001|Treatment Period|Withdrawal by Subject|0|||
42286991|NCT02544633|76119606|FG002|Treatment Period|Withdrawal by Subject|0|||
42286992|NCT02544633|76119607|FG003|Treatment Period|Withdrawal by Subject|0|||
42353750|NCT03496207|76194873|FG004|Base Study|Death|1|||
42353751|NCT03496207|76194869|FG000|Base Study|Withdrawal by Subject|0|||
42353752|NCT03496207|76194870|FG001|Base Study|Withdrawal by Subject|0|||
42353753|NCT03496207|76194871|FG002|Base Study|Withdrawal by Subject|1|||
42353754|NCT03496207|76194872|FG003|Base Study|Withdrawal by Subject|0|||
42353755|NCT03496207|76194873|FG004|Base Study|Withdrawal by Subject|1|||
42353756|NCT03496207|76194869|FG000|Extension Period|Adverse Event|0|||
42353757|NCT03496207|76194870|FG001|Extension Period|Adverse Event|0|||
42353758|NCT03496207|76194871|FG002|Extension Period|Adverse Event|0|||
42353759|NCT03496207|76194872|FG003|Extension Period|Adverse Event|1|||
42353760|NCT03496207|76194873|FG004|Extension Period|Adverse Event|1|||
42353761|NCT03496207|76194869|FG000|Extension Period|Death|1|||
42353762|NCT03496207|76194870|FG001|Extension Period|Death|0|||
42353763|NCT03496207|76194871|FG002|Extension Period|Death|0|||
42353764|NCT03496207|76194872|FG003|Extension Period|Death|1|||
42353765|NCT03496207|76194873|FG004|Extension Period|Death|2|||
42353766|NCT03496207|76194869|FG000|Extension Period|Withdrawal by Subject|1|||
42353767|NCT03496207|76194870|FG001|Extension Period|Withdrawal by Subject|0|||
42353768|NCT03496207|76194871|FG002|Extension Period|Withdrawal by Subject|0|||
42353769|NCT03496207|76194872|FG003|Extension Period|Withdrawal by Subject|1|||
42353770|NCT03496207|76194873|FG004|Extension Period|Withdrawal by Subject|1|||
42353771|NCT03496207|76194869|FG000|Extension Period|Elevated hemoglobin levels|0|||
42353772|NCT03496207|76194870|FG001|Extension Period|Elevated hemoglobin levels|0|||
42353773|NCT03496207|76194871|FG002|Extension Period|Elevated hemoglobin levels|0|||
42353774|NCT03496207|76194872|FG003|Extension Period|Elevated hemoglobin levels|0|||
42353775|NCT03496207|76194873|FG004|Extension Period|Elevated hemoglobin levels|1|||
42353776|NCT03444870|76194898|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
42353777|NCT03444870|76194899|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
42353778|NCT03444870|76194900|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
42353779|NCT03444870|76194901|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
42171899|NCT00040664|75978776|FG002|Overall Study|Insufficient CD4 response|1|||
42171900|NCT00040664|75978777|FG003|Overall Study|Insufficient CD4 response|0|||
42171901|NCT00040664|75978774|FG000|Overall Study|Lost to Follow-up|4|||
42171902|NCT00040664|75978775|FG001|Overall Study|Lost to Follow-up|2|||
42171903|NCT00040664|75978776|FG002|Overall Study|Lost to Follow-up|0|||
42171904|NCT00040664|75978777|FG003|Overall Study|Lost to Follow-up|2|||
42171905|NCT00040664|75978774|FG000|Overall Study|Protocol Violation|2|||
42171906|NCT00040664|75978775|FG001|Overall Study|Protocol Violation|1|||
42171907|NCT00040664|75978776|FG002|Overall Study|Protocol Violation|0|||
42171908|NCT00040664|75978777|FG003|Overall Study|Protocol Violation|1|||
42171909|NCT00040664|75978774|FG000|Overall Study|Withdrawal by Subject|7|||
42286993|NCT02544633|76119604|FG000|Treatment Period|Lost to Follow-up|0|||
42353780|NCT03444870|76194902|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
42353781|NCT03444870|76194903|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
42353782|NCT03444870|76194898|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
42286994|NCT02544633|76119605|FG001|Treatment Period|Lost to Follow-up|1|||
42286995|NCT02544633|76119606|FG002|Treatment Period|Lost to Follow-up|0|||
42286996|NCT02544633|76119607|FG003|Treatment Period|Lost to Follow-up|0|||
42286997|NCT02544633|76119604|FG000|Treatment Period|Death|0|||
42286998|NCT02544633|76119605|FG001|Treatment Period|Death|0|||
42286999|NCT02544633|76119606|FG002|Treatment Period|Death|1|||
42287000|NCT02544633|76119607|FG003|Treatment Period|Death|0|||
42287001|NCT02544633|76119604|FG000|Treatment Period|Non-compliance|0|||
42287002|NCT02544633|76119605|FG001|Treatment Period|Non-compliance|0|||
42287003|NCT02544633|76119606|FG002|Treatment Period|Non-compliance|1|||
42287004|NCT02544633|76119607|FG003|Treatment Period|Non-compliance|0|||
42287005|NCT02544633|76119604|FG000|Treatment Period|Clinical Disease Progression|0|||
42287006|NCT02544633|76119605|FG001|Treatment Period|Clinical Disease Progression|0|||
42287007|NCT02544633|76119606|FG002|Treatment Period|Clinical Disease Progression|0|||
42287008|NCT02544633|76119607|FG003|Treatment Period|Clinical Disease Progression|1|||
42287009|NCT02544633|76119604|FG000|Survival Follow-up Period|Death|12|||
42287010|NCT02544633|76119605|FG001|Survival Follow-up Period|Death|14|||
42287011|NCT02544633|76119606|FG002|Survival Follow-up Period|Death|3|||
42287012|NCT02544633|76119607|FG003|Survival Follow-up Period|Death|9|||
42287013|NCT02544633|76119604|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
42287014|NCT02544633|76119605|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
42287015|NCT02544633|76119606|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
42287016|NCT02544633|76119607|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
42287017|NCT02544633|76119604|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
42287018|NCT02544633|76119605|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
42287019|NCT02544633|76119606|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
42287020|NCT02544633|76119607|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
42287021|NCT02544633|76119604|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
42287022|NCT02544633|76119605|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
42287023|NCT02544633|76119606|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
42287024|NCT02544633|76119607|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
42287025|NCT02678351|76119629|FG000|Overall Study|Withdrawal by Subject|1|||
42287026|NCT02683187|76119633|FG000|Overall Study|Failed IV access|3|||
42287027|NCT02683187|76119633|FG000|Overall Study|Withdrawal by Subject|5|||
42287028|NCT02683109|76119643|FG000|Overall Study|Adverse Event|1|||
42287029|NCT02683109|76119644|FG001|Overall Study|Adverse Event|0|||
42287030|NCT02544321|76119653|FG000|Overall Study|Withdrawal by Subject|1|||
42287031|NCT02544321|76119654|FG001|Overall Study|Withdrawal by Subject|2|||
42287032|NCT02544321|76119653|FG000|Overall Study|Adverse Event|1|||
42287033|NCT02544321|76119654|FG001|Overall Study|Adverse Event|1|||
42287034|NCT02544321|76119653|FG000|Overall Study|Protocol Violation|0|||
42287035|NCT02544321|76119654|FG001|Overall Study|Protocol Violation|1|||
42287036|NCT02533401|76119669|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
42287037|NCT02533401|76119669|FG000|Overall Study|Death|5|||
42287038|NCT02533401|76119669|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
42287039|NCT02533401|76119669|FG000|Overall Study|Lost to Follow-up|1|||
42287040|NCT02533401|76119669|FG000|Overall Study|Violation of Selection Criteria|1|||
42287041|NCT02536833|76119677|FG000|Overall Study|Discontinued Before Treatment|0|||
42287042|NCT02536833|76119678|FG001|Overall Study|Discontinued Before Treatment|0|||
42287043|NCT02536833|76119679|FG002|Overall Study|Discontinued Before Treatment|1|||
42287044|NCT02536833|76119680|FG003|Overall Study|Discontinued Before Treatment|2|||
42287045|NCT02536833|76119677|FG000|Overall Study|Adverse Event|1|||
42287046|NCT02536833|76119678|FG001|Overall Study|Adverse Event|3|||
42287047|NCT02536833|76119679|FG002|Overall Study|Adverse Event|4|||
42287048|NCT02536833|76119680|FG003|Overall Study|Adverse Event|1|||
42287049|NCT02536833|76119677|FG000|Overall Study|Lost to Follow-up|2|||
42287050|NCT02536833|76119678|FG001|Overall Study|Lost to Follow-up|1|||
42287051|NCT02536833|76119679|FG002|Overall Study|Lost to Follow-up|2|||
42287052|NCT02536833|76119680|FG003|Overall Study|Lost to Follow-up|2|||
42287053|NCT02536833|76119677|FG000|Overall Study|Physician Decision|0|||
42287054|NCT02536833|76119678|FG001|Overall Study|Physician Decision|0|||
42287055|NCT02536833|76119679|FG002|Overall Study|Physician Decision|0|||
42287056|NCT02536833|76119680|FG003|Overall Study|Physician Decision|1|||
42287057|NCT02536833|76119677|FG000|Overall Study|Site Terminated by Sponsor|2|||
42287058|NCT02536833|76119678|FG001|Overall Study|Site Terminated by Sponsor|2|||
42287059|NCT02536833|76119679|FG002|Overall Study|Site Terminated by Sponsor|2|||
42287060|NCT02536833|76119680|FG003|Overall Study|Site Terminated by Sponsor|2|||
42287061|NCT02536833|76119677|FG000|Overall Study|Subject Non-Compliance|0|||
42287062|NCT02536833|76119678|FG001|Overall Study|Subject Non-Compliance|1|||
42287063|NCT02536833|76119679|FG002|Overall Study|Subject Non-Compliance|1|||
42287064|NCT02536833|76119680|FG003|Overall Study|Subject Non-Compliance|0|||
42287065|NCT02536833|76119677|FG000|Overall Study|Withdrawal by Subject|4|||
42287066|NCT02536833|76119678|FG001|Overall Study|Withdrawal by Subject|3|||
42287067|NCT02536833|76119679|FG002|Overall Study|Withdrawal by Subject|5|||
42287068|NCT02536833|76119680|FG003|Overall Study|Withdrawal by Subject|11|||
42287069|NCT02680847|76119694|FG000|Overall Study|Other|2|||
42287070|NCT02680847|76119695|FG001|Overall Study|Other|0|||
42287071|NCT02680847|76119696|FG002|Overall Study|Other|0|||
42287072|NCT02680847|76119694|FG000|Overall Study|No longer met eligibility criteria|2|||
42287073|NCT02680847|76119695|FG001|Overall Study|No longer met eligibility criteria|2|||
42287074|NCT02680847|76119696|FG002|Overall Study|No longer met eligibility criteria|0|||
42287075|NCT02680847|76119694|FG000|Overall Study|Unwilling to participate in study|1|||
42287076|NCT02680847|76119695|FG001|Overall Study|Unwilling to participate in study|1|||
42287077|NCT02680847|76119696|FG002|Overall Study|Unwilling to participate in study|0|||
42287078|NCT02680847|76119694|FG000|Overall Study|Lack of Efficacy|0|||
42287079|NCT02680847|76119695|FG001|Overall Study|Lack of Efficacy|0|||
42287080|NCT02680847|76119696|FG002|Overall Study|Lack of Efficacy|2|||
42287081|NCT02680847|76119694|FG000|Overall Study|Adverse Event|0|||
42287082|NCT02680847|76119695|FG001|Overall Study|Adverse Event|0|||
42287083|NCT02680847|76119696|FG002|Overall Study|Adverse Event|1|||
42287084|NCT02532855|76119706|FG000|Overall Study|Lost to Follow-up|4|||
42287085|NCT02532855|76119707|FG001|Overall Study|Lost to Follow-up|3|||
42287086|NCT02532855|76119706|FG000|Overall Study|Withdrawal by Subject|4|||
42287087|NCT02532855|76119707|FG001|Overall Study|Withdrawal by Subject|8|||
42287088|NCT02530125|76119713|FG000|Completed Treatment|Early termination of study|1|||
42287089|NCT02530125|76119713|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
42287090|NCT01661205|76119717|FG000|Overall Study|Physician Decision|2|||
42287091|NCT02055820|76119731|FG000|Phase I: Dose-Finding|Death|1|||
42287092|NCT02055820|76119732|FG001|Phase I: Dose-Finding|Death|0|||
42287093|NCT02055820|76119733|FG002|Phase I: Dose-Finding|Death|1|||
42287094|NCT02055820|76119734|FG003|Phase I: Dose-Finding|Death|2|||
42287095|NCT02055820|76119735|FG004|Phase I: Dose-Finding|Death|0|||
42287096|NCT02055820|76119736|FG005|Phase I: Dose-Finding|Death|1|||
42287097|NCT02055820|76119737|FG006|Phase I: Dose-Finding|Death|1|||
42287098|NCT02055820|76119738|FG007|Phase I: Dose-Finding|Death|0|||
42287099|NCT02055820|76119739|FG008|Phase I: Dose-Finding|Death|0|||
42287100|NCT02055820|76119740|FG009|Phase I: Dose-Finding|Death|0|||
42287101|NCT02055820|76119731|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
42287102|NCT02055820|76119732|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
42287103|NCT02055820|76119733|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
42287104|NCT02055820|76119734|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
42287105|NCT02055820|76119735|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
42287106|NCT02055820|76119736|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
42287107|NCT02055820|76119737|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
42287108|NCT02055820|76119738|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
42287109|NCT02055820|76119739|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
42287110|NCT02055820|76119740|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
42287111|NCT02055820|76119731|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
42287112|NCT02055820|76119732|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
42287113|NCT02055820|76119733|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
42287114|NCT02055820|76119734|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
42287115|NCT02055820|76119735|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
42287116|NCT02055820|76119736|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
42287117|NCT02055820|76119737|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
42287118|NCT02055820|76119738|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
42287119|NCT02055820|76119739|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
42287120|NCT02055820|76119740|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
42287121|NCT02055820|76119731|FG000|Phase II: Expansion|Death|0|||
42287122|NCT02055820|76119732|FG001|Phase II: Expansion|Death|0|||
42287123|NCT02055820|76119733|FG002|Phase II: Expansion|Death|0|||
42287124|NCT02055820|76119734|FG003|Phase II: Expansion|Death|0|||
42287125|NCT02055820|76119735|FG004|Phase II: Expansion|Death|33|||
42287126|NCT02055820|76119736|FG005|Phase II: Expansion|Death|0|||
42287127|NCT02055820|76119737|FG006|Phase II: Expansion|Death|0|||
42287128|NCT02055820|76119738|FG007|Phase II: Expansion|Death|0|||
42287129|NCT02055820|76119739|FG008|Phase II: Expansion|Death|0|||
42287130|NCT02055820|76119740|FG009|Phase II: Expansion|Death|0|||
42287131|NCT02055820|76119731|FG000|Phase II: Expansion|Lost to Follow-up|0|||
42287132|NCT02055820|76119732|FG001|Phase II: Expansion|Lost to Follow-up|0|||
42040817|NCT01386385|75848787|FG006|Phase II Concurrent CRT|Adverse Event|3|||
42040818|NCT01386385|75848788|FG007|Phase II Concurrent CRT|Adverse Event|3|||
42287133|NCT02055820|76119733|FG002|Phase II: Expansion|Lost to Follow-up|0|||
42287134|NCT02055820|76119734|FG003|Phase II: Expansion|Lost to Follow-up|0|||
42287135|NCT02055820|76119735|FG004|Phase II: Expansion|Lost to Follow-up|4|||
42287136|NCT02055820|76119736|FG005|Phase II: Expansion|Lost to Follow-up|0|||
42287137|NCT02055820|76119737|FG006|Phase II: Expansion|Lost to Follow-up|0|||
42287138|NCT02055820|76119738|FG007|Phase II: Expansion|Lost to Follow-up|0|||
42287139|NCT02055820|76119739|FG008|Phase II: Expansion|Lost to Follow-up|0|||
42287140|NCT02055820|76119740|FG009|Phase II: Expansion|Lost to Follow-up|0|||
42287141|NCT02055820|76119731|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
42287142|NCT02055820|76119732|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
42287143|NCT02055820|76119733|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
42287144|NCT02055820|76119734|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
42287145|NCT02055820|76119735|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
42287146|NCT02055820|76119736|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
42287147|NCT02055820|76119737|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
42287148|NCT02055820|76119738|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
42287149|NCT02055820|76119739|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
42287150|NCT02055820|76119740|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
42287151|NCT02055352|76119784|FG000|Overall Study|Adverse Event|0|||
42287152|NCT02055352|76119785|FG001|Overall Study|Adverse Event|1|||
42287153|NCT02055352|76119784|FG000|Overall Study|Non-eligible|0|||
42287154|NCT02055352|76119785|FG001|Overall Study|Non-eligible|1|||
42287155|NCT02055352|76119784|FG000|Overall Study|Poor compliance|1|||
42287156|NCT02055352|76119785|FG001|Overall Study|Poor compliance|1|||
42287157|NCT02055352|76119784|FG000|Overall Study|Death|1|||
42287158|NCT02055352|76119785|FG001|Overall Study|Death|2|||
42287159|NCT02055352|76119784|FG000|Overall Study|Patient decision|1|||
42287160|NCT02055352|76119785|FG001|Overall Study|Patient decision|1|||
42287161|NCT02055352|76119784|FG000|Overall Study|Use of prohibited treatment|0|||
42287162|NCT02055352|76119785|FG001|Overall Study|Use of prohibited treatment|3|||
42287163|NCT02055352|76119784|FG000|Overall Study|AE, study drug would be detrimental|1|||
42287164|NCT02055352|76119785|FG001|Overall Study|AE, study drug would be detrimental|3|||
42287165|NCT02055352|76119784|FG000|Overall Study|Withdrawal of informed consent|1|||
42287166|NCT02055352|76119785|FG001|Overall Study|Withdrawal of informed consent|0|||
42287167|NCT02055352|76119784|FG000|Overall Study|Reason unknown|1|||
42287168|NCT02055352|76119785|FG001|Overall Study|Reason unknown|5|||
42287169|NCT02034916|76119793|FG000|Overall Study|Death|39|||
42287170|NCT02034916|76119794|FG001|Overall Study|Death|28|||
42287171|NCT02034916|76119793|FG000|Overall Study|Withdrawal by Subject|2|||
42287172|NCT02034916|76119794|FG001|Overall Study|Withdrawal by Subject|1|||
42287173|NCT02034916|76119793|FG000|Overall Study|Lost to Follow-up|4|||
42287174|NCT02034916|76119794|FG001|Overall Study|Lost to Follow-up|1|||
42287175|NCT02034916|76119793|FG000|Overall Study|Study terminated by sponsor|4|||
42287176|NCT02034916|76119794|FG001|Overall Study|Study terminated by sponsor|5|||
42287177|NCT01374425|76119803|FG000|Overall Study|Radiographic Disease Progression|86|||
42287178|NCT01374425|76119804|FG001|Overall Study|Radiographic Disease Progression|81|||
42287179|NCT01374425|76119803|FG000|Overall Study|Clinical Disease Progression|9|||
42287180|NCT01374425|76119804|FG001|Overall Study|Clinical Disease Progression|6|||
42287181|NCT01374425|76119803|FG000|Overall Study|Adverse Event|29|||
42287182|NCT01374425|76119804|FG001|Overall Study|Adverse Event|18|||
42287183|NCT01374425|76119803|FG000|Overall Study|Death (Progression of Disease)|1|||
42287184|NCT01374425|76119804|FG001|Overall Study|Death (Progression of Disease)|0|||
42287185|NCT01374425|76119803|FG000|Overall Study|Death (Adverse Event)|2|||
42287186|NCT01374425|76119804|FG001|Overall Study|Death (Adverse Event)|4|||
42287187|NCT01374425|76119803|FG000|Overall Study|Withdrawal by Subject|6|||
42287188|NCT01374425|76119804|FG001|Overall Study|Withdrawal by Subject|7|||
42287189|NCT01374425|76119803|FG000|Overall Study|Refused Treatment|10|||
42287190|NCT01374425|76119804|FG001|Overall Study|Refused Treatment|24|||
42287191|NCT01374425|76119803|FG000|Overall Study|Protocol Violation|2|||
42287192|NCT01374425|76119804|FG001|Overall Study|Protocol Violation|3|||
42353783|NCT03444870|76194899|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
42353784|NCT03444870|76194900|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
42353785|NCT03444870|76194901|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
42287193|NCT01374425|76119803|FG000|Overall Study|Sponsor Decision|0|||
42287194|NCT01374425|76119804|FG001|Overall Study|Sponsor Decision|1|||
42287195|NCT01374425|76119803|FG000|Overall Study|Lost to Follow-up|2|||
42287196|NCT01374425|76119804|FG001|Overall Study|Lost to Follow-up|1|||
42287197|NCT01374425|76119803|FG000|Overall Study|Other|41|||
42353786|NCT03444870|76194902|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
42353787|NCT03444870|76194903|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
42353788|NCT03444870|76194898|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
42353789|NCT03444870|76194899|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
42353790|NCT03444870|76194900|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
42353791|NCT03444870|76194901|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
42015150|NCT01160289|75822263|FG004|Post-Randomization Period|Physician Decision|0|||
42287198|NCT01374425|76119804|FG001|Overall Study|Other|43|||
42287199|NCT02085460|76119834|FG000|Overall Study|Adverse Event|2|||
42287200|NCT02085460|76119835|FG001|Overall Study|Adverse Event|2|||
42287201|NCT02085460|76119836|FG002|Overall Study|Adverse Event|1|||
42287202|NCT02085460|76119834|FG000|Overall Study|Physician Decision|1|||
42287203|NCT02085460|76119835|FG001|Overall Study|Physician Decision|1|||
42287204|NCT02085460|76119836|FG002|Overall Study|Physician Decision|2|||
42287205|NCT02085460|76119834|FG000|Overall Study|Withdrawal by Subject|11|||
42287206|NCT02085460|76119835|FG001|Overall Study|Withdrawal by Subject|5|||
42287207|NCT02085460|76119836|FG002|Overall Study|Withdrawal by Subject|7|||
42287208|NCT02084134|76119846|FG000|Overall Study|Protocol Violation|4|||
42353792|NCT03444870|76194902|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
42287209|NCT02084134|76119847|FG001|Overall Study|Protocol Violation|2|||
42287210|NCT02084134|76119846|FG000|Overall Study|Death|0|||
42287211|NCT02084134|76119847|FG001|Overall Study|Death|1|||
42287212|NCT02034058|76119853|FG000|Overall Study|Death|3|||
42287213|NCT01374269|76119859|FG000|Overall Study|Withdrawal by Subject|4|||
42287214|NCT01374269|76119860|FG001|Overall Study|Withdrawal by Subject|0|||
42287215|NCT01374269|76119859|FG000|Overall Study|Lost to Follow-up|1|||
42353793|NCT03444870|76194903|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
42353794|NCT03444870|76194898|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
42353795|NCT03444870|76194899|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
42353796|NCT03444870|76194900|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
42353797|NCT03444870|76194901|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
42353798|NCT03444870|76194902|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
42353799|NCT03444870|76194903|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
42353800|NCT03444870|76194898|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
42353801|NCT03444870|76194899|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
42353802|NCT03444870|76194900|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
42353803|NCT03444870|76194901|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
42353804|NCT03444870|76194902|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
42353805|NCT03444870|76194903|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
42353806|NCT03444870|76194898|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
42353807|NCT03444870|76194899|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
42353808|NCT03444870|76194900|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
42353809|NCT03444870|76194901|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
42353810|NCT03444870|76194902|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
42353811|NCT03444870|76194903|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
42353812|NCT03444870|76194898|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
42353813|NCT03444870|76194899|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
42353814|NCT03444870|76194900|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
42353815|NCT03444870|76194901|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
42353816|NCT03444870|76194902|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
42353817|NCT03444870|76194903|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
42171910|NCT00040664|75978775|FG001|Overall Study|Withdrawal by Subject|0|||
42287216|NCT01374269|76119860|FG001|Overall Study|Lost to Follow-up|3|||
42287217|NCT01374269|76119859|FG000|Overall Study|closed research|1|||
42287218|NCT01374269|76119860|FG001|Overall Study|closed research|2|||
42287219|NCT02679755|76119868|FG000|Overall Study|Death|0|||
42287220|NCT02679755|76119869|FG001|Overall Study|Death|3|||
42287221|NCT02679755|76119868|FG000|Overall Study|Global deterioration of health status|1|||
42287222|NCT02679755|76119869|FG001|Overall Study|Global deterioration of health status|8|||
42287223|NCT02679755|76119868|FG000|Overall Study|Lost to Follow-up|1|||
42287224|NCT02679755|76119869|FG001|Overall Study|Lost to Follow-up|0|||
42287225|NCT02679755|76119868|FG000|Overall Study|Objective progression or relapse|24|||
42287226|NCT02679755|76119869|FG001|Overall Study|Objective progression or relapse|83|||
42287227|NCT02679755|76119868|FG000|Overall Study|Not defined|0|||
42287228|NCT02679755|76119869|FG001|Overall Study|Not defined|2|||
42287229|NCT02679755|76119868|FG000|Overall Study|Withdrawal by participant|6|||
42287230|NCT02679755|76119869|FG001|Overall Study|Withdrawal by participant|3|||
42287231|NCT02679755|76119868|FG000|Overall Study|Adverse Event|1|||
42287232|NCT02679755|76119869|FG001|Overall Study|Adverse Event|4|||
42287233|NCT02679755|76119868|FG000|Overall Study|Adverse events not related to study drug|1|||
42287234|NCT02679755|76119869|FG001|Overall Study|Adverse events not related to study drug|2|||
42287235|NCT02675075|76119880|FG000|Overall Study|Lost to Follow-up|3|||
42353818|NCT03444870|76194898|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
42353819|NCT03444870|76194899|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
42353820|NCT03444870|76194900|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
42353821|NCT03444870|76194901|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
42353822|NCT03444870|76194902|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
42353823|NCT03444870|76194903|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
42015151|NCT01160289|75822264|FG005|Post-Randomization Period|Physician Decision|0|||
42015152|NCT01160289|75822259|FG000|Post-Randomization Period|Protocol Violation|0|||
42015153|NCT01160289|75822260|FG001|Post-Randomization Period|Protocol Violation|4|||
42015154|NCT01160289|75822261|FG002|Post-Randomization Period|Protocol Violation|2|||
42353824|NCT03444870|76194898|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
42353825|NCT03444870|76194899|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
42171911|NCT00040664|75978776|FG002|Overall Study|Withdrawal by Subject|3|||
42287236|NCT02675075|76119881|FG001|Overall Study|Lost to Follow-up|0|||
42287237|NCT02673515|76119891|FG000|Overall Study|Lack of motivation|2|||
42287238|NCT02673515|76119892|FG001|Overall Study|Lack of motivation|1|||
42287239|NCT02667275|76119900|FG000|Overall Study|Protocol Violation|11|||
42287240|NCT02667275|76119901|FG001|Overall Study|Protocol Violation|7|||
42287241|NCT02667275|76119900|FG000|Overall Study|Lost to Follow-up|0|||
42287242|NCT02667275|76119901|FG001|Overall Study|Lost to Follow-up|2|||
42287243|NCT02667275|76119900|FG000|Overall Study|Withdrawal by Subject|0|||
42287244|NCT02667275|76119901|FG001|Overall Study|Withdrawal by Subject|5|||
42287245|NCT02667275|76119900|FG000|Overall Study|Discontinued early without completing|0|||
42287246|NCT02667275|76119901|FG001|Overall Study|Discontinued early without completing|1|||
42287247|NCT02672423|76119910|FG000|Period 1|Adverse Event|0|||
42287248|NCT02672423|76119911|FG001|Period 1|Adverse Event|0|||
42287249|NCT02672423|76119912|FG002|Period 1|Adverse Event|0|||
42287250|NCT02672423|76119913|FG003|Period 1|Adverse Event|0|||
42287251|NCT02672423|76119914|FG004|Period 1|Adverse Event|1|||
42287252|NCT02672423|76119915|FG005|Period 1|Adverse Event|0|||
42287253|NCT02672423|76119916|FG006|Period 1|Adverse Event|0|||
42287254|NCT02672423|76119917|FG007|Period 1|Adverse Event|0|||
42287255|NCT02672423|76119918|FG008|Period 1|Adverse Event|0|||
42287256|NCT02672423|76119919|FG009|Period 1|Adverse Event|0|||
42287257|NCT02672423|76119910|FG000|Period 2|Withdrawal by Subject|0|||
42287258|NCT02672423|76119911|FG001|Period 2|Withdrawal by Subject|0|||
42287259|NCT02672423|76119912|FG002|Period 2|Withdrawal by Subject|1|||
42287260|NCT02672423|76119913|FG003|Period 2|Withdrawal by Subject|0|||
42287261|NCT02672423|76119914|FG004|Period 2|Withdrawal by Subject|0|||
42353826|NCT03444870|76194900|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
42353827|NCT03444870|76194901|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
42353828|NCT03444870|76194902|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
42353829|NCT03444870|76194903|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
42353830|NCT03444870|76194898|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
42353831|NCT03444870|76194899|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
42353832|NCT03444870|76194900|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
42353833|NCT03444870|76194901|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
42353834|NCT03444870|76194902|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
42353835|NCT03444870|76194903|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
42353836|NCT03444870|76194898|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
42353837|NCT03444870|76194899|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
42353838|NCT03444870|76194900|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
42353839|NCT03444870|76194901|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
42015155|NCT01160289|75822262|FG003|Post-Randomization Period|Protocol Violation|0|||
42015156|NCT01160289|75822263|FG004|Post-Randomization Period|Protocol Violation|1|||
42353840|NCT03444870|76194902|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
42353841|NCT03444870|76194903|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
42353842|NCT03444870|76194898|FG000|Open-Label Extension (OLE) Period|Death|0|||
42353843|NCT03444870|76194899|FG001|Open-Label Extension (OLE) Period|Death|0|||
42015157|NCT01160289|75822264|FG005|Post-Randomization Period|Protocol Violation|3|||
42015158|NCT01160289|75822259|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
42287262|NCT02672423|76119915|FG005|Period 2|Withdrawal by Subject|0|||
42287263|NCT02672423|76119916|FG006|Period 2|Withdrawal by Subject|0|||
42287264|NCT02672423|76119917|FG007|Period 2|Withdrawal by Subject|0|||
42287265|NCT02672423|76119918|FG008|Period 2|Withdrawal by Subject|0|||
42287266|NCT02672423|76119919|FG009|Period 2|Withdrawal by Subject|0|||
42287267|NCT02672423|76119910|FG000|Period 3|Withdrawal by Subject|0|||
42287268|NCT02672423|76119911|FG001|Period 3|Withdrawal by Subject|0|||
42287269|NCT02672423|76119912|FG002|Period 3|Withdrawal by Subject|0|||
42287270|NCT02672423|76119913|FG003|Period 3|Withdrawal by Subject|0|||
42287271|NCT02672423|76119914|FG004|Period 3|Withdrawal by Subject|0|||
42287272|NCT02672423|76119915|FG005|Period 3|Withdrawal by Subject|0|||
42353844|NCT03444870|76194900|FG002|Open-Label Extension (OLE) Period|Death|0|||
42353845|NCT03444870|76194901|FG003|Open-Label Extension (OLE) Period|Death|0|||
42171912|NCT00040664|75978777|FG003|Overall Study|Withdrawal by Subject|4|||
42171913|NCT00040664|75978774|FG000|Overall Study|Pregnancy|3|||
42171914|NCT00040664|75978775|FG001|Overall Study|Pregnancy|0|||
42171915|NCT00040664|75978776|FG002|Overall Study|Pregnancy|0|||
42171916|NCT00040664|75978777|FG003|Overall Study|Pregnancy|3|||
42171917|NCT00040664|75978774|FG000|Overall Study|Medication adherence/compliance problems|8|||
42171918|NCT00040664|75978775|FG001|Overall Study|Medication adherence/compliance problems|2|||
42171919|NCT00040664|75978776|FG002|Overall Study|Medication adherence/compliance problems|1|||
42171920|NCT00040664|75978777|FG003|Overall Study|Medication adherence/compliance problems|5|||
42171921|NCT00040664|75978774|FG000|Overall Study|Poor taste|2|||
42171922|NCT00040664|75978775|FG001|Overall Study|Poor taste|0|||
42171923|NCT00040664|75978776|FG002|Overall Study|Poor taste|2|||
42171924|NCT00040664|75978777|FG003|Overall Study|Poor taste|0|||
42171925|NCT00040664|75978774|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
42171926|NCT00040664|75978775|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
42171927|NCT00040664|75978776|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
42171928|NCT00040664|75978777|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
42171929|NCT00040664|75978774|FG000|Overall Study|Change of formulation|2|||
42171930|NCT00040664|75978775|FG001|Overall Study|Change of formulation|2|||
42171931|NCT00040664|75978776|FG002|Overall Study|Change of formulation|0|||
42171932|NCT00040664|75978777|FG003|Overall Study|Change of formulation|0|||
42171933|NCT00040664|75978774|FG000|Overall Study|Non-viability of oral suspension|1|||
42171934|NCT00040664|75978775|FG001|Overall Study|Non-viability of oral suspension|0|||
42171935|NCT00040664|75978776|FG002|Overall Study|Non-viability of oral suspension|1|||
42171936|NCT00040664|75978777|FG003|Overall Study|Non-viability of oral suspension|0|||
42171937|NCT02952586|75978797|FG000|Lead-In Phase (7 Days)|Death|0|||
42171938|NCT02952586|75978798|FG001|Lead-In Phase (7 Days)|Death|1|||
42171939|NCT02952586|75978797|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
42171940|NCT02952586|75978798|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
42171941|NCT02952586|75978797|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
42287273|NCT02672423|76119916|FG006|Period 3|Withdrawal by Subject|0|||
42287274|NCT02672423|76119917|FG007|Period 3|Withdrawal by Subject|1|||
42287275|NCT02672423|76119918|FG008|Period 3|Withdrawal by Subject|0|||
42015159|NCT01160289|75822260|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
42015160|NCT01160289|75822261|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
42015161|NCT01160289|75822262|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
42015162|NCT01160289|75822263|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
42015163|NCT01160289|75822264|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
42287276|NCT02672423|76119919|FG009|Period 3|Withdrawal by Subject|0|||
42015164|NCT01160289|75822259|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
42287277|NCT02672423|76119910|FG000|Period 3|Physician Decision|0|||
42287278|NCT02672423|76119911|FG001|Period 3|Physician Decision|0|||
42287279|NCT02672423|76119912|FG002|Period 3|Physician Decision|0|||
42287280|NCT02672423|76119913|FG003|Period 3|Physician Decision|0|||
42287281|NCT02672423|76119914|FG004|Period 3|Physician Decision|0|||
42287282|NCT02672423|76119915|FG005|Period 3|Physician Decision|1|||
42287283|NCT02672423|76119916|FG006|Period 3|Physician Decision|0|||
42287284|NCT02672423|76119917|FG007|Period 3|Physician Decision|0|||
42287285|NCT02672423|76119918|FG008|Period 3|Physician Decision|0|||
42287286|NCT02672423|76119919|FG009|Period 3|Physician Decision|0|||
42287287|NCT02670551|76119943|FG000|Overall Study|Adverse Event|4|||
42287288|NCT02670551|76119944|FG001|Overall Study|Adverse Event|7|||
42287289|NCT02670551|76119945|FG002|Overall Study|Adverse Event|9|||
42287290|NCT02670551|76119943|FG000|Overall Study|Lack of Efficacy|2|||
42287291|NCT02670551|76119944|FG001|Overall Study|Lack of Efficacy|0|||
42015165|NCT01160289|75822260|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
42015166|NCT01160289|75822261|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
42015167|NCT01160289|75822262|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
42015168|NCT01160289|75822263|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
42015169|NCT01160289|75822264|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
42015170|NCT01160289|75822259|FG000|Post-Randomization Period|Sponsor Decision|0|||
42015171|NCT01160289|75822260|FG001|Post-Randomization Period|Sponsor Decision|1|||
42015172|NCT01160289|75822261|FG002|Post-Randomization Period|Sponsor Decision|0|||
42015173|NCT01160289|75822262|FG003|Post-Randomization Period|Sponsor Decision|0|||
42015174|NCT01160289|75822263|FG004|Post-Randomization Period|Sponsor Decision|0|||
42015175|NCT01160289|75822264|FG005|Post-Randomization Period|Sponsor Decision|0|||
42015176|NCT01159665|75822283|FG000|Overall Study|Withdrawal by Subject|0|||
42015177|NCT01159665|75822284|FG001|Overall Study|Withdrawal by Subject|1|||
42015178|NCT01159665|75822285|FG002|Overall Study|Withdrawal by Subject|0|||
42015179|NCT01159665|75822286|FG003|Overall Study|Withdrawal by Subject|0|||
42015180|NCT01159665|75822287|FG004|Overall Study|Withdrawal by Subject|0|||
42015181|NCT01159665|75822288|FG005|Overall Study|Withdrawal by Subject|0|||
42015182|NCT01159431|75822304|FG000|Overall Study|Adverse Event|1|||
42015183|NCT01159431|75822305|FG001|Overall Study|Adverse Event|2|||
42353846|NCT03444870|76194902|FG004|Open-Label Extension (OLE) Period|Death|1|||
42353847|NCT03444870|76194903|FG005|Open-Label Extension (OLE) Period|Death|0|||
42353848|NCT03112590|76194931|FG000|Overall Study|Adverse Event|0|||
42353849|NCT03112590|76194932|FG001|Overall Study|Adverse Event|1|||
42353850|NCT03112590|76194933|FG002|Overall Study|Adverse Event|0|||
42353851|NCT03060629|76194943|FG000|Overall Study|Death|4|||
42015184|NCT01159431|75822304|FG000|Overall Study|non-compliance|1|||
42015185|NCT01159431|75822305|FG001|Overall Study|non-compliance|1|||
42015186|NCT01159431|75822304|FG000|Overall Study|Lack of Efficacy|0|||
42171942|NCT02952586|75978798|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
42353852|NCT03060629|76194944|FG001|Overall Study|Death|5|||
42353853|NCT03060629|76194943|FG000|Overall Study|Withdrawal by Subject|50|||
42353854|NCT03060629|76194944|FG001|Overall Study|Withdrawal by Subject|35|||
42353855|NCT03060629|76194943|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
42015187|NCT01159431|75822305|FG001|Overall Study|Lack of Efficacy|3|||
42015188|NCT01158261|75822318|FG000|Overall Study|Lost to Follow-up|9|||
42015189|NCT01158261|75822318|FG000|Overall Study|Death|7|||
42171943|NCT02952586|75978797|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
42171944|NCT02952586|75978798|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
42015190|NCT01158261|75822318|FG000|Overall Study|Withdrawal by Subject|1|||
42015191|NCT01157169|75822324|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
42015192|NCT01157169|75822325|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
42287292|NCT02670551|76119945|FG002|Overall Study|Lack of Efficacy|3|||
42287293|NCT02670551|76119943|FG000|Overall Study|Withdrawal of Consent|6|||
42287294|NCT02670551|76119944|FG001|Overall Study|Withdrawal of Consent|3|||
42287295|NCT02670551|76119945|FG002|Overall Study|Withdrawal of Consent|8|||
42287296|NCT02670551|76119943|FG000|Overall Study|Lost to Follow-up|5|||
42287297|NCT02670551|76119944|FG001|Overall Study|Lost to Follow-up|7|||
42287298|NCT02670551|76119945|FG002|Overall Study|Lost to Follow-up|6|||
42287299|NCT02670551|76119943|FG000|Overall Study|Protocol Violation|1|||
42287300|NCT02670551|76119944|FG001|Overall Study|Protocol Violation|0|||
42287301|NCT02670551|76119945|FG002|Overall Study|Protocol Violation|0|||
42287302|NCT02670551|76119943|FG000|Overall Study|Noncompliance with study drug|3|||
42287303|NCT02670551|76119944|FG001|Overall Study|Noncompliance with study drug|3|||
42287304|NCT02670551|76119945|FG002|Overall Study|Noncompliance with study drug|2|||
42287305|NCT02670551|76119943|FG000|Overall Study|Other Miscellaneous Reasons|2|||
42287306|NCT02670551|76119944|FG001|Overall Study|Other Miscellaneous Reasons|3|||
42287307|NCT02670551|76119945|FG002|Overall Study|Other Miscellaneous Reasons|3|||
42287308|NCT02670551|76119943|FG000|Overall Study|Did Not Receive Treatment|5|||
42287309|NCT02670551|76119944|FG001|Overall Study|Did Not Receive Treatment|3|||
42287310|NCT02670551|76119945|FG002|Overall Study|Did Not Receive Treatment|0|||
42287311|NCT02670473|76119953|FG000|Overall Study|Withdrawal by Subject|1|||
42287312|NCT02667119|76119968|FG000|Overall Study|Lost to Follow-up|3|||
42287313|NCT02667119|76119969|FG001|Overall Study|Lost to Follow-up|0|||
42287314|NCT02670083|76119977|FG000|Overall Study|Adverse Event|16|||
42287315|NCT02670083|76119978|FG001|Overall Study|Adverse Event|13|||
42287316|NCT02670083|76119977|FG000|Overall Study|Death|4|||
42287317|NCT02670083|76119978|FG001|Overall Study|Death|6|||
42287318|NCT02670083|76119977|FG000|Overall Study|Lost to Follow-up|2|||
42015193|NCT01157169|75822324|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
42287319|NCT02670083|76119978|FG001|Overall Study|Lost to Follow-up|2|||
42287320|NCT02670083|76119977|FG000|Overall Study|Multiple Reasons|9|||
42287321|NCT02670083|76119978|FG001|Overall Study|Multiple Reasons|9|||
42287322|NCT02670083|76119977|FG000|Overall Study|Physician Decision|0|||
42353856|NCT03060629|76194944|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
42353857|NCT03060629|76194943|FG000|Overall Study|Participant Relocate|15|||
42353858|NCT03060629|76194944|FG001|Overall Study|Participant Relocate|15|||
42353859|NCT03060629|76194943|FG000|Overall Study|Unable to Contact Participant|34|||
42353860|NCT03060629|76194944|FG001|Overall Study|Unable to Contact Participant|23|||
42353861|NCT03060629|76194943|FG000|Overall Study|Investigator Decision|7|||
42353862|NCT03060629|76194944|FG001|Overall Study|Investigator Decision|7|||
42353863|NCT03060629|76194943|FG000|Overall Study|Study Terminated by Sponsor|1100|||
42353864|NCT03060629|76194944|FG001|Overall Study|Study Terminated by Sponsor|1123|||
42353865|NCT03060629|76194943|FG000|Overall Study|Other|4|||
42353866|NCT03060629|76194944|FG001|Overall Study|Other|4|||
42353867|NCT03021486|76194953|FG000|Overall Study|Withdrawal by Subject|1|||
42353868|NCT03021486|76194954|FG001|Overall Study|Withdrawal by Subject|1|||
42353869|NCT03021486|76194955|FG002|Overall Study|Withdrawal by Subject|3|||
42353870|NCT03021486|76194953|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
42353871|NCT03021486|76194954|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
42353872|NCT03021486|76194955|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
42353873|NCT02999789|76194967|FG000|Overall Study|Withdrawal by Subject|0|||
42353874|NCT02999789|76194968|FG001|Overall Study|Withdrawal by Subject|1|||
42353875|NCT02999789|76194967|FG000|Overall Study|Became ineligible|1|||
42353876|NCT02999789|76194968|FG001|Overall Study|Became ineligible|2|||
42353877|NCT02949128|76194975|FG000|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2|||
42353878|NCT02949128|76194975|FG000|Initial Evaluation Period|Adverse Event|3|||
42353879|NCT02949128|76194975|FG000|Initial Evaluation Period|Death|2|||
42353880|NCT02949128|76194975|FG000|Initial Evaluation Period|Physician Decision|1|||
42353881|NCT02949128|76194975|FG000|Initial Evaluation Period|Protocol Violation|1|||
42353882|NCT02949128|76194975|FG000|Extension Period|Withdrawal by Subject|5|||
42353883|NCT02949128|76194975|FG000|Extension Period|Protocol Violation|1|||
42353884|NCT02949128|76194975|FG000|Extension Period|Physician Decision|2|||
42353885|NCT02949128|76194975|FG000|Extension Period|Ongoing in Extension Period as of 07/02/2019|41|||
42353886|NCT02923115|76194994|FG000|Overall Study|Lost to Follow-up|0|||
42353887|NCT02923115|76194995|FG001|Overall Study|Lost to Follow-up|0|||
42353888|NCT02923115|76194996|FG002|Overall Study|Lost to Follow-up|0|||
42353889|NCT02923115|76194997|FG003|Overall Study|Lost to Follow-up|1|||
42353890|NCT02923115|76194998|FG004|Overall Study|Lost to Follow-up|0|||
42353891|NCT02923115|76194999|FG005|Overall Study|Lost to Follow-up|0|||
42353892|NCT02923115|76194994|FG000|Overall Study|Withdrawal by Subject|0|||
42353893|NCT02923115|76194995|FG001|Overall Study|Withdrawal by Subject|1|||
42353894|NCT02923115|76194996|FG002|Overall Study|Withdrawal by Subject|0|||
42353895|NCT02923115|76194997|FG003|Overall Study|Withdrawal by Subject|0|||
42353896|NCT02923115|76194998|FG004|Overall Study|Withdrawal by Subject|0|||
42353897|NCT02923115|76194999|FG005|Overall Study|Withdrawal by Subject|0|||
42353898|NCT02923115|76194994|FG000|Overall Study|Randomized, but not dosed|0|||
42287323|NCT02670083|76119978|FG001|Overall Study|Physician Decision|2|||
42287324|NCT02670083|76119977|FG000|Overall Study|Study Terminated By Sponsor|257|||
42287325|NCT02670083|76119978|FG001|Overall Study|Study Terminated By Sponsor|254|||
42287326|NCT02670083|76119977|FG000|Overall Study|Symptomatic Deterioration|0|||
42287327|NCT02670083|76119978|FG001|Overall Study|Symptomatic Deterioration|2|||
42287328|NCT02670083|76119977|FG000|Overall Study|Withdrawal by Subject|32|||
42287329|NCT02670083|76119978|FG001|Overall Study|Withdrawal by Subject|31|||
42287330|NCT02670083|76119977|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42287331|NCT02670083|76119978|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42353899|NCT02923115|76194995|FG001|Overall Study|Randomized, but not dosed|0|||
42353900|NCT02923115|76194996|FG002|Overall Study|Randomized, but not dosed|3|||
42353901|NCT02923115|76194997|FG003|Overall Study|Randomized, but not dosed|1|||
42353902|NCT02923115|76194998|FG004|Overall Study|Randomized, but not dosed|5|||
42353903|NCT02923115|76194999|FG005|Overall Study|Randomized, but not dosed|0|||
42353904|NCT02910583|76195015|FG000|Overall Study|Withdrawal by Subject|6|||
42353905|NCT02910583|76195016|FG001|Overall Study|Withdrawal by Subject|7|||
42353906|NCT02910583|76195015|FG000|Overall Study|Other, Not Specified|1|||
42353907|NCT02910583|76195016|FG001|Overall Study|Other, Not Specified|0|||
42353908|NCT02487394|76195061|FG000|Phase 1|Withdrawal by Subject|0|||
42287332|NCT02669849|76119988|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
42287333|NCT02669849|76119989|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
42287334|NCT02669849|76119990|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
42287335|NCT02669849|76119988|FG000|Overall Study|Lost to Follow-up|1|||
42287336|NCT02669849|76119989|FG001|Overall Study|Lost to Follow-up|0|||
42287337|NCT02669849|76119990|FG002|Overall Study|Lost to Follow-up|3|||
42287338|NCT02669849|76119988|FG000|Overall Study|Death|1|||
42287339|NCT02669849|76119989|FG001|Overall Study|Death|1|||
42287340|NCT02669849|76119990|FG002|Overall Study|Death|2|||
42015194|NCT01157169|75822325|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
42015195|NCT01231620|75822334|FG000|Overall Study|Physician Decision|3|||
42015196|NCT01231620|75822335|FG001|Overall Study|Physician Decision|5|||
42015197|NCT01231620|75822336|FG002|Overall Study|Physician Decision|10|||
42015198|NCT01231620|75822334|FG000|Overall Study|Death|12|||
42015199|NCT01231620|75822335|FG001|Overall Study|Death|14|||
42015200|NCT01231620|75822336|FG002|Overall Study|Death|11|||
42015201|NCT01231620|75822334|FG000|Overall Study|Adverse Event|2|||
42015202|NCT01231620|75822335|FG001|Overall Study|Adverse Event|2|||
42015203|NCT01231620|75822336|FG002|Overall Study|Adverse Event|1|||
42015204|NCT01231620|75822334|FG000|Overall Study|Withdrawal by Subject|6|||
42015205|NCT01231620|75822335|FG001|Overall Study|Withdrawal by Subject|6|||
42015206|NCT01231620|75822336|FG002|Overall Study|Withdrawal by Subject|8|||
42015207|NCT01231620|75822334|FG000|Overall Study|Lost to Follow-up|3|||
42015208|NCT01231620|75822335|FG001|Overall Study|Lost to Follow-up|4|||
42015209|NCT01231620|75822336|FG002|Overall Study|Lost to Follow-up|9|||
42015210|NCT01231464|75822346|FG000|Overall Study|Adverse Event|0|||
42015211|NCT01231464|75822347|FG001|Overall Study|Adverse Event|1|||
42015212|NCT01231464|75822346|FG000|Overall Study|Protocol Violation|1|||
42015213|NCT01231464|75822347|FG001|Overall Study|Protocol Violation|2|||
42015214|NCT01231464|75822346|FG000|Overall Study|Lost to Follow-up|1|||
42015215|NCT01231464|75822347|FG001|Overall Study|Lost to Follow-up|2|||
42015216|NCT01231464|75822346|FG000|Overall Study|Withdrawal by Subject|3|||
42015217|NCT01231464|75822347|FG001|Overall Study|Withdrawal by Subject|2|||
42015218|NCT01156311|75822357|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
42015219|NCT01156311|75822358|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
42015220|NCT01156311|75822359|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
42015221|NCT01156311|75822360|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
42015222|NCT01156311|75822357|FG000|2-Month Monotherapy Period|Physician Decision|0|||
42015223|NCT01156311|75822358|FG001|2-Month Monotherapy Period|Physician Decision|1|||
42015224|NCT01156311|75822359|FG002|2-Month Monotherapy Period|Physician Decision|0|||
42015225|NCT01156311|75822360|FG003|2-Month Monotherapy Period|Physician Decision|0|||
42015226|NCT01156311|75822357|FG000|2-Month Monotherapy Period|Other|1|||
42015227|NCT01156311|75822358|FG001|2-Month Monotherapy Period|Other|0|||
42015228|NCT01156311|75822359|FG002|2-Month Monotherapy Period|Other|0|||
42015229|NCT01156311|75822360|FG003|2-Month Monotherapy Period|Other|0|||
42015230|NCT01156311|75822357|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
42353909|NCT02487394|76195062|FG001|Phase 1|Withdrawal by Subject|1|||
42353910|NCT02029846|76195083|FG000|Overall Study|n=1 each arm|1|||
42353911|NCT02029846|76195084|FG001|Overall Study|n=1 each arm|1|||
42353912|NCT05889039|76195094|FG000|Overall Study|error in completing survey|0|||
42353913|NCT05889039|76195095|FG001|Overall Study|error in completing survey|2|||
42353914|NCT05889039|76195096|FG002|Overall Study|error in completing survey|0|||
42353915|NCT05889039|76195097|FG003|Overall Study|error in completing survey|0|||
42353916|NCT05889039|76195094|FG000|Overall Study|Lost to Follow-up|4|||
42353917|NCT05889039|76195095|FG001|Overall Study|Lost to Follow-up|0|||
42353918|NCT05889039|76195096|FG002|Overall Study|Lost to Follow-up|0|||
42353919|NCT05889039|76195097|FG003|Overall Study|Lost to Follow-up|0|||
42015231|NCT01156311|75822358|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
42015232|NCT01156311|75822359|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
42015233|NCT01156311|75822360|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
42015234|NCT01156311|75822357|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
42015235|NCT01156311|75822358|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
42015236|NCT01156311|75822359|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
42015237|NCT01156311|75822360|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
42015238|NCT01156311|75822357|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
42015239|NCT01156311|75822358|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
42015240|NCT01156311|75822359|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
42015241|NCT01156311|75822360|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
42287341|NCT02669849|76119988|FG000|Overall Study|Study terminated by sponsor|16|||
42287342|NCT02669849|76119989|FG001|Overall Study|Study terminated by sponsor|1|||
42287343|NCT02669849|76119990|FG002|Overall Study|Study terminated by sponsor|14|||
42287344|NCT02669849|76119988|FG000|Overall Study|Other|0|||
42287345|NCT02669849|76119989|FG001|Overall Study|Other|0|||
42287346|NCT02669849|76119990|FG002|Overall Study|Other|2|||
42287347|NCT03625895|76119998|FG000|Overall Study|Protocol Violation|585|||
42287348|NCT02663687|76120007|FG000|Overall Study|Adverse Event|1|||
42287349|NCT02663687|76120008|FG001|Overall Study|Adverse Event|0|||
42287350|NCT02663687|76120009|FG002|Overall Study|Adverse Event|0|||
42287351|NCT02663687|76120010|FG003|Overall Study|Adverse Event|0|||
42287352|NCT02663687|76120011|FG004|Overall Study|Adverse Event|0|||
42287353|NCT02663687|76120007|FG000|Overall Study|Other|1|||
42287354|NCT02663687|76120008|FG001|Overall Study|Other|0|||
42287355|NCT02663687|76120009|FG002|Overall Study|Other|1|||
42287356|NCT02663687|76120010|FG003|Overall Study|Other|0|||
42287357|NCT02663687|76120011|FG004|Overall Study|Other|0|||
42287358|NCT02663453|76120042|FG000|Overall Study|Death|4|||
42287359|NCT02663453|76120043|FG001|Overall Study|Death|4|||
42287360|NCT02663453|76120042|FG000|Overall Study|Withdrawal by Subject|1|||
42287361|NCT02663453|76120043|FG001|Overall Study|Withdrawal by Subject|0|||
42287362|NCT02055118|76120052|FG000|Overall Study|Withdrawal by Subject|0|||
42287363|NCT02055118|76120053|FG001|Overall Study|Withdrawal by Subject|2|||
42287364|NCT02055118|76120054|FG002|Overall Study|Withdrawal by Subject|0|||
42287365|NCT02084056|76120065|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
42287366|NCT02084056|76120066|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
42287367|NCT02084056|76120067|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
42287368|NCT02084056|76120068|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
42287369|NCT02084056|76120065|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
42287370|NCT02084056|76120066|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
42287371|NCT02084056|76120067|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
42287372|NCT02084056|76120068|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
42287373|NCT01625182|76120080|FG000|Overall Study|Administrative problems|1|||
42287374|NCT01625182|76120081|FG001|Overall Study|Administrative problems|0|||
42015242|NCT01156311|75822357|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
42287375|NCT01625182|76120080|FG000|Overall Study|Protocol deviation|0|||
42287376|NCT01625182|76120081|FG001|Overall Study|Protocol deviation|2|||
42287377|NCT01625182|76120080|FG000|Overall Study|Adverse Event|2|||
42287378|NCT01625182|76120081|FG001|Overall Study|Adverse Event|0|||
42287379|NCT01625182|76120080|FG000|Overall Study|Withdrawal by Subject|5|||
42353920|NCT05790408|76195107|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
42353921|NCT04944992|76195156|FG000|Overall Study|Lost to Follow-up|1|||
42353922|NCT04944992|76195157|FG001|Overall Study|Lost to Follow-up|1|||
42353923|NCT04944992|76195156|FG000|Overall Study|Physician Decision|1|||
42353924|NCT04944992|76195157|FG001|Overall Study|Physician Decision|0|||
42015243|NCT01156311|75822358|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
42015244|NCT01156311|75822359|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
42015245|NCT01156311|75822360|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
42015246|NCT01156311|75822357|FG000|6-month Add-on Therapy Period|Other|0|||
42015247|NCT01156311|75822358|FG001|6-month Add-on Therapy Period|Other|0|||
42015248|NCT01156311|75822359|FG002|6-month Add-on Therapy Period|Other|1|||
42015249|NCT01156311|75822360|FG003|6-month Add-on Therapy Period|Other|2|||
42015250|NCT01230060|75822371|FG000|Overall Study|Withdrawal by Subject|1|||
42015251|NCT01155531|75822379|FG000|Overall Study|Adverse Event|0|||
42015252|NCT01155531|75822380|FG001|Overall Study|Adverse Event|0|||
42015253|NCT01155531|75822381|FG002|Overall Study|Adverse Event|1|||
42015254|NCT01155531|75822382|FG003|Overall Study|Adverse Event|0|||
42015255|NCT01155531|75822379|FG000|Overall Study|Lost to Follow-up|0|||
42015256|NCT01155531|75822380|FG001|Overall Study|Lost to Follow-up|0|||
42015257|NCT01155531|75822381|FG002|Overall Study|Lost to Follow-up|0|||
42015258|NCT01155531|75822382|FG003|Overall Study|Lost to Follow-up|1|||
42353925|NCT04944992|76195156|FG000|Overall Study|Withdrawal by Subject|6|||
42015259|NCT01155531|75822379|FG000|Overall Study|Withdrawal by Subject|1|||
42287380|NCT01625182|76120081|FG001|Overall Study|Withdrawal by Subject|1|||
42287381|NCT01625182|76120080|FG000|Overall Study|Lack of Efficacy|12|||
42287382|NCT01625182|76120081|FG001|Overall Study|Lack of Efficacy|8|||
42287383|NCT02661815|76120092|FG000|Overall Study|Withdrawal by Subject|1|||
42287384|NCT02661815|76120093|FG001|Overall Study|Withdrawal by Subject|0|||
42287385|NCT02661815|76120094|FG002|Overall Study|Withdrawal by Subject|0|||
42287386|NCT02661815|76120095|FG003|Overall Study|Withdrawal by Subject|0|||
42287387|NCT02053792|76120111|FG000|Overall Study|Physician Decision|0|||
42287388|NCT02053792|76120112|FG001|Overall Study|Physician Decision|1|||
42287389|NCT02053792|76120111|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
42353926|NCT04944992|76195157|FG001|Overall Study|Withdrawal by Subject|1|||
42287390|NCT02053792|76120112|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
42287391|NCT02053792|76120111|FG000|Overall Study|Lack of Efficacy|1|||
42287392|NCT02053792|76120112|FG001|Overall Study|Lack of Efficacy|0|||
42287393|NCT02053792|76120111|FG000|Overall Study|Adverse Event|1|||
42287394|NCT02053792|76120112|FG001|Overall Study|Adverse Event|0|||
42287395|NCT02053792|76120111|FG000|Overall Study|Withdrawal by Subject|2|||
42287396|NCT02053792|76120112|FG001|Overall Study|Withdrawal by Subject|2|||
42287397|NCT02053792|76120111|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
42287398|NCT02053792|76120112|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
42287399|NCT02053792|76120111|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
42287400|NCT02053792|76120112|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
42287401|NCT02082340|76120120|FG000|Overall Study|Lost to Follow-up|1|||
42287402|NCT02082340|76120121|FG001|Overall Study|Lost to Follow-up|1|||
42287403|NCT02053246|76120127|FG000|Overall Study|Withdrawal by Subject|3|||
42287404|NCT02053246|76120127|FG000|Overall Study|Physician Decision|1|||
42287405|NCT02053168|76120131|FG000|Overall Study|Withdrawal by Subject|1|||
42287406|NCT02053168|76120131|FG000|Overall Study|Physician Decision|1|||
42287407|NCT02053168|76120131|FG000|Overall Study|Lost to Follow-up|1|||
42287408|NCT02052466|76120135|FG000|Overall Study|Withdrawal by Subject|1|||
42287409|NCT02052466|76120135|FG000|Overall Study|Acromial fracture|1|||
42287410|NCT02032888|76120142|FG000|Treatment Period|Poor compliance/noncompliance|1|||
42287411|NCT02032888|76120143|FG001|Treatment Period|Poor compliance/noncompliance|1|||
42287412|NCT02032888|76120144|FG002|Treatment Period|Poor compliance/noncompliance|0|||
42287413|NCT02032888|76120142|FG000|Treatment Period|Other|1|||
42287414|NCT02032888|76120143|FG001|Treatment Period|Other|1|||
42287415|NCT02032888|76120144|FG002|Treatment Period|Other|0|||
42287416|NCT02032888|76120142|FG000|Follow-up Period|Lost to Follow-up|1|||
42287417|NCT02032888|76120143|FG001|Follow-up Period|Lost to Follow-up|1|||
42287418|NCT02032888|76120144|FG002|Follow-up Period|Lost to Follow-up|0|||
42287419|NCT02032888|76120142|FG000|Follow-up Period|Death|1|||
42287420|NCT02032888|76120143|FG001|Follow-up Period|Death|1|||
42287421|NCT02032888|76120144|FG002|Follow-up Period|Death|0|||
42287422|NCT02032888|76120142|FG000|Follow-up Period|Other|1|||
42287423|NCT02032888|76120143|FG001|Follow-up Period|Other|0|||
42287424|NCT02032888|76120144|FG002|Follow-up Period|Other|0|||
42287425|NCT02082262|76120161|FG000|Overall Study|Withdrawal by Subject|3|||
42287426|NCT02082262|76120161|FG000|Overall Study|Adverse Event|48|||
42353927|NCT04820530|76195163|FG000|Extension Treatment Period|Ongoing at the time of the data cut-off date 2022-11-02|32|||
42353928|NCT04535583|76195184|FG000|Overall Study|Lost to Follow-up|1|||
42353929|NCT04535583|76195184|FG000|Overall Study|Physician Decision|1|||
42353930|NCT04535583|76195184|FG000|Overall Study|Withdrawal by Subject|1|||
42353931|NCT04484935|76195199|FG000|Overall Study|Other|0|||
42353932|NCT04484935|76195200|FG001|Overall Study|Other|1|||
42353933|NCT04484935|76195199|FG000|Overall Study|Withdrawal by parent/guardian|0|||
42353934|NCT04484935|76195200|FG001|Overall Study|Withdrawal by parent/guardian|1|||
42353935|NCT04484935|76195199|FG000|Overall Study|Lost to Follow-up|1|||
42353936|NCT04484935|76195200|FG001|Overall Study|Lost to Follow-up|0|||
42287427|NCT04697069|76120167|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
42287428|NCT04697069|76120168|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
42287429|NCT04697069|76120167|FG000|Overall Study|Study termination|2|||
42287430|NCT04697069|76120168|FG001|Overall Study|Study termination|1|||
42287431|NCT02082184|76120176|FG000|Overall Study|Adverse Event|1|||
42287432|NCT02082184|76120177|FG001|Overall Study|Adverse Event|0|||
42353937|NCT04484935|76195199|FG000|Overall Study|Death|2|||
42353938|NCT04484935|76195200|FG001|Overall Study|Death|1|||
42353939|NCT04262882|76195209|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
42287433|NCT02082184|76120176|FG000|Overall Study|Medical diagnosis|1|||
42287434|NCT02082184|76120177|FG001|Overall Study|Medical diagnosis|2|||
42287435|NCT02082184|76120176|FG000|Overall Study|Device associated symptoms|5|||
42287436|NCT02082184|76120177|FG001|Overall Study|Device associated symptoms|0|||
42287437|NCT02082184|76120176|FG000|Overall Study|Withdrawal by Subject|3|||
42287438|NCT02082184|76120177|FG001|Overall Study|Withdrawal by Subject|2|||
42287439|NCT02082184|76120176|FG000|Overall Study|Protocol Violation|0|||
42287440|NCT02082184|76120177|FG001|Overall Study|Protocol Violation|6|||
42353940|NCT04262882|76195210|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
42015260|NCT01155531|75822380|FG001|Overall Study|Withdrawal by Subject|0|||
42287441|NCT02082184|76120176|FG000|Overall Study|Lost to Follow-up|0|||
42353941|NCT04262882|76195209|FG000|Overall Study|Lost to Follow-up|1|||
42353942|NCT04262882|76195210|FG001|Overall Study|Lost to Follow-up|0|||
42353943|NCT04135859|76195218|FG000|Overall Study|Withdrawal by Subject|1|||
42353944|NCT04135859|76195219|FG001|Overall Study|Withdrawal by Subject|0|||
42353945|NCT04135859|76195218|FG000|Overall Study|Withdrawal due to screening failure|1|||
42353946|NCT04135859|76195219|FG001|Overall Study|Withdrawal due to screening failure|2|||
42353947|NCT04135859|76195218|FG000|Overall Study|Did not complete stress test|3|||
42353948|NCT04135859|76195219|FG001|Overall Study|Did not complete stress test|3|||
42353949|NCT04135859|76195218|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
42353950|NCT04135859|76195219|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
42353951|NCT04068610|76195237|FG000|Overall Study|Death|4|||
42353952|NCT04068610|76195238|FG001|Overall Study|Death|8|||
42353953|NCT04068610|76195239|FG002|Overall Study|Death|13|||
42353954|NCT04068610|76195237|FG000|Overall Study|Lost to Follow-up|0|||
42353955|NCT04068610|76195238|FG001|Overall Study|Lost to Follow-up|2|||
42353956|NCT04068610|76195239|FG002|Overall Study|Lost to Follow-up|0|||
42353957|NCT04068610|76195237|FG000|Overall Study|Withdrawal by Subject|0|||
42353958|NCT04068610|76195238|FG001|Overall Study|Withdrawal by Subject|4|||
42353959|NCT04068610|76195239|FG002|Overall Study|Withdrawal by Subject|2|||
42353960|NCT04068610|76195237|FG000|Overall Study|Other|3|||
42287442|NCT02082184|76120177|FG001|Overall Study|Lost to Follow-up|2|||
42287443|NCT02082184|76120176|FG000|Overall Study|Subject non-compliance|0|||
42287444|NCT02082184|76120177|FG001|Overall Study|Subject non-compliance|1|||
42287445|NCT01624870|76120183|FG000|Overall Study|Death|19|||
42353961|NCT04068610|76195238|FG001|Overall Study|Other|12|||
42287446|NCT01624870|76120183|FG000|Overall Study|Withdrawal by Subject|1|||
42287447|NCT01624870|76120183|FG000|Overall Study|CoreValve not implanted|6|||
42287448|NCT01624870|76120183|FG000|Overall Study|Lost to follow up|1|||
42287449|NCT02031640|76120194|FG000|Screening Period|Adverse Event|1|||
42287450|NCT02031640|76120195|FG001|Screening Period|Adverse Event|0|||
42287451|NCT02031640|76120196|FG002|Screening Period|Adverse Event|0|||
42287452|NCT02031640|76120197|FG003|Screening Period|Adverse Event|0|||
42287453|NCT02031640|76120198|FG004|Screening Period|Adverse Event|0|||
42287454|NCT02031640|76120199|FG005|Screening Period|Adverse Event|0|||
42287455|NCT02031640|76120194|FG000|Screening Period|Withdrawal by Subject|29|||
42353962|NCT04068610|76195239|FG002|Overall Study|Other|11|||
42287456|NCT02031640|76120195|FG001|Screening Period|Withdrawal by Subject|0|||
42353963|NCT03860844|76195250|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
42353964|NCT03860844|76195251|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
42353965|NCT03860844|76195252|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
42353966|NCT03860844|76195250|FG000|Overall Study|Progressive disease|5|||
42353967|NCT03860844|76195251|FG001|Overall Study|Progressive disease|3|||
42353968|NCT03860844|76195252|FG002|Overall Study|Progressive disease|4|||
42353969|NCT03860844|76195250|FG000|Overall Study|Other, Not related to COVID-19|0|||
42171945|NCT02952586|75978797|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
42171946|NCT02952586|75978798|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
42171947|NCT02952586|75978797|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
42171948|NCT02952586|75978798|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
42171949|NCT02952586|75978797|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
42171950|NCT02952586|75978798|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
42171951|NCT02952586|75978797|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
42171952|NCT02952586|75978798|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
42171953|NCT02952586|75978797|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
42287457|NCT02031640|76120196|FG002|Screening Period|Withdrawal by Subject|0|||
42353970|NCT03860844|76195251|FG001|Overall Study|Other, Not related to COVID-19|1|||
42353971|NCT03860844|76195252|FG002|Overall Study|Other, Not related to COVID-19|0|||
42353972|NCT03459846|76195264|FG000|Overall Study|Death|52|||
42353973|NCT03459846|76195265|FG001|Overall Study|Death|46|||
42353974|NCT03459846|76195264|FG000|Overall Study|Study terminated by sponsor|24|||
42353975|NCT03459846|76195265|FG001|Overall Study|Study terminated by sponsor|28|||
42353976|NCT03459846|76195264|FG000|Overall Study|Withdrawal by Subject|2|||
42353977|NCT03459846|76195265|FG001|Overall Study|Withdrawal by Subject|2|||
42353978|NCT03298984|76195275|FG000|Overall Study|Physician Decision|1|||
42353979|NCT03298984|76195276|FG001|Overall Study|Physician Decision|0|||
42353980|NCT03298984|76195277|FG002|Overall Study|Physician Decision|0|||
42353981|NCT03298984|76195278|FG003|Overall Study|Physician Decision|6|||
42353982|NCT03298984|76195275|FG000|Overall Study|Lack of Efficacy|0|||
42353983|NCT03298984|76195276|FG001|Overall Study|Lack of Efficacy|1|||
42353984|NCT03298984|76195277|FG002|Overall Study|Lack of Efficacy|1|||
42353985|NCT03298984|76195278|FG003|Overall Study|Lack of Efficacy|4|||
42353986|NCT03298984|76195275|FG000|Overall Study|Relapsed disease (following remission)|0|||
42353987|NCT03298984|76195276|FG001|Overall Study|Relapsed disease (following remission)|0|||
42353988|NCT03298984|76195277|FG002|Overall Study|Relapsed disease (following remission)|1|||
42353989|NCT03298984|76195278|FG003|Overall Study|Relapsed disease (following remission)|1|||
42353990|NCT03298984|76195275|FG000|Overall Study|Adverse Event|0|||
42353991|NCT03298984|76195276|FG001|Overall Study|Adverse Event|0|||
42353992|NCT03298984|76195277|FG002|Overall Study|Adverse Event|0|||
42353993|NCT03298984|76195278|FG003|Overall Study|Adverse Event|1|||
42353994|NCT03298984|76195275|FG000|Overall Study|Death|0|||
42353995|NCT03298984|76195276|FG001|Overall Study|Death|0|||
42353996|NCT03298984|76195277|FG002|Overall Study|Death|0|||
42353997|NCT03298984|76195278|FG003|Overall Study|Death|2|||
42287458|NCT02031640|76120197|FG003|Screening Period|Withdrawal by Subject|0|||
42287459|NCT02031640|76120198|FG004|Screening Period|Withdrawal by Subject|0|||
42287460|NCT02031640|76120199|FG005|Screening Period|Withdrawal by Subject|0|||
42287461|NCT02031640|76120194|FG000|Screening Period|Inclusion criteria not met|312|||
42287462|NCT02031640|76120195|FG001|Screening Period|Inclusion criteria not met|0|||
42287463|NCT02031640|76120196|FG002|Screening Period|Inclusion criteria not met|0|||
42287464|NCT02031640|76120197|FG003|Screening Period|Inclusion criteria not met|0|||
42287465|NCT02031640|76120198|FG004|Screening Period|Inclusion criteria not met|0|||
42353998|NCT03298984|76195275|FG000|Overall Study|Insurance Company Decision|0|||
42353999|NCT03298984|76195276|FG001|Overall Study|Insurance Company Decision|0|||
42354000|NCT03298984|76195277|FG002|Overall Study|Insurance Company Decision|0|||
42354001|NCT03298984|76195278|FG003|Overall Study|Insurance Company Decision|1|||
42354002|NCT03248492|76195294|FG000|Overall Study|Ongoing|23|||
42354003|NCT03248492|76195295|FG001|Overall Study|Ongoing|26|||
42354004|NCT03248492|76195296|FG002|Overall Study|Ongoing|3|||
42354005|NCT03248492|76195297|FG003|Overall Study|Ongoing|85|||
42354006|NCT03248492|76195298|FG004|Overall Study|Ongoing|2|||
42354007|NCT03248492|76195294|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
42354008|NCT03248492|76195295|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
42354009|NCT03248492|76195296|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
42354010|NCT03248492|76195297|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
42354011|NCT03248492|76195298|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
42354012|NCT03248492|76195294|FG000|Overall Study|Adverse Event|6|||
42354013|NCT03248492|76195295|FG001|Overall Study|Adverse Event|6|||
42354014|NCT03248492|76195296|FG002|Overall Study|Adverse Event|8|||
42354015|NCT03248492|76195297|FG003|Overall Study|Adverse Event|8|||
42354016|NCT03248492|76195298|FG004|Overall Study|Adverse Event|1|||
42354017|NCT03248492|76195294|FG000|Overall Study|Withdrawal by Subject|3|||
42354018|NCT03248492|76195295|FG001|Overall Study|Withdrawal by Subject|3|||
42354019|NCT03248492|76195296|FG002|Overall Study|Withdrawal by Subject|0|||
42354020|NCT03248492|76195297|FG003|Overall Study|Withdrawal by Subject|3|||
42354021|NCT03248492|76195298|FG004|Overall Study|Withdrawal by Subject|1|||
42354022|NCT03248492|76195294|FG000|Overall Study|Physician Decision|1|||
42354023|NCT03248492|76195295|FG001|Overall Study|Physician Decision|0|||
42354024|NCT03248492|76195296|FG002|Overall Study|Physician Decision|1|||
42354025|NCT03248492|76195297|FG003|Overall Study|Physician Decision|2|||
42354026|NCT03248492|76195298|FG004|Overall Study|Physician Decision|0|||
42354027|NCT03248492|76195294|FG000|Overall Study|Death|1|||
42354028|NCT03248492|76195295|FG001|Overall Study|Death|0|||
42354029|NCT03248492|76195296|FG002|Overall Study|Death|0|||
42354030|NCT03248492|76195297|FG003|Overall Study|Death|6|||
42354031|NCT03248492|76195298|FG004|Overall Study|Death|0|||
42354032|NCT03248492|76195294|FG000|Overall Study|Other|0|||
42354033|NCT03248492|76195295|FG001|Overall Study|Other|1|||
42354034|NCT03248492|76195296|FG002|Overall Study|Other|0|||
42354035|NCT03248492|76195297|FG003|Overall Study|Other|4|||
42354036|NCT03248492|76195298|FG004|Overall Study|Other|0|||
42354037|NCT03224468|76195320|FG000|Overall Study|Did not obtain MM card|53|||
42354038|NCT03224468|76195321|FG001|Overall Study|Did not obtain MM card|0|||
42354039|NCT03224468|76195320|FG000|Overall Study|Lost to Follow-up|4|||
42354040|NCT03224468|76195321|FG001|Overall Study|Lost to Follow-up|11|||
42354041|NCT03224468|76195320|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
42015261|NCT01155531|75822381|FG002|Overall Study|Withdrawal by Subject|1|||
42015262|NCT01155531|75822382|FG003|Overall Study|Withdrawal by Subject|0|||
42015263|NCT01155219|75822394|FG000|Overall Study|Adverse Event|3|||
42015264|NCT01155219|75822395|FG001|Overall Study|Adverse Event|1|||
42171954|NCT02952586|75978798|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
42354042|NCT03224468|76195321|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
42354043|NCT03149003|76195330|FG000|Overall Study|Randomized but not treated|0|||
42354044|NCT03149003|76195331|FG001|Overall Study|Randomized but not treated|1|||
42354045|NCT03149003|76195332|FG002|Overall Study|Randomized but not treated|18|||
42354046|NCT03093974|76195346|FG000|Overall Study|Withdrawal by Subject|32|||
42354047|NCT03093974|76195347|FG001|Overall Study|Withdrawal by Subject|27|||
42354048|NCT03093974|76195346|FG000|Overall Study|Adverse Event|17|||
42354049|NCT03093974|76195347|FG001|Overall Study|Adverse Event|24|||
42354050|NCT03093974|76195346|FG000|Overall Study|Death|0|||
42354051|NCT03093974|76195347|FG001|Overall Study|Death|1|||
42354052|NCT03093974|76195346|FG000|Overall Study|Non-Compliance with Study Drug|1|||
42354053|NCT03093974|76195347|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42354054|NCT03093974|76195346|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
42354055|NCT03093974|76195347|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
42354056|NCT03093974|76195346|FG000|Overall Study|Lost to Follow-up|0|||
42354057|NCT03093974|76195347|FG001|Overall Study|Lost to Follow-up|1|||
42354058|NCT03093974|76195346|FG000|Overall Study|Other|1|||
42354059|NCT03093974|76195347|FG001|Overall Study|Other|2|||
42354060|NCT03089606|76195353|FG000|Overall Study|Progression after Cycle 1|1|||
42354061|NCT03023332|76195369|FG000|Overall Study|Withdrawal by Subject|10|||
42354062|NCT03023332|76195370|FG001|Overall Study|Withdrawal by Subject|5|||
42354063|NCT03023332|76195371|FG002|Overall Study|Withdrawal by Subject|4|||
42354064|NCT03023332|76195372|FG003|Overall Study|Withdrawal by Subject|7|||
42354065|NCT03023332|76195369|FG000|Overall Study|Lost to Follow-up|13|||
42354066|NCT03023332|76195370|FG001|Overall Study|Lost to Follow-up|16|||
42354067|NCT03023332|76195371|FG002|Overall Study|Lost to Follow-up|8|||
42354068|NCT03023332|76195372|FG003|Overall Study|Lost to Follow-up|13|||
42354069|NCT03023332|76195369|FG000|Overall Study|Death|1|||
42354070|NCT03023332|76195370|FG001|Overall Study|Death|0|||
42354071|NCT03023332|76195371|FG002|Overall Study|Death|0|||
42354072|NCT03023332|76195372|FG003|Overall Study|Death|0|||
42354073|NCT02993731|76195401|FG000|Overall Study|Study Termination|101|||
42354074|NCT02993731|76195402|FG001|Overall Study|Study Termination|105|||
42354075|NCT02903368|76195420|FG000|Part 1|Adverse Event|3|||
42354076|NCT02903368|76195421|FG001|Part 1|Adverse Event|0|||
42354077|NCT02903368|76195422|FG002|Part 1|Adverse Event|0|||
42354078|NCT02903368|76195423|FG003|Part 1|Adverse Event|0|||
42354079|NCT02903368|76195420|FG000|Part 1|Withdrawal by Subject|1|||
42354080|NCT02903368|76195421|FG001|Part 1|Withdrawal by Subject|0|||
42354081|NCT02903368|76195422|FG002|Part 1|Withdrawal by Subject|0|||
42354082|NCT02903368|76195423|FG003|Part 1|Withdrawal by Subject|0|||
42354083|NCT02903368|76195420|FG000|Part 2|Adverse Event|0|||
42354084|NCT02903368|76195421|FG001|Part 2|Adverse Event|0|||
42354085|NCT02903368|76195422|FG002|Part 2|Adverse Event|5|||
42354086|NCT02903368|76195423|FG003|Part 2|Adverse Event|0|||
42354087|NCT02903368|76195420|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
42354088|NCT02903368|76195421|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
42354089|NCT02903368|76195422|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
42354090|NCT02903368|76195423|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
42354091|NCT02903368|76195420|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
42354092|NCT02903368|76195421|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
42171955|NCT02952586|75978797|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
42171956|NCT02952586|75978798|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
42287466|NCT02031640|76120199|FG005|Screening Period|Inclusion criteria not met|0|||
42287467|NCT02031640|76120194|FG000|Screening Period|Exclusion criteria met|30|||
42287468|NCT02031640|76120195|FG001|Screening Period|Exclusion criteria met|0|||
42287469|NCT02031640|76120196|FG002|Screening Period|Exclusion criteria met|0|||
42287470|NCT02031640|76120197|FG003|Screening Period|Exclusion criteria met|0|||
42287471|NCT02031640|76120198|FG004|Screening Period|Exclusion criteria met|0|||
42287472|NCT02031640|76120199|FG005|Screening Period|Exclusion criteria met|0|||
42287473|NCT02031640|76120194|FG000|Screening Period|Lost to Follow-up|14|||
42287474|NCT02031640|76120195|FG001|Screening Period|Lost to Follow-up|0|||
42287475|NCT02031640|76120196|FG002|Screening Period|Lost to Follow-up|0|||
42287476|NCT02031640|76120197|FG003|Screening Period|Lost to Follow-up|0|||
42354093|NCT02903368|76195422|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
42354094|NCT02903368|76195423|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
42354095|NCT02903368|76195420|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
42354096|NCT02903368|76195421|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
42354097|NCT02903368|76195422|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
42354098|NCT02903368|76195423|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
42354099|NCT02753127|76195443|FG000|Overall Study|Lost to Follow-up|13|||
42354100|NCT02753127|76195444|FG001|Overall Study|Lost to Follow-up|11|||
42354101|NCT02753127|76195443|FG000|Overall Study|Withdrawal by Subject|37|||
42354102|NCT02753127|76195444|FG001|Overall Study|Withdrawal by Subject|47|||
42354103|NCT02753127|76195443|FG000|Overall Study|Other|3|||
42354104|NCT02753127|76195444|FG001|Overall Study|Other|8|||
42354105|NCT02753127|76195443|FG000|Overall Study|Hospice|0|||
42354106|NCT02753127|76195444|FG001|Overall Study|Hospice|2|||
42354107|NCT02657551|76195458|FG000|Overall Study|Adverse Event|2|||
42354108|NCT02657551|76195458|FG000|Overall Study|Withdrawal by Subject|1|||
42354109|NCT02657551|76195458|FG000|Overall Study|Non-Compliance|1|||
42354110|NCT02657551|76195458|FG000|Overall Study|Progression / Relapse|4|||
42287477|NCT02031640|76120198|FG004|Screening Period|Lost to Follow-up|0|||
42287478|NCT02031640|76120199|FG005|Screening Period|Lost to Follow-up|0|||
42287479|NCT02031640|76120194|FG000|Screening Period|Enrollment closed|26|||
42287480|NCT02031640|76120195|FG001|Screening Period|Enrollment closed|0|||
42287481|NCT02031640|76120196|FG002|Screening Period|Enrollment closed|0|||
42287482|NCT02031640|76120197|FG003|Screening Period|Enrollment closed|0|||
42287483|NCT02031640|76120198|FG004|Screening Period|Enrollment closed|0|||
42287484|NCT02031640|76120199|FG005|Screening Period|Enrollment closed|0|||
42287485|NCT02031640|76120194|FG000|Run-In Period|Adverse Event|4|||
42287486|NCT02031640|76120195|FG001|Run-In Period|Adverse Event|0|||
42287487|NCT02031640|76120196|FG002|Run-In Period|Adverse Event|0|||
42287488|NCT02031640|76120197|FG003|Run-In Period|Adverse Event|0|||
42354111|NCT02577406|76195464|FG000|Randomized Period|Death|1|||
42354112|NCT02577406|76195465|FG001|Randomized Period|Death|0|||
42354113|NCT02577406|76195464|FG000|Randomized Period|Other reasons|0|||
42354114|NCT02577406|76195465|FG001|Randomized Period|Other reasons|20|||
42354115|NCT02577406|76195464|FG000|Treatment Period|Transition to commercially available treatment|1|||
42354116|NCT02577406|76195465|FG001|Treatment Period|Transition to commercially available treatment|0|||
42354117|NCT02577406|76195464|FG000|Treatment Period|Progressive disease|47|||
42354118|NCT02577406|76195465|FG001|Treatment Period|Progressive disease|36|||
42354119|NCT02577406|76195464|FG000|Treatment Period|Death|36|||
42354120|NCT02577406|76195465|FG001|Treatment Period|Death|23|||
42354121|NCT02577406|76195464|FG000|Treatment Period|Other reasons|3|||
42354122|NCT02577406|76195465|FG001|Treatment Period|Other reasons|37|||
42354123|NCT02577406|76195464|FG000|Treatment Period|Withdrawal by Subject|10|||
42354124|NCT02577406|76195465|FG001|Treatment Period|Withdrawal by Subject|24|||
42354125|NCT02577406|76195464|FG000|Treatment Period|Adverse Event|17|||
42354126|NCT02577406|76195465|FG001|Treatment Period|Adverse Event|12|||
42354127|NCT02577406|76195464|FG000|Treatment Period|Disease relapse|27|||
42354128|NCT02577406|76195465|FG001|Treatment Period|Disease relapse|1|||
42354129|NCT02577406|76195464|FG000|Treatment Period|HSCT|6|||
42354130|NCT02577406|76195465|FG001|Treatment Period|HSCT|2|||
42354131|NCT02577406|76195464|FG000|Treatment Period|Lost to Follow-up|0|||
42287489|NCT02031640|76120198|FG004|Run-In Period|Adverse Event|0|||
42287490|NCT02031640|76120199|FG005|Run-In Period|Adverse Event|0|||
42354132|NCT02577406|76195465|FG001|Treatment Period|Lost to Follow-up|1|||
42354133|NCT02577406|76195464|FG000|Treatment Period|Protocol Violation|0|||
42354134|NCT02577406|76195465|FG001|Treatment Period|Protocol Violation|1|||
42354135|NCT02527434|76195478|FG000|Overall Study|Lost to Follow-up|2|||
42354136|NCT02527434|76195479|FG001|Overall Study|Lost to Follow-up|2|||
42287491|NCT02031640|76120194|FG000|Run-In Period|Withdrawal by Subject|17|||
42287492|NCT02031640|76120195|FG001|Run-In Period|Withdrawal by Subject|0|||
42287493|NCT02031640|76120196|FG002|Run-In Period|Withdrawal by Subject|0|||
42287494|NCT02031640|76120197|FG003|Run-In Period|Withdrawal by Subject|0|||
42287495|NCT02031640|76120198|FG004|Run-In Period|Withdrawal by Subject|0|||
42287496|NCT02031640|76120199|FG005|Run-In Period|Withdrawal by Subject|0|||
42287497|NCT02031640|76120194|FG000|Run-In Period|Inclusion criteria not met|38|||
42354137|NCT02527434|76195480|FG002|Overall Study|Lost to Follow-up|0|||
42354138|NCT02527434|76195478|FG000|Overall Study|Death|19|||
42354139|NCT02527434|76195479|FG001|Overall Study|Death|6|||
42354140|NCT02527434|76195480|FG002|Overall Study|Death|17|||
42354141|NCT02527434|76195478|FG000|Overall Study|Withdrawal by Subject|5|||
42354142|NCT02527434|76195479|FG001|Overall Study|Withdrawal by Subject|3|||
42354143|NCT02527434|76195480|FG002|Overall Study|Withdrawal by Subject|3|||
42354144|NCT02527434|76195478|FG000|Overall Study|Reason Not Specified|1|||
42354145|NCT02527434|76195479|FG001|Overall Study|Reason Not Specified|0|||
42354146|NCT02527434|76195480|FG002|Overall Study|Reason Not Specified|0|||
42354147|NCT02527434|76195478|FG000|Overall Study|Site closure|1|||
42354148|NCT02527434|76195479|FG001|Overall Study|Site closure|0|||
42354149|NCT02527434|76195480|FG002|Overall Study|Site closure|0|||
42354150|NCT02460835|76195498|FG000|Overall Study|Disease progression prior to treatment|3|||
42354151|NCT02460835|76195498|FG000|Overall Study|Unable to complete planning scans|2|||
42354152|NCT02460835|76195498|FG000|Overall Study|Decrease in performance status|1|||
42354153|NCT02460835|76195498|FG000|Overall Study|Withdrawal by Subject|3|||
42287498|NCT02031640|76120195|FG001|Run-In Period|Inclusion criteria not met|0|||
42287499|NCT02031640|76120196|FG002|Run-In Period|Inclusion criteria not met|0|||
42354154|NCT02460835|76195498|FG000|Overall Study|Underwent fractionated RT|10|||
42015265|NCT01155219|75822394|FG000|Overall Study|non-medical reason|1|||
42287500|NCT02031640|76120197|FG003|Run-In Period|Inclusion criteria not met|0|||
42287501|NCT02031640|76120198|FG004|Run-In Period|Inclusion criteria not met|0|||
42287502|NCT02031640|76120199|FG005|Run-In Period|Inclusion criteria not met|0|||
42354155|NCT02460835|76195498|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
42354156|NCT02231749|76195534|FG000|Overall Study|Disease progression|229|||
42354157|NCT02231749|76195535|FG001|Overall Study|Disease progression|297|||
42354158|NCT02231749|76195534|FG000|Overall Study|Study Drug Toxicity|134|||
42354159|NCT02231749|76195535|FG001|Overall Study|Study Drug Toxicity|63|||
42354160|NCT02231749|76195534|FG000|Overall Study|Death|1|||
42354161|NCT02231749|76195535|FG001|Overall Study|Death|1|||
42354162|NCT02231749|76195534|FG000|Overall Study|AE unrelated to Study drug|32|||
42354163|NCT02231749|76195535|FG001|Overall Study|AE unrelated to Study drug|31|||
42354164|NCT02231749|76195534|FG000|Overall Study|Participant's request to discontinue|10|||
42354165|NCT02231749|76195535|FG001|Overall Study|Participant's request to discontinue|21|||
42354166|NCT02231749|76195534|FG000|Overall Study|Participant withdrew Consent|8|||
42354167|NCT02231749|76195535|FG001|Overall Study|Participant withdrew Consent|15|||
42354168|NCT02231749|76195534|FG000|Overall Study|Lost to Follow-up|1|||
42354169|NCT02231749|76195535|FG001|Overall Study|Lost to Follow-up|2|||
42287503|NCT02031640|76120194|FG000|Run-In Period|Exclusion criteria met|8|||
42354170|NCT02231749|76195534|FG000|Overall Study|Maximum Clinical Benefit|5|||
42354171|NCT02231749|76195535|FG001|Overall Study|Maximum Clinical Benefit|8|||
42354172|NCT02231749|76195534|FG000|Overall Study|Poor/Non-Compliance|0|||
42354173|NCT02231749|76195535|FG001|Overall Study|Poor/Non-Compliance|3|||
42354174|NCT02231749|76195534|FG000|Overall Study|Pregnancy|1|||
42354175|NCT02231749|76195535|FG001|Overall Study|Pregnancy|0|||
42354176|NCT02231749|76195534|FG000|Overall Study|other|0|||
42354177|NCT02231749|76195535|FG001|Overall Study|other|8|||
42287504|NCT02031640|76120195|FG001|Run-In Period|Exclusion criteria met|0|||
42287505|NCT02031640|76120196|FG002|Run-In Period|Exclusion criteria met|0|||
42287506|NCT02031640|76120197|FG003|Run-In Period|Exclusion criteria met|0|||
42287507|NCT02031640|76120198|FG004|Run-In Period|Exclusion criteria met|0|||
42287508|NCT02031640|76120199|FG005|Run-In Period|Exclusion criteria met|0|||
42287509|NCT02031640|76120194|FG000|Run-In Period|Randomization criteria not met|85|||
42287510|NCT02031640|76120195|FG001|Run-In Period|Randomization criteria not met|0|||
42354178|NCT02231749|76195534|FG000|Overall Study|No longer meets Study Criteria|1|||
42354179|NCT02231749|76195535|FG001|Overall Study|No longer meets Study Criteria|0|||
42354180|NCT01776307|76195600|FG000|Overall Study|Not dosed|0|||
42354181|NCT01776307|76195601|FG001|Overall Study|Not dosed|0|||
42354182|NCT01776307|76195602|FG002|Overall Study|Not dosed|1|||
42354183|NCT05419908|76195664|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
42354184|NCT05419908|76195665|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
42354185|NCT05419908|76195664|FG000|Overall Study|Serious Adverse Event|0|||
42354186|NCT05419908|76195665|FG001|Overall Study|Serious Adverse Event|2|||
42354187|NCT05419908|76195664|FG000|Overall Study|Withdrawal by Subject|2|||
42354188|NCT05419908|76195665|FG001|Overall Study|Withdrawal by Subject|0|||
42354189|NCT05419908|76195664|FG000|Overall Study|Miscellaneous|1|||
42354190|NCT05419908|76195665|FG001|Overall Study|Miscellaneous|1|||
42354191|NCT05091060|76195671|FG000|Overall Study|Lost to Follow-up|1|||
42354192|NCT05056311|76195675|FG000|Overall Study|Lost to Follow-up|14|||
42354193|NCT05056311|76195675|FG000|Overall Study|Withdrawal by Subject|1|||
42040819|NCT01386385|75848781|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
42040820|NCT01386385|75848782|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
42040821|NCT01386385|75848783|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
42040822|NCT01386385|75848784|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
42287511|NCT02031640|76120196|FG002|Run-In Period|Randomization criteria not met|0|||
42040823|NCT01386385|75848785|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
42040824|NCT01386385|75848786|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
42287512|NCT02031640|76120197|FG003|Run-In Period|Randomization criteria not met|0|||
42287513|NCT02031640|76120198|FG004|Run-In Period|Randomization criteria not met|0|||
42040825|NCT01386385|75848787|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
42040826|NCT01386385|75848788|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
42040827|NCT01386385|75848781|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
42040828|NCT01386385|75848782|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
42287514|NCT02031640|76120199|FG005|Run-In Period|Randomization criteria not met|0|||
42287515|NCT02031640|76120194|FG000|Run-In Period|Various administrative reasons|17|||
42287516|NCT02031640|76120195|FG001|Run-In Period|Various administrative reasons|0|||
42287517|NCT02031640|76120196|FG002|Run-In Period|Various administrative reasons|0|||
42354194|NCT05056311|76195675|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
42040829|NCT01386385|75848783|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
42287518|NCT02031640|76120197|FG003|Run-In Period|Various administrative reasons|0|||
42287519|NCT02031640|76120198|FG004|Run-In Period|Various administrative reasons|0|||
42287520|NCT02031640|76120199|FG005|Run-In Period|Various administrative reasons|0|||
42287521|NCT02031640|76120194|FG000|Double-blind Treatment Period|Protocol deviation|0|||
42287522|NCT02031640|76120195|FG001|Double-blind Treatment Period|Protocol deviation|2|||
42287523|NCT02031640|76120196|FG002|Double-blind Treatment Period|Protocol deviation|0|||
42287524|NCT02031640|76120197|FG003|Double-blind Treatment Period|Protocol deviation|1|||
42287525|NCT02031640|76120198|FG004|Double-blind Treatment Period|Protocol deviation|3|||
42287526|NCT02031640|76120199|FG005|Double-blind Treatment Period|Protocol deviation|1|||
42287527|NCT02031640|76120194|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
42287528|NCT02031640|76120195|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
42287529|NCT02031640|76120196|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
42287530|NCT02031640|76120197|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
42287531|NCT02031640|76120198|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
42287532|NCT02031640|76120199|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
42287533|NCT02031640|76120194|FG000|Double-blind Treatment Period|Non-compliance|0|||
42287534|NCT02031640|76120195|FG001|Double-blind Treatment Period|Non-compliance|1|||
42287535|NCT02031640|76120196|FG002|Double-blind Treatment Period|Non-compliance|0|||
42287536|NCT02031640|76120197|FG003|Double-blind Treatment Period|Non-compliance|1|||
42287537|NCT02031640|76120198|FG004|Double-blind Treatment Period|Non-compliance|1|||
42287538|NCT02031640|76120199|FG005|Double-blind Treatment Period|Non-compliance|0|||
42287539|NCT02031640|76120194|FG000|Double-blind Treatment Period|Adverse Event|0|||
42287540|NCT02031640|76120195|FG001|Double-blind Treatment Period|Adverse Event|0|||
42287541|NCT02031640|76120196|FG002|Double-blind Treatment Period|Adverse Event|0|||
42287542|NCT02031640|76120197|FG003|Double-blind Treatment Period|Adverse Event|2|||
42287543|NCT02031640|76120198|FG004|Double-blind Treatment Period|Adverse Event|0|||
42287544|NCT02031640|76120199|FG005|Double-blind Treatment Period|Adverse Event|0|||
42287545|NCT02031640|76120194|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
42287546|NCT02031640|76120195|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
42287547|NCT02031640|76120196|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
42287548|NCT02031640|76120197|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
42287549|NCT02031640|76120198|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
42287550|NCT02031640|76120199|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
42287551|NCT02031640|76120194|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
42287552|NCT02031640|76120195|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
42287553|NCT02031640|76120196|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
42287554|NCT02031640|76120197|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
42287555|NCT02031640|76120198|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
42287556|NCT02031640|76120199|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
42287557|NCT02370173|76120220|FG000|Overall Study|Protocol Violation|1|||
42287558|NCT02370173|76120221|FG001|Overall Study|Protocol Violation|1|||
42287559|NCT02370173|76120220|FG000|Overall Study|Withdrawal by Subject|2|||
42287560|NCT02370173|76120221|FG001|Overall Study|Withdrawal by Subject|2|||
42287561|NCT02660489|76120231|FG000|Overall Study|Lost to Follow-up|1|||
42287562|NCT02660489|76120232|FG001|Overall Study|Lost to Follow-up|1|||
42287563|NCT02660489|76120231|FG000|Overall Study|Adverse Event|1|||
42287564|NCT02660489|76120232|FG001|Overall Study|Adverse Event|3|||
42287565|NCT02660489|76120231|FG000|Overall Study|no rhinovirus infection|4|||
42287566|NCT02660489|76120232|FG001|Overall Study|no rhinovirus infection|4|||
42287567|NCT02052310|76120240|FG000|Overall Study|Death|64|||
42287568|NCT02052310|76120241|FG001|Overall Study|Death|54|||
42287569|NCT02052310|76120240|FG000|Overall Study|Withdrawal by Subject|37|||
42287570|NCT02052310|76120241|FG001|Overall Study|Withdrawal by Subject|49|||
42287571|NCT02052310|76120240|FG000|Overall Study|Other than specified|32|||
42287572|NCT02052310|76120241|FG001|Overall Study|Other than specified|29|||
42287573|NCT02052310|76120240|FG000|Overall Study|Adverse Event|29|||
42287574|NCT02052310|76120241|FG001|Overall Study|Adverse Event|22|||
42287575|NCT02052310|76120240|FG000|Overall Study|Kidney Transplant|23|||
42287576|NCT02052310|76120241|FG001|Overall Study|Kidney Transplant|29|||
42287577|NCT02052310|76120240|FG000|Overall Study|Physician Decision|14|||
42015266|NCT01155219|75822395|FG001|Overall Study|non-medical reason|2|||
42287578|NCT02052310|76120241|FG001|Overall Study|Physician Decision|7|||
42287579|NCT02052310|76120240|FG000|Overall Study|Lack of Efficacy|6|||
42015267|NCT01229436|75822401|FG000|Overall Study|Withdrawal by Subject|2|||
42015268|NCT01229436|75822401|FG000|Overall Study|Lost to Follow-up|3|||
42015269|NCT01155141|75822405|FG000|Overall Study|Withdrawal by Subject|1|||
42287580|NCT02052310|76120241|FG001|Overall Study|Lack of Efficacy|1|||
42287581|NCT02052310|76120240|FG000|Overall Study|Site Terminated by Sponsor|5|||
42287582|NCT02052310|76120241|FG001|Overall Study|Site Terminated by Sponsor|13|||
42287583|NCT02052310|76120240|FG000|Overall Study|Lost to Follow-up|4|||
42287584|NCT02052310|76120241|FG001|Overall Study|Lost to Follow-up|2|||
42015270|NCT01155141|75822405|FG000|Overall Study|Screen Failure|1|||
42287585|NCT02052310|76120240|FG000|Overall Study|Protocol Violation|1|||
42287586|NCT02052310|76120241|FG001|Overall Study|Protocol Violation|6|||
42287587|NCT02051764|76120249|FG000|Overall Study|Study terminated by sponsor|0|||
42287588|NCT02051764|76120250|FG001|Overall Study|Study terminated by sponsor|7|||
42287589|NCT02051296|76120258|FG000|Overall Study|Lost to Follow-up|1|||
42287590|NCT02051296|76120259|FG001|Overall Study|Lost to Follow-up|2|||
42287591|NCT02051296|76120258|FG000|Overall Study|withdraw prior to treatment|7|||
42287592|NCT02051296|76120259|FG001|Overall Study|withdraw prior to treatment|7|||
42287593|NCT02050048|76120267|FG000|Overall Study|Lost to Follow-up|0|||
42287594|NCT02050048|76120268|FG001|Overall Study|Lost to Follow-up|1|||
42287595|NCT02050048|76120267|FG000|Overall Study|Death|1|||
42287596|NCT02050048|76120268|FG001|Overall Study|Death|0|||
42287597|NCT02050048|76120267|FG000|Overall Study|Ineligible after ERCP|4|||
42040830|NCT01386385|75848784|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
42040831|NCT01386385|75848785|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
42040832|NCT01386385|75848786|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
42040833|NCT01386385|75848787|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
42040834|NCT01386385|75848788|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
42040835|NCT01386385|75848781|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
42040836|NCT01386385|75848782|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
42040837|NCT01386385|75848783|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
42040838|NCT01386385|75848784|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
42040839|NCT01386385|75848785|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
42040840|NCT01386385|75848786|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
42040841|NCT01386385|75848787|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
42040842|NCT01386385|75848788|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
42040843|NCT01386385|75848781|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
42040844|NCT01386385|75848782|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
42040845|NCT01386385|75848783|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
42040846|NCT01386385|75848784|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
42040847|NCT01386385|75848785|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
42040848|NCT01386385|75848786|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
42040849|NCT01386385|75848787|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
42040850|NCT01386385|75848788|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
42040851|NCT01371981|75848815|FG000|Overall Study|Adverse Event|12|||
42040852|NCT01371981|75848816|FG001|Overall Study|Adverse Event|17|||
42040853|NCT01371981|75848817|FG002|Overall Study|Adverse Event|0|||
42040854|NCT01371981|75848818|FG003|Overall Study|Adverse Event|4|||
42040855|NCT01371981|75848819|FG004|Overall Study|Adverse Event|1|||
42287598|NCT02050048|76120268|FG001|Overall Study|Ineligible after ERCP|1|||
42287599|NCT02049814|76120276|FG000|Overall Study|Reason not Specified|4|||
42287600|NCT02049814|76120277|FG001|Overall Study|Reason not Specified|3|||
42287601|NCT02049814|76120276|FG000|Overall Study|Pregnancy|1|||
42287602|NCT02049814|76120277|FG001|Overall Study|Pregnancy|0|||
42287603|NCT02049814|76120276|FG000|Overall Study|Lost to Follow-up|2|||
42287604|NCT02049814|76120277|FG001|Overall Study|Lost to Follow-up|3|||
42287605|NCT02049814|76120276|FG000|Overall Study|Serious Protocol Violation|5|||
42287606|NCT02049814|76120277|FG001|Overall Study|Serious Protocol Violation|7|||
42287607|NCT02049814|76120276|FG000|Overall Study|Study Termination|0|||
42287608|NCT02049814|76120277|FG001|Overall Study|Study Termination|1|||
42287609|NCT02049814|76120276|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
42287610|NCT02049814|76120277|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
42287611|NCT02049814|76120276|FG000|Overall Study|Voluntary withdrawal|9|||
42287612|NCT02049814|76120277|FG001|Overall Study|Voluntary withdrawal|8|||
42287613|NCT02079844|76120295|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
42287614|NCT02079844|76120296|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
42287615|NCT02079844|76120297|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
42287616|NCT02079844|76120295|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
42287617|NCT02079844|76120296|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
42287618|NCT02079844|76120297|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
42287619|NCT02048722|76120317|FG000|2 Cycles of Treatment|Adverse Event|2|||
42287620|NCT02048722|76120317|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
42287621|NCT02048722|76120317|FG000|2 Cycles of Treatment|Progressive Disease|2|||
42287622|NCT02048722|76120317|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
42287623|NCT02048722|76120317|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
42287624|NCT02048722|76120317|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
42287625|NCT02030002|76120321|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
42354195|NCT05020899|76195682|FG000|8 Week Follow-up|Lost to Follow-up|3|||
42040856|NCT01371981|75848820|FG005|Overall Study|Adverse Event|0|||
42040857|NCT01371981|75848815|FG000|Overall Study|Death|22|||
42040858|NCT01371981|75848816|FG001|Overall Study|Death|16|||
42040859|NCT01371981|75848817|FG002|Overall Study|Death|0|||
42040860|NCT01371981|75848818|FG003|Overall Study|Death|0|||
42287626|NCT02030002|76120321|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
42287627|NCT02030002|76120321|FG000|Follow-up|Lost to Follow-up|2|||
42287628|NCT02079610|76120329|FG000|Overall Study|Withdrawal by Subject|1|||
42287629|NCT02079610|76120330|FG001|Overall Study|Withdrawal by Subject|1|||
42287630|NCT02079532|76120336|FG000|Overall Study|Adverse Event|7|||
42040861|NCT01371981|75848819|FG004|Overall Study|Death|2|||
42040862|NCT01371981|75848820|FG005|Overall Study|Death|2|||
42040863|NCT01371981|75848815|FG000|Overall Study|Lack of Efficacy|69|||
42040864|NCT01371981|75848816|FG001|Overall Study|Lack of Efficacy|61|||
42040865|NCT01371981|75848817|FG002|Overall Study|Lack of Efficacy|4|||
42040866|NCT01371981|75848818|FG003|Overall Study|Lack of Efficacy|8|||
42040867|NCT01371981|75848819|FG004|Overall Study|Lack of Efficacy|5|||
42040868|NCT01371981|75848820|FG005|Overall Study|Lack of Efficacy|0|||
42040869|NCT01371981|75848815|FG000|Overall Study|Physician Decision|48|||
42040870|NCT01371981|75848816|FG001|Overall Study|Physician Decision|63|||
42040871|NCT01371981|75848817|FG002|Overall Study|Physician Decision|1|||
42040872|NCT01371981|75848818|FG003|Overall Study|Physician Decision|7|||
42040873|NCT01371981|75848819|FG004|Overall Study|Physician Decision|14|||
42040874|NCT01371981|75848820|FG005|Overall Study|Physician Decision|3|||
42040875|NCT01371981|75848815|FG000|Overall Study|Withdrawal by Subject|12|||
42040876|NCT01371981|75848816|FG001|Overall Study|Withdrawal by Subject|19|||
42040877|NCT01371981|75848817|FG002|Overall Study|Withdrawal by Subject|1|||
42040878|NCT01371981|75848818|FG003|Overall Study|Withdrawal by Subject|2|||
42040879|NCT01371981|75848819|FG004|Overall Study|Withdrawal by Subject|10|||
42040880|NCT01371981|75848820|FG005|Overall Study|Withdrawal by Subject|3|||
42287631|NCT02079532|76120336|FG000|Overall Study|Additional or changed therapy|2|||
42287632|NCT02079532|76120336|FG000|Overall Study|Lack of Efficacy|9|||
42287633|NCT02079532|76120336|FG000|Overall Study|Protocol Violation|3|||
42287634|NCT02079532|76120336|FG000|Overall Study|Withdrawal by Subject|1|||
42287635|NCT02079532|76120336|FG000|Overall Study|Administrative problems|1|||
42287636|NCT02079532|76120336|FG000|Overall Study|Inclusion into ReFIRST|3|||
42287637|NCT02079532|76120336|FG000|Overall Study|Other|3|||
42040881|NCT01371981|75848815|FG000|Overall Study|Ineligible|19|||
42040882|NCT01371981|75848816|FG001|Overall Study|Ineligible|13|||
42040883|NCT01371981|75848817|FG002|Overall Study|Ineligible|0|||
42040884|NCT01371981|75848818|FG003|Overall Study|Ineligible|0|||
42040885|NCT01371981|75848819|FG004|Overall Study|Ineligible|0|||
42040886|NCT01371981|75848820|FG005|Overall Study|Ineligible|4|||
42040887|NCT01371981|75848815|FG000|Overall Study|Did not start treatment|2|||
42287638|NCT02357849|76120353|FG000|Overall Study|Withdrawal by Subject|2|||
42287639|NCT02357849|76120354|FG001|Overall Study|Withdrawal by Subject|3|||
42287640|NCT02709889|76120398|FG000|Overall Study|Withdrawal by Subject|11|||
42287641|NCT02709889|76120399|FG001|Overall Study|Withdrawal by Subject|10|||
42287642|NCT02709889|76120400|FG002|Overall Study|Withdrawal by Subject|2|||
42287643|NCT02709889|76120401|FG003|Overall Study|Withdrawal by Subject|12|||
42287644|NCT02709889|76120398|FG000|Overall Study|Death|25|||
42287645|NCT02709889|76120399|FG001|Overall Study|Death|38|||
42287646|NCT02709889|76120400|FG002|Overall Study|Death|4|||
42287647|NCT02709889|76120401|FG003|Overall Study|Death|44|||
42287648|NCT02709889|76120398|FG000|Overall Study|Physician Decision|1|||
42287649|NCT02709889|76120399|FG001|Overall Study|Physician Decision|2|||
42287650|NCT02709889|76120400|FG002|Overall Study|Physician Decision|3|||
42287651|NCT02709889|76120401|FG003|Overall Study|Physician Decision|5|||
42287652|NCT02709889|76120398|FG000|Overall Study|Lost to Follow-up|2|||
42287653|NCT02709889|76120399|FG001|Overall Study|Lost to Follow-up|0|||
42287654|NCT02709889|76120400|FG002|Overall Study|Lost to Follow-up|0|||
42287655|NCT02709889|76120401|FG003|Overall Study|Lost to Follow-up|4|||
42287656|NCT02709889|76120398|FG000|Overall Study|Study Terminated by Sponsor|4|||
42287657|NCT02709889|76120399|FG001|Overall Study|Study Terminated by Sponsor|6|||
42287658|NCT02709889|76120400|FG002|Overall Study|Study Terminated by Sponsor|2|||
42287659|NCT02709889|76120401|FG003|Overall Study|Study Terminated by Sponsor|17|||
42287660|NCT02709889|76120398|FG000|Overall Study|Other, Not Specified|0|||
42287661|NCT02709889|76120399|FG001|Overall Study|Other, Not Specified|1|||
42287662|NCT02709889|76120400|FG002|Overall Study|Other, Not Specified|1|||
42287663|NCT02709889|76120401|FG003|Overall Study|Other, Not Specified|6|||
42287664|NCT02711995|76120446|FG000|Washout (90 Days)|Conflicting medication|1|||
42287665|NCT02514239|76120484|FG000|Overall Study|Refused to continue trial medication|0|||
42287666|NCT02514239|76120485|FG001|Overall Study|Refused to continue trial medication|0|||
42287667|NCT02514239|76120486|FG002|Overall Study|Refused to continue trial medication|0|||
42287668|NCT02514239|76120487|FG003|Overall Study|Refused to continue trial medication|0|||
42287669|NCT02514239|76120488|FG004|Overall Study|Refused to continue trial medication|0|||
42287670|NCT02514239|76120489|FG005|Overall Study|Refused to continue trial medication|0|||
42287671|NCT02514239|76120490|FG006|Overall Study|Refused to continue trial medication|0|||
42287672|NCT02514239|76120491|FG007|Overall Study|Refused to continue trial medication|0|||
42287673|NCT02514239|76120492|FG008|Overall Study|Refused to continue trial medication|0|||
42287674|NCT02514239|76120493|FG009|Overall Study|Refused to continue trial medication|1|||
42287675|NCT02514239|76120484|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
42287676|NCT02514239|76120485|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
42287677|NCT02514239|76120486|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
42287678|NCT02514239|76120487|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
42287679|NCT02514239|76120488|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
42287680|NCT02514239|76120489|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
42287681|NCT02514239|76120490|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
42287682|NCT02514239|76120491|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
42287683|NCT02514239|76120492|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
42287684|NCT02514239|76120493|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
42287685|NCT02514239|76120484|FG000|Overall Study|Not treated|0|||
42287686|NCT02514239|76120485|FG001|Overall Study|Not treated|1|||
42287687|NCT02514239|76120486|FG002|Overall Study|Not treated|0|||
42287688|NCT02514239|76120487|FG003|Overall Study|Not treated|0|||
42287689|NCT02514239|76120488|FG004|Overall Study|Not treated|0|||
42287690|NCT02514239|76120489|FG005|Overall Study|Not treated|0|||
42287691|NCT02514239|76120490|FG006|Overall Study|Not treated|0|||
42287692|NCT02514239|76120491|FG007|Overall Study|Not treated|0|||
42287693|NCT02514239|76120492|FG008|Overall Study|Not treated|0|||
42287694|NCT02514239|76120493|FG009|Overall Study|Not treated|0|||
42287695|NCT02514239|76120484|FG000|Overall Study|Other Adverse Events|2|||
42287696|NCT02514239|76120485|FG001|Overall Study|Other Adverse Events|0|||
42015271|NCT01155063|75822409|FG000|Overall Study|Adverse Event|1|||
42015272|NCT01155063|75822409|FG000|Overall Study|Withdrawal by Subject|1|||
42015273|NCT01155063|75822409|FG000|Overall Study|Study terminated by sponsor|87|||
42015274|NCT01154673|75822415|FG000|Overall Study|Lost to Follow-up|1|||
42015275|NCT01154673|75822416|FG001|Overall Study|Lost to Follow-up|0|||
42015276|NCT01154673|75822415|FG000|Overall Study|moved out of province|1|||
42015277|NCT01154673|75822416|FG001|Overall Study|moved out of province|0|||
42015278|NCT01154283|75822424|FG000|0-6 Weeks|Withdrawal by Subject|7|||
42015279|NCT01154283|75822425|FG001|0-6 Weeks|Withdrawal by Subject|2|||
42015280|NCT01154283|75822424|FG000|0-6 Weeks|Death|0|||
42015281|NCT01154283|75822425|FG001|0-6 Weeks|Death|1|||
42015282|NCT01154283|75822424|FG000|7-12 Weeks|Death|1|||
42015283|NCT01154283|75822425|FG001|7-12 Weeks|Death|0|||
42015284|NCT01154283|75822424|FG000|7-12 Weeks|Withdrawal by Subject|0|||
42287697|NCT02514239|76120486|FG002|Overall Study|Other Adverse Events|0|||
42287698|NCT02514239|76120487|FG003|Overall Study|Other Adverse Events|1|||
42287699|NCT02514239|76120488|FG004|Overall Study|Other Adverse Events|0|||
42287700|NCT02514239|76120489|FG005|Overall Study|Other Adverse Events|1|||
42287701|NCT02514239|76120490|FG006|Overall Study|Other Adverse Events|0|||
42287702|NCT02514239|76120491|FG007|Overall Study|Other Adverse Events|1|||
42287703|NCT02514239|76120492|FG008|Overall Study|Other Adverse Events|2|||
42287704|NCT02514239|76120493|FG009|Overall Study|Other Adverse Events|0|||
42287705|NCT02514239|76120484|FG000|Overall Study|Progressive disease|3|||
42287706|NCT02514239|76120485|FG001|Overall Study|Progressive disease|3|||
42287707|NCT02514239|76120486|FG002|Overall Study|Progressive disease|2|||
42287708|NCT02514239|76120487|FG003|Overall Study|Progressive disease|2|||
42287709|NCT02514239|76120488|FG004|Overall Study|Progressive disease|3|||
42287710|NCT02514239|76120489|FG005|Overall Study|Progressive disease|3|||
42287711|NCT02514239|76120490|FG006|Overall Study|Progressive disease|4|||
42287712|NCT02514239|76120491|FG007|Overall Study|Progressive disease|2|||
42287713|NCT02514239|76120492|FG008|Overall Study|Progressive disease|5|||
42287714|NCT02514239|76120493|FG009|Overall Study|Progressive disease|0|||
42287715|NCT02709109|76120537|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
42287716|NCT02709109|76120538|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
42287717|NCT02709109|76120539|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
42287718|NCT02709109|76120540|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
42287719|NCT02709109|76120537|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
42287720|NCT02709109|76120538|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
42287721|NCT02709109|76120539|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
42171957|NCT02952586|75978797|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
42287722|NCT02709109|76120540|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
42287723|NCT02709109|76120537|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
42287724|NCT02709109|76120538|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
42287725|NCT02709109|76120539|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
42287726|NCT02709109|76120540|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
42287727|NCT02709109|76120537|FG000|Washout Period (28 Days)|Other|2|||
42287728|NCT02709109|76120538|FG001|Washout Period (28 Days)|Other|2|||
42287729|NCT02709109|76120539|FG002|Washout Period (28 Days)|Other|3|||
42287730|NCT02709109|76120540|FG003|Washout Period (28 Days)|Other|0|||
42287731|NCT02709109|76120537|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
42287732|NCT02709109|76120538|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
42287733|NCT02709109|76120539|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
42287734|NCT02709109|76120540|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
42287735|NCT02709109|76120537|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
42287736|NCT02709109|76120538|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
42287737|NCT02709109|76120539|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
42287738|NCT02709109|76120540|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
42287739|NCT02709109|76120537|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
42287740|NCT02709109|76120538|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
42287741|NCT02709109|76120539|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
42354196|NCT05020899|76195683|FG001|8 Week Follow-up|Lost to Follow-up|6|||
42015285|NCT01154283|75822425|FG001|7-12 Weeks|Withdrawal by Subject|1|||
42015286|NCT00944125|75822431|FG000|3 to 6 Months|Withdrawal by Subject|0|||
42015287|NCT00944125|75822432|FG001|3 to 6 Months|Withdrawal by Subject|2|||
42287742|NCT02709109|76120540|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
42287743|NCT02709109|76120537|FG000|Treatment Period 2 (28 Days)|Other|0|||
42287744|NCT02709109|76120538|FG001|Treatment Period 2 (28 Days)|Other|0|||
42354197|NCT05020899|76195682|FG000|12 Week Follow-up|Lost to Follow-up|1|||
42354198|NCT05020899|76195683|FG001|12 Week Follow-up|Lost to Follow-up|0|||
42015288|NCT00944125|75822431|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
42015289|NCT00944125|75822432|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
42015290|NCT00912223|75822438|FG000|Overall Study|Withdrawal by Subject|1|||
42015291|NCT00912223|75822438|FG000|Overall Study|Not transplanted|1|||
42015292|NCT00912223|75822438|FG000|Overall Study|Transformed disease|1|||
42015293|NCT01154127|75822444|FG000|Period 1 (21 Days)|Adverse Event|3|||
42015294|NCT01154127|75822445|FG001|Period 1 (21 Days)|Adverse Event|4|||
42015295|NCT01154127|75822444|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
42015296|NCT01154127|75822445|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
42015297|NCT01154127|75822444|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
42015298|NCT01154127|75822445|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
42015299|NCT01154127|75822444|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
42015300|NCT01154127|75822445|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
42015301|NCT01154127|75822444|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
42015302|NCT01154127|75822445|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
42015303|NCT01228734|75822453|FG000|Overall Study|Randomized, but not treated|0|||
42015304|NCT01228734|75822454|FG001|Overall Study|Randomized, but not treated|4|||
42015305|NCT01227954|75822460|FG000|Overall Study|Protocol Violation|6|||
42171958|NCT02952586|75978798|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
42287745|NCT02709109|76120539|FG002|Treatment Period 2 (28 Days)|Other|1|||
42287746|NCT02709109|76120540|FG003|Treatment Period 2 (28 Days)|Other|0|||
42287747|NCT04289051|76120555|FG000|Overall Study|Lost to Follow-up|0|||
42287748|NCT04289051|76120556|FG001|Overall Study|Lost to Follow-up|0|||
42287749|NCT04289051|76120557|FG002|Overall Study|Lost to Follow-up|2|||
42287750|NCT02709655|76120565|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
42287751|NCT02709655|76120566|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
42287752|NCT02709655|76120567|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
42287753|NCT02709655|76120568|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
42287754|NCT02709655|76120569|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
42287755|NCT02709655|76120565|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
42287756|NCT02709655|76120566|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
42287757|NCT02709655|76120567|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
42287758|NCT02709655|76120568|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
42287759|NCT02709655|76120569|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
42287760|NCT02709655|76120565|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
42287761|NCT02709655|76120566|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
42287762|NCT02709655|76120567|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
42287763|NCT02709655|76120568|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
42287764|NCT02709655|76120569|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
42354199|NCT05020899|76195682|FG000|12 Week Follow-up|Death|0|||
42354200|NCT05020899|76195683|FG001|12 Week Follow-up|Death|1|||
42354201|NCT04806503|76195713|FG000|Overall Study|Lost to Follow-up|0|||
42354202|NCT04806503|76195714|FG001|Overall Study|Lost to Follow-up|0|||
42354203|NCT04806503|76195715|FG002|Overall Study|Lost to Follow-up|1|||
42354204|NCT04806503|76195716|FG003|Overall Study|Lost to Follow-up|0|||
42354205|NCT04806503|76195717|FG004|Overall Study|Lost to Follow-up|0|||
42354206|NCT04806503|76195713|FG000|Overall Study|Withdrawal by Subject|1|||
42354207|NCT04806503|76195714|FG001|Overall Study|Withdrawal by Subject|0|||
42354208|NCT04806503|76195715|FG002|Overall Study|Withdrawal by Subject|1|||
42171959|NCT02952586|75978797|FG000|CRT for Cisplatin (63 Days)|Death|3|||
42171960|NCT02952586|75978798|FG001|CRT for Cisplatin (63 Days)|Death|8|||
42171961|NCT02952586|75978797|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
42171962|NCT02952586|75978798|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
42171963|NCT02952586|75978797|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
42287765|NCT02709655|76120565|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
42287766|NCT02709655|76120566|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
42287767|NCT02709655|76120567|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
42287768|NCT02709655|76120568|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
42171964|NCT02952586|75978798|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
42171965|NCT02952586|75978797|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
42171966|NCT02952586|75978798|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
42287769|NCT02709655|76120569|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
42287770|NCT02709655|76120565|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
42287771|NCT02709655|76120566|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
42015306|NCT01227954|75822460|FG000|Overall Study|No protocol treatment|7|||
42015307|NCT01153971|75822464|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
42287772|NCT02709655|76120567|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
42287773|NCT02709655|76120568|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
42287774|NCT02709655|76120569|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
42287775|NCT02709655|76120565|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
42015308|NCT01153971|75822464|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
42015309|NCT01153971|75822464|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
42015310|NCT01153971|75822464|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
42015311|NCT01153971|75822464|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
42015312|NCT01153971|75822464|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
42015313|NCT01153971|75822464|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
42015314|NCT01153893|75822470|FG000|Overall Study|Adverse Event|1|||
42354209|NCT04806503|76195716|FG003|Overall Study|Withdrawal by Subject|1|||
42287776|NCT02709655|76120566|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
42287777|NCT02709655|76120567|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
42354210|NCT04806503|76195717|FG004|Overall Study|Withdrawal by Subject|1|||
42354211|NCT04806503|76195713|FG000|Overall Study|Adverse Event|1|||
42354212|NCT04806503|76195714|FG001|Overall Study|Adverse Event|1|||
42015315|NCT01153893|75822471|FG001|Overall Study|Adverse Event|0|||
42354213|NCT04806503|76195715|FG002|Overall Study|Adverse Event|0|||
42354214|NCT04806503|76195716|FG003|Overall Study|Adverse Event|1|||
42015316|NCT00951379|75822479|FG000|Overall Study|Adverse Event|4|||
42354215|NCT04806503|76195717|FG004|Overall Study|Adverse Event|0|||
42015317|NCT00951379|75822480|FG001|Overall Study|Adverse Event|1|||
42287778|NCT02709655|76120568|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
42287779|NCT02709655|76120569|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
42287780|NCT02709655|76120565|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
42287781|NCT02709655|76120566|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
42287782|NCT02709655|76120567|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
42287783|NCT02709655|76120568|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
42287784|NCT02709655|76120569|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
42287785|NCT02709655|76120565|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
42287786|NCT02709655|76120566|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
42287787|NCT02709655|76120567|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
42287788|NCT02709655|76120568|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
42287789|NCT02709655|76120569|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
42354216|NCT04508751|76195733|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
42354217|NCT04508751|76195734|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
42354218|NCT04508751|76195735|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
42354219|NCT04473482|76195745|FG000|Overall Study|Death|0|||
42354220|NCT04473482|76195746|FG001|Overall Study|Death|3|||
42354221|NCT04473482|76195745|FG000|Overall Study|Lost to Follow-up|9|||
42354222|NCT04473482|76195746|FG001|Overall Study|Lost to Follow-up|7|||
42354223|NCT04473482|76195745|FG000|Overall Study|Withdrawal by Subject|2|||
42354224|NCT04473482|76195746|FG001|Overall Study|Withdrawal by Subject|1|||
42354225|NCT03919799|76195756|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
42354226|NCT03919799|76195757|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
42287790|NCT02709655|76120565|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
42354227|NCT03919799|76195758|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
42354228|NCT03919799|76195759|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
42354229|NCT03919799|76195760|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
42354230|NCT03919799|76195756|FG000|DB Period (28 Weeks)|Adverse Event|1|||
42354231|NCT03919799|76195757|FG001|DB Period (28 Weeks)|Adverse Event|1|||
42354232|NCT03919799|76195758|FG002|DB Period (28 Weeks)|Adverse Event|1|||
42354233|NCT03919799|76195759|FG003|DB Period (28 Weeks)|Adverse Event|0|||
42354234|NCT03919799|76195760|FG004|DB Period (28 Weeks)|Adverse Event|0|||
42354235|NCT03919799|76195756|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
42354236|NCT03919799|76195757|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
42354237|NCT03919799|76195758|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
42354238|NCT03919799|76195759|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
42354239|NCT03919799|76195760|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
42354240|NCT03919799|76195756|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
42354241|NCT03919799|76195757|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
42354242|NCT03919799|76195758|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
42354243|NCT03919799|76195759|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
42354244|NCT03919799|76195760|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
42354245|NCT03919799|76195756|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
42354246|NCT03919799|76195757|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
42354247|NCT03919799|76195758|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
42354248|NCT03919799|76195759|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
42354249|NCT03919799|76195760|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
42354250|NCT03621735|76195805|FG000|Overall Study|Withdrawal by Subject|13|||
42354251|NCT03621735|76195806|FG001|Overall Study|Withdrawal by Subject|13|||
42354252|NCT03245151|76195866|FG000|Overall Study|Withdrawal by Subject|2|||
42354253|NCT03245151|76195867|FG001|Overall Study|Withdrawal by Subject|0|||
42287791|NCT02709655|76120566|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
42287792|NCT02709655|76120567|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
42287793|NCT02709655|76120568|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
42287794|NCT02709655|76120569|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
42287795|NCT02709655|76120565|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
42287796|NCT02709655|76120566|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
42287797|NCT02709655|76120567|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
42287798|NCT02709655|76120568|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
42287799|NCT02709655|76120569|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
42287800|NCT02709655|76120565|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
42287801|NCT02709655|76120566|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
42287802|NCT02709655|76120567|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
42287803|NCT02709655|76120568|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
42287804|NCT02709655|76120569|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
42287805|NCT02709655|76120565|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
42354254|NCT03245151|76195868|FG002|Overall Study|Withdrawal by Subject|0|||
42354255|NCT03245151|76195869|FG003|Overall Study|Withdrawal by Subject|2|||
42354256|NCT03245151|76195870|FG004|Overall Study|Withdrawal by Subject|1|||
42354257|NCT03245151|76195866|FG000|Overall Study|Death|3|||
42287806|NCT02709655|76120566|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
42287807|NCT02709655|76120567|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
42287808|NCT02709655|76120568|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
42287809|NCT02709655|76120569|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
42287810|NCT02709655|76120565|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
42287811|NCT02709655|76120566|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
42287812|NCT02709655|76120567|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
42287813|NCT02709655|76120568|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
42287814|NCT02709655|76120569|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
42287815|NCT02709655|76120565|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
42287816|NCT02709655|76120566|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
42287817|NCT02709655|76120567|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
42287818|NCT02709655|76120568|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
42287819|NCT02709655|76120569|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
42287820|NCT02709655|76120565|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
42287821|NCT02709655|76120566|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
42287822|NCT02709655|76120567|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
42287823|NCT02709655|76120568|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
42287824|NCT02709655|76120569|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
42287825|NCT02709655|76120565|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
42287826|NCT02709655|76120566|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
42287827|NCT02709655|76120567|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
42287828|NCT02709655|76120568|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
42287829|NCT02709655|76120569|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
42287830|NCT02708485|76120583|FG000|Overall Study|Withdrawal by Subject|3|||
42287831|NCT02708485|76120584|FG001|Overall Study|Withdrawal by Subject|2|||
42287832|NCT02709577|76120596|FG000|Overall Study|non-accommodating anatomy|0|||
42287833|NCT02709577|76120597|FG001|Overall Study|non-accommodating anatomy|1|||
42287834|NCT02709577|76120598|FG002|Overall Study|non-accommodating anatomy|0|||
42287835|NCT02709577|76120599|FG003|Overall Study|non-accommodating anatomy|0|||
42287836|NCT02709577|76120596|FG000|Overall Study|procedural complication|0|||
42287837|NCT02709577|76120597|FG001|Overall Study|procedural complication|1|||
42287838|NCT02709577|76120598|FG002|Overall Study|procedural complication|0|||
42287839|NCT02709577|76120599|FG003|Overall Study|procedural complication|0|||
42354258|NCT03245151|76195867|FG001|Overall Study|Death|14|||
42354259|NCT03245151|76195868|FG002|Overall Study|Death|9|||
42354260|NCT03245151|76195869|FG003|Overall Study|Death|16|||
42354261|NCT03245151|76195870|FG004|Overall Study|Death|7|||
42354262|NCT03245151|76195866|FG000|Overall Study|Sponsor's decision|0|||
42354263|NCT03245151|76195867|FG001|Overall Study|Sponsor's decision|1|||
42354264|NCT03245151|76195868|FG002|Overall Study|Sponsor's decision|0|||
42354265|NCT03245151|76195869|FG003|Overall Study|Sponsor's decision|0|||
42287840|NCT02709577|76120596|FG000|Overall Study|Withdrawal by Subject|2|||
42287841|NCT02709577|76120597|FG001|Overall Study|Withdrawal by Subject|3|||
42287842|NCT02709577|76120598|FG002|Overall Study|Withdrawal by Subject|2|||
42287843|NCT02709577|76120599|FG003|Overall Study|Withdrawal by Subject|0|||
42287844|NCT02078752|76120620|FG000|Overall Study|Death|0|||
42287845|NCT02078752|76120621|FG001|Overall Study|Death|3|||
42287846|NCT02078752|76120622|FG002|Overall Study|Death|0|||
42287847|NCT02078752|76120623|FG003|Overall Study|Death|0|||
42287848|NCT02078752|76120624|FG004|Overall Study|Death|0|||
42287849|NCT02078752|76120625|FG005|Overall Study|Death|1|||
42287850|NCT02078752|76120626|FG006|Overall Study|Death|0|||
42287851|NCT02078752|76120627|FG007|Overall Study|Death|1|||
42287852|NCT02078752|76120628|FG008|Overall Study|Death|0|||
42287853|NCT02078752|76120629|FG009|Overall Study|Death|4|||
42287854|NCT02078752|76120620|FG000|Overall Study|Lost to Follow-up|1|||
42287855|NCT02078752|76120621|FG001|Overall Study|Lost to Follow-up|0|||
42354266|NCT03245151|76195870|FG004|Overall Study|Sponsor's decision|0|||
42287856|NCT02078752|76120622|FG002|Overall Study|Lost to Follow-up|0|||
42287857|NCT02078752|76120623|FG003|Overall Study|Lost to Follow-up|1|||
42287858|NCT02078752|76120624|FG004|Overall Study|Lost to Follow-up|0|||
42287859|NCT02078752|76120625|FG005|Overall Study|Lost to Follow-up|0|||
42287860|NCT02078752|76120626|FG006|Overall Study|Lost to Follow-up|0|||
42287861|NCT02078752|76120627|FG007|Overall Study|Lost to Follow-up|0|||
42354267|NCT02227199|76195904|FG000|Overall Study|Physician Decision|0|||
42354268|NCT02227199|76195905|FG001|Overall Study|Physician Decision|0|||
42354269|NCT02227199|76195906|FG002|Overall Study|Physician Decision|1|||
42287862|NCT02078752|76120628|FG008|Overall Study|Lost to Follow-up|0|||
42287863|NCT02078752|76120629|FG009|Overall Study|Lost to Follow-up|0|||
42287864|NCT02078752|76120620|FG000|Overall Study|Withdrawal by Subject|1|||
42287865|NCT02078752|76120621|FG001|Overall Study|Withdrawal by Subject|1|||
42287866|NCT02078752|76120622|FG002|Overall Study|Withdrawal by Subject|1|||
42287867|NCT02078752|76120623|FG003|Overall Study|Withdrawal by Subject|1|||
42287868|NCT02078752|76120624|FG004|Overall Study|Withdrawal by Subject|0|||
42287869|NCT02078752|76120625|FG005|Overall Study|Withdrawal by Subject|3|||
42287870|NCT02078752|76120626|FG006|Overall Study|Withdrawal by Subject|2|||
42287871|NCT02078752|76120627|FG007|Overall Study|Withdrawal by Subject|1|||
42354270|NCT02227199|76195904|FG000|Overall Study|Adverse Event|0|||
42354271|NCT02227199|76195905|FG001|Overall Study|Adverse Event|0|||
42354272|NCT02227199|76195906|FG002|Overall Study|Adverse Event|3|||
42354273|NCT02087865|76195921|FG000|Overall Study|Withdrawal by Subject|6|||
42354274|NCT02087865|76195922|FG001|Overall Study|Withdrawal by Subject|0|||
42354275|NCT02087865|76195923|FG002|Overall Study|Withdrawal by Subject|1|||
42287872|NCT02078752|76120628|FG008|Overall Study|Withdrawal by Subject|0|||
42287873|NCT02078752|76120629|FG009|Overall Study|Withdrawal by Subject|1|||
42287874|NCT02078752|76120620|FG000|Overall Study|Other|0|||
42287875|NCT02078752|76120621|FG001|Overall Study|Other|3|||
42287876|NCT02078752|76120622|FG002|Overall Study|Other|0|||
42287877|NCT02078752|76120623|FG003|Overall Study|Other|0|||
42287878|NCT02078752|76120624|FG004|Overall Study|Other|1|||
42287879|NCT02078752|76120625|FG005|Overall Study|Other|0|||
42287880|NCT02078752|76120626|FG006|Overall Study|Other|0|||
42287881|NCT02078752|76120627|FG007|Overall Study|Other|1|||
42287882|NCT02078752|76120628|FG008|Overall Study|Other|0|||
42287883|NCT02078752|76120629|FG009|Overall Study|Other|0|||
42287884|NCT02078752|76120620|FG000|Overall Study|Study terminated by sponsor|0|||
42287885|NCT02078752|76120621|FG001|Overall Study|Study terminated by sponsor|0|||
42287886|NCT02078752|76120622|FG002|Overall Study|Study terminated by sponsor|0|||
42287887|NCT02078752|76120623|FG003|Overall Study|Study terminated by sponsor|0|||
42287888|NCT02078752|76120624|FG004|Overall Study|Study terminated by sponsor|0|||
42287889|NCT02078752|76120625|FG005|Overall Study|Study terminated by sponsor|0|||
42354276|NCT02087865|76195921|FG000|Overall Study|Lost to Follow-up|0|||
42354277|NCT02087865|76195922|FG001|Overall Study|Lost to Follow-up|0|||
42354278|NCT02087865|76195923|FG002|Overall Study|Lost to Follow-up|1|||
42354279|NCT02087865|76195921|FG000|Overall Study|Drug Non-compliance|0|||
42354280|NCT02087865|76195922|FG001|Overall Study|Drug Non-compliance|2|||
42354281|NCT02087865|76195923|FG002|Overall Study|Drug Non-compliance|0|||
42287890|NCT02078752|76120626|FG006|Overall Study|Study terminated by sponsor|0|||
42354282|NCT02087865|76195921|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
42354283|NCT02087865|76195922|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
42354284|NCT02087865|76195923|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
42354285|NCT01682083|76195943|FG000|Overall Study|Lost to Follow-up|11|||
42287891|NCT02078752|76120627|FG007|Overall Study|Study terminated by sponsor|0|||
42287892|NCT02078752|76120628|FG008|Overall Study|Study terminated by sponsor|0|||
42287893|NCT02078752|76120629|FG009|Overall Study|Study terminated by sponsor|5|||
42287894|NCT02022748|76120662|FG000|Overall Study|Adverse Event|1|||
42287895|NCT02022748|76120663|FG001|Overall Study|Adverse Event|1|||
42287896|NCT02022748|76120664|FG002|Overall Study|Adverse Event|0|||
42287897|NCT02022748|76120662|FG000|Overall Study|Withdrawal by Subject|0|||
42287898|NCT02022748|76120663|FG001|Overall Study|Withdrawal by Subject|1|||
42287899|NCT02022748|76120664|FG002|Overall Study|Withdrawal by Subject|0|||
42287900|NCT02022670|76120675|FG000|Overall Study|Adverse Event|1|||
42287901|NCT02022670|76120676|FG001|Overall Study|Adverse Event|0|||
42287902|NCT02022670|76120677|FG002|Overall Study|Adverse Event|1|||
42287903|NCT02076334|76120690|FG000|Overall Study|Protocol Violation|1|||
42287904|NCT02076334|76120691|FG001|Overall Study|Protocol Violation|0|||
42287905|NCT02076334|76120692|FG002|Overall Study|Protocol Violation|0|||
42287906|NCT02076334|76120693|FG003|Overall Study|Protocol Violation|0|||
42287907|NCT02076334|76120690|FG000|Overall Study|Lost to Follow-up|0|||
42287908|NCT02076334|76120691|FG001|Overall Study|Lost to Follow-up|1|||
42040888|NCT01371981|75848816|FG001|Overall Study|Did not start treatment|3|||
42287909|NCT02076334|76120692|FG002|Overall Study|Lost to Follow-up|1|||
42287910|NCT02076334|76120693|FG003|Overall Study|Lost to Follow-up|0|||
42287911|NCT02076334|76120690|FG000|Overall Study|muscle soreness|0|||
42287912|NCT02076334|76120691|FG001|Overall Study|muscle soreness|0|||
42287913|NCT02076334|76120692|FG002|Overall Study|muscle soreness|0|||
42287914|NCT02076334|76120693|FG003|Overall Study|muscle soreness|1|||
42287915|NCT02021812|76120703|FG000|Overall Study|Death|8|||
42287916|NCT02021812|76120703|FG000|Overall Study|Withdrawal by Subject|3|||
42287917|NCT02021812|76120703|FG000|Overall Study|Lost to Follow-up|2|||
42287918|NCT02021812|76120703|FG000|Overall Study|Refuse to return, COVD 19|2|||
42287919|NCT02021656|76120707|FG000|Overall Study|Adverse Event|1|||
42354286|NCT01682083|76195944|FG001|Overall Study|Lost to Follow-up|18|||
42354287|NCT01682083|76195943|FG000|Overall Study|Withdrawal by Subject|31|||
42354288|NCT01682083|76195944|FG001|Overall Study|Withdrawal by Subject|40|||
42354289|NCT01682083|76195943|FG000|Overall Study|Death|60|||
42287920|NCT02021656|76120707|FG000|Overall Study|Lack of Efficacy|2|||
42287921|NCT02021656|76120707|FG000|Overall Study|Lost to Follow-up|1|||
42287922|NCT02021656|76120707|FG000|Overall Study|Withdrew Consent|2|||
42287923|NCT02076022|76120717|FG000|Overall Study|Withdrawal by Subject|2|||
42287924|NCT02076022|76120718|FG001|Overall Study|Withdrawal by Subject|0|||
42287925|NCT02075632|76120726|FG000|Overall Study|Adverse Event|1|||
42287926|NCT02075632|76120727|FG001|Overall Study|Adverse Event|1|||
42287927|NCT02075632|76120726|FG000|Overall Study|Lost to Follow-up|0|||
42287928|NCT02075632|76120727|FG001|Overall Study|Lost to Follow-up|3|||
42287929|NCT02075632|76120726|FG000|Overall Study|Withdrawal by Subject|0|||
42287930|NCT02075632|76120727|FG001|Overall Study|Withdrawal by Subject|1|||
42287931|NCT02075554|76120733|FG000|Overall Study|Lost to Follow-up|7|||
42287932|NCT02075554|76120733|FG000|Overall Study|Withdrawal by Subject|5|||
42287933|NCT02075554|76120733|FG000|Overall Study|Physician Decision|3|||
42287934|NCT02075476|76120739|FG000|Overall Study|Death|2|||
42287935|NCT02075476|76120740|FG001|Overall Study|Death|2|||
42287936|NCT02075476|76120739|FG000|Overall Study|Lost to Follow-up|1|||
42287937|NCT02075476|76120740|FG001|Overall Study|Lost to Follow-up|3|||
42287938|NCT02075320|76120746|FG000|Overall Study|Withdrawal by Subject|2|||
42287939|NCT02708095|76120753|FG000|Overall Study|Adverse Event|4|||
42287940|NCT02708095|76120754|FG001|Overall Study|Adverse Event|10|||
42287941|NCT02708095|76120755|FG002|Overall Study|Adverse Event|11|||
42287942|NCT02708095|76120753|FG000|Overall Study|Lack of Efficacy|9|||
42287943|NCT02708095|76120754|FG001|Overall Study|Lack of Efficacy|3|||
42287944|NCT02708095|76120755|FG002|Overall Study|Lack of Efficacy|0|||
42287945|NCT02708095|76120753|FG000|Overall Study|Lost to Follow-up|2|||
42287946|NCT02708095|76120754|FG001|Overall Study|Lost to Follow-up|0|||
42287947|NCT02708095|76120755|FG002|Overall Study|Lost to Follow-up|0|||
42287948|NCT02708095|76120753|FG000|Overall Study|Physician Decision|2|||
42287949|NCT02708095|76120754|FG001|Overall Study|Physician Decision|3|||
42354290|NCT01682083|76195944|FG001|Overall Study|Death|93|||
42354291|NCT01682083|76195943|FG000|Overall Study|Physician Decision|5|||
42354292|NCT01682083|76195944|FG001|Overall Study|Physician Decision|4|||
42354293|NCT01180790|76195961|FG000|Overall Study|Adverse Event|1|||
42354294|NCT01180790|76195962|FG001|Overall Study|Adverse Event|1|||
42354295|NCT01180790|76195963|FG002|Overall Study|Adverse Event|2|||
42354296|NCT01180790|76195964|FG003|Overall Study|Adverse Event|0|||
42354297|NCT01180790|76195965|FG004|Overall Study|Adverse Event|1|||
42354298|NCT01180790|76195966|FG005|Overall Study|Adverse Event|3|||
42354299|NCT01180790|76195967|FG006|Overall Study|Adverse Event|0|||
42354300|NCT01180790|76195961|FG000|Overall Study|Withdrawal by Subject|3|||
42354301|NCT01180790|76195962|FG001|Overall Study|Withdrawal by Subject|0|||
42354302|NCT01180790|76195963|FG002|Overall Study|Withdrawal by Subject|5|||
42354303|NCT01180790|76195964|FG003|Overall Study|Withdrawal by Subject|0|||
42354304|NCT01180790|76195965|FG004|Overall Study|Withdrawal by Subject|2|||
42354305|NCT01180790|76195966|FG005|Overall Study|Withdrawal by Subject|1|||
42354306|NCT01180790|76195967|FG006|Overall Study|Withdrawal by Subject|0|||
42354307|NCT01180790|76195961|FG000|Overall Study|Lost to Follow-up|3|||
42354308|NCT01180790|76195962|FG001|Overall Study|Lost to Follow-up|1|||
42354309|NCT01180790|76195963|FG002|Overall Study|Lost to Follow-up|0|||
42354310|NCT01180790|76195964|FG003|Overall Study|Lost to Follow-up|2|||
42354311|NCT01180790|76195965|FG004|Overall Study|Lost to Follow-up|1|||
42354312|NCT01180790|76195966|FG005|Overall Study|Lost to Follow-up|0|||
42354313|NCT01180790|76195967|FG006|Overall Study|Lost to Follow-up|1|||
42354314|NCT01180790|76195961|FG000|Overall Study|Physician Decision|1|||
42015318|NCT00951379|75822479|FG000|Overall Study|Withdrawal by Subject|1|||
42171967|NCT02952586|75978797|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
42287950|NCT02708095|76120755|FG002|Overall Study|Physician Decision|2|||
42287951|NCT02708095|76120753|FG000|Overall Study|Protocol Violation|0|||
42287952|NCT02708095|76120754|FG001|Overall Study|Protocol Violation|0|||
42287953|NCT02708095|76120755|FG002|Overall Study|Protocol Violation|1|||
42287954|NCT02708095|76120753|FG000|Overall Study|Withdrawal by Subject|5|||
42287955|NCT02708095|76120754|FG001|Overall Study|Withdrawal by Subject|3|||
42287956|NCT02708095|76120755|FG002|Overall Study|Withdrawal by Subject|4|||
42287957|NCT02707861|76120767|FG000|Overall Study|Went onto commercial drug|30|||
42287958|NCT02707861|76120768|FG001|Overall Study|Went onto commercial drug|23|||
42354315|NCT01180790|76195962|FG001|Overall Study|Physician Decision|0|||
42354316|NCT01180790|76195963|FG002|Overall Study|Physician Decision|0|||
42354317|NCT01180790|76195964|FG003|Overall Study|Physician Decision|1|||
42287959|NCT02707861|76120767|FG000|Overall Study|Adverse Event|2|||
42354318|NCT01180790|76195965|FG004|Overall Study|Physician Decision|0|||
42354319|NCT01180790|76195966|FG005|Overall Study|Physician Decision|0|||
42354320|NCT01180790|76195967|FG006|Overall Study|Physician Decision|0|||
42354321|NCT01180790|76195961|FG000|Overall Study|Lack of Efficacy|1|||
42287960|NCT02707861|76120768|FG001|Overall Study|Adverse Event|3|||
42287961|NCT02707861|76120767|FG000|Overall Study|Death|5|||
42287962|NCT02707861|76120768|FG001|Overall Study|Death|2|||
42287963|NCT02707861|76120767|FG000|Overall Study|Lack of Efficacy|0|||
42287964|NCT02707861|76120768|FG001|Overall Study|Lack of Efficacy|2|||
42287965|NCT02707861|76120767|FG000|Overall Study|Physician Decision|1|||
42287966|NCT02707861|76120768|FG001|Overall Study|Physician Decision|4|||
42287967|NCT02707861|76120767|FG000|Overall Study|Withdrawal by Subject|2|||
42287968|NCT02707861|76120768|FG001|Overall Study|Withdrawal by Subject|1|||
42287969|NCT02707861|76120767|FG000|Overall Study|Lost to Follow-up|1|||
42287970|NCT02707861|76120768|FG001|Overall Study|Lost to Follow-up|3|||
42354322|NCT01180790|76195962|FG001|Overall Study|Lack of Efficacy|2|||
42354323|NCT01180790|76195963|FG002|Overall Study|Lack of Efficacy|5|||
42354324|NCT01180790|76195964|FG003|Overall Study|Lack of Efficacy|6|||
42354325|NCT01180790|76195965|FG004|Overall Study|Lack of Efficacy|1|||
42354326|NCT01180790|76195966|FG005|Overall Study|Lack of Efficacy|3|||
42354327|NCT01180790|76195967|FG006|Overall Study|Lack of Efficacy|0|||
42354328|NCT01180790|76195961|FG000|Overall Study|compliance|0|||
42354329|NCT01180790|76195962|FG001|Overall Study|compliance|1|||
42354330|NCT01180790|76195963|FG002|Overall Study|compliance|0|||
42354331|NCT01180790|76195964|FG003|Overall Study|compliance|0|||
42354332|NCT01180790|76195965|FG004|Overall Study|compliance|0|||
42354333|NCT01180790|76195966|FG005|Overall Study|compliance|0|||
42354334|NCT01180790|76195967|FG006|Overall Study|compliance|0|||
42354335|NCT01180790|76195961|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
42354336|NCT01180790|76195962|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
42354337|NCT01180790|76195963|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
42354338|NCT01180790|76195964|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
42354339|NCT01180790|76195965|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
42354340|NCT01180790|76195966|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
42354341|NCT01180790|76195967|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
42354342|NCT00679042|76196016|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
42354343|NCT00679042|76196016|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
42354344|NCT00679042|76196016|FG000|5-Year Follow Up|Death|1|||
42354345|NCT00679042|76196016|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
42354346|NCT00679042|76196016|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
42354347|NCT00350272|76196022|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
42354348|NCT00350272|76196023|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
42354349|NCT00350272|76196022|FG000|Blinded 12-Week Treatment|Death|1|||
42354350|NCT00350272|76196023|FG001|Blinded 12-Week Treatment|Death|0|||
42354351|NCT00350272|76196022|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
42354352|NCT00350272|76196023|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
42354353|NCT00350272|76196022|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
42354354|NCT00350272|76196023|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
42354355|NCT00350272|76196022|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
42354356|NCT00350272|76196023|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
42354357|NCT00350272|76196022|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
42354358|NCT00350272|76196023|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
42354359|NCT00350272|76196022|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
42354360|NCT00350272|76196023|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
42354361|NCT00350272|76196022|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
42354362|NCT00350272|76196023|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
42015319|NCT00951379|75822480|FG001|Overall Study|Withdrawal by Subject|0|||
42015320|NCT00951379|75822479|FG000|Overall Study|Noncompliance|1|||
42015321|NCT00951379|75822480|FG001|Overall Study|Noncompliance|0|||
42354363|NCT00350272|76196022|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
42354364|NCT00350272|76196023|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
42354365|NCT00350272|76196022|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
42354366|NCT00350272|76196023|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
42354367|NCT00350272|76196022|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
42354368|NCT00350272|76196023|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
42354369|NCT02028884|76196034|FG000|Double-blind Period|Adverse Event|5|||
42354370|NCT02028884|76196035|FG001|Double-blind Period|Adverse Event|3|||
42354371|NCT02028884|76196036|FG002|Double-blind Period|Adverse Event|0|||
42015322|NCT00951379|75822479|FG000|Overall Study|Disease Progression|0|||
42354372|NCT02028884|76196034|FG000|Double-blind Period|Eligibility Violation|1|||
42354373|NCT02028884|76196035|FG001|Double-blind Period|Eligibility Violation|0|||
42354374|NCT02028884|76196036|FG002|Double-blind Period|Eligibility Violation|0|||
42354375|NCT02028884|76196034|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
42354376|NCT02028884|76196035|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
42354377|NCT02028884|76196036|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
42354378|NCT02028884|76196034|FG000|Double-blind Period|Withdrawal by Subject|2|||
42354379|NCT02028884|76196035|FG001|Double-blind Period|Withdrawal by Subject|0|||
42354380|NCT02028884|76196036|FG002|Double-blind Period|Withdrawal by Subject|0|||
42354381|NCT02028884|76196034|FG000|Open-label Extension Period|Adverse Event|3|||
42354382|NCT02028884|76196035|FG001|Open-label Extension Period|Adverse Event|1|||
42354383|NCT02028884|76196036|FG002|Open-label Extension Period|Adverse Event|0|||
42354384|NCT02028884|76196034|FG000|Open-label Extension Period|Lack of Efficacy|3|||
42354385|NCT02028884|76196035|FG001|Open-label Extension Period|Lack of Efficacy|0|||
42287971|NCT02027428|76120776|FG000|Induction|Never treated|7|||
42287972|NCT02027428|76120777|FG001|Induction|Never treated|0|||
42287973|NCT02027428|76120778|FG002|Induction|Never treated|0|||
42287974|NCT02027428|76120776|FG000|Induction|Progressive disease|77|||
42287975|NCT02027428|76120777|FG001|Induction|Progressive disease|0|||
42287976|NCT02027428|76120778|FG002|Induction|Progressive disease|0|||
42287977|NCT02027428|76120776|FG000|Induction|Adverse Event|51|||
42287978|NCT02027428|76120777|FG001|Induction|Adverse Event|0|||
42287979|NCT02027428|76120778|FG002|Induction|Adverse Event|0|||
42287980|NCT02027428|76120776|FG000|Induction|Withdrawal by Subject|22|||
42287981|NCT02027428|76120777|FG001|Induction|Withdrawal by Subject|0|||
42287982|NCT02027428|76120778|FG002|Induction|Withdrawal by Subject|0|||
42287983|NCT02027428|76120776|FG000|Induction|Death|21|||
42287984|NCT02027428|76120777|FG001|Induction|Death|0|||
42287985|NCT02027428|76120778|FG002|Induction|Death|0|||
42287986|NCT02027428|76120776|FG000|Induction|Symptomatic deterioration|16|||
42287987|NCT02027428|76120777|FG001|Induction|Symptomatic deterioration|0|||
42287988|NCT02027428|76120778|FG002|Induction|Symptomatic deterioration|0|||
42354386|NCT02028884|76196036|FG002|Open-label Extension Period|Lack of Efficacy|0|||
42354387|NCT02028884|76196034|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
42354388|NCT02028884|76196035|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
42354389|NCT02028884|76196036|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
42015323|NCT00951379|75822480|FG001|Overall Study|Disease Progression|1|||
42287989|NCT02027428|76120776|FG000|Induction|Study terminated by sponsor|12|||
42287990|NCT02027428|76120777|FG001|Induction|Study terminated by sponsor|0|||
42354390|NCT02028884|76196034|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
42287991|NCT02027428|76120778|FG002|Induction|Study terminated by sponsor|0|||
42287992|NCT02027428|76120776|FG000|Induction|Protocol Violation|1|||
42287993|NCT02027428|76120777|FG001|Induction|Protocol Violation|0|||
42287994|NCT02027428|76120778|FG002|Induction|Protocol Violation|0|||
42287995|NCT02027428|76120776|FG000|Induction|Miscellaneous|14|||
42287996|NCT02027428|76120777|FG001|Induction|Miscellaneous|0|||
42287997|NCT02027428|76120778|FG002|Induction|Miscellaneous|0|||
42287998|NCT02027428|76120776|FG000|Induction|Induction Treatment Ongoing|4|||
42287999|NCT02027428|76120777|FG001|Induction|Induction Treatment Ongoing|0|||
42288000|NCT02027428|76120778|FG002|Induction|Induction Treatment Ongoing|0|||
42288001|NCT02027428|76120776|FG000|Maintenance|Death|0|||
42288002|NCT02027428|76120777|FG001|Maintenance|Death|3|||
42288003|NCT02027428|76120778|FG002|Maintenance|Death|2|||
42288004|NCT02027428|76120776|FG000|Maintenance|Adverse Event|0|||
42288005|NCT02027428|76120777|FG001|Maintenance|Adverse Event|21|||
42288006|NCT02027428|76120778|FG002|Maintenance|Adverse Event|1|||
42288007|NCT02027428|76120776|FG000|Maintenance|Progressive disease|0|||
42288008|NCT02027428|76120777|FG001|Maintenance|Progressive disease|84|||
42288009|NCT02027428|76120778|FG002|Maintenance|Progressive disease|47|||
42288010|NCT02027428|76120776|FG000|Maintenance|Symptomatic deterioration|0|||
42288011|NCT02027428|76120777|FG001|Maintenance|Symptomatic deterioration|4|||
42288012|NCT02027428|76120778|FG002|Maintenance|Symptomatic deterioration|1|||
42288013|NCT02027428|76120776|FG000|Maintenance|Withdrawal by Subject|0|||
42288014|NCT02027428|76120777|FG001|Maintenance|Withdrawal by Subject|6|||
42288015|NCT02027428|76120778|FG002|Maintenance|Withdrawal by Subject|5|||
42288016|NCT02027428|76120776|FG000|Maintenance|Protocol Violation|0|||
42288017|NCT02027428|76120777|FG001|Maintenance|Protocol Violation|0|||
42288018|NCT02027428|76120778|FG002|Maintenance|Protocol Violation|1|||
42288019|NCT02027428|76120776|FG000|Maintenance|Other|0|||
42288020|NCT02027428|76120777|FG001|Maintenance|Other|6|||
42354391|NCT02028884|76196035|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
42354392|NCT02028884|76196036|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
42354393|NCT02028884|76196034|FG000|Open-label Extension Period|Switched to another treatment option|3|||
42354394|NCT02028884|76196035|FG001|Open-label Extension Period|Switched to another treatment option|0|||
42288021|NCT02027428|76120778|FG002|Maintenance|Other|3|||
42288022|NCT02027428|76120776|FG000|Survival Follow-up|Death|0|||
42288023|NCT02027428|76120777|FG001|Survival Follow-up|Death|78|||
42354395|NCT02028884|76196036|FG002|Open-label Extension Period|Switched to another treatment option|0|||
42354396|NCT01422187|76196089|FG000|Overall Study|Personal reason|1|||
42354397|NCT01422187|76196090|FG001|Overall Study|Personal reason|0|||
42354398|NCT01422187|76196091|FG002|Overall Study|Personal reason|0|||
42354399|NCT01422187|76196089|FG000|Overall Study|Lost to Follow-up|0|||
42288024|NCT02027428|76120778|FG002|Survival Follow-up|Death|45|||
42288025|NCT02027428|76120776|FG000|Survival Follow-up|Lost to Follow-up|0|||
42288026|NCT02027428|76120777|FG001|Survival Follow-up|Lost to Follow-up|1|||
42288027|NCT02027428|76120778|FG002|Survival Follow-up|Lost to Follow-up|1|||
42288028|NCT01995136|76120801|FG000|Overall Study|Change in residence|1|||
42288029|NCT01994902|76120805|FG000|Test Period 1|Withdrawal by Subject|3|||
42288030|NCT01994902|76120806|FG001|Test Period 1|Withdrawal by Subject|0|||
42288031|NCT01994902|76120805|FG000|Test Period 1|device deficiency with adverse event|0|||
42288032|NCT01994902|76120806|FG001|Test Period 1|device deficiency with adverse event|1|||
42288033|NCT01994902|76120805|FG000|Test Period 1|Adverse Event|2|||
42288034|NCT01994902|76120806|FG001|Test Period 1|Adverse Event|1|||
42288035|NCT01994902|76120805|FG000|Test Period 1|Lack of Efficacy|0|||
42354400|NCT01422187|76196090|FG001|Overall Study|Lost to Follow-up|1|||
42288036|NCT01994902|76120806|FG001|Test Period 1|Lack of Efficacy|1|||
42288037|NCT01994902|76120805|FG000|Test Period 1|bag too small|1|||
42354401|NCT01422187|76196091|FG002|Overall Study|Lost to Follow-up|0|||
42354402|NCT00472212|76196101|FG000|Overall Study|Lost to Follow-up|6|||
42354403|NCT00472212|76196102|FG001|Overall Study|Lost to Follow-up|4|||
42354404|NCT00378105|76196110|FG000|Overall Study|Adverse Event|3|||
42288038|NCT01994902|76120806|FG001|Test Period 1|bag too small|0|||
42288039|NCT01994902|76120805|FG000|Test Period 2|Withdrawal by Subject|0|||
42288040|NCT01994902|76120806|FG001|Test Period 2|Withdrawal by Subject|2|||
42288041|NCT01994902|76120805|FG000|Test Period 2|Lack of Efficacy|0|||
42354405|NCT00378105|76196111|FG001|Overall Study|Adverse Event|1|||
42354406|NCT00378105|76196110|FG000|Overall Study|Withdrawal by Subject|3|||
42288042|NCT01994902|76120806|FG001|Test Period 2|Lack of Efficacy|1|||
42288043|NCT01994902|76120805|FG000|Test Period 2|Other|0|||
42288044|NCT01994902|76120806|FG001|Test Period 2|Other|3|||
42288045|NCT02026258|76120814|FG000|Randomized|Did not start treatment|2|||
42288046|NCT02026258|76120815|FG001|Randomized|Did not start treatment|1|||
42288047|NCT02026258|76120814|FG000|Randomized|Change in treatment plan|1|||
42288048|NCT02026258|76120815|FG001|Randomized|Change in treatment plan|0|||
42288049|NCT02026258|76120814|FG000|Randomized|Presence of periodontal disease|1|||
42288050|NCT02026258|76120815|FG001|Randomized|Presence of periodontal disease|1|||
42288051|NCT02026258|76120814|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
42288052|NCT02026258|76120815|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
42288053|NCT02026258|76120814|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
42288054|NCT02026258|76120815|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
42288055|NCT01994590|76120822|FG000|Overall Study|Adverse Event|1|||
42288056|NCT01994590|76120822|FG000|Overall Study|Trial Terminated|1|||
42288057|NCT02019550|76120828|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
42288058|NCT02019550|76120829|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
42288059|NCT02019472|76120840|FG000|Overall Study|Adverse Event|14|||
42288060|NCT02019472|76120841|FG001|Overall Study|Adverse Event|23|||
42288061|NCT02019472|76120842|FG002|Overall Study|Adverse Event|17|||
42288062|NCT02019472|76120840|FG000|Overall Study|Death|0|||
42288063|NCT02019472|76120841|FG001|Overall Study|Death|1|||
42288064|NCT02019472|76120842|FG002|Overall Study|Death|1|||
42288065|NCT02019472|76120840|FG000|Overall Study|Lack of Efficacy|7|||
42288066|NCT02019472|76120841|FG001|Overall Study|Lack of Efficacy|4|||
42288067|NCT02019472|76120842|FG002|Overall Study|Lack of Efficacy|4|||
42288068|NCT02019472|76120840|FG000|Overall Study|Lost to Follow-up|0|||
42288069|NCT02019472|76120841|FG001|Overall Study|Lost to Follow-up|2|||
42288070|NCT02019472|76120842|FG002|Overall Study|Lost to Follow-up|1|||
42288071|NCT02019472|76120840|FG000|Overall Study|Physician Decision|1|||
42288072|NCT02019472|76120841|FG001|Overall Study|Physician Decision|2|||
42288073|NCT02019472|76120842|FG002|Overall Study|Physician Decision|0|||
42288074|NCT02019472|76120840|FG000|Overall Study|Pregnancy|1|||
42288075|NCT02019472|76120841|FG001|Overall Study|Pregnancy|2|||
42288076|NCT02019472|76120842|FG002|Overall Study|Pregnancy|2|||
42288077|NCT02019472|76120840|FG000|Overall Study|Withdrawal by Subject|11|||
42288078|NCT02019472|76120841|FG001|Overall Study|Withdrawal by Subject|10|||
42288079|NCT02019472|76120842|FG002|Overall Study|Withdrawal by Subject|11|||
42288080|NCT02019472|76120840|FG000|Overall Study|Other|3|||
42288081|NCT02019472|76120841|FG001|Overall Study|Other|8|||
42288082|NCT02019472|76120842|FG002|Overall Study|Other|6|||
42288083|NCT02705755|76120854|FG000|Part A (6 Days)|Adverse Event|1|||
42288084|NCT02705755|76120855|FG001|Part A (6 Days)|Adverse Event|0|||
42288085|NCT02705755|76120856|FG002|Part A (6 Days)|Adverse Event|0|||
42288086|NCT02705755|76120857|FG003|Part A (6 Days)|Adverse Event|0|||
42288087|NCT02705755|76120854|FG000|Part A (6 Days)|Physician Decision|3|||
42288088|NCT02705755|76120855|FG001|Part A (6 Days)|Physician Decision|0|||
42354407|NCT00378105|76196111|FG001|Overall Study|Withdrawal by Subject|3|||
42354408|NCT00378105|76196110|FG000|Overall Study|Death|1|||
42354409|NCT00378105|76196111|FG001|Overall Study|Death|0|||
42354410|NCT00378105|76196110|FG000|Overall Study|Going to transplant|7|||
42354411|NCT00378105|76196111|FG001|Overall Study|Going to transplant|8|||
42354412|NCT00378105|76196110|FG000|Overall Study|Progressive disease|3|||
42354413|NCT00378105|76196111|FG001|Overall Study|Progressive disease|3|||
42354414|NCT00378105|76196110|FG000|Overall Study|remain on study|3|||
42288089|NCT02705755|76120856|FG002|Part A (6 Days)|Physician Decision|0|||
42288090|NCT02705755|76120857|FG003|Part A (6 Days)|Physician Decision|0|||
42288091|NCT02705755|76120854|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
42288092|NCT02705755|76120855|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
42288093|NCT02705755|76120856|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
42288094|NCT02705755|76120857|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
42288095|NCT02705755|76120854|FG000|Part C (20 Weeks)|Physician Decision|0|||
42288096|NCT02705755|76120855|FG001|Part C (20 Weeks)|Physician Decision|0|||
42288097|NCT02705755|76120856|FG002|Part C (20 Weeks)|Physician Decision|0|||
42288098|NCT02705755|76120857|FG003|Part C (20 Weeks)|Physician Decision|2|||
42288099|NCT02705755|76120854|FG000|Part C (20 Weeks)|Adverse Event|0|||
42288100|NCT02705755|76120855|FG001|Part C (20 Weeks)|Adverse Event|0|||
42288101|NCT02705755|76120856|FG002|Part C (20 Weeks)|Adverse Event|0|||
42288102|NCT02705755|76120857|FG003|Part C (20 Weeks)|Adverse Event|6|||
42288103|NCT02705755|76120854|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
42354415|NCT00378105|76196111|FG001|Overall Study|remain on study|11|||
42354416|NCT00378105|76196110|FG000|Overall Study|Physician Decision|0|||
42354417|NCT00378105|76196111|FG001|Overall Study|Physician Decision|2|||
42354418|NCT00378105|76196110|FG000|Overall Study|Going non-protocol therapy|0|||
42015324|NCT01153815|75822496|FG000|Overall Study|Adverse Event|3|||
42015325|NCT01153815|75822497|FG001|Overall Study|Adverse Event|1|||
42288104|NCT02705755|76120855|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
42015326|NCT01153815|75822496|FG000|Overall Study|Withdrawal by Subject|6|||
42288105|NCT02705755|76120856|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
42288106|NCT02705755|76120857|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
42288107|NCT02024932|76120890|FG000|Overall Study|Adverse Event|2|||
42288108|NCT02024932|76120891|FG001|Overall Study|Adverse Event|3|||
42288109|NCT02024932|76120892|FG002|Overall Study|Adverse Event|0|||
42288110|NCT02024932|76120893|FG003|Overall Study|Adverse Event|0|||
42288111|NCT02024932|76120894|FG004|Overall Study|Adverse Event|2|||
42288112|NCT02024932|76120895|FG005|Overall Study|Adverse Event|0|||
42288113|NCT02024932|76120890|FG000|Overall Study|Abnormal laboratory value|0|||
42288114|NCT02024932|76120891|FG001|Overall Study|Abnormal laboratory value|0|||
42288115|NCT02024932|76120892|FG002|Overall Study|Abnormal laboratory value|0|||
42288116|NCT02024932|76120893|FG003|Overall Study|Abnormal laboratory value|2|||
42288117|NCT02024932|76120894|FG004|Overall Study|Abnormal laboratory value|0|||
42288118|NCT02024932|76120895|FG005|Overall Study|Abnormal laboratory value|0|||
42354419|NCT00378105|76196111|FG001|Overall Study|Going non-protocol therapy|1|||
42015327|NCT01153815|75822497|FG001|Overall Study|Withdrawal by Subject|4|||
42015328|NCT01153425|75822505|FG000|Overall Study|Withdrawal by Subject|3|||
42015329|NCT01153425|75822506|FG001|Overall Study|Withdrawal by Subject|3|||
42015330|NCT01153347|75822517|FG000|Overall Study|Withdrawal by Subject|7|||
42015331|NCT01153347|75822518|FG001|Overall Study|Withdrawal by Subject|7|||
42288119|NCT01993888|76120926|FG000|Overall Study|Death|1|||
42288120|NCT01993888|76120927|FG001|Overall Study|Death|1|||
42288121|NCT01993888|76120926|FG000|Overall Study|Lost to Follow-up|1|||
42288122|NCT01993888|76120927|FG001|Overall Study|Lost to Follow-up|1|||
42288123|NCT01993888|76120926|FG000|Overall Study|Withdrawal by Subject|0|||
42288124|NCT01993888|76120927|FG001|Overall Study|Withdrawal by Subject|1|||
42288125|NCT02024698|76120933|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
42015332|NCT01153347|75822519|FG002|Overall Study|Withdrawal by Subject|7|||
42015333|NCT01153347|75822520|FG003|Overall Study|Withdrawal by Subject|7|||
42015334|NCT01153347|75822517|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42015335|NCT01153347|75822518|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
42015336|NCT01153347|75822519|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
42171968|NCT02952586|75978798|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
42015337|NCT01153347|75822520|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
42288126|NCT02024698|76120934|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
42288127|NCT02018458|76120940|FG000|Overall Study|Death|4|||
42288128|NCT02017522|76120944|FG000|Overall Study|Withdrawal by Subject|1|||
42288129|NCT02017444|76120951|FG000|Overall Study|Physician Decision|1|||
42288130|NCT02017444|76120952|FG001|Overall Study|Physician Decision|0|||
42354420|NCT00378105|76196110|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
42354421|NCT00378105|76196111|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
42354422|NCT00139477|76196120|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
42288131|NCT02017444|76120951|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
42288132|NCT02017444|76120952|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
42288133|NCT01993186|76120960|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
42288134|NCT01993186|76120961|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
42288135|NCT01993186|76120960|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
42288136|NCT01993186|76120961|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
42288137|NCT01993186|76120960|FG000|Open-Label Extension Period|Other, Not Specified|0|||
42288138|NCT01993186|76120961|FG001|Open-Label Extension Period|Other, Not Specified|1|||
42288139|NCT01993186|76120960|FG000|Open-Label Extension Period|Adverse Event|1|||
42354423|NCT00139477|76196121|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
42354424|NCT00139477|76196120|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
42354425|NCT00139477|76196121|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
42354426|NCT00139477|76196120|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
42354427|NCT00139477|76196121|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
42354428|NCT00139477|76196120|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
42354429|NCT00139477|76196121|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
42354430|NCT00139477|76196120|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
42354431|NCT00139477|76196121|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
42354432|NCT00139477|76196120|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
42354433|NCT00139477|76196121|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
42354434|NCT00139477|76196120|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
42354435|NCT00139477|76196121|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
42354436|NCT01469013|76196441|FG000|Part A (Treatment Period)|Adverse Event|1|||
42288140|NCT01993186|76120961|FG001|Open-Label Extension Period|Adverse Event|0|||
42288141|NCT01993186|76120960|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
42288142|NCT01993186|76120961|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
42288143|NCT01993186|76120960|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
42288144|NCT01993186|76120961|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
42288145|NCT01993186|76120960|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
42288146|NCT01993186|76120961|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
42288147|NCT02016898|76120970|FG000|Overall Study|Death|1|||
42288148|NCT02016898|76120971|FG001|Overall Study|Death|1|||
42288149|NCT02016898|76120970|FG000|Overall Study|Lost to Follow-up|4|||
42354437|NCT01469013|76196442|FG001|Part A (Treatment Period)|Adverse Event|0|||
42288150|NCT02016898|76120971|FG001|Overall Study|Lost to Follow-up|4|||
42288151|NCT01993030|76120979|FG000|Overall Study|Adverse Event|0|||
42288152|NCT01993030|76120980|FG001|Overall Study|Adverse Event|4|||
42288153|NCT01992094|76120989|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
42288154|NCT01992094|76120990|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
42354438|NCT01469013|76196443|FG002|Part A (Treatment Period)|Adverse Event|0|||
42354439|NCT01469013|76196444|FG003|Part A (Treatment Period)|Adverse Event|0|||
42354440|NCT01469013|76196445|FG004|Part A (Treatment Period)|Adverse Event|1|||
42354441|NCT01469013|76196446|FG005|Part A (Treatment Period)|Adverse Event|0|||
42354442|NCT01469013|76196447|FG006|Part A (Treatment Period)|Adverse Event|0|||
42354443|NCT01469013|76196448|FG007|Part A (Treatment Period)|Adverse Event|0|||
42354444|NCT01469013|76196449|FG008|Part A (Treatment Period)|Adverse Event|0|||
42354445|NCT01469013|76196450|FG009|Part A (Treatment Period)|Adverse Event|0|||
42288155|NCT01992094|76120991|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
42288156|NCT01992094|76120989|FG000|Overall Study|Adverse Event|1|||
42288157|NCT01992094|76120990|FG001|Overall Study|Adverse Event|0|||
42288158|NCT01992094|76120991|FG002|Overall Study|Adverse Event|0|||
42288159|NCT01992094|76120989|FG000|Overall Study|Death|5|||
42288160|NCT01992094|76120990|FG001|Overall Study|Death|5|||
42288161|NCT01992094|76120991|FG002|Overall Study|Death|2|||
42354446|NCT01469013|76196451|FG010|Part A (Treatment Period)|Adverse Event|0|||
42354447|NCT01469013|76196452|FG011|Part A (Treatment Period)|Adverse Event|0|||
42354448|NCT01469013|76196453|FG012|Part A (Treatment Period)|Adverse Event|0|||
42354449|NCT01469013|76196441|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354450|NCT01469013|76196442|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354451|NCT01469013|76196443|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
42354452|NCT01469013|76196444|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354453|NCT01469013|76196445|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354454|NCT01469013|76196446|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354455|NCT01469013|76196447|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354456|NCT01469013|76196448|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354457|NCT01469013|76196449|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354458|NCT01469013|76196450|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354459|NCT01469013|76196451|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354460|NCT01469013|76196452|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354461|NCT01469013|76196453|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
42354462|NCT01469013|76196441|FG000|Part B (Extension Period)|Adverse Event|0|||
42288162|NCT01992094|76120989|FG000|Overall Study|Lost to Follow-up|26|||
42354463|NCT01469013|76196442|FG001|Part B (Extension Period)|Adverse Event|0|||
42354464|NCT01469013|76196443|FG002|Part B (Extension Period)|Adverse Event|0|||
42354465|NCT01469013|76196444|FG003|Part B (Extension Period)|Adverse Event|0|||
42354466|NCT01469013|76196445|FG004|Part B (Extension Period)|Adverse Event|0|||
42354467|NCT01469013|76196446|FG005|Part B (Extension Period)|Adverse Event|2|||
42354468|NCT01469013|76196447|FG006|Part B (Extension Period)|Adverse Event|5|||
42354469|NCT01469013|76196448|FG007|Part B (Extension Period)|Adverse Event|5|||
42354470|NCT01469013|76196449|FG008|Part B (Extension Period)|Adverse Event|3|||
42354471|NCT01469013|76196450|FG009|Part B (Extension Period)|Adverse Event|3|||
42015338|NCT01153347|75822517|FG000|Overall Study|Adverse Event|3|||
42288163|NCT01992094|76120990|FG001|Overall Study|Lost to Follow-up|9|||
42354472|NCT01469013|76196451|FG010|Part B (Extension Period)|Adverse Event|1|||
42354473|NCT01469013|76196452|FG011|Part B (Extension Period)|Adverse Event|6|||
42015339|NCT01153347|75822518|FG001|Overall Study|Adverse Event|9|||
42015340|NCT01153347|75822519|FG002|Overall Study|Adverse Event|21|||
42288164|NCT01992094|76120991|FG002|Overall Study|Lost to Follow-up|13|||
42288165|NCT01992094|76120989|FG000|Overall Study|OTHER|4|||
42288166|NCT01992094|76120990|FG001|Overall Study|OTHER|0|||
42288167|NCT01992094|76120991|FG002|Overall Study|OTHER|0|||
42288168|NCT01992094|76120989|FG000|Overall Study|Protocol Violation|1|||
42288169|NCT01992094|76120990|FG001|Overall Study|Protocol Violation|0|||
42288170|NCT01992094|76120991|FG002|Overall Study|Protocol Violation|1|||
42288171|NCT01992094|76120989|FG000|Overall Study|Withdrawal by Subject|7|||
42288172|NCT01992094|76120990|FG001|Overall Study|Withdrawal by Subject|3|||
42288173|NCT01992094|76120991|FG002|Overall Study|Withdrawal by Subject|4|||
42288174|NCT02706691|76121015|FG000|Overall Study|Adverse Event|1|||
42288175|NCT01991470|76121020|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
42354474|NCT01469013|76196453|FG012|Part B (Extension Period)|Adverse Event|3|||
42015341|NCT01153347|75822520|FG003|Overall Study|Adverse Event|7|||
42015342|NCT01153347|75822517|FG000|Overall Study|Severe non-compliance to protocol|6|||
42015343|NCT01153347|75822518|FG001|Overall Study|Severe non-compliance to protocol|7|||
42015344|NCT01153347|75822519|FG002|Overall Study|Severe non-compliance to protocol|4|||
42015345|NCT01153347|75822520|FG003|Overall Study|Severe non-compliance to protocol|3|||
42288176|NCT01991470|76121020|FG000|Enlite 1 Period|Adverse Event|1|||
42015346|NCT01153347|75822517|FG000|Overall Study|Condition under investigation worsened|1|||
42015347|NCT01153347|75822518|FG001|Overall Study|Condition under investigation worsened|1|||
42288177|NCT01991470|76121020|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
42288178|NCT01991470|76121020|FG000|Enlite 3 Period|Lost to Follow-up|1|||
42288179|NCT01991470|76121020|FG000|Enlite 3 Period|Physician Decision|2|||
42288180|NCT01991470|76121020|FG000|Enlite 3 Period|Physician Decision|8|||
42288181|NCT01991470|76121020|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
42288182|NCT01991314|76121034|FG000|Overall Study|Adverse Event|5|||
42288183|NCT01991314|76121035|FG001|Overall Study|Adverse Event|1|||
42288184|NCT01991314|76121034|FG000|Overall Study|Lost to Follow-up|6|||
42354475|NCT01469013|76196441|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
42288185|NCT01991314|76121035|FG001|Overall Study|Lost to Follow-up|10|||
42288186|NCT01990768|76121044|FG000|Intervention Started|Found to be ineligible|14|||
42288187|NCT01990768|76121045|FG001|Intervention Started|Found to be ineligible|13|||
42354476|NCT01469013|76196442|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
42354477|NCT01469013|76196443|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
42354478|NCT01469013|76196444|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
42354479|NCT01469013|76196445|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
42354480|NCT01469013|76196446|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
42354481|NCT01469013|76196447|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
42288188|NCT01990768|76121046|FG002|Intervention Started|Found to be ineligible|11|||
42288189|NCT01990768|76121044|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
42288190|NCT01990768|76121045|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
42288191|NCT01990768|76121046|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
42288192|NCT01990768|76121044|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
42354482|NCT01469013|76196448|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
42288193|NCT01990768|76121045|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
42288194|NCT01990768|76121046|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
42288195|NCT01990768|76121044|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
42288196|NCT01990768|76121045|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
42288197|NCT01990768|76121046|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
42288198|NCT01990768|76121044|FG000|Intervention Started|Patient care priority|1|||
42288199|NCT01990768|76121045|FG001|Intervention Started|Patient care priority|2|||
42288200|NCT01990768|76121046|FG002|Intervention Started|Patient care priority|3|||
42288201|NCT01990768|76121044|FG000|Intervention Started|IV lost|2|||
42288202|NCT01990768|76121045|FG001|Intervention Started|IV lost|2|||
42288203|NCT01990768|76121046|FG002|Intervention Started|IV lost|2|||
42288204|NCT01990768|76121044|FG000|Intervention Started|Required CPR|1|||
42288205|NCT01990768|76121045|FG001|Intervention Started|Required CPR|1|||
42288206|NCT01990768|76121046|FG002|Intervention Started|Required CPR|0|||
42354483|NCT01469013|76196449|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
42354484|NCT01469013|76196450|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
42354485|NCT01469013|76196451|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
42354486|NCT01469013|76196452|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
42354487|NCT01469013|76196453|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
42354488|NCT01493427|76196480|FG000|Overall Study|Adverse Event|10|||
42354489|NCT01493427|76196480|FG000|Overall Study|Personal Reasons|4|||
42015348|NCT01153347|75822519|FG002|Overall Study|Condition under investigation worsened|0|||
42354490|NCT01493427|76196480|FG000|Overall Study|Lost to Follow-up|2|||
42354491|NCT01493427|76196480|FG000|Overall Study|Inability to Follow Instructions|2|||
42354492|NCT01493427|76196480|FG000|Overall Study|Other|2|||
42354493|NCT01523457|76196486|FG000|Overall Study|Withdrawal by Subject|7|||
42354494|NCT01523457|76196487|FG001|Overall Study|Withdrawal by Subject|2|||
42354495|NCT01523301|76196495|FG000|Overall Study|Adverse Event|25|||
42354496|NCT01523301|76196496|FG001|Overall Study|Adverse Event|16|||
42354497|NCT01523301|76196495|FG000|Overall Study|Lack of Efficacy|0|||
42354498|NCT01523301|76196496|FG001|Overall Study|Lack of Efficacy|2|||
42354499|NCT01523301|76196495|FG000|Overall Study|Protocol Violation|3|||
42354500|NCT01523301|76196496|FG001|Overall Study|Protocol Violation|4|||
42354501|NCT01523301|76196495|FG000|Overall Study|Lost to Follow-up|1|||
42354502|NCT01523301|76196496|FG001|Overall Study|Lost to Follow-up|0|||
42354503|NCT01523301|76196495|FG000|Overall Study|Withdrawal by Subject|6|||
42354504|NCT01523301|76196496|FG001|Overall Study|Withdrawal by Subject|8|||
42354505|NCT01523301|76196495|FG000|Overall Study|Other Reason|0|||
42354506|NCT01523301|76196496|FG001|Overall Study|Other Reason|2|||
42354507|NCT01806506|76196504|FG000|Overall Study|Lost to Follow-up|2|||
42354508|NCT01806506|76196505|FG001|Overall Study|Lost to Follow-up|1|||
42354509|NCT01766336|76196513|FG000|Overall Study|Adverse Event|11|||
42354510|NCT01766336|76196514|FG001|Overall Study|Adverse Event|8|||
42354511|NCT01766336|76196513|FG000|Overall Study|Death|4|||
42354512|NCT01766336|76196514|FG001|Overall Study|Death|3|||
42354513|NCT01766336|76196513|FG000|Overall Study|Lost to Follow-up|1|||
42354514|NCT01766336|76196514|FG001|Overall Study|Lost to Follow-up|3|||
42354515|NCT01766336|76196513|FG000|Overall Study|Physician Decision|4|||
42354516|NCT01766336|76196514|FG001|Overall Study|Physician Decision|2|||
42354517|NCT01766336|76196513|FG000|Overall Study|Protocol Violation|0|||
42354518|NCT01766336|76196514|FG001|Overall Study|Protocol Violation|1|||
42354519|NCT01766336|76196513|FG000|Overall Study|Sponsor Decision|52|||
42354520|NCT01766336|76196514|FG001|Overall Study|Sponsor Decision|43|||
42354521|NCT01766336|76196513|FG000|Overall Study|Withdrawal by Subject|18|||
42354522|NCT01766336|76196514|FG001|Overall Study|Withdrawal by Subject|15|||
42354523|NCT01797536|76196524|FG000|Overall Study|Adverse Event|0|||
42354524|NCT01797536|76196525|FG001|Overall Study|Adverse Event|1|||
42354525|NCT01797536|76196526|FG002|Overall Study|Adverse Event|0|||
42354526|NCT01797536|76196527|FG003|Overall Study|Adverse Event|0|||
42288207|NCT01990768|76121044|FG000|Intervention Started|Seizure or hx of seizure|0|||
42288208|NCT01990768|76121045|FG001|Intervention Started|Seizure or hx of seizure|0|||
42354527|NCT01797302|76196540|FG000|Overall Study|Lost to Follow-up|16|||
42354528|NCT01797302|76196541|FG001|Overall Study|Lost to Follow-up|23|||
42354529|NCT01797302|76196542|FG002|Overall Study|Lost to Follow-up|22|||
42354530|NCT01797302|76196540|FG000|Overall Study|Withdrawal by Subject|1|||
42354531|NCT01797302|76196541|FG001|Overall Study|Withdrawal by Subject|3|||
42354532|NCT01797302|76196542|FG002|Overall Study|Withdrawal by Subject|4|||
42354533|NCT01805180|76196552|FG000|Lead-in Donor Phase|screen failure|1|||
42288209|NCT01990768|76121046|FG002|Intervention Started|Seizure or hx of seizure|2|||
42288210|NCT01990768|76121044|FG000|Intervention Started|Discovered to be pregnant|0|||
42288211|NCT01990768|76121045|FG001|Intervention Started|Discovered to be pregnant|1|||
42288212|NCT01990768|76121046|FG002|Intervention Started|Discovered to be pregnant|0|||
42288213|NCT01990768|76121044|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
42288214|NCT01990768|76121045|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
42288215|NCT01990768|76121046|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
42288216|NCT01990768|76121044|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
42288217|NCT01990768|76121045|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
42288218|NCT01990768|76121046|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
42288219|NCT01990768|76121044|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
42288220|NCT01990768|76121045|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
42288221|NCT01990768|76121046|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
42288222|NCT01990768|76121044|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
42288223|NCT01990768|76121045|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
42288224|NCT01990768|76121046|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
42288225|NCT01990768|76121044|FG000|Prehospital Study Drug Infusion|Death|3|||
42288226|NCT01990768|76121045|FG001|Prehospital Study Drug Infusion|Death|1|||
42288227|NCT01990768|76121046|FG002|Prehospital Study Drug Infusion|Death|1|||
42288228|NCT01990768|76121044|FG000|Prehospital Study Drug Infusion|Discharged|2|||
42288229|NCT01990768|76121045|FG001|Prehospital Study Drug Infusion|Discharged|1|||
42288230|NCT01990768|76121046|FG002|Prehospital Study Drug Infusion|Discharged|0|||
42288231|NCT01990768|76121044|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
42288232|NCT01990768|76121045|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
42288233|NCT01990768|76121046|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
42288234|NCT01990768|76121044|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
42288235|NCT01990768|76121045|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
42288236|NCT01990768|76121046|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
42288237|NCT01990768|76121044|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
42288238|NCT01990768|76121045|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
42288239|NCT01990768|76121046|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
42354534|NCT01805180|76196553|FG001|Lead-in Donor Phase|screen failure|0|||
42354535|NCT01805180|76196554|FG002|Lead-in Donor Phase|screen failure|0|||
42354536|NCT01804946|76196564|FG000|Overall Study|Protocol Violation|1|||
42354537|NCT01804946|76196565|FG001|Overall Study|Protocol Violation|0|||
42288240|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
42288241|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
42288242|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
42288243|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
42288244|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
42288245|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
42288246|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
42288247|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
42288248|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
42288249|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
42288250|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
42288251|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
42288252|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
42288253|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
42288254|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
42288255|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
42354538|NCT01804946|76196564|FG000|Overall Study|Adverse Event|0|||
42354539|NCT01804946|76196565|FG001|Overall Study|Adverse Event|1|||
42354540|NCT01804946|76196564|FG000|Overall Study|Insufficient data available|0|||
42354541|NCT01804946|76196565|FG001|Overall Study|Insufficient data available|1|||
42354542|NCT01804946|76196564|FG000|Overall Study|Do not meet inclusion criteria|1|||
42354543|NCT01804946|76196565|FG001|Overall Study|Do not meet inclusion criteria|2|||
42354544|NCT01737398|76196575|FG000|Overall Study|Adverse event or SAE|16|||
42354545|NCT01737398|76196576|FG001|Overall Study|Adverse event or SAE|1|||
42354546|NCT01737398|76196575|FG000|Overall Study|Stopping rule met|2|||
42354547|NCT01737398|76196576|FG001|Overall Study|Stopping rule met|1|||
42288256|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
42288257|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
42288258|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
42288259|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
42354548|NCT01737398|76196575|FG000|Overall Study|Voluntary withdrawal|2|||
42354549|NCT01737398|76196576|FG001|Overall Study|Voluntary withdrawal|3|||
42354550|NCT01737398|76196575|FG000|Overall Study|Ineligibility|1|||
42354551|NCT01737398|76196576|FG001|Overall Study|Ineligibility|0|||
42354552|NCT01737398|76196575|FG000|Overall Study|Liver transplant|1|||
42354553|NCT01737398|76196576|FG001|Overall Study|Liver transplant|0|||
42354554|NCT01737398|76196575|FG000|Overall Study|Disease progression|2|||
42288260|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
42354555|NCT01737398|76196576|FG001|Overall Study|Disease progression|3|||
42354556|NCT01737398|76196575|FG000|Overall Study|Sponsor's decision|2|||
42354557|NCT01737398|76196576|FG001|Overall Study|Sponsor's decision|0|||
42354558|NCT01795898|76196585|FG000|Overall Study|Adverse Event|27|||
42354559|NCT01795898|76196585|FG000|Overall Study|Lost to Follow-up|20|||
42354560|NCT01795898|76196585|FG000|Overall Study|Withdrawal of consent|6|||
42354561|NCT01795898|76196585|FG000|Overall Study|Diagnosed with metastasis|1|||
42354562|NCT01795898|76196585|FG000|Overall Study|No pain|1|||
42354563|NCT01795898|76196585|FG000|Overall Study|Death|1|||
42354564|NCT01795898|76196585|FG000|Overall Study|Withdrew consent & had adverse events|3|||
42288261|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
42288262|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
42040889|NCT01371981|75848817|FG002|Overall Study|Did not start treatment|0|||
42288263|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
42288264|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
42288265|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
42288266|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
42288267|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
42288268|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
42288269|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
42288270|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
42288271|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
42288272|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
42288273|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
42354565|NCT01795898|76196585|FG000|Overall Study|Physician Decision|1|||
42354566|NCT01736696|76196596|FG000|Overall Study|Withdrawal by Subject|0|||
42354567|NCT01736696|76196597|FG001|Overall Study|Withdrawal by Subject|0|||
42288274|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
42288275|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
42288276|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
42354568|NCT01736696|76196598|FG002|Overall Study|Withdrawal by Subject|1|||
42354569|NCT01736696|76196599|FG003|Overall Study|Withdrawal by Subject|0|||
42354570|NCT01736696|76196600|FG004|Overall Study|Withdrawal by Subject|0|||
42354571|NCT01736696|76196601|FG005|Overall Study|Withdrawal by Subject|0|||
42354572|NCT01736696|76196602|FG006|Overall Study|Withdrawal by Subject|0|||
42354573|NCT01736540|76196626|FG000|Overall Study|Did not complete scan within 45 days|2|||
42288277|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
42354574|NCT01736540|76196626|FG000|Overall Study|Death|1|||
42354575|NCT01736540|76196626|FG000|Overall Study|Abnormal test procedure|1|||
42354576|NCT01736540|76196626|FG000|Overall Study|Withdrawal by Subject|5|||
42354577|NCT01736540|76196626|FG000|Overall Study|Protocol Violation|1|||
42354578|NCT01736540|76196626|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
42354579|NCT01736540|76196626|FG000|Overall Study|No show for MRI appointment|1|||
42354580|NCT01736540|76196626|FG000|Overall Study|Unable to make MRI appointment|3|||
42354581|NCT01794338|76196639|FG000|Overall Study|Death|2|||
42354582|NCT01794338|76196640|FG001|Overall Study|Death|0|||
42354583|NCT01794338|76196639|FG000|Overall Study|Lost to Follow-up|6|||
42288278|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
42288279|NCT01990768|76121044|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
42354584|NCT01794338|76196640|FG001|Overall Study|Lost to Follow-up|9|||
42354585|NCT01609478|76196649|FG000|Overall Study|Adverse Event|3|||
42354586|NCT01609478|76196650|FG001|Overall Study|Adverse Event|1|||
42354587|NCT01609478|76196651|FG002|Overall Study|Adverse Event|5|||
42354588|NCT01609478|76196649|FG000|Overall Study|Protocol Deviation|0|||
42354589|NCT01609478|76196650|FG001|Overall Study|Protocol Deviation|1|||
42354590|NCT01609478|76196651|FG002|Overall Study|Protocol Deviation|1|||
42354591|NCT01609478|76196649|FG000|Overall Study|Non-Compliance with study treatment|1|||
42354592|NCT01609478|76196650|FG001|Overall Study|Non-Compliance with study treatment|0|||
42354593|NCT01609478|76196651|FG002|Overall Study|Non-Compliance with study treatment|0|||
42354594|NCT01609478|76196649|FG000|Overall Study|Physician Decision|1|||
42354595|NCT01609478|76196650|FG001|Overall Study|Physician Decision|0|||
42354596|NCT01609478|76196651|FG002|Overall Study|Physician Decision|1|||
42354597|NCT01609478|76196649|FG000|Overall Study|Withdrawal by Subject|2|||
42288280|NCT01990768|76121045|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
42288281|NCT01990768|76121046|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
42354598|NCT01609478|76196650|FG001|Overall Study|Withdrawal by Subject|0|||
42354599|NCT01609478|76196651|FG002|Overall Study|Withdrawal by Subject|2|||
42354600|NCT01764854|76196663|FG000|Overall Study|Adverse Event|0|||
42354601|NCT01764854|76196664|FG001|Overall Study|Adverse Event|0|||
42354602|NCT01764854|76196665|FG002|Overall Study|Adverse Event|2|||
42354603|NCT01764854|76196666|FG003|Overall Study|Adverse Event|0|||
42354604|NCT01764854|76196663|FG000|Overall Study|Withdrawal by Subject|0|||
42354605|NCT01764854|76196664|FG001|Overall Study|Withdrawal by Subject|0|||
42354606|NCT01764854|76196665|FG002|Overall Study|Withdrawal by Subject|1|||
42288282|NCT01990768|76121044|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
42288283|NCT01990768|76121045|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
42288284|NCT01990768|76121046|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
42288285|NCT01990768|76121044|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
42288286|NCT01990768|76121045|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
42288287|NCT01990768|76121046|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
42288288|NCT01990768|76121044|FG000|6-Month Follow-up|No contact information|5|||
42288289|NCT01990768|76121045|FG001|6-Month Follow-up|No contact information|6|||
42288290|NCT01990768|76121046|FG002|6-Month Follow-up|No contact information|5|||
42288291|NCT01990768|76121044|FG000|6-Month Follow-up|Homeless|4|||
42288292|NCT01990768|76121045|FG001|6-Month Follow-up|Homeless|3|||
42288293|NCT01990768|76121046|FG002|6-Month Follow-up|Homeless|6|||
42288294|NCT01990768|76121044|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
42288295|NCT01990768|76121045|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
42288296|NCT01990768|76121046|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
42288297|NCT01990768|76121044|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
42288298|NCT01990768|76121045|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
42288299|NCT01990768|76121046|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
42288300|NCT01990768|76121044|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
42015349|NCT01153347|75822520|FG003|Overall Study|Condition under investigation worsened|0|||
42288301|NCT01990768|76121045|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
42288302|NCT01990768|76121046|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
42288303|NCT01990612|76121057|FG000|Overall Study|Lost to Follow-up|2|||
42288304|NCT01990612|76121058|FG001|Overall Study|Lost to Follow-up|1|||
42288305|NCT01990612|76121057|FG000|Overall Study|Withdrawal by Subject|5|||
42288306|NCT01990612|76121058|FG001|Overall Study|Withdrawal by Subject|2|||
42288307|NCT01990534|76121064|FG000|Overall Study|Death|22|||
42288308|NCT01990534|76121064|FG000|Overall Study|Progressive disease|3|||
42288309|NCT01990534|76121064|FG000|Overall Study|Protocol Violation|1|||
42288310|NCT01990534|76121064|FG000|Overall Study|Withdrawal of Informed Consent|2|||
42288311|NCT01990534|76121064|FG000|Overall Study|Symptomatic Deterioration|1|||
42288312|NCT01990534|76121064|FG000|Overall Study|Withdrawal by Subject|3|||
42288313|NCT01990534|76121064|FG000|Overall Study|Reason not Specified|2|||
42288314|NCT01990534|76121064|FG000|Overall Study|Lost to Follow-up|1|||
42288315|NCT01967134|76121071|FG000|Overall Study|Lost to Follow-up|0|||
42288316|NCT01967134|76121072|FG001|Overall Study|Lost to Follow-up|1|||
42288317|NCT01967134|76121073|FG002|Overall Study|Lost to Follow-up|0|||
42288318|NCT01966432|76121084|FG000|Overall Study|Lost to Follow-up|3|||
42288319|NCT01966432|76121085|FG001|Overall Study|Lost to Follow-up|2|||
42288320|NCT01966432|76121086|FG002|Overall Study|Lost to Follow-up|5|||
42288321|NCT01966432|76121084|FG000|Overall Study|Withdrawal by Subject|1|||
42288322|NCT01966432|76121085|FG001|Overall Study|Withdrawal by Subject|3|||
42288323|NCT01966432|76121086|FG002|Overall Study|Withdrawal by Subject|0|||
42288324|NCT01966432|76121084|FG000|Overall Study|Subject Incarcerated|0|||
42288325|NCT01966432|76121085|FG001|Overall Study|Subject Incarcerated|0|||
42288326|NCT01966432|76121086|FG002|Overall Study|Subject Incarcerated|1|||
42288327|NCT01966432|76121084|FG000|Overall Study|SBIRT program ended|1|||
42288328|NCT01966432|76121085|FG001|Overall Study|SBIRT program ended|8|||
42288329|NCT01966432|76121086|FG002|Overall Study|SBIRT program ended|20|||
42354607|NCT01764854|76196666|FG003|Overall Study|Withdrawal by Subject|0|||
42354608|NCT01764854|76196663|FG000|Overall Study|relocation|0|||
42354609|NCT01764854|76196664|FG001|Overall Study|relocation|0|||
42354610|NCT01764854|76196665|FG002|Overall Study|relocation|2|||
42354611|NCT01764854|76196666|FG003|Overall Study|relocation|0|||
42354612|NCT01764854|76196663|FG000|Overall Study|Protocol Violation|0|||
42354613|NCT01764854|76196664|FG001|Overall Study|Protocol Violation|0|||
42354614|NCT01764854|76196665|FG002|Overall Study|Protocol Violation|1|||
42354615|NCT01764854|76196666|FG003|Overall Study|Protocol Violation|2|||
42354616|NCT01764464|76196678|FG000|First Intervention|Withdrawal by Subject|1|||
42354617|NCT01764464|76196679|FG001|First Intervention|Withdrawal by Subject|0|||
42354618|NCT01764464|76196678|FG000|First Intervention|Lost to Follow-up|1|||
42354619|NCT01764464|76196679|FG001|First Intervention|Lost to Follow-up|0|||
42354620|NCT01764464|76196678|FG000|First Intervention|Adverse Event|0|||
42288330|NCT02702401|76121098|FG000|Overall Study|Death|242|||
42288331|NCT02702401|76121099|FG001|Overall Study|Death|125|||
42288332|NCT02702401|76121098|FG000|Overall Study|Withdrawal by Subject|15|||
42354621|NCT01764464|76196679|FG001|First Intervention|Adverse Event|2|||
42354622|NCT01764464|76196678|FG000|First Intervention|did not receive study drug|0|||
42354623|NCT01764464|76196679|FG001|First Intervention|did not receive study drug|1|||
42354624|NCT01764464|76196678|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
42354625|NCT01764464|76196679|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
42354626|NCT01764386|76196687|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
42354627|NCT01764386|76196688|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
42354628|NCT01764386|76196687|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
42354629|NCT01764386|76196688|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
42354630|NCT01764386|76196687|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
42354631|NCT01764386|76196688|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
42354632|NCT01764386|76196687|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
42354633|NCT01764386|76196688|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
42354634|NCT01764386|76196687|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
42354635|NCT01764386|76196688|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
42354636|NCT01764386|76196687|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
42354637|NCT01764386|76196688|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
42354638|NCT01764386|76196687|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
42354639|NCT01764386|76196688|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
42354640|NCT01764386|76196687|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
42354641|NCT01764386|76196688|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
42354642|NCT01763918|76196699|FG000|Overall Study|Withdrawal by Subject|2|||
42354643|NCT01763918|76196700|FG001|Overall Study|Withdrawal by Subject|1|||
42354644|NCT01763918|76196701|FG002|Overall Study|Withdrawal by Subject|1|||
42354645|NCT01763918|76196702|FG003|Overall Study|Withdrawal by Subject|2|||
42354646|NCT01763918|76196699|FG000|Overall Study|Sponsor Decision|4|||
42354647|NCT01763918|76196700|FG001|Overall Study|Sponsor Decision|0|||
42015350|NCT01153347|75822517|FG000|Overall Study|Lack of Efficacy|2|||
42015351|NCT01153347|75822518|FG001|Overall Study|Lack of Efficacy|2|||
42288333|NCT02702401|76121099|FG001|Overall Study|Withdrawal by Subject|5|||
42288334|NCT02702401|76121098|FG000|Overall Study|Sponsor Decision|19|||
42288335|NCT02702401|76121099|FG001|Overall Study|Sponsor Decision|3|||
42288336|NCT02702401|76121098|FG000|Overall Study|Physician Decision|1|||
42354648|NCT01763918|76196701|FG002|Overall Study|Sponsor Decision|9|||
42015352|NCT01153347|75822519|FG002|Overall Study|Lack of Efficacy|0|||
42015353|NCT01153347|75822520|FG003|Overall Study|Lack of Efficacy|4|||
42015354|NCT01153347|75822517|FG000|Overall Study|Study-specific withdrawal criteria|4|||
42015355|NCT01153347|75822518|FG001|Overall Study|Study-specific withdrawal criteria|3|||
42288337|NCT02702401|76121099|FG001|Overall Study|Physician Decision|2|||
42354649|NCT01763918|76196702|FG003|Overall Study|Sponsor Decision|0|||
42354650|NCT01763684|76196714|FG000|Overall Study|Study terminated early due to low enrollment|126|||
42354651|NCT01763684|76196715|FG001|Overall Study|Study terminated early due to low enrollment|127|||
42288338|NCT02702401|76121098|FG000|Overall Study|Lost to Follow-up|1|||
42288339|NCT02702401|76121099|FG001|Overall Study|Lost to Follow-up|0|||
42288340|NCT02703337|76121106|FG000|Period One (Part A)|Withdrawal by Subject|0|||
42288341|NCT02703337|76121107|FG001|Period One (Part A)|Withdrawal by Subject|0|||
42288342|NCT02703337|76121108|FG002|Period One (Part A)|Withdrawal by Subject|0|||
42288343|NCT02703337|76121109|FG003|Period One (Part A)|Withdrawal by Subject|0|||
42288344|NCT02703337|76121110|FG004|Period One (Part A)|Withdrawal by Subject|1|||
42288345|NCT02703337|76121111|FG005|Period One (Part A)|Withdrawal by Subject|0|||
42288346|NCT02703337|76121112|FG006|Period One (Part A)|Withdrawal by Subject|0|||
42288347|NCT02703337|76121113|FG007|Period One (Part A)|Withdrawal by Subject|0|||
42288348|NCT01680497|76121131|FG000|Overall Study|Lost to Follow-up|2|||
42288349|NCT01680341|76121137|FG000|Overall Study|Adverse Event|3|||
42288350|NCT01680341|76121138|FG001|Overall Study|Adverse Event|2|||
42288351|NCT01680341|76121137|FG000|Overall Study|Unclassified|18|||
42288352|NCT01680341|76121138|FG001|Overall Study|Unclassified|15|||
42288353|NCT01679405|76121146|FG000|Overall Study|Death|2|||
42288354|NCT01679405|76121147|FG001|Overall Study|Death|5|||
42288355|NCT01603355|76121153|FG000|Overall Study|Lack of Efficacy|2|||
42288356|NCT02703259|76121159|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
42288357|NCT02703259|76121160|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
42288358|NCT02703259|76121159|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
42288359|NCT02703259|76121160|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
42288360|NCT02703259|76121159|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
42288361|NCT02703259|76121160|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
42288362|NCT00701701|76121168|FG000|Overall Study|Withdrawal by Subject|0|||
42288363|NCT00701701|76121169|FG001|Overall Study|Withdrawal by Subject|1|||
42288364|NCT00701701|76121168|FG000|Overall Study|Adverse Event|0|||
42288365|NCT00701701|76121169|FG001|Overall Study|Adverse Event|1|||
42288366|NCT01989754|76121178|FG000|Overall Study|Withdrawal by Subject|10|||
42354652|NCT01763684|76196714|FG000|Overall Study|Study surgery not performed|7|||
42354653|NCT01763684|76196715|FG001|Overall Study|Study surgery not performed|6|||
42354654|NCT01606748|76196723|FG000|Overall Study|Adverse Event|1|||
42354655|NCT01606748|76196724|FG001|Overall Study|Adverse Event|0|||
42354656|NCT01606748|76196723|FG000|Overall Study|Progressive Disease|1|||
42354657|NCT01606748|76196724|FG001|Overall Study|Progressive Disease|0|||
42354658|NCT01606748|76196723|FG000|Overall Study|Withdrawal by Subject|1|||
42354659|NCT01606748|76196724|FG001|Overall Study|Withdrawal by Subject|0|||
42288367|NCT01989754|76121179|FG001|Overall Study|Withdrawal by Subject|14|||
42288368|NCT01989754|76121178|FG000|Overall Study|Lost to Follow-up|28|||
42288369|NCT01989754|76121179|FG001|Overall Study|Lost to Follow-up|20|||
42288370|NCT01989754|76121178|FG000|Overall Study|Closed Site|1|||
42288371|NCT01989754|76121179|FG001|Overall Study|Closed Site|1|||
42288372|NCT01619878|76121185|FG000|6 Week Follow-up Phase|Adverse Event|1|||
42288373|NCT01619878|76121185|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
42354660|NCT01597622|76196742|FG000|Overall Study|Adverse Event|7|||
42288374|NCT01619878|76121185|FG000|Follow-up at 12 Months of Age|Death|2|||
42288375|NCT02015104|76121191|FG000|Overall Study|Withdrew consent after first dose drug|1|||
42288376|NCT02015104|76121192|FG001|Overall Study|Withdrew consent after first dose drug|0|||
42288377|NCT02015104|76121191|FG000|Overall Study|Withdrew consent prior to treatment|0|||
42288378|NCT02015104|76121192|FG001|Overall Study|Withdrew consent prior to treatment|1|||
42288379|NCT01619800|76121203|FG000|Overall Study|study terminated|2|||
42288380|NCT01619800|76121204|FG001|Overall Study|study terminated|0|||
42288381|NCT01989208|76121212|FG000|200 mg (7 Days)|Protocol Violation|0|||
42288382|NCT01989208|76121213|FG001|200 mg (7 Days)|Protocol Violation|1|||
42354661|NCT01597622|76196742|FG000|Overall Study|Lack of Efficacy|3|||
42040890|NCT01371981|75848818|FG003|Overall Study|Did not start treatment|0|||
42288383|NCT01619410|76121233|FG000|Overall Study|Lost to Follow-up|7|||
42288384|NCT01619410|76121234|FG001|Overall Study|Lost to Follow-up|4|||
42288385|NCT01966042|76121240|FG000|Overall Study|Death|2|||
42288386|NCT02014480|76121244|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
42288387|NCT02014480|76121245|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
42288388|NCT02014480|76121246|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
42288389|NCT02014480|76121247|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
42288390|NCT02014480|76121248|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
42354662|NCT01597622|76196742|FG000|Overall Study|Protocol Violation|1|||
42288391|NCT02014480|76121249|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
42288392|NCT02014480|76121244|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42288393|NCT02014480|76121245|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
42288394|NCT02014480|76121246|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42288395|NCT02014480|76121247|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
42354663|NCT01597622|76196742|FG000|Overall Study|Lost to Follow-up|1|||
42354664|NCT01597622|76196742|FG000|Overall Study|Investigator Discretion|5|||
42354665|NCT01597622|76196742|FG000|Overall Study|Withdrawal by Subject|20|||
42354666|NCT01597622|76196742|FG000|Overall Study|Death|1|||
42354667|NCT01761266|76196748|FG000|Overall Study|Death|415|||
42354668|NCT01761266|76196749|FG001|Overall Study|Death|402|||
42354669|NCT01761266|76196748|FG000|Overall Study|Lost to Follow-up|8|||
42354670|NCT01761266|76196749|FG001|Overall Study|Lost to Follow-up|12|||
42354671|NCT01761266|76196748|FG000|Overall Study|Withdrawal by Subject|14|||
42354672|NCT01761266|76196749|FG001|Overall Study|Withdrawal by Subject|10|||
42354673|NCT01761266|76196748|FG000|Overall Study|Sponsor Decision|41|||
42354674|NCT01761266|76196749|FG001|Overall Study|Sponsor Decision|52|||
42288396|NCT02014480|76121248|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
42288397|NCT02014480|76121249|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42288398|NCT02014480|76121244|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
42288399|NCT02014480|76121245|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
42288400|NCT02014480|76121246|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
42288401|NCT02014480|76121247|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
42288402|NCT02014480|76121248|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
42288403|NCT02014480|76121249|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
42288404|NCT02014480|76121244|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
42288405|NCT02014480|76121245|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
42288406|NCT02014480|76121246|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
42354675|NCT01760954|76196762|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
42354676|NCT01760954|76196763|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
42354677|NCT01760954|76196764|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
42354678|NCT01760954|76196765|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
42354679|NCT01760954|76196762|FG000|Treatment Period (6 Months)|Adverse Event|5|||
42354680|NCT01760954|76196763|FG001|Treatment Period (6 Months)|Adverse Event|3|||
42354681|NCT01760954|76196764|FG002|Treatment Period (6 Months)|Adverse Event|4|||
42354682|NCT01760954|76196765|FG003|Treatment Period (6 Months)|Adverse Event|10|||
42354683|NCT01760954|76196762|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
42354684|NCT01760954|76196763|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
42354685|NCT01760954|76196764|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
42354686|NCT01760954|76196765|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
42354687|NCT01760954|76196762|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
42354688|NCT01760954|76196763|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
42354689|NCT01760954|76196764|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
42354690|NCT01760954|76196765|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
42354691|NCT01760954|76196762|FG000|Treatment Period (6 Months)|Pregnancy|5|||
42354692|NCT01760954|76196763|FG001|Treatment Period (6 Months)|Pregnancy|0|||
42354693|NCT01760954|76196764|FG002|Treatment Period (6 Months)|Pregnancy|3|||
42354694|NCT01760954|76196765|FG003|Treatment Period (6 Months)|Pregnancy|2|||
42354695|NCT01760954|76196762|FG000|Treatment Period (6 Months)|Non-compliance|1|||
42354696|NCT01760954|76196763|FG001|Treatment Period (6 Months)|Non-compliance|4|||
42354697|NCT01760954|76196764|FG002|Treatment Period (6 Months)|Non-compliance|0|||
42288407|NCT02014480|76121247|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
42288408|NCT02014480|76121248|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
42288409|NCT02014480|76121249|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
42288410|NCT02014480|76121244|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
42288411|NCT02014480|76121245|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
42288412|NCT02014480|76121246|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
42288413|NCT02014480|76121247|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
42288414|NCT02014480|76121248|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
42288415|NCT02014480|76121249|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
42288416|NCT02014480|76121244|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
42288417|NCT02014480|76121245|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
42288418|NCT02014480|76121246|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
42288419|NCT02014480|76121247|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
42288420|NCT02014480|76121248|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
42288421|NCT02014480|76121249|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
42288422|NCT02014480|76121244|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42288423|NCT02014480|76121245|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42288424|NCT02014480|76121246|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42288425|NCT02014480|76121247|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42288426|NCT02014480|76121248|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
42288427|NCT02014480|76121249|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
42288428|NCT01261247|76121257|FG000|Overall Study|Ineligible|2|||
42288429|NCT01677767|76121261|FG000|Overall Study|Adverse Event|1|||
42288430|NCT01677767|76121261|FG000|Overall Study|Death|4|||
42288431|NCT01677767|76121261|FG000|Overall Study|Protocol Violation|4|||
42288432|NCT01677767|76121261|FG000|Overall Study|Withdrawal by Subject|10|||
42288433|NCT01677767|76121261|FG000|Overall Study|Non-compliance by the participants|3|||
42288434|NCT01603277|76121282|FG000|Overall Study|Adverse Event|1|||
42288435|NCT01603277|76121283|FG001|Overall Study|Adverse Event|2|||
42288436|NCT01603277|76121282|FG000|Overall Study|Physician Decision|0|||
42288437|NCT01603277|76121283|FG001|Overall Study|Physician Decision|1|||
42288438|NCT01603277|76121282|FG000|Overall Study|Protocol Violation|6|||
42288439|NCT01603277|76121283|FG001|Overall Study|Protocol Violation|10|||
42288440|NCT01603277|76121282|FG000|Overall Study|Withdrawal by Subject|5|||
42288441|NCT01603277|76121283|FG001|Overall Study|Withdrawal by Subject|4|||
42288442|NCT01603277|76121282|FG000|Overall Study|Non-Compliance|2|||
42288443|NCT01603277|76121283|FG001|Overall Study|Non-Compliance|1|||
42288444|NCT01678313|76121291|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
42288445|NCT01678313|76121292|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
42288446|NCT01678313|76121291|FG000|Completed the 3-month Therapy|Physician Decision|3|||
42288447|NCT01678313|76121292|FG001|Completed the 3-month Therapy|Physician Decision|4|||
42288448|NCT01678313|76121291|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
42288449|NCT01678313|76121292|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
42288450|NCT01678313|76121291|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
42354698|NCT01760954|76196765|FG003|Treatment Period (6 Months)|Non-compliance|3|||
42354699|NCT01760954|76196762|FG000|Treatment Period (6 Months)|Other|0|||
42354700|NCT01760954|76196763|FG001|Treatment Period (6 Months)|Other|3|||
42288451|NCT01678313|76121292|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
42354701|NCT01760954|76196764|FG002|Treatment Period (6 Months)|Other|3|||
42354702|NCT01760954|76196765|FG003|Treatment Period (6 Months)|Other|1|||
42354703|NCT01760954|76196762|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
42354704|NCT01760954|76196763|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
42354705|NCT01760954|76196764|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
42354706|NCT01760954|76196765|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
42354707|NCT01760954|76196762|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
42354708|NCT01760954|76196763|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
42354709|NCT01760954|76196764|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
42354710|NCT01760954|76196765|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
42354711|NCT01760954|76196762|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
42288452|NCT01603121|76121298|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
42288453|NCT01603121|76121299|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
42288454|NCT01603043|76121307|FG000|Overall Study|Study Futility|7|||
42288455|NCT01603043|76121308|FG001|Overall Study|Study Futility|3|||
42288456|NCT02014402|76121318|FG000|Overall Study|Adverse Event|1|||
42288457|NCT02014402|76121319|FG001|Overall Study|Adverse Event|0|||
42288458|NCT02014402|76121320|FG002|Overall Study|Adverse Event|0|||
42288459|NCT02014402|76121321|FG003|Overall Study|Adverse Event|0|||
42288460|NCT02014402|76121318|FG000|Overall Study|Withdrawal by Subject|1|||
42288461|NCT02014402|76121319|FG001|Overall Study|Withdrawal by Subject|2|||
42288462|NCT02014402|76121320|FG002|Overall Study|Withdrawal by Subject|2|||
42288463|NCT02014402|76121321|FG003|Overall Study|Withdrawal by Subject|1|||
42288464|NCT02014402|76121318|FG000|Overall Study|Subject did not have transportation|0|||
42288465|NCT02014402|76121319|FG001|Overall Study|Subject did not have transportation|1|||
42288466|NCT02014402|76121320|FG002|Overall Study|Subject did not have transportation|0|||
42288467|NCT02014402|76121321|FG003|Overall Study|Subject did not have transportation|0|||
42288468|NCT02014402|76121318|FG000|Overall Study|Lost to Follow-up|0|||
42354712|NCT01760954|76196763|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
42354713|NCT01760954|76196764|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
42354714|NCT01760954|76196765|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
42354715|NCT01760954|76196762|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
42354716|NCT01760954|76196763|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
42354717|NCT01760954|76196764|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
42354718|NCT01760954|76196765|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
42354719|NCT01760954|76196762|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
42354720|NCT01760954|76196763|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
42354721|NCT01760954|76196764|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
42354722|NCT01760954|76196765|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
42354723|NCT01760954|76196762|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
42354724|NCT01760954|76196763|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
42354725|NCT01760954|76196764|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
42354726|NCT01760954|76196765|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
42354727|NCT01760954|76196762|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
42288469|NCT02014402|76121319|FG001|Overall Study|Lost to Follow-up|0|||
42288470|NCT02014402|76121320|FG002|Overall Study|Lost to Follow-up|1|||
42288471|NCT02014402|76121321|FG003|Overall Study|Lost to Follow-up|2|||
42040891|NCT01371981|75848819|FG004|Overall Study|Did not start treatment|0|||
42040892|NCT01371981|75848820|FG005|Overall Study|Did not start treatment|2|||
42288472|NCT01988662|76121340|FG000|Overall Study|Subject/guardian decision|1|||
42288473|NCT01988662|76121341|FG001|Overall Study|Subject/guardian decision|1|||
42288474|NCT01988662|76121340|FG000|Overall Study|Adverse Event|3|||
42288475|NCT01988662|76121341|FG001|Overall Study|Adverse Event|1|||
42288476|NCT02839343|76121350|FG000|Overall Study|Withdrawal by Subject|3|||
42288477|NCT02839343|76121351|FG001|Overall Study|Withdrawal by Subject|1|||
42288478|NCT02839343|76121350|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
42288479|NCT02839343|76121351|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
42288480|NCT02839343|76121350|FG000|Overall Study|Adverse Event|1|||
42288481|NCT02839343|76121351|FG001|Overall Study|Adverse Event|0|||
42288482|NCT01965652|76121380|FG000|Overall Study|Adverse Event|40|||
42288483|NCT01965652|76121381|FG001|Overall Study|Adverse Event|37|||
42354728|NCT01760954|76196763|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
42354729|NCT01760954|76196764|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
42354730|NCT01760954|76196765|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
42354731|NCT01760954|76196762|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
42288484|NCT01965652|76121380|FG000|Overall Study|Withdrawal by Subject|62|||
42288485|NCT01965652|76121381|FG001|Overall Study|Withdrawal by Subject|69|||
42288486|NCT01965652|76121380|FG000|Overall Study|Lost to Follow-up|53|||
42288487|NCT01965652|76121381|FG001|Overall Study|Lost to Follow-up|40|||
42288488|NCT01965652|76121380|FG000|Overall Study|Protocol Violation|34|||
42288489|NCT01965652|76121381|FG001|Overall Study|Protocol Violation|38|||
42288490|NCT01965652|76121380|FG000|Overall Study|Death|3|||
42288491|NCT01965652|76121381|FG001|Overall Study|Death|4|||
42288492|NCT01965652|76121380|FG000|Overall Study|Other - Miscellaneous|18|||
42288493|NCT01965652|76121381|FG001|Overall Study|Other - Miscellaneous|21|||
42354732|NCT01760954|76196763|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
42354733|NCT01760954|76196764|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
42354734|NCT01760954|76196765|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
42354735|NCT01760876|76196775|FG000|Overall Study|Non-cardiac death (head injury)|1|||
42354736|NCT01760876|76196775|FG000|Overall Study|Carcinoma of prostate|1|||
42354737|NCT01760876|76196775|FG000|Overall Study|Impaired renal function|1|||
42288494|NCT01965652|76121380|FG000|Overall Study|Pregnancy|0|||
42288495|NCT01965652|76121381|FG001|Overall Study|Pregnancy|1|||
42288496|NCT01602965|76121389|FG000|Overall Study|Lost to Follow-up|4|||
42288497|NCT01602965|76121390|FG001|Overall Study|Lost to Follow-up|2|||
42288498|NCT01987960|76121398|FG000|Period 1|Adverse Event|24|||
42354738|NCT01760876|76196775|FG000|Overall Study|Major depression|1|||
42354739|NCT01760876|76196775|FG000|Overall Study|Very poor baseline OCT quality|2|||
42354740|NCT01759862|76196781|FG000|Overall Study|Physician Decision|3|||
42354741|NCT01759862|76196782|FG001|Overall Study|Physician Decision|1|||
42354742|NCT01759862|76196781|FG000|Overall Study|Adverse Event|0|||
42040893|NCT01274338|75848845|FG000|Overall Study|Lack of Efficacy|72|||
42354743|NCT01759862|76196782|FG001|Overall Study|Adverse Event|1|||
42354744|NCT01606670|76196788|FG000|Overall Study|Adverse Event|6|||
42354745|NCT01606670|76196788|FG000|Overall Study|Lack of Efficacy|2|||
42354746|NCT01606670|76196788|FG000|Overall Study|Lost to Follow-up|3|||
42354747|NCT01606670|76196788|FG000|Overall Study|Withdrawal by Subject|3|||
42354748|NCT01606670|76196788|FG000|Overall Study|Other Reason|2|||
42354749|NCT01793792|76196792|FG000|Overall Study|Death|5|||
42354750|NCT01793792|76196792|FG000|Overall Study|Lost to Follow-up|5|||
42354751|NCT01793792|76196792|FG000|Overall Study|Withdrawal by Subject|1|||
42354752|NCT01793792|76196792|FG000|Overall Study|Device Not Implanted|1|||
42354753|NCT01790984|76196798|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
42354754|NCT01790984|76196799|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
42354755|NCT01790984|76196800|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
42354756|NCT01790984|76196801|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
42354757|NCT01735994|76196826|FG000|Overall Study|Withdrawal by Subject|6|||
42354758|NCT01735994|76196827|FG001|Overall Study|Withdrawal by Subject|4|||
42354759|NCT01735994|76196826|FG000|Overall Study|Injury|2|||
42354760|NCT01735994|76196827|FG001|Overall Study|Injury|0|||
42354761|NCT01735994|76196826|FG000|Overall Study|Kicked off team|5|||
42354762|NCT01735994|76196827|FG001|Overall Study|Kicked off team|0|||
42354763|NCT01735994|76196826|FG000|Overall Study|Lost to Follow-up|50|||
42354764|NCT01735994|76196827|FG001|Overall Study|Lost to Follow-up|62|||
42354765|NCT01790828|76196833|FG000|Overall Study|Other|34|||
42354766|NCT01790594|76196839|FG000|Overall Study|Death|1|||
42354767|NCT01790594|76196840|FG001|Overall Study|Death|0|||
42354768|NCT01790594|76196841|FG002|Overall Study|Death|0|||
42288499|NCT01987960|76121399|FG001|Period 1|Adverse Event|0|||
42288500|NCT01987960|76121400|FG002|Period 1|Adverse Event|0|||
42288501|NCT01987960|76121401|FG003|Period 1|Adverse Event|0|||
42288502|NCT01987960|76121398|FG000|Period 1|Lack of Efficacy|4|||
42288503|NCT01987960|76121399|FG001|Period 1|Lack of Efficacy|0|||
42354769|NCT01790594|76196839|FG000|Overall Study|Physician Decision|2|||
42354770|NCT01790594|76196840|FG001|Overall Study|Physician Decision|1|||
42288504|NCT01987960|76121400|FG002|Period 1|Lack of Efficacy|0|||
42288505|NCT01987960|76121401|FG003|Period 1|Lack of Efficacy|0|||
42288506|NCT01987960|76121398|FG000|Period 1|Non-compliance with IMP|6|||
42288507|NCT01987960|76121399|FG001|Period 1|Non-compliance with IMP|0|||
42288508|NCT01987960|76121400|FG002|Period 1|Non-compliance with IMP|0|||
42288509|NCT01987960|76121401|FG003|Period 1|Non-compliance with IMP|0|||
42288510|NCT01987960|76121398|FG000|Period 1|Protocol Violation|12|||
42288511|NCT01987960|76121399|FG001|Period 1|Protocol Violation|0|||
42288512|NCT01987960|76121400|FG002|Period 1|Protocol Violation|0|||
42354771|NCT01790594|76196841|FG002|Overall Study|Physician Decision|0|||
42354772|NCT01790594|76196839|FG000|Overall Study|Withdrawal by Subject|2|||
42354773|NCT01790594|76196840|FG001|Overall Study|Withdrawal by Subject|0|||
42288513|NCT01987960|76121401|FG003|Period 1|Protocol Violation|0|||
42288514|NCT01987960|76121398|FG000|Period 1|Withdrawal by Subject|21|||
42288515|NCT01987960|76121399|FG001|Period 1|Withdrawal by Subject|0|||
42288516|NCT01987960|76121400|FG002|Period 1|Withdrawal by Subject|0|||
42288517|NCT01987960|76121401|FG003|Period 1|Withdrawal by Subject|0|||
42288518|NCT01987960|76121398|FG000|Period 1|Lost to Follow-up|40|||
42288519|NCT01987960|76121399|FG001|Period 1|Lost to Follow-up|0|||
42288520|NCT01987960|76121400|FG002|Period 1|Lost to Follow-up|0|||
42288521|NCT01987960|76121401|FG003|Period 1|Lost to Follow-up|0|||
42288522|NCT01987960|76121398|FG000|Period 1|administrative or other reason|75|||
42288523|NCT01987960|76121399|FG001|Period 1|administrative or other reason|0|||
42288524|NCT01987960|76121400|FG002|Period 1|administrative or other reason|0|||
42288525|NCT01987960|76121401|FG003|Period 1|administrative or other reason|0|||
42288526|NCT01987960|76121398|FG000|Period 1|Withdrawal of consent before treatment|4|||
42288527|NCT01987960|76121399|FG001|Period 1|Withdrawal of consent before treatment|0|||
42288528|NCT01987960|76121400|FG002|Period 1|Withdrawal of consent before treatment|0|||
42288529|NCT01987960|76121401|FG003|Period 1|Withdrawal of consent before treatment|0|||
42288530|NCT01987960|76121398|FG000|Period 2|Adverse Event|0|||
42288531|NCT01987960|76121399|FG001|Period 2|Adverse Event|0|||
42354774|NCT01790594|76196841|FG002|Overall Study|Withdrawal by Subject|0|||
42354775|NCT01790594|76196839|FG000|Overall Study|Transplant was not done|0|||
42354776|NCT01790594|76196840|FG001|Overall Study|Transplant was not done|0|||
42354777|NCT01790594|76196841|FG002|Overall Study|Transplant was not done|3|||
42354778|NCT01790594|76196839|FG000|Overall Study|Terminated prior to week 76|0|||
42354779|NCT01790594|76196840|FG001|Overall Study|Terminated prior to week 76|2|||
42354780|NCT01790594|76196841|FG002|Overall Study|Terminated prior to week 76|0|||
42354781|NCT01790516|76196850|FG000|Overall Study|Physician Decision|1|||
42354782|NCT01790516|76196851|FG001|Overall Study|Physician Decision|0|||
42354783|NCT01790438|76196859|FG000|Overall Study|Adverse Event|3|||
42288532|NCT01987960|76121400|FG002|Period 2|Adverse Event|1|||
42288533|NCT01987960|76121401|FG003|Period 2|Adverse Event|0|||
42288534|NCT01987960|76121398|FG000|Period 2|Withdrawal by Subject|0|||
42354784|NCT01790438|76196860|FG001|Overall Study|Adverse Event|2|||
42288535|NCT01987960|76121399|FG001|Period 2|Withdrawal by Subject|0|||
42288536|NCT01987960|76121400|FG002|Period 2|Withdrawal by Subject|1|||
42288537|NCT01987960|76121401|FG003|Period 2|Withdrawal by Subject|0|||
42288538|NCT01987960|76121398|FG000|Period 2|Administrative or other reason|0|||
42288539|NCT01987960|76121399|FG001|Period 2|Administrative or other reason|5|||
42288540|NCT01987960|76121400|FG002|Period 2|Administrative or other reason|7|||
42354785|NCT01790438|76196859|FG000|Overall Study|Death|4|||
42288541|NCT01987960|76121401|FG003|Period 2|Administrative or other reason|0|||
42288542|NCT01987960|76121398|FG000|Period 3|Adverse Event|0|||
42288543|NCT01987960|76121399|FG001|Period 3|Adverse Event|0|||
42288544|NCT01987960|76121400|FG002|Period 3|Adverse Event|0|||
42354786|NCT01790438|76196860|FG001|Overall Study|Death|0|||
42354787|NCT01790438|76196859|FG000|Overall Study|Lost to Follow-up|5|||
42354788|NCT01790438|76196860|FG001|Overall Study|Lost to Follow-up|2|||
42354789|NCT01790438|76196859|FG000|Overall Study|Withdrawal by Subject|13|||
42354790|NCT01790438|76196860|FG001|Overall Study|Withdrawal by Subject|2|||
42354791|NCT01790438|76196859|FG000|Overall Study|Physician Decision|3|||
42354792|NCT01790438|76196860|FG001|Overall Study|Physician Decision|1|||
42354793|NCT01790438|76196859|FG000|Overall Study|Sponsor Decision|0|||
42354794|NCT01790438|76196860|FG001|Overall Study|Sponsor Decision|3|||
42171969|NCT02952586|75978797|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
42288545|NCT01987960|76121401|FG003|Period 3|Adverse Event|7|||
42288546|NCT01987960|76121398|FG000|Period 3|Non-compliance with IMP|0|||
42288547|NCT01987960|76121399|FG001|Period 3|Non-compliance with IMP|0|||
42288548|NCT01987960|76121400|FG002|Period 3|Non-compliance with IMP|0|||
42288549|NCT01987960|76121401|FG003|Period 3|Non-compliance with IMP|1|||
42288550|NCT01987960|76121398|FG000|Period 3|Protocol Violation|0|||
42354795|NCT01790438|76196859|FG000|Overall Study|Protocol Required Discontinuation|7|||
42354796|NCT01790438|76196860|FG001|Overall Study|Protocol Required Discontinuation|1|||
42354797|NCT01735916|76196871|FG000|Overall Study|Subject not eligible to be randomized|11|||
42354798|NCT01735916|76196872|FG001|Overall Study|Subject not eligible to be randomized|0|||
42354799|NCT01735916|76196873|FG002|Overall Study|Subject not eligible to be randomized|0|||
42354800|NCT01735916|76196871|FG000|Overall Study|Early termination of study by sponsor|4|||
42354801|NCT01735916|76196872|FG001|Overall Study|Early termination of study by sponsor|19|||
42354802|NCT01735916|76196873|FG002|Overall Study|Early termination of study by sponsor|7|||
42354803|NCT01735916|76196871|FG000|Overall Study|Withdrawal by Subject|3|||
42354804|NCT01735916|76196872|FG001|Overall Study|Withdrawal by Subject|0|||
42354805|NCT01735916|76196873|FG002|Overall Study|Withdrawal by Subject|0|||
42354806|NCT01790126|76196883|FG000|Overall Study|PSA Progression|12|||
42354807|NCT01790126|76196884|FG001|Overall Study|PSA Progression|16|||
42354808|NCT01790126|76196885|FG002|Overall Study|PSA Progression|16|||
42354809|NCT01790126|76196883|FG000|Overall Study|Other|5|||
42354810|NCT01790126|76196884|FG001|Overall Study|Other|4|||
42354811|NCT01790126|76196885|FG002|Overall Study|Other|8|||
42354812|NCT01790126|76196883|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
42354813|NCT01790126|76196884|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
42354814|NCT01790126|76196885|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
42354815|NCT01790126|76196883|FG000|Overall Study|Withdrawal by Physician|1|||
42354816|NCT01790126|76196884|FG001|Overall Study|Withdrawal by Physician|1|||
42354817|NCT01790126|76196885|FG002|Overall Study|Withdrawal by Physician|2|||
42354818|NCT01790126|76196883|FG000|Overall Study|Withdrawal by Subject|3|||
42354819|NCT01790126|76196884|FG001|Overall Study|Withdrawal by Subject|1|||
42354820|NCT01790126|76196885|FG002|Overall Study|Withdrawal by Subject|2|||
42354821|NCT01790126|76196883|FG000|Overall Study|Lost to Follow-up|1|||
42354822|NCT01790126|76196884|FG001|Overall Study|Lost to Follow-up|0|||
42354823|NCT01790126|76196885|FG002|Overall Study|Lost to Follow-up|1|||
42354824|NCT01790126|76196883|FG000|Overall Study|Adverse Event|0|||
42354825|NCT01790126|76196884|FG001|Overall Study|Adverse Event|2|||
42354826|NCT01790126|76196885|FG002|Overall Study|Adverse Event|0|||
42354827|NCT01790126|76196883|FG000|Overall Study|Death|2|||
42354828|NCT01790126|76196884|FG001|Overall Study|Death|0|||
42354829|NCT01790126|76196885|FG002|Overall Study|Death|0|||
42354830|NCT01790126|76196883|FG000|Overall Study|Radiographic Progression|3|||
42354831|NCT01790126|76196884|FG001|Overall Study|Radiographic Progression|1|||
42354832|NCT01790126|76196885|FG002|Overall Study|Radiographic Progression|0|||
42354833|NCT01734902|76196896|FG000|Overall Study|Other than listed|0|||
42354834|NCT01734902|76196897|FG001|Overall Study|Other than listed|2|||
42288551|NCT01987960|76121399|FG001|Period 3|Protocol Violation|0|||
42288552|NCT01987960|76121400|FG002|Period 3|Protocol Violation|0|||
42288553|NCT01987960|76121401|FG003|Period 3|Protocol Violation|6|||
42288554|NCT01987960|76121398|FG000|Period 3|Withdrawal by Subject|0|||
42288555|NCT01987960|76121399|FG001|Period 3|Withdrawal by Subject|0|||
42288556|NCT01987960|76121400|FG002|Period 3|Withdrawal by Subject|0|||
42288557|NCT01987960|76121401|FG003|Period 3|Withdrawal by Subject|9|||
42288558|NCT01987960|76121398|FG000|Period 3|Lost to Follow-up|0|||
42288559|NCT01987960|76121399|FG001|Period 3|Lost to Follow-up|0|||
42288560|NCT01987960|76121400|FG002|Period 3|Lost to Follow-up|0|||
42288561|NCT01987960|76121401|FG003|Period 3|Lost to Follow-up|5|||
42288562|NCT01987960|76121398|FG000|Period 3|Administrative or other reason|0|||
42288563|NCT01987960|76121399|FG001|Period 3|Administrative or other reason|0|||
42288564|NCT01987960|76121400|FG002|Period 3|Administrative or other reason|0|||
42288565|NCT01987960|76121401|FG003|Period 3|Administrative or other reason|43|||
42288566|NCT02013778|76121411|FG000|Overall Study|Death|4|||
42288567|NCT02013778|76121411|FG000|Overall Study|Withdrawal by Subject|1|||
42288568|NCT02013778|76121411|FG000|Overall Study|Physician Decision|1|||
42288569|NCT02013778|76121411|FG000|Overall Study|Adverse Event|1|||
42288570|NCT02013622|76121415|FG000|Overall Study|Lost to Follow-up|10|||
42288571|NCT02013622|76121415|FG000|Overall Study|Adverse Event|3|||
42288572|NCT02013622|76121415|FG000|Overall Study|Met Withdrawal Criteria|3|||
42288573|NCT02013622|76121415|FG000|Overall Study|Withdrawal by Subject|6|||
42288574|NCT02013622|76121415|FG000|Overall Study|Protocol Deviation|1|||
42288575|NCT02013622|76121415|FG000|Overall Study|Lack of Efficacy|1|||
42288576|NCT01987102|76121421|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
42288577|NCT01987102|76121422|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
42288578|NCT01987102|76121421|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
42288579|NCT01987102|76121422|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
42288580|NCT01987102|76121421|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
42288581|NCT01987102|76121422|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
42288582|NCT01987102|76121421|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
42288583|NCT01987102|76121422|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
42288584|NCT01987102|76121421|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
42288585|NCT01987102|76121422|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
42288586|NCT01987102|76121421|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
42288587|NCT01987102|76121422|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
42288588|NCT02013544|76121431|FG000|Overall Study|Adverse Event|5|||
42288589|NCT02013544|76121432|FG001|Overall Study|Adverse Event|5|||
42288590|NCT02013544|76121431|FG000|Overall Study|Lost to Follow-up|2|||
42288591|NCT02013544|76121432|FG001|Overall Study|Lost to Follow-up|3|||
42288592|NCT02013544|76121431|FG000|Overall Study|Withdrawal by Subject|2|||
42288593|NCT02013544|76121432|FG001|Overall Study|Withdrawal by Subject|8|||
42288594|NCT02013544|76121431|FG000|Overall Study|Physician Decision|0|||
42288595|NCT02013544|76121432|FG001|Overall Study|Physician Decision|1|||
42288596|NCT02013544|76121431|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
42288597|NCT02013544|76121432|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
42288598|NCT02013388|76121446|FG000|Overall Study|work emergency|1|||
42288599|NCT02013388|76121447|FG001|Overall Study|work emergency|0|||
42288600|NCT02013388|76121448|FG002|Overall Study|work emergency|0|||
42288601|NCT02013388|76121449|FG003|Overall Study|work emergency|0|||
42288602|NCT02013388|76121450|FG004|Overall Study|work emergency|1|||
42288603|NCT02013388|76121451|FG005|Overall Study|work emergency|0|||
42288604|NCT02013388|76121452|FG006|Overall Study|work emergency|0|||
42354835|NCT01790048|76196905|FG000|Overall Study|Incorrect Age|9|||
42354836|NCT01790048|76196906|FG001|Overall Study|Incorrect Age|14|||
42354837|NCT01790048|76196905|FG000|Overall Study|data entry error|0|||
42354838|NCT01790048|76196906|FG001|Overall Study|data entry error|1|||
42354839|NCT01790048|76196905|FG000|Overall Study|Other|0|||
42354840|NCT01790048|76196906|FG001|Overall Study|Other|2|||
42354841|NCT01790048|76196905|FG000|Overall Study|SAM at Enrollment|2|||
42354842|NCT01790048|76196906|FG001|Overall Study|SAM at Enrollment|0|||
42354843|NCT01790048|76196905|FG000|Overall Study|Measurement error|1|||
42354844|NCT01790048|76196906|FG001|Overall Study|Measurement error|0|||
42354845|NCT01789970|76196916|FG000|Open-label Titration Period|Adverse Event|68|||
42354846|NCT01789970|76196917|FG001|Open-label Titration Period|Adverse Event|0|||
42354847|NCT01789970|76196918|FG002|Open-label Titration Period|Adverse Event|0|||
42354848|NCT01789970|76196916|FG000|Open-label Titration Period|Lack of Efficacy|31|||
42288605|NCT02013388|76121453|FG007|Overall Study|work emergency|0|||
42288606|NCT02012686|76121477|FG000|Overall Study|muscle contraction|0|||
42288607|NCT02012686|76121478|FG001|Overall Study|muscle contraction|1|||
42288608|NCT02012686|76121477|FG000|Overall Study|electrocardiography monitoring noise|0|||
42288609|NCT02012686|76121478|FG001|Overall Study|electrocardiography monitoring noise|1|||
42354849|NCT01789970|76196917|FG001|Open-label Titration Period|Lack of Efficacy|0|||
42354850|NCT01789970|76196918|FG002|Open-label Titration Period|Lack of Efficacy|0|||
42015356|NCT01153347|75822519|FG002|Overall Study|Study-specific withdrawal criteria|1|||
42288610|NCT02012452|76121486|FG000|Overall Study|Lost to Follow-up|2|||
42288611|NCT02012452|76121487|FG001|Overall Study|Lost to Follow-up|1|||
42288612|NCT02012452|76121486|FG000|Overall Study|Withdrawal by Subject|4|||
42288613|NCT02012452|76121487|FG001|Overall Study|Withdrawal by Subject|0|||
42288614|NCT01676909|76121495|FG000|Overall Study|Withdrawal by Subject|3|||
42288615|NCT01676909|76121496|FG001|Overall Study|Withdrawal by Subject|5|||
42288616|NCT01676909|76121495|FG000|Overall Study|Lost to Follow-up|15|||
42288617|NCT01676909|76121496|FG001|Overall Study|Lost to Follow-up|9|||
42288618|NCT02012296|76121507|FG000|Overall Study|Lack of Efficacy|0|||
42288619|NCT02012296|76121508|FG001|Overall Study|Lack of Efficacy|0|||
42288620|NCT02012296|76121509|FG002|Overall Study|Lack of Efficacy|15|||
42288621|NCT02012296|76121507|FG000|Overall Study|Adverse Event|0|||
42288622|NCT02012296|76121508|FG001|Overall Study|Adverse Event|0|||
42288623|NCT02012296|76121509|FG002|Overall Study|Adverse Event|2|||
42354851|NCT01789970|76196916|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
42354852|NCT01789970|76196917|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
42354853|NCT01789970|76196918|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
42354854|NCT01789970|76196916|FG000|Open-label Titration Period|Protocol Violation|18|||
42354855|NCT01789970|76196917|FG001|Open-label Titration Period|Protocol Violation|0|||
42354856|NCT01789970|76196918|FG002|Open-label Titration Period|Protocol Violation|0|||
42354857|NCT01789970|76196916|FG000|Open-label Titration Period|Lost to Follow-up|5|||
42354858|NCT01789970|76196917|FG001|Open-label Titration Period|Lost to Follow-up|0|||
42354859|NCT01789970|76196918|FG002|Open-label Titration Period|Lost to Follow-up|0|||
42354860|NCT01789970|76196916|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
42354861|NCT01789970|76196917|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
42040894|NCT01274338|75848846|FG001|Overall Study|Lack of Efficacy|108|||
42288624|NCT02012296|76121507|FG000|Overall Study|Early study closure|0|||
42288625|NCT02012296|76121508|FG001|Overall Study|Early study closure|0|||
42354862|NCT01789970|76196918|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
42040895|NCT01274338|75848847|FG002|Overall Study|Lack of Efficacy|116|||
42288626|NCT02012296|76121509|FG002|Overall Study|Early study closure|5|||
42288627|NCT02012296|76121507|FG000|Overall Study|Protocol Violation|0|||
42354863|NCT01789970|76196916|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
42354864|NCT01789970|76196917|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
42354865|NCT01789970|76196918|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
42354866|NCT01789970|76196916|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
42354867|NCT01789970|76196917|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
42354868|NCT01789970|76196918|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
42354869|NCT01789970|76196916|FG000|Open-label Titration Period|Pregnancy|2|||
42354870|NCT01789970|76196917|FG001|Open-label Titration Period|Pregnancy|0|||
42288628|NCT02012296|76121508|FG001|Overall Study|Protocol Violation|1|||
42354871|NCT01789970|76196918|FG002|Open-label Titration Period|Pregnancy|0|||
42354872|NCT01789970|76196916|FG000|Open-label Titration Period|Other|76|||
42354873|NCT01789970|76196917|FG001|Open-label Titration Period|Other|0|||
42354874|NCT01789970|76196918|FG002|Open-label Titration Period|Other|0|||
42288629|NCT02012296|76121509|FG002|Overall Study|Protocol Violation|0|||
42288630|NCT02012218|76121526|FG000|Overall Study|Withdrawal by Subject|1|||
42288631|NCT02012218|76121527|FG001|Overall Study|Withdrawal by Subject|0|||
42288632|NCT02012218|76121528|FG002|Overall Study|Withdrawal by Subject|1|||
42288633|NCT02012218|76121529|FG003|Overall Study|Withdrawal by Subject|1|||
42288634|NCT02012218|76121530|FG004|Overall Study|Withdrawal by Subject|1|||
42288635|NCT02012218|76121526|FG000|Overall Study|Adverse Event|1|||
42288636|NCT02012218|76121527|FG001|Overall Study|Adverse Event|0|||
42288637|NCT02012218|76121528|FG002|Overall Study|Adverse Event|0|||
42288638|NCT02012218|76121529|FG003|Overall Study|Adverse Event|1|||
42288639|NCT02012218|76121530|FG004|Overall Study|Adverse Event|0|||
42288640|NCT02012218|76121526|FG000|Overall Study|Lost to Follow-up|0|||
42288641|NCT02012218|76121527|FG001|Overall Study|Lost to Follow-up|1|||
42288642|NCT02012218|76121528|FG002|Overall Study|Lost to Follow-up|1|||
42288643|NCT02012218|76121529|FG003|Overall Study|Lost to Follow-up|0|||
42288644|NCT02012218|76121530|FG004|Overall Study|Lost to Follow-up|0|||
42288645|NCT02012218|76121526|FG000|Overall Study|Protocol Specified|1|||
42288646|NCT02012218|76121527|FG001|Overall Study|Protocol Specified|0|||
42288647|NCT02012218|76121528|FG002|Overall Study|Protocol Specified|0|||
42288648|NCT02012218|76121529|FG003|Overall Study|Protocol Specified|0|||
42288649|NCT02012218|76121530|FG004|Overall Study|Protocol Specified|0|||
42288650|NCT02012218|76121526|FG000|Overall Study|Protocol Deviation|1|||
42288651|NCT02012218|76121527|FG001|Overall Study|Protocol Deviation|0|||
42288652|NCT02012218|76121528|FG002|Overall Study|Protocol Deviation|0|||
42288653|NCT02012218|76121529|FG003|Overall Study|Protocol Deviation|0|||
42288654|NCT02012218|76121530|FG004|Overall Study|Protocol Deviation|0|||
42288655|NCT01965262|76121542|FG000|Second Intervention (7 Days)|Discontinued|0|||
42288656|NCT01965262|76121543|FG001|Second Intervention (7 Days)|Discontinued|1|||
42288657|NCT01965262|76121542|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
42288658|NCT01965262|76121543|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
42288659|NCT01965262|76121542|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
42288660|NCT01965262|76121543|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
42288661|NCT01677377|76121552|FG000|Overall Study|Protocol Violation|1|||
42288662|NCT01677377|76121553|FG001|Overall Study|Protocol Violation|0|||
42288663|NCT01677377|76121554|FG002|Overall Study|Protocol Violation|0|||
42354875|NCT01789970|76196916|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
42354876|NCT01789970|76196917|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
42171970|NCT02952586|75978798|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
42171971|NCT02952586|75978797|FG000|CRT for Cisplatin (63 Days)|Other|1|||
42288664|NCT01677377|76121552|FG000|Overall Study|Lost to Follow-up|0|||
42354877|NCT01789970|76196918|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
42354878|NCT01789970|76196916|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
42288665|NCT01677377|76121553|FG001|Overall Study|Lost to Follow-up|1|||
42288666|NCT01677377|76121554|FG002|Overall Study|Lost to Follow-up|1|||
42288667|NCT01677377|76121552|FG000|Overall Study|Withdrawal by Subject|0|||
42015357|NCT01153347|75822520|FG003|Overall Study|Study-specific withdrawal criteria|2|||
42288668|NCT01677377|76121553|FG001|Overall Study|Withdrawal by Subject|0|||
42288669|NCT01677377|76121554|FG002|Overall Study|Withdrawal by Subject|3|||
42288670|NCT01677377|76121552|FG000|Overall Study|Lack of Efficacy|0|||
42288671|NCT01677377|76121553|FG001|Overall Study|Lack of Efficacy|0|||
42288672|NCT01677377|76121554|FG002|Overall Study|Lack of Efficacy|1|||
42288673|NCT01677377|76121552|FG000|Overall Study|Pregnancy|0|||
42288674|NCT01677377|76121553|FG001|Overall Study|Pregnancy|0|||
42288675|NCT01677377|76121554|FG002|Overall Study|Pregnancy|1|||
42288676|NCT01964950|76121564|FG000|Overall Study|Protocol Violation|25|||
42288677|NCT01964716|76121573|FG000|Overall Study|Withdrawal by Subject|2|||
42288678|NCT01964716|76121574|FG001|Overall Study|Withdrawal by Subject|3|||
42288679|NCT01964716|76121573|FG000|Overall Study|Lost to Follow-up|1|||
42288680|NCT01964716|76121574|FG001|Overall Study|Lost to Follow-up|2|||
42288681|NCT01964716|76121573|FG000|Overall Study|No longer met eligibility criteria|1|||
42288682|NCT01964716|76121574|FG001|Overall Study|No longer met eligibility criteria|1|||
42288683|NCT01964716|76121573|FG000|Overall Study|Death|1|||
42288684|NCT01964716|76121574|FG001|Overall Study|Death|0|||
42288685|NCT01964560|76121588|FG000|Overall Study|Adverse Event|23|||
42288686|NCT01964560|76121588|FG000|Overall Study|Lack of Efficacy|46|||
42288687|NCT01964560|76121588|FG000|Overall Study|Protocol deviation|2|||
42288688|NCT01964560|76121588|FG000|Overall Study|Lost to Follow-up|4|||
42288689|NCT01964560|76121588|FG000|Overall Study|Withdrawal by Subject|64|||
42288690|NCT01964560|76121588|FG000|Overall Study|Surgery-hemispherotomy|1|||
42288691|NCT01964560|76121588|FG000|Overall Study|Surgery|1|||
42288692|NCT01964560|76121588|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
42288693|NCT01964560|76121588|FG000|Overall Study|Patient and Investigator choice|1|||
42288694|NCT01964560|76121588|FG000|Overall Study|Patient was prescribed CBD|1|||
42288695|NCT01964560|76121588|FG000|Overall Study|Participant moved to another country|1|||
42288696|NCT02659943|76121599|FG000|Overall Study|Switched to alternative treatment|1|||
42288697|NCT02659943|76121600|FG001|Overall Study|Switched to alternative treatment|1|||
42288698|NCT02659943|76121601|FG002|Overall Study|Switched to alternative treatment|0|||
42288699|NCT02659943|76121602|FG003|Overall Study|Switched to alternative treatment|2|||
42288700|NCT02659943|76121603|FG004|Overall Study|Switched to alternative treatment|1|||
42288701|NCT02659943|76121604|FG005|Overall Study|Switched to alternative treatment|0|||
42288702|NCT02659943|76121605|FG006|Overall Study|Switched to alternative treatment|1|||
42288703|NCT02659943|76121599|FG000|Overall Study|Disease progression on study|0|||
42288704|NCT02659943|76121600|FG001|Overall Study|Disease progression on study|1|||
42288705|NCT02659943|76121601|FG002|Overall Study|Disease progression on study|1|||
42288706|NCT02659943|76121602|FG003|Overall Study|Disease progression on study|1|||
42288707|NCT02659943|76121603|FG004|Overall Study|Disease progression on study|1|||
42288708|NCT02659943|76121604|FG005|Overall Study|Disease progression on study|4|||
42288709|NCT02659943|76121605|FG006|Overall Study|Disease progression on study|0|||
42288710|NCT02659943|76121599|FG000|Overall Study|Patient's condition per principal investigator|0|||
42288711|NCT02659943|76121600|FG001|Overall Study|Patient's condition per principal investigator|0|||
42288712|NCT02659943|76121601|FG002|Overall Study|Patient's condition per principal investigator|0|||
42288713|NCT02659943|76121602|FG003|Overall Study|Patient's condition per principal investigator|0|||
42288714|NCT02659943|76121603|FG004|Overall Study|Patient's condition per principal investigator|0|||
42288715|NCT02659943|76121604|FG005|Overall Study|Patient's condition per principal investigator|1|||
42288716|NCT02659943|76121605|FG006|Overall Study|Patient's condition per principal investigator|0|||
42288717|NCT02659943|76121599|FG000|Overall Study|Ineligible|0|||
42288718|NCT02659943|76121600|FG001|Overall Study|Ineligible|0|||
42288719|NCT02659943|76121601|FG002|Overall Study|Ineligible|0|||
42288720|NCT02659943|76121602|FG003|Overall Study|Ineligible|0|||
42288721|NCT02659943|76121603|FG004|Overall Study|Ineligible|0|||
42288722|NCT02659943|76121604|FG005|Overall Study|Ineligible|0|||
42288723|NCT02659943|76121605|FG006|Overall Study|Ineligible|1|||
42288724|NCT02659943|76121599|FG000|Overall Study|No longer meets eligibility|0|||
42354879|NCT01789970|76196917|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
42354880|NCT01789970|76196918|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
42354881|NCT01789970|76196916|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
42354882|NCT01789970|76196917|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
42354883|NCT01789970|76196918|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
42354884|NCT01789970|76196916|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
42354885|NCT01789970|76196917|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
42354886|NCT01789970|76196918|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
42354887|NCT01789970|76196916|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
42015358|NCT01153347|75822517|FG000|Overall Study|Lost to Follow-up|4|||
42015359|NCT01153347|75822518|FG001|Overall Study|Lost to Follow-up|9|||
42015360|NCT01153347|75822519|FG002|Overall Study|Lost to Follow-up|11|||
42288725|NCT02659943|76121600|FG001|Overall Study|No longer meets eligibility|0|||
42015361|NCT01153347|75822520|FG003|Overall Study|Lost to Follow-up|8|||
42015362|NCT01153347|75822517|FG000|Overall Study|Other|5|||
42015363|NCT01153347|75822518|FG001|Overall Study|Other|5|||
42288726|NCT02659943|76121601|FG002|Overall Study|No longer meets eligibility|0|||
42288727|NCT02659943|76121602|FG003|Overall Study|No longer meets eligibility|0|||
42288728|NCT02659943|76121603|FG004|Overall Study|No longer meets eligibility|0|||
42288729|NCT02659943|76121604|FG005|Overall Study|No longer meets eligibility|0|||
42288730|NCT02659943|76121605|FG006|Overall Study|No longer meets eligibility|1|||
42288731|NCT02659943|76121599|FG000|Overall Study|No treatment, per protocol|0|||
42288732|NCT02659943|76121600|FG001|Overall Study|No treatment, per protocol|0|||
42288733|NCT02659943|76121601|FG002|Overall Study|No treatment, per protocol|0|||
42288734|NCT02659943|76121602|FG003|Overall Study|No treatment, per protocol|0|||
42288735|NCT02659943|76121603|FG004|Overall Study|No treatment, per protocol|0|||
42288736|NCT02659943|76121604|FG005|Overall Study|No treatment, per protocol|0|||
42288737|NCT02659943|76121605|FG006|Overall Study|No treatment, per protocol|3|||
42288738|NCT01677299|76121630|FG000|Overall Study|Adverse Event|0|||
42288739|NCT01677299|76121631|FG001|Overall Study|Adverse Event|2|||
42288740|NCT01677299|76121632|FG002|Overall Study|Adverse Event|1|||
42288741|NCT01677299|76121633|FG003|Overall Study|Adverse Event|0|||
42288742|NCT01677299|76121630|FG000|Overall Study|Withdrawal by Subject|0|||
42288743|NCT01677299|76121631|FG001|Overall Study|Withdrawal by Subject|1|||
42288744|NCT01677299|76121632|FG002|Overall Study|Withdrawal by Subject|0|||
42288745|NCT01677299|76121633|FG003|Overall Study|Withdrawal by Subject|1|||
42288746|NCT01964326|76121647|FG000|Overall Study|Adverse Event|48|||
42288747|NCT01964326|76121647|FG000|Overall Study|Death|2|||
42288748|NCT01964326|76121647|FG000|Overall Study|Protocol Violation|4|||
42288749|NCT01964326|76121647|FG000|Overall Study|Lost to Follow-up|88|||
42288750|NCT01964326|76121647|FG000|Overall Study|Withdrawal by Subject|87|||
42288751|NCT01964326|76121647|FG000|Overall Study|Pregnancy|1|||
42354888|NCT01789970|76196917|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
42354889|NCT01789970|76196918|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
42354890|NCT01789970|76196916|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
42354891|NCT01789970|76196917|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
42354892|NCT01789970|76196918|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
42354893|NCT01789970|76196916|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
42354894|NCT01789970|76196917|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
42354895|NCT01789970|76196918|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
42354896|NCT01789970|76196916|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
42354897|NCT01789970|76196917|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
42354898|NCT01789970|76196918|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
42354899|NCT01789970|76196916|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
42354900|NCT01789970|76196917|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
42354901|NCT01789970|76196918|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
42354902|NCT01789970|76196916|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
42354903|NCT01789970|76196917|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
42354904|NCT01789970|76196918|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
42354905|NCT01789970|76196916|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
42354906|NCT01789970|76196917|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
42354907|NCT01789970|76196918|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
42288752|NCT01964326|76121647|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
42288753|NCT01964326|76121647|FG000|Overall Study|Physician Decision|55|||
42288754|NCT01964326|76121647|FG000|Overall Study|Investigator Discretion|1|||
42288755|NCT01964326|76121647|FG000|Overall Study|Other|9|||
42288756|NCT01964326|76121647|FG000|Overall Study|Did not meet eligibility criteria|1|||
42288757|NCT02699749|76121665|FG000|Overall Study|Other|0|||
42288758|NCT02699749|76121666|FG001|Overall Study|Other|0|||
42015364|NCT01153347|75822519|FG002|Overall Study|Other|4|||
42015365|NCT01153347|75822520|FG003|Overall Study|Other|0|||
42288759|NCT02699749|76121667|FG002|Overall Study|Other|2|||
42288760|NCT02699749|76121668|FG003|Overall Study|Other|0|||
42288761|NCT02699749|76121669|FG004|Overall Study|Other|0|||
42288762|NCT02699749|76121670|FG005|Overall Study|Other|1|||
42288763|NCT02699749|76121671|FG006|Overall Study|Other|1|||
42288764|NCT02699749|76121672|FG007|Overall Study|Other|0|||
42288765|NCT02699749|76121673|FG008|Overall Study|Other|0|||
42288766|NCT02699749|76121674|FG009|Overall Study|Other|0|||
42288767|NCT02699749|76121675|FG010|Overall Study|Other|1|||
42288768|NCT02699749|76121676|FG011|Overall Study|Other|0|||
42288769|NCT02699749|76121677|FG012|Overall Study|Other|0|||
42354908|NCT01734434|76196936|FG000|Overall Study|Death Infant|3|||
42354909|NCT01734434|76196937|FG001|Overall Study|Death Infant|1|||
42354910|NCT01734434|76196938|FG002|Overall Study|Death Infant|17|||
42354911|NCT01734434|76196939|FG003|Overall Study|Death Infant|5|||
42354912|NCT01734434|76196936|FG000|Overall Study|Lost to Follow-up|2|||
42354913|NCT01734434|76196937|FG001|Overall Study|Lost to Follow-up|9|||
42354914|NCT01734434|76196938|FG002|Overall Study|Lost to Follow-up|67|||
42354915|NCT01734434|76196939|FG003|Overall Study|Lost to Follow-up|11|||
42354916|NCT01734434|76196936|FG000|Overall Study|No Live Birth|1|||
42354917|NCT01734434|76196937|FG001|Overall Study|No Live Birth|2|||
42354918|NCT01734434|76196938|FG002|Overall Study|No Live Birth|32|||
42354919|NCT01734434|76196939|FG003|Overall Study|No Live Birth|6|||
42354920|NCT01734434|76196936|FG000|Overall Study|Withdrawal by Subject|4|||
42354921|NCT01734434|76196937|FG001|Overall Study|Withdrawal by Subject|0|||
42354922|NCT01734434|76196938|FG002|Overall Study|Withdrawal by Subject|8|||
42015366|NCT01153347|75822517|FG000|Overall Study|Death|1|||
42015367|NCT01153347|75822518|FG001|Overall Study|Death|0|||
42015368|NCT01153347|75822519|FG002|Overall Study|Death|0|||
42015369|NCT01153347|75822520|FG003|Overall Study|Death|0|||
42015370|NCT01153269|75822530|FG000|Overall Study|Withdrawal by Subject|1|||
42015371|NCT01153269|75822530|FG000|Overall Study|Antiretroviral therapy break|1|||
42015372|NCT01152021|75822539|FG000|Overall Study|Adverse Event|4|||
42015373|NCT01152021|75822540|FG001|Overall Study|Adverse Event|4|||
42015374|NCT01152021|75822539|FG000|Overall Study|Study drug had expired|1|||
42015375|NCT01152021|75822540|FG001|Overall Study|Study drug had expired|0|||
42015376|NCT01152021|75822539|FG000|Overall Study|Physician Decision|1|||
42015377|NCT01152021|75822540|FG001|Overall Study|Physician Decision|1|||
42015378|NCT01152021|75822539|FG000|Overall Study|No access to study drug in Pharmacy|0|||
42015379|NCT01152021|75822540|FG001|Overall Study|No access to study drug in Pharmacy|1|||
42354923|NCT01734434|76196939|FG003|Overall Study|Withdrawal by Subject|1|||
42354924|NCT01734434|76196936|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
42354925|NCT01734434|76196937|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
42354926|NCT01734434|76196938|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
42354927|NCT01734434|76196939|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
42354928|NCT01734434|76196936|FG000|Overall Study|Subject Not Reachable|0|||
42354929|NCT01734434|76196937|FG001|Overall Study|Subject Not Reachable|0|||
42354930|NCT01734434|76196938|FG002|Overall Study|Subject Not Reachable|1|||
42354931|NCT01734434|76196939|FG003|Overall Study|Subject Not Reachable|0|||
42354932|NCT01734434|76196936|FG000|Overall Study|Treatment Defaulter|0|||
42015380|NCT01151085|75822548|FG000|Overall Study|Lost to Follow-up|31|||
42015381|NCT01151085|75822548|FG000|Overall Study|Protocol Violation|25|||
42015382|NCT01149681|75822559|FG000|Overall Study|Withdrawal by Subject|7|||
42015383|NCT01149681|75822559|FG000|Overall Study|Progressive disease|1|||
42015384|NCT01149681|75822559|FG000|Overall Study|Physician Decision|2|||
42015385|NCT01149681|75822559|FG000|Overall Study|adverse events nonrelated study drug|2|||
42015386|NCT01149369|75822566|FG000|Overall Study|Adverse Event|6|||
42015387|NCT01149369|75822567|FG001|Overall Study|Adverse Event|3|||
42015388|NCT01149057|75822573|FG000|Overall Study|Lack of Efficacy|16|||
42015389|NCT01149057|75822573|FG000|Overall Study|Adverse Event|13|||
42015390|NCT01149057|75822573|FG000|Overall Study|Withdrawal by Subject|9|||
42015391|NCT01149057|75822573|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
42040896|NCT01274338|75848848|FG003|Overall Study|Lack of Efficacy|0|||
42040897|NCT01274338|75848849|FG004|Overall Study|Lack of Efficacy|0|||
42288770|NCT02699749|76121678|FG013|Overall Study|Other|0|||
42288771|NCT02699749|76121665|FG000|Overall Study|Progressive Disease|3|||
42354933|NCT01734434|76196937|FG001|Overall Study|Treatment Defaulter|0|||
42354934|NCT01734434|76196938|FG002|Overall Study|Treatment Defaulter|1|||
42354935|NCT01734434|76196939|FG003|Overall Study|Treatment Defaulter|0|||
42354936|NCT01734434|76196936|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
42015392|NCT01149057|75822573|FG000|Overall Study|B Cell Depletion|4|||
42015393|NCT01149057|75822573|FG000|Overall Study|Participant Non-Compliance|2|||
42015394|NCT01149057|75822573|FG000|Overall Study|Lost to Follow-up|1|||
42354937|NCT01734434|76196937|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
42354938|NCT01734434|76196938|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
42354939|NCT01734434|76196939|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
42354940|NCT01734434|76196936|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
42354941|NCT01734434|76196937|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
42354942|NCT01734434|76196938|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
42288772|NCT02699749|76121666|FG001|Overall Study|Progressive Disease|3|||
42288773|NCT02699749|76121667|FG002|Overall Study|Progressive Disease|14|||
42288774|NCT02699749|76121668|FG003|Overall Study|Progressive Disease|3|||
42288775|NCT02699749|76121669|FG004|Overall Study|Progressive Disease|3|||
42288776|NCT02699749|76121670|FG005|Overall Study|Progressive Disease|7|||
42288777|NCT02699749|76121671|FG006|Overall Study|Progressive Disease|5|||
42288778|NCT02699749|76121672|FG007|Overall Study|Progressive Disease|5|||
42288779|NCT02699749|76121673|FG008|Overall Study|Progressive Disease|6|||
42288780|NCT02699749|76121674|FG009|Overall Study|Progressive Disease|6|||
42015395|NCT01149057|75822573|FG000|Overall Study|High Parathyroid Hormone Value|1|||
42354943|NCT01734434|76196939|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
42354944|NCT01788566|76196957|FG000|Overall Study|Death|4|||
42354945|NCT01788566|76196957|FG000|Overall Study|Adverse Event|1|||
42354946|NCT01788566|76196957|FG000|Overall Study|Clinical Progressive Disease|3|||
42354947|NCT01733732|76196963|FG000|Overall Study|Adverse Event|1|||
42354948|NCT01733732|76196964|FG001|Overall Study|Adverse Event|0|||
42354949|NCT01733732|76196963|FG000|Overall Study|Did not attend all study visits|1|||
42354950|NCT01733732|76196964|FG001|Overall Study|Did not attend all study visits|0|||
42354951|NCT01732874|76196982|FG000|Overall Study|Withdrawal by Subject|5|||
42354952|NCT01732874|76196983|FG001|Overall Study|Withdrawal by Subject|1|||
42354953|NCT01732874|76196982|FG000|Overall Study|Death of Infant|3|||
42354954|NCT01732874|76196983|FG001|Overall Study|Death of Infant|2|||
42015396|NCT01149057|75822573|FG000|Overall Study|Other|6|||
42015397|NCT01227564|75822580|FG000|Overall Study|No Longer Willing to Participate|4|||
42354955|NCT01732796|76196992|FG000|Overall Study|Adverse Event|16|||
42354956|NCT01732796|76196993|FG001|Overall Study|Adverse Event|16|||
42354957|NCT01732796|76196994|FG002|Overall Study|Adverse Event|4|||
42354958|NCT01732796|76196992|FG000|Overall Study|Lack of Efficacy|21|||
42354959|NCT01732796|76196993|FG001|Overall Study|Lack of Efficacy|18|||
42354960|NCT01732796|76196994|FG002|Overall Study|Lack of Efficacy|5|||
42354961|NCT01732796|76196992|FG000|Overall Study|Lost to Follow-up|2|||
42354962|NCT01732796|76196993|FG001|Overall Study|Lost to Follow-up|0|||
42354963|NCT01732796|76196994|FG002|Overall Study|Lost to Follow-up|0|||
42354964|NCT01732796|76196992|FG000|Overall Study|Withdrawal by Subject|6|||
42354965|NCT01732796|76196993|FG001|Overall Study|Withdrawal by Subject|8|||
42354966|NCT01732796|76196994|FG002|Overall Study|Withdrawal by Subject|2|||
42354967|NCT01732796|76196992|FG000|Overall Study|Other reason not defined above|1|||
42354968|NCT01732796|76196993|FG001|Overall Study|Other reason not defined above|0|||
42354969|NCT01732796|76196994|FG002|Overall Study|Other reason not defined above|2|||
42354970|NCT01732640|76197004|FG000|Overall Study|Adverse Event|0|||
42354971|NCT01732640|76197005|FG001|Overall Study|Adverse Event|1|||
42354972|NCT01732640|76197004|FG000|Overall Study|Death|0|||
42354973|NCT01732640|76197005|FG001|Overall Study|Death|1|||
42354974|NCT01732484|76197015|FG000|Overall Study|Death|7|||
42354975|NCT01732484|76197015|FG000|Overall Study|Lost to Follow-up|14|||
42015398|NCT01227564|75822581|FG001|Overall Study|No Longer Willing to Participate|2|||
42015399|NCT01227564|75822582|FG002|Overall Study|No Longer Willing to Participate|5|||
42015400|NCT01227564|75822580|FG000|Overall Study|Participant moved to another town|0|||
42015401|NCT01227564|75822581|FG001|Overall Study|Participant moved to another town|0|||
42015402|NCT01227564|75822582|FG002|Overall Study|Participant moved to another town|1|||
42288781|NCT02699749|76121675|FG010|Overall Study|Progressive Disease|5|||
42288782|NCT02699749|76121676|FG011|Overall Study|Progressive Disease|4|||
42288783|NCT02699749|76121677|FG012|Overall Study|Progressive Disease|3|||
42354976|NCT01732484|76197015|FG000|Overall Study|chronical illness|5|||
42354977|NCT01786148|76197023|FG000|Overall Study|Lost to Follow-up|21|||
42354978|NCT01786148|76197024|FG001|Overall Study|Lost to Follow-up|13|||
42354979|NCT01786148|76197023|FG000|Overall Study|Death|0|||
42354980|NCT01786148|76197024|FG001|Overall Study|Death|1|||
42354981|NCT01786148|76197023|FG000|Overall Study|Withdrawal by Subject|0|||
42354982|NCT01786148|76197024|FG001|Overall Study|Withdrawal by Subject|7|||
42354983|NCT01786148|76197023|FG000|Overall Study|Incarceration|1|||
42015403|NCT01148979|75822598|FG000|Overall Study|Lost to Follow-up|0|||
42015404|NCT01148979|75822599|FG001|Overall Study|Lost to Follow-up|1|||
42015405|NCT01148511|75822607|FG000|Exposed to Study Drug|Protocol Violation|2|||
42015406|NCT01148511|75822608|FG001|Exposed to Study Drug|Protocol Violation|0|||
42015407|NCT01148511|75822609|FG002|Exposed to Study Drug|Protocol Violation|0|||
42015408|NCT01148511|75822607|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
42015409|NCT01148511|75822608|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
42015410|NCT01148511|75822609|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
42015411|NCT01148511|75822607|FG000|Randomized|Adverse Event|0|||
42015412|NCT01148511|75822608|FG001|Randomized|Adverse Event|1|||
42015413|NCT01148511|75822609|FG002|Randomized|Adverse Event|0|||
42015414|NCT01148511|75822607|FG000|Randomized|Protocol Violation|0|||
42015415|NCT01148511|75822608|FG001|Randomized|Protocol Violation|2|||
42015416|NCT01148511|75822609|FG002|Randomized|Protocol Violation|1|||
42015417|NCT01148511|75822607|FG000|Randomized|Lost to Follow-up|0|||
42015418|NCT01148511|75822608|FG001|Randomized|Lost to Follow-up|1|||
42015419|NCT01148511|75822609|FG002|Randomized|Lost to Follow-up|1|||
42015420|NCT01148511|75822607|FG000|Randomized|Consent withdrawal|0|||
42288784|NCT02699749|76121678|FG013|Overall Study|Progressive Disease|5|||
42288785|NCT02699749|76121665|FG000|Overall Study|Death|0|||
42288786|NCT02699749|76121666|FG001|Overall Study|Death|0|||
42288787|NCT02699749|76121667|FG002|Overall Study|Death|0|||
42040898|NCT01274338|75848850|FG005|Overall Study|Lack of Efficacy|0|||
42040899|NCT01274338|75848845|FG000|Overall Study|Adverse Event|272|||
42040900|NCT01274338|75848846|FG001|Overall Study|Adverse Event|105|||
42354984|NCT01786148|76197024|FG001|Overall Study|Incarceration|1|||
42354985|NCT01785602|76197036|FG000|Overall Study|Withdrawal by Subject|2|||
42354986|NCT01785602|76197037|FG001|Overall Study|Withdrawal by Subject|0|||
42354987|NCT01785602|76197036|FG000|Overall Study|Lost to Follow-up|1|||
42354988|NCT01785602|76197037|FG001|Overall Study|Lost to Follow-up|1|||
42354989|NCT01785602|76197036|FG000|Overall Study|Adverse Event|3|||
42354990|NCT01785602|76197037|FG001|Overall Study|Adverse Event|5|||
42354991|NCT01785602|76197036|FG000|Overall Study|Administrative problems|7|||
42354992|NCT01785602|76197037|FG001|Overall Study|Administrative problems|3|||
42354993|NCT01785524|76197045|FG000|Overall Study|Withdrawal by Subject|2|||
42354994|NCT01785524|76197046|FG001|Overall Study|Withdrawal by Subject|2|||
42354995|NCT01757288|76197055|FG000|Overall Study|Consent withdrawal|0|||
42040901|NCT01274338|75848847|FG002|Overall Study|Adverse Event|180|||
42040902|NCT01274338|75848848|FG003|Overall Study|Adverse Event|1|||
42040903|NCT01274338|75848849|FG004|Overall Study|Adverse Event|0|||
42040904|NCT01274338|75848850|FG005|Overall Study|Adverse Event|0|||
42040905|NCT01274338|75848845|FG000|Overall Study|Death|8|||
42040906|NCT01274338|75848846|FG001|Overall Study|Death|1|||
42040907|NCT01274338|75848847|FG002|Overall Study|Death|0|||
42040908|NCT01274338|75848848|FG003|Overall Study|Death|0|||
42040909|NCT01274338|75848849|FG004|Overall Study|Death|0|||
42040910|NCT01274338|75848850|FG005|Overall Study|Death|0|||
42040911|NCT01274338|75848845|FG000|Overall Study|Withdrawal by Subject|27|||
42040912|NCT01274338|75848846|FG001|Overall Study|Withdrawal by Subject|99|||
42040913|NCT01274338|75848847|FG002|Overall Study|Withdrawal by Subject|17|||
42040914|NCT01274338|75848848|FG003|Overall Study|Withdrawal by Subject|0|||
42040915|NCT01274338|75848849|FG004|Overall Study|Withdrawal by Subject|0|||
42040916|NCT01274338|75848850|FG005|Overall Study|Withdrawal by Subject|0|||
42040917|NCT01274338|75848845|FG000|Overall Study|Did not start treatment|8|||
42040918|NCT01274338|75848846|FG001|Overall Study|Did not start treatment|116|||
42040919|NCT01274338|75848847|FG002|Overall Study|Did not start treatment|7|||
42288788|NCT02699749|76121668|FG003|Overall Study|Death|0|||
42288789|NCT02699749|76121669|FG004|Overall Study|Death|0|||
42288790|NCT02699749|76121670|FG005|Overall Study|Death|0|||
42288791|NCT02699749|76121671|FG006|Overall Study|Death|0|||
42288792|NCT02699749|76121672|FG007|Overall Study|Death|0|||
42354996|NCT01757288|76197056|FG001|Overall Study|Consent withdrawal|4|||
42354997|NCT01757288|76197057|FG002|Overall Study|Consent withdrawal|4|||
42354998|NCT01757288|76197055|FG000|Overall Study|Patient off study, IRB hold.|0|||
42040920|NCT01274338|75848848|FG003|Overall Study|Did not start treatment|0|||
42040921|NCT01274338|75848849|FG004|Overall Study|Did not start treatment|0|||
42288793|NCT02699749|76121673|FG008|Overall Study|Death|0|||
42354999|NCT01757288|76197056|FG001|Overall Study|Patient off study, IRB hold.|0|||
42355000|NCT01757288|76197057|FG002|Overall Study|Patient off study, IRB hold.|1|||
42355001|NCT01757288|76197055|FG000|Overall Study|Patient death prior to starting treatment|0|||
42015421|NCT01148511|75822608|FG001|Randomized|Consent withdrawal|5|||
42015422|NCT01148511|75822609|FG002|Randomized|Consent withdrawal|3|||
42015423|NCT01148511|75822607|FG000|Randomized|Other|0|||
42015424|NCT01148511|75822608|FG001|Randomized|Other|1|||
42015425|NCT01148511|75822609|FG002|Randomized|Other|1|||
42040922|NCT01274338|75848850|FG005|Overall Study|Did not start treatment|0|||
42040923|NCT01274338|75848845|FG000|Overall Study|Alternative therapy|0|||
42040924|NCT01274338|75848846|FG001|Overall Study|Alternative therapy|1|||
42288794|NCT02699749|76121674|FG009|Overall Study|Death|0|||
42288795|NCT02699749|76121675|FG010|Overall Study|Death|0|||
42355002|NCT01757288|76197056|FG001|Overall Study|Patient death prior to starting treatment|0|||
42355003|NCT01757288|76197057|FG002|Overall Study|Patient death prior to starting treatment|1|||
42355004|NCT01757288|76197055|FG000|Overall Study|Wrong medication administered|0|||
42355005|NCT01757288|76197056|FG001|Overall Study|Wrong medication administered|1|||
42355006|NCT01757288|76197057|FG002|Overall Study|Wrong medication administered|0|||
42355007|NCT01757288|76197055|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
42355008|NCT01757288|76197056|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
42288796|NCT02699749|76121676|FG011|Overall Study|Death|0|||
42288797|NCT02699749|76121677|FG012|Overall Study|Death|0|||
42288798|NCT02699749|76121678|FG013|Overall Study|Death|1|||
42288799|NCT02699749|76121665|FG000|Overall Study|Lost to Follow-up|0|||
42288800|NCT02699749|76121666|FG001|Overall Study|Lost to Follow-up|0|||
42288801|NCT02699749|76121667|FG002|Overall Study|Lost to Follow-up|0|||
42288802|NCT02699749|76121668|FG003|Overall Study|Lost to Follow-up|0|||
42288803|NCT02699749|76121669|FG004|Overall Study|Lost to Follow-up|0|||
42288804|NCT02699749|76121670|FG005|Overall Study|Lost to Follow-up|1|||
42288805|NCT02699749|76121671|FG006|Overall Study|Lost to Follow-up|0|||
42288806|NCT02699749|76121672|FG007|Overall Study|Lost to Follow-up|1|||
42288807|NCT02699749|76121673|FG008|Overall Study|Lost to Follow-up|0|||
42288808|NCT02699749|76121674|FG009|Overall Study|Lost to Follow-up|0|||
42288809|NCT02699749|76121675|FG010|Overall Study|Lost to Follow-up|0|||
42288810|NCT02699749|76121676|FG011|Overall Study|Lost to Follow-up|0|||
42288811|NCT02699749|76121677|FG012|Overall Study|Lost to Follow-up|0|||
42355009|NCT01757288|76197057|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
42355010|NCT01757288|76197055|FG000|Overall Study|Not meeting protocol constraints|0|||
42355011|NCT01757288|76197056|FG001|Overall Study|Not meeting protocol constraints|1|||
42355012|NCT01757288|76197057|FG002|Overall Study|Not meeting protocol constraints|1|||
42355013|NCT01757288|76197055|FG000|Overall Study|Multiple missed appointments|0|||
42355014|NCT01757288|76197056|FG001|Overall Study|Multiple missed appointments|1|||
42355015|NCT01757288|76197057|FG002|Overall Study|Multiple missed appointments|0|||
42355016|NCT01757288|76197055|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
42015426|NCT00547339|75822620|FG000|Overall Study|Physician Decision|0|||
42015427|NCT00547339|75822621|FG001|Overall Study|Physician Decision|0|||
42015428|NCT00547339|75822622|FG002|Overall Study|Physician Decision|1|||
42015429|NCT00547339|75822623|FG003|Overall Study|Physician Decision|0|||
42015430|NCT01227252|75822646|FG000|Overall Study|Sponsor Decision|0|||
42015431|NCT01227252|75822647|FG001|Overall Study|Sponsor Decision|1|||
42015432|NCT01227252|75822648|FG002|Overall Study|Sponsor Decision|0|||
42015433|NCT01227252|75822649|FG003|Overall Study|Sponsor Decision|0|||
42015434|NCT01227252|75822646|FG000|Overall Study|Lost to Follow-up|0|||
42015435|NCT01227252|75822647|FG001|Overall Study|Lost to Follow-up|1|||
42015436|NCT01227252|75822648|FG002|Overall Study|Lost to Follow-up|0|||
42015437|NCT01227252|75822649|FG003|Overall Study|Lost to Follow-up|0|||
42288812|NCT02699749|76121678|FG013|Overall Study|Lost to Follow-up|0|||
42288813|NCT02699593|76121708|FG000|Period 1|Unsatisfactory Visual Response|0|||
42288814|NCT02699593|76121709|FG001|Period 1|Unsatisfactory Visual Response|1|||
42288815|NCT02699593|76121708|FG000|Period 1|Torn Contact Len|4|||
42288816|NCT02699593|76121709|FG001|Period 1|Torn Contact Len|3|||
42288817|NCT02699593|76121708|FG000|Period 1|Protocol Violation|0|||
42288818|NCT02699593|76121709|FG001|Period 1|Protocol Violation|1|||
42288819|NCT02699593|76121708|FG000|Period 1|Withdrawal by Subject|0|||
42288820|NCT02699593|76121709|FG001|Period 1|Withdrawal by Subject|1|||
42288821|NCT02699593|76121708|FG000|Period 1|Adverse Event|1|||
42288822|NCT02699593|76121709|FG001|Period 1|Adverse Event|1|||
42288823|NCT02699593|76121708|FG000|Period 2|Adverse Event|1|||
42288824|NCT02699593|76121709|FG001|Period 2|Adverse Event|1|||
42288825|NCT02699593|76121708|FG000|Period 2|Lost Contact Lens|0|||
42288826|NCT02699593|76121709|FG001|Period 2|Lost Contact Lens|1|||
42288827|NCT02699593|76121708|FG000|Period 2|Torn Contact Lens|1|||
42288828|NCT02699593|76121709|FG001|Period 2|Torn Contact Lens|0|||
42288829|NCT00708097|76121715|FG000|Period 1|Protocol Violation|0|||
42288830|NCT00708097|76121716|FG001|Period 1|Protocol Violation|1|||
42288831|NCT00708097|76121717|FG002|Period 1|Protocol Violation|0|||
42288832|NCT00708097|76121718|FG003|Period 1|Protocol Violation|2|||
42288833|NCT00708097|76121719|FG004|Period 1|Protocol Violation|0|||
42288834|NCT00708097|76121715|FG000|Period 1|Other Reason|0|||
42288835|NCT00708097|76121716|FG001|Period 1|Other Reason|0|||
42288836|NCT00708097|76121717|FG002|Period 1|Other Reason|0|||
42288837|NCT00708097|76121718|FG003|Period 1|Other Reason|0|||
42288838|NCT00708097|76121719|FG004|Period 1|Other Reason|1|||
42288839|NCT00708097|76121715|FG000|Period 2|Protocol Violation|0|||
42288840|NCT00708097|76121716|FG001|Period 2|Protocol Violation|1|||
42288841|NCT00708097|76121717|FG002|Period 2|Protocol Violation|1|||
42288842|NCT00708097|76121718|FG003|Period 2|Protocol Violation|1|||
42288843|NCT00708097|76121719|FG004|Period 2|Protocol Violation|0|||
42288844|NCT02659631|76121746|FG000|Overall Study|Lost to Follow-up|0|||
42288845|NCT02659631|76121747|FG001|Overall Study|Lost to Follow-up|0|||
42288846|NCT02659631|76121748|FG002|Overall Study|Lost to Follow-up|2|||
42288847|NCT02659631|76121749|FG003|Overall Study|Lost to Follow-up|0|||
42288848|NCT02659631|76121750|FG004|Overall Study|Lost to Follow-up|0|||
42288849|NCT02659631|76121751|FG005|Overall Study|Lost to Follow-up|1|||
42288850|NCT02659631|76121752|FG006|Overall Study|Lost to Follow-up|0|||
42288851|NCT02659631|76121753|FG007|Overall Study|Lost to Follow-up|0|||
42288852|NCT02659631|76121754|FG008|Overall Study|Lost to Follow-up|0|||
42288853|NCT02659631|76121755|FG009|Overall Study|Lost to Follow-up|0|||
42288854|NCT02659631|76121746|FG000|Overall Study|Withdrawal prior to treatment|0|||
42288855|NCT02659631|76121747|FG001|Overall Study|Withdrawal prior to treatment|0|||
42288856|NCT02659631|76121748|FG002|Overall Study|Withdrawal prior to treatment|0|||
42288857|NCT02659631|76121749|FG003|Overall Study|Withdrawal prior to treatment|0|||
42288858|NCT02659631|76121750|FG004|Overall Study|Withdrawal prior to treatment|1|||
42288859|NCT02659631|76121751|FG005|Overall Study|Withdrawal prior to treatment|0|||
42288860|NCT02659631|76121752|FG006|Overall Study|Withdrawal prior to treatment|0|||
42288861|NCT02659631|76121753|FG007|Overall Study|Withdrawal prior to treatment|0|||
42288862|NCT02659631|76121754|FG008|Overall Study|Withdrawal prior to treatment|0|||
42288863|NCT02659631|76121755|FG009|Overall Study|Withdrawal prior to treatment|0|||
42288864|NCT02659631|76121746|FG000|Overall Study|Participant refused further follow-up|0|||
42288865|NCT02659631|76121747|FG001|Overall Study|Participant refused further follow-up|0|||
42288866|NCT02659631|76121748|FG002|Overall Study|Participant refused further follow-up|0|||
42288867|NCT02659631|76121749|FG003|Overall Study|Participant refused further follow-up|1|||
42288868|NCT02659631|76121750|FG004|Overall Study|Participant refused further follow-up|0|||
42288869|NCT02659631|76121751|FG005|Overall Study|Participant refused further follow-up|0|||
42288870|NCT02659631|76121752|FG006|Overall Study|Participant refused further follow-up|0|||
42288871|NCT02659631|76121753|FG007|Overall Study|Participant refused further follow-up|0|||
42288872|NCT02659631|76121754|FG008|Overall Study|Participant refused further follow-up|1|||
42288873|NCT02659631|76121755|FG009|Overall Study|Participant refused further follow-up|0|||
42288874|NCT02659631|76121746|FG000|Overall Study|Death (follow-up phase)|1|||
42288875|NCT02659631|76121747|FG001|Overall Study|Death (follow-up phase)|2|||
42288876|NCT02659631|76121748|FG002|Overall Study|Death (follow-up phase)|1|||
42288877|NCT02659631|76121749|FG003|Overall Study|Death (follow-up phase)|1|||
42288878|NCT02659631|76121750|FG004|Overall Study|Death (follow-up phase)|3|||
42288879|NCT02659631|76121751|FG005|Overall Study|Death (follow-up phase)|2|||
42288880|NCT02659631|76121752|FG006|Overall Study|Death (follow-up phase)|0|||
42288881|NCT02659631|76121753|FG007|Overall Study|Death (follow-up phase)|3|||
42288882|NCT02659631|76121754|FG008|Overall Study|Death (follow-up phase)|1|||
42288883|NCT02659631|76121755|FG009|Overall Study|Death (follow-up phase)|0|||
42288884|NCT02659631|76121746|FG000|Overall Study|Death (treatment phase)|0|||
42288885|NCT02659631|76121747|FG001|Overall Study|Death (treatment phase)|0|||
42288886|NCT02659631|76121748|FG002|Overall Study|Death (treatment phase)|0|||
42040925|NCT01274338|75848847|FG002|Overall Study|Alternative therapy|0|||
42288887|NCT02659631|76121749|FG003|Overall Study|Death (treatment phase)|0|||
42288888|NCT02659631|76121750|FG004|Overall Study|Death (treatment phase)|1|||
42288889|NCT02659631|76121751|FG005|Overall Study|Death (treatment phase)|0|||
42288890|NCT02659631|76121752|FG006|Overall Study|Death (treatment phase)|1|||
42288891|NCT02659631|76121753|FG007|Overall Study|Death (treatment phase)|0|||
42288892|NCT02659631|76121754|FG008|Overall Study|Death (treatment phase)|0|||
42288893|NCT02659631|76121755|FG009|Overall Study|Death (treatment phase)|0|||
42288894|NCT02699125|76121779|FG000|Placebo|Lost to Follow-up|2|||
42288895|NCT02699125|76121780|FG001|Placebo|Lost to Follow-up|0|||
42288896|NCT02699125|76121779|FG000|Placebo|Protocol Violation|1|||
42355017|NCT01757288|76197056|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
42288897|NCT02699125|76121780|FG001|Placebo|Protocol Violation|0|||
42288898|NCT02699125|76121779|FG000|Placebo|Withdrawal by Subject|0|||
42288899|NCT02699125|76121780|FG001|Placebo|Withdrawal by Subject|4|||
42288900|NCT02699125|76121779|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
42355018|NCT01757288|76197057|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
42355019|NCT01757288|76197055|FG000|Overall Study|>2 weeks treatment break|0|||
42355020|NCT01757288|76197056|FG001|Overall Study|>2 weeks treatment break|0|||
42355021|NCT01757288|76197057|FG002|Overall Study|>2 weeks treatment break|1|||
42355022|NCT01756898|76197070|FG000|Overall Study|Adverse Event|7|||
42355023|NCT01756898|76197071|FG001|Overall Study|Adverse Event|1|||
42288901|NCT02699125|76121780|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
42288902|NCT02698891|76121790|FG000|Overall Study|Withdrawal by Subject|2|||
42288903|NCT02698891|76121790|FG000|Overall Study|deemed ineligible|1|||
42288904|NCT02698891|76121790|FG000|Overall Study|Adverse Event|9|||
42288905|NCT02698423|76121796|FG000|Overall Study|Lost to Follow-up|19|||
42288906|NCT02698423|76121797|FG001|Overall Study|Lost to Follow-up|24|||
42288907|NCT02700997|76121805|FG000|Overall Study|Did not undergo CT imaging|1|||
42288908|NCT02700997|76121805|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
42288909|NCT02658149|76121811|FG000|Overall Study|Physician Decision|1|||
42288910|NCT02658149|76121812|FG001|Overall Study|Physician Decision|0|||
42288911|NCT02698189|76121820|FG000|Overall Study|Physician Decision|3|||
42288912|NCT02698189|76121821|FG001|Overall Study|Physician Decision|0|||
42288913|NCT02698189|76121820|FG000|Overall Study|Progressive disease|0|||
42288914|NCT02698189|76121821|FG001|Overall Study|Progressive disease|5|||
42355024|NCT01756898|76197072|FG002|Overall Study|Adverse Event|0|||
42355025|NCT01756898|76197073|FG003|Overall Study|Adverse Event|0|||
42355026|NCT01756898|76197070|FG000|Overall Study|Lack of Efficacy|4|||
42355027|NCT01756898|76197071|FG001|Overall Study|Lack of Efficacy|7|||
42355028|NCT01756898|76197072|FG002|Overall Study|Lack of Efficacy|6|||
42355029|NCT01756898|76197073|FG003|Overall Study|Lack of Efficacy|6|||
42355030|NCT01756898|76197070|FG000|Overall Study|Lost to Follow-up|2|||
42355031|NCT01756898|76197071|FG001|Overall Study|Lost to Follow-up|4|||
42355032|NCT01756898|76197072|FG002|Overall Study|Lost to Follow-up|2|||
42355033|NCT01756898|76197073|FG003|Overall Study|Lost to Follow-up|3|||
42015438|NCT01227252|75822646|FG000|Overall Study|Withdrawal by Subject|0|||
42015439|NCT01227252|75822647|FG001|Overall Study|Withdrawal by Subject|1|||
42288915|NCT02698189|76121820|FG000|Overall Study|Study terminated by sponsor|0|||
42288916|NCT02698189|76121821|FG001|Overall Study|Study terminated by sponsor|1|||
42288917|NCT02702011|76121833|FG000|Overall Study|Withdrawal by Subject|0|||
42355034|NCT01756898|76197070|FG000|Overall Study|Protocol Violation|1|||
42355035|NCT01756898|76197071|FG001|Overall Study|Protocol Violation|2|||
42288918|NCT02702011|76121834|FG001|Overall Study|Withdrawal by Subject|1|||
42288919|NCT02702011|76121835|FG002|Overall Study|Withdrawal by Subject|0|||
42355036|NCT01756898|76197072|FG002|Overall Study|Protocol Violation|2|||
42355037|NCT01756898|76197073|FG003|Overall Study|Protocol Violation|1|||
42355038|NCT01756898|76197070|FG000|Overall Study|Withdrew Consent|5|||
42288920|NCT02702011|76121836|FG003|Overall Study|Withdrawal by Subject|0|||
42288921|NCT02657369|76121846|FG000|Overall Study|Death|27|||
42288922|NCT02657369|76121846|FG000|Overall Study|Study terminated by sponsor|7|||
42288923|NCT02701777|76121854|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
42288924|NCT02701777|76121855|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
42355039|NCT01756898|76197071|FG001|Overall Study|Withdrew Consent|3|||
42015440|NCT01227252|75822648|FG002|Overall Study|Withdrawal by Subject|0|||
42015441|NCT01227252|75822649|FG003|Overall Study|Withdrawal by Subject|0|||
42015442|NCT01227018|75822662|FG000|Overall Study|Disease progression|9|||
42015443|NCT01227018|75822662|FG000|Overall Study|Toxicity|2|||
42015444|NCT01227018|75822662|FG000|Overall Study|Withdrew after beginning treatment|4|||
42015445|NCT01226472|75822676|FG000|Overall Study|Progressive Disease|1|||
42015446|NCT01225146|75822682|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
42015447|NCT01225146|75822683|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
42015448|NCT01223196|75822693|FG000|Overall Study|Lost to Follow-up|2|||
42015449|NCT01223196|75822694|FG001|Overall Study|Lost to Follow-up|0|||
42015450|NCT01223196|75822693|FG000|Overall Study|Physician Decision|1|||
42015451|NCT01223196|75822694|FG001|Overall Study|Physician Decision|0|||
42015452|NCT01223196|75822693|FG000|Overall Study|Withdrawal by Subject|1|||
42015453|NCT01223196|75822694|FG001|Overall Study|Withdrawal by Subject|0|||
42015454|NCT01222416|75822704|FG000|Overall Study|ineligible;metastasis|3|||
42015455|NCT01222416|75822705|FG001|Overall Study|ineligible;metastasis|0|||
42015456|NCT01222416|75822704|FG000|Overall Study|Adverse Event|4|||
42015457|NCT01222416|75822705|FG001|Overall Study|Adverse Event|0|||
42015458|NCT01222416|75822704|FG000|Overall Study|Withdrawal by Subject|5|||
42015459|NCT01222416|75822705|FG001|Overall Study|Withdrawal by Subject|0|||
42015460|NCT01222416|75822704|FG000|Overall Study|scheduling|6|||
42015461|NCT01222416|75822705|FG001|Overall Study|scheduling|0|||
42015462|NCT01222416|75822704|FG000|Overall Study|missed view/scan|1|||
42015463|NCT01222416|75822705|FG001|Overall Study|missed view/scan|0|||
42288925|NCT02701777|76121856|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
42288926|NCT02701777|76121857|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
42288927|NCT02701777|76121854|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
42288928|NCT02701777|76121855|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
42288929|NCT02701777|76121856|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
42288930|NCT02701777|76121857|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
42288931|NCT04604015|76121871|FG000|Overall Study|Incomplete Data Collection|33|||
42355040|NCT01756898|76197072|FG002|Overall Study|Withdrew Consent|5|||
42355041|NCT01756898|76197073|FG003|Overall Study|Withdrew Consent|6|||
42355042|NCT01756898|76197070|FG000|Overall Study|Other|0|||
42355043|NCT01756898|76197071|FG001|Overall Study|Other|2|||
42355044|NCT01756898|76197072|FG002|Overall Study|Other|2|||
42355045|NCT01756898|76197073|FG003|Overall Study|Other|0|||
42355046|NCT01731938|76197090|FG000|Preliminary Part I|Withdrawal by Subject|2|||
42355047|NCT01731938|76197091|FG001|Preliminary Part I|Withdrawal by Subject|2|||
42355048|NCT01731938|76197090|FG000|Preliminary Part I|Physician Decision|1|||
42355049|NCT01731938|76197091|FG001|Preliminary Part I|Physician Decision|0|||
42355050|NCT01731938|76197090|FG000|Preliminary Part I|Lost to Follow-up|0|||
42288932|NCT01675661|76121887|FG000|Overall Study|Lost to Follow-up|22|||
42288933|NCT01675661|76121888|FG001|Overall Study|Lost to Follow-up|23|||
42355051|NCT01731938|76197091|FG001|Preliminary Part I|Lost to Follow-up|3|||
42015464|NCT01222416|75822704|FG000|Overall Study|Death|1|||
42015465|NCT01222416|75822705|FG001|Overall Study|Death|0|||
42355052|NCT01731938|76197090|FG000|Preliminary Part I|Missed Week 6 visit|0|||
42015466|NCT01222104|75822711|FG000|Overall Study|Lost to Follow-up|37|||
42355053|NCT01731938|76197091|FG001|Preliminary Part I|Missed Week 6 visit|3|||
42171972|NCT02952586|75978798|FG001|CRT for Cisplatin (63 Days)|Other|1|||
42171973|NCT02952586|75978797|FG000|CRT for IMRT (63 Days)|Death|5|||
42288934|NCT01675661|76121887|FG000|Overall Study|Practical problems|9|||
42288935|NCT01675661|76121888|FG001|Overall Study|Practical problems|5|||
42288936|NCT01675661|76121887|FG000|Overall Study|Moved away|5|||
42288937|NCT01675661|76121888|FG001|Overall Study|Moved away|6|||
42288938|NCT01675661|76121887|FG000|Overall Study|Withdrawal by Subject|3|||
42288939|NCT01675661|76121888|FG001|Overall Study|Withdrawal by Subject|7|||
42288940|NCT01675661|76121887|FG000|Overall Study|Physician Decision|0|||
42288941|NCT01675661|76121888|FG001|Overall Study|Physician Decision|2|||
42288942|NCT01675661|76121887|FG000|Overall Study|Death|0|||
42288943|NCT01675661|76121888|FG001|Overall Study|Death|1|||
42288944|NCT01675661|76121887|FG000|Overall Study|Other reason|1|||
42288945|NCT01675661|76121888|FG001|Overall Study|Other reason|2|||
42355054|NCT01731938|76197090|FG000|Primary Part II|Withdrawal by Subject|5|||
42355055|NCT01731938|76197091|FG001|Primary Part II|Withdrawal by Subject|4|||
42355056|NCT01731938|76197090|FG000|Primary Part II|Lost to Follow-up|4|||
42355057|NCT01731938|76197091|FG001|Primary Part II|Lost to Follow-up|5|||
42355058|NCT01731938|76197090|FG000|Primary Part II|Death|2|||
42288946|NCT01602341|76121896|FG000|Overall Study|Adverse Event|0|||
42355059|NCT01731938|76197091|FG001|Primary Part II|Death|1|||
42355060|NCT01731938|76197090|FG000|Primary Part II|Missed Week 6 visit|2|||
42355061|NCT01731938|76197091|FG001|Primary Part II|Missed Week 6 visit|3|||
42355062|NCT01731470|76197098|FG000|Overall Study|Withdrawal by Subject|1|||
42355063|NCT01731470|76197098|FG000|Overall Study|Did not meet study criteria|1|||
42355064|NCT01756352|76197102|FG000|Overall Study|moved away and lost to followup|1|||
42355065|NCT01756274|76197106|FG000|Overall Study|Protocol Violation|2|||
42355066|NCT01756274|76197106|FG000|Overall Study|Laboratory error|1|||
42355067|NCT01731002|76197114|FG000|Overall Study|Adverse Event|0|||
42355068|NCT01731002|76197115|FG001|Overall Study|Adverse Event|2|||
42355069|NCT01731002|76197116|FG002|Overall Study|Adverse Event|2|||
42355070|NCT01731002|76197114|FG000|Overall Study|Non-Compliant|0|||
42355071|NCT01731002|76197115|FG001|Overall Study|Non-Compliant|1|||
42355072|NCT01731002|76197116|FG002|Overall Study|Non-Compliant|0|||
42355073|NCT01731002|76197114|FG000|Overall Study|Lost to Follow-up|1|||
42355074|NCT01731002|76197115|FG001|Overall Study|Lost to Follow-up|0|||
42355075|NCT01731002|76197116|FG002|Overall Study|Lost to Follow-up|0|||
42355076|NCT01731002|76197114|FG000|Overall Study|Test Agent Discontinuation|0|||
42355077|NCT01731002|76197115|FG001|Overall Study|Test Agent Discontinuation|1|||
42355078|NCT01731002|76197116|FG002|Overall Study|Test Agent Discontinuation|0|||
42355079|NCT01731002|76197114|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
42355080|NCT01731002|76197115|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
42355081|NCT01731002|76197116|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
42355082|NCT01731002|76197114|FG000|Overall Study|Elevated IOP|1|||
42355083|NCT01731002|76197115|FG001|Overall Study|Elevated IOP|0|||
42355084|NCT01731002|76197116|FG002|Overall Study|Elevated IOP|0|||
42355085|NCT01731002|76197114|FG000|Overall Study|Inappropriate use of study medications|0|||
42355086|NCT01731002|76197115|FG001|Overall Study|Inappropriate use of study medications|0|||
42355087|NCT01731002|76197116|FG002|Overall Study|Inappropriate use of study medications|1|||
42355088|NCT01783886|76197127|FG000|Overall Study|Lost to Follow-up|0|||
42355089|NCT01783886|76197128|FG001|Overall Study|Lost to Follow-up|3|||
42355090|NCT01783886|76197129|FG002|Overall Study|Lost to Follow-up|0|||
42355091|NCT01783886|76197127|FG000|Overall Study|Protocol deviation|0|||
42355092|NCT01783886|76197128|FG001|Overall Study|Protocol deviation|0|||
42355093|NCT01783886|76197129|FG002|Overall Study|Protocol deviation|2|||
42355094|NCT01783886|76197127|FG000|Overall Study|Withdrawal of consent by participant|1|||
42015467|NCT01222104|75822711|FG000|Overall Study|Death|10|||
42171974|NCT02952586|75978798|FG001|CRT for IMRT (63 Days)|Death|8|||
42288947|NCT01602341|76121897|FG001|Overall Study|Adverse Event|1|||
42288948|NCT02700919|76121910|FG000|Overall Study|Physician Decision|1|||
42355095|NCT01783886|76197128|FG001|Overall Study|Withdrawal of consent by participant|3|||
42355096|NCT01783886|76197129|FG002|Overall Study|Withdrawal of consent by participant|4|||
42288949|NCT02700919|76121911|FG001|Overall Study|Physician Decision|0|||
42288950|NCT02700919|76121912|FG002|Overall Study|Physician Decision|0|||
42288951|NCT02700919|76121910|FG000|Overall Study|Protocol Violation|1|||
42288952|NCT02700919|76121911|FG001|Overall Study|Protocol Violation|0|||
42288953|NCT02700919|76121912|FG002|Overall Study|Protocol Violation|0|||
42288954|NCT02700919|76121910|FG000|Overall Study|Adverse Event|1|||
42288955|NCT02700919|76121911|FG001|Overall Study|Adverse Event|3|||
42288956|NCT02700919|76121912|FG002|Overall Study|Adverse Event|1|||
42288957|NCT02700919|76121910|FG000|Overall Study|Withdrawal by Subject|5|||
42288958|NCT02700919|76121911|FG001|Overall Study|Withdrawal by Subject|8|||
42288959|NCT02700919|76121912|FG002|Overall Study|Withdrawal by Subject|2|||
42288960|NCT02700919|76121910|FG000|Overall Study|Lost to Follow-up|2|||
42288961|NCT02700919|76121911|FG001|Overall Study|Lost to Follow-up|0|||
42288962|NCT02700919|76121912|FG002|Overall Study|Lost to Follow-up|0|||
42288963|NCT02700919|76121910|FG000|Overall Study|Other|2|||
42288964|NCT02700919|76121911|FG001|Overall Study|Other|1|||
42288965|NCT02700919|76121912|FG002|Overall Study|Other|1|||
42288966|NCT01986010|76121937|FG000|Overall Study|Adverse Event|0|||
42288967|NCT01986010|76121938|FG001|Overall Study|Adverse Event|1|||
42288968|NCT01986010|76121939|FG002|Overall Study|Adverse Event|0|||
42288969|NCT01986010|76121940|FG003|Overall Study|Adverse Event|0|||
42288970|NCT01986010|76121941|FG004|Overall Study|Adverse Event|0|||
42288971|NCT01986010|76121942|FG005|Overall Study|Adverse Event|0|||
42355097|NCT01783886|76197127|FG000|Overall Study|Adverse Event|4|||
42355098|NCT01783886|76197128|FG001|Overall Study|Adverse Event|5|||
42355099|NCT01783886|76197129|FG002|Overall Study|Adverse Event|4|||
42355100|NCT01609556|76197153|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
42355101|NCT01609556|76197154|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
42355102|NCT01609556|76197155|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
42355103|NCT01609556|76197156|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
42355104|NCT01609556|76197157|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
42355105|NCT01609556|76197158|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
42355106|NCT01609556|76197159|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
42355107|NCT01609556|76197160|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
42355108|NCT01609556|76197161|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
42355109|NCT01609556|76197162|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
42355110|NCT01609556|76197163|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
42355111|NCT01609556|76197164|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
42355112|NCT01609556|76197165|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
42355113|NCT01609556|76197166|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
42355114|NCT01609556|76197167|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
42015468|NCT01221948|75822721|FG000|Overall Study|Physician Decision|5|||
42015469|NCT01221948|75822721|FG000|Overall Study|Withdrawal by Subject|2|||
42015470|NCT01221948|75822721|FG000|Overall Study|not disclosed|2|||
42015471|NCT01221948|75822721|FG000|Overall Study|Death|1|||
42015472|NCT01221948|75822721|FG000|Overall Study|Protocol Violation|4|||
42015473|NCT01221090|75822729|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
42015474|NCT01221090|75822730|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
42015475|NCT01221090|75822731|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
42015476|NCT01221090|75822732|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
42015477|NCT01221090|75822729|FG000|Overall Study|Withdrawal by Subject|0|||
42015478|NCT01221090|75822730|FG001|Overall Study|Withdrawal by Subject|22|||
42015479|NCT01221090|75822731|FG002|Overall Study|Withdrawal by Subject|27|||
42015480|NCT01221090|75822732|FG003|Overall Study|Withdrawal by Subject|2|||
42015481|NCT00950911|75822744|FG000|Overall Study|Adverse Event|0|||
42015482|NCT00950911|75822745|FG001|Overall Study|Adverse Event|2|||
42015483|NCT00950911|75822744|FG000|Overall Study|Death|4|||
42015484|NCT00950911|75822745|FG001|Overall Study|Death|6|||
42288972|NCT01986010|76121943|FG006|Overall Study|Adverse Event|0|||
42288973|NCT01986010|76121944|FG007|Overall Study|Adverse Event|0|||
42288974|NCT01986010|76121945|FG008|Overall Study|Adverse Event|0|||
42288975|NCT01986010|76121946|FG009|Overall Study|Adverse Event|0|||
42288976|NCT01986010|76121947|FG010|Overall Study|Adverse Event|0|||
42015485|NCT00950911|75822744|FG000|Overall Study|Disease progression|2|||
42015486|NCT00950911|75822745|FG001|Overall Study|Disease progression|2|||
42015487|NCT00950911|75822744|FG000|Overall Study|Consent withdrawn|1|||
42355115|NCT01609556|76197168|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
42355116|NCT01609556|76197153|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
42355117|NCT01609556|76197154|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
42355118|NCT01609556|76197155|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
42355119|NCT01609556|76197156|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
42015488|NCT00950911|75822745|FG001|Overall Study|Consent withdrawn|3|||
42015489|NCT00950911|75822744|FG000|Overall Study|Administrative decision|3|||
42040926|NCT01274338|75848848|FG003|Overall Study|Alternative therapy|0|||
42288977|NCT01986010|76121948|FG011|Overall Study|Adverse Event|0|||
42288978|NCT01986010|76121949|FG012|Overall Study|Adverse Event|0|||
42288979|NCT01986010|76121950|FG013|Overall Study|Adverse Event|0|||
42288980|NCT01986010|76121951|FG014|Overall Study|Adverse Event|0|||
42288981|NCT01986010|76121952|FG015|Overall Study|Adverse Event|1|||
42171975|NCT02952586|75978797|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
42288982|NCT01986010|76121953|FG016|Overall Study|Adverse Event|0|||
42015490|NCT00950911|75822745|FG001|Overall Study|Administrative decision|1|||
42015491|NCT00950911|75822744|FG000|Overall Study|Ineligibility determined|1|||
42015492|NCT00950911|75822745|FG001|Overall Study|Ineligibility determined|0|||
42015493|NCT00950911|75822744|FG000|Overall Study|Noncompliance|1|||
42015494|NCT00950911|75822745|FG001|Overall Study|Noncompliance|0|||
42015495|NCT00950911|75822744|FG000|Overall Study|Poor performance status|0|||
42288983|NCT01986010|76121937|FG000|Overall Study|Lost to Follow-up|2|||
42288984|NCT01986010|76121938|FG001|Overall Study|Lost to Follow-up|1|||
42288985|NCT01986010|76121939|FG002|Overall Study|Lost to Follow-up|2|||
42288986|NCT01986010|76121940|FG003|Overall Study|Lost to Follow-up|2|||
42288987|NCT01986010|76121941|FG004|Overall Study|Lost to Follow-up|2|||
42288988|NCT01986010|76121942|FG005|Overall Study|Lost to Follow-up|2|||
42355120|NCT01609556|76197157|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
42355121|NCT01609556|76197158|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
42355122|NCT01609556|76197159|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
42355123|NCT01609556|76197160|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
42355124|NCT01609556|76197161|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
42355125|NCT01609556|76197162|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
42355126|NCT01609556|76197163|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
42355127|NCT01609556|76197164|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
42355128|NCT01609556|76197165|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
42355129|NCT01609556|76197166|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
42355130|NCT01609556|76197167|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
42355131|NCT01609556|76197168|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
42355132|NCT01609556|76197153|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
42355133|NCT01609556|76197154|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
42355134|NCT01609556|76197155|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
42015496|NCT00950911|75822745|FG001|Overall Study|Poor performance status|1|||
42015497|NCT01220856|75822753|FG000|Overall Study|graft loss|3|||
42015498|NCT01220856|75822754|FG001|Overall Study|graft loss|3|||
42015499|NCT01220856|75822753|FG000|Overall Study|Lost to Follow-up|1|||
42015500|NCT01220856|75822754|FG001|Overall Study|Lost to Follow-up|0|||
42015501|NCT01218594|75822763|FG000|Overall Study|Death|1|||
42015502|NCT01218594|75822763|FG000|Overall Study|Withdrawal by Subject|3|||
42015503|NCT01218594|75822763|FG000|Overall Study|Adverse Event|2|||
42015504|NCT01218594|75822763|FG000|Overall Study|Physician Decision|6|||
42015505|NCT01610557|75822771|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
42015506|NCT01610557|75822772|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
42015507|NCT01610557|75822773|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
42015508|NCT01610557|75822774|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
42015509|NCT01610557|75822775|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
42015510|NCT01610557|75822771|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
42015511|NCT01610557|75822772|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
42015512|NCT01610557|75822773|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
42015513|NCT01610557|75822774|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
42015514|NCT01610557|75822775|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
42015515|NCT00943735|75822786|FG000|Overall Study|Adverse Event|12|||
42015516|NCT00943735|75822786|FG000|Overall Study|Withdrawal by Subject|8|||
42015517|NCT00943735|75822786|FG000|Overall Study|Death|1|||
42015518|NCT00943735|75822786|FG000|Overall Study|Other|8|||
42015519|NCT00943735|75822786|FG000|Overall Study|Other|3|||
42015520|NCT00943579|75822792|FG000|Overall Study|Adverse Event|4|||
42015521|NCT00943579|75822793|FG001|Overall Study|Adverse Event|3|||
42015522|NCT00943579|75822792|FG000|Overall Study|Lack of Efficacy|2|||
42015523|NCT00943579|75822793|FG001|Overall Study|Lack of Efficacy|2|||
42015524|NCT01147809|75822808|FG000|Phase I (168 Days)|Adverse Event|0|||
42015525|NCT01147809|75822809|FG001|Phase I (168 Days)|Adverse Event|0|||
42015526|NCT01147809|75822810|FG002|Phase I (168 Days)|Adverse Event|0|||
42015527|NCT01147809|75822811|FG003|Phase I (168 Days)|Adverse Event|1|||
42015528|NCT01147809|75822812|FG004|Phase I (168 Days)|Adverse Event|0|||
42015529|NCT01147809|75822813|FG005|Phase I (168 Days)|Adverse Event|0|||
42015530|NCT01147809|75822808|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
42015531|NCT01147809|75822809|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
42015532|NCT01147809|75822810|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
42015533|NCT01147809|75822811|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
42015534|NCT01147809|75822812|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
42015535|NCT01147809|75822813|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
42015536|NCT01147809|75822808|FG000|Phase I (168 Days)|Physician Decision|0|||
42015537|NCT01147809|75822809|FG001|Phase I (168 Days)|Physician Decision|1|||
42015538|NCT01147809|75822810|FG002|Phase I (168 Days)|Physician Decision|2|||
42015539|NCT01147809|75822811|FG003|Phase I (168 Days)|Physician Decision|0|||
42015540|NCT01147809|75822812|FG004|Phase I (168 Days)|Physician Decision|0|||
42015541|NCT01147809|75822813|FG005|Phase I (168 Days)|Physician Decision|0|||
42015542|NCT01147809|75822808|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
42015543|NCT01147809|75822809|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
42015544|NCT01147809|75822810|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
42015545|NCT01147809|75822811|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
42015546|NCT01147809|75822812|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
42015547|NCT01147809|75822813|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
42015548|NCT01147809|75822808|FG000|Phase II (168 Days)|Adverse Event|0|||
42355135|NCT01609556|76197156|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
42040927|NCT01274338|75848849|FG004|Overall Study|Alternative therapy|0|||
42040928|NCT01274338|75848850|FG005|Overall Study|Alternative therapy|0|||
42040929|NCT01274338|75848845|FG000|Overall Study|Other complicating diseases|0|||
42040930|NCT01274338|75848846|FG001|Overall Study|Other complicating diseases|3|||
42040931|NCT01274338|75848847|FG002|Overall Study|Other complicating diseases|1|||
42040932|NCT01274338|75848848|FG003|Overall Study|Other complicating diseases|0|||
42040933|NCT01274338|75848849|FG004|Overall Study|Other complicating diseases|0|||
42288989|NCT01986010|76121943|FG006|Overall Study|Lost to Follow-up|0|||
42288990|NCT01986010|76121944|FG007|Overall Study|Lost to Follow-up|0|||
42288991|NCT01986010|76121945|FG008|Overall Study|Lost to Follow-up|4|||
42288992|NCT01986010|76121946|FG009|Overall Study|Lost to Follow-up|2|||
42288993|NCT01986010|76121947|FG010|Overall Study|Lost to Follow-up|0|||
42288994|NCT01986010|76121948|FG011|Overall Study|Lost to Follow-up|1|||
42288995|NCT01986010|76121949|FG012|Overall Study|Lost to Follow-up|1|||
42288996|NCT01986010|76121950|FG013|Overall Study|Lost to Follow-up|1|||
42288997|NCT01986010|76121951|FG014|Overall Study|Lost to Follow-up|2|||
42288998|NCT01986010|76121952|FG015|Overall Study|Lost to Follow-up|0|||
42015549|NCT01147809|75822809|FG001|Phase II (168 Days)|Adverse Event|0|||
42015550|NCT01147809|75822810|FG002|Phase II (168 Days)|Adverse Event|0|||
42015551|NCT01147809|75822811|FG003|Phase II (168 Days)|Adverse Event|0|||
42015552|NCT01147809|75822812|FG004|Phase II (168 Days)|Adverse Event|3|||
42015553|NCT01147809|75822813|FG005|Phase II (168 Days)|Adverse Event|6|||
42015554|NCT01147809|75822808|FG000|Phase II (168 Days)|Protocol Violation|0|||
42015555|NCT01147809|75822809|FG001|Phase II (168 Days)|Protocol Violation|0|||
42015556|NCT01147809|75822810|FG002|Phase II (168 Days)|Protocol Violation|0|||
42015557|NCT01147809|75822811|FG003|Phase II (168 Days)|Protocol Violation|0|||
42015558|NCT01147809|75822812|FG004|Phase II (168 Days)|Protocol Violation|0|||
42015559|NCT01147809|75822813|FG005|Phase II (168 Days)|Protocol Violation|1|||
42015560|NCT01147809|75822808|FG000|Phase II (168 Days)|Physician Decision|0|||
42015561|NCT01147809|75822809|FG001|Phase II (168 Days)|Physician Decision|0|||
42015562|NCT01147809|75822810|FG002|Phase II (168 Days)|Physician Decision|0|||
42288999|NCT01986010|76121953|FG016|Overall Study|Lost to Follow-up|0|||
42289000|NCT01986010|76121937|FG000|Overall Study|Physician Decision|0|||
42289001|NCT01986010|76121938|FG001|Overall Study|Physician Decision|0|||
42289002|NCT01986010|76121939|FG002|Overall Study|Physician Decision|0|||
42015563|NCT01147809|75822811|FG003|Phase II (168 Days)|Physician Decision|0|||
42040934|NCT01274338|75848850|FG005|Overall Study|Other complicating diseases|0|||
42040935|NCT01274338|75848845|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
42040936|NCT01274338|75848846|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
42355136|NCT01609556|76197157|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
42040937|NCT01274338|75848847|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
42289003|NCT01986010|76121940|FG003|Overall Study|Physician Decision|0|||
42289004|NCT01986010|76121941|FG004|Overall Study|Physician Decision|0|||
42355137|NCT01609556|76197158|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
42355138|NCT01609556|76197159|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
42355139|NCT01609556|76197160|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
42355140|NCT01609556|76197161|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
42355141|NCT01609556|76197162|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
42355142|NCT01609556|76197163|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
42355143|NCT01609556|76197164|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
42355144|NCT01609556|76197165|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
42015564|NCT01147809|75822812|FG004|Phase II (168 Days)|Physician Decision|5|||
42015565|NCT01147809|75822813|FG005|Phase II (168 Days)|Physician Decision|11|||
42015566|NCT01147809|75822808|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
42171976|NCT02952586|75978798|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
42289005|NCT01986010|76121942|FG005|Overall Study|Physician Decision|0|||
42289006|NCT01986010|76121943|FG006|Overall Study|Physician Decision|0|||
42289007|NCT01986010|76121944|FG007|Overall Study|Physician Decision|0|||
42289008|NCT01986010|76121945|FG008|Overall Study|Physician Decision|0|||
42289009|NCT01986010|76121946|FG009|Overall Study|Physician Decision|0|||
42289010|NCT01986010|76121947|FG010|Overall Study|Physician Decision|0|||
42289011|NCT01986010|76121948|FG011|Overall Study|Physician Decision|0|||
42289012|NCT01986010|76121949|FG012|Overall Study|Physician Decision|0|||
42289013|NCT01986010|76121950|FG013|Overall Study|Physician Decision|0|||
42289014|NCT01986010|76121951|FG014|Overall Study|Physician Decision|1|||
42289015|NCT01986010|76121952|FG015|Overall Study|Physician Decision|0|||
42355145|NCT01609556|76197166|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
42355146|NCT01609556|76197167|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
42355147|NCT01609556|76197168|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
42355148|NCT01609556|76197153|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355149|NCT01609556|76197154|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355150|NCT01609556|76197155|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355151|NCT01609556|76197156|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355152|NCT01609556|76197157|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355153|NCT01609556|76197158|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
42355154|NCT01609556|76197159|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42040938|NCT01274338|75848848|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
42040939|NCT01274338|75848849|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
42040940|NCT01274338|75848850|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
42040941|NCT01274338|75848845|FG000|Overall Study|Pregnancy|0|||
42040942|NCT01274338|75848846|FG001|Overall Study|Pregnancy|0|||
42040943|NCT01274338|75848847|FG002|Overall Study|Pregnancy|1|||
42040944|NCT01274338|75848848|FG003|Overall Study|Pregnancy|0|||
42040945|NCT01274338|75848849|FG004|Overall Study|Pregnancy|0|||
42040946|NCT01274338|75848850|FG005|Overall Study|Pregnancy|0|||
42040947|NCT01274338|75848845|FG000|Overall Study|Reason not reported|12|||
42040948|NCT01274338|75848846|FG001|Overall Study|Reason not reported|21|||
42040949|NCT01274338|75848847|FG002|Overall Study|Reason not reported|3|||
42040950|NCT01274338|75848848|FG003|Overall Study|Reason not reported|0|||
42040951|NCT01274338|75848849|FG004|Overall Study|Reason not reported|1|||
42040952|NCT01274338|75848850|FG005|Overall Study|Reason not reported|0|||
42040953|NCT01272037|75848865|FG000|Overall Study|Death|25|||
42040954|NCT01272037|75848866|FG001|Overall Study|Death|28|||
42040955|NCT01272037|75848865|FG000|Overall Study|Adverse Event|12|||
42040956|NCT01272037|75848866|FG001|Overall Study|Adverse Event|7|||
42040957|NCT01272037|75848865|FG000|Overall Study|Withdrawal by Subject|175|||
42040958|NCT01272037|75848866|FG001|Overall Study|Withdrawal by Subject|93|||
42015567|NCT01147809|75822809|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
42015568|NCT01147809|75822810|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
42040959|NCT01272037|75848865|FG000|Overall Study|Disease progression|70|||
42171977|NCT02952586|75978797|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
42015569|NCT01147809|75822811|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
42015570|NCT01147809|75822812|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
42015571|NCT01147809|75822813|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
42015572|NCT01147809|75822808|FG000|Phase II (168 Days)|Ongoing|0|||
42015573|NCT01147809|75822809|FG001|Phase II (168 Days)|Ongoing|0|||
42289016|NCT01986010|76121953|FG016|Overall Study|Physician Decision|0|||
42289017|NCT01986010|76121937|FG000|Overall Study|Withdrawal by Subject|2|||
42015574|NCT01147809|75822810|FG002|Phase II (168 Days)|Ongoing|0|||
42015575|NCT01147809|75822811|FG003|Phase II (168 Days)|Ongoing|0|||
42289018|NCT01986010|76121938|FG001|Overall Study|Withdrawal by Subject|2|||
42289019|NCT01986010|76121939|FG002|Overall Study|Withdrawal by Subject|3|||
42015576|NCT01147809|75822812|FG004|Phase II (168 Days)|Ongoing|1|||
42015577|NCT01147809|75822813|FG005|Phase II (168 Days)|Ongoing|0|||
42040960|NCT01272037|75848866|FG001|Overall Study|Disease progression|111|||
42040961|NCT01272037|75848865|FG000|Overall Study|Other reason|42|||
42040962|NCT01272037|75848866|FG001|Overall Study|Other reason|41|||
42040963|NCT01272037|75848865|FG000|Overall Study|Delinquent data|24|||
42040964|NCT01272037|75848866|FG001|Overall Study|Delinquent data|19|||
42040965|NCT01272037|75848865|FG000|Overall Study|Reason under review|33|||
42040966|NCT01272037|75848866|FG001|Overall Study|Reason under review|29|||
42040967|NCT01272037|75848865|FG000|Overall Study|On treatment|626|||
42040968|NCT01272037|75848866|FG001|Overall Study|On treatment|632|||
42040969|NCT01199575|75848872|FG000|Overall Study|Withdrawal by Subject|5|||
42040970|NCT01194570|75848879|FG000|Overall Study|Adverse Event|22|||
42040971|NCT01194570|75848880|FG001|Overall Study|Adverse Event|40|||
42040972|NCT01194570|75848879|FG000|Overall Study|Death|6|||
42040973|NCT01194570|75848880|FG001|Overall Study|Death|20|||
42040974|NCT01194570|75848879|FG000|Overall Study|Lack of Efficacy|32|||
42040975|NCT01194570|75848880|FG001|Overall Study|Lack of Efficacy|33|||
42040976|NCT01194570|75848879|FG000|Overall Study|Lost to Follow-up|4|||
42040977|NCT01194570|75848880|FG001|Overall Study|Lost to Follow-up|15|||
42040978|NCT01194570|75848879|FG000|Overall Study|Non-Compliance|2|||
42040979|NCT01194570|75848880|FG001|Overall Study|Non-Compliance|2|||
42040980|NCT01194570|75848879|FG000|Overall Study|Non-Compliance With Study Drug|2|||
42040981|NCT01194570|75848880|FG001|Overall Study|Non-Compliance With Study Drug|2|||
42040982|NCT01194570|75848879|FG000|Overall Study|Other|18|||
42040983|NCT01194570|75848880|FG001|Overall Study|Other|47|||
42040984|NCT01194570|75848879|FG000|Overall Study|Physician Decision|10|||
42040985|NCT01194570|75848880|FG001|Overall Study|Physician Decision|25|||
42040986|NCT01194570|75848879|FG000|Overall Study|Protocol Violation|1|||
42040987|NCT01194570|75848880|FG001|Overall Study|Protocol Violation|2|||
42040988|NCT01194570|75848879|FG000|Overall Study|Study Terminated By Sponsor|0|||
42040989|NCT01194570|75848880|FG001|Overall Study|Study Terminated By Sponsor|1|||
42015578|NCT00943111|75822830|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
42015579|NCT00943111|75822831|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
42015580|NCT00943111|75822832|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
42015581|NCT00943111|75822830|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
42015582|NCT00943111|75822831|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
42015583|NCT00943111|75822832|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
42015584|NCT00943111|75822830|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
42015585|NCT00943111|75822831|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
42015586|NCT00943111|75822832|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
42015587|NCT00943111|75822830|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
42015588|NCT00943111|75822831|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
42015589|NCT00943111|75822832|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
42015590|NCT00943111|75822830|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
42040990|NCT01194570|75848879|FG000|Overall Study|Withdrawal by Subject|57|||
42040991|NCT01194570|75848880|FG001|Overall Study|Withdrawal by Subject|82|||
42040992|NCT01194570|75848879|FG000|Overall Study|Pregnancy|1|||
42040993|NCT01194570|75848880|FG001|Overall Study|Pregnancy|1|||
42040994|NCT01169337|75848893|FG000|Overall Study|Lack of Efficacy|5|||
42015591|NCT00943111|75822831|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
42289020|NCT01986010|76121940|FG003|Overall Study|Withdrawal by Subject|0|||
42289021|NCT01986010|76121941|FG004|Overall Study|Withdrawal by Subject|2|||
42289022|NCT01986010|76121942|FG005|Overall Study|Withdrawal by Subject|4|||
42289023|NCT01986010|76121943|FG006|Overall Study|Withdrawal by Subject|0|||
42289024|NCT01986010|76121944|FG007|Overall Study|Withdrawal by Subject|0|||
42289025|NCT01986010|76121945|FG008|Overall Study|Withdrawal by Subject|0|||
42289026|NCT01986010|76121946|FG009|Overall Study|Withdrawal by Subject|0|||
42289027|NCT01986010|76121947|FG010|Overall Study|Withdrawal by Subject|0|||
42289028|NCT01986010|76121948|FG011|Overall Study|Withdrawal by Subject|2|||
42289029|NCT01986010|76121949|FG012|Overall Study|Withdrawal by Subject|0|||
42289030|NCT01986010|76121950|FG013|Overall Study|Withdrawal by Subject|1|||
42015592|NCT00943111|75822832|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
42015593|NCT00943111|75822830|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
42289031|NCT01986010|76121951|FG014|Overall Study|Withdrawal by Subject|2|||
42040995|NCT01169337|75848894|FG001|Overall Study|Lack of Efficacy|7|||
42040996|NCT01169337|75848895|FG002|Overall Study|Lack of Efficacy|0|||
42040997|NCT01169337|75848893|FG000|Overall Study|Adverse Event|12|||
42040998|NCT01169337|75848894|FG001|Overall Study|Adverse Event|18|||
42040999|NCT01169337|75848895|FG002|Overall Study|Adverse Event|0|||
42171978|NCT02952586|75978798|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
42355155|NCT01609556|76197160|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355156|NCT01609556|76197161|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355157|NCT01609556|76197162|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355158|NCT01609556|76197163|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355159|NCT01609556|76197164|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
42355160|NCT01609556|76197165|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355161|NCT01609556|76197166|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42041000|NCT01169337|75848893|FG000|Overall Study|Death|2|||
42355162|NCT01609556|76197167|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355163|NCT01609556|76197168|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
42355164|NCT01609556|76197153|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355165|NCT01609556|76197154|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355166|NCT01609556|76197155|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355167|NCT01609556|76197156|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355168|NCT01609556|76197157|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355169|NCT01609556|76197158|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
42355170|NCT01609556|76197159|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42041001|NCT01169337|75848894|FG001|Overall Study|Death|0|||
42041002|NCT01169337|75848895|FG002|Overall Study|Death|0|||
42041003|NCT01169337|75848893|FG000|Overall Study|Withdrawal by Subject|11|||
42041004|NCT01169337|75848894|FG001|Overall Study|Withdrawal by Subject|11|||
42041005|NCT01169337|75848895|FG002|Overall Study|Withdrawal by Subject|6|||
42041006|NCT01169337|75848893|FG000|Overall Study|Noncompliance|2|||
42041007|NCT01169337|75848894|FG001|Overall Study|Noncompliance|0|||
42041008|NCT01169337|75848895|FG002|Overall Study|Noncompliance|0|||
42041009|NCT01169337|75848893|FG000|Overall Study|Other complicating disease|1|||
42041010|NCT01169337|75848894|FG001|Overall Study|Other complicating disease|1|||
42041011|NCT01169337|75848895|FG002|Overall Study|Other complicating disease|0|||
42041012|NCT01169337|75848893|FG000|Overall Study|Physician Decision|1|||
42289032|NCT01986010|76121952|FG015|Overall Study|Withdrawal by Subject|0|||
42289033|NCT01986010|76121953|FG016|Overall Study|Withdrawal by Subject|0|||
42355171|NCT01609556|76197160|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355172|NCT01609556|76197161|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355173|NCT01609556|76197162|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355174|NCT01609556|76197163|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355175|NCT01609556|76197164|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355176|NCT01609556|76197165|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42289034|NCT01986010|76121937|FG000|Overall Study|Status Not Recorded|2|||
42289035|NCT01986010|76121938|FG001|Overall Study|Status Not Recorded|4|||
42289036|NCT01986010|76121939|FG002|Overall Study|Status Not Recorded|2|||
42289037|NCT01986010|76121940|FG003|Overall Study|Status Not Recorded|0|||
42289038|NCT01986010|76121941|FG004|Overall Study|Status Not Recorded|1|||
42289039|NCT01986010|76121942|FG005|Overall Study|Status Not Recorded|2|||
42289040|NCT01986010|76121943|FG006|Overall Study|Status Not Recorded|0|||
42289041|NCT01986010|76121944|FG007|Overall Study|Status Not Recorded|0|||
42289042|NCT01986010|76121945|FG008|Overall Study|Status Not Recorded|2|||
42289043|NCT01986010|76121946|FG009|Overall Study|Status Not Recorded|1|||
42289044|NCT01986010|76121947|FG010|Overall Study|Status Not Recorded|7|||
42289045|NCT01986010|76121948|FG011|Overall Study|Status Not Recorded|7|||
42289046|NCT01986010|76121949|FG012|Overall Study|Status Not Recorded|9|||
42289047|NCT01986010|76121950|FG013|Overall Study|Status Not Recorded|9|||
42355177|NCT01609556|76197166|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355178|NCT01609556|76197167|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42041013|NCT01169337|75848894|FG001|Overall Study|Physician Decision|5|||
42289048|NCT01986010|76121951|FG014|Overall Study|Status Not Recorded|5|||
42289049|NCT01986010|76121952|FG015|Overall Study|Status Not Recorded|10|||
42041014|NCT01169337|75848895|FG002|Overall Study|Physician Decision|0|||
42289050|NCT01986010|76121953|FG016|Overall Study|Status Not Recorded|4|||
42289051|NCT01963780|76121999|FG000|Overall Study|Death|7|||
42289052|NCT02009878|76122006|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
42289053|NCT02009878|76122007|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
42289054|NCT02009878|76122008|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
42289055|NCT02009722|76122018|FG000|Overall Study|Protocol Violation|1|||
42289056|NCT02009722|76122019|FG001|Overall Study|Protocol Violation|2|||
42289057|NCT02009722|76122018|FG000|Overall Study|Did not receive intervention|0|||
42355179|NCT01609556|76197168|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
42355180|NCT01609556|76197153|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42015594|NCT00943111|75822831|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
42015595|NCT00943111|75822832|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
42015596|NCT00943111|75822830|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
42289058|NCT02009722|76122019|FG001|Overall Study|Did not receive intervention|1|||
42289059|NCT02655419|76122027|FG000|Overall Study|Enrolled but not treated|1|||
42171979|NCT02952586|75978797|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
42171980|NCT02952586|75978798|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
42015597|NCT00943111|75822831|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
42015598|NCT00943111|75822832|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
42171981|NCT02952586|75978797|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
42171982|NCT02952586|75978798|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
42355181|NCT01609556|76197154|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42355182|NCT01609556|76197155|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42355183|NCT01609556|76197156|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42355184|NCT01609556|76197157|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42355185|NCT01609556|76197158|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42355186|NCT01609556|76197159|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42355187|NCT01609556|76197160|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42015599|NCT00943111|75822830|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
42289060|NCT02655419|76122028|FG001|Overall Study|Enrolled but not treated|5|||
42289061|NCT02655419|76122027|FG000|Overall Study|Withdrawal by Subject|4|||
42289062|NCT02655419|76122028|FG001|Overall Study|Withdrawal by Subject|1|||
42289063|NCT02655419|76122027|FG000|Overall Study|Other|0|||
42289064|NCT02655419|76122028|FG001|Overall Study|Other|1|||
42289065|NCT01962922|76122040|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
42289066|NCT01962922|76122041|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
42289067|NCT01962922|76122040|FG000|PK Portion Day 7|non-compliance|1|||
42289068|NCT01962922|76122041|FG001|PK Portion Day 7|non-compliance|0|||
42289069|NCT01962922|76122040|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
42289070|NCT01962922|76122041|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
42289071|NCT01962922|76122040|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
42289072|NCT01962922|76122041|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
42289073|NCT01984684|76122049|FG000|Overall Study|Lost to Follow-up|25|||
42289074|NCT01984684|76122050|FG001|Overall Study|Lost to Follow-up|24|||
42289075|NCT01984684|76122049|FG000|Overall Study|Adverse Event|8|||
42289076|NCT01984684|76122050|FG001|Overall Study|Adverse Event|12|||
42289077|NCT01984684|76122049|FG000|Overall Study|Withdrawal by Subject|9|||
42289078|NCT01984684|76122050|FG001|Overall Study|Withdrawal by Subject|9|||
42289079|NCT01984684|76122049|FG000|Overall Study|Lack of Efficacy|3|||
42015600|NCT00943111|75822831|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
42289080|NCT01984684|76122050|FG001|Overall Study|Lack of Efficacy|6|||
42289081|NCT01984684|76122049|FG000|Overall Study|Physician Decision|4|||
42015601|NCT00943111|75822832|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
42015602|NCT01147497|75822841|FG000|Overall Study|failed insertion|2|||
42015603|NCT01147497|75822842|FG001|Overall Study|failed insertion|0|||
42015604|NCT01147341|75822850|FG000|Double Blind Period|Lack of Efficacy|1|||
42015605|NCT01147341|75822851|FG001|Double Blind Period|Lack of Efficacy|1|||
42015606|NCT01147341|75822850|FG000|Double Blind Period|Withdrawal by Subject|0|||
42355188|NCT01609556|76197161|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
42355189|NCT01609556|76197162|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42355190|NCT01609556|76197163|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42355191|NCT01609556|76197164|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42041015|NCT01169337|75848893|FG000|Overall Study|Alternative therapy|0|||
42041016|NCT01169337|75848894|FG001|Overall Study|Alternative therapy|2|||
42041017|NCT01169337|75848895|FG002|Overall Study|Alternative therapy|0|||
42041018|NCT01169337|75848893|FG000|Overall Study|Changed hospital|0|||
42041019|NCT01169337|75848894|FG001|Overall Study|Changed hospital|1|||
42041020|NCT01169337|75848895|FG002|Overall Study|Changed hospital|0|||
42015607|NCT01147341|75822851|FG001|Double Blind Period|Withdrawal by Subject|1|||
42015608|NCT01147341|75822850|FG000|Open Label Period|Lack of Efficacy|3|||
42015609|NCT01147341|75822851|FG001|Open Label Period|Lack of Efficacy|0|||
42015610|NCT01147341|75822850|FG000|Open Label Period|Subject moved|1|||
42015611|NCT01147341|75822851|FG001|Open Label Period|Subject moved|0|||
42015612|NCT00950755|75822857|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
42015613|NCT00950755|75822857|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
42015614|NCT00950755|75822857|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
42041021|NCT01169337|75848893|FG000|Overall Study|Never started treatment|0|||
42015615|NCT00950755|75822857|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
42015616|NCT00950755|75822857|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
42015617|NCT00950755|75822857|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
42015618|NCT00950755|75822857|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
42015619|NCT00950755|75822857|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
42015620|NCT00950755|75822857|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
42015621|NCT00950755|75822857|FG000|Long-Term Follow-Up|Death|8|||
42015622|NCT01147107|75822863|FG000|Overall Study|Lack of Efficacy|5|||
42015623|NCT01147107|75822864|FG001|Overall Study|Lack of Efficacy|0|||
42015624|NCT01147107|75822863|FG000|Overall Study|Withdrawal by Subject|1|||
42015625|NCT01147107|75822864|FG001|Overall Study|Withdrawal by Subject|1|||
42015626|NCT00942409|75822870|FG000|Overall Study|Lack of Efficacy|1|||
42015627|NCT00942409|75822870|FG000|Overall Study|study drug unavailable|2|||
42015628|NCT01146951|75822876|FG000|Overall Study|Adverse Event|4|||
42015629|NCT01146951|75822877|FG001|Overall Study|Adverse Event|1|||
42015630|NCT01146873|75822885|FG000|Overall Study|Transfer out|0|||
42015631|NCT01146873|75822886|FG001|Overall Study|Transfer out|6|||
42015632|NCT01146795|75822892|FG000|Overall Study|Withdrawal by Subject|4|||
42015633|NCT01146795|75822892|FG000|Overall Study|Adverse Event|6|||
42015634|NCT01146795|75822892|FG000|Overall Study|Still in treatment at study closure|10|||
42015635|NCT01146561|75822896|FG000|Overall Study|Withdrawal by Subject|1|||
42041022|NCT01169337|75848894|FG001|Overall Study|Never started treatment|2|||
42355192|NCT01609556|76197165|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42015636|NCT01146561|75822896|FG000|Overall Study|Lost to Follow-up|1|||
42041023|NCT01169337|75848895|FG002|Overall Study|Never started treatment|0|||
42041024|NCT01169337|75848893|FG000|Overall Study|Reason not reported|1|||
42041025|NCT01169337|75848894|FG001|Overall Study|Reason not reported|0|||
42041026|NCT01169337|75848895|FG002|Overall Study|Reason not reported|0|||
42041027|NCT01169337|75848893|FG000|Overall Study|Continuing lenalidomide|9|||
42041028|NCT01169337|75848894|FG001|Overall Study|Continuing lenalidomide|43|||
42041029|NCT01169337|75848895|FG002|Overall Study|Continuing lenalidomide|0|||
42041030|NCT01064648|75848932|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
42041031|NCT01064648|75848933|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
42041032|NCT01064648|75848934|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
42289082|NCT01984684|76122050|FG001|Overall Study|Physician Decision|2|||
42041033|NCT01064648|75848935|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
42289083|NCT01984684|76122049|FG000|Overall Study|Protocol Violation|4|||
42041034|NCT01064648|75848932|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
42041035|NCT01064648|75848933|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
42041036|NCT01064648|75848934|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
42041037|NCT01064648|75848935|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
42041038|NCT01064648|75848932|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
42041039|NCT01064648|75848933|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
42041040|NCT01064648|75848934|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
42041041|NCT01064648|75848935|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
42041042|NCT01064648|75848932|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
42041043|NCT01064648|75848933|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
42041044|NCT01064648|75848934|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
42041045|NCT01064648|75848935|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
42041046|NCT01064648|75848932|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
42041047|NCT01064648|75848933|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
42041048|NCT01064648|75848934|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
42041049|NCT01064648|75848935|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
42289084|NCT01984684|76122050|FG001|Overall Study|Protocol Violation|2|||
42289085|NCT01984684|76122049|FG000|Overall Study|Death|0|||
42289086|NCT01984684|76122050|FG001|Overall Study|Death|1|||
42289087|NCT01984684|76122049|FG000|Overall Study|Noncompliance with study drug|2|||
42289088|NCT01984684|76122050|FG001|Overall Study|Noncompliance with study drug|1|||
42289089|NCT01984684|76122049|FG000|Overall Study|Subject incarcerated|1|||
42289090|NCT01984684|76122050|FG001|Overall Study|Subject incarcerated|0|||
42355193|NCT01609556|76197166|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42355194|NCT01609556|76197167|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42355195|NCT01609556|76197168|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
42355196|NCT01609556|76197153|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
42355197|NCT01609556|76197154|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355198|NCT01609556|76197155|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355199|NCT01609556|76197156|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355200|NCT01609556|76197157|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355201|NCT01609556|76197158|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
42355202|NCT01609556|76197159|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355203|NCT01609556|76197160|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355204|NCT01609556|76197161|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355205|NCT01609556|76197162|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355206|NCT01609556|76197163|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
42355207|NCT01609556|76197164|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355208|NCT01609556|76197165|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355209|NCT01609556|76197166|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355210|NCT01609556|76197167|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355211|NCT01609556|76197168|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
42355212|NCT01609556|76197153|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42355213|NCT01609556|76197154|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42355214|NCT01609556|76197155|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42355215|NCT01609556|76197156|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42355216|NCT01609556|76197157|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42355217|NCT01609556|76197158|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42355218|NCT01609556|76197159|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42355219|NCT01609556|76197160|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42355220|NCT01609556|76197161|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42355221|NCT01609556|76197162|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42355222|NCT01609556|76197163|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42355223|NCT01609556|76197164|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
42041050|NCT01064648|75848932|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
42041051|NCT01064648|75848933|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
42041052|NCT01064648|75848934|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
42289091|NCT01984684|76122049|FG000|Overall Study|Study drug not available at site|1|||
42289092|NCT01984684|76122050|FG001|Overall Study|Study drug not available at site|1|||
42289093|NCT01984684|76122049|FG000|Overall Study|Subject had inadequate IV access|0|||
42289094|NCT01984684|76122050|FG001|Overall Study|Subject had inadequate IV access|1|||
42289095|NCT02694523|76122058|FG000|Part A|Adverse Event|7|||
42289096|NCT02694523|76122059|FG001|Part A|Adverse Event|3|||
42289097|NCT02694523|76122060|FG002|Part A|Adverse Event|0|||
42289098|NCT02694523|76122061|FG003|Part A|Adverse Event|0|||
42289099|NCT02694523|76122062|FG004|Part A|Adverse Event|0|||
42289100|NCT02694523|76122063|FG005|Part A|Adverse Event|0|||
42289101|NCT02694523|76122064|FG006|Part A|Adverse Event|0|||
42289102|NCT02694523|76122058|FG000|Part A|Protocol Violation|1|||
42289103|NCT02694523|76122059|FG001|Part A|Protocol Violation|0|||
42289104|NCT02694523|76122060|FG002|Part A|Protocol Violation|0|||
42289105|NCT02694523|76122061|FG003|Part A|Protocol Violation|0|||
42289106|NCT02694523|76122062|FG004|Part A|Protocol Violation|0|||
42289107|NCT02694523|76122063|FG005|Part A|Protocol Violation|0|||
42289108|NCT02694523|76122064|FG006|Part A|Protocol Violation|0|||
42289109|NCT02694523|76122058|FG000|Part A|Lost to Follow-up|1|||
42289110|NCT02694523|76122059|FG001|Part A|Lost to Follow-up|2|||
42289111|NCT02694523|76122060|FG002|Part A|Lost to Follow-up|0|||
42289112|NCT02694523|76122061|FG003|Part A|Lost to Follow-up|0|||
42289113|NCT02694523|76122062|FG004|Part A|Lost to Follow-up|0|||
42289114|NCT02694523|76122063|FG005|Part A|Lost to Follow-up|0|||
42289115|NCT02694523|76122064|FG006|Part A|Lost to Follow-up|0|||
42289116|NCT02694523|76122058|FG000|Part A|Withdrawal by Subject|3|||
42289117|NCT02694523|76122059|FG001|Part A|Withdrawal by Subject|1|||
42289118|NCT02694523|76122060|FG002|Part A|Withdrawal by Subject|0|||
42289119|NCT02694523|76122061|FG003|Part A|Withdrawal by Subject|0|||
42289120|NCT02694523|76122062|FG004|Part A|Withdrawal by Subject|0|||
42289121|NCT02694523|76122063|FG005|Part A|Withdrawal by Subject|0|||
42289122|NCT02694523|76122064|FG006|Part A|Withdrawal by Subject|0|||
42289123|NCT02694523|76122058|FG000|Part A|Other|1|||
42289124|NCT02694523|76122059|FG001|Part A|Other|1|||
42289125|NCT02694523|76122060|FG002|Part A|Other|0|||
42289126|NCT02694523|76122061|FG003|Part A|Other|0|||
42289127|NCT02694523|76122062|FG004|Part A|Other|0|||
42289128|NCT02694523|76122063|FG005|Part A|Other|0|||
42041053|NCT01064648|75848935|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
42041054|NCT01064648|75848932|FG000|Phase II|Adverse Event|0|||
42041055|NCT01064648|75848933|FG001|Phase II|Adverse Event|0|||
42171983|NCT02952586|75978797|FG000|CRT for IMRT (63 Days)|Other|1|||
42171984|NCT02952586|75978798|FG001|CRT for IMRT (63 Days)|Other|0|||
42171985|NCT02952586|75978797|FG000|Maintenance Phase (12 Months)|Death|17|||
42171986|NCT02952586|75978798|FG001|Maintenance Phase (12 Months)|Death|11|||
42171987|NCT02952586|75978797|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
42171988|NCT02952586|75978798|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
42171989|NCT02952586|75978797|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
42289129|NCT02694523|76122064|FG006|Part A|Other|0|||
42041056|NCT01064648|75848934|FG002|Phase II|Adverse Event|15|||
42041057|NCT01064648|75848935|FG003|Phase II|Adverse Event|8|||
42041058|NCT01064648|75848932|FG000|Phase II|Death|0|||
42015637|NCT00942175|75822904|FG000|Overall Study|Adverse Event|2|||
42015638|NCT00942175|75822905|FG001|Overall Study|Adverse Event|1|||
42015639|NCT00942175|75822906|FG002|Overall Study|Adverse Event|0|||
42015640|NCT00942175|75822907|FG003|Overall Study|Adverse Event|0|||
42015641|NCT00942175|75822904|FG000|Overall Study|Protocol Violation|0|||
42289130|NCT02694523|76122058|FG000|Part B|Adverse Event|0|||
42289131|NCT02694523|76122059|FG001|Part B|Adverse Event|0|||
42289132|NCT02694523|76122060|FG002|Part B|Adverse Event|7|||
42289133|NCT02694523|76122061|FG003|Part B|Adverse Event|1|||
42289134|NCT02694523|76122062|FG004|Part B|Adverse Event|1|||
42289135|NCT02694523|76122063|FG005|Part B|Adverse Event|2|||
42289136|NCT02694523|76122064|FG006|Part B|Adverse Event|0|||
42015642|NCT00942175|75822905|FG001|Overall Study|Protocol Violation|1|||
42171990|NCT02952586|75978798|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
42015643|NCT00942175|75822906|FG002|Overall Study|Protocol Violation|2|||
42015644|NCT00942175|75822907|FG003|Overall Study|Protocol Violation|0|||
42171991|NCT02952586|75978797|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
42289137|NCT02694523|76122058|FG000|Part B|Protocol Violation|0|||
42015645|NCT00942175|75822904|FG000|Overall Study|Pregnancy|0|||
42015646|NCT00942175|75822905|FG001|Overall Study|Pregnancy|0|||
42041059|NCT01064648|75848933|FG001|Phase II|Death|0|||
42289138|NCT02694523|76122059|FG001|Part B|Protocol Violation|0|||
42289139|NCT02694523|76122060|FG002|Part B|Protocol Violation|1|||
42041060|NCT01064648|75848934|FG002|Phase II|Death|4|||
42289140|NCT02694523|76122061|FG003|Part B|Protocol Violation|0|||
42041061|NCT01064648|75848935|FG003|Phase II|Death|5|||
42041062|NCT01064648|75848932|FG000|Phase II|Withdrawal by Subject|0|||
42041063|NCT01064648|75848933|FG001|Phase II|Withdrawal by Subject|0|||
42041064|NCT01064648|75848934|FG002|Phase II|Withdrawal by Subject|2|||
42041065|NCT01064648|75848935|FG003|Phase II|Withdrawal by Subject|5|||
42041066|NCT01064648|75848932|FG000|Phase II|Progression|0|||
42041067|NCT01064648|75848933|FG001|Phase II|Progression|0|||
42041068|NCT01064648|75848934|FG002|Phase II|Progression|21|||
42041069|NCT01064648|75848935|FG003|Phase II|Progression|27|||
42041070|NCT01064648|75848932|FG000|Phase II|Non-protocol specified|0|||
42041071|NCT01064648|75848933|FG001|Phase II|Non-protocol specified|0|||
42041072|NCT01064648|75848934|FG002|Phase II|Non-protocol specified|5|||
42041073|NCT01064648|75848935|FG003|Phase II|Non-protocol specified|3|||
42041074|NCT01064648|75848932|FG000|Phase II|Under Review|0|||
42041075|NCT01064648|75848933|FG001|Phase II|Under Review|0|||
42041076|NCT01064648|75848934|FG002|Phase II|Under Review|2|||
42041077|NCT01064648|75848935|FG003|Phase II|Under Review|0|||
42041078|NCT00980460|75848953|FG000|Overall Study|Death|0|||
42041079|NCT00980460|75848954|FG001|Overall Study|Death|0|||
42041080|NCT00980460|75848955|FG002|Overall Study|Death|1|||
42041081|NCT00980460|75848956|FG003|Overall Study|Death|2|||
42041082|NCT00980460|75848957|FG004|Overall Study|Death|1|||
42041083|NCT00980460|75848953|FG000|Overall Study|Lack of Efficacy|0|||
42041084|NCT00980460|75848954|FG001|Overall Study|Lack of Efficacy|0|||
42041085|NCT00980460|75848955|FG002|Overall Study|Lack of Efficacy|10|||
42041086|NCT00980460|75848956|FG003|Overall Study|Lack of Efficacy|6|||
42041087|NCT00980460|75848957|FG004|Overall Study|Lack of Efficacy|8|||
42041088|NCT00980460|75848953|FG000|Overall Study|Lost to Follow-up|0|||
42041089|NCT00980460|75848954|FG001|Overall Study|Lost to Follow-up|0|||
42041090|NCT00980460|75848955|FG002|Overall Study|Lost to Follow-up|0|||
42041091|NCT00980460|75848956|FG003|Overall Study|Lost to Follow-up|1|||
42041092|NCT00980460|75848957|FG004|Overall Study|Lost to Follow-up|0|||
42041093|NCT00980460|75848953|FG000|Overall Study|Physician Decision|0|||
42041094|NCT00980460|75848954|FG001|Overall Study|Physician Decision|0|||
42041095|NCT00980460|75848955|FG002|Overall Study|Physician Decision|11|||
42041096|NCT00980460|75848956|FG003|Overall Study|Physician Decision|5|||
42041097|NCT00980460|75848957|FG004|Overall Study|Physician Decision|3|||
42289141|NCT02694523|76122062|FG004|Part B|Protocol Violation|0|||
42289142|NCT02694523|76122063|FG005|Part B|Protocol Violation|0|||
42289143|NCT02694523|76122064|FG006|Part B|Protocol Violation|0|||
42289144|NCT02694523|76122058|FG000|Part B|Lost to Follow-up|0|||
42289145|NCT02694523|76122059|FG001|Part B|Lost to Follow-up|0|||
42289146|NCT02694523|76122060|FG002|Part B|Lost to Follow-up|2|||
42289147|NCT02694523|76122061|FG003|Part B|Lost to Follow-up|3|||
42289148|NCT02694523|76122062|FG004|Part B|Lost to Follow-up|2|||
42289149|NCT02694523|76122063|FG005|Part B|Lost to Follow-up|0|||
42289150|NCT02694523|76122064|FG006|Part B|Lost to Follow-up|1|||
42289151|NCT02694523|76122058|FG000|Part B|Withdrawal by Subject|0|||
42289152|NCT02694523|76122059|FG001|Part B|Withdrawal by Subject|0|||
42289153|NCT02694523|76122060|FG002|Part B|Withdrawal by Subject|9|||
42289154|NCT02694523|76122061|FG003|Part B|Withdrawal by Subject|0|||
42289155|NCT02694523|76122062|FG004|Part B|Withdrawal by Subject|1|||
42289156|NCT02694523|76122063|FG005|Part B|Withdrawal by Subject|3|||
42015647|NCT00942175|75822906|FG002|Overall Study|Pregnancy|0|||
42015648|NCT00942175|75822907|FG003|Overall Study|Pregnancy|1|||
42015649|NCT00942175|75822904|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
42015650|NCT00942175|75822905|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
42015651|NCT00942175|75822906|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
42015652|NCT00942175|75822907|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
42015653|NCT00942175|75822904|FG000|Overall Study|Low Platelet Count|0|||
42015654|NCT00942175|75822905|FG001|Overall Study|Low Platelet Count|2|||
42015655|NCT00942175|75822906|FG002|Overall Study|Low Platelet Count|0|||
42015656|NCT00942175|75822907|FG003|Overall Study|Low Platelet Count|0|||
42041098|NCT00980460|75848953|FG000|Overall Study|Withdrawal by Subject|0|||
42041099|NCT00980460|75848954|FG001|Overall Study|Withdrawal by Subject|0|||
42041100|NCT00980460|75848955|FG002|Overall Study|Withdrawal by Subject|1|||
42041101|NCT00980460|75848956|FG003|Overall Study|Withdrawal by Subject|0|||
42041102|NCT00980460|75848957|FG004|Overall Study|Withdrawal by Subject|0|||
42041103|NCT00980460|75848953|FG000|Overall Study|Ineligible|0|||
42041104|NCT00980460|75848954|FG001|Overall Study|Ineligible|2|||
42041105|NCT00980460|75848955|FG002|Overall Study|Ineligible|3|||
42041106|NCT00980460|75848956|FG003|Overall Study|Ineligible|1|||
42041107|NCT00980460|75848957|FG004|Overall Study|Ineligible|4|||
42041108|NCT00980460|75848953|FG000|Overall Study|Refusal of further therapy|0|||
42041109|NCT00980460|75848954|FG001|Overall Study|Refusal of further therapy|2|||
42015657|NCT01145625|75822927|FG000|Overall Study|Lost to Follow-up|8|||
42289157|NCT02694523|76122064|FG006|Part B|Withdrawal by Subject|0|||
42289158|NCT02694523|76122058|FG000|Part B|Other|0|||
42289159|NCT02694523|76122059|FG001|Part B|Other|0|||
42015658|NCT01145625|75822928|FG001|Overall Study|Lost to Follow-up|9|||
42041110|NCT00980460|75848955|FG002|Overall Study|Refusal of further therapy|3|||
42289160|NCT02694523|76122060|FG002|Part B|Other|1|||
42289161|NCT02694523|76122061|FG003|Part B|Other|0|||
42289162|NCT02694523|76122062|FG004|Part B|Other|0|||
42289163|NCT02694523|76122063|FG005|Part B|Other|0|||
42289164|NCT02694523|76122064|FG006|Part B|Other|1|||
42289165|NCT01353703|76122078|FG000|Overall Study|Migrated/moved from study area|1|||
42289166|NCT01353703|76122079|FG001|Overall Study|Migrated/moved from study area|0|||
42041111|NCT00980460|75848956|FG003|Overall Study|Refusal of further therapy|2|||
42289167|NCT02009332|76122093|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
42289168|NCT02009332|76122094|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
42289169|NCT02009332|76122095|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
42015659|NCT01145625|75822927|FG000|Overall Study|Adverse Event|6|||
42015660|NCT01145625|75822928|FG001|Overall Study|Adverse Event|4|||
42015661|NCT01145625|75822927|FG000|Overall Study|Protocol Violation|3|||
42015662|NCT01145625|75822928|FG001|Overall Study|Protocol Violation|1|||
42289170|NCT02009332|76122096|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
42289171|NCT02009332|76122097|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
42015663|NCT01145625|75822927|FG000|Overall Study|Withdrawal by Subject|7|||
42015664|NCT01145625|75822928|FG001|Overall Study|Withdrawal by Subject|16|||
42015665|NCT01145625|75822927|FG000|Overall Study|Pregnancy|0|||
42015666|NCT01145625|75822928|FG001|Overall Study|Pregnancy|1|||
42015667|NCT01144377|75822939|FG000|52 Week Treatment Period|Adverse Event|0|||
42015668|NCT01144377|75822940|FG001|52 Week Treatment Period|Adverse Event|0|||
42015669|NCT01144377|75822941|FG002|52 Week Treatment Period|Adverse Event|3|||
42015670|NCT01144377|75822942|FG003|52 Week Treatment Period|Adverse Event|2|||
42041112|NCT00980460|75848957|FG004|Overall Study|Refusal of further therapy|0|||
42015671|NCT01144377|75822943|FG004|52 Week Treatment Period|Adverse Event|1|||
42015672|NCT01144377|75822939|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
42289172|NCT02009332|76122098|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
42015673|NCT01144377|75822940|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
42015674|NCT01144377|75822941|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
42015675|NCT01144377|75822942|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
42015676|NCT01144377|75822943|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
42041113|NCT00980460|75848953|FG000|Overall Study|No therapy within 42 days of resection|0|||
42041114|NCT00980460|75848954|FG001|Overall Study|No therapy within 42 days of resection|0|||
42041115|NCT00980460|75848955|FG002|Overall Study|No therapy within 42 days of resection|3|||
42041116|NCT00980460|75848956|FG003|Overall Study|No therapy within 42 days of resection|1|||
42041117|NCT00980460|75848957|FG004|Overall Study|No therapy within 42 days of resection|0|||
42041118|NCT00980460|75848953|FG000|Overall Study|No transplant by protocol timepoints|0|||
42041119|NCT00980460|75848954|FG001|Overall Study|No transplant by protocol timepoints|0|||
42041120|NCT00980460|75848955|FG002|Overall Study|No transplant by protocol timepoints|3|||
42041121|NCT00980460|75848956|FG003|Overall Study|No transplant by protocol timepoints|0|||
42041122|NCT00980460|75848957|FG004|Overall Study|No transplant by protocol timepoints|0|||
42041123|NCT00977574|75848979|FG000|Overall Study|Never Treated|4|||
42041124|NCT00977574|75848980|FG001|Overall Study|Never Treated|2|||
42041125|NCT00977574|75848981|FG002|Overall Study|Never Treated|4|||
42041126|NCT00972478|75848991|FG000|Overall Study|Adverse Event|3|||
42171992|NCT02952586|75978798|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
42171993|NCT02952586|75978797|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
42171994|NCT02952586|75978798|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
42171995|NCT02952586|75978797|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
42289173|NCT02009332|76122093|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
42289174|NCT02009332|76122094|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
42289175|NCT02009332|76122095|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
42289176|NCT02009332|76122096|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
42289177|NCT02009332|76122097|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
42041127|NCT00972478|75848992|FG001|Overall Study|Adverse Event|16|||
42041128|NCT00972478|75848991|FG000|Overall Study|Withdrawal by Subject|1|||
42041129|NCT00972478|75848992|FG001|Overall Study|Withdrawal by Subject|8|||
42041130|NCT00972478|75848991|FG000|Overall Study|Progression/Relapse|0|||
42041131|NCT00972478|75848992|FG001|Overall Study|Progression/Relapse|2|||
42041132|NCT00972478|75848991|FG000|Overall Study|Death|0|||
42041133|NCT00972478|75848992|FG001|Overall Study|Death|2|||
42041134|NCT00972478|75848991|FG000|Overall Study|Not protocol specified|1|||
42041135|NCT00972478|75848992|FG001|Overall Study|Not protocol specified|1|||
42041136|NCT00972478|75848991|FG000|Overall Study|Ineligible|1|||
42041137|NCT00972478|75848992|FG001|Overall Study|Ineligible|7|||
42041138|NCT00972478|75848991|FG000|Overall Study|Not start protocol treatment|1|||
42171996|NCT02952586|75978798|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
42171997|NCT02952586|75978797|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
42171998|NCT02952586|75978798|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
42355224|NCT01609556|76197165|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
42355225|NCT01609556|76197166|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
42355226|NCT01609556|76197167|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
42355227|NCT01609556|76197168|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
42355228|NCT01609556|76197153|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355229|NCT01609556|76197154|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355230|NCT01609556|76197155|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355231|NCT01609556|76197156|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355232|NCT01609556|76197157|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355233|NCT01609556|76197158|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355234|NCT01609556|76197159|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355235|NCT01609556|76197160|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355236|NCT01609556|76197161|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355237|NCT01609556|76197162|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355238|NCT01609556|76197163|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355239|NCT01609556|76197164|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
42355240|NCT01609556|76197165|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
42355241|NCT01609556|76197166|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
42015677|NCT01144377|75822939|FG000|52 Week Treatment Period|Protocol Violation|0|||
42015678|NCT01144377|75822940|FG001|52 Week Treatment Period|Protocol Violation|0|||
42015679|NCT01144377|75822941|FG002|52 Week Treatment Period|Protocol Violation|0|||
42015680|NCT01144377|75822942|FG003|52 Week Treatment Period|Protocol Violation|0|||
42015681|NCT01144377|75822943|FG004|52 Week Treatment Period|Protocol Violation|1|||
42015682|NCT01144377|75822939|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
42015683|NCT01144377|75822940|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
42015684|NCT01144377|75822941|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
42015685|NCT01144377|75822942|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
42015686|NCT01144377|75822943|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
42015687|NCT01144377|75822939|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
42015688|NCT01144377|75822940|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
42015689|NCT01144377|75822941|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
42015690|NCT01144377|75822942|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
42015691|NCT01144377|75822943|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
42015692|NCT01144377|75822939|FG000|52 Week Treatment Period|Sponsor Decision|0|||
42015693|NCT01144377|75822940|FG001|52 Week Treatment Period|Sponsor Decision|0|||
42015694|NCT01144377|75822941|FG002|52 Week Treatment Period|Sponsor Decision|0|||
42015695|NCT01144377|75822942|FG003|52 Week Treatment Period|Sponsor Decision|0|||
42015696|NCT01144377|75822943|FG004|52 Week Treatment Period|Sponsor Decision|1|||
42015697|NCT01144377|75822939|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
42015698|NCT01144377|75822940|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
42015699|NCT01144377|75822941|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
42015700|NCT01144377|75822942|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
42015701|NCT01144377|75822943|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
42015702|NCT01144377|75822939|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
42015703|NCT01144377|75822940|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
42015704|NCT01144377|75822941|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
42015705|NCT01144377|75822942|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
42015706|NCT01144377|75822943|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
42015707|NCT01144377|75822939|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
42015708|NCT01144377|75822940|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
42015709|NCT01144377|75822941|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
42015710|NCT01144377|75822942|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
42015711|NCT01144377|75822943|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
42041139|NCT00972478|75848992|FG001|Overall Study|Not start protocol treatment|2|||
42041140|NCT00861705|75849003|FG000|Overall Study|Never Began Treatment|7|||
42041141|NCT00861705|75849004|FG001|Overall Study|Never Began Treatment|3|||
42041142|NCT00861705|75849005|FG002|Overall Study|Never Began Treatment|0|||
42041143|NCT00861705|75849006|FG003|Overall Study|Never Began Treatment|1|||
42041144|NCT00843882|75849027|FG000|Step 1|Lack of Efficacy|14|||
42041145|NCT00843882|75849028|FG001|Step 1|Lack of Efficacy|10|||
42041146|NCT00843882|75849029|FG002|Step 1|Lack of Efficacy|21|||
42041147|NCT00843882|75849027|FG000|Step 1|Adverse Event|8|||
42041148|NCT00843882|75849028|FG001|Step 1|Adverse Event|17|||
42041149|NCT00843882|75849029|FG002|Step 1|Adverse Event|20|||
42041150|NCT00843882|75849027|FG000|Step 1|Death|1|||
42041151|NCT00843882|75849028|FG001|Step 1|Death|2|||
42041152|NCT00843882|75849029|FG002|Step 1|Death|4|||
42041153|NCT00843882|75849027|FG000|Step 1|Withdrawal by Subject|6|||
42041154|NCT00843882|75849028|FG001|Step 1|Withdrawal by Subject|12|||
42041155|NCT00843882|75849029|FG002|Step 1|Withdrawal by Subject|9|||
42041156|NCT00843882|75849027|FG000|Step 1|Physician Decision|0|||
42041157|NCT00843882|75849028|FG001|Step 1|Physician Decision|5|||
42041158|NCT00843882|75849029|FG002|Step 1|Physician Decision|1|||
42041159|NCT00843882|75849027|FG000|Step 1|Patient and physician's decision|0|||
42041160|NCT00843882|75849028|FG001|Step 1|Patient and physician's decision|0|||
42041161|NCT00843882|75849029|FG002|Step 1|Patient and physician's decision|1|||
42041162|NCT00843882|75849027|FG000|Step 1|Other complicating disease|1|||
42041163|NCT00843882|75849028|FG001|Step 1|Other complicating disease|3|||
42041164|NCT00843882|75849029|FG002|Step 1|Other complicating disease|4|||
42041165|NCT00843882|75849027|FG000|Step 1|Alternative therapy|0|||
42041166|NCT00843882|75849028|FG001|Step 1|Alternative therapy|1|||
42041167|NCT00843882|75849029|FG002|Step 1|Alternative therapy|1|||
42041168|NCT00843882|75849027|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
42041169|NCT00843882|75849028|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
42041170|NCT00843882|75849029|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
42041171|NCT00843882|75849027|FG000|Step 1|Off treatment reason unknown|0|||
42041172|NCT00843882|75849028|FG001|Step 1|Off treatment reason unknown|1|||
42041173|NCT00843882|75849029|FG002|Step 1|Off treatment reason unknown|4|||
42041174|NCT00843882|75849027|FG000|Step 1|Never started treatment|2|||
42041175|NCT00843882|75849028|FG001|Step 1|Never started treatment|0|||
42041176|NCT00843882|75849029|FG002|Step 1|Never started treatment|0|||
42041177|NCT00843882|75849027|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
42041178|NCT00843882|75849028|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
42041179|NCT00843882|75849029|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
42041180|NCT00843882|75849027|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
42041181|NCT00843882|75849028|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
42041182|NCT00843882|75849029|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
42041183|NCT00843882|75849027|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
42041184|NCT00843882|75849028|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
42041185|NCT00843882|75849029|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
42171999|NCT02952586|75978797|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
42172000|NCT02952586|75978798|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
42172001|NCT02952586|75978797|FG000|Maintenance Phase (12 Months)|Other|2|||
42172002|NCT02952586|75978798|FG001|Maintenance Phase (12 Months)|Other|1|||
42289178|NCT02009332|76122098|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
42289179|NCT02009332|76122093|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
42289180|NCT02009332|76122094|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
42289181|NCT02009332|76122095|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
42289182|NCT02009332|76122096|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
42289183|NCT02009332|76122097|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
42289184|NCT02009332|76122098|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
42289185|NCT01984294|76122115|FG000|Overall Study|Randomized but Never Treated|0|||
42289186|NCT01984294|76122116|FG001|Overall Study|Randomized but Never Treated|0|||
42289187|NCT01984294|76122117|FG002|Overall Study|Randomized but Never Treated|1|||
42289188|NCT01984294|76122115|FG000|Overall Study|Lack of Efficacy|4|||
42289189|NCT01984294|76122116|FG001|Overall Study|Lack of Efficacy|2|||
42289190|NCT01984294|76122117|FG002|Overall Study|Lack of Efficacy|6|||
42289191|NCT01984294|76122115|FG000|Overall Study|Adverse Event|0|||
42289192|NCT01984294|76122116|FG001|Overall Study|Adverse Event|1|||
42289193|NCT01984294|76122117|FG002|Overall Study|Adverse Event|0|||
42041186|NCT00843882|75849027|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
42041187|NCT00843882|75849028|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
42015712|NCT00950599|75822965|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
42015713|NCT00950599|75822966|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
42015714|NCT00950599|75822967|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
42015715|NCT00950599|75822968|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
42015716|NCT00950599|75822969|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
42015717|NCT00950599|75822970|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
42015718|NCT00950599|75822971|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
42015719|NCT00950599|75822972|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
42289194|NCT01962298|76122130|FG000|Overall Study|Protocol Violation|1|||
42289195|NCT01962298|76122131|FG001|Overall Study|Protocol Violation|0|||
42289196|NCT01962298|76122132|FG002|Overall Study|Protocol Violation|1|||
42289197|NCT01962298|76122133|FG003|Overall Study|Protocol Violation|1|||
42289198|NCT01962298|76122134|FG004|Overall Study|Protocol Violation|0|||
42289199|NCT01962298|76122130|FG000|Overall Study|Data quality insufficient|2|||
42289200|NCT01962298|76122131|FG001|Overall Study|Data quality insufficient|0|||
42289201|NCT01962298|76122132|FG002|Overall Study|Data quality insufficient|3|||
42289202|NCT01962298|76122133|FG003|Overall Study|Data quality insufficient|1|||
42289203|NCT01962298|76122134|FG004|Overall Study|Data quality insufficient|4|||
42289204|NCT01962298|76122130|FG000|Overall Study|Insufficient data|0|||
42289205|NCT01962298|76122131|FG001|Overall Study|Insufficient data|2|||
42289206|NCT01962298|76122132|FG002|Overall Study|Insufficient data|1|||
42289207|NCT01962298|76122133|FG003|Overall Study|Insufficient data|0|||
42289208|NCT01962298|76122134|FG004|Overall Study|Insufficient data|1|||
42289209|NCT01962298|76122130|FG000|Overall Study|Incorrect data recorded|0|||
42289210|NCT01962298|76122131|FG001|Overall Study|Incorrect data recorded|1|||
42289211|NCT01962298|76122132|FG002|Overall Study|Incorrect data recorded|0|||
42289212|NCT01962298|76122133|FG003|Overall Study|Incorrect data recorded|0|||
42289213|NCT01962298|76122134|FG004|Overall Study|Incorrect data recorded|0|||
42289214|NCT01962298|76122130|FG000|Overall Study|Physician Decision|0|||
42289215|NCT01962298|76122131|FG001|Overall Study|Physician Decision|1|||
42289216|NCT01962298|76122132|FG002|Overall Study|Physician Decision|0|||
42289217|NCT01962298|76122133|FG003|Overall Study|Physician Decision|0|||
42289218|NCT01962298|76122134|FG004|Overall Study|Physician Decision|1|||
42289219|NCT02693743|76122148|FG000|Overall Study|Physician Decision|1|||
42289220|NCT02693743|76122149|FG001|Overall Study|Physician Decision|0|||
42041188|NCT00843882|75849029|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
42041189|NCT00843882|75849027|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
42041190|NCT00843882|75849028|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
42355242|NCT01609556|76197167|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
42355243|NCT01609556|76197168|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
42289221|NCT02655887|76122155|FG000|Overall Study|Lost to Follow-up|3|||
42289222|NCT02655887|76122155|FG000|Overall Study|Death|4|||
42289223|NCT02655887|76122155|FG000|Overall Study|Withdrawal by Subject|3|||
42289224|NCT02655887|76122155|FG000|Overall Study|Missed 12-month follow-up visit|4|||
42041191|NCT00843882|75849029|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
42041192|NCT00843882|75849027|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
42041193|NCT00843882|75849028|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
42041194|NCT00843882|75849029|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
42041195|NCT00843882|75849027|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
42041196|NCT00843882|75849028|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
42041197|NCT00843882|75849029|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
42041198|NCT00792948|75849042|FG000|Overall Study|Adverse Event|6|||
42041199|NCT00792948|75849042|FG000|Overall Study|Death|4|||
42041200|NCT00792948|75849042|FG000|Overall Study|Withdrawal by Subject|3|||
42041201|NCT00792948|75849042|FG000|Overall Study|Ineligible|2|||
42041202|NCT00792948|75849042|FG000|Overall Study|Insurance denial - not treated|1|||
42041203|NCT00792948|75849042|FG000|Overall Study|Physician Decision|11|||
42041204|NCT00792948|75849042|FG000|Overall Study|Protocol Violation|1|||
42041205|NCT00769379|75849051|FG000|Overall Study|No follow up data mapped to Other.|3|||
42041206|NCT00769379|75849052|FG001|Overall Study|No follow up data mapped to Other.|13|||
42041207|NCT00658814|75849060|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
42041208|NCT00658814|75849061|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
42041209|NCT00658814|75849060|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
42041210|NCT00658814|75849061|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
42041211|NCT00658814|75849060|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
42041212|NCT00658814|75849061|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
42041213|NCT00658814|75849060|FG000|Remission Induction Chemotherapy|Death|1|||
42041214|NCT00658814|75849061|FG001|Remission Induction Chemotherapy|Death|4|||
42041215|NCT00658814|75849060|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
42041216|NCT00658814|75849061|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
42041217|NCT00658814|75849060|FG000|Remission Induction Chemotherapy|Not eligible|1|||
42041218|NCT00658814|75849061|FG001|Remission Induction Chemotherapy|Not eligible|2|||
42041219|NCT00658814|75849060|FG000|Consolidation Therapy|Not protocol specified|0|||
42041220|NCT00658814|75849061|FG001|Consolidation Therapy|Not protocol specified|1|||
42041221|NCT00658814|75849060|FG000|Consolidation Therapy|Not eligible|2|||
42041222|NCT00658814|75849061|FG001|Consolidation Therapy|Not eligible|2|||
42041223|NCT00658814|75849060|FG000|Maintenance Therapy|Adverse Event|1|||
42041224|NCT00658814|75849061|FG001|Maintenance Therapy|Adverse Event|1|||
42041225|NCT00658814|75849060|FG000|Maintenance Therapy|Not protocol specified|1|||
42041226|NCT00658814|75849061|FG001|Maintenance Therapy|Not protocol specified|0|||
42041227|NCT00658814|75849060|FG000|Maintenance Therapy|Not eligible|1|||
42289225|NCT02008318|76122161|FG000|Overall Study|Adverse Event|4|||
42289226|NCT02008318|76122162|FG001|Overall Study|Adverse Event|0|||
42355244|NCT01609556|76197153|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42355245|NCT01609556|76197154|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42041228|NCT00658814|75849061|FG001|Maintenance Therapy|Not eligible|0|||
42041229|NCT00644228|75849073|FG000|Randomization & Eligibility|Ineligible|31|||
42041230|NCT00644228|75849074|FG001|Randomization & Eligibility|Ineligible|21|||
42041231|NCT00644228|75849073|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
42041232|NCT00644228|75849074|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
42041233|NCT00644228|75849073|FG000|Randomization & Eligibility|Invalid Consent|0|||
42041234|NCT00644228|75849074|FG001|Randomization & Eligibility|Invalid Consent|1|||
42041235|NCT00644228|75849073|FG000|Induction Therapy|Adverse Event|22|||
42355246|NCT01609556|76197155|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42355247|NCT01609556|76197156|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42041236|NCT00644228|75849074|FG001|Induction Therapy|Adverse Event|55|||
42289227|NCT02008318|76122161|FG000|Overall Study|Physician Decision|2|||
42041237|NCT00644228|75849073|FG000|Induction Therapy|Withdrawal by Subject|10|||
42041238|NCT00644228|75849074|FG001|Induction Therapy|Withdrawal by Subject|3|||
42041239|NCT00644228|75849073|FG000|Induction Therapy|Progression/Relapse|24|||
42041240|NCT00644228|75849074|FG001|Induction Therapy|Progression/Relapse|12|||
42041241|NCT00644228|75849073|FG000|Induction Therapy|Death|3|||
42041242|NCT00644228|75849074|FG001|Induction Therapy|Death|7|||
42289228|NCT02008318|76122162|FG001|Overall Study|Physician Decision|0|||
42289229|NCT02008318|76122161|FG000|Overall Study|Progressive Disease|2|||
42289230|NCT02008318|76122162|FG001|Overall Study|Progressive Disease|0|||
42355248|NCT01609556|76197157|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42355249|NCT01609556|76197158|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42355250|NCT01609556|76197159|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42355251|NCT01609556|76197160|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42355252|NCT01609556|76197161|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42355253|NCT01609556|76197162|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42355254|NCT01609556|76197163|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42355255|NCT01609556|76197164|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
42355256|NCT01609556|76197165|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
42355257|NCT01609556|76197166|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
42355258|NCT01609556|76197167|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
42041243|NCT00644228|75849073|FG000|Induction Therapy|Not Protocol-Specified|24|||
42355259|NCT01609556|76197168|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
42355260|NCT01609556|76197153|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355261|NCT01609556|76197154|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355262|NCT01609556|76197155|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355263|NCT01609556|76197156|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355264|NCT01609556|76197157|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355265|NCT01609556|76197158|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355266|NCT01609556|76197159|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355267|NCT01609556|76197160|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42041244|NCT00644228|75849074|FG001|Induction Therapy|Not Protocol-Specified|28|||
42041245|NCT00644228|75849073|FG000|Maintenance|Adverse Event|27|||
42041246|NCT00644228|75849074|FG001|Maintenance|Adverse Event|31|||
42041247|NCT00644228|75849073|FG000|Maintenance|Withdrawal by Subject|6|||
42041248|NCT00644228|75849074|FG001|Maintenance|Withdrawal by Subject|4|||
42041249|NCT00644228|75849073|FG000|Maintenance|Progression/Relapse|67|||
42041250|NCT00644228|75849074|FG001|Maintenance|Progression/Relapse|42|||
42041251|NCT00644228|75849073|FG000|Maintenance|Death|3|||
42041252|NCT00644228|75849074|FG001|Maintenance|Death|3|||
42172003|NCT02952586|75978797|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
42172004|NCT02952586|75978798|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
42172005|NCT02952586|75978797|FG000|Follow-Up Phase (90 Days)|Death|12|||
42015720|NCT00950599|75822973|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
42015721|NCT00950599|75822974|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
42015722|NCT00950599|75822965|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42015723|NCT00950599|75822966|FG001|Double-Blind Treatment Period|Adverse Event|1|||
42015724|NCT00950599|75822967|FG002|Double-Blind Treatment Period|Adverse Event|1|||
42015725|NCT00950599|75822968|FG003|Double-Blind Treatment Period|Adverse Event|1|||
42015726|NCT00950599|75822969|FG004|Double-Blind Treatment Period|Adverse Event|1|||
42015727|NCT00950599|75822970|FG005|Double-Blind Treatment Period|Adverse Event|1|||
42015728|NCT00950599|75822971|FG006|Double-Blind Treatment Period|Adverse Event|0|||
42015729|NCT00950599|75822972|FG007|Double-Blind Treatment Period|Adverse Event|0|||
42015730|NCT00950599|75822973|FG008|Double-Blind Treatment Period|Adverse Event|0|||
42015731|NCT00950599|75822974|FG009|Double-Blind Treatment Period|Adverse Event|0|||
42015732|NCT00950599|75822965|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
42015733|NCT00950599|75822966|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
42015734|NCT00950599|75822967|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
42015735|NCT00950599|75822968|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
42015736|NCT00950599|75822969|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
42041253|NCT00644228|75849073|FG000|Maintenance|Not Protocol-Specified|14|||
42041254|NCT00644228|75849074|FG001|Maintenance|Not Protocol-Specified|15|||
42041255|NCT00644228|75849073|FG000|Maintenance|On Treatment|26|||
42041256|NCT00644228|75849074|FG001|Maintenance|On Treatment|40|||
42041257|NCT00588770|75849082|FG000|Overall Study|Disease progression|85|||
42041258|NCT00588770|75849083|FG001|Overall Study|Disease progression|68|||
42041259|NCT00588770|75849082|FG000|Overall Study|Adverse Event|29|||
42289231|NCT02008318|76122161|FG000|Overall Study|Protocol Violation|1|||
42289232|NCT02008318|76122162|FG001|Overall Study|Protocol Violation|1|||
42289233|NCT02008318|76122161|FG000|Overall Study|Withdrawal by Subject|3|||
42289234|NCT02008318|76122162|FG001|Overall Study|Withdrawal by Subject|0|||
42289235|NCT01982812|76122173|FG000|Overall Study|Death|1|||
42041260|NCT00588770|75849083|FG001|Overall Study|Adverse Event|58|||
42041261|NCT00588770|75849082|FG000|Overall Study|Death|13|||
42041262|NCT00588770|75849083|FG001|Overall Study|Death|22|||
42041263|NCT00588770|75849082|FG000|Overall Study|Withdrawal by Subject|15|||
42041264|NCT00588770|75849083|FG001|Overall Study|Withdrawal by Subject|25|||
42041265|NCT00588770|75849082|FG000|Overall Study|Alternative therapy|2|||
42041266|NCT00588770|75849083|FG001|Overall Study|Alternative therapy|4|||
42041267|NCT00588770|75849082|FG000|Overall Study|Other complicating disease|3|||
42041268|NCT00588770|75849083|FG001|Overall Study|Other complicating disease|2|||
42041269|NCT00588770|75849082|FG000|Overall Study|Not start protocol therapy|0|||
42041270|NCT00588770|75849083|FG001|Overall Study|Not start protocol therapy|9|||
42041271|NCT00588770|75849082|FG000|Overall Study|Lack of Efficacy|8|||
42041272|NCT00588770|75849083|FG001|Overall Study|Lack of Efficacy|10|||
42041273|NCT00588770|75849082|FG000|Overall Study|Physician discretion|2|||
42041274|NCT00588770|75849083|FG001|Overall Study|Physician discretion|0|||
42041275|NCT00588770|75849082|FG000|Overall Study|Patient non-compliance|2|||
42041276|NCT00588770|75849083|FG001|Overall Study|Patient non-compliance|2|||
42041277|NCT00433511|75849092|FG000|Step 1|Adverse Event|50|||
42041278|NCT00433511|75849093|FG001|Step 1|Adverse Event|157|||
42041279|NCT00433511|75849094|FG002|Step 1|Adverse Event|153|||
42041280|NCT00433511|75849092|FG000|Step 1|Withdrawal by Subject|45|||
42041281|NCT00433511|75849093|FG001|Step 1|Withdrawal by Subject|143|||
42041282|NCT00433511|75849094|FG002|Step 1|Withdrawal by Subject|154|||
42041283|NCT00433511|75849092|FG000|Step 1|Death|3|||
42041284|NCT00433511|75849093|FG001|Step 1|Death|1|||
42041285|NCT00433511|75849094|FG002|Step 1|Death|1|||
42041286|NCT00433511|75849092|FG000|Step 1|Physician Decision|1|||
42041287|NCT00433511|75849093|FG001|Step 1|Physician Decision|4|||
42041288|NCT00433511|75849094|FG002|Step 1|Physician Decision|3|||
42041289|NCT00433511|75849092|FG000|Step 1|Never started protocol therapy|28|||
42041290|NCT00433511|75849093|FG001|Step 1|Never started protocol therapy|64|||
42041291|NCT00433511|75849094|FG002|Step 1|Never started protocol therapy|66|||
42041292|NCT00433511|75849092|FG000|Step 1|Alternative therapy|2|||
42041293|NCT00433511|75849093|FG001|Step 1|Alternative therapy|1|||
42041294|NCT00433511|75849094|FG002|Step 1|Alternative therapy|3|||
42041295|NCT00433511|75849092|FG000|Step 1|Disease progression, relapse|5|||
42041296|NCT00433511|75849093|FG001|Step 1|Disease progression, relapse|3|||
42172006|NCT02952586|75978798|FG001|Follow-Up Phase (90 Days)|Death|10|||
42289236|NCT01982812|76122174|FG001|Overall Study|Death|5|||
42289237|NCT01982812|76122173|FG000|Overall Study|Adverse Event|0|||
42041297|NCT00433511|75849094|FG002|Step 1|Disease progression, relapse|3|||
42041298|NCT00433511|75849092|FG000|Step 1|Other complicating disease|2|||
42172007|NCT02952586|75978797|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
42041299|NCT00433511|75849093|FG001|Step 1|Other complicating disease|6|||
42041300|NCT00433511|75849094|FG002|Step 1|Other complicating disease|3|||
42041301|NCT00433511|75849092|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
42041302|NCT00433511|75849093|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
42289238|NCT01982812|76122174|FG001|Overall Study|Adverse Event|5|||
42041303|NCT00433511|75849094|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
42289239|NCT02007070|76122180|FG000|Overall Study|Adverse Event|4|||
42289240|NCT02007070|76122180|FG000|Overall Study|Clinical Progression|4|||
42289241|NCT02007070|76122180|FG000|Overall Study|Death|1|||
42289242|NCT02007070|76122180|FG000|Overall Study|Protocol Violation|2|||
42289243|NCT02007070|76122180|FG000|Overall Study|Physician Decision|1|||
42289244|NCT02007070|76122180|FG000|Overall Study|Progressive Disease|21|||
42289245|NCT02006758|76122184|FG000|Overall Study|Protocol Violation|1|||
42289246|NCT02006758|76122184|FG000|Overall Study|Death|1|||
42289247|NCT02006758|76122184|FG000|Overall Study|Lost to Follow-up|4|||
42289248|NCT02006758|76122184|FG000|Overall Study|Withdrawal by Subject|4|||
42289249|NCT02006758|76122184|FG000|Overall Study|Procedurally excluded|1|||
42289250|NCT02006758|76122184|FG000|Overall Study|Other|2|||
42289251|NCT01960816|76122189|FG000|Overall Study|Lost to Follow-up|1|||
42289252|NCT01602419|76122193|FG000|Overall Study|Not treated with Wilate|9|||
42289253|NCT01602419|76122193|FG000|Overall Study|Adverse Drug Reaction|4|||
42289254|NCT01602419|76122193|FG000|Overall Study|Insurance issues|3|||
42289255|NCT01602419|76122193|FG000|Overall Study|Changed treatment centre|1|||
42289256|NCT01602419|76122193|FG000|Overall Study|Treatment centre closed|1|||
42289257|NCT01602419|76122193|FG000|Overall Study|Withdrawal by Subject|5|||
42289258|NCT01602419|76122193|FG000|Overall Study|Lost to Follow-up|6|||
42289259|NCT01981954|76122238|FG000|Titration Period|Protocol Deviation|1|||
42015737|NCT00950599|75822970|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
42015738|NCT00950599|75822971|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
42015739|NCT00950599|75822972|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
42015740|NCT00950599|75822973|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
42015741|NCT00950599|75822974|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
42015742|NCT00950599|75822965|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
42015743|NCT00950599|75822966|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
42015744|NCT00950599|75822967|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
42015745|NCT00950599|75822968|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
42015746|NCT00950599|75822969|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
42015747|NCT00950599|75822970|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
42015748|NCT00950599|75822971|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
42015749|NCT00950599|75822972|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
42015750|NCT00950599|75822973|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
42015751|NCT00950599|75822974|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
42015752|NCT00950599|75822965|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
42015753|NCT00950599|75822966|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
42015754|NCT00950599|75822967|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
42015755|NCT00950599|75822968|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
42015756|NCT00950599|75822969|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
42015757|NCT00950599|75822970|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
42015758|NCT00950599|75822971|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
42015759|NCT00950599|75822972|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
42015760|NCT00950599|75822973|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
42015761|NCT00950599|75822974|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
42015762|NCT00950599|75822965|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
42015763|NCT00950599|75822966|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
42015764|NCT00950599|75822967|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
42015765|NCT00950599|75822968|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
42015766|NCT00950599|75822969|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
42015767|NCT00950599|75822970|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
42015768|NCT00950599|75822971|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
42015769|NCT00950599|75822972|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
42015770|NCT00950599|75822973|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
42015771|NCT00950599|75822974|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
42015772|NCT00950599|75822965|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
42015773|NCT00950599|75822966|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
42015774|NCT00950599|75822967|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
42015775|NCT00950599|75822968|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
42015776|NCT00950599|75822969|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
42015777|NCT00950599|75822970|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
42015778|NCT00950599|75822971|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
42172008|NCT02952586|75978798|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
42041304|NCT00433511|75849092|FG000|Step 1|Suspected recurrence|0|||
42172009|NCT02952586|75978797|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
42172010|NCT02952586|75978798|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
42172011|NCT02952586|75978797|FG000|Follow-Up Phase (90 Days)|Other|7|||
42172012|NCT02952586|75978798|FG001|Follow-Up Phase (90 Days)|Other|5|||
42172013|NCT02952586|75978797|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
42172014|NCT02952586|75978798|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
42172015|NCT02952586|75978797|FG000|LT Follow-up (up to 45 Months)|Death|51|||
42172016|NCT02952586|75978798|FG001|LT Follow-up (up to 45 Months)|Death|31|||
42172017|NCT02952586|75978797|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
42172018|NCT02952586|75978798|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
42172019|NCT02952586|75978797|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
42172020|NCT02952586|75978798|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
42172021|NCT02952586|75978797|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
42172022|NCT02952586|75978798|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
42172023|NCT03384316|75978807|FG000|Overall Study|Screen failure|0|||
42172024|NCT03384316|75978808|FG001|Overall Study|Screen failure|1|||
42172025|NCT03403192|75978820|FG000|Overall Study|Lost to Follow-up|1|||
42172026|NCT03403192|75978821|FG001|Overall Study|Lost to Follow-up|2|||
42172027|NCT03403192|75978822|FG002|Overall Study|Lost to Follow-up|0|||
42172028|NCT03403192|75978823|FG003|Overall Study|Lost to Follow-up|0|||
42172029|NCT03403192|75978820|FG000|Overall Study|Unable to respond|0|||
42041305|NCT00433511|75849093|FG001|Step 1|Suspected recurrence|1|||
42041306|NCT00433511|75849094|FG002|Step 1|Suspected recurrence|0|||
42041307|NCT00433511|75849092|FG000|Step 1|Insurance/drug distribution issues|0|||
42041308|NCT00433511|75849093|FG001|Step 1|Insurance/drug distribution issues|1|||
42041309|NCT00433511|75849094|FG002|Step 1|Insurance/drug distribution issues|2|||
42041310|NCT00433511|75849092|FG000|Step 1|Patient moved|0|||
42041311|NCT00433511|75849093|FG001|Step 1|Patient moved|0|||
42041312|NCT00433511|75849094|FG002|Step 1|Patient moved|1|||
42041313|NCT00433511|75849092|FG000|Step 2 (Arm D)|Adverse Event|0|||
42041314|NCT00433511|75849093|FG001|Step 2 (Arm D)|Adverse Event|0|||
42041315|NCT00433511|75849094|FG002|Step 2 (Arm D)|Adverse Event|135|||
42041316|NCT00433511|75849092|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
42041317|NCT00433511|75849093|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
42041318|NCT00433511|75849094|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
42041319|NCT00433511|75849092|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
42041320|NCT00433511|75849093|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
42041321|NCT00433511|75849094|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
42041322|NCT00433511|75849092|FG000|Step 2 (Arm D)|Physician Decision|0|||
42041323|NCT00433511|75849093|FG001|Step 2 (Arm D)|Physician Decision|0|||
42041324|NCT00433511|75849094|FG002|Step 2 (Arm D)|Physician Decision|9|||
42041325|NCT00433511|75849092|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
42041326|NCT00433511|75849093|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
42041327|NCT00433511|75849094|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
42172030|NCT03403192|75978821|FG001|Overall Study|Unable to respond|1|||
42172031|NCT03403192|75978822|FG002|Overall Study|Unable to respond|0|||
42172032|NCT03403192|75978823|FG003|Overall Study|Unable to respond|0|||
42172033|NCT03403192|75978820|FG000|Overall Study|Incomplete|3|||
42172034|NCT03403192|75978821|FG001|Overall Study|Incomplete|1|||
42172035|NCT03403192|75978822|FG002|Overall Study|Incomplete|3|||
42172036|NCT03403192|75978823|FG003|Overall Study|Incomplete|6|||
42289260|NCT01981954|76122238|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
42289261|NCT02693119|76122244|FG000|Open-Label Period|Withdrawal by Subject|0|||
42289262|NCT02693119|76122245|FG001|Open-Label Period|Withdrawal by Subject|1|||
42289263|NCT05641311|76122283|FG000|Dosing Period 1|Adverse Event|1|||
42289264|NCT05641311|76122284|FG001|Dosing Period 1|Adverse Event|0|||
42289265|NCT05502289|76122297|FG000|Period 1|Out Of Window|1|||
42289266|NCT05502289|76122298|FG001|Period 1|Out Of Window|0|||
42289267|NCT04934722|76122310|FG000|Overall Study|Death|4|||
42289268|NCT04934722|76122311|FG001|Overall Study|Death|3|||
42289269|NCT04934722|76122310|FG000|Overall Study|Participants Ongoing|88|||
42015779|NCT00950599|75822972|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
42015780|NCT00950599|75822973|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
42015781|NCT00950599|75822974|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
42015782|NCT00950599|75822965|FG000|Follow-Up Period|Adverse Event|0|||
42015783|NCT00950599|75822966|FG001|Follow-Up Period|Adverse Event|0|||
42015784|NCT00950599|75822967|FG002|Follow-Up Period|Adverse Event|0|||
42041328|NCT00433511|75849092|FG000|Step 2 (Arm D)|Other complicating disease|0|||
42041329|NCT00433511|75849093|FG001|Step 2 (Arm D)|Other complicating disease|0|||
42041330|NCT00433511|75849094|FG002|Step 2 (Arm D)|Other complicating disease|3|||
42041331|NCT00433511|75849092|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
42041332|NCT00433511|75849093|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
42041333|NCT00433511|75849094|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
42041334|NCT00433511|75849092|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
42041335|NCT00433511|75849093|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
42041336|NCT00433511|75849094|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
42041337|NCT00433511|75849092|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
42041338|NCT00433511|75849093|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
42041339|NCT00433511|75849094|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
42041340|NCT00433511|75849092|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
42041341|NCT00433511|75849093|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
42041342|NCT00433511|75849094|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
42041343|NCT00408005|75849107|FG000|Induction|Adverse Event|19|||
42041344|NCT00408005|75849108|FG001|Induction|Adverse Event|3|||
42041345|NCT00408005|75849109|FG002|Induction|Adverse Event|0|||
42041346|NCT00408005|75849110|FG003|Induction|Adverse Event|0|||
42041347|NCT00408005|75849111|FG004|Induction|Adverse Event|0|||
42041348|NCT00408005|75849112|FG005|Induction|Adverse Event|0|||
42041349|NCT00408005|75849113|FG006|Induction|Adverse Event|0|||
42041350|NCT00408005|75849114|FG007|Induction|Adverse Event|0|||
42041351|NCT00408005|75849107|FG000|Induction|Death|6|||
42041352|NCT00408005|75849108|FG001|Induction|Death|0|||
42041353|NCT00408005|75849109|FG002|Induction|Death|0|||
42041354|NCT00408005|75849110|FG003|Induction|Death|0|||
42041355|NCT00408005|75849111|FG004|Induction|Death|0|||
42041356|NCT00408005|75849112|FG005|Induction|Death|0|||
42041357|NCT00408005|75849113|FG006|Induction|Death|0|||
42041358|NCT00408005|75849114|FG007|Induction|Death|0|||
42172037|NCT00356525|75978837|FG000|Overall Study|Progressive Disease|8|||
42289270|NCT04934722|76122311|FG001|Overall Study|Participants Ongoing|91|||
42289271|NCT04778592|76122319|FG000|Overall Study|Adverse Event|1|||
42289272|NCT04778592|76122320|FG001|Overall Study|Adverse Event|2|||
42289273|NCT04778592|76122319|FG000|Overall Study|Withdrawal by Subject|1|||
42289274|NCT04778592|76122320|FG001|Overall Study|Withdrawal by Subject|2|||
42289275|NCT04688671|76122328|FG000|Overall Study|Adverse Event|3|||
42289276|NCT04688671|76122329|FG001|Overall Study|Adverse Event|1|||
42015785|NCT00950599|75822968|FG003|Follow-Up Period|Adverse Event|0|||
42015786|NCT00950599|75822969|FG004|Follow-Up Period|Adverse Event|0|||
42015787|NCT00950599|75822970|FG005|Follow-Up Period|Adverse Event|0|||
42015788|NCT00950599|75822971|FG006|Follow-Up Period|Adverse Event|0|||
42015789|NCT00950599|75822972|FG007|Follow-Up Period|Adverse Event|0|||
42015790|NCT00950599|75822973|FG008|Follow-Up Period|Adverse Event|1|||
42015791|NCT00950599|75822974|FG009|Follow-Up Period|Adverse Event|0|||
42015792|NCT00950599|75822965|FG000|Follow-Up Period|Lack of Efficacy|0|||
42015793|NCT00950599|75822966|FG001|Follow-Up Period|Lack of Efficacy|0|||
42041359|NCT00408005|75849107|FG000|Induction|Physician Decision|83|||
42041360|NCT00408005|75849108|FG001|Induction|Physician Decision|9|||
42041361|NCT00408005|75849109|FG002|Induction|Physician Decision|0|||
42041362|NCT00408005|75849110|FG003|Induction|Physician Decision|0|||
42041363|NCT00408005|75849111|FG004|Induction|Physician Decision|0|||
42041364|NCT00408005|75849112|FG005|Induction|Physician Decision|0|||
42172038|NCT00356525|75978838|FG001|Overall Study|Progressive Disease|5|||
42289277|NCT04688671|76122328|FG000|Overall Study|Withdrawal by Subject|3|||
42041365|NCT00408005|75849113|FG006|Induction|Physician Decision|0|||
42041366|NCT00408005|75849114|FG007|Induction|Physician Decision|0|||
42289278|NCT04688671|76122329|FG001|Overall Study|Withdrawal by Subject|1|||
42289279|NCT04688671|76122328|FG000|Overall Study|Lack of Efficacy|1|||
42289280|NCT04688671|76122329|FG001|Overall Study|Lack of Efficacy|1|||
42289281|NCT04688671|76122328|FG000|Overall Study|Protocol Violation|1|||
42289282|NCT04688671|76122329|FG001|Overall Study|Protocol Violation|0|||
42289283|NCT04688671|76122328|FG000|Overall Study|Lost to Follow-up|0|||
42289284|NCT04688671|76122329|FG001|Overall Study|Lost to Follow-up|1|||
42289285|NCT04668209|76122337|FG000|Overall Study|Withdrawal by Subject|2|||
42289286|NCT04668209|76122338|FG001|Overall Study|Withdrawal by Subject|2|||
42289287|NCT04668209|76122337|FG000|Overall Study|Lost to Follow-up|3|||
42289288|NCT04668209|76122338|FG001|Overall Study|Lost to Follow-up|4|||
42289289|NCT04668209|76122337|FG000|Overall Study|Subject Expired|2|||
42289290|NCT04668209|76122338|FG001|Overall Study|Subject Expired|0|||
42355268|NCT01609556|76197161|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355269|NCT01609556|76197162|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355270|NCT01609556|76197163|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42041367|NCT00408005|75849107|FG000|Induction|Withdrawal by Subject|2|||
42041368|NCT00408005|75849108|FG001|Induction|Withdrawal by Subject|4|||
42041369|NCT00408005|75849109|FG002|Induction|Withdrawal by Subject|0|||
42041370|NCT00408005|75849110|FG003|Induction|Withdrawal by Subject|0|||
42041371|NCT00408005|75849111|FG004|Induction|Withdrawal by Subject|0|||
42041372|NCT00408005|75849112|FG005|Induction|Withdrawal by Subject|0|||
42041373|NCT00408005|75849113|FG006|Induction|Withdrawal by Subject|0|||
42041374|NCT00408005|75849114|FG007|Induction|Withdrawal by Subject|0|||
42041375|NCT00408005|75849107|FG000|Induction|Ineligible|33|||
42041376|NCT00408005|75849108|FG001|Induction|Ineligible|14|||
42041377|NCT00408005|75849109|FG002|Induction|Ineligible|0|||
42041378|NCT00408005|75849110|FG003|Induction|Ineligible|0|||
42041379|NCT00408005|75849111|FG004|Induction|Ineligible|0|||
42041380|NCT00408005|75849112|FG005|Induction|Ineligible|0|||
42041381|NCT00408005|75849113|FG006|Induction|Ineligible|0|||
42041382|NCT00408005|75849114|FG007|Induction|Ineligible|0|||
42041383|NCT00408005|75849107|FG000|Induction|Refusal of Further Protocol Therapy|225|||
42041384|NCT00408005|75849108|FG001|Induction|Refusal of Further Protocol Therapy|44|||
42041385|NCT00408005|75849109|FG002|Induction|Refusal of Further Protocol Therapy|0|||
42041386|NCT00408005|75849110|FG003|Induction|Refusal of Further Protocol Therapy|0|||
42041387|NCT00408005|75849111|FG004|Induction|Refusal of Further Protocol Therapy|0|||
42041388|NCT00408005|75849112|FG005|Induction|Refusal of Further Protocol Therapy|0|||
42172039|NCT00356525|75978839|FG002|Overall Study|Progressive Disease|4|||
42172040|NCT00356525|75978840|FG003|Overall Study|Progressive Disease|2|||
42172041|NCT00356525|75978837|FG000|Overall Study|Adverse Event|1|||
42015794|NCT00950599|75822967|FG002|Follow-Up Period|Lack of Efficacy|0|||
42041389|NCT00408005|75849113|FG006|Induction|Refusal of Further Protocol Therapy|0|||
42041390|NCT00408005|75849114|FG007|Induction|Refusal of Further Protocol Therapy|0|||
42041391|NCT00408005|75849107|FG000|Induction|Entered another COG therapeutic protocol|4|||
42041392|NCT00408005|75849108|FG001|Induction|Entered another COG therapeutic protocol|0|||
42041393|NCT00408005|75849109|FG002|Induction|Entered another COG therapeutic protocol|0|||
42041394|NCT00408005|75849110|FG003|Induction|Entered another COG therapeutic protocol|0|||
42041395|NCT00408005|75849111|FG004|Induction|Entered another COG therapeutic protocol|0|||
42041396|NCT00408005|75849112|FG005|Induction|Entered another COG therapeutic protocol|0|||
42041397|NCT00408005|75849113|FG006|Induction|Entered another COG therapeutic protocol|0|||
42041398|NCT00408005|75849114|FG007|Induction|Entered another COG therapeutic protocol|0|||
42041399|NCT00408005|75849107|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
42041400|NCT00408005|75849108|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
42041401|NCT00408005|75849109|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
42041402|NCT00408005|75849110|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
42041403|NCT00408005|75849111|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
42041404|NCT00408005|75849112|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
42041405|NCT00408005|75849113|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
42041406|NCT00408005|75849114|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
42015795|NCT00950599|75822968|FG003|Follow-Up Period|Lack of Efficacy|0|||
42015796|NCT00950599|75822969|FG004|Follow-Up Period|Lack of Efficacy|0|||
42015797|NCT00950599|75822970|FG005|Follow-Up Period|Lack of Efficacy|0|||
42015798|NCT00950599|75822971|FG006|Follow-Up Period|Lack of Efficacy|0|||
42015799|NCT00950599|75822972|FG007|Follow-Up Period|Lack of Efficacy|0|||
42015800|NCT00950599|75822973|FG008|Follow-Up Period|Lack of Efficacy|3|||
42015801|NCT00950599|75822974|FG009|Follow-Up Period|Lack of Efficacy|0|||
42015802|NCT00950599|75822965|FG000|Follow-Up Period|Lost to Follow-up|0|||
42015803|NCT00950599|75822966|FG001|Follow-Up Period|Lost to Follow-up|0|||
42015804|NCT00950599|75822967|FG002|Follow-Up Period|Lost to Follow-up|0|||
42015805|NCT00950599|75822968|FG003|Follow-Up Period|Lost to Follow-up|0|||
42015806|NCT00950599|75822969|FG004|Follow-Up Period|Lost to Follow-up|0|||
42015807|NCT00950599|75822970|FG005|Follow-Up Period|Lost to Follow-up|0|||
42015808|NCT00950599|75822971|FG006|Follow-Up Period|Lost to Follow-up|0|||
42041407|NCT00408005|75849107|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
42015809|NCT00950599|75822972|FG007|Follow-Up Period|Lost to Follow-up|0|||
42015810|NCT00950599|75822973|FG008|Follow-Up Period|Lost to Follow-up|5|||
42015811|NCT00950599|75822974|FG009|Follow-Up Period|Lost to Follow-up|1|||
42015812|NCT00950599|75822965|FG000|Follow-Up Period|Physician Decision|0|||
42041408|NCT00408005|75849108|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
42041409|NCT00408005|75849109|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
42041410|NCT00408005|75849110|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
42041411|NCT00408005|75849111|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
42041412|NCT00408005|75849112|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
42041413|NCT00408005|75849113|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
42172042|NCT00356525|75978838|FG001|Overall Study|Adverse Event|3|||
42015813|NCT00950599|75822966|FG001|Follow-Up Period|Physician Decision|0|||
42041414|NCT00408005|75849114|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
42041415|NCT00408005|75849107|FG000|Induction|Progressive Disease|0|||
42041416|NCT00408005|75849108|FG001|Induction|Progressive Disease|1|||
42041417|NCT00408005|75849109|FG002|Induction|Progressive Disease|0|||
42041418|NCT00408005|75849110|FG003|Induction|Progressive Disease|0|||
42041419|NCT00408005|75849111|FG004|Induction|Progressive Disease|0|||
42041420|NCT00408005|75849112|FG005|Induction|Progressive Disease|0|||
42041421|NCT00408005|75849113|FG006|Induction|Progressive Disease|0|||
42041422|NCT00408005|75849114|FG007|Induction|Progressive Disease|0|||
42041423|NCT00408005|75849107|FG000|Induction|Inevaluable|18|||
42041424|NCT00408005|75849108|FG001|Induction|Inevaluable|14|||
42041425|NCT00408005|75849109|FG002|Induction|Inevaluable|0|||
42041426|NCT00408005|75849110|FG003|Induction|Inevaluable|0|||
42041427|NCT00408005|75849111|FG004|Induction|Inevaluable|0|||
42041428|NCT00408005|75849112|FG005|Induction|Inevaluable|0|||
42041429|NCT00408005|75849113|FG006|Induction|Inevaluable|0|||
42041430|NCT00408005|75849114|FG007|Induction|Inevaluable|0|||
42041431|NCT00408005|75849107|FG000|Induction|Failed to Complete Randomization|3|||
42041432|NCT00408005|75849108|FG001|Induction|Failed to Complete Randomization|2|||
42041433|NCT00408005|75849109|FG002|Induction|Failed to Complete Randomization|0|||
42041434|NCT00408005|75849110|FG003|Induction|Failed to Complete Randomization|0|||
42041435|NCT00408005|75849111|FG004|Induction|Failed to Complete Randomization|0|||
42041436|NCT00408005|75849112|FG005|Induction|Failed to Complete Randomization|0|||
42041437|NCT00408005|75849113|FG006|Induction|Failed to Complete Randomization|0|||
42041438|NCT00408005|75849114|FG007|Induction|Failed to Complete Randomization|0|||
42041439|NCT00408005|75849107|FG000|Induction|Protocol Deviation|3|||
42041440|NCT00408005|75849108|FG001|Induction|Protocol Deviation|1|||
42041441|NCT00408005|75849109|FG002|Induction|Protocol Deviation|0|||
42041442|NCT00408005|75849110|FG003|Induction|Protocol Deviation|0|||
42041443|NCT00408005|75849111|FG004|Induction|Protocol Deviation|0|||
42041444|NCT00408005|75849112|FG005|Induction|Protocol Deviation|0|||
42041445|NCT00408005|75849113|FG006|Induction|Protocol Deviation|0|||
42041446|NCT00408005|75849114|FG007|Induction|Protocol Deviation|0|||
42041447|NCT00408005|75849107|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
42041448|NCT00408005|75849108|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
42041449|NCT00408005|75849109|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
42041450|NCT00408005|75849110|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
42041451|NCT00408005|75849111|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
42041452|NCT00408005|75849112|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
42041453|NCT00408005|75849113|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
42041454|NCT00408005|75849114|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
42041455|NCT00408005|75849107|FG000|Induction|Recurrent leukemia|1|||
42041456|NCT00408005|75849108|FG001|Induction|Recurrent leukemia|0|||
42041457|NCT00408005|75849109|FG002|Induction|Recurrent leukemia|0|||
42041458|NCT00408005|75849110|FG003|Induction|Recurrent leukemia|0|||
42041459|NCT00408005|75849111|FG004|Induction|Recurrent leukemia|0|||
42041460|NCT00408005|75849112|FG005|Induction|Recurrent leukemia|0|||
42041461|NCT00408005|75849113|FG006|Induction|Recurrent leukemia|0|||
42041462|NCT00408005|75849114|FG007|Induction|Recurrent leukemia|0|||
42041463|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
42041464|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
42041465|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
42041466|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
42041467|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
42041468|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
42041469|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
42041470|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
42041471|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
42041472|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
42041473|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
42041474|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
42041475|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
42041476|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
42041477|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
42041478|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
42041479|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
42041480|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
42041481|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
42041482|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
42041483|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
42041484|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
42041485|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
42041486|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
42041487|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
42041488|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
42041489|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
42041490|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
42041491|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
42041492|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
42289291|NCT04668209|76122337|FG000|Overall Study|Withdrawn from study|0|||
42289292|NCT04668209|76122338|FG001|Overall Study|Withdrawn from study|1|||
42289293|NCT04668209|76122337|FG000|Overall Study|Adverse Event|0|||
42289294|NCT04668209|76122338|FG001|Overall Study|Adverse Event|1|||
42289295|NCT04456998|76122348|FG000|Overall Study|Adverse Event|0|||
42289296|NCT04456998|76122349|FG001|Overall Study|Adverse Event|4|||
42289297|NCT04456998|76122348|FG000|Overall Study|Protocol Deviation|0|||
42289298|NCT04456998|76122349|FG001|Overall Study|Protocol Deviation|1|||
42289299|NCT04456998|76122348|FG000|Overall Study|Withdrawal by Subject|0|||
42289300|NCT04456998|76122349|FG001|Overall Study|Withdrawal by Subject|1|||
42289301|NCT04251221|76122378|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
42289302|NCT04251221|76122379|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
42289303|NCT04203238|76122387|FG000|Overall Study|Withdrawal by Subject|1|||
42289304|NCT04203238|76122388|FG001|Overall Study|Withdrawal by Subject|1|||
42289305|NCT04203238|76122387|FG000|Overall Study|Covid-19|3|||
42355271|NCT01609556|76197164|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355272|NCT01609556|76197165|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
42355273|NCT01609556|76197166|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355274|NCT01609556|76197167|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355275|NCT01609556|76197168|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
42355276|NCT01609556|76197153|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42355277|NCT01609556|76197154|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42355278|NCT01609556|76197155|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42355279|NCT01609556|76197156|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42355280|NCT01609556|76197157|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42355281|NCT01609556|76197158|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42355282|NCT01609556|76197159|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42015814|NCT00950599|75822967|FG002|Follow-Up Period|Physician Decision|0|||
42015815|NCT00950599|75822968|FG003|Follow-Up Period|Physician Decision|0|||
42015816|NCT00950599|75822969|FG004|Follow-Up Period|Physician Decision|0|||
42015817|NCT00950599|75822970|FG005|Follow-Up Period|Physician Decision|0|||
42015818|NCT00950599|75822971|FG006|Follow-Up Period|Physician Decision|0|||
42015819|NCT00950599|75822972|FG007|Follow-Up Period|Physician Decision|0|||
42015820|NCT00950599|75822973|FG008|Follow-Up Period|Physician Decision|1|||
42015821|NCT00950599|75822974|FG009|Follow-Up Period|Physician Decision|0|||
42015822|NCT00950599|75822965|FG000|Follow-Up Period|Poor/Noncompliance|0|||
42015823|NCT00950599|75822966|FG001|Follow-Up Period|Poor/Noncompliance|0|||
42015824|NCT00950599|75822967|FG002|Follow-Up Period|Poor/Noncompliance|0|||
42015825|NCT00950599|75822968|FG003|Follow-Up Period|Poor/Noncompliance|0|||
42015826|NCT00950599|75822969|FG004|Follow-Up Period|Poor/Noncompliance|0|||
42015827|NCT00950599|75822970|FG005|Follow-Up Period|Poor/Noncompliance|0|||
42015828|NCT00950599|75822971|FG006|Follow-Up Period|Poor/Noncompliance|0|||
42015829|NCT00950599|75822972|FG007|Follow-Up Period|Poor/Noncompliance|0|||
42289306|NCT04203238|76122388|FG001|Overall Study|Covid-19|0|||
42041493|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
42041494|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
42041495|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
42041496|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
42041497|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
42041498|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
42041499|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
42041500|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
42041501|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
42041502|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
42041503|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
42041504|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
42041505|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
42041506|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
42289307|NCT04055844|76122426|FG000|Overall Study|Adverse Event|12|||
42289308|NCT04055844|76122426|FG000|Overall Study|Poor Performance|1|||
42289309|NCT04055844|76122426|FG000|Overall Study|Death|1|||
42289310|NCT03905655|76122448|FG000|Overall Study|Adverse Event|1|||
42355283|NCT01609556|76197160|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42355284|NCT01609556|76197161|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42355285|NCT01609556|76197162|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42355286|NCT01609556|76197163|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42355287|NCT01609556|76197164|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
42355288|NCT01609556|76197165|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
42355289|NCT01609556|76197166|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
42355290|NCT01609556|76197167|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
42355291|NCT01609556|76197168|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
42015830|NCT00950599|75822973|FG008|Follow-Up Period|Poor/Noncompliance|1|||
42015831|NCT00950599|75822974|FG009|Follow-Up Period|Poor/Noncompliance|0|||
42015832|NCT00950599|75822965|FG000|Follow-Up Period|Subject withdrew Consent|0|||
42015833|NCT00950599|75822966|FG001|Follow-Up Period|Subject withdrew Consent|0|||
42015834|NCT00950599|75822967|FG002|Follow-Up Period|Subject withdrew Consent|0|||
42015835|NCT00950599|75822968|FG003|Follow-Up Period|Subject withdrew Consent|0|||
42015836|NCT00950599|75822969|FG004|Follow-Up Period|Subject withdrew Consent|0|||
42015837|NCT00950599|75822970|FG005|Follow-Up Period|Subject withdrew Consent|0|||
42015838|NCT00950599|75822971|FG006|Follow-Up Period|Subject withdrew Consent|0|||
42015839|NCT00950599|75822972|FG007|Follow-Up Period|Subject withdrew Consent|0|||
42015840|NCT00950599|75822973|FG008|Follow-Up Period|Subject withdrew Consent|2|||
42015841|NCT00950599|75822974|FG009|Follow-Up Period|Subject withdrew Consent|1|||
42015842|NCT01144299|75822999|FG000|Overall Study|Lost to Follow-up|1|||
42015843|NCT01144299|75823000|FG001|Overall Study|Lost to Follow-up|0|||
42015844|NCT01144299|75822999|FG000|Overall Study|Withdrawal by Subject|1|||
42015845|NCT01144299|75823000|FG001|Overall Study|Withdrawal by Subject|0|||
42289311|NCT03905655|76122449|FG001|Overall Study|Adverse Event|0|||
42289312|NCT03905655|76122450|FG002|Overall Study|Adverse Event|1|||
42289313|NCT03905655|76122451|FG003|Overall Study|Adverse Event|1|||
42289314|NCT03761849|76122467|FG000|Overall Study|transferred to OpenLabelExtension|35|||
42355292|NCT01609556|76197153|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355293|NCT01609556|76197154|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355294|NCT01609556|76197155|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355295|NCT01609556|76197156|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42015846|NCT01143207|75823006|FG000|Overall Study|Lost to Follow-up|2|||
42289315|NCT03761849|76122468|FG001|Overall Study|transferred to OpenLabelExtension|34|||
42289316|NCT03761849|76122469|FG002|Overall Study|transferred to OpenLabelExtension|36|||
42015847|NCT01143051|75823016|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
42041507|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
42041508|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
42041509|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
42041510|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
42041511|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
42041512|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
42289317|NCT03761849|76122470|FG003|Overall Study|transferred to OpenLabelExtension|0|||
42289318|NCT03761849|76122471|FG004|Overall Study|transferred to OpenLabelExtension|0|||
42015848|NCT01143051|75823017|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
42015849|NCT01143051|75823018|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
42015850|NCT01143051|75823019|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
42015851|NCT01143051|75823020|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
42289319|NCT03761849|76122472|FG005|Overall Study|transferred to OpenLabelExtension|0|||
42289320|NCT03761849|76122467|FG000|Overall Study|Adverse Event|1|||
42289321|NCT03761849|76122468|FG001|Overall Study|Adverse Event|0|||
42289322|NCT03761849|76122469|FG002|Overall Study|Adverse Event|0|||
42289323|NCT03761849|76122470|FG003|Overall Study|Adverse Event|0|||
42289324|NCT03761849|76122471|FG004|Overall Study|Adverse Event|2|||
42289325|NCT03761849|76122472|FG005|Overall Study|Adverse Event|3|||
42289326|NCT03761849|76122467|FG000|Overall Study|Withdrawal by Subject|0|||
42289327|NCT03761849|76122468|FG001|Overall Study|Withdrawal by Subject|0|||
42289328|NCT03761849|76122469|FG002|Overall Study|Withdrawal by Subject|0|||
42015852|NCT01143051|75823021|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
42015853|NCT01143051|75823016|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
42015854|NCT01143051|75823017|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
42015855|NCT01143051|75823018|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
42041513|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
42015856|NCT01143051|75823019|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
42015857|NCT01143051|75823020|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
42041514|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
42041515|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
42041516|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
42041517|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
42041518|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
42041519|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
42041520|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
42041521|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
42041522|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
42041523|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
42041524|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
42041525|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
42041526|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
42041527|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
42041528|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
42041529|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
42041530|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
42041531|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
42041532|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
42041533|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
42041534|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
42041535|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
42041536|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
42041537|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
42041538|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
42041539|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
42041540|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
42041541|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
42041542|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
42041543|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
42041544|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
42041545|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
42041546|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
42041547|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
42041548|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
42041549|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
42041550|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
42041551|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
42041552|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
42172043|NCT00356525|75978839|FG002|Overall Study|Adverse Event|1|||
42289329|NCT03761849|76122470|FG003|Overall Study|Withdrawal by Subject|41|||
42289330|NCT03761849|76122471|FG004|Overall Study|Withdrawal by Subject|43|||
42289331|NCT03761849|76122472|FG005|Overall Study|Withdrawal by Subject|35|||
42289332|NCT03761849|76122467|FG000|Overall Study|Lost to Follow-up|0|||
42289333|NCT03761849|76122468|FG001|Overall Study|Lost to Follow-up|1|||
42289334|NCT03761849|76122469|FG002|Overall Study|Lost to Follow-up|0|||
42289335|NCT03761849|76122470|FG003|Overall Study|Lost to Follow-up|2|||
42289336|NCT03761849|76122471|FG004|Overall Study|Lost to Follow-up|4|||
42015858|NCT01143051|75823021|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
42015859|NCT01142661|75823031|FG000|Overall Study|Adverse Event|2|||
42015860|NCT01142661|75823031|FG000|Overall Study|Withdrawal by Subject|1|||
42015861|NCT01142661|75823031|FG000|Overall Study|Physician Decision|1|||
42015862|NCT01142193|75823037|FG000|Overall Study|Adverse Event|12|||
42015863|NCT01142193|75823038|FG001|Overall Study|Adverse Event|4|||
42015864|NCT01142193|75823037|FG000|Overall Study|Lack of Efficacy|2|||
42015865|NCT01142193|75823038|FG001|Overall Study|Lack of Efficacy|1|||
42015866|NCT01142193|75823037|FG000|Overall Study|Physician Decision|1|||
42015867|NCT01142193|75823038|FG001|Overall Study|Physician Decision|1|||
42041553|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
42041554|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
42172044|NCT00356525|75978840|FG003|Overall Study|Adverse Event|1|||
42172045|NCT00356525|75978837|FG000|Overall Study|Lost to Follow-up|1|||
42289337|NCT03761849|76122472|FG005|Overall Study|Lost to Follow-up|5|||
42289338|NCT03761849|76122467|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
42289339|NCT03761849|76122468|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
42289340|NCT03761849|76122469|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
42289341|NCT03761849|76122470|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
42289342|NCT03761849|76122471|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
42289343|NCT03761849|76122472|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
42289344|NCT03761849|76122467|FG000|Overall Study|Physician Decision|0|||
42289345|NCT03761849|76122468|FG001|Overall Study|Physician Decision|0|||
42041555|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
42041556|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
42041557|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
42355296|NCT01609556|76197157|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355297|NCT01609556|76197158|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355298|NCT01609556|76197159|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355299|NCT01609556|76197160|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355300|NCT01609556|76197161|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355301|NCT01609556|76197162|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355302|NCT01609556|76197163|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355303|NCT01609556|76197164|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355304|NCT01609556|76197165|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355305|NCT01609556|76197166|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355306|NCT01609556|76197167|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
42355307|NCT01609556|76197168|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
42355308|NCT01609556|76197153|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
42355309|NCT01609556|76197154|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
42041558|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
42041559|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
42041560|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
42041561|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
42172046|NCT00356525|75978838|FG001|Overall Study|Lost to Follow-up|0|||
42355310|NCT01609556|76197155|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
42355311|NCT01609556|76197156|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
42355312|NCT01609556|76197157|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
42355313|NCT01609556|76197158|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
42015868|NCT01142193|75823037|FG000|Overall Study|Withdrawal by Subject|4|||
42015869|NCT01142193|75823038|FG001|Overall Study|Withdrawal by Subject|3|||
42015870|NCT01142193|75823037|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
42015871|NCT01142193|75823038|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
42015872|NCT01142193|75823037|FG000|Overall Study|Other|1|||
42015873|NCT01142193|75823038|FG001|Overall Study|Other|2|||
42015874|NCT01142115|75823044|FG000|First Intervention|Lack of Efficacy|1|||
42015875|NCT01142115|75823045|FG001|First Intervention|Lack of Efficacy|1|||
42015876|NCT01142115|75823044|FG000|First Intervention|Adverse Event|1|||
42015877|NCT01142115|75823045|FG001|First Intervention|Adverse Event|0|||
42289346|NCT03761849|76122469|FG002|Overall Study|Physician Decision|0|||
42289347|NCT03761849|76122470|FG003|Overall Study|Physician Decision|1|||
42289348|NCT03761849|76122471|FG004|Overall Study|Physician Decision|4|||
42289349|NCT03761849|76122472|FG005|Overall Study|Physician Decision|4|||
42289350|NCT03761849|76122467|FG000|Overall Study|Death|0|||
42289351|NCT03761849|76122468|FG001|Overall Study|Death|0|||
42289352|NCT03761849|76122469|FG002|Overall Study|Death|0|||
42289353|NCT03761849|76122470|FG003|Overall Study|Death|1|||
42041562|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
42041563|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
42041564|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
42041565|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
42041566|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
42041567|NCT00408005|75849107|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
42041568|NCT00408005|75849108|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
42041569|NCT00408005|75849109|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
42041570|NCT00408005|75849110|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
42041571|NCT00408005|75849111|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
42041572|NCT00408005|75849112|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
42172047|NCT00356525|75978839|FG002|Overall Study|Lost to Follow-up|0|||
42172048|NCT00356525|75978840|FG003|Overall Study|Lost to Follow-up|0|||
42172049|NCT00356525|75978837|FG000|Overall Study|Physician Decision|2|||
42172050|NCT00356525|75978838|FG001|Overall Study|Physician Decision|2|||
42172051|NCT00356525|75978839|FG002|Overall Study|Physician Decision|2|||
42172052|NCT00356525|75978840|FG003|Overall Study|Physician Decision|1|||
42015878|NCT01140477|75823052|FG000|Overall Study|Lost to Follow-up|4|||
42289354|NCT03761849|76122471|FG004|Overall Study|Death|1|||
42289355|NCT03761849|76122472|FG005|Overall Study|Death|3|||
42289356|NCT03761849|76122467|FG000|Overall Study|Protocol Violation|0|||
42015879|NCT01140477|75823053|FG001|Overall Study|Lost to Follow-up|0|||
42289357|NCT03761849|76122468|FG001|Overall Study|Protocol Violation|0|||
42289358|NCT03761849|76122469|FG002|Overall Study|Protocol Violation|0|||
42289359|NCT03761849|76122470|FG003|Overall Study|Protocol Violation|2|||
42015880|NCT01140477|75823052|FG000|Overall Study|Withdrawal by Subject|1|||
42015881|NCT01140477|75823053|FG001|Overall Study|Withdrawal by Subject|4|||
42015882|NCT01140477|75823052|FG000|Overall Study|Surgical complication preventing implant|2|||
42015883|NCT01140477|75823053|FG001|Overall Study|Surgical complication preventing implant|0|||
42015884|NCT01140477|75823052|FG000|Overall Study|Death|1|||
42015885|NCT01140477|75823053|FG001|Overall Study|Death|1|||
42015886|NCT01140477|75823052|FG000|Overall Study|Subject explanted|0|||
42015887|NCT01140477|75823053|FG001|Overall Study|Subject explanted|1|||
42015888|NCT01139775|75823062|FG000|Overall Study|Adverse Event|0|||
42015889|NCT01139775|75823063|FG001|Overall Study|Adverse Event|6|||
42015890|NCT01139775|75823064|FG002|Overall Study|Adverse Event|2|||
42015891|NCT01139775|75823062|FG000|Overall Study|Protocol Violation|0|||
42289360|NCT03761849|76122471|FG004|Overall Study|Protocol Violation|2|||
42015892|NCT01139775|75823063|FG001|Overall Study|Protocol Violation|5|||
42041573|NCT00408005|75849113|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
42041574|NCT00408005|75849114|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
42041575|NCT00324805|75849136|FG000|Overall Study|Adverse Event|62|||
42041576|NCT00324805|75849137|FG001|Overall Study|Adverse Event|203|||
42041577|NCT00324805|75849136|FG000|Overall Study|Progression|7|||
42041578|NCT00324805|75849137|FG001|Overall Study|Progression|35|||
42041579|NCT00324805|75849136|FG000|Overall Study|Withdrawal by Subject|51|||
42041580|NCT00324805|75849137|FG001|Overall Study|Withdrawal by Subject|174|||
42041581|NCT00324805|75849136|FG000|Overall Study|Death|6|||
42172053|NCT00356525|75978837|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
42041582|NCT00324805|75849137|FG001|Overall Study|Death|9|||
42041583|NCT00324805|75849136|FG000|Overall Study|Alternative therapy|4|||
42041584|NCT00324805|75849137|FG001|Overall Study|Alternative therapy|8|||
42041585|NCT00324805|75849136|FG000|Overall Study|Other complicating disease|1|||
42041586|NCT00324805|75849137|FG001|Overall Study|Other complicating disease|9|||
42041587|NCT00324805|75849136|FG000|Overall Study|Other reasons|7|||
42041588|NCT00324805|75849137|FG001|Overall Study|Other reasons|26|||
42041589|NCT00324805|75849136|FG000|Overall Study|Other|0|||
42041590|NCT00324805|75849137|FG001|Overall Study|Other|2|||
42041591|NCT00324805|75849136|FG000|Overall Study|Did not start therapy|12|||
42041592|NCT00324805|75849137|FG001|Overall Study|Did not start therapy|17|||
42041593|NCT00248040|75849163|FG000|Overall Study|transplantectomy|2|||
42041594|NCT00248040|75849164|FG001|Overall Study|transplantectomy|1|||
42041595|NCT00248040|75849165|FG002|Overall Study|transplantectomy|3|||
42041596|NCT00248040|75849163|FG000|Overall Study|transplant cancelled post treat start|1|||
42041597|NCT00248040|75849164|FG001|Overall Study|transplant cancelled post treat start|0|||
42041598|NCT00248040|75849165|FG002|Overall Study|transplant cancelled post treat start|0|||
42041599|NCT00248040|75849163|FG000|Overall Study|Death|0|||
42041600|NCT00248040|75849164|FG001|Overall Study|Death|0|||
42041601|NCT00248040|75849165|FG002|Overall Study|Death|1|||
42041602|NCT00976716|75849174|FG000|Overall Study|Adverse Event|1|||
42041603|NCT00973674|75849181|FG000|Overall Study|Protocol Violation|2|||
42172054|NCT00356525|75978838|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
42041604|NCT00973674|75849182|FG001|Overall Study|Protocol Violation|0|||
42041605|NCT00819091|75849191|FG000|Overall Study|Adverse Event|3|||
42041606|NCT00819091|75849192|FG001|Overall Study|Adverse Event|5|||
42041607|NCT00819091|75849191|FG000|Overall Study|Protocol Violation|0|||
42172055|NCT00356525|75978839|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
42172056|NCT00356525|75978840|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
42172057|NCT00356525|75978837|FG000|Overall Study|Withdrawal by Subject|1|||
42172058|NCT00356525|75978838|FG001|Overall Study|Withdrawal by Subject|1|||
42172059|NCT00356525|75978839|FG002|Overall Study|Withdrawal by Subject|0|||
42172060|NCT00356525|75978840|FG003|Overall Study|Withdrawal by Subject|3|||
42172061|NCT00356525|75978837|FG000|Overall Study|Death|0|||
42172062|NCT00356525|75978838|FG001|Overall Study|Death|0|||
42172063|NCT00356525|75978839|FG002|Overall Study|Death|0|||
42172064|NCT00356525|75978840|FG003|Overall Study|Death|1|||
42172065|NCT00356525|75978837|FG000|Overall Study|Sponsor Decision|0|||
42172066|NCT00356525|75978838|FG001|Overall Study|Sponsor Decision|0|||
42172067|NCT00356525|75978839|FG002|Overall Study|Sponsor Decision|0|||
42289361|NCT03761849|76122472|FG005|Overall Study|Protocol Violation|1|||
42289362|NCT03761849|76122467|FG000|Overall Study|Participant could not come to site|0|||
42289363|NCT03761849|76122468|FG001|Overall Study|Participant could not come to site|0|||
42289364|NCT03761849|76122469|FG002|Overall Study|Participant could not come to site|0|||
42289365|NCT03761849|76122470|FG003|Overall Study|Participant could not come to site|0|||
42289366|NCT03761849|76122471|FG004|Overall Study|Participant could not come to site|1|||
42289367|NCT03761849|76122472|FG005|Overall Study|Participant could not come to site|0|||
42289368|NCT03761849|76122467|FG000|Overall Study|SF- safety Finding|0|||
42289369|NCT03761849|76122468|FG001|Overall Study|SF- safety Finding|0|||
42172068|NCT00356525|75978840|FG003|Overall Study|Sponsor Decision|1|||
42172069|NCT00356369|75978852|FG000|Active Phase|Withdrawal by Subject|2|||
42015893|NCT01139775|75823064|FG002|Overall Study|Protocol Violation|0|||
42041608|NCT00819091|75849192|FG001|Overall Study|Protocol Violation|1|||
42041609|NCT00819091|75849191|FG000|Overall Study|Lost to Follow-up|2|||
42041610|NCT00819091|75849192|FG001|Overall Study|Lost to Follow-up|0|||
42041611|NCT00819091|75849191|FG000|Overall Study|Withdrawal by Subject|1|||
42172070|NCT00356369|75978853|FG001|Active Phase|Withdrawal by Subject|1|||
42172071|NCT03383614|75978863|FG000|Overall Study|Withdrawal by Subject|0|||
42172072|NCT03383614|75978864|FG001|Overall Study|Withdrawal by Subject|1|||
42172073|NCT03383614|75978865|FG002|Overall Study|Withdrawal by Subject|0|||
42172074|NCT03383614|75978866|FG003|Overall Study|Withdrawal by Subject|0|||
42172075|NCT03403036|75978881|FG000|Overall Study|Lack of Efficacy|5|||
42172076|NCT00356135|75978888|FG000|Overall Study|Protocol Violation|1|||
42172077|NCT00356135|75978889|FG001|Overall Study|Protocol Violation|0|||
42172078|NCT00356135|75978890|FG002|Overall Study|Protocol Violation|0|||
42172079|NCT00356135|75978888|FG000|Overall Study|Adverse Event|1|||
42172080|NCT00356135|75978889|FG001|Overall Study|Adverse Event|0|||
42172081|NCT00356135|75978890|FG002|Overall Study|Adverse Event|0|||
42172082|NCT00356135|75978888|FG000|Overall Study|Lost to Follow-up|0|||
42172083|NCT00356135|75978889|FG001|Overall Study|Lost to Follow-up|0|||
42172084|NCT00356135|75978890|FG002|Overall Study|Lost to Follow-up|1|||
42172085|NCT00356135|75978888|FG000|Overall Study|Physician Decision|1|||
42172086|NCT00356135|75978889|FG001|Overall Study|Physician Decision|1|||
42289370|NCT03761849|76122469|FG002|Overall Study|SF- safety Finding|0|||
42289371|NCT03761849|76122470|FG003|Overall Study|SF- safety Finding|0|||
42289372|NCT03761849|76122471|FG004|Overall Study|SF- safety Finding|0|||
42289373|NCT03761849|76122472|FG005|Overall Study|SF- safety Finding|1|||
42289374|NCT03761849|76122467|FG000|Overall Study|Patient did not attend visit|0|||
42289375|NCT03761849|76122468|FG001|Overall Study|Patient did not attend visit|0|||
42289376|NCT03761849|76122469|FG002|Overall Study|Patient did not attend visit|0|||
42289377|NCT03761849|76122470|FG003|Overall Study|Patient did not attend visit|0|||
42041612|NCT00819091|75849192|FG001|Overall Study|Withdrawal by Subject|2|||
42041613|NCT00819091|75849191|FG000|Overall Study|Other|1|||
42041614|NCT00819091|75849192|FG001|Overall Study|Other|2|||
42041615|NCT00973362|75849200|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
42041616|NCT00973362|75849201|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
42041617|NCT00973362|75849200|FG000|Baseline Evaluation|No colposcopy visit|62|||
42041618|NCT00973362|75849201|FG001|Baseline Evaluation|No colposcopy visit|0|||
42041619|NCT00973362|75849200|FG000|Baseline Evaluation|Inevaluable|686|||
42041620|NCT00973362|75849201|FG001|Baseline Evaluation|Inevaluable|223|||
42041621|NCT00973362|75849200|FG000|3-Year Follow-up|Lost to Follow-up|17|||
42041622|NCT00973362|75849201|FG001|3-Year Follow-up|Lost to Follow-up|0|||
42041623|NCT00819013|75849214|FG000|Overall Study|Not meeting continuing study eligibility|2|||
42041624|NCT00819013|75849215|FG001|Overall Study|Not meeting continuing study eligibility|1|||
42041625|NCT00819013|75849216|FG002|Overall Study|Not meeting continuing study eligibility|2|||
42041626|NCT00819013|75849217|FG003|Overall Study|Not meeting continuing study eligibility|1|||
42041627|NCT00819013|75849214|FG000|Overall Study|Adverse Event|0|||
42041628|NCT00819013|75849215|FG001|Overall Study|Adverse Event|0|||
42041629|NCT00819013|75849216|FG002|Overall Study|Adverse Event|1|||
42041630|NCT00819013|75849217|FG003|Overall Study|Adverse Event|0|||
42041631|NCT00819013|75849214|FG000|Overall Study|Withdrawal by Subject|1|||
42041632|NCT00819013|75849215|FG001|Overall Study|Withdrawal by Subject|0|||
42041633|NCT00819013|75849216|FG002|Overall Study|Withdrawal by Subject|1|||
42041634|NCT00819013|75849217|FG003|Overall Study|Withdrawal by Subject|0|||
42041635|NCT00819013|75849214|FG000|Overall Study|Lost to Follow-up|0|||
42041636|NCT00819013|75849215|FG001|Overall Study|Lost to Follow-up|0|||
42041637|NCT00819013|75849216|FG002|Overall Study|Lost to Follow-up|1|||
42041638|NCT00819013|75849217|FG003|Overall Study|Lost to Follow-up|2|||
42041639|NCT00819013|75849214|FG000|Overall Study|Death|0|||
42041640|NCT00819013|75849215|FG001|Overall Study|Death|0|||
42172087|NCT00356135|75978890|FG002|Overall Study|Physician Decision|1|||
42172088|NCT00356135|75978888|FG000|Overall Study|Subject non-compliance|1|||
42172089|NCT00356135|75978889|FG001|Overall Study|Subject non-compliance|1|||
42172090|NCT00356135|75978890|FG002|Overall Study|Subject non-compliance|3|||
42172091|NCT03383146|75978902|FG000|Overall Study|Screen Failure|1|||
42172092|NCT03383146|75978903|FG001|Overall Study|Screen Failure|0|||
42172093|NCT03383146|75978902|FG000|Overall Study|Adverse Event|6|||
42172094|NCT03383146|75978903|FG001|Overall Study|Adverse Event|18|||
42289378|NCT03761849|76122471|FG004|Overall Study|Patient did not attend visit|0|||
42289379|NCT03761849|76122472|FG005|Overall Study|Patient did not attend visit|1|||
42289380|NCT03698994|76122486|FG000|Overall Study|Adverse Event|2|||
42289381|NCT03698994|76122486|FG000|Overall Study|Death|1|||
42289382|NCT03698994|76122486|FG000|Overall Study|Physician Decision|1|||
42041641|NCT00819013|75849216|FG002|Overall Study|Death|0|||
42041642|NCT00819013|75849217|FG003|Overall Study|Death|1|||
42172095|NCT03383146|75978902|FG000|Overall Study|Lack of Efficacy|0|||
42172096|NCT03383146|75978903|FG001|Overall Study|Lack of Efficacy|3|||
42041643|NCT00976560|75849229|FG000|Overall Study|Adverse Event|5|||
42041644|NCT00976560|75849230|FG001|Overall Study|Adverse Event|5|||
42041645|NCT00976560|75849229|FG000|Overall Study|Lack of Efficacy|3|||
42041646|NCT00976560|75849230|FG001|Overall Study|Lack of Efficacy|5|||
42041647|NCT00976560|75849229|FG000|Overall Study|Protocol Violation|1|||
42041648|NCT00976560|75849230|FG001|Overall Study|Protocol Violation|0|||
42041649|NCT00976560|75849229|FG000|Overall Study|Lost to Follow-up|1|||
42041650|NCT00976560|75849230|FG001|Overall Study|Lost to Follow-up|0|||
42041651|NCT00976560|75849229|FG000|Overall Study|Physician Decision|2|||
42041652|NCT00976560|75849230|FG001|Overall Study|Physician Decision|0|||
42041653|NCT00976560|75849229|FG000|Overall Study|Withdrawal by Subject|2|||
42041654|NCT00976560|75849230|FG001|Overall Study|Withdrawal by Subject|3|||
42041655|NCT00976482|75849236|FG000|Overall Study|Death|208|||
42041656|NCT00976482|75849236|FG000|Overall Study|Withdrawal by Subject|45|||
42041657|NCT00976482|75849236|FG000|Overall Study|Center terminated|1|||
42041658|NCT00976482|75849236|FG000|Overall Study|Protocol Violation|5|||
42041659|NCT00975156|75849242|FG000|Overall Study|Protocol Violation|0|||
42041660|NCT00975156|75849243|FG001|Overall Study|Protocol Violation|1|||
42041661|NCT00810043|75849255|FG000|Overall Study|Withdrawal by Subject|1|||
42041662|NCT00810043|75849256|FG001|Overall Study|Withdrawal by Subject|0|||
42041663|NCT00810043|75849257|FG002|Overall Study|Withdrawal by Subject|2|||
42041664|NCT00810043|75849255|FG000|Overall Study|Lost to Follow-up|1|||
42041665|NCT00810043|75849256|FG001|Overall Study|Lost to Follow-up|0|||
42041666|NCT00810043|75849257|FG002|Overall Study|Lost to Follow-up|0|||
42041667|NCT00810043|75849255|FG000|Overall Study|Physician Decision|0|||
42041668|NCT00810043|75849256|FG001|Overall Study|Physician Decision|0|||
42041669|NCT00810043|75849257|FG002|Overall Study|Physician Decision|2|||
42041670|NCT00810043|75849255|FG000|Overall Study|Death|2|||
42041671|NCT00810043|75849256|FG001|Overall Study|Death|0|||
42041672|NCT00810043|75849257|FG002|Overall Study|Death|0|||
42041673|NCT00810043|75849255|FG000|Overall Study|Unrelated medical problem|0|||
42041674|NCT00810043|75849256|FG001|Overall Study|Unrelated medical problem|1|||
42041675|NCT00810043|75849257|FG002|Overall Study|Unrelated medical problem|0|||
42041676|NCT00810043|75849255|FG000|Overall Study|Non-medical problem|0|||
42041677|NCT00810043|75849256|FG001|Overall Study|Non-medical problem|0|||
42041678|NCT00810043|75849257|FG002|Overall Study|Non-medical problem|1|||
42041679|NCT00810043|75849255|FG000|Overall Study|No longer met enrollment criteria|0|||
42041680|NCT00810043|75849256|FG001|Overall Study|No longer met enrollment criteria|0|||
42041681|NCT00810043|75849257|FG002|Overall Study|No longer met enrollment criteria|3|||
42172097|NCT03383146|75978902|FG000|Overall Study|Withdrawal by Subject|20|||
42172098|NCT03383146|75978903|FG001|Overall Study|Withdrawal by Subject|36|||
42289383|NCT03698994|76122486|FG000|Overall Study|Withdrawal by Subject|3|||
42289384|NCT03698994|76122486|FG000|Overall Study|Progressive Disease|12|||
42289385|NCT03555149|76122511|FG000|Overall Study|Death|18|||
42289386|NCT03555149|76122512|FG001|Overall Study|Death|15|||
42289387|NCT03555149|76122513|FG002|Overall Study|Death|15|||
42289388|NCT03555149|76122514|FG003|Overall Study|Death|4|||
42289389|NCT03555149|76122515|FG004|Overall Study|Death|4|||
42289390|NCT03555149|76122516|FG005|Overall Study|Death|11|||
42289391|NCT03555149|76122517|FG006|Overall Study|Death|12|||
42041682|NCT01120184|75849269|FG000|Overall Study|Adverse Event|0|||
42041683|NCT01120184|75849270|FG001|Overall Study|Adverse Event|1|||
42041684|NCT01120184|75849271|FG002|Overall Study|Adverse Event|0|||
42041685|NCT01120184|75849269|FG000|Overall Study|Lost to Follow-up|13|||
42041686|NCT01120184|75849270|FG001|Overall Study|Lost to Follow-up|13|||
42041687|NCT01120184|75849271|FG002|Overall Study|Lost to Follow-up|11|||
42041688|NCT01120184|75849269|FG000|Overall Study|Physician Decision|9|||
42289392|NCT03555149|76122518|FG007|Overall Study|Death|1|||
42289393|NCT03555149|76122511|FG000|Overall Study|Lost to Follow-up|1|||
42289394|NCT03555149|76122512|FG001|Overall Study|Lost to Follow-up|0|||
42289395|NCT03555149|76122513|FG002|Overall Study|Lost to Follow-up|0|||
42289396|NCT03555149|76122514|FG003|Overall Study|Lost to Follow-up|0|||
42041689|NCT01120184|75849270|FG001|Overall Study|Physician Decision|1|||
42172099|NCT03383146|75978902|FG000|Overall Study|Lost to Follow-up|5|||
42041690|NCT01120184|75849271|FG002|Overall Study|Physician Decision|3|||
42172100|NCT03383146|75978903|FG001|Overall Study|Lost to Follow-up|15|||
42041691|NCT01120184|75849269|FG000|Overall Study|Reason not Specified|8|||
42041692|NCT01120184|75849270|FG001|Overall Study|Reason not Specified|3|||
42289397|NCT03555149|76122515|FG004|Overall Study|Lost to Follow-up|0|||
42289398|NCT03555149|76122516|FG005|Overall Study|Lost to Follow-up|1|||
42289399|NCT03555149|76122517|FG006|Overall Study|Lost to Follow-up|0|||
42289400|NCT03555149|76122518|FG007|Overall Study|Lost to Follow-up|0|||
42289401|NCT03555149|76122511|FG000|Overall Study|Physician Decision|1|||
42289402|NCT03555149|76122512|FG001|Overall Study|Physician Decision|0|||
42289403|NCT03555149|76122513|FG002|Overall Study|Physician Decision|0|||
42289404|NCT03555149|76122514|FG003|Overall Study|Physician Decision|0|||
42289405|NCT03555149|76122515|FG004|Overall Study|Physician Decision|0|||
42355314|NCT01609556|76197159|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
42355315|NCT01609556|76197160|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
42355316|NCT01609556|76197161|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
42355317|NCT01609556|76197162|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
42355318|NCT01609556|76197163|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
42355319|NCT01609556|76197164|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
42355320|NCT01609556|76197165|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
42355321|NCT01609556|76197166|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
42355322|NCT01609556|76197167|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
42355323|NCT01609556|76197168|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
42355324|NCT01609556|76197153|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355325|NCT01609556|76197154|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355326|NCT01609556|76197155|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42289406|NCT03555149|76122516|FG005|Overall Study|Physician Decision|0|||
42289407|NCT03555149|76122517|FG006|Overall Study|Physician Decision|0|||
42289408|NCT03555149|76122518|FG007|Overall Study|Physician Decision|0|||
42289409|NCT03555149|76122511|FG000|Overall Study|Study Terminated By Sponsor|1|||
42289410|NCT03555149|76122512|FG001|Overall Study|Study Terminated By Sponsor|0|||
42289411|NCT03555149|76122513|FG002|Overall Study|Study Terminated By Sponsor|0|||
42289412|NCT03555149|76122514|FG003|Overall Study|Study Terminated By Sponsor|0|||
42289413|NCT03555149|76122515|FG004|Overall Study|Study Terminated By Sponsor|0|||
42289414|NCT03555149|76122516|FG005|Overall Study|Study Terminated By Sponsor|2|||
42289415|NCT03555149|76122517|FG006|Overall Study|Study Terminated By Sponsor|3|||
42289416|NCT03555149|76122518|FG007|Overall Study|Study Terminated By Sponsor|1|||
42289417|NCT03555149|76122511|FG000|Overall Study|Withdrawal by Subject|3|||
42355327|NCT01609556|76197156|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355328|NCT01609556|76197157|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355329|NCT01609556|76197158|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355330|NCT01609556|76197159|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355331|NCT01609556|76197160|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355332|NCT01609556|76197161|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355333|NCT01609556|76197162|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355334|NCT01609556|76197163|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355335|NCT01609556|76197164|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355336|NCT01609556|76197165|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
42355337|NCT01609556|76197166|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355338|NCT01609556|76197167|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42355339|NCT01609556|76197168|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
42289418|NCT03555149|76122512|FG001|Overall Study|Withdrawal by Subject|0|||
42355340|NCT01763996|76197542|FG000|Treatment Period 2|Adverse Event|0|||
42355341|NCT01763996|76197543|FG001|Treatment Period 2|Adverse Event|1|||
42289419|NCT03555149|76122513|FG002|Overall Study|Withdrawal by Subject|0|||
42289420|NCT03555149|76122514|FG003|Overall Study|Withdrawal by Subject|2|||
42289421|NCT03555149|76122515|FG004|Overall Study|Withdrawal by Subject|0|||
42355342|NCT01468701|76197975|FG000|Overall Study|Not eligible|91|||
42355343|NCT01468701|76197976|FG001|Overall Study|Not eligible|140|||
42015894|NCT01139775|75823062|FG000|Overall Study|Withdrawal by Subject|1|||
42015895|NCT01139775|75823063|FG001|Overall Study|Withdrawal by Subject|0|||
42015896|NCT01139775|75823064|FG002|Overall Study|Withdrawal by Subject|2|||
42015897|NCT01139775|75823062|FG000|Overall Study|Physician Decision|0|||
42015898|NCT01139775|75823063|FG001|Overall Study|Physician Decision|2|||
42015899|NCT01139775|75823064|FG002|Overall Study|Physician Decision|2|||
42015900|NCT01283516|75823083|FG000|Overall Study|Adverse Event|0|||
42015901|NCT01283516|75823084|FG001|Overall Study|Adverse Event|0|||
42355344|NCT01468701|76197977|FG002|Overall Study|Not eligible|29|||
42355345|NCT01468701|76197978|FG003|Overall Study|Not eligible|12|||
42355346|NCT01468701|76197979|FG004|Overall Study|Not eligible|22|||
42355347|NCT01468701|76197980|FG005|Overall Study|Not eligible|2|||
42355348|NCT01468701|76197981|FG006|Overall Study|Not eligible|39|||
42355349|NCT01468701|76197982|FG007|Overall Study|Not eligible|1|||
42355350|NCT01468701|76197983|FG008|Overall Study|Not eligible|40|||
42355351|NCT01468701|76197984|FG009|Overall Study|Not eligible|126|||
42355352|NCT01468701|76197985|FG010|Overall Study|Not eligible|39|||
42355353|NCT01468701|76197986|FG011|Overall Study|Not eligible|33|||
42355354|NCT01468701|76197987|FG012|Overall Study|Not eligible|1|||
42355355|NCT01468701|76197988|FG013|Overall Study|Not eligible|19|||
42355356|NCT01468701|76197989|FG014|Overall Study|Not eligible|1|||
42355357|NCT01468701|76197990|FG015|Overall Study|Not eligible|32|||
42355358|NCT01468701|76197991|FG016|Overall Study|Not eligible|0|||
42355359|NCT01468701|76197975|FG000|Overall Study|Lost to Follow-up|306|||
42355360|NCT01468701|76197976|FG001|Overall Study|Lost to Follow-up|0|||
42289422|NCT03555149|76122516|FG005|Overall Study|Withdrawal by Subject|1|||
42289423|NCT03555149|76122517|FG006|Overall Study|Withdrawal by Subject|0|||
42289424|NCT03555149|76122518|FG007|Overall Study|Withdrawal by Subject|0|||
42289425|NCT03515811|76122538|FG000|Overall Study|Lost to Follow-up|2|||
42289426|NCT03515811|76122539|FG001|Overall Study|Lost to Follow-up|1|||
42289427|NCT03515811|76122538|FG000|Overall Study|Protocol Violation|1|||
42289428|NCT03515811|76122539|FG001|Overall Study|Protocol Violation|1|||
42289429|NCT03515811|76122538|FG000|Overall Study|Death|1|||
42289430|NCT03515811|76122539|FG001|Overall Study|Death|1|||
42289431|NCT03515811|76122538|FG000|Overall Study|Withdrawal by Subject|0|||
42355361|NCT01468701|76197977|FG002|Overall Study|Lost to Follow-up|0|||
42355362|NCT01468701|76197978|FG003|Overall Study|Lost to Follow-up|0|||
42355363|NCT01468701|76197979|FG004|Overall Study|Lost to Follow-up|0|||
42355364|NCT01468701|76197980|FG005|Overall Study|Lost to Follow-up|0|||
42355365|NCT01468701|76197981|FG006|Overall Study|Lost to Follow-up|0|||
42289432|NCT03515811|76122539|FG001|Overall Study|Withdrawal by Subject|2|||
42355366|NCT01468701|76197982|FG007|Overall Study|Lost to Follow-up|0|||
42041693|NCT01120184|75849271|FG002|Overall Study|Reason not Specified|12|||
42041694|NCT01120184|75849269|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
42289433|NCT03515811|76122538|FG000|Overall Study|Technical Problems|1|||
42289434|NCT03515811|76122539|FG001|Overall Study|Technical Problems|0|||
42041695|NCT01120184|75849270|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
42041696|NCT01120184|75849271|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
42041697|NCT01120184|75849269|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
42041698|NCT01120184|75849270|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
42041699|NCT01120184|75849271|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
42041700|NCT01120184|75849269|FG000|Overall Study|Death|170|||
42041701|NCT01120184|75849270|FG001|Overall Study|Death|176|||
42289435|NCT03515811|76122538|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
42289436|NCT03515811|76122539|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
42289437|NCT03515811|76122538|FG000|Overall Study|COVID-19|0|||
42289438|NCT03515811|76122539|FG001|Overall Study|COVID-19|1|||
42289439|NCT03246529|76122608|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
42289440|NCT03246529|76122609|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
42289441|NCT03246529|76122610|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
42289442|NCT03246529|76122608|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
42289443|NCT03246529|76122609|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
42289444|NCT03246529|76122610|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
42289445|NCT03246529|76122608|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
42289446|NCT03246529|76122609|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
42289447|NCT03246529|76122610|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
42289448|NCT03246529|76122608|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
42289449|NCT03246529|76122609|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
42289450|NCT03246529|76122610|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
42289451|NCT03246529|76122608|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
42041702|NCT01120184|75849271|FG002|Overall Study|Death|169|||
42041703|NCT01120028|75849283|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
42041704|NCT01120028|75849284|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
42041705|NCT01120028|75849285|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
42041706|NCT01120028|75849286|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
42289452|NCT03246529|76122609|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
42289453|NCT03246529|76122610|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
42289454|NCT03246529|76122608|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
42289455|NCT03246529|76122609|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
42041707|NCT01120028|75849283|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
42041708|NCT01120028|75849284|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
42041709|NCT01120028|75849285|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
42041710|NCT01120028|75849286|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
42041711|NCT00878800|75849302|FG000|Overall Study|Adverse Event|0|||
42041712|NCT00878800|75849303|FG001|Overall Study|Adverse Event|0|||
42041713|NCT00878800|75849304|FG002|Overall Study|Adverse Event|2|||
42041714|NCT00878800|75849305|FG003|Overall Study|Adverse Event|0|||
42041715|NCT00878800|75849306|FG004|Overall Study|Adverse Event|1|||
42041716|NCT00878800|75849302|FG000|Overall Study|Progressive disease|1|||
42041717|NCT00878800|75849303|FG001|Overall Study|Progressive disease|5|||
42041718|NCT00878800|75849304|FG002|Overall Study|Progressive disease|6|||
42041719|NCT00878800|75849305|FG003|Overall Study|Progressive disease|5|||
42041720|NCT00878800|75849306|FG004|Overall Study|Progressive disease|13|||
42041721|NCT00878800|75849302|FG000|Overall Study|Withdrew consent|1|||
42041722|NCT00878800|75849303|FG001|Overall Study|Withdrew consent|1|||
42041723|NCT00878800|75849304|FG002|Overall Study|Withdrew consent|0|||
42041724|NCT00878800|75849305|FG003|Overall Study|Withdrew consent|1|||
42041725|NCT00878800|75849306|FG004|Overall Study|Withdrew consent|1|||
42041726|NCT00878800|75849302|FG000|Overall Study|Death|0|||
42041727|NCT00878800|75849303|FG001|Overall Study|Death|0|||
42041728|NCT00878800|75849304|FG002|Overall Study|Death|1|||
42041729|NCT00878800|75849305|FG003|Overall Study|Death|0|||
42041730|NCT00878800|75849306|FG004|Overall Study|Death|0|||
42041731|NCT00878800|75849302|FG000|Overall Study|Other|1|||
42041732|NCT00878800|75849303|FG001|Overall Study|Other|1|||
42041733|NCT00878800|75849304|FG002|Overall Study|Other|0|||
42041734|NCT00878800|75849305|FG003|Overall Study|Other|0|||
42041735|NCT00878800|75849306|FG004|Overall Study|Other|1|||
42041736|NCT01119950|75849317|FG000|Overall Study|Adverse Event|25|||
42041737|NCT01119950|75849317|FG000|Overall Study|Withdrawal by Subject|9|||
42041738|NCT01119950|75849317|FG000|Overall Study|Protocol Violation|5|||
42041739|NCT01119950|75849317|FG000|Overall Study|Lost to Follow-up|4|||
42041740|NCT01119950|75849317|FG000|Overall Study|Administrative|2|||
42041741|NCT01119950|75849317|FG000|Overall Study|Abnormal lab value|1|||
42041742|NCT01119950|75849317|FG000|Overall Study|Death|1|||
42041743|NCT01145222|75849347|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
42041744|NCT01145222|75849348|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
42041745|NCT01145222|75849349|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
42041746|NCT01145222|75849350|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
42041747|NCT01145222|75849347|FG000|Overall Study|Poor bowel preparation|0|||
42041748|NCT01145222|75849348|FG001|Overall Study|Poor bowel preparation|0|||
42041749|NCT01145222|75849349|FG002|Overall Study|Poor bowel preparation|0|||
42041750|NCT01145222|75849350|FG003|Overall Study|Poor bowel preparation|1|||
42041751|NCT01145066|75849363|FG000|Overall Study|To resume NSAIDs|2|||
42041752|NCT01145066|75849364|FG001|Overall Study|To resume NSAIDs|2|||
42041753|NCT01145066|75849365|FG002|Overall Study|To resume NSAIDs|1|||
42041754|NCT01145066|75849363|FG000|Overall Study|Non-related surgery|0|||
42015902|NCT01283516|75823085|FG002|Overall Study|Adverse Event|0|||
42041755|NCT01145066|75849364|FG001|Overall Study|Non-related surgery|0|||
42041756|NCT01145066|75849365|FG002|Overall Study|Non-related surgery|1|||
42041757|NCT01145066|75849363|FG000|Overall Study|Withdrawal by Subject|0|||
42041758|NCT01145066|75849364|FG001|Overall Study|Withdrawal by Subject|0|||
42041759|NCT01145066|75849365|FG002|Overall Study|Withdrawal by Subject|2|||
42041760|NCT01145066|75849363|FG000|Overall Study|To start new med|1|||
42172101|NCT03383146|75978902|FG000|Overall Study|Death|0|||
42289456|NCT03246529|76122610|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
42289457|NCT03246529|76122608|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
42289458|NCT03246529|76122609|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
42289459|NCT03246529|76122610|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
42015903|NCT01283516|75823086|FG003|Overall Study|Adverse Event|0|||
42289460|NCT03246529|76122608|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
42289461|NCT03246529|76122609|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
42289462|NCT03246529|76122610|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
42015904|NCT01283516|75823087|FG004|Overall Study|Adverse Event|0|||
42015905|NCT01283516|75823088|FG005|Overall Study|Adverse Event|0|||
42015906|NCT01283516|75823089|FG006|Overall Study|Adverse Event|2|||
42015907|NCT01283516|75823090|FG007|Overall Study|Adverse Event|0|||
42015908|NCT01283516|75823091|FG008|Overall Study|Adverse Event|28|||
42015909|NCT01283516|75823083|FG000|Overall Study|Death|0|||
42015910|NCT01283516|75823084|FG001|Overall Study|Death|0|||
42015911|NCT01283516|75823085|FG002|Overall Study|Death|0|||
42015912|NCT01283516|75823086|FG003|Overall Study|Death|0|||
42015913|NCT01283516|75823087|FG004|Overall Study|Death|0|||
42041761|NCT01145066|75849364|FG001|Overall Study|To start new med|0|||
42041762|NCT01145066|75849365|FG002|Overall Study|To start new med|0|||
42041763|NCT01145066|75849363|FG000|Overall Study|problems swallowing capsule|1|||
42041764|NCT01145066|75849364|FG001|Overall Study|problems swallowing capsule|0|||
42041765|NCT01145066|75849365|FG002|Overall Study|problems swallowing capsule|0|||
42041766|NCT01145066|75849363|FG000|Overall Study|Abdominal discomfort|0|||
42041767|NCT01145066|75849364|FG001|Overall Study|Abdominal discomfort|1|||
42041768|NCT01145066|75849365|FG002|Overall Study|Abdominal discomfort|0|||
42041769|NCT01145066|75849363|FG000|Overall Study|Low platelet count|0|||
42041770|NCT01145066|75849364|FG001|Overall Study|Low platelet count|1|||
42041771|NCT01145066|75849365|FG002|Overall Study|Low platelet count|0|||
42041772|NCT01132118|75849375|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
42172102|NCT03383146|75978903|FG001|Overall Study|Death|2|||
42172103|NCT03383146|75978902|FG000|Overall Study|Physician Decision|0|||
42172104|NCT03383146|75978903|FG001|Overall Study|Physician Decision|1|||
42172105|NCT03383146|75978902|FG000|Overall Study|Protocol Deviation|1|||
42172106|NCT03383146|75978903|FG001|Overall Study|Protocol Deviation|8|||
42172107|NCT03383146|75978902|FG000|Overall Study|Study Terminated by the Sponsor|48|||
42172108|NCT03383146|75978903|FG001|Overall Study|Study Terminated by the Sponsor|95|||
42172109|NCT03383146|75978902|FG000|Overall Study|Reason not Specified|4|||
42172110|NCT03383146|75978903|FG001|Overall Study|Reason not Specified|6|||
42172111|NCT03616964|75978913|FG000|Overall Study|Adverse Event|15|||
42172112|NCT03616964|75978914|FG001|Overall Study|Adverse Event|10|||
42172113|NCT03616964|75978915|FG002|Overall Study|Adverse Event|16|||
42172114|NCT03616964|75978913|FG000|Overall Study|Death|3|||
42172115|NCT03616964|75978914|FG001|Overall Study|Death|0|||
42172116|NCT03616964|75978915|FG002|Overall Study|Death|4|||
42172117|NCT03616964|75978913|FG000|Overall Study|Lack of Efficacy|4|||
42355367|NCT01468701|76197983|FG008|Overall Study|Lost to Follow-up|215|||
42355368|NCT01468701|76197984|FG009|Overall Study|Lost to Follow-up|309|||
42355369|NCT01468701|76197985|FG010|Overall Study|Lost to Follow-up|224|||
42355370|NCT01468701|76197986|FG011|Overall Study|Lost to Follow-up|212|||
42355371|NCT01468701|76197987|FG012|Overall Study|Lost to Follow-up|11|||
42355372|NCT01468701|76197988|FG013|Overall Study|Lost to Follow-up|164|||
42355373|NCT01468701|76197989|FG014|Overall Study|Lost to Follow-up|17|||
42355374|NCT01468701|76197990|FG015|Overall Study|Lost to Follow-up|127|||
42355375|NCT01468701|76197991|FG016|Overall Study|Lost to Follow-up|1|||
42355376|NCT01468701|76197975|FG000|Overall Study|Withdrawal by Subject|165|||
42015914|NCT01283516|75823088|FG005|Overall Study|Death|1|||
42015915|NCT01283516|75823089|FG006|Overall Study|Death|0|||
42015916|NCT01283516|75823090|FG007|Overall Study|Death|1|||
42015917|NCT01283516|75823091|FG008|Overall Study|Death|12|||
42015918|NCT01283516|75823083|FG000|Overall Study|Disease Progression|2|||
42015919|NCT01283516|75823084|FG001|Overall Study|Disease Progression|2|||
42015920|NCT01283516|75823085|FG002|Overall Study|Disease Progression|3|||
42015921|NCT01283516|75823086|FG003|Overall Study|Disease Progression|3|||
42015922|NCT01283516|75823087|FG004|Overall Study|Disease Progression|13|||
42015923|NCT01283516|75823088|FG005|Overall Study|Disease Progression|8|||
42015924|NCT01283516|75823089|FG006|Overall Study|Disease Progression|6|||
42015925|NCT01283516|75823090|FG007|Overall Study|Disease Progression|3|||
42015926|NCT01283516|75823091|FG008|Overall Study|Disease Progression|139|||
42015927|NCT01283516|75823083|FG000|Overall Study|Withdrawal by Subject|0|||
42015928|NCT01283516|75823084|FG001|Overall Study|Withdrawal by Subject|0|||
42015929|NCT01283516|75823085|FG002|Overall Study|Withdrawal by Subject|0|||
42015930|NCT01283516|75823086|FG003|Overall Study|Withdrawal by Subject|0|||
42015931|NCT01283516|75823087|FG004|Overall Study|Withdrawal by Subject|1|||
42015932|NCT01283516|75823088|FG005|Overall Study|Withdrawal by Subject|0|||
42015933|NCT01283516|75823089|FG006|Overall Study|Withdrawal by Subject|1|||
42015934|NCT01283516|75823090|FG007|Overall Study|Withdrawal by Subject|0|||
42015935|NCT01283516|75823091|FG008|Overall Study|Withdrawal by Subject|36|||
42015936|NCT01283516|75823083|FG000|Overall Study|Administrative problems|0|||
42015937|NCT01283516|75823084|FG001|Overall Study|Administrative problems|0|||
42015938|NCT01283516|75823085|FG002|Overall Study|Administrative problems|0|||
42015939|NCT01283516|75823086|FG003|Overall Study|Administrative problems|0|||
42015940|NCT01283516|75823087|FG004|Overall Study|Administrative problems|0|||
42015941|NCT01283516|75823088|FG005|Overall Study|Administrative problems|1|||
42041773|NCT01132118|75849376|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
42041774|NCT01132118|75849375|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
42041775|NCT01132118|75849376|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
42041776|NCT01132118|75849375|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
42041777|NCT01132118|75849376|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
42041778|NCT00972816|75849390|FG000|Overall Study|Adverse Event|0|||
42041779|NCT00972816|75849391|FG001|Overall Study|Adverse Event|0|||
42041780|NCT00972816|75849392|FG002|Overall Study|Adverse Event|1|||
42041781|NCT00972816|75849393|FG003|Overall Study|Adverse Event|0|||
42041782|NCT00972816|75849394|FG004|Overall Study|Adverse Event|0|||
42041783|NCT00972816|75849395|FG005|Overall Study|Adverse Event|0|||
42289463|NCT03246529|76122608|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
42289464|NCT03246529|76122609|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
42289465|NCT03246529|76122610|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
42289466|NCT02975934|76122626|FG000|Treatment Phase|Ongoing at data-analysis|33|||
42289467|NCT02975934|76122627|FG001|Treatment Phase|Ongoing at data-analysis|5|||
42289468|NCT02975934|76122626|FG000|Treatment Phase|Discontinued prior to study drug|0|||
42289469|NCT02975934|76122627|FG001|Treatment Phase|Discontinued prior to study drug|5|||
42289470|NCT02975934|76122626|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
42289471|NCT02975934|76122627|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
42289472|NCT02847598|76122641|FG000|Overall Study|Adverse Event|0|||
42289473|NCT02847598|76122642|FG001|Overall Study|Adverse Event|0|||
42355377|NCT01468701|76197976|FG001|Overall Study|Withdrawal by Subject|0|||
42041784|NCT00972816|75849396|FG006|Overall Study|Adverse Event|0|||
42041785|NCT00972816|75849397|FG007|Overall Study|Adverse Event|0|||
42289474|NCT02847598|76122643|FG002|Overall Study|Adverse Event|0|||
42289475|NCT02847598|76122644|FG003|Overall Study|Adverse Event|0|||
42041786|NCT00972816|75849390|FG000|Overall Study|Withdrawal by Subject|4|||
42041787|NCT00972816|75849391|FG001|Overall Study|Withdrawal by Subject|2|||
42041788|NCT00972816|75849392|FG002|Overall Study|Withdrawal by Subject|1|||
42041789|NCT00972816|75849393|FG003|Overall Study|Withdrawal by Subject|3|||
42015942|NCT01283516|75823089|FG006|Overall Study|Administrative problems|1|||
42172118|NCT03616964|75978914|FG001|Overall Study|Lack of Efficacy|8|||
42172119|NCT03616964|75978915|FG002|Overall Study|Lack of Efficacy|8|||
42172120|NCT03616964|75978913|FG000|Overall Study|Lost to Follow-up|2|||
42172121|NCT03616964|75978914|FG001|Overall Study|Lost to Follow-up|1|||
42289476|NCT02847598|76122645|FG004|Overall Study|Adverse Event|0|||
42289477|NCT02847598|76122646|FG005|Overall Study|Adverse Event|0|||
42289478|NCT02847598|76122647|FG006|Overall Study|Adverse Event|0|||
42289479|NCT02847598|76122648|FG007|Overall Study|Adverse Event|1|||
42289480|NCT02847598|76122641|FG000|Overall Study|Consent withdrawn|2|||
42289481|NCT02847598|76122642|FG001|Overall Study|Consent withdrawn|0|||
42289482|NCT02847598|76122643|FG002|Overall Study|Consent withdrawn|0|||
42289483|NCT02847598|76122644|FG003|Overall Study|Consent withdrawn|4|||
42289484|NCT02847598|76122645|FG004|Overall Study|Consent withdrawn|3|||
42289485|NCT02847598|76122646|FG005|Overall Study|Consent withdrawn|2|||
42289486|NCT02847598|76122647|FG006|Overall Study|Consent withdrawn|1|||
42289487|NCT02847598|76122648|FG007|Overall Study|Consent withdrawn|3|||
42172122|NCT03616964|75978915|FG002|Overall Study|Lost to Follow-up|3|||
42172123|NCT03616964|75978913|FG000|Overall Study|Withdrawal by Subject|18|||
42172124|NCT03616964|75978914|FG001|Overall Study|Withdrawal by Subject|14|||
42172125|NCT03616964|75978915|FG002|Overall Study|Withdrawal by Subject|21|||
42172126|NCT03616964|75978913|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
42172127|NCT03616964|75978914|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
42172128|NCT03616964|75978915|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
42172129|NCT03616964|75978913|FG000|Overall Study|Sponsor's Decision|1|||
42172130|NCT03616964|75978914|FG001|Overall Study|Sponsor's Decision|0|||
42172131|NCT03616964|75978915|FG002|Overall Study|Sponsor's Decision|0|||
42172132|NCT03616964|75978913|FG000|Overall Study|Physician Decision|0|||
42172133|NCT03616964|75978914|FG001|Overall Study|Physician Decision|2|||
42172134|NCT03616964|75978915|FG002|Overall Study|Physician Decision|0|||
42172135|NCT03616964|75978913|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
42172136|NCT03616964|75978914|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
42172137|NCT03616964|75978915|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
42172138|NCT03616964|75978913|FG000|Overall Study|Protocol Violation|0|||
42172139|NCT03616964|75978914|FG001|Overall Study|Protocol Violation|1|||
42172140|NCT03616964|75978915|FG002|Overall Study|Protocol Violation|0|||
42172141|NCT03616964|75978913|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
42172142|NCT03616964|75978914|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
42172143|NCT03616964|75978915|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
42172144|NCT03616964|75978913|FG000|Overall Study|Randomized but Never Treated|1|||
42172145|NCT03616964|75978914|FG001|Overall Study|Randomized but Never Treated|1|||
42172146|NCT03616964|75978915|FG002|Overall Study|Randomized but Never Treated|1|||
42172147|NCT00350519|75978927|FG000|Overall Study|Death|0|||
42172148|NCT00350519|75978928|FG001|Overall Study|Death|1|||
42172149|NCT00350519|75978927|FG000|Overall Study|Physician Decision|0|||
42172150|NCT00350519|75978928|FG001|Overall Study|Physician Decision|1|||
42172151|NCT00350519|75978927|FG000|Overall Study|Protocol Violation|1|||
42172152|NCT00350519|75978928|FG001|Overall Study|Protocol Violation|2|||
42172153|NCT00350519|75978927|FG000|Overall Study|Withdrawal by Subject|3|||
42172154|NCT00350519|75978928|FG001|Overall Study|Withdrawal by Subject|2|||
42172155|NCT03382912|75978936|FG000|Overall Study|Physician Decision|0|||
42172156|NCT03382912|75978937|FG001|Overall Study|Physician Decision|1|||
42172157|NCT03382912|75978936|FG000|Overall Study|Sponsor Decision|6|||
42172158|NCT03382912|75978937|FG001|Overall Study|Sponsor Decision|6|||
42172159|NCT03382912|75978936|FG000|Overall Study|Withdrawal by Subject|0|||
42172160|NCT03382912|75978937|FG001|Overall Study|Withdrawal by Subject|5|||
42172161|NCT00350207|75978946|FG000|Overall Study|Adverse Event|5|||
42172162|NCT00350207|75978947|FG001|Overall Study|Adverse Event|2|||
42172163|NCT00350207|75978948|FG002|Overall Study|Adverse Event|2|||
42172164|NCT00350207|75978946|FG000|Overall Study|Lack of Efficacy|1|||
42172165|NCT00350207|75978947|FG001|Overall Study|Lack of Efficacy|0|||
42289488|NCT02847598|76122641|FG000|Overall Study|Death|3|||
42289489|NCT02847598|76122642|FG001|Overall Study|Death|0|||
42355378|NCT01468701|76197977|FG002|Overall Study|Withdrawal by Subject|0|||
42355379|NCT01468701|76197978|FG003|Overall Study|Withdrawal by Subject|0|||
42172166|NCT00350207|75978948|FG002|Overall Study|Lack of Efficacy|2|||
42172167|NCT00350207|75978946|FG000|Overall Study|Lost to Follow-up|1|||
42172168|NCT00350207|75978947|FG001|Overall Study|Lost to Follow-up|0|||
42172169|NCT00350207|75978948|FG002|Overall Study|Lost to Follow-up|1|||
42289490|NCT02847598|76122643|FG002|Overall Study|Death|0|||
42289491|NCT02847598|76122644|FG003|Overall Study|Death|0|||
42289492|NCT02847598|76122645|FG004|Overall Study|Death|0|||
42289493|NCT02847598|76122646|FG005|Overall Study|Death|0|||
42289494|NCT02847598|76122647|FG006|Overall Study|Death|0|||
42041790|NCT00972816|75849394|FG004|Overall Study|Withdrawal by Subject|0|||
42041791|NCT00972816|75849395|FG005|Overall Study|Withdrawal by Subject|1|||
42041792|NCT00972816|75849396|FG006|Overall Study|Withdrawal by Subject|1|||
42041793|NCT00972816|75849397|FG007|Overall Study|Withdrawal by Subject|2|||
42172170|NCT00350207|75978946|FG000|Overall Study|Withdrawal by Subject|0|||
42172171|NCT00350207|75978947|FG001|Overall Study|Withdrawal by Subject|1|||
42172172|NCT00350207|75978948|FG002|Overall Study|Withdrawal by Subject|1|||
42172173|NCT00350207|75978946|FG000|Overall Study|Other|1|||
42172174|NCT00350207|75978947|FG001|Overall Study|Other|3|||
42172175|NCT00350207|75978948|FG002|Overall Study|Other|1|||
42172176|NCT00349973|75978958|FG000|Overall Study|Adverse Event|3|||
42172177|NCT00349973|75978959|FG001|Overall Study|Adverse Event|3|||
42172178|NCT00349973|75978958|FG000|Overall Study|Withdrawal by Subject|1|||
42172179|NCT00349973|75978959|FG001|Overall Study|Withdrawal by Subject|0|||
42172180|NCT03187262|75978965|FG000|Induction|Lack of Efficacy|2|||
42172181|NCT03187262|75978965|FG000|Induction|Progressive Disease|4|||
42172182|NCT03187262|75978965|FG000|Consolidation|Progressive Disease|5|||
42172183|NCT03381196|75978971|FG000|Overall Study|Withdrawal by Subject|7|||
42172184|NCT03381196|75978972|FG001|Overall Study|Withdrawal by Subject|7|||
42172185|NCT03381196|75978971|FG000|Overall Study|Other|0|||
42172186|NCT03381196|75978972|FG001|Overall Study|Other|1|||
42172187|NCT03381196|75978971|FG000|Overall Study|Lost to Follow-up|5|||
42172188|NCT03381196|75978972|FG001|Overall Study|Lost to Follow-up|4|||
42172189|NCT03381196|75978971|FG000|Overall Study|Death|0|||
42172190|NCT03381196|75978972|FG001|Overall Study|Death|1|||
42172191|NCT03381196|75978971|FG000|Overall Study|Adverse Event|1|||
42172192|NCT03381196|75978972|FG001|Overall Study|Adverse Event|0|||
42172193|NCT03381196|75978971|FG000|Overall Study|Randomized, not treated|3|||
42172194|NCT03381196|75978972|FG001|Overall Study|Randomized, not treated|6|||
42172195|NCT02950558|75978980|FG000|Overall Study|Lost to Follow-up|2|||
42172196|NCT02950558|75978981|FG001|Overall Study|Lost to Follow-up|0|||
42172197|NCT03345472|75978988|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
42172198|NCT03345472|75978988|FG000|Implant to 3 Months|Physician Decision|1|||
42172199|NCT03345472|75978988|FG000|Implant to 3 Months|Adverse Event|1|||
42172200|NCT03345472|75978988|FG000|3 Months to 12 Months|Physician Decision|3|||
42172201|NCT03345472|75978988|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
42172202|NCT03345472|75978988|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
42041794|NCT00972816|75849390|FG000|Overall Study|Lost to Follow-up|11|||
42041795|NCT00972816|75849391|FG001|Overall Study|Lost to Follow-up|9|||
42041796|NCT00972816|75849392|FG002|Overall Study|Lost to Follow-up|7|||
42041797|NCT00972816|75849393|FG003|Overall Study|Lost to Follow-up|5|||
42041798|NCT00972816|75849394|FG004|Overall Study|Lost to Follow-up|11|||
42041799|NCT00972816|75849395|FG005|Overall Study|Lost to Follow-up|10|||
42041800|NCT00972816|75849396|FG006|Overall Study|Lost to Follow-up|7|||
42041801|NCT00972816|75849397|FG007|Overall Study|Lost to Follow-up|7|||
42041802|NCT00972816|75849390|FG000|Overall Study|Inappropriate enrolment|0|||
42041803|NCT00972816|75849391|FG001|Overall Study|Inappropriate enrolment|0|||
42041804|NCT00972816|75849392|FG002|Overall Study|Inappropriate enrolment|0|||
42041805|NCT00972816|75849393|FG003|Overall Study|Inappropriate enrolment|0|||
42041806|NCT00972816|75849394|FG004|Overall Study|Inappropriate enrolment|0|||
42041807|NCT00972816|75849395|FG005|Overall Study|Inappropriate enrolment|0|||
42041808|NCT00972816|75849396|FG006|Overall Study|Inappropriate enrolment|2|||
42289495|NCT02847598|76122648|FG007|Overall Study|Death|0|||
42041809|NCT00972816|75849397|FG007|Overall Study|Inappropriate enrolment|0|||
42041810|NCT00972816|75849390|FG000|Overall Study|Unable to classify|2|||
42041811|NCT00972816|75849391|FG001|Overall Study|Unable to classify|0|||
42041812|NCT00972816|75849392|FG002|Overall Study|Unable to classify|0|||
42041813|NCT00972816|75849393|FG003|Overall Study|Unable to classify|0|||
42041814|NCT00972816|75849394|FG004|Overall Study|Unable to classify|1|||
42041815|NCT00972816|75849395|FG005|Overall Study|Unable to classify|0|||
42172203|NCT03345472|75978988|FG000|3 Months to 12 Months|Adverse Event|1|||
42041816|NCT00972816|75849396|FG006|Overall Study|Unable to classify|0|||
42041817|NCT00972816|75849397|FG007|Overall Study|Unable to classify|0|||
42041818|NCT00969618|75849415|FG000|Overall Study|Adverse Event|29|||
42041819|NCT00969618|75849415|FG000|Overall Study|Entry Criteria Not Met|3|||
42041820|NCT00969618|75849415|FG000|Overall Study|Lack of Efficacy|2|||
42041821|NCT00969618|75849415|FG000|Overall Study|Lost to Follow-up|7|||
42041822|NCT00969618|75849415|FG000|Overall Study|Physician Decision|1|||
42041823|NCT00969618|75849415|FG000|Overall Study|Protocol Violation|9|||
42041824|NCT00969618|75849415|FG000|Overall Study|Withdrawal by Subject|27|||
42041825|NCT00969540|75849421|FG000|Overall Study|Lost to Follow-up|1|||
42041826|NCT00969540|75849422|FG001|Overall Study|Lost to Follow-up|1|||
42041827|NCT00975000|75849442|FG000|Overall Study|Other|1|||
42041828|NCT00975000|75849443|FG001|Overall Study|Other|0|||
42041829|NCT00975000|75849442|FG000|Overall Study|Adverse Event|1|||
42041830|NCT00975000|75849443|FG001|Overall Study|Adverse Event|1|||
42041831|NCT00975000|75849442|FG000|Overall Study|Withdrawal by Subject|2|||
42289496|NCT02847598|76122641|FG000|Overall Study|Lost to Follow-up|0|||
42289497|NCT02847598|76122642|FG001|Overall Study|Lost to Follow-up|0|||
42289498|NCT02847598|76122643|FG002|Overall Study|Lost to Follow-up|0|||
42289499|NCT02847598|76122644|FG003|Overall Study|Lost to Follow-up|0|||
42289500|NCT02847598|76122645|FG004|Overall Study|Lost to Follow-up|0|||
42355380|NCT01468701|76197979|FG004|Overall Study|Withdrawal by Subject|0|||
42355381|NCT01468701|76197980|FG005|Overall Study|Withdrawal by Subject|0|||
42355382|NCT01468701|76197981|FG006|Overall Study|Withdrawal by Subject|0|||
42355383|NCT01468701|76197982|FG007|Overall Study|Withdrawal by Subject|0|||
42355384|NCT01468701|76197983|FG008|Overall Study|Withdrawal by Subject|83|||
42355385|NCT01468701|76197984|FG009|Overall Study|Withdrawal by Subject|88|||
42355386|NCT01468701|76197985|FG010|Overall Study|Withdrawal by Subject|100|||
42355387|NCT01468701|76197986|FG011|Overall Study|Withdrawal by Subject|114|||
42355388|NCT01468701|76197987|FG012|Overall Study|Withdrawal by Subject|9|||
42355389|NCT01468701|76197988|FG013|Overall Study|Withdrawal by Subject|47|||
42355390|NCT01468701|76197989|FG014|Overall Study|Withdrawal by Subject|6|||
42355391|NCT01468701|76197990|FG015|Overall Study|Withdrawal by Subject|31|||
42355392|NCT01468701|76197991|FG016|Overall Study|Withdrawal by Subject|0|||
42355393|NCT01468701|76197975|FG000|Overall Study|Other reasons than listed|437|||
42355394|NCT01468701|76197976|FG001|Overall Study|Other reasons than listed|0|||
42355395|NCT01468701|76197977|FG002|Overall Study|Other reasons than listed|0|||
42355396|NCT01468701|76197978|FG003|Overall Study|Other reasons than listed|0|||
42041832|NCT00975000|75849443|FG001|Overall Study|Withdrawal by Subject|2|||
42041833|NCT00975000|75849442|FG000|Overall Study|Lost to Follow-up|0|||
42041834|NCT00975000|75849443|FG001|Overall Study|Lost to Follow-up|1|||
42041835|NCT00975000|75849442|FG000|Overall Study|Protocol-specified Criteria|1|||
42041836|NCT00975000|75849443|FG001|Overall Study|Protocol-specified Criteria|0|||
42041837|NCT00975000|75849442|FG000|Overall Study|Non-compliance|0|||
42041838|NCT00975000|75849443|FG001|Overall Study|Non-compliance|1|||
42041839|NCT00974922|75849449|FG000|Overall Study|study terminated|24|||
42041840|NCT00972504|75849453|FG000|Overall Study|Adverse Event|2|||
42041841|NCT00972504|75849453|FG000|Overall Study|Investigator discretion|1|||
42041842|NCT00969228|75849465|FG000|Overall Study|Adverse Event|1|||
42041843|NCT00969228|75849466|FG001|Overall Study|Adverse Event|0|||
42041844|NCT00969228|75849465|FG000|Overall Study|Withdrawal by Subject|4|||
42041845|NCT00969228|75849466|FG001|Overall Study|Withdrawal by Subject|0|||
42041846|NCT00969228|75849465|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
42041847|NCT00969228|75849466|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
42041848|NCT00969150|75849474|FG000|Overall Study|Adverse Event|4|||
42041849|NCT00969150|75849475|FG001|Overall Study|Adverse Event|14|||
42041850|NCT00969150|75849474|FG000|Overall Study|Lack of Efficacy|1|||
42289501|NCT02847598|76122646|FG005|Overall Study|Lost to Follow-up|1|||
42289502|NCT02847598|76122647|FG006|Overall Study|Lost to Follow-up|1|||
42289503|NCT02847598|76122648|FG007|Overall Study|Lost to Follow-up|0|||
42289504|NCT02834975|76122672|FG000|Overall Study|Physician Decision|2|||
42041851|NCT00969150|75849475|FG001|Overall Study|Lack of Efficacy|1|||
42041852|NCT00969150|75849474|FG000|Overall Study|Protocol Violation|9|||
42289505|NCT02834975|76122672|FG000|Overall Study|Adverse Event|1|||
42355397|NCT01468701|76197979|FG004|Overall Study|Other reasons than listed|0|||
42355398|NCT01468701|76197980|FG005|Overall Study|Other reasons than listed|0|||
42355399|NCT01468701|76197981|FG006|Overall Study|Other reasons than listed|0|||
42355400|NCT01468701|76197982|FG007|Overall Study|Other reasons than listed|0|||
42041853|NCT00969150|75849475|FG001|Overall Study|Protocol Violation|12|||
42041854|NCT00969150|75849474|FG000|Overall Study|Withdrawal by Subject|13|||
42041855|NCT00969150|75849475|FG001|Overall Study|Withdrawal by Subject|9|||
42041856|NCT00969150|75849474|FG000|Overall Study|Lost to Follow-up|5|||
42041857|NCT00969150|75849475|FG001|Overall Study|Lost to Follow-up|4|||
42289506|NCT02834975|76122672|FG000|Overall Study|Withdrawal by Subject|1|||
42289507|NCT02834975|76122672|FG000|Overall Study|Lack of Efficacy|1|||
42289508|NCT02684123|76122695|FG000|Phase 1|Lack of Efficacy|5|||
42355401|NCT01468701|76197983|FG008|Overall Study|Other reasons than listed|318|||
42355402|NCT01468701|76197984|FG009|Overall Study|Other reasons than listed|658|||
42041858|NCT00969150|75849474|FG000|Overall Study|Other reasons|1|||
42041859|NCT00969150|75849475|FG001|Overall Study|Other reasons|0|||
42041860|NCT00974220|75849483|FG000|Treatment Period 1|Adverse Event|2|||
42041861|NCT00974220|75849484|FG001|Treatment Period 1|Adverse Event|1|||
42041862|NCT00974220|75849483|FG000|Treatment Period 1|noncompliant subjects|0|||
42041863|NCT00974220|75849484|FG001|Treatment Period 1|noncompliant subjects|1|||
42041864|NCT00971178|75849493|FG000|Overall Study|Lost to Follow-up|2|||
42041865|NCT00971178|75849494|FG001|Overall Study|Lost to Follow-up|2|||
42041866|NCT00971178|75849495|FG002|Overall Study|Lost to Follow-up|2|||
42041867|NCT03670602|75849505|FG000|Overall Study|Lost to Follow-up|1|||
42041868|NCT03670602|75849506|FG001|Overall Study|Lost to Follow-up|0|||
42041869|NCT03670602|75849505|FG000|Overall Study|Withdrawal by Subject|0|||
42041870|NCT03670602|75849506|FG001|Overall Study|Withdrawal by Subject|3|||
42041871|NCT00968526|75849514|FG000|Overall Study|Adverse Event|2|||
42289509|NCT02684123|76122696|FG001|Phase 1|Lack of Efficacy|0|||
42289510|NCT02684123|76122695|FG000|Phase 1|Adverse Event|3|||
42289511|NCT02684123|76122696|FG001|Phase 1|Adverse Event|0|||
42041872|NCT00968526|75849515|FG001|Overall Study|Adverse Event|0|||
42041873|NCT00968526|75849514|FG000|Overall Study|Migrated/moved from study area|1|||
42041874|NCT00968526|75849515|FG001|Overall Study|Migrated/moved from study area|0|||
42041875|NCT03664674|75849532|FG000|Overall Study|Adverse Event|1|||
42041876|NCT03664674|75849533|FG001|Overall Study|Adverse Event|1|||
42041877|NCT03664674|75849532|FG000|Overall Study|Physician Decision|0|||
42041878|NCT03664674|75849533|FG001|Overall Study|Physician Decision|1|||
42041879|NCT03664674|75849532|FG000|Overall Study|Withdrawal by Subject|2|||
42041880|NCT03664674|75849533|FG001|Overall Study|Withdrawal by Subject|0|||
42041881|NCT00967668|75849544|FG000|Overall Study|Withdrawal by Subject|13|||
42041882|NCT00967668|75849545|FG001|Overall Study|Withdrawal by Subject|8|||
42041883|NCT00967668|75849546|FG002|Overall Study|Withdrawal by Subject|8|||
42041884|NCT00967668|75849544|FG000|Overall Study|Death|0|||
42041885|NCT00967668|75849545|FG001|Overall Study|Death|2|||
42041886|NCT00967668|75849546|FG002|Overall Study|Death|4|||
42041887|NCT00967668|75849544|FG000|Overall Study|Removed due to behavior|1|||
42041888|NCT00967668|75849545|FG001|Overall Study|Removed due to behavior|1|||
42041889|NCT00967668|75849546|FG002|Overall Study|Removed due to behavior|2|||
42041890|NCT00967668|75849544|FG000|Overall Study|Refused Year 2|11|||
42041891|NCT00967668|75849545|FG001|Overall Study|Refused Year 2|6|||
42041892|NCT00967668|75849546|FG002|Overall Study|Refused Year 2|4|||
42041893|NCT00967668|75849544|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
42041894|NCT00967668|75849545|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
42041895|NCT00967668|75849546|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
42041896|NCT00967668|75849544|FG000|Overall Study|Lost to Follow-up|15|||
42041897|NCT00967668|75849545|FG001|Overall Study|Lost to Follow-up|9|||
42041898|NCT00967668|75849546|FG002|Overall Study|Lost to Follow-up|16|||
42041899|NCT00967668|75849544|FG000|Overall Study|Refused 12-mo assessment|3|||
42041900|NCT00967668|75849545|FG001|Overall Study|Refused 12-mo assessment|1|||
42041901|NCT00967668|75849546|FG002|Overall Study|Refused 12-mo assessment|9|||
42289512|NCT02684123|76122695|FG000|Phase 1|Lost to Follow-up|0|||
42289513|NCT02684123|76122696|FG001|Phase 1|Lost to Follow-up|1|||
42289514|NCT02684123|76122695|FG000|Phase 2|Lack of Efficacy|1|||
42289515|NCT02684123|76122696|FG001|Phase 2|Lack of Efficacy|8|||
42289516|NCT02576574|76122717|FG000|Overall Study|still ongoing|65|||
42289517|NCT02576574|76122718|FG001|Overall Study|still ongoing|66|||
42289518|NCT02576574|76122719|FG002|Overall Study|still ongoing|73|||
42289519|NCT02576574|76122717|FG000|Overall Study|Randomized, not treated|5|||
42289520|NCT02576574|76122718|FG001|Overall Study|Randomized, not treated|4|||
42289521|NCT02576574|76122719|FG002|Overall Study|Randomized, not treated|26|||
42289522|NCT02203331|76122789|FG000|Overall Study|Pregnancy|1|||
42289523|NCT02203331|76122790|FG001|Overall Study|Pregnancy|0|||
42289524|NCT02203331|76122791|FG002|Overall Study|Pregnancy|0|||
42289525|NCT02203331|76122792|FG003|Overall Study|Pregnancy|0|||
42289526|NCT02203331|76122793|FG004|Overall Study|Pregnancy|2|||
42041902|NCT00967668|75849544|FG000|Overall Study|Pregnancy|1|||
42041903|NCT00967668|75849545|FG001|Overall Study|Pregnancy|0|||
42289527|NCT02203331|76122794|FG005|Overall Study|Pregnancy|0|||
42289528|NCT02203331|76122789|FG000|Overall Study|Withdrawal by Subject|1|||
42041904|NCT00967668|75849546|FG002|Overall Study|Pregnancy|0|||
42041905|NCT00970944|75849559|FG000|Overall Study|Death|1|||
42289529|NCT02203331|76122790|FG001|Overall Study|Withdrawal by Subject|0|||
42041906|NCT00970944|75849560|FG001|Overall Study|Death|0|||
42041907|NCT00970944|75849559|FG000|Overall Study|Physician Decision|0|||
42041908|NCT00970944|75849560|FG001|Overall Study|Physician Decision|2|||
42041909|NCT04892147|75849569|FG000|Overall Study|Withdrawal by Subject|2|||
42041910|NCT04892147|75849570|FG001|Overall Study|Withdrawal by Subject|0|||
42041911|NCT04839289|75849579|FG000|Overall Study|Withdrawal by Subject|1|||
42041912|NCT04839289|75849580|FG001|Overall Study|Withdrawal by Subject|0|||
42289530|NCT02203331|76122791|FG002|Overall Study|Withdrawal by Subject|1|||
42289531|NCT02203331|76122792|FG003|Overall Study|Withdrawal by Subject|0|||
42289532|NCT02203331|76122793|FG004|Overall Study|Withdrawal by Subject|0|||
42289533|NCT02203331|76122794|FG005|Overall Study|Withdrawal by Subject|3|||
42041913|NCT04544865|75849588|FG000|Overall Study|Death|0|||
42041914|NCT04544865|75849589|FG001|Overall Study|Death|2|||
42041915|NCT04544865|75849588|FG000|Overall Study|Lost to Follow-up|11|||
42041916|NCT04544865|75849589|FG001|Overall Study|Lost to Follow-up|7|||
42041917|NCT04544865|75849588|FG000|Overall Study|Withdrawal by Subject|0|||
42041918|NCT04544865|75849589|FG001|Overall Study|Withdrawal by Subject|1|||
42041919|NCT04544865|75849588|FG000|Overall Study|Other|0|||
42041920|NCT04544865|75849589|FG001|Overall Study|Other|1|||
42289534|NCT02203331|76122789|FG000|Overall Study|Adverse Event|4|||
42289535|NCT02203331|76122790|FG001|Overall Study|Adverse Event|8|||
42289536|NCT02203331|76122791|FG002|Overall Study|Adverse Event|3|||
42289537|NCT02203331|76122792|FG003|Overall Study|Adverse Event|4|||
42289538|NCT02203331|76122793|FG004|Overall Study|Adverse Event|3|||
42289539|NCT02203331|76122794|FG005|Overall Study|Adverse Event|3|||
42289540|NCT02203331|76122789|FG000|Overall Study|Other Reasons|1|||
42289541|NCT02203331|76122790|FG001|Overall Study|Other Reasons|2|||
42289542|NCT02203331|76122791|FG002|Overall Study|Other Reasons|0|||
42289543|NCT02203331|76122792|FG003|Overall Study|Other Reasons|2|||
42289544|NCT02203331|76122793|FG004|Overall Study|Other Reasons|0|||
42289545|NCT02203331|76122794|FG005|Overall Study|Other Reasons|0|||
42289546|NCT02203331|76122789|FG000|Overall Study|Lack of Efficacy|0|||
42289547|NCT02203331|76122790|FG001|Overall Study|Lack of Efficacy|2|||
42289548|NCT02203331|76122791|FG002|Overall Study|Lack of Efficacy|1|||
42289549|NCT02203331|76122792|FG003|Overall Study|Lack of Efficacy|0|||
42289550|NCT02203331|76122793|FG004|Overall Study|Lack of Efficacy|0|||
42289551|NCT02203331|76122794|FG005|Overall Study|Lack of Efficacy|1|||
42289552|NCT02203331|76122789|FG000|Overall Study|Protocol Violation|0|||
42289553|NCT02203331|76122790|FG001|Overall Study|Protocol Violation|2|||
42289554|NCT02203331|76122791|FG002|Overall Study|Protocol Violation|0|||
42289555|NCT02203331|76122792|FG003|Overall Study|Protocol Violation|1|||
42289556|NCT02203331|76122793|FG004|Overall Study|Protocol Violation|1|||
42289557|NCT02203331|76122794|FG005|Overall Study|Protocol Violation|0|||
42289558|NCT02203331|76122789|FG000|Overall Study|Lost to Follow-up|0|||
42289559|NCT02203331|76122790|FG001|Overall Study|Lost to Follow-up|0|||
42289560|NCT02203331|76122791|FG002|Overall Study|Lost to Follow-up|0|||
42289561|NCT02203331|76122792|FG003|Overall Study|Lost to Follow-up|0|||
42289562|NCT02203331|76122793|FG004|Overall Study|Lost to Follow-up|1|||
42289563|NCT02203331|76122794|FG005|Overall Study|Lost to Follow-up|0|||
42289564|NCT02170025|76122823|FG000|Overall Study|Adverse Event|2|||
42289565|NCT02170025|76122824|FG001|Overall Study|Adverse Event|0|||
42289566|NCT02164578|76122832|FG000|Treatment Period|Withdrawal by Subject|3|||
42289567|NCT02164578|76122833|FG001|Treatment Period|Withdrawal by Subject|3|||
42289568|NCT02164578|76122832|FG000|Treatment Period|Adverse Event|13|||
42289569|NCT02164578|76122833|FG001|Treatment Period|Adverse Event|6|||
42289570|NCT02164578|76122832|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
42289571|NCT02164578|76122833|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
42289572|NCT02164578|76122832|FG000|Treatment Period|Protocol Violation|0|||
42289573|NCT02164578|76122833|FG001|Treatment Period|Protocol Violation|2|||
42289574|NCT02164578|76122832|FG000|Extension Period|Withdrawal by Subject|2|||
42289575|NCT02164578|76122833|FG001|Extension Period|Withdrawal by Subject|0|||
42289576|NCT02164578|76122832|FG000|Extension Period|Adverse Event|4|||
42041921|NCT04440813|75849598|FG000|Overall Study|Lost to Follow-up|5|||
42041922|NCT04440813|75849599|FG001|Overall Study|Lost to Follow-up|5|||
42041923|NCT04233073|75849613|FG000|Overall Study|Death|5|||
42041924|NCT04120116|75849621|FG000|Overall Study|Lost to Follow-up|0|||
42041925|NCT04120116|75849622|FG001|Overall Study|Lost to Follow-up|1|||
42041926|NCT04120116|75849623|FG002|Overall Study|Lost to Follow-up|0|||
42041927|NCT04120116|75849624|FG003|Overall Study|Lost to Follow-up|2|||
42289577|NCT02164578|76122833|FG001|Extension Period|Adverse Event|0|||
42041928|NCT04120116|75849621|FG000|Overall Study|Withdrawal by Subject|1|||
42289578|NCT02164578|76122832|FG000|Extension Period|Expiry of study medication|1|||
42289579|NCT02164578|76122833|FG001|Extension Period|Expiry of study medication|0|||
42289580|NCT02164578|76122832|FG000|Extension Period|Protocol Violation|0|||
42041929|NCT04120116|75849622|FG001|Overall Study|Withdrawal by Subject|0|||
42041930|NCT04120116|75849623|FG002|Overall Study|Withdrawal by Subject|1|||
42041931|NCT04120116|75849624|FG003|Overall Study|Withdrawal by Subject|1|||
42172204|NCT03345472|75978988|FG000|3 Months to 12 Months|Death|1|||
42289581|NCT02164578|76122833|FG001|Extension Period|Protocol Violation|1|||
42015943|NCT01283516|75823090|FG007|Overall Study|Administrative problems|1|||
42015944|NCT01283516|75823091|FG008|Overall Study|Administrative problems|39|||
42041932|NCT04120116|75849621|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
42041933|NCT04120116|75849622|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
42041934|NCT04120116|75849623|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
42041935|NCT04120116|75849624|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
42355403|NCT01468701|76197985|FG010|Overall Study|Other reasons than listed|433|||
42355404|NCT01468701|76197986|FG011|Overall Study|Other reasons than listed|504|||
42355405|NCT01468701|76197987|FG012|Overall Study|Other reasons than listed|28|||
42355406|NCT01468701|76197988|FG013|Overall Study|Other reasons than listed|239|||
42355407|NCT01468701|76197989|FG014|Overall Study|Other reasons than listed|39|||
42355408|NCT01468701|76197990|FG015|Overall Study|Other reasons than listed|172|||
42355409|NCT01468701|76197991|FG016|Overall Study|Other reasons than listed|0|||
42355410|NCT01468701|76197975|FG000|Overall Study|No end of study case report form|0|||
42355411|NCT01468701|76197976|FG001|Overall Study|No end of study case report form|0|||
42355412|NCT01468701|76197977|FG002|Overall Study|No end of study case report form|0|||
42355413|NCT01468701|76197978|FG003|Overall Study|No end of study case report form|0|||
42355414|NCT01468701|76197979|FG004|Overall Study|No end of study case report form|0|||
42355415|NCT01468701|76197980|FG005|Overall Study|No end of study case report form|0|||
42355416|NCT01468701|76197981|FG006|Overall Study|No end of study case report form|0|||
42355417|NCT01468701|76197982|FG007|Overall Study|No end of study case report form|0|||
42355418|NCT01468701|76197983|FG008|Overall Study|No end of study case report form|4|||
42355419|NCT01468701|76197984|FG009|Overall Study|No end of study case report form|1|||
42355420|NCT01468701|76197985|FG010|Overall Study|No end of study case report form|2|||
42355421|NCT01468701|76197986|FG011|Overall Study|No end of study case report form|3|||
42355422|NCT01468701|76197987|FG012|Overall Study|No end of study case report form|0|||
42355423|NCT01468701|76197988|FG013|Overall Study|No end of study case report form|1|||
42041936|NCT03657810|75849647|FG000|Overall Study|Adverse Event|0|||
42041937|NCT03657810|75849648|FG001|Overall Study|Adverse Event|1|||
42041938|NCT03657810|75849649|FG002|Overall Study|Adverse Event|0|||
42041939|NCT03657810|75849647|FG000|Overall Study|Lack of Efficacy|4|||
42041940|NCT03657810|75849648|FG001|Overall Study|Lack of Efficacy|1|||
42041941|NCT03657810|75849649|FG002|Overall Study|Lack of Efficacy|3|||
42041942|NCT03657810|75849647|FG000|Overall Study|Protocol Violation|1|||
42041943|NCT03657810|75849648|FG001|Overall Study|Protocol Violation|0|||
42041944|NCT03657810|75849649|FG002|Overall Study|Protocol Violation|0|||
42041945|NCT03657810|75849647|FG000|Overall Study|Lost to Follow-up|0|||
42041946|NCT03657810|75849648|FG001|Overall Study|Lost to Follow-up|1|||
42041947|NCT03657810|75849649|FG002|Overall Study|Lost to Follow-up|0|||
42041948|NCT03657810|75849647|FG000|Overall Study|Not provided|0|||
42041949|NCT03657810|75849648|FG001|Overall Study|Not provided|1|||
42041950|NCT03657810|75849649|FG002|Overall Study|Not provided|0|||
42041951|NCT03370341|75849671|FG000|Overall Study|Lost to Follow-up|0|||
42041952|NCT03370341|75849672|FG001|Overall Study|Lost to Follow-up|1|||
42041953|NCT02544074|75849741|FG000|Overall Study|Withdrawal by Subject|0|||
42355424|NCT01468701|76197989|FG014|Overall Study|No end of study case report form|0|||
42355425|NCT01468701|76197990|FG015|Overall Study|No end of study case report form|0|||
42355426|NCT01468701|76197991|FG016|Overall Study|No end of study case report form|0|||
42015945|NCT01283516|75823083|FG000|Overall Study|Lost to Follow-up|0|||
42015946|NCT01283516|75823084|FG001|Overall Study|Lost to Follow-up|0|||
42015947|NCT01283516|75823085|FG002|Overall Study|Lost to Follow-up|0|||
42015948|NCT01283516|75823086|FG003|Overall Study|Lost to Follow-up|0|||
42015949|NCT01283516|75823087|FG004|Overall Study|Lost to Follow-up|0|||
42015950|NCT01283516|75823088|FG005|Overall Study|Lost to Follow-up|0|||
42015951|NCT01283516|75823089|FG006|Overall Study|Lost to Follow-up|0|||
42015952|NCT01283516|75823090|FG007|Overall Study|Lost to Follow-up|0|||
42015953|NCT01283516|75823091|FG008|Overall Study|Lost to Follow-up|1|||
42015954|NCT01137435|75823119|FG000|Overall Study|Lost to Follow-up|24|||
42015955|NCT01137435|75823119|FG000|Overall Study|Off label usage|4|||
42015956|NCT01283282|75823123|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
42015957|NCT01283282|75823124|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
42015958|NCT01283282|75823123|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
42015959|NCT01283282|75823124|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
42015960|NCT01283282|75823123|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
42015961|NCT01283282|75823124|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
42041954|NCT02544074|75849742|FG001|Overall Study|Withdrawal by Subject|1|||
42041955|NCT02544074|75849743|FG002|Overall Study|Withdrawal by Subject|0|||
42041956|NCT02544074|75849744|FG003|Overall Study|Withdrawal by Subject|0|||
42041957|NCT02544074|75849745|FG004|Overall Study|Withdrawal by Subject|0|||
42041958|NCT02544074|75849746|FG005|Overall Study|Withdrawal by Subject|0|||
42041959|NCT02544074|75849747|FG006|Overall Study|Withdrawal by Subject|0|||
42041960|NCT02544074|75849748|FG007|Overall Study|Withdrawal by Subject|0|||
42041961|NCT02544074|75849749|FG008|Overall Study|Withdrawal by Subject|0|||
42041962|NCT02544074|75849750|FG009|Overall Study|Withdrawal by Subject|0|||
42041963|NCT02544074|75849751|FG010|Overall Study|Withdrawal by Subject|0|||
42041964|NCT02544074|75849752|FG011|Overall Study|Withdrawal by Subject|0|||
42041965|NCT02544074|75849753|FG012|Overall Study|Withdrawal by Subject|0|||
42041966|NCT02544074|75849754|FG013|Overall Study|Withdrawal by Subject|0|||
42041967|NCT02544074|75849755|FG014|Overall Study|Withdrawal by Subject|0|||
42041968|NCT02544074|75849756|FG015|Overall Study|Withdrawal by Subject|0|||
42041969|NCT02544074|75849757|FG016|Overall Study|Withdrawal by Subject|0|||
42041970|NCT02544074|75849758|FG017|Overall Study|Withdrawal by Subject|0|||
42041971|NCT02544074|75849759|FG018|Overall Study|Withdrawal by Subject|0|||
42355427|NCT01468701|76197975|FG000|Overall Study|Not being followed up|0|||
42355428|NCT01468701|76197976|FG001|Overall Study|Not being followed up|4963|||
42355429|NCT01468701|76197977|FG002|Overall Study|Not being followed up|1755|||
42355430|NCT01468701|76197978|FG003|Overall Study|Not being followed up|703|||
42355431|NCT01468701|76197979|FG004|Overall Study|Not being followed up|1714|||
42355432|NCT01468701|76197980|FG005|Overall Study|Not being followed up|126|||
42355433|NCT01468701|76197981|FG006|Overall Study|Not being followed up|1170|||
42355434|NCT01468701|76197982|FG007|Overall Study|Not being followed up|4|||
42355435|NCT01468701|76197983|FG008|Overall Study|Not being followed up|0|||
42355436|NCT01468701|76197984|FG009|Overall Study|Not being followed up|0|||
42355437|NCT01468701|76197985|FG010|Overall Study|Not being followed up|0|||
42355438|NCT01468701|76197986|FG011|Overall Study|Not being followed up|0|||
42355439|NCT01468701|76197987|FG012|Overall Study|Not being followed up|0|||
42355440|NCT01468701|76197988|FG013|Overall Study|Not being followed up|0|||
42355441|NCT01468701|76197989|FG014|Overall Study|Not being followed up|0|||
42355442|NCT01468701|76197990|FG015|Overall Study|Not being followed up|0|||
42355443|NCT01468701|76197991|FG016|Overall Study|Not being followed up|0|||
42355444|NCT01492101|76198006|FG000|Overall Study|Death|323|||
42355445|NCT01492101|76198007|FG001|Overall Study|Death|322|||
42355446|NCT01492101|76198006|FG000|Overall Study|Withdrawal by Subject|14|||
42041972|NCT02544074|75849760|FG019|Overall Study|Withdrawal by Subject|0|||
42041973|NCT02544074|75849761|FG020|Overall Study|Withdrawal by Subject|0|||
42041974|NCT02544074|75849741|FG000|Overall Study|Tablet error|0|||
42041975|NCT02544074|75849742|FG001|Overall Study|Tablet error|0|||
42041976|NCT02544074|75849743|FG002|Overall Study|Tablet error|0|||
42041977|NCT02544074|75849744|FG003|Overall Study|Tablet error|0|||
42172205|NCT00349349|75978995|FG000|Overall Study|Adverse Event|5|||
42172206|NCT00349349|75978996|FG001|Overall Study|Adverse Event|6|||
42172207|NCT00349349|75978997|FG002|Overall Study|Adverse Event|2|||
42172208|NCT00349349|75978995|FG000|Overall Study|Withdrawal by Subject|5|||
42172209|NCT00349349|75978996|FG001|Overall Study|Withdrawal by Subject|2|||
42172210|NCT00349349|75978997|FG002|Overall Study|Withdrawal by Subject|1|||
42172211|NCT00349349|75978995|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
42172212|NCT00349349|75978996|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
42172213|NCT00349349|75978997|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
42172214|NCT00349349|75978995|FG000|Overall Study|Death|13|||
42172215|NCT00349349|75978996|FG001|Overall Study|Death|10|||
42289582|NCT02107703|76122841|FG000|Overall Study|Withdrawal by Subject|46|||
42289583|NCT02107703|76122842|FG001|Overall Study|Withdrawal by Subject|21|||
42289584|NCT02107703|76122841|FG000|Overall Study|Lost to Follow-up|20|||
42289585|NCT02107703|76122842|FG001|Overall Study|Lost to Follow-up|9|||
42289586|NCT02107703|76122841|FG000|Overall Study|On study treatment/follow up|48|||
42289587|NCT02107703|76122842|FG001|Overall Study|On study treatment/follow up|5|||
42289588|NCT02029443|76122866|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
42289589|NCT02029443|76122867|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
42289590|NCT02029443|76122868|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
42355447|NCT01492101|76198007|FG001|Overall Study|Withdrawal by Subject|18|||
42355448|NCT01492101|76198006|FG000|Overall Study|Lost to Follow-up|0|||
42355449|NCT01492101|76198007|FG001|Overall Study|Lost to Follow-up|2|||
42172216|NCT00349349|75978997|FG002|Overall Study|Death|1|||
42172217|NCT00349349|75978995|FG000|Overall Study|Other Treatment Selected|2|||
42172218|NCT00349349|75978996|FG001|Overall Study|Other Treatment Selected|0|||
42172219|NCT00349349|75978997|FG002|Overall Study|Other Treatment Selected|0|||
42172220|NCT00349349|75978995|FG000|Overall Study|Participant Reduced General Condition|0|||
42172221|NCT00349349|75978996|FG001|Overall Study|Participant Reduced General Condition|1|||
42172222|NCT00349349|75978997|FG002|Overall Study|Participant Reduced General Condition|0|||
42355450|NCT01468311|76198013|FG000|Overall Study|mobilization failure|1|||
42172223|NCT00349349|75978995|FG000|Overall Study|Physician Decision|1|||
42172224|NCT00349349|75978996|FG001|Overall Study|Physician Decision|2|||
42172225|NCT00349349|75978997|FG002|Overall Study|Physician Decision|1|||
42172226|NCT00349349|75978995|FG000|Overall Study|No Response|0|||
42172227|NCT00349349|75978996|FG001|Overall Study|No Response|3|||
42172228|NCT00349349|75978997|FG002|Overall Study|No Response|0|||
42355451|NCT01468311|76198013|FG000|Overall Study|Withdrawal by Subject|1|||
42355452|NCT01730534|76198124|FG000|Overall Study|Withdrawal by Subject|97|||
42355453|NCT01730534|76198125|FG001|Overall Study|Withdrawal by Subject|127|||
42355454|NCT01730534|76198124|FG000|Overall Study|Lost to Follow-up|12|||
42355455|NCT01730534|76198125|FG001|Overall Study|Lost to Follow-up|18|||
42355456|NCT01783730|76198145|FG000|Overall Study|Failed to meet inclusion criteria|6|||
42355457|NCT01730378|76198151|FG000|Overall Study|Lost to Follow-up|1|||
42355458|NCT01730378|76198152|FG001|Overall Study|Lost to Follow-up|0|||
42355459|NCT01783496|76198165|FG000|Overall Study|Lost to Follow-up|0|||
42172229|NCT00349349|75978995|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
42172230|NCT00349349|75978996|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
42172231|NCT00349349|75978997|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
42172232|NCT02950480|75979009|FG000|Overall Study|Withdrawal by Subject|1|||
42172233|NCT02950480|75979010|FG001|Overall Study|Withdrawal by Subject|0|||
42172234|NCT00348881|75979018|FG000|Overall Study|Lost to Follow-up|12|||
42172235|NCT00348881|75979019|FG001|Overall Study|Lost to Follow-up|6|||
42172236|NCT00348881|75979018|FG000|Overall Study|Withdrawal by Subject|3|||
42172237|NCT00348881|75979019|FG001|Overall Study|Withdrawal by Subject|4|||
42172238|NCT00348881|75979018|FG000|Overall Study|Adverse Event|2|||
42172239|NCT00348881|75979019|FG001|Overall Study|Adverse Event|0|||
42172240|NCT00348881|75979018|FG000|Overall Study|Serious Adverse Event|0|||
42172241|NCT00348881|75979019|FG001|Overall Study|Serious Adverse Event|2|||
42172242|NCT03376516|75979029|FG000|Overall Study|Not treated|1|||
42289591|NCT02029443|76122869|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
42289592|NCT02029443|76122870|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
42289593|NCT02029443|76122866|FG000|Overall Study|Death|13|||
42289594|NCT02029443|76122867|FG001|Overall Study|Death|2|||
42289595|NCT02029443|76122868|FG002|Overall Study|Death|2|||
42289596|NCT02029443|76122869|FG003|Overall Study|Death|11|||
42289597|NCT02029443|76122870|FG004|Overall Study|Death|2|||
42289598|NCT02029443|76122866|FG000|Overall Study|Lost to Follow-up|1|||
42289599|NCT02029443|76122867|FG001|Overall Study|Lost to Follow-up|0|||
42289600|NCT02029443|76122868|FG002|Overall Study|Lost to Follow-up|1|||
42355460|NCT01783496|76198166|FG001|Overall Study|Lost to Follow-up|0|||
42355461|NCT01783496|76198167|FG002|Overall Study|Lost to Follow-up|0|||
42355462|NCT01783496|76198168|FG003|Overall Study|Lost to Follow-up|2|||
42355463|NCT01783496|76198169|FG004|Overall Study|Lost to Follow-up|0|||
42355464|NCT01783496|76198170|FG005|Overall Study|Lost to Follow-up|1|||
42355465|NCT01783496|76198165|FG000|Overall Study|Withdrawal by Subject|1|||
42355466|NCT01783496|76198166|FG001|Overall Study|Withdrawal by Subject|0|||
42355467|NCT01783496|76198167|FG002|Overall Study|Withdrawal by Subject|0|||
42172243|NCT03376516|75979029|FG000|Overall Study|Consent withdrawn|1|||
42172244|NCT03797144|75979055|FG000|Enrollment|Protocol Violation|4|||
42172245|NCT03797144|75979056|FG001|Enrollment|Protocol Violation|1|||
42172246|NCT03797144|75979055|FG000|Surgery|Protocol Violation|1|||
42289601|NCT02029443|76122869|FG003|Overall Study|Lost to Follow-up|1|||
42355468|NCT01783496|76198168|FG003|Overall Study|Withdrawal by Subject|0|||
42355469|NCT01783496|76198169|FG004|Overall Study|Withdrawal by Subject|0|||
42355470|NCT01783496|76198170|FG005|Overall Study|Withdrawal by Subject|0|||
42355471|NCT01729208|76198195|FG000|Baseline|Physician Decision|5|||
42355472|NCT01729208|76198196|FG001|Baseline|Physician Decision|4|||
42355473|NCT01729208|76198195|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
42355474|NCT01729208|76198196|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
42355475|NCT01729208|76198195|FG000|12 Months Follow-up|Lost to Follow-up|3|||
42355476|NCT01729208|76198196|FG001|12 Months Follow-up|Lost to Follow-up|3|||
42355477|NCT01729208|76198195|FG000|24 Months Follow-up|Lost to Follow-up|3|||
42355478|NCT01729208|76198196|FG001|24 Months Follow-up|Lost to Follow-up|0|||
42355479|NCT01729208|76198195|FG000|36 Months Follow-up|Physician Decision|1|||
42355480|NCT01729208|76198196|FG001|36 Months Follow-up|Physician Decision|0|||
42355481|NCT01729208|76198195|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
42355482|NCT01729208|76198196|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
42355483|NCT01609010|76198213|FG000|Overall Study|Stable disease (SD)|22|||
42355484|NCT01609010|76198214|FG001|Overall Study|Stable disease (SD)|16|||
42355485|NCT01609010|76198213|FG000|Overall Study|Progressive disease (PD)|8|||
42355486|NCT01609010|76198214|FG001|Overall Study|Progressive disease (PD)|10|||
42355487|NCT01609010|76198213|FG000|Overall Study|Adverse Event|3|||
42355488|NCT01609010|76198214|FG001|Overall Study|Adverse Event|6|||
42355489|NCT01609010|76198213|FG000|Overall Study|Withdrawal by Subject|2|||
42355490|NCT01609010|76198214|FG001|Overall Study|Withdrawal by Subject|2|||
42355491|NCT01609010|76198213|FG000|Overall Study|Other|2|||
42355492|NCT01609010|76198214|FG001|Overall Study|Other|0|||
42355493|NCT01609010|76198213|FG000|Overall Study|Other malignancy|1|||
42355494|NCT01609010|76198214|FG001|Overall Study|Other malignancy|0|||
42355495|NCT01609010|76198213|FG000|Overall Study|Pathology review|2|||
42355496|NCT01609010|76198214|FG001|Overall Study|Pathology review|1|||
42355497|NCT01609010|76198213|FG000|Overall Study|Protocol Violation|1|||
42355498|NCT01609010|76198214|FG001|Overall Study|Protocol Violation|1|||
42355499|NCT01609010|76198213|FG000|Overall Study|New cancer|1|||
42355500|NCT01609010|76198214|FG001|Overall Study|New cancer|0|||
42355501|NCT01609010|76198213|FG000|Overall Study|Lost to Follow-up|1|||
42355502|NCT01609010|76198214|FG001|Overall Study|Lost to Follow-up|1|||
42355503|NCT01608308|76198222|FG000|Overall Study|pretreatment medical and billing reasons|0|||
42355504|NCT01608308|76198223|FG001|Overall Study|pretreatment medical and billing reasons|2|||
42355505|NCT01755416|76198254|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
42355506|NCT01755416|76198255|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
42355507|NCT01755026|76198263|FG000|Overall Study|Adverse Event|1|||
42355508|NCT01755026|76198264|FG001|Overall Study|Adverse Event|0|||
42355509|NCT01755026|76198263|FG000|Overall Study|Withdrawal by Subject|1|||
42355510|NCT01755026|76198264|FG001|Overall Study|Withdrawal by Subject|1|||
42355511|NCT01491945|76198279|FG000|Overall Study|Death|30|||
42355512|NCT01491945|76198279|FG000|Overall Study|Withdrwan/LTF|16|||
42355513|NCT01491945|76198279|FG000|Overall Study|Conversion|4|||
42355514|NCT01491945|76198279|FG000|Overall Study|Missed Visit|1|||
42355515|NCT01728584|76198301|FG000|Overall Study|Adverse Event|1|||
42355516|NCT01728584|76198302|FG001|Overall Study|Adverse Event|0|||
42355517|NCT01728584|76198303|FG002|Overall Study|Adverse Event|0|||
42355518|NCT01728584|76198304|FG003|Overall Study|Adverse Event|0|||
42172247|NCT03797144|75979056|FG001|Surgery|Protocol Violation|0|||
42172248|NCT03797144|75979055|FG000|3 Month|Early termination cut-off date|2|||
42172249|NCT03797144|75979056|FG001|3 Month|Early termination cut-off date|0|||
42172250|NCT03797144|75979055|FG000|12 Month|Early termination cut-off date|8|||
42289602|NCT02029443|76122870|FG004|Overall Study|Lost to Follow-up|0|||
42289603|NCT02029443|76122866|FG000|Overall Study|Started other anti-cancer therapy|17|||
42289604|NCT02029443|76122867|FG001|Overall Study|Started other anti-cancer therapy|4|||
42289605|NCT02029443|76122868|FG002|Overall Study|Started other anti-cancer therapy|7|||
42289606|NCT02029443|76122869|FG003|Overall Study|Started other anti-cancer therapy|9|||
42289607|NCT02029443|76122870|FG004|Overall Study|Started other anti-cancer therapy|3|||
42289608|NCT02029443|76122866|FG000|Overall Study|Withdrawal by Subject|3|||
42355519|NCT01728584|76198301|FG000|Overall Study|Physician Decision|4|||
42355520|NCT01728584|76198302|FG001|Overall Study|Physician Decision|0|||
42289609|NCT02029443|76122867|FG001|Overall Study|Withdrawal by Subject|1|||
42289610|NCT02029443|76122868|FG002|Overall Study|Withdrawal by Subject|1|||
42289611|NCT02029443|76122869|FG003|Overall Study|Withdrawal by Subject|1|||
42289612|NCT02029443|76122870|FG004|Overall Study|Withdrawal by Subject|0|||
42289613|NCT02029443|76122866|FG000|Overall Study|Other|6|||
42355521|NCT01728584|76198303|FG002|Overall Study|Physician Decision|1|||
42355522|NCT01728584|76198304|FG003|Overall Study|Physician Decision|0|||
42355523|NCT01728584|76198301|FG000|Overall Study|Withdrawal by Subject|1|||
42355524|NCT01728584|76198302|FG001|Overall Study|Withdrawal by Subject|0|||
42355525|NCT01728584|76198303|FG002|Overall Study|Withdrawal by Subject|0|||
42355526|NCT01728584|76198304|FG003|Overall Study|Withdrawal by Subject|0|||
42355527|NCT01728584|76198301|FG000|Overall Study|Screen failure|1|||
42355528|NCT01728584|76198302|FG001|Overall Study|Screen failure|0|||
42355529|NCT01728584|76198303|FG002|Overall Study|Screen failure|0|||
42355530|NCT01728584|76198304|FG003|Overall Study|Screen failure|0|||
42015962|NCT01282814|75823133|FG000|First Intervention|Emesis During Dosing Interval|0|||
42015963|NCT01282814|75823134|FG001|First Intervention|Emesis During Dosing Interval|3|||
42015964|NCT01282814|75823133|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
42015965|NCT01282814|75823134|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
42041978|NCT02544074|75849745|FG004|Overall Study|Tablet error|0|||
42015966|NCT00941863|75823145|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
42041979|NCT02544074|75849746|FG005|Overall Study|Tablet error|1|||
42041980|NCT02544074|75849747|FG006|Overall Study|Tablet error|0|||
42041981|NCT02544074|75849748|FG007|Overall Study|Tablet error|0|||
42041982|NCT02544074|75849749|FG008|Overall Study|Tablet error|0|||
42041983|NCT02544074|75849750|FG009|Overall Study|Tablet error|1|||
42041984|NCT02544074|75849751|FG010|Overall Study|Tablet error|0|||
42289614|NCT02029443|76122867|FG001|Overall Study|Other|6|||
42289615|NCT02029443|76122868|FG002|Overall Study|Other|4|||
42289616|NCT02029443|76122869|FG003|Overall Study|Other|2|||
42289617|NCT02029443|76122870|FG004|Overall Study|Other|0|||
42289618|NCT01823198|76122911|FG000|Overall Study|Physician Decision|0|||
42289619|NCT01823198|76122912|FG001|Overall Study|Physician Decision|1|||
42289620|NCT01823198|76122913|FG002|Overall Study|Physician Decision|0|||
42289621|NCT01823198|76122914|FG003|Overall Study|Physician Decision|0|||
42289622|NCT01823198|76122915|FG004|Overall Study|Physician Decision|0|||
42172251|NCT03797144|75979056|FG001|12 Month|Early termination cut-off date|9|||
42289623|NCT01823198|76122916|FG005|Overall Study|Physician Decision|3|||
42289624|NCT01823198|76122917|FG006|Overall Study|Physician Decision|3|||
42041985|NCT02544074|75849752|FG011|Overall Study|Tablet error|0|||
42355531|NCT01728584|76198301|FG000|Overall Study|Other reason (not specified)|1|||
42289625|NCT01761292|76122935|FG000|Part 1|Adverse Event|1|||
42289626|NCT01761292|76122935|FG000|Part 1|not receiving treatment in Part 1|1|||
42355532|NCT01728584|76198302|FG001|Overall Study|Other reason (not specified)|0|||
42041986|NCT02544074|75849753|FG012|Overall Study|Tablet error|0|||
42041987|NCT02544074|75849754|FG013|Overall Study|Tablet error|0|||
42041988|NCT02544074|75849755|FG014|Overall Study|Tablet error|0|||
42041989|NCT02544074|75849756|FG015|Overall Study|Tablet error|0|||
42041990|NCT02544074|75849757|FG016|Overall Study|Tablet error|0|||
42041991|NCT02544074|75849758|FG017|Overall Study|Tablet error|0|||
42041992|NCT02544074|75849759|FG018|Overall Study|Tablet error|0|||
42041993|NCT02544074|75849760|FG019|Overall Study|Tablet error|0|||
42041994|NCT02544074|75849761|FG020|Overall Study|Tablet error|0|||
42041995|NCT02502799|75849799|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
42041996|NCT02502799|75849800|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
42041997|NCT02502799|75849801|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
42041998|NCT02502799|75849802|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
42041999|NCT02502799|75849799|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
42042000|NCT02502799|75849800|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
42042001|NCT02502799|75849801|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
42042002|NCT02502799|75849802|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
42042003|NCT02502799|75849799|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
42042004|NCT02502799|75849800|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
42042005|NCT02502799|75849801|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
42042006|NCT02502799|75849802|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
42042007|NCT02502799|75849799|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
42042008|NCT02502799|75849800|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
42042009|NCT02502799|75849801|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
42042010|NCT02502799|75849802|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
42042011|NCT02502799|75849799|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
42042012|NCT02502799|75849800|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
42042013|NCT02502799|75849801|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
42042014|NCT02502799|75849802|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
42042015|NCT02086448|75849815|FG000|Overall Study|Withdrawal by Subject|1|||
42042016|NCT02086448|75849816|FG001|Overall Study|Withdrawal by Subject|0|||
42042017|NCT02086448|75849817|FG002|Overall Study|Withdrawal by Subject|0|||
42042018|NCT02086448|75849818|FG003|Overall Study|Withdrawal by Subject|2|||
42042019|NCT01993836|75849831|FG000|Overall Study|Surgery Cancelled|3|||
42042020|NCT01993836|75849832|FG001|Overall Study|Surgery Cancelled|0|||
42042021|NCT01993836|75849833|FG002|Overall Study|Surgery Cancelled|0|||
42042022|NCT01993836|75849831|FG000|Overall Study|Physician Decision|2|||
42042023|NCT01993836|75849832|FG001|Overall Study|Physician Decision|1|||
42042024|NCT01993836|75849833|FG002|Overall Study|Physician Decision|0|||
42042025|NCT01993836|75849831|FG000|Overall Study|Death|0|||
42042026|NCT01993836|75849832|FG001|Overall Study|Death|2|||
42042027|NCT01993836|75849833|FG002|Overall Study|Death|0|||
42042028|NCT01993836|75849831|FG000|Overall Study|Withdrawal by Subject|12|||
42042029|NCT01993836|75849832|FG001|Overall Study|Withdrawal by Subject|10|||
42042030|NCT01993836|75849833|FG002|Overall Study|Withdrawal by Subject|5|||
42042031|NCT00753545|75849848|FG000|Overall Study|Death|98|||
42042032|NCT00753545|75849849|FG001|Overall Study|Death|112|||
42042033|NCT00753545|75849848|FG000|Overall Study|Lost to Follow-up|2|||
42042034|NCT00753545|75849849|FG001|Overall Study|Lost to Follow-up|3|||
42042035|NCT00753545|75849848|FG000|Overall Study|Protocol Violation|1|||
42042036|NCT00753545|75849849|FG001|Overall Study|Protocol Violation|0|||
42042037|NCT00753545|75849848|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
42042038|NCT00753545|75849849|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
42042039|NCT00278915|75849864|FG000|Overall Study|Lack of Efficacy|1|||
42042040|NCT00970632|75849871|FG000|Overall Study|Adverse Event|2|||
42042041|NCT00970632|75849872|FG001|Overall Study|Adverse Event|2|||
42042042|NCT00970632|75849873|FG002|Overall Study|Adverse Event|1|||
42042043|NCT00970632|75849871|FG000|Overall Study|Lack of Efficacy|3|||
42289627|NCT01761292|76122935|FG000|Extension 1|Withdrawal by Subject|1|||
42289628|NCT01725113|76122946|FG000|Overall Study|Kidney Transplant|1|||
42289629|NCT01725113|76122947|FG001|Overall Study|Kidney Transplant|1|||
42289630|NCT01725113|76122946|FG000|Overall Study|Withdrawal by Subject|0|||
42289631|NCT01725113|76122947|FG001|Overall Study|Withdrawal by Subject|1|||
42289632|NCT01580293|76122960|FG000|Part A_Main Trial|Adverse Event|0|||
42289633|NCT01580293|76122961|FG001|Part A_Main Trial|Adverse Event|2|||
42289634|NCT01580293|76122962|FG002|Part A_Main Trial|Adverse Event|0|||
42289635|NCT01580293|76122960|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
42289636|NCT01580293|76122961|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
42289637|NCT01580293|76122962|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
42289638|NCT01580293|76122960|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
42289639|NCT01580293|76122961|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
42289640|NCT01580293|76122962|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
42289641|NCT01580293|76122960|FG000|Part A_Extension|Adverse Event|0|||
42289642|NCT01580293|76122961|FG001|Part A_Extension|Adverse Event|2|||
42289643|NCT01580293|76122962|FG002|Part A_Extension|Adverse Event|0|||
42289644|NCT01580293|76122960|FG000|Part A_Extension|Withdrawal by Subject|0|||
42289645|NCT01580293|76122961|FG001|Part A_Extension|Withdrawal by Subject|3|||
42289646|NCT01580293|76122962|FG002|Part A_Extension|Withdrawal by Subject|0|||
42289647|NCT01580293|76122960|FG000|Part A_Extension|Lost to Follow-up|0|||
42289648|NCT01580293|76122961|FG001|Part A_Extension|Lost to Follow-up|1|||
42289649|NCT01580293|76122962|FG002|Part A_Extension|Lost to Follow-up|0|||
42289650|NCT01580293|76122960|FG000|Part A_Extension|Other Reason|0|||
42289651|NCT01580293|76122961|FG001|Part A_Extension|Other Reason|1|||
42289652|NCT01580293|76122962|FG002|Part A_Extension|Other Reason|0|||
42289653|NCT01580293|76122960|FG000|Part A_Extension|Completed Japan only|0|||
42289654|NCT01580293|76122961|FG001|Part A_Extension|Completed Japan only|5|||
42289655|NCT01580293|76122962|FG002|Part A_Extension|Completed Japan only|0|||
42289656|NCT01580293|76122960|FG000|Part B|Withdrawal by Subject|0|||
42289657|NCT01580293|76122961|FG001|Part B|Withdrawal by Subject|0|||
42289658|NCT01580293|76122962|FG002|Part B|Withdrawal by Subject|1|||
42289659|NCT01580293|76122960|FG000|Part B|Other reason|0|||
42289660|NCT01580293|76122961|FG001|Part B|Other reason|0|||
42355533|NCT01728584|76198303|FG002|Overall Study|Other reason (not specified)|0|||
42015967|NCT00941863|75823146|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
42015968|NCT00941863|75823147|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
42289661|NCT01580293|76122962|FG002|Part B|Other reason|1|||
42289662|NCT01960348|76123015|FG000|Overall Study|Adverse event, not serious|2|||
42289663|NCT01960348|76123016|FG001|Overall Study|Adverse event, not serious|2|||
42289664|NCT01960348|76123015|FG000|Overall Study|Adverse event, serious fatal|6|||
42289665|NCT01960348|76123016|FG001|Overall Study|Adverse event, serious fatal|5|||
42289666|NCT01960348|76123015|FG000|Overall Study|Adverse event, serious non-fatal|0|||
42289667|NCT01960348|76123016|FG001|Overall Study|Adverse event, serious non-fatal|3|||
42289668|NCT01960348|76123015|FG000|Overall Study|Withdrawal by Subject|1|||
42289669|NCT01960348|76123016|FG001|Overall Study|Withdrawal by Subject|11|||
42289670|NCT01960348|76123015|FG000|Overall Study|Physician Decision|0|||
42015969|NCT00941863|75823148|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
42015970|NCT00941863|75823149|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
42015971|NCT00941863|75823145|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
42015972|NCT00941863|75823146|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
42015973|NCT00941863|75823147|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
42015974|NCT00941863|75823148|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
42015975|NCT00941863|75823149|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
42015976|NCT00941863|75823145|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
42015977|NCT00941863|75823146|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
42015978|NCT00941863|75823147|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
42015979|NCT00941863|75823148|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
42289671|NCT01960348|76123016|FG001|Overall Study|Physician Decision|1|||
42289672|NCT01960348|76123015|FG000|Overall Study|Protocol Violation|1|||
42289673|NCT01960348|76123016|FG001|Overall Study|Protocol Violation|0|||
42289674|NCT02653625|76123022|FG000|Overall Study|Adverse Event|1|||
42289675|NCT02653625|76123022|FG000|Overall Study|Non-compliance with Study Drug|1|||
42289676|NCT02653625|76123022|FG000|Overall Study|Protocol Violation|1|||
42289677|NCT02653625|76123022|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
42289678|NCT01981096|76123028|FG000|Overall Study|Parent illness|1|||
42289679|NCT01981096|76123029|FG001|Overall Study|Parent illness|0|||
42289680|NCT01981096|76123028|FG000|Overall Study|Withdrawal by Subject|0|||
42289681|NCT01981096|76123029|FG001|Overall Study|Withdrawal by Subject|1|||
42289682|NCT01981096|76123028|FG000|Overall Study|Lost to Follow-up|2|||
42289683|NCT01981096|76123029|FG001|Overall Study|Lost to Follow-up|0|||
42289684|NCT02652767|76123035|FG000|Overall Study|Death|2|||
42289685|NCT02652767|76123035|FG000|Overall Study|Lost to Follow-up|1|||
42289686|NCT02652767|76123035|FG000|Overall Study|Withdrawal by Subject|1|||
42289687|NCT01980940|76123049|FG000|Overall Study|Protocol Violation|0|||
42289688|NCT01980940|76123050|FG001|Overall Study|Protocol Violation|0|||
42289689|NCT01980940|76123051|FG002|Overall Study|Protocol Violation|0|||
42289690|NCT01980940|76123052|FG003|Overall Study|Protocol Violation|0|||
42289691|NCT01980940|76123053|FG004|Overall Study|Protocol Violation|0|||
42289692|NCT01980940|76123054|FG005|Overall Study|Protocol Violation|2|||
42289693|NCT01980940|76123055|FG006|Overall Study|Protocol Violation|0|||
42289694|NCT01980940|76123056|FG007|Overall Study|Protocol Violation|0|||
42289695|NCT02699983|76123082|FG000|Overall Study|Withdrawal by Subject|1|||
42042044|NCT00970632|75849872|FG001|Overall Study|Lack of Efficacy|0|||
42289696|NCT02699983|76123083|FG001|Overall Study|Withdrawal by Subject|0|||
42289697|NCT01960114|76123095|FG000|Overall Study|Adverse Event|1|||
42289698|NCT01960114|76123096|FG001|Overall Study|Adverse Event|0|||
42289699|NCT01960114|76123095|FG000|Overall Study|Could not swallow study medication|0|||
42289700|NCT01960114|76123096|FG001|Overall Study|Could not swallow study medication|1|||
42289701|NCT02005276|76123106|FG000|Overall Study|No longer interested|5|||
42289702|NCT02005276|76123107|FG001|Overall Study|No longer interested|2|||
42289703|NCT02005276|76123108|FG002|Overall Study|No longer interested|3|||
42289704|NCT02005276|76123109|FG003|Overall Study|No longer interested|3|||
42289705|NCT01980706|76123124|FG000|Overall Study|Withdrawal by Subject|9|||
42289706|NCT01980706|76123125|FG001|Overall Study|Withdrawal by Subject|6|||
42289707|NCT01980706|76123126|FG002|Overall Study|Withdrawal by Subject|2|||
42289708|NCT01980706|76123124|FG000|Overall Study|Adverse Event|1|||
42289709|NCT01980706|76123125|FG001|Overall Study|Adverse Event|2|||
42289710|NCT01980706|76123126|FG002|Overall Study|Adverse Event|5|||
42289711|NCT01980706|76123124|FG000|Overall Study|Lost to Follow-up|3|||
42289712|NCT01980706|76123125|FG001|Overall Study|Lost to Follow-up|4|||
42289713|NCT01980706|76123126|FG002|Overall Study|Lost to Follow-up|3|||
42289714|NCT01980706|76123124|FG000|Overall Study|miscellaneous|4|||
42289715|NCT01980706|76123125|FG001|Overall Study|miscellaneous|5|||
42289716|NCT01980706|76123126|FG002|Overall Study|miscellaneous|3|||
42289717|NCT02692417|76123136|FG000|Overall Study|Withdrawal by Subject|5|||
42289718|NCT02692417|76123137|FG001|Overall Study|Withdrawal by Subject|1|||
42289719|NCT02692417|76123136|FG000|Overall Study|Adverse Event|1|||
42289720|NCT02692417|76123137|FG001|Overall Study|Adverse Event|0|||
42289721|NCT02004886|76123147|FG000|Overall Study|Adverse Event|0|||
42289722|NCT02004886|76123148|FG001|Overall Study|Adverse Event|1|||
42289723|NCT02004886|76123149|FG002|Overall Study|Adverse Event|0|||
42289724|NCT02004886|76123150|FG003|Overall Study|Adverse Event|0|||
42289725|NCT02004886|76123147|FG000|Overall Study|Unable to attend future visits|1|||
42289726|NCT02004886|76123148|FG001|Overall Study|Unable to attend future visits|0|||
42289727|NCT02004886|76123149|FG002|Overall Study|Unable to attend future visits|0|||
42289728|NCT02004886|76123150|FG003|Overall Study|Unable to attend future visits|0|||
42289729|NCT01959880|76123164|FG000|Overall Study|Withdrawal by Subject|11|||
42289730|NCT01959880|76123165|FG001|Overall Study|Withdrawal by Subject|13|||
42289731|NCT01959880|76123166|FG002|Overall Study|Withdrawal by Subject|8|||
42289732|NCT01959880|76123167|FG003|Overall Study|Withdrawal by Subject|7|||
42289733|NCT01959880|76123164|FG000|Overall Study|Death|1|||
42289734|NCT01959880|76123165|FG001|Overall Study|Death|10|||
42289735|NCT01959880|76123166|FG002|Overall Study|Death|1|||
42289736|NCT01959880|76123167|FG003|Overall Study|Death|2|||
42355534|NCT01728584|76198304|FG003|Overall Study|Other reason (not specified)|1|||
42355535|NCT01522443|76198337|FG000|Overall Study|No longer receiving clinical benefit|36|||
42355536|NCT01522443|76198338|FG001|Overall Study|No longer receiving clinical benefit|28|||
42289737|NCT01959880|76123164|FG000|Overall Study|Lost to Follow-up|95|||
42355537|NCT01522443|76198337|FG000|Overall Study|Adverse Event|10|||
42355538|NCT01522443|76198338|FG001|Overall Study|Adverse Event|15|||
42355539|NCT01522443|76198337|FG000|Overall Study|Withdrawal by Subject|5|||
42355540|NCT01522443|76198338|FG001|Overall Study|Withdrawal by Subject|8|||
42042045|NCT00970632|75849873|FG002|Overall Study|Lack of Efficacy|0|||
42042046|NCT00970632|75849871|FG000|Overall Study|Lost to Follow-up|3|||
42042047|NCT00970632|75849872|FG001|Overall Study|Lost to Follow-up|0|||
42042048|NCT00970632|75849873|FG002|Overall Study|Lost to Follow-up|2|||
42042049|NCT00970632|75849871|FG000|Overall Study|Protocol Violation|8|||
42042050|NCT00970632|75849872|FG001|Overall Study|Protocol Violation|5|||
42042051|NCT00970632|75849873|FG002|Overall Study|Protocol Violation|8|||
42042052|NCT00970632|75849871|FG000|Overall Study|Withdrawal by Subject|7|||
42042053|NCT00970632|75849872|FG001|Overall Study|Withdrawal by Subject|6|||
42042054|NCT00970632|75849873|FG002|Overall Study|Withdrawal by Subject|4|||
42042055|NCT00970632|75849871|FG000|Overall Study|Entry criteria not met|0|||
42042056|NCT00970632|75849872|FG001|Overall Study|Entry criteria not met|2|||
42042057|NCT00970632|75849873|FG002|Overall Study|Entry criteria not met|2|||
42042058|NCT00970632|75849871|FG000|Overall Study|Sponsor decision|1|||
42042059|NCT00970632|75849872|FG001|Overall Study|Sponsor decision|0|||
42042060|NCT00970632|75849873|FG002|Overall Study|Sponsor decision|1|||
42042061|NCT01144364|75849883|FG000|Induction Phase|Disease progression|14|||
42042062|NCT01144364|75849884|FG001|Induction Phase|Disease progression|0|||
42042063|NCT01144364|75849885|FG002|Induction Phase|Disease progression|0|||
42042064|NCT01144364|75849883|FG000|Induction Phase|Adverse Event|9|||
42042065|NCT01144364|75849884|FG001|Induction Phase|Adverse Event|0|||
42042066|NCT01144364|75849885|FG002|Induction Phase|Adverse Event|0|||
42042067|NCT01144364|75849883|FG000|Induction Phase|Death|1|||
42289738|NCT01959880|76123165|FG001|Overall Study|Lost to Follow-up|18|||
42289739|NCT01959880|76123166|FG002|Overall Study|Lost to Follow-up|15|||
42289740|NCT01959880|76123167|FG003|Overall Study|Lost to Follow-up|8|||
42289741|NCT01959880|76123164|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
42289742|NCT01959880|76123165|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
42289743|NCT01959880|76123166|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
42289744|NCT01959880|76123167|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
42289745|NCT01959880|76123164|FG000|Overall Study|Study completed early-FDA approved|1003|||
42355541|NCT01522443|76198337|FG000|Overall Study|No study treatment given|1|||
42289746|NCT01959880|76123165|FG001|Overall Study|Study completed early-FDA approved|311|||
42172252|NCT03797144|75979055|FG000|24 Month|Early termination cut-off date|1|||
42172253|NCT03797144|75979056|FG001|24 Month|Early termination cut-off date|1|||
42172254|NCT00347009|75979063|FG000|Overall Study|Death|1|||
42172255|NCT00347009|75979063|FG000|Overall Study|Adverse Event|6|||
42172256|NCT00347009|75979063|FG000|Overall Study|Withdrawal by Subject|3|||
42172257|NCT00347009|75979063|FG000|Overall Study|Physician Decision|5|||
42172258|NCT00347009|75979063|FG000|Overall Study|Lost to Follow-up|4|||
42172259|NCT00347009|75979063|FG000|Overall Study|Protocol Violation|2|||
42172260|NCT00347009|75979063|FG000|Overall Study|Adverse Laboratory Experience|1|||
42172261|NCT00347009|75979063|FG000|Overall Study|Insufficient Viral Suppression|3|||
42172262|NCT00347009|75979063|FG000|Overall Study|Increased ALT/HBV DNA|1|||
42289747|NCT01959880|76123166|FG002|Overall Study|Study completed early-FDA approved|179|||
42289748|NCT01959880|76123167|FG003|Overall Study|Study completed early-FDA approved|152|||
42289749|NCT01980628|76123177|FG000|Overall Study|Adverse Event|12|||
42289750|NCT01980628|76123177|FG000|Overall Study|Physician Decision|5|||
42289751|NCT01980628|76123177|FG000|Overall Study|Withdrawal by Subject|4|||
42289752|NCT01980628|76123177|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
42289753|NCT01979614|76123184|FG000|Overall Study|Adverse Event|1|||
42289754|NCT01979614|76123185|FG001|Overall Study|Adverse Event|1|||
42355542|NCT01522443|76198338|FG001|Overall Study|No study treatment given|1|||
42172263|NCT00347009|75979063|FG000|Overall Study|Serious Adverse Event|1|||
42172264|NCT00346775|75979071|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
42289755|NCT02654717|76123193|FG000|Overall Study|Adverse Event|2|||
42172265|NCT00346775|75979072|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
42172266|NCT00346775|75979071|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
42172267|NCT00346775|75979072|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
42172268|NCT00346775|75979071|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
42172269|NCT00346775|75979072|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
42172270|NCT00346697|75979084|FG000|Overall Study|Lost to Follow-up|0|||
42172271|NCT00346697|75979085|FG001|Overall Study|Lost to Follow-up|1|||
42172272|NCT03400852|75979095|FG000|Blinded Treatment Period|Physician Decision|0|||
42172273|NCT03400852|75979096|FG001|Blinded Treatment Period|Physician Decision|1|||
42172274|NCT03400852|75979097|FG002|Blinded Treatment Period|Physician Decision|0|||
42172275|NCT03400852|75979095|FG000|Blinded Treatment Period|Adverse Event|1|||
42172276|NCT03400852|75979096|FG001|Blinded Treatment Period|Adverse Event|1|||
42172277|NCT03400852|75979097|FG002|Blinded Treatment Period|Adverse Event|0|||
42172278|NCT03400852|75979095|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
42172279|NCT03400852|75979096|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
42172280|NCT03400852|75979097|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
42172281|NCT03400852|75979095|FG000|Open Label Period|Physician Decision|0|||
42289756|NCT02654717|76123194|FG001|Overall Study|Adverse Event|2|||
42289757|NCT02654717|76123193|FG000|Overall Study|Protocol Violation|1|||
42289758|NCT02654717|76123194|FG001|Overall Study|Protocol Violation|2|||
42289759|NCT02654717|76123193|FG000|Overall Study|Withdrawal by Subject|0|||
42289760|NCT02654717|76123194|FG001|Overall Study|Withdrawal by Subject|1|||
42355543|NCT01522443|76198337|FG000|Overall Study|Other|1|||
42355544|NCT01522443|76198338|FG001|Overall Study|Other|3|||
42289761|NCT02654717|76123193|FG000|Overall Study|Non-permitted medication|3|||
42289762|NCT02654717|76123194|FG001|Overall Study|Non-permitted medication|0|||
42289763|NCT03343301|76123202|FG000|Overall Study|Withdrawal by Subject|1|||
42289764|NCT03343301|76123203|FG001|Overall Study|Withdrawal by Subject|1|||
42289765|NCT03343301|76123202|FG000|Overall Study|Death|0|||
42289766|NCT03343301|76123203|FG001|Overall Study|Death|2|||
42355545|NCT01468233|76198355|FG000|Treatment Period 1|Adverse Event|5|||
42355546|NCT01468233|76198356|FG001|Treatment Period 1|Adverse Event|3|||
42355547|NCT01468233|76198357|FG002|Treatment Period 1|Adverse Event|0|||
42355548|NCT01468233|76198358|FG003|Treatment Period 1|Adverse Event|0|||
42355549|NCT01468233|76198359|FG004|Treatment Period 1|Adverse Event|0|||
42355550|NCT01468233|76198360|FG005|Treatment Period 1|Adverse Event|0|||
42355551|NCT01468233|76198355|FG000|Treatment Period 1|Withdrawal by Subject|3|||
42355552|NCT01468233|76198356|FG001|Treatment Period 1|Withdrawal by Subject|4|||
42355553|NCT01468233|76198357|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42355554|NCT01468233|76198358|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42355555|NCT01468233|76198359|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42355556|NCT01468233|76198360|FG005|Treatment Period 1|Withdrawal by Subject|0|||
42355557|NCT01468233|76198355|FG000|Treatment Period 1|Lost to Follow-up|3|||
42172282|NCT03400852|75979096|FG001|Open Label Period|Physician Decision|0|||
42172283|NCT03400852|75979097|FG002|Open Label Period|Physician Decision|1|||
42172284|NCT03400852|75979095|FG000|Open Label Period|Study terminated by sponsor|0|||
42289767|NCT03343301|76123202|FG000|Overall Study|Other|0|||
42289768|NCT03343301|76123203|FG001|Overall Study|Other|6|||
42289769|NCT03343301|76123202|FG000|Overall Study|Missing|2|||
42355558|NCT01468233|76198356|FG001|Treatment Period 1|Lost to Follow-up|0|||
42355559|NCT01468233|76198357|FG002|Treatment Period 1|Lost to Follow-up|0|||
42355560|NCT01468233|76198358|FG003|Treatment Period 1|Lost to Follow-up|0|||
42355561|NCT01468233|76198359|FG004|Treatment Period 1|Lost to Follow-up|0|||
42355562|NCT01468233|76198360|FG005|Treatment Period 1|Lost to Follow-up|0|||
42355563|NCT01468233|76198355|FG000|Treatment Period 1|Other|1|||
42355564|NCT01468233|76198356|FG001|Treatment Period 1|Other|1|||
42355565|NCT01468233|76198357|FG002|Treatment Period 1|Other|0|||
42355566|NCT01468233|76198358|FG003|Treatment Period 1|Other|0|||
42355567|NCT01468233|76198359|FG004|Treatment Period 1|Other|0|||
42355568|NCT01468233|76198360|FG005|Treatment Period 1|Other|0|||
42355569|NCT01468233|76198355|FG000|Treatment Period 2|Adverse Event|0|||
42355570|NCT01468233|76198356|FG001|Treatment Period 2|Adverse Event|0|||
42355571|NCT01468233|76198357|FG002|Treatment Period 2|Adverse Event|3|||
42355572|NCT01468233|76198358|FG003|Treatment Period 2|Adverse Event|0|||
42355573|NCT01468233|76198359|FG004|Treatment Period 2|Adverse Event|2|||
42355574|NCT01468233|76198360|FG005|Treatment Period 2|Adverse Event|1|||
42355575|NCT01468233|76198355|FG000|Treatment Period 2|Lack of Efficacy|0|||
42355576|NCT01468233|76198356|FG001|Treatment Period 2|Lack of Efficacy|0|||
42355577|NCT01468233|76198357|FG002|Treatment Period 2|Lack of Efficacy|9|||
42355578|NCT01468233|76198358|FG003|Treatment Period 2|Lack of Efficacy|2|||
42289770|NCT03343301|76123203|FG001|Overall Study|Missing|0|||
42289771|NCT02696785|76123213|FG000|Blinded Treatment Period|Adverse Event|0|||
42289772|NCT02696785|76123214|FG001|Blinded Treatment Period|Adverse Event|1|||
42289773|NCT02696785|76123215|FG002|Blinded Treatment Period|Adverse Event|3|||
42289774|NCT02696785|76123216|FG003|Blinded Treatment Period|Adverse Event|0|||
42289775|NCT02696785|76123213|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
42289776|NCT02696785|76123214|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
42289777|NCT02696785|76123215|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
42289778|NCT02696785|76123216|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
42289779|NCT02696785|76123213|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
42289780|NCT02696785|76123214|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
42289781|NCT02696785|76123215|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
42289782|NCT02696785|76123216|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
42355579|NCT01468233|76198359|FG004|Treatment Period 2|Lack of Efficacy|0|||
42355580|NCT01468233|76198360|FG005|Treatment Period 2|Lack of Efficacy|1|||
42355581|NCT01468233|76198355|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42289783|NCT02696785|76123213|FG000|Blinded Treatment Period|Screen Failure|1|||
42355582|NCT01468233|76198356|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42289784|NCT02696785|76123214|FG001|Blinded Treatment Period|Screen Failure|0|||
42042068|NCT01144364|75849884|FG001|Induction Phase|Death|0|||
42289785|NCT02696785|76123215|FG002|Blinded Treatment Period|Screen Failure|0|||
42355583|NCT01468233|76198357|FG002|Treatment Period 2|Withdrawal by Subject|9|||
42355584|NCT01468233|76198358|FG003|Treatment Period 2|Withdrawal by Subject|1|||
42355585|NCT01468233|76198359|FG004|Treatment Period 2|Withdrawal by Subject|1|||
42355586|NCT01468233|76198360|FG005|Treatment Period 2|Withdrawal by Subject|1|||
42355587|NCT01468233|76198355|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
42355588|NCT01468233|76198356|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
42355589|NCT01468233|76198357|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
42172285|NCT03400852|75979096|FG001|Open Label Period|Study terminated by sponsor|0|||
42172286|NCT03400852|75979097|FG002|Open Label Period|Study terminated by sponsor|21|||
42172287|NCT03398356|75979108|FG000|Before Treatment|Lost to Follow-up|1|||
42289786|NCT02696785|76123216|FG003|Blinded Treatment Period|Screen Failure|0|||
42355590|NCT01468233|76198358|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
42355591|NCT01468233|76198359|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
42172288|NCT03398356|75979109|FG001|Before Treatment|Lost to Follow-up|2|||
42172289|NCT03398356|75979110|FG002|Before Treatment|Lost to Follow-up|0|||
42172290|NCT03398356|75979108|FG000|Before Treatment|drug intolerance|2|||
42172291|NCT03398356|75979109|FG001|Before Treatment|drug intolerance|1|||
42172292|NCT03398356|75979110|FG002|Before Treatment|drug intolerance|0|||
42172293|NCT03398356|75979108|FG000|Before Treatment|Withdrawal by Subject|0|||
42172294|NCT03398356|75979109|FG001|Before Treatment|Withdrawal by Subject|5|||
42172295|NCT03398356|75979110|FG002|Before Treatment|Withdrawal by Subject|0|||
42289787|NCT02696785|76123213|FG000|Washout Period|Withdrawal by Subject|0|||
42289788|NCT02696785|76123214|FG001|Washout Period|Withdrawal by Subject|1|||
42289789|NCT02696785|76123215|FG002|Washout Period|Withdrawal by Subject|0|||
42289790|NCT02696785|76123216|FG003|Washout Period|Withdrawal by Subject|0|||
42172296|NCT03398356|75979108|FG000|Before Treatment|Physician Decision|0|||
42172297|NCT03398356|75979109|FG001|Before Treatment|Physician Decision|0|||
42172298|NCT03398356|75979110|FG002|Before Treatment|Physician Decision|11|||
42172299|NCT03398356|75979108|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
42172300|NCT03398356|75979109|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
42172301|NCT03398356|75979110|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
42172302|NCT00346151|75979118|FG000|Overall Study|Withdrawal by Subject|3|||
42172303|NCT00130286|75979126|FG000|Overall Study|Withdrawal by Subject|0|||
42172304|NCT00130286|75979127|FG001|Overall Study|Withdrawal by Subject|1|||
42172305|NCT00130286|75979128|FG002|Overall Study|Withdrawal by Subject|2|||
42172306|NCT00130286|75979129|FG003|Overall Study|Withdrawal by Subject|2|||
42172307|NCT00130286|75979126|FG000|Overall Study|Adverse Event|0|||
42172308|NCT00130286|75979127|FG001|Overall Study|Adverse Event|0|||
42289791|NCT02696785|76123213|FG000|Washout Period|Lack of Efficacy|0|||
42289792|NCT02696785|76123214|FG001|Washout Period|Lack of Efficacy|1|||
42289793|NCT02696785|76123215|FG002|Washout Period|Lack of Efficacy|0|||
42289794|NCT02696785|76123216|FG003|Washout Period|Lack of Efficacy|0|||
42289795|NCT02696785|76123213|FG000|Extended Treatment Period|Adverse Event|2|||
42289796|NCT02696785|76123214|FG001|Extended Treatment Period|Adverse Event|3|||
42289797|NCT02696785|76123215|FG002|Extended Treatment Period|Adverse Event|2|||
42289798|NCT02696785|76123216|FG003|Extended Treatment Period|Adverse Event|1|||
42355592|NCT01468233|76198360|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
42355593|NCT01468233|76198355|FG000|Treatment Period 2|Lost to Follow-up|0|||
42015980|NCT00941863|75823149|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
42015981|NCT00941863|75823145|FG000|Until Primary Completion Date (PCD)|Death|0|||
42015982|NCT00941863|75823146|FG001|Until Primary Completion Date (PCD)|Death|0|||
42015983|NCT00941863|75823147|FG002|Until Primary Completion Date (PCD)|Death|1|||
42172309|NCT00130286|75979128|FG002|Overall Study|Adverse Event|2|||
42172310|NCT00130286|75979129|FG003|Overall Study|Adverse Event|0|||
42172311|NCT00130286|75979126|FG000|Overall Study|Missing lab specimens|0|||
42289799|NCT02696785|76123213|FG000|Extended Treatment Period|Lack of Efficacy|0|||
42289800|NCT02696785|76123214|FG001|Extended Treatment Period|Lack of Efficacy|1|||
42289801|NCT02696785|76123215|FG002|Extended Treatment Period|Lack of Efficacy|0|||
42042069|NCT01144364|75849885|FG002|Induction Phase|Death|0|||
42042070|NCT01144364|75849883|FG000|Induction Phase|Withdrawal by Subject|1|||
42042071|NCT01144364|75849884|FG001|Induction Phase|Withdrawal by Subject|0|||
42042072|NCT01144364|75849885|FG002|Induction Phase|Withdrawal by Subject|0|||
42172312|NCT00130286|75979127|FG001|Overall Study|Missing lab specimens|2|||
42172313|NCT00130286|75979128|FG002|Overall Study|Missing lab specimens|0|||
42172314|NCT00130286|75979129|FG003|Overall Study|Missing lab specimens|0|||
42172315|NCT00346073|75979141|FG000|Overall Study|Serious Adverse Event|2|||
42172316|NCT00346073|75979142|FG001|Overall Study|Serious Adverse Event|0|||
42172317|NCT00346073|75979141|FG000|Overall Study|Lost to Follow-up|39|||
42355594|NCT01468233|76198356|FG001|Treatment Period 2|Lost to Follow-up|0|||
42355595|NCT01468233|76198357|FG002|Treatment Period 2|Lost to Follow-up|3|||
42355596|NCT01468233|76198358|FG003|Treatment Period 2|Lost to Follow-up|0|||
42355597|NCT01468233|76198359|FG004|Treatment Period 2|Lost to Follow-up|2|||
42355598|NCT01468233|76198360|FG005|Treatment Period 2|Lost to Follow-up|0|||
42355599|NCT01468233|76198355|FG000|Treatment Period 2|Other|0|||
42355600|NCT01468233|76198356|FG001|Treatment Period 2|Other|0|||
42042073|NCT01144364|75849883|FG000|Induction Phase|Lost to Follow-up|2|||
42042074|NCT01144364|75849884|FG001|Induction Phase|Lost to Follow-up|0|||
42042075|NCT01144364|75849885|FG002|Induction Phase|Lost to Follow-up|0|||
42042076|NCT01144364|75849883|FG000|Induction Phase|Physician Decision|1|||
42042077|NCT01144364|75849884|FG001|Induction Phase|Physician Decision|0|||
42042078|NCT01144364|75849885|FG002|Induction Phase|Physician Decision|0|||
42042079|NCT01144364|75849883|FG000|Induction Phase|Stable disease|2|||
42042080|NCT01144364|75849884|FG001|Induction Phase|Stable disease|0|||
42042081|NCT01144364|75849885|FG002|Induction Phase|Stable disease|0|||
42042082|NCT01144364|75849883|FG000|Induction Phase|Secondary neoplasia|1|||
42042083|NCT01144364|75849884|FG001|Induction Phase|Secondary neoplasia|0|||
42042084|NCT01144364|75849885|FG002|Induction Phase|Secondary neoplasia|0|||
42042085|NCT01144364|75849883|FG000|Induction Phase|Protocol Violation|1|||
42042086|NCT01144364|75849884|FG001|Induction Phase|Protocol Violation|0|||
42042087|NCT01144364|75849885|FG002|Induction Phase|Protocol Violation|0|||
42042088|NCT01144364|75849883|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
42042089|NCT01144364|75849884|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
42042090|NCT01144364|75849885|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
42042091|NCT01144364|75849883|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
42042092|NCT01144364|75849884|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
42042093|NCT01144364|75849885|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
42042094|NCT01144364|75849883|FG000|Follow-Up/Maintenance Phase|Death|0|||
42042095|NCT01144364|75849884|FG001|Follow-Up/Maintenance Phase|Death|2|||
42042096|NCT01144364|75849885|FG002|Follow-Up/Maintenance Phase|Death|0|||
42042097|NCT01144364|75849883|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
42042098|NCT01144364|75849884|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
42042099|NCT01144364|75849885|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
42042100|NCT01144364|75849883|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
42042101|NCT01144364|75849884|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
42042102|NCT01144364|75849885|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
42042103|NCT01144364|75849883|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
42042104|NCT01144364|75849884|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
42042105|NCT01144364|75849885|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
42042106|NCT01144364|75849883|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
42042107|NCT01144364|75849884|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
42042108|NCT01144364|75849885|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
42042109|NCT01119248|75849895|FG000|Overall Study|Physician Decision|5|||
42042110|NCT01131494|75849900|FG000|Overall Study|Withdrawal by Subject|2|||
42042111|NCT01131260|75849907|FG000|Overall Study|Randomization error|5|||
42042112|NCT01131260|75849908|FG001|Overall Study|Randomization error|1|||
42042113|NCT01131260|75849907|FG000|Overall Study|Declined to continue participation|8|||
42042114|NCT01131260|75849908|FG001|Overall Study|Declined to continue participation|13|||
42042115|NCT01131260|75849907|FG000|Overall Study|Physician Decision|22|||
42042116|NCT01131260|75849908|FG001|Overall Study|Physician Decision|24|||
42042117|NCT01131260|75849907|FG000|Overall Study|Technical problems|7|||
42042118|NCT01131260|75849908|FG001|Overall Study|Technical problems|6|||
42042119|NCT01131260|75849907|FG000|Overall Study|Staff error|2|||
42172318|NCT00346073|75979142|FG001|Overall Study|Lost to Follow-up|24|||
42172319|NCT03374488|75979150|FG000|Overall Study|Death|13|||
42355601|NCT01468233|76198357|FG002|Treatment Period 2|Other|3|||
42355602|NCT01468233|76198358|FG003|Treatment Period 2|Other|0|||
42355603|NCT01468233|76198359|FG004|Treatment Period 2|Other|1|||
42355604|NCT01468233|76198360|FG005|Treatment Period 2|Other|0|||
42289802|NCT02696785|76123216|FG003|Extended Treatment Period|Lack of Efficacy|0|||
42289803|NCT02696785|76123213|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
42289804|NCT02696785|76123214|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
42289805|NCT02696785|76123215|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
42289806|NCT02696785|76123216|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
42289807|NCT02696785|76123213|FG000|Follow-up Period|Adverse Event|0|||
42289808|NCT02696785|76123214|FG001|Follow-up Period|Adverse Event|0|||
42289809|NCT02696785|76123215|FG002|Follow-up Period|Adverse Event|8|||
42289810|NCT02696785|76123216|FG003|Follow-up Period|Adverse Event|2|||
42355605|NCT01468077|76198380|FG000|Overall Study|Adverse Event|2|||
42355606|NCT01468077|76198381|FG001|Overall Study|Adverse Event|2|||
42355607|NCT01468077|76198380|FG000|Overall Study|Lack of Efficacy|1|||
42355608|NCT01468077|76198381|FG001|Overall Study|Lack of Efficacy|1|||
42355609|NCT01468077|76198380|FG000|Overall Study|Physician Decision|1|||
42355610|NCT01468077|76198381|FG001|Overall Study|Physician Decision|0|||
42355611|NCT01522365|76198389|FG000|Overall Study|Withdrawal by Subject|1|||
42355612|NCT01522365|76198390|FG001|Overall Study|Withdrawal by Subject|1|||
42355613|NCT01522365|76198389|FG000|Overall Study|Lost to Follow-up|1|||
42355614|NCT01522365|76198390|FG001|Overall Study|Lost to Follow-up|1|||
42355615|NCT01754402|76198400|FG000|Overall Study|Death|0|||
42355616|NCT01754402|76198401|FG001|Overall Study|Death|0|||
42355617|NCT01754402|76198402|FG002|Overall Study|Death|1|||
42355618|NCT01754402|76198400|FG000|Overall Study|Adverse Event|2|||
42355619|NCT01754402|76198401|FG001|Overall Study|Adverse Event|2|||
42355620|NCT01754402|76198402|FG002|Overall Study|Adverse Event|1|||
42355621|NCT01754402|76198400|FG000|Overall Study|Withdrawal by Subject|0|||
42355622|NCT01754402|76198401|FG001|Overall Study|Withdrawal by Subject|0|||
42355623|NCT01754402|76198402|FG002|Overall Study|Withdrawal by Subject|1|||
42355624|NCT01754402|76198400|FG000|Overall Study|Lack of Efficacy|0|||
42355625|NCT01754402|76198401|FG001|Overall Study|Lack of Efficacy|0|||
42355626|NCT01754402|76198402|FG002|Overall Study|Lack of Efficacy|1|||
42355627|NCT01783418|76198413|FG000|Overall Study|Withdrawal by Subject|1|||
42355628|NCT01783418|76198414|FG001|Overall Study|Withdrawal by Subject|0|||
42355629|NCT01521897|76198420|FG000|Overall Study|Protocol Violation|18|||
42355630|NCT01521897|76198420|FG000|Overall Study|Lost to Follow-up|5|||
42355631|NCT01782872|76198428|FG000|Overall Study|Protocol Violation|0|||
42355632|NCT01782872|76198429|FG001|Overall Study|Protocol Violation|0|||
42355633|NCT01782872|76198430|FG002|Overall Study|Protocol Violation|0|||
42355634|NCT01782872|76198431|FG003|Overall Study|Protocol Violation|1|||
42355635|NCT01782872|76198428|FG000|Overall Study|Withdrawal by Subject|0|||
42355636|NCT01782872|76198429|FG001|Overall Study|Withdrawal by Subject|1|||
42355637|NCT01782872|76198430|FG002|Overall Study|Withdrawal by Subject|0|||
42355638|NCT01782872|76198431|FG003|Overall Study|Withdrawal by Subject|0|||
42289811|NCT02696785|76123213|FG000|Follow-up Period|Lost to Follow-up|0|||
42289812|NCT02696785|76123214|FG001|Follow-up Period|Lost to Follow-up|0|||
42289813|NCT02696785|76123215|FG002|Follow-up Period|Lost to Follow-up|0|||
42289814|NCT02696785|76123216|FG003|Follow-up Period|Lost to Follow-up|1|||
42355639|NCT01490697|76198443|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
42355640|NCT01490697|76198444|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
42355641|NCT01728194|76198452|FG000|Overall Study|Lost to Follow-up|4|||
42355642|NCT01728194|76198453|FG001|Overall Study|Lost to Follow-up|3|||
42355643|NCT01728194|76198452|FG000|Overall Study|Physician Decision|4|||
42355644|NCT01728194|76198453|FG001|Overall Study|Physician Decision|0|||
42355645|NCT01728194|76198452|FG000|Overall Study|Withdrawal by Subject|7|||
42355646|NCT01728194|76198453|FG001|Overall Study|Withdrawal by Subject|3|||
42355647|NCT01728194|76198452|FG000|Overall Study|Perceived Medication Side Effects|4|||
42355648|NCT01728194|76198453|FG001|Overall Study|Perceived Medication Side Effects|0|||
42355649|NCT01728194|76198452|FG000|Overall Study|Family Member Request|1|||
42355650|NCT01728194|76198453|FG001|Overall Study|Family Member Request|0|||
42289815|NCT02696785|76123213|FG000|Follow-up Period|Lack of Efficacy|0|||
42289816|NCT02696785|76123214|FG001|Follow-up Period|Lack of Efficacy|0|||
42289817|NCT02696785|76123215|FG002|Follow-up Period|Lack of Efficacy|0|||
42355651|NCT01782482|76198461|FG000|Overall Study|Adverse Event|2|||
42355652|NCT01782482|76198462|FG001|Overall Study|Adverse Event|1|||
42355653|NCT01782482|76198461|FG000|Overall Study|Lost to Follow-up|2|||
42355654|NCT01782482|76198462|FG001|Overall Study|Lost to Follow-up|3|||
42355655|NCT01782482|76198461|FG000|Overall Study|Physician Decision|1|||
42355656|NCT01782482|76198462|FG001|Overall Study|Physician Decision|0|||
42289818|NCT02696785|76123216|FG003|Follow-up Period|Lack of Efficacy|1|||
42289819|NCT02696785|76123213|FG000|Follow-up Period|Withdrawal by Subject|1|||
42289820|NCT02696785|76123214|FG001|Follow-up Period|Withdrawal by Subject|0|||
42289821|NCT02696785|76123215|FG002|Follow-up Period|Withdrawal by Subject|5|||
42015984|NCT00941863|75823148|FG003|Until Primary Completion Date (PCD)|Death|2|||
42015985|NCT00941863|75823149|FG004|Until Primary Completion Date (PCD)|Death|7|||
42015986|NCT00941863|75823145|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
42015987|NCT00941863|75823146|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
42015988|NCT00941863|75823147|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
42289822|NCT02696785|76123216|FG003|Follow-up Period|Withdrawal by Subject|4|||
42289823|NCT02004262|76123250|FG000|Overall Study|Death|67|||
42289824|NCT02004262|76123251|FG001|Overall Study|Death|64|||
42289825|NCT02004262|76123252|FG002|Overall Study|Death|66|||
42289826|NCT02004262|76123253|FG003|Overall Study|Death|28|||
42289827|NCT02004262|76123254|FG004|Overall Study|Death|29|||
42355657|NCT01782482|76198461|FG000|Overall Study|Protocol Violation|1|||
42355658|NCT01782482|76198462|FG001|Overall Study|Protocol Violation|0|||
42355659|NCT01782482|76198461|FG000|Overall Study|Withdrawal by Subject|2|||
42355660|NCT01782482|76198462|FG001|Overall Study|Withdrawal by Subject|3|||
42355661|NCT01782482|76198461|FG000|Overall Study|Randomized in Error|2|||
42355662|NCT01782482|76198462|FG001|Overall Study|Randomized in Error|2|||
42042120|NCT01131260|75849908|FG001|Overall Study|Staff error|1|||
42289828|NCT02004262|76123255|FG005|Overall Study|Death|22|||
42289829|NCT02004262|76123250|FG000|Overall Study|Withdrawal by Subject|1|||
42355663|NCT01782482|76198461|FG000|Overall Study|Habitually wearing toric lens OS|0|||
42355664|NCT01782482|76198462|FG001|Overall Study|Habitually wearing toric lens OS|1|||
42355665|NCT01466673|76198470|FG000|Overall Study|Non-compliance with study treatment|2|||
42355666|NCT01466673|76198471|FG001|Overall Study|Non-compliance with study treatment|0|||
42355667|NCT01466673|76198470|FG000|Overall Study|Lost to Follow-up|3|||
42042121|NCT01131260|75849907|FG000|Overall Study|Ineligible|0|||
42042122|NCT01131260|75849908|FG001|Overall Study|Ineligible|2|||
42042123|NCT00965094|75849918|FG000|Overall Study|Adverse Event|5|||
42042124|NCT00965094|75849919|FG001|Overall Study|Adverse Event|0|||
42042125|NCT00965094|75849918|FG000|Overall Study|Lost to Follow-up|0|||
42042126|NCT00965094|75849919|FG001|Overall Study|Lost to Follow-up|1|||
42042127|NCT01131182|75849928|FG000|Overall Study|Withdrawal by Subject|1|||
42042128|NCT01131182|75849929|FG001|Overall Study|Withdrawal by Subject|1|||
42042129|NCT01131182|75849928|FG000|Overall Study|Lost to Follow-up|14|||
42042130|NCT01131182|75849929|FG001|Overall Study|Lost to Follow-up|15|||
42042131|NCT01131182|75849928|FG000|Overall Study|Other Reason|1|||
42042132|NCT01131182|75849929|FG001|Overall Study|Other Reason|0|||
42289830|NCT02004262|76123251|FG001|Overall Study|Withdrawal by Subject|0|||
42289831|NCT02004262|76123252|FG002|Overall Study|Withdrawal by Subject|4|||
42289832|NCT02004262|76123253|FG003|Overall Study|Withdrawal by Subject|0|||
42289833|NCT02004262|76123254|FG004|Overall Study|Withdrawal by Subject|1|||
42289834|NCT02004262|76123255|FG005|Overall Study|Withdrawal by Subject|3|||
42289835|NCT02004262|76123250|FG000|Overall Study|Lost to Follow-up|1|||
42289836|NCT02004262|76123251|FG001|Overall Study|Lost to Follow-up|1|||
42042133|NCT00964860|75849937|FG000|Overall Study|Withdrawal by Subject|0|||
42042134|NCT00964860|75849938|FG001|Overall Study|Withdrawal by Subject|1|||
42042135|NCT01131104|75849944|FG000|Overall Study|Withdrawal by Subject|3|||
42042136|NCT01131104|75849944|FG000|Overall Study|Physician Decision|4|||
42042137|NCT01131104|75849944|FG000|Overall Study|Information Not Available|5|||
42042138|NCT01131104|75849944|FG000|Overall Study|No Information on Index Date of Onset|1|||
42042139|NCT01118780|75849950|FG000|Overall Study|Adverse Event|15|||
42042140|NCT01118780|75849951|FG001|Overall Study|Adverse Event|15|||
42042141|NCT01118780|75849950|FG000|Overall Study|Death|1|||
42042142|NCT01118780|75849951|FG001|Overall Study|Death|0|||
42042143|NCT01118780|75849950|FG000|Overall Study|Lack of Efficacy|2|||
42042144|NCT01118780|75849951|FG001|Overall Study|Lack of Efficacy|6|||
42042145|NCT01118780|75849950|FG000|Overall Study|Physician Decision|2|||
42042146|NCT01118780|75849951|FG001|Overall Study|Physician Decision|0|||
42042147|NCT01118780|75849950|FG000|Overall Study|Protocol Violation|3|||
42042148|NCT01118780|75849951|FG001|Overall Study|Protocol Violation|6|||
42042149|NCT01118780|75849950|FG000|Overall Study|Withdrawal by Subject|13|||
42042150|NCT01118780|75849951|FG001|Overall Study|Withdrawal by Subject|8|||
42042151|NCT00964782|75849962|FG000|Overall Study|Lost to Follow-up|1|||
42042152|NCT00964782|75849963|FG001|Overall Study|Lost to Follow-up|0|||
42042153|NCT00966654|75849971|FG000|Overall Study|Study was terminated,PI left institution|12|||
42289837|NCT02004262|76123252|FG002|Overall Study|Lost to Follow-up|0|||
42289838|NCT02004262|76123253|FG003|Overall Study|Lost to Follow-up|0|||
42289839|NCT02004262|76123254|FG004|Overall Study|Lost to Follow-up|0|||
42289840|NCT02004262|76123255|FG005|Overall Study|Lost to Follow-up|0|||
42289841|NCT02004262|76123250|FG000|Overall Study|Study Terminated by Sponsor|4|||
42289842|NCT02004262|76123251|FG001|Overall Study|Study Terminated by Sponsor|3|||
42289843|NCT02004262|76123252|FG002|Overall Study|Study Terminated by Sponsor|2|||
42289844|NCT02004262|76123253|FG003|Overall Study|Study Terminated by Sponsor|1|||
42289845|NCT02004262|76123254|FG004|Overall Study|Study Terminated by Sponsor|1|||
42289846|NCT02004262|76123255|FG005|Overall Study|Study Terminated by Sponsor|5|||
42289847|NCT01675427|76123269|FG000|Overall Study|Withdrawal by Subject|7|||
42289848|NCT01675427|76123269|FG000|Overall Study|Participant Refused Sample Collection|18|||
42355668|NCT01466673|76198471|FG001|Overall Study|Lost to Follow-up|5|||
42042154|NCT03262116|75849983|FG000|Overall Study|Physician Decision|0|||
42042155|NCT03262116|75849984|FG001|Overall Study|Physician Decision|2|||
42042156|NCT03262116|75849985|FG002|Overall Study|Physician Decision|1|||
42042157|NCT03262116|75849986|FG003|Overall Study|Physician Decision|1|||
42042158|NCT03262116|75849987|FG004|Overall Study|Physician Decision|1|||
42042159|NCT03262116|75849988|FG005|Overall Study|Physician Decision|2|||
42042160|NCT01130168|75849996|FG000|Period 1|Withdrawal by Subject|0|||
42289849|NCT01675427|76123269|FG000|Overall Study|Sample not Collected by Mistake|2|||
42289850|NCT01675427|76123269|FG000|Overall Study|Lost to Follow-up|5|||
42289851|NCT01675427|76123269|FG000|Overall Study|Other|2|||
42289852|NCT01978912|76123307|FG000|Overall Study|Adverse Event|0|||
42355669|NCT01466673|76198470|FG000|Overall Study|Adverse Event|2|||
42355670|NCT01466673|76198471|FG001|Overall Study|Adverse Event|1|||
42355671|NCT01753856|76198479|FG000|Overall Study|Adverse Event|1|||
42355672|NCT01753856|76198480|FG001|Overall Study|Adverse Event|0|||
42355673|NCT01753856|76198479|FG000|Overall Study|Withdrawal by Subject|0|||
42355674|NCT01753856|76198480|FG001|Overall Study|Withdrawal by Subject|2|||
42355675|NCT01753856|76198479|FG000|Overall Study|Sponsor Decision|2|||
42355676|NCT01753856|76198480|FG001|Overall Study|Sponsor Decision|0|||
42355677|NCT01464333|76198489|FG000|Overall Study|Adverse Event|34|||
42355678|NCT01464333|76198489|FG000|Overall Study|Lack of Efficacy|72|||
42355679|NCT01464333|76198489|FG000|Overall Study|Withdrawal by Subject|11|||
42355680|NCT01464333|76198489|FG000|Overall Study|Other|4|||
42355681|NCT01464333|76198489|FG000|Overall Study|No Hospital Visit|42|||
42355682|NCT01464255|76198495|FG000|Overall Study|unresolve corneal staining|0|||
42355683|NCT01464255|76198496|FG001|Overall Study|unresolve corneal staining|1|||
42355684|NCT01464021|76198503|FG000|Overall Study|Withdrawal by Subject|13|||
42355685|NCT01464021|76198503|FG000|Overall Study|Lost to Follow-up|1|||
42355686|NCT01464021|76198503|FG000|Overall Study|Lack of Efficacy|1|||
42355687|NCT01464021|76198503|FG000|Overall Study|various|11|||
42355688|NCT01753310|76198509|FG000|Overall Study|Entered into open label extension study|25|||
42355689|NCT01753310|76198510|FG001|Overall Study|Entered into open label extension study|22|||
42355690|NCT01753310|76198509|FG000|Overall Study|Adverse Event|1|||
42355691|NCT01753310|76198510|FG001|Overall Study|Adverse Event|0|||
42015989|NCT00941863|75823148|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
42015990|NCT00941863|75823149|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
42042161|NCT01130168|75849997|FG001|Period 1|Withdrawal by Subject|1|||
42042162|NCT01130168|75849998|FG002|Period 1|Withdrawal by Subject|0|||
42289853|NCT01978912|76123308|FG001|Overall Study|Adverse Event|1|||
42289854|NCT01978912|76123309|FG002|Overall Study|Adverse Event|0|||
42355692|NCT01753310|76198509|FG000|Overall Study|Lost to Follow-up|2|||
42355693|NCT01753310|76198510|FG001|Overall Study|Lost to Follow-up|0|||
42355694|NCT01753310|76198509|FG000|Overall Study|Subject decision|2|||
42355695|NCT01753310|76198510|FG001|Overall Study|Subject decision|2|||
42355696|NCT01753310|76198509|FG000|Overall Study|Sponsor decision|1|||
42289855|NCT01978912|76123310|FG003|Overall Study|Adverse Event|0|||
42289856|NCT01978912|76123307|FG000|Overall Study|Lost to Follow-up|1|||
42289857|NCT01978912|76123308|FG001|Overall Study|Lost to Follow-up|1|||
42289858|NCT01978912|76123309|FG002|Overall Study|Lost to Follow-up|0|||
42289859|NCT01978912|76123310|FG003|Overall Study|Lost to Follow-up|1|||
42289860|NCT01978912|76123307|FG000|Overall Study|Withdrawal by Subject|1|||
42289861|NCT01978912|76123308|FG001|Overall Study|Withdrawal by Subject|0|||
42289862|NCT01978912|76123309|FG002|Overall Study|Withdrawal by Subject|2|||
42355697|NCT01753310|76198510|FG001|Overall Study|Sponsor decision|0|||
42355698|NCT01753310|76198509|FG000|Overall Study|Withdrawal by Subject|1|||
42355699|NCT01753310|76198510|FG001|Overall Study|Withdrawal by Subject|0|||
42355700|NCT01463631|76198520|FG000|Overall Study|Withdrawal by Subject|0|||
42355701|NCT01463631|76198521|FG001|Overall Study|Withdrawal by Subject|0|||
42355702|NCT01463631|76198522|FG002|Overall Study|Withdrawal by Subject|0|||
42015991|NCT00941863|75823145|FG000|Continued After PCD|Withdrawal by Subject|0|||
42015992|NCT00941863|75823146|FG001|Continued After PCD|Withdrawal by Subject|0|||
42015993|NCT00941863|75823147|FG002|Continued After PCD|Withdrawal by Subject|0|||
42015994|NCT00941863|75823148|FG003|Continued After PCD|Withdrawal by Subject|0|||
42015995|NCT00941863|75823149|FG004|Continued After PCD|Withdrawal by Subject|1|||
42015996|NCT00941863|75823145|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
42015997|NCT00941863|75823146|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
42015998|NCT00941863|75823147|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
42289863|NCT01978912|76123310|FG003|Overall Study|Withdrawal by Subject|2|||
42289864|NCT01978912|76123307|FG000|Overall Study|Lumbar Surgery|1|||
42355703|NCT01463631|76198523|FG003|Overall Study|Withdrawal by Subject|1|||
42355704|NCT01463631|76198520|FG000|Overall Study|Death|0|||
42355705|NCT01463631|76198521|FG001|Overall Study|Death|0|||
42015999|NCT00941863|75823148|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
42355706|NCT01463631|76198522|FG002|Overall Study|Death|1|||
42355707|NCT01463631|76198523|FG003|Overall Study|Death|0|||
42355708|NCT01463631|76198520|FG000|Overall Study|Progressive Disease|0|||
42355709|NCT01463631|76198521|FG001|Overall Study|Progressive Disease|0|||
42355710|NCT01463631|76198522|FG002|Overall Study|Progressive Disease|0|||
42355711|NCT01463631|76198523|FG003|Overall Study|Progressive Disease|5|||
42355712|NCT01521507|76198537|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
42355713|NCT01521507|76198538|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
42355714|NCT01521507|76198537|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
42355715|NCT01521507|76198538|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
42355716|NCT01521507|76198537|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
42355717|NCT01521507|76198538|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
42355718|NCT01521507|76198537|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
42355719|NCT01521507|76198538|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
42355720|NCT01521507|76198537|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
42355721|NCT01521507|76198538|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
42355722|NCT01521507|76198537|FG000|Stage 2: Observational Design|Physician Decision|1|||
42355723|NCT01521507|76198538|FG001|Stage 2: Observational Design|Physician Decision|0|||
42355724|NCT01521117|76198551|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
42355725|NCT01521117|76198552|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
42355726|NCT01521117|76198551|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
42355727|NCT01521117|76198552|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
42355728|NCT01521117|76198551|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
42355729|NCT01521117|76198552|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
42355730|NCT01466595|76198560|FG000|Overall Study|Withdrawal by Subject|0|||
42355731|NCT01466595|76198561|FG001|Overall Study|Withdrawal by Subject|1|||
42355732|NCT01728116|76198578|FG000|Overall Study|Sponsor Terminated Study|106|||
42355733|NCT01728116|76198579|FG001|Overall Study|Sponsor Terminated Study|35|||
42355734|NCT01728116|76198578|FG000|Overall Study|Withdrawal by Subject|16|||
42355735|NCT01728116|76198579|FG001|Overall Study|Withdrawal by Subject|9|||
42355736|NCT01728116|76198578|FG000|Overall Study|Adverse Event|13|||
42355737|NCT01728116|76198579|FG001|Overall Study|Adverse Event|0|||
42355738|NCT01728116|76198578|FG000|Overall Study|Procedure/device failure|7|||
42355739|NCT01728116|76198579|FG001|Overall Study|Procedure/device failure|0|||
42289865|NCT01978912|76123308|FG001|Overall Study|Lumbar Surgery|0|||
42289866|NCT01978912|76123309|FG002|Overall Study|Lumbar Surgery|1|||
42289867|NCT01978912|76123310|FG003|Overall Study|Lumbar Surgery|0|||
42289868|NCT01978912|76123307|FG000|Overall Study|Intradiscal Steroid Injection|0|||
42289869|NCT01978912|76123308|FG001|Overall Study|Intradiscal Steroid Injection|1|||
42289870|NCT01978912|76123309|FG002|Overall Study|Intradiscal Steroid Injection|0|||
42289871|NCT01978912|76123310|FG003|Overall Study|Intradiscal Steroid Injection|0|||
42289872|NCT01977898|76123322|FG000|Overall Study|Non functioning catheter|1|||
42289873|NCT01977898|76123323|FG001|Overall Study|Non functioning catheter|1|||
42289874|NCT02003638|76123331|FG000|Overall Study|Withdrawal by Subject|1|||
42289875|NCT02003638|76123332|FG001|Overall Study|Withdrawal by Subject|0|||
42289876|NCT02696317|76123338|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
42289877|NCT02696317|76123339|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
42289878|NCT02696317|76123338|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
42289879|NCT02696317|76123339|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
42289880|NCT01959412|76123347|FG000|Overall Study|Protocol deviation|1|||
42289881|NCT01959412|76123348|FG001|Overall Study|Protocol deviation|1|||
42289882|NCT01959412|76123349|FG002|Overall Study|Protocol deviation|0|||
42289883|NCT01959412|76123350|FG003|Overall Study|Protocol deviation|1|||
42289884|NCT01959412|76123351|FG004|Overall Study|Protocol deviation|3|||
42289885|NCT01959412|76123352|FG005|Overall Study|Protocol deviation|0|||
42289886|NCT01959412|76123347|FG000|Overall Study|Adverse Event|0|||
42289887|NCT01959412|76123348|FG001|Overall Study|Adverse Event|0|||
42289888|NCT01959412|76123349|FG002|Overall Study|Adverse Event|0|||
42289889|NCT01959412|76123350|FG003|Overall Study|Adverse Event|1|||
42289890|NCT01959412|76123351|FG004|Overall Study|Adverse Event|0|||
42289891|NCT01959412|76123352|FG005|Overall Study|Adverse Event|0|||
42289892|NCT01977820|76123368|FG000|Overall Study|Sponsor terminated the study|1|||
42289893|NCT01977820|76123369|FG001|Overall Study|Sponsor terminated the study|1|||
42289894|NCT02003014|76123375|FG000|Overall Study|Case report forms uncollected|9|||
42289895|NCT02003014|76123375|FG000|Overall Study|Treatment started after contract period|1|||
42289896|NCT02003014|76123375|FG000|Overall Study|Patient did not visit the study site|5|||
42289897|NCT02003014|76123375|FG000|Overall Study|Investigator's transfer|4|||
42289898|NCT01977352|76123381|FG000|Overall Study|Lost to Follow-up|1|||
42289899|NCT01977352|76123382|FG001|Overall Study|Lost to Follow-up|2|||
42289900|NCT02001688|76123391|FG000|Overall Study|Withdrawal by Subject|0|||
42289901|NCT02001688|76123392|FG001|Overall Study|Withdrawal by Subject|0|||
42289902|NCT02001688|76123393|FG002|Overall Study|Withdrawal by Subject|1|||
42289903|NCT02001688|76123391|FG000|Overall Study|Adverse Event|0|||
42289904|NCT02001688|76123392|FG001|Overall Study|Adverse Event|1|||
42289905|NCT02001688|76123393|FG002|Overall Study|Adverse Event|0|||
42289906|NCT02001064|76123404|FG000|Overall Study|Withdrawal by Subject|2|||
42289907|NCT02001064|76123405|FG001|Overall Study|Withdrawal by Subject|1|||
42289908|NCT02000752|76123413|FG000|Overall Study|Dystocic delivery|19|||
42289909|NCT02000752|76123414|FG001|Overall Study|Dystocic delivery|8|||
42289910|NCT02000752|76123413|FG000|Overall Study|Shift Changes|12|||
42289911|NCT02000752|76123414|FG001|Overall Study|Shift Changes|5|||
42289912|NCT02000440|76123420|FG000|Overall Study|Adverse Event|3|||
42289913|NCT02000440|76123420|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
42289914|NCT02687815|76123426|FG000|Overall Study|Lost to Follow-up|2|||
42289915|NCT02687815|76123427|FG001|Overall Study|Lost to Follow-up|4|||
42289916|NCT02687815|76123426|FG000|Overall Study|Withdrawal by Subject|2|||
42289917|NCT02687815|76123427|FG001|Overall Study|Withdrawal by Subject|4|||
42289918|NCT01959334|76123435|FG000|Second Dose|Adverse Event|1|||
42289919|NCT01959334|76123436|FG001|Second Dose|Adverse Event|0|||
42289920|NCT01959334|76123435|FG000|Third Dose|Adverse Event|0|||
42289921|NCT01959334|76123436|FG001|Third Dose|Adverse Event|1|||
42289922|NCT02687581|76123446|FG000|Overall Study|Withdrawal by Subject|1|||
42289923|NCT02687581|76123447|FG001|Overall Study|Withdrawal by Subject|0|||
42289924|NCT02687581|76123448|FG002|Overall Study|Withdrawal by Subject|0|||
42289925|NCT02687581|76123449|FG003|Overall Study|Withdrawal by Subject|1|||
42289926|NCT02687581|76123446|FG000|Overall Study|Lost to Follow-up|2|||
42289927|NCT02687581|76123447|FG001|Overall Study|Lost to Follow-up|2|||
42355740|NCT01728116|76198578|FG000|Overall Study|Lost to Follow-up|9|||
42355741|NCT01728116|76198579|FG001|Overall Study|Lost to Follow-up|2|||
42355742|NCT01728116|76198578|FG000|Overall Study|Physician Decision|2|||
42355743|NCT01728116|76198579|FG001|Overall Study|Physician Decision|0|||
42355744|NCT01728116|76198578|FG000|Overall Study|Subject Non-Compliance|2|||
42289928|NCT02687581|76123448|FG002|Overall Study|Lost to Follow-up|0|||
42289929|NCT02687581|76123449|FG003|Overall Study|Lost to Follow-up|0|||
42289930|NCT02687581|76123446|FG000|Overall Study|the device is too small for the patient.|1|||
42289931|NCT02687581|76123447|FG001|Overall Study|the device is too small for the patient.|0|||
42289932|NCT02687581|76123448|FG002|Overall Study|the device is too small for the patient.|0|||
42289933|NCT02687581|76123449|FG003|Overall Study|the device is too small for the patient.|0|||
42289934|NCT01977040|76123459|FG000|Overall Study|Vasa previa not confirmed|2|||
42355745|NCT01728116|76198579|FG001|Overall Study|Subject Non-Compliance|0|||
42355746|NCT01728116|76198578|FG000|Overall Study|Inter-current finding at procedure|1|||
42289935|NCT01958476|76123469|FG000|Overall Study|Parent requested exclusion from analysis|1|||
42289936|NCT01958476|76123470|FG001|Overall Study|Parent requested exclusion from analysis|0|||
42289937|NCT02695537|76123506|FG000|Overall Study|Adverse Event|3|||
42289938|NCT02695537|76123506|FG000|Overall Study|Lack of Efficacy|28|||
42289939|NCT02695537|76123506|FG000|Overall Study|Withdrawal by Subject|4|||
42289940|NCT02695537|76123506|FG000|Overall Study|Protocol Violation|3|||
42289941|NCT02691247|76123513|FG000|Overall Study|Withdrawal by Subject|1|||
42289942|NCT02691247|76123514|FG001|Overall Study|Withdrawal by Subject|2|||
42289943|NCT02691247|76123515|FG002|Overall Study|Withdrawal by Subject|2|||
42289944|NCT02691247|76123513|FG000|Overall Study|Lost to Follow-up|2|||
42289945|NCT02691247|76123514|FG001|Overall Study|Lost to Follow-up|0|||
42289946|NCT02691247|76123515|FG002|Overall Study|Lost to Follow-up|1|||
42289947|NCT01362491|76123526|FG000|Overall Study|Ineligible|1|||
42355747|NCT01728116|76198579|FG001|Overall Study|Inter-current finding at procedure|0|||
42355748|NCT01728116|76198578|FG000|Overall Study|Incorrectly enrolled in Study|0|||
42355749|NCT01728116|76198579|FG001|Overall Study|Incorrectly enrolled in Study|1|||
42355750|NCT01728116|76198578|FG000|Overall Study|various not noted previously|5|||
42355751|NCT01728116|76198579|FG001|Overall Study|various not noted previously|0|||
42355752|NCT01465659|76198590|FG000|Completed 1 Cycle of Treatment|Death|0|||
42355753|NCT01465659|76198591|FG001|Completed 1 Cycle of Treatment|Death|1|||
42355754|NCT01465659|76198592|FG002|Completed 1 Cycle of Treatment|Death|0|||
42355755|NCT01465659|76198593|FG003|Completed 1 Cycle of Treatment|Death|0|||
42355756|NCT01465659|76198590|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
42355757|NCT01465659|76198591|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
42355758|NCT01465659|76198592|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
42355759|NCT01465659|76198593|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
42355760|NCT01465659|76198590|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
42355761|NCT01465659|76198591|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
42355762|NCT01465659|76198592|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
42355763|NCT01465659|76198593|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
42355764|NCT01465659|76198590|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
42355765|NCT01465659|76198591|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
42355766|NCT01465659|76198592|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
42355767|NCT01465659|76198593|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
42355768|NCT01465659|76198590|FG000|Completed Follow for 1 Year|Death|6|||
42355769|NCT01465659|76198591|FG001|Completed Follow for 1 Year|Death|3|||
42355770|NCT01465659|76198592|FG002|Completed Follow for 1 Year|Death|2|||
42355771|NCT01465659|76198593|FG003|Completed Follow for 1 Year|Death|4|||
42355772|NCT01753076|76198608|FG000|Overall Study|Adverse Event|17|||
42355773|NCT01753076|76198609|FG001|Overall Study|Adverse Event|18|||
42355774|NCT01753076|76198608|FG000|Overall Study|Lack of Efficacy|3|||
42355775|NCT01753076|76198609|FG001|Overall Study|Lack of Efficacy|1|||
42355776|NCT01753076|76198608|FG000|Overall Study|Lost to Follow-up|2|||
42355777|NCT01753076|76198609|FG001|Overall Study|Lost to Follow-up|1|||
42355778|NCT01753076|76198608|FG000|Overall Study|Physician Decision|4|||
42355779|NCT01753076|76198609|FG001|Overall Study|Physician Decision|2|||
42355780|NCT01753076|76198608|FG000|Overall Study|Withdrawal by Subject|14|||
42355781|NCT01753076|76198609|FG001|Overall Study|Withdrawal by Subject|24|||
42355782|NCT01753076|76198608|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
42355783|NCT01753076|76198609|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
42355784|NCT01463007|76198617|FG000|Overall Study|Physician Decision|1|||
42355785|NCT01462929|76198625|FG000|Overall Study|Adverse Event|3|||
42289948|NCT01362491|76123527|FG001|Overall Study|Ineligible|0|||
42355786|NCT01462929|76198626|FG001|Overall Study|Adverse Event|3|||
42355787|NCT01462929|76198627|FG002|Overall Study|Adverse Event|4|||
42355788|NCT01462929|76198625|FG000|Overall Study|Withdrawal by Subject|2|||
42355789|NCT01462929|76198626|FG001|Overall Study|Withdrawal by Subject|1|||
42289949|NCT01362491|76123528|FG002|Overall Study|Ineligible|0|||
42289950|NCT02687191|76123543|FG000|Overall Study|Death|0|||
42355790|NCT01462929|76198627|FG002|Overall Study|Withdrawal by Subject|0|||
42355791|NCT01462929|76198625|FG000|Overall Study|Lack of Efficacy|0|||
42355792|NCT01462929|76198626|FG001|Overall Study|Lack of Efficacy|0|||
42355793|NCT01462929|76198627|FG002|Overall Study|Lack of Efficacy|1|||
42355794|NCT01462695|76198637|FG000|Overall Study|Adverse Event|1|||
42355795|NCT01462695|76198638|FG001|Overall Study|Adverse Event|1|||
42355796|NCT01462695|76198637|FG000|Overall Study|Death|2|||
42355797|NCT01462695|76198638|FG001|Overall Study|Death|0|||
42355798|NCT01462695|76198637|FG000|Overall Study|Lack of Efficacy|6|||
42355799|NCT01462695|76198638|FG001|Overall Study|Lack of Efficacy|12|||
42355800|NCT01462695|76198637|FG000|Overall Study|Physician Decision|5|||
42355801|NCT01462695|76198638|FG001|Overall Study|Physician Decision|0|||
42355802|NCT01462695|76198637|FG000|Overall Study|Withdrawal by Subject|2|||
42289951|NCT02687191|76123544|FG001|Overall Study|Death|1|||
42289952|NCT02687191|76123545|FG002|Overall Study|Death|1|||
42289953|NCT02687191|76123546|FG003|Overall Study|Death|0|||
42289954|NCT02687191|76123547|FG004|Overall Study|Death|1|||
42289955|NCT02687191|76123548|FG005|Overall Study|Death|1|||
42289956|NCT02687191|76123543|FG000|Overall Study|Withdrawal by Subject|0|||
42289957|NCT02687191|76123544|FG001|Overall Study|Withdrawal by Subject|0|||
42289958|NCT02687191|76123545|FG002|Overall Study|Withdrawal by Subject|0|||
42289959|NCT02687191|76123546|FG003|Overall Study|Withdrawal by Subject|1|||
42289960|NCT02687191|76123547|FG004|Overall Study|Withdrawal by Subject|0|||
42289961|NCT02687191|76123548|FG005|Overall Study|Withdrawal by Subject|0|||
42289962|NCT02687035|76123562|FG000|Overall Study|Withdrawal by Subject|1|||
42289963|NCT02687035|76123562|FG000|Overall Study|Death|87|||
42289964|NCT02687035|76123562|FG000|Overall Study|Lost to Follow-up|1|||
42289965|NCT02687035|76123562|FG000|Overall Study|Missed Visit|87|||
42289966|NCT02687035|76123562|FG000|Overall Study|Did not receive Study Device|8|||
42289967|NCT02691013|76123568|FG000|Overall Study|Withdrawal by Subject|3|||
42289968|NCT02691013|76123569|FG001|Overall Study|Withdrawal by Subject|0|||
42289969|NCT02690701|76123579|FG000|Treatment Period 1|Adverse Event|2|||
42289970|NCT02690701|76123580|FG001|Treatment Period 1|Adverse Event|2|||
42289971|NCT02690701|76123579|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42289972|NCT02690701|76123580|FG001|Treatment Period 1|Withdrawal by Subject|1|||
42289973|NCT02690701|76123579|FG000|Treatment Period 2|Adverse Event|2|||
42355803|NCT01462695|76198638|FG001|Overall Study|Withdrawal by Subject|0|||
42355804|NCT01462695|76198637|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
42355805|NCT01462695|76198638|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
42289974|NCT02690701|76123580|FG001|Treatment Period 2|Adverse Event|0|||
42289975|NCT02690701|76123579|FG000|Treatment Period 2|Lack of Efficacy|1|||
42289976|NCT02690701|76123580|FG001|Treatment Period 2|Lack of Efficacy|0|||
42355806|NCT01465347|76198644|FG000|Overall Study|Withdrawal by Subject|1|||
42355807|NCT01465347|76198645|FG001|Overall Study|Withdrawal by Subject|1|||
42355808|NCT01465347|76198644|FG000|Overall Study|Physician Decision|0|||
42355809|NCT01465347|76198645|FG001|Overall Study|Physician Decision|1|||
42355810|NCT01465347|76198644|FG000|Overall Study|Admitted to hospice|0|||
42355811|NCT01465347|76198645|FG001|Overall Study|Admitted to hospice|1|||
42355812|NCT01465191|76198657|FG000|Overall Study|Protocol Violation|6|||
42355813|NCT01465191|76198658|FG001|Overall Study|Protocol Violation|3|||
42172320|NCT03374488|75979151|FG001|Overall Study|Death|13|||
42172321|NCT03374488|75979150|FG000|Overall Study|Withdrawal by Subject|3|||
42172322|NCT03374488|75979151|FG001|Overall Study|Withdrawal by Subject|1|||
42289977|NCT02690701|76123579|FG000|Treatment Period 2|Lost to Follow-up|0|||
42289978|NCT02690701|76123580|FG001|Treatment Period 2|Lost to Follow-up|2|||
42289979|NCT02690701|76123579|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42289980|NCT02690701|76123580|FG001|Treatment Period 2|Withdrawal by Subject|2|||
42289981|NCT02690701|76123579|FG000|Treatment Period 2|Protocol Violation|0|||
42355814|NCT01465191|76198659|FG002|Overall Study|Protocol Violation|3|||
42355815|NCT01465191|76198657|FG000|Overall Study|Lost to Follow-up|3|||
42355816|NCT01465191|76198658|FG001|Overall Study|Lost to Follow-up|6|||
42355817|NCT01465191|76198659|FG002|Overall Study|Lost to Follow-up|4|||
42355818|NCT01519947|76198674|FG000|Overall Study|Death|0|||
42355819|NCT01519947|76198675|FG001|Overall Study|Death|0|||
42355820|NCT01519947|76198676|FG002|Overall Study|Death|0|||
42355821|NCT01519947|76198677|FG003|Overall Study|Death|1|||
42355822|NCT01519947|76198674|FG000|Overall Study|Protocol Violation|0|||
42355823|NCT01519947|76198675|FG001|Overall Study|Protocol Violation|0|||
42355824|NCT01519947|76198676|FG002|Overall Study|Protocol Violation|2|||
42355825|NCT01519947|76198677|FG003|Overall Study|Protocol Violation|1|||
42289982|NCT02690701|76123580|FG001|Treatment Period 2|Protocol Violation|1|||
42289983|NCT02694757|76123587|FG000|Overall Study|Lack of Efficacy|3|||
42289984|NCT03805841|76123594|FG000|Overall Study|Clinical Progression|2|||
42355826|NCT01519947|76198674|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
42355827|NCT01519947|76198675|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
42355828|NCT01519947|76198676|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
42355829|NCT01519947|76198677|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
42289985|NCT03805841|76123595|FG001|Overall Study|Clinical Progression|0|||
42172323|NCT03374488|75979150|FG000|Overall Study|Physician Decision|3|||
42172324|NCT03374488|75979151|FG001|Overall Study|Physician Decision|0|||
42172325|NCT00345683|75979160|FG000|Overall Study|Lost to Follow-up|19|||
42172326|NCT00345683|75979161|FG001|Overall Study|Lost to Follow-up|7|||
42172327|NCT00345683|75979160|FG000|Overall Study|Other|6|||
42172328|NCT00345683|75979161|FG001|Overall Study|Other|2|||
42172329|NCT03828383|75979169|FG000|Overall Study|Lost to Follow-up|3|||
42172330|NCT03828383|75979170|FG001|Overall Study|Lost to Follow-up|2|||
42172331|NCT03828383|75979169|FG000|Overall Study|Withdrawal by Subject|4|||
42172332|NCT03828383|75979170|FG001|Overall Study|Withdrawal by Subject|5|||
42172333|NCT00345605|75979176|FG000|Arm 1|Adverse Event|0|||
42172334|NCT00345605|75979177|FG001|Arm 1|Adverse Event|1|||
42172335|NCT00345605|75979176|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
42289986|NCT03805841|76123596|FG002|Overall Study|Clinical Progression|0|||
42289987|NCT03805841|76123594|FG000|Overall Study|Death|0|||
42289988|NCT03805841|76123595|FG001|Overall Study|Death|3|||
42289989|NCT03805841|76123596|FG002|Overall Study|Death|1|||
42289990|NCT03805841|76123594|FG000|Overall Study|Lost to Follow-up|0|||
42289991|NCT03805841|76123595|FG001|Overall Study|Lost to Follow-up|0|||
42289992|NCT03805841|76123596|FG002|Overall Study|Lost to Follow-up|1|||
42289993|NCT03805841|76123594|FG000|Overall Study|Withdrawal by Subject|2|||
42289994|NCT03805841|76123595|FG001|Overall Study|Withdrawal by Subject|3|||
42355830|NCT01519947|76198674|FG000|Overall Study|Development of Anemia|0|||
42355831|NCT01519947|76198675|FG001|Overall Study|Development of Anemia|1|||
42355832|NCT01519947|76198676|FG002|Overall Study|Development of Anemia|0|||
42355833|NCT01519947|76198677|FG003|Overall Study|Development of Anemia|1|||
42355834|NCT01519947|76198674|FG000|Overall Study|Blood Transfusion|0|||
42355835|NCT01519947|76198675|FG001|Overall Study|Blood Transfusion|1|||
42355836|NCT01519947|76198676|FG002|Overall Study|Blood Transfusion|1|||
42355837|NCT01519947|76198677|FG003|Overall Study|Blood Transfusion|0|||
42355838|NCT01519947|76198674|FG000|Overall Study|Withdrawal by Subject|0|||
42355839|NCT01519947|76198675|FG001|Overall Study|Withdrawal by Subject|1|||
42355840|NCT01519947|76198676|FG002|Overall Study|Withdrawal by Subject|0|||
42355841|NCT01519947|76198677|FG003|Overall Study|Withdrawal by Subject|1|||
42355842|NCT01519947|76198674|FG000|Overall Study|Lost to Follow-up|0|||
42355843|NCT01519947|76198675|FG001|Overall Study|Lost to Follow-up|0|||
42355844|NCT01519947|76198676|FG002|Overall Study|Lost to Follow-up|3|||
42355845|NCT01519947|76198677|FG003|Overall Study|Lost to Follow-up|2|||
42355846|NCT01519947|76198674|FG000|Overall Study|Poor Response|1|||
42355847|NCT01519947|76198675|FG001|Overall Study|Poor Response|0|||
42355848|NCT01519947|76198676|FG002|Overall Study|Poor Response|0|||
42355849|NCT01519947|76198677|FG003|Overall Study|Poor Response|1|||
42355850|NCT01519947|76198674|FG000|Overall Study|Adverse Event|1|||
42355851|NCT01519947|76198675|FG001|Overall Study|Adverse Event|0|||
42355852|NCT01519947|76198676|FG002|Overall Study|Adverse Event|1|||
42355853|NCT01519947|76198677|FG003|Overall Study|Adverse Event|1|||
42355854|NCT01462227|76198689|FG000|Second Assignment|Lost to Follow-up|1|||
42355855|NCT01462227|76198690|FG001|Second Assignment|Lost to Follow-up|0|||
42355856|NCT01462227|76198691|FG002|Second Assignment|Lost to Follow-up|0|||
42355857|NCT01462227|76198692|FG003|Second Assignment|Lost to Follow-up|0|||
42355858|NCT01462227|76198689|FG000|Second Assignment|Protocol Violation|0|||
42355859|NCT01462227|76198690|FG001|Second Assignment|Protocol Violation|1|||
42355860|NCT01462227|76198691|FG002|Second Assignment|Protocol Violation|1|||
42355861|NCT01462227|76198692|FG003|Second Assignment|Protocol Violation|0|||
42355862|NCT01464879|76198700|FG000|Overall Study|Physician Decision|1|||
42355863|NCT01464879|76198700|FG000|Overall Study|Non-compliance|1|||
42355864|NCT01519869|76198710|FG000|Overall Study|Lost to Follow-up|1|||
42355865|NCT01519791|76198716|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
42355866|NCT01519791|76198717|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
42355867|NCT01519791|76198716|FG000|Overall Study|Protocol Violation|6|||
42355868|NCT01519791|76198717|FG001|Overall Study|Protocol Violation|19|||
42172336|NCT00345605|75979177|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
42289995|NCT03805841|76123596|FG002|Overall Study|Withdrawal by Subject|0|||
42172337|NCT03394924|75979188|FG000|Overall Study|Adverse Event|0|||
42289996|NCT03805841|76123594|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
42355869|NCT01519791|76198716|FG000|Overall Study|Other Reason|87|||
42289997|NCT03805841|76123595|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
42355870|NCT01519791|76198717|FG001|Overall Study|Other Reason|222|||
42355871|NCT01519791|76198716|FG000|Overall Study|subjects randomized in error|2|||
42355872|NCT01519791|76198717|FG001|Overall Study|subjects randomized in error|0|||
42355873|NCT01519791|76198716|FG000|Overall Study|Lack of Efficacy|16|||
42355874|NCT01519791|76198717|FG001|Overall Study|Lack of Efficacy|20|||
42355875|NCT01519791|76198716|FG000|Overall Study|SAE, non-fatal|6|||
42355876|NCT01519791|76198717|FG001|Overall Study|SAE, non-fatal|22|||
42289998|NCT03805841|76123596|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
42289999|NCT02684617|76123607|FG000|Overall Study|Adverse Event|1|||
42290000|NCT02684617|76123608|FG001|Overall Study|Adverse Event|0|||
42290001|NCT02684617|76123609|FG002|Overall Study|Adverse Event|1|||
42290002|NCT02684617|76123607|FG000|Overall Study|Death|8|||
42290003|NCT02684617|76123608|FG001|Overall Study|Death|16|||
42290004|NCT02684617|76123609|FG002|Overall Study|Death|28|||
42290005|NCT02684617|76123607|FG000|Overall Study|Withdrawal by Subject|2|||
42290006|NCT02684617|76123608|FG001|Overall Study|Withdrawal by Subject|0|||
42355877|NCT01519791|76198716|FG000|Overall Study|AE, serious fatal|0|||
42355878|NCT01519791|76198717|FG001|Overall Study|AE, serious fatal|1|||
42355879|NCT01519791|76198716|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
42355880|NCT01519791|76198717|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
42355881|NCT01519791|76198716|FG000|Overall Study|AE, non-serious non-fatal|12|||
42355882|NCT01519791|76198717|FG001|Overall Study|AE, non-serious non-fatal|31|||
42355883|NCT01519791|76198716|FG000|Overall Study|Withdrawal by Subject|15|||
42290007|NCT02684617|76123609|FG002|Overall Study|Withdrawal by Subject|4|||
42290008|NCT02684617|76123607|FG000|Overall Study|Screen Failure|1|||
42290009|NCT02684617|76123608|FG001|Overall Study|Screen Failure|0|||
42290010|NCT02684617|76123609|FG002|Overall Study|Screen Failure|2|||
42290011|NCT02684617|76123607|FG000|Overall Study|Study Terminated by Sponsor|6|||
42290012|NCT02684617|76123608|FG001|Overall Study|Study Terminated by Sponsor|1|||
42290013|NCT02684617|76123609|FG002|Overall Study|Study Terminated by Sponsor|5|||
42290014|NCT01999972|76123623|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
42290015|NCT01999972|76123624|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
42290016|NCT01999972|76123625|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
42290017|NCT01999972|76123626|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
42290018|NCT01999972|76123627|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
42290019|NCT01999972|76123628|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
42290020|NCT01999972|76123623|FG000|Dose Escalation Part|Death|0|||
42290021|NCT01999972|76123624|FG001|Dose Escalation Part|Death|1|||
42290022|NCT01999972|76123625|FG002|Dose Escalation Part|Death|0|||
42290023|NCT01999972|76123626|FG003|Dose Escalation Part|Death|0|||
42290024|NCT01999972|76123627|FG004|Dose Escalation Part|Death|0|||
42290025|NCT01999972|76123628|FG005|Dose Escalation Part|Death|0|||
42290026|NCT01999972|76123623|FG000|Dose Escalation Part|Enrolled but not treated|0|||
42290027|NCT01999972|76123624|FG001|Dose Escalation Part|Enrolled but not treated|0|||
42290028|NCT01999972|76123625|FG002|Dose Escalation Part|Enrolled but not treated|1|||
42290029|NCT01999972|76123626|FG003|Dose Escalation Part|Enrolled but not treated|1|||
42290030|NCT01999972|76123627|FG004|Dose Escalation Part|Enrolled but not treated|0|||
42290031|NCT01999972|76123628|FG005|Dose Escalation Part|Enrolled but not treated|0|||
42355884|NCT01519791|76198717|FG001|Overall Study|Withdrawal by Subject|37|||
42355885|NCT01519791|76198716|FG000|Overall Study|Lost to Follow-up|6|||
42355886|NCT01519791|76198717|FG001|Overall Study|Lost to Follow-up|14|||
42355887|NCT01461993|76198728|FG000|Overall Study|Withdrawal by Subject|60|||
42355888|NCT01461993|76198729|FG001|Overall Study|Withdrawal by Subject|53|||
42355889|NCT01461993|76198730|FG002|Overall Study|Withdrawal by Subject|16|||
42290032|NCT01999972|76123623|FG000|Dose Escalation Part|Disease progression|3|||
42290033|NCT01999972|76123624|FG001|Dose Escalation Part|Disease progression|2|||
42290034|NCT01999972|76123625|FG002|Dose Escalation Part|Disease progression|3|||
42290035|NCT01999972|76123626|FG003|Dose Escalation Part|Disease progression|6|||
42355890|NCT01461993|76198728|FG000|Overall Study|Lost to Follow-up|44|||
42355891|NCT01461993|76198729|FG001|Overall Study|Lost to Follow-up|48|||
42355892|NCT01461993|76198730|FG002|Overall Study|Lost to Follow-up|22|||
42355893|NCT01461993|76198728|FG000|Overall Study|Protocol Violation|10|||
42355894|NCT01461993|76198729|FG001|Overall Study|Protocol Violation|9|||
42355895|NCT01461993|76198730|FG002|Overall Study|Protocol Violation|7|||
42355896|NCT01461993|76198728|FG000|Overall Study|Adverse Event|9|||
42355897|NCT01461993|76198729|FG001|Overall Study|Adverse Event|11|||
42355898|NCT01461993|76198730|FG002|Overall Study|Adverse Event|3|||
42355899|NCT01461993|76198728|FG000|Overall Study|No longer met eligibility criteria|13|||
42355900|NCT01461993|76198729|FG001|Overall Study|No longer met eligibility criteria|18|||
42355901|NCT01461993|76198730|FG002|Overall Study|No longer met eligibility criteria|10|||
42355902|NCT01461993|76198728|FG000|Overall Study|Did not meet entrance criteria|2|||
42355903|NCT01461993|76198729|FG001|Overall Study|Did not meet entrance criteria|3|||
42355904|NCT01461993|76198730|FG002|Overall Study|Did not meet entrance criteria|0|||
42355905|NCT01461993|76198728|FG000|Overall Study|Other|13|||
42355906|NCT01461993|76198729|FG001|Overall Study|Other|15|||
42355907|NCT01461993|76198730|FG002|Overall Study|Other|6|||
42355908|NCT01782326|76198741|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
42355909|NCT01782326|76198742|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
42355910|NCT01782326|76198741|FG000|Planned Treatment Epoch|Death|29|||
42355911|NCT01782326|76198742|FG001|Planned Treatment Epoch|Death|30|||
42355912|NCT01782326|76198741|FG000|Planned Treatment Epoch|Physician Decision|18|||
42355913|NCT01782326|76198742|FG001|Planned Treatment Epoch|Physician Decision|16|||
42355914|NCT01782326|76198741|FG000|Planned Treatment Epoch|Protocol deviation|2|||
42355915|NCT01782326|76198742|FG001|Planned Treatment Epoch|Protocol deviation|3|||
42355916|NCT01782326|76198741|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
42355917|NCT01782326|76198742|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
42355918|NCT01782326|76198741|FG000|Planned Treatment Epoch|Technical problems|0|||
42355919|NCT01782326|76198742|FG001|Planned Treatment Epoch|Technical problems|4|||
42355920|NCT01782326|76198741|FG000|Double-blind Treatment|Adverse Event|129|||
42355921|NCT01782326|76198742|FG001|Double-blind Treatment|Adverse Event|145|||
42355922|NCT01782326|76198741|FG000|Double-blind Treatment|Subject/guardian decision|111|||
42355923|NCT01782326|76198742|FG001|Double-blind Treatment|Subject/guardian decision|125|||
42355924|NCT01782326|76198741|FG000|Double-blind Treatment|Lack of Efficacy|17|||
42355925|NCT01782326|76198742|FG001|Double-blind Treatment|Lack of Efficacy|22|||
42355926|NCT01782326|76198741|FG000|Double-blind Treatment|Physician Decision|13|||
42355927|NCT01782326|76198742|FG001|Double-blind Treatment|Physician Decision|16|||
42355928|NCT01782326|76198741|FG000|Double-blind Treatment|Protocol deviation|8|||
42355929|NCT01782326|76198742|FG001|Double-blind Treatment|Protocol deviation|7|||
42355930|NCT01782326|76198741|FG000|Double-blind Treatment|Technical problems|0|||
42355931|NCT01782326|76198742|FG001|Double-blind Treatment|Technical problems|5|||
42290036|NCT01999972|76123627|FG004|Dose Escalation Part|Disease progression|0|||
42290037|NCT01999972|76123628|FG005|Dose Escalation Part|Disease progression|0|||
42290038|NCT01999972|76123623|FG000|Dose Escalation Part|Adverse Event|0|||
42290039|NCT01999972|76123624|FG001|Dose Escalation Part|Adverse Event|0|||
42290040|NCT01999972|76123625|FG002|Dose Escalation Part|Adverse Event|0|||
42290041|NCT01999972|76123626|FG003|Dose Escalation Part|Adverse Event|2|||
42290042|NCT01999972|76123627|FG004|Dose Escalation Part|Adverse Event|0|||
42290043|NCT01999972|76123628|FG005|Dose Escalation Part|Adverse Event|0|||
42355932|NCT01439373|76198750|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
42355933|NCT01439373|76198751|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
42355934|NCT01439373|76198750|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
42355935|NCT01439373|76198751|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
42355936|NCT01461369|76198764|FG000|Overall Study|Lack of Efficacy|2|||
42355937|NCT01461369|76198765|FG001|Overall Study|Lack of Efficacy|0|||
42355938|NCT01461369|76198766|FG002|Overall Study|Lack of Efficacy|6|||
42355939|NCT01461369|76198764|FG000|Overall Study|Lost to Follow-up|0|||
42355940|NCT01461369|76198765|FG001|Overall Study|Lost to Follow-up|0|||
42355941|NCT01461369|76198766|FG002|Overall Study|Lost to Follow-up|3|||
42355942|NCT01461369|76198764|FG000|Overall Study|Adverse Event|9|||
42355943|NCT01461369|76198765|FG001|Overall Study|Adverse Event|12|||
42355944|NCT01461369|76198766|FG002|Overall Study|Adverse Event|4|||
42355945|NCT01461369|76198764|FG000|Overall Study|Protocol Violation|1|||
42355946|NCT01461369|76198765|FG001|Overall Study|Protocol Violation|2|||
42355947|NCT01461369|76198766|FG002|Overall Study|Protocol Violation|2|||
42355948|NCT01461369|76198764|FG000|Overall Study|Withdrawal by Subject|1|||
42355949|NCT01461369|76198765|FG001|Overall Study|Withdrawal by Subject|3|||
42355950|NCT01461369|76198766|FG002|Overall Study|Withdrawal by Subject|2|||
42355951|NCT01727258|76198777|FG000|Overall Study|Adverse Event|0|||
42355952|NCT01727258|76198778|FG001|Overall Study|Adverse Event|2|||
42355953|NCT01727258|76198779|FG002|Overall Study|Adverse Event|0|||
42355954|NCT01727258|76198777|FG000|Overall Study|Noncompliance with Study Drug|0|||
42355955|NCT01727258|76198778|FG001|Overall Study|Noncompliance with Study Drug|0|||
42355956|NCT01727258|76198779|FG002|Overall Study|Noncompliance with Study Drug|1|||
42355957|NCT01727258|76198777|FG000|Overall Study|Withdrawal by Subject|1|||
42290044|NCT01999972|76123623|FG000|Dose Escalation Part|Global deterioration of health status|1|||
42290045|NCT01999972|76123624|FG001|Dose Escalation Part|Global deterioration of health status|0|||
42290046|NCT01999972|76123625|FG002|Dose Escalation Part|Global deterioration of health status|0|||
42290047|NCT01999972|76123626|FG003|Dose Escalation Part|Global deterioration of health status|1|||
42290048|NCT01999972|76123627|FG004|Dose Escalation Part|Global deterioration of health status|0|||
42290049|NCT01999972|76123628|FG005|Dose Escalation Part|Global deterioration of health status|0|||
42290050|NCT01999972|76123623|FG000|Dose Expansion Part|Death|0|||
42290051|NCT01999972|76123624|FG001|Dose Expansion Part|Death|0|||
42355958|NCT01727258|76198778|FG001|Overall Study|Withdrawal by Subject|1|||
42355959|NCT01727258|76198779|FG002|Overall Study|Withdrawal by Subject|0|||
42290052|NCT01999972|76123625|FG002|Dose Expansion Part|Death|0|||
42355960|NCT01727258|76198777|FG000|Overall Study|Lost to Follow-up|1|||
42355961|NCT01727258|76198778|FG001|Overall Study|Lost to Follow-up|0|||
42355962|NCT01727258|76198779|FG002|Overall Study|Lost to Follow-up|0|||
42355963|NCT01781390|76198790|FG000|Overall Study|Withdrawal of Consent|0|||
42355964|NCT01781390|76198791|FG001|Overall Study|Withdrawal of Consent|3|||
42172338|NCT03394924|75979189|FG001|Overall Study|Adverse Event|5|||
42172339|NCT03394924|75979190|FG002|Overall Study|Adverse Event|0|||
42172340|NCT03394924|75979188|FG000|Overall Study|Withdrawal by Subject|2|||
42172341|NCT03394924|75979189|FG001|Overall Study|Withdrawal by Subject|0|||
42172342|NCT03394924|75979190|FG002|Overall Study|Withdrawal by Subject|0|||
42172343|NCT03394924|75979188|FG000|Overall Study|Lost to Follow-up|0|||
42172344|NCT03394924|75979189|FG001|Overall Study|Lost to Follow-up|1|||
42172345|NCT03394924|75979190|FG002|Overall Study|Lost to Follow-up|0|||
42290053|NCT01999972|76123626|FG003|Dose Expansion Part|Death|0|||
42290054|NCT01999972|76123627|FG004|Dose Expansion Part|Death|2|||
42290055|NCT01999972|76123628|FG005|Dose Expansion Part|Death|1|||
42290056|NCT01999972|76123623|FG000|Dose Expansion Part|Disease progression|0|||
42290057|NCT01999972|76123624|FG001|Dose Expansion Part|Disease progression|0|||
42290058|NCT01999972|76123625|FG002|Dose Expansion Part|Disease progression|0|||
42290059|NCT01999972|76123626|FG003|Dose Expansion Part|Disease progression|0|||
42355965|NCT01781390|76198792|FG002|Overall Study|Withdrawal of Consent|1|||
42355966|NCT01781390|76198790|FG000|Overall Study|Lost to Follow-up|1|||
42355967|NCT01781390|76198791|FG001|Overall Study|Lost to Follow-up|1|||
42355968|NCT01781390|76198792|FG002|Overall Study|Lost to Follow-up|1|||
42355969|NCT01781390|76198790|FG000|Overall Study|Adverse Event|1|||
42355970|NCT01781390|76198791|FG001|Overall Study|Adverse Event|2|||
42355971|NCT01781390|76198792|FG002|Overall Study|Adverse Event|1|||
42355972|NCT01781390|76198790|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
42355973|NCT01781390|76198791|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
42355974|NCT01781390|76198792|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
42355975|NCT01781234|76198802|FG000|Overall Study|Adverse Event|2|||
42355976|NCT01781234|76198803|FG001|Overall Study|Adverse Event|0|||
42355977|NCT01781234|76198802|FG000|Overall Study|Protocol Violation|3|||
42355978|NCT01781234|76198803|FG001|Overall Study|Protocol Violation|0|||
42172346|NCT03394924|75979188|FG000|Overall Study|Did not meet all inclusion criteria|1|||
42290060|NCT01999972|76123627|FG004|Dose Expansion Part|Disease progression|9|||
42355979|NCT01781234|76198802|FG000|Overall Study|Withdrawal by Subject|4|||
42290061|NCT01999972|76123628|FG005|Dose Expansion Part|Disease progression|3|||
42355980|NCT01781234|76198803|FG001|Overall Study|Withdrawal by Subject|3|||
42355981|NCT01752842|76198813|FG000|Overall Study|Adverse Event|3|||
42355982|NCT01752842|76198814|FG001|Overall Study|Adverse Event|0|||
42355983|NCT01752842|76198813|FG000|Overall Study|Withdrawal by Subject|0|||
42355984|NCT01752842|76198814|FG001|Overall Study|Withdrawal by Subject|2|||
42355985|NCT01461057|76198822|FG000|Overall Study|Death|10|||
42355986|NCT01461057|76198823|FG001|Overall Study|Death|9|||
42355987|NCT01461057|76198822|FG000|Overall Study|Withdrawal by Subject|2|||
42355988|NCT01461057|76198823|FG001|Overall Study|Withdrawal by Subject|3|||
42355989|NCT01461057|76198822|FG000|Overall Study|Physician Decision|0|||
42355990|NCT01461057|76198823|FG001|Overall Study|Physician Decision|2|||
42355991|NCT01461057|76198822|FG000|Overall Study|Adverse Event|0|||
42355992|NCT01461057|76198823|FG001|Overall Study|Adverse Event|1|||
42355993|NCT01461057|76198822|FG000|Overall Study|Progression of Disease|1|||
42355994|NCT01461057|76198823|FG001|Overall Study|Progression of Disease|0|||
42355995|NCT01461057|76198822|FG000|Overall Study|Study Terminated by Sponsor|2|||
42355996|NCT01461057|76198823|FG001|Overall Study|Study Terminated by Sponsor|0|||
42355997|NCT01460901|76198829|FG000|Overall Study|Withdrawal by Subject|2|||
42355998|NCT01519635|76198838|FG000|Overall Study|Withdrawal by Subject|0|||
42355999|NCT01519635|76198839|FG001|Overall Study|Withdrawal by Subject|1|||
42356000|NCT01519635|76198838|FG000|Overall Study|No possibility to put a catheter|1|||
42356001|NCT01519635|76198839|FG001|Overall Study|No possibility to put a catheter|2|||
42356002|NCT01519323|76198845|FG000|Overall Study|Death|3|||
42356003|NCT01519323|76198846|FG001|Overall Study|Death|2|||
42356004|NCT01519323|76198845|FG000|Overall Study|Study terminated by sponsor|0|||
42290062|NCT01999972|76123623|FG000|Dose Expansion Part|Sponsor decision|0|||
42290063|NCT01999972|76123624|FG001|Dose Expansion Part|Sponsor decision|0|||
42290064|NCT01999972|76123625|FG002|Dose Expansion Part|Sponsor decision|0|||
42290065|NCT01999972|76123626|FG003|Dose Expansion Part|Sponsor decision|0|||
42290066|NCT01999972|76123627|FG004|Dose Expansion Part|Sponsor decision|1|||
42356005|NCT01519323|76198846|FG001|Overall Study|Study terminated by sponsor|1|||
42172347|NCT03394924|75979189|FG001|Overall Study|Did not meet all inclusion criteria|0|||
42290067|NCT01999972|76123628|FG005|Dose Expansion Part|Sponsor decision|0|||
42290068|NCT01999972|76123623|FG000|Dose Expansion Part|Adverse Event|0|||
42290069|NCT01999972|76123624|FG001|Dose Expansion Part|Adverse Event|0|||
42290070|NCT01999972|76123625|FG002|Dose Expansion Part|Adverse Event|0|||
42290071|NCT01999972|76123626|FG003|Dose Expansion Part|Adverse Event|0|||
42290072|NCT01999972|76123627|FG004|Dose Expansion Part|Adverse Event|4|||
42290073|NCT01999972|76123628|FG005|Dose Expansion Part|Adverse Event|2|||
42290074|NCT01999972|76123623|FG000|Dose Expansion Part|Participant's non-compliance|0|||
42290075|NCT01999972|76123624|FG001|Dose Expansion Part|Participant's non-compliance|0|||
42290076|NCT01999972|76123625|FG002|Dose Expansion Part|Participant's non-compliance|0|||
42290077|NCT01999972|76123626|FG003|Dose Expansion Part|Participant's non-compliance|0|||
42290078|NCT01999972|76123627|FG004|Dose Expansion Part|Participant's non-compliance|0|||
42290079|NCT01999972|76123628|FG005|Dose Expansion Part|Participant's non-compliance|1|||
42290080|NCT01999972|76123623|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
42290081|NCT01999972|76123624|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
42290082|NCT01999972|76123625|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
42290083|NCT01999972|76123626|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
42290084|NCT01999972|76123627|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
42290085|NCT01999972|76123628|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
42290086|NCT01999972|76123623|FG000|Dose Expansion Part|Changed to standard of care|0|||
42290087|NCT01999972|76123624|FG001|Dose Expansion Part|Changed to standard of care|0|||
42290088|NCT01999972|76123625|FG002|Dose Expansion Part|Changed to standard of care|0|||
42290089|NCT01999972|76123626|FG003|Dose Expansion Part|Changed to standard of care|0|||
42290090|NCT01999972|76123627|FG004|Dose Expansion Part|Changed to standard of care|1|||
42290091|NCT01999972|76123628|FG005|Dose Expansion Part|Changed to standard of care|0|||
42290092|NCT01999894|76123644|FG000|Overall Study|Adverse Event|9|||
42290093|NCT01999894|76123644|FG000|Overall Study|Lack of Efficacy|5|||
42290094|NCT01999894|76123644|FG000|Overall Study|Protocol Violation|1|||
42290095|NCT01999894|76123644|FG000|Overall Study|Withdrawal by Subject|7|||
42356006|NCT01519245|76198854|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
42356007|NCT01519245|76198855|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
42356008|NCT01519167|76198865|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
42172348|NCT03394924|75979190|FG002|Overall Study|Did not meet all inclusion criteria|0|||
42172349|NCT00345293|75979200|FG000|Overall Study|Unable to access line for sample|1|||
42356009|NCT01519167|76198866|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
42356010|NCT01519167|76198865|FG000|Overall Study|Adverse Event|0|||
42356011|NCT01519167|76198866|FG001|Overall Study|Adverse Event|1|||
42356012|NCT01519167|76198865|FG000|Overall Study|Lack of Efficacy|0|||
42172350|NCT00345293|75979201|FG001|Overall Study|Unable to access line for sample|0|||
42290096|NCT01999894|76123644|FG000|Overall Study|Lost to Follow-up|10|||
42290097|NCT01999894|76123644|FG000|Overall Study|Other Reason|3|||
42290098|NCT01999894|76123644|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
42356013|NCT01519167|76198866|FG001|Overall Study|Lack of Efficacy|1|||
42356014|NCT01519167|76198865|FG000|Overall Study|Medical condition changes&deep sedation|0|||
42356015|NCT01519167|76198866|FG001|Overall Study|Medical condition changes&deep sedation|2|||
42356016|NCT01519167|76198865|FG000|Overall Study|Physician Decision|0|||
42356017|NCT01519167|76198866|FG001|Overall Study|Physician Decision|1|||
42290099|NCT02679235|76123649|FG000|Overall Study|Withdrawal by Subject|3|||
42290100|NCT02679235|76123649|FG000|Overall Study|Adverse Event|1|||
42290101|NCT01976806|76123655|FG000|Overall Study|Lost to Follow-up|1|||
42290102|NCT01976806|76123656|FG001|Overall Study|Lost to Follow-up|4|||
42290103|NCT01976806|76123655|FG000|Overall Study|Adverse Event|1|||
42290104|NCT01976806|76123656|FG001|Overall Study|Adverse Event|1|||
42290105|NCT01976806|76123655|FG000|Overall Study|Withdrawal by Subject|1|||
42290106|NCT01976806|76123656|FG001|Overall Study|Withdrawal by Subject|1|||
42290107|NCT02679079|76123665|FG000|Overall Study|Adverse Event|2|||
42290108|NCT02679079|76123666|FG001|Overall Study|Adverse Event|0|||
42290109|NCT02679079|76123667|FG002|Overall Study|Adverse Event|2|||
42290110|NCT02679079|76123665|FG000|Overall Study|Protocol Violation|0|||
42290111|NCT02679079|76123666|FG001|Overall Study|Protocol Violation|1|||
42290112|NCT02679079|76123667|FG002|Overall Study|Protocol Violation|0|||
42290113|NCT02679079|76123665|FG000|Overall Study|Withdrawal by Subject|2|||
42290114|NCT02679079|76123666|FG001|Overall Study|Withdrawal by Subject|1|||
42290115|NCT02679079|76123667|FG002|Overall Study|Withdrawal by Subject|0|||
42290116|NCT02678923|76123677|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
42290117|NCT02678923|76123678|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
42290118|NCT02678923|76123677|FG000|Overall Study|Withdrawal by Subject|3|||
42290119|NCT02678923|76123678|FG001|Overall Study|Withdrawal by Subject|2|||
42290120|NCT02678923|76123677|FG000|Overall Study|Lost to Follow-up|1|||
42290121|NCT02678923|76123678|FG001|Overall Study|Lost to Follow-up|0|||
42290122|NCT02678923|76123677|FG000|Overall Study|Did Not Return for Study Visits|1|||
42290123|NCT02678923|76123678|FG001|Overall Study|Did Not Return for Study Visits|0|||
42290124|NCT01976728|76123688|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
42290125|NCT01976728|76123689|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
42290126|NCT01976728|76123690|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
42290127|NCT01976728|76123691|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
42290128|NCT02689219|76123719|FG000|Overall Study|Death|1|||
42290129|NCT02689219|76123720|FG001|Overall Study|Death|1|||
42290130|NCT02689219|76123719|FG000|Overall Study|Disease Progression|10|||
42290131|NCT02689219|76123720|FG001|Overall Study|Disease Progression|6|||
42290132|NCT02683525|76123726|FG000|Overall Study|Lost to Follow-up|1|||
42290133|NCT02683525|76123726|FG000|Overall Study|Physician Decision|1|||
42290134|NCT02683525|76123726|FG000|Overall Study|Disease Progression|6|||
42290135|NCT01976338|76123732|FG000|Overall Study|Physician Decision|0|||
42290136|NCT01976338|76123733|FG001|Overall Study|Physician Decision|1|||
42290137|NCT01976338|76123732|FG000|Overall Study|Lost to Follow-up|3|||
42290138|NCT01976338|76123733|FG001|Overall Study|Lost to Follow-up|0|||
42290139|NCT01976338|76123732|FG000|Overall Study|Withdrawal by Subject|5|||
42290140|NCT01976338|76123733|FG001|Overall Study|Withdrawal by Subject|2|||
42290141|NCT01976338|76123732|FG000|Overall Study|Adverse Event|5|||
42290142|NCT01976338|76123733|FG001|Overall Study|Adverse Event|1|||
42290143|NCT02674633|76123742|FG000|Overall Study|Lost to Follow-up|3|||
42290144|NCT02674633|76123743|FG001|Overall Study|Lost to Follow-up|2|||
42356018|NCT01519089|76199107|FG000|Overall Study|Adverse Event|4|||
42356019|NCT01519089|76199108|FG001|Overall Study|Adverse Event|4|||
42356020|NCT01519089|76199107|FG000|Overall Study|Lack of Efficacy|0|||
42356021|NCT01519089|76199108|FG001|Overall Study|Lack of Efficacy|2|||
42356022|NCT01519089|76199107|FG000|Overall Study|Lost to Follow-up|1|||
42356023|NCT01519089|76199108|FG001|Overall Study|Lost to Follow-up|0|||
42356024|NCT01519089|76199107|FG000|Overall Study|Withdrawal by Subject|0|||
42356025|NCT01519089|76199108|FG001|Overall Study|Withdrawal by Subject|2|||
42356026|NCT01519089|76199107|FG000|Overall Study|Other|2|||
42356027|NCT01519089|76199108|FG001|Overall Study|Other|6|||
42042163|NCT01130168|75849999|FG003|Period 1|Withdrawal by Subject|1|||
42290145|NCT02674633|76123742|FG000|Overall Study|Physician Decision|1|||
42290146|NCT02674633|76123743|FG001|Overall Study|Physician Decision|0|||
42290147|NCT02674633|76123742|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
42290148|NCT02674633|76123743|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
42290149|NCT02651987|76123751|FG000|Overall Study|Adverse Event|2|||
42290150|NCT02651987|76123752|FG001|Overall Study|Adverse Event|2|||
42290151|NCT02651987|76123751|FG000|Overall Study|Consent Withdrawn|2|||
42290152|NCT02651987|76123752|FG001|Overall Study|Consent Withdrawn|0|||
42290153|NCT02651987|76123751|FG000|Overall Study|Local PD|0|||
42356028|NCT01519089|76199107|FG000|Overall Study|Not received study drug|0|||
42356029|NCT01519089|76199108|FG001|Overall Study|Not received study drug|1|||
42356030|NCT01518699|76199130|FG000|Period 2|Protocol Violation|1|||
42356031|NCT01518699|76199131|FG001|Period 2|Protocol Violation|1|||
42356032|NCT01518699|76199132|FG002|Period 2|Protocol Violation|0|||
42356033|NCT01518699|76199133|FG003|Period 2|Protocol Violation|0|||
42356034|NCT01518699|76199134|FG004|Period 2|Protocol Violation|0|||
42356035|NCT01518699|76199135|FG005|Period 2|Protocol Violation|0|||
42356036|NCT01518699|76199130|FG000|Period 2|Lost to Follow-up|0|||
42356037|NCT01518699|76199131|FG001|Period 2|Lost to Follow-up|1|||
42356038|NCT01518699|76199132|FG002|Period 2|Lost to Follow-up|0|||
42356039|NCT01518699|76199133|FG003|Period 2|Lost to Follow-up|0|||
42356040|NCT01518699|76199134|FG004|Period 2|Lost to Follow-up|0|||
42356041|NCT01518699|76199135|FG005|Period 2|Lost to Follow-up|0|||
42356042|NCT01518699|76199130|FG000|Period 2|Adverse Event|1|||
42356043|NCT01518699|76199131|FG001|Period 2|Adverse Event|0|||
42356044|NCT01518699|76199132|FG002|Period 2|Adverse Event|0|||
42356045|NCT01518699|76199133|FG003|Period 2|Adverse Event|0|||
42356046|NCT01518699|76199134|FG004|Period 2|Adverse Event|0|||
42356047|NCT01518699|76199135|FG005|Period 2|Adverse Event|0|||
42356048|NCT01518309|76199143|FG000|Overall Study|Adverse Event|6|||
42356049|NCT01518309|76199143|FG000|Overall Study|Death|6|||
42356050|NCT01518309|76199143|FG000|Overall Study|Lack of Efficacy|7|||
42356051|NCT01518309|76199143|FG000|Overall Study|Withdrawal by Subject|6|||
42356052|NCT01518309|76199143|FG000|Overall Study|Physician Decision|3|||
42356053|NCT01518309|76199143|FG000|Overall Study|Sponsor Decision|2|||
42356054|NCT01518309|76199143|FG000|Overall Study|Not in Predefined Categories|9|||
42356055|NCT01419717|76199147|FG000|Overall Study|Protocol-specified Criteria|62|||
42356056|NCT01419717|76199147|FG000|Overall Study|Adverse Event|19|||
42356057|NCT01419717|76199147|FG000|Overall Study|Death|17|||
42356058|NCT01419717|76199147|FG000|Overall Study|Withdrawal by Subject|10|||
42356059|NCT01419717|76199147|FG000|Overall Study|Disease Progression|9|||
42356060|NCT01419717|76199147|FG000|Overall Study|Other|4|||
42356061|NCT01419717|76199147|FG000|Overall Study|Lost to Follow-up|2|||
42356062|NCT01419717|76199147|FG000|Overall Study|Administrative Decision|1|||
42356063|NCT01419717|76199147|FG000|Overall Study|Noncompliance|1|||
42356064|NCT01458951|76199154|FG000|Overall Study|Other|1|||
42356065|NCT01458951|76199155|FG001|Overall Study|Other|0|||
42356066|NCT01458951|76199156|FG002|Overall Study|Other|0|||
42356067|NCT01458951|76199154|FG000|Overall Study|Protocol Violation|5|||
42356068|NCT01458951|76199155|FG001|Overall Study|Protocol Violation|1|||
42356069|NCT01458951|76199156|FG002|Overall Study|Protocol Violation|0|||
42290154|NCT02651987|76123752|FG001|Overall Study|Local PD|2|||
42290155|NCT02651987|76123751|FG000|Overall Study|Investigator Decision|1|||
42290156|NCT02651987|76123752|FG001|Overall Study|Investigator Decision|1|||
42290157|NCT02677987|76123763|FG000|Overall Study|Withdrawal by Subject|3|||
42290158|NCT02677987|76123764|FG001|Overall Study|Withdrawal by Subject|0|||
42290159|NCT02677987|76123763|FG000|Overall Study|Lost to Follow-up|1|||
42290160|NCT02677987|76123764|FG001|Overall Study|Lost to Follow-up|0|||
42290161|NCT01999114|76123783|FG000|Overall Study|Adverse Event|8|||
42290162|NCT01999114|76123784|FG001|Overall Study|Adverse Event|7|||
42290163|NCT01999114|76123785|FG002|Overall Study|Adverse Event|2|||
42290164|NCT01999114|76123786|FG003|Overall Study|Adverse Event|2|||
42290165|NCT01999114|76123787|FG004|Overall Study|Adverse Event|1|||
42290166|NCT01999114|76123783|FG000|Overall Study|Withdrawal by Subject|0|||
42290167|NCT01999114|76123784|FG001|Overall Study|Withdrawal by Subject|0|||
42290168|NCT01999114|76123785|FG002|Overall Study|Withdrawal by Subject|1|||
42290169|NCT01999114|76123786|FG003|Overall Study|Withdrawal by Subject|0|||
42290170|NCT01999114|76123787|FG004|Overall Study|Withdrawal by Subject|1|||
42290171|NCT01999114|76123783|FG000|Overall Study|Lost to Follow-up|0|||
42290172|NCT01999114|76123784|FG001|Overall Study|Lost to Follow-up|0|||
42356070|NCT01458951|76199154|FG000|Overall Study|Withdrawal by Subject|2|||
42356071|NCT01458951|76199155|FG001|Overall Study|Withdrawal by Subject|0|||
42356072|NCT01458951|76199156|FG002|Overall Study|Withdrawal by Subject|2|||
42356073|NCT01458951|76199154|FG000|Overall Study|Adverse Event|7|||
42356074|NCT01458951|76199155|FG001|Overall Study|Adverse Event|0|||
42356075|NCT01458951|76199156|FG002|Overall Study|Adverse Event|2|||
42356076|NCT01458951|76199154|FG000|Overall Study|Insufficient Clinical Response|17|||
42356077|NCT01458951|76199155|FG001|Overall Study|Insufficient Clinical Response|0|||
42356078|NCT01458951|76199156|FG002|Overall Study|Insufficient Clinical Response|11|||
42356079|NCT01458639|76199163|FG000|Overall Study|Physician Decision|4|||
42356080|NCT01458639|76199163|FG000|Overall Study|Equipment issue|1|||
42356081|NCT01458639|76199163|FG000|Overall Study|Inability to obtain subject blood sample|1|||
42290173|NCT01999114|76123785|FG002|Overall Study|Lost to Follow-up|1|||
42290174|NCT01999114|76123786|FG003|Overall Study|Lost to Follow-up|0|||
42290175|NCT01999114|76123787|FG004|Overall Study|Lost to Follow-up|0|||
42290176|NCT01999114|76123783|FG000|Overall Study|Administrative|0|||
42290177|NCT01999114|76123784|FG001|Overall Study|Administrative|0|||
42172351|NCT00345293|75979200|FG000|Overall Study|Withdrawal by Subject|1|||
42172352|NCT00345293|75979201|FG001|Overall Study|Withdrawal by Subject|0|||
42172353|NCT00355121|75979210|FG000|Overall Study|Did not receive study vaccine|1|||
42172354|NCT00355121|75979211|FG001|Overall Study|Did not receive study vaccine|0|||
42172355|NCT00355121|75979212|FG002|Overall Study|Did not receive study vaccine|1|||
42172356|NCT00355121|75979210|FG000|Overall Study|Adverse Event|0|||
42290178|NCT01999114|76123785|FG002|Overall Study|Administrative|1|||
42290179|NCT01999114|76123786|FG003|Overall Study|Administrative|1|||
42290180|NCT01999114|76123787|FG004|Overall Study|Administrative|2|||
42290181|NCT02682823|76123818|FG000|Overall Study|Withdrawal by Subject|0|||
42290182|NCT02682823|76123819|FG001|Overall Study|Withdrawal by Subject|0|||
42290183|NCT02682823|76123820|FG002|Overall Study|Withdrawal by Subject|1|||
42290184|NCT02682823|76123821|FG003|Overall Study|Withdrawal by Subject|0|||
42290185|NCT02682823|76123822|FG004|Overall Study|Withdrawal by Subject|1|||
42290186|NCT02682823|76123818|FG000|Overall Study|Protocol Deviation|0|||
42042164|NCT01130168|75850000|FG004|Period 1|Withdrawal by Subject|0|||
42042165|NCT01130168|75850001|FG005|Period 1|Withdrawal by Subject|0|||
42290187|NCT02682823|76123819|FG001|Overall Study|Protocol Deviation|1|||
42290188|NCT02682823|76123820|FG002|Overall Study|Protocol Deviation|0|||
42290189|NCT02682823|76123821|FG003|Overall Study|Protocol Deviation|0|||
42290190|NCT02682823|76123822|FG004|Overall Study|Protocol Deviation|0|||
42290191|NCT02682823|76123818|FG000|Overall Study|Adverse Event|0|||
42290192|NCT02682823|76123819|FG001|Overall Study|Adverse Event|0|||
42290193|NCT02682823|76123820|FG002|Overall Study|Adverse Event|0|||
42290194|NCT02682823|76123821|FG003|Overall Study|Adverse Event|1|||
42290195|NCT02682823|76123822|FG004|Overall Study|Adverse Event|0|||
42290196|NCT01374451|76123836|FG000|Overall Study|Administrative problems|1|||
42290197|NCT01374451|76123837|FG001|Overall Study|Administrative problems|0|||
42290198|NCT02674477|76123845|FG000|Overall Study|Protocol Violation|8|||
42290199|NCT02674477|76123846|FG001|Overall Study|Protocol Violation|2|||
42290200|NCT01352845|76123854|FG000|Overall Study|Lost to Follow-up|313|||
42290201|NCT01352845|76123855|FG001|Overall Study|Lost to Follow-up|92|||
42172357|NCT00355121|75979211|FG001|Overall Study|Adverse Event|1|||
42172358|NCT00355121|75979212|FG002|Overall Study|Adverse Event|0|||
42290202|NCT01352845|76123854|FG000|Overall Study|No Longer Willing to Participate|205|||
42290203|NCT01352845|76123855|FG001|Overall Study|No Longer Willing to Participate|58|||
42290204|NCT01352845|76123854|FG000|Overall Study|Withdrawal by Subject|48|||
42290205|NCT01352845|76123855|FG001|Overall Study|Withdrawal by Subject|16|||
42290206|NCT01352845|76123854|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
42290207|NCT01352845|76123855|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
42290208|NCT01352845|76123854|FG000|Overall Study|Pregnancy|27|||
42290209|NCT01352845|76123855|FG001|Overall Study|Pregnancy|7|||
42172359|NCT00355121|75979210|FG000|Overall Study|Protocol Violation|7|||
42172360|NCT00355121|75979211|FG001|Overall Study|Protocol Violation|9|||
42172361|NCT00355121|75979212|FG002|Overall Study|Protocol Violation|1|||
42290210|NCT01352845|76123854|FG000|Overall Study|Adverse Event|22|||
42290211|NCT01352845|76123855|FG001|Overall Study|Adverse Event|6|||
42290212|NCT01352845|76123854|FG000|Overall Study|Other|17|||
42290213|NCT01352845|76123855|FG001|Overall Study|Other|7|||
42172362|NCT00355121|75979210|FG000|Overall Study|Lost to Follow-up|4|||
42290214|NCT01352845|76123854|FG000|Overall Study|Protocol Violation|12|||
42290215|NCT01352845|76123855|FG001|Overall Study|Protocol Violation|6|||
42290216|NCT01352845|76123854|FG000|Overall Study|Death|3|||
42290217|NCT01352845|76123855|FG001|Overall Study|Death|0|||
42290218|NCT02674399|76123863|FG000|Overall Study|Lost to Follow-up|2|||
42290219|NCT02674399|76123864|FG001|Overall Study|Lost to Follow-up|0|||
42290220|NCT02676895|76123873|FG000|Overall Study|Administrative reason|1|||
42290221|NCT02676895|76123874|FG001|Overall Study|Administrative reason|0|||
42290222|NCT02676895|76123875|FG002|Overall Study|Administrative reason|0|||
42172363|NCT00355121|75979211|FG001|Overall Study|Lost to Follow-up|7|||
42290223|NCT02676895|76123873|FG000|Overall Study|Protocol Violation|1|||
42290224|NCT02676895|76123874|FG001|Overall Study|Protocol Violation|0|||
42290225|NCT02676895|76123875|FG002|Overall Study|Protocol Violation|0|||
42356082|NCT01437423|76199167|FG000|Overall Study|Lost to Follow-up|12|||
42356083|NCT01437423|76199167|FG000|Overall Study|Off label usage|3|||
42356084|NCT01458249|76199198|FG000|Overall Study|Not treated|1|||
42356085|NCT01458249|76199198|FG000|Overall Study|Adverse Event|4|||
42356086|NCT01458249|76199198|FG000|Overall Study|Other|2|||
42356087|NCT01458249|76199198|FG000|Overall Study|Ongoing|1|||
42356088|NCT01458171|76199214|FG000|Overall Study|Adverse Event|1|||
42356089|NCT01457703|76199231|FG000|Overall Study|Screen Failure|5|||
42356090|NCT01457703|76199232|FG001|Overall Study|Screen Failure|7|||
42356091|NCT01457703|76199231|FG000|Overall Study|Withdrawal by Subject|1|||
42016000|NCT00941863|75823149|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
42356092|NCT01457703|76199232|FG001|Overall Study|Withdrawal by Subject|4|||
42356093|NCT01419015|76199250|FG000|Overall Study|Death|2|||
42290226|NCT02676895|76123873|FG000|Overall Study|Adverse Event|0|||
42290227|NCT02676895|76123874|FG001|Overall Study|Adverse Event|3|||
42290228|NCT02676895|76123875|FG002|Overall Study|Adverse Event|1|||
42290229|NCT02676895|76123873|FG000|Overall Study|Lost to Follow-up|0|||
42290230|NCT02676895|76123874|FG001|Overall Study|Lost to Follow-up|0|||
42290231|NCT02676895|76123875|FG002|Overall Study|Lost to Follow-up|1|||
42290232|NCT02676895|76123873|FG000|Overall Study|Withdrawal by Subject|0|||
42356094|NCT01418937|76199271|FG000|Overall Study|Lost to Follow-up|5|||
42356095|NCT01418937|76199271|FG000|Overall Study|Protocol Violation|1|||
42356096|NCT01418937|76199271|FG000|Overall Study|Pregnancy|1|||
42356097|NCT01418937|76199271|FG000|Overall Study|Withdrawal by Subject|1|||
42356098|NCT01417377|76199284|FG000|Overall Study|Lost to Follow-up|12|||
42356099|NCT01417377|76199284|FG000|Overall Study|Enrolled, but not treated|1|||
42356100|NCT01437267|76199331|FG000|Overall Study|Withdrawal by Subject|0|||
42356101|NCT01437267|76199332|FG001|Overall Study|Withdrawal by Subject|0|||
42042166|NCT01130168|75849996|FG000|Period 1|Discontinued For Other Reason|0|||
42042167|NCT01130168|75849997|FG001|Period 1|Discontinued For Other Reason|0|||
42042168|NCT01130168|75849998|FG002|Period 1|Discontinued For Other Reason|1|||
42042169|NCT01130168|75849999|FG003|Period 1|Discontinued For Other Reason|1|||
42042170|NCT01130168|75850000|FG004|Period 1|Discontinued For Other Reason|0|||
42042171|NCT01130168|75850001|FG005|Period 1|Discontinued For Other Reason|0|||
42042172|NCT01130168|75849996|FG000|Period 1|Adverse Event|0|||
42042173|NCT01130168|75849997|FG001|Period 1|Adverse Event|0|||
42042174|NCT01130168|75849998|FG002|Period 1|Adverse Event|0|||
42042175|NCT01130168|75849999|FG003|Period 1|Adverse Event|1|||
42042176|NCT01130168|75850000|FG004|Period 1|Adverse Event|0|||
42042177|NCT01130168|75850001|FG005|Period 1|Adverse Event|0|||
42042178|NCT01144052|75850012|FG000|Overall Study|Withdrawal by Subject|1|||
42042179|NCT01144052|75850013|FG001|Overall Study|Withdrawal by Subject|1|||
42042180|NCT01143896|75850023|FG000|Overall Study|Did not complete Baseline Interview|5|||
42042181|NCT01143896|75850024|FG001|Overall Study|Did not complete Baseline Interview|4|||
42042182|NCT01143896|75850023|FG000|Overall Study|Lost to Follow-up|18|||
42042183|NCT01143896|75850024|FG001|Overall Study|Lost to Follow-up|13|||
42356102|NCT01437267|76199333|FG002|Overall Study|Withdrawal by Subject|0|||
42356103|NCT01437267|76199334|FG003|Overall Study|Withdrawal by Subject|1|||
42356104|NCT01437267|76199335|FG004|Overall Study|Withdrawal by Subject|0|||
42356105|NCT01437267|76199336|FG005|Overall Study|Withdrawal by Subject|0|||
42356106|NCT01437267|76199331|FG000|Overall Study|Protocol Violation|0|||
42356107|NCT01437267|76199332|FG001|Overall Study|Protocol Violation|1|||
42356108|NCT01437267|76199333|FG002|Overall Study|Protocol Violation|0|||
42356109|NCT01437267|76199334|FG003|Overall Study|Protocol Violation|0|||
42356110|NCT01437267|76199335|FG004|Overall Study|Protocol Violation|0|||
42042184|NCT01143896|75850023|FG000|Overall Study|Withdrawal by Subject|13|||
42042185|NCT01143896|75850024|FG001|Overall Study|Withdrawal by Subject|5|||
42042186|NCT01143896|75850023|FG000|Overall Study|Death|6|||
42356111|NCT01437267|76199336|FG005|Overall Study|Protocol Violation|0|||
42042187|NCT01143896|75850024|FG001|Overall Study|Death|3|||
42356112|NCT01456221|76199365|FG000|Overall Study|Withdrawal by Subject|56|||
42356113|NCT01456221|76199366|FG001|Overall Study|Withdrawal by Subject|49|||
42356114|NCT01456221|76199365|FG000|Overall Study|Lost to Follow-up|1|||
42356115|NCT01456221|76199366|FG001|Overall Study|Lost to Follow-up|4|||
42356116|NCT01456221|76199365|FG000|Overall Study|Received medication|3|||
42356117|NCT01456221|76199366|FG001|Overall Study|Received medication|2|||
42356118|NCT01456221|76199365|FG000|Overall Study|Incomplete data|4|||
42356119|NCT01456221|76199366|FG001|Overall Study|Incomplete data|2|||
42356120|NCT01437111|76199372|FG000|Overall Study|Adverse Event|2|||
42356121|NCT01437111|76199372|FG000|Overall Study|Withdrawal by Subject|4|||
42356122|NCT01437111|76199372|FG000|Overall Study|Not reported|5|||
42356123|NCT01437111|76199372|FG000|Overall Study|Physician Decision|1|||
42356124|NCT01437111|76199372|FG000|Overall Study|Lost to Follow-up|5|||
42356125|NCT01437111|76199372|FG000|Overall Study|Protocol Violation|1|||
42356126|NCT01436643|76199420|FG000|2-week Pre-treatment|Abnormal test result|0|||
42356127|NCT01436643|76199421|FG001|2-week Pre-treatment|Abnormal test result|0|||
42356128|NCT01436643|76199422|FG002|2-week Pre-treatment|Abnormal test result|0|||
42356129|NCT01436643|76199423|FG003|2-week Pre-treatment|Abnormal test result|1|||
42356130|NCT01436643|76199420|FG000|2-week Pre-treatment|Adverse Event|0|||
42356131|NCT01436643|76199421|FG001|2-week Pre-treatment|Adverse Event|0|||
42356132|NCT01436643|76199422|FG002|2-week Pre-treatment|Adverse Event|0|||
42356133|NCT01436643|76199423|FG003|2-week Pre-treatment|Adverse Event|5|||
42356134|NCT01436643|76199420|FG000|2-week Pre-treatment|Protocol Violation|0|||
42356135|NCT01436643|76199421|FG001|2-week Pre-treatment|Protocol Violation|0|||
42356136|NCT01436643|76199422|FG002|2-week Pre-treatment|Protocol Violation|0|||
42356137|NCT01436643|76199423|FG003|2-week Pre-treatment|Protocol Violation|4|||
42356138|NCT01436643|76199420|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
42356139|NCT01436643|76199421|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
42356140|NCT01436643|76199422|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
42356141|NCT01436643|76199423|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
42356142|NCT01436643|76199420|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
42356143|NCT01436643|76199421|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
42356144|NCT01436643|76199422|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
42356145|NCT01436643|76199423|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
42356146|NCT01436643|76199420|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
42356147|NCT01436643|76199421|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
42356148|NCT01436643|76199422|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
42356149|NCT01436643|76199423|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
42356150|NCT01454739|76199521|FG000|Overall Study|Protocol Violation|2|||
42356151|NCT01454739|76199522|FG001|Overall Study|Protocol Violation|3|||
42356152|NCT01454739|76199521|FG000|Overall Study|Withdrawal by Subject|2|||
42356153|NCT01454739|76199522|FG001|Overall Study|Withdrawal by Subject|6|||
42356154|NCT01454739|76199521|FG000|Overall Study|Other|3|||
42356155|NCT01454739|76199522|FG001|Overall Study|Other|5|||
42356156|NCT01454739|76199521|FG000|Overall Study|Physician Decision|0|||
42356157|NCT01454739|76199522|FG001|Overall Study|Physician Decision|5|||
42356158|NCT01454739|76199521|FG000|Overall Study|Lost to Follow-up|0|||
42356159|NCT01454739|76199522|FG001|Overall Study|Lost to Follow-up|1|||
42356160|NCT01454739|76199521|FG000|Overall Study|Adverse Event|0|||
42356161|NCT01454739|76199522|FG001|Overall Study|Adverse Event|1|||
42356162|NCT01416441|76199560|FG000|Overall Study|Lost to Follow-up|5|||
42356163|NCT01416441|76199560|FG000|Overall Study|Adverse Event|6|||
42356164|NCT01416441|76199560|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
42356165|NCT01416441|76199560|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
42356166|NCT01416441|76199560|FG000|Overall Study|Investigator Withdrew Subject|2|||
42356167|NCT01416441|76199560|FG000|Overall Study|Subject Withdrew Consent|12|||
42356168|NCT01416441|76199560|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
42356169|NCT01436253|76199569|FG000|Overall Study|Lost to Follow-up|182|||
42356170|NCT01436253|76199569|FG000|Overall Study|Not meeting all eligibility criteria|117|||
42356171|NCT01454583|76200482|FG000|1st Year|Lost to Follow-up|1057|||
42356172|NCT01454583|76200483|FG001|1st Year|Lost to Follow-up|318|||
42356173|NCT01454583|76200484|FG002|1st Year|Lost to Follow-up|180|||
42356174|NCT01454583|76200482|FG000|2nd Year|Lost to Follow-up|3965|||
42356175|NCT01454583|76200483|FG001|2nd Year|Lost to Follow-up|1049|||
42042188|NCT01118312|75850033|FG000|Overall Study|Lost to Follow-up|33|||
42042189|NCT01118312|75850034|FG001|Overall Study|Lost to Follow-up|32|||
42290233|NCT02676895|76123874|FG001|Overall Study|Withdrawal by Subject|0|||
42290234|NCT02676895|76123875|FG002|Overall Study|Withdrawal by Subject|1|||
42290235|NCT02673697|76123886|FG000|Overall Study|Adverse Event|2|||
42290236|NCT02673697|76123887|FG001|Overall Study|Adverse Event|0|||
42290237|NCT02673697|76123886|FG000|Overall Study|Death|32|||
42290238|NCT02673697|76123887|FG001|Overall Study|Death|24|||
42356176|NCT01454583|76200484|FG002|2nd Year|Lost to Follow-up|737|||
42356177|NCT01454583|76200482|FG000|3rd Year|Lost to Follow-up|1959|||
42356178|NCT01454583|76200483|FG001|3rd Year|Lost to Follow-up|512|||
42042190|NCT01118312|75850033|FG000|Overall Study|Withdrawal by Subject|1|||
42042191|NCT01118312|75850034|FG001|Overall Study|Withdrawal by Subject|3|||
42042192|NCT01117766|75850040|FG000|First Intervention|Adverse Event|0|||
42042193|NCT01117766|75850041|FG001|First Intervention|Adverse Event|1|||
42172364|NCT00355121|75979212|FG002|Overall Study|Lost to Follow-up|1|||
42172365|NCT00355121|75979210|FG000|Overall Study|Withdrawal by Subject|9|||
42290239|NCT02673697|76123886|FG000|Overall Study|Lost to Follow-up|5|||
42290240|NCT02673697|76123887|FG001|Overall Study|Lost to Follow-up|2|||
42290241|NCT02673697|76123886|FG000|Overall Study|Physician Decision|2|||
42290242|NCT02673697|76123887|FG001|Overall Study|Physician Decision|1|||
42290243|NCT02673697|76123886|FG000|Overall Study|Withdrawal by Subject|10|||
42290244|NCT02673697|76123887|FG001|Overall Study|Withdrawal by Subject|7|||
42290245|NCT02673697|76123886|FG000|Overall Study|Change subj medical status|1|||
42290246|NCT02673697|76123887|FG001|Overall Study|Change subj medical status|2|||
42290247|NCT02673697|76123886|FG000|Overall Study|Explant|10|||
42290248|NCT02673697|76123887|FG001|Overall Study|Explant|5|||
42042194|NCT01117766|75850040|FG000|First Intervention|Protocol Violation|1|||
42290249|NCT02673697|76123886|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
42290250|NCT02673697|76123887|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
42290251|NCT05168579|76123895|FG000|Overall Study|Lack of Consent|1|||
42290252|NCT05168579|76123896|FG001|Overall Study|Lack of Consent|0|||
42290253|NCT05168579|76123895|FG000|Overall Study|Conflicts with time|2|||
42042195|NCT01117766|75850041|FG001|First Intervention|Protocol Violation|0|||
42042196|NCT01117766|75850040|FG000|Washout Period|Protocol Violation|0|||
42042197|NCT01117766|75850041|FG001|Washout Period|Protocol Violation|2|||
42042198|NCT01117766|75850040|FG000|Second Intervention|Lost to Follow-up|1|||
42356179|NCT01454583|76200484|FG002|3rd Year|Lost to Follow-up|297|||
42356180|NCT01436175|76200507|FG000|Overall Study|Adverse Event|111|||
42356181|NCT01436175|76200507|FG000|Overall Study|Protocol Violation|49|||
42356182|NCT01436175|76200507|FG000|Overall Study|Withdrawal by Subject|108|||
42356183|NCT01436175|76200507|FG000|Overall Study|Lost to Follow-up|89|||
42356184|NCT01436175|76200507|FG000|Overall Study|Lack of Efficacy|24|||
42042199|NCT01117766|75850041|FG001|Second Intervention|Lost to Follow-up|0|||
42042200|NCT01117766|75850040|FG000|Second Intervention|Other|1|||
42042201|NCT01117766|75850041|FG001|Second Intervention|Other|2|||
42042202|NCT01117766|75850040|FG000|Second Intervention|Adverse Event|0|||
42042203|NCT01117766|75850041|FG001|Second Intervention|Adverse Event|2|||
42042204|NCT01117766|75850040|FG000|Second Intervention|Withdrawal by Subject|0|||
42042205|NCT01117766|75850041|FG001|Second Intervention|Withdrawal by Subject|1|||
42042206|NCT01117454|75850049|FG000|Overall Study|Pregnancy|0|||
42356185|NCT01436175|76200507|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
42042207|NCT01117454|75850050|FG001|Overall Study|Pregnancy|1|||
42356186|NCT01436175|76200507|FG000|Overall Study|Other|826|||
42042208|NCT01116440|75850058|FG000|Treatment|Withdrawal by Subject|2|||
42042209|NCT01116440|75850059|FG001|Treatment|Withdrawal by Subject|2|||
42356187|NCT01453725|76200535|FG000|Overall Study|Adverse Event|3|||
42042210|NCT01116440|75850058|FG000|Treatment|Lost to Follow-up|1|||
42042211|NCT01116440|75850059|FG001|Treatment|Lost to Follow-up|1|||
42042212|NCT01116440|75850058|FG000|Treatment|Protocol Violation|0|||
42042213|NCT01116440|75850059|FG001|Treatment|Protocol Violation|2|||
42042214|NCT01116440|75850058|FG000|Treatment|Lack of Efficacy|0|||
42042215|NCT01116440|75850059|FG001|Treatment|Lack of Efficacy|1|||
42042216|NCT01116440|75850058|FG000|Treatment|Adverse Event|0|||
42042217|NCT01116440|75850059|FG001|Treatment|Adverse Event|1|||
42042218|NCT01116440|75850058|FG000|Withdrawal|Withdrawal by Subject|0|||
42042219|NCT01116440|75850059|FG001|Withdrawal|Withdrawal by Subject|1|||
42042220|NCT01116440|75850058|FG000|Withdrawal|Lost to Follow-up|0|||
42042221|NCT01116440|75850059|FG001|Withdrawal|Lost to Follow-up|1|||
42042222|NCT01116440|75850058|FG000|Follow-up|Lost to Follow-up|0|||
42042223|NCT01116440|75850059|FG001|Follow-up|Lost to Follow-up|1|||
42042224|NCT01116440|75850058|FG000|Follow-up|Withdrawal by Subject|0|||
42042225|NCT01116440|75850059|FG001|Follow-up|Withdrawal by Subject|1|||
42042226|NCT01129622|75850067|FG000|Overall Study|Withdrawal by Subject|2|||
42042227|NCT01128842|75850072|FG000|Overall Study|Adverse Event|1|||
42042228|NCT01128842|75850072|FG000|Overall Study|Disease Progression|6|||
42042229|NCT01143038|75850077|FG000|Overall Study|Withdrawal by Subject|4|||
42042230|NCT01143038|75850077|FG000|Overall Study|Requirement for alternative therapy|5|||
42042231|NCT01143038|75850077|FG000|Overall Study|Adverse Event|3|||
42042232|NCT01143038|75850077|FG000|Overall Study|Lost to Follow-up|2|||
42042233|NCT01143038|75850077|FG000|Overall Study|Protocol Deviation|1|||
42042234|NCT01143038|75850077|FG000|Overall Study|Death|1|||
42042235|NCT00966264|75850083|FG000|Overall Study|Lost to Follow-up|4|||
42356188|NCT01453725|76200536|FG001|Overall Study|Adverse Event|3|||
42042236|NCT00966264|75850084|FG001|Overall Study|Lost to Follow-up|3|||
42042237|NCT00915525|75850092|FG000|Overall Study|Protocol Violation|9|||
42042238|NCT00915525|75850093|FG001|Overall Study|Protocol Violation|4|||
42042239|NCT00915525|75850092|FG000|Overall Study|Withdrawal by Subject|59|||
42042240|NCT00915525|75850093|FG001|Overall Study|Withdrawal by Subject|21|||
42042241|NCT00915525|75850092|FG000|Overall Study|Lost to Follow-up|27|||
42356189|NCT01453725|76200535|FG000|Overall Study|Lost to Follow-up|4|||
42356190|NCT01453725|76200536|FG001|Overall Study|Lost to Follow-up|0|||
42042242|NCT00915525|75850093|FG001|Overall Study|Lost to Follow-up|16|||
42042243|NCT00915525|75850092|FG000|Overall Study|Pregnancy|2|||
42042244|NCT00915525|75850093|FG001|Overall Study|Pregnancy|0|||
42042245|NCT00915525|75850092|FG000|Overall Study|Lack of Efficacy|15|||
42042246|NCT00915525|75850093|FG001|Overall Study|Lack of Efficacy|32|||
42042247|NCT00915525|75850092|FG000|Overall Study|Adverse Event|29|||
42042248|NCT00915525|75850093|FG001|Overall Study|Adverse Event|13|||
42042249|NCT00915525|75850092|FG000|Overall Study|Missing|12|||
42042250|NCT00915525|75850093|FG001|Overall Study|Missing|1|||
42042251|NCT00915525|75850092|FG000|Overall Study|Other Reason|35|||
42042252|NCT00915525|75850093|FG001|Overall Study|Other Reason|12|||
42042253|NCT00915525|75850092|FG000|Overall Study|Site Closed|27|||
42042254|NCT00915525|75850093|FG001|Overall Study|Site Closed|9|||
42042255|NCT00915525|75850092|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
42042256|NCT00915525|75850093|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
42042257|NCT00915525|75850092|FG000|Overall Study|Study Burden|28|||
42042258|NCT00915525|75850093|FG001|Overall Study|Study Burden|12|||
42042259|NCT00915525|75850092|FG000|Overall Study|Non-Compliance|3|||
42042260|NCT00915525|75850093|FG001|Overall Study|Non-Compliance|1|||
42042261|NCT00915525|75850092|FG000|Overall Study|Patient Moved|15|||
42042262|NCT00915525|75850093|FG001|Overall Study|Patient Moved|9|||
42042263|NCT01074047|75850121|FG000|Treatment Phase|Adverse Event|89|||
42042264|NCT01074047|75850122|FG001|Treatment Phase|Adverse Event|66|||
42042265|NCT01074047|75850121|FG000|Treatment Phase|Disease Progression|16|||
42042266|NCT01074047|75850122|FG001|Treatment Phase|Disease Progression|21|||
42042267|NCT01074047|75850121|FG000|Treatment Phase|Withdrawal by Subject|27|||
42042268|NCT01074047|75850122|FG001|Treatment Phase|Withdrawal by Subject|48|||
42042269|NCT01074047|75850121|FG000|Treatment Phase|Death|53|||
42042270|NCT01074047|75850122|FG001|Treatment Phase|Death|58|||
42042271|NCT01074047|75850121|FG000|Treatment Phase|Lost to Follow-up|0|||
42042272|NCT01074047|75850122|FG001|Treatment Phase|Lost to Follow-up|1|||
42042273|NCT01074047|75850121|FG000|Treatment Phase|Protocol Violation|0|||
42042274|NCT01074047|75850122|FG001|Treatment Phase|Protocol Violation|1|||
42042275|NCT01074047|75850121|FG000|Treatment Phase|Miscellaneous|32|||
42042276|NCT01074047|75850122|FG001|Treatment Phase|Miscellaneous|39|||
42042277|NCT01074047|75850121|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
42290254|NCT05168579|76123896|FG001|Overall Study|Conflicts with time|0|||
42290255|NCT05168579|76123895|FG000|Overall Study|Time slots were full|3|||
42290256|NCT05168579|76123896|FG001|Overall Study|Time slots were full|0|||
42290257|NCT05168579|76123895|FG000|Overall Study|Lost to Follow-up|0|||
42290258|NCT05168579|76123896|FG001|Overall Study|Lost to Follow-up|15|||
42290259|NCT02673619|76123909|FG000|Overall Study|Lost to Follow-up|1|||
42290260|NCT02673619|76123910|FG001|Overall Study|Lost to Follow-up|0|||
42042278|NCT01074047|75850122|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
42042279|NCT01074047|75850121|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
42042280|NCT01074047|75850122|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
42042281|NCT01074047|75850121|FG000|Survival Follow-Up Phase|Death|116|||
42042282|NCT01074047|75850122|FG001|Survival Follow-Up Phase|Death|124|||
42042283|NCT01074047|75850121|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
42042284|NCT01074047|75850122|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
42042285|NCT01074047|75850121|FG000|Extension Phase|Physician Decision|1|||
42042286|NCT01074047|75850122|FG001|Extension Phase|Physician Decision|0|||
42042287|NCT01074047|75850121|FG000|Extension Phase|Adverse Event|5|||
42042288|NCT01074047|75850122|FG001|Extension Phase|Adverse Event|0|||
42042289|NCT01074047|75850121|FG000|Extension Phase|Disease Progression|9|||
42042290|NCT01074047|75850122|FG001|Extension Phase|Disease Progression|0|||
42042291|NCT01074047|75850121|FG000|Extension Phase|Withdrawal by Subject|2|||
42042292|NCT01074047|75850122|FG001|Extension Phase|Withdrawal by Subject|0|||
42042293|NCT01074047|75850121|FG000|Extension Phase|Death|5|||
42042294|NCT01074047|75850122|FG001|Extension Phase|Death|0|||
42042295|NCT01142726|75850138|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
42042296|NCT01142726|75850139|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
42042297|NCT01142726|75850140|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
42042298|NCT01142726|75850138|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
42042299|NCT01142726|75850139|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
42042300|NCT01142726|75850140|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
42290261|NCT02673619|76123911|FG002|Overall Study|Lost to Follow-up|0|||
42290262|NCT02673619|76123912|FG003|Overall Study|Lost to Follow-up|0|||
42290263|NCT02673619|76123909|FG000|Overall Study|Withdrawal by Subject|1|||
42290264|NCT02673619|76123910|FG001|Overall Study|Withdrawal by Subject|1|||
42356191|NCT01453725|76200535|FG000|Overall Study|Non-compliance With Protocol|1|||
42356192|NCT01453725|76200536|FG001|Overall Study|Non-compliance With Protocol|2|||
42356193|NCT01453725|76200535|FG000|Overall Study|Protocol Violation|1|||
42356194|NCT01453725|76200536|FG001|Overall Study|Protocol Violation|0|||
42356195|NCT01453725|76200535|FG000|Overall Study|Withdrawal by Subject|2|||
42290265|NCT02673619|76123911|FG002|Overall Study|Withdrawal by Subject|1|||
42290266|NCT02673619|76123912|FG003|Overall Study|Withdrawal by Subject|0|||
42290267|NCT02673619|76123909|FG000|Overall Study|Adverse Event|0|||
42290268|NCT02673619|76123910|FG001|Overall Study|Adverse Event|0|||
42290269|NCT02673619|76123911|FG002|Overall Study|Adverse Event|1|||
42290270|NCT02673619|76123912|FG003|Overall Study|Adverse Event|0|||
42290271|NCT02673619|76123909|FG000|Overall Study|Lack of Efficacy|0|||
42290272|NCT02673619|76123910|FG001|Overall Study|Lack of Efficacy|0|||
42290273|NCT02673619|76123911|FG002|Overall Study|Lack of Efficacy|1|||
42356196|NCT01453725|76200536|FG001|Overall Study|Withdrawal by Subject|3|||
42356197|NCT01453725|76200535|FG000|Overall Study|Pregnancy Wish|0|||
42356198|NCT01453725|76200536|FG001|Overall Study|Pregnancy Wish|2|||
42356199|NCT01453725|76200535|FG000|Overall Study|Pregnancy|1|||
42290274|NCT02673619|76123912|FG003|Overall Study|Lack of Efficacy|0|||
42290275|NCT02680639|76123934|FG000|Screening Period|Screen Failure|7|||
42042301|NCT01142726|75850138|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
42042302|NCT01142726|75850139|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
42042303|NCT01142726|75850140|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
42042304|NCT01142726|75850138|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
42042305|NCT01142726|75850139|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
42042306|NCT01142726|75850140|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
42042307|NCT01142726|75850138|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
42042308|NCT01142726|75850139|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
42042309|NCT01142726|75850140|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
42042310|NCT01142726|75850138|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
42042311|NCT01142726|75850139|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
42042312|NCT01142726|75850140|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
42042313|NCT01142726|75850138|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
42042314|NCT01142726|75850139|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
42042315|NCT01142726|75850140|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
42042316|NCT01142726|75850138|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
42042317|NCT01142726|75850139|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
42042318|NCT01142726|75850140|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
42042319|NCT01142726|75850138|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
42042320|NCT01142726|75850139|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
42042321|NCT01142726|75850140|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
42042322|NCT01142726|75850138|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
42042323|NCT01142726|75850139|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
42042324|NCT01142726|75850140|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
42042325|NCT01142726|75850138|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
42042326|NCT01142726|75850139|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
42042327|NCT01142726|75850140|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
42042328|NCT01142726|75850138|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
42042329|NCT01142726|75850139|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
42042330|NCT01142726|75850140|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
42172366|NCT00355121|75979211|FG001|Overall Study|Withdrawal by Subject|10|||
42172367|NCT00355121|75979212|FG002|Overall Study|Withdrawal by Subject|2|||
42172368|NCT00355121|75979210|FG000|Overall Study|Serious adverse events|0|||
42290276|NCT02680639|76123935|FG001|Screening Period|Screen Failure|0|||
42290277|NCT02680639|76123936|FG002|Screening Period|Screen Failure|0|||
42290278|NCT01674725|76123948|FG000|Overall Study|Adverse Event|1|||
42290279|NCT01674725|76123949|FG001|Overall Study|Adverse Event|0|||
42290280|NCT01674725|76123948|FG000|Overall Study|Did not receive study drug|1|||
42290281|NCT01674725|76123949|FG001|Overall Study|Did not receive study drug|0|||
42290282|NCT01674725|76123948|FG000|Overall Study|Withdrawal by Subject|1|||
42290283|NCT01674725|76123949|FG001|Overall Study|Withdrawal by Subject|0|||
42290284|NCT01674725|76123948|FG000|Overall Study|Lost to Follow-up|0|||
42290285|NCT01674725|76123949|FG001|Overall Study|Lost to Follow-up|1|||
42290286|NCT01674569|76123955|FG000|Overall Study|Adverse Event|0|||
42290287|NCT01674569|76123956|FG001|Overall Study|Adverse Event|2|||
42290288|NCT01674569|76123957|FG002|Overall Study|Adverse Event|0|||
42290289|NCT01674569|76123958|FG003|Overall Study|Adverse Event|1|||
42290290|NCT01674569|76123959|FG004|Overall Study|Adverse Event|2|||
42042331|NCT01142726|75850138|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
42042332|NCT01142726|75850139|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
42042333|NCT01142726|75850140|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
42042334|NCT01142726|75850138|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
42042335|NCT01142726|75850139|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
42042336|NCT01142726|75850140|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
42042337|NCT01142726|75850138|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
42042338|NCT01142726|75850139|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
42042339|NCT01142726|75850140|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
42042340|NCT01142726|75850138|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
42042341|NCT01142726|75850139|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
42042342|NCT01142726|75850140|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
42042343|NCT01073267|75850156|FG000|Overall Study|Disease Progression|3|||
42042344|NCT01142336|75850162|FG000|Overall Study|Adverse Event|1|||
42042345|NCT01142336|75850163|FG001|Overall Study|Adverse Event|1|||
42042346|NCT01142336|75850162|FG000|Overall Study|Lost to Follow-up|0|||
42042347|NCT01142336|75850163|FG001|Overall Study|Lost to Follow-up|1|||
42042348|NCT00915681|75850172|FG000|Overall Study|Screening failures|46|||
42042349|NCT01128296|75850176|FG000|Overall Study|Physician Decision|0|||
42042350|NCT01128296|75850177|FG001|Overall Study|Physician Decision|0|||
42042351|NCT01128296|75850178|FG002|Overall Study|Physician Decision|0|||
42042352|NCT01128296|75850179|FG003|Overall Study|Physician Decision|0|||
42042353|NCT01128296|75850180|FG004|Overall Study|Physician Decision|0|||
42042354|NCT01128296|75850181|FG005|Overall Study|Physician Decision|3|||
42042355|NCT01128296|75850176|FG000|Overall Study|Withdrawal by Subject|0|||
42042356|NCT01128296|75850177|FG001|Overall Study|Withdrawal by Subject|0|||
42042357|NCT01128296|75850178|FG002|Overall Study|Withdrawal by Subject|0|||
42042358|NCT01128296|75850179|FG003|Overall Study|Withdrawal by Subject|0|||
42042359|NCT01128296|75850180|FG004|Overall Study|Withdrawal by Subject|0|||
42042360|NCT01128296|75850181|FG005|Overall Study|Withdrawal by Subject|2|||
42042361|NCT01115738|75850195|FG000|Overall Study|Death|1|||
42042362|NCT01115738|75850196|FG001|Overall Study|Death|0|||
42042363|NCT01115738|75850197|FG002|Overall Study|Death|0|||
42042364|NCT01115738|75850195|FG000|Overall Study|Lost to Follow-up|0|||
42042365|NCT01115738|75850196|FG001|Overall Study|Lost to Follow-up|0|||
42042366|NCT01115738|75850197|FG002|Overall Study|Lost to Follow-up|1|||
42042367|NCT01115738|75850195|FG000|Overall Study|Physician Decision|18|||
42042368|NCT01115738|75850196|FG001|Overall Study|Physician Decision|15|||
42042369|NCT01115738|75850197|FG002|Overall Study|Physician Decision|17|||
42042370|NCT01115738|75850195|FG000|Overall Study|Withdrawal by Subject|6|||
42042371|NCT01115738|75850196|FG001|Overall Study|Withdrawal by Subject|6|||
42042372|NCT01115738|75850197|FG002|Overall Study|Withdrawal by Subject|9|||
42042373|NCT01141478|75850215|FG000|Overall Study|Withdrawal by Subject|1|||
42042374|NCT01141478|75850216|FG001|Overall Study|Withdrawal by Subject|1|||
42042375|NCT01114880|75850224|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
42042376|NCT01114880|75850225|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
42172369|NCT00355121|75979211|FG001|Overall Study|Serious adverse events|2|||
42290291|NCT01674569|76123960|FG005|Overall Study|Adverse Event|2|||
42042377|NCT01114880|75850224|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
42290292|NCT01674569|76123955|FG000|Overall Study|Protocol Violation|0|||
42290293|NCT01674569|76123956|FG001|Overall Study|Protocol Violation|1|||
42290294|NCT01674569|76123957|FG002|Overall Study|Protocol Violation|1|||
42290295|NCT01674569|76123958|FG003|Overall Study|Protocol Violation|0|||
42042378|NCT01114880|75850225|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
42290296|NCT01674569|76123959|FG004|Overall Study|Protocol Violation|0|||
42290297|NCT01674569|76123960|FG005|Overall Study|Protocol Violation|0|||
42290298|NCT01674569|76123955|FG000|Overall Study|Withdrawal by Subject|0|||
42356200|NCT01453725|76200536|FG001|Overall Study|Pregnancy|0|||
42356201|NCT01453725|76200535|FG000|Overall Study|Physician Decision|1|||
42356202|NCT01453725|76200536|FG001|Overall Study|Physician Decision|1|||
42356203|NCT01415349|76200575|FG000|Treatment Period 1|Adverse Event|0|||
42356204|NCT01415349|76200576|FG001|Treatment Period 1|Adverse Event|1|||
42356205|NCT01415349|76200575|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42356206|NCT01415349|76200576|FG001|Treatment Period 1|Withdrawal by Subject|1|||
42356207|NCT01453023|76200630|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
42356208|NCT01453023|76200631|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
42356209|NCT01453023|76200630|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
42356210|NCT01453023|76200631|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
42356211|NCT01453023|76200630|FG000|Treatment Period 2|Protocol Violation|0|||
42356212|NCT01453023|76200631|FG001|Treatment Period 2|Protocol Violation|1|||
42356213|NCT01452789|76200639|FG000|Overall Study|Withdrawal by Subject|3|||
42290299|NCT01674569|76123956|FG001|Overall Study|Withdrawal by Subject|0|||
42290300|NCT01674569|76123957|FG002|Overall Study|Withdrawal by Subject|1|||
42290301|NCT01674569|76123958|FG003|Overall Study|Withdrawal by Subject|0|||
42290302|NCT01674569|76123959|FG004|Overall Study|Withdrawal by Subject|0|||
42290303|NCT01674569|76123960|FG005|Overall Study|Withdrawal by Subject|0|||
42290304|NCT01374217|76123964|FG000|Overall Study|Lack of Efficacy|13|||
42290305|NCT01674647|76123970|FG000|Treatment Period|Death|4|||
42290306|NCT01674647|76123971|FG001|Treatment Period|Death|1|||
42290307|NCT01674647|76123970|FG000|Treatment Period|Efficacy outcome reached|0|||
42290308|NCT01674647|76123971|FG001|Treatment Period|Efficacy outcome reached|1|||
42290309|NCT01674647|76123970|FG000|Treatment Period|Physician Decision|3|||
42290310|NCT01674647|76123971|FG001|Treatment Period|Physician Decision|1|||
42290311|NCT01674647|76123970|FG000|Treatment Period|Adverse Event|60|||
42290312|NCT01674647|76123971|FG001|Treatment Period|Adverse Event|22|||
42290313|NCT01674647|76123970|FG000|Treatment Period|Non-compliance with study drug|3|||
42290314|NCT01674647|76123971|FG001|Treatment Period|Non-compliance with study drug|0|||
42356214|NCT01452789|76200640|FG001|Overall Study|Withdrawal by Subject|2|||
42356215|NCT01451931|76200649|FG000|Overall Study|Lost to Follow-up|17|||
42356216|NCT01451931|76200650|FG001|Overall Study|Lost to Follow-up|36|||
42356217|NCT01451931|76200651|FG002|Overall Study|Lost to Follow-up|21|||
42356218|NCT01451931|76200649|FG000|Overall Study|Withdrawal by Subject|16|||
42290315|NCT01674647|76123970|FG000|Treatment Period|Lost to Follow-up|1|||
42290316|NCT01674647|76123971|FG001|Treatment Period|Lost to Follow-up|1|||
42290317|NCT01674647|76123970|FG000|Treatment Period|Withdrawal by Subject|19|||
42290318|NCT01674647|76123971|FG001|Treatment Period|Withdrawal by Subject|16|||
42356219|NCT01451931|76200650|FG001|Overall Study|Withdrawal by Subject|22|||
42356220|NCT01451931|76200651|FG002|Overall Study|Withdrawal by Subject|22|||
42356221|NCT01414257|76200674|FG000|Overall Study|No Visit After First Day of Treatment|12|||
42356222|NCT01414257|76200674|FG000|Overall Study|Protocol Violation|10|||
42356223|NCT01434693|76200717|FG000|Overall Study|Adverse Event|1|||
42356224|NCT01434693|76200718|FG001|Overall Study|Adverse Event|0|||
42356225|NCT01434693|76200719|FG002|Overall Study|Adverse Event|0|||
42356226|NCT01434693|76200720|FG003|Overall Study|Adverse Event|0|||
42356227|NCT01434693|76200717|FG000|Overall Study|Withdrawal by Subject|1|||
42356228|NCT01434693|76200718|FG001|Overall Study|Withdrawal by Subject|0|||
42356229|NCT01434693|76200719|FG002|Overall Study|Withdrawal by Subject|1|||
42356230|NCT01434693|76200720|FG003|Overall Study|Withdrawal by Subject|1|||
42356231|NCT01434693|76200717|FG000|Overall Study|Lost to Follow-up|1|||
42356232|NCT01434693|76200718|FG001|Overall Study|Lost to Follow-up|0|||
42356233|NCT01434693|76200719|FG002|Overall Study|Lost to Follow-up|0|||
42356234|NCT01434693|76200720|FG003|Overall Study|Lost to Follow-up|0|||
42356235|NCT01451541|76200737|FG000|Overall Study|Adverse Event|4|||
42356236|NCT01451541|76200738|FG001|Overall Study|Adverse Event|3|||
42356237|NCT01451541|76200739|FG002|Overall Study|Adverse Event|6|||
42356238|NCT01451541|76200737|FG000|Overall Study|Lack of Efficacy|2|||
42356239|NCT01451541|76200738|FG001|Overall Study|Lack of Efficacy|0|||
42356240|NCT01451541|76200739|FG002|Overall Study|Lack of Efficacy|0|||
42356241|NCT01451541|76200737|FG000|Overall Study|Lost to Follow-up|4|||
42290319|NCT01674647|76123970|FG000|Treatment Period|Switching to other therapy|5|||
42290320|NCT01674647|76123971|FG001|Treatment Period|Switching to other therapy|2|||
42290321|NCT01674647|76123970|FG000|Treatment Period|Logistical difficulties|5|||
42290322|NCT01674647|76123971|FG001|Treatment Period|Logistical difficulties|8|||
42290323|NCT01674647|76123970|FG000|Treatment Period|Treatment failure|0|||
42290324|NCT01674647|76123971|FG001|Treatment Period|Treatment failure|14|||
42290325|NCT01674647|76123970|FG000|Treatment Period|Protocol Violation|56|||
42290326|NCT01674647|76123971|FG001|Treatment Period|Protocol Violation|36|||
42290327|NCT01674647|76123970|FG000|30-day Safety Follow-up Period|Death|3|||
42290328|NCT01674647|76123971|FG001|30-day Safety Follow-up Period|Death|2|||
42290329|NCT01674647|76123970|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
42290330|NCT01674647|76123971|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
42290331|NCT01674647|76123970|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
42290332|NCT01674647|76123971|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
42290333|NCT01674647|76123970|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
42290334|NCT01674647|76123971|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
42290335|NCT01674647|76123970|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
42290336|NCT01674647|76123971|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
42290337|NCT01674647|76123970|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
42290338|NCT01674647|76123971|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
42290339|NCT02669407|76123977|FG000|Overall Study|Physician Decision|3|||
42290340|NCT02667457|76123983|FG000|Overall Study|Withdrawal by Subject|1|||
42290341|NCT02667457|76123984|FG001|Overall Study|Withdrawal by Subject|0|||
42290342|NCT02667457|76123983|FG000|Overall Study|Other Reason|0|||
42290343|NCT02667457|76123984|FG001|Overall Study|Other Reason|2|||
42290344|NCT02669095|76123993|FG000|Overall Study|Adverse Event|1|||
42290345|NCT02669095|76123994|FG001|Overall Study|Adverse Event|0|||
42290346|NCT02669095|76123993|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
42290347|NCT02669095|76123994|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
42290348|NCT02669095|76123993|FG000|Overall Study|Torn Lens|0|||
42290349|NCT02669095|76123994|FG001|Overall Study|Torn Lens|1|||
42290350|NCT02669095|76123993|FG000|Overall Study|Visit 5 assessments not completed|0|||
42290351|NCT02669095|76123994|FG001|Overall Study|Visit 5 assessments not completed|1|||
42290352|NCT02667301|76124000|FG000|Overall Study|Adverse Event|1|||
42290353|NCT02667301|76124000|FG000|Overall Study|Lack of Efficacy|1|||
42356242|NCT01451541|76200738|FG001|Overall Study|Lost to Follow-up|4|||
42356243|NCT01451541|76200739|FG002|Overall Study|Lost to Follow-up|7|||
42356244|NCT01451541|76200737|FG000|Overall Study|Withdrawal by Subject|15|||
42356245|NCT01451541|76200738|FG001|Overall Study|Withdrawal by Subject|8|||
42290354|NCT05274165|76124008|FG000|Overall Study|Withdrawal by Subject|3|||
42290355|NCT05274165|76124009|FG001|Overall Study|Withdrawal by Subject|3|||
42290356|NCT04510090|76124051|FG000|FE-HS|Withdrawal by Subject|0|||
42290357|NCT04510090|76124052|FG001|FE-HS|Withdrawal by Subject|0|||
42290358|NCT04510090|76124053|FG002|FE-HS|Withdrawal by Subject|0|||
42290359|NCT04510090|76124054|FG003|FE-HS|Withdrawal by Subject|0|||
42356246|NCT01451541|76200739|FG002|Overall Study|Withdrawal by Subject|6|||
42356247|NCT01451541|76200737|FG000|Overall Study|randomization error, noncompliance|11|||
42290360|NCT04510090|76124055|FG004|FE-HS|Withdrawal by Subject|1|||
42290361|NCT04510090|76124056|FG005|FE-HS|Withdrawal by Subject|0|||
42290362|NCT04510090|76124057|FG006|FE-HS|Withdrawal by Subject|0|||
42356248|NCT01451541|76200738|FG001|Overall Study|randomization error, noncompliance|10|||
42356249|NCT01451541|76200739|FG002|Overall Study|randomization error, noncompliance|8|||
42356250|NCT01450761|76200867|FG000|Randomization|Subject no longer meets study criteria|1|||
42356251|NCT01450761|76200868|FG001|Randomization|Subject no longer meets study criteria|2|||
42356252|NCT01450761|76200867|FG000|Randomization|Withdrawal by Subject|2|||
42356253|NCT01450761|76200868|FG001|Randomization|Withdrawal by Subject|0|||
42356254|NCT01450761|76200867|FG000|Randomization|Disease progression|0|||
42356255|NCT01450761|76200868|FG001|Randomization|Disease progression|2|||
42356256|NCT01450761|76200867|FG000|Randomization|Adverse Event unrelated to study drug|1|||
42356257|NCT01450761|76200868|FG001|Randomization|Adverse Event unrelated to study drug|0|||
42356258|NCT01450761|76200867|FG000|Randomization|Other|0|||
42356259|NCT01450761|76200868|FG001|Randomization|Other|1|||
42356260|NCT01450761|76200867|FG000|Lead-in Chemotherapy|Disease progression|33|||
42356261|NCT01450761|76200868|FG001|Lead-in Chemotherapy|Disease progression|32|||
42356262|NCT01450761|76200867|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
42356263|NCT01450761|76200868|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
42356264|NCT01450761|76200867|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
42356265|NCT01450761|76200868|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
42356266|NCT01450761|76200867|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
42356267|NCT01450761|76200868|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
42356268|NCT01450761|76200867|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
42356269|NCT01450761|76200868|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
42356270|NCT01450761|76200867|FG000|Lead-in Chemotherapy|Death|3|||
42356271|NCT01450761|76200868|FG001|Lead-in Chemotherapy|Death|3|||
42356272|NCT01450761|76200867|FG000|Lead-in Chemotherapy|Other|2|||
42356273|NCT01450761|76200868|FG001|Lead-in Chemotherapy|Other|2|||
42356274|NCT01450761|76200867|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
42356275|NCT01450761|76200868|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
42356276|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
42356277|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
42356278|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
42356279|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
42356280|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
42356281|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
42356282|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
42356283|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
42042379|NCT01114880|75850224|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
42356284|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
42356285|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
42356286|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Death|5|||
42356287|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Death|6|||
42356288|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
42356289|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
42356290|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
42290363|NCT04510090|76124058|FG007|FE-HS|Withdrawal by Subject|0|||
42290364|NCT04491006|76124088|FG000|Overall Study|Adverse Event|0|||
42290365|NCT04491006|76124089|FG001|Overall Study|Adverse Event|3|||
42290366|NCT04491006|76124090|FG002|Overall Study|Adverse Event|5|||
42290367|NCT04491006|76124088|FG000|Overall Study|Withdrawal by Subject|1|||
42290368|NCT04491006|76124089|FG001|Overall Study|Withdrawal by Subject|0|||
42290369|NCT04491006|76124090|FG002|Overall Study|Withdrawal by Subject|2|||
42290370|NCT04162470|76124133|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
42290371|NCT04122625|76124143|FG000|Part A (up to 2.92 Years)|Death|2|||
42290372|NCT04122625|76124144|FG001|Part A (up to 2.92 Years)|Death|4|||
42290373|NCT04122625|76124145|FG002|Part A (up to 2.92 Years)|Death|0|||
42356291|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
42356292|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
42356293|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
42356294|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
42356295|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
42356296|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
42356297|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
42356298|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
42356299|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
42356300|NCT01450761|76200867|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
42356301|NCT01450761|76200868|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
42356302|NCT01433991|76200918|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
42356303|NCT01433991|76200919|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
42356304|NCT01433991|76200920|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
42356305|NCT01433991|76200921|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
42356306|NCT01433991|76200918|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
42356307|NCT01433991|76200919|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
42356308|NCT01433991|76200920|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
42356309|NCT01433991|76200921|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
42356310|NCT01433991|76200918|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
42356311|NCT01433991|76200919|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
42356312|NCT01433991|76200920|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
42356313|NCT01433991|76200921|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
42356314|NCT01433991|76200918|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
42356315|NCT01433991|76200919|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
42356316|NCT01433991|76200920|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
42356317|NCT01433991|76200921|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
42356318|NCT01433991|76200918|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
42356319|NCT01433991|76200919|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
42356320|NCT01433991|76200920|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
42356321|NCT01433991|76200921|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
42290374|NCT04122625|76124146|FG003|Part A (up to 2.92 Years)|Death|0|||
42290375|NCT04122625|76124147|FG004|Part A (up to 2.92 Years)|Death|0|||
42290376|NCT04122625|76124148|FG005|Part A (up to 2.92 Years)|Death|0|||
42290377|NCT04122625|76124143|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
42290378|NCT04122625|76124144|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
42356322|NCT01433991|76200918|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
42042380|NCT01114880|75850225|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
42042381|NCT01114880|75850224|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
42042382|NCT01114880|75850225|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
42042383|NCT01114880|75850224|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
42290379|NCT04122625|76124145|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
42290380|NCT04122625|76124146|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
42290381|NCT04122625|76124147|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
42290382|NCT04122625|76124148|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
42290383|NCT04122625|76124143|FG000|Part B (up to 2.33 Years)|Death|0|||
42042384|NCT01114880|75850225|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
42290384|NCT04122625|76124144|FG001|Part B (up to 2.33 Years)|Death|0|||
42290385|NCT04122625|76124145|FG002|Part B (up to 2.33 Years)|Death|5|||
42356323|NCT01433991|76200919|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
42356324|NCT01433991|76200920|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
42356325|NCT01433991|76200921|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
42356326|NCT01433991|76200918|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
42356327|NCT01433991|76200919|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
42356328|NCT01433991|76200920|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
42042385|NCT01114880|75850224|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
42042386|NCT01114880|75850225|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
42042387|NCT01114724|75850233|FG000|Overall Study|Death|8|||
42042388|NCT01114724|75850233|FG000|Overall Study|Lost to Follow-up|1|||
42042389|NCT01114724|75850233|FG000|Overall Study|Withdrawal by Subject|1|||
42042390|NCT00964392|75850240|FG000|Overall Study|Withdrawal by Subject|4|||
42042391|NCT00964392|75850241|FG001|Overall Study|Withdrawal by Subject|6|||
42042392|NCT00964392|75850240|FG000|Overall Study|Lost to Follow-up|4|||
42042393|NCT00964392|75850241|FG001|Overall Study|Lost to Follow-up|10|||
42042394|NCT00964392|75850240|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
42042395|NCT00964392|75850241|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
42042396|NCT00964392|75850240|FG000|Overall Study|Not completed|44|||
42172370|NCT00355121|75979212|FG002|Overall Study|Serious adverse events|0|||
42172371|NCT00343889|75979225|FG000|Overall Study|Lost to Follow-up|2|||
42172372|NCT00343889|75979226|FG001|Overall Study|Lost to Follow-up|0|||
42172373|NCT00343889|75979225|FG000|Overall Study|Withdrawal by Subject|0|||
42172374|NCT00343889|75979226|FG001|Overall Study|Withdrawal by Subject|1|||
42172375|NCT00343889|75979225|FG000|Overall Study|Protocol Violation|1|||
42172376|NCT00343889|75979226|FG001|Overall Study|Protocol Violation|0|||
42172377|NCT00354341|75979234|FG000|Overall Study|Adverse Event|1|||
42172378|NCT00354341|75979235|FG001|Overall Study|Adverse Event|0|||
42172379|NCT00354341|75979234|FG000|Overall Study|Death|0|||
42172380|NCT00354341|75979235|FG001|Overall Study|Death|2|||
42172381|NCT00354341|75979234|FG000|Overall Study|Refused treatment|1|||
42172382|NCT00354341|75979235|FG001|Overall Study|Refused treatment|2|||
42172383|NCT00354341|75979234|FG000|Overall Study|Failure to return|0|||
42172384|NCT00354341|75979235|FG001|Overall Study|Failure to return|1|||
42172385|NCT00354341|75979234|FG000|Overall Study|Other|1|||
42172386|NCT00354341|75979235|FG001|Overall Study|Other|2|||
42172387|NCT00354107|75979241|FG000|Overall Study|Adverse Event|2|||
42290386|NCT04122625|76124146|FG003|Part B (up to 2.33 Years)|Death|7|||
42290387|NCT04122625|76124147|FG004|Part B (up to 2.33 Years)|Death|6|||
42290388|NCT04122625|76124148|FG005|Part B (up to 2.33 Years)|Death|7|||
42290389|NCT03824704|76124166|FG000|Overall Study|Study Terminated by Sponsor|1|||
42290390|NCT03766581|76124182|FG000|Randomization|Other reasons|2|||
42290391|NCT03766581|76124183|FG001|Randomization|Other reasons|1|||
42290392|NCT03766581|76124184|FG002|Randomization|Other reasons|0|||
42290393|NCT03766581|76124185|FG003|Randomization|Other reasons|1|||
42290394|NCT03766581|76124186|FG004|Randomization|Other reasons|0|||
42290395|NCT03766581|76124187|FG005|Randomization|Other reasons|0|||
42290396|NCT03766581|76124188|FG006|Randomization|Other reasons|0|||
42290397|NCT03766581|76124189|FG007|Randomization|Other reasons|0|||
42290398|NCT03766581|76124182|FG000|Randomization|Participant no longer meets study criteria|5|||
42290399|NCT03766581|76124183|FG001|Randomization|Participant no longer meets study criteria|3|||
42290400|NCT03766581|76124184|FG002|Randomization|Participant no longer meets study criteria|4|||
42290401|NCT03766581|76124185|FG003|Randomization|Participant no longer meets study criteria|0|||
42290402|NCT03766581|76124186|FG004|Randomization|Participant no longer meets study criteria|2|||
42290403|NCT03766581|76124187|FG005|Randomization|Participant no longer meets study criteria|3|||
42290404|NCT03766581|76124188|FG006|Randomization|Participant no longer meets study criteria|0|||
42290405|NCT03766581|76124189|FG007|Randomization|Participant no longer meets study criteria|1|||
42290406|NCT03766581|76124182|FG000|Randomization|Participant request to discontinue study treatment|1|||
42290407|NCT03766581|76124183|FG001|Randomization|Participant request to discontinue study treatment|0|||
42290408|NCT03766581|76124184|FG002|Randomization|Participant request to discontinue study treatment|0|||
42290409|NCT03766581|76124185|FG003|Randomization|Participant request to discontinue study treatment|0|||
42290410|NCT03766581|76124186|FG004|Randomization|Participant request to discontinue study treatment|1|||
42290411|NCT03766581|76124187|FG005|Randomization|Participant request to discontinue study treatment|2|||
42290412|NCT03766581|76124188|FG006|Randomization|Participant request to discontinue study treatment|0|||
42290413|NCT03766581|76124189|FG007|Randomization|Participant request to discontinue study treatment|0|||
42356329|NCT01433991|76200921|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
42356330|NCT01450683|76200937|FG000|Overall Study|Adverse Event|2|||
42356331|NCT01433055|76200943|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
42042397|NCT00964392|75850241|FG001|Overall Study|Not completed|168|||
42172388|NCT00354107|75979241|FG000|Overall Study|Physician Decision|2|||
42172389|NCT00354107|75979241|FG000|Overall Study|Withdrawal by Subject|1|||
42172390|NCT00354029|75979247|FG000|Overall Study|Protocol Violation|4|||
42172391|NCT00354029|75979248|FG001|Overall Study|Protocol Violation|2|||
42042398|NCT00914589|75850250|FG000|Overall Study|Adverse Event|1|||
42172392|NCT00353873|75979256|FG000|Overall Study|Protocol Violation|1|||
42172393|NCT00353873|75979257|FG001|Overall Study|Protocol Violation|2|||
42172394|NCT00353873|75979256|FG000|Overall Study|Exacerbation|1|||
42172395|NCT00353873|75979257|FG001|Overall Study|Exacerbation|0|||
42172396|NCT00353873|75979256|FG000|Overall Study|Adverse Event|1|||
42172397|NCT00353873|75979257|FG001|Overall Study|Adverse Event|0|||
42172398|NCT00353873|75979256|FG000|Overall Study|Physician Decision|2|||
42172399|NCT00353873|75979257|FG001|Overall Study|Physician Decision|0|||
42290414|NCT03766581|76124182|FG000|Randomization|Participant withdrew consent|1|||
42290415|NCT03766581|76124183|FG001|Randomization|Participant withdrew consent|0|||
42356332|NCT01433055|76200944|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
42290416|NCT03766581|76124184|FG002|Randomization|Participant withdrew consent|1|||
42290417|NCT03766581|76124185|FG003|Randomization|Participant withdrew consent|2|||
42290418|NCT03766581|76124186|FG004|Randomization|Participant withdrew consent|1|||
42356333|NCT01433055|76200943|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
42356334|NCT01433055|76200944|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
42356335|NCT01450137|76200952|FG000|Up to Week 12|Adverse Event|2|||
42356336|NCT01450137|76200953|FG001|Up to Week 12|Adverse Event|1|||
42356337|NCT01450137|76200952|FG000|Up to Week 12|Withdrawal by Subject|0|||
42356338|NCT01450137|76200953|FG001|Up to Week 12|Withdrawal by Subject|2|||
42356339|NCT01450137|76200952|FG000|Week 12 to Study End|Death|0|||
42356340|NCT01450137|76200953|FG001|Week 12 to Study End|Death|1|||
42356341|NCT01450137|76200952|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
42356342|NCT01450137|76200953|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
42290419|NCT03766581|76124187|FG005|Randomization|Participant withdrew consent|1|||
42290420|NCT03766581|76124188|FG006|Randomization|Participant withdrew consent|0|||
42290421|NCT03766581|76124189|FG007|Randomization|Participant withdrew consent|0|||
42290422|NCT03766581|76124182|FG000|Treatment|Adverse Event|82|||
42290423|NCT03766581|76124183|FG001|Treatment|Adverse Event|44|||
42290424|NCT03766581|76124184|FG002|Treatment|Adverse Event|47|||
42290425|NCT03766581|76124185|FG003|Treatment|Adverse Event|46|||
42290426|NCT03766581|76124186|FG004|Treatment|Adverse Event|50|||
42290427|NCT03766581|76124187|FG005|Treatment|Adverse Event|77|||
42290428|NCT03766581|76124188|FG006|Treatment|Adverse Event|5|||
42290429|NCT03766581|76124189|FG007|Treatment|Adverse Event|2|||
42290430|NCT03766581|76124182|FG000|Treatment|Participant request to discontinue treatment|34|||
42290431|NCT03766581|76124183|FG001|Treatment|Participant request to discontinue treatment|6|||
42290432|NCT03766581|76124184|FG002|Treatment|Participant request to discontinue treatment|10|||
42290433|NCT03766581|76124185|FG003|Treatment|Participant request to discontinue treatment|10|||
42290434|NCT03766581|76124186|FG004|Treatment|Participant request to discontinue treatment|14|||
42290435|NCT03766581|76124187|FG005|Treatment|Participant request to discontinue treatment|15|||
42290436|NCT03766581|76124188|FG006|Treatment|Participant request to discontinue treatment|0|||
42290437|NCT03766581|76124189|FG007|Treatment|Participant request to discontinue treatment|1|||
42290438|NCT03766581|76124182|FG000|Treatment|Participant withdrew consent|11|||
42290439|NCT03766581|76124183|FG001|Treatment|Participant withdrew consent|4|||
42290440|NCT03766581|76124184|FG002|Treatment|Participant withdrew consent|5|||
42290441|NCT03766581|76124185|FG003|Treatment|Participant withdrew consent|5|||
42290442|NCT03766581|76124186|FG004|Treatment|Participant withdrew consent|4|||
42356343|NCT01412229|76200959|FG000|Overall Study|Physician Decision|1|||
42356344|NCT01412151|76200964|FG000|Week 0 - 306 - Treatment Period|Death|1|||
42290443|NCT03766581|76124187|FG005|Treatment|Participant withdrew consent|4|||
42290444|NCT03766581|76124188|FG006|Treatment|Participant withdrew consent|0|||
42290445|NCT03766581|76124189|FG007|Treatment|Participant withdrew consent|0|||
42356345|NCT01412151|76200964|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
42356346|NCT01412151|76200964|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
42172400|NCT00353873|75979256|FG000|Overall Study|Withdrawal by Subject|1|||
42172401|NCT00353873|75979257|FG001|Overall Study|Withdrawal by Subject|1|||
42172402|NCT03796676|75979266|FG000|Overall Study|Adverse Event|2|||
42172403|NCT03796676|75979267|FG001|Overall Study|Adverse Event|1|||
42172404|NCT03796676|75979268|FG002|Overall Study|Adverse Event|2|||
42172405|NCT03796676|75979266|FG000|Overall Study|Lost to Follow-up|2|||
42290446|NCT03766581|76124182|FG000|Treatment|Death|1|||
42356347|NCT01412151|76200964|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
42356348|NCT01432275|76200970|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
42356349|NCT01432275|76200971|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
42356350|NCT01432275|76200970|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
42356351|NCT01432275|76200971|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
42356352|NCT01432275|76200970|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
42356353|NCT01432275|76200971|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
42172406|NCT03796676|75979267|FG001|Overall Study|Lost to Follow-up|1|||
42172407|NCT03796676|75979268|FG002|Overall Study|Lost to Follow-up|0|||
42172408|NCT03796676|75979266|FG000|Overall Study|Protocol Violation|0|||
42290447|NCT03766581|76124183|FG001|Treatment|Death|0|||
42290448|NCT03766581|76124184|FG002|Treatment|Death|0|||
42290449|NCT03766581|76124185|FG003|Treatment|Death|0|||
42356354|NCT01432275|76200970|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
42356355|NCT01432275|76200971|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
42356356|NCT01432275|76200970|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
42356357|NCT01432275|76200971|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
42356358|NCT01432275|76200970|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
42356359|NCT01432275|76200971|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
42356360|NCT01432275|76200970|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
42356361|NCT01432275|76200971|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
42356362|NCT01432275|76200970|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
42356363|NCT01432275|76200971|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
42356364|NCT01432275|76200970|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
42356365|NCT01432275|76200971|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
42356366|NCT01411995|76200979|FG000|Overall Study|Failed IUD insertion|0|||
42356367|NCT01411995|76200980|FG001|Overall Study|Failed IUD insertion|1|||
42356368|NCT01411917|76200988|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
42356369|NCT01411917|76200989|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
42356370|NCT01411839|76200997|FG000|Overall Study|Lost to Follow-up|4|||
42042399|NCT00914589|75850251|FG001|Overall Study|Adverse Event|0|||
42042400|NCT00914589|75850252|FG002|Overall Study|Adverse Event|1|||
42042401|NCT00914589|75850250|FG000|Overall Study|Protocol Violation|8|||
42042402|NCT00914589|75850251|FG001|Overall Study|Protocol Violation|6|||
42042403|NCT00914589|75850252|FG002|Overall Study|Protocol Violation|3|||
42042404|NCT00914589|75850250|FG000|Overall Study|unclassified|16|||
42042405|NCT00914589|75850251|FG001|Overall Study|unclassified|9|||
42042406|NCT00914589|75850252|FG002|Overall Study|unclassified|7|||
42042407|NCT00914589|75850250|FG000|Overall Study|Death|0|||
42042408|NCT00914589|75850251|FG001|Overall Study|Death|1|||
42042409|NCT00914589|75850252|FG002|Overall Study|Death|1|||
42042410|NCT00912405|75850260|FG000|Overall Study|Lost to Follow-up|5|||
42042411|NCT00878722|75850272|FG000|Overall Study|Progressive disease|3|||
42042412|NCT00878722|75850273|FG001|Overall Study|Progressive disease|3|||
42042413|NCT00878722|75850274|FG002|Overall Study|Progressive disease|3|||
42042414|NCT00878722|75850275|FG003|Overall Study|Progressive disease|7|||
42290450|NCT03766581|76124186|FG004|Treatment|Death|0|||
42290451|NCT03766581|76124187|FG005|Treatment|Death|0|||
42042415|NCT00878722|75850276|FG004|Overall Study|Progressive disease|7|||
42042416|NCT00878722|75850277|FG005|Overall Study|Progressive disease|1|||
42042417|NCT00878722|75850278|FG006|Overall Study|Progressive disease|4|||
42042418|NCT00878722|75850279|FG007|Overall Study|Progressive disease|3|||
42290452|NCT03766581|76124188|FG006|Treatment|Death|0|||
42290453|NCT03766581|76124189|FG007|Treatment|Death|0|||
42290454|NCT03766581|76124182|FG000|Treatment|Lost to Follow-up|1|||
42290455|NCT03766581|76124183|FG001|Treatment|Lost to Follow-up|0|||
42290456|NCT03766581|76124184|FG002|Treatment|Lost to Follow-up|0|||
42290457|NCT03766581|76124185|FG003|Treatment|Lost to Follow-up|1|||
42290458|NCT03766581|76124186|FG004|Treatment|Lost to Follow-up|0|||
42290459|NCT03766581|76124187|FG005|Treatment|Lost to Follow-up|0|||
42290460|NCT03766581|76124188|FG006|Treatment|Lost to Follow-up|0|||
42290461|NCT03766581|76124189|FG007|Treatment|Lost to Follow-up|0|||
42290462|NCT03766581|76124182|FG000|Treatment|Poor/Non compliance|2|||
42290463|NCT03766581|76124183|FG001|Treatment|Poor/Non compliance|2|||
42290464|NCT03766581|76124184|FG002|Treatment|Poor/Non compliance|1|||
42290465|NCT03766581|76124185|FG003|Treatment|Poor/Non compliance|1|||
42290466|NCT03766581|76124186|FG004|Treatment|Poor/Non compliance|1|||
42290467|NCT03766581|76124187|FG005|Treatment|Poor/Non compliance|1|||
42290468|NCT03766581|76124188|FG006|Treatment|Poor/Non compliance|0|||
42290469|NCT03766581|76124189|FG007|Treatment|Poor/Non compliance|0|||
42290470|NCT03766581|76124182|FG000|Treatment|Participant no longer meets study criteria|9|||
42290471|NCT03766581|76124183|FG001|Treatment|Participant no longer meets study criteria|1|||
42290472|NCT03766581|76124184|FG002|Treatment|Participant no longer meets study criteria|5|||
42042419|NCT00878722|75850272|FG000|Overall Study|Death|0|||
42042420|NCT00878722|75850273|FG001|Overall Study|Death|0|||
42042421|NCT00878722|75850274|FG002|Overall Study|Death|0|||
42042422|NCT00878722|75850275|FG003|Overall Study|Death|1|||
42290473|NCT03766581|76124185|FG003|Treatment|Participant no longer meets study criteria|4|||
42290474|NCT03766581|76124186|FG004|Treatment|Participant no longer meets study criteria|4|||
42290475|NCT03766581|76124187|FG005|Treatment|Participant no longer meets study criteria|4|||
42290476|NCT03766581|76124188|FG006|Treatment|Participant no longer meets study criteria|2|||
42290477|NCT03766581|76124189|FG007|Treatment|Participant no longer meets study criteria|0|||
42290478|NCT03766581|76124182|FG000|Treatment|Other reasons|13|||
42356371|NCT01411839|76200998|FG001|Overall Study|Lost to Follow-up|3|||
42042423|NCT00878722|75850276|FG004|Overall Study|Death|0|||
42042424|NCT00878722|75850277|FG005|Overall Study|Death|1|||
42042425|NCT00878722|75850278|FG006|Overall Study|Death|0|||
42042426|NCT00878722|75850279|FG007|Overall Study|Death|2|||
42042427|NCT00878722|75850272|FG000|Overall Study|Adverse Event|0|||
42042428|NCT00878722|75850273|FG001|Overall Study|Adverse Event|0|||
42290479|NCT03766581|76124183|FG001|Treatment|Other reasons|8|||
42042429|NCT00878722|75850274|FG002|Overall Study|Adverse Event|0|||
42290480|NCT03766581|76124184|FG002|Treatment|Other reasons|3|||
42290481|NCT03766581|76124185|FG003|Treatment|Other reasons|7|||
42290482|NCT03766581|76124186|FG004|Treatment|Other reasons|3|||
42290483|NCT03766581|76124187|FG005|Treatment|Other reasons|3|||
42290484|NCT03766581|76124188|FG006|Treatment|Other reasons|0|||
42290485|NCT03766581|76124189|FG007|Treatment|Other reasons|0|||
42290486|NCT03675321|76124214|FG000|Overall Study|Lack of Efficacy|2|||
42290487|NCT03675321|76124215|FG001|Overall Study|Lack of Efficacy|2|||
42290488|NCT03675321|76124214|FG000|Overall Study|Withdrawal by Subject|1|||
42290489|NCT03675321|76124215|FG001|Overall Study|Withdrawal by Subject|3|||
42290490|NCT03527745|76124261|FG000|Overall Study|Lost to Follow-up|3|||
42290491|NCT03527745|76124262|FG001|Overall Study|Lost to Follow-up|6|||
42290492|NCT03527745|76124263|FG002|Overall Study|Lost to Follow-up|7|||
42290493|NCT03527745|76124264|FG003|Overall Study|Lost to Follow-up|9|||
42290494|NCT03527745|76124265|FG004|Overall Study|Lost to Follow-up|0|||
42290495|NCT03527745|76124266|FG005|Overall Study|Lost to Follow-up|2|||
42290496|NCT03527745|76124267|FG006|Overall Study|Lost to Follow-up|3|||
42290497|NCT03527745|76124268|FG007|Overall Study|Lost to Follow-up|2|||
42290498|NCT03527745|76124269|FG008|Overall Study|Lost to Follow-up|3|||
42290499|NCT03527745|76124270|FG009|Overall Study|Lost to Follow-up|2|||
42290500|NCT03527745|76124271|FG010|Overall Study|Lost to Follow-up|1|||
42290501|NCT03527745|76124272|FG011|Overall Study|Lost to Follow-up|1|||
42290502|NCT03527745|76124273|FG012|Overall Study|Lost to Follow-up|0|||
42290503|NCT03527745|76124274|FG013|Overall Study|Lost to Follow-up|0|||
42290504|NCT03527745|76124275|FG014|Overall Study|Lost to Follow-up|0|||
42290505|NCT03527745|76124276|FG015|Overall Study|Lost to Follow-up|0|||
42290506|NCT03527745|76124277|FG016|Overall Study|Lost to Follow-up|1|||
42290507|NCT03527745|76124278|FG017|Overall Study|Lost to Follow-up|0|||
42290508|NCT03527745|76124279|FG018|Overall Study|Lost to Follow-up|0|||
42290509|NCT03527745|76124280|FG019|Overall Study|Lost to Follow-up|1|||
42290510|NCT03527745|76124281|FG020|Overall Study|Lost to Follow-up|1|||
42290511|NCT03527745|76124282|FG021|Overall Study|Lost to Follow-up|5|||
42290512|NCT03527745|76124283|FG022|Overall Study|Lost to Follow-up|6|||
42290513|NCT03527745|76124284|FG023|Overall Study|Lost to Follow-up|8|||
42290514|NCT03527745|76124285|FG024|Overall Study|Lost to Follow-up|1|||
42290515|NCT03527745|76124286|FG025|Overall Study|Lost to Follow-up|3|||
42290516|NCT03174782|76124368|FG000|Overall Study|Protocol Violation|1|||
42290517|NCT03174782|76124369|FG001|Overall Study|Protocol Violation|0|||
42290518|NCT03174782|76124368|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
42290519|NCT03174782|76124369|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
42290520|NCT02919969|76124375|FG000|Overall Study|Lack of Efficacy|22|||
42290521|NCT02919969|76124375|FG000|Overall Study|Death|4|||
42290522|NCT02919969|76124375|FG000|Overall Study|Physician Decision|3|||
42290523|NCT02919969|76124375|FG000|Overall Study|Withdrawal by Subject|2|||
42290524|NCT01891344|76124397|FG000|Overall Study|Ongoing|6|||
42290525|NCT01891344|76124398|FG001|Overall Study|Ongoing|2|||
42042430|NCT00878722|75850275|FG003|Overall Study|Adverse Event|0|||
42042431|NCT00878722|75850276|FG004|Overall Study|Adverse Event|0|||
42042432|NCT00878722|75850277|FG005|Overall Study|Adverse Event|0|||
42042433|NCT00878722|75850278|FG006|Overall Study|Adverse Event|2|||
42042434|NCT00878722|75850279|FG007|Overall Study|Adverse Event|0|||
42042435|NCT00878722|75850272|FG000|Overall Study|Withdrawal by Subject|0|||
42042436|NCT00878722|75850273|FG001|Overall Study|Withdrawal by Subject|0|||
42042437|NCT00878722|75850274|FG002|Overall Study|Withdrawal by Subject|0|||
42042438|NCT00878722|75850275|FG003|Overall Study|Withdrawal by Subject|0|||
42290526|NCT01891344|76124399|FG002|Overall Study|Ongoing|0|||
42042439|NCT00878722|75850276|FG004|Overall Study|Withdrawal by Subject|0|||
42042440|NCT00878722|75850277|FG005|Overall Study|Withdrawal by Subject|0|||
42042441|NCT00878722|75850278|FG006|Overall Study|Withdrawal by Subject|0|||
42290527|NCT01891344|76124400|FG003|Overall Study|Ongoing|1|||
42290528|NCT01891344|76124401|FG004|Overall Study|Ongoing|4|||
42290529|NCT01891344|76124402|FG005|Overall Study|Ongoing|1|||
42290530|NCT01891344|76124403|FG006|Overall Study|Ongoing|0|||
42290531|NCT01891344|76124404|FG007|Overall Study|Ongoing|0|||
42290532|NCT01188096|76124422|FG000|Overall Study|progression of disease|4|||
42290533|NCT01188096|76124422|FG000|Overall Study|Withdrawal by Subject|2|||
42290534|NCT00579826|76124442|FG000|Overall Study|Withdrawal by Subject|5|||
42290535|NCT00579826|76124443|FG001|Overall Study|Withdrawal by Subject|3|||
42290536|NCT00106691|76124451|FG000|Overall Study|Adverse Event|60|||
42290537|NCT00106691|76124452|FG001|Overall Study|Adverse Event|64|||
42042442|NCT00878722|75850279|FG007|Overall Study|Withdrawal by Subject|2|||
42042443|NCT00878722|75850272|FG000|Overall Study|Relapse|0|||
42042444|NCT00878722|75850273|FG001|Overall Study|Relapse|0|||
42042445|NCT00878722|75850274|FG002|Overall Study|Relapse|0|||
42042446|NCT00878722|75850275|FG003|Overall Study|Relapse|1|||
42042447|NCT00878722|75850276|FG004|Overall Study|Relapse|0|||
42042448|NCT00878722|75850277|FG005|Overall Study|Relapse|0|||
42042449|NCT00878722|75850278|FG006|Overall Study|Relapse|0|||
42042450|NCT00878722|75850279|FG007|Overall Study|Relapse|0|||
42042451|NCT00964158|75850307|FG000|Overall Study|Lost to Follow-up|0|||
42042452|NCT00964158|75850308|FG001|Overall Study|Lost to Follow-up|1|||
42042453|NCT00964158|75850309|FG002|Overall Study|Lost to Follow-up|2|||
42042454|NCT00964158|75850307|FG000|Overall Study|Withdrawal by Subject|0|||
42042455|NCT00964158|75850308|FG001|Overall Study|Withdrawal by Subject|0|||
42290538|NCT00106691|76124451|FG000|Overall Study|Lost to Follow-up|23|||
42290539|NCT00106691|76124452|FG001|Overall Study|Lost to Follow-up|18|||
42290540|NCT00106691|76124451|FG000|Overall Study|Physician Decision|18|||
42290541|NCT00106691|76124452|FG001|Overall Study|Physician Decision|21|||
42290542|NCT00106691|76124451|FG000|Overall Study|Protocol Violation|13|||
42356372|NCT01411215|76201006|FG000|Overall Study|Adverse Event|1|||
42356373|NCT01411215|76201007|FG001|Overall Study|Adverse Event|2|||
42290543|NCT00106691|76124452|FG001|Overall Study|Protocol Violation|18|||
42290544|NCT00106691|76124451|FG000|Overall Study|Withdrawal by Subject|75|||
42290545|NCT00106691|76124452|FG001|Overall Study|Withdrawal by Subject|70|||
42356374|NCT01411215|76201006|FG000|Overall Study|Lack of Efficacy|2|||
42356375|NCT01411215|76201007|FG001|Overall Study|Lack of Efficacy|4|||
42356376|NCT01411215|76201006|FG000|Overall Study|Lost to Follow-up|12|||
42356377|NCT01411215|76201007|FG001|Overall Study|Lost to Follow-up|18|||
42356378|NCT01411215|76201006|FG000|Overall Study|Did not meet entrance criteria|0|||
42356379|NCT01411215|76201007|FG001|Overall Study|Did not meet entrance criteria|1|||
42356380|NCT01411215|76201006|FG000|Overall Study|Study terminated by sponsor|2|||
42356381|NCT01411215|76201007|FG001|Overall Study|Study terminated by sponsor|15|||
42356382|NCT01411215|76201006|FG000|Overall Study|Protocol Violation|3|||
42356383|NCT01411215|76201007|FG001|Overall Study|Protocol Violation|5|||
42356384|NCT01411215|76201006|FG000|Overall Study|Withdrawal by Subject|34|||
42356385|NCT01411215|76201007|FG001|Overall Study|Withdrawal by Subject|21|||
42356386|NCT01411215|76201006|FG000|Overall Study|Other|12|||
42042456|NCT00964158|75850309|FG002|Overall Study|Withdrawal by Subject|6|||
42042457|NCT00961350|75850322|FG000|Overall Study|Adverse Event|18|||
42042458|NCT00961350|75850323|FG001|Overall Study|Adverse Event|33|||
42042459|NCT00961350|75850322|FG000|Overall Study|Withdrawal by Subject|10|||
42042460|NCT00961350|75850323|FG001|Overall Study|Withdrawal by Subject|10|||
42042461|NCT00961350|75850322|FG000|Overall Study|Lost to Follow-up|3|||
42356387|NCT01411215|76201007|FG001|Overall Study|Other|17|||
42356388|NCT01411215|76201006|FG000|Overall Study|Screen failure|0|||
42356389|NCT01411215|76201007|FG001|Overall Study|Screen failure|1|||
42356390|NCT01449279|76201013|FG000|Overall Study|Lack of Efficacy|5|||
42356391|NCT01449279|76201013|FG000|Overall Study|Toxicity|2|||
42290546|NCT00106691|76124451|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
42290547|NCT00106691|76124452|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
42290548|NCT00106691|76124451|FG000|Overall Study|QTc>480|3|||
42290549|NCT00106691|76124452|FG001|Overall Study|QTc>480|1|||
42290550|NCT00106691|76124451|FG000|Overall Study|mililtary deployment|2|||
42290551|NCT00106691|76124452|FG001|Overall Study|mililtary deployment|0|||
42290552|NCT00106691|76124451|FG000|Overall Study|Study Site Closing/PI Moved|1|||
42290553|NCT00106691|76124452|FG001|Overall Study|Study Site Closing/PI Moved|2|||
42290554|NCT00106691|76124451|FG000|Overall Study|Cardiologist recommendation|1|||
42290555|NCT00106691|76124452|FG001|Overall Study|Cardiologist recommendation|0|||
42290556|NCT00106691|76124451|FG000|Overall Study|Pt. moved to another state|1|||
42290557|NCT00106691|76124452|FG001|Overall Study|Pt. moved to another state|0|||
42290558|NCT00106691|76124451|FG000|Overall Study|Taking exclusionary avodart|1|||
42290559|NCT00106691|76124452|FG001|Overall Study|Taking exclusionary avodart|0|||
42290560|NCT00106691|76124451|FG000|Overall Study|Not able to discontinue plavix|0|||
42290561|NCT00106691|76124452|FG001|Overall Study|Not able to discontinue plavix|1|||
42290562|NCT02644967|76124541|FG000|Overall Study|Death|26|||
42290563|NCT02644967|76124541|FG000|Overall Study|Physician Decision|1|||
42290564|NCT02644967|76124541|FG000|Overall Study|Withdrawal by Subject|2|||
42290565|NCT02644967|76124541|FG000|Overall Study|Protocol Violation|1|||
42290566|NCT02644967|76124541|FG000|Overall Study|Progressive Disease|1|||
42356392|NCT01447719|76201017|FG000|Overall Study|Image acquisition failure|2|||
42356393|NCT01447719|76201017|FG000|Overall Study|Invalid image or not imaged|3|||
42356394|NCT01447719|76201017|FG000|Overall Study|Subject still living at end of study|79|||
42356395|NCT01447719|76201017|FG000|Overall Study|Withdrawal by Subject|2|||
42356396|NCT01447719|76201017|FG000|Overall Study|Family withdrew autopsy consent|7|||
42356397|NCT01431963|76201026|FG000|Overall Study|Adverse Event|18|||
42356398|NCT01431963|76201026|FG000|Overall Study|Lack of Efficacy|7|||
42356399|NCT01431963|76201026|FG000|Overall Study|Protocol Violation|1|||
42356400|NCT01431963|76201026|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
42356401|NCT01431963|76201026|FG000|Overall Study|Physician Decision|4|||
42356402|NCT01431963|76201026|FG000|Overall Study|Withdrawal by Subject|3|||
42356403|NCT01447407|76201034|FG000|Overall Study|Withdrawal by Subject|2|||
42356404|NCT01447407|76201035|FG001|Overall Study|Withdrawal by Subject|0|||
42356405|NCT01447407|76201036|FG002|Overall Study|Withdrawal by Subject|0|||
42356406|NCT01447407|76201037|FG003|Overall Study|Withdrawal by Subject|1|||
42356407|NCT01447407|76201034|FG000|Overall Study|Physician Decision|0|||
42290567|NCT02644967|76124541|FG000|Overall Study|Study Terminated by Sponsor|4|||
42290568|NCT02644343|76124545|FG000|Overall Study|Withdrawal by Subject|1|||
42290569|NCT02644109|76124551|FG000|Overall Study|Adverse Event|0|||
42290570|NCT02644109|76124552|FG001|Overall Study|Adverse Event|4|||
42290571|NCT02642159|76124560|FG000|Overall Study|Randomized but not treated|1|||
42290572|NCT02642159|76124561|FG001|Overall Study|Randomized but not treated|0|||
42290573|NCT02642159|76124560|FG000|Overall Study|Adverse Event|10|||
42290574|NCT02642159|76124561|FG001|Overall Study|Adverse Event|4|||
42290575|NCT02642159|76124560|FG000|Overall Study|Withdrawal by Subject|9|||
42356408|NCT01447407|76201035|FG001|Overall Study|Physician Decision|0|||
42172409|NCT03796676|75979267|FG001|Overall Study|Protocol Violation|0|||
42290576|NCT02642159|76124561|FG001|Overall Study|Withdrawal by Subject|1|||
42290577|NCT02642159|76124560|FG000|Overall Study|Poor compliance to study protocol|1|||
42356409|NCT01447407|76201036|FG002|Overall Study|Physician Decision|1|||
42356410|NCT01447407|76201037|FG003|Overall Study|Physician Decision|1|||
42356411|NCT01446237|76201047|FG000|Overall Study|Adverse Event|1|||
42356412|NCT01446237|76201047|FG000|Overall Study|Lost to Follow-up|2|||
42290578|NCT02642159|76124561|FG001|Overall Study|Poor compliance to study protocol|0|||
42290579|NCT02642159|76124560|FG000|Overall Study|Other than specified above|10|||
42290580|NCT02642159|76124561|FG001|Overall Study|Other than specified above|3|||
42356413|NCT01446237|76201047|FG000|Overall Study|Withdrawal by Subject|7|||
42356414|NCT01446159|76201191|FG000|Overall Study|Withdrawal by Subject|1|||
42356415|NCT01446159|76201192|FG001|Overall Study|Withdrawal by Subject|0|||
42356416|NCT01446159|76201193|FG002|Overall Study|Withdrawal by Subject|14|||
42356417|NCT01446159|76201194|FG003|Overall Study|Withdrawal by Subject|11|||
42356418|NCT01446159|76201191|FG000|Overall Study|Lost to Follow-up|0|||
42356419|NCT01446159|76201192|FG001|Overall Study|Lost to Follow-up|0|||
42356420|NCT01446159|76201193|FG002|Overall Study|Lost to Follow-up|1|||
42356421|NCT01446159|76201194|FG003|Overall Study|Lost to Follow-up|2|||
42356422|NCT01446159|76201191|FG000|Overall Study|Death|2|||
42356423|NCT01446159|76201192|FG001|Overall Study|Death|3|||
42356424|NCT01446159|76201193|FG002|Overall Study|Death|43|||
42356425|NCT01446159|76201194|FG003|Overall Study|Death|36|||
42356426|NCT01446159|76201191|FG000|Overall Study|Other|0|||
42356427|NCT01446159|76201192|FG001|Overall Study|Other|0|||
42356428|NCT01446159|76201193|FG002|Overall Study|Other|13|||
42356429|NCT01446159|76201194|FG003|Overall Study|Other|13|||
42356430|NCT01446003|76201230|FG000|Period 1|Protocol Violation|2|||
42356431|NCT01446003|76201231|FG001|Period 1|Protocol Violation|0|||
42356432|NCT01446003|76201230|FG000|Period 2|Adverse Event|1|||
42356433|NCT01446003|76201231|FG001|Period 2|Adverse Event|0|||
42356434|NCT01430559|76201248|FG000|Overall Study|Adverse Event|7|||
42356435|NCT01430559|76201249|FG001|Overall Study|Adverse Event|3|||
42356436|NCT01430559|76201248|FG000|Overall Study|Entry criteria not met|1|||
42356437|NCT01430559|76201249|FG001|Overall Study|Entry criteria not met|1|||
42356438|NCT01430559|76201248|FG000|Overall Study|Lost to Follow-up|1|||
42356439|NCT01430559|76201249|FG001|Overall Study|Lost to Follow-up|0|||
42290581|NCT02669017|76124577|FG000|Overall Study|Death|1|||
42356440|NCT01430559|76201248|FG000|Overall Study|Medication error|1|||
42356441|NCT01430559|76201249|FG001|Overall Study|Medication error|0|||
42356442|NCT01430559|76201248|FG000|Overall Study|Withdrawal by Subject|3|||
42356443|NCT01430559|76201249|FG001|Overall Study|Withdrawal by Subject|2|||
42356444|NCT01430559|76201248|FG000|Overall Study|Protocol Violation|1|||
42356445|NCT01430559|76201249|FG001|Overall Study|Protocol Violation|0|||
42356446|NCT01430559|76201248|FG000|Overall Study|Other|3|||
42356447|NCT01430559|76201249|FG001|Overall Study|Other|3|||
42356448|NCT01430559|76201248|FG000|Overall Study|Randomized, Not Treated|3|||
42356449|NCT01430559|76201249|FG001|Overall Study|Randomized, Not Treated|3|||
42356450|NCT01410357|76201262|FG000|Overall Study|Death|2|||
42356451|NCT01410357|76201263|FG001|Overall Study|Death|1|||
42356452|NCT01410357|76201262|FG000|Overall Study|Withdrawal by Subject|1|||
42356453|NCT01410357|76201263|FG001|Overall Study|Withdrawal by Subject|2|||
42356454|NCT01410357|76201262|FG000|Overall Study|Lost to Follow-up|23|||
42356455|NCT01410357|76201263|FG001|Overall Study|Lost to Follow-up|21|||
42356456|NCT01409811|76201288|FG000|Overall Study|Insurance denial|1|||
42356457|NCT01445847|76201294|FG000|Overall Study|Protocol Violation|13|||
42356458|NCT01445847|76201295|FG001|Overall Study|Protocol Violation|14|||
42356459|NCT01445847|76201294|FG000|Overall Study|Missed Data|1|||
42356460|NCT01445847|76201295|FG001|Overall Study|Missed Data|0|||
42356461|NCT01445769|76201314|FG000|Overall Study|Consent Withdrawn|2|||
42356462|NCT01445769|76201314|FG000|Overall Study|Disease Progression|1|||
42356463|NCT01445769|76201314|FG000|Overall Study|Lost to Follow-up|5|||
42356464|NCT01445613|76201396|FG000|30-day Follow-up|Withdrawal by Subject|6|||
42356465|NCT01445613|76201396|FG000|30-day Follow-up|Physician Decision|3|||
42356466|NCT01445613|76201396|FG000|30-day Follow-up|Missed visit|23|||
42290582|NCT02669017|76124578|FG001|Overall Study|Death|2|||
42290583|NCT02669017|76124579|FG002|Overall Study|Death|2|||
42290584|NCT02669017|76124580|FG003|Overall Study|Death|3|||
42290585|NCT02669017|76124581|FG004|Overall Study|Death|8|||
42016001|NCT01282424|75823165|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
42290586|NCT02669017|76124582|FG005|Overall Study|Death|18|||
42290587|NCT02669017|76124583|FG006|Overall Study|Death|10|||
42290588|NCT02669017|76124584|FG007|Overall Study|Death|47|||
42290589|NCT02669017|76124585|FG008|Overall Study|Death|20|||
42290590|NCT02669017|76124577|FG000|Overall Study|Withdrawal by Subject|0|||
42290591|NCT02669017|76124578|FG001|Overall Study|Withdrawal by Subject|0|||
42290592|NCT02669017|76124579|FG002|Overall Study|Withdrawal by Subject|0|||
42290593|NCT02669017|76124580|FG003|Overall Study|Withdrawal by Subject|1|||
42290594|NCT02669017|76124581|FG004|Overall Study|Withdrawal by Subject|2|||
42290595|NCT02669017|76124582|FG005|Overall Study|Withdrawal by Subject|0|||
42290596|NCT02669017|76124583|FG006|Overall Study|Withdrawal by Subject|0|||
42356467|NCT01445613|76201396|FG000|30-day Follow-up|Death|3|||
42356468|NCT01445613|76201396|FG000|1-year Follow-up|Withdrawal by Subject|12|||
42356469|NCT01445613|76201396|FG000|1-year Follow-up|Missed visit|29|||
42290597|NCT02669017|76124584|FG007|Overall Study|Withdrawal by Subject|2|||
42290598|NCT02669017|76124585|FG008|Overall Study|Withdrawal by Subject|2|||
42290599|NCT02669017|76124577|FG000|Overall Study|Lost to Follow-up|0|||
42290600|NCT02669017|76124578|FG001|Overall Study|Lost to Follow-up|0|||
42290601|NCT02669017|76124579|FG002|Overall Study|Lost to Follow-up|0|||
42290602|NCT02669017|76124580|FG003|Overall Study|Lost to Follow-up|0|||
42290603|NCT02669017|76124581|FG004|Overall Study|Lost to Follow-up|0|||
42290604|NCT02669017|76124582|FG005|Overall Study|Lost to Follow-up|0|||
42290605|NCT02669017|76124583|FG006|Overall Study|Lost to Follow-up|0|||
42290606|NCT02669017|76124584|FG007|Overall Study|Lost to Follow-up|0|||
42290607|NCT02669017|76124585|FG008|Overall Study|Lost to Follow-up|1|||
42290608|NCT02669017|76124577|FG000|Overall Study|Miscellaneous|0|||
42290609|NCT02669017|76124578|FG001|Overall Study|Miscellaneous|0|||
42356470|NCT01445613|76201396|FG000|1-year Follow-up|Lost to Follow-up|2|||
42356471|NCT01445613|76201396|FG000|1-year Follow-up|Death|30|||
42356472|NCT01445613|76201396|FG000|1-year Follow-up|Physician Decision|2|||
42356473|NCT01445613|76201396|FG000|1-year Follow-up|Received a non-study stent|2|||
42356474|NCT01445535|76201500|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
42356475|NCT01445535|76201501|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
42356476|NCT01445535|76201502|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
42356477|NCT01445535|76201503|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
42356478|NCT01445535|76201500|FG000|Overall Study|Disease progression|1|||
42356479|NCT01445535|76201501|FG001|Overall Study|Disease progression|0|||
42356480|NCT01445535|76201502|FG002|Overall Study|Disease progression|1|||
42356481|NCT01445535|76201503|FG003|Overall Study|Disease progression|0|||
42356482|NCT01445535|76201500|FG000|Overall Study|PI discretion|0|||
42356483|NCT01445535|76201501|FG001|Overall Study|PI discretion|0|||
42356484|NCT01445535|76201502|FG002|Overall Study|PI discretion|0|||
42356485|NCT01445535|76201503|FG003|Overall Study|PI discretion|1|||
42356486|NCT01445301|76201517|FG000|Overall Study|Adverse Event|15|||
42042462|NCT00961350|75850323|FG001|Overall Study|Lost to Follow-up|3|||
42042463|NCT00961350|75850322|FG000|Overall Study|Misc|16|||
42042464|NCT00961350|75850323|FG001|Overall Study|Misc|21|||
42042465|NCT00963924|75850331|FG000|Overall Study|Adverse Event|1|||
42042466|NCT00963924|75850332|FG001|Overall Study|Adverse Event|0|||
42042467|NCT00963924|75850331|FG000|Overall Study|Withdrawal by Subject|0|||
42042468|NCT00963924|75850332|FG001|Overall Study|Withdrawal by Subject|1|||
42290610|NCT02669017|76124579|FG002|Overall Study|Miscellaneous|0|||
42290611|NCT02669017|76124580|FG003|Overall Study|Miscellaneous|0|||
42290612|NCT02669017|76124581|FG004|Overall Study|Miscellaneous|2|||
42290613|NCT02669017|76124582|FG005|Overall Study|Miscellaneous|1|||
42290614|NCT02669017|76124583|FG006|Overall Study|Miscellaneous|1|||
42290615|NCT02669017|76124584|FG007|Overall Study|Miscellaneous|13|||
42290616|NCT02669017|76124585|FG008|Overall Study|Miscellaneous|2|||
42290617|NCT02668393|76124615|FG000|Overall Study|Progressive disease|6|||
42356487|NCT01445301|76201518|FG001|Overall Study|Adverse Event|25|||
42042469|NCT00963924|75850331|FG000|Overall Study|Changed antipsychotic|0|||
42290618|NCT02668393|76124616|FG001|Overall Study|Progressive disease|3|||
42290619|NCT02668393|76124615|FG000|Overall Study|Adverse Event|0|||
42042470|NCT00963924|75850332|FG001|Overall Study|Changed antipsychotic|1|||
42042471|NCT00963924|75850331|FG000|Overall Study|Lost to Follow-up|0|||
42290620|NCT02668393|76124616|FG001|Overall Study|Adverse Event|2|||
42290621|NCT02668393|76124615|FG000|Overall Study|Withdrawal from the trial|0|||
42356488|NCT01445301|76201519|FG002|Overall Study|Adverse Event|4|||
42356489|NCT01445301|76201517|FG000|Overall Study|Lack of Efficacy|0|||
42356490|NCT01445301|76201518|FG001|Overall Study|Lack of Efficacy|1|||
42356491|NCT01445301|76201519|FG002|Overall Study|Lack of Efficacy|0|||
42042472|NCT00963924|75850332|FG001|Overall Study|Lost to Follow-up|1|||
42042473|NCT03265665|75850342|FG000|24-week Data Collection|Withdrawal by Subject|2|||
42042474|NCT03265665|75850343|FG001|24-week Data Collection|Withdrawal by Subject|2|||
42042475|NCT03265665|75850342|FG000|24-week Data Collection|Lost to Follow-up|4|||
42042476|NCT03265665|75850343|FG001|24-week Data Collection|Lost to Follow-up|5|||
42042477|NCT03265665|75850342|FG000|36-week Data Collection|Lost to Follow-up|6|||
42042478|NCT03265665|75850343|FG001|36-week Data Collection|Lost to Follow-up|8|||
42042479|NCT01114646|75850353|FG000|Overall Study|Withdrawal by Subject|3|||
42042480|NCT01114646|75850354|FG001|Overall Study|Withdrawal by Subject|2|||
42042481|NCT00965562|75850363|FG000|Overall Study|Lost to Follow-up|1|||
42042482|NCT00965562|75850364|FG001|Overall Study|Lost to Follow-up|2|||
42042483|NCT00965562|75850365|FG002|Overall Study|Lost to Follow-up|3|||
42042484|NCT00965562|75850363|FG000|Overall Study|Withdrawal by Subject|2|||
42042485|NCT00965562|75850364|FG001|Overall Study|Withdrawal by Subject|2|||
42042486|NCT00965562|75850365|FG002|Overall Study|Withdrawal by Subject|0|||
42042487|NCT00912093|75850379|FG000|The Controlled Phase|Death|0|||
42042488|NCT00912093|75850380|FG001|The Controlled Phase|Death|1|||
42042489|NCT00912093|75850381|FG002|The Controlled Phase|Death|0|||
42042490|NCT00912093|75850382|FG003|The Controlled Phase|Death|0|||
42042491|NCT00912093|75850383|FG004|The Controlled Phase|Death|0|||
42042492|NCT00912093|75850379|FG000|The Controlled Phase|Medical Condition|0|||
42042493|NCT00912093|75850380|FG001|The Controlled Phase|Medical Condition|1|||
42042494|NCT00912093|75850381|FG002|The Controlled Phase|Medical Condition|0|||
42042495|NCT00912093|75850382|FG003|The Controlled Phase|Medical Condition|0|||
42042496|NCT00912093|75850383|FG004|The Controlled Phase|Medical Condition|0|||
42042497|NCT00912093|75850379|FG000|The Controlled Phase|Lost to Follow-up|0|||
42042498|NCT00912093|75850380|FG001|The Controlled Phase|Lost to Follow-up|0|||
42042499|NCT00912093|75850381|FG002|The Controlled Phase|Lost to Follow-up|0|||
42042500|NCT00912093|75850382|FG003|The Controlled Phase|Lost to Follow-up|0|||
42042501|NCT00912093|75850383|FG004|The Controlled Phase|Lost to Follow-up|1|||
42042502|NCT00965484|75850391|FG000|Overall Study|Protocol Violation|1|||
42042503|NCT00965484|75850391|FG000|Overall Study|Withdrawal by Subject|1|||
42042504|NCT00961116|75850395|FG000|Washout Period of 7 Days|Adverse Event|1|||
42042505|NCT00961116|75850396|FG001|Washout Period of 7 Days|Adverse Event|1|||
42042506|NCT00961116|75850395|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
42042507|NCT00961116|75850396|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
42042508|NCT00961116|75850395|FG000|Washout Period of 7 Days|Protocol Violation|0|||
42042509|NCT00961116|75850396|FG001|Washout Period of 7 Days|Protocol Violation|1|||
42042510|NCT00912015|75850407|FG000|Overall Study|Lack of Efficacy|1|||
42042511|NCT00912015|75850408|FG001|Overall Study|Lack of Efficacy|0|||
42042512|NCT00912015|75850409|FG002|Overall Study|Lack of Efficacy|0|||
42042513|NCT00912015|75850410|FG003|Overall Study|Lack of Efficacy|0|||
42042514|NCT00912015|75850407|FG000|Overall Study|Withdrawal by Subject|8|||
42042515|NCT00912015|75850408|FG001|Overall Study|Withdrawal by Subject|8|||
42042516|NCT00912015|75850409|FG002|Overall Study|Withdrawal by Subject|3|||
42042517|NCT00912015|75850410|FG003|Overall Study|Withdrawal by Subject|0|||
42042518|NCT00912015|75850407|FG000|Overall Study|Protocol Violation|1|||
42042519|NCT00912015|75850408|FG001|Overall Study|Protocol Violation|0|||
42042520|NCT00912015|75850409|FG002|Overall Study|Protocol Violation|0|||
42042521|NCT00912015|75850410|FG003|Overall Study|Protocol Violation|1|||
42042522|NCT00912015|75850407|FG000|Overall Study|Adverse Event|6|||
42042523|NCT00912015|75850408|FG001|Overall Study|Adverse Event|0|||
42042524|NCT00912015|75850409|FG002|Overall Study|Adverse Event|0|||
42042525|NCT00912015|75850410|FG003|Overall Study|Adverse Event|1|||
42042526|NCT00960804|75850423|FG000|Overall Study|Adverse Event|1|||
42042527|NCT00960804|75850424|FG001|Overall Study|Adverse Event|0|||
42042528|NCT00960804|75850425|FG002|Overall Study|Adverse Event|0|||
42042529|NCT00960804|75850423|FG000|Overall Study|Withdrawal by Subject|1|||
42042530|NCT00960804|75850424|FG001|Overall Study|Withdrawal by Subject|0|||
42042531|NCT00960804|75850425|FG002|Overall Study|Withdrawal by Subject|0|||
42042532|NCT00960804|75850423|FG000|Overall Study|Study terminated by the sponsor|5|||
42042533|NCT00960804|75850424|FG001|Overall Study|Study terminated by the sponsor|4|||
42042534|NCT00960804|75850425|FG002|Overall Study|Study terminated by the sponsor|10|||
42172410|NCT03796676|75979268|FG002|Overall Study|Protocol Violation|1|||
42042535|NCT01126580|75850436|FG000|Overall Study|Adverse Event|14|||
42042536|NCT01126580|75850437|FG001|Overall Study|Adverse Event|8|||
42042537|NCT01126580|75850438|FG002|Overall Study|Adverse Event|12|||
42042538|NCT01126580|75850436|FG000|Overall Study|Withdrawal by Subject|11|||
42042539|NCT01126580|75850437|FG001|Overall Study|Withdrawal by Subject|19|||
42042540|NCT01126580|75850438|FG002|Overall Study|Withdrawal by Subject|14|||
42042541|NCT01126580|75850436|FG000|Overall Study|Sponsor Decision|5|||
42356492|NCT01445301|76201517|FG000|Overall Study|Protocol Violation|1|||
42356493|NCT01445301|76201518|FG001|Overall Study|Protocol Violation|0|||
42356494|NCT01445301|76201519|FG002|Overall Study|Protocol Violation|0|||
42356495|NCT01445301|76201517|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
42356496|NCT01445301|76201518|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
42356497|NCT01445301|76201519|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
42356498|NCT01445301|76201517|FG000|Overall Study|Physician Decision|0|||
42042542|NCT01126580|75850437|FG001|Overall Study|Sponsor Decision|4|||
42042543|NCT01126580|75850438|FG002|Overall Study|Sponsor Decision|7|||
42042544|NCT01126580|75850436|FG000|Overall Study|Physician Decision|1|||
42042545|NCT01126580|75850437|FG001|Overall Study|Physician Decision|1|||
42042546|NCT01126580|75850438|FG002|Overall Study|Physician Decision|2|||
42042547|NCT01126580|75850436|FG000|Overall Study|Entry Criteria Not Met|1|||
42042548|NCT01126580|75850437|FG001|Overall Study|Entry Criteria Not Met|1|||
42042549|NCT01126580|75850438|FG002|Overall Study|Entry Criteria Not Met|2|||
42042550|NCT01126580|75850436|FG000|Overall Study|Lack of Efficacy|2|||
42042551|NCT01126580|75850437|FG001|Overall Study|Lack of Efficacy|3|||
42172411|NCT03796676|75979266|FG000|Overall Study|Withdrawal by Subject|1|||
42042552|NCT01126580|75850438|FG002|Overall Study|Lack of Efficacy|4|||
42172412|NCT03796676|75979267|FG001|Overall Study|Withdrawal by Subject|1|||
42172413|NCT03796676|75979268|FG002|Overall Study|Withdrawal by Subject|0|||
42356499|NCT01445301|76201518|FG001|Overall Study|Physician Decision|2|||
42356500|NCT01445301|76201519|FG002|Overall Study|Physician Decision|0|||
42042553|NCT01126580|75850436|FG000|Overall Study|Protocol Violation|0|||
42042554|NCT01126580|75850437|FG001|Overall Study|Protocol Violation|1|||
42356501|NCT01445301|76201517|FG000|Overall Study|Withdrawal by Subject|5|||
42356502|NCT01445301|76201518|FG001|Overall Study|Withdrawal by Subject|6|||
42356503|NCT01445301|76201519|FG002|Overall Study|Withdrawal by Subject|4|||
42356504|NCT01409031|76201529|FG000|Overall Study|transferred to other hosp|1|||
42356505|NCT01409031|76201530|FG001|Overall Study|transferred to other hosp|0|||
42356506|NCT01430403|76201539|FG000|Overall Study|Lost to Follow-up|5|||
42356507|NCT01430403|76201540|FG001|Overall Study|Lost to Follow-up|5|||
42356508|NCT01430403|76201541|FG002|Overall Study|Lost to Follow-up|3|||
42042555|NCT01126580|75850438|FG002|Overall Study|Protocol Violation|2|||
42042556|NCT01126580|75850436|FG000|Overall Study|Lost to Follow-up|15|||
42042557|NCT01126580|75850437|FG001|Overall Study|Lost to Follow-up|13|||
42042558|NCT01126580|75850438|FG002|Overall Study|Lost to Follow-up|9|||
42042559|NCT01126580|75850436|FG000|Overall Study|Treatment Non-compliance|0|||
42042560|NCT01126580|75850437|FG001|Overall Study|Treatment Non-compliance|2|||
42042561|NCT01126580|75850438|FG002|Overall Study|Treatment Non-compliance|3|||
42042562|NCT00911157|75850449|FG000|Overall Study|Adverse Event|4|||
42042563|NCT00911157|75850450|FG001|Overall Study|Adverse Event|1|||
42042564|NCT00911157|75850449|FG000|Overall Study|Withdrawal by Subject|1|||
42042565|NCT00911157|75850450|FG001|Overall Study|Withdrawal by Subject|1|||
42042566|NCT00911157|75850449|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
42042567|NCT00911157|75850450|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
42042568|NCT00911157|75850449|FG000|Overall Study|Need to treat for lung cancer|1|||
42042569|NCT00911157|75850450|FG001|Overall Study|Need to treat for lung cancer|0|||
42042570|NCT00960570|75850456|FG000|21 Day Washout Period|Adverse Event|1|||
42042571|NCT00960570|75850456|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
42042572|NCT00960570|75850456|FG000|1 Day Period Between Dosing|Adverse Event|2|||
42042573|NCT00960570|75850456|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
42042574|NCT01126424|75850469|FG000|Overall Study|Adverse Event|0|||
42042575|NCT01126424|75850470|FG001|Overall Study|Adverse Event|0|||
42042576|NCT01126424|75850471|FG002|Overall Study|Adverse Event|0|||
42042577|NCT01126424|75850472|FG003|Overall Study|Adverse Event|0|||
42042578|NCT01126424|75850473|FG004|Overall Study|Adverse Event|1|||
42042579|NCT01126424|75850474|FG005|Overall Study|Adverse Event|0|||
42042580|NCT01126424|75850469|FG000|Overall Study|Withdrawal by Subject|0|||
42042581|NCT01126424|75850470|FG001|Overall Study|Withdrawal by Subject|0|||
42042582|NCT01126424|75850471|FG002|Overall Study|Withdrawal by Subject|1|||
42042583|NCT01126424|75850472|FG003|Overall Study|Withdrawal by Subject|3|||
42042584|NCT01126424|75850473|FG004|Overall Study|Withdrawal by Subject|1|||
42042585|NCT01126424|75850474|FG005|Overall Study|Withdrawal by Subject|0|||
42042586|NCT01126268|75850482|FG000|Overall Study|Adverse Event|1|||
42042587|NCT00879658|75850493|FG000|Overall Study|Abnormal laboratory value(s)|3|||
42042588|NCT00879658|75850494|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42172414|NCT03796676|75979266|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
42356509|NCT01430403|76201539|FG000|Overall Study|Physician Decision|1|||
42356510|NCT01430403|76201540|FG001|Overall Study|Physician Decision|0|||
42356511|NCT01430403|76201541|FG002|Overall Study|Physician Decision|0|||
42356512|NCT01430403|76201539|FG000|Overall Study|Protocol Violation|2|||
42356513|NCT01430403|76201540|FG001|Overall Study|Protocol Violation|3|||
42356514|NCT01430403|76201541|FG002|Overall Study|Protocol Violation|2|||
42356515|NCT01430403|76201539|FG000|Overall Study|Withdrawal by Subject|9|||
42356516|NCT01430403|76201540|FG001|Overall Study|Withdrawal by Subject|1|||
42356517|NCT01430403|76201541|FG002|Overall Study|Withdrawal by Subject|3|||
42356518|NCT01429623|76201556|FG000|Overall Study|Death|1|||
42356519|NCT01429623|76201557|FG001|Overall Study|Death|0|||
42356520|NCT01429623|76201556|FG000|Overall Study|Adverse Event|7|||
42042589|NCT00879658|75850495|FG002|Overall Study|Abnormal laboratory value(s)|0|||
42042590|NCT00879658|75850496|FG003|Overall Study|Abnormal laboratory value(s)|1|||
42042591|NCT00879658|75850497|FG004|Overall Study|Abnormal laboratory value(s)|0|||
42042592|NCT00879658|75850498|FG005|Overall Study|Abnormal laboratory value(s)|0|||
42042593|NCT00879658|75850499|FG006|Overall Study|Abnormal laboratory value(s)|0|||
42042594|NCT00879658|75850493|FG000|Overall Study|Administrative problems|2|||
42042595|NCT00879658|75850494|FG001|Overall Study|Administrative problems|1|||
42042596|NCT00879658|75850495|FG002|Overall Study|Administrative problems|0|||
42042597|NCT00879658|75850496|FG003|Overall Study|Administrative problems|1|||
42042598|NCT00879658|75850497|FG004|Overall Study|Administrative problems|0|||
42042599|NCT00879658|75850498|FG005|Overall Study|Administrative problems|0|||
42042600|NCT00879658|75850499|FG006|Overall Study|Administrative problems|0|||
42042601|NCT00879658|75850493|FG000|Overall Study|Adverse Event|6|||
42172415|NCT03796676|75979267|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
42172416|NCT03796676|75979268|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
42042602|NCT00879658|75850494|FG001|Overall Study|Adverse Event|4|||
42042603|NCT00879658|75850495|FG002|Overall Study|Adverse Event|3|||
42042604|NCT00879658|75850496|FG003|Overall Study|Adverse Event|1|||
42172417|NCT03342898|75979282|FG000|Overall Study|Adverse Event|3|||
42356521|NCT01429623|76201557|FG001|Overall Study|Adverse Event|14|||
42356522|NCT01429623|76201556|FG000|Overall Study|Withdrawal by Subject|19|||
42356523|NCT01429623|76201557|FG001|Overall Study|Withdrawal by Subject|13|||
42356524|NCT01429623|76201556|FG000|Overall Study|Physician Decision|2|||
42356525|NCT01429623|76201557|FG001|Overall Study|Physician Decision|3|||
42356526|NCT01429623|76201556|FG000|Overall Study|Protocol Violation|3|||
42356527|NCT01429623|76201557|FG001|Overall Study|Protocol Violation|2|||
42356528|NCT01429623|76201556|FG000|Overall Study|Assorted|1|||
42356529|NCT01429623|76201557|FG001|Overall Study|Assorted|2|||
42042605|NCT00879658|75850497|FG004|Overall Study|Adverse Event|2|||
42356530|NCT01429623|76201556|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
42356531|NCT01429623|76201557|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
42356532|NCT01429623|76201556|FG000|Overall Study|No post baseline data|4|||
42042606|NCT00879658|75850498|FG005|Overall Study|Adverse Event|0|||
42042607|NCT00879658|75850499|FG006|Overall Study|Adverse Event|0|||
42042608|NCT00879658|75850493|FG000|Overall Study|Protocol Violation|1|||
42356533|NCT01429623|76201557|FG001|Overall Study|No post baseline data|4|||
42356534|NCT01408641|76201565|FG000|Overall Study|Physician Decision|1|||
42356535|NCT01408641|76201566|FG001|Overall Study|Physician Decision|0|||
42356536|NCT01429077|76201574|FG000|Overall Study|Lost to Follow-up|0|||
42356537|NCT01429077|76201575|FG001|Overall Study|Lost to Follow-up|3|||
42356538|NCT01428453|76201583|FG000|Overall Study|Adverse Event|2|||
42042609|NCT00879658|75850494|FG001|Overall Study|Protocol Violation|0|||
42042610|NCT00879658|75850495|FG002|Overall Study|Protocol Violation|0|||
42042611|NCT00879658|75850496|FG003|Overall Study|Protocol Violation|0|||
42042612|NCT00879658|75850497|FG004|Overall Study|Protocol Violation|0|||
42042613|NCT00879658|75850498|FG005|Overall Study|Protocol Violation|0|||
42042614|NCT00879658|75850499|FG006|Overall Study|Protocol Violation|0|||
42042615|NCT00879658|75850493|FG000|Overall Study|Withdrawal by Subject|3|||
42042616|NCT00879658|75850494|FG001|Overall Study|Withdrawal by Subject|0|||
42042617|NCT00879658|75850495|FG002|Overall Study|Withdrawal by Subject|2|||
42042618|NCT00879658|75850496|FG003|Overall Study|Withdrawal by Subject|0|||
42042619|NCT00879658|75850497|FG004|Overall Study|Withdrawal by Subject|0|||
42042620|NCT00879658|75850498|FG005|Overall Study|Withdrawal by Subject|1|||
42042621|NCT00879658|75850499|FG006|Overall Study|Withdrawal by Subject|0|||
42042622|NCT00879658|75850493|FG000|Overall Study|Lack of Efficacy|0|||
42042623|NCT00879658|75850494|FG001|Overall Study|Lack of Efficacy|0|||
42042624|NCT00879658|75850495|FG002|Overall Study|Lack of Efficacy|2|||
42042625|NCT00879658|75850496|FG003|Overall Study|Lack of Efficacy|0|||
42042626|NCT00879658|75850497|FG004|Overall Study|Lack of Efficacy|0|||
42042627|NCT00879658|75850498|FG005|Overall Study|Lack of Efficacy|0|||
42042628|NCT00879658|75850499|FG006|Overall Study|Lack of Efficacy|0|||
42042629|NCT00879658|75850493|FG000|Overall Study|misrandomized (never received study med)|0|||
42042630|NCT00879658|75850494|FG001|Overall Study|misrandomized (never received study med)|0|||
42042631|NCT00879658|75850495|FG002|Overall Study|misrandomized (never received study med)|0|||
42042632|NCT00879658|75850496|FG003|Overall Study|misrandomized (never received study med)|1|||
42042633|NCT00879658|75850497|FG004|Overall Study|misrandomized (never received study med)|0|||
42042634|NCT00879658|75850498|FG005|Overall Study|misrandomized (never received study med)|0|||
42042635|NCT00879658|75850499|FG006|Overall Study|misrandomized (never received study med)|0|||
42042636|NCT00959946|75850529|FG000|Overall Study|Adverse Event|0|||
42290622|NCT02668393|76124616|FG001|Overall Study|Withdrawal from the trial|1|||
42290623|NCT02668393|76124615|FG000|Overall Study|Lack of benefit and side effects|1|||
42290624|NCT02668393|76124616|FG001|Overall Study|Lack of benefit and side effects|0|||
42290625|NCT01998958|76124630|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290626|NCT01998958|76124631|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
42290627|NCT01998958|76124632|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290628|NCT01998958|76124633|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290629|NCT01998958|76124634|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290630|NCT01998958|76124635|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290631|NCT01998958|76124636|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42042637|NCT00959946|75850530|FG001|Overall Study|Adverse Event|0|||
42042638|NCT00959946|75850531|FG002|Overall Study|Adverse Event|2|||
42042639|NCT00959946|75850532|FG003|Overall Study|Adverse Event|1|||
42042640|NCT00959946|75850533|FG004|Overall Study|Adverse Event|0|||
42042641|NCT00959946|75850534|FG005|Overall Study|Adverse Event|1|||
42042642|NCT00959946|75850535|FG006|Overall Study|Adverse Event|0|||
42042643|NCT00959946|75850536|FG007|Overall Study|Adverse Event|0|||
42042644|NCT00959946|75850529|FG000|Overall Study|Death|0|||
42042645|NCT00959946|75850530|FG001|Overall Study|Death|0|||
42042646|NCT00959946|75850531|FG002|Overall Study|Death|0|||
42042647|NCT00959946|75850532|FG003|Overall Study|Death|0|||
42042648|NCT00959946|75850533|FG004|Overall Study|Death|0|||
42042649|NCT00959946|75850534|FG005|Overall Study|Death|1|||
42042650|NCT00959946|75850535|FG006|Overall Study|Death|0|||
42042651|NCT00959946|75850536|FG007|Overall Study|Death|0|||
42290632|NCT01998958|76124637|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290633|NCT01998958|76124638|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290634|NCT01998958|76124639|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290635|NCT01998958|76124640|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42356539|NCT01428453|76201584|FG001|Overall Study|Adverse Event|7|||
42042652|NCT00959946|75850529|FG000|Overall Study|Disease Progression|2|||
42042653|NCT00959946|75850530|FG001|Overall Study|Disease Progression|4|||
42042654|NCT00959946|75850531|FG002|Overall Study|Disease Progression|2|||
42042655|NCT00959946|75850532|FG003|Overall Study|Disease Progression|4|||
42042656|NCT00959946|75850533|FG004|Overall Study|Disease Progression|4|||
42042657|NCT00959946|75850534|FG005|Overall Study|Disease Progression|6|||
42290636|NCT01998958|76124641|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290637|NCT01998958|76124642|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290638|NCT01998958|76124643|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290639|NCT01998958|76124644|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290640|NCT01998958|76124645|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290641|NCT01998958|76124646|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290642|NCT01998958|76124647|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290643|NCT01998958|76124648|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290644|NCT01998958|76124649|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42042658|NCT00959946|75850535|FG006|Overall Study|Disease Progression|2|||
42042659|NCT00959946|75850536|FG007|Overall Study|Disease Progression|2|||
42042660|NCT00959946|75850529|FG000|Overall Study|Withdrawal by Subject|0|||
42042661|NCT00959946|75850530|FG001|Overall Study|Withdrawal by Subject|0|||
42042662|NCT00959946|75850531|FG002|Overall Study|Withdrawal by Subject|0|||
42042663|NCT00959946|75850532|FG003|Overall Study|Withdrawal by Subject|0|||
42042664|NCT00959946|75850533|FG004|Overall Study|Withdrawal by Subject|0|||
42042665|NCT00959946|75850534|FG005|Overall Study|Withdrawal by Subject|1|||
42042666|NCT00959946|75850535|FG006|Overall Study|Withdrawal by Subject|0|||
42042667|NCT00959946|75850536|FG007|Overall Study|Withdrawal by Subject|0|||
42042668|NCT00911937|75850561|FG000|Overall Study|Death|1|||
42042669|NCT00911937|75850562|FG001|Overall Study|Death|0|||
42042670|NCT00911937|75850561|FG000|Overall Study|Lost to Follow-up|8|||
42042671|NCT00911937|75850562|FG001|Overall Study|Lost to Follow-up|5|||
42042672|NCT00911937|75850561|FG000|Overall Study|Withdrawal by Subject|10|||
42042673|NCT00911937|75850562|FG001|Overall Study|Withdrawal by Subject|7|||
42042674|NCT00911937|75850561|FG000|Overall Study|Withdrawn due to pregnancy|1|||
42042675|NCT00911937|75850562|FG001|Overall Study|Withdrawn due to pregnancy|0|||
42042676|NCT00911937|75850561|FG000|Overall Study|Adverse Event|11|||
42042677|NCT00911937|75850562|FG001|Overall Study|Adverse Event|25|||
42042678|NCT00911937|75850561|FG000|Overall Study|Lack of Efficacy|11|||
42042679|NCT00911937|75850562|FG001|Overall Study|Lack of Efficacy|6|||
42042680|NCT00911937|75850561|FG000|Overall Study|Did not meet inclusion criteria|9|||
42042681|NCT00911937|75850562|FG001|Overall Study|Did not meet inclusion criteria|11|||
42042682|NCT00911937|75850561|FG000|Overall Study|Protocol Violation|14|||
42042683|NCT00911937|75850562|FG001|Overall Study|Protocol Violation|23|||
42042684|NCT00911937|75850561|FG000|Overall Study|Randomized but not treated|13|||
42290645|NCT01998958|76124650|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290646|NCT01998958|76124651|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290647|NCT01998958|76124652|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290648|NCT01998958|76124653|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42356540|NCT01428453|76201583|FG000|Overall Study|Protocol Violation|1|||
42356541|NCT01428453|76201584|FG001|Overall Study|Protocol Violation|0|||
42356542|NCT01428453|76201583|FG000|Overall Study|Lost to Follow-up|0|||
42356543|NCT01428453|76201584|FG001|Overall Study|Lost to Follow-up|1|||
42356544|NCT01428453|76201583|FG000|Overall Study|Withdrawal by Subject|3|||
42356545|NCT01428453|76201584|FG001|Overall Study|Withdrawal by Subject|1|||
42356546|NCT01408563|76201592|FG000|Overall Study|Ineligible after consent/ registration|2|||
42356547|NCT01442493|76201598|FG000|Overall Study|withdrawn from study|3|||
42356548|NCT01442493|76201599|FG001|Overall Study|withdrawn from study|2|||
42290649|NCT01998958|76124654|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290650|NCT01998958|76124655|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290651|NCT01998958|76124656|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290652|NCT01998958|76124657|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290653|NCT01998958|76124658|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42356549|NCT01442181|76201607|FG000|Overall Study|patient refused surgery|1|||
42356550|NCT01442181|76201608|FG001|Overall Study|patient refused surgery|0|||
42042685|NCT00911937|75850562|FG001|Overall Study|Randomized but not treated|13|||
42042686|NCT00911937|75850561|FG000|Overall Study|Other|9|||
42042687|NCT00911937|75850562|FG001|Overall Study|Other|5|||
42042688|NCT00880048|75850571|FG000|Overall Study|Adverse Event|2|||
42290654|NCT01998958|76124659|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42356551|NCT01442181|76201607|FG000|Overall Study|no insurance for surgery|1|||
42356552|NCT01442181|76201608|FG001|Overall Study|no insurance for surgery|0|||
42356553|NCT01442181|76201607|FG000|Overall Study|low ejection factor|0|||
42356554|NCT01442181|76201608|FG001|Overall Study|low ejection factor|1|||
42356555|NCT01442181|76201607|FG000|Overall Study|Lost to Follow-up|1|||
42042689|NCT00880048|75850572|FG001|Overall Study|Adverse Event|3|||
42042690|NCT00880048|75850573|FG002|Overall Study|Adverse Event|5|||
42042691|NCT00880048|75850571|FG000|Overall Study|Lack of Efficacy|1|||
42042692|NCT00880048|75850572|FG001|Overall Study|Lack of Efficacy|2|||
42042693|NCT00880048|75850573|FG002|Overall Study|Lack of Efficacy|2|||
42042694|NCT00880048|75850571|FG000|Overall Study|Protocol Violation|4|||
42042695|NCT00880048|75850572|FG001|Overall Study|Protocol Violation|6|||
42042696|NCT00880048|75850573|FG002|Overall Study|Protocol Violation|5|||
42042697|NCT00880048|75850571|FG000|Overall Study|Lost to Follow-up|6|||
42042698|NCT00880048|75850572|FG001|Overall Study|Lost to Follow-up|6|||
42042699|NCT00880048|75850573|FG002|Overall Study|Lost to Follow-up|5|||
42042700|NCT00880048|75850571|FG000|Overall Study|Physician Decision|1|||
42042701|NCT00880048|75850572|FG001|Overall Study|Physician Decision|1|||
42042702|NCT00880048|75850573|FG002|Overall Study|Physician Decision|7|||
42042703|NCT00880048|75850571|FG000|Overall Study|Withdrawal by Subject|5|||
42042704|NCT00880048|75850572|FG001|Overall Study|Withdrawal by Subject|8|||
42042705|NCT00880048|75850573|FG002|Overall Study|Withdrawal by Subject|5|||
42042706|NCT00880048|75850571|FG000|Overall Study|Study closed/terminated|9|||
42042707|NCT00880048|75850572|FG001|Overall Study|Study closed/terminated|7|||
42042708|NCT00880048|75850573|FG002|Overall Study|Study closed/terminated|6|||
42042709|NCT00962208|75850583|FG000|Overall Study|Could not achieve good vision|9|||
42042710|NCT00962208|75850584|FG001|Overall Study|Could not achieve good vision|0|||
42042711|NCT00962208|75850583|FG000|Overall Study|Contraindicated to continue study|5|||
42042712|NCT00962208|75850584|FG001|Overall Study|Contraindicated to continue study|1|||
42356556|NCT01442181|76201608|FG001|Overall Study|Lost to Follow-up|1|||
42356557|NCT01442181|76201607|FG000|Overall Study|patient in an additional study|1|||
42356558|NCT01442181|76201608|FG001|Overall Study|patient in an additional study|0|||
42356559|NCT01442181|76201607|FG000|Overall Study|atrial fibrillation not noted|0|||
42356560|NCT01442181|76201608|FG001|Overall Study|atrial fibrillation not noted|1|||
42356561|NCT01442103|76201615|FG000|Overall Study|Lost to Follow-up|2|||
42356562|NCT01428219|76201619|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
42356563|NCT01428063|76201626|FG000|Overall Study|Lack of Efficacy|8|||
42356564|NCT01428063|76201627|FG001|Overall Study|Lack of Efficacy|4|||
42356565|NCT01428063|76201628|FG002|Overall Study|Lack of Efficacy|1|||
42356566|NCT01428063|76201626|FG000|Overall Study|Adverse Event|2|||
42356567|NCT01428063|76201627|FG001|Overall Study|Adverse Event|3|||
42356568|NCT01428063|76201628|FG002|Overall Study|Adverse Event|0|||
42356569|NCT01428063|76201626|FG000|Overall Study|Lost to Follow-up|0|||
42356570|NCT01428063|76201627|FG001|Overall Study|Lost to Follow-up|2|||
42042713|NCT00962208|75850583|FG000|Overall Study|Lost to Follow-up|0|||
42042714|NCT00962208|75850584|FG001|Overall Study|Lost to Follow-up|9|||
42042715|NCT01076543|75850596|FG000|Overall Study|Withdrawal by Subject|2|||
42042716|NCT01076543|75850597|FG001|Overall Study|Withdrawal by Subject|0|||
42042717|NCT01076543|75850598|FG002|Overall Study|Withdrawal by Subject|0|||
42290655|NCT01998958|76124660|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290656|NCT01998958|76124661|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
42290657|NCT01998958|76124630|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290658|NCT01998958|76124631|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
42290659|NCT01998958|76124632|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290660|NCT01998958|76124633|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290661|NCT01998958|76124634|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290662|NCT01998958|76124635|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290663|NCT01998958|76124636|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42356571|NCT01428063|76201628|FG002|Overall Study|Lost to Follow-up|0|||
42042718|NCT01076543|75850599|FG003|Overall Study|Withdrawal by Subject|0|||
42356572|NCT01428063|76201626|FG000|Overall Study|No longer meets study criteria|0|||
42042719|NCT01076543|75850600|FG004|Overall Study|Withdrawal by Subject|0|||
42042720|NCT01076543|75850601|FG005|Overall Study|Withdrawal by Subject|0|||
42042721|NCT01072877|75850621|FG000|Overall Study|Lost to Follow-up|1|||
42042722|NCT01072877|75850622|FG001|Overall Study|Lost to Follow-up|1|||
42042723|NCT01072877|75850623|FG002|Overall Study|Lost to Follow-up|0|||
42042724|NCT01072877|75850624|FG003|Overall Study|Lost to Follow-up|2|||
42042725|NCT01072877|75850625|FG004|Overall Study|Lost to Follow-up|0|||
42290664|NCT01998958|76124637|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290665|NCT01998958|76124638|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290666|NCT01998958|76124639|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290667|NCT01998958|76124640|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42356573|NCT01428063|76201627|FG001|Overall Study|No longer meets study criteria|1|||
42356574|NCT01428063|76201628|FG002|Overall Study|No longer meets study criteria|0|||
42356575|NCT01441635|76201786|FG000|Overall Study|Adverse Event|4|||
42042726|NCT00961896|75850642|FG000|Overall Study|Abnormal laboratory value|0|||
42290668|NCT01998958|76124641|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290669|NCT01998958|76124642|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290670|NCT01998958|76124643|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290671|NCT01998958|76124644|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290672|NCT01998958|76124645|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290673|NCT01998958|76124646|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290674|NCT01998958|76124647|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290675|NCT01998958|76124648|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290676|NCT01998958|76124649|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290677|NCT01998958|76124650|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290678|NCT01998958|76124651|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290679|NCT01998958|76124652|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290680|NCT01998958|76124653|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290681|NCT01998958|76124654|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290682|NCT01998958|76124655|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290683|NCT01998958|76124656|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290684|NCT01998958|76124657|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290685|NCT01998958|76124658|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42172418|NCT03342898|75979283|FG001|Overall Study|Adverse Event|1|||
42172419|NCT03342898|75979284|FG002|Overall Study|Adverse Event|0|||
42172420|NCT03342898|75979282|FG000|Overall Study|Lost to Follow-up|44|||
42172421|NCT03342898|75979283|FG001|Overall Study|Lost to Follow-up|40|||
42290686|NCT01998958|76124659|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290687|NCT01998958|76124660|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42290688|NCT01998958|76124661|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
42356576|NCT01441635|76201787|FG001|Overall Study|Adverse Event|3|||
42356577|NCT01441635|76201788|FG002|Overall Study|Adverse Event|1|||
42356578|NCT01441635|76201789|FG003|Overall Study|Adverse Event|5|||
42356579|NCT01441635|76201790|FG004|Overall Study|Adverse Event|1|||
42356580|NCT01441635|76201791|FG005|Overall Study|Adverse Event|2|||
42356581|NCT01441635|76201792|FG006|Overall Study|Adverse Event|2|||
42356582|NCT01441635|76201793|FG007|Overall Study|Adverse Event|2|||
42356583|NCT01441635|76201794|FG008|Overall Study|Adverse Event|1|||
42356584|NCT01441635|76201795|FG009|Overall Study|Adverse Event|0|||
42356585|NCT01441635|76201786|FG000|Overall Study|Withdrawal by Subject|1|||
42356586|NCT01441635|76201787|FG001|Overall Study|Withdrawal by Subject|1|||
42356587|NCT01441635|76201788|FG002|Overall Study|Withdrawal by Subject|0|||
42356588|NCT01441635|76201789|FG003|Overall Study|Withdrawal by Subject|1|||
42356589|NCT01441635|76201790|FG004|Overall Study|Withdrawal by Subject|0|||
42356590|NCT01441635|76201791|FG005|Overall Study|Withdrawal by Subject|0|||
42356591|NCT01441635|76201792|FG006|Overall Study|Withdrawal by Subject|2|||
42356592|NCT01441635|76201793|FG007|Overall Study|Withdrawal by Subject|0|||
42356593|NCT01441635|76201794|FG008|Overall Study|Withdrawal by Subject|1|||
42356594|NCT01441635|76201795|FG009|Overall Study|Withdrawal by Subject|1|||
42356595|NCT01441635|76201786|FG000|Overall Study|Lost to Follow-up|0|||
42356596|NCT01441635|76201787|FG001|Overall Study|Lost to Follow-up|1|||
42356597|NCT01441635|76201788|FG002|Overall Study|Lost to Follow-up|1|||
42356598|NCT01441635|76201789|FG003|Overall Study|Lost to Follow-up|1|||
42356599|NCT01441635|76201790|FG004|Overall Study|Lost to Follow-up|1|||
42356600|NCT01441635|76201791|FG005|Overall Study|Lost to Follow-up|3|||
42356601|NCT01441635|76201792|FG006|Overall Study|Lost to Follow-up|1|||
42356602|NCT01441635|76201793|FG007|Overall Study|Lost to Follow-up|1|||
42356603|NCT01441635|76201794|FG008|Overall Study|Lost to Follow-up|0|||
42356604|NCT01441635|76201795|FG009|Overall Study|Lost to Follow-up|1|||
42356605|NCT01441635|76201786|FG000|Overall Study|Noncompliance|0|||
42356606|NCT01441635|76201787|FG001|Overall Study|Noncompliance|1|||
42356607|NCT01441635|76201788|FG002|Overall Study|Noncompliance|0|||
42356608|NCT01441635|76201789|FG003|Overall Study|Noncompliance|0|||
42356609|NCT01441635|76201790|FG004|Overall Study|Noncompliance|0|||
42356610|NCT01441635|76201791|FG005|Overall Study|Noncompliance|0|||
42356611|NCT01441635|76201792|FG006|Overall Study|Noncompliance|1|||
42356612|NCT01441635|76201793|FG007|Overall Study|Noncompliance|0|||
42356613|NCT01441635|76201794|FG008|Overall Study|Noncompliance|0|||
42356614|NCT01441635|76201795|FG009|Overall Study|Noncompliance|0|||
42290689|NCT01998958|76124630|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
42290690|NCT01998958|76124631|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
42290691|NCT01998958|76124632|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
42290692|NCT01998958|76124633|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
42290693|NCT01998958|76124634|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
42290694|NCT01998958|76124635|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
42356615|NCT01441635|76201786|FG000|Overall Study|Surgery or Invasive Intervention|0|||
42356616|NCT01441635|76201787|FG001|Overall Study|Surgery or Invasive Intervention|0|||
42356617|NCT01441635|76201788|FG002|Overall Study|Surgery or Invasive Intervention|1|||
42356618|NCT01441635|76201789|FG003|Overall Study|Surgery or Invasive Intervention|0|||
42356619|NCT01441635|76201790|FG004|Overall Study|Surgery or Invasive Intervention|0|||
42356620|NCT01441635|76201791|FG005|Overall Study|Surgery or Invasive Intervention|0|||
42356621|NCT01441635|76201792|FG006|Overall Study|Surgery or Invasive Intervention|0|||
42290695|NCT01998958|76124636|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
42290696|NCT01998958|76124637|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
42290697|NCT01998958|76124638|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
42290698|NCT01998958|76124639|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
42356622|NCT01441635|76201793|FG007|Overall Study|Surgery or Invasive Intervention|0|||
42356623|NCT01441635|76201794|FG008|Overall Study|Surgery or Invasive Intervention|0|||
42356624|NCT01441635|76201795|FG009|Overall Study|Surgery or Invasive Intervention|0|||
42356625|NCT01441635|76201786|FG000|Overall Study|Received Exclusionary Medication|1|||
42356626|NCT01441635|76201787|FG001|Overall Study|Received Exclusionary Medication|0|||
42016002|NCT01282424|75823165|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
42172422|NCT03342898|75979284|FG002|Overall Study|Lost to Follow-up|42|||
42356627|NCT01441635|76201788|FG002|Overall Study|Received Exclusionary Medication|0|||
42356628|NCT01441635|76201789|FG003|Overall Study|Received Exclusionary Medication|0|||
42356629|NCT01441635|76201790|FG004|Overall Study|Received Exclusionary Medication|0|||
42356630|NCT01441635|76201791|FG005|Overall Study|Received Exclusionary Medication|0|||
42356631|NCT01441635|76201792|FG006|Overall Study|Received Exclusionary Medication|0|||
42356632|NCT01441635|76201793|FG007|Overall Study|Received Exclusionary Medication|0|||
42356633|NCT01441635|76201794|FG008|Overall Study|Received Exclusionary Medication|0|||
42356634|NCT01441635|76201795|FG009|Overall Study|Received Exclusionary Medication|0|||
42356635|NCT01441635|76201786|FG000|Overall Study|Other|0|||
42356636|NCT01441635|76201787|FG001|Overall Study|Other|0|||
42356637|NCT01441635|76201788|FG002|Overall Study|Other|0|||
42356638|NCT01441635|76201789|FG003|Overall Study|Other|0|||
42356639|NCT01441635|76201790|FG004|Overall Study|Other|0|||
42356640|NCT01441635|76201791|FG005|Overall Study|Other|0|||
42356641|NCT01441635|76201792|FG006|Overall Study|Other|0|||
42356642|NCT01441635|76201793|FG007|Overall Study|Other|1|||
42356643|NCT01441635|76201794|FG008|Overall Study|Other|0|||
42172423|NCT03342898|75979282|FG000|Overall Study|Withdrawal of Consent|5|||
42172424|NCT03342898|75979283|FG001|Overall Study|Withdrawal of Consent|9|||
42172425|NCT03342898|75979284|FG002|Overall Study|Withdrawal of Consent|11|||
42172426|NCT03342898|75979282|FG000|Overall Study|Death|0|||
42172427|NCT03342898|75979283|FG001|Overall Study|Death|1|||
42172428|NCT03342898|75979284|FG002|Overall Study|Death|1|||
42172429|NCT03342898|75979282|FG000|Overall Study|Reason not Specified|2|||
42172430|NCT03342898|75979283|FG001|Overall Study|Reason not Specified|2|||
42356644|NCT01441635|76201795|FG009|Overall Study|Other|0|||
42356645|NCT01408485|76201817|FG000|Overall Study|Withdrawal by Subject|21|||
42356646|NCT01427907|76201823|FG000|Overall Study|Withdrawal by Subject|3|||
42356647|NCT01427907|76201824|FG001|Overall Study|Withdrawal by Subject|4|||
42356648|NCT01427751|76201832|FG000|Overall Study|Adverse Event|18|||
42356649|NCT01427751|76201833|FG001|Overall Study|Adverse Event|2|||
42356650|NCT01427751|76201832|FG000|Overall Study|No further treatment benefit expected|5|||
42172431|NCT03342898|75979284|FG002|Overall Study|Reason not Specified|0|||
42172432|NCT00339833|75979294|FG000|Overall Study|Withdrawal by Subject|1|||
42172433|NCT00339833|75979295|FG001|Overall Study|Withdrawal by Subject|2|||
42172434|NCT00339833|75979294|FG000|Overall Study|toothache|0|||
42172435|NCT00339833|75979295|FG001|Overall Study|toothache|1|||
42172436|NCT00339833|75979294|FG000|Overall Study|indigestion|0|||
42172437|NCT00339833|75979295|FG001|Overall Study|indigestion|1|||
42172438|NCT00339833|75979294|FG000|Overall Study|Chest pain|0|||
42290699|NCT01998958|76124640|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
42290700|NCT01998958|76124641|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
42290701|NCT01998958|76124642|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
42290702|NCT01998958|76124643|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
42290703|NCT01998958|76124644|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
42290704|NCT01998958|76124645|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
42290705|NCT01998958|76124646|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
42042727|NCT00961896|75850643|FG001|Overall Study|Abnormal laboratory value|0|||
42042728|NCT00961896|75850644|FG002|Overall Study|Abnormal laboratory value|1|||
42042729|NCT00957528|75850658|FG000|Overall Study|Protocol Violation|0|||
42042730|NCT00957528|75850659|FG001|Overall Study|Protocol Violation|1|||
42042731|NCT00957528|75850660|FG002|Overall Study|Protocol Violation|0|||
42042732|NCT00957528|75850658|FG000|Overall Study|Withdrawal by Subject|0|||
42042733|NCT00957528|75850659|FG001|Overall Study|Withdrawal by Subject|0|||
42042734|NCT00957528|75850660|FG002|Overall Study|Withdrawal by Subject|1|||
42042735|NCT00958776|75850670|FG000|Overall Study|Adverse Event|0|||
42042736|NCT00958776|75850671|FG001|Overall Study|Adverse Event|1|||
42042737|NCT00958776|75850670|FG000|Overall Study|Physician Decision|1|||
42042738|NCT00958776|75850671|FG001|Overall Study|Physician Decision|0|||
42042739|NCT00958776|75850670|FG000|Overall Study|Lost to Follow-up|2|||
42042740|NCT00958776|75850671|FG001|Overall Study|Lost to Follow-up|6|||
42172439|NCT00339833|75979295|FG001|Overall Study|Chest pain|1|||
42172440|NCT00339833|75979294|FG000|Overall Study|minor infection|0|||
42290706|NCT01998958|76124647|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
42356651|NCT01427751|76201833|FG001|Overall Study|No further treatment benefit expected|1|||
42042741|NCT00958776|75850670|FG000|Overall Study|Withdrawal by Subject|7|||
42042742|NCT00958776|75850671|FG001|Overall Study|Withdrawal by Subject|16|||
42042743|NCT00958776|75850670|FG000|Overall Study|Protocol Violation|1|||
42172441|NCT00339833|75979295|FG001|Overall Study|minor infection|1|||
42172442|NCT00339833|75979294|FG000|Overall Study|Poor venous access|2|||
42356652|NCT01427751|76201832|FG000|Overall Study|Lost to Follow-up|3|||
42356653|NCT01427751|76201833|FG001|Overall Study|Lost to Follow-up|1|||
42356654|NCT01427751|76201832|FG000|Overall Study|Withdrawal of consent|2|||
42042744|NCT00958776|75850671|FG001|Overall Study|Protocol Violation|1|||
42290707|NCT01998958|76124648|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
42042745|NCT00958776|75850670|FG000|Overall Study|Death|2|||
42042746|NCT00958776|75850671|FG001|Overall Study|Death|1|||
42042747|NCT00958776|75850670|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
42042748|NCT00958776|75850671|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
42042749|NCT00958776|75850670|FG000|Overall Study|Missing|1|||
42042750|NCT00958776|75850671|FG001|Overall Study|Missing|1|||
42042751|NCT00596830|75850680|FG000|Overall Study|Death|258|||
42042752|NCT00596830|75850681|FG001|Overall Study|Death|247|||
42042753|NCT00596830|75850680|FG000|Overall Study|Lost to Follow-up|7|||
42042754|NCT00596830|75850681|FG001|Overall Study|Lost to Follow-up|11|||
42042755|NCT00596830|75850680|FG000|Overall Study|Withdrawal by Subject|22|||
42042756|NCT00596830|75850681|FG001|Overall Study|Withdrawal by Subject|12|||
42042757|NCT00596830|75850680|FG000|Overall Study|Study terminated by sponsor|51|||
42042758|NCT00596830|75850681|FG001|Overall Study|Study terminated by sponsor|62|||
42042759|NCT00596830|75850680|FG000|Overall Study|Follow-up was discontinued|1|||
42042760|NCT00596830|75850681|FG001|Overall Study|Follow-up was discontinued|0|||
42042761|NCT00596830|75850680|FG000|Overall Study|Randomized but not treated|3|||
42042762|NCT00596830|75850681|FG001|Overall Study|Randomized but not treated|7|||
42042763|NCT00957372|75850690|FG000|PART I|Lost to Follow-up|0|||
42042764|NCT00957372|75850691|FG001|PART I|Lost to Follow-up|0|||
42042765|NCT00957372|75850692|FG002|PART I|Lost to Follow-up|1|||
42042766|NCT00957372|75850693|FG003|PART I|Lost to Follow-up|0|||
42042767|NCT00957372|75850690|FG000|PART II|Withdrawal by Subject|0|||
42042768|NCT00957372|75850691|FG001|PART II|Withdrawal by Subject|0|||
42042769|NCT00957372|75850692|FG002|PART II|Withdrawal by Subject|0|||
42042770|NCT00957372|75850693|FG003|PART II|Withdrawal by Subject|8|||
42042771|NCT00957372|75850690|FG000|PART II|Physician Decision|0|||
42042772|NCT00957372|75850691|FG001|PART II|Physician Decision|0|||
42042773|NCT00957372|75850692|FG002|PART II|Physician Decision|0|||
42042774|NCT00957372|75850693|FG003|PART II|Physician Decision|1|||
42042775|NCT00957372|75850690|FG000|PART II|Pregnancy|0|||
42042776|NCT00957372|75850691|FG001|PART II|Pregnancy|0|||
42042777|NCT00957372|75850692|FG002|PART II|Pregnancy|0|||
42042778|NCT00957372|75850693|FG003|PART II|Pregnancy|1|||
42042779|NCT00957372|75850690|FG000|PART II|Not Know|0|||
42042780|NCT00957372|75850691|FG001|PART II|Not Know|0|||
42290708|NCT01998958|76124649|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
42290709|NCT01998958|76124650|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
42290710|NCT01998958|76124651|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
42290711|NCT01998958|76124652|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
42290712|NCT01998958|76124653|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
42290713|NCT01998958|76124654|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
42290714|NCT01998958|76124655|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
42290715|NCT01998958|76124656|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
42290716|NCT01998958|76124657|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
42290717|NCT01998958|76124658|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
42290718|NCT01998958|76124659|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
42290719|NCT01998958|76124660|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
42290720|NCT01998958|76124661|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
42016003|NCT01282424|75823165|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
42016004|NCT01282424|75823165|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
42016005|NCT01282424|75823165|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
42016006|NCT01282424|75823165|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
42016007|NCT01282424|75823165|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
42016008|NCT01282424|75823165|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
42016009|NCT01281956|75823169|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
42016010|NCT01281956|75823170|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
42016011|NCT00949975|75823183|FG000|Overall Study|Voluntary discontinuation|6|||
42016012|NCT00949975|75823184|FG001|Overall Study|Voluntary discontinuation|5|||
42016013|NCT00949975|75823185|FG002|Overall Study|Voluntary discontinuation|3|||
42016014|NCT00949975|75823186|FG003|Overall Study|Voluntary discontinuation|6|||
42016015|NCT00949975|75823183|FG000|Overall Study|Adverse Event|11|||
42016016|NCT00949975|75823184|FG001|Overall Study|Adverse Event|11|||
42016017|NCT00949975|75823185|FG002|Overall Study|Adverse Event|10|||
42042781|NCT00957372|75850692|FG002|PART II|Not Know|0|||
42042782|NCT00957372|75850693|FG003|PART II|Not Know|20|||
42042783|NCT00957372|75850690|FG000|PART II|Adverse Event|0|||
42042784|NCT00957372|75850691|FG001|PART II|Adverse Event|0|||
42042785|NCT00957372|75850692|FG002|PART II|Adverse Event|0|||
42042786|NCT00957372|75850693|FG003|PART II|Adverse Event|10|||
42042787|NCT00957372|75850690|FG000|PART II|Patient non-compliance|0|||
42042788|NCT00957372|75850691|FG001|PART II|Patient non-compliance|0|||
42042789|NCT00957372|75850692|FG002|PART II|Patient non-compliance|0|||
42016018|NCT00949975|75823186|FG003|Overall Study|Adverse Event|10|||
42016019|NCT00949975|75823183|FG000|Overall Study|Safety reason|0|||
42042790|NCT00957372|75850693|FG003|PART II|Patient non-compliance|4|||
42042791|NCT00952848|75850709|FG000|Overall Study|Withdrawal by Subject|4|||
42042792|NCT00952614|75850713|FG000|Overall Study|Death|3|||
42290721|NCT01998958|76124630|FG000|Period 1 (Panel A and B)|Other|1|||
42290722|NCT01998958|76124631|FG001|Period 1 (Panel A and B)|Other|0|||
42356655|NCT01427751|76201833|FG001|Overall Study|Withdrawal of consent|2|||
42356656|NCT01427751|76201832|FG000|Overall Study|Protocol Violation|6|||
42356657|NCT01427751|76201833|FG001|Overall Study|Protocol Violation|4|||
42356658|NCT01427751|76201832|FG000|Overall Study|Death|2|||
42356659|NCT01427751|76201833|FG001|Overall Study|Death|0|||
42356660|NCT01427751|76201832|FG000|Overall Study|Other miscellaneous reasons|6|||
42356661|NCT01427751|76201833|FG001|Overall Study|Other miscellaneous reasons|4|||
42356662|NCT01920061|76201859|FG000|Overall Study|Death|1|||
42356663|NCT01920061|76201860|FG001|Overall Study|Death|1|||
42356664|NCT01920061|76201861|FG002|Overall Study|Death|0|||
42356665|NCT01920061|76201862|FG003|Overall Study|Death|1|||
42356666|NCT01920061|76201863|FG004|Overall Study|Death|1|||
42356667|NCT01920061|76201864|FG005|Overall Study|Death|0|||
42356668|NCT01920061|76201865|FG006|Overall Study|Death|0|||
42356669|NCT01920061|76201866|FG007|Overall Study|Death|1|||
42356670|NCT01920061|76201867|FG008|Overall Study|Death|0|||
42356671|NCT01920061|76201868|FG009|Overall Study|Death|1|||
42356672|NCT01920061|76201869|FG010|Overall Study|Death|0|||
42356673|NCT01920061|76201870|FG011|Overall Study|Death|1|||
42356674|NCT01920061|76201871|FG012|Overall Study|Death|0|||
42356675|NCT01920061|76201872|FG013|Overall Study|Death|2|||
42356676|NCT01920061|76201873|FG014|Overall Study|Death|0|||
42356677|NCT01920061|76201874|FG015|Overall Study|Death|0|||
42356678|NCT01920061|76201875|FG016|Overall Study|Death|0|||
42356679|NCT01920061|76201876|FG017|Overall Study|Death|0|||
42356680|NCT01920061|76201877|FG018|Overall Study|Death|1|||
42042793|NCT00952614|75850713|FG000|Overall Study|Lost to Follow-up|3|||
42042794|NCT00952614|75850713|FG000|Overall Study|other reason|1|||
42042795|NCT00911859|75850721|FG000|Treatment Period|Adverse Event|3|||
42290723|NCT01998958|76124632|FG002|Period 1 (Panel A and B)|Other|0|||
42290724|NCT01998958|76124633|FG003|Period 1 (Panel A and B)|Other|0|||
42290725|NCT01998958|76124634|FG004|Period 1 (Panel A and B)|Other|0|||
42290726|NCT01998958|76124635|FG005|Period 1 (Panel A and B)|Other|0|||
42290727|NCT01998958|76124636|FG006|Period 1 (Panel A and B)|Other|0|||
42290728|NCT01998958|76124637|FG007|Period 1 (Panel A and B)|Other|0|||
42290729|NCT01998958|76124638|FG008|Period 1 (Panel A and B)|Other|0|||
42290730|NCT01998958|76124639|FG009|Period 1 (Panel A and B)|Other|0|||
42290731|NCT01998958|76124640|FG010|Period 1 (Panel A and B)|Other|0|||
42290732|NCT01998958|76124641|FG011|Period 1 (Panel A and B)|Other|0|||
42290733|NCT01998958|76124642|FG012|Period 1 (Panel A and B)|Other|0|||
42290734|NCT01998958|76124643|FG013|Period 1 (Panel A and B)|Other|0|||
42290735|NCT01998958|76124644|FG014|Period 1 (Panel A and B)|Other|0|||
42290736|NCT01998958|76124645|FG015|Period 1 (Panel A and B)|Other|0|||
42290737|NCT01998958|76124646|FG016|Period 1 (Panel A and B)|Other|0|||
42290738|NCT01998958|76124647|FG017|Period 1 (Panel A and B)|Other|0|||
42290739|NCT01998958|76124648|FG018|Period 1 (Panel A and B)|Other|0|||
42290740|NCT01998958|76124649|FG019|Period 1 (Panel A and B)|Other|0|||
42290741|NCT01998958|76124650|FG020|Period 1 (Panel A and B)|Other|0|||
42290742|NCT01998958|76124651|FG021|Period 1 (Panel A and B)|Other|0|||
42290743|NCT01998958|76124652|FG022|Period 1 (Panel A and B)|Other|0|||
42042796|NCT00911859|75850722|FG001|Treatment Period|Adverse Event|3|||
42290744|NCT01998958|76124653|FG023|Period 1 (Panel A and B)|Other|0|||
42290745|NCT01998958|76124654|FG024|Period 1 (Panel A and B)|Other|0|||
42290746|NCT01998958|76124655|FG025|Period 1 (Panel A and B)|Other|0|||
42290747|NCT01998958|76124656|FG026|Period 1 (Panel A and B)|Other|0|||
42356681|NCT01920061|76201878|FG019|Overall Study|Death|0|||
42356682|NCT01920061|76201859|FG000|Overall Study|Lost to Follow-up|0|||
42356683|NCT01920061|76201860|FG001|Overall Study|Lost to Follow-up|2|||
42290748|NCT01998958|76124657|FG027|Period 1 (Panel A and B)|Other|0|||
42290749|NCT01998958|76124658|FG028|Period 1 (Panel A and B)|Other|0|||
42290750|NCT01998958|76124659|FG029|Period 1 (Panel A and B)|Other|0|||
42356684|NCT01920061|76201861|FG002|Overall Study|Lost to Follow-up|0|||
42356685|NCT01920061|76201862|FG003|Overall Study|Lost to Follow-up|0|||
42356686|NCT01920061|76201863|FG004|Overall Study|Lost to Follow-up|0|||
42356687|NCT01920061|76201864|FG005|Overall Study|Lost to Follow-up|0|||
42356688|NCT01920061|76201865|FG006|Overall Study|Lost to Follow-up|1|||
42356689|NCT01920061|76201866|FG007|Overall Study|Lost to Follow-up|0|||
42042797|NCT00911859|75850723|FG002|Treatment Period|Adverse Event|7|||
42042798|NCT00911859|75850721|FG000|Treatment Period|Death|1|||
42042799|NCT00911859|75850722|FG001|Treatment Period|Death|3|||
42042800|NCT00911859|75850723|FG002|Treatment Period|Death|5|||
42042801|NCT00911859|75850721|FG000|Treatment Period|Lack of Efficacy|1|||
42042802|NCT00911859|75850722|FG001|Treatment Period|Lack of Efficacy|7|||
42042803|NCT00911859|75850723|FG002|Treatment Period|Lack of Efficacy|5|||
42042804|NCT00911859|75850721|FG000|Treatment Period|Physician Decision|3|||
42042805|NCT00911859|75850722|FG001|Treatment Period|Physician Decision|3|||
42042806|NCT00911859|75850723|FG002|Treatment Period|Physician Decision|3|||
42042807|NCT00911859|75850721|FG000|Treatment Period|Withdrawal by Subject|0|||
42042808|NCT00911859|75850722|FG001|Treatment Period|Withdrawal by Subject|4|||
42042809|NCT00911859|75850723|FG002|Treatment Period|Withdrawal by Subject|5|||
42042810|NCT00911859|75850721|FG000|Treatment Period|Did not receive study treatment|0|||
42042811|NCT00911859|75850722|FG001|Treatment Period|Did not receive study treatment|1|||
42042812|NCT00911859|75850723|FG002|Treatment Period|Did not receive study treatment|0|||
42042813|NCT00911859|75850721|FG000|Maintainance Period|Lack of Efficacy|0|||
42042814|NCT00911859|75850722|FG001|Maintainance Period|Lack of Efficacy|0|||
42042815|NCT00911859|75850723|FG002|Maintainance Period|Lack of Efficacy|9|||
42042816|NCT00911859|75850721|FG000|Maintainance Period|Physician Decision|0|||
42042817|NCT00911859|75850722|FG001|Maintainance Period|Physician Decision|0|||
42042818|NCT00911859|75850723|FG002|Maintainance Period|Physician Decision|9|||
42042819|NCT00911859|75850721|FG000|Maintainance Period|Withdrawal by Subject|0|||
42042820|NCT00911859|75850722|FG001|Maintainance Period|Withdrawal by Subject|0|||
42042821|NCT00911859|75850723|FG002|Maintainance Period|Withdrawal by Subject|3|||
42042822|NCT00911859|75850721|FG000|Follow-up Period|Death|5|||
42042823|NCT00911859|75850722|FG001|Follow-up Period|Death|8|||
42042824|NCT00911859|75850723|FG002|Follow-up Period|Death|10|||
42042825|NCT00911859|75850721|FG000|Follow-up Period|Lost to Follow-up|1|||
42042826|NCT00911859|75850722|FG001|Follow-up Period|Lost to Follow-up|1|||
42042827|NCT00911859|75850723|FG002|Follow-up Period|Lost to Follow-up|0|||
42042828|NCT00911859|75850721|FG000|Follow-up Period|Withdrawal by Subject|0|||
42042829|NCT00911859|75850722|FG001|Follow-up Period|Withdrawal by Subject|4|||
42042830|NCT00911859|75850723|FG002|Follow-up Period|Withdrawal by Subject|4|||
42042831|NCT00911859|75850721|FG000|Follow-up Period|Study terminated by sponsor|5|||
42042832|NCT00911859|75850722|FG001|Follow-up Period|Study terminated by sponsor|33|||
42042833|NCT00911859|75850723|FG002|Follow-up Period|Study terminated by sponsor|27|||
42042834|NCT00956592|75850733|FG000|Overall Study|Protocol Violation|1|||
42042835|NCT00956592|75850734|FG001|Overall Study|Protocol Violation|3|||
42042836|NCT02725593|75850744|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
42042837|NCT02725593|75850745|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
42042838|NCT02725593|75850744|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
42042839|NCT02725593|75850745|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
42042840|NCT02725593|75850744|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
42042841|NCT02725593|75850745|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
42290751|NCT01998958|76124660|FG030|Period 1 (Panel A and B)|Other|0|||
42290752|NCT01998958|76124661|FG031|Period 1 (Panel A and B)|Other|0|||
42290753|NCT01998958|76124630|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
42290754|NCT01998958|76124631|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
42290755|NCT01998958|76124632|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
42290756|NCT01998958|76124633|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
42290757|NCT01998958|76124634|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
42042842|NCT02725593|75850744|FG000|Long Term Extension|Withdrawal by Subject|1|||
42042843|NCT02725593|75850745|FG001|Long Term Extension|Withdrawal by Subject|3|||
42042844|NCT00911625|75850753|FG000|Overall Study|Lost to Follow-up|7|||
42042845|NCT00911625|75850754|FG001|Overall Study|Lost to Follow-up|0|||
42042846|NCT00596752|75850762|FG000|Overall Study|Other Reason|44|||
42042847|NCT00596752|75850763|FG001|Overall Study|Other Reason|49|||
42042848|NCT00596752|75850762|FG000|Overall Study|Adverse Event|34|||
42042849|NCT00596752|75850763|FG001|Overall Study|Adverse Event|34|||
42042850|NCT00596752|75850762|FG000|Overall Study|Lost to Follow-up|22|||
42290758|NCT01998958|76124635|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
42290759|NCT01998958|76124636|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
42290760|NCT01998958|76124637|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
42290761|NCT01998958|76124638|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
42042851|NCT00596752|75850763|FG001|Overall Study|Lost to Follow-up|38|||
42042852|NCT00596752|75850762|FG000|Overall Study|Withdrawal by Subject|12|||
42042853|NCT00596752|75850763|FG001|Overall Study|Withdrawal by Subject|9|||
42042854|NCT00596752|75850762|FG000|Overall Study|Unsatisfactory Compliance|9|||
42042855|NCT00596752|75850763|FG001|Overall Study|Unsatisfactory Compliance|6|||
42042856|NCT00596752|75850762|FG000|Overall Study|Lack of Efficacy|4|||
42042857|NCT00596752|75850763|FG001|Overall Study|Lack of Efficacy|7|||
42042858|NCT00596752|75850762|FG000|Overall Study|Protocol Violation|1|||
42042859|NCT00596752|75850763|FG001|Overall Study|Protocol Violation|0|||
42042860|NCT00958074|75850771|FG000|Overall Study|Withdrawal by Subject|0|||
42042861|NCT00958074|75850772|FG001|Overall Study|Withdrawal by Subject|1|||
42356690|NCT01920061|76201867|FG008|Overall Study|Lost to Follow-up|0|||
42042862|NCT00809965|75850781|FG000|Overall Study|Death|194|||
42290762|NCT01998958|76124639|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
42290763|NCT01998958|76124640|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
42290764|NCT01998958|76124641|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
42290765|NCT01998958|76124642|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
42290766|NCT01998958|76124643|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
42290767|NCT01998958|76124644|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
42290768|NCT01998958|76124645|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
42290769|NCT01998958|76124646|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
42290770|NCT01998958|76124647|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
42042863|NCT00809965|75850782|FG001|Overall Study|Death|147|||
42042864|NCT00809965|75850783|FG002|Overall Study|Death|196|||
42042865|NCT00809965|75850781|FG000|Overall Study|Lost to Follow-up|17|||
42042866|NCT00809965|75850782|FG001|Overall Study|Lost to Follow-up|10|||
42042867|NCT00809965|75850783|FG002|Overall Study|Lost to Follow-up|18|||
42042868|NCT00809965|75850781|FG000|Overall Study|Withdrawal by Subject|405|||
42042869|NCT00809965|75850782|FG001|Overall Study|Withdrawal by Subject|448|||
42042870|NCT00809965|75850783|FG002|Overall Study|Withdrawal by Subject|441|||
42042871|NCT00809965|75850781|FG000|Overall Study|Other Reason|167|||
42042872|NCT00809965|75850782|FG001|Overall Study|Other Reason|170|||
42042873|NCT00809965|75850783|FG002|Overall Study|Other Reason|189|||
42042874|NCT00597376|75850793|FG000|Overall Study|Withdrawal by Subject|4|||
42042875|NCT00597376|75850794|FG001|Overall Study|Withdrawal by Subject|3|||
42042876|NCT00597376|75850793|FG000|Overall Study|Adverse Event|4|||
42042877|NCT00597376|75850794|FG001|Overall Study|Adverse Event|1|||
42042878|NCT00910689|75850830|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
42042879|NCT00910689|75850831|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
42042880|NCT00910689|75850832|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
42042881|NCT00910689|75850833|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
42042882|NCT00910689|75850830|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
42042883|NCT00910689|75850831|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
42042884|NCT00910689|75850832|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
42042885|NCT00910689|75850833|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
42042886|NCT00910689|75850830|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
42042887|NCT00910689|75850831|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
42042888|NCT00910689|75850832|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
42042889|NCT00910689|75850833|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
42042890|NCT00910689|75850830|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
42042891|NCT00910689|75850831|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
42042892|NCT00910689|75850832|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
42042893|NCT00910689|75850833|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
42042894|NCT00910689|75850830|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
42356691|NCT01920061|76201868|FG009|Overall Study|Lost to Follow-up|0|||
42042895|NCT00910689|75850831|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
42042896|NCT00910689|75850832|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
42042897|NCT00910689|75850833|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
42042898|NCT00910689|75850830|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
42042899|NCT00910689|75850831|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
42042900|NCT00910689|75850832|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
42042901|NCT00910689|75850833|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
42042902|NCT00910689|75850830|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
42042903|NCT00910689|75850831|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
42042904|NCT00910689|75850832|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
42042905|NCT00910689|75850833|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
42042906|NCT00910689|75850830|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
42042907|NCT00910689|75850831|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
42042908|NCT00910689|75850832|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
42042909|NCT00910689|75850833|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
42042910|NCT00910689|75850830|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
42042911|NCT00910689|75850831|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
42042912|NCT00910689|75850832|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
42042913|NCT00910689|75850833|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
42042914|NCT00910689|75850830|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
42042915|NCT00910689|75850831|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
42042916|NCT00910689|75850832|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
42042917|NCT00910689|75850833|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
42042918|NCT00910689|75850830|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
42042919|NCT00910689|75850831|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
42042920|NCT00910689|75850832|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
42042921|NCT00910689|75850833|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
42042922|NCT00910689|75850830|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
42042923|NCT00910689|75850831|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
42042924|NCT00910689|75850832|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
42042925|NCT00910689|75850833|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
42042926|NCT00910689|75850830|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
42042927|NCT00910689|75850831|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
42042928|NCT00910689|75850832|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
42042929|NCT00910689|75850833|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
42042930|NCT00910689|75850830|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
42042931|NCT00910689|75850831|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
42042932|NCT00910689|75850832|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
42172443|NCT00339833|75979295|FG001|Overall Study|Poor venous access|2|||
42172444|NCT00339833|75979294|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
42172445|NCT00339833|75979295|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
42172446|NCT00339833|75979294|FG000|Overall Study|Error in data records|1|||
42172447|NCT00339833|75979295|FG001|Overall Study|Error in data records|0|||
42172448|NCT03793556|75979303|FG000|Overall Study|Withdrawal by Subject|12|||
42172449|NCT03793556|75979304|FG001|Overall Study|Withdrawal by Subject|1|||
42172450|NCT03793556|75979303|FG000|Overall Study|Lost to Follow-up|1|||
42172451|NCT03793556|75979304|FG001|Overall Study|Lost to Follow-up|1|||
42172452|NCT03392194|75979315|FG000|Overall Study|Withdrawal by Subject|1|||
42172453|NCT03392194|75979316|FG001|Overall Study|Withdrawal by Subject|2|||
42290771|NCT01998958|76124648|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
42290772|NCT01998958|76124649|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
42290773|NCT01998958|76124650|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
42290774|NCT01998958|76124651|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
42290775|NCT01998958|76124652|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
42290776|NCT01998958|76124653|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
42290777|NCT01998958|76124654|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
42290778|NCT01998958|76124655|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
42290779|NCT01998958|76124656|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
42290780|NCT01998958|76124657|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
42290781|NCT01998958|76124658|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
42290782|NCT01998958|76124659|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
42016020|NCT00949975|75823184|FG001|Overall Study|Safety reason|1|||
42016021|NCT00949975|75823185|FG002|Overall Study|Safety reason|0|||
42016022|NCT00949975|75823186|FG003|Overall Study|Safety reason|0|||
42016023|NCT00949975|75823183|FG000|Overall Study|Study-specific criteria|0|||
42016024|NCT00949975|75823184|FG001|Overall Study|Study-specific criteria|1|||
42016025|NCT00949975|75823185|FG002|Overall Study|Study-specific criteria|1|||
42016026|NCT00949975|75823186|FG003|Overall Study|Study-specific criteria|0|||
42016027|NCT00949975|75823183|FG000|Overall Study|Incorrect enrolment|5|||
42016028|NCT00949975|75823184|FG001|Overall Study|Incorrect enrolment|10|||
42016029|NCT00949975|75823185|FG002|Overall Study|Incorrect enrolment|4|||
42016030|NCT00949975|75823186|FG003|Overall Study|Incorrect enrolment|7|||
42042933|NCT00910689|75850833|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
42042934|NCT00910689|75850830|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
42172454|NCT03392194|75979315|FG000|Overall Study|Conflicts with personal schedule|1|||
42016031|NCT00949975|75823183|FG000|Overall Study|Severe non-compliance|3|||
42016032|NCT00949975|75823184|FG001|Overall Study|Severe non-compliance|1|||
42042935|NCT00910689|75850831|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
42042936|NCT00910689|75850832|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
42042937|NCT00910689|75850833|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
42042938|NCT00910689|75850830|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
42042939|NCT00910689|75850831|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
42042940|NCT00910689|75850832|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
42042941|NCT00910689|75850833|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
42042942|NCT00910689|75850830|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
42042943|NCT00910689|75850831|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
42042944|NCT00910689|75850832|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
42042945|NCT00910689|75850833|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
42042946|NCT00910689|75850830|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
42042947|NCT00910689|75850831|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
42042948|NCT00910689|75850832|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
42042949|NCT00910689|75850833|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
42042950|NCT00910689|75850830|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
42042951|NCT00910689|75850831|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
42042952|NCT00910689|75850832|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
42042953|NCT00910689|75850833|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
42042954|NCT00910689|75850830|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
42042955|NCT00910689|75850831|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
42042956|NCT00910689|75850832|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
42042957|NCT00910689|75850833|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
42042958|NCT00910689|75850830|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
42042959|NCT00910689|75850831|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
42042960|NCT00910689|75850832|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
42042961|NCT00910689|75850833|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
42042962|NCT00807001|75850848|FG000|Overall Study|Non-compliance|0|||
42042963|NCT00807001|75850849|FG001|Overall Study|Non-compliance|1|||
42042964|NCT00807001|75850850|FG002|Overall Study|Non-compliance|0|||
42042965|NCT00807001|75850851|FG003|Overall Study|Non-compliance|0|||
42042966|NCT00807001|75850852|FG004|Overall Study|Non-compliance|0|||
42042967|NCT00809341|75850866|FG000|Overall Study|Physician Decision|0|||
42042968|NCT00809341|75850867|FG001|Overall Study|Physician Decision|1|||
42042969|NCT01125800|75850878|FG000|Phase I|Protocol Violation|0|||
42042970|NCT01125800|75850879|FG001|Phase I|Protocol Violation|3|||
42042971|NCT01125800|75850880|FG002|Phase I|Protocol Violation|1|||
42042972|NCT01125800|75850881|FG003|Phase I|Protocol Violation|1|||
42042973|NCT01125800|75850882|FG004|Phase I|Protocol Violation|0|||
42042974|NCT01125800|75850878|FG000|Phase I|Adverse Event|2|||
42042975|NCT01125800|75850879|FG001|Phase I|Adverse Event|2|||
42042976|NCT01125800|75850880|FG002|Phase I|Adverse Event|1|||
42042977|NCT01125800|75850881|FG003|Phase I|Adverse Event|7|||
42042978|NCT01125800|75850882|FG004|Phase I|Adverse Event|0|||
42042979|NCT01125800|75850878|FG000|Phase I|Administrative problems|1|||
42042980|NCT01125800|75850879|FG001|Phase I|Administrative problems|0|||
42042981|NCT01125800|75850880|FG002|Phase I|Administrative problems|0|||
42042982|NCT01125800|75850881|FG003|Phase I|Administrative problems|0|||
42042983|NCT01125800|75850882|FG004|Phase I|Administrative problems|0|||
42042984|NCT01125800|75850878|FG000|Phase I|Withdrawal by Subject|0|||
42042985|NCT01125800|75850879|FG001|Phase I|Withdrawal by Subject|0|||
42042986|NCT01125800|75850880|FG002|Phase I|Withdrawal by Subject|1|||
42042987|NCT01125800|75850881|FG003|Phase I|Withdrawal by Subject|0|||
42042988|NCT01125800|75850882|FG004|Phase I|Withdrawal by Subject|0|||
42042989|NCT01125800|75850878|FG000|Phase I|Disease progression|5|||
42042990|NCT01125800|75850879|FG001|Phase I|Disease progression|4|||
42042991|NCT01125800|75850880|FG002|Phase I|Disease progression|1|||
42042992|NCT01125800|75850881|FG003|Phase I|Disease progression|3|||
42042993|NCT01125800|75850882|FG004|Phase I|Disease progression|0|||
42042994|NCT01125800|75850878|FG000|Phase II|Protocol Violation|0|||
42042995|NCT01125800|75850879|FG001|Phase II|Protocol Violation|0|||
42042996|NCT01125800|75850880|FG002|Phase II|Protocol Violation|0|||
42042997|NCT01125800|75850881|FG003|Phase II|Protocol Violation|0|||
42042998|NCT01125800|75850882|FG004|Phase II|Protocol Violation|1|||
42042999|NCT01125800|75850878|FG000|Phase II|Adverse Event|0|||
42043000|NCT01125800|75850879|FG001|Phase II|Adverse Event|0|||
42043001|NCT01125800|75850880|FG002|Phase II|Adverse Event|0|||
42043002|NCT01125800|75850881|FG003|Phase II|Adverse Event|0|||
42043003|NCT01125800|75850882|FG004|Phase II|Adverse Event|2|||
42043004|NCT01125800|75850878|FG000|Phase II|Disease progression|0|||
42043005|NCT01125800|75850879|FG001|Phase II|Disease progression|0|||
42043006|NCT01125800|75850880|FG002|Phase II|Disease progression|0|||
42043007|NCT01125800|75850881|FG003|Phase II|Disease progression|1|||
42043008|NCT01125800|75850882|FG004|Phase II|Disease progression|8|||
42043009|NCT01125722|75850899|FG000|Overall Study|Withdrawal by Subject|2|||
42043010|NCT01125722|75850900|FG001|Overall Study|Withdrawal by Subject|1|||
42043011|NCT01125722|75850899|FG000|Overall Study|Lost to Follow-up|1|||
42043012|NCT01125722|75850900|FG001|Overall Study|Lost to Follow-up|0|||
42043013|NCT00811135|75850906|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
42290783|NCT01998958|76124660|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
42290784|NCT01998958|76124661|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
42290785|NCT01998958|76124630|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290786|NCT01998958|76124631|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42356692|NCT01920061|76201869|FG010|Overall Study|Lost to Follow-up|3|||
42356693|NCT01920061|76201870|FG011|Overall Study|Lost to Follow-up|0|||
42356694|NCT01920061|76201871|FG012|Overall Study|Lost to Follow-up|0|||
42356695|NCT01920061|76201872|FG013|Overall Study|Lost to Follow-up|0|||
42356696|NCT01920061|76201873|FG014|Overall Study|Lost to Follow-up|0|||
42356697|NCT01920061|76201874|FG015|Overall Study|Lost to Follow-up|0|||
42356698|NCT01920061|76201875|FG016|Overall Study|Lost to Follow-up|0|||
42356699|NCT01920061|76201876|FG017|Overall Study|Lost to Follow-up|1|||
42290787|NCT01998958|76124632|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290788|NCT01998958|76124633|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290789|NCT01998958|76124634|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290790|NCT01998958|76124635|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42356700|NCT01920061|76201877|FG018|Overall Study|Lost to Follow-up|4|||
42356701|NCT01920061|76201878|FG019|Overall Study|Lost to Follow-up|3|||
42356702|NCT01920061|76201859|FG000|Overall Study|Other|1|||
42356703|NCT01920061|76201860|FG001|Overall Study|Other|1|||
42356704|NCT01920061|76201861|FG002|Overall Study|Other|2|||
42356705|NCT01920061|76201862|FG003|Overall Study|Other|1|||
42356706|NCT01920061|76201863|FG004|Overall Study|Other|0|||
42356707|NCT01920061|76201864|FG005|Overall Study|Other|1|||
42356708|NCT01920061|76201865|FG006|Overall Study|Other|0|||
42356709|NCT01920061|76201866|FG007|Overall Study|Other|0|||
42356710|NCT01920061|76201867|FG008|Overall Study|Other|0|||
42356711|NCT01920061|76201868|FG009|Overall Study|Other|1|||
42356712|NCT01920061|76201869|FG010|Overall Study|Other|1|||
42356713|NCT01920061|76201870|FG011|Overall Study|Other|2|||
42356714|NCT01920061|76201871|FG012|Overall Study|Other|1|||
42356715|NCT01920061|76201872|FG013|Overall Study|Other|4|||
42356716|NCT01920061|76201873|FG014|Overall Study|Other|0|||
42356717|NCT01920061|76201874|FG015|Overall Study|Other|1|||
42356718|NCT01920061|76201875|FG016|Overall Study|Other|1|||
42356719|NCT01920061|76201876|FG017|Overall Study|Other|0|||
42356720|NCT01920061|76201877|FG018|Overall Study|Other|1|||
42356721|NCT01920061|76201878|FG019|Overall Study|Other|1|||
42356722|NCT01920061|76201859|FG000|Overall Study|Participant refused further follow-up|0|||
42356723|NCT01920061|76201860|FG001|Overall Study|Participant refused further follow-up|0|||
42290791|NCT01998958|76124636|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290792|NCT01998958|76124637|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42356724|NCT01920061|76201861|FG002|Overall Study|Participant refused further follow-up|0|||
42356725|NCT01920061|76201862|FG003|Overall Study|Participant refused further follow-up|0|||
42356726|NCT01920061|76201863|FG004|Overall Study|Participant refused further follow-up|1|||
42043014|NCT00811135|75850906|FG000|Overall Study|Death|3|||
42172455|NCT03392194|75979316|FG001|Overall Study|Conflicts with personal schedule|0|||
42356727|NCT01920061|76201864|FG005|Overall Study|Participant refused further follow-up|1|||
42356728|NCT01920061|76201865|FG006|Overall Study|Participant refused further follow-up|0|||
42356729|NCT01920061|76201866|FG007|Overall Study|Participant refused further follow-up|0|||
42043015|NCT00811135|75850906|FG000|Overall Study|Protocol Violation|2|||
42356730|NCT01920061|76201867|FG008|Overall Study|Participant refused further follow-up|1|||
42356731|NCT01920061|76201868|FG009|Overall Study|Participant refused further follow-up|0|||
42356732|NCT01920061|76201869|FG010|Overall Study|Participant refused further follow-up|1|||
42043016|NCT00811135|75850906|FG000|Overall Study|Violation of Selection Criteria|1|||
42043017|NCT00811135|75850906|FG000|Overall Study|Refused Treatment|1|||
42043018|NCT00811135|75850906|FG000|Overall Study|Withdrawal by Subject|3|||
42043019|NCT00811135|75850906|FG000|Overall Study|Administrative/Other Unspecified|11|||
42043020|NCT00811135|75850906|FG000|Overall Study|Ongoing|59|||
42043021|NCT00811057|75850913|FG000|Overall Study|Protocol Violation|5|||
42043022|NCT00811057|75850914|FG001|Overall Study|Protocol Violation|10|||
42043023|NCT00811057|75850915|FG002|Overall Study|Protocol Violation|10|||
42043024|NCT00879970|75850926|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
42043025|NCT00879970|75850927|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
42043026|NCT00879970|75850928|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
42043027|NCT00879970|75850929|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
42043028|NCT00879970|75850930|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
42043029|NCT00879970|75850926|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
42043030|NCT00879970|75850927|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
42043031|NCT00879970|75850928|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
42043032|NCT00879970|75850929|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
42043033|NCT00879970|75850930|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
42043034|NCT00879970|75850926|FG000|Period 1 TZD Randomization|Death|2|||
42043035|NCT00879970|75850927|FG001|Period 1 TZD Randomization|Death|1|||
42043036|NCT00879970|75850928|FG002|Period 1 TZD Randomization|Death|0|||
42043037|NCT00879970|75850929|FG003|Period 1 TZD Randomization|Death|0|||
42043038|NCT00879970|75850930|FG004|Period 1 TZD Randomization|Death|0|||
42043039|NCT00879970|75850926|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
42043040|NCT00879970|75850927|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
42043041|NCT00879970|75850928|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
42043042|NCT00879970|75850929|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
42043043|NCT00879970|75850930|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
42043044|NCT00879970|75850926|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
42043045|NCT00879970|75850927|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
42043046|NCT00879970|75850928|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
42043047|NCT00879970|75850929|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
42043048|NCT00879970|75850930|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
42043049|NCT00879970|75850926|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
42043050|NCT00879970|75850927|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
42043051|NCT00879970|75850928|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
42043052|NCT00879970|75850929|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
42043053|NCT00879970|75850930|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
42043054|NCT00879970|75850926|FG000|Period 2 Vitamin D Randomization|Death|0|||
42043055|NCT00879970|75850927|FG001|Period 2 Vitamin D Randomization|Death|0|||
42043056|NCT00879970|75850928|FG002|Period 2 Vitamin D Randomization|Death|0|||
42043057|NCT00879970|75850929|FG003|Period 2 Vitamin D Randomization|Death|2|||
42043058|NCT00879970|75850930|FG004|Period 2 Vitamin D Randomization|Death|0|||
42043059|NCT00808639|75850948|FG000|Overall Study|Disease progression before surgery.|1|||
42043060|NCT00810901|75850954|FG000|Overall Study|Lost to Follow-up|88|||
42043061|NCT00810901|75850955|FG001|Overall Study|Lost to Follow-up|58|||
42043062|NCT00910299|75850963|FG000|Overall Study|Withdrawal by Subject|16|||
42043063|NCT00910299|75850964|FG001|Overall Study|Withdrawal by Subject|13|||
42043064|NCT00910299|75850963|FG000|Overall Study|Sponsor Decision|58|||
42043065|NCT00910299|75850964|FG001|Overall Study|Sponsor Decision|60|||
42043066|NCT00910299|75850963|FG000|Overall Study|Didn't receive any study drug|2|||
42043067|NCT00910299|75850964|FG001|Overall Study|Didn't receive any study drug|1|||
42043068|NCT00595504|75850972|FG000|Overall Study|Withdrawal by Subject|1|||
42043069|NCT00595504|75850973|FG001|Overall Study|Withdrawal by Subject|3|||
42043070|NCT00595504|75850972|FG000|Overall Study|Physician Decision|1|||
42043071|NCT00595504|75850973|FG001|Overall Study|Physician Decision|0|||
42043072|NCT00808483|75850981|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
42043073|NCT00808483|75850982|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
42290793|NCT01998958|76124638|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290794|NCT01998958|76124639|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290795|NCT01998958|76124640|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42043074|NCT00808483|75850981|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
42290796|NCT01998958|76124641|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290797|NCT01998958|76124642|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290798|NCT01998958|76124643|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42043075|NCT00808483|75850982|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
42043076|NCT00808483|75850981|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
42043077|NCT00808483|75850982|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
42043078|NCT00810511|75850997|FG000|Overall Study|Protocol Violation|0|||
42043079|NCT00810511|75850998|FG001|Overall Study|Protocol Violation|1|||
42043080|NCT00810511|75850997|FG000|Overall Study|Lack of Efficacy|9|||
42290799|NCT01998958|76124644|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
42290800|NCT01998958|76124645|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290801|NCT01998958|76124646|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290802|NCT01998958|76124647|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290803|NCT01998958|76124648|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
42290804|NCT01998958|76124649|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290805|NCT01998958|76124650|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290806|NCT01998958|76124651|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290807|NCT01998958|76124652|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290808|NCT01998958|76124653|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290809|NCT01998958|76124654|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290810|NCT01998958|76124655|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290811|NCT01998958|76124656|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290812|NCT01998958|76124657|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290813|NCT01998958|76124658|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290814|NCT01998958|76124659|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290815|NCT01998958|76124660|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290816|NCT01998958|76124661|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
42290817|NCT01998958|76124630|FG000|Open Label Phase (Optional)|Adverse Event|0|||
42290818|NCT01998958|76124631|FG001|Open Label Phase (Optional)|Adverse Event|0|||
42290819|NCT01998958|76124632|FG002|Open Label Phase (Optional)|Adverse Event|0|||
42290820|NCT01998958|76124633|FG003|Open Label Phase (Optional)|Adverse Event|0|||
42290821|NCT01998958|76124634|FG004|Open Label Phase (Optional)|Adverse Event|0|||
42290822|NCT01998958|76124635|FG005|Open Label Phase (Optional)|Adverse Event|0|||
42290823|NCT01998958|76124636|FG006|Open Label Phase (Optional)|Adverse Event|0|||
42290824|NCT01998958|76124637|FG007|Open Label Phase (Optional)|Adverse Event|0|||
42290825|NCT01998958|76124638|FG008|Open Label Phase (Optional)|Adverse Event|0|||
42356733|NCT01920061|76201870|FG011|Overall Study|Participant refused further follow-up|0|||
42356734|NCT01920061|76201871|FG012|Overall Study|Participant refused further follow-up|1|||
42016033|NCT00949975|75823185|FG002|Overall Study|Severe non-compliance|0|||
42016034|NCT00949975|75823186|FG003|Overall Study|Severe non-compliance|2|||
42016035|NCT00949975|75823183|FG000|Overall Study|Lost to Follow-up|1|||
42016036|NCT00949975|75823184|FG001|Overall Study|Lost to Follow-up|0|||
42016037|NCT00949975|75823185|FG002|Overall Study|Lost to Follow-up|1|||
42016038|NCT00949975|75823186|FG003|Overall Study|Lost to Follow-up|3|||
42016039|NCT00949975|75823183|FG000|Overall Study|Other|1|||
42016040|NCT00949975|75823184|FG001|Overall Study|Other|0|||
42016041|NCT00949975|75823185|FG002|Overall Study|Other|0|||
42016042|NCT00949975|75823186|FG003|Overall Study|Other|0|||
42016043|NCT00939055|75823198|FG000|Overall Study|Discontinuation prior to procedure|4|||
42016044|NCT00939055|75823199|FG001|Overall Study|Discontinuation prior to procedure|0|||
42016045|NCT01136967|75823208|FG000|Overall Study|Adverse Event|9|||
42016046|NCT01136967|75823209|FG001|Overall Study|Adverse Event|12|||
42016047|NCT01136967|75823208|FG000|Overall Study|Participant Choice|8|||
42016048|NCT01136967|75823209|FG001|Overall Study|Participant Choice|3|||
42016049|NCT01136967|75823208|FG000|Overall Study|Lost to Follow-up|0|||
42016050|NCT01136967|75823209|FG001|Overall Study|Lost to Follow-up|1|||
42016051|NCT01136967|75823208|FG000|Overall Study|Withdrawal by Subject|1|||
42016052|NCT01136967|75823209|FG001|Overall Study|Withdrawal by Subject|2|||
42016053|NCT01136967|75823208|FG000|Overall Study|Clinical Progression|3|||
42016054|NCT01136967|75823209|FG001|Overall Study|Clinical Progression|5|||
42016055|NCT01136967|75823208|FG000|Overall Study|Radiation|1|||
42016056|NCT01136967|75823209|FG001|Overall Study|Radiation|0|||
42016057|NCT01136967|75823208|FG000|Overall Study|Non-compliance|1|||
42016058|NCT01136967|75823209|FG001|Overall Study|Non-compliance|0|||
42016059|NCT01136967|75823208|FG000|Overall Study|Investigator's Choice|1|||
42016060|NCT01136967|75823209|FG001|Overall Study|Investigator's Choice|1|||
42016061|NCT01136967|75823208|FG000|Overall Study|Increase in Lesion Size|0|||
42016062|NCT01136967|75823209|FG001|Overall Study|Increase in Lesion Size|2|||
42016063|NCT01136967|75823208|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
42016064|NCT01136967|75823209|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
42016065|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
42016066|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
42016067|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
42016068|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
42016069|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
42016070|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
42016071|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
42016072|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
42290826|NCT01998958|76124639|FG009|Open Label Phase (Optional)|Adverse Event|0|||
42016073|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
42016074|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
42290827|NCT01998958|76124640|FG010|Open Label Phase (Optional)|Adverse Event|0|||
42290828|NCT01998958|76124641|FG011|Open Label Phase (Optional)|Adverse Event|0|||
42290829|NCT01998958|76124642|FG012|Open Label Phase (Optional)|Adverse Event|0|||
42290830|NCT01998958|76124643|FG013|Open Label Phase (Optional)|Adverse Event|0|||
42290831|NCT01998958|76124644|FG014|Open Label Phase (Optional)|Adverse Event|0|||
42290832|NCT01998958|76124645|FG015|Open Label Phase (Optional)|Adverse Event|0|||
42290833|NCT01998958|76124646|FG016|Open Label Phase (Optional)|Adverse Event|0|||
42290834|NCT01998958|76124647|FG017|Open Label Phase (Optional)|Adverse Event|0|||
42290835|NCT01998958|76124648|FG018|Open Label Phase (Optional)|Adverse Event|0|||
42290836|NCT01998958|76124649|FG019|Open Label Phase (Optional)|Adverse Event|0|||
42290837|NCT01998958|76124650|FG020|Open Label Phase (Optional)|Adverse Event|0|||
42290838|NCT01998958|76124651|FG021|Open Label Phase (Optional)|Adverse Event|0|||
42290839|NCT01998958|76124652|FG022|Open Label Phase (Optional)|Adverse Event|0|||
42290840|NCT01998958|76124653|FG023|Open Label Phase (Optional)|Adverse Event|1|||
42290841|NCT01998958|76124654|FG024|Open Label Phase (Optional)|Adverse Event|0|||
42290842|NCT01998958|76124655|FG025|Open Label Phase (Optional)|Adverse Event|0|||
42290843|NCT01998958|76124656|FG026|Open Label Phase (Optional)|Adverse Event|0|||
42290844|NCT01998958|76124657|FG027|Open Label Phase (Optional)|Adverse Event|0|||
42290845|NCT01998958|76124658|FG028|Open Label Phase (Optional)|Adverse Event|0|||
42290846|NCT01998958|76124659|FG029|Open Label Phase (Optional)|Adverse Event|0|||
42290847|NCT01998958|76124660|FG030|Open Label Phase (Optional)|Adverse Event|0|||
42290848|NCT01998958|76124661|FG031|Open Label Phase (Optional)|Adverse Event|0|||
42290849|NCT01998958|76124630|FG000|Open Label Phase (Optional)|Other|0|||
42290850|NCT01998958|76124631|FG001|Open Label Phase (Optional)|Other|0|||
42290851|NCT01998958|76124632|FG002|Open Label Phase (Optional)|Other|0|||
42290852|NCT01998958|76124633|FG003|Open Label Phase (Optional)|Other|0|||
42290853|NCT01998958|76124634|FG004|Open Label Phase (Optional)|Other|0|||
42290854|NCT01998958|76124635|FG005|Open Label Phase (Optional)|Other|0|||
42290855|NCT01998958|76124636|FG006|Open Label Phase (Optional)|Other|0|||
42290856|NCT01998958|76124637|FG007|Open Label Phase (Optional)|Other|0|||
42290857|NCT01998958|76124638|FG008|Open Label Phase (Optional)|Other|0|||
42290858|NCT01998958|76124639|FG009|Open Label Phase (Optional)|Other|0|||
42290859|NCT01998958|76124640|FG010|Open Label Phase (Optional)|Other|0|||
42290860|NCT01998958|76124641|FG011|Open Label Phase (Optional)|Other|0|||
42290861|NCT01998958|76124642|FG012|Open Label Phase (Optional)|Other|0|||
42290862|NCT01998958|76124643|FG013|Open Label Phase (Optional)|Other|0|||
42290863|NCT01998958|76124644|FG014|Open Label Phase (Optional)|Other|0|||
42290864|NCT01998958|76124645|FG015|Open Label Phase (Optional)|Other|0|||
42290865|NCT01998958|76124646|FG016|Open Label Phase (Optional)|Other|0|||
42290866|NCT01998958|76124647|FG017|Open Label Phase (Optional)|Other|0|||
42290867|NCT01998958|76124648|FG018|Open Label Phase (Optional)|Other|0|||
42290868|NCT01998958|76124649|FG019|Open Label Phase (Optional)|Other|0|||
42290869|NCT01998958|76124650|FG020|Open Label Phase (Optional)|Other|0|||
42290870|NCT01998958|76124651|FG021|Open Label Phase (Optional)|Other|0|||
42290871|NCT01998958|76124652|FG022|Open Label Phase (Optional)|Other|5|||
42290872|NCT01998958|76124653|FG023|Open Label Phase (Optional)|Other|1|||
42290873|NCT01998958|76124654|FG024|Open Label Phase (Optional)|Other|0|||
42356735|NCT01920061|76201872|FG013|Overall Study|Participant refused further follow-up|0|||
42356736|NCT01920061|76201873|FG014|Overall Study|Participant refused further follow-up|1|||
42356737|NCT01920061|76201874|FG015|Overall Study|Participant refused further follow-up|2|||
42356738|NCT01920061|76201875|FG016|Overall Study|Participant refused further follow-up|1|||
42356739|NCT01920061|76201876|FG017|Overall Study|Participant refused further follow-up|1|||
42356740|NCT01920061|76201877|FG018|Overall Study|Participant refused further follow-up|0|||
42356741|NCT01920061|76201878|FG019|Overall Study|Participant refused further follow-up|0|||
42356742|NCT01426425|76201941|FG000|Overall Study|Exited prior to EP study|22|||
42356743|NCT01426425|76201941|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
42356744|NCT01426425|76201941|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
42356745|NCT01426347|76201954|FG000|Overall Study|Lost to Follow-up|0|||
42356746|NCT01426347|76201955|FG001|Overall Study|Lost to Follow-up|3|||
42356747|NCT01426347|76201954|FG000|Overall Study|Protocol Violation|2|||
42356748|NCT01426347|76201955|FG001|Overall Study|Protocol Violation|0|||
42356749|NCT01426347|76201954|FG000|Overall Study|Withdrawal by Subject|5|||
42356750|NCT01426347|76201955|FG001|Overall Study|Withdrawal by Subject|0|||
42356751|NCT01882465|76201961|FG000|Period 1|Lens Discomfort|0|||
42290874|NCT01998958|76124655|FG025|Open Label Phase (Optional)|Other|0|||
42290875|NCT01998958|76124656|FG026|Open Label Phase (Optional)|Other|0|||
42290876|NCT01998958|76124657|FG027|Open Label Phase (Optional)|Other|0|||
42290877|NCT01998958|76124658|FG028|Open Label Phase (Optional)|Other|0|||
42290878|NCT01998958|76124659|FG029|Open Label Phase (Optional)|Other|0|||
42290879|NCT01998958|76124660|FG030|Open Label Phase (Optional)|Other|0|||
42290880|NCT01998958|76124661|FG031|Open Label Phase (Optional)|Other|0|||
42290881|NCT01998958|76124630|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290882|NCT01998958|76124631|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290883|NCT01998958|76124632|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
42356752|NCT01882465|76201962|FG001|Period 1|Lens Discomfort|0|||
42356753|NCT01882465|76201963|FG002|Period 1|Lens Discomfort|0|||
42356754|NCT01882465|76201964|FG003|Period 1|Lens Discomfort|1|||
42356755|NCT01882465|76201965|FG004|Period 1|Lens Discomfort|0|||
42356756|NCT01882465|76201966|FG005|Period 1|Lens Discomfort|0|||
42356757|NCT01882465|76201967|FG006|Period 1|Lens Discomfort|0|||
42356758|NCT01882465|76201961|FG000|Period 1|Withdrawal by Subject|0|||
42356759|NCT01882465|76201962|FG001|Period 1|Withdrawal by Subject|0|||
42356760|NCT01882465|76201963|FG002|Period 1|Withdrawal by Subject|0|||
42356761|NCT01882465|76201964|FG003|Period 1|Withdrawal by Subject|0|||
42356762|NCT01882465|76201965|FG004|Period 1|Withdrawal by Subject|0|||
42356763|NCT01882465|76201966|FG005|Period 1|Withdrawal by Subject|0|||
42356764|NCT01882465|76201967|FG006|Period 1|Withdrawal by Subject|1|||
42356765|NCT01882465|76201961|FG000|Period 2|Protocol Violation|0|||
42356766|NCT01882465|76201962|FG001|Period 2|Protocol Violation|0|||
42290884|NCT01998958|76124633|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290885|NCT01998958|76124634|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290886|NCT01998958|76124635|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290887|NCT01998958|76124636|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290888|NCT01998958|76124637|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290889|NCT01998958|76124638|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
42043081|NCT00810511|75850998|FG001|Overall Study|Lack of Efficacy|1|||
42290890|NCT01998958|76124639|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290891|NCT01998958|76124640|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290892|NCT01998958|76124641|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290893|NCT01998958|76124642|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
42043082|NCT00810511|75850997|FG000|Overall Study|death in the family|0|||
42290894|NCT01998958|76124643|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290895|NCT01998958|76124644|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290896|NCT01998958|76124645|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290897|NCT01998958|76124646|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290898|NCT01998958|76124647|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290899|NCT01998958|76124648|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290900|NCT01998958|76124649|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290901|NCT01998958|76124650|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290902|NCT01998958|76124651|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290903|NCT01998958|76124652|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
42290904|NCT01998958|76124653|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290905|NCT01998958|76124654|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290906|NCT01998958|76124655|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290907|NCT01998958|76124656|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290908|NCT01998958|76124657|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290909|NCT01998958|76124658|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290910|NCT01998958|76124659|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290911|NCT01998958|76124660|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290912|NCT01998958|76124661|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
42290913|NCT01998958|76124630|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290914|NCT01998958|76124631|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290915|NCT01998958|76124632|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290916|NCT01998958|76124633|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290917|NCT01998958|76124634|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290918|NCT01998958|76124635|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290919|NCT01998958|76124636|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290920|NCT01998958|76124637|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290921|NCT01998958|76124638|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290922|NCT01998958|76124639|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290923|NCT01998958|76124640|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290924|NCT01998958|76124641|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290925|NCT01998958|76124642|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290926|NCT01998958|76124643|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290927|NCT01998958|76124644|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290928|NCT01998958|76124645|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
42172456|NCT03828617|75979326|FG000|Overall Study|Lost to Follow-up|22|||
42290929|NCT01998958|76124646|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290930|NCT01998958|76124647|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
42356767|NCT01882465|76201963|FG002|Period 2|Protocol Violation|0|||
42356768|NCT01882465|76201964|FG003|Period 2|Protocol Violation|0|||
42356769|NCT01882465|76201965|FG004|Period 2|Protocol Violation|1|||
42356770|NCT01882465|76201966|FG005|Period 2|Protocol Violation|0|||
42043083|NCT00810511|75850998|FG001|Overall Study|death in the family|1|||
42290931|NCT01998958|76124648|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290932|NCT01998958|76124649|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290933|NCT01998958|76124650|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290934|NCT01998958|76124651|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
42290935|NCT01998958|76124652|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
42290936|NCT01998958|76124653|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290937|NCT01998958|76124654|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290938|NCT01998958|76124655|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290939|NCT01998958|76124656|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290940|NCT01998958|76124657|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290941|NCT01998958|76124658|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290942|NCT01998958|76124659|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290943|NCT01998958|76124660|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290944|NCT01998958|76124661|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
42290945|NCT01998958|76124630|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290946|NCT01998958|76124631|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290947|NCT01998958|76124632|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290948|NCT01998958|76124633|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290949|NCT01998958|76124634|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290950|NCT01998958|76124635|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290951|NCT01998958|76124636|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290952|NCT01998958|76124637|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290953|NCT01998958|76124638|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290954|NCT01998958|76124639|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290955|NCT01998958|76124640|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290956|NCT01998958|76124641|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290957|NCT01998958|76124642|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290958|NCT01998958|76124643|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290959|NCT01998958|76124644|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290960|NCT01998958|76124645|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290961|NCT01998958|76124646|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290962|NCT01998958|76124647|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290963|NCT01998958|76124648|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290964|NCT01998958|76124649|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290965|NCT01998958|76124650|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290966|NCT01998958|76124651|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
42290967|NCT01998958|76124652|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
42290968|NCT01998958|76124653|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
42290969|NCT01998958|76124654|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290970|NCT01998958|76124655|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290971|NCT01998958|76124656|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42356771|NCT01882465|76201967|FG006|Period 2|Protocol Violation|0|||
42356772|NCT01426269|76201975|FG000|Period 1: 12 Weeks|Adverse Event|5|||
42356773|NCT01426269|76201976|FG001|Period 1: 12 Weeks|Adverse Event|0|||
42356774|NCT01426269|76201977|FG002|Period 1: 12 Weeks|Adverse Event|0|||
42356775|NCT01426269|76201975|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
42356776|NCT01426269|76201976|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
42356777|NCT01426269|76201977|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
42356778|NCT01426269|76201975|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
42356779|NCT01426269|76201976|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
42356780|NCT01426269|76201977|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
42356781|NCT01426269|76201975|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
42356782|NCT01426269|76201976|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
42356783|NCT01426269|76201977|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
42356784|NCT01426269|76201975|FG000|Period 1: 12 Weeks|Pregnancy|1|||
42356785|NCT01426269|76201976|FG001|Period 1: 12 Weeks|Pregnancy|0|||
42356786|NCT01426269|76201977|FG002|Period 1: 12 Weeks|Pregnancy|0|||
42356787|NCT01426269|76201975|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
42356788|NCT01426269|76201976|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
42356789|NCT01426269|76201977|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
42356790|NCT01426269|76201975|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
42016075|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
42290972|NCT01998958|76124657|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290973|NCT01998958|76124658|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290974|NCT01998958|76124659|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290975|NCT01998958|76124660|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290976|NCT01998958|76124661|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
42290977|NCT01958164|76124713|FG000|Overall Study|Adverse Event|0|||
42290978|NCT01958164|76124714|FG001|Overall Study|Adverse Event|2|||
42290979|NCT01958164|76124713|FG000|Overall Study|Lost to Follow-up|2|||
42290980|NCT01958164|76124714|FG001|Overall Study|Lost to Follow-up|3|||
42290981|NCT01976104|76124724|FG000|Overall Study|Adverse Event|0|||
42356791|NCT01426269|76201976|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
42356792|NCT01426269|76201977|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
42356793|NCT01426269|76201975|FG000|Period 2: 40 Weeks|Adverse Event|0|||
42043084|NCT00810511|75850997|FG000|Overall Study|Lost to Follow-up|1|||
42172457|NCT03828617|75979327|FG001|Overall Study|Lost to Follow-up|12|||
42290982|NCT01976104|76124725|FG001|Overall Study|Adverse Event|0|||
42290983|NCT01976104|76124726|FG002|Overall Study|Adverse Event|1|||
42290984|NCT01976104|76124727|FG003|Overall Study|Adverse Event|0|||
42290985|NCT01976104|76124724|FG000|Overall Study|Lost to Follow-up|3|||
42290986|NCT01976104|76124725|FG001|Overall Study|Lost to Follow-up|0|||
42290987|NCT01976104|76124726|FG002|Overall Study|Lost to Follow-up|1|||
42290988|NCT01976104|76124727|FG003|Overall Study|Lost to Follow-up|1|||
42290989|NCT01976104|76124724|FG000|Overall Study|Subject Choice|0|||
42290990|NCT01976104|76124725|FG001|Overall Study|Subject Choice|1|||
42290991|NCT01976104|76124726|FG002|Overall Study|Subject Choice|0|||
42290992|NCT01976104|76124727|FG003|Overall Study|Subject Choice|1|||
42290993|NCT01976104|76124724|FG000|Overall Study|Withdrawal by Subject|3|||
42290994|NCT01976104|76124725|FG001|Overall Study|Withdrawal by Subject|0|||
42290995|NCT01976104|76124726|FG002|Overall Study|Withdrawal by Subject|0|||
42290996|NCT01976104|76124727|FG003|Overall Study|Withdrawal by Subject|1|||
42290997|NCT01976104|76124724|FG000|Overall Study|Other|0|||
42043085|NCT00810511|75850998|FG001|Overall Study|Lost to Follow-up|0|||
42290998|NCT01976104|76124725|FG001|Overall Study|Other|1|||
42290999|NCT01976104|76124726|FG002|Overall Study|Other|0|||
42291000|NCT01976104|76124727|FG003|Overall Study|Other|0|||
42291001|NCT01372501|76124738|FG000|Overall Study|Adverse Event|4|||
42291002|NCT01372501|76124738|FG000|Overall Study|Device migration|1|||
42291003|NCT01958008|76124747|FG000|Overall Study|Worsening of disease under study|0|||
42291004|NCT01958008|76124748|FG001|Overall Study|Worsening of disease under study|0|||
42291005|NCT01958008|76124749|FG002|Overall Study|Worsening of disease under study|1|||
42291006|NCT01958008|76124750|FG003|Overall Study|Worsening of disease under study|0|||
42291007|NCT01958008|76124747|FG000|Overall Study|Other adverse event|1|||
42291008|NCT01958008|76124748|FG001|Overall Study|Other adverse event|0|||
42291009|NCT01958008|76124749|FG002|Overall Study|Other adverse event|0|||
42291010|NCT01958008|76124750|FG003|Overall Study|Other adverse event|0|||
42291011|NCT01998880|76124778|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
42291012|NCT01998880|76124779|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
42356794|NCT01426269|76201976|FG001|Period 2: 40 Weeks|Adverse Event|1|||
42043086|NCT00810511|75850997|FG000|Overall Study|deposits on contact lens|0|||
42043087|NCT00810511|75850998|FG001|Overall Study|deposits on contact lens|1|||
42043088|NCT00596362|75851004|FG000|Overall Study|Progressive Disease|1|||
42043089|NCT00907803|75851011|FG000|Overall Study|Withdrawal of consent - long commute|1|||
42043090|NCT00907803|75851012|FG001|Overall Study|Withdrawal of consent - long commute|0|||
42043091|NCT00907803|75851013|FG002|Overall Study|Withdrawal of consent - long commute|0|||
42043092|NCT00907803|75851011|FG000|Overall Study|Adverse Event|2|||
42043093|NCT00907803|75851012|FG001|Overall Study|Adverse Event|0|||
42043094|NCT00907803|75851013|FG002|Overall Study|Adverse Event|0|||
42043095|NCT00907803|75851011|FG000|Overall Study|Withdrawal by Subject|0|||
42043096|NCT00907803|75851012|FG001|Overall Study|Withdrawal by Subject|1|||
42043097|NCT00907803|75851013|FG002|Overall Study|Withdrawal by Subject|0|||
42043098|NCT00907803|75851011|FG000|Overall Study|Lost to Follow-up|0|||
42043099|NCT00907803|75851012|FG001|Overall Study|Lost to Follow-up|1|||
42043100|NCT00907803|75851013|FG002|Overall Study|Lost to Follow-up|0|||
42043101|NCT00907803|75851011|FG000|Overall Study|Protocol Violation|0|||
42043102|NCT00907803|75851012|FG001|Overall Study|Protocol Violation|1|||
42043103|NCT00907803|75851013|FG002|Overall Study|Protocol Violation|0|||
42043104|NCT00808249|75851025|FG000|Overall Study|Adverse Event|4|||
42043105|NCT00808249|75851026|FG001|Overall Study|Adverse Event|7|||
42043106|NCT00808249|75851027|FG002|Overall Study|Adverse Event|10|||
42043107|NCT00808249|75851028|FG003|Overall Study|Adverse Event|6|||
42043108|NCT00808249|75851025|FG000|Overall Study|Lost to Follow-up|2|||
42043109|NCT00808249|75851026|FG001|Overall Study|Lost to Follow-up|3|||
42172458|NCT03828617|75979328|FG002|Overall Study|Lost to Follow-up|23|||
42043110|NCT00808249|75851027|FG002|Overall Study|Lost to Follow-up|3|||
42043111|NCT00808249|75851028|FG003|Overall Study|Lost to Follow-up|5|||
42043112|NCT00808249|75851025|FG000|Overall Study|Withdrawal by Subject|4|||
42043113|NCT00808249|75851026|FG001|Overall Study|Withdrawal by Subject|0|||
42291013|NCT01998880|76124778|FG000|Overall Study|Disease Progression|1|||
42291014|NCT01998880|76124779|FG001|Overall Study|Disease Progression|8|||
42291015|NCT01998880|76124778|FG000|Overall Study|Withdrew Consent|2|||
42291016|NCT01998880|76124779|FG001|Overall Study|Withdrew Consent|1|||
42291017|NCT01998880|76124778|FG000|Overall Study|Death|3|||
42291018|NCT01998880|76124779|FG001|Overall Study|Death|6|||
42291019|NCT01998880|76124778|FG000|Overall Study|Insufficient Therapeutic Response|1|||
42043114|NCT00808249|75851027|FG002|Overall Study|Withdrawal by Subject|2|||
42043115|NCT00808249|75851028|FG003|Overall Study|Withdrawal by Subject|4|||
42043116|NCT00808249|75851025|FG000|Overall Study|Protocol Violation|3|||
42043117|NCT00808249|75851026|FG001|Overall Study|Protocol Violation|3|||
42043118|NCT00808249|75851027|FG002|Overall Study|Protocol Violation|3|||
42043119|NCT00808249|75851028|FG003|Overall Study|Protocol Violation|0|||
42043120|NCT00808249|75851025|FG000|Overall Study|Lack of Efficacy|1|||
42043121|NCT00808249|75851026|FG001|Overall Study|Lack of Efficacy|1|||
42043122|NCT00808249|75851027|FG002|Overall Study|Lack of Efficacy|0|||
42043123|NCT00808249|75851028|FG003|Overall Study|Lack of Efficacy|0|||
42043124|NCT00808249|75851025|FG000|Overall Study|study specific discontinuation criteria|1|||
42043125|NCT00808249|75851026|FG001|Overall Study|study specific discontinuation criteria|0|||
42043126|NCT00808249|75851027|FG002|Overall Study|study specific discontinuation criteria|1|||
42043127|NCT00808249|75851028|FG003|Overall Study|study specific discontinuation criteria|0|||
42043128|NCT00808249|75851025|FG000|Overall Study|All other reasons|2|||
42043129|NCT00808249|75851026|FG001|Overall Study|All other reasons|1|||
42043130|NCT00808249|75851027|FG002|Overall Study|All other reasons|3|||
42291020|NCT01998880|76124779|FG001|Overall Study|Insufficient Therapeutic Response|5|||
42291021|NCT01998880|76124778|FG000|Overall Study|Administrative/Other|1|||
42291022|NCT01998880|76124779|FG001|Overall Study|Administrative/Other|1|||
42291023|NCT01998880|76124778|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
42291024|NCT01998880|76124779|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
42291025|NCT01998880|76124778|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
42291026|NCT01998880|76124779|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
42291027|NCT01998880|76124778|FG000|Overall Study|Did Not Receive Treatment|3|||
42291028|NCT01998880|76124779|FG001|Overall Study|Did Not Receive Treatment|2|||
42291029|NCT01975948|76124789|FG000|Overall Study|Withdrawal by Subject|17|||
42291030|NCT01975948|76124790|FG001|Overall Study|Withdrawal by Subject|21|||
42291031|NCT01975948|76124791|FG002|Overall Study|Withdrawal by Subject|7|||
42016076|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
42016077|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
42016078|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
42016079|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
42016080|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
42016081|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
42016082|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
42016083|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
42016084|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
42016085|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
42016086|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
42016087|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
42016088|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
42016089|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
42016090|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
42016091|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
42016092|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
42016093|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
42016094|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
42016095|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
42016096|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
42016097|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
42016098|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
42016099|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
42016100|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
42016101|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
42016102|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
42016103|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
42016104|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
42016105|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
42016106|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
42043131|NCT00808249|75851028|FG003|Overall Study|All other reasons|1|||
42043132|NCT00908895|75851040|FG000|Overall Study|Lost to Follow-up|1|||
42043133|NCT00908895|75851041|FG001|Overall Study|Lost to Follow-up|3|||
42291032|NCT01975948|76124792|FG003|Overall Study|Withdrawal by Subject|6|||
42291033|NCT01975246|76124804|FG000|Overall Study|Adverse Event|2|||
42291034|NCT01975246|76124805|FG001|Overall Study|Adverse Event|1|||
42356795|NCT01426269|76201977|FG002|Period 2: 40 Weeks|Adverse Event|2|||
42356796|NCT01426269|76201975|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
42356797|NCT01426269|76201976|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
42356798|NCT01426269|76201977|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
42356799|NCT01426269|76201975|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
42356800|NCT01426269|76201976|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
42291035|NCT01975246|76124804|FG000|Overall Study|Lack of Efficacy|1|||
42291036|NCT01975246|76124805|FG001|Overall Study|Lack of Efficacy|0|||
42291037|NCT01975246|76124804|FG000|Overall Study|Protocol Violation|1|||
42291038|NCT01975246|76124805|FG001|Overall Study|Protocol Violation|0|||
42291039|NCT01975246|76124804|FG000|Overall Study|Other than stated|0|||
42291040|NCT01975246|76124805|FG001|Overall Study|Other than stated|1|||
42291041|NCT01621126|76124811|FG000|Overall Study|Physician Decision|6|||
42291042|NCT01973998|76124817|FG000|Overall Study|Death|2|||
42291043|NCT01973998|76124818|FG001|Overall Study|Death|2|||
42291044|NCT02664415|76124826|FG000|Overall Study|Adverse Event|1|||
42291045|NCT02664415|76124827|FG001|Overall Study|Adverse Event|0|||
42291046|NCT02661061|76124835|FG000|Overall Study|Lack of Efficacy|1|||
42291047|NCT02661061|76124836|FG001|Overall Study|Lack of Efficacy|1|||
42291048|NCT02661061|76124835|FG000|Overall Study|Withdrawal by Subject|1|||
42291049|NCT02661061|76124836|FG001|Overall Study|Withdrawal by Subject|1|||
42356801|NCT01426269|76201977|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
42356802|NCT01426269|76201975|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
42356803|NCT01426269|76201976|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
42356804|NCT01426269|76201977|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
42356805|NCT01426269|76201975|FG000|Period 2: 40 Weeks|Site closed|0|||
42356806|NCT01426269|76201976|FG001|Period 2: 40 Weeks|Site closed|6|||
42356807|NCT01426269|76201977|FG002|Period 2: 40 Weeks|Site closed|5|||
42356808|NCT01426269|76201975|FG000|Period 2: 40 Weeks|Relapsed|0|||
42291050|NCT01995838|76124849|FG000|Overall Study|Lost to Follow-up|0|||
42291051|NCT01995838|76124850|FG001|Overall Study|Lost to Follow-up|1|||
42291052|NCT01995838|76124851|FG002|Overall Study|Lost to Follow-up|0|||
42291053|NCT01995838|76124852|FG003|Overall Study|Lost to Follow-up|0|||
42291054|NCT01995838|76124853|FG004|Overall Study|Lost to Follow-up|0|||
42291055|NCT01995838|76124854|FG005|Overall Study|Lost to Follow-up|0|||
42291056|NCT01995838|76124855|FG006|Overall Study|Lost to Follow-up|1|||
42291057|NCT01995838|76124849|FG000|Overall Study|Participant choice|2|||
42291058|NCT01995838|76124850|FG001|Overall Study|Participant choice|0|||
42291059|NCT01995838|76124851|FG002|Overall Study|Participant choice|0|||
42291060|NCT01995838|76124852|FG003|Overall Study|Participant choice|0|||
42291061|NCT01995838|76124853|FG004|Overall Study|Participant choice|0|||
42291062|NCT01995838|76124854|FG005|Overall Study|Participant choice|1|||
42291063|NCT01995838|76124855|FG006|Overall Study|Participant choice|1|||
42291064|NCT01995838|76124849|FG000|Overall Study|Adverse Event|0|||
42291065|NCT01995838|76124850|FG001|Overall Study|Adverse Event|0|||
42291066|NCT01995838|76124851|FG002|Overall Study|Adverse Event|0|||
42291067|NCT01995838|76124852|FG003|Overall Study|Adverse Event|0|||
42291068|NCT01995838|76124853|FG004|Overall Study|Adverse Event|0|||
42291069|NCT01995838|76124854|FG005|Overall Study|Adverse Event|0|||
42291070|NCT01995838|76124855|FG006|Overall Study|Adverse Event|1|||
42291071|NCT01995838|76124849|FG000|Overall Study|Withdrawal by Subject|0|||
42291072|NCT01995838|76124850|FG001|Overall Study|Withdrawal by Subject|0|||
42291073|NCT01995838|76124851|FG002|Overall Study|Withdrawal by Subject|0|||
42291074|NCT01995838|76124852|FG003|Overall Study|Withdrawal by Subject|0|||
42356809|NCT01426269|76201976|FG001|Period 2: 40 Weeks|Relapsed|9|||
42356810|NCT01426269|76201977|FG002|Period 2: 40 Weeks|Relapsed|18|||
42356811|NCT01426113|76201990|FG000|Overall Study|Study Discontinued|1|||
42291075|NCT01995838|76124853|FG004|Overall Study|Withdrawal by Subject|1|||
42043134|NCT00908895|75851040|FG000|Overall Study|algodystrophy|2|||
42043135|NCT00908895|75851041|FG001|Overall Study|algodystrophy|2|||
42043136|NCT00908895|75851040|FG000|Overall Study|Adverse Event|1|||
42043137|NCT00908895|75851041|FG001|Overall Study|Adverse Event|1|||
42043138|NCT00591253|75851050|FG000|Overall Study|Adverse Event|3|||
42043139|NCT00591253|75851051|FG001|Overall Study|Adverse Event|3|||
42043140|NCT00591253|75851052|FG002|Overall Study|Adverse Event|1|||
42043141|NCT00591253|75851050|FG000|Overall Study|Protocol Violation|2|||
42043142|NCT00591253|75851051|FG001|Overall Study|Protocol Violation|2|||
42043143|NCT00591253|75851052|FG002|Overall Study|Protocol Violation|2|||
42043144|NCT00591253|75851050|FG000|Overall Study|Lost to Follow-up|2|||
42043145|NCT00591253|75851051|FG001|Overall Study|Lost to Follow-up|4|||
42043146|NCT00591253|75851052|FG002|Overall Study|Lost to Follow-up|0|||
42043147|NCT00591253|75851050|FG000|Overall Study|Withdrawal by Subject|1|||
42043148|NCT00591253|75851051|FG001|Overall Study|Withdrawal by Subject|7|||
42043149|NCT00591253|75851052|FG002|Overall Study|Withdrawal by Subject|6|||
42043150|NCT00591253|75851050|FG000|Overall Study|Lack of Efficacy|1|||
42043151|NCT00591253|75851051|FG001|Overall Study|Lack of Efficacy|0|||
42043152|NCT00591253|75851052|FG002|Overall Study|Lack of Efficacy|3|||
42043153|NCT00591253|75851050|FG000|Overall Study|Other|5|||
42043154|NCT00591253|75851051|FG001|Overall Study|Other|5|||
42043155|NCT00591253|75851052|FG002|Overall Study|Other|3|||
42043156|NCT00908583|75851060|FG000|Phase 1|Withdrawal by Subject|1|||
42043157|NCT00908583|75851060|FG000|Phase 1|Adverse Event|4|||
42043158|NCT00908583|75851060|FG000|Phase 2|Physician Decision|1|||
42043159|NCT00908583|75851060|FG000|Phase 2|Adverse Event|1|||
42043160|NCT00908583|75851060|FG000|Phase 3|Adverse Event|2|||
42043161|NCT00908583|75851060|FG000|Phase 4|Adverse Event|1|||
42043162|NCT00908583|75851060|FG000|Phase 4|Physician Decision|1|||
42043163|NCT00908583|75851060|FG000|Phase 5|Adverse Event|3|||
42043164|NCT00909363|75851081|FG000|Overall Study|Withdrawal by Subject|1|||
42043165|NCT00909363|75851082|FG001|Overall Study|Withdrawal by Subject|0|||
42043166|NCT00909363|75851083|FG002|Overall Study|Withdrawal by Subject|0|||
42043167|NCT00909363|75851081|FG000|Overall Study|Lack of Efficacy|1|||
42043168|NCT00909363|75851082|FG001|Overall Study|Lack of Efficacy|0|||
42043169|NCT00909363|75851083|FG002|Overall Study|Lack of Efficacy|0|||
42043170|NCT00810355|75851097|FG000|Overall Study|Lost to Follow-up|13|||
42043171|NCT00810355|75851098|FG001|Overall Study|Lost to Follow-up|17|||
42043172|NCT00810355|75851099|FG002|Overall Study|Lost to Follow-up|11|||
42043173|NCT00810355|75851097|FG000|Overall Study|Withdrawal by Subject|1|||
42043174|NCT00810355|75851098|FG001|Overall Study|Withdrawal by Subject|0|||
42043175|NCT00810355|75851099|FG002|Overall Study|Withdrawal by Subject|0|||
42043176|NCT00908349|75851107|FG000|Overall Study|Adverse Event|10|||
42043177|NCT00908349|75851107|FG000|Overall Study|Withdrawal by Subject|9|||
42043178|NCT00908349|75851107|FG000|Overall Study|Physician Decision|5|||
42043179|NCT00908349|75851107|FG000|Overall Study|Lost to Follow-up|5|||
42043180|NCT00908349|75851107|FG000|Overall Study|Various|6|||
42043181|NCT01125566|75851113|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
42043182|NCT01125566|75851114|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
42043183|NCT01125566|75851115|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
42043184|NCT01125566|75851113|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
42043185|NCT01125566|75851114|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
42043186|NCT01125566|75851115|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
42043187|NCT01125566|75851113|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
42043188|NCT01125566|75851114|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
42043189|NCT01125566|75851115|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
42043190|NCT01125566|75851113|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
42043191|NCT01125566|75851114|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
42043192|NCT01125566|75851115|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
42043193|NCT01125566|75851113|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
42043194|NCT01125566|75851114|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
42043195|NCT01125566|75851115|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
42172459|NCT03828617|75979329|FG003|Overall Study|Lost to Follow-up|7|||
42172460|NCT03828617|75979326|FG000|Overall Study|No longer met eligibility criteria|0|||
42172461|NCT03828617|75979327|FG001|Overall Study|No longer met eligibility criteria|1|||
42172462|NCT03828617|75979328|FG002|Overall Study|No longer met eligibility criteria|1|||
42172463|NCT03828617|75979329|FG003|Overall Study|No longer met eligibility criteria|3|||
42172464|NCT03828617|75979326|FG000|Overall Study|Protocol Violation|0|||
42043196|NCT01125566|75851113|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
42043197|NCT01125566|75851114|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
42043198|NCT01125566|75851115|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
42172465|NCT03828617|75979327|FG001|Overall Study|Protocol Violation|2|||
42172466|NCT03828617|75979328|FG002|Overall Study|Protocol Violation|0|||
42043199|NCT01125566|75851113|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
42043200|NCT01125566|75851114|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
42043201|NCT01125566|75851115|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
42043202|NCT01125566|75851113|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
42043203|NCT01125566|75851114|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
42043204|NCT01125566|75851115|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
42043205|NCT01125566|75851113|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
42043206|NCT01125566|75851114|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
42043207|NCT01125566|75851115|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
42043208|NCT01125566|75851113|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
42043209|NCT01125566|75851114|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
42043210|NCT01125566|75851115|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
42043211|NCT01125566|75851113|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
42043212|NCT01125566|75851114|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
42043213|NCT01125566|75851115|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
42043214|NCT01125566|75851113|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
42043215|NCT01125566|75851114|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
42043216|NCT01125566|75851115|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
42043217|NCT00810277|75851122|FG000|Overall Study|Adverse Event|1|||
42043218|NCT00595582|75851126|FG000|Overall Study|Pilot study that PI terminated|2|||
42043219|NCT00595582|75851126|FG000|Overall Study|Lost to Follow-up|1|||
42043220|NCT00595582|75851126|FG000|Overall Study|Adverse Event|2|||
42043221|NCT00595582|75851126|FG000|Overall Study|Physician Decision|5|||
42043222|NCT00808015|75851130|FG000|Overall Study|Death|1|||
42043223|NCT00808015|75851130|FG000|Overall Study|Lack of Efficacy|58|||
42043224|NCT00808015|75851130|FG000|Overall Study|Lost to Follow-up|76|||
42043225|NCT00808015|75851130|FG000|Overall Study|Participants not willing to participate|158|||
42043226|NCT00808015|75851130|FG000|Overall Study|Adverse Event|22|||
42043227|NCT00808015|75851130|FG000|Overall Study|Other|25|||
42043228|NCT00808015|75851130|FG000|Overall Study|Enrolled but not treated|4|||
42043229|NCT00810199|75851136|FG000|Overall Study|Adverse Event|24|||
42043230|NCT00810199|75851137|FG001|Overall Study|Adverse Event|26|||
42043231|NCT00810199|75851136|FG000|Overall Study|Death|4|||
42043232|NCT00810199|75851137|FG001|Overall Study|Death|6|||
42043233|NCT00810199|75851136|FG000|Overall Study|Withdrew consent|9|||
42043234|NCT00810199|75851137|FG001|Overall Study|Withdrew consent|12|||
42043235|NCT00810199|75851136|FG000|Overall Study|Insufficient therapeutic response|5|||
42043236|NCT00810199|75851137|FG001|Overall Study|Insufficient therapeutic response|14|||
42043237|NCT00810199|75851136|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
42043238|NCT00810199|75851137|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
42043239|NCT00810199|75851136|FG000|Overall Study|Administrative/Other|5|||
42043240|NCT00810199|75851137|FG001|Overall Study|Administrative/Other|6|||
42043241|NCT00810199|75851136|FG000|Overall Study|Protocol Violation|2|||
42043242|NCT00810199|75851137|FG001|Overall Study|Protocol Violation|6|||
42043243|NCT00810199|75851136|FG000|Overall Study|Failure to return|1|||
42043244|NCT00810199|75851137|FG001|Overall Study|Failure to return|4|||
42043245|NCT00810199|75851136|FG000|Overall Study|Did not receive study drug|2|||
42043246|NCT00810199|75851137|FG001|Overall Study|Did not receive study drug|1|||
42043247|NCT00877006|75851151|FG000|Treatment Period|Death|2|||
42043248|NCT00877006|75851152|FG001|Treatment Period|Death|1|||
42043249|NCT00877006|75851151|FG000|Treatment Period|Adverse Event|10|||
42043250|NCT00877006|75851152|FG001|Treatment Period|Adverse Event|3|||
42043251|NCT00877006|75851151|FG000|Treatment Period|Withdrawal by Subject|2|||
42043252|NCT00877006|75851152|FG001|Treatment Period|Withdrawal by Subject|3|||
42043253|NCT00877006|75851151|FG000|Treatment Period|Protocol Violation|1|||
42043254|NCT00877006|75851152|FG001|Treatment Period|Protocol Violation|0|||
42043255|NCT00877006|75851151|FG000|Treatment Period|Lost to Follow-up|0|||
42043256|NCT00877006|75851152|FG001|Treatment Period|Lost to Follow-up|1|||
42043257|NCT00877006|75851151|FG000|Treatment Period|Disease Progression|1|||
42043258|NCT00877006|75851152|FG001|Treatment Period|Disease Progression|2|||
42043259|NCT00877006|75851151|FG000|Treatment Period|Started New Treatment Regimen|2|||
42043260|NCT00877006|75851152|FG001|Treatment Period|Started New Treatment Regimen|5|||
42043261|NCT00877006|75851151|FG000|Treatment Period|Other|4|||
42043262|NCT00877006|75851152|FG001|Treatment Period|Other|4|||
42043263|NCT00877006|75851151|FG000|Treatment Period|Randomized but Not Treated|3|||
42043264|NCT00877006|75851152|FG001|Treatment Period|Randomized but Not Treated|8|||
42043265|NCT00877006|75851151|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
42043266|NCT00877006|75851152|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
42043267|NCT00877006|75851151|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
42043268|NCT00877006|75851152|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
42043269|NCT00877006|75851151|FG000|Long-Term Follow-up Period|Death|26|||
42043270|NCT00877006|75851152|FG001|Long-Term Follow-up Period|Death|18|||
42043271|NCT00877006|75851151|FG000|Long-Term Follow-up Period|Other|7|||
42043272|NCT00877006|75851152|FG001|Long-Term Follow-up Period|Other|9|||
42043273|NCT00876928|75851162|FG000|Overall Study|Lost to Follow-up|2|||
42043274|NCT00876928|75851163|FG001|Overall Study|Lost to Follow-up|5|||
42043275|NCT00876928|75851162|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
42043276|NCT00876928|75851163|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
42043277|NCT00807937|75851173|FG000|Overall Study|Adverse Event|12|||
42043278|NCT00807937|75851174|FG001|Overall Study|Adverse Event|12|||
42043279|NCT00807937|75851175|FG002|Overall Study|Adverse Event|5|||
42043280|NCT00807937|75851176|FG003|Overall Study|Adverse Event|4|||
42043281|NCT00807937|75851173|FG000|Overall Study|Protocol Violation|4|||
42043282|NCT00807937|75851174|FG001|Overall Study|Protocol Violation|5|||
42043283|NCT00807937|75851175|FG002|Overall Study|Protocol Violation|3|||
42043284|NCT00807937|75851176|FG003|Overall Study|Protocol Violation|3|||
42043285|NCT00807937|75851173|FG000|Overall Study|Withdrawal by Subject|5|||
42043286|NCT00807937|75851174|FG001|Overall Study|Withdrawal by Subject|4|||
42043287|NCT00807937|75851175|FG002|Overall Study|Withdrawal by Subject|1|||
42043288|NCT00807937|75851176|FG003|Overall Study|Withdrawal by Subject|4|||
42043289|NCT00807937|75851173|FG000|Overall Study|Lost to Follow-up|4|||
42043290|NCT00807937|75851174|FG001|Overall Study|Lost to Follow-up|0|||
42043291|NCT00807937|75851175|FG002|Overall Study|Lost to Follow-up|2|||
42043292|NCT00807937|75851176|FG003|Overall Study|Lost to Follow-up|1|||
42043293|NCT00807937|75851173|FG000|Overall Study|Lack of Efficacy|0|||
42043294|NCT00807937|75851174|FG001|Overall Study|Lack of Efficacy|0|||
42043295|NCT00807937|75851175|FG002|Overall Study|Lack of Efficacy|1|||
42043296|NCT00807937|75851176|FG003|Overall Study|Lack of Efficacy|2|||
42043297|NCT00807937|75851173|FG000|Overall Study|Intake of prohibited medicine|0|||
42043298|NCT00807937|75851174|FG001|Overall Study|Intake of prohibited medicine|0|||
42043299|NCT00807937|75851175|FG002|Overall Study|Intake of prohibited medicine|2|||
42043300|NCT00807937|75851176|FG003|Overall Study|Intake of prohibited medicine|0|||
42043301|NCT00807937|75851173|FG000|Overall Study|All other reasons (not provided)|2|||
42043302|NCT00807937|75851174|FG001|Overall Study|All other reasons (not provided)|4|||
42043303|NCT00807937|75851175|FG002|Overall Study|All other reasons (not provided)|0|||
42043304|NCT00807937|75851176|FG003|Overall Study|All other reasons (not provided)|1|||
42043305|NCT00906945|75851191|FG000|Overall Study|Found to be not eligible|0|||
42043306|NCT00906945|75851192|FG001|Overall Study|Found to be not eligible|0|||
42043307|NCT00906945|75851193|FG002|Overall Study|Found to be not eligible|0|||
42043308|NCT00906945|75851194|FG003|Overall Study|Found to be not eligible|1|||
42043309|NCT00906945|75851195|FG004|Overall Study|Found to be not eligible|1|||
42043310|NCT00906945|75851196|FG005|Overall Study|Found to be not eligible|1|||
42043311|NCT00906945|75851191|FG000|Overall Study|Physician Decision|0|||
42043312|NCT00906945|75851192|FG001|Overall Study|Physician Decision|0|||
42043313|NCT00906945|75851193|FG002|Overall Study|Physician Decision|0|||
42043314|NCT00906945|75851194|FG003|Overall Study|Physician Decision|0|||
42043315|NCT00906945|75851195|FG004|Overall Study|Physician Decision|0|||
42043316|NCT00906945|75851196|FG005|Overall Study|Physician Decision|1|||
42043317|NCT00807235|75851214|FG000|Overall Study|Adverse Event|1|||
42043318|NCT00807235|75851215|FG001|Overall Study|Adverse Event|0|||
42291076|NCT01995838|76124854|FG005|Overall Study|Withdrawal by Subject|0|||
42291077|NCT01995838|76124855|FG006|Overall Study|Withdrawal by Subject|0|||
42291078|NCT01995838|76124849|FG000|Overall Study|Other|3|||
42291079|NCT01995838|76124850|FG001|Overall Study|Other|1|||
42291080|NCT01995838|76124851|FG002|Overall Study|Other|0|||
42291081|NCT01995838|76124852|FG003|Overall Study|Other|2|||
42291082|NCT01995838|76124853|FG004|Overall Study|Other|1|||
42016107|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
42016108|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
42016109|NCT01218516|75823217|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
42016110|NCT01218516|75823218|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
42016111|NCT01218516|75823219|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
42016112|NCT01218516|75823220|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
42016113|NCT00938431|75823233|FG000|Overall Study|Adverse Event|5|||
42016114|NCT00938431|75823234|FG001|Overall Study|Adverse Event|8|||
42016115|NCT00938431|75823235|FG002|Overall Study|Adverse Event|6|||
42016116|NCT00938431|75823233|FG000|Overall Study|Lack of Efficacy|0|||
42016117|NCT00938431|75823234|FG001|Overall Study|Lack of Efficacy|1|||
42016118|NCT00938431|75823235|FG002|Overall Study|Lack of Efficacy|0|||
42016119|NCT00938431|75823233|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
42016120|NCT00938431|75823234|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
42043319|NCT00876694|75851223|FG000|Overall Study|Adverse Event|10|||
42043320|NCT00876694|75851224|FG001|Overall Study|Adverse Event|7|||
42043321|NCT00876694|75851223|FG000|Overall Study|Subject withdrew consent|6|||
42043322|NCT00876694|75851224|FG001|Overall Study|Subject withdrew consent|4|||
42043323|NCT00876694|75851223|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
42291083|NCT01995838|76124854|FG005|Overall Study|Other|1|||
42291084|NCT01995838|76124855|FG006|Overall Study|Other|2|||
42356812|NCT01426113|76201991|FG001|Overall Study|Study Discontinued|1|||
42043324|NCT00876694|75851224|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42043325|NCT00876694|75851223|FG000|Overall Study|Abnormal test procedure result(s)|1|||
42043326|NCT00876694|75851224|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42043327|NCT00876694|75851223|FG000|Overall Study|Administrative problems|1|||
42043328|NCT00876694|75851224|FG001|Overall Study|Administrative problems|1|||
42043329|NCT00876694|75851223|FG000|Overall Study|Death|1|||
42043330|NCT00876694|75851224|FG001|Overall Study|Death|0|||
42043331|NCT00805441|75851232|FG000|Overall Study|Adverse Event|5|||
42043332|NCT00805441|75851233|FG001|Overall Study|Adverse Event|2|||
42043333|NCT00805441|75851232|FG000|Overall Study|Lack of Efficacy|0|||
42043334|NCT00805441|75851233|FG001|Overall Study|Lack of Efficacy|2|||
42043335|NCT00805441|75851232|FG000|Overall Study|Protocol Violation|4|||
42043336|NCT00805441|75851233|FG001|Overall Study|Protocol Violation|8|||
42043337|NCT00805441|75851232|FG000|Overall Study|Lost to Follow-up|10|||
42043338|NCT00805441|75851233|FG001|Overall Study|Lost to Follow-up|13|||
42043339|NCT00805441|75851232|FG000|Overall Study|Withdrawal by Subject|15|||
42043340|NCT00805441|75851233|FG001|Overall Study|Withdrawal by Subject|9|||
42043341|NCT00805441|75851232|FG000|Overall Study|Physician Decision|0|||
42043342|NCT00805441|75851233|FG001|Overall Study|Physician Decision|1|||
42043343|NCT00805441|75851232|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
42043344|NCT00805441|75851233|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
42043345|NCT00590317|75851241|FG000|Overall Study|Lack of Efficacy|1|||
42043346|NCT00590317|75851242|FG001|Overall Study|Lack of Efficacy|5|||
42043347|NCT01139762|75851251|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
42043348|NCT01139762|75851252|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
42043349|NCT01139762|75851253|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
42043350|NCT01139762|75851251|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
42043351|NCT01139762|75851252|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
42043352|NCT01139762|75851253|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
42043353|NCT01139762|75851251|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
42043354|NCT01139762|75851252|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
42043355|NCT01139762|75851253|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
42043356|NCT01139762|75851251|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
42043357|NCT01139762|75851252|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
42043358|NCT01139762|75851253|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
42043359|NCT01139762|75851251|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
42043360|NCT01139762|75851252|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
42043361|NCT01139762|75851253|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
42043362|NCT01139762|75851251|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
42043363|NCT01139762|75851252|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
42043364|NCT01139762|75851253|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
42043365|NCT01139762|75851251|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
42043366|NCT01139762|75851252|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
42043367|NCT01139762|75851253|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
42043368|NCT01139762|75851251|FG000|Double-Blind Randomized Active Treatment|Death|0|||
42043369|NCT01139762|75851252|FG001|Double-Blind Randomized Active Treatment|Death|1|||
42043370|NCT01139762|75851253|FG002|Double-Blind Randomized Active Treatment|Death|1|||
42043371|NCT01139762|75851251|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
42043372|NCT01139762|75851252|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
42043373|NCT01139762|75851253|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
42043374|NCT01139762|75851251|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
42043375|NCT01139762|75851252|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
42043376|NCT01139762|75851253|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
42043377|NCT01139762|75851251|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
42043378|NCT01139762|75851252|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
42043379|NCT01139762|75851253|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
42043380|NCT01139762|75851251|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
42043381|NCT01139762|75851252|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
42043382|NCT01139762|75851253|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
42043383|NCT01139762|75851251|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
42043384|NCT01139762|75851252|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
42043385|NCT01139762|75851253|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
42172467|NCT03828617|75979329|FG003|Overall Study|Protocol Violation|0|||
42043386|NCT01139762|75851251|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
42043387|NCT01139762|75851252|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
42043388|NCT01139762|75851253|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
42043389|NCT01139762|75851251|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
42043390|NCT01139762|75851252|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
42043391|NCT01139762|75851253|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
42043392|NCT00805285|75851260|FG000|Overall Study|Lack of Efficacy|1|||
42043393|NCT01139450|75851267|FG000|Overall Study|Withdrawal by Subject|7|||
42043394|NCT01139450|75851268|FG001|Overall Study|Withdrawal by Subject|10|||
42043395|NCT01139450|75851269|FG002|Overall Study|Withdrawal by Subject|13|||
42043396|NCT01139450|75851267|FG000|Overall Study|Lack of Efficacy|3|||
42043397|NCT01139450|75851268|FG001|Overall Study|Lack of Efficacy|1|||
42043398|NCT01139450|75851269|FG002|Overall Study|Lack of Efficacy|8|||
42043399|NCT01139450|75851267|FG000|Overall Study|Protocol Violation|6|||
42043400|NCT01139450|75851268|FG001|Overall Study|Protocol Violation|5|||
42043401|NCT01139450|75851269|FG002|Overall Study|Protocol Violation|2|||
42043402|NCT01139450|75851267|FG000|Overall Study|Lost to Follow-up|9|||
42043403|NCT01139450|75851268|FG001|Overall Study|Lost to Follow-up|7|||
42043404|NCT01139450|75851269|FG002|Overall Study|Lost to Follow-up|11|||
42043405|NCT01139450|75851267|FG000|Overall Study|Administrative|0|||
42043406|NCT01139450|75851268|FG001|Overall Study|Administrative|0|||
42043407|NCT01139450|75851269|FG002|Overall Study|Administrative|1|||
42043408|NCT01139450|75851267|FG000|Overall Study|Adverse Event|2|||
42043409|NCT01139450|75851268|FG001|Overall Study|Adverse Event|2|||
42043410|NCT01139450|75851269|FG002|Overall Study|Adverse Event|3|||
42043411|NCT00805207|75851286|FG000|Overall Study|Protocol Violation|0|||
42043412|NCT00805207|75851287|FG001|Overall Study|Protocol Violation|0|||
42043413|NCT00805207|75851288|FG002|Overall Study|Protocol Violation|1|||
42043414|NCT00805207|75851289|FG003|Overall Study|Protocol Violation|0|||
42043415|NCT00805207|75851290|FG004|Overall Study|Protocol Violation|0|||
42043416|NCT00805207|75851291|FG005|Overall Study|Protocol Violation|0|||
42043417|NCT00805207|75851292|FG006|Overall Study|Protocol Violation|0|||
42043418|NCT00805207|75851293|FG007|Overall Study|Protocol Violation|0|||
42043419|NCT00805207|75851294|FG008|Overall Study|Protocol Violation|0|||
42043420|NCT00805207|75851286|FG000|Overall Study|Physician Decision|0|||
42043421|NCT00805207|75851287|FG001|Overall Study|Physician Decision|1|||
42043422|NCT00805207|75851288|FG002|Overall Study|Physician Decision|0|||
42043423|NCT00805207|75851289|FG003|Overall Study|Physician Decision|0|||
42043424|NCT00805207|75851290|FG004|Overall Study|Physician Decision|0|||
42043425|NCT00805207|75851291|FG005|Overall Study|Physician Decision|1|||
42043426|NCT00805207|75851292|FG006|Overall Study|Physician Decision|0|||
42043427|NCT00805207|75851293|FG007|Overall Study|Physician Decision|0|||
42043428|NCT00805207|75851294|FG008|Overall Study|Physician Decision|0|||
42043429|NCT00805207|75851286|FG000|Overall Study|Withdrawal by Subject|0|||
42043430|NCT00805207|75851287|FG001|Overall Study|Withdrawal by Subject|1|||
42043431|NCT00805207|75851288|FG002|Overall Study|Withdrawal by Subject|0|||
42043432|NCT00805207|75851289|FG003|Overall Study|Withdrawal by Subject|0|||
42043433|NCT00805207|75851290|FG004|Overall Study|Withdrawal by Subject|1|||
42356813|NCT01426113|76201990|FG000|Overall Study|Adverse Event|0|||
42043434|NCT00805207|75851291|FG005|Overall Study|Withdrawal by Subject|2|||
42043435|NCT00805207|75851292|FG006|Overall Study|Withdrawal by Subject|0|||
42043436|NCT00805207|75851293|FG007|Overall Study|Withdrawal by Subject|0|||
42043437|NCT00805207|75851294|FG008|Overall Study|Withdrawal by Subject|0|||
42043438|NCT00805675|75851321|FG000|Overall Study|Adverse Event|0|||
42043439|NCT00805675|75851322|FG001|Overall Study|Adverse Event|0|||
42043440|NCT00805675|75851323|FG002|Overall Study|Adverse Event|1|||
42043441|NCT00589303|75851337|FG000|Overall Study|Withdrawal by Subject|2|||
42043442|NCT00589303|75851338|FG001|Overall Study|Withdrawal by Subject|1|||
42043443|NCT00952380|75851349|FG000|Overall Study|Other|0|||
42043444|NCT00952380|75851350|FG001|Overall Study|Other|0|||
42043445|NCT00952380|75851351|FG002|Overall Study|Other|0|||
42043446|NCT00952380|75851352|FG003|Overall Study|Other|0|||
42043447|NCT00952380|75851353|FG004|Overall Study|Other|1|||
42043448|NCT00952380|75851349|FG000|Overall Study|Withdrawal by Subject|0|||
42043449|NCT00952380|75851350|FG001|Overall Study|Withdrawal by Subject|0|||
42043450|NCT00952380|75851351|FG002|Overall Study|Withdrawal by Subject|1|||
42043451|NCT00952380|75851352|FG003|Overall Study|Withdrawal by Subject|0|||
42043452|NCT00952380|75851353|FG004|Overall Study|Withdrawal by Subject|2|||
42043453|NCT00952380|75851349|FG000|Overall Study|Adverse Event|0|||
42043454|NCT00952380|75851350|FG001|Overall Study|Adverse Event|1|||
42043455|NCT00952380|75851351|FG002|Overall Study|Adverse Event|0|||
42043456|NCT00952380|75851352|FG003|Overall Study|Adverse Event|0|||
42043457|NCT00952380|75851353|FG004|Overall Study|Adverse Event|3|||
42043458|NCT00952380|75851349|FG000|Overall Study|Physician Decision|0|||
42043459|NCT00952380|75851350|FG001|Overall Study|Physician Decision|0|||
42043460|NCT00952380|75851351|FG002|Overall Study|Physician Decision|1|||
42043461|NCT00952380|75851352|FG003|Overall Study|Physician Decision|2|||
42043462|NCT00952380|75851353|FG004|Overall Study|Physician Decision|0|||
42043463|NCT00952380|75851349|FG000|Overall Study|Non-compliant to protocol|0|||
42043464|NCT00952380|75851350|FG001|Overall Study|Non-compliant to protocol|0|||
42043465|NCT00952380|75851351|FG002|Overall Study|Non-compliant to protocol|0|||
42043466|NCT00952380|75851352|FG003|Overall Study|Non-compliant to protocol|1|||
42043467|NCT00952380|75851353|FG004|Overall Study|Non-compliant to protocol|0|||
42043468|NCT00803179|75851370|FG000|Overall Study|Lost to Follow-up|3|||
42043469|NCT00804193|75851377|FG000|Overall Study|Lack of baseline fungus|32|||
42043470|NCT00804193|75851378|FG001|Overall Study|Lack of baseline fungus|31|||
42043471|NCT00804193|75851379|FG002|Overall Study|Lack of baseline fungus|19|||
42043472|NCT00804193|75851377|FG000|Overall Study|Adverse Event|0|||
42043473|NCT00804193|75851378|FG001|Overall Study|Adverse Event|0|||
42043474|NCT00804193|75851379|FG002|Overall Study|Adverse Event|2|||
42043475|NCT00804193|75851377|FG000|Overall Study|Lack of Efficacy|1|||
42043476|NCT00804193|75851378|FG001|Overall Study|Lack of Efficacy|1|||
42043477|NCT00804193|75851379|FG002|Overall Study|Lack of Efficacy|3|||
42043478|NCT00804193|75851377|FG000|Overall Study|Protocol Violation|0|||
42043479|NCT00804193|75851378|FG001|Overall Study|Protocol Violation|8|||
42043480|NCT00804193|75851379|FG002|Overall Study|Protocol Violation|2|||
42043481|NCT00804193|75851377|FG000|Overall Study|Lost to Follow-up|3|||
42043482|NCT00804193|75851378|FG001|Overall Study|Lost to Follow-up|3|||
42043483|NCT00804193|75851379|FG002|Overall Study|Lost to Follow-up|4|||
42043484|NCT00804193|75851377|FG000|Overall Study|Withdrawal by Subject|3|||
42043485|NCT00804193|75851378|FG001|Overall Study|Withdrawal by Subject|1|||
42043486|NCT00804193|75851379|FG002|Overall Study|Withdrawal by Subject|2|||
42043487|NCT00957996|75851389|FG000|Overall Study|Death|4|||
42043488|NCT00957996|75851390|FG001|Overall Study|Death|10|||
42043489|NCT00957996|75851389|FG000|Overall Study|Lost to Follow-up|4|||
42043490|NCT00957996|75851390|FG001|Overall Study|Lost to Follow-up|7|||
42043491|NCT00957996|75851389|FG000|Overall Study|Withdrawal by Subject|9|||
42043492|NCT00957996|75851390|FG001|Overall Study|Withdrawal by Subject|2|||
42043493|NCT00957996|75851389|FG000|Overall Study|Adverse Event|2|||
42043494|NCT00957996|75851390|FG001|Overall Study|Adverse Event|1|||
42043495|NCT00957996|75851389|FG000|Overall Study|Physician Decision|1|||
42043496|NCT00957996|75851390|FG001|Overall Study|Physician Decision|1|||
42043497|NCT00957996|75851389|FG000|Overall Study|Influenza-related complication|0|||
42043498|NCT00957996|75851390|FG001|Overall Study|Influenza-related complication|1|||
42043499|NCT00957996|75851389|FG000|Overall Study|Missing|1|||
42043500|NCT00957996|75851390|FG001|Overall Study|Missing|0|||
42043501|NCT00957996|75851389|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
42043502|NCT00957996|75851390|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
42043503|NCT00589693|75851400|FG000|Overall Study|randomized in error|12|||
42043504|NCT00589693|75851401|FG001|Overall Study|randomized in error|6|||
42043505|NCT00589693|75851400|FG000|Overall Study|Adverse Event|4|||
42043506|NCT00589693|75851401|FG001|Overall Study|Adverse Event|4|||
42043507|NCT00589693|75851400|FG000|Overall Study|Death|26|||
42043508|NCT00589693|75851401|FG001|Overall Study|Death|16|||
42043509|NCT00589693|75851400|FG000|Overall Study|Lack of Efficacy|0|||
42043510|NCT00589693|75851401|FG001|Overall Study|Lack of Efficacy|1|||
42043511|NCT00589693|75851400|FG000|Overall Study|Lost to Follow-up|1|||
42043512|NCT00589693|75851401|FG001|Overall Study|Lost to Follow-up|0|||
42043513|NCT00589693|75851400|FG000|Overall Study|Physician Decision|0|||
42043514|NCT00589693|75851401|FG001|Overall Study|Physician Decision|1|||
42043515|NCT00589693|75851400|FG000|Overall Study|Protocol Violation|1|||
42043516|NCT00589693|75851401|FG001|Overall Study|Protocol Violation|1|||
42043517|NCT00803101|75851409|FG000|Overall Study|Death / Serious Adverse Event|4|||
42043518|NCT00803101|75851410|FG001|Overall Study|Death / Serious Adverse Event|6|||
42356814|NCT01426113|76201991|FG001|Overall Study|Adverse Event|1|||
42043519|NCT00803101|75851409|FG000|Overall Study|Withdrawal by Subject|6|||
42043520|NCT00803101|75851410|FG001|Overall Study|Withdrawal by Subject|4|||
42043521|NCT00803101|75851409|FG000|Overall Study|Lost to Follow-up|2|||
42043522|NCT00803101|75851410|FG001|Overall Study|Lost to Follow-up|2|||
42043523|NCT00803101|75851409|FG000|Overall Study|Protocol Violation|1|||
42043524|NCT00803101|75851410|FG001|Overall Study|Protocol Violation|7|||
42043525|NCT00803101|75851409|FG000|Overall Study|Surgery finished outside protocol window|1|||
42043526|NCT00803101|75851410|FG001|Overall Study|Surgery finished outside protocol window|1|||
42043527|NCT00803101|75851409|FG000|Overall Study|Patient died outside SAE report period|1|||
42043528|NCT00803101|75851410|FG001|Overall Study|Patient died outside SAE report period|0|||
42043529|NCT00803101|75851409|FG000|Overall Study|Patient did not attend scheduled visit|2|||
42043530|NCT00803101|75851410|FG001|Overall Study|Patient did not attend scheduled visit|1|||
42043531|NCT00803101|75851409|FG000|Overall Study|Patient did not have surgery|1|||
42043532|NCT00803101|75851410|FG001|Overall Study|Patient did not have surgery|1|||
42043533|NCT00801229|75851418|FG000|Signed Consent|Withdrawal by Subject|2|||
42043534|NCT00801229|75851419|FG001|Signed Consent|Withdrawal by Subject|2|||
42043535|NCT00801229|75851418|FG000|Signed Consent|Found Ineligible|1|||
42043536|NCT00801229|75851419|FG001|Signed Consent|Found Ineligible|1|||
42043537|NCT00801229|75851418|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
42043538|NCT00801229|75851419|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
42043539|NCT00801229|75851418|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
42043540|NCT00801229|75851419|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
42043541|NCT00801229|75851418|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
42043542|NCT00801229|75851419|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
42043543|NCT00801229|75851418|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
42043544|NCT00801229|75851419|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
42043545|NCT00801229|75851418|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
42043546|NCT00801229|75851419|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
42043547|NCT00801229|75851418|FG000|Received Study Drug/Placebo|Adverse Event|1|||
42043548|NCT00801229|75851419|FG001|Received Study Drug/Placebo|Adverse Event|1|||
42043549|NCT00948246|75851425|FG000|Overall Study|Lost to Follow-up|11|||
42043550|NCT00948246|75851425|FG000|Overall Study|Adverse Event|11|||
42043551|NCT00948246|75851425|FG000|Overall Study|Death|1|||
42043552|NCT00948246|75851425|FG000|Overall Study|Withdrawal by Subject|1|||
42043553|NCT00800683|75851431|FG000|Overall Study|Adverse Event|11|||
42043554|NCT00800683|75851432|FG001|Overall Study|Adverse Event|8|||
42043555|NCT00800683|75851431|FG000|Overall Study|Lost to Follow-up|3|||
42172468|NCT03828617|75979326|FG000|Overall Study|Withdrawal by Subject|2|||
42172469|NCT03828617|75979327|FG001|Overall Study|Withdrawal by Subject|0|||
42172470|NCT03828617|75979328|FG002|Overall Study|Withdrawal by Subject|2|||
42172471|NCT03828617|75979329|FG003|Overall Study|Withdrawal by Subject|0|||
42172472|NCT03391960|75979338|FG000|Overall Study|Protocol Violation|0|||
42172473|NCT03391960|75979339|FG001|Overall Study|Protocol Violation||||
42172474|NCT03390166|75979365|FG000|Overall Study|Death|0|||
42172475|NCT03390166|75979366|FG001|Overall Study|Death|1|||
42172476|NCT03390166|75979365|FG000|Overall Study|Lost to Follow-up|6|||
42172477|NCT03390166|75979366|FG001|Overall Study|Lost to Follow-up|4|||
42172478|NCT03390166|75979365|FG000|Overall Study|Physician Decision|2|||
42172479|NCT03390166|75979366|FG001|Overall Study|Physician Decision|1|||
42172480|NCT03390166|75979365|FG000|Overall Study|Move from study area|3|||
42172481|NCT03390166|75979366|FG001|Overall Study|Move from study area|2|||
42172482|NCT03390166|75979365|FG000|Overall Study|To militarycamp for conscript|1|||
42172483|NCT03390166|75979366|FG001|Overall Study|To militarycamp for conscript|0|||
42172484|NCT03390166|75979365|FG000|Overall Study|To drug therapy course|0|||
42043556|NCT00800683|75851432|FG001|Overall Study|Lost to Follow-up|1|||
42043557|NCT00800683|75851431|FG000|Overall Study|Withdrawal by Subject|1|||
42043558|NCT00800683|75851432|FG001|Overall Study|Withdrawal by Subject|7|||
42043559|NCT00800683|75851431|FG000|Overall Study|Lack of Efficacy|1|||
42043560|NCT00800683|75851432|FG001|Overall Study|Lack of Efficacy|1|||
42043561|NCT00800683|75851431|FG000|Overall Study|Other|1|||
42172485|NCT03390166|75979366|FG001|Overall Study|To drug therapy course|1|||
42172486|NCT03390166|75979365|FG000|Overall Study|Move to work oversea|0|||
42356815|NCT01864603|76201999|FG000|Stage 2|DSMB design modification|86056|||
42356816|NCT01864603|76202000|FG001|Stage 2|DSMB design modification|92558|||
42043562|NCT00800683|75851432|FG001|Overall Study|Other|2|||
42043563|NCT01124864|75851444|FG000|Overall Study|Follow up phase competed as per protocol|18|||
42043564|NCT01124864|75851445|FG001|Overall Study|Follow up phase competed as per protocol|22|||
42043565|NCT01124864|75851446|FG002|Overall Study|Follow up phase competed as per protocol|24|||
42043566|NCT01124864|75851447|FG003|Overall Study|Follow up phase competed as per protocol|18|||
42172487|NCT03390166|75979366|FG001|Overall Study|Move to work oversea|1|||
42172488|NCT03828539|75979374|FG000|Overall Study|Adverse Event|3|||
42172489|NCT03828539|75979375|FG001|Overall Study|Adverse Event|12|||
42043567|NCT01124864|75851448|FG004|Overall Study|Follow up phase competed as per protocol|26|||
42043568|NCT01124864|75851449|FG005|Overall Study|Follow up phase competed as per protocol|2|||
42043569|NCT01124864|75851444|FG000|Overall Study|Death|6|||
42043570|NCT01124864|75851445|FG001|Overall Study|Death|9|||
42043571|NCT01124864|75851446|FG002|Overall Study|Death|6|||
42043572|NCT01124864|75851447|FG003|Overall Study|Death|2|||
42043573|NCT01124864|75851448|FG004|Overall Study|Death|1|||
42043574|NCT01124864|75851449|FG005|Overall Study|Death|0|||
42043575|NCT01124864|75851444|FG000|Overall Study|Withdrawal by Subject|2|||
42043576|NCT01124864|75851445|FG001|Overall Study|Withdrawal by Subject|3|||
42043577|NCT01124864|75851446|FG002|Overall Study|Withdrawal by Subject|4|||
42043578|NCT01124864|75851447|FG003|Overall Study|Withdrawal by Subject|0|||
42043579|NCT01124864|75851448|FG004|Overall Study|Withdrawal by Subject|2|||
42043580|NCT01124864|75851449|FG005|Overall Study|Withdrawal by Subject|1|||
42043581|NCT01124864|75851444|FG000|Overall Study|Lost to Follow-up|1|||
42043582|NCT01124864|75851445|FG001|Overall Study|Lost to Follow-up|1|||
42043583|NCT01124864|75851446|FG002|Overall Study|Lost to Follow-up|0|||
42043584|NCT01124864|75851447|FG003|Overall Study|Lost to Follow-up|1|||
42043585|NCT01124864|75851448|FG004|Overall Study|Lost to Follow-up|0|||
42043586|NCT01124864|75851449|FG005|Overall Study|Lost to Follow-up|0|||
42043587|NCT01124864|75851444|FG000|Overall Study|Protocol Violation|1|||
42043588|NCT01124864|75851445|FG001|Overall Study|Protocol Violation|0|||
42172490|NCT03828539|75979374|FG000|Overall Study|Patient's/guardian's decision|3|||
42172491|NCT03828539|75979375|FG001|Overall Study|Patient's/guardian's decision|5|||
42172492|NCT03828539|75979374|FG000|Overall Study|Lost to Follow-up|4|||
42172493|NCT03828539|75979375|FG001|Overall Study|Lost to Follow-up|2|||
42356817|NCT01892293|76202011|FG000|Overall Study|Apheresed but not treated|4|||
42356818|NCT01393899|76202018|FG000|Overall Study|Study terminated by sponsor|1|||
42356819|NCT01393899|76202019|FG001|Overall Study|Study terminated by sponsor|0|||
42043589|NCT01124864|75851446|FG002|Overall Study|Protocol Violation|0|||
42043590|NCT01124864|75851447|FG003|Overall Study|Protocol Violation|0|||
42043591|NCT01124864|75851448|FG004|Overall Study|Protocol Violation|1|||
42043592|NCT01124864|75851449|FG005|Overall Study|Protocol Violation|0|||
42043593|NCT01113710|75851465|FG000|Overall Study|Adverse Event|64|||
42043594|NCT01113710|75851465|FG000|Overall Study|Lack of Efficacy|41|||
42043595|NCT01113710|75851465|FG000|Overall Study|No Information Available|40|||
42043596|NCT01113710|75851465|FG000|Overall Study|Withdrawal by Subject|28|||
42043597|NCT01113710|75851465|FG000|Overall Study|Lost to Follow-up|20|||
42043598|NCT01113710|75851465|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
42043599|NCT01113710|75851465|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
42043600|NCT01113710|75851465|FG000|Overall Study|Lack of Patient's Compliance|8|||
42043601|NCT01113710|75851465|FG000|Overall Study|Other|7|||
42043602|NCT01113710|75851465|FG000|Overall Study|Adverse Event/Other|5|||
42043603|NCT01113710|75851465|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
42043604|NCT01113710|75851465|FG000|Overall Study|Lack of Efficacy/Other|4|||
42043605|NCT01113710|75851465|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
42043606|NCT01113710|75851465|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
42043607|NCT01113710|75851465|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
42043608|NCT01113710|75851465|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
42043609|NCT01113710|75851465|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
42043610|NCT01113710|75851465|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
42043611|NCT01113710|75851465|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
42043612|NCT01113710|75851465|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
42043613|NCT01113710|75851465|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
42043614|NCT01113710|75851465|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
42043615|NCT01113710|75851465|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
42043616|NCT01113710|75851465|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
42043617|NCT01113710|75851465|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
42172494|NCT03828539|75979374|FG000|Overall Study|Protocol Violation|3|||
42172495|NCT03828539|75979375|FG001|Overall Study|Protocol Violation|2|||
42016121|NCT00938431|75823235|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
42016122|NCT00938431|75823233|FG000|Overall Study|Dosing compliance issue|0|||
42016123|NCT00938431|75823234|FG001|Overall Study|Dosing compliance issue|0|||
42016124|NCT00938431|75823235|FG002|Overall Study|Dosing compliance issue|1|||
42016125|NCT00938431|75823233|FG000|Overall Study|Reached maximum dose early|0|||
42016126|NCT00938431|75823234|FG001|Overall Study|Reached maximum dose early|0|||
42016127|NCT00938431|75823235|FG002|Overall Study|Reached maximum dose early|1|||
42016128|NCT01136811|75823247|FG000|Overall Study|Physician Decision|11|||
42016129|NCT00949117|75823253|FG000|Overall Study|Lack of Efficacy|2|||
42016130|NCT00949117|75823254|FG001|Overall Study|Lack of Efficacy|3|||
42016131|NCT00949117|75823253|FG000|Overall Study|Protocol Violation|1|||
42016132|NCT00949117|75823254|FG001|Overall Study|Protocol Violation|1|||
42016133|NCT00949117|75823253|FG000|Overall Study|Adverse Event|0|||
42356820|NCT01393899|76202020|FG002|Overall Study|Study terminated by sponsor|1|||
42016134|NCT00949117|75823254|FG001|Overall Study|Adverse Event|1|||
42016135|NCT00938041|75823262|FG000|Overall Study|Lost to Follow-up|6|||
42043618|NCT01124162|75851471|FG000|First Intervention|Adverse Event|2|||
42043619|NCT01124162|75851472|FG001|First Intervention|Adverse Event|0|||
42043620|NCT01124162|75851471|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
42043621|NCT01124162|75851472|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
42043622|NCT00906399|75851481|FG000|Year 1|Randomized But Not Treated|0|||
42043623|NCT00906399|75851482|FG001|Year 1|Randomized But Not Treated|1|||
42043624|NCT00906399|75851483|FG002|Year 1|Randomized But Not Treated|3|||
42043625|NCT00906399|75851484|FG003|Year 1|Randomized But Not Treated|0|||
42043626|NCT00906399|75851485|FG004|Year 1|Randomized But Not Treated|0|||
42043627|NCT00906399|75851486|FG005|Year 1|Randomized But Not Treated|0|||
42043628|NCT00906399|75851487|FG006|Year 1|Randomized But Not Treated|0|||
42043629|NCT00906399|75851481|FG000|Year 1|Adverse Event|4|||
42043630|NCT00906399|75851482|FG001|Year 1|Adverse Event|22|||
42043631|NCT00906399|75851483|FG002|Year 1|Adverse Event|24|||
42043632|NCT00906399|75851484|FG003|Year 1|Adverse Event|0|||
42043633|NCT00906399|75851485|FG004|Year 1|Adverse Event|0|||
42043634|NCT00906399|75851486|FG005|Year 1|Adverse Event|0|||
42043635|NCT00906399|75851487|FG006|Year 1|Adverse Event|0|||
42043636|NCT00906399|75851481|FG000|Year 1|Lost to Follow-up|4|||
42043637|NCT00906399|75851482|FG001|Year 1|Lost to Follow-up|4|||
42043638|NCT00906399|75851483|FG002|Year 1|Lost to Follow-up|2|||
42043639|NCT00906399|75851484|FG003|Year 1|Lost to Follow-up|0|||
42043640|NCT00906399|75851485|FG004|Year 1|Lost to Follow-up|0|||
42043641|NCT00906399|75851486|FG005|Year 1|Lost to Follow-up|0|||
42043642|NCT00906399|75851487|FG006|Year 1|Lost to Follow-up|0|||
42043643|NCT00906399|75851481|FG000|Year 1|Withdrawal by Subject|30|||
42043644|NCT00906399|75851482|FG001|Year 1|Withdrawal by Subject|32|||
42043645|NCT00906399|75851483|FG002|Year 1|Withdrawal by Subject|36|||
42043646|NCT00906399|75851484|FG003|Year 1|Withdrawal by Subject|0|||
42043647|NCT00906399|75851485|FG004|Year 1|Withdrawal by Subject|0|||
42043648|NCT00906399|75851486|FG005|Year 1|Withdrawal by Subject|0|||
42043649|NCT00906399|75851487|FG006|Year 1|Withdrawal by Subject|0|||
42043650|NCT00906399|75851481|FG000|Year 1|Physician Decision|0|||
42043651|NCT00906399|75851482|FG001|Year 1|Physician Decision|1|||
42043652|NCT00906399|75851483|FG002|Year 1|Physician Decision|3|||
42043653|NCT00906399|75851484|FG003|Year 1|Physician Decision|0|||
42043654|NCT00906399|75851485|FG004|Year 1|Physician Decision|0|||
42043655|NCT00906399|75851486|FG005|Year 1|Physician Decision|0|||
42043656|NCT00906399|75851487|FG006|Year 1|Physician Decision|0|||
42043657|NCT00906399|75851481|FG000|Year 1|Death|2|||
42043658|NCT00906399|75851482|FG001|Year 1|Death|1|||
42043659|NCT00906399|75851483|FG002|Year 1|Death|1|||
42043660|NCT00906399|75851484|FG003|Year 1|Death|0|||
42043661|NCT00906399|75851485|FG004|Year 1|Death|0|||
42043662|NCT00906399|75851486|FG005|Year 1|Death|0|||
42043663|NCT00906399|75851487|FG006|Year 1|Death|0|||
42043664|NCT00906399|75851481|FG000|Year 1|Other|4|||
42043665|NCT00906399|75851482|FG001|Year 1|Other|2|||
42043666|NCT00906399|75851483|FG002|Year 1|Other|7|||
42043667|NCT00906399|75851484|FG003|Year 1|Other|0|||
42043668|NCT00906399|75851485|FG004|Year 1|Other|0|||
42043669|NCT00906399|75851486|FG005|Year 1|Other|0|||
42043670|NCT00906399|75851487|FG006|Year 1|Other|0|||
42043671|NCT00906399|75851481|FG000|Year 2|Adverse Event|0|||
42043672|NCT00906399|75851482|FG001|Year 2|Adverse Event|0|||
42043673|NCT00906399|75851483|FG002|Year 2|Adverse Event|0|||
42043674|NCT00906399|75851484|FG003|Year 2|Adverse Event|9|||
42043675|NCT00906399|75851485|FG004|Year 2|Adverse Event|8|||
42043676|NCT00906399|75851486|FG005|Year 2|Adverse Event|11|||
42043677|NCT00906399|75851487|FG006|Year 2|Adverse Event|6|||
42043678|NCT00906399|75851481|FG000|Year 2|Lost to Follow-up|0|||
42043679|NCT00906399|75851482|FG001|Year 2|Lost to Follow-up|0|||
42043680|NCT00906399|75851483|FG002|Year 2|Lost to Follow-up|0|||
42043681|NCT00906399|75851484|FG003|Year 2|Lost to Follow-up|1|||
42043682|NCT00906399|75851485|FG004|Year 2|Lost to Follow-up|4|||
42043683|NCT00906399|75851486|FG005|Year 2|Lost to Follow-up|2|||
42043684|NCT00906399|75851487|FG006|Year 2|Lost to Follow-up|4|||
42043685|NCT00906399|75851481|FG000|Year 2|Withdrawal by Subject|0|||
42043686|NCT00906399|75851482|FG001|Year 2|Withdrawal by Subject|0|||
42043687|NCT00906399|75851483|FG002|Year 2|Withdrawal by Subject|0|||
42043688|NCT00906399|75851484|FG003|Year 2|Withdrawal by Subject|17|||
42043689|NCT00906399|75851485|FG004|Year 2|Withdrawal by Subject|18|||
42043690|NCT00906399|75851486|FG005|Year 2|Withdrawal by Subject|27|||
42043691|NCT00906399|75851487|FG006|Year 2|Withdrawal by Subject|13|||
42043692|NCT00906399|75851481|FG000|Year 2|Physician Decision|0|||
42043693|NCT00906399|75851482|FG001|Year 2|Physician Decision|0|||
42043694|NCT00906399|75851483|FG002|Year 2|Physician Decision|0|||
42043695|NCT00906399|75851484|FG003|Year 2|Physician Decision|0|||
42043696|NCT00906399|75851485|FG004|Year 2|Physician Decision|2|||
42043697|NCT00906399|75851486|FG005|Year 2|Physician Decision|6|||
42043698|NCT00906399|75851487|FG006|Year 2|Physician Decision|3|||
42043699|NCT00906399|75851481|FG000|Year 2|Death|0|||
42043700|NCT00906399|75851482|FG001|Year 2|Death|0|||
42043701|NCT00906399|75851483|FG002|Year 2|Death|0|||
42043702|NCT00906399|75851484|FG003|Year 2|Death|1|||
42043703|NCT00906399|75851485|FG004|Year 2|Death|0|||
42043704|NCT00906399|75851486|FG005|Year 2|Death|0|||
42043705|NCT00906399|75851487|FG006|Year 2|Death|3|||
42043706|NCT00906399|75851481|FG000|Year 2|Other|0|||
42043707|NCT00906399|75851482|FG001|Year 2|Other|0|||
42043708|NCT00906399|75851483|FG002|Year 2|Other|0|||
42043709|NCT00906399|75851484|FG003|Year 2|Other|2|||
42043710|NCT00906399|75851485|FG004|Year 2|Other|3|||
42043711|NCT00906399|75851486|FG005|Year 2|Other|1|||
42043712|NCT00906399|75851487|FG006|Year 2|Other|0|||
42043713|NCT01111838|75851499|FG000|Overall Study|Patient Ineligible|2|||
42043714|NCT01111838|75851499|FG000|Overall Study|Not Treated|3|||
42043715|NCT01111838|75851499|FG000|Overall Study|Clinical deterioration|1|||
42043716|NCT01111838|75851499|FG000|Overall Study|Other Complicating Disease|1|||
42043717|NCT00947856|75851505|FG000|Treatment Period|Progressive Disease|33|||
42043718|NCT00947856|75851506|FG001|Treatment Period|Progressive Disease|12|||
42043719|NCT00947856|75851505|FG000|Treatment Period|Adverse Event|15|||
42043720|NCT00947856|75851506|FG001|Treatment Period|Adverse Event|9|||
42043721|NCT00947856|75851505|FG000|Treatment Period|Physician Decision|14|||
42043722|NCT00947856|75851506|FG001|Treatment Period|Physician Decision|6|||
42043723|NCT00947856|75851505|FG000|Treatment Period|Study Stopped by Sponsor|4|||
42043724|NCT00947856|75851506|FG001|Treatment Period|Study Stopped by Sponsor|4|||
42043725|NCT00947856|75851505|FG000|Treatment Period|Withdrawal by Subject|12|||
42043726|NCT00947856|75851506|FG001|Treatment Period|Withdrawal by Subject|1|||
42043727|NCT00947856|75851505|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
42043728|NCT00947856|75851506|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
42043729|NCT00947856|75851505|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
42043730|NCT00947856|75851506|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
42043731|NCT00947856|75851505|FG000|Follow-up Period|Lost to Follow-up|7|||
42043732|NCT00947856|75851506|FG001|Follow-up Period|Lost to Follow-up|0|||
42043733|NCT00947856|75851505|FG000|Follow-up Period|Patient unavailable for site visits|1|||
42043734|NCT00947856|75851506|FG001|Follow-up Period|Patient unavailable for site visits|0|||
42043735|NCT00947856|75851505|FG000|Follow-up Period|Withdrawal by Subject|1|||
42043736|NCT00947856|75851506|FG001|Follow-up Period|Withdrawal by Subject|0|||
42043737|NCT00947544|75851521|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
42043738|NCT00947544|75851522|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
42043739|NCT00907335|75851534|FG000|Overall Study|Withdrawal by Subject|2|||
42043740|NCT00907335|75851535|FG001|Overall Study|Withdrawal by Subject|0|||
42043741|NCT00907335|75851534|FG000|Overall Study|Adverse Event|4|||
42043742|NCT00907335|75851535|FG001|Overall Study|Adverse Event|1|||
42043743|NCT00907335|75851534|FG000|Overall Study|Lost to Follow-up|2|||
42043744|NCT00907335|75851535|FG001|Overall Study|Lost to Follow-up|0|||
42043745|NCT00947154|75851541|FG000|Overall Study|Lost to Follow-up|1|||
42043746|NCT01124006|75851549|FG000|Overall Study|Withdrawal by Subject|2|||
42043747|NCT01124006|75851550|FG001|Overall Study|Withdrawal by Subject|2|||
42043748|NCT01124006|75851551|FG002|Overall Study|Withdrawal by Subject|0|||
42043749|NCT01124006|75851549|FG000|Overall Study|Lost to Follow-up|1|||
42043750|NCT01124006|75851550|FG001|Overall Study|Lost to Follow-up|0|||
42043751|NCT01124006|75851551|FG002|Overall Study|Lost to Follow-up|1|||
42043752|NCT01124006|75851549|FG000|Overall Study|Other|0|||
42043753|NCT01124006|75851550|FG001|Overall Study|Other|0|||
42043754|NCT01124006|75851551|FG002|Overall Study|Other|1|||
42043755|NCT00952068|75851559|FG000|Overall Study|Adverse Event|3|||
42043756|NCT00952068|75851559|FG000|Overall Study|Withdrawal by Subject|4|||
42043757|NCT01123850|75851563|FG000|Overall Study|Slow enrollment|45|||
42043758|NCT01123382|75851569|FG000|Overall Study|Withdrawal by Subject|1|||
42043759|NCT01123382|75851570|FG001|Overall Study|Withdrawal by Subject|4|||
42043760|NCT01123382|75851569|FG000|Overall Study|Lost to Follow-up|1|||
42043761|NCT01123382|75851570|FG001|Overall Study|Lost to Follow-up|2|||
42043762|NCT00951912|75851579|FG000|Overall Study|Lack of Efficacy|1|||
42043763|NCT00951912|75851580|FG001|Overall Study|Lack of Efficacy|0|||
42172496|NCT03828539|75979374|FG000|Overall Study|Withdrawal of informed consent|2|||
42043764|NCT00951912|75851581|FG002|Overall Study|Lack of Efficacy|0|||
42043765|NCT00951912|75851579|FG000|Overall Study|Adverse Event|0|||
42043766|NCT00951912|75851580|FG001|Overall Study|Adverse Event|1|||
42043767|NCT00951912|75851581|FG002|Overall Study|Adverse Event|1|||
42043768|NCT00951912|75851579|FG000|Overall Study|Lost to Follow-up|2|||
42043769|NCT00951912|75851580|FG001|Overall Study|Lost to Follow-up|2|||
42043770|NCT00951912|75851581|FG002|Overall Study|Lost to Follow-up|0|||
42043771|NCT00951912|75851579|FG000|Overall Study|Physician Decision|1|||
42043772|NCT00951912|75851580|FG001|Overall Study|Physician Decision|0|||
42043773|NCT00951912|75851581|FG002|Overall Study|Physician Decision|1|||
42043774|NCT00951912|75851579|FG000|Overall Study|Withdrawal by Subject|1|||
42043775|NCT00951912|75851580|FG001|Overall Study|Withdrawal by Subject|1|||
42043776|NCT00951912|75851581|FG002|Overall Study|Withdrawal by Subject|0|||
42043777|NCT00951912|75851579|FG000|Overall Study|Other:Depression|1|||
42043778|NCT00951912|75851580|FG001|Overall Study|Other:Depression|0|||
42043779|NCT00951912|75851581|FG002|Overall Study|Other:Depression|0|||
42043780|NCT00951912|75851579|FG000|Overall Study|Other: Colon cancer|1|||
42043781|NCT00951912|75851580|FG001|Overall Study|Other: Colon cancer|0|||
42043782|NCT00951912|75851581|FG002|Overall Study|Other: Colon cancer|0|||
42043783|NCT00951912|75851579|FG000|Overall Study|Other: Stroke|0|||
42043784|NCT00951912|75851580|FG001|Overall Study|Other: Stroke|1|||
42043785|NCT00951912|75851581|FG002|Overall Study|Other: Stroke|0|||
42043786|NCT01123148|75851589|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
42043787|NCT01123148|75851589|FG000|Overall Study|Didn't meet milestone criteria|1|||
42043788|NCT01123070|75851597|FG000|Part B Double Blind Period|Protocol Violation|0|||
42043789|NCT01123070|75851598|FG001|Part B Double Blind Period|Protocol Violation|0|||
42043790|NCT01123070|75851599|FG002|Part B Double Blind Period|Protocol Violation|0|||
42043791|NCT01123070|75851600|FG003|Part B Double Blind Period|Protocol Violation|1|||
42043792|NCT01123070|75851597|FG000|Part B Double Blind Period|Adverse Event|0|||
42043793|NCT01123070|75851598|FG001|Part B Double Blind Period|Adverse Event|0|||
42043794|NCT01123070|75851599|FG002|Part B Double Blind Period|Adverse Event|2|||
42043795|NCT01123070|75851600|FG003|Part B Double Blind Period|Adverse Event|0|||
42043796|NCT01123070|75851597|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
42043797|NCT01123070|75851598|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
42043798|NCT01123070|75851599|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
42043799|NCT01123070|75851600|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
42043800|NCT01122680|75851611|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
42043801|NCT01122680|75851612|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
42043802|NCT01122680|75851613|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
42043803|NCT01122680|75851614|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
42043804|NCT01122680|75851611|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
42043805|NCT01122680|75851612|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
42043806|NCT01122680|75851613|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
42043807|NCT01122680|75851614|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
42043808|NCT01122680|75851611|FG000|Period 1 (4 Weeks)|Other|1|||
42043809|NCT01122680|75851612|FG001|Period 1 (4 Weeks)|Other|1|||
42043810|NCT01122680|75851613|FG002|Period 1 (4 Weeks)|Other|0|||
42043811|NCT01122680|75851614|FG003|Period 1 (4 Weeks)|Other|0|||
42043812|NCT01122680|75851611|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
42043813|NCT01122680|75851612|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
42043814|NCT01122680|75851613|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
42043815|NCT01122680|75851614|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
42043816|NCT01122680|75851611|FG000|Period 2 (4 Weeks)|Other|1|||
42043817|NCT01122680|75851612|FG001|Period 2 (4 Weeks)|Other|0|||
42043818|NCT01122680|75851613|FG002|Period 2 (4 Weeks)|Other|0|||
42043819|NCT01122680|75851614|FG003|Period 2 (4 Weeks)|Other|0|||
42043820|NCT01122680|75851611|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
42043821|NCT01122680|75851612|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
42043822|NCT01122680|75851613|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
42043823|NCT01122680|75851614|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
42043824|NCT01122680|75851611|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
42043825|NCT01122680|75851612|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
42043826|NCT01122680|75851613|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
42043827|NCT01122680|75851614|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
42043828|NCT00946998|75851626|FG000|Overall Study|Exited prior to first outcome assessment|5|||
42043829|NCT00946998|75851627|FG001|Overall Study|Exited prior to first outcome assessment|3|||
42043830|NCT01138826|75851633|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
42043831|NCT01138826|75851634|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
42043832|NCT01138826|75851635|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
42043833|NCT01138826|75851636|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
42043834|NCT01138826|75851637|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
42043835|NCT01138826|75851638|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
42043836|NCT00906087|75851646|FG000|Initial Washout|Withdrawal by Subject|1|||
42043837|NCT00906087|75851646|FG000|Initial Washout|Physician Decision|1|||
42043838|NCT00907257|75851655|FG000|Overall Study|Adverse Event|0|||
42043839|NCT00907257|75851656|FG001|Overall Study|Adverse Event|4|||
42043840|NCT00907257|75851655|FG000|Overall Study|Protocol Violation|1|||
42043841|NCT00907257|75851656|FG001|Overall Study|Protocol Violation|2|||
42043842|NCT00907257|75851655|FG000|Overall Study|Lost to Follow-up|3|||
42043843|NCT00907257|75851656|FG001|Overall Study|Lost to Follow-up|3|||
42043844|NCT00907257|75851655|FG000|Overall Study|Withdrawal by Subject|1|||
42043845|NCT00907257|75851656|FG001|Overall Study|Withdrawal by Subject|2|||
42043846|NCT00907257|75851655|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
42043847|NCT00907257|75851656|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
42043848|NCT00907257|75851655|FG000|Overall Study|Moved|1|||
42043849|NCT00907257|75851656|FG001|Overall Study|Moved|0|||
42043850|NCT00907257|75851655|FG000|Overall Study|Personal Reasons|6|||
42043851|NCT00907257|75851656|FG001|Overall Study|Personal Reasons|1|||
42043852|NCT01138046|75851662|FG000|Overall Study|Withdrawal due to death|6|||
42043853|NCT00876460|75851674|FG000|Combination Therapy Phase|Progressive disease|2|||
42043854|NCT00876460|75851675|FG001|Combination Therapy Phase|Progressive disease|3|||
42043855|NCT00876460|75851676|FG002|Combination Therapy Phase|Progressive disease|3|||
42043856|NCT00876460|75851677|FG003|Combination Therapy Phase|Progressive disease|3|||
42043857|NCT00876460|75851678|FG004|Combination Therapy Phase|Progressive disease|3|||
42043858|NCT00876460|75851679|FG005|Combination Therapy Phase|Progressive disease|1|||
42043859|NCT00876460|75851680|FG006|Combination Therapy Phase|Progressive disease|1|||
42043860|NCT00876460|75851681|FG007|Combination Therapy Phase|Progressive disease|1|||
42043861|NCT00876460|75851674|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
42043862|NCT00876460|75851675|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
42043863|NCT00876460|75851676|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
42043864|NCT00876460|75851677|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
42043865|NCT00876460|75851678|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
42043866|NCT00876460|75851679|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
42043867|NCT00876460|75851680|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
42043868|NCT00876460|75851681|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
42043869|NCT00876460|75851674|FG000|Combination Therapy Phase|Adverse Event|0|||
42043870|NCT00876460|75851675|FG001|Combination Therapy Phase|Adverse Event|2|||
42043871|NCT00876460|75851676|FG002|Combination Therapy Phase|Adverse Event|0|||
42043872|NCT00876460|75851677|FG003|Combination Therapy Phase|Adverse Event|2|||
42043873|NCT00876460|75851678|FG004|Combination Therapy Phase|Adverse Event|2|||
42043874|NCT00876460|75851679|FG005|Combination Therapy Phase|Adverse Event|0|||
42043875|NCT00876460|75851680|FG006|Combination Therapy Phase|Adverse Event|3|||
42043876|NCT00876460|75851681|FG007|Combination Therapy Phase|Adverse Event|2|||
42043877|NCT00876460|75851674|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
42043878|NCT00876460|75851675|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
42043879|NCT00876460|75851676|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
42043880|NCT00876460|75851677|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
42043881|NCT00876460|75851678|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
42043882|NCT00876460|75851679|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
42043883|NCT00876460|75851680|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
42043884|NCT00876460|75851681|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
42043885|NCT00876460|75851674|FG000|Combination Therapy Phase|Other reason not defined above|0|||
42043886|NCT00876460|75851675|FG001|Combination Therapy Phase|Other reason not defined above|0|||
42043887|NCT00876460|75851676|FG002|Combination Therapy Phase|Other reason not defined above|0|||
42043888|NCT00876460|75851677|FG003|Combination Therapy Phase|Other reason not defined above|0|||
42043889|NCT00876460|75851678|FG004|Combination Therapy Phase|Other reason not defined above|0|||
42043890|NCT00876460|75851679|FG005|Combination Therapy Phase|Other reason not defined above|0|||
42043891|NCT00876460|75851680|FG006|Combination Therapy Phase|Other reason not defined above|1|||
42043892|NCT00876460|75851681|FG007|Combination Therapy Phase|Other reason not defined above|2|||
42043893|NCT00876460|75851674|FG000|Combination Therapy Phase|Not treated|0|||
42043894|NCT00876460|75851675|FG001|Combination Therapy Phase|Not treated|0|||
42043895|NCT00876460|75851676|FG002|Combination Therapy Phase|Not treated|0|||
42043896|NCT00876460|75851677|FG003|Combination Therapy Phase|Not treated|0|||
42043897|NCT00876460|75851678|FG004|Combination Therapy Phase|Not treated|0|||
42043898|NCT00876460|75851679|FG005|Combination Therapy Phase|Not treated|0|||
42043899|NCT00876460|75851680|FG006|Combination Therapy Phase|Not treated|1|||
42043900|NCT00876460|75851681|FG007|Combination Therapy Phase|Not treated|0|||
42043901|NCT00876460|75851674|FG000|Mono Therapy Phase|Progressive disease|0|||
42043902|NCT00876460|75851675|FG001|Mono Therapy Phase|Progressive disease|0|||
42043903|NCT00876460|75851676|FG002|Mono Therapy Phase|Progressive disease|0|||
42043904|NCT00876460|75851677|FG003|Mono Therapy Phase|Progressive disease|0|||
42043905|NCT00876460|75851678|FG004|Mono Therapy Phase|Progressive disease|2|||
42043906|NCT00876460|75851679|FG005|Mono Therapy Phase|Progressive disease|0|||
42043907|NCT00876460|75851680|FG006|Mono Therapy Phase|Progressive disease|1|||
42043908|NCT00876460|75851681|FG007|Mono Therapy Phase|Progressive disease|3|||
42043909|NCT00876460|75851674|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
42043910|NCT00876460|75851675|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
42043911|NCT00876460|75851676|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
42043912|NCT00876460|75851677|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
42043913|NCT00876460|75851678|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
42043914|NCT00876460|75851679|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
42043915|NCT00876460|75851680|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
42043916|NCT00876460|75851681|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
42291085|NCT01957462|76124876|FG000|Test Period 1|Withdrawal by Subject|1|||
42291086|NCT01957462|76124877|FG001|Test Period 1|Withdrawal by Subject|0|||
42291087|NCT01957462|76124876|FG000|Test Period 1|Adverse Event|1|||
42291088|NCT01957462|76124877|FG001|Test Period 1|Adverse Event|0|||
42291089|NCT01957150|76124885|FG000|Overall Study|Adverse Event|23|||
42291090|NCT01957150|76124886|FG001|Overall Study|Adverse Event|20|||
42291091|NCT01957150|76124885|FG000|Overall Study|Withdrawal by Subject|13|||
42291092|NCT01957150|76124886|FG001|Overall Study|Withdrawal by Subject|17|||
42291093|NCT01957150|76124885|FG000|Overall Study|Physician Decision|3|||
42291094|NCT01957150|76124886|FG001|Overall Study|Physician Decision|6|||
42291095|NCT01957150|76124885|FG000|Overall Study|Lost to Follow-up|4|||
42043917|NCT00876460|75851674|FG000|Mono Therapy Phase|Adverse Event|0|||
42043918|NCT00876460|75851675|FG001|Mono Therapy Phase|Adverse Event|0|||
42043919|NCT00876460|75851676|FG002|Mono Therapy Phase|Adverse Event|0|||
42043920|NCT00876460|75851677|FG003|Mono Therapy Phase|Adverse Event|1|||
42291096|NCT01957150|76124886|FG001|Overall Study|Lost to Follow-up|4|||
42291097|NCT01957150|76124885|FG000|Overall Study|Protocol Violation|1|||
42043921|NCT00876460|75851678|FG004|Mono Therapy Phase|Adverse Event|0|||
42043922|NCT00876460|75851679|FG005|Mono Therapy Phase|Adverse Event|0|||
42043923|NCT00876460|75851680|FG006|Mono Therapy Phase|Adverse Event|0|||
42043924|NCT00876460|75851681|FG007|Mono Therapy Phase|Adverse Event|0|||
42043925|NCT00908115|75851711|FG000|Overall Study|Other|14|||
42043926|NCT01137812|75851717|FG000|Overall Study|Adverse Event|21|||
42043927|NCT01137812|75851718|FG001|Overall Study|Adverse Event|14|||
42043928|NCT01137812|75851717|FG000|Overall Study|Lost to Follow-up|6|||
42043929|NCT01137812|75851718|FG001|Overall Study|Lost to Follow-up|8|||
42043930|NCT01137812|75851717|FG000|Overall Study|Physician Decision|25|||
42043931|NCT01137812|75851718|FG001|Overall Study|Physician Decision|17|||
42043932|NCT01137812|75851717|FG000|Overall Study|Protocol Violation|5|||
42043933|NCT01137812|75851718|FG001|Overall Study|Protocol Violation|4|||
42043934|NCT01137812|75851717|FG000|Overall Study|Withdrawal by Subject|5|||
42043935|NCT01137812|75851718|FG001|Overall Study|Withdrawal by Subject|13|||
42043936|NCT01137812|75851717|FG000|Overall Study|Death|2|||
42043937|NCT01137812|75851718|FG001|Overall Study|Death|0|||
42043938|NCT01137812|75851717|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
42043939|NCT01137812|75851718|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
42043940|NCT01137812|75851717|FG000|Overall Study|Other|19|||
42043941|NCT01137812|75851718|FG001|Overall Study|Other|27|||
42043942|NCT01137578|75851724|FG000|Overall Study|Participant requested to Discontinue|3|||
42043943|NCT01137578|75851725|FG001|Overall Study|Participant requested to Discontinue|0|||
42043944|NCT01137578|75851726|FG002|Overall Study|Participant requested to Discontinue|0|||
42043945|NCT01137578|75851724|FG000|Overall Study|Withdrawal by Subject|1|||
42043946|NCT01137578|75851725|FG001|Overall Study|Withdrawal by Subject|0|||
42043947|NCT01137578|75851726|FG002|Overall Study|Withdrawal by Subject|0|||
42043948|NCT01137578|75851724|FG000|Overall Study|Other|12|||
42043949|NCT01137578|75851725|FG001|Overall Study|Other|2|||
42043950|NCT01137578|75851726|FG002|Overall Study|Other|6|||
42043951|NCT00946920|75851756|FG000|Overall Study|Withdrawal by Subject|28|||
42043952|NCT00946920|75851757|FG001|Overall Study|Withdrawal by Subject|15|||
42043953|NCT00946920|75851756|FG000|Overall Study|Lost to Follow-up|2|||
42043954|NCT00946920|75851757|FG001|Overall Study|Lost to Follow-up|2|||
42043955|NCT00946920|75851756|FG000|Overall Study|Physician Decision|5|||
42043956|NCT00946920|75851757|FG001|Overall Study|Physician Decision|2|||
42043957|NCT00946920|75851756|FG000|Overall Study|Adverse Event|41|||
42043958|NCT00946920|75851757|FG001|Overall Study|Adverse Event|14|||
42043959|NCT00946920|75851756|FG000|Overall Study|Protocol Violation|16|||
42043960|NCT00946920|75851757|FG001|Overall Study|Protocol Violation|8|||
42043961|NCT00946920|75851756|FG000|Overall Study|Miscellaneous reasons|18|||
42043962|NCT00946920|75851757|FG001|Overall Study|Miscellaneous reasons|3|||
42043963|NCT00946530|75851767|FG000|Overall Study|Withdrawal by Subject|0|||
42043964|NCT00946530|75851768|FG001|Overall Study|Withdrawal by Subject|3|||
42043965|NCT00946530|75851769|FG002|Overall Study|Withdrawal by Subject|0|||
42172497|NCT03828539|75979375|FG001|Overall Study|Withdrawal of informed consent|1|||
42172498|NCT03828539|75979374|FG000|Overall Study|New therapy for study indication|1|||
42172499|NCT03828539|75979375|FG001|Overall Study|New therapy for study indication|0|||
42172500|NCT03336502|75979383|FG000|Overall Study|Physician Decision|0|||
42172501|NCT03336502|75979384|FG001|Overall Study|Physician Decision|1|||
42172502|NCT03336502|75979383|FG000|Overall Study|Prohibited Drugs|1|||
42172503|NCT03336502|75979384|FG001|Overall Study|Prohibited Drugs|1|||
42172504|NCT03336502|75979383|FG000|Overall Study|Death|1|||
42172505|NCT03336502|75979384|FG001|Overall Study|Death|2|||
42172506|NCT03336502|75979383|FG000|Overall Study|Adverse Event|2|||
42356821|NCT01393899|76202018|FG000|Overall Study|Other|1|||
42016136|NCT00938041|75823262|FG000|Overall Study|Received Alternative Therapy|1|||
42016137|NCT00938041|75823262|FG000|Overall Study|Progressive Disease|5|||
42016138|NCT00938041|75823262|FG000|Overall Study|Death|12|||
42016139|NCT00938041|75823262|FG000|Overall Study|Adrenal Insufficiency|3|||
42016140|NCT01218438|75823266|FG000|Epoch 1|Physician Decision|2|||
42016141|NCT01218438|75823266|FG000|Epoch 1|Adverse Event|1|||
42016142|NCT01218438|75823266|FG000|Epoch 3|Withdrawal by Subject|3|||
42016143|NCT01218438|75823266|FG000|Epoch 3|Adverse Event|1|||
42016144|NCT01218438|75823266|FG000|Epoch 4|Physician Decision|1|||
42016145|NCT01218438|75823266|FG000|Epoch 4|Withdrawal by Subject|2|||
42016146|NCT00935701|75823340|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
42016147|NCT01277510|75823347|FG000|Double-blind Phase|Non-compliance|0|||
42016148|NCT01277510|75823348|FG001|Double-blind Phase|Non-compliance|1|||
42043966|NCT00946530|75851770|FG003|Overall Study|Withdrawal by Subject|3|||
42043967|NCT00946530|75851767|FG000|Overall Study|Physician Decision|1|||
42043968|NCT00946530|75851768|FG001|Overall Study|Physician Decision|1|||
42016149|NCT01277510|75823347|FG000|Double-blind Phase|Adverse Event|1|||
42016150|NCT01277510|75823348|FG001|Double-blind Phase|Adverse Event|0|||
42016151|NCT01277510|75823347|FG000|Double-blind Phase|Withdrawal by Subject|2|||
42016152|NCT01277510|75823348|FG001|Double-blind Phase|Withdrawal by Subject|0|||
42043969|NCT00946530|75851769|FG002|Overall Study|Physician Decision|1|||
42043970|NCT00946530|75851770|FG003|Overall Study|Physician Decision|1|||
42172507|NCT03336502|75979384|FG001|Overall Study|Adverse Event|5|||
42043971|NCT00946296|75851786|FG000|Overall Study|Physician Decision|3|||
42043972|NCT00946296|75851787|FG001|Overall Study|Physician Decision|0|||
42043973|NCT00945906|75851793|FG000|Overall Study|Withdrawal by Subject|1|||
42043974|NCT00945906|75851793|FG000|Overall Study|Did not want to return for last visit|2|||
42043975|NCT00945906|75851793|FG000|Overall Study|Unable to return for last visit|2|||
42043976|NCT00945906|75851793|FG000|Overall Study|Moved to another country|2|||
42043977|NCT00594646|75851797|FG000|Overall Study|Withdrawal by Subject|1|||
42043978|NCT00594646|75851797|FG000|Overall Study|Lost to Follow-up|15|||
42043979|NCT01111604|75851805|FG000|Overall Study|Lost to Follow-up|0|||
42043980|NCT01111604|75851806|FG001|Overall Study|Lost to Follow-up|0|||
42043981|NCT01111604|75851807|FG002|Overall Study|Lost to Follow-up|1|||
42043982|NCT01111604|75851805|FG000|Overall Study|Withdrew Consent|3|||
42043983|NCT01111604|75851806|FG001|Overall Study|Withdrew Consent|0|||
42043984|NCT01111604|75851807|FG002|Overall Study|Withdrew Consent|2|||
42043985|NCT01111604|75851805|FG000|Overall Study|Withdrawal by Subject|2|||
42043986|NCT01111604|75851806|FG001|Overall Study|Withdrawal by Subject|0|||
42043987|NCT01111604|75851807|FG002|Overall Study|Withdrawal by Subject|0|||
42043988|NCT01111604|75851805|FG000|Overall Study|Death|1|||
42043989|NCT01111604|75851806|FG001|Overall Study|Death|0|||
42043990|NCT01111604|75851807|FG002|Overall Study|Death|0|||
42043991|NCT01111604|75851805|FG000|Overall Study|Met Exclusion Criteria|2|||
42043992|NCT01111604|75851806|FG001|Overall Study|Met Exclusion Criteria|0|||
42043993|NCT01111604|75851807|FG002|Overall Study|Met Exclusion Criteria|0|||
42043994|NCT00950742|75851835|FG000|Overall Study|Other Adverse Event|1|||
42043995|NCT00950742|75851836|FG001|Overall Study|Other Adverse Event|0|||
42043996|NCT00950742|75851835|FG000|Overall Study|Withdrawal by Subject|3|||
42043997|NCT00950742|75851836|FG001|Overall Study|Withdrawal by Subject|0|||
42043998|NCT00950742|75851835|FG000|Overall Study|Progressive Disease|6|||
42043999|NCT00950742|75851836|FG001|Overall Study|Progressive Disease|2|||
42044000|NCT00950742|75851835|FG000|Overall Study|Dose limiting toxicity|6|||
42044001|NCT00950742|75851836|FG001|Overall Study|Dose limiting toxicity|0|||
42044002|NCT00955110|75851846|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
42044003|NCT00955110|75851846|FG000|Treatment Phase|Adverse Event|2|||
42044004|NCT00955110|75851846|FG000|Treatment Phase|Administrative reasons|2|||
42044005|NCT00955110|75851846|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
42044006|NCT00955110|75851846|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
42044007|NCT00950664|75851860|FG000|First Intervention|Lost to Follow-up|1|||
42044008|NCT00950664|75851861|FG001|First Intervention|Lost to Follow-up|3|||
42044009|NCT00950664|75851860|FG000|First Intervention|Withdrawal by Subject|2|||
42044010|NCT00950664|75851861|FG001|First Intervention|Withdrawal by Subject|2|||
42044011|NCT01111526|75851867|FG000|Overall Study|GVHD Disease Progression|0|||
42044012|NCT01111526|75851868|FG001|Overall Study|GVHD Disease Progression|1|||
42044013|NCT01111526|75851869|FG002|Overall Study|GVHD Disease Progression|2|||
42044014|NCT01111292|75851875|FG000|Treatment|Physician Decision|1|||
42044015|NCT01111292|75851876|FG001|Treatment|Physician Decision|1|||
42044016|NCT00944658|75851884|FG000|Treatment 12 Weeks|Adverse Event|0|||
42044017|NCT00944658|75851885|FG001|Treatment 12 Weeks|Adverse Event|2|||
42044018|NCT01110200|75851893|FG000|Overall Study|Adverse Event|28|||
42044019|NCT01110200|75851894|FG001|Overall Study|Adverse Event|28|||
42044020|NCT01110200|75851893|FG000|Overall Study|Withdrawal by Subject|25|||
42044021|NCT01110200|75851894|FG001|Overall Study|Withdrawal by Subject|32|||
42044022|NCT01110200|75851893|FG000|Overall Study|Lack of Efficacy|16|||
42044023|NCT01110200|75851894|FG001|Overall Study|Lack of Efficacy|25|||
42044024|NCT01110200|75851893|FG000|Overall Study|Protocol Violation|14|||
42044025|NCT01110200|75851894|FG001|Overall Study|Protocol Violation|12|||
42044026|NCT01110200|75851893|FG000|Overall Study|Physician Decision|13|||
42044027|NCT01110200|75851894|FG001|Overall Study|Physician Decision|17|||
42044028|NCT01110200|75851893|FG000|Overall Study|Lost to Follow-up|10|||
42044029|NCT01110200|75851894|FG001|Overall Study|Lost to Follow-up|7|||
42044030|NCT01108796|75851904|FG000|Overall Study|Adverse Event|0|||
42172508|NCT00338741|75979392|FG000|Overall Study|Lost to Follow-up|2|||
42172509|NCT00338741|75979393|FG001|Overall Study|Lost to Follow-up|0|||
42172510|NCT03370510|75979401|FG000|Overall Study|COVID-19|2|||
42044031|NCT01108796|75851905|FG001|Overall Study|Adverse Event|1|||
42044032|NCT01108796|75851904|FG000|Overall Study|Lost to Follow-up|7|||
42172511|NCT03370510|75979402|FG001|Overall Study|COVID-19|0|||
42172512|NCT00351611|75979410|FG000|Overall Study|Adverse Event|11|||
42044033|NCT01108796|75851905|FG001|Overall Study|Lost to Follow-up|6|||
42044034|NCT01108718|75851915|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
42044035|NCT01108718|75851916|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
42044036|NCT01137110|75851923|FG000|Overall Study|Protocol Violation|1|||
42044037|NCT01137110|75851924|FG001|Overall Study|Protocol Violation|0|||
42044038|NCT01136954|75851932|FG000|Overall Study|Adverse Event|3|||
42044039|NCT01136954|75851933|FG001|Overall Study|Adverse Event|2|||
42044040|NCT01136954|75851932|FG000|Overall Study|Withdrawal by Subject|6|||
42044041|NCT01136954|75851933|FG001|Overall Study|Withdrawal by Subject|2|||
42044042|NCT01136954|75851932|FG000|Overall Study|Lack of Efficacy|14|||
42172513|NCT00351611|75979411|FG001|Overall Study|Adverse Event|3|||
42044043|NCT01136954|75851933|FG001|Overall Study|Lack of Efficacy|13|||
42044044|NCT01136954|75851932|FG000|Overall Study|Physician Decision|0|||
42044045|NCT01136954|75851933|FG001|Overall Study|Physician Decision|1|||
42044046|NCT01136954|75851932|FG000|Overall Study|Other|1|||
42044047|NCT01136954|75851933|FG001|Overall Study|Other|3|||
42044048|NCT01136876|75851942|FG000|Overall Study|Lost to Follow-up|0|||
42044049|NCT01136876|75851943|FG001|Overall Study|Lost to Follow-up|1|||
42044050|NCT01136876|75851942|FG000|Overall Study|Physician Decision|3|||
42044051|NCT01136876|75851943|FG001|Overall Study|Physician Decision|5|||
42044052|NCT01136876|75851942|FG000|Overall Study|Missing NGAL measurement|2|||
42044053|NCT01136876|75851943|FG001|Overall Study|Missing NGAL measurement|5|||
42044054|NCT01105130|75851954|FG000|Overall Study|Withdrawal by Subject|4|||
42044055|NCT01105130|75851955|FG001|Overall Study|Withdrawal by Subject|6|||
42044056|NCT01105130|75851956|FG002|Overall Study|Withdrawal by Subject|2|||
42044057|NCT01105130|75851954|FG000|Overall Study|Never Started|2|||
42044058|NCT01105130|75851955|FG001|Overall Study|Never Started|2|||
42044059|NCT01105130|75851956|FG002|Overall Study|Never Started|4|||
42044060|NCT01105130|75851954|FG000|Overall Study|Toxicity|1|||
42044061|NCT01105130|75851955|FG001|Overall Study|Toxicity|3|||
42356822|NCT01393899|76202019|FG001|Overall Study|Other|0|||
42356823|NCT01393899|76202020|FG002|Overall Study|Other|0|||
42356824|NCT01393899|76202018|FG000|Overall Study|Withdrawal by Subject|2|||
42356825|NCT01393899|76202019|FG001|Overall Study|Withdrawal by Subject|2|||
42356826|NCT01393899|76202020|FG002|Overall Study|Withdrawal by Subject|1|||
42356827|NCT01393899|76202018|FG000|Overall Study|Lost to Follow-up|0|||
42356828|NCT01393899|76202019|FG001|Overall Study|Lost to Follow-up|0|||
42356829|NCT01393899|76202020|FG002|Overall Study|Lost to Follow-up|1|||
42356830|NCT01393899|76202018|FG000|Overall Study|Does not meet entrance criteria|1|||
42356831|NCT01393899|76202019|FG001|Overall Study|Does not meet entrance criteria|0|||
42356832|NCT01393899|76202020|FG002|Overall Study|Does not meet entrance criteria|1|||
42356833|NCT01393899|76202018|FG000|Overall Study|Lack of Efficacy|26|||
42356834|NCT01393899|76202019|FG001|Overall Study|Lack of Efficacy|21|||
42044062|NCT01105130|75851956|FG002|Overall Study|Toxicity|2|||
42044063|NCT01105130|75851954|FG000|Overall Study|Multiple Reasons|3|||
42044064|NCT01105130|75851955|FG001|Overall Study|Multiple Reasons|0|||
42044065|NCT01105130|75851956|FG002|Overall Study|Multiple Reasons|2|||
42044066|NCT01108094|75851968|FG000|Overall Study|Adverse Event|2|||
42044067|NCT01108094|75851969|FG001|Overall Study|Adverse Event|0|||
42044068|NCT01108094|75851970|FG002|Overall Study|Adverse Event|0|||
42044069|NCT01108094|75851971|FG003|Overall Study|Adverse Event|0|||
42044070|NCT01108094|75851968|FG000|Overall Study|Withdrawal by Subject|1|||
42044071|NCT01108094|75851969|FG001|Overall Study|Withdrawal by Subject|0|||
42044072|NCT01108094|75851970|FG002|Overall Study|Withdrawal by Subject|0|||
42044073|NCT01108094|75851971|FG003|Overall Study|Withdrawal by Subject|0|||
42044074|NCT00954174|75851988|FG000|Overall Study|Adverse Event|28|||
42291098|NCT01957150|76124886|FG001|Overall Study|Protocol Violation|0|||
42291099|NCT01957150|76124885|FG000|Overall Study|Lack of Efficacy|11|||
42291100|NCT01957150|76124886|FG001|Overall Study|Lack of Efficacy|11|||
42291101|NCT01955122|76124894|FG000|Overall Study|Physician Decision|5|||
42291102|NCT01955122|76124895|FG001|Overall Study|Physician Decision|5|||
42291103|NCT01995526|76124907|FG000|Overall Study|Physician Decision|1|||
42291104|NCT01955044|76124914|FG000|Overall Study|Death|1|||
42291105|NCT01955044|76124915|FG001|Overall Study|Death|1|||
42291106|NCT01955044|76124916|FG002|Overall Study|Death|0|||
42291107|NCT01973218|76124926|FG000|Overall Study|Adverse Event|1|||
42291108|NCT01973218|76124927|FG001|Overall Study|Adverse Event|0|||
42291109|NCT01973218|76124926|FG000|Overall Study|Withdrawal by Subject|1|||
42291110|NCT01973218|76124927|FG001|Overall Study|Withdrawal by Subject|0|||
42291111|NCT01954342|76124939|FG000|Overall Study|Missing data from 13-16week study visit|0|||
42291112|NCT01954342|76124940|FG001|Overall Study|Missing data from 13-16week study visit|0|||
42356835|NCT01393899|76202020|FG002|Overall Study|Lack of Efficacy|16|||
42044075|NCT00954174|75851989|FG001|Overall Study|Adverse Event|23|||
42044076|NCT00954174|75851990|FG002|Overall Study|Adverse Event|4|||
42044077|NCT00954174|75851991|FG003|Overall Study|Adverse Event|9|||
42356836|NCT01393899|76202018|FG000|Overall Study|Adverse Event|1|||
42356837|NCT01393899|76202019|FG001|Overall Study|Adverse Event|5|||
42356838|NCT01393899|76202020|FG002|Overall Study|Adverse Event|3|||
42356839|NCT01393743|76202032|FG000|Core Study|Adverse Event|5|||
42356840|NCT01393743|76202033|FG001|Core Study|Adverse Event|9|||
42356841|NCT01393743|76202034|FG002|Core Study|Adverse Event|0|||
42044078|NCT00954174|75851988|FG000|Overall Study|Death|4|||
42291113|NCT01954342|76124941|FG002|Overall Study|Missing data from 13-16week study visit|0|||
42044079|NCT00954174|75851989|FG001|Overall Study|Death|2|||
42044080|NCT00954174|75851990|FG002|Overall Study|Death|0|||
42044081|NCT00954174|75851991|FG003|Overall Study|Death|0|||
42044082|NCT00954174|75851988|FG000|Overall Study|Lack of Efficacy|32|||
42044083|NCT00954174|75851989|FG001|Overall Study|Lack of Efficacy|22|||
42044084|NCT00954174|75851990|FG002|Overall Study|Lack of Efficacy|8|||
42044085|NCT00954174|75851991|FG003|Overall Study|Lack of Efficacy|6|||
42044086|NCT00954174|75851988|FG000|Overall Study|Withdrawal by Subject|14|||
42044087|NCT00954174|75851989|FG001|Overall Study|Withdrawal by Subject|10|||
42044088|NCT00954174|75851990|FG002|Overall Study|Withdrawal by Subject|4|||
42044089|NCT00954174|75851991|FG003|Overall Study|Withdrawal by Subject|3|||
42044090|NCT00954174|75851988|FG000|Overall Study|Medical Reason|4|||
42044091|NCT00954174|75851989|FG001|Overall Study|Medical Reason|2|||
42044092|NCT00954174|75851990|FG002|Overall Study|Medical Reason|1|||
42044093|NCT00954174|75851991|FG003|Overall Study|Medical Reason|0|||
42044094|NCT00954174|75851988|FG000|Overall Study|Ineligible|40|||
42044095|NCT00954174|75851989|FG001|Overall Study|Ineligible|47|||
42044096|NCT00954174|75851990|FG002|Overall Study|Ineligible|7|||
42044097|NCT00954174|75851991|FG003|Overall Study|Ineligible|4|||
42044098|NCT00954174|75851988|FG000|Overall Study|Never Treated|4|||
42044099|NCT00954174|75851989|FG001|Overall Study|Never Treated|17|||
42044100|NCT00954174|75851990|FG002|Overall Study|Never Treated|0|||
42044101|NCT00954174|75851991|FG003|Overall Study|Never Treated|3|||
42044102|NCT01136408|75852007|FG000|Overall Study|Adverse Event|4|||
42044103|NCT01136408|75852008|FG001|Overall Study|Adverse Event|8|||
42291114|NCT01954342|76124942|FG003|Overall Study|Missing data from 13-16week study visit|1|||
42291115|NCT01954342|76124939|FG000|Overall Study|Miscarriage|0|||
42291116|NCT01954342|76124940|FG001|Overall Study|Miscarriage|0|||
42291117|NCT01954342|76124941|FG002|Overall Study|Miscarriage|0|||
42291118|NCT01954342|76124942|FG003|Overall Study|Miscarriage|3|||
42291119|NCT01954342|76124939|FG000|Overall Study|Lost to Follow-up|0|||
42291120|NCT01954342|76124940|FG001|Overall Study|Lost to Follow-up|0|||
42291121|NCT01954342|76124941|FG002|Overall Study|Lost to Follow-up|0|||
42291122|NCT01954342|76124942|FG003|Overall Study|Lost to Follow-up|5|||
42291123|NCT01954342|76124939|FG000|Overall Study|Preterm delivery|0|||
42044104|NCT01136408|75852009|FG002|Overall Study|Adverse Event|4|||
42044105|NCT01136408|75852007|FG000|Overall Study|Protocol Violation|1|||
42044106|NCT01136408|75852008|FG001|Overall Study|Protocol Violation|1|||
42044107|NCT01136408|75852009|FG002|Overall Study|Protocol Violation|1|||
42044108|NCT01136174|75852025|FG000|Overall Study|Adverse Event|0|||
42044109|NCT01136174|75852026|FG001|Overall Study|Adverse Event|0|||
42044110|NCT01136174|75852027|FG002|Overall Study|Adverse Event|0|||
42044111|NCT01136174|75852028|FG003|Overall Study|Adverse Event|4|||
42044112|NCT01135394|75852047|FG000|Screening|Lost to Follow-up|2|||
42044113|NCT01135394|75852047|FG000|Screening|Withdrawal by Subject|10|||
42044114|NCT01135394|75852047|FG000|Screening|Screening failure|16|||
42291124|NCT01954342|76124940|FG001|Overall Study|Preterm delivery|0|||
42291125|NCT01954342|76124941|FG002|Overall Study|Preterm delivery|0|||
42291126|NCT01954342|76124942|FG003|Overall Study|Preterm delivery|3|||
42291127|NCT01954342|76124939|FG000|Overall Study|Pre-eclampsia|0|||
42291128|NCT01954342|76124940|FG001|Overall Study|Pre-eclampsia|0|||
42291129|NCT01954342|76124941|FG002|Overall Study|Pre-eclampsia|0|||
42291130|NCT01954342|76124942|FG003|Overall Study|Pre-eclampsia|4|||
42291131|NCT01954342|76124939|FG000|Overall Study|Unreliable Data|0|||
42291132|NCT01954342|76124940|FG001|Overall Study|Unreliable Data|0|||
42291133|NCT01954342|76124941|FG002|Overall Study|Unreliable Data|0|||
42291134|NCT01954342|76124942|FG003|Overall Study|Unreliable Data|2|||
42291135|NCT01972438|76124954|FG000|Baseline-Month 3 Crossover Period|Death|1|||
42291136|NCT01972438|76124955|FG001|Baseline-Month 3 Crossover Period|Death|0|||
42291137|NCT01972438|76124954|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
42291138|NCT01972438|76124955|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
42291139|NCT01972438|76124954|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
42291140|NCT01972438|76124955|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
42291141|NCT01972438|76124954|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
42291142|NCT01972438|76124955|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
42291143|NCT01972438|76124954|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
42291144|NCT01972438|76124955|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
42044115|NCT01135394|75852047|FG000|Screening|Physician Decision|5|||
42044116|NCT01135394|75852047|FG000|Baseline Assessment|Withdrawal by Subject|9|||
42044117|NCT01135394|75852047|FG000|Baseline Assessment|Physician Decision|3|||
42044118|NCT01135394|75852047|FG000|Baseline Assessment|Lost to Follow-up|2|||
42044119|NCT01135394|75852047|FG000|Baseline Assessment|Adverse Event|1|||
42044120|NCT01135394|75852047|FG000|Study Treatment|Withdrawal by Subject|1|||
42044121|NCT01135394|75852047|FG000|Study Treatment|Physician Decision|1|||
42044122|NCT01135394|75852047|FG000|Study Treatment|Adverse Event|2|||
42044123|NCT00949884|75852054|FG000|Overall Study|Adverse Event|14|||
42044124|NCT00949884|75852055|FG001|Overall Study|Adverse Event|3|||
42044125|NCT00949884|75852056|FG002|Overall Study|Adverse Event|12|||
42291145|NCT01972438|76124954|FG000|Months 6-12 Study Period|Death|1|||
42044126|NCT00949884|75852054|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
42044127|NCT00949884|75852055|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
42044128|NCT00949884|75852056|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
42044129|NCT00949884|75852054|FG000|Overall Study|Lost to Follow-up|7|||
42044130|NCT00949884|75852055|FG001|Overall Study|Lost to Follow-up|5|||
42044131|NCT00949884|75852056|FG002|Overall Study|Lost to Follow-up|5|||
42044132|NCT00949884|75852054|FG000|Overall Study|Physician Decision|5|||
42044133|NCT00949884|75852055|FG001|Overall Study|Physician Decision|0|||
42044134|NCT00949884|75852056|FG002|Overall Study|Physician Decision|6|||
42044135|NCT00949884|75852054|FG000|Overall Study|Treatment non-compliance|5|||
42044136|NCT00949884|75852055|FG001|Overall Study|Treatment non-compliance|0|||
42044137|NCT00949884|75852056|FG002|Overall Study|Treatment non-compliance|8|||
42044138|NCT00949884|75852054|FG000|Overall Study|Withdrawal by Subject|13|||
42044139|NCT00949884|75852055|FG001|Overall Study|Withdrawal by Subject|4|||
42044140|NCT00949884|75852056|FG002|Overall Study|Withdrawal by Subject|16|||
42044141|NCT00949884|75852054|FG000|Overall Study|Lack of Efficacy|4|||
42044142|NCT00949884|75852055|FG001|Overall Study|Lack of Efficacy|2|||
42044143|NCT00949884|75852056|FG002|Overall Study|Lack of Efficacy|7|||
42044144|NCT00949884|75852054|FG000|Overall Study|Study terminated by sponsor|0|||
42044145|NCT00949884|75852055|FG001|Overall Study|Study terminated by sponsor|0|||
42044146|NCT00949884|75852056|FG002|Overall Study|Study terminated by sponsor|1|||
42044147|NCT00949650|75852067|FG000|Overall Study|Progressive disease|188|||
42044148|NCT00949650|75852068|FG001|Overall Study|Progressive disease|19|||
42044149|NCT00949650|75852067|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
42044150|NCT00949650|75852068|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
42044151|NCT00949650|75852067|FG000|Overall Study|Other Adverse Event (AE)|28|||
42044152|NCT00949650|75852068|FG001|Overall Study|Other Adverse Event (AE)|17|||
42044153|NCT00949650|75852067|FG000|Overall Study|Protocol Violation|1|||
42044154|NCT00949650|75852068|FG001|Overall Study|Protocol Violation|4|||
42044155|NCT00949650|75852067|FG000|Overall Study|Refusal to continue medication|7|||
42044156|NCT00949650|75852068|FG001|Overall Study|Refusal to continue medication|11|||
42044157|NCT00949650|75852067|FG000|Overall Study|Not treated|1|||
42044158|NCT00949650|75852068|FG001|Overall Study|Not treated|4|||
42044159|NCT00949650|75852067|FG000|Overall Study|Other not specified above|5|||
42044160|NCT00949650|75852068|FG001|Overall Study|Other not specified above|0|||
42044161|NCT00908037|75852085|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
42044162|NCT00908037|75852086|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
42044163|NCT00908037|75852087|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
42044164|NCT00908037|75852088|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
42044165|NCT00908037|75852089|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
42044166|NCT00908037|75852090|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
42044167|NCT00908037|75852091|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
42044168|NCT00908037|75852092|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
42044169|NCT00908037|75852093|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
42044170|NCT00908037|75852094|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
42044171|NCT00908037|75852095|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
42044172|NCT00908037|75852096|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
42044173|NCT00908037|75852085|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
42044174|NCT00908037|75852086|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
42044175|NCT00908037|75852087|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
42044176|NCT00908037|75852088|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
42172514|NCT00351611|75979410|FG000|Overall Study|Death|1|||
42044177|NCT00908037|75852089|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
42044178|NCT00908037|75852090|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
42044179|NCT00908037|75852091|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
42044180|NCT00908037|75852092|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
42044181|NCT00908037|75852093|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
42044182|NCT00908037|75852094|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
42044183|NCT00908037|75852095|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
42044184|NCT00908037|75852096|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
42044185|NCT00908037|75852085|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
42044186|NCT00908037|75852086|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
42044187|NCT00908037|75852087|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
42044188|NCT00908037|75852088|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
42044189|NCT00908037|75852089|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
42044190|NCT00908037|75852090|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
42044191|NCT00908037|75852091|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
42044192|NCT00908037|75852092|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
42044193|NCT00908037|75852093|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
42044194|NCT00908037|75852094|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
42044195|NCT00908037|75852095|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
42044196|NCT00908037|75852096|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
42044197|NCT00908037|75852085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
42044198|NCT00908037|75852086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
42044199|NCT00908037|75852087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
42044200|NCT00908037|75852088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
42044201|NCT00908037|75852089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
42044202|NCT00908037|75852090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
42044203|NCT00908037|75852091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
42044204|NCT00908037|75852092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
42044205|NCT00908037|75852093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
42044206|NCT00908037|75852094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
42044207|NCT00908037|75852095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
42044208|NCT00908037|75852096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
42044209|NCT00908037|75852085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
42044210|NCT00908037|75852086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
42044211|NCT00908037|75852087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
42044212|NCT00908037|75852088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
42044213|NCT00908037|75852089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
42044214|NCT00908037|75852090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
42044215|NCT00908037|75852091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
42044216|NCT00908037|75852092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
42044217|NCT00908037|75852093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
42044218|NCT00908037|75852094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
42044219|NCT00908037|75852095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
42044220|NCT00908037|75852096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
42044221|NCT00908037|75852085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
42044222|NCT00908037|75852086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
42044223|NCT00908037|75852087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
42044224|NCT00908037|75852088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
42044225|NCT00908037|75852089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
42044226|NCT00908037|75852090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
42044227|NCT00908037|75852091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
42044228|NCT00908037|75852092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
42044229|NCT00908037|75852093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
42044230|NCT00908037|75852094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
42044231|NCT00908037|75852095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
42044232|NCT00908037|75852096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
42044233|NCT00908037|75852085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
42044234|NCT00908037|75852086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
42044235|NCT00908037|75852087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
42044236|NCT00908037|75852088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
42044237|NCT00908037|75852089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
42044238|NCT00908037|75852090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
42044239|NCT00908037|75852091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
42044240|NCT00908037|75852092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
42044241|NCT00908037|75852093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
42044242|NCT00908037|75852094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
42044243|NCT00908037|75852095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
42044244|NCT00908037|75852096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
42044245|NCT00908037|75852085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
42044246|NCT00908037|75852086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
42044247|NCT00908037|75852087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
42044248|NCT00908037|75852088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
42044249|NCT00908037|75852089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
42044250|NCT00908037|75852090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
42044251|NCT00908037|75852091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
42044252|NCT00908037|75852092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
42044253|NCT00908037|75852093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
42044254|NCT00908037|75852094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
42044255|NCT00908037|75852095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
42044256|NCT00908037|75852096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
42044257|NCT00908037|75852085|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
42172515|NCT00351611|75979411|FG001|Overall Study|Death|0|||
42356842|NCT01393743|76202032|FG000|Core Study|Lost to Follow-up|1|||
42044258|NCT00908037|75852086|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
42044259|NCT00908037|75852087|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
42044260|NCT00908037|75852088|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
42044261|NCT00908037|75852089|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
42044262|NCT00908037|75852090|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
42044263|NCT00908037|75852091|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
42044264|NCT00908037|75852092|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
42044265|NCT00908037|75852093|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
42044266|NCT00908037|75852094|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
42044267|NCT00908037|75852095|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
42044268|NCT00908037|75852096|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
42044269|NCT00904215|75852148|FG000|Overall Study|Adverse Event|25|||
42044270|NCT00904215|75852148|FG000|Overall Study|Protocol Violation|10|||
42044271|NCT00904215|75852148|FG000|Overall Study|Lost to Follow-up|63|||
42044272|NCT00904215|75852148|FG000|Overall Study|Withdrawal by Subject|9|||
42044273|NCT00904215|75852148|FG000|Overall Study|Other|28|||
42044274|NCT00905307|75852158|FG000|Overall Study|Switched to Open Label Rescue|7|||
42044275|NCT00905307|75852159|FG001|Overall Study|Switched to Open Label Rescue|17|||
42044276|NCT00905307|75852160|FG002|Overall Study|Switched to Open Label Rescue|11|||
42044277|NCT00905307|75852161|FG003|Overall Study|Switched to Open Label Rescue|11|||
42044278|NCT00905307|75852162|FG004|Overall Study|Switched to Open Label Rescue|4|||
42044279|NCT00905307|75852163|FG005|Overall Study|Switched to Open Label Rescue|15|||
42044280|NCT00905307|75852158|FG000|Overall Study|Lost to Follow-up|0|||
42044281|NCT00905307|75852159|FG001|Overall Study|Lost to Follow-up|0|||
42044282|NCT00905307|75852160|FG002|Overall Study|Lost to Follow-up|0|||
42044283|NCT00905307|75852161|FG003|Overall Study|Lost to Follow-up|0|||
42044284|NCT00905307|75852162|FG004|Overall Study|Lost to Follow-up|1|||
42044285|NCT00905307|75852163|FG005|Overall Study|Lost to Follow-up|1|||
42044286|NCT00905307|75852158|FG000|Overall Study|Adverse Event|3|||
42044287|NCT00905307|75852159|FG001|Overall Study|Adverse Event|4|||
42044288|NCT00905307|75852160|FG002|Overall Study|Adverse Event|5|||
42044289|NCT00905307|75852161|FG003|Overall Study|Adverse Event|11|||
42044290|NCT00905307|75852162|FG004|Overall Study|Adverse Event|3|||
42044291|NCT00905307|75852163|FG005|Overall Study|Adverse Event|5|||
42044292|NCT00905307|75852158|FG000|Overall Study|Withdrawal by Subject|5|||
42044293|NCT00905307|75852159|FG001|Overall Study|Withdrawal by Subject|13|||
42044294|NCT00905307|75852160|FG002|Overall Study|Withdrawal by Subject|15|||
42044295|NCT00905307|75852161|FG003|Overall Study|Withdrawal by Subject|11|||
42044296|NCT00905307|75852162|FG004|Overall Study|Withdrawal by Subject|4|||
42044297|NCT00905307|75852163|FG005|Overall Study|Withdrawal by Subject|13|||
42044298|NCT00905307|75852158|FG000|Overall Study|Protocol Violation|1|||
42044299|NCT00905307|75852159|FG001|Overall Study|Protocol Violation|0|||
42044300|NCT00905307|75852160|FG002|Overall Study|Protocol Violation|1|||
42044301|NCT00905307|75852161|FG003|Overall Study|Protocol Violation|0|||
42044302|NCT00905307|75852162|FG004|Overall Study|Protocol Violation|0|||
42044303|NCT00905307|75852163|FG005|Overall Study|Protocol Violation|0|||
42044304|NCT00905307|75852158|FG000|Overall Study|Lack of Efficacy|6|||
42044305|NCT00905307|75852159|FG001|Overall Study|Lack of Efficacy|3|||
42044306|NCT00905307|75852160|FG002|Overall Study|Lack of Efficacy|5|||
42044307|NCT00905307|75852161|FG003|Overall Study|Lack of Efficacy|4|||
42044308|NCT00905307|75852162|FG004|Overall Study|Lack of Efficacy|4|||
42044309|NCT00905307|75852163|FG005|Overall Study|Lack of Efficacy|8|||
42044310|NCT00907881|75852190|FG000|Overall Study|Lost to Follow-up|59|||
42044311|NCT00907881|75852190|FG000|Overall Study|Noncompliance|5|||
42044312|NCT00907881|75852190|FG000|Overall Study|Withdrawal by Subject|5|||
42044313|NCT00907881|75852190|FG000|Overall Study|Protocol Violation|1|||
42044314|NCT00907881|75852190|FG000|Overall Study|Missing discontinuation information|15|||
42044315|NCT00904917|75852198|FG000|Overall Study|Lost to Follow-up|2|||
42044316|NCT00904917|75852199|FG001|Overall Study|Lost to Follow-up|2|||
42044317|NCT00904917|75852200|FG002|Overall Study|Lost to Follow-up|2|||
42044318|NCT00904917|75852201|FG003|Overall Study|Lost to Follow-up|2|||
42044319|NCT00904839|75852216|FG000|Overall Study|Adverse Event|0|||
42044320|NCT00904839|75852217|FG001|Overall Study|Adverse Event|5|||
42356843|NCT01393743|76202033|FG001|Core Study|Lost to Follow-up|1|||
42356844|NCT01393743|76202034|FG002|Core Study|Lost to Follow-up|0|||
42044321|NCT00904839|75852218|FG002|Overall Study|Adverse Event|4|||
42044322|NCT00904839|75852216|FG000|Overall Study|Protocol Violation|0|||
42044323|NCT00904839|75852217|FG001|Overall Study|Protocol Violation|1|||
42044324|NCT00904839|75852218|FG002|Overall Study|Protocol Violation|1|||
42044325|NCT00904839|75852216|FG000|Overall Study|Lost to Follow-up|0|||
42044326|NCT00904839|75852217|FG001|Overall Study|Lost to Follow-up|1|||
42044327|NCT00904839|75852218|FG002|Overall Study|Lost to Follow-up|2|||
42044328|NCT00904839|75852216|FG000|Overall Study|Withdrawal by Subject|0|||
42044329|NCT00904839|75852217|FG001|Overall Study|Withdrawal by Subject|2|||
42044330|NCT00904839|75852218|FG002|Overall Study|Withdrawal by Subject|0|||
42044331|NCT00904839|75852216|FG000|Overall Study|Not treated|1|||
42044332|NCT00904839|75852217|FG001|Overall Study|Not treated|0|||
42044333|NCT00904839|75852218|FG002|Overall Study|Not treated|1|||
42044334|NCT00904839|75852216|FG000|Overall Study|Other than above|0|||
42044335|NCT00904839|75852217|FG001|Overall Study|Other than above|9|||
42044336|NCT00904839|75852218|FG002|Overall Study|Other than above|7|||
42044337|NCT00903357|75852229|FG000|First Intervention|Withdrawal by Subject|5|||
42044338|NCT00903357|75852230|FG001|First Intervention|Withdrawal by Subject|3|||
42044339|NCT00903357|75852229|FG000|First Intervention|Flu|0|||
42044340|NCT00903357|75852230|FG001|First Intervention|Flu|1|||
42044341|NCT00903357|75852229|FG000|Wash Out Period of 2 Weeks|Flu|0|||
42044342|NCT00903357|75852230|FG001|Wash Out Period of 2 Weeks|Flu|1|||
42044343|NCT00903357|75852229|FG000|Second Intervention|Lost to Follow-up|1|||
42044344|NCT00903357|75852230|FG001|Second Intervention|Lost to Follow-up|0|||
42044345|NCT00904371|75852240|FG000|Overall Study|Adverse Event|2|||
42044346|NCT00904371|75852240|FG000|Overall Study|Lost to Follow-up|4|||
42044347|NCT00904371|75852240|FG000|Overall Study|Discontinued at target blood pressure|2|||
42044348|NCT00904371|75852240|FG000|Overall Study|Continued with Tritace|1|||
42044349|NCT01104662|75852252|FG000|Overall Study|Adverse Event|2|||
42044350|NCT01104662|75852253|FG001|Overall Study|Adverse Event|2|||
42044351|NCT01104662|75852254|FG002|Overall Study|Adverse Event|0|||
42044352|NCT01104662|75852255|FG003|Overall Study|Adverse Event|1|||
42044353|NCT01104662|75852256|FG004|Overall Study|Adverse Event|1|||
42044354|NCT01104662|75852257|FG005|Overall Study|Adverse Event|1|||
42044355|NCT01104662|75852258|FG006|Overall Study|Adverse Event|0|||
42044356|NCT01104662|75852259|FG007|Overall Study|Adverse Event|0|||
42044357|NCT01104662|75852252|FG000|Overall Study|Clinical Failure|1|||
42044358|NCT01104662|75852253|FG001|Overall Study|Clinical Failure|0|||
42044359|NCT01104662|75852254|FG002|Overall Study|Clinical Failure|0|||
42044360|NCT01104662|75852255|FG003|Overall Study|Clinical Failure|0|||
42044361|NCT01104662|75852256|FG004|Overall Study|Clinical Failure|0|||
42044362|NCT01104662|75852257|FG005|Overall Study|Clinical Failure|1|||
42044363|NCT01104662|75852258|FG006|Overall Study|Clinical Failure|0|||
42044364|NCT01104662|75852259|FG007|Overall Study|Clinical Failure|0|||
42044365|NCT01104662|75852252|FG000|Overall Study|Participant left investigator's care|1|||
42044366|NCT01104662|75852253|FG001|Overall Study|Participant left investigator's care|1|||
42044367|NCT01104662|75852254|FG002|Overall Study|Participant left investigator's care|0|||
42044368|NCT01104662|75852255|FG003|Overall Study|Participant left investigator's care|0|||
42044369|NCT01104662|75852256|FG004|Overall Study|Participant left investigator's care|0|||
42044370|NCT01104662|75852257|FG005|Overall Study|Participant left investigator's care|0|||
42044371|NCT01104662|75852258|FG006|Overall Study|Participant left investigator's care|0|||
42044372|NCT01104662|75852259|FG007|Overall Study|Participant left investigator's care|0|||
42044373|NCT01104662|75852252|FG000|Overall Study|Reason not specified|3|||
42044374|NCT01104662|75852253|FG001|Overall Study|Reason not specified|3|||
42044375|NCT01104662|75852254|FG002|Overall Study|Reason not specified|0|||
42044376|NCT01104662|75852255|FG003|Overall Study|Reason not specified|0|||
42044377|NCT01104662|75852256|FG004|Overall Study|Reason not specified|0|||
42044378|NCT01104662|75852257|FG005|Overall Study|Reason not specified|1|||
42044379|NCT01104662|75852258|FG006|Overall Study|Reason not specified|0|||
42044380|NCT01104662|75852259|FG007|Overall Study|Reason not specified|0|||
42044381|NCT01104662|75852252|FG000|Overall Study|Randomized but not treated|3|||
42044382|NCT01104662|75852253|FG001|Overall Study|Randomized but not treated|4|||
42044383|NCT01104662|75852254|FG002|Overall Study|Randomized but not treated|1|||
42044384|NCT01104662|75852255|FG003|Overall Study|Randomized but not treated|0|||
42044385|NCT01104662|75852256|FG004|Overall Study|Randomized but not treated|0|||
42172516|NCT00351611|75979410|FG000|Overall Study|Lost to Follow-up|1|||
42044386|NCT01104662|75852257|FG005|Overall Study|Randomized but not treated|1|||
42044387|NCT01104662|75852258|FG006|Overall Study|Randomized but not treated|0|||
42044388|NCT01104662|75852259|FG007|Overall Study|Randomized but not treated|0|||
42044389|NCT01104584|75852278|FG000|Overall Study|Study drug never administered|21|||
42172517|NCT00351611|75979411|FG001|Overall Study|Lost to Follow-up|0|||
42291146|NCT01972438|76124955|FG001|Months 6-12 Study Period|Death|0|||
42044390|NCT01104584|75852278|FG000|Overall Study|Study prematurely discontinued|2|||
42044391|NCT01103960|75852302|FG000|Overall Study|Adverse Event|2|||
42044392|NCT01103960|75852303|FG001|Overall Study|Adverse Event|1|||
42044393|NCT01103960|75852302|FG000|Overall Study|Withdrawal by Subject|2|||
42044394|NCT01103960|75852303|FG001|Overall Study|Withdrawal by Subject|1|||
42044395|NCT01103960|75852302|FG000|Overall Study|Other|1|||
42044396|NCT01103960|75852303|FG001|Overall Study|Other|0|||
42044397|NCT01107392|75852311|FG000|Overall Study|Adverse Event|2|||
42044398|NCT01107392|75852312|FG001|Overall Study|Adverse Event|0|||
42044399|NCT01107392|75852311|FG000|Overall Study|Personal Reasons|2|||
42044400|NCT01107392|75852312|FG001|Overall Study|Personal Reasons|3|||
42044401|NCT01107392|75852311|FG000|Overall Study|Administrative decision|1|||
42044402|NCT01107392|75852312|FG001|Overall Study|Administrative decision|0|||
42044403|NCT01106846|75852320|FG000|Overall Study|Change in surgical procedure|0|||
42044404|NCT01106846|75852321|FG001|Overall Study|Change in surgical procedure|1|||
42044405|NCT00902577|75852327|FG000|Overall Study|Withdrawal by Subject|6|||
42044406|NCT00902577|75852327|FG000|Overall Study|FMISO production failure|2|||
42044407|NCT01106690|75852362|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
42044408|NCT01106690|75852363|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
42044409|NCT01106690|75852364|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
42044410|NCT01106690|75852362|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
42044411|NCT01106690|75852363|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
42044412|NCT01106690|75852364|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
42044413|NCT01106690|75852362|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
42044414|NCT01106690|75852363|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
42044415|NCT01106690|75852364|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
42044416|NCT01106690|75852362|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
42044417|NCT01106690|75852363|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
42044418|NCT01106690|75852364|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
42044419|NCT01106690|75852362|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
42172518|NCT00351611|75979410|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
42172519|NCT00351611|75979411|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
42172520|NCT00351611|75979410|FG000|Overall Study|Other|1|||
42291147|NCT01972438|76124954|FG000|Months 6-12 Study Period|Early Study Closure|2|||
42044420|NCT01106690|75852363|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
42044421|NCT01106690|75852364|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
42044422|NCT01106690|75852362|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
42044423|NCT01106690|75852363|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
42044424|NCT01106690|75852364|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
42044425|NCT01106690|75852362|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
42044426|NCT01106690|75852363|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
42044427|NCT01106690|75852364|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
42044428|NCT01106690|75852362|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
42044429|NCT01106690|75852363|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
42044430|NCT01106690|75852364|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
42044431|NCT01106690|75852362|FG000|Core Period: Baseline to Week 26|Other|10|||
42044432|NCT01106690|75852363|FG001|Core Period: Baseline to Week 26|Other|2|||
42044433|NCT01106690|75852364|FG002|Core Period: Baseline to Week 26|Other|6|||
42044434|NCT01106690|75852362|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
42044435|NCT01106690|75852363|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
42044436|NCT01106690|75852364|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
42044437|NCT01106690|75852362|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
42044438|NCT01106690|75852363|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
42044439|NCT01106690|75852364|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
42044440|NCT01106690|75852362|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
42044441|NCT01106690|75852363|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
42044442|NCT01106690|75852364|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
42044443|NCT01106690|75852362|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
42044444|NCT01106690|75852363|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
42044445|NCT01106690|75852364|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
42044446|NCT01106690|75852362|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
42044447|NCT01106690|75852363|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
42044448|NCT01106690|75852364|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
42044449|NCT01106690|75852362|FG000|Extension Period: Week 26 to Week 52|Other|8|||
42044450|NCT01106690|75852363|FG001|Extension Period: Week 26 to Week 52|Other|3|||
42044451|NCT01106690|75852364|FG002|Extension Period: Week 26 to Week 52|Other|4|||
42044452|NCT01106690|75852362|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
42044453|NCT01106690|75852363|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
42044454|NCT01106690|75852364|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
42044455|NCT01103180|75852394|FG000|Overall Study|Withdrawal by Subject|8|||
42291148|NCT01972438|76124955|FG001|Months 6-12 Study Period|Early Study Closure|2|||
42291149|NCT01972438|76124954|FG000|Post Month 12 Study Period|Early Study Closure|3|||
42291150|NCT01972438|76124955|FG001|Post Month 12 Study Period|Early Study Closure|4|||
42044456|NCT01103180|75852395|FG001|Overall Study|Withdrawal by Subject|13|||
42044457|NCT01103180|75852394|FG000|Overall Study|Lost to Follow-up|13|||
42044458|NCT01103180|75852395|FG001|Overall Study|Lost to Follow-up|7|||
42044459|NCT01103180|75852394|FG000|Overall Study|Physician Decision|1|||
42044460|NCT01103180|75852395|FG001|Overall Study|Physician Decision|0|||
42044461|NCT01103180|75852394|FG000|Overall Study|Protocol Violation|0|||
42044462|NCT01103180|75852395|FG001|Overall Study|Protocol Violation|1|||
42044463|NCT00944034|75852413|FG000|Overall Study|Inappropriate enrollment|0|||
42044464|NCT00944034|75852414|FG001|Overall Study|Inappropriate enrollment|1|||
42044465|NCT00944034|75852415|FG002|Overall Study|Inappropriate enrollment|0|||
42044466|NCT00944034|75852416|FG003|Overall Study|Inappropriate enrollment|1|||
42044467|NCT00944034|75852417|FG004|Overall Study|Inappropriate enrollment|2|||
42044468|NCT00944034|75852418|FG005|Overall Study|Inappropriate enrollment|1|||
42044469|NCT00944034|75852419|FG006|Overall Study|Inappropriate enrollment|0|||
42044470|NCT00944034|75852420|FG007|Overall Study|Inappropriate enrollment|0|||
42044471|NCT00944034|75852421|FG008|Overall Study|Inappropriate enrollment|1|||
42044472|NCT00944034|75852422|FG009|Overall Study|Inappropriate enrollment|1|||
42044473|NCT00944034|75852423|FG010|Overall Study|Inappropriate enrollment|0|||
42044474|NCT00944034|75852424|FG011|Overall Study|Inappropriate enrollment|0|||
42044475|NCT00944034|75852413|FG000|Overall Study|Withdrawal by Subject|3|||
42044476|NCT00944034|75852414|FG001|Overall Study|Withdrawal by Subject|2|||
42044477|NCT00944034|75852415|FG002|Overall Study|Withdrawal by Subject|6|||
42044478|NCT00944034|75852416|FG003|Overall Study|Withdrawal by Subject|2|||
42044479|NCT00944034|75852417|FG004|Overall Study|Withdrawal by Subject|5|||
42044480|NCT00944034|75852418|FG005|Overall Study|Withdrawal by Subject|8|||
42044481|NCT00944034|75852419|FG006|Overall Study|Withdrawal by Subject|2|||
42044482|NCT00944034|75852420|FG007|Overall Study|Withdrawal by Subject|2|||
42044483|NCT00944034|75852421|FG008|Overall Study|Withdrawal by Subject|3|||
42044484|NCT00944034|75852422|FG009|Overall Study|Withdrawal by Subject|4|||
42044485|NCT00944034|75852423|FG010|Overall Study|Withdrawal by Subject|0|||
42044486|NCT00944034|75852424|FG011|Overall Study|Withdrawal by Subject|4|||
42044487|NCT00944034|75852413|FG000|Overall Study|Lost to Follow-up|0|||
42044488|NCT00944034|75852414|FG001|Overall Study|Lost to Follow-up|4|||
42044489|NCT00944034|75852415|FG002|Overall Study|Lost to Follow-up|2|||
42044490|NCT00944034|75852416|FG003|Overall Study|Lost to Follow-up|0|||
42044491|NCT00944034|75852417|FG004|Overall Study|Lost to Follow-up|5|||
42044492|NCT00944034|75852418|FG005|Overall Study|Lost to Follow-up|7|||
42044493|NCT00944034|75852419|FG006|Overall Study|Lost to Follow-up|0|||
42044494|NCT00944034|75852420|FG007|Overall Study|Lost to Follow-up|1|||
42044495|NCT00944034|75852421|FG008|Overall Study|Lost to Follow-up|5|||
42044496|NCT00944034|75852422|FG009|Overall Study|Lost to Follow-up|1|||
42044497|NCT00944034|75852423|FG010|Overall Study|Lost to Follow-up|1|||
42044498|NCT00944034|75852424|FG011|Overall Study|Lost to Follow-up|0|||
42044499|NCT00944034|75852413|FG000|Overall Study|Death|0|||
42044500|NCT00944034|75852414|FG001|Overall Study|Death|0|||
42044501|NCT00944034|75852415|FG002|Overall Study|Death|1|||
42044502|NCT00944034|75852416|FG003|Overall Study|Death|0|||
42044503|NCT00944034|75852417|FG004|Overall Study|Death|0|||
42044504|NCT00944034|75852418|FG005|Overall Study|Death|0|||
42044505|NCT00944034|75852419|FG006|Overall Study|Death|0|||
42356845|NCT01393743|76202032|FG000|Core Study|Participant's Choice|2|||
42356846|NCT01393743|76202033|FG001|Core Study|Participant's Choice|3|||
42044506|NCT00944034|75852420|FG007|Overall Study|Death|0|||
42044507|NCT00944034|75852421|FG008|Overall Study|Death|0|||
42044508|NCT00944034|75852422|FG009|Overall Study|Death|0|||
42044509|NCT00944034|75852423|FG010|Overall Study|Death|0|||
42044510|NCT00944034|75852424|FG011|Overall Study|Death|0|||
42044511|NCT00944034|75852413|FG000|Overall Study|Protocol Violation|2|||
42044512|NCT00944034|75852414|FG001|Overall Study|Protocol Violation|0|||
42044513|NCT00944034|75852415|FG002|Overall Study|Protocol Violation|0|||
42044514|NCT00944034|75852416|FG003|Overall Study|Protocol Violation|1|||
42044515|NCT00944034|75852417|FG004|Overall Study|Protocol Violation|2|||
42044516|NCT00944034|75852418|FG005|Overall Study|Protocol Violation|3|||
42044517|NCT00944034|75852419|FG006|Overall Study|Protocol Violation|0|||
42044518|NCT00944034|75852420|FG007|Overall Study|Protocol Violation|1|||
42044519|NCT00944034|75852421|FG008|Overall Study|Protocol Violation|1|||
42044520|NCT00944034|75852422|FG009|Overall Study|Protocol Violation|4|||
42044521|NCT00944034|75852423|FG010|Overall Study|Protocol Violation|0|||
42044522|NCT00944034|75852424|FG011|Overall Study|Protocol Violation|0|||
42044523|NCT00944034|75852413|FG000|Overall Study|Unable to classify|0|||
42044524|NCT00944034|75852414|FG001|Overall Study|Unable to classify|0|||
42044525|NCT00944034|75852415|FG002|Overall Study|Unable to classify|0|||
42044526|NCT00944034|75852416|FG003|Overall Study|Unable to classify|0|||
42044527|NCT00944034|75852417|FG004|Overall Study|Unable to classify|0|||
42044528|NCT00944034|75852418|FG005|Overall Study|Unable to classify|1|||
42356847|NCT01393743|76202034|FG002|Core Study|Participant's Choice|0|||
42044529|NCT00944034|75852419|FG006|Overall Study|Unable to classify|1|||
42044530|NCT00944034|75852420|FG007|Overall Study|Unable to classify|1|||
42044531|NCT00944034|75852421|FG008|Overall Study|Unable to classify|0|||
42044532|NCT00944034|75852422|FG009|Overall Study|Unable to classify|0|||
42044533|NCT00944034|75852423|FG010|Overall Study|Unable to classify|0|||
42044534|NCT00944034|75852424|FG011|Overall Study|Unable to classify|0|||
42044535|NCT00944034|75852413|FG000|Overall Study|Administrative reason|0|||
42044536|NCT00944034|75852414|FG001|Overall Study|Administrative reason|0|||
42044537|NCT00944034|75852415|FG002|Overall Study|Administrative reason|0|||
42044538|NCT00944034|75852416|FG003|Overall Study|Administrative reason|0|||
42044539|NCT00944034|75852417|FG004|Overall Study|Administrative reason|0|||
42044540|NCT00944034|75852418|FG005|Overall Study|Administrative reason|0|||
42044541|NCT00944034|75852419|FG006|Overall Study|Administrative reason|1|||
42044542|NCT00944034|75852420|FG007|Overall Study|Administrative reason|0|||
42044543|NCT00944034|75852421|FG008|Overall Study|Administrative reason|0|||
42044544|NCT00944034|75852422|FG009|Overall Study|Administrative reason|0|||
42044545|NCT00944034|75852423|FG010|Overall Study|Administrative reason|0|||
42044546|NCT00944034|75852424|FG011|Overall Study|Administrative reason|0|||
42044547|NCT00941304|75852472|FG000|Overall Study|Lost to Follow-up|1|||
42044548|NCT00941304|75852473|FG001|Overall Study|Lost to Follow-up|0|||
42044549|NCT00941304|75852474|FG002|Overall Study|Lost to Follow-up|0|||
42044550|NCT00941304|75852475|FG003|Overall Study|Lost to Follow-up|0|||
42044551|NCT00941304|75852476|FG004|Overall Study|Lost to Follow-up|0|||
42044552|NCT00941070|75852488|FG000|Overall Study|Patient non-compliant|1|||
42044553|NCT01098812|75852497|FG000|Overall Study|Death|2|||
42044554|NCT01098812|75852498|FG001|Overall Study|Death|0|||
42044555|NCT01098812|75852499|FG002|Overall Study|Death|1|||
42044556|NCT01098812|75852497|FG000|Overall Study|Lost to Follow-up|0|||
42044557|NCT01098812|75852498|FG001|Overall Study|Lost to Follow-up|1|||
42044558|NCT01098812|75852499|FG002|Overall Study|Lost to Follow-up|0|||
42044559|NCT00903201|75852509|FG000|Overall Study|Adverse Event|1|||
42044560|NCT00903201|75852510|FG001|Overall Study|Adverse Event|4|||
42044561|NCT00903201|75852511|FG002|Overall Study|Adverse Event|0|||
42044562|NCT00903201|75852509|FG000|Overall Study|Protocol Violation|2|||
42044563|NCT00903201|75852510|FG001|Overall Study|Protocol Violation|1|||
42044564|NCT00903201|75852511|FG002|Overall Study|Protocol Violation|0|||
42044565|NCT00903201|75852509|FG000|Overall Study|Lost to Follow-up|0|||
42044566|NCT00903201|75852510|FG001|Overall Study|Lost to Follow-up|1|||
42044567|NCT00903201|75852511|FG002|Overall Study|Lost to Follow-up|0|||
42044568|NCT00903201|75852509|FG000|Overall Study|Physician Decision|1|||
42044569|NCT00903201|75852510|FG001|Overall Study|Physician Decision|0|||
42044570|NCT00903201|75852511|FG002|Overall Study|Physician Decision|1|||
42044571|NCT00903201|75852509|FG000|Overall Study|Withdrawal by Subject|1|||
42044572|NCT00903201|75852510|FG001|Overall Study|Withdrawal by Subject|0|||
42044573|NCT00903201|75852511|FG002|Overall Study|Withdrawal by Subject|1|||
42044574|NCT00902265|75852521|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
42044575|NCT00902265|75852521|FG000|Overall Study|Adverse Event|2|||
42044576|NCT00902265|75852521|FG000|Overall Study|Lack of Efficacy|2|||
42044577|NCT00902265|75852521|FG000|Overall Study|Protocol Violation|1|||
42044578|NCT00943722|75852539|FG000|Base Study|Adverse Event|0|||
42044579|NCT00943722|75852540|FG001|Base Study|Adverse Event|0|||
42044580|NCT00943722|75852541|FG002|Base Study|Adverse Event|0|||
42044581|NCT00943722|75852542|FG003|Base Study|Adverse Event|1|||
42044582|NCT00943722|75852543|FG004|Base Study|Adverse Event|0|||
42044583|NCT00943722|75852544|FG005|Base Study|Adverse Event|0|||
42044584|NCT00943722|75852545|FG006|Base Study|Adverse Event|0|||
42044585|NCT00943722|75852539|FG000|Base Study|Lost to Follow-up|12|||
42044586|NCT00943722|75852540|FG001|Base Study|Lost to Follow-up|8|||
42044587|NCT00943722|75852541|FG002|Base Study|Lost to Follow-up|10|||
42044588|NCT00943722|75852542|FG003|Base Study|Lost to Follow-up|8|||
42044589|NCT00943722|75852543|FG004|Base Study|Lost to Follow-up|11|||
42044590|NCT00943722|75852544|FG005|Base Study|Lost to Follow-up|0|||
42044591|NCT00943722|75852545|FG006|Base Study|Lost to Follow-up|0|||
42044592|NCT00943722|75852539|FG000|Base Study|Physician Decision|1|||
42044593|NCT00943722|75852540|FG001|Base Study|Physician Decision|0|||
42044594|NCT00943722|75852541|FG002|Base Study|Physician Decision|0|||
42291151|NCT01946152|76124967|FG000|Overall Study|Adverse Event|1|||
42044595|NCT00943722|75852542|FG003|Base Study|Physician Decision|0|||
42044596|NCT00943722|75852543|FG004|Base Study|Physician Decision|1|||
42044597|NCT00943722|75852544|FG005|Base Study|Physician Decision|0|||
42044598|NCT00943722|75852545|FG006|Base Study|Physician Decision|0|||
42291152|NCT01946152|76124968|FG001|Overall Study|Adverse Event|0|||
42044599|NCT00943722|75852539|FG000|Base Study|Pregnancy|0|||
42044600|NCT00943722|75852540|FG001|Base Study|Pregnancy|0|||
42044601|NCT00943722|75852541|FG002|Base Study|Pregnancy|1|||
42291153|NCT01946152|76124969|FG002|Overall Study|Adverse Event|0|||
42044602|NCT00943722|75852542|FG003|Base Study|Pregnancy|0|||
42044603|NCT00943722|75852543|FG004|Base Study|Pregnancy|2|||
42044604|NCT00943722|75852544|FG005|Base Study|Pregnancy|0|||
42044605|NCT00943722|75852545|FG006|Base Study|Pregnancy|0|||
42044606|NCT00943722|75852539|FG000|Base Study|Protocol Violation|0|||
42044607|NCT00943722|75852540|FG001|Base Study|Protocol Violation|1|||
42044608|NCT00943722|75852541|FG002|Base Study|Protocol Violation|0|||
42044609|NCT00943722|75852542|FG003|Base Study|Protocol Violation|0|||
42044610|NCT00943722|75852543|FG004|Base Study|Protocol Violation|2|||
42044611|NCT00943722|75852544|FG005|Base Study|Protocol Violation|0|||
42044612|NCT00943722|75852545|FG006|Base Study|Protocol Violation|0|||
42044613|NCT00943722|75852539|FG000|Base Study|Withdrawal by Subject|12|||
42044614|NCT00943722|75852540|FG001|Base Study|Withdrawal by Subject|13|||
42044615|NCT00943722|75852541|FG002|Base Study|Withdrawal by Subject|2|||
42044616|NCT00943722|75852542|FG003|Base Study|Withdrawal by Subject|13|||
42044617|NCT00943722|75852543|FG004|Base Study|Withdrawal by Subject|8|||
42044618|NCT00943722|75852544|FG005|Base Study|Withdrawal by Subject|0|||
42044619|NCT00943722|75852545|FG006|Base Study|Withdrawal by Subject|0|||
42044620|NCT00943722|75852539|FG000|Base Study|Month 12 visit not completed|0|||
42044621|NCT00943722|75852540|FG001|Base Study|Month 12 visit not completed|0|||
42044622|NCT00943722|75852541|FG002|Base Study|Month 12 visit not completed|0|||
42044623|NCT00943722|75852542|FG003|Base Study|Month 12 visit not completed|0|||
42044624|NCT00943722|75852543|FG004|Base Study|Month 12 visit not completed|2|||
42044625|NCT00943722|75852544|FG005|Base Study|Month 12 visit not completed|0|||
42044626|NCT00943722|75852545|FG006|Base Study|Month 12 visit not completed|0|||
42044627|NCT00943722|75852539|FG000|First Extension Study: EXT 1|Adverse Event|0|||
42044628|NCT00943722|75852540|FG001|First Extension Study: EXT 1|Adverse Event|0|||
42044629|NCT00943722|75852541|FG002|First Extension Study: EXT 1|Adverse Event|0|||
42044630|NCT00943722|75852542|FG003|First Extension Study: EXT 1|Adverse Event|0|||
42044631|NCT00943722|75852543|FG004|First Extension Study: EXT 1|Adverse Event|0|||
42044632|NCT00943722|75852544|FG005|First Extension Study: EXT 1|Adverse Event|1|||
42044633|NCT00943722|75852545|FG006|First Extension Study: EXT 1|Adverse Event|0|||
42044634|NCT00943722|75852539|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
42044635|NCT00943722|75852540|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
42044636|NCT00943722|75852541|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
42044637|NCT00943722|75852542|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
42044638|NCT00943722|75852543|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
42044639|NCT00943722|75852544|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
42044640|NCT00943722|75852545|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
42044641|NCT00943722|75852539|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
42044642|NCT00943722|75852540|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
42044643|NCT00943722|75852541|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
42044644|NCT00943722|75852542|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
42044645|NCT00943722|75852543|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
42044646|NCT00943722|75852544|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
42044647|NCT00943722|75852545|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
42044648|NCT00943722|75852539|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
42044649|NCT00943722|75852540|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
42044650|NCT00943722|75852541|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
42044651|NCT00943722|75852542|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
42044652|NCT00943722|75852543|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
42044653|NCT00943722|75852544|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
42044654|NCT00943722|75852545|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
42044655|NCT00943722|75852539|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
42044656|NCT00943722|75852540|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
42044657|NCT00943722|75852541|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
42044658|NCT00943722|75852542|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
42044659|NCT00943722|75852543|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
42044660|NCT00943722|75852544|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
42044661|NCT00943722|75852545|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
42044662|NCT00943722|75852539|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
42044663|NCT00943722|75852540|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
42044664|NCT00943722|75852541|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
42044665|NCT00943722|75852542|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
42044666|NCT00943722|75852543|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
42044667|NCT00943722|75852544|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
42044668|NCT00943722|75852545|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
42044669|NCT00943722|75852539|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
42044670|NCT00943722|75852540|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
42172521|NCT00351611|75979411|FG001|Overall Study|Other|0|||
42172522|NCT00351611|75979410|FG000|Overall Study|Protocol Violation|0|||
42291154|NCT01946152|76124970|FG003|Overall Study|Adverse Event|0|||
42291155|NCT01946152|76124967|FG000|Overall Study|Withdrawal by Subject|0|||
42291156|NCT01946152|76124968|FG001|Overall Study|Withdrawal by Subject|2|||
42291157|NCT01946152|76124969|FG002|Overall Study|Withdrawal by Subject|0|||
42291158|NCT01946152|76124970|FG003|Overall Study|Withdrawal by Subject|0|||
42291159|NCT01946152|76124967|FG000|Overall Study|Progression|0|||
42291160|NCT01946152|76124968|FG001|Overall Study|Progression|1|||
42291161|NCT01946152|76124969|FG002|Overall Study|Progression|4|||
42044671|NCT00943722|75852541|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
42291162|NCT01946152|76124970|FG003|Overall Study|Progression|7|||
42291163|NCT01946152|76124967|FG000|Overall Study|Physician Decision|0|||
42044672|NCT00943722|75852542|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
42044673|NCT00943722|75852543|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
42044674|NCT00943722|75852544|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
42044675|NCT00943722|75852545|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
42044676|NCT00943722|75852539|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
42044677|NCT00943722|75852540|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
42044678|NCT00943722|75852541|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
42044679|NCT00943722|75852542|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
42044680|NCT00943722|75852543|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
42044681|NCT00943722|75852544|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
42044682|NCT00943722|75852545|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
42044683|NCT00943722|75852539|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
42044684|NCT00943722|75852540|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
42044685|NCT00943722|75852541|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
42044686|NCT00943722|75852542|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
42044687|NCT00943722|75852543|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
42044688|NCT00943722|75852544|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
42044689|NCT00943722|75852545|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
42044690|NCT00901485|75852568|FG000|Overall Study|Lack of Efficacy|0|||
42044691|NCT00901485|75852569|FG001|Overall Study|Lack of Efficacy|2|||
42044692|NCT00901485|75852568|FG000|Overall Study|Withdrawal by Subject|1|||
42044693|NCT00901485|75852569|FG001|Overall Study|Withdrawal by Subject|2|||
42044694|NCT00896337|75852575|FG000|Overall Study|Death|7|||
42044695|NCT00896337|75852575|FG000|Overall Study|Withdrawal by Subject|7|||
42044696|NCT00896337|75852575|FG000|Overall Study|Lost to Follow-up|11|||
42044697|NCT00953706|75852586|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
42044698|NCT00953706|75852587|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
42044699|NCT00953706|75852588|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
42044700|NCT00953706|75852589|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
42044701|NCT00953706|75852586|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
42044702|NCT00953706|75852587|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
42044703|NCT00953706|75852588|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
42044704|NCT00953706|75852589|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
42044705|NCT00953706|75852586|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
42044706|NCT00953706|75852587|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
42044707|NCT00953706|75852588|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
42044708|NCT00953706|75852589|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
42044709|NCT00953706|75852586|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
42044710|NCT00953706|75852587|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
42044711|NCT00953706|75852588|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
42044712|NCT00953706|75852589|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
42044713|NCT00953706|75852586|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
42044714|NCT00953706|75852587|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
42044715|NCT00953706|75852588|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
42044716|NCT00953706|75852589|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
42044717|NCT00953706|75852586|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
42044718|NCT00953706|75852587|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
42044719|NCT00953706|75852588|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
42044720|NCT00953706|75852589|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
42044721|NCT00953706|75852586|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
42044722|NCT00953706|75852587|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
42044723|NCT00953706|75852588|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
42044724|NCT00953706|75852589|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
42044725|NCT00953706|75852586|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
42044726|NCT00953706|75852587|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
42044727|NCT00953706|75852588|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
42044728|NCT00953706|75852589|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
42044729|NCT00953706|75852586|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
42044730|NCT00953706|75852587|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
42044731|NCT00953706|75852588|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
42044732|NCT00953706|75852589|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
42044733|NCT00953706|75852586|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
42044734|NCT00953706|75852587|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
42044735|NCT00953706|75852588|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
42172523|NCT00351611|75979411|FG001|Overall Study|Protocol Violation|2|||
42044736|NCT00953706|75852589|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
42044737|NCT00953706|75852586|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
42044738|NCT00953706|75852587|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
42044739|NCT00953706|75852588|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
42044740|NCT00953706|75852589|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
42044741|NCT00940992|75852602|FG000|Overall Study|Adverse Event|2|||
42044742|NCT00940992|75852603|FG001|Overall Study|Adverse Event|0|||
42044743|NCT00940992|75852604|FG002|Overall Study|Adverse Event|1|||
42044744|NCT00940992|75852602|FG000|Overall Study|subject request|2|||
42044745|NCT00940992|75852603|FG001|Overall Study|subject request|1|||
42044746|NCT00940992|75852604|FG002|Overall Study|subject request|0|||
42044747|NCT00940992|75852602|FG000|Overall Study|Lost to Follow-up|0|||
42044748|NCT00940992|75852603|FG001|Overall Study|Lost to Follow-up|1|||
42044749|NCT00940992|75852604|FG002|Overall Study|Lost to Follow-up|1|||
42044750|NCT00938964|75852614|FG000|Overall Study|Death|3|||
42044751|NCT00938964|75852615|FG001|Overall Study|Death|3|||
42044752|NCT00938964|75852614|FG000|Overall Study|Lost to Follow-up|2|||
42044753|NCT00938964|75852615|FG001|Overall Study|Lost to Follow-up|3|||
42044754|NCT00938964|75852614|FG000|Overall Study|Withdrawal by Subject|22|||
42044755|NCT00938964|75852615|FG001|Overall Study|Withdrawal by Subject|18|||
42044756|NCT00938964|75852614|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
42044757|NCT00938964|75852615|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
42044758|NCT00938886|75852623|FG000|Overall Study|Death|0|||
42044759|NCT00938886|75852624|FG001|Overall Study|Death|1|||
42044760|NCT00938886|75852623|FG000|Overall Study|Withdrawal by Subject|4|||
42044761|NCT00938886|75852624|FG001|Overall Study|Withdrawal by Subject|7|||
42044762|NCT00938886|75852623|FG000|Overall Study|Lost to Follow-up|3|||
42044763|NCT00938886|75852624|FG001|Overall Study|Lost to Follow-up|2|||
42044764|NCT00942708|75852630|FG000|Overall Study|Withdrawal by Subject|1|||
42044765|NCT00937950|75852635|FG000|Overall Study|Withdrawal by Subject|23|||
42044766|NCT00937950|75852635|FG000|Overall Study|Migrated/moved from study area|27|||
42044767|NCT00937950|75852635|FG000|Overall Study|Lost to Follow-up|144|||
42044768|NCT00937950|75852635|FG000|Overall Study|Missing confirmed|4|||
42044769|NCT00937950|75852635|FG000|Overall Study|Other|18|||
42044770|NCT00942162|75852642|FG000|Overall Study|Death|45|||
42044771|NCT00942162|75852643|FG001|Overall Study|Death|35|||
42044772|NCT00942162|75852644|FG002|Overall Study|Death|0|||
42044773|NCT00942162|75852642|FG000|Overall Study|Withdrawal by Subject|7|||
42291164|NCT01946152|76124968|FG001|Overall Study|Physician Decision|0|||
42291165|NCT01946152|76124969|FG002|Overall Study|Physician Decision|1|||
42044774|NCT00942162|75852643|FG001|Overall Study|Withdrawal by Subject|2|||
42044775|NCT00942162|75852644|FG002|Overall Study|Withdrawal by Subject|0|||
42044776|NCT00942162|75852642|FG000|Overall Study|Lost to Follow-up|4|||
42044777|NCT00942162|75852643|FG001|Overall Study|Lost to Follow-up|0|||
42044778|NCT00942162|75852644|FG002|Overall Study|Lost to Follow-up|0|||
42044779|NCT00942162|75852642|FG000|Overall Study|Other|14|||
42044780|NCT00942162|75852643|FG001|Overall Study|Other|13|||
42044781|NCT00942162|75852644|FG002|Overall Study|Other|2|||
42044782|NCT00942084|75852654|FG000|Overall Study|Death|2|||
42044783|NCT00941928|75852658|FG000|Overall Study|Withdrawal by Subject|1|||
42044784|NCT00941928|75852658|FG000|Overall Study|Disease Progression|1|||
42044785|NCT00937560|75852662|FG000|Initial Treatment|Death|6|||
42044786|NCT00937560|75852662|FG000|Initial Treatment|Withdraw consent|3|||
42044787|NCT00937560|75852662|FG000|Initial Treatment|Adverse Event|1|||
42044788|NCT00937560|75852662|FG000|Initial Treatment|Lost to Follow-up|1|||
42044789|NCT00937560|75852662|FG000|Initial Treatment|No end of study page|10|||
42044790|NCT00937560|75852662|FG000|Maintenance Treatment|Death|12|||
42044791|NCT00937560|75852662|FG000|Maintenance Treatment|Withdraw consent|5|||
42044792|NCT00937560|75852662|FG000|Maintenance Treatment|According to protocol|1|||
42044793|NCT00594568|75852669|FG000|Initial Treatment|Adverse Event|51|||
42044794|NCT00594568|75852670|FG001|Initial Treatment|Adverse Event|121|||
42044795|NCT00594568|75852671|FG002|Initial Treatment|Adverse Event|144|||
42044796|NCT00594568|75852669|FG000|Initial Treatment|Death|6|||
42044797|NCT00594568|75852670|FG001|Initial Treatment|Death|11|||
42044798|NCT00594568|75852671|FG002|Initial Treatment|Death|15|||
42044799|NCT00594568|75852669|FG000|Initial Treatment|Lost to Follow-up|4|||
42044800|NCT00594568|75852670|FG001|Initial Treatment|Lost to Follow-up|1|||
42044801|NCT00594568|75852671|FG002|Initial Treatment|Lost to Follow-up|4|||
42044802|NCT00594568|75852669|FG000|Initial Treatment|Physician Decision|3|||
42044803|NCT00594568|75852670|FG001|Initial Treatment|Physician Decision|2|||
42044804|NCT00594568|75852671|FG002|Initial Treatment|Physician Decision|4|||
42044805|NCT00594568|75852669|FG000|Initial Treatment|Protocol Violation|2|||
42044806|NCT00594568|75852670|FG001|Initial Treatment|Protocol Violation|2|||
42044807|NCT00594568|75852671|FG002|Initial Treatment|Protocol Violation|5|||
42044808|NCT00594568|75852669|FG000|Initial Treatment|Withdrawal by Subject|25|||
42044809|NCT00594568|75852670|FG001|Initial Treatment|Withdrawal by Subject|31|||
42044810|NCT00594568|75852671|FG002|Initial Treatment|Withdrawal by Subject|46|||
42044811|NCT00594568|75852669|FG000|Initial Treatment|Sponsor decision|193|||
42291166|NCT01946152|76124970|FG003|Overall Study|Physician Decision|0|||
42044812|NCT00594568|75852670|FG001|Initial Treatment|Sponsor decision|142|||
42044813|NCT00594568|75852671|FG002|Initial Treatment|Sponsor decision|147|||
42044814|NCT00594568|75852669|FG000|Initial Treatment|Caregiver decision|21|||
42044815|NCT00594568|75852670|FG001|Initial Treatment|Caregiver decision|36|||
42044816|NCT00594568|75852671|FG002|Initial Treatment|Caregiver decision|36|||
42044817|NCT00594568|75852669|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
42044818|NCT00594568|75852670|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
42044819|NCT00594568|75852671|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
42044820|NCT00594568|75852669|FG000|Initial Treatment|Entry criteria exclusion|0|||
42044821|NCT00594568|75852670|FG001|Initial Treatment|Entry criteria exclusion|1|||
42044822|NCT00594568|75852671|FG002|Initial Treatment|Entry criteria exclusion|1|||
42044823|NCT00594568|75852669|FG000|Delayed Start|Death|0|||
42044824|NCT00594568|75852670|FG001|Delayed Start|Death|0|||
42044825|NCT00594568|75852671|FG002|Delayed Start|Death|1|||
42044826|NCT00594568|75852669|FG000|Delayed Start|Adverse Event|12|||
42044827|NCT00594568|75852670|FG001|Delayed Start|Adverse Event|2|||
42044828|NCT00594568|75852671|FG002|Delayed Start|Adverse Event|2|||
42044829|NCT00594568|75852669|FG000|Delayed Start|Withdrawal by Subject|4|||
42044830|NCT00594568|75852670|FG001|Delayed Start|Withdrawal by Subject|3|||
42044831|NCT00594568|75852671|FG002|Delayed Start|Withdrawal by Subject|0|||
42044832|NCT00594568|75852669|FG000|Delayed Start|Physician Decision|0|||
42044833|NCT00594568|75852670|FG001|Delayed Start|Physician Decision|0|||
42044834|NCT00594568|75852671|FG002|Delayed Start|Physician Decision|1|||
42044835|NCT00594568|75852669|FG000|Delayed Start|Lost to Follow-up|0|||
42044836|NCT00594568|75852670|FG001|Delayed Start|Lost to Follow-up|0|||
42044837|NCT00594568|75852671|FG002|Delayed Start|Lost to Follow-up|1|||
42044838|NCT00594568|75852669|FG000|Delayed Start|Caregiver Decision|5|||
42044839|NCT00594568|75852670|FG001|Delayed Start|Caregiver Decision|6|||
42044840|NCT00594568|75852671|FG002|Delayed Start|Caregiver Decision|2|||
42044841|NCT00594568|75852669|FG000|Delayed Start|Sponsor Decision|77|||
42044842|NCT00594568|75852670|FG001|Delayed Start|Sponsor Decision|66|||
42044843|NCT00594568|75852671|FG002|Delayed Start|Sponsor Decision|59|||
42044844|NCT00594568|75852669|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
42044845|NCT00594568|75852670|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
42044846|NCT00594568|75852671|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
42044847|NCT00594568|75852669|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
42044848|NCT00594568|75852670|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
42044849|NCT00594568|75852671|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
42044850|NCT00594568|75852669|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
42044851|NCT00594568|75852670|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
42044852|NCT00594568|75852671|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
42044853|NCT00594568|75852669|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
42044854|NCT00594568|75852670|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
42044855|NCT00594568|75852671|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
42044856|NCT00594568|75852669|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
42044857|NCT00594568|75852670|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
42044858|NCT00594568|75852671|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
42044859|NCT00594568|75852669|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
42044860|NCT00594568|75852670|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
42044861|NCT00594568|75852671|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
42044862|NCT00875056|75852699|FG000|Overall Study|Adverse Event|6|||
42044863|NCT00875056|75852700|FG001|Overall Study|Adverse Event|1|||
42044864|NCT00875056|75852701|FG002|Overall Study|Adverse Event|2|||
42044865|NCT00875056|75852699|FG000|Overall Study|Progressive Disease|14|||
42044866|NCT00875056|75852700|FG001|Overall Study|Progressive Disease|8|||
42044867|NCT00875056|75852701|FG002|Overall Study|Progressive Disease|3|||
42044868|NCT00875056|75852699|FG000|Overall Study|Withdrawal by Subject|3|||
42044869|NCT00875056|75852700|FG001|Overall Study|Withdrawal by Subject|0|||
42044870|NCT00875056|75852701|FG002|Overall Study|Withdrawal by Subject|1|||
42044871|NCT00940602|75852711|FG000|Overall Study|Administrative problems|1|||
42044872|NCT00940602|75852712|FG001|Overall Study|Administrative problems|1|||
42044873|NCT00940602|75852711|FG000|Overall Study|Patient/guardian decision|13|||
42044874|NCT00940602|75852712|FG001|Overall Study|Patient/guardian decision|28|||
42044875|NCT00940602|75852711|FG000|Overall Study|Physician Decision|8|||
42044876|NCT00940602|75852712|FG001|Overall Study|Physician Decision|5|||
42044877|NCT00940602|75852711|FG000|Overall Study|Pregnancy|1|||
42044878|NCT00940602|75852712|FG001|Overall Study|Pregnancy|0|||
42044879|NCT00940602|75852711|FG000|Overall Study|Protocol Deviation (untreated)|1|||
42044880|NCT00940602|75852712|FG001|Overall Study|Protocol Deviation (untreated)|0|||
42044881|NCT00940602|75852711|FG000|Overall Study|Disease progression|8|||
42044882|NCT00940602|75852712|FG001|Overall Study|Disease progression|2|||
42044883|NCT00940602|75852711|FG000|Overall Study|Death|38|||
42044884|NCT00940602|75852712|FG001|Overall Study|Death|19|||
42172524|NCT00351533|75979419|FG000|Overall Study|Extubated before first BAL|1|||
42044885|NCT00940602|75852711|FG000|Overall Study|Lost to Follow-up|3|||
42044886|NCT00940602|75852712|FG001|Overall Study|Lost to Follow-up|1|||
42044887|NCT00940602|75852711|FG000|Overall Study|Patient withdrew consent|26|||
42044888|NCT00940602|75852712|FG001|Overall Study|Patient withdrew consent|13|||
42044889|NCT00940602|75852711|FG000|Overall Study|Adverse Event|7|||
42044890|NCT00940602|75852712|FG001|Overall Study|Adverse Event|2|||
42044891|NCT00940602|75852711|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
42044892|NCT00940602|75852712|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
42044893|NCT00875524|75852721|FG000|Overall Study|Serious adverse event|0|||
42044894|NCT00875524|75852722|FG001|Overall Study|Serious adverse event|1|||
42044895|NCT00875524|75852721|FG000|Overall Study|Protocol Violation|4|||
42044896|NCT00875524|75852722|FG001|Overall Study|Protocol Violation|0|||
42044897|NCT00875524|75852721|FG000|Overall Study|Lost to Follow-up|1|||
42044898|NCT00875524|75852722|FG001|Overall Study|Lost to Follow-up|0|||
42044899|NCT00875524|75852721|FG000|Overall Study|Withdrawal by Subject|3|||
42044900|NCT00875524|75852722|FG001|Overall Study|Withdrawal by Subject|5|||
42044901|NCT01094288|75852736|FG000|Overall Study|Adverse Event|0|||
42044902|NCT01094288|75852737|FG001|Overall Study|Adverse Event|3|||
42044903|NCT01094288|75852738|FG002|Overall Study|Adverse Event|1|||
42044904|NCT01094288|75852739|FG003|Overall Study|Adverse Event|1|||
42044905|NCT01094288|75852740|FG004|Overall Study|Adverse Event|0|||
42044906|NCT01094288|75852741|FG005|Overall Study|Adverse Event|0|||
42044907|NCT01094288|75852742|FG006|Overall Study|Adverse Event|0|||
42044908|NCT01094288|75852743|FG007|Overall Study|Adverse Event|0|||
42044909|NCT01094288|75852736|FG000|Overall Study|Withdrawal by Subject|0|||
42044910|NCT01094288|75852737|FG001|Overall Study|Withdrawal by Subject|1|||
42044911|NCT01094288|75852738|FG002|Overall Study|Withdrawal by Subject|2|||
42044912|NCT01094288|75852739|FG003|Overall Study|Withdrawal by Subject|0|||
42044913|NCT01094288|75852740|FG004|Overall Study|Withdrawal by Subject|0|||
42044914|NCT01094288|75852741|FG005|Overall Study|Withdrawal by Subject|0|||
42044915|NCT01094288|75852742|FG006|Overall Study|Withdrawal by Subject|0|||
42044916|NCT01094288|75852743|FG007|Overall Study|Withdrawal by Subject|2|||
42044917|NCT01094288|75852736|FG000|Overall Study|Initiation of Alternative Therapy|0|||
42044918|NCT01094288|75852737|FG001|Overall Study|Initiation of Alternative Therapy|0|||
42044919|NCT01094288|75852738|FG002|Overall Study|Initiation of Alternative Therapy|1|||
42044920|NCT01094288|75852739|FG003|Overall Study|Initiation of Alternative Therapy|0|||
42044921|NCT01094288|75852740|FG004|Overall Study|Initiation of Alternative Therapy|0|||
42044922|NCT01094288|75852741|FG005|Overall Study|Initiation of Alternative Therapy|0|||
42044923|NCT01094288|75852742|FG006|Overall Study|Initiation of Alternative Therapy|0|||
42044924|NCT01094288|75852743|FG007|Overall Study|Initiation of Alternative Therapy|0|||
42044925|NCT01094288|75852736|FG000|Overall Study|Reason not Specified|2|||
42044926|NCT01094288|75852737|FG001|Overall Study|Reason not Specified|3|||
42044927|NCT01094288|75852738|FG002|Overall Study|Reason not Specified|0|||
42044928|NCT01094288|75852739|FG003|Overall Study|Reason not Specified|1|||
42044929|NCT01094288|75852740|FG004|Overall Study|Reason not Specified|0|||
42044930|NCT01094288|75852741|FG005|Overall Study|Reason not Specified|0|||
42044931|NCT01094288|75852742|FG006|Overall Study|Reason not Specified|0|||
42044932|NCT01094288|75852743|FG007|Overall Study|Reason not Specified|0|||
42044933|NCT01094288|75852736|FG000|Overall Study|Ongoing Participants|0|||
42044934|NCT01094288|75852737|FG001|Overall Study|Ongoing Participants|3|||
42044935|NCT01094288|75852738|FG002|Overall Study|Ongoing Participants|0|||
42044936|NCT01094288|75852739|FG003|Overall Study|Ongoing Participants|0|||
42044937|NCT01094288|75852740|FG004|Overall Study|Ongoing Participants|0|||
42044938|NCT01094288|75852741|FG005|Overall Study|Ongoing Participants|0|||
42044939|NCT01094288|75852742|FG006|Overall Study|Ongoing Participants|0|||
42044940|NCT01094288|75852743|FG007|Overall Study|Ongoing Participants|0|||
42044941|NCT00874120|75852767|FG000|First Intervention|Adverse Event|0|||
42044942|NCT00874120|75852768|FG001|First Intervention|Adverse Event|1|||
42044943|NCT00874120|75852767|FG000|First Intervention|Withdrawal by Subject|2|||
42044944|NCT00874120|75852768|FG001|First Intervention|Withdrawal by Subject|0|||
42044945|NCT00874120|75852767|FG000|First Intervention|Lost to Follow-up|0|||
42044946|NCT00874120|75852768|FG001|First Intervention|Lost to Follow-up|1|||
42044947|NCT00874120|75852767|FG000|First Intervention|Protocol Violation|3|||
42291167|NCT01946152|76124967|FG000|Overall Study|Second malignancy|0|||
42044948|NCT00874120|75852768|FG001|First Intervention|Protocol Violation|0|||
42044949|NCT00874120|75852767|FG000|First Intervention|positive drug test|1|||
42044950|NCT00874120|75852768|FG001|First Intervention|positive drug test|0|||
42044951|NCT00874120|75852767|FG000|Second Intervention|Withdrawal by Subject|1|||
42044952|NCT00874120|75852768|FG001|Second Intervention|Withdrawal by Subject|0|||
42044953|NCT00874120|75852767|FG000|Second Intervention|Protocol Violation|1|||
42044954|NCT00874120|75852768|FG001|Second Intervention|Protocol Violation|0|||
42044955|NCT00939822|75852776|FG000|Overall Study|Lost to Follow-up|1|||
42044956|NCT00939822|75852777|FG001|Overall Study|Lost to Follow-up|0|||
42044957|NCT00939822|75852776|FG000|Overall Study|withdrew from study due to busy schedule|1|||
42044958|NCT00939822|75852777|FG001|Overall Study|withdrew from study due to busy schedule|1|||
42044959|NCT00939822|75852776|FG000|Overall Study|Mental health issues|0|||
42044960|NCT00939822|75852777|FG001|Overall Study|Mental health issues|2|||
42044961|NCT00939510|75852783|FG000|Overall Study|Withdrawal by Subject|1|||
42044962|NCT01098266|75852789|FG000|Overall Study|Physician Decision|1|||
42044963|NCT01098266|75852790|FG001|Overall Study|Physician Decision|0|||
42044964|NCT01098266|75852789|FG000|Overall Study|Death|3|||
42044965|NCT01098266|75852790|FG001|Overall Study|Death|2|||
42044966|NCT01098266|75852789|FG000|Overall Study|Withdrawal by Subject|3|||
42044967|NCT01098266|75852790|FG001|Overall Study|Withdrawal by Subject|5|||
42044968|NCT00935532|75852798|FG000|Overall Study|Adverse Event|11|||
42044969|NCT00935532|75852799|FG001|Overall Study|Adverse Event|6|||
42044970|NCT00935532|75852798|FG000|Overall Study|Death|1|||
42044971|NCT00935532|75852799|FG001|Overall Study|Death|0|||
42044972|NCT00935532|75852798|FG000|Overall Study|Lost to Follow-up|1|||
42044973|NCT00935532|75852799|FG001|Overall Study|Lost to Follow-up|0|||
42044974|NCT00935532|75852798|FG000|Overall Study|Physician Decision|1|||
42044975|NCT00935532|75852799|FG001|Overall Study|Physician Decision|2|||
42044976|NCT00935532|75852798|FG000|Overall Study|Protocol Violation|2|||
42044977|NCT00935532|75852799|FG001|Overall Study|Protocol Violation|1|||
42044978|NCT00935532|75852798|FG000|Overall Study|Subject Decision|2|||
42044979|NCT00935532|75852799|FG001|Overall Study|Subject Decision|1|||
42044980|NCT00935532|75852798|FG000|Overall Study|Sponsor Decision|0|||
42044981|NCT00935532|75852799|FG001|Overall Study|Sponsor Decision|1|||
42044982|NCT00935532|75852798|FG000|Overall Study|Loss Glucose Control|4|||
42044983|NCT00935532|75852799|FG001|Overall Study|Loss Glucose Control|0|||
42044984|NCT01093586|75852805|FG000|Overall Study|Failed to engraft|3|||
42044985|NCT00937404|75852809|FG000|Overall Study|Protocol Violation|1|||
42044986|NCT00937404|75852809|FG000|Overall Study|Withdrawal by Subject|1|||
42044987|NCT01098110|75852816|FG000|Overall Study|Withdrawal by Subject|14|||
42044988|NCT01098110|75852817|FG001|Overall Study|Withdrawal by Subject|24|||
42044989|NCT01098110|75852818|FG002|Overall Study|Withdrawal by Subject|19|||
42044990|NCT01098110|75852816|FG000|Overall Study|Adverse Event|30|||
42044991|NCT01098110|75852817|FG001|Overall Study|Adverse Event|32|||
42044992|NCT01098110|75852818|FG002|Overall Study|Adverse Event|43|||
42044993|NCT01098110|75852816|FG000|Overall Study|Lack of Efficacy|13|||
42044994|NCT01098110|75852817|FG001|Overall Study|Lack of Efficacy|9|||
42044995|NCT01098110|75852818|FG002|Overall Study|Lack of Efficacy|27|||
42044996|NCT01098110|75852816|FG000|Overall Study|Other|4|||
42044997|NCT01098110|75852817|FG001|Overall Study|Other|7|||
42044998|NCT01098110|75852818|FG002|Overall Study|Other|5|||
42044999|NCT01098110|75852816|FG000|Overall Study|Untreated|1|||
42045000|NCT01098110|75852817|FG001|Overall Study|Untreated|1|||
42045001|NCT01098110|75852818|FG002|Overall Study|Untreated|0|||
42045002|NCT01092728|75852828|FG000|Overall Study|Withdrawal by Subject|2|||
42045003|NCT01092728|75852829|FG001|Overall Study|Withdrawal by Subject|0|||
42045004|NCT01092728|75852828|FG000|Overall Study|Adverse Event|0|||
42045005|NCT01092728|75852829|FG001|Overall Study|Adverse Event|1|||
42045006|NCT01092728|75852828|FG000|Overall Study|Disease Progression|1|||
42045007|NCT01092728|75852829|FG001|Overall Study|Disease Progression|13|||
42045008|NCT01092728|75852828|FG000|Overall Study|Prohibited Concomitant Medications|1|||
42045009|NCT01092728|75852829|FG001|Overall Study|Prohibited Concomitant Medications|0|||
42045010|NCT01096550|75852837|FG000|Overall Study|discontinued site|10|||
42045011|NCT01096550|75852838|FG001|Overall Study|discontinued site|11|||
42045012|NCT01096550|75852837|FG000|Overall Study|non-regular treatment track at clinic|1|||
42045013|NCT01096550|75852838|FG001|Overall Study|non-regular treatment track at clinic|1|||
42045014|NCT01096550|75852837|FG000|Overall Study|clinic readmission|1|||
42045015|NCT01096550|75852838|FG001|Overall Study|clinic readmission|1|||
42045016|NCT01096550|75852837|FG000|Overall Study|Withdrawal by Subject|0|||
42045017|NCT01096550|75852838|FG001|Overall Study|Withdrawal by Subject|1|||
42045018|NCT01096550|75852837|FG000|Overall Study|non-African American participant|13|||
42045019|NCT01096550|75852838|FG001|Overall Study|non-African American participant|6|||
42045020|NCT01096550|75852837|FG000|Overall Study|Lost to Follow-up|12|||
42045021|NCT01096550|75852838|FG001|Overall Study|Lost to Follow-up|9|||
42045022|NCT01101542|75852844|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
42045023|NCT01101542|75852844|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
42045024|NCT01101542|75852844|FG000|Year 4 Surveillance Period|Other|287|||
42045025|NCT01101542|75852844|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
42045026|NCT01101542|75852844|FG000|Year 5 Surveillance Period|Pregnancy|1|||
42045027|NCT01101542|75852844|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
42045028|NCT01101542|75852844|FG000|Year 6 Surveillance Period|Pregnancy|1|||
42045029|NCT01101542|75852844|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
42045030|NCT00937326|75852853|FG000|Overall Study|Adverse Event|0|||
42045031|NCT00937326|75852854|FG001|Overall Study|Adverse Event|3|||
42045032|NCT00937326|75852855|FG002|Overall Study|Adverse Event|1|||
42045033|NCT00937326|75852856|FG003|Overall Study|Adverse Event|1|||
42045034|NCT00937326|75852857|FG004|Overall Study|Adverse Event|2|||
42045035|NCT00937326|75852853|FG000|Overall Study|Death|0|||
42045036|NCT00937326|75852854|FG001|Overall Study|Death|0|||
42045037|NCT00937326|75852855|FG002|Overall Study|Death|1|||
42045038|NCT00937326|75852856|FG003|Overall Study|Death|0|||
42045039|NCT00937326|75852857|FG004|Overall Study|Death|0|||
42045040|NCT00937326|75852853|FG000|Overall Study|Withdrawal by Subject|3|||
42045041|NCT00937326|75852854|FG001|Overall Study|Withdrawal by Subject|4|||
42045042|NCT00937326|75852855|FG002|Overall Study|Withdrawal by Subject|1|||
42045043|NCT00937326|75852856|FG003|Overall Study|Withdrawal by Subject|4|||
42045044|NCT00937326|75852857|FG004|Overall Study|Withdrawal by Subject|3|||
42045045|NCT00937326|75852853|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
42045046|NCT00937326|75852854|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
42045047|NCT00937326|75852855|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
42045048|NCT00937326|75852856|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
42045049|NCT00937326|75852857|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
42045050|NCT00873730|75852876|FG000|Overall Study|Protocol Deviation|5|||
42045051|NCT00873730|75852877|FG001|Overall Study|Protocol Deviation|2|||
42045052|NCT00873730|75852876|FG000|Overall Study|Adverse Event|0|||
42045053|NCT00873730|75852877|FG001|Overall Study|Adverse Event|2|||
42045054|NCT00873730|75852876|FG000|Overall Study|Withdrawal by Subject|0|||
42045055|NCT00873730|75852877|FG001|Overall Study|Withdrawal by Subject|1|||
42045056|NCT00873730|75852876|FG000|Overall Study|Sponsor decision|1|||
42045057|NCT00873730|75852877|FG001|Overall Study|Sponsor decision|0|||
42045058|NCT00874432|75852887|FG000|Overall Study|Withdrawal by Subject|1|||
42045059|NCT00874432|75852888|FG001|Overall Study|Withdrawal by Subject|0|||
42045060|NCT00874432|75852889|FG002|Overall Study|Withdrawal by Subject|0|||
42045061|NCT00874432|75852890|FG003|Overall Study|Withdrawal by Subject|0|||
42045062|NCT00874432|75852887|FG000|Overall Study|Physician Decision|1|||
42045063|NCT00874432|75852888|FG001|Overall Study|Physician Decision|0|||
42045064|NCT00874432|75852889|FG002|Overall Study|Physician Decision|0|||
42045065|NCT00874432|75852890|FG003|Overall Study|Physician Decision|0|||
42045066|NCT00874432|75852887|FG000|Overall Study|Other|1|||
42045067|NCT00874432|75852888|FG001|Overall Study|Other|2|||
42045068|NCT00874432|75852889|FG002|Overall Study|Other|8|||
42045069|NCT00874432|75852890|FG003|Overall Study|Other|3|||
42045070|NCT00935220|75852902|FG000|Overall Study|Adverse Event|1|||
42045071|NCT00935220|75852902|FG000|Overall Study|Other reason (not specified)|1|||
42045072|NCT00874276|75852908|FG000|Overall Study|Withdrawal by Subject|1|||
42045073|NCT00874276|75852909|FG001|Overall Study|Withdrawal by Subject|1|||
42045074|NCT00594958|75852920|FG000|Overall Study|Withdrawal by Subject|1|||
42045075|NCT00594958|75852921|FG001|Overall Study|Withdrawal by Subject|0|||
42045076|NCT00594958|75852922|FG002|Overall Study|Withdrawal by Subject|1|||
42045077|NCT00594958|75852920|FG000|Overall Study|Adverse Event|4|||
42045078|NCT00594958|75852921|FG001|Overall Study|Adverse Event|1|||
42045079|NCT00594958|75852922|FG002|Overall Study|Adverse Event|2|||
42045080|NCT00594958|75852920|FG000|Overall Study|Pregnancy|0|||
42045081|NCT00594958|75852921|FG001|Overall Study|Pregnancy|2|||
42045082|NCT00594958|75852922|FG002|Overall Study|Pregnancy|0|||
42045083|NCT00594958|75852920|FG000|Overall Study|Protocol Violation|1|||
42045084|NCT00594958|75852921|FG001|Overall Study|Protocol Violation|0|||
42045085|NCT00594958|75852922|FG002|Overall Study|Protocol Violation|2|||
42045086|NCT00594958|75852920|FG000|Overall Study|Lost to Follow-up|5|||
42045087|NCT00594958|75852921|FG001|Overall Study|Lost to Follow-up|0|||
42045088|NCT00594958|75852922|FG002|Overall Study|Lost to Follow-up|3|||
42045089|NCT00594958|75852920|FG000|Overall Study|administrative|3|||
42045090|NCT00594958|75852921|FG001|Overall Study|administrative|0|||
42045091|NCT00594958|75852922|FG002|Overall Study|administrative|2|||
42045092|NCT00594880|75852932|FG000|Overall Study|Withdrawal by Subject|1|||
42045093|NCT00594880|75852933|FG001|Overall Study|Withdrawal by Subject|1|||
42045094|NCT00594880|75852932|FG000|Overall Study|Lost to Follow-up|1|||
42045095|NCT00594880|75852933|FG001|Overall Study|Lost to Follow-up|0|||
42045096|NCT00871858|75852945|FG000|Overall Study|Protocol Violation|3|||
42045097|NCT00871858|75852946|FG001|Overall Study|Protocol Violation|4|||
42045098|NCT00871858|75852945|FG000|Overall Study|Adverse Event|1|||
42045099|NCT00871858|75852946|FG001|Overall Study|Adverse Event|1|||
42045100|NCT00871858|75852945|FG000|Overall Study|Withdrawal by Subject|1|||
42045101|NCT00871858|75852946|FG001|Overall Study|Withdrawal by Subject|1|||
42045102|NCT00871858|75852945|FG000|Overall Study|Lost to Follow-up|0|||
42045103|NCT00871858|75852946|FG001|Overall Study|Lost to Follow-up|1|||
42045104|NCT00871780|75852952|FG000|Overall Study|Enrolled But Not Treated|6|||
42045105|NCT00871780|75852952|FG000|Overall Study|Withdrawal by Subject|9|||
42045106|NCT00871780|75852952|FG000|Overall Study|Adverse Event|6|||
42045107|NCT00871780|75852952|FG000|Overall Study|Voluntary Discontinuation|4|||
42045108|NCT00871780|75852952|FG000|Overall Study|Death|1|||
42045109|NCT00871780|75852952|FG000|Overall Study|Physician Decision|1|||
42045110|NCT00594178|75852959|FG000|Overall Study|Physician Decision|5|||
42045111|NCT00933270|75852963|FG000|Overall Study|Withdrawal by Subject|26|||
42045112|NCT00933270|75852963|FG000|Overall Study|Insufficient Follow-up|10|||
42045113|NCT00933270|75852963|FG000|Overall Study|Lost to Follow-up|14|||
42045114|NCT00933270|75852963|FG000|Overall Study|Adverse Event|1|||
42045115|NCT00933270|75852963|FG000|Overall Study|Missed Visit|2|||
42045116|NCT00933270|75852963|FG000|Overall Study|Death|24|||
42045117|NCT00933270|75852963|FG000|Overall Study|Moved or would not return|10|||
42045118|NCT00936858|75852968|FG000|Overall Study|Death|3|||
42045119|NCT00936858|75852968|FG000|Overall Study|Progression|29|||
42045120|NCT00936858|75852968|FG000|Overall Study|Withdrawal by Subject|5|||
42045121|NCT00936858|75852968|FG000|Overall Study|Adverse Event|1|||
42045122|NCT00936858|75852968|FG000|Overall Study|Physician Decision|7|||
42045123|NCT00936858|75852968|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
42045124|NCT00936858|75852968|FG000|Overall Study|Lost to Follow-up|1|||
42045125|NCT00872170|75852975|FG000|Overall Study|Adverse Event|1|||
42045126|NCT00872170|75852976|FG001|Overall Study|Adverse Event|0|||
42045127|NCT00936702|75852981|FG000|Overall Study|Disease progression|34|||
42045128|NCT00936702|75852981|FG000|Overall Study|Adverse Event|8|||
42045129|NCT00936702|75852981|FG000|Overall Study|Withdrawal by Subject|2|||
42045130|NCT00936702|75852981|FG000|Overall Study|Alternative Treatment|1|||
42045131|NCT00936702|75852981|FG000|Overall Study|Other|1|||
42045132|NCT00594100|75852985|FG000|Procedure|Technical Failure|9|||
42045133|NCT00594100|75852985|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
42045134|NCT00594100|75852985|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
42045135|NCT00594100|75852985|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
42045136|NCT01092182|75852992|FG000|Overall Study|Death|0|||
42045137|NCT01092182|75852993|FG001|Overall Study|Death|5|||
42045138|NCT01092182|75852994|FG002|Overall Study|Death|3|||
42045139|NCT01092182|75852992|FG000|Overall Study|participant safety|1|||
42045140|NCT01092182|75852993|FG001|Overall Study|participant safety|2|||
42045141|NCT01092182|75852994|FG002|Overall Study|participant safety|0|||
42045142|NCT01092182|75852992|FG000|Overall Study|Physician Decision|0|||
42045143|NCT01092182|75852993|FG001|Overall Study|Physician Decision|6|||
42045144|NCT01092182|75852994|FG002|Overall Study|Physician Decision|0|||
42045145|NCT01092182|75852992|FG000|Overall Study|Did not meet criteria|0|||
42045146|NCT01092182|75852993|FG001|Overall Study|Did not meet criteria|0|||
42045147|NCT01092182|75852994|FG002|Overall Study|Did not meet criteria|25|||
42045148|NCT01092182|75852992|FG000|Overall Study|Non-compliance|0|||
42045149|NCT01092182|75852993|FG001|Overall Study|Non-compliance|3|||
42045150|NCT01092182|75852994|FG002|Overall Study|Non-compliance|0|||
42045151|NCT01092182|75852992|FG000|Overall Study|Participant refused follow-up|0|||
42045152|NCT01092182|75852993|FG001|Overall Study|Participant refused follow-up|2|||
42045153|NCT01092182|75852994|FG002|Overall Study|Participant refused follow-up|0|||
42045154|NCT00932646|75853002|FG000|Overall Study|Adverse Event|2|||
42045155|NCT00932646|75853003|FG001|Overall Study|Adverse Event|1|||
42045156|NCT00932646|75853004|FG002|Overall Study|Adverse Event|1|||
42045157|NCT00932646|75853005|FG003|Overall Study|Adverse Event|1|||
42045158|NCT00932646|75853002|FG000|Overall Study|Lost to Follow-up|2|||
42045159|NCT00932646|75853003|FG001|Overall Study|Lost to Follow-up|1|||
42045160|NCT00932646|75853004|FG002|Overall Study|Lost to Follow-up|0|||
42045161|NCT00932646|75853005|FG003|Overall Study|Lost to Follow-up|0|||
42045162|NCT00932646|75853002|FG000|Overall Study|Withdrawal by Subject|1|||
42045163|NCT00932646|75853003|FG001|Overall Study|Withdrawal by Subject|1|||
42045164|NCT00932646|75853004|FG002|Overall Study|Withdrawal by Subject|3|||
42045165|NCT00932646|75853005|FG003|Overall Study|Withdrawal by Subject|0|||
42045166|NCT00871234|75853019|FG000|Overall Study|Adverse Event|2|||
42045167|NCT00871234|75853019|FG000|Overall Study|Lost to Follow-up|3|||
42045168|NCT01091246|75853026|FG000|Overall Study|Lost to Follow-up|23|||
42045169|NCT01091246|75853027|FG001|Overall Study|Lost to Follow-up|11|||
42045170|NCT01091246|75853028|FG002|Overall Study|Lost to Follow-up|7|||
42045171|NCT01091246|75853026|FG000|Overall Study|Adverse Event|1|||
42045172|NCT01091246|75853027|FG001|Overall Study|Adverse Event|0|||
42045173|NCT01091246|75853028|FG002|Overall Study|Adverse Event|1|||
42045174|NCT01091246|75853026|FG000|Overall Study|Withdrawal by Subject|9|||
42045175|NCT01091246|75853027|FG001|Overall Study|Withdrawal by Subject|5|||
42045176|NCT01091246|75853028|FG002|Overall Study|Withdrawal by Subject|4|||
42045177|NCT01091246|75853026|FG000|Overall Study|Subject not dosed|2|||
42045178|NCT01091246|75853027|FG001|Overall Study|Subject not dosed|0|||
42045179|NCT01091246|75853028|FG002|Overall Study|Subject not dosed|1|||
42045180|NCT01097330|75853040|FG000|Overall Study|Study terminated early|7|||
42045181|NCT01097330|75853041|FG001|Overall Study|Study terminated early|5|||
42045182|NCT00934440|75853047|FG000|Overall Study|Lost to Follow-up|1|||
42045183|NCT00934362|75853054|FG000|Overall Study|Adverse Event|1|||
42045184|NCT00934362|75853055|FG001|Overall Study|Adverse Event|0|||
42045185|NCT00934128|75853063|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
42045186|NCT00934128|75853064|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
42045187|NCT00934128|75853063|FG000|First Intervention (2 Hours)|Adverse Event|4|||
42045188|NCT00934128|75853064|FG001|First Intervention (2 Hours)|Adverse Event|1|||
42045189|NCT00934128|75853063|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
42045190|NCT00934128|75853064|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
42291168|NCT01946152|76124968|FG001|Overall Study|Second malignancy|0|||
42045191|NCT00934128|75853063|FG000|Washout Period (1 Hour)|Patient preference|1|||
42045192|NCT00934128|75853064|FG001|Washout Period (1 Hour)|Patient preference|3|||
42045193|NCT00934128|75853063|FG000|Washout Period (1 Hour)|Pain|1|||
42045194|NCT00934128|75853064|FG001|Washout Period (1 Hour)|Pain|0|||
42045195|NCT00934128|75853063|FG000|Washout Period (1 Hour)|Too tired|1|||
42045196|NCT00934128|75853064|FG001|Washout Period (1 Hour)|Too tired|0|||
42045197|NCT00934128|75853063|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
42045198|NCT00934128|75853064|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
42045199|NCT00934128|75853063|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
42045200|NCT00934128|75853064|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
42045201|NCT00871000|75853072|FG000|Overall Study|Withdrawal by Subject|1|||
42045202|NCT00871000|75853073|FG001|Overall Study|Withdrawal by Subject|0|||
42045203|NCT01096784|75853081|FG000|Overall Study|Withdrawal by Subject|2|||
42045204|NCT01096784|75853082|FG001|Overall Study|Withdrawal by Subject|1|||
42045205|NCT01096784|75853081|FG000|Overall Study|Adverse Event|11|||
42045206|NCT01096784|75853082|FG001|Overall Study|Adverse Event|9|||
42045207|NCT01096784|75853081|FG000|Overall Study|Protocol Deviation|2|||
42045208|NCT01096784|75853082|FG001|Overall Study|Protocol Deviation|2|||
42045209|NCT01096784|75853081|FG000|Overall Study|Administrative Decision|0|||
42045210|NCT01096784|75853082|FG001|Overall Study|Administrative Decision|1|||
42045211|NCT01096784|75853081|FG000|Overall Study|Other Unspecified|0|||
42045212|NCT01096784|75853082|FG001|Overall Study|Other Unspecified|1|||
42045213|NCT00934050|75853096|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
42045214|NCT00934050|75853097|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
42045215|NCT00934050|75853098|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
42045216|NCT00934050|75853099|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
42045217|NCT00934050|75853100|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
42045218|NCT00934050|75853101|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
42045219|NCT00934050|75853096|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
42045220|NCT00934050|75853097|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
42045221|NCT00934050|75853098|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
42045222|NCT00934050|75853099|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
42045223|NCT00934050|75853100|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
42045224|NCT00934050|75853101|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
42045225|NCT00934050|75853096|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
42045226|NCT00934050|75853097|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
42045227|NCT00934050|75853098|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
42045228|NCT00934050|75853099|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
42045229|NCT00934050|75853100|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
42045230|NCT00934050|75853101|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
42045231|NCT00934050|75853096|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
42045232|NCT00934050|75853097|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
42045233|NCT00934050|75853098|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
42045234|NCT00934050|75853099|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
42045235|NCT00934050|75853100|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
42045236|NCT00934050|75853101|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
42045237|NCT00934050|75853096|FG000|Enrolled After 15 Dec 2009|Death|0|||
42045238|NCT00934050|75853097|FG001|Enrolled After 15 Dec 2009|Death|0|||
42045239|NCT00934050|75853098|FG002|Enrolled After 15 Dec 2009|Death|0|||
42045240|NCT00934050|75853099|FG003|Enrolled After 15 Dec 2009|Death|0|||
42045241|NCT00934050|75853100|FG004|Enrolled After 15 Dec 2009|Death|0|||
42045242|NCT00934050|75853101|FG005|Enrolled After 15 Dec 2009|Death|1|||
42045243|NCT00934050|75853096|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
42045244|NCT00934050|75853097|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
42045245|NCT00934050|75853098|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
42045246|NCT00934050|75853099|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
42045247|NCT00934050|75853100|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
42045248|NCT00934050|75853101|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
42045249|NCT00934050|75853096|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
42045250|NCT00934050|75853097|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
42045251|NCT00934050|75853098|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
42045252|NCT00934050|75853099|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
42045253|NCT00934050|75853100|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
42045254|NCT00934050|75853101|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
42045255|NCT01091168|75853113|FG000|Overall Study|Progressive disease|250|||
42045256|NCT01091168|75853114|FG001|Overall Study|Progressive disease|234|||
42045257|NCT01091168|75853113|FG000|Overall Study|Adverse Event|21|||
42045258|NCT01091168|75853114|FG001|Overall Study|Adverse Event|24|||
42045259|NCT01091168|75853113|FG000|Overall Study|Lost to Follow-up|0|||
42045260|NCT01091168|75853114|FG001|Overall Study|Lost to Follow-up|1|||
42045261|NCT01091168|75853113|FG000|Overall Study|Physician, patient's decision, other|27|||
42045262|NCT01091168|75853114|FG001|Overall Study|Physician, patient's decision, other|37|||
42045263|NCT00864916|75853122|FG000|Overall Study|Lost to Follow-up|4|||
42045264|NCT00864916|75853123|FG001|Overall Study|Lost to Follow-up|4|||
42045265|NCT00864916|75853122|FG000|Overall Study|Protocol Violation|1|||
42045266|NCT00864916|75853123|FG001|Overall Study|Protocol Violation|0|||
42045267|NCT00864916|75853122|FG000|Overall Study|Withdrawal by Subject|1|||
42045268|NCT00864916|75853123|FG001|Overall Study|Withdrawal by Subject|0|||
42045269|NCT00864682|75853132|FG000|Overall Study|Protocol Violation|2|||
42045270|NCT00864682|75853133|FG001|Overall Study|Protocol Violation|1|||
42045271|NCT00864682|75853134|FG002|Overall Study|Protocol Violation|2|||
42045272|NCT00931944|75853142|FG000|Overall Study|Adverse Event|4|||
42045273|NCT00931944|75853142|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
42045274|NCT00931944|75853142|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
42045275|NCT00931944|75853142|FG000|Overall Study|Death|28|||
42045276|NCT00931944|75853142|FG000|Overall Study|Other|2|||
42045277|NCT00929994|75853146|FG000|Overall Study|Withdrawal by Subject|1|||
42045278|NCT00929994|75853146|FG000|Overall Study|medical issue unrelated to intervention|4|||
42045279|NCT00929994|75853146|FG000|Overall Study|employment|1|||
42045280|NCT01090310|75853157|FG000|Core Study|Adverse Event|2|||
42045281|NCT01090310|75853158|FG001|Core Study|Adverse Event|2|||
42045282|NCT01090310|75853159|FG002|Core Study|Adverse Event|1|||
42045283|NCT01090310|75853160|FG003|Core Study|Adverse Event|1|||
42045284|NCT01090310|75853157|FG000|Core Study|Subject withdrew consent|0|||
42045285|NCT01090310|75853158|FG001|Core Study|Subject withdrew consent|3|||
42045286|NCT01090310|75853159|FG002|Core Study|Subject withdrew consent|1|||
42045287|NCT01090310|75853160|FG003|Core Study|Subject withdrew consent|1|||
42045288|NCT01090310|75853157|FG000|Core Study|Abnormal test procedure result|0|||
42045289|NCT01090310|75853158|FG001|Core Study|Abnormal test procedure result|0|||
42045290|NCT01090310|75853159|FG002|Core Study|Abnormal test procedure result|1|||
42045291|NCT01090310|75853160|FG003|Core Study|Abnormal test procedure result|0|||
42045292|NCT01090310|75853157|FG000|Core Study|Administrative reasons|5|||
42045293|NCT01090310|75853158|FG001|Core Study|Administrative reasons|6|||
42045294|NCT01090310|75853159|FG002|Core Study|Administrative reasons|4|||
42045295|NCT01090310|75853160|FG003|Core Study|Administrative reasons|4|||
42045296|NCT01090310|75853157|FG000|Core Study|Protocol deviation|1|||
42045297|NCT01090310|75853158|FG001|Core Study|Protocol deviation|0|||
42045298|NCT01090310|75853159|FG002|Core Study|Protocol deviation|0|||
42045299|NCT01090310|75853160|FG003|Core Study|Protocol deviation|1|||
42045300|NCT01090310|75853157|FG000|Extension Study|Aministrative problems|13|||
42045301|NCT01090310|75853158|FG001|Extension Study|Aministrative problems|15|||
42045302|NCT01090310|75853159|FG002|Extension Study|Aministrative problems|14|||
42172525|NCT00351533|75979420|FG001|Overall Study|Extubated before first BAL|0|||
42172526|NCT00351533|75979419|FG000|Overall Study|Lost to Follow-up|1|||
42172527|NCT00351533|75979420|FG001|Overall Study|Lost to Follow-up|3|||
42172528|NCT00351533|75979419|FG000|Overall Study|Physician Decision|0|||
42172529|NCT00351533|75979420|FG001|Overall Study|Physician Decision|1|||
42172530|NCT00351533|75979419|FG000|Overall Study|Withdrawal by Subject|0|||
42172531|NCT00351533|75979420|FG001|Overall Study|Withdrawal by Subject|1|||
42172532|NCT00351377|75979426|FG000|Overall Study|Adverse Event|5|||
42172533|NCT00351377|75979426|FG000|Overall Study|Death|1|||
42172534|NCT00351377|75979426|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42172535|NCT00337727|75979432|FG000|Overall Study|Adverse Event|5|||
42172536|NCT00337727|75979433|FG001|Overall Study|Adverse Event|3|||
42172537|NCT00337727|75979432|FG000|Overall Study|Lost to Follow-up|5|||
42172538|NCT00337727|75979433|FG001|Overall Study|Lost to Follow-up|4|||
42172539|NCT00337727|75979432|FG000|Overall Study|Physician Decision|1|||
42172540|NCT00337727|75979433|FG001|Overall Study|Physician Decision|0|||
42172541|NCT00337727|75979432|FG000|Overall Study|Protocol Violation|4|||
42172542|NCT00337727|75979433|FG001|Overall Study|Protocol Violation|0|||
42172543|NCT00337727|75979432|FG000|Overall Study|Withdrawal by Subject|3|||
42172544|NCT00337727|75979433|FG001|Overall Study|Withdrawal by Subject|5|||
42172545|NCT00324233|75979441|FG000|First Period|unable to insert catheter|1|||
42172546|NCT00324233|75979442|FG001|First Period|unable to insert catheter|0|||
42172547|NCT00324233|75979441|FG000|Second Period|unable to insert catheter|1|||
42172548|NCT00324233|75979442|FG001|Second Period|unable to insert catheter|1|||
42172549|NCT00324233|75979441|FG000|Second Period|Protocol Violation|4|||
42172550|NCT00324233|75979442|FG001|Second Period|Protocol Violation|6|||
42045303|NCT01090310|75853160|FG003|Extension Study|Aministrative problems|18|||
42356848|NCT01393743|76202032|FG000|Core Study|Inadequate therapeutic effect|2|||
42045304|NCT01090310|75853157|FG000|Extension Study|Adverse Event|0|||
42045305|NCT01090310|75853158|FG001|Extension Study|Adverse Event|0|||
42045306|NCT01090310|75853159|FG002|Extension Study|Adverse Event|0|||
42045307|NCT01090310|75853160|FG003|Extension Study|Adverse Event|1|||
42045308|NCT01090310|75853157|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
42172551|NCT03335566|75979450|FG000|Overall Study|Adverse Event|0|||
42172552|NCT03335566|75979451|FG001|Overall Study|Adverse Event|1|||
42356849|NCT01393743|76202033|FG001|Core Study|Inadequate therapeutic effect|0|||
42172553|NCT03335566|75979450|FG000|Overall Study|Lost to Follow-up|1|||
42045309|NCT01090310|75853158|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
42045310|NCT01090310|75853159|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
42045311|NCT01090310|75853160|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
42045312|NCT01090310|75853157|FG000|Extension Study|Subject withdrew consent|0|||
42045313|NCT01090310|75853158|FG001|Extension Study|Subject withdrew consent|1|||
42045314|NCT01090310|75853159|FG002|Extension Study|Subject withdrew consent|0|||
42045315|NCT01090310|75853160|FG003|Extension Study|Subject withdrew consent|0|||
42045316|NCT01090076|75853172|FG000|Overall Study|Death|1|||
42045317|NCT01090076|75853173|FG001|Overall Study|Death|1|||
42045318|NCT01090076|75853172|FG000|Overall Study|Withdrawal by Subject|0|||
42045319|NCT01090076|75853173|FG001|Overall Study|Withdrawal by Subject|1|||
42045320|NCT00869050|75853181|FG000|Overall Study|Screen Failure|3|||
42045321|NCT00927186|75853187|FG000|12 Months Primary Study|Adverse Event|5|||
42045322|NCT00927186|75853188|FG001|12 Months Primary Study|Adverse Event|2|||
42045323|NCT00927186|75853187|FG000|12 Months Primary Study|Lost to Follow-up|1|||
42045324|NCT00927186|75853188|FG001|12 Months Primary Study|Lost to Follow-up|0|||
42045325|NCT00927186|75853187|FG000|12 Months Primary Study|Protocol Violation|0|||
42045326|NCT00927186|75853188|FG001|12 Months Primary Study|Protocol Violation|1|||
42045327|NCT00927186|75853187|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
42045328|NCT00927186|75853188|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
42045329|NCT00593554|75853199|FG000|Overall Study|Death|1|||
42045330|NCT00593554|75853200|FG001|Overall Study|Death|2|||
42045331|NCT00593554|75853199|FG000|Overall Study|Physician Decision|0|||
42045332|NCT00593554|75853200|FG001|Overall Study|Physician Decision|1|||
42045333|NCT00593554|75853199|FG000|Overall Study|Withdrawal by Subject|1|||
42045334|NCT00593554|75853200|FG001|Overall Study|Withdrawal by Subject|0|||
42045335|NCT00593554|75853199|FG000|Overall Study|Disease Progression|1|||
42045336|NCT00593554|75853200|FG001|Overall Study|Disease Progression|2|||
42045337|NCT01101308|75853206|FG000|Period 1|Adverse Event|2|||
42045338|NCT01101308|75853207|FG001|Period 1|Adverse Event|1|||
42045339|NCT01101308|75853206|FG000|Period 1|Positive for cotinine|1|||
42045340|NCT01101308|75853207|FG001|Period 1|Positive for cotinine|0|||
42045341|NCT00926796|75853216|FG000|Overall Study|Did not receive randomized treatment|4|||
42045342|NCT00926796|75853217|FG001|Overall Study|Did not receive randomized treatment|7|||
42045343|NCT00926796|75853216|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
42045344|NCT00926796|75853217|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
42045345|NCT00926796|75853216|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
42045346|NCT00926796|75853217|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
42045347|NCT00926796|75853216|FG000|Overall Study|Adverse Event|7|||
42045348|NCT00926796|75853217|FG001|Overall Study|Adverse Event|14|||
42045349|NCT00926796|75853216|FG000|Overall Study|Lost to Follow-up|22|||
42045350|NCT00926796|75853217|FG001|Overall Study|Lost to Follow-up|13|||
42045351|NCT00926796|75853216|FG000|Overall Study|Protocol Violation|15|||
42045352|NCT00926796|75853217|FG001|Overall Study|Protocol Violation|11|||
42045353|NCT00926796|75853216|FG000|Overall Study|Withdrawal by Subject|1|||
42045354|NCT00926796|75853217|FG001|Overall Study|Withdrawal by Subject|0|||
42045355|NCT01087736|75853227|FG000|Overall Study|Lost to Follow-up|1|||
42045356|NCT01087736|75853228|FG001|Overall Study|Lost to Follow-up|0|||
42045357|NCT01087736|75853227|FG000|Overall Study|Death|0|||
42045358|NCT01087736|75853228|FG001|Overall Study|Death|1|||
42045359|NCT01087736|75853227|FG000|Overall Study|Withdrawal by Subject|0|||
42045360|NCT01087736|75853228|FG001|Overall Study|Withdrawal by Subject|1|||
42045361|NCT01079936|75853238|FG000|Phase I: MTD|First Remission Status|2|||
42045362|NCT01079936|75853239|FG001|Phase I: MTD|First Remission Status|0|||
42045363|NCT01079936|75853240|FG002|Phase I: MTD|First Remission Status|0|||
42045364|NCT01079936|75853241|FG003|Phase I: MTD|First Remission Status|0|||
42045365|NCT01079936|75853242|FG004|Phase I: MTD|First Remission Status|0|||
42045366|NCT01079936|75853238|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
42045367|NCT01079936|75853239|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
42045368|NCT01079936|75853240|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
42045369|NCT01079936|75853241|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
42045370|NCT01079936|75853242|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
42045371|NCT01079936|75853238|FG000|Phase II|Adverse Event|0|||
42172554|NCT03335566|75979451|FG001|Overall Study|Lost to Follow-up|0|||
42172555|NCT03335566|75979450|FG000|Overall Study|Technical Problems|1|||
42045372|NCT01079936|75853239|FG001|Phase II|Adverse Event|0|||
42045373|NCT01079936|75853240|FG002|Phase II|Adverse Event|1|||
42045374|NCT01079936|75853241|FG003|Phase II|Adverse Event|0|||
42045375|NCT01079936|75853242|FG004|Phase II|Adverse Event|0|||
42045376|NCT01079936|75853238|FG000|Phase II|Insurance Issue|0|||
42045377|NCT01079936|75853239|FG001|Phase II|Insurance Issue|0|||
42172556|NCT03335566|75979451|FG001|Overall Study|Technical Problems|0|||
42172557|NCT03335566|75979450|FG000|Overall Study|Protocol Violation|1|||
42045378|NCT01079936|75853240|FG002|Phase II|Insurance Issue|0|||
42045379|NCT01079936|75853241|FG003|Phase II|Insurance Issue|0|||
42045380|NCT01079936|75853242|FG004|Phase II|Insurance Issue|1|||
42045381|NCT00931710|75853255|FG000|Overall Study|Adverse Event|16|||
42045382|NCT00931710|75853256|FG001|Overall Study|Adverse Event|10|||
42045383|NCT00931710|75853255|FG000|Overall Study|Abnormal test procedure results|2|||
42045384|NCT00931710|75853256|FG001|Overall Study|Abnormal test procedure results|0|||
42045385|NCT00931710|75853255|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
42045386|NCT00931710|75853256|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
42045387|NCT00931710|75853255|FG000|Overall Study|Patient withdrew consent|4|||
42045388|NCT00931710|75853256|FG001|Overall Study|Patient withdrew consent|9|||
42045389|NCT00931710|75853255|FG000|Overall Study|Lost to Follow-up|6|||
42045390|NCT00931710|75853256|FG001|Overall Study|Lost to Follow-up|5|||
42045391|NCT00931710|75853255|FG000|Overall Study|Protocol deviation|1|||
42045392|NCT00931710|75853256|FG001|Overall Study|Protocol deviation|2|||
42045393|NCT01100528|75853262|FG000|Overall Study|Death|1|||
42045394|NCT01100528|75853262|FG000|Overall Study|Withdrawal by Subject|2|||
42045395|NCT01079234|75853269|FG000|Main: Week 0 to 26|Adverse Event|5|||
42045396|NCT01079234|75853270|FG001|Main: Week 0 to 26|Adverse Event|4|||
42045397|NCT01079234|75853271|FG002|Main: Week 0 to 26|Adverse Event|1|||
42045398|NCT01079234|75853272|FG003|Main: Week 0 to 26|Adverse Event|0|||
42172558|NCT03335566|75979451|FG001|Overall Study|Protocol Violation|0|||
42172559|NCT03335566|75979450|FG000|Overall Study|Other than specified above|1|||
42172560|NCT03335566|75979451|FG001|Overall Study|Other than specified above|2|||
42172561|NCT03369418|75979459|FG000|Overall Study|Withdrawal by Subject|3|||
42172562|NCT03369418|75979460|FG001|Overall Study|Withdrawal by Subject|3|||
42172563|NCT03334630|75979468|FG000|Overall Study|Withdrawal by Subject|7|||
42172564|NCT03334630|75979469|FG001|Overall Study|Withdrawal by Subject|7|||
42172565|NCT03334630|75979468|FG000|Overall Study|Lost to Follow-up|3|||
42172566|NCT03334630|75979469|FG001|Overall Study|Lost to Follow-up|1|||
42172567|NCT03334630|75979468|FG000|Overall Study|Adverse Event|0|||
42172568|NCT03334630|75979469|FG001|Overall Study|Adverse Event|1|||
42172569|NCT03334630|75979468|FG000|Overall Study|Physician Decision|1|||
42172570|NCT03334630|75979469|FG001|Overall Study|Physician Decision|1|||
42172571|NCT03334630|75979468|FG000|Overall Study|Enrollment closed|2|||
42172572|NCT03334630|75979469|FG001|Overall Study|Enrollment closed|1|||
42172573|NCT03334630|75979468|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
42172574|NCT03334630|75979469|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
42172575|NCT03334630|75979468|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
42172576|NCT03334630|75979469|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
42172577|NCT03368170|75979477|FG000|Overall Study|Adverse Event|2|||
42172578|NCT03368170|75979478|FG001|Overall Study|Adverse Event|1|||
42172579|NCT00324155|75979486|FG000|Enrolled and Randomized|No longer met study criteria|3|||
42172580|NCT00324155|75979487|FG001|Enrolled and Randomized|No longer met study criteria|0|||
42172581|NCT00324155|75979486|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
42172582|NCT00324155|75979487|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
42172583|NCT00324155|75979486|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
42172584|NCT00324155|75979487|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
42172585|NCT00324155|75979486|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
42172586|NCT00324155|75979487|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
42172587|NCT00324155|75979486|FG000|Received Treatment in Induction Phase|Death|8|||
42045399|NCT01079234|75853269|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
42045400|NCT01079234|75853270|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
42045401|NCT01079234|75853271|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
42172588|NCT00324155|75979487|FG001|Received Treatment in Induction Phase|Death|15|||
42172589|NCT00324155|75979486|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
42045402|NCT01079234|75853272|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
42045403|NCT01079234|75853269|FG000|Main: Week 0 to 26|Protocol Violation|6|||
42045404|NCT01079234|75853270|FG001|Main: Week 0 to 26|Protocol Violation|2|||
42045405|NCT01079234|75853271|FG002|Main: Week 0 to 26|Protocol Violation|4|||
42045406|NCT01079234|75853272|FG003|Main: Week 0 to 26|Protocol Violation|0|||
42045407|NCT01079234|75853269|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
42045408|NCT01079234|75853270|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
42045409|NCT01079234|75853271|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
42045410|NCT01079234|75853272|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
42045411|NCT01079234|75853269|FG000|Main: Week 0 to 26|Unclassified|7|||
42045412|NCT01079234|75853270|FG001|Main: Week 0 to 26|Unclassified|13|||
42045413|NCT01079234|75853271|FG002|Main: Week 0 to 26|Unclassified|4|||
42045414|NCT01079234|75853272|FG003|Main: Week 0 to 26|Unclassified|0|||
42045415|NCT01079234|75853269|FG000|Extension: Week 27 to 52|Adverse Event|0|||
42045416|NCT01079234|75853270|FG001|Extension: Week 27 to 52|Adverse Event|0|||
42045417|NCT01079234|75853271|FG002|Extension: Week 27 to 52|Adverse Event|1|||
42045418|NCT01079234|75853272|FG003|Extension: Week 27 to 52|Adverse Event|0|||
42045419|NCT01079234|75853269|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
42045420|NCT01079234|75853270|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
42045421|NCT01079234|75853271|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
42045422|NCT01079234|75853272|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
42045423|NCT01079234|75853269|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
42045424|NCT01079234|75853270|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
42045425|NCT01079234|75853271|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
42045426|NCT01079234|75853272|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
42045427|NCT01079234|75853269|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
42045428|NCT01079234|75853270|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
42045429|NCT01079234|75853271|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
42045430|NCT01079234|75853272|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
42045431|NCT01079234|75853269|FG000|Extension: Week 27 to 52|Unclassified|0|||
42045432|NCT01079234|75853270|FG001|Extension: Week 27 to 52|Unclassified|0|||
42045433|NCT01079234|75853271|FG002|Extension: Week 27 to 52|Unclassified|4|||
42045434|NCT01079234|75853272|FG003|Extension: Week 27 to 52|Unclassified|7|||
42045435|NCT00931632|75853283|FG000|Overall Study|Withdrawal by Subject|2|||
42045436|NCT00931632|75853284|FG001|Overall Study|Withdrawal by Subject|3|||
42045437|NCT00931632|75853283|FG000|Overall Study|Adverse Event|19|||
42045438|NCT00931632|75853284|FG001|Overall Study|Adverse Event|15|||
42045439|NCT01078922|75853290|FG000|Overall Study|Adverse Event|1|||
42045440|NCT00863746|75853297|FG000|Treatment|Not treated|4|||
42045441|NCT00863746|75853298|FG001|Treatment|Not treated|2|||
42045442|NCT00863746|75853297|FG000|Treatment|Adverse Event|41|||
42045443|NCT00863746|75853298|FG001|Treatment|Adverse Event|16|||
42045444|NCT00863746|75853297|FG000|Treatment|non-compliant with study medication|4|||
42045445|NCT00863746|75853298|FG001|Treatment|non-compliant with study medication|0|||
42045446|NCT00863746|75853297|FG000|Treatment|Consent withdrawn|15|||
42045447|NCT00863746|75853298|FG001|Treatment|Consent withdrawn|14|||
42045448|NCT00863746|75853297|FG000|Treatment|Lost to Follow-up|1|||
42045449|NCT00863746|75853298|FG001|Treatment|Lost to Follow-up|0|||
42045450|NCT00863746|75853297|FG000|Treatment|Protocol Violation|5|||
42045451|NCT00863746|75853298|FG001|Treatment|Protocol Violation|3|||
42045452|NCT00863746|75853297|FG000|Treatment|Other|1|||
42045453|NCT00863746|75853298|FG001|Treatment|Other|0|||
42045454|NCT00863746|75853297|FG000|Survival Follow up|Death|244|||
42045455|NCT00863746|75853298|FG001|Survival Follow up|Death|271|||
42045456|NCT00863746|75853297|FG000|Survival Follow up|Lost to Follow-up|2|||
42045457|NCT00863746|75853298|FG001|Survival Follow up|Lost to Follow-up|1|||
42045458|NCT00863746|75853297|FG000|Survival Follow up|Consent Withdrawn|7|||
42045459|NCT00863746|75853298|FG001|Survival Follow up|Consent Withdrawn|8|||
42045460|NCT00926328|75853306|FG000|Overall Study|Lost to Follow-up|12|||
42045461|NCT00926328|75853307|FG001|Overall Study|Lost to Follow-up|14|||
42045462|NCT00863512|75853315|FG000|Overall Study|Adverse Event|2|||
42045463|NCT00863512|75853316|FG001|Overall Study|Adverse Event|0|||
42045464|NCT00863512|75853315|FG000|Overall Study|Withdrawal by Subject|11|||
42045465|NCT00863512|75853316|FG001|Overall Study|Withdrawal by Subject|0|||
42045466|NCT00863512|75853315|FG000|Overall Study|Physician Decision|1|||
42045467|NCT00863512|75853316|FG001|Overall Study|Physician Decision|0|||
42045468|NCT00868192|75853322|FG000|Overall Study|Ineligible|4|||
42045469|NCT00930930|75853328|FG000|Overall Study|Death|1|||
42045470|NCT00930930|75853329|FG001|Overall Study|Death|0|||
42045471|NCT00930930|75853328|FG000|Overall Study|Physician Decision|1|||
42045472|NCT00930930|75853329|FG001|Overall Study|Physician Decision|0|||
42045473|NCT00930930|75853328|FG000|Overall Study|Adverse Event|13|||
42045474|NCT00930930|75853329|FG001|Overall Study|Adverse Event|3|||
42045475|NCT00930930|75853328|FG000|Overall Study|Withdrawal by Subject|3|||
42045476|NCT00930930|75853329|FG001|Overall Study|Withdrawal by Subject|1|||
42045477|NCT00930930|75853328|FG000|Overall Study|Disease progression|2|||
42045478|NCT00930930|75853329|FG001|Overall Study|Disease progression|3|||
42045479|NCT00930930|75853328|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
42045480|NCT00930930|75853329|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
42045481|NCT00930930|75853328|FG000|Overall Study|patients not compliant|1|||
42045482|NCT00930930|75853329|FG001|Overall Study|patients not compliant|1|||
42045483|NCT00862654|75853339|FG000|Overall Study|Lack of Efficacy|1|||
42045484|NCT00862654|75853340|FG001|Overall Study|Lack of Efficacy|0|||
42045485|NCT00862654|75853341|FG002|Overall Study|Lack of Efficacy|1|||
42045486|NCT00862654|75853342|FG003|Overall Study|Lack of Efficacy|0|||
42045487|NCT00862654|75853339|FG000|Overall Study|Lost to Follow-up|1|||
42045488|NCT00862654|75853340|FG001|Overall Study|Lost to Follow-up|2|||
42045489|NCT00862654|75853341|FG002|Overall Study|Lost to Follow-up|1|||
42045490|NCT00862654|75853342|FG003|Overall Study|Lost to Follow-up|3|||
42045491|NCT00862654|75853339|FG000|Overall Study|Adverse Event|0|||
42045492|NCT00862654|75853340|FG001|Overall Study|Adverse Event|1|||
42045493|NCT00862654|75853341|FG002|Overall Study|Adverse Event|1|||
42045494|NCT00862654|75853342|FG003|Overall Study|Adverse Event|0|||
42045495|NCT00862654|75853339|FG000|Overall Study|Pregnancy|1|||
42045496|NCT00862654|75853340|FG001|Overall Study|Pregnancy|1|||
42045497|NCT00862654|75853341|FG002|Overall Study|Pregnancy|0|||
42045498|NCT00862654|75853342|FG003|Overall Study|Pregnancy|0|||
42045499|NCT00862654|75853339|FG000|Overall Study|Withdrawal by Subject|2|||
42045500|NCT00862654|75853340|FG001|Overall Study|Withdrawal by Subject|2|||
42045501|NCT00862654|75853341|FG002|Overall Study|Withdrawal by Subject|2|||
42045502|NCT00862654|75853342|FG003|Overall Study|Withdrawal by Subject|3|||
42045503|NCT00862654|75853339|FG000|Overall Study|Subject mistake|0|||
42045504|NCT00862654|75853340|FG001|Overall Study|Subject mistake|1|||
42045505|NCT00862654|75853341|FG002|Overall Study|Subject mistake|0|||
42045506|NCT00862654|75853342|FG003|Overall Study|Subject mistake|0|||
42045507|NCT00862654|75853339|FG000|Overall Study|Familly constraint|0|||
42045508|NCT00862654|75853340|FG001|Overall Study|Familly constraint|1|||
42045509|NCT00862654|75853341|FG002|Overall Study|Familly constraint|0|||
42045510|NCT00862654|75853342|FG003|Overall Study|Familly constraint|0|||
42045511|NCT00862654|75853339|FG000|Overall Study|Never used study drugs|1|||
42045512|NCT00862654|75853340|FG001|Overall Study|Never used study drugs|0|||
42045513|NCT00862654|75853341|FG002|Overall Study|Never used study drugs|0|||
42045514|NCT00862654|75853342|FG003|Overall Study|Never used study drugs|0|||
42045515|NCT00862654|75853339|FG000|Overall Study|Included after end of inclusions|0|||
42045516|NCT00862654|75853340|FG001|Overall Study|Included after end of inclusions|0|||
42045517|NCT00862654|75853341|FG002|Overall Study|Included after end of inclusions|1|||
42045518|NCT00862654|75853342|FG003|Overall Study|Included after end of inclusions|0|||
42045519|NCT00867490|75853352|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
42045520|NCT00867490|75853352|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
42045521|NCT00867490|75853352|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
42045522|NCT00867490|75853352|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
42045523|NCT00867490|75853352|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
42045524|NCT00930774|75853363|FG000|Overall Study|Withdrawal by Subject|1|||
42045525|NCT00930774|75853364|FG001|Overall Study|Withdrawal by Subject|9|||
42045526|NCT00930774|75853365|FG002|Overall Study|Withdrawal by Subject|2|||
42045527|NCT00930774|75853366|FG003|Overall Study|Withdrawal by Subject|0|||
42045528|NCT00867334|75853379|FG000|Overall Study|Withdrawal by Subject|0|||
42045529|NCT00867334|75853380|FG001|Overall Study|Withdrawal by Subject|1|||
42045530|NCT00867334|75853379|FG000|Overall Study|Withdrawal by Subject|1|||
42045531|NCT00867334|75853380|FG001|Overall Study|Withdrawal by Subject|0|||
42045532|NCT00867334|75853379|FG000|Overall Study|Withdrawal by Subject|1|||
42045533|NCT00867334|75853380|FG001|Overall Study|Withdrawal by Subject|0|||
42045534|NCT00925704|75853392|FG000|First Intervention|Withdrew consent|0|||
42045535|NCT00925704|75853393|FG001|First Intervention|Withdrew consent|0|||
42045536|NCT00925704|75853394|FG002|First Intervention|Withdrew consent|0|||
42045537|NCT00925704|75853395|FG003|First Intervention|Withdrew consent|1|||
42045538|NCT00925704|75853396|FG004|First Intervention|Withdrew consent|1|||
42045539|NCT00925704|75853397|FG005|First Intervention|Withdrew consent|0|||
42045540|NCT00925704|75853392|FG000|Second Intervention|Withdrawal by Subject|1|||
42045541|NCT00925704|75853393|FG001|Second Intervention|Withdrawal by Subject|0|||
42045542|NCT00925704|75853394|FG002|Second Intervention|Withdrawal by Subject|0|||
42045543|NCT00925704|75853395|FG003|Second Intervention|Withdrawal by Subject|0|||
42045544|NCT00925704|75853396|FG004|Second Intervention|Withdrawal by Subject|1|||
42172590|NCT00324155|75979487|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
42045545|NCT00925704|75853397|FG005|Second Intervention|Withdrawal by Subject|0|||
42045546|NCT00925704|75853392|FG000|Third Intervention|Withdrew consent|0|||
42045547|NCT00925704|75853393|FG001|Third Intervention|Withdrew consent|0|||
42045548|NCT00925704|75853394|FG002|Third Intervention|Withdrew consent|0|||
42045549|NCT00925704|75853395|FG003|Third Intervention|Withdrew consent|0|||
42045550|NCT00925704|75853396|FG004|Third Intervention|Withdrew consent|0|||
42045551|NCT00925704|75853397|FG005|Third Intervention|Withdrew consent|1|||
42045552|NCT01076192|75853408|FG000|Overall Study|Other|197|||
42045553|NCT01076036|75853413|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
42045554|NCT01075958|75853417|FG000|Overall Study|Blood sample could not be obtained|44|||
42045555|NCT01096316|75853423|FG000|Overall Study|Lost to Follow-up|15|||
42045556|NCT01096316|75853424|FG001|Overall Study|Lost to Follow-up|9|||
42045557|NCT00925548|75853432|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
42045558|NCT00925548|75853433|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
42045559|NCT00866788|75853444|FG000|Overall Study|Adverse Event|0|||
42045560|NCT00866788|75853445|FG001|Overall Study|Adverse Event|2|||
42045561|NCT00866788|75853446|FG002|Overall Study|Adverse Event|0|||
42045562|NCT00866788|75853447|FG003|Overall Study|Adverse Event|1|||
42045563|NCT00866788|75853444|FG000|Overall Study|Lost to Follow-up|1|||
42045564|NCT00866788|75853445|FG001|Overall Study|Lost to Follow-up|1|||
42045565|NCT00866788|75853446|FG002|Overall Study|Lost to Follow-up|0|||
42045566|NCT00866788|75853447|FG003|Overall Study|Lost to Follow-up|2|||
42045567|NCT00866788|75853444|FG000|Overall Study|Withdrawal by Subject|2|||
42045568|NCT00866788|75853445|FG001|Overall Study|Withdrawal by Subject|1|||
42045569|NCT00866788|75853446|FG002|Overall Study|Withdrawal by Subject|0|||
42045570|NCT00866788|75853447|FG003|Overall Study|Withdrawal by Subject|1|||
42045571|NCT00866788|75853444|FG000|Overall Study|Pregnancy|0|||
42045572|NCT00866788|75853445|FG001|Overall Study|Pregnancy|1|||
42045573|NCT00866788|75853446|FG002|Overall Study|Pregnancy|0|||
42045574|NCT00866788|75853447|FG003|Overall Study|Pregnancy|0|||
42045575|NCT00866788|75853444|FG000|Overall Study|Disease progression|3|||
42045576|NCT00866788|75853445|FG001|Overall Study|Disease progression|1|||
42045577|NCT00866788|75853446|FG002|Overall Study|Disease progression|1|||
42045578|NCT00866788|75853447|FG003|Overall Study|Disease progression|0|||
42045579|NCT00866788|75853444|FG000|Overall Study|Physician Decision|0|||
42045580|NCT00866788|75853445|FG001|Overall Study|Physician Decision|0|||
42045581|NCT00866788|75853446|FG002|Overall Study|Physician Decision|1|||
42045582|NCT00866788|75853447|FG003|Overall Study|Physician Decision|1|||
42045583|NCT00860470|75853462|FG000|Overall Study|Death|6|||
42045584|NCT00860470|75853463|FG001|Overall Study|Death|10|||
42045585|NCT00860470|75853462|FG000|Overall Study|Moved away|8|||
42045586|NCT00860470|75853463|FG001|Overall Study|Moved away|10|||
42045587|NCT00860470|75853462|FG000|Overall Study|Lost to Follow-up|34|||
42045588|NCT00860470|75853463|FG001|Overall Study|Lost to Follow-up|39|||
42045589|NCT00923364|75853469|FG000|Overall Study|Death|3|||
42045590|NCT00923364|75853470|FG001|Overall Study|Death|0|||
42045591|NCT00923364|75853469|FG000|Overall Study|Did not go to transplant|1|||
42045592|NCT00923364|75853470|FG001|Overall Study|Did not go to transplant|0|||
42045593|NCT01096160|75853485|FG000|Overall Study|Adverse Event|0|||
42045594|NCT01096160|75853486|FG001|Overall Study|Adverse Event|0|||
42045595|NCT01096160|75853487|FG002|Overall Study|Adverse Event|1|||
42045596|NCT01096160|75853488|FG003|Overall Study|Adverse Event|0|||
42045597|NCT01096160|75853489|FG004|Overall Study|Adverse Event|0|||
42045598|NCT01096160|75853490|FG005|Overall Study|Adverse Event|0|||
42045599|NCT01096160|75853491|FG006|Overall Study|Adverse Event|0|||
42045600|NCT01096160|75853492|FG007|Overall Study|Adverse Event|0|||
42045601|NCT01096160|75853493|FG008|Overall Study|Adverse Event|0|||
42045602|NCT01096160|75853494|FG009|Overall Study|Adverse Event|1|||
42045603|NCT01096160|75853485|FG000|Overall Study|Met stopping criteria per protocol|0|||
42045604|NCT01096160|75853486|FG001|Overall Study|Met stopping criteria per protocol|0|||
42045605|NCT01096160|75853487|FG002|Overall Study|Met stopping criteria per protocol|0|||
42045606|NCT01096160|75853488|FG003|Overall Study|Met stopping criteria per protocol|0|||
42045607|NCT01096160|75853489|FG004|Overall Study|Met stopping criteria per protocol|1|||
42045608|NCT01096160|75853490|FG005|Overall Study|Met stopping criteria per protocol|0|||
42045609|NCT01096160|75853491|FG006|Overall Study|Met stopping criteria per protocol|2|||
42045610|NCT01096160|75853492|FG007|Overall Study|Met stopping criteria per protocol|0|||
42045611|NCT01096160|75853493|FG008|Overall Study|Met stopping criteria per protocol|2|||
42045612|NCT01096160|75853494|FG009|Overall Study|Met stopping criteria per protocol|0|||
42356850|NCT01393743|76202034|FG002|Core Study|Inadequate therapeutic effect|0|||
42045613|NCT00860158|75853529|FG000|Overall Study|Study Terminated|1|||
42045614|NCT00929526|75853535|FG000|Overall Study|Withdrawal by Subject|1|||
42045615|NCT00929526|75853536|FG001|Overall Study|Withdrawal by Subject|11|||
42045616|NCT00929526|75853535|FG000|Overall Study|Lost to Follow-up|8|||
42045617|NCT00929526|75853536|FG001|Overall Study|Lost to Follow-up|12|||
42045618|NCT00929526|75853535|FG000|Overall Study|Other|8|||
42356851|NCT01393743|76202032|FG000|Extension Phase|Adverse Event|0|||
42045619|NCT00929526|75853536|FG001|Overall Study|Other|6|||
42045620|NCT00859456|75853542|FG000|Overall Study|Adverse Event|3|||
42045621|NCT00859456|75853542|FG000|Overall Study|Progressive disease|2|||
42045622|NCT00859456|75853542|FG000|Overall Study|Non-compliance|3|||
42356852|NCT01393743|76202033|FG001|Extension Phase|Adverse Event|0|||
42045623|NCT01075646|75853550|FG000|Overall Study|Lost to Follow-up|4|||
42045624|NCT01075646|75853551|FG001|Overall Study|Lost to Follow-up|3|||
42045625|NCT01075646|75853552|FG002|Overall Study|Lost to Follow-up|1|||
42045626|NCT01075646|75853553|FG003|Overall Study|Lost to Follow-up|2|||
42045627|NCT01075412|75853565|FG000|Overall Study|Withdrawal by Subject|0|||
42045628|NCT01075412|75853566|FG001|Overall Study|Withdrawal by Subject|1|||
42045629|NCT00799903|75853573|FG000|Overall Study|Investigator Site Closed|25|||
42045630|NCT00799903|75853574|FG001|Overall Study|Investigator Site Closed|23|||
42045631|NCT00799903|75853573|FG000|Overall Study|Withdrawal by Subject|179|||
42045632|NCT00799903|75853574|FG001|Overall Study|Withdrawal by Subject|175|||
42045633|NCT00799903|75853573|FG000|Overall Study|Lost to Follow-up|69|||
42045634|NCT00799903|75853574|FG001|Overall Study|Lost to Follow-up|80|||
42045635|NCT01075256|75853583|FG000|Overall Study|Withdrawal by Subject|1|||
42045636|NCT01075256|75853584|FG001|Overall Study|Withdrawal by Subject|0|||
42045637|NCT01075256|75853585|FG002|Overall Study|Withdrawal by Subject|0|||
42045638|NCT00923130|75853598|FG000|Overall Study|Stopped treatment due to progression|17|||
42045639|NCT00923130|75853598|FG000|Overall Study|Death|1|||
42045640|NCT00923130|75853598|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
42045641|NCT00923130|75853598|FG000|Overall Study|Switched to alternative treatment|2|||
42045642|NCT00923130|75853598|FG000|Overall Study|Refused further treatment|2|||
42045643|NCT03253627|75853604|FG000|Overall Study|Lost to Follow-up|1|||
42045644|NCT03253627|75853605|FG001|Overall Study|Lost to Follow-up|2|||
42045645|NCT03253627|75853604|FG000|Overall Study|Withdrawal by Subject|0|||
42045646|NCT03253627|75853605|FG001|Overall Study|Withdrawal by Subject|2|||
42045647|NCT03253627|75853604|FG000|Overall Study|Inability to complete MRI|1|||
42045648|NCT03253627|75853605|FG001|Overall Study|Inability to complete MRI|0|||
42045649|NCT01075178|75853613|FG000|Subject Matching|eligible but not matched|130|||
42045650|NCT01075178|75853614|FG001|Subject Matching|eligible but not matched|403|||
42045651|NCT01075178|75853613|FG000|Subject Chart Review|died before chart review period|0|||
42045652|NCT01075178|75853614|FG001|Subject Chart Review|died before chart review period|2|||
42045653|NCT01075178|75853613|FG000|Subject Chart Review|no data collected due to site closure|3|||
42045654|NCT01075178|75853614|FG001|Subject Chart Review|no data collected due to site closure|4|||
42172591|NCT00324155|75979486|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
42045655|NCT01075178|75853613|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
42045656|NCT01075178|75853614|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
42045657|NCT00799825|75853620|FG000|Overall Study|Adverse Event|1|||
42045658|NCT00799825|75853620|FG000|Overall Study|Withdrawal by Subject|6|||
42045659|NCT00799825|75853620|FG000|Overall Study|Lost to Follow-up|38|||
42045660|NCT00799825|75853620|FG000|Overall Study|Pregnancy|3|||
42045661|NCT00799591|75853624|FG000|Overall Study|De-escalation of doses|20|||
42045662|NCT00799591|75853624|FG000|Overall Study|Death|14|||
42045663|NCT00799591|75853624|FG000|Overall Study|Technical failure|12|||
42045664|NCT00799591|75853624|FG000|Overall Study|Resistant germ|11|||
42045665|NCT00799591|75853624|FG000|Overall Study|New infection|4|||
42045666|NCT00799591|75853624|FG000|Overall Study|Resistance germ and technical failure|2|||
42045667|NCT00799591|75853624|FG000|Overall Study|Persistance of fever undetermined origin|1|||
42045668|NCT00799591|75853624|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
42045669|NCT00799591|75853624|FG000|Overall Study|Infectious origin not probable|1|||
42045670|NCT01075100|75853630|FG000|Overall Study|Adverse Event|15|||
42045671|NCT01075100|75853631|FG001|Overall Study|Adverse Event|18|||
42045672|NCT01075100|75853630|FG000|Overall Study|Patient Request|4|||
42045673|NCT01075100|75853631|FG001|Overall Study|Patient Request|4|||
42045674|NCT01075100|75853630|FG000|Overall Study|Investigator Request|2|||
42045675|NCT01075100|75853631|FG001|Overall Study|Investigator Request|1|||
42045676|NCT01075100|75853630|FG000|Overall Study|Disease Progression|25|||
42045677|NCT01075100|75853631|FG001|Overall Study|Disease Progression|29|||
42045678|NCT01075100|75853630|FG000|Overall Study|Other|3|||
42045679|NCT01075100|75853631|FG001|Overall Study|Other|1|||
42045680|NCT00803023|75853643|FG000|Overall Study|Adverse Event|5|||
42045681|NCT00803023|75853644|FG001|Overall Study|Adverse Event|4|||
42045682|NCT00803023|75853645|FG002|Overall Study|Adverse Event|8|||
42045683|NCT00803023|75853646|FG003|Overall Study|Adverse Event|6|||
42045684|NCT00803023|75853643|FG000|Overall Study|Withdrawal by Subject|0|||
42045685|NCT00803023|75853644|FG001|Overall Study|Withdrawal by Subject|2|||
42045686|NCT00803023|75853645|FG002|Overall Study|Withdrawal by Subject|0|||
42045687|NCT00803023|75853646|FG003|Overall Study|Withdrawal by Subject|0|||
42045688|NCT00803023|75853643|FG000|Overall Study|Lost to Follow-up|0|||
42172592|NCT00324155|75979487|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
42045689|NCT00803023|75853644|FG001|Overall Study|Lost to Follow-up|1|||
42045690|NCT00803023|75853645|FG002|Overall Study|Lost to Follow-up|2|||
42045691|NCT00803023|75853646|FG003|Overall Study|Lost to Follow-up|1|||
42045692|NCT00803023|75853643|FG000|Overall Study|Lack of Efficacy|0|||
42045693|NCT00803023|75853644|FG001|Overall Study|Lack of Efficacy|1|||
42045694|NCT00803023|75853645|FG002|Overall Study|Lack of Efficacy|1|||
42045695|NCT00803023|75853646|FG003|Overall Study|Lack of Efficacy|1|||
42045696|NCT00859222|75853659|FG000|Overall Study|Adverse Event|2|||
42045697|NCT00859222|75853660|FG001|Overall Study|Adverse Event|3|||
42045698|NCT00859222|75853661|FG002|Overall Study|Adverse Event|6|||
42045699|NCT00859222|75853662|FG003|Overall Study|Adverse Event|24|||
42045700|NCT00859222|75853663|FG004|Overall Study|Adverse Event|15|||
42045701|NCT00859222|75853659|FG000|Overall Study|DLT|1|||
42045702|NCT00859222|75853660|FG001|Overall Study|DLT|0|||
42045703|NCT00859222|75853661|FG002|Overall Study|DLT|0|||
42045704|NCT00859222|75853662|FG003|Overall Study|DLT|0|||
42045705|NCT00859222|75853663|FG004|Overall Study|DLT|0|||
42045706|NCT01072448|75853680|FG000|Overall Study|Adverse Event|9|||
42045707|NCT01072448|75853681|FG001|Overall Study|Adverse Event|10|||
42045708|NCT01072448|75853680|FG000|Overall Study|Subject withdrew consent|4|||
42045709|NCT01072448|75853681|FG001|Overall Study|Subject withdrew consent|9|||
42045710|NCT01072448|75853680|FG000|Overall Study|Protocol deviation|3|||
42045711|NCT01072448|75853681|FG001|Overall Study|Protocol deviation|4|||
42045712|NCT01072448|75853680|FG000|Overall Study|Abnormal test procedure result(s)|1|||
42045713|NCT01072448|75853681|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42045714|NCT01072448|75853680|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42045715|NCT01072448|75853681|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
42045716|NCT01072448|75853680|FG000|Overall Study|Lost to Follow-up|1|||
42045717|NCT01072448|75853681|FG001|Overall Study|Lost to Follow-up|1|||
42045718|NCT01072448|75853680|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42045719|NCT01072448|75853681|FG001|Overall Study|Abnormal laboratory value(s)|1|||
42045720|NCT01072448|75853680|FG000|Overall Study|Death|0|||
42045721|NCT01072448|75853681|FG001|Overall Study|Death|2|||
42045722|NCT00922974|75853690|FG000|Phase II Component|Protocol Violation|2|||
42045723|NCT00922974|75853691|FG001|Phase II Component|Protocol Violation|0|||
42045724|NCT00922974|75853690|FG000|Phase II Component|Not evaluable for treatment review|5|||
42045725|NCT00922974|75853691|FG001|Phase II Component|Not evaluable for treatment review|0|||
42045726|NCT00922974|75853690|FG000|Phase III Component|Protocol Violation|8|||
42045727|NCT00922974|75853691|FG001|Phase III Component|Protocol Violation|6|||
42045728|NCT00858988|75853701|FG000|Analysis|Lactulose unable to be detected in urine|2|||
42045729|NCT00858988|75853702|FG001|Analysis|Lactulose unable to be detected in urine|1|||
42045730|NCT00858832|75853710|FG000|Overall Study|became ineligible: delivered vaginally|1|||
42291169|NCT01946152|76124969|FG002|Overall Study|Second malignancy|1|||
42291170|NCT01946152|76124970|FG003|Overall Study|Second malignancy|0|||
42291171|NCT01946152|76124967|FG000|Overall Study|Adverse Event|0|||
42045731|NCT00858832|75853711|FG001|Overall Study|became ineligible: delivered vaginally|0|||
42045732|NCT00858832|75853710|FG000|Overall Study|Adverse Event|0|||
42045733|NCT00858832|75853711|FG001|Overall Study|Adverse Event|1|||
42045734|NCT01071512|75853717|FG000|Overall Study|Adverse Event|1|||
42045735|NCT01071512|75853717|FG000|Overall Study|Development of antibodies to drug|2|||
42045736|NCT01071512|75853717|FG000|Overall Study|positive anti-JC virus antibody test|2|||
42045737|NCT00858442|75853723|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
42045738|NCT00858442|75853724|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
42045739|NCT01071278|75853731|FG000|Overall Study|Premature Discontinuation|254|||
42045740|NCT01071278|75853731|FG000|Overall Study|Completion Status Unknown|459|||
42045741|NCT00858208|75853737|FG000|Overall Study|Adverse Event|3|||
42045742|NCT00858208|75853737|FG000|Overall Study|Lost to Follow-up|26|||
42045743|NCT00858208|75853737|FG000|Overall Study|Participant refused|40|||
42045744|NCT00858208|75853737|FG000|Overall Study|Other|10|||
42045745|NCT01071200|75853743|FG000|Overall Study|Lack of ovarian response|1|||
42045746|NCT01071200|75853744|FG001|Overall Study|Lack of ovarian response|1|||
42045747|NCT01071200|75853743|FG000|Overall Study|No fertilization|4|||
42045748|NCT01071200|75853744|FG001|Overall Study|No fertilization|0|||
42045749|NCT01071200|75853743|FG000|Overall Study|No oocytes retrieved|1|||
42045750|NCT01071200|75853744|FG001|Overall Study|No oocytes retrieved|1|||
42045751|NCT01071200|75853743|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
42045752|NCT01071200|75853744|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
42045753|NCT01071200|75853743|FG000|Overall Study|No viable embryos|0|||
42045754|NCT01071200|75853744|FG001|Overall Study|No viable embryos|1|||
42045755|NCT02207569|75853750|FG000|1-Month|Death|6|||
42045756|NCT02207569|75853750|FG000|1-Month|Withdrawal by Subject|2|||
42045757|NCT02207569|75853750|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
42045758|NCT02207569|75853750|FG000|6-Month|Death|8|||
42045759|NCT02207569|75853750|FG000|6-Month|Withdrawal by Subject|2|||
42045760|NCT02207569|75853750|FG000|12-Month|Death|14|||
42045761|NCT02207569|75853750|FG000|12-Month|Withdrawal by Subject|2|||
42045762|NCT02207569|75853750|FG000|24-Month|Death|23|||
42045763|NCT02207569|75853750|FG000|24-Month|Withdrawal by Subject|3|||
42045764|NCT02207569|75853750|FG000|36-Month|Death|23|||
42045765|NCT02207569|75853750|FG000|36-Month|Withdrawal by Subject|4|||
42045766|NCT02207569|75853750|FG000|48-Month|Death|25|||
42045767|NCT02207569|75853750|FG000|48-Month|Withdrawal by Subject|2|||
42045768|NCT02207569|75853750|FG000|48-Month|Lost to Follow-up|4|||
42045769|NCT02207569|75853750|FG000|60-Month|Death|1|||
42045770|NCT02207569|75853750|FG000|60-Month|Lost to Follow-up|1|||
42045771|NCT02207569|75853750|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
42045772|NCT02207569|75853750|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
42045773|NCT01070966|75853754|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
42045774|NCT01070966|75853754|FG000|Participants for Safety Evaluation|Off-label use|9|||
42045775|NCT01070966|75853754|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
42291172|NCT01946152|76124968|FG001|Overall Study|Adverse Event|0|||
42045776|NCT01070966|75853754|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
42045777|NCT01070966|75853754|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
42045778|NCT01070966|75853754|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
42045779|NCT01070966|75853754|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
42045780|NCT01070966|75853754|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
42045781|NCT01070888|75853767|FG000|First Intervention (14 Days)|Adverse Event|0|||
42045782|NCT01070888|75853768|FG001|First Intervention (14 Days)|Adverse Event|1|||
42045783|NCT01070888|75853767|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
42045784|NCT01070888|75853768|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
42045785|NCT01070888|75853767|FG000|Washout (14 Days)|Physician Decision|1|||
42045786|NCT01070888|75853768|FG001|Washout (14 Days)|Physician Decision|0|||
42045787|NCT00857896|75853774|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
42045788|NCT00857818|75853781|FG000|Overall Study|Lack of Efficacy|1|||
42045789|NCT00857818|75853782|FG001|Overall Study|Lack of Efficacy|0|||
42045790|NCT00857818|75853781|FG000|Overall Study|Adverse Event|3|||
42045791|NCT00857818|75853782|FG001|Overall Study|Adverse Event|0|||
42045792|NCT00857818|75853781|FG000|Overall Study|Withdrawal by Subject|0|||
42045793|NCT00857818|75853782|FG001|Overall Study|Withdrawal by Subject|4|||
42045794|NCT00857818|75853781|FG000|Overall Study|Sponsor terminated study|6|||
42045795|NCT00857818|75853782|FG001|Overall Study|Sponsor terminated study|4|||
42045796|NCT00857818|75853781|FG000|Overall Study|Investigator decision|1|||
42045797|NCT00857818|75853782|FG001|Overall Study|Investigator decision|0|||
42045798|NCT01074944|75853788|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
42045799|NCT01074944|75853789|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
42045800|NCT01074944|75853790|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
42045801|NCT01074944|75853791|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
42045802|NCT01074944|75853792|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
42045803|NCT01074944|75853788|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
42045804|NCT01074944|75853789|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
42045805|NCT01074944|75853790|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
42045806|NCT01074944|75853791|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
42045807|NCT01074944|75853792|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
42045808|NCT01074944|75853788|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
42045809|NCT01074944|75853789|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
42045810|NCT01074944|75853790|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
42045811|NCT01074944|75853791|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
42045812|NCT01074944|75853792|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
42045813|NCT01074944|75853788|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
42045814|NCT01074944|75853789|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
42045815|NCT01074944|75853790|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
42045816|NCT01074944|75853791|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
42045817|NCT01074944|75853792|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
42045818|NCT01074944|75853788|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
42045819|NCT01074944|75853789|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
42045820|NCT01074944|75853790|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
42045821|NCT01074944|75853791|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
42045822|NCT01074944|75853792|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
42045823|NCT01074944|75853788|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
42045824|NCT01074944|75853789|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
42045825|NCT01074944|75853790|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
42045826|NCT01074944|75853791|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
42045827|NCT01074944|75853792|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
42045828|NCT01074944|75853788|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
42045829|NCT01074944|75853789|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
42045830|NCT01074944|75853790|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
42045831|NCT01074944|75853791|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
42045832|NCT01074944|75853792|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
42045833|NCT01074944|75853788|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
42045834|NCT01074944|75853789|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
42045835|NCT01074944|75853790|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
42045836|NCT01074944|75853791|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
42172593|NCT00324155|75979486|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
42045837|NCT01074944|75853792|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
42045838|NCT01074944|75853788|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
42045839|NCT01074944|75853789|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
42045840|NCT01074944|75853790|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
42172594|NCT00324155|75979487|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
42172595|NCT00324155|75979486|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
42172596|NCT00324155|75979487|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
42172597|NCT00324155|75979486|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
42172598|NCT00324155|75979487|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
42172599|NCT00324155|75979486|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
42172600|NCT00324155|75979487|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
42172601|NCT00324155|75979486|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
42291173|NCT01946152|76124969|FG002|Overall Study|Adverse Event|0|||
42291174|NCT01946152|76124970|FG003|Overall Study|Adverse Event|1|||
42291175|NCT01945996|76124984|FG000|Overall Study|Lost to Follow-up|3|||
42291176|NCT01945996|76124985|FG001|Overall Study|Lost to Follow-up|5|||
42291177|NCT01971346|76124993|FG000|Overall Study|Protocol Violation|3|||
42291178|NCT01971346|76124993|FG000|Overall Study|Lost to Follow-up|2|||
42291179|NCT01971346|76124993|FG000|Overall Study|Withdrawal by Subject|2|||
42291180|NCT01971346|76124993|FG000|Overall Study|Physician Decision|1|||
42291181|NCT01945216|76125008|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
42291182|NCT01945216|76125008|FG000|Overall Study|Protocol Violation|42|||
42291183|NCT01945216|76125008|FG000|Overall Study|CRF not assured by investigators|5|||
42291184|NCT02641379|76125027|FG000|Overall Study|Exclusion criterion during screening|1|||
42291185|NCT02641379|76125028|FG001|Overall Study|Exclusion criterion during screening|0|||
42291186|NCT02641379|76125029|FG002|Overall Study|Exclusion criterion during screening|0|||
42291187|NCT02641379|76125030|FG003|Overall Study|Exclusion criterion during screening|1|||
42291188|NCT02641379|76125031|FG004|Overall Study|Exclusion criterion during screening|2|||
42291189|NCT02641379|76125032|FG005|Overall Study|Exclusion criterion during screening|0|||
42291190|NCT02641379|76125033|FG006|Overall Study|Exclusion criterion during screening|0|||
42291191|NCT02641379|76125034|FG007|Overall Study|Exclusion criterion during screening|0|||
42291192|NCT02641379|76125035|FG008|Overall Study|Exclusion criterion during screening|0|||
42291193|NCT02641379|76125036|FG009|Overall Study|Exclusion criterion during screening|0|||
42291194|NCT02641379|76125037|FG010|Overall Study|Exclusion criterion during screening|0|||
42291195|NCT02641379|76125027|FG000|Overall Study|Withdrawal of informed consent|0|||
42291196|NCT02641379|76125028|FG001|Overall Study|Withdrawal of informed consent|1|||
42291197|NCT02641379|76125029|FG002|Overall Study|Withdrawal of informed consent|0|||
42291198|NCT02641379|76125030|FG003|Overall Study|Withdrawal of informed consent|0|||
42291199|NCT02641379|76125031|FG004|Overall Study|Withdrawal of informed consent|0|||
42291200|NCT02641379|76125032|FG005|Overall Study|Withdrawal of informed consent|0|||
42291201|NCT02641379|76125033|FG006|Overall Study|Withdrawal of informed consent|0|||
42291202|NCT02641379|76125034|FG007|Overall Study|Withdrawal of informed consent|1|||
42291203|NCT02641379|76125035|FG008|Overall Study|Withdrawal of informed consent|0|||
42291204|NCT02641379|76125036|FG009|Overall Study|Withdrawal of informed consent|0|||
42291205|NCT02641379|76125037|FG010|Overall Study|Withdrawal of informed consent|0|||
42045841|NCT01074944|75853791|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
42045842|NCT01074944|75853792|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
42045843|NCT01074944|75853788|FG000|Long Term Treatment|Adverse Event|0|||
42045844|NCT01074944|75853789|FG001|Long Term Treatment|Adverse Event|0|||
42045845|NCT01074944|75853790|FG002|Long Term Treatment|Adverse Event|0|||
42045846|NCT01074944|75853791|FG003|Long Term Treatment|Adverse Event|3|||
42045847|NCT01074944|75853792|FG004|Long Term Treatment|Adverse Event|0|||
42045848|NCT01074944|75853788|FG000|Long Term Treatment|Lost to Follow-up|0|||
42045849|NCT01074944|75853789|FG001|Long Term Treatment|Lost to Follow-up|0|||
42172602|NCT00324155|75979487|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
42172603|NCT00324155|75979486|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
42172604|NCT00324155|75979487|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
42172605|NCT00324155|75979486|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
42172606|NCT00324155|75979487|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
42172607|NCT00324155|75979486|FG000|Follow-up Phase|On-going participants still on drug|11|||
42172608|NCT00324155|75979487|FG001|Follow-up Phase|On-going participants still on drug|6|||
42172609|NCT03334396|75979514|FG000|Overall Study|Adverse Event|1|||
42172610|NCT03334396|75979515|FG001|Overall Study|Adverse Event|0|||
42172611|NCT03334396|75979516|FG002|Overall Study|Adverse Event|1|||
42172612|NCT03334396|75979517|FG003|Overall Study|Adverse Event|0|||
42172613|NCT03334396|75979518|FG004|Overall Study|Adverse Event|0|||
42172614|NCT03334396|75979519|FG005|Overall Study|Adverse Event|0|||
42172615|NCT03334396|75979520|FG006|Overall Study|Adverse Event|0|||
42172616|NCT03334396|75979521|FG007|Overall Study|Adverse Event|0|||
42172617|NCT03334396|75979514|FG000|Overall Study|Lack of Efficacy|10|||
42172618|NCT03334396|75979515|FG001|Overall Study|Lack of Efficacy|4|||
42172619|NCT03334396|75979516|FG002|Overall Study|Lack of Efficacy|1|||
42291206|NCT02641379|76125027|FG000|Overall Study|Adverse Event|7|||
42291207|NCT02641379|76125028|FG001|Overall Study|Adverse Event|8|||
42045850|NCT01074944|75853790|FG002|Long Term Treatment|Lost to Follow-up|0|||
42045851|NCT01074944|75853791|FG003|Long Term Treatment|Lost to Follow-up|2|||
42045852|NCT01074944|75853792|FG004|Long Term Treatment|Lost to Follow-up|0|||
42045853|NCT01074944|75853788|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
42045854|NCT01074944|75853789|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
42045855|NCT01074944|75853790|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
42045856|NCT01074944|75853791|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
42045857|NCT01074944|75853792|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
42045858|NCT01074944|75853788|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
42045859|NCT01074944|75853789|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
42045860|NCT01074944|75853790|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
42045861|NCT01074944|75853791|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
42045862|NCT01074944|75853792|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
42045863|NCT01074944|75853788|FG000|Long Term Treatment|Withdrawal by Subject|0|||
42045864|NCT01074944|75853789|FG001|Long Term Treatment|Withdrawal by Subject|0|||
42045865|NCT01074944|75853790|FG002|Long Term Treatment|Withdrawal by Subject|0|||
42045866|NCT01074944|75853791|FG003|Long Term Treatment|Withdrawal by Subject|2|||
42045867|NCT01074944|75853792|FG004|Long Term Treatment|Withdrawal by Subject|0|||
42045868|NCT01074944|75853788|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
42045869|NCT01074944|75853789|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
42045870|NCT01074944|75853790|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
42045871|NCT01074944|75853791|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
42045872|NCT01074944|75853792|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
42045873|NCT01074944|75853788|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
42045874|NCT01074944|75853789|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
42045875|NCT01074944|75853790|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
42045876|NCT01074944|75853791|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
42045877|NCT01074944|75853792|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
42045878|NCT00802945|75853802|FG000|Overall Study|Death|27|||
42045879|NCT00802945|75853803|FG001|Overall Study|Death|23|||
42045880|NCT00802945|75853802|FG000|Overall Study|Terminated by sponsor|8|||
42045881|NCT00802945|75853803|FG001|Overall Study|Terminated by sponsor|12|||
42045882|NCT01074554|75853813|FG000|Overall Study|Adverse Event|3|||
42045883|NCT01074554|75853814|FG001|Overall Study|Adverse Event|3|||
42045884|NCT01074554|75853813|FG000|Overall Study|Lost to Follow-up|0|||
42045885|NCT01074554|75853814|FG001|Overall Study|Lost to Follow-up|1|||
42045886|NCT00857584|75853822|FG000|Overall Study|Lack of Efficacy|1|||
42045887|NCT00857584|75853823|FG001|Overall Study|Lack of Efficacy|2|||
42045888|NCT00857584|75853822|FG000|Overall Study|Adverse Event|2|||
42045889|NCT00857584|75853823|FG001|Overall Study|Adverse Event|2|||
42045890|NCT00857584|75853822|FG000|Overall Study|Physician Decision|1|||
42045891|NCT00857584|75853823|FG001|Overall Study|Physician Decision|1|||
42045892|NCT00798967|75853831|FG000|Overall Study|Adverse Event|2|||
42356853|NCT01393743|76202034|FG002|Extension Phase|Adverse Event|12|||
42356854|NCT01393743|76202032|FG000|Extension Phase|Lost to Follow-up|0|||
42356855|NCT01393743|76202033|FG001|Extension Phase|Lost to Follow-up|0|||
42045893|NCT00798967|75853832|FG001|Overall Study|Adverse Event|3|||
42045894|NCT00798967|75853831|FG000|Overall Study|Withdrawal by Subject|0|||
42045895|NCT00798967|75853832|FG001|Overall Study|Withdrawal by Subject|1|||
42045896|NCT00798967|75853831|FG000|Overall Study|Physician Decision|1|||
42045897|NCT00798967|75853832|FG001|Overall Study|Physician Decision|0|||
42045898|NCT00798967|75853831|FG000|Overall Study|Randomized in error by site|1|||
42045899|NCT00798967|75853832|FG001|Overall Study|Randomized in error by site|0|||
42045900|NCT01074242|75853839|FG000|Overall Study|Case report before date of contract|40|||
42045901|NCT01074242|75853839|FG000|Overall Study|Lost to Follow-up|1|||
42045902|NCT01074242|75853839|FG000|Overall Study|Case report unclear|6|||
42045903|NCT01074242|75853839|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
42045904|NCT01074242|75853839|FG000|Overall Study|Duplicate Case Report Form|5|||
42045905|NCT00798889|75853843|FG000|Overall Study|Adverse Event|53|||
42045906|NCT00798889|75853843|FG000|Overall Study|Protocol Violation|2|||
42045907|NCT00798889|75853843|FG000|Overall Study|Withdrawal by Subject|31|||
42045908|NCT00798889|75853843|FG000|Overall Study|Lost to Follow-up|1|||
42045909|NCT00798889|75853843|FG000|Overall Study|Lack of Efficacy|213|||
42045910|NCT00798889|75853843|FG000|Overall Study|Decision of Sponsor|11|||
42045911|NCT00798889|75853843|FG000|Overall Study|Enrolled, Not treated|3|||
42045912|NCT00796861|75853847|FG000|Overall Study|Withdrawal by Subject|2|||
42045913|NCT00796861|75853847|FG000|Overall Study|Death|2|||
42045914|NCT00802867|75853851|FG000|Overall Study|Lost to Follow-up|6|||
42045915|NCT00802867|75853851|FG000|Overall Study|Protocol Violation|6|||
42172620|NCT03334396|75979517|FG003|Overall Study|Lack of Efficacy|3|||
42356856|NCT01393743|76202034|FG002|Extension Phase|Lost to Follow-up|2|||
42356857|NCT01393743|76202032|FG000|Extension Phase|Participant choice|0|||
42045916|NCT00802867|75853851|FG000|Overall Study|Withdrawal by Subject|1|||
42045917|NCT00798655|75853855|FG000|Overall Study|Did not receive at least one dose of pan|2|||
42045918|NCT00796549|75853859|FG000|Overall Study|Adverse Event|11|||
42045919|NCT00796549|75853859|FG000|Overall Study|not entered|149|||
42045920|NCT00796549|75853859|FG000|Overall Study|Other|2|||
42045921|NCT00796549|75853859|FG000|Overall Study|Progressive disease|56|||
42045922|NCT00856492|75853868|FG000|Overall Study|Ineligible or withdrew consent|1|||
42045923|NCT00856492|75853869|FG001|Overall Study|Ineligible or withdrew consent|1|||
42045924|NCT00856492|75853870|FG002|Overall Study|Ineligible or withdrew consent|2|||
42045925|NCT00856180|75853881|FG000|Overall Study|Adverse Event|4|||
42045926|NCT00856180|75853881|FG000|Overall Study|Progressive Disease|16|||
42045927|NCT00900627|75853893|FG000|Overall Study|Condition under investigation worsened|4|||
42045928|NCT00900627|75853894|FG001|Overall Study|Condition under investigation worsened|0|||
42045929|NCT00900627|75853895|FG002|Overall Study|Condition under investigation worsened|5|||
42291208|NCT02641379|76125029|FG002|Overall Study|Adverse Event|2|||
42291209|NCT02641379|76125030|FG003|Overall Study|Adverse Event|2|||
42291210|NCT02641379|76125031|FG004|Overall Study|Adverse Event|5|||
42291211|NCT02641379|76125032|FG005|Overall Study|Adverse Event|1|||
42045930|NCT00900627|75853896|FG003|Overall Study|Condition under investigation worsened|3|||
42045931|NCT00900627|75853897|FG004|Overall Study|Condition under investigation worsened|0|||
42045932|NCT00900627|75853898|FG005|Overall Study|Condition under investigation worsened|0|||
42045933|NCT00900627|75853893|FG000|Overall Study|Withdrawal by Subject|1|||
42045934|NCT00900627|75853894|FG001|Overall Study|Withdrawal by Subject|0|||
42045935|NCT00900627|75853895|FG002|Overall Study|Withdrawal by Subject|1|||
42045936|NCT00900627|75853896|FG003|Overall Study|Withdrawal by Subject|0|||
42045937|NCT00900627|75853897|FG004|Overall Study|Withdrawal by Subject|1|||
42045938|NCT00900627|75853898|FG005|Overall Study|Withdrawal by Subject|2|||
42045939|NCT00900627|75853893|FG000|Overall Study|Adverse Event|1|||
42045940|NCT00900627|75853894|FG001|Overall Study|Adverse Event|2|||
42045941|NCT00900627|75853895|FG002|Overall Study|Adverse Event|0|||
42045942|NCT00900627|75853896|FG003|Overall Study|Adverse Event|3|||
42045943|NCT00900627|75853897|FG004|Overall Study|Adverse Event|0|||
42045944|NCT00900627|75853898|FG005|Overall Study|Adverse Event|0|||
42045945|NCT00900627|75853893|FG000|Overall Study|Death|0|||
42045946|NCT00900627|75853894|FG001|Overall Study|Death|0|||
42045947|NCT00900627|75853895|FG002|Overall Study|Death|0|||
42045948|NCT00900627|75853896|FG003|Overall Study|Death|0|||
42045949|NCT00900627|75853897|FG004|Overall Study|Death|28|||
42045950|NCT00900627|75853898|FG005|Overall Study|Death|24|||
42045951|NCT00866320|75853912|FG000|Overall Study|Withdrawal by Subject|4|||
42045952|NCT00866320|75853912|FG000|Overall Study|Death|2|||
42045953|NCT00869518|75853920|FG000|Overall Study|Lost to Follow-up|1|||
42045954|NCT00869518|75853921|FG001|Overall Study|Lost to Follow-up|1|||
42045955|NCT00797563|75853927|FG000|Overall Study|Adverse Event|1|||
42045956|NCT00869440|75853935|FG000|Overall Study|Withdrawal by Subject|1|||
42045957|NCT00869440|75853936|FG001|Overall Study|Withdrawal by Subject|0|||
42045958|NCT00869440|75853937|FG002|Overall Study|Withdrawal by Subject|0|||
42045959|NCT00869440|75853938|FG003|Overall Study|Withdrawal by Subject|0|||
42045960|NCT00869440|75853935|FG000|Overall Study|Physician Decision|1|||
42045961|NCT00869440|75853936|FG001|Overall Study|Physician Decision|1|||
42045962|NCT00869440|75853937|FG002|Overall Study|Physician Decision|0|||
42045963|NCT00869440|75853938|FG003|Overall Study|Physician Decision|0|||
42045964|NCT00895947|75853950|FG000|Overall Study|Adverse Event|3|||
42045965|NCT00895947|75853951|FG001|Overall Study|Adverse Event|4|||
42045966|NCT00895947|75853950|FG000|Overall Study|Lost to Follow-up|3|||
42045967|NCT00895947|75853951|FG001|Overall Study|Lost to Follow-up|4|||
42045968|NCT00895947|75853950|FG000|Overall Study|Protocol Violation|4|||
42045969|NCT00895947|75853951|FG001|Overall Study|Protocol Violation|2|||
42045970|NCT00895947|75853950|FG000|Overall Study|Withdrawal by Subject|2|||
42045971|NCT00895947|75853951|FG001|Overall Study|Withdrawal by Subject|0|||
42045972|NCT00869362|75853959|FG000|Overall Study|Death|0|||
42045973|NCT00869362|75853960|FG001|Overall Study|Death|2|||
42045974|NCT00869362|75853959|FG000|Overall Study|Lost to Follow-up|1|||
42291212|NCT02641379|76125033|FG006|Overall Study|Adverse Event|5|||
42291213|NCT02641379|76125034|FG007|Overall Study|Adverse Event|0|||
42291214|NCT02641379|76125035|FG008|Overall Study|Adverse Event|1|||
42291215|NCT02641379|76125036|FG009|Overall Study|Adverse Event|1|||
42291216|NCT02641379|76125037|FG010|Overall Study|Adverse Event|5|||
42291217|NCT02641379|76125027|FG000|Overall Study|Lack of Efficacy|0|||
42045975|NCT00869362|75853960|FG001|Overall Study|Lost to Follow-up|3|||
42045976|NCT00588445|75853967|FG000|Overall Study|Protocol Violation|1|||
42045977|NCT00588445|75853967|FG000|Overall Study|Withdrawal by Subject|3|||
42045978|NCT00588445|75853967|FG000|Overall Study|Disease Progression|1|||
42045979|NCT00588445|75853967|FG000|Overall Study|Not Treated|10|||
42045980|NCT00796315|75853973|FG000|Overall Study|Protocol Violation|0|||
42045981|NCT00796315|75853974|FG001|Overall Study|Protocol Violation|1|||
42045982|NCT00796315|75853975|FG002|Overall Study|Protocol Violation|0|||
42045983|NCT00855166|75853988|FG000|Overall Study|Adverse Event|0|||
42291218|NCT02641379|76125028|FG001|Overall Study|Lack of Efficacy|0|||
42045984|NCT00855166|75853989|FG001|Overall Study|Adverse Event|2|||
42045985|NCT00855166|75853988|FG000|Overall Study|Death|0|||
42045986|NCT00855166|75853989|FG001|Overall Study|Death|1|||
42045987|NCT00855166|75853988|FG000|Overall Study|Withdrawal by Subject|1|||
42045988|NCT00855166|75853989|FG001|Overall Study|Withdrawal by Subject|4|||
42045989|NCT00855166|75853988|FG000|Overall Study|Poor/non-compliance|2|||
42045990|NCT00855166|75853989|FG001|Overall Study|Poor/non-compliance|0|||
42045991|NCT00855166|75853988|FG000|Overall Study|Administrative reasons by sponsor|1|||
42045992|NCT00855166|75853989|FG001|Overall Study|Administrative reasons by sponsor|0|||
42045993|NCT00855166|75853988|FG000|Overall Study|Subject no longer meets study criteria|1|||
42045994|NCT00855166|75853989|FG001|Overall Study|Subject no longer meets study criteria|1|||
42045995|NCT00587587|75853999|FG000|Overall Study|Lost to Follow-up|6|||
42045996|NCT00587587|75854000|FG001|Overall Study|Lost to Follow-up|1|||
42045997|NCT00854620|75854008|FG000|Overall Study|Adverse Event|1|||
42045998|NCT00793585|75854014|FG000|Overall Study|Adverse Event|1|||
42045999|NCT00793585|75854015|FG001|Overall Study|Adverse Event|1|||
42046000|NCT00793585|75854014|FG000|Overall Study|Protocol Violation|1|||
42046001|NCT00793585|75854015|FG001|Overall Study|Protocol Violation|2|||
42046002|NCT00898443|75854023|FG000|Overall Study|Withdrawal by Subject|1|||
42046003|NCT00898443|75854024|FG001|Overall Study|Withdrawal by Subject|0|||
42046004|NCT00900159|75854032|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
42046005|NCT00900159|75854033|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
42046006|NCT00854308|75854052|FG000|Overall Study|Disease progression|42|||
42046007|NCT00854308|75854053|FG001|Overall Study|Disease progression|50|||
42046008|NCT00854308|75854052|FG000|Overall Study|Adverse Event|8|||
42046009|NCT00854308|75854053|FG001|Overall Study|Adverse Event|3|||
42046010|NCT00854308|75854052|FG000|Overall Study|Death|2|||
42046011|NCT00854308|75854053|FG001|Overall Study|Death|5|||
42046012|NCT00854308|75854052|FG000|Overall Study|Physician Decision|6|||
42046013|NCT00854308|75854053|FG001|Overall Study|Physician Decision|6|||
42046014|NCT00854308|75854052|FG000|Overall Study|Withdrawal by Subject|4|||
42046015|NCT00854308|75854053|FG001|Overall Study|Withdrawal by Subject|2|||
42046016|NCT00854308|75854052|FG000|Overall Study|Sponsor's decision to terminate study|0|||
42046017|NCT00854308|75854053|FG001|Overall Study|Sponsor's decision to terminate study|1|||
42046018|NCT00592852|75854059|FG000|Overall Study|Non-compliance|1|||
42046019|NCT00592852|75854059|FG000|Overall Study|Adverse Event|3|||
42046020|NCT00592852|75854059|FG000|Overall Study|Found ineligible|1|||
42046021|NCT00592852|75854059|FG000|Overall Study|Withdrawal by Subject|1|||
42046022|NCT00895245|75854063|FG000|Overall Study|Lack of Efficacy|6|||
42046023|NCT00865306|75854069|FG000|Controlled Trial|Lost to Follow-up|1|||
42046024|NCT00865306|75854070|FG001|Controlled Trial|Lost to Follow-up|1|||
42046025|NCT00865306|75854069|FG000|Controlled Trial|Difficulty commuting|2|||
42046026|NCT00865306|75854070|FG001|Controlled Trial|Difficulty commuting|0|||
42046027|NCT00865306|75854069|FG000|Controlled Trial|Improved btw baseline and first session|1|||
42046028|NCT00865306|75854070|FG001|Controlled Trial|Improved btw baseline and first session|0|||
42046029|NCT00865306|75854069|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
42046030|NCT00865306|75854070|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
42046031|NCT00865306|75854069|FG000|Controlled Trial|Withdrawal by Subject|0|||
42046032|NCT00865306|75854070|FG001|Controlled Trial|Withdrawal by Subject|1|||
42046033|NCT00896649|75854076|FG000|Overall Study|Physician Decision|1|||
42046034|NCT00896649|75854076|FG000|Overall Study|Pregnancy|1|||
42046035|NCT00896649|75854076|FG000|Overall Study|missing documentation|1|||
42046036|NCT00896649|75854076|FG000|Overall Study|technical difficulties|2|||
42046037|NCT00796003|75854083|FG000|Overall Study|Disease Progression|2|||
42046038|NCT00796003|75854084|FG001|Overall Study|Disease Progression|13|||
42046039|NCT00796003|75854083|FG000|Overall Study|Adverse Event|1|||
42046040|NCT00796003|75854084|FG001|Overall Study|Adverse Event|7|||
42046041|NCT00796003|75854083|FG000|Overall Study|Specified organ function not met|0|||
42046042|NCT00796003|75854084|FG001|Overall Study|Specified organ function not met|1|||
42046043|NCT00796003|75854083|FG000|Overall Study|Physician Decision|0|||
42046044|NCT00796003|75854084|FG001|Overall Study|Physician Decision|4|||
42046045|NCT00796003|75854083|FG000|Overall Study|Withdrawal by Subject|0|||
42046046|NCT00796003|75854084|FG001|Overall Study|Withdrawal by Subject|1|||
42046047|NCT00796003|75854083|FG000|Overall Study|Other|0|||
42046048|NCT00796003|75854084|FG001|Overall Study|Other|1|||
42046049|NCT00796003|75854083|FG000|Overall Study|Participants Not treated|0|||
42172621|NCT03334396|75979518|FG004|Overall Study|Lack of Efficacy|1|||
42172622|NCT03334396|75979519|FG005|Overall Study|Lack of Efficacy|0|||
42172623|NCT03334396|75979520|FG006|Overall Study|Lack of Efficacy|0|||
42172624|NCT03334396|75979521|FG007|Overall Study|Lack of Efficacy|1|||
42046050|NCT00796003|75854084|FG001|Overall Study|Participants Not treated|2|||
42046051|NCT00895011|75854096|FG000|Overall Study|Withdrawal by Subject|14|||
42046052|NCT00895011|75854097|FG001|Overall Study|Withdrawal by Subject|7|||
42046053|NCT00895011|75854098|FG002|Overall Study|Withdrawal by Subject|2|||
42046054|NCT00895011|75854096|FG000|Overall Study|Lost to Follow-up|5|||
42046055|NCT00895011|75854097|FG001|Overall Study|Lost to Follow-up|4|||
42172625|NCT03334396|75979514|FG000|Overall Study|Lost to Follow-up|0|||
42046056|NCT00895011|75854098|FG002|Overall Study|Lost to Follow-up|1|||
42046057|NCT00895011|75854096|FG000|Overall Study|Protocol Violation|3|||
42046058|NCT00895011|75854097|FG001|Overall Study|Protocol Violation|1|||
42046059|NCT00895011|75854098|FG002|Overall Study|Protocol Violation|3|||
42046060|NCT00895011|75854096|FG000|Overall Study|Adverse Event|1|||
42046061|NCT00895011|75854097|FG001|Overall Study|Adverse Event|2|||
42046062|NCT00895011|75854098|FG002|Overall Study|Adverse Event|2|||
42046063|NCT00895011|75854096|FG000|Overall Study|schedule conflict|1|||
42046064|NCT00895011|75854097|FG001|Overall Study|schedule conflict|0|||
42046065|NCT00895011|75854098|FG002|Overall Study|schedule conflict|0|||
42046066|NCT00899847|75854107|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
42046067|NCT00795535|75854113|FG000|Overall Study|incomplete data and technical problems|20|||
42046068|NCT00853762|75854121|FG000|Overall Study|Premature Termination|16|||
42046069|NCT00853762|75854122|FG001|Overall Study|Premature Termination|15|||
42046070|NCT00853762|75854123|FG002|Overall Study|Premature Termination|14|||
42046071|NCT00853762|75854124|FG003|Overall Study|Premature Termination|21|||
42046072|NCT00853762|75854121|FG000|Overall Study|Protocol Violation|0|||
42046073|NCT00853762|75854122|FG001|Overall Study|Protocol Violation|0|||
42046074|NCT00853762|75854123|FG002|Overall Study|Protocol Violation|0|||
42046075|NCT00853762|75854124|FG003|Overall Study|Protocol Violation|1|||
42046076|NCT00853762|75854121|FG000|Overall Study|Withdrawal by Subject|0|||
42046077|NCT00853762|75854122|FG001|Overall Study|Withdrawal by Subject|0|||
42046078|NCT00853762|75854123|FG002|Overall Study|Withdrawal by Subject|1|||
42046079|NCT00853762|75854124|FG003|Overall Study|Withdrawal by Subject|0|||
42046080|NCT00853762|75854121|FG000|Overall Study|Other|0|||
42046081|NCT00853762|75854122|FG001|Overall Study|Other|2|||
42046082|NCT00853762|75854123|FG002|Overall Study|Other|0|||
42046083|NCT00853762|75854124|FG003|Overall Study|Other|0|||
42046084|NCT00853762|75854121|FG000|Overall Study|Randomised but not Treated|0|||
42046085|NCT00853762|75854122|FG001|Overall Study|Randomised but not Treated|2|||
42046086|NCT00853762|75854123|FG002|Overall Study|Randomised but not Treated|2|||
42046087|NCT00853762|75854124|FG003|Overall Study|Randomised but not Treated|0|||
42046088|NCT00789529|75854136|FG000|Overall Study|Withdrawal by Subject|0|||
42046089|NCT00789529|75854137|FG001|Overall Study|Withdrawal by Subject|1|||
42046090|NCT00789529|75854136|FG000|Overall Study|Other Reason|1|||
42046091|NCT00789529|75854137|FG001|Overall Study|Other Reason|0|||
42046092|NCT00894933|75854143|FG000|Overall Study|Lost to Follow-up|2|||
42046093|NCT00894933|75854143|FG000|Overall Study|Cancelled Procedure|1|||
42046094|NCT00894933|75854143|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
42046095|NCT00792805|75854150|FG000|Overall Study|Adverse Event|12|||
42046096|NCT00792805|75854151|FG001|Overall Study|Adverse Event|10|||
42046097|NCT00792805|75854152|FG002|Overall Study|Adverse Event|10|||
42046098|NCT00792805|75854150|FG000|Overall Study|Subject withdrew consent|5|||
42046099|NCT00792805|75854151|FG001|Overall Study|Subject withdrew consent|6|||
42046100|NCT00792805|75854152|FG002|Overall Study|Subject withdrew consent|5|||
42046101|NCT00792805|75854150|FG000|Overall Study|Administrative problems|2|||
42046102|NCT00792805|75854151|FG001|Overall Study|Administrative problems|0|||
42046103|NCT00792805|75854152|FG002|Overall Study|Administrative problems|4|||
42046104|NCT00792805|75854150|FG000|Overall Study|Abnormal test procedure result(s)|1|||
42046105|NCT00792805|75854151|FG001|Overall Study|Abnormal test procedure result(s)|2|||
42046106|NCT00792805|75854152|FG002|Overall Study|Abnormal test procedure result(s)|0|||
42046107|NCT00792805|75854150|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42046108|NCT00792805|75854151|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
42046109|NCT00792805|75854152|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
42046110|NCT00792805|75854150|FG000|Overall Study|Lost to Follow-up|1|||
42046111|NCT00792805|75854151|FG001|Overall Study|Lost to Follow-up|1|||
42046112|NCT00792805|75854152|FG002|Overall Study|Lost to Follow-up|6|||
42172626|NCT03334396|75979515|FG001|Overall Study|Lost to Follow-up|0|||
42172627|NCT03334396|75979516|FG002|Overall Study|Lost to Follow-up|1|||
42172628|NCT03334396|75979517|FG003|Overall Study|Lost to Follow-up|0|||
42172629|NCT03334396|75979518|FG004|Overall Study|Lost to Follow-up|0|||
42291219|NCT02641379|76125029|FG002|Overall Study|Lack of Efficacy|2|||
42291220|NCT02641379|76125030|FG003|Overall Study|Lack of Efficacy|0|||
42046113|NCT00792805|75854150|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42172630|NCT03334396|75979519|FG005|Overall Study|Lost to Follow-up|0|||
42172631|NCT03334396|75979520|FG006|Overall Study|Lost to Follow-up|1|||
42172632|NCT03334396|75979521|FG007|Overall Study|Lost to Follow-up|0|||
42046114|NCT00792805|75854151|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42046115|NCT00792805|75854152|FG002|Overall Study|Abnormal laboratory value(s)|1|||
42046116|NCT00792805|75854150|FG000|Overall Study|Protocol deviation|0|||
42046117|NCT00792805|75854151|FG001|Overall Study|Protocol deviation|1|||
42046118|NCT00792805|75854152|FG002|Overall Study|Protocol deviation|1|||
42046119|NCT00925002|75854163|FG000|Overall Study|Other|1|||
42046120|NCT00925002|75854164|FG001|Overall Study|Other|4|||
42046121|NCT00925002|75854165|FG002|Overall Study|Other|0|||
42046122|NCT00925002|75854163|FG000|Overall Study|Death|1|||
42046123|NCT00925002|75854164|FG001|Overall Study|Death|1|||
42046124|NCT00925002|75854165|FG002|Overall Study|Death|5|||
42046125|NCT00925002|75854163|FG000|Overall Study|Adverse Event|3|||
42046126|NCT00925002|75854164|FG001|Overall Study|Adverse Event|1|||
42046127|NCT00925002|75854165|FG002|Overall Study|Adverse Event|2|||
42046128|NCT00925002|75854163|FG000|Overall Study|Participant withdrew consent|1|||
42046129|NCT00925002|75854164|FG001|Overall Study|Participant withdrew consent|3|||
42046130|NCT00925002|75854165|FG002|Overall Study|Participant withdrew consent|3|||
42046131|NCT00928746|75854174|FG000|Overall Study|Adverse Event|2|||
42046132|NCT00928746|75854174|FG000|Overall Study|Protocol Violation|1|||
42046133|NCT00928746|75854174|FG000|Overall Study|Withdrawal by Subject|1|||
42046134|NCT00928746|75854174|FG000|Overall Study|Other|2|||
42046135|NCT00922428|75854180|FG000|Overall Study|retrospective/extremely implausible data|2|||
42046136|NCT00922428|75854180|FG000|Overall Study|no medication use or questionable use|13|||
42046137|NCT00894543|75854192|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
42046138|NCT00894543|75854193|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
42046139|NCT00894543|75854192|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
42046140|NCT00894543|75854193|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
42046141|NCT00922272|75854199|FG000|Open-label Phase|Adverse Event|5|||
42046142|NCT00922272|75854200|FG001|Open-label Phase|Adverse Event|0|||
42046143|NCT00922272|75854199|FG000|Open-label Phase|Protocol Violation|1|||
42046144|NCT00922272|75854200|FG001|Open-label Phase|Protocol Violation|0|||
42046145|NCT00922272|75854199|FG000|Open-label Phase|Withdrawal by Subject|11|||
42046146|NCT00922272|75854200|FG001|Open-label Phase|Withdrawal by Subject|0|||
42046147|NCT00922272|75854199|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
42046148|NCT00922272|75854200|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
42046149|NCT00922272|75854199|FG000|Open-label Phase|Withdrawal criteria met|5|||
42046150|NCT00922272|75854200|FG001|Open-label Phase|Withdrawal criteria met|0|||
42046151|NCT00922272|75854199|FG000|Double-blind Phase|Adverse Event|1|||
42046152|NCT00922272|75854200|FG001|Double-blind Phase|Adverse Event|1|||
42046153|NCT00922272|75854199|FG000|Double-blind Phase|Withdrawal by Subject|1|||
42046154|NCT00922272|75854200|FG001|Double-blind Phase|Withdrawal by Subject|1|||
42046155|NCT00922272|75854199|FG000|Double-blind Phase|Lost to Follow-up|2|||
42046156|NCT00922272|75854200|FG001|Double-blind Phase|Lost to Follow-up|1|||
42046157|NCT00922272|75854199|FG000|Double-blind Phase|Withdrawal criteria met|1|||
42046158|NCT00922272|75854200|FG001|Double-blind Phase|Withdrawal criteria met|1|||
42046159|NCT00922272|75854199|FG000|Double-blind Phase|Noncompliance|1|||
42046160|NCT00922272|75854200|FG001|Double-blind Phase|Noncompliance|1|||
42046161|NCT00922272|75854199|FG000|Double-blind Phase|Positive urine drug screen|1|||
42046162|NCT00922272|75854200|FG001|Double-blind Phase|Positive urine drug screen|1|||
42046163|NCT00853372|75854210|FG000|Overall Study|Death|30|||
42046164|NCT00853372|75854211|FG001|Overall Study|Death|26|||
42046165|NCT00853372|75854210|FG000|Overall Study|Lost to Follow-up|1|||
42046166|NCT00853372|75854211|FG001|Overall Study|Lost to Follow-up|2|||
42046167|NCT00853372|75854210|FG000|Overall Study|Full Consent Withdrawn|1|||
42046168|NCT00853372|75854211|FG001|Overall Study|Full Consent Withdrawn|1|||
42046169|NCT00848536|75854219|FG000|Overall Study|Adverse Event|2|||
42046170|NCT00848536|75854220|FG001|Overall Study|Adverse Event|2|||
42046171|NCT00848536|75854219|FG000|Overall Study|Withdrawal by Subject|0|||
42046172|NCT00848536|75854220|FG001|Overall Study|Withdrawal by Subject|1|||
42046173|NCT00848536|75854219|FG000|Overall Study|Protocol Violation|0|||
42046174|NCT00848536|75854220|FG001|Overall Study|Protocol Violation|1|||
42046175|NCT00848536|75854219|FG000|Overall Study|Noncompliance|1|||
42046176|NCT00848536|75854220|FG001|Overall Study|Noncompliance|0|||
42046177|NCT00848536|75854219|FG000|Overall Study|Inadequate Control of IOP|1|||
42046178|NCT00848536|75854220|FG001|Overall Study|Inadequate Control of IOP|1|||
42046179|NCT00848536|75854219|FG000|Overall Study|Patient Moved|0|||
42046180|NCT00848536|75854220|FG001|Overall Study|Patient Moved|2|||
42046181|NCT00922116|75854226|FG000|Overall Study|Adverse Event|4|||
42046182|NCT00922116|75854226|FG000|Overall Study|Death|1|||
42046183|NCT00922116|75854226|FG000|Overall Study|Lost to Follow-up|1|||
42046184|NCT00922116|75854226|FG000|Overall Study|Withdrawal by Subject|4|||
42172633|NCT03334396|75979514|FG000|Overall Study|Physician Decision|1|||
42172634|NCT03334396|75979515|FG001|Overall Study|Physician Decision|0|||
42172635|NCT03334396|75979516|FG002|Overall Study|Physician Decision|0|||
42172636|NCT03334396|75979517|FG003|Overall Study|Physician Decision|0|||
42172637|NCT03334396|75979518|FG004|Overall Study|Physician Decision|0|||
42046185|NCT00922116|75854226|FG000|Overall Study|Other|5|||
42046186|NCT00921024|75854232|FG000|Overall Study|Lost to Follow-up|2|||
42046187|NCT00921024|75854233|FG001|Overall Study|Lost to Follow-up|0|||
42046188|NCT00921024|75854232|FG000|Overall Study|Received concomittant therapy|2|||
42046189|NCT00921024|75854233|FG001|Overall Study|Received concomittant therapy|0|||
42046190|NCT00921024|75854232|FG000|Overall Study|Withdrawal by Subject|0|||
42046191|NCT00921024|75854233|FG001|Overall Study|Withdrawal by Subject|3|||
42046192|NCT00928668|75854239|FG000|Overall Study|Adverse Event|1|||
42172638|NCT03334396|75979519|FG005|Overall Study|Physician Decision|0|||
42046193|NCT00928668|75854240|FG001|Overall Study|Adverse Event|0|||
42046194|NCT00928668|75854241|FG002|Overall Study|Adverse Event|0|||
42172639|NCT03334396|75979520|FG006|Overall Study|Physician Decision|0|||
42046195|NCT00928668|75854242|FG003|Overall Study|Adverse Event|0|||
42046196|NCT00928668|75854243|FG004|Overall Study|Adverse Event|0|||
42046197|NCT00928668|75854239|FG000|Overall Study|Protocol Violation|0|||
42046198|NCT00928668|75854240|FG001|Overall Study|Protocol Violation|0|||
42046199|NCT00928668|75854241|FG002|Overall Study|Protocol Violation|0|||
42046200|NCT00928668|75854242|FG003|Overall Study|Protocol Violation|0|||
42046201|NCT00928668|75854243|FG004|Overall Study|Protocol Violation|1|||
42046202|NCT00928668|75854239|FG000|Overall Study|Withdrawal by Subject|0|||
42046203|NCT00928668|75854240|FG001|Overall Study|Withdrawal by Subject|1|||
42046204|NCT00928668|75854241|FG002|Overall Study|Withdrawal by Subject|1|||
42046205|NCT00928668|75854242|FG003|Overall Study|Withdrawal by Subject|0|||
42046206|NCT00928668|75854243|FG004|Overall Study|Withdrawal by Subject|0|||
42046207|NCT00928668|75854239|FG000|Overall Study|Other reasons not listed above|0|||
42046208|NCT00928668|75854240|FG001|Overall Study|Other reasons not listed above|0|||
42046209|NCT00928668|75854241|FG002|Overall Study|Other reasons not listed above|0|||
42046210|NCT00928668|75854242|FG003|Overall Study|Other reasons not listed above|1|||
42046211|NCT00928668|75854243|FG004|Overall Study|Other reasons not listed above|0|||
42046212|NCT00592774|75854265|FG000|Overall Study|Adverse Event|5|||
42046213|NCT00592774|75854266|FG001|Overall Study|Adverse Event|19|||
42046214|NCT00592774|75854267|FG002|Overall Study|Adverse Event|2|||
42046215|NCT00592774|75854268|FG003|Overall Study|Adverse Event|14|||
42046216|NCT00592774|75854269|FG004|Overall Study|Adverse Event|8|||
42046217|NCT00592774|75854265|FG000|Overall Study|Protocol Violation|0|||
42046218|NCT00592774|75854266|FG001|Overall Study|Protocol Violation|1|||
42046219|NCT00592774|75854267|FG002|Overall Study|Protocol Violation|0|||
42046220|NCT00592774|75854268|FG003|Overall Study|Protocol Violation|0|||
42046221|NCT00592774|75854269|FG004|Overall Study|Protocol Violation|1|||
42046222|NCT00592774|75854265|FG000|Overall Study|Withdrawal by Subject|3|||
42046223|NCT00592774|75854266|FG001|Overall Study|Withdrawal by Subject|7|||
42046224|NCT00592774|75854267|FG002|Overall Study|Withdrawal by Subject|0|||
42046225|NCT00592774|75854268|FG003|Overall Study|Withdrawal by Subject|0|||
42046226|NCT00592774|75854269|FG004|Overall Study|Withdrawal by Subject|0|||
42046227|NCT00592774|75854265|FG000|Overall Study|Lack of Efficacy|3|||
42046228|NCT00592774|75854266|FG001|Overall Study|Lack of Efficacy|3|||
42046229|NCT00592774|75854267|FG002|Overall Study|Lack of Efficacy|0|||
42046230|NCT00592774|75854268|FG003|Overall Study|Lack of Efficacy|0|||
42046231|NCT00592774|75854269|FG004|Overall Study|Lack of Efficacy|2|||
42046232|NCT00592774|75854265|FG000|Overall Study|Physician Decision|0|||
42046233|NCT00592774|75854266|FG001|Overall Study|Physician Decision|1|||
42046234|NCT00592774|75854267|FG002|Overall Study|Physician Decision|1|||
42046235|NCT00592774|75854268|FG003|Overall Study|Physician Decision|0|||
42046236|NCT00592774|75854269|FG004|Overall Study|Physician Decision|1|||
42046237|NCT00592774|75854265|FG000|Overall Study|Other|0|||
42046238|NCT00592774|75854266|FG001|Overall Study|Other|1|||
42046239|NCT00592774|75854267|FG002|Overall Study|Other|1|||
42046240|NCT00592774|75854268|FG003|Overall Study|Other|0|||
42046241|NCT00592774|75854269|FG004|Overall Study|Other|2|||
42046242|NCT00837694|75854287|FG000|Overall Study|Lost to Follow-up|2|||
42046243|NCT00837694|75854288|FG001|Overall Study|Lost to Follow-up|0|||
42046244|NCT00837694|75854289|FG002|Overall Study|Lost to Follow-up|2|||
42046245|NCT00837694|75854290|FG003|Overall Study|Lost to Follow-up|1|||
42046246|NCT00837694|75854291|FG004|Overall Study|Lost to Follow-up|1|||
42046247|NCT00837694|75854292|FG005|Overall Study|Lost to Follow-up|1|||
42046248|NCT00852202|75854309|FG000|Overall Study|Adverse Event|2|||
42046249|NCT00852202|75854310|FG001|Overall Study|Adverse Event|3|||
42046250|NCT00852202|75854311|FG002|Overall Study|Adverse Event|7|||
42046251|NCT00852202|75854309|FG000|Overall Study|Lack of Efficacy|4|||
42046252|NCT00852202|75854310|FG001|Overall Study|Lack of Efficacy|1|||
42046253|NCT00852202|75854311|FG002|Overall Study|Lack of Efficacy|2|||
42046254|NCT00852202|75854309|FG000|Overall Study|Protocol Violation|2|||
42046255|NCT00852202|75854310|FG001|Overall Study|Protocol Violation|2|||
42291221|NCT02641379|76125031|FG004|Overall Study|Lack of Efficacy|0|||
42291222|NCT02641379|76125032|FG005|Overall Study|Lack of Efficacy|2|||
42291223|NCT02641379|76125033|FG006|Overall Study|Lack of Efficacy|0|||
42172640|NCT03334396|75979521|FG007|Overall Study|Physician Decision|0|||
42291224|NCT02641379|76125034|FG007|Overall Study|Lack of Efficacy|5|||
42046256|NCT00852202|75854311|FG002|Overall Study|Protocol Violation|7|||
42046257|NCT00852202|75854309|FG000|Overall Study|Withdrawal by Subject|3|||
42046258|NCT00852202|75854310|FG001|Overall Study|Withdrawal by Subject|1|||
42172641|NCT03334396|75979514|FG000|Overall Study|Withdrawal by Subject|10|||
42172642|NCT03334396|75979515|FG001|Overall Study|Withdrawal by Subject|5|||
42046259|NCT00852202|75854311|FG002|Overall Study|Withdrawal by Subject|2|||
42046260|NCT00852202|75854309|FG000|Overall Study|Lost to Follow-up|5|||
42046261|NCT00852202|75854310|FG001|Overall Study|Lost to Follow-up|5|||
42046262|NCT00852202|75854311|FG002|Overall Study|Lost to Follow-up|6|||
42046263|NCT00852202|75854309|FG000|Overall Study|pregnancy,moving away and surgery|1|||
42046264|NCT00852202|75854310|FG001|Overall Study|pregnancy,moving away and surgery|0|||
42046265|NCT00852202|75854311|FG002|Overall Study|pregnancy,moving away and surgery|2|||
42172643|NCT03334396|75979516|FG002|Overall Study|Withdrawal by Subject|7|||
42046266|NCT01074008|75854329|FG000|Overall Study|Adverse Event|0|||
42046267|NCT01074008|75854330|FG001|Overall Study|Adverse Event|1|||
42046268|NCT01074008|75854331|FG002|Overall Study|Adverse Event|0|||
42046269|NCT01074008|75854332|FG003|Overall Study|Adverse Event|0|||
42046270|NCT01074008|75854333|FG004|Overall Study|Adverse Event|0|||
42046271|NCT01074008|75854334|FG005|Overall Study|Adverse Event|0|||
42046272|NCT01074008|75854335|FG006|Overall Study|Adverse Event|0|||
42046273|NCT01074008|75854336|FG007|Overall Study|Adverse Event|0|||
42046274|NCT01074008|75854337|FG008|Overall Study|Adverse Event|0|||
42046275|NCT01074008|75854329|FG000|Overall Study|Withdrawal by Subject|1|||
42046276|NCT01074008|75854330|FG001|Overall Study|Withdrawal by Subject|1|||
42046277|NCT01074008|75854331|FG002|Overall Study|Withdrawal by Subject|1|||
42046278|NCT01074008|75854332|FG003|Overall Study|Withdrawal by Subject|0|||
42046279|NCT01074008|75854333|FG004|Overall Study|Withdrawal by Subject|1|||
42046280|NCT01074008|75854334|FG005|Overall Study|Withdrawal by Subject|0|||
42046281|NCT01074008|75854335|FG006|Overall Study|Withdrawal by Subject|0|||
42046282|NCT01074008|75854336|FG007|Overall Study|Withdrawal by Subject|0|||
42046283|NCT01074008|75854337|FG008|Overall Study|Withdrawal by Subject|0|||
42046284|NCT01074008|75854329|FG000|Overall Study|Lost to Follow-up|0|||
42046285|NCT01074008|75854330|FG001|Overall Study|Lost to Follow-up|1|||
42046286|NCT01074008|75854331|FG002|Overall Study|Lost to Follow-up|1|||
42046287|NCT01074008|75854332|FG003|Overall Study|Lost to Follow-up|1|||
42046288|NCT01074008|75854333|FG004|Overall Study|Lost to Follow-up|1|||
42046289|NCT01074008|75854334|FG005|Overall Study|Lost to Follow-up|0|||
42046290|NCT01074008|75854335|FG006|Overall Study|Lost to Follow-up|1|||
42046291|NCT01074008|75854336|FG007|Overall Study|Lost to Follow-up|0|||
42046292|NCT01074008|75854337|FG008|Overall Study|Lost to Follow-up|4|||
42046293|NCT01073930|75854368|FG000|Overall Study|Withdrawal by Subject|3|||
42046294|NCT01073930|75854369|FG001|Overall Study|Withdrawal by Subject|2|||
42046295|NCT01073930|75854368|FG000|Overall Study|Lost to Follow-up|0|||
42046296|NCT01073930|75854369|FG001|Overall Study|Lost to Follow-up|1|||
42046297|NCT01073930|75854368|FG000|Overall Study|Adverse Event|0|||
42046298|NCT01073930|75854369|FG001|Overall Study|Adverse Event|1|||
42046299|NCT01073930|75854368|FG000|Overall Study|Noncompliance with study drug|0|||
42046300|NCT01073930|75854369|FG001|Overall Study|Noncompliance with study drug|1|||
42046301|NCT01073930|75854368|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
42046302|NCT01073930|75854369|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
42046303|NCT01073618|75854375|FG000|Overall Study|Death|208|||
42046304|NCT01073618|75854375|FG000|Overall Study|Adverse Event|19|||
42046305|NCT01073618|75854375|FG000|Overall Study|Other|80|||
42046306|NCT01073462|75854379|FG000|Overall Study|Death|14|||
42046307|NCT01073462|75854379|FG000|Overall Study|Kidney transplant|10|||
42046308|NCT01073462|75854379|FG000|Overall Study|Low parathyroid hormone levels|8|||
42046309|NCT01073462|75854379|FG000|Overall Study|Serious adverse event|2|||
42046310|NCT01073462|75854379|FG000|Overall Study|Lost to Follow-up|7|||
42046311|NCT00789373|75854383|FG000|Induction|Adverse Event|64|||
42046312|NCT00789373|75854384|FG001|Induction|Adverse Event|0|||
42046313|NCT00789373|75854385|FG002|Induction|Adverse Event|0|||
42046314|NCT00789373|75854383|FG000|Induction|Death Due to study disease|24|||
42046315|NCT00789373|75854384|FG001|Induction|Death Due to study disease|0|||
42046316|NCT00789373|75854385|FG002|Induction|Death Due to study disease|0|||
42046317|NCT00789373|75854383|FG000|Induction|Death due to adverse event|19|||
42046318|NCT00789373|75854384|FG001|Induction|Death due to adverse event|0|||
42046319|NCT00789373|75854385|FG002|Induction|Death due to adverse event|0|||
42046320|NCT00789373|75854383|FG000|Induction|Death due to toxicity|11|||
42046321|NCT00789373|75854384|FG001|Induction|Death due to toxicity|0|||
42046322|NCT00789373|75854385|FG002|Induction|Death due to toxicity|0|||
42046323|NCT00789373|75854383|FG000|Induction|Death due to procedure|1|||
42046324|NCT00789373|75854384|FG001|Induction|Death due to procedure|0|||
42046325|NCT00789373|75854385|FG002|Induction|Death due to procedure|0|||
42046326|NCT00789373|75854383|FG000|Induction|Investigator decision|7|||
42046327|NCT00789373|75854384|FG001|Induction|Investigator decision|0|||
42046328|NCT00789373|75854385|FG002|Induction|Investigator decision|0|||
42046329|NCT00789373|75854383|FG000|Induction|Protocol entry criteria not met|9|||
42046330|NCT00789373|75854384|FG001|Induction|Protocol entry criteria not met|0|||
42046331|NCT00789373|75854385|FG002|Induction|Protocol entry criteria not met|0|||
42046332|NCT00789373|75854383|FG000|Induction|Lost to Follow-up|6|||
42046333|NCT00789373|75854384|FG001|Induction|Lost to Follow-up|0|||
42172644|NCT03334396|75979517|FG003|Overall Study|Withdrawal by Subject|2|||
42172645|NCT03334396|75979518|FG004|Overall Study|Withdrawal by Subject|2|||
42172646|NCT03334396|75979519|FG005|Overall Study|Withdrawal by Subject|1|||
42046334|NCT00789373|75854385|FG002|Induction|Lost to Follow-up|0|||
42046335|NCT00789373|75854383|FG000|Induction|Protocol Violation|1|||
42046336|NCT00789373|75854384|FG001|Induction|Protocol Violation|0|||
42046337|NCT00789373|75854385|FG002|Induction|Protocol Violation|0|||
42046338|NCT00789373|75854383|FG000|Induction|Progressive Disease|220|||
42046339|NCT00789373|75854384|FG001|Induction|Progressive Disease|0|||
42046340|NCT00789373|75854385|FG002|Induction|Progressive Disease|0|||
42046341|NCT00789373|75854383|FG000|Induction|Withdrawal by Subject|37|||
42046342|NCT00789373|75854384|FG001|Induction|Withdrawal by Subject|0|||
42046343|NCT00789373|75854385|FG002|Induction|Withdrawal by Subject|0|||
42046344|NCT00789373|75854383|FG000|Maintenance|Adverse Event|0|||
42046345|NCT00789373|75854384|FG001|Maintenance|Adverse Event|65|||
42046346|NCT00789373|75854385|FG002|Maintenance|Adverse Event|12|||
42046347|NCT00789373|75854383|FG000|Maintenance|Death due to study disease|0|||
42046348|NCT00789373|75854384|FG001|Maintenance|Death due to study disease|3|||
42046349|NCT00789373|75854385|FG002|Maintenance|Death due to study disease|1|||
42046350|NCT00789373|75854383|FG000|Maintenance|Death due to adverse event|0|||
42046351|NCT00789373|75854384|FG001|Maintenance|Death due to adverse event|4|||
42046352|NCT00789373|75854385|FG002|Maintenance|Death due to adverse event|1|||
42046353|NCT00789373|75854383|FG000|Maintenance|Death due to toxicity|0|||
42046354|NCT00789373|75854384|FG001|Maintenance|Death due to toxicity|1|||
42046355|NCT00789373|75854385|FG002|Maintenance|Death due to toxicity|2|||
42046356|NCT00789373|75854383|FG000|Maintenance|Investigator Decision|0|||
42046357|NCT00789373|75854384|FG001|Maintenance|Investigator Decision|4|||
42046358|NCT00789373|75854385|FG002|Maintenance|Investigator Decision|2|||
42046359|NCT00789373|75854383|FG000|Maintenance|Protocol entry criteria not met|0|||
42046360|NCT00789373|75854384|FG001|Maintenance|Protocol entry criteria not met|2|||
42046361|NCT00789373|75854385|FG002|Maintenance|Protocol entry criteria not met|0|||
42046362|NCT00789373|75854383|FG000|Maintenance|Lost to Follow-up|0|||
42046363|NCT00789373|75854384|FG001|Maintenance|Lost to Follow-up|2|||
42046364|NCT00789373|75854385|FG002|Maintenance|Lost to Follow-up|0|||
42046365|NCT00789373|75854383|FG000|Maintenance|Progressive Disease|0|||
42046366|NCT00789373|75854384|FG001|Maintenance|Progressive Disease|253|||
42046367|NCT00789373|75854385|FG002|Maintenance|Progressive Disease|152|||
42046368|NCT00789373|75854383|FG000|Maintenance|Withdrawal by Subject|0|||
42046369|NCT00789373|75854384|FG001|Maintenance|Withdrawal by Subject|21|||
42046370|NCT00789373|75854385|FG002|Maintenance|Withdrawal by Subject|8|||
42046371|NCT00789373|75854383|FG000|Maintenance|Sponsor Decision|0|||
42291225|NCT02641379|76125035|FG008|Overall Study|Lack of Efficacy|0|||
42291226|NCT02641379|76125036|FG009|Overall Study|Lack of Efficacy|0|||
42046372|NCT00789373|75854384|FG001|Maintenance|Sponsor Decision|0|||
42046373|NCT00789373|75854385|FG002|Maintenance|Sponsor Decision|2|||
42046374|NCT00789373|75854383|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
42046375|NCT00789373|75854384|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
42046376|NCT00789373|75854385|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
42046377|NCT00851890|75854400|FG000|Overall Study|Lost to Follow-up|0|||
42046378|NCT00851890|75854401|FG001|Overall Study|Lost to Follow-up|1|||
42046379|NCT00851890|75854402|FG002|Overall Study|Lost to Follow-up|0|||
42046380|NCT00851890|75854403|FG003|Overall Study|Lost to Follow-up|1|||
42046381|NCT00788827|75854413|FG000|Overall Study|Lack of Efficacy|2|||
42046382|NCT00592072|75854419|FG000|Wash Out Period|Lost to Follow-up|1|||
42046383|NCT00592072|75854420|FG001|Wash Out Period|Lost to Follow-up|1|||
42046384|NCT00792571|75854426|FG000|Overall Study|Death|1|||
42046385|NCT00792571|75854426|FG000|Overall Study|Adverse Event|4|||
42046386|NCT00792571|75854426|FG000|Overall Study|Withdrawal by Subject|1|||
42046387|NCT00792571|75854426|FG000|Overall Study|Other|4|||
42046388|NCT01069484|75854432|FG000|Overall Study|Death-in-near-family|1|||
42046389|NCT01069484|75854433|FG001|Overall Study|Death-in-near-family|0|||
42046390|NCT01069484|75854432|FG000|Overall Study|No specific reason|8|||
42046391|NCT01069484|75854433|FG001|Overall Study|No specific reason|2|||
42046392|NCT01069484|75854432|FG000|Overall Study|Illness mother or child|3|||
42046393|NCT01069484|75854433|FG001|Overall Study|Illness mother or child|1|||
42046394|NCT00794365|75854440|FG000|Overall Study|Lost to Follow-up|38|||
42046395|NCT00794365|75854440|FG000|Overall Study|Other|17|||
42046396|NCT00794365|75854440|FG000|Overall Study|Poor Compliance|11|||
42046397|NCT00794365|75854440|FG000|Overall Study|Adverse Event|10|||
42046398|NCT00794365|75854440|FG000|Overall Study|Lack of Efficacy|3|||
42046399|NCT01067144|75854446|FG000|Treatment|Did not receive allocated intervention|4|||
42046400|NCT01067144|75854447|FG001|Treatment|Did not receive allocated intervention|7|||
42046401|NCT01067144|75854446|FG000|Follow-up|Lost to Follow-up|22|||
42046402|NCT01067144|75854447|FG001|Follow-up|Lost to Follow-up|12|||
42046403|NCT01067144|75854446|FG000|Follow-up|Censored owing to second surgery|19|||
42046404|NCT01067144|75854447|FG001|Follow-up|Censored owing to second surgery|28|||
42046405|NCT01067144|75854446|FG000|Follow-up|Withdrawal by Subject|18|||
42046406|NCT01067144|75854447|FG001|Follow-up|Withdrawal by Subject|14|||
42291227|NCT02641379|76125037|FG010|Overall Study|Lack of Efficacy|0|||
42046407|NCT01067144|75854446|FG000|Follow-up|Surgery cancelled|0|||
42046408|NCT01067144|75854447|FG001|Follow-up|Surgery cancelled|1|||
42046409|NCT01067144|75854446|FG000|Follow-up|Death|0|||
42046410|NCT01067144|75854447|FG001|Follow-up|Death|1|||
42046411|NCT01078298|75854455|FG000|Overall Study|Lost to Follow-up|12|||
42046412|NCT01078298|75854456|FG001|Overall Study|Lost to Follow-up|13|||
42046413|NCT01078298|75854455|FG000|Overall Study|Withdrawal by Subject|31|||
42172647|NCT03334396|75979520|FG006|Overall Study|Withdrawal by Subject|2|||
42046414|NCT01078298|75854456|FG001|Overall Study|Withdrawal by Subject|33|||
42046415|NCT01078298|75854455|FG000|Overall Study|Protocol Violation|6|||
42046416|NCT01078298|75854456|FG001|Overall Study|Protocol Violation|6|||
42046417|NCT01078298|75854455|FG000|Overall Study|Adverse Event|6|||
42046418|NCT01078298|75854456|FG001|Overall Study|Adverse Event|5|||
42046419|NCT01078298|75854455|FG000|Overall Study|Death|2|||
42046420|NCT01078298|75854456|FG001|Overall Study|Death|0|||
42046421|NCT01078298|75854455|FG000|Overall Study|Did not meet entrance criteria|0|||
42046422|NCT01078298|75854456|FG001|Overall Study|Did not meet entrance criteria|1|||
42046423|NCT01078298|75854455|FG000|Overall Study|Other|24|||
42046424|NCT01078298|75854456|FG001|Overall Study|Other|32|||
42046425|NCT00788593|75854462|FG000|Placebo Run-in Phase|Adverse Event|2|||
42046426|NCT00788593|75854463|FG001|Placebo Run-in Phase|Adverse Event|0|||
42046427|NCT00788593|75854464|FG002|Placebo Run-in Phase|Adverse Event|0|||
42046428|NCT00788593|75854462|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
42046429|NCT00788593|75854463|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
42046430|NCT00788593|75854464|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
42046431|NCT00788593|75854462|FG000|Placebo Run-in Phase|Protocol Violation|2|||
42046432|NCT00788593|75854463|FG001|Placebo Run-in Phase|Protocol Violation|0|||
42046433|NCT00788593|75854464|FG002|Placebo Run-in Phase|Protocol Violation|0|||
42046434|NCT00788593|75854462|FG000|First Intervention Period|Adverse Event|0|||
42046435|NCT00788593|75854463|FG001|First Intervention Period|Adverse Event|1|||
42046436|NCT00788593|75854464|FG002|First Intervention Period|Adverse Event|0|||
42046437|NCT00788593|75854462|FG000|Second Intervention Period|Lost to Follow-up|0|||
42046438|NCT00788593|75854463|FG001|Second Intervention Period|Lost to Follow-up|1|||
42046439|NCT00788593|75854464|FG002|Second Intervention Period|Lost to Follow-up|0|||
42046440|NCT00788593|75854462|FG000|Second Intervention Period|Other|0|||
42046441|NCT00788593|75854463|FG001|Second Intervention Period|Other|0|||
42046442|NCT00788593|75854464|FG002|Second Intervention Period|Other|1|||
42046443|NCT00793819|75854476|FG000|Overall Study|Adverse Event|8|||
42046444|NCT00793819|75854477|FG001|Overall Study|Adverse Event|4|||
42046445|NCT00793819|75854476|FG000|Overall Study|Lack of Efficacy|1|||
42046446|NCT00793819|75854477|FG001|Overall Study|Lack of Efficacy|1|||
42046447|NCT00793819|75854476|FG000|Overall Study|Withdrawal by Subject|4|||
42046448|NCT00793819|75854477|FG001|Overall Study|Withdrawal by Subject|3|||
42046449|NCT00793819|75854476|FG000|Overall Study|Lost to Follow-up|1|||
42046450|NCT00793819|75854477|FG001|Overall Study|Lost to Follow-up|1|||
42046451|NCT00792259|75854486|FG000|Overall Study|Poor Quality Scans|1|||
42046452|NCT00792259|75854487|FG001|Overall Study|Poor Quality Scans|0|||
42046453|NCT00792259|75854488|FG002|Overall Study|Poor Quality Scans|0|||
42046454|NCT00894387|75854498|FG000|Overall Study|Adverse Event|44|||
42046455|NCT00894387|75854499|FG001|Overall Study|Adverse Event|45|||
42046456|NCT00894387|75854498|FG000|Overall Study|Abnormal Laboratory values|2|||
42046457|NCT00894387|75854499|FG001|Overall Study|Abnormal Laboratory values|2|||
42046458|NCT00894387|75854498|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42046459|NCT00894387|75854499|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
42046460|NCT00894387|75854498|FG000|Overall Study|Lost to Follow-up|3|||
42046461|NCT00894387|75854499|FG001|Overall Study|Lost to Follow-up|5|||
42046462|NCT00894387|75854498|FG000|Overall Study|Administrative problems|2|||
42046463|NCT00894387|75854499|FG001|Overall Study|Administrative problems|2|||
42046464|NCT00894387|75854498|FG000|Overall Study|Death|77|||
42046465|NCT00894387|75854499|FG001|Overall Study|Death|76|||
42046466|NCT00894387|75854498|FG000|Overall Study|Protocol Deviation|4|||
42046467|NCT00894387|75854499|FG001|Overall Study|Protocol Deviation|0|||
42046468|NCT00894387|75854498|FG000|Overall Study|Patient's request|25|||
42046469|NCT00894387|75854499|FG001|Overall Study|Patient's request|30|||
42046470|NCT00894387|75854498|FG000|Overall Study|Other (Missing)|5|||
42046471|NCT00894387|75854499|FG001|Overall Study|Other (Missing)|3|||
42046472|NCT00894387|75854498|FG000|Overall Study|Mis-randomized|13|||
42291228|NCT02641379|76125027|FG000|Overall Study|Participant unable to attend study visit|4|||
42291229|NCT02641379|76125028|FG001|Overall Study|Participant unable to attend study visit|10|||
42291230|NCT02641379|76125029|FG002|Overall Study|Participant unable to attend study visit|1|||
42291231|NCT02641379|76125030|FG003|Overall Study|Participant unable to attend study visit|2|||
42291232|NCT02641379|76125031|FG004|Overall Study|Participant unable to attend study visit|5|||
42291233|NCT02641379|76125032|FG005|Overall Study|Participant unable to attend study visit|1|||
42291234|NCT02641379|76125033|FG006|Overall Study|Participant unable to attend study visit|1|||
42291235|NCT02641379|76125034|FG007|Overall Study|Participant unable to attend study visit|1|||
42291236|NCT02641379|76125035|FG008|Overall Study|Participant unable to attend study visit|0|||
42291237|NCT02641379|76125036|FG009|Overall Study|Participant unable to attend study visit|2|||
42291238|NCT02641379|76125037|FG010|Overall Study|Participant unable to attend study visit|0|||
42046473|NCT00894387|75854499|FG001|Overall Study|Mis-randomized|9|||
42046474|NCT00894387|75854498|FG000|Overall Study|GCP non-compliance|0|||
42046475|NCT00894387|75854499|FG001|Overall Study|GCP non-compliance|2|||
42046476|NCT00928512|75854510|FG000|Overall Study|Adverse Event|4|||
42046477|NCT00928512|75854511|FG001|Overall Study|Adverse Event|3|||
42046478|NCT00928512|75854512|FG002|Overall Study|Adverse Event|2|||
42046479|NCT00928512|75854513|FG003|Overall Study|Adverse Event|8|||
42046480|NCT00928512|75854514|FG004|Overall Study|Adverse Event|6|||
42046481|NCT00928512|75854510|FG000|Overall Study|Lack of Efficacy|2|||
42291239|NCT02641379|76125027|FG000|Overall Study|Participant's compliance|0|||
42291240|NCT02641379|76125028|FG001|Overall Study|Participant's compliance|1|||
42291241|NCT02641379|76125029|FG002|Overall Study|Participant's compliance|0|||
42291242|NCT02641379|76125030|FG003|Overall Study|Participant's compliance|1|||
42291243|NCT02641379|76125031|FG004|Overall Study|Participant's compliance|0|||
42291244|NCT02641379|76125032|FG005|Overall Study|Participant's compliance|2|||
42291245|NCT02641379|76125033|FG006|Overall Study|Participant's compliance|0|||
42291246|NCT02641379|76125034|FG007|Overall Study|Participant's compliance|0|||
42291247|NCT02641379|76125035|FG008|Overall Study|Participant's compliance|1|||
42291248|NCT02641379|76125036|FG009|Overall Study|Participant's compliance|1|||
42291249|NCT02641379|76125037|FG010|Overall Study|Participant's compliance|1|||
42046482|NCT00928512|75854511|FG001|Overall Study|Lack of Efficacy|0|||
42046483|NCT00928512|75854512|FG002|Overall Study|Lack of Efficacy|4|||
42172648|NCT03334396|75979521|FG007|Overall Study|Withdrawal by Subject|0|||
42172649|NCT03334396|75979514|FG000|Overall Study|Pregnancy|0|||
42172650|NCT03334396|75979515|FG001|Overall Study|Pregnancy|1|||
42172651|NCT03334396|75979516|FG002|Overall Study|Pregnancy|0|||
42172652|NCT03334396|75979517|FG003|Overall Study|Pregnancy|0|||
42172653|NCT03334396|75979518|FG004|Overall Study|Pregnancy|0|||
42172654|NCT03334396|75979519|FG005|Overall Study|Pregnancy|0|||
42291250|NCT02641379|76125027|FG000|Overall Study|Participant cannot be reached|4|||
42291251|NCT02641379|76125028|FG001|Overall Study|Participant cannot be reached|4|||
42291252|NCT02641379|76125029|FG002|Overall Study|Participant cannot be reached|0|||
42291253|NCT02641379|76125030|FG003|Overall Study|Participant cannot be reached|8|||
42046484|NCT00928512|75854513|FG003|Overall Study|Lack of Efficacy|7|||
42046485|NCT00928512|75854514|FG004|Overall Study|Lack of Efficacy|3|||
42046486|NCT00928512|75854510|FG000|Overall Study|Protocol Violation|0|||
42172655|NCT03334396|75979520|FG006|Overall Study|Pregnancy|0|||
42172656|NCT03334396|75979521|FG007|Overall Study|Pregnancy|0|||
42172657|NCT03334396|75979514|FG000|Overall Study|Ineligible|0|||
42172658|NCT03334396|75979515|FG001|Overall Study|Ineligible|1|||
42172659|NCT03334396|75979516|FG002|Overall Study|Ineligible|0|||
42172660|NCT03334396|75979517|FG003|Overall Study|Ineligible|0|||
42172661|NCT03334396|75979518|FG004|Overall Study|Ineligible|0|||
42172662|NCT03334396|75979519|FG005|Overall Study|Ineligible|0|||
42172663|NCT03334396|75979520|FG006|Overall Study|Ineligible|0|||
42172664|NCT03334396|75979521|FG007|Overall Study|Ineligible|0|||
42172665|NCT03334396|75979514|FG000|Overall Study|Started New Job|1|||
42172666|NCT03334396|75979515|FG001|Overall Study|Started New Job|0|||
42172667|NCT03334396|75979516|FG002|Overall Study|Started New Job|0|||
42172668|NCT03334396|75979517|FG003|Overall Study|Started New Job|0|||
42172669|NCT03334396|75979518|FG004|Overall Study|Started New Job|0|||
42172670|NCT03334396|75979519|FG005|Overall Study|Started New Job|0|||
42172671|NCT03334396|75979520|FG006|Overall Study|Started New Job|0|||
42172672|NCT03334396|75979521|FG007|Overall Study|Started New Job|0|||
42172673|NCT03338998|75979540|FG000|Treatment Period|Withdrawal by Subject|1|||
42172674|NCT03338998|75979541|FG001|Treatment Period|Withdrawal by Subject|1|||
42172675|NCT03338998|75979540|FG000|Treatment Period|Adverse Event|0|||
42172676|NCT03338998|75979541|FG001|Treatment Period|Adverse Event|2|||
42172677|NCT03338998|75979540|FG000|Treatment Period|Protocol deviation|1|||
42172678|NCT03338998|75979541|FG001|Treatment Period|Protocol deviation|0|||
42172679|NCT03338998|75979540|FG000|Treatment Period|Physician Decision|2|||
42172680|NCT03338998|75979541|FG001|Treatment Period|Physician Decision|0|||
42172681|NCT03338998|75979540|FG000|Treatment Period|Subject failed swallow test|4|||
42172682|NCT03338998|75979541|FG001|Treatment Period|Subject failed swallow test|0|||
42172683|NCT03338998|75979540|FG000|Safety Follow-Up Period|Adverse Event|0|||
42172684|NCT03338998|75979541|FG001|Safety Follow-Up Period|Adverse Event|1|||
42172685|NCT03338998|75979540|FG000|Safety Follow-Up Period|Protocol deviation|1|||
42172686|NCT03338998|75979541|FG001|Safety Follow-Up Period|Protocol deviation|0|||
42172687|NCT03338998|75979540|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
42172688|NCT03338998|75979541|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
42291254|NCT02641379|76125031|FG004|Overall Study|Participant cannot be reached|2|||
42172689|NCT03338296|75979550|FG000|Overall Study|Adverse Event|0|||
42291255|NCT02641379|76125032|FG005|Overall Study|Participant cannot be reached|1|||
42172690|NCT03338296|75979551|FG001|Overall Study|Adverse Event|1|||
42172691|NCT03338296|75979550|FG000|Overall Study|Withdrawal by Subject|14|||
42172692|NCT03338296|75979551|FG001|Overall Study|Withdrawal by Subject|13|||
42172693|NCT03338296|75979550|FG000|Overall Study|Lost to Follow-up|10|||
42172694|NCT03338296|75979551|FG001|Overall Study|Lost to Follow-up|10|||
42172695|NCT03338296|75979550|FG000|Overall Study|Study Terminated by Sponsor|77|||
42172696|NCT03338296|75979551|FG001|Overall Study|Study Terminated by Sponsor|76|||
42172697|NCT03338296|75979550|FG000|Overall Study|Other|2|||
42172698|NCT03338296|75979551|FG001|Overall Study|Other|7|||
42172699|NCT03338296|75979550|FG000|Overall Study|Missing|0|||
42172700|NCT03338296|75979551|FG001|Overall Study|Missing|1|||
42046487|NCT00928512|75854511|FG001|Overall Study|Protocol Violation|1|||
42172701|NCT03338062|75979559|FG000|Overall Study|Alternative Therapy|1|||
42291256|NCT02641379|76125033|FG006|Overall Study|Participant cannot be reached|0|||
42291257|NCT02641379|76125034|FG007|Overall Study|Participant cannot be reached|1|||
42046488|NCT00928512|75854512|FG002|Overall Study|Protocol Violation|0|||
42046489|NCT00928512|75854513|FG003|Overall Study|Protocol Violation|1|||
42046490|NCT00928512|75854514|FG004|Overall Study|Protocol Violation|3|||
42046491|NCT00928512|75854510|FG000|Overall Study|Withdrawal by Subject|3|||
42046492|NCT00928512|75854511|FG001|Overall Study|Withdrawal by Subject|0|||
42046493|NCT00928512|75854512|FG002|Overall Study|Withdrawal by Subject|3|||
42046494|NCT00928512|75854513|FG003|Overall Study|Withdrawal by Subject|4|||
42046495|NCT00928512|75854514|FG004|Overall Study|Withdrawal by Subject|0|||
42046496|NCT00928512|75854510|FG000|Overall Study|Lost to Follow-up|1|||
42046497|NCT00928512|75854511|FG001|Overall Study|Lost to Follow-up|1|||
42046498|NCT00928512|75854512|FG002|Overall Study|Lost to Follow-up|2|||
42046499|NCT00928512|75854513|FG003|Overall Study|Lost to Follow-up|1|||
42046500|NCT00928512|75854514|FG004|Overall Study|Lost to Follow-up|3|||
42046501|NCT00928512|75854510|FG000|Overall Study|Administrative Problems|0|||
42046502|NCT00928512|75854511|FG001|Overall Study|Administrative Problems|1|||
42046503|NCT00928512|75854512|FG002|Overall Study|Administrative Problems|0|||
42046504|NCT00928512|75854513|FG003|Overall Study|Administrative Problems|0|||
42046505|NCT00928512|75854514|FG004|Overall Study|Administrative Problems|0|||
42046506|NCT00787891|75854532|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
42046507|NCT00787891|75854533|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
42046508|NCT00787891|75854532|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
42046509|NCT00787891|75854533|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
42046510|NCT00787891|75854532|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
42046511|NCT00787891|75854533|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
42046512|NCT00787891|75854532|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
42046513|NCT00787891|75854533|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
42046514|NCT00787891|75854532|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
42046515|NCT00787891|75854533|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
42046516|NCT00787891|75854532|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
42046517|NCT00787891|75854533|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
42046518|NCT00787891|75854532|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
42046519|NCT00787891|75854533|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
42046520|NCT00787891|75854532|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
42046521|NCT00787891|75854533|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
42046522|NCT00787891|75854532|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
42046523|NCT00787891|75854533|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
42046524|NCT00787891|75854532|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
42046525|NCT00787891|75854533|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
42046526|NCT00892437|75854543|FG000|Randomized Phase|Randomized but not treated|6|||
42046527|NCT00892437|75854544|FG001|Randomized Phase|Randomized but not treated|0|||
42046528|NCT00892437|75854543|FG000|Randomized Phase|Adverse Event|2|||
42046529|NCT00892437|75854544|FG001|Randomized Phase|Adverse Event|2|||
42046530|NCT00892437|75854543|FG000|Randomized Phase|Lost to Follow-up|1|||
42046531|NCT00892437|75854544|FG001|Randomized Phase|Lost to Follow-up|3|||
42046532|NCT00892437|75854543|FG000|Randomized Phase|Investigator's Discretion|1|||
42046533|NCT00892437|75854544|FG001|Randomized Phase|Investigator's Discretion|0|||
42046534|NCT00892437|75854543|FG000|Randomized Phase|Withdrew Consent|1|||
42046535|NCT00892437|75854544|FG001|Randomized Phase|Withdrew Consent|0|||
42046536|NCT00892437|75854543|FG000|Open-Label Extension Phase|Adverse Event|4|||
42046537|NCT00892437|75854544|FG001|Open-Label Extension Phase|Adverse Event|2|||
42046538|NCT00892437|75854543|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
42046539|NCT00892437|75854544|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
42046540|NCT00892437|75854543|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
42046541|NCT00892437|75854544|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
42046542|NCT00892437|75854543|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
42046543|NCT00892437|75854544|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
42046544|NCT00892437|75854543|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
42046545|NCT00892437|75854544|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
42046546|NCT00792103|75854551|FG000|Overall Study|Enrolled, not treated|15|||
42046547|NCT00792103|75854551|FG000|Overall Study|Lost to Follow-up|17|||
42046548|NCT00792103|75854551|FG000|Overall Study|Adverse Event|25|||
42046549|NCT00792103|75854551|FG000|Overall Study|Withdrawal by Subject|52|||
42046550|NCT00792103|75854551|FG000|Overall Study|Protocol Violation|10|||
42046551|NCT00792103|75854551|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
42046552|NCT00892281|75854557|FG000|Overall Study|Adverse Event|65|||
42046553|NCT00892281|75854558|FG001|Overall Study|Adverse Event|8|||
42046554|NCT00892281|75854557|FG000|Overall Study|Lost to Follow-up|81|||
42046555|NCT00892281|75854558|FG001|Overall Study|Lost to Follow-up|8|||
42046556|NCT00892281|75854557|FG000|Overall Study|Pregnancy|1|||
42046557|NCT00892281|75854558|FG001|Overall Study|Pregnancy|0|||
42046558|NCT00892281|75854557|FG000|Overall Study|Protocol Violation|7|||
42046559|NCT00892281|75854558|FG001|Overall Study|Protocol Violation|2|||
42046560|NCT00892281|75854557|FG000|Overall Study|Withdrawal by Subject|86|||
42046561|NCT00892281|75854558|FG001|Overall Study|Withdrawal by Subject|14|||
42046562|NCT00892281|75854557|FG000|Overall Study|Subject failed to return for final visit|2|||
42046563|NCT00892281|75854558|FG001|Overall Study|Subject failed to return for final visit|0|||
42046564|NCT00892281|75854557|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
42046565|NCT00892281|75854558|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
42046566|NCT00892281|75854557|FG000|Overall Study|Final visit completed 4 weeks late|0|||
42046567|NCT00892281|75854558|FG001|Overall Study|Final visit completed 4 weeks late|1|||
42046568|NCT00892281|75854557|FG000|Overall Study|Subject completed day after study closed|1|||
42046569|NCT00892281|75854558|FG001|Overall Study|Subject completed day after study closed|0|||
42046570|NCT00892281|75854557|FG000|Overall Study|Family emergency|1|||
42046571|NCT00892281|75854558|FG001|Overall Study|Family emergency|0|||
42046572|NCT00892281|75854557|FG000|Overall Study|Last visit not done - death in family|1|||
42046573|NCT00892281|75854558|FG001|Overall Study|Last visit not done - death in family|0|||
42046574|NCT00892281|75854557|FG000|Overall Study|Did not meet incl/excl criteria|1|||
42046575|NCT00892281|75854558|FG001|Overall Study|Did not meet incl/excl criteria|0|||
42046576|NCT00892281|75854557|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
42046577|NCT00892281|75854558|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
42046578|NCT00892281|75854557|FG000|Overall Study|Unable to redeem the drug voucher|1|||
42046579|NCT00892281|75854558|FG001|Overall Study|Unable to redeem the drug voucher|0|||
42046580|NCT00892281|75854557|FG000|Overall Study|Subject not good candidate for study|1|||
42046581|NCT00892281|75854558|FG001|Overall Study|Subject not good candidate for study|0|||
42046582|NCT00892281|75854557|FG000|Overall Study|Subject did not return for any visits|1|||
42046583|NCT00892281|75854558|FG001|Overall Study|Subject did not return for any visits|0|||
42046584|NCT00892281|75854557|FG000|Overall Study|Subject missed several visits/lost meds|1|||
42046585|NCT00892281|75854558|FG001|Overall Study|Subject missed several visits/lost meds|0|||
42046586|NCT00892281|75854557|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
42046587|NCT00892281|75854558|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
42046588|NCT00892281|75854557|FG000|Overall Study|Scheduled for knee replacement|0|||
42046589|NCT00892281|75854558|FG001|Overall Study|Scheduled for knee replacement|1|||
42046590|NCT00892281|75854557|FG000|Overall Study|PI complained of inadequate compensation|3|||
42046591|NCT00892281|75854558|FG001|Overall Study|PI complained of inadequate compensation|0|||
42046592|NCT00892281|75854557|FG000|Overall Study|Subject lost interest in program|0|||
42046593|NCT00892281|75854558|FG001|Overall Study|Subject lost interest in program|1|||
42046594|NCT00892281|75854557|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
42046595|NCT00892281|75854558|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
42046596|NCT00892281|75854557|FG000|Overall Study|Death in family|1|||
42046597|NCT00892281|75854558|FG001|Overall Study|Death in family|0|||
42046598|NCT00892281|75854557|FG000|Overall Study|Lack of efficacy of study product|2|||
42046599|NCT00892281|75854558|FG001|Overall Study|Lack of efficacy of study product|0|||
42046600|NCT00892281|75854557|FG000|Overall Study|Subject not seen by PI at final visit|1|||
42046601|NCT00892281|75854558|FG001|Overall Study|Subject not seen by PI at final visit|0|||
42046602|NCT00892281|75854557|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
42046603|NCT00892281|75854558|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
42046604|NCT00892281|75854557|FG000|Overall Study|Missed multiple visits|1|||
42046605|NCT00892281|75854558|FG001|Overall Study|Missed multiple visits|0|||
42046606|NCT00892281|75854557|FG000|Overall Study|Missed visits rescheduled out of window|1|||
42046607|NCT00892281|75854558|FG001|Overall Study|Missed visits rescheduled out of window|0|||
42046608|NCT00892281|75854557|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
42046609|NCT00892281|75854558|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
42046610|NCT00892281|75854557|FG000|Overall Study|Subject had history of drug abuse|1|||
42046611|NCT00892281|75854558|FG001|Overall Study|Subject had history of drug abuse|0|||
42172702|NCT03338062|75979560|FG001|Overall Study|Alternative Therapy|0|||
42172703|NCT03364192|75979567|FG000|Overall Study|Ineligible|10|||
42172704|NCT03364192|75979567|FG000|Overall Study|Withdrawal by Subject|5|||
42172705|NCT03364192|75979567|FG000|Overall Study|Lost to Follow-up|1|||
42172706|NCT03783962|75979574|FG000|Overall Study|Lost to Follow-up|3|||
42172707|NCT03783962|75979575|FG001|Overall Study|Lost to Follow-up|6|||
42291258|NCT02641379|76125035|FG008|Overall Study|Participant cannot be reached|0|||
42172708|NCT03783962|75979574|FG000|Overall Study|Protocol Violation|0|||
42046612|NCT00892281|75854557|FG000|Overall Study|Rash on hand|1|||
42046613|NCT00892281|75854558|FG001|Overall Study|Rash on hand|0|||
42046614|NCT00892281|75854557|FG000|Overall Study|Visit 4 date out of window|1|||
42046615|NCT00892281|75854558|FG001|Overall Study|Visit 4 date out of window|0|||
42046616|NCT00784693|75854566|FG000|Overall Study|Lost to Follow-up|0|||
42046617|NCT00784693|75854567|FG001|Overall Study|Lost to Follow-up|1|||
42046618|NCT00784693|75854566|FG000|Overall Study|Lack of Efficacy|1|||
42046619|NCT00784693|75854567|FG001|Overall Study|Lack of Efficacy|1|||
42046620|NCT00784693|75854566|FG000|Overall Study|Withdrawal by Subject|0|||
42046621|NCT00784693|75854567|FG001|Overall Study|Withdrawal by Subject|4|||
42046622|NCT00784693|75854566|FG000|Overall Study|Randomized but not Treated|1|||
42046623|NCT00784693|75854567|FG001|Overall Study|Randomized but not Treated|0|||
42046624|NCT00784693|75854566|FG000|Overall Study|Other|1|||
42046625|NCT00784693|75854567|FG001|Overall Study|Other|0|||
42046626|NCT00893763|75854575|FG000|Overall Study|extubated|110|||
42046627|NCT00893763|75854576|FG001|Overall Study|extubated|110|||
42046628|NCT00892047|75854586|FG000|Overall Study|Adverse Event|2|||
42046629|NCT00892047|75854587|FG001|Overall Study|Adverse Event|2|||
42046630|NCT00892047|75854586|FG000|Overall Study|subject burden|2|||
42046631|NCT00892047|75854587|FG001|Overall Study|subject burden|3|||
42046632|NCT00892047|75854586|FG000|Overall Study|Lack of Efficacy|0|||
42046633|NCT00892047|75854587|FG001|Overall Study|Lack of Efficacy|2|||
42046634|NCT00787267|75854595|FG000|Overall Study|Screen failure/Ineligible|10|||
42046635|NCT00787267|75854595|FG000|Overall Study|No Reason Provided|1|||
42046636|NCT00787267|75854595|FG000|Overall Study|Withdrawal by Subject|1|||
42046637|NCT00928434|75854602|FG000|Overall Study|Adverse Event|14|||
42046638|NCT00928434|75854603|FG001|Overall Study|Adverse Event|5|||
42046639|NCT00928434|75854604|FG002|Overall Study|Adverse Event|18|||
42046640|NCT00928434|75854602|FG000|Overall Study|Protocol Violation|5|||
42046641|NCT00928434|75854603|FG001|Overall Study|Protocol Violation|0|||
42046642|NCT00928434|75854604|FG002|Overall Study|Protocol Violation|8|||
42046643|NCT00928434|75854602|FG000|Overall Study|Physician Decision|2|||
42046644|NCT00928434|75854603|FG001|Overall Study|Physician Decision|0|||
42046645|NCT00928434|75854604|FG002|Overall Study|Physician Decision|3|||
42046646|NCT00928434|75854602|FG000|Overall Study|Lost to Follow-up|1|||
42046647|NCT00928434|75854603|FG001|Overall Study|Lost to Follow-up|0|||
42046648|NCT00928434|75854604|FG002|Overall Study|Lost to Follow-up|3|||
42046649|NCT00928434|75854602|FG000|Overall Study|Withdrawal by Subject|5|||
42046650|NCT00928434|75854603|FG001|Overall Study|Withdrawal by Subject|3|||
42046651|NCT00928434|75854604|FG002|Overall Study|Withdrawal by Subject|2|||
42046652|NCT00928434|75854602|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
42046653|NCT00928434|75854603|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
42046654|NCT00928434|75854604|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
42046655|NCT00928434|75854602|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
42046656|NCT00928434|75854603|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
42046657|NCT00928434|75854604|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
42046658|NCT00928434|75854602|FG000|Overall Study|Other (not meeting above criteria)|5|||
42046659|NCT00928434|75854603|FG001|Overall Study|Other (not meeting above criteria)|1|||
42046660|NCT00928434|75854604|FG002|Overall Study|Other (not meeting above criteria)|2|||
42046661|NCT00787189|75854622|FG000|Overall Study|Lost to Follow-up|2|||
42046662|NCT00787189|75854623|FG001|Overall Study|Lost to Follow-up|2|||
42046663|NCT00784459|75854631|FG000|Overall Study|Adverse Event|0|||
42046664|NCT00784459|75854632|FG001|Overall Study|Adverse Event|2|||
42046665|NCT00786799|75854640|FG000|Overall Study|Lost to Follow-up|1|||
42046666|NCT00786799|75854641|FG001|Overall Study|Lost to Follow-up|1|||
42046667|NCT00786565|75854652|FG000|Enrollment Prior to Surgery|Site Closed|3|||
42046668|NCT00786565|75854652|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
42046669|NCT00786565|75854652|FG000|Post Surgery|Abnormal macular pucker|1|||
42046670|NCT00786565|75854652|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
42291259|NCT02641379|76125036|FG009|Overall Study|Participant cannot be reached|2|||
42291260|NCT02641379|76125037|FG010|Overall Study|Participant cannot be reached|1|||
42046671|NCT00784147|75854660|FG000|Overall Study|Lost to Follow-up|2|||
42046672|NCT00784147|75854661|FG001|Overall Study|Lost to Follow-up|4|||
42046673|NCT00784147|75854660|FG000|Overall Study|Withdrawal by Subject|1|||
42046674|NCT00784147|75854661|FG001|Overall Study|Withdrawal by Subject|3|||
42046675|NCT00784147|75854660|FG000|Overall Study|Physician Decision|2|||
42046676|NCT00784147|75854661|FG001|Overall Study|Physician Decision|1|||
42046677|NCT00784147|75854660|FG000|Overall Study|Protocol Violation|1|||
42046678|NCT00784147|75854661|FG001|Overall Study|Protocol Violation|1|||
42046679|NCT00784147|75854660|FG000|Overall Study|Death|2|||
42046680|NCT00784147|75854661|FG001|Overall Study|Death|0|||
42046681|NCT00891813|75854667|FG000|Overall Study|Adverse Event|3|||
42046682|NCT00891813|75854667|FG000|Overall Study|Withdrawal by Subject|1|||
42046683|NCT00891813|75854667|FG000|Overall Study|Patient Noncompliance|6|||
42046684|NCT00891813|75854667|FG000|Overall Study|Protocol Violation|2|||
42291261|NCT02641379|76125027|FG000|Overall Study|PCR positive at Week 24|15|||
42046685|NCT00783835|75854684|FG000|Overall Study|Adverse Event|3|||
42046686|NCT00783835|75854684|FG000|Overall Study|Medical Criteria|1|||
42046687|NCT00783835|75854684|FG000|Overall Study|Withdrawal by Subject|2|||
42046688|NCT00783835|75854684|FG000|Overall Study|Lost to Follow-up|1|||
42046689|NCT00783835|75854684|FG000|Overall Study|Participant not Adherent|3|||
42046690|NCT00783289|75854692|FG000|Overall Study|Protocol Violation|0|||
42046691|NCT00783289|75854693|FG001|Overall Study|Protocol Violation|1|||
42046692|NCT00783289|75854694|FG002|Overall Study|Protocol Violation|0|||
42046693|NCT00783289|75854695|FG003|Overall Study|Protocol Violation|0|||
42046694|NCT00847912|75854710|FG000|Overall Study|Protocol Violation|6|||
42046695|NCT00847912|75854711|FG001|Overall Study|Protocol Violation|7|||
42046696|NCT00847912|75854710|FG000|Overall Study|Withdrawal by Subject|3|||
42046697|NCT00847912|75854711|FG001|Overall Study|Withdrawal by Subject|6|||
42046698|NCT00850564|75854718|FG000|Overall Study|Withdrawal by Subject|2|||
42046699|NCT00837148|75854722|FG000|Overall Study|Adverse Event|1|||
42046700|NCT00837148|75854722|FG000|Overall Study|Death|1|||
42046701|NCT00849940|75854726|FG000|Overall Study|Physician Decision|4|||
42046702|NCT00849472|75854730|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
42172709|NCT03783962|75979575|FG001|Overall Study|Protocol Violation|1|||
42172710|NCT03361228|75979583|FG000|Overall Study|Other|1|||
42172711|NCT03361228|75979584|FG001|Overall Study|Other|1|||
42172712|NCT03361228|75979583|FG000|Overall Study|Death|3|||
42172713|NCT03361228|75979584|FG001|Overall Study|Death|0|||
42172714|NCT03359590|75979590|FG000|First Intervention|Withdrawal by Subject|1|||
42291262|NCT02641379|76125028|FG001|Overall Study|PCR positive at Week 24|21|||
42291263|NCT02641379|76125029|FG002|Overall Study|PCR positive at Week 24|62|||
42291264|NCT02641379|76125030|FG003|Overall Study|PCR positive at Week 24|0|||
42291265|NCT02641379|76125031|FG004|Overall Study|PCR positive at Week 24|0|||
42291266|NCT02641379|76125032|FG005|Overall Study|PCR positive at Week 24|6|||
42291267|NCT02641379|76125033|FG006|Overall Study|PCR positive at Week 24|3|||
42291268|NCT02641379|76125034|FG007|Overall Study|PCR positive at Week 24|8|||
42291269|NCT02641379|76125035|FG008|Overall Study|PCR positive at Week 24|0|||
42291270|NCT02641379|76125036|FG009|Overall Study|PCR positive at Week 24|1|||
42291271|NCT02641379|76125037|FG010|Overall Study|PCR positive at Week 24|0|||
42291272|NCT02641379|76125027|FG000|Overall Study|PCR positive at follow up 2|1|||
42291273|NCT02641379|76125028|FG001|Overall Study|PCR positive at follow up 2|0|||
42291274|NCT02641379|76125029|FG002|Overall Study|PCR positive at follow up 2|0|||
42291275|NCT02641379|76125030|FG003|Overall Study|PCR positive at follow up 2|0|||
42291276|NCT02641379|76125031|FG004|Overall Study|PCR positive at follow up 2|0|||
42291277|NCT02641379|76125032|FG005|Overall Study|PCR positive at follow up 2|0|||
42291278|NCT02641379|76125033|FG006|Overall Study|PCR positive at follow up 2|0|||
42291279|NCT02641379|76125034|FG007|Overall Study|PCR positive at follow up 2|0|||
42356858|NCT01393743|76202033|FG001|Extension Phase|Participant choice|0|||
42046703|NCT00849472|75854730|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
42046704|NCT00849472|75854730|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
42046705|NCT00849472|75854730|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
42046706|NCT00849472|75854730|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
42172715|NCT03359590|75979591|FG001|First Intervention|Withdrawal by Subject|1|||
42172716|NCT03359590|75979590|FG000|First Intervention|Protocol Violation|0|||
42046707|NCT00849472|75854730|FG000|Weekly Paclitaxel|Disease Progression|1|||
42046708|NCT00849472|75854730|FG000|Weekly Paclitaxel|Adverse Event|11|||
42046709|NCT00849472|75854730|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
42046710|NCT00849472|75854730|FG000|Weekly Paclitaxel|Physician Decision|3|||
42046711|NCT00849472|75854730|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
42046712|NCT00849472|75854730|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
42046713|NCT00849472|75854730|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
42172717|NCT03359590|75979591|FG001|First Intervention|Protocol Violation|1|||
42172718|NCT05085964|75979599|FG000|Overall Study|Premature termination of study|21|||
42172719|NCT05085964|75979600|FG001|Overall Study|Premature termination of study|0|||
42172720|NCT02891200|75979609|FG000|Overall Study|Lost to Follow-up|31|||
42172721|NCT02891200|75979610|FG001|Overall Study|Lost to Follow-up|36|||
42046714|NCT00849472|75854730|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
42046715|NCT00849472|75854730|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
42046716|NCT00849472|75854730|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
42172722|NCT02891200|75979609|FG000|Overall Study|Death|10|||
42172723|NCT02891200|75979610|FG001|Overall Study|Death|9|||
42172724|NCT02891200|75979609|FG000|Overall Study|Withdrawal by Subject|1|||
42172725|NCT02891200|75979610|FG001|Overall Study|Withdrawal by Subject|4|||
42291280|NCT02641379|76125035|FG008|Overall Study|PCR positive at follow up 2|0|||
42291281|NCT02641379|76125036|FG009|Overall Study|PCR positive at follow up 2|0|||
42291282|NCT02641379|76125037|FG010|Overall Study|PCR positive at follow up 2|0|||
42291283|NCT02641379|76125027|FG000|Overall Study|Participant showed relapse|1|||
42046717|NCT00849472|75854730|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
42046718|NCT00849472|75854730|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
42046719|NCT00782509|75854738|FG000|Overall Study|Adverse Event|20|||
42046720|NCT00782509|75854739|FG001|Overall Study|Adverse Event|10|||
42046721|NCT00782509|75854740|FG002|Overall Study|Adverse Event|20|||
42046722|NCT00782509|75854738|FG000|Overall Study|Lost to Follow-up|1|||
42046723|NCT00782509|75854739|FG001|Overall Study|Lost to Follow-up|2|||
42046724|NCT00782509|75854740|FG002|Overall Study|Lost to Follow-up|3|||
42046725|NCT00782509|75854738|FG000|Overall Study|Withdrawal by Subject|3|||
42046726|NCT00782509|75854739|FG001|Overall Study|Withdrawal by Subject|5|||
42046727|NCT00782509|75854740|FG002|Overall Study|Withdrawal by Subject|8|||
42046728|NCT00782509|75854738|FG000|Overall Study|Non compliance with protocol|2|||
42046729|NCT00782509|75854739|FG001|Overall Study|Non compliance with protocol|0|||
42046730|NCT00782509|75854740|FG002|Overall Study|Non compliance with protocol|0|||
42046731|NCT00782509|75854738|FG000|Overall Study|Other reasons not stated above|5|||
42046732|NCT00782509|75854739|FG001|Overall Study|Other reasons not stated above|2|||
42046733|NCT00782509|75854740|FG002|Overall Study|Other reasons not stated above|3|||
42046734|NCT00782509|75854738|FG000|Overall Study|Lack of Efficacy|10|||
42046735|NCT00782509|75854739|FG001|Overall Study|Lack of Efficacy|5|||
42046736|NCT00782509|75854740|FG002|Overall Study|Lack of Efficacy|2|||
42046737|NCT00927810|75854759|FG000|Overall Study|Withdrawal by Subject|0|||
42046738|NCT00927810|75854760|FG001|Overall Study|Withdrawal by Subject|3|||
42046739|NCT00927810|75854761|FG002|Overall Study|Withdrawal by Subject|0|||
42046740|NCT00927810|75854762|FG003|Overall Study|Withdrawal by Subject|1|||
42046741|NCT00927810|75854759|FG000|Overall Study|Lost to Follow-up|0|||
42046742|NCT00927810|75854760|FG001|Overall Study|Lost to Follow-up|2|||
42046743|NCT00927810|75854761|FG002|Overall Study|Lost to Follow-up|1|||
42046744|NCT00927810|75854762|FG003|Overall Study|Lost to Follow-up|1|||
42046745|NCT00927810|75854759|FG000|Overall Study|Death|0|||
42046746|NCT00927810|75854760|FG001|Overall Study|Death|2|||
42046747|NCT00927810|75854761|FG002|Overall Study|Death|0|||
42046748|NCT00927810|75854762|FG003|Overall Study|Death|0|||
42046749|NCT00927810|75854759|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42046750|NCT00927810|75854760|FG001|Overall Study|Abnormal laboratory value(s)|1|||
42046751|NCT00927810|75854761|FG002|Overall Study|Abnormal laboratory value(s)|0|||
42046752|NCT00927810|75854762|FG003|Overall Study|Abnormal laboratory value(s)|0|||
42046753|NCT00848926|75854780|FG000|Treatment Period|Progressive disease|45|||
42046754|NCT00848926|75854780|FG000|Treatment Period|Adverse Event|20|||
42046755|NCT00848926|75854780|FG000|Treatment Period|Physician Decision|12|||
42046756|NCT00848926|75854780|FG000|Treatment Period|Withdrawal by Subject|7|||
42046757|NCT00848926|75854780|FG000|Follow-up Period|Lost to Follow-up|7|||
42046758|NCT00848926|75854780|FG000|Follow-up Period|Withdrawal by Subject|3|||
42046759|NCT00848926|75854780|FG000|Follow-up Period|Other|2|||
42046760|NCT00847132|75854786|FG000|Overall Study|Death|1|||
42046761|NCT00847132|75854787|FG001|Overall Study|Death|1|||
42046762|NCT00918138|75854795|FG000|Overall Study|Subject withdrew consent|1|||
42046763|NCT00918138|75854796|FG001|Overall Study|Subject withdrew consent|1|||
42046764|NCT00918138|75854795|FG000|Overall Study|Death|1|||
42046765|NCT00918138|75854796|FG001|Overall Study|Death|0|||
42046766|NCT00782275|75854802|FG000|Overall Study|Adverse Event|11|||
42046767|NCT00782275|75854802|FG000|Overall Study|Withdrawal by Subject|1|||
42046768|NCT00782275|75854802|FG000|Overall Study|Progressive Disease|21|||
42046769|NCT00782275|75854802|FG000|Overall Study|Physician Decision|4|||
42046770|NCT00782275|75854802|FG000|Overall Study|Not started treatment|1|||
42046771|NCT00782275|75854802|FG000|Overall Study|Other|3|||
42046772|NCT00791557|75854806|FG000|Overall Study|Adverse Event|1|||
42046773|NCT00920790|75854810|FG000|Overall Study|aggravation of general condition|14|||
42046774|NCT00781963|75854816|FG000|Overall Study|Death|3|||
42046775|NCT00781963|75854817|FG001|Overall Study|Death|0|||
42046776|NCT00781963|75854816|FG000|Overall Study|Lost to Follow-up|2|||
42046777|NCT00781963|75854817|FG001|Overall Study|Lost to Follow-up|1|||
42046778|NCT00781963|75854816|FG000|Overall Study|Withdrawal by Subject|3|||
42046779|NCT00781963|75854817|FG001|Overall Study|Withdrawal by Subject|1|||
42046780|NCT00781963|75854816|FG000|Overall Study|Refused follow-up|9|||
42046781|NCT00781963|75854817|FG001|Overall Study|Refused follow-up|0|||
42046782|NCT00920556|75854823|FG000|Overall Study|Adverse Event|16|||
42046783|NCT00920556|75854823|FG000|Overall Study|Physician Decision|7|||
42046784|NCT00920556|75854823|FG000|Overall Study|Withdrawal by Subject|1|||
42046785|NCT00781885|75854831|FG000|Overall Study|Physician Decision|1|||
42046786|NCT00918684|75854835|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
42046787|NCT00918684|75854835|FG000|Treatment Phase|Lack of Efficacy|6|||
42046788|NCT00918684|75854835|FG000|Treatment Phase|Lost to Follow-up|2|||
42046789|NCT00918684|75854835|FG000|Treatment Phase|Physician Decision|8|||
42046790|NCT00918684|75854835|FG000|Treatment Phase|Protocol Violation|1|||
42046791|NCT00918684|75854835|FG000|Treatment Phase|Withdrawal by Subject|8|||
42046792|NCT00786409|75854839|FG000|Overall Study|Withdrawal by Subject|2|||
42046793|NCT00786409|75854839|FG000|Overall Study|Adverse Event|2|||
42046794|NCT00786409|75854839|FG000|Overall Study|Pregnancy|2|||
42046795|NCT00786409|75854839|FG000|Overall Study|Lost to Follow-up|1|||
42046796|NCT00919854|75854843|FG000|Overall Study|Adverse Event|1|||
42046797|NCT00891735|75854851|FG000|Overall Study|Adverse Event|2|||
42046798|NCT00891735|75854852|FG001|Overall Study|Adverse Event|0|||
42046799|NCT00891735|75854853|FG002|Overall Study|Adverse Event|2|||
42046800|NCT00891735|75854854|FG003|Overall Study|Adverse Event|0|||
42046801|NCT00891735|75854851|FG000|Overall Study|Death|8|||
42046802|NCT00891735|75854852|FG001|Overall Study|Death|5|||
42046803|NCT00891735|75854853|FG002|Overall Study|Death|4|||
42046804|NCT00891735|75854854|FG003|Overall Study|Death|5|||
42046805|NCT00891735|75854851|FG000|Overall Study|Lost to Follow-up|2|||
42046806|NCT00891735|75854852|FG001|Overall Study|Lost to Follow-up|2|||
42046807|NCT00891735|75854853|FG002|Overall Study|Lost to Follow-up|2|||
42046808|NCT00891735|75854854|FG003|Overall Study|Lost to Follow-up|2|||
42046809|NCT00891735|75854851|FG000|Overall Study|Physician's decision to withdraw patient|1|||
42046810|NCT00891735|75854852|FG001|Overall Study|Physician's decision to withdraw patient|0|||
42046811|NCT00891735|75854853|FG002|Overall Study|Physician's decision to withdraw patient|0|||
42046812|NCT00891735|75854854|FG003|Overall Study|Physician's decision to withdraw patient|0|||
42046813|NCT00891735|75854851|FG000|Overall Study|Patient's decision to withdraw|4|||
42046814|NCT00891735|75854852|FG001|Overall Study|Patient's decision to withdraw|9|||
42046815|NCT00891735|75854853|FG002|Overall Study|Patient's decision to withdraw|4|||
42046816|NCT00891735|75854854|FG003|Overall Study|Patient's decision to withdraw|8|||
42046817|NCT00891657|75854866|FG000|Overall Study|Withdrawal by Subject|1|||
42046818|NCT00891657|75854867|FG001|Overall Study|Withdrawal by Subject|1|||
42046819|NCT00917124|75854875|FG000|Overall Study|Protocol Violation|4|||
42046820|NCT00917124|75854876|FG001|Overall Study|Protocol Violation|6|||
42046821|NCT00889863|75854882|FG000|Part I: Open Label|Death|1|||
42046822|NCT00889863|75854883|FG001|Part I: Open Label|Death|0|||
42046823|NCT00889863|75854882|FG000|Part I: Open Label|Adverse Event|4|||
42046824|NCT00889863|75854883|FG001|Part I: Open Label|Adverse Event|0|||
42046825|NCT00889863|75854882|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
42046826|NCT00889863|75854883|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
42046827|NCT00889863|75854882|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
42046828|NCT00889863|75854883|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
42046829|NCT00889863|75854882|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
42046830|NCT00889863|75854883|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
42046831|NCT00889863|75854882|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
42291284|NCT02641379|76125028|FG001|Overall Study|Participant showed relapse|0|||
42291285|NCT02641379|76125029|FG002|Overall Study|Participant showed relapse|0|||
42291286|NCT02641379|76125030|FG003|Overall Study|Participant showed relapse|0|||
42291287|NCT02641379|76125031|FG004|Overall Study|Participant showed relapse|0|||
42291288|NCT02641379|76125032|FG005|Overall Study|Participant showed relapse|0|||
42291289|NCT02641379|76125033|FG006|Overall Study|Participant showed relapse|1|||
42291290|NCT02641379|76125034|FG007|Overall Study|Participant showed relapse|0|||
42291291|NCT02641379|76125035|FG008|Overall Study|Participant showed relapse|0|||
42291292|NCT02641379|76125036|FG009|Overall Study|Participant showed relapse|0|||
42291293|NCT02641379|76125037|FG010|Overall Study|Participant showed relapse|0|||
42046832|NCT00889863|75854883|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
42046833|NCT00889863|75854882|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
42046834|NCT00889863|75854883|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
42046835|NCT00915018|75854893|FG000|Overall Study|Death|75|||
42046836|NCT00915018|75854894|FG001|Overall Study|Death|70|||
42046837|NCT00915018|75854893|FG000|Overall Study|Lost to Follow-up|10|||
42046838|NCT00915018|75854894|FG001|Overall Study|Lost to Follow-up|5|||
42046839|NCT00915018|75854893|FG000|Overall Study|Withdrawal by Subject|38|||
42046840|NCT00915018|75854894|FG001|Overall Study|Withdrawal by Subject|27|||
42046841|NCT00915018|75854893|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
42046842|NCT00915018|75854894|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
42046843|NCT00916578|75854900|FG000|Overall Study|Physician Decision|2|||
42046844|NCT00916578|75854900|FG000|Overall Study|Withdrawal by Subject|3|||
42046845|NCT00916578|75854900|FG000|Overall Study|Insurance Denial|2|||
42046846|NCT00889707|75854906|FG000|Overall Study|Adverse Event|1|||
42046847|NCT00889707|75854907|FG001|Overall Study|Adverse Event|0|||
42046848|NCT00889707|75854906|FG000|Overall Study|Withdrawal by Subject|4|||
42046849|NCT00889707|75854907|FG001|Overall Study|Withdrawal by Subject|3|||
42046850|NCT00889707|75854906|FG000|Overall Study|Lost to Follow-up|0|||
42046851|NCT00889707|75854907|FG001|Overall Study|Lost to Follow-up|2|||
42046852|NCT00889707|75854906|FG000|Overall Study|Lack of Efficacy|2|||
42046853|NCT00889707|75854907|FG001|Overall Study|Lack of Efficacy|5|||
42046854|NCT00914940|75854913|FG000|D0 to D100 Post-transplant|Death|2|||
42046855|NCT00914940|75854913|FG000|D101 to 2 Years Post-transplant|Death|8|||
42046856|NCT00914940|75854913|FG000|2 Years to 5 Years Post-transplant|Death|3|||
42046857|NCT00835978|75854921|FG000|Overall Study|Death|33|||
42046858|NCT00835978|75854922|FG001|Overall Study|Death|40|||
42291294|NCT02641379|76125027|FG000|Overall Study|Participant stopped study/treatment|1|||
42291295|NCT02641379|76125028|FG001|Overall Study|Participant stopped study/treatment|3|||
42046859|NCT00835978|75854923|FG002|Overall Study|Death|49|||
42046860|NCT00835978|75854924|FG003|Overall Study|Death|4|||
42046861|NCT00835978|75854921|FG000|Overall Study|Lost to Follow-up|3|||
42046862|NCT00835978|75854922|FG001|Overall Study|Lost to Follow-up|4|||
42046863|NCT00835978|75854923|FG002|Overall Study|Lost to Follow-up|2|||
42046864|NCT00835978|75854924|FG003|Overall Study|Lost to Follow-up|1|||
42046865|NCT00835978|75854921|FG000|Overall Study|Other|5|||
42046866|NCT00835978|75854922|FG001|Overall Study|Other|1|||
42046867|NCT00835978|75854923|FG002|Overall Study|Other|8|||
42046868|NCT00835978|75854924|FG003|Overall Study|Other|0|||
42046869|NCT00835978|75854921|FG000|Overall Study|Objective progression or relapse|2|||
42046870|NCT00835978|75854922|FG001|Overall Study|Objective progression or relapse|0|||
42046871|NCT00835978|75854923|FG002|Overall Study|Objective progression or relapse|1|||
42046872|NCT00835978|75854924|FG003|Overall Study|Objective progression or relapse|0|||
42046873|NCT00835978|75854921|FG000|Overall Study|Adverse Event|1|||
42046874|NCT00835978|75854922|FG001|Overall Study|Adverse Event|0|||
42046875|NCT00835978|75854923|FG002|Overall Study|Adverse Event|1|||
42046876|NCT00835978|75854924|FG003|Overall Study|Adverse Event|0|||
42046877|NCT00835978|75854921|FG000|Overall Study|Withdrawal by Subject|0|||
42046878|NCT00835978|75854922|FG001|Overall Study|Withdrawal by Subject|3|||
42046879|NCT00835978|75854923|FG002|Overall Study|Withdrawal by Subject|0|||
42046880|NCT00835978|75854924|FG003|Overall Study|Withdrawal by Subject|5|||
42046881|NCT00835978|75854921|FG000|Overall Study|Study terminated by sponsor|12|||
42046882|NCT00835978|75854922|FG001|Overall Study|Study terminated by sponsor|8|||
42046883|NCT00835978|75854923|FG002|Overall Study|Study terminated by sponsor|30|||
42046884|NCT00835978|75854924|FG003|Overall Study|Study terminated by sponsor|0|||
42046885|NCT00914628|75854941|FG000|Overall Study|Death|35|||
42046886|NCT00914628|75854942|FG001|Overall Study|Death|17|||
42046887|NCT00914628|75854941|FG000|Overall Study|Medical decision|4|||
42046888|NCT00914628|75854942|FG001|Overall Study|Medical decision|0|||
42046889|NCT00914628|75854941|FG000|Overall Study|Protocol Violation|1|||
42046890|NCT00914628|75854942|FG001|Overall Study|Protocol Violation|0|||
42046891|NCT00914628|75854941|FG000|Overall Study|Lack of Efficacy|1|||
42046892|NCT00914628|75854942|FG001|Overall Study|Lack of Efficacy|0|||
42046893|NCT00914628|75854941|FG000|Overall Study|non-randomized|1|||
42046894|NCT00914628|75854942|FG001|Overall Study|non-randomized|0|||
42046895|NCT00914628|75854941|FG000|Overall Study|Relapse|1|||
42046896|NCT00914628|75854942|FG001|Overall Study|Relapse|2|||
42046897|NCT00914628|75854941|FG000|Overall Study|Study terminated by Sponsor|14|||
42046898|NCT00914628|75854942|FG001|Overall Study|Study terminated by Sponsor|8|||
42046899|NCT00914628|75854941|FG000|Overall Study|Patients who did not receive a single dose|7|||
42046900|NCT00914628|75854942|FG001|Overall Study|Patients who did not receive a single dose|1|||
42046901|NCT01077518|75854954|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
42046902|NCT01077518|75854955|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
42046903|NCT01077518|75854956|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
42046904|NCT01077518|75854954|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
42046905|NCT01077518|75854955|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
42046906|NCT01077518|75854956|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
42046907|NCT01077518|75854954|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
42046908|NCT01077518|75854955|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
42046909|NCT01077518|75854956|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
42046910|NCT01077518|75854954|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
42046911|NCT01077518|75854955|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
42046912|NCT01077518|75854956|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
42046913|NCT01077518|75854954|FG000|Optional Ofa Phase|Physician Decision|0|||
42046914|NCT01077518|75854955|FG001|Optional Ofa Phase|Physician Decision|0|||
42046915|NCT01077518|75854956|FG002|Optional Ofa Phase|Physician Decision|1|||
42046916|NCT01077518|75854954|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
42046917|NCT01077518|75854955|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
42046918|NCT01077518|75854956|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
42046919|NCT01077518|75854954|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
42046920|NCT01077518|75854955|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
42046921|NCT01077518|75854956|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
42046922|NCT00835120|75854965|FG000|Overall Study|Lack of Efficacy|1|||
42046923|NCT00835120|75854965|FG000|Overall Study|Lost to Follow-up|3|||
42046924|NCT00835120|75854965|FG000|Overall Study|Adverse Event|2|||
42046925|NCT00835120|75854965|FG000|Overall Study|Withdrawal by Subject|2|||
42046926|NCT00914316|75854973|FG000|Phase 1|Physician Decision|4|||
42046927|NCT00914316|75854974|FG001|Phase 1|Physician Decision|0|||
42046928|NCT00914316|75854975|FG002|Phase 1|Physician Decision|1|||
42046929|NCT00914316|75854976|FG003|Phase 1|Physician Decision|2|||
42172726|NCT02946580|75979618|FG000|Overall Study|Withdrawal by Subject|1|||
42172727|NCT02946580|75979619|FG001|Overall Study|Withdrawal by Subject|2|||
42172728|NCT02946580|75979618|FG000|Overall Study|Adverse Event|0|||
42046930|NCT00914316|75854973|FG000|Phase 1|Withdrawal by Subject|0|||
42046931|NCT00914316|75854974|FG001|Phase 1|Withdrawal by Subject|2|||
42046932|NCT00914316|75854975|FG002|Phase 1|Withdrawal by Subject|4|||
42046933|NCT00914316|75854976|FG003|Phase 1|Withdrawal by Subject|0|||
42046934|NCT00914316|75854973|FG000|Phase 1|Adverse Event|1|||
42046935|NCT00914316|75854974|FG001|Phase 1|Adverse Event|0|||
42046936|NCT00914316|75854975|FG002|Phase 1|Adverse Event|0|||
42291296|NCT02641379|76125029|FG002|Overall Study|Participant stopped study/treatment|1|||
42291297|NCT02641379|76125030|FG003|Overall Study|Participant stopped study/treatment|0|||
42291298|NCT02641379|76125031|FG004|Overall Study|Participant stopped study/treatment|0|||
42291299|NCT02641379|76125032|FG005|Overall Study|Participant stopped study/treatment|1|||
42291300|NCT02641379|76125033|FG006|Overall Study|Participant stopped study/treatment|2|||
42291301|NCT02641379|76125034|FG007|Overall Study|Participant stopped study/treatment|0|||
42291302|NCT02641379|76125035|FG008|Overall Study|Participant stopped study/treatment|1|||
42291303|NCT02641379|76125036|FG009|Overall Study|Participant stopped study/treatment|0|||
42291304|NCT02641379|76125037|FG010|Overall Study|Participant stopped study/treatment|0|||
42291305|NCT02641379|76125027|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
42291306|NCT02641379|76125028|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
42291307|NCT02641379|76125029|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
42291308|NCT02641379|76125030|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
42291309|NCT02641379|76125031|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
42046937|NCT00914316|75854976|FG003|Phase 1|Adverse Event|0|||
42046938|NCT00914316|75854973|FG000|Phase 2|Withdrawal by Subject|1|||
42046939|NCT00914316|75854974|FG001|Phase 2|Withdrawal by Subject|0|||
42046940|NCT00914316|75854975|FG002|Phase 2|Withdrawal by Subject|1|||
42046941|NCT00914316|75854976|FG003|Phase 2|Withdrawal by Subject|0|||
42046942|NCT00827632|75854988|FG000|Overall Study|Lost to Follow-up|8|||
42046943|NCT00827632|75854989|FG001|Overall Study|Lost to Follow-up|12|||
42046944|NCT00827632|75854988|FG000|Overall Study|Early withdrawal|14|||
42046945|NCT00827632|75854989|FG001|Overall Study|Early withdrawal|11|||
42046946|NCT00827242|75854997|FG000|Overall Study|Withdrawal by Subject|2|||
42046947|NCT00827242|75854998|FG001|Overall Study|Withdrawal by Subject|4|||
42046948|NCT00827242|75854997|FG000|Overall Study|Protocol Violation|1|||
42046949|NCT00827242|75854998|FG001|Overall Study|Protocol Violation|3|||
42046950|NCT00827242|75854997|FG000|Overall Study|Lost to Follow-up|0|||
42046951|NCT00827242|75854998|FG001|Overall Study|Lost to Follow-up|3|||
42046952|NCT00827242|75854997|FG000|Overall Study|Adverse Event Excluding Death|2|||
42046953|NCT00827242|75854998|FG001|Overall Study|Adverse Event Excluding Death|1|||
42291310|NCT02641379|76125032|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
42291311|NCT02641379|76125033|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
42291312|NCT02641379|76125034|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
42291313|NCT02641379|76125035|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
42046954|NCT00827242|75854997|FG000|Overall Study|Entry Criteria Not Met|4|||
42046955|NCT00827242|75854998|FG001|Overall Study|Entry Criteria Not Met|1|||
42046956|NCT00827242|75854997|FG000|Overall Study|Physician Decision|2|||
42046957|NCT00827242|75854998|FG001|Overall Study|Physician Decision|0|||
42046958|NCT00827242|75854997|FG000|Overall Study|Death|1|||
42046959|NCT00827242|75854998|FG001|Overall Study|Death|0|||
42046960|NCT00827242|75854997|FG000|Overall Study|Lack of Efficacy|1|||
42046961|NCT00827242|75854998|FG001|Overall Study|Lack of Efficacy|0|||
42046962|NCT01077362|75855007|FG000|Overall Study|Lack of Efficacy|13|||
42046963|NCT01077362|75855008|FG001|Overall Study|Lack of Efficacy|8|||
42046964|NCT01077362|75855009|FG002|Overall Study|Lack of Efficacy|10|||
42046965|NCT01077362|75855007|FG000|Overall Study|Lost to Follow-up|1|||
42046966|NCT01077362|75855008|FG001|Overall Study|Lost to Follow-up|0|||
42046967|NCT01077362|75855009|FG002|Overall Study|Lost to Follow-up|3|||
42046968|NCT01077362|75855007|FG000|Overall Study|Adverse Event|12|||
42046969|NCT01077362|75855008|FG001|Overall Study|Adverse Event|7|||
42046970|NCT01077362|75855009|FG002|Overall Study|Adverse Event|4|||
42046971|NCT01077362|75855007|FG000|Overall Study|Withdrawal by Subject|5|||
42046972|NCT01077362|75855008|FG001|Overall Study|Withdrawal by Subject|3|||
42046973|NCT01077362|75855009|FG002|Overall Study|Withdrawal by Subject|5|||
42046974|NCT01077362|75855007|FG000|Overall Study|Other|0|||
42046975|NCT01077362|75855008|FG001|Overall Study|Other|1|||
42046976|NCT01077362|75855009|FG002|Overall Study|Other|2|||
42046977|NCT00846586|75855024|FG000|Overall Study|Adverse Event|20|||
42046978|NCT00846586|75855025|FG001|Overall Study|Adverse Event|10|||
42291314|NCT02641379|76125036|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
42046979|NCT00846586|75855024|FG000|Overall Study|Subject withdrew consent|8|||
42046980|NCT00846586|75855025|FG001|Overall Study|Subject withdrew consent|10|||
42046981|NCT00846586|75855024|FG000|Overall Study|Administrative problems|5|||
42046982|NCT00846586|75855025|FG001|Overall Study|Administrative problems|4|||
42046983|NCT00846586|75855024|FG000|Overall Study|Death|2|||
42046984|NCT00846586|75855025|FG001|Overall Study|Death|0|||
42291315|NCT02641379|76125037|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
42291316|NCT02641379|76125027|FG000|Overall Study|Financial problems|0|||
42046985|NCT00846586|75855024|FG000|Overall Study|Protocol deviation|2|||
42046986|NCT00846586|75855025|FG001|Overall Study|Protocol deviation|6|||
42046987|NCT00846586|75855024|FG000|Overall Study|Abnormal test procedure result(s)|1|||
42046988|NCT00846586|75855025|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42046989|NCT00846586|75855024|FG000|Overall Study|Lost to Follow-up|1|||
42046990|NCT00846586|75855025|FG001|Overall Study|Lost to Follow-up|4|||
42046991|NCT00846586|75855024|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42046992|NCT00846586|75855025|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
42046993|NCT00785785|75855033|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
42046994|NCT00785785|75855034|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
42046995|NCT00785785|75855033|FG000|Core Phase up to 36 Months|Adverse Event|31|||
42046996|NCT00785785|75855034|FG001|Core Phase up to 36 Months|Adverse Event|21|||
42046997|NCT00785785|75855033|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
42046998|NCT00785785|75855034|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
42046999|NCT00785785|75855033|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
42047000|NCT00785785|75855034|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
42047001|NCT00785785|75855033|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
42047002|NCT00785785|75855034|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
42047003|NCT00785785|75855033|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
42047004|NCT00785785|75855034|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
42047005|NCT00785785|75855033|FG000|Core Phase up to 36 Months|Administrative problems|3|||
42047006|NCT00785785|75855034|FG001|Core Phase up to 36 Months|Administrative problems|3|||
42047007|NCT00785785|75855033|FG000|Core Phase up to 36 Months|Death|5|||
42047008|NCT00785785|75855034|FG001|Core Phase up to 36 Months|Death|8|||
42047009|NCT00785785|75855033|FG000|Core Phase up to 36 Months|Disease progression|139|||
42047010|NCT00785785|75855034|FG001|Core Phase up to 36 Months|Disease progression|119|||
42047011|NCT00785785|75855033|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
42047012|NCT00785785|75855034|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
42047013|NCT00785785|75855033|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
42047014|NCT00785785|75855034|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
42047015|NCT00785785|75855033|FG000|Optional Extension Phase|Adverse Event|4|||
42047016|NCT00785785|75855034|FG001|Optional Extension Phase|Adverse Event|5|||
42047017|NCT00785785|75855033|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
42047018|NCT00785785|75855034|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
42047019|NCT00785785|75855033|FG000|Optional Extension Phase|Lost to Follow-up|1|||
42047020|NCT00785785|75855034|FG001|Optional Extension Phase|Lost to Follow-up|0|||
42047021|NCT00785785|75855033|FG000|Optional Extension Phase|Administrative problems|2|||
42047022|NCT00785785|75855034|FG001|Optional Extension Phase|Administrative problems|0|||
42047023|NCT00785785|75855033|FG000|Optional Extension Phase|Death|1|||
42047024|NCT00785785|75855034|FG001|Optional Extension Phase|Death|5|||
42047025|NCT00785785|75855033|FG000|Optional Extension Phase|Disease progression|22|||
42047026|NCT00785785|75855034|FG001|Optional Extension Phase|Disease progression|70|||
42291317|NCT02641379|76125028|FG001|Overall Study|Financial problems|1|||
42291318|NCT02641379|76125029|FG002|Overall Study|Financial problems|0|||
42291319|NCT02641379|76125030|FG003|Overall Study|Financial problems|0|||
42291320|NCT02641379|76125031|FG004|Overall Study|Financial problems|0|||
42291321|NCT02641379|76125032|FG005|Overall Study|Financial problems|0|||
42291322|NCT02641379|76125033|FG006|Overall Study|Financial problems|0|||
42291323|NCT02641379|76125034|FG007|Overall Study|Financial problems|0|||
42047027|NCT00785785|75855033|FG000|Optional Extension Phase|Protocol deviation|0|||
42047028|NCT00785785|75855034|FG001|Optional Extension Phase|Protocol deviation|2|||
42047029|NCT00785785|75855033|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
42047030|NCT00785785|75855034|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
42047031|NCT01077284|75855045|FG000|Overall Study|Adverse Event|2|||
42047032|NCT01077284|75855046|FG001|Overall Study|Adverse Event|0|||
42047033|NCT01077284|75855047|FG002|Overall Study|Adverse Event|1|||
42291324|NCT02641379|76125035|FG008|Overall Study|Financial problems|0|||
42291325|NCT02641379|76125036|FG009|Overall Study|Financial problems|0|||
42047034|NCT01077284|75855045|FG000|Overall Study|Lost to Follow-up|1|||
42291326|NCT02641379|76125037|FG010|Overall Study|Financial problems|0|||
42047035|NCT01077284|75855046|FG001|Overall Study|Lost to Follow-up|2|||
42047036|NCT01077284|75855047|FG002|Overall Study|Lost to Follow-up|0|||
42047037|NCT01077284|75855045|FG000|Overall Study|Withdrawal by Subject|2|||
42047038|NCT01077284|75855046|FG001|Overall Study|Withdrawal by Subject|3|||
42047039|NCT01077284|75855047|FG002|Overall Study|Withdrawal by Subject|1|||
42047040|NCT01077284|75855045|FG000|Overall Study|Other|0|||
42047041|NCT01077284|75855046|FG001|Overall Study|Other|0|||
42047042|NCT01077284|75855047|FG002|Overall Study|Other|1|||
42047043|NCT00826618|75855055|FG000|Overall Study|Withdrawal by Subject|1|||
42047044|NCT01077128|75855059|FG000|Overall Study|Adverse Event|8|||
42047045|NCT01077128|75855059|FG000|Overall Study|Lack of Efficacy|1|||
42047046|NCT01077128|75855059|FG000|Overall Study|Disease exacerbation|1|||
42047047|NCT01077128|75855059|FG000|Overall Study|Adverse event and consent withdrawal|1|||
42047048|NCT01077128|75855059|FG000|Overall Study|Adverse event and disease exacerbation|1|||
42047049|NCT01077128|75855059|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
42047050|NCT01077128|75855059|FG000|Overall Study|Other|54|||
42047051|NCT00826540|75855113|FG000|Overall Study|ineligible|3|||
42047052|NCT00826540|75855113|FG000|Overall Study|Withdrawal by Subject|1|||
42047053|NCT01077050|75855117|FG000|Overall Study|Subjects signed ICF could not be located|1|||
42047054|NCT01077050|75855117|FG000|Overall Study|Screen failure|8|||
42047055|NCT00592384|75855123|FG000|Overall Study|Withdrawal by Subject|5|||
42047056|NCT00592384|75855124|FG001|Overall Study|Withdrawal by Subject|6|||
42047057|NCT00846040|75855133|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
42047058|NCT00846040|75855134|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
42047059|NCT00846040|75855135|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
42047060|NCT00846040|75855133|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
42047061|NCT00846040|75855134|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
42047062|NCT00846040|75855135|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
42047063|NCT00826228|75855144|FG000|Overall Study|Withdrawal by Subject|1|||
42047064|NCT00825994|75855149|FG000|Overall Study|Withdrawal by Subject|2|||
42047065|NCT00825994|75855149|FG000|Overall Study|Lost to Follow-up|1|||
42047066|NCT00825994|75855149|FG000|Overall Study|Protocol Violation|1|||
42047067|NCT00825994|75855149|FG000|Overall Study|Placebo Responder at V2|1|||
42047068|NCT00825916|75855156|FG000|Overall Study|Lost to Follow-up|4|||
42047069|NCT00825916|75855157|FG001|Overall Study|Lost to Follow-up|2|||
42047070|NCT00825916|75855158|FG002|Overall Study|Lost to Follow-up|1|||
42047071|NCT00791479|75855205|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
42047072|NCT00791479|75855206|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
42047073|NCT00791479|75855207|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
42047074|NCT00791479|75855208|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
42047075|NCT00791479|75855209|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
42047076|NCT00791479|75855210|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
42047077|NCT00791479|75855205|FG000|Overall Study|Adverse Event|0|||
42047078|NCT00791479|75855206|FG001|Overall Study|Adverse Event|1|||
42047079|NCT00791479|75855207|FG002|Overall Study|Adverse Event|0|||
42047080|NCT00791479|75855208|FG003|Overall Study|Adverse Event|2|||
42047081|NCT00791479|75855209|FG004|Overall Study|Adverse Event|0|||
42047082|NCT00791479|75855210|FG005|Overall Study|Adverse Event|1|||
42047083|NCT00791479|75855205|FG000|Overall Study|Lost to Follow-up|0|||
42047084|NCT00791479|75855206|FG001|Overall Study|Lost to Follow-up|1|||
42047085|NCT00791479|75855207|FG002|Overall Study|Lost to Follow-up|0|||
42047086|NCT00791479|75855208|FG003|Overall Study|Lost to Follow-up|0|||
42047087|NCT00791479|75855209|FG004|Overall Study|Lost to Follow-up|0|||
42047088|NCT00791479|75855210|FG005|Overall Study|Lost to Follow-up|1|||
42047089|NCT00791479|75855205|FG000|Overall Study|Protocol Violation|2|||
42047090|NCT00791479|75855206|FG001|Overall Study|Protocol Violation|1|||
42047091|NCT00791479|75855207|FG002|Overall Study|Protocol Violation|0|||
42047092|NCT00791479|75855208|FG003|Overall Study|Protocol Violation|1|||
42047093|NCT00791479|75855209|FG004|Overall Study|Protocol Violation|0|||
42047094|NCT00791479|75855210|FG005|Overall Study|Protocol Violation|0|||
42047095|NCT00791479|75855205|FG000|Overall Study|Withdrawal by Subject|0|||
42047096|NCT00791479|75855206|FG001|Overall Study|Withdrawal by Subject|0|||
42047097|NCT00791479|75855207|FG002|Overall Study|Withdrawal by Subject|0|||
42047098|NCT00791479|75855208|FG003|Overall Study|Withdrawal by Subject|1|||
42047099|NCT00791479|75855209|FG004|Overall Study|Withdrawal by Subject|0|||
42047100|NCT00791479|75855210|FG005|Overall Study|Withdrawal by Subject|1|||
42047101|NCT00890097|75855234|FG000|Overall Study|Adverse Event|21|||
42047102|NCT00890097|75855235|FG001|Overall Study|Adverse Event|32|||
42047103|NCT00890097|75855236|FG002|Overall Study|Adverse Event|28|||
42047104|NCT00890097|75855234|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
42047105|NCT00890097|75855235|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
42047106|NCT00890097|75855236|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
42047107|NCT00890097|75855234|FG000|Overall Study|Withdrew Consent|9|||
42047108|NCT00890097|75855235|FG001|Overall Study|Withdrew Consent|6|||
42047109|NCT00890097|75855236|FG002|Overall Study|Withdrew Consent|9|||
42047110|NCT00890097|75855234|FG000|Overall Study|Lost to Follow-up|5|||
42047111|NCT00890097|75855235|FG001|Overall Study|Lost to Follow-up|5|||
42047112|NCT00890097|75855236|FG002|Overall Study|Lost to Follow-up|5|||
42047113|NCT00890097|75855234|FG000|Overall Study|Noncompliance|0|||
42047114|NCT00890097|75855235|FG001|Overall Study|Noncompliance|4|||
42047115|NCT00890097|75855236|FG002|Overall Study|Noncompliance|4|||
42047116|NCT00890097|75855234|FG000|Overall Study|Sponsor Decision|7|||
42047117|NCT00890097|75855235|FG001|Overall Study|Sponsor Decision|11|||
42047118|NCT00890097|75855236|FG002|Overall Study|Sponsor Decision|7|||
42047119|NCT00890097|75855234|FG000|Overall Study|Did not attend final visit|2|||
42047120|NCT00890097|75855235|FG001|Overall Study|Did not attend final visit|3|||
42047121|NCT00890097|75855236|FG002|Overall Study|Did not attend final visit|0|||
42047122|NCT00890097|75855234|FG000|Overall Study|Subject Decision|3|||
42047123|NCT00890097|75855235|FG001|Overall Study|Subject Decision|2|||
42047124|NCT00890097|75855236|FG002|Overall Study|Subject Decision|6|||
42047125|NCT00890097|75855234|FG000|Overall Study|Randomization Error|2|||
42047126|NCT00890097|75855235|FG001|Overall Study|Randomization Error|0|||
42047127|NCT00890097|75855236|FG002|Overall Study|Randomization Error|0|||
42047128|NCT00890097|75855234|FG000|Overall Study|Failed inclusion criteria|3|||
42047129|NCT00890097|75855235|FG001|Overall Study|Failed inclusion criteria|4|||
42047130|NCT00890097|75855236|FG002|Overall Study|Failed inclusion criteria|0|||
42047131|NCT00890097|75855234|FG000|Overall Study|Transportation|0|||
42047132|NCT00890097|75855235|FG001|Overall Study|Transportation|2|||
42047133|NCT00890097|75855236|FG002|Overall Study|Transportation|0|||
42047134|NCT00890097|75855234|FG000|Overall Study|Subject Moved|0|||
42047135|NCT00890097|75855235|FG001|Overall Study|Subject Moved|4|||
42047136|NCT00890097|75855236|FG002|Overall Study|Subject Moved|0|||
42047137|NCT00890097|75855234|FG000|Overall Study|Protocol Deviation|1|||
42047138|NCT00890097|75855235|FG001|Overall Study|Protocol Deviation|1|||
42047139|NCT00890097|75855236|FG002|Overall Study|Protocol Deviation|1|||
42047140|NCT00913458|75855244|FG000|Phase 1|Non-Responder|54|||
42047141|NCT00913458|75855245|FG001|Phase 1|Non-Responder|0|||
42047142|NCT00913458|75855246|FG002|Phase 1|Non-Responder|0|||
42047143|NCT00913458|75855247|FG003|Phase 1|Non-Responder|0|||
42047144|NCT00913458|75855248|FG004|Phase 1|Non-Responder|0|||
42047145|NCT00913458|75855249|FG005|Phase 1|Non-Responder|0|||
42047146|NCT00913458|75855250|FG006|Phase 1|Non-Responder|0|||
42047147|NCT00913458|75855244|FG000|Phase 1|Subject Request|17|||
42047148|NCT00913458|75855245|FG001|Phase 1|Subject Request|0|||
42047149|NCT00913458|75855246|FG002|Phase 1|Subject Request|0|||
42047150|NCT00913458|75855247|FG003|Phase 1|Subject Request|0|||
42047151|NCT00913458|75855248|FG004|Phase 1|Subject Request|0|||
42047152|NCT00913458|75855249|FG005|Phase 1|Subject Request|0|||
42047153|NCT00913458|75855250|FG006|Phase 1|Subject Request|0|||
42047154|NCT00913458|75855244|FG000|Phase 1|Adverse Event|20|||
42047155|NCT00913458|75855245|FG001|Phase 1|Adverse Event|0|||
42047156|NCT00913458|75855246|FG002|Phase 1|Adverse Event|0|||
42047157|NCT00913458|75855247|FG003|Phase 1|Adverse Event|0|||
42047158|NCT00913458|75855248|FG004|Phase 1|Adverse Event|0|||
42047159|NCT00913458|75855249|FG005|Phase 1|Adverse Event|0|||
42047160|NCT00913458|75855250|FG006|Phase 1|Adverse Event|0|||
42047161|NCT00913458|75855244|FG000|Phase 1|Lost to Follow-up|2|||
42047162|NCT00913458|75855245|FG001|Phase 1|Lost to Follow-up|0|||
42047163|NCT00913458|75855246|FG002|Phase 1|Lost to Follow-up|0|||
42047164|NCT00913458|75855247|FG003|Phase 1|Lost to Follow-up|0|||
42047165|NCT00913458|75855248|FG004|Phase 1|Lost to Follow-up|0|||
42047166|NCT00913458|75855249|FG005|Phase 1|Lost to Follow-up|0|||
42047167|NCT00913458|75855250|FG006|Phase 1|Lost to Follow-up|0|||
42047168|NCT00913458|75855244|FG000|Phase 1|Protocol Violation|10|||
42047169|NCT00913458|75855245|FG001|Phase 1|Protocol Violation|0|||
42047170|NCT00913458|75855246|FG002|Phase 1|Protocol Violation|0|||
42047171|NCT00913458|75855247|FG003|Phase 1|Protocol Violation|0|||
42047172|NCT00913458|75855248|FG004|Phase 1|Protocol Violation|0|||
42047173|NCT00913458|75855249|FG005|Phase 1|Protocol Violation|0|||
42047174|NCT00913458|75855250|FG006|Phase 1|Protocol Violation|0|||
42047175|NCT00913458|75855244|FG000|Phase 1|Sponsor|2|||
42047176|NCT00913458|75855245|FG001|Phase 1|Sponsor|0|||
42047177|NCT00913458|75855246|FG002|Phase 1|Sponsor|0|||
42047178|NCT00913458|75855247|FG003|Phase 1|Sponsor|0|||
42047179|NCT00913458|75855248|FG004|Phase 1|Sponsor|0|||
42047180|NCT00913458|75855249|FG005|Phase 1|Sponsor|0|||
42047181|NCT00913458|75855250|FG006|Phase 1|Sponsor|0|||
42047182|NCT00913458|75855244|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
42047183|NCT00913458|75855245|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
42047184|NCT00913458|75855246|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
42047185|NCT00913458|75855247|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
42047186|NCT00913458|75855248|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
42047187|NCT00913458|75855249|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
42047188|NCT00913458|75855250|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
42047189|NCT00913458|75855244|FG000|Phase 2|Non-Responder|0|||
42047190|NCT00913458|75855245|FG001|Phase 2|Non-Responder|5|||
42047191|NCT00913458|75855246|FG002|Phase 2|Non-Responder|7|||
42047192|NCT00913458|75855247|FG003|Phase 2|Non-Responder|12|||
42047193|NCT00913458|75855248|FG004|Phase 2|Non-Responder|0|||
42047194|NCT00913458|75855249|FG005|Phase 2|Non-Responder|0|||
42047195|NCT00913458|75855250|FG006|Phase 2|Non-Responder|0|||
42047196|NCT00913458|75855244|FG000|Phase 2|Subject Request|0|||
42047197|NCT00913458|75855245|FG001|Phase 2|Subject Request|0|||
42047198|NCT00913458|75855246|FG002|Phase 2|Subject Request|1|||
42047199|NCT00913458|75855247|FG003|Phase 2|Subject Request|2|||
42047200|NCT00913458|75855248|FG004|Phase 2|Subject Request|0|||
42047201|NCT00913458|75855249|FG005|Phase 2|Subject Request|0|||
42047202|NCT00913458|75855250|FG006|Phase 2|Subject Request|0|||
42047203|NCT00913458|75855244|FG000|Phase 2|Adverse Event|0|||
42047204|NCT00913458|75855245|FG001|Phase 2|Adverse Event|3|||
42047205|NCT00913458|75855246|FG002|Phase 2|Adverse Event|0|||
42047206|NCT00913458|75855247|FG003|Phase 2|Adverse Event|1|||
42047207|NCT00913458|75855248|FG004|Phase 2|Adverse Event|0|||
42047208|NCT00913458|75855249|FG005|Phase 2|Adverse Event|0|||
42047209|NCT00913458|75855250|FG006|Phase 2|Adverse Event|0|||
42047210|NCT00913458|75855244|FG000|Phase 2|Lost to Follow-up|0|||
42047211|NCT00913458|75855245|FG001|Phase 2|Lost to Follow-up|0|||
42047212|NCT00913458|75855246|FG002|Phase 2|Lost to Follow-up|0|||
42047213|NCT00913458|75855247|FG003|Phase 2|Lost to Follow-up|1|||
42047214|NCT00913458|75855248|FG004|Phase 2|Lost to Follow-up|0|||
42047215|NCT00913458|75855249|FG005|Phase 2|Lost to Follow-up|0|||
42047216|NCT00913458|75855250|FG006|Phase 2|Lost to Follow-up|0|||
42047217|NCT00913458|75855244|FG000|Phase 2|Protocol Violation|0|||
42047218|NCT00913458|75855245|FG001|Phase 2|Protocol Violation|2|||
42047219|NCT00913458|75855246|FG002|Phase 2|Protocol Violation|0|||
42047220|NCT00913458|75855247|FG003|Phase 2|Protocol Violation|0|||
42047221|NCT00913458|75855248|FG004|Phase 2|Protocol Violation|0|||
42047222|NCT00913458|75855249|FG005|Phase 2|Protocol Violation|0|||
42047223|NCT00913458|75855250|FG006|Phase 2|Protocol Violation|0|||
42047224|NCT00913458|75855244|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
42047225|NCT00913458|75855245|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
42047226|NCT00913458|75855246|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
42047227|NCT00913458|75855247|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
42047228|NCT00913458|75855248|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
42047229|NCT00913458|75855249|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
42047230|NCT00913458|75855250|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
42047231|NCT00913458|75855244|FG000|Phase 3|Adverse Event|0|||
42047232|NCT00913458|75855245|FG001|Phase 3|Adverse Event|0|||
42047233|NCT00913458|75855246|FG002|Phase 3|Adverse Event|0|||
42047234|NCT00913458|75855247|FG003|Phase 3|Adverse Event|0|||
42047235|NCT00913458|75855248|FG004|Phase 3|Adverse Event|5|||
42047236|NCT00913458|75855249|FG005|Phase 3|Adverse Event|4|||
42047237|NCT00913458|75855250|FG006|Phase 3|Adverse Event|1|||
42047238|NCT00913458|75855244|FG000|Phase 3|Lost to Follow-up|0|||
42047239|NCT00913458|75855245|FG001|Phase 3|Lost to Follow-up|0|||
42047240|NCT00913458|75855246|FG002|Phase 3|Lost to Follow-up|0|||
42047241|NCT00913458|75855247|FG003|Phase 3|Lost to Follow-up|0|||
42047242|NCT00913458|75855248|FG004|Phase 3|Lost to Follow-up|2|||
42047243|NCT00913458|75855249|FG005|Phase 3|Lost to Follow-up|0|||
42047244|NCT00913458|75855250|FG006|Phase 3|Lost to Follow-up|0|||
42047245|NCT00913458|75855244|FG000|Phase 3|Non-Responder|0|||
42047246|NCT00913458|75855245|FG001|Phase 3|Non-Responder|0|||
42047247|NCT00913458|75855246|FG002|Phase 3|Non-Responder|0|||
42047248|NCT00913458|75855247|FG003|Phase 3|Non-Responder|0|||
42047249|NCT00913458|75855248|FG004|Phase 3|Non-Responder|0|||
42047250|NCT00913458|75855249|FG005|Phase 3|Non-Responder|1|||
42172729|NCT02946580|75979619|FG001|Overall Study|Adverse Event|2|||
42356859|NCT01393743|76202034|FG002|Extension Phase|Participant choice|16|||
42047251|NCT00913458|75855250|FG006|Phase 3|Non-Responder|3|||
42047252|NCT00913458|75855244|FG000|Phase 3|Withdrawal by Subject|0|||
42047253|NCT00913458|75855245|FG001|Phase 3|Withdrawal by Subject|0|||
42047254|NCT00913458|75855246|FG002|Phase 3|Withdrawal by Subject|0|||
42047255|NCT00913458|75855247|FG003|Phase 3|Withdrawal by Subject|0|||
42047256|NCT00913458|75855248|FG004|Phase 3|Withdrawal by Subject|1|||
42047257|NCT00913458|75855249|FG005|Phase 3|Withdrawal by Subject|2|||
42047258|NCT00913458|75855250|FG006|Phase 3|Withdrawal by Subject|0|||
42047259|NCT00913458|75855244|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
42047260|NCT00913458|75855245|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
42047261|NCT00913458|75855246|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
42047262|NCT00913458|75855247|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
42047263|NCT00913458|75855248|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
42047264|NCT00913458|75855249|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
42047265|NCT00913458|75855250|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
42047266|NCT00785707|75855267|FG000|Overall Study|Lost to Follow-up|7|||
42172730|NCT02946580|75979618|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
42047267|NCT00913380|75855273|FG000|Clinical Outcomes|Lost to Follow-up|6|||
42047268|NCT00913380|75855274|FG001|Clinical Outcomes|Lost to Follow-up|6|||
42047269|NCT00785629|75855284|FG000|Overall Study|Adverse Event|2|||
42047270|NCT00785629|75855285|FG001|Overall Study|Adverse Event|1|||
42047271|NCT00785629|75855286|FG002|Overall Study|Adverse Event|1|||
42047272|NCT00785629|75855287|FG003|Overall Study|Adverse Event|5|||
42047273|NCT00785629|75855284|FG000|Overall Study|Protocol Violation|1|||
42047274|NCT00785629|75855285|FG001|Overall Study|Protocol Violation|2|||
42047275|NCT00785629|75855286|FG002|Overall Study|Protocol Violation|4|||
42047276|NCT00785629|75855287|FG003|Overall Study|Protocol Violation|5|||
42047277|NCT00785629|75855284|FG000|Overall Study|administrative decision|5|||
42047278|NCT00785629|75855285|FG001|Overall Study|administrative decision|1|||
42047279|NCT00785629|75855286|FG002|Overall Study|administrative decision|3|||
42047280|NCT00785629|75855287|FG003|Overall Study|administrative decision|4|||
42047281|NCT00785629|75855284|FG000|Overall Study|Withdrawal by Subject|0|||
42047282|NCT00785629|75855285|FG001|Overall Study|Withdrawal by Subject|1|||
42047283|NCT00785629|75855286|FG002|Overall Study|Withdrawal by Subject|2|||
42047284|NCT00785629|75855287|FG003|Overall Study|Withdrawal by Subject|2|||
42047285|NCT00916344|75855295|FG000|Overall Study|Death|2|||
42047286|NCT00916344|75855295|FG000|Overall Study|ICD upgrade|1|||
42047287|NCT00916344|75855295|FG000|Overall Study|Drop-out|5|||
42047288|NCT00913770|75855302|FG000|Overall Study|Unable to contact|24|||
42047289|NCT00913770|75855303|FG001|Overall Study|Unable to contact|19|||
42047290|NCT00913770|75855304|FG002|Overall Study|Unable to contact|13|||
42047291|NCT00913770|75855302|FG000|Overall Study|Refused|11|||
42047292|NCT00913770|75855303|FG001|Overall Study|Refused|10|||
42047293|NCT00913770|75855304|FG002|Overall Study|Refused|8|||
42047294|NCT00780559|75855314|FG000|Overall Study|Lost to Follow-up|2|||
42047295|NCT00780559|75855315|FG001|Overall Study|Lost to Follow-up|7|||
42047296|NCT00780559|75855314|FG000|Overall Study|Death|1|||
42047297|NCT00780559|75855315|FG001|Overall Study|Death|0|||
42047298|NCT00912912|75855323|FG000|Overall Study|Withdrawal by Subject|1|||
42047299|NCT00912912|75855323|FG000|Overall Study|Disease Progression|3|||
42047300|NCT00889005|75855329|FG000|Overall Study|Lost to Follow-up|4|||
42047301|NCT00889005|75855330|FG001|Overall Study|Lost to Follow-up|2|||
42047302|NCT00889005|75855329|FG000|Overall Study|Withdrawal by Subject|4|||
42047303|NCT00889005|75855330|FG001|Overall Study|Withdrawal by Subject|0|||
42047304|NCT00779857|75855336|FG000|Overall Study|Death|1|||
42047305|NCT00779857|75855336|FG000|Overall Study|Withdrawal by Subject|3|||
42047306|NCT00779857|75855336|FG000|Overall Study|Missed Visit|2|||
42047307|NCT00913692|75855340|FG000|Screening (4 Months)|Physician Decision|3|||
42047308|NCT00913692|75855340|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
42047309|NCT00913692|75855340|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
42047310|NCT00784927|75855347|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
42047311|NCT00784927|75855347|FG000|Overall Study|Protocol Violation|1|||
42047312|NCT00784927|75855347|FG000|Overall Study|Ineligible|1|||
42047313|NCT00779779|75855352|FG000|Overall Study|Adverse Event|1|||
42047314|NCT00779779|75855352|FG000|Overall Study|Protocol Violation|14|||
42047315|NCT00779779|75855352|FG000|Overall Study|Withdrawal by Subject|4|||
42047316|NCT00779779|75855352|FG000|Overall Study|Lost to Follow-up|5|||
42047317|NCT00845728|75855358|FG000|Overall Study|Abnormal laboratory value (s)|2|||
42047318|NCT00845728|75855359|FG001|Overall Study|Abnormal laboratory value (s)|2|||
42047319|NCT00845728|75855358|FG000|Overall Study|Patient's inability to use the device|4|||
42047320|NCT00845728|75855359|FG001|Overall Study|Patient's inability to use the device|6|||
42047321|NCT00845728|75855358|FG000|Overall Study|Abnormal test procedure result (s)|7|||
42047322|NCT00845728|75855359|FG001|Overall Study|Abnormal test procedure result (s)|2|||
42047323|NCT00845728|75855358|FG000|Overall Study|Lost to Follow-up|22|||
42047324|NCT00845728|75855359|FG001|Overall Study|Lost to Follow-up|13|||
42047325|NCT00845728|75855358|FG000|Overall Study|Death|24|||
42047326|NCT00845728|75855359|FG001|Overall Study|Death|26|||
42047327|NCT00845728|75855358|FG000|Overall Study|Administrative Problems|34|||
42047328|NCT00845728|75855359|FG001|Overall Study|Administrative Problems|26|||
42047329|NCT00845728|75855358|FG000|Overall Study|Protocol Violation|36|||
42047330|NCT00845728|75855359|FG001|Overall Study|Protocol Violation|24|||
42047331|NCT00845728|75855358|FG000|Overall Study|Lack of Efficacy|51|||
42047332|NCT00845728|75855359|FG001|Overall Study|Lack of Efficacy|39|||
42047333|NCT00845728|75855358|FG000|Overall Study|Adverse Event|101|||
42047334|NCT00845728|75855359|FG001|Overall Study|Adverse Event|96|||
42047335|NCT00845728|75855358|FG000|Overall Study|Withdrawal by Subject|105|||
42047336|NCT00845728|75855359|FG001|Overall Study|Withdrawal by Subject|108|||
42047337|NCT00779467|75855369|FG000|Overall Study|Lack of Efficacy|11|||
42047338|NCT00779467|75855370|FG001|Overall Study|Lack of Efficacy|2|||
42047339|NCT00779467|75855371|FG002|Overall Study|Lack of Efficacy|6|||
42047340|NCT00779467|75855372|FG003|Overall Study|Lack of Efficacy|11|||
42047341|NCT00779467|75855369|FG000|Overall Study|failed inclusion criteria|3|||
42047342|NCT00779467|75855370|FG001|Overall Study|failed inclusion criteria|3|||
42047343|NCT00779467|75855371|FG002|Overall Study|failed inclusion criteria|1|||
42047344|NCT00779467|75855372|FG003|Overall Study|failed inclusion criteria|2|||
42047345|NCT00779467|75855369|FG000|Overall Study|missing data|1|||
42047346|NCT00779467|75855370|FG001|Overall Study|missing data|0|||
42047347|NCT00779467|75855371|FG002|Overall Study|missing data|1|||
42047348|NCT00779467|75855372|FG003|Overall Study|missing data|4|||
42047349|NCT00779467|75855369|FG000|Overall Study|technical issue|0|||
42047350|NCT00779467|75855370|FG001|Overall Study|technical issue|0|||
42047351|NCT00779467|75855371|FG002|Overall Study|technical issue|2|||
42047352|NCT00779467|75855372|FG003|Overall Study|technical issue|1|||
42047353|NCT00779467|75855369|FG000|Overall Study|unavailable research staff|0|||
42047354|NCT00779467|75855370|FG001|Overall Study|unavailable research staff|0|||
42047355|NCT00779467|75855371|FG002|Overall Study|unavailable research staff|0|||
42047356|NCT00779467|75855372|FG003|Overall Study|unavailable research staff|1|||
42047357|NCT00778921|75855385|FG000|Overall Study|Adverse Event|9|||
42047358|NCT00778921|75855386|FG001|Overall Study|Adverse Event|10|||
42047359|NCT00778921|75855387|FG002|Overall Study|Adverse Event|14|||
42047360|NCT00778921|75855385|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
42047361|NCT00778921|75855386|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
42047362|NCT00778921|75855387|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
42047363|NCT00778921|75855385|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
42047364|NCT00778921|75855386|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
42047365|NCT00778921|75855387|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
42047366|NCT00778921|75855385|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
42047367|NCT00778921|75855386|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
42047368|NCT00778921|75855387|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
42047369|NCT00778921|75855385|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
42047370|NCT00778921|75855386|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
42047371|NCT00778921|75855387|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
42047372|NCT00778921|75855385|FG000|Overall Study|Patient withdrew request|3|||
42047373|NCT00778921|75855386|FG001|Overall Study|Patient withdrew request|1|||
42047374|NCT00778921|75855387|FG002|Overall Study|Patient withdrew request|6|||
42047375|NCT00778921|75855385|FG000|Overall Study|Lost to Follow-up|0|||
42047376|NCT00778921|75855386|FG001|Overall Study|Lost to Follow-up|2|||
42047377|NCT00778921|75855387|FG002|Overall Study|Lost to Follow-up|1|||
42047378|NCT00778921|75855385|FG000|Overall Study|Administrative Problems|1|||
42047379|NCT00778921|75855386|FG001|Overall Study|Administrative Problems|2|||
42047380|NCT00778921|75855387|FG002|Overall Study|Administrative Problems|0|||
42047381|NCT00778921|75855385|FG000|Overall Study|Protocol Violation|3|||
42047382|NCT00778921|75855386|FG001|Overall Study|Protocol Violation|0|||
42047383|NCT00778921|75855387|FG002|Overall Study|Protocol Violation|2|||
42047384|NCT00778921|75855385|FG000|Overall Study|Not treated|0|||
42047385|NCT00778921|75855386|FG001|Overall Study|Not treated|2|||
42047386|NCT00778921|75855387|FG002|Overall Study|Not treated|2|||
42047387|NCT00915876|75855397|FG000|Overall Study|Adverse Event|0|||
42047388|NCT00915876|75855398|FG001|Overall Study|Adverse Event|1|||
42047389|NCT00776659|75855404|FG000|Overall Study|Lost to Follow-up|15|||
42047390|NCT00776659|75855404|FG000|Overall Study|Withdrawal by Subject|10|||
42047391|NCT00776659|75855404|FG000|Overall Study|Study Terminated by Sponsor|1|||
42047392|NCT00825682|75855410|FG000|Overall Study|personal reasons/ inconvenience|13|||
42047393|NCT00825682|75855411|FG001|Overall Study|personal reasons/ inconvenience|5|||
42047394|NCT00833794|75855420|FG000|Open-label Phase|Adverse Event|225|||
42047395|NCT00833794|75855421|FG001|Open-label Phase|Adverse Event|0|||
42047396|NCT00833794|75855420|FG000|Open-label Phase|Lack of Efficacy|28|||
42047397|NCT00833794|75855421|FG001|Open-label Phase|Lack of Efficacy|0|||
42172731|NCT02946580|75979619|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
42172732|NCT00323609|75979627|FG000|Overall Study|Death|16|||
42172733|NCT00323609|75979628|FG001|Overall Study|Death|21|||
42172734|NCT00323609|75979629|FG002|Overall Study|Death|0|||
42172735|NCT00323609|75979630|FG003|Overall Study|Death|0|||
42172736|NCT00323609|75979627|FG000|Overall Study|Lost to Follow-up|9|||
42172737|NCT00323609|75979628|FG001|Overall Study|Lost to Follow-up|10|||
42172738|NCT00323609|75979629|FG002|Overall Study|Lost to Follow-up|0|||
42047398|NCT00833794|75855420|FG000|Open-label Phase|Withdrawal by Subject|48|||
42047399|NCT00833794|75855421|FG001|Open-label Phase|Withdrawal by Subject|0|||
42047400|NCT00833794|75855420|FG000|Open-label Phase|Physician Decision|20|||
42047401|NCT00833794|75855421|FG001|Open-label Phase|Physician Decision|0|||
42047402|NCT00833794|75855420|FG000|Open-label Phase|Administrative reason|1|||
42047403|NCT00833794|75855421|FG001|Open-label Phase|Administrative reason|0|||
42047404|NCT00833794|75855420|FG000|Open-label Phase|Protocol Violation|47|||
42047405|NCT00833794|75855421|FG001|Open-label Phase|Protocol Violation|0|||
42047406|NCT00833794|75855420|FG000|Open-label Phase|Did not complete wash-out period|12|||
42047407|NCT00833794|75855421|FG001|Open-label Phase|Did not complete wash-out period|0|||
42047408|NCT00833794|75855420|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
42047409|NCT00833794|75855421|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
42047410|NCT00833794|75855420|FG000|Double-blind Phase|Adverse Event|44|||
42047411|NCT00833794|75855421|FG001|Double-blind Phase|Adverse Event|11|||
42047412|NCT00833794|75855420|FG000|Double-blind Phase|Lack of Efficacy|34|||
42047413|NCT00833794|75855421|FG001|Double-blind Phase|Lack of Efficacy|22|||
42047414|NCT00833794|75855420|FG000|Double-blind Phase|Withdrawal by Subject|23|||
42047415|NCT00833794|75855421|FG001|Double-blind Phase|Withdrawal by Subject|6|||
42047416|NCT00833794|75855420|FG000|Double-blind Phase|Physician Decision|4|||
42047417|NCT00833794|75855421|FG001|Double-blind Phase|Physician Decision|7|||
42356860|NCT01393743|76202032|FG000|Extension Phase|Inadequate therapeutic effect|0|||
42047418|NCT00833794|75855420|FG000|Double-blind Phase|Administrative reason|1|||
42047419|NCT00833794|75855421|FG001|Double-blind Phase|Administrative reason|3|||
42047420|NCT00912288|75855431|FG000|Overall Study|Death|0|||
42047421|NCT00912288|75855432|FG001|Overall Study|Death|1|||
42047422|NCT00912288|75855431|FG000|Overall Study|Adverse Event|1|||
42047423|NCT00912288|75855432|FG001|Overall Study|Adverse Event|1|||
42047424|NCT00912288|75855431|FG000|Overall Study|Lost to Follow-up|1|||
42047425|NCT00912288|75855432|FG001|Overall Study|Lost to Follow-up|0|||
42047426|NCT00912288|75855431|FG000|Overall Study|Protocol Violation|1|||
42047427|NCT00912288|75855432|FG001|Overall Study|Protocol Violation|0|||
42047428|NCT00912288|75855431|FG000|Overall Study|Withdrawal by Subject|3|||
42047429|NCT00912288|75855432|FG001|Overall Study|Withdrawal by Subject|3|||
42047430|NCT00912288|75855431|FG000|Overall Study|Study terminated by sponsor|34|||
42047431|NCT00912288|75855432|FG001|Overall Study|Study terminated by sponsor|35|||
42047432|NCT00912288|75855431|FG000|Overall Study|Other|1|||
42047433|NCT00912288|75855432|FG001|Overall Study|Other|0|||
42047434|NCT00778375|75855438|FG000|Overall Study|Ineligible|3|||
42047435|NCT00777829|75855444|FG000|Overall Study|Withdrawal by Subject|0|||
42047436|NCT00777829|75855445|FG001|Overall Study|Withdrawal by Subject|2|||
42047437|NCT00775021|75855453|FG000|First Intervention|Lost to Follow-up|1|||
42047438|NCT00775021|75855454|FG001|First Intervention|Lost to Follow-up|0|||
42047439|NCT00775021|75855453|FG000|Second Intervention|Adverse Event|0|||
42047440|NCT00775021|75855454|FG001|Second Intervention|Adverse Event|1|||
42047441|NCT00777205|75855462|FG000|Overall Study|Lost to Follow-up|25|||
42047442|NCT00777205|75855463|FG001|Overall Study|Lost to Follow-up|9|||
42047443|NCT00777205|75855462|FG000|Overall Study|Withdrawal by Subject|6|||
42047444|NCT00777205|75855463|FG001|Overall Study|Withdrawal by Subject|4|||
42047445|NCT00777205|75855462|FG000|Overall Study|Death|0|||
42047446|NCT00777205|75855463|FG001|Overall Study|Death|2|||
42047447|NCT00777205|75855462|FG000|Overall Study|Protocol Violation|0|||
42047448|NCT00777205|75855463|FG001|Overall Study|Protocol Violation|56|||
42047449|NCT00833638|75855474|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
42047450|NCT00833638|75855475|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
42047451|NCT00833638|75855476|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
42047452|NCT00833638|75855474|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
42047453|NCT00833638|75855475|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
42047454|NCT00833638|75855476|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
42047455|NCT00833638|75855474|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
42047456|NCT00833638|75855475|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
42047457|NCT00833638|75855476|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
42047458|NCT00833638|75855474|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
42047459|NCT00833638|75855475|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
42047460|NCT00833638|75855476|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
42047461|NCT00833638|75855474|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
42047462|NCT00833638|75855475|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
42047463|NCT00833638|75855476|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
42047464|NCT00833638|75855474|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
42047465|NCT00833638|75855475|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
42047466|NCT00833638|75855476|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
42047467|NCT00833638|75855474|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
42047468|NCT00833638|75855475|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
42047469|NCT00833638|75855476|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
42047470|NCT00833638|75855474|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
42047471|NCT00833638|75855475|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
42047472|NCT00833638|75855476|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
42047473|NCT00833638|75855474|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
42047474|NCT00833638|75855475|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
42047475|NCT00833638|75855476|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
42047476|NCT01041404|75855494|FG000|Overall Study|Adverse Event|45|||
42047477|NCT01041404|75855495|FG001|Overall Study|Adverse Event|35|||
42047478|NCT01041404|75855494|FG000|Overall Study|Lack of Efficacy|200|||
42047479|NCT01041404|75855495|FG001|Overall Study|Lack of Efficacy|210|||
42047480|NCT01041404|75855494|FG000|Overall Study|Violation of Selection Criteria|0|||
42047481|NCT01041404|75855495|FG001|Overall Study|Violation of Selection Criteria|1|||
42047482|NCT01041404|75855494|FG000|Overall Study|Protocol Violation|4|||
42047483|NCT01041404|75855495|FG001|Overall Study|Protocol Violation|0|||
42047484|NCT01041404|75855494|FG000|Overall Study|Withdrawal by Subject|29|||
42047485|NCT01041404|75855495|FG001|Overall Study|Withdrawal by Subject|23|||
42047486|NCT01041404|75855494|FG000|Overall Study|Failure to Return|1|||
42047487|NCT01041404|75855495|FG001|Overall Study|Failure to Return|2|||
42047488|NCT01041404|75855494|FG000|Overall Study|Other|11|||
42047489|NCT01041404|75855495|FG001|Overall Study|Other|23|||
42047490|NCT00777049|75855506|FG000|Overall Study|Withdrawal by Subject|1|||
42047491|NCT00777049|75855507|FG001|Overall Study|Withdrawal by Subject|0|||
42047492|NCT00777049|75855506|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
42047493|NCT00777049|75855507|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
42047494|NCT00774787|75855513|FG000|Overall Study|Lost to Follow-up|1|||
42047495|NCT00888927|75855521|FG000|Overall Study|Adverse Event|0|||
42047496|NCT00888927|75855522|FG001|Overall Study|Adverse Event|0|||
42047497|NCT00888927|75855523|FG002|Overall Study|Adverse Event|0|||
42047498|NCT00888927|75855524|FG003|Overall Study|Adverse Event|1|||
42047499|NCT00888927|75855521|FG000|Overall Study|Withdrawal of consent|0|||
42047500|NCT00888927|75855522|FG001|Overall Study|Withdrawal of consent|0|||
42047501|NCT00888927|75855523|FG002|Overall Study|Withdrawal of consent|0|||
42047502|NCT00888927|75855524|FG003|Overall Study|Withdrawal of consent|1|||
42047503|NCT01040780|75855536|FG000|Overall Study|Protocol Violation|1|||
42047504|NCT01040780|75855537|FG001|Overall Study|Protocol Violation|3|||
42047505|NCT00888849|75855548|FG000|Overall Study|Death|4|||
42047506|NCT00888849|75855549|FG001|Overall Study|Death|7|||
42047507|NCT00888849|75855548|FG000|Overall Study|Lost to Follow-up|1|||
42047508|NCT00888849|75855549|FG001|Overall Study|Lost to Follow-up|2|||
42047509|NCT01059812|75855557|FG000|Overall Study|Adverse Event|9|||
42047510|NCT01059812|75855558|FG001|Overall Study|Adverse Event|5|||
42047511|NCT01059812|75855557|FG000|Overall Study|Lack of Efficacy|2|||
42047512|NCT01059812|75855558|FG001|Overall Study|Lack of Efficacy|2|||
42047513|NCT01059812|75855557|FG000|Overall Study|Protocol Violation|3|||
42047514|NCT01059812|75855558|FG001|Overall Study|Protocol Violation|1|||
42047515|NCT01059812|75855557|FG000|Overall Study|Withdrawal Criteria|9|||
42047516|NCT01059812|75855558|FG001|Overall Study|Withdrawal Criteria|4|||
42047517|NCT01059812|75855557|FG000|Overall Study|Unclassified|14|||
42047518|NCT01059812|75855558|FG001|Overall Study|Unclassified|4|||
42047519|NCT00888615|75855564|FG000|Overall Study|No treatment|2|||
42047520|NCT00845650|75855574|FG000|Overall Study|Withdrawal by Subject|0|||
42047521|NCT00845650|75855575|FG001|Overall Study|Withdrawal by Subject|0|||
42047522|NCT00845650|75855576|FG002|Overall Study|Withdrawal by Subject|0|||
42047523|NCT00845650|75855577|FG003|Overall Study|Withdrawal by Subject|0|||
42047524|NCT00845650|75855578|FG004|Overall Study|Withdrawal by Subject|2|||
42047525|NCT00845650|75855579|FG005|Overall Study|Withdrawal by Subject|0|||
42047526|NCT00845650|75855574|FG000|Overall Study|Lost to Follow-up|0|||
42047527|NCT00845650|75855575|FG001|Overall Study|Lost to Follow-up|0|||
42047528|NCT00845650|75855576|FG002|Overall Study|Lost to Follow-up|3|||
42047529|NCT00845650|75855577|FG003|Overall Study|Lost to Follow-up|1|||
42047530|NCT00845650|75855578|FG004|Overall Study|Lost to Follow-up|0|||
42047531|NCT00845650|75855579|FG005|Overall Study|Lost to Follow-up|1|||
42047532|NCT00845650|75855574|FG000|Overall Study|Sponsor hold on dosing|0|||
42047533|NCT00845650|75855575|FG001|Overall Study|Sponsor hold on dosing|0|||
42047534|NCT00845650|75855576|FG002|Overall Study|Sponsor hold on dosing|0|||
42047535|NCT00845650|75855577|FG003|Overall Study|Sponsor hold on dosing|0|||
42047536|NCT00845650|75855578|FG004|Overall Study|Sponsor hold on dosing|1|||
42047537|NCT00845650|75855579|FG005|Overall Study|Sponsor hold on dosing|1|||
42047538|NCT00845650|75855574|FG000|Overall Study|Unable to access IV line|1|||
42047539|NCT00845650|75855575|FG001|Overall Study|Unable to access IV line|0|||
42047540|NCT00845650|75855576|FG002|Overall Study|Unable to access IV line|0|||
42047541|NCT00845650|75855577|FG003|Overall Study|Unable to access IV line|0|||
42047542|NCT00845650|75855578|FG004|Overall Study|Unable to access IV line|0|||
42047543|NCT00845650|75855579|FG005|Overall Study|Unable to access IV line|0|||
42047544|NCT00888381|75855597|FG000|Overall Study|Lost to Follow-up|0|||
42047545|NCT00888381|75855598|FG001|Overall Study|Lost to Follow-up|1|||
42047546|NCT00887913|75855604|FG000|Overall Study|Withdrawal by Subject|6|||
42047547|NCT00833560|75855608|FG000|Overall Study|Toxicity|13|||
42047548|NCT00833560|75855608|FG000|Overall Study|Adverse Event|11|||
42172739|NCT00323609|75979630|FG003|Overall Study|Lost to Follow-up|0|||
42172740|NCT00323609|75979627|FG000|Overall Study|Physician Decision|2|||
42172741|NCT00323609|75979628|FG001|Overall Study|Physician Decision|0|||
42172742|NCT00323609|75979629|FG002|Overall Study|Physician Decision|0|||
42172743|NCT00323609|75979630|FG003|Overall Study|Physician Decision|1|||
42172744|NCT00323609|75979627|FG000|Overall Study|Withdrawal by Subject|11|||
42356861|NCT01393743|76202033|FG001|Extension Phase|Inadequate therapeutic effect|0|||
42047549|NCT00833560|75855608|FG000|Overall Study|Protocol Violation|6|||
42047550|NCT00833560|75855608|FG000|Overall Study|Lack of Efficacy|4|||
42047551|NCT00833560|75855608|FG000|Overall Study|Death|2|||
42047552|NCT00833560|75855608|FG000|Overall Study|Pregression of other disease|1|||
42047553|NCT00833560|75855608|FG000|Overall Study|Other|5|||
42047554|NCT00887679|75855612|FG000|Overall Study|Withdrawal by Subject|1|||
42047555|NCT00887679|75855612|FG000|Overall Study|Lost to Follow-up|4|||
42047556|NCT00887679|75855612|FG000|Overall Study|Physician Decision|5|||
42047557|NCT00833482|75855619|FG000|Days 11-20|Adverse Event|0|||
42047558|NCT00833482|75855620|FG001|Days 11-20|Adverse Event|2|||
42047559|NCT00833482|75855621|FG002|Days 11-20|Adverse Event|0|||
42047560|NCT00833482|75855622|FG003|Days 11-20|Adverse Event|0|||
42047561|NCT00833482|75855623|FG004|Days 11-20|Adverse Event|0|||
42047562|NCT00833482|75855624|FG005|Days 11-20|Adverse Event|0|||
42172745|NCT00323609|75979628|FG001|Overall Study|Withdrawal by Subject|23|||
42047563|NCT00833482|75855619|FG000|Days 11-20|Withdrawal by Subject|0|||
42047564|NCT00833482|75855620|FG001|Days 11-20|Withdrawal by Subject|1|||
42047565|NCT00833482|75855621|FG002|Days 11-20|Withdrawal by Subject|0|||
42047566|NCT00833482|75855622|FG003|Days 11-20|Withdrawal by Subject|0|||
42047567|NCT00833482|75855623|FG004|Days 11-20|Withdrawal by Subject|0|||
42047568|NCT00833482|75855624|FG005|Days 11-20|Withdrawal by Subject|0|||
42047569|NCT00833482|75855619|FG000|Days 21-30|Adverse Event|0|||
42047570|NCT00833482|75855620|FG001|Days 21-30|Adverse Event|0|||
42047571|NCT00833482|75855621|FG002|Days 21-30|Adverse Event|1|||
42047572|NCT00833482|75855622|FG003|Days 21-30|Adverse Event|0|||
42047573|NCT00833482|75855623|FG004|Days 21-30|Adverse Event|0|||
42047574|NCT00833482|75855624|FG005|Days 21-30|Adverse Event|0|||
42047575|NCT00833482|75855619|FG000|Days 21-30|Withdrawal by Subject|0|||
42047576|NCT00833482|75855620|FG001|Days 21-30|Withdrawal by Subject|0|||
42047577|NCT00833482|75855621|FG002|Days 21-30|Withdrawal by Subject|0|||
42047578|NCT00833482|75855622|FG003|Days 21-30|Withdrawal by Subject|0|||
42047579|NCT00833482|75855623|FG004|Days 21-30|Withdrawal by Subject|1|||
42047580|NCT00833482|75855624|FG005|Days 21-30|Withdrawal by Subject|0|||
42047581|NCT00845182|75855649|FG000|Overall Study|Lost to Follow-up|3|||
42047582|NCT00845182|75855650|FG001|Overall Study|Lost to Follow-up|3|||
42047583|NCT00845182|75855651|FG002|Overall Study|Lost to Follow-up|4|||
42047584|NCT00845182|75855649|FG000|Overall Study|Adverse Event|0|||
42047585|NCT00845182|75855650|FG001|Overall Study|Adverse Event|1|||
42047586|NCT00845182|75855651|FG002|Overall Study|Adverse Event|1|||
42047587|NCT00845182|75855649|FG000|Overall Study|Physician Decision|0|||
42047588|NCT00845182|75855650|FG001|Overall Study|Physician Decision|0|||
42047589|NCT00845182|75855651|FG002|Overall Study|Physician Decision|1|||
42047590|NCT00833248|75855665|FG000|Overall Study|Adverse Event|3|||
42047591|NCT00833248|75855666|FG001|Overall Study|Adverse Event|0|||
42047592|NCT00833248|75855665|FG000|Overall Study|Protocol Violation|1|||
42047593|NCT00833248|75855666|FG001|Overall Study|Protocol Violation|2|||
42047594|NCT00833248|75855665|FG000|Overall Study|Withdrawal by Subject|0|||
42047595|NCT00833248|75855666|FG001|Overall Study|Withdrawal by Subject|1|||
42047596|NCT00887289|75855672|FG000|Overall Study|Lack of Efficacy|14|||
42047597|NCT00887289|75855672|FG000|Overall Study|Adverse Event|27|||
42047598|NCT00887289|75855672|FG000|Overall Study|Withdrawal by Subject|26|||
42047599|NCT00887289|75855672|FG000|Overall Study|Lost to Follow-up|8|||
42047600|NCT00887289|75855672|FG000|Overall Study|Other|20|||
42047601|NCT00833092|75855678|FG000|Overall Study|Withdrawal by Subject|2|||
42047602|NCT00833092|75855679|FG001|Overall Study|Withdrawal by Subject|3|||
42047603|NCT00833092|75855678|FG000|Overall Study|Protocol Violation|2|||
42047604|NCT00833092|75855679|FG001|Overall Study|Protocol Violation|1|||
42047605|NCT00833092|75855678|FG000|Overall Study|Diarrhea|0|||
42172746|NCT00323609|75979629|FG002|Overall Study|Withdrawal by Subject|4|||
42172747|NCT00323609|75979630|FG003|Overall Study|Withdrawal by Subject|4|||
42172748|NCT00323609|75979627|FG000|Overall Study|Other non-VCF-related medical condition|3|||
42172749|NCT00323609|75979628|FG001|Overall Study|Other non-VCF-related medical condition|2|||
42172750|NCT00323609|75979629|FG002|Overall Study|Other non-VCF-related medical condition|0|||
42172751|NCT00323609|75979630|FG003|Overall Study|Other non-VCF-related medical condition|0|||
42172752|NCT00323609|75979627|FG000|Overall Study|Sponsor discontinued trial|29|||
42172753|NCT00323609|75979628|FG001|Overall Study|Sponsor discontinued trial|29|||
42172754|NCT00323609|75979629|FG002|Overall Study|Sponsor discontinued trial|0|||
42172755|NCT00323609|75979630|FG003|Overall Study|Sponsor discontinued trial|0|||
42172756|NCT00323609|75979627|FG000|Overall Study|Unrelenting or severe back pain|1|||
42172757|NCT00323609|75979628|FG001|Overall Study|Unrelenting or severe back pain|1|||
42172758|NCT00323609|75979629|FG002|Overall Study|Unrelenting or severe back pain|0|||
42047606|NCT00833092|75855679|FG001|Overall Study|Diarrhea|2|||
42047607|NCT00833092|75855678|FG000|Overall Study|constipation|0|||
42047608|NCT00833092|75855679|FG001|Overall Study|constipation|1|||
42047609|NCT00823264|75855687|FG000|Overall Study|Protocol Violation|2|||
42047610|NCT00823264|75855688|FG001|Overall Study|Protocol Violation|0|||
42047611|NCT00832780|75855694|FG000|Overall Study|Death|16|||
42047612|NCT00832780|75855694|FG000|Overall Study|Lost to Follow-up|4|||
42047613|NCT00832780|75855694|FG000|Overall Study|no reason given|2|||
42047614|NCT00832780|75855694|FG000|Overall Study|other complicating condition|2|||
42047615|NCT00832780|75855694|FG000|Overall Study|Physician Decision|1|||
42047616|NCT00591838|75855703|FG000|Overall Study|Withdrawal by Subject|0|||
42047617|NCT00591838|75855704|FG001|Overall Study|Withdrawal by Subject|0|||
42047618|NCT00591838|75855705|FG002|Overall Study|Withdrawal by Subject|0|||
42047619|NCT00591838|75855706|FG003|Overall Study|Withdrawal by Subject|1|||
42172759|NCT00323609|75979630|FG003|Overall Study|Unrelenting or severe back pain|0|||
42047620|NCT00591838|75855707|FG004|Overall Study|Withdrawal by Subject|0|||
42047621|NCT00832624|75855720|FG000|Overall Study|Study Terminated|10|||
42047622|NCT00832078|75855724|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
42047623|NCT00832078|75855725|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
42047624|NCT00832078|75855724|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
42047625|NCT00832078|75855725|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
42047626|NCT00822172|75855733|FG000|Overall Study|Adverse Event|10|||
42047627|NCT00822172|75855734|FG001|Overall Study|Adverse Event|12|||
42047628|NCT00822172|75855733|FG000|Overall Study|Death|1|||
42047629|NCT00822172|75855734|FG001|Overall Study|Death|0|||
42047630|NCT00822172|75855733|FG000|Overall Study|Lost to Follow-up|3|||
42047631|NCT00822172|75855734|FG001|Overall Study|Lost to Follow-up|1|||
42047632|NCT00822172|75855733|FG000|Overall Study|Withdrawal by Subject|1|||
42047633|NCT00822172|75855734|FG001|Overall Study|Withdrawal by Subject|4|||
42047634|NCT00822172|75855733|FG000|Overall Study|site closed|0|||
42047635|NCT00822172|75855734|FG001|Overall Study|site closed|1|||
42047636|NCT00822172|75855733|FG000|Overall Study|Other|0|||
42047637|NCT00822172|75855734|FG001|Overall Study|Other|1|||
42047638|NCT00832000|75855740|FG000|Overall Study|Adverse Event|2|||
42047639|NCT00832000|75855741|FG001|Overall Study|Adverse Event|0|||
42047640|NCT00832000|75855740|FG000|Overall Study|Withdrawal by Subject|1|||
42047641|NCT00832000|75855741|FG001|Overall Study|Withdrawal by Subject|0|||
42047642|NCT00832000|75855740|FG000|Overall Study|No calls to IVR in either period|1|||
42047643|NCT00832000|75855741|FG001|Overall Study|No calls to IVR in either period|1|||
42047644|NCT00832000|75855740|FG000|Overall Study|No calls to IVR in period 2|2|||
42047645|NCT00832000|75855741|FG001|Overall Study|No calls to IVR in period 2|0|||
42047646|NCT00911508|75855778|FG000|Overall Study|Lost to Follow-up|27|||
42047647|NCT00911508|75855779|FG001|Overall Study|Lost to Follow-up|18|||
42047648|NCT00911508|75855778|FG000|Overall Study|Withdrawal by Subject|79|||
42047649|NCT00911508|75855779|FG001|Overall Study|Withdrawal by Subject|112|||
42047650|NCT00774397|75855805|FG000|Overall Study|Adverse Event|1|||
42047651|NCT00774397|75855806|FG001|Overall Study|Adverse Event|3|||
42047652|NCT00774397|75855807|FG002|Overall Study|Adverse Event|16|||
42047653|NCT00774397|75855808|FG003|Overall Study|Adverse Event|8|||
42047654|NCT00774397|75855809|FG004|Overall Study|Adverse Event|8|||
42047655|NCT00774397|75855810|FG005|Overall Study|Adverse Event|3|||
42047656|NCT00774397|75855811|FG006|Overall Study|Adverse Event|16|||
42047657|NCT00774397|75855805|FG000|Overall Study|Lack of Efficacy|11|||
42047658|NCT00774397|75855806|FG001|Overall Study|Lack of Efficacy|4|||
42047659|NCT00774397|75855807|FG002|Overall Study|Lack of Efficacy|5|||
42047660|NCT00774397|75855808|FG003|Overall Study|Lack of Efficacy|3|||
42047661|NCT00774397|75855809|FG004|Overall Study|Lack of Efficacy|27|||
42047662|NCT00774397|75855810|FG005|Overall Study|Lack of Efficacy|15|||
42047663|NCT00774397|75855811|FG006|Overall Study|Lack of Efficacy|9|||
42047664|NCT00774397|75855805|FG000|Overall Study|Protocol Violation|0|||
42047665|NCT00774397|75855806|FG001|Overall Study|Protocol Violation|1|||
42047666|NCT00774397|75855807|FG002|Overall Study|Protocol Violation|3|||
42047667|NCT00774397|75855808|FG003|Overall Study|Protocol Violation|1|||
42047668|NCT00774397|75855809|FG004|Overall Study|Protocol Violation|2|||
42047669|NCT00774397|75855810|FG005|Overall Study|Protocol Violation|1|||
42047670|NCT00774397|75855811|FG006|Overall Study|Protocol Violation|0|||
42047671|NCT00774397|75855805|FG000|Overall Study|Lost to Follow-up|0|||
42047672|NCT00774397|75855806|FG001|Overall Study|Lost to Follow-up|1|||
42047673|NCT00774397|75855807|FG002|Overall Study|Lost to Follow-up|1|||
42047674|NCT00774397|75855808|FG003|Overall Study|Lost to Follow-up|1|||
42047675|NCT00774397|75855809|FG004|Overall Study|Lost to Follow-up|0|||
42047676|NCT00774397|75855810|FG005|Overall Study|Lost to Follow-up|1|||
42047677|NCT00774397|75855811|FG006|Overall Study|Lost to Follow-up|0|||
42047678|NCT00774397|75855805|FG000|Overall Study|Refused to continue trial medication|1|||
42047679|NCT00774397|75855806|FG001|Overall Study|Refused to continue trial medication|3|||
42047680|NCT00774397|75855807|FG002|Overall Study|Refused to continue trial medication|2|||
42047681|NCT00774397|75855808|FG003|Overall Study|Refused to continue trial medication|2|||
42047682|NCT00774397|75855809|FG004|Overall Study|Refused to continue trial medication|6|||
42047683|NCT00774397|75855810|FG005|Overall Study|Refused to continue trial medication|2|||
42047684|NCT00774397|75855811|FG006|Overall Study|Refused to continue trial medication|3|||
42047685|NCT00774397|75855805|FG000|Overall Study|Not treated|0|||
42047686|NCT00774397|75855806|FG001|Overall Study|Not treated|0|||
42291327|NCT02641379|76125027|FG000|Overall Study|PCR positive at Week 68|0|||
42047687|NCT00774397|75855807|FG002|Overall Study|Not treated|0|||
42047688|NCT00774397|75855808|FG003|Overall Study|Not treated|0|||
42047689|NCT00774397|75855809|FG004|Overall Study|Not treated|1|||
42047690|NCT00774397|75855810|FG005|Overall Study|Not treated|0|||
42047691|NCT00774397|75855811|FG006|Overall Study|Not treated|1|||
42047692|NCT00774397|75855805|FG000|Overall Study|Other than those stated above|1|||
42047693|NCT00774397|75855806|FG001|Overall Study|Other than those stated above|1|||
42047694|NCT00774397|75855807|FG002|Overall Study|Other than those stated above|3|||
42047695|NCT00774397|75855808|FG003|Overall Study|Other than those stated above|2|||
42047696|NCT00774397|75855809|FG004|Overall Study|Other than those stated above|2|||
42047697|NCT00774397|75855810|FG005|Overall Study|Other than those stated above|0|||
42047698|NCT00774397|75855811|FG006|Overall Study|Other than those stated above|1|||
42047699|NCT00909870|75855866|FG000|Overall Study|Adverse Event|13|||
42047700|NCT00909870|75855867|FG001|Overall Study|Adverse Event|7|||
42172760|NCT00323609|75979627|FG000|Overall Study|Logistical withdrawal|9|||
42047701|NCT00909870|75855866|FG000|Overall Study|Protocol Violation|1|||
42047702|NCT00909870|75855867|FG001|Overall Study|Protocol Violation|2|||
42356862|NCT01393743|76202034|FG002|Extension Phase|Inadequate therapeutic effect|7|||
42047703|NCT00909870|75855866|FG000|Overall Study|Withdrawal by Subject|5|||
42047704|NCT00909870|75855867|FG001|Overall Study|Withdrawal by Subject|8|||
42047705|NCT00909870|75855866|FG000|Overall Study|Lost to Follow-up|3|||
42047706|NCT00909870|75855867|FG001|Overall Study|Lost to Follow-up|3|||
42047707|NCT00909870|75855866|FG000|Overall Study|Physician Decision|0|||
42047708|NCT00909870|75855867|FG001|Overall Study|Physician Decision|2|||
42047709|NCT00909870|75855866|FG000|Overall Study|Other|1|||
42047710|NCT00909870|75855867|FG001|Overall Study|Other|5|||
42047711|NCT00768469|75855876|FG000|Overall Study|Adverse Event|0|||
42047712|NCT00768469|75855877|FG001|Overall Study|Adverse Event|2|||
42047713|NCT00768469|75855876|FG000|Overall Study|Disease Progression|3|||
42047714|NCT00768469|75855877|FG001|Overall Study|Disease Progression|4|||
42047715|NCT00768469|75855876|FG000|Overall Study|Withdrawal by Subject|0|||
42047716|NCT00768469|75855877|FG001|Overall Study|Withdrawal by Subject|1|||
42047717|NCT00886821|75855898|FG000|Stage 2|Adverse Event|0|||
42047718|NCT00886821|75855899|FG001|Stage 2|Adverse Event|0|||
42047719|NCT00886821|75855900|FG002|Stage 2|Adverse Event|0|||
42047720|NCT00886821|75855901|FG003|Stage 2|Adverse Event|0|||
42047721|NCT00886821|75855902|FG004|Stage 2|Adverse Event|0|||
42047722|NCT00886821|75855903|FG005|Stage 2|Adverse Event|0|||
42047723|NCT00886821|75855904|FG006|Stage 2|Adverse Event|0|||
42047724|NCT00886821|75855905|FG007|Stage 2|Adverse Event|0|||
42047725|NCT00886821|75855906|FG008|Stage 2|Adverse Event|0|||
42047726|NCT00886821|75855907|FG009|Stage 2|Adverse Event|0|||
42047727|NCT00886821|75855908|FG010|Stage 2|Adverse Event|0|||
42047728|NCT00886821|75855909|FG011|Stage 2|Adverse Event|1|||
42047729|NCT00886821|75855910|FG012|Stage 2|Adverse Event|3|||
42047730|NCT00886821|75855911|FG013|Stage 2|Adverse Event|0|||
42047731|NCT00886821|75855898|FG000|Stage 2|Lost to Follow-up|0|||
42047732|NCT00886821|75855899|FG001|Stage 2|Lost to Follow-up|0|||
42047733|NCT00886821|75855900|FG002|Stage 2|Lost to Follow-up|0|||
42047734|NCT00886821|75855901|FG003|Stage 2|Lost to Follow-up|0|||
42047735|NCT00886821|75855902|FG004|Stage 2|Lost to Follow-up|0|||
42047736|NCT00886821|75855903|FG005|Stage 2|Lost to Follow-up|0|||
42047737|NCT00886821|75855904|FG006|Stage 2|Lost to Follow-up|0|||
42047738|NCT00886821|75855905|FG007|Stage 2|Lost to Follow-up|0|||
42047739|NCT00886821|75855906|FG008|Stage 2|Lost to Follow-up|0|||
42047740|NCT00886821|75855907|FG009|Stage 2|Lost to Follow-up|0|||
42047741|NCT00886821|75855908|FG010|Stage 2|Lost to Follow-up|0|||
42047742|NCT00886821|75855909|FG011|Stage 2|Lost to Follow-up|0|||
42047743|NCT00886821|75855910|FG012|Stage 2|Lost to Follow-up|2|||
42047744|NCT00886821|75855911|FG013|Stage 2|Lost to Follow-up|1|||
42047745|NCT00886743|75855955|FG000|Overall Study|Adverse Event|3|||
42047746|NCT00886743|75855955|FG000|Overall Study|Other|1|||
42047747|NCT00886587|75855961|FG000|Overall Study|Adverse Event|2|||
42047748|NCT00886587|75855962|FG001|Overall Study|Adverse Event|1|||
42047749|NCT00886587|75855961|FG000|Overall Study|Protocol Violation|2|||
42047750|NCT00886587|75855962|FG001|Overall Study|Protocol Violation|0|||
42047751|NCT00886587|75855961|FG000|Overall Study|Withdrawal by Subject|0|||
42047752|NCT00886587|75855962|FG001|Overall Study|Withdrawal by Subject|1|||
42047753|NCT00886119|75855968|FG000|Period 1|Did not meet inclusion criteria|1|||
42047754|NCT00886119|75855969|FG001|Period 1|Did not meet inclusion criteria|0|||
42047755|NCT00768079|75855978|FG000|Overall Study|Lost to Follow-up|2|||
42047756|NCT00768079|75855979|FG001|Overall Study|Lost to Follow-up|0|||
42047757|NCT00768079|75855980|FG002|Overall Study|Lost to Follow-up|4|||
42047758|NCT00768079|75855978|FG000|Overall Study|Participant incarcerated|0|||
42047759|NCT00768079|75855979|FG001|Overall Study|Participant incarcerated|1|||
42047760|NCT00768079|75855980|FG002|Overall Study|Participant incarcerated|0|||
42047761|NCT00767455|75855990|FG000|Overall Study|Investigator error|19|||
42047762|NCT00766831|75855996|FG000|Overall Study|Withdrawal by Subject|4|||
42047763|NCT00766831|75855996|FG000|Overall Study|Lost to Follow-up|3|||
42047764|NCT00766831|75855996|FG000|Overall Study|Adverse Event|20|||
42047765|NCT00766831|75855996|FG000|Overall Study|Protocol Violation|15|||
42047766|NCT00766831|75855996|FG000|Overall Study|Physician Decision|5|||
42047767|NCT00766831|75855996|FG000|Overall Study|Withdrawal of consent|26|||
42047768|NCT00766831|75855996|FG000|Overall Study|Non cooperation by participants|14|||
42047769|NCT00766831|75855996|FG000|Overall Study|Other|28|||
42047770|NCT00766675|75856000|FG000|Overall Study|Adverse Event|16|||
42047771|NCT00766675|75856000|FG000|Overall Study|Lost to Follow-up|2|||
42047772|NCT00766675|75856000|FG000|Overall Study|Withdrawal by Subject|11|||
42047773|NCT00766675|75856000|FG000|Overall Study|Protocol Violation|8|||
42047774|NCT00766675|75856000|FG000|Overall Study|Participant took prohibited medication|1|||
42047775|NCT00766675|75856000|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
42047776|NCT00766675|75856000|FG000|Overall Study|Insufficient therapy|1|||
42047777|NCT00766597|75856004|FG000|Overall Study|Unexpected closure of study|4|||
42047778|NCT00766597|75856004|FG000|Overall Study|Without CCR5-tropic virus|5|||
42047779|NCT00910962|75856013|FG000|Overall Study|Adverse Event|5|||
42047780|NCT00910962|75856014|FG001|Overall Study|Adverse Event|20|||
42047781|NCT00910962|75856015|FG002|Overall Study|Adverse Event|17|||
42047782|NCT00910962|75856013|FG000|Overall Study|Protocol Violation|1|||
42172761|NCT00323609|75979628|FG001|Overall Study|Logistical withdrawal|5|||
42047783|NCT00910962|75856014|FG001|Overall Study|Protocol Violation|3|||
42047784|NCT00910962|75856015|FG002|Overall Study|Protocol Violation|3|||
42047785|NCT00910962|75856013|FG000|Overall Study|Lost to Follow-up|0|||
42047786|NCT00910962|75856014|FG001|Overall Study|Lost to Follow-up|3|||
42047787|NCT00910962|75856015|FG002|Overall Study|Lost to Follow-up|1|||
42047788|NCT00910962|75856013|FG000|Overall Study|Physician Decision|0|||
42047789|NCT00910962|75856014|FG001|Overall Study|Physician Decision|6|||
42047790|NCT00910962|75856015|FG002|Overall Study|Physician Decision|6|||
42047791|NCT00910962|75856013|FG000|Overall Study|Withdrawal by Subject|25|||
42047792|NCT00910962|75856014|FG001|Overall Study|Withdrawal by Subject|32|||
42047793|NCT00910962|75856015|FG002|Overall Study|Withdrawal by Subject|32|||
42047794|NCT00910962|75856013|FG000|Overall Study|Reached defined stopping criteria|12|||
42047795|NCT00910962|75856014|FG001|Overall Study|Reached defined stopping criteria|14|||
42047796|NCT00910962|75856015|FG002|Overall Study|Reached defined stopping criteria|17|||
42047797|NCT00773461|75856027|FG000|Overall Study|Adverse Event|1|||
42047798|NCT00773461|75856028|FG001|Overall Study|Adverse Event|3|||
42047799|NCT00773461|75856027|FG000|Overall Study|Withdrawal by Subject|4|||
42047800|NCT00773461|75856028|FG001|Overall Study|Withdrawal by Subject|1|||
42047801|NCT00773383|75856035|FG000|Overall Study|Adverse Event|4|||
42047802|NCT00773383|75856035|FG000|Overall Study|Death|1|||
42047803|NCT00773383|75856035|FG000|Overall Study|Progression of Disease|23|||
42047804|NCT00773383|75856035|FG000|Overall Study|Other|2|||
42047805|NCT00773383|75856035|FG000|Overall Study|No study dose received|1|||
42047806|NCT00757003|75856043|FG000|Overall Study|Death|33|||
42047807|NCT00757003|75856043|FG000|Overall Study|Lost to Follow-up|9|||
42047808|NCT00757003|75856043|FG000|Overall Study|Withdrawal by Subject|4|||
42047809|NCT00757003|75856043|FG000|Overall Study|Surgically explanted|2|||
42047810|NCT00757003|75856043|FG000|Overall Study|Not implanted|1|||
42047811|NCT00766363|75856052|FG000|Overall Study|Withdrawal by Subject|1|||
42047812|NCT00766363|75856053|FG001|Overall Study|Withdrawal by Subject|0|||
42047813|NCT00766363|75856054|FG002|Overall Study|Withdrawal by Subject|0|||
42047814|NCT00766363|75856055|FG003|Overall Study|Withdrawal by Subject|0|||
42047815|NCT00766363|75856052|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
42047816|NCT00766363|75856053|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
42047817|NCT00766363|75856054|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
42047818|NCT00766363|75856055|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
42047819|NCT02636946|75856068|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
42047820|NCT02636946|75856069|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
42047821|NCT02636946|75856068|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
42047822|NCT02636946|75856069|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
42047823|NCT02636946|75856068|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
42047824|NCT02636946|75856069|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
42047825|NCT02636946|75856068|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
42047826|NCT02636946|75856069|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
42047827|NCT02636946|75856068|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
42047828|NCT02636946|75856069|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
42047829|NCT02636946|75856068|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
42047830|NCT02636946|75856069|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
42047831|NCT00766051|75856077|FG000|Overall Study|Withdrawal by Subject|2|||
42047832|NCT00766051|75856078|FG001|Overall Study|Withdrawal by Subject|0|||
42047833|NCT00909792|75856086|FG000|Period 1|Did not meet inclusion criteria|0|||
42047834|NCT00909792|75856087|FG001|Period 1|Did not meet inclusion criteria|1|||
42047835|NCT00909792|75856086|FG000|Period 2|Biomicroscopy|1|||
42047836|NCT00909792|75856087|FG001|Period 2|Biomicroscopy|0|||
42047837|NCT00909792|75856086|FG000|Period 2|Lost to Follow-up|0|||
42047838|NCT00909792|75856087|FG001|Period 2|Lost to Follow-up|1|||
42172762|NCT00323609|75979629|FG002|Overall Study|Logistical withdrawal|0|||
42047839|NCT00765817|75856095|FG000|Overall Study|Adverse Event|13|||
42047840|NCT00765817|75856096|FG001|Overall Study|Adverse Event|1|||
42047841|NCT00765817|75856095|FG000|Overall Study|Death|0|||
42047842|NCT00765817|75856096|FG001|Overall Study|Death|1|||
42047843|NCT00765817|75856095|FG000|Overall Study|Entry criteria not met|2|||
42172763|NCT00323609|75979630|FG003|Overall Study|Logistical withdrawal|1|||
42172764|NCT00323609|75979627|FG000|Overall Study|Other reason|11|||
42047844|NCT00765817|75856096|FG001|Overall Study|Entry criteria not met|2|||
42047845|NCT00765817|75856095|FG000|Overall Study|Loss of glucose control|0|||
42047846|NCT00765817|75856096|FG001|Overall Study|Loss of glucose control|2|||
42047847|NCT00765817|75856095|FG000|Overall Study|Lost to Follow-up|1|||
42047848|NCT00765817|75856096|FG001|Overall Study|Lost to Follow-up|3|||
42047849|NCT00765817|75856095|FG000|Overall Study|Physician Decision|2|||
42047850|NCT00765817|75856096|FG001|Overall Study|Physician Decision|1|||
42047851|NCT00765817|75856095|FG000|Overall Study|Protocol Violation|1|||
42047852|NCT00765817|75856096|FG001|Overall Study|Protocol Violation|1|||
42047853|NCT00765817|75856095|FG000|Overall Study|Subject decision|7|||
42047854|NCT00765817|75856096|FG001|Overall Study|Subject decision|11|||
42047855|NCT00772603|75856105|FG000|Overall Study|Withdrawal by Subject|11|||
42047856|NCT00772603|75856106|FG001|Overall Study|Withdrawal by Subject|10|||
42047857|NCT00772603|75856107|FG002|Overall Study|Withdrawal by Subject|6|||
42047858|NCT00772603|75856105|FG000|Overall Study|Adverse Event|37|||
42047859|NCT00772603|75856106|FG001|Overall Study|Adverse Event|18|||
42047860|NCT00772603|75856107|FG002|Overall Study|Adverse Event|10|||
42047861|NCT00772603|75856105|FG000|Overall Study|Subject Non-compliance|1|||
42047862|NCT00772603|75856106|FG001|Overall Study|Subject Non-compliance|6|||
42047863|NCT00772603|75856107|FG002|Overall Study|Subject Non-compliance|4|||
42047864|NCT00772603|75856105|FG000|Overall Study|Protocol Violation|0|||
42047865|NCT00772603|75856106|FG001|Overall Study|Protocol Violation|1|||
42047866|NCT00772603|75856107|FG002|Overall Study|Protocol Violation|1|||
42047867|NCT00772603|75856105|FG000|Overall Study|Lost to Follow-up|1|||
42047868|NCT00772603|75856106|FG001|Overall Study|Lost to Follow-up|5|||
42047869|NCT00772603|75856107|FG002|Overall Study|Lost to Follow-up|2|||
42047870|NCT00772603|75856105|FG000|Overall Study|Physician Decision|0|||
42047871|NCT00772603|75856106|FG001|Overall Study|Physician Decision|0|||
42047872|NCT00772603|75856107|FG002|Overall Study|Physician Decision|1|||
42047873|NCT00772603|75856105|FG000|Overall Study|Other|2|||
42047874|NCT00772603|75856106|FG001|Overall Study|Other|0|||
42047875|NCT00772603|75856107|FG002|Overall Study|Other|2|||
42047876|NCT00772447|75856120|FG000|Overall Study|Withdrawal by Subject|9|||
42047877|NCT00772447|75856121|FG001|Overall Study|Withdrawal by Subject|5|||
42047878|NCT00772447|75856120|FG000|Overall Study|Physician Decision|4|||
42047879|NCT00772447|75856121|FG001|Overall Study|Physician Decision|8|||
42047880|NCT00772447|75856120|FG000|Overall Study|Lost to Follow-up|2|||
42047881|NCT00772447|75856121|FG001|Overall Study|Lost to Follow-up|4|||
42047882|NCT00772447|75856120|FG000|Overall Study|incorrect enrolment|3|||
42047883|NCT00772447|75856121|FG001|Overall Study|incorrect enrolment|4|||
42047884|NCT00772447|75856120|FG000|Overall Study|Protocol Violation|0|||
42047885|NCT00772447|75856121|FG001|Overall Study|Protocol Violation|1|||
42047886|NCT00772447|75856120|FG000|Overall Study|all others|2|||
42047887|NCT00772447|75856121|FG001|Overall Study|all others|2|||
42047888|NCT00765037|75856128|FG000|Overall Study|Lost to Follow-up|5|||
42047889|NCT00765037|75856128|FG000|Overall Study|Adverse Event|1|||
42047890|NCT00831844|75856142|FG000|Overall Study|Adverse Event|2|||
42047891|NCT00831844|75856143|FG001|Overall Study|Adverse Event|0|||
42047892|NCT00831844|75856144|FG002|Overall Study|Adverse Event|0|||
42047893|NCT00831844|75856145|FG003|Overall Study|Adverse Event|0|||
42047894|NCT00831844|75856146|FG004|Overall Study|Adverse Event|1|||
42047895|NCT00831844|75856147|FG005|Overall Study|Adverse Event|1|||
42047896|NCT00831844|75856148|FG006|Overall Study|Adverse Event|2|||
42047897|NCT00831844|75856149|FG007|Overall Study|Adverse Event|0|||
42047898|NCT00831844|75856150|FG008|Overall Study|Adverse Event|0|||
42047899|NCT00831844|75856151|FG009|Overall Study|Adverse Event|0|||
42047900|NCT00831844|75856142|FG000|Overall Study|Death|0|||
42047901|NCT00831844|75856143|FG001|Overall Study|Death|0|||
42047902|NCT00831844|75856144|FG002|Overall Study|Death|0|||
42047903|NCT00831844|75856145|FG003|Overall Study|Death|1|||
42047904|NCT00831844|75856146|FG004|Overall Study|Death|0|||
42047905|NCT00831844|75856147|FG005|Overall Study|Death|0|||
42047906|NCT00831844|75856148|FG006|Overall Study|Death|0|||
42047907|NCT00831844|75856149|FG007|Overall Study|Death|0|||
42047908|NCT00831844|75856150|FG008|Overall Study|Death|0|||
42047909|NCT00831844|75856151|FG009|Overall Study|Death|0|||
42047910|NCT00831844|75856142|FG000|Overall Study|Lack of Efficacy|8|||
42047911|NCT00831844|75856143|FG001|Overall Study|Lack of Efficacy|10|||
42047912|NCT00831844|75856144|FG002|Overall Study|Lack of Efficacy|15|||
42047913|NCT00831844|75856145|FG003|Overall Study|Lack of Efficacy|8|||
42047914|NCT00831844|75856146|FG004|Overall Study|Lack of Efficacy|11|||
42047915|NCT00831844|75856147|FG005|Overall Study|Lack of Efficacy|17|||
42047916|NCT00831844|75856148|FG006|Overall Study|Lack of Efficacy|8|||
42047917|NCT00831844|75856149|FG007|Overall Study|Lack of Efficacy|9|||
42047918|NCT00831844|75856150|FG008|Overall Study|Lack of Efficacy|7|||
42047919|NCT00831844|75856151|FG009|Overall Study|Lack of Efficacy|0|||
42047920|NCT00831844|75856142|FG000|Overall Study|Physician Decision|0|||
42047921|NCT00831844|75856143|FG001|Overall Study|Physician Decision|1|||
42047922|NCT00831844|75856144|FG002|Overall Study|Physician Decision|3|||
42047923|NCT00831844|75856145|FG003|Overall Study|Physician Decision|1|||
42047924|NCT00831844|75856146|FG004|Overall Study|Physician Decision|1|||
42047925|NCT00831844|75856147|FG005|Overall Study|Physician Decision|1|||
42047926|NCT00831844|75856148|FG006|Overall Study|Physician Decision|0|||
42047927|NCT00831844|75856149|FG007|Overall Study|Physician Decision|0|||
42047928|NCT00831844|75856150|FG008|Overall Study|Physician Decision|1|||
42047929|NCT00831844|75856151|FG009|Overall Study|Physician Decision|0|||
42047930|NCT00831844|75856142|FG000|Overall Study|Withdrawal by Subject|0|||
42047931|NCT00831844|75856143|FG001|Overall Study|Withdrawal by Subject|0|||
42047932|NCT00831844|75856144|FG002|Overall Study|Withdrawal by Subject|1|||
42047933|NCT00831844|75856145|FG003|Overall Study|Withdrawal by Subject|0|||
42047934|NCT00831844|75856146|FG004|Overall Study|Withdrawal by Subject|0|||
42047935|NCT00831844|75856147|FG005|Overall Study|Withdrawal by Subject|0|||
42047936|NCT00831844|75856148|FG006|Overall Study|Withdrawal by Subject|0|||
42047937|NCT00831844|75856149|FG007|Overall Study|Withdrawal by Subject|1|||
42047938|NCT00831844|75856150|FG008|Overall Study|Withdrawal by Subject|1|||
42047939|NCT00831844|75856151|FG009|Overall Study|Withdrawal by Subject|0|||
42047940|NCT00831844|75856142|FG000|Overall Study|Ineligible|0|||
42047941|NCT00831844|75856143|FG001|Overall Study|Ineligible|1|||
42047942|NCT00831844|75856144|FG002|Overall Study|Ineligible|1|||
42047943|NCT00831844|75856145|FG003|Overall Study|Ineligible|0|||
42047944|NCT00831844|75856146|FG004|Overall Study|Ineligible|1|||
42047945|NCT00831844|75856147|FG005|Overall Study|Ineligible|0|||
42047946|NCT00831844|75856148|FG006|Overall Study|Ineligible|0|||
42047947|NCT00831844|75856149|FG007|Overall Study|Ineligible|0|||
42047948|NCT00831844|75856150|FG008|Overall Study|Ineligible|0|||
42047949|NCT00831844|75856151|FG009|Overall Study|Ineligible|0|||
42047950|NCT00764881|75856175|FG000|Overall Study|Adverse Event|5|||
42047951|NCT00764881|75856176|FG001|Overall Study|Adverse Event|1|||
42047952|NCT00764881|75856175|FG000|Overall Study|Withdrawal by Subject|1|||
42047953|NCT00764881|75856176|FG001|Overall Study|Withdrawal by Subject|3|||
42047954|NCT00764881|75856175|FG000|Overall Study|Protocol Violation|2|||
42047955|NCT00764881|75856176|FG001|Overall Study|Protocol Violation|2|||
42047956|NCT00764881|75856175|FG000|Overall Study|Lost to Follow-up|2|||
42047957|NCT00764881|75856176|FG001|Overall Study|Lost to Follow-up|0|||
42047958|NCT00764881|75856175|FG000|Overall Study|Noncompliant|1|||
42047959|NCT00764881|75856176|FG001|Overall Study|Noncompliant|0|||
42047960|NCT00764881|75856175|FG000|Overall Study|Accidentally discontinued study drug|1|||
42047961|NCT00764881|75856176|FG001|Overall Study|Accidentally discontinued study drug|0|||
42047962|NCT00764881|75856175|FG000|Overall Study|Wished to become pregnant|1|||
42047963|NCT00764881|75856176|FG001|Overall Study|Wished to become pregnant|0|||
42047964|NCT00764881|75856175|FG000|Overall Study|Carcinoma detected|1|||
42047965|NCT00764881|75856176|FG001|Overall Study|Carcinoma detected|0|||
42047966|NCT00764881|75856175|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
42047967|NCT00764881|75856176|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
42047968|NCT00764881|75856175|FG000|Overall Study|no treatment or no observation|2|||
42047969|NCT00764881|75856176|FG001|Overall Study|no treatment or no observation|2|||
42047970|NCT00844558|75856184|FG000|Overall Study|Withdrawal by Subject|9|||
42047971|NCT00844558|75856185|FG001|Overall Study|Withdrawal by Subject|2|||
42047972|NCT00844558|75856184|FG000|Overall Study|Death|1|||
42047973|NCT00844558|75856185|FG001|Overall Study|Death|0|||
42047974|NCT00844558|75856184|FG000|Overall Study|Protocol Violation|1|||
42047975|NCT00844558|75856185|FG001|Overall Study|Protocol Violation|1|||
42047976|NCT00844558|75856184|FG000|Overall Study|Lost to Follow-up|0|||
42172765|NCT00323609|75979628|FG001|Overall Study|Other reason|8|||
42172766|NCT00323609|75979629|FG002|Overall Study|Other reason|4|||
42172767|NCT00323609|75979630|FG003|Overall Study|Other reason|9|||
42172768|NCT04598152|75979636|FG000|Overall Study|Lost to Follow-up|0|||
42047977|NCT00844558|75856185|FG001|Overall Study|Lost to Follow-up|1|||
42047978|NCT00844558|75856184|FG000|Overall Study|Physician Decision|1|||
42047979|NCT00844558|75856185|FG001|Overall Study|Physician Decision|0|||
42172769|NCT04598152|75979637|FG001|Overall Study|Lost to Follow-up|1|||
42172770|NCT00323297|75979645|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
42172771|NCT00323297|75979646|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
42047980|NCT00772369|75856196|FG000|Overall Study|Did not return record release form|1|||
42047981|NCT00821236|75856203|FG000|Overall Study|Lost to Follow-up|3|||
42047982|NCT00756457|75856213|FG000|Overall Study|Lost to Follow-up|1|||
42047983|NCT00756457|75856214|FG001|Overall Study|Lost to Follow-up|2|||
42047984|NCT00844480|75856238|FG000|Overall Study|Withdrawal by Subject|2|||
42047985|NCT00844480|75856239|FG001|Overall Study|Withdrawal by Subject|3|||
42047986|NCT00771901|75856248|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
42047987|NCT00771901|75856249|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
42047988|NCT00771901|75856250|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
42172772|NCT00323297|75979645|FG000|Part A (Double Blind Randomized)|Death|0|||
42047989|NCT00843856|75856260|FG000|Overall Study|Lost to Follow-up|1|||
42047990|NCT00843856|75856261|FG001|Overall Study|Lost to Follow-up|2|||
42047991|NCT00764491|75856269|FG000|Overall Study|Lost to Follow-up|35|||
42047992|NCT00764491|75856270|FG001|Overall Study|Lost to Follow-up|17|||
42047993|NCT00843778|75856276|FG000|Overall Study|Adverse Event|15|||
42047994|NCT00843778|75856276|FG000|Overall Study|Lack of Efficacy|14|||
42047995|NCT00843778|75856276|FG000|Overall Study|Loss of efficacy|2|||
42047996|NCT00843778|75856276|FG000|Overall Study|Withdrawal by Subject|4|||
42047997|NCT00910728|75856289|FG000|Overall Study|Lack of Efficacy|2|||
42047998|NCT00910728|75856290|FG001|Overall Study|Lack of Efficacy|3|||
42047999|NCT00910728|75856291|FG002|Overall Study|Lack of Efficacy|1|||
42048000|NCT00910728|75856292|FG003|Overall Study|Lack of Efficacy|2|||
42048001|NCT00910728|75856293|FG004|Overall Study|Lack of Efficacy|1|||
42048002|NCT00910728|75856294|FG005|Overall Study|Lack of Efficacy|0|||
42048003|NCT00910728|75856295|FG006|Overall Study|Lack of Efficacy|2|||
42048004|NCT00910728|75856296|FG007|Overall Study|Lack of Efficacy|2|||
42048005|NCT00910728|75856297|FG008|Overall Study|Lack of Efficacy|2|||
42048006|NCT00910728|75856289|FG000|Overall Study|Withdrawal by Subject|0|||
42048007|NCT00910728|75856290|FG001|Overall Study|Withdrawal by Subject|0|||
42048008|NCT00910728|75856291|FG002|Overall Study|Withdrawal by Subject|0|||
42048009|NCT00910728|75856292|FG003|Overall Study|Withdrawal by Subject|0|||
42048010|NCT00910728|75856293|FG004|Overall Study|Withdrawal by Subject|3|||
42048011|NCT00910728|75856294|FG005|Overall Study|Withdrawal by Subject|1|||
42048012|NCT00910728|75856295|FG006|Overall Study|Withdrawal by Subject|2|||
42048013|NCT00910728|75856296|FG007|Overall Study|Withdrawal by Subject|0|||
42048014|NCT00910728|75856297|FG008|Overall Study|Withdrawal by Subject|0|||
42048015|NCT00910728|75856289|FG000|Overall Study|(not specified)|2|||
42048016|NCT00910728|75856290|FG001|Overall Study|(not specified)|0|||
42048017|NCT00910728|75856291|FG002|Overall Study|(not specified)|1|||
42048018|NCT00910728|75856292|FG003|Overall Study|(not specified)|0|||
42048019|NCT00910728|75856293|FG004|Overall Study|(not specified)|1|||
42048020|NCT00910728|75856294|FG005|Overall Study|(not specified)|0|||
42048021|NCT00910728|75856295|FG006|Overall Study|(not specified)|0|||
42048022|NCT00910728|75856296|FG007|Overall Study|(not specified)|0|||
42048023|NCT00910728|75856297|FG008|Overall Study|(not specified)|0|||
42048024|NCT00910728|75856289|FG000|Overall Study|Adverse Event|2|||
42048025|NCT00910728|75856290|FG001|Overall Study|Adverse Event|0|||
42048026|NCT00910728|75856291|FG002|Overall Study|Adverse Event|1|||
42048027|NCT00910728|75856292|FG003|Overall Study|Adverse Event|1|||
42048028|NCT00910728|75856293|FG004|Overall Study|Adverse Event|0|||
42048029|NCT00910728|75856294|FG005|Overall Study|Adverse Event|0|||
42048030|NCT00910728|75856295|FG006|Overall Study|Adverse Event|2|||
42048031|NCT00910728|75856296|FG007|Overall Study|Adverse Event|1|||
42048032|NCT00910728|75856297|FG008|Overall Study|Adverse Event|1|||
42048033|NCT00820222|75856319|FG000|Overall Study|Lost to Follow-up|10|||
42048034|NCT00820222|75856320|FG001|Overall Study|Lost to Follow-up|9|||
42048035|NCT00820222|75856319|FG000|Overall Study|Withdrawal by Subject|19|||
42048036|NCT00820222|75856320|FG001|Overall Study|Withdrawal by Subject|21|||
42048037|NCT00820222|75856319|FG000|Overall Study|Physician Decision|93|||
42048038|NCT00820222|75856320|FG001|Overall Study|Physician Decision|88|||
42048039|NCT00820222|75856319|FG000|Overall Study|Sponsor Terminated Study|43|||
42048040|NCT00820222|75856320|FG001|Overall Study|Sponsor Terminated Study|65|||
42048041|NCT00820222|75856319|FG000|Overall Study|Unkown|11|||
42048042|NCT00820222|75856320|FG001|Overall Study|Unkown|7|||
42048043|NCT01039688|75856329|FG000|Overall Study|Adverse Event|38|||
42048044|NCT01039688|75856330|FG001|Overall Study|Adverse Event|39|||
42048045|NCT01039688|75856331|FG002|Overall Study|Adverse Event|24|||
42048046|NCT01039688|75856329|FG000|Overall Study|Lack of Efficacy|20|||
42048047|NCT01039688|75856330|FG001|Overall Study|Lack of Efficacy|11|||
42172773|NCT00323297|75979646|FG001|Part A (Double Blind Randomized)|Death|1|||
42172774|NCT00323297|75979645|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
42048048|NCT01039688|75856331|FG002|Overall Study|Lack of Efficacy|26|||
42048049|NCT01039688|75856329|FG000|Overall Study|Lost to Follow-up|11|||
42048050|NCT01039688|75856330|FG001|Overall Study|Lost to Follow-up|9|||
42172775|NCT00323297|75979646|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
42172776|NCT00323297|75979645|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
42172777|NCT00323297|75979646|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
42048051|NCT01039688|75856331|FG002|Overall Study|Lost to Follow-up|5|||
42048052|NCT01039688|75856329|FG000|Overall Study|Other|13|||
42048053|NCT01039688|75856330|FG001|Overall Study|Other|25|||
42048054|NCT01039688|75856331|FG002|Overall Study|Other|12|||
42172778|NCT00323297|75979645|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
42048055|NCT01039688|75856329|FG000|Overall Study|Withdrawal by Subject|23|||
42172779|NCT00323297|75979646|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
42048056|NCT01039688|75856330|FG001|Overall Study|Withdrawal by Subject|27|||
42048057|NCT01039688|75856331|FG002|Overall Study|Withdrawal by Subject|13|||
42048058|NCT01039688|75856329|FG000|Overall Study|Death|2|||
42048059|NCT01039688|75856330|FG001|Overall Study|Death|0|||
42048060|NCT01039688|75856331|FG002|Overall Study|Death|0|||
42048061|NCT02237508|75856352|FG000|Overall Study|Withdrawal by Subject|0|||
42048062|NCT02237508|75856353|FG001|Overall Study|Withdrawal by Subject|2|||
42048063|NCT02237508|75856354|FG002|Overall Study|Withdrawal by Subject|0|||
42048064|NCT02237508|75856355|FG003|Overall Study|Withdrawal by Subject|1|||
42048065|NCT02237508|75856356|FG004|Overall Study|Withdrawal by Subject|0|||
42048066|NCT02237508|75856357|FG005|Overall Study|Withdrawal by Subject|1|||
42048067|NCT02237508|75856358|FG006|Overall Study|Withdrawal by Subject|1|||
42048068|NCT02237508|75856359|FG007|Overall Study|Withdrawal by Subject|0|||
42048069|NCT02237508|75856360|FG008|Overall Study|Withdrawal by Subject|1|||
42048070|NCT02237508|75856361|FG009|Overall Study|Withdrawal by Subject|0|||
42048071|NCT02237508|75856352|FG000|Overall Study|Physician Decision|0|||
42048072|NCT02237508|75856353|FG001|Overall Study|Physician Decision|1|||
42048073|NCT02237508|75856354|FG002|Overall Study|Physician Decision|0|||
42048074|NCT02237508|75856355|FG003|Overall Study|Physician Decision|0|||
42048075|NCT02237508|75856356|FG004|Overall Study|Physician Decision|0|||
42048076|NCT02237508|75856357|FG005|Overall Study|Physician Decision|0|||
42048077|NCT02237508|75856358|FG006|Overall Study|Physician Decision|0|||
42048078|NCT02237508|75856359|FG007|Overall Study|Physician Decision|0|||
42048079|NCT02237508|75856360|FG008|Overall Study|Physician Decision|0|||
42048080|NCT02237508|75856361|FG009|Overall Study|Physician Decision|0|||
42048081|NCT02237508|75856352|FG000|Overall Study|Protocol Violation|0|||
42048082|NCT02237508|75856353|FG001|Overall Study|Protocol Violation|0|||
42048083|NCT02237508|75856354|FG002|Overall Study|Protocol Violation|1|||
42048084|NCT02237508|75856355|FG003|Overall Study|Protocol Violation|0|||
42048085|NCT02237508|75856356|FG004|Overall Study|Protocol Violation|0|||
42048086|NCT02237508|75856357|FG005|Overall Study|Protocol Violation|0|||
42048087|NCT02237508|75856358|FG006|Overall Study|Protocol Violation|0|||
42048088|NCT02237508|75856359|FG007|Overall Study|Protocol Violation|0|||
42048089|NCT02237508|75856360|FG008|Overall Study|Protocol Violation|0|||
42048090|NCT02237508|75856361|FG009|Overall Study|Protocol Violation|0|||
42048091|NCT00909090|75856381|FG000|Overall Study|Lost to Follow-up|17|||
42048092|NCT00909090|75856382|FG001|Overall Study|Lost to Follow-up|17|||
42048093|NCT00909480|75856393|FG000|Overall Study|Adverse Event|5|||
42048094|NCT00909480|75856394|FG001|Overall Study|Adverse Event|3|||
42048095|NCT00909480|75856393|FG000|Overall Study|Protocol Violation|6|||
42048096|NCT00909480|75856394|FG001|Overall Study|Protocol Violation|8|||
42048097|NCT00909480|75856393|FG000|Overall Study|Withdrawal criteria|9|||
42048098|NCT00909480|75856394|FG001|Overall Study|Withdrawal criteria|11|||
42048099|NCT00909480|75856393|FG000|Overall Study|Unclassified|18|||
42048100|NCT00909480|75856394|FG001|Overall Study|Unclassified|19|||
42048101|NCT01058096|75856402|FG000|Double-blind Treatment Phase|Adverse Event|11|||
42048102|NCT01058096|75856403|FG001|Double-blind Treatment Phase|Adverse Event|15|||
42048103|NCT01058096|75856402|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
42048104|NCT01058096|75856403|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
42048105|NCT01058096|75856402|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
42048106|NCT01058096|75856403|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
42048107|NCT01058096|75856402|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
42048108|NCT01058096|75856403|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
42048109|NCT01058096|75856402|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
42048110|NCT01058096|75856403|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
42048111|NCT01058096|75856402|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
42048112|NCT01058096|75856403|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
42048113|NCT01057862|75856411|FG000|Overall Study|Withdrawal by Subject|1|||
42048114|NCT01057862|75856412|FG001|Overall Study|Withdrawal by Subject|2|||
42048115|NCT01038128|75856418|FG000|Overall Study|Lack of Efficacy|1|||
42048116|NCT01038128|75856418|FG000|Overall Study|Lost to Follow-up|1|||
42048117|NCT01038128|75856418|FG000|Overall Study|Withdrawal by Subject|2|||
42048118|NCT00842530|75856439|FG000|Overall Study|Serious adverse event|0|||
42048119|NCT00842530|75856440|FG001|Overall Study|Serious adverse event|6|||
42048120|NCT00842530|75856439|FG000|Overall Study|Other adverse event|6|||
42048121|NCT00842530|75856440|FG001|Overall Study|Other adverse event|1|||
42356863|NCT01393743|76202032|FG000|Extension Phase|Withdrawal by Subject|0|||
42048122|NCT00842530|75856439|FG000|Overall Study|Protocol Violation|32|||
42048123|NCT00842530|75856440|FG001|Overall Study|Protocol Violation|14|||
42048124|NCT00842530|75856439|FG000|Overall Study|Lost to Follow-up|6|||
42048125|NCT00842530|75856440|FG001|Overall Study|Lost to Follow-up|8|||
42356864|NCT01393743|76202033|FG001|Extension Phase|Withdrawal by Subject|0|||
42356865|NCT01393743|76202034|FG002|Extension Phase|Withdrawal by Subject|8|||
42048126|NCT00842530|75856439|FG000|Overall Study|Withdrawal by Subject|73|||
42048127|NCT00842530|75856440|FG001|Overall Study|Withdrawal by Subject|28|||
42048128|NCT00819910|75856451|FG000|Overall Study|Adverse Event|0|||
42048129|NCT00819910|75856452|FG001|Overall Study|Adverse Event|0|||
42048130|NCT00819910|75856453|FG002|Overall Study|Adverse Event|2|||
42048131|NCT00819910|75856454|FG003|Overall Study|Adverse Event|1|||
42172780|NCT00323297|75979645|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
42356866|NCT01393743|76202032|FG000|Extension Phase|Pregnancy|0|||
42048132|NCT00819910|75856451|FG000|Overall Study|Withdrawal by Subject|1|||
42048133|NCT00819910|75856452|FG001|Overall Study|Withdrawal by Subject|1|||
42048134|NCT00819910|75856453|FG002|Overall Study|Withdrawal by Subject|1|||
42048135|NCT00819910|75856454|FG003|Overall Study|Withdrawal by Subject|0|||
42048136|NCT00819910|75856451|FG000|Overall Study|Lost to Follow-up|1|||
42048137|NCT00819910|75856452|FG001|Overall Study|Lost to Follow-up|0|||
42048138|NCT00819910|75856453|FG002|Overall Study|Lost to Follow-up|0|||
42048139|NCT00819910|75856454|FG003|Overall Study|Lost to Follow-up|0|||
42048140|NCT00830518|75856468|FG000|Overall Study|Progressive Disease|18|||
42048141|NCT00830518|75856469|FG001|Overall Study|Progressive Disease|8|||
42048142|NCT00830518|75856468|FG000|Overall Study|Symptomatic Deterioration|4|||
42048143|NCT00830518|75856469|FG001|Overall Study|Symptomatic Deterioration|1|||
42048144|NCT00830518|75856468|FG000|Overall Study|Adverse Event|14|||
42048145|NCT00830518|75856469|FG001|Overall Study|Adverse Event|1|||
42048146|NCT00830518|75856468|FG000|Overall Study|Withdrawal by Patient|2|||
42048147|NCT00830518|75856469|FG001|Overall Study|Withdrawal by Patient|0|||
42048148|NCT00830518|75856468|FG000|Overall Study|Reason not Specified|8|||
42048149|NCT00830518|75856469|FG001|Overall Study|Reason not Specified|1|||
42048150|NCT00908544|75856478|FG000|Overall Study|Withdrawal by Subject|2|||
42048151|NCT00908544|75856479|FG001|Overall Study|Withdrawal by Subject|4|||
42048152|NCT00908544|75856478|FG000|Overall Study|Lack of Efficacy|0|||
42048153|NCT00908544|75856479|FG001|Overall Study|Lack of Efficacy|1|||
42048154|NCT00908544|75856478|FG000|Overall Study|Pregnancy|1|||
42048155|NCT00908544|75856479|FG001|Overall Study|Pregnancy|0|||
42048156|NCT00908544|75856478|FG000|Overall Study|Relocation abroad|1|||
42172781|NCT00323297|75979646|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
42172782|NCT00323297|75979645|FG000|Part B (Open-label)|Death|0|||
42172783|NCT00323297|75979646|FG001|Part B (Open-label)|Death|1|||
42172784|NCT00323297|75979645|FG000|Part B (Open-label)|Reason unspecified|0|||
42172785|NCT00323297|75979646|FG001|Part B (Open-label)|Reason unspecified|1|||
42172786|NCT00323297|75979645|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
42172787|NCT00323297|75979646|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
42172788|NCT00323297|75979645|FG000|Part B (Open-label)|Lack of Efficacy|3|||
42172789|NCT00323297|75979646|FG001|Part B (Open-label)|Lack of Efficacy|1|||
42172790|NCT00323297|75979645|FG000|Part B (Open-label)|Adverse Event|5|||
42172791|NCT00323297|75979646|FG001|Part B (Open-label)|Adverse Event|5|||
42172792|NCT00323297|75979645|FG000|Part B (Open-label)|Protocol Violation|0|||
42172793|NCT00323297|75979646|FG001|Part B (Open-label)|Protocol Violation|1|||
42172794|NCT00323063|75979654|FG000|Overall Study|Adverse Event|1|||
42172795|NCT00323063|75979655|FG001|Overall Study|Adverse Event|0|||
42172796|NCT00323063|75979654|FG000|Overall Study|brain mets discovered prior to treatment|1|||
42172797|NCT00323063|75979655|FG001|Overall Study|brain mets discovered prior to treatment|0|||
42172798|NCT00322049|75979665|FG000|Overall Study|Moved out of area|0|||
42172799|NCT00322049|75979666|FG001|Overall Study|Moved out of area|0|||
42172800|NCT00322049|75979667|FG002|Overall Study|Moved out of area|0|||
42172801|NCT00322049|75979668|FG003|Overall Study|Moved out of area|1|||
42172802|NCT00322049|75979665|FG000|Overall Study|Infected with Dengue during study|0|||
42172803|NCT00322049|75979666|FG001|Overall Study|Infected with Dengue during study|1|||
42172804|NCT00322049|75979667|FG002|Overall Study|Infected with Dengue during study|0|||
42172805|NCT00322049|75979668|FG003|Overall Study|Infected with Dengue during study|0|||
42172806|NCT00321893|75979689|FG000|Overall Study|Non-Compliance/Refusal|16|||
42172807|NCT00321893|75979690|FG001|Overall Study|Non-Compliance/Refusal|10|||
42172808|NCT00321893|75979689|FG000|Overall Study|Lost to Follow-up|2|||
42172809|NCT00321893|75979690|FG001|Overall Study|Lost to Follow-up|1|||
42172810|NCT00321893|75979689|FG000|Overall Study|Adverse Event|6|||
42172811|NCT00321893|75979690|FG001|Overall Study|Adverse Event|3|||
42172812|NCT00371345|75979698|FG000|Overall Study|Disease Progression|21|||
42048157|NCT00908544|75856479|FG001|Overall Study|Relocation abroad|1|||
42048158|NCT00908544|75856478|FG000|Overall Study|Unable to visit sutdy center|1|||
42048159|NCT00908544|75856479|FG001|Overall Study|Unable to visit sutdy center|0|||
42048160|NCT00830440|75856487|FG000|Overall Study|Protocol Violation|1|||
42048161|NCT00830440|75856488|FG001|Overall Study|Protocol Violation|0|||
42048162|NCT00830440|75856487|FG000|Overall Study|Withdrawal by Subject|1|||
42048163|NCT00830440|75856488|FG001|Overall Study|Withdrawal by Subject|0|||
42048164|NCT00830440|75856487|FG000|Overall Study|unsuccessful procedure|4|||
42172813|NCT00371345|75979699|FG001|Overall Study|Disease Progression|35|||
42172814|NCT00371345|75979698|FG000|Overall Study|Study Drug Toxicity|1|||
42048165|NCT00830440|75856488|FG001|Overall Study|unsuccessful procedure|0|||
42048166|NCT00830440|75856487|FG000|Overall Study|Adverse Event|2|||
42048167|NCT00830440|75856488|FG001|Overall Study|Adverse Event|0|||
42172815|NCT00371345|75979699|FG001|Overall Study|Study Drug Toxicity|7|||
42172816|NCT00371345|75979698|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
42172817|NCT00371345|75979699|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
42048168|NCT00908310|75856495|FG000|Overall Study|Death|37|||
42172818|NCT00371345|75979698|FG000|Overall Study|Participant Request|1|||
42048169|NCT00908310|75856495|FG000|Overall Study|Withdrawal by Subject|7|||
42048170|NCT00908310|75856495|FG000|Overall Study|Lost to Follow-up|7|||
42172819|NCT00371345|75979699|FG001|Overall Study|Participant Request|1|||
42172820|NCT00371345|75979698|FG000|Overall Study|Participant Withdrew Consent|0|||
42172821|NCT00371345|75979699|FG001|Overall Study|Participant Withdrew Consent|1|||
42172822|NCT00321737|75979722|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
42172823|NCT00321737|75979723|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
42172824|NCT00321737|75979724|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
42172825|NCT00321737|75979722|FG000|Overall Study|Adverse Event|11|||
42172826|NCT00321737|75979723|FG001|Overall Study|Adverse Event|3|||
42172827|NCT00321737|75979724|FG002|Overall Study|Adverse Event|6|||
42172828|NCT00321737|75979722|FG000|Overall Study|Lost to Follow-up|5|||
42172829|NCT00321737|75979723|FG001|Overall Study|Lost to Follow-up|5|||
42172830|NCT00321737|75979724|FG002|Overall Study|Lost to Follow-up|6|||
42172831|NCT00321737|75979722|FG000|Overall Study|Withdrawal by Subject|19|||
42172832|NCT00321737|75979723|FG001|Overall Study|Withdrawal by Subject|12|||
42172833|NCT00321737|75979724|FG002|Overall Study|Withdrawal by Subject|17|||
42172834|NCT00321737|75979722|FG000|Overall Study|Protocol Violation|0|||
42172835|NCT00321737|75979723|FG001|Overall Study|Protocol Violation|0|||
42172836|NCT00321737|75979724|FG002|Overall Study|Protocol Violation|1|||
42172837|NCT00321737|75979722|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
42172838|NCT00321737|75979723|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
42172839|NCT00321737|75979724|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
42172840|NCT00321737|75979722|FG000|Overall Study|Possible Barrett's Esophagus|2|||
42172841|NCT00321737|75979723|FG001|Overall Study|Possible Barrett's Esophagus|1|||
42172842|NCT00321737|75979724|FG002|Overall Study|Possible Barrett's Esophagus|1|||
42172843|NCT00321737|75979722|FG000|Overall Study|Therapeutic Failure|6|||
42172844|NCT00321737|75979723|FG001|Overall Study|Therapeutic Failure|0|||
42172845|NCT00321737|75979724|FG002|Overall Study|Therapeutic Failure|2|||
42172846|NCT00321737|75979722|FG000|Overall Study|Pregnancy|0|||
42172847|NCT00321737|75979723|FG001|Overall Study|Pregnancy|2|||
42172848|NCT00321737|75979724|FG002|Overall Study|Pregnancy|0|||
42172849|NCT00321737|75979722|FG000|Overall Study|Noncompliance|2|||
42172850|NCT00321737|75979723|FG001|Overall Study|Noncompliance|0|||
42172851|NCT00321737|75979724|FG002|Overall Study|Noncompliance|0|||
42172852|NCT00321737|75979722|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
42356867|NCT01393743|76202033|FG001|Extension Phase|Pregnancy|0|||
42356868|NCT01393743|76202034|FG002|Extension Phase|Pregnancy|1|||
42356869|NCT01393743|76202032|FG000|Extension Phase|Other|0|||
42356870|NCT01393743|76202033|FG001|Extension Phase|Other|0|||
42048171|NCT00908310|75856495|FG000|Overall Study|Screening failure|5|||
42048172|NCT00908310|75856495|FG000|Overall Study|Other reasons|4|||
42048173|NCT00830128|75856499|FG000|Overall Study|Adverse Event|5|||
42048174|NCT00830128|75856499|FG000|Overall Study|Lack of Efficacy|7|||
42048175|NCT00830128|75856499|FG000|Overall Study|Protocol Violation|1|||
42048176|NCT00830128|75856499|FG000|Overall Study|Withdrawal by Subject|2|||
42048177|NCT00830128|75856499|FG000|Overall Study|Family obligation|1|||
42048178|NCT00830128|75856499|FG000|Overall Study|Relocation|1|||
42048179|NCT00830128|75856499|FG000|Overall Study|Work obligation|1|||
42048180|NCT00830128|75856499|FG000|Overall Study|Operating a vehicle|1|||
42048181|NCT00841906|75856505|FG000|Overall Study|Withdrawal by Subject|2|||
42048182|NCT00841906|75856506|FG001|Overall Study|Withdrawal by Subject|0|||
42048183|NCT00771667|75856518|FG000|Induction Phase|Adverse Event|5|||
42048184|NCT00771667|75856519|FG001|Induction Phase|Adverse Event|2|||
42048185|NCT00771667|75856520|FG002|Induction Phase|Adverse Event|4|||
42048186|NCT00771667|75856521|FG003|Induction Phase|Adverse Event|1|||
42048187|NCT00771667|75856522|FG004|Induction Phase|Adverse Event|0|||
42048188|NCT00771667|75856523|FG005|Induction Phase|Adverse Event|0|||
42048189|NCT00771667|75856524|FG006|Induction Phase|Adverse Event|0|||
42048190|NCT00771667|75856525|FG007|Induction Phase|Adverse Event|0|||
42048191|NCT00771667|75856526|FG008|Induction Phase|Adverse Event|0|||
42048192|NCT00771667|75856527|FG009|Induction Phase|Adverse Event|0|||
42048193|NCT00771667|75856518|FG000|Induction Phase|Lack of Efficacy|9|||
42356871|NCT01393743|76202034|FG002|Extension Phase|Other|14|||
42048194|NCT00771667|75856519|FG001|Induction Phase|Lack of Efficacy|2|||
42048195|NCT00771667|75856520|FG002|Induction Phase|Lack of Efficacy|4|||
42048196|NCT00771667|75856521|FG003|Induction Phase|Lack of Efficacy|3|||
42048197|NCT00771667|75856522|FG004|Induction Phase|Lack of Efficacy|0|||
42048198|NCT00771667|75856523|FG005|Induction Phase|Lack of Efficacy|0|||
42356872|NCT01405911|76202053|FG000|Overall Study|Pre-treatment lab AE|0|||
42048199|NCT00771667|75856524|FG006|Induction Phase|Lack of Efficacy|0|||
42172853|NCT00321737|75979723|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
42172854|NCT00321737|75979724|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
42172855|NCT00320801|75979734|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
42172856|NCT00320801|75979735|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
42356873|NCT01405911|76202054|FG001|Overall Study|Pre-treatment lab AE|1|||
42356874|NCT01405911|76202055|FG002|Overall Study|Pre-treatment lab AE|0|||
42048200|NCT00771667|75856525|FG007|Induction Phase|Lack of Efficacy|0|||
42048201|NCT00771667|75856526|FG008|Induction Phase|Lack of Efficacy|0|||
42048202|NCT00771667|75856527|FG009|Induction Phase|Lack of Efficacy|0|||
42048203|NCT00771667|75856518|FG000|Induction Phase|Lost to Follow-up|1|||
42048204|NCT00771667|75856519|FG001|Induction Phase|Lost to Follow-up|0|||
42048205|NCT00771667|75856520|FG002|Induction Phase|Lost to Follow-up|1|||
42048206|NCT00771667|75856521|FG003|Induction Phase|Lost to Follow-up|0|||
42048207|NCT00771667|75856522|FG004|Induction Phase|Lost to Follow-up|0|||
42048208|NCT00771667|75856523|FG005|Induction Phase|Lost to Follow-up|0|||
42048209|NCT00771667|75856524|FG006|Induction Phase|Lost to Follow-up|0|||
42048210|NCT00771667|75856525|FG007|Induction Phase|Lost to Follow-up|0|||
42048211|NCT00771667|75856526|FG008|Induction Phase|Lost to Follow-up|0|||
42048212|NCT00771667|75856527|FG009|Induction Phase|Lost to Follow-up|0|||
42048213|NCT00771667|75856518|FG000|Induction Phase|Other|4|||
42048214|NCT00771667|75856519|FG001|Induction Phase|Other|6|||
42048215|NCT00771667|75856520|FG002|Induction Phase|Other|3|||
42048216|NCT00771667|75856521|FG003|Induction Phase|Other|4|||
42048217|NCT00771667|75856522|FG004|Induction Phase|Other|0|||
42048218|NCT00771667|75856523|FG005|Induction Phase|Other|0|||
42048219|NCT00771667|75856524|FG006|Induction Phase|Other|0|||
42048220|NCT00771667|75856525|FG007|Induction Phase|Other|0|||
42048221|NCT00771667|75856526|FG008|Induction Phase|Other|0|||
42048222|NCT00771667|75856527|FG009|Induction Phase|Other|0|||
42048223|NCT00771667|75856518|FG000|Maintenance Phase|Adverse Event|0|||
42048224|NCT00771667|75856519|FG001|Maintenance Phase|Adverse Event|0|||
42048225|NCT00771667|75856520|FG002|Maintenance Phase|Adverse Event|0|||
42048226|NCT00771667|75856521|FG003|Maintenance Phase|Adverse Event|0|||
42048227|NCT00771667|75856522|FG004|Maintenance Phase|Adverse Event|1|||
42048228|NCT00771667|75856523|FG005|Maintenance Phase|Adverse Event|3|||
42048229|NCT00771667|75856524|FG006|Maintenance Phase|Adverse Event|5|||
42048230|NCT00771667|75856525|FG007|Maintenance Phase|Adverse Event|1|||
42048231|NCT00771667|75856526|FG008|Maintenance Phase|Adverse Event|8|||
42048232|NCT00771667|75856527|FG009|Maintenance Phase|Adverse Event|7|||
42048233|NCT00771667|75856518|FG000|Maintenance Phase|Lack of Efficacy|0|||
42048234|NCT00771667|75856519|FG001|Maintenance Phase|Lack of Efficacy|0|||
42048235|NCT00771667|75856520|FG002|Maintenance Phase|Lack of Efficacy|0|||
42048236|NCT00771667|75856521|FG003|Maintenance Phase|Lack of Efficacy|0|||
42048237|NCT00771667|75856522|FG004|Maintenance Phase|Lack of Efficacy|1|||
42048238|NCT00771667|75856523|FG005|Maintenance Phase|Lack of Efficacy|3|||
42048239|NCT00771667|75856524|FG006|Maintenance Phase|Lack of Efficacy|3|||
42048240|NCT00771667|75856525|FG007|Maintenance Phase|Lack of Efficacy|2|||
42048241|NCT00771667|75856526|FG008|Maintenance Phase|Lack of Efficacy|11|||
42048242|NCT00771667|75856527|FG009|Maintenance Phase|Lack of Efficacy|7|||
42048243|NCT00771667|75856518|FG000|Maintenance Phase|Other|0|||
42048244|NCT00771667|75856519|FG001|Maintenance Phase|Other|0|||
42048245|NCT00771667|75856520|FG002|Maintenance Phase|Other|0|||
42048246|NCT00771667|75856521|FG003|Maintenance Phase|Other|0|||
42048247|NCT00771667|75856522|FG004|Maintenance Phase|Other|0|||
42048248|NCT00771667|75856523|FG005|Maintenance Phase|Other|1|||
42048249|NCT00771667|75856524|FG006|Maintenance Phase|Other|2|||
42048250|NCT00771667|75856525|FG007|Maintenance Phase|Other|2|||
42048251|NCT00771667|75856526|FG008|Maintenance Phase|Other|3|||
42048252|NCT00771667|75856527|FG009|Maintenance Phase|Other|3|||
42048253|NCT00770965|75856549|FG000|Safety Set|Withdrawal by Subject|0|||
42048254|NCT00770965|75856550|FG001|Safety Set|Withdrawal by Subject|0|||
42048255|NCT00770965|75856551|FG002|Safety Set|Withdrawal by Subject|0|||
42048256|NCT00770965|75856552|FG003|Safety Set|Withdrawal by Subject|1|||
42048257|NCT00770965|75856549|FG000|Safety Set|Protocol deviation|0|||
42048258|NCT00770965|75856550|FG001|Safety Set|Protocol deviation|0|||
42048259|NCT00770965|75856551|FG002|Safety Set|Protocol deviation|1|||
42048260|NCT00770965|75856552|FG003|Safety Set|Protocol deviation|0|||
42048261|NCT00770965|75856549|FG000|Excluded Set|Administrative problems|14|||
42048262|NCT00770965|75856550|FG001|Excluded Set|Administrative problems|12|||
42048263|NCT00770965|75856551|FG002|Excluded Set|Administrative problems|12|||
42048264|NCT00770965|75856552|FG003|Excluded Set|Administrative problems|10|||
42048265|NCT00770965|75856549|FG000|Excluded Set|Withdrawal by Subject|1|||
42048266|NCT00770965|75856550|FG001|Excluded Set|Withdrawal by Subject|1|||
42048267|NCT00770965|75856551|FG002|Excluded Set|Withdrawal by Subject|2|||
42048268|NCT00770965|75856552|FG003|Excluded Set|Withdrawal by Subject|3|||
42048269|NCT00763555|75856564|FG000|Overall Study|Adverse Event|2|||
42048270|NCT00763555|75856565|FG001|Overall Study|Adverse Event|1|||
42048271|NCT00763555|75856564|FG000|Overall Study|Withdrawal by Subject|2|||
42048272|NCT00763555|75856565|FG001|Overall Study|Withdrawal by Subject|6|||
42048273|NCT00763555|75856564|FG000|Overall Study|Lost to Follow-up|0|||
42048274|NCT00763555|75856565|FG001|Overall Study|Lost to Follow-up|3|||
42048275|NCT00763321|75856574|FG000|Open-label Period|Adverse Event|24|||
42048276|NCT00763321|75856575|FG001|Open-label Period|Adverse Event|0|||
42048277|NCT00763321|75856576|FG002|Open-label Period|Adverse Event|0|||
42048278|NCT00763321|75856574|FG000|Open-label Period|Lost to Follow-up|14|||
42048279|NCT00763321|75856575|FG001|Open-label Period|Lost to Follow-up|0|||
42048280|NCT00763321|75856576|FG002|Open-label Period|Lost to Follow-up|0|||
42048281|NCT00763321|75856574|FG000|Open-label Period|Withdrawal by Subject|7|||
42048282|NCT00763321|75856575|FG001|Open-label Period|Withdrawal by Subject|0|||
42048283|NCT00763321|75856576|FG002|Open-label Period|Withdrawal by Subject|0|||
42048284|NCT00763321|75856574|FG000|Open-label Period|Subject noncompliant|7|||
42048285|NCT00763321|75856575|FG001|Open-label Period|Subject noncompliant|0|||
42048286|NCT00763321|75856576|FG002|Open-label Period|Subject noncompliant|0|||
42048287|NCT00763321|75856574|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
42048288|NCT00763321|75856575|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
42048289|NCT00763321|75856576|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
42048290|NCT00763321|75856574|FG000|Open-label Period|Lack of Efficacy|2|||
42048291|NCT00763321|75856575|FG001|Open-label Period|Lack of Efficacy|0|||
42048292|NCT00763321|75856576|FG002|Open-label Period|Lack of Efficacy|0|||
42048293|NCT00763321|75856574|FG000|Open-label Period|Other|4|||
42048294|NCT00763321|75856575|FG001|Open-label Period|Other|0|||
42048295|NCT00763321|75856576|FG002|Open-label Period|Other|0|||
42048296|NCT00763321|75856574|FG000|Double-blind Period|Lack of Efficacy|0|||
42048297|NCT00763321|75856575|FG001|Double-blind Period|Lack of Efficacy|9|||
42048298|NCT00763321|75856576|FG002|Double-blind Period|Lack of Efficacy|17|||
42048299|NCT00763321|75856574|FG000|Double-blind Period|Adverse Event|0|||
42048300|NCT00763321|75856575|FG001|Double-blind Period|Adverse Event|4|||
42048301|NCT00763321|75856576|FG002|Double-blind Period|Adverse Event|4|||
42048302|NCT00763321|75856574|FG000|Double-blind Period|Lost to Follow-up|0|||
42048303|NCT00763321|75856575|FG001|Double-blind Period|Lost to Follow-up|4|||
42048304|NCT00763321|75856576|FG002|Double-blind Period|Lost to Follow-up|2|||
42048305|NCT00763321|75856574|FG000|Double-blind Period|Withdrawal by Subject|0|||
42048306|NCT00763321|75856575|FG001|Double-blind Period|Withdrawal by Subject|2|||
42048307|NCT00763321|75856576|FG002|Double-blind Period|Withdrawal by Subject|3|||
42048308|NCT00763321|75856574|FG000|Double-blind Period|Other|0|||
42048309|NCT00763321|75856575|FG001|Double-blind Period|Other|2|||
42048310|NCT00763321|75856576|FG002|Double-blind Period|Other|3|||
42048311|NCT00770653|75856585|FG000|Overall Study|Adverse Event|13|||
42048312|NCT00770653|75856586|FG001|Overall Study|Adverse Event|5|||
42048313|NCT00770653|75856585|FG000|Overall Study|Protocol Violation|8|||
42048314|NCT00770653|75856586|FG001|Overall Study|Protocol Violation|6|||
42048315|NCT00770653|75856585|FG000|Overall Study|Withdrawal by Subject|4|||
42048316|NCT00770653|75856586|FG001|Overall Study|Withdrawal by Subject|7|||
42048317|NCT00770653|75856585|FG000|Overall Study|Lack of Compliance|1|||
42048318|NCT00770653|75856586|FG001|Overall Study|Lack of Compliance|4|||
42048319|NCT00770653|75856585|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
42048320|NCT00770653|75856586|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
42048321|NCT00770653|75856585|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
42048322|NCT00770653|75856586|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
42048323|NCT00770653|75856585|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
42048324|NCT00770653|75856586|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
42048325|NCT00770653|75856585|FG000|Overall Study|Lost to Follow-up|1|||
42048326|NCT00770653|75856586|FG001|Overall Study|Lost to Follow-up|2|||
42048327|NCT00770653|75856585|FG000|Overall Study|Physician Decision|1|||
42048328|NCT00770653|75856586|FG001|Overall Study|Physician Decision|0|||
42048329|NCT00819052|75856594|FG000|Overall Study|Adverse Event|0|||
42048330|NCT00819052|75856595|FG001|Overall Study|Adverse Event|5|||
42048331|NCT00819052|75856594|FG000|Overall Study|Protocol Violation|1|||
42048332|NCT00819052|75856595|FG001|Overall Study|Protocol Violation|2|||
42048333|NCT00819052|75856594|FG000|Overall Study|Lost to Follow-up|1|||
42048334|NCT00819052|75856595|FG001|Overall Study|Lost to Follow-up|2|||
42048335|NCT00819052|75856594|FG000|Overall Study|Withdrawal by Subject|1|||
42048336|NCT00819052|75856595|FG001|Overall Study|Withdrawal by Subject|2|||
42048337|NCT00819052|75856594|FG000|Overall Study|Lack of Efficacy|1|||
42048338|NCT00819052|75856595|FG001|Overall Study|Lack of Efficacy|1|||
42048339|NCT00819052|75856594|FG000|Overall Study|Pregnancy|1|||
42048340|NCT00819052|75856595|FG001|Overall Study|Pregnancy|2|||
42048341|NCT00819052|75856594|FG000|Overall Study|Death or events leading to death|1|||
42172857|NCT00320801|75979736|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
42048342|NCT00819052|75856595|FG001|Overall Study|Death or events leading to death|0|||
42048343|NCT00763009|75856604|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
42048344|NCT00841672|75856611|FG000|Overall Study|Adverse Event|7|||
42048345|NCT00841672|75856612|FG001|Overall Study|Adverse Event|16|||
42048346|NCT00841672|75856611|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42048347|NCT00841672|75856612|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42048348|NCT00841672|75856611|FG000|Overall Study|Subject withdrew consent|2|||
42172858|NCT00320801|75979737|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
42172859|NCT00320801|75979734|FG000|Open-label Run-in Period|Adverse Event|33|||
42172860|NCT00320801|75979735|FG001|Open-label Run-in Period|Adverse Event|0|||
42172861|NCT00320801|75979736|FG002|Open-label Run-in Period|Adverse Event|0|||
42048349|NCT00841672|75856612|FG001|Overall Study|Subject withdrew consent|4|||
42048350|NCT00841672|75856611|FG000|Overall Study|Lost to Follow-up|1|||
42048351|NCT00841672|75856612|FG001|Overall Study|Lost to Follow-up|1|||
42048352|NCT00841672|75856611|FG000|Overall Study|Administrative problems|9|||
42048353|NCT00841672|75856612|FG001|Overall Study|Administrative problems|9|||
42048354|NCT00841672|75856611|FG000|Overall Study|Misrandomized|1|||
42048355|NCT00841672|75856612|FG001|Overall Study|Misrandomized|0|||
42048356|NCT00841672|75856611|FG000|Overall Study|Protocol Deviation|0|||
42048357|NCT00841672|75856612|FG001|Overall Study|Protocol Deviation|1|||
42048358|NCT00908232|75856618|FG000|Cycle 1 to 4|Death|5|||
42048359|NCT00908232|75856619|FG001|Cycle 1 to 4|Death|0|||
42048360|NCT00908232|75856620|FG002|Cycle 1 to 4|Death|0|||
42048361|NCT00908232|75856621|FG003|Cycle 1 to 4|Death|0|||
42048362|NCT00908232|75856618|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
42048363|NCT00908232|75856619|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
42048364|NCT00908232|75856620|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
42048365|NCT00908232|75856621|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
42048366|NCT00908232|75856618|FG000|Cycle 1 to 4|Progressive Disease|6|||
42048367|NCT00908232|75856619|FG001|Cycle 1 to 4|Progressive Disease|0|||
42048368|NCT00908232|75856620|FG002|Cycle 1 to 4|Progressive Disease|0|||
42048369|NCT00908232|75856621|FG003|Cycle 1 to 4|Progressive Disease|0|||
42048370|NCT00908232|75856618|FG000|Cycle 1 to 4|Adverse Event|12|||
42048371|NCT00908232|75856619|FG001|Cycle 1 to 4|Adverse Event|0|||
42048372|NCT00908232|75856620|FG002|Cycle 1 to 4|Adverse Event|0|||
42048373|NCT00908232|75856621|FG003|Cycle 1 to 4|Adverse Event|0|||
42048374|NCT00908232|75856618|FG000|Cycle 1 to 4|Other|1|||
42048375|NCT00908232|75856619|FG001|Cycle 1 to 4|Other|0|||
42048376|NCT00908232|75856620|FG002|Cycle 1 to 4|Other|0|||
42048377|NCT00908232|75856621|FG003|Cycle 1 to 4|Other|0|||
42048378|NCT00908232|75856618|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
42172862|NCT00320801|75979737|FG003|Open-label Run-in Period|Adverse Event|0|||
42172863|NCT00320801|75979734|FG000|Open-label Run-in Period|Administrative|10|||
42172864|NCT00320801|75979735|FG001|Open-label Run-in Period|Administrative|0|||
42172865|NCT00320801|75979736|FG002|Open-label Run-in Period|Administrative|0|||
42172866|NCT00320801|75979737|FG003|Open-label Run-in Period|Administrative|0|||
42172867|NCT00320801|75979734|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
42172868|NCT00320801|75979735|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
42172869|NCT00320801|75979736|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
42172870|NCT00320801|75979737|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
42172871|NCT00320801|75979734|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
42172872|NCT00320801|75979735|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
42172873|NCT00320801|75979736|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
42172874|NCT00320801|75979737|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
42172875|NCT00320801|75979734|FG000|Open-label Run-in Period|Did not qualify|1|||
42172876|NCT00320801|75979735|FG001|Open-label Run-in Period|Did not qualify|0|||
42172877|NCT00320801|75979736|FG002|Open-label Run-in Period|Did not qualify|0|||
42172878|NCT00320801|75979737|FG003|Open-label Run-in Period|Did not qualify|0|||
42172879|NCT00320801|75979734|FG000|Double-blind Phase|Withdrawal by Subject|0|||
42172880|NCT00320801|75979735|FG001|Double-blind Phase|Withdrawal by Subject|0|||
42172881|NCT00320801|75979736|FG002|Double-blind Phase|Withdrawal by Subject|1|||
42172882|NCT00320801|75979737|FG003|Double-blind Phase|Withdrawal by Subject|0|||
42172883|NCT00320801|75979734|FG000|Double-blind Phase|Adverse Event|0|||
42172884|NCT00320801|75979735|FG001|Double-blind Phase|Adverse Event|2|||
42172885|NCT00320801|75979736|FG002|Double-blind Phase|Adverse Event|8|||
42172886|NCT00320801|75979737|FG003|Double-blind Phase|Adverse Event|0|||
42172887|NCT00320801|75979734|FG000|Double-blind Phase|Administrative|0|||
42172888|NCT00320801|75979735|FG001|Double-blind Phase|Administrative|0|||
42172889|NCT00320801|75979736|FG002|Double-blind Phase|Administrative|4|||
42172890|NCT00320801|75979737|FG003|Double-blind Phase|Administrative|0|||
42172891|NCT00320801|75979734|FG000|Double-blind Phase|Lack of Efficacy|0|||
42172892|NCT00320801|75979735|FG001|Double-blind Phase|Lack of Efficacy|9|||
42172893|NCT00320801|75979736|FG002|Double-blind Phase|Lack of Efficacy|1|||
42172894|NCT00320801|75979737|FG003|Double-blind Phase|Lack of Efficacy|0|||
42172895|NCT00320801|75979734|FG000|Extension Phase|Withdrawal by Subject|0|||
42172896|NCT00320801|75979735|FG001|Extension Phase|Withdrawal by Subject|0|||
42291328|NCT02641379|76125028|FG001|Overall Study|PCR positive at Week 68|1|||
42291329|NCT02641379|76125029|FG002|Overall Study|PCR positive at Week 68|0|||
42048379|NCT00908232|75856619|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
42048380|NCT00908232|75856620|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
42048381|NCT00908232|75856621|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
42048382|NCT00908232|75856618|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
42172897|NCT00320801|75979736|FG002|Extension Phase|Withdrawal by Subject|0|||
42172898|NCT00320801|75979737|FG003|Extension Phase|Withdrawal by Subject|6|||
42172899|NCT00320801|75979734|FG000|Extension Phase|Adverse Event|0|||
42172900|NCT00320801|75979735|FG001|Extension Phase|Adverse Event|0|||
42172901|NCT00320801|75979736|FG002|Extension Phase|Adverse Event|0|||
42048383|NCT00908232|75856619|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
42048384|NCT00908232|75856620|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
42048385|NCT00908232|75856621|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
42048386|NCT00908232|75856618|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
42048387|NCT00908232|75856619|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
42048388|NCT00908232|75856620|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
42048389|NCT00908232|75856621|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
42048390|NCT00908232|75856618|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
42048391|NCT00908232|75856619|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
42048392|NCT00908232|75856620|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
42048393|NCT00908232|75856621|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
42048394|NCT00908232|75856618|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
42172902|NCT00320801|75979737|FG003|Extension Phase|Adverse Event|8|||
42172903|NCT00320801|75979734|FG000|Extension Phase|Administrative|0|||
42172904|NCT00320801|75979735|FG001|Extension Phase|Administrative|0|||
42172905|NCT00320801|75979736|FG002|Extension Phase|Administrative|0|||
42172906|NCT00320801|75979737|FG003|Extension Phase|Administrative|29|||
42172907|NCT00320801|75979734|FG000|Extension Phase|Lack of Efficacy|0|||
42172908|NCT00320801|75979735|FG001|Extension Phase|Lack of Efficacy|0|||
42172909|NCT00320801|75979736|FG002|Extension Phase|Lack of Efficacy|0|||
42172910|NCT00320801|75979737|FG003|Extension Phase|Lack of Efficacy|2|||
42172911|NCT00320801|75979734|FG000|Extension Phase|Lost to Follow-up|0|||
42172912|NCT00320801|75979735|FG001|Extension Phase|Lost to Follow-up|0|||
42172913|NCT00320801|75979736|FG002|Extension Phase|Lost to Follow-up|0|||
42172914|NCT00320801|75979737|FG003|Extension Phase|Lost to Follow-up|3|||
42172915|NCT00320489|75979749|FG000|Overall Study|Adverse Event|26|||
42172916|NCT00320489|75979750|FG001|Overall Study|Adverse Event|25|||
42172917|NCT00320489|75979749|FG000|Overall Study|Clinical Relapse|26|||
42172918|NCT00320489|75979750|FG001|Overall Study|Clinical Relapse|20|||
42172919|NCT00320489|75979749|FG000|Overall Study|Death|0|||
42172920|NCT00320489|75979750|FG001|Overall Study|Death|2|||
42172921|NCT00320489|75979749|FG000|Overall Study|Entry Criteria Exclusion|2|||
42172922|NCT00320489|75979750|FG001|Overall Study|Entry Criteria Exclusion|4|||
42172923|NCT00320489|75979749|FG000|Overall Study|Lack of Efficacy|16|||
42172924|NCT00320489|75979750|FG001|Overall Study|Lack of Efficacy|7|||
42172925|NCT00320489|75979749|FG000|Overall Study|Lost to Follow-up|21|||
42172926|NCT00320489|75979750|FG001|Overall Study|Lost to Follow-up|22|||
42172927|NCT00320489|75979749|FG000|Overall Study|Physician Decision|8|||
42172928|NCT00320489|75979750|FG001|Overall Study|Physician Decision|8|||
42172929|NCT00320489|75979749|FG000|Overall Study|Protocol Violation|4|||
42172930|NCT00320489|75979750|FG001|Overall Study|Protocol Violation|4|||
42172931|NCT00320489|75979749|FG000|Overall Study|Sponsor Decision|3|||
42172932|NCT00320489|75979750|FG001|Overall Study|Sponsor Decision|3|||
42172933|NCT00320489|75979749|FG000|Overall Study|Withdrawal by Subject|39|||
42172934|NCT00320489|75979750|FG001|Overall Study|Withdrawal by Subject|41|||
42172935|NCT03928028|75979759|FG000|Overall Study|Physician Decision|9|||
42172936|NCT03928028|75979760|FG001|Overall Study|Physician Decision|6|||
42172937|NCT03928028|75979761|FG002|Overall Study|Physician Decision|3|||
42356875|NCT01405911|76202053|FG000|Overall Study|Lost to Follow-up|0|||
42048395|NCT00908232|75856619|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
42048396|NCT00908232|75856620|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
42048397|NCT00908232|75856621|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
42048398|NCT00908232|75856618|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
42048399|NCT00908232|75856619|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
42048400|NCT00908232|75856620|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
42048401|NCT00908232|75856621|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
42048402|NCT00908232|75856618|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
42048403|NCT00908232|75856619|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
42048404|NCT00908232|75856620|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
42048405|NCT00908232|75856621|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
42048406|NCT00908232|75856618|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
42048407|NCT00908232|75856619|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
42048408|NCT00908232|75856620|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
42048409|NCT00908232|75856621|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
42048410|NCT00770341|75856630|FG000|Overall Study|Did not meet eligibility criteria|1|||
42048411|NCT00770341|75856631|FG001|Overall Study|Did not meet eligibility criteria|0|||
42048412|NCT00770341|75856632|FG002|Overall Study|Did not meet eligibility criteria|0|||
42172938|NCT03928028|75979759|FG000|Overall Study|Withdrawal by Subject|12|||
42172939|NCT03928028|75979760|FG001|Overall Study|Withdrawal by Subject|3|||
42172940|NCT03928028|75979761|FG002|Overall Study|Withdrawal by Subject|3|||
42172941|NCT00320411|75979769|FG000|Overall Study|No investigational product admin.|4|||
42172942|NCT00320255|75979779|FG000|Overall Study|Lack of Efficacy|1|||
42172943|NCT00320255|75979780|FG001|Overall Study|Lack of Efficacy|0|||
42172944|NCT00320255|75979781|FG002|Overall Study|Lack of Efficacy|0|||
42172945|NCT00320255|75979782|FG003|Overall Study|Lack of Efficacy|0|||
42172946|NCT00320255|75979783|FG004|Overall Study|Lack of Efficacy|0|||
42048413|NCT00770341|75856630|FG000|Overall Study|Withdrawal by Subject|0|||
42048414|NCT00770341|75856631|FG001|Overall Study|Withdrawal by Subject|1|||
42048415|NCT00770341|75856632|FG002|Overall Study|Withdrawal by Subject|0|||
42048416|NCT00770341|75856630|FG000|Overall Study|Clinical Adverse Event|3|||
42048417|NCT00770341|75856631|FG001|Overall Study|Clinical Adverse Event|1|||
42048418|NCT00770341|75856632|FG002|Overall Study|Clinical Adverse Event|2|||
42048419|NCT00770341|75856630|FG000|Overall Study|Laboratory adverse event|3|||
42048420|NCT00770341|75856631|FG001|Overall Study|Laboratory adverse event|3|||
42048421|NCT00770341|75856632|FG002|Overall Study|Laboratory adverse event|0|||
42048422|NCT00770341|75856630|FG000|Overall Study|Lack of Efficacy|3|||
42048423|NCT00770341|75856631|FG001|Overall Study|Lack of Efficacy|0|||
42048424|NCT00770341|75856632|FG002|Overall Study|Lack of Efficacy|1|||
42048425|NCT00770341|75856630|FG000|Overall Study|Other|1|||
42048426|NCT00770341|75856631|FG001|Overall Study|Other|0|||
42048427|NCT00770341|75856632|FG002|Overall Study|Other|0|||
42048428|NCT00770341|75856630|FG000|Overall Study|Not treated|1|||
42048429|NCT00770341|75856631|FG001|Overall Study|Not treated|0|||
42048430|NCT00770341|75856632|FG002|Overall Study|Not treated|0|||
42048431|NCT00762463|75856649|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
42048432|NCT00762463|75856650|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
42048433|NCT00762463|75856651|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
42048434|NCT00762463|75856652|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
42048435|NCT00762463|75856649|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
42048436|NCT00762463|75856650|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
42048437|NCT00762463|75856651|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
42048438|NCT00762463|75856652|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
42048439|NCT00762463|75856649|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
42048440|NCT00762463|75856650|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
42048441|NCT00762463|75856651|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
42048442|NCT00762463|75856652|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
42048443|NCT00762463|75856649|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
42048444|NCT00762463|75856650|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
42048445|NCT00762463|75856651|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
42048446|NCT00762463|75856652|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
42048447|NCT00762463|75856649|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
42048448|NCT00762463|75856650|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
42048449|NCT00762463|75856651|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
42048450|NCT00762463|75856652|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
42048451|NCT00762463|75856649|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
42048452|NCT00762463|75856650|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
42048453|NCT00762463|75856651|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
42048454|NCT00762463|75856652|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
42048455|NCT00762463|75856649|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
42048456|NCT00762463|75856650|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
42048457|NCT00762463|75856651|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
42048458|NCT00762463|75856652|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
42048459|NCT00762463|75856649|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
42048460|NCT00762463|75856650|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
42048461|NCT00762463|75856651|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
42048462|NCT00762463|75856652|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
42048463|NCT00762385|75856665|FG000|First Intervention|Lens Issue|1|||
42048464|NCT00762385|75856666|FG001|First Intervention|Lens Issue|1|||
42048465|NCT00762385|75856665|FG000|First Intervention|Lost to Follow-up|0|||
42048466|NCT00762385|75856666|FG001|First Intervention|Lost to Follow-up|2|||
42048467|NCT00762385|75856665|FG000|First Intervention|Ineligible|1|||
42048468|NCT00762385|75856666|FG001|First Intervention|Ineligible|0|||
42048469|NCT00762385|75856665|FG000|First Intervention|Protocol Violation|0|||
42048470|NCT00762385|75856666|FG001|First Intervention|Protocol Violation|1|||
42048471|NCT00762385|75856665|FG000|Second Intervention|Protocol Violation|3|||
42048472|NCT00762385|75856666|FG001|Second Intervention|Protocol Violation|3|||
42048473|NCT00906282|75856675|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
42048474|NCT00906282|75856675|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
42048475|NCT00906282|75856675|FG000|Preoperative Chemotherapy|Progressive disease|6|||
42048476|NCT00906282|75856675|FG000|Preoperative Chemotherapy|Toxicity|1|||
42048477|NCT00762229|75856682|FG000|Overall Study|Lost to Follow-up|1|||
42048478|NCT00762229|75856683|FG001|Overall Study|Lost to Follow-up|1|||
42048479|NCT00762229|75856682|FG000|Overall Study|did not recveive intervention|0|||
42172947|NCT00320255|75979784|FG005|Overall Study|Lack of Efficacy|0|||
42172948|NCT00320255|75979779|FG000|Overall Study|Adverse Event|5|||
42048480|NCT00762229|75856683|FG001|Overall Study|did not recveive intervention|1|||
42048481|NCT00907374|75856691|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
42048482|NCT00907374|75856692|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
42172949|NCT00320255|75979780|FG001|Overall Study|Adverse Event|2|||
42172950|NCT00320255|75979781|FG002|Overall Study|Adverse Event|3|||
42172951|NCT00320255|75979782|FG003|Overall Study|Adverse Event|2|||
42172952|NCT00320255|75979783|FG004|Overall Study|Adverse Event|0|||
42048483|NCT00818662|75856702|FG000|Overall Study|Adverse Event|5|||
42048484|NCT00818662|75856703|FG001|Overall Study|Adverse Event|14|||
42048485|NCT00818662|75856704|FG002|Overall Study|Adverse Event|4|||
42048486|NCT00818662|75856705|FG003|Overall Study|Adverse Event|3|||
42048487|NCT00818662|75856702|FG000|Overall Study|Withdrawal by Subject|5|||
42048488|NCT00818662|75856703|FG001|Overall Study|Withdrawal by Subject|4|||
42048489|NCT00818662|75856704|FG002|Overall Study|Withdrawal by Subject|2|||
42048490|NCT00818662|75856705|FG003|Overall Study|Withdrawal by Subject|2|||
42048491|NCT00818662|75856702|FG000|Overall Study|Death|1|||
42048492|NCT00818662|75856703|FG001|Overall Study|Death|3|||
42048493|NCT00818662|75856704|FG002|Overall Study|Death|0|||
42048494|NCT00818662|75856705|FG003|Overall Study|Death|0|||
42048495|NCT00818662|75856702|FG000|Overall Study|Physician Decision|1|||
42048496|NCT00818662|75856703|FG001|Overall Study|Physician Decision|0|||
42048497|NCT00818662|75856704|FG002|Overall Study|Physician Decision|0|||
42048498|NCT00818662|75856705|FG003|Overall Study|Physician Decision|0|||
42048499|NCT00818662|75856702|FG000|Overall Study|Lost to Follow-up|0|||
42048500|NCT00818662|75856703|FG001|Overall Study|Lost to Follow-up|0|||
42048501|NCT00818662|75856704|FG002|Overall Study|Lost to Follow-up|0|||
42048502|NCT00818662|75856705|FG003|Overall Study|Lost to Follow-up|1|||
42048503|NCT00818662|75856702|FG000|Overall Study|Unwilling or Unable to Participate|4|||
42048504|NCT00818662|75856703|FG001|Overall Study|Unwilling or Unable to Participate|6|||
42048505|NCT00818662|75856704|FG002|Overall Study|Unwilling or Unable to Participate|2|||
42048506|NCT00818662|75856705|FG003|Overall Study|Unwilling or Unable to Participate|4|||
42048507|NCT00818662|75856702|FG000|Overall Study|Protocol Violation|1|||
42048508|NCT00818662|75856703|FG001|Overall Study|Protocol Violation|1|||
42048509|NCT00818662|75856704|FG002|Overall Study|Protocol Violation|0|||
42048510|NCT00818662|75856705|FG003|Overall Study|Protocol Violation|0|||
42048511|NCT00818662|75856702|FG000|Overall Study|Requires a Prohibited Medication|1|||
42048512|NCT00818662|75856703|FG001|Overall Study|Requires a Prohibited Medication|0|||
42048513|NCT00818662|75856704|FG002|Overall Study|Requires a Prohibited Medication|0|||
42048514|NCT00818662|75856705|FG003|Overall Study|Requires a Prohibited Medication|0|||
42048515|NCT00818662|75856702|FG000|Overall Study|Safety Risk|1|||
42048516|NCT00818662|75856703|FG001|Overall Study|Safety Risk|1|||
42048517|NCT00818662|75856704|FG002|Overall Study|Safety Risk|0|||
42048518|NCT00818662|75856705|FG003|Overall Study|Safety Risk|1|||
42048519|NCT00818662|75856702|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
42048520|NCT00818662|75856703|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
42048521|NCT00818662|75856704|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
42172953|NCT00320255|75979784|FG005|Overall Study|Adverse Event|0|||
42172954|NCT00320255|75979779|FG000|Overall Study|Withdrawal by Subject|1|||
42172955|NCT00320255|75979780|FG001|Overall Study|Withdrawal by Subject|2|||
42048522|NCT00818662|75856705|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
42048523|NCT00818662|75856702|FG000|Overall Study|Participant's health declined|0|||
42048524|NCT00818662|75856703|FG001|Overall Study|Participant's health declined|0|||
42048525|NCT00818662|75856704|FG002|Overall Study|Participant's health declined|0|||
42048526|NCT00818662|75856705|FG003|Overall Study|Participant's health declined|1|||
42048527|NCT00818662|75856702|FG000|Overall Study|Caregiver to pursue other treatment|0|||
42048528|NCT00818662|75856703|FG001|Overall Study|Caregiver to pursue other treatment|1|||
42048529|NCT00818662|75856704|FG002|Overall Study|Caregiver to pursue other treatment|0|||
42048530|NCT00818662|75856705|FG003|Overall Study|Caregiver to pursue other treatment|0|||
42048531|NCT00818662|75856702|FG000|Overall Study|Moving out of state|0|||
42048532|NCT00818662|75856703|FG001|Overall Study|Moving out of state|0|||
42048533|NCT00818662|75856704|FG002|Overall Study|Moving out of state|0|||
42048534|NCT00818662|75856705|FG003|Overall Study|Moving out of state|1|||
42048535|NCT00818662|75856702|FG000|Overall Study|Declined move to another study site|1|||
42048536|NCT00818662|75856703|FG001|Overall Study|Declined move to another study site|0|||
42048537|NCT00818662|75856704|FG002|Overall Study|Declined move to another study site|0|||
42048538|NCT00818662|75856705|FG003|Overall Study|Declined move to another study site|0|||
42048539|NCT00818662|75856702|FG000|Overall Study|Change in living situation|0|||
42048540|NCT00818662|75856703|FG001|Overall Study|Change in living situation|0|||
42048541|NCT00818662|75856704|FG002|Overall Study|Change in living situation|0|||
42048542|NCT00818662|75856705|FG003|Overall Study|Change in living situation|1|||
42048543|NCT00818662|75856702|FG000|Overall Study|Study partner decision|0|||
42048544|NCT00818662|75856703|FG001|Overall Study|Study partner decision|0|||
42048545|NCT00818662|75856704|FG002|Overall Study|Study partner decision|0|||
42048546|NCT00818662|75856705|FG003|Overall Study|Study partner decision|1|||
42048547|NCT00818662|75856702|FG000|Overall Study|Admitted to long term nursing care|0|||
42048548|NCT00818662|75856703|FG001|Overall Study|Admitted to long term nursing care|1|||
42048549|NCT00818662|75856704|FG002|Overall Study|Admitted to long term nursing care|0|||
42048550|NCT00818662|75856705|FG003|Overall Study|Admitted to long term nursing care|0|||
42048551|NCT00903786|75856716|FG000|Overall Study|Physician Decision|6|||
42048552|NCT00903786|75856716|FG000|Overall Study|Lack of Efficacy|5|||
42048553|NCT00903786|75856716|FG000|Overall Study|Reason other than lack of efficacy|4|||
42048554|NCT00762073|75856725|FG000|Overall Study|Lack of Efficacy|1|||
42048555|NCT00762073|75856726|FG001|Overall Study|Lack of Efficacy|1|||
42048556|NCT00762073|75856727|FG002|Overall Study|Lack of Efficacy|0|||
42048557|NCT00762073|75856728|FG003|Overall Study|Lack of Efficacy|0|||
42048558|NCT00762073|75856725|FG000|Overall Study|Adverse Event|1|||
42048559|NCT00762073|75856726|FG001|Overall Study|Adverse Event|0|||
42048560|NCT00762073|75856727|FG002|Overall Study|Adverse Event|1|||
42048561|NCT00762073|75856728|FG003|Overall Study|Adverse Event|1|||
42048562|NCT00762073|75856725|FG000|Overall Study|Significant Subject Noncompliance|0|||
42048563|NCT00762073|75856726|FG001|Overall Study|Significant Subject Noncompliance|1|||
42048564|NCT00762073|75856727|FG002|Overall Study|Significant Subject Noncompliance|0|||
42048565|NCT00762073|75856728|FG003|Overall Study|Significant Subject Noncompliance|1|||
42048566|NCT00762073|75856725|FG000|Overall Study|Withdrawal by Subject|1|||
42048567|NCT00762073|75856726|FG001|Overall Study|Withdrawal by Subject|2|||
42048568|NCT00762073|75856727|FG002|Overall Study|Withdrawal by Subject|1|||
42048569|NCT00762073|75856728|FG003|Overall Study|Withdrawal by Subject|1|||
42048570|NCT00762073|75856725|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
42048571|NCT00762073|75856726|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
42048572|NCT00762073|75856727|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
42048573|NCT00762073|75856728|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
42048574|NCT00761761|75856747|FG000|Overall Study|Lost to Follow-up|3|||
42048575|NCT00761761|75856748|FG001|Overall Study|Lost to Follow-up|1|||
42048576|NCT00761761|75856747|FG000|Overall Study|Withdrawal by Subject|3|||
42048577|NCT00761761|75856748|FG001|Overall Study|Withdrawal by Subject|0|||
42048578|NCT00761605|75856756|FG000|Overall Study|Adverse Event|26|||
42048579|NCT00761605|75856756|FG000|Overall Study|Death|2|||
42048580|NCT00761605|75856756|FG000|Overall Study|Lack of Efficacy|26|||
42048581|NCT00761605|75856756|FG000|Overall Study|Lost to Follow-up|29|||
42048582|NCT00761605|75856756|FG000|Overall Study|Withdrawal by Subject|37|||
42048583|NCT00761605|75856756|FG000|Overall Study|Other|21|||
42048584|NCT00761527|75856764|FG000|Overall Study|Adverse Event|3|||
42048585|NCT00761527|75856764|FG000|Overall Study|Poor Compliance|8|||
42048586|NCT00761527|75856764|FG000|Overall Study|Lost to Follow-up|9|||
42048587|NCT00761527|75856764|FG000|Overall Study|Unknown reason|2|||
42048588|NCT00770029|75856770|FG000|Overall Study|Lost to Follow-up|2|||
42048589|NCT00770029|75856771|FG001|Overall Study|Lost to Follow-up|0|||
42048590|NCT00770029|75856770|FG000|Overall Study|Withdrawal by Subject|3|||
42356876|NCT01405911|76202054|FG001|Overall Study|Lost to Follow-up|1|||
42048591|NCT00770029|75856771|FG001|Overall Study|Withdrawal by Subject|3|||
42048592|NCT00770029|75856770|FG000|Overall Study|Adverse Event|1|||
42356877|NCT01405911|76202055|FG002|Overall Study|Lost to Follow-up|0|||
42356878|NCT01405911|76202053|FG000|Overall Study|Protocol Violation|1|||
42048593|NCT00770029|75856771|FG001|Overall Study|Adverse Event|0|||
42048594|NCT00817414|75856782|FG000|Overall Study|Adverse Event|1|||
42048595|NCT00817414|75856783|FG001|Overall Study|Adverse Event|1|||
42172956|NCT00320255|75979781|FG002|Overall Study|Withdrawal by Subject|2|||
42048596|NCT00817414|75856784|FG002|Overall Study|Adverse Event|1|||
42048597|NCT00817414|75856785|FG003|Overall Study|Adverse Event|0|||
42048598|NCT00817414|75856786|FG004|Overall Study|Adverse Event|0|||
42048599|NCT00817414|75856782|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
42048600|NCT00817414|75856783|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
42048601|NCT00817414|75856784|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
42048602|NCT00817414|75856785|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
42048603|NCT00817414|75856786|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
42048604|NCT00817414|75856782|FG000|Overall Study|Withdrawal by Subject|1|||
42048605|NCT00817414|75856783|FG001|Overall Study|Withdrawal by Subject|1|||
42048606|NCT00817414|75856784|FG002|Overall Study|Withdrawal by Subject|0|||
42048607|NCT00817414|75856785|FG003|Overall Study|Withdrawal by Subject|0|||
42048608|NCT00817414|75856786|FG004|Overall Study|Withdrawal by Subject|0|||
42048609|NCT00817414|75856782|FG000|Overall Study|Lost to Follow-up|0|||
42048610|NCT00817414|75856783|FG001|Overall Study|Lost to Follow-up|0|||
42048611|NCT00817414|75856784|FG002|Overall Study|Lost to Follow-up|1|||
42048612|NCT00817414|75856785|FG003|Overall Study|Lost to Follow-up|1|||
42048613|NCT00817414|75856786|FG004|Overall Study|Lost to Follow-up|1|||
42048614|NCT00817414|75856782|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
42048615|NCT00817414|75856783|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
42048616|NCT00817414|75856784|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
42048617|NCT00817414|75856785|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
42048618|NCT00817414|75856786|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
42048619|NCT00817414|75856782|FG000|Overall Study|Protocol Violation|0|||
42048620|NCT00817414|75856783|FG001|Overall Study|Protocol Violation|0|||
42048621|NCT00817414|75856784|FG002|Overall Study|Protocol Violation|0|||
42048622|NCT00817414|75856785|FG003|Overall Study|Protocol Violation|0|||
42048623|NCT00817414|75856786|FG004|Overall Study|Protocol Violation|1|||
42048624|NCT00769561|75856805|FG000|Overall Study|Withdrawal by Subject|2|||
42172957|NCT00320255|75979782|FG003|Overall Study|Withdrawal by Subject|4|||
42172958|NCT00320255|75979783|FG004|Overall Study|Withdrawal by Subject|0|||
42172959|NCT00320255|75979784|FG005|Overall Study|Withdrawal by Subject|0|||
42172960|NCT00320255|75979779|FG000|Overall Study|Poor compliance/noncompliance|1|||
42172961|NCT00320255|75979780|FG001|Overall Study|Poor compliance/noncompliance|1|||
42172962|NCT00320255|75979781|FG002|Overall Study|Poor compliance/noncompliance|0|||
42172963|NCT00320255|75979782|FG003|Overall Study|Poor compliance/noncompliance|1|||
42172964|NCT00320255|75979783|FG004|Overall Study|Poor compliance/noncompliance|0|||
42172965|NCT00320255|75979784|FG005|Overall Study|Poor compliance/noncompliance|0|||
42172966|NCT00320255|75979779|FG000|Overall Study|No longer meets study criteria|0|||
42172967|NCT00320255|75979780|FG001|Overall Study|No longer meets study criteria|0|||
42172968|NCT00320255|75979781|FG002|Overall Study|No longer meets study criteria|0|||
42172969|NCT00320255|75979782|FG003|Overall Study|No longer meets study criteria|1|||
42172970|NCT00320255|75979783|FG004|Overall Study|No longer meets study criteria|0|||
42172971|NCT00320255|75979784|FG005|Overall Study|No longer meets study criteria|0|||
42172972|NCT00320255|75979779|FG000|Overall Study|Other|3|||
42172973|NCT00320255|75979780|FG001|Overall Study|Other|2|||
42172974|NCT00320255|75979781|FG002|Overall Study|Other|1|||
42172975|NCT00320255|75979782|FG003|Overall Study|Other|0|||
42172976|NCT00320255|75979783|FG004|Overall Study|Other|0|||
42172977|NCT00320255|75979784|FG005|Overall Study|Other|0|||
42172978|NCT00370331|75979801|FG000|Overall Study|Adverse Event|4|||
42172979|NCT00370331|75979802|FG001|Overall Study|Adverse Event|13|||
42172980|NCT00370331|75979801|FG000|Overall Study|Withdrawal by Subject|2|||
42172981|NCT00370331|75979802|FG001|Overall Study|Withdrawal by Subject|4|||
42172982|NCT00370331|75979801|FG000|Overall Study|Lost to Follow-up|0|||
42172983|NCT00370331|75979802|FG001|Overall Study|Lost to Follow-up|3|||
42172984|NCT00370331|75979801|FG000|Overall Study|Lack of Efficacy|0|||
42048625|NCT00769561|75856806|FG001|Overall Study|Withdrawal by Subject|2|||
42048626|NCT00769561|75856805|FG000|Overall Study|Lost to Follow-up|1|||
42048627|NCT00769561|75856806|FG001|Overall Study|Lost to Follow-up|3|||
42048628|NCT00817336|75856814|FG000|Overall Study|Withdrawal by Subject|1|||
42172985|NCT00370331|75979802|FG001|Overall Study|Lack of Efficacy|1|||
42172986|NCT00370331|75979801|FG000|Overall Study|Non-compliance|0|||
42048629|NCT00817336|75856815|FG001|Overall Study|Withdrawal by Subject|1|||
42048630|NCT00761215|75856823|FG000|Overall Study|Randomized but didn't receive drug|1|||
42048631|NCT00761215|75856824|FG001|Overall Study|Randomized but didn't receive drug|1|||
42172987|NCT00370331|75979802|FG001|Overall Study|Non-compliance|1|||
42172988|NCT00370331|75979801|FG000|Overall Study|Protocol Violation|1|||
42172989|NCT00370331|75979802|FG001|Overall Study|Protocol Violation|1|||
42172990|NCT02962960|75979811|FG000|Overall Study|Withdrawal by Subject|1|||
42172991|NCT02962960|75979812|FG001|Overall Study|Withdrawal by Subject|1|||
42048632|NCT00761215|75856825|FG002|Overall Study|Randomized but didn't receive drug|2|||
42048633|NCT00761215|75856823|FG000|Overall Study|Lost to Follow-up|6|||
42048634|NCT00761215|75856824|FG001|Overall Study|Lost to Follow-up|3|||
42048635|NCT00761215|75856825|FG002|Overall Study|Lost to Follow-up|6|||
42048636|NCT00761215|75856823|FG000|Overall Study|Withdrawal by Subject|1|||
42048637|NCT00761215|75856824|FG001|Overall Study|Withdrawal by Subject|0|||
42048638|NCT00761215|75856825|FG002|Overall Study|Withdrawal by Subject|0|||
42048639|NCT00761215|75856823|FG000|Overall Study|Bacteremia|1|||
42048640|NCT00761215|75856824|FG001|Overall Study|Bacteremia|0|||
42048641|NCT00761215|75856825|FG002|Overall Study|Bacteremia|0|||
42048642|NCT05101122|75856858|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
42048643|NCT05101122|75856858|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
42048644|NCT05101122|75856858|FG000|AD313 80/5|Withdrawal by Subject|1|||
42048645|NCT05101122|75856858|FG000|AD313 80/10|Physician Decision|1|||
42048646|NCT05038163|75856871|FG000|Stage 1|Did not complete survey|374|||
42172992|NCT02962960|75979813|FG002|Overall Study|Withdrawal by Subject|0|||
42172993|NCT02962960|75979811|FG000|Overall Study|Adverse Event|1|||
42172994|NCT02962960|75979812|FG001|Overall Study|Adverse Event|1|||
42172995|NCT02962960|75979813|FG002|Overall Study|Adverse Event|0|||
42172996|NCT02962960|75979811|FG000|Overall Study|Protocol Violation|1|||
42172997|NCT02962960|75979812|FG001|Overall Study|Protocol Violation|0|||
42172998|NCT02962960|75979813|FG002|Overall Study|Protocol Violation|0|||
42172999|NCT00369941|75979825|FG000|Overall Study|Never Treated|1|||
42173000|NCT00369941|75979826|FG001|Overall Study|Never Treated|2|||
42173001|NCT00369941|75979825|FG000|Overall Study|Adverse Event|14|||
42173002|NCT00369941|75979826|FG001|Overall Study|Adverse Event|28|||
42173003|NCT00369941|75979825|FG000|Overall Study|Lack of Efficacy|6|||
42173004|NCT00369941|75979826|FG001|Overall Study|Lack of Efficacy|10|||
42173005|NCT00369941|75979825|FG000|Overall Study|Lost to Follow-up|12|||
42173006|NCT00369941|75979826|FG001|Overall Study|Lost to Follow-up|22|||
42173007|NCT00369941|75979825|FG000|Overall Study|Protocol Violation|5|||
42173008|NCT00369941|75979826|FG001|Overall Study|Protocol Violation|3|||
42173009|NCT00369941|75979825|FG000|Overall Study|Withdrawal by Subject|5|||
42173010|NCT00369941|75979826|FG001|Overall Study|Withdrawal by Subject|18|||
42173011|NCT00369941|75979825|FG000|Overall Study|Pregnancy|4|||
42173012|NCT00369941|75979826|FG001|Overall Study|Pregnancy|2|||
42173013|NCT00369941|75979825|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
42173014|NCT00369941|75979826|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
42173015|NCT00369941|75979825|FG000|Overall Study|Moved|11|||
42173016|NCT00369941|75979826|FG001|Overall Study|Moved|5|||
42173017|NCT00369941|75979825|FG000|Overall Study|Treatment with Prohibited Medication|3|||
42173018|NCT00369941|75979826|FG001|Overall Study|Treatment with Prohibited Medication|1|||
42173019|NCT00369941|75979825|FG000|Overall Study|Employment Interfered with Study Visits|1|||
42173020|NCT00369941|75979826|FG001|Overall Study|Employment Interfered with Study Visits|0|||
42173021|NCT00369941|75979825|FG000|Overall Study|Study Site Terminated|2|||
42173022|NCT00369941|75979826|FG001|Overall Study|Study Site Terminated|0|||
42173023|NCT00369941|75979825|FG000|Overall Study|Miscellaneous|3|||
42173024|NCT00369941|75979826|FG001|Overall Study|Miscellaneous|3|||
42291330|NCT02641379|76125030|FG003|Overall Study|PCR positive at Week 68|0|||
42291331|NCT02641379|76125031|FG004|Overall Study|PCR positive at Week 68|0|||
42291332|NCT02641379|76125032|FG005|Overall Study|PCR positive at Week 68|0|||
42291333|NCT02641379|76125033|FG006|Overall Study|PCR positive at Week 68|0|||
42291334|NCT02641379|76125034|FG007|Overall Study|PCR positive at Week 68|0|||
42291335|NCT02641379|76125035|FG008|Overall Study|PCR positive at Week 68|0|||
42291336|NCT02641379|76125036|FG009|Overall Study|PCR positive at Week 68|0|||
42048647|NCT05038163|75856872|FG001|Stage 1|Did not complete survey|0|||
42048648|NCT05038163|75856873|FG002|Stage 1|Did not complete survey|0|||
42048649|NCT05038163|75856874|FG003|Stage 1|Did not complete survey|0|||
42173025|NCT00319553|75979835|FG000|Overall Study|Protocol Violation|1|||
42173026|NCT00319553|75979836|FG001|Overall Study|Protocol Violation|2|||
42173027|NCT00319553|75979835|FG000|Overall Study|Lost to Follow-up|2|||
42173028|NCT00319553|75979836|FG001|Overall Study|Lost to Follow-up|1|||
42173029|NCT00319553|75979835|FG000|Overall Study|Withdrawal by Subject|1|||
42291337|NCT02641379|76125037|FG010|Overall Study|PCR positive at Week 68|0|||
42048650|NCT05038163|75856875|FG004|Stage 1|Did not complete survey|0|||
42173030|NCT00319553|75979836|FG001|Overall Study|Withdrawal by Subject|1|||
42173031|NCT00369785|75979844|FG000|Overall Study|Physician Decision|3|||
42173032|NCT00369785|75979845|FG001|Overall Study|Physician Decision|2|||
42048651|NCT05038163|75856876|FG005|Stage 1|Did not complete survey|0|||
42173033|NCT00369785|75979844|FG000|Overall Study|Death|1|||
42173034|NCT00369785|75979845|FG001|Overall Study|Death|2|||
42173035|NCT00369785|75979844|FG000|Overall Study|Withdrawal by Subject|7|||
42173036|NCT00369785|75979845|FG001|Overall Study|Withdrawal by Subject|6|||
42291338|NCT02641379|76125027|FG000|Overall Study|PCR positive at Week 48|0|||
42291339|NCT02641379|76125028|FG001|Overall Study|PCR positive at Week 48|1|||
42291340|NCT02641379|76125029|FG002|Overall Study|PCR positive at Week 48|0|||
42291341|NCT02641379|76125030|FG003|Overall Study|PCR positive at Week 48|0|||
42291342|NCT02641379|76125031|FG004|Overall Study|PCR positive at Week 48|0|||
42291343|NCT02641379|76125032|FG005|Overall Study|PCR positive at Week 48|0|||
42291344|NCT02641379|76125033|FG006|Overall Study|PCR positive at Week 48|0|||
42048652|NCT05038163|75856871|FG000|Stage 2|Did not complete Stage 2 survey|0|||
42048653|NCT05038163|75856872|FG001|Stage 2|Did not complete Stage 2 survey|29|||
42048654|NCT05038163|75856873|FG002|Stage 2|Did not complete Stage 2 survey|30|||
42048655|NCT05038163|75856874|FG003|Stage 2|Did not complete Stage 2 survey|24|||
42048656|NCT05038163|75856875|FG004|Stage 2|Did not complete Stage 2 survey|21|||
42048657|NCT05038163|75856876|FG005|Stage 2|Did not complete Stage 2 survey|100|||
42048658|NCT04516746|75856904|FG000|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|21090|||
42048659|NCT04516746|75856905|FG001|Overall Study|Ongoing in the study at clinical DCO for the primary analysis.|10305|||
42048660|NCT04516746|75856904|FG000|Overall Study|Withdrawal by Subject|362|||
42048661|NCT04516746|75856905|FG001|Overall Study|Withdrawal by Subject|408|||
42048662|NCT04516746|75856904|FG000|Overall Study|Lost to Follow-up|157|||
42048663|NCT04516746|75856905|FG001|Overall Study|Lost to Follow-up|86|||
42048664|NCT04516746|75856904|FG000|Overall Study|Protocol deviation|18|||
42048665|NCT04516746|75856905|FG001|Overall Study|Protocol deviation|7|||
42048666|NCT04516746|75856904|FG000|Overall Study|Death|8|||
42048667|NCT04516746|75856905|FG001|Overall Study|Death|7|||
42048668|NCT04516746|75856904|FG000|Overall Study|Physician Decision|0|||
42048669|NCT04516746|75856905|FG001|Overall Study|Physician Decision|2|||
42048670|NCT04516746|75856904|FG000|Overall Study|Other|0|||
42048671|NCT04516746|75856905|FG001|Overall Study|Other|1|||
42048672|NCT04413617|75856935|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
42048673|NCT04413617|75856936|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
42048674|NCT04413617|75856937|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
42048675|NCT04413617|75856938|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
42048676|NCT04413617|75856939|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
42048677|NCT04413617|75856935|FG000|Overall Study|Protocol Violation|0|||
42048678|NCT04413617|75856936|FG001|Overall Study|Protocol Violation|1|||
42048679|NCT04413617|75856937|FG002|Overall Study|Protocol Violation|0|||
42048680|NCT04413617|75856938|FG003|Overall Study|Protocol Violation|0|||
42048681|NCT04413617|75856939|FG004|Overall Study|Protocol Violation|1|||
42048682|NCT04413617|75856935|FG000|Overall Study|Lack of Efficacy|2|||
42048683|NCT04413617|75856936|FG001|Overall Study|Lack of Efficacy|0|||
42048684|NCT04413617|75856937|FG002|Overall Study|Lack of Efficacy|2|||
42173037|NCT00369785|75979844|FG000|Overall Study|Toxicity|6|||
42048685|NCT04413617|75856938|FG003|Overall Study|Lack of Efficacy|1|||
42048686|NCT04413617|75856939|FG004|Overall Study|Lack of Efficacy|0|||
42048687|NCT04413617|75856935|FG000|Overall Study|Withdrawal by Subject|3|||
42048688|NCT04413617|75856936|FG001|Overall Study|Withdrawal by Subject|4|||
42048689|NCT04413617|75856937|FG002|Overall Study|Withdrawal by Subject|2|||
42048690|NCT04413617|75856938|FG003|Overall Study|Withdrawal by Subject|5|||
42048691|NCT04413617|75856939|FG004|Overall Study|Withdrawal by Subject|3|||
42048692|NCT04413617|75856935|FG000|Overall Study|Death|1|||
42048693|NCT04413617|75856936|FG001|Overall Study|Death|0|||
42048694|NCT04413617|75856937|FG002|Overall Study|Death|0|||
42048695|NCT04413617|75856938|FG003|Overall Study|Death|0|||
42048696|NCT04413617|75856939|FG004|Overall Study|Death|0|||
42048697|NCT04413617|75856935|FG000|Overall Study|Adverse Event|1|||
42048698|NCT04413617|75856936|FG001|Overall Study|Adverse Event|0|||
42048699|NCT04413617|75856937|FG002|Overall Study|Adverse Event|0|||
42048700|NCT04413617|75856938|FG003|Overall Study|Adverse Event|1|||
42048701|NCT04413617|75856939|FG004|Overall Study|Adverse Event|1|||
42048702|NCT04413617|75856935|FG000|Overall Study|COVID-19|0|||
42048703|NCT04413617|75856936|FG001|Overall Study|COVID-19|1|||
42048704|NCT04413617|75856937|FG002|Overall Study|COVID-19|0|||
42048705|NCT04413617|75856938|FG003|Overall Study|COVID-19|0|||
42048706|NCT04413617|75856939|FG004|Overall Study|COVID-19|0|||
42048707|NCT04055116|75856971|FG000|First Intervention|Physician Decision|2|||
42048708|NCT04055116|75856972|FG001|First Intervention|Physician Decision|7|||
42173038|NCT00369785|75979845|FG001|Overall Study|Toxicity|4|||
42173039|NCT00369785|75979844|FG000|Overall Study|Never started|0|||
42048709|NCT03512262|75857018|FG000|Overall Study|Adverse Event|8|||
42048710|NCT03512262|75857019|FG001|Overall Study|Adverse Event|3|||
42173040|NCT00369785|75979845|FG001|Overall Study|Never started|2|||
42291345|NCT02641379|76125034|FG007|Overall Study|PCR positive at Week 48|0|||
42048711|NCT03512262|75857018|FG000|Overall Study|Death (non-treatment emergent)|1|||
42048712|NCT03512262|75857019|FG001|Overall Study|Death (non-treatment emergent)|0|||
42048713|NCT03512262|75857018|FG000|Overall Study|Withdrawal by Subject|17|||
42048714|NCT03512262|75857019|FG001|Overall Study|Withdrawal by Subject|9|||
42048715|NCT03512262|75857018|FG000|Overall Study|Lost to Follow-up|7|||
42048716|NCT03512262|75857019|FG001|Overall Study|Lost to Follow-up|1|||
42048717|NCT03512262|75857018|FG000|Overall Study|Other than Specified|2|||
42048718|NCT03512262|75857019|FG001|Overall Study|Other than Specified|2|||
42048719|NCT03499600|75857027|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
42048720|NCT03499600|75857028|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
42048721|NCT03007979|75857042|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
42048722|NCT02960893|75857048|FG000|Randomization Phase (8-week)|Adverse Event|5|||
42048723|NCT02960893|75857049|FG001|Randomization Phase (8-week)|Adverse Event|0|||
42048724|NCT02960893|75857048|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
42048725|NCT02960893|75857049|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
42048726|NCT02960893|75857048|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
42048727|NCT02960893|75857049|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
42048728|NCT02960893|75857048|FG000|Extension Phase (48-week)|Adverse Event|2|||
42048729|NCT02960893|75857049|FG001|Extension Phase (48-week)|Adverse Event|3|||
42048730|NCT02960893|75857048|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
42048731|NCT02960893|75857049|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
42048732|NCT02960893|75857048|FG000|Extension Phase (48-week)|Other Reason|2|||
42048733|NCT02960893|75857049|FG001|Extension Phase (48-week)|Other Reason|1|||
42048734|NCT02960893|75857048|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
42048735|NCT02960893|75857049|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
42048736|NCT02960893|75857048|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
42048737|NCT02960893|75857049|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
42048738|NCT02867813|75857064|FG000|Overall Study|Withdrawal by Subject|57|||
42048739|NCT02867813|75857065|FG001|Overall Study|Withdrawal by Subject|56|||
42048740|NCT02867813|75857064|FG000|Overall Study|Decision by Sponsor|7|||
42048741|NCT02867813|75857065|FG001|Overall Study|Decision by Sponsor|7|||
42048742|NCT02867813|75857064|FG000|Overall Study|Lost to Follow-up|91|||
42048743|NCT02867813|75857065|FG001|Overall Study|Lost to Follow-up|78|||
42048744|NCT02867813|75857064|FG000|Overall Study|Missing|2|||
42048745|NCT02867813|75857065|FG001|Overall Study|Missing|1|||
42048746|NCT02867813|75857064|FG000|Overall Study|Death|294|||
42048747|NCT02867813|75857065|FG001|Overall Study|Death|268|||
42048748|NCT02278055|75857077|FG000|Overall Study|Adverse Event|1|||
42048749|NCT02278055|75857077|FG000|Overall Study|Lost to Follow-up|1|||
42048750|NCT02278055|75857077|FG000|Overall Study|Withdrawal by Subject|2|||
42048751|NCT02278055|75857077|FG000|Overall Study|Progressive Disease|4|||
42048752|NCT02231879|75857083|FG000|Overall Study|Adverse Event|2|||
42048753|NCT02231879|75857084|FG001|Overall Study|Adverse Event|1|||
42048754|NCT02231879|75857083|FG000|Overall Study|Lack of Efficacy|0|||
42048755|NCT02231879|75857084|FG001|Overall Study|Lack of Efficacy|1|||
42048756|NCT01833806|75857105|FG000|Overall Study|Alternative treatment|2|||
42048757|NCT01833806|75857105|FG000|Overall Study|Death|5|||
42048758|NCT01833806|75857105|FG000|Overall Study|Physician Decision|1|||
42048759|NCT01833806|75857105|FG000|Overall Study|Lost to Follow-up|1|||
42048760|NCT01712490|75857111|FG000|Overall Study|Ongoing|601|||
42048761|NCT01712490|75857112|FG001|Overall Study|Ongoing|586|||
42048762|NCT01712490|75857111|FG000|Overall Study|Other|11|||
42048763|NCT01712490|75857112|FG001|Overall Study|Other|11|||
42048764|NCT01712490|75857111|FG000|Overall Study|Withdrawal by Subject|36|||
42048765|NCT01712490|75857112|FG001|Overall Study|Withdrawal by Subject|44|||
42048766|NCT01712490|75857111|FG000|Overall Study|Lost to Follow-up|16|||
42048767|NCT01712490|75857112|FG001|Overall Study|Lost to Follow-up|29|||
42048768|NCT01439802|75857118|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
42048769|NCT01439802|75857118|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
42048770|NCT00816556|75857129|FG000|Overall Study|Adverse Event|1|||
42048771|NCT00816556|75857130|FG001|Overall Study|Adverse Event|1|||
42048772|NCT00816556|75857131|FG002|Overall Study|Adverse Event|1|||
42048773|NCT00816556|75857129|FG000|Overall Study|Withdrawal by Subject|1|||
42048774|NCT00816556|75857130|FG001|Overall Study|Withdrawal by Subject|1|||
42048775|NCT00816556|75857131|FG002|Overall Study|Withdrawal by Subject|1|||
42048776|NCT00816556|75857129|FG000|Overall Study|Lost to Follow-up|0|||
42048777|NCT00816556|75857130|FG001|Overall Study|Lost to Follow-up|0|||
42048778|NCT00816556|75857131|FG002|Overall Study|Lost to Follow-up|1|||
42291346|NCT02641379|76125035|FG008|Overall Study|PCR positive at Week 48|0|||
42291347|NCT02641379|76125036|FG009|Overall Study|PCR positive at Week 48|0|||
42048779|NCT00760747|75857141|FG000|Study Period II|Adverse Event|3|||
42048780|NCT00760747|75857142|FG001|Study Period II|Adverse Event|4|||
42048781|NCT00760747|75857141|FG000|Study Period II|Lack of Efficacy|0|||
42048782|NCT00760747|75857142|FG001|Study Period II|Lack of Efficacy|6|||
42048783|NCT00760747|75857141|FG000|Study Period II|Parent/Caregiver Decision|3|||
42048784|NCT00760747|75857142|FG001|Study Period II|Parent/Caregiver Decision|0|||
42048785|NCT00760747|75857141|FG000|Study Period II|Protocol Violation|6|||
42048786|NCT00760747|75857142|FG001|Study Period II|Protocol Violation|3|||
42048787|NCT00760747|75857141|FG000|Study Period II|Withdrawal by Subject|1|||
42048788|NCT00760747|75857142|FG001|Study Period II|Withdrawal by Subject|0|||
42048789|NCT00760747|75857141|FG000|Study Period II|No drug administered|0|||
42048790|NCT00760747|75857142|FG001|Study Period II|No drug administered|1|||
42048791|NCT00760747|75857141|FG000|Study Period III|Adverse Event|1|||
42048792|NCT00760747|75857142|FG001|Study Period III|Adverse Event|0|||
42048793|NCT00760747|75857141|FG000|Study Period III|Lack of Efficacy|1|||
42048794|NCT00760747|75857142|FG001|Study Period III|Lack of Efficacy|0|||
42048795|NCT00760747|75857141|FG000|Study Period III|Parent/Caregiver Decision|0|||
42048796|NCT00760747|75857142|FG001|Study Period III|Parent/Caregiver Decision|1|||
42048797|NCT00760747|75857141|FG000|Study Period III|Protocol Violation|1|||
42048798|NCT00760747|75857142|FG001|Study Period III|Protocol Violation|1|||
42048799|NCT00760747|75857141|FG000|Study Period III|Physician Decision|0|||
42048800|NCT00760747|75857142|FG001|Study Period III|Physician Decision|1|||
42048801|NCT00760669|75857148|FG000|Overall Study|Not assessed for overall improvement|18|||
42048802|NCT00760669|75857148|FG000|Overall Study|Participants missing efficacy assessment|6|||
42048803|NCT00760669|75857148|FG000|Overall Study|Participants with overlapping cases|1|||
42048804|NCT00760669|75857148|FG000|Overall Study|Took drug before entering in contract|5|||
42048805|NCT00769483|75857158|FG000|Overall Study|Withdrawal by Subject|0|||
42048806|NCT00769483|75857159|FG001|Overall Study|Withdrawal by Subject|1|||
42048807|NCT00769483|75857160|FG002|Overall Study|Withdrawal by Subject|0|||
42048808|NCT00769483|75857161|FG003|Overall Study|Withdrawal by Subject|0|||
42048809|NCT00769483|75857162|FG004|Overall Study|Withdrawal by Subject|1|||
42048810|NCT00769483|75857163|FG005|Overall Study|Withdrawal by Subject|0|||
42048811|NCT00760513|75857181|FG000|Overall Study|Withdrawal by Subject|5|||
42048812|NCT00760513|75857182|FG001|Overall Study|Withdrawal by Subject|7|||
42048813|NCT00907296|75857200|FG000|Overall Study|Ineligibility Determined|1|||
42048814|NCT00907296|75857201|FG001|Overall Study|Ineligibility Determined|0|||
42048815|NCT00907296|75857202|FG002|Overall Study|Ineligibility Determined|0|||
42048816|NCT00907296|75857203|FG003|Overall Study|Ineligibility Determined|1|||
42048817|NCT00907296|75857204|FG004|Overall Study|Ineligibility Determined|0|||
42048818|NCT00907296|75857205|FG005|Overall Study|Ineligibility Determined|0|||
42048819|NCT00907296|75857206|FG006|Overall Study|Ineligibility Determined|0|||
42048820|NCT00907296|75857207|FG007|Overall Study|Ineligibility Determined|1|||
42048821|NCT00907296|75857208|FG008|Overall Study|Ineligibility Determined|0|||
42048822|NCT00907296|75857209|FG009|Overall Study|Ineligibility Determined|0|||
42048823|NCT00907296|75857200|FG000|Overall Study|Protocol Deviation|0|||
42048824|NCT00907296|75857201|FG001|Overall Study|Protocol Deviation|1|||
42048825|NCT00907296|75857202|FG002|Overall Study|Protocol Deviation|0|||
42048826|NCT00907296|75857203|FG003|Overall Study|Protocol Deviation|0|||
42048827|NCT00907296|75857204|FG004|Overall Study|Protocol Deviation|0|||
42048828|NCT00907296|75857205|FG005|Overall Study|Protocol Deviation|0|||
42048829|NCT00907296|75857206|FG006|Overall Study|Protocol Deviation|0|||
42048830|NCT00907296|75857207|FG007|Overall Study|Protocol Deviation|0|||
42048831|NCT00907296|75857208|FG008|Overall Study|Protocol Deviation|0|||
42048832|NCT00907296|75857209|FG009|Overall Study|Protocol Deviation|0|||
42048833|NCT00907296|75857200|FG000|Overall Study|Noncompliance|1|||
42048834|NCT00907296|75857201|FG001|Overall Study|Noncompliance|1|||
42048835|NCT00907296|75857202|FG002|Overall Study|Noncompliance|1|||
42048836|NCT00907296|75857203|FG003|Overall Study|Noncompliance|0|||
42048837|NCT00907296|75857204|FG004|Overall Study|Noncompliance|0|||
42048838|NCT00907296|75857205|FG005|Overall Study|Noncompliance|1|||
42048839|NCT00907296|75857206|FG006|Overall Study|Noncompliance|0|||
42048840|NCT00907296|75857207|FG007|Overall Study|Noncompliance|2|||
42048841|NCT00907296|75857208|FG008|Overall Study|Noncompliance|0|||
42048842|NCT00907296|75857209|FG009|Overall Study|Noncompliance|0|||
42048843|NCT00907296|75857200|FG000|Overall Study|Adverse Event|2|||
42048844|NCT00907296|75857201|FG001|Overall Study|Adverse Event|0|||
42048845|NCT00907296|75857202|FG002|Overall Study|Adverse Event|0|||
42048846|NCT00907296|75857203|FG003|Overall Study|Adverse Event|0|||
42048847|NCT00907296|75857204|FG004|Overall Study|Adverse Event|0|||
42048848|NCT00907296|75857205|FG005|Overall Study|Adverse Event|0|||
42048849|NCT00907296|75857206|FG006|Overall Study|Adverse Event|1|||
42048850|NCT00907296|75857207|FG007|Overall Study|Adverse Event|0|||
42173041|NCT00369785|75979844|FG000|Overall Study|Progression|4|||
42173042|NCT00369785|75979845|FG001|Overall Study|Progression|4|||
42173043|NCT00369785|75979844|FG000|Overall Study|Multiple reasons|6|||
42173044|NCT00369785|75979845|FG001|Overall Study|Multiple reasons|5|||
42048851|NCT00907296|75857208|FG008|Overall Study|Adverse Event|0|||
42048852|NCT00907296|75857209|FG009|Overall Study|Adverse Event|1|||
42048853|NCT00907296|75857200|FG000|Overall Study|Withdrawal by Subject|7|||
42048854|NCT00907296|75857201|FG001|Overall Study|Withdrawal by Subject|2|||
42048855|NCT00907296|75857202|FG002|Overall Study|Withdrawal by Subject|1|||
42048856|NCT00907296|75857203|FG003|Overall Study|Withdrawal by Subject|1|||
42048857|NCT00907296|75857204|FG004|Overall Study|Withdrawal by Subject|1|||
42356879|NCT01405911|76202054|FG001|Overall Study|Protocol Violation|0|||
42048858|NCT00907296|75857205|FG005|Overall Study|Withdrawal by Subject|5|||
42048859|NCT00907296|75857206|FG006|Overall Study|Withdrawal by Subject|3|||
42048860|NCT00907296|75857207|FG007|Overall Study|Withdrawal by Subject|2|||
42048861|NCT00907296|75857208|FG008|Overall Study|Withdrawal by Subject|4|||
42048862|NCT00907296|75857209|FG009|Overall Study|Withdrawal by Subject|2|||
42048863|NCT00907296|75857200|FG000|Overall Study|Lost to Follow-up|9|||
42048864|NCT00907296|75857201|FG001|Overall Study|Lost to Follow-up|1|||
42048865|NCT00907296|75857202|FG002|Overall Study|Lost to Follow-up|0|||
42048866|NCT00907296|75857203|FG003|Overall Study|Lost to Follow-up|2|||
42048867|NCT00907296|75857204|FG004|Overall Study|Lost to Follow-up|0|||
42048868|NCT00907296|75857205|FG005|Overall Study|Lost to Follow-up|3|||
42048869|NCT00907296|75857206|FG006|Overall Study|Lost to Follow-up|2|||
42048870|NCT00907296|75857207|FG007|Overall Study|Lost to Follow-up|2|||
42048871|NCT00907296|75857208|FG008|Overall Study|Lost to Follow-up|0|||
42048872|NCT00907296|75857209|FG009|Overall Study|Lost to Follow-up|4|||
42048873|NCT00816400|75857240|FG000|Overall Study|Death|2|||
42048874|NCT00816400|75857241|FG001|Overall Study|Death|3|||
42048875|NCT00816400|75857242|FG002|Overall Study|Death|3|||
42048876|NCT00816400|75857243|FG003|Overall Study|Death|3|||
42048877|NCT00816400|75857244|FG004|Overall Study|Death|2|||
42048878|NCT00816400|75857245|FG005|Overall Study|Death|3|||
42048879|NCT00816400|75857246|FG006|Overall Study|Death|2|||
42048880|NCT00816400|75857247|FG007|Overall Study|Death|5|||
42048881|NCT00816400|75857248|FG008|Overall Study|Death|6|||
42048882|NCT00816400|75857240|FG000|Overall Study|In hospice care at the end of the study|0|||
42048883|NCT00816400|75857241|FG001|Overall Study|In hospice care at the end of the study|0|||
42048884|NCT00816400|75857242|FG002|Overall Study|In hospice care at the end of the study|2|||
42048885|NCT00816400|75857243|FG003|Overall Study|In hospice care at the end of the study|0|||
42048886|NCT00816400|75857244|FG004|Overall Study|In hospice care at the end of the study|0|||
42048887|NCT00816400|75857245|FG005|Overall Study|In hospice care at the end of the study|0|||
42048888|NCT00816400|75857246|FG006|Overall Study|In hospice care at the end of the study|0|||
42048889|NCT00816400|75857247|FG007|Overall Study|In hospice care at the end of the study|0|||
42048890|NCT00816400|75857248|FG008|Overall Study|In hospice care at the end of the study|0|||
42048891|NCT00906204|75857271|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
42048892|NCT00906204|75857272|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
42048893|NCT00906204|75857271|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
42048894|NCT00906204|75857272|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
42048895|NCT00906204|75857271|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
42048896|NCT00906204|75857272|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
42048897|NCT00906204|75857271|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
42048898|NCT00906204|75857272|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
42048899|NCT00906204|75857271|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
42048900|NCT00906204|75857272|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
42048901|NCT00905424|75857309|FG000|Overall Study|Lost to Follow-up|3|||
42048902|NCT00905424|75857310|FG001|Overall Study|Lost to Follow-up|3|||
42048903|NCT00905424|75857309|FG000|Overall Study|Withdrawal by Subject|1|||
42048904|NCT00905424|75857310|FG001|Overall Study|Withdrawal by Subject|2|||
42048905|NCT00905424|75857309|FG000|Overall Study|Adverse Event|4|||
42048906|NCT00905424|75857310|FG001|Overall Study|Adverse Event|2|||
42048907|NCT00905424|75857309|FG000|Overall Study|Non-compliance with study medication|2|||
42048908|NCT00905424|75857310|FG001|Overall Study|Non-compliance with study medication|0|||
42048909|NCT00905424|75857309|FG000|Overall Study|Sponsor decision|1|||
42048910|NCT00905424|75857310|FG001|Overall Study|Sponsor decision|0|||
42173045|NCT00369707|75979851|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
42048911|NCT00905424|75857309|FG000|Overall Study|Positive urine drug screen|0|||
42048912|NCT00905424|75857310|FG001|Overall Study|Positive urine drug screen|1|||
42048913|NCT00905424|75857309|FG000|Overall Study|Non-adherence to visit schedule|0|||
42048914|NCT00905424|75857310|FG001|Overall Study|Non-adherence to visit schedule|1|||
42048915|NCT00816166|75857320|FG000|Overall Study|Lost to Follow-up|6|||
42048916|NCT00816166|75857321|FG001|Overall Study|Lost to Follow-up|10|||
42048917|NCT00816166|75857320|FG000|Overall Study|Death|4|||
42048918|NCT00816166|75857321|FG001|Overall Study|Death|2|||
42048919|NCT00815308|75857327|FG000|Overall Study|Adverse Event|4|||
42048920|NCT00815308|75857327|FG000|Overall Study|Withdrawal by Subject|0|||
42048921|NCT00815308|75857327|FG000|Overall Study|Protocol Violation|6|||
42048922|NCT01039376|75857333|FG000|Overall Study|Lost to Follow-up|5|||
42048923|NCT01039376|75857334|FG001|Overall Study|Lost to Follow-up|12|||
42048924|NCT01039376|75857333|FG000|Overall Study|Physician Decision|15|||
42048925|NCT01039376|75857334|FG001|Overall Study|Physician Decision|10|||
42048926|NCT01039376|75857333|FG000|Overall Study|Withdrawal by Subject|20|||
42048927|NCT01039376|75857334|FG001|Overall Study|Withdrawal by Subject|32|||
42048928|NCT01039376|75857333|FG000|Overall Study|Study terminated by Sponsor|90|||
42048929|NCT01039376|75857334|FG001|Overall Study|Study terminated by Sponsor|72|||
42048930|NCT00905034|75857341|FG000|Overall Study|Withdrawal by Subject|1|||
42048931|NCT00828568|75857348|FG000|Randomized|Withdrawal by Subject|1|||
42048932|NCT00828568|75857349|FG001|Randomized|Withdrawal by Subject|0|||
42048933|NCT00828568|75857350|FG002|Randomized|Withdrawal by Subject|2|||
42048934|NCT00828568|75857348|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
42048935|NCT00828568|75857349|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
42048936|NCT00828568|75857350|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
42048937|NCT00828568|75857348|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
42048938|NCT00828568|75857349|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
42048939|NCT00828568|75857350|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
42048940|NCT00828568|75857348|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
42048941|NCT00828568|75857349|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
42048942|NCT00828568|75857350|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
42048943|NCT00828568|75857348|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
42048944|NCT00828568|75857349|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
42048945|NCT00828568|75857350|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
42048946|NCT01038752|75857361|FG000|Overall Study|Tumor Progression|2|||
42048947|NCT01038752|75857362|FG001|Overall Study|Tumor Progression|2|||
42048948|NCT01038752|75857361|FG000|Overall Study|Lost to Follow-up|3|||
42048949|NCT01038752|75857362|FG001|Overall Study|Lost to Follow-up|3|||
42048950|NCT00903630|75857371|FG000|Phase 2|Adverse Event|0|||
42048951|NCT00903630|75857372|FG001|Phase 2|Adverse Event|0|||
42048952|NCT00903630|75857373|FG002|Phase 2|Adverse Event|1|||
42048953|NCT01037114|75857383|FG000|Year 20|Others|1|||
42048954|NCT00840970|75857387|FG000|Overall Study|Adverse Event|0|||
42048955|NCT00840970|75857388|FG001|Overall Study|Adverse Event|0|||
42048956|NCT00840970|75857389|FG002|Overall Study|Adverse Event|1|||
42048957|NCT01054820|75857399|FG000|Overall Study|Withdrawal by Subject|2|||
42048958|NCT00840658|75857407|FG000|Overall Study|Death|2|||
42048959|NCT00840658|75857408|FG001|Overall Study|Death|2|||
42048960|NCT00840658|75857409|FG002|Overall Study|Death|3|||
42048961|NCT00840658|75857410|FG003|Overall Study|Death|3|||
42048962|NCT00840658|75857407|FG000|Overall Study|Lost to Follow-up|3|||
42048963|NCT00840658|75857408|FG001|Overall Study|Lost to Follow-up|1|||
42048964|NCT00840658|75857409|FG002|Overall Study|Lost to Follow-up|2|||
42048965|NCT00840658|75857410|FG003|Overall Study|Lost to Follow-up|1|||
42048966|NCT01036724|75857426|FG000|Overall Study|Adverse Event|1|||
42048967|NCT01036724|75857427|FG001|Overall Study|Adverse Event|2|||
42048968|NCT01036724|75857426|FG000|Overall Study|Lack of Efficacy|1|||
42048969|NCT01036724|75857427|FG001|Overall Study|Lack of Efficacy|1|||
42048970|NCT01036724|75857426|FG000|Overall Study|Protocol Violation|4|||
42048971|NCT01036724|75857427|FG001|Overall Study|Protocol Violation|5|||
42048972|NCT01052714|75857435|FG000|Overall Study|Adverse Event|6|||
42048973|NCT01052714|75857436|FG001|Overall Study|Adverse Event|3|||
42048974|NCT01052714|75857437|FG002|Overall Study|Adverse Event|0|||
42048975|NCT01052714|75857435|FG000|Overall Study|Death|1|||
42048976|NCT01052714|75857436|FG001|Overall Study|Death|2|||
42048977|NCT01052714|75857437|FG002|Overall Study|Death|0|||
42048978|NCT01052714|75857435|FG000|Overall Study|Lost to Follow-up|2|||
42048979|NCT01052714|75857436|FG001|Overall Study|Lost to Follow-up|3|||
42048980|NCT01052714|75857437|FG002|Overall Study|Lost to Follow-up|0|||
42048981|NCT01052714|75857435|FG000|Overall Study|Physician Decision|9|||
42048982|NCT01052714|75857436|FG001|Overall Study|Physician Decision|9|||
42048983|NCT01052714|75857437|FG002|Overall Study|Physician Decision|1|||
42048984|NCT01052714|75857435|FG000|Overall Study|Withdrawal by Subject|7|||
42048985|NCT01052714|75857436|FG001|Overall Study|Withdrawal by Subject|12|||
42291348|NCT02641379|76125037|FG010|Overall Study|PCR positive at Week 48|0|||
42048986|NCT01052714|75857437|FG002|Overall Study|Withdrawal by Subject|1|||
42048987|NCT01052480|75857454|FG000|Overall Study|Lost to Follow-up|3|||
42048988|NCT01052480|75857455|FG001|Overall Study|Lost to Follow-up|3|||
42048989|NCT01052480|75857454|FG000|Overall Study|Protocol Violation|1|||
42048990|NCT01052480|75857455|FG001|Overall Study|Protocol Violation|0|||
42048991|NCT01052480|75857454|FG000|Overall Study|Withdrawal by Subject|3|||
42048992|NCT01052480|75857455|FG001|Overall Study|Withdrawal by Subject|7|||
42048993|NCT01052480|75857454|FG000|Overall Study|Physician Decision|0|||
42048994|NCT01052480|75857455|FG001|Overall Study|Physician Decision|2|||
42048995|NCT01052480|75857454|FG000|Overall Study|Death|1|||
42048996|NCT01052480|75857455|FG001|Overall Study|Death|5|||
42048997|NCT00904722|75857461|FG000|Overall Study|Physician Decision|1|||
42048998|NCT01029782|75857467|FG000|Overall Study|Lost to Follow-up|2|||
42048999|NCT01029782|75857468|FG001|Overall Study|Lost to Follow-up|2|||
42049000|NCT01029782|75857467|FG000|Overall Study|Diagnosis changed|1|||
42049001|NCT01029782|75857468|FG001|Overall Study|Diagnosis changed|1|||
42049002|NCT01029782|75857467|FG000|Overall Study|Adverse Event|0|||
42049003|NCT01029782|75857468|FG001|Overall Study|Adverse Event|1|||
42049004|NCT01029782|75857467|FG000|Overall Study|Physician Decision|0|||
42049005|NCT01029782|75857468|FG001|Overall Study|Physician Decision|1|||
42049006|NCT01029782|75857467|FG000|Overall Study|Protocol Violation|0|||
42049007|NCT01029782|75857468|FG001|Overall Study|Protocol Violation|2|||
42049008|NCT01029782|75857467|FG000|Overall Study|Withdrawal by Subject|0|||
42049009|NCT01029782|75857468|FG001|Overall Study|Withdrawal by Subject|1|||
42049010|NCT01029704|75857483|FG000|Overall Study|Adverse Event|0|||
42049011|NCT01029704|75857484|FG001|Overall Study|Adverse Event|0|||
42049012|NCT01029704|75857485|FG002|Overall Study|Adverse Event|0|||
42049013|NCT01029704|75857486|FG003|Overall Study|Adverse Event|0|||
42049014|NCT01029704|75857487|FG004|Overall Study|Adverse Event|0|||
42049015|NCT01029704|75857488|FG005|Overall Study|Adverse Event|0|||
42049016|NCT01029704|75857489|FG006|Overall Study|Adverse Event|1|||
42049017|NCT01029704|75857490|FG007|Overall Study|Adverse Event|1|||
42049018|NCT01029704|75857491|FG008|Overall Study|Adverse Event|0|||
42049019|NCT01029704|75857483|FG000|Overall Study|Withdrawal by Subject|0|||
42049020|NCT01029704|75857484|FG001|Overall Study|Withdrawal by Subject|0|||
42049021|NCT01029704|75857485|FG002|Overall Study|Withdrawal by Subject|0|||
42049022|NCT01029704|75857486|FG003|Overall Study|Withdrawal by Subject|0|||
42049023|NCT01029704|75857487|FG004|Overall Study|Withdrawal by Subject|2|||
42049024|NCT01029704|75857488|FG005|Overall Study|Withdrawal by Subject|1|||
42049025|NCT01029704|75857489|FG006|Overall Study|Withdrawal by Subject|1|||
42049026|NCT01029704|75857490|FG007|Overall Study|Withdrawal by Subject|1|||
42049027|NCT01029704|75857491|FG008|Overall Study|Withdrawal by Subject|0|||
42049028|NCT01029704|75857483|FG000|Overall Study|Lost to Follow-up|0|||
42049029|NCT01029704|75857484|FG001|Overall Study|Lost to Follow-up|0|||
42049030|NCT01029704|75857485|FG002|Overall Study|Lost to Follow-up|0|||
42049031|NCT01029704|75857486|FG003|Overall Study|Lost to Follow-up|0|||
42049032|NCT01029704|75857487|FG004|Overall Study|Lost to Follow-up|0|||
42049033|NCT01029704|75857488|FG005|Overall Study|Lost to Follow-up|0|||
42049034|NCT01029704|75857489|FG006|Overall Study|Lost to Follow-up|1|||
42049035|NCT01029704|75857490|FG007|Overall Study|Lost to Follow-up|1|||
42049036|NCT01029704|75857491|FG008|Overall Study|Lost to Follow-up|1|||
42049037|NCT01029704|75857483|FG000|Overall Study|Lack of Efficacy|0|||
42049038|NCT01029704|75857484|FG001|Overall Study|Lack of Efficacy|0|||
42049039|NCT01029704|75857485|FG002|Overall Study|Lack of Efficacy|0|||
42049040|NCT01029704|75857486|FG003|Overall Study|Lack of Efficacy|0|||
42173046|NCT00369707|75979851|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
42173047|NCT00369707|75979851|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
42173048|NCT00369707|75979851|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
42173049|NCT00369707|75979851|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
42173050|NCT00369707|75979851|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
42173051|NCT00369707|75979851|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
42173052|NCT00369707|75979851|FG000|Follow up for 2 Years After Treatment|Death|1|||
42173053|NCT00369707|75979851|FG000|Follow up for 2 Years After Treatment|Other|2|||
42173054|NCT02943460|75979858|FG000|Blinded Study Phase|Adverse Event|3|||
42173055|NCT02943460|75979859|FG001|Blinded Study Phase|Adverse Event|0|||
42173056|NCT02943460|75979860|FG002|Blinded Study Phase|Adverse Event|0|||
42173057|NCT02943460|75979858|FG000|Blinded Study Phase|Withdrew Consent|0|||
42173058|NCT02943460|75979859|FG001|Blinded Study Phase|Withdrew Consent|1|||
42173059|NCT02943460|75979860|FG002|Blinded Study Phase|Withdrew Consent|0|||
42173060|NCT02943460|75979858|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
42173061|NCT02943460|75979859|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
42173062|NCT02943460|75979860|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
42173063|NCT02943460|75979858|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
42049041|NCT01029704|75857487|FG004|Overall Study|Lack of Efficacy|2|||
42049042|NCT01029704|75857488|FG005|Overall Study|Lack of Efficacy|3|||
42049043|NCT01029704|75857489|FG006|Overall Study|Lack of Efficacy|1|||
42049044|NCT01029704|75857490|FG007|Overall Study|Lack of Efficacy|2|||
42049045|NCT01029704|75857491|FG008|Overall Study|Lack of Efficacy|0|||
42049046|NCT01029704|75857483|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
42356880|NCT01405911|76202055|FG002|Overall Study|Protocol Violation|0|||
42049047|NCT01029704|75857484|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
42049048|NCT01029704|75857485|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
42049049|NCT01029704|75857486|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
42049050|NCT01029704|75857487|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
42049051|NCT01029704|75857488|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
42049052|NCT01029704|75857489|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
42049053|NCT01029704|75857490|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
42049054|NCT01029704|75857491|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
42049055|NCT00840034|75857513|FG000|Acute Treatment Phase|Adverse Event|6|||
42049056|NCT00840034|75857514|FG001|Acute Treatment Phase|Adverse Event|8|||
42049057|NCT00840034|75857513|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
42049058|NCT00840034|75857514|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
42173064|NCT02943460|75979859|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
42173065|NCT02943460|75979860|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
42173066|NCT02943460|75979858|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
42173067|NCT02943460|75979859|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
42173068|NCT02943460|75979860|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
42173069|NCT03768206|75979871|FG000|Overall Study|Lost to Follow-up|2|||
42173070|NCT03768206|75979872|FG001|Overall Study|Lost to Follow-up|1|||
42173071|NCT03768206|75979871|FG000|Overall Study|Withdrawal by Subject|0|||
42173072|NCT03768206|75979872|FG001|Overall Study|Withdrawal by Subject|1|||
42173073|NCT03767894|75979879|FG000|Overall Study|Withdrawal by Subject|1|||
42173074|NCT03766646|75979885|FG000|Overall Study|Withdrawal by Subject|1|||
42173075|NCT03766646|75979886|FG001|Overall Study|Withdrawal by Subject|0|||
42173076|NCT03766646|75979885|FG000|Overall Study|Protocol Violation|0|||
42173077|NCT03766646|75979886|FG001|Overall Study|Protocol Violation|3|||
42173078|NCT03765164|75979894|FG000|Pre-intervention|Withdrawal by Subject|5|||
42173079|NCT03765164|75979895|FG001|Pre-intervention|Withdrawal by Subject|6|||
42173080|NCT00369629|75979901|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
42173081|NCT00369629|75979902|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
42173082|NCT00369629|75979903|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
42173083|NCT00369629|75979904|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
42173084|NCT00369629|75979901|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
42173085|NCT00369629|75979902|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
42173086|NCT00369629|75979903|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
42173087|NCT00369629|75979904|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
42173088|NCT00369629|75979901|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
42173089|NCT00369629|75979902|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
42173090|NCT00369629|75979903|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
42173091|NCT00369629|75979904|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
42173092|NCT00369629|75979901|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
42173093|NCT00369629|75979902|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
42173094|NCT00369629|75979903|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
42173095|NCT00369629|75979904|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
42173096|NCT00369629|75979901|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
42173097|NCT00369629|75979902|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
42173098|NCT00369629|75979903|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
42173099|NCT00369629|75979904|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
42173100|NCT00369629|75979901|FG000|Completed 4 More Cycles|Progressive disease|2|||
42173101|NCT00369629|75979902|FG001|Completed 4 More Cycles|Progressive disease|1|||
42173102|NCT00369629|75979903|FG002|Completed 4 More Cycles|Progressive disease|2|||
42173103|NCT00369629|75979904|FG003|Completed 4 More Cycles|Progressive disease|0|||
42173104|NCT00369629|75979901|FG000|Follow up for 1 Year|Death|2|||
42173105|NCT00369629|75979902|FG001|Follow up for 1 Year|Death|1|||
42173106|NCT00369629|75979903|FG002|Follow up for 1 Year|Death|1|||
42173107|NCT00369629|75979904|FG003|Follow up for 1 Year|Death|0|||
42173108|NCT00369629|75979901|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
42049059|NCT00840034|75857513|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
42049060|NCT00840034|75857514|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
42049061|NCT00840034|75857513|FG000|Acute Treatment Phase|Physician Decision|0|||
42049062|NCT00840034|75857514|FG001|Acute Treatment Phase|Physician Decision|1|||
42049063|NCT00840034|75857513|FG000|Acute Treatment Phase|Protocol Violation|2|||
42049064|NCT00840034|75857514|FG001|Acute Treatment Phase|Protocol Violation|4|||
42049065|NCT00840034|75857513|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
42049066|NCT00840034|75857514|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
42049067|NCT00840034|75857513|FG000|Taper Phase|Adverse Event|1|||
42049068|NCT00840034|75857514|FG001|Taper Phase|Adverse Event|0|||
42049069|NCT00840034|75857513|FG000|Taper Phase|Lost to Follow-up|1|||
42049070|NCT00840034|75857514|FG001|Taper Phase|Lost to Follow-up|1|||
42049071|NCT00840034|75857513|FG000|Taper Phase|Withdrawal by Subject|1|||
42049072|NCT00840034|75857514|FG001|Taper Phase|Withdrawal by Subject|1|||
42173109|NCT00369629|75979902|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
42173110|NCT00369629|75979903|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
42173111|NCT00369629|75979904|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
42173112|NCT00369629|75979901|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
42049073|NCT00813904|75857522|FG000|Overall Study|Death|1|||
42049074|NCT00839956|75857526|FG000|Overall Study|Adverse Event|2|||
42173113|NCT00369629|75979902|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
42173114|NCT00369629|75979903|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
42173115|NCT00369629|75979904|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
42173116|NCT02469064|75979916|FG000|Overall Study|Request not to receive intervention.|1|||
42173117|NCT02469064|75979917|FG001|Overall Study|Request not to receive intervention.|3|||
42173118|NCT02446912|75979926|FG000|Overall Study|Adverse Event|3|||
42173119|NCT02446912|75979927|FG001|Overall Study|Adverse Event|13|||
42173120|NCT02446912|75979928|FG002|Overall Study|Adverse Event|5|||
42173121|NCT02446912|75979926|FG000|Overall Study|Condition under investigation worsened|0|||
42173122|NCT02446912|75979927|FG001|Overall Study|Condition under investigation worsened|1|||
42173123|NCT02446912|75979928|FG002|Overall Study|Condition under investigation worsened|1|||
42356881|NCT01405911|76202053|FG000|Overall Study|Withdrawal by Subject|3|||
42356882|NCT01405911|76202054|FG001|Overall Study|Withdrawal by Subject|1|||
42173124|NCT02446912|75979926|FG000|Overall Study|Study-specific withdrawal criteria|1|||
42173125|NCT02446912|75979927|FG001|Overall Study|Study-specific withdrawal criteria|0|||
42173126|NCT02446912|75979928|FG002|Overall Study|Study-specific withdrawal criteria|0|||
42173127|NCT02446912|75979926|FG000|Overall Study|Lack of Efficacy|1|||
42173128|NCT02446912|75979927|FG001|Overall Study|Lack of Efficacy|4|||
42173129|NCT02446912|75979928|FG002|Overall Study|Lack of Efficacy|7|||
42173130|NCT02446912|75979926|FG000|Overall Study|Lost to Follow-up|0|||
42291349|NCT02641379|76125027|FG000|Overall Study|PCR not performed at Week 12|0|||
42291350|NCT02641379|76125028|FG001|Overall Study|PCR not performed at Week 12|0|||
42291351|NCT02641379|76125029|FG002|Overall Study|PCR not performed at Week 12|1|||
42291352|NCT02641379|76125030|FG003|Overall Study|PCR not performed at Week 12|0|||
42291353|NCT02641379|76125031|FG004|Overall Study|PCR not performed at Week 12|0|||
42291354|NCT02641379|76125032|FG005|Overall Study|PCR not performed at Week 12|0|||
42356883|NCT01405911|76202055|FG002|Overall Study|Withdrawal by Subject|1|||
42356884|NCT01425801|76202063|FG000|Period 1|Withdrawal by Subject|0|||
42291355|NCT02641379|76125033|FG006|Overall Study|PCR not performed at Week 12|0|||
42291356|NCT02641379|76125034|FG007|Overall Study|PCR not performed at Week 12|0|||
42291357|NCT02641379|76125035|FG008|Overall Study|PCR not performed at Week 12|0|||
42291358|NCT02641379|76125036|FG009|Overall Study|PCR not performed at Week 12|0|||
42356885|NCT01425801|76202064|FG001|Period 1|Withdrawal by Subject|0|||
42356886|NCT01425801|76202065|FG002|Period 1|Withdrawal by Subject|0|||
42173131|NCT02446912|75979927|FG001|Overall Study|Lost to Follow-up|0|||
42356887|NCT01425801|76202066|FG003|Period 1|Withdrawal by Subject|0|||
42356888|NCT01425801|76202067|FG004|Period 1|Withdrawal by Subject|1|||
42356889|NCT01425801|76202068|FG005|Period 1|Withdrawal by Subject|0|||
42356890|NCT01425801|76202063|FG000|Period 2|Withdrawal by Subject|0|||
42356891|NCT01425801|76202064|FG001|Period 2|Withdrawal by Subject|0|||
42173132|NCT02446912|75979928|FG002|Overall Study|Lost to Follow-up|2|||
42291359|NCT02641379|76125037|FG010|Overall Study|PCR not performed at Week 12|0|||
42291360|NCT02641379|76125027|FG000|Overall Study|No PCR at baseline|0|||
42356892|NCT01425801|76202065|FG002|Period 2|Withdrawal by Subject|0|||
42356893|NCT01425801|76202066|FG003|Period 2|Withdrawal by Subject|0|||
42356894|NCT01425801|76202067|FG004|Period 2|Withdrawal by Subject|1|||
42173133|NCT02446912|75979926|FG000|Overall Study|Severe non-compliance to protocol|1|||
42291361|NCT02641379|76125028|FG001|Overall Study|No PCR at baseline|0|||
42356895|NCT01425801|76202068|FG005|Period 2|Withdrawal by Subject|0|||
42173134|NCT02446912|75979927|FG001|Overall Study|Severe non-compliance to protocol|0|||
42173135|NCT02446912|75979928|FG002|Overall Study|Severe non-compliance to protocol|1|||
42173136|NCT02446912|75979926|FG000|Overall Study|Withdrawal by Subject|10|||
42173137|NCT02446912|75979927|FG001|Overall Study|Withdrawal by Subject|15|||
42173138|NCT02446912|75979928|FG002|Overall Study|Withdrawal by Subject|15|||
42173139|NCT02446912|75979926|FG000|Overall Study|Miscellaneous|2|||
42173140|NCT02446912|75979927|FG001|Overall Study|Miscellaneous|2|||
42173141|NCT02446912|75979928|FG002|Overall Study|Miscellaneous|4|||
42173142|NCT00736840|75979936|FG000|Overall Study|Lost to Follow-up|13|||
42173143|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Adverse Event|11|||
42173144|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Adverse Event|23|||
42173145|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Adverse Event|29|||
42173146|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Adverse Event|2|||
42173147|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Adverse Event|8|||
42173148|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
42173149|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
42173150|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
42173151|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
42173152|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
42173153|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
42173154|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
42173155|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
42173156|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
42173157|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
42173158|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
42173159|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
42173160|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
42173161|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
42173162|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
42173163|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
42173164|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
42173165|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
42173166|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
42173167|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
42173168|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
42173169|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
42173170|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
42173171|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
42173172|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
42173173|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
42173174|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
42173175|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
42173176|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
42173177|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
42173178|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Move|0|||
42173179|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Move|1|||
42173180|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Move|0|||
42173181|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Move|0|||
42173182|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Move|0|||
42173183|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
42173184|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
42173185|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
42173186|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
42291362|NCT02641379|76125029|FG002|Overall Study|No PCR at baseline|1|||
42049075|NCT00839956|75857526|FG000|Overall Study|Lack of Efficacy|6|||
42049076|NCT00839956|75857526|FG000|Overall Study|Physician Decision|1|||
42049077|NCT00839956|75857526|FG000|Overall Study|Withdrawal by Subject|3|||
42049078|NCT00839800|75857532|FG000|Overall Study|Adverse Event|8|||
42049079|NCT00839800|75857533|FG001|Overall Study|Adverse Event|12|||
42049080|NCT00839800|75857532|FG000|Overall Study|Lost to Follow-up|31|||
42049081|NCT00839800|75857533|FG001|Overall Study|Lost to Follow-up|26|||
42049082|NCT00839800|75857532|FG000|Overall Study|Withdrawal by Subject|28|||
42173187|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
42173188|NCT00318461|75979945|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
42291363|NCT02641379|76125030|FG003|Overall Study|No PCR at baseline|0|||
42049083|NCT00839800|75857533|FG001|Overall Study|Withdrawal by Subject|34|||
42049084|NCT00839800|75857532|FG000|Overall Study|Incorrect Enrolment|3|||
42049085|NCT00839800|75857533|FG001|Overall Study|Incorrect Enrolment|3|||
42049086|NCT00839800|75857532|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
42049087|NCT00839800|75857533|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
42049088|NCT00839800|75857532|FG000|Overall Study|Safety Reasons|2|||
42049089|NCT00839800|75857533|FG001|Overall Study|Safety Reasons|1|||
42049090|NCT00839800|75857532|FG000|Overall Study|Other|8|||
42049091|NCT00839800|75857533|FG001|Overall Study|Other|14|||
42049092|NCT00839800|75857532|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
42049093|NCT00839800|75857533|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
42049094|NCT00753415|75857567|FG000|Part A|Disease progression|1|||
42049095|NCT00753415|75857568|FG001|Part A|Disease progression|0|||
42049096|NCT00753415|75857569|FG002|Part A|Disease progression|1|||
42049097|NCT00753415|75857570|FG003|Part A|Disease progression|2|||
42049098|NCT00753415|75857571|FG004|Part A|Disease progression|0|||
42049099|NCT00753415|75857572|FG005|Part A|Disease progression|0|||
42049100|NCT00753415|75857573|FG006|Part A|Disease progression|0|||
42049101|NCT00753415|75857574|FG007|Part A|Disease progression|0|||
42049102|NCT00753415|75857575|FG008|Part A|Disease progression|0|||
42049103|NCT00753415|75857576|FG009|Part A|Disease progression|0|||
42049104|NCT00753415|75857567|FG000|Part A|Withdrawal by Subject|0|||
42049105|NCT00753415|75857568|FG001|Part A|Withdrawal by Subject|0|||
42049106|NCT00753415|75857569|FG002|Part A|Withdrawal by Subject|1|||
42049107|NCT00753415|75857570|FG003|Part A|Withdrawal by Subject|0|||
42049108|NCT00753415|75857571|FG004|Part A|Withdrawal by Subject|0|||
42049109|NCT00753415|75857572|FG005|Part A|Withdrawal by Subject|0|||
42049110|NCT00753415|75857573|FG006|Part A|Withdrawal by Subject|0|||
42049111|NCT00753415|75857574|FG007|Part A|Withdrawal by Subject|0|||
42049112|NCT00753415|75857575|FG008|Part A|Withdrawal by Subject|0|||
42049113|NCT00753415|75857576|FG009|Part A|Withdrawal by Subject|0|||
42049114|NCT00753415|75857567|FG000|Part B|Lost to Follow-up|0|||
42049115|NCT00753415|75857568|FG001|Part B|Lost to Follow-up|0|||
42049116|NCT00753415|75857569|FG002|Part B|Lost to Follow-up|0|||
42049117|NCT00753415|75857570|FG003|Part B|Lost to Follow-up|0|||
42049118|NCT00753415|75857571|FG004|Part B|Lost to Follow-up|0|||
42049119|NCT00753415|75857572|FG005|Part B|Lost to Follow-up|0|||
42049120|NCT00753415|75857573|FG006|Part B|Lost to Follow-up|0|||
42049121|NCT00753415|75857574|FG007|Part B|Lost to Follow-up|1|||
42049122|NCT00753415|75857575|FG008|Part B|Lost to Follow-up|1|||
42049123|NCT00753415|75857576|FG009|Part B|Lost to Follow-up|0|||
42049124|NCT00753415|75857567|FG000|Part B|Disease progression|0|||
42049125|NCT00753415|75857568|FG001|Part B|Disease progression|0|||
42049126|NCT00753415|75857569|FG002|Part B|Disease progression|0|||
42049127|NCT00753415|75857570|FG003|Part B|Disease progression|0|||
42049128|NCT00753415|75857571|FG004|Part B|Disease progression|0|||
42049129|NCT00753415|75857572|FG005|Part B|Disease progression|0|||
42049130|NCT00753415|75857573|FG006|Part B|Disease progression|0|||
42049131|NCT00753415|75857574|FG007|Part B|Disease progression|0|||
42049132|NCT00753415|75857575|FG008|Part B|Disease progression|2|||
42049133|NCT00753415|75857576|FG009|Part B|Disease progression|1|||
42049134|NCT00754741|75857603|FG000|Overall Study|Died or disenrolled|57|||
42049135|NCT00754741|75857604|FG001|Overall Study|Died or disenrolled|69|||
42049136|NCT00754741|75857605|FG002|Overall Study|Died or disenrolled|54|||
42049137|NCT00752791|75857613|FG000|Overall Study|Adverse Event|7|||
42049138|NCT00752791|75857613|FG000|Overall Study|Withdrawal by Subject|1|||
42049139|NCT00752791|75857613|FG000|Overall Study|Physician Decision|1|||
42049140|NCT00752791|75857613|FG000|Overall Study|Death|1|||
42049141|NCT00752791|75857613|FG000|Overall Study|Renal transplant|3|||
42049142|NCT00752791|75857613|FG000|Overall Study|Switched to hemodialysis|2|||
42049143|NCT00752791|75857613|FG000|Overall Study|Protocol deviation|1|||
42049144|NCT00902304|75857624|FG000|Overall Study|Adverse Event|4|||
42049145|NCT00902304|75857625|FG001|Overall Study|Adverse Event|10|||
42049146|NCT00902304|75857626|FG002|Overall Study|Adverse Event|25|||
42049147|NCT00902304|75857624|FG000|Overall Study|Investigator discretion|3|||
42049148|NCT00902304|75857625|FG001|Overall Study|Investigator discretion|5|||
42049149|NCT00902304|75857626|FG002|Overall Study|Investigator discretion|13|||
42049150|NCT00902304|75857624|FG000|Overall Study|Lost to Follow-up|7|||
42049151|NCT00902304|75857625|FG001|Overall Study|Lost to Follow-up|7|||
42049152|NCT00902304|75857626|FG002|Overall Study|Lost to Follow-up|7|||
42049153|NCT00902304|75857624|FG000|Overall Study|Protocol Violation|9|||
42049154|NCT00902304|75857625|FG001|Overall Study|Protocol Violation|18|||
42049155|NCT00902304|75857626|FG002|Overall Study|Protocol Violation|20|||
42049156|NCT00902304|75857624|FG000|Overall Study|Withdrawal by Subject|32|||
42049157|NCT00902304|75857625|FG001|Overall Study|Withdrawal by Subject|22|||
42049158|NCT00902304|75857626|FG002|Overall Study|Withdrawal by Subject|43|||
42049159|NCT00902304|75857624|FG000|Overall Study|includes pregnancy|3|||
42049160|NCT00902304|75857625|FG001|Overall Study|includes pregnancy|9|||
42049161|NCT00902304|75857626|FG002|Overall Study|includes pregnancy|2|||
42049162|NCT00759109|75857637|FG000|Overall Study|Adverse Event|17|||
42049163|NCT00759109|75857638|FG001|Overall Study|Adverse Event|12|||
42049164|NCT00759109|75857637|FG000|Overall Study|Inability to comply|1|||
42049165|NCT00759109|75857638|FG001|Overall Study|Inability to comply|1|||
42049166|NCT00759109|75857637|FG000|Overall Study|Withdrawal by Subject|9|||
42049167|NCT00759109|75857638|FG001|Overall Study|Withdrawal by Subject|5|||
42049168|NCT00759109|75857637|FG000|Overall Study|Death|4|||
42049169|NCT00759109|75857638|FG001|Overall Study|Death|3|||
42049170|NCT00759109|75857637|FG000|Overall Study|Lost to Follow-up|4|||
42049171|NCT00759109|75857638|FG001|Overall Study|Lost to Follow-up|6|||
42049172|NCT00759109|75857637|FG000|Overall Study|Started new therapy|2|||
42049173|NCT00759109|75857638|FG001|Overall Study|Started new therapy|6|||
42049174|NCT00759109|75857637|FG000|Overall Study|HCV RNA negative|1|||
42049175|NCT00759109|75857638|FG001|Overall Study|HCV RNA negative|0|||
42049176|NCT00759109|75857637|FG000|Overall Study|Participant moved to a different city|0|||
42049177|NCT00759109|75857638|FG001|Overall Study|Participant moved to a different city|1|||
42049178|NCT00759109|75857637|FG000|Overall Study|Participant had a liver transplant|0|||
42049179|NCT00759109|75857638|FG001|Overall Study|Participant had a liver transplant|1|||
42049180|NCT00759109|75857637|FG000|Overall Study|Lost during study|1|||
42049181|NCT00759109|75857638|FG001|Overall Study|Lost during study|0|||
42049182|NCT00759031|75857646|FG000|First Intervention (1 Day)|Physician Decision|1|||
42049183|NCT00759031|75857647|FG001|First Intervention (1 Day)|Physician Decision|0|||
42049184|NCT00759031|75857646|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
42049185|NCT00759031|75857647|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
42049186|NCT00759031|75857646|FG000|First Intervention (1 Day)|Screening failure|1|||
42049187|NCT00759031|75857647|FG001|First Intervention (1 Day)|Screening failure|0|||
42049188|NCT00758485|75857655|FG000|Overall Study|Lost to Follow-up|0|||
42049189|NCT00758485|75857656|FG001|Overall Study|Lost to Follow-up|1|||
42049190|NCT00758485|75857655|FG000|Overall Study|Not Treated|1|||
42049191|NCT00758485|75857656|FG001|Overall Study|Not Treated|2|||
42173189|NCT00318461|75979946|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
42173190|NCT00318461|75979947|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
42049192|NCT00757783|75857665|FG000|Overall Study|Adverse Event|0|||
42049193|NCT00757783|75857666|FG001|Overall Study|Adverse Event|2|||
42049194|NCT00757783|75857665|FG000|Overall Study|Lost to Follow-up|1|||
42049195|NCT00757783|75857666|FG001|Overall Study|Lost to Follow-up|1|||
42049196|NCT00757783|75857665|FG000|Overall Study|Protocol Violation|1|||
42049197|NCT00757783|75857666|FG001|Overall Study|Protocol Violation|0|||
42049198|NCT00757783|75857665|FG000|Overall Study|Withdrawal by Subject|2|||
42049199|NCT00757783|75857666|FG001|Overall Study|Withdrawal by Subject|1|||
42049200|NCT00757783|75857665|FG000|Overall Study|Other|1|||
42049201|NCT00757783|75857666|FG001|Overall Study|Other|2|||
42049202|NCT00757705|75857672|FG000|Overall Study|Adverse Event|19|||
42049203|NCT00757705|75857672|FG000|Overall Study|Lost to Follow-up|16|||
42049204|NCT00757705|75857672|FG000|Overall Study|Withdrawal by Subject|25|||
42049205|NCT00757705|75857672|FG000|Overall Study|Insufficient Response|26|||
42049206|NCT00757705|75857672|FG000|Overall Study|Ineligible to continue|8|||
42049207|NCT00757705|75857672|FG000|Overall Study|Non-compliant|9|||
42049208|NCT00757705|75857672|FG000|Overall Study|Other|18|||
42049209|NCT00757627|75857676|FG000|Overall Study|Adverse Event|15|||
42049210|NCT00757627|75857676|FG000|Overall Study|Lack of Efficacy|10|||
42049211|NCT00757627|75857676|FG000|Overall Study|Lost to Follow-up|28|||
42049212|NCT00757627|75857676|FG000|Overall Study|Withdrawal by Subject|27|||
42049213|NCT00757627|75857676|FG000|Overall Study|Other|1|||
42049214|NCT01023308|75857687|FG000|Overall Study|Abnormal test proceedure results|3|||
42049215|NCT01023308|75857688|FG001|Overall Study|Abnormal test proceedure results|8|||
42049216|NCT01023308|75857687|FG000|Overall Study|Administrative problems|2|||
42049217|NCT01023308|75857688|FG001|Overall Study|Administrative problems|1|||
42049218|NCT01023308|75857687|FG000|Overall Study|Adverse Event|130|||
42049219|NCT01023308|75857688|FG001|Overall Study|Adverse Event|66|||
42049220|NCT01023308|75857687|FG000|Overall Study|Death|21|||
42049221|NCT01023308|75857688|FG001|Overall Study|Death|17|||
42049222|NCT01023308|75857687|FG000|Overall Study|Disease progression|82|||
42049223|NCT01023308|75857688|FG001|Overall Study|Disease progression|153|||
42049224|NCT01023308|75857687|FG000|Overall Study|New Cancer therapy|4|||
42049225|NCT01023308|75857688|FG001|Overall Study|New Cancer therapy|7|||
42049226|NCT01023308|75857687|FG000|Overall Study|Protocol Violation|3|||
42049227|NCT01023308|75857688|FG001|Overall Study|Protocol Violation|4|||
42049228|NCT01023308|75857687|FG000|Overall Study|Untreated|5|||
42049229|NCT01023308|75857688|FG001|Overall Study|Untreated|5|||
42049230|NCT01023308|75857687|FG000|Overall Study|Lost to Follow-up|1|||
42049231|NCT01023308|75857688|FG001|Overall Study|Lost to Follow-up|0|||
42049232|NCT01023308|75857687|FG000|Overall Study|Withdrawal by Subject|34|||
42049233|NCT01023308|75857688|FG001|Overall Study|Withdrawal by Subject|18|||
42049234|NCT01022996|75857694|FG000|Overall Study|Adverse Event|14|||
42049235|NCT01022996|75857694|FG000|Overall Study|Withdrawal by Subject|3|||
42173191|NCT00318461|75979948|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
42173192|NCT00318461|75979949|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
42049236|NCT01022996|75857694|FG000|Overall Study|Lost to Follow-up|1|||
42049237|NCT01022996|75857694|FG000|Overall Study|Administrative problems|6|||
42049238|NCT01022996|75857694|FG000|Overall Study|Disease Progression|32|||
42049239|NCT01022996|75857694|FG000|Overall Study|Protocol Violation|1|||
42049240|NCT00757237|75857700|FG000|Overall Study|Lost to Follow-up|0|||
42049241|NCT00757237|75857701|FG001|Overall Study|Lost to Follow-up|1|||
42049242|NCT00757237|75857700|FG000|Overall Study|Protocol Violation|0|||
42049243|NCT00757237|75857701|FG001|Overall Study|Protocol Violation|2|||
42049244|NCT00757237|75857700|FG000|Overall Study|Physician Decision|2|||
42049245|NCT00757237|75857701|FG001|Overall Study|Physician Decision|3|||
42049246|NCT00757237|75857700|FG000|Overall Study|Withdrawal by Subject|8|||
42049247|NCT00757237|75857701|FG001|Overall Study|Withdrawal by Subject|12|||
42049248|NCT00757237|75857700|FG000|Overall Study|Safety or Tolerability|3|||
42049249|NCT00757237|75857701|FG001|Overall Study|Safety or Tolerability|5|||
42049250|NCT00757237|75857700|FG000|Overall Study|Other|0|||
42049251|NCT00757237|75857701|FG001|Overall Study|Other|2|||
42049252|NCT01029392|75857709|FG000|Overall Study|Withdrawal by Subject|18|||
42049253|NCT01029392|75857710|FG001|Overall Study|Withdrawal by Subject|11|||
42049254|NCT01029392|75857709|FG000|Overall Study|Physician Decision|2|||
42049255|NCT01029392|75857710|FG001|Overall Study|Physician Decision|0|||
42049256|NCT00903006|75857722|FG000|Overall Study|Withdrawal by Subject|2|||
42049257|NCT00903006|75857723|FG001|Overall Study|Withdrawal by Subject|0|||
42049258|NCT00903006|75857724|FG002|Overall Study|Withdrawal by Subject|0|||
42049259|NCT00903006|75857725|FG003|Overall Study|Withdrawal by Subject|0|||
42049260|NCT00903006|75857722|FG000|Overall Study|Progressive Disease|0|||
42049261|NCT00903006|75857723|FG001|Overall Study|Progressive Disease|3|||
42049262|NCT00903006|75857724|FG002|Overall Study|Progressive Disease|1|||
42049263|NCT00903006|75857725|FG003|Overall Study|Progressive Disease|0|||
42049264|NCT00839332|75857738|FG000|Phase 1|Disease Progression|38|||
42049265|NCT00839332|75857739|FG001|Phase 1|Disease Progression|0|||
42049266|NCT00839332|75857740|FG002|Phase 1|Disease Progression|0|||
42049267|NCT00839332|75857738|FG000|Phase 1|Adverse Event|6|||
42049268|NCT00839332|75857739|FG001|Phase 1|Adverse Event|0|||
42049269|NCT00839332|75857740|FG002|Phase 1|Adverse Event|0|||
42049270|NCT00839332|75857738|FG000|Phase 1|Withdrawal by Subject|4|||
42049271|NCT00839332|75857739|FG001|Phase 1|Withdrawal by Subject|0|||
42049272|NCT00839332|75857740|FG002|Phase 1|Withdrawal by Subject|0|||
42049273|NCT00839332|75857738|FG000|Phase 1|Physician Decision|2|||
42049274|NCT00839332|75857739|FG001|Phase 1|Physician Decision|0|||
42049275|NCT00839332|75857740|FG002|Phase 1|Physician Decision|0|||
42049276|NCT00839332|75857738|FG000|Phase 2|Protocol Violation|0|||
42049277|NCT00839332|75857739|FG001|Phase 2|Protocol Violation|1|||
42049278|NCT00839332|75857740|FG002|Phase 2|Protocol Violation|0|||
42049279|NCT00839332|75857738|FG000|Phase 2|Disease Progression|0|||
42049280|NCT00839332|75857739|FG001|Phase 2|Disease Progression|46|||
42049281|NCT00839332|75857740|FG002|Phase 2|Disease Progression|21|||
42049282|NCT00839332|75857738|FG000|Phase 2|Adverse Event|0|||
42049283|NCT00839332|75857739|FG001|Phase 2|Adverse Event|8|||
42049284|NCT00839332|75857740|FG002|Phase 2|Adverse Event|6|||
42049285|NCT00839332|75857738|FG000|Phase 2|Death|0|||
42049286|NCT00839332|75857739|FG001|Phase 2|Death|4|||
42049287|NCT00839332|75857740|FG002|Phase 2|Death|2|||
42049288|NCT00839332|75857738|FG000|Phase 2|Withdrawal by Subject|0|||
42049289|NCT00839332|75857739|FG001|Phase 2|Withdrawal by Subject|5|||
42049290|NCT00839332|75857740|FG002|Phase 2|Withdrawal by Subject|8|||
42049291|NCT00839332|75857738|FG000|Phase 2|Physician Decision|0|||
42049292|NCT00839332|75857739|FG001|Phase 2|Physician Decision|4|||
42049293|NCT00839332|75857740|FG002|Phase 2|Physician Decision|1|||
42049294|NCT00839332|75857738|FG000|Phase 2|Lost to Follow-up|0|||
42049295|NCT00839332|75857739|FG001|Phase 2|Lost to Follow-up|0|||
42049296|NCT00839332|75857740|FG002|Phase 2|Lost to Follow-up|1|||
42049297|NCT00902850|75857751|FG000|Overall Study|Physician Decision|2|||
42049298|NCT00902850|75857752|FG001|Overall Study|Physician Decision|2|||
42049299|NCT00902538|75857761|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
42049300|NCT00902538|75857762|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
42049301|NCT00902538|75857763|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
42049302|NCT00902538|75857764|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
42049303|NCT00902538|75857765|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
42049304|NCT00902538|75857766|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
42049305|NCT00902538|75857761|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
42049306|NCT00902538|75857762|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
42049307|NCT00902538|75857763|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
42049308|NCT00902538|75857764|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
42049309|NCT00902538|75857765|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
42049310|NCT00902538|75857766|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
42049311|NCT00902538|75857761|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
42049312|NCT00902538|75857762|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
42049313|NCT00902538|75857763|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
42049314|NCT00902538|75857764|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
42049315|NCT00902538|75857765|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
42049316|NCT00902538|75857766|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
42049317|NCT00902538|75857761|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
42049318|NCT00902538|75857762|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
42049319|NCT00902538|75857763|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
42049320|NCT00902538|75857764|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
42049321|NCT00902538|75857765|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
42049322|NCT00902538|75857766|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
42049323|NCT00902538|75857761|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
42049324|NCT00902538|75857762|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
42049325|NCT00902538|75857763|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
42049326|NCT00902538|75857764|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
42049327|NCT00902538|75857765|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
42049328|NCT00902538|75857766|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
42049329|NCT00902538|75857761|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
42049330|NCT00902538|75857762|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
42049331|NCT00902538|75857763|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
42049332|NCT00902538|75857764|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
42049333|NCT00902538|75857765|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
42049334|NCT00902538|75857766|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
42049335|NCT00902538|75857761|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
42049336|NCT00902538|75857762|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
42049337|NCT00902538|75857763|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
42049338|NCT00902538|75857764|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
42049339|NCT00902538|75857765|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
42049340|NCT00902538|75857766|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
42049341|NCT00902538|75857761|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
42049342|NCT00902538|75857762|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
42049343|NCT00902538|75857763|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
42049344|NCT00902538|75857764|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
42049345|NCT00902538|75857765|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
42049346|NCT00902538|75857766|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
42049347|NCT00902538|75857761|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
42049348|NCT00902538|75857762|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
42049349|NCT00902538|75857763|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
42049350|NCT00902538|75857764|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
42049351|NCT00902538|75857765|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
42049352|NCT00902538|75857766|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
42049353|NCT00902538|75857761|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
42049354|NCT00902538|75857762|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
42049355|NCT00902538|75857763|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
42049356|NCT00902538|75857764|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
42049357|NCT00902538|75857765|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
42049358|NCT00902538|75857766|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
42049359|NCT00902538|75857761|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
42049360|NCT00902538|75857762|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
42049361|NCT00902538|75857763|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
42049362|NCT00902538|75857764|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
42049363|NCT00902538|75857765|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
42049364|NCT00902538|75857766|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
42049365|NCT00902538|75857761|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
42049366|NCT00902538|75857762|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
42049367|NCT00902538|75857763|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
42049368|NCT00902538|75857764|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
42049369|NCT00902538|75857765|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
42049370|NCT00902538|75857766|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
42049371|NCT00902538|75857761|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
42049372|NCT00902538|75857762|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
42049373|NCT00902538|75857763|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
42049374|NCT00902538|75857764|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
42049375|NCT00902538|75857765|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
42049376|NCT00902538|75857766|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
42049377|NCT00902538|75857761|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
42049378|NCT00902538|75857762|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
42049379|NCT00902538|75857763|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
42049380|NCT00902538|75857764|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
42049381|NCT00902538|75857765|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
42049382|NCT00902538|75857766|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
42049383|NCT00902538|75857761|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
42049384|NCT00902538|75857762|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
42049385|NCT00902538|75857763|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
42049386|NCT00902538|75857764|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
42049387|NCT00902538|75857765|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
42049388|NCT00902538|75857766|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
42049389|NCT00902538|75857761|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
42049390|NCT00902538|75857762|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
42049391|NCT00902538|75857763|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
42049392|NCT00902538|75857764|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
42049393|NCT00902538|75857765|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
42049394|NCT00902538|75857766|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
42049395|NCT00902538|75857761|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
42049396|NCT00902538|75857762|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
42049397|NCT00902538|75857763|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
42049398|NCT00902538|75857764|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
42049399|NCT00902538|75857765|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
42049400|NCT00902538|75857766|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
42049401|NCT01036022|75857788|FG000|Overall Study|Adverse Event|1|||
42049402|NCT01036022|75857789|FG001|Overall Study|Adverse Event|3|||
42049403|NCT01036022|75857790|FG002|Overall Study|Adverse Event|2|||
42049404|NCT01036022|75857791|FG003|Overall Study|Adverse Event|1|||
42049405|NCT01036022|75857792|FG004|Overall Study|Adverse Event|0|||
42049406|NCT01036022|75857793|FG005|Overall Study|Adverse Event|2|||
42049407|NCT01036022|75857788|FG000|Overall Study|Lack of Efficacy|1|||
42049408|NCT01036022|75857789|FG001|Overall Study|Lack of Efficacy|1|||
42049409|NCT01036022|75857790|FG002|Overall Study|Lack of Efficacy|1|||
42049410|NCT01036022|75857791|FG003|Overall Study|Lack of Efficacy|0|||
42049411|NCT01036022|75857792|FG004|Overall Study|Lack of Efficacy|1|||
42049412|NCT01036022|75857793|FG005|Overall Study|Lack of Efficacy|1|||
42049413|NCT01036022|75857788|FG000|Overall Study|Physician Decision|0|||
42049414|NCT01036022|75857789|FG001|Overall Study|Physician Decision|0|||
42049415|NCT01036022|75857790|FG002|Overall Study|Physician Decision|1|||
42049416|NCT01036022|75857791|FG003|Overall Study|Physician Decision|0|||
42049417|NCT01036022|75857792|FG004|Overall Study|Physician Decision|0|||
42049418|NCT01036022|75857793|FG005|Overall Study|Physician Decision|0|||
42049419|NCT01036022|75857788|FG000|Overall Study|Withdrawal by Subject|0|||
42049420|NCT01036022|75857789|FG001|Overall Study|Withdrawal by Subject|0|||
42049421|NCT01036022|75857790|FG002|Overall Study|Withdrawal by Subject|0|||
42049422|NCT01036022|75857791|FG003|Overall Study|Withdrawal by Subject|1|||
42049423|NCT01036022|75857792|FG004|Overall Study|Withdrawal by Subject|2|||
42049424|NCT01036022|75857793|FG005|Overall Study|Withdrawal by Subject|0|||
42049425|NCT00752557|75857818|FG000|Overall Study|Withdrawal by Subject|4|||
42049426|NCT00752557|75857819|FG001|Overall Study|Withdrawal by Subject|3|||
42049427|NCT00752557|75857820|FG002|Overall Study|Withdrawal by Subject|3|||
42049428|NCT00752557|75857818|FG000|Overall Study|Unspecified resaons|0|||
42049429|NCT00752557|75857819|FG001|Overall Study|Unspecified resaons|2|||
42049430|NCT00752557|75857820|FG002|Overall Study|Unspecified resaons|2|||
42049431|NCT00752557|75857818|FG000|Overall Study|Lost to Follow-up|1|||
42049432|NCT00752557|75857819|FG001|Overall Study|Lost to Follow-up|0|||
42049433|NCT00752557|75857820|FG002|Overall Study|Lost to Follow-up|1|||
42049434|NCT00747643|75857832|FG000|Overall Study|Withdrawal by Subject|36|||
42049435|NCT00747643|75857833|FG001|Overall Study|Withdrawal by Subject|27|||
42049436|NCT01022762|75857841|FG000|Overall Study|Adverse Event|3|||
42049437|NCT01022762|75857842|FG001|Overall Study|Adverse Event|1|||
42049438|NCT01022762|75857841|FG000|Overall Study|Lack of Efficacy|0|||
42049439|NCT01022762|75857842|FG001|Overall Study|Lack of Efficacy|1|||
42049440|NCT01022762|75857841|FG000|Overall Study|Protocol Violation|7|||
42049441|NCT01022762|75857842|FG001|Overall Study|Protocol Violation|6|||
42049442|NCT01022762|75857841|FG000|Overall Study|Unclassified|12|||
42049443|NCT01022762|75857842|FG001|Overall Study|Unclassified|20|||
42049444|NCT01028378|75857848|FG000|Overall Study|Lost to Follow-up|12|||
42049445|NCT01028378|75857848|FG000|Overall Study|Withdrawal by Subject|1|||
42049446|NCT01028378|75857848|FG000|Overall Study|Adminstrative Reasons|4|||
42049447|NCT00747565|75857854|FG000|Overall Study|Withdrawal by Subject|10|||
42049448|NCT00747565|75857855|FG001|Overall Study|Withdrawal by Subject|6|||
42049449|NCT00747565|75857854|FG000|Overall Study|Lost to Follow-up|4|||
42049450|NCT00747565|75857855|FG001|Overall Study|Lost to Follow-up|1|||
42049451|NCT01028300|75857861|FG000|Overall Study|Study Terminated|4|||
42049452|NCT00752089|75857865|FG000|Overall Study|Adverse Event|1|||
42049453|NCT00752089|75857865|FG000|Overall Study|Protocol Deviation|2|||
42049454|NCT00752089|75857865|FG000|Overall Study|Could not attend visit 9|1|||
42049455|NCT00752089|75857865|FG000|Overall Study|Not capable of wearing partial denture|1|||
42049456|NCT00752089|75857865|FG000|Overall Study|Cannot continue the study|1|||
42049457|NCT00751933|75857876|FG000|Overall Study|Withdrawal by Subject|0|||
42049458|NCT00751933|75857877|FG001|Overall Study|Withdrawal by Subject|1|||
42049459|NCT00751933|75857878|FG002|Overall Study|Withdrawal by Subject|0|||
42049460|NCT00751933|75857879|FG003|Overall Study|Withdrawal by Subject|0|||
42049461|NCT00751933|75857876|FG000|Overall Study|Physician Decision|0|||
42049462|NCT00751933|75857877|FG001|Overall Study|Physician Decision|0|||
42049463|NCT00751933|75857878|FG002|Overall Study|Physician Decision|1|||
42049464|NCT00751933|75857879|FG003|Overall Study|Physician Decision|1|||
42049465|NCT00751621|75857883|FG000|Overall Study|Adverse Event|1|||
42049466|NCT00751621|75857883|FG000|Overall Study|Withdrawal by Subject|1|||
42049467|NCT00751621|75857883|FG000|Overall Study|Subject moved to another country|1|||
42049468|NCT00751621|75857883|FG000|Overall Study|Poor adherence to asthma treatment|1|||
42049469|NCT01028222|75857891|FG000|Overall Study|Protocol deviation|1|||
42049470|NCT01028222|75857892|FG001|Overall Study|Protocol deviation|0|||
42049471|NCT01028222|75857891|FG000|Overall Study|Disease progression|33|||
42291364|NCT02641379|76125031|FG004|Overall Study|No PCR at baseline|0|||
42291365|NCT02641379|76125032|FG005|Overall Study|No PCR at baseline|0|||
42291366|NCT02641379|76125033|FG006|Overall Study|No PCR at baseline|0|||
42291367|NCT02641379|76125034|FG007|Overall Study|No PCR at baseline|0|||
42356896|NCT01425801|76202063|FG000|Period 3|Stability criteria not fullfilled|0|||
42049472|NCT01028222|75857892|FG001|Overall Study|Disease progression|9|||
42049473|NCT01028222|75857891|FG000|Overall Study|Administrative problems|1|||
42049474|NCT01028222|75857892|FG001|Overall Study|Administrative problems|1|||
42049475|NCT01028222|75857891|FG000|Overall Study|Lost to Follow-up|0|||
42049476|NCT01028222|75857892|FG001|Overall Study|Lost to Follow-up|1|||
42049477|NCT01028222|75857891|FG000|Overall Study|Withdrawal by Subject|1|||
42049478|NCT01028222|75857892|FG001|Overall Study|Withdrawal by Subject|0|||
42049479|NCT01028222|75857891|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
42049480|NCT01028222|75857892|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
42049481|NCT01028222|75857891|FG000|Overall Study|Adverse Event|2|||
42049482|NCT01028222|75857892|FG001|Overall Study|Adverse Event|0|||
42049483|NCT00586495|75857899|FG000|Treatment Period|Adverse Event|11|||
42049484|NCT00586495|75857899|FG000|Treatment Period|Death|1|||
42049485|NCT00586495|75857899|FG000|Treatment Period|Protocol Violation|1|||
42049486|NCT00586495|75857899|FG000|Treatment Period|Withdrawal by Subject|1|||
42049487|NCT00586495|75857899|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
42356897|NCT01425801|76202064|FG001|Period 3|Stability criteria not fullfilled|0|||
42356898|NCT01425801|76202065|FG002|Period 3|Stability criteria not fullfilled|1|||
42356899|NCT01425801|76202066|FG003|Period 3|Stability criteria not fullfilled|0|||
42356900|NCT01425801|76202067|FG004|Period 3|Stability criteria not fullfilled|0|||
42049488|NCT00586495|75857899|FG000|Treatment Period|Switch to commercial drug|10|||
42049489|NCT00586495|75857899|FG000|Follow-up|Death|40|||
42049490|NCT00586495|75857899|FG000|Follow-up|Lost to Follow-up|1|||
42049491|NCT00586495|75857899|FG000|Follow-up|Withdrawal by Subject|4|||
42173193|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Work commitment|0|||
42291368|NCT02641379|76125035|FG008|Overall Study|No PCR at baseline|0|||
42291369|NCT02641379|76125036|FG009|Overall Study|No PCR at baseline|0|||
42291370|NCT02641379|76125037|FG010|Overall Study|No PCR at baseline|0|||
42291371|NCT02641379|76125027|FG000|Overall Study|PCR positive at Week 28|0|||
42049492|NCT00586495|75857899|FG000|Follow-up|Protocol driven decision point|37|||
42049493|NCT00586495|75857899|FG000|Follow-up|Switch to commercial drug|10|||
42049494|NCT01027754|75857905|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
42173194|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Work commitment|0|||
42173195|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Work commitment|0|||
42173196|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Work commitment|0|||
42173197|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Work commitment|1|||
42173198|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Investigator decision|0|||
42173199|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Investigator decision|0|||
42173200|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Investigator decision|0|||
42173201|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Investigator decision|0|||
42356901|NCT01425801|76202068|FG005|Period 3|Stability criteria not fullfilled|0|||
42356902|NCT01425801|76202063|FG000|Period 4|Not able to maintain visit schedule|0|||
42173202|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Investigator decision|1|||
42291372|NCT02641379|76125028|FG001|Overall Study|PCR positive at Week 28|0|||
42049495|NCT01027754|75857906|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
42049496|NCT01027754|75857905|FG000|Overall Study|Withdrawal by Subject|0|||
42049497|NCT01027754|75857906|FG001|Overall Study|Withdrawal by Subject|5|||
42049498|NCT01034540|75857918|FG000|Overall Study|Adverse Event|0|||
42049499|NCT01034540|75857919|FG001|Overall Study|Adverse Event|1|||
42049500|NCT00774930|75857929|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
42049501|NCT00774930|75857930|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
42049502|NCT00774930|75857929|FG000|DB Phase|Adverse Event|1|||
42049503|NCT00774930|75857930|FG001|DB Phase|Adverse Event|2|||
42049504|NCT00774930|75857929|FG000|DB Phase|Subject Decision|1|||
42049505|NCT00774930|75857930|FG001|DB Phase|Subject Decision|5|||
42049506|NCT00774930|75857929|FG000|DB Phase|Sponsor Decision|0|||
42049507|NCT00774930|75857930|FG001|DB Phase|Sponsor Decision|1|||
42049508|NCT00774930|75857929|FG000|DB Phase|Disease Progression|1|||
42049509|NCT00774930|75857930|FG001|DB Phase|Disease Progression|1|||
42049510|NCT00774930|75857929|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
42049511|NCT00774930|75857930|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
42049512|NCT00774930|75857929|FG000|IOL Phase|Adverse Event|1|||
42049513|NCT00774930|75857930|FG001|IOL Phase|Adverse Event|1|||
42049514|NCT00774930|75857929|FG000|IOL Phase|Subject Decision|4|||
42049515|NCT00774930|75857930|FG001|IOL Phase|Subject Decision|3|||
42049516|NCT00774930|75857929|FG000|IOL Phase|Physician Decision|3|||
42049517|NCT00774930|75857930|FG001|IOL Phase|Physician Decision|2|||
42049518|NCT00774930|75857929|FG000|IOL Phase|Sponsor Decision|1|||
42049519|NCT00774930|75857930|FG001|IOL Phase|Sponsor Decision|0|||
42049520|NCT00774930|75857929|FG000|IOL Phase|Disease Progression|2|||
42049521|NCT00774930|75857930|FG001|IOL Phase|Disease Progression|1|||
42049522|NCT00774930|75857929|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
42049523|NCT00774930|75857930|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
42049524|NCT00774930|75857929|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
42049525|NCT00774930|75857930|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
42049526|NCT00774930|75857929|FG000|IOL Phase|Other|1|||
42049527|NCT00774930|75857930|FG001|IOL Phase|Other|0|||
42049528|NCT00774930|75857929|FG000|IOL Phase|Brain radiation|0|||
42049529|NCT00774930|75857930|FG001|IOL Phase|Brain radiation|1|||
42049530|NCT00774930|75857929|FG000|LTOLE Phase|Adverse Event|7|||
42049531|NCT00774930|75857930|FG001|LTOLE Phase|Adverse Event|3|||
42049532|NCT00774930|75857929|FG000|LTOLE Phase|Subject decision|0|||
42049533|NCT00774930|75857930|FG001|LTOLE Phase|Subject decision|5|||
42049534|NCT00774930|75857929|FG000|LTOLE Phase|Physician Decision|4|||
42049535|NCT00774930|75857930|FG001|LTOLE Phase|Physician Decision|1|||
42049536|NCT00774930|75857929|FG000|LTOLE Phase|Sponsor decision|2|||
42049537|NCT00774930|75857930|FG001|LTOLE Phase|Sponsor decision|1|||
42049538|NCT00774930|75857929|FG000|LTOLE Phase|Disease Progression|2|||
42049539|NCT00774930|75857930|FG001|LTOLE Phase|Disease Progression|5|||
42049540|NCT00774930|75857929|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
42049541|NCT00774930|75857930|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
42049542|NCT00774930|75857929|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
42049543|NCT00774930|75857930|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
42049544|NCT01027364|75857951|FG000|Overall Study|Adverse Event|1|||
42049545|NCT01027364|75857952|FG001|Overall Study|Adverse Event|0|||
42049546|NCT01027364|75857953|FG002|Overall Study|Adverse Event|1|||
42049547|NCT01027364|75857954|FG003|Overall Study|Adverse Event|0|||
42049548|NCT01027364|75857951|FG000|Overall Study|Lost to Follow-up|1|||
42049549|NCT01027364|75857952|FG001|Overall Study|Lost to Follow-up|0|||
42049550|NCT01027364|75857953|FG002|Overall Study|Lost to Follow-up|0|||
42049551|NCT01027364|75857954|FG003|Overall Study|Lost to Follow-up|0|||
42049552|NCT01027364|75857951|FG000|Overall Study|Protocol Violation|1|||
42291373|NCT02641379|76125029|FG002|Overall Study|PCR positive at Week 28|1|||
42291374|NCT02641379|76125030|FG003|Overall Study|PCR positive at Week 28|0|||
42291375|NCT02641379|76125031|FG004|Overall Study|PCR positive at Week 28|0|||
42291376|NCT02641379|76125032|FG005|Overall Study|PCR positive at Week 28|0|||
42291377|NCT02641379|76125033|FG006|Overall Study|PCR positive at Week 28|0|||
42291378|NCT02641379|76125034|FG007|Overall Study|PCR positive at Week 28|0|||
42291379|NCT02641379|76125035|FG008|Overall Study|PCR positive at Week 28|0|||
42291380|NCT02641379|76125036|FG009|Overall Study|PCR positive at Week 28|0|||
42291381|NCT02641379|76125037|FG010|Overall Study|PCR positive at Week 28|0|||
42291382|NCT02641379|76125027|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
42291383|NCT02641379|76125028|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
42291384|NCT02641379|76125029|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
42049553|NCT01027364|75857952|FG001|Overall Study|Protocol Violation|0|||
42049554|NCT01027364|75857953|FG002|Overall Study|Protocol Violation|0|||
42049555|NCT01027364|75857954|FG003|Overall Study|Protocol Violation|1|||
42049556|NCT01027364|75857951|FG000|Overall Study|Withdrawal by Subject|1|||
42049557|NCT01027364|75857952|FG001|Overall Study|Withdrawal by Subject|2|||
42049558|NCT01027364|75857953|FG002|Overall Study|Withdrawal by Subject|0|||
42049559|NCT01027364|75857954|FG003|Overall Study|Withdrawal by Subject|0|||
42049560|NCT01027286|75857982|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
42049561|NCT01027286|75857983|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
42049562|NCT01027286|75857982|FG000|Overall Study|Lost to Follow-up|0|||
42049563|NCT01027286|75857983|FG001|Overall Study|Lost to Follow-up|1|||
42049564|NCT01026974|75857993|FG000|Overall Study|Withdrawal by Subject|0|||
42049565|NCT01026974|75857994|FG001|Overall Study|Withdrawal by Subject|1|||
42049566|NCT01026974|75857995|FG002|Overall Study|Withdrawal by Subject|7|||
42049567|NCT01026974|75857996|FG003|Overall Study|Withdrawal by Subject|2|||
42049568|NCT01026974|75857993|FG000|Overall Study|Lost to Follow-up|1|||
42049569|NCT01026974|75857994|FG001|Overall Study|Lost to Follow-up|1|||
42049570|NCT01026974|75857995|FG002|Overall Study|Lost to Follow-up|4|||
42049571|NCT01026974|75857996|FG003|Overall Study|Lost to Follow-up|0|||
42049572|NCT01026974|75857993|FG000|Overall Study|Adverse Event|0|||
42049573|NCT01026974|75857994|FG001|Overall Study|Adverse Event|0|||
42049574|NCT01026974|75857995|FG002|Overall Study|Adverse Event|0|||
42049575|NCT01026974|75857996|FG003|Overall Study|Adverse Event|1|||
42049576|NCT01026974|75857993|FG000|Overall Study|Inappropriate enrollment|0|||
42049577|NCT01026974|75857994|FG001|Overall Study|Inappropriate enrollment|0|||
42049578|NCT01026974|75857995|FG002|Overall Study|Inappropriate enrollment|1|||
42049579|NCT01026974|75857996|FG003|Overall Study|Inappropriate enrollment|0|||
42049580|NCT00897390|75858011|FG000|Overall Study|Adverse Event|2|||
42049581|NCT00897390|75858011|FG000|Overall Study|No Longer Met Study Criteria|1|||
42049582|NCT00897390|75858011|FG000|Overall Study|Personal Reasons|1|||
42049583|NCT00897390|75858011|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
42049584|NCT01034462|75858024|FG000|Overall Study|Adverse Event|7|||
42049585|NCT01034462|75858025|FG001|Overall Study|Adverse Event|17|||
42049586|NCT01034462|75858024|FG000|Overall Study|Lack of Efficacy|4|||
42049587|NCT01034462|75858025|FG001|Overall Study|Lack of Efficacy|4|||
42049588|NCT01034462|75858024|FG000|Overall Study|Protocol Violation|10|||
42049589|NCT01034462|75858025|FG001|Overall Study|Protocol Violation|7|||
42049590|NCT01034462|75858024|FG000|Overall Study|Withdrawal by Subject|9|||
42049591|NCT01034462|75858025|FG001|Overall Study|Withdrawal by Subject|8|||
42049592|NCT01034462|75858024|FG000|Overall Study|Lost to Follow-up|14|||
42049593|NCT01034462|75858025|FG001|Overall Study|Lost to Follow-up|16|||
42049594|NCT01034462|75858024|FG000|Overall Study|Other reasons|1|||
42049595|NCT01034462|75858025|FG001|Overall Study|Other reasons|2|||
42049596|NCT01033448|75858033|FG000|Overall Study|Withdrawal by Subject|4|||
42049597|NCT01033448|75858033|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
42049598|NCT01033448|75858033|FG000|Overall Study|Lost to Follow-up|3|||
42049599|NCT01033448|75858033|FG000|Overall Study|Withdrew due to other reasons|3|||
42049600|NCT01033448|75858033|FG000|Overall Study|Unknown disposition|1|||
42049601|NCT00746941|75858043|FG000|Overall Study|Death|2|||
42049602|NCT00746941|75858044|FG001|Overall Study|Death|0|||
42049603|NCT00746941|75858045|FG002|Overall Study|Death|0|||
42049604|NCT00746941|75858046|FG003|Overall Study|Death|6|||
42049605|NCT00746941|75858043|FG000|Overall Study|Physician Decision|0|||
42049606|NCT00746941|75858044|FG001|Overall Study|Physician Decision|0|||
42049607|NCT00746941|75858045|FG002|Overall Study|Physician Decision|2|||
42049608|NCT00746941|75858046|FG003|Overall Study|Physician Decision|0|||
42049609|NCT00746941|75858043|FG000|Overall Study|Withdrawal by Subject|3|||
42049610|NCT00746941|75858044|FG001|Overall Study|Withdrawal by Subject|0|||
42049611|NCT00746941|75858045|FG002|Overall Study|Withdrawal by Subject|0|||
42049612|NCT00746941|75858046|FG003|Overall Study|Withdrawal by Subject|2|||
42049613|NCT00746941|75858043|FG000|Overall Study|Other, reason not provided|2|||
42049614|NCT00746941|75858044|FG001|Overall Study|Other, reason not provided|4|||
42049615|NCT00746941|75858045|FG002|Overall Study|Other, reason not provided|0|||
42049616|NCT00746941|75858046|FG003|Overall Study|Other, reason not provided|4|||
42049617|NCT00746941|75858043|FG000|Overall Study|Adverse Event|0|||
42049618|NCT00746941|75858044|FG001|Overall Study|Adverse Event|0|||
42049619|NCT00746941|75858045|FG002|Overall Study|Adverse Event|0|||
42049620|NCT00746941|75858046|FG003|Overall Study|Adverse Event|1|||
42049621|NCT00746785|75858058|FG000|Overall Study|Lost to Follow-up|29|||
42049622|NCT00746785|75858059|FG001|Overall Study|Lost to Follow-up|25|||
42049623|NCT00746785|75858060|FG002|Overall Study|Lost to Follow-up|27|||
42049624|NCT00750919|75858068|FG000|Overall Study|Adverse Event|9|||
42049625|NCT00750919|75858068|FG000|Overall Study|Withdrawal by Subject|1|||
42049626|NCT00750919|75858068|FG000|Overall Study|Lack of Efficacy|8|||
42049627|NCT00750919|75858068|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
42049628|NCT00750919|75858068|FG000|Overall Study|Other|36|||
42049629|NCT00746551|75858074|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
42049630|NCT00746551|75858075|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
42049631|NCT00746551|75858074|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
42049632|NCT00746551|75858075|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
42049633|NCT00746551|75858074|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
42049634|NCT00746551|75858075|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
42049635|NCT00753649|75858083|FG000|Overall Study|Migrated/moved from study area|1|||
42049636|NCT00753649|75858084|FG001|Overall Study|Migrated/moved from study area|0|||
42049637|NCT00753649|75858083|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
42049638|NCT00753649|75858084|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
42049639|NCT00753649|75858083|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
42049640|NCT00753649|75858084|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
42049641|NCT00753649|75858083|FG000|Overall Study|Protocol Violation|2|||
42049642|NCT00753649|75858084|FG001|Overall Study|Protocol Violation|0|||
42049643|NCT00750139|75858094|FG000|Overall Study|Adverse Event|1|||
42049644|NCT00750139|75858095|FG001|Overall Study|Adverse Event|2|||
42049645|NCT00750139|75858096|FG002|Overall Study|Adverse Event|0|||
42049646|NCT00750139|75858097|FG003|Overall Study|Adverse Event|1|||
42049647|NCT00750139|75858094|FG000|Overall Study|Lost to Follow-up|17|||
42049648|NCT00750139|75858095|FG001|Overall Study|Lost to Follow-up|12|||
42049649|NCT00750139|75858096|FG002|Overall Study|Lost to Follow-up|15|||
42049650|NCT00750139|75858097|FG003|Overall Study|Lost to Follow-up|6|||
42049651|NCT00750139|75858094|FG000|Overall Study|Withdrawal by Subject|3|||
42049652|NCT00750139|75858095|FG001|Overall Study|Withdrawal by Subject|2|||
42049653|NCT00750139|75858096|FG002|Overall Study|Withdrawal by Subject|6|||
42049654|NCT00750139|75858097|FG003|Overall Study|Withdrawal by Subject|2|||
42049655|NCT00750139|75858094|FG000|Overall Study|Physician Decision|1|||
42049656|NCT00750139|75858095|FG001|Overall Study|Physician Decision|1|||
42049657|NCT00750139|75858096|FG002|Overall Study|Physician Decision|0|||
42049658|NCT00750139|75858097|FG003|Overall Study|Physician Decision|0|||
42049659|NCT00750139|75858094|FG000|Overall Study|Non-compliance|1|||
42049660|NCT00750139|75858095|FG001|Overall Study|Non-compliance|0|||
42049661|NCT00750139|75858096|FG002|Overall Study|Non-compliance|1|||
42049662|NCT00750139|75858097|FG003|Overall Study|Non-compliance|3|||
42049663|NCT00750139|75858094|FG000|Overall Study|Termination by sponsor|4|||
42049664|NCT00750139|75858095|FG001|Overall Study|Termination by sponsor|0|||
42049665|NCT00750139|75858096|FG002|Overall Study|Termination by sponsor|0|||
42049666|NCT00750139|75858097|FG003|Overall Study|Termination by sponsor|1|||
42049667|NCT00750139|75858094|FG000|Overall Study|Non-specific|62|||
42049668|NCT00750139|75858095|FG001|Overall Study|Non-specific|42|||
42049669|NCT00750139|75858096|FG002|Overall Study|Non-specific|79|||
42049670|NCT00750139|75858097|FG003|Overall Study|Non-specific|33|||
42049671|NCT00750061|75858111|FG000|Overall Study|Adverse Event|2|||
42049672|NCT00750061|75858112|FG001|Overall Study|Adverse Event|0|||
42049673|NCT00750061|75858111|FG000|Overall Study|Withdrawal by Subject|0|||
42049674|NCT00750061|75858112|FG001|Overall Study|Withdrawal by Subject|1|||
42049675|NCT00750061|75858111|FG000|Overall Study|Physician Decision|0|||
42049676|NCT00750061|75858112|FG001|Overall Study|Physician Decision|1|||
42049677|NCT00744757|75858118|FG000|Overall Study|Objective disease progression|7|||
42049678|NCT00744757|75858118|FG000|Overall Study|Physician Decision|5|||
42173203|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Lack of time|1|||
42173204|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Lack of time|0|||
42173205|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Lack of time|0|||
42173206|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Lack of time|0|||
42173207|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Lack of time|0|||
42173208|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
42173209|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
42173210|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
42173211|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
42173212|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
42173213|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
42049679|NCT00744757|75858118|FG000|Overall Study|Withdrawal by Subject|1|||
42049680|NCT00744757|75858118|FG000|Overall Study|Death|6|||
42049681|NCT00744757|75858118|FG000|Overall Study|Adverse Event|2|||
42049682|NCT00745849|75858122|FG000|First Intervention|Withdrawal by Subject|0|||
42049683|NCT00745849|75858123|FG001|First Intervention|Withdrawal by Subject|1|||
42049684|NCT00745849|75858122|FG000|First Intervention|Lost to Follow-up|1|||
42049685|NCT00745849|75858123|FG001|First Intervention|Lost to Follow-up|1|||
42049686|NCT00745849|75858122|FG000|Second Intervention|Lost to Follow-up|2|||
42049687|NCT00745849|75858123|FG001|Second Intervention|Lost to Follow-up|1|||
42049688|NCT00749203|75858140|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
42049689|NCT00749203|75858141|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
42049690|NCT00749203|75858140|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
42049691|NCT00749203|75858141|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
42049692|NCT00749203|75858140|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
42049693|NCT00749203|75858141|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
42049694|NCT00749203|75858140|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
42049695|NCT00749203|75858141|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
42049696|NCT00749203|75858140|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
42049697|NCT00749203|75858141|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
42049698|NCT00749203|75858140|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
42049699|NCT00749203|75858141|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
42173214|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
42173215|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
42173216|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
42049700|NCT00748969|75858149|FG000|Overall Study|Withdrawal by Subject|1|||
42049701|NCT00748969|75858150|FG001|Overall Study|Withdrawal by Subject|0|||
42049702|NCT00748969|75858149|FG000|Overall Study|Withdrawal by Subject|0|||
42049703|NCT00748969|75858150|FG001|Overall Study|Withdrawal by Subject|1|||
42049704|NCT00745615|75858160|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
42049705|NCT00745615|75858161|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
42049706|NCT00745615|75858162|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
42049707|NCT00745615|75858163|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
42049708|NCT00745615|75858164|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
42049709|NCT00745615|75858165|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
42049710|NCT00745615|75858160|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
42049711|NCT00745615|75858161|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
42049712|NCT00745615|75858162|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
42049713|NCT00745615|75858163|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
42049714|NCT00745615|75858164|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
42049715|NCT00745615|75858165|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
42049716|NCT00745615|75858160|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
42049717|NCT00745615|75858161|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
42049718|NCT00745615|75858162|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
42049719|NCT00745615|75858163|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
42049720|NCT00745615|75858164|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
42049721|NCT00745615|75858165|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
42049722|NCT00745615|75858160|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
42049723|NCT00745615|75858161|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
42049724|NCT00745615|75858162|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
42049725|NCT00745615|75858163|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
42049726|NCT00745615|75858164|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
42049727|NCT00745615|75858165|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
42049728|NCT00745615|75858160|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
42049729|NCT00745615|75858161|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
42049730|NCT00745615|75858162|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
42049731|NCT00745615|75858163|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
42049732|NCT00745615|75858164|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
42049733|NCT00745615|75858165|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
42049734|NCT00745615|75858160|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
42049735|NCT00745615|75858161|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
42049736|NCT00745615|75858162|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
42049737|NCT00745615|75858163|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
42049738|NCT00745615|75858164|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
42049739|NCT00745615|75858165|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
42049740|NCT00745615|75858160|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
42049741|NCT00745615|75858161|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
42049742|NCT00745615|75858162|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
42049743|NCT00745615|75858163|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
42049744|NCT00745615|75858164|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
42049745|NCT00745615|75858165|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
42049746|NCT00745615|75858160|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
42049747|NCT00745615|75858161|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
42049748|NCT00745615|75858162|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
42049749|NCT00745615|75858163|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
42049750|NCT00745615|75858164|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
42049751|NCT00745615|75858165|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
42049752|NCT00745615|75858160|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
42049753|NCT00745615|75858161|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
42049754|NCT00745615|75858162|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
42049755|NCT00745615|75858163|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
42049756|NCT00745615|75858164|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
42049757|NCT00745615|75858165|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
42049758|NCT00745615|75858160|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
42049759|NCT00745615|75858161|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
42049760|NCT00745615|75858162|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
42049761|NCT00745615|75858163|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
42049762|NCT00745615|75858164|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
42049763|NCT00745615|75858165|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
42049764|NCT00745615|75858160|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
42049765|NCT00745615|75858161|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
42049766|NCT00745615|75858162|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
42049767|NCT00745615|75858163|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
42049768|NCT00745615|75858164|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
42049769|NCT00745615|75858165|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
42049770|NCT00745615|75858160|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
42049771|NCT00745615|75858161|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
42049772|NCT00745615|75858162|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
42049773|NCT00745615|75858163|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
42049774|NCT00745615|75858164|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
42049775|NCT00745615|75858165|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
42049776|NCT00745615|75858160|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
42049777|NCT00745615|75858161|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
42049778|NCT00745615|75858162|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
42049779|NCT00745615|75858163|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
42049780|NCT00745615|75858164|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
42049781|NCT00745615|75858165|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
42049782|NCT00745615|75858160|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
42049783|NCT00745615|75858161|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
42049784|NCT00745615|75858162|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
42049785|NCT00745615|75858163|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
42049786|NCT00745615|75858164|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
42049787|NCT00745615|75858165|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
42049788|NCT00744523|75858188|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
42049789|NCT00744523|75858189|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
42049790|NCT00744991|75858197|FG000|Overall Study|Progressive Disease|11|||
42049791|NCT00744991|75858197|FG000|Overall Study|Withdrawal by Subject|8|||
42049792|NCT00744991|75858197|FG000|Overall Study|Physician Decision|3|||
42049793|NCT00744991|75858197|FG000|Overall Study|Adverse Event|2|||
42049794|NCT00744991|75858197|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
42049795|NCT00839254|75858221|FG000|Overall Study|Protocol Violation|0|||
42049796|NCT00839254|75858222|FG001|Overall Study|Protocol Violation|1|||
42049797|NCT00839254|75858223|FG002|Overall Study|Protocol Violation|1|||
42049798|NCT00839254|75858224|FG003|Overall Study|Protocol Violation|1|||
42049799|NCT00839254|75858225|FG004|Overall Study|Protocol Violation|0|||
42049800|NCT00839254|75858226|FG005|Overall Study|Protocol Violation|0|||
42049801|NCT00839254|75858227|FG006|Overall Study|Protocol Violation|1|||
42049802|NCT00839254|75858228|FG007|Overall Study|Protocol Violation|2|||
42049803|NCT00839254|75858221|FG000|Overall Study|Physician Decision|0|||
42049804|NCT00839254|75858222|FG001|Overall Study|Physician Decision|1|||
42049805|NCT00839254|75858223|FG002|Overall Study|Physician Decision|0|||
42049806|NCT00839254|75858224|FG003|Overall Study|Physician Decision|0|||
42049807|NCT00839254|75858225|FG004|Overall Study|Physician Decision|0|||
42049808|NCT00839254|75858226|FG005|Overall Study|Physician Decision|0|||
42049809|NCT00839254|75858227|FG006|Overall Study|Physician Decision|0|||
42049810|NCT00839254|75858228|FG007|Overall Study|Physician Decision|1|||
42049811|NCT00839254|75858221|FG000|Overall Study|Wrong treatment number allocation|0|||
42049812|NCT00839254|75858222|FG001|Overall Study|Wrong treatment number allocation|1|||
42049813|NCT00839254|75858223|FG002|Overall Study|Wrong treatment number allocation|0|||
42049814|NCT00839254|75858224|FG003|Overall Study|Wrong treatment number allocation|0|||
42049815|NCT00839254|75858225|FG004|Overall Study|Wrong treatment number allocation|0|||
42049816|NCT00839254|75858226|FG005|Overall Study|Wrong treatment number allocation|1|||
42049817|NCT00839254|75858227|FG006|Overall Study|Wrong treatment number allocation|0|||
42049818|NCT00839254|75858228|FG007|Overall Study|Wrong treatment number allocation|0|||
42049819|NCT00839254|75858221|FG000|Overall Study|Adverse Event|12|||
42049820|NCT00839254|75858222|FG001|Overall Study|Adverse Event|6|||
42049821|NCT00839254|75858223|FG002|Overall Study|Adverse Event|3|||
42049822|NCT00839254|75858224|FG003|Overall Study|Adverse Event|5|||
42049823|NCT00839254|75858225|FG004|Overall Study|Adverse Event|2|||
42049824|NCT00839254|75858226|FG005|Overall Study|Adverse Event|1|||
42049825|NCT00839254|75858227|FG006|Overall Study|Adverse Event|0|||
42049826|NCT00839254|75858228|FG007|Overall Study|Adverse Event|1|||
42173217|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
42173218|NCT00318461|75979945|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
42173219|NCT00318461|75979946|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
42173220|NCT00318461|75979947|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
42291385|NCT02641379|76125030|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
42049827|NCT00839254|75858221|FG000|Overall Study|Withdrawal by Subject|87|||
42049828|NCT00839254|75858222|FG001|Overall Study|Withdrawal by Subject|53|||
42049829|NCT00839254|75858223|FG002|Overall Study|Withdrawal by Subject|54|||
42049830|NCT00839254|75858224|FG003|Overall Study|Withdrawal by Subject|32|||
42049831|NCT00839254|75858225|FG004|Overall Study|Withdrawal by Subject|27|||
42049832|NCT00839254|75858226|FG005|Overall Study|Withdrawal by Subject|15|||
42049833|NCT00839254|75858227|FG006|Overall Study|Withdrawal by Subject|22|||
42049834|NCT00839254|75858228|FG007|Overall Study|Withdrawal by Subject|9|||
42049835|NCT00839254|75858221|FG000|Overall Study|Wrong group allocation|0|||
42049836|NCT00839254|75858222|FG001|Overall Study|Wrong group allocation|0|||
42049837|NCT00839254|75858223|FG002|Overall Study|Wrong group allocation|0|||
42049838|NCT00839254|75858224|FG003|Overall Study|Wrong group allocation|0|||
42049839|NCT00839254|75858225|FG004|Overall Study|Wrong group allocation|0|||
42049840|NCT00839254|75858226|FG005|Overall Study|Wrong group allocation|0|||
42049841|NCT00839254|75858227|FG006|Overall Study|Wrong group allocation|1|||
42049842|NCT00839254|75858228|FG007|Overall Study|Wrong group allocation|0|||
42049843|NCT00839254|75858221|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
42049844|NCT00839254|75858222|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
42049845|NCT00839254|75858223|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
42049846|NCT00839254|75858224|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
42049847|NCT00839254|75858225|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
42049848|NCT00839254|75858226|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
42049849|NCT00839254|75858227|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
42049850|NCT00839254|75858228|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
42049851|NCT00839254|75858221|FG000|Overall Study|Withdrawn due to non-compliance|2|||
42049852|NCT00839254|75858222|FG001|Overall Study|Withdrawn due to non-compliance|0|||
42049853|NCT00839254|75858223|FG002|Overall Study|Withdrawn due to non-compliance|0|||
42049854|NCT00839254|75858224|FG003|Overall Study|Withdrawn due to non-compliance|0|||
42049855|NCT00839254|75858225|FG004|Overall Study|Withdrawn due to non-compliance|0|||
42049856|NCT00839254|75858226|FG005|Overall Study|Withdrawn due to non-compliance|0|||
42049857|NCT00839254|75858227|FG006|Overall Study|Withdrawn due to non-compliance|0|||
42049858|NCT00839254|75858228|FG007|Overall Study|Withdrawn due to non-compliance|0|||
42049859|NCT00839254|75858221|FG000|Overall Study|Lost to Follow-up|51|||
42049860|NCT00839254|75858222|FG001|Overall Study|Lost to Follow-up|30|||
42049861|NCT00839254|75858223|FG002|Overall Study|Lost to Follow-up|32|||
42049862|NCT00839254|75858224|FG003|Overall Study|Lost to Follow-up|24|||
42049863|NCT00839254|75858225|FG004|Overall Study|Lost to Follow-up|8|||
42049864|NCT00839254|75858226|FG005|Overall Study|Lost to Follow-up|8|||
42049865|NCT00839254|75858227|FG006|Overall Study|Lost to Follow-up|4|||
42049866|NCT00839254|75858228|FG007|Overall Study|Lost to Follow-up|2|||
42049867|NCT00586339|75858280|FG000|Overall Study|Withdrawal by Subject|1|||
42049868|NCT00586339|75858281|FG001|Overall Study|Withdrawal by Subject|3|||
42049869|NCT00586339|75858282|FG002|Overall Study|Withdrawal by Subject|1|||
42049870|NCT00586339|75858280|FG000|Overall Study|Migrated/moved from study area|3|||
42049871|NCT00586339|75858281|FG001|Overall Study|Migrated/moved from study area|2|||
42049872|NCT00586339|75858282|FG002|Overall Study|Migrated/moved from study area|4|||
42049873|NCT00586339|75858280|FG000|Overall Study|Lost to Follow-up|3|||
42049874|NCT00586339|75858281|FG001|Overall Study|Lost to Follow-up|2|||
42049875|NCT00586339|75858282|FG002|Overall Study|Lost to Follow-up|1|||
42049876|NCT00812968|75858290|FG000|Overall Study|Relapse after erythroid response|6|||
42049877|NCT00812968|75858290|FG000|Overall Study|Disease progression|1|||
42049878|NCT00812968|75858290|FG000|Overall Study|No further treatment required|1|||
42049879|NCT00812968|75858290|FG000|Overall Study|Study closed due to marketing approval|3|||
42049880|NCT00839098|75858299|FG000|Overall Study|Withdrawal by Subject|2|||
42049881|NCT00839098|75858300|FG001|Overall Study|Withdrawal by Subject|1|||
42049882|NCT00839098|75858301|FG002|Overall Study|Withdrawal by Subject|7|||
42049883|NCT00813748|75858311|FG000|Skin Test Substudy|Physician Decision|0|||
42049884|NCT00813748|75858312|FG001|Skin Test Substudy|Physician Decision|1|||
42049885|NCT00813592|75858320|FG000|Overall Study|Disease assessment was not completed per|2|||
42049886|NCT05067647|75858325|FG000|Overall Study|Lost to Follow-up|1|||
42049887|NCT04795323|75858331|FG000|Overall Study|Did not interact with TARA|1|||
42049888|NCT04795323|75858332|FG001|Overall Study|Did not interact with TARA|0|||
42049889|NCT04732871|75858350|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
42049890|NCT04732871|75858351|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
42049891|NCT04732871|75858352|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
42049892|NCT04732871|75858350|FG000|Overall Study|Lost to Follow-up|7|||
42049893|NCT04732871|75858351|FG001|Overall Study|Lost to Follow-up|4|||
42049894|NCT04732871|75858352|FG002|Overall Study|Lost to Follow-up|3|||
42049895|NCT04732871|75858350|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
42049896|NCT04732871|75858351|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
42049897|NCT04732871|75858352|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
42049898|NCT04732871|75858350|FG000|Overall Study|Migrated / moved from the study area|5|||
42049899|NCT04732871|75858351|FG001|Overall Study|Migrated / moved from the study area|0|||
42049900|NCT04732871|75858352|FG002|Overall Study|Migrated / moved from the study area|0|||
42291386|NCT02641379|76125031|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
42291387|NCT02641379|76125032|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
42049901|NCT04732871|75858350|FG000|Overall Study|Other|1|||
42049902|NCT04732871|75858351|FG001|Overall Study|Other|0|||
42049903|NCT04732871|75858352|FG002|Overall Study|Other|1|||
42049904|NCT04732871|75858350|FG000|Overall Study|Ongoing|6|||
42291388|NCT02641379|76125033|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
42049905|NCT04732871|75858351|FG001|Overall Study|Ongoing|0|||
42049906|NCT04732871|75858352|FG002|Overall Study|Ongoing|1|||
42049907|NCT04732871|75858350|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
42049908|NCT04732871|75858351|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
42049909|NCT04732871|75858352|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
42049910|NCT04497389|75858378|FG000|Overall Study|Withdrawal by Subject|1|||
42049911|NCT04497389|75858379|FG001|Overall Study|Withdrawal by Subject|0|||
42049912|NCT04425629|75858447|FG000|Overall Study|Adverse Event|0|||
42049913|NCT04425629|75858448|FG001|Overall Study|Adverse Event|0|||
42049914|NCT04425629|75858449|FG002|Overall Study|Adverse Event|0|||
42049915|NCT04425629|75858450|FG003|Overall Study|Adverse Event|0|||
42049916|NCT04425629|75858451|FG004|Overall Study|Adverse Event|1|||
42049917|NCT04425629|75858452|FG005|Overall Study|Adverse Event|0|||
42049918|NCT04425629|75858453|FG006|Overall Study|Adverse Event|0|||
42049919|NCT04425629|75858454|FG007|Overall Study|Adverse Event|0|||
42049920|NCT04425629|75858455|FG008|Overall Study|Adverse Event|0|||
42049921|NCT04425629|75858456|FG009|Overall Study|Adverse Event|3|||
42049922|NCT04425629|75858457|FG010|Overall Study|Adverse Event|2|||
42049923|NCT04425629|75858458|FG011|Overall Study|Adverse Event|1|||
42049924|NCT04425629|75858459|FG012|Overall Study|Adverse Event|1|||
42049925|NCT04425629|75858460|FG013|Overall Study|Adverse Event|0|||
42049926|NCT04425629|75858461|FG014|Overall Study|Adverse Event|0|||
42049927|NCT04425629|75858462|FG015|Overall Study|Adverse Event|0|||
42049928|NCT04425629|75858463|FG016|Overall Study|Adverse Event|0|||
42049929|NCT04425629|75858464|FG017|Overall Study|Adverse Event|0|||
42049930|NCT04425629|75858465|FG018|Overall Study|Adverse Event|0|||
42049931|NCT04425629|75858447|FG000|Overall Study|Lost to Follow-up|1|||
42049932|NCT04425629|75858448|FG001|Overall Study|Lost to Follow-up|3|||
42049933|NCT04425629|75858449|FG002|Overall Study|Lost to Follow-up|1|||
42049934|NCT04425629|75858450|FG003|Overall Study|Lost to Follow-up|7|||
42049935|NCT04425629|75858451|FG004|Overall Study|Lost to Follow-up|1|||
42049936|NCT04425629|75858452|FG005|Overall Study|Lost to Follow-up|2|||
42049937|NCT04425629|75858453|FG006|Overall Study|Lost to Follow-up|1|||
42049938|NCT04425629|75858454|FG007|Overall Study|Lost to Follow-up|0|||
42049939|NCT04425629|75858455|FG008|Overall Study|Lost to Follow-up|1|||
42049940|NCT04425629|75858456|FG009|Overall Study|Lost to Follow-up|64|||
42049941|NCT04425629|75858457|FG010|Overall Study|Lost to Follow-up|70|||
42049942|NCT04425629|75858458|FG011|Overall Study|Lost to Follow-up|98|||
42049943|NCT04425629|75858459|FG012|Overall Study|Lost to Follow-up|30|||
42049944|NCT04425629|75858460|FG013|Overall Study|Lost to Follow-up|0|||
42049945|NCT04425629|75858461|FG014|Overall Study|Lost to Follow-up|5|||
42049946|NCT04425629|75858462|FG015|Overall Study|Lost to Follow-up|4|||
42049947|NCT04425629|75858463|FG016|Overall Study|Lost to Follow-up|0|||
42049948|NCT04425629|75858464|FG017|Overall Study|Lost to Follow-up|3|||
42049949|NCT04425629|75858465|FG018|Overall Study|Lost to Follow-up|1|||
42049950|NCT04425629|75858447|FG000|Overall Study|Subject Decision|0|||
42049951|NCT04425629|75858448|FG001|Overall Study|Subject Decision|2|||
42049952|NCT04425629|75858449|FG002|Overall Study|Subject Decision|1|||
42049953|NCT04425629|75858450|FG003|Overall Study|Subject Decision|3|||
42049954|NCT04425629|75858451|FG004|Overall Study|Subject Decision|6|||
42049955|NCT04425629|75858452|FG005|Overall Study|Subject Decision|6|||
42049956|NCT04425629|75858453|FG006|Overall Study|Subject Decision|3|||
42049957|NCT04425629|75858454|FG007|Overall Study|Subject Decision|3|||
42049958|NCT04425629|75858455|FG008|Overall Study|Subject Decision|1|||
42049959|NCT04425629|75858456|FG009|Overall Study|Subject Decision|70|||
42049960|NCT04425629|75858457|FG010|Overall Study|Subject Decision|95|||
42049961|NCT04425629|75858458|FG011|Overall Study|Subject Decision|124|||
42049962|NCT04425629|75858459|FG012|Overall Study|Subject Decision|25|||
42049963|NCT04425629|75858460|FG013|Overall Study|Subject Decision|0|||
42049964|NCT04425629|75858461|FG014|Overall Study|Subject Decision|1|||
42049965|NCT04425629|75858462|FG015|Overall Study|Subject Decision|4|||
42049966|NCT04425629|75858463|FG016|Overall Study|Subject Decision|1|||
42049967|NCT04425629|75858464|FG017|Overall Study|Subject Decision|0|||
42049968|NCT04425629|75858465|FG018|Overall Study|Subject Decision|2|||
42049969|NCT04425629|75858447|FG000|Overall Study|Death|0|||
42049970|NCT04425629|75858448|FG001|Overall Study|Death|0|||
42049971|NCT04425629|75858449|FG002|Overall Study|Death|0|||
42291389|NCT02641379|76125034|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
42291390|NCT02641379|76125035|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
42049972|NCT04425629|75858450|FG003|Overall Study|Death|0|||
42049973|NCT04425629|75858451|FG004|Overall Study|Death|0|||
42049974|NCT04425629|75858452|FG005|Overall Study|Death|0|||
42049975|NCT04425629|75858453|FG006|Overall Study|Death|0|||
42291391|NCT02641379|76125036|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
42049976|NCT04425629|75858454|FG007|Overall Study|Death|0|||
42049977|NCT04425629|75858455|FG008|Overall Study|Death|0|||
42049978|NCT04425629|75858456|FG009|Overall Study|Death|11|||
42049979|NCT04425629|75858457|FG010|Overall Study|Death|2|||
42049980|NCT04425629|75858458|FG011|Overall Study|Death|4|||
42049981|NCT04425629|75858459|FG012|Overall Study|Death|0|||
42049982|NCT04425629|75858460|FG013|Overall Study|Death|0|||
42049983|NCT04425629|75858461|FG014|Overall Study|Death|0|||
42049984|NCT04425629|75858462|FG015|Overall Study|Death|0|||
42049985|NCT04425629|75858463|FG016|Overall Study|Death|0|||
42049986|NCT04425629|75858464|FG017|Overall Study|Death|0|||
42049987|NCT04425629|75858465|FG018|Overall Study|Death|0|||
42049988|NCT04425629|75858447|FG000|Overall Study|Sponsor Request|0|||
42049989|NCT04425629|75858448|FG001|Overall Study|Sponsor Request|0|||
42049990|NCT04425629|75858449|FG002|Overall Study|Sponsor Request|0|||
42049991|NCT04425629|75858450|FG003|Overall Study|Sponsor Request|2|||
42049992|NCT04425629|75858451|FG004|Overall Study|Sponsor Request|2|||
42049993|NCT04425629|75858452|FG005|Overall Study|Sponsor Request|2|||
42049994|NCT04425629|75858453|FG006|Overall Study|Sponsor Request|1|||
42049995|NCT04425629|75858454|FG007|Overall Study|Sponsor Request|0|||
42049996|NCT04425629|75858455|FG008|Overall Study|Sponsor Request|0|||
42049997|NCT04425629|75858456|FG009|Overall Study|Sponsor Request|9|||
42049998|NCT04425629|75858457|FG010|Overall Study|Sponsor Request|9|||
42049999|NCT04425629|75858458|FG011|Overall Study|Sponsor Request|10|||
42050000|NCT04425629|75858459|FG012|Overall Study|Sponsor Request|8|||
42050001|NCT04425629|75858460|FG013|Overall Study|Sponsor Request|0|||
42050002|NCT04425629|75858461|FG014|Overall Study|Sponsor Request|0|||
42050003|NCT04425629|75858462|FG015|Overall Study|Sponsor Request|1|||
42050004|NCT04425629|75858463|FG016|Overall Study|Sponsor Request|0|||
42050005|NCT04425629|75858464|FG017|Overall Study|Sponsor Request|0|||
42050006|NCT04425629|75858465|FG018|Overall Study|Sponsor Request|0|||
42050007|NCT04425629|75858447|FG000|Overall Study|Physician Decision|0|||
42050008|NCT04425629|75858448|FG001|Overall Study|Physician Decision|0|||
42050009|NCT04425629|75858449|FG002|Overall Study|Physician Decision|0|||
42050010|NCT04425629|75858450|FG003|Overall Study|Physician Decision|0|||
42050011|NCT04425629|75858451|FG004|Overall Study|Physician Decision|0|||
42050012|NCT04425629|75858452|FG005|Overall Study|Physician Decision|0|||
42050013|NCT04425629|75858453|FG006|Overall Study|Physician Decision|0|||
42050014|NCT04425629|75858454|FG007|Overall Study|Physician Decision|0|||
42050015|NCT04425629|75858455|FG008|Overall Study|Physician Decision|0|||
42050016|NCT04425629|75858456|FG009|Overall Study|Physician Decision|4|||
42050017|NCT04425629|75858457|FG010|Overall Study|Physician Decision|3|||
42050018|NCT04425629|75858458|FG011|Overall Study|Physician Decision|5|||
42050019|NCT04425629|75858459|FG012|Overall Study|Physician Decision|1|||
42050020|NCT04425629|75858460|FG013|Overall Study|Physician Decision|0|||
42050021|NCT04425629|75858461|FG014|Overall Study|Physician Decision|0|||
42050022|NCT04425629|75858462|FG015|Overall Study|Physician Decision|1|||
42050023|NCT04425629|75858463|FG016|Overall Study|Physician Decision|0|||
42050024|NCT04425629|75858464|FG017|Overall Study|Physician Decision|0|||
42050025|NCT04425629|75858465|FG018|Overall Study|Physician Decision|0|||
42050026|NCT04425629|75858447|FG000|Overall Study|Lack of Efficacy|0|||
42050027|NCT04425629|75858448|FG001|Overall Study|Lack of Efficacy|0|||
42050028|NCT04425629|75858449|FG002|Overall Study|Lack of Efficacy|0|||
42050029|NCT04425629|75858450|FG003|Overall Study|Lack of Efficacy|0|||
42050030|NCT04425629|75858451|FG004|Overall Study|Lack of Efficacy|0|||
42050031|NCT04425629|75858452|FG005|Overall Study|Lack of Efficacy|0|||
42050032|NCT04425629|75858453|FG006|Overall Study|Lack of Efficacy|0|||
42050033|NCT04425629|75858454|FG007|Overall Study|Lack of Efficacy|0|||
42050034|NCT04425629|75858455|FG008|Overall Study|Lack of Efficacy|0|||
42050035|NCT04425629|75858456|FG009|Overall Study|Lack of Efficacy|0|||
42050036|NCT04425629|75858457|FG010|Overall Study|Lack of Efficacy|1|||
42050037|NCT04425629|75858458|FG011|Overall Study|Lack of Efficacy|0|||
42050038|NCT04425629|75858459|FG012|Overall Study|Lack of Efficacy|0|||
42050039|NCT04425629|75858460|FG013|Overall Study|Lack of Efficacy|0|||
42050040|NCT04425629|75858461|FG014|Overall Study|Lack of Efficacy|0|||
42050041|NCT04425629|75858462|FG015|Overall Study|Lack of Efficacy|0|||
42050042|NCT04425629|75858463|FG016|Overall Study|Lack of Efficacy|0|||
42050043|NCT04425629|75858464|FG017|Overall Study|Lack of Efficacy|0|||
42050044|NCT04425629|75858465|FG018|Overall Study|Lack of Efficacy|0|||
42050045|NCT04417218|75858615|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
42050046|NCT04417218|75858616|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
42050047|NCT04134767|75858624|FG000|Overall Study|Death|0|||
42050048|NCT04134767|75858625|FG001|Overall Study|Death|1|||
42050049|NCT04134767|75858624|FG000|Overall Study|Removed for harassing staff|0|||
42050050|NCT04134767|75858625|FG001|Overall Study|Removed for harassing staff|1|||
42050051|NCT04134767|75858624|FG000|Overall Study|Lost to Follow-up|44|||
42050052|NCT04134767|75858625|FG001|Overall Study|Lost to Follow-up|40|||
42050053|NCT04024462|75858655|FG000|Overall Study|Withdrawal by Subject|6|||
42291392|NCT02641379|76125037|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
42050054|NCT04024462|75858656|FG001|Overall Study|Withdrawal by Subject|7|||
42050055|NCT04024462|75858655|FG000|Overall Study|Progressive Disease|0|||
42050056|NCT04024462|75858656|FG001|Overall Study|Progressive Disease|1|||
42050057|NCT04024462|75858655|FG000|Overall Study|Adverse Event|0|||
42050058|NCT04024462|75858656|FG001|Overall Study|Adverse Event|1|||
42050059|NCT04024462|75858655|FG000|Overall Study|Death|0|||
42050060|NCT04024462|75858656|FG001|Overall Study|Death|1|||
42050061|NCT04024462|75858655|FG000|Overall Study|Lost to Follow-up|1|||
42050062|NCT04024462|75858656|FG001|Overall Study|Lost to Follow-up|0|||
42050063|NCT04024462|75858655|FG000|Overall Study|Ongoing in the Study|94|||
42291393|NCT02641379|76125027|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
42050064|NCT04024462|75858656|FG001|Overall Study|Ongoing in the Study|89|||
42050065|NCT03960580|75858665|FG000|Overall Study|Adverse Event|2|||
42050066|NCT03960580|75858666|FG001|Overall Study|Adverse Event|1|||
42050067|NCT03960580|75858667|FG002|Overall Study|Adverse Event|1|||
42050068|NCT03960580|75858665|FG000|Overall Study|Lost to Follow-up|1|||
42050069|NCT03960580|75858666|FG001|Overall Study|Lost to Follow-up|0|||
42050070|NCT03960580|75858667|FG002|Overall Study|Lost to Follow-up|0|||
42050071|NCT03960580|75858665|FG000|Overall Study|Lack of Efficacy|2|||
42050072|NCT03960580|75858666|FG001|Overall Study|Lack of Efficacy|1|||
42050073|NCT03960580|75858667|FG002|Overall Study|Lack of Efficacy|0|||
42050074|NCT03960580|75858665|FG000|Overall Study|Protocol Violation|0|||
42050075|NCT03960580|75858666|FG001|Overall Study|Protocol Violation|0|||
42050076|NCT03960580|75858667|FG002|Overall Study|Protocol Violation|1|||
42050077|NCT03960580|75858665|FG000|Overall Study|Withdrawal by Subject|1|||
42050078|NCT03960580|75858666|FG001|Overall Study|Withdrawal by Subject|1|||
42050079|NCT03960580|75858667|FG002|Overall Study|Withdrawal by Subject|1|||
42050080|NCT03960580|75858665|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
42050081|NCT03960580|75858666|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
42050082|NCT03960580|75858667|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
42050083|NCT03803202|75858684|FG000|Overall Study|Other|0|||
42050084|NCT03803202|75858685|FG001|Overall Study|Other|1|||
42050085|NCT03803202|75858686|FG002|Overall Study|Other|0|||
42050086|NCT03803202|75858687|FG003|Overall Study|Other|0|||
42050087|NCT03803202|75858688|FG004|Overall Study|Other|0|||
42050088|NCT03803202|75858689|FG005|Overall Study|Other|0|||
42050089|NCT03803202|75858690|FG006|Overall Study|Other|0|||
42050090|NCT03803202|75858691|FG007|Overall Study|Other|0|||
42050091|NCT03803202|75858692|FG008|Overall Study|Other|0|||
42050092|NCT03803202|75858684|FG000|Overall Study|Death|0|||
42050093|NCT03803202|75858685|FG001|Overall Study|Death|0|||
42050094|NCT03803202|75858686|FG002|Overall Study|Death|0|||
42050095|NCT03803202|75858687|FG003|Overall Study|Death|0|||
42050096|NCT03803202|75858688|FG004|Overall Study|Death|0|||
42050097|NCT03803202|75858689|FG005|Overall Study|Death|1|||
42050098|NCT03803202|75858690|FG006|Overall Study|Death|0|||
42050099|NCT03803202|75858691|FG007|Overall Study|Death|0|||
42050100|NCT03803202|75858692|FG008|Overall Study|Death|0|||
42050101|NCT03803202|75858684|FG000|Overall Study|Withdrawal by Subject|0|||
42050102|NCT03803202|75858685|FG001|Overall Study|Withdrawal by Subject|0|||
42050103|NCT03803202|75858686|FG002|Overall Study|Withdrawal by Subject|1|||
42050104|NCT03803202|75858687|FG003|Overall Study|Withdrawal by Subject|0|||
42050105|NCT03803202|75858688|FG004|Overall Study|Withdrawal by Subject|0|||
42050106|NCT03803202|75858689|FG005|Overall Study|Withdrawal by Subject|0|||
42050107|NCT03803202|75858690|FG006|Overall Study|Withdrawal by Subject|0|||
42050108|NCT03803202|75858691|FG007|Overall Study|Withdrawal by Subject|1|||
42050109|NCT03803202|75858692|FG008|Overall Study|Withdrawal by Subject|0|||
42050110|NCT03803202|75858684|FG000|Overall Study|Lost to Follow-up|0|||
42050111|NCT03803202|75858685|FG001|Overall Study|Lost to Follow-up|0|||
42050112|NCT03803202|75858686|FG002|Overall Study|Lost to Follow-up|0|||
42050113|NCT03803202|75858687|FG003|Overall Study|Lost to Follow-up|1|||
42050114|NCT03803202|75858688|FG004|Overall Study|Lost to Follow-up|1|||
42050115|NCT03803202|75858689|FG005|Overall Study|Lost to Follow-up|0|||
42050116|NCT03803202|75858690|FG006|Overall Study|Lost to Follow-up|1|||
42050117|NCT03803202|75858691|FG007|Overall Study|Lost to Follow-up|0|||
42050118|NCT03803202|75858692|FG008|Overall Study|Lost to Follow-up|0|||
42173221|NCT00318461|75979948|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
42173222|NCT00318461|75979949|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
42173223|NCT00318461|75979945|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
42173224|NCT00318461|75979946|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
42291394|NCT02641379|76125028|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
42291395|NCT02641379|76125029|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
42050119|NCT03782727|75858726|FG000|Overall Study|Lost to Follow-up|32|||
42050120|NCT03737812|75858733|FG000|Overall Study|Withdrawal by Subject|1|||
42050121|NCT03737812|75858734|FG001|Overall Study|Withdrawal by Subject|2|||
42173225|NCT00318461|75979947|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
42291396|NCT02641379|76125030|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
42173226|NCT00318461|75979948|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
42291397|NCT02641379|76125031|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
42050122|NCT03737812|75858735|FG002|Overall Study|Withdrawal by Subject|1|||
42050123|NCT03737812|75858733|FG000|Overall Study|Sponsor Discontinued the Study|4|||
42050124|NCT03737812|75858734|FG001|Overall Study|Sponsor Discontinued the Study|3|||
42050125|NCT03737812|75858735|FG002|Overall Study|Sponsor Discontinued the Study|2|||
42173227|NCT00318461|75979949|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
42050126|NCT03737812|75858733|FG000|Overall Study|Adverse Event|0|||
42050127|NCT03737812|75858734|FG001|Overall Study|Adverse Event|1|||
42050128|NCT03737812|75858735|FG002|Overall Study|Adverse Event|0|||
42050129|NCT03737812|75858733|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
42050130|NCT03737812|75858734|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
42050131|NCT03737812|75858735|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
42050132|NCT03662659|75858745|FG000|Pre-treatment|Participant no longer met study criteria|1|||
42050133|NCT03662659|75858746|FG001|Pre-treatment|Participant no longer met study criteria|1|||
42050134|NCT03662659|75858745|FG000|Pre-treatment|Other reasons|1|||
42050135|NCT03662659|75858746|FG001|Pre-treatment|Other reasons|0|||
42050136|NCT03662659|75858745|FG000|Treatment|Completed Treatment|0|||
42050137|NCT03662659|75858746|FG001|Treatment|Completed Treatment|3|||
42050138|NCT03662659|75858745|FG000|Treatment|Disease Progression|69|||
42050139|NCT03662659|75858746|FG001|Treatment|Disease Progression|78|||
42050140|NCT03662659|75858745|FG000|Treatment|Study Drug Toxicity|18|||
42050141|NCT03662659|75858746|FG001|Treatment|Study Drug Toxicity|8|||
42050142|NCT03662659|75858745|FG000|Treatment|Death|12|||
42050143|NCT03662659|75858746|FG001|Treatment|Death|7|||
42050144|NCT03662659|75858745|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
42050145|NCT03662659|75858746|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
42050146|NCT03662659|75858745|FG000|Treatment|Withdrawal by Subject|1|||
42050147|NCT03662659|75858746|FG001|Treatment|Withdrawal by Subject|1|||
42050148|NCT03662659|75858745|FG000|Treatment|Poor/Non-compliance|1|||
42050149|NCT03662659|75858746|FG001|Treatment|Poor/Non-compliance|0|||
42050150|NCT03662659|75858745|FG000|Treatment|Participant no longer meets study criteria|1|||
42050151|NCT03662659|75858746|FG001|Treatment|Participant no longer meets study criteria|0|||
42050152|NCT03662659|75858745|FG000|Treatment|Other reasons|6|||
42050153|NCT03662659|75858746|FG001|Treatment|Other reasons|5|||
42050154|NCT03646123|75858755|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
42050155|NCT03646123|75858756|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
42050156|NCT03646123|75858757|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
42050157|NCT03646123|75858755|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
42050158|NCT03646123|75858756|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
42050159|NCT03646123|75858757|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
42050160|NCT03646123|75858755|FG000|Overall Study|Non-compliance to study protocol|1|||
42050161|NCT03646123|75858756|FG001|Overall Study|Non-compliance to study protocol|0|||
42050162|NCT03646123|75858757|FG002|Overall Study|Non-compliance to study protocol|0|||
42050163|NCT03646123|75858755|FG000|Overall Study|Ineligible due to progression during screening|0|||
42050164|NCT03646123|75858756|FG001|Overall Study|Ineligible due to progression during screening|0|||
42050165|NCT03646123|75858757|FG002|Overall Study|Ineligible due to progression during screening|1|||
42050166|NCT03646123|75858755|FG000|Overall Study|Withdrawal by Subject|2|||
42050167|NCT03646123|75858756|FG001|Overall Study|Withdrawal by Subject|1|||
42050168|NCT03646123|75858757|FG002|Overall Study|Withdrawal by Subject|3|||
42050169|NCT03646123|75858755|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
42050170|NCT03646123|75858756|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
42050171|NCT03646123|75858757|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
42050172|NCT03646123|75858755|FG000|Overall Study|Death|2|||
42050173|NCT03646123|75858756|FG001|Overall Study|Death|1|||
42050174|NCT03646123|75858757|FG002|Overall Study|Death|1|||
42050175|NCT03646123|75858755|FG000|Overall Study|Lost to Follow-up|4|||
42050176|NCT03646123|75858756|FG001|Overall Study|Lost to Follow-up|7|||
42050177|NCT03646123|75858757|FG002|Overall Study|Lost to Follow-up|6|||
42050178|NCT03646123|75858755|FG000|Overall Study|Participants in long term follow-up|0|||
42050179|NCT03646123|75858756|FG001|Overall Study|Participants in long term follow-up|48|||
42050180|NCT03646123|75858757|FG002|Overall Study|Participants in long term follow-up|144|||
42050181|NCT03635424|75858765|FG000|Overall Study|Adverse Event|1|||
42050182|NCT03635424|75858765|FG000|Overall Study|Death|1|||
42050183|NCT03635424|75858765|FG000|Overall Study|Device not implanted|1|||
42173228|NCT00318461|75979945|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
42050184|NCT03565367|75858771|FG000|Overall Study|No scan due to technical issues|4|||
42050185|NCT03565367|75858772|FG001|Overall Study|No scan due to technical issues|0|||
42050186|NCT03554317|75858778|FG000|Overall Study|Withdrawal by Subject|1|||
42050187|NCT03554317|75858778|FG000|Overall Study|PSA Progression|3|||
42050188|NCT03554317|75858778|FG000|Overall Study|Radiographic Progression|4|||
42050189|NCT03443687|75858784|FG000|Overall Study|Lost to Follow-up|3|||
42050190|NCT03443687|75858785|FG001|Overall Study|Lost to Follow-up|5|||
42050191|NCT03443687|75858784|FG000|Overall Study|Withdrawal by Subject|1|||
42050192|NCT03443687|75858785|FG001|Overall Study|Withdrawal by Subject|0|||
42050193|NCT03443687|75858784|FG000|Overall Study|Discontinued intervention|1|||
42050194|NCT03443687|75858785|FG001|Overall Study|Discontinued intervention|1|||
42050195|NCT03384654|75858795|FG000|Overall Study|Withdrawal by Subject|0|||
42050196|NCT03384654|75858796|FG001|Overall Study|Withdrawal by Subject|0|||
42173229|NCT00318461|75979946|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
42356903|NCT01425801|76202064|FG001|Period 4|Not able to maintain visit schedule|0|||
42050197|NCT03384654|75858797|FG002|Overall Study|Withdrawal by Subject|1|||
42050198|NCT03384654|75858798|FG003|Overall Study|Withdrawal by Subject|0|||
42050199|NCT03085485|75858826|FG000|Overall Study|Death|1|||
42050200|NCT03085485|75858827|FG001|Overall Study|Death|0|||
42050201|NCT03085485|75858826|FG000|Overall Study|Lost to Follow-up|1|||
42050202|NCT03085485|75858827|FG001|Overall Study|Lost to Follow-up|0|||
42050203|NCT03043872|75858845|FG000|Overall Study|Withdrawal by Subject|6|||
42050204|NCT03043872|75858846|FG001|Overall Study|Withdrawal by Subject|6|||
42050205|NCT03043872|75858847|FG002|Overall Study|Withdrawal by Subject|15|||
42050206|NCT03043872|75858845|FG000|Overall Study|Lost to Follow-up|2|||
42050207|NCT03043872|75858846|FG001|Overall Study|Lost to Follow-up|1|||
42050208|NCT03043872|75858847|FG002|Overall Study|Lost to Follow-up|1|||
42050209|NCT03043872|75858845|FG000|Overall Study|Death|270|||
42050210|NCT03043872|75858846|FG001|Overall Study|Death|269|||
42050211|NCT03043872|75858847|FG002|Overall Study|Death|296|||
42050212|NCT02928224|75858869|FG000|Overall Study|Lost to Follow-up|1|||
42050213|NCT02928224|75858870|FG001|Overall Study|Lost to Follow-up|1|||
42050214|NCT02928224|75858871|FG002|Overall Study|Lost to Follow-up|3|||
42050215|NCT02928224|75858872|FG003|Overall Study|Lost to Follow-up|0|||
42050216|NCT02928224|75858869|FG000|Overall Study|Death|30|||
42050217|NCT02928224|75858870|FG001|Overall Study|Death|209|||
42050218|NCT02928224|75858871|FG002|Overall Study|Death|193|||
42050219|NCT02928224|75858872|FG003|Overall Study|Death|198|||
42050220|NCT02928224|75858869|FG000|Overall Study|Withdrawal by Subject|0|||
42050221|NCT02928224|75858870|FG001|Overall Study|Withdrawal by Subject|3|||
42050222|NCT02928224|75858871|FG002|Overall Study|Withdrawal by Subject|7|||
42050223|NCT02928224|75858872|FG003|Overall Study|Withdrawal by Subject|20|||
42050224|NCT02928224|75858869|FG000|Overall Study|Study participation terminated by sponsor|3|||
42050225|NCT02928224|75858870|FG001|Overall Study|Study participation terminated by sponsor|8|||
42050226|NCT02928224|75858871|FG002|Overall Study|Study participation terminated by sponsor|12|||
42050227|NCT02928224|75858872|FG003|Overall Study|Study participation terminated by sponsor|3|||
42050228|NCT02928224|75858869|FG000|Overall Study|Other|3|||
42050229|NCT02928224|75858870|FG001|Overall Study|Other|3|||
42050230|NCT02928224|75858871|FG002|Overall Study|Other|5|||
42050231|NCT02928224|75858872|FG003|Overall Study|Other|0|||
42050232|NCT02842086|75858891|FG000|Overall Study|Randomized but Never Treated|6|||
42050233|NCT02842086|75858892|FG001|Overall Study|Randomized but Never Treated|6|||
42050234|NCT02842086|75858891|FG000|Overall Study|Still in Double-Blind Phase|7|||
42050235|NCT02842086|75858892|FG001|Overall Study|Still in Double-Blind Phase|3|||
42050236|NCT02842086|75858891|FG000|Overall Study|Adverse Event|18|||
42050237|NCT02842086|75858892|FG001|Overall Study|Adverse Event|20|||
42050238|NCT02842086|75858891|FG000|Overall Study|Death|3|||
42050239|NCT02842086|75858892|FG001|Overall Study|Death|3|||
42050240|NCT02842086|75858891|FG000|Overall Study|Investigator's Discretion|9|||
42050241|NCT02842086|75858892|FG001|Overall Study|Investigator's Discretion|13|||
42050242|NCT02842086|75858891|FG000|Overall Study|Non-Compliance with Study Drug|9|||
42050243|NCT02842086|75858892|FG001|Overall Study|Non-Compliance with Study Drug|8|||
42050244|NCT02842086|75858891|FG000|Overall Study|Protocol Violation|8|||
42050245|NCT02842086|75858892|FG001|Overall Study|Protocol Violation|4|||
42050246|NCT02842086|75858891|FG000|Overall Study|Withdrew Consent|205|||
42050247|NCT02842086|75858892|FG001|Overall Study|Withdrew Consent|194|||
42050248|NCT02842086|75858891|FG000|Overall Study|Lost to Follow-up|274|||
42050249|NCT02842086|75858892|FG001|Overall Study|Lost to Follow-up|236|||
42050250|NCT02842086|75858891|FG000|Overall Study|HIV-1 Infection|5|||
42050251|NCT02842086|75858892|FG001|Overall Study|HIV-1 Infection|6|||
42050252|NCT02788474|75858900|FG000|Double Blind Treatment Period|Not treated|1|||
42050253|NCT02788474|75858901|FG001|Double Blind Treatment Period|Not treated|0|||
42050254|NCT02788474|75858900|FG000|Double Blind Treatment Period|Patient's refusal|3|||
42050255|NCT02788474|75858901|FG001|Double Blind Treatment Period|Patient's refusal|0|||
42050256|NCT02788474|75858900|FG000|Double Blind Treatment Period|Adverse Event|6|||
42050257|NCT02788474|75858901|FG001|Double Blind Treatment Period|Adverse Event|4|||
42050258|NCT02788474|75858900|FG000|Open Label Treatment Period|Adverse Event|29|||
42050259|NCT02788474|75858901|FG001|Open Label Treatment Period|Adverse Event|9|||
42050260|NCT02788474|75858900|FG000|Open Label Treatment Period|Other than reason specified|1|||
42050261|NCT02788474|75858901|FG001|Open Label Treatment Period|Other than reason specified|0|||
42050262|NCT02788474|75858900|FG000|Open Label Treatment Period|Patient's refusal|1|||
42050263|NCT02788474|75858901|FG001|Open Label Treatment Period|Patient's refusal|3|||
42050264|NCT02788474|75858900|FG000|Open Label Treatment Period|Non-compliance|1|||
42050265|NCT02788474|75858901|FG001|Open Label Treatment Period|Non-compliance|0|||
42050266|NCT02631746|75858908|FG000|Overall Study|Lack of Efficacy|3|||
42050267|NCT02166463|75858925|FG000|Overall Study|Lost to Follow-up|0|||
42050268|NCT02166463|75858926|FG001|Overall Study|Lost to Follow-up|1|||
42050269|NCT02166463|75858925|FG000|Overall Study|Physician Decision|10|||
42050270|NCT02166463|75858926|FG001|Overall Study|Physician Decision|10|||
42050271|NCT02166463|75858925|FG000|Overall Study|Ineligible|11|||
42050272|NCT02166463|75858926|FG001|Overall Study|Ineligible|2|||
42050273|NCT02166463|75858925|FG000|Overall Study|Progressive Disease|9|||
42050274|NCT02166463|75858926|FG001|Overall Study|Progressive Disease|6|||
42050275|NCT02166463|75858925|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
42050276|NCT02166463|75858926|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
42050277|NCT02166463|75858925|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
42050278|NCT02166463|75858926|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
42050279|NCT02166463|75858925|FG000|Overall Study|Refusal of further protocol therapy|5|||
42050280|NCT02166463|75858926|FG001|Overall Study|Refusal of further protocol therapy|6|||
42050281|NCT02101034|75858937|FG000|Overall Study|Enrolled but did not start treatment|0|||
42050282|NCT02101034|75858938|FG001|Overall Study|Enrolled but did not start treatment|0|||
42050283|NCT02101034|75858939|FG002|Overall Study|Enrolled but did not start treatment|1|||
42050284|NCT02101034|75858940|FG003|Overall Study|Enrolled but did not start treatment|0|||
42050285|NCT02101034|75858941|FG004|Overall Study|Enrolled but did not start treatment|0|||
42050286|NCT02000622|75858964|FG000|Overall Study|Withdrawal by Subject|5|||
42050287|NCT02000622|75858965|FG001|Overall Study|Withdrawal by Subject|7|||
42050288|NCT02000622|75858964|FG000|Overall Study|Lost to Follow-up|4|||
42050289|NCT02000622|75858965|FG001|Overall Study|Lost to Follow-up|0|||
42050290|NCT02000622|75858964|FG000|Overall Study|Death|159|||
42050291|NCT02000622|75858965|FG001|Overall Study|Death|73|||
42050292|NCT02000622|75858964|FG000|Overall Study|Withdrawn due to site closure|1|||
42050293|NCT02000622|75858965|FG001|Overall Study|Withdrawn due to site closure|0|||
42050294|NCT00798135|75858980|FG000|Overall Study|Disease progression, relapse|11|||
42050295|NCT00798135|75858980|FG000|Overall Study|Disease progression, refractory|1|||
42050296|NCT00798135|75858980|FG000|Overall Study|Physician Decision|1|||
42050297|NCT00813358|75859003|FG000|Overall Study|Death|32|||
42050298|NCT00813358|75859003|FG000|Overall Study|Lost to Follow-up|12|||
42050299|NCT00813358|75859003|FG000|Overall Study|other endpoints|5|||
42050300|NCT00813358|75859003|FG000|Overall Study|Withdrawal by Subject|20|||
42050301|NCT00812812|75859009|FG000|Overall Study|Adverse Event|2|||
42050302|NCT00812812|75859010|FG001|Overall Study|Adverse Event|1|||
42050303|NCT00812812|75859009|FG000|Overall Study|Lack of Efficacy|1|||
42050304|NCT00812812|75859010|FG001|Overall Study|Lack of Efficacy|0|||
42050305|NCT00812812|75859009|FG000|Overall Study|Lost to Follow-up|0|||
42050306|NCT00812812|75859010|FG001|Overall Study|Lost to Follow-up|1|||
42050307|NCT00812812|75859009|FG000|Overall Study|Withdrawal by Subject|0|||
42050308|NCT00812812|75859010|FG001|Overall Study|Withdrawal by Subject|2|||
42050309|NCT00810082|75859020|FG000|Overall Study|Lost to Follow-up|0|||
42050310|NCT00810082|75859021|FG001|Overall Study|Lost to Follow-up|4|||
42050311|NCT00748189|75859029|FG000|Overall Study|Death|99|||
42050312|NCT00748189|75859030|FG001|Overall Study|Death|84|||
42050313|NCT00748189|75859029|FG000|Overall Study|Withdrawal by Subject|23|||
42050314|NCT00748189|75859030|FG001|Overall Study|Withdrawal by Subject|29|||
42050315|NCT00748189|75859029|FG000|Overall Study|Physician Decision|16|||
42050316|NCT00748189|75859030|FG001|Overall Study|Physician Decision|5|||
42050317|NCT00748189|75859029|FG000|Overall Study|Lost to Follow-up|8|||
42050318|NCT00748189|75859030|FG001|Overall Study|Lost to Follow-up|15|||
42050319|NCT00748189|75859029|FG000|Overall Study|Study terminated by Sponsor|70|||
42050320|NCT00748189|75859030|FG001|Overall Study|Study terminated by Sponsor|79|||
42050321|NCT00744055|75859043|FG000|Overall Study|Withdrawal by Subject|6|||
42050322|NCT00744055|75859044|FG001|Overall Study|Withdrawal by Subject|9|||
42050323|NCT00744055|75859043|FG000|Overall Study|Lack of Efficacy|0|||
42050324|NCT00744055|75859044|FG001|Overall Study|Lack of Efficacy|1|||
42050325|NCT00744055|75859043|FG000|Overall Study|Physician Decision|0|||
42050326|NCT00744055|75859044|FG001|Overall Study|Physician Decision|2|||
42050327|NCT00744055|75859043|FG000|Overall Study|Protocol Violation|1|||
42050328|NCT00744055|75859044|FG001|Overall Study|Protocol Violation|1|||
42050329|NCT00744055|75859043|FG000|Overall Study|Lost to Follow-up|0|||
42050330|NCT00744055|75859044|FG001|Overall Study|Lost to Follow-up|1|||
42050331|NCT00748033|75859052|FG000|Overall Study|Adverse Event|0|||
42050332|NCT00748033|75859053|FG001|Overall Study|Adverse Event|1|||
42173230|NCT00318461|75979947|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
42173231|NCT00318461|75979948|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
42291398|NCT02641379|76125032|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
42291399|NCT02641379|76125033|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
42050333|NCT00735553|75859070|FG000|Overall Study|Study prematurely terminated|77|||
42050334|NCT00740779|75859081|FG000|Overall Study|Adverse Event|4|||
42050335|NCT00740779|75859082|FG001|Overall Study|Adverse Event|6|||
42050336|NCT00740779|75859083|FG002|Overall Study|Adverse Event|3|||
42050337|NCT00740779|75859081|FG000|Overall Study|Protocol Violation|1|||
42050338|NCT00740779|75859082|FG001|Overall Study|Protocol Violation|1|||
42050339|NCT00740779|75859083|FG002|Overall Study|Protocol Violation|1|||
42050340|NCT00740779|75859081|FG000|Overall Study|Lack of Efficacy|0|||
42050341|NCT00740779|75859082|FG001|Overall Study|Lack of Efficacy|0|||
42050342|NCT00740779|75859083|FG002|Overall Study|Lack of Efficacy|2|||
42050343|NCT00740779|75859081|FG000|Overall Study|Withdrawal by Subject|2|||
42050344|NCT00740779|75859082|FG001|Overall Study|Withdrawal by Subject|4|||
42050345|NCT00740779|75859083|FG002|Overall Study|Withdrawal by Subject|2|||
42050346|NCT00740779|75859081|FG000|Overall Study|Lost to Follow-up|2|||
42050347|NCT00740779|75859082|FG001|Overall Study|Lost to Follow-up|3|||
42050348|NCT00740779|75859083|FG002|Overall Study|Lost to Follow-up|5|||
42050349|NCT00735475|75859093|FG000|Overall Study|Adverse Event|0|||
42050350|NCT00735475|75859094|FG001|Overall Study|Adverse Event|1|||
42050351|NCT00735475|75859093|FG000|Overall Study|Death|1|||
42050352|NCT00735475|75859094|FG001|Overall Study|Death|1|||
42050353|NCT00735475|75859093|FG000|Overall Study|Lost to Follow-up|3|||
42050354|NCT00735475|75859094|FG001|Overall Study|Lost to Follow-up|3|||
42050355|NCT00735475|75859093|FG000|Overall Study|Physician Decision|0|||
42050356|NCT00735475|75859094|FG001|Overall Study|Physician Decision|1|||
42050357|NCT00735475|75859093|FG000|Overall Study|Withdrawal by Subject|4|||
42050358|NCT00735475|75859094|FG001|Overall Study|Withdrawal by Subject|5|||
42050359|NCT01026818|75859103|FG000|Screening Period|Entry Criteria Not Met|105|||
42050360|NCT01026818|75859104|FG001|Screening Period|Entry Criteria Not Met|0|||
42050361|NCT01026818|75859105|FG002|Screening Period|Entry Criteria Not Met|0|||
42050362|NCT01026818|75859106|FG003|Screening Period|Entry Criteria Not Met|0|||
42050363|NCT01026818|75859103|FG000|Screening Period|Withdrawal by Subject|49|||
42050364|NCT01026818|75859104|FG001|Screening Period|Withdrawal by Subject|0|||
42050365|NCT01026818|75859105|FG002|Screening Period|Withdrawal by Subject|0|||
42050366|NCT01026818|75859106|FG003|Screening Period|Withdrawal by Subject|0|||
42050367|NCT01026818|75859103|FG000|Screening Period|Protocol Deviation|3|||
42050368|NCT01026818|75859104|FG001|Screening Period|Protocol Deviation|0|||
42050369|NCT01026818|75859105|FG002|Screening Period|Protocol Deviation|0|||
42050370|NCT01026818|75859106|FG003|Screening Period|Protocol Deviation|0|||
42050371|NCT01026818|75859103|FG000|Screening Period|Adverse Event|2|||
42050372|NCT01026818|75859104|FG001|Screening Period|Adverse Event|0|||
42050373|NCT01026818|75859105|FG002|Screening Period|Adverse Event|0|||
42050374|NCT01026818|75859106|FG003|Screening Period|Adverse Event|0|||
42050375|NCT01026818|75859103|FG000|Screening Period|Physician Decision|1|||
42050376|NCT01026818|75859104|FG001|Screening Period|Physician Decision|0|||
42050377|NCT01026818|75859105|FG002|Screening Period|Physician Decision|0|||
42050378|NCT01026818|75859106|FG003|Screening Period|Physician Decision|0|||
42050379|NCT01026818|75859103|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
42050380|NCT01026818|75859104|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
42050381|NCT01026818|75859105|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
42050382|NCT01026818|75859106|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
42050383|NCT01026818|75859103|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
42050384|NCT01026818|75859104|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
42050385|NCT01026818|75859105|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
42050386|NCT01026818|75859106|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
42050387|NCT01026818|75859103|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
42050388|NCT01026818|75859104|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
42050389|NCT01026818|75859105|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
42050390|NCT01026818|75859106|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
42050391|NCT01026818|75859103|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
42050392|NCT01026818|75859104|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
42050393|NCT01026818|75859105|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
42050394|NCT01026818|75859106|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
42050395|NCT01026818|75859103|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
42050396|NCT01026818|75859104|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
42050397|NCT01026818|75859105|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
42050398|NCT01026818|75859106|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
42050399|NCT01026818|75859103|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
42050400|NCT01026818|75859104|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
42050401|NCT01026818|75859105|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
42050402|NCT01026818|75859106|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
42050403|NCT01026818|75859103|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
42050404|NCT01026818|75859104|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
42050405|NCT01026818|75859105|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
42050406|NCT01026818|75859106|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
42050407|NCT01026818|75859103|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
42050408|NCT01026818|75859104|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
42050409|NCT01026818|75859105|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
42050410|NCT01026818|75859106|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
42050411|NCT01026818|75859103|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
42050412|NCT01026818|75859104|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
42050413|NCT01026818|75859105|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
42050414|NCT01026818|75859106|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
42050415|NCT01026818|75859103|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
42050416|NCT01026818|75859104|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
42050417|NCT01026818|75859105|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
42050418|NCT01026818|75859106|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
42050419|NCT01026818|75859103|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
42050420|NCT01026818|75859104|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
42050421|NCT01026818|75859105|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
42050422|NCT01026818|75859106|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
42050423|NCT01026818|75859103|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
42050424|NCT01026818|75859104|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
42050425|NCT01026818|75859105|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
42050426|NCT01026818|75859106|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
42050427|NCT01026818|75859103|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
42050428|NCT01026818|75859104|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
42050429|NCT01026818|75859105|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
42050430|NCT01026818|75859106|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
42050431|NCT01026818|75859103|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
42050432|NCT01026818|75859104|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
42050433|NCT01026818|75859105|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
42050434|NCT01026818|75859106|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
42050435|NCT01026818|75859103|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
42050436|NCT01026818|75859104|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
42050437|NCT01026818|75859105|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
42050438|NCT01026818|75859106|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
42050439|NCT01026818|75859103|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
42050440|NCT01026818|75859104|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
42050441|NCT01026818|75859105|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
42050442|NCT01026818|75859106|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
42050443|NCT01026818|75859103|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
42050444|NCT01026818|75859104|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
42050445|NCT01026818|75859105|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
42050446|NCT01026818|75859106|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
42050447|NCT01026818|75859103|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
42050448|NCT01026818|75859104|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
42050449|NCT01026818|75859105|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
42050450|NCT01026818|75859106|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
42050451|NCT01026818|75859103|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
42050452|NCT01026818|75859104|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
42050453|NCT01026818|75859105|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
42356904|NCT01425801|76202065|FG002|Period 4|Not able to maintain visit schedule|1|||
42356905|NCT01425801|76202066|FG003|Period 4|Not able to maintain visit schedule|0|||
42356906|NCT01425801|76202067|FG004|Period 4|Not able to maintain visit schedule|0|||
42356907|NCT01425801|76202068|FG005|Period 4|Not able to maintain visit schedule|0|||
42356908|NCT01425723|76202093|FG000|Overall Study|Lack of Efficacy|0|||
42356909|NCT01425723|76202094|FG001|Overall Study|Lack of Efficacy|1|||
42356910|NCT01425723|76202093|FG000|Overall Study|Withdrawal by Subject|1|||
42050454|NCT01026818|75859106|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
42050455|NCT00735397|75859118|FG000|Overall Study|Adverse Event|194|||
42050456|NCT00735397|75859118|FG000|Overall Study|Lost to Follow-up|33|||
42050457|NCT00735397|75859118|FG000|Overall Study|Participant choice|252|||
42050458|NCT00735397|75859118|FG000|Overall Study|Inadequate therapeutic effect|202|||
42050459|NCT00735397|75859118|FG000|Overall Study|Administrative/Other|502|||
42050460|NCT00735007|75859125|FG000|Overall Study|Adverse Event|4|||
42050461|NCT00735007|75859125|FG000|Overall Study|Protocol Violation|1|||
42173232|NCT00318461|75979949|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
42173233|NCT00318461|75979945|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
42291400|NCT02641379|76125034|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
42291401|NCT02641379|76125035|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
42291402|NCT02641379|76125036|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
42291403|NCT02641379|76125037|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
42291404|NCT02641379|76125027|FG000|Overall Study|Baseline viral load unavailable|0|||
42291405|NCT02641379|76125028|FG001|Overall Study|Baseline viral load unavailable|0|||
42291406|NCT02641379|76125029|FG002|Overall Study|Baseline viral load unavailable|0|||
42291407|NCT02641379|76125030|FG003|Overall Study|Baseline viral load unavailable|1|||
42050462|NCT00743509|75859129|FG000|Overall Study|Withdrawal by Subject|2|||
42050463|NCT00734929|75859135|FG000|Overall Study|Lost to Follow-up|1|||
42050464|NCT00734929|75859136|FG001|Overall Study|Lost to Follow-up|2|||
42173234|NCT00318461|75979946|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
42291408|NCT02641379|76125031|FG004|Overall Study|Baseline viral load unavailable|0|||
42291409|NCT02641379|76125032|FG005|Overall Study|Baseline viral load unavailable|0|||
42173235|NCT00318461|75979947|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
42050465|NCT00734929|75859135|FG000|Overall Study|No intervention/ screen fail|5|||
42050466|NCT00734929|75859136|FG001|Overall Study|No intervention/ screen fail|3|||
42050467|NCT00734851|75859144|FG000|Overall Study|Withdrawal by Subject|2|||
42050468|NCT00734851|75859144|FG000|Overall Study|Lost to Follow-up|1|||
42050469|NCT00734851|75859144|FG000|Overall Study|Physician Decision|18|||
42050470|NCT00734617|75859150|FG000|Overall Study|Adverse Event|4|||
42050471|NCT00734617|75859151|FG001|Overall Study|Adverse Event|7|||
42050472|NCT00734617|75859150|FG000|Overall Study|Withdrawal by Subject|103|||
42050473|NCT00734617|75859151|FG001|Overall Study|Withdrawal by Subject|95|||
42050474|NCT00743431|75859157|FG000|Overall Study|Toxicity|6|||
42050475|NCT00743431|75859157|FG000|Overall Study|Tumor progression|56|||
42050476|NCT00743431|75859157|FG000|Overall Study|Withdrawal by Subject|13|||
42050477|NCT00743431|75859157|FG000|Overall Study|Death|9|||
42050478|NCT00743431|75859157|FG000|Overall Study|Reason for discontinuation not specified|29|||
42050479|NCT00743431|75859157|FG000|Overall Study|No documentation available|13|||
42050480|NCT00734539|75859163|FG000|Main Study|Death|33|||
42173236|NCT00318461|75979948|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
42173237|NCT00318461|75979949|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
42173238|NCT00318461|75979945|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
42173239|NCT00318461|75979946|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
42173240|NCT00318461|75979947|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
42173241|NCT00318461|75979948|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
42173242|NCT00318461|75979949|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
42173243|NCT00318461|75979945|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
42173244|NCT00318461|75979946|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
42173245|NCT00318461|75979947|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
42173246|NCT00318461|75979948|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
42173247|NCT00318461|75979949|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
42173248|NCT03764072|75979976|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
42173249|NCT03764072|75979977|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
42173250|NCT03764072|75979978|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
42173251|NCT03764072|75979979|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
42173252|NCT03764072|75979980|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
42173253|NCT03764072|75979981|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
42173254|NCT03764072|75979976|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
42173255|NCT03764072|75979977|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
42173256|NCT03764072|75979978|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
42173257|NCT03764072|75979979|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
42173258|NCT03764072|75979980|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
42173259|NCT03764072|75979981|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
42173260|NCT03764072|75979976|FG000|Overall Study|Lost to Follow-up|0|||
42173261|NCT03764072|75979977|FG001|Overall Study|Lost to Follow-up|0|||
42173262|NCT03764072|75979978|FG002|Overall Study|Lost to Follow-up|0|||
42173263|NCT03764072|75979979|FG003|Overall Study|Lost to Follow-up|0|||
42173264|NCT03764072|75979980|FG004|Overall Study|Lost to Follow-up|1|||
42173265|NCT03764072|75979981|FG005|Overall Study|Lost to Follow-up|0|||
42173266|NCT03333928|75980003|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
42173267|NCT03333928|75980004|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
42173268|NCT03333928|75980005|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
42173269|NCT03333928|75980003|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
42173270|NCT03333928|75980004|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
42173271|NCT03333928|75980005|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
42173272|NCT03333928|75980003|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
42173273|NCT03333928|75980004|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
42173274|NCT03333928|75980005|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
42173275|NCT03333928|75980003|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
42173276|NCT03333928|75980004|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
42173277|NCT03333928|75980005|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
42173278|NCT03333928|75980003|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
42173279|NCT03333928|75980004|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
42291410|NCT02641379|76125033|FG006|Overall Study|Baseline viral load unavailable|0|||
42050481|NCT00734539|75859164|FG001|Main Study|Death|32|||
42050482|NCT00734539|75859163|FG000|Main Study|Physician Decision|2|||
42050483|NCT00734539|75859164|FG001|Main Study|Physician Decision|0|||
42050484|NCT00734539|75859163|FG000|Main Study|Withdrawal by Subject|1|||
42050485|NCT00734539|75859164|FG001|Main Study|Withdrawal by Subject|3|||
42050486|NCT00734539|75859163|FG000|Main Study|Enrolled in error; ineligible|1|||
42050487|NCT00734539|75859164|FG001|Main Study|Enrolled in error; ineligible|0|||
42050488|NCT00743275|75859175|FG000|Overall Study|Protocol Violation|0|||
42050489|NCT00743275|75859176|FG001|Overall Study|Protocol Violation|1|||
42050490|NCT00743197|75859184|FG000|Overall Study|Study terminated due to departure of PI.|1|||
42050491|NCT00743197|75859185|FG001|Overall Study|Study terminated due to departure of PI.|2|||
42050492|NCT00734071|75859193|FG000|Overall Study|Adverse Event|4|||
42050493|NCT00734071|75859194|FG001|Overall Study|Adverse Event|3|||
42050494|NCT00734071|75859193|FG000|Overall Study|Lack of Efficacy|3|||
42050495|NCT00734071|75859194|FG001|Overall Study|Lack of Efficacy|1|||
42050496|NCT00734071|75859193|FG000|Overall Study|Noncompliance|2|||
42050497|NCT00734071|75859194|FG001|Overall Study|Noncompliance|2|||
42050498|NCT00734071|75859193|FG000|Overall Study|Protocol Deviations|3|||
42050499|NCT00734071|75859194|FG001|Overall Study|Protocol Deviations|4|||
42050500|NCT00734071|75859193|FG000|Overall Study|Voluntary Withdrawal|9|||
42050501|NCT00734071|75859194|FG001|Overall Study|Voluntary Withdrawal|7|||
42050502|NCT00734071|75859193|FG000|Overall Study|Lost to Follow-up|16|||
42050503|NCT00734071|75859194|FG001|Overall Study|Lost to Follow-up|8|||
42050504|NCT00734071|75859193|FG000|Overall Study|Other|1|||
42050505|NCT00734071|75859194|FG001|Overall Study|Other|2|||
42050506|NCT00739297|75859200|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
42050507|NCT00739297|75859201|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
42050508|NCT00739297|75859202|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
42050509|NCT00739297|75859203|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
42050510|NCT00739297|75859204|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
42050511|NCT00739297|75859205|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
42173280|NCT03333928|75980005|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
42050512|NCT00739297|75859206|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
42050513|NCT00739297|75859200|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
42050514|NCT00739297|75859201|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
42050515|NCT00739297|75859202|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
42050516|NCT00739297|75859203|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
42050517|NCT00739297|75859204|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
42050518|NCT00739297|75859205|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
42050519|NCT00739297|75859206|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
42050520|NCT00739063|75859222|FG000|Overall Study|Screen failures|8|||
42050521|NCT01026194|75859228|FG000|Period 1：Double Blind Period|Adverse Event|2|||
42050522|NCT01026194|75859229|FG001|Period 1：Double Blind Period|Adverse Event|1|||
42050523|NCT01026194|75859228|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
42050524|NCT01026194|75859229|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
42050525|NCT01026194|75859228|FG000|Period 1：Double Blind Period|Physician Decision|0|||
42050526|NCT01026194|75859229|FG001|Period 1：Double Blind Period|Physician Decision|4|||
42050527|NCT01026194|75859228|FG000|Period 2：Open-label Period|Adverse Event|4|||
42050528|NCT01026194|75859229|FG001|Period 2：Open-label Period|Adverse Event|5|||
42050529|NCT01026194|75859228|FG000|Period 2：Open-label Period|Physician Decision|3|||
42050530|NCT01026194|75859229|FG001|Period 2：Open-label Period|Physician Decision|1|||
42050531|NCT01026194|75859228|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
42050532|NCT01026194|75859229|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
42050533|NCT01033136|75859239|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
42050534|NCT01033136|75859240|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
42050535|NCT00738673|75859250|FG000|Overall Study|Adverse Event|1|||
42050536|NCT00738673|75859251|FG001|Overall Study|Adverse Event|0|||
42050537|NCT00738673|75859250|FG000|Overall Study|Lack of Efficacy|19|||
42050538|NCT00738673|75859251|FG001|Overall Study|Lack of Efficacy|8|||
42050539|NCT00738673|75859250|FG000|Overall Study|Protocol Violation|1|||
42050540|NCT00738673|75859251|FG001|Overall Study|Protocol Violation|2|||
42050541|NCT00738673|75859250|FG000|Overall Study|Withdrawal by Subject|3|||
42050542|NCT00738673|75859251|FG001|Overall Study|Withdrawal by Subject|1|||
42050543|NCT00811954|75859260|FG000|Overall Study|Death|10|||
42050544|NCT00811954|75859261|FG001|Overall Study|Death|6|||
42050545|NCT00811954|75859262|FG002|Overall Study|Death|13|||
42050546|NCT00811954|75859260|FG000|Overall Study|Lost to Follow-up|29|||
42050547|NCT00811954|75859261|FG001|Overall Study|Lost to Follow-up|23|||
42050548|NCT00811954|75859262|FG002|Overall Study|Lost to Follow-up|34|||
42050549|NCT00811954|75859260|FG000|Overall Study|Not able to get to clinic|28|||
42173281|NCT03333928|75980003|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
42050550|NCT00811954|75859261|FG001|Overall Study|Not able to get to clinic|35|||
42050551|NCT00811954|75859262|FG002|Overall Study|Not able to get to clinic|30|||
42050552|NCT00811954|75859260|FG000|Overall Study|Not willing to adhere to requirements|12|||
42050553|NCT00811954|75859261|FG001|Overall Study|Not willing to adhere to requirements|2|||
42050554|NCT00811954|75859262|FG002|Overall Study|Not willing to adhere to requirements|16|||
42050555|NCT00811954|75859260|FG000|Overall Study|Withdraw consent prior study completion|4|||
42050556|NCT00811954|75859261|FG001|Overall Study|Withdraw consent prior study completion|6|||
42050557|NCT00811954|75859262|FG002|Overall Study|Withdraw consent prior study completion|5|||
42050558|NCT00811954|75859260|FG000|Overall Study|Site Closure|4|||
42050559|NCT00811954|75859261|FG001|Overall Study|Site Closure|0|||
42050560|NCT00811954|75859262|FG002|Overall Study|Site Closure|1|||
42050561|NCT00811954|75859260|FG000|Overall Study|Severe Debilitation|2|||
42050562|NCT00811954|75859261|FG001|Overall Study|Severe Debilitation|0|||
42050563|NCT00811954|75859262|FG002|Overall Study|Severe Debilitation|1|||
42050564|NCT00811954|75859260|FG000|Overall Study|Complete Protocol: No follow-up|0|||
42050565|NCT00811954|75859261|FG001|Overall Study|Complete Protocol: No follow-up|0|||
42050566|NCT00811954|75859262|FG002|Overall Study|Complete Protocol: No follow-up|1|||
42050567|NCT01032200|75859272|FG000|Overall Study|Death|1|||
42050568|NCT01032200|75859273|FG001|Overall Study|Death|1|||
42050569|NCT01032200|75859272|FG000|Overall Study|Withdrawal by Subject|1|||
42050570|NCT01032200|75859273|FG001|Overall Study|Withdrawal by Subject|3|||
42050571|NCT01032200|75859272|FG000|Overall Study|Toxicity|0|||
42050572|NCT01032200|75859273|FG001|Overall Study|Toxicity|2|||
42050573|NCT01032200|75859272|FG000|Overall Study|Progression|1|||
42050574|NCT01032200|75859273|FG001|Overall Study|Progression|0|||
42050575|NCT01032200|75859272|FG000|Overall Study|Multiple|1|||
42050576|NCT01032200|75859273|FG001|Overall Study|Multiple|1|||
42050577|NCT00738283|75859279|FG000|Overall Study|Death|1|||
42050578|NCT00738283|75859279|FG000|Overall Study|Transfer to another facility|2|||
42050579|NCT00738283|75859279|FG000|Overall Study|Discharge home prior to end of study|1|||
42050580|NCT00586105|75859292|FG000|Overall Study|Adverse Event|4|||
42050581|NCT00586105|75859292|FG000|Overall Study|Death|2|||
42050582|NCT00586105|75859292|FG000|Overall Study|Protocol Violation|1|||
42050583|NCT00586105|75859292|FG000|Overall Study|Withdrawal by Subject|3|||
42050584|NCT00586105|75859292|FG000|Overall Study|Disease progression|19|||
42050585|NCT00586105|75859292|FG000|Overall Study|Switched to commercial drug|9|||
42050586|NCT00586105|75859292|FG000|Overall Study|Reason not reported|1|||
42050587|NCT00743119|75859296|FG000|Overall Study|unreliable|3|||
42050588|NCT00743119|75859296|FG000|Overall Study|Withdrawal by Subject|1|||
42050589|NCT00733369|75859310|FG000|Overall Study|Lost to Follow-up|2|||
42050590|NCT00733369|75859311|FG001|Overall Study|Lost to Follow-up|1|||
42050591|NCT00733369|75859310|FG000|Overall Study|Adverse Event|4|||
42050592|NCT00733369|75859311|FG001|Overall Study|Adverse Event|4|||
42050593|NCT00733369|75859310|FG000|Overall Study|Protocol Violation|4|||
42050594|NCT00733369|75859311|FG001|Overall Study|Protocol Violation|4|||
42050595|NCT00813124|75859317|FG000|Overall Study|Death|2|||
42050596|NCT00813124|75859317|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
42050597|NCT00813124|75859317|FG000|Overall Study|Withdrawal by Subject|1|||
42050598|NCT00733291|75859323|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
42050599|NCT00733291|75859324|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
42050600|NCT00733291|75859325|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
42050601|NCT00733291|75859326|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
42050602|NCT00732199|75859339|FG000|Overall Study|Withdrawal by Subject|25|||
42050603|NCT00732199|75859340|FG001|Overall Study|Withdrawal by Subject|18|||
42050604|NCT00732199|75859339|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
42050605|NCT00732199|75859340|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
42050606|NCT00807040|75859351|FG000|Overall Study|Death|24|||
42050607|NCT00807040|75859352|FG001|Overall Study|Death|29|||
42050608|NCT00807040|75859351|FG000|Overall Study|Withdrawal by Subject|8|||
42050609|NCT00807040|75859352|FG001|Overall Study|Withdrawal by Subject|6|||
42050610|NCT00807040|75859351|FG000|Overall Study|Lost to Follow-up|4|||
42050611|NCT00807040|75859352|FG001|Overall Study|Lost to Follow-up|6|||
42050612|NCT00811720|75859360|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
42050613|NCT00811720|75859361|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
42050614|NCT00811720|75859360|FG000|All Treated Patients|Adverse Event|20|||
42050615|NCT00811720|75859361|FG001|All Treated Patients|Adverse Event|62|||
42050616|NCT00811720|75859360|FG000|All Treated Patients|Lack of Efficacy|22|||
42050617|NCT00811720|75859361|FG001|All Treated Patients|Lack of Efficacy|18|||
42050618|NCT00811720|75859360|FG000|All Treated Patients|Non-compliance|0|||
42050619|NCT00811720|75859361|FG001|All Treated Patients|Non-compliance|14|||
42050620|NCT00811720|75859360|FG000|All Treated Patients|Protocol Violation|9|||
42050621|NCT00811720|75859361|FG001|All Treated Patients|Protocol Violation|16|||
42050622|NCT00811720|75859360|FG000|All Treated Patients|Withdrawal by Subject|28|||
42050623|NCT00811720|75859361|FG001|All Treated Patients|Withdrawal by Subject|34|||
42050624|NCT00811720|75859360|FG000|All Treated Patients|Lost to Follow-up|10|||
42050625|NCT00811720|75859361|FG001|All Treated Patients|Lost to Follow-up|16|||
42050626|NCT00811720|75859360|FG000|All Treated Patients|Other Reason|7|||
42050627|NCT00811720|75859361|FG001|All Treated Patients|Other Reason|4|||
42050628|NCT04202679|75859369|FG000|Overall Study|Adverse Event|2|||
42050629|NCT04202679|75859370|FG001|Overall Study|Adverse Event|0|||
42050630|NCT04202679|75859369|FG000|Overall Study|Poor compliance to protocol|1|||
42050631|NCT04202679|75859370|FG001|Overall Study|Poor compliance to protocol|0|||
42050632|NCT04202679|75859369|FG000|Overall Study|Withdrawal by Subject|23|||
42050633|NCT04202679|75859370|FG001|Overall Study|Withdrawal by Subject|6|||
42050634|NCT00811642|75859377|FG000|Overall Study|Adverse Event|3|||
42050635|NCT00811642|75859377|FG000|Overall Study|Protocol Violation|1|||
42050636|NCT00811642|75859377|FG000|Overall Study|Death|2|||
42050637|NCT00811642|75859377|FG000|Overall Study|Withdrawal by Subject|7|||
42050638|NCT00811642|75859377|FG000|Overall Study|Cumulative use of antifungal agent|2|||
42050639|NCT00809926|75859383|FG000|Overall Study|Adverse Event|18|||
42050640|NCT00809926|75859384|FG001|Overall Study|Adverse Event|10|||
42050641|NCT00809926|75859383|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
42050642|NCT00809926|75859384|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
42050643|NCT00809926|75859383|FG000|Overall Study|Patient withdrew consent|8|||
42050644|NCT00809926|75859384|FG001|Overall Study|Patient withdrew consent|6|||
42050645|NCT00809926|75859383|FG000|Overall Study|Lost to Follow-up|2|||
42050646|NCT00809926|75859384|FG001|Overall Study|Lost to Follow-up|1|||
42050647|NCT00809926|75859383|FG000|Overall Study|Administrative Problems|0|||
42050648|NCT00809926|75859384|FG001|Overall Study|Administrative Problems|1|||
42050649|NCT00809926|75859383|FG000|Overall Study|Protocol deviation|0|||
42050650|NCT00809926|75859384|FG001|Overall Study|Protocol deviation|2|||
42050651|NCT00590980|75859390|FG000|Overall Study|Did not meet all inclusion criteria|10|||
42050652|NCT00590824|75859398|FG000|Overall Study|Disease could not be resected|0|||
42050653|NCT00590824|75859399|FG001|Overall Study|Disease could not be resected|2|||
42050654|NCT00590824|75859400|FG002|Overall Study|Disease could not be resected|1|||
42050655|NCT00590824|75859401|FG003|Overall Study|Disease could not be resected|0|||
42050656|NCT00590824|75859398|FG000|Overall Study|Adverse Event|0|||
42050657|NCT00590824|75859399|FG001|Overall Study|Adverse Event|0|||
42050658|NCT00590824|75859400|FG002|Overall Study|Adverse Event|0|||
42050659|NCT00590824|75859401|FG003|Overall Study|Adverse Event|1|||
42050660|NCT00590590|75859414|FG000|Overall Study|Lack of Efficacy|1|||
42050661|NCT00590590|75859415|FG001|Overall Study|Lack of Efficacy|2|||
42050662|NCT00590590|75859416|FG002|Overall Study|Lack of Efficacy|0|||
42050663|NCT00590590|75859414|FG000|Overall Study|Adverse Event|1|||
42050664|NCT00590590|75859415|FG001|Overall Study|Adverse Event|0|||
42050665|NCT00590590|75859416|FG002|Overall Study|Adverse Event|0|||
42050666|NCT00590590|75859414|FG000|Overall Study|Protocol Violation|0|||
42050667|NCT00590590|75859415|FG001|Overall Study|Protocol Violation|0|||
42050668|NCT00590590|75859416|FG002|Overall Study|Protocol Violation|2|||
42050669|NCT00590590|75859414|FG000|Overall Study|Lost to Follow-up|4|||
42050670|NCT00590590|75859415|FG001|Overall Study|Lost to Follow-up|1|||
42050671|NCT00590590|75859416|FG002|Overall Study|Lost to Follow-up|2|||
42050672|NCT00590590|75859414|FG000|Overall Study|Withdrawal by Subject|0|||
42050673|NCT00590590|75859415|FG001|Overall Study|Withdrawal by Subject|1|||
42173282|NCT03333928|75980004|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
42173283|NCT03333928|75980005|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
42173284|NCT03333928|75980003|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
42173285|NCT03333928|75980004|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
42173286|NCT03333928|75980005|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
42173287|NCT03333928|75980003|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
42173288|NCT03333928|75980004|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
42173289|NCT03333928|75980005|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
42173290|NCT02945410|75980027|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
42173291|NCT02945410|75980028|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
42173292|NCT02945410|75980029|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
42173293|NCT02945410|75980030|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
42173294|NCT02945410|75980031|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
42173295|NCT02945410|75980032|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
42173296|NCT02945410|75980027|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
42173297|NCT02945410|75980028|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
42173298|NCT02945410|75980029|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
42173299|NCT02945410|75980030|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
42173300|NCT02945410|75980031|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
42050674|NCT00590590|75859416|FG002|Overall Study|Withdrawal by Subject|1|||
42050675|NCT00590590|75859414|FG000|Overall Study|Did not complete due to study closure|1|||
42050676|NCT00590590|75859415|FG001|Overall Study|Did not complete due to study closure|1|||
42173301|NCT02945410|75980032|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
42173302|NCT02945410|75980027|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
42050677|NCT00590590|75859416|FG002|Overall Study|Did not complete due to study closure|1|||
42173303|NCT02945410|75980028|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
42050678|NCT00590590|75859414|FG000|Overall Study|Did not complete study|0|||
42050679|NCT00590590|75859415|FG001|Overall Study|Did not complete study|1|||
42050680|NCT00590590|75859416|FG002|Overall Study|Did not complete study|0|||
42050681|NCT00809614|75859426|FG000|Overall Study|Lack of Efficacy|2|||
42050682|NCT00809614|75859427|FG001|Overall Study|Lack of Efficacy|3|||
42050683|NCT00809614|75859426|FG000|Overall Study|Withdrawal by Subject|1|||
42050684|NCT00809614|75859427|FG001|Overall Study|Withdrawal by Subject|1|||
42050685|NCT00731731|75859436|FG000|Overall Study|Protocol Violation|0|||
42050686|NCT00731731|75859437|FG001|Overall Study|Protocol Violation|0|||
42050687|NCT00731731|75859438|FG002|Overall Study|Protocol Violation|1|||
42050688|NCT00731731|75859436|FG000|Overall Study|Cancel prior to treatment|0|||
42050689|NCT00731731|75859437|FG001|Overall Study|Cancel prior to treatment|0|||
42050690|NCT00731731|75859438|FG002|Overall Study|Cancel prior to treatment|2|||
42050691|NCT00806494|75859451|FG000|Overall Study|Adverse Event|29|||
42050692|NCT00806494|75859451|FG000|Overall Study|Lack of Efficacy|6|||
42050693|NCT00806494|75859451|FG000|Overall Study|Lost to Follow-up|10|||
42050694|NCT00806494|75859451|FG000|Overall Study|Other|30|||
42050695|NCT00806494|75859451|FG000|Overall Study|Withdrawal by Subject|5|||
42050696|NCT00806416|75859458|FG000|Period 1 - Part I|Adverse Event|0|||
42050697|NCT00806416|75859459|FG001|Period 1 - Part I|Adverse Event|1|||
42050698|NCT00806416|75859460|FG002|Period 1 - Part I|Adverse Event|0|||
42050699|NCT00806416|75859461|FG003|Period 1 - Part I|Adverse Event|0|||
42050700|NCT00806416|75859458|FG000|Period 1 - Part I|Lost to Follow-up|0|||
42050701|NCT00806416|75859459|FG001|Period 1 - Part I|Lost to Follow-up|2|||
42050702|NCT00806416|75859460|FG002|Period 1 - Part I|Lost to Follow-up|0|||
42050703|NCT00806416|75859461|FG003|Period 1 - Part I|Lost to Follow-up|0|||
42050704|NCT00806416|75859458|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
42050705|NCT00806416|75859459|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
42050706|NCT00806416|75859460|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
42050707|NCT00806416|75859461|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
42050708|NCT00806416|75859458|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
42050709|NCT00806416|75859459|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
42050710|NCT00806416|75859460|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
42050711|NCT00806416|75859461|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
42050712|NCT02724969|75859471|FG000|Overall Study|Lost to Follow-up|12|||
42050713|NCT02724969|75859472|FG001|Overall Study|Lost to Follow-up|6|||
42050714|NCT02724969|75859471|FG000|Overall Study|Withdrawal by Subject|3|||
42050715|NCT02724969|75859472|FG001|Overall Study|Withdrawal by Subject|3|||
42050716|NCT02724969|75859471|FG000|Overall Study|Infant demise|0|||
42050717|NCT02724969|75859472|FG001|Overall Study|Infant demise|2|||
42050718|NCT00811252|75859481|FG000|Overall Study|Adverse Event|6|||
42050719|NCT00811252|75859482|FG001|Overall Study|Adverse Event|10|||
42050720|NCT00811252|75859483|FG002|Overall Study|Adverse Event|15|||
42050721|NCT00811252|75859481|FG000|Overall Study|Lack of Efficacy|7|||
42050722|NCT00811252|75859482|FG001|Overall Study|Lack of Efficacy|2|||
42050723|NCT00811252|75859483|FG002|Overall Study|Lack of Efficacy|0|||
42050724|NCT00811252|75859481|FG000|Overall Study|Protocol Violation|3|||
42050725|NCT00811252|75859482|FG001|Overall Study|Protocol Violation|3|||
42050726|NCT00811252|75859483|FG002|Overall Study|Protocol Violation|2|||
42050727|NCT00811252|75859481|FG000|Overall Study|Withdrawal of Consent|1|||
42050728|NCT00811252|75859482|FG001|Overall Study|Withdrawal of Consent|2|||
42050729|NCT00811252|75859483|FG002|Overall Study|Withdrawal of Consent|2|||
42050730|NCT00811252|75859481|FG000|Overall Study|Lost to Follow-up|0|||
42050731|NCT00811252|75859482|FG001|Overall Study|Lost to Follow-up|0|||
42050732|NCT00811252|75859483|FG002|Overall Study|Lost to Follow-up|2|||
42050733|NCT00811252|75859481|FG000|Overall Study|Administrative or Other Reasons|0|||
42050734|NCT00811252|75859482|FG001|Overall Study|Administrative or Other Reasons|3|||
42050735|NCT00811252|75859483|FG002|Overall Study|Administrative or Other Reasons|2|||
42050736|NCT00736957|75859500|FG000|Overall Study|Adverse Event|43|||
42050737|NCT00736957|75859500|FG000|Overall Study|Withdrawal by Subject|49|||
42050738|NCT00736957|75859500|FG000|Overall Study|violation of eligibility criteria|2|||
42050739|NCT00736957|75859500|FG000|Overall Study|did not attend hospital appointments|1|||
42050740|NCT00736957|75859500|FG000|Overall Study|not eligible for Treatment Period I|22|||
42050741|NCT00736957|75859500|FG000|Overall Study|Physician Decision|5|||
42050742|NCT00736879|75859508|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
42050743|NCT00736879|75859509|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
42050744|NCT00736879|75859510|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
42050745|NCT00736879|75859511|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
42050746|NCT00736879|75859508|FG000|Double Blind Treatment Period|Adverse Event|0|||
42050747|NCT00736879|75859509|FG001|Double Blind Treatment Period|Adverse Event|1|||
42050748|NCT00736879|75859510|FG002|Double Blind Treatment Period|Adverse Event|1|||
42050749|NCT00736879|75859511|FG003|Double Blind Treatment Period|Adverse Event|0|||
42050750|NCT00736879|75859508|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
42050751|NCT00736879|75859509|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
42050752|NCT00736879|75859510|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
42050753|NCT00736879|75859511|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
42050754|NCT00736879|75859508|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
42050755|NCT00736879|75859509|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
42050756|NCT00736879|75859510|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
42050757|NCT00736879|75859511|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
42050758|NCT00736879|75859508|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
42050759|NCT00736879|75859509|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
42050760|NCT00736879|75859510|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
42050761|NCT00736879|75859511|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
42050762|NCT00736879|75859508|FG000|Double Blind Treatment Period|No longer met criteria|0|||
42050763|NCT00736879|75859509|FG001|Double Blind Treatment Period|No longer met criteria|1|||
42050764|NCT00736879|75859510|FG002|Double Blind Treatment Period|No longer met criteria|0|||
42050765|NCT00736879|75859511|FG003|Double Blind Treatment Period|No longer met criteria|0|||
42050766|NCT00736879|75859508|FG000|Double Blind Treatment Period|non-specified|0|||
42050767|NCT00736879|75859509|FG001|Double Blind Treatment Period|non-specified|1|||
42050768|NCT00736879|75859510|FG002|Double Blind Treatment Period|non-specified|0|||
42050769|NCT00736879|75859511|FG003|Double Blind Treatment Period|non-specified|0|||
42050770|NCT00736879|75859508|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
42050771|NCT00736879|75859509|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
42050772|NCT00736879|75859510|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
42050773|NCT00736879|75859511|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
42050774|NCT00736879|75859508|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
42050775|NCT00736879|75859509|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
42050776|NCT00736879|75859510|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
42050777|NCT00736879|75859511|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
42050778|NCT00806260|75859530|FG000|Period 1 (1 Day)|Adverse Event|0|||
42050779|NCT00806260|75859531|FG001|Period 1 (1 Day)|Adverse Event|0|||
42050780|NCT00806260|75859532|FG002|Period 1 (1 Day)|Adverse Event|0|||
42050781|NCT00806260|75859533|FG003|Period 1 (1 Day)|Adverse Event|0|||
42050782|NCT00806260|75859534|FG004|Period 1 (1 Day)|Adverse Event|3|||
42050783|NCT00806260|75859535|FG005|Period 1 (1 Day)|Adverse Event|0|||
42050784|NCT00806260|75859530|FG000|Period 2|Adverse Event|0|||
42050785|NCT00806260|75859531|FG001|Period 2|Adverse Event|0|||
42050786|NCT00806260|75859532|FG002|Period 2|Adverse Event|0|||
42050787|NCT00806260|75859533|FG003|Period 2|Adverse Event|1|||
42050788|NCT00806260|75859534|FG004|Period 2|Adverse Event|0|||
42050789|NCT00806260|75859535|FG005|Period 2|Adverse Event|0|||
42050790|NCT00806260|75859530|FG000|Period 2|Protocol Violation|1|||
42050791|NCT00806260|75859531|FG001|Period 2|Protocol Violation|0|||
42050792|NCT00806260|75859532|FG002|Period 2|Protocol Violation|1|||
42050793|NCT00806260|75859533|FG003|Period 2|Protocol Violation|0|||
42050794|NCT00806260|75859534|FG004|Period 2|Protocol Violation|0|||
42050795|NCT00806260|75859535|FG005|Period 2|Protocol Violation|0|||
42050796|NCT00806260|75859530|FG000|Period 2|Need to take concomitant medication|1|||
42050797|NCT00806260|75859531|FG001|Period 2|Need to take concomitant medication|0|||
42050798|NCT00806260|75859532|FG002|Period 2|Need to take concomitant medication|0|||
42050799|NCT00806260|75859533|FG003|Period 2|Need to take concomitant medication|0|||
42050800|NCT00806260|75859534|FG004|Period 2|Need to take concomitant medication|0|||
42050801|NCT00806260|75859535|FG005|Period 2|Need to take concomitant medication|0|||
42050802|NCT00806260|75859530|FG000|Period 2|sponsor request|0|||
42050803|NCT00806260|75859531|FG001|Period 2|sponsor request|0|||
42050804|NCT00806260|75859532|FG002|Period 2|sponsor request|1|||
42050805|NCT00806260|75859533|FG003|Period 2|sponsor request|1|||
42050806|NCT00806260|75859534|FG004|Period 2|sponsor request|0|||
42050807|NCT00806260|75859535|FG005|Period 2|sponsor request|0|||
42050808|NCT00806260|75859530|FG000|Period 3|Protocol Violation|0|||
42050809|NCT00806260|75859531|FG001|Period 3|Protocol Violation|1|||
42050810|NCT00806260|75859532|FG002|Period 3|Protocol Violation|1|||
42050811|NCT00806260|75859533|FG003|Period 3|Protocol Violation|0|||
42050812|NCT00806260|75859534|FG004|Period 3|Protocol Violation|0|||
42050813|NCT00806260|75859535|FG005|Period 3|Protocol Violation|0|||
42050814|NCT00806260|75859530|FG000|Period 3|Pregnancy|1|||
42050815|NCT00806260|75859531|FG001|Period 3|Pregnancy|0|||
42050816|NCT00806260|75859532|FG002|Period 3|Pregnancy|0|||
42050817|NCT00806260|75859533|FG003|Period 3|Pregnancy|0|||
42050818|NCT00806260|75859534|FG004|Period 3|Pregnancy|0|||
42050819|NCT00806260|75859535|FG005|Period 3|Pregnancy|0|||
42050820|NCT00742885|75859549|FG000|Overall Study|Lost to Follow-up|1|||
42050821|NCT00742885|75859550|FG001|Overall Study|Lost to Follow-up|0|||
42050822|NCT00811174|75859559|FG000|Overall Study|Protocol Violation|2|||
42050823|NCT00811174|75859559|FG000|Overall Study|Sponsors Decision|1|||
42173304|NCT02945410|75980029|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
42173305|NCT02945410|75980030|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
42173306|NCT02945410|75980031|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
42173307|NCT02945410|75980032|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
42050824|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
42050825|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
42173308|NCT02945254|75980042|FG000|Overall Study|Lost to Follow-up|1|||
42050826|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
42050827|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
42050828|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
42050829|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
42050830|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
42050831|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
42050832|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
42050833|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
42050834|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
42050835|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
42050836|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
42050837|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
42050838|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
42050839|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
42050840|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
42050841|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
42050842|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
42050843|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
42291411|NCT02641379|76125034|FG007|Overall Study|Baseline viral load unavailable|0|||
42291412|NCT02641379|76125035|FG008|Overall Study|Baseline viral load unavailable|0|||
42050844|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
42050845|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
42050846|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
42050847|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
42050848|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
42050849|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
42050850|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
42050851|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
42050852|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
42050853|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
42050854|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
42050855|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
42050856|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
42050857|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
42050858|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
42050859|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
42050860|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
42050861|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
42050862|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
42050863|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
42050864|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
42050865|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
42050866|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
42291413|NCT02641379|76125036|FG009|Overall Study|Baseline viral load unavailable|0|||
42291414|NCT02641379|76125037|FG010|Overall Study|Baseline viral load unavailable|0|||
42291415|NCT02641379|76125027|FG000|Overall Study|Blood could not be drawn|0|||
42291416|NCT02641379|76125028|FG001|Overall Study|Blood could not be drawn|0|||
42291417|NCT02641379|76125029|FG002|Overall Study|Blood could not be drawn|0|||
42291418|NCT02641379|76125030|FG003|Overall Study|Blood could not be drawn|0|||
42291419|NCT02641379|76125031|FG004|Overall Study|Blood could not be drawn|1|||
42291420|NCT02641379|76125032|FG005|Overall Study|Blood could not be drawn|0|||
42050867|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
42050868|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
42050869|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
42050870|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
42050871|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
42050872|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
42050873|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
42050874|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
42050875|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
42050876|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
42050877|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
42050878|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
42173309|NCT02945254|75980043|FG001|Overall Study|Lost to Follow-up|0|||
42173310|NCT02945254|75980042|FG000|Overall Study|Withdrawal by Subject|1|||
42291421|NCT02641379|76125033|FG006|Overall Study|Blood could not be drawn|0|||
42291422|NCT02641379|76125034|FG007|Overall Study|Blood could not be drawn|0|||
42291423|NCT02641379|76125035|FG008|Overall Study|Blood could not be drawn|0|||
42291424|NCT02641379|76125036|FG009|Overall Study|Blood could not be drawn|0|||
42050879|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
42050880|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
42050881|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
42050882|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
42050883|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
42050884|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
42050885|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
42050886|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
42050887|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
42050888|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
42050889|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
42050890|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
42050891|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
42050892|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
42050893|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
42050894|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Change of location|0|||
42050895|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Change of location|0|||
42050896|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Change of location|0|||
42050897|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Change of location|1|||
42050898|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Change of location|0|||
42050899|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
42050900|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
42050901|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
42050902|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
42050903|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
42050904|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
42050905|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
42050906|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
42050907|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
42050908|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
42050909|NCT00730405|75859568|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
42050910|NCT00730405|75859569|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
42050911|NCT00730405|75859570|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
42050912|NCT00730405|75859571|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
42050913|NCT00730405|75859572|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
42050914|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
42050915|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
42050916|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
42050917|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
42050918|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
42050919|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
42050920|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
42050921|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
42050922|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
42050923|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
42050924|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
42050925|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
42050926|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
42050927|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
42050928|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
42050929|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Death|0|||
42050930|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Death|1|||
42050931|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Death|0|||
42050932|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Death|1|||
42050933|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Death|0|||
42050934|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Change of location|1|||
42050935|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Change of location|1|||
42050936|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Change of location|0|||
42356911|NCT01425723|76202094|FG001|Overall Study|Withdrawal by Subject|4|||
42356912|NCT01425723|76202093|FG000|Overall Study|Lost to Follow-up|0|||
42356913|NCT01425723|76202094|FG001|Overall Study|Lost to Follow-up|3|||
42050937|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Change of location|1|||
42050938|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Change of location|0|||
42050939|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
42050940|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
42050941|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
42050942|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
42050943|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
42050944|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
42050945|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
42050946|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
42050947|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
42050948|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
42050949|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
42050950|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
42050951|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
42050952|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
42050953|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
42050954|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
42050955|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
42050956|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
42050957|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
42050958|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
42050959|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
42050960|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
42050961|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
42050962|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
42050963|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
42050964|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
42050965|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
42050966|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
42050967|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
42050968|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
42050969|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
42050970|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
42050971|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
42050972|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
42050973|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
42050974|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
42050975|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
42050976|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
42050977|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
42050978|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
42050979|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
42050980|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
42050981|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
42050982|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
42050983|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
42050984|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
42050985|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
42173311|NCT02945254|75980043|FG001|Overall Study|Withdrawal by Subject|0|||
42173312|NCT02943070|75980061|FG000|Overall Study|Physician Decision|1|||
42173313|NCT02943070|75980061|FG000|Overall Study|Adverse Event|2|||
42173314|NCT02943070|75980061|FG000|Overall Study|Death|2|||
42173315|NCT02943070|75980061|FG000|Overall Study|Withdrawal by Subject|3|||
42173316|NCT02943070|75980061|FG000|Overall Study|Lost to Follow-up|4|||
42173317|NCT02943070|75980061|FG000|Overall Study|Retreatment or TURP|13|||
42173318|NCT02943070|75980061|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
42050986|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
42050987|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
42050988|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
42050989|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Missing|0|||
42050990|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Missing|0|||
42050991|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Missing|2|||
42050992|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Missing|0|||
42050993|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Missing|0|||
42050994|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
42173319|NCT03332212|75980085|FG000|Overall Study|Not treated|0|||
42173320|NCT03332212|75980086|FG001|Overall Study|Not treated|1|||
42173321|NCT03332212|75980087|FG002|Overall Study|Not treated|0|||
42173322|NCT03332212|75980088|FG003|Overall Study|Not treated|0|||
42173323|NCT03332212|75980085|FG000|Overall Study|Adverse Event|0|||
42050995|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
42050996|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
42050997|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
42050998|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
42050999|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
42051000|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
42051001|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
42051002|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
42051003|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
42051004|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
42051005|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
42051006|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
42051007|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
42051008|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
42051009|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
42051010|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
42051011|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
42051012|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
42051013|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
42051014|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
42051015|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
42051016|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
42051017|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
42051018|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
42051019|NCT00730405|75859568|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
42051020|NCT00730405|75859569|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
42051021|NCT00730405|75859570|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
42051022|NCT00730405|75859571|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
42051023|NCT00730405|75859572|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
42051024|NCT00736723|75859588|FG000|Overall Study|Withdrawal by Subject|4|||
42051025|NCT00736723|75859589|FG001|Overall Study|Withdrawal by Subject|3|||
42051026|NCT00736645|75859599|FG000|Overall Study|Adverse Event|0|||
42051027|NCT00736645|75859600|FG001|Overall Study|Adverse Event|2|||
42051028|NCT00736645|75859601|FG002|Overall Study|Adverse Event|0|||
42051029|NCT00736645|75859602|FG003|Overall Study|Adverse Event|0|||
42051030|NCT00736489|75859612|FG000|Period 1|Lost to Follow-up|1|||
42051031|NCT00736489|75859613|FG001|Period 1|Lost to Follow-up|0|||
42051032|NCT00736489|75859614|FG002|Period 1|Lost to Follow-up|0|||
42051033|NCT00736489|75859615|FG003|Period 1|Lost to Follow-up|0|||
42051034|NCT00736489|75859616|FG004|Period 1|Lost to Follow-up|0|||
42051035|NCT00736489|75859617|FG005|Period 1|Lost to Follow-up|0|||
42051036|NCT00736489|75859612|FG000|Period 1|Withdrawal by Subject|0|||
42051037|NCT00736489|75859613|FG001|Period 1|Withdrawal by Subject|0|||
42051038|NCT00736489|75859614|FG002|Period 1|Withdrawal by Subject|0|||
42051039|NCT00736489|75859615|FG003|Period 1|Withdrawal by Subject|0|||
42051040|NCT00736489|75859616|FG004|Period 1|Withdrawal by Subject|0|||
42051041|NCT00736489|75859617|FG005|Period 1|Withdrawal by Subject|1|||
42051042|NCT00730327|75859649|FG000|Overall Study|Lost to Follow-up|14|||
42051043|NCT00730327|75859650|FG001|Overall Study|Lost to Follow-up|16|||
42051044|NCT00730327|75859649|FG000|Overall Study|Adverse Event|8|||
42051045|NCT00730327|75859650|FG001|Overall Study|Adverse Event|1|||
42051046|NCT00730327|75859649|FG000|Overall Study|Withdrawal by Subject|3|||
42051047|NCT00730327|75859650|FG001|Overall Study|Withdrawal by Subject|13|||
42051048|NCT00730327|75859649|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
42051049|NCT00730327|75859650|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
42051050|NCT00742417|75859665|FG000|Randomized|Withdrawal by legal representative|0|||
42051051|NCT00742417|75859666|FG001|Randomized|Withdrawal by legal representative|1|||
42051052|NCT00742417|75859665|FG000|Randomized|Withdrawal by Subject|1|||
42051053|NCT00742417|75859666|FG001|Randomized|Withdrawal by Subject|0|||
42051054|NCT00742417|75859665|FG000|Randomized|Physician Decision|1|||
42051055|NCT00742417|75859666|FG001|Randomized|Physician Decision|0|||
42051056|NCT00742417|75859665|FG000|Intensive Period|Withdrawal by Subject|1|||
42051057|NCT00742417|75859666|FG001|Intensive Period|Withdrawal by Subject|1|||
42051058|NCT00742417|75859665|FG000|Intensive Period|Adverse Event|2|||
42051059|NCT00742417|75859666|FG001|Intensive Period|Adverse Event|0|||
42051060|NCT00811018|75859674|FG000|Overall Study|Additional Chronic Treatment|31|||
42051061|NCT00811018|75859674|FG000|Overall Study|Adverse Event|79|||
42051062|NCT00811018|75859674|FG000|Overall Study|Death|147|||
42051063|NCT00811018|75859674|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
42051064|NCT00811018|75859674|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
42051065|NCT00811018|75859674|FG000|Overall Study|Investigator Decision|57|||
42051066|NCT00811018|75859674|FG000|Overall Study|Lost to Follow-up|19|||
42051067|NCT00811018|75859674|FG000|Overall Study|Pregnancy|6|||
42051068|NCT00811018|75859674|FG000|Overall Study|Sponsor Decision|450|||
42051069|NCT00811018|75859674|FG000|Overall Study|Withdrawal by Subject|70|||
42051070|NCT00811018|75859674|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
42051071|NCT00811018|75859674|FG000|Overall Study|Other|26|||
42051072|NCT00730171|75859683|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
42051073|NCT00730171|75859683|FG000|Overall Study|Adverse Event|193|||
42051074|NCT00730171|75859683|FG000|Overall Study|Protocol Violation|48|||
42051075|NCT00730171|75859683|FG000|Overall Study|Withdrawal by Subject|202|||
42051076|NCT00730171|75859683|FG000|Overall Study|Lost to Follow-up|121|||
42051077|NCT00730171|75859683|FG000|Overall Study|Insufficient Therapeutic Response|141|||
42051078|NCT00730171|75859683|FG000|Overall Study|Other|61|||
42051079|NCT00730015|75859694|FG000|Overall Study|Adverse Event|11|||
42051080|NCT00730015|75859695|FG001|Overall Study|Adverse Event|10|||
42051081|NCT00730015|75859696|FG002|Overall Study|Adverse Event|8|||
42051082|NCT00730015|75859694|FG000|Overall Study|Protocol Violation|2|||
42051083|NCT00730015|75859695|FG001|Overall Study|Protocol Violation|6|||
42051084|NCT00730015|75859696|FG002|Overall Study|Protocol Violation|4|||
42051085|NCT00730015|75859694|FG000|Overall Study|Withdrawal by Subject|12|||
42051086|NCT00730015|75859695|FG001|Overall Study|Withdrawal by Subject|12|||
42051087|NCT00730015|75859696|FG002|Overall Study|Withdrawal by Subject|8|||
42051088|NCT00730015|75859694|FG000|Overall Study|Lost to Follow-up|4|||
42051089|NCT00730015|75859695|FG001|Overall Study|Lost to Follow-up|10|||
42051090|NCT00730015|75859696|FG002|Overall Study|Lost to Follow-up|3|||
42051091|NCT00730015|75859694|FG000|Overall Study|Lack of Efficacy|1|||
42051092|NCT00730015|75859695|FG001|Overall Study|Lack of Efficacy|2|||
42051093|NCT00730015|75859696|FG002|Overall Study|Lack of Efficacy|8|||
42051094|NCT00730015|75859694|FG000|Overall Study|Other Reason|1|||
42291425|NCT02641379|76125037|FG010|Overall Study|Blood could not be drawn|0|||
42356914|NCT01425723|76202093|FG000|Overall Study|Physician Decision|2|||
42356915|NCT01425723|76202094|FG001|Overall Study|Physician Decision|0|||
42356916|NCT01425723|76202093|FG000|Overall Study|Other|1|||
42356917|NCT01425723|76202094|FG001|Overall Study|Other|10|||
42356918|NCT01424397|76202125|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
42051095|NCT00730015|75859695|FG001|Overall Study|Other Reason|0|||
42051096|NCT00730015|75859696|FG002|Overall Study|Other Reason|1|||
42051097|NCT00806026|75859715|FG000|Overall Study|Death|0|||
42051098|NCT00806026|75859716|FG001|Overall Study|Death|0|||
42291426|NCT02641379|76125027|FG000|Overall Study|Protocol Violation|0|||
42291427|NCT02641379|76125028|FG001|Overall Study|Protocol Violation|0|||
42291428|NCT02641379|76125029|FG002|Overall Study|Protocol Violation|0|||
42291429|NCT02641379|76125030|FG003|Overall Study|Protocol Violation|0|||
42291430|NCT02641379|76125031|FG004|Overall Study|Protocol Violation|2|||
42291431|NCT02641379|76125032|FG005|Overall Study|Protocol Violation|0|||
42291432|NCT02641379|76125033|FG006|Overall Study|Protocol Violation|0|||
42291433|NCT02641379|76125034|FG007|Overall Study|Protocol Violation|0|||
42291434|NCT02641379|76125035|FG008|Overall Study|Protocol Violation|1|||
42291435|NCT02641379|76125036|FG009|Overall Study|Protocol Violation|0|||
42291436|NCT02641379|76125037|FG010|Overall Study|Protocol Violation|0|||
42291437|NCT02641379|76125027|FG000|Overall Study|Participation in sili rescue study|0|||
42291438|NCT02641379|76125028|FG001|Overall Study|Participation in sili rescue study|0|||
42291439|NCT02641379|76125029|FG002|Overall Study|Participation in sili rescue study|0|||
42291440|NCT02641379|76125030|FG003|Overall Study|Participation in sili rescue study|0|||
42291441|NCT02641379|76125031|FG004|Overall Study|Participation in sili rescue study|0|||
42291442|NCT02641379|76125032|FG005|Overall Study|Participation in sili rescue study|1|||
42291443|NCT02641379|76125033|FG006|Overall Study|Participation in sili rescue study|0|||
42291444|NCT02641379|76125034|FG007|Overall Study|Participation in sili rescue study|0|||
42291445|NCT02641379|76125035|FG008|Overall Study|Participation in sili rescue study|0|||
42291446|NCT02641379|76125036|FG009|Overall Study|Participation in sili rescue study|0|||
42291447|NCT02641379|76125037|FG010|Overall Study|Participation in sili rescue study|0|||
42291448|NCT02641379|76125027|FG000|Overall Study|Lost to Follow-up|0|||
42051099|NCT00806026|75859717|FG002|Overall Study|Death|0|||
42051100|NCT00806026|75859718|FG003|Overall Study|Death|1|||
42051101|NCT00806026|75859719|FG004|Overall Study|Death|0|||
42291449|NCT02641379|76125028|FG001|Overall Study|Lost to Follow-up|0|||
42291450|NCT02641379|76125029|FG002|Overall Study|Lost to Follow-up|0|||
42291451|NCT02641379|76125030|FG003|Overall Study|Lost to Follow-up|0|||
42291452|NCT02641379|76125031|FG004|Overall Study|Lost to Follow-up|0|||
42291453|NCT02641379|76125032|FG005|Overall Study|Lost to Follow-up|0|||
42291454|NCT02641379|76125033|FG006|Overall Study|Lost to Follow-up|0|||
42291455|NCT02641379|76125034|FG007|Overall Study|Lost to Follow-up|0|||
42291456|NCT02641379|76125035|FG008|Overall Study|Lost to Follow-up|1|||
42291457|NCT02641379|76125036|FG009|Overall Study|Lost to Follow-up|0|||
42356919|NCT01424397|76202126|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
42051102|NCT00806026|75859720|FG005|Overall Study|Death|0|||
42051103|NCT00806026|75859715|FG000|Overall Study|Did not meet entrance criteria|4|||
42051104|NCT00806026|75859716|FG001|Overall Study|Did not meet entrance criteria|1|||
42356920|NCT01424397|76202127|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
42173324|NCT03332212|75980086|FG001|Overall Study|Adverse Event|0|||
42173325|NCT03332212|75980087|FG002|Overall Study|Adverse Event|0|||
42173326|NCT03332212|75980088|FG003|Overall Study|Adverse Event|1|||
42173327|NCT03332212|75980085|FG000|Overall Study|worsening of disease under study|1|||
42173328|NCT03332212|75980086|FG001|Overall Study|worsening of disease under study|1|||
42173329|NCT03332212|75980087|FG002|Overall Study|worsening of disease under study|0|||
42173330|NCT03332212|75980088|FG003|Overall Study|worsening of disease under study|0|||
42173331|NCT03331666|75980098|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
42173332|NCT03331666|75980099|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
42173333|NCT03331042|75980109|FG000|Overall Study|Protocol Violation|1|||
42173334|NCT03331042|75980110|FG001|Overall Study|Protocol Violation|0|||
42173335|NCT03331042|75980111|FG002|Overall Study|Protocol Violation|0|||
42173336|NCT03331042|75980112|FG003|Overall Study|Protocol Violation|0|||
42173337|NCT03331042|75980109|FG000|Overall Study|Physician Decision|0|||
42173338|NCT03331042|75980110|FG001|Overall Study|Physician Decision|0|||
42173339|NCT03331042|75980111|FG002|Overall Study|Physician Decision|1|||
42173340|NCT03331042|75980112|FG003|Overall Study|Physician Decision|0|||
42173341|NCT03331042|75980109|FG000|Overall Study|Lost to Follow-up|0|||
42173342|NCT03331042|75980110|FG001|Overall Study|Lost to Follow-up|0|||
42173343|NCT03331042|75980111|FG002|Overall Study|Lost to Follow-up|0|||
42173344|NCT03331042|75980112|FG003|Overall Study|Lost to Follow-up|1|||
42173345|NCT03762668|75980130|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
42173346|NCT03762668|75980131|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
42173347|NCT03762200|75980137|FG000|Overall Study|Death|2|||
42173348|NCT03711370|75980143|FG000|Overall Study|Lost to Follow-up|16|||
42173349|NCT03711370|75980144|FG001|Overall Study|Lost to Follow-up|10|||
42173350|NCT03711370|75980143|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
42173351|NCT03711370|75980144|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
42173352|NCT03329404|75980160|FG000|Overall Study|The study was suspended.|1|||
42173353|NCT03329404|75980161|FG001|Overall Study|The study was suspended.|4|||
42173354|NCT03478930|75980169|FG000|Overall Study|Adverse Event|0|||
42173355|NCT03478930|75980170|FG001|Overall Study|Adverse Event|1|||
42173356|NCT03478930|75980169|FG000|Overall Study|Lack of Efficacy|3|||
42173357|NCT03478930|75980170|FG001|Overall Study|Lack of Efficacy|3|||
42173358|NCT03478930|75980169|FG000|Overall Study|Withdrawal by Subject|6|||
42173359|NCT03478930|75980170|FG001|Overall Study|Withdrawal by Subject|5|||
42173360|NCT03038438|75980176|FG000|Overall Study|Death|3|||
42173361|NCT03038438|75980176|FG000|Overall Study|Lost to Follow-up|8|||
42173362|NCT03038438|75980176|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
42173363|NCT03038438|75980176|FG000|Overall Study|Withdrawal by Subject|5|||
42173364|NCT03038438|75980176|FG000|Overall Study|No 36-Month Follow-Up|18|||
42173365|NCT03523000|75980180|FG000|Overall Study|Withdrawal by Subject|3|||
42173366|NCT03523000|75980181|FG001|Overall Study|Withdrawal by Subject|0|||
42173367|NCT03523000|75980180|FG000|Overall Study|Unsuccessful trial|2|||
42173368|NCT03523000|75980181|FG001|Overall Study|Unsuccessful trial|0|||
42173369|NCT03327220|75980192|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
42173370|NCT03327220|75980193|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
42173371|NCT03327220|75980192|FG000|Overall Study|Investigator Decision|2|||
42173372|NCT03327220|75980193|FG001|Overall Study|Investigator Decision|0|||
42173373|NCT03327220|75980192|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
42173374|NCT03327220|75980193|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
42173375|NCT03327220|75980192|FG000|Overall Study|Fungal infection|1|||
42291458|NCT02641379|76125037|FG010|Overall Study|Lost to Follow-up|0|||
42291459|NCT02641379|76125027|FG000|Overall Study|Source data not found|0|||
42291460|NCT02641379|76125028|FG001|Overall Study|Source data not found|0|||
42291461|NCT02641379|76125029|FG002|Overall Study|Source data not found|0|||
42291462|NCT02641379|76125030|FG003|Overall Study|Source data not found|0|||
42291463|NCT02641379|76125031|FG004|Overall Study|Source data not found|0|||
42291464|NCT02641379|76125032|FG005|Overall Study|Source data not found|1|||
42291465|NCT02641379|76125033|FG006|Overall Study|Source data not found|0|||
42291466|NCT02641379|76125034|FG007|Overall Study|Source data not found|0|||
42173376|NCT03327220|75980193|FG001|Overall Study|Fungal infection|0|||
42173377|NCT03327220|75980192|FG000|Overall Study|Discharged to Rehabilitation|0|||
42173378|NCT03327220|75980193|FG001|Overall Study|Discharged to Rehabilitation|1|||
42173379|NCT03327220|75980192|FG000|Overall Study|Missing|1|||
42173380|NCT03327220|75980193|FG001|Overall Study|Missing|0|||
42291467|NCT02641379|76125035|FG008|Overall Study|Source data not found|0|||
42173381|NCT00318149|75980205|FG000|Overall Study|Adverse Event|0|||
42173382|NCT00318149|75980206|FG001|Overall Study|Adverse Event|0|||
42173383|NCT00318149|75980207|FG002|Overall Study|Adverse Event|0|||
42356921|NCT01424397|76202128|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
42173384|NCT00318149|75980208|FG003|Overall Study|Adverse Event|0|||
42291468|NCT02641379|76125036|FG009|Overall Study|Source data not found|0|||
42291469|NCT02641379|76125037|FG010|Overall Study|Source data not found|0|||
42051105|NCT00806026|75859717|FG002|Overall Study|Did not meet entrance criteria|2|||
42051106|NCT00806026|75859718|FG003|Overall Study|Did not meet entrance criteria|1|||
42051107|NCT00806026|75859719|FG004|Overall Study|Did not meet entrance criteria|0|||
42051108|NCT00806026|75859720|FG005|Overall Study|Did not meet entrance criteria|0|||
42051109|NCT00806026|75859715|FG000|Overall Study|Lack of Efficacy|5|||
42051110|NCT00806026|75859716|FG001|Overall Study|Lack of Efficacy|18|||
42051111|NCT00806026|75859717|FG002|Overall Study|Lack of Efficacy|13|||
42051112|NCT00806026|75859718|FG003|Overall Study|Lack of Efficacy|4|||
42051113|NCT00806026|75859719|FG004|Overall Study|Lack of Efficacy|8|||
42051114|NCT00806026|75859720|FG005|Overall Study|Lack of Efficacy|7|||
42051115|NCT00806026|75859715|FG000|Overall Study|Lost to Follow-up|8|||
42051116|NCT00806026|75859716|FG001|Overall Study|Lost to Follow-up|15|||
42051117|NCT00806026|75859717|FG002|Overall Study|Lost to Follow-up|8|||
42051118|NCT00806026|75859718|FG003|Overall Study|Lost to Follow-up|2|||
42051119|NCT00806026|75859719|FG004|Overall Study|Lost to Follow-up|6|||
42051120|NCT00806026|75859720|FG005|Overall Study|Lost to Follow-up|6|||
42051121|NCT00806026|75859715|FG000|Overall Study|Withdrawal by Subject|14|||
42051122|NCT00806026|75859716|FG001|Overall Study|Withdrawal by Subject|17|||
42051123|NCT00806026|75859717|FG002|Overall Study|Withdrawal by Subject|9|||
42051124|NCT00806026|75859718|FG003|Overall Study|Withdrawal by Subject|2|||
42051125|NCT00806026|75859719|FG004|Overall Study|Withdrawal by Subject|5|||
42051126|NCT00806026|75859720|FG005|Overall Study|Withdrawal by Subject|3|||
42051127|NCT00806026|75859715|FG000|Overall Study|Other|3|||
42051128|NCT00806026|75859716|FG001|Overall Study|Other|6|||
42051129|NCT00806026|75859717|FG002|Overall Study|Other|8|||
42051130|NCT00806026|75859718|FG003|Overall Study|Other|2|||
42051131|NCT00806026|75859719|FG004|Overall Study|Other|0|||
42051132|NCT00806026|75859720|FG005|Overall Study|Other|4|||
42051133|NCT00806026|75859715|FG000|Overall Study|Protocol Violation|6|||
42051134|NCT00806026|75859716|FG001|Overall Study|Protocol Violation|9|||
42051135|NCT00806026|75859717|FG002|Overall Study|Protocol Violation|9|||
42051136|NCT00806026|75859718|FG003|Overall Study|Protocol Violation|0|||
42051137|NCT00806026|75859719|FG004|Overall Study|Protocol Violation|2|||
42051138|NCT00806026|75859720|FG005|Overall Study|Protocol Violation|3|||
42051139|NCT00806026|75859715|FG000|Overall Study|Adverse Event|52|||
42051140|NCT00806026|75859716|FG001|Overall Study|Adverse Event|35|||
42051141|NCT00806026|75859717|FG002|Overall Study|Adverse Event|44|||
42051142|NCT00806026|75859718|FG003|Overall Study|Adverse Event|17|||
42051143|NCT00806026|75859719|FG004|Overall Study|Adverse Event|9|||
42051144|NCT00806026|75859720|FG005|Overall Study|Adverse Event|9|||
42051145|NCT04026165|75859735|FG000|Run-in Placebo Period|Enrollment Error|13|||
42051146|NCT04026165|75859736|FG001|Run-in Placebo Period|Enrollment Error|0|||
42051147|NCT04026165|75859737|FG002|Run-in Placebo Period|Enrollment Error|0|||
42051148|NCT04026165|75859738|FG003|Run-in Placebo Period|Enrollment Error|0|||
42051149|NCT04026165|75859735|FG000|Run-in Placebo Period|Run-in Failure|4|||
42051150|NCT04026165|75859736|FG001|Run-in Placebo Period|Run-in Failure|0|||
42291470|NCT02641379|76125027|FG000|Overall Study|Participant showed weight reduction|0|||
42291471|NCT02641379|76125028|FG001|Overall Study|Participant showed weight reduction|0|||
42291472|NCT02641379|76125029|FG002|Overall Study|Participant showed weight reduction|0|||
42291473|NCT02641379|76125030|FG003|Overall Study|Participant showed weight reduction|0|||
42291474|NCT02641379|76125031|FG004|Overall Study|Participant showed weight reduction|0|||
42291475|NCT02641379|76125032|FG005|Overall Study|Participant showed weight reduction|0|||
42291476|NCT02641379|76125033|FG006|Overall Study|Participant showed weight reduction|0|||
42291477|NCT02641379|76125034|FG007|Overall Study|Participant showed weight reduction|1|||
42291478|NCT02641379|76125035|FG008|Overall Study|Participant showed weight reduction|0|||
42291479|NCT02641379|76125036|FG009|Overall Study|Participant showed weight reduction|0|||
42051151|NCT04026165|75859737|FG002|Run-in Placebo Period|Run-in Failure|0|||
42051152|NCT04026165|75859738|FG003|Run-in Placebo Period|Run-in Failure|0|||
42051153|NCT04026165|75859735|FG000|Run-in Placebo Period|Protocol Violation|2|||
42051154|NCT04026165|75859736|FG001|Run-in Placebo Period|Protocol Violation|0|||
42051155|NCT04026165|75859737|FG002|Run-in Placebo Period|Protocol Violation|0|||
42051156|NCT04026165|75859738|FG003|Run-in Placebo Period|Protocol Violation|0|||
42051157|NCT04026165|75859735|FG000|Run-in Placebo Period|Withdrew Consent|2|||
42051158|NCT04026165|75859736|FG001|Run-in Placebo Period|Withdrew Consent|0|||
42051159|NCT04026165|75859737|FG002|Run-in Placebo Period|Withdrew Consent|0|||
42051160|NCT04026165|75859738|FG003|Run-in Placebo Period|Withdrew Consent|0|||
42051161|NCT04026165|75859735|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
42291480|NCT02641379|76125037|FG010|Overall Study|Participant showed weight reduction|0|||
42291481|NCT02641379|76125027|FG000|Overall Study|Non-response Week 12|0|||
42291482|NCT02641379|76125028|FG001|Overall Study|Non-response Week 12|0|||
42051162|NCT04026165|75859736|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
42051163|NCT04026165|75859737|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
42051164|NCT04026165|75859738|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
42051165|NCT04026165|75859735|FG000|Run-in SEL Period|Run-in Failure|0|||
42051166|NCT04026165|75859736|FG001|Run-in SEL Period|Run-in Failure|26|||
42051167|NCT04026165|75859737|FG002|Run-in SEL Period|Run-in Failure|0|||
42051168|NCT04026165|75859738|FG003|Run-in SEL Period|Run-in Failure|0|||
42051169|NCT04026165|75859735|FG000|Run-in SEL Period|Withdrew Consent|0|||
42051170|NCT04026165|75859736|FG001|Run-in SEL Period|Withdrew Consent|10|||
42051171|NCT04026165|75859737|FG002|Run-in SEL Period|Withdrew Consent|0|||
42051172|NCT04026165|75859738|FG003|Run-in SEL Period|Withdrew Consent|0|||
42051173|NCT04026165|75859735|FG000|Run-in SEL Period|Enrollment Error|0|||
42051174|NCT04026165|75859736|FG001|Run-in SEL Period|Enrollment Error|4|||
42051175|NCT04026165|75859737|FG002|Run-in SEL Period|Enrollment Error|0|||
42051176|NCT04026165|75859738|FG003|Run-in SEL Period|Enrollment Error|0|||
42051177|NCT04026165|75859735|FG000|Run-in SEL Period|Protocol Violation|0|||
42051178|NCT04026165|75859736|FG001|Run-in SEL Period|Protocol Violation|3|||
42051179|NCT04026165|75859737|FG002|Run-in SEL Period|Protocol Violation|0|||
42051180|NCT04026165|75859738|FG003|Run-in SEL Period|Protocol Violation|0|||
42051181|NCT04026165|75859735|FG000|Run-in SEL Period|Investigator's Discretion|0|||
42051182|NCT04026165|75859736|FG001|Run-in SEL Period|Investigator's Discretion|2|||
42051183|NCT04026165|75859737|FG002|Run-in SEL Period|Investigator's Discretion|0|||
42051184|NCT04026165|75859738|FG003|Run-in SEL Period|Investigator's Discretion|0|||
42051185|NCT04026165|75859735|FG000|Run-in SEL Period|Death|0|||
42051186|NCT04026165|75859736|FG001|Run-in SEL Period|Death|1|||
42051187|NCT04026165|75859737|FG002|Run-in SEL Period|Death|0|||
42051188|NCT04026165|75859738|FG003|Run-in SEL Period|Death|0|||
42051189|NCT04026165|75859735|FG000|Randomized Period|Withdrew Consent|0|||
42051190|NCT04026165|75859736|FG001|Randomized Period|Withdrew Consent|0|||
42051191|NCT04026165|75859737|FG002|Randomized Period|Withdrew Consent|5|||
42051192|NCT04026165|75859738|FG003|Randomized Period|Withdrew Consent|8|||
42051193|NCT04026165|75859735|FG000|Randomized Period|Death|0|||
42051194|NCT04026165|75859736|FG001|Randomized Period|Death|0|||
42051195|NCT04026165|75859737|FG002|Randomized Period|Death|5|||
42051196|NCT04026165|75859738|FG003|Randomized Period|Death|7|||
42051197|NCT04026165|75859735|FG000|Randomized Period|Investigator's Discretion|0|||
42051198|NCT04026165|75859736|FG001|Randomized Period|Investigator's Discretion|0|||
42051199|NCT04026165|75859737|FG002|Randomized Period|Investigator's Discretion|2|||
42051200|NCT04026165|75859738|FG003|Randomized Period|Investigator's Discretion|2|||
42051201|NCT04026165|75859735|FG000|Randomized Period|Lost to Follow-up|0|||
42051202|NCT04026165|75859736|FG001|Randomized Period|Lost to Follow-up|0|||
42051203|NCT04026165|75859737|FG002|Randomized Period|Lost to Follow-up|2|||
42051204|NCT04026165|75859738|FG003|Randomized Period|Lost to Follow-up|2|||
42051205|NCT00805792|75859746|FG000|Overall Study|Death|3|||
42051206|NCT00805792|75859746|FG000|Overall Study|Lost to Follow-up|2|||
42051207|NCT00590044|75859752|FG000|Overall Study|Withdrawal by Subject|2|||
42051208|NCT00590044|75859753|FG001|Overall Study|Withdrawal by Subject|2|||
42051209|NCT00590044|75859752|FG000|Overall Study|wrong insulin arm assigned|1|||
42051210|NCT00590044|75859753|FG001|Overall Study|wrong insulin arm assigned|0|||
42051211|NCT00590044|75859752|FG000|Overall Study|Protocol Violation|1|||
42051212|NCT00590044|75859753|FG001|Overall Study|Protocol Violation|0|||
42051213|NCT00805480|75859766|FG000|Overall Study|Withdrawal by Subject|13|||
42051214|NCT00805480|75859767|FG001|Overall Study|Withdrawal by Subject|5|||
42051215|NCT00805480|75859768|FG002|Overall Study|Withdrawal by Subject|11|||
42051216|NCT00805480|75859769|FG003|Overall Study|Withdrawal by Subject|5|||
42051217|NCT00805480|75859766|FG000|Overall Study|Lost to Follow-up|1|||
42051218|NCT00805480|75859767|FG001|Overall Study|Lost to Follow-up|2|||
42051219|NCT00805480|75859768|FG002|Overall Study|Lost to Follow-up|0|||
42051220|NCT00805480|75859769|FG003|Overall Study|Lost to Follow-up|0|||
42051221|NCT00805480|75859766|FG000|Overall Study|Adverse Event|0|||
42051222|NCT00805480|75859767|FG001|Overall Study|Adverse Event|0|||
42051223|NCT00805480|75859768|FG002|Overall Study|Adverse Event|1|||
42051224|NCT00805480|75859769|FG003|Overall Study|Adverse Event|0|||
42173385|NCT00318149|75980209|FG004|Overall Study|Adverse Event|0|||
42173386|NCT00318149|75980210|FG005|Overall Study|Adverse Event|2|||
42173387|NCT00317603|75980226|FG000|Overall Study|Progressive Disease|3|||
42173388|NCT03326518|75980233|FG000|Overall Study|Protocol Violation|1|||
42173389|NCT03326518|75980234|FG001|Overall Study|Protocol Violation|0|||
42173390|NCT03326518|75980235|FG002|Overall Study|Protocol Violation|0|||
42051225|NCT00729937|75859785|FG000|Overall Study|Lost to Follow-up|49|||
42051226|NCT00729937|75859786|FG001|Overall Study|Lost to Follow-up|58|||
42051227|NCT00729937|75859787|FG002|Overall Study|Lost to Follow-up|18|||
42173391|NCT03326518|75980233|FG000|Overall Study|Withdrawal by Subject|1|||
42051228|NCT00729937|75859788|FG003|Overall Study|Lost to Follow-up|33|||
42051229|NCT00729937|75859789|FG004|Overall Study|Lost to Follow-up|18|||
42051230|NCT00729937|75859790|FG005|Overall Study|Lost to Follow-up|23|||
42051231|NCT00729937|75859785|FG000|Overall Study|Physician Decision|7|||
42051232|NCT00729937|75859786|FG001|Overall Study|Physician Decision|16|||
42051233|NCT00729937|75859787|FG002|Overall Study|Physician Decision|2|||
42051234|NCT00729937|75859788|FG003|Overall Study|Physician Decision|0|||
42051235|NCT00729937|75859789|FG004|Overall Study|Physician Decision|5|||
42051236|NCT00729937|75859790|FG005|Overall Study|Physician Decision|8|||
42173392|NCT03326518|75980234|FG001|Overall Study|Withdrawal by Subject|0|||
42051237|NCT00729937|75859785|FG000|Overall Study|Death|1|||
42051238|NCT00729937|75859786|FG001|Overall Study|Death|0|||
42051239|NCT00729937|75859787|FG002|Overall Study|Death|1|||
42051240|NCT00729937|75859788|FG003|Overall Study|Death|0|||
42051241|NCT00729937|75859789|FG004|Overall Study|Death|0|||
42051242|NCT00729937|75859790|FG005|Overall Study|Death|1|||
42051243|NCT00729937|75859785|FG000|Overall Study|Withdrawal by Subject|3|||
42051244|NCT00729937|75859786|FG001|Overall Study|Withdrawal by Subject|5|||
42051245|NCT00729937|75859787|FG002|Overall Study|Withdrawal by Subject|6|||
42051246|NCT00729937|75859788|FG003|Overall Study|Withdrawal by Subject|0|||
42051247|NCT00729937|75859789|FG004|Overall Study|Withdrawal by Subject|4|||
42051248|NCT00729937|75859790|FG005|Overall Study|Withdrawal by Subject|2|||
42051249|NCT00729937|75859785|FG000|Overall Study|Randomized but not treated|12|||
42051250|NCT00729937|75859786|FG001|Overall Study|Randomized but not treated|6|||
42051251|NCT00729937|75859787|FG002|Overall Study|Randomized but not treated|1|||
42051252|NCT00729937|75859788|FG003|Overall Study|Randomized but not treated|0|||
42051253|NCT00729937|75859789|FG004|Overall Study|Randomized but not treated|1|||
42051254|NCT00729937|75859790|FG005|Overall Study|Randomized but not treated|3|||
42051255|NCT00729937|75859785|FG000|Overall Study|Did not meet eligibility criteria|2|||
42051256|NCT00729937|75859786|FG001|Overall Study|Did not meet eligibility criteria|1|||
42051257|NCT00729937|75859787|FG002|Overall Study|Did not meet eligibility criteria|0|||
42051258|NCT00729937|75859788|FG003|Overall Study|Did not meet eligibility criteria|0|||
42051259|NCT00729937|75859789|FG004|Overall Study|Did not meet eligibility criteria|0|||
42051260|NCT00729937|75859790|FG005|Overall Study|Did not meet eligibility criteria|0|||
42051261|NCT00729937|75859785|FG000|Overall Study|Incarcerated|0|||
42051262|NCT00729937|75859786|FG001|Overall Study|Incarcerated|2|||
42051263|NCT00729937|75859787|FG002|Overall Study|Incarcerated|1|||
42051264|NCT00729937|75859788|FG003|Overall Study|Incarcerated|1|||
42051265|NCT00729937|75859789|FG004|Overall Study|Incarcerated|0|||
42051266|NCT00729937|75859790|FG005|Overall Study|Incarcerated|0|||
42051267|NCT00729859|75859807|FG000|Overall Study|Adverse Event|0|||
42051268|NCT00729859|75859808|FG001|Overall Study|Adverse Event|1|||
42051269|NCT00729859|75859809|FG002|Overall Study|Adverse Event|0|||
42051270|NCT00729859|75859807|FG000|Overall Study|Withdrawal by Subject|0|||
42051271|NCT00729859|75859808|FG001|Overall Study|Withdrawal by Subject|1|||
42051272|NCT00729859|75859809|FG002|Overall Study|Withdrawal by Subject|0|||
42051273|NCT00810394|75859825|FG000|Overall Study|Withdrawal by Subject|3|||
42051274|NCT00736333|75859829|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
42051275|NCT00736333|75859829|FG000|Overall Study|Data Missing|2|||
42051276|NCT00736333|75859829|FG000|Overall Study|Tumor Progression|75|||
42051277|NCT00736333|75859829|FG000|Overall Study|Toxicity|6|||
42051278|NCT00736333|75859829|FG000|Overall Study|Withdrawal by Subject|10|||
42051279|NCT00736333|75859829|FG000|Overall Study|Death|7|||
42051280|NCT00736333|75859829|FG000|Overall Study|Other|4|||
42051281|NCT00736255|75859835|FG000|Overall Study|Adverse Event|1|||
42051282|NCT00736255|75859836|FG001|Overall Study|Adverse Event|0|||
42051283|NCT00736255|75859835|FG000|Overall Study|Physician Decision|1|||
42051284|NCT00736255|75859836|FG001|Overall Study|Physician Decision|0|||
42051285|NCT00736255|75859835|FG000|Overall Study|Non-compliance|1|||
42051286|NCT00736255|75859836|FG001|Overall Study|Non-compliance|1|||
42051287|NCT03920254|75859845|FG000|Overall Study|Adverse Event|1|||
42051288|NCT03920254|75859846|FG001|Overall Study|Adverse Event|0|||
42051289|NCT03920254|75859847|FG002|Overall Study|Adverse Event|0|||
42051290|NCT03920254|75859845|FG000|Overall Study|Physician Decision|0|||
42051291|NCT03920254|75859846|FG001|Overall Study|Physician Decision|1|||
42051292|NCT03920254|75859847|FG002|Overall Study|Physician Decision|2|||
42051293|NCT03920254|75859845|FG000|Overall Study|Study Terminated By Sponsor|12|||
42051294|NCT03920254|75859846|FG001|Overall Study|Study Terminated By Sponsor|17|||
42051295|NCT03920254|75859847|FG002|Overall Study|Study Terminated By Sponsor|12|||
42051296|NCT03920254|75859845|FG000|Overall Study|Withdrawal by Subject|0|||
42051297|NCT03920254|75859846|FG001|Overall Study|Withdrawal by Subject|0|||
42051298|NCT03920254|75859847|FG002|Overall Study|Withdrawal by Subject|1|||
42051299|NCT00729469|75859857|FG000|Overall Study|Adverse Event|14|||
42051300|NCT00729469|75859858|FG001|Overall Study|Adverse Event|25|||
42356922|NCT01424397|76202129|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
42051301|NCT00729469|75859857|FG000|Overall Study|Lost to Follow-up|9|||
42051302|NCT00729469|75859858|FG001|Overall Study|Lost to Follow-up|9|||
42051303|NCT00729469|75859857|FG000|Overall Study|Protocol Violation|2|||
42051304|NCT00729469|75859858|FG001|Overall Study|Protocol Violation|1|||
42051305|NCT00729469|75859857|FG000|Overall Study|Withdrawal by Subject|19|||
42051306|NCT00729469|75859858|FG001|Overall Study|Withdrawal by Subject|8|||
42051307|NCT00729469|75859857|FG000|Overall Study|Other-Not mentioned|9|||
42051308|NCT00729469|75859858|FG001|Overall Study|Other-Not mentioned|4|||
42051309|NCT00742183|75859866|FG000|Overall Study|Adverse Event|2|||
42051310|NCT00742183|75859867|FG001|Overall Study|Adverse Event|2|||
42051311|NCT00742183|75859866|FG000|Overall Study|Death|1|||
42051312|NCT00742183|75859867|FG001|Overall Study|Death|0|||
42051313|NCT00742183|75859866|FG000|Overall Study|Physician Decision|0|||
42051314|NCT00742183|75859867|FG001|Overall Study|Physician Decision|2|||
42051315|NCT00742183|75859866|FG000|Overall Study|Lost to Follow-up|4|||
42051316|NCT00742183|75859867|FG001|Overall Study|Lost to Follow-up|4|||
42173393|NCT03326518|75980235|FG002|Overall Study|Withdrawal by Subject|0|||
42173394|NCT03326518|75980233|FG000|Overall Study|Lost to Follow-up|1|||
42173395|NCT03326518|75980234|FG001|Overall Study|Lost to Follow-up|0|||
42173396|NCT03326518|75980235|FG002|Overall Study|Lost to Follow-up|1|||
42173397|NCT00317369|75980246|FG000|Overall Study|Adverse Event|2|||
42173398|NCT00317369|75980247|FG001|Overall Study|Adverse Event|1|||
42173399|NCT00317369|75980248|FG002|Overall Study|Adverse Event|0|||
42173400|NCT00317369|75980246|FG000|Overall Study|Lack of Efficacy|0|||
42173401|NCT00317369|75980247|FG001|Overall Study|Lack of Efficacy|1|||
42173402|NCT00317369|75980248|FG002|Overall Study|Lack of Efficacy|1|||
42173403|NCT00317369|75980246|FG000|Overall Study|Withdrawal by Subject|0|||
42173404|NCT00317369|75980247|FG001|Overall Study|Withdrawal by Subject|0|||
42173405|NCT00317369|75980248|FG002|Overall Study|Withdrawal by Subject|1|||
42173406|NCT03325894|75980258|FG000|Overall Study|Adverse Event|2|||
42173407|NCT03325894|75980259|FG001|Overall Study|Adverse Event|3|||
42173408|NCT03325894|75980258|FG000|Overall Study|Protocol Violation|1|||
42173409|NCT03325894|75980259|FG001|Overall Study|Protocol Violation|2|||
42173410|NCT03325894|75980258|FG000|Overall Study|Withdrawal by Subject|10|||
42173411|NCT03325894|75980259|FG001|Overall Study|Withdrawal by Subject|6|||
42173412|NCT03325894|75980258|FG000|Overall Study|Lost to Follow-up|4|||
42173413|NCT03325894|75980259|FG001|Overall Study|Lost to Follow-up|9|||
42173414|NCT03325894|75980258|FG000|Overall Study|Lack of Efficacy|8|||
42173415|NCT03325894|75980259|FG001|Overall Study|Lack of Efficacy|14|||
42173416|NCT03325894|75980258|FG000|Overall Study|Study Terminated by Sponsor|38|||
42173417|NCT03325894|75980259|FG001|Overall Study|Study Terminated by Sponsor|43|||
42173418|NCT03325894|75980258|FG000|Overall Study|Other (Not received Treatment)|1|||
42291483|NCT02641379|76125029|FG002|Overall Study|Non-response Week 12|0|||
42291484|NCT02641379|76125030|FG003|Overall Study|Non-response Week 12|0|||
42051317|NCT00742183|75859866|FG000|Overall Study|Required skin-graft|1|||
42051318|NCT00742183|75859867|FG001|Overall Study|Required skin-graft|1|||
42051319|NCT00742183|75859866|FG000|Overall Study|Withdrawal by Subject|1|||
42051320|NCT00742183|75859867|FG001|Overall Study|Withdrawal by Subject|0|||
42051321|NCT00742183|75859866|FG000|Overall Study|Lack of Efficacy|0|||
42051322|NCT00742183|75859867|FG001|Overall Study|Lack of Efficacy|3|||
42051323|NCT00808444|75859875|FG000|Overall Study|Withdrawal by Subject|1|||
42051324|NCT00808444|75859876|FG001|Overall Study|Withdrawal by Subject|0|||
42051325|NCT00808444|75859875|FG000|Overall Study|Lost to Follow-up|0|||
42051326|NCT00808444|75859876|FG001|Overall Study|Lost to Follow-up|1|||
42051327|NCT00742027|75859882|FG000|Overall Study|Disease Progression|76|||
42051328|NCT00742027|75859882|FG000|Overall Study|New Cancer Therapy|19|||
42051329|NCT00742027|75859882|FG000|Overall Study|Withdrawal by Subject|18|||
42051330|NCT00742027|75859882|FG000|Overall Study|Death|7|||
42051331|NCT00742027|75859882|FG000|Overall Study|Lost to Follow-up|4|||
42051332|NCT00742027|75859882|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
42051333|NCT00742027|75859882|FG000|Overall Study|Missing|2|||
42051334|NCT00742027|75859882|FG000|Overall Study|Administrative Problems|1|||
42051335|NCT03996369|75859888|FG000|Overall Study|Protocol deviation|1|||
42051336|NCT03996369|75859889|FG001|Overall Study|Protocol deviation|1|||
42051337|NCT03996369|75859888|FG000|Overall Study|Physician Decision|4|||
42051338|NCT03996369|75859889|FG001|Overall Study|Physician Decision|2|||
42051339|NCT03996369|75859888|FG000|Overall Study|Participant decision|0|||
42051340|NCT03996369|75859889|FG001|Overall Study|Participant decision|1|||
42051341|NCT03996369|75859888|FG000|Overall Study|Lack of Efficacy|4|||
42051342|NCT03996369|75859889|FG001|Overall Study|Lack of Efficacy|0|||
42051343|NCT03996369|75859888|FG000|Overall Study|Adverse Event|9|||
42051344|NCT03996369|75859889|FG001|Overall Study|Adverse Event|0|||
42173419|NCT03325894|75980259|FG001|Overall Study|Other (Not received Treatment)|0|||
42173420|NCT01239368|75980278|FG000|Overall Study|Principal investigator discretion|1|||
42173421|NCT01239368|75980279|FG001|Overall Study|Principal investigator discretion|0|||
42051345|NCT03996369|75859888|FG000|Overall Study|Withdrawal by Subject|6|||
42051346|NCT03996369|75859889|FG001|Overall Study|Withdrawal by Subject|8|||
42051347|NCT03996369|75859888|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
42051348|NCT03996369|75859889|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
42051349|NCT03996369|75859888|FG000|Overall Study|Lost to Follow-up|0|||
42051350|NCT03996369|75859889|FG001|Overall Study|Lost to Follow-up|1|||
42173422|NCT01239368|75980280|FG002|Overall Study|Principal investigator discretion|0|||
42173423|NCT01239368|75980281|FG003|Overall Study|Principal investigator discretion|0|||
42173424|NCT01239368|75980282|FG004|Overall Study|Principal investigator discretion|1|||
42173425|NCT01239368|75980283|FG005|Overall Study|Principal investigator discretion|2|||
42173426|NCT01239368|75980284|FG006|Overall Study|Principal investigator discretion|0|||
42173427|NCT01239368|75980285|FG007|Overall Study|Principal investigator discretion|0|||
42173428|NCT01239368|75980286|FG008|Overall Study|Principal investigator discretion|0|||
42173429|NCT01239368|75980287|FG009|Overall Study|Principal investigator discretion|1|||
42291485|NCT02641379|76125031|FG004|Overall Study|Non-response Week 12|0|||
42051351|NCT00808210|75859897|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
42051352|NCT00808210|75859898|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
42051353|NCT00808210|75859897|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
42051354|NCT00808210|75859898|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
42051355|NCT00808210|75859897|FG000|Double-Blind TX Period|Adverse Event|0|||
42051356|NCT00808210|75859898|FG001|Double-Blind TX Period|Adverse Event|1|||
42051357|NCT00808210|75859897|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
42051358|NCT00808210|75859898|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
42051359|NCT00808210|75859897|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
42051360|NCT00808210|75859898|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
42051361|NCT00808210|75859897|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
42051362|NCT00808210|75859898|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
42051363|NCT00736099|75859906|FG000|Overall Study|Adverse Event|61|||
42051364|NCT00736099|75859907|FG001|Overall Study|Adverse Event|18|||
42051365|NCT00736099|75859906|FG000|Overall Study|Protocol Violation|10|||
42051366|NCT00736099|75859907|FG001|Overall Study|Protocol Violation|4|||
42051367|NCT00736099|75859906|FG000|Overall Study|Lost to Follow-up|12|||
42051368|NCT00736099|75859907|FG001|Overall Study|Lost to Follow-up|5|||
42051369|NCT00736099|75859906|FG000|Overall Study|Withdrawal by Subject|42|||
42051370|NCT00736099|75859907|FG001|Overall Study|Withdrawal by Subject|13|||
42051371|NCT00736099|75859906|FG000|Overall Study|Lack of Efficacy|15|||
42051372|NCT00736099|75859907|FG001|Overall Study|Lack of Efficacy|8|||
42051373|NCT00736099|75859906|FG000|Overall Study|Other reason|43|||
42051374|NCT00736099|75859907|FG001|Overall Study|Other reason|10|||
42051375|NCT00735943|75859913|FG000|Overall Study|Lost to Follow-up|1|||
42051376|NCT00735943|75859913|FG000|Overall Study|Adverse Event|1|||
42051377|NCT00735709|75859921|FG000|Overall Study|Adverse Event|2|||
42051378|NCT00735709|75859922|FG001|Overall Study|Adverse Event|3|||
42051379|NCT00735709|75859923|FG002|Overall Study|Adverse Event|1|||
42051380|NCT00735709|75859924|FG003|Overall Study|Adverse Event|5|||
42051381|NCT00735709|75859921|FG000|Overall Study|Lack of Efficacy|8|||
42051382|NCT00735709|75859922|FG001|Overall Study|Lack of Efficacy|4|||
42051383|NCT00735709|75859923|FG002|Overall Study|Lack of Efficacy|2|||
42051384|NCT00735709|75859924|FG003|Overall Study|Lack of Efficacy|3|||
42051385|NCT00735709|75859921|FG000|Overall Study|Noncompliance|0|||
42051386|NCT00735709|75859922|FG001|Overall Study|Noncompliance|0|||
42051387|NCT00735709|75859923|FG002|Overall Study|Noncompliance|1|||
42051388|NCT00735709|75859924|FG003|Overall Study|Noncompliance|0|||
42051389|NCT00735709|75859921|FG000|Overall Study|Protocol deviations|1|||
42051390|NCT00735709|75859922|FG001|Overall Study|Protocol deviations|2|||
42051391|NCT00735709|75859923|FG002|Overall Study|Protocol deviations|1|||
42051392|NCT00735709|75859924|FG003|Overall Study|Protocol deviations|1|||
42051393|NCT00735709|75859921|FG000|Overall Study|Voluntary Withdrawal|1|||
42051394|NCT00735709|75859922|FG001|Overall Study|Voluntary Withdrawal|3|||
42051395|NCT00735709|75859923|FG002|Overall Study|Voluntary Withdrawal|5|||
42051396|NCT00735709|75859924|FG003|Overall Study|Voluntary Withdrawal|7|||
42051397|NCT00735709|75859921|FG000|Overall Study|Lost to Follow-up|0|||
42051398|NCT00735709|75859922|FG001|Overall Study|Lost to Follow-up|1|||
42051399|NCT00735709|75859923|FG002|Overall Study|Lost to Follow-up|1|||
42051400|NCT00735709|75859924|FG003|Overall Study|Lost to Follow-up|1|||
42051401|NCT00735709|75859921|FG000|Overall Study|Excluded medication|1|||
42051402|NCT00735709|75859922|FG001|Overall Study|Excluded medication|0|||
42051403|NCT00735709|75859923|FG002|Overall Study|Excluded medication|0|||
42051404|NCT00735709|75859924|FG003|Overall Study|Excluded medication|1|||
42051405|NCT00729157|75859934|FG000|Overall Study|Withdrawal by Subject|1|||
42051406|NCT00728689|75859940|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
42051407|NCT00728689|75859941|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
42051408|NCT00727909|75859949|FG000|Overall Study|Withdrawal by Subject|5|||
42051409|NCT00727909|75859950|FG001|Overall Study|Withdrawal by Subject|11|||
42051410|NCT00727909|75859951|FG002|Overall Study|Withdrawal by Subject|8|||
42051411|NCT00727909|75859952|FG003|Overall Study|Withdrawal by Subject|5|||
42051412|NCT00727909|75859949|FG000|Overall Study|Death|0|||
42051413|NCT00727909|75859950|FG001|Overall Study|Death|0|||
42051414|NCT00727909|75859951|FG002|Overall Study|Death|1|||
42051415|NCT00727909|75859952|FG003|Overall Study|Death|0|||
42051416|NCT00726895|75859956|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
42051417|NCT00726895|75859957|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
42051418|NCT00585325|75859966|FG000|Overall Study|Withdrawal by Subject|1|||
42051419|NCT00585325|75859967|FG001|Overall Study|Withdrawal by Subject|1|||
42051420|NCT00726661|75859975|FG000|Overall Study|Lost to Follow-up|36|||
42356923|NCT01424397|76202130|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
42051421|NCT00726661|75859976|FG001|Overall Study|Lost to Follow-up|11|||
42051422|NCT00726661|75859975|FG000|Overall Study|Withdrawal by Subject|17|||
42051423|NCT00726661|75859976|FG001|Overall Study|Withdrawal by Subject|13|||
42051424|NCT00726661|75859975|FG000|Overall Study|Trial terminated by sponsor|214|||
42051425|NCT00726661|75859976|FG001|Overall Study|Trial terminated by sponsor|187|||
42051426|NCT00726661|75859975|FG000|Overall Study|Death|475|||
42051427|NCT00726661|75859976|FG001|Overall Study|Death|159|||
42051428|NCT00726661|75859975|FG000|Overall Study|Physician Decision|25|||
42051429|NCT00726661|75859976|FG001|Overall Study|Physician Decision|13|||
42051430|NCT00726661|75859975|FG000|Overall Study|Other|47|||
42051431|NCT00726661|75859976|FG001|Overall Study|Other|35|||
42051432|NCT00741091|75859992|FG000|Overall Study|Death|13|||
42051433|NCT00741091|75859992|FG000|Overall Study|Lost to Follow-up|16|||
42051434|NCT00741091|75859992|FG000|Overall Study|Withdrawal by Subject|6|||
42051435|NCT00741091|75859992|FG000|Overall Study|Missed Visit|22|||
42051436|NCT00741013|75859999|FG000|Overall Study|Adverse Event|1|||
42051437|NCT00741013|75860000|FG001|Overall Study|Adverse Event|0|||
42051438|NCT00741013|75860001|FG002|Overall Study|Adverse Event|0|||
42051439|NCT00741013|75859999|FG000|Overall Study|Withdrawal by Subject|0|||
42051440|NCT00741013|75860000|FG001|Overall Study|Withdrawal by Subject|0|||
42051441|NCT00741013|75860001|FG002|Overall Study|Withdrawal by Subject|1|||
42051442|NCT00741013|75859999|FG000|Overall Study|Discovered failed screen after enrolled|0|||
42051443|NCT00741013|75860000|FG001|Overall Study|Discovered failed screen after enrolled|2|||
42051444|NCT00741013|75860001|FG002|Overall Study|Discovered failed screen after enrolled|0|||
42051445|NCT00740857|75860012|FG000|Overall Study|Withdrawal by Subject|1|||
42051446|NCT00740857|75860013|FG001|Overall Study|Withdrawal by Subject|0|||
42051447|NCT00740857|75860014|FG002|Overall Study|Withdrawal by Subject|0|||
42051448|NCT00808132|75860027|FG000|Overall Study|Adverse Event|34|||
42051449|NCT00808132|75860028|FG001|Overall Study|Adverse Event|33|||
42051450|NCT00808132|75860029|FG002|Overall Study|Adverse Event|16|||
42051451|NCT00808132|75860030|FG003|Overall Study|Adverse Event|31|||
42051452|NCT00808132|75860031|FG004|Overall Study|Adverse Event|33|||
42051453|NCT00808132|75860027|FG000|Overall Study|Death|0|||
42051454|NCT00808132|75860028|FG001|Overall Study|Death|0|||
42051455|NCT00808132|75860029|FG002|Overall Study|Death|0|||
42051456|NCT00808132|75860030|FG003|Overall Study|Death|0|||
42051457|NCT00808132|75860031|FG004|Overall Study|Death|1|||
42051458|NCT00808132|75860027|FG000|Overall Study|Physician Decision|0|||
42051459|NCT00808132|75860028|FG001|Overall Study|Physician Decision|1|||
42051460|NCT00808132|75860029|FG002|Overall Study|Physician Decision|0|||
42173430|NCT01239368|75980278|FG000|Overall Study|Disease progression on study|1|||
42173431|NCT01239368|75980279|FG001|Overall Study|Disease progression on study|1|||
42173432|NCT01239368|75980280|FG002|Overall Study|Disease progression on study|1|||
42173433|NCT01239368|75980281|FG003|Overall Study|Disease progression on study|1|||
42173434|NCT01239368|75980282|FG004|Overall Study|Disease progression on study|4|||
42173435|NCT01239368|75980283|FG005|Overall Study|Disease progression on study|2|||
42173436|NCT01239368|75980284|FG006|Overall Study|Disease progression on study|5|||
42173437|NCT01239368|75980285|FG007|Overall Study|Disease progression on study|0|||
42173438|NCT01239368|75980286|FG008|Overall Study|Disease progression on study|0|||
42173439|NCT01239368|75980287|FG009|Overall Study|Disease progression on study|2|||
42173440|NCT01239368|75980278|FG000|Overall Study|Refused further treatment|0|||
42173441|NCT01239368|75980279|FG001|Overall Study|Refused further treatment|0|||
42173442|NCT01239368|75980280|FG002|Overall Study|Refused further treatment|0|||
42173443|NCT01239368|75980281|FG003|Overall Study|Refused further treatment|0|||
42173444|NCT01239368|75980282|FG004|Overall Study|Refused further treatment|0|||
42173445|NCT01239368|75980283|FG005|Overall Study|Refused further treatment|0|||
42173446|NCT01239368|75980284|FG006|Overall Study|Refused further treatment|0|||
42173447|NCT01239368|75980285|FG007|Overall Study|Refused further treatment|0|||
42173448|NCT01239368|75980286|FG008|Overall Study|Refused further treatment|0|||
42173449|NCT01239368|75980287|FG009|Overall Study|Refused further treatment|1|||
42173450|NCT01239368|75980278|FG000|Overall Study|Death|0|||
42173451|NCT01239368|75980279|FG001|Overall Study|Death|0|||
42173452|NCT01239368|75980280|FG002|Overall Study|Death|0|||
42173453|NCT01239368|75980281|FG003|Overall Study|Death|0|||
42173454|NCT01239368|75980282|FG004|Overall Study|Death|0|||
42356924|NCT01424397|76202131|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
42356925|NCT01424397|76202132|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
42356926|NCT01424397|76202133|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
42051461|NCT00808132|75860030|FG003|Overall Study|Physician Decision|0|||
42173455|NCT01239368|75980283|FG005|Overall Study|Death|0|||
42173456|NCT01239368|75980284|FG006|Overall Study|Death|1|||
42173457|NCT01239368|75980285|FG007|Overall Study|Death|0|||
42173458|NCT01239368|75980286|FG008|Overall Study|Death|0|||
42051462|NCT00808132|75860031|FG004|Overall Study|Physician Decision|0|||
42051463|NCT00808132|75860027|FG000|Overall Study|Lost to Follow-up|8|||
42051464|NCT00808132|75860028|FG001|Overall Study|Lost to Follow-up|10|||
42051465|NCT00808132|75860029|FG002|Overall Study|Lost to Follow-up|11|||
42051466|NCT00808132|75860030|FG003|Overall Study|Lost to Follow-up|8|||
42051467|NCT00808132|75860031|FG004|Overall Study|Lost to Follow-up|9|||
42051468|NCT00808132|75860027|FG000|Overall Study|Protocol Violation|8|||
42051469|NCT00808132|75860028|FG001|Overall Study|Protocol Violation|9|||
42051470|NCT00808132|75860029|FG002|Overall Study|Protocol Violation|4|||
42051471|NCT00808132|75860030|FG003|Overall Study|Protocol Violation|9|||
42051472|NCT00808132|75860031|FG004|Overall Study|Protocol Violation|5|||
42051473|NCT00808132|75860027|FG000|Overall Study|Withdrawal by Subject|27|||
42051474|NCT00808132|75860028|FG001|Overall Study|Withdrawal by Subject|18|||
42051475|NCT00808132|75860029|FG002|Overall Study|Withdrawal by Subject|2|||
42051476|NCT00808132|75860030|FG003|Overall Study|Withdrawal by Subject|7|||
42051477|NCT00808132|75860031|FG004|Overall Study|Withdrawal by Subject|16|||
42051478|NCT00808132|75860027|FG000|Overall Study|Other|6|||
42051479|NCT00808132|75860028|FG001|Overall Study|Other|4|||
42051480|NCT00808132|75860029|FG002|Overall Study|Other|6|||
42051481|NCT00808132|75860030|FG003|Overall Study|Other|2|||
42051482|NCT00808132|75860031|FG004|Overall Study|Other|15|||
42051483|NCT00808132|75860027|FG000|Overall Study|Randomized, but not treated|10|||
42051484|NCT00808132|75860028|FG001|Overall Study|Randomized, but not treated|7|||
42173459|NCT01239368|75980287|FG009|Overall Study|Death|0|||
42173460|NCT00369161|75980335|FG000|Overall Study|Adverse Event|15|||
42173461|NCT00369161|75980336|FG001|Overall Study|Adverse Event|13|||
42173462|NCT00369161|75980335|FG000|Overall Study|Abnormal laboratory value|0|||
42173463|NCT00369161|75980336|FG001|Overall Study|Abnormal laboratory value|1|||
42173464|NCT00369161|75980335|FG000|Overall Study|Lack of Efficacy|3|||
42173465|NCT00369161|75980336|FG001|Overall Study|Lack of Efficacy|1|||
42173466|NCT00369161|75980335|FG000|Overall Study|Protocol Violation|0|||
42173467|NCT00369161|75980336|FG001|Overall Study|Protocol Violation|2|||
42173468|NCT00369161|75980335|FG000|Overall Study|Withdrawal by Subject|2|||
42173469|NCT00369161|75980336|FG001|Overall Study|Withdrawal by Subject|3|||
42173470|NCT00369161|75980335|FG000|Overall Study|Death|1|||
42173471|NCT00369161|75980336|FG001|Overall Study|Death|2|||
42173472|NCT00369161|75980335|FG000|Overall Study|Graft loss|4|||
42173473|NCT00369161|75980336|FG001|Overall Study|Graft loss|0|||
42173474|NCT00369161|75980335|FG000|Overall Study|Administrative Problem|2|||
42173475|NCT00369161|75980336|FG001|Overall Study|Administrative Problem|2|||
42173476|NCT00337571|75980346|FG000|Overall Study|Lack of Efficacy|3|||
42173477|NCT00337571|75980347|FG001|Overall Study|Lack of Efficacy|0|||
42173478|NCT00337571|75980348|FG002|Overall Study|Lack of Efficacy|0|||
42173479|NCT00337571|75980349|FG003|Overall Study|Lack of Efficacy|0|||
42173480|NCT00337571|75980346|FG000|Overall Study|Adverse Event|4|||
42173481|NCT00337571|75980347|FG001|Overall Study|Adverse Event|5|||
42173482|NCT00337571|75980348|FG002|Overall Study|Adverse Event|8|||
42051485|NCT00808132|75860029|FG002|Overall Study|Randomized, but not treated|9|||
42051486|NCT00808132|75860030|FG003|Overall Study|Randomized, but not treated|8|||
42173483|NCT00337571|75980349|FG003|Overall Study|Adverse Event|4|||
42173484|NCT00337571|75980346|FG000|Overall Study|Withdrawal by Subject|2|||
42173485|NCT00337571|75980347|FG001|Overall Study|Withdrawal by Subject|2|||
42173486|NCT00337571|75980348|FG002|Overall Study|Withdrawal by Subject|1|||
42051487|NCT00808132|75860031|FG004|Overall Study|Randomized, but not treated|9|||
42051488|NCT00808132|75860027|FG000|Overall Study|Unsatisfactory response|5|||
42051489|NCT00808132|75860028|FG001|Overall Study|Unsatisfactory response|6|||
42051490|NCT00808132|75860029|FG002|Overall Study|Unsatisfactory response|6|||
42051491|NCT00808132|75860030|FG003|Overall Study|Unsatisfactory response|4|||
42051492|NCT00808132|75860031|FG004|Overall Study|Unsatisfactory response|12|||
42051493|NCT00727441|75860046|FG000|Overall Study|Disease Progression|11|||
42051494|NCT00727441|75860047|FG001|Overall Study|Disease Progression|14|||
42173487|NCT00337571|75980349|FG003|Overall Study|Withdrawal by Subject|0|||
42173488|NCT00337571|75980346|FG000|Overall Study|Lost to Follow-up|3|||
42173489|NCT00337571|75980347|FG001|Overall Study|Lost to Follow-up|1|||
42051495|NCT00727441|75860048|FG002|Overall Study|Disease Progression|17|||
42051496|NCT00727441|75860046|FG000|Overall Study|Eligibility|7|||
42173490|NCT00337571|75980348|FG002|Overall Study|Lost to Follow-up|0|||
42051497|NCT00727441|75860047|FG001|Overall Study|Eligibility|5|||
42051498|NCT00727441|75860048|FG002|Overall Study|Eligibility|7|||
42051499|NCT00727441|75860046|FG000|Overall Study|Death|0|||
42051500|NCT00727441|75860047|FG001|Overall Study|Death|1|||
42051501|NCT00727441|75860048|FG002|Overall Study|Death|1|||
42051502|NCT00727441|75860046|FG000|Overall Study|Physician Decision|0|||
42051503|NCT00727441|75860047|FG001|Overall Study|Physician Decision|1|||
42051504|NCT00727441|75860048|FG002|Overall Study|Physician Decision|0|||
42051505|NCT00727441|75860046|FG000|Overall Study|Withdrawal by Subject|0|||
42051506|NCT00727441|75860047|FG001|Overall Study|Withdrawal by Subject|1|||
42173491|NCT00337571|75980349|FG003|Overall Study|Lost to Follow-up|1|||
42173492|NCT00337571|75980346|FG000|Overall Study|Poor/noncompliance|1|||
42173493|NCT00337571|75980347|FG001|Overall Study|Poor/noncompliance|1|||
42173494|NCT00337571|75980348|FG002|Overall Study|Poor/noncompliance|1|||
42173495|NCT00337571|75980349|FG003|Overall Study|Poor/noncompliance|1|||
42173496|NCT00337571|75980346|FG000|Overall Study|No longer met study criteria|1|||
42173497|NCT00337571|75980347|FG001|Overall Study|No longer met study criteria|0|||
42173498|NCT00337571|75980348|FG002|Overall Study|No longer met study criteria|0|||
42173499|NCT00337571|75980349|FG003|Overall Study|No longer met study criteria|0|||
42173500|NCT00337571|75980346|FG000|Overall Study|High Potassium level|0|||
42173501|NCT00337571|75980347|FG001|Overall Study|High Potassium level|0|||
42173502|NCT00337571|75980348|FG002|Overall Study|High Potassium level|0|||
42173503|NCT00337571|75980349|FG003|Overall Study|High Potassium level|1|||
42173504|NCT00368927|75980361|FG000|Overall Study|Lost to Follow-up|2|||
42291486|NCT02641379|76125032|FG005|Overall Study|Non-response Week 12|0|||
42291487|NCT02641379|76125033|FG006|Overall Study|Non-response Week 12|0|||
42291488|NCT02641379|76125034|FG007|Overall Study|Non-response Week 12|1|||
42291489|NCT02641379|76125035|FG008|Overall Study|Non-response Week 12|0|||
42291490|NCT02641379|76125036|FG009|Overall Study|Non-response Week 12|0|||
42291491|NCT02641379|76125037|FG010|Overall Study|Non-response Week 12|0|||
42291492|NCT02641379|76125027|FG000|Overall Study|No 2 Log drop at Week 12|0|||
42291493|NCT02641379|76125028|FG001|Overall Study|No 2 Log drop at Week 12|0|||
42291494|NCT02641379|76125029|FG002|Overall Study|No 2 Log drop at Week 12|0|||
42291495|NCT02641379|76125030|FG003|Overall Study|No 2 Log drop at Week 12|0|||
42291496|NCT02641379|76125031|FG004|Overall Study|No 2 Log drop at Week 12|0|||
42291497|NCT02641379|76125032|FG005|Overall Study|No 2 Log drop at Week 12|0|||
42291498|NCT02641379|76125033|FG006|Overall Study|No 2 Log drop at Week 12|0|||
42291499|NCT02641379|76125034|FG007|Overall Study|No 2 Log drop at Week 12|0|||
42291500|NCT02641379|76125035|FG008|Overall Study|No 2 Log drop at Week 12|0|||
42291501|NCT02641379|76125036|FG009|Overall Study|No 2 Log drop at Week 12|0|||
42291502|NCT02641379|76125037|FG010|Overall Study|No 2 Log drop at Week 12|1|||
42291503|NCT02641379|76125027|FG000|Overall Study|Negative PCR result|0|||
42291504|NCT02641379|76125028|FG001|Overall Study|Negative PCR result|0|||
42291505|NCT02641379|76125029|FG002|Overall Study|Negative PCR result|0|||
42291506|NCT02641379|76125030|FG003|Overall Study|Negative PCR result|0|||
42291507|NCT02641379|76125031|FG004|Overall Study|Negative PCR result|0|||
42291508|NCT02641379|76125032|FG005|Overall Study|Negative PCR result|0|||
42291509|NCT02641379|76125033|FG006|Overall Study|Negative PCR result|0|||
42291510|NCT02641379|76125034|FG007|Overall Study|Negative PCR result|0|||
42291511|NCT02641379|76125035|FG008|Overall Study|Negative PCR result|0|||
42291512|NCT02641379|76125036|FG009|Overall Study|Negative PCR result|1|||
42291513|NCT02641379|76125037|FG010|Overall Study|Negative PCR result|0|||
42291514|NCT02641379|76125027|FG000|Overall Study|Participant's PCR high|0|||
42291515|NCT02641379|76125028|FG001|Overall Study|Participant's PCR high|0|||
42291516|NCT02641379|76125029|FG002|Overall Study|Participant's PCR high|0|||
42291517|NCT02641379|76125030|FG003|Overall Study|Participant's PCR high|0|||
42291518|NCT02641379|76125031|FG004|Overall Study|Participant's PCR high|0|||
42291519|NCT02641379|76125032|FG005|Overall Study|Participant's PCR high|0|||
42291520|NCT02641379|76125033|FG006|Overall Study|Participant's PCR high|0|||
42291521|NCT02641379|76125034|FG007|Overall Study|Participant's PCR high|1|||
42291522|NCT02641379|76125035|FG008|Overall Study|Participant's PCR high|0|||
42291523|NCT02641379|76125036|FG009|Overall Study|Participant's PCR high|0|||
42291524|NCT02641379|76125037|FG010|Overall Study|Participant's PCR high|0|||
42173505|NCT00368927|75980362|FG001|Overall Study|Lost to Follow-up|0|||
42291525|NCT02641379|76125027|FG000|Overall Study|Participant treated after Week 24|0|||
42291526|NCT02641379|76125028|FG001|Overall Study|Participant treated after Week 24|0|||
42291527|NCT02641379|76125029|FG002|Overall Study|Participant treated after Week 24|0|||
42291528|NCT02641379|76125030|FG003|Overall Study|Participant treated after Week 24|0|||
42291529|NCT02641379|76125031|FG004|Overall Study|Participant treated after Week 24|0|||
42051507|NCT00727441|75860048|FG002|Overall Study|Withdrawal by Subject|0|||
42051508|NCT00717769|75860062|FG000|Overall Study|Adverse Event|9|||
42051509|NCT00717769|75860063|FG001|Overall Study|Adverse Event|6|||
42051510|NCT00717769|75860064|FG002|Overall Study|Adverse Event|1|||
42291530|NCT02641379|76125032|FG005|Overall Study|Participant treated after Week 24|0|||
42291531|NCT02641379|76125033|FG006|Overall Study|Participant treated after Week 24|0|||
42291532|NCT02641379|76125034|FG007|Overall Study|Participant treated after Week 24|0|||
42291533|NCT02641379|76125035|FG008|Overall Study|Participant treated after Week 24|1|||
42051511|NCT00717769|75860062|FG000|Overall Study|Lack of compliance|0|||
42051512|NCT00717769|75860063|FG001|Overall Study|Lack of compliance|2|||
42051513|NCT00717769|75860064|FG002|Overall Study|Lack of compliance|0|||
42051514|NCT00717769|75860062|FG000|Overall Study|Lost to Follow-up|3|||
42051515|NCT00717769|75860063|FG001|Overall Study|Lost to Follow-up|4|||
42051516|NCT00717769|75860064|FG002|Overall Study|Lost to Follow-up|0|||
42051517|NCT00717769|75860062|FG000|Overall Study|Lack of Efficacy|1|||
42051518|NCT00717769|75860063|FG001|Overall Study|Lack of Efficacy|2|||
42051519|NCT00717769|75860064|FG002|Overall Study|Lack of Efficacy|0|||
42051520|NCT00717769|75860062|FG000|Overall Study|Protocol Violation|0|||
42051521|NCT00717769|75860063|FG001|Overall Study|Protocol Violation|2|||
42051522|NCT00717769|75860064|FG002|Overall Study|Protocol Violation|0|||
42051523|NCT00717769|75860062|FG000|Overall Study|Sponsor decision|1|||
42051524|NCT00717769|75860063|FG001|Overall Study|Sponsor decision|0|||
42051525|NCT00717769|75860064|FG002|Overall Study|Sponsor decision|10|||
42051526|NCT00717769|75860062|FG000|Overall Study|Withdrew consent|2|||
42051527|NCT00717769|75860063|FG001|Overall Study|Withdrew consent|2|||
42291534|NCT02641379|76125036|FG009|Overall Study|Participant treated after Week 24|0|||
42291535|NCT02641379|76125037|FG010|Overall Study|Participant treated after Week 24|0|||
42291536|NCT02641379|76125027|FG000|Overall Study|Missing PCR result at Week 8|0|||
42291537|NCT02641379|76125028|FG001|Overall Study|Missing PCR result at Week 8|0|||
42016153|NCT01277510|75823347|FG000|Double-blind Phase|Administrative decision|7|||
42016154|NCT01277510|75823348|FG001|Double-blind Phase|Administrative decision|9|||
42016155|NCT01277510|75823347|FG000|Double-blind Phase|Death|0|||
42016156|NCT01277510|75823348|FG001|Double-blind Phase|Death|1|||
42016157|NCT01277510|75823347|FG000|Double-blind Phase|Protocol-specified criteria|2|||
42016158|NCT01277510|75823348|FG001|Double-blind Phase|Protocol-specified criteria|6|||
42016159|NCT01277510|75823347|FG000|Double-blind Phase|Other|1|||
42016160|NCT01277510|75823348|FG001|Double-blind Phase|Other|1|||
42016161|NCT01277510|75823347|FG000|Open-label Phase|Administrative decision|4|||
42016162|NCT01277510|75823348|FG001|Open-label Phase|Administrative decision|3|||
42016163|NCT01277510|75823347|FG000|Open-label Phase|Protocol-specified criteria|1|||
42016164|NCT01277510|75823348|FG001|Open-label Phase|Protocol-specified criteria|0|||
42016165|NCT01277510|75823347|FG000|Open-label Phase|Never received investigational product|2|||
42016166|NCT01277510|75823348|FG001|Open-label Phase|Never received investigational product|0|||
42016167|NCT00937495|75823356|FG000|Overall Study|Protocol Violation|2|||
42016168|NCT01268306|75823360|FG000|Overall Study|Lost to Follow-up|1|||
42016169|NCT00936715|75823364|FG000|Overall Study|Investigators Discretion|1|||
42016170|NCT00936715|75823364|FG000|Overall Study|Protocol Violation|1|||
42016171|NCT00936715|75823364|FG000|Overall Study|Safety or Tolerability Reasons|4|||
42016172|NCT01267994|75823368|FG000|Overall Study|Adverse Event|2|||
42016173|NCT00934843|75823375|FG000|Overall Study|Protocol Violation|0|||
42016174|NCT00934843|75823376|FG001|Overall Study|Protocol Violation|1|||
42016175|NCT01266902|75823384|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
42016176|NCT01266902|75823385|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
42016177|NCT01266902|75823386|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
42016178|NCT01266902|75823384|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
42016179|NCT01266902|75823385|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
42016180|NCT01266902|75823386|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
42016181|NCT01266902|75823384|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
42016182|NCT01266902|75823385|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
42016183|NCT01266902|75823386|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
42016184|NCT01266902|75823384|FG000|Period 1 (Main Study)|Adverse Event|3|||
42016185|NCT01266902|75823385|FG001|Period 1 (Main Study)|Adverse Event|11|||
42016186|NCT01266902|75823386|FG002|Period 1 (Main Study)|Adverse Event|0|||
42016187|NCT01266902|75823384|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
42016188|NCT01266902|75823385|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
42016189|NCT01266902|75823386|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
42016190|NCT01266902|75823384|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
42016191|NCT01266902|75823385|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
42016192|NCT01266902|75823386|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
42016193|NCT01266902|75823384|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
42016194|NCT01266902|75823385|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
42016195|NCT01266902|75823386|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
42016196|NCT01266902|75823384|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
42016197|NCT01266902|75823385|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
42016198|NCT01266902|75823386|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
42016199|NCT01266902|75823384|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
42016200|NCT01266902|75823385|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
42016201|NCT01266902|75823386|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
42051528|NCT00717769|75860064|FG002|Overall Study|Withdrew consent|0|||
42051529|NCT04153929|75860082|FG000|Overall Study|Other than listed|2|||
42051530|NCT04153929|75860083|FG001|Overall Study|Other than listed|2|||
42051531|NCT04153929|75860084|FG002|Overall Study|Other than listed|0|||
42051532|NCT04153929|75860085|FG003|Overall Study|Other than listed|1|||
42051533|NCT04153929|75860086|FG004|Overall Study|Other than listed|0|||
42051534|NCT04153929|75860087|FG005|Overall Study|Other than listed|2|||
42051535|NCT04153929|75860088|FG006|Overall Study|Other than listed|2|||
42051536|NCT04153929|75860089|FG007|Overall Study|Other than listed|1|||
42051537|NCT04153929|75860082|FG000|Overall Study|Lost to Follow-up|2|||
42051538|NCT04153929|75860083|FG001|Overall Study|Lost to Follow-up|1|||
42051539|NCT04153929|75860084|FG002|Overall Study|Lost to Follow-up|0|||
42051540|NCT04153929|75860085|FG003|Overall Study|Lost to Follow-up|1|||
42051541|NCT04153929|75860086|FG004|Overall Study|Lost to Follow-up|1|||
42051542|NCT04153929|75860087|FG005|Overall Study|Lost to Follow-up|0|||
42051543|NCT04153929|75860088|FG006|Overall Study|Lost to Follow-up|0|||
42051544|NCT04153929|75860089|FG007|Overall Study|Lost to Follow-up|0|||
42051545|NCT04153929|75860082|FG000|Overall Study|Withdrawal by Subject|3|||
42051546|NCT04153929|75860083|FG001|Overall Study|Withdrawal by Subject|1|||
42051547|NCT04153929|75860084|FG002|Overall Study|Withdrawal by Subject|0|||
42051548|NCT04153929|75860085|FG003|Overall Study|Withdrawal by Subject|3|||
42051549|NCT04153929|75860086|FG004|Overall Study|Withdrawal by Subject|1|||
42051550|NCT04153929|75860087|FG005|Overall Study|Withdrawal by Subject|0|||
42051551|NCT04153929|75860088|FG006|Overall Study|Withdrawal by Subject|1|||
42051552|NCT04153929|75860089|FG007|Overall Study|Withdrawal by Subject|0|||
42051553|NCT04153929|75860082|FG000|Overall Study|Protocol Violation|0|||
42051554|NCT04153929|75860083|FG001|Overall Study|Protocol Violation|0|||
42051555|NCT04153929|75860084|FG002|Overall Study|Protocol Violation|0|||
42051556|NCT04153929|75860085|FG003|Overall Study|Protocol Violation|0|||
42051557|NCT04153929|75860086|FG004|Overall Study|Protocol Violation|0|||
42051558|NCT04153929|75860087|FG005|Overall Study|Protocol Violation|0|||
42051559|NCT04153929|75860088|FG006|Overall Study|Protocol Violation|1|||
42051560|NCT04153929|75860089|FG007|Overall Study|Protocol Violation|2|||
42051561|NCT04153929|75860082|FG000|Overall Study|Adverse Event|3|||
42051562|NCT04153929|75860083|FG001|Overall Study|Adverse Event|5|||
42051563|NCT04153929|75860084|FG002|Overall Study|Adverse Event|5|||
42051564|NCT04153929|75860085|FG003|Overall Study|Adverse Event|11|||
42051565|NCT04153929|75860086|FG004|Overall Study|Adverse Event|15|||
42051566|NCT04153929|75860087|FG005|Overall Study|Adverse Event|4|||
42051567|NCT04153929|75860088|FG006|Overall Study|Adverse Event|8|||
42051568|NCT04153929|75860089|FG007|Overall Study|Adverse Event|2|||
42051569|NCT04153929|75860082|FG000|Overall Study|Not treated|1|||
42051570|NCT04153929|75860083|FG001|Overall Study|Not treated|0|||
42051571|NCT04153929|75860084|FG002|Overall Study|Not treated|0|||
42051572|NCT04153929|75860085|FG003|Overall Study|Not treated|0|||
42051573|NCT04153929|75860086|FG004|Overall Study|Not treated|0|||
42051574|NCT04153929|75860087|FG005|Overall Study|Not treated|0|||
42051575|NCT04153929|75860088|FG006|Overall Study|Not treated|1|||
42051576|NCT04153929|75860089|FG007|Overall Study|Not treated|0|||
42051577|NCT00591214|75860107|FG000|Overall Study|Physician Decision|7|||
42051578|NCT00591214|75860107|FG000|Overall Study|Withdrawal by Subject|1|||
42051579|NCT00725725|75860114|FG000|Overall Study|Adverse Event|1|||
42051580|NCT00725725|75860115|FG001|Overall Study|Adverse Event|3|||
42173506|NCT00368927|75980361|FG000|Overall Study|Adverse Event|1|||
42173507|NCT00368927|75980362|FG001|Overall Study|Adverse Event|1|||
42173508|NCT00368927|75980361|FG000|Overall Study|Withdrawal by Subject|1|||
42173509|NCT00368927|75980362|FG001|Overall Study|Withdrawal by Subject|2|||
42173510|NCT00368927|75980361|FG000|Overall Study|Physician Decision|1|||
42173511|NCT00368927|75980362|FG001|Overall Study|Physician Decision|0|||
42173512|NCT00316589|75980385|FG000|Overall Study|Withdrawal by Subject|0|||
42173513|NCT00316589|75980386|FG001|Overall Study|Withdrawal by Subject|5|||
42173514|NCT00316589|75980387|FG002|Overall Study|Withdrawal by Subject|0|||
42173515|NCT00316589|75980388|FG003|Overall Study|Withdrawal by Subject|1|||
42291538|NCT02641379|76125029|FG002|Overall Study|Missing PCR result at Week 8|0|||
42291539|NCT02641379|76125030|FG003|Overall Study|Missing PCR result at Week 8|0|||
42291540|NCT02641379|76125031|FG004|Overall Study|Missing PCR result at Week 8|0|||
42173516|NCT00316589|75980385|FG000|Overall Study|Subject unwilling/unable to comply|0|||
42173517|NCT00316589|75980386|FG001|Overall Study|Subject unwilling/unable to comply|6|||
42173518|NCT00316589|75980387|FG002|Overall Study|Subject unwilling/unable to comply|0|||
42173519|NCT00316589|75980388|FG003|Overall Study|Subject unwilling/unable to comply|2|||
42173520|NCT00316589|75980385|FG000|Overall Study|Adverse Event|1|||
42173521|NCT00316589|75980386|FG001|Overall Study|Adverse Event|0|||
42173522|NCT00316589|75980387|FG002|Overall Study|Adverse Event|0|||
42291541|NCT02641379|76125032|FG005|Overall Study|Missing PCR result at Week 8|0|||
42173523|NCT00316589|75980388|FG003|Overall Study|Adverse Event|1|||
42173524|NCT00316589|75980385|FG000|Overall Study|Physician Decision|0|||
42051581|NCT00725725|75860116|FG002|Overall Study|Adverse Event|2|||
42051582|NCT00725725|75860114|FG000|Overall Study|Lost to Follow-up|2|||
42051583|NCT00725725|75860115|FG001|Overall Study|Lost to Follow-up|0|||
42051584|NCT00725725|75860116|FG002|Overall Study|Lost to Follow-up|2|||
42051585|NCT00725725|75860114|FG000|Overall Study|Withdrawal by Subject|1|||
42051586|NCT00725725|75860115|FG001|Overall Study|Withdrawal by Subject|0|||
42051587|NCT00725725|75860116|FG002|Overall Study|Withdrawal by Subject|1|||
42051588|NCT00725725|75860114|FG000|Overall Study|Protocol Violation|0|||
42051589|NCT00725725|75860115|FG001|Overall Study|Protocol Violation|1|||
42051590|NCT00725725|75860116|FG002|Overall Study|Protocol Violation|0|||
42051591|NCT00725101|75860124|FG000|Overall Study|Death|3|||
42051592|NCT00725101|75860124|FG000|Overall Study|Lost to Follow-up|353|||
42051593|NCT00725101|75860124|FG000|Overall Study|Protocol Violation|1|||
42051594|NCT00725101|75860124|FG000|Overall Study|Withdrawal by Subject|127|||
42051595|NCT00725101|75860124|FG000|Overall Study|not specified/no reason given|11|||
42051596|NCT00585169|75860128|FG000|Overall Study|Withdrawal by Subject|1|||
42051597|NCT00807742|75860136|FG000|Overall Study|Death|9|||
42051598|NCT00807742|75860137|FG001|Overall Study|Death|2|||
42051599|NCT00807742|75860136|FG000|Overall Study|Withdrawal by Subject|2|||
42051600|NCT00807742|75860137|FG001|Overall Study|Withdrawal by Subject|1|||
42051601|NCT00807742|75860136|FG000|Overall Study|Lost to Follow-up|35|||
42051602|NCT00807742|75860137|FG001|Overall Study|Lost to Follow-up|51|||
42051603|NCT00724945|75860143|FG000|Period 1|non-compliance|1|||
42051604|NCT00724945|75860144|FG001|Period 1|non-compliance|0|||
42051605|NCT00724945|75860143|FG000|Period 1|Adverse Event|1|||
42051606|NCT00724945|75860144|FG001|Period 1|Adverse Event|1|||
42051607|NCT00724945|75860143|FG000|Period 1|Lost to Follow-up|1|||
42051608|NCT00724945|75860144|FG001|Period 1|Lost to Follow-up|0|||
42051609|NCT00724945|75860143|FG000|Period 2|lens comfort issue|3|||
42051610|NCT00724945|75860144|FG001|Period 2|lens comfort issue|0|||
42051611|NCT00724945|75860143|FG000|Period 2|lens physiology issue|1|||
42051612|NCT00724945|75860144|FG001|Period 2|lens physiology issue|0|||
42051613|NCT00803452|75860152|FG000|Overall Study|Adverse Event|0|||
42051614|NCT00803452|75860153|FG001|Overall Study|Adverse Event|2|||
42051615|NCT00803452|75860152|FG000|Overall Study|Lost to Follow-up|0|||
42051616|NCT00803452|75860153|FG001|Overall Study|Lost to Follow-up|3|||
42051617|NCT00589108|75860162|FG000|Overall Study|Lost to Follow-up|1|||
42051618|NCT00589108|75860163|FG001|Overall Study|Lost to Follow-up|1|||
42051619|NCT00589108|75860164|FG002|Overall Study|Lost to Follow-up|1|||
42051620|NCT00589108|75860162|FG000|Overall Study|Death|3|||
42051621|NCT00589108|75860163|FG001|Overall Study|Death|3|||
42051622|NCT00589108|75860164|FG002|Overall Study|Death|4|||
42051623|NCT00717067|75860177|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
42051624|NCT00717067|75860178|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
42051625|NCT00717067|75860179|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
42051626|NCT00717067|75860180|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
42051627|NCT00717067|75860181|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
42051628|NCT00802438|75860203|FG000|Overall Study|Screen Failure|20|||
42051629|NCT00802438|75860203|FG000|Overall Study|Withdrawal by Subject|7|||
42051630|NCT00802438|75860203|FG000|Overall Study|Physician Decision|1|||
42051631|NCT00588952|75860213|FG000|Overall Study|Adverse Event|0|||
42051632|NCT00588952|75860214|FG001|Overall Study|Adverse Event|2|||
42051633|NCT00588952|75860213|FG000|Overall Study|Withdrawal by Subject|3|||
42051634|NCT00588952|75860214|FG001|Overall Study|Withdrawal by Subject|5|||
42051635|NCT01021748|75860229|FG000|Overall Study|Adverse Event|2|||
42051636|NCT01021748|75860230|FG001|Overall Study|Adverse Event|1|||
42051637|NCT01021748|75860231|FG002|Overall Study|Adverse Event|2|||
42173525|NCT00316589|75980386|FG001|Overall Study|Physician Decision|1|||
42051638|NCT01021748|75860232|FG003|Overall Study|Adverse Event|0|||
42051639|NCT01021748|75860233|FG004|Overall Study|Adverse Event|2|||
42051640|NCT01021748|75860234|FG005|Overall Study|Adverse Event|0|||
42051641|NCT01021748|75860235|FG006|Overall Study|Adverse Event|1|||
42051642|NCT01021748|75860236|FG007|Overall Study|Adverse Event|0|||
42051643|NCT01021748|75860237|FG008|Overall Study|Adverse Event|7|||
42051644|NCT01021748|75860229|FG000|Overall Study|Physician Decision|1|||
42051645|NCT01021748|75860230|FG001|Overall Study|Physician Decision|0|||
42051646|NCT01021748|75860231|FG002|Overall Study|Physician Decision|1|||
42051647|NCT01021748|75860232|FG003|Overall Study|Physician Decision|1|||
42051648|NCT01021748|75860233|FG004|Overall Study|Physician Decision|0|||
42051649|NCT01021748|75860234|FG005|Overall Study|Physician Decision|0|||
42173526|NCT00316589|75980387|FG002|Overall Study|Physician Decision|0|||
42051650|NCT01021748|75860235|FG006|Overall Study|Physician Decision|1|||
42051651|NCT01021748|75860236|FG007|Overall Study|Physician Decision|1|||
42051652|NCT01021748|75860237|FG008|Overall Study|Physician Decision|2|||
42051653|NCT01021748|75860229|FG000|Overall Study|Progressive Disease|3|||
42051654|NCT01021748|75860230|FG001|Overall Study|Progressive Disease|3|||
42051655|NCT01021748|75860231|FG002|Overall Study|Progressive Disease|4|||
42173527|NCT00316589|75980388|FG003|Overall Study|Physician Decision|0|||
42051656|NCT01021748|75860232|FG003|Overall Study|Progressive Disease|6|||
42016202|NCT01266902|75823384|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
42016203|NCT01266902|75823385|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
42016204|NCT01266902|75823386|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
42016205|NCT01266824|75823396|FG000|Overall Study|Study terminated prior to completion|2|||
42016206|NCT01266824|75823397|FG001|Overall Study|Study terminated prior to completion|3|||
42016207|NCT01266590|75823403|FG000|Overall Study|Adverse Event|3|||
42016208|NCT01266590|75823403|FG000|Overall Study|Lost to Follow-up|1|||
42016209|NCT01266590|75823403|FG000|Overall Study|Withdrawal by Subject|1|||
42016210|NCT01266590|75823403|FG000|Overall Study|Physician Decision|1|||
42016211|NCT01266122|75823412|FG000|Overall Study|Lost to Follow-up|6|||
42016212|NCT01266122|75823413|FG001|Overall Study|Lost to Follow-up|6|||
42016213|NCT01265498|75823421|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
42016214|NCT01265498|75823422|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
42016215|NCT01265420|75823428|FG000|Overall Study|Lost to Follow-up|1|||
42016216|NCT01264718|75823434|FG000|Overall Study|Lost to Follow-up|3|||
42016217|NCT01264718|75823435|FG001|Overall Study|Lost to Follow-up|2|||
42016218|NCT01264718|75823434|FG000|Overall Study|Withdrawal by Subject|9|||
42016219|NCT01264718|75823435|FG001|Overall Study|Withdrawal by Subject|15|||
42016220|NCT01264718|75823434|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
42016221|NCT01264718|75823435|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
42016222|NCT01264016|75823441|FG000|Overall Study|Withdrawal by Subject|1|||
42016223|NCT01264016|75823441|FG000|Overall Study|Felt faint at sight of blood|1|||
42051657|NCT01021748|75860233|FG004|Overall Study|Progressive Disease|7|||
42051658|NCT01021748|75860234|FG005|Overall Study|Progressive Disease|3|||
42051659|NCT01021748|75860235|FG006|Overall Study|Progressive Disease|0|||
42051660|NCT01021748|75860236|FG007|Overall Study|Progressive Disease|5|||
42051661|NCT01021748|75860237|FG008|Overall Study|Progressive Disease|6|||
42051662|NCT01021748|75860229|FG000|Overall Study|Withdrawal by Subject|0|||
42051663|NCT01021748|75860230|FG001|Overall Study|Withdrawal by Subject|0|||
42051664|NCT01021748|75860231|FG002|Overall Study|Withdrawal by Subject|0|||
42051665|NCT01021748|75860232|FG003|Overall Study|Withdrawal by Subject|0|||
42051666|NCT01021748|75860233|FG004|Overall Study|Withdrawal by Subject|0|||
42051667|NCT01021748|75860234|FG005|Overall Study|Withdrawal by Subject|0|||
42051668|NCT01021748|75860235|FG006|Overall Study|Withdrawal by Subject|1|||
42051669|NCT01021748|75860236|FG007|Overall Study|Withdrawal by Subject|0|||
42051670|NCT01021748|75860237|FG008|Overall Study|Withdrawal by Subject|1|||
42051671|NCT01021748|75860229|FG000|Overall Study|Not Treated|0|||
42051672|NCT01021748|75860230|FG001|Overall Study|Not Treated|1|||
42051673|NCT01021748|75860231|FG002|Overall Study|Not Treated|0|||
42051674|NCT01021748|75860232|FG003|Overall Study|Not Treated|0|||
42051675|NCT01021748|75860233|FG004|Overall Study|Not Treated|0|||
42051676|NCT01021748|75860234|FG005|Overall Study|Not Treated|0|||
42051677|NCT01021748|75860235|FG006|Overall Study|Not Treated|0|||
42051678|NCT01021748|75860236|FG007|Overall Study|Not Treated|0|||
42051679|NCT01021748|75860237|FG008|Overall Study|Not Treated|0|||
42051680|NCT00802360|75860261|FG000|Overall Study|Stimulation failure|4|||
42051681|NCT00802360|75860262|FG001|Overall Study|Stimulation failure|0|||
42051682|NCT00802360|75860263|FG002|Overall Study|Stimulation failure|3|||
42051683|NCT00802360|75860264|FG003|Overall Study|Stimulation failure|3|||
42051684|NCT00802360|75860261|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
42051685|NCT00802360|75860262|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
42051686|NCT00802360|75860263|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
42051687|NCT00802360|75860264|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
42051688|NCT00802360|75860261|FG000|Overall Study|Cycle cancelled|0|||
42051689|NCT00802360|75860262|FG001|Overall Study|Cycle cancelled|1|||
42051690|NCT00802360|75860263|FG002|Overall Study|Cycle cancelled|1|||
42051691|NCT00802360|75860264|FG003|Overall Study|Cycle cancelled|1|||
42051692|NCT00802360|75860261|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
42051693|NCT00802360|75860262|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
42051694|NCT00802360|75860263|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
42173528|NCT00316589|75980385|FG000|Overall Study|Other reason|0|||
42173529|NCT00316589|75980386|FG001|Overall Study|Other reason|12|||
42051695|NCT00802360|75860264|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
42173530|NCT00316589|75980387|FG002|Overall Study|Other reason|1|||
42173531|NCT00316589|75980388|FG003|Overall Study|Other reason|1|||
42173532|NCT00316277|75980402|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
42016224|NCT01263782|75823450|FG000|Overall Study|Death|0|||
42016225|NCT01263782|75823451|FG001|Overall Study|Death|0|||
42016226|NCT01263782|75823452|FG002|Overall Study|Death|1|||
42051696|NCT00802360|75860261|FG000|Overall Study|No positive serum pregnancy|17|||
42051697|NCT00802360|75860262|FG001|Overall Study|No positive serum pregnancy|20|||
42051698|NCT00802360|75860263|FG002|Overall Study|No positive serum pregnancy|14|||
42051699|NCT00802360|75860264|FG003|Overall Study|No positive serum pregnancy|10|||
42173533|NCT00316277|75980403|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
42016227|NCT01263782|75823453|FG003|Overall Study|Death|0|||
42016228|NCT01263782|75823450|FG000|Overall Study|Progressive disease|0|||
42051700|NCT00802360|75860261|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
42051701|NCT00802360|75860262|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
42051702|NCT00802360|75860263|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
42051703|NCT00802360|75860264|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
42051704|NCT00802360|75860261|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
42051705|NCT00802360|75860262|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
42051706|NCT00802360|75860263|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
42051707|NCT00802360|75860264|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
42051708|NCT00802360|75860261|FG000|Overall Study|Other|2|||
42051709|NCT00802360|75860262|FG001|Overall Study|Other|3|||
42051710|NCT00802360|75860263|FG002|Overall Study|Other|6|||
42051711|NCT00802360|75860264|FG003|Overall Study|Other|3|||
42051712|NCT01026038|75860279|FG000|Overall Study|Lost to Follow-up|1|||
42051713|NCT01026038|75860280|FG001|Overall Study|Lost to Follow-up|1|||
42051714|NCT01026038|75860281|FG002|Overall Study|Lost to Follow-up|0|||
42051715|NCT00801892|75860300|FG000|Main Study Period|Withdrawal by Subject|0|||
42051716|NCT00801892|75860301|FG001|Main Study Period|Withdrawal by Subject|1|||
42051717|NCT00801892|75860300|FG000|Sham Crossover Period|Lost to Follow-up|0|||
42051718|NCT00801892|75860301|FG001|Sham Crossover Period|Lost to Follow-up|2|||
42051719|NCT02680587|75860315|FG000|Overall Study|Withdrawal by Subject|1|||
42051720|NCT02680587|75860316|FG001|Overall Study|Withdrawal by Subject|0|||
42051721|NCT00589420|75860326|FG000|Overall Study|screen failure|1|||
42051722|NCT01025336|75860335|FG000|Overall Study|Protocol Violation|0|||
42051723|NCT01025336|75860336|FG001|Overall Study|Protocol Violation|0|||
42051724|NCT01025336|75860337|FG002|Overall Study|Protocol Violation|0|||
42051725|NCT01025336|75860338|FG003|Overall Study|Protocol Violation|2|||
42051726|NCT01025336|75860339|FG004|Overall Study|Protocol Violation|0|||
42051727|NCT00796978|75860373|FG000|Overall Study|Cardiac adverse event|5|||
42051728|NCT00796978|75860373|FG000|Overall Study|Adverse Event|4|||
42051729|NCT00796978|75860373|FG000|Overall Study|Withdrawal by Subject|3|||
42051730|NCT00796822|75860379|FG000|Overall Study|Lost to Follow-up|2|||
42051731|NCT00796822|75860380|FG001|Overall Study|Lost to Follow-up|0|||
42051732|NCT00796822|75860379|FG000|Overall Study|Adverse Event|1|||
42051733|NCT00796822|75860380|FG001|Overall Study|Adverse Event|0|||
42051734|NCT01020812|75860386|FG000|Overall Study|Physician Decision|1|||
42051735|NCT01020812|75860386|FG000|Overall Study|Withdrawal by Subject|1|||
42051736|NCT01020812|75860386|FG000|Overall Study|Protocol Violation|1|||
42051737|NCT01032044|75860392|FG000|Overall Study|Protocol Violation|14|||
42051738|NCT01032044|75860393|FG001|Overall Study|Protocol Violation|8|||
42051739|NCT01032044|75860392|FG000|Overall Study|Adverse Event|0|||
42051740|NCT01032044|75860393|FG001|Overall Study|Adverse Event|1|||
42051741|NCT01032044|75860392|FG000|Overall Study|Lost to Follow-up|11|||
42051742|NCT01032044|75860393|FG001|Overall Study|Lost to Follow-up|11|||
42051743|NCT01024946|75860399|FG000|Overall Study|Screen Failure|3|||
42051744|NCT01024946|75860399|FG000|Overall Study|Withdrawal by Subject|1|||
42051745|NCT01024946|75860399|FG000|Overall Study|Adverse Event|1|||
42051746|NCT00724867|75860403|FG000|Overall Study|Adverse Event|25|||
42051747|NCT00724867|75860403|FG000|Overall Study|Lack of Efficacy|14|||
42051748|NCT00724867|75860403|FG000|Overall Study|Lost to Follow-up|12|||
42051749|NCT00724867|75860403|FG000|Overall Study|Non-compliance with study drug|6|||
42291542|NCT02641379|76125033|FG006|Overall Study|Missing PCR result at Week 8|0|||
42291543|NCT02641379|76125034|FG007|Overall Study|Missing PCR result at Week 8|0|||
42291544|NCT02641379|76125035|FG008|Overall Study|Missing PCR result at Week 8|0|||
42291545|NCT02641379|76125036|FG009|Overall Study|Missing PCR result at Week 8|1|||
42291546|NCT02641379|76125037|FG010|Overall Study|Missing PCR result at Week 8|0|||
42291547|NCT02641379|76125027|FG000|Overall Study|PCR positive|0|||
42291548|NCT02641379|76125028|FG001|Overall Study|PCR positive|0|||
42291549|NCT02641379|76125029|FG002|Overall Study|PCR positive|0|||
42291550|NCT02641379|76125030|FG003|Overall Study|PCR positive|0|||
42291551|NCT02641379|76125031|FG004|Overall Study|PCR positive|0|||
42291552|NCT02641379|76125032|FG005|Overall Study|PCR positive|0|||
42291553|NCT02641379|76125033|FG006|Overall Study|PCR positive|1|||
42291554|NCT02641379|76125034|FG007|Overall Study|PCR positive|0|||
42291555|NCT02641379|76125035|FG008|Overall Study|PCR positive|0|||
42291556|NCT02641379|76125036|FG009|Overall Study|PCR positive|0|||
42291557|NCT02641379|76125037|FG010|Overall Study|PCR positive|0|||
42291558|NCT02660983|76125068|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
42291559|NCT02660983|76125069|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
42051750|NCT00724867|75860403|FG000|Overall Study|Physician Decision|17|||
42051751|NCT00724867|75860403|FG000|Overall Study|Protocol Violation|1|||
42051752|NCT00724867|75860403|FG000|Overall Study|Withdrawal by Subject|31|||
42051753|NCT00724867|75860403|FG000|Overall Study|Sponsor decision to end study|14|||
42051754|NCT00724867|75860403|FG000|Overall Study|Subject incarcerated|1|||
42051755|NCT00724867|75860403|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
42291560|NCT02660983|76125068|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
42291561|NCT02660983|76125069|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
42291562|NCT02660983|76125068|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
42051756|NCT00724867|75860403|FG000|Overall Study|Subject moved out of state|1|||
42051757|NCT00724867|75860403|FG000|Overall Study|Elected to exit due to site closure|2|||
42051758|NCT00724711|75860412|FG000|Overall Study|Adverse Event|7|||
42051759|NCT00724711|75860413|FG001|Overall Study|Adverse Event|3|||
42051760|NCT00724711|75860412|FG000|Overall Study|Pregnancy|0|||
42051761|NCT00724711|75860413|FG001|Overall Study|Pregnancy|1|||
42051762|NCT00724711|75860412|FG000|Overall Study|Lack of Efficacy|0|||
42051763|NCT00724711|75860413|FG001|Overall Study|Lack of Efficacy|1|||
42051764|NCT00724711|75860412|FG000|Overall Study|Physician Decision|0|||
42051765|NCT00724711|75860413|FG001|Overall Study|Physician Decision|3|||
42051766|NCT00724711|75860412|FG000|Overall Study|Withdrawal by Subject|5|||
42051767|NCT00724711|75860413|FG001|Overall Study|Withdrawal by Subject|4|||
42051768|NCT00724711|75860412|FG000|Overall Study|Lost to Follow-up|4|||
42051769|NCT00724711|75860413|FG001|Overall Study|Lost to Follow-up|5|||
42051770|NCT00724711|75860412|FG000|Overall Study|Protocol Violation|1|||
42051771|NCT00724711|75860413|FG001|Overall Study|Protocol Violation|0|||
42051772|NCT01024244|75860424|FG000|Overall Study|Adverse Event|1|||
42051773|NCT01024244|75860425|FG001|Overall Study|Adverse Event|2|||
42051774|NCT01024244|75860426|FG002|Overall Study|Adverse Event|0|||
42051775|NCT01024244|75860427|FG003|Overall Study|Adverse Event|1|||
42051776|NCT01024244|75860428|FG004|Overall Study|Adverse Event|2|||
42051777|NCT01024244|75860424|FG000|Overall Study|Entry Criteria Not Met|0|||
42051778|NCT01024244|75860425|FG001|Overall Study|Entry Criteria Not Met|1|||
42051779|NCT01024244|75860426|FG002|Overall Study|Entry Criteria Not Met|0|||
42051780|NCT01024244|75860427|FG003|Overall Study|Entry Criteria Not Met|0|||
42051781|NCT01024244|75860428|FG004|Overall Study|Entry Criteria Not Met|0|||
42051782|NCT01024244|75860424|FG000|Overall Study|Lack of Efficacy|1|||
42051783|NCT01024244|75860425|FG001|Overall Study|Lack of Efficacy|0|||
42051784|NCT01024244|75860426|FG002|Overall Study|Lack of Efficacy|0|||
42051785|NCT01024244|75860427|FG003|Overall Study|Lack of Efficacy|0|||
42051786|NCT01024244|75860428|FG004|Overall Study|Lack of Efficacy|0|||
42051787|NCT01024244|75860424|FG000|Overall Study|Protocol Violation|1|||
42051788|NCT01024244|75860425|FG001|Overall Study|Protocol Violation|0|||
42051789|NCT01024244|75860426|FG002|Overall Study|Protocol Violation|0|||
42051790|NCT01024244|75860427|FG003|Overall Study|Protocol Violation|0|||
42051791|NCT01024244|75860428|FG004|Overall Study|Protocol Violation|2|||
42051792|NCT01024244|75860424|FG000|Overall Study|Sponsor Decision|14|||
42051793|NCT01024244|75860425|FG001|Overall Study|Sponsor Decision|7|||
42051794|NCT01024244|75860426|FG002|Overall Study|Sponsor Decision|14|||
42051795|NCT01024244|75860427|FG003|Overall Study|Sponsor Decision|12|||
42051796|NCT01024244|75860428|FG004|Overall Study|Sponsor Decision|10|||
42051797|NCT01024244|75860424|FG000|Overall Study|Withdrawal by Subject|0|||
42051798|NCT01024244|75860425|FG001|Overall Study|Withdrawal by Subject|1|||
42051799|NCT01024244|75860426|FG002|Overall Study|Withdrawal by Subject|0|||
42051800|NCT01024244|75860427|FG003|Overall Study|Withdrawal by Subject|0|||
42051801|NCT01024244|75860428|FG004|Overall Study|Withdrawal by Subject|0|||
42051802|NCT00721279|75860442|FG000|Overall Study|Lack of Efficacy|6|||
42051803|NCT00721279|75860443|FG001|Overall Study|Lack of Efficacy|3|||
42051804|NCT00721279|75860442|FG000|Overall Study|Tolerability insufficient|5|||
42051805|NCT00721279|75860443|FG001|Overall Study|Tolerability insufficient|2|||
42051806|NCT00721279|75860442|FG000|Overall Study|Withdrawal by Subject|13|||
42051807|NCT00721279|75860443|FG001|Overall Study|Withdrawal by Subject|3|||
42051808|NCT00721279|75860442|FG000|Overall Study|Other|12|||
42051809|NCT00721279|75860443|FG001|Overall Study|Other|16|||
42051810|NCT01030952|75860452|FG000|Overall Study|Protocol Violation|0|||
42051811|NCT01030952|75860453|FG001|Overall Study|Protocol Violation|1|||
42051812|NCT01030952|75860452|FG000|Overall Study|Informed consent withdrawal|1|||
42051813|NCT01030952|75860453|FG001|Overall Study|Informed consent withdrawal|0|||
42051814|NCT01030952|75860452|FG000|Overall Study|Lost to Follow-up|0|||
42051815|NCT01030952|75860453|FG001|Overall Study|Lost to Follow-up|1|||
42051816|NCT01030952|75860452|FG000|Overall Study|Unexplained|1|||
42051817|NCT01030952|75860453|FG001|Overall Study|Unexplained|1|||
42051818|NCT01030874|75860463|FG000|Overall Study|Withdrawal by Subject|1|||
42051819|NCT01030874|75860464|FG001|Overall Study|Withdrawal by Subject|0|||
42051820|NCT01030874|75860463|FG000|Overall Study|Discharged in first 2 weeks|17|||
42051821|NCT01030874|75860464|FG001|Overall Study|Discharged in first 2 weeks|16|||
42051822|NCT03611751|75860473|FG000|Pre-treatment|Randomized but not treated|1|||
42051823|NCT03611751|75860474|FG001|Pre-treatment|Randomized but not treated|1|||
42051824|NCT03611751|75860475|FG002|Pre-treatment|Randomized but not treated|0|||
42051825|NCT03611751|75860473|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
42051826|NCT03611751|75860474|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
42051827|NCT03611751|75860475|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
42051828|NCT03611751|75860473|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
42051829|NCT03611751|75860474|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
42051830|NCT03611751|75860475|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
42051831|NCT03611751|75860473|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
42051832|NCT03611751|75860474|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
42051833|NCT03611751|75860475|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
42051834|NCT03611751|75860473|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
42051835|NCT03611751|75860474|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
42051836|NCT03611751|75860475|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
42051837|NCT03611751|75860473|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
42051838|NCT03611751|75860474|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
42051839|NCT03611751|75860475|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
42051840|NCT03611751|75860473|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
42051841|NCT03611751|75860474|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
42051842|NCT03611751|75860475|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
42051843|NCT03611751|75860473|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
42051844|NCT03611751|75860474|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
42051845|NCT03611751|75860475|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
42051846|NCT03611751|75860473|FG000|Treatment Week 0 - Week 16|Death|0|||
42051847|NCT03611751|75860474|FG001|Treatment Week 0 - Week 16|Death|0|||
42051848|NCT03611751|75860475|FG002|Treatment Week 0 - Week 16|Death|1|||
42051849|NCT03611751|75860473|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
42051850|NCT03611751|75860474|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
42051851|NCT03611751|75860475|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
42051852|NCT03611751|75860473|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
42051853|NCT03611751|75860474|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
42051854|NCT03611751|75860475|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
42051855|NCT03611751|75860473|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
42051856|NCT03611751|75860474|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
42051857|NCT03611751|75860475|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
42051858|NCT03611751|75860473|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
42051859|NCT03611751|75860474|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
42051860|NCT03611751|75860475|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
42051861|NCT03611751|75860473|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
42051862|NCT03611751|75860474|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
42051863|NCT03611751|75860475|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
42051864|NCT03611751|75860473|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
42051865|NCT03611751|75860474|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
42051866|NCT03611751|75860475|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
42051867|NCT03611751|75860473|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
42051868|NCT03611751|75860474|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
42051869|NCT03611751|75860475|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
42051870|NCT03611751|75860473|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
42051871|NCT03611751|75860474|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
42051872|NCT03611751|75860475|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
42051873|NCT03611751|75860473|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
42051874|NCT03611751|75860474|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
42051875|NCT03611751|75860475|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
42051876|NCT03611751|75860473|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
42051877|NCT03611751|75860474|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
42051878|NCT03611751|75860475|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
42051879|NCT03611751|75860473|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
42051880|NCT03611751|75860474|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
42051881|NCT03611751|75860475|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
42051882|NCT03611751|75860473|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
42051883|NCT03611751|75860474|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
42051884|NCT03611751|75860475|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
42051885|NCT03611751|75860473|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
42051886|NCT03611751|75860474|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
42051887|NCT03611751|75860475|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
42051888|NCT03611751|75860473|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
42051889|NCT03611751|75860474|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
42051890|NCT03611751|75860475|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
42051891|NCT00721123|75860492|FG000|Overall Study|Adverse Event|96|||
42051892|NCT00721123|75860492|FG000|Overall Study|Death|10|||
42051893|NCT00721123|75860492|FG000|Overall Study|Insufficient Therapeutic Response|21|||
42051894|NCT00721123|75860492|FG000|Overall Study|Protocol Violation|1|||
42051895|NCT00721123|75860492|FG000|Overall Study|Refused Treatment|41|||
42051896|NCT00721123|75860492|FG000|Overall Study|Failure to Return|9|||
42051897|NCT00721123|75860492|FG000|Overall Study|Withdrawal by Subject|5|||
42051898|NCT00720499|75860512|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
42051899|NCT00720499|75860513|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
42051900|NCT00720499|75860512|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
42051901|NCT00720499|75860513|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
42173534|NCT00316277|75980402|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
42173535|NCT00316277|75980403|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
42051902|NCT00720499|75860512|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
42173536|NCT00316277|75980402|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
42051903|NCT00720499|75860513|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
42051904|NCT00724243|75860520|FG000|Overall Study|Lack of Efficacy|10|||
42051905|NCT00724243|75860520|FG000|Overall Study|Adverse Event|5|||
42051906|NCT00720343|75860524|FG000|Overall Study|Physician Decision|3|||
42051907|NCT00720343|75860524|FG000|Overall Study|No data|3|||
42051908|NCT00720109|75860530|FG000|Induction Period|Did not meet eligibility criteria|3|||
42051909|NCT00720109|75860531|FG001|Induction Period|Did not meet eligibility criteria|0|||
42051910|NCT00720109|75860532|FG002|Induction Period|Did not meet eligibility criteria|0|||
42051911|NCT00720109|75860530|FG000|Induction Period|Bone Marrow Transplant|2|||
42051912|NCT00720109|75860531|FG001|Induction Period|Bone Marrow Transplant|0|||
42051913|NCT00720109|75860532|FG002|Induction Period|Bone Marrow Transplant|0|||
42051914|NCT00720109|75860530|FG000|Induction Period|Physician Decision|1|||
42051915|NCT00720109|75860531|FG001|Induction Period|Physician Decision|0|||
42051916|NCT00720109|75860532|FG002|Induction Period|Physician Decision|0|||
42051917|NCT00720109|75860530|FG000|Risk Stratification Period|Adverse Event|0|||
42051918|NCT00720109|75860531|FG001|Risk Stratification Period|Adverse Event|1|||
42051919|NCT00720109|75860532|FG002|Risk Stratification Period|Adverse Event|0|||
42051920|NCT00720109|75860530|FG000|Risk Stratification Period|Physician Decision|0|||
42051921|NCT00720109|75860531|FG001|Risk Stratification Period|Physician Decision|2|||
42051922|NCT00720109|75860532|FG002|Risk Stratification Period|Physician Decision|1|||
42051923|NCT00720109|75860530|FG000|Risk Stratification Period|Bone marrow transplant|0|||
42051924|NCT00720109|75860531|FG001|Risk Stratification Period|Bone marrow transplant|9|||
42051925|NCT00720109|75860532|FG002|Risk Stratification Period|Bone marrow transplant|7|||
42051926|NCT00720109|75860530|FG000|Risk Stratification Period|Disease progression or relapse|0|||
42051927|NCT00720109|75860531|FG001|Risk Stratification Period|Disease progression or relapse|2|||
42051928|NCT00720109|75860532|FG002|Risk Stratification Period|Disease progression or relapse|0|||
42051929|NCT00720109|75860530|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
42051930|NCT00720109|75860531|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
42051931|NCT00720109|75860532|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
42051932|NCT01015118|75860543|FG000|Overall Study|Protocol Violation|5|||
42051933|NCT01015118|75860544|FG001|Overall Study|Protocol Violation|6|||
42051934|NCT01015118|75860543|FG000|Overall Study|Withdrawal by Subject|103|||
42051935|NCT01015118|75860544|FG001|Overall Study|Withdrawal by Subject|27|||
42051936|NCT01015118|75860543|FG000|Overall Study|Other Adverse Event (AE)|141|||
42051937|NCT01015118|75860544|FG001|Overall Study|Other Adverse Event (AE)|33|||
42051938|NCT01015118|75860543|FG000|Overall Study|Worsening or AE of underlying disease|5|||
42051939|NCT01015118|75860544|FG001|Overall Study|Worsening or AE of underlying disease|4|||
42051940|NCT01015118|75860543|FG000|Overall Study|Progressive disease|364|||
42051941|NCT01015118|75860544|FG001|Overall Study|Progressive disease|229|||
42051942|NCT01015118|75860543|FG000|Overall Study|Not treated|9|||
42051943|NCT01015118|75860544|FG001|Overall Study|Not treated|5|||
42051944|NCT01015118|75860543|FG000|Overall Study|Other than stated above|42|||
42051945|NCT01015118|75860544|FG001|Overall Study|Other than stated above|23|||
42051946|NCT00800176|75860556|FG000|Overall Study|Adverse Event|2|||
42051947|NCT00800176|75860557|FG001|Overall Study|Adverse Event|1|||
42051948|NCT00800176|75860558|FG002|Overall Study|Adverse Event|0|||
42051949|NCT00800176|75860559|FG003|Overall Study|Adverse Event|2|||
42051950|NCT00800176|75860560|FG004|Overall Study|Adverse Event|1|||
42051951|NCT00800176|75860561|FG005|Overall Study|Adverse Event|1|||
42051952|NCT00800176|75860556|FG000|Overall Study|Refused treatment|3|||
42051953|NCT00800176|75860557|FG001|Overall Study|Refused treatment|2|||
42051954|NCT00800176|75860558|FG002|Overall Study|Refused treatment|0|||
42051955|NCT00800176|75860559|FG003|Overall Study|Refused treatment|0|||
42051956|NCT00800176|75860560|FG004|Overall Study|Refused treatment|1|||
42051957|NCT00800176|75860561|FG005|Overall Study|Refused treatment|4|||
42051958|NCT00800176|75860556|FG000|Overall Study|Failure to return|3|||
42051959|NCT00800176|75860557|FG001|Overall Study|Failure to return|3|||
42051960|NCT00800176|75860558|FG002|Overall Study|Failure to return|0|||
42051961|NCT00800176|75860559|FG003|Overall Study|Failure to return|2|||
42051962|NCT00800176|75860560|FG004|Overall Study|Failure to return|0|||
42051963|NCT00800176|75860561|FG005|Overall Study|Failure to return|0|||
42051964|NCT00800176|75860556|FG000|Overall Study|Other|1|||
42051965|NCT00800176|75860557|FG001|Overall Study|Other|0|||
42051966|NCT00800176|75860558|FG002|Overall Study|Other|0|||
42051967|NCT00800176|75860559|FG003|Overall Study|Other|0|||
42051968|NCT00800176|75860560|FG004|Overall Study|Other|2|||
42051969|NCT00800176|75860561|FG005|Overall Study|Other|0|||
42051970|NCT00715429|75860577|FG000|Overall Study|Did not complete the study diary|0|||
42051971|NCT00715429|75860578|FG001|Overall Study|Did not complete the study diary|1|||
42051972|NCT00715117|75860600|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
42051973|NCT00715117|75860601|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
42051974|NCT00723229|75860614|FG000|First Intervention|Lost to Follow-up|7|||
42051975|NCT00723229|75860615|FG001|First Intervention|Lost to Follow-up|3|||
42051976|NCT01030718|75860630|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
42051977|NCT01030718|75860631|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
42051978|NCT01030718|75860632|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
42051979|NCT01030718|75860630|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
42051980|NCT01030718|75860631|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
42051981|NCT01030718|75860632|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
42051982|NCT01030718|75860630|FG000|Studies CA180-031 and -036 Combined|Death|0|||
42051983|NCT01030718|75860631|FG001|Studies CA180-031 and -036 Combined|Death|1|||
42051984|NCT01030718|75860632|FG002|Studies CA180-031 and -036 Combined|Death|0|||
42051985|NCT01030718|75860630|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
42051986|NCT01030718|75860631|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
42051987|NCT01030718|75860632|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
42051988|NCT01030718|75860630|FG000|Study CA180-036 Only|insufficient effect|1|||
42051989|NCT01030718|75860631|FG001|Study CA180-036 Only|insufficient effect|1|||
42051990|NCT01030718|75860632|FG002|Study CA180-036 Only|insufficient effect|5|||
42051991|NCT01030718|75860630|FG000|Study CA180-036 Only|Adverse Event|2|||
42051992|NCT01030718|75860631|FG001|Study CA180-036 Only|Adverse Event|3|||
42051993|NCT01030718|75860632|FG002|Study CA180-036 Only|Adverse Event|0|||
42051994|NCT01030718|75860630|FG000|Study CA180-036 Only|Death|0|||
42051995|NCT01030718|75860631|FG001|Study CA180-036 Only|Death|1|||
42051996|NCT01030718|75860632|FG002|Study CA180-036 Only|Death|0|||
42051997|NCT01030718|75860630|FG000|Study CA180-036 Only|Other Reasons|0|||
42051998|NCT01030718|75860631|FG001|Study CA180-036 Only|Other Reasons|2|||
42051999|NCT01030718|75860632|FG002|Study CA180-036 Only|Other Reasons|0|||
42052000|NCT00722761|75860652|FG000|Overall Study|Lost to Follow-up|1|||
42052001|NCT00722761|75860653|FG001|Overall Study|Lost to Follow-up|4|||
42052002|NCT00722761|75860652|FG000|Overall Study|Withdrawal by Subject|5|||
42052003|NCT00722761|75860653|FG001|Overall Study|Withdrawal by Subject|2|||
42052004|NCT00719953|75860659|FG000|Overall Study|Adverse Event|4|||
42052005|NCT01019486|75860666|FG000|Overall Study|Withdrawal by Subject|1|||
42052006|NCT01019486|75860667|FG001|Overall Study|Withdrawal by Subject|1|||
42052007|NCT01019486|75860668|FG002|Overall Study|Withdrawal by Subject|1|||
42052008|NCT02803203|75860677|FG000|Overall Study|Adverse Event|4|||
42052009|NCT02803203|75860677|FG000|Overall Study|Death|4|||
42052010|NCT02803203|75860677|FG000|Overall Study|Progressive disease|29|||
42052011|NCT02803203|75860677|FG000|Overall Study|Withdrawal by Subject|8|||
42052012|NCT02803203|75860677|FG000|Overall Study|Complete resection of target disease|2|||
42052013|NCT02803203|75860677|FG000|Overall Study|Switched to commercial Osi|1|||
42052014|NCT02803203|75860677|FG000|Overall Study|Participant moved away|1|||
42052015|NCT00714493|75860682|FG000|Overall Study|Adverse Event|11|||
42052016|NCT00714493|75860682|FG000|Overall Study|Death|3|||
42052017|NCT00714493|75860682|FG000|Overall Study|Lack of Efficacy|10|||
42052018|NCT00714493|75860682|FG000|Overall Study|Lost to Follow-up|3|||
42052019|NCT00714493|75860682|FG000|Overall Study|Protocol Violation|12|||
42052020|NCT00714493|75860682|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
42052021|NCT00714493|75860682|FG000|Overall Study|OTHER|2|||
42052022|NCT01019252|75860688|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
42052023|NCT01019252|75860689|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
42052024|NCT01019252|75860688|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
42052025|NCT01019252|75860689|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
42052026|NCT01019252|75860688|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
42052027|NCT01019252|75860689|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
42052028|NCT01019252|75860688|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
42052029|NCT01019252|75860689|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
42052030|NCT01013870|75860697|FG000|Overall Study|Lost to Follow-up|1|||
42052031|NCT01013870|75860698|FG001|Overall Study|Lost to Follow-up|3|||
42052032|NCT01013792|75860706|FG000|Overall Study|Study suspended|2|||
42052033|NCT01013792|75860707|FG001|Overall Study|Study suspended|1|||
42052034|NCT01013792|75860706|FG000|Overall Study|Adverse Event|0|||
42052035|NCT01013792|75860707|FG001|Overall Study|Adverse Event|3|||
42052036|NCT01013792|75860706|FG000|Overall Study|Lost to Follow-up|0|||
42052037|NCT01013792|75860707|FG001|Overall Study|Lost to Follow-up|1|||
42052038|NCT01018862|75860716|FG000|Overall Study|Adverse Event|2|||
42052039|NCT01018862|75860717|FG001|Overall Study|Adverse Event|0|||
42052040|NCT01018862|75860718|FG002|Overall Study|Adverse Event|6|||
42052041|NCT01018862|75860716|FG000|Overall Study|Lack of Efficacy|1|||
42052042|NCT01018862|75860717|FG001|Overall Study|Lack of Efficacy|0|||
42052043|NCT01018862|75860718|FG002|Overall Study|Lack of Efficacy|2|||
42052044|NCT01018862|75860716|FG000|Overall Study|Lost to Follow-up|3|||
42052045|NCT01018862|75860717|FG001|Overall Study|Lost to Follow-up|1|||
42052046|NCT01018862|75860718|FG002|Overall Study|Lost to Follow-up|0|||
42052047|NCT01018862|75860716|FG000|Overall Study|Protocol Violation|1|||
42052048|NCT01018862|75860717|FG001|Overall Study|Protocol Violation|3|||
42052049|NCT01018862|75860718|FG002|Overall Study|Protocol Violation|3|||
42052050|NCT01018862|75860716|FG000|Overall Study|Withdrawal by Subject|1|||
42052051|NCT01018862|75860717|FG001|Overall Study|Withdrawal by Subject|2|||
42052052|NCT01018862|75860718|FG002|Overall Study|Withdrawal by Subject|1|||
42052053|NCT01018862|75860716|FG000|Overall Study|administrative problems|5|||
42052054|NCT01018862|75860717|FG001|Overall Study|administrative problems|4|||
42052055|NCT01018862|75860718|FG002|Overall Study|administrative problems|4|||
42052056|NCT01018394|75860728|FG000|Overall Study|Withdrawal by Subject|5|||
42052057|NCT01018394|75860729|FG001|Overall Study|Withdrawal by Subject|5|||
42052058|NCT01018394|75860728|FG000|Overall Study|Lost to Follow-up|4|||
42052059|NCT01018394|75860729|FG001|Overall Study|Lost to Follow-up|3|||
42052060|NCT01017146|75860737|FG000|Overall Study|Adverse Event|11|||
42052061|NCT01017146|75860738|FG001|Overall Study|Adverse Event|1|||
42052062|NCT01017146|75860737|FG000|Overall Study|Lost to Follow-up|14|||
42052063|NCT01017146|75860738|FG001|Overall Study|Lost to Follow-up|14|||
42052064|NCT01017146|75860737|FG000|Overall Study|Noncompliance with Study Product|1|||
42052065|NCT01017146|75860738|FG001|Overall Study|Noncompliance with Study Product|1|||
42052066|NCT01017146|75860737|FG000|Overall Study|Withdrawal by Subject|32|||
42052067|NCT01017146|75860738|FG001|Overall Study|Withdrawal by Subject|16|||
42052068|NCT01017146|75860737|FG000|Overall Study|Relocation|0|||
42052069|NCT01017146|75860738|FG001|Overall Study|Relocation|4|||
42052070|NCT01017146|75860737|FG000|Overall Study|Pregnancy|2|||
42052071|NCT01017146|75860738|FG001|Overall Study|Pregnancy|1|||
42052072|NCT01017146|75860737|FG000|Overall Study|Protocol Violation|2|||
42052073|NCT01017146|75860738|FG001|Overall Study|Protocol Violation|0|||
42052074|NCT01017146|75860737|FG000|Overall Study|Took Excluded Medication|2|||
42052075|NCT01017146|75860738|FG001|Overall Study|Took Excluded Medication|0|||
42052076|NCT01017146|75860737|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
42052077|NCT01017146|75860738|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
42052078|NCT01017146|75860737|FG000|Overall Study|Change in Work Situation|1|||
42052079|NCT01017146|75860738|FG001|Overall Study|Change in Work Situation|0|||
42052080|NCT01010750|75860750|FG000|Second Intervention|Adverse Event|0|||
42052081|NCT01010750|75860751|FG001|Second Intervention|Adverse Event|1|||
42052082|NCT01010750|75860752|FG002|Second Intervention|Adverse Event|0|||
42052083|NCT01010750|75860753|FG003|Second Intervention|Adverse Event|0|||
42052084|NCT01010750|75860754|FG004|Second Intervention|Adverse Event|0|||
42052085|NCT01010750|75860755|FG005|Second Intervention|Adverse Event|0|||
42052086|NCT01012622|75860763|FG000|Overall Study|Withdrawal by Subject|6|||
42052087|NCT01012622|75860763|FG000|Overall Study|Lost to Follow-up|5|||
42052088|NCT01012622|75860763|FG000|Overall Study|Adverse Event|7|||
42052089|NCT01012622|75860763|FG000|Overall Study|non-compliance with the drug|9|||
42052090|NCT01012622|75860763|FG000|Overall Study|Other|1|||
42052091|NCT01012622|75860763|FG000|Overall Study|screening failure|1|||
42052092|NCT01012622|75860763|FG000|Overall Study|withdrawal of consent by a parent|2|||
42052093|NCT00722371|75860774|FG000|Overall Study|Adverse Event|6|||
42052094|NCT00722371|75860775|FG001|Overall Study|Adverse Event|13|||
42052095|NCT00722371|75860776|FG002|Overall Study|Adverse Event|9|||
42052096|NCT00722371|75860777|FG003|Overall Study|Adverse Event|10|||
42052097|NCT00722371|75860778|FG004|Overall Study|Adverse Event|6|||
42052098|NCT00722371|75860779|FG005|Overall Study|Adverse Event|8|||
42052099|NCT00722371|75860780|FG006|Overall Study|Adverse Event|4|||
42052100|NCT00722371|75860774|FG000|Overall Study|Contraindication|0|||
42052101|NCT00722371|75860775|FG001|Overall Study|Contraindication|0|||
42052102|NCT00722371|75860776|FG002|Overall Study|Contraindication|1|||
42052103|NCT00722371|75860777|FG003|Overall Study|Contraindication|0|||
42052104|NCT00722371|75860778|FG004|Overall Study|Contraindication|0|||
42052105|NCT00722371|75860779|FG005|Overall Study|Contraindication|0|||
42052106|NCT00722371|75860780|FG006|Overall Study|Contraindication|0|||
42052107|NCT00722371|75860774|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
42052108|NCT00722371|75860775|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
42173537|NCT00316277|75980403|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
42173538|NCT00316277|75980402|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
42173539|NCT00316277|75980403|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
42173540|NCT00316277|75980402|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
42173541|NCT00316277|75980403|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
42291563|NCT02660983|76125069|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
42291564|NCT02660983|76125068|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
42291565|NCT02660983|76125069|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
42291566|NCT02660983|76125068|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
42291567|NCT02660983|76125069|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
42052109|NCT00722371|75860776|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
42052110|NCT00722371|75860777|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
42052111|NCT00722371|75860778|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
42052112|NCT00722371|75860779|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
42052113|NCT00722371|75860780|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
42052114|NCT00722371|75860774|FG000|Overall Study|Excluded medication|0|||
42052115|NCT00722371|75860775|FG001|Overall Study|Excluded medication|1|||
42052116|NCT00722371|75860776|FG002|Overall Study|Excluded medication|1|||
42052117|NCT00722371|75860777|FG003|Overall Study|Excluded medication|0|||
42052118|NCT00722371|75860778|FG004|Overall Study|Excluded medication|0|||
42052119|NCT00722371|75860779|FG005|Overall Study|Excluded medication|0|||
42052120|NCT00722371|75860780|FG006|Overall Study|Excluded medication|1|||
42173542|NCT00368849|75980417|FG000|Overall Study|Withdrawal by Subject|0|||
42173543|NCT00368849|75980418|FG001|Overall Study|Withdrawal by Subject|1|||
42173544|NCT00368849|75980417|FG000|Overall Study|Physician Decision|0|||
42173545|NCT00368849|75980418|FG001|Overall Study|Physician Decision|1|||
42173546|NCT00316199|75980425|FG000|Overall Study|Adverse Event|2|||
42173547|NCT00316199|75980425|FG000|Overall Study|Death|8|||
42173548|NCT00316199|75980425|FG000|Overall Study|Lost to Follow-up|2|||
42173549|NCT00316121|75980431|FG000|Overall Study|Death|1|||
42173550|NCT00316121|75980432|FG001|Overall Study|Death|0|||
42173551|NCT00316121|75980431|FG000|Overall Study|Lost to Follow-up|14|||
42173552|NCT00316121|75980432|FG001|Overall Study|Lost to Follow-up|8|||
42173553|NCT00316121|75980431|FG000|Overall Study|Withdrawal by Subject|2|||
42173554|NCT00316121|75980432|FG001|Overall Study|Withdrawal by Subject|0|||
42173555|NCT00316121|75980431|FG000|Overall Study|Reason is missing|1|||
42173556|NCT00316121|75980432|FG001|Overall Study|Reason is missing|0|||
42173557|NCT00316121|75980431|FG000|Overall Study|Subject relocated|1|||
42173558|NCT00316121|75980432|FG001|Overall Study|Subject relocated|1|||
42173559|NCT00316121|75980431|FG000|Overall Study|Subject refused to return|1|||
42173560|NCT00316121|75980432|FG001|Overall Study|Subject refused to return|0|||
42173561|NCT00316121|75980431|FG000|Overall Study|Subject no show for visit x 3|1|||
42173562|NCT00316121|75980432|FG001|Overall Study|Subject no show for visit x 3|0|||
42173563|NCT00316121|75980431|FG000|Overall Study|Subject did not have 24 month visit|1|||
42173564|NCT00316121|75980432|FG001|Overall Study|Subject did not have 24 month visit|0|||
42173565|NCT00337103|75980451|FG000|Overall Study|Progressive Disease|414|||
42173566|NCT00337103|75980452|FG001|Overall Study|Progressive Disease|410|||
42173567|NCT00337103|75980451|FG000|Overall Study|Adverse Event|45|||
42173568|NCT00337103|75980452|FG001|Overall Study|Adverse Event|59|||
42173569|NCT00337103|75980451|FG000|Overall Study|Subject Choice|34|||
42173570|NCT00337103|75980452|FG001|Overall Study|Subject Choice|27|||
42173571|NCT00337103|75980451|FG000|Overall Study|Clinical Progression|27|||
42052121|NCT00722371|75860774|FG000|Overall Study|Hyperglycemia|2|||
42052122|NCT00722371|75860775|FG001|Overall Study|Hyperglycemia|6|||
42052123|NCT00722371|75860776|FG002|Overall Study|Hyperglycemia|4|||
42052124|NCT00722371|75860777|FG003|Overall Study|Hyperglycemia|2|||
42052125|NCT00722371|75860778|FG004|Overall Study|Hyperglycemia|5|||
42052126|NCT00722371|75860779|FG005|Overall Study|Hyperglycemia|1|||
42052127|NCT00722371|75860780|FG006|Overall Study|Hyperglycemia|1|||
42052128|NCT00722371|75860774|FG000|Overall Study|Hypoglycemia|1|||
42052129|NCT00722371|75860775|FG001|Overall Study|Hypoglycemia|0|||
42052130|NCT00722371|75860776|FG002|Overall Study|Hypoglycemia|0|||
42173572|NCT00337103|75980452|FG001|Overall Study|Clinical Progression|24|||
42016229|NCT01263782|75823451|FG001|Overall Study|Progressive disease|0|||
42016230|NCT01263782|75823452|FG002|Overall Study|Progressive disease|0|||
42016231|NCT01263782|75823453|FG003|Overall Study|Progressive disease|1|||
42016232|NCT01263782|75823450|FG000|Overall Study|Too early|0|||
42016233|NCT01263782|75823451|FG001|Overall Study|Too early|0|||
42016234|NCT01263782|75823452|FG002|Overall Study|Too early|1|||
42016235|NCT01263782|75823453|FG003|Overall Study|Too early|0|||
42016236|NCT01263782|75823450|FG000|Overall Study|Inevaluable|0|||
42016237|NCT01263782|75823451|FG001|Overall Study|Inevaluable|0|||
42016238|NCT01263782|75823452|FG002|Overall Study|Inevaluable|1|||
42016239|NCT01263782|75823453|FG003|Overall Study|Inevaluable|0|||
42016240|NCT01263704|75823463|FG000|Overall Study|Progressive disease|18|||
42016241|NCT01263704|75823463|FG000|Overall Study|Adverse Event|3|||
42016242|NCT01263704|75823463|FG000|Overall Study|Death|2|||
42016243|NCT01263704|75823463|FG000|Overall Study|Patient withdrew consent|2|||
42016244|NCT01263704|75823463|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
42016245|NCT01263704|75823463|FG000|Overall Study|Lost to Follow-up|1|||
42016246|NCT01263704|75823463|FG000|Overall Study|Colon metastases|1|||
42173573|NCT00337103|75980451|FG000|Overall Study|Physician Decision|15|||
42173574|NCT00337103|75980452|FG001|Overall Study|Physician Decision|14|||
42016247|NCT01263704|75823463|FG000|Overall Study|Principal Investigator (PI) decision|1|||
42016248|NCT01263470|75823473|FG000|Overall Study|Adverse Event|2|||
42016249|NCT01263470|75823474|FG001|Overall Study|Adverse Event|2|||
42016250|NCT01263470|75823475|FG002|Overall Study|Adverse Event|1|||
42016251|NCT01263470|75823476|FG003|Overall Study|Adverse Event|1|||
42016252|NCT01263470|75823477|FG004|Overall Study|Adverse Event|2|||
42052131|NCT00722371|75860777|FG003|Overall Study|Hypoglycemia|0|||
42052132|NCT00722371|75860778|FG004|Overall Study|Hypoglycemia|0|||
42052133|NCT00722371|75860779|FG005|Overall Study|Hypoglycemia|0|||
42173575|NCT00337103|75980451|FG000|Overall Study|Withdrawal by Subject|8|||
42173576|NCT00337103|75980452|FG001|Overall Study|Withdrawal by Subject|5|||
42173577|NCT00337103|75980451|FG000|Overall Study|Other|5|||
42173578|NCT00337103|75980452|FG001|Overall Study|Other|6|||
42052134|NCT00722371|75860780|FG006|Overall Study|Hypoglycemia|0|||
42052135|NCT00722371|75860774|FG000|Overall Study|Lack of Efficacy|4|||
42052136|NCT00722371|75860775|FG001|Overall Study|Lack of Efficacy|6|||
42052137|NCT00722371|75860776|FG002|Overall Study|Lack of Efficacy|6|||
42052138|NCT00722371|75860777|FG003|Overall Study|Lack of Efficacy|6|||
42052139|NCT00722371|75860778|FG004|Overall Study|Lack of Efficacy|2|||
42052140|NCT00722371|75860779|FG005|Overall Study|Lack of Efficacy|3|||
42052141|NCT00722371|75860780|FG006|Overall Study|Lack of Efficacy|0|||
42052142|NCT00722371|75860774|FG000|Overall Study|Lost to Follow-up|11|||
42052143|NCT00722371|75860775|FG001|Overall Study|Lost to Follow-up|14|||
42052144|NCT00722371|75860776|FG002|Overall Study|Lost to Follow-up|21|||
42052145|NCT00722371|75860777|FG003|Overall Study|Lost to Follow-up|13|||
42052146|NCT00722371|75860778|FG004|Overall Study|Lost to Follow-up|8|||
42052147|NCT00722371|75860779|FG005|Overall Study|Lost to Follow-up|16|||
42052148|NCT00722371|75860780|FG006|Overall Study|Lost to Follow-up|13|||
42052149|NCT00722371|75860774|FG000|Overall Study|Physician Decision|5|||
42052150|NCT00722371|75860775|FG001|Overall Study|Physician Decision|2|||
42052151|NCT00722371|75860776|FG002|Overall Study|Physician Decision|2|||
42052152|NCT00722371|75860777|FG003|Overall Study|Physician Decision|5|||
42052153|NCT00722371|75860778|FG004|Overall Study|Physician Decision|2|||
42052154|NCT00722371|75860779|FG005|Overall Study|Physician Decision|3|||
42052155|NCT00722371|75860780|FG006|Overall Study|Physician Decision|4|||
42052156|NCT00722371|75860774|FG000|Overall Study|Pregnancy|1|||
42052157|NCT00722371|75860775|FG001|Overall Study|Pregnancy|1|||
42291568|NCT02660983|76125068|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
42291569|NCT02660983|76125069|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
42291570|NCT02660983|76125068|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
42291571|NCT02660983|76125069|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
42291572|NCT01953328|76125084|FG000|Overall Study|Withdrawal by Subject|0|||
42291573|NCT01953328|76125085|FG001|Overall Study|Withdrawal by Subject|0|||
42291574|NCT01953328|76125086|FG002|Overall Study|Withdrawal by Subject|0|||
42291575|NCT01953328|76125087|FG003|Overall Study|Withdrawal by Subject|0|||
42291576|NCT01953328|76125088|FG004|Overall Study|Withdrawal by Subject|1|||
42291577|NCT01953328|76125089|FG005|Overall Study|Withdrawal by Subject|0|||
42052158|NCT00722371|75860776|FG002|Overall Study|Pregnancy|0|||
42052159|NCT00722371|75860777|FG003|Overall Study|Pregnancy|0|||
42052160|NCT00722371|75860778|FG004|Overall Study|Pregnancy|0|||
42052161|NCT00722371|75860779|FG005|Overall Study|Pregnancy|1|||
42052162|NCT00722371|75860780|FG006|Overall Study|Pregnancy|0|||
42052163|NCT00722371|75860774|FG000|Overall Study|Protocol Violation|6|||
42052164|NCT00722371|75860775|FG001|Overall Study|Protocol Violation|1|||
42052165|NCT00722371|75860776|FG002|Overall Study|Protocol Violation|0|||
42052166|NCT00722371|75860777|FG003|Overall Study|Protocol Violation|1|||
42052167|NCT00722371|75860778|FG004|Overall Study|Protocol Violation|4|||
42052168|NCT00722371|75860779|FG005|Overall Study|Protocol Violation|2|||
42052169|NCT00722371|75860780|FG006|Overall Study|Protocol Violation|1|||
42052170|NCT00722371|75860774|FG000|Overall Study|Withdrawal by Subject|18|||
42052171|NCT00722371|75860775|FG001|Overall Study|Withdrawal by Subject|27|||
42052172|NCT00722371|75860776|FG002|Overall Study|Withdrawal by Subject|19|||
42052173|NCT00722371|75860777|FG003|Overall Study|Withdrawal by Subject|23|||
42052174|NCT00722371|75860778|FG004|Overall Study|Withdrawal by Subject|19|||
42173579|NCT00337103|75980451|FG000|Overall Study|Entry Criteria Not Met|4|||
42291578|NCT01953328|76125090|FG006|Overall Study|Withdrawal by Subject|0|||
42291579|NCT01953328|76125091|FG007|Overall Study|Withdrawal by Subject|0|||
42291580|NCT01953328|76125084|FG000|Overall Study|Lost to Follow-up|0|||
42016253|NCT01263470|75823478|FG005|Overall Study|Adverse Event|2|||
42016254|NCT01263470|75823473|FG000|Overall Study|Protocol Violation|0|||
42016255|NCT01263470|75823474|FG001|Overall Study|Protocol Violation|1|||
42016256|NCT01263470|75823475|FG002|Overall Study|Protocol Violation|0|||
42016257|NCT01263470|75823476|FG003|Overall Study|Protocol Violation|0|||
42016258|NCT01263470|75823477|FG004|Overall Study|Protocol Violation|0|||
42016259|NCT01263470|75823478|FG005|Overall Study|Protocol Violation|1|||
42016260|NCT01263470|75823473|FG000|Overall Study|Withdrawal by Subject|0|||
42016261|NCT01263470|75823474|FG001|Overall Study|Withdrawal by Subject|1|||
42016262|NCT01263470|75823475|FG002|Overall Study|Withdrawal by Subject|1|||
42016263|NCT01263470|75823476|FG003|Overall Study|Withdrawal by Subject|2|||
42016264|NCT01263470|75823477|FG004|Overall Study|Withdrawal by Subject|0|||
42016265|NCT01263470|75823478|FG005|Overall Study|Withdrawal by Subject|2|||
42016266|NCT01263470|75823473|FG000|Overall Study|Lack of Efficacy|0|||
42016267|NCT01263470|75823474|FG001|Overall Study|Lack of Efficacy|0|||
42052175|NCT00722371|75860779|FG005|Overall Study|Withdrawal by Subject|18|||
42052176|NCT00722371|75860780|FG006|Overall Study|Withdrawal by Subject|26|||
42052177|NCT00722137|75860798|FG000|Overall Study|Overt Disease Progression|5|||
42052178|NCT00722137|75860799|FG001|Overall Study|Overt Disease Progression|4|||
42052179|NCT00722137|75860798|FG000|Overall Study|Adverse Event|17|||
42052180|NCT00722137|75860799|FG001|Overall Study|Adverse Event|21|||
42052181|NCT00722137|75860798|FG000|Overall Study|Death|12|||
42052182|NCT00722137|75860799|FG001|Overall Study|Death|7|||
42052183|NCT00722137|75860798|FG000|Overall Study|Withdrawal by Subject|6|||
42016268|NCT01263470|75823475|FG002|Overall Study|Lack of Efficacy|2|||
42016269|NCT01263470|75823476|FG003|Overall Study|Lack of Efficacy|0|||
42016270|NCT01263470|75823477|FG004|Overall Study|Lack of Efficacy|0|||
42016271|NCT01263470|75823478|FG005|Overall Study|Lack of Efficacy|0|||
42016272|NCT01263470|75823473|FG000|Overall Study|Participant Unavailability|0|||
42016273|NCT01263470|75823474|FG001|Overall Study|Participant Unavailability|1|||
42016274|NCT01263470|75823475|FG002|Overall Study|Participant Unavailability|0|||
42016275|NCT01263470|75823476|FG003|Overall Study|Participant Unavailability|0|||
42016276|NCT01263470|75823477|FG004|Overall Study|Participant Unavailability|0|||
42052184|NCT00722137|75860799|FG001|Overall Study|Withdrawal by Subject|9|||
42052185|NCT00722137|75860798|FG000|Overall Study|Other Reason Unknown|3|||
42052186|NCT00722137|75860799|FG001|Overall Study|Other Reason Unknown|4|||
42052187|NCT00722137|75860798|FG000|Overall Study|Randomized But Not Treated|2|||
42052188|NCT00722137|75860799|FG001|Overall Study|Randomized But Not Treated|3|||
42052189|NCT00796666|75860813|FG000|Overall Study|Death|2|||
42052190|NCT00796666|75860814|FG001|Overall Study|Death|4|||
42052191|NCT00796666|75860813|FG000|Overall Study|Withdrawal by Subject|2|||
42052192|NCT00796666|75860814|FG001|Overall Study|Withdrawal by Subject|0|||
42052193|NCT00796666|75860813|FG000|Overall Study|Adverse Event|7|||
42052194|NCT00796666|75860814|FG001|Overall Study|Adverse Event|5|||
42052195|NCT00796666|75860813|FG000|Overall Study|Protocol Violation|1|||
42052196|NCT00796666|75860814|FG001|Overall Study|Protocol Violation|0|||
42052197|NCT00796666|75860813|FG000|Overall Study|Other|1|||
42052198|NCT00796666|75860814|FG001|Overall Study|Other|0|||
42052199|NCT00796666|75860813|FG000|Overall Study|Terminated by sponsor|53|||
42052200|NCT00796666|75860814|FG001|Overall Study|Terminated by sponsor|55|||
42052201|NCT00796666|75860813|FG000|Overall Study|Randomized and not treated|1|||
42052202|NCT00796666|75860814|FG001|Overall Study|Randomized and not treated|0|||
42052203|NCT00799708|75860823|FG000|Overall Study|non-compliance|1|||
42052204|NCT00799708|75860824|FG001|Overall Study|non-compliance|0|||
42052205|NCT00799708|75860825|FG002|Overall Study|non-compliance|0|||
42052206|NCT00796510|75860837|FG000|Overall Study|Death|1|||
42052207|NCT00796510|75860838|FG001|Overall Study|Death|0|||
42052208|NCT00796510|75860837|FG000|Overall Study|Study Terminated|2|||
42052209|NCT00796510|75860838|FG001|Overall Study|Study Terminated|0|||
42052210|NCT00588640|75860844|FG000|Overall Study|Physician Decision|1|||
42052211|NCT00588640|75860844|FG000|Overall Study|Ineligible Patient|1|||
42052212|NCT01016912|75860853|FG000|End of Treatment Period|Lack of Efficacy|0|||
42052213|NCT01016912|75860854|FG001|End of Treatment Period|Lack of Efficacy|1|||
42052214|NCT01016912|75860855|FG002|End of Treatment Period|Lack of Efficacy|0|||
42052215|NCT01016912|75860856|FG003|End of Treatment Period|Lack of Efficacy|4|||
42052216|NCT01016912|75860857|FG004|End of Treatment Period|Lack of Efficacy|4|||
42052217|NCT01016912|75860853|FG000|End of Treatment Period|Adverse Event|0|||
42052218|NCT01016912|75860854|FG001|End of Treatment Period|Adverse Event|1|||
42052219|NCT01016912|75860855|FG002|End of Treatment Period|Adverse Event|1|||
42052220|NCT01016912|75860856|FG003|End of Treatment Period|Adverse Event|0|||
42052221|NCT01016912|75860857|FG004|End of Treatment Period|Adverse Event|0|||
42052222|NCT01016912|75860853|FG000|End of Treatment Period|Completed double-blind period only|0|||
42052223|NCT01016912|75860854|FG001|End of Treatment Period|Completed double-blind period only|1|||
42052224|NCT01016912|75860855|FG002|End of Treatment Period|Completed double-blind period only|0|||
42052225|NCT01016912|75860856|FG003|End of Treatment Period|Completed double-blind period only|0|||
42052226|NCT01016912|75860857|FG004|End of Treatment Period|Completed double-blind period only|0|||
42052227|NCT01016912|75860853|FG000|Follow-up Period|Other reason|0|||
42052228|NCT01016912|75860854|FG001|Follow-up Period|Other reason|0|||
42052229|NCT01016912|75860855|FG002|Follow-up Period|Other reason|1|||
42052230|NCT01016912|75860856|FG003|Follow-up Period|Other reason|1|||
42052231|NCT01016912|75860857|FG004|Follow-up Period|Other reason|0|||
42052232|NCT00802672|75860892|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
42052233|NCT00802672|75860893|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
42052234|NCT00802672|75860894|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
42052235|NCT00802672|75860892|FG000|Overall Study|Adverse Event|1|||
42052236|NCT00802672|75860893|FG001|Overall Study|Adverse Event|1|||
42052237|NCT00802672|75860894|FG002|Overall Study|Adverse Event|1|||
42052238|NCT00802672|75860892|FG000|Overall Study|Protocol Violation|2|||
42052239|NCT00802672|75860893|FG001|Overall Study|Protocol Violation|1|||
42052240|NCT00802672|75860894|FG002|Overall Study|Protocol Violation|1|||
42052241|NCT00802672|75860892|FG000|Overall Study|Lost to Follow-up|5|||
42052242|NCT00802672|75860893|FG001|Overall Study|Lost to Follow-up|5|||
42052243|NCT00802672|75860894|FG002|Overall Study|Lost to Follow-up|3|||
42016277|NCT01263470|75823478|FG005|Overall Study|Participant Unavailability|0|||
42052244|NCT00802672|75860892|FG000|Overall Study|Withdrawal by Subject|1|||
42016278|NCT01263470|75823473|FG000|Overall Study|Study Drug Non-compliance|0|||
42052245|NCT00802672|75860893|FG001|Overall Study|Withdrawal by Subject|1|||
42052246|NCT00802672|75860894|FG002|Overall Study|Withdrawal by Subject|2|||
42052247|NCT00802672|75860892|FG000|Overall Study|other|3|||
42052248|NCT00802672|75860893|FG001|Overall Study|other|1|||
42052249|NCT00802672|75860894|FG002|Overall Study|other|2|||
42052250|NCT00714415|75860904|FG000|Overall Study|Lack of Efficacy|1|||
42052251|NCT00714415|75860905|FG001|Overall Study|Lack of Efficacy|0|||
42052252|NCT00714415|75860904|FG000|Overall Study|Death|1|||
42052253|NCT00714415|75860905|FG001|Overall Study|Death|0|||
42052254|NCT00714259|75860911|FG000|Overall Study|Death|2|||
42052255|NCT00796120|75860917|FG000|Overall Study|Death|3|||
42052256|NCT00796120|75860918|FG001|Overall Study|Death|0|||
42052257|NCT00796120|75860917|FG000|Overall Study|Adverse Event|11|||
42052258|NCT00796120|75860918|FG001|Overall Study|Adverse Event|6|||
42052259|NCT00796120|75860917|FG000|Overall Study|Progressive disease|22|||
42052260|NCT00796120|75860918|FG001|Overall Study|Progressive disease|13|||
42052261|NCT00796120|75860917|FG000|Overall Study|Participant refusal|3|||
42052262|NCT00796120|75860918|FG001|Overall Study|Participant refusal|4|||
42052263|NCT00796120|75860917|FG000|Overall Study|Other|6|||
42052264|NCT00796120|75860918|FG001|Overall Study|Other|17|||
42052265|NCT00796120|75860917|FG000|Overall Study|Physician Decision|16|||
42052266|NCT00796120|75860918|FG001|Overall Study|Physician Decision|17|||
42052267|NCT00796120|75860917|FG000|Overall Study|Randomized but not treated|0|||
42052268|NCT00796120|75860918|FG001|Overall Study|Randomized but not treated|3|||
42052269|NCT00795886|75860924|FG000|Overall Study|Death|10|||
42052270|NCT00719563|75860931|FG000|Overall Study|Adverse Event|16|||
42052271|NCT00719563|75860932|FG001|Overall Study|Adverse Event|13|||
42052272|NCT00719563|75860931|FG000|Overall Study|Medical condition changed|3|||
42052273|NCT00719563|75860932|FG001|Overall Study|Medical condition changed|5|||
42052274|NCT00719563|75860931|FG000|Overall Study|Lack of Efficacy|3|||
42052275|NCT00719563|75860932|FG001|Overall Study|Lack of Efficacy|7|||
42052276|NCT00719563|75860931|FG000|Overall Study|Personal reasons|6|||
42052277|NCT00719563|75860932|FG001|Overall Study|Personal reasons|7|||
42052278|NCT00719563|75860931|FG000|Overall Study|Unknown reasons|4|||
42052279|NCT00719563|75860932|FG001|Overall Study|Unknown reasons|6|||
42052280|NCT00719563|75860931|FG000|Overall Study|Noncompliant|1|||
42052281|NCT00719563|75860932|FG001|Overall Study|Noncompliant|1|||
42052282|NCT00719563|75860931|FG000|Overall Study|Lost to Follow-up|5|||
42052283|NCT00719563|75860932|FG001|Overall Study|Lost to Follow-up|3|||
42052284|NCT00795184|75860939|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
42052285|NCT00795184|75860940|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
42052286|NCT00718861|75860951|FG000|Overall Study|Withdrawal by Subject|15|||
42052287|NCT00718861|75860952|FG001|Overall Study|Withdrawal by Subject|10|||
42052288|NCT00718861|75860951|FG000|Overall Study|Adverse Event|2|||
42052289|NCT00718861|75860952|FG001|Overall Study|Adverse Event|1|||
42052290|NCT00718861|75860951|FG000|Overall Study|Lost to Follow-up|2|||
42052291|NCT00718861|75860952|FG001|Overall Study|Lost to Follow-up|1|||
42052292|NCT00718861|75860951|FG000|Overall Study|Administrative Problems|1|||
42052293|NCT00718861|75860952|FG001|Overall Study|Administrative Problems|1|||
42052294|NCT00718861|75860951|FG000|Overall Study|Death|1|||
42052295|NCT00718861|75860952|FG001|Overall Study|Death|5|||
42052296|NCT01016600|75860962|FG000|Overall Study|Did not start treatment|1|||
42052297|NCT01016600|75860963|FG001|Overall Study|Did not start treatment|0|||
42052298|NCT01016600|75860964|FG002|Overall Study|Did not start treatment|0|||
42052299|NCT01016600|75860965|FG003|Overall Study|Did not start treatment|0|||
42052300|NCT01016132|75860976|FG000|Overall Study|Discomfort|1|||
42052301|NCT01015820|75860982|FG000|Overall Study|Suboptimal measurements|1|||
42052302|NCT01015820|75860983|FG001|Overall Study|Suboptimal measurements|0|||
42052303|NCT01010204|75861006|FG000|Overall Study|Lost to Follow-up|2|||
42052304|NCT01010204|75861007|FG001|Overall Study|Lost to Follow-up|2|||
42052305|NCT01010204|75861006|FG000|Overall Study|Adverse Event|1|||
42052306|NCT01010204|75861007|FG001|Overall Study|Adverse Event|3|||
42052307|NCT01010204|75861006|FG000|Overall Study|Withdrawal by Subject|2|||
42052308|NCT01010204|75861007|FG001|Overall Study|Withdrawal by Subject|3|||
42052309|NCT01010204|75861006|FG000|Overall Study|psychiatric hospitalization|2|||
42052310|NCT01010204|75861007|FG001|Overall Study|psychiatric hospitalization|1|||
42052311|NCT00718549|75861013|FG000|Induction Phase|Disease Progression|1|||
42052312|NCT00718549|75861014|FG001|Induction Phase|Disease Progression|0|||
42052313|NCT00718549|75861015|FG002|Induction Phase|Disease Progression|0|||
42052314|NCT00718549|75861013|FG000|Induction Phase|Eligibility Criteria Violation|2|||
42052315|NCT00718549|75861014|FG001|Induction Phase|Eligibility Criteria Violation|0|||
42052316|NCT00718549|75861015|FG002|Induction Phase|Eligibility Criteria Violation|0|||
42052317|NCT00718549|75861013|FG000|Induction Phase|Early Termination - No Additional Info|59|||
42052318|NCT00718549|75861014|FG001|Induction Phase|Early Termination - No Additional Info|0|||
42052319|NCT00718549|75861015|FG002|Induction Phase|Early Termination - No Additional Info|0|||
42052320|NCT00718549|75861013|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
42052321|NCT00718549|75861014|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
42052322|NCT00718549|75861015|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
42052323|NCT00718549|75861013|FG000|Maintenance/ Observation Phase|Death|0|||
42052324|NCT00718549|75861014|FG001|Maintenance/ Observation Phase|Death|1|||
42052325|NCT00718549|75861015|FG002|Maintenance/ Observation Phase|Death|2|||
42052326|NCT00718549|75861013|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
42052327|NCT00718549|75861014|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
42052328|NCT00718549|75861015|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
42052329|NCT00718549|75861013|FG000|Maintenance/ Observation Phase|Progression|0|||
42052330|NCT00718549|75861014|FG001|Maintenance/ Observation Phase|Progression|5|||
42052331|NCT00718549|75861015|FG002|Maintenance/ Observation Phase|Progression|14|||
42052332|NCT00718549|75861013|FG000|Maintenance/ Observation Phase|Relapse|0|||
42052333|NCT00718549|75861014|FG001|Maintenance/ Observation Phase|Relapse|3|||
42052334|NCT00718549|75861015|FG002|Maintenance/ Observation Phase|Relapse|2|||
42052335|NCT00793624|75861032|FG000|Overall Study|Adverse Event|18|||
42052336|NCT00793624|75861033|FG001|Overall Study|Adverse Event|16|||
42052337|NCT00793624|75861034|FG002|Overall Study|Adverse Event|15|||
42052338|NCT00793624|75861035|FG003|Overall Study|Adverse Event|20|||
42052339|NCT00793624|75861032|FG000|Overall Study|Lost to Follow-up|2|||
42052340|NCT00793624|75861033|FG001|Overall Study|Lost to Follow-up|2|||
42052341|NCT00793624|75861034|FG002|Overall Study|Lost to Follow-up|4|||
42052342|NCT00793624|75861035|FG003|Overall Study|Lost to Follow-up|0|||
42052343|NCT00793624|75861032|FG000|Overall Study|Withdrawal by Subject|20|||
42052344|NCT00793624|75861033|FG001|Overall Study|Withdrawal by Subject|9|||
42052345|NCT00793624|75861034|FG002|Overall Study|Withdrawal by Subject|11|||
42052346|NCT00793624|75861035|FG003|Overall Study|Withdrawal by Subject|14|||
42052347|NCT00793624|75861032|FG000|Overall Study|Lack of Efficacy|9|||
42052348|NCT00793624|75861033|FG001|Overall Study|Lack of Efficacy|2|||
42052349|NCT00793624|75861034|FG002|Overall Study|Lack of Efficacy|1|||
42052350|NCT00793624|75861035|FG003|Overall Study|Lack of Efficacy|3|||
42052351|NCT00793624|75861032|FG000|Overall Study|Non compliance with protocol|2|||
42052352|NCT00793624|75861033|FG001|Overall Study|Non compliance with protocol|3|||
42052353|NCT00793624|75861034|FG002|Overall Study|Non compliance with protocol|2|||
42052354|NCT00793624|75861035|FG003|Overall Study|Non compliance with protocol|3|||
42052355|NCT00793624|75861032|FG000|Overall Study|Other reason not described above|6|||
42052356|NCT00793624|75861033|FG001|Overall Study|Other reason not described above|4|||
42052357|NCT00793624|75861034|FG002|Overall Study|Other reason not described above|6|||
42052358|NCT00793624|75861035|FG003|Overall Study|Other reason not described above|3|||
42052359|NCT00794950|75861053|FG000|BCG Induction|Withdrawal by Subject|2|||
42052360|NCT00794950|75861053|FG000|BCG Induction|ineligible|3|||
42052361|NCT00794950|75861053|FG000|BCG Induction|noncompliant w. BCG|1|||
42052362|NCT00794950|75861053|FG000|BCG Induction|Adverse Event|1|||
42052363|NCT00794950|75861053|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
42052364|NCT00794950|75861053|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
42052365|NCT00794950|75861053|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
42052366|NCT00794950|75861053|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
42052367|NCT00793546|75861060|FG000|Overall Study|Death|3|||
42052368|NCT00793546|75861061|FG001|Overall Study|Death|0|||
42052369|NCT00793546|75861060|FG000|Overall Study|Lost to Follow-up|1|||
42052370|NCT00793546|75861061|FG001|Overall Study|Lost to Follow-up|0|||
42052371|NCT00793546|75861060|FG000|Overall Study|Withdrawal by Subject|1|||
42052372|NCT00793546|75861061|FG001|Overall Study|Withdrawal by Subject|1|||
42052373|NCT00793546|75861060|FG000|Overall Study|Study Terminated by Sponsor|8|||
42052374|NCT00793546|75861061|FG001|Overall Study|Study Terminated by Sponsor|27|||
42052375|NCT00793546|75861060|FG000|Overall Study|Other|1|||
42052376|NCT00793546|75861061|FG001|Overall Study|Other|0|||
42052377|NCT00798694|75861071|FG000|Overall Study|Lost to Follow-up|1|||
42052378|NCT00798694|75861072|FG001|Overall Study|Lost to Follow-up|1|||
42052379|NCT00798694|75861071|FG000|Overall Study|Physician Decision|1|||
42052380|NCT00798694|75861072|FG001|Overall Study|Physician Decision|0|||
42052381|NCT00718315|75861087|FG000|Overall Study|Adverse Event|1|||
42052382|NCT00718315|75861088|FG001|Overall Study|Adverse Event|2|||
42052383|NCT00718315|75861089|FG002|Overall Study|Adverse Event|3|||
42356927|NCT01424397|76202134|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
42052384|NCT00718315|75861087|FG000|Overall Study|Death|6|||
42052385|NCT00718315|75861088|FG001|Overall Study|Death|6|||
42052386|NCT00718315|75861089|FG002|Overall Study|Death|5|||
42052387|NCT00718315|75861087|FG000|Overall Study|Lost to Follow-up|2|||
42356928|NCT01424397|76202135|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
42052388|NCT00718315|75861088|FG001|Overall Study|Lost to Follow-up|3|||
42052389|NCT00718315|75861089|FG002|Overall Study|Lost to Follow-up|4|||
42052390|NCT00718315|75861087|FG000|Overall Study|Protocol Violation|5|||
42052391|NCT00718315|75861088|FG001|Overall Study|Protocol Violation|5|||
42173580|NCT00337103|75980452|FG001|Overall Study|Entry Criteria Not Met|1|||
42052392|NCT00718315|75861089|FG002|Overall Study|Protocol Violation|3|||
42052393|NCT00718315|75861087|FG000|Overall Study|Erlotinib dose decreased|4|||
42052394|NCT00718315|75861088|FG001|Overall Study|Erlotinib dose decreased|3|||
42052395|NCT00718315|75861089|FG002|Overall Study|Erlotinib dose decreased|1|||
42052396|NCT00718315|75861087|FG000|Overall Study|Use of Minocyclin|1|||
42052397|NCT00718315|75861088|FG001|Overall Study|Use of Minocyclin|1|||
42052398|NCT00718315|75861089|FG002|Overall Study|Use of Minocyclin|1|||
42052399|NCT00718315|75861087|FG000|Overall Study|Disease progression|0|||
42052400|NCT00718315|75861088|FG001|Overall Study|Disease progression|1|||
42052401|NCT00718315|75861089|FG002|Overall Study|Disease progression|1|||
42052402|NCT00718315|75861087|FG000|Overall Study|Other|0|||
42052403|NCT00718315|75861088|FG001|Overall Study|Other|0|||
42052404|NCT00718315|75861089|FG002|Overall Study|Other|1|||
42052405|NCT00718315|75861087|FG000|Overall Study|Use of ATB and Corticoids|0|||
42052406|NCT00718315|75861088|FG001|Overall Study|Use of ATB and Corticoids|1|||
42052407|NCT00718315|75861089|FG002|Overall Study|Use of ATB and Corticoids|2|||
42052408|NCT00798304|75861100|FG000|Overall Study|Adverse Event|0|||
42052409|NCT00798304|75861101|FG001|Overall Study|Adverse Event|1|||
42052410|NCT00798304|75861102|FG002|Overall Study|Adverse Event|1|||
42052411|NCT00798304|75861100|FG000|Overall Study|Discontinuation by Sponsor|14|||
42052412|NCT00798304|75861101|FG001|Overall Study|Discontinuation by Sponsor|21|||
42052413|NCT00798304|75861102|FG002|Overall Study|Discontinuation by Sponsor|9|||
42052414|NCT00718237|75861112|FG000|Overall Study|Adverse Event|1|||
42052415|NCT00718237|75861113|FG001|Overall Study|Adverse Event|3|||
42052416|NCT00718237|75861112|FG000|Overall Study|Lost to Follow-up|2|||
42052417|NCT00718237|75861113|FG001|Overall Study|Lost to Follow-up|2|||
42052418|NCT00718237|75861112|FG000|Overall Study|Physician Decision|1|||
42052419|NCT00718237|75861113|FG001|Overall Study|Physician Decision|0|||
42052420|NCT00718237|75861112|FG000|Overall Study|Withdrawal by Subject|9|||
42052421|NCT00718237|75861113|FG001|Overall Study|Withdrawal by Subject|10|||
42052422|NCT00793780|75861123|FG000|Overall Study|Withdrawal by Subject|2|||
42052423|NCT00793780|75861124|FG001|Overall Study|Withdrawal by Subject|1|||
42052424|NCT02643303|75861139|FG000|Overall Study|Progressive Disease|4|||
42052425|NCT02643303|75861140|FG001|Overall Study|Progressive Disease|4|||
42052426|NCT02643303|75861141|FG002|Overall Study|Progressive Disease|1|||
42052427|NCT02643303|75861142|FG003|Overall Study|Progressive Disease|12|||
42052428|NCT02643303|75861143|FG004|Overall Study|Progressive Disease|6|||
42052429|NCT02643303|75861144|FG005|Overall Study|Progressive Disease|4|||
42052430|NCT02643303|75861145|FG006|Overall Study|Progressive Disease|8|||
42052431|NCT02643303|75861146|FG007|Overall Study|Progressive Disease|2|||
42052432|NCT02643303|75861147|FG008|Overall Study|Progressive Disease|6|||
42052433|NCT02643303|75861139|FG000|Overall Study|Adverse Event|0|||
42052434|NCT02643303|75861140|FG001|Overall Study|Adverse Event|1|||
42052435|NCT02643303|75861141|FG002|Overall Study|Adverse Event|0|||
42052436|NCT02643303|75861142|FG003|Overall Study|Adverse Event|0|||
42052437|NCT02643303|75861143|FG004|Overall Study|Adverse Event|1|||
42052438|NCT02643303|75861144|FG005|Overall Study|Adverse Event|0|||
42052439|NCT02643303|75861145|FG006|Overall Study|Adverse Event|0|||
42052440|NCT02643303|75861146|FG007|Overall Study|Adverse Event|0|||
42052441|NCT02643303|75861147|FG008|Overall Study|Adverse Event|0|||
42052442|NCT02643303|75861139|FG000|Overall Study|Withdrawal by Subject|0|||
42052443|NCT02643303|75861140|FG001|Overall Study|Withdrawal by Subject|0|||
42052444|NCT02643303|75861141|FG002|Overall Study|Withdrawal by Subject|0|||
42052445|NCT02643303|75861142|FG003|Overall Study|Withdrawal by Subject|1|||
42052446|NCT02643303|75861143|FG004|Overall Study|Withdrawal by Subject|0|||
42052447|NCT02643303|75861144|FG005|Overall Study|Withdrawal by Subject|0|||
42052448|NCT02643303|75861145|FG006|Overall Study|Withdrawal by Subject|1|||
42052449|NCT02643303|75861146|FG007|Overall Study|Withdrawal by Subject|1|||
42052450|NCT02643303|75861147|FG008|Overall Study|Withdrawal by Subject|1|||
42052451|NCT00790036|75861169|FG000|Overall Study|Abnormal lab values|3|||
42052452|NCT00790036|75861170|FG001|Overall Study|Abnormal lab values|2|||
42052453|NCT00790036|75861169|FG000|Overall Study|Administrative problems|5|||
42052454|NCT00790036|75861170|FG001|Overall Study|Administrative problems|9|||
42052455|NCT00790036|75861169|FG000|Overall Study|Adverse Event|113|||
42052456|NCT00790036|75861170|FG001|Overall Study|Adverse Event|44|||
42052457|NCT00790036|75861169|FG000|Overall Study|Death|1|||
42052458|NCT00790036|75861170|FG001|Overall Study|Death|0|||
42052459|NCT00790036|75861169|FG000|Overall Study|Disease progression|24|||
42052460|NCT00790036|75861170|FG001|Overall Study|Disease progression|48|||
42052461|NCT00790036|75861169|FG000|Overall Study|Lost to Follow-up|1|||
42052462|NCT00790036|75861170|FG001|Overall Study|Lost to Follow-up|2|||
42052463|NCT00790036|75861169|FG000|Overall Study|Protocol Violation|10|||
42052464|NCT00790036|75861170|FG001|Overall Study|Protocol Violation|2|||
42052465|NCT00790036|75861169|FG000|Overall Study|Withdrawal by Subject|18|||
42052466|NCT00790036|75861170|FG001|Overall Study|Withdrawal by Subject|7|||
42052467|NCT00790036|75861169|FG000|Overall Study|Subject/guardian decision|20|||
42052468|NCT00790036|75861170|FG001|Overall Study|Subject/guardian decision|7|||
42052469|NCT00789958|75861177|FG000|Overall Study|Adverse Event|3|||
42052470|NCT00789958|75861177|FG000|Overall Study|Withdrawal by Subject|4|||
42052471|NCT00789958|75861177|FG000|Overall Study|Progression|3|||
42052472|NCT00789958|75861177|FG000|Overall Study|not protocol specified|1|||
42052473|NCT00789958|75861177|FG000|Overall Study|Not eligible/not analyzable|26|||
42052474|NCT00789880|75861189|FG000|Overall Study|Adverse Event|0|||
42052475|NCT00789880|75861190|FG001|Overall Study|Adverse Event|0|||
42052476|NCT00789880|75861191|FG002|Overall Study|Adverse Event|0|||
42052477|NCT00789880|75861192|FG003|Overall Study|Adverse Event|0|||
42052478|NCT00789880|75861193|FG004|Overall Study|Adverse Event|1|||
42052479|NCT00789880|75861194|FG005|Overall Study|Adverse Event|0|||
42052480|NCT00789880|75861189|FG000|Overall Study|Protocol Violation|0|||
42052481|NCT00789880|75861190|FG001|Overall Study|Protocol Violation|1|||
42052482|NCT00789880|75861191|FG002|Overall Study|Protocol Violation|0|||
42052483|NCT00789880|75861192|FG003|Overall Study|Protocol Violation|1|||
42052484|NCT00789880|75861193|FG004|Overall Study|Protocol Violation|0|||
42052485|NCT00789880|75861194|FG005|Overall Study|Protocol Violation|0|||
42052486|NCT00789880|75861189|FG000|Overall Study|Withdrawal by Subject|1|||
42052487|NCT00789880|75861190|FG001|Overall Study|Withdrawal by Subject|0|||
42052488|NCT00789880|75861191|FG002|Overall Study|Withdrawal by Subject|0|||
42052489|NCT00789880|75861192|FG003|Overall Study|Withdrawal by Subject|0|||
42052490|NCT00789880|75861193|FG004|Overall Study|Withdrawal by Subject|2|||
42052491|NCT00789880|75861194|FG005|Overall Study|Withdrawal by Subject|0|||
42052492|NCT00792298|75861208|FG000|Treatment Period 1|Adverse Event|0|||
42052493|NCT00792298|75861209|FG001|Treatment Period 1|Adverse Event|1|||
42052494|NCT00792298|75861210|FG002|Treatment Period 1|Adverse Event|0|||
42052495|NCT00792298|75861211|FG003|Treatment Period 1|Adverse Event|1|||
42052496|NCT00792298|75861212|FG004|Treatment Period 1|Adverse Event|0|||
42052497|NCT00792298|75861213|FG005|Treatment Period 1|Adverse Event|1|||
42052498|NCT00792298|75861214|FG006|Treatment Period 1|Adverse Event|1|||
42052499|NCT00792298|75861215|FG007|Treatment Period 1|Adverse Event|0|||
42052500|NCT00792298|75861208|FG000|Treatment Period 1|Lack of Efficacy|0|||
42052501|NCT00792298|75861209|FG001|Treatment Period 1|Lack of Efficacy|0|||
42052502|NCT00792298|75861210|FG002|Treatment Period 1|Lack of Efficacy|1|||
42052503|NCT00792298|75861211|FG003|Treatment Period 1|Lack of Efficacy|0|||
42052504|NCT00792298|75861212|FG004|Treatment Period 1|Lack of Efficacy|0|||
42052505|NCT00792298|75861213|FG005|Treatment Period 1|Lack of Efficacy|0|||
42052506|NCT00792298|75861214|FG006|Treatment Period 1|Lack of Efficacy|0|||
42052507|NCT00792298|75861215|FG007|Treatment Period 1|Lack of Efficacy|0|||
42052508|NCT00792298|75861208|FG000|Treatment Period 1|Withdrawal by Subject|1|||
42052509|NCT00792298|75861209|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42052510|NCT00792298|75861210|FG002|Treatment Period 1|Withdrawal by Subject|1|||
42052511|NCT00792298|75861211|FG003|Treatment Period 1|Withdrawal by Subject|2|||
42052512|NCT00792298|75861212|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42052513|NCT00792298|75861213|FG005|Treatment Period 1|Withdrawal by Subject|2|||
42052514|NCT00792298|75861214|FG006|Treatment Period 1|Withdrawal by Subject|1|||
42052515|NCT00792298|75861215|FG007|Treatment Period 1|Withdrawal by Subject|0|||
42052516|NCT00792298|75861208|FG000|Treatment Period 1|Lost to Follow-up|0|||
42052517|NCT00792298|75861209|FG001|Treatment Period 1|Lost to Follow-up|0|||
42052518|NCT00792298|75861210|FG002|Treatment Period 1|Lost to Follow-up|0|||
42052519|NCT00792298|75861211|FG003|Treatment Period 1|Lost to Follow-up|0|||
42052520|NCT00792298|75861212|FG004|Treatment Period 1|Lost to Follow-up|0|||
42052521|NCT00792298|75861213|FG005|Treatment Period 1|Lost to Follow-up|0|||
42052522|NCT00792298|75861214|FG006|Treatment Period 1|Lost to Follow-up|1|||
42052523|NCT00792298|75861215|FG007|Treatment Period 1|Lost to Follow-up|0|||
42052524|NCT00792298|75861208|FG000|Treatment Period 1|Physician Decision|0|||
42052525|NCT00792298|75861209|FG001|Treatment Period 1|Physician Decision|0|||
42052526|NCT00792298|75861210|FG002|Treatment Period 1|Physician Decision|0|||
42052527|NCT00792298|75861211|FG003|Treatment Period 1|Physician Decision|1|||
42052528|NCT00792298|75861212|FG004|Treatment Period 1|Physician Decision|0|||
42291581|NCT01953328|76125085|FG001|Overall Study|Lost to Follow-up|0|||
42052529|NCT00792298|75861213|FG005|Treatment Period 1|Physician Decision|0|||
42052530|NCT00792298|75861214|FG006|Treatment Period 1|Physician Decision|1|||
42052531|NCT00792298|75861215|FG007|Treatment Period 1|Physician Decision|0|||
42052532|NCT00792298|75861208|FG000|Treatment Period 1|Protocol Violation|0|||
42291582|NCT01953328|76125086|FG002|Overall Study|Lost to Follow-up|0|||
42291583|NCT01953328|76125087|FG003|Overall Study|Lost to Follow-up|0|||
42052533|NCT00792298|75861209|FG001|Treatment Period 1|Protocol Violation|0|||
42052534|NCT00792298|75861210|FG002|Treatment Period 1|Protocol Violation|0|||
42052535|NCT00792298|75861211|FG003|Treatment Period 1|Protocol Violation|0|||
42052536|NCT00792298|75861212|FG004|Treatment Period 1|Protocol Violation|0|||
42052537|NCT00792298|75861213|FG005|Treatment Period 1|Protocol Violation|0|||
42052538|NCT00792298|75861214|FG006|Treatment Period 1|Protocol Violation|0|||
42052539|NCT00792298|75861215|FG007|Treatment Period 1|Protocol Violation|1|||
42052540|NCT00792298|75861208|FG000|Washout|Adverse Event|0|||
42052541|NCT00792298|75861209|FG001|Washout|Adverse Event|0|||
42173581|NCT00337103|75980451|FG000|Overall Study|Lost to Follow-up|1|||
42052542|NCT00792298|75861210|FG002|Washout|Adverse Event|0|||
42052543|NCT00792298|75861211|FG003|Washout|Adverse Event|0|||
42052544|NCT00792298|75861212|FG004|Washout|Adverse Event|0|||
42291584|NCT01953328|76125088|FG004|Overall Study|Lost to Follow-up|1|||
42052545|NCT00792298|75861213|FG005|Washout|Adverse Event|1|||
42052546|NCT00792298|75861214|FG006|Washout|Adverse Event|0|||
42052547|NCT00792298|75861215|FG007|Washout|Adverse Event|0|||
42052548|NCT00792298|75861208|FG000|Washout|Withdrawal by Subject|0|||
42052549|NCT00792298|75861209|FG001|Washout|Withdrawal by Subject|0|||
42052550|NCT00792298|75861210|FG002|Washout|Withdrawal by Subject|1|||
42052551|NCT00792298|75861211|FG003|Washout|Withdrawal by Subject|0|||
42052552|NCT00792298|75861212|FG004|Washout|Withdrawal by Subject|0|||
42052553|NCT00792298|75861213|FG005|Washout|Withdrawal by Subject|1|||
42052554|NCT00792298|75861214|FG006|Washout|Withdrawal by Subject|0|||
42052555|NCT00792298|75861215|FG007|Washout|Withdrawal by Subject|0|||
42052556|NCT00792298|75861208|FG000|Treatment Period 2|Lack of Efficacy|0|||
42052557|NCT00792298|75861209|FG001|Treatment Period 2|Lack of Efficacy|0|||
42052558|NCT00792298|75861210|FG002|Treatment Period 2|Lack of Efficacy|0|||
42052559|NCT00792298|75861211|FG003|Treatment Period 2|Lack of Efficacy|0|||
42052560|NCT00792298|75861212|FG004|Treatment Period 2|Lack of Efficacy|1|||
42052561|NCT00792298|75861213|FG005|Treatment Period 2|Lack of Efficacy|0|||
42052562|NCT00792298|75861214|FG006|Treatment Period 2|Lack of Efficacy|0|||
42052563|NCT00792298|75861215|FG007|Treatment Period 2|Lack of Efficacy|0|||
42052564|NCT00792298|75861208|FG000|Treatment Period 2|Physician Decision|0|||
42052565|NCT00792298|75861209|FG001|Treatment Period 2|Physician Decision|0|||
42052566|NCT00792298|75861210|FG002|Treatment Period 2|Physician Decision|0|||
42052567|NCT00792298|75861211|FG003|Treatment Period 2|Physician Decision|0|||
42052568|NCT00792298|75861212|FG004|Treatment Period 2|Physician Decision|0|||
42052569|NCT00792298|75861213|FG005|Treatment Period 2|Physician Decision|0|||
42052570|NCT00792298|75861214|FG006|Treatment Period 2|Physician Decision|1|||
42052571|NCT00792298|75861215|FG007|Treatment Period 2|Physician Decision|0|||
42052572|NCT00792298|75861208|FG000|Treatment Period 2|Pregnancy|0|||
42052573|NCT00792298|75861209|FG001|Treatment Period 2|Pregnancy|0|||
42052574|NCT00792298|75861210|FG002|Treatment Period 2|Pregnancy|1|||
42052575|NCT00792298|75861211|FG003|Treatment Period 2|Pregnancy|0|||
42052576|NCT00792298|75861212|FG004|Treatment Period 2|Pregnancy|0|||
42052577|NCT00792298|75861213|FG005|Treatment Period 2|Pregnancy|0|||
42052578|NCT00792298|75861214|FG006|Treatment Period 2|Pregnancy|0|||
42052579|NCT00792298|75861215|FG007|Treatment Period 2|Pregnancy|0|||
42052580|NCT00792298|75861208|FG000|Treatment Period 2|Withdrawal by Subject|1|||
42052581|NCT00792298|75861209|FG001|Treatment Period 2|Withdrawal by Subject|1|||
42052582|NCT00792298|75861210|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42052583|NCT00792298|75861211|FG003|Treatment Period 2|Withdrawal by Subject|2|||
42052584|NCT00792298|75861212|FG004|Treatment Period 2|Withdrawal by Subject|1|||
42052585|NCT00792298|75861213|FG005|Treatment Period 2|Withdrawal by Subject|0|||
42052586|NCT00792298|75861214|FG006|Treatment Period 2|Withdrawal by Subject|0|||
42052587|NCT00792298|75861215|FG007|Treatment Period 2|Withdrawal by Subject|2|||
42052588|NCT00718159|75861239|FG000|Overall Study|Progressive Disease|3|||
42052589|NCT00718159|75861240|FG001|Overall Study|Progressive Disease|3|||
42052590|NCT00718159|75861241|FG002|Overall Study|Progressive Disease|2|||
42052591|NCT00718159|75861242|FG003|Overall Study|Progressive Disease|0|||
42052592|NCT00718159|75861243|FG004|Overall Study|Progressive Disease|6|||
42052593|NCT00718159|75861244|FG005|Overall Study|Progressive Disease|0|||
42052594|NCT00718159|75861245|FG006|Overall Study|Progressive Disease|0|||
42052595|NCT00718159|75861239|FG000|Overall Study|Death due to Adverse Event|0|||
42052596|NCT00718159|75861240|FG001|Overall Study|Death due to Adverse Event|0|||
42052597|NCT00718159|75861241|FG002|Overall Study|Death due to Adverse Event|0|||
42052598|NCT00718159|75861242|FG003|Overall Study|Death due to Adverse Event|2|||
42052599|NCT00718159|75861243|FG004|Overall Study|Death due to Adverse Event|2|||
42052600|NCT00718159|75861244|FG005|Overall Study|Death due to Adverse Event|0|||
42052601|NCT00718159|75861245|FG006|Overall Study|Death due to Adverse Event|0|||
42052602|NCT00718159|75861239|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
42052603|NCT00718159|75861240|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
42016279|NCT01263470|75823474|FG001|Overall Study|Study Drug Non-compliance|0|||
42016280|NCT01263470|75823475|FG002|Overall Study|Study Drug Non-compliance|0|||
42016281|NCT01263470|75823476|FG003|Overall Study|Study Drug Non-compliance|0|||
42016282|NCT01263470|75823477|FG004|Overall Study|Study Drug Non-compliance|1|||
42016283|NCT01263470|75823478|FG005|Overall Study|Study Drug Non-compliance|0|||
42016284|NCT01262456|75823495|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
42016285|NCT01262456|75823496|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
42052604|NCT00718159|75861241|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
42052605|NCT00718159|75861242|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
42052606|NCT00718159|75861243|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
42052607|NCT00718159|75861244|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
42052608|NCT00718159|75861245|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
42052609|NCT00718159|75861239|FG000|Overall Study|Investigator Decision|0|||
42052610|NCT00718159|75861240|FG001|Overall Study|Investigator Decision|0|||
42052611|NCT00718159|75861241|FG002|Overall Study|Investigator Decision|0|||
42052612|NCT00718159|75861242|FG003|Overall Study|Investigator Decision|0|||
42016286|NCT01262456|75823497|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
42052613|NCT00718159|75861243|FG004|Overall Study|Investigator Decision|0|||
42052614|NCT00718159|75861244|FG005|Overall Study|Investigator Decision|1|||
42052615|NCT00718159|75861245|FG006|Overall Study|Investigator Decision|1|||
42052616|NCT00718081|75861264|FG000|Overall Study|Adverse Event|0|||
42052617|NCT00718081|75861265|FG001|Overall Study|Adverse Event|1|||
42052618|NCT00718081|75861266|FG002|Overall Study|Adverse Event|0|||
42052619|NCT00718081|75861264|FG000|Overall Study|Lack of Efficacy|7|||
42052620|NCT00718081|75861265|FG001|Overall Study|Lack of Efficacy|3|||
42052621|NCT00718081|75861266|FG002|Overall Study|Lack of Efficacy|21|||
42052622|NCT00788710|75861277|FG000|Overall Study|Adverse Event|1|||
42052623|NCT00788710|75861278|FG001|Overall Study|Adverse Event|3|||
42052624|NCT00788710|75861279|FG002|Overall Study|Adverse Event|4|||
42052625|NCT00788710|75861277|FG000|Overall Study|Lack of Efficacy|0|||
42052626|NCT00788710|75861278|FG001|Overall Study|Lack of Efficacy|0|||
42052627|NCT00788710|75861279|FG002|Overall Study|Lack of Efficacy|1|||
42052628|NCT00788710|75861277|FG000|Overall Study|Lost to Follow-up|0|||
42052629|NCT00788710|75861278|FG001|Overall Study|Lost to Follow-up|1|||
42052630|NCT00788710|75861279|FG002|Overall Study|Lost to Follow-up|0|||
42052631|NCT00788710|75861277|FG000|Overall Study|Physician Decision|2|||
42052632|NCT00788710|75861278|FG001|Overall Study|Physician Decision|1|||
42052633|NCT00788710|75861279|FG002|Overall Study|Physician Decision|0|||
42052634|NCT00788710|75861277|FG000|Overall Study|Protocol Violation|0|||
42052635|NCT00788710|75861278|FG001|Overall Study|Protocol Violation|1|||
42052636|NCT00788710|75861279|FG002|Overall Study|Protocol Violation|1|||
42052637|NCT00788710|75861277|FG000|Overall Study|Withdrawal by Subject|2|||
42052638|NCT00788710|75861278|FG001|Overall Study|Withdrawal by Subject|2|||
42052639|NCT00788710|75861279|FG002|Overall Study|Withdrawal by Subject|0|||
42052640|NCT00787930|75861287|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
42052641|NCT00588094|75861297|FG000|Overall Study|Adverse Event|3|||
42052642|NCT00588094|75861297|FG000|Overall Study|Progression of Disease|2|||
42052643|NCT00784654|75861301|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
42052644|NCT00784654|75861302|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
42291585|NCT01953328|76125089|FG005|Overall Study|Lost to Follow-up|0|||
42291586|NCT01953328|76125090|FG006|Overall Study|Lost to Follow-up|0|||
42052645|NCT00784654|75861303|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
42052646|NCT00784654|75861301|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
42052647|NCT00784654|75861302|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
42052648|NCT00784654|75861303|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
42052649|NCT00784654|75861301|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
42052650|NCT00784654|75861302|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
42052651|NCT00784654|75861303|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
42052652|NCT00784654|75861301|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
42052653|NCT00784654|75861302|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
42052654|NCT00784654|75861303|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
42052655|NCT00784654|75861301|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
42052656|NCT00784654|75861302|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
42052657|NCT00784654|75861303|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
42052658|NCT00784654|75861301|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
42052659|NCT00784654|75861302|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
42052660|NCT00784654|75861303|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
42052661|NCT00784654|75861301|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
42173582|NCT00337103|75980452|FG001|Overall Study|Lost to Follow-up|2|||
42173583|NCT00337103|75980451|FG000|Overall Study|Death|1|||
42173584|NCT00337103|75980452|FG001|Overall Study|Death|0|||
42173585|NCT00415532|75980461|FG000|Treatment Period|Adverse Event|2|||
42173586|NCT00415532|75980462|FG001|Treatment Period|Adverse Event|3|||
42173587|NCT00415532|75980461|FG000|Treatment Period|Death|2|||
42173588|NCT00415532|75980462|FG001|Treatment Period|Death|1|||
42173589|NCT00415532|75980461|FG000|Treatment Period|Lost to Follow-up|1|||
42173590|NCT00415532|75980462|FG001|Treatment Period|Lost to Follow-up|1|||
42173591|NCT00415532|75980461|FG000|Treatment Period|Protocol Violation|1|||
42173592|NCT00415532|75980462|FG001|Treatment Period|Protocol Violation|0|||
42173593|NCT00415532|75980461|FG000|Treatment Period|Withdrawal by Subject|6|||
42173594|NCT00415532|75980462|FG001|Treatment Period|Withdrawal by Subject|6|||
42173595|NCT00415532|75980461|FG000|Treatment Period|Other|2|||
42173596|NCT00415532|75980462|FG001|Treatment Period|Other|2|||
42173597|NCT00415532|75980461|FG000|Treatment Period|Ineligibility determined|1|||
42173598|NCT00415532|75980462|FG001|Treatment Period|Ineligibility determined|1|||
42173599|NCT00415532|75980461|FG000|Treatment Period|Noncompliance|1|||
42173600|NCT00415532|75980462|FG001|Treatment Period|Noncompliance|1|||
42173601|NCT00415532|75980461|FG000|Treatment Period|Requirement for alternative therapy|1|||
42173602|NCT00415532|75980462|FG001|Treatment Period|Requirement for alternative therapy|0|||
42173603|NCT00415532|75980461|FG000|Safety Follow Up Period|Adverse Event|1|||
42173604|NCT00415532|75980462|FG001|Safety Follow Up Period|Adverse Event|3|||
42052662|NCT00784654|75861302|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
42052663|NCT00784654|75861303|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
42052664|NCT00784654|75861301|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
42052665|NCT00784654|75861302|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
42052666|NCT00784654|75861303|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
42052667|NCT00784654|75861301|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
42052668|NCT00784654|75861302|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
42052669|NCT00784654|75861303|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
42052670|NCT00784654|75861301|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
42052671|NCT00784654|75861302|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
42052672|NCT00784654|75861303|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
42052673|NCT00784654|75861301|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
42052674|NCT00784654|75861302|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
42052675|NCT00784654|75861303|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
42052676|NCT00784654|75861301|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
42052677|NCT00784654|75861302|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
42052678|NCT00784654|75861303|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
42052679|NCT00784654|75861301|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
42052680|NCT00784654|75861302|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
42052681|NCT00784654|75861303|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
42052682|NCT00784654|75861301|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42052683|NCT00784654|75861302|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
42052684|NCT00784654|75861303|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
42052685|NCT00784654|75861301|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
42052686|NCT00784654|75861302|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
42291587|NCT01953328|76125091|FG007|Overall Study|Lost to Follow-up|0|||
42291588|NCT02640755|76125111|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
42291589|NCT02640755|76125112|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
42291590|NCT02640755|76125111|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
42291591|NCT02640755|76125112|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
42291592|NCT02640755|76125111|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
42291593|NCT02640755|76125112|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
42291594|NCT02640677|76125119|FG000|Overall Study|Lost to Follow-up|1|||
42291595|NCT02640677|76125119|FG000|Overall Study|Withdrawal by Subject|1|||
42291596|NCT02643251|76125125|FG000|Overall Study|Adverse Event|3|||
42291597|NCT02643251|76125126|FG001|Overall Study|Adverse Event|1|||
42291598|NCT02643251|76125125|FG000|Overall Study|Withdrawal by Subject|2|||
42291599|NCT02643251|76125126|FG001|Overall Study|Withdrawal by Subject|0|||
42291600|NCT02643251|76125125|FG000|Overall Study|Lost to Follow-up|4|||
42356929|NCT01424397|76202136|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
42356930|NCT01392963|76202152|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
42052687|NCT00784654|75861303|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
42052688|NCT00784654|75861301|FG000|Randomized Withdrawal Period|Adverse Event|0|||
42052689|NCT00784654|75861302|FG001|Randomized Withdrawal Period|Adverse Event|1|||
42052690|NCT00784654|75861303|FG002|Randomized Withdrawal Period|Adverse Event|1|||
42052691|NCT00784654|75861301|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
42052692|NCT00784654|75861302|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
42052693|NCT00784654|75861303|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
42052694|NCT00784654|75861301|FG000|Randomized Withdrawal Period|Family reasons|0|||
42052695|NCT00784654|75861302|FG001|Randomized Withdrawal Period|Family reasons|0|||
42052696|NCT00784654|75861303|FG002|Randomized Withdrawal Period|Family reasons|1|||
42052697|NCT00787150|75861317|FG000|Overall Study|Adverse Event|4|||
42052698|NCT00787150|75861318|FG001|Overall Study|Adverse Event|4|||
42052699|NCT00787150|75861319|FG002|Overall Study|Adverse Event|4|||
42052700|NCT00787150|75861317|FG000|Overall Study|Physician Decision|1|||
42052701|NCT00787150|75861318|FG001|Overall Study|Physician Decision|2|||
42052702|NCT00787150|75861319|FG002|Overall Study|Physician Decision|1|||
42052703|NCT00787150|75861317|FG000|Overall Study|Withdrawal by Subject|2|||
42052704|NCT00787150|75861318|FG001|Overall Study|Withdrawal by Subject|1|||
42052705|NCT00787150|75861319|FG002|Overall Study|Withdrawal by Subject|0|||
42052706|NCT00787150|75861317|FG000|Overall Study|Dosing incorrect study durg|2|||
42052707|NCT00787150|75861318|FG001|Overall Study|Dosing incorrect study durg|0|||
42052708|NCT00787150|75861319|FG002|Overall Study|Dosing incorrect study durg|0|||
42052709|NCT00786838|75861329|FG000|Overall Study|Physician Decision|4|||
42052710|NCT00786838|75861329|FG000|Overall Study|Death|4|||
42291601|NCT02643251|76125126|FG001|Overall Study|Lost to Follow-up|1|||
42356931|NCT01392963|76202153|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
42052711|NCT00786838|75861329|FG000|Overall Study|Adverse Event|6|||
42052712|NCT00786838|75861329|FG000|Overall Study|Progressive disease|31|||
42052713|NCT00786838|75861329|FG000|Overall Study|Withdrawal by Subject|4|||
42052714|NCT00785980|75861338|FG000|7 Day Washout Period|Protocol Violation|3|||
42052715|NCT00791518|75861345|FG000|Overall Study|Protocol Violation|93|||
42052716|NCT00785512|75861366|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
42052717|NCT00785512|75861367|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
42052718|NCT00785512|75861366|FG000|Overall Study|Adverse Event|0|||
42052719|NCT00785512|75861367|FG001|Overall Study|Adverse Event|0|||
42052720|NCT00785512|75861366|FG000|Overall Study|Lack of Efficacy|0|||
42052721|NCT00785512|75861367|FG001|Overall Study|Lack of Efficacy|2|||
42052722|NCT00785512|75861366|FG000|Overall Study|Withdrawal by Subject|0|||
42052723|NCT00785512|75861367|FG001|Overall Study|Withdrawal by Subject|1|||
42052724|NCT00785512|75861366|FG000|Overall Study|Lost to Follow-up|3|||
42052725|NCT00785512|75861367|FG001|Overall Study|Lost to Follow-up|0|||
42052726|NCT00785512|75861366|FG000|Overall Study|Precedure Refused|0|||
42052727|NCT00785512|75861367|FG001|Overall Study|Precedure Refused|0|||
42052728|NCT00785512|75861366|FG000|Overall Study|IVRS Programing Error|0|||
42052729|NCT00785512|75861367|FG001|Overall Study|IVRS Programing Error|0|||
42052730|NCT00785512|75861366|FG000|Overall Study|Physician Decision|0|||
42052731|NCT00785512|75861367|FG001|Overall Study|Physician Decision|0|||
42052732|NCT00785512|75861366|FG000|Overall Study|Lack of compliance|0|||
42052733|NCT00785512|75861367|FG001|Overall Study|Lack of compliance|1|||
42052734|NCT00785356|75861377|FG000|Overall Study|Study prematurely terminated|8|||
42052735|NCT00785044|75861385|FG000|Overall Study|Dosed at non-participating sites|152|||
42052736|NCT00785044|75861385|FG000|Overall Study|Death|77|||
42052737|NCT00785044|75861385|FG000|Overall Study|Lost to Follow-up|266|||
42052738|NCT00785044|75861385|FG000|Overall Study|Withdrawal by Subject|1|||
42052739|NCT00784810|75861392|FG000|Overall Study|Adverse Event|32|||
42052740|NCT00784810|75861393|FG001|Overall Study|Adverse Event|20|||
42052741|NCT00784810|75861392|FG000|Overall Study|Lack of Efficacy|14|||
42052742|NCT00784810|75861393|FG001|Overall Study|Lack of Efficacy|11|||
42052743|NCT00784810|75861392|FG000|Overall Study|Withdrawal by Subject|11|||
42052744|NCT00784810|75861393|FG001|Overall Study|Withdrawal by Subject|9|||
42052745|NCT00784810|75861392|FG000|Overall Study|Administrative|5|||
42052746|NCT00784810|75861393|FG001|Overall Study|Administrative|8|||
42052747|NCT00784810|75861392|FG000|Overall Study|Lost to Follow-up|1|||
42052748|NCT00784810|75861393|FG001|Overall Study|Lost to Follow-up|1|||
42052749|NCT00791128|75861399|FG000|Overall Study|Adverse Event|4|||
42052750|NCT00791128|75861399|FG000|Overall Study|Device migration|2|||
42052751|NCT00791128|75861399|FG000|Overall Study|non-compliance by subject|2|||
42052752|NCT00791128|75861399|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
42052753|NCT00776230|75861419|FG000|Overall Study|Lost to Follow-up|2|||
42052754|NCT00776230|75861420|FG001|Overall Study|Lost to Follow-up|1|||
42052755|NCT00776230|75861421|FG002|Overall Study|Lost to Follow-up|5|||
42052756|NCT00776230|75861419|FG000|Overall Study|Not vaccinated at Day 0|1|||
42052757|NCT00776230|75861420|FG001|Overall Study|Not vaccinated at Day 0|0|||
42052758|NCT00776230|75861421|FG002|Overall Study|Not vaccinated at Day 0|0|||
42052759|NCT00776230|75861419|FG000|Overall Study|Withdrawal by Subject|0|||
42173605|NCT00415532|75980461|FG000|Safety Follow Up Period|Death|3|||
42173606|NCT00415532|75980462|FG001|Safety Follow Up Period|Death|0|||
42173607|NCT00415532|75980461|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
42173608|NCT00415532|75980462|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
42173609|NCT00415532|75980461|FG000|Safety Follow Up Period|Other|1|||
42291602|NCT02643251|76125125|FG000|Overall Study|Protocol Violation|1|||
42291603|NCT02643251|76125126|FG001|Overall Study|Protocol Violation|0|||
42291604|NCT02643251|76125125|FG000|Overall Study|PI Decision to terminate patient|1|||
42291605|NCT02643251|76125126|FG001|Overall Study|PI Decision to terminate patient|0|||
42291606|NCT01970878|76125136|FG000|Overall Study|Withdrawal by Subject|11|||
42291607|NCT01970878|76125137|FG001|Overall Study|Withdrawal by Subject|10|||
42291608|NCT01970878|76125138|FG002|Overall Study|Withdrawal by Subject|14|||
42291609|NCT01970878|76125139|FG003|Overall Study|Withdrawal by Subject|7|||
42291610|NCT01970878|76125136|FG000|Overall Study|Lost to Follow-up|1|||
42173610|NCT00415532|75980462|FG001|Safety Follow Up Period|Other|4|||
42173611|NCT00415532|75980461|FG000|Safety Follow Up Period|Ineligibility determined|1|||
42173612|NCT00415532|75980462|FG001|Safety Follow Up Period|Ineligibility determined|1|||
42052760|NCT00776230|75861420|FG001|Overall Study|Withdrawal by Subject|1|||
42052761|NCT00776230|75861421|FG002|Overall Study|Withdrawal by Subject|0|||
42173613|NCT00415532|75980461|FG000|Safety Follow Up Period|Noncompliance|1|||
42052762|NCT00776230|75861419|FG000|Overall Study|Subject missed Visit 4|0|||
42052763|NCT00776230|75861420|FG001|Overall Study|Subject missed Visit 4|1|||
42052764|NCT00776230|75861421|FG002|Overall Study|Subject missed Visit 4|0|||
42173614|NCT00415532|75980462|FG001|Safety Follow Up Period|Noncompliance|0|||
42291611|NCT01970878|76125137|FG001|Overall Study|Lost to Follow-up|3|||
42052765|NCT00775606|75861431|FG000|Overall Study|Study sponsor terminated funding|3|||
42052766|NCT00775606|75861432|FG001|Overall Study|Study sponsor terminated funding|0|||
42052767|NCT02960763|75861451|FG000|Step 1|Withdrawal by Subject|10|||
42052768|NCT02960763|75861452|FG001|Step 1|Withdrawal by Subject|8|||
42052769|NCT02960763|75861453|FG002|Step 1|Withdrawal by Subject|13|||
42052770|NCT02960763|75861454|FG003|Step 1|Withdrawal by Subject|0|||
42052771|NCT02960763|75861455|FG004|Step 1|Withdrawal by Subject|0|||
42052772|NCT02960763|75861451|FG000|Step 1|Lost to Follow-up|7|||
42052773|NCT02960763|75861452|FG001|Step 1|Lost to Follow-up|9|||
42052774|NCT02960763|75861453|FG002|Step 1|Lost to Follow-up|12|||
42052775|NCT02960763|75861454|FG003|Step 1|Lost to Follow-up|0|||
42052776|NCT02960763|75861455|FG004|Step 1|Lost to Follow-up|0|||
42052777|NCT02960763|75861451|FG000|Step 1|Death|1|||
42052778|NCT02960763|75861452|FG001|Step 1|Death|1|||
42052779|NCT02960763|75861453|FG002|Step 1|Death|1|||
42052780|NCT02960763|75861454|FG003|Step 1|Death|0|||
42052781|NCT02960763|75861455|FG004|Step 1|Death|0|||
42052782|NCT02960763|75861451|FG000|Step 1|Investigator discretion|1|||
42052783|NCT02960763|75861452|FG001|Step 1|Investigator discretion|0|||
42052784|NCT02960763|75861453|FG002|Step 1|Investigator discretion|1|||
42052785|NCT02960763|75861454|FG003|Step 1|Investigator discretion|0|||
42052786|NCT02960763|75861455|FG004|Step 1|Investigator discretion|0|||
42052787|NCT02960763|75861451|FG000|Step 1|Other|0|||
42052788|NCT02960763|75861452|FG001|Step 1|Other|0|||
42052789|NCT02960763|75861453|FG002|Step 1|Other|1|||
42052790|NCT02960763|75861454|FG003|Step 1|Other|0|||
42052791|NCT02960763|75861455|FG004|Step 1|Other|0|||
42052792|NCT02960763|75861451|FG000|Step 2|Withdrawal by Subject|0|||
42052793|NCT02960763|75861452|FG001|Step 2|Withdrawal by Subject|0|||
42052794|NCT02960763|75861453|FG002|Step 2|Withdrawal by Subject|0|||
42052795|NCT02960763|75861454|FG003|Step 2|Withdrawal by Subject|7|||
42052796|NCT02960763|75861455|FG004|Step 2|Withdrawal by Subject|3|||
42052797|NCT02960763|75861451|FG000|Step 2|Lost to Follow-up|0|||
42052798|NCT02960763|75861452|FG001|Step 2|Lost to Follow-up|0|||
42052799|NCT02960763|75861453|FG002|Step 2|Lost to Follow-up|0|||
42052800|NCT02960763|75861454|FG003|Step 2|Lost to Follow-up|4|||
42052801|NCT02960763|75861455|FG004|Step 2|Lost to Follow-up|1|||
42052802|NCT02960763|75861451|FG000|Step 2|Investigator discretion|0|||
42052803|NCT02960763|75861452|FG001|Step 2|Investigator discretion|0|||
42052804|NCT02960763|75861453|FG002|Step 2|Investigator discretion|0|||
42052805|NCT02960763|75861454|FG003|Step 2|Investigator discretion|0|||
42052806|NCT02960763|75861455|FG004|Step 2|Investigator discretion|1|||
42052807|NCT00775528|75861467|FG000|Overall Study|Protocol Violation|1|||
42052808|NCT00775450|75861476|FG000|Overall Study|Serious Adverse Event|2|||
42052809|NCT00775450|75861477|FG001|Overall Study|Serious Adverse Event|0|||
42052810|NCT00775450|75861478|FG002|Overall Study|Serious Adverse Event|0|||
42052811|NCT00775450|75861479|FG003|Overall Study|Serious Adverse Event|0|||
42052812|NCT00775450|75861480|FG004|Overall Study|Serious Adverse Event|0|||
42052813|NCT00775450|75861476|FG000|Overall Study|Protocol Violation|0|||
42052814|NCT00775450|75861477|FG001|Overall Study|Protocol Violation|0|||
42052815|NCT00775450|75861478|FG002|Overall Study|Protocol Violation|0|||
42052816|NCT00775450|75861479|FG003|Overall Study|Protocol Violation|0|||
42052817|NCT00775450|75861480|FG004|Overall Study|Protocol Violation|1|||
42052818|NCT00775450|75861476|FG000|Overall Study|Withdrawal by Subject|1|||
42052819|NCT00775450|75861477|FG001|Overall Study|Withdrawal by Subject|0|||
42052820|NCT00775450|75861478|FG002|Overall Study|Withdrawal by Subject|0|||
42052821|NCT00775450|75861479|FG003|Overall Study|Withdrawal by Subject|0|||
42052822|NCT00775450|75861480|FG004|Overall Study|Withdrawal by Subject|1|||
42052823|NCT00775138|75861496|FG000|Overall Study|Withdrawal by Subject|0|||
42052824|NCT00775138|75861497|FG001|Overall Study|Withdrawal by Subject|0|||
42052825|NCT00775138|75861498|FG002|Overall Study|Withdrawal by Subject|2|||
42052826|NCT00775138|75861499|FG003|Overall Study|Withdrawal by Subject|2|||
42052827|NCT00775138|75861496|FG000|Overall Study|Adverse Event|0|||
42052828|NCT00775138|75861497|FG001|Overall Study|Adverse Event|0|||
42052829|NCT00775138|75861498|FG002|Overall Study|Adverse Event|1|||
42052830|NCT00775138|75861499|FG003|Overall Study|Adverse Event|0|||
42052831|NCT04605991|75861511|FG000|Overall Study|Adverse Event|5|||
42052832|NCT04605991|75861511|FG000|Overall Study|Lack of Efficacy|1|||
42291612|NCT01970878|76125138|FG002|Overall Study|Lost to Follow-up|2|||
42291613|NCT01970878|76125139|FG003|Overall Study|Lost to Follow-up|4|||
42291614|NCT01970878|76125136|FG000|Overall Study|Administrative Reasons|1|||
42291615|NCT01970878|76125137|FG001|Overall Study|Administrative Reasons|0|||
42052833|NCT04605991|75861511|FG000|Overall Study|Lost to Follow-up|8|||
42052834|NCT04605991|75861511|FG000|Overall Study|Physician Decision|4|||
42052835|NCT04605991|75861511|FG000|Overall Study|Withdrawal by Subject|14|||
42052836|NCT04605991|75861511|FG000|Overall Study|Non-compliance with study|1|||
42052837|NCT00783796|75861515|FG000|Overall Study|Did not receive any stent|4|||
42052838|NCT00783796|75861515|FG000|Overall Study|Received non-XIENCE V stent|1|||
42052839|NCT00783796|75861515|FG000|Overall Study|Received commercial XIENCE V stent|1|||
42052840|NCT00783718|75861524|FG000|Induction Phase|Adverse Event|4|||
42052841|NCT00783718|75861525|FG001|Induction Phase|Adverse Event|0|||
42052842|NCT00783718|75861526|FG002|Induction Phase|Adverse Event|7|||
42291616|NCT01970878|76125138|FG002|Overall Study|Administrative Reasons|0|||
42052843|NCT00783718|75861527|FG003|Induction Phase|Adverse Event|0|||
42052844|NCT00783718|75861528|FG004|Induction Phase|Adverse Event|0|||
42052845|NCT00783718|75861529|FG005|Induction Phase|Adverse Event|0|||
42052846|NCT00783718|75861530|FG006|Induction Phase|Adverse Event|0|||
42052847|NCT00783718|75861524|FG000|Induction Phase|Protocol Violation|1|||
42052848|NCT00783718|75861525|FG001|Induction Phase|Protocol Violation|1|||
42052849|NCT00783718|75861526|FG002|Induction Phase|Protocol Violation|6|||
42052850|NCT00783718|75861527|FG003|Induction Phase|Protocol Violation|0|||
42052851|NCT00783718|75861528|FG004|Induction Phase|Protocol Violation|0|||
42052852|NCT00783718|75861529|FG005|Induction Phase|Protocol Violation|0|||
42052853|NCT00783718|75861530|FG006|Induction Phase|Protocol Violation|0|||
42052854|NCT00783718|75861524|FG000|Induction Phase|Lack of Efficacy|5|||
42052855|NCT00783718|75861525|FG001|Induction Phase|Lack of Efficacy|2|||
42052856|NCT00783718|75861526|FG002|Induction Phase|Lack of Efficacy|14|||
42052857|NCT00783718|75861527|FG003|Induction Phase|Lack of Efficacy|0|||
42052858|NCT00783718|75861528|FG004|Induction Phase|Lack of Efficacy|0|||
42052859|NCT00783718|75861529|FG005|Induction Phase|Lack of Efficacy|0|||
42052860|NCT00783718|75861530|FG006|Induction Phase|Lack of Efficacy|0|||
42052861|NCT00783718|75861524|FG000|Induction Phase|Withdrawal by Subject|3|||
42052862|NCT00783718|75861525|FG001|Induction Phase|Withdrawal by Subject|4|||
42052863|NCT00783718|75861526|FG002|Induction Phase|Withdrawal by Subject|8|||
42052864|NCT00783718|75861527|FG003|Induction Phase|Withdrawal by Subject|0|||
42052865|NCT00783718|75861528|FG004|Induction Phase|Withdrawal by Subject|0|||
42052866|NCT00783718|75861529|FG005|Induction Phase|Withdrawal by Subject|0|||
42052867|NCT00783718|75861530|FG006|Induction Phase|Withdrawal by Subject|0|||
42052868|NCT00783718|75861524|FG000|Induction Phase|Lost to Follow-up|1|||
42052869|NCT00783718|75861525|FG001|Induction Phase|Lost to Follow-up|0|||
42052870|NCT00783718|75861526|FG002|Induction Phase|Lost to Follow-up|1|||
42052871|NCT00783718|75861527|FG003|Induction Phase|Lost to Follow-up|0|||
42052872|NCT00783718|75861528|FG004|Induction Phase|Lost to Follow-up|0|||
42052873|NCT00783718|75861529|FG005|Induction Phase|Lost to Follow-up|0|||
42052874|NCT00783718|75861530|FG006|Induction Phase|Lost to Follow-up|0|||
42052875|NCT00783718|75861524|FG000|Maintenance Phase|Adverse Event|12|||
42052876|NCT00783718|75861525|FG001|Maintenance Phase|Adverse Event|0|||
42052877|NCT00783718|75861526|FG002|Maintenance Phase|Adverse Event|0|||
42052878|NCT00783718|75861527|FG003|Maintenance Phase|Adverse Event|15|||
42052879|NCT00783718|75861528|FG004|Maintenance Phase|Adverse Event|7|||
42052880|NCT00783718|75861529|FG005|Maintenance Phase|Adverse Event|6|||
42052881|NCT00783718|75861530|FG006|Maintenance Phase|Adverse Event|16|||
42052882|NCT00783718|75861524|FG000|Maintenance Phase|Protocol Violation|1|||
42052883|NCT00783718|75861525|FG001|Maintenance Phase|Protocol Violation|0|||
42052884|NCT00783718|75861526|FG002|Maintenance Phase|Protocol Violation|0|||
42052885|NCT00783718|75861527|FG003|Maintenance Phase|Protocol Violation|0|||
42052886|NCT00783718|75861528|FG004|Maintenance Phase|Protocol Violation|0|||
42052887|NCT00783718|75861529|FG005|Maintenance Phase|Protocol Violation|0|||
42052888|NCT00783718|75861530|FG006|Maintenance Phase|Protocol Violation|2|||
42052889|NCT00783718|75861524|FG000|Maintenance Phase|Lack of Efficacy|83|||
42052890|NCT00783718|75861525|FG001|Maintenance Phase|Lack of Efficacy|0|||
42052891|NCT00783718|75861526|FG002|Maintenance Phase|Lack of Efficacy|0|||
42052892|NCT00783718|75861527|FG003|Maintenance Phase|Lack of Efficacy|61|||
42052893|NCT00783718|75861528|FG004|Maintenance Phase|Lack of Efficacy|31|||
42052894|NCT00783718|75861529|FG005|Maintenance Phase|Lack of Efficacy|33|||
42052895|NCT00783718|75861530|FG006|Maintenance Phase|Lack of Efficacy|155|||
42052896|NCT00783718|75861524|FG000|Maintenance Phase|Withdrawal by Subject|6|||
42052897|NCT00783718|75861525|FG001|Maintenance Phase|Withdrawal by Subject|0|||
42052898|NCT00783718|75861526|FG002|Maintenance Phase|Withdrawal by Subject|0|||
42052899|NCT00783718|75861527|FG003|Maintenance Phase|Withdrawal by Subject|2|||
42052900|NCT00783718|75861528|FG004|Maintenance Phase|Withdrawal by Subject|5|||
42052901|NCT00783718|75861529|FG005|Maintenance Phase|Withdrawal by Subject|2|||
42052902|NCT00783718|75861530|FG006|Maintenance Phase|Withdrawal by Subject|20|||
42052903|NCT00783718|75861524|FG000|Maintenance Phase|Lost to Follow-up|3|||
42052904|NCT00783718|75861525|FG001|Maintenance Phase|Lost to Follow-up|0|||
42052905|NCT00783718|75861526|FG002|Maintenance Phase|Lost to Follow-up|0|||
42052906|NCT00783718|75861527|FG003|Maintenance Phase|Lost to Follow-up|0|||
42052907|NCT00783718|75861528|FG004|Maintenance Phase|Lost to Follow-up|2|||
42052908|NCT00783718|75861529|FG005|Maintenance Phase|Lost to Follow-up|0|||
42052909|NCT00783718|75861530|FG006|Maintenance Phase|Lost to Follow-up|2|||
42052910|NCT00774748|75861549|FG000|Overall Study|Lost to Follow-up|3|||
42052911|NCT00587860|75861559|FG000|Overall Study|Lost to Follow-up|2|||
42052912|NCT00587860|75861560|FG001|Overall Study|Lost to Follow-up|2|||
42173615|NCT00415532|75980461|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
42052913|NCT00587860|75861559|FG000|Overall Study|Withdrawal by Subject|3|||
42052914|NCT00587860|75861560|FG001|Overall Study|Withdrawal by Subject|3|||
42052915|NCT00583453|75861568|FG000|Overall Study|discontinued intervention|0|||
42052916|NCT00583453|75861569|FG001|Overall Study|discontinued intervention|2|||
42052917|NCT00583219|75861577|FG000|Phase 2|Withdrawal by Subject|1|||
42052918|NCT01072175|75861597|FG000|Part A (Drug-Drug Interaction)|Death|1|||
42052919|NCT01072175|75861598|FG001|Part A (Drug-Drug Interaction)|Death|0|||
42052920|NCT01072175|75861599|FG002|Part A (Drug-Drug Interaction)|Death|0|||
42052921|NCT01072175|75861600|FG003|Part A (Drug-Drug Interaction)|Death|0|||
42052922|NCT01072175|75861601|FG004|Part A (Drug-Drug Interaction)|Death|0|||
42052923|NCT01072175|75861602|FG005|Part A (Drug-Drug Interaction)|Death|0|||
42052924|NCT01072175|75861603|FG006|Part A (Drug-Drug Interaction)|Death|0|||
42052925|NCT01072175|75861604|FG007|Part A (Drug-Drug Interaction)|Death|0|||
42052926|NCT01072175|75861605|FG008|Part A (Drug-Drug Interaction)|Death|0|||
42052927|NCT01072175|75861606|FG009|Part A (Drug-Drug Interaction)|Death|0|||
42052928|NCT01072175|75861607|FG010|Part A (Drug-Drug Interaction)|Death|0|||
42052929|NCT01072175|75861608|FG011|Part A (Drug-Drug Interaction)|Death|0|||
42052930|NCT01072175|75861609|FG012|Part A (Drug-Drug Interaction)|Death|0|||
42052931|NCT01072175|75861597|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
42052932|NCT01072175|75861598|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052933|NCT01072175|75861599|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052934|NCT01072175|75861600|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052935|NCT01072175|75861601|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052936|NCT01072175|75861602|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052937|NCT01072175|75861603|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052938|NCT01072175|75861604|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052939|NCT01072175|75861605|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052940|NCT01072175|75861606|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052941|NCT01072175|75861607|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052942|NCT01072175|75861608|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052943|NCT01072175|75861609|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
42052944|NCT01072175|75861597|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
42052945|NCT01072175|75861598|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052946|NCT01072175|75861599|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052947|NCT01072175|75861600|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052948|NCT01072175|75861601|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052949|NCT01072175|75861602|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052950|NCT01072175|75861603|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052951|NCT01072175|75861604|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052952|NCT01072175|75861605|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052953|NCT01072175|75861606|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052954|NCT01072175|75861607|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052955|NCT01072175|75861608|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052956|NCT01072175|75861609|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
42052957|NCT01072175|75861597|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
42052958|NCT01072175|75861598|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
42052959|NCT01072175|75861599|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
42052960|NCT01072175|75861600|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
42052961|NCT01072175|75861601|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
42052962|NCT01072175|75861602|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
42052963|NCT01072175|75861603|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
42052964|NCT01072175|75861604|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
42052965|NCT01072175|75861605|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
42052966|NCT01072175|75861606|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
42052967|NCT01072175|75861607|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
42052968|NCT01072175|75861608|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
42052969|NCT01072175|75861609|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
42052970|NCT01072175|75861597|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
42173616|NCT00415532|75980462|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
42173617|NCT00315731|75980468|FG000|Overall Study|Lost to Follow-up|1|||
42173618|NCT00315731|75980468|FG000|Overall Study|Death|5|||
42173619|NCT00062868|75980495|FG000|Dose Level 1|Death|2|||
42173620|NCT00062868|75980496|FG001|Dose Level 1|Death|0|||
42173621|NCT00062868|75980497|FG002|Dose Level 1|Death|0|||
42173622|NCT00062868|75980498|FG003|Dose Level 1|Death|2|||
42291617|NCT01970878|76125139|FG003|Overall Study|Administrative Reasons|4|||
42291618|NCT01970878|76125136|FG000|Overall Study|Lack of Efficacy|2|||
42291619|NCT01970878|76125137|FG001|Overall Study|Lack of Efficacy|1|||
42052971|NCT01072175|75861598|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
42173623|NCT00062868|75980499|FG004|Dose Level 1|Death|0|||
42173624|NCT00062868|75980500|FG005|Dose Level 1|Death|0|||
42173625|NCT00062868|75980501|FG006|Dose Level 1|Death|3|||
42291620|NCT01970878|76125138|FG002|Overall Study|Lack of Efficacy|2|||
42052972|NCT01072175|75861599|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
42052973|NCT01072175|75861600|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
42173626|NCT00062868|75980502|FG007|Dose Level 1|Death|0|||
42052974|NCT01072175|75861601|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
42052975|NCT01072175|75861602|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
42052976|NCT01072175|75861603|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
42052977|NCT01072175|75861604|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
42052978|NCT01072175|75861605|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
42052979|NCT01072175|75861606|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
42052980|NCT01072175|75861607|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
42052981|NCT01072175|75861608|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
42052982|NCT01072175|75861609|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
42052983|NCT01072175|75861597|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
42052984|NCT01072175|75861598|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
42052985|NCT01072175|75861599|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
42052986|NCT01072175|75861600|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
42052987|NCT01072175|75861601|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
42052988|NCT01072175|75861602|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
42052989|NCT01072175|75861603|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
42052990|NCT01072175|75861604|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
42052991|NCT01072175|75861605|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
42052992|NCT01072175|75861606|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
42052993|NCT01072175|75861607|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
42052994|NCT01072175|75861608|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
42052995|NCT01072175|75861609|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
42052996|NCT01072175|75861597|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
42052997|NCT01072175|75861598|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
42052998|NCT01072175|75861599|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
42052999|NCT01072175|75861600|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
42053000|NCT01072175|75861601|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
42053001|NCT01072175|75861602|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
42053002|NCT01072175|75861603|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
42053003|NCT01072175|75861604|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
42053004|NCT01072175|75861605|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
42053005|NCT01072175|75861606|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
42053006|NCT01072175|75861607|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
42053007|NCT01072175|75861608|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
42053008|NCT01072175|75861609|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
42053009|NCT01072175|75861597|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
42053010|NCT01072175|75861598|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
42053011|NCT01072175|75861599|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
42053012|NCT01072175|75861600|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
42053013|NCT01072175|75861601|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
42053014|NCT01072175|75861602|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
42053015|NCT01072175|75861603|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
42053016|NCT01072175|75861604|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
42053017|NCT01072175|75861605|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
42053018|NCT01072175|75861606|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
42053019|NCT01072175|75861607|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
42053020|NCT01072175|75861608|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
42053021|NCT01072175|75861609|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
42053022|NCT01072175|75861597|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
42053023|NCT01072175|75861598|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
42053024|NCT01072175|75861599|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
42053025|NCT01072175|75861600|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
42053026|NCT01072175|75861601|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
42291621|NCT01970878|76125139|FG003|Overall Study|Lack of Efficacy|0|||
42053027|NCT01072175|75861602|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
42053028|NCT01072175|75861603|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
42053029|NCT01072175|75861604|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
42053030|NCT01072175|75861605|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
42053031|NCT01072175|75861606|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
42053032|NCT01072175|75861607|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
42053033|NCT01072175|75861608|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
42053034|NCT01072175|75861609|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
42053035|NCT01072175|75861597|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
42053036|NCT01072175|75861598|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
42053037|NCT01072175|75861599|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
42053038|NCT01072175|75861600|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
42053039|NCT01072175|75861601|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
42053040|NCT01072175|75861602|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
42053041|NCT01072175|75861603|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
42053042|NCT01072175|75861604|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
42053043|NCT01072175|75861605|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
42053044|NCT01072175|75861606|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
42053045|NCT01072175|75861607|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
42053046|NCT01072175|75861608|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
42053047|NCT01072175|75861609|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
42053048|NCT01072175|75861597|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
42053049|NCT01072175|75861598|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
42053050|NCT01072175|75861599|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
42053051|NCT01072175|75861600|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
42053052|NCT01072175|75861601|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
42053053|NCT01072175|75861602|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
42053054|NCT01072175|75861603|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
42053055|NCT01072175|75861604|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
42053056|NCT01072175|75861605|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
42053057|NCT01072175|75861606|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
42053058|NCT01072175|75861607|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
42053059|NCT01072175|75861608|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
42053060|NCT01072175|75861609|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
42053061|NCT01072175|75861597|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
42053062|NCT01072175|75861598|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
42053063|NCT01072175|75861599|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
42053064|NCT01072175|75861600|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
42053065|NCT01072175|75861601|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
42053066|NCT01072175|75861602|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
42053067|NCT01072175|75861603|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
42053068|NCT01072175|75861604|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
42053069|NCT01072175|75861605|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
42053070|NCT01072175|75861606|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
42053071|NCT01072175|75861607|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
42053072|NCT01072175|75861608|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
42053073|NCT01072175|75861609|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
42053074|NCT01072175|75861597|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
42053075|NCT01072175|75861598|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
42053076|NCT01072175|75861599|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
42053077|NCT01072175|75861600|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
42053078|NCT01072175|75861601|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
42053079|NCT01072175|75861602|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
42053080|NCT01072175|75861603|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
42053081|NCT01072175|75861604|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
42053082|NCT01072175|75861605|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
42053083|NCT01072175|75861606|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
42053084|NCT01072175|75861607|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
42053085|NCT01072175|75861608|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
42053086|NCT01072175|75861609|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
42053087|NCT01072175|75861597|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42053088|NCT01072175|75861598|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42053089|NCT01072175|75861599|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42053090|NCT01072175|75861600|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42053091|NCT01072175|75861601|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42053092|NCT01072175|75861602|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42053093|NCT01072175|75861603|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42053094|NCT01072175|75861604|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42053095|NCT01072175|75861605|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
42053096|NCT01072175|75861606|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42053097|NCT01072175|75861607|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42356932|NCT01392963|76202152|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
42356933|NCT01392963|76202153|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
42356934|NCT01392963|76202152|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
42356935|NCT01392963|76202153|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
42356936|NCT01392573|76202163|FG000|Overall Study|Adverse Event|1|||
42356937|NCT01392573|76202164|FG001|Overall Study|Adverse Event|3|||
42053098|NCT01072175|75861608|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42053099|NCT01072175|75861609|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
42053100|NCT01072175|75861597|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053101|NCT01072175|75861598|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053102|NCT01072175|75861599|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053103|NCT01072175|75861600|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053104|NCT01072175|75861601|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053105|NCT01072175|75861602|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053106|NCT01072175|75861603|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053107|NCT01072175|75861604|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053108|NCT01072175|75861605|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
42053109|NCT01072175|75861606|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053110|NCT01072175|75861607|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053111|NCT01072175|75861608|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053112|NCT01072175|75861609|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
42053113|NCT01072175|75861597|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42053114|NCT01072175|75861598|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42053115|NCT01072175|75861599|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42053116|NCT01072175|75861600|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42053117|NCT01072175|75861601|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42053118|NCT01072175|75861602|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42053119|NCT01072175|75861603|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42053120|NCT01072175|75861604|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42053121|NCT01072175|75861605|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
42053122|NCT01072175|75861606|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42053123|NCT01072175|75861607|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42053124|NCT01072175|75861608|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42053125|NCT01072175|75861609|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
42173627|NCT00062868|75980503|FG008|Dose Level 1|Death|0|||
42173628|NCT00062868|75980504|FG009|Dose Level 1|Death|0|||
42173629|NCT00062868|75980505|FG010|Dose Level 1|Death|0|||
42173630|NCT00062868|75980506|FG011|Dose Level 1|Death|0|||
42173631|NCT00062868|75980507|FG012|Dose Level 1|Death|0|||
42173632|NCT00062868|75980508|FG013|Dose Level 1|Death|0|||
42173633|NCT00062868|75980509|FG014|Dose Level 1|Death|0|||
42173634|NCT00062868|75980510|FG015|Dose Level 1|Death|0|||
42173635|NCT00062868|75980511|FG016|Dose Level 1|Death|0|||
42173636|NCT00062868|75980512|FG017|Dose Level 1|Death|0|||
42173637|NCT00062868|75980513|FG018|Dose Level 1|Death|7|||
42173638|NCT00062868|75980514|FG019|Dose Level 1|Death|0|||
42173639|NCT00062868|75980515|FG020|Dose Level 1|Death|1|||
42173640|NCT00062868|75980495|FG000|Dose Level 1|Lost to Follow-up|0|||
42173641|NCT00062868|75980496|FG001|Dose Level 1|Lost to Follow-up|0|||
42173642|NCT00062868|75980497|FG002|Dose Level 1|Lost to Follow-up|0|||
42173643|NCT00062868|75980498|FG003|Dose Level 1|Lost to Follow-up|0|||
42173644|NCT00062868|75980499|FG004|Dose Level 1|Lost to Follow-up|0|||
42173645|NCT00062868|75980500|FG005|Dose Level 1|Lost to Follow-up|0|||
42053126|NCT01072175|75861597|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42053127|NCT01072175|75861598|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42053128|NCT01072175|75861599|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42053129|NCT01072175|75861600|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42053130|NCT01072175|75861601|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42053131|NCT01072175|75861602|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42053132|NCT01072175|75861603|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42173646|NCT00062868|75980501|FG006|Dose Level 1|Lost to Follow-up|0|||
42173647|NCT00062868|75980502|FG007|Dose Level 1|Lost to Follow-up|0|||
42173648|NCT00062868|75980503|FG008|Dose Level 1|Lost to Follow-up|0|||
42173649|NCT00062868|75980504|FG009|Dose Level 1|Lost to Follow-up|0|||
42173650|NCT00062868|75980505|FG010|Dose Level 1|Lost to Follow-up|0|||
42173651|NCT00062868|75980506|FG011|Dose Level 1|Lost to Follow-up|0|||
42173652|NCT00062868|75980507|FG012|Dose Level 1|Lost to Follow-up|1|||
42173653|NCT00062868|75980508|FG013|Dose Level 1|Lost to Follow-up|0|||
42173654|NCT00062868|75980509|FG014|Dose Level 1|Lost to Follow-up|0|||
42173655|NCT00062868|75980510|FG015|Dose Level 1|Lost to Follow-up|0|||
42173656|NCT00062868|75980511|FG016|Dose Level 1|Lost to Follow-up|0|||
42173657|NCT00062868|75980512|FG017|Dose Level 1|Lost to Follow-up|0|||
42173658|NCT00062868|75980513|FG018|Dose Level 1|Lost to Follow-up|2|||
42173659|NCT00062868|75980514|FG019|Dose Level 1|Lost to Follow-up|0|||
42173660|NCT00062868|75980515|FG020|Dose Level 1|Lost to Follow-up|1|||
42053133|NCT01072175|75861604|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42053134|NCT01072175|75861605|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
42053135|NCT01072175|75861606|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42053136|NCT01072175|75861607|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42053137|NCT01072175|75861608|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42053138|NCT01072175|75861609|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
42053139|NCT01072175|75861597|FG000|Part D (HPMC Capsules)|Death|0|||
42053140|NCT01072175|75861598|FG001|Part D (HPMC Capsules)|Death|0|||
42053141|NCT01072175|75861599|FG002|Part D (HPMC Capsules)|Death|0|||
42053142|NCT01072175|75861600|FG003|Part D (HPMC Capsules)|Death|0|||
42053143|NCT01072175|75861601|FG004|Part D (HPMC Capsules)|Death|0|||
42053144|NCT01072175|75861602|FG005|Part D (HPMC Capsules)|Death|0|||
42053145|NCT01072175|75861603|FG006|Part D (HPMC Capsules)|Death|0|||
42053146|NCT01072175|75861604|FG007|Part D (HPMC Capsules)|Death|0|||
42053147|NCT01072175|75861605|FG008|Part D (HPMC Capsules)|Death|0|||
42053148|NCT01072175|75861606|FG009|Part D (HPMC Capsules)|Death|10|||
42053149|NCT01072175|75861607|FG010|Part D (HPMC Capsules)|Death|12|||
42053150|NCT01072175|75861608|FG011|Part D (HPMC Capsules)|Death|28|||
42053151|NCT01072175|75861609|FG012|Part D (HPMC Capsules)|Death|26|||
42053152|NCT01072175|75861597|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
42053153|NCT01072175|75861598|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
42053154|NCT01072175|75861599|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
42053155|NCT01072175|75861600|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
42053156|NCT01072175|75861601|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
42053157|NCT01072175|75861602|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
42053158|NCT01072175|75861603|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
42053159|NCT01072175|75861604|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
42053160|NCT01072175|75861605|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
42053161|NCT01072175|75861606|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
42053162|NCT01072175|75861607|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
42053163|NCT01072175|75861608|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
42053164|NCT01072175|75861609|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
42053165|NCT01072175|75861597|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
42053166|NCT01072175|75861598|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
42053167|NCT01072175|75861599|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
42053168|NCT01072175|75861600|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
42053169|NCT01072175|75861601|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
42053170|NCT01072175|75861602|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
42053171|NCT01072175|75861603|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
42053172|NCT01072175|75861604|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
42053173|NCT01072175|75861605|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
42053174|NCT01072175|75861606|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
42053175|NCT01072175|75861607|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
42053176|NCT01072175|75861608|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
42053177|NCT01072175|75861609|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
42053178|NCT01072175|75861597|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
42053179|NCT01072175|75861598|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
42053180|NCT01072175|75861599|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
42053181|NCT01072175|75861600|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
42053182|NCT01072175|75861601|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
42053183|NCT01072175|75861602|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
42053184|NCT01072175|75861603|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
42053185|NCT01072175|75861604|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
42053186|NCT01072175|75861605|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
42053187|NCT01072175|75861606|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
42053188|NCT01072175|75861607|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
42053189|NCT01072175|75861608|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
42053190|NCT01072175|75861609|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
42053191|NCT01072175|75861597|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
42053192|NCT01072175|75861598|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
42053193|NCT01072175|75861599|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
42053194|NCT01072175|75861600|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
42053195|NCT01072175|75861601|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
42053196|NCT01072175|75861602|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
42053197|NCT01072175|75861603|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
42053198|NCT01072175|75861604|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
42053199|NCT01072175|75861605|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
42053200|NCT01072175|75861606|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
42053201|NCT01072175|75861607|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
42053202|NCT01072175|75861608|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
42053203|NCT01072175|75861609|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
42053204|NCT01071317|75861643|FG000|Overall Study|Lost to Follow-up|2|||
42053205|NCT01071317|75861644|FG001|Overall Study|Lost to Follow-up|2|||
42053206|NCT00783094|75861661|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
42053207|NCT00783094|75861662|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
42053208|NCT00783094|75861663|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
42053209|NCT00783094|75861661|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
42053210|NCT00783094|75861662|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
42053211|NCT00783094|75861663|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
42053212|NCT00783094|75861661|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
42053213|NCT00783094|75861662|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
42053214|NCT00783094|75861663|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
42053215|NCT00783094|75861661|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
42053216|NCT00783094|75861662|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
42053217|NCT00783094|75861663|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
42053218|NCT00783094|75861661|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
42053219|NCT00783094|75861662|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
42053220|NCT00783094|75861663|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
42053221|NCT00783094|75861661|FG000|Open-Label Extension Period|Adverse Event|12|||
42053222|NCT00783094|75861662|FG001|Open-Label Extension Period|Adverse Event|7|||
42053223|NCT00783094|75861663|FG002|Open-Label Extension Period|Adverse Event|16|||
42053224|NCT00783094|75861661|FG000|Open-Label Extension Period|Death|0|||
42053225|NCT00783094|75861662|FG001|Open-Label Extension Period|Death|0|||
42053226|NCT00783094|75861663|FG002|Open-Label Extension Period|Death|1|||
42053227|NCT00783094|75861661|FG000|Open-Label Extension Period|Protocol Violation|4|||
42053228|NCT00783094|75861662|FG001|Open-Label Extension Period|Protocol Violation|5|||
42053229|NCT00783094|75861663|FG002|Open-Label Extension Period|Protocol Violation|7|||
42053230|NCT00783094|75861661|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
42053231|NCT00783094|75861662|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
42053232|NCT00783094|75861663|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
42053233|NCT00783094|75861661|FG000|Open-Label Extension Period|Physician Decision|4|||
42053234|NCT00783094|75861662|FG001|Open-Label Extension Period|Physician Decision|2|||
42053235|NCT00783094|75861663|FG002|Open-Label Extension Period|Physician Decision|3|||
42053236|NCT00783094|75861661|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
42053237|NCT00783094|75861662|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
42053238|NCT00783094|75861663|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
42053239|NCT00790582|75861676|FG000|Overall Study|Death|14|||
42053240|NCT00790582|75861677|FG001|Overall Study|Death|32|||
42053241|NCT00790582|75861676|FG000|Overall Study|Physician Decision|7|||
42053242|NCT00790582|75861677|FG001|Overall Study|Physician Decision|1|||
42053243|NCT00790582|75861676|FG000|Overall Study|Lost to Follow-up|3|||
42053244|NCT00790582|75861677|FG001|Overall Study|Lost to Follow-up|3|||
42053245|NCT00790582|75861676|FG000|Overall Study|Withdrawal by Subject|7|||
42053246|NCT00790582|75861677|FG001|Overall Study|Withdrawal by Subject|51|||
42053247|NCT01048541|75861685|FG000|Overall Study|Withdrawal by Subject|1|||
42053248|NCT01048541|75861686|FG001|Overall Study|Withdrawal by Subject|0|||
42053249|NCT00774046|75861692|FG000|Screening|Not eligible|56|||
42053250|NCT00774046|75861692|FG000|Enrollment|Desired other therapy/refused|28|||
42053251|NCT00774046|75861692|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
42053252|NCT01046903|75861696|FG000|Overall Study|Lost to Follow-up|16|||
42053253|NCT01046903|75861696|FG000|Overall Study|Adverse Event|4|||
42053254|NCT01046903|75861696|FG000|Overall Study|Withdrawal by Subject|3|||
42016287|NCT01262456|75823495|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
42016288|NCT01262456|75823496|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
42016289|NCT01262456|75823497|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
42016290|NCT01262456|75823495|FG000|3-Month Double-Blind Period|Adverse Event|6|||
42016291|NCT01262456|75823496|FG001|3-Month Double-Blind Period|Adverse Event|4|||
42016292|NCT01262456|75823497|FG002|3-Month Double-Blind Period|Adverse Event|8|||
42016293|NCT01262456|75823495|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
42016294|NCT01262456|75823496|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
42016295|NCT01262456|75823497|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
42016296|NCT01262456|75823495|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
42016297|NCT01262456|75823496|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
42016298|NCT01262456|75823497|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
42016299|NCT01262456|75823495|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
42016300|NCT01262456|75823496|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
42016301|NCT01262456|75823497|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
42016302|NCT01262456|75823495|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
42016303|NCT01262456|75823496|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
42016304|NCT01262456|75823497|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
42016305|NCT01262456|75823495|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
42016306|NCT01262456|75823496|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
42016307|NCT01262456|75823497|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
42053255|NCT01046903|75861696|FG000|Overall Study|Other|5|||
42173661|NCT00062868|75980495|FG000|Dose Level 2|Death|0|||
42173662|NCT00062868|75980496|FG001|Dose Level 2|Death|3|||
42173663|NCT00062868|75980497|FG002|Dose Level 2|Death|0|||
42173664|NCT00062868|75980498|FG003|Dose Level 2|Death|0|||
42173665|NCT00062868|75980499|FG004|Dose Level 2|Death|2|||
42173666|NCT00062868|75980500|FG005|Dose Level 2|Death|0|||
42173667|NCT00062868|75980501|FG006|Dose Level 2|Death|0|||
42173668|NCT00062868|75980502|FG007|Dose Level 2|Death|0|||
42173669|NCT00062868|75980503|FG008|Dose Level 2|Death|0|||
42173670|NCT00062868|75980504|FG009|Dose Level 2|Death|0|||
42173671|NCT00062868|75980505|FG010|Dose Level 2|Death|1|||
42173672|NCT00062868|75980506|FG011|Dose Level 2|Death|0|||
42173673|NCT00062868|75980507|FG012|Dose Level 2|Death|0|||
42173674|NCT00062868|75980508|FG013|Dose Level 2|Death|0|||
42173675|NCT00062868|75980509|FG014|Dose Level 2|Death|0|||
42173676|NCT00062868|75980510|FG015|Dose Level 2|Death|0|||
42173677|NCT00062868|75980511|FG016|Dose Level 2|Death|2|||
42173678|NCT00062868|75980512|FG017|Dose Level 2|Death|0|||
42173679|NCT00062868|75980513|FG018|Dose Level 2|Death|0|||
42173680|NCT00062868|75980514|FG019|Dose Level 2|Death|0|||
42173681|NCT00062868|75980515|FG020|Dose Level 2|Death|0|||
42173682|NCT00062868|75980495|FG000|Dose Level 2|Lost to Follow-up|0|||
42173683|NCT00062868|75980496|FG001|Dose Level 2|Lost to Follow-up|0|||
42173684|NCT00062868|75980497|FG002|Dose Level 2|Lost to Follow-up|0|||
42173685|NCT00062868|75980498|FG003|Dose Level 2|Lost to Follow-up|0|||
42173686|NCT00062868|75980499|FG004|Dose Level 2|Lost to Follow-up|0|||
42173687|NCT00062868|75980500|FG005|Dose Level 2|Lost to Follow-up|0|||
42173688|NCT00062868|75980501|FG006|Dose Level 2|Lost to Follow-up|0|||
42173689|NCT00062868|75980502|FG007|Dose Level 2|Lost to Follow-up|0|||
42173690|NCT00062868|75980503|FG008|Dose Level 2|Lost to Follow-up|0|||
42173691|NCT00062868|75980504|FG009|Dose Level 2|Lost to Follow-up|0|||
42173692|NCT00062868|75980505|FG010|Dose Level 2|Lost to Follow-up|0|||
42173693|NCT00062868|75980506|FG011|Dose Level 2|Lost to Follow-up|0|||
42173694|NCT00062868|75980507|FG012|Dose Level 2|Lost to Follow-up|0|||
42173695|NCT00062868|75980508|FG013|Dose Level 2|Lost to Follow-up|1|||
42173696|NCT00062868|75980509|FG014|Dose Level 2|Lost to Follow-up|0|||
42173697|NCT00062868|75980510|FG015|Dose Level 2|Lost to Follow-up|0|||
42173698|NCT00062868|75980511|FG016|Dose Level 2|Lost to Follow-up|1|||
42173699|NCT00062868|75980512|FG017|Dose Level 2|Lost to Follow-up|0|||
42173700|NCT00062868|75980513|FG018|Dose Level 2|Lost to Follow-up|0|||
42173701|NCT00062868|75980514|FG019|Dose Level 2|Lost to Follow-up|0|||
42173702|NCT00062868|75980515|FG020|Dose Level 2|Lost to Follow-up|0|||
42173703|NCT00062868|75980495|FG000|Dose Level 3|Death|0|||
42173704|NCT00062868|75980496|FG001|Dose Level 3|Death|0|||
42173705|NCT00062868|75980497|FG002|Dose Level 3|Death|0|||
42173706|NCT00062868|75980498|FG003|Dose Level 3|Death|0|||
42173707|NCT00062868|75980499|FG004|Dose Level 3|Death|0|||
42173708|NCT00062868|75980500|FG005|Dose Level 3|Death|0|||
42173709|NCT00062868|75980501|FG006|Dose Level 3|Death|0|||
42173710|NCT00062868|75980502|FG007|Dose Level 3|Death|0|||
42173711|NCT00062868|75980503|FG008|Dose Level 3|Death|0|||
42173712|NCT00062868|75980504|FG009|Dose Level 3|Death|0|||
42173713|NCT00062868|75980505|FG010|Dose Level 3|Death|0|||
42173714|NCT00062868|75980506|FG011|Dose Level 3|Death|1|||
42173715|NCT00062868|75980507|FG012|Dose Level 3|Death|0|||
42173716|NCT00062868|75980508|FG013|Dose Level 3|Death|0|||
42173717|NCT00062868|75980509|FG014|Dose Level 3|Death|0|||
42173718|NCT00062868|75980510|FG015|Dose Level 3|Death|0|||
42173719|NCT00062868|75980511|FG016|Dose Level 3|Death|0|||
42173720|NCT00062868|75980512|FG017|Dose Level 3|Death|1|||
42173721|NCT00062868|75980513|FG018|Dose Level 3|Death|0|||
42173722|NCT00062868|75980514|FG019|Dose Level 3|Death|0|||
42173723|NCT00062868|75980515|FG020|Dose Level 3|Death|0|||
42291622|NCT01970878|76125136|FG000|Overall Study|Adverse Event|12|||
42291623|NCT01970878|76125137|FG001|Overall Study|Adverse Event|7|||
42173724|NCT00062868|75980495|FG000|Dose Level 3|Lost to Follow-up|0|||
42173725|NCT00062868|75980496|FG001|Dose Level 3|Lost to Follow-up|0|||
42173726|NCT00062868|75980497|FG002|Dose Level 3|Lost to Follow-up|0|||
42173727|NCT00062868|75980498|FG003|Dose Level 3|Lost to Follow-up|0|||
42173728|NCT00062868|75980499|FG004|Dose Level 3|Lost to Follow-up|0|||
42173729|NCT00062868|75980500|FG005|Dose Level 3|Lost to Follow-up|0|||
42173730|NCT00062868|75980501|FG006|Dose Level 3|Lost to Follow-up|0|||
42173731|NCT00062868|75980502|FG007|Dose Level 3|Lost to Follow-up|0|||
42173732|NCT00062868|75980503|FG008|Dose Level 3|Lost to Follow-up|0|||
42173733|NCT00062868|75980504|FG009|Dose Level 3|Lost to Follow-up|0|||
42173734|NCT00062868|75980505|FG010|Dose Level 3|Lost to Follow-up|0|||
42173735|NCT00062868|75980506|FG011|Dose Level 3|Lost to Follow-up|0|||
42173736|NCT00062868|75980507|FG012|Dose Level 3|Lost to Follow-up|0|||
42173737|NCT00062868|75980508|FG013|Dose Level 3|Lost to Follow-up|0|||
42173738|NCT00062868|75980509|FG014|Dose Level 3|Lost to Follow-up|1|||
42173739|NCT00062868|75980510|FG015|Dose Level 3|Lost to Follow-up|0|||
42291624|NCT01970878|76125138|FG002|Overall Study|Adverse Event|4|||
42053256|NCT00773968|75861700|FG000|Overall Study|Adverse Event|2|||
42053257|NCT00773968|75861700|FG000|Overall Study|Death|1|||
42053258|NCT00773968|75861700|FG000|Overall Study|Failure to Return|2|||
42053259|NCT00773968|75861700|FG000|Overall Study|Lack of Efficacy|3|||
42053260|NCT00773968|75861700|FG000|Overall Study|Protocol Violation|1|||
42053261|NCT00773968|75861700|FG000|Overall Study|Withdrawal by Subject|11|||
42053262|NCT00773968|75861700|FG000|Overall Study|Screen Failure|17|||
42053263|NCT00773968|75861700|FG000|Overall Study|Other|8|||
42053264|NCT00782626|75861704|FG000|Overall Study|Adverse Event|1|||
42053265|NCT00782626|75861704|FG000|Overall Study|Progressive Disease|5|||
42053266|NCT00782626|75861704|FG000|Overall Study|Other Complicating Disease|1|||
42053267|NCT01071083|75861713|FG000|Overall Study|Adverse Event|1|||
42053268|NCT01071083|75861714|FG001|Overall Study|Adverse Event|0|||
42053269|NCT01071083|75861715|FG002|Overall Study|Adverse Event|1|||
42053270|NCT01071083|75861716|FG003|Overall Study|Adverse Event|0|||
42053271|NCT01071083|75861717|FG004|Overall Study|Adverse Event|1|||
42053272|NCT01071083|75861713|FG000|Overall Study|Withdrawal by Subject|3|||
42053273|NCT01071083|75861714|FG001|Overall Study|Withdrawal by Subject|0|||
42053274|NCT01071083|75861715|FG002|Overall Study|Withdrawal by Subject|2|||
42053275|NCT01071083|75861716|FG003|Overall Study|Withdrawal by Subject|0|||
42053276|NCT01071083|75861717|FG004|Overall Study|Withdrawal by Subject|3|||
42053277|NCT01071083|75861713|FG000|Overall Study|Physician Decision|1|||
42053278|NCT01071083|75861714|FG001|Overall Study|Physician Decision|0|||
42053279|NCT01071083|75861715|FG002|Overall Study|Physician Decision|0|||
42053280|NCT01071083|75861716|FG003|Overall Study|Physician Decision|1|||
42053281|NCT01071083|75861717|FG004|Overall Study|Physician Decision|1|||
42053282|NCT01071083|75861713|FG000|Overall Study|Early Rescue|1|||
42053283|NCT01071083|75861714|FG001|Overall Study|Early Rescue|0|||
42053284|NCT01071083|75861715|FG002|Overall Study|Early Rescue|0|||
42053285|NCT01071083|75861716|FG003|Overall Study|Early Rescue|0|||
42053286|NCT01071083|75861717|FG004|Overall Study|Early Rescue|1|||
42053287|NCT01071083|75861713|FG000|Overall Study|Subject Moved|0|||
42053288|NCT01071083|75861714|FG001|Overall Study|Subject Moved|1|||
42053289|NCT01071083|75861715|FG002|Overall Study|Subject Moved|0|||
42053290|NCT01071083|75861716|FG003|Overall Study|Subject Moved|0|||
42053291|NCT01071083|75861717|FG004|Overall Study|Subject Moved|0|||
42053292|NCT01071083|75861713|FG000|Overall Study|Images Not Usable (Motion)|0|||
42053293|NCT01071083|75861714|FG001|Overall Study|Images Not Usable (Motion)|1|||
42053294|NCT01071083|75861715|FG002|Overall Study|Images Not Usable (Motion)|0|||
42053295|NCT01071083|75861716|FG003|Overall Study|Images Not Usable (Motion)|0|||
42053296|NCT01071083|75861717|FG004|Overall Study|Images Not Usable (Motion)|0|||
42053297|NCT01071083|75861713|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
42053298|NCT01071083|75861714|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
42053299|NCT01071083|75861715|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
42053300|NCT01071083|75861716|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
42053301|NCT01071083|75861717|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
42053302|NCT01071083|75861713|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
42053303|NCT01071083|75861714|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
42053304|NCT01071083|75861715|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
42053305|NCT01071083|75861716|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
42053306|NCT01071083|75861717|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
42053307|NCT01071083|75861713|FG000|Overall Study|Subject Refused to Continue|1|||
42053308|NCT01071083|75861714|FG001|Overall Study|Subject Refused to Continue|0|||
42053309|NCT01071083|75861715|FG002|Overall Study|Subject Refused to Continue|0|||
42053310|NCT01071083|75861716|FG003|Overall Study|Subject Refused to Continue|0|||
42053311|NCT01071083|75861717|FG004|Overall Study|Subject Refused to Continue|0|||
42053312|NCT01070771|75861729|FG000|Overall Study|Adverse Event|2|||
42291625|NCT01970878|76125139|FG003|Overall Study|Adverse Event|3|||
42291626|NCT01970878|76125136|FG000|Overall Study|Protocol Specified Criteria|10|||
42053313|NCT01070771|75861729|FG000|Overall Study|Protocol Violation|1|||
42053314|NCT01070381|75861734|FG000|Period 2, 1 Week of Wear|Handling|0|||
42053315|NCT01070381|75861735|FG001|Period 2, 1 Week of Wear|Handling|1|||
42053316|NCT01070381|75861734|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
42053317|NCT01070381|75861735|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
42053318|NCT01010126|75861756|FG000|Overall Study|Withdrawal by Subject|1|||
42053319|NCT01010126|75861757|FG001|Overall Study|Withdrawal by Subject|0|||
42053320|NCT01010126|75861758|FG002|Overall Study|Withdrawal by Subject|1|||
42053321|NCT01010126|75861759|FG003|Overall Study|Withdrawal by Subject|0|||
42053322|NCT01010126|75861760|FG004|Overall Study|Withdrawal by Subject|3|||
42053323|NCT01010126|75861761|FG005|Overall Study|Withdrawal by Subject|0|||
42053324|NCT01043705|75861778|FG000|Overall Study|Death|28|||
42053325|NCT01043705|75861779|FG001|Overall Study|Death|60|||
42053326|NCT01043705|75861780|FG002|Overall Study|Death|26|||
42053327|NCT01043705|75861778|FG000|Overall Study|Lost to Follow-up|27|||
42053328|NCT01043705|75861779|FG001|Overall Study|Lost to Follow-up|12|||
42053329|NCT01043705|75861780|FG002|Overall Study|Lost to Follow-up|0|||
42053330|NCT01043705|75861778|FG000|Overall Study|Multiple Reasons|4|||
42053331|NCT01043705|75861779|FG001|Overall Study|Multiple Reasons|7|||
42053332|NCT01043705|75861780|FG002|Overall Study|Multiple Reasons|0|||
42053333|NCT01043705|75861778|FG000|Overall Study|Protocol Violation|2|||
42053334|NCT01043705|75861779|FG001|Overall Study|Protocol Violation|1|||
42053335|NCT01043705|75861780|FG002|Overall Study|Protocol Violation|0|||
42053336|NCT01043705|75861778|FG000|Overall Study|Withdrawal by Subject|8|||
42053337|NCT01043705|75861779|FG001|Overall Study|Withdrawal by Subject|6|||
42053338|NCT01043705|75861780|FG002|Overall Study|Withdrawal by Subject|0|||
42053339|NCT01043705|75861778|FG000|Overall Study|Site Closure|8|||
42053340|NCT01043705|75861779|FG001|Overall Study|Site Closure|0|||
42053341|NCT01043705|75861780|FG002|Overall Study|Site Closure|0|||
42053342|NCT01043705|75861778|FG000|Overall Study|Subsequent Procedure|9|||
42053343|NCT01043705|75861779|FG001|Overall Study|Subsequent Procedure|24|||
42053344|NCT01043705|75861780|FG002|Overall Study|Subsequent Procedure|29|||
42053345|NCT01043705|75861778|FG000|Overall Study|Adverse Event|0|||
42053346|NCT01043705|75861779|FG001|Overall Study|Adverse Event|2|||
42053347|NCT01043705|75861780|FG002|Overall Study|Adverse Event|0|||
42053348|NCT01043705|75861778|FG000|Overall Study|Screen Fail|21|||
42053349|NCT01043705|75861779|FG001|Overall Study|Screen Fail|0|||
42053350|NCT01043705|75861780|FG002|Overall Study|Screen Fail|0|||
42053351|NCT01043705|75861778|FG000|Overall Study|Other|0|||
42053352|NCT01043705|75861779|FG001|Overall Study|Other|19|||
42053353|NCT01043705|75861780|FG002|Overall Study|Other|25|||
42053354|NCT01070303|75861799|FG000|Overall Study|Adverse Event|39|||
42053355|NCT01070303|75861799|FG000|Overall Study|Withdrawal by Subject|20|||
42053356|NCT01070303|75861799|FG000|Overall Study|Lost to Follow-up|9|||
42053357|NCT01070303|75861799|FG000|Overall Study|Protocol Violation|0|||
42053358|NCT01070303|75861799|FG000|Overall Study|Lack of Efficacy|2|||
42053359|NCT01070303|75861799|FG000|Overall Study|Administrative Reason|1|||
42053360|NCT01070303|75861799|FG000|Overall Study|Other|18|||
42053361|NCT01009814|75861814|FG000|Overall Study|No longer met study criteria|1|||
42053362|NCT01009814|75861815|FG001|Overall Study|No longer met study criteria|1|||
42053363|NCT01009814|75861816|FG002|Overall Study|No longer met study criteria|0|||
42053364|NCT01009814|75861817|FG003|Overall Study|No longer met study criteria|0|||
42053365|NCT01009814|75861818|FG004|Overall Study|No longer met study criteria|0|||
42053366|NCT03824587|75861836|FG000|Run-in Period|Screen Failure|0|||
42053367|NCT03824587|75861837|FG001|Run-in Period|Screen Failure|275|||
42053368|NCT03824587|75861836|FG000|Treatment Period|Adverse Event|4|||
42053369|NCT03824587|75861837|FG001|Treatment Period|Adverse Event|1|||
42053370|NCT03824587|75861836|FG000|Treatment Period|Withdrawal by Subject|0|||
42053371|NCT03824587|75861837|FG001|Treatment Period|Withdrawal by Subject|1|||
42053372|NCT03824587|75861836|FG000|Treatment Period|Kidney Transplant|1|||
42053373|NCT03824587|75861837|FG001|Treatment Period|Kidney Transplant|1|||
42053374|NCT00773734|75861847|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
42053375|NCT00773734|75861848|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
42053376|NCT00773734|75861849|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
42053377|NCT00773734|75861850|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
42053378|NCT00773734|75861851|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
42053379|NCT00773734|75861852|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
42053380|NCT00773734|75861847|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
42053381|NCT00773734|75861848|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
42053382|NCT00773734|75861849|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
42053383|NCT00773734|75861850|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
42053384|NCT00773734|75861851|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
42053385|NCT00773734|75861852|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
42053386|NCT00773734|75861847|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
42053387|NCT00773734|75861848|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
42053388|NCT00773734|75861849|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
42053389|NCT00773734|75861850|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
42053390|NCT00773734|75861851|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
42053391|NCT00773734|75861852|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
42053392|NCT00773734|75861847|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
42053393|NCT00773734|75861848|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
42053394|NCT00773734|75861849|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
42053395|NCT00773734|75861850|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
42053396|NCT00773734|75861851|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
42053397|NCT00773734|75861852|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
42053398|NCT00773734|75861847|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
42053399|NCT00773734|75861848|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
42053400|NCT00773734|75861849|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
42053401|NCT00773734|75861850|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
42053402|NCT00773734|75861851|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
42053403|NCT00773734|75861852|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
42053404|NCT00773734|75861847|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
42053405|NCT00773734|75861848|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
42053406|NCT00773734|75861849|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
42053407|NCT00773734|75861850|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
42053408|NCT00773734|75861851|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
42053409|NCT00773734|75861852|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
42053410|NCT00773734|75861847|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
42053411|NCT00773734|75861848|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
42053412|NCT00773734|75861849|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
42053413|NCT00773734|75861850|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
42173740|NCT00062868|75980511|FG016|Dose Level 3|Lost to Follow-up|0|||
42173741|NCT00062868|75980512|FG017|Dose Level 3|Lost to Follow-up|0|||
42173742|NCT00062868|75980513|FG018|Dose Level 3|Lost to Follow-up|0|||
42173743|NCT00062868|75980514|FG019|Dose Level 3|Lost to Follow-up|0|||
42173744|NCT00062868|75980515|FG020|Dose Level 3|Lost to Follow-up|0|||
42173745|NCT00062868|75980495|FG000|Dose Level 3|Withdrew|0|||
42173746|NCT00062868|75980496|FG001|Dose Level 3|Withdrew|0|||
42173747|NCT00062868|75980497|FG002|Dose Level 3|Withdrew|2|||
42173748|NCT00062868|75980498|FG003|Dose Level 3|Withdrew|0|||
42173749|NCT00062868|75980499|FG004|Dose Level 3|Withdrew|0|||
42173750|NCT00062868|75980500|FG005|Dose Level 3|Withdrew|0|||
42173751|NCT00062868|75980501|FG006|Dose Level 3|Withdrew|0|||
42173752|NCT00062868|75980502|FG007|Dose Level 3|Withdrew|0|||
42173753|NCT00062868|75980503|FG008|Dose Level 3|Withdrew|0|||
42173754|NCT00062868|75980504|FG009|Dose Level 3|Withdrew|0|||
42173755|NCT00062868|75980505|FG010|Dose Level 3|Withdrew|0|||
42173756|NCT00062868|75980506|FG011|Dose Level 3|Withdrew|0|||
42173757|NCT00062868|75980507|FG012|Dose Level 3|Withdrew|0|||
42173758|NCT00062868|75980508|FG013|Dose Level 3|Withdrew|0|||
42173759|NCT00062868|75980509|FG014|Dose Level 3|Withdrew|0|||
42173760|NCT00062868|75980510|FG015|Dose Level 3|Withdrew|0|||
42173761|NCT00062868|75980511|FG016|Dose Level 3|Withdrew|0|||
42173762|NCT00062868|75980512|FG017|Dose Level 3|Withdrew|0|||
42173763|NCT00062868|75980513|FG018|Dose Level 3|Withdrew|0|||
42173764|NCT00062868|75980514|FG019|Dose Level 3|Withdrew|0|||
42173765|NCT00062868|75980515|FG020|Dose Level 3|Withdrew|0|||
42173766|NCT00075504|75980561|FG000|Overall Study|Withdrawal by Subject|9|||
42173767|NCT00075504|75980562|FG001|Overall Study|Withdrawal by Subject|7|||
42291627|NCT01970878|76125137|FG001|Overall Study|Protocol Specified Criteria|4|||
42291628|NCT01970878|76125138|FG002|Overall Study|Protocol Specified Criteria|3|||
42291629|NCT01970878|76125139|FG003|Overall Study|Protocol Specified Criteria|6|||
42291630|NCT01970878|76125136|FG000|Overall Study|Physician Decision|0|||
42291631|NCT01970878|76125137|FG001|Overall Study|Physician Decision|1|||
42291632|NCT01970878|76125138|FG002|Overall Study|Physician Decision|1|||
42291633|NCT01970878|76125139|FG003|Overall Study|Physician Decision|0|||
42291634|NCT01970878|76125136|FG000|Overall Study|No Completion Status|0|||
42291635|NCT01970878|76125137|FG001|Overall Study|No Completion Status|1|||
42291636|NCT01970878|76125138|FG002|Overall Study|No Completion Status|0|||
42291637|NCT01970878|76125139|FG003|Overall Study|No Completion Status|0|||
42291638|NCT01970488|76125151|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
42291639|NCT01970488|76125152|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
42291640|NCT01970488|76125153|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
42291641|NCT01970488|76125154|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
42173768|NCT00062166|75980568|FG000|Overall Study|Withdrawal by Subject|6|||
42173769|NCT00087438|75980573|FG000|Overall Study|Ineligible / No protocol treatment|4|||
42173770|NCT00321464|75980581|FG000|Overall Study|Death|169|||
42173771|NCT00321464|75980582|FG001|Overall Study|Death|174|||
42173772|NCT00321464|75980581|FG000|Overall Study|Disease progression|124|||
42173773|NCT00321464|75980582|FG001|Overall Study|Disease progression|124|||
42173774|NCT00321464|75980581|FG000|Overall Study|Withdrawal by Subject|117|||
42173775|NCT00321464|75980582|FG001|Overall Study|Withdrawal by Subject|118|||
42173776|NCT00321464|75980581|FG000|Overall Study|Participant request|57|||
42173777|NCT00321464|75980582|FG001|Overall Study|Participant request|61|||
42173778|NCT00321464|75980581|FG000|Overall Study|Adverse Event|43|||
42291642|NCT01970488|76125155|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
42291643|NCT01970488|76125151|FG000|Part 1: Through Week 16|Protocol Violation|1|||
42291644|NCT01970488|76125152|FG001|Part 1: Through Week 16|Protocol Violation|2|||
42291645|NCT01970488|76125153|FG002|Part 1: Through Week 16|Protocol Violation|0|||
42053414|NCT00773734|75861851|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
42173779|NCT00321464|75980582|FG001|Overall Study|Adverse Event|28|||
42173780|NCT00321464|75980581|FG000|Overall Study|Physician Decision|15|||
42173781|NCT00321464|75980582|FG001|Overall Study|Physician Decision|14|||
42173782|NCT00321464|75980581|FG000|Overall Study|Noncompliance|4|||
42173783|NCT00321464|75980582|FG001|Overall Study|Noncompliance|10|||
42173784|NCT00321464|75980581|FG000|Overall Study|Lost to Follow-up|7|||
42173785|NCT00321464|75980582|FG001|Overall Study|Lost to Follow-up|8|||
42053415|NCT00773734|75861852|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
42053416|NCT00773734|75861847|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
42053417|NCT00773734|75861848|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
42053418|NCT00773734|75861849|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
42053419|NCT00773734|75861850|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
42053420|NCT00773734|75861851|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
42053421|NCT00773734|75861852|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
42053422|NCT00773734|75861847|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
42053423|NCT00773734|75861848|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
42053424|NCT00773734|75861849|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
42053425|NCT00773734|75861850|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
42053426|NCT00773734|75861851|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
42053427|NCT00773734|75861852|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
42053428|NCT00773734|75861847|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
42053429|NCT00773734|75861848|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
42053430|NCT00773734|75861849|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
42053431|NCT00773734|75861850|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
42053432|NCT00773734|75861851|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
42053433|NCT00773734|75861852|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
42053434|NCT00773734|75861847|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
42053435|NCT00773734|75861848|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
42053436|NCT00773734|75861849|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
42053437|NCT00773734|75861850|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
42053438|NCT00773734|75861851|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
42053439|NCT00773734|75861852|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
42053440|NCT00773734|75861847|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
42053441|NCT00773734|75861848|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
42053442|NCT00773734|75861849|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
42053443|NCT00773734|75861850|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
42053444|NCT00773734|75861851|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
42053445|NCT00773734|75861852|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
42053446|NCT00773734|75861847|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
42053447|NCT00773734|75861848|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
42053448|NCT00773734|75861849|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
42053449|NCT00773734|75861850|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
42053450|NCT00773734|75861851|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
42053451|NCT00773734|75861852|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
42053452|NCT00773734|75861847|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
42053453|NCT00773734|75861848|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
42053454|NCT00773734|75861849|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
42053455|NCT00773734|75861850|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
42053456|NCT00773734|75861851|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
42053457|NCT00773734|75861852|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
42053458|NCT00773734|75861847|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
42053459|NCT00773734|75861848|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
42053460|NCT00773734|75861849|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
42053461|NCT00773734|75861850|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
42053462|NCT00773734|75861851|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
42053463|NCT00773734|75861852|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
42053464|NCT00773734|75861847|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
42053465|NCT00773734|75861848|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
42053466|NCT00773734|75861849|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
42053467|NCT00773734|75861850|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
42053468|NCT00773734|75861851|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
42173786|NCT00321464|75980581|FG000|Overall Study|Protocol deviation|0|||
42173787|NCT00321464|75980582|FG001|Overall Study|Protocol deviation|2|||
42173788|NCT00321464|75980581|FG000|Overall Study|Ineligibility determined|2|||
42173789|NCT00321464|75980582|FG001|Overall Study|Ineligibility determined|1|||
42291646|NCT01970488|76125154|FG003|Part 1: Through Week 16|Protocol Violation|0|||
42291647|NCT01970488|76125155|FG004|Part 1: Through Week 16|Protocol Violation|0|||
42173790|NCT00321464|75980581|FG000|Overall Study|Other|21|||
42173791|NCT00321464|75980582|FG001|Overall Study|Other|18|||
42291648|NCT01970488|76125151|FG000|Part 1: Through Week 16|Adverse Event|6|||
42291649|NCT01970488|76125152|FG001|Part 1: Through Week 16|Adverse Event|5|||
42291650|NCT01970488|76125153|FG002|Part 1: Through Week 16|Adverse Event|0|||
42291651|NCT01970488|76125154|FG003|Part 1: Through Week 16|Adverse Event|0|||
42173792|NCT02889796|75980592|FG000|Overall Study|Withdrew Consent|18|||
42053469|NCT00773734|75861852|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
42053470|NCT00773734|75861847|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
42053471|NCT00773734|75861848|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
42053472|NCT00773734|75861849|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
42053473|NCT00773734|75861850|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
42053474|NCT00773734|75861851|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
42053475|NCT00773734|75861852|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
42053476|NCT00773734|75861847|FG000|Extension: Active Treatment Week 24-52|Other|0|||
42053477|NCT00773734|75861848|FG001|Extension: Active Treatment Week 24-52|Other|0|||
42053478|NCT00773734|75861849|FG002|Extension: Active Treatment Week 24-52|Other|1|||
42053479|NCT00773734|75861850|FG003|Extension: Active Treatment Week 24-52|Other|2|||
42053480|NCT00773734|75861851|FG004|Extension: Active Treatment Week 24-52|Other|0|||
42053481|NCT00773734|75861852|FG005|Extension: Active Treatment Week 24-52|Other|1|||
42053482|NCT00773734|75861847|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
42053483|NCT00773734|75861848|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
42053484|NCT00773734|75861849|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
42053485|NCT00773734|75861850|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
42053486|NCT00773734|75861851|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
42053487|NCT00773734|75861852|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
42053488|NCT00773734|75861847|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
42053489|NCT00773734|75861848|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
42053490|NCT00773734|75861849|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
42053491|NCT00773734|75861850|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
42053492|NCT00773734|75861851|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
42053493|NCT00773734|75861852|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
42053494|NCT00773734|75861847|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
42053495|NCT00773734|75861848|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
42053496|NCT00773734|75861849|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
42053497|NCT00773734|75861850|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
42053498|NCT00773734|75861851|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
42053499|NCT00773734|75861852|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
42053500|NCT00773734|75861847|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
42053501|NCT00773734|75861848|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
42053502|NCT00773734|75861849|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
42053503|NCT00773734|75861850|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
42053504|NCT00773734|75861851|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
42053505|NCT00773734|75861852|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
42053506|NCT01009580|75861911|FG000|Overall Study|Adverse Event|4|||
42053507|NCT01009580|75861912|FG001|Overall Study|Adverse Event|4|||
42053508|NCT01009580|75861911|FG000|Overall Study|Lack of Efficacy|0|||
42053509|NCT01009580|75861912|FG001|Overall Study|Lack of Efficacy|1|||
42053510|NCT01009580|75861911|FG000|Overall Study|Protocol Violation|2|||
42053511|NCT01009580|75861912|FG001|Overall Study|Protocol Violation|3|||
42053512|NCT01009580|75861911|FG000|Overall Study|Withdrawal Criteria|4|||
42053513|NCT01009580|75861912|FG001|Overall Study|Withdrawal Criteria|6|||
42053514|NCT01009580|75861911|FG000|Overall Study|Unclassified|17|||
42053515|NCT01009580|75861912|FG001|Overall Study|Unclassified|21|||
42053516|NCT01009346|75861918|FG000|Overall Study|Adverse Event|4|||
42053517|NCT01001702|75861923|FG000|Overall Study|Lost to Follow-up|7|||
42053518|NCT01001702|75861923|FG000|Overall Study|Adverse Event|7|||
42053519|NCT01001702|75861923|FG000|Overall Study|Sponsor Discontinued Study|4|||
42053520|NCT01001702|75861923|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
42053521|NCT01001702|75861923|FG000|Overall Study|Investigator withdrew Subject|10|||
42053522|NCT01001702|75861923|FG000|Overall Study|Withdrawal by Subject|19|||
42053523|NCT01001702|75861923|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
42053524|NCT01070069|75861932|FG000|Overall Study|Death|1|||
42053525|NCT01070069|75861933|FG001|Overall Study|Death|0|||
42053526|NCT01070069|75861934|FG002|Overall Study|Death|2|||
42053527|NCT01070069|75861935|FG003|Overall Study|Death|0|||
42053528|NCT01070069|75861936|FG004|Overall Study|Death|1|||
42291652|NCT01970488|76125155|FG004|Part 1: Through Week 16|Adverse Event|0|||
42053529|NCT01070069|75861932|FG000|Overall Study|Withdrawal by Subject|1|||
42053530|NCT01070069|75861933|FG001|Overall Study|Withdrawal by Subject|1|||
42053531|NCT01070069|75861934|FG002|Overall Study|Withdrawal by Subject|4|||
42053532|NCT01070069|75861935|FG003|Overall Study|Withdrawal by Subject|0|||
42291653|NCT01970488|76125151|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
42053533|NCT01070069|75861936|FG004|Overall Study|Withdrawal by Subject|0|||
42053534|NCT01070069|75861932|FG000|Overall Study|Lost to Follow-up|4|||
42053535|NCT01070069|75861933|FG001|Overall Study|Lost to Follow-up|1|||
42053536|NCT01070069|75861934|FG002|Overall Study|Lost to Follow-up|0|||
42053537|NCT01070069|75861935|FG003|Overall Study|Lost to Follow-up|0|||
42053538|NCT01070069|75861936|FG004|Overall Study|Lost to Follow-up|3|||
42053539|NCT01068665|75861953|FG000|Overall Study|Adverse Event|5|||
42053540|NCT01068665|75861954|FG001|Overall Study|Adverse Event|4|||
42053541|NCT01068665|75861953|FG000|Overall Study|Lack of Efficacy|0|||
42053542|NCT01068665|75861954|FG001|Overall Study|Lack of Efficacy|2|||
42053543|NCT01068665|75861953|FG000|Overall Study|Protocol Violation|5|||
42053544|NCT01068665|75861954|FG001|Overall Study|Protocol Violation|2|||
42053545|NCT01068665|75861953|FG000|Overall Study|Withdrawal Criteria|3|||
42053546|NCT01068665|75861954|FG001|Overall Study|Withdrawal Criteria|9|||
42053547|NCT01068665|75861953|FG000|Overall Study|Other|17|||
42053548|NCT01068665|75861954|FG001|Overall Study|Other|12|||
42053549|NCT01001390|75861960|FG000|Overall Study|Failure to wear AFO device|2|||
42053550|NCT01001390|75861961|FG001|Overall Study|Failure to wear AFO device|0|||
42053551|NCT00772954|75861969|FG000|Overall Study|Adverse Event|0|||
42053552|NCT00772954|75861970|FG001|Overall Study|Adverse Event|0|||
42053553|NCT00772954|75861971|FG002|Overall Study|Adverse Event|1|||
42053554|NCT00781768|75861985|FG000|Overall Study|Not transplanted.|0|||
42053555|NCT00781768|75861986|FG001|Overall Study|Not transplanted.|2|||
42053556|NCT01005680|75861994|FG000|Overall Study|Lost to Follow-up|4|||
42053557|NCT01005680|75861995|FG001|Overall Study|Lost to Follow-up|6|||
42053558|NCT01005680|75861994|FG000|Overall Study|Withdrawal by Subject|1|||
42053559|NCT01005680|75861995|FG001|Overall Study|Withdrawal by Subject|4|||
42053560|NCT01005680|75861994|FG000|Overall Study|Physician Decision|1|||
42053561|NCT01005680|75861995|FG001|Overall Study|Physician Decision|1|||
42053562|NCT01005602|75862004|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
42053563|NCT01005602|75862005|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
42053564|NCT01068509|75862021|FG000|Overall Study|Death|0|||
42053565|NCT01068509|75862022|FG001|Overall Study|Death|0|||
42053566|NCT01068509|75862023|FG002|Overall Study|Death|1|||
42053567|NCT01068509|75862021|FG000|Overall Study|Disease Progression|5|||
42053568|NCT01068509|75862022|FG001|Overall Study|Disease Progression|20|||
42053569|NCT01068509|75862023|FG002|Overall Study|Disease Progression|18|||
42053570|NCT01068509|75862021|FG000|Overall Study|Lost to Follow-up|1|||
42053571|NCT01068509|75862022|FG001|Overall Study|Lost to Follow-up|0|||
42053572|NCT01068509|75862023|FG002|Overall Study|Lost to Follow-up|0|||
42053573|NCT01068509|75862021|FG000|Overall Study|Withdrew Consent|0|||
42053574|NCT01068509|75862022|FG001|Overall Study|Withdrew Consent|1|||
42053575|NCT01068509|75862023|FG002|Overall Study|Withdrew Consent|2|||
42053576|NCT01068509|75862021|FG000|Overall Study|Reason Not Specified|0|||
42053577|NCT01068509|75862022|FG001|Overall Study|Reason Not Specified|1|||
42053578|NCT01068509|75862023|FG002|Overall Study|Reason Not Specified|0|||
42053579|NCT01009034|75862030|FG000|Overall Study|Lost to Follow-up|2|||
42053580|NCT01009034|75862030|FG000|Overall Study|Withdrawal by Subject|2|||
42053581|NCT00768430|75862036|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
42053582|NCT00768430|75862037|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
42053583|NCT01064297|75862046|FG000|Overall Study|Lost to Follow-up|791|||
42053584|NCT01064297|75862047|FG001|Overall Study|Lost to Follow-up|48|||
42053585|NCT01064297|75862048|FG002|Overall Study|Lost to Follow-up|133|||
42053586|NCT00781456|75862065|FG000|Overall Study|Adverse Event|3|||
42053587|NCT00781456|75862066|FG001|Overall Study|Adverse Event|3|||
42053588|NCT00781456|75862065|FG000|Overall Study|Withdrawal by Subject|3|||
42053589|NCT00781456|75862066|FG001|Overall Study|Withdrawal by Subject|5|||
42053590|NCT00781456|75862065|FG000|Overall Study|Protocol Violation|4|||
42053591|NCT00781456|75862066|FG001|Overall Study|Protocol Violation|1|||
42053592|NCT00781456|75862065|FG000|Overall Study|Noncompliance With Protocol|1|||
42053593|NCT00781456|75862066|FG001|Overall Study|Noncompliance With Protocol|1|||
42053594|NCT00781456|75862065|FG000|Overall Study|Lost to Follow-up|10|||
42053595|NCT00781456|75862066|FG001|Overall Study|Lost to Follow-up|5|||
42053596|NCT00781456|75862065|FG000|Overall Study|Other Reason, Unknown|0|||
42053597|NCT00781456|75862066|FG001|Overall Study|Other Reason, Unknown|1|||
42053598|NCT00587158|75862074|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
42053599|NCT00587158|75862075|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
42053600|NCT00587158|75862074|FG000|Overall Study|Physician Decision|0|||
42053601|NCT00587158|75862075|FG001|Overall Study|Physician Decision|1|||
42053602|NCT00587158|75862074|FG000|Overall Study|Lost to Follow-up|1|||
42053603|NCT00587158|75862075|FG001|Overall Study|Lost to Follow-up|2|||
42053604|NCT00587158|75862074|FG000|Overall Study|Death|0|||
42053605|NCT00587158|75862075|FG001|Overall Study|Death|1|||
42053606|NCT00587158|75862074|FG000|Overall Study|Subject did not want to take study med|0|||
42053607|NCT00587158|75862075|FG001|Overall Study|Subject did not want to take study med|1|||
42053608|NCT00582907|75862081|FG000|1st Course|Withdrawal by Subject|1|||
42053609|NCT00582907|75862082|FG001|1st Course|Withdrawal by Subject|0|||
42053610|NCT00582907|75862083|FG002|1st Course|Withdrawal by Subject|0|||
42053611|NCT00582907|75862084|FG003|1st Course|Withdrawal by Subject|0|||
42053612|NCT00582907|75862081|FG000|1st Course|Lost to Follow-up|0|||
42053613|NCT00582907|75862082|FG001|1st Course|Lost to Follow-up|0|||
42053614|NCT00582907|75862083|FG002|1st Course|Lost to Follow-up|0|||
42053615|NCT00582907|75862084|FG003|1st Course|Lost to Follow-up|1|||
42053616|NCT00582907|75862081|FG000|2nd Course|Lack of Efficacy|1|||
42053617|NCT00582907|75862082|FG001|2nd Course|Lack of Efficacy|0|||
42053618|NCT00582907|75862083|FG002|2nd Course|Lack of Efficacy|0|||
42053619|NCT00582907|75862084|FG003|2nd Course|Lack of Efficacy|0|||
42053620|NCT01062113|75862093|FG000|Overall Study|Adverse Event|1|||
42053621|NCT01062113|75862094|FG001|Overall Study|Adverse Event|0|||
42053622|NCT01062113|75862095|FG002|Overall Study|Adverse Event|0|||
42053623|NCT01062113|75862093|FG000|Overall Study|Lack of Efficacy|38|||
42053624|NCT01062113|75862094|FG001|Overall Study|Lack of Efficacy|22|||
42053625|NCT01062113|75862095|FG002|Overall Study|Lack of Efficacy|31|||
42053626|NCT01062113|75862093|FG000|Overall Study|Withdrawal by Subject|1|||
42053627|NCT01062113|75862094|FG001|Overall Study|Withdrawal by Subject|0|||
42053628|NCT01062113|75862095|FG002|Overall Study|Withdrawal by Subject|0|||
42053629|NCT00772330|75862103|FG000|Overall Study|Lost to Follow-up|3|||
42053630|NCT01038869|75862110|FG000|Overall Study|Withdrawal by Subject|1|||
42053631|NCT01038869|75862110|FG000|Overall Study|Lost to Follow-up|6|||
42053632|NCT01038713|75862121|FG000|Overall Study|Patient to hospice|1|||
42053633|NCT01038713|75862122|FG001|Overall Study|Patient to hospice|1|||
42053634|NCT01038713|75862123|FG002|Overall Study|Patient to hospice|1|||
42053635|NCT01038713|75862121|FG000|Overall Study|Lost to Follow-up|3|||
42053636|NCT01038713|75862122|FG001|Overall Study|Lost to Follow-up|0|||
42053637|NCT01038713|75862123|FG002|Overall Study|Lost to Follow-up|0|||
42053638|NCT01038713|75862121|FG000|Overall Study|Neuroendocrine Tumor|0|||
42053639|NCT01038713|75862122|FG001|Overall Study|Neuroendocrine Tumor|1|||
42053640|NCT01038713|75862123|FG002|Overall Study|Neuroendocrine Tumor|0|||
42053641|NCT01038713|75862121|FG000|Overall Study|died from PEP|0|||
42053642|NCT01038713|75862122|FG001|Overall Study|died from PEP|1|||
42053643|NCT01038713|75862123|FG002|Overall Study|died from PEP|0|||
42053644|NCT01038713|75862121|FG000|Overall Study|Autoimmune Pancreatitis|1|||
42053645|NCT01038713|75862122|FG001|Overall Study|Autoimmune Pancreatitis|0|||
42053646|NCT01038713|75862123|FG002|Overall Study|Autoimmune Pancreatitis|0|||
42053647|NCT00768040|75862133|FG000|Overall Study|Adverse Event|3|||
42053648|NCT00768040|75862134|FG001|Overall Study|Adverse Event|2|||
42053649|NCT00768040|75862133|FG000|Overall Study|Abnormal laboratory value|1|||
42053650|NCT00768040|75862134|FG001|Overall Study|Abnormal laboratory value|1|||
42053651|NCT00767806|75862142|FG000|Overall Study|Adverse Event|30|||
42053652|NCT00767806|75862143|FG001|Overall Study|Adverse Event|11|||
42053653|NCT00767806|75862142|FG000|Overall Study|Withdrawal by Subject|8|||
42053654|NCT00767806|75862143|FG001|Overall Study|Withdrawal by Subject|13|||
42053655|NCT00767806|75862142|FG000|Overall Study|Protocol Violation|6|||
42053656|NCT00767806|75862143|FG001|Overall Study|Protocol Violation|5|||
42053657|NCT00767806|75862142|FG000|Overall Study|Lack of Efficacy|1|||
42053658|NCT00767806|75862143|FG001|Overall Study|Lack of Efficacy|9|||
42053659|NCT00767806|75862142|FG000|Overall Study|Physician Decision|4|||
42053660|NCT00767806|75862143|FG001|Overall Study|Physician Decision|3|||
42053661|NCT00767806|75862142|FG000|Overall Study|Lost to Follow-up|1|||
42053662|NCT00767806|75862143|FG001|Overall Study|Lost to Follow-up|4|||
42053663|NCT00767806|75862142|FG000|Overall Study|Entry Criteria Not Met|1|||
42053664|NCT00767806|75862143|FG001|Overall Study|Entry Criteria Not Met|1|||
42053665|NCT00767806|75862142|FG000|Overall Study|Sponsor Decision|0|||
42053666|NCT00767806|75862143|FG001|Overall Study|Sponsor Decision|1|||
42053667|NCT00780910|75862149|FG000|Overall Study|Adverse Event|2|||
42053668|NCT00767104|75862155|FG000|Overall Study|Lost to Follow-up|1|||
42053669|NCT00767104|75862156|FG001|Overall Study|Lost to Follow-up|2|||
42053670|NCT00771472|75862164|FG000|Overall Study|Physician Decision|2|||
42053671|NCT00771472|75862165|FG001|Overall Study|Physician Decision|3|||
42053672|NCT00771472|75862164|FG000|Overall Study|Progressive Disease|3|||
42053673|NCT00771472|75862165|FG001|Overall Study|Progressive Disease|1|||
42053674|NCT00771472|75862164|FG000|Overall Study|Protocol Violation|1|||
42053675|NCT00771472|75862165|FG001|Overall Study|Protocol Violation|0|||
42053676|NCT00771316|75862172|FG000|Overall Study|Adverse Event|0|||
42053677|NCT00771316|75862173|FG001|Overall Study|Adverse Event|1|||
42053678|NCT00771316|75862172|FG000|Overall Study|Patient withdrew consent|1|||
42053679|NCT00771316|75862173|FG001|Overall Study|Patient withdrew consent|0|||
42053680|NCT00771316|75862172|FG000|Overall Study|Discontinued due to early termination|1|||
42053681|NCT00771316|75862173|FG001|Overall Study|Discontinued due to early termination|0|||
42053682|NCT05066165|75862185|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
42053683|NCT05066165|75862186|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
42053684|NCT05066165|75862185|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
42053685|NCT05066165|75862186|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
42053686|NCT04731298|75862198|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
42053687|NCT04731298|75862199|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
42053688|NCT04676412|75862208|FG000|Overall Study|Death|17|||
42053689|NCT04676412|75862209|FG001|Overall Study|Death|23|||
42053690|NCT04676412|75862208|FG000|Overall Study|Withdrawal by Subject|0|||
42053691|NCT04676412|75862209|FG001|Overall Study|Withdrawal by Subject|2|||
42053692|NCT04676412|75862208|FG000|Overall Study|Participants ongoing|32|||
42053693|NCT04676412|75862209|FG001|Overall Study|Participants ongoing|33|||
42053694|NCT04641975|75862219|FG000|Overall Study|Protocol Violation|1|||
42053695|NCT04641975|75862220|FG001|Overall Study|Protocol Violation|2|||
42053696|NCT04641975|75862221|FG002|Overall Study|Protocol Violation|0|||
42053697|NCT04641975|75862222|FG003|Overall Study|Protocol Violation|0|||
42053698|NCT04641975|75862219|FG000|Overall Study|Adverse Event|0|||
42053699|NCT04641975|75862220|FG001|Overall Study|Adverse Event|0|||
42053700|NCT04641975|75862221|FG002|Overall Study|Adverse Event|1|||
42053701|NCT04641975|75862222|FG003|Overall Study|Adverse Event|1|||
42053702|NCT04641975|75862219|FG000|Overall Study|Withdrawal by Subject|1|||
42053703|NCT04641975|75862220|FG001|Overall Study|Withdrawal by Subject|0|||
42053704|NCT04641975|75862221|FG002|Overall Study|Withdrawal by Subject|0|||
42053705|NCT04641975|75862222|FG003|Overall Study|Withdrawal by Subject|0|||
42053706|NCT04633200|75862237|FG000|Overall Study|Lost to Follow-up|3|||
42053707|NCT04633200|75862238|FG001|Overall Study|Lost to Follow-up|5|||
42053708|NCT04435366|75862265|FG000|Overall Study|Adverse Event|3|||
42053709|NCT04435366|75862266|FG001|Overall Study|Adverse Event|2|||
42053710|NCT04435366|75862265|FG000|Overall Study|Death|2|||
42053711|NCT04435366|75862266|FG001|Overall Study|Death|1|||
42053712|NCT04435366|75862265|FG000|Overall Study|Lost to Follow-up|2|||
42053713|NCT04435366|75862266|FG001|Overall Study|Lost to Follow-up|1|||
42053714|NCT04435366|75862265|FG000|Overall Study|Withdrawal by Subject|17|||
42053715|NCT04435366|75862266|FG001|Overall Study|Withdrawal by Subject|13|||
42053716|NCT04435366|75862265|FG000|Overall Study|Patient non-compliance|1|||
42053717|NCT04435366|75862266|FG001|Overall Study|Patient non-compliance|0|||
42053718|NCT03439137|75862274|FG000|Overall Study|Adverse Event|16|||
42053719|NCT03439137|75862275|FG001|Overall Study|Adverse Event|12|||
42053720|NCT03439137|75862274|FG000|Overall Study|Physician Decision|0|||
42053721|NCT03439137|75862275|FG001|Overall Study|Physician Decision|5|||
42053722|NCT03439137|75862274|FG000|Overall Study|Withdrawal by Subject|14|||
42053723|NCT03439137|75862275|FG001|Overall Study|Withdrawal by Subject|4|||
42053724|NCT03439137|75862274|FG000|Overall Study|Conducting rescue therapy|2|||
42053725|NCT03439137|75862275|FG001|Overall Study|Conducting rescue therapy|1|||
42053726|NCT03439137|75862274|FG000|Overall Study|Difficult to control Hb|10|||
42053727|NCT03439137|75862275|FG001|Overall Study|Difficult to control Hb|2|||
42053728|NCT03439137|75862274|FG000|Overall Study|Initiation of a renal transplant|0|||
42053729|NCT03439137|75862275|FG001|Overall Study|Initiation of a renal transplant|2|||
42053730|NCT03402386|75862281|FG000|Overall Study|Adverse Event|3|||
42053731|NCT03402386|75862281|FG000|Overall Study|Physician Decision|1|||
42053732|NCT03402386|75862281|FG000|Overall Study|Difficult to control Hb|2|||
42053733|NCT03329196|75862287|FG000|Overall Study|Adverse Event|10|||
42053734|NCT03329196|75862288|FG001|Overall Study|Adverse Event|5|||
42053735|NCT03329196|75862287|FG000|Overall Study|Physician Decision|2|||
42053736|NCT03329196|75862288|FG001|Overall Study|Physician Decision|2|||
42053737|NCT03329196|75862287|FG000|Overall Study|Withdrawal by Subject|11|||
42053738|NCT03329196|75862288|FG001|Overall Study|Withdrawal by Subject|3|||
42053739|NCT03329196|75862287|FG000|Overall Study|Hepatic function abnormalities|0|||
42053740|NCT03329196|75862288|FG001|Overall Study|Hepatic function abnormalities|1|||
42053741|NCT03329196|75862287|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
42053742|NCT03329196|75862288|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
42053743|NCT03329196|75862287|FG000|Overall Study|Difficult to control Hb|2|||
42053744|NCT03329196|75862288|FG001|Overall Study|Difficult to control Hb|3|||
42053745|NCT03329196|75862287|FG000|Overall Study|Dialysis or renal transplant|13|||
42053746|NCT03329196|75862288|FG001|Overall Study|Dialysis or renal transplant|15|||
42053747|NCT02967692|75862298|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
42053748|NCT02967692|75862299|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
42053749|NCT02967692|75862300|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
42053750|NCT02967692|75862301|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
42053751|NCT02967692|75862298|FG000|Overall Study|Progressive disease|3|||
42053752|NCT02967692|75862299|FG001|Overall Study|Progressive disease|15|||
42053753|NCT02967692|75862300|FG002|Overall Study|Progressive disease|99|||
42053754|NCT02967692|75862301|FG003|Overall Study|Progressive disease|128|||
42053755|NCT02967692|75862298|FG000|Overall Study|Subject/guardian decision|1|||
42053756|NCT02967692|75862299|FG001|Overall Study|Subject/guardian decision|1|||
42053757|NCT02967692|75862300|FG002|Overall Study|Subject/guardian decision|6|||
42053758|NCT02967692|75862301|FG003|Overall Study|Subject/guardian decision|13|||
42053759|NCT02967692|75862298|FG000|Overall Study|Death|0|||
42053760|NCT02967692|75862299|FG001|Overall Study|Death|1|||
42053761|NCT02967692|75862300|FG002|Overall Study|Death|10|||
42053762|NCT02967692|75862301|FG003|Overall Study|Death|9|||
42053763|NCT02967692|75862298|FG000|Overall Study|Protocol deviation|1|||
42053764|NCT02967692|75862299|FG001|Overall Study|Protocol deviation|0|||
42053765|NCT02967692|75862300|FG002|Overall Study|Protocol deviation|1|||
42053766|NCT02967692|75862301|FG003|Overall Study|Protocol deviation|1|||
42053767|NCT02967692|75862298|FG000|Overall Study|Lost to Follow-up|0|||
42053768|NCT02967692|75862299|FG001|Overall Study|Lost to Follow-up|0|||
42053769|NCT02967692|75862300|FG002|Overall Study|Lost to Follow-up|1|||
42053770|NCT02967692|75862301|FG003|Overall Study|Lost to Follow-up|0|||
42053771|NCT02967692|75862298|FG000|Overall Study|Physician Decision|0|||
42053772|NCT02967692|75862299|FG001|Overall Study|Physician Decision|0|||
42053773|NCT02967692|75862300|FG002|Overall Study|Physician Decision|13|||
42053774|NCT02967692|75862301|FG003|Overall Study|Physician Decision|9|||
42053775|NCT02967692|75862298|FG000|Overall Study|Adverse Event|1|||
42053776|NCT02967692|75862299|FG001|Overall Study|Adverse Event|9|||
42053777|NCT02967692|75862300|FG002|Overall Study|Adverse Event|51|||
42053778|NCT02967692|75862301|FG003|Overall Study|Adverse Event|23|||
42053779|NCT02949219|75862319|FG000|Overall Study|Withdrawal by Subject|1|||
42053780|NCT02873195|75862329|FG000|Overall Study|Ineligible|5|||
42053781|NCT02873195|75862330|FG001|Overall Study|Ineligible|0|||
42053782|NCT02026232|75862353|FG000|Overall Study|incomplete visit/missing data|3|||
42053783|NCT02026232|75862354|FG001|Overall Study|incomplete visit/missing data|2|||
42053784|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
42053785|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
42053786|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
42053787|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
42053788|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
42053789|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
42053790|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
42053791|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
42053792|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
42053793|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
42053794|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
42053795|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
42053796|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
42053797|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
42053798|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
42053799|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
42053800|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
42053801|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
42053802|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
42053803|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
42053804|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
42053805|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
42053806|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
42053807|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
42053808|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
42053809|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
42053810|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
42053811|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
42053812|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
42053813|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
42053814|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
42053815|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
42053816|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
42053817|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
42053818|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
42053819|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
42053820|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
42053821|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
42053822|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
42053823|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
42053824|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
42053825|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
42053826|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
42053827|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
42053828|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
42053829|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
42356938|NCT01392573|76202163|FG000|Overall Study|Lack of Efficacy|1|||
42356939|NCT01392573|76202164|FG001|Overall Study|Lack of Efficacy|2|||
42356940|NCT01392573|76202163|FG000|Overall Study|Protocol Violation|0|||
42356941|NCT01392573|76202164|FG001|Overall Study|Protocol Violation|2|||
42053830|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
42053831|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
42053832|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
42053833|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
42053834|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
42053835|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
42053836|NCT02008357|75862362|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
42053837|NCT02008357|75862363|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
42053838|NCT02008357|75862362|FG000|Open-label Extension Period|Adverse Event|8|||
42053839|NCT02008357|75862363|FG001|Open-label Extension Period|Adverse Event|7|||
42053840|NCT02008357|75862362|FG000|Open-label Extension Period|Death|7|||
42053841|NCT02008357|75862363|FG001|Open-label Extension Period|Death|4|||
42053842|NCT02008357|75862362|FG000|Open-label Extension Period|Lack of Efficacy|9|||
42053843|NCT02008357|75862363|FG001|Open-label Extension Period|Lack of Efficacy|5|||
42053844|NCT02008357|75862362|FG000|Open-label Extension Period|Lost to Follow-up|2|||
42053845|NCT02008357|75862363|FG001|Open-label Extension Period|Lost to Follow-up|2|||
42053846|NCT02008357|75862362|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
42053847|NCT02008357|75862363|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
42053848|NCT02008357|75862362|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
42053849|NCT02008357|75862363|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
42053850|NCT02008357|75862362|FG000|Open-label Extension Period|Safety Risk|2|||
42053851|NCT02008357|75862363|FG001|Open-label Extension Period|Safety Risk|1|||
42053852|NCT02008357|75862362|FG000|Open-label Extension Period|Non-Compliance|0|||
42053853|NCT02008357|75862363|FG001|Open-label Extension Period|Non-Compliance|1|||
42053854|NCT02008357|75862362|FG000|Open-label Extension Period|Investigator Recommendation|0|||
42053855|NCT02008357|75862363|FG001|Open-label Extension Period|Investigator Recommendation|1|||
42053856|NCT02008357|75862362|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
42053857|NCT02008357|75862363|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
42053858|NCT02008357|75862362|FG000|Open-label Extension Period|Coordinating Center Request|2|||
42053859|NCT02008357|75862363|FG001|Open-label Extension Period|Coordinating Center Request|4|||
42053860|NCT02008357|75862362|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
42053861|NCT02008357|75862363|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
42053862|NCT02008357|75862362|FG000|Open-label Extension Period|Study Ended|20|||
42053863|NCT02008357|75862363|FG001|Open-label Extension Period|Study Ended|25|||
42053864|NCT02008357|75862362|FG000|Open-label Extension Period|Personal Reasons|0|||
42053865|NCT02008357|75862363|FG001|Open-label Extension Period|Personal Reasons|1|||
42053866|NCT02008357|75862362|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
42053867|NCT02008357|75862363|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
42053868|NCT02008357|75862362|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
42053869|NCT02008357|75862363|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
42053870|NCT02008357|75862362|FG000|Open-label Extension Period|Other|2|||
42053871|NCT02008357|75862363|FG001|Open-label Extension Period|Other|0|||
42053872|NCT01784068|75862373|FG000|NTCS Phase|Adverse Event|5|||
42053873|NCT01784068|75862374|FG001|NTCS Phase|Adverse Event|0|||
42053874|NCT01784068|75862373|FG000|NTCS Phase|Physician Decision|2|||
42053875|NCT01784068|75862374|FG001|NTCS Phase|Physician Decision|0|||
42053876|NCT01784068|75862373|FG000|NTCS Phase|Patient/guardian decision|3|||
42053877|NCT01784068|75862374|FG001|NTCS Phase|Patient/guardian decision|0|||
42053878|NCT01784068|75862373|FG000|NTCS Phase|Death|2|||
42053879|NCT01784068|75862374|FG001|NTCS Phase|Death|0|||
42053880|NCT01784068|75862373|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
42053881|NCT01784068|75862374|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
42053882|NCT01784068|75862373|FG000|TFR Phase|Physician Decision|0|||
42053883|NCT01784068|75862374|FG001|TFR Phase|Physician Decision|1|||
42173793|NCT02889796|75980593|FG001|Overall Study|Withdrew Consent|29|||
42016308|NCT01262456|75823495|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
42016309|NCT01262456|75823496|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
42016310|NCT01262456|75823497|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
42016311|NCT00932893|75823515|FG000|Overall Study|Death|115|||
42016312|NCT00932893|75823516|FG001|Overall Study|Death|24|||
42016313|NCT00932893|75823515|FG000|Overall Study|Lost to Follow-up|8|||
42016314|NCT00932893|75823516|FG001|Overall Study|Lost to Follow-up|0|||
42016315|NCT00932893|75823515|FG000|Overall Study|Withdrawal by Subject|5|||
42016316|NCT00932893|75823516|FG001|Overall Study|Withdrawal by Subject|2|||
42016317|NCT00932893|75823515|FG000|Overall Study|Other|5|||
42016318|NCT00932893|75823516|FG001|Overall Study|Other|144|||
42016319|NCT01260896|75823525|FG000|First Intervention|Withdrawn Due to Emesis|2|||
42016320|NCT01260896|75823526|FG001|First Intervention|Withdrawn Due to Emesis|0|||
42016321|NCT00932737|75823534|FG000|Overall Study|Not treated in second episode|1|||
42053884|NCT01784068|75862373|FG000|TFR Phase|Patient/guardian decision|0|||
42053885|NCT01784068|75862374|FG001|TFR Phase|Patient/guardian decision|3|||
42053886|NCT01784068|75862373|FG000|TFR Phase|Death|0|||
42053887|NCT01784068|75862374|FG001|TFR Phase|Death|1|||
42053888|NCT01784068|75862373|FG000|TFR Phase|Lack of Efficacy|0|||
42053889|NCT01784068|75862374|FG001|TFR Phase|Lack of Efficacy|88|||
42053890|NCT01065454|75862389|FG000|Treatment|Adverse Event|7|||
42053891|NCT01065454|75862390|FG001|Treatment|Adverse Event|4|||
42053892|NCT01065454|75862391|FG002|Treatment|Adverse Event|3|||
42053893|NCT01065454|75862392|FG003|Treatment|Adverse Event|6|||
42053894|NCT01065454|75862389|FG000|Treatment|Death|1|||
42053895|NCT01065454|75862390|FG001|Treatment|Death|0|||
42053896|NCT01065454|75862391|FG002|Treatment|Death|0|||
42053897|NCT01065454|75862392|FG003|Treatment|Death|0|||
42053898|NCT01065454|75862389|FG000|Treatment|Non-compliance|1|||
42053899|NCT01065454|75862390|FG001|Treatment|Non-compliance|0|||
42053900|NCT01065454|75862391|FG002|Treatment|Non-compliance|0|||
42053901|NCT01065454|75862392|FG003|Treatment|Non-compliance|1|||
42053902|NCT01065454|75862389|FG000|Treatment|Protocol Decision|0|||
42053903|NCT01065454|75862390|FG001|Treatment|Protocol Decision|0|||
42053904|NCT01065454|75862391|FG002|Treatment|Protocol Decision|3|||
42053905|NCT01065454|75862392|FG003|Treatment|Protocol Decision|2|||
42053906|NCT01065454|75862389|FG000|Treatment|Protocol Violation|1|||
42053907|NCT01065454|75862390|FG001|Treatment|Protocol Violation|0|||
42053908|NCT01065454|75862391|FG002|Treatment|Protocol Violation|1|||
42053909|NCT01065454|75862392|FG003|Treatment|Protocol Violation|0|||
42053910|NCT01065454|75862389|FG000|Treatment|Withdrawal by Subject|3|||
42053911|NCT01065454|75862390|FG001|Treatment|Withdrawal by Subject|1|||
42053912|NCT01065454|75862391|FG002|Treatment|Withdrawal by Subject|2|||
42053913|NCT01065454|75862392|FG003|Treatment|Withdrawal by Subject|3|||
42053914|NCT01065454|75862389|FG000|Follow up|Adverse Event|1|||
42053915|NCT01065454|75862390|FG001|Follow up|Adverse Event|0|||
42053916|NCT01065454|75862391|FG002|Follow up|Adverse Event|0|||
42053917|NCT01065454|75862392|FG003|Follow up|Adverse Event|1|||
42053918|NCT01065454|75862389|FG000|Follow up|Death|0|||
42053919|NCT01065454|75862390|FG001|Follow up|Death|1|||
42053920|NCT01065454|75862391|FG002|Follow up|Death|1|||
42053921|NCT01065454|75862392|FG003|Follow up|Death|0|||
42053922|NCT01065454|75862389|FG000|Follow up|Lost to Follow-up|0|||
42053923|NCT01065454|75862390|FG001|Follow up|Lost to Follow-up|0|||
42053924|NCT01065454|75862391|FG002|Follow up|Lost to Follow-up|0|||
42053925|NCT01065454|75862392|FG003|Follow up|Lost to Follow-up|1|||
42053926|NCT01065454|75862389|FG000|Follow up|Progressive disease|0|||
42053927|NCT01065454|75862390|FG001|Follow up|Progressive disease|0|||
42053928|NCT01065454|75862391|FG002|Follow up|Progressive disease|0|||
42053929|NCT01065454|75862392|FG003|Follow up|Progressive disease|1|||
42053930|NCT01065454|75862389|FG000|Follow up|Withdrawal by Subject|1|||
42053931|NCT01065454|75862390|FG001|Follow up|Withdrawal by Subject|1|||
42053932|NCT01065454|75862391|FG002|Follow up|Withdrawal by Subject|1|||
42053933|NCT01065454|75862392|FG003|Follow up|Withdrawal by Subject|0|||
42053934|NCT01065454|75862389|FG000|Follow up|study ongoing|37|||
42053935|NCT01065454|75862390|FG001|Follow up|study ongoing|22|||
42053936|NCT01065454|75862391|FG002|Follow up|study ongoing|15|||
42053937|NCT01065454|75862392|FG003|Follow up|study ongoing|41|||
42053938|NCT00775463|75862404|FG000|Overall Study|Withdrawal by Subject|0|||
42053939|NCT00775463|75862405|FG001|Overall Study|Withdrawal by Subject|1|||
42053940|NCT00775463|75862404|FG000|Overall Study|Adverse Event|7|||
42053941|NCT00775463|75862405|FG001|Overall Study|Adverse Event|9|||
42053942|NCT00775463|75862404|FG000|Overall Study|Protocol Violation|2|||
42053943|NCT00775463|75862405|FG001|Overall Study|Protocol Violation|2|||
42291654|NCT01970488|76125152|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
42291655|NCT01970488|76125153|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
42291656|NCT01970488|76125154|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
42291657|NCT01970488|76125155|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
42291658|NCT01970488|76125151|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
42291659|NCT01970488|76125152|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
42173794|NCT02889796|75980594|FG002|Overall Study|Withdrew Consent|20|||
42291660|NCT01970488|76125153|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
42053944|NCT00775463|75862404|FG000|Overall Study|Lost to Follow-up|1|||
42053945|NCT00775463|75862405|FG001|Overall Study|Lost to Follow-up|0|||
42053946|NCT00775463|75862404|FG000|Overall Study|Lack of Efficacy|1|||
42053947|NCT00775463|75862405|FG001|Overall Study|Lack of Efficacy|1|||
42053948|NCT00406640|75862419|FG000|Acute Phase|Adverse Event|18|||
42173795|NCT02889796|75980595|FG003|Overall Study|Withdrew Consent|1|||
42053949|NCT00406640|75862420|FG001|Acute Phase|Adverse Event|13|||
42053950|NCT00406640|75862419|FG000|Acute Phase|Failed to Return|5|||
42053951|NCT00406640|75862420|FG001|Acute Phase|Failed to Return|1|||
42053952|NCT00406640|75862419|FG000|Acute Phase|Physician Decision|0|||
42053953|NCT00406640|75862420|FG001|Acute Phase|Physician Decision|1|||
42053954|NCT00406640|75862419|FG000|Acute Phase|Lost to Follow-up|7|||
42053955|NCT00406640|75862420|FG001|Acute Phase|Lost to Follow-up|4|||
42053956|NCT00406640|75862419|FG000|Acute Phase|Protocol deviation|4|||
42173796|NCT02889796|75980596|FG004|Overall Study|Withdrew Consent|2|||
42053957|NCT00406640|75862420|FG001|Acute Phase|Protocol deviation|10|||
42053958|NCT00406640|75862419|FG000|Acute Phase|Protocol Violation|3|||
42053959|NCT00406640|75862420|FG001|Acute Phase|Protocol Violation|2|||
42053960|NCT00406640|75862419|FG000|Acute Phase|Withdrawal by Subject|11|||
42053961|NCT00406640|75862420|FG001|Acute Phase|Withdrawal by Subject|9|||
42053962|NCT00406640|75862419|FG000|Acute Phase|Lack of Efficacy|3|||
42053963|NCT00406640|75862420|FG001|Acute Phase|Lack of Efficacy|3|||
42053964|NCT00406640|75862419|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
42053965|NCT00406640|75862420|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
42053966|NCT00406640|75862419|FG000|DB Continuation Phase for Responders|Death|1|||
42053967|NCT00406640|75862420|FG001|DB Continuation Phase for Responders|Death|0|||
42053968|NCT00406640|75862419|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
42053969|NCT00406640|75862420|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
42053970|NCT00406640|75862419|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
42053971|NCT00406640|75862420|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
42053972|NCT00406640|75862419|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
42053973|NCT00406640|75862420|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
42053974|NCT00406640|75862419|FG000|DB Continuation Phase for Responders|non-compliance|7|||
42053975|NCT00406640|75862420|FG001|DB Continuation Phase for Responders|non-compliance|5|||
42053976|NCT00406640|75862419|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
42053977|NCT00406640|75862420|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
42053978|NCT00406640|75862419|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
42053979|NCT00406640|75862420|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
42053980|NCT00406640|75862419|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
42356942|NCT01392573|76202163|FG000|Overall Study|Withdrawal Criteria|13|||
42356943|NCT01392573|76202164|FG001|Overall Study|Withdrawal Criteria|15|||
42053981|NCT00406640|75862420|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
42053982|NCT00406640|75862419|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
42053983|NCT00406640|75862420|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
42053984|NCT00406640|75862419|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
42053985|NCT00406640|75862420|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
42053986|NCT00406640|75862419|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
42053987|NCT00406640|75862420|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
42053988|NCT00406640|75862419|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
42053989|NCT00406640|75862420|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
42053990|NCT00406640|75862419|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
42053991|NCT00406640|75862420|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
42053992|NCT00406640|75862419|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
42053993|NCT00406640|75862420|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
42053994|NCT00406640|75862419|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
42053995|NCT00406640|75862420|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
42053996|NCT00229931|75862434|FG000|Overall Study|Death|1|||
42053997|NCT00229931|75862435|FG001|Overall Study|Death|0|||
42053998|NCT00229931|75862434|FG000|Overall Study|Lost to Follow-up|3|||
42053999|NCT00229931|75862435|FG001|Overall Study|Lost to Follow-up|2|||
42054000|NCT00150969|75862443|FG000|24 Month Main Study|Adverse Event|3|||
42054001|NCT00150969|75862444|FG001|24 Month Main Study|Adverse Event|4|||
42054002|NCT00150969|75862443|FG000|24 Month Main Study|Death|1|||
42054003|NCT00150969|75862444|FG001|24 Month Main Study|Death|1|||
42356944|NCT01392573|76202163|FG000|Overall Study|Site closure|8|||
42356945|NCT01392573|76202164|FG001|Overall Study|Site closure|7|||
42016322|NCT00932737|75823535|FG001|Overall Study|Not treated in second episode|0|||
42016323|NCT00932737|75823534|FG000|Overall Study|Adverse Event|0|||
42016324|NCT00932737|75823535|FG001|Overall Study|Adverse Event|1|||
42016325|NCT00939523|75823541|FG000|Overall Study|Lack of Efficacy|1|||
42016326|NCT00939523|75823541|FG000|Overall Study|Physician Decision|2|||
42016327|NCT01260584|75823549|FG000|Period 1|Protocol Violation|0|||
42016328|NCT01260584|75823550|FG001|Period 1|Protocol Violation|0|||
42016329|NCT01260584|75823551|FG002|Period 1|Protocol Violation|1|||
42016330|NCT01260584|75823552|FG003|Period 1|Protocol Violation|1|||
42016331|NCT01260584|75823549|FG000|Period 1|Adverse Event|0|||
42016332|NCT01260584|75823550|FG001|Period 1|Adverse Event|0|||
42016333|NCT01260584|75823551|FG002|Period 1|Adverse Event|1|||
42016334|NCT01260584|75823552|FG003|Period 1|Adverse Event|0|||
42016335|NCT01260584|75823549|FG000|Period 2|Protocol Violation|0|||
42016336|NCT01260584|75823550|FG001|Period 2|Protocol Violation|2|||
42016337|NCT01260584|75823551|FG002|Period 2|Protocol Violation|3|||
42016338|NCT01260584|75823552|FG003|Period 2|Protocol Violation|1|||
42054004|NCT00150969|75862443|FG000|24 Month Main Study|Lack of Efficacy|1|||
42054005|NCT00150969|75862444|FG001|24 Month Main Study|Lack of Efficacy|8|||
42054006|NCT00150969|75862443|FG000|24 Month Main Study|Lost to Follow-up|3|||
42054007|NCT00150969|75862444|FG001|24 Month Main Study|Lost to Follow-up|2|||
42054008|NCT00150969|75862443|FG000|24 Month Main Study|Protocol Violation|4|||
42054009|NCT00150969|75862444|FG001|24 Month Main Study|Protocol Violation|2|||
42054010|NCT00150969|75862443|FG000|24 Month Main Study|Withdrawal by Subject|7|||
42054011|NCT00150969|75862444|FG001|24 Month Main Study|Withdrawal by Subject|4|||
42054012|NCT00150969|75862443|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
42054013|NCT00150969|75862444|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
42054014|NCT00150969|75862443|FG000|24-48 Month Extension|Lack of Efficacy|0|||
42054015|NCT00150969|75862444|FG001|24-48 Month Extension|Lack of Efficacy|1|||
42054016|NCT00150969|75862443|FG000|24-48 Month Extension|Adverse Event|1|||
42054017|NCT00150969|75862444|FG001|24-48 Month Extension|Adverse Event|3|||
42054018|NCT00150969|75862443|FG000|24-48 Month Extension|Other Reason|81|||
42054019|NCT00150969|75862444|FG001|24-48 Month Extension|Other Reason|91|||
42054020|NCT00770770|75862453|FG000|Overall Study|Lost to Follow-up|1|||
42054021|NCT00770770|75862454|FG001|Overall Study|Lost to Follow-up|0|||
42054022|NCT00770770|75862453|FG000|Overall Study|Withdrawal by Subject|1|||
42054023|NCT00770770|75862454|FG001|Overall Study|Withdrawal by Subject|0|||
42054024|NCT00770770|75862453|FG000|Overall Study|Death|0|||
42054025|NCT00770770|75862454|FG001|Overall Study|Death|1|||
42054026|NCT00770770|75862453|FG000|Overall Study|Study Terminated|8|||
42054027|NCT00770770|75862454|FG001|Overall Study|Study Terminated|0|||
42054028|NCT00766636|75862462|FG000|Overall Study|Withdrawal by Subject|1|||
42054029|NCT00766636|75862463|FG001|Overall Study|Withdrawal by Subject|1|||
42054030|NCT00766636|75862462|FG000|Overall Study|Incomplete Treatment|0|||
42054031|NCT00766636|75862463|FG001|Overall Study|Incomplete Treatment|1|||
42054032|NCT00766636|75862462|FG000|Overall Study|Adverse Event|1|||
42054033|NCT00766636|75862463|FG001|Overall Study|Adverse Event|0|||
42054034|NCT00766636|75862462|FG000|Overall Study|Disease Progression|1|||
42054035|NCT00766636|75862463|FG001|Overall Study|Disease Progression|0|||
42054036|NCT00770692|75862473|FG000|Overall Study|Withdrawal by Subject|7|||
42054037|NCT00770692|75862474|FG001|Overall Study|Withdrawal by Subject|9|||
42054038|NCT00770692|75862475|FG002|Overall Study|Withdrawal by Subject|9|||
42054039|NCT00770692|75862476|FG003|Overall Study|Withdrawal by Subject|6|||
42054040|NCT00770692|75862473|FG000|Overall Study|Adverse Event|3|||
42054041|NCT00770692|75862474|FG001|Overall Study|Adverse Event|0|||
42054042|NCT00770692|75862475|FG002|Overall Study|Adverse Event|4|||
42054043|NCT00770692|75862476|FG003|Overall Study|Adverse Event|4|||
42054044|NCT00770692|75862473|FG000|Overall Study|Investigator judgment|2|||
42054045|NCT00770692|75862474|FG001|Overall Study|Investigator judgment|0|||
42054046|NCT00770692|75862475|FG002|Overall Study|Investigator judgment|1|||
42054047|NCT00770692|75862476|FG003|Overall Study|Investigator judgment|1|||
42054048|NCT02743819|75862490|FG000|Overall Study|Lack of Efficacy|5|||
42054049|NCT02743819|75862490|FG000|Overall Study|Death|2|||
42054050|NCT02743819|75862490|FG000|Overall Study|Adverse Event|1|||
42054051|NCT01004822|75862502|FG000|Overall Study|Objective progression or relapse|3|||
42054052|NCT01004822|75862503|FG001|Overall Study|Objective progression or relapse|3|||
42054053|NCT01004822|75862504|FG002|Overall Study|Objective progression or relapse|0|||
42054054|NCT01004822|75862505|FG003|Overall Study|Objective progression or relapse|1|||
42054055|NCT01004822|75862506|FG004|Overall Study|Objective progression or relapse|2|||
42054056|NCT01004822|75862507|FG005|Overall Study|Objective progression or relapse|2|||
42054057|NCT01004822|75862508|FG006|Overall Study|Objective progression or relapse|1|||
42054058|NCT01004822|75862509|FG007|Overall Study|Objective progression or relapse|4|||
42054059|NCT01004822|75862502|FG000|Overall Study|Global deterioration of health status|0|||
42054060|NCT01004822|75862503|FG001|Overall Study|Global deterioration of health status|0|||
42054061|NCT01004822|75862504|FG002|Overall Study|Global deterioration of health status|0|||
42356946|NCT01392573|76202163|FG000|Overall Study|Unclassified|9|||
42356947|NCT01392573|76202164|FG001|Overall Study|Unclassified|6|||
42054062|NCT01004822|75862505|FG003|Overall Study|Global deterioration of health status|1|||
42054063|NCT01004822|75862506|FG004|Overall Study|Global deterioration of health status|0|||
42054064|NCT01004822|75862507|FG005|Overall Study|Global deterioration of health status|0|||
42054065|NCT01004822|75862508|FG006|Overall Study|Global deterioration of health status|1|||
42054066|NCT01004822|75862509|FG007|Overall Study|Global deterioration of health status|0|||
42054067|NCT01004822|75862502|FG000|Overall Study|No longer willing to continue|0|||
42054068|NCT01004822|75862503|FG001|Overall Study|No longer willing to continue|0|||
42054069|NCT01004822|75862504|FG002|Overall Study|No longer willing to continue|0|||
42054070|NCT01004822|75862505|FG003|Overall Study|No longer willing to continue|1|||
42054071|NCT01004822|75862506|FG004|Overall Study|No longer willing to continue|2|||
42054072|NCT01004822|75862507|FG005|Overall Study|No longer willing to continue|1|||
42356948|NCT01392495|76202170|FG000|Overall Study|Death|3|||
42356949|NCT01392495|76202170|FG000|Overall Study|Administrative problems|8|||
42356950|NCT01392495|76202170|FG000|Overall Study|Withdrawal by Subject|2|||
42356951|NCT01392495|76202170|FG000|Overall Study|Adverse Event|3|||
42054073|NCT01004822|75862508|FG006|Overall Study|No longer willing to continue|1|||
42054074|NCT01004822|75862509|FG007|Overall Study|No longer willing to continue|0|||
42054075|NCT01004822|75862502|FG000|Overall Study|Adverse Event|0|||
42054076|NCT01004822|75862503|FG001|Overall Study|Adverse Event|0|||
42054077|NCT01004822|75862504|FG002|Overall Study|Adverse Event|0|||
42054078|NCT01004822|75862505|FG003|Overall Study|Adverse Event|0|||
42054079|NCT01004822|75862506|FG004|Overall Study|Adverse Event|0|||
42054080|NCT01004822|75862507|FG005|Overall Study|Adverse Event|0|||
42054081|NCT01004822|75862508|FG006|Overall Study|Adverse Event|1|||
42054082|NCT01004822|75862509|FG007|Overall Study|Adverse Event|1|||
42054083|NCT01004822|75862502|FG000|Overall Study|Other|0|||
42054084|NCT01004822|75862503|FG001|Overall Study|Other|0|||
42054085|NCT01004822|75862504|FG002|Overall Study|Other|4|||
42054086|NCT01004822|75862505|FG003|Overall Study|Other|1|||
42054087|NCT01004822|75862506|FG004|Overall Study|Other|0|||
42054088|NCT01004822|75862507|FG005|Overall Study|Other|1|||
42054089|NCT01004822|75862508|FG006|Overall Study|Other|0|||
42054090|NCT01004822|75862509|FG007|Overall Study|Other|0|||
42054091|NCT01001234|75862534|FG000|Overall Study|Withdrawal by Subject|2|||
42054092|NCT01001234|75862535|FG001|Overall Study|Withdrawal by Subject|0|||
42054093|NCT01001234|75862536|FG002|Overall Study|Withdrawal by Subject|3|||
42054094|NCT01001234|75862537|FG003|Overall Study|Withdrawal by Subject|0|||
42054095|NCT01001234|75862538|FG004|Overall Study|Withdrawal by Subject|0|||
42054096|NCT01001234|75862534|FG000|Overall Study|Protocol Violation|34|||
42054097|NCT01001234|75862535|FG001|Overall Study|Protocol Violation|3|||
42054098|NCT01001234|75862536|FG002|Overall Study|Protocol Violation|19|||
42054099|NCT01001234|75862537|FG003|Overall Study|Protocol Violation|18|||
42054100|NCT01001234|75862538|FG004|Overall Study|Protocol Violation|0|||
42291661|NCT01970488|76125154|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
42291662|NCT01970488|76125155|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
42054101|NCT01001234|75862534|FG000|Overall Study|Lost to Follow-up|0|||
42054102|NCT01001234|75862535|FG001|Overall Study|Lost to Follow-up|0|||
42054103|NCT01001234|75862536|FG002|Overall Study|Lost to Follow-up|1|||
42054104|NCT01001234|75862537|FG003|Overall Study|Lost to Follow-up|2|||
42054105|NCT01001234|75862538|FG004|Overall Study|Lost to Follow-up|0|||
42054106|NCT01001234|75862534|FG000|Overall Study|Physician Decision|1|||
42054107|NCT01001234|75862535|FG001|Overall Study|Physician Decision|0|||
42054108|NCT01001234|75862536|FG002|Overall Study|Physician Decision|0|||
42054109|NCT01001234|75862537|FG003|Overall Study|Physician Decision|0|||
42054110|NCT01001234|75862538|FG004|Overall Study|Physician Decision|0|||
42291663|NCT01970488|76125151|FG000|Part 2: Post Week 16|Physician Decision|0|||
42291664|NCT01970488|76125152|FG001|Part 2: Post Week 16|Physician Decision|0|||
42291665|NCT01970488|76125153|FG002|Part 2: Post Week 16|Physician Decision|0|||
42291666|NCT01970488|76125154|FG003|Part 2: Post Week 16|Physician Decision|0|||
42356952|NCT01405053|76202178|FG000|Overall Study|Adverse Event|3|||
42016339|NCT01260584|75823549|FG000|Period 2|Adverse Event|1|||
42016340|NCT01260584|75823550|FG001|Period 2|Adverse Event|0|||
42016341|NCT01260584|75823551|FG002|Period 2|Adverse Event|2|||
42016342|NCT01260584|75823552|FG003|Period 2|Adverse Event|0|||
42016343|NCT01260584|75823549|FG000|Period 2|Withdrawal by Subject|0|||
42016344|NCT01260584|75823550|FG001|Period 2|Withdrawal by Subject|1|||
42016345|NCT01260584|75823551|FG002|Period 2|Withdrawal by Subject|0|||
42016346|NCT01260584|75823552|FG003|Period 2|Withdrawal by Subject|0|||
42016347|NCT00927589|75823562|FG000|Overall Study|Death|1|||
42016348|NCT00927589|75823562|FG000|Overall Study|Physician Decision|1|||
42016349|NCT00927589|75823562|FG000|Overall Study|Withdrawal by Subject|3|||
42016350|NCT00927589|75823562|FG000|Overall Study|Adverse Event|2|||
42016351|NCT00927589|75823562|FG000|Overall Study|Disease Progression|8|||
42016352|NCT00927589|75823562|FG000|Overall Study|Non-compliance|1|||
42016353|NCT00932425|75823568|FG000|Overall Study|Lost to Follow-up|0|||
42016354|NCT00932425|75823569|FG001|Overall Study|Lost to Follow-up|1|||
42016355|NCT00932425|75823568|FG000|Overall Study|Withdrawal by Subject|0|||
42016356|NCT00932425|75823569|FG001|Overall Study|Withdrawal by Subject|1|||
42016357|NCT05867342|75823575|FG000|Overall Study|Investigator Decision|3|||
42016358|NCT05867342|75823576|FG001|Overall Study|Investigator Decision|3|||
42016359|NCT04340362|75823611|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
42016360|NCT03980808|75823633|FG000|Overall Study|Lost to Follow-up|2|||
42016361|NCT03980808|75823634|FG001|Overall Study|Lost to Follow-up|2|||
42016362|NCT03943953|75823651|FG000|Trial of ITG 1|Lost to Follow-up|19|||
42016363|NCT03943953|75823652|FG001|Trial of ITG 1|Lost to Follow-up|1|||
42016364|NCT03943953|75823651|FG000|Trial of ITG 2|Lost to Follow-up|8|||
42016365|NCT03943953|75823652|FG001|Trial of ITG 2|Lost to Follow-up|0|||
42016366|NCT03943953|75823651|FG000|Trial of ITG 3|Lost to Follow-up|2|||
42054111|NCT01001234|75862534|FG000|Overall Study|Not Treated: Adverse Event|1|||
42054112|NCT01001234|75862535|FG001|Overall Study|Not Treated: Adverse Event|0|||
42054113|NCT01001234|75862536|FG002|Overall Study|Not Treated: Adverse Event|0|||
42054114|NCT01001234|75862537|FG003|Overall Study|Not Treated: Adverse Event|0|||
42054115|NCT01001234|75862538|FG004|Overall Study|Not Treated: Adverse Event|0|||
42054116|NCT01001234|75862534|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
42054117|NCT01001234|75862535|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
42054118|NCT01001234|75862536|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
42054119|NCT01001234|75862537|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
42054120|NCT01001234|75862538|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
42054121|NCT01001234|75862534|FG000|Overall Study|Not Treated: Protocol Violation|3|||
42054122|NCT01001234|75862535|FG001|Overall Study|Not Treated: Protocol Violation|0|||
42054123|NCT01001234|75862536|FG002|Overall Study|Not Treated: Protocol Violation|0|||
42054124|NCT01001234|75862537|FG003|Overall Study|Not Treated: Protocol Violation|0|||
42054125|NCT01001234|75862538|FG004|Overall Study|Not Treated: Protocol Violation|0|||
42054126|NCT01001234|75862534|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
42054127|NCT01001234|75862535|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
42054128|NCT01001234|75862536|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
42054129|NCT01001234|75862537|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
42054130|NCT01001234|75862538|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
42054131|NCT01001234|75862534|FG000|Overall Study|Not Treated: Pregnancy|3|||
42054132|NCT01001234|75862535|FG001|Overall Study|Not Treated: Pregnancy|0|||
42054133|NCT01001234|75862536|FG002|Overall Study|Not Treated: Pregnancy|0|||
42054134|NCT01001234|75862537|FG003|Overall Study|Not Treated: Pregnancy|0|||
42054135|NCT01001234|75862538|FG004|Overall Study|Not Treated: Pregnancy|0|||
42054136|NCT01001234|75862534|FG000|Overall Study|Not Treated: Physician Decision|37|||
42054137|NCT01001234|75862535|FG001|Overall Study|Not Treated: Physician Decision|4|||
42054138|NCT01001234|75862536|FG002|Overall Study|Not Treated: Physician Decision|0|||
42054139|NCT01001234|75862537|FG003|Overall Study|Not Treated: Physician Decision|0|||
42054140|NCT01001234|75862538|FG004|Overall Study|Not Treated: Physician Decision|0|||
42054141|NCT01001234|75862534|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
42054142|NCT01001234|75862535|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
42054143|NCT01001234|75862536|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
42054144|NCT01001234|75862537|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
42054145|NCT01001234|75862538|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
42054146|NCT01004510|75862544|FG000|Overall Study|Adverse Event|1|||
42054147|NCT01004432|75862548|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
42054148|NCT01004432|75862549|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
42054149|NCT01004432|75862550|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
42054150|NCT01004432|75862551|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
42054151|NCT01004432|75862552|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
42054152|NCT01004432|75862548|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
42054153|NCT01004432|75862549|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
42054154|NCT01004432|75862550|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
42054155|NCT01004432|75862551|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
42054156|NCT01004432|75862552|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
42054157|NCT01004432|75862548|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
42054158|NCT01004432|75862549|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
42054159|NCT01004432|75862550|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
42054160|NCT01004432|75862551|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
42054161|NCT01004432|75862552|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
42054162|NCT01004432|75862548|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
42054163|NCT01004432|75862549|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
42054164|NCT01004432|75862550|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
42054165|NCT01004432|75862551|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
42054166|NCT01004432|75862552|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
42054167|NCT01004432|75862548|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
42054168|NCT01004432|75862549|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
42054169|NCT01004432|75862550|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
42054170|NCT01004432|75862551|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
42054171|NCT01004432|75862552|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
42054172|NCT01004432|75862548|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
42054173|NCT01004432|75862549|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
42054174|NCT01004432|75862550|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
42054175|NCT01004432|75862551|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
42054176|NCT01004432|75862552|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
42054177|NCT01004432|75862548|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
42054178|NCT01004432|75862549|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
42054179|NCT01004432|75862550|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
42054180|NCT01004432|75862551|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
42054181|NCT01004432|75862552|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
42054182|NCT01004432|75862548|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
42173797|NCT02889796|75980597|FG005|Overall Study|Withdrew Consent|35|||
42173798|NCT02889796|75980592|FG000|Overall Study|Investigator's Discretion|10|||
42054183|NCT01004432|75862549|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
42054184|NCT01004432|75862550|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
42054185|NCT01004432|75862551|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
42054186|NCT01004432|75862552|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
42054187|NCT01004432|75862548|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
42054188|NCT01004432|75862549|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
42054189|NCT01004432|75862550|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
42054190|NCT01004432|75862551|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
42054191|NCT01004432|75862552|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
42054192|NCT01004432|75862548|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
42054193|NCT01004432|75862549|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
42054194|NCT01004432|75862550|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
42054195|NCT01004432|75862551|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
42054196|NCT01004432|75862552|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
42054197|NCT01004432|75862548|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
42054198|NCT01004432|75862549|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
42054199|NCT01004432|75862550|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
42054200|NCT01004432|75862551|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
42054201|NCT01004432|75862552|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
42054202|NCT01004432|75862548|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
42054203|NCT01004432|75862549|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
42054204|NCT01004432|75862550|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
42054205|NCT01004432|75862551|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
42054206|NCT01004432|75862552|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
42054207|NCT01004432|75862548|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
42054208|NCT01004432|75862549|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
42054209|NCT01004432|75862550|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
42054210|NCT01004432|75862551|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
42054211|NCT01004432|75862552|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
42054212|NCT01004432|75862548|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
42054213|NCT01004432|75862549|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
42054214|NCT01004432|75862550|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
42054215|NCT01004432|75862551|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
42054216|NCT01004432|75862552|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
42054217|NCT01004432|75862548|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
42054218|NCT01004432|75862549|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
42054219|NCT01004432|75862550|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
42054220|NCT01004432|75862551|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
42054221|NCT01004432|75862552|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
42054222|NCT01000610|75862566|FG000|Overall Study|Adverse Event|1|||
42054223|NCT01000610|75862566|FG000|Overall Study|Lost to Follow-up|4|||
42054224|NCT01000610|75862566|FG000|Overall Study|Treatment failure|1|||
42054225|NCT01877655|75862572|FG000|Overall Study|Death|57|||
42054226|NCT01877655|75862573|FG001|Overall Study|Death|52|||
42054227|NCT01877655|75862572|FG000|Overall Study|Withdrawal by Subject|18|||
42054228|NCT01877655|75862573|FG001|Overall Study|Withdrawal by Subject|26|||
42054229|NCT01877655|75862572|FG000|Overall Study|Physician Decision|11|||
42054230|NCT01877655|75862573|FG001|Overall Study|Physician Decision|10|||
42054231|NCT01877655|75862572|FG000|Overall Study|Miscellaneous|4|||
42054232|NCT01877655|75862573|FG001|Overall Study|Miscellaneous|4|||
42054233|NCT01877655|75862572|FG000|Overall Study|Randomized but Never Received Drug|8|||
42054234|NCT01877655|75862573|FG001|Overall Study|Randomized but Never Received Drug|5|||
42054235|NCT00586924|75862585|FG000|Overall Study|Adverse event/serious adverse event|0|||
42054236|NCT00586924|75862586|FG001|Overall Study|Adverse event/serious adverse event|0|||
42054237|NCT00586924|75862587|FG002|Overall Study|Adverse event/serious adverse event|0|||
42054238|NCT00586924|75862588|FG003|Overall Study|Adverse event/serious adverse event|1|||
42054239|NCT00586924|75862589|FG004|Overall Study|Adverse event/serious adverse event|0|||
42054240|NCT00586924|75862590|FG005|Overall Study|Adverse event/serious adverse event|2|||
42054241|NCT00586924|75862585|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
42054242|NCT00586924|75862586|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
42054243|NCT00586924|75862587|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
42173799|NCT02889796|75980593|FG001|Overall Study|Investigator's Discretion|9|||
42173800|NCT02889796|75980594|FG002|Overall Study|Investigator's Discretion|10|||
42291667|NCT01970488|76125155|FG004|Part 2: Post Week 16|Physician Decision|1|||
42291668|NCT01970488|76125151|FG000|Part 2: Post Week 16|Non-compliance|0|||
42054244|NCT00586924|75862588|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
42054245|NCT00586924|75862589|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
42054246|NCT00586924|75862590|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
42291669|NCT01970488|76125152|FG001|Part 2: Post Week 16|Non-compliance|0|||
42054247|NCT00586924|75862585|FG000|Overall Study|Disease progression|0|||
42054248|NCT00586924|75862586|FG001|Overall Study|Disease progression|0|||
42054249|NCT00586924|75862587|FG002|Overall Study|Disease progression|0|||
42054250|NCT00586924|75862588|FG003|Overall Study|Disease progression|1|||
42054251|NCT00586924|75862589|FG004|Overall Study|Disease progression|1|||
42054252|NCT00586924|75862590|FG005|Overall Study|Disease progression|0|||
42054253|NCT00586924|75862585|FG000|Overall Study|Development of neutralizing antibodies|2|||
42054254|NCT00586924|75862586|FG001|Overall Study|Development of neutralizing antibodies|2|||
42054255|NCT00586924|75862587|FG002|Overall Study|Development of neutralizing antibodies|2|||
42054256|NCT00586924|75862588|FG003|Overall Study|Development of neutralizing antibodies|0|||
42054257|NCT00586924|75862589|FG004|Overall Study|Development of neutralizing antibodies|0|||
42054258|NCT00586924|75862590|FG005|Overall Study|Development of neutralizing antibodies|22|||
42054259|NCT00586924|75862585|FG000|Overall Study|Complete response|0|||
42054260|NCT00586924|75862586|FG001|Overall Study|Complete response|1|||
42054261|NCT00586924|75862587|FG002|Overall Study|Complete response|0|||
42054262|NCT00586924|75862588|FG003|Overall Study|Complete response|0|||
42054263|NCT00586924|75862589|FG004|Overall Study|Complete response|2|||
42054264|NCT00586924|75862590|FG005|Overall Study|Complete response|2|||
42054265|NCT00586924|75862585|FG000|Overall Study|Other|1|||
42054266|NCT00586924|75862586|FG001|Overall Study|Other|0|||
42054267|NCT00586924|75862587|FG002|Overall Study|Other|1|||
42054268|NCT00586924|75862588|FG003|Overall Study|Other|1|||
42054269|NCT00586924|75862589|FG004|Overall Study|Other|1|||
42054270|NCT00586924|75862590|FG005|Overall Study|Other|6|||
42054271|NCT01000376|75862606|FG000|Cycle 1 Day 1|Adverse Event|1|||
42054272|NCT01000376|75862607|FG001|Cycle 1 Day 1|Adverse Event|0|||
42054273|NCT01000376|75862606|FG000|Cycle 1 Day 1|Progressive Disease|1|||
42054274|NCT01000376|75862607|FG001|Cycle 1 Day 1|Progressive Disease|0|||
42054275|NCT01038635|75862622|FG000|Overall Study|Disease Progression|2|||
42054276|NCT01038635|75862623|FG001|Overall Study|Disease Progression|0|||
42054277|NCT01038635|75862624|FG002|Overall Study|Disease Progression|0|||
42054278|NCT01038635|75862625|FG003|Overall Study|Disease Progression|0|||
42054279|NCT01038635|75862626|FG004|Overall Study|Disease Progression|0|||
42054280|NCT01038635|75862627|FG005|Overall Study|Disease Progression|0|||
42054281|NCT01038635|75862628|FG006|Overall Study|Disease Progression|1|||
42054282|NCT01038635|75862629|FG007|Overall Study|Disease Progression|4|||
42054283|NCT01038635|75862630|FG008|Overall Study|Disease Progression|0|||
42054284|NCT01038635|75862622|FG000|Overall Study|Death|0|||
42054285|NCT01038635|75862623|FG001|Overall Study|Death|0|||
42054286|NCT01038635|75862624|FG002|Overall Study|Death|0|||
42054287|NCT01038635|75862625|FG003|Overall Study|Death|0|||
42054288|NCT01038635|75862626|FG004|Overall Study|Death|1|||
42054289|NCT01038635|75862627|FG005|Overall Study|Death|0|||
42054290|NCT01038635|75862628|FG006|Overall Study|Death|1|||
42054291|NCT01038635|75862629|FG007|Overall Study|Death|1|||
42054292|NCT01038635|75862630|FG008|Overall Study|Death|2|||
42054293|NCT01000064|75862651|FG000|Overall Study|Withdrawal by Subject|1|||
42054294|NCT01000064|75862652|FG001|Overall Study|Withdrawal by Subject|1|||
42054295|NCT00766090|75862663|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42054296|NCT00766090|75862664|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42054297|NCT00766090|75862665|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42054298|NCT00766090|75862666|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42054299|NCT00766090|75862667|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42054300|NCT00766090|75862668|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42054301|NCT00766090|75862669|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42054302|NCT00766090|75862670|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42054303|NCT00766090|75862671|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
42054304|NCT00766090|75862672|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42054305|NCT00766090|75862673|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42054306|NCT00766090|75862674|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42054307|NCT00766090|75862663|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
42054308|NCT00766090|75862664|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
42054309|NCT00766090|75862665|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
42054310|NCT00766090|75862666|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
42054311|NCT00766090|75862667|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
42054312|NCT00766090|75862668|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
42054313|NCT00766090|75862669|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
42054314|NCT00766090|75862670|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
42054315|NCT00766090|75862671|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
42054316|NCT00766090|75862672|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
42054317|NCT00766090|75862673|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
42054318|NCT00766090|75862674|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
42054319|NCT00766090|75862663|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
42054320|NCT00766090|75862664|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42054321|NCT00766090|75862665|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42054322|NCT00766090|75862666|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
42054323|NCT00766090|75862667|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42054324|NCT00766090|75862668|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42054325|NCT00766090|75862669|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42054326|NCT00766090|75862670|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42054327|NCT00766090|75862671|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42054328|NCT00766090|75862672|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42054329|NCT00766090|75862673|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42054330|NCT00766090|75862674|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42054331|NCT00766090|75862663|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
42054332|NCT00766090|75862664|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
42054333|NCT00766090|75862665|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
42054334|NCT00766090|75862666|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
42054335|NCT00766090|75862667|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
42054336|NCT00766090|75862668|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
42054337|NCT00766090|75862669|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
42054338|NCT00766090|75862670|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
42054339|NCT00766090|75862671|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
42054340|NCT00766090|75862672|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
42054341|NCT00766090|75862673|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
42054342|NCT00766090|75862674|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
42054343|NCT00766090|75862663|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42054344|NCT00766090|75862664|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42054345|NCT00766090|75862665|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42054346|NCT00766090|75862666|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42054347|NCT00766090|75862667|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
42054348|NCT00766090|75862668|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42054349|NCT00766090|75862669|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42054350|NCT00766090|75862670|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42054351|NCT00766090|75862671|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42054352|NCT00766090|75862672|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42054353|NCT00766090|75862673|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42054354|NCT00766090|75862674|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
42054355|NCT00766090|75862663|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
42054356|NCT00766090|75862664|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
42054357|NCT00766090|75862665|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
42054358|NCT00766090|75862666|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
42054359|NCT00766090|75862667|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
42054360|NCT00766090|75862668|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
42054361|NCT00766090|75862669|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
42054362|NCT00766090|75862670|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
42054363|NCT00766090|75862671|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
42054364|NCT00766090|75862672|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
42054365|NCT00766090|75862673|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
42054366|NCT00766090|75862674|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
42054367|NCT00766090|75862663|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
42054368|NCT00766090|75862664|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
42054369|NCT00766090|75862665|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
42054370|NCT00766090|75862666|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
42054371|NCT00766090|75862667|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
42054372|NCT00766090|75862668|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
42054373|NCT00766090|75862669|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
42054374|NCT00766090|75862670|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
42054375|NCT00766090|75862671|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
42054376|NCT00766090|75862672|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
42054377|NCT00766090|75862673|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
42054378|NCT00766090|75862674|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
42054379|NCT00766090|75862663|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
42054380|NCT00766090|75862664|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
42054381|NCT00766090|75862665|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
42173801|NCT02889796|75980595|FG003|Overall Study|Investigator's Discretion|3|||
42173802|NCT02889796|75980596|FG004|Overall Study|Investigator's Discretion|0|||
42054382|NCT00766090|75862666|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
42054383|NCT00766090|75862667|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
42054384|NCT00766090|75862668|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
42054385|NCT00766090|75862669|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
42054386|NCT00766090|75862670|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
42054387|NCT00766090|75862671|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
42054388|NCT00766090|75862672|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
42054389|NCT00766090|75862673|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
42173803|NCT02889796|75980597|FG005|Overall Study|Investigator's Discretion|15|||
42054390|NCT00766090|75862674|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
42054391|NCT00766090|75862663|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
42054392|NCT00766090|75862664|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
42054393|NCT00766090|75862665|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
42054394|NCT00766090|75862666|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
42054395|NCT00766090|75862667|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
42054396|NCT00766090|75862668|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
42054397|NCT00766090|75862669|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
42054398|NCT00766090|75862670|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
42054399|NCT00766090|75862671|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
42054400|NCT00766090|75862672|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
42054401|NCT00766090|75862673|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
42054402|NCT00766090|75862674|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
42054403|NCT00766090|75862663|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
42054404|NCT00766090|75862664|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
42054405|NCT00766090|75862665|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
42054406|NCT00766090|75862666|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
42054407|NCT00766090|75862667|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
42054408|NCT00766090|75862668|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
42054409|NCT00766090|75862669|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
42054410|NCT00766090|75862670|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
42054411|NCT00766090|75862671|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
42054412|NCT00766090|75862672|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
42054413|NCT00766090|75862673|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
42054414|NCT00766090|75862674|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
42054415|NCT00580801|75862691|FG000|Overall Study|Physician Decision|1|||
42054416|NCT00580801|75862692|FG001|Overall Study|Physician Decision|0|||
42054417|NCT00580801|75862693|FG002|Overall Study|Physician Decision|0|||
42054418|NCT00580801|75862691|FG000|Overall Study|Adverse Event|2|||
42054419|NCT00580801|75862692|FG001|Overall Study|Adverse Event|0|||
42054420|NCT00580801|75862693|FG002|Overall Study|Adverse Event|0|||
42054421|NCT00580801|75862691|FG000|Overall Study|Lost to Follow-up|2|||
42054422|NCT00580801|75862692|FG001|Overall Study|Lost to Follow-up|0|||
42054423|NCT00580801|75862693|FG002|Overall Study|Lost to Follow-up|0|||
42054424|NCT00580801|75862691|FG000|Overall Study|Reached a virologic endpoint|0|||
42054425|NCT00580801|75862692|FG001|Overall Study|Reached a virologic endpoint|1|||
42054426|NCT00580801|75862693|FG002|Overall Study|Reached a virologic endpoint|2|||
42054427|NCT00580801|75862691|FG000|Overall Study|Participant non-compliant|0|||
42054428|NCT00580801|75862692|FG001|Overall Study|Participant non-compliant|0|||
42054429|NCT00580801|75862693|FG002|Overall Study|Participant non-compliant|1|||
42054430|NCT00580801|75862691|FG000|Overall Study|Travel|1|||
42054431|NCT00580801|75862692|FG001|Overall Study|Travel|0|||
42054432|NCT00580801|75862693|FG002|Overall Study|Travel|0|||
42054433|NCT01059539|75862701|FG000|Overall Study|Adverse Event|66|||
42054434|NCT01059539|75862701|FG000|Overall Study|Insufficient Therapeutic Response|26|||
42054435|NCT01059539|75862701|FG000|Overall Study|Protocol Violation|55|||
42054436|NCT01059539|75862701|FG000|Overall Study|Withdrawal of Consent|80|||
42054437|NCT01059539|75862701|FG000|Overall Study|Lost to Follow-up|42|||
42054438|NCT01059539|75862701|FG000|Overall Study|Reason Not Specified|2|||
42054439|NCT00999908|75862705|FG000|Treatment Period 1|Subject withdrew consent|2|||
42054440|NCT00999908|75862706|FG001|Treatment Period 1|Subject withdrew consent|0|||
42054441|NCT00999908|75862707|FG002|Treatment Period 1|Subject withdrew consent|0|||
42054442|NCT00999908|75862705|FG000|Treatment Period 2|Protocol Violation|1|||
42054443|NCT00999908|75862706|FG001|Treatment Period 2|Protocol Violation|0|||
42054444|NCT00999908|75862707|FG002|Treatment Period 2|Protocol Violation|0|||
42054445|NCT00580723|75862715|FG000|Overall Study|Did not want to participate in extension|3|||
42054446|NCT00580723|75862715|FG000|Overall Study|Lost to Follow-up|5|||
42054447|NCT00999596|75862719|FG000|Overall Study|Statistical population not required|101|||
42054448|NCT04676867|75862728|FG000|Overall Study|Screen failure|0|||
42054449|NCT04676867|75862729|FG001|Overall Study|Screen failure|0|||
42291670|NCT01970488|76125153|FG002|Part 2: Post Week 16|Non-compliance|1|||
42291671|NCT01970488|76125154|FG003|Part 2: Post Week 16|Non-compliance|0|||
42054450|NCT04676867|75862730|FG002|Overall Study|Screen failure|6|||
42054451|NCT04676867|75862731|FG003|Overall Study|Screen failure|2|||
42054452|NCT04676867|75862728|FG000|Overall Study|Death|0|||
42054453|NCT04676867|75862729|FG001|Overall Study|Death|0|||
42054454|NCT04676867|75862730|FG002|Overall Study|Death|1|||
42054455|NCT04676867|75862731|FG003|Overall Study|Death|0|||
42054456|NCT04676867|75862728|FG000|Overall Study|Withdrawal by Subject|2|||
42054457|NCT04676867|75862729|FG001|Overall Study|Withdrawal by Subject|2|||
42054458|NCT04676867|75862730|FG002|Overall Study|Withdrawal by Subject|4|||
42054459|NCT04676867|75862731|FG003|Overall Study|Withdrawal by Subject|4|||
42054460|NCT04676867|75862728|FG000|Overall Study|Lost to Follow-up|1|||
42054461|NCT04676867|75862729|FG001|Overall Study|Lost to Follow-up|0|||
42054462|NCT04676867|75862730|FG002|Overall Study|Lost to Follow-up|0|||
42054463|NCT04676867|75862731|FG003|Overall Study|Lost to Follow-up|0|||
42054464|NCT00770224|75862741|FG000|Step 1: Induction|Adverse Event|3|||
42054465|NCT00770224|75862742|FG001|Step 1: Induction|Adverse Event|0|||
42054466|NCT00770224|75862741|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
42054467|NCT00770224|75862742|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
42054468|NCT00770224|75862741|FG000|Step 1: Induction|Other reason not protocol specified|2|||
42054469|NCT00770224|75862742|FG001|Step 1: Induction|Other reason not protocol specified|0|||
42054470|NCT00770224|75862741|FG000|Step 1: Induction|Ineligible|2|||
42054471|NCT00770224|75862742|FG001|Step 1: Induction|Ineligible|0|||
42054472|NCT00770224|75862741|FG000|Step 1: Induction|No protocol treatment given|1|||
42054473|NCT00770224|75862742|FG001|Step 1: Induction|No protocol treatment given|0|||
42054474|NCT00770224|75862741|FG000|Step 2: Maintenance|Adverse Event|0|||
42054475|NCT00770224|75862742|FG001|Step 2: Maintenance|Adverse Event|10|||
42054476|NCT00770224|75862741|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
42054477|NCT00770224|75862742|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
42054478|NCT00770224|75862741|FG000|Step 2: Maintenance|Progression/relapse|0|||
42054479|NCT00770224|75862742|FG001|Step 2: Maintenance|Progression/relapse|1|||
42054480|NCT00770224|75862741|FG000|Step 2: Maintenance|Death|0|||
42054481|NCT00770224|75862742|FG001|Step 2: Maintenance|Death|2|||
42054482|NCT00770224|75862741|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
42054483|NCT00770224|75862742|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
42054484|NCT00770224|75862741|FG000|Step 2: Maintenance|Ineligible|0|||
42054485|NCT00770224|75862742|FG001|Step 2: Maintenance|Ineligible|2|||
42054486|NCT02389465|75862753|FG000|Overall Study|Lost to Follow-up|1|||
42054487|NCT02389465|75862754|FG001|Overall Study|Lost to Follow-up|3|||
42054488|NCT02389465|75862755|FG002|Overall Study|Lost to Follow-up|3|||
42054489|NCT02389465|75862756|FG003|Overall Study|Lost to Follow-up|0|||
42054490|NCT02389465|75862753|FG000|Overall Study|Physician Decision|0|||
42054491|NCT02389465|75862754|FG001|Overall Study|Physician Decision|0|||
42054492|NCT02389465|75862755|FG002|Overall Study|Physician Decision|0|||
42054493|NCT02389465|75862756|FG003|Overall Study|Physician Decision|1|||
42054494|NCT02389465|75862753|FG000|Overall Study|Withdrawal by Subject|0|||
42054495|NCT02389465|75862754|FG001|Overall Study|Withdrawal by Subject|1|||
42054496|NCT02389465|75862755|FG002|Overall Study|Withdrawal by Subject|2|||
42054497|NCT02389465|75862756|FG003|Overall Study|Withdrawal by Subject|2|||
42054498|NCT01057589|75862766|FG000|Overall Study|Disease Progression|35|||
42054499|NCT01057589|75862766|FG000|Overall Study|Adverse Event|10|||
42054500|NCT01057589|75862766|FG000|Overall Study|Physician Decision|8|||
42054501|NCT01057589|75862766|FG000|Overall Study|Withdrawal by Subject|3|||
42054502|NCT01057589|75862766|FG000|Overall Study|Sponsor Decision|1|||
42054503|NCT01057589|75862766|FG000|Overall Study|Death|8|||
42054504|NCT01057589|75862766|FG000|Overall Study|Lost to Follow-up|1|||
42054505|NCT01716117|75862772|FG000|Overall Study|Death|5|||
42054506|NCT01716117|75862773|FG001|Overall Study|Death|2|||
42054507|NCT01716117|75862772|FG000|Overall Study|Withdrawal by Subject|2|||
42054508|NCT01716117|75862773|FG001|Overall Study|Withdrawal by Subject|0|||
42054509|NCT00579553|75862789|FG000|Overall Study|Lost to Follow-up|16|||
42054510|NCT00579553|75862790|FG001|Overall Study|Lost to Follow-up|13|||
42054511|NCT01650831|75862796|FG000|Overall Study|Screen failure|1|||
42054512|NCT00581893|75862804|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
42054513|NCT00581893|75862805|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
42054514|NCT00770146|75862813|FG000|Treatment Period|Withdrawal by Subject|6|||
42054515|NCT00770146|75862814|FG001|Treatment Period|Withdrawal by Subject|13|||
42054516|NCT00770146|75862813|FG000|Treatment Period|Adverse Event|2|||
42054517|NCT00770146|75862814|FG001|Treatment Period|Adverse Event|26|||
42054518|NCT00770146|75862813|FG000|Treatment Period|Other|1|||
42054519|NCT00770146|75862814|FG001|Treatment Period|Other|5|||
42054520|NCT00770146|75862813|FG000|Treatment Period|Protocol non-compliance|0|||
42054521|NCT00770146|75862814|FG001|Treatment Period|Protocol non-compliance|1|||
42054522|NCT00770146|75862813|FG000|Follow-up Period|Withdrawal by Subject|7|||
42054523|NCT00770146|75862814|FG001|Follow-up Period|Withdrawal by Subject|13|||
42054524|NCT00770146|75862813|FG000|Follow-up Period|Adverse Event|0|||
42054525|NCT00770146|75862814|FG001|Follow-up Period|Adverse Event|2|||
42054526|NCT00770146|75862813|FG000|Follow-up Period|Other|4|||
42356953|NCT01405053|76202179|FG001|Overall Study|Adverse Event|0|||
42054527|NCT00770146|75862814|FG001|Follow-up Period|Other|5|||
42054528|NCT01056341|75862825|FG000|Overall Study|Treatment Intolerance|0|||
42054529|NCT01056341|75862826|FG001|Overall Study|Treatment Intolerance|2|||
42054530|NCT01056341|75862827|FG002|Overall Study|Treatment Intolerance|0|||
42054531|NCT01056341|75862828|FG003|Overall Study|Treatment Intolerance|2|||
42054532|NCT01056341|75862829|FG004|Overall Study|Treatment Intolerance|0|||
42054533|NCT01056341|75862825|FG000|Overall Study|Lack of Efficacy|32|||
42054534|NCT01056341|75862826|FG001|Overall Study|Lack of Efficacy|30|||
42054535|NCT01056341|75862827|FG002|Overall Study|Lack of Efficacy|7|||
42054536|NCT01056341|75862828|FG003|Overall Study|Lack of Efficacy|25|||
42054537|NCT01056341|75862829|FG004|Overall Study|Lack of Efficacy|9|||
42054538|NCT01056341|75862825|FG000|Overall Study|Other reasons|4|||
42054539|NCT01056341|75862826|FG001|Overall Study|Other reasons|4|||
42054540|NCT01056341|75862827|FG002|Overall Study|Other reasons|8|||
42054541|NCT01056341|75862828|FG003|Overall Study|Other reasons|9|||
42054542|NCT01056341|75862829|FG004|Overall Study|Other reasons|5|||
42054543|NCT00999518|75862852|FG000|Overall Study|Adverse Event|1|||
42054544|NCT00999518|75862853|FG001|Overall Study|Adverse Event|6|||
42054545|NCT00999518|75862854|FG002|Overall Study|Adverse Event|3|||
42054546|NCT00999518|75862855|FG003|Overall Study|Adverse Event|1|||
42054547|NCT00999518|75862856|FG004|Overall Study|Adverse Event|2|||
42054548|NCT00999518|75862852|FG000|Overall Study|Lack of Efficacy|2|||
42054549|NCT00999518|75862853|FG001|Overall Study|Lack of Efficacy|0|||
42054550|NCT00999518|75862854|FG002|Overall Study|Lack of Efficacy|0|||
42054551|NCT00999518|75862855|FG003|Overall Study|Lack of Efficacy|2|||
42054552|NCT00999518|75862856|FG004|Overall Study|Lack of Efficacy|2|||
42054553|NCT00999518|75862852|FG000|Overall Study|Lost to Follow-up|0|||
42054554|NCT00999518|75862853|FG001|Overall Study|Lost to Follow-up|0|||
42054555|NCT00999518|75862854|FG002|Overall Study|Lost to Follow-up|0|||
42054556|NCT00999518|75862855|FG003|Overall Study|Lost to Follow-up|4|||
42173804|NCT02889796|75980592|FG000|Overall Study|Adverse Event|17|||
42173805|NCT02889796|75980593|FG001|Overall Study|Adverse Event|8|||
42173806|NCT02889796|75980594|FG002|Overall Study|Adverse Event|8|||
42173807|NCT02889796|75980595|FG003|Overall Study|Adverse Event|4|||
42173808|NCT02889796|75980596|FG004|Overall Study|Adverse Event|1|||
42173809|NCT02889796|75980597|FG005|Overall Study|Adverse Event|7|||
42173810|NCT02889796|75980592|FG000|Overall Study|Lost to Follow-up|5|||
42173811|NCT02889796|75980593|FG001|Overall Study|Lost to Follow-up|7|||
42173812|NCT02889796|75980594|FG002|Overall Study|Lost to Follow-up|2|||
42173813|NCT02889796|75980595|FG003|Overall Study|Lost to Follow-up|0|||
42173814|NCT02889796|75980596|FG004|Overall Study|Lost to Follow-up|2|||
42173815|NCT02889796|75980597|FG005|Overall Study|Lost to Follow-up|6|||
42173816|NCT02889796|75980592|FG000|Overall Study|Protocol Violation|0|||
42291672|NCT01970488|76125155|FG004|Part 2: Post Week 16|Non-compliance|0|||
42291673|NCT01970488|76125151|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
42291674|NCT01970488|76125152|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
42291675|NCT01970488|76125153|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
42054557|NCT00999518|75862856|FG004|Overall Study|Lost to Follow-up|1|||
42054558|NCT00999518|75862852|FG000|Overall Study|Did not meet entrance criteria|0|||
42054559|NCT00999518|75862853|FG001|Overall Study|Did not meet entrance criteria|0|||
42054560|NCT00999518|75862854|FG002|Overall Study|Did not meet entrance criteria|0|||
42054561|NCT00999518|75862855|FG003|Overall Study|Did not meet entrance criteria|0|||
42054562|NCT00999518|75862856|FG004|Overall Study|Did not meet entrance criteria|1|||
42054563|NCT00999518|75862852|FG000|Overall Study|Study terminated by sponsor|10|||
42054564|NCT00999518|75862853|FG001|Overall Study|Study terminated by sponsor|6|||
42054565|NCT00999518|75862854|FG002|Overall Study|Study terminated by sponsor|5|||
42054566|NCT00999518|75862855|FG003|Overall Study|Study terminated by sponsor|5|||
42054567|NCT00999518|75862856|FG004|Overall Study|Study terminated by sponsor|9|||
42173817|NCT02889796|75980593|FG001|Overall Study|Protocol Violation|1|||
42173818|NCT02889796|75980594|FG002|Overall Study|Protocol Violation|3|||
42173819|NCT02889796|75980595|FG003|Overall Study|Protocol Violation|0|||
42173820|NCT02889796|75980596|FG004|Overall Study|Protocol Violation|0|||
42173821|NCT02889796|75980597|FG005|Overall Study|Protocol Violation|4|||
42173822|NCT02889796|75980592|FG000|Overall Study|Non-compliance With Study Drug|0|||
42173823|NCT02889796|75980593|FG001|Overall Study|Non-compliance With Study Drug|2|||
42173824|NCT02889796|75980594|FG002|Overall Study|Non-compliance With Study Drug|0|||
42173825|NCT02889796|75980595|FG003|Overall Study|Non-compliance With Study Drug|0|||
42173826|NCT02889796|75980596|FG004|Overall Study|Non-compliance With Study Drug|1|||
42173827|NCT02889796|75980597|FG005|Overall Study|Non-compliance With Study Drug|2|||
42173828|NCT02889796|75980592|FG000|Overall Study|Death|1|||
42173829|NCT02889796|75980593|FG001|Overall Study|Death|1|||
42173830|NCT02889796|75980594|FG002|Overall Study|Death|0|||
42173831|NCT02889796|75980595|FG003|Overall Study|Death|1|||
42173832|NCT02889796|75980596|FG004|Overall Study|Death|0|||
42173833|NCT02889796|75980597|FG005|Overall Study|Death|1|||
42173834|NCT02889796|75980592|FG000|Overall Study|Pregnancy|0|||
42173835|NCT02889796|75980593|FG001|Overall Study|Pregnancy|1|||
42173836|NCT02889796|75980594|FG002|Overall Study|Pregnancy|1|||
42173837|NCT02889796|75980595|FG003|Overall Study|Pregnancy|0|||
42173838|NCT02889796|75980596|FG004|Overall Study|Pregnancy|0|||
42173839|NCT02889796|75980597|FG005|Overall Study|Pregnancy|0|||
42291676|NCT01970488|76125154|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
42054568|NCT00999518|75862852|FG000|Overall Study|Pregnancy|0|||
42054569|NCT00999518|75862853|FG001|Overall Study|Pregnancy|0|||
42054570|NCT00999518|75862854|FG002|Overall Study|Pregnancy|1|||
42173840|NCT02889796|75980592|FG000|Overall Study|Randomized but not Dosed|2|||
42173841|NCT02889796|75980593|FG001|Overall Study|Randomized but not Dosed|0|||
42173842|NCT02889796|75980594|FG002|Overall Study|Randomized but not Dosed|0|||
42054571|NCT00999518|75862855|FG003|Overall Study|Pregnancy|0|||
42054572|NCT00999518|75862856|FG004|Overall Study|Pregnancy|0|||
42054573|NCT00999518|75862852|FG000|Overall Study|Protocol Violation|0|||
42054574|NCT00999518|75862853|FG001|Overall Study|Protocol Violation|1|||
42054575|NCT00999518|75862854|FG002|Overall Study|Protocol Violation|0|||
42054576|NCT00999518|75862855|FG003|Overall Study|Protocol Violation|0|||
42054577|NCT00999518|75862856|FG004|Overall Study|Protocol Violation|2|||
42054578|NCT00999518|75862852|FG000|Overall Study|Withdrawal by Subject|5|||
42054579|NCT00999518|75862853|FG001|Overall Study|Withdrawal by Subject|4|||
42054580|NCT00999518|75862854|FG002|Overall Study|Withdrawal by Subject|10|||
42054581|NCT00999518|75862855|FG003|Overall Study|Withdrawal by Subject|6|||
42054582|NCT00999518|75862856|FG004|Overall Study|Withdrawal by Subject|1|||
42054583|NCT00999518|75862852|FG000|Overall Study|Other|5|||
42054584|NCT00999518|75862853|FG001|Overall Study|Other|7|||
42054585|NCT00999518|75862854|FG002|Overall Study|Other|1|||
42054586|NCT00999518|75862855|FG003|Overall Study|Other|4|||
42054587|NCT00999518|75862856|FG004|Overall Study|Other|5|||
42054588|NCT00999518|75862852|FG000|Overall Study|Randomized but not Treated|1|||
42054589|NCT00999518|75862853|FG001|Overall Study|Randomized but not Treated|1|||
42054590|NCT00999518|75862854|FG002|Overall Study|Randomized but not Treated|2|||
42054591|NCT00999518|75862855|FG003|Overall Study|Randomized but not Treated|0|||
42054592|NCT00999518|75862856|FG004|Overall Study|Randomized but not Treated|1|||
42054593|NCT01056263|75862872|FG000|Overall Study|Adverse Event|12|||
42054594|NCT01056263|75862872|FG000|Overall Study|Death|1|||
42054595|NCT01056263|75862872|FG000|Overall Study|Withdrawal by Subject|1|||
42054596|NCT01056263|75862872|FG000|Overall Study|Lack of Efficacy|29|||
42054597|NCT01056263|75862872|FG000|Overall Study|Progressive disease|2|||
42054598|NCT01056263|75862872|FG000|Overall Study|Neoplasm progression|1|||
42054599|NCT01056263|75862872|FG000|Overall Study|Objective progression or relapse|1|||
42054600|NCT01056263|75862872|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
42054601|NCT01056107|75862880|FG000|Overall Study|Withdrawal by Subject|0|||
42054602|NCT01056107|75862881|FG001|Overall Study|Withdrawal by Subject|1|||
42054603|NCT01056107|75862882|FG002|Overall Study|Withdrawal by Subject|3|||
42054604|NCT01056107|75862883|FG003|Overall Study|Withdrawal by Subject|0|||
42054605|NCT01003886|75862893|FG000|Overall Study|Lack of Efficacy|5|||
42054606|NCT01003886|75862893|FG000|Overall Study|Lost to Follow-up|169|||
42054607|NCT01003886|75862893|FG000|Overall Study|Withdrawal by Subject|39|||
42054608|NCT01003886|75862893|FG000|Overall Study|Other|14|||
42054609|NCT01003886|75862893|FG000|Overall Study|Adverse Event|3|||
42054610|NCT01003184|75862899|FG000|Overall Study|Adverse Event|12|||
42054611|NCT01003184|75862900|FG001|Overall Study|Adverse Event|5|||
42054612|NCT01003184|75862899|FG000|Overall Study|Lost to Follow-up|1|||
42054613|NCT01003184|75862900|FG001|Overall Study|Lost to Follow-up|0|||
42054614|NCT01003184|75862899|FG000|Overall Study|Loss of glucose control|1|||
42054615|NCT01003184|75862900|FG001|Overall Study|Loss of glucose control|1|||
42054616|NCT01003184|75862899|FG000|Overall Study|Protocol Violation|3|||
42054617|NCT01003184|75862900|FG001|Overall Study|Protocol Violation|0|||
42054618|NCT01003184|75862899|FG000|Overall Study|Withdrawal by Subject|1|||
42054619|NCT01003184|75862900|FG001|Overall Study|Withdrawal by Subject|6|||
42054620|NCT01003184|75862899|FG000|Overall Study|Physician Decision|1|||
42054621|NCT01003184|75862900|FG001|Overall Study|Physician Decision|0|||
42054622|NCT01029353|75862910|FG000|Overall Study|Lost to Follow-up|4|||
42291677|NCT01970488|76125155|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
42291678|NCT01970488|76125151|FG000|Part 2: Post Week 16|Adverse Event|0|||
42016367|NCT03943953|75823652|FG001|Trial of ITG 3|Lost to Follow-up|0|||
42016368|NCT03943953|75823651|FG000|Trial of ITG 4|Lost to Follow-up|2|||
42016369|NCT03943953|75823652|FG001|Trial of ITG 4|Lost to Follow-up|0|||
42016370|NCT03670628|75823662|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
42016371|NCT03670628|75823663|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
42016372|NCT03670628|75823662|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
42016373|NCT03670628|75823663|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
42016374|NCT03637764|75823673|FG000|Overall Study|Adverse Event|2|||
42016375|NCT03637764|75823674|FG001|Overall Study|Adverse Event|0|||
42016376|NCT03637764|75823675|FG002|Overall Study|Adverse Event|0|||
42016377|NCT03637764|75823676|FG003|Overall Study|Adverse Event|1|||
42016378|NCT03637764|75823673|FG000|Overall Study|Progressive Disease|23|||
42016379|NCT03637764|75823674|FG001|Overall Study|Progressive Disease|23|||
42054623|NCT01029353|75862911|FG001|Overall Study|Lost to Follow-up|5|||
42054624|NCT01029353|75862912|FG002|Overall Study|Lost to Follow-up|5|||
42054625|NCT01029353|75862913|FG003|Overall Study|Lost to Follow-up|4|||
42054626|NCT01029353|75862910|FG000|Overall Study|Consent Withdrawn|2|||
42054627|NCT01029353|75862911|FG001|Overall Study|Consent Withdrawn|0|||
42054628|NCT01029353|75862912|FG002|Overall Study|Consent Withdrawn|0|||
42054629|NCT01029353|75862913|FG003|Overall Study|Consent Withdrawn|0|||
42054630|NCT01029353|75862910|FG000|Overall Study|Primary Outcome Indeterminate|1|||
42054631|NCT01029353|75862911|FG001|Overall Study|Primary Outcome Indeterminate|3|||
42054632|NCT01029353|75862912|FG002|Overall Study|Primary Outcome Indeterminate|2|||
42054633|NCT01029353|75862913|FG003|Overall Study|Primary Outcome Indeterminate|0|||
42054634|NCT01008410|75862925|FG000|Overall Study|Adverse Event|13|||
42054635|NCT01008410|75862926|FG001|Overall Study|Adverse Event|7|||
42054636|NCT01008410|75862925|FG000|Overall Study|Withdrawal by Subject|6|||
42054637|NCT01008410|75862926|FG001|Overall Study|Withdrawal by Subject|2|||
42054638|NCT01008410|75862925|FG000|Overall Study|Lost to Follow-up|1|||
42054639|NCT01008410|75862926|FG001|Overall Study|Lost to Follow-up|0|||
42054640|NCT01008410|75862925|FG000|Overall Study|Noncompliance|1|||
42054641|NCT01008410|75862926|FG001|Overall Study|Noncompliance|0|||
42054642|NCT01008410|75862925|FG000|Overall Study|Low Cortisol|2|||
42054643|NCT01008410|75862926|FG001|Overall Study|Low Cortisol|0|||
42054644|NCT01008410|75862925|FG000|Overall Study|Lack of Efficacy|2|||
42054645|NCT01008410|75862926|FG001|Overall Study|Lack of Efficacy|6|||
42054646|NCT01008410|75862925|FG000|Overall Study|Met Exclusion Criterion|0|||
42054647|NCT01008410|75862926|FG001|Overall Study|Met Exclusion Criterion|1|||
42054648|NCT01023269|75862932|FG000|Overall Study|early termination of the study|2|||
42054649|NCT01023269|75862933|FG001|Overall Study|early termination of the study|0|||
42054650|NCT01007942|75862965|FG000|Overall Study|Adverse Event|29|||
42054651|NCT01007942|75862966|FG001|Overall Study|Adverse Event|14|||
42054652|NCT01007942|75862965|FG000|Overall Study|Abnormal test procedure|0|||
42054653|NCT01007942|75862966|FG001|Overall Study|Abnormal test procedure|1|||
42054654|NCT01007942|75862965|FG000|Overall Study|Disease progression|217|||
42054655|NCT01007942|75862966|FG001|Overall Study|Disease progression|242|||
42054656|NCT01007942|75862965|FG000|Overall Study|New cancer therapy|5|||
42054657|NCT01007942|75862966|FG001|Overall Study|New cancer therapy|1|||
42054658|NCT01007942|75862965|FG000|Overall Study|Protocol Violation|1|||
42054659|NCT01007942|75862966|FG001|Overall Study|Protocol Violation|1|||
42054660|NCT01007942|75862965|FG000|Overall Study|Withdrawal by Subject|19|||
42054661|NCT01007942|75862966|FG001|Overall Study|Withdrawal by Subject|14|||
42054662|NCT01007942|75862965|FG000|Overall Study|Lost to Follow-up|1|||
42054663|NCT01007942|75862966|FG001|Overall Study|Lost to Follow-up|0|||
42054664|NCT01007942|75862965|FG000|Overall Study|Administrative problems|2|||
42054665|NCT01007942|75862966|FG001|Overall Study|Administrative problems|0|||
42054666|NCT01007942|75862965|FG000|Overall Study|Death|3|||
42054667|NCT01007942|75862966|FG001|Overall Study|Death|2|||
42054668|NCT01007942|75862965|FG000|Overall Study|Patients untreated|4|||
42054669|NCT01007942|75862966|FG001|Overall Study|Patients untreated|3|||
42054670|NCT01023035|75862979|FG000|Treatment Period|Adverse Event|27|||
42054671|NCT01023035|75862980|FG001|Treatment Period|Adverse Event|32|||
42054672|NCT01023035|75862981|FG002|Treatment Period|Adverse Event|50|||
42054673|NCT01023035|75862979|FG000|Treatment Period|Non-Medical Reasons|19|||
42054674|NCT01023035|75862980|FG001|Treatment Period|Non-Medical Reasons|22|||
42054675|NCT01023035|75862981|FG002|Treatment Period|Non-Medical Reasons|44|||
42054676|NCT01023035|75862979|FG000|Treatment Period|Treatment Failure|26|||
42054677|NCT01023035|75862980|FG001|Treatment Period|Treatment Failure|31|||
42054678|NCT01023035|75862981|FG002|Treatment Period|Treatment Failure|24|||
42054679|NCT01023035|75862979|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
42054680|NCT01023035|75862980|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
42054681|NCT01023035|75862981|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
42054682|NCT01023035|75862979|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
42054683|NCT01023035|75862980|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
42054684|NCT01023035|75862981|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
42054685|NCT01028651|75862991|FG000|Overall Study|Death|2|||
42054686|NCT01028651|75862991|FG000|Overall Study|Adverse Event|1|||
42054687|NCT01028027|75862999|FG000|Overall Study|Lost to Follow-up|4|||
42054688|NCT01028027|75863000|FG001|Overall Study|Lost to Follow-up|1|||
42054689|NCT01028027|75862999|FG000|Overall Study|Withdrawal by Subject|5|||
42054690|NCT01028027|75863000|FG001|Overall Study|Withdrawal by Subject|3|||
42054691|NCT01028027|75862999|FG000|Overall Study|Adverse Event|4|||
42054692|NCT01028027|75863000|FG001|Overall Study|Adverse Event|7|||
42054693|NCT01028027|75862999|FG000|Overall Study|Protocol Violation|3|||
42054694|NCT01028027|75863000|FG001|Overall Study|Protocol Violation|1|||
42054695|NCT01028027|75862999|FG000|Overall Study|Lack of Efficacy|0|||
42054696|NCT01028027|75863000|FG001|Overall Study|Lack of Efficacy|1|||
42054697|NCT01007552|75863006|FG000|Overall Study|Withdrawal by Subject|1|||
42054698|NCT01007396|75863010|FG000|Overall Study|Lost to Follow-up|47|||
42054699|NCT00998738|75863014|FG000|Overall Study|Uknown|1|||
42356954|NCT01405053|76202178|FG000|Overall Study|Lost to Follow-up|0|||
42054700|NCT00997334|75863018|FG000|Overall Study|still on therapy|12|||
42054701|NCT00997334|75863018|FG000|Overall Study|Adverse Event|3|||
42054702|NCT00997334|75863018|FG000|Overall Study|Patient non-compliance|1|||
42054703|NCT00997334|75863018|FG000|Overall Study|Withdrawal by Subject|3|||
42054704|NCT00997334|75863018|FG000|Overall Study|Death|2|||
42054705|NCT00997334|75863018|FG000|Overall Study|Urgent Palliative Care|2|||
42054706|NCT00997334|75863018|FG000|Overall Study|No lesion amenable|1|||
42054707|NCT00997334|75863018|FG000|Overall Study|Ineligible|1|||
42054708|NCT00996944|75863024|FG000|Double-blind Treatment Period|Adverse Event|2|||
42054709|NCT00996944|75863025|FG001|Double-blind Treatment Period|Adverse Event|1|||
42054710|NCT00996944|75863024|FG000|Double-blind Treatment Period|Protocol Violation|1|||
42054711|NCT00996944|75863025|FG001|Double-blind Treatment Period|Protocol Violation|0|||
42054712|NCT00996944|75863024|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
42054713|NCT00996944|75863025|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
42054714|NCT00996944|75863024|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
42054715|NCT00996944|75863025|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
42054716|NCT00996944|75863024|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
42054717|NCT00996944|75863025|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
42054718|NCT01002482|75863035|FG000|Overall Study|Withdrawal by Subject|14|||
42054719|NCT01002482|75863036|FG001|Overall Study|Withdrawal by Subject|21|||
42054720|NCT01002482|75863035|FG000|Overall Study|Included twice|1|||
42054721|NCT01002482|75863036|FG001|Overall Study|Included twice|0|||
42054722|NCT01027949|75863042|FG000|Overall Study|Death|174|||
42054723|NCT01027949|75863042|FG000|Overall Study|Progressive Disease|163|||
42054724|NCT01027949|75863042|FG000|Overall Study|Adverse Event|172|||
42054725|NCT01027949|75863042|FG000|Overall Study|Withdrawal by Subject|113|||
42054726|NCT01027949|75863042|FG000|Overall Study|Lost to Follow-up|17|||
42054727|NCT01027949|75863042|FG000|Overall Study|Protocol Violation|13|||
42054728|NCT01027949|75863042|FG000|Overall Study|PI Decision|8|||
42054729|NCT01027949|75863042|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
42054730|NCT01027949|75863042|FG000|Overall Study|Non-compliance with Study Procedures|7|||
42054731|NCT01027949|75863042|FG000|Overall Study|Lung Transplant|5|||
42054732|NCT01027949|75863042|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
42054733|NCT01027949|75863042|FG000|Overall Study|Use of Excluded Medication|2|||
42054734|NCT01027949|75863042|FG000|Overall Study|Patient Self-discontinuation|1|||
42054735|NCT01027949|75863042|FG000|Overall Study|Pregnancy|1|||
42054736|NCT01027949|75863042|FG000|Overall Study|Surgery|1|||
42054737|NCT01038323|75863049|FG000|Overall Study|Withdrawal by Subject|3|||
42054738|NCT01038323|75863050|FG001|Overall Study|Withdrawal by Subject|2|||
42054739|NCT01038323|75863051|FG002|Overall Study|Withdrawal by Subject|4|||
42054740|NCT01027871|75863062|FG000|Overall Study|Physician Decision|1|||
42054741|NCT01027871|75863063|FG001|Overall Study|Physician Decision|5|||
42054742|NCT01027871|75863064|FG002|Overall Study|Physician Decision|0|||
42173843|NCT02889796|75980595|FG003|Overall Study|Randomized but not Dosed|0|||
42173844|NCT02889796|75980596|FG004|Overall Study|Randomized but not Dosed|0|||
42173845|NCT02889796|75980597|FG005|Overall Study|Randomized but not Dosed|2|||
42173846|NCT02889562|75980622|FG000|Overall Study|Physician Decision|0|||
42173847|NCT02889562|75980623|FG001|Overall Study|Physician Decision|1|||
42173848|NCT02889562|75980622|FG000|Overall Study|Withdrawal by Subject|0|||
42173849|NCT02889562|75980623|FG001|Overall Study|Withdrawal by Subject|1|||
42173850|NCT03323164|75980631|FG000|Overall Study|Poor quality imaging/scans|2|||
42173851|NCT03323164|75980632|FG001|Overall Study|Poor quality imaging/scans|2|||
42173852|NCT03323086|75980644|FG000|Overall Study|Lost to Follow-up|3|||
42173853|NCT03323086|75980645|FG001|Overall Study|Lost to Follow-up|2|||
42173854|NCT02888080|75980653|FG000|Overall Study|Subject / Guardian decision|1|||
42173855|NCT02888080|75980654|FG001|Overall Study|Subject / Guardian decision|3|||
42173856|NCT02888080|75980653|FG000|Overall Study|New Therapy for study indication|1|||
42173857|NCT02888080|75980654|FG001|Overall Study|New Therapy for study indication|0|||
42173858|NCT02888080|75980653|FG000|Overall Study|Lack of Efficacy|0|||
42173859|NCT02888080|75980654|FG001|Overall Study|Lack of Efficacy|1|||
42173860|NCT02888080|75980653|FG000|Overall Study|Adverse Event|0|||
42173861|NCT02888080|75980654|FG001|Overall Study|Adverse Event|1|||
42173862|NCT03322462|75980660|FG000|Overall Study|Technical difficulties|2|||
42173863|NCT03322462|75980660|FG000|Overall Study|Other|1|||
42173864|NCT00086580|75980668|FG000|Treatment Period|Disease progression|9|||
42173865|NCT00086580|75980669|FG001|Treatment Period|Disease progression|8|||
42173866|NCT00086580|75980668|FG000|Treatment Period|Unable to comply with protocol|3|||
42173867|NCT00086580|75980669|FG001|Treatment Period|Unable to comply with protocol|1|||
42173868|NCT00086580|75980668|FG000|Treatment Period|Withdrawal by Subject|7|||
42173869|NCT00086580|75980669|FG001|Treatment Period|Withdrawal by Subject|8|||
42356955|NCT01405053|76202179|FG001|Overall Study|Lost to Follow-up|1|||
42054743|NCT01027871|75863062|FG000|Overall Study|Protocol Violation|0|||
42054744|NCT01027871|75863063|FG001|Overall Study|Protocol Violation|2|||
42054745|NCT01027871|75863064|FG002|Overall Study|Protocol Violation|2|||
42054746|NCT01027871|75863062|FG000|Overall Study|Withdrawal by Subject|1|||
42054747|NCT01027871|75863063|FG001|Overall Study|Withdrawal by Subject|2|||
42054748|NCT01027871|75863064|FG002|Overall Study|Withdrawal by Subject|2|||
42054749|NCT01027871|75863062|FG000|Overall Study|Adverse Event|0|||
42054750|NCT01027871|75863063|FG001|Overall Study|Adverse Event|2|||
42054751|NCT01027871|75863064|FG002|Overall Study|Adverse Event|2|||
42173870|NCT00086580|75980668|FG000|Treatment Period|Physician Decision|13|||
42173871|NCT00086580|75980669|FG001|Treatment Period|Physician Decision|7|||
42173872|NCT00086580|75980668|FG000|Treatment Period|AE - not treatment related|7|||
42054752|NCT01027871|75863062|FG000|Overall Study|Sponsor Decision|0|||
42054753|NCT01027871|75863063|FG001|Overall Study|Sponsor Decision|2|||
42054754|NCT01027871|75863064|FG002|Overall Study|Sponsor Decision|0|||
42054755|NCT01027871|75863062|FG000|Overall Study|Discontinued Prior to Treatment|0|||
42054756|NCT01027871|75863063|FG001|Overall Study|Discontinued Prior to Treatment|0|||
42054757|NCT01027871|75863064|FG002|Overall Study|Discontinued Prior to Treatment|1|||
42054758|NCT01021553|75863080|FG000|Overall Study|Adverse Event|1|||
42054759|NCT01021553|75863081|FG001|Overall Study|Adverse Event|0|||
42054760|NCT01021553|75863082|FG002|Overall Study|Adverse Event|0|||
42054761|NCT01021553|75863080|FG000|Overall Study|Lack of Efficacy|2|||
42054762|NCT01021553|75863081|FG001|Overall Study|Lack of Efficacy|2|||
42054763|NCT01021553|75863082|FG002|Overall Study|Lack of Efficacy|0|||
42054764|NCT01021553|75863080|FG000|Overall Study|Protocol Violation|0|||
42054765|NCT01021553|75863081|FG001|Overall Study|Protocol Violation|2|||
42054766|NCT01021553|75863082|FG002|Overall Study|Protocol Violation|2|||
42054767|NCT01021553|75863080|FG000|Overall Study|Lost to Follow-up|0|||
42054768|NCT01021553|75863081|FG001|Overall Study|Lost to Follow-up|0|||
42054769|NCT01021553|75863082|FG002|Overall Study|Lost to Follow-up|1|||
42054770|NCT01021553|75863080|FG000|Overall Study|Withdrawal by Subject|1|||
42054771|NCT01021553|75863081|FG001|Overall Study|Withdrawal by Subject|1|||
42054772|NCT01021553|75863082|FG002|Overall Study|Withdrawal by Subject|0|||
42054773|NCT01026389|75863097|FG000|Overall Study|Withdrawal by Subject|1|||
42054774|NCT01026389|75863098|FG001|Overall Study|Withdrawal by Subject|3|||
42054775|NCT01026389|75863097|FG000|Overall Study|change of treatment, patient moved|4|||
42054776|NCT01026389|75863098|FG001|Overall Study|change of treatment, patient moved|2|||
42054777|NCT01006616|75863108|FG000|Period 1 (6 Months)|Adverse Event|10|||
42054778|NCT01006616|75863109|FG001|Period 1 (6 Months)|Adverse Event|31|||
42054779|NCT01006616|75863110|FG002|Period 1 (6 Months)|Adverse Event|37|||
42054780|NCT01006616|75863111|FG003|Period 1 (6 Months)|Adverse Event|9|||
42054781|NCT01006616|75863108|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
42054782|NCT01006616|75863109|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
42054783|NCT01006616|75863110|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
42054784|NCT01006616|75863111|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
42054785|NCT01006616|75863108|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
42054786|NCT01006616|75863109|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
42054787|NCT01006616|75863110|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
42054788|NCT01006616|75863111|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
42054789|NCT01006616|75863108|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
42054790|NCT01006616|75863109|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
42054791|NCT01006616|75863110|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
42054792|NCT01006616|75863111|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
42054793|NCT01006616|75863108|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
42054794|NCT01006616|75863109|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
42054795|NCT01006616|75863110|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
42054796|NCT01006616|75863111|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
42054797|NCT01006616|75863108|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
42054798|NCT01006616|75863109|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
42054799|NCT01006616|75863110|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
42054800|NCT01006616|75863111|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
42054801|NCT01006616|75863108|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
42054802|NCT01006616|75863109|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
42054803|NCT01006616|75863110|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
42054804|NCT01006616|75863111|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
42054805|NCT01006616|75863108|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
42054806|NCT01006616|75863109|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
42054807|NCT01006616|75863110|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
42054808|NCT01006616|75863111|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
42054809|NCT01006616|75863108|FG000|Period 1 (6 Months)|Not Treated|0|||
42054810|NCT01006616|75863109|FG001|Period 1 (6 Months)|Not Treated|0|||
42054811|NCT01006616|75863110|FG002|Period 1 (6 Months)|Not Treated|1|||
42054812|NCT01006616|75863111|FG003|Period 1 (6 Months)|Not Treated|1|||
42054813|NCT01006616|75863108|FG000|Period 2 (18 Months)|Adverse Event|6|||
42054814|NCT01006616|75863109|FG001|Period 2 (18 Months)|Adverse Event|6|||
42054815|NCT01006616|75863110|FG002|Period 2 (18 Months)|Adverse Event|6|||
42054816|NCT01006616|75863111|FG003|Period 2 (18 Months)|Adverse Event|4|||
42054817|NCT01006616|75863108|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
42054818|NCT01006616|75863109|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
42054819|NCT01006616|75863110|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
42054820|NCT01006616|75863111|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
42054821|NCT01006616|75863108|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
42054822|NCT01006616|75863109|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
42054823|NCT01006616|75863110|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
42054824|NCT01006616|75863111|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
42054825|NCT01006616|75863108|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
42356956|NCT01405053|76202178|FG000|Overall Study|Participant choice|2|||
42016380|NCT03637764|75823675|FG002|Overall Study|Progressive Disease|18|||
42016381|NCT03637764|75823676|FG003|Overall Study|Progressive Disease|31|||
42016382|NCT03637764|75823673|FG000|Overall Study|Withdrawal by Subject|1|||
42016383|NCT03637764|75823674|FG001|Overall Study|Withdrawal by Subject|3|||
42016384|NCT03637764|75823675|FG002|Overall Study|Withdrawal by Subject|0|||
42016385|NCT03637764|75823676|FG003|Overall Study|Withdrawal by Subject|1|||
42016386|NCT03483116|75823706|FG000|Overall Study|Adverse Event|0|||
42016387|NCT03483116|75823707|FG001|Overall Study|Adverse Event|1|||
42016388|NCT03483116|75823708|FG002|Overall Study|Adverse Event|0|||
42016389|NCT03483116|75823709|FG003|Overall Study|Adverse Event|1|||
42016390|NCT03483116|75823706|FG000|Overall Study|Protocol Violation|1|||
42016391|NCT03483116|75823707|FG001|Overall Study|Protocol Violation|0|||
42016392|NCT03483116|75823708|FG002|Overall Study|Protocol Violation|0|||
42016393|NCT03483116|75823709|FG003|Overall Study|Protocol Violation|7|||
42016394|NCT03483116|75823706|FG000|Overall Study|Lost to Follow-up|9|||
42016395|NCT03483116|75823707|FG001|Overall Study|Lost to Follow-up|4|||
42016396|NCT03483116|75823708|FG002|Overall Study|Lost to Follow-up|9|||
42016397|NCT03483116|75823709|FG003|Overall Study|Lost to Follow-up|5|||
42016398|NCT03483116|75823706|FG000|Overall Study|Death|1|||
42016399|NCT03483116|75823707|FG001|Overall Study|Death|0|||
42016400|NCT03483116|75823708|FG002|Overall Study|Death|2|||
42016401|NCT03483116|75823709|FG003|Overall Study|Death|1|||
42016402|NCT03483116|75823706|FG000|Overall Study|Withdrawal by Subject|14|||
42016403|NCT03483116|75823707|FG001|Overall Study|Withdrawal by Subject|16|||
42016404|NCT03483116|75823708|FG002|Overall Study|Withdrawal by Subject|14|||
42016405|NCT03483116|75823709|FG003|Overall Study|Withdrawal by Subject|16|||
42016406|NCT03483116|75823706|FG000|Overall Study|Unknown other reason|3|||
42016407|NCT03483116|75823707|FG001|Overall Study|Unknown other reason|2|||
42016408|NCT03483116|75823708|FG002|Overall Study|Unknown other reason|1|||
42016409|NCT03483116|75823709|FG003|Overall Study|Unknown other reason|1|||
42016410|NCT02811861|75823740|FG000|Overall Study|Radiological Disease Progression|123|||
42016411|NCT02811861|75823741|FG001|Overall Study|Radiological Disease Progression|97|||
42016412|NCT02811861|75823742|FG002|Overall Study|Radiological Disease Progression|174|||
42016413|NCT02811861|75823740|FG000|Overall Study|Clinical Disease Progression|20|||
42016414|NCT02811861|75823741|FG001|Overall Study|Clinical Disease Progression|19|||
42016415|NCT02811861|75823742|FG002|Overall Study|Clinical Disease Progression|22|||
42016416|NCT02811861|75823740|FG000|Overall Study|Adverse Event|63|||
42016417|NCT02811861|75823741|FG001|Overall Study|Adverse Event|60|||
42016418|NCT02811861|75823742|FG002|Overall Study|Adverse Event|41|||
42016419|NCT02811861|75823740|FG000|Overall Study|Lost to Follow-up|0|||
42016420|NCT02811861|75823741|FG001|Overall Study|Lost to Follow-up|0|||
42016421|NCT02811861|75823742|FG002|Overall Study|Lost to Follow-up|1|||
42016422|NCT02811861|75823740|FG000|Overall Study|Subject Choice|29|||
42016423|NCT02811861|75823741|FG001|Overall Study|Subject Choice|17|||
42016424|NCT02811861|75823742|FG002|Overall Study|Subject Choice|23|||
42016425|NCT02811861|75823740|FG000|Overall Study|Withdrawal by Subject|4|||
42016426|NCT02811861|75823741|FG001|Overall Study|Withdrawal by Subject|4|||
42016427|NCT02811861|75823742|FG002|Overall Study|Withdrawal by Subject|9|||
42016428|NCT02811861|75823740|FG000|Overall Study|Other|4|||
42016429|NCT02811861|75823741|FG001|Overall Study|Other|13|||
42016430|NCT02811861|75823742|FG002|Overall Study|Other|3|||
42016431|NCT02811861|75823740|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
42016432|NCT02811861|75823741|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
42016433|NCT02811861|75823742|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
42016434|NCT02811861|75823740|FG000|Overall Study|Randomized but not treated|2|||
42016435|NCT02811861|75823741|FG001|Overall Study|Randomized but not treated|3|||
42016436|NCT02811861|75823742|FG002|Overall Study|Randomized but not treated|17|||
42016437|NCT02700451|75823753|FG000|Overall Study|Protocol Violation|2|||
42016438|NCT02700451|75823754|FG001|Overall Study|Protocol Violation|2|||
42016439|NCT02700451|75823755|FG002|Overall Study|Protocol Violation|3|||
42016440|NCT02700451|75823753|FG000|Overall Study|Discontinued intervention|14|||
42016441|NCT02700451|75823754|FG001|Overall Study|Discontinued intervention|15|||
42016442|NCT02700451|75823755|FG002|Overall Study|Discontinued intervention|14|||
42016443|NCT02623426|75823766|FG000|Overall Study|Lost to Follow-up|0|||
42016444|NCT02623426|75823767|FG001|Overall Study|Lost to Follow-up|0|||
42016445|NCT02623426|75823768|FG002|Overall Study|Lost to Follow-up|1|||
42016446|NCT02623426|75823766|FG000|Overall Study|Withdrawal by Subject|1|||
42016447|NCT02623426|75823767|FG001|Overall Study|Withdrawal by Subject|2|||
42016448|NCT02623426|75823768|FG002|Overall Study|Withdrawal by Subject|2|||
42016449|NCT02580058|75823779|FG000|Overall Study|Adverse Event|16|||
42016450|NCT02580058|75823780|FG001|Overall Study|Adverse Event|30|||
42016451|NCT02580058|75823781|FG002|Overall Study|Adverse Event|20|||
42016452|NCT02580058|75823779|FG000|Overall Study|Death|4|||
42054826|NCT01006616|75863109|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
42054827|NCT01006616|75863110|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
42054828|NCT01006616|75863111|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
42054829|NCT01006616|75863108|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
42054830|NCT01006616|75863109|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
42054831|NCT01006616|75863110|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
42054832|NCT01006616|75863111|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
42054833|NCT01006616|75863108|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
42054834|NCT01006616|75863109|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
42054835|NCT01006616|75863110|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
42054836|NCT01006616|75863111|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
42054837|NCT01006616|75863108|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
42054838|NCT01006616|75863109|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
42054839|NCT01006616|75863110|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
42054840|NCT01006616|75863111|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
42054841|NCT01006616|75863108|FG000|Period 2 (18 Months)|Study Terminated|63|||
42054842|NCT01006616|75863109|FG001|Period 2 (18 Months)|Study Terminated|46|||
42054843|NCT01006616|75863110|FG002|Period 2 (18 Months)|Study Terminated|44|||
42054844|NCT01006616|75863111|FG003|Period 2 (18 Months)|Study Terminated|70|||
42054845|NCT00996632|75863123|FG000|Overall Study|Physician Decision|0|||
42054846|NCT00996632|75863124|FG001|Overall Study|Physician Decision|0|||
42054847|NCT01025843|75863140|FG000|Washout 4|Withdrawal by Subject|0|||
42054848|NCT01025843|75863141|FG001|Washout 4|Withdrawal by Subject|0|||
42054849|NCT01025843|75863142|FG002|Washout 4|Withdrawal by Subject|1|||
42054850|NCT01025843|75863143|FG003|Washout 4|Withdrawal by Subject|1|||
42054851|NCT01025843|75863144|FG004|Washout 4|Withdrawal by Subject|0|||
42054852|NCT01025843|75863145|FG005|Washout 4|Withdrawal by Subject|0|||
42054853|NCT01025843|75863146|FG006|Washout 4|Withdrawal by Subject|0|||
42054854|NCT01025843|75863147|FG007|Washout 4|Withdrawal by Subject|0|||
42054855|NCT01025843|75863148|FG008|Washout 4|Withdrawal by Subject|0|||
42054856|NCT01025843|75863149|FG009|Washout 4|Withdrawal by Subject|0|||
42054857|NCT01036763|75863177|FG000|Overall Study|Adverse Event|25|||
42054858|NCT01036763|75863177|FG000|Overall Study|Lost to Follow-up|28|||
42054859|NCT01036763|75863177|FG000|Overall Study|Other reason (not specified)|40|||
42054860|NCT01021007|75863183|FG000|Overall Study|Lost to Follow-up|1|||
42054861|NCT01021007|75863184|FG001|Overall Study|Lost to Follow-up|1|||
42054862|NCT01021007|75863183|FG000|Overall Study|Adverse Event|1|||
42054863|NCT01021007|75863184|FG001|Overall Study|Adverse Event|3|||
42054864|NCT01020773|75863192|FG000|Overall Study|Withdrawal by Subject|4|||
42054865|NCT01020773|75863193|FG001|Overall Study|Withdrawal by Subject|3|||
42054866|NCT01020305|75863199|FG000|Overall Study|Adverse Event|2|||
42054867|NCT01036529|75863205|FG000|Overall Study|Adverse Event|0|||
42054868|NCT01036529|75863206|FG001|Overall Study|Adverse Event|1|||
42054869|NCT01036529|75863205|FG000|Overall Study|Lost to Follow-up|0|||
42054870|NCT01036529|75863206|FG001|Overall Study|Lost to Follow-up|1|||
42054871|NCT01036529|75863205|FG000|Overall Study|Physician Decision|1|||
42054872|NCT01036529|75863206|FG001|Overall Study|Physician Decision|0|||
42054873|NCT01036529|75863205|FG000|Overall Study|Withdrawal by Subject|1|||
42054874|NCT01036529|75863206|FG001|Overall Study|Withdrawal by Subject|1|||
42054875|NCT01036529|75863205|FG000|Overall Study|Sponsor study termination|11|||
42054876|NCT01036529|75863206|FG001|Overall Study|Sponsor study termination|12|||
42054877|NCT01024751|75863214|FG000|Enrolled Participants|Ineligible at baseline|3|||
42054878|NCT01024751|75863215|FG001|Enrolled Participants|Ineligible at baseline|4|||
42054879|NCT01024751|75863214|FG000|Eligible Participants|Withdrawal by Subject|0|||
42054880|NCT01024751|75863215|FG001|Eligible Participants|Withdrawal by Subject|1|||
42054881|NCT01024751|75863214|FG000|Eligible Participants|Lost to Follow-up|0|||
42173873|NCT00086580|75980669|FG001|Treatment Period|AE - not treatment related|7|||
42173874|NCT00086580|75980668|FG000|Treatment Period|Toxicity - treatment related|15|||
42291679|NCT01970488|76125152|FG001|Part 2: Post Week 16|Adverse Event|0|||
42291680|NCT01970488|76125153|FG002|Part 2: Post Week 16|Adverse Event|5|||
42291681|NCT01970488|76125154|FG003|Part 2: Post Week 16|Adverse Event|1|||
42054882|NCT01024751|75863215|FG001|Eligible Participants|Lost to Follow-up|1|||
42054883|NCT01024751|75863214|FG000|Eligible Participants|Ineligible|0|||
42054884|NCT01024751|75863215|FG001|Eligible Participants|Ineligible|1|||
42173875|NCT00086580|75980669|FG001|Treatment Period|Toxicity - treatment related|15|||
42054885|NCT01019369|75863223|FG000|Overall Study|Lost to Follow-up|10|||
42054886|NCT01019369|75863224|FG001|Overall Study|Lost to Follow-up|6|||
42173876|NCT00086580|75980668|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
42291682|NCT01970488|76125155|FG004|Part 2: Post Week 16|Adverse Event|1|||
42054887|NCT01019369|75863223|FG000|Overall Study|Withdrawal by Subject|0|||
42054888|NCT01019369|75863224|FG001|Overall Study|Withdrawal by Subject|1|||
42054889|NCT01019135|75863234|FG000|Overall Study|Did not receive allocated intervention|12|||
42054890|NCT01019135|75863235|FG001|Overall Study|Did not receive allocated intervention|6|||
42054891|NCT01019135|75863236|FG002|Overall Study|Did not receive allocated intervention|25|||
42054892|NCT01019135|75863234|FG000|Overall Study|Did not attend CR|8|||
42054893|NCT01019135|75863235|FG001|Overall Study|Did not attend CR|13|||
42054894|NCT01019135|75863236|FG002|Overall Study|Did not attend CR|6|||
42054895|NCT01018979|75863246|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
42054896|NCT01018979|75863247|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
42054897|NCT01018979|75863246|FG000|Overall Study|Not received at least one dose|0|||
42054898|NCT01018979|75863247|FG001|Overall Study|Not received at least one dose|1|||
42054899|NCT01572493|75863265|FG000|Overall Study|Physician Decision|1|||
42054900|NCT01572493|75863266|FG001|Overall Study|Physician Decision|0|||
42054901|NCT01572493|75863267|FG002|Overall Study|Physician Decision|0|||
42054902|NCT01572493|75863268|FG003|Overall Study|Physician Decision|0|||
42054903|NCT01572493|75863269|FG004|Overall Study|Physician Decision|0|||
42054904|NCT01572493|75863270|FG005|Overall Study|Physician Decision|0|||
42054905|NCT01572493|75863271|FG006|Overall Study|Physician Decision|0|||
42054906|NCT01572493|75863272|FG007|Overall Study|Physician Decision|0|||
42054907|NCT01572493|75863273|FG008|Overall Study|Physician Decision|0|||
42054908|NCT01572493|75863265|FG000|Overall Study|Switched to alternative treatment|0|||
42054909|NCT01572493|75863266|FG001|Overall Study|Switched to alternative treatment|1|||
42054910|NCT01572493|75863267|FG002|Overall Study|Switched to alternative treatment|2|||
42054911|NCT01572493|75863268|FG003|Overall Study|Switched to alternative treatment|1|||
42054912|NCT01572493|75863269|FG004|Overall Study|Switched to alternative treatment|2|||
42054913|NCT01572493|75863270|FG005|Overall Study|Switched to alternative treatment|0|||
42054914|NCT01572493|75863271|FG006|Overall Study|Switched to alternative treatment|2|||
42054915|NCT01572493|75863272|FG007|Overall Study|Switched to alternative treatment|0|||
42054916|NCT01572493|75863273|FG008|Overall Study|Switched to alternative treatment|2|||
42054917|NCT01572493|75863265|FG000|Overall Study|Death|0|||
42054918|NCT01572493|75863266|FG001|Overall Study|Death|0|||
42054919|NCT01572493|75863267|FG002|Overall Study|Death|0|||
42054920|NCT01572493|75863268|FG003|Overall Study|Death|1|||
42054921|NCT01572493|75863269|FG004|Overall Study|Death|0|||
42054922|NCT01572493|75863270|FG005|Overall Study|Death|1|||
42054923|NCT01572493|75863271|FG006|Overall Study|Death|0|||
42054924|NCT01572493|75863272|FG007|Overall Study|Death|0|||
42054925|NCT01572493|75863273|FG008|Overall Study|Death|0|||
42054926|NCT01572493|75863265|FG000|Overall Study|Adverse Event|0|||
42054927|NCT01572493|75863266|FG001|Overall Study|Adverse Event|0|||
42054928|NCT01572493|75863267|FG002|Overall Study|Adverse Event|0|||
42054929|NCT01572493|75863268|FG003|Overall Study|Adverse Event|0|||
42054930|NCT01572493|75863269|FG004|Overall Study|Adverse Event|0|||
42054931|NCT01572493|75863270|FG005|Overall Study|Adverse Event|0|||
42054932|NCT01572493|75863271|FG006|Overall Study|Adverse Event|1|||
42054933|NCT01572493|75863272|FG007|Overall Study|Adverse Event|0|||
42054934|NCT01572493|75863273|FG008|Overall Study|Adverse Event|0|||
42054935|NCT01018511|75863300|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
42054936|NCT01018511|75863301|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
42054937|NCT01018511|75863302|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
42054938|NCT01018511|75863303|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
42054939|NCT01018511|75863300|FG000|Overall Study|Adverse Event|5|||
42054940|NCT01018511|75863301|FG001|Overall Study|Adverse Event|9|||
42054941|NCT01018511|75863302|FG002|Overall Study|Adverse Event|13|||
42054942|NCT01018511|75863303|FG003|Overall Study|Adverse Event|10|||
42054943|NCT01018511|75863300|FG000|Overall Study|Lack of Efficacy|4|||
42054944|NCT01018511|75863301|FG001|Overall Study|Lack of Efficacy|1|||
42054945|NCT01018511|75863302|FG002|Overall Study|Lack of Efficacy|1|||
42054946|NCT01018511|75863303|FG003|Overall Study|Lack of Efficacy|2|||
42173877|NCT00086580|75980669|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
42173878|NCT00086580|75980668|FG000|Treatment Period|Death|5|||
42173879|NCT00086580|75980669|FG001|Treatment Period|Death|7|||
42291683|NCT01970488|76125151|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
42356957|NCT01405053|76202179|FG001|Overall Study|Participant choice|1|||
42054947|NCT01018511|75863300|FG000|Overall Study|Withdrawal by Subject|6|||
42054948|NCT01018511|75863301|FG001|Overall Study|Withdrawal by Subject|5|||
42054949|NCT01018511|75863302|FG002|Overall Study|Withdrawal by Subject|11|||
42054950|NCT01018511|75863303|FG003|Overall Study|Withdrawal by Subject|9|||
42054951|NCT01018511|75863300|FG000|Overall Study|Lost to Follow-up|0|||
42054952|NCT01018511|75863301|FG001|Overall Study|Lost to Follow-up|0|||
42054953|NCT01018511|75863302|FG002|Overall Study|Lost to Follow-up|1|||
42054954|NCT01018511|75863303|FG003|Overall Study|Lost to Follow-up|0|||
42054955|NCT01018511|75863300|FG000|Overall Study|Protocol Violation|5|||
42054956|NCT01018511|75863301|FG001|Overall Study|Protocol Violation|8|||
42054957|NCT01018511|75863302|FG002|Overall Study|Protocol Violation|7|||
42054958|NCT01018511|75863303|FG003|Overall Study|Protocol Violation|9|||
42054959|NCT01018511|75863300|FG000|Overall Study|Miscellaneous|0|||
42054960|NCT01018511|75863301|FG001|Overall Study|Miscellaneous|2|||
42054961|NCT01018511|75863302|FG002|Overall Study|Miscellaneous|0|||
42054962|NCT01018511|75863303|FG003|Overall Study|Miscellaneous|0|||
42054963|NCT00996476|75863324|FG000|Overall Study|Withdrawal by Subject|1|||
42173880|NCT00086580|75980668|FG000|Treatment Period|Other|5|||
42173881|NCT00086580|75980669|FG001|Treatment Period|Other|3|||
42054964|NCT00996476|75863325|FG001|Overall Study|Withdrawal by Subject|2|||
42054965|NCT00996476|75863326|FG002|Overall Study|Withdrawal by Subject|1|||
42054966|NCT00996476|75863327|FG003|Overall Study|Withdrawal by Subject|0|||
42054967|NCT00996476|75863328|FG004|Overall Study|Withdrawal by Subject|1|||
42054968|NCT00996476|75863324|FG000|Overall Study|Adverse Event|0|||
42054969|NCT00996476|75863325|FG001|Overall Study|Adverse Event|1|||
42054970|NCT00996476|75863326|FG002|Overall Study|Adverse Event|0|||
42054971|NCT00996476|75863327|FG003|Overall Study|Adverse Event|0|||
42054972|NCT00996476|75863328|FG004|Overall Study|Adverse Event|1|||
42054973|NCT02269267|75863345|FG000|Overall Study|Death|5|||
42054974|NCT01017731|75863349|FG000|Overall Study|Lost to Follow-up|2|||
42054975|NCT01017731|75863349|FG000|Overall Study|Withdrawal by Subject|3|||
42054976|NCT01017731|75863349|FG000|Overall Study|Physician Decision|2|||
42054977|NCT01017731|75863349|FG000|Overall Study|Adverse Event|1|||
42054978|NCT01035905|75863356|FG000|Overall Study|Lack of Efficacy|1|||
42054979|NCT01035905|75863357|FG001|Overall Study|Lack of Efficacy|1|||
42054980|NCT00779584|75863381|FG000|Overall Study|Protocol Violation|0|||
42054981|NCT00779584|75863382|FG001|Overall Study|Protocol Violation|0|||
42054982|NCT00779584|75863383|FG002|Overall Study|Protocol Violation|0|||
42054983|NCT00779584|75863384|FG003|Overall Study|Protocol Violation|0|||
42054984|NCT00779584|75863385|FG004|Overall Study|Protocol Violation|0|||
42054985|NCT00779584|75863386|FG005|Overall Study|Protocol Violation|1|||
42054986|NCT00779584|75863387|FG006|Overall Study|Protocol Violation|0|||
42054987|NCT00779584|75863388|FG007|Overall Study|Protocol Violation|0|||
42054988|NCT00779584|75863389|FG008|Overall Study|Protocol Violation|0|||
42054989|NCT00779584|75863381|FG000|Overall Study|Withdrawal by Subject|1|||
42054990|NCT00779584|75863382|FG001|Overall Study|Withdrawal by Subject|1|||
42054991|NCT00779584|75863383|FG002|Overall Study|Withdrawal by Subject|2|||
42054992|NCT00779584|75863384|FG003|Overall Study|Withdrawal by Subject|0|||
42054993|NCT00779584|75863385|FG004|Overall Study|Withdrawal by Subject|0|||
42054994|NCT00779584|75863386|FG005|Overall Study|Withdrawal by Subject|2|||
42054995|NCT00779584|75863387|FG006|Overall Study|Withdrawal by Subject|1|||
42054996|NCT00779584|75863388|FG007|Overall Study|Withdrawal by Subject|0|||
42054997|NCT00779584|75863389|FG008|Overall Study|Withdrawal by Subject|0|||
42054998|NCT00779584|75863381|FG000|Overall Study|Lost to Follow-up|0|||
42054999|NCT00779584|75863382|FG001|Overall Study|Lost to Follow-up|0|||
42055000|NCT00779584|75863383|FG002|Overall Study|Lost to Follow-up|0|||
42055001|NCT00779584|75863384|FG003|Overall Study|Lost to Follow-up|0|||
42055002|NCT00779584|75863385|FG004|Overall Study|Lost to Follow-up|1|||
42055003|NCT00779584|75863386|FG005|Overall Study|Lost to Follow-up|0|||
42055004|NCT00779584|75863387|FG006|Overall Study|Lost to Follow-up|0|||
42055005|NCT00779584|75863388|FG007|Overall Study|Lost to Follow-up|0|||
42055006|NCT00779584|75863389|FG008|Overall Study|Lost to Follow-up|0|||
42055007|NCT00779584|75863381|FG000|Overall Study|Progression of Disease|0|||
42055008|NCT00779584|75863382|FG001|Overall Study|Progression of Disease|1|||
42055009|NCT00779584|75863383|FG002|Overall Study|Progression of Disease|2|||
42055010|NCT00779584|75863384|FG003|Overall Study|Progression of Disease|6|||
42055011|NCT00779584|75863385|FG004|Overall Study|Progression of Disease|5|||
42055012|NCT00779584|75863386|FG005|Overall Study|Progression of Disease|1|||
42291684|NCT01970488|76125152|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
42291685|NCT01970488|76125153|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
42291686|NCT01970488|76125154|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
42291687|NCT01970488|76125155|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
42291688|NCT01970488|76125151|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
42291689|NCT01970488|76125152|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
42291690|NCT01970488|76125153|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
42291691|NCT01970488|76125154|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
42055013|NCT00779584|75863387|FG006|Overall Study|Progression of Disease|4|||
42055014|NCT00779584|75863388|FG007|Overall Study|Progression of Disease|2|||
42055015|NCT00779584|75863389|FG008|Overall Study|Progression of Disease|1|||
42055016|NCT00779584|75863381|FG000|Overall Study|Adverse Event|1|||
42055017|NCT00779584|75863382|FG001|Overall Study|Adverse Event|0|||
42055018|NCT00779584|75863383|FG002|Overall Study|Adverse Event|2|||
42055019|NCT00779584|75863384|FG003|Overall Study|Adverse Event|0|||
42055020|NCT00779584|75863385|FG004|Overall Study|Adverse Event|0|||
42055021|NCT00779584|75863386|FG005|Overall Study|Adverse Event|0|||
42055022|NCT00779584|75863387|FG006|Overall Study|Adverse Event|2|||
42055023|NCT00779584|75863388|FG007|Overall Study|Adverse Event|1|||
42055024|NCT00779584|75863389|FG008|Overall Study|Adverse Event|1|||
42055025|NCT00779584|75863381|FG000|Overall Study|Symptomatic Deterioration|1|||
42055026|NCT00779584|75863382|FG001|Overall Study|Symptomatic Deterioration|1|||
42055027|NCT00779584|75863383|FG002|Overall Study|Symptomatic Deterioration|1|||
42055028|NCT00779584|75863384|FG003|Overall Study|Symptomatic Deterioration|0|||
42291692|NCT01970488|76125155|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
42291693|NCT02661217|76125172|FG000|Overall Study|Physician Decision|12|||
42055029|NCT00779584|75863385|FG004|Overall Study|Symptomatic Deterioration|0|||
42055030|NCT00779584|75863386|FG005|Overall Study|Symptomatic Deterioration|1|||
42055031|NCT00779584|75863387|FG006|Overall Study|Symptomatic Deterioration|1|||
42055032|NCT00779584|75863388|FG007|Overall Study|Symptomatic Deterioration|0|||
42055033|NCT00779584|75863389|FG008|Overall Study|Symptomatic Deterioration|0|||
42055034|NCT00779584|75863381|FG000|Overall Study|Ongoing in Study|0|||
42055035|NCT00779584|75863382|FG001|Overall Study|Ongoing in Study|0|||
42055036|NCT00779584|75863383|FG002|Overall Study|Ongoing in Study|0|||
42055037|NCT00779584|75863384|FG003|Overall Study|Ongoing in Study|0|||
42055038|NCT00779584|75863385|FG004|Overall Study|Ongoing in Study|1|||
42055039|NCT00779584|75863386|FG005|Overall Study|Ongoing in Study|1|||
42055040|NCT00779584|75863387|FG006|Overall Study|Ongoing in Study|0|||
42055041|NCT00779584|75863388|FG007|Overall Study|Ongoing in Study|0|||
42055042|NCT00779584|75863389|FG008|Overall Study|Ongoing in Study|0|||
42055043|NCT00995930|75863411|FG000|Overall Study|Protocol deviation|2|||
42055044|NCT00995930|75863412|FG001|Overall Study|Protocol deviation|5|||
42055045|NCT00995930|75863411|FG000|Overall Study|Death|0|||
42055046|NCT00995930|75863412|FG001|Overall Study|Death|1|||
42055047|NCT00995930|75863411|FG000|Overall Study|Administrative problems|4|||
42055048|NCT00995930|75863412|FG001|Overall Study|Administrative problems|2|||
42055049|NCT00995930|75863411|FG000|Overall Study|Lost to Follow-up|1|||
42055050|NCT00995930|75863412|FG001|Overall Study|Lost to Follow-up|2|||
42055051|NCT00995930|75863411|FG000|Overall Study|Withdrawal by Subject|3|||
42055052|NCT00995930|75863412|FG001|Overall Study|Withdrawal by Subject|4|||
42055053|NCT00995930|75863411|FG000|Overall Study|Adverse Event|11|||
42055054|NCT00995930|75863412|FG001|Overall Study|Adverse Event|14|||
42055055|NCT00779506|75863419|FG000|Overall Study|Screening Failed|2|||
42055056|NCT00779506|75863419|FG000|Overall Study|Adverse Event|4|||
42055057|NCT00779506|75863419|FG000|Overall Study|Lack of Efficacy|11|||
42055058|NCT00779506|75863419|FG000|Overall Study|Protocol Violation|5|||
42055059|NCT00779506|75863419|FG000|Overall Study|Withdrawal by Subject|6|||
42055060|NCT00779506|75863419|FG000|Overall Study|Lost to Follow-up|1|||
42055061|NCT00995774|75863425|FG000|Training Period 2|Withdrawal by Subject|2|||
42055062|NCT00995774|75863426|FG001|Training Period 2|Withdrawal by Subject|0|||
42055063|NCT00765388|75863432|FG000|Period 1|Lack of Efficacy|1|||
42055064|NCT00765388|75863433|FG001|Period 1|Lack of Efficacy|2|||
42055065|NCT00765388|75863432|FG000|Period 1|Lost to Follow-up|0|||
42055066|NCT00765388|75863433|FG001|Period 1|Lost to Follow-up|1|||
42055067|NCT00765388|75863432|FG000|Period 1|Herpes Zoster|0|||
42055068|NCT00765388|75863433|FG001|Period 1|Herpes Zoster|1|||
42055069|NCT00765388|75863432|FG000|Period 1|Hip operation|0|||
42055070|NCT00765388|75863433|FG001|Period 1|Hip operation|1|||
42055071|NCT00769132|75863448|FG000|Period 1|Adverse Event|1|||
42055072|NCT00769132|75863449|FG001|Period 1|Adverse Event|0|||
42055073|NCT00769132|75863450|FG002|Period 1|Adverse Event|0|||
42055074|NCT00769132|75863451|FG003|Period 1|Adverse Event|1|||
42055075|NCT00769132|75863448|FG000|Period 2|Withdrawal by Subject|0|||
42055076|NCT00769132|75863449|FG001|Period 2|Withdrawal by Subject|0|||
42055077|NCT00769132|75863450|FG002|Period 2|Withdrawal by Subject|0|||
42055078|NCT00769132|75863451|FG003|Period 2|Withdrawal by Subject|1|||
42055079|NCT00769132|75863448|FG000|Period 3|Withdrawal by Subject|1|||
42055080|NCT00769132|75863449|FG001|Period 3|Withdrawal by Subject|0|||
42055081|NCT00769132|75863450|FG002|Period 3|Withdrawal by Subject|0|||
42055082|NCT00769132|75863451|FG003|Period 3|Withdrawal by Subject|0|||
42055083|NCT00769132|75863448|FG000|Period 4|Withdrawal by Subject|0|||
42055084|NCT00769132|75863449|FG001|Period 4|Withdrawal by Subject|1|||
42055085|NCT00769132|75863450|FG002|Period 4|Withdrawal by Subject|0|||
42055086|NCT00769132|75863451|FG003|Period 4|Withdrawal by Subject|0|||
42055087|NCT00991952|75863463|FG000|Overall Study|Adverse Event|0|||
42055088|NCT00991952|75863464|FG001|Overall Study|Adverse Event|1|||
42055089|NCT00779038|75863470|FG000|Overall Study|Study Prematurely Terminated|13|||
42055090|NCT00765076|75863477|FG000|Overall Study|Adverse Event|1|||
42291694|NCT02661217|76125173|FG001|Overall Study|Physician Decision|15|||
42291695|NCT02661217|76125172|FG000|Overall Study|Lost to Follow-up|1|||
42291696|NCT02661217|76125173|FG001|Overall Study|Lost to Follow-up|4|||
42291697|NCT02661217|76125172|FG000|Overall Study|Protocol Deviation|0|||
42291698|NCT02661217|76125173|FG001|Overall Study|Protocol Deviation|4|||
42055091|NCT00765076|75863478|FG001|Overall Study|Adverse Event|0|||
42055092|NCT00765076|75863479|FG002|Overall Study|Adverse Event|0|||
42055093|NCT00765076|75863477|FG000|Overall Study|Withdrawal by Subject|0|||
42055094|NCT00765076|75863478|FG001|Overall Study|Withdrawal by Subject|0|||
42291699|NCT02661217|76125172|FG000|Overall Study|Non-compliance with study treatment|5|||
42291700|NCT02661217|76125173|FG001|Overall Study|Non-compliance with study treatment|5|||
42055095|NCT00765076|75863479|FG002|Overall Study|Withdrawal by Subject|1|||
42055096|NCT00994682|75863489|FG000|Double Bilnd|Withdrawal by Subject|5|||
42055097|NCT00994682|75863490|FG001|Double Bilnd|Withdrawal by Subject|6|||
42055098|NCT00994682|75863489|FG000|Double Bilnd|Lost to Follow-up|3|||
42291701|NCT02661217|76125172|FG000|Overall Study|Death|21|||
42055099|NCT00994682|75863490|FG001|Double Bilnd|Lost to Follow-up|3|||
42055100|NCT00994682|75863489|FG000|Double Bilnd|Adverse Event|1|||
42055101|NCT00994682|75863490|FG001|Double Bilnd|Adverse Event|0|||
42055102|NCT00994682|75863489|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
42055103|NCT00994682|75863490|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
42055104|NCT00994682|75863489|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
42055105|NCT00994682|75863490|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
42055106|NCT00994682|75863489|FG000|Pioglitazone Open Label|Physician Decision|6|||
42055107|NCT00994682|75863490|FG001|Pioglitazone Open Label|Physician Decision|1|||
42055108|NCT00768898|75863500|FG000|Overall Study|Unrelated injury|1|||
42055109|NCT00768898|75863500|FG000|Overall Study|Headache|1|||
42055110|NCT00994448|75863511|FG000|Overall Study|Adverse Event|1|||
42055111|NCT00994448|75863512|FG001|Overall Study|Adverse Event|0|||
42055112|NCT00994448|75863511|FG000|Overall Study|Lost to Follow-up|5|||
42055113|NCT00994448|75863512|FG001|Overall Study|Lost to Follow-up|1|||
42055114|NCT00994448|75863511|FG000|Overall Study|Withdrawal by Subject|1|||
42055115|NCT00994448|75863512|FG001|Overall Study|Withdrawal by Subject|1|||
42055116|NCT00994448|75863511|FG000|Overall Study|Physician Decision|1|||
42055117|NCT00994448|75863512|FG001|Overall Study|Physician Decision|0|||
42055118|NCT00991406|75863518|FG000|Overall Study|One participant did not respond to FES.|1|||
42055119|NCT01017575|75863527|FG000|Overall Study|Lack of Efficacy|0|||
42055120|NCT01017575|75863528|FG001|Overall Study|Lack of Efficacy|1|||
42055121|NCT01017575|75863529|FG002|Overall Study|Lack of Efficacy|0|||
42055122|NCT01017575|75863530|FG003|Overall Study|Lack of Efficacy|1|||
42055123|NCT01017575|75863531|FG004|Overall Study|Lack of Efficacy|1|||
42055124|NCT01017575|75863527|FG000|Overall Study|Adverse Event|0|||
42055125|NCT01017575|75863528|FG001|Overall Study|Adverse Event|1|||
42055126|NCT01017575|75863529|FG002|Overall Study|Adverse Event|0|||
42055127|NCT01017575|75863530|FG003|Overall Study|Adverse Event|0|||
42055128|NCT01017575|75863531|FG004|Overall Study|Adverse Event|2|||
42055129|NCT01017575|75863527|FG000|Overall Study|Withdrawal by Subject|1|||
42055130|NCT01017575|75863528|FG001|Overall Study|Withdrawal by Subject|0|||
42055131|NCT01017575|75863529|FG002|Overall Study|Withdrawal by Subject|0|||
42055132|NCT01017575|75863530|FG003|Overall Study|Withdrawal by Subject|0|||
42055133|NCT01017575|75863531|FG004|Overall Study|Withdrawal by Subject|0|||
42055134|NCT01017263|75863543|FG000|Overall Study|not eligible|12|||
42055135|NCT00768664|75863547|FG000|Overall Study|Death|57|||
42055136|NCT00768664|75863547|FG000|Overall Study|Lost to Follow-up|2|||
42055137|NCT00768664|75863547|FG000|Overall Study|Other|9|||
42055138|NCT00768664|75863547|FG000|Overall Study|Participant refused|1|||
42055139|NCT00778336|75863555|FG000|Index Procedure-Discharge|Death|6|||
42055140|NCT00778336|75863556|FG001|Index Procedure-Discharge|Death|3|||
42055141|NCT00778336|75863557|FG002|Index Procedure-Discharge|Death|2|||
42055142|NCT00778336|75863558|FG003|Index Procedure-Discharge|Death|0|||
42055143|NCT00778336|75863555|FG000|3 Month Follow Up|Lost to Follow-up|15|||
42055144|NCT00778336|75863556|FG001|3 Month Follow Up|Lost to Follow-up|20|||
42055145|NCT00778336|75863557|FG002|3 Month Follow Up|Lost to Follow-up|3|||
42055146|NCT00778336|75863558|FG003|3 Month Follow Up|Lost to Follow-up|0|||
42055147|NCT00778336|75863555|FG000|3 Month Follow Up|Death|8|||
42055148|NCT00778336|75863556|FG001|3 Month Follow Up|Death|3|||
42055149|NCT00778336|75863557|FG002|3 Month Follow Up|Death|2|||
42055150|NCT00778336|75863558|FG003|3 Month Follow Up|Death|0|||
42055151|NCT01253161|75863568|FG000|Overall Study|Adverse Event|1|||
42055152|NCT00581113|75863574|FG000|Overall Study|Withdrawal by Subject|0|||
42055153|NCT00581113|75863575|FG001|Overall Study|Withdrawal by Subject|1|||
42055154|NCT01016015|75863581|FG000|Overall Study|Not Treated|3|||
42016453|NCT02580058|75823780|FG001|Overall Study|Death|4|||
42016454|NCT02580058|75823781|FG002|Overall Study|Death|5|||
42016455|NCT02580058|75823779|FG000|Overall Study|Physician Decision|1|||
42016456|NCT02580058|75823780|FG001|Overall Study|Physician Decision|3|||
42016457|NCT02580058|75823781|FG002|Overall Study|Physician Decision|11|||
42016458|NCT02580058|75823779|FG000|Overall Study|Other|5|||
42016459|NCT02580058|75823780|FG001|Overall Study|Other|1|||
42016460|NCT02580058|75823781|FG002|Overall Study|Other|3|||
42016461|NCT02580058|75823779|FG000|Overall Study|Withdrawal by Subject|4|||
42016462|NCT02580058|75823780|FG001|Overall Study|Withdrawal by Subject|7|||
42016463|NCT02580058|75823781|FG002|Overall Study|Withdrawal by Subject|31|||
42016464|NCT02580058|75823779|FG000|Overall Study|Global Deterioration of Health Status|19|||
42016465|NCT02580058|75823780|FG001|Overall Study|Global Deterioration of Health Status|18|||
42016466|NCT02580058|75823781|FG002|Overall Study|Global Deterioration of Health Status|24|||
42016467|NCT02580058|75823779|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
42016468|NCT02580058|75823780|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
42016469|NCT02580058|75823781|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
42016470|NCT02580058|75823779|FG000|Overall Study|Progressive Disease|137|||
42055155|NCT01016015|75863581|FG000|Overall Study|Withdrawal by Subject|1|||
42055156|NCT01016015|75863581|FG000|Overall Study|Adverse Event|15|||
42055157|NCT01015703|75863590|FG000|Overall Study|Withdrawal by Subject|0|||
42055158|NCT01015703|75863591|FG001|Overall Study|Withdrawal by Subject|1|||
42055159|NCT01015703|75863592|FG002|Overall Study|Withdrawal by Subject|0|||
42016471|NCT02580058|75823780|FG001|Overall Study|Progressive Disease|125|||
42016472|NCT02580058|75823781|FG002|Overall Study|Progressive Disease|94|||
42016473|NCT02580058|75823779|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42055160|NCT01015703|75863593|FG003|Overall Study|Withdrawal by Subject|0|||
42055161|NCT01015703|75863594|FG004|Overall Study|Withdrawal by Subject|0|||
42055162|NCT01015703|75863590|FG000|Overall Study|Adverse Event|1|||
42055163|NCT01015703|75863591|FG001|Overall Study|Adverse Event|0|||
42055164|NCT01015703|75863592|FG002|Overall Study|Adverse Event|0|||
42055165|NCT01015703|75863593|FG003|Overall Study|Adverse Event|0|||
42055166|NCT01015703|75863594|FG004|Overall Study|Adverse Event|0|||
42055167|NCT01015703|75863590|FG000|Overall Study|Protocol Violation|1|||
42055168|NCT01015703|75863591|FG001|Overall Study|Protocol Violation|0|||
42055169|NCT01015703|75863592|FG002|Overall Study|Protocol Violation|0|||
42055170|NCT01015703|75863593|FG003|Overall Study|Protocol Violation|0|||
42055171|NCT01015703|75863594|FG004|Overall Study|Protocol Violation|0|||
42055172|NCT04439071|75863608|FG000|Overall Study|Lost to Follow-up|0|||
42055173|NCT04439071|75863609|FG001|Overall Study|Lost to Follow-up|3|||
42055174|NCT04439071|75863608|FG000|Overall Study|Withdrawal by Subject|3|||
42055175|NCT04439071|75863609|FG001|Overall Study|Withdrawal by Subject|8|||
42055176|NCT04439071|75863608|FG000|Overall Study|Death|6|||
42055177|NCT04439071|75863609|FG001|Overall Study|Death|4|||
42055178|NCT04439071|75863608|FG000|Overall Study|Other than specified|3|||
42055179|NCT04439071|75863609|FG001|Overall Study|Other than specified|3|||
42055180|NCT04439071|75863608|FG000|Overall Study|Randomized but not treated|2|||
42055181|NCT04439071|75863609|FG001|Overall Study|Randomized but not treated|0|||
42055182|NCT01017029|75863617|FG000|Overall Study|Lost to Follow-up|1|||
42055183|NCT01017029|75863618|FG001|Overall Study|Lost to Follow-up|0|||
42055184|NCT01017029|75863617|FG000|Overall Study|Administrative problem|0|||
42055185|NCT01017029|75863618|FG001|Overall Study|Administrative problem|1|||
42055186|NCT01017029|75863617|FG000|Overall Study|Death|3|||
42055187|NCT01017029|75863618|FG001|Overall Study|Death|1|||
42055188|NCT00994214|75863628|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
42055189|NCT00994214|75863629|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
42055190|NCT00994214|75863630|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
42055191|NCT00994214|75863631|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
42055192|NCT00994214|75863628|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
42055193|NCT00994214|75863629|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
42055194|NCT00994214|75863630|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
42055195|NCT00994214|75863631|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
42055196|NCT00994214|75863628|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
42055197|NCT00994214|75863629|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
42055198|NCT00994214|75863630|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
42055199|NCT00994214|75863631|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
42055200|NCT00994214|75863628|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
42055201|NCT00994214|75863629|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
42055202|NCT00994214|75863630|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
42055203|NCT00994214|75863631|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
42055204|NCT00994214|75863628|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
42055205|NCT00994214|75863629|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
42055206|NCT00994214|75863630|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
42055207|NCT00994214|75863631|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
42055208|NCT00994214|75863628|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
42055209|NCT00994214|75863629|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
42055210|NCT00994214|75863630|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
42055211|NCT00994214|75863631|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
42055212|NCT01034657|75863659|FG000|Core Phase|Withdrawal by Subject|1|||
42055213|NCT01034657|75863660|FG001|Core Phase|Withdrawal by Subject|0|||
42055214|NCT01034657|75863661|FG002|Core Phase|Withdrawal by Subject|0|||
42055215|NCT01034657|75863659|FG000|Core Phase|Lack of Efficacy|2|||
42055216|NCT01034657|75863660|FG001|Core Phase|Lack of Efficacy|0|||
42055217|NCT01034657|75863661|FG002|Core Phase|Lack of Efficacy|0|||
42055218|NCT01034657|75863659|FG000|Core Phase|Abnormal laboratory value|1|||
42055219|NCT01034657|75863660|FG001|Core Phase|Abnormal laboratory value|0|||
42055220|NCT01034657|75863661|FG002|Core Phase|Abnormal laboratory value|0|||
42173882|NCT00086580|75980668|FG000|Follow-up Period|Disease progression|72|||
42173883|NCT00086580|75980669|FG001|Follow-up Period|Disease progression|99|||
42173884|NCT00086580|75980668|FG000|Follow-up Period|Unable to comply with protocol|5|||
42291702|NCT02661217|76125173|FG001|Overall Study|Death|15|||
42055221|NCT01034657|75863659|FG000|Core Phase|Adverse Event|8|||
42055222|NCT01034657|75863660|FG001|Core Phase|Adverse Event|0|||
42055223|NCT01034657|75863661|FG002|Core Phase|Adverse Event|0|||
42055224|NCT01034657|75863659|FG000|Core Phase|Protocol Violation|2|||
42055225|NCT01034657|75863660|FG001|Core Phase|Protocol Violation|0|||
42055226|NCT01034657|75863661|FG002|Core Phase|Protocol Violation|0|||
42055227|NCT01034657|75863659|FG000|Randomized Phase|Withdrawal by Subject|0|||
42055228|NCT01034657|75863660|FG001|Randomized Phase|Withdrawal by Subject|2|||
42055229|NCT01034657|75863661|FG002|Randomized Phase|Withdrawal by Subject|0|||
42055230|NCT01034657|75863659|FG000|Randomized Phase|Lack of Efficacy|5|||
42055231|NCT01034657|75863660|FG001|Randomized Phase|Lack of Efficacy|1|||
42055232|NCT01034657|75863661|FG002|Randomized Phase|Lack of Efficacy|0|||
42055233|NCT01034657|75863659|FG000|Randomized Phase|Abnormal laboratory value|0|||
42055234|NCT01034657|75863660|FG001|Randomized Phase|Abnormal laboratory value|1|||
42055235|NCT01034657|75863661|FG002|Randomized Phase|Abnormal laboratory value|0|||
42055236|NCT01034657|75863659|FG000|Randomized Phase|Adverse Event|0|||
42055237|NCT01034657|75863660|FG001|Randomized Phase|Adverse Event|2|||
42055238|NCT01034657|75863661|FG002|Randomized Phase|Adverse Event|1|||
42055239|NCT01014767|75863675|FG000|Overall Study|PI left institution, data unavailable|12|||
42055240|NCT01014767|75863676|FG001|Overall Study|PI left institution, data unavailable|1|||
42055241|NCT01014767|75863677|FG002|Overall Study|PI left institution, data unavailable|4|||
42055242|NCT01014767|75863678|FG003|Overall Study|PI left institution, data unavailable|1|||
42055243|NCT02016781|75863690|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
42055244|NCT02016781|75863691|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
42055245|NCT02016781|75863690|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
42055246|NCT02016781|75863691|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
42055247|NCT02016781|75863690|FG000|Final Database Lock|Withdrawal by Subject|2|||
42055248|NCT02016781|75863691|FG001|Final Database Lock|Withdrawal by Subject|1|||
42055249|NCT02016781|75863690|FG000|Final Database Lock|Lost to Follow-up|11|||
42055250|NCT02016781|75863691|FG001|Final Database Lock|Lost to Follow-up|4|||
42055251|NCT02016781|75863690|FG000|Final Database Lock|Missing data|0|||
42055252|NCT02016781|75863691|FG001|Final Database Lock|Missing data|3|||
42055253|NCT01014689|75863699|FG000|Overall Study|Lack of Efficacy|0|||
42055254|NCT01014689|75863700|FG001|Overall Study|Lack of Efficacy|1|||
42055255|NCT01014689|75863699|FG000|Overall Study|Adverse Event|3|||
42055256|NCT01014689|75863700|FG001|Overall Study|Adverse Event|0|||
42055257|NCT01014689|75863699|FG000|Overall Study|Withdrawal by Subject|5|||
42055258|NCT01014689|75863700|FG001|Overall Study|Withdrawal by Subject|4|||
42055259|NCT01014689|75863699|FG000|Overall Study|Protocol Violation|1|||
42055260|NCT01014689|75863700|FG001|Overall Study|Protocol Violation|1|||
42055261|NCT01014689|75863699|FG000|Overall Study|Lost to Follow-up|3|||
42055262|NCT01014689|75863700|FG001|Overall Study|Lost to Follow-up|7|||
42055263|NCT01014689|75863699|FG000|Overall Study|Pregnancy|1|||
42055264|NCT01014689|75863700|FG001|Overall Study|Pregnancy|0|||
42055265|NCT01014533|75863708|FG000|Overall Study|Protocol Violation|3|||
42055266|NCT01014533|75863709|FG001|Overall Study|Protocol Violation|2|||
42055267|NCT01014533|75863708|FG000|Overall Study|Withdrawal by Subject|2|||
42055268|NCT01014533|75863709|FG001|Overall Study|Withdrawal by Subject|0|||
42055269|NCT01014533|75863708|FG000|Overall Study|unable to come to appointment|0|||
42055270|NCT01014533|75863709|FG001|Overall Study|unable to come to appointment|3|||
42055271|NCT01014143|75863732|FG000|Second Intervention|Lost to Follow-up|2|||
42055272|NCT01014143|75863733|FG001|Second Intervention|Lost to Follow-up|0|||
42055273|NCT01014143|75863734|FG002|Second Intervention|Lost to Follow-up|0|||
42173885|NCT00086580|75980669|FG001|Follow-up Period|Unable to comply with protocol|0|||
42173886|NCT00086580|75980668|FG000|Follow-up Period|Withdrawal by Subject|6|||
42173887|NCT00086580|75980669|FG001|Follow-up Period|Withdrawal by Subject|6|||
42173888|NCT00086580|75980668|FG000|Follow-up Period|Physician Decision|0|||
42173889|NCT00086580|75980669|FG001|Follow-up Period|Physician Decision|1|||
42173890|NCT00086580|75980668|FG000|Follow-up Period|AE - not related|1|||
42173891|NCT00086580|75980669|FG001|Follow-up Period|AE - not related|0|||
42173892|NCT00086580|75980668|FG000|Follow-up Period|Death|13|||
42173893|NCT00086580|75980669|FG001|Follow-up Period|Death|7|||
42173894|NCT00086580|75980668|FG000|Follow-up Period|Other|7|||
42173895|NCT00086580|75980669|FG001|Follow-up Period|Other|6|||
42173896|NCT00086580|75980668|FG000|Observation Period|Unable to comply with protocol|1|||
42173897|NCT00086580|75980669|FG001|Observation Period|Unable to comply with protocol|1|||
42173898|NCT00086580|75980668|FG000|Observation Period|Withdrawal by Subject|4|||
42173899|NCT00086580|75980669|FG001|Observation Period|Withdrawal by Subject|2|||
42173900|NCT00086580|75980668|FG000|Observation Period|Death|33|||
42173901|NCT00086580|75980669|FG001|Observation Period|Death|55|||
42173902|NCT00086580|75980668|FG000|Observation Period|Other|8|||
42173903|NCT00086580|75980669|FG001|Observation Period|Other|7|||
42173904|NCT00086502|75980677|FG000|Overall Study|Adverse Event|11|||
42173905|NCT00086502|75980678|FG001|Overall Study|Adverse Event|2|||
42173906|NCT00086502|75980677|FG000|Overall Study|Lack of Efficacy|0|||
42173907|NCT00086502|75980678|FG001|Overall Study|Lack of Efficacy|2|||
42173908|NCT00086502|75980677|FG000|Overall Study|Lost to Follow-up|3|||
42173909|NCT00086502|75980678|FG001|Overall Study|Lost to Follow-up|1|||
42173910|NCT00086502|75980677|FG000|Overall Study|Physician Decision|1|||
42173911|NCT00086502|75980678|FG001|Overall Study|Physician Decision|1|||
42173912|NCT00086502|75980677|FG000|Overall Study|Pregnancy|0|||
42173913|NCT00086502|75980678|FG001|Overall Study|Pregnancy|1|||
42173914|NCT00086502|75980677|FG000|Overall Study|Protocol Violation|3|||
42173915|NCT00086502|75980678|FG001|Overall Study|Protocol Violation|3|||
42173916|NCT00086502|75980677|FG000|Overall Study|Withdrawal by Subject|5|||
42173917|NCT00086502|75980678|FG001|Overall Study|Withdrawal by Subject|6|||
42055274|NCT01013753|75863742|FG000|Overall Study|Adverse Event|8|||
42055275|NCT01013753|75863742|FG000|Overall Study|Protocol Violation|3|||
42055276|NCT01013753|75863742|FG000|Overall Study|Lost to Follow-up|1|||
42055277|NCT01013753|75863742|FG000|Overall Study|Withdrawal by Subject|2|||
42055278|NCT01013753|75863742|FG000|Overall Study|Other|2|||
42055279|NCT00757042|75863767|FG000|Overall Study|Lost to Follow-up|0|||
42055280|NCT00757042|75863768|FG001|Overall Study|Lost to Follow-up|0|||
42055281|NCT00757042|75863769|FG002|Overall Study|Lost to Follow-up|0|||
42055282|NCT00757042|75863770|FG003|Overall Study|Lost to Follow-up|0|||
42055283|NCT00757042|75863771|FG004|Overall Study|Lost to Follow-up|0|||
42055284|NCT00757042|75863772|FG005|Overall Study|Lost to Follow-up|0|||
42055285|NCT00757042|75863773|FG006|Overall Study|Lost to Follow-up|0|||
42055286|NCT00757042|75863774|FG007|Overall Study|Lost to Follow-up|0|||
42055287|NCT00757042|75863775|FG008|Overall Study|Lost to Follow-up|1|||
42055288|NCT00757042|75863776|FG009|Overall Study|Lost to Follow-up|0|||
42055289|NCT00757042|75863777|FG010|Overall Study|Lost to Follow-up|0|||
42055290|NCT00757042|75863767|FG000|Overall Study|Ineligibility Determined|0|||
42055291|NCT00757042|75863768|FG001|Overall Study|Ineligibility Determined|0|||
42055292|NCT00757042|75863769|FG002|Overall Study|Ineligibility Determined|0|||
42055293|NCT00757042|75863770|FG003|Overall Study|Ineligibility Determined|0|||
42055294|NCT00757042|75863771|FG004|Overall Study|Ineligibility Determined|0|||
42055295|NCT00757042|75863772|FG005|Overall Study|Ineligibility Determined|0|||
42055296|NCT00757042|75863773|FG006|Overall Study|Ineligibility Determined|0|||
42055297|NCT00757042|75863774|FG007|Overall Study|Ineligibility Determined|0|||
42055298|NCT00757042|75863775|FG008|Overall Study|Ineligibility Determined|0|||
42055299|NCT00757042|75863776|FG009|Overall Study|Ineligibility Determined|0|||
42055300|NCT00757042|75863777|FG010|Overall Study|Ineligibility Determined|1|||
42055301|NCT00757042|75863767|FG000|Overall Study|Withdrawal by Subject|0|||
42055302|NCT00757042|75863768|FG001|Overall Study|Withdrawal by Subject|0|||
42055303|NCT00757042|75863769|FG002|Overall Study|Withdrawal by Subject|0|||
42055304|NCT00757042|75863770|FG003|Overall Study|Withdrawal by Subject|0|||
42055305|NCT00757042|75863771|FG004|Overall Study|Withdrawal by Subject|0|||
42055306|NCT00757042|75863772|FG005|Overall Study|Withdrawal by Subject|0|||
42055307|NCT00757042|75863773|FG006|Overall Study|Withdrawal by Subject|0|||
42055308|NCT00757042|75863774|FG007|Overall Study|Withdrawal by Subject|0|||
42055309|NCT00757042|75863775|FG008|Overall Study|Withdrawal by Subject|0|||
42055310|NCT00757042|75863776|FG009|Overall Study|Withdrawal by Subject|1|||
42055311|NCT00757042|75863777|FG010|Overall Study|Withdrawal by Subject|0|||
42055312|NCT01013597|75863808|FG000|Overall Study|Withdrawal by Subject|1|||
42055313|NCT01013285|75863827|FG000|Overall Study|Death|48|||
42055314|NCT01013285|75863828|FG001|Overall Study|Death|89|||
42055315|NCT01033643|75863838|FG000|Overall Study|Withdrew Consent|0|||
42055316|NCT01033643|75863839|FG001|Overall Study|Withdrew Consent|3|||
42055317|NCT01033643|75863840|FG002|Overall Study|Withdrew Consent|0|||
42055318|NCT01033643|75863841|FG003|Overall Study|Withdrew Consent|0|||
42055319|NCT01033643|75863842|FG004|Overall Study|Withdrew Consent|0|||
42055320|NCT01033643|75863843|FG005|Overall Study|Withdrew Consent|1|||
42055321|NCT01013207|75863857|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
42055322|NCT01033487|75863861|FG000|Fourth Intervention Period|Adverse Event|0|||
42055323|NCT01033487|75863862|FG001|Fourth Intervention Period|Adverse Event|0|||
42055324|NCT01033487|75863863|FG002|Fourth Intervention Period|Adverse Event|0|||
42055325|NCT01033487|75863864|FG003|Fourth Intervention Period|Adverse Event|0|||
42055326|NCT01033487|75863865|FG004|Fourth Intervention Period|Adverse Event|0|||
42055327|NCT01033487|75863866|FG005|Fourth Intervention Period|Adverse Event|0|||
42055328|NCT01033487|75863867|FG006|Fourth Intervention Period|Adverse Event|0|||
42055329|NCT01033487|75863868|FG007|Fourth Intervention Period|Adverse Event|0|||
42055330|NCT01033487|75863869|FG008|Fourth Intervention Period|Adverse Event|1|||
42055331|NCT01033487|75863870|FG009|Fourth Intervention Period|Adverse Event|0|||
42055332|NCT01033019|75863886|FG000|Overall Study|Withdrawal by Subject|1|||
42055333|NCT01033019|75863887|FG001|Overall Study|Withdrawal by Subject|0|||
42055334|NCT00603447|75863901|FG000|Overall Study|Adverse Event|0|||
42055335|NCT00603447|75863902|FG001|Overall Study|Adverse Event|1|||
42055336|NCT00603447|75863903|FG002|Overall Study|Adverse Event|1|||
42055337|NCT00603447|75863904|FG003|Overall Study|Adverse Event|2|||
42173918|NCT00086502|75980677|FG000|Overall Study|Patient Moved|1|||
42055338|NCT00603447|75863905|FG004|Overall Study|Adverse Event|1|||
42055339|NCT00603447|75863906|FG005|Overall Study|Adverse Event|2|||
42055340|NCT00603447|75863907|FG006|Overall Study|Adverse Event|10|||
42055341|NCT00603447|75863901|FG000|Overall Study|Other|0|||
42055342|NCT00603447|75863902|FG001|Overall Study|Other|0|||
42055343|NCT00603447|75863903|FG002|Overall Study|Other|1|||
42055344|NCT00603447|75863904|FG003|Overall Study|Other|0|||
42055345|NCT00603447|75863905|FG004|Overall Study|Other|3|||
42055346|NCT00603447|75863906|FG005|Overall Study|Other|0|||
42055347|NCT00603447|75863907|FG006|Overall Study|Other|13|||
42055348|NCT00603447|75863901|FG000|Overall Study|Withdrew Consent|0|||
42055349|NCT00603447|75863902|FG001|Overall Study|Withdrew Consent|2|||
42055350|NCT00603447|75863903|FG002|Overall Study|Withdrew Consent|0|||
42055351|NCT00603447|75863904|FG003|Overall Study|Withdrew Consent|0|||
42055352|NCT00603447|75863905|FG004|Overall Study|Withdrew Consent|1|||
42055353|NCT00603447|75863906|FG005|Overall Study|Withdrew Consent|0|||
42055354|NCT00603447|75863907|FG006|Overall Study|Withdrew Consent|1|||
42173919|NCT00086502|75980678|FG001|Overall Study|Patient Moved|1|||
42173920|NCT00086502|75980677|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
42173921|NCT00086502|75980678|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
42173922|NCT00086502|75980677|FG000|Overall Study|Patient Accidentally Unblinded|1|||
42173923|NCT00086502|75980678|FG001|Overall Study|Patient Accidentally Unblinded|0|||
42173924|NCT03826667|75980684|FG000|Overall Study|Protocol deviation|21|||
42173925|NCT03636542|75980696|FG000|Overall Study|Lost to Follow-up|1|||
42173926|NCT03636542|75980697|FG001|Overall Study|Lost to Follow-up|1|||
42173927|NCT03636542|75980696|FG000|Overall Study|Physician Decision|0|||
42173928|NCT03636542|75980697|FG001|Overall Study|Physician Decision|1|||
42173929|NCT03636542|75980696|FG000|Overall Study|Withdrawal by Subject|1|||
42173930|NCT03636542|75980697|FG001|Overall Study|Withdrawal by Subject|0|||
42173931|NCT03305770|75980705|FG000|Overall Study|Physician Decision - prior to dispense|0|||
42173932|NCT03305770|75980706|FG001|Overall Study|Physician Decision - prior to dispense|1|||
42173933|NCT03305770|75980705|FG000|Overall Study|Subject moved|1|||
42173934|NCT03305770|75980706|FG001|Overall Study|Subject moved|0|||
42173935|NCT00086190|75980717|FG000|Overall Study|Adverse Event|6|||
42173936|NCT00086190|75980718|FG001|Overall Study|Adverse Event|2|||
42173937|NCT00086190|75980719|FG002|Overall Study|Adverse Event|2|||
42173938|NCT00086190|75980717|FG000|Overall Study|Withdrawal by Subject|0|||
42173939|NCT00086190|75980718|FG001|Overall Study|Withdrawal by Subject|2|||
42173940|NCT00086190|75980719|FG002|Overall Study|Withdrawal by Subject|2|||
42173941|NCT00086190|75980717|FG000|Overall Study|Protocol Violation|1|||
42173942|NCT00086190|75980718|FG001|Overall Study|Protocol Violation|0|||
42173943|NCT00086190|75980719|FG002|Overall Study|Protocol Violation|0|||
42173944|NCT00086190|75980717|FG000|Overall Study|Moved|1|||
42173945|NCT00086190|75980718|FG001|Overall Study|Moved|0|||
42173946|NCT00086190|75980719|FG002|Overall Study|Moved|0|||
42173947|NCT00086190|75980717|FG000|Overall Study|Worsening depression|0|||
42173948|NCT00086190|75980718|FG001|Overall Study|Worsening depression|0|||
42173949|NCT00086190|75980719|FG002|Overall Study|Worsening depression|2|||
42173950|NCT03320824|75980729|FG000|Overall Study|Withdrawal by Subject|8|||
42173951|NCT03320824|75980730|FG001|Overall Study|Withdrawal by Subject|1|||
42173952|NCT03320824|75980729|FG000|Overall Study|Lost to Follow-up|10|||
42173953|NCT03320824|75980730|FG001|Overall Study|Lost to Follow-up|1|||
42173954|NCT03320824|75980729|FG000|Overall Study|moved out of state|0|||
42173955|NCT03320824|75980730|FG001|Overall Study|moved out of state|1|||
42173956|NCT03320824|75980729|FG000|Overall Study|could not complete final visit|0|||
42173957|NCT03320824|75980730|FG001|Overall Study|could not complete final visit|1|||
42173958|NCT03275350|75980742|FG000|Overall Study|Lost to Follow-up|4|||
42173959|NCT03275350|75980743|FG001|Overall Study|Lost to Follow-up|6|||
42173960|NCT03275350|75980742|FG000|Overall Study|Death|2|||
42173961|NCT03275350|75980743|FG001|Overall Study|Death|1|||
42173962|NCT03275350|75980742|FG000|Overall Study|Physician Decision|1|||
42173963|NCT03275350|75980743|FG001|Overall Study|Physician Decision|0|||
42173964|NCT03275350|75980742|FG000|Overall Study|Incarcerated|1|||
42173965|NCT03275350|75980743|FG001|Overall Study|Incarcerated|1|||
42173966|NCT03319732|75980750|FG000|Overall Study|Adverse Event|40|||
42173967|NCT03319732|75980750|FG000|Overall Study|Withdrawal by Subject|50|||
42173968|NCT03319732|75980750|FG000|Overall Study|MS relapse|10|||
42173969|NCT03319732|75980750|FG000|Overall Study|reason not specified|5|||
42173970|NCT03304522|75980757|FG000|Overall Study|Adverse Event|0|||
42173971|NCT03304522|75980758|FG001|Overall Study|Adverse Event|4|||
42173972|NCT03304522|75980757|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
42173973|NCT03304522|75980758|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
42173974|NCT03304522|75980757|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
42173975|NCT03304522|75980758|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
42173976|NCT03304522|75980757|FG000|Overall Study|Other|0|||
42173977|NCT03304522|75980758|FG001|Overall Study|Other|1|||
42173978|NCT03315286|75980766|FG000|Overall Study|Lost to Follow-up|0|||
42055355|NCT00778258|75863932|FG000|Overall Study|Adverse Event|1|||
42173979|NCT03315286|75980767|FG001|Overall Study|Lost to Follow-up|3|||
42173980|NCT03315286|75980766|FG000|Overall Study|Withdrawal by Subject|1|||
42055356|NCT00778258|75863933|FG001|Overall Study|Adverse Event|0|||
42173981|NCT03315286|75980767|FG001|Overall Study|Withdrawal by Subject|0|||
42173982|NCT03315286|75980766|FG000|Overall Study|Protocol Violation|0|||
42173983|NCT03315286|75980767|FG001|Overall Study|Protocol Violation|1|||
42173984|NCT03273946|75980773|FG000|Overall Study|Withdrawal by Subject|5|||
42173985|NCT03273946|75980773|FG000|Overall Study|Unwillingness of the guardian|1|||
42173986|NCT03273946|75980773|FG000|Overall Study|Participant refused to use the drug|2|||
42173987|NCT03273946|75980773|FG000|Overall Study|Participant relative refused to use drug|1|||
42173988|NCT00314951|75980779|FG000|Treatment|Didn't meet criteria for mITT population|16|||
42055357|NCT00778258|75863934|FG002|Overall Study|Adverse Event|0|||
42055358|NCT00778258|75863935|FG003|Overall Study|Adverse Event|0|||
42055359|NCT00778258|75863936|FG004|Overall Study|Adverse Event|0|||
42055360|NCT00778258|75863937|FG005|Overall Study|Adverse Event|1|||
42055361|NCT00778258|75863938|FG006|Overall Study|Adverse Event|0|||
42055362|NCT00778258|75863939|FG007|Overall Study|Adverse Event|0|||
42055363|NCT00778258|75863940|FG008|Overall Study|Adverse Event|0|||
42055364|NCT00778258|75863932|FG000|Overall Study|Lost to Follow-up|0|||
42055365|NCT00778258|75863933|FG001|Overall Study|Lost to Follow-up|0|||
42055366|NCT00778258|75863934|FG002|Overall Study|Lost to Follow-up|2|||
42055367|NCT00778258|75863935|FG003|Overall Study|Lost to Follow-up|0|||
42055368|NCT00778258|75863936|FG004|Overall Study|Lost to Follow-up|0|||
42055369|NCT00778258|75863937|FG005|Overall Study|Lost to Follow-up|3|||
42055370|NCT00778258|75863938|FG006|Overall Study|Lost to Follow-up|2|||
42055371|NCT00778258|75863939|FG007|Overall Study|Lost to Follow-up|2|||
42055372|NCT00778258|75863940|FG008|Overall Study|Lost to Follow-up|0|||
42055373|NCT00778258|75863932|FG000|Overall Study|Withdrawal by Subject|6|||
42055374|NCT00778258|75863933|FG001|Overall Study|Withdrawal by Subject|2|||
42055375|NCT00778258|75863934|FG002|Overall Study|Withdrawal by Subject|8|||
42055376|NCT00778258|75863935|FG003|Overall Study|Withdrawal by Subject|2|||
42055377|NCT00778258|75863936|FG004|Overall Study|Withdrawal by Subject|0|||
42055378|NCT00778258|75863937|FG005|Overall Study|Withdrawal by Subject|6|||
42055379|NCT00778258|75863938|FG006|Overall Study|Withdrawal by Subject|12|||
42055380|NCT00778258|75863939|FG007|Overall Study|Withdrawal by Subject|12|||
42055381|NCT00778258|75863940|FG008|Overall Study|Withdrawal by Subject|4|||
42055382|NCT00778258|75863932|FG000|Overall Study|New Contraindication|0|||
42055383|NCT00778258|75863933|FG001|Overall Study|New Contraindication|0|||
42055384|NCT00778258|75863934|FG002|Overall Study|New Contraindication|0|||
42055385|NCT00778258|75863935|FG003|Overall Study|New Contraindication|0|||
42055386|NCT00778258|75863936|FG004|Overall Study|New Contraindication|0|||
42055387|NCT00778258|75863937|FG005|Overall Study|New Contraindication|0|||
42055388|NCT00778258|75863938|FG006|Overall Study|New Contraindication|0|||
42055389|NCT00778258|75863939|FG007|Overall Study|New Contraindication|1|||
42055390|NCT00778258|75863940|FG008|Overall Study|New Contraindication|0|||
42055391|NCT00778258|75863932|FG000|Overall Study|Non-compliance|0|||
42055392|NCT00778258|75863933|FG001|Overall Study|Non-compliance|0|||
42055393|NCT00778258|75863934|FG002|Overall Study|Non-compliance|0|||
42055394|NCT00778258|75863935|FG003|Overall Study|Non-compliance|1|||
42055395|NCT00778258|75863936|FG004|Overall Study|Non-compliance|0|||
42055396|NCT00778258|75863937|FG005|Overall Study|Non-compliance|0|||
42055397|NCT00778258|75863938|FG006|Overall Study|Non-compliance|0|||
42055398|NCT00778258|75863939|FG007|Overall Study|Non-compliance|0|||
42055399|NCT00778258|75863940|FG008|Overall Study|Non-compliance|0|||
42055400|NCT00778258|75863932|FG000|Overall Study|Other|0|||
42055401|NCT00778258|75863933|FG001|Overall Study|Other|0|||
42291703|NCT02661217|76125172|FG000|Overall Study|Adverse Event|10|||
42055402|NCT00778258|75863934|FG002|Overall Study|Other|0|||
42055403|NCT00778258|75863935|FG003|Overall Study|Other|0|||
42055404|NCT00778258|75863936|FG004|Overall Study|Other|0|||
42055405|NCT00778258|75863937|FG005|Overall Study|Other|0|||
42055406|NCT00778258|75863938|FG006|Overall Study|Other|1|||
42055407|NCT00778258|75863939|FG007|Overall Study|Other|0|||
42055408|NCT00778258|75863940|FG008|Overall Study|Other|0|||
42055409|NCT00988208|75863968|FG000|Overall Study|Adverse Event|71|||
42055410|NCT00988208|75863969|FG001|Overall Study|Adverse Event|122|||
42055411|NCT00988208|75863968|FG000|Overall Study|Disease Progression|103|||
42055412|NCT00988208|75863969|FG001|Overall Study|Disease Progression|89|||
42055413|NCT00988208|75863968|FG000|Overall Study|Withdrawal by Subject|50|||
42055414|NCT00988208|75863969|FG001|Overall Study|Withdrawal by Subject|57|||
42173989|NCT00314951|75980780|FG001|Treatment|Didn't meet criteria for mITT population|11|||
42173990|NCT00314951|75980779|FG000|Follow-up|mITT failure|44|||
42173991|NCT00314951|75980780|FG001|Follow-up|mITT failure|34|||
42173992|NCT00085644|75980788|FG000|Double-Blind Period|Adverse Event|5|||
42055415|NCT00988208|75863968|FG000|Overall Study|Death|9|||
42055416|NCT00988208|75863969|FG001|Overall Study|Death|15|||
42055417|NCT00988208|75863968|FG000|Overall Study|Lost to Follow-up|2|||
42055418|NCT00988208|75863969|FG001|Overall Study|Lost to Follow-up|3|||
42055419|NCT00988208|75863968|FG000|Overall Study|Protocol Violation|9|||
42055420|NCT00988208|75863969|FG001|Overall Study|Protocol Violation|2|||
42055421|NCT00988208|75863968|FG000|Overall Study|Sponsor Decision|102|||
42055422|NCT00988208|75863969|FG001|Overall Study|Sponsor Decision|78|||
42055423|NCT00988208|75863968|FG000|Overall Study|Clinical Progression|17|||
42055424|NCT00988208|75863969|FG001|Overall Study|Clinical Progression|16|||
42055425|NCT00988208|75863968|FG000|Overall Study|Biochemical Progression|21|||
42055426|NCT00988208|75863969|FG001|Overall Study|Biochemical Progression|7|||
42055427|NCT00988208|75863968|FG000|Overall Study|Clinical Deterioration|7|||
42055428|NCT00988208|75863969|FG001|Overall Study|Clinical Deterioration|14|||
42055429|NCT00988208|75863968|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
42173993|NCT00085644|75980789|FG001|Double-Blind Period|Adverse Event|2|||
42173994|NCT00085644|75980790|FG002|Double-Blind Period|Adverse Event|0|||
42055430|NCT00988208|75863969|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
42055431|NCT00988208|75863968|FG000|Overall Study|Other|8|||
42055432|NCT00988208|75863969|FG001|Overall Study|Other|3|||
42055433|NCT00990704|75863977|FG000|Overall Study|Adverse Event|1|||
42055434|NCT00990704|75863978|FG001|Overall Study|Adverse Event|1|||
42055435|NCT00990704|75863977|FG000|Overall Study|Physician Decision|0|||
42055436|NCT00990704|75863978|FG001|Overall Study|Physician Decision|1|||
42055437|NCT04089553|75863986|FG000|Overall Study|Death|12|||
42055438|NCT04089553|75863987|FG001|Overall Study|Death|11|||
42055439|NCT04089553|75863986|FG000|Overall Study|Lost to Follow-up|2|||
42055440|NCT04089553|75863987|FG001|Overall Study|Lost to Follow-up|2|||
42055441|NCT04089553|75863986|FG000|Overall Study|Progressive disease|0|||
42055442|NCT04089553|75863987|FG001|Overall Study|Progressive disease|1|||
42055443|NCT04089553|75863986|FG000|Overall Study|Withdrawal by Subject|5|||
42055444|NCT04089553|75863987|FG001|Overall Study|Withdrawal by Subject|2|||
42055445|NCT04089553|75863986|FG000|Overall Study|Other|6|||
42055446|NCT04089553|75863987|FG001|Overall Study|Other|2|||
42055447|NCT00993668|75863996|FG000|Single-Blind Period|Adverse Event|1|||
42055448|NCT00993668|75863997|FG001|Single-Blind Period|Adverse Event|1|||
42055449|NCT00993668|75863996|FG000|Single-Blind Period|Lack of Efficacy|0|||
42055450|NCT00993668|75863997|FG001|Single-Blind Period|Lack of Efficacy|1|||
42055451|NCT00993668|75863996|FG000|Single-Blind Period|Lost to Follow-up|3|||
42055452|NCT00993668|75863997|FG001|Single-Blind Period|Lost to Follow-up|1|||
42055453|NCT00993668|75863996|FG000|Open-Label Period|Adverse Event|9|||
42055454|NCT00993668|75863997|FG001|Open-Label Period|Adverse Event|8|||
42055455|NCT00993668|75863996|FG000|Open-Label Period|Lack of Efficacy|4|||
42055456|NCT00993668|75863997|FG001|Open-Label Period|Lack of Efficacy|3|||
42055457|NCT00993668|75863996|FG000|Open-Label Period|Withdrawal by Subject|4|||
42055458|NCT00993668|75863997|FG001|Open-Label Period|Withdrawal by Subject|3|||
42055459|NCT00993668|75863996|FG000|Open-Label Period|Lost to Follow-up|6|||
42055460|NCT00993668|75863997|FG001|Open-Label Period|Lost to Follow-up|1|||
42055461|NCT00778102|75864006|FG000|Overall Study|Adverse Event|8|||
42055462|NCT00778102|75864007|FG001|Overall Study|Adverse Event|5|||
42055463|NCT00778102|75864006|FG000|Overall Study|Death|1|||
42055464|NCT00778102|75864007|FG001|Overall Study|Death|1|||
42055465|NCT00778102|75864006|FG000|Overall Study|Lost to Follow-up|1|||
42055466|NCT00778102|75864007|FG001|Overall Study|Lost to Follow-up|0|||
42055467|NCT00778102|75864006|FG000|Overall Study|Violation of Selection Criteria|1|||
42055468|NCT00778102|75864007|FG001|Overall Study|Violation of Selection Criteria|1|||
42055469|NCT00778102|75864006|FG000|Overall Study|Protocol Violation|0|||
42055470|NCT00778102|75864007|FG001|Overall Study|Protocol Violation|1|||
42055471|NCT00778102|75864006|FG000|Overall Study|Refused Treatment|2|||
42055472|NCT00778102|75864007|FG001|Overall Study|Refused Treatment|3|||
42055473|NCT00778102|75864006|FG000|Overall Study|Withdrawal by Subject|1|||
42173995|NCT00085644|75980788|FG000|Double-Blind Period|Withdrawal by Subject|3|||
42173996|NCT00085644|75980789|FG001|Double-Blind Period|Withdrawal by Subject|0|||
42173997|NCT00085644|75980790|FG002|Double-Blind Period|Withdrawal by Subject|0|||
42173998|NCT00085644|75980788|FG000|Double-Blind Period|Lost to Follow-up|2|||
42173999|NCT00085644|75980789|FG001|Double-Blind Period|Lost to Follow-up|1|||
42055474|NCT00778102|75864007|FG001|Overall Study|Withdrawal by Subject|1|||
42055475|NCT00778102|75864006|FG000|Overall Study|Administrative Reason|7|||
42055476|NCT00778102|75864007|FG001|Overall Study|Administrative Reason|10|||
42055477|NCT00756886|75864015|FG000|Overall Study|Lost to Follow-up|1|||
42055478|NCT00756886|75864016|FG001|Overall Study|Lost to Follow-up|0|||
42055479|NCT00756886|75864015|FG000|Overall Study|Adverse Event|0|||
42055480|NCT00756886|75864016|FG001|Overall Study|Adverse Event|3|||
42055481|NCT00756886|75864015|FG000|Overall Study|Lack of Efficacy|1|||
42055482|NCT00756886|75864016|FG001|Overall Study|Lack of Efficacy|0|||
42055483|NCT00756886|75864015|FG000|Overall Study|Ineligible|9|||
42055484|NCT00756886|75864016|FG001|Overall Study|Ineligible|4|||
42055485|NCT00756730|75864024|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
42174000|NCT00085644|75980790|FG002|Double-Blind Period|Lost to Follow-up|0|||
42174001|NCT00085644|75980788|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
42174002|NCT00085644|75980789|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
42055486|NCT00756730|75864025|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
42055487|NCT00756730|75864024|FG000|Overall Study|persistent low-level viremmia|0|||
42055488|NCT00756730|75864025|FG001|Overall Study|persistent low-level viremmia|1|||
42055489|NCT00984620|75864033|FG000|Overall Study|Adverse Event|5|||
42055490|NCT00984620|75864034|FG001|Overall Study|Adverse Event|5|||
42055491|NCT00984620|75864033|FG000|Overall Study|Lost to Follow-up|1|||
42055492|NCT00984620|75864034|FG001|Overall Study|Lost to Follow-up|1|||
42055493|NCT00984620|75864033|FG000|Overall Study|Withdrawal by Subject|0|||
42055494|NCT00984620|75864034|FG001|Overall Study|Withdrawal by Subject|2|||
42055495|NCT00984620|75864033|FG000|Overall Study|reason other than listed above|0|||
42055496|NCT00984620|75864034|FG001|Overall Study|reason other than listed above|4|||
42055497|NCT00777946|75864045|FG000|Overall Study|Adverse Event|11|||
42055498|NCT00777946|75864046|FG001|Overall Study|Adverse Event|1|||
42055499|NCT00777946|75864047|FG002|Overall Study|Adverse Event|3|||
42055500|NCT00777946|75864045|FG000|Overall Study|Lack of Efficacy|0|||
42055501|NCT00777946|75864046|FG001|Overall Study|Lack of Efficacy|0|||
42055502|NCT00777946|75864047|FG002|Overall Study|Lack of Efficacy|9|||
42055503|NCT00777946|75864045|FG000|Overall Study|Condition no longer required study drug|1|||
42055504|NCT00777946|75864046|FG001|Overall Study|Condition no longer required study drug|0|||
42055505|NCT00777946|75864047|FG002|Overall Study|Condition no longer required study drug|0|||
42055506|NCT00777946|75864045|FG000|Overall Study|Patient withdrew consent|3|||
42055507|NCT00777946|75864046|FG001|Overall Study|Patient withdrew consent|2|||
42055508|NCT00777946|75864047|FG002|Overall Study|Patient withdrew consent|3|||
42055509|NCT00777946|75864045|FG000|Overall Study|Lost to Follow-up|3|||
42055510|NCT00777946|75864046|FG001|Overall Study|Lost to Follow-up|1|||
42055511|NCT00777946|75864047|FG002|Overall Study|Lost to Follow-up|0|||
42055512|NCT00777946|75864045|FG000|Overall Study|Protocol deviation|2|||
42055513|NCT00777946|75864046|FG001|Overall Study|Protocol deviation|1|||
42055514|NCT00777946|75864047|FG002|Overall Study|Protocol deviation|1|||
42055515|NCT00777946|75864045|FG000|Overall Study|Randomized in error|1|||
42055516|NCT00777946|75864046|FG001|Overall Study|Randomized in error|1|||
42055517|NCT00777946|75864047|FG002|Overall Study|Randomized in error|0|||
42055518|NCT00990314|75864055|FG000|Overall Study|Death|2|||
42055519|NCT00990314|75864055|FG000|Overall Study|Adverse Event|2|||
42055520|NCT00990314|75864055|FG000|Overall Study|Withdrawal by Subject|3|||
42055521|NCT00990314|75864055|FG000|Overall Study|Non-Compliance|1|||
42055522|NCT00990314|75864055|FG000|Overall Study|Physician Decision|3|||
42055523|NCT00990314|75864055|FG000|Overall Study|Lack of Efficacy|1|||
42055524|NCT00756652|75864061|FG000|Original Phase|Withdrawal by Subject|864|||
42055525|NCT00756652|75864062|FG001|Original Phase|Withdrawal by Subject|23|||
42055526|NCT00756652|75864061|FG000|Original Phase|Lost to Follow-up|601|||
42055527|NCT00756652|75864062|FG001|Original Phase|Lost to Follow-up|0|||
42055528|NCT00756652|75864061|FG000|Original Phase|Other Discontinuation|797|||
42055529|NCT00756652|75864062|FG001|Original Phase|Other Discontinuation|5|||
42055530|NCT00756652|75864061|FG000|Original Phase|Participant Noncompliance|18622|||
42055531|NCT00756652|75864062|FG001|Original Phase|Participant Noncompliance|424|||
42055532|NCT00756652|75864061|FG000|Original Phase|Unknown Discontinuation Reason|2|||
42055533|NCT00756652|75864062|FG001|Original Phase|Unknown Discontinuation Reason|0|||
42055534|NCT00756652|75864061|FG000|Original Phase|Participants without data|3259|||
42055535|NCT00756652|75864062|FG001|Original Phase|Participants without data|466|||
42055536|NCT00756652|75864061|FG000|Original Phase|Death|168|||
42055537|NCT00756652|75864062|FG001|Original Phase|Death|1|||
42055538|NCT00756652|75864061|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
42055539|NCT00756652|75864062|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
42055540|NCT00756652|75864061|FG000|Re-Op Phase|Withdrawal by Subject|62|||
42055541|NCT00756652|75864062|FG001|Re-Op Phase|Withdrawal by Subject|0|||
42055542|NCT00756652|75864061|FG000|Re-Op Phase|Death|6|||
42055543|NCT00756652|75864062|FG001|Re-Op Phase|Death|0|||
42055544|NCT00756652|75864061|FG000|Re-Op Phase|Lost to Follow-up|340|||
42055545|NCT00756652|75864062|FG001|Re-Op Phase|Lost to Follow-up|0|||
42055546|NCT00756652|75864061|FG000|Re-Op Phase|Site Closed|2454|||
42055547|NCT00756652|75864062|FG001|Re-Op Phase|Site Closed|0|||
42055548|NCT00756652|75864061|FG000|Re-Op Phase|Withdrawn after explant|14|||
42055549|NCT00756652|75864062|FG001|Re-Op Phase|Withdrawn after explant|0|||
42055550|NCT00777556|75864066|FG000|Overall Study|Inappropriate self-selection|34|||
42055551|NCT00777556|75864066|FG000|Overall Study|Dispensed but did not use product|12|||
42055552|NCT00777556|75864066|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
42055553|NCT00602979|75864075|FG000|Overall Study|Lost to Follow-up|3|||
42055554|NCT00602979|75864076|FG001|Overall Study|Lost to Follow-up|2|||
42055555|NCT00602979|75864077|FG002|Overall Study|Lost to Follow-up|3|||
42055556|NCT00602979|75864078|FG003|Overall Study|Lost to Follow-up|2|||
42055557|NCT00602979|75864079|FG004|Overall Study|Lost to Follow-up|3|||
42055558|NCT00602979|75864075|FG000|Overall Study|Failed Intubation|0|||
42055559|NCT00602979|75864076|FG001|Overall Study|Failed Intubation|1|||
42055560|NCT00602979|75864077|FG002|Overall Study|Failed Intubation|0|||
42055561|NCT00602979|75864078|FG003|Overall Study|Failed Intubation|1|||
42055562|NCT00602979|75864079|FG004|Overall Study|Failed Intubation|0|||
42055563|NCT04081363|75864093|FG000|Overall Study|Withdrawal by Subject|1|||
42055564|NCT04081363|75864094|FG001|Overall Study|Withdrawal by Subject|0|||
42055565|NCT00777088|75864109|FG000|Overall Study|PED Treatment not attempted|1|||
42055566|NCT00763282|75864125|FG000|Overall Study|Withdrawal by Subject|6|||
42055567|NCT00763282|75864126|FG001|Overall Study|Withdrawal by Subject|5|||
42055568|NCT00763282|75864125|FG000|Overall Study|Death|4|||
42055569|NCT00763282|75864126|FG001|Overall Study|Death|3|||
42055570|NCT00763282|75864125|FG000|Overall Study|Lost to Follow-up|22|||
42055571|NCT00763282|75864126|FG001|Overall Study|Lost to Follow-up|26|||
42055572|NCT00988598|75864136|FG000|Overall Study|Withdrawal by Subject|2|||
42055573|NCT00988598|75864137|FG001|Overall Study|Withdrawal by Subject|0|||
42055574|NCT00979628|75864146|FG000|Overall Study|received regimen < 24 hours|7|||
42055575|NCT00979628|75864147|FG001|Overall Study|received regimen < 24 hours|6|||
42055576|NCT00979628|75864148|FG002|Overall Study|received regimen < 24 hours|5|||
42055577|NCT00979628|75864146|FG000|Overall Study|received steroids|1|||
42055578|NCT00979628|75864147|FG001|Overall Study|received steroids|1|||
42055579|NCT00979628|75864148|FG002|Overall Study|received steroids|0|||
42055580|NCT00979628|75864146|FG000|Overall Study|transferred to ICU|1|||
42055581|NCT00979628|75864147|FG001|Overall Study|transferred to ICU|2|||
42055582|NCT00979628|75864148|FG002|Overall Study|transferred to ICU|1|||
42055583|NCT00762970|75864162|FG000|Overall Study|Withdrawal by Subject|7|||
42055584|NCT00762970|75864163|FG001|Overall Study|Withdrawal by Subject|4|||
42055585|NCT00762970|75864164|FG002|Overall Study|Withdrawal by Subject|0|||
42055586|NCT00762970|75864162|FG000|Overall Study|Protocol Violation|3|||
42055587|NCT00762970|75864163|FG001|Overall Study|Protocol Violation|1|||
42055588|NCT00762970|75864164|FG002|Overall Study|Protocol Violation|1|||
42055589|NCT00762970|75864162|FG000|Overall Study|Lost to Follow-up|1|||
42055590|NCT00762970|75864163|FG001|Overall Study|Lost to Follow-up|2|||
42055591|NCT00762970|75864164|FG002|Overall Study|Lost to Follow-up|0|||
42055592|NCT00762970|75864162|FG000|Overall Study|Difficulty of handling lens|1|||
42055593|NCT00762970|75864163|FG001|Overall Study|Difficulty of handling lens|2|||
42055594|NCT00762970|75864164|FG002|Overall Study|Difficulty of handling lens|0|||
42055595|NCT00988442|75864174|FG000|Overall Study|Death|1|||
42055596|NCT00988442|75864175|FG001|Overall Study|Death|2|||
42055597|NCT00988442|75864174|FG000|Overall Study|Lost to Follow-up|0|||
42055598|NCT00988442|75864175|FG001|Overall Study|Lost to Follow-up|1|||
42055599|NCT00988442|75864174|FG000|Overall Study|Early Study Closure|29|||
42055600|NCT00988442|75864175|FG001|Overall Study|Early Study Closure|25|||
42055601|NCT03258723|75864184|FG000|Overall Study|COVID Interruption of study|54|||
42055602|NCT03258723|75864184|FG000|Overall Study|Lost to Follow-up|8|||
42055603|NCT00992186|75864188|FG000|Overall Study|Withdrawal by Subject|2|||
42055604|NCT00992186|75864188|FG000|Overall Study|Protocol Violation|1|||
42055605|NCT00992186|75864188|FG000|Overall Study|Physician Decision|1|||
42055606|NCT00992186|75864188|FG000|Overall Study|Adverse Event|9|||
42055607|NCT00992186|75864188|FG000|Overall Study|Progressive Disease|30|||
42055608|NCT00992186|75864188|FG000|Overall Study|Refusal To Receive Study Agent|3|||
42055609|NCT00992108|75864195|FG000|Overall Study|Lost to Follow-up|0|||
42055610|NCT00992108|75864196|FG001|Overall Study|Lost to Follow-up|1|||
42055611|NCT00752986|75864205|FG000|Overall Study|Withdrawal by Subject|2|||
42055612|NCT00752986|75864206|FG001|Overall Study|Withdrawal by Subject|1|||
42055613|NCT00752986|75864207|FG002|Overall Study|Withdrawal by Subject|2|||
42055614|NCT00752986|75864205|FG000|Overall Study|Protocol Violation|3|||
42055615|NCT00752986|75864206|FG001|Overall Study|Protocol Violation|0|||
42055616|NCT00752986|75864207|FG002|Overall Study|Protocol Violation|0|||
42055617|NCT00762892|75864217|FG000|Overall Study|Lost to Follow-up|2|||
42055618|NCT00762892|75864218|FG001|Overall Study|Lost to Follow-up|5|||
42055619|NCT00762892|75864217|FG000|Overall Study|Withdrawal by Subject|0|||
42055620|NCT00762892|75864218|FG001|Overall Study|Withdrawal by Subject|1|||
42055621|NCT00762892|75864217|FG000|Overall Study|Death|1|||
42055622|NCT00762892|75864218|FG001|Overall Study|Death|0|||
42055623|NCT00762892|75864217|FG000|Overall Study|Pregnancy|1|||
42055624|NCT00762892|75864218|FG001|Overall Study|Pregnancy|0|||
42055625|NCT00762892|75864217|FG000|Overall Study|Incarceration|1|||
42055626|NCT00762892|75864218|FG001|Overall Study|Incarceration|0|||
42055627|NCT00755716|75864227|FG000|Overall Study|Adverse Event|1|||
42055628|NCT00755716|75864228|FG001|Overall Study|Adverse Event|4|||
42055629|NCT00755716|75864229|FG002|Overall Study|Adverse Event|1|||
42055630|NCT00755716|75864227|FG000|Overall Study|Lack of Efficacy|2|||
42055631|NCT00755716|75864228|FG001|Overall Study|Lack of Efficacy|0|||
42055632|NCT00755716|75864229|FG002|Overall Study|Lack of Efficacy|0|||
42055633|NCT00755716|75864227|FG000|Overall Study|Lost to Follow-up|5|||
42055634|NCT00755716|75864228|FG001|Overall Study|Lost to Follow-up|3|||
42055635|NCT00755716|75864229|FG002|Overall Study|Lost to Follow-up|1|||
42055636|NCT00755716|75864227|FG000|Overall Study|work schedule issues|0|||
42055637|NCT00755716|75864228|FG001|Overall Study|work schedule issues|1|||
42055638|NCT00755716|75864229|FG002|Overall Study|work schedule issues|1|||
42055639|NCT00755326|75864239|FG000|Overall Study|Lost to Follow-up|2|||
42055640|NCT00755326|75864240|FG001|Overall Study|Lost to Follow-up|3|||
42055641|NCT03084471|75864247|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
42055642|NCT03084471|75864247|FG000|Overall Study|Condition under investigation worsened|84|||
42055643|NCT03084471|75864247|FG000|Overall Study|Lack of therapeutic response|2|||
42055644|NCT03084471|75864247|FG000|Overall Study|Protocol Violation|1|||
42055645|NCT03084471|75864247|FG000|Overall Study|Adverse Event|73|||
42055646|NCT03084471|75864247|FG000|Overall Study|Withdrawal by Subject|12|||
42055647|NCT03084471|75864247|FG000|Overall Study|Disease relapse|181|||
42055648|NCT03084471|75864247|FG000|Overall Study|Subjective disease progression|359|||
42055649|NCT03084471|75864247|FG000|Overall Study|Other (as recorded)|33|||
42055650|NCT03084471|75864247|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
42055651|NCT00754936|75864254|FG000|Overall Study|Lost to Follow-up|3|||
42055652|NCT00754936|75864254|FG000|Overall Study|Physician Decision|1|||
42055653|NCT00754936|75864254|FG000|Overall Study|Withdrawal by Subject|2|||
42055654|NCT00754936|75864254|FG000|Overall Study|Side Effects|3|||
42055655|NCT00754936|75864254|FG000|Overall Study|Inter-current medical events|3|||
42055656|NCT00762502|75864261|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
42055657|NCT00762502|75864262|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
42055658|NCT00762502|75864263|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
42055659|NCT00762502|75864261|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
42055660|NCT00762502|75864262|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
42055661|NCT00762502|75864263|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
42055662|NCT00762502|75864261|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
42055663|NCT00762502|75864262|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
42055664|NCT00762502|75864263|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
42055665|NCT00762268|75864271|FG000|Overall Study|Withdrawal by Subject|3|||
42055666|NCT00762268|75864272|FG001|Overall Study|Withdrawal by Subject|3|||
42055667|NCT00975884|75864280|FG000|Overall Study|Adverse Event|1|||
42055668|NCT00975884|75864281|FG001|Overall Study|Adverse Event|0|||
42055669|NCT00975884|75864280|FG000|Overall Study|Lost to Follow-up|5|||
42055670|NCT00975884|75864281|FG001|Overall Study|Lost to Follow-up|3|||
42055671|NCT00975884|75864280|FG000|Overall Study|Withdrawal by Subject|9|||
42055672|NCT00975884|75864281|FG001|Overall Study|Withdrawal by Subject|9|||
42055673|NCT00975884|75864280|FG000|Overall Study|Other|1|||
42055674|NCT00975884|75864281|FG001|Overall Study|Other|3|||
42055675|NCT00578227|75864300|FG000|Overall Study|Lost to Follow-up|0|||
42055676|NCT00578227|75864301|FG001|Overall Study|Lost to Follow-up|1|||
42055677|NCT00578227|75864302|FG002|Overall Study|Lost to Follow-up|1|||
42055678|NCT00578227|75864300|FG000|Overall Study|Withdrawal by Subject|5|||
42055679|NCT00578227|75864301|FG001|Overall Study|Withdrawal by Subject|1|||
42055680|NCT00578227|75864302|FG002|Overall Study|Withdrawal by Subject|3|||
42055681|NCT00978380|75864312|FG000|Overall Study|Protocol Violation|2|||
42055682|NCT00978380|75864312|FG000|Overall Study|Withdrawal criteria|9|||
42055683|NCT00978380|75864312|FG000|Overall Study|Unclassified|8|||
42055684|NCT00577993|75864320|FG000|Overall Study|Adverse Event|1|||
42055685|NCT00577993|75864321|FG001|Overall Study|Adverse Event|0|||
42055686|NCT00577993|75864322|FG002|Overall Study|Adverse Event|0|||
42055687|NCT00577993|75864320|FG000|Overall Study|Death|0|||
42055688|NCT00577993|75864321|FG001|Overall Study|Death|1|||
42055689|NCT00577993|75864322|FG002|Overall Study|Death|1|||
42055690|NCT00577993|75864320|FG000|Overall Study|Lack of Efficacy|0|||
42055691|NCT00577993|75864321|FG001|Overall Study|Lack of Efficacy|1|||
42055692|NCT00577993|75864322|FG002|Overall Study|Lack of Efficacy|0|||
42055693|NCT00577993|75864320|FG000|Overall Study|Protocol Violation|2|||
42055694|NCT00577993|75864321|FG001|Overall Study|Protocol Violation|3|||
42055695|NCT00577993|75864322|FG002|Overall Study|Protocol Violation|0|||
42055696|NCT00577993|75864320|FG000|Overall Study|Withdrawal by Subject|1|||
42055697|NCT00577993|75864321|FG001|Overall Study|Withdrawal by Subject|0|||
42055698|NCT00577993|75864322|FG002|Overall Study|Withdrawal by Subject|2|||
42055699|NCT00577993|75864320|FG000|Overall Study|Conversion|2|||
42055700|NCT00577993|75864321|FG001|Overall Study|Conversion|5|||
42055701|NCT00577993|75864322|FG002|Overall Study|Conversion|0|||
42055702|NCT00577993|75864320|FG000|Overall Study|Uninsured|1|||
42055703|NCT00577993|75864321|FG001|Overall Study|Uninsured|0|||
42055704|NCT00577993|75864322|FG002|Overall Study|Uninsured|0|||
42055705|NCT00975806|75864331|FG000|Overall Study|Adverse Event|2|||
42055706|NCT00975806|75864332|FG001|Overall Study|Adverse Event|1|||
42055707|NCT00975806|75864333|FG002|Overall Study|Adverse Event|2|||
42055708|NCT00975806|75864331|FG000|Overall Study|Disease Progression|1|||
42055709|NCT00975806|75864332|FG001|Overall Study|Disease Progression|5|||
42055710|NCT00975806|75864333|FG002|Overall Study|Disease Progression|1|||
42055711|NCT00975806|75864331|FG000|Overall Study|Withdrawal by Subject|1|||
42055712|NCT00975806|75864332|FG001|Overall Study|Withdrawal by Subject|0|||
42055713|NCT00975806|75864333|FG002|Overall Study|Withdrawal by Subject|0|||
42055714|NCT00975806|75864331|FG000|Overall Study|Death|0|||
42055715|NCT00975806|75864332|FG001|Overall Study|Death|1|||
42055716|NCT00975806|75864333|FG002|Overall Study|Death|0|||
42055717|NCT00975806|75864331|FG000|Overall Study|Physician decision and disease related|1|||
42174003|NCT00085644|75980790|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
42055718|NCT00975806|75864332|FG001|Overall Study|Physician decision and disease related|0|||
42055719|NCT00975806|75864333|FG002|Overall Study|Physician decision and disease related|1|||
42055720|NCT00978068|75864345|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
42055721|NCT00978068|75864346|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
42055722|NCT00978068|75864345|FG000|Overall Study|Death|1|||
42055723|NCT00978068|75864346|FG001|Overall Study|Death|2|||
42291704|NCT02661217|76125173|FG001|Overall Study|Adverse Event|8|||
42291705|NCT02661217|76125172|FG000|Overall Study|Withdrawal by Subject|15|||
42055724|NCT00978068|75864345|FG000|Overall Study|Lost to Follow-up|1|||
42055725|NCT00978068|75864346|FG001|Overall Study|Lost to Follow-up|2|||
42055726|NCT00978068|75864345|FG000|Overall Study|Physician Decision|0|||
42055727|NCT00978068|75864346|FG001|Overall Study|Physician Decision|1|||
42055728|NCT00978068|75864345|FG000|Overall Study|Unable to Comply with Study|0|||
42055729|NCT00978068|75864346|FG001|Overall Study|Unable to Comply with Study|2|||
42055730|NCT00603525|75864358|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
42055731|NCT00603525|75864359|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
42055732|NCT00603525|75864360|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
42055733|NCT00603525|75864358|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
42055734|NCT00603525|75864359|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
42055735|NCT00603525|75864360|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
42055736|NCT00603525|75864358|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
42055737|NCT00603525|75864359|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
42055738|NCT00603525|75864360|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
42055739|NCT00603525|75864358|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
42055740|NCT00603525|75864359|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
42055741|NCT00603525|75864360|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42055742|NCT00603525|75864358|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
42055743|NCT00603525|75864359|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
42055744|NCT00603525|75864360|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
42055745|NCT00603525|75864358|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
42055746|NCT00603525|75864359|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
42055747|NCT00603525|75864360|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
42055748|NCT00603525|75864358|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
42055749|NCT00603525|75864359|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
42055750|NCT00603525|75864360|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
42055751|NCT00603525|75864358|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
42055752|NCT00603525|75864359|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
42055753|NCT00603525|75864360|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
42055754|NCT00603525|75864358|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
42055755|NCT00603525|75864359|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
42055756|NCT00603525|75864360|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
42055757|NCT00603525|75864358|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
42055758|NCT00603525|75864359|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
42055759|NCT00603525|75864360|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
42055760|NCT00603525|75864358|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
42055761|NCT00603525|75864359|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
42055762|NCT00603525|75864360|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
42055763|NCT00603525|75864358|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
42055764|NCT00603525|75864359|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
42055765|NCT00603525|75864360|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
42055766|NCT00603525|75864358|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
42055767|NCT00603525|75864359|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
42055768|NCT00603525|75864360|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
42055769|NCT00603525|75864358|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
42055770|NCT00603525|75864359|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
42055771|NCT00603525|75864360|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
42055772|NCT00603525|75864358|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
42055773|NCT00603525|75864359|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
42055774|NCT00603525|75864360|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
42055775|NCT00762034|75864373|FG000|Induction Period|Protocol Violation|1|||
42055776|NCT00762034|75864374|FG001|Induction Period|Protocol Violation|2|||
42055777|NCT00762034|75864373|FG000|Induction Period|Entry Criterion Not Met|12|||
42055778|NCT00762034|75864374|FG001|Induction Period|Entry Criterion Not Met|11|||
42055779|NCT00762034|75864373|FG000|Induction Period|Adverse Event|27|||
42055780|NCT00762034|75864374|FG001|Induction Period|Adverse Event|38|||
42055781|NCT00762034|75864373|FG000|Induction Period|Lost to Follow-up|1|||
42055782|NCT00762034|75864374|FG001|Induction Period|Lost to Follow-up|1|||
42055783|NCT00762034|75864373|FG000|Induction Period|Progressive Disease|73|||
42055784|NCT00762034|75864374|FG001|Induction Period|Progressive Disease|55|||
42055785|NCT00762034|75864373|FG000|Induction Period|Physician Decision|21|||
42055786|NCT00762034|75864374|FG001|Induction Period|Physician Decision|20|||
42055787|NCT00762034|75864373|FG000|Induction Period|Withdrawal by Subject|15|||
42055788|NCT00762034|75864374|FG001|Induction Period|Withdrawal by Subject|19|||
42174004|NCT00085644|75980788|FG000|Double-Blind Period|Contemplating pregnancy|1|||
42291706|NCT02661217|76125173|FG001|Overall Study|Withdrawal by Subject|19|||
42055789|NCT00762034|75864373|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
42055790|NCT00762034|75864374|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
42055791|NCT00762034|75864373|FG000|Induction Period|Deaths Due to Study Disease|9|||
42055792|NCT00762034|75864374|FG001|Induction Period|Deaths Due to Study Disease|9|||
42055793|NCT00762034|75864373|FG000|Maintenance Period|Protocol Violation|1|||
42055794|NCT00762034|75864374|FG001|Maintenance Period|Protocol Violation|3|||
42055795|NCT00762034|75864373|FG000|Maintenance Period|Entry Criterion Not Met|0|||
42055796|NCT00762034|75864374|FG001|Maintenance Period|Entry Criterion Not Met|2|||
42055797|NCT00762034|75864373|FG000|Maintenance Period|Adverse Event|42|||
42055798|NCT00762034|75864374|FG001|Maintenance Period|Adverse Event|26|||
42055799|NCT00762034|75864373|FG000|Maintenance Period|Progressive Disease|186|||
42055800|NCT00762034|75864374|FG001|Maintenance Period|Progressive Disease|224|||
42055801|NCT00762034|75864373|FG000|Maintenance Period|Physician Decision|25|||
42055802|NCT00762034|75864374|FG001|Maintenance Period|Physician Decision|20|||
42055803|NCT00762034|75864373|FG000|Maintenance Period|Withdrawal by Subject|34|||
42055804|NCT00762034|75864374|FG001|Maintenance Period|Withdrawal by Subject|14|||
42055805|NCT00762034|75864373|FG000|Maintenance Period|Death not due to study disease|2|||
42055806|NCT00762034|75864374|FG001|Maintenance Period|Death not due to study disease|5|||
42055807|NCT00762034|75864373|FG000|Maintenance Period|Death due to study disease|3|||
42055808|NCT00762034|75864374|FG001|Maintenance Period|Death due to study disease|3|||
42055809|NCT00762034|75864373|FG000|Maintenance Period|Other|1|||
42055810|NCT00762034|75864374|FG001|Maintenance Period|Other|1|||
42055811|NCT00761956|75864406|FG000|Overall Study|Lost to Follow-up|6|||
42055812|NCT00761956|75864407|FG001|Overall Study|Lost to Follow-up|11|||
42055813|NCT00761956|75864406|FG000|Overall Study|Withdrawal by Subject|3|||
42055814|NCT00761956|75864407|FG001|Overall Study|Withdrawal by Subject|8|||
42055815|NCT00761956|75864406|FG000|Overall Study|Death|0|||
42055816|NCT00761956|75864407|FG001|Overall Study|Death|1|||
42055817|NCT00761956|75864406|FG000|Overall Study|Adverse Event|26|||
42055818|NCT00761956|75864407|FG001|Overall Study|Adverse Event|34|||
42055819|NCT00754624|75864413|FG000|Overall Study|Adverse Event|16|||
42055820|NCT00754624|75864413|FG000|Overall Study|Death|1|||
42055821|NCT00754624|75864413|FG000|Overall Study|Physician Decision|8|||
42055822|NCT00754624|75864413|FG000|Overall Study|Protocol Violation|1|||
42055823|NCT00754624|75864413|FG000|Overall Study|Withdrawal by Subject|28|||
42055824|NCT00754624|75864413|FG000|Overall Study|Various|12|||
42055825|NCT00754624|75864413|FG000|Overall Study|Lost to Follow-up|3|||
42055826|NCT00586846|75864426|FG000|Overall Study|Physician Decision|1|||
42055827|NCT00586846|75864426|FG000|Overall Study|Death|1|||
42055828|NCT00586846|75864426|FG000|Overall Study|Evaluable for Toxicity Only|4|||
42055829|NCT00973700|75864435|FG000|Overall Study|Withdrawal by Subject|2|||
42055830|NCT00973700|75864436|FG001|Overall Study|Withdrawal by Subject|2|||
42055831|NCT00973700|75864437|FG002|Overall Study|Withdrawal by Subject|8|||
42055832|NCT00973700|75864438|FG003|Overall Study|Withdrawal by Subject|4|||
42055833|NCT00973700|75864439|FG004|Overall Study|Withdrawal by Subject|4|||
42055834|NCT00973700|75864435|FG000|Overall Study|Lost to Follow-up|5|||
42055835|NCT00973700|75864436|FG001|Overall Study|Lost to Follow-up|0|||
42055836|NCT00973700|75864437|FG002|Overall Study|Lost to Follow-up|1|||
42055837|NCT00973700|75864438|FG003|Overall Study|Lost to Follow-up|8|||
42055838|NCT00973700|75864439|FG004|Overall Study|Lost to Follow-up|5|||
42055839|NCT00973700|75864435|FG000|Overall Study|Inappropriate enrolment|0|||
42055840|NCT00973700|75864436|FG001|Overall Study|Inappropriate enrolment|0|||
42055841|NCT00973700|75864437|FG002|Overall Study|Inappropriate enrolment|0|||
42055842|NCT00973700|75864438|FG003|Overall Study|Inappropriate enrolment|4|||
42055843|NCT00973700|75864439|FG004|Overall Study|Inappropriate enrolment|0|||
42055844|NCT00973700|75864435|FG000|Overall Study|Unable to Classify|0|||
42055845|NCT00973700|75864436|FG001|Overall Study|Unable to Classify|0|||
42055846|NCT00973700|75864437|FG002|Overall Study|Unable to Classify|1|||
42055847|NCT00973700|75864438|FG003|Overall Study|Unable to Classify|2|||
42055848|NCT00973700|75864439|FG004|Overall Study|Unable to Classify|1|||
42055849|NCT00754390|75864466|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
42055850|NCT00754390|75864466|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
42055851|NCT00754390|75864466|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
42055852|NCT00754390|75864466|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
42055853|NCT00754234|75864473|FG000|Overall Study|Withdrawal by Subject|3|||
42055854|NCT00753922|75864481|FG000|Overall Study|Lost to Follow-up|155|||
42055855|NCT00753922|75864482|FG001|Overall Study|Lost to Follow-up|24|||
42055856|NCT00753922|75864483|FG002|Overall Study|Lost to Follow-up|28|||
42055857|NCT00753922|75864484|FG003|Overall Study|Lost to Follow-up|5|||
42055858|NCT00753922|75864481|FG000|Overall Study|Withdrawal by Subject|9|||
42055859|NCT00753922|75864482|FG001|Overall Study|Withdrawal by Subject|11|||
42055860|NCT00753922|75864483|FG002|Overall Study|Withdrawal by Subject|4|||
42055861|NCT00753922|75864484|FG003|Overall Study|Withdrawal by Subject|2|||
42055862|NCT00753922|75864481|FG000|Overall Study|Patient Non-compliance|55|||
42055863|NCT00753922|75864482|FG001|Overall Study|Patient Non-compliance|22|||
42055864|NCT00753922|75864483|FG002|Overall Study|Patient Non-compliance|14|||
42055865|NCT00753922|75864484|FG003|Overall Study|Patient Non-compliance|11|||
42055866|NCT00753922|75864481|FG000|Overall Study|Patients Not Completing Visit|11|||
42055867|NCT00753922|75864482|FG001|Overall Study|Patients Not Completing Visit|0|||
42055868|NCT00753922|75864483|FG002|Overall Study|Patients Not Completing Visit|1|||
42055869|NCT00753922|75864484|FG003|Overall Study|Patients Not Completing Visit|0|||
42055870|NCT00753922|75864481|FG000|Overall Study|Death|2|||
42055871|NCT00753922|75864482|FG001|Overall Study|Death|23|||
42055872|NCT00753922|75864483|FG002|Overall Study|Death|2|||
42055873|NCT00753922|75864484|FG003|Overall Study|Death|1|||
42055874|NCT00753922|75864481|FG000|Overall Study|Discontinuation Due to Explantation|14|||
42055875|NCT00753922|75864482|FG001|Overall Study|Discontinuation Due to Explantation|14|||
42055876|NCT00753922|75864483|FG002|Overall Study|Discontinuation Due to Explantation|14|||
42055877|NCT00753922|75864484|FG003|Overall Study|Discontinuation Due to Explantation|4|||
42055878|NCT00761176|75864496|FG000|Overall Study|Death|1|||
42055879|NCT00761176|75864497|FG001|Overall Study|Death|0|||
42055880|NCT00761176|75864496|FG000|Overall Study|Withdrawal by Subject|1|||
42055881|NCT00761176|75864497|FG001|Overall Study|Withdrawal by Subject|1|||
42055882|NCT00760552|75864505|FG000|Overall Study|Death|2|||
42055883|NCT00760552|75864506|FG001|Overall Study|Death|0|||
42055884|NCT00760552|75864505|FG000|Overall Study|Lost to Follow-up|11|||
42055885|NCT00760552|75864506|FG001|Overall Study|Lost to Follow-up|10|||
42055886|NCT00753766|75864514|FG000|Overall Study|Physician Decision|1|||
42055887|NCT00753766|75864515|FG001|Overall Study|Physician Decision|0|||
42055888|NCT00976898|75864522|FG000|Overall Study|Protocol Violation|1|||
42055889|NCT00976898|75864522|FG000|Overall Study|Adverse Event|1|||
42055890|NCT00976898|75864522|FG000|Overall Study|Physician Decision|1|||
42055891|NCT00976898|75864522|FG000|Overall Study|Liver Transplant|1|||
42055892|NCT00976898|75864522|FG000|Overall Study|Progressive Disease|1|||
42055893|NCT02620579|75864534|FG000|Overall Study|Physician Decision|0|||
42055894|NCT02620579|75864535|FG001|Overall Study|Physician Decision|0|||
42055895|NCT02620579|75864536|FG002|Overall Study|Physician Decision|0|||
42055896|NCT02620579|75864537|FG003|Overall Study|Physician Decision|1|||
42055897|NCT02620579|75864534|FG000|Overall Study|Withdrawal by Subject|0|||
42055898|NCT02620579|75864535|FG001|Overall Study|Withdrawal by Subject|1|||
42055899|NCT02620579|75864536|FG002|Overall Study|Withdrawal by Subject|1|||
42055900|NCT02620579|75864537|FG003|Overall Study|Withdrawal by Subject|0|||
42055901|NCT00753688|75864553|FG000|Overall Study|Death|102|||
42055902|NCT00753688|75864554|FG001|Overall Study|Death|203|||
42055903|NCT00753688|75864553|FG000|Overall Study|Missing|4|||
42055904|NCT00753688|75864554|FG001|Overall Study|Missing|9|||
42055905|NCT00753688|75864553|FG000|Overall Study|Participant Withdrew Consent|2|||
42055906|NCT00753688|75864554|FG001|Overall Study|Participant Withdrew Consent|2|||
42055907|NCT00753688|75864553|FG000|Overall Study|Ongoing - in Follow-up|15|||
42055908|NCT00753688|75864554|FG001|Overall Study|Ongoing - in Follow-up|31|||
42055909|NCT00753688|75864553|FG000|Overall Study|Adverse Event|0|||
42055910|NCT00753688|75864554|FG001|Overall Study|Adverse Event|1|||
42055911|NCT00586612|75864562|FG000|Primary Phase|Protocol Violation|1|||
42055912|NCT00586612|75864563|FG001|Primary Phase|Protocol Violation|0|||
42055913|NCT00586612|75864562|FG000|Primary Phase|Lost to Follow-up|0|||
42055914|NCT00586612|75864563|FG001|Primary Phase|Lost to Follow-up|1|||
42055915|NCT00586612|75864562|FG000|Primary Phase|Withdrawal by Subject|0|||
42055916|NCT00586612|75864563|FG001|Primary Phase|Withdrawal by Subject|2|||
42055917|NCT00586612|75864562|FG000|Booster Phase|Lost to Follow-up|3|||
42055918|NCT00586612|75864563|FG001|Booster Phase|Lost to Follow-up|1|||
42055919|NCT00586690|75864571|FG000|Overall Study|Death|2|||
42055920|NCT00586690|75864572|FG001|Overall Study|Death|0|||
42055921|NCT00586690|75864571|FG000|Overall Study|Disease Progression|10|||
42055922|NCT00586690|75864572|FG001|Overall Study|Disease Progression|0|||
42055923|NCT00586690|75864571|FG000|Overall Study|Adverse Event|1|||
42055924|NCT00586690|75864572|FG001|Overall Study|Adverse Event|0|||
42055925|NCT00586690|75864571|FG000|Overall Study|Lack of Efficacy|2|||
42055926|NCT00586690|75864572|FG001|Overall Study|Lack of Efficacy|0|||
42055927|NCT00586690|75864571|FG000|Overall Study|Lab can't accommodate|1|||
42055928|NCT00586690|75864572|FG001|Overall Study|Lab can't accommodate|0|||
42055929|NCT00976820|75864581|FG000|Overall Study|Lost to Follow-up|5|||
42055930|NCT00976820|75864582|FG001|Overall Study|Lost to Follow-up|16|||
42055931|NCT00976820|75864583|FG002|Overall Study|Lost to Follow-up|2|||
42055932|NCT00976820|75864584|FG003|Overall Study|Lost to Follow-up|3|||
42055933|NCT00976820|75864581|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
42055934|NCT00976820|75864582|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
42055935|NCT00976820|75864583|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
42055936|NCT00976820|75864584|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
42055937|NCT00976820|75864581|FG000|Overall Study|Withdrawal by Subject|2|||
42055938|NCT00976820|75864582|FG001|Overall Study|Withdrawal by Subject|4|||
42055939|NCT00976820|75864583|FG002|Overall Study|Withdrawal by Subject|1|||
42055940|NCT00976820|75864584|FG003|Overall Study|Withdrawal by Subject|4|||
42055941|NCT00760474|75864635|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
42055942|NCT00760474|75864636|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
42055943|NCT00760474|75864635|FG000|Placebo Washout Period|Other|0|||
42055944|NCT00760474|75864636|FG001|Placebo Washout Period|Other|1|||
42055945|NCT00760474|75864635|FG000|Period 2 (P2)|Lost to Follow-up|1|||
42055946|NCT00760474|75864636|FG001|Period 2 (P2)|Lost to Follow-up|0|||
42055947|NCT00760474|75864635|FG000|Period 2 (P2)|Adverse Event|0|||
42055948|NCT00760474|75864636|FG001|Period 2 (P2)|Adverse Event|1|||
42055949|NCT00975416|75864645|FG000|Overall Study|early discharge from tx|3|||
42055950|NCT00975416|75864646|FG001|Overall Study|early discharge from tx|5|||
42055951|NCT00760084|75864653|FG000|Overall Study|Physician Decision|5|||
42055952|NCT00760084|75864653|FG000|Overall Study|Withdrawal by Subject|2|||
42055953|NCT00760084|75864653|FG000|Overall Study|Progressive Disease|3|||
42055954|NCT00752206|75864659|FG000|Overall Study|Disease progression|8|||
42055955|NCT00752206|75864660|FG001|Overall Study|Disease progression|11|||
42055956|NCT00752206|75864659|FG000|Overall Study|Pregnancy|1|||
42055957|NCT00752206|75864660|FG001|Overall Study|Pregnancy|0|||
42055958|NCT00752128|75864666|FG000|Overall Study|Withdrawal by Subject|4|||
42055959|NCT00976508|75864673|FG000|Overall Study|Death|7|||
42055960|NCT00976508|75864674|FG001|Overall Study|Death|1|||
42055961|NCT00976508|75864673|FG000|Overall Study|Lost to Follow-up|1|||
42055962|NCT00976508|75864674|FG001|Overall Study|Lost to Follow-up|0|||
42055963|NCT00976508|75864673|FG000|Overall Study|Withdrawal by Subject|1|||
42055964|NCT00976508|75864674|FG001|Overall Study|Withdrawal by Subject|0|||
42055965|NCT00976508|75864673|FG000|Overall Study|Disease Progression|4|||
42055966|NCT00976508|75864674|FG001|Overall Study|Disease Progression|4|||
42055967|NCT00976508|75864673|FG000|Overall Study|Subject Enrolled in Hospice|1|||
42055968|NCT00976508|75864674|FG001|Overall Study|Subject Enrolled in Hospice|0|||
42055969|NCT00976508|75864673|FG000|Overall Study|Terminated by the Sponsor|0|||
42055970|NCT00976508|75864674|FG001|Overall Study|Terminated by the Sponsor|1|||
42055971|NCT00973622|75864685|FG000|Overall Study|did not attend MRI|14|||
42055972|NCT00973622|75864686|FG001|Overall Study|did not attend MRI|3|||
42055973|NCT00973622|75864685|FG000|Overall Study|did not pass MRI screen|6|||
42055974|NCT00973622|75864686|FG001|Overall Study|did not pass MRI screen|0|||
42055975|NCT00973622|75864685|FG000|Overall Study|did not complete rTMS sessions|11|||
42055976|NCT00973622|75864686|FG001|Overall Study|did not complete rTMS sessions|2|||
42055977|NCT04044716|75864694|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
42055978|NCT04044716|75864695|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
42055979|NCT04044716|75864696|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
42055980|NCT04044716|75864694|FG000|Overall Study|Lost to Follow-up|2|||
42055981|NCT04044716|75864695|FG001|Overall Study|Lost to Follow-up|3|||
42055982|NCT04044716|75864696|FG002|Overall Study|Lost to Follow-up|0|||
42055983|NCT04041284|75864705|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
42055984|NCT04041284|75864706|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
42055985|NCT04041284|75864705|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
42055986|NCT04041284|75864706|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
42055987|NCT04041284|75864705|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
42055988|NCT04041284|75864706|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
42055989|NCT04041284|75864705|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
42055990|NCT04041284|75864706|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
42055991|NCT04041284|75864705|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
42055992|NCT04041284|75864706|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
42055993|NCT04041284|75864705|FG000|DB Phase (12 Weeks)|Other than specified|1|||
42055994|NCT04041284|75864706|FG001|DB Phase (12 Weeks)|Other than specified|0|||
42055995|NCT04041284|75864705|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
42055996|NCT04041284|75864706|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
42055997|NCT04041284|75864705|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
42055998|NCT04041284|75864706|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
42055999|NCT04041284|75864705|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
42056000|NCT04041284|75864706|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
42056001|NCT04041284|75864705|FG000|OL Phase (12 Weeks)|Other than specified|6|||
42056002|NCT04041284|75864706|FG001|OL Phase (12 Weeks)|Other than specified|2|||
42056003|NCT00753454|75864716|FG000|Overall Study|Adverse Event|4|||
42056004|NCT00753454|75864716|FG000|Overall Study|Lack of Efficacy|1|||
42056005|NCT00753454|75864716|FG000|Overall Study|Lost to Follow-up|3|||
42056006|NCT00753454|75864716|FG000|Overall Study|Withdrawal by Subject|5|||
42056007|NCT00753454|75864716|FG000|Overall Study|Investigator Decision|1|||
42056008|NCT00976274|75864722|FG000|Overall Study|Lost to Follow-up|5|||
42056009|NCT00976274|75864723|FG001|Overall Study|Lost to Follow-up|5|||
42291707|NCT02661217|76125172|FG000|Overall Study|Did not enter follow-up epoch|7|||
42291708|NCT02661217|76125173|FG001|Overall Study|Did not enter follow-up epoch|10|||
42056010|NCT00976274|75864722|FG000|Overall Study|Withdrawal by Subject|1|||
42056011|NCT00976274|75864723|FG001|Overall Study|Withdrawal by Subject|1|||
42056012|NCT00976274|75864722|FG000|Overall Study|Physician Decision|1|||
42056013|NCT00976274|75864723|FG001|Overall Study|Physician Decision|2|||
42056014|NCT00759148|75864731|FG000|Overall Study|Adverse Event|1|||
42056015|NCT00759148|75864732|FG001|Overall Study|Adverse Event|6|||
42056016|NCT00759148|75864731|FG000|Overall Study|Withdrawal by Subject|3|||
42174005|NCT00085644|75980789|FG001|Double-Blind Period|Contemplating pregnancy|0|||
42291709|NCT02661217|76125172|FG000|Overall Study|Death - no study drug received|1|||
42056017|NCT00759148|75864732|FG001|Overall Study|Withdrawal by Subject|7|||
42056018|NCT00759148|75864731|FG000|Overall Study|Lost to Follow-up|3|||
42056019|NCT00759148|75864732|FG001|Overall Study|Lost to Follow-up|9|||
42056020|NCT00759148|75864731|FG000|Overall Study|Treatment Failure|6|||
42056021|NCT00759148|75864732|FG001|Overall Study|Treatment Failure|10|||
42056022|NCT00759148|75864731|FG000|Overall Study|Reason not given|1|||
42056023|NCT00759148|75864732|FG001|Overall Study|Reason not given|0|||
42056024|NCT02794285|75864742|FG000|Overall Study|Adverse Event|11|||
42056025|NCT02794285|75864743|FG001|Overall Study|Adverse Event|4|||
42056026|NCT02794285|75864744|FG002|Overall Study|Adverse Event|5|||
42056027|NCT02794285|75864745|FG003|Overall Study|Adverse Event|8|||
42056028|NCT02794285|75864742|FG000|Overall Study|Condition Under Investigation Improved|1|||
42056029|NCT02794285|75864743|FG001|Overall Study|Condition Under Investigation Improved|0|||
42056030|NCT02794285|75864744|FG002|Overall Study|Condition Under Investigation Improved|0|||
42056031|NCT02794285|75864745|FG003|Overall Study|Condition Under Investigation Improved|0|||
42056032|NCT02794285|75864742|FG000|Overall Study|Condition Under Investigation Worsened|0|||
42056033|NCT02794285|75864743|FG001|Overall Study|Condition Under Investigation Worsened|2|||
42056034|NCT02794285|75864744|FG002|Overall Study|Condition Under Investigation Worsened|1|||
42056035|NCT02794285|75864745|FG003|Overall Study|Condition Under Investigation Worsened|0|||
42056036|NCT02794285|75864742|FG000|Overall Study|Death|2|||
42056037|NCT02794285|75864743|FG001|Overall Study|Death|1|||
42056038|NCT02794285|75864744|FG002|Overall Study|Death|2|||
42056039|NCT02794285|75864745|FG003|Overall Study|Death|0|||
42056040|NCT02794285|75864742|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
42056041|NCT02794285|75864743|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
42056042|NCT02794285|75864744|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
42056043|NCT02794285|75864745|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
42056044|NCT02794285|75864742|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
42056045|NCT02794285|75864743|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
42056046|NCT02794285|75864744|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
42056047|NCT02794285|75864745|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
42056048|NCT02794285|75864742|FG000|Overall Study|Lack of Efficacy|10|||
42056049|NCT02794285|75864743|FG001|Overall Study|Lack of Efficacy|6|||
42056050|NCT02794285|75864744|FG002|Overall Study|Lack of Efficacy|3|||
42056051|NCT02794285|75864745|FG003|Overall Study|Lack of Efficacy|3|||
42056052|NCT02794285|75864742|FG000|Overall Study|Lost to Follow-up|5|||
42056053|NCT02794285|75864743|FG001|Overall Study|Lost to Follow-up|6|||
42056054|NCT02794285|75864744|FG002|Overall Study|Lost to Follow-up|3|||
42056055|NCT02794285|75864745|FG003|Overall Study|Lost to Follow-up|1|||
42056056|NCT02794285|75864742|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
42056057|NCT02794285|75864743|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
42056058|NCT02794285|75864744|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
42056059|NCT02794285|75864745|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
42056060|NCT02794285|75864742|FG000|Overall Study|Withdrawal by Subject|38|||
42056061|NCT02794285|75864743|FG001|Overall Study|Withdrawal by Subject|29|||
42056062|NCT02794285|75864744|FG002|Overall Study|Withdrawal by Subject|20|||
42056063|NCT02794285|75864745|FG003|Overall Study|Withdrawal by Subject|12|||
42056064|NCT02794285|75864742|FG000|Overall Study|Missing|1|||
42056065|NCT02794285|75864743|FG001|Overall Study|Missing|0|||
42056066|NCT02794285|75864744|FG002|Overall Study|Missing|0|||
42056067|NCT02794285|75864745|FG003|Overall Study|Missing|0|||
42056068|NCT02794285|75864742|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
42056069|NCT02794285|75864743|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
42056070|NCT02794285|75864744|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
42056071|NCT02794285|75864745|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
42056072|NCT02794285|75864742|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
42056073|NCT02794285|75864743|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
42056074|NCT02794285|75864744|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
42056075|NCT02794285|75864745|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
42056076|NCT00970268|75864757|FG000|Overall Study|Withdrawal by Subject|12|||
42056077|NCT00970268|75864758|FG001|Overall Study|Withdrawal by Subject|19|||
42056078|NCT00970268|75864757|FG000|Overall Study|Adverse Event|15|||
42056079|NCT00970268|75864758|FG001|Overall Study|Adverse Event|12|||
42056080|NCT00970268|75864757|FG000|Overall Study|Lack of Efficacy|3|||
42356958|NCT01405053|76202178|FG000|Overall Study|Inadequate therapeutic effect|2|||
42356959|NCT01405053|76202179|FG001|Overall Study|Inadequate therapeutic effect|1|||
42356960|NCT01405053|76202178|FG000|Overall Study|Withdrawal by Subject|3|||
42356961|NCT01405053|76202179|FG001|Overall Study|Withdrawal by Subject|4|||
42356962|NCT01405053|76202178|FG000|Overall Study|Other|0|||
42056081|NCT00970268|75864758|FG001|Overall Study|Lack of Efficacy|6|||
42056082|NCT00970268|75864757|FG000|Overall Study|Protocol Violation|4|||
42056083|NCT00970268|75864758|FG001|Overall Study|Protocol Violation|7|||
42056084|NCT00970268|75864757|FG000|Overall Study|Other Reason|3|||
42056085|NCT00970268|75864758|FG001|Overall Study|Other Reason|1|||
42056086|NCT00970268|75864757|FG000|Overall Study|COPD Exacerbation|4|||
42056087|NCT00970268|75864758|FG001|Overall Study|COPD Exacerbation|2|||
42056088|NCT00970268|75864757|FG000|Overall Study|Lost to Follow-up|1|||
42056089|NCT00970268|75864758|FG001|Overall Study|Lost to Follow-up|2|||
42056090|NCT00970268|75864757|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
42056091|NCT00970268|75864758|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
42056092|NCT00969332|75864770|FG000|Overall Study|Physician Decision|8|||
42056093|NCT00969332|75864770|FG000|Overall Study|Withdrawal by Subject|3|||
42056094|NCT00968864|75864775|FG000|Overall Study|Protocol exception/ not evaluable|1|||
42056095|NCT00758680|75864784|FG000|Overall Study|Adverse Event|0|||
42056096|NCT00758680|75864785|FG001|Overall Study|Adverse Event|0|||
42056097|NCT00758680|75864786|FG002|Overall Study|Adverse Event|0|||
42056098|NCT00758680|75864787|FG003|Overall Study|Adverse Event|0|||
42056099|NCT00758680|75864788|FG004|Overall Study|Adverse Event|0|||
42056100|NCT00758680|75864789|FG005|Overall Study|Adverse Event|0|||
42056101|NCT00758680|75864790|FG006|Overall Study|Adverse Event|0|||
42056102|NCT00758680|75864791|FG007|Overall Study|Adverse Event|1|||
42056103|NCT00758680|75864792|FG008|Overall Study|Adverse Event|0|||
42056104|NCT00758680|75864793|FG009|Overall Study|Adverse Event|1|||
42056105|NCT00758680|75864784|FG000|Overall Study|Laboratory Adverse Event|0|||
42056106|NCT00758680|75864785|FG001|Overall Study|Laboratory Adverse Event|0|||
42056107|NCT00758680|75864786|FG002|Overall Study|Laboratory Adverse Event|0|||
42056108|NCT00758680|75864787|FG003|Overall Study|Laboratory Adverse Event|0|||
42056109|NCT00758680|75864788|FG004|Overall Study|Laboratory Adverse Event|0|||
42056110|NCT00758680|75864789|FG005|Overall Study|Laboratory Adverse Event|0|||
42056111|NCT00758680|75864790|FG006|Overall Study|Laboratory Adverse Event|0|||
42056112|NCT00758680|75864791|FG007|Overall Study|Laboratory Adverse Event|0|||
42056113|NCT00758680|75864792|FG008|Overall Study|Laboratory Adverse Event|1|||
42056114|NCT00758680|75864793|FG009|Overall Study|Laboratory Adverse Event|0|||
42056115|NCT00758680|75864784|FG000|Overall Study|Withdrawal by Subject|0|||
42056116|NCT00758680|75864785|FG001|Overall Study|Withdrawal by Subject|0|||
42056117|NCT00758680|75864786|FG002|Overall Study|Withdrawal by Subject|0|||
42056118|NCT00758680|75864787|FG003|Overall Study|Withdrawal by Subject|0|||
42056119|NCT00758680|75864788|FG004|Overall Study|Withdrawal by Subject|0|||
42056120|NCT00758680|75864789|FG005|Overall Study|Withdrawal by Subject|0|||
42056121|NCT00758680|75864790|FG006|Overall Study|Withdrawal by Subject|1|||
42056122|NCT00758680|75864791|FG007|Overall Study|Withdrawal by Subject|0|||
42056123|NCT00758680|75864792|FG008|Overall Study|Withdrawal by Subject|1|||
42056124|NCT00758680|75864793|FG009|Overall Study|Withdrawal by Subject|0|||
42056125|NCT00758602|75864818|FG000|Overall Study|Adverse Event|11|||
42056126|NCT00758602|75864819|FG001|Overall Study|Adverse Event|10|||
42056127|NCT00758602|75864818|FG000|Overall Study|Lost to Follow-up|4|||
42056128|NCT00758602|75864819|FG001|Overall Study|Lost to Follow-up|3|||
42056129|NCT00758602|75864818|FG000|Overall Study|Withdrawal by Subject|1|||
42056130|NCT00758602|75864819|FG001|Overall Study|Withdrawal by Subject|3|||
42056131|NCT00758602|75864818|FG000|Overall Study|Protocol Violation|0|||
42056132|NCT00758602|75864819|FG001|Overall Study|Protocol Violation|2|||
42056133|NCT00758602|75864818|FG000|Overall Study|Death|0|||
42056134|NCT00758602|75864819|FG001|Overall Study|Death|1|||
42056135|NCT00758602|75864818|FG000|Overall Study|Reason not specified|3|||
42056136|NCT00758602|75864819|FG001|Overall Study|Reason not specified|3|||
42056137|NCT00711529|75864828|FG000|Overall Study|Protocol Violation|2|||
42056138|NCT00711529|75864829|FG001|Overall Study|Protocol Violation|0|||
42056139|NCT00711529|75864828|FG000|Overall Study|Withdrawal by Subject|2|||
42056140|NCT00711529|75864829|FG001|Overall Study|Withdrawal by Subject|6|||
42056141|NCT00601419|75864835|FG000|Overall Study|Lost to Follow-up|3|||
42056142|NCT00601419|75864835|FG000|Overall Study|Missed Visits|1|||
42056143|NCT00712933|75864855|FG000|Overall Study|Adverse Event|69|||
42056144|NCT00712933|75864855|FG000|Overall Study|Lack of Efficacy|6|||
42056145|NCT00712933|75864855|FG000|Overall Study|Lost to Follow-up|22|||
42056146|NCT00712933|75864855|FG000|Overall Study|Non-compliance with study drug|13|||
42056147|NCT00712933|75864855|FG000|Overall Study|Other Pregnancy|37|||
42056148|NCT00712933|75864855|FG000|Overall Study|Sponsor decision|14|||
42056149|NCT00712933|75864855|FG000|Overall Study|Withdrew consent|4|||
42056150|NCT00712933|75864855|FG000|Overall Study|Hip replacement surgery|1|||
42056151|NCT00712933|75864855|FG000|Overall Study|Involved in Clinical research|3|||
42056152|NCT00712933|75864855|FG000|Overall Study|Participant hospitalized|1|||
42056153|NCT00712933|75864855|FG000|Overall Study|Participant travelled overseas|2|||
42056154|NCT00712933|75864855|FG000|Overall Study|Death of patient|1|||
42056155|NCT00712933|75864855|FG000|Overall Study|Other Physician decision|1|||
42056156|NCT00712933|75864855|FG000|Overall Study|Not committed to contraception|1|||
42056157|NCT00712933|75864855|FG000|Overall Study|Participant received medication|1|||
42056158|NCT00712933|75864855|FG000|Overall Study|Physician Decision|36|||
42056159|NCT00712933|75864855|FG000|Overall Study|Protocol Violation|4|||
42291710|NCT02661217|76125173|FG001|Overall Study|Death - no study drug received|2|||
42291711|NCT02661217|76125172|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
42056160|NCT00712933|75864855|FG000|Overall Study|Withdrawal by Subject|151|||
42056161|NCT00712543|75864865|FG000|Day 8-14|Lost to Follow-up|0|||
42056162|NCT00712543|75864866|FG001|Day 8-14|Lost to Follow-up|2|||
42056163|NCT00709111|75864872|FG000|Overall Study|Withdrawal by Subject|1|||
42056164|NCT00709111|75864872|FG000|Overall Study|Unable to attend clinic visits|1|||
42056165|NCT00710749|75864876|FG000|First Intervention|Withdrawal by Subject|1|||
42056166|NCT00710749|75864877|FG001|First Intervention|Withdrawal by Subject|0|||
42056167|NCT00699907|75864897|FG000|Overall Study|Withdrawal by Subject|2|||
42056168|NCT00699907|75864898|FG001|Overall Study|Withdrawal by Subject|1|||
42056169|NCT00699907|75864899|FG002|Overall Study|Withdrawal by Subject|0|||
42056170|NCT00699907|75864897|FG000|Overall Study|No usable sample|0|||
42056171|NCT00699907|75864898|FG001|Overall Study|No usable sample|9|||
42056172|NCT00699907|75864899|FG002|Overall Study|No usable sample|8|||
42056173|NCT00710593|75864909|FG000|Overall Study|Incarceration|1|||
42056174|NCT00710593|75864910|FG001|Overall Study|Incarceration|0|||
42056175|NCT00710593|75864909|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
42056176|NCT00710593|75864910|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
42056177|NCT00710593|75864909|FG000|Overall Study|Lost to Follow-up|3|||
42056178|NCT00710593|75864910|FG001|Overall Study|Lost to Follow-up|1|||
42056179|NCT00710593|75864909|FG000|Overall Study|Moved out of area|1|||
42056180|NCT00710593|75864910|FG001|Overall Study|Moved out of area|0|||
42056181|NCT00710593|75864909|FG000|Overall Study|Failure to adhere or complete study eval|1|||
42056182|NCT00710593|75864910|FG001|Overall Study|Failure to adhere or complete study eval|1|||
42056183|NCT00710593|75864909|FG000|Overall Study|Protocol Violation|1|||
42056184|NCT00710593|75864910|FG001|Overall Study|Protocol Violation|1|||
42056185|NCT00710593|75864909|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
42056186|NCT00710593|75864910|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
42056187|NCT00599313|75864932|FG000|Overall Study|Adverse Event|19|||
42056188|NCT00599313|75864932|FG000|Overall Study|Disease Progression|12|||
42056189|NCT00599313|75864932|FG000|Overall Study|Patient Request|4|||
42056190|NCT00599313|75864932|FG000|Overall Study|Ineligible|1|||
42056191|NCT00708175|75864938|FG000|Overall Study|Adverse Event|4|||
42056192|NCT00708175|75864939|FG001|Overall Study|Adverse Event|5|||
42056193|NCT00708175|75864938|FG000|Overall Study|Protocol Violation|2|||
42056194|NCT00708175|75864939|FG001|Overall Study|Protocol Violation|3|||
42056195|NCT00708175|75864938|FG000|Overall Study|Lost to Follow-up|5|||
42056196|NCT00708175|75864939|FG001|Overall Study|Lost to Follow-up|3|||
42056197|NCT00708175|75864938|FG000|Overall Study|Withdrawal by Subject|5|||
42056198|NCT00708175|75864939|FG001|Overall Study|Withdrawal by Subject|7|||
42056199|NCT00708175|75864938|FG000|Overall Study|BMD loss >7%|2|||
42056200|NCT00708175|75864939|FG001|Overall Study|BMD loss >7%|3|||
42356963|NCT01405053|76202179|FG001|Overall Study|Other|1|||
42356964|NCT01403805|76202187|FG000|Overall Study|Withdrawal by Subject|0|||
42356965|NCT01403805|76202188|FG001|Overall Study|Withdrawal by Subject|4|||
42356966|NCT01403805|76202187|FG000|Overall Study|Lost to Follow-up|0|||
42356967|NCT01403805|76202188|FG001|Overall Study|Lost to Follow-up|2|||
42356968|NCT01403805|76202187|FG000|Overall Study|Death|0|||
42356969|NCT01403805|76202188|FG001|Overall Study|Death|1|||
42356970|NCT01423617|76202200|FG000|Overall Study|Lost to Follow-up|0|||
42356971|NCT01423617|76202201|FG001|Overall Study|Lost to Follow-up|1|||
42056201|NCT00707239|75864948|FG000|Overall Study|Adverse Event|5|||
42056202|NCT00707239|75864949|FG001|Overall Study|Adverse Event|3|||
42056203|NCT00707239|75864950|FG002|Overall Study|Adverse Event|2|||
42056204|NCT00707239|75864948|FG000|Overall Study|Death|3|||
42056205|NCT00707239|75864949|FG001|Overall Study|Death|1|||
42056206|NCT00707239|75864950|FG002|Overall Study|Death|3|||
42056207|NCT00707239|75864948|FG000|Overall Study|Physician Decision|1|||
42056208|NCT00707239|75864949|FG001|Overall Study|Physician Decision|1|||
42056209|NCT00707239|75864950|FG002|Overall Study|Physician Decision|2|||
42056210|NCT00707239|75864948|FG000|Overall Study|Protocol Violation|0|||
42056211|NCT00707239|75864949|FG001|Overall Study|Protocol Violation|0|||
42056212|NCT00707239|75864950|FG002|Overall Study|Protocol Violation|1|||
42056213|NCT00707239|75864948|FG000|Overall Study|Lack of Efficacy|1|||
42056214|NCT00707239|75864949|FG001|Overall Study|Lack of Efficacy|2|||
42056215|NCT00707239|75864950|FG002|Overall Study|Lack of Efficacy|0|||
42056216|NCT00707239|75864948|FG000|Overall Study|Randomized, but not treated|1|||
42056217|NCT00707239|75864949|FG001|Overall Study|Randomized, but not treated|1|||
42356972|NCT01392183|76202209|FG000|First Drug Administration|Adverse Event|3|||
42356973|NCT01392183|76202210|FG001|First Drug Administration|Adverse Event|2|||
42356974|NCT01392183|76202209|FG000|First Drug Administration|Death|1|||
42056218|NCT00707239|75864950|FG002|Overall Study|Randomized, but not treated|1|||
42056219|NCT00707239|75864948|FG000|Overall Study|Other|8|||
42056220|NCT00707239|75864949|FG001|Overall Study|Other|3|||
42056221|NCT00707239|75864950|FG002|Overall Study|Other|5|||
42056222|NCT00968708|75864963|FG000|Overall Study|Adverse Event|169|||
42056223|NCT00968708|75864964|FG001|Overall Study|Adverse Event|150|||
42056224|NCT00968708|75864963|FG000|Overall Study|Major Protocol Deviation|0|||
42356975|NCT01392183|76202210|FG001|First Drug Administration|Death|0|||
42056225|NCT00968708|75864964|FG001|Overall Study|Major Protocol Deviation|1|||
42056226|NCT00968708|75864963|FG000|Overall Study|Lost to Follow-up|19|||
42056227|NCT00968708|75864964|FG001|Overall Study|Lost to Follow-up|11|||
42291712|NCT02661217|76125173|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
42291713|NCT01952080|76125184|FG000|Overall Study|Withdrawal by Subject|0|||
42291714|NCT01952080|76125185|FG001|Overall Study|Withdrawal by Subject|0|||
42291715|NCT01952080|76125186|FG002|Overall Study|Withdrawal by Subject|0|||
42291716|NCT01952080|76125187|FG003|Overall Study|Withdrawal by Subject|1|||
42056228|NCT00968708|75864963|FG000|Overall Study|Voluntary Withdrawal|104|||
42056229|NCT00968708|75864964|FG001|Overall Study|Voluntary Withdrawal|101|||
42056230|NCT00968708|75864963|FG000|Overall Study|Investigator Discretion|0|||
42056231|NCT00968708|75864964|FG001|Overall Study|Investigator Discretion|1|||
42056232|NCT00968708|75864963|FG000|Overall Study|Other|26|||
42056233|NCT00968708|75864964|FG001|Overall Study|Other|34|||
42056234|NCT00967694|75864970|FG000|Overall Study|Withdrawal by Subject|6|||
42056235|NCT00967616|75864976|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
42056236|NCT00967616|75864977|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
42056237|NCT00967616|75864976|FG000|Overall Study|Death|0|||
42056238|NCT00967616|75864977|FG001|Overall Study|Death|3|||
42056239|NCT00967616|75864976|FG000|Overall Study|Withdrawal by Subject|8|||
42056240|NCT00967616|75864977|FG001|Overall Study|Withdrawal by Subject|4|||
42056241|NCT00967616|75864976|FG000|Overall Study|Progressive Disease|31|||
42056242|NCT00967616|75864977|FG001|Overall Study|Progressive Disease|18|||
42056243|NCT00967616|75864976|FG000|Overall Study|Other|8|||
42056244|NCT00967616|75864977|FG001|Overall Study|Other|8|||
42056245|NCT00967616|75864976|FG000|Overall Study|Protocol Violation|1|||
42056246|NCT00967616|75864977|FG001|Overall Study|Protocol Violation|0|||
42056247|NCT00971204|75864987|FG000|Overall Study|Did not meet all criteria-not treated|14|||
42056248|NCT00971204|75864987|FG000|Overall Study|Lost to Follow-up|10|||
42056249|NCT00974090|75864993|FG000|Period 1: Double Blind Period|Adverse Event|2|||
42056250|NCT00974090|75864994|FG001|Period 1: Double Blind Period|Adverse Event|1|||
42056251|NCT00974090|75864993|FG000|Period 1: Double Blind Period|Physician Decision|1|||
42056252|NCT00974090|75864994|FG001|Period 1: Double Blind Period|Physician Decision|0|||
42056253|NCT00974090|75864993|FG000|Period 2: Open-label Period|Adverse Event|4|||
42056254|NCT00974090|75864994|FG001|Period 2: Open-label Period|Adverse Event|6|||
42056255|NCT00974090|75864993|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
42056256|NCT00974090|75864994|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
42056257|NCT00974090|75864993|FG000|Period 2: Open-label Period|Physician Decision|0|||
42056258|NCT00974090|75864994|FG001|Period 2: Open-label Period|Physician Decision|3|||
42056259|NCT00974090|75864993|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
42056260|NCT00974090|75864994|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
42056261|NCT00971048|75865006|FG000|Overall Study|Protocol Violation|1|||
42056262|NCT00971048|75865007|FG001|Overall Study|Protocol Violation|2|||
42056263|NCT00971048|75865008|FG002|Overall Study|Protocol Violation|0|||
42056264|NCT00971048|75865009|FG003|Overall Study|Protocol Violation|1|||
42056265|NCT00971048|75865006|FG000|Overall Study|Adverse Event|0|||
42056266|NCT00971048|75865007|FG001|Overall Study|Adverse Event|0|||
42056267|NCT00971048|75865008|FG002|Overall Study|Adverse Event|1|||
42056268|NCT00971048|75865009|FG003|Overall Study|Adverse Event|0|||
42056269|NCT00971048|75865006|FG000|Overall Study|Physician Decision|0|||
42056270|NCT00971048|75865007|FG001|Overall Study|Physician Decision|0|||
42056271|NCT00971048|75865008|FG002|Overall Study|Physician Decision|0|||
42056272|NCT00971048|75865009|FG003|Overall Study|Physician Decision|1|||
42056273|NCT00699751|75865023|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
42056274|NCT00699751|75865024|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
42056275|NCT00699751|75865023|FG000|Period 1: Without/Before Drug Switch|Death|28|||
42056276|NCT00699751|75865024|FG001|Period 1: Without/Before Drug Switch|Death|29|||
42056277|NCT00699751|75865023|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
42056278|NCT00699751|75865024|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
42056279|NCT00699751|75865023|FG000|Period 1: Without/Before Drug Switch|Other|30|||
42056280|NCT00699751|75865024|FG001|Period 1: Without/Before Drug Switch|Other|20|||
42291717|NCT01952080|76125184|FG000|Overall Study|Protocol Non-compliance|0|||
42056281|NCT00699751|75865023|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
42056282|NCT00699751|75865024|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
42056283|NCT00699751|75865023|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
42056284|NCT00699751|75865024|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
42056285|NCT00699751|75865023|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
42291718|NCT01952080|76125185|FG001|Overall Study|Protocol Non-compliance|1|||
42291719|NCT01952080|76125186|FG002|Overall Study|Protocol Non-compliance|0|||
42291720|NCT01952080|76125187|FG003|Overall Study|Protocol Non-compliance|0|||
42056286|NCT00699751|75865024|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
42056287|NCT00699751|75865023|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
42056288|NCT00699751|75865024|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
42056289|NCT00970502|75865031|FG000|Overall Study|Withdrawal by Subject|1|||
42056290|NCT00967226|75865041|FG000|Overall Study|Adverse Event|0|||
42291721|NCT01951378|76125199|FG000|Overall Study|Study Terminated-Not completed|23|||
42056291|NCT00967226|75865042|FG001|Overall Study|Adverse Event|5|||
42291722|NCT01951378|76125200|FG001|Overall Study|Study Terminated-Not completed|17|||
42291723|NCT01944670|76125206|FG000|Overall Study|Lost to Follow-up|2|||
42056292|NCT00967226|75865041|FG000|Overall Study|Protocol Violation|2|||
42056293|NCT00967226|75865042|FG001|Overall Study|Protocol Violation|0|||
42056294|NCT00967226|75865041|FG000|Overall Study|Physician Decision|0|||
42056295|NCT00967226|75865042|FG001|Overall Study|Physician Decision|1|||
42056296|NCT00706381|75865076|FG000|Overall Study|Lost to Follow-up|0|||
42056297|NCT00706381|75865077|FG001|Overall Study|Lost to Follow-up|1|||
42056298|NCT00706381|75865078|FG002|Overall Study|Lost to Follow-up|1|||
42056299|NCT00706381|75865079|FG003|Overall Study|Lost to Follow-up|0|||
42056300|NCT00964886|75865096|FG000|Overall Study|Lost to Follow-up|2|||
42056301|NCT00964886|75865097|FG001|Overall Study|Lost to Follow-up|2|||
42056302|NCT00964886|75865098|FG002|Overall Study|Lost to Follow-up|6|||
42056303|NCT00964886|75865099|FG003|Overall Study|Lost to Follow-up|4|||
42056304|NCT00964886|75865096|FG000|Overall Study|Withdrawal by Subject|6|||
42056305|NCT00964886|75865097|FG001|Overall Study|Withdrawal by Subject|2|||
42056306|NCT00964886|75865098|FG002|Overall Study|Withdrawal by Subject|5|||
42056307|NCT00964886|75865099|FG003|Overall Study|Withdrawal by Subject|3|||
42056308|NCT00964886|75865096|FG000|Overall Study|Adverse Event|3|||
42056309|NCT00964886|75865097|FG001|Overall Study|Adverse Event|1|||
42056310|NCT00964886|75865098|FG002|Overall Study|Adverse Event|5|||
42056311|NCT00964886|75865099|FG003|Overall Study|Adverse Event|2|||
42056312|NCT00964886|75865096|FG000|Overall Study|Protocol Violation|0|||
42056313|NCT00964886|75865097|FG001|Overall Study|Protocol Violation|2|||
42056314|NCT00964886|75865098|FG002|Overall Study|Protocol Violation|0|||
42056315|NCT00964886|75865099|FG003|Overall Study|Protocol Violation|0|||
42056316|NCT00705757|75865116|FG000|Overall Study|Lack of Efficacy|5|||
42056317|NCT00705757|75865117|FG001|Overall Study|Lack of Efficacy|1|||
42056318|NCT00705757|75865118|FG002|Overall Study|Lack of Efficacy|3|||
42056319|NCT00705757|75865116|FG000|Overall Study|Lost to Follow-up|7|||
42056320|NCT00705757|75865117|FG001|Overall Study|Lost to Follow-up|6|||
42056321|NCT00705757|75865118|FG002|Overall Study|Lost to Follow-up|6|||
42056322|NCT00705757|75865116|FG000|Overall Study|Withdrawal by Subject|1|||
42056323|NCT00705757|75865117|FG001|Overall Study|Withdrawal by Subject|1|||
42056324|NCT00705757|75865118|FG002|Overall Study|Withdrawal by Subject|2|||
42291724|NCT01361009|76125210|FG000|Overall Study|Protocol Violation|116|||
42056325|NCT00960752|75865146|FG000|Overall Study|Adverse Event|0|||
42056326|NCT00960752|75865147|FG001|Overall Study|Adverse Event|0|||
42056327|NCT00960752|75865148|FG002|Overall Study|Adverse Event|1|||
42056328|NCT00960752|75865146|FG000|Overall Study|Progression|0|||
42056329|NCT00960752|75865147|FG001|Overall Study|Progression|0|||
42056330|NCT00960752|75865148|FG002|Overall Study|Progression|1|||
42056331|NCT00758524|75865162|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
42056332|NCT00758524|75865163|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
42056333|NCT00758524|75865164|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
42056334|NCT00758524|75865165|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056335|NCT00758524|75865166|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
42056336|NCT00758524|75865167|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
42056337|NCT00758524|75865168|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056338|NCT00758524|75865169|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056339|NCT00758524|75865170|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056340|NCT00758524|75865171|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056341|NCT00758524|75865172|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056342|NCT00758524|75865173|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056343|NCT00758524|75865174|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056344|NCT00758524|75865175|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056345|NCT00758524|75865176|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056346|NCT00758524|75865177|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056347|NCT00758524|75865178|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
42056348|NCT00758524|75865162|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
42056349|NCT00758524|75865163|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42056350|NCT00758524|75865164|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
42056351|NCT00758524|75865165|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
42291725|NCT01944046|76125216|FG000|Randomized to DB|Adverse Event|5|||
42291726|NCT01944046|76125217|FG001|Randomized to DB|Adverse Event|2|||
42291727|NCT01944046|76125216|FG000|Randomized to DB|Clinical Worsening|3|||
42291728|NCT01944046|76125217|FG001|Randomized to DB|Clinical Worsening|2|||
42291729|NCT01944046|76125216|FG000|Randomized to DB|Lost to Follow-up|3|||
42056352|NCT00758524|75865166|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
42291730|NCT01944046|76125217|FG001|Randomized to DB|Lost to Follow-up|3|||
42056353|NCT00758524|75865167|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
42056354|NCT00758524|75865168|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42056355|NCT00758524|75865169|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42056356|NCT00758524|75865170|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42056357|NCT00758524|75865171|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42056358|NCT00758524|75865172|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42291731|NCT01944046|76125216|FG000|Randomized to DB|Withdrawal by Subject|2|||
42056359|NCT00758524|75865173|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42056360|NCT00758524|75865174|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42056361|NCT00758524|75865175|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42056362|NCT00758524|75865176|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42056363|NCT00758524|75865177|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42056364|NCT00758524|75865178|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
42056365|NCT00758524|75865162|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
42056366|NCT00758524|75865163|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
42056367|NCT00758524|75865164|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
42056368|NCT00758524|75865165|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
42056369|NCT00758524|75865166|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
42056370|NCT00758524|75865167|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
42056371|NCT00758524|75865168|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
42056372|NCT00758524|75865169|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
42056373|NCT00758524|75865170|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
42056374|NCT00758524|75865171|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
42056375|NCT00758524|75865172|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
42056376|NCT00758524|75865173|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
42056377|NCT00758524|75865174|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
42056378|NCT00758524|75865175|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
42056379|NCT00758524|75865176|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
42056380|NCT00758524|75865177|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
42056381|NCT00758524|75865178|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
42056382|NCT00758524|75865162|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056383|NCT00758524|75865163|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
42056384|NCT00758524|75865164|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
42056385|NCT00758524|75865165|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056386|NCT00758524|75865166|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
42056387|NCT00758524|75865167|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
42056388|NCT00758524|75865168|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056389|NCT00758524|75865169|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056390|NCT00758524|75865170|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056391|NCT00758524|75865171|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056392|NCT00758524|75865172|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056393|NCT00758524|75865173|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056394|NCT00758524|75865174|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056395|NCT00758524|75865175|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056396|NCT00758524|75865176|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056397|NCT00758524|75865177|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056398|NCT00758524|75865178|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
42056399|NCT00758524|75865162|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056400|NCT00758524|75865163|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056401|NCT00758524|75865164|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
42056402|NCT00758524|75865165|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
42056403|NCT00758524|75865166|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056404|NCT00758524|75865167|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056405|NCT00758524|75865168|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056406|NCT00758524|75865169|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056407|NCT00758524|75865170|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056408|NCT00758524|75865171|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056409|NCT00758524|75865172|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056410|NCT00758524|75865173|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056411|NCT00758524|75865174|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056412|NCT00758524|75865175|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056413|NCT00758524|75865176|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056414|NCT00758524|75865177|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056415|NCT00758524|75865178|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
42056416|NCT00758524|75865162|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056417|NCT00758524|75865163|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056418|NCT00758524|75865164|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056419|NCT00758524|75865165|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056420|NCT00758524|75865166|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
42056421|NCT00758524|75865167|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056422|NCT00758524|75865168|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056423|NCT00758524|75865169|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056424|NCT00758524|75865170|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056425|NCT00758524|75865171|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056426|NCT00758524|75865172|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056427|NCT00758524|75865173|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056428|NCT00758524|75865174|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056429|NCT00758524|75865175|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056430|NCT00758524|75865176|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056431|NCT00758524|75865177|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056432|NCT00758524|75865178|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
42056433|NCT00758524|75865162|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056434|NCT00758524|75865163|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
42056435|NCT00758524|75865164|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056436|NCT00758524|75865165|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056437|NCT00758524|75865166|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056438|NCT00758524|75865167|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056439|NCT00758524|75865168|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056440|NCT00758524|75865169|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056441|NCT00758524|75865170|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056442|NCT00758524|75865171|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056443|NCT00758524|75865172|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42174006|NCT00085644|75980790|FG002|Double-Blind Period|Contemplating pregnancy|0|||
42174007|NCT00085644|75980788|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
42174008|NCT00085644|75980789|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
42174009|NCT00085644|75980790|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
42174010|NCT00085644|75980788|FG000|Open-Label Period|Adverse Event|0|||
42174011|NCT00085644|75980789|FG001|Open-Label Period|Adverse Event|0|||
42174012|NCT00085644|75980790|FG002|Open-Label Period|Adverse Event|38|||
42174013|NCT00085644|75980788|FG000|Open-Label Period|Withdrawal by Subject|0|||
42174014|NCT00085644|75980789|FG001|Open-Label Period|Withdrawal by Subject|0|||
42174015|NCT00085644|75980790|FG002|Open-Label Period|Withdrawal by Subject|29|||
42174016|NCT00085644|75980788|FG000|Open-Label Period|Lost to Follow-up|0|||
42174017|NCT00085644|75980789|FG001|Open-Label Period|Lost to Follow-up|0|||
42174018|NCT00085644|75980790|FG002|Open-Label Period|Lost to Follow-up|13|||
42174019|NCT00085644|75980788|FG000|Open-Label Period|Lack of Efficacy|0|||
42174020|NCT00085644|75980789|FG001|Open-Label Period|Lack of Efficacy|0|||
42174021|NCT00085644|75980790|FG002|Open-Label Period|Lack of Efficacy|15|||
42174022|NCT00085644|75980788|FG000|Open-Label Period|Pregnancy|0|||
42174023|NCT00085644|75980789|FG001|Open-Label Period|Pregnancy|0|||
42174024|NCT00085644|75980790|FG002|Open-Label Period|Pregnancy|3|||
42174025|NCT00085644|75980788|FG000|Open-Label Period|Contemplating pregnancy|0|||
42174026|NCT00085644|75980789|FG001|Open-Label Period|Contemplating pregnancy|0|||
42174027|NCT00085644|75980790|FG002|Open-Label Period|Contemplating pregnancy|3|||
42174028|NCT00085644|75980788|FG000|Open-Label Period|Protocol Violation|0|||
42174029|NCT00085644|75980789|FG001|Open-Label Period|Protocol Violation|0|||
42174030|NCT00085644|75980790|FG002|Open-Label Period|Protocol Violation|4|||
42174031|NCT00085644|75980788|FG000|Open-Label Period|Personal reason|0|||
42174032|NCT00085644|75980789|FG001|Open-Label Period|Personal reason|0|||
42174033|NCT00085644|75980790|FG002|Open-Label Period|Personal reason|4|||
42174034|NCT03315208|75980799|FG000|Overall Study|Lost to Follow-up|11|||
42174035|NCT03315208|75980800|FG001|Overall Study|Lost to Follow-up|6|||
42174036|NCT03315208|75980799|FG000|Overall Study|Withdrawal by Subject|2|||
42174037|NCT03315208|75980800|FG001|Overall Study|Withdrawal by Subject|0|||
42174038|NCT00314795|75980807|FG000|Overall Study|Adverse Event|8|||
42174039|NCT00314795|75980807|FG000|Overall Study|Death|4|||
42174040|NCT00314795|75980807|FG000|Overall Study|Reason not Specified|3|||
42174041|NCT00314795|75980807|FG000|Overall Study|Renal Transplant|3|||
42174042|NCT00314795|75980807|FG000|Overall Study|Participants Withdrew Consent|2|||
42174043|NCT00314327|75980811|FG000|Overall Study|Withdrawal by Subject|1|||
42174044|NCT00336479|75980819|FG000|Overall Study|Adverse Event|8|||
42174045|NCT00336479|75980820|FG001|Overall Study|Adverse Event|11|||
42174046|NCT00336479|75980821|FG002|Overall Study|Adverse Event|18|||
42174047|NCT00336479|75980822|FG003|Overall Study|Adverse Event|4|||
42174048|NCT00336479|75980819|FG000|Overall Study|Noncompliant|1|||
42174049|NCT00336479|75980820|FG001|Overall Study|Noncompliant|7|||
42174050|NCT00336479|75980821|FG002|Overall Study|Noncompliant|3|||
42174051|NCT00336479|75980822|FG003|Overall Study|Noncompliant|0|||
42174052|NCT00336479|75980819|FG000|Overall Study|Physician Decision|2|||
42056444|NCT00758524|75865173|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056445|NCT00758524|75865174|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42174053|NCT00336479|75980820|FG001|Overall Study|Physician Decision|3|||
42174054|NCT00336479|75980821|FG002|Overall Study|Physician Decision|1|||
42056446|NCT00758524|75865175|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42174055|NCT00336479|75980822|FG003|Overall Study|Physician Decision|0|||
42174056|NCT00336479|75980819|FG000|Overall Study|Lost to Follow-up|3|||
42174057|NCT00336479|75980820|FG001|Overall Study|Lost to Follow-up|2|||
42056447|NCT00758524|75865176|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056448|NCT00758524|75865177|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056449|NCT00758524|75865178|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
42056450|NCT00758524|75865162|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056451|NCT00758524|75865163|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
42056452|NCT00758524|75865164|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056453|NCT00758524|75865165|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056454|NCT00758524|75865166|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056455|NCT00758524|75865167|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056456|NCT00758524|75865168|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056457|NCT00758524|75865169|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056458|NCT00758524|75865170|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056459|NCT00758524|75865171|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056460|NCT00758524|75865172|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056461|NCT00758524|75865173|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056462|NCT00758524|75865174|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056463|NCT00758524|75865175|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056464|NCT00758524|75865176|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056465|NCT00758524|75865177|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056466|NCT00758524|75865178|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
42056467|NCT00758524|75865162|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056468|NCT00758524|75865163|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056469|NCT00758524|75865164|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056470|NCT00758524|75865165|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056471|NCT00758524|75865166|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056472|NCT00758524|75865167|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056473|NCT00758524|75865168|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056474|NCT00758524|75865169|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056475|NCT00758524|75865170|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
42056476|NCT00758524|75865171|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056477|NCT00758524|75865172|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056478|NCT00758524|75865173|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056479|NCT00758524|75865174|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056480|NCT00758524|75865175|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056481|NCT00758524|75865176|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056482|NCT00758524|75865177|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056483|NCT00758524|75865178|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
42056484|NCT00758524|75865162|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056485|NCT00758524|75865163|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056486|NCT00758524|75865164|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056487|NCT00758524|75865165|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056488|NCT00758524|75865166|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056489|NCT00758524|75865167|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056490|NCT00758524|75865168|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
42056491|NCT00758524|75865169|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056492|NCT00758524|75865170|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056493|NCT00758524|75865171|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056494|NCT00758524|75865172|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056495|NCT00758524|75865173|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056496|NCT00758524|75865174|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056497|NCT00758524|75865175|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056498|NCT00758524|75865176|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056499|NCT00758524|75865177|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056500|NCT00758524|75865178|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
42056501|NCT00757588|75865218|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
42056502|NCT00757588|75865219|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
42056503|NCT00757588|75865218|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
42056504|NCT00757588|75865219|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
42056505|NCT00757588|75865218|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
42174058|NCT00336479|75980821|FG002|Overall Study|Lost to Follow-up|0|||
42291732|NCT01944046|76125217|FG001|Randomized to DB|Withdrawal by Subject|4|||
42291733|NCT01944046|76125216|FG000|Randomized to DB|Physician Decision|1|||
42291734|NCT01944046|76125217|FG001|Randomized to DB|Physician Decision|2|||
42291735|NCT01944046|76125216|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
42056506|NCT00757588|75865219|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
42056507|NCT00757588|75865218|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
42056508|NCT00757588|75865219|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
42056509|NCT00757588|75865218|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
42056510|NCT00757588|75865219|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
42056511|NCT00757588|75865218|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
42056512|NCT00757588|75865219|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
42056513|NCT00757588|75865218|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
42056514|NCT00757588|75865219|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
42056515|NCT00757588|75865218|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
42056516|NCT00757588|75865219|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
42056517|NCT00757588|75865218|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
42056518|NCT00757588|75865219|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
42056519|NCT00757588|75865218|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
42056520|NCT00757588|75865219|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
42056521|NCT00757588|75865218|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
42056522|NCT00757588|75865219|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
42056523|NCT00757588|75865218|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
42056524|NCT00757588|75865219|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
42056525|NCT00757588|75865218|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
42056526|NCT00757588|75865219|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
42056527|NCT00757588|75865218|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
42056528|NCT00757588|75865219|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
42056529|NCT00757588|75865218|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
42056530|NCT00757588|75865219|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
42056531|NCT00757588|75865218|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
42056532|NCT00757588|75865219|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
42056533|NCT00744796|75865225|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
42056534|NCT00705679|75865234|FG000|Overall Study|Adverse Event|1|||
42056535|NCT00705679|75865235|FG001|Overall Study|Adverse Event|1|||
42056536|NCT00705679|75865236|FG002|Overall Study|Adverse Event|0|||
42056537|NCT00705679|75865237|FG003|Overall Study|Adverse Event|0|||
42056538|NCT00705679|75865238|FG004|Overall Study|Adverse Event|0|||
42056539|NCT00705679|75865234|FG000|Overall Study|Death|0|||
42056540|NCT00705679|75865235|FG001|Overall Study|Death|0|||
42056541|NCT00705679|75865236|FG002|Overall Study|Death|3|||
42056542|NCT00705679|75865237|FG003|Overall Study|Death|2|||
42056543|NCT00705679|75865238|FG004|Overall Study|Death|1|||
42056544|NCT00705679|75865234|FG000|Overall Study|Lost to Follow-up|32|||
42056545|NCT00705679|75865235|FG001|Overall Study|Lost to Follow-up|60|||
42056546|NCT00705679|75865236|FG002|Overall Study|Lost to Follow-up|44|||
42056547|NCT00705679|75865237|FG003|Overall Study|Lost to Follow-up|30|||
42056548|NCT00705679|75865238|FG004|Overall Study|Lost to Follow-up|35|||
42056549|NCT00705679|75865234|FG000|Overall Study|Physician Decision|0|||
42056550|NCT00705679|75865235|FG001|Overall Study|Physician Decision|1|||
42056551|NCT00705679|75865236|FG002|Overall Study|Physician Decision|0|||
42056552|NCT00705679|75865237|FG003|Overall Study|Physician Decision|1|||
42056553|NCT00705679|75865238|FG004|Overall Study|Physician Decision|0|||
42056554|NCT00705679|75865234|FG000|Overall Study|Withdrawal by Subject|32|||
42056555|NCT00705679|75865235|FG001|Overall Study|Withdrawal by Subject|77|||
42056556|NCT00705679|75865236|FG002|Overall Study|Withdrawal by Subject|68|||
42056557|NCT00705679|75865237|FG003|Overall Study|Withdrawal by Subject|47|||
42056558|NCT00705679|75865238|FG004|Overall Study|Withdrawal by Subject|33|||
42056559|NCT00751348|75865261|FG000|Overall Study|Withdrawal by Subject|5|||
42056560|NCT00751348|75865262|FG001|Overall Study|Withdrawal by Subject|2|||
42056561|NCT00751348|75865261|FG000|Overall Study|Migration from study area|1|||
42056562|NCT00751348|75865262|FG001|Overall Study|Migration from study area|0|||
42056563|NCT00751114|75865270|FG000|Overall Study|Adverse Event|2|||
42056564|NCT00751114|75865271|FG001|Overall Study|Adverse Event|4|||
42056565|NCT00751114|75865270|FG000|Overall Study|Protocol Violation|8|||
42056566|NCT00751114|75865271|FG001|Overall Study|Protocol Violation|9|||
42356976|NCT01392183|76202209|FG000|First Drug Administration|Withdrawal by Subject|10|||
42356977|NCT01392183|76202210|FG001|First Drug Administration|Withdrawal by Subject|17|||
42056567|NCT00751114|75865270|FG000|Overall Study|Withdrawal by Subject|9|||
42056568|NCT00751114|75865271|FG001|Overall Study|Withdrawal by Subject|4|||
42056569|NCT00751114|75865270|FG000|Overall Study|Lost to Follow-up|4|||
42056570|NCT00751114|75865271|FG001|Overall Study|Lost to Follow-up|7|||
42056571|NCT00751114|75865270|FG000|Overall Study|Lack of Efficacy|0|||
42056572|NCT00751114|75865271|FG001|Overall Study|Lack of Efficacy|7|||
42056573|NCT00751114|75865270|FG000|Overall Study|Not Treated|13|||
42056574|NCT00751114|75865271|FG001|Overall Study|Not Treated|1|||
42056575|NCT00751114|75865270|FG000|Overall Study|Out of country for 2 months|1|||
42056576|NCT00751114|75865271|FG001|Overall Study|Out of country for 2 months|0|||
42356978|NCT01402947|76202220|FG000|First Intervention|Adverse Event|0|||
42056577|NCT00751114|75865270|FG000|Overall Study|Move to another city|1|||
42056578|NCT00751114|75865271|FG001|Overall Study|Move to another city|0|||
42056579|NCT00960440|75865281|FG000|Overall Study|Death|0|||
42056580|NCT00960440|75865282|FG001|Overall Study|Death|0|||
42056581|NCT00960440|75865283|FG002|Overall Study|Death|0|||
42056582|NCT00960440|75865284|FG003|Overall Study|Death|1|||
42056583|NCT00960440|75865281|FG000|Overall Study|Adverse Event|12|||
42056584|NCT00960440|75865282|FG001|Overall Study|Adverse Event|12|||
42056585|NCT00960440|75865283|FG002|Overall Study|Adverse Event|4|||
42056586|NCT00960440|75865284|FG003|Overall Study|Adverse Event|4|||
42056587|NCT00960440|75865281|FG000|Overall Study|Lack of Efficacy|2|||
42056588|NCT00960440|75865282|FG001|Overall Study|Lack of Efficacy|5|||
42056589|NCT00960440|75865283|FG002|Overall Study|Lack of Efficacy|3|||
42056590|NCT00960440|75865284|FG003|Overall Study|Lack of Efficacy|8|||
42056591|NCT00960440|75865281|FG000|Overall Study|Protocol Violation|2|||
42056592|NCT00960440|75865282|FG001|Overall Study|Protocol Violation|8|||
42056593|NCT00960440|75865283|FG002|Overall Study|Protocol Violation|3|||
42056594|NCT00960440|75865284|FG003|Overall Study|Protocol Violation|4|||
42056595|NCT00960440|75865281|FG000|Overall Study|Withdrawal by Subject|9|||
42056596|NCT00960440|75865282|FG001|Overall Study|Withdrawal by Subject|5|||
42056597|NCT00960440|75865283|FG002|Overall Study|Withdrawal by Subject|2|||
42056598|NCT00960440|75865284|FG003|Overall Study|Withdrawal by Subject|1|||
42056599|NCT00960440|75865281|FG000|Overall Study|Other|1|||
42056600|NCT00960440|75865282|FG001|Overall Study|Other|1|||
42056601|NCT00960440|75865283|FG002|Overall Study|Other|1|||
42056602|NCT00960440|75865284|FG003|Overall Study|Other|0|||
42056603|NCT04909853|75865328|FG000|Part 1|Assigned but not treated|0|||
42056604|NCT04909853|75865329|FG001|Part 1|Assigned but not treated|0|||
42056605|NCT04909853|75865330|FG002|Part 1|Assigned but not treated|1|||
42056606|NCT04909853|75865331|FG003|Part 1|Assigned but not treated|0|||
42056607|NCT04909853|75865328|FG000|Part 2|Adverse Event|0|||
42056608|NCT04909853|75865329|FG001|Part 2|Adverse Event|0|||
42056609|NCT04909853|75865330|FG002|Part 2|Adverse Event|0|||
42056610|NCT04909853|75865331|FG003|Part 2|Adverse Event|1|||
42056611|NCT04811664|75865344|FG000|Overall Study|Lost to Follow-up|78|||
42056612|NCT04811664|75865345|FG001|Overall Study|Lost to Follow-up|125|||
42056613|NCT04811664|75865346|FG002|Overall Study|Lost to Follow-up|46|||
42056614|NCT04811664|75865344|FG000|Overall Study|Withdrawal by Subject|39|||
42056615|NCT04811664|75865345|FG001|Overall Study|Withdrawal by Subject|76|||
42056616|NCT04811664|75865346|FG002|Overall Study|Withdrawal by Subject|12|||
42056617|NCT04811664|75865344|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
42056618|NCT04811664|75865345|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
42056619|NCT04811664|75865346|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
42056620|NCT04811664|75865344|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
42056621|NCT04811664|75865345|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
42056622|NCT04811664|75865346|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
42056623|NCT04811664|75865344|FG000|Overall Study|Protocol Violation|0|||
42056624|NCT04811664|75865345|FG001|Overall Study|Protocol Violation|5|||
42056625|NCT04811664|75865346|FG002|Overall Study|Protocol Violation|11|||
42056626|NCT04811664|75865344|FG000|Overall Study|Study Terminated by Sponsor|4|||
42056627|NCT04811664|75865345|FG001|Overall Study|Study Terminated by Sponsor|3|||
42056628|NCT04811664|75865346|FG002|Overall Study|Study Terminated by Sponsor|34|||
42056629|NCT04811664|75865344|FG000|Overall Study|Early Study Closure|3|||
42056630|NCT04811664|75865345|FG001|Overall Study|Early Study Closure|7|||
42056631|NCT04811664|75865346|FG002|Overall Study|Early Study Closure|79|||
42056632|NCT04811664|75865344|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
42056633|NCT04811664|75865345|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
42056634|NCT04811664|75865346|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
42056635|NCT04119414|75865363|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
42056636|NCT03762265|75865392|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
42056637|NCT03762265|75865393|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
42056638|NCT03762265|75865392|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
42056639|NCT03762265|75865393|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
42056640|NCT03762265|75865392|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
42056641|NCT03762265|75865393|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
42056642|NCT03762265|75865392|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
42056643|NCT03762265|75865393|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
42056644|NCT03762265|75865392|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
42056645|NCT03762265|75865393|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
42291736|NCT01944046|76125217|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
42056646|NCT03762265|75865392|FG000|BT Period: Weeks 1 to 37|Other|0|||
42056647|NCT03762265|75865393|FG001|BT Period: Weeks 1 to 37|Other|1|||
42056648|NCT03762265|75865392|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
42056649|NCT03762265|75865393|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
42056650|NCT03762265|75865392|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
42056651|NCT03762265|75865393|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
42056652|NCT03762265|75865392|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
42056653|NCT03762265|75865393|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
42056654|NCT03762265|75865392|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
42056655|NCT03762265|75865393|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
42056656|NCT03762265|75865392|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
42056657|NCT03762265|75865393|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
42056658|NCT03762265|75865392|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
42056659|NCT03762265|75865393|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
42056660|NCT03762265|75865392|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
42056661|NCT03762265|75865393|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
42056662|NCT03762265|75865392|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
42056663|NCT03762265|75865393|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
42056664|NCT03762265|75865392|FG000|LTE Period: Weeks 61 to 109|Other|1|||
42056665|NCT03762265|75865393|FG001|LTE Period: Weeks 61 to 109|Other|0|||
42056666|NCT03704051|75865426|FG000|Overall Study|Withdrawal by Subject|4|||
42056667|NCT03704051|75865427|FG001|Overall Study|Withdrawal by Subject|0|||
42056668|NCT03642938|75865443|FG000|Overall Study|Withdrawal by Subject|0|||
42056669|NCT03642938|75865444|FG001|Overall Study|Withdrawal by Subject|0|||
42056670|NCT03642938|75865445|FG002|Overall Study|Withdrawal by Subject|0|||
42056671|NCT03642938|75865446|FG003|Overall Study|Withdrawal by Subject|1|||
42056672|NCT03562767|75865459|FG000|Overall Study|Physician Decision|2|||
42056673|NCT03562767|75865460|FG001|Overall Study|Physician Decision|0|||
42056674|NCT03562767|75865461|FG002|Overall Study|Physician Decision|0|||
42056675|NCT03562767|75865459|FG000|Overall Study|Logistic Reason|1|||
42056676|NCT03562767|75865460|FG001|Overall Study|Logistic Reason|3|||
42056677|NCT03562767|75865461|FG002|Overall Study|Logistic Reason|0|||
42356979|NCT01402947|76202221|FG001|First Intervention|Adverse Event|1|||
42356980|NCT01402869|76202230|FG000|Overall Study|Required Tooth Extraction|0|||
42356981|NCT01402869|76202231|FG001|Overall Study|Required Tooth Extraction|0|||
42356982|NCT01402869|76202232|FG002|Overall Study|Required Tooth Extraction|1|||
42356983|NCT01391793|76202242|FG000|Overall Study|Ineligible|3|||
42356984|NCT01391793|76202243|FG001|Overall Study|Ineligible|0|||
42356985|NCT01391793|76202242|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
42356986|NCT01391793|76202243|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
42356987|NCT01391793|76202242|FG000|Overall Study|No DMSA|73|||
42356988|NCT01391793|76202243|FG001|Overall Study|No DMSA|57|||
42056688|NCT03333941|75865484|FG000|Overall Study|Lost to Follow-up|10|||
42056689|NCT03333941|75865484|FG000|Overall Study|Death|2|||
42056690|NCT03333941|75865484|FG000|Overall Study|Adverse Event|1|||
42056691|NCT03315754|75865488|FG000|Overall Study|COVID-19 complications leading to death|1|||
42056692|NCT03315754|75865488|FG000|Overall Study|insurance coverage issue|1|||
42056693|NCT02440711|75865507|FG000|Second Intervention|Lost to Follow-up|1|||
42056694|NCT02440711|75865508|FG001|Second Intervention|Lost to Follow-up|0|||
42056695|NCT02358031|75865519|FG000|Overall Study|Death|226|||
42056696|NCT02358031|75865520|FG001|Overall Study|Death|204|||
42056697|NCT02358031|75865521|FG002|Overall Study|Death|249|||
42056698|NCT02358031|75865519|FG000|Overall Study|Lost to Follow-up|0|||
42056699|NCT02358031|75865520|FG001|Overall Study|Lost to Follow-up|1|||
42056700|NCT02358031|75865521|FG002|Overall Study|Lost to Follow-up|1|||
42056701|NCT02358031|75865519|FG000|Overall Study|Withdrawal by Subject|14|||
42056702|NCT02358031|75865520|FG001|Overall Study|Withdrawal by Subject|12|||
42056703|NCT02358031|75865521|FG002|Overall Study|Withdrawal by Subject|17|||
42056704|NCT02358031|75865519|FG000|Overall Study|Ongoing in Study|61|||
42056705|NCT02358031|75865520|FG001|Overall Study|Ongoing in Study|64|||
42056706|NCT02358031|75865521|FG002|Overall Study|Ongoing in Study|33|||
42056707|NCT02223767|75865531|FG000|Overall Study|Withdrawal by Subject|4|||
42056708|NCT02223767|75865532|FG001|Overall Study|Withdrawal by Subject|4|||
42056709|NCT01956773|75865551|FG000|Overall Study|Lost to Follow-up|628|||
42056710|NCT01956773|75865552|FG001|Overall Study|Lost to Follow-up|1|||
42056711|NCT01946529|75865561|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
42056712|NCT01946529|75865562|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
42056713|NCT01946529|75865563|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
42356989|NCT01422915|76202249|FG000|Overall Study|Adverse Event|1|||
42356990|NCT01727024|76202254|FG000|Period 1|Lost to Follow-up|1|||
42356991|NCT01727024|76202255|FG001|Period 1|Lost to Follow-up|1|||
42356992|NCT01727024|76202254|FG000|Period 1|Withdrawal by Subject|2|||
42356993|NCT01727024|76202255|FG001|Period 1|Withdrawal by Subject|3|||
42056714|NCT01946529|75865561|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
42056715|NCT01946529|75865562|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
42056716|NCT01946529|75865563|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
42056717|NCT01666808|75865585|FG000|Overall Study|Lost to Follow-up|9|||
42056718|NCT01666808|75865586|FG001|Overall Study|Lost to Follow-up|15|||
42056719|NCT01666808|75865585|FG000|Overall Study|Withdrawal by Subject|3|||
42056720|NCT01666808|75865586|FG001|Overall Study|Withdrawal by Subject|1|||
42056721|NCT01666808|75865585|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
42056722|NCT01666808|75865586|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
42056723|NCT00964028|75865603|FG000|Overall Study|Withdrawal by Subject|0|||
42056724|NCT00964028|75865604|FG001|Overall Study|Withdrawal by Subject|1|||
42056725|NCT00960206|75865613|FG000|Overall Study|Death|7|||
42056726|NCT00960206|75865614|FG001|Overall Study|Death|4|||
42056727|NCT00960206|75865615|FG002|Overall Study|Death|1|||
42056728|NCT00960206|75865613|FG000|Overall Study|Unwilling/Unable to return|1|||
42056729|NCT00960206|75865614|FG001|Overall Study|Unwilling/Unable to return|2|||
42056730|NCT00960206|75865615|FG002|Overall Study|Unwilling/Unable to return|0|||
42056731|NCT00960206|75865613|FG000|Overall Study|Lost to Follow-up|8|||
42056732|NCT00960206|75865614|FG001|Overall Study|Lost to Follow-up|14|||
42056733|NCT00960206|75865615|FG002|Overall Study|Lost to Follow-up|8|||
42056734|NCT00960206|75865613|FG000|Overall Study|Withdrawal by Subject|2|||
42056735|NCT00960206|75865614|FG001|Overall Study|Withdrawal by Subject|4|||
42056736|NCT00960206|75865615|FG002|Overall Study|Withdrawal by Subject|0|||
42056737|NCT00960206|75865613|FG000|Overall Study|Revision of study component|2|||
42056738|NCT00960206|75865614|FG001|Overall Study|Revision of study component|2|||
42056739|NCT00960206|75865615|FG002|Overall Study|Revision of study component|2|||
42056740|NCT00960206|75865613|FG000|Overall Study|Missing 10 year data|20|||
42056741|NCT00960206|75865614|FG001|Overall Study|Missing 10 year data|1|||
42056742|NCT00960206|75865615|FG002|Overall Study|Missing 10 year data|1|||
42056743|NCT00751036|75865626|FG000|Overall Study|Disease Progression|28|||
42056744|NCT00751036|75865627|FG001|Overall Study|Disease Progression|29|||
42056745|NCT00751036|75865626|FG000|Overall Study|Adverse Event|6|||
42056746|NCT00751036|75865627|FG001|Overall Study|Adverse Event|4|||
42056747|NCT00751036|75865626|FG000|Overall Study|Administrative Problems|3|||
42056748|NCT00751036|75865627|FG001|Overall Study|Administrative Problems|4|||
42056749|NCT00751036|75865626|FG000|Overall Study|Withdrawal by Subject|5|||
42056750|NCT00751036|75865627|FG001|Overall Study|Withdrawal by Subject|2|||
42056751|NCT00751036|75865626|FG000|Overall Study|Death|3|||
42056752|NCT00751036|75865627|FG001|Overall Study|Death|3|||
42056753|NCT00751036|75865626|FG000|Overall Study|Lost to Follow-up|0|||
42056754|NCT00751036|75865627|FG001|Overall Study|Lost to Follow-up|1|||
42056755|NCT00751036|75865626|FG000|Overall Study|Protocol Violation|1|||
42056756|NCT00751036|75865627|FG001|Overall Study|Protocol Violation|0|||
42056757|NCT00751036|75865626|FG000|Overall Study|Missing end of Treatment Page|2|||
42056758|NCT00751036|75865627|FG001|Overall Study|Missing end of Treatment Page|3|||
42056759|NCT00961298|75865633|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
42056760|NCT00961298|75865633|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
42056761|NCT00961298|75865633|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
42056762|NCT00744328|75865640|FG000|Overall Study|Lost to Follow-up|2|||
42056763|NCT00744328|75865641|FG001|Overall Study|Lost to Follow-up|5|||
42056764|NCT00744328|75865642|FG002|Overall Study|Lost to Follow-up|3|||
42056765|NCT00744328|75865640|FG000|Overall Study|Withdrawal by Subject|5|||
42056766|NCT00744328|75865641|FG001|Overall Study|Withdrawal by Subject|3|||
42056767|NCT00744328|75865642|FG002|Overall Study|Withdrawal by Subject|4|||
42056768|NCT00744328|75865640|FG000|Overall Study|Found ineligible after randomization|0|||
42056769|NCT00744328|75865641|FG001|Overall Study|Found ineligible after randomization|0|||
42056770|NCT00744328|75865642|FG002|Overall Study|Found ineligible after randomization|1|||
42056771|NCT03245840|75865652|FG000|Overall Study|Adverse Event|6|||
42056772|NCT03245840|75865653|FG001|Overall Study|Adverse Event|0|||
42056773|NCT03245840|75865652|FG000|Overall Study|Death|2|||
42056774|NCT03245840|75865653|FG001|Overall Study|Death|0|||
42056775|NCT03245840|75865652|FG000|Overall Study|Withdrawal by Subject|31|||
42056776|NCT03245840|75865653|FG001|Overall Study|Withdrawal by Subject|1|||
42056777|NCT03245840|75865652|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
42056778|NCT03245840|75865653|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
42056779|NCT03245840|75865652|FG000|Overall Study|Physician Decision|4|||
42056780|NCT03245840|75865653|FG001|Overall Study|Physician Decision|1|||
42056781|NCT03245840|75865652|FG000|Overall Study|Study Terminated by Sponsor|56|||
42056782|NCT03245840|75865653|FG001|Overall Study|Study Terminated by Sponsor|6|||
42056783|NCT03245840|75865652|FG000|Overall Study|Site Terminated by Sponsor|4|||
42056784|NCT03245840|75865653|FG001|Overall Study|Site Terminated by Sponsor|0|||
42056785|NCT03245840|75865652|FG000|Overall Study|Lost to Follow-up|12|||
42056786|NCT03245840|75865653|FG001|Overall Study|Lost to Follow-up|2|||
42056787|NCT03245840|75865652|FG000|Overall Study|Pregnancy|2|||
42056788|NCT03245840|75865653|FG001|Overall Study|Pregnancy|0|||
42056789|NCT03245840|75865652|FG000|Overall Study|Non-Compliance with Study Drug|2|||
42056790|NCT03245840|75865653|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42056791|NCT03245840|75865652|FG000|Overall Study|Not treated|1|||
42056792|NCT03245840|75865653|FG001|Overall Study|Not treated|1|||
42056793|NCT00959894|75865659|FG000|Overall Study|Lost to Follow-up|10|||
42056794|NCT00959894|75865659|FG000|Overall Study|Adverse Event|3|||
42056795|NCT00959894|75865659|FG000|Overall Study|Withdrawal by Subject|1|||
42056796|NCT00959894|75865659|FG000|Overall Study|Need for contraindicated medication|1|||
42056797|NCT00959894|75865659|FG000|Overall Study|Subject moved out of town|1|||
42056798|NCT00750880|75865664|FG000|Overall Study|Adverse Event|76|||
42056799|NCT00750880|75865664|FG000|Overall Study|Death|4|||
42056800|NCT00750880|75865664|FG000|Overall Study|Lack of Efficacy|46|||
42056801|NCT00750880|75865664|FG000|Overall Study|Lost to Follow-up|10|||
42056802|NCT00750880|75865664|FG000|Overall Study|Protocol Violation|15|||
42056803|NCT00750880|75865664|FG000|Overall Study|Withdrawal by Subject|33|||
42056804|NCT00750880|75865664|FG000|Overall Study|Physician Decision|20|||
42056805|NCT00750880|75865664|FG000|Overall Study|Administrative|11|||
42056806|NCT00746590|75865669|FG000|Overall Study|Death|1|||
42056807|NCT01032629|75865676|FG000|Overall Study|Closed Site|21|||
42056808|NCT01032629|75865677|FG001|Overall Study|Closed Site|18|||
42056809|NCT01032629|75865678|FG002|Overall Study|Closed Site|16|||
42056810|NCT01032629|75865676|FG000|Overall Study|Withdrawal by Subject|50|||
42056811|NCT01032629|75865677|FG001|Overall Study|Withdrawal by Subject|36|||
42056812|NCT01032629|75865678|FG002|Overall Study|Withdrawal by Subject|35|||
42056813|NCT01032629|75865676|FG000|Overall Study|Lost to Follow-up|74|||
42056814|NCT01032629|75865677|FG001|Overall Study|Lost to Follow-up|47|||
42056815|NCT01032629|75865678|FG002|Overall Study|Lost to Follow-up|37|||
42056816|NCT00749944|75865689|FG000|Overall Study|Lost to Follow-up|2|||
42056817|NCT00749944|75865690|FG001|Overall Study|Lost to Follow-up|1|||
42056818|NCT00749944|75865689|FG000|Overall Study|Other|1|||
42056819|NCT00749944|75865690|FG001|Overall Study|Other|0|||
42056820|NCT00749944|75865689|FG000|Overall Study|Withdrawal by Subject|2|||
42056821|NCT00749944|75865690|FG001|Overall Study|Withdrawal by Subject|0|||
42056822|NCT00749398|75865696|FG000|Overall Study|Lack of Efficacy|7|||
42056823|NCT00749398|75865696|FG000|Overall Study|Adverse Event|4|||
42056824|NCT00749398|75865696|FG000|Overall Study|Serious adverse event|11|||
42056825|NCT00749398|75865696|FG000|Overall Study|Withdrawal by Subject|17|||
42056826|NCT00749398|75865696|FG000|Overall Study|Lost to Follow-up|11|||
42056827|NCT00749398|75865696|FG000|Overall Study|Reason not specified|2|||
42056828|NCT00749398|75865696|FG000|Overall Study|Unknown reason|1|||
42056829|NCT00746356|75865700|FG000|Overall Study|Withdrawal by Subject|2|||
42056830|NCT00746356|75865701|FG001|Overall Study|Withdrawal by Subject|3|||
42056831|NCT00746356|75865700|FG000|Overall Study|Death|7|||
42056832|NCT00746356|75865701|FG001|Overall Study|Death|3|||
42056833|NCT00746356|75865700|FG000|Overall Study|Lost to Follow-up|1|||
42056834|NCT00746356|75865701|FG001|Overall Study|Lost to Follow-up|0|||
42056835|NCT00746356|75865700|FG000|Overall Study|Removal of Device|0|||
42056836|NCT00746356|75865701|FG001|Overall Study|Removal of Device|1|||
42056837|NCT00746356|75865700|FG000|Overall Study|Patient relocated|1|||
42056838|NCT00746356|75865701|FG001|Overall Study|Patient relocated|0|||
42056839|NCT01012973|75865711|FG000|Overall Study|Adverse Event|5|||
42056840|NCT01012973|75865712|FG001|Overall Study|Adverse Event|5|||
42056841|NCT01012973|75865711|FG000|Overall Study|Lack of Efficacy|0|||
42056842|NCT01012973|75865712|FG001|Overall Study|Lack of Efficacy|5|||
42056843|NCT01012973|75865711|FG000|Overall Study|Lost to Follow-up|1|||
42056844|NCT01012973|75865712|FG001|Overall Study|Lost to Follow-up|0|||
42056845|NCT01012973|75865711|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
42056846|NCT01012973|75865712|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
42056847|NCT01012973|75865711|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
42056848|NCT01012973|75865712|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
42056849|NCT01012973|75865711|FG000|Overall Study|Protocol Violation|5|||
42056850|NCT01012973|75865712|FG001|Overall Study|Protocol Violation|2|||
42056851|NCT01012973|75865711|FG000|Overall Study|Withdrawal by Subject|4|||
42056852|NCT01012973|75865712|FG001|Overall Study|Withdrawal by Subject|6|||
42056853|NCT00748540|75865722|FG000|Overall Study|Physician Decision|1|||
42056854|NCT01012739|75865726|FG000|Treatment Period 1|Adverse Event|0|||
42056855|NCT01012739|75865727|FG001|Treatment Period 1|Adverse Event|0|||
42056856|NCT01012739|75865728|FG002|Treatment Period 1|Adverse Event|0|||
42056857|NCT01012739|75865729|FG003|Treatment Period 1|Adverse Event|1|||
42056858|NCT01012739|75865726|FG000|Treatment Period 2|Abnormal test procedure results|0|||
42056859|NCT01012739|75865727|FG001|Treatment Period 2|Abnormal test procedure results|0|||
42056860|NCT01012739|75865728|FG002|Treatment Period 2|Abnormal test procedure results|0|||
42056861|NCT01012739|75865729|FG003|Treatment Period 2|Abnormal test procedure results|1|||
42056862|NCT00742924|75865744|FG000|Overall Study|Adverse Event|0|||
42056863|NCT00742924|75865745|FG001|Overall Study|Adverse Event|0|||
42291737|NCT01944046|76125216|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
42291738|NCT01944046|76125217|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
42056864|NCT00742924|75865746|FG002|Overall Study|Adverse Event|1|||
42056865|NCT00742924|75865747|FG003|Overall Study|Adverse Event|1|||
42056866|NCT00742924|75865744|FG000|Overall Study|Lack of Efficacy|5|||
42056867|NCT00742924|75865745|FG001|Overall Study|Lack of Efficacy|1|||
42056868|NCT00742924|75865746|FG002|Overall Study|Lack of Efficacy|2|||
42056869|NCT00742924|75865747|FG003|Overall Study|Lack of Efficacy|4|||
42056870|NCT00742924|75865744|FG000|Overall Study|Physician Decision|0|||
42056871|NCT00742924|75865745|FG001|Overall Study|Physician Decision|0|||
42056872|NCT00742924|75865746|FG002|Overall Study|Physician Decision|0|||
42056873|NCT00742924|75865747|FG003|Overall Study|Physician Decision|1|||
42056874|NCT00742924|75865744|FG000|Overall Study|Withdrawal by Subject|0|||
42056875|NCT00742924|75865745|FG001|Overall Study|Withdrawal by Subject|1|||
42056876|NCT00742924|75865746|FG002|Overall Study|Withdrawal by Subject|1|||
42056877|NCT00742924|75865747|FG003|Overall Study|Withdrawal by Subject|0|||
42056878|NCT00698815|75865760|FG000|Overall Study|Death|1|||
42056879|NCT00698815|75865761|FG001|Overall Study|Death|2|||
42056880|NCT00698815|75865762|FG002|Overall Study|Death|4|||
42056881|NCT00698815|75865760|FG000|Overall Study|Withdrawal by Subject|6|||
42056882|NCT00698815|75865761|FG001|Overall Study|Withdrawal by Subject|3|||
42056883|NCT00698815|75865762|FG002|Overall Study|Withdrawal by Subject|2|||
42056884|NCT00698815|75865760|FG000|Overall Study|MD discretion|2|||
42056885|NCT00698815|75865761|FG001|Overall Study|MD discretion|7|||
42056886|NCT00698815|75865762|FG002|Overall Study|MD discretion|2|||
42056887|NCT00698815|75865760|FG000|Overall Study|Did not receive protocol treatment|1|||
42056888|NCT00698815|75865761|FG001|Overall Study|Did not receive protocol treatment|2|||
42056889|NCT00698815|75865762|FG002|Overall Study|Did not receive protocol treatment|2|||
42056890|NCT00745498|75865773|FG000|Overall Study|Lost to Follow-up|1|||
42056891|NCT00745498|75865774|FG001|Overall Study|Lost to Follow-up|1|||
42056892|NCT00745498|75865775|FG002|Overall Study|Lost to Follow-up|3|||
42056893|NCT00745498|75865773|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
42056894|NCT00745498|75865774|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
42056895|NCT00745498|75865775|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
42056896|NCT00745498|75865773|FG000|Overall Study|Non-PDR related VH|0|||
42056897|NCT00745498|75865774|FG001|Overall Study|Non-PDR related VH|1|||
42056898|NCT00745498|75865775|FG002|Overall Study|Non-PDR related VH|1|||
42056899|NCT00745498|75865773|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
42056900|NCT00745498|75865774|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
42056901|NCT00745498|75865775|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
42056902|NCT00744874|75865783|FG000|Overall Study|Lost to Follow-up|1|||
42056903|NCT00744874|75865783|FG000|Overall Study|Withdrawal by Subject|1|||
42056904|NCT00744874|75865783|FG000|Overall Study|Study Device not available at procedure|1|||
42056905|NCT00744874|75865783|FG000|Overall Study|Unable to accomodate schedule|1|||
42056906|NCT00576901|75865794|FG000|Overall Study|Withdrawal by Subject|1|||
42056907|NCT00576901|75865794|FG000|Overall Study|Disease course|1|||
42056908|NCT00576901|75865794|FG000|Overall Study|Protocol Violation|1|||
42056909|NCT00699283|75865800|FG000|Overall Study|Lack of Efficacy|15|||
42056910|NCT00699283|75865801|FG001|Overall Study|Lack of Efficacy|5|||
42056911|NCT00699283|75865800|FG000|Overall Study|Lost to Follow-up|2|||
42056912|NCT00699283|75865801|FG001|Overall Study|Lost to Follow-up|0|||
42056913|NCT00699283|75865800|FG000|Overall Study|Withdrawal by Subject|1|||
42056914|NCT00699283|75865801|FG001|Overall Study|Withdrawal by Subject|0|||
42056915|NCT00699283|75865800|FG000|Overall Study|Other Reason|5|||
42056916|NCT00699283|75865801|FG001|Overall Study|Other Reason|1|||
42056917|NCT00699283|75865800|FG000|Overall Study|SAE, non-fatal|1|||
42056918|NCT00699283|75865801|FG001|Overall Study|SAE, non-fatal|1|||
42056919|NCT00699283|75865800|FG000|Overall Study|AE, non-serious non-fatal|8|||
42056920|NCT00699283|75865801|FG001|Overall Study|AE, non-serious non-fatal|1|||
42056921|NCT00699283|75865800|FG000|Overall Study|AE of unknown type|1|||
42056922|NCT00699283|75865801|FG001|Overall Study|AE of unknown type|0|||
42056923|NCT00740584|75865806|FG000|Overall Study|Withdrawal by Subject|1|||
42056924|NCT01023815|75865815|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
42056925|NCT01023815|75865816|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
42056926|NCT01023815|75865817|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
42056927|NCT01023815|75865818|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
42056928|NCT01023815|75865815|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
42056929|NCT01023815|75865816|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
42056930|NCT01023815|75865817|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
42056931|NCT01023815|75865818|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
42056932|NCT01023815|75865815|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
42056933|NCT01023815|75865816|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
42056934|NCT01023815|75865817|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
42056935|NCT01023815|75865818|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
42056936|NCT01023815|75865815|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
42056937|NCT01023815|75865816|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
42056938|NCT01023815|75865817|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
42056939|NCT01023815|75865818|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
42056940|NCT01023815|75865815|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
42056941|NCT01023815|75865816|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
42056942|NCT01023815|75865817|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
42174059|NCT00336479|75980822|FG003|Overall Study|Lost to Follow-up|0|||
42056943|NCT01023815|75865818|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
42056944|NCT01023659|75865832|FG000|Overall Study|Lost to Follow-up|73|||
42056945|NCT01023659|75865833|FG001|Overall Study|Lost to Follow-up|228|||
42056946|NCT01023659|75865834|FG002|Overall Study|Lost to Follow-up|99|||
42056947|NCT00740116|75865845|FG000|Overall Study|Withdrawal by Subject|1|||
42056948|NCT00740116|75865846|FG001|Overall Study|Withdrawal by Subject|1|||
42056949|NCT00740116|75865845|FG000|Overall Study|Protocol Violation|1|||
42356994|NCT01422213|76202264|FG000|Overall Study|Adverse Event|8|||
42356995|NCT01422213|76202265|FG001|Overall Study|Adverse Event|7|||
42056950|NCT00740116|75865846|FG001|Overall Study|Protocol Violation|4|||
42056951|NCT00698581|75865856|FG000|Overall Study|Lack of Efficacy|23|||
42056952|NCT00698581|75865857|FG001|Overall Study|Lack of Efficacy|11|||
42056953|NCT00698581|75865856|FG000|Overall Study|Withdrawal by Subject|6|||
42056954|NCT00698581|75865857|FG001|Overall Study|Withdrawal by Subject|0|||
42056955|NCT00698581|75865856|FG000|Overall Study|Other reason|9|||
42056956|NCT00698581|75865857|FG001|Overall Study|Other reason|1|||
42056957|NCT00698581|75865856|FG000|Overall Study|SAE, non-fatal|1|||
42056958|NCT00698581|75865857|FG001|Overall Study|SAE, non-fatal|0|||
42056959|NCT00698581|75865856|FG000|Overall Study|AE, non-serious non-fatal|4|||
42056960|NCT00698581|75865857|FG001|Overall Study|AE, non-serious non-fatal|0|||
42056961|NCT00698581|75865856|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
42056962|NCT00698581|75865857|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
42056963|NCT00698581|75865856|FG000|Overall Study|AE of unknown type|1|||
42056964|NCT00698581|75865857|FG001|Overall Study|AE of unknown type|0|||
42056965|NCT01023581|75865871|FG000|Overall Study|Adverse Event|4|||
42056966|NCT01023581|75865872|FG001|Overall Study|Adverse Event|4|||
42056967|NCT01023581|75865873|FG002|Overall Study|Adverse Event|7|||
42056968|NCT01023581|75865874|FG003|Overall Study|Adverse Event|3|||
42056969|NCT01023581|75865875|FG004|Overall Study|Adverse Event|2|||
42056970|NCT01023581|75865876|FG005|Overall Study|Adverse Event|5|||
42056971|NCT01023581|75865877|FG006|Overall Study|Adverse Event|11|||
42056972|NCT01023581|75865871|FG000|Overall Study|Major protocol deviation|2|||
42056973|NCT01023581|75865872|FG001|Overall Study|Major protocol deviation|0|||
42056974|NCT01023581|75865873|FG002|Overall Study|Major protocol deviation|3|||
42056975|NCT01023581|75865874|FG003|Overall Study|Major protocol deviation|0|||
42056976|NCT01023581|75865875|FG004|Overall Study|Major protocol deviation|0|||
42056977|NCT01023581|75865876|FG005|Overall Study|Major protocol deviation|0|||
42056978|NCT01023581|75865877|FG006|Overall Study|Major protocol deviation|0|||
42056979|NCT01023581|75865871|FG000|Overall Study|Lost to Follow-up|4|||
42056980|NCT01023581|75865872|FG001|Overall Study|Lost to Follow-up|8|||
42056981|NCT01023581|75865873|FG002|Overall Study|Lost to Follow-up|7|||
42056982|NCT01023581|75865874|FG003|Overall Study|Lost to Follow-up|2|||
42056983|NCT01023581|75865875|FG004|Overall Study|Lost to Follow-up|5|||
42056984|NCT01023581|75865876|FG005|Overall Study|Lost to Follow-up|2|||
42056985|NCT01023581|75865877|FG006|Overall Study|Lost to Follow-up|2|||
42056986|NCT01023581|75865871|FG000|Overall Study|Withdrawal by Subject|13|||
42056987|NCT01023581|75865872|FG001|Overall Study|Withdrawal by Subject|8|||
42056988|NCT01023581|75865873|FG002|Overall Study|Withdrawal by Subject|16|||
42056989|NCT01023581|75865874|FG003|Overall Study|Withdrawal by Subject|10|||
42056990|NCT01023581|75865875|FG004|Overall Study|Withdrawal by Subject|6|||
42056991|NCT01023581|75865876|FG005|Overall Study|Withdrawal by Subject|8|||
42056992|NCT01023581|75865877|FG006|Overall Study|Withdrawal by Subject|5|||
42056993|NCT01023581|75865871|FG000|Overall Study|Pregnancy|0|||
42056994|NCT01023581|75865872|FG001|Overall Study|Pregnancy|0|||
42056995|NCT01023581|75865873|FG002|Overall Study|Pregnancy|0|||
42056996|NCT01023581|75865874|FG003|Overall Study|Pregnancy|2|||
42056997|NCT01023581|75865875|FG004|Overall Study|Pregnancy|0|||
42291739|NCT01944046|76125216|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
42291740|NCT01944046|76125217|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
42291741|NCT01944046|76125216|FG000|Open Label Eligible and Consented|Adverse Event|6|||
42291742|NCT01944046|76125217|FG001|Open Label Eligible and Consented|Adverse Event|1|||
42291743|NCT01944046|76125216|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
42291744|NCT01944046|76125217|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
42291745|NCT01944046|76125216|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
42291746|NCT01944046|76125217|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
42291747|NCT01969084|76125229|FG000|Overall Study|Adverse Event|0|||
42291748|NCT01969084|76125230|FG001|Overall Study|Adverse Event|1|||
42291749|NCT01942486|76125240|FG000|Overall Study|Lost to Follow-up|27|||
42056998|NCT01023581|75865876|FG005|Overall Study|Pregnancy|1|||
42056999|NCT01023581|75865877|FG006|Overall Study|Pregnancy|0|||
42057000|NCT01023581|75865871|FG000|Overall Study|Lack of Efficacy|9|||
42057001|NCT01023581|75865872|FG001|Overall Study|Lack of Efficacy|3|||
42057002|NCT01023581|75865873|FG002|Overall Study|Lack of Efficacy|6|||
42057003|NCT01023581|75865874|FG003|Overall Study|Lack of Efficacy|2|||
42291750|NCT01941940|76125244|FG000|Overall Study|Adverse Event|11|||
42356996|NCT01422213|76202266|FG002|Overall Study|Adverse Event|11|||
42057004|NCT01023581|75865875|FG004|Overall Study|Lack of Efficacy|1|||
42057005|NCT01023581|75865876|FG005|Overall Study|Lack of Efficacy|2|||
42057006|NCT01023581|75865877|FG006|Overall Study|Lack of Efficacy|1|||
42057007|NCT01023581|75865871|FG000|Overall Study|Physician Decision|2|||
42057008|NCT01023581|75865872|FG001|Overall Study|Physician Decision|0|||
42057009|NCT01023581|75865873|FG002|Overall Study|Physician Decision|2|||
42057010|NCT01023581|75865874|FG003|Overall Study|Physician Decision|1|||
42057011|NCT01023581|75865875|FG004|Overall Study|Physician Decision|1|||
42057012|NCT01023581|75865876|FG005|Overall Study|Physician Decision|1|||
42057013|NCT01023581|75865877|FG006|Overall Study|Physician Decision|1|||
42057014|NCT01023581|75865871|FG000|Overall Study|Other|1|||
42057015|NCT01023581|75865872|FG001|Overall Study|Other|0|||
42057016|NCT01023581|75865873|FG002|Overall Study|Other|1|||
42057017|NCT01023581|75865874|FG003|Overall Study|Other|0|||
42057018|NCT01023581|75865875|FG004|Overall Study|Other|1|||
42057019|NCT01023581|75865876|FG005|Overall Study|Other|0|||
42057020|NCT01023581|75865877|FG006|Overall Study|Other|0|||
42057021|NCT00962780|75865895|FG000|Overall Study|Death|0|||
42057022|NCT00962780|75865896|FG001|Overall Study|Death|1|||
42057023|NCT00962780|75865895|FG000|Overall Study|Protocol Violation|9|||
42057024|NCT00962780|75865896|FG001|Overall Study|Protocol Violation|4|||
42057025|NCT00962780|75865895|FG000|Overall Study|Withdrawal by Subject|1|||
42057026|NCT00962780|75865896|FG001|Overall Study|Withdrawal by Subject|8|||
42057027|NCT00962780|75865895|FG000|Overall Study|Other|0|||
42057028|NCT00962780|75865896|FG001|Overall Study|Other|1|||
42057029|NCT00739882|75865910|FG000|Double-blind Period|Adverse Event|1|||
42057030|NCT00739882|75865911|FG001|Double-blind Period|Adverse Event|2|||
42057031|NCT00739882|75865910|FG000|Double-blind Period|Protocol Violation|1|||
42057032|NCT00739882|75865911|FG001|Double-blind Period|Protocol Violation|0|||
42057033|NCT00739882|75865910|FG000|Double-blind Period|Lack of Efficacy|1|||
42057034|NCT00739882|75865911|FG001|Double-blind Period|Lack of Efficacy|1|||
42057035|NCT00739882|75865910|FG000|Double-blind Period|Other|16|||
42057036|NCT00739882|75865911|FG001|Double-blind Period|Other|8|||
42057037|NCT00739882|75865910|FG000|Open-label Period|Adverse Event|1|||
42057038|NCT00739882|75865911|FG001|Open-label Period|Adverse Event|0|||
42057039|NCT00739882|75865910|FG000|Open-label Period|Other|9|||
42057040|NCT00739882|75865911|FG001|Open-label Period|Other|5|||
42057041|NCT00961220|75865919|FG000|Overall Study|Adverse Event|3|||
42057042|NCT00961220|75865919|FG000|Overall Study|Lack of Efficacy|1|||
42057043|NCT00961220|75865919|FG000|Overall Study|No IV access for O6BG|1|||
42057044|NCT00961220|75865919|FG000|Overall Study|O6BG no longer supplied|1|||
42057045|NCT00961220|75865919|FG000|Overall Study|Complete Response prior to 12 courses|1|||
42057046|NCT00734656|75865925|FG000|Lab Session 1|Withdrawal by Subject|2|||
42057047|NCT00734656|75865926|FG001|Lab Session 1|Withdrawal by Subject|0|||
42057048|NCT00734656|75865927|FG002|Lab Session 1|Withdrawal by Subject|0|||
42057049|NCT00734656|75865928|FG003|Lab Session 1|Withdrawal by Subject|0|||
42057050|NCT00734656|75865925|FG000|Washout 1|Withdrawal by Subject|1|||
42057051|NCT00734656|75865926|FG001|Washout 1|Withdrawal by Subject|5|||
42057052|NCT00734656|75865927|FG002|Washout 1|Withdrawal by Subject|2|||
42057053|NCT00734656|75865928|FG003|Washout 1|Withdrawal by Subject|3|||
42057054|NCT00734656|75865925|FG000|Lab Session 2|Withdrawal by Subject|1|||
42057055|NCT00734656|75865926|FG001|Lab Session 2|Withdrawal by Subject|0|||
42057056|NCT00734656|75865927|FG002|Lab Session 2|Withdrawal by Subject|0|||
42057057|NCT00734656|75865928|FG003|Lab Session 2|Withdrawal by Subject|1|||
42057058|NCT00734656|75865925|FG000|Washout 2|Withdrawal by Subject|1|||
42057059|NCT00734656|75865926|FG001|Washout 2|Withdrawal by Subject|1|||
42057060|NCT00734656|75865927|FG002|Washout 2|Withdrawal by Subject|1|||
42057061|NCT00734656|75865928|FG003|Washout 2|Withdrawal by Subject|0|||
42057062|NCT00734656|75865925|FG000|Washout 3|Withdrawal by Subject|1|||
42057063|NCT00734656|75865926|FG001|Washout 3|Withdrawal by Subject|0|||
42057064|NCT00734656|75865927|FG002|Washout 3|Withdrawal by Subject|0|||
42057065|NCT00734656|75865928|FG003|Washout 3|Withdrawal by Subject|1|||
42057066|NCT00734656|75865925|FG000|Lab Session 4|Withdrawal by Subject|0|||
42057067|NCT00734656|75865926|FG001|Lab Session 4|Withdrawal by Subject|0|||
42057068|NCT00734656|75865927|FG002|Lab Session 4|Withdrawal by Subject|0|||
42057069|NCT00734656|75865928|FG003|Lab Session 4|Withdrawal by Subject|1|||
42057070|NCT00739648|75865940|FG000|Overall Study|Adverse Event|3|||
42291751|NCT01941940|76125244|FG000|Overall Study|Lost to Follow-up|2|||
42057071|NCT00739648|75865941|FG001|Overall Study|Adverse Event|15|||
42057072|NCT00739648|75865940|FG000|Overall Study|Withdrawal by Subject|13|||
42057073|NCT00739648|75865941|FG001|Overall Study|Withdrawal by Subject|25|||
42057074|NCT00739648|75865940|FG000|Overall Study|Lost to Follow-up|4|||
42057075|NCT00739648|75865941|FG001|Overall Study|Lost to Follow-up|7|||
42057076|NCT00739648|75865940|FG000|Overall Study|Death|2|||
42057077|NCT00739648|75865941|FG001|Overall Study|Death|0|||
42057078|NCT00739648|75865940|FG000|Overall Study|Do not know|4|||
42057079|NCT00739648|75865941|FG001|Overall Study|Do not know|6|||
42057080|NCT01032239|75865953|FG000|Overall Study|Lost to Follow-up|3|||
42057081|NCT01032239|75865954|FG001|Overall Study|Lost to Follow-up|2|||
42291752|NCT01941940|76125244|FG000|Overall Study|Physician Decision|2|||
42291753|NCT01941940|76125244|FG000|Overall Study|Withdrawal by Subject|15|||
42291754|NCT01941940|76125244|FG000|Overall Study|Death|1|||
42291755|NCT01941940|76125244|FG000|Overall Study|Other|1|||
42291756|NCT01941940|76125244|FG000|Overall Study|Other|1|||
42057082|NCT01032239|75865953|FG000|Overall Study|Withdrawal by Subject|2|||
42057083|NCT01032239|75865954|FG001|Overall Study|Withdrawal by Subject|3|||
42057084|NCT01032239|75865953|FG000|Overall Study|Death|1|||
42057085|NCT01032239|75865954|FG001|Overall Study|Death|0|||
42057086|NCT01032239|75865953|FG000|Overall Study|Protocol Violation|1|||
42057087|NCT01032239|75865954|FG001|Overall Study|Protocol Violation|0|||
42057088|NCT00734578|75865963|FG000|Overall Study|Adverse Event|4|||
42057089|NCT00734578|75865964|FG001|Overall Study|Adverse Event|6|||
42057090|NCT00734578|75865965|FG002|Overall Study|Adverse Event|1|||
42057091|NCT00734578|75865963|FG000|Overall Study|Protocol Violation|8|||
42057092|NCT00734578|75865964|FG001|Overall Study|Protocol Violation|6|||
42057093|NCT00734578|75865965|FG002|Overall Study|Protocol Violation|3|||
42057094|NCT00734578|75865963|FG000|Overall Study|Withdrawal by Subject|7|||
42016474|NCT02580058|75823780|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42016475|NCT02580058|75823781|FG002|Overall Study|Non-Compliance With Study Drug|0|||
42057095|NCT00734578|75865964|FG001|Overall Study|Withdrawal by Subject|8|||
42057096|NCT00734578|75865965|FG002|Overall Study|Withdrawal by Subject|11|||
42057097|NCT00734578|75865963|FG000|Overall Study|Lost to Follow-up|9|||
42057098|NCT00734578|75865964|FG001|Overall Study|Lost to Follow-up|3|||
42057099|NCT00734578|75865965|FG002|Overall Study|Lost to Follow-up|5|||
42057100|NCT00734578|75865963|FG000|Overall Study|Lack of Efficacy|3|||
42057101|NCT00734578|75865964|FG001|Overall Study|Lack of Efficacy|2|||
42057102|NCT00734578|75865965|FG002|Overall Study|Lack of Efficacy|5|||
42057103|NCT00734578|75865963|FG000|Overall Study|Randomized in error|1|||
42057104|NCT00734578|75865964|FG001|Overall Study|Randomized in error|0|||
42057105|NCT00734578|75865965|FG002|Overall Study|Randomized in error|0|||
42057106|NCT00734578|75865963|FG000|Overall Study|Exclusion criteria|1|||
42057107|NCT00734578|75865964|FG001|Overall Study|Exclusion criteria|0|||
42057108|NCT00734578|75865965|FG002|Overall Study|Exclusion criteria|0|||
42057109|NCT00739102|75865973|FG000|Overall Study|Death|5|||
42057110|NCT00739102|75865973|FG000|Overall Study|Withdrawal by Subject|10|||
42057111|NCT00959192|75865981|FG000|Overall Study|Adverse Event|1|||
42057112|NCT00959192|75865982|FG001|Overall Study|Adverse Event|1|||
42057113|NCT00959192|75865983|FG002|Overall Study|Adverse Event|1|||
42057114|NCT00959192|75865984|FG003|Overall Study|Adverse Event|0|||
42057115|NCT00959192|75865981|FG000|Overall Study|Investigator Request|1|||
42057116|NCT00959192|75865982|FG001|Overall Study|Investigator Request|0|||
42057117|NCT00959192|75865983|FG002|Overall Study|Investigator Request|0|||
42057118|NCT00959192|75865984|FG003|Overall Study|Investigator Request|0|||
42057119|NCT00959192|75865981|FG000|Overall Study|Caregiver Request|0|||
42291757|NCT01968694|76125250|FG000|Washout (1 Month)|Lost to Follow-up|0|||
42291758|NCT01968694|76125251|FG001|Washout (1 Month)|Lost to Follow-up|1|||
42291759|NCT01968226|76125259|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
42291760|NCT02640053|76125265|FG000|Overall Study|Withdrawal by Subject|2|||
42016476|NCT02539394|75823793|FG000|Overall Study|Protocol Violation|1|||
42016477|NCT02539394|75823794|FG001|Overall Study|Protocol Violation|3|||
42016478|NCT02539394|75823793|FG000|Overall Study|Lost to Follow-up|1|||
42016479|NCT02539394|75823794|FG001|Overall Study|Lost to Follow-up|2|||
42016480|NCT02539394|75823793|FG000|Overall Study|Incomplete dataset|6|||
42016481|NCT02539394|75823794|FG001|Overall Study|Incomplete dataset|6|||
42016482|NCT02412670|75823808|FG000|Overall Study|Adverse Event|4|||
42016483|NCT02412670|75823809|FG001|Overall Study|Adverse Event|1|||
42016484|NCT02412670|75823808|FG000|Overall Study|Physician Decision|1|||
42016485|NCT02412670|75823809|FG001|Overall Study|Physician Decision|0|||
42016486|NCT02412670|75823808|FG000|Overall Study|Withdrawal by Subject|1|||
42016487|NCT02412670|75823809|FG001|Overall Study|Withdrawal by Subject|0|||
42016488|NCT02412670|75823808|FG000|Overall Study|Ineligible|1|||
42016489|NCT02412670|75823809|FG001|Overall Study|Ineligible|0|||
42016490|NCT05111145|75823829|FG000|Overall Study|Commercial drug is available for participant|76|||
42016491|NCT05111145|75823829|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
42016492|NCT04823130|75823848|FG000|Overall Study|Withdrawal by Subject|2|||
42016493|NCT04823130|75823849|FG001|Overall Study|Withdrawal by Subject|3|||
42016494|NCT04823130|75823848|FG000|Overall Study|Failure to meet inclusion criteria|6|||
42016495|NCT04823130|75823849|FG001|Overall Study|Failure to meet inclusion criteria|4|||
42016496|NCT04823130|75823848|FG000|Overall Study|Other-unspecified|1|||
42016497|NCT04823130|75823849|FG001|Overall Study|Other-unspecified|0|||
42016498|NCT04402385|75823908|FG000|Overall Study|Withdrawal by Subject|4|||
42016499|NCT04402385|75823909|FG001|Overall Study|Withdrawal by Subject|4|||
42016500|NCT04402385|75823908|FG000|Overall Study|Lost to Follow-up|1|||
42016501|NCT04402385|75823909|FG001|Overall Study|Lost to Follow-up|1|||
42016502|NCT04402385|75823908|FG000|Overall Study|Physician Decision|0|||
42016503|NCT04402385|75823909|FG001|Overall Study|Physician Decision|1|||
42016504|NCT03785210|75823919|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
42016505|NCT03785210|75823920|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
42016506|NCT03750968|75823928|FG000|Overall Study|Adverse Event|2|||
42057120|NCT00959192|75865982|FG001|Overall Study|Caregiver Request|0|||
42057121|NCT00959192|75865983|FG002|Overall Study|Caregiver Request|2|||
42291761|NCT02640053|76125266|FG001|Overall Study|Withdrawal by Subject|1|||
42057122|NCT00959192|75865984|FG003|Overall Study|Caregiver Request|1|||
42057123|NCT00696787|75865998|FG000|Overall Study|Adverse Event|1|||
42057124|NCT00696787|75865999|FG001|Overall Study|Adverse Event|0|||
42057125|NCT00696787|75866000|FG002|Overall Study|Adverse Event|6|||
42057126|NCT00696787|75865998|FG000|Overall Study|Discontinuation by Sponsor|9|||
42057127|NCT00696787|75865999|FG001|Overall Study|Discontinuation by Sponsor|13|||
42057128|NCT00696787|75866000|FG002|Overall Study|Discontinuation by Sponsor|14|||
42057129|NCT00696787|75865998|FG000|Overall Study|Lack of Efficacy|0|||
42057130|NCT00696787|75865999|FG001|Overall Study|Lack of Efficacy|1|||
42057131|NCT00696787|75866000|FG002|Overall Study|Lack of Efficacy|0|||
42057132|NCT00696787|75865998|FG000|Overall Study|Lost to Follow-up|4|||
42057133|NCT00696787|75865999|FG001|Overall Study|Lost to Follow-up|0|||
42057134|NCT00696787|75866000|FG002|Overall Study|Lost to Follow-up|3|||
42057135|NCT00696787|75865998|FG000|Overall Study|Withdrawal by Subject|0|||
42057136|NCT00696787|75865999|FG001|Overall Study|Withdrawal by Subject|3|||
42057137|NCT00696787|75866000|FG002|Overall Study|Withdrawal by Subject|2|||
42057138|NCT00696787|75865998|FG000|Overall Study|Failed to return|1|||
42057139|NCT00696787|75865999|FG001|Overall Study|Failed to return|3|||
42057140|NCT00696787|75866000|FG002|Overall Study|Failed to return|1|||
42057141|NCT01012037|75866011|FG000|Overall Study|Adverse Event|0|||
42057142|NCT01012037|75866012|FG001|Overall Study|Adverse Event|8|||
42057143|NCT01012037|75866013|FG002|Overall Study|Adverse Event|3|||
42057144|NCT01012037|75866011|FG000|Overall Study|Protocol Violation|0|||
42057145|NCT01012037|75866012|FG001|Overall Study|Protocol Violation|3|||
42057146|NCT01012037|75866013|FG002|Overall Study|Protocol Violation|5|||
42057147|NCT01012037|75866011|FG000|Overall Study|Withdrawal by Subject|0|||
42057148|NCT01012037|75866012|FG001|Overall Study|Withdrawal by Subject|4|||
42057149|NCT01012037|75866013|FG002|Overall Study|Withdrawal by Subject|1|||
42057150|NCT01012037|75866011|FG000|Overall Study|Other reason (not specified)|1|||
42057151|NCT01012037|75866012|FG001|Overall Study|Other reason (not specified)|1|||
42057152|NCT01012037|75866013|FG002|Overall Study|Other reason (not specified)|1|||
42057153|NCT00734032|75866025|FG000|Overall Study|Adverse Event|0|||
42057154|NCT00734032|75866026|FG001|Overall Study|Adverse Event|1|||
42057155|NCT00734032|75866027|FG002|Overall Study|Adverse Event|0|||
42057156|NCT00734032|75866028|FG003|Overall Study|Adverse Event|0|||
42057157|NCT01010633|75866040|FG000|Overall Study|Adverse Event|1|||
42057158|NCT01010633|75866041|FG001|Overall Study|Adverse Event|1|||
42057159|NCT01010633|75866040|FG000|Overall Study|Protocol Violation|1|||
42057160|NCT01010633|75866041|FG001|Overall Study|Protocol Violation|2|||
42057161|NCT01010633|75866040|FG000|Overall Study|Withdrawal by Subject|2|||
42057162|NCT01010633|75866041|FG001|Overall Study|Withdrawal by Subject|1|||
42057163|NCT01010633|75866040|FG000|Overall Study|Investigator decision|0|||
42057164|NCT01010633|75866041|FG001|Overall Study|Investigator decision|1|||
42057165|NCT00733954|75866049|FG000|Overall Study|Lost to Follow-up|5|||
42057166|NCT00733954|75866050|FG001|Overall Study|Lost to Follow-up|2|||
42057167|NCT00733954|75866049|FG000|Overall Study|Protocol Violation|1|||
42057168|NCT00733954|75866050|FG001|Overall Study|Protocol Violation|0|||
42057169|NCT00733954|75866049|FG000|Overall Study|Withdrawal by Subject|2|||
42057170|NCT00733954|75866050|FG001|Overall Study|Withdrawal by Subject|0|||
42057171|NCT00733408|75866056|FG000|Overall Study|Adverse Event|4|||
42057172|NCT01010867|75866060|FG000|Overall Study|< 50% adherence to probiotic|1|||
42057173|NCT00576823|75866067|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
42057174|NCT00576823|75866068|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
42057175|NCT00576823|75866069|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
42057176|NCT00576823|75866067|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
42057177|NCT00576823|75866068|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
42057178|NCT00576823|75866069|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
42057179|NCT00732940|75866082|FG000|Overall Study|Withdrawal by Subject|1|||
42057180|NCT00732940|75866083|FG001|Overall Study|Withdrawal by Subject|2|||
42057181|NCT00732940|75866082|FG000|Overall Study|Adverse Event|0|||
42057182|NCT00732940|75866083|FG001|Overall Study|Adverse Event|1|||
42057183|NCT00732940|75866082|FG000|Overall Study|Lost to Follow-up|1|||
42057184|NCT00732940|75866083|FG001|Overall Study|Lost to Follow-up|0|||
42057185|NCT00962390|75866093|FG000|Overall Study|Adverse Event|0|||
42057186|NCT00962390|75866094|FG001|Overall Study|Adverse Event|0|||
42057187|NCT00962390|75866095|FG002|Overall Study|Adverse Event|3|||
42057188|NCT00962390|75866096|FG003|Overall Study|Adverse Event|1|||
42057189|NCT00962390|75866093|FG000|Overall Study|Lost to Follow-up|2|||
42057190|NCT00962390|75866094|FG001|Overall Study|Lost to Follow-up|2|||
42057191|NCT00962390|75866095|FG002|Overall Study|Lost to Follow-up|0|||
42174060|NCT00336479|75980819|FG000|Overall Study|Withdrawal by Subject|3|||
42174061|NCT00336479|75980820|FG001|Overall Study|Withdrawal by Subject|2|||
42057192|NCT00962390|75866096|FG003|Overall Study|Lost to Follow-up|0|||
42057193|NCT00962390|75866093|FG000|Overall Study|Protocol Violation|1|||
42057194|NCT00962390|75866094|FG001|Overall Study|Protocol Violation|0|||
42057195|NCT00962390|75866095|FG002|Overall Study|Protocol Violation|0|||
42057196|NCT00962390|75866096|FG003|Overall Study|Protocol Violation|0|||
42057197|NCT00962390|75866093|FG000|Overall Study|Withdrawal by Subject|1|||
42057198|NCT00962390|75866094|FG001|Overall Study|Withdrawal by Subject|1|||
42057199|NCT00962390|75866095|FG002|Overall Study|Withdrawal by Subject|1|||
42057200|NCT00962390|75866096|FG003|Overall Study|Withdrawal by Subject|0|||
42057201|NCT00732472|75866110|FG000|Overall Study|Adverse Event|0|||
42057202|NCT00732472|75866111|FG001|Overall Study|Adverse Event|1|||
42057203|NCT00732472|75866112|FG002|Overall Study|Adverse Event|1|||
42057204|NCT00732472|75866113|FG003|Overall Study|Adverse Event|1|||
42057205|NCT00732472|75866110|FG000|Overall Study|Protocol Violation|0|||
42057206|NCT00732472|75866111|FG001|Overall Study|Protocol Violation|0|||
42057207|NCT00732472|75866112|FG002|Overall Study|Protocol Violation|0|||
42057208|NCT00732472|75866113|FG003|Overall Study|Protocol Violation|1|||
42057209|NCT00732472|75866110|FG000|Overall Study|Withdrawal by Subject|0|||
42057210|NCT00732472|75866111|FG001|Overall Study|Withdrawal by Subject|2|||
42057211|NCT00732472|75866112|FG002|Overall Study|Withdrawal by Subject|0|||
42057212|NCT00732472|75866113|FG003|Overall Study|Withdrawal by Subject|1|||
42057213|NCT00960986|75866128|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
42057214|NCT00960986|75866129|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
42057215|NCT00960986|75866130|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
42057216|NCT00960986|75866131|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
42057217|NCT00960986|75866128|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
42057218|NCT00960986|75866129|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
42057219|NCT00960986|75866130|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
42057220|NCT00960986|75866131|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
42057221|NCT00960986|75866128|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
42057222|NCT00960986|75866129|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
42057223|NCT00960986|75866130|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
42057224|NCT00960986|75866131|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
42057225|NCT00960986|75866128|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
42057226|NCT00960986|75866129|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
42057227|NCT00960986|75866130|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
42057228|NCT00960986|75866131|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
42057229|NCT00960986|75866128|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
42057230|NCT00960986|75866129|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
42057231|NCT00960986|75866130|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
42057232|NCT00960986|75866131|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
42057233|NCT00960986|75866128|FG000|Period 3 (7-week Therapy Period)|Death|0|||
42057234|NCT00960986|75866129|FG001|Period 3 (7-week Therapy Period)|Death|0|||
42057235|NCT00960986|75866130|FG002|Period 3 (7-week Therapy Period)|Death|1|||
42057236|NCT00960986|75866131|FG003|Period 3 (7-week Therapy Period)|Death|0|||
42057237|NCT00960986|75866128|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
42057238|NCT00960986|75866129|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
42057239|NCT00960986|75866130|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
42057240|NCT00960986|75866131|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
42016507|NCT03750968|75823929|FG001|Overall Study|Adverse Event|0|||
42016508|NCT03750968|75823928|FG000|Overall Study|Lost to Follow-up|1|||
42057241|NCT00960986|75866128|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
42057242|NCT00960986|75866129|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
42057243|NCT00960986|75866130|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
42057244|NCT00960986|75866131|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
42057245|NCT00960986|75866128|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
42174062|NCT00336479|75980821|FG002|Overall Study|Withdrawal by Subject|3|||
42174063|NCT00336479|75980822|FG003|Overall Study|Withdrawal by Subject|0|||
42291762|NCT02640053|76125265|FG000|Overall Study|Adverse Event|1|||
42016509|NCT03750968|75823929|FG001|Overall Study|Lost to Follow-up|3|||
42016510|NCT03690388|75823941|FG000|Overall Study|Adverse Event|8|||
42016511|NCT03690388|75823942|FG001|Overall Study|Adverse Event|1|||
42016512|NCT03690388|75823941|FG000|Overall Study|Radiographic Progression|14|||
42016513|NCT03690388|75823942|FG001|Overall Study|Radiographic Progression|29|||
42016514|NCT03690388|75823941|FG000|Overall Study|Clinical deterioration|10|||
42016515|NCT03690388|75823942|FG001|Overall Study|Clinical deterioration|6|||
42016516|NCT03690388|75823941|FG000|Overall Study|Withdrawal by Subject|2|||
42016517|NCT03690388|75823942|FG001|Overall Study|Withdrawal by Subject|0|||
42057246|NCT00960986|75866129|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
42057247|NCT00960986|75866130|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
42057248|NCT00960986|75866131|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
42057249|NCT00960986|75866128|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
42057250|NCT00960986|75866129|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
42057251|NCT00960986|75866130|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
42057252|NCT00960986|75866131|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
42057253|NCT00732238|75866143|FG000|Overall Study|Bacteremia|4|||
42057254|NCT00732238|75866144|FG001|Overall Study|Bacteremia|1|||
42057255|NCT00732238|75866143|FG000|Overall Study|Asymptomatic bacteriuria|1|||
42057256|NCT00732238|75866144|FG001|Overall Study|Asymptomatic bacteriuria|0|||
42057257|NCT00958880|75866154|FG000|Overall Study|Lost to Follow-up|2|||
42057258|NCT00958880|75866155|FG001|Overall Study|Lost to Follow-up|2|||
42057259|NCT00732160|75866165|FG000|Overall Study|Adverse Event|1|||
42057260|NCT00732160|75866166|FG001|Overall Study|Adverse Event|0|||
42057261|NCT00732160|75866167|FG002|Overall Study|Adverse Event|1|||
42057262|NCT00732160|75866168|FG003|Overall Study|Adverse Event|1|||
42057263|NCT00732160|75866165|FG000|Overall Study|scheduling|4|||
42057264|NCT00732160|75866166|FG001|Overall Study|scheduling|4|||
42057265|NCT00732160|75866167|FG002|Overall Study|scheduling|2|||
42057266|NCT00732160|75866168|FG003|Overall Study|scheduling|1|||
42057267|NCT00958724|75866178|FG000|Overall Study|Disease Progression|6|||
42057268|NCT00738400|75866184|FG000|Overall Study|Adverse Event|3|||
42057269|NCT00738400|75866185|FG001|Overall Study|Adverse Event|1|||
42057270|NCT00738400|75866184|FG000|Overall Study|Withdrawal by Subject|0|||
42057271|NCT00738400|75866185|FG001|Overall Study|Withdrawal by Subject|1|||
42057272|NCT00738400|75866184|FG000|Overall Study|Lack of Efficacy|0|||
42057273|NCT00738400|75866185|FG001|Overall Study|Lack of Efficacy|1|||
42057274|NCT00738400|75866184|FG000|Overall Study|Lost to Follow-up|0|||
42057275|NCT00738400|75866185|FG001|Overall Study|Lost to Follow-up|3|||
42057276|NCT00738400|75866184|FG000|Overall Study|Protocol Violation|1|||
42057277|NCT00738400|75866185|FG001|Overall Study|Protocol Violation|0|||
42057278|NCT00738400|75866184|FG000|Overall Study|Non-compliant with study medication|0|||
42057279|NCT00738400|75866185|FG001|Overall Study|Non-compliant with study medication|1|||
42057280|NCT01009463|75866195|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
42057281|NCT01009463|75866196|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
42057282|NCT01009463|75866197|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
42057283|NCT01009463|75866198|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
42057284|NCT01009463|75866199|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
42057285|NCT01009463|75866195|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
42057286|NCT01009463|75866196|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
42057287|NCT01009463|75866197|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
42057288|NCT01009463|75866198|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
42057289|NCT01009463|75866199|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
42057290|NCT01009463|75866195|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
42057291|NCT01009463|75866196|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
42057292|NCT01009463|75866197|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
42057293|NCT01009463|75866198|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
42057294|NCT01009463|75866199|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
42057295|NCT01009463|75866195|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
42057296|NCT01009463|75866196|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
42057297|NCT01009463|75866197|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
42057298|NCT01009463|75866198|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
42291763|NCT02640053|76125266|FG001|Overall Study|Adverse Event|1|||
42291764|NCT02640053|76125265|FG000|Overall Study|Alternative Therapy|1|||
42057299|NCT01009463|75866199|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
42057300|NCT01009463|75866195|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
42057301|NCT01009463|75866196|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
42057302|NCT01009463|75866197|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
42057303|NCT01009463|75866198|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
42057304|NCT01009463|75866199|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
42057305|NCT01009463|75866195|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
42291765|NCT02640053|76125266|FG001|Overall Study|Alternative Therapy|1|||
42291766|NCT02640053|76125265|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
42291767|NCT02640053|76125266|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
42291768|NCT01950364|76125274|FG000|Overall Study|Adverse Event|3|||
42291769|NCT01950364|76125275|FG001|Overall Study|Adverse Event|0|||
42057306|NCT01009463|75866196|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
42057307|NCT01009463|75866197|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
42057308|NCT01009463|75866198|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
42057309|NCT01009463|75866199|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
42057310|NCT01009463|75866195|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
42057311|NCT01009463|75866196|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
42057312|NCT01009463|75866197|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
42057313|NCT01009463|75866198|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
42057314|NCT01009463|75866199|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
42057315|NCT01009463|75866195|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
42057316|NCT01009463|75866196|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
42057317|NCT01009463|75866197|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
42057318|NCT01009463|75866198|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
42057319|NCT01009463|75866199|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
42057320|NCT01009463|75866195|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
42057321|NCT01009463|75866196|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
42057322|NCT01009463|75866197|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
42057323|NCT01009463|75866198|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
42057324|NCT01009463|75866199|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
42057325|NCT01009463|75866195|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
42057326|NCT01009463|75866196|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
42057327|NCT01009463|75866197|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
42057328|NCT01009463|75866198|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
42057329|NCT01009463|75866199|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
42057330|NCT01009463|75866195|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
42057331|NCT01009463|75866196|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
42057332|NCT01009463|75866197|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
42057333|NCT01009463|75866198|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
42057334|NCT01009463|75866199|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
42057335|NCT01009463|75866195|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
42057336|NCT01009463|75866196|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
42057337|NCT01009463|75866197|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
42057338|NCT01009463|75866198|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
42057339|NCT01009463|75866199|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
42057340|NCT01009463|75866195|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
42057341|NCT01009463|75866196|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
42057342|NCT01009463|75866197|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
42057343|NCT01009463|75866198|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
42057344|NCT01009463|75866199|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
42057345|NCT00958568|75866210|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
42057346|NCT00958568|75866211|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
42057347|NCT00958568|75866212|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
42057348|NCT00958568|75866213|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
42057349|NCT00958568|75866210|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
42057350|NCT00958568|75866211|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
42057351|NCT00958568|75866212|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
42057352|NCT00958568|75866213|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
42057353|NCT00958568|75866210|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
42057354|NCT00958568|75866211|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
42057355|NCT00958568|75866212|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
42057356|NCT00958568|75866213|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
42057357|NCT00958568|75866210|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
42057358|NCT00958568|75866211|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
42057359|NCT00958568|75866212|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
42057360|NCT00958568|75866213|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
42057361|NCT00958568|75866210|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
42057362|NCT00958568|75866211|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
42057363|NCT00958568|75866212|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
42057364|NCT00958568|75866213|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
42057365|NCT00958568|75866210|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
42057366|NCT00958568|75866211|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
42057367|NCT00958568|75866212|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
42057368|NCT00958568|75866213|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
42057369|NCT00958568|75866210|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
42057370|NCT00958568|75866211|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
42057371|NCT00958568|75866212|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
42291770|NCT01950364|76125274|FG000|Overall Study|Stem Cell Transplant|2|||
42291771|NCT01950364|76125275|FG001|Overall Study|Stem Cell Transplant|6|||
42291772|NCT01950364|76125274|FG000|Overall Study|Disease Progression|5|||
42291773|NCT01950364|76125275|FG001|Overall Study|Disease Progression|2|||
42291774|NCT01950364|76125274|FG000|Overall Study|Withdrawal by Subject|0|||
42016518|NCT03690388|75823941|FG000|Overall Study|Lack of Efficacy|1|||
42016519|NCT03690388|75823942|FG001|Overall Study|Lack of Efficacy|0|||
42016520|NCT03690388|75823941|FG000|Overall Study|Lost to Follow-up|1|||
42016521|NCT03690388|75823942|FG001|Overall Study|Lost to Follow-up|0|||
42016522|NCT03619213|75823954|FG000|Overall Study|Lost to Follow-up|2|||
42016523|NCT03619213|75823955|FG001|Overall Study|Lost to Follow-up|1|||
42016524|NCT03619213|75823954|FG000|Overall Study|Withdrawal by Subject|8|||
42016525|NCT03619213|75823955|FG001|Overall Study|Withdrawal by Subject|10|||
42016526|NCT03342690|75823961|FG000|Overall Study|Missing Information|9|||
42356997|NCT01422213|76202264|FG000|Overall Study|Lack of Efficacy|10|||
42356998|NCT01422213|76202265|FG001|Overall Study|Lack of Efficacy|2|||
42356999|NCT01422213|76202266|FG002|Overall Study|Lack of Efficacy|2|||
42357000|NCT01422213|76202264|FG000|Overall Study|Non-compliance with study drug|0|||
42357001|NCT01422213|76202265|FG001|Overall Study|Non-compliance with study drug|1|||
42057372|NCT00958568|75866213|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
42057373|NCT00958568|75866210|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
42057374|NCT00958568|75866211|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
42057375|NCT00958568|75866212|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
42057376|NCT00958568|75866213|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
42057377|NCT00958568|75866210|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
42057378|NCT00958568|75866211|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
42057379|NCT00958568|75866212|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
42057380|NCT00958568|75866213|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
42057381|NCT00958568|75866210|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
42057382|NCT00958568|75866211|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
42057383|NCT00958568|75866212|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
42057384|NCT00958568|75866213|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
42057385|NCT00958568|75866210|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
42057386|NCT00958568|75866211|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
42057387|NCT00958568|75866212|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
42057388|NCT00958568|75866213|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
42057389|NCT00958568|75866210|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
42057390|NCT00958568|75866211|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
42057391|NCT00958568|75866212|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
42057392|NCT00958568|75866213|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
42057393|NCT00958568|75866210|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
42057394|NCT00958568|75866211|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
42057395|NCT00958568|75866212|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
42057396|NCT00958568|75866213|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
42057397|NCT00958568|75866210|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
42057398|NCT00958568|75866211|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
42057399|NCT00958568|75866212|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
42057400|NCT00958568|75866213|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
42057401|NCT00958568|75866210|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
42057402|NCT00958568|75866211|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
42057403|NCT00958568|75866212|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
42057404|NCT00958568|75866213|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
42057405|NCT00958568|75866210|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
42057406|NCT00958568|75866211|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
42057407|NCT00958568|75866212|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
42057408|NCT00958568|75866213|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
42057409|NCT00958568|75866210|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
42057410|NCT00958568|75866211|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
42174064|NCT00336479|75980819|FG000|Overall Study|Other|0|||
42291775|NCT01950364|76125275|FG001|Overall Study|Withdrawal by Subject|1|||
42057411|NCT00958568|75866212|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
42057412|NCT00958568|75866213|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
42057413|NCT00958568|75866210|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
42174065|NCT00336479|75980820|FG001|Overall Study|Other|0|||
42174066|NCT00336479|75980821|FG002|Overall Study|Other|1|||
42174067|NCT00336479|75980822|FG003|Overall Study|Other|0|||
42174068|NCT00336479|75980819|FG000|Overall Study|Virologic Stopping Rule|20|||
42291776|NCT01950364|76125274|FG000|Overall Study|Protocol Violation|0|||
42291777|NCT01950364|76125275|FG001|Overall Study|Protocol Violation|1|||
42291778|NCT01968070|76125299|FG000|Period 1|Withdrawal by Subject|0|||
42291779|NCT01968070|76125300|FG001|Period 1|Withdrawal by Subject|1|||
42291780|NCT01968070|76125301|FG002|Period 1|Withdrawal by Subject|0|||
42291781|NCT01968070|76125302|FG003|Period 1|Withdrawal by Subject|0|||
42291782|NCT01968070|76125303|FG004|Period 1|Withdrawal by Subject|0|||
42057414|NCT00958568|75866211|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
42057415|NCT00958568|75866212|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
42057416|NCT00958568|75866213|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
42057417|NCT00958568|75866210|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
42057418|NCT00958568|75866211|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
42057419|NCT00958568|75866212|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
42057420|NCT00958568|75866213|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
42057421|NCT00958568|75866210|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
42057422|NCT00958568|75866211|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
42057423|NCT00958568|75866212|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
42057424|NCT00958568|75866213|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
42057425|NCT00958568|75866210|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
42057426|NCT00958568|75866211|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
42057427|NCT00958568|75866212|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
42057428|NCT00958568|75866213|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
42057429|NCT00958568|75866210|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
42057430|NCT00958568|75866211|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
42057431|NCT00958568|75866212|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
42057432|NCT00958568|75866213|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
42057433|NCT00958568|75866210|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
42057434|NCT00958568|75866211|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
42057435|NCT00958568|75866212|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
42057436|NCT00958568|75866213|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
42057437|NCT00958568|75866210|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
42057438|NCT00958568|75866211|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
42057439|NCT00958568|75866212|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
42057440|NCT00958568|75866213|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
42057441|NCT00958568|75866210|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
42057442|NCT00958568|75866211|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
42057443|NCT00958568|75866212|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
42057444|NCT00958568|75866213|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
42057445|NCT00958568|75866210|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
42057446|NCT00958568|75866211|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
42057447|NCT00958568|75866212|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
42057448|NCT00958568|75866213|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
42057449|NCT00958568|75866210|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
42057450|NCT00958568|75866211|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
42057451|NCT00958568|75866212|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
42057452|NCT00958568|75866213|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
42057453|NCT00958568|75866210|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
42057454|NCT00958568|75866211|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
42057455|NCT00958568|75866212|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
42057456|NCT00958568|75866213|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
42057457|NCT00958568|75866210|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
42057458|NCT00958568|75866211|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
42057459|NCT00958568|75866212|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
42057460|NCT00958568|75866213|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
42057461|NCT00958412|75866224|FG000|Overall Study|Study prematurely terminated|18|||
42057462|NCT00958256|75866228|FG000|Overall Study|Adverse Event|3|||
42057463|NCT00696709|75866237|FG000|Overall Study|Withdrawal by Subject|1|||
42057464|NCT00696709|75866238|FG001|Overall Study|Withdrawal by Subject|2|||
42057465|NCT00696709|75866239|FG002|Overall Study|Withdrawal by Subject|1|||
42057466|NCT00696709|75866240|FG003|Overall Study|Withdrawal by Subject|4|||
42057467|NCT00696709|75866241|FG004|Overall Study|Withdrawal by Subject|3|||
42057468|NCT00696709|75866237|FG000|Overall Study|Protocol Violation|1|||
42057469|NCT00696709|75866238|FG001|Overall Study|Protocol Violation|0|||
42057470|NCT00696709|75866239|FG002|Overall Study|Protocol Violation|0|||
42174069|NCT00336479|75980820|FG001|Overall Study|Virologic Stopping Rule|0|||
42174070|NCT00336479|75980821|FG002|Overall Study|Virologic Stopping Rule|0|||
42174071|NCT00336479|75980822|FG003|Overall Study|Virologic Stopping Rule|0|||
42174072|NCT00314249|75980835|FG000|Overall Study|Adverse Event|73|||
42057471|NCT00696709|75866240|FG003|Overall Study|Protocol Violation|0|||
42057472|NCT00696709|75866241|FG004|Overall Study|Protocol Violation|0|||
42057473|NCT00696709|75866237|FG000|Overall Study|Lost to Follow-up|1|||
42057474|NCT00696709|75866238|FG001|Overall Study|Lost to Follow-up|1|||
42174073|NCT00314249|75980836|FG001|Overall Study|Adverse Event|94|||
42057475|NCT00696709|75866239|FG002|Overall Study|Lost to Follow-up|0|||
42057476|NCT00696709|75866240|FG003|Overall Study|Lost to Follow-up|0|||
42057477|NCT00696709|75866241|FG004|Overall Study|Lost to Follow-up|0|||
42057478|NCT00696709|75866237|FG000|Overall Study|Adverse Event|0|||
42057479|NCT00696709|75866238|FG001|Overall Study|Adverse Event|0|||
42057480|NCT00696709|75866239|FG002|Overall Study|Adverse Event|0|||
42057481|NCT00696709|75866240|FG003|Overall Study|Adverse Event|1|||
42057482|NCT00696709|75866241|FG004|Overall Study|Adverse Event|0|||
42057483|NCT01006265|75866261|FG000|Overall Study|Lost to Follow-up|1|||
42057484|NCT01006265|75866262|FG001|Overall Study|Lost to Follow-up|0|||
42057485|NCT01006265|75866263|FG002|Overall Study|Lost to Follow-up|1|||
42057486|NCT01006265|75866264|FG003|Overall Study|Lost to Follow-up|0|||
42057487|NCT01006265|75866261|FG000|Overall Study|Withdrawal by Subject|4|||
42057488|NCT01006265|75866262|FG001|Overall Study|Withdrawal by Subject|7|||
42057489|NCT01006265|75866263|FG002|Overall Study|Withdrawal by Subject|5|||
42057490|NCT01006265|75866264|FG003|Overall Study|Withdrawal by Subject|5|||
42291783|NCT01968070|76125304|FG005|Period 1|Withdrawal by Subject|0|||
42291784|NCT01968070|76125305|FG006|Period 1|Withdrawal by Subject|1|||
42291785|NCT01968070|76125306|FG007|Period 1|Withdrawal by Subject|0|||
42291786|NCT01968070|76125307|FG008|Period 1|Withdrawal by Subject|0|||
42291787|NCT01968070|76125308|FG009|Period 1|Withdrawal by Subject|0|||
42291788|NCT01968070|76125309|FG010|Period 1|Withdrawal by Subject|0|||
42057491|NCT01006265|75866261|FG000|Overall Study|Administrative reason|1|||
42057492|NCT01006265|75866262|FG001|Overall Study|Administrative reason|2|||
42057493|NCT01006265|75866263|FG002|Overall Study|Administrative reason|3|||
42057494|NCT01006265|75866264|FG003|Overall Study|Administrative reason|0|||
42057495|NCT01008995|75866276|FG000|Controlled Period|Adverse Event|1|||
42057496|NCT01008995|75866277|FG001|Controlled Period|Adverse Event|2|||
42057497|NCT01008995|75866278|FG002|Controlled Period|Adverse Event|0|||
42057498|NCT01008995|75866279|FG003|Controlled Period|Adverse Event|0|||
42057499|NCT01008995|75866276|FG000|Controlled Period|Other|2|||
42057500|NCT01008995|75866277|FG001|Controlled Period|Other|1|||
42057501|NCT01008995|75866278|FG002|Controlled Period|Other|0|||
42057502|NCT01008995|75866279|FG003|Controlled Period|Other|0|||
42057503|NCT01008995|75866276|FG000|After Controlled Period|Adverse Event|0|||
42057504|NCT01008995|75866277|FG001|After Controlled Period|Adverse Event|0|||
42057505|NCT01008995|75866278|FG002|After Controlled Period|Adverse Event|1|||
42057506|NCT01008995|75866279|FG003|After Controlled Period|Adverse Event|1|||
42057507|NCT01008995|75866276|FG000|After Controlled Period|Other|0|||
42057508|NCT01008995|75866277|FG001|After Controlled Period|Other|0|||
42057509|NCT01008995|75866278|FG002|After Controlled Period|Other|1|||
42057510|NCT01008995|75866279|FG003|After Controlled Period|Other|0|||
42057511|NCT00957944|75866289|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
42057512|NCT00957944|75866290|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
42057513|NCT01005875|75866296|FG000|Overall Study|Death|3|||
42057514|NCT01005719|75866300|FG000|Period 1|Adverse Event|0|||
42057515|NCT01005719|75866301|FG001|Period 1|Adverse Event|0|||
42057516|NCT01005719|75866302|FG002|Period 1|Adverse Event|0|||
42057517|NCT01005719|75866303|FG003|Period 1|Adverse Event|1|||
42057518|NCT01005719|75866304|FG004|Period 1|Adverse Event|0|||
42057519|NCT01005719|75866305|FG005|Period 1|Adverse Event|0|||
42057520|NCT01005719|75866300|FG000|Period 1|Delay in completing study procedures|0|||
42057521|NCT01005719|75866301|FG001|Period 1|Delay in completing study procedures|0|||
42057522|NCT01005719|75866302|FG002|Period 1|Delay in completing study procedures|0|||
42057523|NCT01005719|75866303|FG003|Period 1|Delay in completing study procedures|0|||
42057524|NCT01005719|75866304|FG004|Period 1|Delay in completing study procedures|0|||
42057525|NCT01005719|75866305|FG005|Period 1|Delay in completing study procedures|1|||
42057526|NCT01005719|75866300|FG000|Period 2|Adverse Event|0|||
42057527|NCT01005719|75866301|FG001|Period 2|Adverse Event|0|||
42057528|NCT01005719|75866302|FG002|Period 2|Adverse Event|0|||
42291789|NCT01968070|76125310|FG011|Period 1|Withdrawal by Subject|0|||
42291790|NCT01968070|76125311|FG012|Period 1|Withdrawal by Subject|0|||
42057529|NCT01005719|75866303|FG003|Period 2|Adverse Event|0|||
42057530|NCT01005719|75866304|FG004|Period 2|Adverse Event|1|||
42057531|NCT01005719|75866305|FG005|Period 2|Adverse Event|1|||
42057532|NCT00953576|75866316|FG000|Overall Study|Adverse Event|0|||
42057533|NCT00953576|75866317|FG001|Overall Study|Adverse Event|1|||
42057534|NCT00953576|75866316|FG000|Overall Study|Ineligible after Consent|2|||
42057535|NCT00953576|75866317|FG001|Overall Study|Ineligible after Consent|0|||
42174074|NCT00314249|75980835|FG000|Overall Study|Lack of Efficacy|33|||
42291791|NCT01968070|76125312|FG013|Period 1|Withdrawal by Subject|0|||
42291792|NCT01968070|76125313|FG014|Period 1|Withdrawal by Subject|0|||
42291793|NCT01968070|76125314|FG015|Period 1|Withdrawal by Subject|1|||
42057536|NCT01005329|75866326|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
42057537|NCT01005251|75866336|FG000|Overall Study|Withdrawal by Subject|2|||
42057538|NCT01005251|75866337|FG001|Overall Study|Withdrawal by Subject|5|||
42057539|NCT01005251|75866338|FG002|Overall Study|Withdrawal by Subject|3|||
42291794|NCT01968070|76125315|FG016|Period 1|Withdrawal by Subject|0|||
42057540|NCT01005251|75866339|FG003|Overall Study|Withdrawal by Subject|4|||
42057541|NCT01005251|75866340|FG004|Overall Study|Withdrawal by Subject|9|||
42057542|NCT01005251|75866336|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
42057543|NCT01005251|75866337|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
42057544|NCT01005251|75866338|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
42057545|NCT01005251|75866339|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
42057546|NCT01005251|75866340|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
42057547|NCT01005251|75866336|FG000|Overall Study|Adverse Event|2|||
42057548|NCT01005251|75866337|FG001|Overall Study|Adverse Event|6|||
42057549|NCT01005251|75866338|FG002|Overall Study|Adverse Event|8|||
42057550|NCT01005251|75866339|FG003|Overall Study|Adverse Event|5|||
42057551|NCT01005251|75866340|FG004|Overall Study|Adverse Event|4|||
42057552|NCT01005251|75866336|FG000|Overall Study|Protocol Violation|1|||
42057553|NCT01005251|75866337|FG001|Overall Study|Protocol Violation|0|||
42057554|NCT01005251|75866338|FG002|Overall Study|Protocol Violation|0|||
42057555|NCT01005251|75866339|FG003|Overall Study|Protocol Violation|0|||
42057556|NCT01005251|75866340|FG004|Overall Study|Protocol Violation|2|||
42057557|NCT01005251|75866336|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
42057558|NCT01005251|75866337|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
42057559|NCT01005251|75866338|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
42057560|NCT01005251|75866339|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
42057561|NCT01005251|75866340|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
42057562|NCT01005251|75866336|FG000|Overall Study|Lost to Follow-up|1|||
42057563|NCT01005251|75866337|FG001|Overall Study|Lost to Follow-up|4|||
42057564|NCT01005251|75866338|FG002|Overall Study|Lost to Follow-up|2|||
42057565|NCT01005251|75866339|FG003|Overall Study|Lost to Follow-up|0|||
42057566|NCT01005251|75866340|FG004|Overall Study|Lost to Follow-up|0|||
42057567|NCT01005251|75866336|FG000|Overall Study|Physician Decision|0|||
42057568|NCT01005251|75866337|FG001|Overall Study|Physician Decision|0|||
42057569|NCT01005251|75866338|FG002|Overall Study|Physician Decision|0|||
42057570|NCT01005251|75866339|FG003|Overall Study|Physician Decision|0|||
42057571|NCT01005251|75866340|FG004|Overall Study|Physician Decision|2|||
42057572|NCT01005251|75866336|FG000|Overall Study|Patient moved|1|||
42057573|NCT01005251|75866337|FG001|Overall Study|Patient moved|0|||
42057574|NCT01005251|75866338|FG002|Overall Study|Patient moved|0|||
42057575|NCT01005251|75866339|FG003|Overall Study|Patient moved|0|||
42057576|NCT01005251|75866340|FG004|Overall Study|Patient moved|0|||
42057577|NCT01005251|75866336|FG000|Overall Study|Wrong drug dispensed|0|||
42057578|NCT01005251|75866337|FG001|Overall Study|Wrong drug dispensed|1|||
42057579|NCT01005251|75866338|FG002|Overall Study|Wrong drug dispensed|0|||
42057580|NCT01005251|75866339|FG003|Overall Study|Wrong drug dispensed|0|||
42057581|NCT01005251|75866340|FG004|Overall Study|Wrong drug dispensed|0|||
42057582|NCT01005251|75866336|FG000|Overall Study|Randomized in error|0|||
42057583|NCT01005251|75866337|FG001|Overall Study|Randomized in error|0|||
42057584|NCT01005251|75866338|FG002|Overall Study|Randomized in error|1|||
42057585|NCT01005251|75866339|FG003|Overall Study|Randomized in error|1|||
42057586|NCT01005251|75866340|FG004|Overall Study|Randomized in error|0|||
42057587|NCT01005251|75866336|FG000|Overall Study|Lack of Efficacy|0|||
42291795|NCT01968070|76125316|FG017|Period 1|Withdrawal by Subject|0|||
42016527|NCT03342690|75823961|FG000|Overall Study|Protocol Violation|16|||
42016528|NCT03257267|75823980|FG000|Overall Study|Adverse Event|9|||
42016529|NCT03257267|75823981|FG001|Overall Study|Adverse Event|7|||
42016530|NCT03257267|75823980|FG000|Overall Study|Death|92|||
42016531|NCT03257267|75823981|FG001|Overall Study|Death|95|||
42016532|NCT03257267|75823980|FG000|Overall Study|Lost to Follow-up|2|||
42016533|NCT03257267|75823981|FG001|Overall Study|Lost to Follow-up|2|||
42016534|NCT03257267|75823980|FG000|Overall Study|Non-compliance with Study Drug|0|||
42016535|NCT03257267|75823981|FG001|Overall Study|Non-compliance with Study Drug|1|||
42016536|NCT03257267|75823980|FG000|Overall Study|Participant Decision|34|||
42016537|NCT03257267|75823981|FG001|Overall Study|Participant Decision|42|||
42016538|NCT03257267|75823980|FG000|Overall Study|Physician Decision|1|||
42016539|NCT03257267|75823981|FG001|Overall Study|Physician Decision|3|||
42016540|NCT03257267|75823980|FG000|Overall Study|Disease Progression|98|||
42016541|NCT03257267|75823981|FG001|Overall Study|Disease Progression|117|||
42016542|NCT03257267|75823980|FG000|Overall Study|Withdrawal of Consent|8|||
42016543|NCT03257267|75823981|FG001|Overall Study|Withdrawal of Consent|26|||
42016544|NCT03257267|75823980|FG000|Overall Study|Study Ongoing|53|||
42016545|NCT03257267|75823981|FG001|Overall Study|Study Ongoing|11|||
42016546|NCT02991456|75823998|FG000|Overall Study|Adverse Event|2|||
42016547|NCT02991456|75823999|FG001|Overall Study|Adverse Event|0|||
42016548|NCT02991456|75823998|FG000|Overall Study|Lost to Follow-up|0|||
42016549|NCT02991456|75823999|FG001|Overall Study|Lost to Follow-up|2|||
42016550|NCT02991456|75823998|FG000|Overall Study|Withdrawal by Subject|1|||
42016551|NCT02991456|75823999|FG001|Overall Study|Withdrawal by Subject|0|||
42057588|NCT01005251|75866337|FG001|Overall Study|Lack of Efficacy|0|||
42057589|NCT01005251|75866338|FG002|Overall Study|Lack of Efficacy|1|||
42057590|NCT01005251|75866339|FG003|Overall Study|Lack of Efficacy|1|||
42057591|NCT01005251|75866340|FG004|Overall Study|Lack of Efficacy|0|||
42057592|NCT03048578|75866354|FG000|Overall Study|Withdrawal by Subject|5|||
42057593|NCT03048578|75866355|FG001|Overall Study|Withdrawal by Subject|6|||
42057594|NCT03048578|75866354|FG000|Overall Study|Lost to Follow-up|22|||
42057595|NCT03048578|75866355|FG001|Overall Study|Lost to Follow-up|10|||
42057596|NCT03048578|75866354|FG000|Overall Study|Adverse Event|1|||
42057597|NCT03048578|75866355|FG001|Overall Study|Adverse Event|2|||
42057598|NCT03048578|75866354|FG000|Overall Study|Terminated|3|||
42057599|NCT03048578|75866355|FG001|Overall Study|Terminated|2|||
42057600|NCT01008449|75866363|FG000|Overall Study|Lost to Follow-up|29|||
42057601|NCT01008449|75866364|FG001|Overall Study|Lost to Follow-up|19|||
42057602|NCT00696241|75866375|FG000|Overall Study|Adverse Event|11|||
42057603|NCT00696241|75866376|FG001|Overall Study|Adverse Event|3|||
42057604|NCT00696241|75866377|FG002|Overall Study|Adverse Event|6|||
42057605|NCT00696241|75866378|FG003|Overall Study|Adverse Event|4|||
42057606|NCT00696241|75866379|FG004|Overall Study|Adverse Event|5|||
42057607|NCT00696241|75866375|FG000|Overall Study|Protocol Violation|1|||
42057608|NCT00696241|75866376|FG001|Overall Study|Protocol Violation|1|||
42057609|NCT00696241|75866377|FG002|Overall Study|Protocol Violation|2|||
42057610|NCT00696241|75866378|FG003|Overall Study|Protocol Violation|0|||
42057611|NCT00696241|75866379|FG004|Overall Study|Protocol Violation|3|||
42057612|NCT00696241|75866375|FG000|Overall Study|Lost to Follow-up|1|||
42057613|NCT00696241|75866376|FG001|Overall Study|Lost to Follow-up|4|||
42057614|NCT00696241|75866377|FG002|Overall Study|Lost to Follow-up|1|||
42057615|NCT00696241|75866378|FG003|Overall Study|Lost to Follow-up|2|||
42057616|NCT00696241|75866379|FG004|Overall Study|Lost to Follow-up|0|||
42057617|NCT00696241|75866375|FG000|Overall Study|Withdrawal by Subject|4|||
42057618|NCT00696241|75866376|FG001|Overall Study|Withdrawal by Subject|8|||
42057619|NCT00696241|75866377|FG002|Overall Study|Withdrawal by Subject|6|||
42057620|NCT00696241|75866378|FG003|Overall Study|Withdrawal by Subject|1|||
42057621|NCT00696241|75866379|FG004|Overall Study|Withdrawal by Subject|0|||
42057622|NCT00696241|75866375|FG000|Overall Study|Lack of Efficacy|1|||
42057623|NCT00696241|75866376|FG001|Overall Study|Lack of Efficacy|5|||
42057624|NCT00696241|75866377|FG002|Overall Study|Lack of Efficacy|4|||
42057625|NCT00696241|75866378|FG003|Overall Study|Lack of Efficacy|5|||
42057626|NCT00696241|75866379|FG004|Overall Study|Lack of Efficacy|3|||
42057627|NCT00696241|75866375|FG000|Overall Study|Other|6|||
42057628|NCT00696241|75866376|FG001|Overall Study|Other|1|||
42057629|NCT00696241|75866377|FG002|Overall Study|Other|5|||
42057630|NCT00696241|75866378|FG003|Overall Study|Other|2|||
42057631|NCT00696241|75866379|FG004|Overall Study|Other|1|||
42057632|NCT00957008|75866395|FG000|Overall Study|Withdrawal by Subject|13|||
42057633|NCT00957008|75866396|FG001|Overall Study|Withdrawal by Subject|10|||
42057634|NCT00957008|75866397|FG002|Overall Study|Withdrawal by Subject|12|||
42057635|NCT00957008|75866398|FG003|Overall Study|Withdrawal by Subject|16|||
42057636|NCT00957008|75866395|FG000|Overall Study|Lost to Follow-up|3|||
42057637|NCT00957008|75866396|FG001|Overall Study|Lost to Follow-up|1|||
42057638|NCT00957008|75866397|FG002|Overall Study|Lost to Follow-up|3|||
42057639|NCT00957008|75866398|FG003|Overall Study|Lost to Follow-up|4|||
42057640|NCT00957008|75866395|FG000|Overall Study|Physician Decision|1|||
42057641|NCT00957008|75866396|FG001|Overall Study|Physician Decision|0|||
42057642|NCT00957008|75866397|FG002|Overall Study|Physician Decision|1|||
42057643|NCT00957008|75866398|FG003|Overall Study|Physician Decision|1|||
42057644|NCT00957008|75866395|FG000|Overall Study|Relocated; Family conflict|4|||
42057645|NCT00957008|75866396|FG001|Overall Study|Relocated; Family conflict|1|||
42057646|NCT00957008|75866397|FG002|Overall Study|Relocated; Family conflict|1|||
42057647|NCT00957008|75866398|FG003|Overall Study|Relocated; Family conflict|3|||
42057648|NCT00952484|75866415|FG000|Overall Study|Withdrawal by Subject|0|||
42057649|NCT00952484|75866416|FG001|Overall Study|Withdrawal by Subject|1|||
42057650|NCT00952484|75866417|FG002|Overall Study|Withdrawal by Subject|0|||
42057651|NCT00689611|75866428|FG000|Overall Study|Death|6|||
42057652|NCT00689611|75866429|FG001|Overall Study|Death|9|||
42057653|NCT00689611|75866428|FG000|Overall Study|Withdrawal by Subject|8|||
42057654|NCT00689611|75866429|FG001|Overall Study|Withdrawal by Subject|9|||
42057655|NCT00689611|75866428|FG000|Overall Study|Lost to Follow-up|27|||
42057656|NCT00689611|75866429|FG001|Overall Study|Lost to Follow-up|28|||
42057657|NCT00689299|75866438|FG000|Overall Study|Adverse Event|2|||
42057658|NCT00689299|75866439|FG001|Overall Study|Adverse Event|1|||
42057659|NCT00689299|75866440|FG002|Overall Study|Adverse Event|1|||
42057660|NCT00689299|75866438|FG000|Overall Study|Lost to Follow-up|0|||
42057661|NCT00689299|75866439|FG001|Overall Study|Lost to Follow-up|1|||
42057662|NCT00689299|75866440|FG002|Overall Study|Lost to Follow-up|1|||
42057663|NCT00689299|75866438|FG000|Overall Study|Withdrawal by Subject|4|||
42057664|NCT00689299|75866439|FG001|Overall Study|Withdrawal by Subject|1|||
42057665|NCT00689299|75866440|FG002|Overall Study|Withdrawal by Subject|3|||
42057666|NCT00689299|75866438|FG000|Overall Study|Protocol Violation|1|||
42057667|NCT00689299|75866439|FG001|Overall Study|Protocol Violation|0|||
42057668|NCT00689299|75866440|FG002|Overall Study|Protocol Violation|0|||
42057669|NCT02506244|75866451|FG000|Overall Study|Did not undergo active monitoring|458|||
42057670|NCT02506244|75866452|FG001|Overall Study|Did not undergo active monitoring|459|||
42057671|NCT02506244|75866453|FG002|Overall Study|Did not undergo active monitoring|0|||
42057672|NCT00948974|75866463|FG000|Overall Study|Lost to Follow-up|23|||
42057673|NCT00948974|75866464|FG001|Overall Study|Lost to Follow-up|20|||
42057674|NCT01007435|75866474|FG000|Overall Study|Adverse Event|16|||
42057675|NCT01007435|75866475|FG001|Overall Study|Adverse Event|25|||
42057676|NCT01007435|75866476|FG002|Overall Study|Adverse Event|47|||
42057677|NCT01007435|75866477|FG003|Overall Study|Adverse Event|31|||
42057678|NCT01007435|75866474|FG000|Overall Study|Death|2|||
42057679|NCT01007435|75866475|FG001|Overall Study|Death|4|||
42057680|NCT01007435|75866476|FG002|Overall Study|Death|2|||
42174075|NCT00314249|75980836|FG001|Overall Study|Lack of Efficacy|24|||
42174076|NCT00314249|75980835|FG000|Overall Study|Withdrawal by Subject|21|||
42174077|NCT00314249|75980836|FG001|Overall Study|Withdrawal by Subject|28|||
42174078|NCT00314249|75980835|FG000|Overall Study|Lost to Follow-up|15|||
42174079|NCT00314249|75980836|FG001|Overall Study|Lost to Follow-up|9|||
42174080|NCT00314249|75980835|FG000|Overall Study|Physician Decision|1|||
42174081|NCT00314249|75980836|FG001|Overall Study|Physician Decision|1|||
42174082|NCT00314249|75980835|FG000|Overall Study|Withdrawn for other reasons|4|||
42174083|NCT00314249|75980836|FG001|Overall Study|Withdrawn for other reasons|1|||
42174084|NCT00314249|75980835|FG000|Overall Study|Non-Compliant|5|||
42174085|NCT00314249|75980836|FG001|Overall Study|Non-Compliant|6|||
42174086|NCT03315130|75980845|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
42174087|NCT03315130|75980846|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
42174088|NCT03315130|75980847|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
42174089|NCT03315130|75980848|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
42174090|NCT03315130|75980845|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
42174091|NCT03315130|75980846|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
42174092|NCT03315130|75980847|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
42174093|NCT03315130|75980848|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
42174094|NCT03315130|75980845|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
42174095|NCT03315130|75980846|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
42174096|NCT03315130|75980847|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
42174097|NCT03315130|75980848|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
42174098|NCT03315130|75980845|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
42174099|NCT03315130|75980846|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
42174100|NCT03315130|75980847|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
42174101|NCT03315130|75980848|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
42174102|NCT03315130|75980845|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
42174103|NCT03315130|75980846|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
42174104|NCT03315130|75980847|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
42174105|NCT03315130|75980848|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
42174106|NCT03315130|75980845|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
42174107|NCT03315130|75980846|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
42016552|NCT02842827|75824016|FG000|Overall Study|Adverse Event|0|||
42174108|NCT03315130|75980847|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
42174109|NCT03315130|75980848|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
42174110|NCT03273166|75980868|FG000|Overall Study|Withdrawn prior to Completion|31|||
42016553|NCT02842827|75824017|FG001|Overall Study|Adverse Event|1|||
42016554|NCT02842827|75824018|FG002|Overall Study|Adverse Event|0|||
42016555|NCT02842827|75824019|FG003|Overall Study|Adverse Event|1|||
42016556|NCT02842827|75824020|FG004|Overall Study|Adverse Event|0|||
42016557|NCT02842827|75824021|FG005|Overall Study|Adverse Event|1|||
42016558|NCT02842827|75824022|FG006|Overall Study|Adverse Event|0|||
42016559|NCT02842827|75824023|FG007|Overall Study|Adverse Event|0|||
42016560|NCT02842827|75824016|FG000|Overall Study|Death|1|||
42016561|NCT02842827|75824017|FG001|Overall Study|Death|0|||
42016562|NCT02842827|75824018|FG002|Overall Study|Death|2|||
42016563|NCT02842827|75824019|FG003|Overall Study|Death|3|||
42016564|NCT02842827|75824020|FG004|Overall Study|Death|2|||
42016565|NCT02842827|75824021|FG005|Overall Study|Death|1|||
42016566|NCT02842827|75824022|FG006|Overall Study|Death|0|||
42016567|NCT02842827|75824023|FG007|Overall Study|Death|4|||
42016568|NCT02842827|75824016|FG000|Overall Study|Physician Decision|1|||
42016569|NCT02842827|75824017|FG001|Overall Study|Physician Decision|3|||
42016570|NCT02842827|75824018|FG002|Overall Study|Physician Decision|0|||
42016571|NCT02842827|75824019|FG003|Overall Study|Physician Decision|0|||
42016572|NCT02842827|75824020|FG004|Overall Study|Physician Decision|1|||
42016573|NCT02842827|75824021|FG005|Overall Study|Physician Decision|4|||
42016574|NCT02842827|75824022|FG006|Overall Study|Physician Decision|2|||
42016575|NCT02842827|75824023|FG007|Overall Study|Physician Decision|1|||
42016576|NCT02842827|75824016|FG000|Overall Study|Protocol Defined Disease Progression|0|||
42016577|NCT02842827|75824017|FG001|Overall Study|Protocol Defined Disease Progression|0|||
42057681|NCT01007435|75866477|FG003|Overall Study|Death|1|||
42057682|NCT01007435|75866474|FG000|Overall Study|Insufficient Therapeutic Response|21|||
42057683|NCT01007435|75866475|FG001|Overall Study|Insufficient Therapeutic Response|7|||
42057684|NCT01007435|75866476|FG002|Overall Study|Insufficient Therapeutic Response|2|||
42057685|NCT01007435|75866477|FG003|Overall Study|Insufficient Therapeutic Response|9|||
42057686|NCT01007435|75866474|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
42057687|NCT01007435|75866475|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
42057688|NCT01007435|75866476|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
42057689|NCT01007435|75866477|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
42057690|NCT01007435|75866474|FG000|Overall Study|Other Protocol Violation|2|||
42057691|NCT01007435|75866475|FG001|Overall Study|Other Protocol Violation|0|||
42057692|NCT01007435|75866476|FG002|Overall Study|Other Protocol Violation|1|||
42057693|NCT01007435|75866477|FG003|Overall Study|Other Protocol Violation|0|||
42057694|NCT01007435|75866474|FG000|Overall Study|Refused Treatment|13|||
42057695|NCT01007435|75866475|FG001|Overall Study|Refused Treatment|13|||
42057696|NCT01007435|75866476|FG002|Overall Study|Refused Treatment|5|||
42057697|NCT01007435|75866477|FG003|Overall Study|Refused Treatment|8|||
42057698|NCT01007435|75866474|FG000|Overall Study|Failure to Return|5|||
42057699|NCT01007435|75866475|FG001|Overall Study|Failure to Return|4|||
42057700|NCT01007435|75866476|FG002|Overall Study|Failure to Return|3|||
42057701|NCT01007435|75866477|FG003|Overall Study|Failure to Return|6|||
42057702|NCT01007435|75866474|FG000|Overall Study|Reason not Specified|1|||
42057703|NCT01007435|75866475|FG001|Overall Study|Reason not Specified|1|||
42057704|NCT01007435|75866476|FG002|Overall Study|Reason not Specified|2|||
42057705|NCT01007435|75866477|FG003|Overall Study|Reason not Specified|1|||
42057706|NCT00948896|75866495|FG000|Randomization to 24 Months of Age|Death|1|||
42057707|NCT00948896|75866496|FG001|Randomization to 24 Months of Age|Death|0|||
42057708|NCT00948896|75866497|FG002|Randomization to 24 Months of Age|Death|0|||
42057709|NCT00948896|75866498|FG003|Randomization to 24 Months of Age|Death|0|||
42057710|NCT00948896|75866499|FG004|Randomization to 24 Months of Age|Death|2|||
42057711|NCT00948896|75866500|FG005|Randomization to 24 Months of Age|Death|1|||
42057712|NCT00948896|75866501|FG006|Randomization to 24 Months of Age|Death|2|||
42057713|NCT00948896|75866502|FG007|Randomization to 24 Months of Age|Death|1|||
42057714|NCT00948896|75866495|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
42057715|NCT00948896|75866496|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
42057716|NCT00948896|75866497|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
42057717|NCT00948896|75866498|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
42057718|NCT00948896|75866499|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
42057719|NCT00948896|75866500|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
42057720|NCT00948896|75866501|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
42057721|NCT00948896|75866502|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
42057722|NCT00948896|75866495|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
42057723|NCT00948896|75866496|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
42057724|NCT00948896|75866497|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
42057725|NCT00948896|75866498|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
42057726|NCT00948896|75866499|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
42057727|NCT00948896|75866500|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
42057728|NCT00948896|75866501|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
42057729|NCT00948896|75866502|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
42057730|NCT00948896|75866495|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
42057731|NCT00948896|75866496|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
42057732|NCT00948896|75866497|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
42057733|NCT00948896|75866498|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
42057734|NCT00948896|75866499|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
42057735|NCT00948896|75866500|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
42057736|NCT00948896|75866501|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
42057737|NCT00948896|75866502|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
42057738|NCT00948896|75866495|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
42057739|NCT00948896|75866496|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
42057740|NCT00948896|75866497|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
42057741|NCT00948896|75866498|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
42057742|NCT00948896|75866499|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
42057743|NCT00948896|75866500|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
42057744|NCT00948896|75866501|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
42057745|NCT00948896|75866502|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
42057746|NCT00948896|75866495|FG000|24 Months of Age to 36 Months of Age|Death|0|||
42057747|NCT00948896|75866496|FG001|24 Months of Age to 36 Months of Age|Death|2|||
42057748|NCT00948896|75866497|FG002|24 Months of Age to 36 Months of Age|Death|2|||
42057749|NCT00948896|75866498|FG003|24 Months of Age to 36 Months of Age|Death|0|||
42057750|NCT00948896|75866499|FG004|24 Months of Age to 36 Months of Age|Death|0|||
42057751|NCT00948896|75866500|FG005|24 Months of Age to 36 Months of Age|Death|1|||
42291796|NCT01968070|76125299|FG000|Period 1|Protocol Violation|0|||
42057752|NCT00948896|75866501|FG006|24 Months of Age to 36 Months of Age|Death|0|||
42057753|NCT00948896|75866502|FG007|24 Months of Age to 36 Months of Age|Death|0|||
42057754|NCT00948896|75866495|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
42057755|NCT00948896|75866496|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
42057756|NCT00948896|75866497|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
42057757|NCT00948896|75866498|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
42057758|NCT00948896|75866499|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
42057759|NCT00948896|75866500|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
42057760|NCT00948896|75866501|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
42057761|NCT00948896|75866502|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
42057762|NCT00948896|75866495|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
42057763|NCT00948896|75866496|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
42057764|NCT00948896|75866497|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
42057765|NCT00948896|75866498|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
42057766|NCT00948896|75866499|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
42057767|NCT00948896|75866500|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
42057768|NCT00948896|75866501|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
42057769|NCT00948896|75866502|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
42057770|NCT00948896|75866495|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
42057771|NCT00948896|75866496|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
42057772|NCT00948896|75866497|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
42057773|NCT00948896|75866498|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
42057774|NCT00948896|75866499|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
42057775|NCT00948896|75866500|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
42057776|NCT00948896|75866501|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
42057777|NCT00948896|75866502|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
42057778|NCT00948896|75866495|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
42057779|NCT00948896|75866496|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
42057780|NCT00948896|75866497|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
42057781|NCT00948896|75866498|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
42057782|NCT00948896|75866499|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
42057783|NCT00948896|75866500|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
42057784|NCT00948896|75866501|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
42057785|NCT00948896|75866502|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
42057786|NCT01004159|75866524|FG000|Overall Study|Adverse Event|2|||
42057787|NCT01004159|75866524|FG000|Overall Study|Disease Progression|18|||
42057788|NCT00948818|75866530|FG000|Overall Study|Adverse Event|10|||
42057789|NCT00948818|75866531|FG001|Overall Study|Adverse Event|32|||
42057790|NCT00948818|75866530|FG000|Overall Study|Protocol Violation|9|||
42057791|NCT00948818|75866531|FG001|Overall Study|Protocol Violation|10|||
42057792|NCT00948818|75866530|FG000|Overall Study|Withdrawal by Subject|25|||
42057793|NCT00948818|75866531|FG001|Overall Study|Withdrawal by Subject|25|||
42057794|NCT00948818|75866530|FG000|Overall Study|Lost to Follow-up|10|||
42057795|NCT00948818|75866531|FG001|Overall Study|Lost to Follow-up|17|||
42057796|NCT00948818|75866530|FG000|Overall Study|Lack of Efficacy|4|||
42057797|NCT00948818|75866531|FG001|Overall Study|Lack of Efficacy|5|||
42057798|NCT00948818|75866530|FG000|Overall Study|Other Reason|4|||
42057799|NCT00948818|75866531|FG001|Overall Study|Other Reason|5|||
42057800|NCT00948506|75866542|FG000|Overall Study|Withdrawal by Subject|3|||
42057801|NCT00948506|75866543|FG001|Overall Study|Withdrawal by Subject|1|||
42057802|NCT00955682|75866554|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
42057803|NCT00955682|75866555|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
42057804|NCT00689221|75866571|FG000|Overall Study|Ongoing at cut-off date|39|||
42057805|NCT00689221|75866572|FG001|Overall Study|Ongoing at cut-off date|36|||
42057806|NCT01875445|75866580|FG000|Overall Study|Lost to Follow-up|5|||
42057807|NCT01875445|75866581|FG001|Overall Study|Lost to Follow-up|0|||
42057808|NCT01875445|75866580|FG000|Overall Study|Withdrawal by Subject|2|||
42057809|NCT01875445|75866581|FG001|Overall Study|Withdrawal by Subject|0|||
42057810|NCT00688909|75866587|FG000|Overall Study|Adverse Event|28|||
42057811|NCT00688909|75866587|FG000|Overall Study|Patient withdrew consent|2|||
42057812|NCT00688909|75866587|FG000|Overall Study|Administrative problems|1|||
42057813|NCT00688909|75866587|FG000|Overall Study|Protocol Violation|2|||
42057814|NCT00948428|75866595|FG000|Overall Study|Withdrawal by Subject|6|||
42057815|NCT00948428|75866596|FG001|Overall Study|Withdrawal by Subject|12|||
42057816|NCT00948428|75866597|FG002|Overall Study|Withdrawal by Subject|7|||
42057817|NCT00948428|75866595|FG000|Overall Study|Adverse Event|6|||
42291797|NCT01968070|76125300|FG001|Period 1|Protocol Violation|0|||
42291798|NCT01968070|76125301|FG002|Period 1|Protocol Violation|0|||
42057818|NCT00948428|75866596|FG001|Overall Study|Adverse Event|3|||
42057819|NCT00948428|75866597|FG002|Overall Study|Adverse Event|0|||
42291799|NCT01968070|76125302|FG003|Period 1|Protocol Violation|1|||
42057820|NCT00948428|75866595|FG000|Overall Study|Lost to Follow-up|2|||
42057821|NCT00948428|75866596|FG001|Overall Study|Lost to Follow-up|1|||
42057822|NCT00948428|75866597|FG002|Overall Study|Lost to Follow-up|1|||
42057823|NCT00948428|75866595|FG000|Overall Study|Death|2|||
42057824|NCT00948428|75866596|FG001|Overall Study|Death|0|||
42057825|NCT00948428|75866597|FG002|Overall Study|Death|0|||
42057826|NCT00948428|75866595|FG000|Overall Study|Intercurrent Illness|1|||
42057827|NCT00948428|75866596|FG001|Overall Study|Intercurrent Illness|0|||
42057828|NCT00948428|75866597|FG002|Overall Study|Intercurrent Illness|0|||
42057829|NCT00948428|75866595|FG000|Overall Study|Non-compliance|1|||
42057830|NCT00948428|75866596|FG001|Overall Study|Non-compliance|2|||
42057831|NCT00948428|75866597|FG002|Overall Study|Non-compliance|0|||
42057832|NCT00948194|75866607|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
42057833|NCT00948194|75866608|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
42057834|NCT00691483|75866616|FG000|Overall Study|Adverse Event|14|||
42057835|NCT00691483|75866617|FG001|Overall Study|Adverse Event|6|||
42057836|NCT00691483|75866616|FG000|Overall Study|Lost to Follow-up|17|||
42057837|NCT00691483|75866617|FG001|Overall Study|Lost to Follow-up|10|||
42057838|NCT00691483|75866616|FG000|Overall Study|Withdrawal by Subject|24|||
42057839|NCT00691483|75866617|FG001|Overall Study|Withdrawal by Subject|7|||
42057840|NCT00691483|75866616|FG000|Overall Study|Other known cause|6|||
42057841|NCT00691483|75866617|FG001|Overall Study|Other known cause|1|||
42057842|NCT00691483|75866616|FG000|Overall Study|Randomized by not treated|7|||
42057843|NCT00691483|75866617|FG001|Overall Study|Randomized by not treated|1|||
42057844|NCT00691093|75866623|FG000|Overall Study|Adverse Event|1|||
42057845|NCT00691093|75866623|FG000|Overall Study|Lost to Follow-up|1|||
42057846|NCT00691093|75866623|FG000|Overall Study|Lack of Efficacy|1|||
42057847|NCT00691093|75866623|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
42057848|NCT00947882|75866636|FG000|Overall Study|Adverse Event|0|||
42057849|NCT00947882|75866637|FG001|Overall Study|Adverse Event|1|||
42057850|NCT00947882|75866638|FG002|Overall Study|Adverse Event|4|||
42057851|NCT00947882|75866639|FG003|Overall Study|Adverse Event|4|||
42057852|NCT00947882|75866636|FG000|Overall Study|Withdrawal by Subject|2|||
42057853|NCT00947882|75866637|FG001|Overall Study|Withdrawal by Subject|0|||
42057854|NCT00947882|75866638|FG002|Overall Study|Withdrawal by Subject|8|||
42057855|NCT00947882|75866639|FG003|Overall Study|Withdrawal by Subject|2|||
42057856|NCT00947882|75866636|FG000|Overall Study|Protocol Violation|0|||
42057857|NCT00947882|75866637|FG001|Overall Study|Protocol Violation|0|||
42057858|NCT00947882|75866638|FG002|Overall Study|Protocol Violation|1|||
42057859|NCT00947882|75866639|FG003|Overall Study|Protocol Violation|0|||
42057860|NCT00947882|75866636|FG000|Overall Study|Lost to Follow-up|0|||
42057861|NCT00947882|75866637|FG001|Overall Study|Lost to Follow-up|2|||
42057862|NCT00947882|75866638|FG002|Overall Study|Lost to Follow-up|1|||
42057863|NCT00947882|75866639|FG003|Overall Study|Lost to Follow-up|0|||
42057864|NCT00947882|75866636|FG000|Overall Study|Other/Unknown|10|||
42057865|NCT00947882|75866637|FG001|Overall Study|Other/Unknown|13|||
42057866|NCT00947882|75866638|FG002|Overall Study|Other/Unknown|3|||
42057867|NCT00947882|75866639|FG003|Overall Study|Other/Unknown|6|||
42057868|NCT00947882|75866636|FG000|Overall Study|Trial Terminated by Sponsor|62|||
42057869|NCT00947882|75866637|FG001|Overall Study|Trial Terminated by Sponsor|61|||
42057870|NCT00947882|75866638|FG002|Overall Study|Trial Terminated by Sponsor|62|||
42057871|NCT00947882|75866639|FG003|Overall Study|Trial Terminated by Sponsor|70|||
42057872|NCT00688753|75866650|FG000|Overall Study|Disease progression|55|||
42057873|NCT00688753|75866650|FG000|Overall Study|Missing|1|||
42057874|NCT00688753|75866650|FG000|Overall Study|Death|9|||
42057875|NCT00688753|75866650|FG000|Overall Study|Withdrawal by Subject|3|||
42057876|NCT00688753|75866650|FG000|Overall Study|Adverse Event|20|||
42057877|NCT00688753|75866650|FG000|Overall Study|Protocol Violation|1|||
42057878|NCT00688753|75866650|FG000|Overall Study|Lost to Follow-up|3|||
42057879|NCT00951080|75866656|FG000|Overall Study|Adverse Event|3|||
42057880|NCT00951080|75866657|FG001|Overall Study|Adverse Event|3|||
42057881|NCT00951080|75866656|FG000|Overall Study|Lost to Follow-up|0|||
42057882|NCT00951080|75866657|FG001|Overall Study|Lost to Follow-up|1|||
42057883|NCT00951080|75866656|FG000|Overall Study|Physician Decision|4|||
42057884|NCT00951080|75866657|FG001|Overall Study|Physician Decision|1|||
42291800|NCT01968070|76125303|FG004|Period 1|Protocol Violation|1|||
42291801|NCT01968070|76125304|FG005|Period 1|Protocol Violation|0|||
42291802|NCT01968070|76125305|FG006|Period 1|Protocol Violation|0|||
42291803|NCT01968070|76125306|FG007|Period 1|Protocol Violation|0|||
42291804|NCT01968070|76125307|FG008|Period 1|Protocol Violation|0|||
42291805|NCT01968070|76125308|FG009|Period 1|Protocol Violation|0|||
42291806|NCT01968070|76125309|FG010|Period 1|Protocol Violation|0|||
42057885|NCT00951080|75866656|FG000|Overall Study|Other|19|||
42057886|NCT00951080|75866657|FG001|Overall Study|Other|22|||
42057887|NCT00946322|75866663|FG000|Pre-treatment|participant failure to follow up|1|||
42057888|NCT00946322|75866663|FG000|Post-treatment|participant failure to follow up|2|||
42057889|NCT00950690|75866667|FG000|Overall Study|Death|4|||
42057890|NCT00950690|75866667|FG000|Overall Study|Adverse Event|15|||
42291807|NCT01968070|76125310|FG011|Period 1|Protocol Violation|0|||
42057891|NCT00950690|75866667|FG000|Overall Study|Lack of Efficacy|22|||
42057892|NCT00950690|75866667|FG000|Overall Study|Lost to Follow-up|40|||
42057893|NCT00950690|75866667|FG000|Overall Study|Other|163|||
42057894|NCT00694369|75866676|FG000|Overall Study|Adverse Event|0|||
42057895|NCT00694369|75866677|FG001|Overall Study|Adverse Event|1|||
42057896|NCT00694369|75866678|FG002|Overall Study|Adverse Event|0|||
42057897|NCT00694369|75866679|FG003|Overall Study|Adverse Event|1|||
42057898|NCT00694369|75866680|FG004|Overall Study|Adverse Event|3|||
42057899|NCT00694369|75866676|FG000|Overall Study|Lost to Follow-up|0|||
42057900|NCT00694369|75866677|FG001|Overall Study|Lost to Follow-up|0|||
42057901|NCT00694369|75866678|FG002|Overall Study|Lost to Follow-up|1|||
42057902|NCT00694369|75866679|FG003|Overall Study|Lost to Follow-up|1|||
42057903|NCT00694369|75866680|FG004|Overall Study|Lost to Follow-up|0|||
42057904|NCT00694369|75866676|FG000|Overall Study|Physician Decision|0|||
42057905|NCT00694369|75866677|FG001|Overall Study|Physician Decision|0|||
42057906|NCT00694369|75866678|FG002|Overall Study|Physician Decision|0|||
42057907|NCT00694369|75866679|FG003|Overall Study|Physician Decision|0|||
42057908|NCT00694369|75866680|FG004|Overall Study|Physician Decision|1|||
42057909|NCT00694369|75866676|FG000|Overall Study|Protocol Violation|0|||
42057910|NCT00694369|75866677|FG001|Overall Study|Protocol Violation|1|||
42057911|NCT00694369|75866678|FG002|Overall Study|Protocol Violation|0|||
42057912|NCT00694369|75866679|FG003|Overall Study|Protocol Violation|0|||
42057913|NCT00694369|75866680|FG004|Overall Study|Protocol Violation|0|||
42057914|NCT00694369|75866676|FG000|Overall Study|Withdrawal by Subject|1|||
42057915|NCT00694369|75866677|FG001|Overall Study|Withdrawal by Subject|1|||
42057916|NCT00694369|75866678|FG002|Overall Study|Withdrawal by Subject|1|||
42057917|NCT00694369|75866679|FG003|Overall Study|Withdrawal by Subject|1|||
42057918|NCT00694369|75866680|FG004|Overall Study|Withdrawal by Subject|2|||
42057919|NCT00513019|75866694|FG000|Overall Study|Adverse Event|1|||
42057920|NCT00513019|75866695|FG001|Overall Study|Adverse Event|0|||
42057921|NCT00513019|75866694|FG000|Overall Study|Withdrawal by Subject|4|||
42057922|NCT00513019|75866695|FG001|Overall Study|Withdrawal by Subject|5|||
42057923|NCT00954512|75866716|FG000|Overall Study|Withdrawal by Subject|0|||
42057924|NCT00954512|75866717|FG001|Overall Study|Withdrawal by Subject|0|||
42057925|NCT00954512|75866718|FG002|Overall Study|Withdrawal by Subject|0|||
42174111|NCT03314662|75980876|FG000|Overall Study|Withdrawal by Subject|1|||
42174112|NCT03314662|75980877|FG001|Overall Study|Withdrawal by Subject|1|||
42016578|NCT02842827|75824018|FG002|Overall Study|Protocol Defined Disease Progression|0|||
42016579|NCT02842827|75824019|FG003|Overall Study|Protocol Defined Disease Progression|0|||
42016580|NCT02842827|75824020|FG004|Overall Study|Protocol Defined Disease Progression|0|||
42016581|NCT02842827|75824021|FG005|Overall Study|Protocol Defined Disease Progression|1|||
42016582|NCT02842827|75824022|FG006|Overall Study|Protocol Defined Disease Progression|0|||
42016583|NCT02842827|75824023|FG007|Overall Study|Protocol Defined Disease Progression|0|||
42016584|NCT02842827|75824016|FG000|Overall Study|Participant Withdrawal of Consent|1|||
42016585|NCT02842827|75824017|FG001|Overall Study|Participant Withdrawal of Consent|2|||
42016586|NCT02842827|75824018|FG002|Overall Study|Participant Withdrawal of Consent|2|||
42016587|NCT02842827|75824019|FG003|Overall Study|Participant Withdrawal of Consent|2|||
42016588|NCT02842827|75824020|FG004|Overall Study|Participant Withdrawal of Consent|2|||
42016589|NCT02842827|75824021|FG005|Overall Study|Participant Withdrawal of Consent|1|||
42016590|NCT02842827|75824022|FG006|Overall Study|Participant Withdrawal of Consent|2|||
42057926|NCT00954512|75866719|FG003|Overall Study|Withdrawal by Subject|0|||
42057927|NCT00954512|75866720|FG004|Overall Study|Withdrawal by Subject|0|||
42057928|NCT00954512|75866721|FG005|Overall Study|Withdrawal by Subject|1|||
42057929|NCT00954512|75866716|FG000|Overall Study|Adverse Event|0|||
42057930|NCT00954512|75866717|FG001|Overall Study|Adverse Event|0|||
42057931|NCT00954512|75866718|FG002|Overall Study|Adverse Event|0|||
42057932|NCT00954512|75866719|FG003|Overall Study|Adverse Event|0|||
42057933|NCT00954512|75866720|FG004|Overall Study|Adverse Event|1|||
42057934|NCT00954512|75866721|FG005|Overall Study|Adverse Event|2|||
42057935|NCT00954512|75866716|FG000|Overall Study|Physician Decision|0|||
42057936|NCT00954512|75866717|FG001|Overall Study|Physician Decision|1|||
42057937|NCT00954512|75866718|FG002|Overall Study|Physician Decision|0|||
42057938|NCT00954512|75866719|FG003|Overall Study|Physician Decision|1|||
42174113|NCT03314662|75980878|FG002|Overall Study|Withdrawal by Subject|1|||
42174114|NCT03314662|75980876|FG000|Overall Study|Lost to Follow-up|5|||
42174115|NCT03314662|75980877|FG001|Overall Study|Lost to Follow-up|4|||
42174116|NCT03314662|75980878|FG002|Overall Study|Lost to Follow-up|4|||
42174117|NCT03314662|75980876|FG000|Overall Study|Death|2|||
42174118|NCT03314662|75980877|FG001|Overall Study|Death|0|||
42174119|NCT03314662|75980878|FG002|Overall Study|Death|0|||
42174120|NCT03271528|75980896|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
42174121|NCT03271528|75980897|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
42174122|NCT03271528|75980896|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
42174123|NCT03271528|75980897|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
42174124|NCT03271528|75980896|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
42174125|NCT03271528|75980897|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
42174126|NCT03271528|75980896|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
42174127|NCT03271528|75980897|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
42174128|NCT03271528|75980896|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
42174129|NCT03271528|75980897|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
42291808|NCT01968070|76125311|FG012|Period 1|Protocol Violation|0|||
42291809|NCT01968070|76125312|FG013|Period 1|Protocol Violation|0|||
42291810|NCT01968070|76125313|FG014|Period 1|Protocol Violation|0|||
42057939|NCT00954512|75866720|FG004|Overall Study|Physician Decision|0|||
42057940|NCT00954512|75866721|FG005|Overall Study|Physician Decision|0|||
42057941|NCT00954512|75866716|FG000|Overall Study|Symptomatic Deterioration|0|||
42057942|NCT00954512|75866717|FG001|Overall Study|Symptomatic Deterioration|1|||
42057943|NCT00954512|75866718|FG002|Overall Study|Symptomatic Deterioration|0|||
42057944|NCT00954512|75866719|FG003|Overall Study|Symptomatic Deterioration|0|||
42057945|NCT00954512|75866720|FG004|Overall Study|Symptomatic Deterioration|2|||
42057946|NCT00954512|75866721|FG005|Overall Study|Symptomatic Deterioration|0|||
42057947|NCT00954512|75866716|FG000|Overall Study|Progression of Disease|2|||
42057948|NCT00954512|75866717|FG001|Overall Study|Progression of Disease|1|||
42057949|NCT00954512|75866718|FG002|Overall Study|Progression of Disease|0|||
42057950|NCT00954512|75866719|FG003|Overall Study|Progression of Disease|1|||
42057951|NCT00954512|75866720|FG004|Overall Study|Progression of Disease|1|||
42057952|NCT00954512|75866721|FG005|Overall Study|Progression of Disease|1|||
42057953|NCT00691015|75866734|FG000|Overall Study|Refused further treatment|1|||
42057954|NCT00950300|75866740|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
42057955|NCT00950300|75866741|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
42057956|NCT00950300|75866740|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
42057957|NCT00950300|75866741|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
42057958|NCT00950300|75866740|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
42057959|NCT00950300|75866741|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
42174130|NCT03271528|75980896|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
42057960|NCT00950300|75866740|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
42057961|NCT00950300|75866741|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
42057962|NCT00950300|75866740|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
42174131|NCT03271528|75980897|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
42174132|NCT03271528|75980896|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
42291811|NCT01968070|76125314|FG015|Period 1|Protocol Violation|0|||
42291812|NCT01968070|76125315|FG016|Period 1|Protocol Violation|0|||
42057963|NCT00950300|75866741|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
42057964|NCT00950300|75866740|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
42057965|NCT00950300|75866741|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
42057966|NCT00950300|75866740|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
42057967|NCT00950300|75866741|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
42057968|NCT00950300|75866740|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
42057969|NCT00950300|75866741|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
42057970|NCT00950300|75866740|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
42057971|NCT00950300|75866741|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
42057972|NCT00950300|75866740|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
42057973|NCT00950300|75866741|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
42057974|NCT00950300|75866740|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
42057975|NCT00950300|75866741|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
42057976|NCT00950300|75866740|FG000|TFFU Period|Death|4|||
42057977|NCT00950300|75866741|FG001|TFFU Period|Death|1|||
42057978|NCT00950300|75866740|FG000|TFFU Period|Refused Treatment|10|||
42057979|NCT00950300|75866741|FG001|TFFU Period|Refused Treatment|11|||
42057980|NCT00950300|75866740|FG000|TFFU Period|Failure to Return|16|||
42057981|NCT00950300|75866741|FG001|TFFU Period|Failure to Return|16|||
42057982|NCT00950300|75866740|FG000|TFFU Period|Recurrence of Disease|63|||
42057983|NCT00950300|75866741|FG001|TFFU Period|Recurrence of Disease|72|||
42057984|NCT00950300|75866740|FG000|TFFU Period|Other|4|||
42057985|NCT00950300|75866741|FG001|TFFU Period|Other|3|||
42057986|NCT00950300|75866740|FG000|SFU Period|Death|44|||
42057987|NCT00950300|75866741|FG001|SFU Period|Death|42|||
42057988|NCT00950300|75866740|FG000|SFU Period|Lost to Follow-up|30|||
42057989|NCT00950300|75866741|FG001|SFU Period|Lost to Follow-up|28|||
42057990|NCT00950300|75866740|FG000|SFU Period|Withdrawal by Subject|4|||
42057991|NCT00950300|75866741|FG001|SFU Period|Withdrawal by Subject|8|||
42057992|NCT00949988|75866748|FG000|Overall Study|Withdrawal by Subject|3|||
42057993|NCT00731692|75866755|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
42057994|NCT00731692|75866756|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
42057995|NCT00731692|75866757|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
42057996|NCT00731692|75866755|FG000|Core Study (36 Months)|Physician Decision|1|||
42057997|NCT00731692|75866756|FG001|Core Study (36 Months)|Physician Decision|0|||
42057998|NCT00731692|75866757|FG002|Core Study (36 Months)|Physician Decision|2|||
42057999|NCT00731692|75866755|FG000|Core Study (36 Months)|Death|2|||
42058000|NCT00731692|75866756|FG001|Core Study (36 Months)|Death|1|||
42058001|NCT00731692|75866757|FG002|Core Study (36 Months)|Death|2|||
42058002|NCT00731692|75866755|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
42058003|NCT00731692|75866756|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
42058004|NCT00731692|75866757|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
42058005|NCT00731692|75866755|FG000|Core Study (36 Months)|Administrative|2|||
42058006|NCT00731692|75866756|FG001|Core Study (36 Months)|Administrative|2|||
42058007|NCT00731692|75866757|FG002|Core Study (36 Months)|Administrative|6|||
42058008|NCT00731692|75866755|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
42058009|NCT00731692|75866756|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
42058010|NCT00731692|75866757|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
42058011|NCT00731692|75866755|FG000|Core Study (36 Months)|Protocol Violation|4|||
42058012|NCT00731692|75866756|FG001|Core Study (36 Months)|Protocol Violation|5|||
42058013|NCT00731692|75866757|FG002|Core Study (36 Months)|Protocol Violation|8|||
42058014|NCT00731692|75866755|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
42058015|NCT00731692|75866756|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
42058016|NCT00731692|75866757|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
42058017|NCT00731692|75866755|FG000|Core Study (36 Months)|Adverse Event|25|||
42058018|NCT00731692|75866756|FG001|Core Study (36 Months)|Adverse Event|28|||
42058019|NCT00731692|75866757|FG002|Core Study (36 Months)|Adverse Event|29|||
42058020|NCT00731692|75866755|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
42058021|NCT00731692|75866756|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
42058022|NCT00731692|75866757|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
42058023|NCT00731692|75866755|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
42058024|NCT00731692|75866756|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
42058025|NCT00731692|75866757|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
42058026|NCT00731692|75866755|FG000|Extension Phase|Abnormal test procedure|0|||
42058027|NCT00731692|75866756|FG001|Extension Phase|Abnormal test procedure|0|||
42058028|NCT00731692|75866757|FG002|Extension Phase|Abnormal test procedure|1|||
42058029|NCT00731692|75866755|FG000|Extension Phase|Abnormal lab values|0|||
42058030|NCT00731692|75866756|FG001|Extension Phase|Abnormal lab values|0|||
42058031|NCT00731692|75866757|FG002|Extension Phase|Abnormal lab values|1|||
42058032|NCT00731692|75866755|FG000|Extension Phase|Lost to Follow-up|0|||
42058033|NCT00731692|75866756|FG001|Extension Phase|Lost to Follow-up|1|||
42058034|NCT00731692|75866757|FG002|Extension Phase|Lost to Follow-up|4|||
42058035|NCT00731692|75866755|FG000|Extension Phase|Withdrawal by Subject|4|||
42058036|NCT00731692|75866756|FG001|Extension Phase|Withdrawal by Subject|5|||
42058037|NCT00731692|75866757|FG002|Extension Phase|Withdrawal by Subject|3|||
42058038|NCT00731692|75866755|FG000|Extension Phase|Adverse Event|1|||
42058039|NCT00731692|75866756|FG001|Extension Phase|Adverse Event|1|||
42058040|NCT00731692|75866757|FG002|Extension Phase|Adverse Event|15|||
42058041|NCT00687193|75866779|FG000|Overall Study|Adverse Event|0|||
42058042|NCT00687193|75866780|FG001|Overall Study|Adverse Event|1|||
42058043|NCT00687193|75866781|FG002|Overall Study|Adverse Event|2|||
42058044|NCT00687193|75866782|FG003|Overall Study|Adverse Event|3|||
42058045|NCT00687193|75866783|FG004|Overall Study|Adverse Event|0|||
42058046|NCT00687193|75866784|FG005|Overall Study|Adverse Event|2|||
42058047|NCT00687193|75866779|FG000|Overall Study|Lack of Efficacy|1|||
42058048|NCT00687193|75866780|FG001|Overall Study|Lack of Efficacy|1|||
42058049|NCT00687193|75866781|FG002|Overall Study|Lack of Efficacy|0|||
42058050|NCT00687193|75866782|FG003|Overall Study|Lack of Efficacy|0|||
42058051|NCT00687193|75866783|FG004|Overall Study|Lack of Efficacy|0|||
42058052|NCT00687193|75866784|FG005|Overall Study|Lack of Efficacy|2|||
42058053|NCT00687193|75866779|FG000|Overall Study|Protocol Violation|1|||
42058054|NCT00687193|75866780|FG001|Overall Study|Protocol Violation|2|||
42058055|NCT00687193|75866781|FG002|Overall Study|Protocol Violation|0|||
42058056|NCT00687193|75866782|FG003|Overall Study|Protocol Violation|1|||
42058057|NCT00687193|75866783|FG004|Overall Study|Protocol Violation|2|||
42058058|NCT00687193|75866784|FG005|Overall Study|Protocol Violation|0|||
42058059|NCT00730912|75866804|FG000|Overall Study|Discontinued|0|||
42058060|NCT00730912|75866805|FG001|Overall Study|Discontinued|0|||
42058061|NCT00730912|75866806|FG002|Overall Study|Discontinued|1|||
42058062|NCT00730756|75866816|FG000|Overall Study|Adverse Event|2|||
42058063|NCT00730756|75866817|FG001|Overall Study|Adverse Event|0|||
42058064|NCT00730756|75866816|FG000|Overall Study|Lack of Efficacy|1|||
42058065|NCT00730756|75866817|FG001|Overall Study|Lack of Efficacy|1|||
42058066|NCT00730756|75866816|FG000|Overall Study|Protocol Deviation|1|||
42058067|NCT00730756|75866817|FG001|Overall Study|Protocol Deviation|2|||
42058068|NCT00730756|75866816|FG000|Overall Study|Lost to Follow-up|0|||
42058069|NCT00730756|75866817|FG001|Overall Study|Lost to Follow-up|1|||
42058070|NCT00730756|75866816|FG000|Overall Study|Withdrew Consent|0|||
42058071|NCT00730756|75866817|FG001|Overall Study|Withdrew Consent|1|||
42058072|NCT00730132|75866823|FG000|Overall Study|Protocol Violation|154|||
42058073|NCT00730132|75866823|FG000|Overall Study|Death|1|||
42058074|NCT00737464|75866830|FG000|Overall Study|Adverse Event|1|||
42058075|NCT00737464|75866830|FG000|Overall Study|Death|6|||
42058076|NCT00737464|75866830|FG000|Overall Study|Other - Failure to Return|1|||
42058077|NCT00737464|75866830|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
42058078|NCT00737464|75866830|FG000|Overall Study|Other reasons|4|||
42058079|NCT00729586|75866836|FG000|Overall Study|Ineligible|0|||
42058080|NCT00729586|75866837|FG001|Overall Study|Ineligible|1|||
42058081|NCT00729586|75866836|FG000|Overall Study|never treated|1|||
42058082|NCT00729586|75866837|FG001|Overall Study|never treated|0|||
42058083|NCT00949910|75866844|FG000|Overall Study|Progressive Disease|3750|||
42058084|NCT00949910|75866844|FG000|Overall Study|Symptomatic Deterioration|1088|||
42291813|NCT01968070|76125316|FG017|Period 1|Protocol Violation|0|||
42016591|NCT02842827|75824023|FG007|Overall Study|Participant Withdrawal of Consent|1|||
42016592|NCT02432274|75824049|FG000|Overall Study|Death|2|||
42016593|NCT02432274|75824050|FG001|Overall Study|Death|6|||
42016594|NCT02432274|75824051|FG002|Overall Study|Death|7|||
42016595|NCT02432274|75824052|FG003|Overall Study|Death|0|||
42016596|NCT02432274|75824053|FG004|Overall Study|Death|27|||
42016597|NCT02432274|75824054|FG005|Overall Study|Death|7|||
42016598|NCT02432274|75824055|FG006|Overall Study|Death|9|||
42016599|NCT02432274|75824056|FG007|Overall Study|Death|14|||
42016600|NCT02432274|75824049|FG000|Overall Study|Withdrawal of Consent|0|||
42016601|NCT02432274|75824050|FG001|Overall Study|Withdrawal of Consent|0|||
42016602|NCT02432274|75824051|FG002|Overall Study|Withdrawal of Consent|0|||
42016603|NCT02432274|75824052|FG003|Overall Study|Withdrawal of Consent|0|||
42016604|NCT02432274|75824053|FG004|Overall Study|Withdrawal of Consent|2|||
42016605|NCT02432274|75824054|FG005|Overall Study|Withdrawal of Consent|0|||
42016606|NCT02432274|75824055|FG006|Overall Study|Withdrawal of Consent|1|||
42016607|NCT02432274|75824056|FG007|Overall Study|Withdrawal of Consent|2|||
42016608|NCT02393859|75824092|FG000|Overall Study|Decision by Sponsor|2|||
42016609|NCT02393859|75824093|FG001|Overall Study|Decision by Sponsor|4|||
42016610|NCT02393859|75824092|FG000|Overall Study|Withdrawal by Subject|11|||
42016611|NCT02393859|75824093|FG001|Overall Study|Withdrawal by Subject|6|||
42016612|NCT02393859|75824092|FG000|Overall Study|Death|27|||
42016613|NCT02393859|75824093|FG001|Overall Study|Death|10|||
42058085|NCT00949910|75866844|FG000|Overall Study|Lost to Follow-up|100|||
42058086|NCT00949910|75866844|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
42058087|NCT00949910|75866844|FG000|Overall Study|Participant Refusal|390|||
42058088|NCT00949910|75866844|FG000|Overall Study|Death Due to Malignant Disease|456|||
42058089|NCT00949910|75866844|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
42058090|NCT00949910|75866844|FG000|Overall Study|Death Due to Adverse Event|115|||
42058091|NCT00949910|75866844|FG000|Overall Study|Death Due to Toxicity|3|||
42058092|NCT00949910|75866844|FG000|Overall Study|Death from Unknown Cause|5|||
42058093|NCT00949910|75866844|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
42058094|NCT00949910|75866844|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
42058095|NCT00949910|75866844|FG000|Overall Study|Switched to Commercial Treatment|4|||
42058096|NCT00949910|75866844|FG000|Overall Study|Violation of Eligibility|23|||
42058097|NCT00949910|75866844|FG000|Overall Study|Logistical Reasons|13|||
42058098|NCT00949910|75866844|FG000|Overall Study|Non-Compliance|10|||
42058099|NCT00949910|75866844|FG000|Overall Study|Prolonged Dosing Interruption|4|||
42058100|NCT00949910|75866844|FG000|Overall Study|Adverse Event|83|||
42058101|NCT00949910|75866844|FG000|Overall Study|Serious Adverse Event|6|||
42058102|NCT00949910|75866844|FG000|Overall Study|Physician/Participant Decision|7|||
42058103|NCT00949910|75866844|FG000|Overall Study|Other|4|||
42058104|NCT00949910|75866844|FG000|Overall Study|No Data|9|||
42058105|NCT00686959|75866850|FG000|Overall Study|Participants censored (no death events)|124|||
42058106|NCT00686959|75866851|FG001|Overall Study|Participants censored (no death events)|117|||
42058107|NCT00946088|75866859|FG000|Overall Study|Withdrawal by Subject|0|||
42058108|NCT00946088|75866860|FG001|Overall Study|Withdrawal by Subject|1|||
42058109|NCT00736996|75866871|FG000|Overall Study|Lost to Follow-up|1|||
42058110|NCT00736996|75866872|FG001|Overall Study|Lost to Follow-up|9|||
42058111|NCT00736996|75866873|FG002|Overall Study|Lost to Follow-up|2|||
42058112|NCT00728962|75866887|FG000|Implant Placement Surgery|Adverse Event|8|||
42058113|NCT00728962|75866887|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
42058114|NCT00728962|75866887|FG000|Implant Placement Surgery|Protocol Violation|1|||
42058115|NCT00728962|75866887|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
42058116|NCT00728962|75866887|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
42058117|NCT00954122|75866891|FG000|Overall Study|Withdrawal by Subject|5|||
42058118|NCT00954122|75866891|FG000|Overall Study|Adverse Event|1|||
42058119|NCT00954122|75866891|FG000|Overall Study|Safety Reason|1|||
42058120|NCT00586066|75866898|FG000|Overall Study|Lost to Follow-up|6|||
42058121|NCT00586066|75866899|FG001|Overall Study|Lost to Follow-up|3|||
42058122|NCT00586066|75866898|FG000|Overall Study|Lack of Efficacy|5|||
42058123|NCT00586066|75866899|FG001|Overall Study|Lack of Efficacy|3|||
42058124|NCT00586066|75866898|FG000|Overall Study|Adverse Event|2|||
42058125|NCT00586066|75866899|FG001|Overall Study|Adverse Event|2|||
42058126|NCT00586066|75866898|FG000|Overall Study|Physician Decision|1|||
42058127|NCT00586066|75866899|FG001|Overall Study|Physician Decision|0|||
42058128|NCT00586066|75866898|FG000|Overall Study|Withdrawal of consent|4|||
42058129|NCT00586066|75866899|FG001|Overall Study|Withdrawal of consent|2|||
42058132|NCT00728494|75866911|FG000|Overall Study|Adverse Event|7|||
42058133|NCT00728494|75866912|FG001|Overall Study|Adverse Event|0|||
42058134|NCT00728494|75866911|FG000|Overall Study|Withdrawal by Subject|0|||
42058135|NCT00728494|75866912|FG001|Overall Study|Withdrawal by Subject|2|||
42058136|NCT00728494|75866911|FG000|Overall Study|Lack of Efficacy|2|||
42058137|NCT00728494|75866912|FG001|Overall Study|Lack of Efficacy|4|||
42058138|NCT00728494|75866911|FG000|Overall Study|No data available|0|||
42058139|NCT00728494|75866912|FG001|Overall Study|No data available|1|||
42058140|NCT00728416|75866920|FG000|Overall Study|Adverse Event|1|||
42058141|NCT00728416|75866921|FG001|Overall Study|Adverse Event|1|||
42058142|NCT00728416|75866920|FG000|Overall Study|Treatment Failure|0|||
42058143|NCT00728416|75866921|FG001|Overall Study|Treatment Failure|1|||
42058144|NCT00728416|75866920|FG000|Overall Study|Withdrawal by Subject|1|||
42058145|NCT00728416|75866921|FG001|Overall Study|Withdrawal by Subject|0|||
42058146|NCT00728182|75866929|FG000|Overall Study|Adverse Event|1|||
42058147|NCT00728182|75866930|FG001|Overall Study|Adverse Event|0|||
42058148|NCT00728182|75866929|FG000|Overall Study|Lost to Follow-up|2|||
42058149|NCT00728182|75866930|FG001|Overall Study|Lost to Follow-up|0|||
42058150|NCT00728182|75866929|FG000|Overall Study|Death|0|||
42058151|NCT00728182|75866930|FG001|Overall Study|Death|2|||
42058152|NCT00728182|75866929|FG000|Overall Study|Protocol Noncompliance|0|||
42058153|NCT00728182|75866930|FG001|Overall Study|Protocol Noncompliance|1|||
42058154|NCT00941330|75866940|FG000|Overall Study|Other|1|||
42058155|NCT00941330|75866941|FG001|Overall Study|Other|0|||
42058156|NCT00941330|75866940|FG000|Overall Study|Physician Decision|0|||
42174133|NCT03271528|75980897|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
42174134|NCT03301714|75980906|FG000|Overall Study|Lost to Follow-up|10|||
42058157|NCT00941330|75866941|FG001|Overall Study|Physician Decision|2|||
42058158|NCT00686881|75866949|FG000|Overall Study|Withdrawal by Subject|11|||
42174135|NCT03301714|75980907|FG001|Overall Study|Lost to Follow-up|4|||
42058159|NCT00686881|75866950|FG001|Overall Study|Withdrawal by Subject|18|||
42058160|NCT00686881|75866949|FG000|Overall Study|Lost to Follow-up|0|||
42058161|NCT00686881|75866950|FG001|Overall Study|Lost to Follow-up|1|||
42058162|NCT00686881|75866949|FG000|Overall Study|Treatment-related adverse event|10|||
42058163|NCT00686881|75866950|FG001|Overall Study|Treatment-related adverse event|9|||
42058164|NCT00686881|75866949|FG000|Overall Study|Met discontinuation criteria|5|||
42058165|NCT00686881|75866950|FG001|Overall Study|Met discontinuation criteria|0|||
42058166|NCT00686881|75866949|FG000|Overall Study|Onset of malignant tumor|11|||
42058167|NCT00686881|75866950|FG001|Overall Study|Onset of malignant tumor|11|||
42058168|NCT00686881|75866949|FG000|Overall Study|Lack of Efficacy|4|||
42058169|NCT00686881|75866950|FG001|Overall Study|Lack of Efficacy|3|||
42058170|NCT00686881|75866949|FG000|Overall Study|Physician Decision|1|||
42058171|NCT00686881|75866950|FG001|Overall Study|Physician Decision|0|||
42058172|NCT00686881|75866949|FG000|Overall Study|Circumstances of site|1|||
42058173|NCT00686881|75866950|FG001|Overall Study|Circumstances of site|1|||
42058174|NCT00686881|75866949|FG000|Overall Study|Did not meet protocol eligibility|1|||
42058175|NCT00686881|75866950|FG001|Overall Study|Did not meet protocol eligibility|0|||
42058176|NCT00686881|75866949|FG000|Overall Study|Irregular visits|1|||
42058177|NCT00686881|75866950|FG001|Overall Study|Irregular visits|0|||
42058178|NCT00686881|75866949|FG000|Overall Study|Study discontinuation|35|||
42058179|NCT00686881|75866950|FG001|Overall Study|Study discontinuation|32|||
42058180|NCT00686881|75866949|FG000|Overall Study|Never received study drug|2|||
42058181|NCT00686881|75866950|FG001|Overall Study|Never received study drug|6|||
42058182|NCT00727714|75866958|FG000|Overall Study|Lost to Follow-up|2|||
42058183|NCT00727558|75866964|FG000|Overall Study|Lens issue|0|||
42058184|NCT00727558|75866965|FG001|Overall Study|Lens issue|1|||
42058185|NCT00727558|75866964|FG000|Overall Study|Adverse Event|0|||
42058186|NCT00727558|75866965|FG001|Overall Study|Adverse Event|1|||
42058187|NCT00727558|75866964|FG000|Overall Study|Subject unable to return for follow-up|1|||
42058188|NCT00727558|75866965|FG001|Overall Study|Subject unable to return for follow-up|1|||
42058189|NCT00727558|75866964|FG000|Overall Study|Lost to Follow-up|1|||
42058190|NCT00727558|75866965|FG001|Overall Study|Lost to Follow-up|0|||
42058191|NCT00688597|75866974|FG000|Overall Study|Adverse Event|2|||
42058192|NCT00688597|75866975|FG001|Overall Study|Adverse Event|0|||
42058193|NCT00688597|75866976|FG002|Overall Study|Adverse Event|0|||
42058194|NCT00688597|75866974|FG000|Overall Study|Physician Decision|1|||
42058195|NCT00688597|75866975|FG001|Overall Study|Physician Decision|0|||
42058196|NCT00688597|75866976|FG002|Overall Study|Physician Decision|0|||
42058197|NCT00735904|75866984|FG000|Overall Study|Adverse Event|3|||
42058198|NCT00735904|75866984|FG000|Overall Study|Death|20|||
42058199|NCT00735904|75866984|FG000|Overall Study|Protocol Violation|1|||
42058200|NCT00735904|75866984|FG000|Overall Study|Withdrawal by Subject|1|||
42058201|NCT00735904|75866984|FG000|Overall Study|Study Terminated by Sponsor|5|||
42058202|NCT00735904|75866984|FG000|Overall Study|Other|8|||
42058203|NCT00688519|75866990|FG000|Overall Study|Adverse Event|2|||
42058204|NCT00688519|75866991|FG001|Overall Study|Adverse Event|3|||
42058205|NCT00688519|75866990|FG000|Overall Study|Lost to Follow-up|3|||
42058206|NCT00688519|75866991|FG001|Overall Study|Lost to Follow-up|3|||
42058207|NCT00688519|75866990|FG000|Overall Study|Lack of Efficacy|3|||
42058208|NCT00688519|75866991|FG001|Overall Study|Lack of Efficacy|1|||
42058209|NCT00688519|75866990|FG000|Overall Study|Withdrawal by Subject|7|||
42058210|NCT00688519|75866991|FG001|Overall Study|Withdrawal by Subject|6|||
42058211|NCT00688519|75866990|FG000|Overall Study|Prohibited medication|1|||
42058212|NCT00688519|75866991|FG001|Overall Study|Prohibited medication|0|||
42058213|NCT00688519|75866990|FG000|Overall Study|Non-compliance|0|||
42058214|NCT00688519|75866991|FG001|Overall Study|Non-compliance|1|||
42058215|NCT00688519|75866990|FG000|Overall Study|Subject moved out of state|1|||
42058216|NCT00688519|75866991|FG001|Overall Study|Subject moved out of state|0|||
42058217|NCT00688519|75866990|FG000|Overall Study|Investigator decision|1|||
42058218|NCT00688519|75866991|FG001|Overall Study|Investigator decision|0|||
42058219|NCT00688519|75866990|FG000|Overall Study|Subject moved out of area|1|||
42058220|NCT00688519|75866991|FG001|Overall Study|Subject moved out of area|0|||
42058221|NCT00688519|75866990|FG000|Overall Study|Pregnancy|0|||
42058222|NCT00688519|75866991|FG001|Overall Study|Pregnancy|1|||
42058223|NCT00721630|75866997|FG000|Overall Study|Participant found to be ineligible|1|||
42357002|NCT01422213|76202266|FG002|Overall Study|Non-compliance with study drug|0|||
42058224|NCT00686725|75867003|FG000|Overall Study|Adverse Event|1|||
42058225|NCT00686725|75867004|FG001|Overall Study|Adverse Event|1|||
42357003|NCT01422213|76202264|FG000|Overall Study|Protocol Violation|0|||
42058226|NCT00686725|75867003|FG000|Overall Study|Progressive Disease|17|||
42058227|NCT00686725|75867004|FG001|Overall Study|Progressive Disease|23|||
42174136|NCT03301714|75980908|FG002|Overall Study|Lost to Follow-up|4|||
42058228|NCT00686725|75867003|FG000|Overall Study|Lost to Follow-up|7|||
42058229|NCT00686725|75867004|FG001|Overall Study|Lost to Follow-up|5|||
42058230|NCT00686725|75867003|FG000|Overall Study|Death|6|||
42058231|NCT00686725|75867004|FG001|Overall Study|Death|3|||
42058232|NCT00686725|75867003|FG000|Overall Study|Withdrawal by Subject|13|||
42058233|NCT00686725|75867004|FG001|Overall Study|Withdrawal by Subject|4|||
42058234|NCT00686725|75867003|FG000|Overall Study|Protocol Violation|1|||
42058235|NCT00686725|75867004|FG001|Overall Study|Protocol Violation|3|||
42058236|NCT00686725|75867003|FG000|Overall Study|Other|1|||
42058237|NCT00686725|75867004|FG001|Overall Study|Other|3|||
42058238|NCT00727402|75867010|FG000|Overall Study|Physician Decision|116|||
42058239|NCT00727246|75867018|FG000|Overall Study|could not complete MRI|0|||
42058240|NCT00727246|75867019|FG001|Overall Study|could not complete MRI|1|||
42058241|NCT00727246|75867020|FG002|Overall Study|could not complete MRI|0|||
42058242|NCT00727246|75867021|FG003|Overall Study|could not complete MRI|1|||
42058243|NCT00727246|75867018|FG000|Overall Study|incidental finding|0|||
42058244|NCT00727246|75867019|FG001|Overall Study|incidental finding|0|||
42058245|NCT00727246|75867020|FG002|Overall Study|incidental finding|0|||
42058246|NCT00727246|75867021|FG003|Overall Study|incidental finding|1|||
42058247|NCT00727246|75867018|FG000|Overall Study|withdrawn|0|||
42058248|NCT00727246|75867019|FG001|Overall Study|withdrawn|0|||
42058249|NCT00727246|75867020|FG002|Overall Study|withdrawn|1|||
42058250|NCT00727246|75867021|FG003|Overall Study|withdrawn|0|||
42058251|NCT00686647|75867031|FG000|Overall Study|Lost to Follow-up|1|||
42058252|NCT00686647|75867031|FG000|Overall Study|Death|1|||
42174137|NCT03301714|75980906|FG000|Overall Study|Did not receive allocated intervention|0|||
42174138|NCT03301714|75980907|FG001|Overall Study|Did not receive allocated intervention|2|||
42174139|NCT03301714|75980908|FG002|Overall Study|Did not receive allocated intervention|3|||
42174140|NCT03299686|75980921|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
42174141|NCT03299686|75980922|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
42174142|NCT03299686|75980921|FG000|Treatment Epoch|Physician Decision|1|||
42174143|NCT03299686|75980922|FG001|Treatment Epoch|Physician Decision|0|||
42174144|NCT03299686|75980921|FG000|Treatment Epoch|Adverse Event|8|||
42174145|NCT03299686|75980922|FG001|Treatment Epoch|Adverse Event|4|||
42174146|NCT03299686|75980921|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
42174147|NCT03299686|75980922|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
42174148|NCT03462758|75980930|FG000|Overall Study|Chose no or other method of contraception|20|||
42174149|NCT03462758|75980931|FG001|Overall Study|Chose no or other method of contraception|23|||
42174150|NCT03462758|75980930|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
42174151|NCT03462758|75980931|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
42174152|NCT03462758|75980930|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
42174153|NCT03462758|75980931|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
42174154|NCT03462758|75980930|FG000|Overall Study|Medical contraindication|2|||
42174155|NCT03462758|75980931|FG001|Overall Study|Medical contraindication|2|||
42174156|NCT03462758|75980930|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
42174157|NCT03462758|75980931|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
42174158|NCT00075270|75980939|FG000|Overall Study|Withdrawal by Subject|28|||
42174159|NCT00075270|75980940|FG001|Overall Study|Withdrawal by Subject|21|||
42174160|NCT00075270|75980939|FG000|Overall Study|Lost to Follow-up|25|||
42174161|NCT00075270|75980940|FG001|Overall Study|Lost to Follow-up|28|||
42174162|NCT00075270|75980939|FG000|Overall Study|Protocol Violation|0|||
42174163|NCT00075270|75980940|FG001|Overall Study|Protocol Violation|2|||
42174164|NCT00075270|75980939|FG000|Overall Study|Death|198|||
42174165|NCT00075270|75980940|FG001|Overall Study|Death|215|||
42174166|NCT00075270|75980939|FG000|Overall Study|Other/Unknown|9|||
42174167|NCT00075270|75980940|FG001|Overall Study|Other/Unknown|5|||
42174168|NCT00075270|75980939|FG000|Overall Study|Missing|26|||
42174169|NCT00075270|75980940|FG001|Overall Study|Missing|13|||
42174170|NCT00074958|75980947|FG000|Overall Study|Adverse Event|1|||
42058253|NCT00687973|75867038|FG000|Overall Study|Adverse Event|18|||
42174171|NCT02940574|75980953|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
42174172|NCT02940574|75980954|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
42174173|NCT02940574|75980953|FG000|1-year Follow-up|Lost to Follow-up|3|||
42174174|NCT02940574|75980954|FG001|1-year Follow-up|Lost to Follow-up|4|||
42174175|NCT03760250|75980973|FG000|Overall Study|Withdrawal by Subject|1|||
42291814|NCT01968070|76125299|FG000|Period 1|Lost to Follow-up|0|||
42058254|NCT00687973|75867039|FG001|Overall Study|Adverse Event|28|||
42058255|NCT00687973|75867038|FG000|Overall Study|Lack of Efficacy|2|||
42058256|NCT00687973|75867039|FG001|Overall Study|Lack of Efficacy|3|||
42058257|NCT00687973|75867038|FG000|Overall Study|Protocol Violation|1|||
42058258|NCT00687973|75867039|FG001|Overall Study|Protocol Violation|2|||
42174176|NCT03760250|75980973|FG000|Overall Study|Physician Decision|1|||
42174177|NCT03757988|75980977|FG000|Overall Study|Withdrawal by Subject|1|||
42174178|NCT00313781|75980984|FG000|Before Crossover|Death|22|||
42174179|NCT00313781|75980985|FG001|Before Crossover|Death|8|||
42058259|NCT00687973|75867038|FG000|Overall Study|Administrative Reasons|0|||
42058260|NCT00687973|75867039|FG001|Overall Study|Administrative Reasons|2|||
42174180|NCT00313781|75980986|FG002|Before Crossover|Death|0|||
42174181|NCT00313781|75980984|FG000|Before Crossover|Lost to Follow-up|0|||
42174182|NCT00313781|75980985|FG001|Before Crossover|Lost to Follow-up|3|||
42174183|NCT00313781|75980986|FG002|Before Crossover|Lost to Follow-up|0|||
42174184|NCT00313781|75980984|FG000|Before Crossover|Withdrawal by Subject|3|||
42174185|NCT00313781|75980985|FG001|Before Crossover|Withdrawal by Subject|1|||
42174186|NCT00313781|75980986|FG002|Before Crossover|Withdrawal by Subject|0|||
42174187|NCT00313781|75980984|FG000|Before Crossover|Other|45|||
42174188|NCT00313781|75980985|FG001|Before Crossover|Other|30|||
42174189|NCT00313781|75980986|FG002|Before Crossover|Other|0|||
42174190|NCT00313781|75980984|FG000|Before Crossover|Crossover|0|||
42174191|NCT00313781|75980985|FG001|Before Crossover|Crossover|37|||
42174192|NCT00313781|75980986|FG002|Before Crossover|Crossover|0|||
42174193|NCT00313781|75980984|FG000|Before Crossover|Randomized, not treated|5|||
42174194|NCT00313781|75980985|FG001|Before Crossover|Randomized, not treated|0|||
42174195|NCT00313781|75980986|FG002|Before Crossover|Randomized, not treated|0|||
42174196|NCT00313781|75980984|FG000|After Crossover|Death|0|||
42174197|NCT00313781|75980985|FG001|After Crossover|Death|0|||
42174198|NCT00313781|75980986|FG002|After Crossover|Death|6|||
42174199|NCT00313781|75980984|FG000|After Crossover|Withdrawal by Subject|0|||
42174200|NCT00313781|75980985|FG001|After Crossover|Withdrawal by Subject|0|||
42174201|NCT00313781|75980986|FG002|After Crossover|Withdrawal by Subject|3|||
42174202|NCT00313781|75980984|FG000|After Crossover|Other|0|||
42174203|NCT00313781|75980985|FG001|After Crossover|Other|0|||
42174204|NCT00313781|75980986|FG002|After Crossover|Other|18|||
42174205|NCT00368537|75980997|FG000|Randomization|No study drug dosed|13|||
42174206|NCT00368537|75980998|FG001|Randomization|No study drug dosed|6|||
42174207|NCT00368537|75980997|FG000|Baseline Participants|Lost to Follow-up|16|||
42174208|NCT00368537|75980998|FG001|Baseline Participants|Lost to Follow-up|17|||
42174209|NCT00368537|75980997|FG000|Baseline Participants|Withdrawal by Subject|6|||
42174210|NCT00368537|75980998|FG001|Baseline Participants|Withdrawal by Subject|4|||
42174211|NCT00368537|75980997|FG000|Baseline Participants|Death|1|||
42174212|NCT00368537|75980998|FG001|Baseline Participants|Death|2|||
42174213|NCT00368537|75980997|FG000|Baseline Participants|No susceptibility|1|||
42174214|NCT00368537|75980998|FG001|Baseline Participants|No susceptibility|0|||
42174215|NCT00368537|75980997|FG000|Baseline Participants|Patient uncompliant|0|||
42174216|NCT00368537|75980998|FG001|Baseline Participants|Patient uncompliant|1|||
42174217|NCT00313703|75981008|FG000|Overall Study|Lost to Follow-up|11|||
42174218|NCT00313703|75981009|FG001|Overall Study|Lost to Follow-up|2|||
42174219|NCT00313703|75981010|FG002|Overall Study|Lost to Follow-up|5|||
42174220|NCT00313703|75981011|FG003|Overall Study|Lost to Follow-up|12|||
42174221|NCT00313313|75981024|FG000|Overall Study|Lack of Efficacy|14|||
42174222|NCT00313313|75981025|FG001|Overall Study|Lack of Efficacy|9|||
42174223|NCT00313313|75981026|FG002|Overall Study|Lack of Efficacy|20|||
42174224|NCT00313313|75981024|FG000|Overall Study|Withdrawal of consent by subject|18|||
42174225|NCT00313313|75981025|FG001|Overall Study|Withdrawal of consent by subject|17|||
42174226|NCT00313313|75981026|FG002|Overall Study|Withdrawal of consent by subject|31|||
42174227|NCT00313313|75981024|FG000|Overall Study|Lost to Follow-up|10|||
42174228|NCT00313313|75981025|FG001|Overall Study|Lost to Follow-up|7|||
42174229|NCT00313313|75981026|FG002|Overall Study|Lost to Follow-up|9|||
42174230|NCT00313313|75981024|FG000|Overall Study|Adverse Event|15|||
42174231|NCT00313313|75981025|FG001|Overall Study|Adverse Event|16|||
42174232|NCT00313313|75981026|FG002|Overall Study|Adverse Event|12|||
42174233|NCT00313313|75981024|FG000|Overall Study|Physician Decision|2|||
42174234|NCT00313313|75981025|FG001|Overall Study|Physician Decision|6|||
42174235|NCT00313313|75981026|FG002|Overall Study|Physician Decision|4|||
42174236|NCT00313313|75981024|FG000|Overall Study|Poor/Noncompliance|3|||
42291815|NCT01968070|76125300|FG001|Period 1|Lost to Follow-up|0|||
42291816|NCT01968070|76125301|FG002|Period 1|Lost to Follow-up|0|||
42016614|NCT02393859|75824092|FG000|Overall Study|Lost to Follow-up|1|||
42016615|NCT02393859|75824093|FG001|Overall Study|Lost to Follow-up|1|||
42016616|NCT02096588|75824102|FG000|Overall Study|Lack of Efficacy|2|||
42016617|NCT02096588|75824103|FG001|Overall Study|Lack of Efficacy|0|||
42016618|NCT02096588|75824102|FG000|Overall Study|Withdrawal by Subject|0|||
42016619|NCT02096588|75824103|FG001|Overall Study|Withdrawal by Subject|1|||
42016620|NCT01359592|75824109|FG000|Initial Registration|Adverse Event|1|||
42016621|NCT01359592|75824110|FG001|Initial Registration|Adverse Event|0|||
42016622|NCT01359592|75824111|FG002|Initial Registration|Adverse Event|0|||
42016623|NCT01359592|75824112|FG003|Initial Registration|Adverse Event|0|||
42016624|NCT01359592|75824109|FG000|Initial Registration|Death|1|||
42016625|NCT01359592|75824110|FG001|Initial Registration|Death|0|||
42016626|NCT01359592|75824111|FG002|Initial Registration|Death|0|||
42016627|NCT01359592|75824112|FG003|Initial Registration|Death|0|||
42016628|NCT01359592|75824109|FG000|Initial Registration|Other reason not protocol specified|1|||
42016629|NCT01359592|75824110|FG001|Initial Registration|Other reason not protocol specified|0|||
42174237|NCT00313313|75981025|FG001|Overall Study|Poor/Noncompliance|6|||
42174238|NCT00313313|75981026|FG002|Overall Study|Poor/Noncompliance|2|||
42174239|NCT00313313|75981024|FG000|Overall Study|Pregnancy|1|||
42174240|NCT00313313|75981025|FG001|Overall Study|Pregnancy|2|||
42058261|NCT00687973|75867038|FG000|Overall Study|Withdrawal by Subject|3|||
42058262|NCT00687973|75867039|FG001|Overall Study|Withdrawal by Subject|3|||
42058263|NCT00721396|75867050|FG000|Overall Study|Adverse Event|4|||
42058264|NCT00721396|75867051|FG001|Overall Study|Adverse Event|7|||
42058265|NCT00721396|75867052|FG002|Overall Study|Adverse Event|2|||
42058266|NCT00721396|75867053|FG003|Overall Study|Adverse Event|0|||
42058267|NCT00721396|75867050|FG000|Overall Study|Withdrawal by Subject|12|||
42058268|NCT00721396|75867051|FG001|Overall Study|Withdrawal by Subject|15|||
42058269|NCT00721396|75867052|FG002|Overall Study|Withdrawal by Subject|3|||
42058270|NCT00721396|75867053|FG003|Overall Study|Withdrawal by Subject|7|||
42058271|NCT00721396|75867050|FG000|Overall Study|Lost to Follow-up|7|||
42058272|NCT00721396|75867051|FG001|Overall Study|Lost to Follow-up|9|||
42058273|NCT00721396|75867052|FG002|Overall Study|Lost to Follow-up|3|||
42058274|NCT00721396|75867053|FG003|Overall Study|Lost to Follow-up|3|||
42058275|NCT00721396|75867050|FG000|Overall Study|Protocol Violation|4|||
42058276|NCT00721396|75867051|FG001|Overall Study|Protocol Violation|3|||
42058277|NCT00721396|75867052|FG002|Overall Study|Protocol Violation|1|||
42058278|NCT00721396|75867053|FG003|Overall Study|Protocol Violation|0|||
42058279|NCT00721396|75867050|FG000|Overall Study|Inappropriate enrollment|0|||
42058280|NCT00721396|75867051|FG001|Overall Study|Inappropriate enrollment|2|||
42058281|NCT00721396|75867052|FG002|Overall Study|Inappropriate enrollment|0|||
42058282|NCT00721396|75867053|FG003|Overall Study|Inappropriate enrollment|0|||
42058283|NCT00721396|75867050|FG000|Overall Study|Administrative reason|3|||
42058284|NCT00721396|75867051|FG001|Overall Study|Administrative reason|0|||
42058285|NCT00721396|75867052|FG002|Overall Study|Administrative reason|1|||
42058286|NCT00721396|75867053|FG003|Overall Study|Administrative reason|0|||
42058287|NCT00943826|75867070|FG000|Concurrent Phase|Adverse Event|50|||
42058288|NCT00943826|75867071|FG001|Concurrent Phase|Adverse Event|27|||
42058289|NCT00943826|75867070|FG000|Concurrent Phase|Withdrew consent|3|||
42058290|NCT00943826|75867071|FG001|Concurrent Phase|Withdrew consent|7|||
42058291|NCT00943826|75867070|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
42058292|NCT00943826|75867071|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
42058293|NCT00943826|75867070|FG000|Concurrent Phase|Administrative reasons|2|||
42058294|NCT00943826|75867071|FG001|Concurrent Phase|Administrative reasons|1|||
42058295|NCT00943826|75867070|FG000|Concurrent Phase|Protocol Violation|1|||
42058296|NCT00943826|75867071|FG001|Concurrent Phase|Protocol Violation|0|||
42058297|NCT00943826|75867070|FG000|Maintenance Phase|Adverse Event|31|||
42058298|NCT00943826|75867071|FG001|Maintenance Phase|Adverse Event|30|||
42058299|NCT00943826|75867070|FG000|Maintenance Phase|Withdrew consent|2|||
42058300|NCT00943826|75867071|FG001|Maintenance Phase|Withdrew consent|4|||
42058301|NCT00943826|75867070|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
42058302|NCT00943826|75867071|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
42058303|NCT00943826|75867070|FG000|Maintenance Phase|Administrative reasons|4|||
42058304|NCT00943826|75867071|FG001|Maintenance Phase|Administrative reasons|1|||
42058305|NCT00943826|75867070|FG000|Maintenance Phase|Failure to return|0|||
42058306|NCT00943826|75867071|FG001|Maintenance Phase|Failure to return|1|||
42058307|NCT00943826|75867070|FG000|Monotherapy Phase|Adverse Event|42|||
42058308|NCT00943826|75867071|FG001|Monotherapy Phase|Adverse Event|5|||
42058309|NCT00943826|75867070|FG000|Monotherapy Phase|Administrative reasons|11|||
42291817|NCT01968070|76125302|FG003|Period 1|Lost to Follow-up|1|||
42058310|NCT00943826|75867071|FG001|Monotherapy Phase|Administrative reasons|5|||
42058311|NCT00943826|75867070|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
42058312|NCT00943826|75867071|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
42058313|NCT00943826|75867070|FG000|Monotherapy Phase|Withdrew Consent|2|||
42058314|NCT00943826|75867071|FG001|Monotherapy Phase|Withdrew Consent|3|||
42058315|NCT00943826|75867070|FG000|Monotherapy Phase|Failure to return|2|||
42058316|NCT00943826|75867071|FG001|Monotherapy Phase|Failure to return|1|||
42058317|NCT00943826|75867070|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
42058318|NCT00943826|75867071|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
42058319|NCT00943826|75867070|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
42058320|NCT00943826|75867071|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
42291818|NCT01968070|76125303|FG004|Period 1|Lost to Follow-up|0|||
42291819|NCT01968070|76125304|FG005|Period 1|Lost to Follow-up|0|||
42291820|NCT01968070|76125305|FG006|Period 1|Lost to Follow-up|0|||
42058321|NCT00943826|75867070|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
42058322|NCT00943826|75867071|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
42058323|NCT00943826|75867070|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
42058324|NCT00943826|75867071|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
42058325|NCT01004003|75867087|FG000|Overall Study|Progressive disease|2|||
42058326|NCT01004003|75867088|FG001|Overall Study|Progressive disease|1|||
42058327|NCT01004003|75867089|FG002|Overall Study|Progressive disease|1|||
42058328|NCT01004003|75867090|FG003|Overall Study|Progressive disease|0|||
42058329|NCT01004003|75867091|FG004|Overall Study|Progressive disease|2|||
42058330|NCT01004003|75867092|FG005|Overall Study|Progressive disease|1|||
42291821|NCT01968070|76125306|FG007|Period 1|Lost to Follow-up|0|||
42058331|NCT01004003|75867093|FG006|Overall Study|Progressive disease|1|||
42058332|NCT01004003|75867094|FG007|Overall Study|Progressive disease|39|||
42058333|NCT01004003|75867095|FG008|Overall Study|Progressive disease|22|||
42058334|NCT01004003|75867087|FG000|Overall Study|Adverse Event|4|||
42058335|NCT01004003|75867088|FG001|Overall Study|Adverse Event|2|||
42058336|NCT01004003|75867089|FG002|Overall Study|Adverse Event|3|||
42058337|NCT01004003|75867090|FG003|Overall Study|Adverse Event|3|||
42058338|NCT01004003|75867091|FG004|Overall Study|Adverse Event|2|||
42058339|NCT01004003|75867092|FG005|Overall Study|Adverse Event|2|||
42058340|NCT01004003|75867093|FG006|Overall Study|Adverse Event|7|||
42058341|NCT01004003|75867094|FG007|Overall Study|Adverse Event|21|||
42058342|NCT01004003|75867095|FG008|Overall Study|Adverse Event|6|||
42058343|NCT01004003|75867087|FG000|Overall Study|Refused to continue taking trial med.|0|||
42058344|NCT01004003|75867088|FG001|Overall Study|Refused to continue taking trial med.|0|||
42058345|NCT01004003|75867089|FG002|Overall Study|Refused to continue taking trial med.|0|||
42058346|NCT01004003|75867090|FG003|Overall Study|Refused to continue taking trial med.|0|||
42058347|NCT01004003|75867091|FG004|Overall Study|Refused to continue taking trial med.|0|||
42058348|NCT01004003|75867092|FG005|Overall Study|Refused to continue taking trial med.|0|||
42058349|NCT01004003|75867093|FG006|Overall Study|Refused to continue taking trial med.|0|||
42058350|NCT01004003|75867094|FG007|Overall Study|Refused to continue taking trial med.|0|||
42058351|NCT01004003|75867095|FG008|Overall Study|Refused to continue taking trial med.|2|||
42058352|NCT01004003|75867087|FG000|Overall Study|Other|0|||
42058353|NCT01004003|75867088|FG001|Overall Study|Other|0|||
42058354|NCT01004003|75867089|FG002|Overall Study|Other|0|||
42058355|NCT01004003|75867090|FG003|Overall Study|Other|0|||
42058356|NCT01004003|75867091|FG004|Overall Study|Other|0|||
42058357|NCT01004003|75867092|FG005|Overall Study|Other|1|||
42058358|NCT01004003|75867093|FG006|Overall Study|Other|0|||
42058359|NCT01004003|75867094|FG007|Overall Study|Other|0|||
42058360|NCT01004003|75867095|FG008|Overall Study|Other|0|||
42058361|NCT00943670|75867117|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
42058362|NCT00943670|75867117|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
42058363|NCT00943670|75867117|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
42058364|NCT00943670|75867117|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
42058365|NCT00943670|75867117|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
42058366|NCT00943670|75867117|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
42058367|NCT00943670|75867117|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
42058368|NCT00943670|75867117|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
42058369|NCT00943670|75867117|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
42058370|NCT00943670|75867117|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
42058371|NCT00938366|75867134|FG000|Overall Study|Withdrawal by Subject|1|||
42174241|NCT00313313|75981026|FG002|Overall Study|Pregnancy|0|||
42174242|NCT00313313|75981024|FG000|Overall Study|Death|0|||
42174243|NCT00313313|75981025|FG001|Overall Study|Death|0|||
42174244|NCT00313313|75981026|FG002|Overall Study|Death|2|||
42174245|NCT00313313|75981024|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
42174246|NCT00313313|75981025|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
42174247|NCT00313313|75981026|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
42174248|NCT00312845|75981036|FG000|Overall Study|Adverse Event|19|||
42174249|NCT00312845|75981037|FG001|Overall Study|Adverse Event|5|||
42174250|NCT00312845|75981036|FG000|Overall Study|Death|2|||
42174251|NCT00312845|75981037|FG001|Overall Study|Death|2|||
42174252|NCT00312845|75981036|FG000|Overall Study|Withdrawal by Subject|14|||
42174253|NCT00312845|75981037|FG001|Overall Study|Withdrawal by Subject|6|||
42174254|NCT00312845|75981036|FG000|Overall Study|Disease Progression|56|||
42174255|NCT00312845|75981037|FG001|Overall Study|Disease Progression|77|||
42174256|NCT00312845|75981036|FG000|Overall Study|Lost to Follow-up|2|||
42174257|NCT00312845|75981037|FG001|Overall Study|Lost to Follow-up|0|||
42174258|NCT00312845|75981036|FG000|Overall Study|Other|6|||
42174259|NCT00312845|75981037|FG001|Overall Study|Other|5|||
42174260|NCT00368069|75981045|FG000|Overall Study|Adverse Event|5|||
42174261|NCT00368069|75981046|FG001|Overall Study|Adverse Event|2|||
42174262|NCT00368069|75981045|FG000|Overall Study|Lack of Efficacy|0|||
42174263|NCT00368069|75981046|FG001|Overall Study|Lack of Efficacy|1|||
42174264|NCT00368069|75981045|FG000|Overall Study|Lost to Follow-up|1|||
42058372|NCT00938366|75867135|FG001|Overall Study|Withdrawal by Subject|0|||
42058373|NCT00943592|75867141|FG000|Overall Study|Death|3|||
42058374|NCT00943124|75867145|FG000|Period 1|Withdrawal by Subject|1|||
42058375|NCT00943124|75867146|FG001|Period 1|Withdrawal by Subject|1|||
42058376|NCT00943124|75867145|FG000|Period 1|Did Not Follow Study Procedures|1|||
42058377|NCT00943124|75867146|FG001|Period 1|Did Not Follow Study Procedures|0|||
42058378|NCT00943124|75867145|FG000|Period 1|Personal Reasons|0|||
42058379|NCT00943124|75867146|FG001|Period 1|Personal Reasons|1|||
42058380|NCT00726622|75867154|FG000|Overall Study|Withdrawal by Subject|16|||
42058381|NCT00726622|75867155|FG001|Overall Study|Withdrawal by Subject|2|||
42174265|NCT00368069|75981046|FG001|Overall Study|Lost to Follow-up|0|||
42058382|NCT00726622|75867154|FG000|Overall Study|Physician Decision|0|||
42058383|NCT00726622|75867155|FG001|Overall Study|Physician Decision|1|||
42058384|NCT00726622|75867154|FG000|Overall Study|Metastasis|2|||
42058385|NCT00726622|75867155|FG001|Overall Study|Metastasis|0|||
42058386|NCT00940316|75867164|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
42058387|NCT00940316|75867165|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
42058388|NCT00940316|75867166|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
42058389|NCT00940316|75867164|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
42058390|NCT00940316|75867165|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
42058391|NCT00940316|75867166|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
42058392|NCT00940316|75867164|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
42058393|NCT00940316|75867165|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
42058394|NCT00940316|75867166|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
42058395|NCT00940316|75867164|FG000|Treated After Cycle 5|Adverse Event|0|||
42058396|NCT00940316|75867165|FG001|Treated After Cycle 5|Adverse Event|0|||
42058397|NCT00940316|75867166|FG002|Treated After Cycle 5|Adverse Event|1|||
42058398|NCT00940316|75867164|FG000|Treated After Cycle 5|Progressive disease|0|||
42058399|NCT00940316|75867165|FG001|Treated After Cycle 5|Progressive disease|1|||
42058400|NCT00940316|75867166|FG002|Treated After Cycle 5|Progressive disease|0|||
42058401|NCT00726388|75867182|FG000|Overall Study|Withdrawal by Subject|5|||
42058402|NCT00726388|75867182|FG000|Overall Study|Adverse Event|3|||
42058403|NCT00726388|75867182|FG000|Overall Study|Lost to Follow-up|10|||
42058404|NCT00726388|75867182|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
42058405|NCT00726388|75867182|FG000|Overall Study|Other|5|||
42058406|NCT00726388|75867182|FG000|Overall Study|Enrolled, Not Treated|79|||
42058407|NCT00572455|75867200|FG000|Stage I (14 Days)|Adverse Event|0|||
42058408|NCT00572455|75867201|FG001|Stage I (14 Days)|Adverse Event|0|||
42058409|NCT00572455|75867202|FG002|Stage I (14 Days)|Adverse Event|0|||
42058410|NCT00572455|75867203|FG003|Stage I (14 Days)|Adverse Event|0|||
42058411|NCT00572455|75867204|FG004|Stage I (14 Days)|Adverse Event|0|||
42058412|NCT00572455|75867205|FG005|Stage I (14 Days)|Adverse Event|3|||
42058413|NCT00572455|75867206|FG006|Stage I (14 Days)|Adverse Event|0|||
42058414|NCT00572455|75867207|FG007|Stage I (14 Days)|Adverse Event|0|||
42058415|NCT00572455|75867208|FG008|Stage I (14 Days)|Adverse Event|0|||
42058416|NCT00572455|75867209|FG009|Stage I (14 Days)|Adverse Event|0|||
42058417|NCT00572455|75867210|FG010|Stage I (14 Days)|Adverse Event|0|||
42058418|NCT00572455|75867211|FG011|Stage I (14 Days)|Adverse Event|0|||
42058419|NCT00572455|75867212|FG012|Stage I (14 Days)|Adverse Event|0|||
42058420|NCT00572455|75867213|FG013|Stage I (14 Days)|Adverse Event|0|||
42058421|NCT00572455|75867200|FG000|Stage I (14 Days)|Other|0|||
42058422|NCT00572455|75867201|FG001|Stage I (14 Days)|Other|0|||
42058423|NCT00572455|75867202|FG002|Stage I (14 Days)|Other|0|||
42058424|NCT00572455|75867203|FG003|Stage I (14 Days)|Other|0|||
42058425|NCT00572455|75867204|FG004|Stage I (14 Days)|Other|1|||
42058426|NCT00572455|75867205|FG005|Stage I (14 Days)|Other|0|||
42058427|NCT00572455|75867206|FG006|Stage I (14 Days)|Other|0|||
42058428|NCT00572455|75867207|FG007|Stage I (14 Days)|Other|0|||
42058429|NCT00572455|75867208|FG008|Stage I (14 Days)|Other|0|||
42058430|NCT00572455|75867209|FG009|Stage I (14 Days)|Other|0|||
42058431|NCT00572455|75867210|FG010|Stage I (14 Days)|Other|0|||
42058432|NCT00572455|75867211|FG011|Stage I (14 Days)|Other|0|||
42058433|NCT00572455|75867212|FG012|Stage I (14 Days)|Other|0|||
42058434|NCT00572455|75867213|FG013|Stage I (14 Days)|Other|0|||
42058435|NCT00572455|75867200|FG000|Stage II (28 Days)|Adverse Event|0|||
42058436|NCT00572455|75867201|FG001|Stage II (28 Days)|Adverse Event|0|||
42058437|NCT00572455|75867202|FG002|Stage II (28 Days)|Adverse Event|0|||
42174266|NCT00368069|75981045|FG000|Overall Study|Protocol Violation|0|||
42174267|NCT00368069|75981046|FG001|Overall Study|Protocol Violation|2|||
42174268|NCT00368069|75981045|FG000|Overall Study|Withdrawal of Consent|2|||
42174269|NCT00368069|75981046|FG001|Overall Study|Withdrawal of Consent|1|||
42174270|NCT00368069|75981045|FG000|Overall Study|no blood sampling possible|0|||
42174271|NCT00368069|75981046|FG001|Overall Study|no blood sampling possible|1|||
42174272|NCT00367991|75981054|FG000|Overall Study|Withdrawal by Subject|1|||
42174273|NCT00367991|75981055|FG001|Overall Study|Withdrawal by Subject|1|||
42174274|NCT00367991|75981054|FG000|Overall Study|Adverse Event|1|||
42174275|NCT00367991|75981055|FG001|Overall Study|Adverse Event|1|||
42058438|NCT00572455|75867203|FG003|Stage II (28 Days)|Adverse Event|0|||
42174276|NCT00367835|75981063|FG000|Overall Study|Adverse Event|14|||
42058439|NCT00572455|75867204|FG004|Stage II (28 Days)|Adverse Event|0|||
42058440|NCT00572455|75867205|FG005|Stage II (28 Days)|Adverse Event|0|||
42058441|NCT00572455|75867206|FG006|Stage II (28 Days)|Adverse Event|0|||
42058442|NCT00572455|75867207|FG007|Stage II (28 Days)|Adverse Event|0|||
42058443|NCT00572455|75867208|FG008|Stage II (28 Days)|Adverse Event|1|||
42058444|NCT00572455|75867209|FG009|Stage II (28 Days)|Adverse Event|3|||
42058445|NCT00572455|75867210|FG010|Stage II (28 Days)|Adverse Event|3|||
42058446|NCT00572455|75867211|FG011|Stage II (28 Days)|Adverse Event|4|||
42058447|NCT00572455|75867212|FG012|Stage II (28 Days)|Adverse Event|5|||
42058448|NCT00572455|75867213|FG013|Stage II (28 Days)|Adverse Event|1|||
42058449|NCT00572455|75867200|FG000|Stage II (28 Days)|Death|0|||
42174277|NCT00367835|75981064|FG001|Overall Study|Adverse Event|1|||
42058450|NCT00572455|75867201|FG001|Stage II (28 Days)|Death|0|||
42058451|NCT00572455|75867202|FG002|Stage II (28 Days)|Death|0|||
42058452|NCT00572455|75867203|FG003|Stage II (28 Days)|Death|0|||
42058453|NCT00572455|75867204|FG004|Stage II (28 Days)|Death|0|||
42058454|NCT00572455|75867205|FG005|Stage II (28 Days)|Death|0|||
42058455|NCT00572455|75867206|FG006|Stage II (28 Days)|Death|0|||
42058456|NCT00572455|75867207|FG007|Stage II (28 Days)|Death|0|||
42058457|NCT00572455|75867208|FG008|Stage II (28 Days)|Death|1|||
42058458|NCT00572455|75867209|FG009|Stage II (28 Days)|Death|0|||
42058459|NCT00572455|75867210|FG010|Stage II (28 Days)|Death|0|||
42058460|NCT00572455|75867211|FG011|Stage II (28 Days)|Death|0|||
42058461|NCT00572455|75867212|FG012|Stage II (28 Days)|Death|0|||
42058462|NCT00572455|75867213|FG013|Stage II (28 Days)|Death|0|||
42058463|NCT00572455|75867200|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
42058464|NCT00572455|75867201|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
42058465|NCT00572455|75867202|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
42058466|NCT00572455|75867203|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
42058467|NCT00572455|75867204|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
42058468|NCT00572455|75867205|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
42058469|NCT00572455|75867206|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
42058470|NCT00572455|75867207|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
42058471|NCT00572455|75867208|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
42058472|NCT00572455|75867209|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
42058473|NCT00572455|75867210|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
42058474|NCT00572455|75867211|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
42058475|NCT00572455|75867212|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
42058476|NCT00572455|75867213|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
42058477|NCT00572455|75867200|FG000|Stage II (28 Days)|Other|0|||
42058478|NCT00572455|75867201|FG001|Stage II (28 Days)|Other|0|||
42058479|NCT00572455|75867202|FG002|Stage II (28 Days)|Other|0|||
42058480|NCT00572455|75867203|FG003|Stage II (28 Days)|Other|0|||
42058481|NCT00572455|75867204|FG004|Stage II (28 Days)|Other|0|||
42058482|NCT00572455|75867205|FG005|Stage II (28 Days)|Other|0|||
42058483|NCT00572455|75867206|FG006|Stage II (28 Days)|Other|0|||
42058484|NCT00572455|75867207|FG007|Stage II (28 Days)|Other|0|||
42058485|NCT00572455|75867208|FG008|Stage II (28 Days)|Other|1|||
42058486|NCT00572455|75867209|FG009|Stage II (28 Days)|Other|0|||
42058487|NCT00572455|75867210|FG010|Stage II (28 Days)|Other|0|||
42058488|NCT00572455|75867211|FG011|Stage II (28 Days)|Other|0|||
42058489|NCT00572455|75867212|FG012|Stage II (28 Days)|Other|0|||
42058490|NCT00572455|75867213|FG013|Stage II (28 Days)|Other|0|||
42058491|NCT00572455|75867200|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
42058492|NCT00572455|75867201|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
42058493|NCT00572455|75867202|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
42058494|NCT00572455|75867203|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
42058495|NCT00572455|75867204|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
42058496|NCT00572455|75867205|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
42058497|NCT00572455|75867206|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
42058498|NCT00572455|75867207|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
42058499|NCT00572455|75867208|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
42058500|NCT00572455|75867209|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
42058501|NCT00572455|75867210|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
42058502|NCT00572455|75867211|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
42058503|NCT00572455|75867212|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
42058504|NCT00572455|75867213|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
42058505|NCT01003691|75867247|FG000|Overall Study|Adverse Event|0|||
42058506|NCT01003691|75867248|FG001|Overall Study|Adverse Event|0|||
42058507|NCT01003691|75867249|FG002|Overall Study|Adverse Event|0|||
42058508|NCT01003691|75867250|FG003|Overall Study|Adverse Event|1|||
42058509|NCT00686335|75867261|FG000|Run-in Period|Adverse Event|1|||
42058510|NCT00686335|75867261|FG000|Run-in Period|asthma exacerbation|1|||
42058511|NCT00686335|75867261|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
42058512|NCT01002989|75867267|FG000|Overall Study|exclusion criteria, no consent|5|||
42058513|NCT00685945|75867271|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
42058514|NCT01007123|75867285|FG000|Overall Study|Adverse Event|3|||
42058515|NCT01007123|75867286|FG001|Overall Study|Adverse Event|4|||
42058516|NCT01007123|75867287|FG002|Overall Study|Adverse Event|7|||
42058517|NCT01007123|75867288|FG003|Overall Study|Adverse Event|1|||
42058518|NCT01007123|75867285|FG000|Overall Study|Lack of Efficacy|1|||
42058519|NCT01007123|75867286|FG001|Overall Study|Lack of Efficacy|0|||
42058520|NCT01007123|75867287|FG002|Overall Study|Lack of Efficacy|1|||
42058521|NCT01007123|75867288|FG003|Overall Study|Lack of Efficacy|4|||
42058522|NCT01007123|75867285|FG000|Overall Study|Protocol Violation|1|||
42058523|NCT01007123|75867286|FG001|Overall Study|Protocol Violation|1|||
42058524|NCT01007123|75867287|FG002|Overall Study|Protocol Violation|2|||
42058525|NCT01007123|75867288|FG003|Overall Study|Protocol Violation|1|||
42058526|NCT01007123|75867285|FG000|Overall Study|Withdrawal by Subject|1|||
42058527|NCT01007123|75867286|FG001|Overall Study|Withdrawal by Subject|0|||
42058528|NCT01007123|75867287|FG002|Overall Study|Withdrawal by Subject|1|||
42058529|NCT01007123|75867288|FG003|Overall Study|Withdrawal by Subject|0|||
42058530|NCT01007123|75867285|FG000|Overall Study|Lost to Follow-up|0|||
42058531|NCT01007123|75867286|FG001|Overall Study|Lost to Follow-up|1|||
42058532|NCT01007123|75867287|FG002|Overall Study|Lost to Follow-up|0|||
42058533|NCT01007123|75867288|FG003|Overall Study|Lost to Follow-up|0|||
42058534|NCT00687739|75867303|FG000|Overall Study|Lost to Follow-up|2|||
42058535|NCT00687739|75867304|FG001|Overall Study|Lost to Follow-up|2|||
42058536|NCT00687739|75867305|FG002|Overall Study|Lost to Follow-up|1|||
42058537|NCT00687739|75867306|FG003|Overall Study|Lost to Follow-up|2|||
42058538|NCT00687739|75867303|FG000|Overall Study|Adverse Event|0|||
42058539|NCT00687739|75867304|FG001|Overall Study|Adverse Event|1|||
42058540|NCT00687739|75867305|FG002|Overall Study|Adverse Event|1|||
42058541|NCT00687739|75867306|FG003|Overall Study|Adverse Event|0|||
42058542|NCT01006889|75867318|FG000|Overall Study|Withdrawal by Subject|3|||
42058543|NCT01001429|75867325|FG000|Overall Study|surgery cancelled|0|||
42058544|NCT01001429|75867326|FG001|Overall Study|surgery cancelled|1|||
42058545|NCT01000961|75867356|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
42058546|NCT01000961|75867357|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
42058547|NCT01000961|75867356|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
42058548|NCT01000961|75867357|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
42058549|NCT01000805|75867367|FG000|Overall Study|Adverse Event|21|||
42058550|NCT01000805|75867368|FG001|Overall Study|Adverse Event|9|||
42058551|NCT01000805|75867367|FG000|Overall Study|Lack of Efficacy|5|||
42058552|NCT01000805|75867368|FG001|Overall Study|Lack of Efficacy|16|||
42058553|NCT01000805|75867367|FG000|Overall Study|Lost to Follow-up|16|||
42058554|NCT01000805|75867368|FG001|Overall Study|Lost to Follow-up|21|||
42058555|NCT01000805|75867367|FG000|Overall Study|Physician Decision|0|||
42058556|NCT01000805|75867368|FG001|Overall Study|Physician Decision|1|||
42058557|NCT01000805|75867367|FG000|Overall Study|Protocol Violation|12|||
42058558|NCT01000805|75867368|FG001|Overall Study|Protocol Violation|8|||
42058559|NCT01000805|75867367|FG000|Overall Study|Withdrawal by Subject|16|||
42058560|NCT01000805|75867368|FG001|Overall Study|Withdrawal by Subject|6|||
42058561|NCT01000805|75867367|FG000|Overall Study|Sponsor Decision|0|||
42058562|NCT01000805|75867368|FG001|Overall Study|Sponsor Decision|1|||
42058563|NCT00684307|75867380|FG000|Overall Study|Adverse Event|11|||
42058564|NCT00684307|75867381|FG001|Overall Study|Adverse Event|6|||
42058565|NCT00684307|75867382|FG002|Overall Study|Adverse Event|15|||
42058566|NCT00684307|75867383|FG003|Overall Study|Adverse Event|16|||
42058567|NCT00684307|75867384|FG004|Overall Study|Adverse Event|8|||
42058568|NCT00684307|75867380|FG000|Overall Study|Development of increasing Liver Function|0|||
42058569|NCT00684307|75867381|FG001|Overall Study|Development of increasing Liver Function|2|||
42058570|NCT00684307|75867382|FG002|Overall Study|Development of increasing Liver Function|0|||
42058571|NCT00684307|75867383|FG003|Overall Study|Development of increasing Liver Function|1|||
42058572|NCT00684307|75867384|FG004|Overall Study|Development of increasing Liver Function|0|||
42058573|NCT00684307|75867380|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
42058574|NCT00684307|75867381|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
42058575|NCT00684307|75867382|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
42058576|NCT00684307|75867383|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
42058577|NCT00684307|75867384|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
42058578|NCT00684307|75867380|FG000|Overall Study|Incorrect enrolment or randomization|4|||
42058579|NCT00684307|75867381|FG001|Overall Study|Incorrect enrolment or randomization|0|||
42058580|NCT00684307|75867382|FG002|Overall Study|Incorrect enrolment or randomization|0|||
42058581|NCT00684307|75867383|FG003|Overall Study|Incorrect enrolment or randomization|0|||
42058582|NCT00684307|75867384|FG004|Overall Study|Incorrect enrolment or randomization|0|||
42058583|NCT00684307|75867380|FG000|Overall Study|Interupted IP for more than 7 days|0|||
42058584|NCT00684307|75867381|FG001|Overall Study|Interupted IP for more than 7 days|4|||
42058585|NCT00684307|75867382|FG002|Overall Study|Interupted IP for more than 7 days|1|||
42058586|NCT00684307|75867383|FG003|Overall Study|Interupted IP for more than 7 days|3|||
42058587|NCT00684307|75867384|FG004|Overall Study|Interupted IP for more than 7 days|3|||
42058588|NCT00684307|75867380|FG000|Overall Study|Severe non compliance to protocol|1|||
42058589|NCT00684307|75867381|FG001|Overall Study|Severe non compliance to protocol|0|||
42058590|NCT00684307|75867382|FG002|Overall Study|Severe non compliance to protocol|0|||
42058591|NCT00684307|75867383|FG003|Overall Study|Severe non compliance to protocol|1|||
42058592|NCT00684307|75867384|FG004|Overall Study|Severe non compliance to protocol|2|||
42058593|NCT00684307|75867380|FG000|Overall Study|Participant not willing to continue|7|||
42058594|NCT00684307|75867381|FG001|Overall Study|Participant not willing to continue|10|||
42058595|NCT00684307|75867382|FG002|Overall Study|Participant not willing to continue|11|||
42058596|NCT00684307|75867383|FG003|Overall Study|Participant not willing to continue|5|||
42058597|NCT00684307|75867384|FG004|Overall Study|Participant not willing to continue|8|||
42058598|NCT00684307|75867380|FG000|Overall Study|Criteria from the CSR|0|||
42058599|NCT00684307|75867381|FG001|Overall Study|Criteria from the CSR|0|||
42058600|NCT00684307|75867382|FG002|Overall Study|Criteria from the CSR|1|||
42058601|NCT00684307|75867383|FG003|Overall Study|Criteria from the CSR|3|||
42058602|NCT00684307|75867384|FG004|Overall Study|Criteria from the CSR|3|||
42058603|NCT00683917|75867399|FG000|Overall Study|Study prematurely terminated|10|||
42058604|NCT00687271|75867411|FG000|Overall Study|Adverse Event|1|||
42058605|NCT00687271|75867412|FG001|Overall Study|Adverse Event|3|||
42058606|NCT00687271|75867413|FG002|Overall Study|Adverse Event|1|||
42058607|NCT00687271|75867414|FG003|Overall Study|Adverse Event|0|||
42058608|NCT00687271|75867411|FG000|Overall Study|Lost to Follow-up|0|||
42058609|NCT00687271|75867412|FG001|Overall Study|Lost to Follow-up|1|||
42058610|NCT00687271|75867413|FG002|Overall Study|Lost to Follow-up|0|||
42058611|NCT00687271|75867414|FG003|Overall Study|Lost to Follow-up|0|||
42058612|NCT00687271|75867411|FG000|Overall Study|Protocol Violation|2|||
42058613|NCT00687271|75867412|FG001|Overall Study|Protocol Violation|1|||
42058614|NCT00687271|75867413|FG002|Overall Study|Protocol Violation|1|||
42058615|NCT00687271|75867414|FG003|Overall Study|Protocol Violation|0|||
42058616|NCT00687271|75867411|FG000|Overall Study|Withdrawal by Subject|0|||
42058617|NCT00687271|75867412|FG001|Overall Study|Withdrawal by Subject|1|||
42058618|NCT00687271|75867413|FG002|Overall Study|Withdrawal by Subject|3|||
42058619|NCT00687271|75867414|FG003|Overall Study|Withdrawal by Subject|0|||
42058620|NCT04617275|75867432|FG000|Treatment Period|Adverse Event|1|||
42058621|NCT04617275|75867433|FG001|Treatment Period|Adverse Event|6|||
42058622|NCT04617275|75867434|FG002|Treatment Period|Adverse Event|4|||
42058623|NCT04617275|75867435|FG003|Treatment Period|Adverse Event|6|||
42058624|NCT04617275|75867436|FG004|Treatment Period|Adverse Event|7|||
42058625|NCT04617275|75867437|FG005|Treatment Period|Adverse Event|8|||
42058626|NCT04617275|75867438|FG006|Treatment Period|Adverse Event|0|||
42058627|NCT04617275|75867439|FG007|Treatment Period|Adverse Event|12|||
42058628|NCT04617275|75867432|FG000|Treatment Period|Lost to Follow-up|0|||
42058629|NCT04617275|75867433|FG001|Treatment Period|Lost to Follow-up|0|||
42058630|NCT04617275|75867434|FG002|Treatment Period|Lost to Follow-up|2|||
42058631|NCT04617275|75867435|FG003|Treatment Period|Lost to Follow-up|0|||
42058632|NCT04617275|75867436|FG004|Treatment Period|Lost to Follow-up|0|||
42058633|NCT04617275|75867437|FG005|Treatment Period|Lost to Follow-up|3|||
42058634|NCT04617275|75867438|FG006|Treatment Period|Lost to Follow-up|0|||
42058635|NCT04617275|75867439|FG007|Treatment Period|Lost to Follow-up|2|||
42058636|NCT04617275|75867432|FG000|Treatment Period|No longer meets eligibility criteria|0|||
42058637|NCT04617275|75867433|FG001|Treatment Period|No longer meets eligibility criteria|0|||
42058638|NCT04617275|75867434|FG002|Treatment Period|No longer meets eligibility criteria|0|||
42058639|NCT04617275|75867435|FG003|Treatment Period|No longer meets eligibility criteria|1|||
42058640|NCT04617275|75867436|FG004|Treatment Period|No longer meets eligibility criteria|0|||
42058641|NCT04617275|75867437|FG005|Treatment Period|No longer meets eligibility criteria|0|||
42058642|NCT04617275|75867438|FG006|Treatment Period|No longer meets eligibility criteria|0|||
42058643|NCT04617275|75867439|FG007|Treatment Period|No longer meets eligibility criteria|0|||
42058644|NCT04617275|75867432|FG000|Treatment Period|Other|0|||
42058645|NCT04617275|75867433|FG001|Treatment Period|Other|1|||
42058646|NCT04617275|75867434|FG002|Treatment Period|Other|0|||
42058647|NCT04617275|75867435|FG003|Treatment Period|Other|0|||
42058648|NCT04617275|75867436|FG004|Treatment Period|Other|0|||
42058649|NCT04617275|75867437|FG005|Treatment Period|Other|0|||
42058650|NCT04617275|75867438|FG006|Treatment Period|Other|0|||
42058651|NCT04617275|75867439|FG007|Treatment Period|Other|0|||
42058652|NCT04617275|75867432|FG000|Treatment Period|Withdrawal by Subject|2|||
42058653|NCT04617275|75867433|FG001|Treatment Period|Withdrawal by Subject|0|||
42058654|NCT04617275|75867434|FG002|Treatment Period|Withdrawal by Subject|0|||
42058655|NCT04617275|75867435|FG003|Treatment Period|Withdrawal by Subject|2|||
42058656|NCT04617275|75867436|FG004|Treatment Period|Withdrawal by Subject|2|||
42058657|NCT04617275|75867437|FG005|Treatment Period|Withdrawal by Subject|0|||
42058658|NCT04617275|75867438|FG006|Treatment Period|Withdrawal by Subject|1|||
42058659|NCT04617275|75867439|FG007|Treatment Period|Withdrawal by Subject|2|||
42174278|NCT00367835|75981063|FG000|Overall Study|Protocol Violation|1|||
42357004|NCT01422213|76202265|FG001|Overall Study|Protocol Violation|2|||
42357005|NCT01422213|76202266|FG002|Overall Study|Protocol Violation|4|||
42357006|NCT01422213|76202264|FG000|Overall Study|Withdrawal of Consent|7|||
42357007|NCT01422213|76202265|FG001|Overall Study|Withdrawal of Consent|3|||
42357008|NCT01422213|76202266|FG002|Overall Study|Withdrawal of Consent|5|||
42357009|NCT01422213|76202264|FG000|Overall Study|Lost to Follow-up|3|||
42357010|NCT01422213|76202265|FG001|Overall Study|Lost to Follow-up|3|||
42357011|NCT01422213|76202266|FG002|Overall Study|Lost to Follow-up|5|||
42357012|NCT01422213|76202264|FG000|Overall Study|Administrative or Other Reason(s)|5|||
42357013|NCT01422213|76202265|FG001|Overall Study|Administrative or Other Reason(s)|4|||
42357014|NCT01422213|76202266|FG002|Overall Study|Administrative or Other Reason(s)|2|||
42357015|NCT01390857|76202274|FG000|Overall Study|Protocol Violation|2|||
42357016|NCT01390857|76202274|FG000|Overall Study|Lost to Follow-up|1|||
42357017|NCT01390857|76202274|FG000|Overall Study|No Visit after the First Visit|7|||
42357018|NCT01725386|76202280|FG000|Overall Study|Death|84|||
42357019|NCT01725386|76202281|FG001|Overall Study|Death|40|||
42357020|NCT01725386|76202280|FG000|Overall Study|Lost to Follow-up|81|||
42357021|NCT01725386|76202281|FG001|Overall Study|Lost to Follow-up|6|||
42357022|NCT01725386|76202280|FG000|Overall Study|Withdrawal by Subject|10|||
42357023|NCT01725386|76202281|FG001|Overall Study|Withdrawal by Subject|0|||
42357024|NCT01402011|76202290|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
42357025|NCT01402011|76202291|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
42357026|NCT01402011|76202292|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
42357027|NCT01402011|76202290|FG000|Active Treatment Period|Withdrawal by Subject|1|||
42357028|NCT01402011|76202291|FG001|Active Treatment Period|Withdrawal by Subject|3|||
42357029|NCT01402011|76202292|FG002|Active Treatment Period|Withdrawal by Subject|0|||
42357030|NCT01402011|76202290|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
42357031|NCT01402011|76202291|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
42357032|NCT01402011|76202292|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
42357033|NCT01421667|76202307|FG000|Overall Study|Withdrawal by Subject|0|||
42357034|NCT01421667|76202308|FG001|Overall Study|Withdrawal by Subject|1|||
42357035|NCT01421667|76202309|FG002|Overall Study|Withdrawal by Subject|2|||
42357036|NCT01421667|76202310|FG003|Overall Study|Withdrawal by Subject|1|||
42357037|NCT01421667|76202307|FG000|Overall Study|Lost to Follow-up|0|||
42357038|NCT01421667|76202308|FG001|Overall Study|Lost to Follow-up|1|||
42357039|NCT01421667|76202309|FG002|Overall Study|Lost to Follow-up|0|||
42357040|NCT01421667|76202310|FG003|Overall Study|Lost to Follow-up|0|||
42357041|NCT01390779|76202328|FG000|Overall Study|Physician Decision|1|||
42357042|NCT01891669|76202342|FG000|Overall Study|Death|0|||
42357043|NCT01891669|76202343|FG001|Overall Study|Death|0|||
42357044|NCT01891669|76202344|FG002|Overall Study|Death|0|||
42357045|NCT01891669|76202345|FG003|Overall Study|Death|0|||
42357046|NCT01891669|76202346|FG004|Overall Study|Death|0|||
42357047|NCT01891669|76202347|FG005|Overall Study|Death|0|||
42357048|NCT01891669|76202348|FG006|Overall Study|Death|0|||
42357049|NCT01891669|76202349|FG007|Overall Study|Death|1|||
42357050|NCT01891669|76202350|FG008|Overall Study|Death|0|||
42357051|NCT01891669|76202351|FG009|Overall Study|Death|1|||
42357052|NCT01891669|76202342|FG000|Overall Study|Withdrawal by Subject|1|||
42357053|NCT01891669|76202343|FG001|Overall Study|Withdrawal by Subject|1|||
42357054|NCT01891669|76202344|FG002|Overall Study|Withdrawal by Subject|0|||
42357055|NCT01891669|76202345|FG003|Overall Study|Withdrawal by Subject|0|||
42357056|NCT01891669|76202346|FG004|Overall Study|Withdrawal by Subject|0|||
42357057|NCT01891669|76202347|FG005|Overall Study|Withdrawal by Subject|0|||
42357058|NCT01891669|76202348|FG006|Overall Study|Withdrawal by Subject|1|||
42357059|NCT01891669|76202349|FG007|Overall Study|Withdrawal by Subject|2|||
42357060|NCT01891669|76202350|FG008|Overall Study|Withdrawal by Subject|1|||
42357061|NCT01891669|76202351|FG009|Overall Study|Withdrawal by Subject|1|||
42357062|NCT01891669|76202342|FG000|Overall Study|Other|1|||
42357063|NCT01891669|76202343|FG001|Overall Study|Other|0|||
42357064|NCT01891669|76202344|FG002|Overall Study|Other|0|||
42357065|NCT01891669|76202345|FG003|Overall Study|Other|0|||
42357066|NCT01891669|76202346|FG004|Overall Study|Other|0|||
42357067|NCT01891669|76202347|FG005|Overall Study|Other|0|||
42058660|NCT04617275|75867432|FG000|Follow-up Period|Adverse Event|1|||
42058661|NCT04617275|75867433|FG001|Follow-up Period|Adverse Event|1|||
42357068|NCT01891669|76202348|FG006|Overall Study|Other|0|||
42357069|NCT01891669|76202349|FG007|Overall Study|Other|1|||
42357070|NCT01891669|76202350|FG008|Overall Study|Other|0|||
42357071|NCT01891669|76202351|FG009|Overall Study|Other|0|||
42357072|NCT01421511|76202384|FG000|Overall Study|Lost to Follow-up|11|||
42357073|NCT01421511|76202385|FG001|Overall Study|Lost to Follow-up|14|||
42357074|NCT01421511|76202384|FG000|Overall Study|Randomized but didn't receive study drug|1|||
42357075|NCT01421511|76202385|FG001|Overall Study|Randomized but didn't receive study drug|7|||
42357076|NCT01421511|76202384|FG000|Overall Study|Physician Decision|0|||
42058662|NCT04617275|75867434|FG002|Follow-up Period|Adverse Event|2|||
42058663|NCT04617275|75867435|FG003|Follow-up Period|Adverse Event|3|||
42058664|NCT04617275|75867436|FG004|Follow-up Period|Adverse Event|4|||
42058665|NCT04617275|75867437|FG005|Follow-up Period|Adverse Event|3|||
42058666|NCT04617275|75867438|FG006|Follow-up Period|Adverse Event|0|||
42058667|NCT04617275|75867439|FG007|Follow-up Period|Adverse Event|3|||
42058668|NCT04617275|75867432|FG000|Follow-up Period|Lost to Follow-up|0|||
42058669|NCT04617275|75867433|FG001|Follow-up Period|Lost to Follow-up|1|||
42058670|NCT04617275|75867434|FG002|Follow-up Period|Lost to Follow-up|2|||
42058671|NCT04617275|75867435|FG003|Follow-up Period|Lost to Follow-up|0|||
42058672|NCT04617275|75867436|FG004|Follow-up Period|Lost to Follow-up|0|||
42058673|NCT04617275|75867437|FG005|Follow-up Period|Lost to Follow-up|4|||
42058674|NCT04617275|75867438|FG006|Follow-up Period|Lost to Follow-up|0|||
42058675|NCT04617275|75867439|FG007|Follow-up Period|Lost to Follow-up|3|||
42058676|NCT04617275|75867432|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
42058677|NCT04617275|75867433|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
42058678|NCT04617275|75867434|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
42058679|NCT04617275|75867435|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
42058680|NCT04617275|75867436|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
42058681|NCT04617275|75867437|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
42058682|NCT04617275|75867438|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
42058683|NCT04617275|75867439|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
42058684|NCT04617275|75867432|FG000|Follow-up Period|Other|0|||
42058685|NCT04617275|75867433|FG001|Follow-up Period|Other|1|||
42058686|NCT04617275|75867434|FG002|Follow-up Period|Other|0|||
42058687|NCT04617275|75867435|FG003|Follow-up Period|Other|0|||
42058688|NCT04617275|75867436|FG004|Follow-up Period|Other|0|||
42058689|NCT04617275|75867437|FG005|Follow-up Period|Other|0|||
42058690|NCT04617275|75867438|FG006|Follow-up Period|Other|0|||
42058691|NCT04617275|75867439|FG007|Follow-up Period|Other|0|||
42058692|NCT04617275|75867432|FG000|Follow-up Period|Withdrawal by Subject|2|||
42058693|NCT04617275|75867433|FG001|Follow-up Period|Withdrawal by Subject|0|||
42058694|NCT04617275|75867434|FG002|Follow-up Period|Withdrawal by Subject|0|||
42058695|NCT04617275|75867435|FG003|Follow-up Period|Withdrawal by Subject|2|||
42058696|NCT04617275|75867436|FG004|Follow-up Period|Withdrawal by Subject|2|||
42058697|NCT04617275|75867437|FG005|Follow-up Period|Withdrawal by Subject|0|||
42058698|NCT04617275|75867438|FG006|Follow-up Period|Withdrawal by Subject|1|||
42058699|NCT04617275|75867439|FG007|Follow-up Period|Withdrawal by Subject|2|||
42058700|NCT01031537|75867474|FG000|Overall Study|medical reasons not related to study|3|||
42058701|NCT01031537|75867474|FG000|Overall Study|Lack of Efficacy|1|||
42058702|NCT01031537|75867474|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
42058703|NCT01031537|75867474|FG000|Overall Study|moved, met exclusion criteria|10|||
42058704|NCT01031537|75867474|FG000|Overall Study|Withdrawal by Subject|5|||
42058705|NCT01031537|75867474|FG000|Overall Study|PI removal, no longer met eligibility|12|||
42058706|NCT01031381|75867478|FG000|Overall Study|Physician Decision|3|||
42058707|NCT01031381|75867478|FG000|Overall Study|Withdrawal by Subject|6|||
42058708|NCT00685399|75867490|FG000|Treatment Period 1|Withdrawal by Subject|2|||
42058709|NCT00685399|75867491|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42058710|NCT00685399|75867492|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42058711|NCT00685399|75867493|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42058712|NCT00685399|75867494|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42058713|NCT00685399|75867495|FG005|Treatment Period 1|Withdrawal by Subject|0|||
42058714|NCT00685399|75867496|FG006|Treatment Period 1|Withdrawal by Subject|0|||
42058715|NCT00685399|75867497|FG007|Treatment Period 1|Withdrawal by Subject|0|||
42058716|NCT00685399|75867490|FG000|Treatment Period 1|Protocol Violation|1|||
42058717|NCT00685399|75867491|FG001|Treatment Period 1|Protocol Violation|0|||
42058718|NCT00685399|75867492|FG002|Treatment Period 1|Protocol Violation|0|||
42058719|NCT00685399|75867493|FG003|Treatment Period 1|Protocol Violation|0|||
42058720|NCT00685399|75867494|FG004|Treatment Period 1|Protocol Violation|0|||
42058721|NCT00685399|75867495|FG005|Treatment Period 1|Protocol Violation|0|||
42058722|NCT00685399|75867496|FG006|Treatment Period 1|Protocol Violation|0|||
42058723|NCT00685399|75867497|FG007|Treatment Period 1|Protocol Violation|0|||
42058724|NCT00685399|75867490|FG000|Treatment Period 1|Administrative|2|||
42058725|NCT00685399|75867491|FG001|Treatment Period 1|Administrative|0|||
42058726|NCT00685399|75867492|FG002|Treatment Period 1|Administrative|0|||
42357077|NCT01421511|76202385|FG001|Overall Study|Physician Decision|1|||
42058727|NCT00685399|75867493|FG003|Treatment Period 1|Administrative|0|||
42058728|NCT00685399|75867494|FG004|Treatment Period 1|Administrative|0|||
42058729|NCT00685399|75867495|FG005|Treatment Period 1|Administrative|0|||
42058730|NCT00685399|75867496|FG006|Treatment Period 1|Administrative|0|||
42058731|NCT00685399|75867497|FG007|Treatment Period 1|Administrative|0|||
42058732|NCT00685399|75867490|FG000|Treatment Period 1|Lack of Efficacy|1|||
42058733|NCT00685399|75867491|FG001|Treatment Period 1|Lack of Efficacy|0|||
42058734|NCT00685399|75867492|FG002|Treatment Period 1|Lack of Efficacy|0|||
42058735|NCT00685399|75867493|FG003|Treatment Period 1|Lack of Efficacy|0|||
42058736|NCT00685399|75867494|FG004|Treatment Period 1|Lack of Efficacy|0|||
42058737|NCT00685399|75867495|FG005|Treatment Period 1|Lack of Efficacy|0|||
42058738|NCT00685399|75867496|FG006|Treatment Period 1|Lack of Efficacy|0|||
42058739|NCT00685399|75867497|FG007|Treatment Period 1|Lack of Efficacy|0|||
42058740|NCT00685399|75867490|FG000|Treatment Period 2|Administrative Problems|0|||
42058741|NCT00685399|75867491|FG001|Treatment Period 2|Administrative Problems|2|||
42058742|NCT00685399|75867492|FG002|Treatment Period 2|Administrative Problems|1|||
42058743|NCT00685399|75867493|FG003|Treatment Period 2|Administrative Problems|0|||
42058744|NCT00685399|75867494|FG004|Treatment Period 2|Administrative Problems|0|||
42058745|NCT00685399|75867495|FG005|Treatment Period 2|Administrative Problems|0|||
42058746|NCT00685399|75867496|FG006|Treatment Period 2|Administrative Problems|0|||
42058747|NCT00685399|75867497|FG007|Treatment Period 2|Administrative Problems|0|||
42058748|NCT00685399|75867490|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42058749|NCT00685399|75867491|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42058750|NCT00685399|75867492|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42058751|NCT00685399|75867493|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42058752|NCT00685399|75867494|FG004|Treatment Period 2|Withdrawal by Subject|0|||
42058753|NCT00685399|75867495|FG005|Treatment Period 2|Withdrawal by Subject|0|||
42058754|NCT00685399|75867496|FG006|Treatment Period 2|Withdrawal by Subject|0|||
42058755|NCT00685399|75867497|FG007|Treatment Period 2|Withdrawal by Subject|2|||
42058756|NCT00685399|75867490|FG000|Treatment Period 2|Adverse Event|0|||
42058757|NCT00685399|75867491|FG001|Treatment Period 2|Adverse Event|0|||
42058758|NCT00685399|75867492|FG002|Treatment Period 2|Adverse Event|0|||
42058759|NCT00685399|75867493|FG003|Treatment Period 2|Adverse Event|0|||
42058760|NCT00685399|75867494|FG004|Treatment Period 2|Adverse Event|0|||
42058761|NCT00685399|75867495|FG005|Treatment Period 2|Adverse Event|1|||
42058762|NCT00685399|75867496|FG006|Treatment Period 2|Adverse Event|0|||
42058763|NCT00685399|75867497|FG007|Treatment Period 2|Adverse Event|0|||
42058764|NCT00685399|75867490|FG000|Treatment Period 2|Lack of Efficacy|0|||
42058765|NCT00685399|75867491|FG001|Treatment Period 2|Lack of Efficacy|10|||
42058766|NCT00685399|75867492|FG002|Treatment Period 2|Lack of Efficacy|2|||
42058767|NCT00685399|75867493|FG003|Treatment Period 2|Lack of Efficacy|0|||
42058768|NCT00685399|75867494|FG004|Treatment Period 2|Lack of Efficacy|0|||
42058769|NCT00685399|75867495|FG005|Treatment Period 2|Lack of Efficacy|1|||
42058770|NCT00685399|75867496|FG006|Treatment Period 2|Lack of Efficacy|0|||
42058771|NCT00685399|75867497|FG007|Treatment Period 2|Lack of Efficacy|0|||
42058772|NCT00685399|75867490|FG000|Extension|Administrative Issues|0|||
42058773|NCT00685399|75867491|FG001|Extension|Administrative Issues|0|||
42058774|NCT00685399|75867492|FG002|Extension|Administrative Issues|0|||
42058775|NCT00685399|75867493|FG003|Extension|Administrative Issues|1|||
42058776|NCT00685399|75867494|FG004|Extension|Administrative Issues|0|||
42058777|NCT00685399|75867495|FG005|Extension|Administrative Issues|0|||
42058778|NCT00685399|75867496|FG006|Extension|Administrative Issues|0|||
42058779|NCT00685399|75867497|FG007|Extension|Administrative Issues|0|||
42058780|NCT00685399|75867490|FG000|Extension|Withdrawal by Subject|0|||
42058781|NCT00685399|75867491|FG001|Extension|Withdrawal by Subject|0|||
42058782|NCT00685399|75867492|FG002|Extension|Withdrawal by Subject|0|||
42058783|NCT00685399|75867493|FG003|Extension|Withdrawal by Subject|1|||
42058784|NCT00685399|75867494|FG004|Extension|Withdrawal by Subject|0|||
42058785|NCT00685399|75867495|FG005|Extension|Withdrawal by Subject|0|||
42058786|NCT00685399|75867496|FG006|Extension|Withdrawal by Subject|0|||
42058787|NCT00685399|75867497|FG007|Extension|Withdrawal by Subject|0|||
42058788|NCT00685399|75867490|FG000|Extension|Protocol Violation|0|||
42058789|NCT00685399|75867491|FG001|Extension|Protocol Violation|0|||
42058790|NCT00685399|75867492|FG002|Extension|Protocol Violation|0|||
42058791|NCT00685399|75867493|FG003|Extension|Protocol Violation|1|||
42058792|NCT00685399|75867494|FG004|Extension|Protocol Violation|0|||
42058793|NCT00685399|75867495|FG005|Extension|Protocol Violation|0|||
42058794|NCT00685399|75867496|FG006|Extension|Protocol Violation|0|||
42058795|NCT00685399|75867497|FG007|Extension|Protocol Violation|0|||
42058796|NCT00685399|75867490|FG000|Extension|Lack of Efficacy|0|||
42058797|NCT00685399|75867491|FG001|Extension|Lack of Efficacy|0|||
42058798|NCT00685399|75867492|FG002|Extension|Lack of Efficacy|0|||
42058799|NCT00685399|75867493|FG003|Extension|Lack of Efficacy|2|||
42058800|NCT00685399|75867494|FG004|Extension|Lack of Efficacy|0|||
42058801|NCT00685399|75867495|FG005|Extension|Lack of Efficacy|0|||
42058802|NCT00685399|75867496|FG006|Extension|Lack of Efficacy|0|||
42058803|NCT00685399|75867497|FG007|Extension|Lack of Efficacy|0|||
42058804|NCT00685399|75867490|FG000|Extension|Adverse Event|0|||
42058805|NCT00685399|75867491|FG001|Extension|Adverse Event|0|||
42291822|NCT01968070|76125307|FG008|Period 1|Lost to Follow-up|0|||
42291823|NCT01968070|76125308|FG009|Period 1|Lost to Follow-up|0|||
42291824|NCT01968070|76125309|FG010|Period 1|Lost to Follow-up|0|||
42291825|NCT01968070|76125310|FG011|Period 1|Lost to Follow-up|0|||
42058806|NCT00685399|75867492|FG002|Extension|Adverse Event|0|||
42058807|NCT00685399|75867493|FG003|Extension|Adverse Event|2|||
42291826|NCT01968070|76125311|FG012|Period 1|Lost to Follow-up|0|||
42058808|NCT00685399|75867494|FG004|Extension|Adverse Event|0|||
42058809|NCT00685399|75867495|FG005|Extension|Adverse Event|0|||
42058810|NCT00685399|75867496|FG006|Extension|Adverse Event|0|||
42058811|NCT00685399|75867497|FG007|Extension|Adverse Event|0|||
42058812|NCT00685165|75867524|FG000|Washout Period of 14 Days|Adverse Event|1|||
42058813|NCT00685165|75867525|FG001|Washout Period of 14 Days|Adverse Event|0|||
42058814|NCT00683449|75867536|FG000|Overall Study|Lost to Follow-up|0|||
42058815|NCT00683449|75867537|FG001|Overall Study|Lost to Follow-up|1|||
42058816|NCT00683449|75867538|FG002|Overall Study|Lost to Follow-up|0|||
42058817|NCT00683449|75867539|FG003|Overall Study|Lost to Follow-up|0|||
42058818|NCT00683449|75867540|FG004|Overall Study|Lost to Follow-up|0|||
42058819|NCT00683293|75867559|FG000|Overall Study|Withdrawal by Subject|2|||
42058820|NCT00683293|75867560|FG001|Overall Study|Withdrawal by Subject|3|||
42058821|NCT00726232|75867572|FG000|Initial Phase (Dose-finding)|Death|0|||
42058822|NCT00726232|75867573|FG001|Initial Phase (Dose-finding)|Death|0|||
42058823|NCT00726232|75867574|FG002|Initial Phase (Dose-finding)|Death|0|||
42058824|NCT00726232|75867575|FG003|Initial Phase (Dose-finding)|Death|0|||
42058825|NCT00726232|75867576|FG004|Initial Phase (Dose-finding)|Death|1|||
42058826|NCT00726232|75867577|FG005|Initial Phase (Dose-finding)|Death|0|||
42058827|NCT00726232|75867578|FG006|Initial Phase (Dose-finding)|Death|0|||
42058828|NCT00726232|75867579|FG007|Initial Phase (Dose-finding)|Death|0|||
42058829|NCT00726232|75867572|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
42058830|NCT00726232|75867573|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
42058831|NCT00726232|75867574|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
42058832|NCT00726232|75867575|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
42058833|NCT00726232|75867576|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
42058834|NCT00726232|75867577|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
42058835|NCT00726232|75867578|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
42058836|NCT00726232|75867579|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
42058837|NCT00726232|75867572|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
42058838|NCT00726232|75867573|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
42058839|NCT00726232|75867574|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
42058840|NCT00726232|75867575|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
42058841|NCT00726232|75867576|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
42058842|NCT00726232|75867577|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
42058843|NCT00726232|75867578|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
42058844|NCT00726232|75867579|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
42058845|NCT00726232|75867572|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
42058846|NCT00726232|75867573|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
42058847|NCT00726232|75867574|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
42058848|NCT00726232|75867575|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
42058849|NCT00726232|75867576|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
42058850|NCT00726232|75867577|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
42058851|NCT00726232|75867578|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
42058852|NCT00726232|75867579|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
42058853|NCT00726232|75867572|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
42058854|NCT00726232|75867573|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
42058855|NCT00726232|75867574|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
42058856|NCT00726232|75867575|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
42058857|NCT00726232|75867576|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
42058858|NCT00726232|75867577|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
42058859|NCT00726232|75867578|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
42058860|NCT00726232|75867579|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
42058861|NCT00726232|75867572|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
42058862|NCT00726232|75867573|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
42058863|NCT00726232|75867574|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
42058864|NCT00726232|75867575|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
42058865|NCT00726232|75867576|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
42058866|NCT00726232|75867577|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
42058867|NCT00726232|75867578|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
42058868|NCT00726232|75867579|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
42058869|NCT00726232|75867572|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
42058870|NCT00726232|75867573|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
42058871|NCT00726232|75867574|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
42058872|NCT00726232|75867575|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
42058873|NCT00726232|75867576|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
42058874|NCT00726232|75867577|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
42058875|NCT00726232|75867578|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
42058876|NCT00726232|75867579|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
42058877|NCT00726232|75867572|FG000|Expansion Phase|Death|0|||
42058878|NCT00726232|75867573|FG001|Expansion Phase|Death|0|||
42058879|NCT00726232|75867574|FG002|Expansion Phase|Death|0|||
42058880|NCT00726232|75867575|FG003|Expansion Phase|Death|0|||
42058881|NCT00726232|75867576|FG004|Expansion Phase|Death|0|||
42058882|NCT00726232|75867577|FG005|Expansion Phase|Death|0|||
42058883|NCT00726232|75867578|FG006|Expansion Phase|Death|0|||
42058884|NCT00726232|75867579|FG007|Expansion Phase|Death|1|||
42058885|NCT00726232|75867572|FG000|Expansion Phase|Adverse Event|0|||
42058886|NCT00726232|75867573|FG001|Expansion Phase|Adverse Event|0|||
42058887|NCT00726232|75867574|FG002|Expansion Phase|Adverse Event|0|||
42058888|NCT00726232|75867575|FG003|Expansion Phase|Adverse Event|0|||
42058889|NCT00726232|75867576|FG004|Expansion Phase|Adverse Event|0|||
42058890|NCT00726232|75867577|FG005|Expansion Phase|Adverse Event|0|||
42058891|NCT00726232|75867578|FG006|Expansion Phase|Adverse Event|6|||
42058892|NCT00726232|75867579|FG007|Expansion Phase|Adverse Event|11|||
42058893|NCT00726232|75867572|FG000|Expansion Phase|Withdrawal by Subject|0|||
42058894|NCT00726232|75867573|FG001|Expansion Phase|Withdrawal by Subject|0|||
42058895|NCT00726232|75867574|FG002|Expansion Phase|Withdrawal by Subject|0|||
42058896|NCT00726232|75867575|FG003|Expansion Phase|Withdrawal by Subject|0|||
42058897|NCT00726232|75867576|FG004|Expansion Phase|Withdrawal by Subject|0|||
42058898|NCT00726232|75867577|FG005|Expansion Phase|Withdrawal by Subject|0|||
42058899|NCT00726232|75867578|FG006|Expansion Phase|Withdrawal by Subject|2|||
42058900|NCT00726232|75867579|FG007|Expansion Phase|Withdrawal by Subject|3|||
42058901|NCT00726232|75867572|FG000|Expansion Phase|Disease progression|0|||
42058902|NCT00726232|75867573|FG001|Expansion Phase|Disease progression|0|||
42058903|NCT00726232|75867574|FG002|Expansion Phase|Disease progression|0|||
42058904|NCT00726232|75867575|FG003|Expansion Phase|Disease progression|0|||
42058905|NCT00726232|75867576|FG004|Expansion Phase|Disease progression|0|||
42058906|NCT00726232|75867577|FG005|Expansion Phase|Disease progression|0|||
42058907|NCT00726232|75867578|FG006|Expansion Phase|Disease progression|4|||
42058908|NCT00726232|75867579|FG007|Expansion Phase|Disease progression|0|||
42058909|NCT00726232|75867572|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
42058910|NCT00726232|75867573|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
42058911|NCT00726232|75867574|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
42058912|NCT00726232|75867575|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
42058913|NCT00726232|75867576|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
42058914|NCT00726232|75867577|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
42058915|NCT00726232|75867578|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
42058916|NCT00726232|75867579|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
42058917|NCT00726232|75867572|FG000|Expansion Phase|Per Investigator: lack of response|0|||
42291827|NCT01968070|76125312|FG013|Period 1|Lost to Follow-up|0|||
42291828|NCT01968070|76125313|FG014|Period 1|Lost to Follow-up|0|||
42291829|NCT01968070|76125314|FG015|Period 1|Lost to Follow-up|0|||
42291830|NCT01968070|76125315|FG016|Period 1|Lost to Follow-up|0|||
42291831|NCT01968070|76125316|FG017|Period 1|Lost to Follow-up|0|||
42291832|NCT01968070|76125299|FG000|Period 1|Adverse Event|0|||
42291833|NCT01968070|76125300|FG001|Period 1|Adverse Event|0|||
42291834|NCT01968070|76125301|FG002|Period 1|Adverse Event|0|||
42291835|NCT01968070|76125302|FG003|Period 1|Adverse Event|0|||
42291836|NCT01968070|76125303|FG004|Period 1|Adverse Event|0|||
42291837|NCT01968070|76125304|FG005|Period 1|Adverse Event|0|||
42291838|NCT01968070|76125305|FG006|Period 1|Adverse Event|1|||
42291839|NCT01968070|76125306|FG007|Period 1|Adverse Event|0|||
42291840|NCT01968070|76125307|FG008|Period 1|Adverse Event|0|||
42291841|NCT01968070|76125308|FG009|Period 1|Adverse Event|0|||
42291842|NCT01968070|76125309|FG010|Period 1|Adverse Event|0|||
42291843|NCT01968070|76125310|FG011|Period 1|Adverse Event|0|||
42291844|NCT01968070|76125311|FG012|Period 1|Adverse Event|0|||
42291845|NCT01968070|76125312|FG013|Period 1|Adverse Event|0|||
42291846|NCT01968070|76125313|FG014|Period 1|Adverse Event|0|||
42291847|NCT01968070|76125314|FG015|Period 1|Adverse Event|0|||
42291848|NCT01968070|76125315|FG016|Period 1|Adverse Event|0|||
42291849|NCT01968070|76125316|FG017|Period 1|Adverse Event|0|||
42291850|NCT01968070|76125299|FG000|Period 1|Physician Decision|0|||
42291851|NCT01968070|76125300|FG001|Period 1|Physician Decision|0|||
42291852|NCT01968070|76125301|FG002|Period 1|Physician Decision|0|||
42291853|NCT01968070|76125302|FG003|Period 1|Physician Decision|0|||
42291854|NCT01968070|76125303|FG004|Period 1|Physician Decision|0|||
42291855|NCT01968070|76125304|FG005|Period 1|Physician Decision|0|||
42291856|NCT01968070|76125305|FG006|Period 1|Physician Decision|0|||
42291857|NCT01968070|76125306|FG007|Period 1|Physician Decision|0|||
42291858|NCT01968070|76125307|FG008|Period 1|Physician Decision|0|||
42291859|NCT01968070|76125308|FG009|Period 1|Physician Decision|0|||
42291860|NCT01968070|76125309|FG010|Period 1|Physician Decision|0|||
42291861|NCT01968070|76125310|FG011|Period 1|Physician Decision|1|||
42291862|NCT01968070|76125311|FG012|Period 1|Physician Decision|0|||
42291863|NCT01968070|76125312|FG013|Period 1|Physician Decision|0|||
42291864|NCT01968070|76125313|FG014|Period 1|Physician Decision|0|||
42291865|NCT01968070|76125314|FG015|Period 1|Physician Decision|0|||
42058918|NCT00726232|75867573|FG001|Expansion Phase|Per Investigator: lack of response|0|||
42058919|NCT00726232|75867574|FG002|Expansion Phase|Per Investigator: lack of response|0|||
42058920|NCT00726232|75867575|FG003|Expansion Phase|Per Investigator: lack of response|0|||
42058921|NCT00726232|75867576|FG004|Expansion Phase|Per Investigator: lack of response|0|||
42058922|NCT00726232|75867577|FG005|Expansion Phase|Per Investigator: lack of response|0|||
42058923|NCT00726232|75867578|FG006|Expansion Phase|Per Investigator: lack of response|1|||
42058924|NCT00726232|75867579|FG007|Expansion Phase|Per Investigator: lack of response|7|||
42058925|NCT00726232|75867572|FG000|Expansion Phase|Unspecified reason|0|||
42058926|NCT00726232|75867573|FG001|Expansion Phase|Unspecified reason|0|||
42058927|NCT00726232|75867574|FG002|Expansion Phase|Unspecified reason|0|||
42058928|NCT00726232|75867575|FG003|Expansion Phase|Unspecified reason|0|||
42058929|NCT00726232|75867576|FG004|Expansion Phase|Unspecified reason|0|||
42058930|NCT00726232|75867577|FG005|Expansion Phase|Unspecified reason|0|||
42058931|NCT00726232|75867578|FG006|Expansion Phase|Unspecified reason|1|||
42058932|NCT00726232|75867579|FG007|Expansion Phase|Unspecified reason|0|||
42058933|NCT00720382|75867600|FG000|Overall Study|Adverse Event|54|||
42058934|NCT00720382|75867601|FG001|Overall Study|Adverse Event|17|||
42058935|NCT00720382|75867600|FG000|Overall Study|Lack of Efficacy|18|||
42058936|NCT00720382|75867601|FG001|Overall Study|Lack of Efficacy|7|||
42058937|NCT00720382|75867600|FG000|Overall Study|Non-Compliance|15|||
42058938|NCT00720382|75867601|FG001|Overall Study|Non-Compliance|5|||
42058939|NCT00720382|75867600|FG000|Overall Study|Withdrawal by Subject|47|||
42058940|NCT00720382|75867601|FG001|Overall Study|Withdrawal by Subject|11|||
42058941|NCT00720382|75867600|FG000|Overall Study|Lost to Follow-up|28|||
42058942|NCT00720382|75867601|FG001|Overall Study|Lost to Follow-up|14|||
42058943|NCT00720382|75867600|FG000|Overall Study|administrative|14|||
42058944|NCT00720382|75867601|FG001|Overall Study|administrative|5|||
42058945|NCT00720226|75867609|FG000|Overall Study|Withdrawal by Subject|7|||
42058946|NCT00720226|75867610|FG001|Overall Study|Withdrawal by Subject|4|||
42058947|NCT00725920|75867618|FG000|Overall Study|Lack of Efficacy|3|||
42058948|NCT00725920|75867619|FG001|Overall Study|Lack of Efficacy|6|||
42058949|NCT00725842|75867625|FG000|Overall Study|Lost to Follow-up|19|||
42058950|NCT00725842|75867625|FG000|Overall Study|Death|1|||
42058951|NCT00725842|75867625|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
42058952|NCT00725842|75867625|FG000|Overall Study|Consent date prior to study start date|5|||
42058953|NCT00725842|75867625|FG000|Overall Study|Inclusion criterion not met|1|||
42058954|NCT00725842|75867625|FG000|Overall Study|No Visit 1 data|1|||
42058955|NCT00725764|75867629|FG000|Overall Study|Withdrawal by Subject|2|||
42058956|NCT00725764|75867629|FG000|Overall Study|Physician Decision|1|||
42058957|NCT00725764|75867629|FG000|Overall Study|Progressive Disease|7|||
42058958|NCT00725764|75867629|FG000|Overall Study|Lost to Follow-up|1|||
42058959|NCT00725764|75867629|FG000|Overall Study|Death|1|||
42058960|NCT00725764|75867629|FG000|Overall Study|Participant non compliant with protocol|1|||
42058961|NCT00725764|75867629|FG000|Overall Study|Decline in performance status|1|||
42058962|NCT00725608|75867634|FG000|Overall Study|Lost to Follow-up|60|||
42058963|NCT00725608|75867634|FG000|Overall Study|Adverse Event|14|||
42058964|NCT00725608|75867634|FG000|Overall Study|Individual reasons|86|||
42058965|NCT00725608|75867634|FG000|Overall Study|Other|7|||
42058966|NCT00725452|75867638|FG000|Overall Study|Adverse Event|3|||
42058967|NCT00725452|75867638|FG000|Overall Study|Lack of Efficacy|2|||
42058968|NCT00725452|75867638|FG000|Overall Study|Reason not specified|1|||
42058969|NCT00725452|75867638|FG000|Overall Study|Physician Decision|1|||
42058970|NCT00725452|75867638|FG000|Overall Study|Withdrawal by Subject|3|||
42058971|NCT00725452|75867638|FG000|Overall Study|Lost to Follow-up|1|||
42058972|NCT00725296|75867642|FG000|Overall Study|Adverse Event|11|||
42058973|NCT00725296|75867642|FG000|Overall Study|Lack of Efficacy|7|||
42058974|NCT00725296|75867642|FG000|Overall Study|Withdrawal by Subject|3|||
42058975|NCT00725296|75867642|FG000|Overall Study|Non-Compliance|2|||
42058976|NCT00725296|75867642|FG000|Overall Study|Lost to Follow-up|1|||
42058977|NCT00725296|75867642|FG000|Overall Study|Other|38|||
42058978|NCT00719680|75867647|FG000|Overall Study|Adverse Event|1|||
42058979|NCT00719680|75867647|FG000|Overall Study|Lost to Follow-up|1|||
42058980|NCT00719680|75867647|FG000|Overall Study|Withdrawal by Subject|3|||
42058981|NCT00719212|75867651|FG000|Overall Study|Death|41|||
42058982|NCT00719212|75867651|FG000|Overall Study|Lost to Follow-up|2|||
42058983|NCT00719212|75867651|FG000|Overall Study|Withdrawal by Subject|1|||
42058984|NCT00585052|75867655|FG000|Overall Study|Withdrawal by Subject|1|||
42058985|NCT00724282|75867659|FG000|Overall Study|Withdrawal by Subject|3|||
42058986|NCT00724282|75867659|FG000|Overall Study|Physician Decision|1|||
42058987|NCT00724126|75867665|FG000|Overall Study|Adverse Event|2|||
42357078|NCT01421511|76202384|FG000|Overall Study|Withdrawal by Subject|6|||
42058988|NCT00724126|75867666|FG001|Overall Study|Adverse Event|0|||
42058989|NCT00724126|75867665|FG000|Overall Study|Withdrawal by Subject|8|||
42058990|NCT00724126|75867666|FG001|Overall Study|Withdrawal by Subject|6|||
42058991|NCT00724126|75867665|FG000|Overall Study|Lost to Follow-up|6|||
42058992|NCT00724126|75867666|FG001|Overall Study|Lost to Follow-up|6|||
42058993|NCT00724126|75867665|FG000|Overall Study|Noncompliance|2|||
42058994|NCT00724126|75867666|FG001|Overall Study|Noncompliance|1|||
42058995|NCT00724126|75867665|FG000|Overall Study|Subject randomized although ineligible|1|||
42058996|NCT00724126|75867666|FG001|Overall Study|Subject randomized although ineligible|1|||
42058997|NCT00724126|75867665|FG000|Overall Study|Subject had to leave vicinity of site|0|||
42058998|NCT00724126|75867666|FG001|Overall Study|Subject had to leave vicinity of site|1|||
42058999|NCT00723892|75867674|FG000|Overall Study|Participant not tracked|33|||
42059000|NCT00723892|75867675|FG001|Overall Study|Participant not tracked|35|||
42059001|NCT00723892|75867674|FG000|Overall Study|Virological criterion|24|||
42059002|NCT00723892|75867675|FG001|Overall Study|Virological criterion|9|||
42059003|NCT00723892|75867674|FG000|Overall Study|Withdrawal by Subject|6|||
42059004|NCT00723892|75867675|FG001|Overall Study|Withdrawal by Subject|9|||
42059005|NCT00723892|75867674|FG000|Overall Study|End planned|11|||
42059006|NCT00723892|75867675|FG001|Overall Study|End planned|7|||
42059007|NCT00723892|75867674|FG000|Overall Study|Bad tolerance|5|||
42059008|NCT00723892|75867675|FG001|Overall Study|Bad tolerance|5|||
42059009|NCT00723892|75867674|FG000|Overall Study|Multiple reasons|17|||
42059010|NCT00723892|75867675|FG001|Overall Study|Multiple reasons|12|||
42059011|NCT00723892|75867674|FG000|Overall Study|Other|6|||
42059012|NCT00723892|75867675|FG001|Overall Study|Other|3|||
42059013|NCT00723892|75867674|FG000|Overall Study|Study end|1|||
42059014|NCT00723892|75867675|FG001|Overall Study|Study end|3|||
42059015|NCT00723892|75867674|FG000|Overall Study|Weight loss|1|||
42059016|NCT00723892|75867675|FG001|Overall Study|Weight loss|3|||
42059017|NCT00723892|75867674|FG000|Overall Study|Alcohol abuse|0|||
42059018|NCT00723892|75867675|FG001|Overall Study|Alcohol abuse|1|||
42059019|NCT00723892|75867674|FG000|Overall Study|Intercurrent infection|2|||
42059020|NCT00723892|75867675|FG001|Overall Study|Intercurrent infection|0|||
42059021|NCT00723892|75867674|FG000|Overall Study|Drug addiction|1|||
42059022|NCT00723892|75867675|FG001|Overall Study|Drug addiction|0|||
42059023|NCT00718666|75867684|FG000|Booster Phase Year 5|No active participation request|0|||
42059024|NCT00718666|75867685|FG001|Booster Phase Year 5|No active participation request|0|||
42059025|NCT00718666|75867686|FG002|Booster Phase Year 5|No active participation request|1|||
42059026|NCT00718666|75867684|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
42059027|NCT00718666|75867685|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
42059028|NCT00718666|75867686|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
42059029|NCT00718666|75867684|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
42059030|NCT00718666|75867685|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
42059031|NCT00718666|75867686|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
42059032|NCT00718666|75867684|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
42059033|NCT00718666|75867685|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
42059034|NCT00718666|75867686|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
42059035|NCT03950440|75867707|FG000|Overall Study|Death|8|||
42059036|NCT03950440|75867708|FG001|Overall Study|Death|2|||
42059037|NCT03950440|75867709|FG002|Overall Study|Death|1|||
42059038|NCT00718510|75867719|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
42059039|NCT00718510|75867720|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
42059040|NCT00718510|75867719|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
42059041|NCT00718510|75867720|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
42059042|NCT00585286|75867726|FG000|Overall Study|Lost to Follow-up|1|||
42059043|NCT00723190|75867730|FG000|Overall Study|Withdrawal by Subject|45|||
42059044|NCT00723190|75867730|FG000|Overall Study|Lost to Follow-up|37|||
42059045|NCT00723190|75867730|FG000|Overall Study|Adverse Event|18|||
42059046|NCT00723190|75867730|FG000|Overall Study|Lack of Efficacy|16|||
42059047|NCT00723190|75867730|FG000|Overall Study|Protocol Violation|15|||
42059048|NCT00723190|75867730|FG000|Overall Study|Other-Premature Discontinuation|9|||
42059049|NCT00723190|75867730|FG000|Overall Study|Other-Not included in safety population|2|||
42357079|NCT01421511|76202385|FG001|Overall Study|Withdrawal by Subject|5|||
42357080|NCT01421511|76202384|FG000|Overall Study|Death|1|||
42357081|NCT01421511|76202385|FG001|Overall Study|Death|1|||
42357082|NCT01864525|76202394|FG000|Overall Study|Adverse Event|1|||
42357083|NCT01864525|76202395|FG001|Overall Study|Adverse Event|0|||
42357084|NCT01421277|76202403|FG000|Overall Study|Lack of qualifying event|0|||
42059050|NCT00722800|75867736|FG000|Overall Study|Withdrawal by Subject|1|||
42059051|NCT00722800|75867737|FG001|Overall Study|Withdrawal by Subject|0|||
42059052|NCT00722800|75867736|FG000|Overall Study|Physician Decision|1|||
42059053|NCT00722800|75867737|FG001|Overall Study|Physician Decision|0|||
42059054|NCT00718042|75867749|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
42059055|NCT00718042|75867750|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
42059056|NCT00718042|75867751|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
42059057|NCT00718042|75867752|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
42059058|NCT00718042|75867753|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
42059059|NCT00718042|75867754|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
42059060|NCT00718042|75867749|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
42174279|NCT00367835|75981064|FG001|Overall Study|Protocol Violation|7|||
42357085|NCT01421277|76202404|FG001|Overall Study|Lack of qualifying event|61|||
42059061|NCT00718042|75867750|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
42059062|NCT00718042|75867751|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
42059063|NCT00718042|75867752|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
42059064|NCT00718042|75867753|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
42059065|NCT00718042|75867754|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
42059066|NCT00718042|75867749|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
42059067|NCT00718042|75867750|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
42059068|NCT00718042|75867751|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
42059069|NCT00718042|75867752|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
42059070|NCT00718042|75867753|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
42059071|NCT00718042|75867754|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
42059072|NCT00718042|75867749|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
42059073|NCT00718042|75867750|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
42059074|NCT00718042|75867751|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
42059075|NCT00718042|75867752|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
42059076|NCT00718042|75867753|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
42059077|NCT00718042|75867754|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
42059078|NCT00718042|75867749|FG000|Donor Follow-up|Lost to Follow-up|13|||
42059079|NCT00718042|75867750|FG001|Donor Follow-up|Lost to Follow-up|0|||
42059080|NCT00718042|75867751|FG002|Donor Follow-up|Lost to Follow-up|0|||
42059081|NCT00718042|75867752|FG003|Donor Follow-up|Lost to Follow-up|0|||
42059082|NCT00718042|75867753|FG004|Donor Follow-up|Lost to Follow-up|19|||
42059083|NCT00718042|75867754|FG005|Donor Follow-up|Lost to Follow-up|0|||
42059084|NCT00741598|75867768|FG000|Overall Study|Lost to Follow-up|3|||
42059085|NCT00741598|75867769|FG001|Overall Study|Lost to Follow-up|4|||
42059086|NCT00741598|75867768|FG000|Overall Study|Lack of Efficacy|1|||
42059087|NCT00741598|75867769|FG001|Overall Study|Lack of Efficacy|2|||
42059088|NCT00741598|75867768|FG000|Overall Study|Physician Decision|1|||
42059089|NCT00741598|75867769|FG001|Overall Study|Physician Decision|1|||
42059090|NCT00741598|75867768|FG000|Overall Study|Pregnancy|1|||
42059091|NCT00741598|75867769|FG001|Overall Study|Pregnancy|0|||
42059092|NCT00741598|75867768|FG000|Overall Study|Withdrawal by Subject|3|||
42059093|NCT00741598|75867769|FG001|Overall Study|Withdrawal by Subject|2|||
42059094|NCT00717886|75867776|FG000|Overall Study|Withdrawal by Subject|3|||
42059095|NCT00717886|75867776|FG000|Overall Study|Treatment Failure|1|||
42059096|NCT00741286|75867782|FG000|Overall Study|Lost to Follow-up|15|||
42059097|NCT00741286|75867783|FG001|Overall Study|Lost to Follow-up|10|||
42059098|NCT00741286|75867782|FG000|Overall Study|Adverse Event|1|||
42059099|NCT00741286|75867783|FG001|Overall Study|Adverse Event|6|||
42059100|NCT00741286|75867782|FG000|Overall Study|Protocol Violation|3|||
42059101|NCT00741286|75867783|FG001|Overall Study|Protocol Violation|2|||
42059102|NCT00741286|75867782|FG000|Overall Study|Primary Outcome|1|||
42059103|NCT00741286|75867783|FG001|Overall Study|Primary Outcome|1|||
42059104|NCT00716482|75867789|FG000|Overall Study|Lost to Follow-up|6|||
42059105|NCT00716482|75867789|FG000|Overall Study|Inadequate acquisition or analysis|50|||
42059106|NCT00716482|75867789|FG000|Overall Study|no pathology obtained|10|||
42059107|NCT00716482|75867789|FG000|Overall Study|technical/machine error|28|||
42059108|NCT00716482|75867789|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
42059109|NCT00716092|75867802|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
42059110|NCT00716092|75867803|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
42059111|NCT00716092|75867804|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
42059112|NCT00715624|75867814|FG000|Overall Study|Adverse Event|12|||
42059113|NCT00715624|75867815|FG001|Overall Study|Adverse Event|37|||
42059114|NCT00715624|75867814|FG000|Overall Study|Lack of Efficacy|11|||
42059115|NCT00715624|75867815|FG001|Overall Study|Lack of Efficacy|11|||
42059116|NCT00715624|75867814|FG000|Overall Study|Lost to Follow-up|1|||
42059117|NCT00715624|75867815|FG001|Overall Study|Lost to Follow-up|2|||
42059118|NCT00715624|75867814|FG000|Overall Study|Protocol Violation|1|||
42059119|NCT00715624|75867815|FG001|Overall Study|Protocol Violation|0|||
42059120|NCT00715624|75867814|FG000|Overall Study|Withdrawal by Subject|11|||
42059121|NCT00715624|75867815|FG001|Overall Study|Withdrawal by Subject|25|||
42059122|NCT00715624|75867814|FG000|Overall Study|Familial and personal reasons|10|||
42059123|NCT00715624|75867815|FG001|Overall Study|Familial and personal reasons|22|||
42357086|NCT01421277|76202403|FG000|Overall Study|Incomplete baseline data|0|||
42357087|NCT01421277|76202404|FG001|Overall Study|Incomplete baseline data|31|||
42059124|NCT00715624|75867814|FG000|Overall Study|Poor compliance|6|||
42059125|NCT00715624|75867815|FG001|Overall Study|Poor compliance|13|||
42059126|NCT00715624|75867814|FG000|Overall Study|Sponsor decision|0|||
42059127|NCT00715624|75867815|FG001|Overall Study|Sponsor decision|4|||
42059128|NCT00715624|75867814|FG000|Overall Study|Incorrect randomization (not treated)|0|||
42059129|NCT00715624|75867815|FG001|Overall Study|Incorrect randomization (not treated)|1|||
42059130|NCT00715624|75867814|FG000|Overall Study|Other|0|||
42059131|NCT00715624|75867815|FG001|Overall Study|Other|1|||
42059132|NCT00576199|75867821|FG000|Overall Study|Adverse Event|12|||
42059133|NCT00576199|75867821|FG000|Overall Study|Insufficient Therapeutic Response|14|||
42357088|NCT01891357|76202410|FG000|Overall Study|Protocol Violation|3|||
42059134|NCT00576199|75867821|FG000|Overall Study|Refused Treatment|2|||
42059135|NCT00576199|75867821|FG000|Overall Study|Reason Unspecified|2|||
42059136|NCT00715078|75867828|FG000|Overall Study|Death|29|||
42059137|NCT00715078|75867829|FG001|Overall Study|Death|36|||
42059138|NCT00715078|75867830|FG002|Overall Study|Death|36|||
42059139|NCT00715078|75867828|FG000|Overall Study|Withdrawal by Subject|1|||
42059140|NCT00715078|75867829|FG001|Overall Study|Withdrawal by Subject|0|||
42059141|NCT00715078|75867830|FG002|Overall Study|Withdrawal by Subject|1|||
42059142|NCT00715078|75867828|FG000|Overall Study|Unable to start due to disease prog.|0|||
42059143|NCT00715078|75867829|FG001|Overall Study|Unable to start due to disease prog.|0|||
42059144|NCT00715078|75867830|FG002|Overall Study|Unable to start due to disease prog.|1|||
42059145|NCT00679627|75867840|FG000|Overall Study|Death|41|||
42059146|NCT00679627|75867841|FG001|Overall Study|Death|29|||
42059147|NCT00679627|75867840|FG000|Overall Study|Adverse Event|43|||
42059148|NCT00679627|75867841|FG001|Overall Study|Adverse Event|53|||
42059149|NCT00679627|75867840|FG000|Overall Study|Withdrawal by Subject|168|||
42059150|NCT00679627|75867841|FG001|Overall Study|Withdrawal by Subject|172|||
42059151|NCT00679627|75867840|FG000|Overall Study|Lost to Follow-up|22|||
42059152|NCT00679627|75867841|FG001|Overall Study|Lost to Follow-up|26|||
42059153|NCT00679627|75867840|FG000|Overall Study|Early Study Closure|425|||
42059154|NCT00679627|75867841|FG001|Overall Study|Early Study Closure|405|||
42059155|NCT00714688|75867850|FG000|Overall Study|Lack of Efficacy|14|||
42059156|NCT00714688|75867851|FG001|Overall Study|Lack of Efficacy|1|||
42059157|NCT00714688|75867852|FG002|Overall Study|Lack of Efficacy|4|||
42059158|NCT00714688|75867850|FG000|Overall Study|Withdrawal by Subject|4|||
42059159|NCT00714688|75867851|FG001|Overall Study|Withdrawal by Subject|3|||
42059160|NCT00714688|75867852|FG002|Overall Study|Withdrawal by Subject|3|||
42059161|NCT00714688|75867850|FG000|Overall Study|Lost to Follow-up|5|||
42059162|NCT00714688|75867851|FG001|Overall Study|Lost to Follow-up|2|||
42059163|NCT00714688|75867852|FG002|Overall Study|Lost to Follow-up|0|||
42059164|NCT00714688|75867850|FG000|Overall Study|Adverse Event|2|||
42059165|NCT00714688|75867851|FG001|Overall Study|Adverse Event|15|||
42059166|NCT00714688|75867852|FG002|Overall Study|Adverse Event|19|||
42059167|NCT00714688|75867850|FG000|Overall Study|Subject Non-compliant|3|||
42059168|NCT00714688|75867851|FG001|Overall Study|Subject Non-compliant|5|||
42059169|NCT00714688|75867852|FG002|Overall Study|Subject Non-compliant|5|||
42059170|NCT00714688|75867850|FG000|Overall Study|Ineligible to Continue the Study|0|||
42059171|NCT00714688|75867851|FG001|Overall Study|Ineligible to Continue the Study|1|||
42059172|NCT00714688|75867852|FG002|Overall Study|Ineligible to Continue the Study|1|||
42059173|NCT00714688|75867850|FG000|Overall Study|Sponsor's Decision|0|||
42059174|NCT00714688|75867851|FG001|Overall Study|Sponsor's Decision|2|||
42059175|NCT00714688|75867852|FG002|Overall Study|Sponsor's Decision|0|||
42059176|NCT00714688|75867850|FG000|Overall Study|Other|1|||
42059177|NCT00714688|75867851|FG001|Overall Study|Other|6|||
42059178|NCT00714688|75867852|FG002|Overall Study|Other|5|||
42059179|NCT00679549|75867862|FG000|Overall Study|dropout|2|||
42059180|NCT00679549|75867863|FG001|Overall Study|dropout|4|||
42059181|NCT00679549|75867862|FG000|Overall Study|missing outcome echocardiograms|4|||
42059182|NCT00679549|75867863|FG001|Overall Study|missing outcome echocardiograms|5|||
42059183|NCT01031069|75867873|FG000|Overall Study|Serious Adverse Event|0|||
42059184|NCT01031069|75867874|FG001|Overall Study|Serious Adverse Event|1|||
42059185|NCT01031069|75867875|FG002|Overall Study|Serious Adverse Event|0|||
42059186|NCT01031069|75867876|FG003|Overall Study|Serious Adverse Event|0|||
42059187|NCT01031069|75867873|FG000|Overall Study|Withdrawal by Subject|2|||
42059188|NCT01031069|75867874|FG001|Overall Study|Withdrawal by Subject|3|||
42059189|NCT01031069|75867875|FG002|Overall Study|Withdrawal by Subject|18|||
42059190|NCT01031069|75867876|FG003|Overall Study|Withdrawal by Subject|18|||
42059191|NCT01031069|75867873|FG000|Overall Study|Migrated/moved from study area|1|||
42059192|NCT01031069|75867874|FG001|Overall Study|Migrated/moved from study area|2|||
42059193|NCT01031069|75867875|FG002|Overall Study|Migrated/moved from study area|1|||
42059194|NCT01031069|75867876|FG003|Overall Study|Migrated/moved from study area|1|||
42059195|NCT01031069|75867873|FG000|Overall Study|Lost to Follow-up|9|||
42059196|NCT01031069|75867874|FG001|Overall Study|Lost to Follow-up|5|||
42059197|NCT01031069|75867875|FG002|Overall Study|Lost to Follow-up|21|||
42059198|NCT01031069|75867876|FG003|Overall Study|Lost to Follow-up|15|||
42059199|NCT01031069|75867873|FG000|Overall Study|Other|0|||
42059200|NCT01031069|75867874|FG001|Overall Study|Other|0|||
42059201|NCT01031069|75867875|FG002|Overall Study|Other|1|||
42059202|NCT01031069|75867876|FG003|Overall Study|Other|0|||
42059203|NCT00679081|75867888|FG000|Overall Study|Lost to Follow-up|1|||
42059204|NCT00682435|75867896|FG000|Overall Study|Insufficient data|5|||
42016630|NCT01359592|75824111|FG002|Initial Registration|Other reason not protocol specified|0|||
42016631|NCT01359592|75824112|FG003|Initial Registration|Other reason not protocol specified|0|||
42016632|NCT01359592|75824109|FG000|Initial Registration|Ineligible|26|||
42016633|NCT01359592|75824110|FG001|Initial Registration|Ineligible|0|||
42016634|NCT01359592|75824111|FG002|Initial Registration|Ineligible|0|||
42016635|NCT01359592|75824112|FG003|Initial Registration|Ineligible|0|||
42016636|NCT01359592|75824109|FG000|PET-Directed Therapy|Adverse Event|0|||
42016637|NCT01359592|75824110|FG001|PET-Directed Therapy|Adverse Event|0|||
42016638|NCT01359592|75824111|FG002|PET-Directed Therapy|Adverse Event|1|||
42016639|NCT01359592|75824112|FG003|PET-Directed Therapy|Adverse Event|0|||
42016640|NCT01359592|75824109|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
42016641|NCT01359592|75824110|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
42016642|NCT01359592|75824111|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
42016643|NCT01359592|75824112|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
42016644|NCT01359592|75824109|FG000|PET-Directed Therapy|Ineligible|0|||
42016645|NCT01359592|75824110|FG001|PET-Directed Therapy|Ineligible|0|||
42016646|NCT01359592|75824111|FG002|PET-Directed Therapy|Ineligible|24|||
42016647|NCT01359592|75824112|FG003|PET-Directed Therapy|Ineligible|0|||
42016648|NCT00699816|75824129|FG000|Overall Study|Protocol Violation|1|||
42016649|NCT00699816|75824130|FG001|Overall Study|Protocol Violation|3|||
42016650|NCT00697073|75824136|FG000|Overall Study|Withdrawal by Subject|2|||
42016651|NCT00697073|75824136|FG000|Overall Study|Pregnancy|1|||
42016652|NCT00697073|75824136|FG000|Overall Study|non compliance and other|6|||
42016653|NCT00653432|75824142|FG000|Overall Study|Adverse Event|4|||
42016654|NCT00653432|75824143|FG001|Overall Study|Adverse Event|1|||
42016655|NCT00653432|75824142|FG000|Overall Study|Withdrawal by Subject|4|||
42059205|NCT00682435|75867896|FG000|Overall Study|Erroneously enrolled twice|2|||
42059206|NCT00713830|75867902|FG000|Overall Study|Adverse Event|23|||
42059207|NCT00713830|75867903|FG001|Overall Study|Adverse Event|71|||
42059208|NCT00713830|75867902|FG000|Overall Study|Lack of Efficacy|24|||
42059209|NCT00713830|75867903|FG001|Overall Study|Lack of Efficacy|16|||
42059210|NCT00713830|75867902|FG000|Overall Study|Lost to Follow-up|2|||
42059211|NCT00713830|75867903|FG001|Overall Study|Lost to Follow-up|9|||
42059212|NCT00713830|75867902|FG000|Overall Study|Withdrawal by Subject|13|||
42059213|NCT00713830|75867903|FG001|Overall Study|Withdrawal by Subject|23|||
42016656|NCT00653432|75824143|FG001|Overall Study|Withdrawal by Subject|5|||
42174280|NCT00367835|75981063|FG000|Overall Study|Withdrawal by Subject|7|||
42174281|NCT00367835|75981064|FG001|Overall Study|Withdrawal by Subject|6|||
42174282|NCT00367835|75981063|FG000|Overall Study|Lost to Follow-up|1|||
42174283|NCT00367835|75981064|FG001|Overall Study|Lost to Follow-up|4|||
42174284|NCT00367835|75981063|FG000|Overall Study|Lack of Efficacy|3|||
42174285|NCT00367835|75981064|FG001|Overall Study|Lack of Efficacy|12|||
42174286|NCT00367835|75981063|FG000|Overall Study|Subject in juvenile detention center|1|||
42174287|NCT00367835|75981064|FG001|Overall Study|Subject in juvenile detention center|0|||
42174288|NCT00367835|75981063|FG000|Overall Study|refused blood collection|1|||
42174289|NCT00367835|75981064|FG001|Overall Study|refused blood collection|0|||
42174290|NCT00367835|75981063|FG000|Overall Study|Did not respond to calls|1|||
42174291|NCT00367835|75981064|FG001|Overall Study|Did not respond to calls|0|||
42174292|NCT00367835|75981063|FG000|Overall Study|History of lead poisoning|0|||
42174293|NCT00367835|75981064|FG001|Overall Study|History of lead poisoning|1|||
42174294|NCT03267940|75981076|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
42174295|NCT03267940|75981077|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
42174296|NCT03267940|75981078|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
42174297|NCT03267940|75981079|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
42174298|NCT03267940|75981080|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
42174299|NCT03267940|75981081|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
42174300|NCT03267940|75981076|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
42059214|NCT00713830|75867902|FG000|Overall Study|Poor Compliance to Protocol|7|||
42174301|NCT03267940|75981077|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
42174302|NCT03267940|75981078|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
42174303|NCT03267940|75981079|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
42174304|NCT03267940|75981080|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
42174305|NCT03267940|75981081|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
42174306|NCT03267940|75981076|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
42174307|NCT03267940|75981077|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
42174308|NCT03267940|75981078|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
42174309|NCT03267940|75981079|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
42174310|NCT03267940|75981080|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
42016657|NCT00653432|75824142|FG000|Overall Study|Lost to Follow-up|7|||
42016658|NCT00653432|75824143|FG001|Overall Study|Lost to Follow-up|6|||
42016659|NCT00653432|75824142|FG000|Overall Study|Use/Need of Con Therapy|2|||
42016660|NCT00653432|75824143|FG001|Overall Study|Use/Need of Con Therapy|1|||
42016661|NCT00653432|75824142|FG000|Overall Study|Other - Reason Not Provided|5|||
42016662|NCT00653432|75824143|FG001|Overall Study|Other - Reason Not Provided|3|||
42016663|NCT00446043|75824162|FG000|Overall Study|Adverse Event|9|||
42016664|NCT00446043|75824162|FG000|Overall Study|Withdrawal by Subject|70|||
42059215|NCT00713830|75867903|FG001|Overall Study|Poor Compliance to Protocol|14|||
42059216|NCT00713830|75867902|FG000|Overall Study|Familial and Personal Reasons|9|||
42174311|NCT03267940|75981081|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
42174312|NCT03267940|75981076|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
42174313|NCT03267940|75981077|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
42174314|NCT03267940|75981078|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
42291866|NCT01968070|76125315|FG016|Period 1|Physician Decision|0|||
42174315|NCT03267940|75981079|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
42174316|NCT03267940|75981080|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
42174317|NCT03267940|75981081|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
42174318|NCT03267940|75981076|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
42174319|NCT03267940|75981077|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
42174320|NCT03267940|75981078|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
42174321|NCT03267940|75981079|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
42291867|NCT01968070|76125316|FG017|Period 1|Physician Decision|0|||
42291868|NCT01968070|76125299|FG000|Period 2|Withdrawal by Subject|0|||
42291869|NCT01968070|76125300|FG001|Period 2|Withdrawal by Subject|0|||
42291870|NCT01968070|76125301|FG002|Period 2|Withdrawal by Subject|0|||
42016665|NCT00446043|75824162|FG000|Overall Study|Protocol Violation|2|||
42059217|NCT00713830|75867903|FG001|Overall Study|Familial and Personal Reasons|34|||
42059218|NCT00713830|75867902|FG000|Overall Study|Sponsor Decision|4|||
42059219|NCT00713830|75867903|FG001|Overall Study|Sponsor Decision|10|||
42059220|NCT00681811|75867911|FG000|Overall Study|Adverse Event|1|||
42059221|NCT00681811|75867912|FG001|Overall Study|Adverse Event|1|||
42059222|NCT00681811|75867911|FG000|Overall Study|Withdrawal by Subject|2|||
42059223|NCT00681811|75867912|FG001|Overall Study|Withdrawal by Subject|2|||
42059224|NCT00681811|75867911|FG000|Overall Study|Non-compliance|0|||
42059225|NCT00681811|75867912|FG001|Overall Study|Non-compliance|1|||
42059226|NCT00681187|75867931|FG000|Overall Study|Withdrawal by Subject|1|||
42059227|NCT00681187|75867932|FG001|Overall Study|Withdrawal by Subject|0|||
42059228|NCT00681187|75867931|FG000|Overall Study|Death|0|||
42059229|NCT00681187|75867932|FG001|Overall Study|Death|1|||
42059230|NCT00681187|75867931|FG000|Overall Study|Adverse Event|0|||
42059231|NCT00681187|75867932|FG001|Overall Study|Adverse Event|1|||
42059232|NCT00681109|75867954|FG000|Overall Study|Lost to Follow-up|2|||
42059233|NCT00681109|75867955|FG001|Overall Study|Lost to Follow-up|6|||
42059234|NCT00681109|75867956|FG002|Overall Study|Lost to Follow-up|0|||
42059235|NCT02588950|75867967|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
42059236|NCT02588950|75867968|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
42059237|NCT02588950|75867969|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
42059238|NCT02588950|75867970|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
42059239|NCT02588950|75867967|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
42059240|NCT02588950|75867968|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
42059241|NCT02588950|75867969|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
42059242|NCT02588950|75867970|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
42059243|NCT00680407|75867983|FG000|Overall Study|Lost to Follow-up|3|||
42059244|NCT00680407|75867984|FG001|Overall Study|Lost to Follow-up|3|||
42059245|NCT00680407|75867985|FG002|Overall Study|Lost to Follow-up|1|||
42059246|NCT00680407|75867983|FG000|Overall Study|Withdrawal by Subject|5|||
42059247|NCT00680407|75867984|FG001|Overall Study|Withdrawal by Subject|2|||
42059248|NCT00680407|75867985|FG002|Overall Study|Withdrawal by Subject|2|||
42059249|NCT00677365|75867997|FG000|Overall Study|Adverse Event|2|||
42059250|NCT00677365|75867998|FG001|Overall Study|Adverse Event|1|||
42059251|NCT00677365|75867999|FG002|Overall Study|Adverse Event|1|||
42059252|NCT00677365|75868000|FG003|Overall Study|Adverse Event|2|||
42059253|NCT00677365|75867997|FG000|Overall Study|Withdrawal by Subject|0|||
42059254|NCT00677365|75867998|FG001|Overall Study|Withdrawal by Subject|0|||
42059255|NCT00677365|75867999|FG002|Overall Study|Withdrawal by Subject|1|||
42059256|NCT00677365|75868000|FG003|Overall Study|Withdrawal by Subject|0|||
42059257|NCT00677365|75867997|FG000|Overall Study|Other reason|0|||
42059258|NCT00677365|75867998|FG001|Overall Study|Other reason|0|||
42059259|NCT00677365|75867999|FG002|Overall Study|Other reason|0|||
42059260|NCT00677365|75868000|FG003|Overall Study|Other reason|1|||
42059261|NCT00680017|75868012|FG000|Overall Study|Adverse Event|13|||
42059262|NCT00680017|75868013|FG001|Overall Study|Adverse Event|7|||
42059263|NCT00680017|75868012|FG000|Overall Study|Withdrawal by Subject|2|||
42059264|NCT00680017|75868013|FG001|Overall Study|Withdrawal by Subject|5|||
42059265|NCT00680017|75868012|FG000|Overall Study|Lost to Follow-up|2|||
42059266|NCT00680017|75868013|FG001|Overall Study|Lost to Follow-up|0|||
42059267|NCT00676663|75868021|FG000|Overall Study|Death|43|||
42059268|NCT00676663|75868022|FG001|Overall Study|Death|27|||
42059269|NCT00676663|75868021|FG000|Overall Study|Withdrew Consent|1|||
42059270|NCT00676663|75868022|FG001|Overall Study|Withdrew Consent|8|||
42059271|NCT00676663|75868021|FG000|Overall Study|Lost to Follow-up|1|||
42059272|NCT00676663|75868022|FG001|Overall Study|Lost to Follow-up|3|||
42059273|NCT00678691|75868032|FG000|Overall Study|Adverse Event|6|||
42059274|NCT00678691|75868033|FG001|Overall Study|Adverse Event|4|||
42059275|NCT00679939|75868041|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
42059276|NCT00679939|75868042|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
42059277|NCT00679939|75868041|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
42059278|NCT00679939|75868042|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
42059279|NCT00679939|75868041|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
42059280|NCT00679939|75868042|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
42059281|NCT00679939|75868041|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
42059282|NCT00679939|75868042|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
42059283|NCT00679939|75868041|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
42059284|NCT00679939|75868042|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
42059285|NCT00679939|75868041|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
42059286|NCT00679939|75868042|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
42059287|NCT00679939|75868041|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
42059288|NCT00679939|75868042|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
42059289|NCT00679939|75868041|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
42059290|NCT00679939|75868042|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
42059291|NCT00679939|75868041|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
42059292|NCT00679939|75868042|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
42059293|NCT00679939|75868041|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
42059294|NCT00679939|75868042|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
42059295|NCT00673933|75868052|FG000|Overall Study|Withdrawal by Subject|2|||
42059296|NCT00673933|75868052|FG000|Overall Study|Lost to Follow-up|1|||
42059297|NCT00571519|75868065|FG000|Overall Study|Subject withdrew consent|0|||
42059298|NCT00571519|75868066|FG001|Overall Study|Subject withdrew consent|1|||
42059299|NCT00571519|75868067|FG002|Overall Study|Subject withdrew consent|0|||
42059300|NCT00571519|75868068|FG003|Overall Study|Subject withdrew consent|2|||
42059301|NCT00571519|75868069|FG004|Overall Study|Subject withdrew consent|1|||
42059302|NCT00571519|75868070|FG005|Overall Study|Subject withdrew consent|1|||
42059303|NCT00571519|75868071|FG006|Overall Study|Subject withdrew consent|2|||
42059304|NCT00571519|75868065|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
42059305|NCT00571519|75868066|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
42059306|NCT00571519|75868067|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
42059307|NCT00571519|75868068|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
42059308|NCT00571519|75868069|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
42059309|NCT00571519|75868070|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
42059310|NCT00571519|75868071|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
42059311|NCT00571519|75868065|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
42059312|NCT00571519|75868066|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
42059313|NCT00571519|75868067|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
42059314|NCT00571519|75868068|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
42059315|NCT00571519|75868069|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
42059316|NCT00571519|75868070|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
42059317|NCT00571519|75868071|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
42059318|NCT00571519|75868065|FG000|Overall Study|Termination of study by Sponsor|2|||
42059319|NCT00571519|75868066|FG001|Overall Study|Termination of study by Sponsor|7|||
42059320|NCT00571519|75868067|FG002|Overall Study|Termination of study by Sponsor|10|||
42059321|NCT00571519|75868068|FG003|Overall Study|Termination of study by Sponsor|24|||
42059322|NCT00571519|75868069|FG004|Overall Study|Termination of study by Sponsor|8|||
42059323|NCT00571519|75868070|FG005|Overall Study|Termination of study by Sponsor|9|||
42059324|NCT00571519|75868071|FG006|Overall Study|Termination of study by Sponsor|22|||
42059325|NCT00571519|75868065|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
42059326|NCT00571519|75868066|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
42059327|NCT00571519|75868067|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
42059328|NCT00571519|75868068|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
42059329|NCT00571519|75868069|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
42059330|NCT00571519|75868070|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
42059331|NCT00571519|75868071|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
42059332|NCT00676195|75868087|FG000|Overall Study|Lost to Follow-up|1|||
42059333|NCT00676195|75868087|FG000|Overall Study|Adverse Event|1|||
42059334|NCT00676195|75868087|FG000|Overall Study|Physician Decision|1|||
42059335|NCT00675103|75868092|FG000|Overall Study|Lack of Efficacy|2|||
42059336|NCT00675103|75868092|FG000|Overall Study|Adverse Event|1|||
42059337|NCT00675025|75868098|FG000|Overall Study|Study Terminated by Sponsor|38|||
42059338|NCT00675025|75868099|FG001|Overall Study|Study Terminated by Sponsor|42|||
42059339|NCT00675025|75868098|FG000|Overall Study|Adverse Event|6|||
42059340|NCT00675025|75868099|FG001|Overall Study|Adverse Event|11|||
42059341|NCT00675025|75868098|FG000|Overall Study|Lost to Follow-up|6|||
42059342|NCT00675025|75868099|FG001|Overall Study|Lost to Follow-up|4|||
42059343|NCT00675025|75868098|FG000|Overall Study|Withdrawal by Subject|4|||
42059344|NCT00675025|75868099|FG001|Overall Study|Withdrawal by Subject|6|||
42059345|NCT00678379|75868117|FG000|Overall Study|Injection performed after tonsillectomy|2|||
42059346|NCT00678379|75868118|FG001|Overall Study|Injection performed after tonsillectomy|0|||
42059347|NCT00678379|75868119|FG002|Overall Study|Injection performed after tonsillectomy|1|||
42059348|NCT00678379|75868117|FG000|Overall Study|Incomplete Data|4|||
42059349|NCT00678379|75868118|FG001|Overall Study|Incomplete Data|3|||
42059350|NCT00678379|75868119|FG002|Overall Study|Incomplete Data|3|||
42059351|NCT00674323|75868130|FG000|Overall Study|Adverse Event|0|||
42059352|NCT00674323|75868131|FG001|Overall Study|Adverse Event|1|||
42059353|NCT00674323|75868132|FG002|Overall Study|Adverse Event|0|||
42174322|NCT03267940|75981080|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
42174323|NCT03267940|75981081|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
42059354|NCT00674323|75868130|FG000|Overall Study|Protocol Violation|1|||
42059355|NCT00674323|75868131|FG001|Overall Study|Protocol Violation|0|||
42059356|NCT00674323|75868132|FG002|Overall Study|Protocol Violation|0|||
42059357|NCT00678301|75868142|FG000|Overall Study|Non-compliance with study procedures|0|||
42174324|NCT03267940|75981076|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
42174325|NCT03267940|75981077|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
42059358|NCT00678301|75868143|FG001|Overall Study|Non-compliance with study procedures|1|||
42059359|NCT00678301|75868142|FG000|Overall Study|Adverse Event|1|||
42059360|NCT00678301|75868143|FG001|Overall Study|Adverse Event|0|||
42059361|NCT00678301|75868142|FG000|Overall Study|Withdrawal by Subject|4|||
42059362|NCT00678301|75868143|FG001|Overall Study|Withdrawal by Subject|0|||
42059363|NCT00678301|75868142|FG000|Overall Study|Lost to Follow-up|3|||
42059364|NCT00678301|75868143|FG001|Overall Study|Lost to Follow-up|1|||
42059365|NCT00939770|75868157|FG000|Overall Study|Adverse Event|1|||
42059366|NCT00939770|75868158|FG001|Overall Study|Adverse Event|1|||
42059367|NCT00939770|75868159|FG002|Overall Study|Adverse Event|0|||
42357089|NCT01420965|76202417|FG000|Overall Study|Withdrawal by Subject|1|||
42357090|NCT01420965|76202418|FG001|Overall Study|Withdrawal by Subject|0|||
42357091|NCT01420965|76202419|FG002|Overall Study|Withdrawal by Subject|0|||
42357092|NCT01420965|76202417|FG000|Overall Study|Adverse Event|0|||
42357093|NCT01420965|76202418|FG001|Overall Study|Adverse Event|1|||
42357094|NCT01420965|76202419|FG002|Overall Study|Adverse Event|0|||
42357095|NCT01390389|76202429|FG000|Overall Study|Withdrawal by Subject|2|||
42357096|NCT01390389|76202430|FG001|Overall Study|Withdrawal by Subject|0|||
42357097|NCT01390389|76202429|FG000|Overall Study|Screen Fail|2|||
42357098|NCT01390389|76202430|FG001|Overall Study|Screen Fail|1|||
42357099|NCT01401465|76202442|FG000|Treatment Period 1|Adverse Event|4|||
42357100|NCT01401465|76202443|FG001|Treatment Period 1|Adverse Event|1|||
42357101|NCT01401465|76202442|FG000|Treatment Period 1|Pregnancy|0|||
42357102|NCT01401465|76202443|FG001|Treatment Period 1|Pregnancy|1|||
42357103|NCT01401465|76202442|FG000|Treatment Period 1|Protocol Violation|5|||
42357104|NCT01401465|76202443|FG001|Treatment Period 1|Protocol Violation|0|||
42357105|NCT01401465|76202442|FG000|Treatment Period 1|Withdrawal by Subject|1|||
42357106|NCT01401465|76202443|FG001|Treatment Period 1|Withdrawal by Subject|4|||
42357107|NCT01401465|76202442|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
42357108|NCT01401465|76202443|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
42357109|NCT01401465|76202442|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
42357110|NCT01401465|76202443|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
42357111|NCT01401465|76202442|FG000|Treatment Period 1|Scheduling Difficulties|1|||
42357112|NCT01401465|76202443|FG001|Treatment Period 1|Scheduling Difficulties|1|||
42357113|NCT01401465|76202442|FG000|Treatment Period 2|Lost to Follow-up|0|||
42357114|NCT01401465|76202443|FG001|Treatment Period 2|Lost to Follow-up|1|||
42357115|NCT01401465|76202442|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42357116|NCT01401465|76202443|FG001|Treatment Period 2|Withdrawal by Subject|1|||
42357117|NCT01401153|76202454|FG000|First Test Day|Learning disabilities; illness|1|||
42357118|NCT01401153|76202455|FG001|First Test Day|Learning disabilities; illness|10|||
42357119|NCT01401153|76202454|FG000|Second Test Day|illness|0|||
42357120|NCT01401153|76202455|FG001|Second Test Day|illness|5|||
42357121|NCT01890967|76202468|FG000|Overall Study|Adverse Event|3|||
42357122|NCT01890967|76202469|FG001|Overall Study|Adverse Event|3|||
42357123|NCT01890967|76202470|FG002|Overall Study|Adverse Event|3|||
42357124|NCT01890967|76202471|FG003|Overall Study|Adverse Event|2|||
42357125|NCT01890967|76202472|FG004|Overall Study|Adverse Event|1|||
42357126|NCT01890967|76202473|FG005|Overall Study|Adverse Event|7|||
42357127|NCT01890967|76202468|FG000|Overall Study|Death|1|||
42357128|NCT01890967|76202469|FG001|Overall Study|Death|0|||
42357129|NCT01890967|76202470|FG002|Overall Study|Death|0|||
42357130|NCT01890967|76202471|FG003|Overall Study|Death|0|||
42357131|NCT01890967|76202472|FG004|Overall Study|Death|0|||
42357132|NCT01890967|76202473|FG005|Overall Study|Death|0|||
42357133|NCT01890967|76202468|FG000|Overall Study|Lost to Follow-up|1|||
42357134|NCT01890967|76202469|FG001|Overall Study|Lost to Follow-up|1|||
42357135|NCT01890967|76202470|FG002|Overall Study|Lost to Follow-up|1|||
42357136|NCT01890967|76202471|FG003|Overall Study|Lost to Follow-up|1|||
42357137|NCT01890967|76202472|FG004|Overall Study|Lost to Follow-up|0|||
42357138|NCT01890967|76202473|FG005|Overall Study|Lost to Follow-up|1|||
42357139|NCT01890967|76202468|FG000|Overall Study|Protocol Violation|0|||
42357140|NCT01890967|76202469|FG001|Overall Study|Protocol Violation|3|||
42357141|NCT01890967|76202470|FG002|Overall Study|Protocol Violation|3|||
42357142|NCT01890967|76202471|FG003|Overall Study|Protocol Violation|2|||
42357143|NCT01890967|76202472|FG004|Overall Study|Protocol Violation|4|||
42357144|NCT01890967|76202473|FG005|Overall Study|Protocol Violation|1|||
42357145|NCT01890967|76202468|FG000|Overall Study|Sponsor Decision|2|||
42357146|NCT01890967|76202469|FG001|Overall Study|Sponsor Decision|0|||
42357147|NCT01890967|76202470|FG002|Overall Study|Sponsor Decision|1|||
42059368|NCT00939770|75868160|FG003|Overall Study|Adverse Event|0|||
42059369|NCT00939770|75868161|FG004|Overall Study|Adverse Event|6|||
42059370|NCT00939770|75868162|FG005|Overall Study|Adverse Event|2|||
42059371|NCT00939770|75868163|FG006|Overall Study|Adverse Event|1|||
42059372|NCT00939770|75868164|FG007|Overall Study|Adverse Event|1|||
42357148|NCT01890967|76202471|FG003|Overall Study|Sponsor Decision|3|||
42357149|NCT01890967|76202472|FG004|Overall Study|Sponsor Decision|2|||
42357150|NCT01890967|76202473|FG005|Overall Study|Sponsor Decision|3|||
42059373|NCT00939770|75868157|FG000|Overall Study|Lack of Efficacy|4|||
42357151|NCT01890967|76202468|FG000|Overall Study|Withdrawal by Subject|3|||
42357152|NCT01890967|76202469|FG001|Overall Study|Withdrawal by Subject|4|||
42357153|NCT01890967|76202470|FG002|Overall Study|Withdrawal by Subject|2|||
42357154|NCT01890967|76202471|FG003|Overall Study|Withdrawal by Subject|3|||
42357155|NCT01890967|76202472|FG004|Overall Study|Withdrawal by Subject|3|||
42357156|NCT01890967|76202473|FG005|Overall Study|Withdrawal by Subject|1|||
42357157|NCT01400919|76202492|FG000|Overall Study|Withdrawal by Subject|4|||
42357158|NCT01400919|76202492|FG000|Overall Study|Lost to Follow-up|2|||
42357159|NCT01400919|76202492|FG000|Overall Study|Missed visit|2|||
42357160|NCT01864291|76202496|FG000|Overall Study|need for revision surgery|2|||
42357161|NCT01400841|76202500|FG000|Initial Study Phase (6 Months)|Death|1|||
42357162|NCT01400841|76202500|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
42357163|NCT01863667|76202506|FG000|Overall Study|Adverse Event|1|||
42357164|NCT01863667|76202507|FG001|Overall Study|Adverse Event|0|||
42357165|NCT01863667|76202506|FG000|Overall Study|Study terminated by Sponsor|30|||
42357166|NCT01863667|76202507|FG001|Overall Study|Study terminated by Sponsor|30|||
42357167|NCT01863667|76202506|FG000|Overall Study|Withdrawal by Subject|2|||
42357168|NCT01863667|76202507|FG001|Overall Study|Withdrawal by Subject|2|||
42357169|NCT01614769|76202513|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
42357170|NCT01614769|76202514|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
42357171|NCT01614769|76202515|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
42357172|NCT01614769|76202516|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
42357173|NCT01614769|76202517|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
42357174|NCT01614769|76202518|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
42357175|NCT01614769|76202513|FG000|Period 1|Protocol Violation|0|||
42357176|NCT01614769|76202514|FG001|Period 1|Protocol Violation|0|||
42357177|NCT01614769|76202515|FG002|Period 1|Protocol Violation|0|||
42357178|NCT01614769|76202516|FG003|Period 1|Protocol Violation|1|||
42357179|NCT01614769|76202517|FG004|Period 1|Protocol Violation|0|||
42357180|NCT01614769|76202518|FG005|Period 1|Protocol Violation|0|||
42357181|NCT01614769|76202513|FG000|Period 1|Withdrawal by Subject|1|||
42357182|NCT01614769|76202514|FG001|Period 1|Withdrawal by Subject|0|||
42357183|NCT01614769|76202515|FG002|Period 1|Withdrawal by Subject|0|||
42357184|NCT01614769|76202516|FG003|Period 1|Withdrawal by Subject|0|||
42357185|NCT01614769|76202517|FG004|Period 1|Withdrawal by Subject|0|||
42357186|NCT01614769|76202518|FG005|Period 1|Withdrawal by Subject|0|||
42059374|NCT00939770|75868158|FG001|Overall Study|Lack of Efficacy|6|||
42059375|NCT00939770|75868159|FG002|Overall Study|Lack of Efficacy|13|||
42059376|NCT00939770|75868160|FG003|Overall Study|Lack of Efficacy|9|||
42059377|NCT00939770|75868161|FG004|Overall Study|Lack of Efficacy|16|||
42059378|NCT00939770|75868162|FG005|Overall Study|Lack of Efficacy|8|||
42059379|NCT00939770|75868163|FG006|Overall Study|Lack of Efficacy|11|||
42059380|NCT00939770|75868164|FG007|Overall Study|Lack of Efficacy|1|||
42059381|NCT00939770|75868157|FG000|Overall Study|Lost to Follow-up|0|||
42059382|NCT00939770|75868158|FG001|Overall Study|Lost to Follow-up|0|||
42059383|NCT00939770|75868159|FG002|Overall Study|Lost to Follow-up|0|||
42059384|NCT00939770|75868160|FG003|Overall Study|Lost to Follow-up|0|||
42059385|NCT00939770|75868161|FG004|Overall Study|Lost to Follow-up|1|||
42059386|NCT00939770|75868162|FG005|Overall Study|Lost to Follow-up|0|||
42059387|NCT00939770|75868163|FG006|Overall Study|Lost to Follow-up|0|||
42059388|NCT00939770|75868164|FG007|Overall Study|Lost to Follow-up|0|||
42059389|NCT00939770|75868157|FG000|Overall Study|Physician Decision|0|||
42059390|NCT00939770|75868158|FG001|Overall Study|Physician Decision|0|||
42059391|NCT00939770|75868159|FG002|Overall Study|Physician Decision|2|||
42059392|NCT00939770|75868160|FG003|Overall Study|Physician Decision|0|||
42059393|NCT00939770|75868161|FG004|Overall Study|Physician Decision|7|||
42291871|NCT01968070|76125302|FG003|Period 2|Withdrawal by Subject|0|||
42291872|NCT01968070|76125303|FG004|Period 2|Withdrawal by Subject|1|||
42291873|NCT01968070|76125304|FG005|Period 2|Withdrawal by Subject|0|||
42291874|NCT01968070|76125305|FG006|Period 2|Withdrawal by Subject|0|||
42291875|NCT01968070|76125306|FG007|Period 2|Withdrawal by Subject|0|||
42291876|NCT01968070|76125307|FG008|Period 2|Withdrawal by Subject|0|||
42291877|NCT01968070|76125308|FG009|Period 2|Withdrawal by Subject|0|||
42291878|NCT01968070|76125309|FG010|Period 2|Withdrawal by Subject|0|||
42291879|NCT01968070|76125310|FG011|Period 2|Withdrawal by Subject|0|||
42291880|NCT01968070|76125311|FG012|Period 2|Withdrawal by Subject|0|||
42291881|NCT01968070|76125312|FG013|Period 2|Withdrawal by Subject|0|||
42291882|NCT01968070|76125313|FG014|Period 2|Withdrawal by Subject|0|||
42291883|NCT01968070|76125314|FG015|Period 2|Withdrawal by Subject|0|||
42291884|NCT01968070|76125315|FG016|Period 2|Withdrawal by Subject|0|||
42291885|NCT01968070|76125316|FG017|Period 2|Withdrawal by Subject|0|||
42291886|NCT01918774|76125354|FG000|Overall Study|Lost prior to first CBTw session|4|||
42357187|NCT01614769|76202513|FG000|Period 3|Withdrawal by Subject|0|||
42357188|NCT01614769|76202514|FG001|Period 3|Withdrawal by Subject|0|||
42357189|NCT01614769|76202515|FG002|Period 3|Withdrawal by Subject|1|||
42357190|NCT01614769|76202516|FG003|Period 3|Withdrawal by Subject|0|||
42291887|NCT01918774|76125354|FG000|Overall Study|Lost to Follow-up|1|||
42059394|NCT00939770|75868162|FG005|Overall Study|Physician Decision|1|||
42059395|NCT00939770|75868163|FG006|Overall Study|Physician Decision|0|||
42357191|NCT01614769|76202517|FG004|Period 3|Withdrawal by Subject|0|||
42059396|NCT00939770|75868164|FG007|Overall Study|Physician Decision|6|||
42059397|NCT00939770|75868157|FG000|Overall Study|Protocol Violation|0|||
42059398|NCT00939770|75868158|FG001|Overall Study|Protocol Violation|0|||
42059399|NCT00939770|75868159|FG002|Overall Study|Protocol Violation|0|||
42059400|NCT00939770|75868160|FG003|Overall Study|Protocol Violation|0|||
42059401|NCT00939770|75868161|FG004|Overall Study|Protocol Violation|1|||
42059402|NCT00939770|75868162|FG005|Overall Study|Protocol Violation|0|||
42059403|NCT00939770|75868163|FG006|Overall Study|Protocol Violation|0|||
42059404|NCT00939770|75868164|FG007|Overall Study|Protocol Violation|0|||
42059405|NCT00939770|75868157|FG000|Overall Study|Withdrawal by Subject|0|||
42059406|NCT00939770|75868158|FG001|Overall Study|Withdrawal by Subject|1|||
42059407|NCT00939770|75868159|FG002|Overall Study|Withdrawal by Subject|5|||
42059408|NCT00939770|75868160|FG003|Overall Study|Withdrawal by Subject|2|||
42059409|NCT00939770|75868161|FG004|Overall Study|Withdrawal by Subject|6|||
42059410|NCT00939770|75868162|FG005|Overall Study|Withdrawal by Subject|0|||
42059411|NCT00939770|75868163|FG006|Overall Study|Withdrawal by Subject|2|||
42059412|NCT00939770|75868164|FG007|Overall Study|Withdrawal by Subject|2|||
42059413|NCT00939692|75868197|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
42059414|NCT00939692|75868198|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
42059415|NCT00939692|75868197|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
42059416|NCT00939692|75868198|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
42059417|NCT04672252|75868206|FG000|Overall Study|Protocol Violation|1|||
42059418|NCT04672252|75868207|FG001|Overall Study|Protocol Violation|0|||
42059419|NCT00584740|75868215|FG000|Overall Study|Adverse Event|1|||
42059420|NCT00584740|75868216|FG001|Overall Study|Adverse Event|1|||
42059421|NCT00584740|75868215|FG000|Overall Study|Lack of Efficacy|8|||
42059422|NCT00584740|75868216|FG001|Overall Study|Lack of Efficacy|2|||
42059423|NCT00584740|75868215|FG000|Overall Study|Withdrawal by Subject|3|||
42059424|NCT00584740|75868216|FG001|Overall Study|Withdrawal by Subject|2|||
42059425|NCT00584740|75868215|FG000|Overall Study|Lost to Follow-up|0|||
42059426|NCT00584740|75868216|FG001|Overall Study|Lost to Follow-up|1|||
42059427|NCT00942968|75868222|FG000|Overall Study|Adverse Event|60|||
42059428|NCT00942968|75868222|FG000|Overall Study|Death|76|||
42059429|NCT00942968|75868222|FG000|Overall Study|Protocol Violation|9|||
42059430|NCT00942968|75868222|FG000|Overall Study|Lost to Follow-up|4|||
42059431|NCT00942968|75868222|FG000|Overall Study|Withdrawal by Subject|44|||
42059432|NCT00942968|75868222|FG000|Overall Study|Sponsor request|5|||
42059433|NCT00942968|75868222|FG000|Overall Study|Physician Decision|11|||
42059434|NCT00942968|75868222|FG000|Overall Study|Progression of disease|12|||
42059435|NCT00942968|75868222|FG000|Overall Study|Inferior vena cava filter placement|4|||
42059436|NCT00942968|75868222|FG000|Overall Study|Pulmonary embolism (PE)|1|||
42059437|NCT00942968|75868222|FG000|Overall Study|Participant required pancreatic biopsy|1|||
42059438|NCT00942968|75868222|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
42059439|NCT00942734|75868226|FG000|Overall Study|Adverse Event|2|||
42059440|NCT00942734|75868226|FG000|Overall Study|Protocol Violation|3|||
42059441|NCT00942734|75868226|FG000|Overall Study|Disease Progression|2|||
42059442|NCT00942734|75868226|FG000|Overall Study|Physician Decision|1|||
42059443|NCT00584194|75868230|FG000|Overall Study|Other|135|||
42059444|NCT00942422|75868234|FG000|Overall Study|Withdrawal by Subject|1|||
42059445|NCT00942422|75868234|FG000|Overall Study|Death|1|||
42059446|NCT00942422|75868234|FG000|Overall Study|Progressive diease|1|||
42059447|NCT00677833|75868242|FG000|Overall Study|Withdrawal by Subject|4|||
42059448|NCT00677833|75868243|FG001|Overall Study|Withdrawal by Subject|0|||
42059449|NCT00677833|75868244|FG002|Overall Study|Withdrawal by Subject|1|||
42059450|NCT00677833|75868245|FG003|Overall Study|Withdrawal by Subject|3|||
42059451|NCT00677833|75868242|FG000|Overall Study|Lost to Follow-up|0|||
42059452|NCT00677833|75868243|FG001|Overall Study|Lost to Follow-up|0|||
42059453|NCT00677833|75868244|FG002|Overall Study|Lost to Follow-up|1|||
42059454|NCT00677833|75868245|FG003|Overall Study|Lost to Follow-up|0|||
42059455|NCT00942266|75868255|FG000|Overall Study|Withdrawal by Subject|1|||
42059456|NCT00942266|75868256|FG001|Overall Study|Withdrawal by Subject|0|||
42059457|NCT00942266|75868255|FG000|Overall Study|Adverse Event|2|||
42059458|NCT00942266|75868256|FG001|Overall Study|Adverse Event|1|||
42059459|NCT00942266|75868255|FG000|Overall Study|Disease Progression|38|||
42059460|NCT00942266|75868256|FG001|Overall Study|Disease Progression|11|||
42059461|NCT00942266|75868255|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
42059462|NCT00942266|75868256|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
42059463|NCT00942266|75868255|FG000|Overall Study|Intercurrent illness|0|||
42059464|NCT00942266|75868256|FG001|Overall Study|Intercurrent illness|1|||
42059465|NCT00942266|75868255|FG000|Overall Study|Physician Decision|2|||
42059466|NCT00942266|75868256|FG001|Overall Study|Physician Decision|0|||
42059467|NCT00942266|75868255|FG000|Overall Study|medical deterioration (pneumonia)|0|||
42059468|NCT00942266|75868256|FG001|Overall Study|medical deterioration (pneumonia)|1|||
42059469|NCT00942188|75868266|FG000|Overall Study|Adverse Event|0|||
42059470|NCT00942188|75868267|FG001|Overall Study|Adverse Event|3|||
42059471|NCT00942188|75868268|FG002|Overall Study|Adverse Event|2|||
42059472|NCT00942188|75868269|FG003|Overall Study|Adverse Event|0|||
42059473|NCT00942188|75868266|FG000|Overall Study|Lack of Efficacy|0|||
42059474|NCT00942188|75868267|FG001|Overall Study|Lack of Efficacy|0|||
42059475|NCT00942188|75868268|FG002|Overall Study|Lack of Efficacy|0|||
42059476|NCT00942188|75868269|FG003|Overall Study|Lack of Efficacy|1|||
42059477|NCT00942188|75868266|FG000|Overall Study|Protocol Violation|1|||
42059478|NCT00942188|75868267|FG001|Overall Study|Protocol Violation|1|||
42059479|NCT00942188|75868268|FG002|Overall Study|Protocol Violation|0|||
42059480|NCT00942188|75868269|FG003|Overall Study|Protocol Violation|0|||
42059481|NCT00942188|75868266|FG000|Overall Study|Lost to Follow-up|2|||
42059482|NCT00942188|75868267|FG001|Overall Study|Lost to Follow-up|1|||
42059483|NCT00942188|75868268|FG002|Overall Study|Lost to Follow-up|2|||
42059484|NCT00942188|75868269|FG003|Overall Study|Lost to Follow-up|0|||
42059485|NCT00942188|75868266|FG000|Overall Study|Withdrawal by Subject|1|||
42059486|NCT00942188|75868267|FG001|Overall Study|Withdrawal by Subject|3|||
42059487|NCT00942188|75868268|FG002|Overall Study|Withdrawal by Subject|4|||
42059488|NCT00942188|75868269|FG003|Overall Study|Withdrawal by Subject|2|||
42059489|NCT00942188|75868266|FG000|Overall Study|Physician Decision|0|||
42059490|NCT00942188|75868267|FG001|Overall Study|Physician Decision|0|||
42059491|NCT00942188|75868268|FG002|Overall Study|Physician Decision|1|||
42059492|NCT00942188|75868269|FG003|Overall Study|Physician Decision|0|||
42059493|NCT00942188|75868266|FG000|Overall Study|Sponsor Decision|0|||
42059494|NCT00942188|75868267|FG001|Overall Study|Sponsor Decision|2|||
42059495|NCT00942188|75868268|FG002|Overall Study|Sponsor Decision|0|||
42059496|NCT00942188|75868269|FG003|Overall Study|Sponsor Decision|1|||
42059497|NCT00673231|75868283|FG000|Overall Study|Withdrawal by Subject|14|||
42059498|NCT00673231|75868284|FG001|Overall Study|Withdrawal by Subject|10|||
42059499|NCT00673231|75868285|FG002|Overall Study|Withdrawal by Subject|8|||
42059500|NCT00673231|75868286|FG003|Overall Study|Withdrawal by Subject|6|||
42059501|NCT00673231|75868283|FG000|Overall Study|Adverse Event|6|||
42059502|NCT00673231|75868284|FG001|Overall Study|Adverse Event|5|||
42059503|NCT00673231|75868285|FG002|Overall Study|Adverse Event|9|||
42059504|NCT00673231|75868286|FG003|Overall Study|Adverse Event|6|||
42059505|NCT00673231|75868283|FG000|Overall Study|Lost to Follow-up|1|||
42059506|NCT00673231|75868284|FG001|Overall Study|Lost to Follow-up|2|||
42059507|NCT00673231|75868285|FG002|Overall Study|Lost to Follow-up|1|||
42059508|NCT00673231|75868286|FG003|Overall Study|Lost to Follow-up|2|||
42059509|NCT00673231|75868283|FG000|Overall Study|Death|0|||
42059510|NCT00673231|75868284|FG001|Overall Study|Death|0|||
42059511|NCT00673231|75868285|FG002|Overall Study|Death|1|||
42059512|NCT00673231|75868286|FG003|Overall Study|Death|0|||
42059513|NCT00673231|75868283|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
42059514|NCT00673231|75868284|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
42059515|NCT00673231|75868285|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
42059516|NCT00673231|75868286|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
42059517|NCT00672841|75868298|FG000|Overall Study|Comfort care|1|||
42059518|NCT00672841|75868299|FG001|Overall Study|Comfort care|4|||
42059519|NCT00672841|75868298|FG000|Overall Study|icteric specimens|0|||
42059520|NCT00672841|75868299|FG001|Overall Study|icteric specimens|3|||
42059521|NCT00672841|75868298|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
42059522|NCT00672841|75868299|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
42059523|NCT00672841|75868298|FG000|Overall Study|Adverse Event|0|||
42059524|NCT00672841|75868299|FG001|Overall Study|Adverse Event|3|||
42059525|NCT00672841|75868298|FG000|Overall Study|Pregnancy|0|||
42059526|NCT00672841|75868299|FG001|Overall Study|Pregnancy|1|||
42059527|NCT00673465|75868308|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
42059528|NCT00673465|75868309|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
42059529|NCT00673465|75868310|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
42059530|NCT00673465|75868311|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
42059531|NCT00673465|75868312|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
42059532|NCT00673465|75868313|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
42059533|NCT00673465|75868314|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
42059534|NCT00673465|75868315|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
42059535|NCT00673465|75868316|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
42059536|NCT00673465|75868317|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
42059537|NCT00673465|75868318|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
42059538|NCT00673465|75868319|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
42059539|NCT00673465|75868308|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
42059540|NCT00673465|75868309|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
42059541|NCT00673465|75868310|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
42059542|NCT00673465|75868311|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
42059543|NCT00673465|75868312|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
42291888|NCT01949116|76125360|FG000|Overall Study|Death|2|||
42059544|NCT00673465|75868313|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
42059545|NCT00673465|75868314|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
42059546|NCT00673465|75868315|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
42059547|NCT00673465|75868316|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
42059548|NCT00673465|75868317|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
42059549|NCT00673465|75868318|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
42059550|NCT00673465|75868319|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
42059551|NCT00941798|75868329|FG000|Overall Study|Withdrawal by Subject|72|||
42059552|NCT00941798|75868330|FG001|Overall Study|Withdrawal by Subject|74|||
42059553|NCT00941798|75868329|FG000|Overall Study|Adverse Event|43|||
42059554|NCT00941798|75868330|FG001|Overall Study|Adverse Event|23|||
42059555|NCT00941798|75868329|FG000|Overall Study|Lost to Follow-up|29|||
42059556|NCT00941798|75868330|FG001|Overall Study|Lost to Follow-up|23|||
42059557|NCT00941798|75868329|FG000|Overall Study|Protocol Violation|17|||
42059558|NCT00941798|75868330|FG001|Overall Study|Protocol Violation|20|||
42059559|NCT00941798|75868329|FG000|Overall Study|Administrative problems|13|||
42059560|NCT00941798|75868330|FG001|Overall Study|Administrative problems|23|||
42059561|NCT00941798|75868329|FG000|Overall Study|Lack of Efficacy|10|||
42059562|NCT00941798|75868330|FG001|Overall Study|Lack of Efficacy|17|||
42059563|NCT00941798|75868329|FG000|Overall Study|Patient's inability to use device|6|||
42059564|NCT00941798|75868330|FG001|Overall Study|Patient's inability to use device|1|||
42059565|NCT00941798|75868329|FG000|Overall Study|Abnormal test procedure results|3|||
42059566|NCT00941798|75868330|FG001|Overall Study|Abnormal test procedure results|1|||
42059567|NCT00941798|75868329|FG000|Overall Study|Abnormal laboratory values|1|||
42059568|NCT00941798|75868330|FG001|Overall Study|Abnormal laboratory values|2|||
42059569|NCT00941798|75868329|FG000|Overall Study|Death|0|||
42059570|NCT00941798|75868330|FG001|Overall Study|Death|1|||
42059571|NCT00583102|75868336|FG000|Overall Study|Adverse Event|3|||
42059572|NCT05208866|75868344|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
42059573|NCT04745351|75868359|FG000|Overall Study|Death|51|||
42059574|NCT04745351|75868360|FG001|Overall Study|Death|25|||
42059575|NCT04745351|75868359|FG000|Overall Study|Lost to Follow-up|9|||
42059576|NCT04745351|75868360|FG001|Overall Study|Lost to Follow-up|3|||
42059577|NCT04745351|75868359|FG000|Overall Study|Randomized but Never Treated|3|||
42059578|NCT04745351|75868360|FG001|Overall Study|Randomized but Never Treated|3|||
42059579|NCT04745351|75868359|FG000|Overall Study|Adverse Event|4|||
42059580|NCT04745351|75868360|FG001|Overall Study|Adverse Event|0|||
42059581|NCT04745351|75868359|FG000|Overall Study|Withdrew Consent|1|||
42059582|NCT04745351|75868360|FG001|Overall Study|Withdrew Consent|2|||
42059583|NCT04745351|75868359|FG000|Overall Study|Investigator's Discretion|2|||
42059584|NCT04745351|75868360|FG001|Overall Study|Investigator's Discretion|0|||
42059585|NCT04745351|75868359|FG000|Overall Study|Protocol Violation|1|||
42059586|NCT04745351|75868360|FG001|Overall Study|Protocol Violation|0|||
42059587|NCT04427501|75868385|FG000|Overall Study|Death|0|||
42059588|NCT04427501|75868386|FG001|Overall Study|Death|0|||
42059589|NCT04427501|75868387|FG002|Overall Study|Death|0|||
42059590|NCT04427501|75868388|FG003|Overall Study|Death|0|||
42059591|NCT04427501|75868389|FG004|Overall Study|Death|0|||
42059592|NCT04427501|75868390|FG005|Overall Study|Death|15|||
42059593|NCT04427501|75868391|FG006|Overall Study|Death|0|||
42059594|NCT04427501|75868392|FG007|Overall Study|Death|0|||
42059595|NCT04427501|75868393|FG008|Overall Study|Death|0|||
42059596|NCT04427501|75868394|FG009|Overall Study|Death|0|||
42059597|NCT04427501|75868385|FG000|Overall Study|Lost to Follow-up|5|||
42059598|NCT04427501|75868386|FG001|Overall Study|Lost to Follow-up|1|||
42059599|NCT04427501|75868387|FG002|Overall Study|Lost to Follow-up|2|||
42059600|NCT04427501|75868388|FG003|Overall Study|Lost to Follow-up|0|||
42059601|NCT04427501|75868389|FG004|Overall Study|Lost to Follow-up|2|||
42059602|NCT04427501|75868390|FG005|Overall Study|Lost to Follow-up|11|||
42059603|NCT04427501|75868391|FG006|Overall Study|Lost to Follow-up|10|||
42059604|NCT04427501|75868392|FG007|Overall Study|Lost to Follow-up|10|||
42059605|NCT04427501|75868393|FG008|Overall Study|Lost to Follow-up|2|||
42291889|NCT01949116|76125361|FG001|Overall Study|Death|0|||
42059606|NCT04427501|75868394|FG009|Overall Study|Lost to Follow-up|5|||
42059607|NCT04427501|75868385|FG000|Overall Study|Physician Decision|0|||
42059608|NCT04427501|75868386|FG001|Overall Study|Physician Decision|3|||
42059609|NCT04427501|75868387|FG002|Overall Study|Physician Decision|0|||
42059610|NCT04427501|75868388|FG003|Overall Study|Physician Decision|0|||
42059611|NCT04427501|75868389|FG004|Overall Study|Physician Decision|0|||
42059612|NCT04427501|75868390|FG005|Overall Study|Physician Decision|0|||
42059613|NCT04427501|75868391|FG006|Overall Study|Physician Decision|2|||
42059614|NCT04427501|75868392|FG007|Overall Study|Physician Decision|0|||
42059615|NCT04427501|75868393|FG008|Overall Study|Physician Decision|0|||
42059616|NCT04427501|75868394|FG009|Overall Study|Physician Decision|0|||
42059617|NCT04427501|75868385|FG000|Overall Study|Withdrawal by Subject|9|||
42059618|NCT04427501|75868386|FG001|Overall Study|Withdrawal by Subject|2|||
42059619|NCT04427501|75868387|FG002|Overall Study|Withdrawal by Subject|2|||
42059620|NCT04427501|75868388|FG003|Overall Study|Withdrawal by Subject|3|||
42059621|NCT04427501|75868389|FG004|Overall Study|Withdrawal by Subject|7|||
42059622|NCT04427501|75868390|FG005|Overall Study|Withdrawal by Subject|25|||
42059623|NCT04427501|75868391|FG006|Overall Study|Withdrawal by Subject|15|||
42059624|NCT04427501|75868392|FG007|Overall Study|Withdrawal by Subject|7|||
42059625|NCT04427501|75868393|FG008|Overall Study|Withdrawal by Subject|4|||
42059626|NCT04427501|75868394|FG009|Overall Study|Withdrawal by Subject|1|||
42059627|NCT04427501|75868385|FG000|Overall Study|Other - as reported by the investigator|1|||
42059628|NCT04427501|75868386|FG001|Overall Study|Other - as reported by the investigator|0|||
42059629|NCT04427501|75868387|FG002|Overall Study|Other - as reported by the investigator|0|||
42059630|NCT04427501|75868388|FG003|Overall Study|Other - as reported by the investigator|0|||
42059631|NCT04427501|75868389|FG004|Overall Study|Other - as reported by the investigator|0|||
42059632|NCT04427501|75868390|FG005|Overall Study|Other - as reported by the investigator|6|||
42059633|NCT04427501|75868391|FG006|Overall Study|Other - as reported by the investigator|6|||
42059634|NCT04427501|75868392|FG007|Overall Study|Other - as reported by the investigator|0|||
42059635|NCT04427501|75868393|FG008|Overall Study|Other - as reported by the investigator|0|||
42059636|NCT04427501|75868394|FG009|Overall Study|Other - as reported by the investigator|0|||
42059637|NCT03439124|75868446|FG000|Overall Study|Adverse Event|2|||
42059638|NCT03439124|75868447|FG001|Overall Study|Adverse Event|0|||
42059639|NCT03439124|75868446|FG000|Overall Study|Lost to Follow-up|1|||
42059640|NCT03439124|75868447|FG001|Overall Study|Lost to Follow-up|0|||
42059641|NCT03439124|75868446|FG000|Overall Study|Other reasons|1|||
42059642|NCT03439124|75868447|FG001|Overall Study|Other reasons|0|||
42059643|NCT03212989|75868466|FG000|Overall Study|Physician Decision|8|||
42059644|NCT03200548|75868474|FG000|Overall Study|Withdrawal by Subject|5|||
42059645|NCT03200548|75868475|FG001|Overall Study|Withdrawal by Subject|11|||
42059646|NCT03200548|75868476|FG002|Overall Study|Withdrawal by Subject|7|||
42059647|NCT03200548|75868477|FG003|Overall Study|Withdrawal by Subject|6|||
42059648|NCT03158688|75868489|FG000|Overall Study|Withdrawal by Subject|14|||
42059649|NCT03158688|75868490|FG001|Overall Study|Withdrawal by Subject|28|||
42059650|NCT03158688|75868489|FG000|Overall Study|Decision by sponsor|13|||
42059651|NCT03158688|75868490|FG001|Overall Study|Decision by sponsor|37|||
42059652|NCT03158688|75868489|FG000|Overall Study|Lost to Follow-up|4|||
42059653|NCT03158688|75868490|FG001|Overall Study|Lost to Follow-up|3|||
42059654|NCT03158688|75868489|FG000|Overall Study|Death|74|||
42059655|NCT03158688|75868490|FG001|Overall Study|Death|142|||
42059656|NCT03137173|75868498|FG000|Overall Study|Withdrawal by Subject|8|||
42059657|NCT03137173|75868499|FG001|Overall Study|Withdrawal by Subject|13|||
42059658|NCT03137173|75868498|FG000|Overall Study|Death|1|||
42059659|NCT03137173|75868499|FG001|Overall Study|Death|3|||
42059660|NCT03137173|75868498|FG000|Overall Study|Physician Decision|1|||
42059661|NCT03137173|75868499|FG001|Overall Study|Physician Decision|0|||
42059662|NCT03137173|75868498|FG000|Overall Study|Lost to Follow-up|13|||
42059663|NCT03137173|75868499|FG001|Overall Study|Lost to Follow-up|18|||
42059664|NCT03137173|75868498|FG000|Overall Study|Other reasons|3|||
42059665|NCT03137173|75868499|FG001|Overall Study|Other reasons|2|||
42059666|NCT01575808|75868528|FG000|Overall Study|Death|2|||
42059667|NCT01575808|75868529|FG001|Overall Study|Death|0|||
42059668|NCT01575808|75868528|FG000|Overall Study|Withdrawal by Subject|1|||
42059669|NCT01575808|75868529|FG001|Overall Study|Withdrawal by Subject|0|||
42059670|NCT01546753|75868539|FG000|Overall Study|anxiety|1|||
42059671|NCT01546753|75868540|FG001|Overall Study|anxiety|1|||
42059672|NCT01546753|75868539|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
42059673|NCT01546753|75868540|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
42059674|NCT00941720|75868553|FG000|Overall Study|Withdrawal by Subject|1|||
42059675|NCT00941720|75868553|FG000|Overall Study|Insurance denied participation|11|||
42059676|NCT00941720|75868553|FG000|Overall Study|ineligible|2|||
42059677|NCT00933686|75868559|FG000|Overall Study|Protocol Violation|0|||
42059678|NCT00933686|75868560|FG001|Overall Study|Protocol Violation|1|||
42059679|NCT00933686|75868559|FG000|Overall Study|Lost to Follow-up|2|||
42059680|NCT00933686|75868560|FG001|Overall Study|Lost to Follow-up|2|||
42357192|NCT01614769|76202518|FG005|Period 3|Withdrawal by Subject|0|||
42357193|NCT01614457|76202528|FG000|Overall Study|Non-Compliance|1|||
42059681|NCT00933686|75868559|FG000|Overall Study|Withdrawal by Subject|6|||
42059682|NCT00933686|75868560|FG001|Overall Study|Withdrawal by Subject|5|||
42059683|NCT00933686|75868559|FG000|Overall Study|Adverse Event|1|||
42059684|NCT00933686|75868560|FG001|Overall Study|Adverse Event|1|||
42059685|NCT00933686|75868559|FG000|Overall Study|Physician Decision|1|||
42059686|NCT00933686|75868560|FG001|Overall Study|Physician Decision|0|||
42059687|NCT00933686|75868559|FG000|Overall Study|Failure to show up at endpoint visits|0|||
42059688|NCT00933686|75868560|FG001|Overall Study|Failure to show up at endpoint visits|2|||
42059689|NCT00937040|75868568|FG000|Overall Study|Adverse Event|5|||
42059690|NCT00937040|75868569|FG001|Overall Study|Adverse Event|8|||
42059691|NCT00937040|75868568|FG000|Overall Study|Lost to Follow-up|12|||
42059692|NCT00937040|75868569|FG001|Overall Study|Lost to Follow-up|12|||
42059693|NCT00937040|75868568|FG000|Overall Study|Protocol Violation|3|||
42357194|NCT01614457|76202529|FG001|Overall Study|Non-Compliance|0|||
42059694|NCT00937040|75868569|FG001|Overall Study|Protocol Violation|0|||
42059695|NCT00937040|75868568|FG000|Overall Study|Withdrawal by Subject|13|||
42059696|NCT00937040|75868569|FG001|Overall Study|Withdrawal by Subject|7|||
42059697|NCT00937040|75868568|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
42059698|NCT00937040|75868569|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
42059699|NCT00937040|75868568|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
42059700|NCT00937040|75868569|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
42059701|NCT00673387|75868583|FG000|Overall Study|Withdrawal by Subject|15|||
42059702|NCT00673387|75868584|FG001|Overall Study|Withdrawal by Subject|16|||
42059703|NCT00673387|75868585|FG002|Overall Study|Withdrawal by Subject|20|||
42059704|NCT00673387|75868586|FG003|Overall Study|Withdrawal by Subject|16|||
42059705|NCT00673387|75868587|FG004|Overall Study|Withdrawal by Subject|18|||
42059706|NCT00673387|75868588|FG005|Overall Study|Withdrawal by Subject|21|||
42059707|NCT00673387|75868589|FG006|Overall Study|Withdrawal by Subject|15|||
42059708|NCT00673387|75868590|FG007|Overall Study|Withdrawal by Subject|21|||
42059709|NCT00673387|75868583|FG000|Overall Study|Adverse Event|3|||
42059710|NCT00673387|75868584|FG001|Overall Study|Adverse Event|1|||
42059711|NCT00673387|75868585|FG002|Overall Study|Adverse Event|5|||
42059712|NCT00673387|75868586|FG003|Overall Study|Adverse Event|2|||
42059713|NCT00673387|75868587|FG004|Overall Study|Adverse Event|6|||
42059714|NCT00673387|75868588|FG005|Overall Study|Adverse Event|2|||
42059715|NCT00673387|75868589|FG006|Overall Study|Adverse Event|5|||
42059716|NCT00673387|75868590|FG007|Overall Study|Adverse Event|5|||
42059717|NCT00673387|75868583|FG000|Overall Study|Physician Decision|0|||
42059718|NCT00673387|75868584|FG001|Overall Study|Physician Decision|0|||
42059719|NCT00673387|75868585|FG002|Overall Study|Physician Decision|0|||
42059720|NCT00673387|75868586|FG003|Overall Study|Physician Decision|0|||
42059721|NCT00673387|75868587|FG004|Overall Study|Physician Decision|0|||
42059722|NCT00673387|75868588|FG005|Overall Study|Physician Decision|5|||
42059723|NCT00673387|75868589|FG006|Overall Study|Physician Decision|1|||
42059724|NCT00673387|75868590|FG007|Overall Study|Physician Decision|1|||
42059725|NCT00673387|75868583|FG000|Overall Study|Protocol Violation|3|||
42059726|NCT00673387|75868584|FG001|Overall Study|Protocol Violation|0|||
42059727|NCT00673387|75868585|FG002|Overall Study|Protocol Violation|1|||
42059728|NCT00673387|75868586|FG003|Overall Study|Protocol Violation|2|||
42059729|NCT00673387|75868587|FG004|Overall Study|Protocol Violation|0|||
42059730|NCT00673387|75868588|FG005|Overall Study|Protocol Violation|1|||
42059731|NCT00673387|75868589|FG006|Overall Study|Protocol Violation|1|||
42059732|NCT00673387|75868590|FG007|Overall Study|Protocol Violation|3|||
42059733|NCT00673387|75868583|FG000|Overall Study|Lost to Follow-up|8|||
42059734|NCT00673387|75868584|FG001|Overall Study|Lost to Follow-up|6|||
42059735|NCT00673387|75868585|FG002|Overall Study|Lost to Follow-up|5|||
42059736|NCT00673387|75868586|FG003|Overall Study|Lost to Follow-up|6|||
42174326|NCT03267940|75981078|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
42059737|NCT00673387|75868587|FG004|Overall Study|Lost to Follow-up|6|||
42059738|NCT00673387|75868588|FG005|Overall Study|Lost to Follow-up|5|||
42059739|NCT00673387|75868589|FG006|Overall Study|Lost to Follow-up|8|||
42059740|NCT00673387|75868590|FG007|Overall Study|Lost to Follow-up|5|||
42059741|NCT00933608|75868620|FG000|Overall Study|Adverse Event|4|||
42059742|NCT00933608|75868621|FG001|Overall Study|Adverse Event|2|||
42059743|NCT00933608|75868620|FG000|Overall Study|Physician Decision|1|||
42059744|NCT00933608|75868621|FG001|Overall Study|Physician Decision|0|||
42059745|NCT00574951|75868627|FG000|Overall Study|Ineligible - improper prior treatment|1|||
42174327|NCT03267940|75981079|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
42357195|NCT01614457|76202528|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
42357196|NCT01614457|76202529|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
42357197|NCT01863433|76202535|FG000|Overall Study|Protocol Violation|1|||
42357198|NCT01862029|76202539|FG000|Overall Study|Physician Decision|1|||
42357199|NCT01835431|76202546|FG000|Overall Study|Adverse Event|1|||
42357200|NCT01835431|76202547|FG001|Overall Study|Adverse Event|0|||
42357201|NCT01835431|76202546|FG000|Overall Study|other|0|||
42357202|NCT01835431|76202547|FG001|Overall Study|other|2|||
42357203|NCT01835431|76202546|FG000|Overall Study|Withdrawal by Subject|6|||
42357204|NCT01835431|76202547|FG001|Overall Study|Withdrawal by Subject|10|||
42174328|NCT03267940|75981080|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
42174329|NCT03267940|75981081|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
42357205|NCT01835431|76202546|FG000|Overall Study|Protocol Violation|1|||
42357206|NCT01835431|76202547|FG001|Overall Study|Protocol Violation|0|||
42059746|NCT01557751|75868631|FG000|Overall Study|Physician Decision|3|||
42357207|NCT01880593|76202555|FG000|Overall Study|Adverse Event|1|||
42059747|NCT00936884|75868637|FG000|Double-blind|Withdrawal by Subject|6|||
42059748|NCT00936884|75868638|FG001|Double-blind|Withdrawal by Subject|4|||
42059749|NCT00936884|75868639|FG002|Double-blind|Withdrawal by Subject|0|||
42059750|NCT00936884|75868637|FG000|Double-blind|Death|2|||
42059751|NCT00936884|75868638|FG001|Double-blind|Death|1|||
42059752|NCT00936884|75868639|FG002|Double-blind|Death|0|||
42059753|NCT00936884|75868637|FG000|Double-blind|Lack of Efficacy|1|||
42059754|NCT00936884|75868638|FG001|Double-blind|Lack of Efficacy|1|||
42059755|NCT00936884|75868639|FG002|Double-blind|Lack of Efficacy|0|||
42059756|NCT00936884|75868637|FG000|Double-blind|Adverse Event|1|||
42059757|NCT00936884|75868638|FG001|Double-blind|Adverse Event|0|||
42059758|NCT00936884|75868639|FG002|Double-blind|Adverse Event|0|||
42059759|NCT00936884|75868637|FG000|Double-blind|Physician Decision|1|||
42059760|NCT00936884|75868638|FG001|Double-blind|Physician Decision|0|||
42059761|NCT00936884|75868639|FG002|Double-blind|Physician Decision|0|||
42059762|NCT00936884|75868637|FG000|Double-blind|No post baseline diary entry|1|||
42059763|NCT00936884|75868638|FG001|Double-blind|No post baseline diary entry|0|||
42059764|NCT00936884|75868639|FG002|Double-blind|No post baseline diary entry|0|||
42059765|NCT00936884|75868637|FG000|Double-blind|Did not receive study drug|0|||
42059766|NCT00936884|75868638|FG001|Double-blind|Did not receive study drug|1|||
42059767|NCT00936884|75868639|FG002|Double-blind|Did not receive study drug|0|||
42059768|NCT00668863|75868655|FG000|Overall Study|Objective Progression or Relapse|42|||
42059769|NCT00668863|75868655|FG000|Overall Study|Adverse Event|13|||
42059770|NCT00668863|75868655|FG000|Overall Study|Study Terminated by Sponsor|8|||
42059771|NCT00668863|75868655|FG000|Overall Study|Global Deterioration of Health Status|4|||
42059772|NCT00668863|75868655|FG000|Overall Study|Withdrawal by Subject|1|||
42059773|NCT00668863|75868655|FG000|Overall Study|Surgery|1|||
42059774|NCT00668863|75868655|FG000|Overall Study|Subject's work scheduling problem|1|||
42059775|NCT00668863|75868655|FG000|Overall Study|Physician Decision|1|||
42059776|NCT00935012|75868659|FG000|Overall Study|Death|19|||
42059777|NCT00935012|75868659|FG000|Overall Study|Withdrawal by Subject|3|||
42059778|NCT00935012|75868659|FG000|Overall Study|Other|5|||
42059779|NCT00935012|75868659|FG000|Overall Study|Adverse Event|2|||
42059780|NCT00932360|75868663|FG000|Washout (One Week)|Withdrawal by Subject|0|||
42059781|NCT00932360|75868664|FG001|Washout (One Week)|Withdrawal by Subject|0|||
42059782|NCT00932360|75868665|FG002|Washout (One Week)|Withdrawal by Subject|0|||
42059783|NCT00932360|75868666|FG003|Washout (One Week)|Withdrawal by Subject|0|||
42059784|NCT00932360|75868667|FG004|Washout (One Week)|Withdrawal by Subject|2|||
42059785|NCT00932360|75868668|FG005|Washout (One Week)|Withdrawal by Subject|0|||
42059786|NCT00668707|75868684|FG000|Overall Study|Cancer Recurrence|58|||
42059787|NCT00668707|75868685|FG001|Overall Study|Cancer Recurrence|58|||
42059788|NCT00668707|75868684|FG000|Overall Study|Withdrawal by Subject|117|||
42059789|NCT00668707|75868685|FG001|Overall Study|Withdrawal by Subject|100|||
42059790|NCT00668707|75868684|FG000|Overall Study|Lost to Follow-up|3|||
42059791|NCT00668707|75868685|FG001|Overall Study|Lost to Follow-up|6|||
42059792|NCT00668707|75868684|FG000|Overall Study|Protocol Violation|10|||
42059793|NCT00668707|75868685|FG001|Overall Study|Protocol Violation|12|||
42059794|NCT00668707|75868684|FG000|Overall Study|Death|11|||
42059795|NCT00668707|75868685|FG001|Overall Study|Death|4|||
42059796|NCT00668395|75868699|FG000|Overall Study|Withdrawal by Subject|4|||
42059797|NCT00668395|75868700|FG001|Overall Study|Withdrawal by Subject|4|||
42059798|NCT00668395|75868701|FG002|Overall Study|Withdrawal by Subject|1|||
42059799|NCT00668395|75868699|FG000|Overall Study|Adverse Event|1|||
42059800|NCT00668395|75868700|FG001|Overall Study|Adverse Event|1|||
42059801|NCT00668395|75868701|FG002|Overall Study|Adverse Event|0|||
42059802|NCT00668395|75868699|FG000|Overall Study|Physician Decision|1|||
42059803|NCT00668395|75868700|FG001|Overall Study|Physician Decision|1|||
42059804|NCT00668395|75868701|FG002|Overall Study|Physician Decision|0|||
42059805|NCT00668317|75868709|FG000|Overall Study|Adverse Event|2|||
42059806|NCT00670111|75868730|FG000|Enrollment to One Month|Testing Failure|0|||
42059807|NCT00670111|75868731|FG001|Enrollment to One Month|Testing Failure|0|||
42059808|NCT00670111|75868732|FG002|Enrollment to One Month|Testing Failure|13|||
42059809|NCT00670111|75868730|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
42059810|NCT00670111|75868731|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
42059811|NCT00670111|75868732|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
42059812|NCT00670111|75868730|FG000|Enrollment to One Month|Physician Decision|1|||
42059813|NCT00670111|75868731|FG001|Enrollment to One Month|Physician Decision|0|||
42059814|NCT00670111|75868732|FG002|Enrollment to One Month|Physician Decision|0|||
42059815|NCT00672139|75868742|FG000|Overall Study|Death|14|||
42357208|NCT01880593|76202556|FG001|Overall Study|Adverse Event|0|||
42357209|NCT01880593|76202555|FG000|Overall Study|Lack of Efficacy|1|||
42357210|NCT01880593|76202556|FG001|Overall Study|Lack of Efficacy|5|||
42357211|NCT01880593|76202555|FG000|Overall Study|Withdrawal by Subject|6|||
42357212|NCT01880593|76202556|FG001|Overall Study|Withdrawal by Subject|1|||
42357213|NCT01400451|76202565|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
42357214|NCT01400451|76202566|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
42357215|NCT01400451|76202567|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
42357216|NCT01400451|76202565|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
42357217|NCT01400451|76202566|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
42357218|NCT01400451|76202567|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
42059816|NCT00672139|75868743|FG001|Overall Study|Death|23|||
42059817|NCT00672139|75868742|FG000|Overall Study|Withdrawal by Subject|2|||
42357219|NCT01400451|76202565|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
42059818|NCT00672139|75868743|FG001|Overall Study|Withdrawal by Subject|11|||
42059819|NCT00672139|75868742|FG000|Overall Study|Adverse Event|4|||
42059820|NCT00672139|75868743|FG001|Overall Study|Adverse Event|7|||
42059821|NCT00672139|75868742|FG000|Overall Study|Physician Decision|2|||
42059822|NCT00672139|75868743|FG001|Overall Study|Physician Decision|0|||
42059823|NCT00672139|75868742|FG000|Overall Study|Lack of Efficacy|4|||
42059824|NCT00672139|75868743|FG001|Overall Study|Lack of Efficacy|1|||
42059825|NCT00672139|75868742|FG000|Overall Study|Protocol Violation|1|||
42059826|NCT00672139|75868743|FG001|Overall Study|Protocol Violation|1|||
42059827|NCT00672139|75868742|FG000|Overall Study|hospice discharge, caregiver requests|3|||
42059828|NCT00672139|75868743|FG001|Overall Study|hospice discharge, caregiver requests|2|||
42059829|NCT00570739|75868753|FG000|Overall Study|Adverse Event|8|||
42059830|NCT00570739|75868754|FG001|Overall Study|Adverse Event|6|||
42059831|NCT00570739|75868755|FG002|Overall Study|Adverse Event|2|||
42059832|NCT00570739|75868756|FG003|Overall Study|Adverse Event|2|||
42059833|NCT00570739|75868753|FG000|Overall Study|Lost to Follow-up|4|||
42059834|NCT00570739|75868754|FG001|Overall Study|Lost to Follow-up|5|||
42059835|NCT00570739|75868755|FG002|Overall Study|Lost to Follow-up|4|||
42059836|NCT00570739|75868756|FG003|Overall Study|Lost to Follow-up|1|||
42059837|NCT00570739|75868753|FG000|Overall Study|Physician Decision|1|||
42059838|NCT00570739|75868754|FG001|Overall Study|Physician Decision|1|||
42059839|NCT00570739|75868755|FG002|Overall Study|Physician Decision|0|||
42059840|NCT00570739|75868756|FG003|Overall Study|Physician Decision|0|||
42059841|NCT00570739|75868753|FG000|Overall Study|Withdrawal by Subject|7|||
42059842|NCT00570739|75868754|FG001|Overall Study|Withdrawal by Subject|7|||
42059843|NCT00570739|75868755|FG002|Overall Study|Withdrawal by Subject|3|||
42059844|NCT00570739|75868756|FG003|Overall Study|Withdrawal by Subject|5|||
42059845|NCT00570739|75868753|FG000|Overall Study|Required restricted medication|0|||
42059846|NCT00570739|75868754|FG001|Overall Study|Required restricted medication|0|||
42059847|NCT00570739|75868755|FG002|Overall Study|Required restricted medication|1|||
42059848|NCT00570739|75868756|FG003|Overall Study|Required restricted medication|0|||
42059849|NCT00570739|75868753|FG000|Overall Study|Met discontinuation criteria|1|||
42059850|NCT00570739|75868754|FG001|Overall Study|Met discontinuation criteria|0|||
42059851|NCT00570739|75868755|FG002|Overall Study|Met discontinuation criteria|1|||
42059852|NCT00570739|75868756|FG003|Overall Study|Met discontinuation criteria|1|||
42059853|NCT00570739|75868753|FG000|Overall Study|Other|0|||
42059854|NCT00570739|75868754|FG001|Overall Study|Other|2|||
42059855|NCT00570739|75868755|FG002|Overall Study|Other|5|||
42059856|NCT00570739|75868756|FG003|Overall Study|Other|3|||
42059857|NCT03689530|75868788|FG000|Overall Study|Withdrawal by Subject|53|||
42059858|NCT03689530|75868789|FG001|Overall Study|Withdrawal by Subject|16|||
42059859|NCT04188106|75868795|FG000|Overall Study|Lost to Follow-up|5|||
42059860|NCT04188106|75868795|FG000|Overall Study|Non-Compliance|1|||
42059861|NCT00669955|75868803|FG000|Overall Study|Adverse Event|3|||
42059862|NCT00669955|75868804|FG001|Overall Study|Adverse Event|5|||
42059863|NCT00669955|75868803|FG000|Overall Study|Death|0|||
42059864|NCT00669955|75868804|FG001|Overall Study|Death|1|||
42059865|NCT00669955|75868803|FG000|Overall Study|Withdrawal by Subject|2|||
42059866|NCT00669955|75868804|FG001|Overall Study|Withdrawal by Subject|3|||
42059867|NCT00669955|75868803|FG000|Overall Study|Lost to Follow-up|5|||
42059868|NCT00669955|75868804|FG001|Overall Study|Lost to Follow-up|7|||
42059869|NCT00669955|75868803|FG000|Overall Study|Protocol Violation|2|||
42059870|NCT00669955|75868804|FG001|Overall Study|Protocol Violation|7|||
42059871|NCT00669955|75868803|FG000|Overall Study|Investigator Sponsor Judgement|0|||
42059872|NCT00669955|75868804|FG001|Overall Study|Investigator Sponsor Judgement|1|||
42059873|NCT00669955|75868803|FG000|Overall Study|not compliant with study drug/visit|2|||
42059874|NCT00669955|75868804|FG001|Overall Study|not compliant with study drug/visit|3|||
42059875|NCT00671749|75868810|FG000|Overall Study|Adverse Event|2|||
42059876|NCT00671749|75868810|FG000|Overall Study|Withdrawal by Subject|4|||
42059877|NCT00671749|75868810|FG000|Overall Study|Protocol Violation|1|||
42059878|NCT00671749|75868810|FG000|Overall Study|Lost to Follow-up|1|||
42357220|NCT01400451|76202566|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
42357221|NCT01400451|76202567|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
42059879|NCT00669877|75868814|FG000|Overall Study|Disease Progression/Death|4|||
42059880|NCT00882999|75868825|FG000|Overall Study|Adverse Event|0|||
42059881|NCT00882999|75868826|FG001|Overall Study|Adverse Event|0|||
42059882|NCT00882999|75868827|FG002|Overall Study|Adverse Event|0|||
42059883|NCT00882999|75868828|FG003|Overall Study|Adverse Event|0|||
42059884|NCT00882999|75868829|FG004|Overall Study|Adverse Event|1|||
42059885|NCT00882999|75868830|FG005|Overall Study|Adverse Event|0|||
42059886|NCT00882999|75868831|FG006|Overall Study|Adverse Event|0|||
42059887|NCT00882999|75868825|FG000|Overall Study|Death|0|||
42059888|NCT00882999|75868826|FG001|Overall Study|Death|1|||
42357222|NCT01400451|76202565|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
42059889|NCT00882999|75868827|FG002|Overall Study|Death|0|||
42059890|NCT00882999|75868828|FG003|Overall Study|Death|0|||
42059891|NCT00882999|75868829|FG004|Overall Study|Death|0|||
42059892|NCT00882999|75868830|FG005|Overall Study|Death|0|||
42059893|NCT00882999|75868831|FG006|Overall Study|Death|0|||
42059894|NCT00882999|75868825|FG000|Overall Study|Withdrawal by Subject|7|||
42059895|NCT00882999|75868826|FG001|Overall Study|Withdrawal by Subject|6|||
42059896|NCT00882999|75868827|FG002|Overall Study|Withdrawal by Subject|3|||
42059897|NCT00882999|75868828|FG003|Overall Study|Withdrawal by Subject|3|||
42059898|NCT00882999|75868829|FG004|Overall Study|Withdrawal by Subject|6|||
42059899|NCT00882999|75868830|FG005|Overall Study|Withdrawal by Subject|5|||
42059900|NCT00882999|75868831|FG006|Overall Study|Withdrawal by Subject|5|||
42059901|NCT00882999|75868825|FG000|Overall Study|Lost to Follow-up|0|||
42059902|NCT00882999|75868826|FG001|Overall Study|Lost to Follow-up|1|||
42059903|NCT00882999|75868827|FG002|Overall Study|Lost to Follow-up|1|||
42059904|NCT00882999|75868828|FG003|Overall Study|Lost to Follow-up|2|||
42059905|NCT00882999|75868829|FG004|Overall Study|Lost to Follow-up|1|||
42059906|NCT00882999|75868830|FG005|Overall Study|Lost to Follow-up|1|||
42059907|NCT00882999|75868831|FG006|Overall Study|Lost to Follow-up|2|||
42059908|NCT00882999|75868825|FG000|Overall Study|Physician Decision|1|||
42059909|NCT00882999|75868826|FG001|Overall Study|Physician Decision|0|||
42059910|NCT00882999|75868827|FG002|Overall Study|Physician Decision|0|||
42059911|NCT00882999|75868828|FG003|Overall Study|Physician Decision|0|||
42059912|NCT00882999|75868829|FG004|Overall Study|Physician Decision|0|||
42059913|NCT00882999|75868830|FG005|Overall Study|Physician Decision|1|||
42059914|NCT00882999|75868831|FG006|Overall Study|Physician Decision|1|||
42059915|NCT00671437|75868854|FG000|Overall Study|Progressive disease before C1 week 8|8|||
42059916|NCT00671437|75868854|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
42059917|NCT00671437|75868854|FG000|Overall Study|Adverse Event|3|||
42059918|NCT00671437|75868854|FG000|Overall Study|Ineligible post-hoc|1|||
42059919|NCT00882921|75868866|FG000|Overall Study|Death|2|||
42059920|NCT00882921|75868866|FG000|Overall Study|Other|3|||
42059921|NCT00882921|75868866|FG000|Overall Study|Lost to Follow-up|2|||
42059922|NCT00882921|75868866|FG000|Overall Study|Termination By Investigator|3|||
42059923|NCT00882921|75868866|FG000|Overall Study|Withdrawal Of Consent|1|||
42059924|NCT00582712|75868871|FG000|Overall Study|Adverse Event|1|||
42059925|NCT00582712|75868871|FG000|Overall Study|Lack of Efficacy|1|||
42059926|NCT00582712|75868871|FG000|Overall Study|Withdrawal by Subject|1|||
42059927|NCT00582712|75868871|FG000|Overall Study|Complicating disease requiring treatment|1|||
42059928|NCT00582790|75868875|FG000|Overall Study|Rapid progression of disease|1|||
42059929|NCT00881751|75868882|FG000|Overall Study|Physician Decision|0|||
42059930|NCT00881751|75868883|FG001|Overall Study|Physician Decision|1|||
42059931|NCT00881751|75868882|FG000|Overall Study|Adverse Event|0|||
42059932|NCT00881751|75868883|FG001|Overall Study|Adverse Event|2|||
42059933|NCT00881751|75868882|FG000|Overall Study|Withdrawal by Subject|0|||
42059934|NCT00881751|75868883|FG001|Overall Study|Withdrawal by Subject|2|||
42059935|NCT00934856|75868895|FG000|Feasibility Part|Progressive disease|4|||
42059936|NCT00934856|75868896|FG001|Feasibility Part|Progressive disease|4|||
42059937|NCT00934856|75868897|FG002|Feasibility Part|Progressive disease|2|||
42059938|NCT00934856|75868898|FG003|Feasibility Part|Progressive disease|3|||
42059939|NCT00934856|75868899|FG004|Feasibility Part|Progressive disease|0|||
42291890|NCT01949116|76125360|FG000|Overall Study|Lost to Follow-up|1|||
42291891|NCT01949116|76125361|FG001|Overall Study|Lost to Follow-up|3|||
42291892|NCT01949116|76125360|FG000|Overall Study|Withdrawal by Subject|5|||
42291893|NCT01949116|76125361|FG001|Overall Study|Withdrawal by Subject|3|||
42291894|NCT01673009|76125371|FG000|Overall Study|Physician Decision|5|||
42291895|NCT01673009|76125371|FG000|Overall Study|Withdrawal by Subject|8|||
42291896|NCT01939366|76125380|FG000|Overall Study|Adverse Event|8|||
42291897|NCT01939366|76125381|FG001|Overall Study|Adverse Event|17|||
42357223|NCT01400451|76202566|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
42059940|NCT00934856|75868900|FG005|Feasibility Part|Progressive disease|0|||
42059941|NCT00934856|75868895|FG000|Feasibility Part|Physician Decision|0|||
42059942|NCT00934856|75868896|FG001|Feasibility Part|Physician Decision|0|||
42059943|NCT00934856|75868897|FG002|Feasibility Part|Physician Decision|1|||
42059944|NCT00934856|75868898|FG003|Feasibility Part|Physician Decision|0|||
42291898|NCT01939366|76125382|FG002|Overall Study|Adverse Event|30|||
42174330|NCT03267940|75981076|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
42291899|NCT01939366|76125383|FG003|Overall Study|Adverse Event|8|||
42357224|NCT01400451|76202567|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
42059945|NCT00934856|75868899|FG004|Feasibility Part|Physician Decision|0|||
42059946|NCT00934856|75868900|FG005|Feasibility Part|Physician Decision|0|||
42059947|NCT00934856|75868895|FG000|Feasibility Part|Adverse Event|1|||
42059948|NCT00934856|75868896|FG001|Feasibility Part|Adverse Event|1|||
42059949|NCT00934856|75868897|FG002|Feasibility Part|Adverse Event|0|||
42059950|NCT00934856|75868898|FG003|Feasibility Part|Adverse Event|1|||
42059951|NCT00934856|75868899|FG004|Feasibility Part|Adverse Event|0|||
42059952|NCT00934856|75868900|FG005|Feasibility Part|Adverse Event|2|||
42059953|NCT00934856|75868895|FG000|Feasibility Part|Withdrawal by Subject|0|||
42059954|NCT00934856|75868896|FG001|Feasibility Part|Withdrawal by Subject|0|||
42059955|NCT00934856|75868897|FG002|Feasibility Part|Withdrawal by Subject|0|||
42059956|NCT00934856|75868898|FG003|Feasibility Part|Withdrawal by Subject|1|||
42059957|NCT00934856|75868899|FG004|Feasibility Part|Withdrawal by Subject|0|||
42059958|NCT00934856|75868900|FG005|Feasibility Part|Withdrawal by Subject|1|||
42059959|NCT00934856|75868895|FG000|Extension Part|Adverse Event|0|||
42059960|NCT00934856|75868896|FG001|Extension Part|Adverse Event|0|||
42059961|NCT00934856|75868897|FG002|Extension Part|Adverse Event|0|||
42174331|NCT03267940|75981077|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
42174332|NCT03267940|75981078|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
42174333|NCT03267940|75981079|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
42174334|NCT03267940|75981080|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
42174335|NCT03267940|75981081|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
42174336|NCT03267940|75981076|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
42174337|NCT03267940|75981077|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
42174338|NCT03267940|75981078|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
42174339|NCT03267940|75981079|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
42174340|NCT03267940|75981080|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
42174341|NCT03267940|75981081|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
42174342|NCT03267940|75981076|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
42174343|NCT03267940|75981077|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
42174344|NCT03267940|75981078|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
42174345|NCT03267940|75981079|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
42174346|NCT03267940|75981080|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
42174347|NCT03267940|75981081|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
42174348|NCT03296566|75981101|FG000|Overall Study|Lost to Follow-up|19|||
42174349|NCT03296566|75981102|FG001|Overall Study|Lost to Follow-up|46|||
42174350|NCT03296566|75981101|FG000|Overall Study|Withdrawal by Subject|0|||
42174351|NCT03296566|75981102|FG001|Overall Study|Withdrawal by Subject|3|||
42174352|NCT03755882|75981108|FG000|Period 1|Protocol Violation|1|||
42174353|NCT03755882|75981109|FG001|Period 1|Protocol Violation|0|||
42174354|NCT03755882|75981108|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
42174355|NCT03755882|75981109|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
42174356|NCT00312377|75981117|FG000|Overall Study|Death|403|||
42174357|NCT00312377|75981118|FG001|Overall Study|Death|418|||
42174358|NCT00312377|75981117|FG000|Overall Study|Withdrawal by Subject|23|||
42174359|NCT00312377|75981118|FG001|Overall Study|Withdrawal by Subject|30|||
42174360|NCT00312377|75981117|FG000|Overall Study|Lost to Follow-up|9|||
42174361|NCT00312377|75981118|FG001|Overall Study|Lost to Follow-up|12|||
42174362|NCT00312377|75981117|FG000|Overall Study|Non-compliance|0|||
42174363|NCT00312377|75981118|FG001|Overall Study|Non-compliance|2|||
42174364|NCT00312377|75981117|FG000|Overall Study|Randomised but never received treatment|6|||
42174365|NCT00312377|75981118|FG001|Overall Study|Randomised but never received treatment|6|||
42174366|NCT00312377|75981117|FG000|Overall Study|Discontinue treatment survival follow up|202|||
42174367|NCT00312377|75981118|FG001|Overall Study|Discontinue treatment survival follow up|200|||
42174368|NCT00312377|75981117|FG000|Overall Study|Site ended participation in study|1|||
42174369|NCT00312377|75981118|FG001|Overall Study|Site ended participation in study|0|||
42174370|NCT03295318|75981127|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
42174371|NCT03295318|75981128|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
42174372|NCT03295318|75981129|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
42174373|NCT03295318|75981127|FG000|Overall Study|Death|1|||
42174374|NCT03295318|75981128|FG001|Overall Study|Death|1|||
42174375|NCT03295318|75981129|FG002|Overall Study|Death|1|||
42174376|NCT03295318|75981127|FG000|Overall Study|Protocol Violation|4|||
42174377|NCT03295318|75981128|FG001|Overall Study|Protocol Violation|3|||
42174378|NCT03295318|75981129|FG002|Overall Study|Protocol Violation|3|||
42174379|NCT03295318|75981127|FG000|Overall Study|Withdrawal by Subject|0|||
42174380|NCT03295318|75981128|FG001|Overall Study|Withdrawal by Subject|0|||
42174381|NCT03295318|75981129|FG002|Overall Study|Withdrawal by Subject|1|||
42174382|NCT03295318|75981127|FG000|Overall Study|Subject discontinued due to travel|0|||
42174383|NCT03295318|75981128|FG001|Overall Study|Subject discontinued due to travel|1|||
42174384|NCT03295318|75981129|FG002|Overall Study|Subject discontinued due to travel|0|||
42174385|NCT03311230|75981159|FG000|Overall Study|Withdrawal by Subject|1|||
42174386|NCT03311230|75981160|FG001|Overall Study|Withdrawal by Subject|4|||
42174387|NCT03311230|75981161|FG002|Overall Study|Withdrawal by Subject|2|||
42174388|NCT03311230|75981162|FG003|Overall Study|Withdrawal by Subject|7|||
42174389|NCT03311230|75981159|FG000|Overall Study|Unrelated injury|0|||
42174390|NCT03311230|75981160|FG001|Overall Study|Unrelated injury|1|||
42174391|NCT03311230|75981161|FG002|Overall Study|Unrelated injury|0|||
42174392|NCT03311230|75981162|FG003|Overall Study|Unrelated injury|0|||
42174393|NCT00312221|75981175|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
42291900|NCT01939366|76125384|FG004|Overall Study|Adverse Event|5|||
42059962|NCT00934856|75868898|FG003|Extension Part|Adverse Event|1|||
42059963|NCT00934856|75868899|FG004|Extension Part|Adverse Event|4|||
42059964|NCT00934856|75868900|FG005|Extension Part|Adverse Event|4|||
42059965|NCT00934856|75868895|FG000|Extension Part|Progressive disease|0|||
42059966|NCT00934856|75868896|FG001|Extension Part|Progressive disease|0|||
42059967|NCT00934856|75868897|FG002|Extension Part|Progressive disease|0|||
42059968|NCT00934856|75868898|FG003|Extension Part|Progressive disease|1|||
42059969|NCT00934856|75868899|FG004|Extension Part|Progressive disease|0|||
42059970|NCT00934856|75868900|FG005|Extension Part|Progressive disease|0|||
42059971|NCT00934856|75868895|FG000|Extension Part|Non-compliance with drug|0|||
42059972|NCT00934856|75868896|FG001|Extension Part|Non-compliance with drug|0|||
42059973|NCT00934856|75868897|FG002|Extension Part|Non-compliance with drug|0|||
42059974|NCT00934856|75868898|FG003|Extension Part|Non-compliance with drug|0|||
42059975|NCT00934856|75868899|FG004|Extension Part|Non-compliance with drug|0|||
42059976|NCT00934856|75868900|FG005|Extension Part|Non-compliance with drug|1|||
42059977|NCT00934700|75868934|FG000|Overall Study|missing scan|5|||
42059978|NCT00934700|75868935|FG001|Overall Study|missing scan|9|||
42059979|NCT00934700|75868934|FG000|Overall Study|Death|8|||
42059980|NCT00934700|75868935|FG001|Overall Study|Death|3|||
42059981|NCT00930176|75868942|FG000|Overall Study|Death|1|||
42059982|NCT00669409|75868952|FG000|Part 2|Withdrawal by Subject|0|||
42059983|NCT00669409|75868953|FG001|Part 2|Withdrawal by Subject|0|||
42059984|NCT00669409|75868954|FG002|Part 2|Withdrawal by Subject|0|||
42059985|NCT00669409|75868955|FG003|Part 2|Withdrawal by Subject|0|||
42059986|NCT00669409|75868956|FG004|Part 2|Withdrawal by Subject|0|||
42059987|NCT00669409|75868957|FG005|Part 2|Withdrawal by Subject|0|||
42059988|NCT00669409|75868958|FG006|Part 2|Withdrawal by Subject|0|||
42059989|NCT00669409|75868959|FG007|Part 2|Withdrawal by Subject|0|||
42059990|NCT00669409|75868960|FG008|Part 2|Withdrawal by Subject|0|||
42059991|NCT00669409|75868961|FG009|Part 2|Withdrawal by Subject|1|||
42059992|NCT00669409|75868962|FG010|Part 2|Withdrawal by Subject|0|||
42059993|NCT00669331|75868991|FG000|Randomisation to First Dose|Adverse Event|1|||
42059994|NCT00669331|75868992|FG001|Randomisation to First Dose|Adverse Event|0|||
42059995|NCT00669331|75868991|FG000|Randomisation to First Dose|Protocol Violation|1|||
42059996|NCT00669331|75868992|FG001|Randomisation to First Dose|Protocol Violation|0|||
42059997|NCT00669331|75868991|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
42059998|NCT00669331|75868992|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
42059999|NCT00669331|75868991|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
42060000|NCT00669331|75868992|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
42060001|NCT00669331|75868991|FG000|Randomisation to First Dose|Death|1|||
42060002|NCT00669331|75868992|FG001|Randomisation to First Dose|Death|0|||
42060003|NCT00669331|75868991|FG000|Randomisation to First Dose|Sponsor decision|0|||
42060004|NCT00669331|75868992|FG001|Randomisation to First Dose|Sponsor decision|1|||
42060005|NCT00669331|75868991|FG000|Randomisation to First Dose|Randomised in error|3|||
42060006|NCT00669331|75868992|FG001|Randomisation to First Dose|Randomised in error|10|||
42060007|NCT00669331|75868991|FG000|Blinded Treatment Period|Adverse Event|16|||
42060008|NCT00669331|75868992|FG001|Blinded Treatment Period|Adverse Event|10|||
42060009|NCT00669331|75868991|FG000|Blinded Treatment Period|Protocol Violation|1|||
42060010|NCT00669331|75868992|FG001|Blinded Treatment Period|Protocol Violation|1|||
42060011|NCT00669331|75868991|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
42060012|NCT00669331|75868992|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
42060013|NCT00669331|75868991|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
42060014|NCT00669331|75868992|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
42060015|NCT00669331|75868991|FG000|Blinded Treatment Period|Death|0|||
42060016|NCT00669331|75868992|FG001|Blinded Treatment Period|Death|2|||
42060017|NCT00669331|75868991|FG000|Blinded Treatment Period|Physician Decision|3|||
42060018|NCT00669331|75868992|FG001|Blinded Treatment Period|Physician Decision|3|||
42060019|NCT00669331|75868991|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
42060020|NCT00669331|75868992|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
42060021|NCT00932126|75869000|FG000|Overall Study|Adverse Event|0|||
42060022|NCT00932126|75869001|FG001|Overall Study|Adverse Event|0|||
42060023|NCT00932126|75869002|FG002|Overall Study|Adverse Event|0|||
42060024|NCT00932126|75869003|FG003|Overall Study|Adverse Event|0|||
42060025|NCT00932126|75869004|FG004|Overall Study|Adverse Event|0|||
42060026|NCT00932126|75869005|FG005|Overall Study|Adverse Event|0|||
42060027|NCT00932126|75869006|FG006|Overall Study|Adverse Event|1|||
42060028|NCT00932126|75869007|FG007|Overall Study|Adverse Event|2|||
42060029|NCT00932126|75869000|FG000|Overall Study|Protocol Violation|0|||
42060030|NCT00932126|75869001|FG001|Overall Study|Protocol Violation|0|||
42060031|NCT00932126|75869002|FG002|Overall Study|Protocol Violation|0|||
42060032|NCT00932126|75869003|FG003|Overall Study|Protocol Violation|0|||
42060033|NCT00932126|75869004|FG004|Overall Study|Protocol Violation|1|||
42060034|NCT00932126|75869005|FG005|Overall Study|Protocol Violation|0|||
42060035|NCT00932126|75869006|FG006|Overall Study|Protocol Violation|0|||
42291901|NCT01939366|76125380|FG000|Overall Study|Lack of Efficacy|2|||
42060036|NCT00932126|75869007|FG007|Overall Study|Protocol Violation|0|||
42060037|NCT00932126|75869000|FG000|Overall Study|Withdrawal by Subject|0|||
42060038|NCT00932126|75869001|FG001|Overall Study|Withdrawal by Subject|0|||
42060039|NCT00932126|75869002|FG002|Overall Study|Withdrawal by Subject|1|||
42060040|NCT00932126|75869003|FG003|Overall Study|Withdrawal by Subject|0|||
42060041|NCT00932126|75869004|FG004|Overall Study|Withdrawal by Subject|0|||
42060042|NCT00932126|75869005|FG005|Overall Study|Withdrawal by Subject|0|||
42060043|NCT00932126|75869006|FG006|Overall Study|Withdrawal by Subject|0|||
42060044|NCT00932126|75869007|FG007|Overall Study|Withdrawal by Subject|1|||
42060045|NCT00932126|75869000|FG000|Overall Study|Objective progression or relapse|3|||
42060046|NCT00932126|75869001|FG001|Overall Study|Objective progression or relapse|3|||
42060047|NCT00932126|75869002|FG002|Overall Study|Objective progression or relapse|2|||
42060048|NCT00932126|75869003|FG003|Overall Study|Objective progression or relapse|3|||
42060049|NCT00932126|75869004|FG004|Overall Study|Objective progression or relapse|3|||
42060050|NCT00932126|75869005|FG005|Overall Study|Objective progression or relapse|3|||
42060051|NCT00932126|75869006|FG006|Overall Study|Objective progression or relapse|3|||
42060052|NCT00932126|75869007|FG007|Overall Study|Objective progression or relapse|5|||
42060053|NCT00932126|75869000|FG000|Overall Study|Other|0|||
42060054|NCT00932126|75869001|FG001|Overall Study|Other|0|||
42060055|NCT00932126|75869002|FG002|Overall Study|Other|0|||
42060056|NCT00932126|75869003|FG003|Overall Study|Other|0|||
42060057|NCT00932126|75869004|FG004|Overall Study|Other|1|||
42060058|NCT00932126|75869005|FG005|Overall Study|Other|0|||
42060059|NCT00932126|75869006|FG006|Overall Study|Other|1|||
42060060|NCT00932126|75869007|FG007|Overall Study|Other|2|||
42060061|NCT00667225|75869029|FG000|Overall Study|Subject had no more lesions to treat.|1|||
42060062|NCT00667225|75869030|FG001|Overall Study|Subject had no more lesions to treat.|0|||
42060063|NCT00667225|75869029|FG000|Overall Study|Lost to Follow-up|0|||
42060064|NCT00667225|75869030|FG001|Overall Study|Lost to Follow-up|1|||
42060065|NCT00929864|75869038|FG000|Overall Study|Death|1|||
42060066|NCT00929864|75869039|FG001|Overall Study|Death|1|||
42060067|NCT00929864|75869038|FG000|Overall Study|Adverse Event|11|||
42060068|NCT00929864|75869039|FG001|Overall Study|Adverse Event|30|||
42060069|NCT00929864|75869038|FG000|Overall Study|Lack of Efficacy|19|||
42060070|NCT00929864|75869039|FG001|Overall Study|Lack of Efficacy|16|||
42060071|NCT00929864|75869038|FG000|Overall Study|Lost to Follow-up|7|||
42060072|NCT00929864|75869039|FG001|Overall Study|Lost to Follow-up|12|||
42060073|NCT00929864|75869038|FG000|Overall Study|Withdrawal by Subject|20|||
42060074|NCT00929864|75869039|FG001|Overall Study|Withdrawal by Subject|9|||
42060075|NCT00929864|75869038|FG000|Overall Study|No longer met criteria|2|||
42060076|NCT00929864|75869039|FG001|Overall Study|No longer met criteria|1|||
42060077|NCT00929864|75869038|FG000|Overall Study|Poor or non-compliance|3|||
42060078|NCT00929864|75869039|FG001|Overall Study|Poor or non-compliance|3|||
42060079|NCT00929864|75869038|FG000|Overall Study|Pregnancy|0|||
42060080|NCT00929864|75869039|FG001|Overall Study|Pregnancy|3|||
42060081|NCT00929864|75869038|FG000|Overall Study|Administrative reason by Sponsor|1|||
42060082|NCT00929864|75869039|FG001|Overall Study|Administrative reason by Sponsor|1|||
42060083|NCT00929864|75869038|FG000|Overall Study|Non-specified|2|||
42060084|NCT00929864|75869039|FG001|Overall Study|Non-specified|7|||
42060085|NCT00597753|75869047|FG000|Overall Study|Adverse Event|6|||
42060086|NCT00597753|75869048|FG001|Overall Study|Adverse Event|2|||
42060087|NCT00597753|75869047|FG000|Overall Study|Death|55|||
42060088|NCT00597753|75869048|FG001|Overall Study|Death|29|||
42060089|NCT00597753|75869047|FG000|Overall Study|Lack of Efficacy|2|||
42060090|NCT00597753|75869048|FG001|Overall Study|Lack of Efficacy|0|||
42060091|NCT00597753|75869047|FG000|Overall Study|Lost to Follow-up|10|||
42060092|NCT00597753|75869048|FG001|Overall Study|Lost to Follow-up|3|||
42060093|NCT00597753|75869047|FG000|Overall Study|Physician Decision|5|||
42060094|NCT00597753|75869048|FG001|Overall Study|Physician Decision|1|||
42060095|NCT00597753|75869047|FG000|Overall Study|Pregnancy|1|||
42060096|NCT00597753|75869048|FG001|Overall Study|Pregnancy|0|||
42060097|NCT00597753|75869047|FG000|Overall Study|Withdrawal by Subject|35|||
42060098|NCT00597753|75869048|FG001|Overall Study|Withdrawal by Subject|12|||
42060099|NCT00597753|75869047|FG000|Overall Study|Discontinued Dialysis|0|||
42060100|NCT00597753|75869048|FG001|Overall Study|Discontinued Dialysis|1|||
42060101|NCT00597753|75869047|FG000|Overall Study|Never dosed|2|||
42060102|NCT00597753|75869048|FG001|Overall Study|Never dosed|0|||
42060103|NCT00597753|75869047|FG000|Overall Study|Noncompliance|2|||
42060104|NCT00597753|75869048|FG001|Overall Study|Noncompliance|1|||
42060105|NCT00597753|75869047|FG000|Overall Study|Relocation|17|||
42060106|NCT00597753|75869048|FG001|Overall Study|Relocation|6|||
42060107|NCT00597753|75869047|FG000|Overall Study|Renal transplant|10|||
42060108|NCT00597753|75869048|FG001|Overall Study|Renal transplant|3|||
42060109|NCT00597753|75869047|FG000|Overall Study|Site closed by sponsor|19|||
42060110|NCT00597753|75869048|FG001|Overall Study|Site closed by sponsor|7|||
42060111|NCT00597753|75869047|FG000|Overall Study|Site elected to close|2|||
42060112|NCT00597753|75869048|FG001|Overall Study|Site elected to close|4|||
42060113|NCT00665431|75869057|FG000|Overall Study|Adverse Event|16|||
42060114|NCT00665431|75869058|FG001|Overall Study|Adverse Event|22|||
42060115|NCT00665431|75869059|FG002|Overall Study|Adverse Event|6|||
42060116|NCT00665431|75869057|FG000|Overall Study|Withdrawal by Subject|17|||
42060117|NCT00665431|75869058|FG001|Overall Study|Withdrawal by Subject|25|||
42060118|NCT00665431|75869059|FG002|Overall Study|Withdrawal by Subject|15|||
42060119|NCT00665431|75869057|FG000|Overall Study|Lost to Follow-up|3|||
42060120|NCT00665431|75869058|FG001|Overall Study|Lost to Follow-up|3|||
42060121|NCT00665431|75869059|FG002|Overall Study|Lost to Follow-up|1|||
42060122|NCT00665431|75869057|FG000|Overall Study|Other|4|||
42060123|NCT00665431|75869058|FG001|Overall Study|Other|7|||
42060124|NCT00665431|75869059|FG002|Overall Study|Other|2|||
42060125|NCT00934622|75869067|FG000|Overall Study|Lost to Follow-up|7|||
42060126|NCT00934622|75869067|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
42060127|NCT00881361|75869073|FG000|Overall Study|Terminated prior to surgery|27|||
42060128|NCT00881361|75869074|FG001|Overall Study|Terminated prior to surgery|7|||
42060129|NCT00881361|75869075|FG002|Overall Study|Terminated prior to surgery|0|||
42060130|NCT00881361|75869073|FG000|Overall Study|Ineligible|17|||
42060131|NCT00881361|75869074|FG001|Overall Study|Ineligible|2|||
42060132|NCT00881361|75869075|FG002|Overall Study|Ineligible|2|||
42060133|NCT01000727|75869086|FG000|Overall Study|Lost to Follow-up|41|||
42060134|NCT01000727|75869087|FG001|Overall Study|Lost to Follow-up|43|||
42060135|NCT01000727|75869086|FG000|Overall Study|Withdrawal by Subject|111|||
42060136|NCT01000727|75869087|FG001|Overall Study|Withdrawal by Subject|109|||
42060137|NCT01000727|75869086|FG000|Overall Study|Study closed/terminated|23|||
42060138|NCT01000727|75869087|FG001|Overall Study|Study closed/terminated|24|||
42060139|NCT00881205|75869097|FG000|Overall Study|Adverse Event|8|||
42060140|NCT00881205|75869098|FG001|Overall Study|Adverse Event|3|||
42060141|NCT00881205|75869097|FG000|Overall Study|Withdrawal by Subject|1|||
42060142|NCT00881205|75869098|FG001|Overall Study|Withdrawal by Subject|2|||
42060143|NCT00881205|75869097|FG000|Overall Study|Lost to Follow-up|0|||
42060144|NCT00881205|75869098|FG001|Overall Study|Lost to Follow-up|1|||
42060145|NCT00881205|75869097|FG000|Overall Study|Administrative problems|1|||
42060146|NCT00881205|75869098|FG001|Overall Study|Administrative problems|1|||
42060147|NCT00881205|75869097|FG000|Overall Study|Condition no longer requires drug|1|||
42060148|NCT00881205|75869098|FG001|Overall Study|Condition no longer requires drug|0|||
42060149|NCT00879879|75869105|FG000|Overall Study|Death|1|||
42060150|NCT00879879|75869105|FG000|Overall Study|Withdrawal by Subject|1|||
42060151|NCT00879879|75869105|FG000|Overall Study|Physician Decision|1|||
42060152|NCT00661999|75869114|FG000|Overall Study|Adverse Event|11|||
42060153|NCT00661999|75869115|FG001|Overall Study|Adverse Event|5|||
42060154|NCT00661999|75869116|FG002|Overall Study|Adverse Event|8|||
42060155|NCT00661999|75869114|FG000|Overall Study|Death|8|||
42060156|NCT00661999|75869115|FG001|Overall Study|Death|6|||
42060157|NCT00661999|75869116|FG002|Overall Study|Death|3|||
42060158|NCT00661999|75869114|FG000|Overall Study|Other Reasons|5|||
42060159|NCT00661999|75869115|FG001|Overall Study|Other Reasons|12|||
42060160|NCT00661999|75869116|FG002|Overall Study|Other Reasons|23|||
42060161|NCT00661999|75869114|FG000|Overall Study|Withdrawal by Subject|30|||
42060162|NCT00661999|75869115|FG001|Overall Study|Withdrawal by Subject|23|||
42060163|NCT00661999|75869116|FG002|Overall Study|Withdrawal by Subject|14|||
42060164|NCT00661999|75869114|FG000|Overall Study|Alternative Treatment|1|||
42060165|NCT00661999|75869115|FG001|Overall Study|Alternative Treatment|0|||
42060166|NCT00661999|75869116|FG002|Overall Study|Alternative Treatment|0|||
42060167|NCT00661999|75869114|FG000|Overall Study|Other Medical Problems|4|||
42060168|NCT00661999|75869115|FG001|Overall Study|Other Medical Problems|4|||
42060169|NCT00661999|75869116|FG002|Overall Study|Other Medical Problems|9|||
42060170|NCT00665353|75869124|FG000|Study Step 1|Adverse Event|1|||
42060171|NCT00665353|75869124|FG000|Study Step 1|Withdrawal by Subject|2|||
42060172|NCT00665353|75869124|FG000|Study Step 2|Lost to Follow-up|2|||
42060173|NCT00665353|75869124|FG000|Study Step 2|Lack of Efficacy|12|||
42060174|NCT00597207|75869130|FG000|Overall Study|Lost to Follow-up|5|||
42060175|NCT00597207|75869131|FG001|Overall Study|Lost to Follow-up|7|||
42060176|NCT00879645|75869141|FG000|Overall Study|Adverse Event|1|||
42060177|NCT00879645|75869142|FG001|Overall Study|Adverse Event|0|||
42060178|NCT00879645|75869143|FG002|Overall Study|Adverse Event|0|||
42060179|NCT00879645|75869144|FG003|Overall Study|Adverse Event|0|||
42060180|NCT00664105|75869154|FG000|Overall Study|Death|3|||
42060181|NCT00664105|75869154|FG000|Overall Study|Withdrawal by Subject|5|||
42060182|NCT00664105|75869154|FG000|Overall Study|Adverse Event|9|||
42060183|NCT00664105|75869154|FG000|Overall Study|Disease progression|7|||
42060184|NCT00661687|75869159|FG000|Overall Study|Study related symptoms and complaints|5|||
42060185|NCT00661687|75869159|FG000|Overall Study|Positive slit lamp findings|4|||
42060186|NCT00661687|75869159|FG000|Overall Study|Inability to maintain wearing schedule|3|||
42060187|NCT00661687|75869159|FG000|Overall Study|Physician Decision|1|||
42060188|NCT00661687|75869159|FG000|Overall Study|Adverse Event|2|||
42060189|NCT00596817|75869168|FG000|Open-label Period|Adverse Event|0|||
42060190|NCT00596817|75869169|FG001|Open-label Period|Adverse Event|49|||
42060191|NCT00596817|75869168|FG000|Open-label Period|Lack of Efficacy|0|||
42291902|NCT01939366|76125381|FG001|Overall Study|Lack of Efficacy|1|||
42060192|NCT00596817|75869169|FG001|Open-label Period|Lack of Efficacy|33|||
42060193|NCT00596817|75869168|FG000|Open-label Period|Other Reasons|0|||
42060194|NCT00596817|75869169|FG001|Open-label Period|Other Reasons|65|||
42060195|NCT00596817|75869168|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
42060196|NCT00596817|75869169|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
42060197|NCT00596817|75869168|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
42060198|NCT00596817|75869169|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
42060199|NCT00596817|75869168|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
42060200|NCT00596817|75869169|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
42060201|NCT00596817|75869168|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
42060202|NCT00596817|75869169|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
42060203|NCT00596817|75869168|FG000|Double-blind Period|Adverse Event|5|||
42060204|NCT00596817|75869169|FG001|Double-blind Period|Adverse Event|16|||
42060205|NCT00596817|75869168|FG000|Double-blind Period|Lack of Efficacy|52|||
42060206|NCT00596817|75869169|FG001|Double-blind Period|Lack of Efficacy|28|||
42060207|NCT00596817|75869168|FG000|Double-blind Period|Non-compliance With Study Product|3|||
42060208|NCT00596817|75869169|FG001|Double-blind Period|Non-compliance With Study Product|4|||
42060209|NCT00596817|75869168|FG000|Double-blind Period|Protocol Violation|11|||
42060210|NCT00596817|75869169|FG001|Double-blind Period|Protocol Violation|8|||
42060211|NCT00596817|75869168|FG000|Double-blind Period|Withdrawal of Consent|7|||
42060212|NCT00596817|75869169|FG001|Double-blind Period|Withdrawal of Consent|3|||
42060213|NCT00596817|75869168|FG000|Double-blind Period|Lost to Follow-up|0|||
42060214|NCT00596817|75869169|FG001|Double-blind Period|Lost to Follow-up|2|||
42060215|NCT00596817|75869168|FG000|Double-blind Period|Other Reasons|10|||
42060216|NCT00596817|75869169|FG001|Double-blind Period|Other Reasons|18|||
42060217|NCT01000649|75869180|FG000|Overall Study|Adverse Event|5|||
42060218|NCT01000649|75869181|FG001|Overall Study|Adverse Event|1|||
42060219|NCT01000649|75869182|FG002|Overall Study|Adverse Event|2|||
42060220|NCT01000649|75869183|FG003|Overall Study|Adverse Event|4|||
42060221|NCT01000649|75869180|FG000|Overall Study|Lost to Follow-up|0|||
42060222|NCT01000649|75869181|FG001|Overall Study|Lost to Follow-up|2|||
42060223|NCT01000649|75869182|FG002|Overall Study|Lost to Follow-up|0|||
42060224|NCT01000649|75869183|FG003|Overall Study|Lost to Follow-up|2|||
42060225|NCT00879411|75869192|FG000|Overall Study|lost to follow-up (non-AE)|162|||
42060226|NCT01000493|75869198|FG000|Overall Study|Adverse Event|3|||
42060227|NCT01000493|75869199|FG001|Overall Study|Adverse Event|6|||
42060228|NCT01000493|75869198|FG000|Overall Study|Lack of Efficacy|1|||
42060229|NCT01000493|75869199|FG001|Overall Study|Lack of Efficacy|1|||
42060230|NCT01000493|75869198|FG000|Overall Study|Protocol Violation|1|||
42060231|NCT01000493|75869199|FG001|Overall Study|Protocol Violation|8|||
42060232|NCT01000493|75869198|FG000|Overall Study|Study closed/terminated|25|||
42060233|NCT01000493|75869199|FG001|Overall Study|Study closed/terminated|23|||
42060234|NCT01000493|75869198|FG000|Overall Study|Lost to Follow-up|5|||
42060235|NCT01000493|75869199|FG001|Overall Study|Lost to Follow-up|9|||
42060236|NCT01000493|75869198|FG000|Overall Study|Physician Decision|1|||
42060237|NCT01000493|75869199|FG001|Overall Study|Physician Decision|1|||
42060238|NCT01000493|75869198|FG000|Overall Study|Withdrawal by Subject|3|||
42060239|NCT01000493|75869199|FG001|Overall Study|Withdrawal by Subject|7|||
42060240|NCT00666757|75869207|FG000|Overall Study|Lost to Follow-up|39|||
42060241|NCT00666757|75869208|FG001|Overall Study|Lost to Follow-up|35|||
42060242|NCT00666757|75869207|FG000|Overall Study|Protocol Violation|23|||
42060243|NCT00666757|75869208|FG001|Overall Study|Protocol Violation|24|||
42060244|NCT00666757|75869207|FG000|Overall Study|Adverse Event|22|||
42060245|NCT00666757|75869208|FG001|Overall Study|Adverse Event|12|||
42060246|NCT00666757|75869207|FG000|Overall Study|Withdrawal by Subject|13|||
42060247|NCT00666757|75869208|FG001|Overall Study|Withdrawal by Subject|17|||
42060248|NCT00666757|75869207|FG000|Overall Study|Lack of Efficacy|3|||
42060249|NCT00666757|75869208|FG001|Overall Study|Lack of Efficacy|6|||
42060250|NCT00666757|75869207|FG000|Overall Study|Physician Decision|0|||
42060251|NCT00666757|75869208|FG001|Overall Study|Physician Decision|2|||
42060252|NCT00666757|75869207|FG000|Overall Study|Sponsor decision|0|||
42060253|NCT00666757|75869208|FG001|Overall Study|Sponsor decision|1|||
42060254|NCT01000337|75869219|FG000|Overall Study|Lost to Follow-up|4|||
42060255|NCT01000337|75869220|FG001|Overall Study|Lost to Follow-up|3|||
42174394|NCT00312221|75981176|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
42174395|NCT00312221|75981177|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
42174396|NCT00312221|75981178|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
42174397|NCT00312221|75981175|FG000|Open-label Run-in Period|Adverse Event|74|||
42060256|NCT00666679|75869228|FG000|First Intervention|Lost to Follow-up|1|||
42060257|NCT00666679|75869229|FG001|First Intervention|Lost to Follow-up|0|||
42060258|NCT00666679|75869228|FG000|First Intervention|Protocol Violation|1|||
42291903|NCT01939366|76125382|FG002|Overall Study|Lack of Efficacy|1|||
42060259|NCT00666679|75869229|FG001|First Intervention|Protocol Violation|0|||
42060260|NCT00666679|75869228|FG000|First Intervention|Withdrawal by Subject|1|||
42060261|NCT00666679|75869229|FG001|First Intervention|Withdrawal by Subject|0|||
42060262|NCT00666679|75869228|FG000|First Intervention|Randomized did not start treatment|1|||
42060263|NCT00666679|75869229|FG001|First Intervention|Randomized did not start treatment|1|||
42060264|NCT00666679|75869228|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
42174398|NCT00312221|75981176|FG001|Open-label Run-in Period|Adverse Event|0|||
42291904|NCT01939366|76125383|FG003|Overall Study|Lack of Efficacy|1|||
42060265|NCT00666679|75869229|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
42060266|NCT00666679|75869228|FG000|Washout Period of 1 Week|Protocol Violation|0|||
42060267|NCT00666679|75869229|FG001|Washout Period of 1 Week|Protocol Violation|1|||
42060268|NCT00666679|75869228|FG000|Second Intervention|Adverse Event|1|||
42060269|NCT00666679|75869229|FG001|Second Intervention|Adverse Event|0|||
42060270|NCT00666679|75869228|FG000|Second Intervention|Death|0|||
42060271|NCT00666679|75869229|FG001|Second Intervention|Death|1|||
42060272|NCT00595413|75869239|FG000|Overall Study|Adverse Event|0|||
42060273|NCT00595413|75869240|FG001|Overall Study|Adverse Event|2|||
42060274|NCT00595413|75869241|FG002|Overall Study|Adverse Event|1|||
42060275|NCT00595413|75869242|FG003|Overall Study|Adverse Event|1|||
42060276|NCT00595413|75869239|FG000|Overall Study|Lost to Follow-up|2|||
42060277|NCT00595413|75869240|FG001|Overall Study|Lost to Follow-up|2|||
42060278|NCT00595413|75869241|FG002|Overall Study|Lost to Follow-up|1|||
42060279|NCT00595413|75869242|FG003|Overall Study|Lost to Follow-up|3|||
42060280|NCT00595413|75869239|FG000|Overall Study|Death|0|||
42060281|NCT00595413|75869240|FG001|Overall Study|Death|0|||
42060282|NCT00595413|75869241|FG002|Overall Study|Death|1|||
42060283|NCT00595413|75869242|FG003|Overall Study|Death|0|||
42174399|NCT00312221|75981177|FG002|Open-label Run-in Period|Adverse Event|0|||
42174400|NCT00312221|75981178|FG003|Open-label Run-in Period|Adverse Event|0|||
42174401|NCT00312221|75981175|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
42174402|NCT00312221|75981176|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
42174403|NCT00312221|75981177|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
42060284|NCT00595413|75869239|FG000|Overall Study|Other|5|||
42060285|NCT00595413|75869240|FG001|Overall Study|Other|1|||
42060286|NCT00595413|75869241|FG002|Overall Study|Other|5|||
42060287|NCT00595413|75869242|FG003|Overall Study|Other|0|||
42060288|NCT01000025|75869254|FG000|Overall Study|Adverse Event|43|||
42060289|NCT01000025|75869255|FG001|Overall Study|Adverse Event|2|||
42060290|NCT01000025|75869254|FG000|Overall Study|Withdrawal by Subject|13|||
42060291|NCT01000025|75869255|FG001|Overall Study|Withdrawal by Subject|8|||
42060292|NCT01000025|75869254|FG000|Overall Study|Death|23|||
42060293|NCT01000025|75869255|FG001|Overall Study|Death|13|||
42060294|NCT01000025|75869254|FG000|Overall Study|Lack of Efficacy|363|||
42060295|NCT01000025|75869255|FG001|Overall Study|Lack of Efficacy|208|||
42060296|NCT01000025|75869254|FG000|Overall Study|Intercurrent Illness|26|||
42060297|NCT01000025|75869255|FG001|Overall Study|Intercurrent Illness|7|||
42060298|NCT00595335|75869263|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
42060299|NCT00595335|75869264|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
42060300|NCT00595335|75869263|FG000|Baseline to Six Months|Disease Progression|1|||
42060301|NCT00595335|75869264|FG001|Baseline to Six Months|Disease Progression|1|||
42060302|NCT00595335|75869263|FG000|Baseline to Six Months|Adverse Event|1|||
42060303|NCT00595335|75869264|FG001|Baseline to Six Months|Adverse Event|0|||
42060304|NCT00595335|75869263|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
42060305|NCT00595335|75869264|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
42060306|NCT00595335|75869263|FG000|Six Months to Twelve Months|Disease Progression|1|||
42060307|NCT00595335|75869264|FG001|Six Months to Twelve Months|Disease Progression|0|||
42060308|NCT00661609|75869274|FG000|Overall Study|Adverse Event|4|||
42060309|NCT00661609|75869274|FG000|Overall Study|Death|20|||
42060310|NCT00661609|75869274|FG000|Overall Study|Withdrawal by Subject|2|||
42060311|NCT00661609|75869274|FG000|Overall Study|PI Decision|1|||
42060312|NCT00661609|75869274|FG000|Overall Study|Survival follow up stage discontinued|11|||
42060313|NCT00661609|75869274|FG000|Overall Study|Disease progression|3|||
42060314|NCT00661531|75869278|FG000|Overall Study|Withdrawal by Subject|3|||
42060315|NCT00998309|75869282|FG000|Overall Study|Protocol Violation|4|||
42060316|NCT00999713|75869336|FG000|Overall Study|Physician Decision|2|||
42060317|NCT00999713|75869337|FG001|Overall Study|Physician Decision|0|||
42060318|NCT00997373|75869345|FG000|Overall Study|Withdrawal by Subject|5|||
42060319|NCT00997373|75869346|FG001|Overall Study|Withdrawal by Subject|0|||
42060320|NCT00997373|75869345|FG000|Overall Study|wrong tumor type|4|||
42060321|NCT00997373|75869346|FG001|Overall Study|wrong tumor type|0|||
42060322|NCT00997373|75869345|FG000|Overall Study|could not have hysterectomy|6|||
42060323|NCT00997373|75869346|FG001|Overall Study|could not have hysterectomy|0|||
42060324|NCT00663871|75869354|FG000|Overall Study|Lost to Follow-up|5|||
42060325|NCT00663871|75869355|FG001|Overall Study|Lost to Follow-up|5|||
42060326|NCT00663871|75869354|FG000|Overall Study|Withdrawal by Subject|5|||
42060327|NCT00663871|75869355|FG001|Overall Study|Withdrawal by Subject|2|||
42060328|NCT04152447|75869365|FG000|Overall Study|Lost to Follow-up|1|||
42060329|NCT04152447|75869366|FG001|Overall Study|Lost to Follow-up|0|||
42060330|NCT04152447|75869365|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
42060331|NCT04152447|75869366|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
42060332|NCT04152447|75869365|FG000|Overall Study|Withdrawal by Subject|0|||
42060333|NCT04152447|75869366|FG001|Overall Study|Withdrawal by Subject|1|||
42060334|NCT04152447|75869365|FG000|Overall Study|Found ineligible after enrolling|1|||
42060335|NCT04152447|75869366|FG001|Overall Study|Found ineligible after enrolling|1|||
42060336|NCT04152447|75869365|FG000|Overall Study|Did not receive VR headset in time.|0|||
42060337|NCT04152447|75869366|FG001|Overall Study|Did not receive VR headset in time.|2|||
42060338|NCT00996593|75869372|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
42060339|NCT00996593|75869372|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
42060340|NCT00996593|75869372|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
42060341|NCT00996593|75869372|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
42060342|NCT00996593|75869372|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
42060343|NCT00996593|75869372|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
42060344|NCT00996593|75869372|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
42060345|NCT00996593|75869372|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
42060346|NCT00996593|75869372|FG000|Long-Term Follow-Up|Site Closed|1|||
42060347|NCT00570661|75869376|FG000|Overall Study|Disease worsening|5|||
42060348|NCT00570661|75869376|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
42060349|NCT00570661|75869376|FG000|Overall Study|Adverse Event|1|||
42060350|NCT00934544|75869383|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
42060351|NCT00934544|75869384|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
42060352|NCT00934544|75869385|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
42060353|NCT00934544|75869383|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
42060354|NCT00934544|75869384|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
42060355|NCT00934544|75869385|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
42060356|NCT00934544|75869383|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
42060357|NCT00934544|75869384|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
42060358|NCT00934544|75869385|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
42060359|NCT00934544|75869383|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
42060360|NCT00934544|75869384|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
42060361|NCT00934544|75869385|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
42060362|NCT00934544|75869383|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
42060363|NCT00934544|75869384|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
42060364|NCT00934544|75869385|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
42060365|NCT00934544|75869383|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
42060366|NCT00934544|75869384|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
42060367|NCT00934544|75869385|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
42060368|NCT00934544|75869383|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
42060369|NCT00934544|75869384|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
42060370|NCT00934544|75869385|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
42060371|NCT00934544|75869383|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
42060372|NCT00934544|75869384|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
42060373|NCT00934544|75869385|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
42060374|NCT00934544|75869383|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
42060375|NCT00934544|75869384|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
42060376|NCT00934544|75869385|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
42060377|NCT00934544|75869383|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
42060378|NCT00934544|75869384|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
42060379|NCT00934544|75869385|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
42060380|NCT00934544|75869383|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
42060381|NCT00934544|75869384|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
42060382|NCT00934544|75869385|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
42060383|NCT00934544|75869383|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
42060384|NCT00934544|75869384|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
42060385|NCT00934544|75869385|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
42060386|NCT00934544|75869383|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
42174404|NCT00312221|75981178|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
42174405|NCT00312221|75981175|FG000|Open-label Run-in Period|Administrative|42|||
42174406|NCT00312221|75981176|FG001|Open-label Run-in Period|Administrative|0|||
42174407|NCT00312221|75981177|FG002|Open-label Run-in Period|Administrative|0|||
42174408|NCT00312221|75981178|FG003|Open-label Run-in Period|Administrative|0|||
42174409|NCT00312221|75981175|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
42174410|NCT00312221|75981176|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
42174411|NCT00312221|75981177|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
42174412|NCT00312221|75981178|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
42174413|NCT00312221|75981175|FG000|Open-label Run-in Period|Did not qualify|5|||
42174414|NCT00312221|75981176|FG001|Open-label Run-in Period|Did not qualify|0|||
42174415|NCT00312221|75981177|FG002|Open-label Run-in Period|Did not qualify|0|||
42174416|NCT00312221|75981178|FG003|Open-label Run-in Period|Did not qualify|0|||
42174417|NCT00312221|75981175|FG000|Double-blind Phase|Withdrawal by Subject|0|||
42174418|NCT00312221|75981176|FG001|Double-blind Phase|Withdrawal by Subject|6|||
42060387|NCT00934544|75869384|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
42060388|NCT00934544|75869385|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
42060389|NCT00934544|75869383|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
42060390|NCT00934544|75869384|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
42060391|NCT00934544|75869385|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
42060392|NCT00934544|75869383|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
42060393|NCT00934544|75869384|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
42060394|NCT00934544|75869385|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
42060395|NCT00934544|75869383|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
42060396|NCT00934544|75869384|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
42060397|NCT00934544|75869385|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
42060398|NCT00999167|75869404|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
42060399|NCT00999167|75869405|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
42060400|NCT00999167|75869406|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
42060401|NCT00999167|75869404|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
42060402|NCT00999167|75869405|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
42060403|NCT00999167|75869406|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
42060404|NCT00999167|75869404|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
42060405|NCT00999167|75869405|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
42060406|NCT00999167|75869406|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
42060407|NCT00999167|75869404|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
42060408|NCT00999167|75869405|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
42060409|NCT00999167|75869406|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
42060410|NCT00999167|75869404|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
42060411|NCT00999167|75869405|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
42060412|NCT00999167|75869406|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
42060413|NCT00999167|75869404|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
42060414|NCT00999167|75869405|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
42357225|NCT01400451|76202565|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
42357226|NCT01400451|76202566|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
42357227|NCT01400451|76202567|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
42357228|NCT01400139|76202580|FG000|HYD Core Study|Adverse Event|210|||
42357229|NCT01400139|76202580|FG000|HYD Core Study|Lack of Efficacy|59|||
42357230|NCT01400139|76202580|FG000|HYD Core Study|Withdrawal by Subject|114|||
42357231|NCT01400139|76202580|FG000|HYD Core Study|Lost to Follow-up|39|||
42357232|NCT01400139|76202580|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
42357233|NCT01400139|76202580|FG000|HYD Core Study|Administrative|56|||
42357234|NCT01400139|76202580|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
42357235|NCT01400139|76202580|FG000|HYD Extension Period|Adverse Event|8|||
42357236|NCT01400139|76202580|FG000|HYD Extension Period|Withdrawal by Subject|5|||
42357237|NCT01400139|76202580|FG000|HYD Extension Period|Administrative|10|||
42357238|NCT01399905|76202588|FG000|Overall Study|Withdrawal by Subject|1|||
42060415|NCT00999167|75869406|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
42060416|NCT00999167|75869404|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
42060417|NCT00999167|75869405|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
42060418|NCT00999167|75869406|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
42060419|NCT00999167|75869404|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
42060420|NCT00999167|75869405|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
42060421|NCT00999167|75869406|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
42060422|NCT00570505|75869416|FG000|Overall Study|Adverse Event|7|||
42060423|NCT00570505|75869416|FG000|Overall Study|Withdrawal by Subject|7|||
42060424|NCT00570505|75869416|FG000|Overall Study|Lost to Follow-up|23|||
42060425|NCT00570505|75869416|FG000|Overall Study|Other loss to follow-up|4|||
42060426|NCT00931892|75869422|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
42060427|NCT00931892|75869423|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
42060428|NCT00666211|75869471|FG000|Overall Study|Withdrawal by Subject|10|||
42060429|NCT00666211|75869472|FG001|Overall Study|Withdrawal by Subject|13|||
42060430|NCT00666211|75869471|FG000|Overall Study|went off medication, no more pain|1|||
42060431|NCT00666211|75869472|FG001|Overall Study|went off medication, no more pain|0|||
42060432|NCT00666211|75869471|FG000|Overall Study|patient non-compliant|6|||
42174419|NCT00312221|75981177|FG002|Double-blind Phase|Withdrawal by Subject|8|||
42174420|NCT00312221|75981178|FG003|Double-blind Phase|Withdrawal by Subject|7|||
42174421|NCT00312221|75981175|FG000|Double-blind Phase|Adverse Event|0|||
42174422|NCT00312221|75981176|FG001|Double-blind Phase|Adverse Event|10|||
42357239|NCT01399905|76202589|FG001|Overall Study|Withdrawal by Subject|1|||
42357240|NCT01725308|76202603|FG000|Treatment Period I|Did Not Receive Drug|1|||
42060433|NCT00666211|75869472|FG001|Overall Study|patient non-compliant|6|||
42060434|NCT00666211|75869471|FG000|Overall Study|disease progression|1|||
42060435|NCT00666211|75869472|FG001|Overall Study|disease progression|8|||
42060436|NCT00666211|75869471|FG000|Overall Study|Lost to Follow-up|2|||
42060437|NCT00666211|75869472|FG001|Overall Study|Lost to Follow-up|0|||
42060438|NCT00666211|75869471|FG000|Overall Study|toxicity|0|||
42060439|NCT00666211|75869472|FG001|Overall Study|toxicity|2|||
42060440|NCT00666211|75869471|FG000|Overall Study|hospital admission|0|||
42060441|NCT00666211|75869472|FG001|Overall Study|hospital admission|5|||
42060442|NCT00666211|75869471|FG000|Overall Study|Death|0|||
42060443|NCT00666211|75869472|FG001|Overall Study|Death|2|||
42060444|NCT00666211|75869471|FG000|Overall Study|off tx for other complicating disease|0|||
42060445|NCT00666211|75869472|FG001|Overall Study|off tx for other complicating disease|1|||
42060446|NCT00666211|75869471|FG000|Overall Study|Physician Decision|0|||
42060447|NCT00666211|75869472|FG001|Overall Study|Physician Decision|1|||
42060448|NCT00878709|75869480|FG000|Overall Study|Withdrawal by Subject|197|||
42060449|NCT00878709|75869481|FG001|Overall Study|Withdrawal by Subject|120|||
42060450|NCT00878709|75869480|FG000|Overall Study|Lost to Follow-up|35|||
42060451|NCT00878709|75869481|FG001|Overall Study|Lost to Follow-up|33|||
42060452|NCT00878709|75869480|FG000|Overall Study|Other Reasons|93|||
42060453|NCT00878709|75869481|FG001|Overall Study|Other Reasons|84|||
42060454|NCT00927758|75869488|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
42060455|NCT00927758|75869489|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
42060456|NCT00927758|75869490|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
42060457|NCT00927758|75869491|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
42060458|NCT00927758|75869492|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
42174423|NCT00312221|75981177|FG002|Double-blind Phase|Adverse Event|19|||
42174424|NCT00312221|75981178|FG003|Double-blind Phase|Adverse Event|18|||
42060459|NCT00927758|75869493|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
42060460|NCT00927758|75869488|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
42060461|NCT00927758|75869489|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
42060462|NCT00927758|75869490|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
42060463|NCT00927758|75869491|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
42060464|NCT00927758|75869492|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
42060465|NCT00927758|75869493|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
42060466|NCT00927368|75869504|FG000|Overall Study|enrollment in another study|1|||
42060467|NCT00927368|75869505|FG001|Overall Study|enrollment in another study|1|||
42060468|NCT00927368|75869506|FG002|Overall Study|enrollment in another study|2|||
42060469|NCT00927368|75869504|FG000|Overall Study|Lost to Follow-up|4|||
42060470|NCT00927368|75869505|FG001|Overall Study|Lost to Follow-up|0|||
42060471|NCT00927368|75869506|FG002|Overall Study|Lost to Follow-up|0|||
42060472|NCT00927368|75869504|FG000|Overall Study|equipment failure|1|||
42060473|NCT00927368|75869505|FG001|Overall Study|equipment failure|0|||
42060474|NCT00927368|75869506|FG002|Overall Study|equipment failure|0|||
42060475|NCT00927368|75869504|FG000|Overall Study|ineligible post randomization|0|||
42060476|NCT00927368|75869505|FG001|Overall Study|ineligible post randomization|3|||
42060477|NCT00927368|75869506|FG002|Overall Study|ineligible post randomization|1|||
42060478|NCT00927368|75869504|FG000|Overall Study|cancellation of surgery|0|||
42060479|NCT00927368|75869505|FG001|Overall Study|cancellation of surgery|1|||
42060480|NCT00927368|75869506|FG002|Overall Study|cancellation of surgery|2|||
42060481|NCT00662857|75869514|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
42060482|NCT00662857|75869515|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
42060483|NCT00662857|75869514|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
42060484|NCT00662857|75869515|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
42060485|NCT00662857|75869514|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
42060486|NCT00662857|75869515|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
42060487|NCT00878553|75869528|FG000|Sleep Study|Withdrawal by Subject|2|||
42060488|NCT00878553|75869529|FG001|Sleep Study|Withdrawal by Subject|0|||
42060489|NCT00878553|75869530|FG002|Sleep Study|Withdrawal by Subject|0|||
42060490|NCT00878553|75869531|FG003|Sleep Study|Withdrawal by Subject|0|||
42060491|NCT00878553|75869532|FG004|Sleep Study|Withdrawal by Subject|0|||
42060492|NCT00878553|75869528|FG000|Sleep Study|Lost to Follow-up|1|||
42060493|NCT00878553|75869529|FG001|Sleep Study|Lost to Follow-up|0|||
42060494|NCT00878553|75869530|FG002|Sleep Study|Lost to Follow-up|0|||
42060495|NCT00878553|75869531|FG003|Sleep Study|Lost to Follow-up|0|||
42060496|NCT00878553|75869532|FG004|Sleep Study|Lost to Follow-up|0|||
42060497|NCT00878553|75869528|FG000|Sleep Study|car accident|1|||
42060498|NCT00878553|75869529|FG001|Sleep Study|car accident|0|||
42060499|NCT00878553|75869530|FG002|Sleep Study|car accident|0|||
42060500|NCT00878553|75869531|FG003|Sleep Study|car accident|0|||
42060501|NCT00878553|75869532|FG004|Sleep Study|car accident|0|||
42060502|NCT00878553|75869528|FG000|Sleep Study|family emergency|1|||
42060503|NCT00878553|75869529|FG001|Sleep Study|family emergency|0|||
42060504|NCT00878553|75869530|FG002|Sleep Study|family emergency|0|||
42060505|NCT00878553|75869531|FG003|Sleep Study|family emergency|0|||
42060506|NCT00878553|75869532|FG004|Sleep Study|family emergency|0|||
42060507|NCT00878553|75869528|FG000|PK Study|Withdrawal by Subject|0|||
42060508|NCT00878553|75869529|FG001|PK Study|Withdrawal by Subject|0|||
42060509|NCT00878553|75869530|FG002|PK Study|Withdrawal by Subject|0|||
42060510|NCT00878553|75869531|FG003|PK Study|Withdrawal by Subject|1|||
42060511|NCT00878553|75869532|FG004|PK Study|Withdrawal by Subject|0|||
42060512|NCT00996437|75869551|FG000|Overall Study|Death|1|||
42060513|NCT00996437|75869552|FG001|Overall Study|Death|0|||
42060514|NCT00996437|75869551|FG000|Overall Study|Dropped|2|||
42060515|NCT00996437|75869552|FG001|Overall Study|Dropped|2|||
42060516|NCT00996437|75869551|FG000|Overall Study|Missed|2|||
42060517|NCT00996437|75869552|FG001|Overall Study|Missed|5|||
42060518|NCT00662311|75869561|FG000|Overall Study|Respiratory Infection|1|||
42060519|NCT00662311|75869562|FG001|Overall Study|Respiratory Infection|0|||
42060520|NCT00662311|75869563|FG002|Overall Study|Respiratory Infection|0|||
42060521|NCT00929708|75869576|FG000|Overall Study|Protocol Violation|2|||
42060522|NCT00929708|75869577|FG001|Overall Study|Protocol Violation|1|||
42060523|NCT00929708|75869578|FG002|Overall Study|Protocol Violation|1|||
42060524|NCT00929708|75869579|FG003|Overall Study|Protocol Violation|1|||
42060525|NCT00929708|75869580|FG004|Overall Study|Protocol Violation|1|||
42060526|NCT00929708|75869576|FG000|Overall Study|Withdrawal by Subject|2|||
42060527|NCT00929708|75869577|FG001|Overall Study|Withdrawal by Subject|0|||
42060528|NCT00929708|75869578|FG002|Overall Study|Withdrawal by Subject|0|||
42060529|NCT00929708|75869579|FG003|Overall Study|Withdrawal by Subject|2|||
42060530|NCT00929708|75869580|FG004|Overall Study|Withdrawal by Subject|1|||
42060531|NCT00929708|75869576|FG000|Overall Study|Adverse Event|0|||
42060532|NCT00929708|75869577|FG001|Overall Study|Adverse Event|0|||
42060533|NCT00929708|75869578|FG002|Overall Study|Adverse Event|0|||
42060534|NCT00929708|75869579|FG003|Overall Study|Adverse Event|0|||
42060535|NCT00929708|75869580|FG004|Overall Study|Adverse Event|3|||
42060536|NCT00929708|75869576|FG000|Overall Study|Physician Decision|0|||
42060537|NCT00929708|75869577|FG001|Overall Study|Physician Decision|2|||
42060538|NCT00929708|75869578|FG002|Overall Study|Physician Decision|2|||
42060539|NCT00929708|75869579|FG003|Overall Study|Physician Decision|2|||
42060540|NCT00929708|75869580|FG004|Overall Study|Physician Decision|1|||
42060541|NCT00929708|75869576|FG000|Overall Study|Lost to Follow-up|0|||
42060542|NCT00929708|75869577|FG001|Overall Study|Lost to Follow-up|0|||
42060543|NCT00929708|75869578|FG002|Overall Study|Lost to Follow-up|0|||
42060544|NCT00929708|75869579|FG003|Overall Study|Lost to Follow-up|1|||
42060545|NCT00929708|75869580|FG004|Overall Study|Lost to Follow-up|0|||
42060546|NCT00996281|75869594|FG000|Overall Study|Adverse Event|75|||
42060547|NCT00996281|75869595|FG001|Overall Study|Adverse Event|37|||
42060548|NCT00996281|75869594|FG000|Overall Study|Major Protocol Deviation|6|||
42060549|NCT00996281|75869595|FG001|Overall Study|Major Protocol Deviation|7|||
42060550|NCT00996281|75869594|FG000|Overall Study|Lost to Follow-up|14|||
42060551|NCT00996281|75869595|FG001|Overall Study|Lost to Follow-up|16|||
42060552|NCT00996281|75869594|FG000|Overall Study|Withdrawal by Subject|31|||
42060553|NCT00996281|75869595|FG001|Overall Study|Withdrawal by Subject|20|||
42060554|NCT00996281|75869594|FG000|Overall Study|Lack of Efficacy|0|||
42060555|NCT00996281|75869595|FG001|Overall Study|Lack of Efficacy|2|||
42060556|NCT00996281|75869594|FG000|Overall Study|Other|5|||
42060557|NCT00996281|75869595|FG001|Overall Study|Other|7|||
42060558|NCT00996203|75869601|FG000|Overall Study|Adverse Event|3|||
42060559|NCT00996203|75869601|FG000|Overall Study|Lost to Follow-up|1|||
42060560|NCT00996203|75869601|FG000|Overall Study|Lack of Efficacy|1|||
42060561|NCT00996203|75869601|FG000|Overall Study|Protocol Violation|2|||
42060562|NCT00877929|75869608|FG000|Overall Study|Adverse Event|11|||
42060563|NCT00877929|75869609|FG001|Overall Study|Adverse Event|20|||
42060564|NCT00877929|75869608|FG000|Overall Study|Protocol Violation|3|||
42060565|NCT00877929|75869609|FG001|Overall Study|Protocol Violation|3|||
42060566|NCT00877929|75869608|FG000|Overall Study|Lost to Follow-up|0|||
42060567|NCT00877929|75869609|FG001|Overall Study|Lost to Follow-up|1|||
42060568|NCT00877929|75869608|FG000|Overall Study|Withdrawal by Subject|4|||
42060569|NCT00877929|75869609|FG001|Overall Study|Withdrawal by Subject|4|||
42060570|NCT00877929|75869608|FG000|Overall Study|Lack of Efficacy|0|||
42060571|NCT00877929|75869609|FG001|Overall Study|Lack of Efficacy|1|||
42060572|NCT00877929|75869608|FG000|Overall Study|Other reason (not specified)|2|||
42060573|NCT00877929|75869609|FG001|Overall Study|Other reason (not specified)|6|||
42060574|NCT00931268|75869619|FG000|Overall Study|Lost to Follow-up|6|||
42060575|NCT00996125|75869625|FG000|Overall Study|Adverse Event|0|||
42060576|NCT00996125|75869626|FG001|Overall Study|Adverse Event|2|||
42060577|NCT00996125|75869625|FG000|Overall Study|Lost to Follow-up|1|||
42060578|NCT00996125|75869626|FG001|Overall Study|Lost to Follow-up|6|||
42060579|NCT00996125|75869625|FG000|Overall Study|Withdrawal by Subject|4|||
42060580|NCT00996125|75869626|FG001|Overall Study|Withdrawal by Subject|3|||
42060581|NCT04211363|75869634|FG000|Overall Study|Adverse Event|5|||
42060582|NCT04211363|75869635|FG001|Overall Study|Adverse Event|2|||
42060583|NCT04211363|75869634|FG000|Overall Study|Physician Decision|0|||
42060584|NCT04211363|75869635|FG001|Overall Study|Physician Decision|1|||
42060585|NCT04211363|75869634|FG000|Overall Study|Protocol Violation|1|||
42060586|NCT04211363|75869635|FG001|Overall Study|Protocol Violation|0|||
42060587|NCT04211363|75869634|FG000|Overall Study|Pregnancy|1|||
42060588|NCT04211363|75869635|FG001|Overall Study|Pregnancy|0|||
42060589|NCT04211363|75869634|FG000|Overall Study|Lost to Follow-up|12|||
42060590|NCT04211363|75869635|FG001|Overall Study|Lost to Follow-up|4|||
42060591|NCT04211363|75869634|FG000|Overall Study|Withdrawal by Subject|11|||
42060592|NCT04211363|75869635|FG001|Overall Study|Withdrawal by Subject|11|||
42060593|NCT04211363|75869634|FG000|Overall Study|Other|1|||
42060594|NCT04211363|75869635|FG001|Overall Study|Other|2|||
42060595|NCT00995345|75869646|FG000|Overall Study|Withdrawal by Subject|4|||
42060596|NCT00995345|75869647|FG001|Overall Study|Withdrawal by Subject|2|||
42060597|NCT00995345|75869648|FG002|Overall Study|Withdrawal by Subject|1|||
42060598|NCT00995345|75869649|FG003|Overall Study|Withdrawal by Subject|3|||
42060599|NCT00995345|75869650|FG004|Overall Study|Withdrawal by Subject|1|||
42060600|NCT00995345|75869646|FG000|Overall Study|Adverse Event|3|||
42060601|NCT00995345|75869647|FG001|Overall Study|Adverse Event|1|||
42060602|NCT00995345|75869648|FG002|Overall Study|Adverse Event|2|||
42060603|NCT00995345|75869649|FG003|Overall Study|Adverse Event|0|||
42060604|NCT00995345|75869650|FG004|Overall Study|Adverse Event|1|||
42060605|NCT00995345|75869646|FG000|Overall Study|Lost to Follow-up|2|||
42060606|NCT00995345|75869647|FG001|Overall Study|Lost to Follow-up|2|||
42060607|NCT00995345|75869648|FG002|Overall Study|Lost to Follow-up|2|||
42060608|NCT00995345|75869649|FG003|Overall Study|Lost to Follow-up|1|||
42060609|NCT00995345|75869650|FG004|Overall Study|Lost to Follow-up|0|||
42060610|NCT00995345|75869646|FG000|Overall Study|all other reasons combined|2|||
42060611|NCT00995345|75869647|FG001|Overall Study|all other reasons combined|2|||
42060612|NCT00995345|75869648|FG002|Overall Study|all other reasons combined|2|||
42060613|NCT00995345|75869649|FG003|Overall Study|all other reasons combined|1|||
42060614|NCT00995345|75869650|FG004|Overall Study|all other reasons combined|3|||
42060615|NCT00660907|75869664|FG000|Overall Study|Incorrect Enrollment|1|||
42060616|NCT00660907|75869665|FG001|Overall Study|Incorrect Enrollment|1|||
42060617|NCT00660907|75869664|FG000|Overall Study|Adverse Event|33|||
42060618|NCT00660907|75869665|FG001|Overall Study|Adverse Event|19|||
42060619|NCT00660907|75869664|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
42060620|NCT00660907|75869665|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
42060621|NCT00660907|75869664|FG000|Overall Study|Withdrawal by Subject|23|||
42060622|NCT00660907|75869665|FG001|Overall Study|Withdrawal by Subject|32|||
42060623|NCT00660907|75869664|FG000|Overall Study|Lost to Follow-up|3|||
42060624|NCT00660907|75869665|FG001|Overall Study|Lost to Follow-up|3|||
42060625|NCT00660907|75869664|FG000|Overall Study|Poor/Non-Compliance|5|||
42060626|NCT00660907|75869665|FG001|Overall Study|Poor/Non-Compliance|1|||
42060627|NCT00660907|75869664|FG000|Overall Study|Safety|1|||
42060628|NCT00660907|75869665|FG001|Overall Study|Safety|0|||
42060629|NCT00660907|75869664|FG000|Overall Study|Death|1|||
42060630|NCT00660907|75869665|FG001|Overall Study|Death|3|||
42060631|NCT00660907|75869664|FG000|Overall Study|Various|11|||
42060632|NCT00660907|75869665|FG001|Overall Study|Various|8|||
42060633|NCT00877773|75869671|FG000|Overall Study|Disease Progression|44|||
42060634|NCT00659815|75869677|FG000|Overall Study|Study related symptoms and complaints|2|||
42357241|NCT01725308|76202604|FG001|Treatment Period I|Did Not Receive Drug|0|||
42357242|NCT01725308|76202605|FG002|Treatment Period I|Did Not Receive Drug|0|||
42060635|NCT00659815|75869678|FG001|Overall Study|Study related symptoms and complaints|1|||
42060636|NCT00659815|75869677|FG000|Overall Study|Inability to maintain wearing schedule|1|||
42060637|NCT00659815|75869678|FG001|Overall Study|Inability to maintain wearing schedule|2|||
42060638|NCT00659815|75869677|FG000|Overall Study|Withdrawal by Subject|1|||
42060639|NCT00659815|75869678|FG001|Overall Study|Withdrawal by Subject|1|||
42060640|NCT00994643|75869684|FG000|Overall Study|Withdrawal by Subject|1|||
42060641|NCT00660829|75869690|FG000|Overall Study|Adverse Event|3|||
42060642|NCT00660829|75869691|FG001|Overall Study|Adverse Event|4|||
42060643|NCT00660829|75869690|FG000|Overall Study|Lack of Efficacy|2|||
42060644|NCT00660829|75869691|FG001|Overall Study|Lack of Efficacy|3|||
42060645|NCT00660829|75869690|FG000|Overall Study|Non-Compliance|0|||
42060646|NCT00660829|75869691|FG001|Overall Study|Non-Compliance|4|||
42060647|NCT00660829|75869690|FG000|Overall Study|Withdrawal by Subject|1|||
42060648|NCT00660829|75869691|FG001|Overall Study|Withdrawal by Subject|2|||
42060649|NCT00660829|75869690|FG000|Overall Study|Lost to Follow-up|3|||
42060650|NCT00660829|75869691|FG001|Overall Study|Lost to Follow-up|2|||
42060651|NCT00660829|75869690|FG000|Overall Study|Other|9|||
42060652|NCT00660829|75869691|FG001|Overall Study|Other|4|||
42060653|NCT00877383|75869699|FG000|Overall Study|Adverse Event|13|||
42060654|NCT00877383|75869700|FG001|Overall Study|Adverse Event|14|||
42060655|NCT00877383|75869699|FG000|Overall Study|Lost to Follow-up|5|||
42060656|NCT00877383|75869700|FG001|Overall Study|Lost to Follow-up|3|||
42357243|NCT01725308|76202603|FG000|Treatment Period I|Adverse Event|5|||
42060657|NCT00877383|75869699|FG000|Overall Study|Subject withdrew consent|3|||
42060658|NCT00877383|75869700|FG001|Overall Study|Subject withdrew consent|12|||
42060659|NCT00877383|75869699|FG000|Overall Study|Subject no longer requires study drug|2|||
42060660|NCT00877383|75869700|FG001|Overall Study|Subject no longer requires study drug|0|||
42357244|NCT01725308|76202604|FG001|Treatment Period I|Adverse Event|4|||
42060661|NCT00877383|75869699|FG000|Overall Study|Administrative problems|2|||
42060662|NCT00877383|75869700|FG001|Overall Study|Administrative problems|0|||
42060663|NCT00877383|75869699|FG000|Overall Study|Protocol deviation|2|||
42060664|NCT00877383|75869700|FG001|Overall Study|Protocol deviation|6|||
42060665|NCT00877383|75869699|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42060666|NCT00877383|75869700|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42060667|NCT00877383|75869699|FG000|Overall Study|Death|1|||
42060668|NCT00877383|75869700|FG001|Overall Study|Death|2|||
42060669|NCT00993473|75869708|FG000|Overall Study|Adverse Event|0|||
42060670|NCT00993473|75869709|FG001|Overall Study|Adverse Event|2|||
42060671|NCT00993473|75869708|FG000|Overall Study|Protocol Violation|1|||
42060672|NCT00993473|75869709|FG001|Overall Study|Protocol Violation|2|||
42060673|NCT00993473|75869708|FG000|Overall Study|Lost to Follow-up|1|||
42060674|NCT00993473|75869709|FG001|Overall Study|Lost to Follow-up|0|||
42060675|NCT00993473|75869708|FG000|Overall Study|Withdrawal by Subject|1|||
42060676|NCT00993473|75869709|FG001|Overall Study|Withdrawal by Subject|5|||
42060677|NCT00993473|75869708|FG000|Overall Study|Technical problem with CGM device|0|||
42060678|NCT00993473|75869709|FG001|Overall Study|Technical problem with CGM device|1|||
42060679|NCT00993473|75869708|FG000|Overall Study|Family event|1|||
42060680|NCT00993473|75869709|FG001|Overall Study|Family event|0|||
42174425|NCT00312221|75981175|FG000|Double-blind Phase|Lost to Follow-up|0|||
42174426|NCT00312221|75981176|FG001|Double-blind Phase|Lost to Follow-up|0|||
42291905|NCT01939366|76125384|FG004|Overall Study|Lack of Efficacy|3|||
42060681|NCT00660595|75869717|FG000|Overall Study|Lost to Follow-up|0|||
42060682|NCT00660595|75869718|FG001|Overall Study|Lost to Follow-up|1|||
42060683|NCT00660595|75869717|FG000|Overall Study|Did not consent to participate in study|12|||
42060684|NCT00660595|75869718|FG001|Overall Study|Did not consent to participate in study|8|||
42060685|NCT00660595|75869717|FG000|Overall Study|Participant left hospital|1|||
42060686|NCT00660595|75869718|FG001|Overall Study|Participant left hospital|0|||
42060687|NCT00660595|75869717|FG000|Overall Study|Non Specified reasons|5|||
42060688|NCT00660595|75869718|FG001|Overall Study|Non Specified reasons|0|||
42060689|NCT00929240|75869724|FG000|Initial Treatment Phase|Adverse Event|31|||
42060690|NCT00929240|75869725|FG001|Initial Treatment Phase|Adverse Event|0|||
42060691|NCT00929240|75869726|FG002|Initial Treatment Phase|Adverse Event|0|||
42060692|NCT00929240|75869724|FG000|Initial Treatment Phase|Disease progression|41|||
42060693|NCT00929240|75869725|FG001|Initial Treatment Phase|Disease progression|0|||
42060694|NCT00929240|75869726|FG002|Initial Treatment Phase|Disease progression|0|||
42060695|NCT00929240|75869724|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
42060696|NCT00929240|75869725|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
42060697|NCT00929240|75869726|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
42060698|NCT00929240|75869724|FG000|Initial Treatment Phase|Protocol Violation|5|||
42060699|NCT00929240|75869725|FG001|Initial Treatment Phase|Protocol Violation|0|||
42060700|NCT00929240|75869726|FG002|Initial Treatment Phase|Protocol Violation|0|||
42060701|NCT00929240|75869724|FG000|Initial Treatment Phase|Death|2|||
42060702|NCT00929240|75869725|FG001|Initial Treatment Phase|Death|0|||
42060703|NCT00929240|75869726|FG002|Initial Treatment Phase|Death|0|||
42060704|NCT00929240|75869724|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
42060705|NCT00929240|75869725|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
42060706|NCT00929240|75869726|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
42060707|NCT00929240|75869724|FG000|Initial Treatment Phase|Physician Decision|4|||
42060708|NCT00929240|75869725|FG001|Initial Treatment Phase|Physician Decision|0|||
42060709|NCT00929240|75869726|FG002|Initial Treatment Phase|Physician Decision|0|||
42060710|NCT00929240|75869724|FG000|Maintenance Phase|Disease progression|0|||
42060711|NCT00929240|75869725|FG001|Maintenance Phase|Disease progression|73|||
42060712|NCT00929240|75869726|FG002|Maintenance Phase|Disease progression|60|||
42060713|NCT00929240|75869724|FG000|Maintenance Phase|Adverse Event|0|||
42174427|NCT00312221|75981177|FG002|Double-blind Phase|Lost to Follow-up|2|||
42174428|NCT00312221|75981178|FG003|Double-blind Phase|Lost to Follow-up|2|||
42174429|NCT00312221|75981175|FG000|Double-blind Phase|Administrative|0|||
42291906|NCT01939366|76125380|FG000|Overall Study|Lost to Follow-up|1|||
42291907|NCT01939366|76125381|FG001|Overall Study|Lost to Follow-up|1|||
42291908|NCT01939366|76125382|FG002|Overall Study|Lost to Follow-up|0|||
42060714|NCT00929240|75869725|FG001|Maintenance Phase|Adverse Event|9|||
42060715|NCT00929240|75869726|FG002|Maintenance Phase|Adverse Event|12|||
42060716|NCT00929240|75869724|FG000|Maintenance Phase|Withdrawal by Subject|0|||
42060717|NCT00929240|75869725|FG001|Maintenance Phase|Withdrawal by Subject|2|||
42174430|NCT00312221|75981176|FG001|Double-blind Phase|Administrative|26|||
42174431|NCT00312221|75981177|FG002|Double-blind Phase|Administrative|37|||
42291909|NCT01939366|76125383|FG003|Overall Study|Lost to Follow-up|0|||
42060718|NCT00929240|75869726|FG002|Maintenance Phase|Withdrawal by Subject|6|||
42060719|NCT00929240|75869724|FG000|Maintenance Phase|Protocol Violation|0|||
42060720|NCT00929240|75869725|FG001|Maintenance Phase|Protocol Violation|1|||
42060721|NCT00929240|75869726|FG002|Maintenance Phase|Protocol Violation|0|||
42060722|NCT00929240|75869724|FG000|Maintenance Phase|Health authority/Study termination|0|||
42060723|NCT00929240|75869725|FG001|Maintenance Phase|Health authority/Study termination|1|||
42060724|NCT00929240|75869726|FG002|Maintenance Phase|Health authority/Study termination|2|||
42060725|NCT00929240|75869724|FG000|Maintenance Phase|Physician Decision|0|||
42060726|NCT00929240|75869725|FG001|Maintenance Phase|Physician Decision|2|||
42060727|NCT00929240|75869726|FG002|Maintenance Phase|Physician Decision|1|||
42060728|NCT00929240|75869724|FG000|Maintenance Phase|Change of treatment|0|||
42060729|NCT00929240|75869725|FG001|Maintenance Phase|Change of treatment|4|||
42060730|NCT00929240|75869726|FG002|Maintenance Phase|Change of treatment|0|||
42060731|NCT00929240|75869724|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
42060732|NCT00929240|75869725|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
42060733|NCT00929240|75869726|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
42060734|NCT00929240|75869724|FG000|Maintenance Phase|Participant not treated|0|||
42060735|NCT00929240|75869725|FG001|Maintenance Phase|Participant not treated|2|||
42060736|NCT00929240|75869726|FG002|Maintenance Phase|Participant not treated|0|||
42060737|NCT00993317|75869737|FG000|Overall Study|Adverse Event|2|||
42060738|NCT00993317|75869738|FG001|Overall Study|Adverse Event|4|||
42060739|NCT00993317|75869737|FG000|Overall Study|Lack of Efficacy|18|||
42060740|NCT00993317|75869738|FG001|Overall Study|Lack of Efficacy|18|||
42060741|NCT00993317|75869737|FG000|Overall Study|Withdrawal by Subject|0|||
42060742|NCT00993317|75869738|FG001|Overall Study|Withdrawal by Subject|2|||
42060743|NCT00993317|75869737|FG000|Overall Study|Investigator's opinion|0|||
42060744|NCT00993317|75869738|FG001|Overall Study|Investigator's opinion|1|||
42060745|NCT00993317|75869737|FG000|Overall Study|Early study termination at the site|1|||
42060746|NCT00993317|75869738|FG001|Overall Study|Early study termination at the site|0|||
42060747|NCT01030133|75869746|FG000|Overall Study|failed to experience pain at level 7/10|2|||
42060748|NCT01030133|75869747|FG001|Overall Study|failed to experience pain at level 7/10|2|||
42060749|NCT00877071|75869757|FG000|Overall Study|disease progression|2|||
42060750|NCT00987389|75869763|FG000|Overall Study|Ineligible|0|||
42060751|NCT00987389|75869764|FG001|Overall Study|Ineligible|3|||
42060752|NCT00987389|75869765|FG002|Overall Study|Ineligible|0|||
42060753|NCT00987389|75869766|FG003|Overall Study|Ineligible|0|||
42060754|NCT00987389|75869763|FG000|Overall Study|Lost to Follow-up|4|||
42060755|NCT00987389|75869764|FG001|Overall Study|Lost to Follow-up|1|||
42060756|NCT00987389|75869765|FG002|Overall Study|Lost to Follow-up|3|||
42060757|NCT00987389|75869766|FG003|Overall Study|Lost to Follow-up|1|||
42060758|NCT00987389|75869763|FG000|Overall Study|Withdrawal by Subject|4|||
42060759|NCT00987389|75869764|FG001|Overall Study|Withdrawal by Subject|3|||
42060760|NCT00987389|75869765|FG002|Overall Study|Withdrawal by Subject|2|||
42060761|NCT00987389|75869766|FG003|Overall Study|Withdrawal by Subject|1|||
42060762|NCT00987389|75869763|FG000|Overall Study|Withdrawn from Treatment|0|||
42060763|NCT00987389|75869764|FG001|Overall Study|Withdrawn from Treatment|1|||
42060764|NCT00987389|75869765|FG002|Overall Study|Withdrawn from Treatment|0|||
42060765|NCT00987389|75869766|FG003|Overall Study|Withdrawn from Treatment|0|||
42060766|NCT00987389|75869763|FG000|Overall Study|Multiple different reasons|1|||
42060767|NCT00987389|75869764|FG001|Overall Study|Multiple different reasons|0|||
42060768|NCT00987389|75869765|FG002|Overall Study|Multiple different reasons|3|||
42060769|NCT00987389|75869766|FG003|Overall Study|Multiple different reasons|1|||
42060770|NCT00929162|75869776|FG000|Overall Study|Adverse Event|8|||
42060771|NCT00929162|75869777|FG001|Overall Study|Adverse Event|5|||
42060772|NCT00929162|75869776|FG000|Overall Study|Withdrawal by Subject|3|||
42060773|NCT00929162|75869777|FG001|Overall Study|Withdrawal by Subject|1|||
42060774|NCT00929162|75869776|FG000|Overall Study|Protocol Violation|32|||
42060775|NCT00929162|75869777|FG001|Overall Study|Protocol Violation|30|||
42060776|NCT00929162|75869776|FG000|Overall Study|Other termination reason|5|||
42060777|NCT00929162|75869777|FG001|Overall Study|Other termination reason|6|||
42060778|NCT00992459|75869785|FG000|Overall Study|Withdrawal by Subject|0|||
42060779|NCT00992459|75869786|FG001|Overall Study|Withdrawal by Subject|1|||
42060780|NCT00992459|75869785|FG000|Overall Study|Adverse Event|1|||
42060781|NCT00992459|75869786|FG001|Overall Study|Adverse Event|0|||
42060782|NCT00930722|75869792|FG000|Overall Study|Lost to Follow-up|16|||
42060783|NCT00930722|75869792|FG000|Overall Study|No longer willing to participate|9|||
42060784|NCT00930722|75869792|FG000|Overall Study|Study terminated by sponsor|2|||
42060785|NCT00992225|75869796|FG000|Overall Study|Entry Criteria Not Met|8|||
42060786|NCT00992225|75869796|FG000|Overall Study|Adverse Event|2|||
42291910|NCT01939366|76125384|FG004|Overall Study|Lost to Follow-up|0|||
42291911|NCT01939366|76125380|FG000|Overall Study|Withdrawal by Subject|1|||
42060787|NCT00659581|75869800|FG000|Overall Study|Adverse Event|1006|||
42060788|NCT00659581|75869800|FG000|Overall Study|Lack of Efficacy|1183|||
42060789|NCT00659581|75869800|FG000|Overall Study|Other|6393|||
42060790|NCT00991289|75869804|FG000|Overall Study|Adverse Event|1|||
42060791|NCT00991289|75869804|FG000|Overall Study|Physician Decision|2|||
42060792|NCT00991289|75869804|FG000|Overall Study|Withdrawal by Subject|3|||
42060793|NCT00991289|75869804|FG000|Overall Study|Lost to Follow-up|4|||
42060794|NCT00991289|75869804|FG000|Overall Study|Protocol Violation|2|||
42060795|NCT00930644|75869808|FG000|Overall Study|Withdrawal by Subject|4|||
42060796|NCT00930644|75869808|FG000|Overall Study|Physician Decision|2|||
42060797|NCT00930644|75869808|FG000|Overall Study|Death|1|||
42060798|NCT00930644|75869808|FG000|Overall Study|Adverse Event|16|||
42060799|NCT00990821|75869829|FG000|Overall Study|Withdrawal by Subject|0|||
42060800|NCT00990821|75869830|FG001|Overall Study|Withdrawal by Subject|2|||
42060801|NCT00990821|75869831|FG002|Overall Study|Withdrawal by Subject|0|||
42060802|NCT00990821|75869832|FG003|Overall Study|Withdrawal by Subject|0|||
42060803|NCT00990821|75869833|FG004|Overall Study|Withdrawal by Subject|3|||
42060804|NCT00990821|75869834|FG005|Overall Study|Withdrawal by Subject|3|||
42174432|NCT00312221|75981178|FG003|Double-blind Phase|Administrative|33|||
42174433|NCT00312221|75981175|FG000|Double-blind Phase|Lack of Efficacy|0|||
42174434|NCT00312221|75981176|FG001|Double-blind Phase|Lack of Efficacy|17|||
42174435|NCT00312221|75981177|FG002|Double-blind Phase|Lack of Efficacy|6|||
42174436|NCT00312221|75981178|FG003|Double-blind Phase|Lack of Efficacy|10|||
42174437|NCT03294538|75981202|FG000|Overall Study|Adverse Event|0|||
42174438|NCT03294538|75981203|FG001|Overall Study|Adverse Event|1|||
42174439|NCT03294538|75981204|FG002|Overall Study|Adverse Event|1|||
42174440|NCT03294538|75981202|FG000|Overall Study|Lost to Follow-up|1|||
42174441|NCT03294538|75981203|FG001|Overall Study|Lost to Follow-up|0|||
42174442|NCT03294538|75981204|FG002|Overall Study|Lost to Follow-up|0|||
42174443|NCT03294538|75981202|FG000|Overall Study|Outside of Visit Window|4|||
42174444|NCT03294538|75981203|FG001|Overall Study|Outside of Visit Window|4|||
42174445|NCT03294538|75981204|FG002|Overall Study|Outside of Visit Window|1|||
42174446|NCT03265600|75981214|FG000|Overall Study|Lost to Follow-up|17|||
42174447|NCT03265600|75981215|FG001|Overall Study|Lost to Follow-up|5|||
42174448|NCT03265600|75981214|FG000|Overall Study|Withdrawal by Subject|4|||
42174449|NCT03265600|75981215|FG001|Overall Study|Withdrawal by Subject|2|||
42174450|NCT03265600|75981214|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
42174451|NCT03265600|75981215|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
42174452|NCT00335153|75981221|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
42174453|NCT00335153|75981221|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
42174454|NCT00335153|75981221|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
42174455|NCT00335153|75981221|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
42174456|NCT00335153|75981221|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
42174457|NCT00335153|75981221|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
42174458|NCT00335153|75981221|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
42174459|NCT00335153|75981221|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
42174460|NCT00335153|75981221|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
42174461|NCT00335153|75981221|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
42174462|NCT03265132|75981227|FG000|Overall Study|Adverse Event|0|||
42174463|NCT03265132|75981228|FG001|Overall Study|Adverse Event|1|||
42174464|NCT03265132|75981227|FG000|Overall Study|Lack of Efficacy|0|||
42174465|NCT03265132|75981228|FG001|Overall Study|Lack of Efficacy|2|||
42174466|NCT03265132|75981227|FG000|Overall Study|Progressive disease|0|||
42174467|NCT03265132|75981228|FG001|Overall Study|Progressive disease|2|||
42174468|NCT03265132|75981227|FG000|Overall Study|Withdrawal by Subject|0|||
42174469|NCT03265132|75981228|FG001|Overall Study|Withdrawal by Subject|1|||
42174470|NCT02939950|75981238|FG000|Overall Study|Lost to Follow-up|13|||
42174471|NCT02939950|75981239|FG001|Overall Study|Lost to Follow-up|16|||
42174472|NCT02939950|75981238|FG000|Overall Study|Positive slit lamp findings|0|||
42174473|NCT02939950|75981239|FG001|Overall Study|Positive slit lamp findings|1|||
42174474|NCT02939950|75981238|FG000|Overall Study|Chalazion upper lid|0|||
42174475|NCT02939950|75981239|FG001|Overall Study|Chalazion upper lid|1|||
42174476|NCT02939950|75981238|FG000|Overall Study|Lack of motivation|0|||
42174477|NCT02939950|75981239|FG001|Overall Study|Lack of motivation|2|||
42174478|NCT02939950|75981238|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
42174479|NCT02939950|75981239|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
42174480|NCT02939950|75981238|FG000|Overall Study|Military orders|1|||
42174481|NCT02939950|75981239|FG001|Overall Study|Military orders|0|||
42174482|NCT02939950|75981238|FG000|Overall Study|Participant Relocated|5|||
42174483|NCT02939950|75981239|FG001|Overall Study|Participant Relocated|3|||
42174484|NCT02939950|75981238|FG000|Overall Study|Study related symptoms|8|||
42174485|NCT02939950|75981239|FG001|Overall Study|Study related symptoms|8|||
42174486|NCT02939950|75981238|FG000|Overall Study|Unacceptable lens movement|2|||
42174487|NCT02939950|75981239|FG001|Overall Study|Unacceptable lens movement|0|||
42174488|NCT02939950|75981238|FG000|Overall Study|Protocol Violation|6|||
42174489|NCT02939950|75981239|FG001|Overall Study|Protocol Violation|3|||
42174490|NCT02939950|75981238|FG000|Overall Study|Physician Decision|2|||
42174491|NCT02939950|75981239|FG001|Overall Study|Physician Decision|0|||
42174492|NCT02939950|75981238|FG000|Overall Study|Pregnancy|6|||
42174493|NCT02939950|75981239|FG001|Overall Study|Pregnancy|7|||
42174494|NCT02939950|75981238|FG000|Overall Study|Withdrawal by Subject|12|||
42174495|NCT02939950|75981239|FG001|Overall Study|Withdrawal by Subject|28|||
42174496|NCT02939950|75981238|FG000|Overall Study|Adverse Event|7|||
42174497|NCT02939950|75981239|FG001|Overall Study|Adverse Event|3|||
42060805|NCT00990821|75869835|FG006|Overall Study|Withdrawal by Subject|1|||
42060806|NCT00990821|75869836|FG007|Overall Study|Withdrawal by Subject|0|||
42060807|NCT00990821|75869837|FG008|Overall Study|Withdrawal by Subject|0|||
42060808|NCT00990821|75869838|FG009|Overall Study|Withdrawal by Subject|1|||
42060809|NCT00990821|75869839|FG010|Overall Study|Withdrawal by Subject|3|||
42060810|NCT00990821|75869840|FG011|Overall Study|Withdrawal by Subject|5|||
42060811|NCT00990821|75869841|FG012|Overall Study|Withdrawal by Subject|2|||
42060812|NCT00990821|75869842|FG013|Overall Study|Withdrawal by Subject|1|||
42060813|NCT00990665|75869859|FG000|Overall Study|Unsuccessful Implant|8|||
42060814|NCT00990665|75869859|FG000|Overall Study|Death|29|||
42060815|NCT00990665|75869859|FG000|Overall Study|Heart Transplant|1|||
42060816|NCT00990665|75869859|FG000|Overall Study|Withdrawal by Subject|6|||
42060817|NCT00990665|75869859|FG000|Overall Study|Lost to Follow-up|1|||
42060818|NCT00990665|75869859|FG000|Overall Study|System Explant|3|||
42060819|NCT00658567|75869868|FG000|Overall Study|Adverse Event|5|||
42060820|NCT00658567|75869869|FG001|Overall Study|Adverse Event|2|||
42060821|NCT00658567|75869870|FG002|Overall Study|Adverse Event|3|||
42060822|NCT00658567|75869868|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
42060823|NCT00658567|75869869|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
42060824|NCT00658567|75869870|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
42060825|NCT00658567|75869868|FG000|Overall Study|Physician Decision|0|||
42060826|NCT00658567|75869869|FG001|Overall Study|Physician Decision|1|||
42060827|NCT00658567|75869870|FG002|Overall Study|Physician Decision|0|||
42060828|NCT00658567|75869868|FG000|Overall Study|At Discretion of Sponsor|1|||
42060829|NCT00658567|75869869|FG001|Overall Study|At Discretion of Sponsor|1|||
42060830|NCT00658567|75869870|FG002|Overall Study|At Discretion of Sponsor|1|||
42060831|NCT00875433|75869878|FG000|Overall Study|Progressive disease|41|||
42060832|NCT00875433|75869878|FG000|Overall Study|Other Adverse Event|14|||
42060833|NCT00875433|75869878|FG000|Overall Study|Withdrawal by Subject|2|||
42060834|NCT00875433|75869878|FG000|Overall Study|Other|3|||
42060835|NCT00985985|75869886|FG000|Overall Study|Adverse Event|4|||
42060836|NCT00985985|75869887|FG001|Overall Study|Adverse Event|2|||
42060837|NCT00985985|75869888|FG002|Overall Study|Adverse Event|2|||
42060838|NCT00985985|75869889|FG003|Overall Study|Adverse Event|2|||
42060839|NCT00985985|75869886|FG000|Overall Study|Lost to Follow-up|4|||
42060840|NCT00985985|75869887|FG001|Overall Study|Lost to Follow-up|11|||
42060841|NCT00985985|75869888|FG002|Overall Study|Lost to Follow-up|2|||
42060842|NCT00985985|75869889|FG003|Overall Study|Lost to Follow-up|3|||
42060843|NCT00985985|75869886|FG000|Overall Study|Protocol Violation|1|||
42060844|NCT00985985|75869887|FG001|Overall Study|Protocol Violation|2|||
42060845|NCT00985985|75869888|FG002|Overall Study|Protocol Violation|0|||
42060846|NCT00985985|75869889|FG003|Overall Study|Protocol Violation|1|||
42060847|NCT00985985|75869886|FG000|Overall Study|Lack of Efficacy|5|||
42060848|NCT00985985|75869887|FG001|Overall Study|Lack of Efficacy|6|||
42060849|NCT00985985|75869888|FG002|Overall Study|Lack of Efficacy|1|||
42060850|NCT00985985|75869889|FG003|Overall Study|Lack of Efficacy|3|||
42060851|NCT00985985|75869886|FG000|Overall Study|Withdrawal by Subject|4|||
42060852|NCT00985985|75869887|FG001|Overall Study|Withdrawal by Subject|2|||
42060853|NCT00985985|75869888|FG002|Overall Study|Withdrawal by Subject|2|||
42060854|NCT00985985|75869889|FG003|Overall Study|Withdrawal by Subject|2|||
42060855|NCT00985985|75869886|FG000|Overall Study|Other Reason|6|||
42060856|NCT00985985|75869887|FG001|Overall Study|Other Reason|1|||
42060857|NCT00985985|75869888|FG002|Overall Study|Other Reason|4|||
42060858|NCT00985985|75869889|FG003|Overall Study|Other Reason|2|||
42060859|NCT00923936|75869906|FG000|Overall Study|progressive disease on study|2|||
42060860|NCT00923936|75869907|FG001|Overall Study|progressive disease on study|1|||
42060861|NCT00923936|75869906|FG000|Overall Study|Adverse Event|2|||
42060862|NCT00923936|75869907|FG001|Overall Study|Adverse Event|1|||
42060863|NCT00923936|75869906|FG000|Overall Study|Lost to follow up|2|||
42060864|NCT00923936|75869907|FG001|Overall Study|Lost to follow up|0|||
42291912|NCT01939366|76125381|FG001|Overall Study|Withdrawal by Subject|0|||
42291913|NCT01939366|76125382|FG002|Overall Study|Withdrawal by Subject|2|||
42291914|NCT01939366|76125383|FG003|Overall Study|Withdrawal by Subject|2|||
42060865|NCT00923936|75869906|FG000|Overall Study|Continuing in follow up period|2|||
42060866|NCT00923936|75869907|FG001|Overall Study|Continuing in follow up period|1|||
42060867|NCT00924950|75869915|FG000|Overall Study|Lost to Follow-up|2|||
42060868|NCT00988637|75869924|FG000|Overall Study|Lost to Follow-up|2|||
42060869|NCT00988637|75869925|FG001|Overall Study|Lost to Follow-up|1|||
42060870|NCT00988637|75869924|FG000|Overall Study|Withdrawal by Subject|1|||
42060871|NCT00988637|75869925|FG001|Overall Study|Withdrawal by Subject|1|||
42060872|NCT00988637|75869924|FG000|Overall Study|non-compliance with study drug|0|||
42060873|NCT00988637|75869925|FG001|Overall Study|non-compliance with study drug|1|||
42060874|NCT00923156|75869934|FG000|Overall Study|Adverse Event|0|||
42060875|NCT00923156|75869935|FG001|Overall Study|Adverse Event|2|||
42060876|NCT00923156|75869936|FG002|Overall Study|Adverse Event|1|||
42060877|NCT00923156|75869934|FG000|Overall Study|Abnormal laboratory values|0|||
42060878|NCT00923156|75869935|FG001|Overall Study|Abnormal laboratory values|0|||
42060879|NCT00923156|75869936|FG002|Overall Study|Abnormal laboratory values|1|||
42060880|NCT00923156|75869934|FG000|Overall Study|Withdrawal by Subject|0|||
42060881|NCT00923156|75869935|FG001|Overall Study|Withdrawal by Subject|1|||
42060882|NCT00923156|75869936|FG002|Overall Study|Withdrawal by Subject|0|||
42060883|NCT00923156|75869934|FG000|Overall Study|Death|0|||
42060884|NCT00923156|75869935|FG001|Overall Study|Death|1|||
42060885|NCT00923156|75869936|FG002|Overall Study|Death|0|||
42060886|NCT00923156|75869934|FG000|Overall Study|Lack of Efficacy|0|||
42060887|NCT00923156|75869935|FG001|Overall Study|Lack of Efficacy|0|||
42060888|NCT00923156|75869936|FG002|Overall Study|Lack of Efficacy|1|||
42060889|NCT00874731|75869944|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
42060890|NCT00874731|75869945|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
42060891|NCT00874731|75869946|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
42060892|NCT00874731|75869944|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
42060893|NCT00874731|75869945|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
42060894|NCT00874731|75869946|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
42060895|NCT00874731|75869944|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
42060896|NCT00874731|75869945|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
42060897|NCT00874731|75869946|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
42060898|NCT00924638|75869956|FG000|Overall Study|Death|3|||
42060899|NCT00924638|75869957|FG001|Overall Study|Death|2|||
42060900|NCT00924638|75869956|FG000|Overall Study|Lost to Follow-up|1|||
42060901|NCT00924638|75869957|FG001|Overall Study|Lost to Follow-up|1|||
42060902|NCT00924638|75869956|FG000|Overall Study|Withdrawal by Subject|5|||
42060903|NCT00924638|75869957|FG001|Overall Study|Withdrawal by Subject|7|||
42060904|NCT00924638|75869956|FG000|Overall Study|Physician Decision|3|||
42060905|NCT00924638|75869957|FG001|Overall Study|Physician Decision|3|||
42060906|NCT00874497|75869965|FG000|Overall Study|Lost to Follow-up|2|||
42060907|NCT00874497|75869966|FG001|Overall Study|Lost to Follow-up|4|||
42060908|NCT00874497|75869965|FG000|Overall Study|Adverse Event|9|||
42060909|NCT00874497|75869966|FG001|Overall Study|Adverse Event|4|||
42060910|NCT00874497|75869965|FG000|Overall Study|Sponsor Discontinued Trial|7|||
42060911|NCT00874497|75869966|FG001|Overall Study|Sponsor Discontinued Trial|3|||
42060912|NCT00874497|75869965|FG000|Overall Study|Met Withdrawal Criteria|4|||
42060913|NCT00874497|75869966|FG001|Overall Study|Met Withdrawal Criteria|2|||
42060914|NCT00874497|75869965|FG000|Overall Study|Physician Decision|1|||
42060915|NCT00874497|75869966|FG001|Overall Study|Physician Decision|1|||
42060916|NCT00874497|75869965|FG000|Overall Study|Withdrawal by Subject|5|||
42060917|NCT00874497|75869966|FG001|Overall Study|Withdrawal by Subject|4|||
42060918|NCT00924560|75869975|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
42060919|NCT00924560|75869976|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
42060920|NCT00924560|75869977|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
42060921|NCT00924560|75869975|FG000|Overall Study|Non Compliance with the Protocol|20|||
42060922|NCT00924560|75869976|FG001|Overall Study|Non Compliance with the Protocol|15|||
42060923|NCT00924560|75869977|FG002|Overall Study|Non Compliance with the Protocol|4|||
42060924|NCT00924560|75869975|FG000|Overall Study|Physician Decision|2|||
42060925|NCT00924560|75869976|FG001|Overall Study|Physician Decision|3|||
42060926|NCT00924560|75869977|FG002|Overall Study|Physician Decision|4|||
42060927|NCT00924560|75869975|FG000|Overall Study|Withdrawal by Subject|50|||
42060928|NCT00924560|75869976|FG001|Overall Study|Withdrawal by Subject|44|||
42060929|NCT00924560|75869977|FG002|Overall Study|Withdrawal by Subject|18|||
42060930|NCT00924560|75869975|FG000|Overall Study|Adverse Event|39|||
42060931|NCT00924560|75869976|FG001|Overall Study|Adverse Event|33|||
42060932|NCT00924560|75869977|FG002|Overall Study|Adverse Event|0|||
42060933|NCT00924560|75869975|FG000|Overall Study|Pregnancy|5|||
42060934|NCT00924560|75869976|FG001|Overall Study|Pregnancy|7|||
42060935|NCT00924560|75869977|FG002|Overall Study|Pregnancy|1|||
42060936|NCT00924560|75869975|FG000|Overall Study|Lost to Follow-up|78|||
42060937|NCT00924560|75869976|FG001|Overall Study|Lost to Follow-up|94|||
42060938|NCT00924560|75869977|FG002|Overall Study|Lost to Follow-up|45|||
42060939|NCT00924560|75869975|FG000|Overall Study|Miscellaneous Reasons|13|||
42060940|NCT00924560|75869976|FG001|Overall Study|Miscellaneous Reasons|10|||
42060941|NCT00924560|75869977|FG002|Overall Study|Miscellaneous Reasons|10|||
42060942|NCT00923078|75869990|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
42060943|NCT00923078|75869991|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
42060944|NCT00923078|75869992|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
42060945|NCT00923078|75869990|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
42060946|NCT00923078|75869991|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
42060947|NCT00923078|75869992|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
42060948|NCT00978731|75870003|FG000|Overall Study|Death|4|||
42060949|NCT00978731|75870004|FG001|Overall Study|Death|1|||
42060950|NCT00978731|75870005|FG002|Overall Study|Death|1|||
42060951|NCT00978731|75870006|FG003|Overall Study|Death|0|||
42060952|NCT00978731|75870003|FG000|Overall Study|Lost to Follow-up|0|||
42060953|NCT00978731|75870004|FG001|Overall Study|Lost to Follow-up|0|||
42060954|NCT00978731|75870005|FG002|Overall Study|Lost to Follow-up|0|||
42060955|NCT00978731|75870006|FG003|Overall Study|Lost to Follow-up|1|||
42060956|NCT00978731|75870003|FG000|Overall Study|Adverse Event|5|||
42060957|NCT00978731|75870004|FG001|Overall Study|Adverse Event|2|||
42357245|NCT01725308|76202605|FG002|Treatment Period I|Adverse Event|21|||
42357246|NCT01725308|76202603|FG000|Treatment Period I|Insufficient Response|7|||
42060958|NCT00978731|75870005|FG002|Overall Study|Adverse Event|0|||
42060959|NCT00978731|75870006|FG003|Overall Study|Adverse Event|0|||
42357247|NCT01725308|76202604|FG001|Treatment Period I|Insufficient Response|0|||
42357248|NCT01725308|76202605|FG002|Treatment Period I|Insufficient Response|5|||
42357249|NCT01725308|76202603|FG000|Treatment Period I|Worsening of the Target Disease|8|||
42357250|NCT01725308|76202604|FG001|Treatment Period I|Worsening of the Target Disease|0|||
42357251|NCT01725308|76202605|FG002|Treatment Period I|Worsening of the Target Disease|2|||
42357252|NCT01725308|76202603|FG000|Treatment Period I|Changes in the Episodes|3|||
42060960|NCT00978731|75870003|FG000|Overall Study|Participant's request|1|||
42060961|NCT00978731|75870004|FG001|Overall Study|Participant's request|0|||
42060962|NCT00978731|75870005|FG002|Overall Study|Participant's request|0|||
42060963|NCT00978731|75870006|FG003|Overall Study|Participant's request|0|||
42060964|NCT00978731|75870003|FG000|Overall Study|Administrative reason|3|||
42357253|NCT01725308|76202604|FG001|Treatment Period I|Changes in the Episodes|0|||
42357254|NCT01725308|76202605|FG002|Treatment Period I|Changes in the Episodes|2|||
42291915|NCT01939366|76125384|FG004|Overall Study|Withdrawal by Subject|3|||
42291916|NCT01939366|76125380|FG000|Overall Study|Inclusion criteria not met|0|||
42291917|NCT01939366|76125381|FG001|Overall Study|Inclusion criteria not met|1|||
42174498|NCT02939950|75981238|FG000|Overall Study|Randomized, not dispensed|1|||
42174499|NCT02939950|75981239|FG001|Overall Study|Randomized, not dispensed|0|||
42174500|NCT02939950|75981238|FG000|Overall Study|Ineligible at Baseline|2|||
42291918|NCT01939366|76125382|FG002|Overall Study|Inclusion criteria not met|1|||
42291919|NCT01939366|76125383|FG003|Overall Study|Inclusion criteria not met|0|||
42291920|NCT01939366|76125384|FG004|Overall Study|Inclusion criteria not met|1|||
42060965|NCT00978731|75870004|FG001|Overall Study|Administrative reason|3|||
42060966|NCT00978731|75870005|FG002|Overall Study|Administrative reason|1|||
42060967|NCT00978731|75870006|FG003|Overall Study|Administrative reason|0|||
42060968|NCT00978731|75870003|FG000|Overall Study|Deterioration without progression|0|||
42060969|NCT00978731|75870004|FG001|Overall Study|Deterioration without progression|1|||
42060970|NCT00978731|75870005|FG002|Overall Study|Deterioration without progression|0|||
42060971|NCT00978731|75870006|FG003|Overall Study|Deterioration without progression|0|||
42060972|NCT00978731|75870003|FG000|Overall Study|Disease progression/relapse|5|||
42060973|NCT00978731|75870004|FG001|Overall Study|Disease progression/relapse|4|||
42060974|NCT00978731|75870005|FG002|Overall Study|Disease progression/relapse|2|||
42060975|NCT00978731|75870006|FG003|Overall Study|Disease progression/relapse|2|||
42060976|NCT00978731|75870003|FG000|Overall Study|Study closure|3|||
42060977|NCT00978731|75870004|FG001|Overall Study|Study closure|4|||
42060978|NCT00978731|75870005|FG002|Overall Study|Study closure|1|||
42060979|NCT00978731|75870006|FG003|Overall Study|Study closure|1|||
42060980|NCT00978731|75870003|FG000|Overall Study|No response|1|||
42060981|NCT00978731|75870004|FG001|Overall Study|No response|0|||
42060982|NCT00978731|75870005|FG002|Overall Study|No response|0|||
42060983|NCT00978731|75870006|FG003|Overall Study|No response|0|||
42060984|NCT05056870|75870020|FG000|Period 1|Site COVID-19 Related|3|||
42060985|NCT05056870|75870021|FG001|Period 1|Site COVID-19 Related|3|||
42060986|NCT05056870|75870020|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
42060987|NCT05056870|75870021|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
42060988|NCT05056870|75870020|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
42060989|NCT05056870|75870021|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
42060990|NCT05056870|75870020|FG000|Period 2|COVID-19 Related|1|||
42060991|NCT05056870|75870021|FG001|Period 2|COVID-19 Related|0|||
42060992|NCT05056870|75870020|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
42060993|NCT05056870|75870021|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
42060994|NCT04488822|75870045|FG000|Overall Study|Adverse Event|8|||
42060995|NCT04488822|75870045|FG000|Overall Study|Withdrawal by Subject|1|||
42060996|NCT04396626|75870058|FG000|Overall Study|Premature termination of study|975|||
42060997|NCT04242186|75870062|FG000|Overall Study|Death|5|||
42060998|NCT03934216|75870069|FG000|Randomization|Randomized in Error|1|||
42060999|NCT03934216|75870070|FG001|Randomization|Randomized in Error|1|||
42061000|NCT03934216|75870069|FG000|Treatment Period|Adverse Event|10|||
42061001|NCT03934216|75870070|FG001|Treatment Period|Adverse Event|3|||
42061002|NCT03934216|75870069|FG000|Treatment Period|Withdrawal by Participant|6|||
42061003|NCT03934216|75870070|FG001|Treatment Period|Withdrawal by Participant|2|||
42061004|NCT03934216|75870069|FG000|Treatment Period|Other Reasons|2|||
42061005|NCT03934216|75870070|FG001|Treatment Period|Other Reasons|2|||
42061006|NCT03183128|75870107|FG000|Overall Study|Adverse Event|1|||
42061007|NCT03183128|75870108|FG001|Overall Study|Adverse Event|2|||
42061008|NCT03183128|75870107|FG000|Overall Study|Withdrawal by Subject|1|||
42061009|NCT03183128|75870108|FG001|Overall Study|Withdrawal by Subject|8|||
42061010|NCT03183128|75870107|FG000|Overall Study|Protocol Violation|2|||
42061011|NCT03183128|75870108|FG001|Overall Study|Protocol Violation|0|||
42061012|NCT03183128|75870107|FG000|Overall Study|Lack of Efficacy|4|||
42061013|NCT03183128|75870108|FG001|Overall Study|Lack of Efficacy|27|||
42061014|NCT03183128|75870107|FG000|Overall Study|Lost to Follow-up|1|||
42061015|NCT03183128|75870108|FG001|Overall Study|Lost to Follow-up|0|||
42061016|NCT03183128|75870107|FG000|Overall Study|Death|2|||
42061017|NCT03183128|75870108|FG001|Overall Study|Death|0|||
42061018|NCT03183128|75870107|FG000|Overall Study|Physician Decision|1|||
42061019|NCT03183128|75870108|FG001|Overall Study|Physician Decision|0|||
42061020|NCT02308488|75870141|FG000|Overall Study|Withdrawal by Subject|2|||
42061021|NCT02159950|75870147|FG000|Overall Study|Adverse Event|0|||
42061022|NCT02159950|75870148|FG001|Overall Study|Adverse Event|1|||
42061023|NCT02159950|75870147|FG000|Overall Study|Progression|0|||
42061024|NCT02159950|75870148|FG001|Overall Study|Progression|1|||
42061025|NCT02152137|75870154|FG000|Overall Study|Withdrawal by Subject|1|||
42061026|NCT02152137|75870154|FG000|Overall Study|Originally assigned to Arm B|3|||
42061027|NCT02007512|75870162|FG000|Double Blind Treatment Period|Adverse Event|4|||
42061028|NCT02007512|75870163|FG001|Double Blind Treatment Period|Adverse Event|2|||
42061029|NCT02007512|75870164|FG002|Double Blind Treatment Period|Adverse Event|6|||
42061030|NCT02007512|75870165|FG003|Double Blind Treatment Period|Adverse Event|2|||
42061031|NCT02007512|75870162|FG000|Double Blind Treatment Period|Death|1|||
42061032|NCT02007512|75870163|FG001|Double Blind Treatment Period|Death|0|||
42061033|NCT02007512|75870164|FG002|Double Blind Treatment Period|Death|0|||
42061034|NCT02007512|75870165|FG003|Double Blind Treatment Period|Death|0|||
42061035|NCT02007512|75870162|FG000|Double Blind Treatment Period|Disease progression|44|||
42061036|NCT02007512|75870163|FG001|Double Blind Treatment Period|Disease progression|49|||
42061037|NCT02007512|75870164|FG002|Double Blind Treatment Period|Disease progression|45|||
42061038|NCT02007512|75870165|FG003|Double Blind Treatment Period|Disease progression|51|||
42061039|NCT02007512|75870162|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
42061040|NCT02007512|75870163|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
42061041|NCT02007512|75870164|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
42061042|NCT02007512|75870165|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
42061043|NCT02007512|75870162|FG000|Double Blind Treatment Period|Protocol Violation|0|||
42061044|NCT02007512|75870163|FG001|Double Blind Treatment Period|Protocol Violation|0|||
42061045|NCT02007512|75870164|FG002|Double Blind Treatment Period|Protocol Violation|0|||
42061046|NCT02007512|75870165|FG003|Double Blind Treatment Period|Protocol Violation|1|||
42061047|NCT02007512|75870162|FG000|Double Blind Treatment Period|Other|0|||
42061048|NCT02007512|75870163|FG001|Double Blind Treatment Period|Other|0|||
42061049|NCT02007512|75870164|FG002|Double Blind Treatment Period|Other|1|||
42061050|NCT02007512|75870165|FG003|Double Blind Treatment Period|Other|2|||
42061051|NCT02007512|75870162|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
42061052|NCT02007512|75870163|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
42061053|NCT02007512|75870164|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
42061054|NCT02007512|75870165|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
42061055|NCT02007512|75870162|FG000|Open Label Treatment Period|Adverse Event|0|||
42061056|NCT02007512|75870163|FG001|Open Label Treatment Period|Adverse Event|1|||
42061057|NCT02007512|75870164|FG002|Open Label Treatment Period|Adverse Event|0|||
42061058|NCT02007512|75870165|FG003|Open Label Treatment Period|Adverse Event|0|||
42061059|NCT02007512|75870162|FG000|Open Label Treatment Period|Other|0|||
42061060|NCT02007512|75870163|FG001|Open Label Treatment Period|Other|0|||
42061061|NCT02007512|75870164|FG002|Open Label Treatment Period|Other|0|||
42061062|NCT02007512|75870165|FG003|Open Label Treatment Period|Other|1|||
42061063|NCT02007512|75870162|FG000|Open Label Treatment Period|Disease progression|0|||
42061064|NCT02007512|75870163|FG001|Open Label Treatment Period|Disease progression|17|||
42061065|NCT02007512|75870164|FG002|Open Label Treatment Period|Disease progression|0|||
42061066|NCT02007512|75870165|FG003|Open Label Treatment Period|Disease progression|11|||
42061067|NCT02007512|75870162|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
42061068|NCT02007512|75870163|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
42061069|NCT02007512|75870164|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
42061070|NCT02007512|75870165|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
42061071|NCT01942135|75870180|FG000|Overall Study|Adverse Event|9|||
42061072|NCT01942135|75870181|FG001|Overall Study|Adverse Event|3|||
42061073|NCT01942135|75870180|FG000|Overall Study|Global deterioration of health status|8|||
42061074|NCT01942135|75870181|FG001|Overall Study|Global deterioration of health status|3|||
42061075|NCT01942135|75870180|FG000|Overall Study|Randomized Not Treated|2|||
42061076|NCT01942135|75870181|FG001|Overall Study|Randomized Not Treated|2|||
42061077|NCT01942135|75870180|FG000|Overall Study|Death|0|||
42061078|NCT01942135|75870181|FG001|Overall Study|Death|1|||
42061079|NCT01942135|75870180|FG000|Overall Study|ObjectiveProgression+Progressive Disease|85|||
42061080|NCT01942135|75870181|FG001|Overall Study|ObjectiveProgression+Progressive Disease|87|||
42061081|NCT01942135|75870180|FG000|Overall Study|Participant Refused toContinue Treatment|1|||
42061082|NCT01942135|75870181|FG001|Overall Study|Participant Refused toContinue Treatment|1|||
42061083|NCT01942135|75870180|FG000|Overall Study|Withdrawal by Subject|4|||
42061084|NCT01942135|75870181|FG001|Overall Study|Withdrawal by Subject|2|||
42061085|NCT01942135|75870180|FG000|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238|||
42061086|NCT01942135|75870181|FG001|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75|||
42061087|NCT01889238|75870187|FG000|Overall Study|Treatment ongoing|9|||
42061088|NCT00978341|75870213|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
42061089|NCT00978341|75870214|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
42061090|NCT00978029|75870224|FG000|Overall Study|Adverse Event|1|||
42061091|NCT00978029|75870225|FG001|Overall Study|Adverse Event|2|||
42061092|NCT00978029|75870226|FG002|Overall Study|Adverse Event|5|||
42061093|NCT00978029|75870224|FG000|Overall Study|Withdrawal by Subject|0|||
42061094|NCT00978029|75870225|FG001|Overall Study|Withdrawal by Subject|0|||
42061095|NCT00978029|75870226|FG002|Overall Study|Withdrawal by Subject|1|||
42061096|NCT00978029|75870224|FG000|Overall Study|Protocol Violation|0|||
42061097|NCT00978029|75870225|FG001|Overall Study|Protocol Violation|1|||
42061098|NCT00978029|75870226|FG002|Overall Study|Protocol Violation|0|||
42061099|NCT00871377|75870234|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
42061100|NCT00871377|75870235|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
42061101|NCT00871377|75870236|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
42061102|NCT00871377|75870237|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
42061103|NCT00871377|75870238|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
42061104|NCT00871377|75870239|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
42061105|NCT00871377|75870234|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
42061106|NCT00871377|75870235|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
42061107|NCT00871377|75870236|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
42061108|NCT00871377|75870237|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
42061109|NCT00871377|75870238|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
42061110|NCT00871377|75870239|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
42061111|NCT00871377|75870234|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
42061112|NCT00871377|75870235|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
42061113|NCT00871377|75870236|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
42061114|NCT00871377|75870237|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
42061115|NCT00871377|75870238|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
42061116|NCT00871377|75870239|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
42061117|NCT00871377|75870234|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
42061118|NCT00871377|75870235|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
42061119|NCT00871377|75870236|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
42061120|NCT00871377|75870237|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
42061121|NCT00871377|75870238|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
42061122|NCT00871377|75870239|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
42357255|NCT01725308|76202603|FG000|Treatment Period I|Withdrawal of Consent|12|||
42357256|NCT01725308|76202604|FG001|Treatment Period I|Withdrawal of Consent|7|||
42357257|NCT01725308|76202605|FG002|Treatment Period I|Withdrawal of Consent|5|||
42357258|NCT01725308|76202603|FG000|Treatment Period I|Lost to Follow-up|3|||
42357259|NCT01725308|76202604|FG001|Treatment Period I|Lost to Follow-up|2|||
42357260|NCT01725308|76202605|FG002|Treatment Period I|Lost to Follow-up|2|||
42357261|NCT01725308|76202603|FG000|Treatment Period I|Protocol Deviations|3|||
42357262|NCT01725308|76202604|FG001|Treatment Period I|Protocol Deviations|1|||
42357263|NCT01725308|76202605|FG002|Treatment Period I|Protocol Deviations|1|||
42357264|NCT01725308|76202603|FG000|Treatment Period I|Miscellaneous|2|||
42357265|NCT01725308|76202604|FG001|Treatment Period I|Miscellaneous|0|||
42357266|NCT01725308|76202605|FG002|Treatment Period I|Miscellaneous|3|||
42357267|NCT01725308|76202603|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
42357268|NCT01725308|76202604|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
42174501|NCT02939950|75981239|FG001|Overall Study|Ineligible at Baseline|8|||
42174502|NCT03753542|75981247|FG000|Overall Study|Lost to Follow-up|9|||
42061123|NCT00871377|75870234|FG000|Third Intervention (10 Weeks)|Death|0|||
42357269|NCT01725308|76202605|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
42061124|NCT00871377|75870235|FG001|Third Intervention (10 Weeks)|Death|0|||
42357270|NCT01725308|76202603|FG000|Treatment Period II|Did Not Receive Drug|4|||
42357271|NCT01725308|76202604|FG001|Treatment Period II|Did Not Receive Drug|0|||
42357272|NCT01725308|76202605|FG002|Treatment Period II|Did Not Receive Drug|0|||
42357273|NCT01725308|76202603|FG000|Treatment Period II|Adverse Event|13|||
42357274|NCT01725308|76202604|FG001|Treatment Period II|Adverse Event|8|||
42357275|NCT01725308|76202605|FG002|Treatment Period II|Adverse Event|20|||
42357276|NCT01725308|76202603|FG000|Treatment Period II|Insufficient Response|2|||
42357277|NCT01725308|76202604|FG001|Treatment Period II|Insufficient Response|4|||
42357278|NCT01725308|76202605|FG002|Treatment Period II|Insufficient Response|6|||
42357279|NCT01725308|76202603|FG000|Treatment Period II|Worsening of the Target Disease|1|||
42357280|NCT01725308|76202604|FG001|Treatment Period II|Worsening of the Target Disease|4|||
42061125|NCT00871377|75870236|FG002|Third Intervention (10 Weeks)|Death|0|||
42061126|NCT00871377|75870237|FG003|Third Intervention (10 Weeks)|Death|1|||
42061127|NCT00871377|75870238|FG004|Third Intervention (10 Weeks)|Death|0|||
42061128|NCT00871377|75870239|FG005|Third Intervention (10 Weeks)|Death|0|||
42061129|NCT00977561|75870249|FG000|Overall Study|Death|3|||
42357281|NCT01725308|76202605|FG002|Treatment Period II|Worsening of the Target Disease|2|||
42357282|NCT01725308|76202603|FG000|Treatment Period II|Changes in the Episodes|1|||
42357283|NCT01725308|76202604|FG001|Treatment Period II|Changes in the Episodes|0|||
42357284|NCT01725308|76202605|FG002|Treatment Period II|Changes in the Episodes|5|||
42357285|NCT01725308|76202603|FG000|Treatment Period II|Withdrawal of Consent|28|||
42061130|NCT00977561|75870250|FG001|Overall Study|Death|2|||
42061131|NCT00977561|75870249|FG000|Overall Study|Study terminated|0|||
42061132|NCT00977561|75870250|FG001|Overall Study|Study terminated|2|||
42061133|NCT00977561|75870249|FG000|Overall Study|Other|2|||
42061134|NCT00977561|75870250|FG001|Overall Study|Other|0|||
42061135|NCT00594165|75870258|FG000|Overall Study|Major protocol violation|1|||
42061136|NCT00594165|75870258|FG000|Overall Study|Lack of Efficacy|12|||
42061137|NCT00594165|75870258|FG000|Overall Study|Adverse Event|52|||
42061138|NCT00594165|75870258|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
42061139|NCT00594165|75870258|FG000|Overall Study|Subject withdrew consent|27|||
42061140|NCT00594165|75870258|FG000|Overall Study|Study ended per sponsor|102|||
42061141|NCT00594165|75870258|FG000|Overall Study|Lost to Follow-up|4|||
42061142|NCT00594165|75870258|FG000|Overall Study|Other: PI discretion|5|||
42061143|NCT00594165|75870258|FG000|Overall Study|Other: Subject moving|3|||
42061144|NCT00594165|75870258|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
42061145|NCT00594165|75870258|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
42061146|NCT00594165|75870258|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
42061147|NCT00594165|75870258|FG000|Overall Study|Other: Site terminated participation|2|||
42061148|NCT00975923|75870264|FG000|Overall Study|Withdrawal by Subject|0|||
42061149|NCT00975923|75870265|FG001|Overall Study|Withdrawal by Subject|1|||
42061150|NCT00928070|75870274|FG000|Overall Study|Lost to Follow-up|1|||
42061151|NCT00928070|75870275|FG001|Overall Study|Lost to Follow-up|2|||
42061152|NCT00928070|75870274|FG000|Overall Study|Withdrawal by Subject|10|||
42061153|NCT00928070|75870275|FG001|Overall Study|Withdrawal by Subject|3|||
42061154|NCT00928070|75870274|FG000|Overall Study|Adverse Event|14|||
42061155|NCT00928070|75870275|FG001|Overall Study|Adverse Event|26|||
42061156|NCT00928070|75870274|FG000|Overall Study|Lack of Efficacy|9|||
42061157|NCT00928070|75870275|FG001|Overall Study|Lack of Efficacy|5|||
42061158|NCT00928070|75870274|FG000|Overall Study|Did not meet entrance criteria|16|||
42061159|NCT00928070|75870275|FG001|Overall Study|Did not meet entrance criteria|9|||
42061160|NCT00928070|75870274|FG000|Overall Study|Protocol Violation|6|||
42061161|NCT00928070|75870275|FG001|Overall Study|Protocol Violation|5|||
42061162|NCT00928070|75870274|FG000|Overall Study|Randomized but not treated|2|||
42061163|NCT00928070|75870275|FG001|Overall Study|Randomized but not treated|2|||
42061164|NCT00928070|75870274|FG000|Overall Study|Other|5|||
42061165|NCT00928070|75870275|FG001|Overall Study|Other|5|||
42061166|NCT00924404|75870283|FG000|Overall Study|Lost to Follow-up|6|||
42061167|NCT00924404|75870284|FG001|Overall Study|Lost to Follow-up|4|||
42061168|NCT00976937|75870292|FG000|Overall Study|Adverse Event|4|||
42061169|NCT00976937|75870293|FG001|Overall Study|Adverse Event|5|||
42061170|NCT00976937|75870292|FG000|Overall Study|Lost to Follow-up|2|||
42061171|NCT00976937|75870293|FG001|Overall Study|Lost to Follow-up|1|||
42061172|NCT00976937|75870292|FG000|Overall Study|Withdrawal by Subject|5|||
42061173|NCT00976937|75870293|FG001|Overall Study|Withdrawal by Subject|3|||
42061174|NCT00976937|75870292|FG000|Overall Study|Poor compliance to protocol|3|||
42061175|NCT00976937|75870293|FG001|Overall Study|Poor compliance to protocol|0|||
42061176|NCT00976937|75870292|FG000|Overall Study|Personal and Familial Reason|2|||
42061177|NCT00976937|75870293|FG001|Overall Study|Personal and Familial Reason|2|||
42061178|NCT00976703|75870301|FG000|Overall Study|Physician Decision|1|||
42061179|NCT00976703|75870302|FG001|Overall Study|Physician Decision|1|||
42061180|NCT00976703|75870301|FG000|Overall Study|ineligible for study|2|||
42061181|NCT00976703|75870302|FG001|Overall Study|ineligible for study|2|||
42061182|NCT00975689|75870310|FG000|Overall Study|Adverse Event|0|||
42061183|NCT00975689|75870311|FG001|Overall Study|Adverse Event|3|||
42061184|NCT00975689|75870310|FG000|Overall Study|Withdrawal by Subject|1|||
42061185|NCT00975689|75870311|FG001|Overall Study|Withdrawal by Subject|0|||
42061186|NCT00975689|75870310|FG000|Overall Study|Physician Decision|1|||
42061187|NCT00975689|75870311|FG001|Overall Study|Physician Decision|0|||
42061188|NCT00922766|75870317|FG000|Overall Study|Death|3|||
42061189|NCT00922766|75870317|FG000|Overall Study|Withdrawal by Subject|2|||
42061190|NCT00922766|75870317|FG000|Overall Study|Other|1|||
42291921|NCT01939366|76125380|FG000|Overall Study|Other|0|||
42291922|NCT01939366|76125381|FG001|Overall Study|Other|0|||
42291923|NCT01939366|76125382|FG002|Overall Study|Other|2|||
42291924|NCT01939366|76125383|FG003|Overall Study|Other|2|||
42061191|NCT00922766|75870317|FG000|Overall Study|Adverse Event|1|||
42061192|NCT00917852|75870321|FG000|Overall Study|Death|6|||
42061193|NCT00976391|75870328|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
42061194|NCT00976391|75870329|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
42061195|NCT00976391|75870328|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
42061196|NCT00976391|75870329|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
42061197|NCT00976391|75870328|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
42061198|NCT00976391|75870329|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
42061199|NCT00976391|75870328|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
42061200|NCT00976391|75870329|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
42061201|NCT00976391|75870328|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
42061202|NCT00976391|75870329|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
42291925|NCT01939366|76125384|FG004|Overall Study|Other|1|||
42061203|NCT00976391|75870328|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
42061204|NCT00976391|75870329|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
42061205|NCT00976391|75870328|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
42061206|NCT00976391|75870329|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
42061207|NCT00976391|75870328|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
42061208|NCT00976391|75870329|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
42061209|NCT00976391|75870328|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
42061210|NCT00976391|75870329|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
42061211|NCT00976391|75870328|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
42061212|NCT00976391|75870329|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
42061213|NCT00976391|75870328|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
42061214|NCT00976391|75870329|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
42061215|NCT00976391|75870328|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
42061216|NCT00976391|75870329|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
42061217|NCT00976391|75870328|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
42061218|NCT00976391|75870329|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
42061219|NCT00976391|75870328|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
42061220|NCT00976391|75870329|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
42061221|NCT00917462|75870335|FG000|Overall Study|Clinical Deterioration|1|||
42061222|NCT00979901|75870343|FG000|Overall Study|Adverse Event|1|||
42061223|NCT00979901|75870344|FG001|Overall Study|Adverse Event|3|||
42061224|NCT00979901|75870345|FG002|Overall Study|Adverse Event|9|||
42061225|NCT00979901|75870346|FG003|Overall Study|Adverse Event|2|||
42061226|NCT00979901|75870343|FG000|Overall Study|Lack of Efficacy|8|||
42061227|NCT00979901|75870344|FG001|Overall Study|Lack of Efficacy|4|||
42061228|NCT00979901|75870345|FG002|Overall Study|Lack of Efficacy|9|||
42061229|NCT00979901|75870346|FG003|Overall Study|Lack of Efficacy|0|||
42061230|NCT00979901|75870343|FG000|Overall Study|Lost to Follow-up|1|||
42061231|NCT00979901|75870344|FG001|Overall Study|Lost to Follow-up|1|||
42061232|NCT00979901|75870345|FG002|Overall Study|Lost to Follow-up|2|||
42061233|NCT00979901|75870346|FG003|Overall Study|Lost to Follow-up|0|||
42061234|NCT00979901|75870343|FG000|Overall Study|Protocol Violation|2|||
42061235|NCT00979901|75870344|FG001|Overall Study|Protocol Violation|2|||
42061236|NCT00979901|75870345|FG002|Overall Study|Protocol Violation|7|||
42061237|NCT00979901|75870346|FG003|Overall Study|Protocol Violation|1|||
42061238|NCT00979901|75870343|FG000|Overall Study|Withdrawal by Subject|2|||
42061239|NCT00979901|75870344|FG001|Overall Study|Withdrawal by Subject|1|||
42061240|NCT00979901|75870345|FG002|Overall Study|Withdrawal by Subject|1|||
42061241|NCT00979901|75870346|FG003|Overall Study|Withdrawal by Subject|1|||
42061242|NCT00979901|75870343|FG000|Overall Study|Noncompliance|1|||
42061243|NCT00979901|75870344|FG001|Overall Study|Noncompliance|0|||
42061244|NCT00979901|75870345|FG002|Overall Study|Noncompliance|0|||
42061245|NCT00979901|75870346|FG003|Overall Study|Noncompliance|0|||
42061246|NCT00979901|75870343|FG000|Overall Study|out-of-state|1|||
42061247|NCT00979901|75870344|FG001|Overall Study|out-of-state|0|||
42061248|NCT00979901|75870345|FG002|Overall Study|out-of-state|0|||
42061249|NCT00979901|75870346|FG003|Overall Study|out-of-state|0|||
42061250|NCT00979901|75870343|FG000|Overall Study|vacation|1|||
42061251|NCT00979901|75870344|FG001|Overall Study|vacation|0|||
42061252|NCT00979901|75870345|FG002|Overall Study|vacation|0|||
42061253|NCT00979901|75870346|FG003|Overall Study|vacation|0|||
42061254|NCT00979901|75870343|FG000|Overall Study|elevated lab values pre-randomization|1|||
42061255|NCT00979901|75870344|FG001|Overall Study|elevated lab values pre-randomization|0|||
42061256|NCT00979901|75870345|FG002|Overall Study|elevated lab values pre-randomization|0|||
42061257|NCT00979901|75870346|FG003|Overall Study|elevated lab values pre-randomization|0|||
42061258|NCT00979901|75870343|FG000|Overall Study|Discontinued in Error|0|||
42061259|NCT00979901|75870344|FG001|Overall Study|Discontinued in Error|1|||
42061260|NCT00979901|75870345|FG002|Overall Study|Discontinued in Error|0|||
42061261|NCT00979901|75870346|FG003|Overall Study|Discontinued in Error|0|||
42061262|NCT00979901|75870343|FG000|Overall Study|Left Country|0|||
42061263|NCT00979901|75870344|FG001|Overall Study|Left Country|0|||
42061264|NCT00979901|75870345|FG002|Overall Study|Left Country|1|||
42174503|NCT03753542|75981248|FG001|Overall Study|Lost to Follow-up|14|||
42061265|NCT00979901|75870346|FG003|Overall Study|Left Country|0|||
42061266|NCT00979901|75870343|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
42061267|NCT00979901|75870344|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
42061268|NCT00979901|75870345|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
42061269|NCT00979901|75870346|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
42061270|NCT00975611|75870355|FG000|Overall Study|Screen Fail|16|||
42061271|NCT00975611|75870355|FG000|Overall Study|Physician Decision|1|||
42061272|NCT00970307|75870362|FG000|Overall Study|Serious Adverse Event|1|||
42061273|NCT00970307|75870363|FG001|Overall Study|Serious Adverse Event|0|||
42061274|NCT00970307|75870364|FG002|Overall Study|Serious Adverse Event|0|||
42061275|NCT00970307|75870362|FG000|Overall Study|Withdrawal by Subject|2|||
42061276|NCT00970307|75870363|FG001|Overall Study|Withdrawal by Subject|3|||
42061277|NCT00970307|75870364|FG002|Overall Study|Withdrawal by Subject|2|||
42061278|NCT00917384|75870374|FG000|Overall Study|Lost to Follow-up|4|||
42061279|NCT00917384|75870375|FG001|Overall Study|Lost to Follow-up|2|||
42061280|NCT00917384|75870374|FG000|Overall Study|Withdrawal by Subject|10|||
42061281|NCT00917384|75870375|FG001|Overall Study|Withdrawal by Subject|2|||
42061282|NCT00864513|75870381|FG000|Overall Study|Withdrawal by Subject|3|||
42061283|NCT00917150|75870389|FG000|Overall Study|Adverse Event|12|||
42061284|NCT00917150|75870390|FG001|Overall Study|Adverse Event|7|||
42061285|NCT00917150|75870391|FG002|Overall Study|Adverse Event|12|||
42061286|NCT00917150|75870392|FG003|Overall Study|Adverse Event|11|||
42061287|NCT00917150|75870389|FG000|Overall Study|Death|1|||
42061288|NCT00917150|75870390|FG001|Overall Study|Death|4|||
42061289|NCT00917150|75870391|FG002|Overall Study|Death|3|||
42061290|NCT00917150|75870392|FG003|Overall Study|Death|2|||
42061291|NCT00917150|75870389|FG000|Overall Study|Lost to Follow-up|1|||
42061292|NCT00917150|75870390|FG001|Overall Study|Lost to Follow-up|0|||
42061293|NCT00917150|75870391|FG002|Overall Study|Lost to Follow-up|4|||
42061294|NCT00917150|75870392|FG003|Overall Study|Lost to Follow-up|2|||
42061295|NCT00917150|75870389|FG000|Overall Study|Physician Decision|0|||
42061296|NCT00917150|75870390|FG001|Overall Study|Physician Decision|2|||
42061297|NCT00917150|75870391|FG002|Overall Study|Physician Decision|0|||
42061298|NCT00917150|75870392|FG003|Overall Study|Physician Decision|1|||
42061299|NCT00917150|75870389|FG000|Overall Study|Protocol Violation|5|||
42061300|NCT00917150|75870390|FG001|Overall Study|Protocol Violation|5|||
42061301|NCT00917150|75870391|FG002|Overall Study|Protocol Violation|3|||
42061302|NCT00917150|75870392|FG003|Overall Study|Protocol Violation|5|||
42061303|NCT00917150|75870389|FG000|Overall Study|Withdrawal by Subject|15|||
42061304|NCT00917150|75870390|FG001|Overall Study|Withdrawal by Subject|16|||
42061305|NCT00917150|75870391|FG002|Overall Study|Withdrawal by Subject|18|||
42061306|NCT00917150|75870392|FG003|Overall Study|Withdrawal by Subject|11|||
42061307|NCT00917150|75870389|FG000|Overall Study|Other than specified|3|||
42061308|NCT00917150|75870390|FG001|Overall Study|Other than specified|3|||
42061309|NCT00917150|75870391|FG002|Overall Study|Other than specified|2|||
42061310|NCT00917150|75870392|FG003|Overall Study|Other than specified|2|||
42061311|NCT00659425|75870412|FG000|Overall Study|Disease progression|1|||
42061312|NCT00659425|75870413|FG001|Overall Study|Disease progression|0|||
42061313|NCT00659425|75870414|FG002|Overall Study|Disease progression|0|||
42061314|NCT00659425|75870415|FG003|Overall Study|Disease progression|1|||
42061315|NCT00659425|75870416|FG004|Overall Study|Disease progression|0|||
42061316|NCT00659425|75870417|FG005|Overall Study|Disease progression|2|||
42061317|NCT00659425|75870418|FG006|Overall Study|Disease progression|4|||
42061318|NCT00659425|75870419|FG007|Overall Study|Disease progression|3|||
42061319|NCT00659425|75870420|FG008|Overall Study|Disease progression|5|||
42061320|NCT00659425|75870421|FG009|Overall Study|Disease progression|3|||
42061321|NCT00659425|75870412|FG000|Overall Study|Death|0|||
42061322|NCT00659425|75870413|FG001|Overall Study|Death|0|||
42061323|NCT00659425|75870414|FG002|Overall Study|Death|0|||
42061324|NCT00659425|75870415|FG003|Overall Study|Death|1|||
42061325|NCT00659425|75870416|FG004|Overall Study|Death|0|||
42061326|NCT00659425|75870417|FG005|Overall Study|Death|0|||
42061327|NCT00659425|75870418|FG006|Overall Study|Death|1|||
42061328|NCT00659425|75870419|FG007|Overall Study|Death|0|||
42061329|NCT00659425|75870420|FG008|Overall Study|Death|0|||
42061330|NCT00659425|75870421|FG009|Overall Study|Death|0|||
42061331|NCT00659425|75870412|FG000|Overall Study|Adverse Event|0|||
42061332|NCT00659425|75870413|FG001|Overall Study|Adverse Event|0|||
42061333|NCT00659425|75870414|FG002|Overall Study|Adverse Event|0|||
42357286|NCT01725308|76202604|FG001|Treatment Period II|Withdrawal of Consent|2|||
42061334|NCT00659425|75870415|FG003|Overall Study|Adverse Event|0|||
42061335|NCT00659425|75870416|FG004|Overall Study|Adverse Event|0|||
42061336|NCT00659425|75870417|FG005|Overall Study|Adverse Event|1|||
42061337|NCT00659425|75870418|FG006|Overall Study|Adverse Event|0|||
42061338|NCT00659425|75870419|FG007|Overall Study|Adverse Event|3|||
42061339|NCT00659425|75870420|FG008|Overall Study|Adverse Event|1|||
42061340|NCT00659425|75870421|FG009|Overall Study|Adverse Event|4|||
42061341|NCT00659425|75870412|FG000|Overall Study|Investigator Discretion|0|||
42061342|NCT00659425|75870413|FG001|Overall Study|Investigator Discretion|0|||
42061343|NCT00659425|75870414|FG002|Overall Study|Investigator Discretion|0|||
42061344|NCT00659425|75870415|FG003|Overall Study|Investigator Discretion|0|||
42061345|NCT00659425|75870416|FG004|Overall Study|Investigator Discretion|0|||
42061346|NCT00659425|75870417|FG005|Overall Study|Investigator Discretion|1|||
42061347|NCT00659425|75870418|FG006|Overall Study|Investigator Discretion|0|||
42061348|NCT00659425|75870419|FG007|Overall Study|Investigator Discretion|3|||
42061349|NCT00659425|75870420|FG008|Overall Study|Investigator Discretion|0|||
42061350|NCT00659425|75870421|FG009|Overall Study|Investigator Discretion|0|||
42061351|NCT00659425|75870412|FG000|Overall Study|Other|0|||
42061352|NCT00659425|75870413|FG001|Overall Study|Other|1|||
42061353|NCT00659425|75870414|FG002|Overall Study|Other|1|||
42061354|NCT00659425|75870415|FG003|Overall Study|Other|2|||
42061355|NCT00659425|75870416|FG004|Overall Study|Other|4|||
42061356|NCT00659425|75870417|FG005|Overall Study|Other|0|||
42061357|NCT00659425|75870418|FG006|Overall Study|Other|3|||
42061358|NCT00659425|75870419|FG007|Overall Study|Other|2|||
42061359|NCT00659425|75870420|FG008|Overall Study|Other|0|||
42061360|NCT00659425|75870421|FG009|Overall Study|Other|6|||
42061361|NCT00656851|75870458|FG000|Overall Study|Withdrawal by Subject|0|||
42061362|NCT00656851|75870459|FG001|Overall Study|Withdrawal by Subject|4|||
42061363|NCT00656617|75870465|FG000|Overall Study|Adverse Event|1|||
42061364|NCT00656617|75870465|FG000|Overall Study|Death|2|||
42061365|NCT00656617|75870465|FG000|Overall Study|Insurance Issues|2|||
42061366|NCT00656617|75870465|FG000|Overall Study|Move to different clinical trial|2|||
42061367|NCT00659269|75870472|FG000|Overall Study|Physician Decision|1|||
42061368|NCT00659269|75870473|FG001|Overall Study|Physician Decision|1|||
42061369|NCT00658333|75870490|FG000|Overall Study|Adverse Event|2|||
42061370|NCT00658333|75870491|FG001|Overall Study|Adverse Event|1|||
42061371|NCT00570037|75870499|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
42061372|NCT00570037|75870500|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
42061373|NCT00863655|75870508|FG000|Overall Study|Protocol Violation|4|||
42061374|NCT00863655|75870509|FG001|Overall Study|Protocol Violation|0|||
42061375|NCT00863655|75870508|FG000|Overall Study|Adverse Event|52|||
42061376|NCT00863655|75870509|FG001|Overall Study|Adverse Event|8|||
42061377|NCT00863655|75870508|FG000|Overall Study|Withdrawal by Subject|47|||
42061378|NCT00863655|75870509|FG001|Overall Study|Withdrawal by Subject|7|||
42061379|NCT00863655|75870508|FG000|Overall Study|Administrative problems|1|||
42061380|NCT00863655|75870509|FG001|Overall Study|Administrative problems|0|||
42061381|NCT00863655|75870508|FG000|Overall Study|Death|7|||
42061382|NCT00863655|75870509|FG001|Overall Study|Death|1|||
42061383|NCT00863655|75870508|FG000|Overall Study|New cancer therapy|5|||
42061384|NCT00863655|75870509|FG001|Overall Study|New cancer therapy|1|||
42061385|NCT00863655|75870508|FG000|Overall Study|Disease progression|364|||
42061386|NCT00863655|75870509|FG001|Overall Study|Disease progression|221|||
42061387|NCT00863655|75870508|FG000|Overall Study|Treatment completed as per protocol|5|||
42061388|NCT00863655|75870509|FG001|Overall Study|Treatment completed as per protocol|1|||
42061389|NCT00658723|75870517|FG000|Overall Study|Lost to Follow-up|0|||
42061390|NCT00658723|75870518|FG001|Overall Study|Lost to Follow-up|2|||
42061391|NCT00658723|75870519|FG002|Overall Study|Lost to Follow-up|2|||
42061392|NCT00658723|75870517|FG000|Overall Study|Death|2|||
42061393|NCT00658723|75870518|FG001|Overall Study|Death|1|||
42061394|NCT00658723|75870519|FG002|Overall Study|Death|4|||
42061395|NCT00658723|75870517|FG000|Overall Study|Scheduling Issue|1|||
42061396|NCT00658723|75870518|FG001|Overall Study|Scheduling Issue|1|||
42061397|NCT00658723|75870519|FG002|Overall Study|Scheduling Issue|0|||
42061398|NCT00658723|75870517|FG000|Overall Study|Withdrawal by Subject|1|||
42061399|NCT00658723|75870518|FG001|Overall Study|Withdrawal by Subject|0|||
42061400|NCT00658723|75870519|FG002|Overall Study|Withdrawal by Subject|1|||
42061401|NCT00593385|75870530|FG000|Overall Study|Death|14|||
42061402|NCT00593385|75870530|FG000|Overall Study|Lost to Follow-up|17|||
42061403|NCT00593385|75870530|FG000|Overall Study|Withdrawal by Subject|9|||
42061404|NCT00658021|75870539|FG000|28-Week Treatment Period|Adverse Event|3|||
42061405|NCT00658021|75870540|FG001|28-Week Treatment Period|Adverse Event|1|||
42061406|NCT00658021|75870541|FG002|28-Week Treatment Period|Adverse Event|0|||
42061407|NCT00658021|75870539|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
42061408|NCT00658021|75870540|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
42061409|NCT00658021|75870541|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
42061410|NCT00658021|75870539|FG000|28-Week Treatment Period|Protocol Violation|0|||
42061411|NCT00658021|75870540|FG001|28-Week Treatment Period|Protocol Violation|2|||
42291926|NCT01939366|76125380|FG000|Overall Study|Protocol Violation|0|||
42291927|NCT01939366|76125381|FG001|Overall Study|Protocol Violation|0|||
42061412|NCT00658021|75870541|FG002|28-Week Treatment Period|Protocol Violation|1|||
42061413|NCT00658021|75870539|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
42061414|NCT00658021|75870540|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
42061415|NCT00658021|75870541|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
42061416|NCT00658021|75870539|FG000|28-Week Treatment Period|Physician Decision|1|||
42061417|NCT00658021|75870540|FG001|28-Week Treatment Period|Physician Decision|2|||
42061418|NCT00658021|75870541|FG002|28-Week Treatment Period|Physician Decision|1|||
42061419|NCT00658021|75870539|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
42061420|NCT00658021|75870540|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
42061421|NCT00658021|75870541|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
42061422|NCT00658021|75870539|FG000|28-Week Treatment Period|Loss of glucose control|1|||
42061423|NCT00658021|75870540|FG001|28-Week Treatment Period|Loss of glucose control|1|||
42061424|NCT00658021|75870541|FG002|28-Week Treatment Period|Loss of glucose control|10|||
42174504|NCT03292588|75981256|FG000|Overall Study|Death|1|||
42061425|NCT00658021|75870539|FG000|28-Week Treatment Period|Other|2|||
42061426|NCT00658021|75870540|FG001|28-Week Treatment Period|Other|3|||
42061427|NCT00658021|75870541|FG002|28-Week Treatment Period|Other|1|||
42061428|NCT00658021|75870539|FG000|28-Week Treatment Period|Did not receive treatment|2|||
42061429|NCT00658021|75870540|FG001|28-Week Treatment Period|Did not receive treatment|0|||
42061430|NCT00658021|75870541|FG002|28-Week Treatment Period|Did not receive treatment|0|||
42061431|NCT00658021|75870539|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
42061432|NCT00658021|75870540|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
42061433|NCT00658021|75870541|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
42061434|NCT00658021|75870539|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
42061435|NCT00658021|75870540|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
42061436|NCT00658021|75870541|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
42061437|NCT00920816|75870555|FG000|Overall Study|Death|116|||
42061438|NCT00920816|75870556|FG001|Overall Study|Death|63|||
42061439|NCT00920816|75870557|FG002|Overall Study|Death|8|||
42061440|NCT00920816|75870558|FG003|Overall Study|Death|3|||
42061441|NCT00920816|75870555|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
42061442|NCT00920816|75870556|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
42061443|NCT00920816|75870557|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
42061444|NCT00920816|75870558|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
42061445|NCT00920816|75870555|FG000|Overall Study|Global deterioration of health status|2|||
42061446|NCT00920816|75870556|FG001|Overall Study|Global deterioration of health status|0|||
42061447|NCT00920816|75870557|FG002|Overall Study|Global deterioration of health status|0|||
42061448|NCT00920816|75870558|FG003|Overall Study|Global deterioration of health status|0|||
42061449|NCT00920816|75870555|FG000|Overall Study|Objective progression or relapse|6|||
42061450|NCT00920816|75870556|FG001|Overall Study|Objective progression or relapse|2|||
42061451|NCT00920816|75870557|FG002|Overall Study|Objective progression or relapse|0|||
42061452|NCT00920816|75870558|FG003|Overall Study|Objective progression or relapse|0|||
42061453|NCT00920816|75870555|FG000|Overall Study|Other|26|||
42061454|NCT00920816|75870556|FG001|Overall Study|Other|15|||
42061455|NCT00920816|75870557|FG002|Overall Study|Other|1|||
42061456|NCT00920816|75870558|FG003|Overall Study|Other|2|||
42061457|NCT00920816|75870555|FG000|Overall Study|Lost to Follow-up|11|||
42061458|NCT00920816|75870556|FG001|Overall Study|Lost to Follow-up|2|||
42061459|NCT00920816|75870557|FG002|Overall Study|Lost to Follow-up|0|||
42061460|NCT00920816|75870558|FG003|Overall Study|Lost to Follow-up|0|||
42061461|NCT00920816|75870555|FG000|Overall Study|Adverse Event|1|||
42061462|NCT00920816|75870556|FG001|Overall Study|Adverse Event|1|||
42061463|NCT00920816|75870557|FG002|Overall Study|Adverse Event|1|||
42061464|NCT00920816|75870558|FG003|Overall Study|Adverse Event|0|||
42061465|NCT00920816|75870555|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
42061466|NCT00920816|75870556|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
42061467|NCT00920816|75870557|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
42061468|NCT00920816|75870558|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
42061469|NCT00920816|75870555|FG000|Overall Study|Randomized but not treated|3|||
42061470|NCT00920816|75870556|FG001|Overall Study|Randomized but not treated|0|||
42061471|NCT00920816|75870557|FG002|Overall Study|Randomized but not treated|0|||
42061472|NCT00920816|75870558|FG003|Overall Study|Randomized but not treated|0|||
42061473|NCT00657709|75870573|FG000|Overall Study|AE or Death|7|||
42061474|NCT00657709|75870574|FG001|Overall Study|AE or Death|7|||
42061475|NCT00657709|75870575|FG002|Overall Study|AE or Death|6|||
42061476|NCT00657709|75870576|FG003|Overall Study|AE or Death|7|||
42061477|NCT00657709|75870577|FG004|Overall Study|AE or Death|1|||
42061478|NCT00657709|75870573|FG000|Overall Study|Withdrawal by Subject|7|||
42061479|NCT00657709|75870574|FG001|Overall Study|Withdrawal by Subject|15|||
42061480|NCT00657709|75870575|FG002|Overall Study|Withdrawal by Subject|15|||
42061481|NCT00657709|75870576|FG003|Overall Study|Withdrawal by Subject|5|||
42174505|NCT03292588|75981257|FG001|Overall Study|Death|0|||
42291928|NCT01939366|76125382|FG002|Overall Study|Protocol Violation|0|||
42291929|NCT01939366|76125383|FG003|Overall Study|Protocol Violation|1|||
42291930|NCT01939366|76125384|FG004|Overall Study|Protocol Violation|0|||
42291931|NCT01939366|76125380|FG000|Overall Study|Sponsor decision|0|||
42291932|NCT01939366|76125381|FG001|Overall Study|Sponsor decision|0|||
42291933|NCT01939366|76125382|FG002|Overall Study|Sponsor decision|0|||
42291934|NCT01939366|76125383|FG003|Overall Study|Sponsor decision|0|||
42291935|NCT01939366|76125384|FG004|Overall Study|Sponsor decision|2|||
42291936|NCT01939366|76125380|FG000|Overall Study|GCP non-compliance at site|2|||
42291937|NCT01939366|76125381|FG001|Overall Study|GCP non-compliance at site|3|||
42061482|NCT00657709|75870577|FG004|Overall Study|Withdrawal by Subject|9|||
42061483|NCT00657709|75870573|FG000|Overall Study|Lost to Follow-up|9|||
42061484|NCT00657709|75870574|FG001|Overall Study|Lost to Follow-up|9|||
42061485|NCT00657709|75870575|FG002|Overall Study|Lost to Follow-up|7|||
42061486|NCT00657709|75870576|FG003|Overall Study|Lost to Follow-up|1|||
42061487|NCT00657709|75870577|FG004|Overall Study|Lost to Follow-up|21|||
42061488|NCT00657709|75870573|FG000|Overall Study|Protocol Violation|0|||
42061489|NCT00657709|75870574|FG001|Overall Study|Protocol Violation|2|||
42061490|NCT00657709|75870575|FG002|Overall Study|Protocol Violation|0|||
42061491|NCT00657709|75870576|FG003|Overall Study|Protocol Violation|1|||
42291938|NCT01939366|76125382|FG002|Overall Study|GCP non-compliance at site|2|||
42061492|NCT00657709|75870577|FG004|Overall Study|Protocol Violation|2|||
42061493|NCT00915356|75870604|FG000|Overall Study|Withdrawal by Subject|1|||
42061494|NCT00915356|75870605|FG001|Overall Study|Withdrawal by Subject|0|||
42061495|NCT00915356|75870606|FG002|Overall Study|Withdrawal by Subject|0|||
42061496|NCT00915356|75870607|FG003|Overall Study|Withdrawal by Subject|0|||
42061497|NCT00915356|75870608|FG004|Overall Study|Withdrawal by Subject|0|||
42061498|NCT00657553|75870622|FG000|Overall Study|low accrual, no analysis run|5|||
42061499|NCT00657553|75870623|FG001|Overall Study|low accrual, no analysis run|5|||
42061500|NCT00862719|75870633|FG000|Overall Study|Disease Progression|5|||
42061501|NCT00862719|75870634|FG001|Overall Study|Disease Progression|0|||
42061502|NCT00862719|75870635|FG002|Overall Study|Disease Progression|1|||
42061503|NCT00862719|75870636|FG003|Overall Study|Disease Progression|0|||
42061504|NCT00862719|75870633|FG000|Overall Study|Death|5|||
42061505|NCT00862719|75870634|FG001|Overall Study|Death|6|||
42061506|NCT00862719|75870635|FG002|Overall Study|Death|1|||
42061507|NCT00862719|75870636|FG003|Overall Study|Death|1|||
42061508|NCT00862719|75870633|FG000|Overall Study|Engraftment failure|0|||
42061509|NCT00862719|75870634|FG001|Overall Study|Engraftment failure|0|||
42061510|NCT00862719|75870635|FG002|Overall Study|Engraftment failure|1|||
42061511|NCT00862719|75870636|FG003|Overall Study|Engraftment failure|0|||
42061512|NCT00862719|75870633|FG000|Overall Study|Veno-Occlusive Disease|0|||
42061513|NCT00862719|75870634|FG001|Overall Study|Veno-Occlusive Disease|0|||
42061514|NCT00862719|75870635|FG002|Overall Study|Veno-Occlusive Disease|1|||
42061515|NCT00862719|75870636|FG003|Overall Study|Veno-Occlusive Disease|0|||
42061516|NCT00862641|75870650|FG000|Overall Study|Randomized, but drug not received|1|||
42061517|NCT00862641|75870651|FG001|Overall Study|Randomized, but drug not received|4|||
42061518|NCT00862641|75870652|FG002|Overall Study|Randomized, but drug not received|1|||
42061519|NCT00862641|75870653|FG003|Overall Study|Randomized, but drug not received|4|||
42061520|NCT00861471|75870663|FG000|Overall Study|Withdrawal by Subject|1|||
42061521|NCT00861471|75870663|FG000|Overall Study|Adverse Event|2|||
42061522|NCT00861471|75870663|FG000|Overall Study|Lack of Efficacy|3|||
42061523|NCT00861471|75870663|FG000|Overall Study|treatment for lumbar laminectomy|1|||
42061524|NCT00861471|75870663|FG000|Overall Study|Physician Decision|2|||
42061525|NCT00860067|75870670|FG000|Overall Study|Lost to Follow-up|46|||
42061526|NCT00860067|75870671|FG001|Overall Study|Lost to Follow-up|9|||
42061527|NCT00860067|75870672|FG002|Overall Study|Lost to Follow-up|9|||
42061528|NCT00860067|75870670|FG000|Overall Study|Withdrawal by Subject|4|||
42061529|NCT00860067|75870671|FG001|Overall Study|Withdrawal by Subject|0|||
42061530|NCT00860067|75870672|FG002|Overall Study|Withdrawal by Subject|0|||
42061531|NCT00860067|75870670|FG000|Overall Study|Pregnancy|1|||
42061532|NCT00860067|75870671|FG001|Overall Study|Pregnancy|0|||
42061533|NCT00860067|75870672|FG002|Overall Study|Pregnancy|0|||
42061534|NCT00858117|75870683|FG000|Treatment on Study|Adverse Event|2|||
42061535|NCT00858117|75870683|FG000|Follow up for 5 Years|Death|4|||
42061536|NCT00858117|75870683|FG000|Follow up for 5 Years|No further data collected for study|9|||
42061537|NCT00652951|75870690|FG000|Booster Phase|Adverse event, non-fatal|0|||
42061538|NCT00652951|75870691|FG001|Booster Phase|Adverse event, non-fatal|1|||
42061539|NCT00652951|75870692|FG002|Booster Phase|Adverse event, non-fatal|0|||
42061540|NCT00652951|75870690|FG000|Booster Phase|Other|1|||
42061541|NCT00652951|75870691|FG001|Booster Phase|Other|0|||
42061542|NCT00652951|75870692|FG002|Booster Phase|Other|0|||
42061543|NCT00848211|75870704|FG000|Overall Study|Protocol Violation|0|||
42061544|NCT00848211|75870705|FG001|Overall Study|Protocol Violation|1|||
42061545|NCT00848211|75870706|FG002|Overall Study|Protocol Violation|1|||
42061546|NCT00848211|75870707|FG003|Overall Study|Protocol Violation|0|||
42061547|NCT00848211|75870704|FG000|Overall Study|Adverse Event|0|||
42061548|NCT00848211|75870705|FG001|Overall Study|Adverse Event|0|||
42061549|NCT00848211|75870706|FG002|Overall Study|Adverse Event|0|||
42061550|NCT00848211|75870707|FG003|Overall Study|Adverse Event|0|||
42061551|NCT00592683|75870719|FG000|Overall Study|Found ineligible|0|||
42061552|NCT00592683|75870720|FG001|Overall Study|Found ineligible|1|||
42061553|NCT00592683|75870719|FG000|Overall Study|Withdrawal by Subject|1|||
42061554|NCT00592683|75870720|FG001|Overall Study|Withdrawal by Subject|0|||
42061555|NCT00592683|75870719|FG000|Overall Study|Adverse Event|0|||
42061556|NCT00592683|75870720|FG001|Overall Study|Adverse Event|2|||
42174506|NCT03292588|75981256|FG000|Overall Study|Lost to Follow-up|12|||
42061557|NCT00592683|75870719|FG000|Overall Study|Protocol Violation|1|||
42061558|NCT00592683|75870720|FG001|Overall Study|Protocol Violation|0|||
42061559|NCT00592683|75870719|FG000|Overall Study|Study drug expired|1|||
42061560|NCT00592683|75870720|FG001|Overall Study|Study drug expired|0|||
42061561|NCT00592683|75870719|FG000|Overall Study|Other|1|||
42061562|NCT00592683|75870720|FG001|Overall Study|Other|0|||
42061563|NCT00592683|75870719|FG000|Overall Study|Lost to Follow-up|0|||
42061564|NCT00592683|75870720|FG001|Overall Study|Lost to Follow-up|1|||
42061565|NCT00847665|75870728|FG000|Overall Study|Withdrawal by Subject|1|||
42061566|NCT00847665|75870729|FG001|Overall Study|Withdrawal by Subject|0|||
42061567|NCT00916370|75870737|FG000|Overall Study|Death|3|||
42061568|NCT00916370|75870738|FG001|Overall Study|Death|1|||
42061569|NCT00916370|75870737|FG000|Overall Study|Withdrawal by Subject|2|||
42061570|NCT00916370|75870738|FG001|Overall Study|Withdrawal by Subject|0|||
42061571|NCT00916370|75870737|FG000|Overall Study|Physician Decision|0|||
42061572|NCT00916370|75870738|FG001|Overall Study|Physician Decision|1|||
42061573|NCT00847197|75870747|FG000|Overall Study|Adverse Event|21|||
42061574|NCT00847197|75870748|FG001|Overall Study|Adverse Event|3|||
42061575|NCT00847197|75870747|FG000|Overall Study|Protocol Violation|0|||
42061576|NCT00847197|75870748|FG001|Overall Study|Protocol Violation|1|||
42061577|NCT00847197|75870747|FG000|Overall Study|Withdrawal by Subject|3|||
42061578|NCT00847197|75870748|FG001|Overall Study|Withdrawal by Subject|1|||
42061579|NCT00654901|75870758|FG000|Overall Study|Lost to Follow-up|1|||
42061580|NCT00654901|75870759|FG001|Overall Study|Lost to Follow-up|0|||
42061581|NCT00654901|75870760|FG002|Overall Study|Lost to Follow-up|1|||
42061582|NCT00654901|75870761|FG003|Overall Study|Lost to Follow-up|0|||
42061583|NCT00654901|75870758|FG000|Overall Study|Withdrawal by Subject|3|||
42061584|NCT00654901|75870759|FG001|Overall Study|Withdrawal by Subject|0|||
42061585|NCT00654901|75870760|FG002|Overall Study|Withdrawal by Subject|1|||
42061586|NCT00654901|75870761|FG003|Overall Study|Withdrawal by Subject|0|||
42061587|NCT00846807|75870771|FG000|Overall Study|Adverse Event|270|||
42061588|NCT00846807|75870771|FG000|Overall Study|Lost to Follow-up|94|||
42061589|NCT00846807|75870771|FG000|Overall Study|Withdrawal by Subject|56|||
42061590|NCT00846807|75870771|FG000|Overall Study|Non compliant with European label|7|||
42061591|NCT00846807|75870771|FG000|Overall Study|Switch to other anticoagulants|89|||
42061592|NCT00846807|75870771|FG000|Overall Study|No prescription after hospital discharge|56|||
42061593|NCT00846807|75870771|FG000|Overall Study|Other|60|||
42061594|NCT00846495|75870777|FG000|Overall Study|Lost to Follow-up|1|||
42061595|NCT00846495|75870778|FG001|Overall Study|Lost to Follow-up|0|||
42061596|NCT00846495|75870777|FG000|Overall Study|Adverse Event|5|||
42061597|NCT00846495|75870778|FG001|Overall Study|Adverse Event|1|||
42061598|NCT00846495|75870777|FG000|Overall Study|Lack of Efficacy|1|||
42061599|NCT00846495|75870778|FG001|Overall Study|Lack of Efficacy|2|||
42061600|NCT00846495|75870777|FG000|Overall Study|Physician Decision|1|||
42061601|NCT00846495|75870778|FG001|Overall Study|Physician Decision|0|||
42061602|NCT00654745|75870784|FG000|Overall Study|Adverse Event|12|||
42061603|NCT00654745|75870784|FG000|Overall Study|Lost to Follow-up|7|||
42061604|NCT00654745|75870784|FG000|Overall Study|Protocol Violation|11|||
42061605|NCT00654745|75870784|FG000|Overall Study|Withdrawal by Subject|10|||
42061606|NCT00654745|75870784|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
42061607|NCT00846027|75870794|FG000|Overall Study|Death|3|||
42061608|NCT00846027|75870794|FG000|Overall Study|Disease Progression|30|||
42061609|NCT00846027|75870794|FG000|Overall Study|Toxicity|12|||
42061610|NCT00846027|75870794|FG000|Overall Study|Patient Decision|7|||
42061611|NCT00846027|75870794|FG000|Overall Study|Investigator Discretion|29|||
42061612|NCT00846027|75870794|FG000|Overall Study|Protocol Violation|2|||
42061613|NCT00846027|75870794|FG000|Overall Study|Subject Not Treated|7|||
42061614|NCT00646399|75870800|FG000|Overall Study|Death|63|||
42061615|NCT00646399|75870801|FG001|Overall Study|Death|53|||
42061616|NCT00646399|75870800|FG000|Overall Study|Withdrawal by Subject|9|||
42061617|NCT00646399|75870801|FG001|Overall Study|Withdrawal by Subject|10|||
42061618|NCT00646399|75870800|FG000|Overall Study|Other Reason|11|||
42061619|NCT00646399|75870801|FG001|Overall Study|Other Reason|11|||
42061620|NCT00652327|75870809|FG000|Overall Study|Adverse Event|0|||
42061621|NCT00652327|75870810|FG001|Overall Study|Adverse Event|2|||
42061622|NCT00652327|75870809|FG000|Overall Study|Lost to Follow-up|0|||
42061623|NCT00652327|75870810|FG001|Overall Study|Lost to Follow-up|3|||
42061624|NCT00645853|75870818|FG000|Overall Study|Adverse Event|18|||
42061625|NCT00645853|75870819|FG001|Overall Study|Adverse Event|7|||
42061626|NCT00645853|75870818|FG000|Overall Study|AZ study closure in Hungary|60|||
42174507|NCT03292588|75981257|FG001|Overall Study|Lost to Follow-up|16|||
42174508|NCT03292588|75981256|FG000|Overall Study|Physician Decision|0|||
42061627|NCT00645853|75870819|FG001|Overall Study|AZ study closure in Hungary|40|||
42174509|NCT03292588|75981257|FG001|Overall Study|Physician Decision|1|||
42174510|NCT03292588|75981256|FG000|Overall Study|Withdrawal by Subject|4|||
42061628|NCT00645853|75870818|FG000|Overall Study|Withdrawal by Subject|5|||
42061629|NCT00645853|75870819|FG001|Overall Study|Withdrawal by Subject|2|||
42061630|NCT00645853|75870818|FG000|Overall Study|Protocol Violation|0|||
42061631|NCT00645853|75870819|FG001|Overall Study|Protocol Violation|2|||
42061632|NCT00645853|75870818|FG000|Overall Study|Discontinuation criteria|2|||
42061633|NCT00645853|75870819|FG001|Overall Study|Discontinuation criteria|2|||
42061634|NCT00645853|75870818|FG000|Overall Study|recall of ICF, planned operation, death|7|||
42061635|NCT00645853|75870819|FG001|Overall Study|recall of ICF, planned operation, death|4|||
42061636|NCT00652093|75870831|FG000|Overall Study|Withdrawal by Subject|0|||
42061637|NCT00652093|75870832|FG001|Overall Study|Withdrawal by Subject|0|||
42061638|NCT00652093|75870833|FG002|Overall Study|Withdrawal by Subject|1|||
42061639|NCT00652093|75870834|FG003|Overall Study|Withdrawal by Subject|0|||
42061640|NCT00652093|75870835|FG004|Overall Study|Withdrawal by Subject|1|||
42061641|NCT00652093|75870836|FG005|Overall Study|Withdrawal by Subject|0|||
42061642|NCT00652093|75870831|FG000|Overall Study|Physician Decision|0|||
42061643|NCT00652093|75870832|FG001|Overall Study|Physician Decision|0|||
42061644|NCT00652093|75870833|FG002|Overall Study|Physician Decision|0|||
42061645|NCT00652093|75870834|FG003|Overall Study|Physician Decision|0|||
42061646|NCT00652093|75870835|FG004|Overall Study|Physician Decision|1|||
42061647|NCT00652093|75870836|FG005|Overall Study|Physician Decision|0|||
42061648|NCT00651937|75870852|FG000|Overall Study|Withdrawal by Subject|4|||
42061649|NCT00651937|75870853|FG001|Overall Study|Withdrawal by Subject|1|||
42061650|NCT00654355|75870861|FG000|Overall Study|Lost to Follow-up|2|||
42061651|NCT00654355|75870862|FG001|Overall Study|Lost to Follow-up|2|||
42061652|NCT00651313|75870870|FG000|Overall Study|Adverse Event|0|||
42061653|NCT00651313|75870871|FG001|Overall Study|Adverse Event|1|||
42061654|NCT00651313|75870870|FG000|Overall Study|Withdrawal by Subject|3|||
42061655|NCT00651313|75870871|FG001|Overall Study|Withdrawal by Subject|1|||
42061656|NCT00651313|75870870|FG000|Overall Study|Lost to Follow-up|1|||
42061657|NCT00651313|75870871|FG001|Overall Study|Lost to Follow-up|1|||
42061658|NCT00651313|75870870|FG000|Overall Study|Adminstrative Discontinuation|2|||
42061659|NCT00651313|75870871|FG001|Overall Study|Adminstrative Discontinuation|3|||
42061660|NCT00969761|75870889|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
42061661|NCT00969761|75870890|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
42061662|NCT00969761|75870891|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
42061663|NCT00969761|75870892|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
42061664|NCT00969761|75870893|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
42061665|NCT00969761|75870894|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
42061666|NCT00969761|75870895|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
42061667|NCT00969761|75870896|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
42061668|NCT00969761|75870897|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
42061669|NCT00969761|75870898|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
42061670|NCT00969761|75870899|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
42061671|NCT00969761|75870900|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
42061672|NCT00969761|75870889|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
42061673|NCT00969761|75870890|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
42061674|NCT00969761|75870891|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
42061675|NCT00969761|75870892|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
42061676|NCT00969761|75870893|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
42061677|NCT00969761|75870894|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
42061678|NCT00969761|75870895|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
42061679|NCT00969761|75870896|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
42061680|NCT00969761|75870897|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
42061681|NCT00969761|75870898|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
42061682|NCT00969761|75870899|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
42061683|NCT00969761|75870900|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
42061684|NCT00969761|75870889|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
42061685|NCT00969761|75870890|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
42061686|NCT00969761|75870891|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
42061687|NCT00969761|75870892|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
42061688|NCT00969761|75870893|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
42061689|NCT00969761|75870894|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
42061690|NCT00969761|75870895|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
42061691|NCT00969761|75870896|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
42061692|NCT00969761|75870897|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
42061693|NCT00969761|75870898|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
42061694|NCT00969761|75870899|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
42061695|NCT00969761|75870900|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
42061696|NCT00969761|75870889|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
42061697|NCT00969761|75870890|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
42061698|NCT00969761|75870891|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
42061699|NCT00969761|75870892|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
42061700|NCT00969761|75870893|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
42061701|NCT00969761|75870894|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
42061702|NCT00969761|75870895|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
42061703|NCT00969761|75870896|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
42061704|NCT00969761|75870897|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
42061705|NCT00969761|75870898|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
42061706|NCT00969761|75870899|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
42291939|NCT01939366|76125383|FG003|Overall Study|GCP non-compliance at site|3|||
42061707|NCT00969761|75870900|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
42061708|NCT00969761|75870889|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
42061709|NCT00969761|75870890|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
42061710|NCT00969761|75870891|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
42061711|NCT00969761|75870892|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
42061712|NCT00969761|75870893|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
42061713|NCT00969761|75870894|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
42061714|NCT00969761|75870895|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
42061715|NCT00969761|75870896|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
42061716|NCT00969761|75870897|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
42061717|NCT00969761|75870898|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
42061718|NCT00969761|75870899|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
42061719|NCT00969761|75870900|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
42061720|NCT00969761|75870889|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
42061721|NCT00969761|75870890|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
42061722|NCT00969761|75870891|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
42061723|NCT00969761|75870892|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
42061724|NCT00969761|75870893|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
42061725|NCT00969761|75870894|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
42061726|NCT00969761|75870895|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
42061727|NCT00969761|75870896|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
42061728|NCT00969761|75870897|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
42061729|NCT00969761|75870898|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
42061730|NCT00969761|75870899|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
42061731|NCT00969761|75870900|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
42061732|NCT00845871|75870926|FG000|Assessment Period|Adverse Event|2|||
42061733|NCT00845871|75870926|FG000|Assessment Period|Abnormal laboratory values|1|||
42061734|NCT00845871|75870926|FG000|Assessment Period|Abnormal test procedure results|1|||
42061735|NCT00845871|75870926|FG000|Assessment Period|Patient withdrew consent|3|||
42061736|NCT00915278|75870956|FG000|Overall Study|Death|1|||
42061737|NCT00915278|75870957|FG001|Overall Study|Death|0|||
42061738|NCT00915278|75870958|FG002|Overall Study|Death|0|||
42061739|NCT00915278|75870959|FG003|Overall Study|Death|0|||
42061740|NCT00915278|75870960|FG004|Overall Study|Death|0|||
42061741|NCT00915278|75870961|FG005|Overall Study|Death|0|||
42061742|NCT00915278|75870956|FG000|Overall Study|Lost to Follow-up|0|||
42061743|NCT00915278|75870957|FG001|Overall Study|Lost to Follow-up|1|||
42061744|NCT00915278|75870958|FG002|Overall Study|Lost to Follow-up|0|||
42061745|NCT00915278|75870959|FG003|Overall Study|Lost to Follow-up|0|||
42061746|NCT00915278|75870960|FG004|Overall Study|Lost to Follow-up|0|||
42061747|NCT00915278|75870961|FG005|Overall Study|Lost to Follow-up|0|||
42061748|NCT00915278|75870956|FG000|Overall Study|Withdrawal by Subject|0|||
42061749|NCT00915278|75870957|FG001|Overall Study|Withdrawal by Subject|1|||
42061750|NCT00915278|75870958|FG002|Overall Study|Withdrawal by Subject|0|||
42061751|NCT00915278|75870959|FG003|Overall Study|Withdrawal by Subject|0|||
42061752|NCT00915278|75870960|FG004|Overall Study|Withdrawal by Subject|1|||
42061753|NCT00915278|75870961|FG005|Overall Study|Withdrawal by Subject|4|||
42061754|NCT00915278|75870956|FG000|Overall Study|Adverse Event|4|||
42061755|NCT00915278|75870957|FG001|Overall Study|Adverse Event|1|||
42061756|NCT00915278|75870958|FG002|Overall Study|Adverse Event|0|||
42061757|NCT00915278|75870959|FG003|Overall Study|Adverse Event|0|||
42061758|NCT00915278|75870960|FG004|Overall Study|Adverse Event|0|||
42061759|NCT00915278|75870961|FG005|Overall Study|Adverse Event|0|||
42061760|NCT00915278|75870956|FG000|Overall Study|Progressive disease/clinical progression|0|||
42061761|NCT00915278|75870957|FG001|Overall Study|Progressive disease/clinical progression|0|||
42061762|NCT00915278|75870958|FG002|Overall Study|Progressive disease/clinical progression|0|||
42061763|NCT00915278|75870959|FG003|Overall Study|Progressive disease/clinical progression|3|||
42061764|NCT00915278|75870960|FG004|Overall Study|Progressive disease/clinical progression|1|||
42061765|NCT00915278|75870961|FG005|Overall Study|Progressive disease/clinical progression|2|||
42061766|NCT00915278|75870956|FG000|Overall Study|Infusion related AEs|0|||
42061767|NCT00915278|75870957|FG001|Overall Study|Infusion related AEs|0|||
42061768|NCT00915278|75870958|FG002|Overall Study|Infusion related AEs|0|||
42061769|NCT00915278|75870959|FG003|Overall Study|Infusion related AEs|0|||
42061770|NCT00915278|75870960|FG004|Overall Study|Infusion related AEs|0|||
42061771|NCT00915278|75870961|FG005|Overall Study|Infusion related AEs|2|||
42061772|NCT00915278|75870956|FG000|Overall Study|Admission to hospice|0|||
42061773|NCT00915278|75870957|FG001|Overall Study|Admission to hospice|0|||
42061774|NCT00915278|75870958|FG002|Overall Study|Admission to hospice|1|||
42061775|NCT00915278|75870959|FG003|Overall Study|Admission to hospice|0|||
42061776|NCT00915278|75870960|FG004|Overall Study|Admission to hospice|0|||
42061777|NCT00915278|75870961|FG005|Overall Study|Admission to hospice|0|||
42061778|NCT00844857|75870977|FG000|Overall Study|Adverse Event|24|||
42061779|NCT00844857|75870978|FG001|Overall Study|Adverse Event|5|||
42061780|NCT00844857|75870977|FG000|Overall Study|Sponsor Decision|1|||
42061781|NCT00844857|75870978|FG001|Overall Study|Sponsor Decision|1|||
42061782|NCT00844857|75870977|FG000|Overall Study|Physician Decision|2|||
42061783|NCT00844857|75870978|FG001|Overall Study|Physician Decision|0|||
42061784|NCT00844857|75870977|FG000|Overall Study|Parent/Caregiver Decision|6|||
42061785|NCT00844857|75870978|FG001|Overall Study|Parent/Caregiver Decision|2|||
42061786|NCT00844857|75870977|FG000|Overall Study|Withdrawal by Subject|8|||
42061787|NCT00844857|75870978|FG001|Overall Study|Withdrawal by Subject|7|||
42061788|NCT00844857|75870977|FG000|Overall Study|Protocol Violation|6|||
42061789|NCT00844857|75870978|FG001|Overall Study|Protocol Violation|0|||
42061790|NCT00844857|75870977|FG000|Overall Study|Lack of Efficacy|5|||
42061791|NCT00844857|75870978|FG001|Overall Study|Lack of Efficacy|5|||
42061792|NCT00844857|75870977|FG000|Overall Study|Clinical Relapse|0|||
42061793|NCT00844857|75870978|FG001|Overall Study|Clinical Relapse|1|||
42061794|NCT00844857|75870977|FG000|Overall Study|Entry Criteria Not Met|0|||
42061795|NCT00844857|75870978|FG001|Overall Study|Entry Criteria Not Met|1|||
42061796|NCT00844857|75870977|FG000|Overall Study|Lost to Follow-up|2|||
42061797|NCT00844857|75870978|FG001|Overall Study|Lost to Follow-up|3|||
42061798|NCT00844857|75870977|FG000|Overall Study|Did Not Take Study Drug|3|||
42061799|NCT00844857|75870978|FG001|Overall Study|Did Not Take Study Drug|1|||
42061800|NCT00844857|75870977|FG000|Overall Study|Good Clinical Practice Violations|21|||
42061801|NCT00844857|75870978|FG001|Overall Study|Good Clinical Practice Violations|11|||
42061802|NCT00569803|75870995|FG000|Overall Study|Lost to Follow-up|1|||
42061803|NCT00569803|75870996|FG001|Overall Study|Lost to Follow-up|0|||
42061804|NCT00569803|75870997|FG002|Overall Study|Lost to Follow-up|0|||
42061805|NCT00569803|75870998|FG003|Overall Study|Lost to Follow-up|0|||
42061806|NCT00569803|75870999|FG004|Overall Study|Lost to Follow-up|0|||
42061807|NCT00569803|75871000|FG005|Overall Study|Lost to Follow-up|0|||
42061808|NCT00569803|75871001|FG006|Overall Study|Lost to Follow-up|0|||
42061809|NCT00569803|75871002|FG007|Overall Study|Lost to Follow-up|0|||
42061810|NCT00569803|75870995|FG000|Overall Study|injection syringe leaked during dosing|0|||
42061811|NCT00569803|75870996|FG001|Overall Study|injection syringe leaked during dosing|0|||
42061812|NCT00569803|75870997|FG002|Overall Study|injection syringe leaked during dosing|0|||
42061813|NCT00569803|75870998|FG003|Overall Study|injection syringe leaked during dosing|1|||
42061814|NCT00569803|75870999|FG004|Overall Study|injection syringe leaked during dosing|0|||
42061815|NCT00569803|75871000|FG005|Overall Study|injection syringe leaked during dosing|0|||
42061816|NCT00569803|75871001|FG006|Overall Study|injection syringe leaked during dosing|0|||
42061817|NCT00569803|75871002|FG007|Overall Study|injection syringe leaked during dosing|0|||
42061818|NCT00569803|75870995|FG000|Overall Study|Withdrawal by Subject|0|||
42061819|NCT00569803|75870996|FG001|Overall Study|Withdrawal by Subject|0|||
42061820|NCT00569803|75870997|FG002|Overall Study|Withdrawal by Subject|0|||
42061821|NCT00569803|75870998|FG003|Overall Study|Withdrawal by Subject|0|||
42061822|NCT00569803|75870999|FG004|Overall Study|Withdrawal by Subject|0|||
42061823|NCT00569803|75871000|FG005|Overall Study|Withdrawal by Subject|0|||
42061824|NCT00569803|75871001|FG006|Overall Study|Withdrawal by Subject|0|||
42061825|NCT00569803|75871002|FG007|Overall Study|Withdrawal by Subject|1|||
42061826|NCT00920426|75871027|FG000|ITZ111451|Adverse Event|1|||
42061827|NCT00920426|75871028|FG001|ITZ111451|Adverse Event|0|||
42061828|NCT00920426|75871029|FG002|ITZ111451|Adverse Event|0|||
42061829|NCT00920426|75871030|FG003|ITZ111451|Adverse Event|0|||
42061830|NCT00644995|75871044|FG000|Overall Study|Lost to Follow-up|1|||
42061831|NCT00644995|75871045|FG001|Overall Study|Lost to Follow-up|4|||
42061832|NCT00644995|75871044|FG000|Overall Study|Refused|1|||
42061833|NCT00644995|75871045|FG001|Overall Study|Refused|0|||
42061834|NCT00914966|75871053|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
42061835|NCT00914966|75871053|FG000|Step 1: 1500 Units|Physician Decision|1|||
42061836|NCT00914966|75871053|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
42061837|NCT00914810|75871064|FG000|Overall Study|Withdrawal by Subject|1|||
42061838|NCT00914810|75871065|FG001|Overall Study|Withdrawal by Subject|0|||
42061839|NCT00914810|75871064|FG000|Overall Study|Relocated out of state|1|||
42061840|NCT00914810|75871065|FG001|Overall Study|Relocated out of state|0|||
42061841|NCT00914810|75871064|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
42061842|NCT00914810|75871065|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
42061843|NCT00644917|75871071|FG000|Overall Study|Withdrawal by Subject|2|||
42061844|NCT00914732|75871082|FG000|Overall Study|Lost to Follow-up|6|||
42061845|NCT00914732|75871083|FG001|Overall Study|Lost to Follow-up|7|||
42061846|NCT00914732|75871084|FG002|Overall Study|Lost to Follow-up|9|||
42061847|NCT00914732|75871082|FG000|Overall Study|Withdrawal by Subject|3|||
42061848|NCT00914732|75871083|FG001|Overall Study|Withdrawal by Subject|0|||
42061849|NCT00914732|75871084|FG002|Overall Study|Withdrawal by Subject|2|||
42061850|NCT00914732|75871082|FG000|Overall Study|Adverse Event|1|||
42061851|NCT00914732|75871083|FG001|Overall Study|Adverse Event|0|||
42061852|NCT00914732|75871084|FG002|Overall Study|Adverse Event|0|||
42061853|NCT00844545|75871093|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
42061854|NCT00844545|75871093|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
42061855|NCT00844545|75871093|FG000|Extension Treatment Period|Adverse Event|2|||
42174511|NCT03292588|75981257|FG001|Overall Study|Withdrawal by Subject|4|||
42174512|NCT03292588|75981256|FG000|Overall Study|Move out of town|1|||
42174513|NCT03292588|75981257|FG001|Overall Study|Move out of town|0|||
42357287|NCT01725308|76202605|FG002|Treatment Period II|Withdrawal of Consent|16|||
42061856|NCT00844545|75871093|FG000|Post Treatment Period|Withdrawal by Subject|1|||
42061857|NCT00651157|75871098|FG000|Overall Study|Death|1|||
42061858|NCT00651157|75871098|FG000|Overall Study|Protocol Violation|1|||
42061859|NCT00843843|75871104|FG000|Overall Study|Physician Decision|1|||
42061860|NCT00843843|75871105|FG001|Overall Study|Physician Decision|1|||
42061861|NCT00843843|75871104|FG000|Overall Study|Protocol Violation|1|||
42061862|NCT00843843|75871105|FG001|Overall Study|Protocol Violation|1|||
42061863|NCT00650845|75871113|FG000|Overall Study|Withdrawal by Subject|5|||
42061864|NCT00650845|75871114|FG001|Overall Study|Withdrawal by Subject|0|||
42061865|NCT00650845|75871113|FG000|Overall Study|Protocol Violation|0|||
42061866|NCT00650845|75871114|FG001|Overall Study|Protocol Violation|13|||
42061867|NCT00842985|75871121|FG000|Screening|Did not meet entrance requirements|27|||
42061868|NCT00842985|75871121|FG000|First Intervention|Withdrawal by Subject|3|||
42061869|NCT00842985|75871121|FG000|First Intervention|Protocol Violation|3|||
42061870|NCT00842985|75871121|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
42061871|NCT00842985|75871121|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
42061872|NCT00842829|75871130|FG000|Dose Titration Period|Adverse Event|11|||
42061873|NCT00842829|75871131|FG001|Dose Titration Period|Adverse Event|10|||
42061874|NCT00842829|75871132|FG002|Dose Titration Period|Adverse Event|0|||
42061875|NCT00842829|75871130|FG000|Dose Titration Period|Lack of Efficacy|4|||
42061876|NCT00842829|75871131|FG001|Dose Titration Period|Lack of Efficacy|1|||
42061877|NCT00842829|75871132|FG002|Dose Titration Period|Lack of Efficacy|0|||
42061878|NCT00842829|75871130|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
42061879|NCT00842829|75871131|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
42061880|NCT00842829|75871132|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
42061881|NCT00842829|75871130|FG000|Dose Titration Period|Withdrawal by Subject|2|||
42061882|NCT00842829|75871131|FG001|Dose Titration Period|Withdrawal by Subject|6|||
42061883|NCT00842829|75871132|FG002|Dose Titration Period|Withdrawal by Subject|0|||
42061884|NCT00842829|75871130|FG000|Dose Titration Period|Other|5|||
42061885|NCT00842829|75871131|FG001|Dose Titration Period|Other|4|||
42061886|NCT00842829|75871132|FG002|Dose Titration Period|Other|0|||
42061887|NCT00842829|75871130|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
42061888|NCT00842829|75871131|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
42061889|NCT00842829|75871132|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
42061890|NCT00842829|75871130|FG000|Dose Titration Period|Non-compliance to study drug|2|||
42061891|NCT00842829|75871131|FG001|Dose Titration Period|Non-compliance to study drug|1|||
42061892|NCT00842829|75871132|FG002|Dose Titration Period|Non-compliance to study drug|0|||
42061893|NCT00842829|75871130|FG000|Treatment Period|Adverse Event|0|||
42016666|NCT00446043|75824162|FG000|Overall Study|Lost to Follow-up|42|||
42016667|NCT00446043|75824162|FG000|Overall Study|Pregnancy|2|||
42016668|NCT00400725|75824169|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
42016669|NCT00400725|75824170|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
42016670|NCT00400725|75824171|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
42016671|NCT00400725|75824169|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
42016672|NCT00400725|75824170|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
42016673|NCT00400725|75824171|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
42016674|NCT00400725|75824169|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
42061894|NCT00842829|75871131|FG001|Treatment Period|Adverse Event|0|||
42061895|NCT00842829|75871132|FG002|Treatment Period|Adverse Event|15|||
42061896|NCT00842829|75871130|FG000|Treatment Period|Lack of Efficacy|0|||
42061897|NCT00842829|75871131|FG001|Treatment Period|Lack of Efficacy|0|||
42061898|NCT00842829|75871132|FG002|Treatment Period|Lack of Efficacy|6|||
42061899|NCT00842829|75871130|FG000|Treatment Period|Unstable persistent cancer pain|0|||
42061900|NCT00842829|75871131|FG001|Treatment Period|Unstable persistent cancer pain|0|||
42174514|NCT03292588|75981256|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
42357288|NCT01725308|76202603|FG000|Treatment Period II|Lost to Follow-up|1|||
42061901|NCT00842829|75871132|FG002|Treatment Period|Unstable persistent cancer pain|5|||
42061902|NCT00842829|75871130|FG000|Treatment Period|Withdrawal by Subject|0|||
42357289|NCT01725308|76202604|FG001|Treatment Period II|Lost to Follow-up|5|||
42061903|NCT00842829|75871131|FG001|Treatment Period|Withdrawal by Subject|0|||
42061904|NCT00842829|75871132|FG002|Treatment Period|Withdrawal by Subject|11|||
42061905|NCT00842829|75871130|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
42061906|NCT00842829|75871131|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
42174515|NCT03292588|75981257|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
42357290|NCT01725308|76202605|FG002|Treatment Period II|Lost to Follow-up|3|||
42061907|NCT00842829|75871132|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
42061908|NCT00842829|75871130|FG000|Treatment Period|Protocol Violation|0|||
42061909|NCT00842829|75871131|FG001|Treatment Period|Protocol Violation|0|||
42061910|NCT00842829|75871132|FG002|Treatment Period|Protocol Violation|2|||
42061911|NCT00842829|75871130|FG000|Treatment Period|Other|0|||
42061912|NCT00842829|75871131|FG001|Treatment Period|Other|0|||
42061913|NCT00842829|75871132|FG002|Treatment Period|Other|18|||
42061914|NCT00842829|75871130|FG000|Treatment Period|Non-compliance to study procedures|0|||
42061915|NCT00842829|75871131|FG001|Treatment Period|Non-compliance to study procedures|0|||
42061916|NCT00842829|75871132|FG002|Treatment Period|Non-compliance to study procedures|4|||
42061917|NCT00842829|75871130|FG000|Treatment Period|Unclear completion status|0|||
42061918|NCT00842829|75871131|FG001|Treatment Period|Unclear completion status|0|||
42061919|NCT00842829|75871132|FG002|Treatment Period|Unclear completion status|1|||
42061920|NCT00842829|75871130|FG000|Continuation Period|Adverse Event|0|||
42061921|NCT00842829|75871131|FG001|Continuation Period|Adverse Event|0|||
42061922|NCT00842829|75871132|FG002|Continuation Period|Adverse Event|32|||
42061923|NCT00842829|75871130|FG000|Continuation Period|Lack of Efficacy|0|||
42061924|NCT00842829|75871131|FG001|Continuation Period|Lack of Efficacy|0|||
42061925|NCT00842829|75871132|FG002|Continuation Period|Lack of Efficacy|6|||
42061926|NCT00842829|75871130|FG000|Continuation Period|Unstable persistent cancer pain|0|||
42061927|NCT00842829|75871131|FG001|Continuation Period|Unstable persistent cancer pain|0|||
42061928|NCT00842829|75871132|FG002|Continuation Period|Unstable persistent cancer pain|3|||
42061929|NCT00842829|75871130|FG000|Continuation Period|Withdrawal by Subject|0|||
42061930|NCT00842829|75871131|FG001|Continuation Period|Withdrawal by Subject|0|||
42061931|NCT00842829|75871132|FG002|Continuation Period|Withdrawal by Subject|10|||
42061932|NCT00842829|75871130|FG000|Continuation Period|Other|0|||
42061933|NCT00842829|75871131|FG001|Continuation Period|Other|0|||
42061934|NCT00842829|75871132|FG002|Continuation Period|Other|7|||
42061935|NCT00842829|75871130|FG000|Continuation Period|Non-compliance to study procedures|0|||
42061936|NCT00842829|75871131|FG001|Continuation Period|Non-compliance to study procedures|0|||
42061937|NCT00842829|75871132|FG002|Continuation Period|Non-compliance to study procedures|2|||
42061938|NCT00842829|75871130|FG000|Continuation Period|Non-compliance to study drug|0|||
42061939|NCT00842829|75871131|FG001|Continuation Period|Non-compliance to study drug|0|||
42061940|NCT00842829|75871132|FG002|Continuation Period|Non-compliance to study drug|1|||
42061941|NCT00653263|75871144|FG000|Overall Study|Withdrawal by Subject|1|||
42061942|NCT00653263|75871144|FG000|Overall Study|Physician Decision|1|||
42357291|NCT01725308|76202603|FG000|Treatment Period II|Protocol Deviations|0|||
42357292|NCT01725308|76202604|FG001|Treatment Period II|Protocol Deviations|0|||
42357293|NCT01725308|76202605|FG002|Treatment Period II|Protocol Deviations|1|||
42061943|NCT00842361|75871150|FG000|Overall Study|Protocol Violation|1|||
42061944|NCT00842361|75871151|FG001|Overall Study|Protocol Violation|0|||
42061945|NCT00842361|75871150|FG000|Overall Study|Unclassified|0|||
42061946|NCT00842361|75871151|FG001|Overall Study|Unclassified|2|||
42061947|NCT00841035|75871157|FG000|Phase 1 Overall Study|Physician Decision|13|||
42061948|NCT00642811|75871168|FG000|Overall Study|Adverse Event|2|||
42061949|NCT00642811|75871169|FG001|Overall Study|Adverse Event|3|||
42061950|NCT00642811|75871170|FG002|Overall Study|Adverse Event|0|||
42061951|NCT00642811|75871171|FG003|Overall Study|Adverse Event|0|||
42061952|NCT00642811|75871172|FG004|Overall Study|Adverse Event|0|||
42061953|NCT00642811|75871173|FG005|Overall Study|Adverse Event|1|||
42061954|NCT00642811|75871168|FG000|Overall Study|Developement of discontinuation criteria|0|||
42061955|NCT00642811|75871169|FG001|Overall Study|Developement of discontinuation criteria|0|||
42061956|NCT00642811|75871170|FG002|Overall Study|Developement of discontinuation criteria|0|||
42061957|NCT00642811|75871171|FG003|Overall Study|Developement of discontinuation criteria|0|||
42061958|NCT00642811|75871172|FG004|Overall Study|Developement of discontinuation criteria|1|||
42061959|NCT00642811|75871173|FG005|Overall Study|Developement of discontinuation criteria|0|||
42061960|NCT00642811|75871168|FG000|Overall Study|Severe Non-compliance to protocol|1|||
42061961|NCT00642811|75871169|FG001|Overall Study|Severe Non-compliance to protocol|0|||
42061962|NCT00642811|75871170|FG002|Overall Study|Severe Non-compliance to protocol|0|||
42061963|NCT00642811|75871171|FG003|Overall Study|Severe Non-compliance to protocol|0|||
42061964|NCT00642811|75871172|FG004|Overall Study|Severe Non-compliance to protocol|0|||
42061965|NCT00642811|75871173|FG005|Overall Study|Severe Non-compliance to protocol|0|||
42061966|NCT00642811|75871168|FG000|Overall Study|Other|0|||
42061967|NCT00642811|75871169|FG001|Overall Study|Other|1|||
42061968|NCT00642811|75871170|FG002|Overall Study|Other|0|||
42061969|NCT00642811|75871171|FG003|Overall Study|Other|1|||
42061970|NCT00642811|75871172|FG004|Overall Study|Other|0|||
42061971|NCT00642811|75871173|FG005|Overall Study|Other|0|||
42061972|NCT00838929|75871190|FG000|Overall Study|Protocol Violation|0|||
42357294|NCT01725308|76202603|FG000|Treatment Period II|Miscellaneous|5|||
42357295|NCT01725308|76202604|FG001|Treatment Period II|Miscellaneous|3|||
42061973|NCT00838929|75871191|FG001|Overall Study|Protocol Violation|1|||
42061974|NCT00838929|75871192|FG002|Overall Study|Protocol Violation|0|||
42061975|NCT00838929|75871190|FG000|Overall Study|Disease progression|0|||
42061976|NCT00838929|75871191|FG001|Overall Study|Disease progression|2|||
42061977|NCT00838929|75871192|FG002|Overall Study|Disease progression|1|||
42061978|NCT00916058|75871205|FG000|Phase 1|Screen Failure|0|||
42061979|NCT00916058|75871206|FG001|Phase 1|Screen Failure|0|||
42061980|NCT00916058|75871207|FG002|Phase 1|Screen Failure|0|||
42061981|NCT00916058|75871208|FG003|Phase 1|Screen Failure|0|||
42061982|NCT00916058|75871209|FG004|Phase 1|Screen Failure|0|||
42061983|NCT00916058|75871210|FG005|Phase 1|Screen Failure|1|||
42061984|NCT00916058|75871211|FG006|Phase 1|Screen Failure|0|||
42061985|NCT00916058|75871205|FG000|Phase 2|Screen Failure|0|||
42061986|NCT00916058|75871206|FG001|Phase 2|Screen Failure|0|||
42061987|NCT00916058|75871207|FG002|Phase 2|Screen Failure|0|||
42061988|NCT00916058|75871208|FG003|Phase 2|Screen Failure|0|||
42061989|NCT00916058|75871209|FG004|Phase 2|Screen Failure|0|||
42061990|NCT00916058|75871210|FG005|Phase 2|Screen Failure|0|||
42061991|NCT00916058|75871211|FG006|Phase 2|Screen Failure|3|||
42061992|NCT00912782|75871231|FG000|Overall Study|Death|2|||
42061993|NCT00912782|75871232|FG001|Overall Study|Death|1|||
42061994|NCT00912782|75871231|FG000|Overall Study|Lost to Follow-up|0|||
42061995|NCT00912782|75871232|FG001|Overall Study|Lost to Follow-up|1|||
42061996|NCT00912782|75871231|FG000|Overall Study|Did not receive vascular access type|1|||
42061997|NCT00912782|75871232|FG001|Overall Study|Did not receive vascular access type|2|||
42061998|NCT00912782|75871231|FG000|Overall Study|Relocated before study completion|0|||
42061999|NCT00912782|75871232|FG001|Overall Study|Relocated before study completion|1|||
42062000|NCT03444038|75871238|FG000|Overall Study|Adverse Event|12|||
42062001|NCT03444038|75871238|FG000|Overall Study|Withdrawal by Subject|7|||
42062002|NCT03444038|75871238|FG000|Overall Study|Lost to Follow-up|1|||
42062003|NCT03444038|75871238|FG000|Overall Study|Physician Decision|2|||
42062004|NCT03444038|75871238|FG000|Overall Study|Lack of Efficacy|7|||
42062005|NCT00911534|75871244|FG000|Overall Study|Adverse Event|4|||
42062006|NCT00911534|75871245|FG001|Overall Study|Adverse Event|4|||
42062007|NCT00911534|75871244|FG000|Overall Study|Lost to Follow-up|2|||
42062008|NCT00911534|75871245|FG001|Overall Study|Lost to Follow-up|4|||
42062009|NCT00911534|75871244|FG000|Overall Study|Withdrawal by Subject|2|||
42062010|NCT00911534|75871245|FG001|Overall Study|Withdrawal by Subject|1|||
42062011|NCT00911534|75871244|FG000|Overall Study|Lack of Efficacy|4|||
42062012|NCT00911534|75871245|FG001|Overall Study|Lack of Efficacy|1|||
42062013|NCT00911534|75871244|FG000|Overall Study|Withdrawal of consent|1|||
42062014|NCT00911534|75871245|FG001|Overall Study|Withdrawal of consent|4|||
42062015|NCT00911534|75871244|FG000|Overall Study|Other|2|||
42062016|NCT00911534|75871245|FG001|Overall Study|Other|2|||
42062017|NCT00911300|75871253|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
42062018|NCT00911300|75871254|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
42062019|NCT00911300|75871253|FG000|Overall Study|Death|1|||
42062020|NCT00911300|75871254|FG001|Overall Study|Death|0|||
42062021|NCT00911300|75871253|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
42062022|NCT00911300|75871254|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
42062023|NCT00911300|75871253|FG000|Overall Study|Adverse Event|14|||
42062024|NCT00911300|75871254|FG001|Overall Study|Adverse Event|6|||
42062025|NCT00911300|75871253|FG000|Overall Study|Protocol Violation|3|||
42062026|NCT00911300|75871254|FG001|Overall Study|Protocol Violation|2|||
42062027|NCT00911300|75871253|FG000|Overall Study|Consent Withdrawn|4|||
42062028|NCT00911300|75871254|FG001|Overall Study|Consent Withdrawn|12|||
42062029|NCT00911300|75871253|FG000|Overall Study|Coronary Angiography Performed|1|||
42062030|NCT00911300|75871254|FG001|Overall Study|Coronary Angiography Performed|0|||
42062031|NCT00911300|75871253|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
42062032|NCT00911300|75871254|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
42062033|NCT00911300|75871253|FG000|Overall Study|Received Commercial Treatment|1|||
42062034|NCT00911300|75871254|FG001|Overall Study|Received Commercial Treatment|0|||
42062035|NCT00911300|75871253|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
42062036|NCT00911300|75871254|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
42062037|NCT00911300|75871253|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
42062038|NCT00911300|75871254|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
42062039|NCT00911300|75871253|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
42062040|NCT00911300|75871254|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
42062041|NCT00911300|75871253|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
42062042|NCT00911300|75871254|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
42062043|NCT00911300|75871253|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
42062044|NCT00911300|75871254|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
42062045|NCT00911300|75871253|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
42062046|NCT00911300|75871254|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
42062047|NCT00911300|75871253|FG000|Overall Study|International Normalized Ratio Too High|0|||
42062048|NCT00911300|75871254|FG001|Overall Study|International Normalized Ratio Too High|1|||
42062049|NCT00911300|75871253|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
42062050|NCT00911300|75871254|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
42062051|NCT00911300|75871253|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
42062052|NCT00911300|75871254|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
42062053|NCT00911300|75871253|FG000|Overall Study|Physician Decision|0|||
42062054|NCT00911300|75871254|FG001|Overall Study|Physician Decision|1|||
42062055|NCT00911300|75871253|FG000|Overall Study|Treatment Stopped by Mistake|0|||
42062056|NCT00911300|75871254|FG001|Overall Study|Treatment Stopped by Mistake|1|||
42062057|NCT00911300|75871253|FG000|Overall Study|Randomized; No Study Medication Received|0|||
42062058|NCT00911300|75871254|FG001|Overall Study|Randomized; No Study Medication Received|2|||
42062059|NCT00911144|75871263|FG000|Overall Study|Withdrawal by Subject|16|||
42062060|NCT00911144|75871264|FG001|Overall Study|Withdrawal by Subject|5|||
42062061|NCT00910988|75871274|FG000|Overall Study|Lost to Follow-up|2|||
42062062|NCT00910988|75871275|FG001|Overall Study|Lost to Follow-up|4|||
42062063|NCT00910988|75871276|FG002|Overall Study|Lost to Follow-up|3|||
42062064|NCT00910988|75871277|FG003|Overall Study|Lost to Follow-up|0|||
42062065|NCT00644059|75871306|FG000|Overall Study|Lost to Follow-up|37|||
42062066|NCT00644059|75871307|FG001|Overall Study|Lost to Follow-up|34|||
42062067|NCT00644059|75871308|FG002|Overall Study|Lost to Follow-up|16|||
42062068|NCT00644059|75871306|FG000|Overall Study|Withdrawal by Subject|52|||
42062069|NCT00644059|75871307|FG001|Overall Study|Withdrawal by Subject|60|||
42062070|NCT00644059|75871308|FG002|Overall Study|Withdrawal by Subject|30|||
42062071|NCT00644059|75871306|FG000|Overall Study|Adverse Event|8|||
42062072|NCT00644059|75871307|FG001|Overall Study|Adverse Event|5|||
42062073|NCT00644059|75871308|FG002|Overall Study|Adverse Event|1|||
42062074|NCT00644059|75871306|FG000|Overall Study|Inappropriate Enrollment|1|||
42062075|NCT00644059|75871307|FG001|Overall Study|Inappropriate Enrollment|3|||
42062076|NCT00644059|75871308|FG002|Overall Study|Inappropriate Enrollment|0|||
42062077|NCT00644059|75871306|FG000|Overall Study|Protocol Deviation/violation|20|||
42062078|NCT00644059|75871307|FG001|Overall Study|Protocol Deviation/violation|19|||
42062079|NCT00644059|75871308|FG002|Overall Study|Protocol Deviation/violation|15|||
42062080|NCT00644059|75871306|FG000|Overall Study|Unable to classify|6|||
42062081|NCT00644059|75871307|FG001|Overall Study|Unable to classify|2|||
42062082|NCT00644059|75871308|FG002|Overall Study|Unable to classify|3|||
42062083|NCT00910910|75871359|FG000|Overall Study|Adverse Event|63|||
42062084|NCT00910910|75871360|FG001|Overall Study|Adverse Event|35|||
42062085|NCT00910910|75871359|FG000|Overall Study|PD without histologic change|27|||
42062086|NCT00910910|75871360|FG001|Overall Study|PD without histologic change|23|||
42062087|NCT00910910|75871359|FG000|Overall Study|PD with histologic change|0|||
42062088|NCT00910910|75871360|FG001|Overall Study|PD with histologic change|2|||
42062089|NCT00910910|75871359|FG000|Overall Study|Withdrawal by Subject|7|||
42062090|NCT00910910|75871360|FG001|Overall Study|Withdrawal by Subject|5|||
42062091|NCT00910910|75871359|FG000|Overall Study|Lost to Follow-up|2|||
42062092|NCT00910910|75871360|FG001|Overall Study|Lost to Follow-up|2|||
42062093|NCT00910910|75871359|FG000|Overall Study|Death|9|||
42062094|NCT00910910|75871360|FG001|Overall Study|Death|3|||
42062095|NCT00910910|75871359|FG000|Overall Study|Protocol Violation|2|||
42062096|NCT00910910|75871360|FG001|Overall Study|Protocol Violation|2|||
42062097|NCT00910910|75871359|FG000|Overall Study|Completed 13 cycles of treatment|0|||
42062098|NCT00910910|75871360|FG001|Overall Study|Completed 13 cycles of treatment|118|||
42062099|NCT00910910|75871359|FG000|Overall Study|Other|114|||
42062100|NCT00910910|75871360|FG001|Overall Study|Other|32|||
42062101|NCT00910910|75871359|FG000|Overall Study|Untreated before cycle 1|1|||
42062102|NCT00910910|75871360|FG001|Overall Study|Untreated before cycle 1|2|||
42062103|NCT00911768|75871368|FG000|Overall Study|Protocol Violation|5|||
42062104|NCT00911768|75871369|FG001|Overall Study|Protocol Violation|4|||
42062105|NCT00911768|75871368|FG000|Overall Study|Withdrawal by Subject|1|||
42062106|NCT00911768|75871369|FG001|Overall Study|Withdrawal by Subject|0|||
42062107|NCT00909038|75871375|FG000|Overall Study|Protocol Violation|187|||
42062108|NCT00909038|75871375|FG000|Overall Study|Non-evaluable Subjects|230|||
42062109|NCT00909428|75871382|FG000|Overall Study|Lost to Follow-up|13|||
42062110|NCT00909428|75871383|FG001|Overall Study|Lost to Follow-up|10|||
42062111|NCT00909428|75871384|FG002|Overall Study|Lost to Follow-up|9|||
42062112|NCT00908960|75871394|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
42062113|NCT00908960|75871395|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
42062114|NCT00908960|75871396|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
42062115|NCT00650767|75871414|FG000|Overall Study|Adverse Event|0|||
42174516|NCT03752528|75981265|FG000|Part A|Lost to Follow-up|1|||
42062116|NCT00650767|75871415|FG001|Overall Study|Adverse Event|3|||
42062117|NCT00650767|75871416|FG002|Overall Study|Adverse Event|10|||
42062118|NCT00650767|75871417|FG003|Overall Study|Adverse Event|8|||
42174517|NCT03752528|75981265|FG000|Part A|Protocol Violation|1|||
42062119|NCT00650767|75871414|FG000|Overall Study|Death|1|||
42062120|NCT00650767|75871415|FG001|Overall Study|Death|0|||
42062121|NCT00650767|75871416|FG002|Overall Study|Death|0|||
42062122|NCT00650767|75871417|FG003|Overall Study|Death|0|||
42062123|NCT00650767|75871414|FG000|Overall Study|Withdrawal by Subject|2|||
42062124|NCT00650767|75871415|FG001|Overall Study|Withdrawal by Subject|4|||
42062125|NCT00650767|75871416|FG002|Overall Study|Withdrawal by Subject|3|||
42062126|NCT00650767|75871417|FG003|Overall Study|Withdrawal by Subject|3|||
42062127|NCT00650767|75871414|FG000|Overall Study|Lost to Follow-up|1|||
42062128|NCT00650767|75871415|FG001|Overall Study|Lost to Follow-up|1|||
42062129|NCT00650767|75871416|FG002|Overall Study|Lost to Follow-up|1|||
42174518|NCT03752528|75981265|FG000|Part B|Protocol Violation|1|||
42062130|NCT00650767|75871417|FG003|Overall Study|Lost to Follow-up|0|||
42062131|NCT00650767|75871414|FG000|Overall Study|Other|1|||
42062132|NCT00650767|75871415|FG001|Overall Study|Other|1|||
42062133|NCT00650767|75871416|FG002|Overall Study|Other|0|||
42062134|NCT00650767|75871417|FG003|Overall Study|Other|0|||
42062135|NCT00973349|75871443|FG000|Overall Study|Adverse Event|0|||
42062136|NCT00973349|75871444|FG001|Overall Study|Adverse Event|0|||
42062137|NCT00973349|75871445|FG002|Overall Study|Adverse Event|0|||
42062138|NCT00973349|75871446|FG003|Overall Study|Adverse Event|0|||
42062139|NCT00973349|75871447|FG004|Overall Study|Adverse Event|1|||
42062140|NCT00973349|75871448|FG005|Overall Study|Adverse Event|0|||
42062141|NCT00973349|75871449|FG006|Overall Study|Adverse Event|0|||
42062142|NCT00973349|75871450|FG007|Overall Study|Adverse Event|0|||
42062143|NCT00973349|75871451|FG008|Overall Study|Adverse Event|1|||
42062144|NCT00973349|75871452|FG009|Overall Study|Adverse Event|0|||
42062145|NCT00973349|75871453|FG010|Overall Study|Adverse Event|0|||
42062146|NCT00973349|75871454|FG011|Overall Study|Adverse Event|0|||
42062147|NCT00973349|75871455|FG012|Overall Study|Adverse Event|0|||
42062148|NCT00973349|75871456|FG013|Overall Study|Adverse Event|0|||
42062149|NCT00973349|75871457|FG014|Overall Study|Adverse Event|1|||
42062150|NCT00973349|75871458|FG015|Overall Study|Adverse Event|0|||
42062151|NCT00973349|75871443|FG000|Overall Study|Withdrawal by Subject|1|||
42062152|NCT00973349|75871444|FG001|Overall Study|Withdrawal by Subject|2|||
42062153|NCT00973349|75871445|FG002|Overall Study|Withdrawal by Subject|2|||
42062154|NCT00973349|75871446|FG003|Overall Study|Withdrawal by Subject|3|||
42062155|NCT00973349|75871447|FG004|Overall Study|Withdrawal by Subject|2|||
42062156|NCT00973349|75871448|FG005|Overall Study|Withdrawal by Subject|0|||
42062157|NCT00973349|75871449|FG006|Overall Study|Withdrawal by Subject|2|||
42062158|NCT00973349|75871450|FG007|Overall Study|Withdrawal by Subject|2|||
42062159|NCT00973349|75871451|FG008|Overall Study|Withdrawal by Subject|0|||
42062160|NCT00973349|75871452|FG009|Overall Study|Withdrawal by Subject|2|||
42062161|NCT00973349|75871453|FG010|Overall Study|Withdrawal by Subject|0|||
42062162|NCT00973349|75871454|FG011|Overall Study|Withdrawal by Subject|1|||
42062163|NCT00973349|75871455|FG012|Overall Study|Withdrawal by Subject|0|||
42062164|NCT00973349|75871456|FG013|Overall Study|Withdrawal by Subject|0|||
42062165|NCT00973349|75871457|FG014|Overall Study|Withdrawal by Subject|0|||
42062166|NCT00973349|75871458|FG015|Overall Study|Withdrawal by Subject|0|||
42062167|NCT00973349|75871443|FG000|Overall Study|Lost to Follow-up|3|||
42062168|NCT00973349|75871444|FG001|Overall Study|Lost to Follow-up|1|||
42062169|NCT00973349|75871445|FG002|Overall Study|Lost to Follow-up|2|||
42062170|NCT00973349|75871446|FG003|Overall Study|Lost to Follow-up|2|||
42062171|NCT00973349|75871447|FG004|Overall Study|Lost to Follow-up|1|||
42062172|NCT00973349|75871448|FG005|Overall Study|Lost to Follow-up|3|||
42062173|NCT00973349|75871449|FG006|Overall Study|Lost to Follow-up|0|||
42062174|NCT00973349|75871450|FG007|Overall Study|Lost to Follow-up|1|||
42062175|NCT00973349|75871451|FG008|Overall Study|Lost to Follow-up|2|||
42062176|NCT00973349|75871452|FG009|Overall Study|Lost to Follow-up|1|||
42062177|NCT00973349|75871453|FG010|Overall Study|Lost to Follow-up|0|||
42062178|NCT00973349|75871454|FG011|Overall Study|Lost to Follow-up|1|||
42062179|NCT00973349|75871455|FG012|Overall Study|Lost to Follow-up|0|||
42062180|NCT00973349|75871456|FG013|Overall Study|Lost to Follow-up|0|||
42062181|NCT00973349|75871457|FG014|Overall Study|Lost to Follow-up|0|||
42062182|NCT00973349|75871458|FG015|Overall Study|Lost to Follow-up|1|||
42062183|NCT00973349|75871443|FG000|Overall Study|Inappropriate enrolment|0|||
42062184|NCT00973349|75871444|FG001|Overall Study|Inappropriate enrolment|0|||
42062185|NCT00973349|75871445|FG002|Overall Study|Inappropriate enrolment|1|||
42062186|NCT00973349|75871446|FG003|Overall Study|Inappropriate enrolment|0|||
42062187|NCT00973349|75871447|FG004|Overall Study|Inappropriate enrolment|0|||
42062188|NCT00973349|75871448|FG005|Overall Study|Inappropriate enrolment|0|||
42062189|NCT00973349|75871449|FG006|Overall Study|Inappropriate enrolment|0|||
42062190|NCT00973349|75871450|FG007|Overall Study|Inappropriate enrolment|0|||
42062191|NCT00973349|75871451|FG008|Overall Study|Inappropriate enrolment|0|||
42062192|NCT00973349|75871452|FG009|Overall Study|Inappropriate enrolment|2|||
42062193|NCT00973349|75871453|FG010|Overall Study|Inappropriate enrolment|0|||
42062194|NCT00973349|75871454|FG011|Overall Study|Inappropriate enrolment|0|||
42062195|NCT00973349|75871455|FG012|Overall Study|Inappropriate enrolment|1|||
42062196|NCT00973349|75871456|FG013|Overall Study|Inappropriate enrolment|0|||
42062197|NCT00973349|75871457|FG014|Overall Study|Inappropriate enrolment|1|||
42062198|NCT00973349|75871458|FG015|Overall Study|Inappropriate enrolment|1|||
42062199|NCT00973349|75871443|FG000|Overall Study|Protocol Violation|0|||
42062200|NCT00973349|75871444|FG001|Overall Study|Protocol Violation|0|||
42062201|NCT00973349|75871445|FG002|Overall Study|Protocol Violation|0|||
42062202|NCT00973349|75871446|FG003|Overall Study|Protocol Violation|0|||
42062203|NCT00973349|75871447|FG004|Overall Study|Protocol Violation|0|||
42062204|NCT00973349|75871448|FG005|Overall Study|Protocol Violation|0|||
42062205|NCT00973349|75871449|FG006|Overall Study|Protocol Violation|0|||
42062206|NCT00973349|75871450|FG007|Overall Study|Protocol Violation|0|||
42062207|NCT00973349|75871451|FG008|Overall Study|Protocol Violation|1|||
42062208|NCT00973349|75871452|FG009|Overall Study|Protocol Violation|0|||
42062209|NCT00973349|75871453|FG010|Overall Study|Protocol Violation|0|||
42062210|NCT00973349|75871454|FG011|Overall Study|Protocol Violation|0|||
42062211|NCT00973349|75871455|FG012|Overall Study|Protocol Violation|0|||
42062212|NCT00973349|75871456|FG013|Overall Study|Protocol Violation|0|||
42062213|NCT00973349|75871457|FG014|Overall Study|Protocol Violation|0|||
42062214|NCT00973349|75871458|FG015|Overall Study|Protocol Violation|0|||
42062215|NCT00973349|75871443|FG000|Overall Study|Unable to classify|0|||
42062216|NCT00973349|75871444|FG001|Overall Study|Unable to classify|0|||
42062217|NCT00973349|75871445|FG002|Overall Study|Unable to classify|0|||
42062218|NCT00973349|75871446|FG003|Overall Study|Unable to classify|0|||
42062219|NCT00973349|75871447|FG004|Overall Study|Unable to classify|1|||
42062220|NCT00973349|75871448|FG005|Overall Study|Unable to classify|1|||
42062221|NCT00973349|75871449|FG006|Overall Study|Unable to classify|0|||
42062222|NCT00973349|75871450|FG007|Overall Study|Unable to classify|0|||
42062223|NCT00973349|75871451|FG008|Overall Study|Unable to classify|0|||
42062224|NCT00973349|75871452|FG009|Overall Study|Unable to classify|1|||
42062225|NCT00973349|75871453|FG010|Overall Study|Unable to classify|0|||
42062226|NCT00973349|75871454|FG011|Overall Study|Unable to classify|0|||
42062227|NCT00973349|75871455|FG012|Overall Study|Unable to classify|0|||
42062228|NCT00973349|75871456|FG013|Overall Study|Unable to classify|0|||
42062229|NCT00973349|75871457|FG014|Overall Study|Unable to classify|0|||
42062230|NCT00973349|75871458|FG015|Overall Study|Unable to classify|0|||
42062231|NCT00643201|75871486|FG000|Randomized, Completed 6 Months of Study|Death|20|||
42062232|NCT00643201|75871487|FG001|Randomized, Completed 6 Months of Study|Death|26|||
42062233|NCT00643201|75871486|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
42062234|NCT00643201|75871487|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
42062235|NCT00643201|75871486|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
42062236|NCT00643201|75871487|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
42062237|NCT00643201|75871486|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
42062238|NCT00643201|75871487|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
42062239|NCT00643201|75871486|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
42062240|NCT00643201|75871487|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
42062241|NCT00643201|75871486|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
42062242|NCT00643201|75871487|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
42062243|NCT00643201|75871486|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
42174519|NCT03752528|75981265|FG000|Part B|Study terminated by sponsor|3|||
42174520|NCT00334295|75981272|FG000|Overall Study|Patients received fewer than 3 injection|5|||
42174521|NCT03292432|75981278|FG000|Overall Study|Lost to Follow-up|11|||
42174522|NCT03292432|75981279|FG001|Overall Study|Lost to Follow-up|8|||
42174523|NCT03292432|75981278|FG000|Overall Study|Death|2|||
42174524|NCT03292432|75981279|FG001|Overall Study|Death|1|||
42174525|NCT03292432|75981278|FG000|Overall Study|Withdrawal by Subject|1|||
42174526|NCT03292432|75981279|FG001|Overall Study|Withdrawal by Subject|2|||
42174527|NCT03292432|75981278|FG000|Overall Study|Site closed before any data collected|1|||
42174528|NCT03292432|75981279|FG001|Overall Study|Site closed before any data collected|0|||
42174529|NCT03291808|75981285|FG000|Overall Study|Lost to Follow-up|6|||
42174530|NCT03291808|75981285|FG000|Overall Study|Research burden|4|||
42174531|NCT03263806|75981291|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
42174532|NCT03263806|75981292|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
42174533|NCT03263806|75981291|FG000|Overall Study|Withdrawal by Subject|0|||
42174534|NCT03263806|75981292|FG001|Overall Study|Withdrawal by Subject|1|||
42174535|NCT03263806|75981291|FG000|Overall Study|Study Termination|5|||
42174536|NCT03263806|75981292|FG001|Overall Study|Study Termination|6|||
42174537|NCT03751280|75981300|FG000|Overall Study|Adverse Event|0|||
42174538|NCT03751280|75981301|FG001|Overall Study|Adverse Event|1|||
42174539|NCT03751280|75981300|FG000|Overall Study|Lost to Follow-up|3|||
42174540|NCT03751280|75981301|FG001|Overall Study|Lost to Follow-up|5|||
42174541|NCT03751280|75981300|FG000|Overall Study|Physician Decision|0|||
42174542|NCT03751280|75981301|FG001|Overall Study|Physician Decision|2|||
42062244|NCT00643201|75871487|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
42062245|NCT00643201|75871486|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
42062246|NCT00643201|75871487|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
42062247|NCT00643201|75871486|FG000|Randomized, Completed 6 Months of Study|Other|107|||
42062248|NCT00643201|75871487|FG001|Randomized, Completed 6 Months of Study|Other|107|||
42062249|NCT00643201|75871486|FG000|Completed Study Follow Up|Death|28|||
42062250|NCT00643201|75871487|FG001|Completed Study Follow Up|Death|34|||
42062251|NCT00643201|75871486|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
42062252|NCT00643201|75871487|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
42062253|NCT00643201|75871486|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
42062254|NCT00643201|75871487|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
42174543|NCT03751280|75981300|FG000|Overall Study|Protocol Violation|0|||
42174544|NCT03751280|75981301|FG001|Overall Study|Protocol Violation|2|||
42174545|NCT03751280|75981300|FG000|Overall Study|Withdrawal by Subject|5|||
42174546|NCT03751280|75981301|FG001|Overall Study|Withdrawal by Subject|2|||
42062255|NCT00643201|75871486|FG000|Completed Study Follow Up|non-specified|1|||
42062256|NCT00643201|75871487|FG001|Completed Study Follow Up|non-specified|0|||
42062257|NCT00643123|75871497|FG000|Overall Study|Lost to Follow-up|4|||
42062258|NCT00643123|75871498|FG001|Overall Study|Lost to Follow-up|0|||
42062259|NCT00643123|75871497|FG000|Overall Study|Withdrawal by Subject|1|||
42062260|NCT00643123|75871498|FG001|Overall Study|Withdrawal by Subject|1|||
42062261|NCT00968981|75871507|FG000|Overall Study|Adverse Event|2|||
42062262|NCT00968981|75871508|FG001|Overall Study|Adverse Event|0|||
42062263|NCT00968981|75871509|FG002|Overall Study|Adverse Event|0|||
42062264|NCT00968981|75871507|FG000|Overall Study|Disease Progression|14|||
42062265|NCT00968981|75871508|FG001|Overall Study|Disease Progression|16|||
42062266|NCT00968981|75871509|FG002|Overall Study|Disease Progression|13|||
42062267|NCT00968981|75871507|FG000|Overall Study|Lost to Follow-up|0|||
42062268|NCT00968981|75871508|FG001|Overall Study|Lost to Follow-up|0|||
42062269|NCT00968981|75871509|FG002|Overall Study|Lost to Follow-up|1|||
42062270|NCT00968981|75871507|FG000|Overall Study|Physician Decision|5|||
42062271|NCT00968981|75871508|FG001|Overall Study|Physician Decision|3|||
42062272|NCT00968981|75871509|FG002|Overall Study|Physician Decision|5|||
42062273|NCT00968981|75871507|FG000|Overall Study|Withdrawal by Subject|1|||
42062274|NCT00968981|75871508|FG001|Overall Study|Withdrawal by Subject|3|||
42062275|NCT00968981|75871509|FG002|Overall Study|Withdrawal by Subject|3|||
42062276|NCT00641719|75871520|FG000|Overall Study|Lack of Efficacy|1|||
42062277|NCT00641719|75871521|FG001|Overall Study|Lack of Efficacy|2|||
42062278|NCT00641719|75871520|FG000|Overall Study|Adverse Event|24|||
42062279|NCT00641719|75871521|FG001|Overall Study|Adverse Event|29|||
42062280|NCT00641719|75871520|FG000|Overall Study|Withdrawal by Subject|4|||
42062281|NCT00641719|75871521|FG001|Overall Study|Withdrawal by Subject|4|||
42062282|NCT00641719|75871520|FG000|Overall Study|Reason Not Specified|1|||
42062283|NCT00641719|75871521|FG001|Overall Study|Reason Not Specified|2|||
42062284|NCT00648895|75871529|FG000|Overall Study|Lack of Efficacy|0|||
42062285|NCT00648895|75871530|FG001|Overall Study|Lack of Efficacy|1|||
42062286|NCT00975221|75871538|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
42062287|NCT00975221|75871539|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
42062288|NCT00975221|75871538|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
42062289|NCT00975221|75871539|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
42062290|NCT00975221|75871538|FG000|Titration Phase (Weeks 1-12)|Other|0|||
42062291|NCT00975221|75871539|FG001|Titration Phase (Weeks 1-12)|Other|1|||
42062292|NCT00975221|75871538|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
42062293|NCT00975221|75871539|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
42062294|NCT00975221|75871538|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
42062295|NCT00975221|75871539|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
42062296|NCT00975221|75871538|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
42062297|NCT00975221|75871539|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
42062298|NCT00972179|75871554|FG000|Overall Study|Noncompliance|1|||
42062299|NCT00972179|75871555|FG001|Overall Study|Noncompliance|0|||
42062300|NCT00972179|75871556|FG002|Overall Study|Noncompliance|0|||
42062301|NCT00972179|75871557|FG003|Overall Study|Noncompliance|0|||
42062302|NCT00972179|75871558|FG004|Overall Study|Noncompliance|1|||
42062303|NCT00972179|75871559|FG005|Overall Study|Noncompliance|0|||
42062304|NCT00972179|75871560|FG006|Overall Study|Noncompliance|1|||
42062305|NCT00972179|75871554|FG000|Overall Study|Withdrawal by Subject|0|||
42062306|NCT00972179|75871555|FG001|Overall Study|Withdrawal by Subject|3|||
42062307|NCT00972179|75871556|FG002|Overall Study|Withdrawal by Subject|0|||
42062308|NCT00972179|75871557|FG003|Overall Study|Withdrawal by Subject|1|||
42062309|NCT00972179|75871558|FG004|Overall Study|Withdrawal by Subject|0|||
42062310|NCT00972179|75871559|FG005|Overall Study|Withdrawal by Subject|0|||
42062311|NCT00972179|75871560|FG006|Overall Study|Withdrawal by Subject|2|||
42062312|NCT00972179|75871554|FG000|Overall Study|Administrative Decision|0|||
42062313|NCT00972179|75871555|FG001|Overall Study|Administrative Decision|0|||
42062314|NCT00972179|75871556|FG002|Overall Study|Administrative Decision|0|||
42062315|NCT00972179|75871557|FG003|Overall Study|Administrative Decision|0|||
42062316|NCT00972179|75871558|FG004|Overall Study|Administrative Decision|1|||
42062317|NCT00972179|75871559|FG005|Overall Study|Administrative Decision|0|||
42062318|NCT00972179|75871560|FG006|Overall Study|Administrative Decision|0|||
42291940|NCT01939366|76125384|FG004|Overall Study|GCP non-compliance at site|3|||
42291941|NCT01918306|76125398|FG000|Overall Study|progresive disease|4|||
42062319|NCT00972179|75871554|FG000|Overall Study|Lost to Follow-up|0|||
42062320|NCT00972179|75871555|FG001|Overall Study|Lost to Follow-up|0|||
42062321|NCT00972179|75871556|FG002|Overall Study|Lost to Follow-up|1|||
42062322|NCT00972179|75871557|FG003|Overall Study|Lost to Follow-up|0|||
42062323|NCT00972179|75871558|FG004|Overall Study|Lost to Follow-up|0|||
42062324|NCT00972179|75871559|FG005|Overall Study|Lost to Follow-up|3|||
42062325|NCT00972179|75871560|FG006|Overall Study|Lost to Follow-up|1|||
42062326|NCT00906698|75871586|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
42062327|NCT00906698|75871587|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
42291942|NCT01918306|76125399|FG001|Overall Study|progresive disease|0|||
42062328|NCT00906698|75871588|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
42062329|NCT00906698|75871589|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
42062330|NCT00906698|75871590|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
42062331|NCT00906698|75871591|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
42062332|NCT00906698|75871586|FG000|Overall Study|Adverse Event|0|||
42062333|NCT00906698|75871587|FG001|Overall Study|Adverse Event|0|||
42062334|NCT00906698|75871588|FG002|Overall Study|Adverse Event|2|||
42062335|NCT00906698|75871589|FG003|Overall Study|Adverse Event|0|||
42062336|NCT00906698|75871590|FG004|Overall Study|Adverse Event|4|||
42062337|NCT00906698|75871591|FG005|Overall Study|Adverse Event|1|||
42062338|NCT00906698|75871586|FG000|Overall Study|Disease progression|3|||
42062339|NCT00906698|75871587|FG001|Overall Study|Disease progression|12|||
42062340|NCT00906698|75871588|FG002|Overall Study|Disease progression|4|||
42062341|NCT00906698|75871589|FG003|Overall Study|Disease progression|4|||
42062342|NCT00906698|75871590|FG004|Overall Study|Disease progression|12|||
42062343|NCT00906698|75871591|FG005|Overall Study|Disease progression|4|||
42062344|NCT00906698|75871586|FG000|Overall Study|Withdrawal by Subject|0|||
42062345|NCT00906698|75871587|FG001|Overall Study|Withdrawal by Subject|0|||
42062346|NCT00906698|75871588|FG002|Overall Study|Withdrawal by Subject|0|||
42062347|NCT00906698|75871589|FG003|Overall Study|Withdrawal by Subject|0|||
42062348|NCT00906698|75871590|FG004|Overall Study|Withdrawal by Subject|1|||
42062349|NCT00906698|75871591|FG005|Overall Study|Withdrawal by Subject|0|||
42062350|NCT00906698|75871586|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
42062351|NCT00906698|75871587|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
42062352|NCT00906698|75871588|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
42062353|NCT00906698|75871589|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
42062354|NCT00906698|75871590|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
42062355|NCT00906698|75871591|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
42062356|NCT00972023|75871623|FG000|Overall Study|Withdrawal by Subject|1|||
42062357|NCT00971945|75871629|FG000|Overall Study|Progressive Disease|3|||
42062358|NCT00971945|75871629|FG000|Overall Study|Change in treatment policy|1|||
42062359|NCT00971945|75871629|FG000|Overall Study|Other reasons|2|||
42062360|NCT00971867|75871633|FG000|Overall Study|Adverse Event|4|||
42062361|NCT00971867|75871633|FG000|Overall Study|Participant Withdrew Consent|1|||
42062362|NCT00971867|75871633|FG000|Overall Study|Disease Progression|6|||
42062363|NCT00971321|75871639|FG000|Up to Month 7|Withdrawal by Subject|1|||
42062364|NCT00971321|75871640|FG001|Up to Month 7|Withdrawal by Subject|0|||
42062365|NCT00971321|75871639|FG000|Up to Month 7|Migrated/moved from study area|3|||
42062366|NCT00971321|75871640|FG001|Up to Month 7|Migrated/moved from study area|2|||
42062367|NCT00971321|75871639|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
42062368|NCT00971321|75871640|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
42062369|NCT00971321|75871639|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
42062370|NCT00971321|75871640|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
42062371|NCT00971321|75871639|FG000|Up to Month 11-12|Lost to Follow-up|1|||
42062372|NCT00971321|75871640|FG001|Up to Month 11-12|Lost to Follow-up|0|||
42062373|NCT00648739|75871646|FG000|Overall Study|Adverse Event|1|||
42062374|NCT00648739|75871647|FG001|Overall Study|Adverse Event|0|||
42062375|NCT00648739|75871648|FG002|Overall Study|Adverse Event|1|||
42062376|NCT00648739|75871649|FG003|Overall Study|Adverse Event|2|||
42062377|NCT00648739|75871650|FG004|Overall Study|Adverse Event|1|||
42062378|NCT00648739|75871651|FG005|Overall Study|Adverse Event|0|||
42062379|NCT00648739|75871652|FG006|Overall Study|Adverse Event|0|||
42062380|NCT00648739|75871646|FG000|Overall Study|Withdrawal by Subject|1|||
42062381|NCT00648739|75871647|FG001|Overall Study|Withdrawal by Subject|0|||
42062382|NCT00648739|75871648|FG002|Overall Study|Withdrawal by Subject|1|||
42062383|NCT00648739|75871649|FG003|Overall Study|Withdrawal by Subject|0|||
42062384|NCT00648739|75871650|FG004|Overall Study|Withdrawal by Subject|0|||
42062385|NCT00648739|75871651|FG005|Overall Study|Withdrawal by Subject|2|||
42062386|NCT00648739|75871652|FG006|Overall Study|Withdrawal by Subject|0|||
42062387|NCT00648739|75871646|FG000|Overall Study|Lack of Efficacy|0|||
42062388|NCT00648739|75871647|FG001|Overall Study|Lack of Efficacy|0|||
42062389|NCT00648739|75871648|FG002|Overall Study|Lack of Efficacy|0|||
42062390|NCT00648739|75871649|FG003|Overall Study|Lack of Efficacy|0|||
42062391|NCT00648739|75871650|FG004|Overall Study|Lack of Efficacy|1|||
42062392|NCT00648739|75871651|FG005|Overall Study|Lack of Efficacy|2|||
42062393|NCT00648739|75871652|FG006|Overall Study|Lack of Efficacy|0|||
42062394|NCT00648739|75871646|FG000|Overall Study|Investigator Considered it Advisable|0|||
42062395|NCT00648739|75871647|FG001|Overall Study|Investigator Considered it Advisable|0|||
42062396|NCT00648739|75871648|FG002|Overall Study|Investigator Considered it Advisable|0|||
42062397|NCT00648739|75871649|FG003|Overall Study|Investigator Considered it Advisable|0|||
42062398|NCT00648739|75871650|FG004|Overall Study|Investigator Considered it Advisable|0|||
42062399|NCT00648739|75871651|FG005|Overall Study|Investigator Considered it Advisable|1|||
42062400|NCT00648739|75871652|FG006|Overall Study|Investigator Considered it Advisable|1|||
42062401|NCT00648739|75871646|FG000|Overall Study|Death|0|||
42062402|NCT00648739|75871647|FG001|Overall Study|Death|1|||
42062403|NCT00648739|75871648|FG002|Overall Study|Death|0|||
42062404|NCT00648739|75871649|FG003|Overall Study|Death|0|||
42062405|NCT00648739|75871650|FG004|Overall Study|Death|0|||
42062406|NCT00648739|75871651|FG005|Overall Study|Death|0|||
42062407|NCT00648739|75871652|FG006|Overall Study|Death|0|||
42062408|NCT00648739|75871646|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
42062409|NCT00648739|75871647|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
42062410|NCT00648739|75871648|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
42062411|NCT00648739|75871649|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
42062412|NCT00648739|75871650|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
42062413|NCT00648739|75871651|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
42062414|NCT00648739|75871652|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
42062415|NCT00648739|75871646|FG000|Overall Study|Follow-up Visits Not Completed|0|||
42062416|NCT00648739|75871647|FG001|Overall Study|Follow-up Visits Not Completed|1|||
42062417|NCT00648739|75871648|FG002|Overall Study|Follow-up Visits Not Completed|0|||
42062418|NCT00648739|75871649|FG003|Overall Study|Follow-up Visits Not Completed|0|||
42062419|NCT00648739|75871650|FG004|Overall Study|Follow-up Visits Not Completed|0|||
42062420|NCT00648739|75871651|FG005|Overall Study|Follow-up Visits Not Completed|0|||
42062421|NCT00648739|75871652|FG006|Overall Study|Follow-up Visits Not Completed|0|||
42062422|NCT00648037|75871673|FG000|Overall Study|Not Treated|1|||
42062423|NCT00648037|75871673|FG000|Overall Study|Withdrawal by Subject|1|||
42062424|NCT00648037|75871673|FG000|Overall Study|Adverse Event|11|||
42062425|NCT00648037|75871673|FG000|Overall Study|Relapse|2|||
42062426|NCT00648037|75871673|FG000|Overall Study|Other|1|||
42062427|NCT00627523|75871679|FG000|Overall Study|Lack of Efficacy|1|||
42062428|NCT00627523|75871680|FG001|Overall Study|Lack of Efficacy|0|||
42062429|NCT00627523|75871679|FG000|Overall Study|Withdrawal by Subject|0|||
42062430|NCT00627523|75871680|FG001|Overall Study|Withdrawal by Subject|2|||
42062431|NCT00627523|75871679|FG000|Overall Study|Other|1|||
42062432|NCT00627523|75871680|FG001|Overall Study|Other|0|||
42062433|NCT00640393|75871686|FG000|Part 1|Lost to Follow-up|2|||
42062434|NCT00640393|75871687|FG001|Part 1|Lost to Follow-up|0|||
42062435|NCT00640393|75871688|FG002|Part 1|Lost to Follow-up|0|||
42062436|NCT00640393|75871686|FG000|Part 1|Withdrawal by Subject|3|||
42062437|NCT00640393|75871687|FG001|Part 1|Withdrawal by Subject|0|||
42062438|NCT00640393|75871688|FG002|Part 1|Withdrawal by Subject|0|||
42062439|NCT00640393|75871686|FG000|Randomization|Withdrawn per protocol|17|||
42062440|NCT00640393|75871687|FG001|Randomization|Withdrawn per protocol|0|||
42062441|NCT00640393|75871688|FG002|Randomization|Withdrawn per protocol|0|||
42062442|NCT00640393|75871686|FG000|Randomization|Never randomized by site|2|||
42062443|NCT00640393|75871687|FG001|Randomization|Never randomized by site|0|||
42062444|NCT00640393|75871688|FG002|Randomization|Never randomized by site|0|||
42062445|NCT00640393|75871686|FG000|Part 2|Lost to Follow-up|0|||
42062446|NCT00640393|75871687|FG001|Part 2|Lost to Follow-up|2|||
42062447|NCT00640393|75871688|FG002|Part 2|Lost to Follow-up|2|||
42062448|NCT00640393|75871686|FG000|Part 2|Withdrawal by Subject|0|||
42062449|NCT00640393|75871687|FG001|Part 2|Withdrawal by Subject|6|||
42062450|NCT00640393|75871688|FG002|Part 2|Withdrawal by Subject|1|||
42062451|NCT00640393|75871686|FG000|Part 2|Non-adherence|0|||
42062452|NCT00640393|75871687|FG001|Part 2|Non-adherence|1|||
42062453|NCT00640393|75871688|FG002|Part 2|Non-adherence|0|||
42062454|NCT00640393|75871686|FG000|Part 2|Adverse Event|0|||
42062455|NCT00640393|75871687|FG001|Part 2|Adverse Event|1|||
42062456|NCT00640393|75871688|FG002|Part 2|Adverse Event|0|||
42062457|NCT00907478|75871699|FG000|Overall Study|Ineligibility determined|0|||
42062458|NCT00907478|75871700|FG001|Overall Study|Ineligibility determined|0|||
42062459|NCT00907478|75871701|FG002|Overall Study|Ineligibility determined|1|||
42062460|NCT00907478|75871699|FG000|Overall Study|Noncompliance|0|||
42062461|NCT00907478|75871700|FG001|Overall Study|Noncompliance|0|||
42062462|NCT00907478|75871701|FG002|Overall Study|Noncompliance|1|||
42062463|NCT00907478|75871699|FG000|Overall Study|Adverse Event|3|||
42062464|NCT00907478|75871700|FG001|Overall Study|Adverse Event|1|||
42062465|NCT00907478|75871701|FG002|Overall Study|Adverse Event|2|||
42291943|NCT01918306|76125400|FG002|Overall Study|progresive disease|1|||
42062466|NCT00907478|75871699|FG000|Overall Study|Withdrawal by Subject|8|||
42291944|NCT01918306|76125401|FG003|Overall Study|progresive disease|1|||
42291945|NCT01918306|76125398|FG000|Overall Study|Withdrawal by Subject|0|||
42062467|NCT00907478|75871700|FG001|Overall Study|Withdrawal by Subject|9|||
42062468|NCT00907478|75871701|FG002|Overall Study|Withdrawal by Subject|6|||
42062469|NCT00907478|75871699|FG000|Overall Study|Requirement for alternative therapy|1|||
42062470|NCT00907478|75871700|FG001|Overall Study|Requirement for alternative therapy|2|||
42062471|NCT00907478|75871701|FG002|Overall Study|Requirement for alternative therapy|3|||
42062472|NCT00907478|75871699|FG000|Overall Study|Physician Decision|2|||
42062473|NCT00907478|75871700|FG001|Overall Study|Physician Decision|0|||
42062474|NCT00907478|75871701|FG002|Overall Study|Physician Decision|3|||
42062475|NCT00907478|75871699|FG000|Overall Study|Death|4|||
42062476|NCT00907478|75871700|FG001|Overall Study|Death|2|||
42062477|NCT00907478|75871701|FG002|Overall Study|Death|1|||
42291946|NCT01918306|76125399|FG001|Overall Study|Withdrawal by Subject|0|||
42062478|NCT00907478|75871699|FG000|Overall Study|Protocol-specified criteria|5|||
42062479|NCT00907478|75871700|FG001|Overall Study|Protocol-specified criteria|2|||
42062480|NCT00907478|75871701|FG002|Overall Study|Protocol-specified criteria|3|||
42062481|NCT00907478|75871699|FG000|Overall Study|Pregnancy|0|||
42062482|NCT00907478|75871700|FG001|Overall Study|Pregnancy|1|||
42062483|NCT00907478|75871701|FG002|Overall Study|Pregnancy|1|||
42062484|NCT00907478|75871699|FG000|Overall Study|Lost to Follow-up|1|||
42062485|NCT00907478|75871700|FG001|Overall Study|Lost to Follow-up|0|||
42062486|NCT00907478|75871701|FG002|Overall Study|Lost to Follow-up|0|||
42062487|NCT00907478|75871699|FG000|Overall Study|Other|3|||
42062488|NCT00907478|75871700|FG001|Overall Study|Other|0|||
42062489|NCT00907478|75871701|FG002|Overall Study|Other|1|||
42062490|NCT00627445|75871713|FG000|Overall Study|Adverse Event|3|||
42062491|NCT00627445|75871714|FG001|Overall Study|Adverse Event|3|||
42062492|NCT00627445|75871713|FG000|Overall Study|Lack of Efficacy|0|||
42062493|NCT00627445|75871714|FG001|Overall Study|Lack of Efficacy|1|||
42062494|NCT00627445|75871713|FG000|Overall Study|Other|6|||
42062495|NCT00627445|75871714|FG001|Overall Study|Other|8|||
42062496|NCT00905840|75871722|FG000|Overall Study|Lost to Follow-up|11|||
42062497|NCT00905840|75871722|FG000|Overall Study|Death|3|||
42062498|NCT00905840|75871722|FG000|Overall Study|Withdrawal by Subject|1|||
42062499|NCT00905840|75871722|FG000|Overall Study|Adverse Event|1|||
42062500|NCT00626821|75871729|FG000|Overall Study|Adverse Event|44|||
42062501|NCT00626821|75871729|FG000|Overall Study|Protocol Violation|33|||
42062502|NCT00626821|75871729|FG000|Overall Study|Withdrawal by Subject|10|||
42062503|NCT00626821|75871729|FG000|Overall Study|Physician Decision|9|||
42062504|NCT00626821|75871729|FG000|Overall Study|Product dysfunction|21|||
42062505|NCT00626821|75871729|FG000|Overall Study|other/unknown reason|104|||
42062506|NCT00625183|75871733|FG000|Overall Study|Disease Progression|1|||
42062507|NCT00904982|75871743|FG000|Overall Study|Withdrawal by Subject|2|||
42062508|NCT00904982|75871744|FG001|Overall Study|Withdrawal by Subject|0|||
42062509|NCT00904982|75871745|FG002|Overall Study|Withdrawal by Subject|0|||
42062510|NCT00904982|75871746|FG003|Overall Study|Withdrawal by Subject|0|||
42062511|NCT00640315|75871758|FG000|Overall Study|Withdrawal by Subject|0|||
42062512|NCT00640315|75871759|FG001|Overall Study|Withdrawal by Subject|1|||
42062513|NCT00904748|75871765|FG000|Overall Study|Withdrawal by Subject|1|||
42062514|NCT00904748|75871766|FG001|Overall Study|Withdrawal by Subject|1|||
42062515|NCT00904748|75871767|FG002|Overall Study|Withdrawal by Subject|1|||
42062516|NCT00904748|75871768|FG003|Overall Study|Withdrawal by Subject|2|||
42062517|NCT00904748|75871769|FG004|Overall Study|Withdrawal by Subject|0|||
42062518|NCT00904748|75871770|FG005|Overall Study|Withdrawal by Subject|0|||
42062519|NCT00904748|75871765|FG000|Overall Study|Adverse Event|0|||
42062520|NCT00904748|75871766|FG001|Overall Study|Adverse Event|0|||
42062521|NCT00904748|75871767|FG002|Overall Study|Adverse Event|0|||
42062522|NCT00904748|75871768|FG003|Overall Study|Adverse Event|0|||
42062523|NCT00904748|75871769|FG004|Overall Study|Adverse Event|1|||
42062524|NCT00904748|75871770|FG005|Overall Study|Adverse Event|0|||
42062525|NCT00574405|75871781|FG000|Overall Study|Withdrawal by Subject|3|||
42062526|NCT00574405|75871782|FG001|Overall Study|Withdrawal by Subject|2|||
42062527|NCT00971243|75871793|FG000|Double Blind Period|Adverse Event|2|||
42062528|NCT00971243|75871794|FG001|Double Blind Period|Adverse Event|3|||
42062529|NCT00971243|75871795|FG002|Double Blind Period|Adverse Event|2|||
42062530|NCT00971243|75871796|FG003|Double Blind Period|Adverse Event|2|||
42062531|NCT00971243|75871797|FG004|Double Blind Period|Adverse Event|3|||
42062532|NCT00971243|75871793|FG000|Double Blind Period|Lost to Follow-up|0|||
42062533|NCT00971243|75871794|FG001|Double Blind Period|Lost to Follow-up|1|||
42062534|NCT00971243|75871795|FG002|Double Blind Period|Lost to Follow-up|1|||
42062535|NCT00971243|75871796|FG003|Double Blind Period|Lost to Follow-up|0|||
42062536|NCT00971243|75871797|FG004|Double Blind Period|Lost to Follow-up|1|||
42062537|NCT00971243|75871793|FG000|Double Blind Period|Physician Decision|10|||
42357296|NCT01725308|76202605|FG002|Treatment Period II|Miscellaneous|7|||
42357297|NCT01724528|76202622|FG000|Overall Study|Death|3|||
42062538|NCT00971243|75871794|FG001|Double Blind Period|Physician Decision|6|||
42062539|NCT00971243|75871795|FG002|Double Blind Period|Physician Decision|7|||
42062540|NCT00971243|75871796|FG003|Double Blind Period|Physician Decision|6|||
42062541|NCT00971243|75871797|FG004|Double Blind Period|Physician Decision|7|||
42062542|NCT00971243|75871793|FG000|Double Blind Period|Protocol Violation|2|||
42062543|NCT00971243|75871794|FG001|Double Blind Period|Protocol Violation|0|||
42062544|NCT00971243|75871795|FG002|Double Blind Period|Protocol Violation|3|||
42357298|NCT01724528|76202623|FG001|Overall Study|Death|0|||
42062545|NCT00971243|75871796|FG003|Double Blind Period|Protocol Violation|2|||
42062546|NCT00971243|75871797|FG004|Double Blind Period|Protocol Violation|2|||
42062547|NCT00971243|75871793|FG000|Double Blind Period|Withdrawal by Subject|4|||
42062548|NCT00971243|75871794|FG001|Double Blind Period|Withdrawal by Subject|1|||
42062549|NCT00971243|75871795|FG002|Double Blind Period|Withdrawal by Subject|4|||
42062550|NCT00971243|75871796|FG003|Double Blind Period|Withdrawal by Subject|4|||
42062551|NCT00971243|75871797|FG004|Double Blind Period|Withdrawal by Subject|4|||
42062552|NCT00971243|75871793|FG000|Double Blind Period|Other reasons|1|||
42062553|NCT00971243|75871794|FG001|Double Blind Period|Other reasons|0|||
42062554|NCT00971243|75871795|FG002|Double Blind Period|Other reasons|2|||
42062555|NCT00971243|75871796|FG003|Double Blind Period|Other reasons|0|||
42062556|NCT00971243|75871797|FG004|Double Blind Period|Other reasons|1|||
42062557|NCT00971243|75871793|FG000|Open-label Period|Adverse Event|1|||
42062558|NCT00971243|75871794|FG001|Open-label Period|Adverse Event|0|||
42062559|NCT00971243|75871795|FG002|Open-label Period|Adverse Event|1|||
42174547|NCT00311363|75981311|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
42174548|NCT00311363|75981312|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
42174549|NCT00311363|75981313|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
42174550|NCT00311363|75981311|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
42174551|NCT00311363|75981312|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
42174552|NCT00311363|75981313|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
42174553|NCT00311363|75981311|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
42174554|NCT00311363|75981312|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
42174555|NCT00311363|75981313|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
42174556|NCT00311363|75981311|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
42174557|NCT00311363|75981312|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
42174558|NCT00311363|75981313|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
42174559|NCT00311363|75981311|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
42174560|NCT00311363|75981312|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
42174561|NCT00311363|75981313|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
42174562|NCT00311363|75981311|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
42174563|NCT00311363|75981312|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
42174564|NCT00311363|75981313|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
42174565|NCT00311363|75981311|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
42174566|NCT00311363|75981312|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
42174567|NCT00311363|75981313|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
42174568|NCT00311363|75981311|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
42174569|NCT00311363|75981312|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
42174570|NCT00311363|75981313|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
42174571|NCT00311363|75981311|FG000|24-Week Single-Blind Treatment Period|Death|1|||
42174572|NCT00311363|75981312|FG001|24-Week Single-Blind Treatment Period|Death|0|||
42174573|NCT00311363|75981313|FG002|24-Week Single-Blind Treatment Period|Death|0|||
42174574|NCT00311363|75981311|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
42174575|NCT00311363|75981312|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
42174576|NCT00311363|75981313|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
42174577|NCT00311363|75981311|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
42174578|NCT00311363|75981312|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
42174579|NCT00311363|75981313|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
42174580|NCT00311363|75981311|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
42174581|NCT00311363|75981312|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
42174582|NCT00311363|75981313|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
42174583|NCT00311363|75981311|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
42174584|NCT00311363|75981312|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
42174585|NCT00311363|75981313|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
42174586|NCT00311363|75981311|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
42174587|NCT00311363|75981312|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
42174588|NCT00311363|75981313|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
42174589|NCT00311363|75981311|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
42174590|NCT00311363|75981312|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
42174591|NCT00311363|75981313|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
42174592|NCT00333983|75981326|FG000|Overall Study|Lost to Follow-up|2|||
42174593|NCT00333983|75981327|FG001|Overall Study|Lost to Follow-up|1|||
42174594|NCT00333983|75981328|FG002|Overall Study|Lost to Follow-up|0|||
42174595|NCT00333983|75981326|FG000|Overall Study|Adverse Event|1|||
42174596|NCT00333983|75981327|FG001|Overall Study|Adverse Event|1|||
42174597|NCT00333983|75981328|FG002|Overall Study|Adverse Event|1|||
42174598|NCT00333983|75981326|FG000|Overall Study|Withdrawal by Subject|0|||
42174599|NCT00333983|75981327|FG001|Overall Study|Withdrawal by Subject|3|||
42174600|NCT00333983|75981328|FG002|Overall Study|Withdrawal by Subject|1|||
42174601|NCT03262012|75981340|FG000|Overall Study|Withdrawal by Subject|15|||
42174602|NCT03262012|75981341|FG001|Overall Study|Withdrawal by Subject|13|||
42174603|NCT03262012|75981342|FG002|Overall Study|Withdrawal by Subject|8|||
42291947|NCT01918306|76125400|FG002|Overall Study|Withdrawal by Subject|0|||
42291948|NCT01918306|76125401|FG003|Overall Study|Withdrawal by Subject|2|||
42291949|NCT01918306|76125398|FG000|Overall Study|neutropenia|1|||
42291950|NCT01918306|76125399|FG001|Overall Study|neutropenia|0|||
42291951|NCT01918306|76125400|FG002|Overall Study|neutropenia|0|||
42062560|NCT00971243|75871796|FG003|Open-label Period|Adverse Event|1|||
42062561|NCT00971243|75871797|FG004|Open-label Period|Adverse Event|0|||
42062562|NCT00971243|75871793|FG000|Open-label Period|Physician Decision|5|||
42062563|NCT00971243|75871794|FG001|Open-label Period|Physician Decision|9|||
42062564|NCT00971243|75871795|FG002|Open-label Period|Physician Decision|3|||
42062565|NCT00971243|75871796|FG003|Open-label Period|Physician Decision|7|||
42062566|NCT00971243|75871797|FG004|Open-label Period|Physician Decision|2|||
42062567|NCT00971243|75871793|FG000|Open-label Period|Protocol Violation|1|||
42062568|NCT00971243|75871794|FG001|Open-label Period|Protocol Violation|1|||
42062569|NCT00971243|75871795|FG002|Open-label Period|Protocol Violation|1|||
42062570|NCT00971243|75871796|FG003|Open-label Period|Protocol Violation|0|||
42062571|NCT00971243|75871797|FG004|Open-label Period|Protocol Violation|1|||
42062572|NCT00971243|75871793|FG000|Open-label Period|Withdrawal by Subject|1|||
42062573|NCT00971243|75871794|FG001|Open-label Period|Withdrawal by Subject|0|||
42062574|NCT00971243|75871795|FG002|Open-label Period|Withdrawal by Subject|0|||
42062575|NCT00971243|75871796|FG003|Open-label Period|Withdrawal by Subject|2|||
42062576|NCT00971243|75871797|FG004|Open-label Period|Withdrawal by Subject|1|||
42062577|NCT00971243|75871793|FG000|Open-label Period|Other reason|0|||
42062578|NCT00971243|75871794|FG001|Open-label Period|Other reason|0|||
42062579|NCT00971243|75871795|FG002|Open-label Period|Other reason|0|||
42062580|NCT00971243|75871796|FG003|Open-label Period|Other reason|0|||
42062581|NCT00971243|75871797|FG004|Open-label Period|Other reason|2|||
42062582|NCT00568555|75871811|FG000|Overall Study|Withdrawal by Subject|1|||
42062583|NCT00568555|75871812|FG001|Overall Study|Withdrawal by Subject|1|||
42062584|NCT00904670|75871820|FG000|Open Label Phase|Withdrawal by Subject|2|||
42062585|NCT00904670|75871821|FG001|Open Label Phase|Withdrawal by Subject|0|||
42062586|NCT00904670|75871820|FG000|Open Label Phase|Adverse Event|2|||
42062587|NCT00904670|75871821|FG001|Open Label Phase|Adverse Event|0|||
42062588|NCT00904670|75871820|FG000|Open Label Phase|Lack of Efficacy|1|||
42062589|NCT00904670|75871821|FG001|Open Label Phase|Lack of Efficacy|0|||
42062590|NCT00904670|75871820|FG000|Open Label Phase|Lost to Follow-up|1|||
42062591|NCT00904670|75871821|FG001|Open Label Phase|Lost to Follow-up|0|||
42062592|NCT00638443|75871829|FG000|First Intervention|Adverse Event|2|||
42062593|NCT00638443|75871830|FG001|First Intervention|Adverse Event|1|||
42062594|NCT00636181|75871841|FG000|Overall Study|Withdrawal by Subject|8|||
42062595|NCT00636181|75871842|FG001|Overall Study|Withdrawal by Subject|6|||
42062596|NCT00636181|75871843|FG002|Overall Study|Withdrawal by Subject|10|||
42062597|NCT00968669|75871855|FG000|Overall Study|Lost to Follow-up|5|||
42062598|NCT00968669|75871856|FG001|Overall Study|Lost to Follow-up|2|||
42062599|NCT00968669|75871857|FG002|Overall Study|Lost to Follow-up|1|||
42062600|NCT00968669|75871858|FG003|Overall Study|Lost to Follow-up|4|||
42062601|NCT00968669|75871855|FG000|Overall Study|Withdrawal by Subject|9|||
42062602|NCT00968669|75871856|FG001|Overall Study|Withdrawal by Subject|7|||
42062603|NCT00968669|75871857|FG002|Overall Study|Withdrawal by Subject|5|||
42062604|NCT00968669|75871858|FG003|Overall Study|Withdrawal by Subject|3|||
42062605|NCT00968669|75871855|FG000|Overall Study|Pregnancy|0|||
42062606|NCT00968669|75871856|FG001|Overall Study|Pregnancy|0|||
42062607|NCT00968669|75871857|FG002|Overall Study|Pregnancy|2|||
42062608|NCT00968669|75871858|FG003|Overall Study|Pregnancy|0|||
42062609|NCT00968669|75871855|FG000|Overall Study|AE|1|||
42062610|NCT00968669|75871856|FG001|Overall Study|AE|0|||
42174604|NCT03262012|75981343|FG003|Overall Study|Withdrawal by Subject|7|||
42174605|NCT03262012|75981340|FG000|Overall Study|Adverse Event|10|||
42174606|NCT03262012|75981341|FG001|Overall Study|Adverse Event|12|||
42174607|NCT03262012|75981342|FG002|Overall Study|Adverse Event|4|||
42174608|NCT03262012|75981343|FG003|Overall Study|Adverse Event|6|||
42174609|NCT03262012|75981340|FG000|Overall Study|Physician Decision|2|||
42174610|NCT03262012|75981341|FG001|Overall Study|Physician Decision|5|||
42174611|NCT03262012|75981342|FG002|Overall Study|Physician Decision|1|||
42174612|NCT03262012|75981343|FG003|Overall Study|Physician Decision|0|||
42062611|NCT00968669|75871857|FG002|Overall Study|AE|0|||
42062612|NCT00968669|75871858|FG003|Overall Study|AE|0|||
42062613|NCT00968669|75871855|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
42062614|NCT00968669|75871856|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
42062615|NCT00968669|75871857|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
42062616|NCT00968669|75871858|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
42174613|NCT03262012|75981340|FG000|Overall Study|Lack of Efficacy|0|||
42174614|NCT03262012|75981341|FG001|Overall Study|Lack of Efficacy|5|||
42062617|NCT00968669|75871855|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
42062618|NCT00968669|75871856|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
42062619|NCT00968669|75871857|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
42062620|NCT00968669|75871858|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
42062621|NCT00968669|75871855|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
42062622|NCT00968669|75871856|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
42062623|NCT00968669|75871857|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
42062624|NCT00968669|75871858|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
42062625|NCT00968669|75871855|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
42062626|NCT00968669|75871856|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
42062627|NCT00968669|75871857|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
42062628|NCT00968669|75871858|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
42062629|NCT00968669|75871855|FG000|Overall Study|EARLY WITHDRAWAL|0|||
42062630|NCT00968669|75871856|FG001|Overall Study|EARLY WITHDRAWAL|1|||
42062631|NCT00968669|75871857|FG002|Overall Study|EARLY WITHDRAWAL|0|||
42062632|NCT00968669|75871858|FG003|Overall Study|EARLY WITHDRAWAL|0|||
42062633|NCT00968669|75871855|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
42062634|NCT00968669|75871856|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
42062635|NCT00968669|75871857|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
42062636|NCT00968669|75871858|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
42062637|NCT00968669|75871855|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
42062638|NCT00968669|75871856|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
42062639|NCT00968669|75871857|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
42062640|NCT00968669|75871858|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
42062641|NCT00968669|75871855|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
42062642|NCT00968669|75871856|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
42062643|NCT00968669|75871857|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
42062644|NCT00968669|75871858|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
42062645|NCT00968669|75871855|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
42062646|NCT00968669|75871856|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
42062647|NCT00968669|75871857|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
42062648|NCT00968669|75871858|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
42062649|NCT00968669|75871855|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
42062650|NCT00968669|75871856|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
42062651|NCT00968669|75871857|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
42062652|NCT00968669|75871858|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
42062653|NCT00968669|75871855|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
42062654|NCT00968669|75871856|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
42062655|NCT00968669|75871857|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
42062656|NCT00968669|75871858|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
42062657|NCT00968669|75871855|FG000|Overall Study|SPONSOR DECISION|0|||
42062658|NCT00968669|75871856|FG001|Overall Study|SPONSOR DECISION|1|||
42062659|NCT00968669|75871857|FG002|Overall Study|SPONSOR DECISION|0|||
42062660|NCT00968669|75871858|FG003|Overall Study|SPONSOR DECISION|0|||
42062661|NCT00968669|75871855|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
42062662|NCT00968669|75871856|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
42062663|NCT00968669|75871857|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
42062664|NCT00968669|75871858|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
42062665|NCT00968669|75871855|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
42062666|NCT00968669|75871856|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
42062667|NCT00968669|75871857|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
42062668|NCT00968669|75871858|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
42062669|NCT00968669|75871855|FG000|Overall Study|SUBJECT INCARCERATED|0|||
42062670|NCT00968669|75871856|FG001|Overall Study|SUBJECT INCARCERATED|1|||
42174615|NCT03262012|75981342|FG002|Overall Study|Lack of Efficacy|1|||
42174616|NCT03262012|75981343|FG003|Overall Study|Lack of Efficacy|2|||
42174617|NCT03262012|75981340|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
42174618|NCT03262012|75981341|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
42174619|NCT03262012|75981342|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
42174620|NCT03262012|75981343|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
42174621|NCT03288142|75981355|FG000|Overall Study|Lost to Follow-up|22|||
42174622|NCT03288142|75981356|FG001|Overall Study|Lost to Follow-up|15|||
42174623|NCT00310817|75981368|FG000|Overall Study|AE or Death|3|||
42174624|NCT00310817|75981369|FG001|Overall Study|AE or Death|1|||
42062671|NCT00968669|75871857|FG002|Overall Study|SUBJECT INCARCERATED|0|||
42062672|NCT00968669|75871858|FG003|Overall Study|SUBJECT INCARCERATED|0|||
42062673|NCT00968669|75871855|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
42062674|NCT00968669|75871856|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
42062675|NCT00968669|75871857|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
42062676|NCT00968669|75871858|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
42062677|NCT00968669|75871855|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
42062678|NCT00968669|75871856|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
42174625|NCT00310817|75981370|FG002|Overall Study|AE or Death|0|||
42174626|NCT00310817|75981371|FG003|Overall Study|AE or Death|0|||
42174627|NCT00310817|75981368|FG000|Overall Study|Withdrawal by Subject|1|||
42174628|NCT00310817|75981369|FG001|Overall Study|Withdrawal by Subject|4|||
42062679|NCT00968669|75871857|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
42062680|NCT00968669|75871858|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
42062681|NCT00568399|75871868|FG000|Overall Study|Death|2|||
42174629|NCT00310817|75981370|FG002|Overall Study|Withdrawal by Subject|6|||
42174630|NCT00310817|75981371|FG003|Overall Study|Withdrawal by Subject|7|||
42174631|NCT00310817|75981368|FG000|Overall Study|Lost to Follow-up|2|||
42291952|NCT01918306|76125401|FG003|Overall Study|neutropenia|0|||
42062682|NCT00568399|75871868|FG000|Overall Study|Adverse Event|5|||
42062683|NCT00568399|75871868|FG000|Overall Study|Withdrawal by Subject|8|||
42062684|NCT00975143|75871874|FG000|Overall Study|Adverse Event|19|||
42062685|NCT00975143|75871875|FG001|Overall Study|Adverse Event|15|||
42062686|NCT00975143|75871874|FG000|Overall Study|Withdrawal by Subject|15|||
42062687|NCT00975143|75871875|FG001|Overall Study|Withdrawal by Subject|15|||
42062688|NCT00975143|75871874|FG000|Overall Study|Lost to Follow-up|20|||
42062689|NCT00975143|75871875|FG001|Overall Study|Lost to Follow-up|16|||
42062690|NCT00975143|75871874|FG000|Overall Study|Non-compliance|5|||
42062691|NCT00975143|75871875|FG001|Overall Study|Non-compliance|8|||
42062692|NCT00975143|75871874|FG000|Overall Study|Physician Decision|1|||
42062693|NCT00975143|75871875|FG001|Overall Study|Physician Decision|2|||
42062694|NCT00975143|75871874|FG000|Overall Study|Details not available|10|||
42062695|NCT00975143|75871875|FG001|Overall Study|Details not available|4|||
42062696|NCT00974675|75871898|FG000|Overall Study|Adverse Event|2|||
42062697|NCT00974675|75871899|FG001|Overall Study|Adverse Event|1|||
42062698|NCT00974675|75871900|FG002|Overall Study|Adverse Event|1|||
42062699|NCT00974675|75871901|FG003|Overall Study|Adverse Event|1|||
42062700|NCT00974675|75871898|FG000|Overall Study|Physician Decision|0|||
42062701|NCT00974675|75871899|FG001|Overall Study|Physician Decision|0|||
42062702|NCT00974675|75871900|FG002|Overall Study|Physician Decision|1|||
42062703|NCT00974675|75871901|FG003|Overall Study|Physician Decision|0|||
42062704|NCT00974675|75871898|FG000|Overall Study|Participant on holiday; unable to attend|0|||
42062705|NCT00974675|75871899|FG001|Overall Study|Participant on holiday; unable to attend|0|||
42062706|NCT00974675|75871900|FG002|Overall Study|Participant on holiday; unable to attend|0|||
42062707|NCT00974675|75871901|FG003|Overall Study|Participant on holiday; unable to attend|1|||
42062708|NCT00634933|75871914|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
42062709|NCT00634933|75871915|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
42062710|NCT00634933|75871916|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
42062711|NCT00634933|75871917|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
42062712|NCT00634933|75871918|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
42062713|NCT00634933|75871914|FG000|Part A: Baseline to Week 24|Death|1|||
42062714|NCT00634933|75871915|FG001|Part A: Baseline to Week 24|Death|0|||
42062715|NCT00634933|75871916|FG002|Part A: Baseline to Week 24|Death|0|||
42062716|NCT00634933|75871917|FG003|Part A: Baseline to Week 24|Death|0|||
42062717|NCT00634933|75871918|FG004|Part A: Baseline to Week 24|Death|0|||
42062718|NCT00634933|75871914|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
42291953|NCT01918306|76125398|FG000|Overall Study|Lack of Efficacy|1|||
42291954|NCT01918306|76125399|FG001|Overall Study|Lack of Efficacy|0|||
42291955|NCT01918306|76125400|FG002|Overall Study|Lack of Efficacy|0|||
42062719|NCT00634933|75871915|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
42062720|NCT00634933|75871916|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
42062721|NCT00634933|75871917|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
42062722|NCT00634933|75871918|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
42062723|NCT00634933|75871914|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
42062724|NCT00634933|75871915|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
42062725|NCT00634933|75871916|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
42062726|NCT00634933|75871917|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
42062727|NCT00634933|75871918|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
42062728|NCT00634933|75871914|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
42062729|NCT00634933|75871915|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
42062730|NCT00634933|75871916|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
42062731|NCT00634933|75871917|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
42062732|NCT00634933|75871918|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
42062733|NCT00634933|75871914|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
42062734|NCT00634933|75871915|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
42062735|NCT00634933|75871916|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
42062736|NCT00634933|75871917|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
42062737|NCT00634933|75871918|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
42062738|NCT00634933|75871914|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
42062739|NCT00634933|75871915|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
42062740|NCT00634933|75871916|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
42062741|NCT00634933|75871917|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
42062742|NCT00634933|75871918|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
42062743|NCT00634933|75871914|FG000|Part A: Baseline to Week 24|Other|1|||
42062744|NCT00634933|75871915|FG001|Part A: Baseline to Week 24|Other|8|||
42062745|NCT00634933|75871916|FG002|Part A: Baseline to Week 24|Other|5|||
42062746|NCT00634933|75871917|FG003|Part A: Baseline to Week 24|Other|0|||
42062747|NCT00634933|75871918|FG004|Part A: Baseline to Week 24|Other|0|||
42062748|NCT00634933|75871914|FG000|Between Part A and Part B|Physician Decision|0|||
42062749|NCT00634933|75871915|FG001|Between Part A and Part B|Physician Decision|1|||
42062750|NCT00634933|75871916|FG002|Between Part A and Part B|Physician Decision|0|||
42062751|NCT00634933|75871917|FG003|Between Part A and Part B|Physician Decision|0|||
42062752|NCT00634933|75871918|FG004|Between Part A and Part B|Physician Decision|0|||
42062753|NCT00634933|75871914|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
42062754|NCT00634933|75871915|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
42062755|NCT00634933|75871916|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
42062756|NCT00634933|75871917|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
42062757|NCT00634933|75871918|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
42062758|NCT00634933|75871914|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
42062759|NCT00634933|75871915|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
42062760|NCT00634933|75871916|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
42062761|NCT00634933|75871917|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
42062762|NCT00634933|75871918|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
42062763|NCT00634933|75871914|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
42062764|NCT00634933|75871915|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
42062765|NCT00634933|75871916|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
42062766|NCT00634933|75871917|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
42062767|NCT00634933|75871918|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
42062768|NCT00634933|75871914|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
42062769|NCT00634933|75871915|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
42062770|NCT00634933|75871916|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
42062771|NCT00634933|75871917|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
42062772|NCT00634933|75871918|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
42062773|NCT00634933|75871914|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
42062774|NCT00634933|75871915|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
42062775|NCT00634933|75871916|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
42062776|NCT00634933|75871917|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
42062777|NCT00634933|75871918|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
42062778|NCT00634933|75871914|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
42062779|NCT00634933|75871915|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
42062780|NCT00634933|75871916|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
42062781|NCT00634933|75871917|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
42062782|NCT00634933|75871918|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
42062783|NCT00634933|75871914|FG000|Part B: Week 24 to Week 52|Other|0|||
42062784|NCT00634933|75871915|FG001|Part B: Week 24 to Week 52|Other|0|||
42062785|NCT00634933|75871916|FG002|Part B: Week 24 to Week 52|Other|5|||
42357299|NCT01724528|76202622|FG000|Overall Study|Withdrawal by Subject|0|||
42062786|NCT00634933|75871917|FG003|Part B: Week 24 to Week 52|Other|0|||
42062787|NCT00634933|75871918|FG004|Part B: Week 24 to Week 52|Other|1|||
42062788|NCT00967499|75871932|FG000|Overall Study|Adverse Event|0|||
42062789|NCT00967499|75871933|FG001|Overall Study|Adverse Event|1|||
42062790|NCT00967499|75871932|FG000|Overall Study|Protocol Violation|1|||
42062791|NCT00967499|75871933|FG001|Overall Study|Protocol Violation|0|||
42062792|NCT00967499|75871932|FG000|Overall Study|Sponsor Decision|1|||
42062793|NCT00967499|75871933|FG001|Overall Study|Sponsor Decision|0|||
42062794|NCT00967499|75871932|FG000|Overall Study|Randomized but not treated|63|||
42062795|NCT00967499|75871933|FG001|Overall Study|Randomized but not treated|59|||
42062796|NCT03909971|75871941|FG000|Overall Study|Other Reasons Not Specified|0|||
42062797|NCT03909971|75871942|FG001|Overall Study|Other Reasons Not Specified|1|||
42062798|NCT03909971|75871941|FG000|Overall Study|Global Deterioration of Health Status|2|||
42062799|NCT03909971|75871942|FG001|Overall Study|Global Deterioration of Health Status|1|||
42062800|NCT03909971|75871941|FG000|Overall Study|Progressive Disease|6|||
42062801|NCT03909971|75871942|FG001|Overall Study|Progressive Disease|14|||
42062802|NCT03909971|75871941|FG000|Overall Study|Death|2|||
42062803|NCT03909971|75871942|FG001|Overall Study|Death|6|||
42062804|NCT00967343|75871949|FG000|Overall Study|Study termination by sponsor|12|||
42062805|NCT00967343|75871949|FG000|Overall Study|Death|24|||
42062806|NCT00967343|75871949|FG000|Overall Study|Relapse|1|||
42062807|NCT00967343|75871949|FG000|Overall Study|Lost to Follow-up|1|||
42062808|NCT00973973|75871955|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
42062809|NCT00973973|75871956|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
42062810|NCT00973973|75871955|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
42062811|NCT00973973|75871956|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
42062812|NCT00973973|75871955|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
42062813|NCT00973973|75871956|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
42062814|NCT00973973|75871955|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
42062815|NCT00973973|75871956|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
42062816|NCT00973973|75871955|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
42062817|NCT00973973|75871956|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
42062818|NCT00973973|75871955|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
42062819|NCT00973973|75871956|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
42062820|NCT00973973|75871955|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
42174632|NCT00310817|75981369|FG001|Overall Study|Lost to Follow-up|1|||
42174633|NCT00310817|75981370|FG002|Overall Study|Lost to Follow-up|0|||
42174634|NCT00310817|75981371|FG003|Overall Study|Lost to Follow-up|0|||
42062821|NCT00973973|75871956|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
42062822|NCT00973973|75871955|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
42062823|NCT00973973|75871956|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
42174635|NCT00310817|75981368|FG000|Overall Study|Inappropriate Enrollment|1|||
42174636|NCT00310817|75981369|FG001|Overall Study|Inappropriate Enrollment|0|||
42174637|NCT00310817|75981370|FG002|Overall Study|Inappropriate Enrollment|1|||
42174638|NCT00310817|75981371|FG003|Overall Study|Inappropriate Enrollment|0|||
42174639|NCT00310817|75981368|FG000|Overall Study|Protocol Violation|1|||
42174640|NCT00310817|75981369|FG001|Overall Study|Protocol Violation|1|||
42174641|NCT00310817|75981370|FG002|Overall Study|Protocol Violation|1|||
42174642|NCT00310817|75981371|FG003|Overall Study|Protocol Violation|1|||
42174643|NCT00310817|75981368|FG000|Overall Study|Unable to classify|3|||
42174644|NCT00310817|75981369|FG001|Overall Study|Unable to classify|1|||
42174645|NCT00310817|75981370|FG002|Overall Study|Unable to classify|0|||
42174646|NCT00310817|75981371|FG003|Overall Study|Unable to classify|0|||
42174647|NCT02940886|75981416|FG000|Overall Study|Adverse Event|7|||
42174648|NCT02940886|75981417|FG001|Overall Study|Adverse Event|3|||
42174649|NCT02940886|75981416|FG000|Overall Study|Protocol Violation|0|||
42174650|NCT02940886|75981417|FG001|Overall Study|Protocol Violation|2|||
42174651|NCT02940886|75981416|FG000|Overall Study|Withdrawal by Subject|28|||
42174652|NCT02940886|75981417|FG001|Overall Study|Withdrawal by Subject|20|||
42174653|NCT02940886|75981416|FG000|Overall Study|Death|1|||
42174654|NCT02940886|75981417|FG001|Overall Study|Death|0|||
42174655|NCT02940886|75981416|FG000|Overall Study|Lack of Efficacy|1|||
42174656|NCT02940886|75981417|FG001|Overall Study|Lack of Efficacy|0|||
42174657|NCT02940886|75981416|FG000|Overall Study|Lost to Follow-up|49|||
42174658|NCT02940886|75981417|FG001|Overall Study|Lost to Follow-up|21|||
42174659|NCT02940886|75981416|FG000|Overall Study|Physician Decision|9|||
42174660|NCT02940886|75981417|FG001|Overall Study|Physician Decision|4|||
42174661|NCT02940886|75981416|FG000|Overall Study|Sponsor decision|0|||
42174662|NCT02940886|75981417|FG001|Overall Study|Sponsor decision|1|||
42174663|NCT02940886|75981416|FG000|Overall Study|No treatment|7|||
42174664|NCT02940886|75981417|FG001|Overall Study|No treatment|2|||
42174665|NCT02940886|75981416|FG000|Overall Study|Enrolment error|0|||
42291956|NCT01918306|76125401|FG003|Overall Study|Lack of Efficacy|0|||
42174666|NCT02940886|75981417|FG001|Overall Study|Enrolment error|1|||
42174667|NCT03285958|75981427|FG000|Overall Study|Lost to Follow-up|1|||
42174668|NCT03285958|75981428|FG001|Overall Study|Lost to Follow-up|1|||
42291957|NCT01918306|76125398|FG000|Overall Study|progress disease, crossover|0|||
42291958|NCT01918306|76125399|FG001|Overall Study|progress disease, crossover|0|||
42062824|NCT00973973|75871955|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
42062825|NCT00973973|75871956|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
42062826|NCT00973973|75871955|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
42174669|NCT03285958|75981427|FG000|Overall Study|Withdrawal by Subject|1|||
42174670|NCT03285958|75981428|FG001|Overall Study|Withdrawal by Subject|0|||
42174671|NCT03285958|75981427|FG000|Overall Study|Not able to attend required orientation|3|||
42174672|NCT03285958|75981428|FG001|Overall Study|Not able to attend required orientation|0|||
42174673|NCT03285646|75981437|FG000|Overall Study|Adverse Event|1|||
42174674|NCT03285646|75981438|FG001|Overall Study|Adverse Event|0|||
42174675|NCT03285646|75981437|FG000|Overall Study|Withdrawal by Subject|10|||
42174676|NCT03285646|75981438|FG001|Overall Study|Withdrawal by Subject|2|||
42174677|NCT03285646|75981437|FG000|Overall Study|Lost to Follow-up|2|||
42174678|NCT03285646|75981438|FG001|Overall Study|Lost to Follow-up|1|||
42174679|NCT03285646|75981437|FG000|Overall Study|Investigator/Sponsor Decision|0|||
42174680|NCT03285646|75981438|FG001|Overall Study|Investigator/Sponsor Decision|1|||
42174681|NCT03309202|75981449|FG000|Overall Study|Lost to Follow-up|1|||
42174682|NCT03309202|75981450|FG001|Overall Study|Lost to Follow-up|0|||
42174683|NCT03309202|75981451|FG002|Overall Study|Lost to Follow-up|0|||
42174684|NCT03309202|75981452|FG003|Overall Study|Lost to Follow-up|0|||
42174685|NCT00074490|75981467|FG000|Overall Study|Progressive malignancy|0|||
42174686|NCT00074490|75981468|FG001|Overall Study|Progressive malignancy|7|||
42174687|NCT00074490|75981469|FG002|Overall Study|Progressive malignancy|0|||
42174688|NCT00074490|75981470|FG003|Overall Study|Progressive malignancy|0|||
42174689|NCT00074490|75981471|FG004|Overall Study|Progressive malignancy|3|||
42174690|NCT00074490|75981472|FG005|Overall Study|Progressive malignancy|0|||
42174691|NCT03285490|75981487|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
42174692|NCT03285490|75981488|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
42174693|NCT03285490|75981487|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
42062827|NCT00973973|75871956|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
42062828|NCT00973973|75871955|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
42062829|NCT00973973|75871956|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
42062830|NCT00973973|75871955|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
42062831|NCT00973973|75871956|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
42062832|NCT00633139|75871965|FG000|Overall Study|Non compliance|0|||
42062833|NCT00633139|75871966|FG001|Overall Study|Non compliance|0|||
42062834|NCT00633139|75871967|FG002|Overall Study|Non compliance|1|||
42062835|NCT00633139|75871965|FG000|Overall Study|Withdrawal by Subject|0|||
42062836|NCT00633139|75871966|FG001|Overall Study|Withdrawal by Subject|1|||
42062837|NCT00633139|75871967|FG002|Overall Study|Withdrawal by Subject|0|||
42062838|NCT00965081|75871977|FG000|Overall Study|Adverse Event|14|||
42062839|NCT00965081|75871978|FG001|Overall Study|Adverse Event|9|||
42062840|NCT00965081|75871977|FG000|Overall Study|Lack of Efficacy|2|||
42174694|NCT03285490|75981488|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
42174695|NCT02939716|75981495|FG000|Overall Study|scanner failure|0|||
42174696|NCT02939716|75981496|FG001|Overall Study|scanner failure|0|||
42174697|NCT02939716|75981497|FG002|Overall Study|scanner failure|0|||
42174698|NCT02939716|75981498|FG003|Overall Study|scanner failure|1|||
42174699|NCT02939716|75981499|FG004|Overall Study|scanner failure|1|||
42174700|NCT02939716|75981500|FG005|Overall Study|scanner failure|1|||
42174701|NCT00367133|75981529|FG000|2 Years|Death|20|||
42174702|NCT00367133|75981530|FG001|2 Years|Death|12|||
42174703|NCT00367133|75981531|FG002|2 Years|Death|12|||
42174704|NCT00367133|75981529|FG000|2 Years|Dropped|34|||
42174705|NCT00367133|75981530|FG001|2 Years|Dropped|19|||
42174706|NCT00367133|75981531|FG002|2 Years|Dropped|33|||
42174707|NCT00367133|75981529|FG000|2 Years|Missed visit|4|||
42174708|NCT00367133|75981530|FG001|2 Years|Missed visit|5|||
42174709|NCT00367133|75981531|FG002|2 Years|Missed visit|4|||
42174710|NCT00367055|75981541|FG000|Overall Study|Adverse Event|6|||
42174711|NCT00367055|75981542|FG001|Overall Study|Adverse Event|3|||
42174712|NCT00367055|75981541|FG000|Overall Study|Patient's Willing|3|||
42174713|NCT00367055|75981542|FG001|Overall Study|Patient's Willing|2|||
42174714|NCT00367055|75981541|FG000|Overall Study|Lack of Efficacy|1|||
42062841|NCT00965081|75871978|FG001|Overall Study|Lack of Efficacy|5|||
42062842|NCT00965081|75871977|FG000|Overall Study|Lost to Follow-up|4|||
42062843|NCT00965081|75871978|FG001|Overall Study|Lost to Follow-up|5|||
42062844|NCT00965081|75871977|FG000|Overall Study|Physician Decision|2|||
42062845|NCT00965081|75871978|FG001|Overall Study|Physician Decision|0|||
42174715|NCT00367055|75981542|FG001|Overall Study|Lack of Efficacy|2|||
42174716|NCT00367055|75981541|FG000|Overall Study|Lost to Follow-up|1|||
42174717|NCT00367055|75981542|FG001|Overall Study|Lost to Follow-up|1|||
42062846|NCT00965081|75871977|FG000|Overall Study|Protocol Violation|2|||
42174718|NCT00367055|75981541|FG000|Overall Study|Protocol Violation|0|||
42291959|NCT01918306|76125400|FG002|Overall Study|progress disease, crossover|1|||
42291960|NCT01918306|76125401|FG003|Overall Study|progress disease, crossover|0|||
42062847|NCT00965081|75871978|FG001|Overall Study|Protocol Violation|5|||
42062848|NCT00965081|75871977|FG000|Overall Study|Sponsor Decision|1|||
42062849|NCT00965081|75871978|FG001|Overall Study|Sponsor Decision|0|||
42062850|NCT00965081|75871977|FG000|Overall Study|Withdrawal by Subject|4|||
42174719|NCT00367055|75981542|FG001|Overall Study|Protocol Violation|1|||
42174720|NCT00367055|75981541|FG000|Overall Study|Stopping Criterion Met|0|||
42174721|NCT00367055|75981542|FG001|Overall Study|Stopping Criterion Met|1|||
42174722|NCT00367055|75981541|FG000|Overall Study|Participant Living too Far from Hospital|0|||
42174723|NCT00367055|75981542|FG001|Overall Study|Participant Living too Far from Hospital|1|||
42174724|NCT00057330|75981550|FG000|Overall Study|Adverse Event|9|||
42357300|NCT01724528|76202623|FG001|Overall Study|Withdrawal by Subject|2|||
42062851|NCT00965081|75871978|FG001|Overall Study|Withdrawal by Subject|7|||
42062852|NCT00965081|75871977|FG000|Overall Study|Switched to Rescue Arm|5|||
42062853|NCT00965081|75871978|FG001|Overall Study|Switched to Rescue Arm|12|||
42062854|NCT00961649|75871989|FG000|Overall Study|Adverse Event|4|||
42062855|NCT00961649|75871990|FG001|Overall Study|Adverse Event|0|||
42062856|NCT00961649|75871991|FG002|Overall Study|Adverse Event|0|||
42062857|NCT00961649|75871992|FG003|Overall Study|Adverse Event|2|||
42062858|NCT00961649|75871989|FG000|Overall Study|Inadequate control of IOP|0|||
42357301|NCT01724528|76202622|FG000|Overall Study|Protocol Violation|0|||
42357302|NCT01724528|76202623|FG001|Overall Study|Protocol Violation|1|||
42357303|NCT01724528|76202622|FG000|Overall Study|Patient refused to attend last visit|1|||
42357304|NCT01724528|76202623|FG001|Overall Study|Patient refused to attend last visit|0|||
42357305|NCT01779440|76202631|FG000|Overall Study|Withdrawal by Subject|3|||
42357306|NCT01779440|76202632|FG001|Overall Study|Withdrawal by Subject|5|||
42062859|NCT00961649|75871990|FG001|Overall Study|Inadequate control of IOP|0|||
42062860|NCT00961649|75871991|FG002|Overall Study|Inadequate control of IOP|0|||
42062861|NCT00961649|75871992|FG003|Overall Study|Inadequate control of IOP|1|||
42062862|NCT00961649|75871989|FG000|Overall Study|Patient has travel plans during holidays|0|||
42062863|NCT00961649|75871990|FG001|Overall Study|Patient has travel plans during holidays|0|||
42062864|NCT00961649|75871991|FG002|Overall Study|Patient has travel plans during holidays|1|||
42062865|NCT00961649|75871992|FG003|Overall Study|Patient has travel plans during holidays|0|||
42062866|NCT00961649|75871989|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
42062867|NCT00961649|75871990|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
42062868|NCT00961649|75871991|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
42062869|NCT00961649|75871992|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
42062870|NCT00961649|75871989|FG000|Overall Study|Study terminated by sponsor|4|||
42062871|NCT00961649|75871990|FG001|Overall Study|Study terminated by sponsor|4|||
42062872|NCT00961649|75871991|FG002|Overall Study|Study terminated by sponsor|4|||
42062873|NCT00961649|75871992|FG003|Overall Study|Study terminated by sponsor|1|||
42062874|NCT00632125|75872002|FG000|Overall Study|Death|82|||
42062875|NCT00632125|75872002|FG000|Overall Study|Withdrawal by Subject|44|||
42062876|NCT00632125|75872002|FG000|Overall Study|Adverse Event|36|||
42062877|NCT00632125|75872002|FG000|Overall Study|Renal transplantation|17|||
42062878|NCT00632125|75872002|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
42062879|NCT00632125|75872002|FG000|Overall Study|Non-compliance|8|||
42062880|NCT00632125|75872002|FG000|Overall Study|Development of uncontrolled hypertension|5|||
42062881|NCT00632125|75872002|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
42062882|NCT00903968|75872008|FG000|Overall Study|Adverse Event|0|||
42062883|NCT00903968|75872009|FG001|Overall Study|Adverse Event|0|||
42062884|NCT00903968|75872010|FG002|Overall Study|Adverse Event|0|||
42062885|NCT00903968|75872011|FG003|Overall Study|Adverse Event|0|||
42062886|NCT00903968|75872012|FG004|Overall Study|Adverse Event|0|||
42062887|NCT00903968|75872013|FG005|Overall Study|Adverse Event|0|||
42062888|NCT00903968|75872014|FG006|Overall Study|Adverse Event|1|||
42062889|NCT00903968|75872015|FG007|Overall Study|Adverse Event|8|||
42062890|NCT00903968|75872008|FG000|Overall Study|DLT|0|||
42062891|NCT00903968|75872009|FG001|Overall Study|DLT|0|||
42062892|NCT00903968|75872010|FG002|Overall Study|DLT|0|||
42062893|NCT00903968|75872011|FG003|Overall Study|DLT|0|||
42062894|NCT00903968|75872012|FG004|Overall Study|DLT|0|||
42062895|NCT00903968|75872013|FG005|Overall Study|DLT|0|||
42062896|NCT00903968|75872014|FG006|Overall Study|DLT|2|||
42062897|NCT00903968|75872015|FG007|Overall Study|DLT|0|||
42062898|NCT00903968|75872008|FG000|Overall Study|Withdrawal by Subject|1|||
42062899|NCT00903968|75872009|FG001|Overall Study|Withdrawal by Subject|0|||
42062900|NCT00903968|75872010|FG002|Overall Study|Withdrawal by Subject|1|||
42062901|NCT00903968|75872011|FG003|Overall Study|Withdrawal by Subject|0|||
42062902|NCT00903968|75872012|FG004|Overall Study|Withdrawal by Subject|1|||
42062903|NCT00903968|75872013|FG005|Overall Study|Withdrawal by Subject|1|||
42062904|NCT00903968|75872014|FG006|Overall Study|Withdrawal by Subject|0|||
42062905|NCT00903968|75872015|FG007|Overall Study|Withdrawal by Subject|4|||
42062906|NCT00903968|75872008|FG000|Overall Study|Non-Compliance|0|||
42062907|NCT00903968|75872009|FG001|Overall Study|Non-Compliance|0|||
42062908|NCT00903968|75872010|FG002|Overall Study|Non-Compliance|0|||
42174725|NCT00057330|75981551|FG001|Overall Study|Adverse Event|12|||
42174726|NCT00057330|75981550|FG000|Overall Study|Death|1|||
42062909|NCT00903968|75872011|FG003|Overall Study|Non-Compliance|0|||
42062910|NCT00903968|75872012|FG004|Overall Study|Non-Compliance|0|||
42062911|NCT00903968|75872013|FG005|Overall Study|Non-Compliance|1|||
42062912|NCT00903968|75872014|FG006|Overall Study|Non-Compliance|0|||
42062913|NCT00903968|75872015|FG007|Overall Study|Non-Compliance|0|||
42062914|NCT00903968|75872008|FG000|Overall Study|Physician Decision|0|||
42062915|NCT00903968|75872009|FG001|Overall Study|Physician Decision|0|||
42062916|NCT00903968|75872010|FG002|Overall Study|Physician Decision|0|||
42062917|NCT00903968|75872011|FG003|Overall Study|Physician Decision|0|||
42062918|NCT00903968|75872012|FG004|Overall Study|Physician Decision|0|||
42062919|NCT00903968|75872013|FG005|Overall Study|Physician Decision|1|||
42062920|NCT00903968|75872014|FG006|Overall Study|Physician Decision|0|||
42062921|NCT00903968|75872015|FG007|Overall Study|Physician Decision|0|||
42062922|NCT00903968|75872008|FG000|Overall Study|Progressive Disease|2|||
42062923|NCT00903968|75872009|FG001|Overall Study|Progressive Disease|3|||
42062924|NCT00903968|75872010|FG002|Overall Study|Progressive Disease|2|||
42062925|NCT00903968|75872011|FG003|Overall Study|Progressive Disease|3|||
42062926|NCT00903968|75872012|FG004|Overall Study|Progressive Disease|3|||
42062927|NCT00903968|75872013|FG005|Overall Study|Progressive Disease|3|||
42062928|NCT00903968|75872014|FG006|Overall Study|Progressive Disease|0|||
42062929|NCT00903968|75872015|FG007|Overall Study|Progressive Disease|18|||
42062930|NCT00903968|75872008|FG000|Overall Study|Lack of Efficacy|0|||
42062931|NCT00903968|75872009|FG001|Overall Study|Lack of Efficacy|0|||
42062932|NCT00903968|75872010|FG002|Overall Study|Lack of Efficacy|0|||
42062933|NCT00903968|75872011|FG003|Overall Study|Lack of Efficacy|0|||
42062934|NCT00903968|75872012|FG004|Overall Study|Lack of Efficacy|0|||
42062935|NCT00903968|75872013|FG005|Overall Study|Lack of Efficacy|0|||
42062936|NCT00903968|75872014|FG006|Overall Study|Lack of Efficacy|0|||
42062937|NCT00903968|75872015|FG007|Overall Study|Lack of Efficacy|3|||
42062938|NCT00903344|75872038|FG000|Overall Study|Pregnancy|2|||
42062939|NCT00903344|75872039|FG001|Overall Study|Pregnancy|3|||
42062940|NCT00903344|75872038|FG000|Overall Study|Lost to Follow-up|3|||
42062941|NCT00903344|75872039|FG001|Overall Study|Lost to Follow-up|0|||
42291961|NCT01917526|76125423|FG000|Overall Study|Protocol Violation|1|||
42291962|NCT01917526|76125424|FG001|Overall Study|Protocol Violation|1|||
42291963|NCT01948258|76125430|FG000|Overall Study|Pregnancy|41|||
42291964|NCT01948258|76125430|FG000|Overall Study|Did not complete by cut-off date|35|||
42291965|NCT01948258|76125430|FG000|Overall Study|Lost to Follow-up|27|||
42291966|NCT01948258|76125430|FG000|Overall Study|Withdrawal by SPD|8|||
42062942|NCT00903032|75872047|FG000|Overall Study|Withdrawal by Subject|5|||
42291967|NCT01948258|76125430|FG000|Overall Study|Withdrawal by Subject|6|||
42062943|NCT00903032|75872048|FG001|Overall Study|Withdrawal by Subject|3|||
42062944|NCT00903032|75872047|FG000|Overall Study|Lost to Follow-up|2|||
42062945|NCT00903032|75872048|FG001|Overall Study|Lost to Follow-up|2|||
42062946|NCT00902564|75872063|FG000|Overall Study|Withdrawal by Subject|2|||
42062947|NCT00626197|75872070|FG000|Overall Study|Did not cooperate|2|||
42062948|NCT00626197|75872071|FG001|Overall Study|Did not cooperate|6|||
42062949|NCT00626197|75872072|FG002|Overall Study|Did not cooperate|1|||
42062950|NCT00626197|75872070|FG000|Overall Study|Failure to return|6|||
42062951|NCT00626197|75872071|FG001|Overall Study|Failure to return|5|||
42016675|NCT00400725|75824170|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
42016676|NCT00400725|75824171|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
42016677|NCT00400725|75824169|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
42016678|NCT00400725|75824170|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
42016679|NCT00400725|75824171|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
42016680|NCT00400725|75824169|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
42016681|NCT00400725|75824170|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
42016682|NCT00400725|75824171|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
42016683|NCT00400725|75824169|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
42016684|NCT00400725|75824170|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
42016685|NCT00400725|75824171|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
42016686|NCT00400725|75824169|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
42016687|NCT00400725|75824170|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
42016688|NCT00400725|75824171|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
42016689|NCT00400725|75824169|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
42062952|NCT00626197|75872072|FG002|Overall Study|Failure to return|6|||
42062953|NCT00626197|75872070|FG000|Overall Study|Adverse event, serious fatal|3|||
42062954|NCT00626197|75872071|FG001|Overall Study|Adverse event, serious fatal|6|||
42062955|NCT00626197|75872072|FG002|Overall Study|Adverse event, serious fatal|6|||
42062956|NCT00626197|75872070|FG000|Overall Study|Adverse Event|1|||
42062957|NCT00626197|75872071|FG001|Overall Study|Adverse Event|1|||
42062958|NCT00626197|75872072|FG002|Overall Study|Adverse Event|2|||
42291968|NCT01948258|76125430|FG000|Overall Study|Health Care Professional|43|||
42062959|NCT00626197|75872070|FG000|Overall Study|Withdrawal by Subject|17|||
42062960|NCT00626197|75872071|FG001|Overall Study|Withdrawal by Subject|17|||
42062961|NCT00626197|75872072|FG002|Overall Study|Withdrawal by Subject|7|||
42062962|NCT00626197|75872070|FG000|Overall Study|Administrative reasons|15|||
42062963|NCT00626197|75872071|FG001|Overall Study|Administrative reasons|19|||
42062964|NCT00626197|75872072|FG002|Overall Study|Administrative reasons|55|||
42062965|NCT00626275|75872086|FG000|Part A - Treatment Period 1|Adverse Event|1|||
42062966|NCT00626275|75872087|FG001|Part A - Treatment Period 1|Adverse Event|0|||
42062967|NCT00626275|75872088|FG002|Part A - Treatment Period 1|Adverse Event|0|||
42062968|NCT00626275|75872089|FG003|Part A - Treatment Period 1|Adverse Event|0|||
42062969|NCT00626275|75872090|FG004|Part A - Treatment Period 1|Adverse Event|0|||
42062970|NCT00626275|75872091|FG005|Part A - Treatment Period 1|Adverse Event|0|||
42062971|NCT00626275|75872092|FG006|Part A - Treatment Period 1|Adverse Event|0|||
42062972|NCT00626275|75872093|FG007|Part A - Treatment Period 1|Adverse Event|0|||
42062973|NCT00626275|75872086|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
42062974|NCT00626275|75872087|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
42062975|NCT00626275|75872088|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
42062976|NCT00626275|75872089|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
42062977|NCT00626275|75872090|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
42062978|NCT00626275|75872091|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
42062979|NCT00626275|75872092|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
42062980|NCT00626275|75872093|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
42062981|NCT00626275|75872086|FG000|Part B|Lost to Follow-up|0|||
42062982|NCT00626275|75872087|FG001|Part B|Lost to Follow-up|0|||
42062983|NCT00626275|75872088|FG002|Part B|Lost to Follow-up|0|||
42062984|NCT00626275|75872089|FG003|Part B|Lost to Follow-up|0|||
42062985|NCT00626275|75872090|FG004|Part B|Lost to Follow-up|0|||
42062986|NCT00626275|75872091|FG005|Part B|Lost to Follow-up|0|||
42062987|NCT00626275|75872092|FG006|Part B|Lost to Follow-up|1|||
42062988|NCT00626275|75872093|FG007|Part B|Lost to Follow-up|0|||
42062989|NCT00626275|75872086|FG000|Part B|Withdrawal by Subject|0|||
42062990|NCT00626275|75872087|FG001|Part B|Withdrawal by Subject|0|||
42062991|NCT00626275|75872088|FG002|Part B|Withdrawal by Subject|0|||
42062992|NCT00626275|75872089|FG003|Part B|Withdrawal by Subject|0|||
42174727|NCT00057330|75981551|FG001|Overall Study|Death|0|||
42174728|NCT00057330|75981550|FG000|Overall Study|Protocol Violation|1|||
42174729|NCT00057330|75981551|FG001|Overall Study|Protocol Violation|1|||
42174730|NCT00057330|75981550|FG000|Overall Study|Withdrawal by Subject|115|||
42174731|NCT00057330|75981551|FG001|Overall Study|Withdrawal by Subject|84|||
42174732|NCT00057330|75981550|FG000|Overall Study|Lost to Follow-up|745|||
42174733|NCT00057330|75981551|FG001|Overall Study|Lost to Follow-up|617|||
42174734|NCT00057330|75981550|FG000|Overall Study|Physician Decision|1|||
42174735|NCT00057330|75981551|FG001|Overall Study|Physician Decision|0|||
42174736|NCT00057330|75981550|FG000|Overall Study|Other|260|||
42174737|NCT00057330|75981551|FG001|Overall Study|Other|206|||
42174738|NCT03283696|75981559|FG000|Overall Study|Physician Decision|5|||
42174739|NCT03283696|75981560|FG001|Overall Study|Physician Decision|6|||
42174740|NCT03283696|75981559|FG000|Overall Study|Withdrawal by Subject|2|||
42174741|NCT03283696|75981560|FG001|Overall Study|Withdrawal by Subject|0|||
42174742|NCT02939560|75981566|FG000|Overall Study|Withdrawal by Subject|2|||
42174743|NCT02939560|75981566|FG000|Overall Study|Protocol Violation|1|||
42174744|NCT03748706|75981570|FG000|Overall Study|Lost to Follow-up|1|||
42174745|NCT03747302|75981576|FG000|Overall Study|Withdrawal by Subject|1|||
42174746|NCT03747302|75981577|FG001|Overall Study|Withdrawal by Subject|2|||
42174747|NCT00056862|75981587|FG000|Overall Study|Protocol Violation|1|||
42174748|NCT00056862|75981588|FG001|Overall Study|Protocol Violation|0|||
42174749|NCT00056316|75981596|FG000|Overall Study|Withdrawal by Subject|2|||
42174750|NCT00056316|75981597|FG001|Overall Study|Withdrawal by Subject|2|||
42174751|NCT00056316|75981596|FG000|Overall Study|Death/NH placement of pt|1|||
42174752|NCT00056316|75981597|FG001|Overall Study|Death/NH placement of pt|1|||
42174753|NCT03308968|75981606|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
42174754|NCT03308968|75981607|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
42174755|NCT03308968|75981608|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
42174756|NCT03308968|75981606|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
42174757|NCT03308968|75981607|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
42174758|NCT03308968|75981608|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
42174759|NCT03308968|75981606|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
42174760|NCT03308968|75981607|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
42174761|NCT03308968|75981608|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
42174762|NCT03308968|75981606|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
42174763|NCT03308968|75981607|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
42174764|NCT03308968|75981608|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
42174765|NCT03308968|75981606|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
42174766|NCT03308968|75981607|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
42174767|NCT03308968|75981608|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
42174768|NCT03308968|75981606|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
42174769|NCT03308968|75981607|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
42174770|NCT03308968|75981608|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
42062993|NCT00626275|75872090|FG004|Part B|Withdrawal by Subject|0|||
42062994|NCT00626275|75872091|FG005|Part B|Withdrawal by Subject|0|||
42062995|NCT00626275|75872092|FG006|Part B|Withdrawal by Subject|0|||
42062996|NCT00626275|75872093|FG007|Part B|Withdrawal by Subject|1|||
42062997|NCT00623935|75872107|FG000|Overall Study|Death|1|||
42062998|NCT00623935|75872107|FG000|Overall Study|Patient Declined Transplant|1|||
42062999|NCT00623779|75872114|FG000|Overall Study|Adverse Event|1|||
42063000|NCT00623779|75872115|FG001|Overall Study|Adverse Event|3|||
42063001|NCT00623779|75872116|FG002|Overall Study|Adverse Event|0|||
42063002|NCT00623779|75872114|FG000|Overall Study|Criteria from CSR|2|||
42063003|NCT00623779|75872115|FG001|Overall Study|Criteria from CSR|0|||
42063004|NCT00623779|75872116|FG002|Overall Study|Criteria from CSR|1|||
42063005|NCT00629707|75872147|FG000|Overall Study|Withdrawal by Subject|0|||
42063006|NCT00629707|75872148|FG001|Overall Study|Withdrawal by Subject|1|||
42063007|NCT00629707|75872147|FG000|Overall Study|Physician Decision|0|||
42063008|NCT00629707|75872148|FG001|Overall Study|Physician Decision|1|||
42063009|NCT00902330|75872156|FG000|Overall Study|Too overwhelmed by treatment|2|||
42063010|NCT00902330|75872157|FG001|Overall Study|Too overwhelmed by treatment|5|||
42063011|NCT00902330|75872156|FG000|Overall Study|Adverse Event|1|||
42063012|NCT00902330|75872157|FG001|Overall Study|Adverse Event|0|||
42063013|NCT00902330|75872156|FG000|Overall Study|No post baseline data|1|||
42063014|NCT00902330|75872157|FG001|Overall Study|No post baseline data|0|||
42063015|NCT00901394|75872194|FG000|Overall Study|Physician Decision|1|||
42063016|NCT00901394|75872195|FG001|Overall Study|Physician Decision|1|||
42063017|NCT00901394|75872196|FG002|Overall Study|Physician Decision|2|||
42063018|NCT00896532|75872212|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063019|NCT00896532|75872213|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063020|NCT00896532|75872214|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063021|NCT00896532|75872215|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
42063022|NCT00896532|75872216|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063023|NCT00896532|75872217|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
42063024|NCT00896532|75872218|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063025|NCT00896532|75872219|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063026|NCT00896532|75872220|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063027|NCT00896532|75872221|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063028|NCT00896532|75872222|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063029|NCT00896532|75872223|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063030|NCT00896532|75872224|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063031|NCT00896532|75872225|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063032|NCT00896532|75872226|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063033|NCT00896532|75872227|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063034|NCT00896532|75872228|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063035|NCT00896532|75872229|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063036|NCT00896532|75872230|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063037|NCT00896532|75872231|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063038|NCT00896532|75872232|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063039|NCT00896532|75872233|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063040|NCT00896532|75872234|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
42063041|NCT00896532|75872212|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
42063042|NCT00896532|75872213|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
42063043|NCT00896532|75872214|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
42063044|NCT00896532|75872215|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
42063045|NCT00896532|75872216|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
42063046|NCT00896532|75872217|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
42063047|NCT00896532|75872218|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
42063048|NCT00896532|75872219|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063049|NCT00896532|75872220|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42174771|NCT03308968|75981606|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
42174772|NCT03308968|75981607|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
42174773|NCT03308968|75981608|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
42174774|NCT03308968|75981606|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
42291969|NCT01948258|76125430|FG000|Overall Study|Removed from statistical analysis|2|||
42291970|NCT01916980|76125436|FG000|Overall Study|Adverse Event|4|||
42063050|NCT00896532|75872221|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063051|NCT00896532|75872222|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063052|NCT00896532|75872223|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063053|NCT00896532|75872224|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063054|NCT00896532|75872225|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42174775|NCT03308968|75981607|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
42063055|NCT00896532|75872226|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063056|NCT00896532|75872227|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063057|NCT00896532|75872228|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063058|NCT00896532|75872229|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063059|NCT00896532|75872230|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063060|NCT00896532|75872231|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063061|NCT00896532|75872232|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063062|NCT00896532|75872233|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063063|NCT00896532|75872234|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
42063064|NCT00896532|75872212|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
42063065|NCT00896532|75872213|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
42063066|NCT00896532|75872214|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
42063067|NCT00896532|75872215|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
42063068|NCT00896532|75872216|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
42063069|NCT00896532|75872217|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
42063070|NCT00896532|75872218|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
42063071|NCT00896532|75872219|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
42063072|NCT00896532|75872220|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063073|NCT00896532|75872221|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063074|NCT00896532|75872222|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063075|NCT00896532|75872223|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063076|NCT00896532|75872224|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063077|NCT00896532|75872225|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063078|NCT00896532|75872226|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063079|NCT00896532|75872227|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063080|NCT00896532|75872228|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063081|NCT00896532|75872229|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063082|NCT00896532|75872230|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063083|NCT00896532|75872231|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063084|NCT00896532|75872232|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063085|NCT00896532|75872233|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063086|NCT00896532|75872234|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
42063087|NCT00896532|75872212|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063088|NCT00896532|75872213|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063089|NCT00896532|75872214|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
42063090|NCT00896532|75872215|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063091|NCT00896532|75872216|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
42063092|NCT00896532|75872217|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063093|NCT00896532|75872218|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063094|NCT00896532|75872219|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063095|NCT00896532|75872220|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063096|NCT00896532|75872221|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063097|NCT00896532|75872222|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063098|NCT00896532|75872223|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063099|NCT00896532|75872224|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063100|NCT00896532|75872225|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063101|NCT00896532|75872226|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063102|NCT00896532|75872227|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063103|NCT00896532|75872228|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063104|NCT00896532|75872229|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063105|NCT00896532|75872230|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063106|NCT00896532|75872231|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42291971|NCT01916980|76125437|FG001|Overall Study|Adverse Event|2|||
42291972|NCT01916980|76125436|FG000|Overall Study|Lack of Efficacy|2|||
42291973|NCT01916980|76125437|FG001|Overall Study|Lack of Efficacy|2|||
42291974|NCT01916980|76125436|FG000|Overall Study|Withdrawal by Subject|1|||
42063107|NCT00896532|75872232|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063108|NCT00896532|75872233|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063109|NCT00896532|75872234|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
42063110|NCT00896532|75872212|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
42063111|NCT00896532|75872213|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063112|NCT00896532|75872214|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063113|NCT00896532|75872215|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
42063114|NCT00896532|75872216|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063115|NCT00896532|75872217|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063116|NCT00896532|75872218|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063117|NCT00896532|75872219|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063118|NCT00896532|75872220|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063119|NCT00896532|75872221|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063120|NCT00896532|75872222|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063121|NCT00896532|75872223|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063122|NCT00896532|75872224|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063123|NCT00896532|75872225|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063124|NCT00896532|75872226|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063125|NCT00896532|75872227|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063126|NCT00896532|75872228|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063127|NCT00896532|75872229|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063128|NCT00896532|75872230|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063129|NCT00896532|75872231|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063130|NCT00896532|75872232|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063131|NCT00896532|75872233|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063132|NCT00896532|75872234|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
42063133|NCT00896532|75872212|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063134|NCT00896532|75872213|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063135|NCT00896532|75872214|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
42063136|NCT00896532|75872215|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063137|NCT00896532|75872216|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063138|NCT00896532|75872217|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063139|NCT00896532|75872218|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063140|NCT00896532|75872219|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063141|NCT00896532|75872220|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063142|NCT00896532|75872221|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063143|NCT00896532|75872222|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063144|NCT00896532|75872223|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063145|NCT00896532|75872224|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063146|NCT00896532|75872225|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063147|NCT00896532|75872226|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063148|NCT00896532|75872227|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063149|NCT00896532|75872228|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063150|NCT00896532|75872229|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063151|NCT00896532|75872230|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063152|NCT00896532|75872231|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063153|NCT00896532|75872232|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063154|NCT00896532|75872233|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063155|NCT00896532|75872234|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
42063156|NCT00896532|75872212|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063157|NCT00896532|75872213|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42291975|NCT01916980|76125437|FG001|Overall Study|Withdrawal by Subject|0|||
42174776|NCT03308968|75981608|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
42357307|NCT01750346|76202641|FG000|Overall Study|Adverse Event|1|||
42357308|NCT01750346|76202642|FG001|Overall Study|Adverse Event|0|||
42063158|NCT00896532|75872214|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
42063159|NCT00896532|75872215|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063160|NCT00896532|75872216|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063161|NCT00896532|75872217|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063162|NCT00896532|75872218|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063163|NCT00896532|75872219|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063164|NCT00896532|75872220|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063165|NCT00896532|75872221|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063166|NCT00896532|75872222|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063167|NCT00896532|75872223|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063168|NCT00896532|75872224|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063169|NCT00896532|75872225|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063170|NCT00896532|75872226|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063171|NCT00896532|75872227|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063172|NCT00896532|75872228|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063173|NCT00896532|75872229|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063174|NCT00896532|75872230|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063175|NCT00896532|75872231|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063176|NCT00896532|75872232|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063177|NCT00896532|75872233|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063178|NCT00896532|75872234|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
42063179|NCT00896532|75872212|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063180|NCT00896532|75872213|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063181|NCT00896532|75872214|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063182|NCT00896532|75872215|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
42063183|NCT00896532|75872216|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063184|NCT00896532|75872217|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063185|NCT00896532|75872218|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063186|NCT00896532|75872219|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063187|NCT00896532|75872220|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063188|NCT00896532|75872221|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063189|NCT00896532|75872222|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063190|NCT00896532|75872223|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063191|NCT00896532|75872224|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063192|NCT00896532|75872225|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063193|NCT00896532|75872226|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063194|NCT00896532|75872227|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063195|NCT00896532|75872228|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063196|NCT00896532|75872229|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063197|NCT00896532|75872230|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063198|NCT00896532|75872231|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063199|NCT00896532|75872232|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063200|NCT00896532|75872233|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063201|NCT00896532|75872234|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
42063202|NCT00896532|75872212|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063203|NCT00896532|75872213|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
42063204|NCT00896532|75872214|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063205|NCT00896532|75872215|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
42063206|NCT00896532|75872216|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
42063207|NCT00896532|75872217|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063208|NCT00896532|75872218|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063209|NCT00896532|75872219|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063210|NCT00896532|75872220|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063211|NCT00896532|75872221|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42174777|NCT03308968|75981606|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
42174778|NCT03308968|75981607|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
42174779|NCT03308968|75981608|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
42174780|NCT03308968|75981606|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
42174781|NCT03308968|75981607|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
42174782|NCT03308968|75981608|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
42174783|NCT03308968|75981606|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
42174784|NCT03308968|75981607|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
42174785|NCT03308968|75981608|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
42357309|NCT01750346|76202643|FG002|Overall Study|Adverse Event|0|||
42063212|NCT00896532|75872222|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063213|NCT00896532|75872223|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063214|NCT00896532|75872224|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063215|NCT00896532|75872225|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063216|NCT00896532|75872226|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063217|NCT00896532|75872227|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063218|NCT00896532|75872228|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063219|NCT00896532|75872229|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063220|NCT00896532|75872230|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063221|NCT00896532|75872231|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063222|NCT00896532|75872232|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063223|NCT00896532|75872233|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063224|NCT00896532|75872234|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
42063225|NCT00896532|75872212|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063226|NCT00896532|75872213|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063227|NCT00896532|75872214|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063228|NCT00896532|75872215|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063229|NCT00896532|75872216|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063230|NCT00896532|75872217|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063231|NCT00896532|75872218|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063232|NCT00896532|75872219|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063233|NCT00896532|75872220|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
42063234|NCT00896532|75872221|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063235|NCT00896532|75872222|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063236|NCT00896532|75872223|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063237|NCT00896532|75872224|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063238|NCT00896532|75872225|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063239|NCT00896532|75872226|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063240|NCT00896532|75872227|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063241|NCT00896532|75872228|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063242|NCT00896532|75872229|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063243|NCT00896532|75872230|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063244|NCT00896532|75872231|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063245|NCT00896532|75872232|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063246|NCT00896532|75872233|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063247|NCT00896532|75872234|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
42063248|NCT00896532|75872212|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063249|NCT00896532|75872213|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063250|NCT00896532|75872214|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063251|NCT00896532|75872215|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063252|NCT00896532|75872216|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063253|NCT00896532|75872217|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063254|NCT00896532|75872218|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063255|NCT00896532|75872219|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063256|NCT00896532|75872220|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063257|NCT00896532|75872221|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063258|NCT00896532|75872222|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063259|NCT00896532|75872223|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063260|NCT00896532|75872224|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
42063261|NCT00896532|75872225|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063262|NCT00896532|75872226|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063263|NCT00896532|75872227|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063264|NCT00896532|75872228|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063265|NCT00896532|75872229|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063266|NCT00896532|75872230|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063267|NCT00896532|75872231|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42174786|NCT03308968|75981606|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
42291976|NCT05940077|76125443|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
42291977|NCT05011513|76125457|FG000|Overall Study|Death|0|||
42291978|NCT05011513|76125458|FG001|Overall Study|Death|1|||
42291979|NCT05011513|76125457|FG000|Overall Study|Lost to Follow-up|4|||
42291980|NCT05011513|76125458|FG001|Overall Study|Lost to Follow-up|0|||
42174787|NCT03308968|75981607|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
42174788|NCT03308968|75981608|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
42291981|NCT05011513|76125457|FG000|Overall Study|Withdrawal by Subject|18|||
42063268|NCT00896532|75872232|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063269|NCT00896532|75872233|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063270|NCT00896532|75872234|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
42063271|NCT00896532|75872212|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063272|NCT00896532|75872213|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063273|NCT00896532|75872214|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063274|NCT00896532|75872215|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063275|NCT00896532|75872216|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063276|NCT00896532|75872217|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063277|NCT00896532|75872218|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063278|NCT00896532|75872219|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063279|NCT00896532|75872220|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063280|NCT00896532|75872221|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063281|NCT00896532|75872222|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
42063282|NCT00896532|75872223|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063283|NCT00896532|75872224|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
42063284|NCT00896532|75872225|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063285|NCT00896532|75872226|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063286|NCT00896532|75872227|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063287|NCT00896532|75872228|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063288|NCT00896532|75872229|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063289|NCT00896532|75872230|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063290|NCT00896532|75872231|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063291|NCT00896532|75872232|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063292|NCT00896532|75872233|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063293|NCT00896532|75872234|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
42063294|NCT00896532|75872212|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063295|NCT00896532|75872213|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063296|NCT00896532|75872214|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063297|NCT00896532|75872215|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063298|NCT00896532|75872216|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063299|NCT00896532|75872217|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063300|NCT00896532|75872218|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063301|NCT00896532|75872219|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063302|NCT00896532|75872220|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063303|NCT00896532|75872221|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063304|NCT00896532|75872222|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063305|NCT00896532|75872223|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063306|NCT00896532|75872224|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
42063307|NCT00896532|75872225|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
42063308|NCT00896532|75872226|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063309|NCT00896532|75872227|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063310|NCT00896532|75872228|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063311|NCT00896532|75872229|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063312|NCT00896532|75872230|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063313|NCT00896532|75872231|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063314|NCT00896532|75872232|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063315|NCT00896532|75872233|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063316|NCT00896532|75872234|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
42063317|NCT00896532|75872212|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
42063318|NCT00896532|75872213|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
42063319|NCT00896532|75872214|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
42063320|NCT00896532|75872215|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
42063321|NCT00896532|75872216|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
42063322|NCT00896532|75872217|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
42063323|NCT00896532|75872218|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
42063324|NCT00896532|75872219|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
42063325|NCT00896532|75872220|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
42063326|NCT00896532|75872221|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
42063327|NCT00896532|75872222|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
42063328|NCT00896532|75872223|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
42063329|NCT00896532|75872224|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
42174789|NCT03308968|75981606|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
42357310|NCT01750268|76202653|FG000|Overall Study|Lost to Follow-up|0|||
42357311|NCT01750268|76202654|FG001|Overall Study|Lost to Follow-up|2|||
42063330|NCT00896532|75872225|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
42063331|NCT00896532|75872226|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
42063332|NCT00896532|75872227|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
42063333|NCT00896532|75872228|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
42063334|NCT00896532|75872229|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
42063335|NCT00896532|75872230|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
42063336|NCT00896532|75872231|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
42063337|NCT00896532|75872232|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
42063338|NCT00896532|75872233|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
42063339|NCT00896532|75872234|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
42063340|NCT00896532|75872212|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063341|NCT00896532|75872213|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063342|NCT00896532|75872214|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063343|NCT00896532|75872215|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063344|NCT00896532|75872216|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063345|NCT00896532|75872217|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063346|NCT00896532|75872218|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063347|NCT00896532|75872219|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063348|NCT00896532|75872220|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063349|NCT00896532|75872221|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063350|NCT00896532|75872222|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063351|NCT00896532|75872223|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063352|NCT00896532|75872224|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063353|NCT00896532|75872225|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063354|NCT00896532|75872226|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063355|NCT00896532|75872227|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
42063356|NCT00896532|75872228|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
42063357|NCT00896532|75872229|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063358|NCT00896532|75872230|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063359|NCT00896532|75872231|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063360|NCT00896532|75872232|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063361|NCT00896532|75872233|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063362|NCT00896532|75872234|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
42063363|NCT00896532|75872212|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063364|NCT00896532|75872213|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063365|NCT00896532|75872214|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063366|NCT00896532|75872215|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063367|NCT00896532|75872216|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063368|NCT00896532|75872217|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063369|NCT00896532|75872218|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063370|NCT00896532|75872219|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063371|NCT00896532|75872220|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063372|NCT00896532|75872221|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063373|NCT00896532|75872222|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063374|NCT00896532|75872223|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063375|NCT00896532|75872224|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063376|NCT00896532|75872225|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063377|NCT00896532|75872226|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063378|NCT00896532|75872227|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
42063379|NCT00896532|75872228|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
42063380|NCT00896532|75872229|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
42063381|NCT00896532|75872230|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063382|NCT00896532|75872231|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063383|NCT00896532|75872232|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063384|NCT00896532|75872233|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063385|NCT00896532|75872234|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
42063386|NCT00896532|75872212|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063387|NCT00896532|75872213|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063388|NCT00896532|75872214|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063389|NCT00896532|75872215|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063390|NCT00896532|75872216|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063391|NCT00896532|75872217|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063392|NCT00896532|75872218|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42291982|NCT05011513|76125458|FG001|Overall Study|Withdrawal by Subject|17|||
42291983|NCT05011513|76125457|FG000|Overall Study|Other|4|||
42063393|NCT00896532|75872219|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063394|NCT00896532|75872220|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063395|NCT00896532|75872221|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063396|NCT00896532|75872222|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063397|NCT00896532|75872223|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063398|NCT00896532|75872224|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063399|NCT00896532|75872225|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063400|NCT00896532|75872226|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063401|NCT00896532|75872227|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063402|NCT00896532|75872228|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
42063403|NCT00896532|75872229|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063404|NCT00896532|75872230|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063405|NCT00896532|75872231|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063406|NCT00896532|75872232|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063407|NCT00896532|75872233|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063408|NCT00896532|75872234|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
42063409|NCT00896532|75872212|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
42063410|NCT00896532|75872213|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
42063411|NCT00896532|75872214|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
42063412|NCT00896532|75872215|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
42063413|NCT00896532|75872216|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
42063414|NCT00896532|75872217|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
42063415|NCT00896532|75872218|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
42063416|NCT00896532|75872219|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
42063417|NCT00896532|75872220|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
42063418|NCT00896532|75872221|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
42063419|NCT00896532|75872222|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
42063420|NCT00896532|75872223|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
42063421|NCT00896532|75872224|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
42174790|NCT03308968|75981607|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
42174791|NCT03308968|75981608|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
42174792|NCT03308968|75981606|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
42291984|NCT05011513|76125458|FG001|Overall Study|Other|2|||
42291985|NCT04750239|76125464|FG000|Overall Study|Withdrawal by Subject|2|||
42291986|NCT04750239|76125464|FG000|Overall Study|Trial terminated by sponsor|1|||
42291987|NCT04590248|76125469|FG000|Overall Study|Lost to Follow-up|1|||
42357312|NCT01750268|76202653|FG000|Overall Study|Physician Decision|0|||
42357313|NCT01750268|76202654|FG001|Overall Study|Physician Decision|3|||
42357314|NCT01750268|76202653|FG000|Overall Study|Withdrawal by Subject|2|||
42357315|NCT01750268|76202654|FG001|Overall Study|Withdrawal by Subject|0|||
42357316|NCT01880437|76202663|FG000|Overall Study|Death|12|||
42357317|NCT01880437|76202664|FG001|Overall Study|Death|4|||
42357318|NCT01880437|76202665|FG002|Overall Study|Death|17|||
42357319|NCT01880437|76202663|FG000|Overall Study|Study terminated by Sponsor|3|||
42357320|NCT01880437|76202664|FG001|Overall Study|Study terminated by Sponsor|0|||
42357321|NCT01880437|76202665|FG002|Overall Study|Study terminated by Sponsor|2|||
42291988|NCT04590248|76125469|FG000|Overall Study|Withdrawal by Subject|16|||
42291989|NCT04590248|76125469|FG000|Overall Study|Other|2|||
42291990|NCT04560816|76125473|FG000|Overall Study|Withdrawal by Subject|1|||
42291991|NCT04560816|76125474|FG001|Overall Study|Withdrawal by Subject|1|||
42291992|NCT04560816|76125475|FG002|Overall Study|Withdrawal by Subject|1|||
42291993|NCT04560816|76125476|FG003|Overall Study|Withdrawal by Subject|0|||
42291994|NCT04560816|76125477|FG004|Overall Study|Withdrawal by Subject|3|||
42291995|NCT04560816|76125478|FG005|Overall Study|Withdrawal by Subject|0|||
42291996|NCT04560816|76125473|FG000|Overall Study|Lost to Follow-up|1|||
42291997|NCT04560816|76125474|FG001|Overall Study|Lost to Follow-up|0|||
42291998|NCT04560816|76125475|FG002|Overall Study|Lost to Follow-up|0|||
42291999|NCT04560816|76125476|FG003|Overall Study|Lost to Follow-up|0|||
42357322|NCT01861717|76202675|FG000|Overall Study|Lost to Follow-up|1|||
42357323|NCT01861717|76202675|FG000|Overall Study|Withdrawal by Subject|1|||
42357324|NCT01834729|76202684|FG000|Overall Study|Did not return bowel diaries|0|||
42357325|NCT01834729|76202685|FG001|Overall Study|Did not return bowel diaries|0|||
42016690|NCT00400725|75824170|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
42016691|NCT00400725|75824171|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
42016692|NCT00400725|75824169|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
42016693|NCT00400725|75824170|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
42016694|NCT00400725|75824171|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
42016695|NCT00932113|75824187|FG000|Overall Study|Lost to Follow-up|1|||
42016696|NCT00932113|75824188|FG001|Overall Study|Lost to Follow-up|0|||
42016697|NCT00931801|75824197|FG000|Overall Study|Adverse Event|0|||
42016698|NCT00931801|75824198|FG001|Overall Study|Adverse Event|0|||
42016699|NCT00931801|75824199|FG002|Overall Study|Adverse Event|1|||
42357326|NCT01834729|76202686|FG002|Overall Study|Did not return bowel diaries|3|||
42357327|NCT01834729|76202687|FG003|Overall Study|Did not return bowel diaries|0|||
42063422|NCT00896532|75872225|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
42063423|NCT00896532|75872226|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
42063424|NCT00896532|75872227|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
42063425|NCT00896532|75872228|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
42063426|NCT00896532|75872229|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
42174793|NCT03308968|75981607|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
42174794|NCT03308968|75981608|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
42174795|NCT02940730|75981621|FG000|Intervention 2|Physician Decision|7|||
42292000|NCT04560816|76125477|FG004|Overall Study|Lost to Follow-up|0|||
42292001|NCT04560816|76125478|FG005|Overall Study|Lost to Follow-up|0|||
42292002|NCT04560816|76125473|FG000|Overall Study|Protocol Violation|1|||
42292003|NCT04560816|76125474|FG001|Overall Study|Protocol Violation|0|||
42292004|NCT04560816|76125475|FG002|Overall Study|Protocol Violation|0|||
42292005|NCT04560816|76125476|FG003|Overall Study|Protocol Violation|0|||
42292006|NCT04560816|76125477|FG004|Overall Study|Protocol Violation|0|||
42292007|NCT04560816|76125478|FG005|Overall Study|Protocol Violation|0|||
42292008|NCT04092582|76125492|FG000|Overall Study|Death|1|||
42292009|NCT04092582|76125493|FG001|Overall Study|Death|1|||
42292010|NCT04092582|76125492|FG000|Overall Study|Withdrawal by Subject|4|||
42292011|NCT04092582|76125493|FG001|Overall Study|Withdrawal by Subject|1|||
42292012|NCT04092582|76125492|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
42292013|NCT04092582|76125493|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
42292014|NCT03636256|76125529|FG000|Overall Study|Lost to Follow-up|3|||
42292015|NCT03636256|76125530|FG001|Overall Study|Lost to Follow-up|0|||
42292016|NCT03636256|76125531|FG002|Overall Study|Lost to Follow-up|2|||
42292017|NCT03636256|76125532|FG003|Overall Study|Lost to Follow-up|1|||
42292018|NCT03636256|76125533|FG004|Overall Study|Lost to Follow-up|0|||
42292019|NCT03636256|76125534|FG005|Overall Study|Lost to Follow-up|4|||
42292020|NCT03636256|76125535|FG006|Overall Study|Lost to Follow-up|2|||
42292021|NCT03636256|76125536|FG007|Overall Study|Lost to Follow-up|0|||
42292022|NCT03636256|76125537|FG008|Overall Study|Lost to Follow-up|4|||
42292023|NCT03636256|76125529|FG000|Overall Study|Withdrawal by Subject|0|||
42292024|NCT03636256|76125530|FG001|Overall Study|Withdrawal by Subject|0|||
42292025|NCT03636256|76125531|FG002|Overall Study|Withdrawal by Subject|0|||
42292026|NCT03636256|76125532|FG003|Overall Study|Withdrawal by Subject|0|||
42292027|NCT03636256|76125533|FG004|Overall Study|Withdrawal by Subject|0|||
42292028|NCT03636256|76125534|FG005|Overall Study|Withdrawal by Subject|0|||
42292029|NCT03636256|76125535|FG006|Overall Study|Withdrawal by Subject|0|||
42292030|NCT03636256|76125536|FG007|Overall Study|Withdrawal by Subject|0|||
42292031|NCT03636256|76125537|FG008|Overall Study|Withdrawal by Subject|1|||
42292032|NCT03614676|76125568|FG000|Overall Study|Delivery before planned visit|2|||
42292033|NCT03614676|76125569|FG001|Overall Study|Delivery before planned visit|0|||
42292034|NCT03614676|76125568|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
42063427|NCT00896532|75872230|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
42063428|NCT00896532|75872231|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
42063429|NCT00896532|75872232|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
42063430|NCT00896532|75872233|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
42063431|NCT00896532|75872234|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
42292035|NCT03614676|76125569|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
42357328|NCT01834729|76202684|FG000|Overall Study|Withdrawal by Subject|1|||
42357329|NCT01834729|76202685|FG001|Overall Study|Withdrawal by Subject|1|||
42357330|NCT01834729|76202686|FG002|Overall Study|Withdrawal by Subject|0|||
42357331|NCT01834729|76202687|FG003|Overall Study|Withdrawal by Subject|0|||
42357332|NCT01834729|76202684|FG000|Overall Study|Adverse Event|0|||
42357333|NCT01834729|76202685|FG001|Overall Study|Adverse Event|0|||
42357334|NCT01834729|76202686|FG002|Overall Study|Adverse Event|0|||
42357335|NCT01834729|76202687|FG003|Overall Study|Adverse Event|2|||
42357336|NCT01860703|76202698|FG000|Overall Study|Adverse Event|1|||
42357337|NCT01860703|76202699|FG001|Overall Study|Adverse Event|4|||
42357338|NCT01860703|76202700|FG002|Overall Study|Adverse Event|0|||
42357339|NCT01860703|76202701|FG003|Overall Study|Adverse Event|2|||
42357340|NCT01860703|76202698|FG000|Overall Study|Withdrawal by Subject|0|||
42063432|NCT00896532|75872212|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063433|NCT00896532|75872213|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063434|NCT00896532|75872214|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42174796|NCT02940730|75981622|FG001|Intervention 2|Physician Decision|0|||
42174797|NCT03741062|75981630|FG000|Overall Study|Protocol Violation|1|||
42292036|NCT03614676|76125568|FG000|Overall Study|Migrated / moved from the study area|30|||
42292037|NCT03614676|76125569|FG001|Overall Study|Migrated / moved from the study area|22|||
42292038|NCT03614676|76125568|FG000|Overall Study|Lost to Follow-up|17|||
42292039|NCT03614676|76125569|FG001|Overall Study|Lost to Follow-up|42|||
42063435|NCT00896532|75872215|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063436|NCT00896532|75872216|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063437|NCT00896532|75872217|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063438|NCT00896532|75872218|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063439|NCT00896532|75872219|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063440|NCT00896532|75872220|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063441|NCT00896532|75872221|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063442|NCT00896532|75872222|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063443|NCT00896532|75872223|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063444|NCT00896532|75872224|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063445|NCT00896532|75872225|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063446|NCT00896532|75872226|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063447|NCT00896532|75872227|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063448|NCT00896532|75872228|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
42063449|NCT00896532|75872229|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063450|NCT00896532|75872230|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063451|NCT00896532|75872231|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063452|NCT00896532|75872232|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063453|NCT00896532|75872233|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063454|NCT00896532|75872234|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
42063455|NCT00896532|75872212|FG000|Months 48-72: Follow-on Phase|Death|0|||
42063456|NCT00896532|75872213|FG001|Months 48-72: Follow-on Phase|Death|0|||
42063457|NCT00896532|75872214|FG002|Months 48-72: Follow-on Phase|Death|0|||
42063458|NCT00896532|75872215|FG003|Months 48-72: Follow-on Phase|Death|0|||
42063459|NCT00896532|75872216|FG004|Months 48-72: Follow-on Phase|Death|0|||
42063460|NCT00896532|75872217|FG005|Months 48-72: Follow-on Phase|Death|0|||
42063461|NCT00896532|75872218|FG006|Months 48-72: Follow-on Phase|Death|0|||
42063462|NCT00896532|75872219|FG007|Months 48-72: Follow-on Phase|Death|0|||
42063463|NCT00896532|75872220|FG008|Months 48-72: Follow-on Phase|Death|0|||
42063464|NCT00896532|75872221|FG009|Months 48-72: Follow-on Phase|Death|0|||
42063465|NCT00896532|75872222|FG010|Months 48-72: Follow-on Phase|Death|0|||
42063466|NCT00896532|75872223|FG011|Months 48-72: Follow-on Phase|Death|0|||
42063467|NCT00896532|75872224|FG012|Months 48-72: Follow-on Phase|Death|0|||
42063468|NCT00896532|75872225|FG013|Months 48-72: Follow-on Phase|Death|0|||
42063469|NCT00896532|75872226|FG014|Months 48-72: Follow-on Phase|Death|0|||
42063470|NCT00896532|75872227|FG015|Months 48-72: Follow-on Phase|Death|0|||
42063471|NCT00896532|75872228|FG016|Months 48-72: Follow-on Phase|Death|0|||
42063472|NCT00896532|75872229|FG017|Months 48-72: Follow-on Phase|Death|0|||
42063473|NCT00896532|75872230|FG018|Months 48-72: Follow-on Phase|Death|1|||
42063474|NCT00896532|75872231|FG019|Months 48-72: Follow-on Phase|Death|0|||
42063475|NCT00896532|75872232|FG020|Months 48-72: Follow-on Phase|Death|0|||
42063476|NCT00896532|75872233|FG021|Months 48-72: Follow-on Phase|Death|0|||
42063477|NCT00896532|75872234|FG022|Months 48-72: Follow-on Phase|Death|0|||
42063478|NCT00896532|75872212|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063479|NCT00896532|75872213|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063480|NCT00896532|75872214|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063481|NCT00896532|75872215|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063482|NCT00896532|75872216|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063483|NCT00896532|75872217|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063484|NCT00896532|75872218|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063485|NCT00896532|75872219|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063486|NCT00896532|75872220|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063487|NCT00896532|75872221|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063488|NCT00896532|75872222|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063489|NCT00896532|75872223|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063490|NCT00896532|75872224|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063491|NCT00896532|75872225|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063492|NCT00896532|75872226|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063493|NCT00896532|75872227|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063494|NCT00896532|75872228|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42174798|NCT03741062|75981631|FG001|Overall Study|Protocol Violation|0|||
42174799|NCT03281668|75981637|FG000|Overall Study|Physician Decision|1|||
42174800|NCT03281668|75981637|FG000|Overall Study|scheduling conflict, family circumstance|2|||
42174801|NCT03281668|75981637|FG000|Overall Study|Withdrawal by Subject|4|||
42174802|NCT03281668|75981637|FG000|Overall Study|Lost to Follow-up|1|||
42174803|NCT03307174|75981643|FG000|Overall Study|Unplanned ICU Administrion|5|||
42174804|NCT03307174|75981644|FG001|Overall Study|Unplanned ICU Administrion|3|||
42174805|NCT03307174|75981643|FG000|Overall Study|Aborted Surgery|1|||
42174806|NCT03307174|75981644|FG001|Overall Study|Aborted Surgery|2|||
42063495|NCT00896532|75872229|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063496|NCT00896532|75872230|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063497|NCT00896532|75872231|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063498|NCT00896532|75872232|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42174807|NCT03307174|75981643|FG000|Overall Study|Hypotension|6|||
42174808|NCT03307174|75981644|FG001|Overall Study|Hypotension|0|||
42174809|NCT03307174|75981643|FG000|Overall Study|Nonfunctional epidural|1|||
42174810|NCT03307174|75981644|FG001|Overall Study|Nonfunctional epidural|1|||
42174811|NCT03307174|75981643|FG000|Overall Study|Planned epidural removal|1|||
42174812|NCT03307174|75981644|FG001|Overall Study|Planned epidural removal|0|||
42174813|NCT03307174|75981643|FG000|Overall Study|Intrathecal catheter placement|0|||
42174814|NCT03307174|75981644|FG001|Overall Study|Intrathecal catheter placement|1|||
42174815|NCT03258814|75981652|FG000|Overall Study|Early Termination|4|||
42174816|NCT03258814|75981653|FG001|Overall Study|Early Termination|3|||
42174817|NCT03258814|75981654|FG002|Overall Study|Early Termination|10|||
42174818|NCT03257410|75981663|FG000|Overall Study|Adverse Event|2|||
42174819|NCT03257410|75981664|FG001|Overall Study|Adverse Event|3|||
42174820|NCT03257410|75981663|FG000|Overall Study|Protocol Violation|1|||
42174821|NCT03257410|75981664|FG001|Overall Study|Protocol Violation|2|||
42174822|NCT03257410|75981663|FG000|Overall Study|Lost to Follow-up|1|||
42174823|NCT03257410|75981664|FG001|Overall Study|Lost to Follow-up|0|||
42174824|NCT03257410|75981663|FG000|Overall Study|Withdrawal by Subject|1|||
42174825|NCT03257410|75981664|FG001|Overall Study|Withdrawal by Subject|2|||
42174826|NCT03257410|75981663|FG000|Overall Study|Physician Decision|1|||
42174827|NCT03257410|75981664|FG001|Overall Study|Physician Decision|1|||
42174828|NCT03257410|75981663|FG000|Overall Study|Renal transplantation|2|||
42174829|NCT03257410|75981664|FG001|Overall Study|Renal transplantation|0|||
42174830|NCT03257410|75981663|FG000|Overall Study|Switch to peritoneal dialysis|1|||
42174831|NCT03257410|75981664|FG001|Overall Study|Switch to peritoneal dialysis|0|||
42174832|NCT03257410|75981663|FG000|Overall Study|Death|3|||
42174833|NCT03257410|75981664|FG001|Overall Study|Death|2|||
42174834|NCT03257410|75981663|FG000|Overall Study|Change to another dialysis center|2|||
42174835|NCT03257410|75981664|FG001|Overall Study|Change to another dialysis center|2|||
42174836|NCT03257410|75981663|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
42174837|NCT03257410|75981664|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
42174838|NCT03257410|75981663|FG000|Overall Study|Miscellaneous|2|||
42174839|NCT03257410|75981664|FG001|Overall Study|Miscellaneous|2|||
42174840|NCT03257410|75981663|FG000|Overall Study|Other|0|||
42174841|NCT03257410|75981664|FG001|Overall Study|Other|1|||
42174842|NCT00056160|75981672|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
42174843|NCT00056160|75981673|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
42174844|NCT00056160|75981672|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
42174845|NCT00056160|75981673|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
42174846|NCT00056160|75981672|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
42174847|NCT00056160|75981673|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
42174848|NCT00056160|75981672|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
42174849|NCT00056160|75981673|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
42174850|NCT00056160|75981672|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
42174851|NCT00056160|75981673|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
42174852|NCT00056160|75981672|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
42174853|NCT00056160|75981673|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
42174854|NCT00056160|75981672|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
42174855|NCT00056160|75981673|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
42063499|NCT00896532|75872233|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
42063500|NCT00896532|75872234|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
42063501|NCT00896532|75872212|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063502|NCT00896532|75872213|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063503|NCT00896532|75872214|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42174856|NCT00056160|75981672|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
42174857|NCT00056160|75981673|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
42174858|NCT00056160|75981672|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
42063504|NCT00896532|75872215|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42174859|NCT00056160|75981673|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
42174860|NCT00056160|75981672|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
42174861|NCT00056160|75981673|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
42174862|NCT00056160|75981672|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
42174863|NCT00056160|75981673|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
42174864|NCT00056160|75981672|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
42174865|NCT00056160|75981673|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
42174866|NCT00056160|75981672|FG000|Final Follow-up|Transferred into expanded access study.|3|||
42174867|NCT00056160|75981673|FG001|Final Follow-up|Transferred into expanded access study.|0|||
42174868|NCT00056160|75981672|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
42174869|NCT00056160|75981673|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
42174870|NCT00056160|75981672|FG000|Final Follow-up|Adverse Event|1|||
42174871|NCT00056160|75981673|FG001|Final Follow-up|Adverse Event|0|||
42174872|NCT00061932|75981681|FG000|Overall Study|Withdrawal by Subject|13|||
42174873|NCT00061932|75981682|FG001|Overall Study|Withdrawal by Subject|4|||
42174874|NCT04984889|75981724|FG000|Extension Part|Ongoing|5|||
42174875|NCT04769739|75981750|FG000|Overall Study|Colorectal cancer obstruction|2|||
42174876|NCT04769739|75981751|FG001|Overall Study|Colorectal cancer obstruction|0|||
42174877|NCT04769739|75981752|FG002|Overall Study|Colorectal cancer obstruction|0|||
42174878|NCT04769739|75981753|FG003|Overall Study|Colorectal cancer obstruction|0|||
42174879|NCT04769739|75981750|FG000|Overall Study|Failed cecal intubation|1|||
42174880|NCT04769739|75981751|FG001|Overall Study|Failed cecal intubation|0|||
42174881|NCT04769739|75981752|FG002|Overall Study|Failed cecal intubation|0|||
42174882|NCT04769739|75981753|FG003|Overall Study|Failed cecal intubation|1|||
42174883|NCT04769739|75981750|FG000|Overall Study|Poor bowel preparation|0|||
42174884|NCT04769739|75981751|FG001|Overall Study|Poor bowel preparation|0|||
42174885|NCT04769739|75981752|FG002|Overall Study|Poor bowel preparation|0|||
42174886|NCT04769739|75981753|FG003|Overall Study|Poor bowel preparation|1|||
42174887|NCT04750278|75981766|FG000|Overall Study|Death|9|||
42174888|NCT04750278|75981767|FG001|Overall Study|Death|10|||
42174889|NCT04750278|75981768|FG002|Overall Study|Death|10|||
42174890|NCT04750278|75981766|FG000|Overall Study|Withdrawal by Subject|4|||
42174891|NCT04750278|75981767|FG001|Overall Study|Withdrawal by Subject|1|||
42174892|NCT04750278|75981768|FG002|Overall Study|Withdrawal by Subject|2|||
42174893|NCT04750278|75981766|FG000|Overall Study|Lost to Follow-up|1|||
42174894|NCT04750278|75981767|FG001|Overall Study|Lost to Follow-up|1|||
42174895|NCT04750278|75981768|FG002|Overall Study|Lost to Follow-up|1|||
42174896|NCT04750278|75981766|FG000|Overall Study|Pregnancy|1|||
42174897|NCT04750278|75981767|FG001|Overall Study|Pregnancy|0|||
42174898|NCT04750278|75981768|FG002|Overall Study|Pregnancy|0|||
42174899|NCT04750278|75981766|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
42174900|NCT04750278|75981767|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
42174901|NCT04750278|75981768|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
42174902|NCT04750278|75981766|FG000|Overall Study|Non-compliance|0|||
42174903|NCT04750278|75981767|FG001|Overall Study|Non-compliance|0|||
42174904|NCT04750278|75981768|FG002|Overall Study|Non-compliance|1|||
42174905|NCT04750278|75981766|FG000|Overall Study|Transfer to Outside Facility|0|||
42174906|NCT04750278|75981767|FG001|Overall Study|Transfer to Outside Facility|2|||
42174907|NCT04750278|75981768|FG002|Overall Study|Transfer to Outside Facility|1|||
42174908|NCT04750278|75981766|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
42174909|NCT04750278|75981767|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
42174910|NCT04750278|75981768|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
42174911|NCT04750278|75981766|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
42174912|NCT04750278|75981767|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
42174913|NCT04750278|75981768|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
42174914|NCT04423718|75981815|FG000|Overall Study|Adverse Event|6|||
42174915|NCT04423718|75981816|FG001|Overall Study|Adverse Event|2|||
42174916|NCT04423718|75981817|FG002|Overall Study|Adverse Event|5|||
42174917|NCT04423718|75981815|FG000|Overall Study|Physician Decision|1|||
42174918|NCT04423718|75981816|FG001|Overall Study|Physician Decision|4|||
42174919|NCT04423718|75981817|FG002|Overall Study|Physician Decision|1|||
42357341|NCT01860703|76202699|FG001|Overall Study|Withdrawal by Subject|1|||
42016700|NCT00931801|75824197|FG000|Overall Study|Lost to Follow-up|0|||
42016701|NCT00931801|75824198|FG001|Overall Study|Lost to Follow-up|1|||
42016702|NCT00931801|75824199|FG002|Overall Study|Lost to Follow-up|0|||
42016703|NCT00931801|75824197|FG000|Overall Study|Withdrawal by Subject|1|||
42016704|NCT00931801|75824198|FG001|Overall Study|Withdrawal by Subject|0|||
42016705|NCT00931801|75824199|FG002|Overall Study|Withdrawal by Subject|0|||
42016706|NCT00931801|75824197|FG000|Overall Study|Confirmed Virologic Failure|0|||
42016707|NCT00931801|75824198|FG001|Overall Study|Confirmed Virologic Failure|0|||
42016708|NCT00931801|75824199|FG002|Overall Study|Confirmed Virologic Failure|3|||
42016709|NCT00931723|75824213|FG000|Overall Study|Withdrawal by Subject|11|||
42016710|NCT00931723|75824214|FG001|Overall Study|Withdrawal by Subject|13|||
42063505|NCT00896532|75872216|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063506|NCT00896532|75872217|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063507|NCT00896532|75872218|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063508|NCT00896532|75872219|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063509|NCT00896532|75872220|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063510|NCT00896532|75872221|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063511|NCT00896532|75872222|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063512|NCT00896532|75872223|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063513|NCT00896532|75872224|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063514|NCT00896532|75872225|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063515|NCT00896532|75872226|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063516|NCT00896532|75872227|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063517|NCT00896532|75872228|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063518|NCT00896532|75872229|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063519|NCT00896532|75872230|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063520|NCT00896532|75872231|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063521|NCT00896532|75872232|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063522|NCT00896532|75872233|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
42063523|NCT00896532|75872234|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
42063524|NCT00574873|75872283|FG000|Overall Study|Withdrawal by Subject|18|||
42063525|NCT00574873|75872284|FG001|Overall Study|Withdrawal by Subject|19|||
42063526|NCT00574873|75872283|FG000|Overall Study|Investigator request|18|||
42063527|NCT00574873|75872284|FG001|Overall Study|Investigator request|8|||
42063528|NCT00574873|75872283|FG000|Overall Study|Death|15|||
42063529|NCT00574873|75872284|FG001|Overall Study|Death|14|||
42063530|NCT00574873|75872283|FG000|Overall Study|Lost to Follow-up|14|||
42063531|NCT00574873|75872284|FG001|Overall Study|Lost to Follow-up|5|||
42063532|NCT00574873|75872283|FG000|Overall Study|Other|40|||
42063533|NCT00574873|75872284|FG001|Overall Study|Other|4|||
42063534|NCT00574873|75872283|FG000|Overall Study|Discontinuation of study by sponsor|5|||
42063535|NCT00574873|75872284|FG001|Overall Study|Discontinuation of study by sponsor|199|||
42063536|NCT00574873|75872283|FG000|Overall Study|Blank, site closed per local regulations|2|||
42063537|NCT00574873|75872284|FG001|Overall Study|Blank, site closed per local regulations|2|||
42063538|NCT00574873|75872283|FG000|Overall Study|Extension Study|126|||
42063539|NCT00574873|75872284|FG001|Overall Study|Extension Study|0|||
42063540|NCT00902174|75872292|FG000|Overall Study|Adverse Event|27|||
42063541|NCT00902174|75872293|FG001|Overall Study|Adverse Event|7|||
42063542|NCT00902174|75872292|FG000|Overall Study|Lack of Efficacy|1|||
42063543|NCT00902174|75872293|FG001|Overall Study|Lack of Efficacy|5|||
42063544|NCT00902174|75872292|FG000|Overall Study|Death|2|||
42063545|NCT00902174|75872293|FG001|Overall Study|Death|2|||
42063546|NCT00902174|75872292|FG000|Overall Study|Withdrawal by Subject|2|||
42063547|NCT00902174|75872293|FG001|Overall Study|Withdrawal by Subject|1|||
42063548|NCT00902174|75872292|FG000|Overall Study|Abnormal labs|1|||
42063549|NCT00902174|75872293|FG001|Overall Study|Abnormal labs|1|||
42063550|NCT00902174|75872292|FG000|Overall Study|Protocol Violation|1|||
42063551|NCT00902174|75872293|FG001|Overall Study|Protocol Violation|1|||
42063552|NCT00902174|75872292|FG000|Overall Study|Administration problem|0|||
42063553|NCT00902174|75872293|FG001|Overall Study|Administration problem|1|||
42063554|NCT00623623|75872317|FG000|Overall Study|Previous enrolment into this study|1|||
42063555|NCT00623623|75872318|FG001|Overall Study|Previous enrolment into this study|1|||
42063556|NCT00896454|75872324|FG000|Overall Study|Death|10|||
42063557|NCT00896454|75872324|FG000|Overall Study|Adverse Event|8|||
42063558|NCT00896454|75872324|FG000|Overall Study|Disease Progression|5|||
42063559|NCT00896454|75872324|FG000|Overall Study|Other|4|||
42063560|NCT00896454|75872324|FG000|Overall Study|Requirement for alternative therapy|3|||
42063561|NCT00896454|75872324|FG000|Overall Study|Ongoing in study|2|||
42063562|NCT00896454|75872324|FG000|Overall Study|Withdrawal by Subject|1|||
42063563|NCT00629239|75872330|FG000|Overall Study|Adverse Event|7|||
42063564|NCT00629239|75872331|FG001|Overall Study|Adverse Event|4|||
42063565|NCT00629239|75872330|FG000|Overall Study|Physician Decision|1|||
42063566|NCT00629239|75872331|FG001|Overall Study|Physician Decision|0|||
42063567|NCT00625807|75872339|FG000|Overall Study|schedule conflict|2|||
42063568|NCT00625807|75872340|FG001|Overall Study|schedule conflict|8|||
42063569|NCT00629083|75872350|FG000|Overall Study|Adverse Event|0|||
42063570|NCT00629083|75872351|FG001|Overall Study|Adverse Event|2|||
42063571|NCT00629083|75872350|FG000|Overall Study|Lack of Efficacy|3|||
42063572|NCT00629083|75872351|FG001|Overall Study|Lack of Efficacy|1|||
42063573|NCT00629083|75872350|FG000|Overall Study|Withdrawal by Subject|10|||
42063574|NCT00629083|75872351|FG001|Overall Study|Withdrawal by Subject|2|||
42063575|NCT00629083|75872350|FG000|Overall Study|Lost to Follow-up|12|||
42063576|NCT00629083|75872351|FG001|Overall Study|Lost to Follow-up|8|||
42063577|NCT00629083|75872350|FG000|Overall Study|Moved out of country/state|2|||
42063578|NCT00629083|75872351|FG001|Overall Study|Moved out of country/state|1|||
42063579|NCT00629083|75872350|FG000|Overall Study|Refused to return for 12 month visit|1|||
42063580|NCT00629083|75872351|FG001|Overall Study|Refused to return for 12 month visit|0|||
42063581|NCT00901628|75872361|FG000|Overall Study|disconnection of catheter|4|||
42063582|NCT00901628|75872362|FG001|Overall Study|disconnection of catheter|8|||
42063583|NCT00901628|75872361|FG000|Overall Study|disconnection of drain|0|||
42063584|NCT00901628|75872362|FG001|Overall Study|disconnection of drain|1|||
42063585|NCT00901628|75872361|FG000|Overall Study|peroneal nerve palsy|0|||
42063586|NCT00901628|75872362|FG001|Overall Study|peroneal nerve palsy|1|||
42063587|NCT00623545|75872368|FG000|Overall Study|Adverse Event|6|||
42063588|NCT00623545|75872368|FG000|Overall Study|Withdrawal by Subject|4|||
42063589|NCT00628927|75872375|FG000|Overall Study|Problems performing blood draw|6|||
42063590|NCT00628927|75872376|FG001|Overall Study|Problems performing blood draw|0|||
42063591|NCT00628927|75872375|FG000|Overall Study|Lost to Follow-up|1|||
42063592|NCT00628927|75872376|FG001|Overall Study|Lost to Follow-up|0|||
42063593|NCT00628927|75872375|FG000|Overall Study|Equipment failure|1|||
42063594|NCT00628927|75872376|FG001|Overall Study|Equipment failure|0|||
42063595|NCT00623467|75872387|FG000|Overall Study|Lost to Follow-up|1|||
42063596|NCT00623467|75872387|FG000|Overall Study|Protocol Violation|4|||
42063597|NCT00623467|75872387|FG000|Overall Study|Withdrawal by Subject|2|||
42063598|NCT00838539|75872405|FG000|Overall Study|Disease Progression|2|||
42063599|NCT00838539|75872406|FG001|Overall Study|Disease Progression|4|||
42063600|NCT00838539|75872407|FG002|Overall Study|Disease Progression|3|||
42063601|NCT00838539|75872408|FG003|Overall Study|Disease Progression|2|||
42063602|NCT00838539|75872409|FG004|Overall Study|Disease Progression|4|||
42063603|NCT00838539|75872410|FG005|Overall Study|Disease Progression|2|||
42063604|NCT00838539|75872411|FG006|Overall Study|Disease Progression|3|||
42063605|NCT00838539|75872412|FG007|Overall Study|Disease Progression|4|||
42063606|NCT00838539|75872413|FG008|Overall Study|Disease Progression|4|||
42063607|NCT00838539|75872414|FG009|Overall Study|Disease Progression|5|||
42063608|NCT00838539|75872415|FG010|Overall Study|Disease Progression|1|||
42063609|NCT00838539|75872416|FG011|Overall Study|Disease Progression|4|||
42063610|NCT00838539|75872405|FG000|Overall Study|Adverse Event|1|||
42063611|NCT00838539|75872406|FG001|Overall Study|Adverse Event|1|||
42063612|NCT00838539|75872407|FG002|Overall Study|Adverse Event|1|||
42063613|NCT00838539|75872408|FG003|Overall Study|Adverse Event|1|||
42063614|NCT00838539|75872409|FG004|Overall Study|Adverse Event|2|||
42063615|NCT00838539|75872410|FG005|Overall Study|Adverse Event|1|||
42063616|NCT00838539|75872411|FG006|Overall Study|Adverse Event|0|||
42063617|NCT00838539|75872412|FG007|Overall Study|Adverse Event|2|||
42063618|NCT00838539|75872413|FG008|Overall Study|Adverse Event|0|||
42063619|NCT00838539|75872414|FG009|Overall Study|Adverse Event|1|||
42063620|NCT00838539|75872415|FG010|Overall Study|Adverse Event|2|||
42063621|NCT00838539|75872416|FG011|Overall Study|Adverse Event|0|||
42063622|NCT00838539|75872405|FG000|Overall Study|Withdrawal by Subject|0|||
42063623|NCT00838539|75872406|FG001|Overall Study|Withdrawal by Subject|1|||
42063624|NCT00838539|75872407|FG002|Overall Study|Withdrawal by Subject|0|||
42063625|NCT00838539|75872408|FG003|Overall Study|Withdrawal by Subject|0|||
42063626|NCT00838539|75872409|FG004|Overall Study|Withdrawal by Subject|0|||
42063627|NCT00838539|75872410|FG005|Overall Study|Withdrawal by Subject|0|||
42063628|NCT00838539|75872411|FG006|Overall Study|Withdrawal by Subject|0|||
42063629|NCT00838539|75872412|FG007|Overall Study|Withdrawal by Subject|0|||
42063630|NCT00838539|75872413|FG008|Overall Study|Withdrawal by Subject|0|||
42063631|NCT00838539|75872414|FG009|Overall Study|Withdrawal by Subject|1|||
42063632|NCT00838539|75872415|FG010|Overall Study|Withdrawal by Subject|2|||
42063633|NCT00838539|75872416|FG011|Overall Study|Withdrawal by Subject|0|||
42063634|NCT00838539|75872405|FG000|Overall Study|Death|0|||
42063635|NCT00838539|75872406|FG001|Overall Study|Death|0|||
42063636|NCT00838539|75872407|FG002|Overall Study|Death|0|||
42063637|NCT00838539|75872408|FG003|Overall Study|Death|0|||
42063638|NCT00838539|75872409|FG004|Overall Study|Death|0|||
42063639|NCT00838539|75872410|FG005|Overall Study|Death|0|||
42063640|NCT00838539|75872411|FG006|Overall Study|Death|1|||
42292040|NCT03614676|76125568|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
42292041|NCT03614676|76125569|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
42292042|NCT03614676|76125568|FG000|Overall Study|Other|16|||
42063641|NCT00838539|75872412|FG007|Overall Study|Death|0|||
42292043|NCT03614676|76125569|FG001|Overall Study|Other|47|||
42063642|NCT00838539|75872413|FG008|Overall Study|Death|0|||
42063643|NCT00838539|75872414|FG009|Overall Study|Death|0|||
42063644|NCT00838539|75872415|FG010|Overall Study|Death|0|||
42063645|NCT00838539|75872416|FG011|Overall Study|Death|0|||
42063646|NCT00838539|75872405|FG000|Overall Study|Physician Decision|0|||
42063647|NCT00838539|75872406|FG001|Overall Study|Physician Decision|0|||
42063648|NCT00838539|75872407|FG002|Overall Study|Physician Decision|0|||
42063649|NCT00838539|75872408|FG003|Overall Study|Physician Decision|0|||
42063650|NCT00838539|75872409|FG004|Overall Study|Physician Decision|0|||
42063651|NCT00838539|75872410|FG005|Overall Study|Physician Decision|0|||
42063652|NCT00838539|75872411|FG006|Overall Study|Physician Decision|0|||
42063653|NCT00838539|75872412|FG007|Overall Study|Physician Decision|0|||
42292044|NCT03614676|76125568|FG000|Overall Study|Protocol Violation|0|||
42063654|NCT00838539|75872413|FG008|Overall Study|Physician Decision|1|||
42063655|NCT00838539|75872414|FG009|Overall Study|Physician Decision|0|||
42063656|NCT00838539|75872415|FG010|Overall Study|Physician Decision|0|||
42063657|NCT00838539|75872416|FG011|Overall Study|Physician Decision|0|||
42063658|NCT00838539|75872405|FG000|Overall Study|Clinical Progression|0|||
42063659|NCT00838539|75872406|FG001|Overall Study|Clinical Progression|0|||
42063660|NCT00838539|75872407|FG002|Overall Study|Clinical Progression|0|||
42063661|NCT00838539|75872408|FG003|Overall Study|Clinical Progression|0|||
42063662|NCT00838539|75872409|FG004|Overall Study|Clinical Progression|0|||
42063663|NCT00838539|75872410|FG005|Overall Study|Clinical Progression|0|||
42063664|NCT00838539|75872411|FG006|Overall Study|Clinical Progression|1|||
42063665|NCT00838539|75872412|FG007|Overall Study|Clinical Progression|0|||
42063666|NCT00838539|75872413|FG008|Overall Study|Clinical Progression|0|||
42063667|NCT00838539|75872414|FG009|Overall Study|Clinical Progression|0|||
42063668|NCT00838539|75872415|FG010|Overall Study|Clinical Progression|0|||
42063669|NCT00838539|75872416|FG011|Overall Study|Clinical Progression|0|||
42063670|NCT00838539|75872405|FG000|Overall Study|Symptomatic Deterioration|0|||
42063671|NCT00838539|75872406|FG001|Overall Study|Symptomatic Deterioration|0|||
42063672|NCT00838539|75872407|FG002|Overall Study|Symptomatic Deterioration|1|||
42063673|NCT00838539|75872408|FG003|Overall Study|Symptomatic Deterioration|1|||
42063674|NCT00838539|75872409|FG004|Overall Study|Symptomatic Deterioration|0|||
42063675|NCT00838539|75872410|FG005|Overall Study|Symptomatic Deterioration|1|||
42063676|NCT00838539|75872411|FG006|Overall Study|Symptomatic Deterioration|0|||
42063677|NCT00838539|75872412|FG007|Overall Study|Symptomatic Deterioration|0|||
42063678|NCT00838539|75872413|FG008|Overall Study|Symptomatic Deterioration|0|||
42063679|NCT00838539|75872414|FG009|Overall Study|Symptomatic Deterioration|1|||
42063680|NCT00838539|75872415|FG010|Overall Study|Symptomatic Deterioration|0|||
42063681|NCT00838539|75872416|FG011|Overall Study|Symptomatic Deterioration|0|||
42063682|NCT00837759|75872456|FG000|Overall Study|Protocol Violation|3|||
42063683|NCT00837759|75872456|FG000|Overall Study|Lost to Follow-up|1|||
42063684|NCT00891774|75872460|FG000|Overall Study|Lost to Follow-up|5|||
42063685|NCT00891774|75872460|FG000|Overall Study|Illness (Self/Mother)|3|||
42063686|NCT00891774|75872460|FG000|Overall Study|Withdrawal by Subject|2|||
42063687|NCT00891774|75872460|FG000|Overall Study|Protocol Violation|4|||
42063688|NCT05421754|75872464|FG000|Overall Study|Technical issue with sensor|1|||
42063689|NCT04644276|75872477|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
42063690|NCT04644276|75872478|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
42063691|NCT04644276|75872479|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
42063692|NCT01596621|75872545|FG000|Overall Study|Death|4|||
42063693|NCT01596621|75872545|FG000|Overall Study|Withdrawal by Subject|9|||
42063694|NCT01596621|75872545|FG000|Overall Study|Disease Progression|49|||
42063695|NCT01596621|75872545|FG000|Overall Study|Lost to Follow-up|3|||
42063696|NCT01596621|75872545|FG000|Overall Study|Other than specified|13|||
42063697|NCT01337245|75872549|FG000|Overall Study|Lost to Follow-up|1|||
42063698|NCT00566098|75872559|FG000|Collection of MILs|Withdrawal by Subject|1|||
42063699|NCT00566098|75872559|FG000|Collection of MILs|Relapsed|1|||
42063700|NCT00566098|75872559|FG000|Generation of MILs Product|Relapsed|1|||
42063701|NCT00566098|75872559|FG000|Administration of ASCT+MILs|Death|10|||
42063702|NCT00566098|75872559|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
42063703|NCT00248287|75872566|FG000|Overall Study|Adverse Event|11|||
42063704|NCT00248287|75872567|FG001|Overall Study|Adverse Event|10|||
42063705|NCT00248287|75872566|FG000|Overall Study|Death|1|||
42063706|NCT00248287|75872567|FG001|Overall Study|Death|0|||
42063707|NCT00248287|75872566|FG000|Overall Study|Lost to Follow-up|0|||
42063708|NCT00248287|75872567|FG001|Overall Study|Lost to Follow-up|1|||
42063709|NCT00248287|75872566|FG000|Overall Study|Investigator Request|4|||
42063710|NCT00248287|75872567|FG001|Overall Study|Investigator Request|3|||
42063711|NCT00248287|75872566|FG000|Overall Study|Patient Request|5|||
42063712|NCT00248287|75872567|FG001|Overall Study|Patient Request|3|||
42063713|NCT00248287|75872566|FG000|Overall Study|Other|3|||
42063714|NCT00248287|75872567|FG001|Overall Study|Other|2|||
42063715|NCT00837213|75872575|FG000|Overall Study|Lost to Follow-up|3|||
42063716|NCT00837213|75872576|FG001|Overall Study|Lost to Follow-up|2|||
42063717|NCT00837213|75872575|FG000|Overall Study|Withdrawal by Subject|2|||
42174920|NCT04423718|75981815|FG000|Overall Study|Protocol Violation|0|||
42174921|NCT04423718|75981816|FG001|Overall Study|Protocol Violation|1|||
42174922|NCT04423718|75981817|FG002|Overall Study|Protocol Violation|1|||
42063718|NCT00837213|75872576|FG001|Overall Study|Withdrawal by Subject|2|||
42063719|NCT00837213|75872575|FG000|Overall Study|not stated|1|||
42063720|NCT00837213|75872576|FG001|Overall Study|not stated|1|||
42063721|NCT00902486|75872586|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
42063722|NCT00902486|75872587|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
42063723|NCT00902486|75872588|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
42063724|NCT00902486|75872589|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
42063725|NCT00902486|75872590|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
42174923|NCT04423718|75981815|FG000|Overall Study|Lost to Follow-up|1|||
42063726|NCT00902486|75872591|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
42063727|NCT00902486|75872586|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
42063728|NCT00902486|75872587|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
42063729|NCT00902486|75872588|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
42063730|NCT00902486|75872589|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
42063731|NCT00902486|75872590|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
42063732|NCT00902486|75872591|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
42063733|NCT00902486|75872586|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
42063734|NCT00902486|75872587|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
42063735|NCT00902486|75872588|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
42063736|NCT00902486|75872589|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
42063737|NCT00902486|75872590|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
42063738|NCT00902486|75872591|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
42063739|NCT00902486|75872586|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
42063740|NCT00902486|75872587|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
42063741|NCT00902486|75872588|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
42063742|NCT00902486|75872589|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
42063743|NCT00902486|75872590|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
42063744|NCT00902486|75872591|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
42063745|NCT00902486|75872586|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
42063746|NCT00902486|75872587|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
42063747|NCT00902486|75872588|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
42063748|NCT00902486|75872589|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
42063749|NCT00902486|75872590|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
42063750|NCT00902486|75872591|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
42063751|NCT00902486|75872586|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
42063752|NCT00902486|75872587|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
42063753|NCT00902486|75872588|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
42063754|NCT00902486|75872589|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
42063755|NCT00902486|75872590|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
42063756|NCT00902486|75872591|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
42063757|NCT00902486|75872586|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
42063758|NCT00902486|75872587|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
42063759|NCT00902486|75872588|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
42063760|NCT00902486|75872589|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
42063761|NCT00902486|75872590|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
42063762|NCT00902486|75872591|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
42063763|NCT00902486|75872586|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
42063764|NCT00902486|75872587|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
42063765|NCT00902486|75872588|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
42063766|NCT00902486|75872589|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
42063767|NCT00902486|75872590|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
42063768|NCT00902486|75872591|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
42063769|NCT00902486|75872586|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
42063770|NCT00902486|75872587|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
42063771|NCT00902486|75872588|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
42063772|NCT00902486|75872589|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
42063773|NCT00902486|75872590|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
42063774|NCT00902486|75872591|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
42063775|NCT00902486|75872586|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
42063776|NCT00902486|75872587|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
42063777|NCT00902486|75872588|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
42063778|NCT00902486|75872589|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
42063779|NCT00902486|75872590|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
42063780|NCT00902486|75872591|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
42063781|NCT00902486|75872586|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
42063782|NCT00902486|75872587|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
42063783|NCT00902486|75872588|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
42063784|NCT00902486|75872589|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
42063785|NCT00902486|75872590|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
42063786|NCT00902486|75872591|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
42063787|NCT00836745|75872621|FG000|Overall Study|Death|2|||
42063788|NCT00836745|75872621|FG000|Overall Study|Lost to Follow-up|10|||
42063789|NCT00836745|75872621|FG000|Overall Study|Adverse Event|3|||
42292045|NCT03614676|76125569|FG001|Overall Study|Protocol Violation|2|||
42063790|NCT00836745|75872621|FG000|Overall Study|Objective progression or relapse|4|||
42063791|NCT00836745|75872621|FG000|Overall Study|Other|2|||
42063792|NCT00891618|75872625|FG000|Overall Study|Withdrawal by Subject|1|||
42063793|NCT00836589|75872629|FG000|Overall Study|Lost to Follow-up|246|||
42063794|NCT00836589|75872629|FG000|Overall Study|Death|429|||
42063795|NCT00836589|75872629|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
42063796|NCT00574795|75872641|FG000|Infant Series|Withdrawal by Subject|2|||
42063797|NCT00574795|75872641|FG000|Infant Series|Protocol Violation|2|||
42063798|NCT00574795|75872641|FG000|Infant Series|Adverse Event|1|||
42063799|NCT00574795|75872641|FG000|After Infant Series|Withdrawal by Subject|1|||
42063800|NCT00574795|75872641|FG000|After Infant Series|Adverse Event|2|||
42063801|NCT00574795|75872641|FG000|Toddler Dose|Withdrawal by Subject|1|||
42063802|NCT02297516|75872658|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
42063803|NCT02297516|75872659|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
42063804|NCT02297516|75872658|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
42063805|NCT02297516|75872659|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
42063806|NCT02297516|75872658|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
42063807|NCT02297516|75872659|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
42063808|NCT00836277|75872672|FG000|Overall Study|Not evaluable for response|6|||
42063809|NCT00835731|75872678|FG000|Overall Study|Withdrawal by Subject|1|||
42063810|NCT00835731|75872679|FG001|Overall Study|Withdrawal by Subject|0|||
42063811|NCT00835731|75872678|FG000|Overall Study|Physician Decision|1|||
42063812|NCT00835731|75872679|FG001|Overall Study|Physician Decision|1|||
42063813|NCT00835341|75872687|FG000|Overall Study|Lost to Follow-up|3|||
42063814|NCT00835341|75872688|FG001|Overall Study|Lost to Follow-up|12|||
42063815|NCT00574249|75872696|FG000|Overall Study|Adverse Event|6|||
42063816|NCT00574249|75872697|FG001|Overall Study|Adverse Event|18|||
42063817|NCT00574249|75872696|FG000|Overall Study|Lack of Efficacy|5|||
42063818|NCT00574249|75872697|FG001|Overall Study|Lack of Efficacy|3|||
42063819|NCT00574249|75872696|FG000|Overall Study|Lost to Follow-up|4|||
42063820|NCT00574249|75872697|FG001|Overall Study|Lost to Follow-up|3|||
42063821|NCT00574249|75872696|FG000|Overall Study|Protocol Violation|5|||
42063822|NCT00574249|75872697|FG001|Overall Study|Protocol Violation|2|||
42063823|NCT00574249|75872696|FG000|Overall Study|History of carcinoma|1|||
42063824|NCT00574249|75872697|FG001|Overall Study|History of carcinoma|0|||
42063825|NCT00574249|75872696|FG000|Overall Study|Withdrawal by Subject|3|||
42063826|NCT00574249|75872697|FG001|Overall Study|Withdrawal by Subject|0|||
42063827|NCT00574249|75872696|FG000|Overall Study|Physician Decision|1|||
42063828|NCT00574249|75872697|FG001|Overall Study|Physician Decision|0|||
42063829|NCT00574249|75872696|FG000|Overall Study|Pregnancy|1|||
42063830|NCT00574249|75872697|FG001|Overall Study|Pregnancy|0|||
42063831|NCT00574249|75872696|FG000|Overall Study|Excluded by company|0|||
42063832|NCT00574249|75872697|FG001|Overall Study|Excluded by company|1|||
42063833|NCT00574249|75872696|FG000|Overall Study|PPD test taken twice|0|||
42063834|NCT00574249|75872697|FG001|Overall Study|PPD test taken twice|1|||
42063835|NCT00891228|75872706|FG000|Overall Study|Adverse Event|0|||
42063836|NCT00891228|75872707|FG001|Overall Study|Adverse Event|2|||
42063837|NCT00891228|75872708|FG002|Overall Study|Adverse Event|3|||
42063838|NCT00891228|75872706|FG000|Overall Study|Withdrawal by Subject|2|||
42063839|NCT00891228|75872707|FG001|Overall Study|Withdrawal by Subject|4|||
42063840|NCT00891228|75872708|FG002|Overall Study|Withdrawal by Subject|5|||
42063841|NCT00891228|75872706|FG000|Overall Study|Protocol Violation|3|||
42357342|NCT01860703|76202700|FG002|Overall Study|Withdrawal by Subject|0|||
42357343|NCT01860703|76202701|FG003|Overall Study|Withdrawal by Subject|0|||
42357344|NCT01860703|76202698|FG000|Overall Study|Personal reason|1|||
42063842|NCT00891228|75872707|FG001|Overall Study|Protocol Violation|1|||
42063843|NCT00891228|75872708|FG002|Overall Study|Protocol Violation|2|||
42357345|NCT01860703|76202699|FG001|Overall Study|Personal reason|0|||
42357346|NCT01860703|76202700|FG002|Overall Study|Personal reason|1|||
42063844|NCT00891228|75872706|FG000|Overall Study|Physician Decision|2|||
42063845|NCT00891228|75872707|FG001|Overall Study|Physician Decision|1|||
42063846|NCT00891228|75872708|FG002|Overall Study|Physician Decision|0|||
42292046|NCT03614676|76125568|FG000|Overall Study|Neonatal event of interest|0|||
42292047|NCT03614676|76125569|FG001|Overall Study|Neonatal event of interest|6|||
42292048|NCT03614676|76125568|FG000|Overall Study|Death in infant greater than 28 days old|0|||
42292049|NCT03614676|76125569|FG001|Overall Study|Death in infant greater than 28 days old|12|||
42063847|NCT00891228|75872706|FG000|Overall Study|Lost to Follow-up|4|||
42063848|NCT00891228|75872707|FG001|Overall Study|Lost to Follow-up|4|||
42063849|NCT00891228|75872708|FG002|Overall Study|Lost to Follow-up|5|||
42063850|NCT00891228|75872706|FG000|Overall Study|Pregnancy|0|||
42063851|NCT00891228|75872707|FG001|Overall Study|Pregnancy|1|||
42063852|NCT00891228|75872708|FG002|Overall Study|Pregnancy|0|||
42063853|NCT00896168|75872718|FG000|Overall Study|Adverse Event|4|||
42063854|NCT00896168|75872719|FG001|Overall Study|Adverse Event|7|||
42292050|NCT03614676|76125568|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
42292051|NCT03614676|76125569|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
42063855|NCT00896168|75872718|FG000|Overall Study|Treatment failure|8|||
42063856|NCT00896168|75872719|FG001|Overall Study|Treatment failure|10|||
42063857|NCT00896168|75872718|FG000|Overall Study|Lost to Follow-up|1|||
42063858|NCT00896168|75872719|FG001|Overall Study|Lost to Follow-up|1|||
42063859|NCT00896168|75872718|FG000|Overall Study|Other|1|||
42063860|NCT00896168|75872719|FG001|Overall Study|Other|1|||
42063861|NCT00833703|75872727|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
42063862|NCT00833703|75872728|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
42063863|NCT00833547|75872736|FG000|Overall Study|Withdrawal by Subject|2|||
42063864|NCT00833547|75872737|FG001|Overall Study|Withdrawal by Subject|2|||
42063865|NCT00833469|75872743|FG000|Overall Study|Withdrawal by Subject|1|||
42063866|NCT00833469|75872743|FG000|Overall Study|Lost to Follow-up|1|||
42063867|NCT00832377|75872747|FG000|Overall Study|Protocol Violation|1|||
42063868|NCT00892008|75872751|FG000|Overall Study|Death|5|||
42063869|NCT00892008|75872751|FG000|Overall Study|Lack of Efficacy|3|||
42063870|NCT00892008|75872751|FG000|Overall Study|Lost to Follow-up|142|||
42063871|NCT00892008|75872751|FG000|Overall Study|Other|378|||
42063872|NCT00892008|75872751|FG000|Overall Study|Adverse Event|37|||
42063873|NCT00623233|75872755|FG000|Overall Study|Adverse Event|10|||
42063874|NCT00623233|75872755|FG000|Overall Study|Physician Decision|10|||
42063875|NCT00623233|75872755|FG000|Overall Study|Lost to Follow-up|1|||
42063876|NCT00623233|75872755|FG000|Overall Study|Withdrawal by Subject|3|||
42063877|NCT03369236|75872770|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
42063878|NCT03369236|75872771|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
42063879|NCT03369236|75872770|FG000|Open-label Extension Period|Lack of Efficacy|2|||
42063880|NCT03369236|75872771|FG001|Open-label Extension Period|Lack of Efficacy|1|||
42063881|NCT03369236|75872770|FG000|Open-label Extension Period|Adverse Event|0|||
42063882|NCT03369236|75872771|FG001|Open-label Extension Period|Adverse Event|1|||
42063883|NCT03369236|75872770|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
42063884|NCT03369236|75872771|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
42063885|NCT00621751|75872785|FG000|Overall Study|Adverse Event|0|||
42063886|NCT00621751|75872786|FG001|Overall Study|Adverse Event|1|||
42063887|NCT00891930|75872803|FG000|Part 1: Panitumumab +Irinotecan|Death|38|||
42063888|NCT00891930|75872803|FG000|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1|||
42063889|NCT00891930|75872803|FG000|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1|||
42063890|NCT00891930|75872803|FG000|Part 2: Panitumumab + Ganitumab|Death|30|||
42063891|NCT00891930|75872803|FG000|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1|||
42063892|NCT00891462|75872814|FG000|Overall Study|Withdrawal by Subject|9|||
42063893|NCT00891462|75872815|FG001|Overall Study|Withdrawal by Subject|6|||
42063894|NCT00891462|75872816|FG002|Overall Study|Withdrawal by Subject|7|||
42063895|NCT00891462|75872814|FG000|Overall Study|Adverse Event|7|||
42063896|NCT00891462|75872815|FG001|Overall Study|Adverse Event|8|||
42063897|NCT00891462|75872816|FG002|Overall Study|Adverse Event|7|||
42063898|NCT00891462|75872814|FG000|Overall Study|Lack of Efficacy|10|||
42063899|NCT00891462|75872815|FG001|Overall Study|Lack of Efficacy|5|||
42063900|NCT00891462|75872816|FG002|Overall Study|Lack of Efficacy|1|||
42063901|NCT00891462|75872814|FG000|Overall Study|COPD exacerbation|7|||
42063902|NCT00891462|75872815|FG001|Overall Study|COPD exacerbation|4|||
42063903|NCT00891462|75872816|FG002|Overall Study|COPD exacerbation|1|||
42063904|NCT00891462|75872814|FG000|Overall Study|Other Reason|2|||
42063905|NCT00891462|75872815|FG001|Overall Study|Other Reason|5|||
42063906|NCT00891462|75872816|FG002|Overall Study|Other Reason|3|||
42063907|NCT00891462|75872814|FG000|Overall Study|Protocol Violation|2|||
42063908|NCT00891462|75872815|FG001|Overall Study|Protocol Violation|1|||
42063909|NCT00891462|75872816|FG002|Overall Study|Protocol Violation|3|||
42063910|NCT00891462|75872814|FG000|Overall Study|Inclusion/exclusion criteria|0|||
42063911|NCT00891462|75872815|FG001|Overall Study|Inclusion/exclusion criteria|2|||
42063912|NCT00891462|75872816|FG002|Overall Study|Inclusion/exclusion criteria|2|||
42063913|NCT00891462|75872814|FG000|Overall Study|Lost to Follow-up|0|||
42063914|NCT00891462|75872815|FG001|Overall Study|Lost to Follow-up|2|||
42063915|NCT00891462|75872816|FG002|Overall Study|Lost to Follow-up|0|||
42063916|NCT00900146|75872831|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
42063917|NCT00900146|75872832|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
42063918|NCT00900146|75872833|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
42063919|NCT00900146|75872834|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
42063920|NCT00900146|75872835|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
42063921|NCT00900146|75872831|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
42063922|NCT00900146|75872832|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
42063923|NCT00900146|75872833|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
42063924|NCT00900146|75872834|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
42063925|NCT00900146|75872835|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
42063926|NCT00900146|75872831|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
42063927|NCT00900146|75872832|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
42063928|NCT00900146|75872833|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
42063929|NCT00900146|75872834|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
42063930|NCT00900146|75872835|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
42063931|NCT00900146|75872831|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
42063932|NCT00900146|75872832|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
42063933|NCT00900146|75872833|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
42063934|NCT00900146|75872834|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
42063935|NCT00900146|75872835|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
42063936|NCT00900146|75872831|FG000|Intermediate: Period III|Lost to Follow-up|2|||
42063937|NCT00900146|75872832|FG001|Intermediate: Period III|Lost to Follow-up|0|||
42063938|NCT00900146|75872833|FG002|Intermediate: Period III|Lost to Follow-up|0|||
42063939|NCT00900146|75872834|FG003|Intermediate: Period III|Lost to Follow-up|0|||
42063940|NCT00900146|75872835|FG004|Intermediate: Period III|Lost to Follow-up|1|||
42063941|NCT00900146|75872831|FG000|Intermediate: Period III|Administrative problems|85|||
42063942|NCT00900146|75872832|FG001|Intermediate: Period III|Administrative problems|92|||
42063943|NCT00900146|75872833|FG002|Intermediate: Period III|Administrative problems|84|||
42063944|NCT00900146|75872834|FG003|Intermediate: Period III|Administrative problems|90|||
42063945|NCT00900146|75872835|FG004|Intermediate: Period III|Administrative problems|163|||
42063946|NCT00895310|75872847|FG000|Overall Study|Withdrawal by Subject|1|||
42063947|NCT00895154|75872853|FG000|Overall Study|Lost to Follow-up|1|||
42063948|NCT00895154|75872854|FG001|Overall Study|Lost to Follow-up|1|||
42063949|NCT00895154|75872853|FG000|Overall Study|Withdrawal by Subject|0|||
42063950|NCT00895154|75872854|FG001|Overall Study|Withdrawal by Subject|1|||
42063951|NCT00888654|75872860|FG000|Overall Study|Problems swallowing oral meds.|1|||
42063952|NCT00888654|75872860|FG000|Overall Study|Not enough oral meds before surgery|3|||
42063953|NCT00888654|75872860|FG000|Overall Study|Surgery aborted|2|||
42063954|NCT00888654|75872860|FG000|Overall Study|Withdrawal by Subject|1|||
42063955|NCT00888654|75872860|FG000|Overall Study|Inelig. due to contraindication of med|1|||
42063956|NCT00888654|75872860|FG000|Overall Study|Change in surg date|1|||
42063957|NCT00888654|75872860|FG000|Overall Study|Stopped meds due to headaches|1|||
42063958|NCT00899678|75872867|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
42063959|NCT00899678|75872868|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
42063960|NCT00899678|75872869|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
42063961|NCT00899678|75872867|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
42063962|NCT00899678|75872868|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
42063963|NCT00899678|75872869|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
42063964|NCT00899678|75872867|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
42063965|NCT00899678|75872868|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
42063966|NCT00899678|75872869|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
42063967|NCT00899678|75872867|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
42063968|NCT00899678|75872868|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
42063969|NCT00899678|75872869|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
42063970|NCT00899678|75872867|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
42063971|NCT00899678|75872868|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
42063972|NCT00899678|75872869|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
42063973|NCT00899678|75872867|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
42063974|NCT00899678|75872868|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
42063975|NCT00899678|75872869|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
42063976|NCT00899678|75872867|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
42063977|NCT00899678|75872868|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
42063978|NCT00899678|75872869|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
42063979|NCT00899678|75872867|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
42063980|NCT00899678|75872868|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
42063981|NCT00899678|75872869|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
42063982|NCT00899678|75872867|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
42063983|NCT00899678|75872868|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
42063984|NCT00899678|75872869|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
42063985|NCT00887484|75872877|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
42063986|NCT00887484|75872877|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
42063987|NCT00887484|75872877|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
42063988|NCT00886938|75872886|FG000|Overall Study|Adverse Event|1|||
42063989|NCT00886938|75872886|FG000|Overall Study|Withdrawal by Subject|1|||
42063990|NCT00620659|75872890|FG000|Treatment Period 1|Adverse Event|1|||
42357347|NCT01860703|76202701|FG003|Overall Study|Personal reason|0|||
42357348|NCT01399593|76202719|FG000|Overall Study|Physician Decision|1|||
42357349|NCT01399593|76202720|FG001|Overall Study|Physician Decision|0|||
42063991|NCT00620659|75872891|FG001|Treatment Period 1|Adverse Event|0|||
42063992|NCT00620659|75872892|FG002|Treatment Period 1|Adverse Event|0|||
42063993|NCT00620659|75872893|FG003|Treatment Period 1|Adverse Event|3|||
42063994|NCT00620659|75872894|FG004|Treatment Period 1|Adverse Event|0|||
42357350|NCT01399593|76202719|FG000|Overall Study|Adverse Event|1|||
42357351|NCT01399593|76202720|FG001|Overall Study|Adverse Event|0|||
42063995|NCT00620659|75872895|FG005|Treatment Period 1|Adverse Event|0|||
42063996|NCT00620659|75872890|FG000|Treatment Period 1|Protocol Violation|1|||
42063997|NCT00620659|75872891|FG001|Treatment Period 1|Protocol Violation|0|||
42063998|NCT00620659|75872892|FG002|Treatment Period 1|Protocol Violation|0|||
42063999|NCT00620659|75872893|FG003|Treatment Period 1|Protocol Violation|0|||
42064000|NCT00620659|75872894|FG004|Treatment Period 1|Protocol Violation|0|||
42064001|NCT00620659|75872895|FG005|Treatment Period 1|Protocol Violation|0|||
42064002|NCT00620659|75872890|FG000|Treatment Period 1|Withdrawal by Subject|1|||
42064003|NCT00620659|75872891|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42064004|NCT00620659|75872892|FG002|Treatment Period 1|Withdrawal by Subject|1|||
42064005|NCT00620659|75872893|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42064006|NCT00620659|75872894|FG004|Treatment Period 1|Withdrawal by Subject|1|||
42064007|NCT00620659|75872895|FG005|Treatment Period 1|Withdrawal by Subject|0|||
42064008|NCT00620659|75872890|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
42064009|NCT00620659|75872891|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
42064010|NCT00620659|75872892|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
42064011|NCT00620659|75872893|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
42064012|NCT00620659|75872894|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
42064013|NCT00620659|75872895|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
42064014|NCT00620659|75872890|FG000|Treatment Period 2|Adverse Event|0|||
42064015|NCT00620659|75872891|FG001|Treatment Period 2|Adverse Event|3|||
42064016|NCT00620659|75872892|FG002|Treatment Period 2|Adverse Event|0|||
42064017|NCT00620659|75872893|FG003|Treatment Period 2|Adverse Event|0|||
42064018|NCT00620659|75872894|FG004|Treatment Period 2|Adverse Event|2|||
42064019|NCT00620659|75872895|FG005|Treatment Period 2|Adverse Event|0|||
42064020|NCT00620659|75872890|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42064021|NCT00620659|75872891|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42064022|NCT00620659|75872892|FG002|Treatment Period 2|Withdrawal by Subject|1|||
42064023|NCT00620659|75872893|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42064024|NCT00620659|75872894|FG004|Treatment Period 2|Withdrawal by Subject|3|||
42064025|NCT00620659|75872895|FG005|Treatment Period 2|Withdrawal by Subject|0|||
42064026|NCT00620659|75872890|FG000|Placebo Washout Period 2|Adverse Event|2|||
42064027|NCT00620659|75872891|FG001|Placebo Washout Period 2|Adverse Event|0|||
42064028|NCT00620659|75872892|FG002|Placebo Washout Period 2|Adverse Event|0|||
42064029|NCT00620659|75872893|FG003|Placebo Washout Period 2|Adverse Event|0|||
42064030|NCT00620659|75872894|FG004|Placebo Washout Period 2|Adverse Event|0|||
42064031|NCT00620659|75872895|FG005|Placebo Washout Period 2|Adverse Event|0|||
42064032|NCT00620659|75872890|FG000|Treatment Period 3|Adverse Event|0|||
42064033|NCT00620659|75872891|FG001|Treatment Period 3|Adverse Event|2|||
42292052|NCT02727478|76125581|FG000|Overall Study|Withdrawal by Subject|8|||
42292053|NCT02727478|76125582|FG001|Overall Study|Withdrawal by Subject|10|||
42064034|NCT00620659|75872892|FG002|Treatment Period 3|Adverse Event|0|||
42064035|NCT00620659|75872893|FG003|Treatment Period 3|Adverse Event|0|||
42064036|NCT00620659|75872894|FG004|Treatment Period 3|Adverse Event|0|||
42064037|NCT00620659|75872895|FG005|Treatment Period 3|Adverse Event|0|||
42064038|NCT00620659|75872890|FG000|Treatment Period 3|Withdrawal by Subject|0|||
42064039|NCT00620659|75872891|FG001|Treatment Period 3|Withdrawal by Subject|0|||
42292054|NCT02614794|76125590|FG000|Overall Study|Death|258|||
42292055|NCT02614794|76125591|FG001|Overall Study|Death|151|||
42292056|NCT02614794|76125590|FG000|Overall Study|Study closure by Sponsor|119|||
42292057|NCT02614794|76125591|FG001|Overall Study|Study closure by Sponsor|45|||
42292058|NCT02614794|76125590|FG000|Overall Study|Withdrawal by Subject|24|||
42292059|NCT02614794|76125591|FG001|Overall Study|Withdrawal by Subject|5|||
42292060|NCT02614794|76125590|FG000|Overall Study|Lost to Follow-up|7|||
42292061|NCT02614794|76125591|FG001|Overall Study|Lost to Follow-up|0|||
42292062|NCT02614794|76125590|FG000|Overall Study|Physician Decision|1|||
42292063|NCT02614794|76125591|FG001|Overall Study|Physician Decision|1|||
42292064|NCT02614794|76125590|FG000|Overall Study|Hospital closure|1|||
42292065|NCT02614794|76125591|FG001|Overall Study|Hospital closure|0|||
42064040|NCT00620659|75872892|FG002|Treatment Period 3|Withdrawal by Subject|0|||
42064041|NCT00620659|75872893|FG003|Treatment Period 3|Withdrawal by Subject|1|||
42064042|NCT00620659|75872894|FG004|Treatment Period 3|Withdrawal by Subject|0|||
42064043|NCT00620659|75872895|FG005|Treatment Period 3|Withdrawal by Subject|0|||
42064044|NCT00894686|75872908|FG000|Overall Study|Withdrawal by Subject|50|||
42064045|NCT00894686|75872908|FG000|Overall Study|Physician Decision|1|||
42064046|NCT00894686|75872908|FG000|Overall Study|Other|5|||
42064047|NCT00885846|75872915|FG000|Overall Study|Withdrawal by Subject|2|||
42064048|NCT00885846|75872916|FG001|Overall Study|Withdrawal by Subject|5|||
42292066|NCT02361944|76125599|FG000|Overall Study|surgery cancellation|0|||
42292067|NCT02361944|76125600|FG001|Overall Study|surgery cancellation|1|||
42064049|NCT00885846|75872917|FG002|Overall Study|Withdrawal by Subject|2|||
42064050|NCT00621517|75872927|FG000|Overall Study|Lost to Follow-up|3|||
42064051|NCT00621517|75872928|FG001|Overall Study|Lost to Follow-up|3|||
42064052|NCT00621517|75872927|FG000|Overall Study|Withdrawal by Subject|3|||
42064053|NCT00621517|75872928|FG001|Overall Study|Withdrawal by Subject|4|||
42064054|NCT00621517|75872927|FG000|Overall Study|Adverse Event|1|||
42064055|NCT00621517|75872928|FG001|Overall Study|Adverse Event|0|||
42064056|NCT05333900|75872936|FG000|Overall Study|Protocol Violation|0|||
42064057|NCT05333900|75872937|FG001|Overall Study|Protocol Violation|1|||
42064058|NCT05333900|75872936|FG000|Overall Study|Withdrawal by Subject|0|||
42064059|NCT05333900|75872937|FG001|Overall Study|Withdrawal by Subject|1|||
42064060|NCT05333900|75872936|FG000|Overall Study|COVID-19 Pandemic|1|||
42064061|NCT05333900|75872937|FG001|Overall Study|COVID-19 Pandemic|1|||
42064062|NCT00573937|75872945|FG000|Overall Study|Study Terminated|0|||
42064063|NCT00573937|75872946|FG001|Overall Study|Study Terminated|1|||
42064064|NCT00573859|75872952|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
42064065|NCT00573859|75872952|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
42064066|NCT00831441|75872958|FG000|Randomized|Death|82|||
42064067|NCT00831441|75872959|FG001|Randomized|Death|81|||
42064068|NCT00831441|75872958|FG000|Randomized|Adverse Event|248|||
42064069|NCT00831441|75872959|FG001|Randomized|Adverse Event|321|||
42064070|NCT00831441|75872958|FG000|Randomized|Emergency procedure|2|||
42064071|NCT00831441|75872959|FG001|Randomized|Emergency procedure|2|||
42064072|NCT00831441|75872958|FG000|Randomized|Elective procedure|26|||
42064073|NCT00831441|75872959|FG001|Randomized|Elective procedure|25|||
42064074|NCT00831441|75872958|FG000|Randomized|Physician Decision|26|||
42064075|NCT00831441|75872959|FG001|Randomized|Physician Decision|35|||
42064076|NCT00831441|75872958|FG000|Randomized|No longer met criteria|13|||
42064077|NCT00831441|75872959|FG001|Randomized|No longer met criteria|19|||
42064078|NCT00831441|75872958|FG000|Randomized|Withdrawal by Subject|178|||
42064079|NCT00831441|75872959|FG001|Randomized|Withdrawal by Subject|212|||
42064080|NCT00831441|75872958|FG000|Randomized|Lost to Follow-up|26|||
42174924|NCT04423718|75981816|FG001|Overall Study|Lost to Follow-up|1|||
42174925|NCT04423718|75981817|FG002|Overall Study|Lost to Follow-up|2|||
42174926|NCT04423718|75981815|FG000|Overall Study|Lack of Efficacy|2|||
42174927|NCT04423718|75981816|FG001|Overall Study|Lack of Efficacy|0|||
42174928|NCT04423718|75981817|FG002|Overall Study|Lack of Efficacy|0|||
42174929|NCT04423718|75981815|FG000|Overall Study|Withdrawal by Subject|6|||
42174930|NCT04423718|75981816|FG001|Overall Study|Withdrawal by Subject|8|||
42174931|NCT04423718|75981817|FG002|Overall Study|Withdrawal by Subject|14|||
42174932|NCT04423718|75981815|FG000|Overall Study|Death|5|||
42174933|NCT04423718|75981816|FG001|Overall Study|Death|3|||
42174934|NCT04423718|75981817|FG002|Overall Study|Death|2|||
42174935|NCT04423718|75981815|FG000|Overall Study|COVID-19 pandemic|2|||
42174936|NCT04423718|75981816|FG001|Overall Study|COVID-19 pandemic|2|||
42174937|NCT04423718|75981817|FG002|Overall Study|COVID-19 pandemic|2|||
42174938|NCT04423718|75981815|FG000|Overall Study|Other|6|||
42174939|NCT04423718|75981816|FG001|Overall Study|Other|2|||
42174940|NCT04423718|75981817|FG002|Overall Study|Other|2|||
42174941|NCT04423718|75981815|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
42174942|NCT04423718|75981816|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
42174943|NCT04423718|75981817|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
42174944|NCT04317274|75981851|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
42174945|NCT04317274|75981852|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
42174946|NCT04317274|75981853|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
42174947|NCT04317274|75981854|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
42174948|NCT03875911|75981867|FG000|Overall Study|Lost to Follow-up|3|||
42174949|NCT03875911|75981868|FG001|Overall Study|Lost to Follow-up|6|||
42174950|NCT03875911|75981869|FG002|Overall Study|Lost to Follow-up|2|||
42174951|NCT03875911|75981867|FG000|Overall Study|Surgery cancelled|1|||
42174952|NCT03875911|75981868|FG001|Overall Study|Surgery cancelled|0|||
42174953|NCT03875911|75981869|FG002|Overall Study|Surgery cancelled|1|||
42174954|NCT03875911|75981867|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
42357352|NCT01399593|76202719|FG000|Overall Study|Death|1|||
42064081|NCT00831441|75872959|FG001|Randomized|Lost to Follow-up|35|||
42064082|NCT00831441|75872958|FG000|Randomized|Administrative reason by sponsor|2780|||
42174955|NCT03875911|75981868|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
42174956|NCT03875911|75981869|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
42174957|NCT03836053|75981891|FG000|Overall Study|Protocol-specified criteria|0|||
42064083|NCT00831441|75872959|FG001|Randomized|Administrative reason by sponsor|2671|||
42064084|NCT00831441|75872958|FG000|Randomized|poor/non-compliance|30|||
42064085|NCT00831441|75872959|FG001|Randomized|poor/non-compliance|38|||
42064086|NCT00831441|75872958|FG000|Randomized|non-specified|276|||
42064087|NCT00831441|75872959|FG001|Randomized|non-specified|266|||
42064088|NCT00831441|75872958|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
42064089|NCT00831441|75872959|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
42064090|NCT00831441|75872958|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
42064091|NCT00831441|75872959|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
42064092|NCT00831441|75872958|FG000|Follow Up (30 Days)|Death|63|||
42064093|NCT00831441|75872959|FG001|Follow Up (30 Days)|Death|86|||
42064094|NCT00831441|75872958|FG000|Follow Up (30 Days)|non-specified|16|||
42064095|NCT00831441|75872959|FG001|Follow Up (30 Days)|non-specified|26|||
42292068|NCT01649232|76125613|FG000|Overall Study|Physician Decision|2|||
42292069|NCT01649232|76125614|FG001|Overall Study|Physician Decision|0|||
42292070|NCT00955968|76125628|FG000|Overall Study|Death|2|||
42292071|NCT00955968|76125629|FG001|Overall Study|Death|4|||
42292072|NCT00955968|76125628|FG000|Overall Study|Withdrawal by Subject|35|||
42292073|NCT00955968|76125629|FG001|Overall Study|Withdrawal by Subject|31|||
42292074|NCT00955968|76125628|FG000|Overall Study|Lost to Follow-up|45|||
42292075|NCT00955968|76125629|FG001|Overall Study|Lost to Follow-up|39|||
42292076|NCT00955968|76125628|FG000|Overall Study|Site closed|55|||
42292077|NCT00955968|76125629|FG001|Overall Study|Site closed|52|||
42292078|NCT05062759|76125653|FG000|Overall Study|Death|0|||
42292079|NCT05062759|76125654|FG001|Overall Study|Death|1|||
42292080|NCT05062759|76125653|FG000|Overall Study|Lost to Follow-up|1|||
42292081|NCT05062759|76125654|FG001|Overall Study|Lost to Follow-up|0|||
42292082|NCT05033262|76125673|FG000|Overall Study|Lost to Follow-up|1|||
42292083|NCT05033262|76125674|FG001|Overall Study|Lost to Follow-up|0|||
42292084|NCT05033262|76125675|FG002|Overall Study|Lost to Follow-up|0|||
42292085|NCT05033262|76125676|FG003|Overall Study|Lost to Follow-up|1|||
42292086|NCT04963062|76125690|FG000|Overall Study|withdrew by the study team|4|||
42292087|NCT04963062|76125691|FG001|Overall Study|withdrew by the study team|2|||
42292088|NCT04900220|76125703|FG000|Overall Study|Lost to Follow-up|1|||
42292089|NCT04900220|76125704|FG001|Overall Study|Lost to Follow-up|1|||
42292090|NCT04599062|76125716|FG000|Overall Study|Physician Decision|1|||
42292091|NCT04599062|76125717|FG001|Overall Study|Physician Decision|0|||
42292092|NCT04537208|76125734|FG000|Overall Study|Adverse Event|0|||
42292093|NCT04537208|76125735|FG001|Overall Study|Adverse Event|0|||
42292094|NCT04537208|76125736|FG002|Overall Study|Adverse Event|0|||
42292095|NCT04537208|76125737|FG003|Overall Study|Adverse Event|0|||
42292096|NCT04537208|76125738|FG004|Overall Study|Adverse Event|0|||
42292097|NCT04537208|76125739|FG005|Overall Study|Adverse Event|0|||
42292098|NCT04537208|76125740|FG006|Overall Study|Adverse Event|0|||
42292099|NCT04537208|76125741|FG007|Overall Study|Adverse Event|0|||
42292100|NCT04537208|76125742|FG008|Overall Study|Adverse Event|1|||
42292101|NCT04537208|76125743|FG009|Overall Study|Adverse Event|0|||
42292102|NCT04537208|76125744|FG010|Overall Study|Adverse Event|0|||
42292103|NCT04537208|76125734|FG000|Overall Study|Protocol deviation|0|||
42292104|NCT04537208|76125735|FG001|Overall Study|Protocol deviation|0|||
42292105|NCT04537208|76125736|FG002|Overall Study|Protocol deviation|2|||
42292106|NCT04537208|76125737|FG003|Overall Study|Protocol deviation|0|||
42292107|NCT04537208|76125738|FG004|Overall Study|Protocol deviation|0|||
42292108|NCT04537208|76125739|FG005|Overall Study|Protocol deviation|2|||
42292109|NCT04537208|76125740|FG006|Overall Study|Protocol deviation|4|||
42292110|NCT04537208|76125741|FG007|Overall Study|Protocol deviation|0|||
42292111|NCT04537208|76125742|FG008|Overall Study|Protocol deviation|1|||
42292112|NCT04537208|76125743|FG009|Overall Study|Protocol deviation|0|||
42292113|NCT04537208|76125744|FG010|Overall Study|Protocol deviation|2|||
42292114|NCT04537208|76125734|FG000|Overall Study|Withdrawal by Subject|4|||
42064096|NCT00831441|75872958|FG000|Follow Up (30 Days)|missing end of study status|0|||
42064097|NCT00831441|75872959|FG001|Follow Up (30 Days)|missing end of study status|1|||
42064098|NCT00831129|75872968|FG000|Overall Study|Adverse Event|0|||
42064099|NCT00831129|75872969|FG001|Overall Study|Adverse Event|1|||
42064100|NCT00831129|75872968|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
42064101|NCT00831129|75872969|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
42064102|NCT00620113|75872979|FG000|Overall Study|Adverse Event|3|||
42064103|NCT00620113|75872980|FG001|Overall Study|Adverse Event|2|||
42064104|NCT00620113|75872981|FG002|Overall Study|Adverse Event|2|||
42064105|NCT00620113|75872982|FG003|Overall Study|Adverse Event|1|||
42064106|NCT00620113|75872979|FG000|Overall Study|Lack of Efficacy|2|||
42064107|NCT00620113|75872980|FG001|Overall Study|Lack of Efficacy|3|||
42357353|NCT01399593|76202720|FG001|Overall Study|Death|1|||
42357354|NCT01399593|76202719|FG000|Overall Study|Transplantectomy|0|||
42064108|NCT00620113|75872981|FG002|Overall Study|Lack of Efficacy|0|||
42064109|NCT00620113|75872982|FG003|Overall Study|Lack of Efficacy|2|||
42064110|NCT00620113|75872979|FG000|Overall Study|Physician Decision|1|||
42292115|NCT04537208|76125735|FG001|Overall Study|Withdrawal by Subject|2|||
42292116|NCT04537208|76125736|FG002|Overall Study|Withdrawal by Subject|1|||
42292117|NCT04537208|76125737|FG003|Overall Study|Withdrawal by Subject|3|||
42292118|NCT04537208|76125738|FG004|Overall Study|Withdrawal by Subject|5|||
42292119|NCT04537208|76125739|FG005|Overall Study|Withdrawal by Subject|1|||
42292120|NCT04537208|76125740|FG006|Overall Study|Withdrawal by Subject|6|||
42292121|NCT04537208|76125741|FG007|Overall Study|Withdrawal by Subject|1|||
42064111|NCT00620113|75872980|FG001|Overall Study|Physician Decision|0|||
42292122|NCT04537208|76125742|FG008|Overall Study|Withdrawal by Subject|7|||
42064112|NCT00620113|75872981|FG002|Overall Study|Physician Decision|0|||
42064113|NCT00620113|75872982|FG003|Overall Study|Physician Decision|2|||
42064114|NCT00620113|75872979|FG000|Overall Study|Protocol Violation|2|||
42064115|NCT00620113|75872980|FG001|Overall Study|Protocol Violation|1|||
42064116|NCT00620113|75872981|FG002|Overall Study|Protocol Violation|0|||
42064117|NCT00620113|75872982|FG003|Overall Study|Protocol Violation|0|||
42064118|NCT00620113|75872979|FG000|Overall Study|Withdrawal by Subject|5|||
42064119|NCT00620113|75872980|FG001|Overall Study|Withdrawal by Subject|1|||
42064120|NCT00620113|75872981|FG002|Overall Study|Withdrawal by Subject|3|||
42064121|NCT00620113|75872982|FG003|Overall Study|Withdrawal by Subject|5|||
42064122|NCT00830115|75872992|FG000|Overall Study|Adverse Event|2|||
42064123|NCT00830115|75872992|FG000|Overall Study|Improvement/recovery|1|||
42064124|NCT00830037|75873000|FG000|Overall Study|Withdrawal by Subject|2|||
42064125|NCT00830037|75873001|FG001|Overall Study|Withdrawal by Subject|3|||
42064126|NCT00830037|75873000|FG000|Overall Study|Lost to Follow-up|1|||
42064127|NCT00830037|75873001|FG001|Overall Study|Lost to Follow-up|2|||
42064128|NCT00830037|75873000|FG000|Overall Study|Active when terminated by DSMB|15|||
42064129|NCT00830037|75873001|FG001|Overall Study|Active when terminated by DSMB|14|||
42064130|NCT00829413|75873007|FG000|Overall Study|No study drug admimnistered|13|||
42064131|NCT00829413|75873007|FG000|Overall Study|Training Patients|67|||
42064132|NCT00829413|75873007|FG000|Overall Study|No truth standard procedure available|9|||
42064133|NCT00829413|75873007|FG000|Overall Study|Technically inadequate truth standard|2|||
42064134|NCT00829413|75873007|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
42064135|NCT00829179|75873018|FG000|Overall Study|Withdrawal by Subject|1|||
42064136|NCT00591591|75873024|FG000|Overall Study|Withdrawal by Subject|1|||
42064137|NCT00591591|75873025|FG001|Overall Study|Withdrawal by Subject|37|||
42064138|NCT00591591|75873024|FG000|Overall Study|Lack of Efficacy|10|||
42064139|NCT00591591|75873025|FG001|Overall Study|Lack of Efficacy|2|||
42064140|NCT00828945|75873031|FG000|Overall Study|Death|4|||
42064141|NCT00828945|75873031|FG000|Overall Study|Participant was missing|1|||
42064142|NCT00828945|75873031|FG000|Overall Study|Other|36|||
42064143|NCT00966875|75873044|FG000|Part A|Adverse Event|2|||
42064144|NCT00966875|75873045|FG001|Part A|Adverse Event|1|||
42064145|NCT00966875|75873046|FG002|Part A|Adverse Event|0|||
42064146|NCT00966875|75873047|FG003|Part A|Adverse Event|1|||
42064147|NCT00966875|75873048|FG004|Part A|Adverse Event|0|||
42064148|NCT00966875|75873049|FG005|Part A|Adverse Event|1|||
42064149|NCT00966875|75873050|FG006|Part A|Adverse Event|0|||
42064150|NCT00966875|75873051|FG007|Part A|Adverse Event|3|||
42064151|NCT00966875|75873052|FG008|Part A|Adverse Event|3|||
42064152|NCT00966875|75873044|FG000|Part A|Entry Criteria|0|||
42064153|NCT00966875|75873045|FG001|Part A|Entry Criteria|0|||
42064154|NCT00966875|75873046|FG002|Part A|Entry Criteria|0|||
42064155|NCT00966875|75873047|FG003|Part A|Entry Criteria|0|||
42064156|NCT00966875|75873048|FG004|Part A|Entry Criteria|0|||
42064157|NCT00966875|75873049|FG005|Part A|Entry Criteria|2|||
42064158|NCT00966875|75873050|FG006|Part A|Entry Criteria|0|||
42064159|NCT00966875|75873051|FG007|Part A|Entry Criteria|0|||
42064160|NCT00966875|75873052|FG008|Part A|Entry Criteria|0|||
42064161|NCT00966875|75873044|FG000|Part A|Lack of Efficacy|0|||
42064162|NCT00966875|75873045|FG001|Part A|Lack of Efficacy|1|||
42064163|NCT00966875|75873046|FG002|Part A|Lack of Efficacy|0|||
42064164|NCT00966875|75873047|FG003|Part A|Lack of Efficacy|0|||
42174958|NCT03836053|75981892|FG001|Overall Study|Protocol-specified criteria|2|||
42174959|NCT03836053|75981893|FG002|Overall Study|Protocol-specified criteria|1|||
42174960|NCT03836053|75981891|FG000|Overall Study|Death|1|||
42174961|NCT03836053|75981892|FG001|Overall Study|Death|6|||
42064165|NCT00966875|75873048|FG004|Part A|Lack of Efficacy|0|||
42064166|NCT00966875|75873049|FG005|Part A|Lack of Efficacy|0|||
42064167|NCT00966875|75873050|FG006|Part A|Lack of Efficacy|4|||
42064168|NCT00966875|75873051|FG007|Part A|Lack of Efficacy|0|||
42064169|NCT00966875|75873052|FG008|Part A|Lack of Efficacy|0|||
42064170|NCT00966875|75873044|FG000|Part A|Lost to Follow-up|2|||
42064171|NCT00966875|75873045|FG001|Part A|Lost to Follow-up|0|||
42064172|NCT00966875|75873046|FG002|Part A|Lost to Follow-up|0|||
42064173|NCT00966875|75873047|FG003|Part A|Lost to Follow-up|0|||
42064174|NCT00966875|75873048|FG004|Part A|Lost to Follow-up|0|||
42064175|NCT00966875|75873049|FG005|Part A|Lost to Follow-up|1|||
42064176|NCT00966875|75873050|FG006|Part A|Lost to Follow-up|0|||
42064177|NCT00966875|75873051|FG007|Part A|Lost to Follow-up|0|||
42064178|NCT00966875|75873052|FG008|Part A|Lost to Follow-up|0|||
42064179|NCT00966875|75873044|FG000|Part A|Parent/Caregiver Decision|0|||
42064180|NCT00966875|75873045|FG001|Part A|Parent/Caregiver Decision|0|||
42064181|NCT00966875|75873046|FG002|Part A|Parent/Caregiver Decision|0|||
42064182|NCT00966875|75873047|FG003|Part A|Parent/Caregiver Decision|1|||
42064183|NCT00966875|75873048|FG004|Part A|Parent/Caregiver Decision|0|||
42064184|NCT00966875|75873049|FG005|Part A|Parent/Caregiver Decision|0|||
42064185|NCT00966875|75873050|FG006|Part A|Parent/Caregiver Decision|0|||
42064186|NCT00966875|75873051|FG007|Part A|Parent/Caregiver Decision|0|||
42064187|NCT00966875|75873052|FG008|Part A|Parent/Caregiver Decision|0|||
42064188|NCT00966875|75873044|FG000|Part A|Physician Decision|0|||
42064189|NCT00966875|75873045|FG001|Part A|Physician Decision|0|||
42064190|NCT00966875|75873046|FG002|Part A|Physician Decision|0|||
42064191|NCT00966875|75873047|FG003|Part A|Physician Decision|0|||
42064192|NCT00966875|75873048|FG004|Part A|Physician Decision|1|||
42064193|NCT00966875|75873049|FG005|Part A|Physician Decision|0|||
42064194|NCT00966875|75873050|FG006|Part A|Physician Decision|1|||
42064195|NCT00966875|75873051|FG007|Part A|Physician Decision|0|||
42064196|NCT00966875|75873052|FG008|Part A|Physician Decision|2|||
42064197|NCT00966875|75873044|FG000|Part A|Sponsor Decision|0|||
42064198|NCT00966875|75873045|FG001|Part A|Sponsor Decision|0|||
42064199|NCT00966875|75873046|FG002|Part A|Sponsor Decision|1|||
42064200|NCT00966875|75873047|FG003|Part A|Sponsor Decision|0|||
42064201|NCT00966875|75873048|FG004|Part A|Sponsor Decision|1|||
42064202|NCT00966875|75873049|FG005|Part A|Sponsor Decision|0|||
42064203|NCT00966875|75873050|FG006|Part A|Sponsor Decision|0|||
42064204|NCT00966875|75873051|FG007|Part A|Sponsor Decision|2|||
42064205|NCT00966875|75873052|FG008|Part A|Sponsor Decision|1|||
42064206|NCT00966875|75873044|FG000|Part A|Withdrawal by Subject|2|||
42064207|NCT00966875|75873045|FG001|Part A|Withdrawal by Subject|2|||
42064208|NCT00966875|75873046|FG002|Part A|Withdrawal by Subject|1|||
42064209|NCT00966875|75873047|FG003|Part A|Withdrawal by Subject|1|||
42064210|NCT00966875|75873048|FG004|Part A|Withdrawal by Subject|3|||
42064211|NCT00966875|75873049|FG005|Part A|Withdrawal by Subject|0|||
42064212|NCT00966875|75873050|FG006|Part A|Withdrawal by Subject|5|||
42064213|NCT00966875|75873051|FG007|Part A|Withdrawal by Subject|1|||
42064214|NCT00966875|75873052|FG008|Part A|Withdrawal by Subject|1|||
42064215|NCT00966875|75873044|FG000|Part A|Protocol Violation|0|||
42064216|NCT00966875|75873045|FG001|Part A|Protocol Violation|0|||
42064217|NCT00966875|75873046|FG002|Part A|Protocol Violation|0|||
42064218|NCT00966875|75873047|FG003|Part A|Protocol Violation|0|||
42064219|NCT00966875|75873048|FG004|Part A|Protocol Violation|0|||
42064220|NCT00966875|75873049|FG005|Part A|Protocol Violation|0|||
42064221|NCT00966875|75873050|FG006|Part A|Protocol Violation|2|||
42064222|NCT00966875|75873051|FG007|Part A|Protocol Violation|1|||
42064223|NCT00966875|75873052|FG008|Part A|Protocol Violation|1|||
42064224|NCT00966875|75873044|FG000|Part B|Adverse Event|0|||
42064225|NCT00966875|75873045|FG001|Part B|Adverse Event|1|||
42064226|NCT00966875|75873046|FG002|Part B|Adverse Event|1|||
42064227|NCT00966875|75873047|FG003|Part B|Adverse Event|0|||
42064228|NCT00966875|75873048|FG004|Part B|Adverse Event|1|||
42174962|NCT03836053|75981893|FG002|Overall Study|Death|4|||
42174963|NCT03836053|75981891|FG000|Overall Study|Withdrawal of consent from study|0|||
42174964|NCT03836053|75981892|FG001|Overall Study|Withdrawal of consent from study|0|||
42174965|NCT03836053|75981893|FG002|Overall Study|Withdrawal of consent from study|1|||
42174966|NCT03836053|75981891|FG000|Overall Study|Decision by sponsor|0|||
42174967|NCT03836053|75981892|FG001|Overall Study|Decision by sponsor|2|||
42174968|NCT03836053|75981893|FG002|Overall Study|Decision by sponsor|4|||
42174969|NCT03647137|75981922|FG000|Overall Study|Scan Limitation|2|||
42174970|NCT03647137|75981923|FG001|Overall Study|Scan Limitation|1|||
42174971|NCT03647137|75981924|FG002|Overall Study|Scan Limitation|1|||
42174972|NCT03647137|75981925|FG003|Overall Study|Scan Limitation|2|||
42174973|NCT03481660|75981938|FG000|Overall Study|Adverse Event|5|||
42174974|NCT03481660|75981939|FG001|Overall Study|Adverse Event|4|||
42174975|NCT03481660|75981938|FG000|Overall Study|Death|13|||
42292123|NCT04537208|76125743|FG009|Overall Study|Withdrawal by Subject|2|||
42292124|NCT04537208|76125744|FG010|Overall Study|Withdrawal by Subject|4|||
42292125|NCT04537208|76125734|FG000|Overall Study|Lost to Follow-up|4|||
42292126|NCT04537208|76125735|FG001|Overall Study|Lost to Follow-up|1|||
42064229|NCT00966875|75873049|FG005|Part B|Adverse Event|0|||
42064230|NCT00966875|75873050|FG006|Part B|Adverse Event|5|||
42064231|NCT00966875|75873051|FG007|Part B|Adverse Event|2|||
42174976|NCT03481660|75981939|FG001|Overall Study|Death|9|||
42174977|NCT03481660|75981938|FG000|Overall Study|Lost to Follow-up|2|||
42174978|NCT03481660|75981939|FG001|Overall Study|Lost to Follow-up|2|||
42292127|NCT04537208|76125736|FG002|Overall Study|Lost to Follow-up|3|||
42292128|NCT04537208|76125737|FG003|Overall Study|Lost to Follow-up|4|||
42064232|NCT00966875|75873052|FG008|Part B|Adverse Event|2|||
42292129|NCT04537208|76125738|FG004|Overall Study|Lost to Follow-up|3|||
42064233|NCT00966875|75873044|FG000|Part B|Death|0|||
42064234|NCT00966875|75873045|FG001|Part B|Death|0|||
42064235|NCT00966875|75873046|FG002|Part B|Death|1|||
42064236|NCT00966875|75873047|FG003|Part B|Death|0|||
42064237|NCT00966875|75873048|FG004|Part B|Death|0|||
42064238|NCT00966875|75873049|FG005|Part B|Death|0|||
42064239|NCT00966875|75873050|FG006|Part B|Death|0|||
42174979|NCT03481660|75981938|FG000|Overall Study|Physician Decision|2|||
42174980|NCT03481660|75981939|FG001|Overall Study|Physician Decision|3|||
42292130|NCT04537208|76125739|FG005|Overall Study|Lost to Follow-up|2|||
42064240|NCT00966875|75873051|FG007|Part B|Death|1|||
42064241|NCT00966875|75873052|FG008|Part B|Death|0|||
42064242|NCT00966875|75873044|FG000|Part B|Lack of Efficacy|2|||
42064243|NCT00966875|75873045|FG001|Part B|Lack of Efficacy|1|||
42064244|NCT00966875|75873046|FG002|Part B|Lack of Efficacy|1|||
42064245|NCT00966875|75873047|FG003|Part B|Lack of Efficacy|1|||
42064246|NCT00966875|75873048|FG004|Part B|Lack of Efficacy|2|||
42174981|NCT03481660|75981938|FG000|Overall Study|Withdrawal by Subject|14|||
42357355|NCT01399593|76202720|FG001|Overall Study|Transplantectomy|1|||
42357356|NCT01833169|76202726|FG000|Overall Study|Disease Progression|99|||
42357357|NCT01833169|76202726|FG000|Overall Study|Adverse Event|33|||
42357358|NCT01833169|76202726|FG000|Overall Study|Withdrawal by Subject|9|||
42357359|NCT01833169|76202726|FG000|Overall Study|Death|3|||
42357360|NCT01833169|76202726|FG000|Overall Study|Physician Decision|2|||
42357361|NCT01860079|76202732|FG000|Overall Study|Physician Decision|14|||
42357362|NCT01860079|76202733|FG001|Overall Study|Physician Decision|22|||
42357363|NCT01388985|76202741|FG000|Overall Study|Death|0|||
42357364|NCT01388985|76202742|FG001|Overall Study|Death|1|||
42357365|NCT01388985|76202741|FG000|Overall Study|Lost to Follow-up|30|||
42357366|NCT01388985|76202742|FG001|Overall Study|Lost to Follow-up|30|||
42357367|NCT01388985|76202741|FG000|Overall Study|Withdrawal by Subject|13|||
42357368|NCT01388985|76202742|FG001|Overall Study|Withdrawal by Subject|4|||
42357369|NCT01388985|76202741|FG000|Overall Study|Subject unavailable|1|||
42357370|NCT01388985|76202742|FG001|Overall Study|Subject unavailable|1|||
42357371|NCT01388985|76202741|FG000|Overall Study|Other (no reason)|0|||
42357372|NCT01388985|76202742|FG001|Overall Study|Other (no reason)|1|||
42357373|NCT01388985|76202741|FG000|Overall Study|Error of nurse|5|||
42357374|NCT01388985|76202742|FG001|Overall Study|Error of nurse|1|||
42357375|NCT01388907|76202750|FG000|Overall Study|Adverse Event|2|||
42357376|NCT01388907|76202751|FG001|Overall Study|Adverse Event|0|||
42357377|NCT01388361|76202762|FG000|Overall Study|Adverse Event|0|||
42357378|NCT01388361|76202763|FG001|Overall Study|Adverse Event|5|||
42357379|NCT01388361|76202764|FG002|Overall Study|Adverse Event|1|||
42357380|NCT01388361|76202762|FG000|Overall Study|Protocol Violation|0|||
42357381|NCT01388361|76202763|FG001|Overall Study|Protocol Violation|0|||
42357382|NCT01388361|76202764|FG002|Overall Study|Protocol Violation|2|||
42357383|NCT01388361|76202762|FG000|Overall Study|Withdrawal criteria|12|||
42357384|NCT01388361|76202763|FG001|Overall Study|Withdrawal criteria|7|||
42357385|NCT01388361|76202764|FG002|Overall Study|Withdrawal criteria|10|||
42357386|NCT01388361|76202762|FG000|Overall Study|Unclassified|0|||
42357387|NCT01388361|76202763|FG001|Overall Study|Unclassified|0|||
42357388|NCT01388361|76202764|FG002|Overall Study|Unclassified|1|||
42357389|NCT01399125|76202774|FG000|Overall Study|Adverse Event|32|||
42357390|NCT01399125|76202775|FG001|Overall Study|Adverse Event|30|||
42357391|NCT01399125|76202774|FG000|Overall Study|Abnormal Lab values|0|||
42357392|NCT01399125|76202775|FG001|Overall Study|Abnormal Lab values|1|||
42357393|NCT01399125|76202774|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
42357394|NCT01399125|76202775|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
42357395|NCT01399125|76202774|FG000|Overall Study|Withdrawal by Subject|5|||
42357396|NCT01399125|76202775|FG001|Overall Study|Withdrawal by Subject|8|||
42357397|NCT01399125|76202774|FG000|Overall Study|Lost to Follow-up|2|||
42357398|NCT01399125|76202775|FG001|Overall Study|Lost to Follow-up|3|||
42357399|NCT01399125|76202774|FG000|Overall Study|Administrative Problems|7|||
42357400|NCT01399125|76202775|FG001|Overall Study|Administrative Problems|11|||
42357401|NCT01399125|76202774|FG000|Overall Study|Death|0|||
42357402|NCT01399125|76202775|FG001|Overall Study|Death|1|||
42357403|NCT01399125|76202774|FG000|Overall Study|Protocol Deviation|5|||
42357404|NCT01399125|76202775|FG001|Overall Study|Protocol Deviation|2|||
42174982|NCT03481660|75981939|FG001|Overall Study|Withdrawal by Subject|7|||
42174983|NCT03454893|75981946|FG000|Overall Study|Study Terminated by the Sponsor|5|||
42174984|NCT03454893|75981946|FG000|Overall Study|Did not pass screening|4|||
42174985|NCT03379792|75981956|FG000|Overall Study|Physician Decision|0|||
42292131|NCT04537208|76125740|FG006|Overall Study|Lost to Follow-up|3|||
42292132|NCT04537208|76125741|FG007|Overall Study|Lost to Follow-up|2|||
42292133|NCT04537208|76125742|FG008|Overall Study|Lost to Follow-up|7|||
42292134|NCT04537208|76125743|FG009|Overall Study|Lost to Follow-up|2|||
42292135|NCT04537208|76125744|FG010|Overall Study|Lost to Follow-up|2|||
42292136|NCT04502433|76125773|FG000|Overall Study|Death|2|||
42292137|NCT04502433|76125774|FG001|Overall Study|Death|4|||
42292138|NCT04502433|76125773|FG000|Overall Study|Lost to Follow-up|1|||
42292139|NCT04502433|76125774|FG001|Overall Study|Lost to Follow-up|0|||
42357405|NCT01399047|76202783|FG000|Overall Study|Withdrawal by Subject|0|||
42357406|NCT01399047|76202784|FG001|Overall Study|Withdrawal by Subject|1|||
42357407|NCT01387737|76202794|FG000|Overall Study|Adverse Event|20|||
42357408|NCT01387737|76202795|FG001|Overall Study|Adverse Event|30|||
42357409|NCT01387737|76202794|FG000|Overall Study|Lack of Efficacy|1|||
42357410|NCT01387737|76202795|FG001|Overall Study|Lack of Efficacy|0|||
42357411|NCT01387737|76202794|FG000|Overall Study|Physician Decision|3|||
42357412|NCT01387737|76202795|FG001|Overall Study|Physician Decision|10|||
42357413|NCT01387737|76202794|FG000|Overall Study|Withdrawal by Subject|27|||
42357414|NCT01387737|76202795|FG001|Overall Study|Withdrawal by Subject|31|||
42357415|NCT01387737|76202794|FG000|Overall Study|Clearly not eligible for the study|1|||
42357416|NCT01387737|76202795|FG001|Overall Study|Clearly not eligible for the study|3|||
42357417|NCT01387347|76202803|FG000|Overall Study|Lost to Follow-up|2|||
42174986|NCT03379792|75981957|FG001|Overall Study|Physician Decision|0|||
42292140|NCT04502433|76125773|FG000|Overall Study|Physician Decision|0|||
42292141|NCT04502433|76125774|FG001|Overall Study|Physician Decision|1|||
42357418|NCT01387347|76202804|FG001|Overall Study|Lost to Follow-up|1|||
42357419|NCT01859923|76202818|FG000|Overall Study|Adverse Event|0|||
42357420|NCT01859923|76202819|FG001|Overall Study|Adverse Event|0|||
42357421|NCT01859923|76202820|FG002|Overall Study|Adverse Event|1|||
42357422|NCT01859923|76202821|FG003|Overall Study|Adverse Event|1|||
42357423|NCT01832155|76202836|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
42357424|NCT01832155|76202837|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
42357425|NCT01832155|76202836|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
42357426|NCT01832155|76202837|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
42357427|NCT01879579|76202851|FG000|Overall Study|Phone incompatible with texting platform|3|||
42357428|NCT01879579|76202852|FG001|Overall Study|Phone incompatible with texting platform|0|||
42357429|NCT01879579|76202851|FG000|Overall Study|Did not enroll in texting platform|1|||
42357430|NCT01879579|76202852|FG001|Overall Study|Did not enroll in texting platform|0|||
42357431|NCT01879579|76202851|FG000|Overall Study|Did not initiate insulin treatment|1|||
42357432|NCT01879579|76202852|FG001|Overall Study|Did not initiate insulin treatment|0|||
42357433|NCT01879579|76202851|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
42357434|NCT01879579|76202852|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
42357435|NCT01879579|76202851|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
42357436|NCT01879579|76202852|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
42357437|NCT01386645|76202864|FG000|Overall Study|Physician Decision|0|||
42357438|NCT01386645|76202865|FG001|Overall Study|Physician Decision|0|||
42357439|NCT01386645|76202866|FG002|Overall Study|Physician Decision|1|||
42357440|NCT01386645|76202864|FG000|Overall Study|Withdrawal by Subject|0|||
42357441|NCT01386645|76202865|FG001|Overall Study|Withdrawal by Subject|1|||
42357442|NCT01386645|76202866|FG002|Overall Study|Withdrawal by Subject|1|||
42357443|NCT01387269|76202876|FG000|Overall Study|Death|38|||
42357444|NCT01387269|76202877|FG001|Overall Study|Death|20|||
42357445|NCT01387269|76202876|FG000|Overall Study|Other|8|||
42357446|NCT01387269|76202877|FG001|Overall Study|Other|7|||
42174987|NCT03379792|75981958|FG002|Overall Study|Physician Decision|0|||
42174988|NCT03379792|75981959|FG003|Overall Study|Physician Decision|1|||
42174989|NCT03379792|75981960|FG004|Overall Study|Physician Decision|0|||
42174990|NCT03379792|75981961|FG005|Overall Study|Physician Decision|0|||
42174991|NCT03379792|75981956|FG000|Overall Study|Withdrawal by Subject|0|||
42174992|NCT03379792|75981957|FG001|Overall Study|Withdrawal by Subject|0|||
42174993|NCT03379792|75981958|FG002|Overall Study|Withdrawal by Subject|0|||
42174994|NCT03379792|75981959|FG003|Overall Study|Withdrawal by Subject|0|||
42174995|NCT03379792|75981960|FG004|Overall Study|Withdrawal by Subject|1|||
42174996|NCT03379792|75981961|FG005|Overall Study|Withdrawal by Subject|1|||
42174997|NCT03370133|75981978|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
42292142|NCT04411914|76125782|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
42292143|NCT04411914|76125783|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
42292144|NCT04389671|76125802|FG000|Overall Study|Death|7|||
42292145|NCT04381494|76125806|FG000|Overall Study|Early termination of trial|19|||
42292146|NCT04381494|76125806|FG000|Overall Study|Investigator's discretion|1|||
42292147|NCT04381494|76125806|FG000|Overall Study|Withdrawal by Subject|9|||
42292148|NCT04381494|76125806|FG000|Overall Study|NSCLC disease progression|4|||
42292149|NCT04381494|76125806|FG000|Overall Study|Device-Related Adverse Event|2|||
42292150|NCT04094584|76125861|FG000|Overall Study|No interest in study|88|||
42292151|NCT04094584|76125861|FG000|Overall Study|Unwilling to undergo screening tests|36|||
42292152|NCT04094584|76125861|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
42292153|NCT04094584|76125861|FG000|Overall Study|Opioid use|7|||
42292154|NCT04094584|76125861|FG000|Overall Study|Need for major surgery in study period|4|||
42292155|NCT04094584|76125861|FG000|Overall Study|eligible but declined enrollment|4|||
42292156|NCT04094584|76125861|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
42292157|NCT04094584|76125861|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
42292158|NCT04094584|76125861|FG000|Overall Study|Lost to Follow-up|3|||
42292159|NCT04094584|76125861|FG000|Overall Study|Withdrawal by Subject|2|||
42292160|NCT04020341|76125876|FG000|Overall Study|Adverse Event|8|||
42292161|NCT04020341|76125877|FG001|Overall Study|Adverse Event|6|||
42292162|NCT04020341|76125876|FG000|Overall Study|Lost to Follow-up|8|||
42292163|NCT04020341|76125877|FG001|Overall Study|Lost to Follow-up|2|||
42292164|NCT04020341|76125876|FG000|Overall Study|Withdrawal by Subject|16|||
42292165|NCT04020341|76125877|FG001|Overall Study|Withdrawal by Subject|16|||
42292166|NCT04020341|76125876|FG000|Overall Study|Participant not able to swallow the tablet|1|||
42292167|NCT04020341|76125877|FG001|Overall Study|Participant not able to swallow the tablet|0|||
42292168|NCT04020341|76125876|FG000|Overall Study|Physician Decision|0|||
42292169|NCT04020341|76125877|FG001|Overall Study|Physician Decision|2|||
42292170|NCT04020341|76125876|FG000|Overall Study|Protocol Deviation|0|||
42292171|NCT04020341|76125877|FG001|Overall Study|Protocol Deviation|2|||
42292172|NCT03868891|76125899|FG000|Overall Study|Adverse Event|1|||
42292173|NCT03868891|76125900|FG001|Overall Study|Adverse Event|0|||
42292174|NCT03868891|76125899|FG000|Overall Study|Lost to Follow-up|2|||
42292175|NCT03868891|76125900|FG001|Overall Study|Lost to Follow-up|1|||
42292176|NCT03868891|76125899|FG000|Overall Study|COVID-19 Restrictions|1|||
42357447|NCT01387269|76202876|FG000|Overall Study|Unrelated AE|12|||
42357448|NCT01387269|76202877|FG001|Overall Study|Unrelated AE|3|||
42357449|NCT01387269|76202876|FG000|Overall Study|Withdrawal by patient|32|||
42064247|NCT00966875|75873049|FG005|Part B|Lack of Efficacy|3|||
42064248|NCT00966875|75873050|FG006|Part B|Lack of Efficacy|12|||
42064249|NCT00966875|75873051|FG007|Part B|Lack of Efficacy|9|||
42064250|NCT00966875|75873052|FG008|Part B|Lack of Efficacy|6|||
42064251|NCT00966875|75873044|FG000|Part B|Lost to Follow-up|0|||
42064252|NCT00966875|75873045|FG001|Part B|Lost to Follow-up|0|||
42064253|NCT00966875|75873046|FG002|Part B|Lost to Follow-up|0|||
42064254|NCT00966875|75873047|FG003|Part B|Lost to Follow-up|1|||
42064255|NCT00966875|75873048|FG004|Part B|Lost to Follow-up|0|||
42064256|NCT00966875|75873049|FG005|Part B|Lost to Follow-up|0|||
42064257|NCT00966875|75873050|FG006|Part B|Lost to Follow-up|0|||
42064258|NCT00966875|75873051|FG007|Part B|Lost to Follow-up|0|||
42064259|NCT00966875|75873052|FG008|Part B|Lost to Follow-up|1|||
42064260|NCT00966875|75873044|FG000|Part B|Physician Decision|0|||
42064261|NCT00966875|75873045|FG001|Part B|Physician Decision|0|||
42064262|NCT00966875|75873046|FG002|Part B|Physician Decision|1|||
42064263|NCT00966875|75873047|FG003|Part B|Physician Decision|0|||
42064264|NCT00966875|75873048|FG004|Part B|Physician Decision|2|||
42064265|NCT00966875|75873049|FG005|Part B|Physician Decision|1|||
42064266|NCT00966875|75873050|FG006|Part B|Physician Decision|0|||
42064267|NCT00966875|75873051|FG007|Part B|Physician Decision|0|||
42064268|NCT00966875|75873052|FG008|Part B|Physician Decision|2|||
42064269|NCT00966875|75873044|FG000|Part B|Sponsor Decision|1|||
42064270|NCT00966875|75873045|FG001|Part B|Sponsor Decision|0|||
42064271|NCT00966875|75873046|FG002|Part B|Sponsor Decision|0|||
42064272|NCT00966875|75873047|FG003|Part B|Sponsor Decision|0|||
42064273|NCT00966875|75873048|FG004|Part B|Sponsor Decision|0|||
42064274|NCT00966875|75873049|FG005|Part B|Sponsor Decision|1|||
42064275|NCT00966875|75873050|FG006|Part B|Sponsor Decision|0|||
42064276|NCT00966875|75873051|FG007|Part B|Sponsor Decision|2|||
42064277|NCT00966875|75873052|FG008|Part B|Sponsor Decision|1|||
42064278|NCT00966875|75873044|FG000|Part B|Withdrawal by Subject|2|||
42064279|NCT00966875|75873045|FG001|Part B|Withdrawal by Subject|1|||
42064280|NCT00966875|75873046|FG002|Part B|Withdrawal by Subject|2|||
42064281|NCT00966875|75873047|FG003|Part B|Withdrawal by Subject|1|||
42064282|NCT00966875|75873048|FG004|Part B|Withdrawal by Subject|2|||
42064283|NCT00966875|75873049|FG005|Part B|Withdrawal by Subject|1|||
42064284|NCT00966875|75873050|FG006|Part B|Withdrawal by Subject|4|||
42064285|NCT00966875|75873051|FG007|Part B|Withdrawal by Subject|5|||
42064286|NCT00966875|75873052|FG008|Part B|Withdrawal by Subject|5|||
42064287|NCT00966875|75873044|FG000|Part B|Entry Criteria|0|||
42064288|NCT00966875|75873045|FG001|Part B|Entry Criteria|0|||
42064289|NCT00966875|75873046|FG002|Part B|Entry Criteria|0|||
42064290|NCT00966875|75873047|FG003|Part B|Entry Criteria|0|||
42064291|NCT00966875|75873048|FG004|Part B|Entry Criteria|0|||
42064292|NCT00966875|75873049|FG005|Part B|Entry Criteria|0|||
42064293|NCT00966875|75873050|FG006|Part B|Entry Criteria|1|||
42064294|NCT00966875|75873051|FG007|Part B|Entry Criteria|0|||
42064295|NCT00966875|75873052|FG008|Part B|Entry Criteria|1|||
42064296|NCT00828711|75873128|FG000|Overall Study|Lost to Follow-up|1|||
42064297|NCT00828711|75873129|FG001|Overall Study|Lost to Follow-up|0|||
42064298|NCT00828711|75873130|FG002|Overall Study|Lost to Follow-up|0|||
42064299|NCT00966719|75873140|FG000|Overall Study|Lost to Follow-up|6|||
42064300|NCT00966719|75873141|FG001|Overall Study|Lost to Follow-up|11|||
42064301|NCT00818649|75873147|FG000|Overall Study|Declining performance status|2|||
42064302|NCT00818649|75873147|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
42064303|NCT00818649|75873147|FG000|Overall Study|Adverse Event|1|||
42064304|NCT00961571|75873152|FG000|Overall Study|Physician Decision|39|||
42064305|NCT00964223|75873156|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
42064306|NCT00620815|75873164|FG000|Overall Study|Adverse Event|1|||
42064307|NCT00620815|75873165|FG001|Overall Study|Adverse Event|1|||
42064308|NCT00620815|75873166|FG002|Overall Study|Adverse Event|2|||
42064309|NCT00620815|75873164|FG000|Overall Study|Withdrawal by Subject|1|||
42174998|NCT03370133|75981979|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
42064310|NCT00620815|75873165|FG001|Overall Study|Withdrawal by Subject|2|||
42174999|NCT03370133|75981980|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
42064311|NCT00620815|75873166|FG002|Overall Study|Withdrawal by Subject|0|||
42064312|NCT00620815|75873164|FG000|Overall Study|Lost to Follow-up|1|||
42064313|NCT00620815|75873165|FG001|Overall Study|Lost to Follow-up|6|||
42064314|NCT00620815|75873166|FG002|Overall Study|Lost to Follow-up|3|||
42064315|NCT00620815|75873164|FG000|Overall Study|Inappropriate enrolment|0|||
42064316|NCT00620815|75873165|FG001|Overall Study|Inappropriate enrolment|0|||
42064317|NCT00620815|75873166|FG002|Overall Study|Inappropriate enrolment|1|||
42064318|NCT00620815|75873164|FG000|Overall Study|Protocol Violation|1|||
42064319|NCT00620815|75873165|FG001|Overall Study|Protocol Violation|2|||
42064320|NCT00620815|75873166|FG002|Overall Study|Protocol Violation|1|||
42064321|NCT03372941|75873192|FG000|Overall Study|Lost to Follow-up|2|||
42064322|NCT03372941|75873193|FG001|Overall Study|Lost to Follow-up|4|||
42064323|NCT00619957|75873201|FG000|Month 24 Double-Blind|Adverse Event|9|||
42064324|NCT00619957|75873202|FG001|Month 24 Double-Blind|Adverse Event|7|||
42064325|NCT00619957|75873201|FG000|Month 24 Double-Blind|Protocol Violation|1|||
42064326|NCT00619957|75873202|FG001|Month 24 Double-Blind|Protocol Violation|0|||
42064327|NCT00619957|75873201|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
42064328|NCT00619957|75873202|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
42064329|NCT00619957|75873201|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
42064330|NCT00619957|75873202|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
42064331|NCT00619957|75873201|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
42064332|NCT00619957|75873202|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
42064333|NCT00619957|75873201|FG000|Month 48 Open-Label|Adverse Event|4|||
42064334|NCT00619957|75873202|FG001|Month 48 Open-Label|Adverse Event|4|||
42064335|NCT00619957|75873201|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
42064336|NCT00619957|75873202|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
42064337|NCT00619957|75873201|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
42064338|NCT00619957|75873202|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
42064339|NCT00961415|75873212|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
42064340|NCT00961415|75873213|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
42064341|NCT00961415|75873214|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
42064342|NCT00961415|75873212|FG000|Induction Treatment Phase|Death|77|||
42064343|NCT00961415|75873213|FG001|Induction Treatment Phase|Death|0|||
42064344|NCT00961415|75873214|FG002|Induction Treatment Phase|Death|0|||
42064345|NCT00961415|75873212|FG000|Induction Treatment Phase|Protocol Violation|1|||
42064346|NCT00961415|75873213|FG001|Induction Treatment Phase|Protocol Violation|0|||
42064347|NCT00961415|75873214|FG002|Induction Treatment Phase|Protocol Violation|0|||
42064348|NCT00961415|75873212|FG000|Induction Treatment Phase|Physician Decision|2|||
42064349|NCT00961415|75873213|FG001|Induction Treatment Phase|Physician Decision|0|||
42064350|NCT00961415|75873214|FG002|Induction Treatment Phase|Physician Decision|0|||
42064351|NCT00961415|75873212|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
42064352|NCT00961415|75873213|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
42064353|NCT00961415|75873214|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
42064354|NCT00961415|75873212|FG000|Induction Treatment Phase|Other Reason|5|||
42064355|NCT00961415|75873213|FG001|Induction Treatment Phase|Other Reason|0|||
42064356|NCT00961415|75873214|FG002|Induction Treatment Phase|Other Reason|0|||
42064357|NCT00961415|75873212|FG000|Maintenance Treatment Phase|Death|0|||
42064358|NCT00961415|75873213|FG001|Maintenance Treatment Phase|Death|42|||
42064359|NCT00961415|75873214|FG002|Maintenance Treatment Phase|Death|34|||
42064360|NCT00961415|75873212|FG000|Maintenance Treatment Phase|Investigators decision|0|||
42064361|NCT00961415|75873213|FG001|Maintenance Treatment Phase|Investigators decision|2|||
42064362|NCT00961415|75873214|FG002|Maintenance Treatment Phase|Investigators decision|0|||
42064363|NCT00961415|75873212|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
42064364|NCT00961415|75873213|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
42064365|NCT00961415|75873214|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
42064366|NCT00961415|75873212|FG000|Maintenance Treatment Phase|Other reason|0|||
42064367|NCT00961415|75873213|FG001|Maintenance Treatment Phase|Other reason|1|||
42064368|NCT00961415|75873214|FG002|Maintenance Treatment Phase|Other reason|3|||
42064369|NCT00963599|75873232|FG000|Overall Study|Adverse Event|2|||
42064370|NCT00963599|75873233|FG001|Overall Study|Adverse Event|0|||
42064371|NCT00963599|75873234|FG002|Overall Study|Adverse Event|1|||
42064372|NCT00963599|75873235|FG003|Overall Study|Adverse Event|2|||
42064373|NCT00963599|75873232|FG000|Overall Study|Lack of Efficacy|0|||
42064374|NCT00963599|75873233|FG001|Overall Study|Lack of Efficacy|2|||
42064375|NCT00963599|75873234|FG002|Overall Study|Lack of Efficacy|1|||
42064376|NCT00963599|75873235|FG003|Overall Study|Lack of Efficacy|4|||
42064377|NCT00963599|75873232|FG000|Overall Study|Lost to Follow-up|0|||
42064378|NCT00963599|75873233|FG001|Overall Study|Lost to Follow-up|1|||
42064379|NCT00963599|75873234|FG002|Overall Study|Lost to Follow-up|1|||
42064380|NCT00963599|75873235|FG003|Overall Study|Lost to Follow-up|1|||
42064381|NCT00963599|75873232|FG000|Overall Study|Protocol Violation|2|||
42064382|NCT00963599|75873233|FG001|Overall Study|Protocol Violation|2|||
42064383|NCT00963599|75873234|FG002|Overall Study|Protocol Violation|3|||
42064384|NCT00963599|75873235|FG003|Overall Study|Protocol Violation|4|||
42064385|NCT00963599|75873232|FG000|Overall Study|Withdrawal by Subject|2|||
42064386|NCT00963599|75873233|FG001|Overall Study|Withdrawal by Subject|1|||
42357450|NCT01387269|76202877|FG001|Overall Study|Withdrawal by patient|10|||
42357451|NCT01387269|76202876|FG000|Overall Study|Study drug-related AE|1|||
42064387|NCT00963599|75873234|FG002|Overall Study|Withdrawal by Subject|3|||
42064388|NCT00963599|75873235|FG003|Overall Study|Withdrawal by Subject|3|||
42064389|NCT00619801|75873247|FG000|Overall Study|Lack of Efficacy|0|||
42064390|NCT00619801|75873248|FG001|Overall Study|Lack of Efficacy|1|||
42064391|NCT00619801|75873247|FG000|Overall Study|Withdrawal by Subject|1|||
42064392|NCT00619801|75873248|FG001|Overall Study|Withdrawal by Subject|1|||
42064393|NCT00619801|75873247|FG000|Overall Study|Loss of efficacy|0|||
42064394|NCT00619801|75873248|FG001|Overall Study|Loss of efficacy|1|||
42064395|NCT00962741|75873254|FG000|Overall Study|Failed to return|3|||
42064396|NCT00962741|75873254|FG000|Overall Study|Lost to Follow-up|2|||
42357452|NCT01387269|76202877|FG001|Overall Study|Study drug-related AE|0|||
42292177|NCT03868891|76125900|FG001|Overall Study|COVID-19 Restrictions|2|||
42292178|NCT03827655|76125911|FG000|Overall Study|Death|0|||
42292179|NCT03827655|76125912|FG001|Overall Study|Death|0|||
42292180|NCT03827655|76125913|FG002|Overall Study|Death|0|||
42292181|NCT03827655|76125914|FG003|Overall Study|Death|0|||
42292182|NCT03827655|76125915|FG004|Overall Study|Death|1|||
42064397|NCT00962741|75873254|FG000|Overall Study|Withdrawal by Subject|1|||
42064398|NCT00962741|75873254|FG000|Overall Study|Lack of Efficacy|1|||
42064399|NCT00962741|75873254|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
42064400|NCT00619645|75873258|FG000|Overall Study|Adverse Event|1|||
42064401|NCT00619177|75873262|FG000|Overall Study|Adverse Event|18|||
42064402|NCT00619177|75873262|FG000|Overall Study|Lost to Follow-up|2|||
42064403|NCT00619177|75873262|FG000|Overall Study|Lack of Efficacy|1|||
42064404|NCT00619177|75873262|FG000|Overall Study|Missing termination information|481|||
42064405|NCT00619177|75873262|FG000|Overall Study|Not specified reasons|6|||
42064406|NCT00818259|75873273|FG000|Part I|Withdrawal by Subject|1|||
42064407|NCT00818259|75873274|FG001|Part I|Withdrawal by Subject|0|||
42064408|NCT00818259|75873275|FG002|Part I|Withdrawal by Subject|0|||
42064409|NCT00818259|75873276|FG003|Part I|Withdrawal by Subject|0|||
42064410|NCT00818259|75873277|FG004|Part I|Withdrawal by Subject|0|||
42064411|NCT00818259|75873278|FG005|Part I|Withdrawal by Subject|0|||
42064412|NCT00818259|75873279|FG006|Part I|Withdrawal by Subject|0|||
42064413|NCT00818259|75873280|FG007|Part I|Withdrawal by Subject|0|||
42064414|NCT00818259|75873281|FG008|Part I|Withdrawal by Subject|0|||
42064415|NCT00818259|75873273|FG000|Part II|Physician Decision|0|||
42064416|NCT00818259|75873274|FG001|Part II|Physician Decision|0|||
42064417|NCT00818259|75873275|FG002|Part II|Physician Decision|1|||
42064418|NCT00818259|75873276|FG003|Part II|Physician Decision|0|||
42064419|NCT00818259|75873277|FG004|Part II|Physician Decision|0|||
42064420|NCT00818259|75873278|FG005|Part II|Physician Decision|0|||
42064421|NCT00818259|75873279|FG006|Part II|Physician Decision|0|||
42064422|NCT00818259|75873280|FG007|Part II|Physician Decision|0|||
42064423|NCT00818259|75873281|FG008|Part II|Physician Decision|0|||
42064424|NCT00818259|75873273|FG000|Part II|Lack of Efficacy|0|||
42064425|NCT00818259|75873274|FG001|Part II|Lack of Efficacy|0|||
42064426|NCT00818259|75873275|FG002|Part II|Lack of Efficacy|0|||
42064427|NCT00818259|75873276|FG003|Part II|Lack of Efficacy|1|||
42064428|NCT00818259|75873277|FG004|Part II|Lack of Efficacy|0|||
42064429|NCT00818259|75873278|FG005|Part II|Lack of Efficacy|0|||
42064430|NCT00818259|75873279|FG006|Part II|Lack of Efficacy|0|||
42064431|NCT00818259|75873280|FG007|Part II|Lack of Efficacy|0|||
42064432|NCT00818259|75873281|FG008|Part II|Lack of Efficacy|0|||
42064433|NCT00818259|75873273|FG000|Part II|Not Treated|0|||
42064434|NCT00818259|75873274|FG001|Part II|Not Treated|0|||
42064435|NCT00818259|75873275|FG002|Part II|Not Treated|0|||
42064436|NCT00818259|75873276|FG003|Part II|Not Treated|1|||
42064437|NCT00818259|75873277|FG004|Part II|Not Treated|0|||
42064438|NCT00818259|75873278|FG005|Part II|Not Treated|0|||
42064439|NCT00818259|75873279|FG006|Part II|Not Treated|0|||
42064440|NCT00818259|75873280|FG007|Part II|Not Treated|0|||
42064441|NCT00818259|75873281|FG008|Part II|Not Treated|0|||
42064442|NCT00818259|75873273|FG000|Part IV|Physician Decision|0|||
42064443|NCT00818259|75873274|FG001|Part IV|Physician Decision|0|||
42064444|NCT00818259|75873275|FG002|Part IV|Physician Decision|0|||
42064445|NCT00818259|75873276|FG003|Part IV|Physician Decision|0|||
42064446|NCT00818259|75873277|FG004|Part IV|Physician Decision|0|||
42064447|NCT00818259|75873278|FG005|Part IV|Physician Decision|1|||
42064448|NCT00818259|75873279|FG006|Part IV|Physician Decision|0|||
42064449|NCT00818259|75873280|FG007|Part IV|Physician Decision|0|||
42064450|NCT00818259|75873281|FG008|Part IV|Physician Decision|0|||
42064451|NCT00818259|75873273|FG000|Part V|Adverse Event|0|||
42064452|NCT00818259|75873274|FG001|Part V|Adverse Event|0|||
42064453|NCT00818259|75873275|FG002|Part V|Adverse Event|0|||
42292183|NCT03827655|76125911|FG000|Overall Study|Protocol Deviation|1|||
42064454|NCT00818259|75873276|FG003|Part V|Adverse Event|0|||
42292184|NCT03827655|76125912|FG001|Overall Study|Protocol Deviation|0|||
42064455|NCT00818259|75873277|FG004|Part V|Adverse Event|0|||
42064456|NCT00818259|75873278|FG005|Part V|Adverse Event|0|||
42064457|NCT00818259|75873279|FG006|Part V|Adverse Event|0|||
42292185|NCT03827655|76125913|FG002|Overall Study|Protocol Deviation|1|||
42292186|NCT03827655|76125914|FG003|Overall Study|Protocol Deviation|1|||
42064458|NCT00818259|75873280|FG007|Part V|Adverse Event|1|||
42064459|NCT00818259|75873281|FG008|Part V|Adverse Event|0|||
42064460|NCT00619099|75873299|FG000|Overall Study|Progressive Disease|7|||
42064461|NCT00619099|75873300|FG001|Overall Study|Progressive Disease|5|||
42064462|NCT00619099|75873299|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
42064463|NCT00619099|75873300|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
42064464|NCT00619099|75873299|FG000|Overall Study|Adverse Event|4|||
42064465|NCT00619099|75873300|FG001|Overall Study|Adverse Event|3|||
42064466|NCT00619099|75873299|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
42064467|NCT00619099|75873300|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
42064468|NCT00619099|75873299|FG000|Overall Study|Withdrawal by Subject|10|||
42064469|NCT00619099|75873300|FG001|Overall Study|Withdrawal by Subject|2|||
42064470|NCT00619099|75873299|FG000|Overall Study|Physician Decision|9|||
42064471|NCT00619099|75873300|FG001|Overall Study|Physician Decision|6|||
42064472|NCT00962585|75873310|FG000|Overall Study|Adverse Event|0|||
42064473|NCT00962585|75873311|FG001|Overall Study|Adverse Event|2|||
42064474|NCT00962585|75873312|FG002|Overall Study|Adverse Event|1|||
42064475|NCT00962585|75873313|FG003|Overall Study|Adverse Event|0|||
42064476|NCT00962585|75873310|FG000|Overall Study|Lost to Follow-up|3|||
42064477|NCT00962585|75873311|FG001|Overall Study|Lost to Follow-up|0|||
42064478|NCT00962585|75873312|FG002|Overall Study|Lost to Follow-up|1|||
42064479|NCT00962585|75873313|FG003|Overall Study|Lost to Follow-up|0|||
42064480|NCT00962585|75873310|FG000|Overall Study|Protocol Violation|0|||
42064481|NCT00962585|75873311|FG001|Overall Study|Protocol Violation|0|||
42064482|NCT00962585|75873312|FG002|Overall Study|Protocol Violation|1|||
42064483|NCT00962585|75873313|FG003|Overall Study|Protocol Violation|0|||
42064484|NCT00962585|75873310|FG000|Overall Study|Withdrawal by Subject|1|||
42064485|NCT00962585|75873311|FG001|Overall Study|Withdrawal by Subject|0|||
42064486|NCT00962585|75873312|FG002|Overall Study|Withdrawal by Subject|0|||
42064487|NCT00962585|75873313|FG003|Overall Study|Withdrawal by Subject|0|||
42175000|NCT03370133|75981981|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
42175001|NCT03370133|75981982|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
42175002|NCT03370133|75981983|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
42175003|NCT03370133|75981978|FG000|Initial Treatment Period (WK 16)|Death|1|||
42175004|NCT03370133|75981979|FG001|Initial Treatment Period (WK 16)|Death|1|||
42175005|NCT03370133|75981980|FG002|Initial Treatment Period (WK 16)|Death|1|||
42175006|NCT03370133|75981981|FG003|Initial Treatment Period (WK 16)|Death|0|||
42175007|NCT03370133|75981982|FG004|Initial Treatment Period (WK 16)|Death|0|||
42175008|NCT03370133|75981983|FG005|Initial Treatment Period (WK 16)|Death|0|||
42175009|NCT03370133|75981978|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
42175010|NCT03370133|75981979|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
42175011|NCT03370133|75981980|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
42175012|NCT03370133|75981981|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
42175013|NCT03370133|75981982|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
42175014|NCT03370133|75981983|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
42175015|NCT03370133|75981978|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
42175016|NCT03370133|75981979|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
42175017|NCT03370133|75981980|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
42175018|NCT03370133|75981981|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
42175019|NCT03370133|75981982|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
42175020|NCT03370133|75981983|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
42175021|NCT03370133|75981978|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
42175022|NCT03370133|75981979|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
42175023|NCT03370133|75981980|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
42175024|NCT03370133|75981981|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
42175025|NCT03370133|75981982|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
42175026|NCT03370133|75981983|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
42175027|NCT03370133|75981978|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
42175028|NCT03370133|75981979|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
42175029|NCT03370133|75981980|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
42175030|NCT03370133|75981981|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
42175031|NCT03370133|75981982|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
42175032|NCT03370133|75981983|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
42175033|NCT03370133|75981978|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
42175034|NCT03370133|75981979|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
42292187|NCT03827655|76125915|FG004|Overall Study|Protocol Deviation|0|||
42064488|NCT00962585|75873310|FG000|Overall Study|Withdrew Consent|2|||
42064489|NCT00962585|75873311|FG001|Overall Study|Withdrew Consent|0|||
42064490|NCT00962585|75873312|FG002|Overall Study|Withdrew Consent|0|||
42064491|NCT00962585|75873313|FG003|Overall Study|Withdrew Consent|0|||
42064492|NCT00621985|75873325|FG000|Dexamethasone Admission|Adverse Event|1|||
42064493|NCT00961259|75873335|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
42064494|NCT00961259|75873336|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
42064495|NCT00961259|75873337|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
42064496|NCT00961181|75873346|FG000|Overall Study|Death|2|||
42064497|NCT00961181|75873346|FG000|Overall Study|Withdrawal by Subject|2|||
42064498|NCT00961181|75873346|FG000|Overall Study|Lost to Follow-up|1|||
42064499|NCT00817635|75873355|FG000|Overall Study|Adverse Event|1|||
42064500|NCT00817635|75873356|FG001|Overall Study|Adverse Event|0|||
42064501|NCT00817635|75873357|FG002|Overall Study|Adverse Event|0|||
42064502|NCT00817635|75873358|FG003|Overall Study|Adverse Event|1|||
42064503|NCT00817635|75873359|FG004|Overall Study|Adverse Event|1|||
42064504|NCT00817635|75873355|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
42064505|NCT00817635|75873356|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
42064506|NCT00817635|75873357|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
42064507|NCT00817635|75873358|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
42064508|NCT00817635|75873359|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
42064509|NCT00817635|75873355|FG000|Overall Study|Withdrawal by Subject|2|||
42064510|NCT00817635|75873356|FG001|Overall Study|Withdrawal by Subject|1|||
42064511|NCT00817635|75873357|FG002|Overall Study|Withdrawal by Subject|0|||
42064512|NCT00817635|75873358|FG003|Overall Study|Withdrawal by Subject|1|||
42064513|NCT00817635|75873359|FG004|Overall Study|Withdrawal by Subject|2|||
42064514|NCT00817635|75873355|FG000|Overall Study|Lost to Follow-up|0|||
42064515|NCT00817635|75873356|FG001|Overall Study|Lost to Follow-up|1|||
42064516|NCT00817635|75873357|FG002|Overall Study|Lost to Follow-up|0|||
42064517|NCT00817635|75873358|FG003|Overall Study|Lost to Follow-up|1|||
42064518|NCT00817635|75873359|FG004|Overall Study|Lost to Follow-up|0|||
42064519|NCT00817635|75873355|FG000|Overall Study|Administrative Problems|0|||
42064520|NCT00817635|75873356|FG001|Overall Study|Administrative Problems|0|||
42064521|NCT00817635|75873357|FG002|Overall Study|Administrative Problems|0|||
42064522|NCT00817635|75873358|FG003|Overall Study|Administrative Problems|0|||
42064523|NCT00817635|75873359|FG004|Overall Study|Administrative Problems|1|||
42064524|NCT00817635|75873355|FG000|Overall Study|Protocol Violation|5|||
42064525|NCT00817635|75873356|FG001|Overall Study|Protocol Violation|1|||
42064526|NCT00817635|75873357|FG002|Overall Study|Protocol Violation|3|||
42064527|NCT00817635|75873358|FG003|Overall Study|Protocol Violation|2|||
42064528|NCT00817635|75873359|FG004|Overall Study|Protocol Violation|3|||
42064529|NCT00817479|75873380|FG000|Overall Study|Physician Decision|1|||
42064530|NCT00817479|75873381|FG001|Overall Study|Physician Decision|1|||
42064531|NCT00961961|75873391|FG000|Phase I|Withdrawal by Subject|7|||
42064532|NCT00961961|75873392|FG001|Phase I|Withdrawal by Subject|0|||
42064533|NCT00961961|75873393|FG002|Phase I|Withdrawal by Subject|0|||
42064534|NCT00961961|75873394|FG003|Phase I|Withdrawal by Subject|0|||
42064535|NCT00961961|75873391|FG000|Phase I|Lost to Follow-up|10|||
42064536|NCT00961961|75873392|FG001|Phase I|Lost to Follow-up|0|||
42064537|NCT00961961|75873393|FG002|Phase I|Lost to Follow-up|0|||
42064538|NCT00961961|75873394|FG003|Phase I|Lost to Follow-up|0|||
42064539|NCT00961961|75873391|FG000|Phase I|Lack of Efficacy|94|||
42064540|NCT00961961|75873392|FG001|Phase I|Lack of Efficacy|0|||
42064541|NCT00961961|75873393|FG002|Phase I|Lack of Efficacy|0|||
42064542|NCT00961961|75873394|FG003|Phase I|Lack of Efficacy|0|||
42064543|NCT00961961|75873391|FG000|Phase I|Adverse Event|7|||
42064544|NCT00961961|75873392|FG001|Phase I|Adverse Event|0|||
42064545|NCT00961961|75873393|FG002|Phase I|Adverse Event|0|||
42064546|NCT00961961|75873394|FG003|Phase I|Adverse Event|0|||
42064547|NCT00961961|75873391|FG000|Phase I|Physician Decision|8|||
42064548|NCT00961961|75873392|FG001|Phase I|Physician Decision|0|||
42064549|NCT00961961|75873393|FG002|Phase I|Physician Decision|0|||
42064550|NCT00961961|75873394|FG003|Phase I|Physician Decision|0|||
42064551|NCT00961961|75873391|FG000|Phase II|Lost to Follow-up|0|||
42064552|NCT00961961|75873392|FG001|Phase II|Lost to Follow-up|0|||
42064553|NCT00961961|75873393|FG002|Phase II|Lost to Follow-up|10|||
42064554|NCT00961961|75873394|FG003|Phase II|Lost to Follow-up|7|||
42064555|NCT00961961|75873391|FG000|Phase II|Adverse Event|0|||
42064556|NCT00961961|75873392|FG001|Phase II|Adverse Event|0|||
42064557|NCT00961961|75873393|FG002|Phase II|Adverse Event|0|||
42064558|NCT00961961|75873394|FG003|Phase II|Adverse Event|1|||
42064559|NCT00961961|75873391|FG000|Phase II|Physician Decision|0|||
42064560|NCT00961961|75873392|FG001|Phase II|Physician Decision|0|||
42064561|NCT00961961|75873393|FG002|Phase II|Physician Decision|1|||
42064562|NCT00961961|75873394|FG003|Phase II|Physician Decision|0|||
42064563|NCT00961961|75873391|FG000|Phase II|Withdrawal by Subject|0|||
42064564|NCT00961961|75873392|FG001|Phase II|Withdrawal by Subject|0|||
42064565|NCT00961961|75873393|FG002|Phase II|Withdrawal by Subject|1|||
42292188|NCT03827655|76125911|FG000|Overall Study|Withdrawal by Subject|3|||
42292189|NCT03827655|76125912|FG001|Overall Study|Withdrawal by Subject|2|||
42064566|NCT00961961|75873394|FG003|Phase II|Withdrawal by Subject|0|||
42064567|NCT00817089|75873418|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
42292190|NCT03827655|76125913|FG002|Overall Study|Withdrawal by Subject|2|||
42064568|NCT00817089|75873419|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
42064569|NCT00817089|75873420|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
42064570|NCT00817089|75873421|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
42064571|NCT00817089|75873418|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
42064572|NCT00817089|75873419|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
42064573|NCT00817089|75873420|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
42064574|NCT00817089|75873421|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
42064575|NCT00815919|75873435|FG000|Overall Study|Unrelated Fungal Infection|1|||
42064576|NCT00815919|75873435|FG000|Overall Study|AML Relapse|1|||
42064577|NCT00815919|75873435|FG000|Overall Study|Lack of Efficacy|2|||
42064578|NCT00957905|75873441|FG000|Part B|Not Treated|0|||
42064579|NCT00957905|75873442|FG001|Part B|Not Treated|1|||
42064580|NCT00957905|75873441|FG000|Part B|Physician Decision|0|||
42064581|NCT00957905|75873442|FG001|Part B|Physician Decision|1|||
42064582|NCT00957905|75873441|FG000|Part B|Death|0|||
42064583|NCT00957905|75873442|FG001|Part B|Death|1|||
42064584|NCT00957905|75873441|FG000|Part B|Protocol Violation|0|||
42064585|NCT00957905|75873442|FG001|Part B|Protocol Violation|1|||
42064586|NCT00960323|75873448|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
42064587|NCT00617929|75873456|FG000|Overall Study|Physician Decision|1|||
42064588|NCT00815295|75873463|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
42064589|NCT00815295|75873464|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
42064590|NCT00815295|75873465|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
42064591|NCT00814983|75873475|FG000|Overall Study|Screen failure|1|||
42064592|NCT00814983|75873476|FG001|Overall Study|Screen failure|0|||
42064593|NCT00814983|75873475|FG000|Overall Study|Withdrawal by Subject|1|||
42064594|NCT00814983|75873476|FG001|Overall Study|Withdrawal by Subject|0|||
42064595|NCT00814983|75873475|FG000|Overall Study|Graft failure|1|||
42064596|NCT00814983|75873476|FG001|Overall Study|Graft failure|0|||
42064597|NCT00960869|75873484|FG000|Overall Study|Adverse Event|17|||
42064598|NCT00960869|75873485|FG001|Overall Study|Adverse Event|26|||
42064599|NCT00960869|75873484|FG000|Overall Study|Withdrawal by Subject|16|||
42064600|NCT00960869|75873485|FG001|Overall Study|Withdrawal by Subject|14|||
42064601|NCT00960869|75873484|FG000|Overall Study|Lost to Follow-up|1|||
42292191|NCT03827655|76125914|FG003|Overall Study|Withdrawal by Subject|0|||
42064602|NCT00960869|75873485|FG001|Overall Study|Lost to Follow-up|4|||
42064603|NCT00960869|75873484|FG000|Overall Study|Misc|19|||
42064604|NCT00960869|75873485|FG001|Overall Study|Misc|18|||
42064605|NCT00618787|75873493|FG000|Overall Study|Adverse Event|0|||
42064606|NCT00618787|75873494|FG001|Overall Study|Adverse Event|1|||
42064607|NCT00618787|75873493|FG000|Overall Study|Withdrawal by Subject|2|||
42064608|NCT00618787|75873494|FG001|Overall Study|Withdrawal by Subject|1|||
42064609|NCT00618787|75873493|FG000|Overall Study|Lost to Follow-up|1|||
42064610|NCT00618787|75873494|FG001|Overall Study|Lost to Follow-up|0|||
42064611|NCT00813813|75873502|FG000|Overall Study|Withdrawal by Subject|1|||
42064612|NCT00813813|75873503|FG001|Overall Study|Withdrawal by Subject|1|||
42064613|NCT00813813|75873502|FG000|Overall Study|Lost to Follow-up|2|||
42064614|NCT00813813|75873503|FG001|Overall Study|Lost to Follow-up|7|||
42064615|NCT00813813|75873502|FG000|Overall Study|Other|0|||
42064616|NCT00813813|75873503|FG001|Overall Study|Other|1|||
42064617|NCT05317312|75873513|FG000|Overall Study|Withdrawal by Subject|0|||
42064618|NCT05317312|75873514|FG001|Overall Study|Withdrawal by Subject|1|||
42064619|NCT05317312|75873515|FG002|Overall Study|Withdrawal by Subject|0|||
42064620|NCT05317312|75873516|FG003|Overall Study|Withdrawal by Subject|0|||
42064621|NCT05317312|75873513|FG000|Overall Study|Lost to Follow-up|0|||
42064622|NCT05317312|75873514|FG001|Overall Study|Lost to Follow-up|0|||
42064623|NCT05317312|75873515|FG002|Overall Study|Lost to Follow-up|0|||
42064624|NCT05317312|75873516|FG003|Overall Study|Lost to Follow-up|1|||
42064625|NCT05317312|75873513|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
42064626|NCT05317312|75873514|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
42064627|NCT05317312|75873515|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
42064628|NCT05317312|75873516|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
42064629|NCT04644315|75873526|FG000|Overall Study|Subject withdrawal of consent|1|||
42064630|NCT04410523|75873536|FG000|Overall Study|Study terminated by sponsor|1|||
42064631|NCT04410523|75873537|FG001|Overall Study|Study terminated by sponsor|3|||
42064632|NCT04410523|75873538|FG002|Overall Study|Study terminated by sponsor|2|||
42064633|NCT04410523|75873539|FG003|Overall Study|Study terminated by sponsor|6|||
42064634|NCT04410523|75873540|FG004|Overall Study|Study terminated by sponsor|3|||
42064635|NCT04410523|75873541|FG005|Overall Study|Study terminated by sponsor|4|||
42064636|NCT04410523|75873536|FG000|Overall Study|Adverse Event|1|||
42064637|NCT04410523|75873537|FG001|Overall Study|Adverse Event|0|||
42064638|NCT04410523|75873538|FG002|Overall Study|Adverse Event|0|||
42064639|NCT04410523|75873539|FG003|Overall Study|Adverse Event|0|||
42064640|NCT04410523|75873540|FG004|Overall Study|Adverse Event|0|||
42064641|NCT04410523|75873541|FG005|Overall Study|Adverse Event|2|||
42064642|NCT04410523|75873536|FG000|Overall Study|Lost to Follow-up|0|||
42064643|NCT04410523|75873537|FG001|Overall Study|Lost to Follow-up|1|||
42064644|NCT04410523|75873538|FG002|Overall Study|Lost to Follow-up|0|||
42064645|NCT04410523|75873539|FG003|Overall Study|Lost to Follow-up|0|||
42292192|NCT03827655|76125915|FG004|Overall Study|Withdrawal by Subject|1|||
42292193|NCT03827655|76125911|FG000|Overall Study|Reason not Specified|3|||
42064646|NCT04410523|75873540|FG004|Overall Study|Lost to Follow-up|0|||
42292194|NCT03827655|76125912|FG001|Overall Study|Reason not Specified|1|||
42064647|NCT04410523|75873541|FG005|Overall Study|Lost to Follow-up|0|||
42064648|NCT04410523|75873536|FG000|Overall Study|Physician Decision|0|||
42064649|NCT04410523|75873537|FG001|Overall Study|Physician Decision|1|||
42064650|NCT04410523|75873538|FG002|Overall Study|Physician Decision|0|||
42064651|NCT04410523|75873539|FG003|Overall Study|Physician Decision|0|||
42064652|NCT04410523|75873540|FG004|Overall Study|Physician Decision|0|||
42064653|NCT04410523|75873541|FG005|Overall Study|Physician Decision|0|||
42064654|NCT04410523|75873536|FG000|Overall Study|Pregnancy|0|||
42064655|NCT04410523|75873537|FG001|Overall Study|Pregnancy|0|||
42064656|NCT04410523|75873538|FG002|Overall Study|Pregnancy|0|||
42064657|NCT04410523|75873539|FG003|Overall Study|Pregnancy|0|||
42064658|NCT04410523|75873540|FG004|Overall Study|Pregnancy|0|||
42064659|NCT04410523|75873541|FG005|Overall Study|Pregnancy|1|||
42064660|NCT04410523|75873536|FG000|Overall Study|Protocol deviation|0|||
42064661|NCT04410523|75873537|FG001|Overall Study|Protocol deviation|0|||
42064662|NCT04410523|75873538|FG002|Overall Study|Protocol deviation|0|||
42064663|NCT04410523|75873539|FG003|Overall Study|Protocol deviation|0|||
42064664|NCT04410523|75873540|FG004|Overall Study|Protocol deviation|0|||
42064665|NCT04410523|75873541|FG005|Overall Study|Protocol deviation|2|||
42064666|NCT04410523|75873536|FG000|Overall Study|Subject decision|2|||
42064667|NCT04410523|75873537|FG001|Overall Study|Subject decision|0|||
42064668|NCT04410523|75873538|FG002|Overall Study|Subject decision|0|||
42064669|NCT04410523|75873539|FG003|Overall Study|Subject decision|1|||
42064670|NCT04410523|75873540|FG004|Overall Study|Subject decision|0|||
42064671|NCT04410523|75873541|FG005|Overall Study|Subject decision|1|||
42064672|NCT03889418|75873580|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
42064673|NCT03889418|75873581|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
42064674|NCT03889418|75873582|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
42064675|NCT03889418|75873583|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
42064676|NCT03889418|75873584|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
42064677|NCT03889418|75873585|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
42064678|NCT03889418|75873586|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
42064679|NCT03889418|75873587|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
42064680|NCT03889418|75873588|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
42064681|NCT03889418|75873589|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
42064682|NCT03889418|75873580|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
42064683|NCT03889418|75873581|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
42064684|NCT03889418|75873582|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
42064685|NCT03889418|75873583|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
42064686|NCT03889418|75873584|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
42064687|NCT03889418|75873585|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
42064688|NCT03889418|75873586|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
42064689|NCT03889418|75873587|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
42064690|NCT03889418|75873588|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
42064691|NCT03889418|75873589|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
42064692|NCT03889418|75873580|FG000|October-December 2019 (Month 7-9)|Death|0|||
42064693|NCT03889418|75873581|FG001|October-December 2019 (Month 7-9)|Death|0|||
42064694|NCT03889418|75873582|FG002|October-December 2019 (Month 7-9)|Death|0|||
42064695|NCT03889418|75873583|FG003|October-December 2019 (Month 7-9)|Death|0|||
42064696|NCT03889418|75873584|FG004|October-December 2019 (Month 7-9)|Death|0|||
42064697|NCT03889418|75873585|FG005|October-December 2019 (Month 7-9)|Death|0|||
42064698|NCT03889418|75873586|FG006|October-December 2019 (Month 7-9)|Death|0|||
42064699|NCT03889418|75873587|FG007|October-December 2019 (Month 7-9)|Death|0|||
42064700|NCT03889418|75873588|FG008|October-December 2019 (Month 7-9)|Death|1|||
42064701|NCT03889418|75873589|FG009|October-December 2019 (Month 7-9)|Death|0|||
42064702|NCT03889418|75873580|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
42064703|NCT03889418|75873581|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
42064704|NCT03889418|75873582|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
42064705|NCT03889418|75873583|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
42064706|NCT03889418|75873584|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
42064707|NCT03889418|75873585|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
42064708|NCT03889418|75873586|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
42064709|NCT03889418|75873587|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
42064710|NCT03889418|75873588|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
42064711|NCT03889418|75873589|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
42064712|NCT03889418|75873580|FG000|April - June 2020 (Month 13-15)|Death|0|||
42064713|NCT03889418|75873581|FG001|April - June 2020 (Month 13-15)|Death|1|||
42064714|NCT03889418|75873582|FG002|April - June 2020 (Month 13-15)|Death|0|||
42064715|NCT03889418|75873583|FG003|April - June 2020 (Month 13-15)|Death|0|||
42064716|NCT03889418|75873584|FG004|April - June 2020 (Month 13-15)|Death|0|||
42064717|NCT03889418|75873585|FG005|April - June 2020 (Month 13-15)|Death|0|||
42064718|NCT03889418|75873586|FG006|April - June 2020 (Month 13-15)|Death|0|||
42064719|NCT03889418|75873587|FG007|April - June 2020 (Month 13-15)|Death|0|||
42064720|NCT03889418|75873588|FG008|April - June 2020 (Month 13-15)|Death|0|||
42064721|NCT03889418|75873589|FG009|April - June 2020 (Month 13-15)|Death|0|||
42064722|NCT03889418|75873580|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
42064723|NCT03889418|75873581|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
42064724|NCT03889418|75873582|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
42175035|NCT03370133|75981980|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
42175036|NCT03370133|75981981|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
42175037|NCT03370133|75981982|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
42175038|NCT03370133|75981983|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
42175039|NCT03370133|75981978|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
42175040|NCT03370133|75981979|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
42292195|NCT03827655|76125913|FG002|Overall Study|Reason not Specified|1|||
42292196|NCT03827655|76125914|FG003|Overall Study|Reason not Specified|1|||
42016711|NCT00931723|75824213|FG000|Overall Study|Adverse Event|6|||
42016712|NCT00931723|75824214|FG001|Overall Study|Adverse Event|13|||
42016713|NCT00931723|75824213|FG000|Overall Study|Lithium found in blood|0|||
42016714|NCT00931723|75824214|FG001|Overall Study|Lithium found in blood|1|||
42016715|NCT00931723|75824213|FG000|Overall Study|Condition under investigation worsened|1|||
42016716|NCT00931723|75824214|FG001|Overall Study|Condition under investigation worsened|2|||
42016717|NCT00931723|75824213|FG000|Overall Study|Lost to Follow-up|1|||
42016718|NCT00931723|75824214|FG001|Overall Study|Lost to Follow-up|2|||
42016719|NCT00931723|75824213|FG000|Overall Study|Study-specific discontinuation criteria|1|||
42016720|NCT00931723|75824214|FG001|Overall Study|Study-specific discontinuation criteria|1|||
42016721|NCT00931723|75824213|FG000|Overall Study|Severe non-compliance to protocol|2|||
42016722|NCT00931723|75824214|FG001|Overall Study|Severe non-compliance to protocol|0|||
42016723|NCT00931723|75824213|FG000|Overall Study|Safety reasons|0|||
42016724|NCT00931723|75824214|FG001|Overall Study|Safety reasons|1|||
42016725|NCT00931723|75824213|FG000|Overall Study|Took prohibited concomitant medication|0|||
42016726|NCT00931723|75824214|FG001|Overall Study|Took prohibited concomitant medication|1|||
42016727|NCT00931723|75824213|FG000|Overall Study|Lack or insufficient theraputic response|2|||
42016728|NCT00931723|75824214|FG001|Overall Study|Lack or insufficient theraputic response|5|||
42016729|NCT00931723|75824213|FG000|Overall Study|Sponsor decision|1|||
42016730|NCT00931723|75824214|FG001|Overall Study|Sponsor decision|0|||
42016731|NCT00931723|75824213|FG000|Overall Study|Late hospital discharge|1|||
42016732|NCT00931723|75824214|FG001|Overall Study|Late hospital discharge|0|||
42016733|NCT00931411|75824222|FG000|First Intervention - 42 Days|Adverse Event|2|||
42016734|NCT00931411|75824223|FG001|First Intervention - 42 Days|Adverse Event|3|||
42016735|NCT00931411|75824222|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
42016736|NCT00931411|75824223|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
42016737|NCT00931411|75824222|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
42016738|NCT00931411|75824223|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
42016739|NCT00931255|75824235|FG000|Overall Study|Follow up biopsy not done|2|||
42016740|NCT00931255|75824236|FG001|Overall Study|Follow up biopsy not done|3|||
42016741|NCT00930553|75824242|FG000|Overall Study|Adverse Event|1|||
42016742|NCT00930553|75824242|FG000|Overall Study|Lack of Efficacy|7|||
42016743|NCT00930553|75824242|FG000|Overall Study|Physician Decision|39|||
42016744|NCT00930553|75824242|FG000|Overall Study|Protocol Violation|1|||
42016745|NCT00930553|75824242|FG000|Overall Study|Pregnancy|1|||
42016746|NCT00930553|75824242|FG000|Overall Study|Withdrawal by Subject|88|||
42016747|NCT00930553|75824242|FG000|Overall Study|Lost to Follow-up|25|||
42016748|NCT00930553|75824242|FG000|Overall Study|Death|9|||
42016749|NCT00930553|75824242|FG000|Overall Study|Study terminated by sponsor|24|||
42016750|NCT00930553|75824242|FG000|Overall Study|Other than specified above|28|||
42016751|NCT00929695|75824266|FG000|Overall Study|Death|2|||
42016752|NCT00929695|75824267|FG001|Overall Study|Death|1|||
42016753|NCT00929695|75824266|FG000|Overall Study|Withdrawal by Subject|0|||
42016754|NCT00929695|75824267|FG001|Overall Study|Withdrawal by Subject|2|||
42016755|NCT00929695|75824266|FG000|Overall Study|discharge home|4|||
42016756|NCT00929695|75824267|FG001|Overall Study|discharge home|3|||
42016757|NCT00929695|75824266|FG000|Overall Study|incorrect stratification|2|||
42016758|NCT00929695|75824267|FG001|Overall Study|incorrect stratification|0|||
42016759|NCT00927355|75824280|FG000|Overall Study|Adverse Event|1|||
42016760|NCT00927355|75824281|FG001|Overall Study|Adverse Event|1|||
42016761|NCT00923845|75824301|FG000|Induction Therapy|Poor performance status|0|||
42016762|NCT00923845|75824302|FG001|Induction Therapy|Poor performance status|2|||
42016763|NCT00922987|75824309|FG000|Overall Study|Insufficient clinical response|1|||
42016764|NCT00922987|75824309|FG000|Overall Study|Protocol Violation|2|||
42016765|NCT00922987|75824309|FG000|Overall Study|Adverse Event|1|||
42016766|NCT00928135|75824315|FG000|Overall Study|Withdrawal by Subject|1|||
42016767|NCT00928135|75824316|FG001|Overall Study|Withdrawal by Subject|0|||
42016768|NCT00928057|75824324|FG000|Overall Study|Adverse Event|1|||
42175041|NCT03370133|75981980|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
42175042|NCT03370133|75981981|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
42175043|NCT03370133|75981982|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
42175044|NCT03370133|75981983|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
42175045|NCT03370133|75981978|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
42175046|NCT03370133|75981979|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
42175047|NCT03370133|75981980|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
42175048|NCT03370133|75981981|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
42175049|NCT03370133|75981982|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
42175050|NCT03370133|75981983|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
42175051|NCT03370133|75981978|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
42175052|NCT03370133|75981979|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
42175053|NCT03370133|75981980|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
42175054|NCT03370133|75981981|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
42175055|NCT03370133|75981982|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
42175056|NCT03370133|75981983|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
42175057|NCT03370133|75981978|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
42175058|NCT03370133|75981979|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
42175059|NCT03370133|75981980|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
42175060|NCT03370133|75981981|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
42175061|NCT03370133|75981982|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
42175062|NCT03370133|75981983|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
42175063|NCT03370133|75981978|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
42175064|NCT03370133|75981979|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
42175065|NCT03370133|75981980|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
42175066|NCT03370133|75981981|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
42175067|NCT03370133|75981982|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
42175068|NCT03370133|75981983|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
42175069|NCT03370133|75981978|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
42175070|NCT03370133|75981979|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
42175071|NCT03370133|75981980|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
42175072|NCT03370133|75981981|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
42175073|NCT03370133|75981982|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
42175074|NCT03370133|75981983|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
42175075|NCT03370133|75981978|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
42175076|NCT03370133|75981979|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
42175077|NCT03370133|75981980|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
42175078|NCT03370133|75981981|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
42175079|NCT03370133|75981982|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
42175080|NCT03370133|75981983|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
42175081|NCT03370133|75981978|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
42175082|NCT03370133|75981979|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
42175083|NCT03370133|75981980|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
42175084|NCT03370133|75981981|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
42175085|NCT03370133|75981982|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
42175086|NCT03370133|75981983|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
42175087|NCT03227757|75982001|FG000|Overall Study|Death|7|||
42175088|NCT03227757|75982001|FG000|Overall Study|Withdrawal|5|||
42175089|NCT03227757|75982001|FG000|Overall Study|Missed visits|4|||
42175090|NCT03149549|75982018|FG000|Study Discontinuation--Treatment Period|Death|0|||
42175091|NCT03149549|75982019|FG001|Study Discontinuation--Treatment Period|Death|0|||
42175092|NCT03149549|75982020|FG002|Study Discontinuation--Treatment Period|Death|0|||
42175093|NCT03149549|75982021|FG003|Study Discontinuation--Treatment Period|Death|1|||
42175094|NCT03149549|75982022|FG004|Study Discontinuation--Treatment Period|Death|2|||
42175095|NCT03149549|75982023|FG005|Study Discontinuation--Treatment Period|Death|1|||
42292197|NCT03827655|76125915|FG004|Overall Study|Reason not Specified|1|||
42292198|NCT03782064|76125950|FG000|Overall Study|Lack of Efficacy|2|||
42292199|NCT03782064|76125950|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
42292200|NCT03772522|76125956|FG000|Pre-intervention|Withdrawal by Subject|3|||
42292201|NCT03772522|76125957|FG001|Pre-intervention|Withdrawal by Subject|4|||
42292202|NCT03772522|76125956|FG000|Intervention|Withdrawal by Subject|1|||
42064725|NCT03889418|75873583|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
42064726|NCT03889418|75873584|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
42064727|NCT03889418|75873585|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
42064728|NCT03889418|75873586|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
42064729|NCT03889418|75873587|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
42064730|NCT03889418|75873588|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
42064731|NCT03889418|75873589|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
42064732|NCT03889418|75873580|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
42064733|NCT03889418|75873581|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
42064734|NCT03889418|75873582|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
42064735|NCT03889418|75873583|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
42064736|NCT03889418|75873584|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
42064737|NCT03889418|75873585|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
42064738|NCT03889418|75873586|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
42064739|NCT03889418|75873587|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
42064740|NCT03889418|75873588|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
42064741|NCT03889418|75873589|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
42064742|NCT03889418|75873580|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
42064743|NCT03889418|75873581|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
42064744|NCT03889418|75873582|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
42064745|NCT03889418|75873583|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
42064746|NCT03889418|75873584|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
42064747|NCT03889418|75873585|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
42064748|NCT03889418|75873586|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
42064749|NCT03889418|75873587|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
42064750|NCT03889418|75873588|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
42064751|NCT03889418|75873589|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
42064752|NCT03749109|75873599|FG000|Overall Study|Adverse Event|2|||
42064753|NCT03749109|75873600|FG001|Overall Study|Adverse Event|0|||
42064754|NCT03709706|75873609|FG000|Overall Study|Adverse Event|0|||
42064755|NCT03709706|75873610|FG001|Overall Study|Adverse Event|1|||
42064756|NCT03709706|75873609|FG000|Overall Study|Physician Decision|14|||
42064757|NCT03709706|75873610|FG001|Overall Study|Physician Decision|8|||
42064758|NCT03709706|75873609|FG000|Overall Study|Withdrawal by Subject|2|||
42064759|NCT03709706|75873610|FG001|Overall Study|Withdrawal by Subject|1|||
42064760|NCT03709706|75873609|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
42064761|NCT03709706|75873610|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
42064762|NCT03497689|75873617|FG000|Overall Study|Adverse Event|2|||
42064763|NCT03497689|75873617|FG000|Overall Study|Death|1|||
42064764|NCT03497689|75873617|FG000|Overall Study|Physician Decision|1|||
42064765|NCT03497689|75873617|FG000|Overall Study|Withdrawal by Subject|1|||
42064766|NCT03497689|75873617|FG000|Overall Study|Protocol Violation|2|||
42064767|NCT03492437|75873621|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42064768|NCT03492437|75873622|FG001|Treatment Period 2|Withdrawal by Subject|1|||
42064769|NCT03193853|75873628|FG000|Overall Study|Death|6|||
42064770|NCT02756637|75873634|FG000|Overall Study|Not eligible for initial SWOG study|10|||
42064771|NCT02756637|75873635|FG001|Overall Study|Not eligible for initial SWOG study|10|||
42064772|NCT02756637|75873634|FG000|Overall Study|No available NLR value|44|||
42064773|NCT02756637|75873635|FG001|Overall Study|No available NLR value|44|||
42064774|NCT02756637|75873634|FG000|Overall Study|Did not complete curative therapy|33|||
42064775|NCT02756637|75873635|FG001|Overall Study|Did not complete curative therapy|0|||
42064776|NCT02041195|75873649|FG000|Overall Study|Adverse Event|1|||
42064777|NCT02041195|75873650|FG001|Overall Study|Adverse Event|2|||
42064778|NCT02041195|75873651|FG002|Overall Study|Adverse Event|0|||
42064779|NCT02041195|75873652|FG003|Overall Study|Adverse Event|0|||
42064780|NCT02041195|75873653|FG004|Overall Study|Adverse Event|0|||
42064781|NCT02041195|75873654|FG005|Overall Study|Adverse Event|0|||
42064782|NCT02041195|75873655|FG006|Overall Study|Adverse Event|3|||
42064783|NCT02041195|75873656|FG007|Overall Study|Adverse Event|0|||
42064784|NCT02041195|75873649|FG000|Overall Study|Withdrawal by Subject|1|||
42064785|NCT02041195|75873650|FG001|Overall Study|Withdrawal by Subject|0|||
42064786|NCT02041195|75873651|FG002|Overall Study|Withdrawal by Subject|0|||
42064787|NCT02041195|75873652|FG003|Overall Study|Withdrawal by Subject|0|||
42064788|NCT02041195|75873653|FG004|Overall Study|Withdrawal by Subject|0|||
42064789|NCT02041195|75873654|FG005|Overall Study|Withdrawal by Subject|0|||
42064790|NCT02041195|75873655|FG006|Overall Study|Withdrawal by Subject|4|||
42064791|NCT02041195|75873656|FG007|Overall Study|Withdrawal by Subject|3|||
42064792|NCT02041195|75873649|FG000|Overall Study|Unable to comply with study visits|0|||
42064793|NCT02041195|75873650|FG001|Overall Study|Unable to comply with study visits|1|||
42064794|NCT02041195|75873651|FG002|Overall Study|Unable to comply with study visits|0|||
42064795|NCT02041195|75873652|FG003|Overall Study|Unable to comply with study visits|0|||
42064796|NCT02041195|75873653|FG004|Overall Study|Unable to comply with study visits|1|||
42064797|NCT02041195|75873654|FG005|Overall Study|Unable to comply with study visits|0|||
42064798|NCT02041195|75873655|FG006|Overall Study|Unable to comply with study visits|0|||
42064799|NCT02041195|75873656|FG007|Overall Study|Unable to comply with study visits|0|||
42064800|NCT01583218|75873715|FG000|Overall Study|Withdrawal by Subject|43|||
42064801|NCT01583218|75873716|FG001|Overall Study|Withdrawal by Subject|29|||
42064802|NCT01583218|75873715|FG000|Overall Study|Death|206|||
42064803|NCT01583218|75873716|FG001|Overall Study|Death|211|||
42064804|NCT01583218|75873715|FG000|Overall Study|Lost to Follow-up|11|||
42064805|NCT01583218|75873716|FG001|Overall Study|Lost to Follow-up|17|||
42064806|NCT01583218|75873715|FG000|Overall Study|Adverse event or serious adverse event|3|||
42064807|NCT01583218|75873716|FG001|Overall Study|Adverse event or serious adverse event|3|||
42064808|NCT01583218|75873715|FG000|Overall Study|Patient /Family decision|3|||
42064809|NCT01583218|75873716|FG001|Overall Study|Patient /Family decision|0|||
42064810|NCT01583218|75873715|FG000|Overall Study|Cannot contact patient directly|1|||
42064811|NCT01583218|75873716|FG001|Overall Study|Cannot contact patient directly|2|||
42064812|NCT01583218|75873715|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
42064813|NCT01583218|75873716|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
42064814|NCT01583218|75873715|FG000|Overall Study|Patient did not wish to attend visits|0|||
42064815|NCT01583218|75873716|FG001|Overall Study|Patient did not wish to attend visits|1|||
42064816|NCT01583218|75873715|FG000|Overall Study|Patient randomized but not dosed|17|||
42064817|NCT01583218|75873716|FG001|Overall Study|Patient randomized but not dosed|16|||
42064818|NCT01583218|75873715|FG000|Overall Study|Patient was assessed via phone in person|1|||
42064819|NCT01583218|75873716|FG001|Overall Study|Patient was assessed via phone in person|0|||
42064820|NCT01583218|75873715|FG000|Overall Study|Patient deemed ineligible after random|2|||
42064821|NCT01583218|75873716|FG001|Overall Study|Patient deemed ineligible after random|0|||
42064822|NCT01583218|75873715|FG000|Overall Study|Patient was early terminated from study|0|||
42064823|NCT01583218|75873716|FG001|Overall Study|Patient was early terminated from study|1|||
42064824|NCT01583218|75873715|FG000|Overall Study|Patient was randomized due to mistake|1|||
42064825|NCT01583218|75873716|FG001|Overall Study|Patient was randomized due to mistake|0|||
42064826|NCT01583218|75873715|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
42064827|NCT01583218|75873716|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
42064828|NCT01583218|75873715|FG000|Overall Study|Withdraw of consent on day of random|1|||
42064829|NCT01583218|75873716|FG001|Overall Study|Withdraw of consent on day of random|0|||
42064830|NCT00742859|75873726|FG000|Overall Study|Adverse Event|5|||
42064831|NCT00742859|75873727|FG001|Overall Study|Adverse Event|6|||
42064832|NCT00742859|75873728|FG002|Overall Study|Adverse Event|3|||
42064833|NCT00742859|75873729|FG003|Overall Study|Adverse Event|1|||
42064834|NCT00742859|75873726|FG000|Overall Study|Death|1|||
42064835|NCT00742859|75873727|FG001|Overall Study|Death|0|||
42064836|NCT00742859|75873728|FG002|Overall Study|Death|0|||
42064837|NCT00742859|75873729|FG003|Overall Study|Death|1|||
42064838|NCT00742859|75873726|FG000|Overall Study|Physician Decision|1|||
42064839|NCT00742859|75873727|FG001|Overall Study|Physician Decision|2|||
42064840|NCT00742859|75873728|FG002|Overall Study|Physician Decision|0|||
42064841|NCT00742859|75873729|FG003|Overall Study|Physician Decision|0|||
42064842|NCT00742859|75873726|FG000|Overall Study|Withdrawal by Subject|4|||
42064843|NCT00742859|75873727|FG001|Overall Study|Withdrawal by Subject|2|||
42064844|NCT00742859|75873728|FG002|Overall Study|Withdrawal by Subject|4|||
42064845|NCT00742859|75873729|FG003|Overall Study|Withdrawal by Subject|1|||
42064846|NCT00742859|75873726|FG000|Overall Study|Endpoint|0|||
42064847|NCT00742859|75873727|FG001|Overall Study|Endpoint|1|||
42064848|NCT00742859|75873728|FG002|Overall Study|Endpoint|1|||
42064849|NCT00742859|75873729|FG003|Overall Study|Endpoint|2|||
42064850|NCT00742859|75873726|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
42292203|NCT03772522|76125957|FG001|Intervention|Withdrawal by Subject|0|||
42292204|NCT03772522|76125956|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
42292205|NCT03772522|76125957|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
42292206|NCT03755518|76125967|FG000|Overall Study|Adverse Event|6|||
42064851|NCT00742859|75873727|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
42064852|NCT00742859|75873728|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
42064853|NCT00742859|75873729|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
42064854|NCT00742859|75873726|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
42064855|NCT00742859|75873727|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
42064856|NCT00742859|75873728|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
42064857|NCT00742859|75873729|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
42064858|NCT00742859|75873726|FG000|Overall Study|Sponsor request patient out of town|0|||
42064859|NCT00742859|75873727|FG001|Overall Study|Sponsor request patient out of town|0|||
42064860|NCT00742859|75873728|FG002|Overall Study|Sponsor request patient out of town|1|||
42064861|NCT00742859|75873729|FG003|Overall Study|Sponsor request patient out of town|1|||
42064862|NCT00742859|75873726|FG000|Overall Study|Site error|0|||
42175096|NCT03149549|75982024|FG006|Study Discontinuation--Treatment Period|Death|1|||
42175097|NCT03149549|75982025|FG007|Study Discontinuation--Treatment Period|Death|2|||
42175098|NCT03149549|75982026|FG008|Study Discontinuation--Treatment Period|Death|4|||
42175099|NCT03149549|75982027|FG009|Study Discontinuation--Treatment Period|Death|1|||
42175100|NCT03149549|75982028|FG010|Study Discontinuation--Treatment Period|Death|0|||
42175101|NCT03149549|75982029|FG011|Study Discontinuation--Treatment Period|Death|0|||
42175102|NCT03149549|75982030|FG012|Study Discontinuation--Treatment Period|Death|1|||
42175103|NCT03149549|75982018|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
42175104|NCT03149549|75982019|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
42175105|NCT03149549|75982020|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
42175106|NCT03149549|75982021|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
42175107|NCT03149549|75982022|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
42175108|NCT03149549|75982023|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
42175109|NCT03149549|75982024|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
42175110|NCT03149549|75982025|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
42175111|NCT03149549|75982026|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
42175112|NCT03149549|75982027|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
42175113|NCT03149549|75982028|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
42175114|NCT03149549|75982029|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
42175115|NCT03149549|75982030|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
42175116|NCT03149549|75982018|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
42175117|NCT03149549|75982019|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
42175118|NCT03149549|75982020|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
42175119|NCT03149549|75982021|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
42175120|NCT03149549|75982022|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
42175121|NCT03149549|75982023|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
42175122|NCT03149549|75982024|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
42175123|NCT03149549|75982025|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
42175124|NCT03149549|75982026|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
42292207|NCT03755518|76125967|FG000|Overall Study|Lack of Efficacy|6|||
42064863|NCT00742859|75873727|FG001|Overall Study|Site error|0|||
42064864|NCT00742859|75873728|FG002|Overall Study|Site error|1|||
42064865|NCT00742859|75873729|FG003|Overall Study|Site error|1|||
42064866|NCT00667342|75873742|FG000|Overall Study|Protocol Violation|1|||
42064867|NCT00667342|75873743|FG001|Overall Study|Protocol Violation|0|||
42064868|NCT00667342|75873744|FG002|Overall Study|Protocol Violation|0|||
42064869|NCT00667342|75873742|FG000|Overall Study|Withdrawal by Subject|1|||
42064870|NCT00667342|75873743|FG001|Overall Study|Withdrawal by Subject|0|||
42064871|NCT00667342|75873744|FG002|Overall Study|Withdrawal by Subject|0|||
42064872|NCT00667342|75873742|FG000|Overall Study|Physician Decision|3|||
42064873|NCT00667342|75873743|FG001|Overall Study|Physician Decision|0|||
42064874|NCT00667342|75873744|FG002|Overall Study|Physician Decision|0|||
42064875|NCT00667342|75873742|FG000|Overall Study|Relapse or tumor progression|9|||
42064876|NCT00667342|75873743|FG001|Overall Study|Relapse or tumor progression|0|||
42064877|NCT00667342|75873744|FG002|Overall Study|Relapse or tumor progression|7|||
42064878|NCT00667342|75873742|FG000|Overall Study|Adverse Event|0|||
42064879|NCT00667342|75873743|FG001|Overall Study|Adverse Event|0|||
42064880|NCT00667342|75873744|FG002|Overall Study|Adverse Event|1|||
42064881|NCT00667342|75873742|FG000|Overall Study|Ineligible|0|||
42064882|NCT00667342|75873743|FG001|Overall Study|Ineligible|0|||
42064883|NCT00667342|75873744|FG002|Overall Study|Ineligible|1|||
42064884|NCT00375609|75873761|FG000|Overall Study|Did not receive treatment|1|||
42064885|NCT00375609|75873762|FG001|Overall Study|Did not receive treatment|0|||
42064886|NCT00375609|75873763|FG002|Overall Study|Did not receive treatment|0|||
42064887|NCT00375609|75873761|FG000|Overall Study|Adverse Event|0|||
42064888|NCT00375609|75873762|FG001|Overall Study|Adverse Event|3|||
42064889|NCT00375609|75873763|FG002|Overall Study|Adverse Event|0|||
42064890|NCT00375609|75873761|FG000|Overall Study|Lost to Follow-up|1|||
42064891|NCT00375609|75873762|FG001|Overall Study|Lost to Follow-up|0|||
42064892|NCT00375609|75873763|FG002|Overall Study|Lost to Follow-up|0|||
42064893|NCT00375609|75873761|FG000|Overall Study|Physician Decision|0|||
42064894|NCT00375609|75873762|FG001|Overall Study|Physician Decision|0|||
42064895|NCT00375609|75873763|FG002|Overall Study|Physician Decision|1|||
42064896|NCT00375609|75873761|FG000|Overall Study|Withdrawal by Subject|1|||
42064897|NCT00375609|75873762|FG001|Overall Study|Withdrawal by Subject|4|||
42064898|NCT00375609|75873763|FG002|Overall Study|Withdrawal by Subject|0|||
42064899|NCT00375609|75873761|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
42064900|NCT00375609|75873762|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
42064901|NCT00375609|75873763|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
42064902|NCT00960011|75873773|FG000|Overall Study|Death|5|||
42064903|NCT00960011|75873774|FG001|Overall Study|Death|0|||
42064904|NCT00960011|75873773|FG000|Overall Study|Lost to Follow-up|6|||
42064905|NCT00960011|75873774|FG001|Overall Study|Lost to Follow-up|2|||
42064906|NCT00617851|75873818|FG000|Overall Study|Death|0|||
42064907|NCT00617851|75873819|FG001|Overall Study|Death|0|||
42064908|NCT00617851|75873820|FG002|Overall Study|Death|0|||
42064909|NCT00617851|75873821|FG003|Overall Study|Death|1|||
42064910|NCT00617851|75873818|FG000|Overall Study|Withdrawal by Subject|14|||
42064911|NCT00617851|75873819|FG001|Overall Study|Withdrawal by Subject|7|||
42064912|NCT00617851|75873820|FG002|Overall Study|Withdrawal by Subject|12|||
42064913|NCT00617851|75873821|FG003|Overall Study|Withdrawal by Subject|4|||
42064914|NCT00617851|75873818|FG000|Overall Study|Lost to Follow-up|27|||
42064915|NCT00617851|75873819|FG001|Overall Study|Lost to Follow-up|29|||
42064916|NCT00617851|75873820|FG002|Overall Study|Lost to Follow-up|31|||
42064917|NCT00617851|75873821|FG003|Overall Study|Lost to Follow-up|19|||
42064918|NCT00617851|75873818|FG000|Overall Study|Inappropriate Enrollment|5|||
42064919|NCT00617851|75873819|FG001|Overall Study|Inappropriate Enrollment|4|||
42064920|NCT00617851|75873820|FG002|Overall Study|Inappropriate Enrollment|1|||
42064921|NCT00617851|75873821|FG003|Overall Study|Inappropriate Enrollment|1|||
42064922|NCT00617851|75873818|FG000|Overall Study|Unable to classify|1|||
42064923|NCT00617851|75873819|FG001|Overall Study|Unable to classify|0|||
42064924|NCT00617851|75873820|FG002|Overall Study|Unable to classify|1|||
42064925|NCT00617851|75873821|FG003|Overall Study|Unable to classify|0|||
42064926|NCT00812955|75873845|FG000|Overall Study|Adverse Event|7|||
42064927|NCT00812955|75873846|FG001|Overall Study|Adverse Event|6|||
42064928|NCT00812955|75873847|FG002|Overall Study|Adverse Event|3|||
42064929|NCT00812955|75873848|FG003|Overall Study|Adverse Event|4|||
42064930|NCT00812955|75873845|FG000|Overall Study|Lost to Follow-up|2|||
42064931|NCT00812955|75873846|FG001|Overall Study|Lost to Follow-up|1|||
42016769|NCT00928057|75824325|FG001|Overall Study|Adverse Event|2|||
42064932|NCT00812955|75873847|FG002|Overall Study|Lost to Follow-up|1|||
42016770|NCT00928057|75824324|FG000|Overall Study|Withdrawal by Subject|1|||
42016771|NCT00928057|75824325|FG001|Overall Study|Withdrawal by Subject|0|||
42016772|NCT00928057|75824324|FG000|Overall Study|Lost to Follow-up|0|||
42016773|NCT00928057|75824325|FG001|Overall Study|Lost to Follow-up|1|||
42016774|NCT00928057|75824324|FG000|Overall Study|Protocol Violation|0|||
42016775|NCT00928057|75824325|FG001|Overall Study|Protocol Violation|1|||
42016776|NCT00927901|75824341|FG000|Treatment Period 1|Subject withdrew consent|0|||
42016777|NCT00927901|75824342|FG001|Treatment Period 1|Subject withdrew consent|0|||
42016778|NCT00927901|75824343|FG002|Treatment Period 1|Subject withdrew consent|1|||
42016779|NCT00927901|75824344|FG003|Treatment Period 1|Subject withdrew consent|0|||
42064933|NCT00812955|75873848|FG003|Overall Study|Lost to Follow-up|2|||
42064934|NCT00812955|75873845|FG000|Overall Study|Withdrawal by Subject|1|||
42064935|NCT00812955|75873846|FG001|Overall Study|Withdrawal by Subject|0|||
42016780|NCT00927901|75824341|FG000|Treatment Period 4|Adverse Event|0|||
42016781|NCT00927901|75824342|FG001|Treatment Period 4|Adverse Event|0|||
42016782|NCT00927901|75824343|FG002|Treatment Period 4|Adverse Event|0|||
42064936|NCT00812955|75873847|FG002|Overall Study|Withdrawal by Subject|1|||
42064937|NCT00812955|75873848|FG003|Overall Study|Withdrawal by Subject|2|||
42064938|NCT00812955|75873845|FG000|Overall Study|randomized in error|0|||
42064939|NCT00812955|75873846|FG001|Overall Study|randomized in error|0|||
42064940|NCT00812955|75873847|FG002|Overall Study|randomized in error|1|||
42064941|NCT00812955|75873848|FG003|Overall Study|randomized in error|0|||
42064942|NCT00619489|75873864|FG000|Overall Study|Adverse Event|0|||
42064943|NCT00619489|75873865|FG001|Overall Study|Adverse Event|7|||
42064944|NCT00619489|75873864|FG000|Overall Study|Withdrawal by Subject|1|||
42064945|NCT00619489|75873865|FG001|Overall Study|Withdrawal by Subject|1|||
42064946|NCT00619489|75873864|FG000|Overall Study|Lack of Efficacy|0|||
42064947|NCT00619489|75873865|FG001|Overall Study|Lack of Efficacy|11|||
42064948|NCT00619489|75873864|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
42064949|NCT00619489|75873865|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
42064950|NCT00959699|75873873|FG000|Treatment Period|Adverse Event|3|||
42064951|NCT00959699|75873874|FG001|Treatment Period|Adverse Event|13|||
42064952|NCT00959699|75873873|FG000|Treatment Period|Lack of Efficacy|15|||
42064953|NCT00959699|75873874|FG001|Treatment Period|Lack of Efficacy|6|||
42064954|NCT00959699|75873873|FG000|Treatment Period|Lost to Follow-up|0|||
42064955|NCT00959699|75873874|FG001|Treatment Period|Lost to Follow-up|1|||
42064956|NCT00959699|75873873|FG000|Treatment Period|Withdrawal by Subject|1|||
42064957|NCT00959699|75873874|FG001|Treatment Period|Withdrawal by Subject|3|||
42064958|NCT00959699|75873873|FG000|Treatment Period|Non-Compliance with Protocol|0|||
42064959|NCT00959699|75873874|FG001|Treatment Period|Non-Compliance with Protocol|1|||
42064960|NCT00959699|75873873|FG000|Treatment Period|Did not receive treatment|0|||
42064961|NCT00959699|75873874|FG001|Treatment Period|Did not receive treatment|1|||
42064962|NCT00959699|75873873|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
42064963|NCT00959699|75873874|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
42064964|NCT00959699|75873873|FG000|Follow-up Period|Lost to Follow-up|3|||
42064965|NCT00959699|75873874|FG001|Follow-up Period|Lost to Follow-up|2|||
42064966|NCT00959699|75873873|FG000|Follow-up Period|Withdrawal by Subject|3|||
42064967|NCT00959699|75873874|FG001|Follow-up Period|Withdrawal by Subject|4|||
42064968|NCT00617773|75873881|FG000|Overall Study|Physician Decision|1|||
42064969|NCT00617773|75873881|FG000|Overall Study|Lack of compliance with the protocol|1|||
42064970|NCT00617773|75873881|FG000|Overall Study|Withdrawal by Subject|1|||
42064971|NCT00617773|75873881|FG000|Overall Study|Death|1|||
42064972|NCT00617773|75873881|FG000|Overall Study|Progressive disease|19|||
42064973|NCT00617773|75873881|FG000|Overall Study|Protocol Violation|1|||
42064974|NCT00956813|75873887|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
42064975|NCT00956813|75873888|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
42064976|NCT00956813|75873887|FG000|Flaxseed and Placebo|Ineligible|3|||
42064977|NCT00956813|75873888|FG001|Flaxseed and Placebo|Ineligible|1|||
42064978|NCT00955955|75873898|FG000|Overall Study|Lost to Follow-up|2|||
42064979|NCT00955955|75873899|FG001|Overall Study|Lost to Follow-up|0|||
42064980|NCT00955955|75873900|FG002|Overall Study|Lost to Follow-up|0|||
42064981|NCT00955721|75873916|FG000|Overall Study|Physician Decision|1|||
42064982|NCT00955721|75873917|FG001|Overall Study|Physician Decision|0|||
42064983|NCT00955721|75873916|FG000|Overall Study|Death|1|||
42064984|NCT00955721|75873917|FG001|Overall Study|Death|0|||
42064985|NCT00955721|75873916|FG000|Overall Study|Withdrawal by Subject|1|||
42064986|NCT00955721|75873917|FG001|Overall Study|Withdrawal by Subject|0|||
42064987|NCT00573469|75873927|FG000|Overall Study|Adverse Event|1|||
42064988|NCT00573469|75873928|FG001|Overall Study|Adverse Event|1|||
42064989|NCT00573469|75873929|FG002|Overall Study|Adverse Event|1|||
42064990|NCT00573469|75873927|FG000|Overall Study|Withdrawal by Subject|0|||
42064991|NCT00573469|75873928|FG001|Overall Study|Withdrawal by Subject|2|||
42064992|NCT00573469|75873929|FG002|Overall Study|Withdrawal by Subject|0|||
42064993|NCT00573469|75873927|FG000|Overall Study|Other|5|||
42064994|NCT00573469|75873928|FG001|Overall Study|Other|1|||
42064995|NCT00573469|75873929|FG002|Overall Study|Other|3|||
42064996|NCT00812565|75873945|FG000|Overall Study|Did Not Receive Study Medication|1|||
42064997|NCT00812565|75873946|FG001|Overall Study|Did Not Receive Study Medication|1|||
42064998|NCT00812565|75873947|FG002|Overall Study|Did Not Receive Study Medication|0|||
42292208|NCT03755518|76125967|FG000|Overall Study|Bone Marrow Transplant|4|||
42064999|NCT00812565|75873948|FG003|Overall Study|Did Not Receive Study Medication|0|||
42065000|NCT00812565|75873949|FG004|Overall Study|Did Not Receive Study Medication|0|||
42065001|NCT00812565|75873950|FG005|Overall Study|Did Not Receive Study Medication|0|||
42065002|NCT00812565|75873951|FG006|Overall Study|Did Not Receive Study Medication|0|||
42065003|NCT00812565|75873952|FG007|Overall Study|Did Not Receive Study Medication|0|||
42065004|NCT00812565|75873945|FG000|Overall Study|Adverse Event|0|||
42292209|NCT03755518|76125967|FG000|Overall Study|Withdrawal by participant|4|||
42292210|NCT03755518|76125967|FG000|Overall Study|Progressive Disease|2|||
42065005|NCT00812565|75873946|FG001|Overall Study|Adverse Event|0|||
42065006|NCT00812565|75873947|FG002|Overall Study|Adverse Event|0|||
42065007|NCT00812565|75873948|FG003|Overall Study|Adverse Event|2|||
42065008|NCT00812565|75873949|FG004|Overall Study|Adverse Event|0|||
42065009|NCT00812565|75873950|FG005|Overall Study|Adverse Event|0|||
42065010|NCT00812565|75873951|FG006|Overall Study|Adverse Event|0|||
42292211|NCT03755518|76125967|FG000|Overall Study|Death|1|||
42065011|NCT00812565|75873952|FG007|Overall Study|Adverse Event|1|||
42065012|NCT00812565|75873945|FG000|Overall Study|Did Not Come to Study Visit|1|||
42065013|NCT00812565|75873946|FG001|Overall Study|Did Not Come to Study Visit|0|||
42065014|NCT00812565|75873947|FG002|Overall Study|Did Not Come to Study Visit|0|||
42065015|NCT00812565|75873948|FG003|Overall Study|Did Not Come to Study Visit|0|||
42065016|NCT00812565|75873949|FG004|Overall Study|Did Not Come to Study Visit|0|||
42065017|NCT00812565|75873950|FG005|Overall Study|Did Not Come to Study Visit|0|||
42065018|NCT00812565|75873951|FG006|Overall Study|Did Not Come to Study Visit|0|||
42065019|NCT00812565|75873952|FG007|Overall Study|Did Not Come to Study Visit|0|||
42065020|NCT00812565|75873945|FG000|Overall Study|Withdrawal of Consent|1|||
42065021|NCT00812565|75873946|FG001|Overall Study|Withdrawal of Consent|0|||
42065022|NCT00812565|75873947|FG002|Overall Study|Withdrawal of Consent|0|||
42065023|NCT00812565|75873948|FG003|Overall Study|Withdrawal of Consent|0|||
42065024|NCT00812565|75873949|FG004|Overall Study|Withdrawal of Consent|1|||
42065025|NCT00812565|75873950|FG005|Overall Study|Withdrawal of Consent|0|||
42065026|NCT00812565|75873951|FG006|Overall Study|Withdrawal of Consent|0|||
42065027|NCT00812565|75873952|FG007|Overall Study|Withdrawal of Consent|0|||
42065028|NCT00812565|75873945|FG000|Overall Study|Reason Not Specified|0|||
42065029|NCT00812565|75873946|FG001|Overall Study|Reason Not Specified|0|||
42065030|NCT00812565|75873947|FG002|Overall Study|Reason Not Specified|0|||
42065031|NCT00812565|75873948|FG003|Overall Study|Reason Not Specified|0|||
42065032|NCT00812565|75873949|FG004|Overall Study|Reason Not Specified|0|||
42065033|NCT00812565|75873950|FG005|Overall Study|Reason Not Specified|1|||
42065034|NCT00812565|75873951|FG006|Overall Study|Reason Not Specified|0|||
42065035|NCT00812565|75873952|FG007|Overall Study|Reason Not Specified|0|||
42065036|NCT00812487|75873972|FG000|Overall Study|Lost to Follow-up|2|||
42065037|NCT00812487|75873973|FG001|Overall Study|Lost to Follow-up|0|||
42065038|NCT00812487|75873972|FG000|Overall Study|Withdrawal by Subject|3|||
42065039|NCT00812487|75873973|FG001|Overall Study|Withdrawal by Subject|2|||
42065040|NCT00812487|75873972|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
42065041|NCT00812487|75873973|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
42065042|NCT00812487|75873972|FG000|Overall Study|Protocol Violation|0|||
42065043|NCT00812487|75873973|FG001|Overall Study|Protocol Violation|1|||
42065044|NCT00617461|75873983|FG000|First Treatment Intervention Period|Adverse Event|2|||
42065045|NCT00617461|75873984|FG001|First Treatment Intervention Period|Adverse Event|0|||
42065046|NCT00617461|75873983|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
42065047|NCT00617461|75873984|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
42065048|NCT00617461|75873983|FG000|First Treatment Intervention Period|Protocol Violation|2|||
42065049|NCT00617461|75873984|FG001|First Treatment Intervention Period|Protocol Violation|1|||
42065050|NCT00617461|75873983|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
42065051|NCT00617461|75873984|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
42065052|NCT00617461|75873983|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
42065053|NCT00617461|75873984|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
42065054|NCT00617461|75873983|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
42065055|NCT00617461|75873984|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
42065056|NCT00617461|75873983|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
42065057|NCT00617461|75873984|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
42065058|NCT00617461|75873983|FG000|Second Treatment Intervention Period|Adverse Event|0|||
42065059|NCT00617461|75873984|FG001|Second Treatment Intervention Period|Adverse Event|1|||
42065060|NCT00617461|75873983|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
42065061|NCT00617461|75873984|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
42065062|NCT00617461|75873983|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
42065063|NCT00617461|75873984|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
42065064|NCT00617461|75873983|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
42065065|NCT00617461|75873984|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
42065066|NCT00812331|75874011|FG000|Overall Study|Adverse Event|1|||
42065067|NCT00812331|75874012|FG001|Overall Study|Adverse Event|0|||
42065068|NCT00812331|75874013|FG002|Overall Study|Adverse Event|0|||
42065069|NCT00812331|75874014|FG003|Overall Study|Adverse Event|0|||
42065070|NCT00812331|75874015|FG004|Overall Study|Adverse Event|0|||
42065071|NCT00812253|75874025|FG000|Overall Study|Withdrawal by Subject|3|||
42065072|NCT00812253|75874026|FG001|Overall Study|Withdrawal by Subject|2|||
42065073|NCT00812253|75874025|FG000|Overall Study|Protocol Violation|1|||
42065074|NCT00812253|75874026|FG001|Overall Study|Protocol Violation|1|||
42065075|NCT00812253|75874025|FG000|Overall Study|Lost to Follow-up|2|||
42065076|NCT00812253|75874026|FG001|Overall Study|Lost to Follow-up|0|||
42065077|NCT00616759|75874034|FG000|Overall Study|Physician Decision|2|||
42065078|NCT00616759|75874035|FG001|Overall Study|Physician Decision|0|||
42065079|NCT00616759|75874034|FG000|Overall Study|Withdrawal by Subject|1|||
42065080|NCT00616759|75874035|FG001|Overall Study|Withdrawal by Subject|2|||
42065081|NCT00812097|75874045|FG000|Overall Study|Death|3|||
42065082|NCT00812097|75874046|FG001|Overall Study|Death|10|||
42065083|NCT00812097|75874047|FG002|Overall Study|Death|3|||
42065084|NCT00812097|75874048|FG003|Overall Study|Death|3|||
42065085|NCT00812097|75874045|FG000|Overall Study|Withdrawal by Subject|14|||
42065086|NCT00812097|75874046|FG001|Overall Study|Withdrawal by Subject|12|||
42065087|NCT00812097|75874047|FG002|Overall Study|Withdrawal by Subject|8|||
42065088|NCT00812097|75874048|FG003|Overall Study|Withdrawal by Subject|2|||
42065089|NCT00812097|75874045|FG000|Overall Study|Lost to Follow-up|90|||
42065090|NCT00812097|75874046|FG001|Overall Study|Lost to Follow-up|14|||
42065091|NCT00812097|75874047|FG002|Overall Study|Lost to Follow-up|17|||
42065092|NCT00812097|75874048|FG003|Overall Study|Lost to Follow-up|5|||
42065093|NCT00812097|75874045|FG000|Overall Study|Explantation of study device(s)|27|||
42065094|NCT00812097|75874046|FG001|Overall Study|Explantation of study device(s)|29|||
42065095|NCT00812097|75874047|FG002|Overall Study|Explantation of study device(s)|14|||
42065096|NCT00812097|75874048|FG003|Overall Study|Explantation of study device(s)|20|||
42065097|NCT00812097|75874045|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
42065098|NCT00812097|75874046|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
42065099|NCT00812097|75874047|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
42065100|NCT00812097|75874048|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
42065101|NCT00811941|75874060|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
42065102|NCT00811941|75874061|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
42065103|NCT00811941|75874060|FG000|All Treated Patients|Adverse Event|2|||
42065104|NCT00811941|75874061|FG001|All Treated Patients|Adverse Event|43|||
42065105|NCT00811941|75874060|FG000|All Treated Patients|Lack of Efficacy|2|||
42065106|NCT00811941|75874061|FG001|All Treated Patients|Lack of Efficacy|3|||
42065107|NCT00811941|75874060|FG000|All Treated Patients|Non-compliance|1|||
42065108|NCT00811941|75874061|FG001|All Treated Patients|Non-compliance|8|||
42065109|NCT00811941|75874060|FG000|All Treated Patients|Protocol Violation|5|||
42065110|NCT00811941|75874061|FG001|All Treated Patients|Protocol Violation|17|||
42065111|NCT00811941|75874060|FG000|All Treated Patients|Withdrawal by Subject|35|||
42065112|NCT00811941|75874061|FG001|All Treated Patients|Withdrawal by Subject|94|||
42065113|NCT00811941|75874060|FG000|All Treated Patients|Lost to Follow-up|3|||
42065114|NCT00811941|75874061|FG001|All Treated Patients|Lost to Follow-up|12|||
42065115|NCT00811941|75874060|FG000|All Treated Patients|Other Reason|4|||
42065116|NCT00811941|75874061|FG001|All Treated Patients|Other Reason|14|||
42065117|NCT00811473|75874069|FG000|Overall Study|Adverse Event|3|||
42065118|NCT00811473|75874070|FG001|Overall Study|Adverse Event|12|||
42065119|NCT00811473|75874069|FG000|Overall Study|Lost to Follow-up|5|||
42065120|NCT00811473|75874070|FG001|Overall Study|Lost to Follow-up|1|||
42065121|NCT00811473|75874069|FG000|Overall Study|Withdrawal by Subject|2|||
42065122|NCT00811473|75874070|FG001|Overall Study|Withdrawal by Subject|4|||
42065123|NCT00811473|75874069|FG000|Overall Study|Severe non-compliance to protocol|2|||
42065124|NCT00811473|75874070|FG001|Overall Study|Severe non-compliance to protocol|4|||
42065125|NCT00811473|75874069|FG000|Overall Study|Lack of therapeutic response|4|||
42065126|NCT00811473|75874070|FG001|Overall Study|Lack of therapeutic response|1|||
42065127|NCT00811473|75874069|FG000|Overall Study|Condition under investigation worsened|1|||
42065128|NCT00811473|75874070|FG001|Overall Study|Condition under investigation worsened|3|||
42065129|NCT00811473|75874069|FG000|Overall Study|Other 2|4|||
42065130|NCT00811473|75874070|FG001|Overall Study|Other 2|1|||
42065131|NCT00811473|75874069|FG000|Overall Study|Incorrect Enrollment|1|||
42065132|NCT00811473|75874070|FG001|Overall Study|Incorrect Enrollment|0|||
42065133|NCT00811473|75874069|FG000|Overall Study|Safety Reasons|1|||
42065134|NCT00811473|75874070|FG001|Overall Study|Safety Reasons|0|||
42065135|NCT00617305|75874083|FG000|Overall Study|Adverse Event|4|||
42065136|NCT00617305|75874084|FG001|Overall Study|Adverse Event|0|||
42065137|NCT00617305|75874085|FG002|Overall Study|Adverse Event|0|||
42065138|NCT00617305|75874083|FG000|Overall Study|Death|1|||
42065139|NCT00617305|75874084|FG001|Overall Study|Death|0|||
42065140|NCT00617305|75874085|FG002|Overall Study|Death|0|||
42065141|NCT00617305|75874083|FG000|Overall Study|Physician Decision|1|||
42065142|NCT00617305|75874084|FG001|Overall Study|Physician Decision|0|||
42065143|NCT00617305|75874085|FG002|Overall Study|Physician Decision|0|||
42065144|NCT00617305|75874083|FG000|Overall Study|Protocol Violation|1|||
42065145|NCT00617305|75874084|FG001|Overall Study|Protocol Violation|0|||
42065146|NCT00617305|75874085|FG002|Overall Study|Protocol Violation|1|||
42065147|NCT00617305|75874083|FG000|Overall Study|Withdrawal by Subject|1|||
42065148|NCT00617305|75874084|FG001|Overall Study|Withdrawal by Subject|0|||
42065149|NCT00617305|75874085|FG002|Overall Study|Withdrawal by Subject|0|||
42065150|NCT00811395|75874102|FG000|Extension Treatment|Adverse Event|1|||
42065151|NCT00811395|75874103|FG001|Extension Treatment|Adverse Event|2|||
42065152|NCT00811395|75874104|FG002|Extension Treatment|Adverse Event|2|||
42065153|NCT00811395|75874105|FG003|Extension Treatment|Adverse Event|2|||
42065154|NCT00811395|75874106|FG004|Extension Treatment|Adverse Event|0|||
42065155|NCT00811395|75874107|FG005|Extension Treatment|Adverse Event|1|||
42065156|NCT00811395|75874102|FG000|Extension Treatment|Progressive disease|1|||
42065157|NCT00811395|75874103|FG001|Extension Treatment|Progressive disease|1|||
42065158|NCT00811395|75874104|FG002|Extension Treatment|Progressive disease|0|||
42065159|NCT00811395|75874105|FG003|Extension Treatment|Progressive disease|0|||
42065160|NCT00811395|75874106|FG004|Extension Treatment|Progressive disease|0|||
42065161|NCT00811395|75874107|FG005|Extension Treatment|Progressive disease|0|||
42065162|NCT00811395|75874102|FG000|Extension Treatment|Participant did not wish to continue|0|||
42065163|NCT00811395|75874103|FG001|Extension Treatment|Participant did not wish to continue|3|||
42065164|NCT00811395|75874104|FG002|Extension Treatment|Participant did not wish to continue|0|||
42065165|NCT00811395|75874105|FG003|Extension Treatment|Participant did not wish to continue|1|||
42065166|NCT00811395|75874106|FG004|Extension Treatment|Participant did not wish to continue|0|||
42065167|NCT00811395|75874107|FG005|Extension Treatment|Participant did not wish to continue|1|||
42065168|NCT00811395|75874102|FG000|Extension Treatment|Other than above|0|||
42065169|NCT00811395|75874103|FG001|Extension Treatment|Other than above|0|||
42065170|NCT00811395|75874104|FG002|Extension Treatment|Other than above|1|||
42065171|NCT00811395|75874105|FG003|Extension Treatment|Other than above|0|||
42065172|NCT00811395|75874106|FG004|Extension Treatment|Other than above|0|||
42065173|NCT00811395|75874107|FG005|Extension Treatment|Other than above|0|||
42065174|NCT00955409|75874134|FG000|Overall Study|Lack of Efficacy|1|||
42065175|NCT00955409|75874135|FG001|Overall Study|Lack of Efficacy|0|||
42065176|NCT00955409|75874136|FG002|Overall Study|Lack of Efficacy|0|||
42065177|NCT00955409|75874137|FG003|Overall Study|Lack of Efficacy|0|||
42065178|NCT00955409|75874138|FG004|Overall Study|Lack of Efficacy|0|||
42065179|NCT00955409|75874139|FG005|Overall Study|Lack of Efficacy|0|||
42065180|NCT00955409|75874140|FG006|Overall Study|Lack of Efficacy|0|||
42065181|NCT00955409|75874141|FG007|Overall Study|Lack of Efficacy|0|||
42065182|NCT00955409|75874142|FG008|Overall Study|Lack of Efficacy|0|||
42065183|NCT00955409|75874143|FG009|Overall Study|Lack of Efficacy|0|||
42065184|NCT00955409|75874134|FG000|Overall Study|Withdrawal by Subject|1|||
42065185|NCT00955409|75874135|FG001|Overall Study|Withdrawal by Subject|0|||
42065186|NCT00955409|75874136|FG002|Overall Study|Withdrawal by Subject|5|||
42065187|NCT00955409|75874137|FG003|Overall Study|Withdrawal by Subject|2|||
42065188|NCT00955409|75874138|FG004|Overall Study|Withdrawal by Subject|0|||
42065189|NCT00955409|75874139|FG005|Overall Study|Withdrawal by Subject|0|||
42065190|NCT00955409|75874140|FG006|Overall Study|Withdrawal by Subject|2|||
42065191|NCT00955409|75874141|FG007|Overall Study|Withdrawal by Subject|0|||
42065192|NCT00955409|75874142|FG008|Overall Study|Withdrawal by Subject|1|||
42065193|NCT00955409|75874143|FG009|Overall Study|Withdrawal by Subject|0|||
42065194|NCT00955409|75874134|FG000|Overall Study|Caregiver Request|2|||
42065195|NCT00955409|75874135|FG001|Overall Study|Caregiver Request|0|||
42065196|NCT00955409|75874136|FG002|Overall Study|Caregiver Request|6|||
42065197|NCT00955409|75874137|FG003|Overall Study|Caregiver Request|5|||
42065198|NCT00955409|75874138|FG004|Overall Study|Caregiver Request|0|||
42065199|NCT00955409|75874139|FG005|Overall Study|Caregiver Request|2|||
42065200|NCT00955409|75874140|FG006|Overall Study|Caregiver Request|3|||
42065201|NCT00955409|75874141|FG007|Overall Study|Caregiver Request|1|||
42065202|NCT00955409|75874142|FG008|Overall Study|Caregiver Request|3|||
42065203|NCT00955409|75874143|FG009|Overall Study|Caregiver Request|0|||
42065204|NCT00955409|75874134|FG000|Overall Study|Investigator Request|0|||
42065205|NCT00955409|75874135|FG001|Overall Study|Investigator Request|0|||
42065206|NCT00955409|75874136|FG002|Overall Study|Investigator Request|1|||
42065207|NCT00955409|75874137|FG003|Overall Study|Investigator Request|0|||
42065208|NCT00955409|75874138|FG004|Overall Study|Investigator Request|0|||
42065209|NCT00955409|75874139|FG005|Overall Study|Investigator Request|0|||
42065210|NCT00955409|75874140|FG006|Overall Study|Investigator Request|0|||
42065211|NCT00955409|75874141|FG007|Overall Study|Investigator Request|0|||
42065212|NCT00955409|75874142|FG008|Overall Study|Investigator Request|0|||
42065213|NCT00955409|75874143|FG009|Overall Study|Investigator Request|0|||
42175125|NCT03149549|75982027|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
42175126|NCT03149549|75982028|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
42175127|NCT03149549|75982029|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
42175128|NCT03149549|75982030|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
42175129|NCT03149549|75982018|FG000|Study Discontinuation--Treatment Period|Other|0|||
42065214|NCT00955409|75874134|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
42175130|NCT03149549|75982019|FG001|Study Discontinuation--Treatment Period|Other|0|||
42175131|NCT03149549|75982020|FG002|Study Discontinuation--Treatment Period|Other|0|||
42357453|NCT01387269|76202876|FG000|Overall Study|Lost to Follow-up|1|||
42065215|NCT00955409|75874135|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
42065216|NCT00955409|75874136|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
42065217|NCT00955409|75874137|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
42065218|NCT00955409|75874138|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
42065219|NCT00955409|75874139|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
42065220|NCT00955409|75874140|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
42065221|NCT00955409|75874141|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
42065222|NCT00955409|75874142|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
42065223|NCT00955409|75874143|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
42065224|NCT00955409|75874134|FG000|Overall Study|Lost to Follow-up|0|||
42175132|NCT03149549|75982021|FG003|Study Discontinuation--Treatment Period|Other|0|||
42175133|NCT03149549|75982022|FG004|Study Discontinuation--Treatment Period|Other|0|||
42175134|NCT03149549|75982023|FG005|Study Discontinuation--Treatment Period|Other|0|||
42175135|NCT03149549|75982024|FG006|Study Discontinuation--Treatment Period|Other|0|||
42175136|NCT03149549|75982025|FG007|Study Discontinuation--Treatment Period|Other|1|||
42175137|NCT03149549|75982026|FG008|Study Discontinuation--Treatment Period|Other|0|||
42175138|NCT03149549|75982027|FG009|Study Discontinuation--Treatment Period|Other|1|||
42175139|NCT03149549|75982028|FG010|Study Discontinuation--Treatment Period|Other|0|||
42175140|NCT03149549|75982029|FG011|Study Discontinuation--Treatment Period|Other|0|||
42175141|NCT03149549|75982030|FG012|Study Discontinuation--Treatment Period|Other|0|||
42175142|NCT03149549|75982018|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
42175143|NCT03149549|75982019|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
42175144|NCT03149549|75982020|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
42175145|NCT03149549|75982021|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
42175146|NCT03149549|75982022|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
42175147|NCT03149549|75982023|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
42175148|NCT03149549|75982024|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
42175149|NCT03149549|75982025|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
42175150|NCT03149549|75982026|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
42175151|NCT03149549|75982027|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
42175152|NCT03149549|75982028|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
42175153|NCT03149549|75982029|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
42175154|NCT03149549|75982030|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
42175155|NCT03149549|75982018|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
42175156|NCT03149549|75982019|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
42175157|NCT03149549|75982020|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
42175158|NCT03149549|75982021|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
42175159|NCT03149549|75982022|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
42175160|NCT03149549|75982023|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
42175161|NCT03149549|75982024|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
42175162|NCT03149549|75982025|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
42175163|NCT03149549|75982026|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
42175164|NCT03149549|75982027|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
42175165|NCT03149549|75982028|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
42175166|NCT03149549|75982029|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
42175167|NCT03149549|75982030|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
42175168|NCT03149549|75982018|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
42175169|NCT03149549|75982019|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
42175170|NCT03149549|75982020|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
42175171|NCT03149549|75982021|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
42175172|NCT03149549|75982022|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
42175173|NCT03149549|75982023|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
42175174|NCT03149549|75982024|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
42175175|NCT03149549|75982025|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
42175176|NCT03149549|75982026|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
42175177|NCT03149549|75982027|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
42175178|NCT03149549|75982028|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
42175179|NCT03149549|75982029|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
42175180|NCT03149549|75982030|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
42175181|NCT03149549|75982018|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
42175182|NCT03149549|75982019|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
42175183|NCT03149549|75982020|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
42175184|NCT03149549|75982021|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
42175185|NCT03149549|75982022|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
42175186|NCT03149549|75982023|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
42175187|NCT03149549|75982024|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
42175188|NCT03149549|75982025|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
42175189|NCT03149549|75982026|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
42175190|NCT03149549|75982027|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
42292212|NCT03755518|76125967|FG000|Overall Study|Physician Decision|1|||
42065225|NCT00955409|75874135|FG001|Overall Study|Lost to Follow-up|0|||
42065226|NCT00955409|75874136|FG002|Overall Study|Lost to Follow-up|1|||
42065227|NCT00955409|75874137|FG003|Overall Study|Lost to Follow-up|0|||
42065228|NCT00955409|75874138|FG004|Overall Study|Lost to Follow-up|0|||
42065229|NCT00955409|75874139|FG005|Overall Study|Lost to Follow-up|0|||
42065230|NCT00955409|75874140|FG006|Overall Study|Lost to Follow-up|1|||
42065231|NCT00955409|75874141|FG007|Overall Study|Lost to Follow-up|0|||
42065232|NCT00955409|75874142|FG008|Overall Study|Lost to Follow-up|0|||
42065233|NCT00955409|75874143|FG009|Overall Study|Lost to Follow-up|0|||
42065234|NCT00955409|75874134|FG000|Overall Study|Failed to Return|2|||
42065235|NCT00955409|75874135|FG001|Overall Study|Failed to Return|0|||
42065236|NCT00955409|75874136|FG002|Overall Study|Failed to Return|0|||
42065237|NCT00955409|75874137|FG003|Overall Study|Failed to Return|0|||
42065238|NCT00955409|75874138|FG004|Overall Study|Failed to Return|0|||
42065239|NCT00955409|75874139|FG005|Overall Study|Failed to Return|0|||
42065240|NCT00955409|75874140|FG006|Overall Study|Failed to Return|0|||
42065241|NCT00955409|75874141|FG007|Overall Study|Failed to Return|2|||
42065242|NCT00955409|75874142|FG008|Overall Study|Failed to Return|0|||
42065243|NCT00955409|75874143|FG009|Overall Study|Failed to Return|0|||
42065244|NCT00955409|75874134|FG000|Overall Study|Adverse Event (AE)|2|||
42065245|NCT00955409|75874135|FG001|Overall Study|Adverse Event (AE)|0|||
42065246|NCT00955409|75874136|FG002|Overall Study|Adverse Event (AE)|0|||
42357454|NCT01387269|76202877|FG001|Overall Study|Lost to Follow-up|0|||
42357455|NCT01859143|76202885|FG000|Overall Study|Lost to Follow-up|2|||
42357456|NCT01859143|76202886|FG001|Overall Study|Lost to Follow-up|0|||
42357457|NCT01878253|76202893|FG000|Overall Study|Death|1|||
42357458|NCT01878253|76202893|FG000|Overall Study|SIdus System Removal|3|||
42357459|NCT01878253|76202893|FG000|Overall Study|Withdrawal by Subject|1|||
42357460|NCT01878253|76202893|FG000|Overall Study|Lost to Follow-up|2|||
42357461|NCT01878253|76202893|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
42357462|NCT01878175|76202902|FG000|Overall Study|Developed contraindicated health problem|2|||
42357463|NCT01878097|76202909|FG000|Baseline|Surveys not fully completed|2497|||
42357464|NCT01878097|76202910|FG001|Baseline|Surveys not fully completed|1800|||
42357465|NCT01878097|76202909|FG000|Implementation Year 1|Surveys not fully completed|3202|||
42357466|NCT01878097|76202910|FG001|Implementation Year 1|Surveys not fully completed|2549|||
42357467|NCT01878097|76202909|FG000|Implementation Year 2|Surveys not fully completed|3281|||
42357468|NCT01878097|76202910|FG001|Implementation Year 2|Surveys not fully completed|2841|||
42357469|NCT01878097|76202909|FG000|Implementation Year 3|Surveys not fully completed|3494|||
42357470|NCT01878097|76202910|FG001|Implementation Year 3|Surveys not fully completed|2980|||
42357471|NCT01878097|76202909|FG000|Implementation Year 4|Surveys not fully completed|3604|||
42357472|NCT01878097|76202910|FG001|Implementation Year 4|Surveys not fully completed|3007|||
42357473|NCT01750190|76202918|FG000|Overall Study|Adverse Event|47|||
42357474|NCT01750190|76202919|FG001|Overall Study|Adverse Event|19|||
42357475|NCT01750190|76202918|FG000|Overall Study|Death|38|||
42357476|NCT01750190|76202919|FG001|Overall Study|Death|11|||
42357477|NCT01750190|76202918|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
42357478|NCT01750190|76202919|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
42357479|NCT01750190|76202918|FG000|Overall Study|Lost to Follow-up|28|||
42357480|NCT01750190|76202919|FG001|Overall Study|Lost to Follow-up|7|||
42357481|NCT01750190|76202918|FG000|Overall Study|Physician Decision|16|||
42357482|NCT01750190|76202919|FG001|Overall Study|Physician Decision|17|||
42357483|NCT01750190|76202918|FG000|Overall Study|Protocol Violation|6|||
42357484|NCT01750190|76202919|FG001|Overall Study|Protocol Violation|5|||
42357485|NCT01750190|76202918|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
42357486|NCT01750190|76202919|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
42065247|NCT00955409|75874137|FG003|Overall Study|Adverse Event (AE)|0|||
42065248|NCT00955409|75874138|FG004|Overall Study|Adverse Event (AE)|0|||
42065249|NCT00955409|75874139|FG005|Overall Study|Adverse Event (AE)|1|||
42065250|NCT00955409|75874140|FG006|Overall Study|Adverse Event (AE)|2|||
42065251|NCT00955409|75874141|FG007|Overall Study|Adverse Event (AE)|0|||
42175191|NCT03149549|75982028|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
42175192|NCT03149549|75982029|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
42175193|NCT03149549|75982030|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
42357487|NCT01750190|76202918|FG000|Overall Study|Withdrawal by Subject|83|||
42357488|NCT01750190|76202919|FG001|Overall Study|Withdrawal by Subject|89|||
42357489|NCT01750190|76202918|FG000|Overall Study|Kidney Transplant|8|||
42357490|NCT01750190|76202919|FG001|Overall Study|Kidney Transplant|4|||
42357491|NCT01750190|76202918|FG000|Overall Study|Dialysis|22|||
42357492|NCT01750190|76202919|FG001|Overall Study|Dialysis|8|||
42065252|NCT00955409|75874142|FG008|Overall Study|Adverse Event (AE)|2|||
42065253|NCT00955409|75874143|FG009|Overall Study|Adverse Event (AE)|0|||
42065254|NCT00955409|75874134|FG000|Overall Study|Reason not Specified|2|||
42065255|NCT00955409|75874135|FG001|Overall Study|Reason not Specified|1|||
42065256|NCT00955409|75874136|FG002|Overall Study|Reason not Specified|13|||
42065257|NCT00955409|75874137|FG003|Overall Study|Reason not Specified|1|||
42065258|NCT00955409|75874138|FG004|Overall Study|Reason not Specified|2|||
42065259|NCT00955409|75874139|FG005|Overall Study|Reason not Specified|0|||
42065260|NCT00955409|75874140|FG006|Overall Study|Reason not Specified|16|||
42065261|NCT00955409|75874141|FG007|Overall Study|Reason not Specified|0|||
42065262|NCT00955409|75874142|FG008|Overall Study|Reason not Specified|8|||
42065263|NCT00955409|75874143|FG009|Overall Study|Reason not Specified|1|||
42065264|NCT00615901|75874169|FG000|Overall Study|Withdrawal by Subject|2|||
42065265|NCT00615901|75874169|FG000|Overall Study|Adverse Event|7|||
42065266|NCT00616603|75874181|FG000|Overall Study|Physician Decision|2|||
42065267|NCT00616603|75874182|FG001|Overall Study|Physician Decision|0|||
42065268|NCT00616603|75874183|FG002|Overall Study|Physician Decision|2|||
42065269|NCT00573313|75874195|FG000|Overall Study|Protocol Violation|5|||
42065270|NCT00573313|75874196|FG001|Overall Study|Protocol Violation|0|||
42065271|NCT00573313|75874197|FG002|Overall Study|Protocol Violation|6|||
42065272|NCT00573313|75874198|FG003|Overall Study|Protocol Violation|0|||
42065273|NCT00953615|75874205|FG000|Overall Study|Adverse Event|1|||
42065274|NCT00810615|75874211|FG000|Overall Study|Withdrawal by Subject|1|||
42065275|NCT00810615|75874212|FG001|Overall Study|Withdrawal by Subject|1|||
42065276|NCT00573391|75874232|FG000|Overall Study|study stopped|2|||
42065277|NCT00573391|75874233|FG001|Overall Study|study stopped|2|||
42065278|NCT00573391|75874232|FG000|Overall Study|Death|1|||
42065279|NCT00573391|75874233|FG001|Overall Study|Death|0|||
42065280|NCT00590967|75874241|FG000|Overall Study|Withdrawal by Subject|1|||
42065281|NCT00590967|75874242|FG001|Overall Study|Withdrawal by Subject|1|||
42065282|NCT00590967|75874241|FG000|Overall Study|Ineligible|1|||
42065283|NCT00590967|75874242|FG001|Overall Study|Ineligible|0|||
42065284|NCT00590967|75874241|FG000|Overall Study|Poor performance status|0|||
42065285|NCT00590967|75874242|FG001|Overall Study|Poor performance status|1|||
42065286|NCT00590967|75874241|FG000|Overall Study|Non-compliant|0|||
42065287|NCT00590967|75874242|FG001|Overall Study|Non-compliant|2|||
42065288|NCT00590967|75874241|FG000|Overall Study|Did not sign consent form|0|||
42065289|NCT00590967|75874242|FG001|Overall Study|Did not sign consent form|1|||
42065290|NCT00590967|75874241|FG000|Overall Study|Did not receive chemo per protocol|1|||
42065291|NCT00590967|75874242|FG001|Overall Study|Did not receive chemo per protocol|0|||
42065292|NCT05102162|75874271|FG000|Overall Study|Withdrawal by Subject|3|||
42065293|NCT05102162|75874272|FG001|Overall Study|Withdrawal by Subject|0|||
42065294|NCT05102162|75874271|FG000|Overall Study|Baseline cultures negative|4|||
42065295|NCT05102162|75874272|FG001|Overall Study|Baseline cultures negative|2|||
42065296|NCT05102162|75874271|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
42065297|NCT05102162|75874272|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
42065298|NCT05102162|75874271|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
42065299|NCT05102162|75874272|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
42065300|NCT04899349|75874280|FG000|Overall Study|Study terminated by Sponsor|2|||
42065301|NCT04899349|75874281|FG001|Overall Study|Study terminated by Sponsor|0|||
42065302|NCT04891107|75874287|FG000|Overall Study|Physician Decision|1|||
42065303|NCT04891107|75874287|FG000|Overall Study|Withdrawal by Subject|1|||
42065304|NCT04891107|75874287|FG000|Overall Study|Screen failure after consent|1|||
42065305|NCT04848220|75874294|FG000|Overall Study|Unable to proceed to study procedure|0|||
42065306|NCT04848220|75874295|FG001|Overall Study|Unable to proceed to study procedure|1|||
42065307|NCT04848220|75874296|FG002|Overall Study|Unable to proceed to study procedure|0|||
42065308|NCT04848220|75874294|FG000|Overall Study|Fractional flow not significant|0|||
42065309|NCT04848220|75874295|FG001|Overall Study|Fractional flow not significant|1|||
42065310|NCT04848220|75874296|FG002|Overall Study|Fractional flow not significant|0|||
42065311|NCT04743804|75874306|FG000|Overall Study|Other|1|||
42065312|NCT04743804|75874307|FG001|Overall Study|Other|0|||
42065313|NCT04743804|75874306|FG000|Overall Study|Withdrawal by Subject|0|||
42065314|NCT04743804|75874307|FG001|Overall Study|Withdrawal by Subject|1|||
42065315|NCT04743804|75874306|FG000|Overall Study|Study Terminated by Sponsor|1|||
42065316|NCT04743804|75874307|FG001|Overall Study|Study Terminated by Sponsor|4|||
42065317|NCT04743804|75874306|FG000|Overall Study|Physician Decision|0|||
42065318|NCT04743804|75874307|FG001|Overall Study|Physician Decision|1|||
42065319|NCT04743804|75874306|FG000|Overall Study|Death|3|||
42065320|NCT04743804|75874307|FG001|Overall Study|Death|0|||
42065321|NCT04659161|75874315|FG000|Overall Study|Adverse Event|10|||
42065322|NCT04659161|75874316|FG001|Overall Study|Adverse Event|6|||
42065323|NCT04659161|75874315|FG000|Overall Study|Withdrawal by Subject|13|||
42065324|NCT04659161|75874316|FG001|Overall Study|Withdrawal by Subject|12|||
42065325|NCT04659161|75874315|FG000|Overall Study|Other|9|||
42065326|NCT04659161|75874316|FG001|Overall Study|Other|8|||
42065327|NCT04640766|75874322|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
42065328|NCT04214288|75874330|FG000|Overall Study|Ongoing in the study|41|||
42065329|NCT04214288|75874331|FG001|Overall Study|Ongoing in the study|51|||
42065330|NCT04214288|75874332|FG002|Overall Study|Ongoing in the study|12|||
42065331|NCT04214288|75874333|FG003|Overall Study|Ongoing in the study|39|||
42065332|NCT04214288|75874330|FG000|Overall Study|Adverse Event|1|||
42065333|NCT04214288|75874331|FG001|Overall Study|Adverse Event|0|||
42065334|NCT04214288|75874332|FG002|Overall Study|Adverse Event|0|||
42065335|NCT04214288|75874333|FG003|Overall Study|Adverse Event|0|||
42065336|NCT04214288|75874330|FG000|Overall Study|Death|22|||
42065337|NCT04214288|75874331|FG001|Overall Study|Death|13|||
42065338|NCT04214288|75874332|FG002|Overall Study|Death|7|||
42065339|NCT04214288|75874333|FG003|Overall Study|Death|19|||
42065340|NCT04214288|75874330|FG000|Overall Study|Lost to Follow-up|1|||
42065341|NCT04214288|75874331|FG001|Overall Study|Lost to Follow-up|2|||
42065342|NCT04214288|75874332|FG002|Overall Study|Lost to Follow-up|1|||
42065343|NCT04214288|75874333|FG003|Overall Study|Lost to Follow-up|0|||
42065344|NCT04214288|75874330|FG000|Overall Study|Other|1|||
42065345|NCT04214288|75874331|FG001|Overall Study|Other|2|||
42065346|NCT04214288|75874332|FG002|Overall Study|Other|0|||
42065347|NCT04214288|75874333|FG003|Overall Study|Other|6|||
42065348|NCT04214288|75874330|FG000|Overall Study|Protocol Violation|0|||
42065349|NCT04214288|75874331|FG001|Overall Study|Protocol Violation|1|||
42065350|NCT04214288|75874332|FG002|Overall Study|Protocol Violation|0|||
42065351|NCT04214288|75874333|FG003|Overall Study|Protocol Violation|0|||
42065352|NCT04214288|75874330|FG000|Overall Study|Withdrawal by Subject|8|||
42065353|NCT04214288|75874331|FG001|Overall Study|Withdrawal by Subject|4|||
42065354|NCT04214288|75874332|FG002|Overall Study|Withdrawal by Subject|0|||
42065355|NCT04214288|75874333|FG003|Overall Study|Withdrawal by Subject|9|||
42065356|NCT04118166|75874343|FG000|Overall Study|Adverse Event|1|||
42065357|NCT04034251|75874395|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
42065358|NCT04034251|75874396|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
42065359|NCT04034251|75874397|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
42065360|NCT03783078|75874407|FG000|Overall Study|Participants Ongoing|29|||
42065361|NCT03783078|75874407|FG000|Overall Study|Death|26|||
42065362|NCT03778294|75874411|FG000|Overall Study|Death|1|||
42065363|NCT03778294|75874411|FG000|Overall Study|Issues with insurance|1|||
42065364|NCT03778294|75874411|FG000|Overall Study|disease progression before treatment|2|||
42065365|NCT03662542|75874422|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
42065366|NCT03662542|75874423|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
42065367|NCT03662542|75874424|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
42065368|NCT03662542|75874425|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
42065369|NCT03662542|75874426|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
42065370|NCT03662542|75874427|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
42065371|NCT03662542|75874428|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
42065372|NCT03662542|75874429|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
42065373|NCT03662542|75874430|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
42065374|NCT03662542|75874422|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
42065375|NCT03662542|75874423|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
42065376|NCT03662542|75874424|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
42065377|NCT03662542|75874425|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
42065378|NCT03662542|75874426|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
42065379|NCT03662542|75874427|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
42065380|NCT03662542|75874428|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
42065381|NCT03662542|75874429|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
42065382|NCT03662542|75874430|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
42065383|NCT03662542|75874422|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
42292213|NCT03755518|76125967|FG000|Overall Study|Withdrawal by investigator for non compliance|1|||
42292214|NCT03739112|76125973|FG000|Overall Study|Adverse Event|2|||
42292215|NCT03739112|76125974|FG001|Overall Study|Adverse Event|2|||
42292216|NCT03739112|76125973|FG000|Overall Study|Withdrawal by Subject|38|||
42292217|NCT03739112|76125974|FG001|Overall Study|Withdrawal by Subject|19|||
42016783|NCT00927901|75824344|FG003|Treatment Period 4|Adverse Event|1|||
42016784|NCT00927901|75824341|FG000|Treatment Period 4|Subject withdrew consent|0|||
42065384|NCT03662542|75874423|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
42065385|NCT03662542|75874424|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
42292218|NCT03739112|76125973|FG000|Overall Study|Lost to Follow-up|31|||
42292219|NCT03739112|76125974|FG001|Overall Study|Lost to Follow-up|33|||
42292220|NCT03739112|76125973|FG000|Overall Study|Protocol Deviation|12|||
42016785|NCT00927901|75824342|FG001|Treatment Period 4|Subject withdrew consent|0|||
42016786|NCT00927901|75824343|FG002|Treatment Period 4|Subject withdrew consent|1|||
42016787|NCT00927901|75824344|FG003|Treatment Period 4|Subject withdrew consent|0|||
42016788|NCT01218204|75824359|FG000|Part B Washout|Adverse Event|0|||
42016789|NCT01218204|75824360|FG001|Part B Washout|Adverse Event|1|||
42016790|NCT01218204|75824361|FG002|Part B Washout|Adverse Event|0|||
42016791|NCT01218204|75824362|FG003|Part B Washout|Adverse Event|0|||
42016792|NCT01218204|75824359|FG000|Part B Washout|Lost to Follow-up|0|||
42016793|NCT01218204|75824360|FG001|Part B Washout|Lost to Follow-up|2|||
42065386|NCT03662542|75874425|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
42065387|NCT03662542|75874426|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
42065388|NCT03662542|75874427|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
42065389|NCT03662542|75874428|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
42065390|NCT03662542|75874429|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
42065391|NCT03662542|75874430|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
42065392|NCT03662542|75874422|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
42065393|NCT03662542|75874423|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
42065394|NCT03662542|75874424|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
42065395|NCT03662542|75874425|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
42292221|NCT03739112|76125974|FG001|Overall Study|Protocol Deviation|9|||
42292222|NCT03739112|76125973|FG000|Overall Study|Physician Decision|1|||
42292223|NCT03739112|76125974|FG001|Overall Study|Physician Decision|0|||
42016794|NCT01218204|75824361|FG002|Part B Washout|Lost to Follow-up|0|||
42016795|NCT01218204|75824362|FG003|Part B Washout|Lost to Follow-up|0|||
42016796|NCT01218204|75824359|FG000|Part B Washout|Physician Decision|0|||
42016797|NCT01218204|75824360|FG001|Part B Washout|Physician Decision|14|||
42016798|NCT01218204|75824361|FG002|Part B Washout|Physician Decision|0|||
42016799|NCT01218204|75824362|FG003|Part B Washout|Physician Decision|0|||
42016800|NCT01218204|75824359|FG000|Part B Washout|Withdrawal by Subject|0|||
42016801|NCT01218204|75824360|FG001|Part B Washout|Withdrawal by Subject|14|||
42016802|NCT01218204|75824361|FG002|Part B Washout|Withdrawal by Subject|0|||
42016803|NCT01218204|75824362|FG003|Part B Washout|Withdrawal by Subject|0|||
42016804|NCT01218204|75824359|FG000|Part B Washout|Reached defined stopping criteria|0|||
42016805|NCT01218204|75824360|FG001|Part B Washout|Reached defined stopping criteria|2|||
42016806|NCT01218204|75824361|FG002|Part B Washout|Reached defined stopping criteria|0|||
42016807|NCT01218204|75824362|FG003|Part B Washout|Reached defined stopping criteria|0|||
42016808|NCT01218204|75824359|FG000|Part B Washout|Did not meet continuation criteria|0|||
42016809|NCT01218204|75824360|FG001|Part B Washout|Did not meet continuation criteria|112|||
42016810|NCT01218204|75824361|FG002|Part B Washout|Did not meet continuation criteria|0|||
42016811|NCT01218204|75824362|FG003|Part B Washout|Did not meet continuation criteria|0|||
42016812|NCT01218204|75824359|FG000|Part B Run-in|Adverse Event|0|||
42016813|NCT01218204|75824360|FG001|Part B Run-in|Adverse Event|0|||
42016814|NCT01218204|75824361|FG002|Part B Run-in|Adverse Event|1|||
42016815|NCT01218204|75824362|FG003|Part B Run-in|Adverse Event|0|||
42016816|NCT01218204|75824359|FG000|Part B Run-in|Protocol Violation|0|||
42016817|NCT01218204|75824360|FG001|Part B Run-in|Protocol Violation|0|||
42016818|NCT01218204|75824361|FG002|Part B Run-in|Protocol Violation|2|||
42016819|NCT01218204|75824362|FG003|Part B Run-in|Protocol Violation|0|||
42016820|NCT01218204|75824359|FG000|Part B Run-in|Withdrawal by Subject|0|||
42016821|NCT01218204|75824360|FG001|Part B Run-in|Withdrawal by Subject|0|||
42016822|NCT01218204|75824361|FG002|Part B Run-in|Withdrawal by Subject|3|||
42016823|NCT01218204|75824362|FG003|Part B Run-in|Withdrawal by Subject|0|||
42016824|NCT01218204|75824359|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
42016825|NCT01218204|75824360|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
42016826|NCT01218204|75824361|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
42016827|NCT01218204|75824362|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
42016828|NCT01218204|75824359|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
42016829|NCT01218204|75824360|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
42016830|NCT01218204|75824361|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
42016831|NCT01218204|75824362|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
42016832|NCT00926575|75824411|FG000|Overall Study|Adverse Event|1|||
42016833|NCT00926575|75824412|FG001|Overall Study|Adverse Event|1|||
42016834|NCT00926575|75824411|FG000|Overall Study|Death|4|||
42016835|NCT00926575|75824412|FG001|Overall Study|Death|4|||
42016836|NCT00926575|75824411|FG000|Overall Study|Lost to Follow-up|1|||
42016837|NCT00926575|75824412|FG001|Overall Study|Lost to Follow-up|1|||
42016838|NCT00926575|75824411|FG000|Overall Study|Physician Decision|1|||
42016839|NCT00926575|75824412|FG001|Overall Study|Physician Decision|2|||
42016840|NCT00926575|75824411|FG000|Overall Study|Protocol Violation|1|||
42016841|NCT00926575|75824412|FG001|Overall Study|Protocol Violation|0|||
42016842|NCT00926575|75824411|FG000|Overall Study|Withdrawal by Subject|8|||
42016843|NCT00926575|75824412|FG001|Overall Study|Withdrawal by Subject|9|||
42016844|NCT01218126|75824422|FG000|Overall Study|Adverse Event|8|||
42016845|NCT01218126|75824423|FG001|Overall Study|Adverse Event|10|||
42016846|NCT01218126|75824424|FG002|Overall Study|Adverse Event|12|||
42016847|NCT01218126|75824425|FG003|Overall Study|Adverse Event|16|||
42016848|NCT01218126|75824422|FG000|Overall Study|Lack of Efficacy|7|||
42016849|NCT01218126|75824423|FG001|Overall Study|Lack of Efficacy|2|||
42016850|NCT01218126|75824424|FG002|Overall Study|Lack of Efficacy|2|||
42016851|NCT01218126|75824425|FG003|Overall Study|Lack of Efficacy|6|||
42016852|NCT01218126|75824422|FG000|Overall Study|Protocol Violation|5|||
42016853|NCT01218126|75824423|FG001|Overall Study|Protocol Violation|2|||
42016854|NCT01218126|75824424|FG002|Overall Study|Protocol Violation|2|||
42016855|NCT01218126|75824425|FG003|Overall Study|Protocol Violation|3|||
42016856|NCT01218126|75824422|FG000|Overall Study|Protocol-defined stopping criteria|1|||
42065396|NCT03662542|75874426|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
42065397|NCT03662542|75874427|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
42065398|NCT03662542|75874428|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
42065399|NCT03662542|75874429|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
42065400|NCT03662542|75874430|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
42065401|NCT03662542|75874422|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
42065402|NCT03662542|75874423|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
42065403|NCT03662542|75874424|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
42065404|NCT03662542|75874425|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
42065405|NCT03662542|75874426|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
42065406|NCT03662542|75874427|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
42065407|NCT03662542|75874428|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
42065408|NCT03662542|75874429|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
42065409|NCT03662542|75874430|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
42065410|NCT03662542|75874422|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
42065411|NCT03662542|75874423|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
42065412|NCT03662542|75874424|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
42065413|NCT03662542|75874425|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
42065414|NCT03662542|75874426|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
42065415|NCT03662542|75874427|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
42065416|NCT03662542|75874428|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
42065417|NCT03662542|75874429|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
42065418|NCT03662542|75874430|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
42065419|NCT03662542|75874422|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
42065420|NCT03662542|75874423|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
42065421|NCT03662542|75874424|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
42065422|NCT03662542|75874425|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
42065423|NCT03662542|75874426|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
42065424|NCT03662542|75874427|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
42065425|NCT03662542|75874428|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
42065426|NCT03662542|75874429|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
42065427|NCT03662542|75874430|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
42065428|NCT03662542|75874422|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
42065429|NCT03662542|75874423|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
42065430|NCT03662542|75874424|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
42065431|NCT03662542|75874425|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
42065432|NCT03662542|75874426|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
42065433|NCT03662542|75874427|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
42065434|NCT03662542|75874428|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
42065435|NCT03662542|75874429|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
42065436|NCT03662542|75874430|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
42065437|NCT03662542|75874422|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
42065438|NCT03662542|75874423|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
42065439|NCT03662542|75874424|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
42065440|NCT03662542|75874425|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
42065441|NCT03662542|75874426|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
42065442|NCT03662542|75874427|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
42065443|NCT03662542|75874428|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
42065444|NCT03662542|75874429|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
42065445|NCT03662542|75874430|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
42065446|NCT03662542|75874422|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
42065447|NCT03662542|75874423|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
42065448|NCT03662542|75874424|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
42065449|NCT03662542|75874425|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
42065450|NCT03662542|75874426|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
42065451|NCT03662542|75874427|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
42065452|NCT03662542|75874428|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
42065453|NCT03662542|75874429|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
42065454|NCT03662542|75874430|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
42065455|NCT03662542|75874422|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
42065456|NCT03662542|75874423|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
42065457|NCT03662542|75874424|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
42065458|NCT03662542|75874425|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
42065459|NCT03662542|75874426|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
42065460|NCT03662542|75874427|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
42065461|NCT03662542|75874428|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
42065462|NCT03662542|75874429|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
42065463|NCT03662542|75874430|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
42065464|NCT03662542|75874422|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
42065465|NCT03662542|75874423|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
42065466|NCT03662542|75874424|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
42065467|NCT03662542|75874425|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
42065468|NCT03662542|75874426|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
42065469|NCT03662542|75874427|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
42065470|NCT03662542|75874428|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
42065471|NCT03662542|75874429|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
42065472|NCT03662542|75874430|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
42065473|NCT03662542|75874422|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
42065474|NCT03662542|75874423|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
42065475|NCT03662542|75874424|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
42065476|NCT03662542|75874425|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
42065477|NCT03662542|75874426|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
42065478|NCT03662542|75874427|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
42065479|NCT03662542|75874428|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
42065480|NCT03662542|75874429|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
42065481|NCT03662542|75874430|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
42065482|NCT03555591|75874453|FG000|Overall Study|Protocol Violation|77|||
42065483|NCT03525392|75874462|FG000|Overall Study|Adverse Event|1|||
42065484|NCT03525392|75874463|FG001|Overall Study|Adverse Event|0|||
42065485|NCT03525392|75874464|FG002|Overall Study|Adverse Event|2|||
42065486|NCT03525392|75874465|FG003|Overall Study|Adverse Event|0|||
42065487|NCT03525392|75874466|FG004|Overall Study|Adverse Event|0|||
42065488|NCT03525392|75874462|FG000|Overall Study|Progressive disease|0|||
42065489|NCT03525392|75874463|FG001|Overall Study|Progressive disease|1|||
42065490|NCT03525392|75874464|FG002|Overall Study|Progressive disease|1|||
42065491|NCT03525392|75874465|FG003|Overall Study|Progressive disease|3|||
42065492|NCT03525392|75874466|FG004|Overall Study|Progressive disease|1|||
42065493|NCT03496662|75874482|FG000|Overall Study|Adverse Event|1|||
42065494|NCT03496662|75874483|FG001|Overall Study|Adverse Event|0|||
42065495|NCT03496662|75874484|FG002|Overall Study|Adverse Event|1|||
42065496|NCT03496662|75874482|FG000|Overall Study|Physician Decision|1|||
42065497|NCT03496662|75874483|FG001|Overall Study|Physician Decision|0|||
42065498|NCT03496662|75874484|FG002|Overall Study|Physician Decision|3|||
42065499|NCT03496662|75874482|FG000|Overall Study|Withdrawal by Subject|0|||
42065500|NCT03496662|75874483|FG001|Overall Study|Withdrawal by Subject|0|||
42065501|NCT03496662|75874484|FG002|Overall Study|Withdrawal by Subject|2|||
42065502|NCT03496662|75874482|FG000|Overall Study|Death|0|||
42065503|NCT03496662|75874483|FG001|Overall Study|Death|0|||
42065504|NCT03496662|75874484|FG002|Overall Study|Death|2|||
42065505|NCT03496662|75874482|FG000|Overall Study|Noncompliance|0|||
42065506|NCT03496662|75874483|FG001|Overall Study|Noncompliance|0|||
42065507|NCT03496662|75874484|FG002|Overall Study|Noncompliance|1|||
42065508|NCT03472885|75874492|FG000|24-Week Treatment Period|Adverse Event|1|||
42065509|NCT03117049|75874510|FG000|Overall Study|Continued the follow-up period|109|||
42065510|NCT03117049|75874511|FG001|Overall Study|Continued the follow-up period|129|||
42065511|NCT03117049|75874510|FG000|Overall Study|Died|82|||
42065512|NCT03117049|75874511|FG001|Overall Study|Died|93|||
42065513|NCT03117049|75874510|FG000|Overall Study|Consent withdrawal|7|||
42065514|NCT03117049|75874511|FG001|Overall Study|Consent withdrawal|6|||
42065515|NCT03117049|75874510|FG000|Overall Study|Missing contact|3|||
42065516|NCT03117049|75874511|FG001|Overall Study|Missing contact|3|||
42065517|NCT02716038|75874530|FG000|Overall Study|Not evaluable|1|||
42065518|NCT02716038|75874530|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
42065519|NCT02716038|75874530|FG000|Overall Study|Unresectable|3|||
42065520|NCT02512068|75874536|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
42065521|NCT02512068|75874537|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
42065522|NCT02512068|75874536|FG000|Overall Study|Major Protocol Deviation|1|||
42065523|NCT02512068|75874537|FG001|Overall Study|Major Protocol Deviation|0|||
42065524|NCT02512068|75874536|FG000|Overall Study|Voluntary Withdrawal|0|||
42175194|NCT03149549|75982018|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
42175195|NCT03149549|75982019|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
42065525|NCT02512068|75874537|FG001|Overall Study|Voluntary Withdrawal|1|||
42065526|NCT02512068|75874536|FG000|Overall Study|Lack of Efficacy|0|||
42065527|NCT02512068|75874537|FG001|Overall Study|Lack of Efficacy|1|||
42065528|NCT02512068|75874536|FG000|Overall Study|Reason Not Specified|3|||
42065529|NCT02512068|75874537|FG001|Overall Study|Reason Not Specified|5|||
42065530|NCT02324569|75874554|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
42065531|NCT02324569|75874555|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
42175196|NCT03149549|75982020|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
42175197|NCT03149549|75982021|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
42065532|NCT02324569|75874554|FG000|Overall Study|Voluntary Withdrawal|3|||
42065533|NCT02324569|75874555|FG001|Overall Study|Voluntary Withdrawal|6|||
42065534|NCT02324569|75874554|FG000|Overall Study|Lack of Efficacy|2|||
42065535|NCT02324569|75874555|FG001|Overall Study|Lack of Efficacy|3|||
42065536|NCT02324569|75874554|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
42065537|NCT02324569|75874555|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
42065538|NCT02324569|75874554|FG000|Overall Study|Inconvenient Schedule|2|||
42065539|NCT02324569|75874555|FG001|Overall Study|Inconvenient Schedule|0|||
42065540|NCT02038075|75874593|FG000|Overall Study|Withdrawal by Subject|3|||
42065541|NCT02038075|75874594|FG001|Overall Study|Withdrawal by Subject|0|||
42065542|NCT01864746|75874602|FG000|Overall Study|Disease recurrence|25|||
42065543|NCT01864746|75874603|FG001|Overall Study|Disease recurrence|40|||
42065544|NCT01864746|75874602|FG000|Overall Study|Second primary invasive nonbreast|2|||
42065545|NCT01864746|75874603|FG001|Overall Study|Second primary invasive nonbreast|3|||
42065546|NCT01864746|75874602|FG000|Overall Study|Death|2|||
42065547|NCT01864746|75874603|FG001|Overall Study|Death|1|||
42065548|NCT01864746|75874602|FG000|Overall Study|Adverse Event|33|||
42065549|NCT01864746|75874603|FG001|Overall Study|Adverse Event|5|||
42065550|NCT01864746|75874602|FG000|Overall Study|Withdrawal by Subject|56|||
42065551|NCT01864746|75874603|FG001|Overall Study|Withdrawal by Subject|41|||
42065552|NCT01864746|75874602|FG000|Overall Study|Physician Decision|5|||
42065553|NCT01864746|75874603|FG001|Overall Study|Physician Decision|6|||
42065554|NCT00590577|75874650|FG000|Overall Study|Lack of Efficacy|31|||
42065555|NCT00590577|75874651|FG001|Overall Study|Lack of Efficacy|28|||
42065556|NCT00590577|75874652|FG002|Overall Study|Lack of Efficacy|23|||
42065557|NCT00590577|75874653|FG003|Overall Study|Lack of Efficacy|45|||
42065558|NCT00590577|75874650|FG000|Overall Study|Withdrawal by Subject|23|||
42065559|NCT00590577|75874651|FG001|Overall Study|Withdrawal by Subject|28|||
42065560|NCT00590577|75874652|FG002|Overall Study|Withdrawal by Subject|30|||
42065561|NCT00590577|75874653|FG003|Overall Study|Withdrawal by Subject|26|||
42065562|NCT00590577|75874650|FG000|Overall Study|Adverse Event|10|||
42065563|NCT00590577|75874651|FG001|Overall Study|Adverse Event|10|||
42065564|NCT00590577|75874652|FG002|Overall Study|Adverse Event|13|||
42065565|NCT00590577|75874653|FG003|Overall Study|Adverse Event|11|||
42065566|NCT00590577|75874650|FG000|Overall Study|Lost to Follow-up|12|||
42065567|NCT00590577|75874651|FG001|Overall Study|Lost to Follow-up|6|||
42065568|NCT00590577|75874652|FG002|Overall Study|Lost to Follow-up|6|||
42065569|NCT00590577|75874653|FG003|Overall Study|Lost to Follow-up|9|||
42065570|NCT00590577|75874650|FG000|Overall Study|Pregnancy|0|||
42065571|NCT00590577|75874651|FG001|Overall Study|Pregnancy|1|||
42175198|NCT03149549|75982022|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
42175199|NCT03149549|75982023|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
42175200|NCT03149549|75982024|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
42175201|NCT03149549|75982025|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
42175202|NCT03149549|75982026|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
42175203|NCT03149549|75982027|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
42175204|NCT03149549|75982028|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
42175205|NCT03149549|75982029|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
42175206|NCT03149549|75982030|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
42175207|NCT02562235|75982072|FG000|Overall Study|Adverse Event|3|||
42175208|NCT02316340|75982083|FG000|First Progression|Clinical progression|2|||
42175209|NCT02316340|75982084|FG001|First Progression|Clinical progression|1|||
42175210|NCT02316340|75982083|FG000|First Progression|Withdrawal by Subject|1|||
42175211|NCT02316340|75982084|FG001|First Progression|Withdrawal by Subject|0|||
42175212|NCT02063724|75982090|FG000|Overall Study|Disease progression|1|||
42175213|NCT01722266|75982098|FG000|Overall Study|Withdrawal by Subject|1|||
42175214|NCT01722266|75982099|FG001|Overall Study|Withdrawal by Subject|2|||
42175215|NCT01722266|75982100|FG002|Overall Study|Withdrawal by Subject|0|||
42175216|NCT01722266|75982101|FG003|Overall Study|Withdrawal by Subject|0|||
42175217|NCT01722266|75982098|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
42175218|NCT01722266|75982099|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
42175219|NCT01722266|75982100|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
42175220|NCT01722266|75982101|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
42357493|NCT01750190|76202918|FG000|Overall Study|Other than Specified|13|||
42175221|NCT01722266|75982098|FG000|Overall Study|Dropped out due to Nausea|0|||
42175222|NCT01722266|75982099|FG001|Overall Study|Dropped out due to Nausea|0|||
42016857|NCT01218126|75824423|FG001|Overall Study|Protocol-defined stopping criteria|1|||
42016858|NCT01218126|75824424|FG002|Overall Study|Protocol-defined stopping criteria|0|||
42016859|NCT01218126|75824425|FG003|Overall Study|Protocol-defined stopping criteria|0|||
42016860|NCT01218126|75824422|FG000|Overall Study|Lost to Follow-up|0|||
42016861|NCT01218126|75824423|FG001|Overall Study|Lost to Follow-up|0|||
42016862|NCT01218126|75824424|FG002|Overall Study|Lost to Follow-up|0|||
42016863|NCT01218126|75824425|FG003|Overall Study|Lost to Follow-up|2|||
42016864|NCT01218126|75824422|FG000|Overall Study|Physician Decision|1|||
42016865|NCT01218126|75824423|FG001|Overall Study|Physician Decision|2|||
42016866|NCT01218126|75824424|FG002|Overall Study|Physician Decision|4|||
42016867|NCT01218126|75824425|FG003|Overall Study|Physician Decision|2|||
42016868|NCT01218126|75824422|FG000|Overall Study|Withdrawal by Subject|2|||
42016869|NCT01218126|75824423|FG001|Overall Study|Withdrawal by Subject|5|||
42065572|NCT00590577|75874652|FG002|Overall Study|Pregnancy|0|||
42065573|NCT00590577|75874653|FG003|Overall Study|Pregnancy|0|||
42065574|NCT00590577|75874650|FG000|Overall Study|Various reasons|1|||
42065575|NCT00590577|75874651|FG001|Overall Study|Various reasons|3|||
42065576|NCT00590577|75874652|FG002|Overall Study|Various reasons|1|||
42065577|NCT00590577|75874653|FG003|Overall Study|Various reasons|2|||
42065578|NCT00614575|75874663|FG000|Overall Study|Adverse Event|106|||
42065579|NCT00614575|75874663|FG000|Overall Study|Lost to Follow-up|55|||
42065580|NCT00614575|75874663|FG000|Overall Study|Lack of Efficacy|14|||
42065581|NCT00614575|75874663|FG000|Overall Study|Withdrawal by Subject|6|||
42065582|NCT00614575|75874663|FG000|Overall Study|Death|3|||
42065583|NCT00614575|75874663|FG000|Overall Study|Physician Decision|2|||
42065584|NCT00614575|75874663|FG000|Overall Study|No data were collected.|18|||
42065585|NCT00614575|75874663|FG000|Overall Study|Irregularly enrolled patients|23|||
42065586|NCT00614575|75874663|FG000|Overall Study|No treatment|1|||
42065587|NCT00805935|75874671|FG000|Overall Study|Stimulation Failure|1|||
42065588|NCT00805935|75874672|FG001|Overall Study|Stimulation Failure|5|||
42065589|NCT00805935|75874673|FG002|Overall Study|Stimulation Failure|2|||
42065590|NCT00805935|75874674|FG003|Overall Study|Stimulation Failure|2|||
42065591|NCT00805935|75874671|FG000|Overall Study|Cycle cancelled|0|||
42065592|NCT00805935|75874672|FG001|Overall Study|Cycle cancelled|0|||
42065593|NCT00805935|75874673|FG002|Overall Study|Cycle cancelled|2|||
42065594|NCT00805935|75874674|FG003|Overall Study|Cycle cancelled|0|||
42065595|NCT00805935|75874671|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
42065596|NCT00805935|75874672|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
42065597|NCT00805935|75874673|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
42065598|NCT00805935|75874674|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
42065599|NCT00805935|75874671|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
42065600|NCT00805935|75874672|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
42065601|NCT00805935|75874673|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
42065602|NCT00805935|75874674|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
42065603|NCT00805935|75874671|FG000|Overall Study|Lost to Follow-up|1|||
42065604|NCT00805935|75874672|FG001|Overall Study|Lost to Follow-up|0|||
42065605|NCT00805935|75874673|FG002|Overall Study|Lost to Follow-up|0|||
42065606|NCT00805935|75874674|FG003|Overall Study|Lost to Follow-up|0|||
42065607|NCT00805935|75874671|FG000|Overall Study|No positive serum pregnancy|8|||
42065608|NCT00805935|75874672|FG001|Overall Study|No positive serum pregnancy|7|||
42065609|NCT00805935|75874673|FG002|Overall Study|No positive serum pregnancy|6|||
42065610|NCT00805935|75874674|FG003|Overall Study|No positive serum pregnancy|5|||
42065611|NCT00805935|75874671|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
42065612|NCT00805935|75874672|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
42065613|NCT00805935|75874673|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
42065614|NCT00805935|75874674|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
42065615|NCT00805935|75874671|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
42065616|NCT00805935|75874672|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
42065617|NCT00805935|75874673|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
42065618|NCT00805935|75874674|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
42065619|NCT00805935|75874671|FG000|Overall Study|Biochemical pregnancy|0|||
42065620|NCT00805935|75874672|FG001|Overall Study|Biochemical pregnancy|1|||
42065621|NCT00805935|75874673|FG002|Overall Study|Biochemical pregnancy|0|||
42065622|NCT00805935|75874674|FG003|Overall Study|Biochemical pregnancy|0|||
42065623|NCT00805935|75874671|FG000|Overall Study|Chemical pregnancy|0|||
42065624|NCT00805935|75874672|FG001|Overall Study|Chemical pregnancy|5|||
42065625|NCT00805935|75874673|FG002|Overall Study|Chemical pregnancy|3|||
42065626|NCT00805935|75874674|FG003|Overall Study|Chemical pregnancy|2|||
42065627|NCT00805935|75874671|FG000|Overall Study|Ectopic pregnancy|0|||
42065628|NCT00805935|75874672|FG001|Overall Study|Ectopic pregnancy|0|||
42065629|NCT00805935|75874673|FG002|Overall Study|Ectopic pregnancy|1|||
42065630|NCT00805935|75874674|FG003|Overall Study|Ectopic pregnancy|0|||
42065631|NCT00805935|75874671|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
42065632|NCT00805935|75874672|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
42065633|NCT00805935|75874673|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
42065634|NCT00805935|75874674|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
42065635|NCT00805545|75874688|FG000|Overall Study|Protocol Violation|3|||
42065636|NCT00805545|75874689|FG001|Overall Study|Protocol Violation|2|||
42065637|NCT00805545|75874688|FG000|Overall Study|Protocol Violation|3|||
42065638|NCT00805545|75874689|FG001|Overall Study|Protocol Violation|1|||
42065639|NCT00590031|75874721|FG000|Overall Study|Adverse Event|3|||
42065640|NCT00590031|75874721|FG000|Overall Study|Withdrawal by Subject|1|||
42065641|NCT00590031|75874721|FG000|Overall Study|Metastatic Disease|1|||
42065642|NCT00590031|75874721|FG000|Overall Study|Admin Hold|1|||
42065643|NCT00615199|75874729|FG000|Overall Study|Adverse Event|3|||
42065644|NCT00615199|75874730|FG001|Overall Study|Adverse Event|1|||
42065645|NCT00615199|75874731|FG002|Overall Study|Adverse Event|1|||
42065646|NCT00615199|75874732|FG003|Overall Study|Adverse Event|0|||
42065647|NCT00615199|75874729|FG000|Overall Study|Lack of Efficacy|2|||
42065648|NCT00615199|75874730|FG001|Overall Study|Lack of Efficacy|0|||
42065649|NCT00615199|75874731|FG002|Overall Study|Lack of Efficacy|0|||
42065650|NCT00615199|75874732|FG003|Overall Study|Lack of Efficacy|1|||
42065651|NCT00615199|75874729|FG000|Overall Study|Lost to Follow-up|1|||
42065652|NCT00615199|75874730|FG001|Overall Study|Lost to Follow-up|0|||
42065653|NCT00615199|75874731|FG002|Overall Study|Lost to Follow-up|0|||
42065654|NCT00615199|75874732|FG003|Overall Study|Lost to Follow-up|0|||
42065655|NCT00615199|75874729|FG000|Overall Study|Other|0|||
42065656|NCT00615199|75874730|FG001|Overall Study|Other|0|||
42065657|NCT00615199|75874731|FG002|Overall Study|Other|0|||
42065658|NCT00615199|75874732|FG003|Overall Study|Other|1|||
42065659|NCT00615199|75874729|FG000|Overall Study|Withdrawal by Subject|2|||
42065660|NCT00615199|75874730|FG001|Overall Study|Withdrawal by Subject|1|||
42065661|NCT00615199|75874731|FG002|Overall Study|Withdrawal by Subject|0|||
42065662|NCT00615199|75874732|FG003|Overall Study|Withdrawal by Subject|0|||
42065663|NCT00613951|75874745|FG000|Overall Study|Adverse Event|1|||
42065664|NCT00613951|75874746|FG001|Overall Study|Adverse Event|0|||
42065665|NCT00613951|75874747|FG002|Overall Study|Adverse Event|1|||
42065666|NCT00613951|75874745|FG000|Overall Study|Lack of Efficacy|0|||
42065667|NCT00613951|75874746|FG001|Overall Study|Lack of Efficacy|1|||
42065668|NCT00613951|75874747|FG002|Overall Study|Lack of Efficacy|1|||
42065669|NCT00613951|75874745|FG000|Overall Study|Protocol Violation|1|||
42065670|NCT00613951|75874746|FG001|Overall Study|Protocol Violation|1|||
42065671|NCT00613951|75874747|FG002|Overall Study|Protocol Violation|1|||
42065672|NCT00613951|75874745|FG000|Overall Study|Unclassified|5|||
42065673|NCT00613951|75874746|FG001|Overall Study|Unclassified|3|||
42065674|NCT00613951|75874747|FG002|Overall Study|Unclassified|2|||
42065675|NCT00805467|75874762|FG000|Overall Study|Lack of Efficacy|0|||
42065676|NCT00805467|75874763|FG001|Overall Study|Lack of Efficacy|8|||
42065677|NCT00805467|75874764|FG002|Overall Study|Lack of Efficacy|13|||
42065678|NCT00805467|75874765|FG003|Overall Study|Lack of Efficacy|86|||
42065679|NCT00805467|75874762|FG000|Overall Study|Lost to Follow-up|0|||
42065680|NCT00805467|75874763|FG001|Overall Study|Lost to Follow-up|1|||
42065681|NCT00805467|75874764|FG002|Overall Study|Lost to Follow-up|7|||
42065682|NCT00805467|75874765|FG003|Overall Study|Lost to Follow-up|21|||
42065683|NCT00805467|75874762|FG000|Overall Study|Withdrawal by Subject|0|||
42065684|NCT00805467|75874763|FG001|Overall Study|Withdrawal by Subject|6|||
42065685|NCT00805467|75874764|FG002|Overall Study|Withdrawal by Subject|45|||
42065686|NCT00805467|75874765|FG003|Overall Study|Withdrawal by Subject|50|||
42065687|NCT00805467|75874762|FG000|Overall Study|Protocol Violation|0|||
42065688|NCT00805467|75874763|FG001|Overall Study|Protocol Violation|3|||
42065689|NCT00805467|75874764|FG002|Overall Study|Protocol Violation|0|||
42065690|NCT00805467|75874765|FG003|Overall Study|Protocol Violation|5|||
42065691|NCT00805467|75874762|FG000|Overall Study|Adverse Event|0|||
42065692|NCT00805467|75874763|FG001|Overall Study|Adverse Event|13|||
42065693|NCT00805467|75874764|FG002|Overall Study|Adverse Event|26|||
42065694|NCT00805467|75874765|FG003|Overall Study|Adverse Event|57|||
42065695|NCT00805467|75874762|FG000|Overall Study|Death|0|||
42065696|NCT00805467|75874763|FG001|Overall Study|Death|2|||
42065697|NCT00805467|75874764|FG002|Overall Study|Death|7|||
42065698|NCT00805467|75874765|FG003|Overall Study|Death|5|||
42065699|NCT00805467|75874762|FG000|Overall Study|Physician Decision|0|||
42065700|NCT00805467|75874763|FG001|Overall Study|Physician Decision|1|||
42065701|NCT00805467|75874764|FG002|Overall Study|Physician Decision|2|||
42065702|NCT00805467|75874765|FG003|Overall Study|Physician Decision|6|||
42065703|NCT00805467|75874762|FG000|Overall Study|Not reported|0|||
42065704|NCT00805467|75874763|FG001|Overall Study|Not reported|0|||
42065705|NCT00805467|75874764|FG002|Overall Study|Not reported|3|||
42065706|NCT00805467|75874765|FG003|Overall Study|Not reported|7|||
42065707|NCT00958841|75874775|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42065708|NCT00958841|75874775|FG000|Overall Study|Abnormal test procedure result(s)|3|||
42065709|NCT00958841|75874775|FG000|Overall Study|Administrative problems|1|||
42065710|NCT00958841|75874775|FG000|Overall Study|Adverse Event|8|||
42065711|NCT00958841|75874775|FG000|Overall Study|New cancer therapy|5|||
42065712|NCT00958841|75874775|FG000|Overall Study|Withdrawal by Subject|1|||
42065713|NCT00958841|75874775|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
42065714|NCT00958841|75874775|FG000|Overall Study|Completed M6/did not enter extension|27|||
42065715|NCT00958841|75874775|FG000|Overall Study|Discontinued prior to M*|28|||
42065716|NCT03927105|75874838|FG000|Overall Study|Death|1|||
42065717|NCT03927105|75874838|FG000|Overall Study|In observation for potential re-treatment|2|||
42065718|NCT03927105|75874838|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
42065719|NCT00613327|75874842|FG000|Overall Study|Adverse Event|38|||
42065720|NCT00613327|75874842|FG000|Overall Study|Lost to Follow-up|8|||
42065721|NCT00613327|75874842|FG000|Overall Study|Withdrawal by Subject|6|||
42065722|NCT00613327|75874842|FG000|Overall Study|Protocol Violation|2|||
42065723|NCT00613327|75874842|FG000|Overall Study|Other|47|||
42065724|NCT00954941|75874848|FG000|Overall Study|Received treatment at home|1|||
42065725|NCT00954941|75874849|FG001|Overall Study|Received treatment at home|0|||
42065726|NCT00954941|75874848|FG000|Overall Study|Withdrawal by Subject|1|||
42065727|NCT00954941|75874849|FG001|Overall Study|Withdrawal by Subject|0|||
42065728|NCT00954941|75874848|FG000|Overall Study|Insurance Denial|2|||
42065729|NCT00954941|75874849|FG001|Overall Study|Insurance Denial|2|||
42175223|NCT01722266|75982100|FG002|Overall Study|Dropped out due to Nausea|2|||
42065730|NCT00954941|75874848|FG000|Overall Study|Physician Decision|2|||
42065731|NCT00954941|75874849|FG001|Overall Study|Physician Decision|2|||
42065732|NCT00954941|75874848|FG000|Overall Study|Ineligible|2|||
42065733|NCT00954941|75874849|FG001|Overall Study|Ineligible|2|||
42065734|NCT00954941|75874848|FG000|Overall Study|Adverse Event|0|||
42065735|NCT00954941|75874849|FG001|Overall Study|Adverse Event|1|||
42065736|NCT00954707|75874855|FG000|Overall Study|Death|34|||
42065737|NCT00954707|75874855|FG000|Overall Study|Withdrawal by Subject|100|||
42065738|NCT00954707|75874855|FG000|Overall Study|Lost to Follow-up|33|||
42065739|NCT00589797|75874861|FG000|Overall Study|Death|1|||
42065740|NCT00589797|75874862|FG001|Overall Study|Death|0|||
42065741|NCT00589797|75874861|FG000|Overall Study|Lost to Follow-up|12|||
42065742|NCT00589797|75874862|FG001|Overall Study|Lost to Follow-up|9|||
42065743|NCT00589797|75874861|FG000|Overall Study|Physician Decision|8|||
42065744|NCT00589797|75874862|FG001|Overall Study|Physician Decision|3|||
42065745|NCT00589797|75874861|FG000|Overall Study|Withdrawal by Subject|6|||
42065746|NCT00589797|75874862|FG001|Overall Study|Withdrawal by Subject|5|||
42065747|NCT00589797|75874861|FG000|Overall Study|Non-Randomized Training Subjects|46|||
42065748|NCT00589797|75874862|FG001|Overall Study|Non-Randomized Training Subjects|6|||
42065749|NCT00613171|75874868|FG000|Overall Study|Adverse Event|7|||
42065750|NCT00613171|75874868|FG000|Overall Study|Withdrawal by Subject|3|||
42065751|NCT00613171|75874868|FG000|Overall Study|Reason not Specified|4|||
42065752|NCT00896480|75874873|FG000|Overall Study|Disease progression/recurrence|21|||
42065753|NCT00953225|75874882|FG000|Overall Study|Withdrawal by Subject|2|||
42065754|NCT00953225|75874883|FG001|Overall Study|Withdrawal by Subject|0|||
42065755|NCT00613015|75874895|FG000|Overall Study|Lost to Follow-up|0|||
42065756|NCT00613015|75874896|FG001|Overall Study|Lost to Follow-up|1|||
42065757|NCT00613015|75874897|FG002|Overall Study|Lost to Follow-up|3|||
42065758|NCT00613015|75874898|FG003|Overall Study|Lost to Follow-up|3|||
42065759|NCT00613015|75874899|FG004|Overall Study|Lost to Follow-up|2|||
42065760|NCT00613015|75874900|FG005|Overall Study|Lost to Follow-up|3|||
42065761|NCT00803595|75874917|FG000|Overall Study|Adverse Event|3|||
42065762|NCT00803595|75874918|FG001|Overall Study|Adverse Event|4|||
42065763|NCT00803595|75874919|FG002|Overall Study|Adverse Event|1|||
42065764|NCT00803595|75874917|FG000|Overall Study|Protocol Violation|7|||
42065765|NCT00803595|75874918|FG001|Overall Study|Protocol Violation|2|||
42065766|NCT00803595|75874919|FG002|Overall Study|Protocol Violation|12|||
42065767|NCT00803595|75874917|FG000|Overall Study|Withdrawal by Subject|5|||
42065768|NCT00803595|75874918|FG001|Overall Study|Withdrawal by Subject|2|||
42065769|NCT00803595|75874919|FG002|Overall Study|Withdrawal by Subject|3|||
42065770|NCT00953927|75874929|FG000|Overall Study|Lost to Follow-up|61|||
42065771|NCT00953927|75874930|FG001|Overall Study|Lost to Follow-up|65|||
42065772|NCT00953927|75874929|FG000|Overall Study|Withdrawal by Subject|36|||
42065773|NCT00953927|75874930|FG001|Overall Study|Withdrawal by Subject|25|||
42065774|NCT00953927|75874929|FG000|Overall Study|Death|7|||
42065775|NCT00953927|75874930|FG001|Overall Study|Death|4|||
42065776|NCT00953927|75874929|FG000|Overall Study|Other study discontinuation|1|||
42065777|NCT00953927|75874930|FG001|Overall Study|Other study discontinuation|1|||
42065778|NCT00611767|75874938|FG000|Overall Study|Withdrawal by Subject|4|||
42065779|NCT00611767|75874939|FG001|Overall Study|Withdrawal by Subject|1|||
42065780|NCT00611767|75874938|FG000|Overall Study|Thiopental not available|3|||
42065781|NCT00611767|75874939|FG001|Overall Study|Thiopental not available|0|||
42065782|NCT00611767|75874938|FG000|Overall Study|didn't like the medication|1|||
42065783|NCT00611767|75874939|FG001|Overall Study|didn't like the medication|1|||
42065784|NCT00611767|75874938|FG000|Overall Study|Physician Decision|1|||
42065785|NCT00611767|75874939|FG001|Overall Study|Physician Decision|0|||
42065786|NCT00803361|75874947|FG000|Overall Study|Adverse Event|13|||
42065787|NCT00803361|75874948|FG001|Overall Study|Adverse Event|3|||
42065788|NCT00803361|75874947|FG000|Overall Study|Lack of Efficacy|4|||
42065789|NCT00803361|75874948|FG001|Overall Study|Lack of Efficacy|13|||
42065790|NCT00803361|75874947|FG000|Overall Study|Lost to Follow-up|1|||
42065791|NCT00803361|75874948|FG001|Overall Study|Lost to Follow-up|2|||
42065792|NCT00803361|75874947|FG000|Overall Study|Physician Decision|1|||
42065793|NCT00803361|75874948|FG001|Overall Study|Physician Decision|0|||
42357494|NCT01750190|76202919|FG001|Overall Study|Other than Specified|4|||
42065794|NCT00803361|75874947|FG000|Overall Study|Protocol Violation|2|||
42065795|NCT00803361|75874948|FG001|Overall Study|Protocol Violation|4|||
42065796|NCT00803361|75874947|FG000|Overall Study|Withdrawal by Subject|5|||
42065797|NCT00803361|75874948|FG001|Overall Study|Withdrawal by Subject|6|||
42065798|NCT00611533|75874954|FG000|First Intervention (6 Weeks)|Never started study|0|||
42065799|NCT00611533|75874955|FG001|First Intervention (6 Weeks)|Never started study|1|||
42065800|NCT00611533|75874954|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
42065801|NCT00611533|75874955|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
42065802|NCT00611533|75874954|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
42065803|NCT00611533|75874955|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
42065804|NCT00953147|75874974|FG000|Overall Study|Adverse Event|8|||
42065805|NCT00953147|75874975|FG001|Overall Study|Adverse Event|16|||
42065806|NCT00953147|75874976|FG002|Overall Study|Adverse Event|6|||
42065807|NCT00953147|75874974|FG000|Overall Study|Protocol Violation|2|||
42065808|NCT00953147|75874975|FG001|Overall Study|Protocol Violation|8|||
42065809|NCT00953147|75874976|FG002|Overall Study|Protocol Violation|4|||
42065810|NCT00953147|75874974|FG000|Overall Study|Withdrawal by Subject|13|||
42065811|NCT00953147|75874975|FG001|Overall Study|Withdrawal by Subject|15|||
42065812|NCT00953147|75874976|FG002|Overall Study|Withdrawal by Subject|12|||
42065813|NCT00953147|75874974|FG000|Overall Study|Lost to Follow-up|8|||
42065814|NCT00953147|75874975|FG001|Overall Study|Lost to Follow-up|9|||
42065815|NCT00953147|75874976|FG002|Overall Study|Lost to Follow-up|4|||
42065816|NCT00953147|75874974|FG000|Overall Study|Physician Decision|2|||
42065817|NCT00953147|75874975|FG001|Overall Study|Physician Decision|7|||
42065818|NCT00953147|75874976|FG002|Overall Study|Physician Decision|3|||
42065819|NCT00953147|75874974|FG000|Overall Study|Other|4|||
42065820|NCT00953147|75874975|FG001|Overall Study|Other|11|||
42065821|NCT00953147|75874976|FG002|Overall Study|Other|13|||
42065822|NCT00803205|75874986|FG000|Overall Study|Adverse Event|7|||
42065823|NCT00803205|75874987|FG001|Overall Study|Adverse Event|2|||
42065824|NCT00803205|75874986|FG000|Overall Study|Lost to Follow-up|1|||
42065825|NCT00803205|75874987|FG001|Overall Study|Lost to Follow-up|0|||
42065826|NCT00803205|75874986|FG000|Overall Study|Withdrawal by Subject|9|||
42065827|NCT00803205|75874987|FG001|Overall Study|Withdrawal by Subject|9|||
42065828|NCT00803205|75874986|FG000|Overall Study|Physician Decision|1|||
42065829|NCT00803205|75874987|FG001|Overall Study|Physician Decision|0|||
42065830|NCT00803205|75874986|FG000|Overall Study|Protocol Violation|1|||
42065831|NCT00803205|75874987|FG001|Overall Study|Protocol Violation|1|||
42065832|NCT00803205|75874986|FG000|Overall Study|Medical Monitor Decision|1|||
42065833|NCT00803205|75874987|FG001|Overall Study|Medical Monitor Decision|0|||
42065834|NCT00803205|75874986|FG000|Overall Study|Acquired a Lung Infection|0|||
42065835|NCT00803205|75874987|FG001|Overall Study|Acquired a Lung Infection|1|||
42065836|NCT00803205|75874986|FG000|Overall Study|Sponsor Decision|0|||
42065837|NCT00803205|75874987|FG001|Overall Study|Sponsor Decision|1|||
42065838|NCT00952523|75874993|FG000|Overall Study|Withdrawal by Subject|7|||
42065839|NCT02232737|75875002|FG000|Overall Study|Lost to Follow-up|18|||
42065840|NCT02232737|75875003|FG001|Overall Study|Lost to Follow-up|28|||
42065841|NCT02232737|75875004|FG002|Overall Study|Lost to Follow-up|33|||
42065842|NCT02232737|75875002|FG000|Overall Study|Personal reasons|7|||
42065843|NCT02232737|75875003|FG001|Overall Study|Personal reasons|8|||
42065844|NCT02232737|75875004|FG002|Overall Study|Personal reasons|14|||
42065845|NCT02232737|75875002|FG000|Overall Study|Adverse Event|6|||
42065846|NCT02232737|75875003|FG001|Overall Study|Adverse Event|3|||
42065847|NCT02232737|75875004|FG002|Overall Study|Adverse Event|8|||
42065848|NCT02232737|75875002|FG000|Overall Study|Incarcerated|2|||
42065849|NCT02232737|75875003|FG001|Overall Study|Incarcerated|1|||
42065850|NCT02232737|75875004|FG002|Overall Study|Incarcerated|2|||
42065851|NCT02232737|75875002|FG000|Overall Study|Withdrawal by Subject|0|||
42065852|NCT02232737|75875003|FG001|Overall Study|Withdrawal by Subject|1|||
42065853|NCT02232737|75875004|FG002|Overall Study|Withdrawal by Subject|2|||
42065854|NCT02232737|75875002|FG000|Overall Study|Death|0|||
42065855|NCT02232737|75875003|FG001|Overall Study|Death|1|||
42065856|NCT02232737|75875004|FG002|Overall Study|Death|1|||
42065857|NCT02232737|75875002|FG000|Overall Study|Physician Decision|1|||
42065858|NCT02232737|75875003|FG001|Overall Study|Physician Decision|3|||
42065859|NCT02232737|75875004|FG002|Overall Study|Physician Decision|1|||
42065860|NCT02232737|75875002|FG000|Overall Study|Protocol Violation|1|||
42065861|NCT02232737|75875003|FG001|Overall Study|Protocol Violation|0|||
42065862|NCT02232737|75875004|FG002|Overall Study|Protocol Violation|1|||
42065863|NCT02232737|75875002|FG000|Overall Study|Reason unknown|1|||
42065864|NCT02232737|75875003|FG001|Overall Study|Reason unknown|0|||
42065865|NCT02232737|75875004|FG002|Overall Study|Reason unknown|0|||
42065866|NCT00952367|75875012|FG000|Overall Study|Withdrawal by Subject|2|||
42065867|NCT00952367|75875012|FG000|Overall Study|Noncoordination|1|||
42065868|NCT00952367|75875012|FG000|Overall Study|Protocol Violation|3|||
42065869|NCT00948857|75875018|FG000|Overall Study|Lost to Follow-up|1|||
42065870|NCT00948857|75875019|FG001|Overall Study|Lost to Follow-up|0|||
42065871|NCT00948389|75875034|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
42065872|NCT00948389|75875035|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
42065873|NCT00948389|75875036|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
42065874|NCT00948389|75875037|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
42065875|NCT00948389|75875038|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
42065876|NCT00948389|75875034|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
42065877|NCT00948389|75875035|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
42065878|NCT00948389|75875036|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
42065879|NCT00948389|75875037|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
42065880|NCT00948389|75875038|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
42065881|NCT00948389|75875034|FG000|Overall Study|Both Progression and Toxicity|1|||
42065882|NCT00948389|75875035|FG001|Overall Study|Both Progression and Toxicity|0|||
42065883|NCT00948389|75875036|FG002|Overall Study|Both Progression and Toxicity|0|||
42065884|NCT00948389|75875037|FG003|Overall Study|Both Progression and Toxicity|0|||
42065885|NCT00948389|75875038|FG004|Overall Study|Both Progression and Toxicity|0|||
42065886|NCT00948155|75875054|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
42065887|NCT00948155|75875055|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
42065888|NCT00948155|75875054|FG000|Washout 14 Days|Lost to Follow-up|1|||
42065889|NCT00948155|75875055|FG001|Washout 14 Days|Lost to Follow-up|2|||
42065890|NCT00958217|75875065|FG000|Overall Study|Death|2|||
42065891|NCT00958217|75875066|FG001|Overall Study|Death|1|||
42065892|NCT00958217|75875065|FG000|Overall Study|Withdrawal by Subject|4|||
42065893|NCT00958217|75875066|FG001|Overall Study|Withdrawal by Subject|3|||
42065894|NCT00958217|75875065|FG000|Overall Study|Lost to Follow-up|17|||
42065895|NCT00958217|75875066|FG001|Overall Study|Lost to Follow-up|19|||
42065896|NCT00958217|75875065|FG000|Overall Study|Moved out of area|1|||
42065897|NCT00958217|75875066|FG001|Overall Study|Moved out of area|1|||
42065898|NCT00958217|75875065|FG000|Overall Study|Inpatient hospitalization|0|||
42065899|NCT00958217|75875066|FG001|Overall Study|Inpatient hospitalization|1|||
42065900|NCT00891020|75875076|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
42065901|NCT00891020|75875077|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
42065902|NCT00891020|75875078|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
42065903|NCT00891020|75875076|FG000|24 Week Treatment Period|Death|0|||
42065904|NCT00891020|75875077|FG001|24 Week Treatment Period|Death|2|||
42065905|NCT00891020|75875078|FG002|24 Week Treatment Period|Death|0|||
42065906|NCT00891020|75875076|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
42065907|NCT00891020|75875077|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
42065908|NCT00891020|75875078|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
42065909|NCT00891020|75875076|FG000|24 Week Treatment Period|Failure to return|4|||
42065910|NCT00891020|75875077|FG001|24 Week Treatment Period|Failure to return|5|||
42065911|NCT00891020|75875078|FG002|24 Week Treatment Period|Failure to return|5|||
42065912|NCT00891020|75875076|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
42065913|NCT00891020|75875077|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
42065914|NCT00891020|75875078|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
42065915|NCT00891020|75875076|FG000|24 Week Treatment Period|Other protocol violation|1|||
42065916|NCT00891020|75875077|FG001|24 Week Treatment Period|Other protocol violation|1|||
42065917|NCT00891020|75875078|FG002|24 Week Treatment Period|Other protocol violation|2|||
42065918|NCT00891020|75875076|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
42065919|NCT00891020|75875077|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
42065920|NCT00891020|75875078|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
42065921|NCT00891020|75875076|FG000|24 Week Treatment Period|Withdrew consent|6|||
42065922|NCT00891020|75875077|FG001|24 Week Treatment Period|Withdrew consent|3|||
42065923|NCT00891020|75875078|FG002|24 Week Treatment Period|Withdrew consent|15|||
42065924|NCT00891020|75875076|FG000|24 Week Treatment Period|Administrative/Other|5|||
42065925|NCT00891020|75875077|FG001|24 Week Treatment Period|Administrative/Other|6|||
42065926|NCT00891020|75875078|FG002|24 Week Treatment Period|Administrative/Other|1|||
42065927|NCT00891020|75875076|FG000|Long-term Extension Period|Adverse Event|1|||
42065928|NCT00891020|75875077|FG001|Long-term Extension Period|Adverse Event|11|||
42065929|NCT00891020|75875078|FG002|Long-term Extension Period|Adverse Event|10|||
42065930|NCT00891020|75875076|FG000|Long-term Extension Period|Death|0|||
42065931|NCT00891020|75875077|FG001|Long-term Extension Period|Death|0|||
42065932|NCT00891020|75875078|FG002|Long-term Extension Period|Death|1|||
42065933|NCT00891020|75875076|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
42065934|NCT00891020|75875077|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
42065935|NCT00891020|75875078|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
42065936|NCT00891020|75875076|FG000|Long-term Extension Period|Protocol Violation|0|||
42065937|NCT00891020|75875077|FG001|Long-term Extension Period|Protocol Violation|1|||
42065938|NCT00891020|75875078|FG002|Long-term Extension Period|Protocol Violation|1|||
42065939|NCT00891020|75875076|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
42065940|NCT00891020|75875077|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
42065941|NCT00891020|75875078|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
42065942|NCT00891020|75875076|FG000|Long-term Extension Period|Failure to return|0|||
42065943|NCT00891020|75875077|FG001|Long-term Extension Period|Failure to return|2|||
42016870|NCT01218126|75824424|FG002|Overall Study|Withdrawal by Subject|4|||
42016871|NCT01218126|75824425|FG003|Overall Study|Withdrawal by Subject|6|||
42016872|NCT01217892|75824439|FG000|Overall Study|Adverse Event|1|||
42016873|NCT01217892|75824440|FG001|Overall Study|Adverse Event|1|||
42016874|NCT01217892|75824441|FG002|Overall Study|Adverse Event|1|||
42016875|NCT01217892|75824442|FG003|Overall Study|Adverse Event|0|||
42016876|NCT01217892|75824439|FG000|Overall Study|Withdrawal by Subject|0|||
42016877|NCT01217892|75824440|FG001|Overall Study|Withdrawal by Subject|2|||
42016878|NCT01217892|75824441|FG002|Overall Study|Withdrawal by Subject|1|||
42016879|NCT01217892|75824442|FG003|Overall Study|Withdrawal by Subject|0|||
42065944|NCT00891020|75875078|FG002|Long-term Extension Period|Failure to return|3|||
42065945|NCT00891020|75875076|FG000|Long-term Extension Period|Administrative|1|||
42016880|NCT01217892|75824439|FG000|Overall Study|Lab value|1|||
42016881|NCT01217892|75824440|FG001|Overall Study|Lab value|0|||
42065946|NCT00891020|75875077|FG001|Long-term Extension Period|Administrative|2|||
42065947|NCT00891020|75875078|FG002|Long-term Extension Period|Administrative|2|||
42065948|NCT00611455|75875090|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
42065949|NCT00611455|75875091|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
42065950|NCT00611455|75875092|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
42065951|NCT00611455|75875090|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
42065952|NCT00611455|75875091|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
42065953|NCT00611455|75875092|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
42065954|NCT00611455|75875090|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
42065955|NCT00611455|75875091|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
42065956|NCT00611455|75875092|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
42065957|NCT00611455|75875090|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
42065958|NCT00611455|75875091|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
42065959|NCT00611455|75875092|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
42065960|NCT00611455|75875090|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
42065961|NCT00611455|75875091|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
42065962|NCT00611455|75875092|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
42065963|NCT00611455|75875090|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
42065964|NCT00611455|75875091|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
42065965|NCT00611455|75875092|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
42065966|NCT00611455|75875090|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
42065967|NCT00611455|75875091|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
42065968|NCT00611455|75875092|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
42065969|NCT00611455|75875090|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
42065970|NCT00611455|75875091|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
42065971|NCT00611455|75875092|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
42065972|NCT00611455|75875090|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
42065973|NCT00611455|75875091|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
42065974|NCT00611455|75875092|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
42065975|NCT00611455|75875090|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
42065976|NCT00611455|75875091|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
42065977|NCT00611455|75875092|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
42065978|NCT00611455|75875090|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
42065979|NCT00611455|75875091|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
42065980|NCT00611455|75875092|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
42065981|NCT00611455|75875090|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
42065982|NCT00611455|75875091|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
42065983|NCT00611455|75875092|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
42065984|NCT00611455|75875090|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
42065985|NCT00611455|75875091|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
42065986|NCT00611455|75875092|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
42065987|NCT00611455|75875090|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
42065988|NCT00611455|75875091|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
42065989|NCT00611455|75875092|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
42065990|NCT00611455|75875090|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
42065991|NCT00611455|75875091|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
42065992|NCT00611455|75875092|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
42065993|NCT00611455|75875090|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
42065994|NCT00611455|75875091|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
42065995|NCT00611455|75875092|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
42065996|NCT00611455|75875090|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
42065997|NCT00611455|75875091|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
42065998|NCT00611455|75875092|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
42065999|NCT00611455|75875090|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
42066000|NCT00611455|75875091|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
42066001|NCT00611455|75875092|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
42066002|NCT00611455|75875090|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
42066003|NCT00611455|75875091|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
42066004|NCT00611455|75875092|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
42066005|NCT00611455|75875090|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
42066006|NCT00611455|75875091|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
42066007|NCT00611455|75875092|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
42066008|NCT00611455|75875090|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
42066009|NCT00611455|75875091|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
42175224|NCT01722266|75982101|FG003|Overall Study|Dropped out due to Nausea|0|||
42357495|NCT01831765|76202928|FG000|Overall Study|Lack of Efficacy|1|||
42357496|NCT01831765|76202929|FG001|Overall Study|Lack of Efficacy|0|||
42357497|NCT01831765|76202930|FG002|Overall Study|Lack of Efficacy|0|||
42357498|NCT01831765|76202928|FG000|Overall Study|Other, sponsor withdrew subject|0|||
42357499|NCT01831765|76202929|FG001|Overall Study|Other, sponsor withdrew subject|1|||
42357500|NCT01831765|76202930|FG002|Overall Study|Other, sponsor withdrew subject|0|||
42357501|NCT01831765|76202928|FG000|Overall Study|Pregnancy|1|||
42357502|NCT01831765|76202929|FG001|Overall Study|Pregnancy|1|||
42357503|NCT01831765|76202930|FG002|Overall Study|Pregnancy|2|||
42357504|NCT01831765|76202928|FG000|Overall Study|Death|0|||
42357505|NCT01831765|76202929|FG001|Overall Study|Death|1|||
42292224|NCT03739112|76125973|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
42292225|NCT03739112|76125974|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
42292226|NCT03739112|76125973|FG000|Overall Study|Site went on hold|65|||
42066010|NCT00611455|75875092|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
42357506|NCT01831765|76202930|FG002|Overall Study|Death|1|||
42357507|NCT01831765|76202928|FG000|Overall Study|Other, site closed|1|||
42357508|NCT01831765|76202929|FG001|Overall Study|Other, site closed|1|||
42357509|NCT01831765|76202930|FG002|Overall Study|Other, site closed|0|||
42357510|NCT01831765|76202928|FG000|Overall Study|Adverse Event|5|||
42357511|NCT01831765|76202929|FG001|Overall Study|Adverse Event|3|||
42357512|NCT01831765|76202930|FG002|Overall Study|Adverse Event|3|||
42357513|NCT01831765|76202928|FG000|Overall Study|Withdrawal by Subject|22|||
42357514|NCT01831765|76202929|FG001|Overall Study|Withdrawal by Subject|7|||
42175245|NCT00953771|75982132|FG000|Overall Study|Death|1|||
42175246|NCT00953771|75982133|FG001|Overall Study|Death|0|||
42175247|NCT00673816|75982145|FG000|Overall Study|Adverse Event|1|||
42175248|NCT00673816|75982145|FG000|Overall Study|Withdrawal by Subject|1|||
42175249|NCT00026312|75982170|FG000|Overall Study|Adverse Event|0|||
42175250|NCT00026312|75982171|FG001|Overall Study|Adverse Event|32|||
42175251|NCT00026312|75982170|FG000|Overall Study|Death|1|||
42175252|NCT00026312|75982171|FG001|Overall Study|Death|7|||
42175253|NCT00026312|75982170|FG000|Overall Study|Lack of Efficacy|19|||
42175254|NCT00026312|75982171|FG001|Overall Study|Lack of Efficacy|114|||
42175255|NCT00026312|75982170|FG000|Overall Study|Lost to Follow-up|0|||
42175256|NCT00026312|75982171|FG001|Overall Study|Lost to Follow-up|5|||
42175257|NCT00026312|75982170|FG000|Overall Study|Physician Decision|1|||
42175258|NCT00026312|75982171|FG001|Overall Study|Physician Decision|37|||
42175259|NCT00026312|75982170|FG000|Overall Study|Protocol Violation|0|||
42175260|NCT00026312|75982171|FG001|Overall Study|Protocol Violation|3|||
42175261|NCT00026312|75982170|FG000|Overall Study|Withdrawal by Subject|1|||
42175262|NCT00026312|75982171|FG001|Overall Study|Withdrawal by Subject|6|||
42175263|NCT00026312|75982170|FG000|Overall Study|Ineligible|4|||
42175264|NCT00026312|75982171|FG001|Overall Study|Ineligible|5|||
42175265|NCT00026312|75982170|FG000|Overall Study|Entry onto another COG study|0|||
42175266|NCT00026312|75982171|FG001|Overall Study|Entry onto another COG study|1|||
42175267|NCT00026312|75982170|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
42292227|NCT03739112|76125974|FG001|Overall Study|Site went on hold|67|||
42292228|NCT03739112|76125973|FG000|Overall Study|Other than specified|8|||
42292229|NCT03739112|76125974|FG001|Overall Study|Other than specified|5|||
42066011|NCT00952289|75875104|FG000|All Participants|Death|9|||
42066012|NCT00952289|75875105|FG001|All Participants|Death|9|||
42066013|NCT00952289|75875104|FG000|All Participants|Adverse Event|8|||
42066014|NCT00952289|75875105|FG001|All Participants|Adverse Event|8|||
42066015|NCT00952289|75875104|FG000|All Participants|Disease progression|3|||
42066016|NCT00952289|75875105|FG001|All Participants|Disease progression|12|||
42066017|NCT00952289|75875104|FG000|All Participants|Withdrawal by Subject|1|||
42066018|NCT00952289|75875105|FG001|All Participants|Withdrawal by Subject|10|||
42066019|NCT00952289|75875104|FG000|All Participants|Data lost during site relocation|0|||
42066020|NCT00952289|75875105|FG001|All Participants|Data lost during site relocation|1|||
42066021|NCT00952289|75875104|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
42357515|NCT01831765|76202930|FG002|Overall Study|Withdrawal by Subject|17|||
42066022|NCT00952289|75875105|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
42175268|NCT00026312|75982171|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
42175269|NCT03280264|75982181|FG000|Overall Study|Adverse Event|1|||
42175270|NCT03280264|75982181|FG000|Overall Study|Physician Decision|1|||
42175271|NCT03280264|75982181|FG000|Overall Study|Withdrawal by Subject|1|||
42175272|NCT00060840|75982188|FG000|Overall Study|Change in surgical plan|2|||
42175273|NCT00060840|75982189|FG001|Overall Study|Change in surgical plan|6|||
42175274|NCT00060840|75982188|FG000|Overall Study|Death|0|||
42175275|NCT00060840|75982189|FG001|Overall Study|Death|1|||
42175276|NCT00060840|75982188|FG000|Overall Study|Withdrawal by Subject|0|||
42175277|NCT00060840|75982189|FG001|Overall Study|Withdrawal by Subject|1|||
42175278|NCT00060840|75982188|FG000|Overall Study|Subinvestigator unavailable|0|||
42175279|NCT00060840|75982189|FG001|Overall Study|Subinvestigator unavailable|1|||
42292230|NCT03739112|76125973|FG000|Overall Study|Randomized but not vaccinated|31|||
42066023|NCT00952289|75875104|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
42357516|NCT01831765|76202928|FG000|Overall Study|Withdrawal criteria|12|||
42357517|NCT01831765|76202929|FG001|Overall Study|Withdrawal criteria|10|||
42066024|NCT00952289|75875105|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
42066025|NCT00952289|75875104|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
42066026|NCT00952289|75875105|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
42066027|NCT00952289|75875104|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
42066028|NCT00952289|75875105|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
42066029|NCT00952289|75875104|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
42066030|NCT00952289|75875105|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
42066031|NCT00612313|75875113|FG000|Overall Study|Withdrawal by Subject|6|||
42066032|NCT00612313|75875114|FG001|Overall Study|Withdrawal by Subject|9|||
42066033|NCT00612313|75875113|FG000|Overall Study|Lost to Follow-up|11|||
42066034|NCT00612313|75875114|FG001|Overall Study|Lost to Follow-up|4|||
42066035|NCT00890552|75875126|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
42066036|NCT00890552|75875126|FG000|On-treatment|Early prog disease/ death|10|||
42066037|NCT00946985|75875130|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
42066038|NCT00946985|75875130|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
42066039|NCT00946985|75875130|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
42066040|NCT00946985|75875130|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
42066041|NCT00946985|75875130|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
42066042|NCT00946985|75875130|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
42066043|NCT00946985|75875130|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
42175280|NCT00060840|75982188|FG000|Overall Study|Physician Decision|1|||
42175281|NCT00060840|75982189|FG001|Overall Study|Physician Decision|0|||
42175282|NCT00060840|75982188|FG000|Overall Study|Other|1|||
42175283|NCT00060840|75982189|FG001|Overall Study|Other|0|||
42175284|NCT03280108|75982197|FG000|Overall Study|Lost to Follow-up|2|||
42175285|NCT03280108|75982198|FG001|Overall Study|Lost to Follow-up|0|||
42175286|NCT00059202|75982211|FG000|Overall Study|Withdrawal by Subject|5|||
42175287|NCT00059202|75982212|FG001|Overall Study|Withdrawal by Subject|9|||
42175288|NCT00059202|75982211|FG000|Overall Study|Protocol Violation|1|||
42175289|NCT00059202|75982212|FG001|Overall Study|Protocol Violation|3|||
42175290|NCT00059202|75982211|FG000|Overall Study|drug toxicity|0|||
42175291|NCT00059202|75982212|FG001|Overall Study|drug toxicity|3|||
42175292|NCT03278626|75982221|FG000|Overall Study|Death|2|||
42175293|NCT03278626|75982221|FG000|Overall Study|Toxicity|1|||
42175294|NCT03278626|75982221|FG000|Overall Study|Disease Progression|2|||
42175295|NCT03277846|75982227|FG000|Overall Study|Inpatient stay too brief|12|||
42175296|NCT03277846|75982228|FG001|Overall Study|Inpatient stay too brief|11|||
42175297|NCT00073008|75982236|FG000|Overall Study|Missing|6|||
42175298|NCT00073008|75982237|FG001|Overall Study|Missing|6|||
42175299|NCT00073008|75982236|FG000|Overall Study|Withdrawal by Subject|2|||
42175300|NCT00073008|75982237|FG001|Overall Study|Withdrawal by Subject|2|||
42175301|NCT00073008|75982236|FG000|Overall Study|Lost to Follow-up|1|||
42175302|NCT00073008|75982237|FG001|Overall Study|Lost to Follow-up|3|||
42175303|NCT00073008|75982236|FG000|Overall Study|Death|46|||
42175304|NCT00073008|75982237|FG001|Overall Study|Death|47|||
42175305|NCT00073008|75982236|FG000|Overall Study|"Other selected on Case Report Form"|7|||
42175306|NCT00073008|75982237|FG001|Overall Study|"Other selected on Case Report Form"|5|||
42175307|NCT00058422|75982243|FG000|Overall Study|Not treated|2|||
42175308|NCT00072384|75982247|FG000|Overall Study|Physician Decision|1|||
42175309|NCT00072384|75982247|FG000|Overall Study|Ineligible|8|||
42175310|NCT00054132|75982253|FG000|Overall Study|Not Treated|1|||
42175311|NCT00053898|75982260|FG000|Overall Study|No follow-up data from any source|9|||
42175312|NCT00053898|75982261|FG001|Overall Study|No follow-up data from any source|12|||
42175313|NCT00053898|75982260|FG000|Overall Study|Follow-up from telephone contact only|5|||
42175314|NCT00053898|75982261|FG001|Overall Study|Follow-up from telephone contact only|1|||
42175315|NCT03256552|75982297|FG000|Overall Study|Protocol Violation|1|||
42175316|NCT03256552|75982297|FG000|Overall Study|Physician Decision|1|||
42175317|NCT03256552|75982297|FG000|Overall Study|Adverse Event|1|||
42175318|NCT03256552|75982297|FG000|Overall Study|Withdrawal by Subject|2|||
42175319|NCT00071058|75982307|FG000|Overall Study|brain tumor-removed from study|1|||
42175320|NCT00053352|75982314|FG000|Overall Study|Lost to Follow-up|0|||
42175321|NCT00053352|75982315|FG001|Overall Study|Lost to Follow-up|1|||
42175322|NCT00053352|75982314|FG000|Overall Study|Physician Decision|11|||
42175323|NCT00053352|75982315|FG001|Overall Study|Physician Decision|1|||
42175324|NCT00053352|75982314|FG000|Overall Study|Withdrawal by Subject|1|||
42175325|NCT00053352|75982315|FG001|Overall Study|Withdrawal by Subject|0|||
42175326|NCT00053352|75982314|FG000|Overall Study|Ineligible|8|||
42175327|NCT00053352|75982315|FG001|Overall Study|Ineligible|8|||
42175328|NCT00053352|75982314|FG000|Overall Study|Disease at new site|1|||
42175329|NCT00053352|75982315|FG001|Overall Study|Disease at new site|0|||
42175330|NCT03245398|75982324|FG000|Overall Study|Travelled to another island|1|||
42175331|NCT03245398|75982325|FG001|Overall Study|Travelled to another island|0|||
42066044|NCT00946985|75875130|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
42066045|NCT00946985|75875130|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
42066046|NCT00611923|75875136|FG000|Overall Study|Withdrawal by Subject|2|||
42175332|NCT03244618|75982335|FG000|Overall Study|Lost to Follow-up|3|||
42175333|NCT03244618|75982336|FG001|Overall Study|Lost to Follow-up|4|||
42175334|NCT03244618|75982335|FG000|Overall Study|Protocol Violation|4|||
42175335|NCT03244618|75982336|FG001|Overall Study|Protocol Violation|3|||
42175336|NCT03244618|75982335|FG000|Overall Study|Withdrawal by Subject|0|||
42175337|NCT03244618|75982336|FG001|Overall Study|Withdrawal by Subject|2|||
42175338|NCT00052962|75982344|FG000|Overall Study|Not evaluable|0|||
42175339|NCT00052962|75982345|FG001|Overall Study|Not evaluable|2|||
42175340|NCT00052962|75982344|FG000|Overall Study|Not randomized/not evaluable|1|||
42175341|NCT00052962|75982345|FG001|Overall Study|Not randomized/not evaluable|0|||
42175342|NCT00051636|75982353|FG000|Period 1 - Core|Adverse Event|2|||
42175343|NCT00051636|75982354|FG001|Period 1 - Core|Adverse Event|2|||
42175344|NCT00051636|75982353|FG000|Period 1 - Core|Protocol Violation|1|||
42175345|NCT00051636|75982354|FG001|Period 1 - Core|Protocol Violation|0|||
42175346|NCT00051636|75982353|FG000|Period 1 - Core|Withdrawal by Subject|1|||
42175347|NCT00051636|75982354|FG001|Period 1 - Core|Withdrawal by Subject|2|||
42175348|NCT00051636|75982353|FG000|Period 1 - Core|Lost to Follow-up|0|||
42175349|NCT00051636|75982354|FG001|Period 1 - Core|Lost to Follow-up|2|||
42175350|NCT00051636|75982353|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
42175351|NCT00051636|75982354|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
42175352|NCT00051636|75982353|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
42175353|NCT00051636|75982354|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
42175354|NCT00051636|75982353|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
42175355|NCT00051636|75982354|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
42175356|NCT00051636|75982353|FG000|Period 2- Extended Observation Period|Death|4|||
42175357|NCT00051636|75982354|FG001|Period 2- Extended Observation Period|Death|5|||
42175358|NCT00051636|75982353|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
42175359|NCT00051636|75982354|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
42175360|NCT03255382|75982362|FG000|Overall Study|Adverse Event|3|||
42175361|NCT03255382|75982363|FG001|Overall Study|Adverse Event|0|||
42175362|NCT03255382|75982362|FG000|Overall Study|Lost to Follow-up|2|||
42175363|NCT03255382|75982363|FG001|Overall Study|Lost to Follow-up|0|||
42175364|NCT03255382|75982362|FG000|Overall Study|Withdrawal by Subject|2|||
42175365|NCT03255382|75982363|FG001|Overall Study|Withdrawal by Subject|0|||
42175366|NCT03255382|75982362|FG000|Overall Study|Other|6|||
42175367|NCT03255382|75982363|FG001|Overall Study|Other|0|||
42175368|NCT03254602|75982370|FG000|Overall Study|Lost to Follow-up|4|||
42175369|NCT00038142|75982376|FG000|Overall Study|Ineligible|1|||
42175370|NCT00038142|75982377|FG001|Overall Study|Ineligible|0|||
42175371|NCT00038142|75982376|FG000|Overall Study|Progressive Disease|11|||
42175372|NCT00038142|75982377|FG001|Overall Study|Progressive Disease|7|||
42175373|NCT00038142|75982376|FG000|Overall Study|Death|1|||
42175374|NCT00038142|75982377|FG001|Overall Study|Death|0|||
42175375|NCT00038142|75982376|FG000|Overall Study|Adverse Event|1|||
42175376|NCT00038142|75982377|FG001|Overall Study|Adverse Event|0|||
42175377|NCT00038142|75982376|FG000|Overall Study|Unknown Reason|8|||
42175378|NCT00038142|75982377|FG001|Overall Study|Unknown Reason|0|||
42175379|NCT00366899|75982385|FG000|Infant Series|Withdrawal by Subject|4|||
42175380|NCT00366899|75982386|FG001|Infant Series|Withdrawal by Subject|7|||
42175381|NCT00366899|75982385|FG000|Infant Series|Protocol Violation|2|||
42175382|NCT00366899|75982386|FG001|Infant Series|Protocol Violation|1|||
42175383|NCT00366899|75982385|FG000|Infant Series|Failed to return|1|||
42175384|NCT00366899|75982386|FG001|Infant Series|Failed to return|1|||
42175385|NCT00366899|75982385|FG000|Infant Series|Lost to Follow-up|0|||
42175386|NCT00366899|75982386|FG001|Infant Series|Lost to Follow-up|2|||
42066047|NCT00611923|75875137|FG001|Overall Study|Withdrawal by Subject|2|||
42066048|NCT00609973|75875147|FG000|Overall Study|Adverse Event|2|||
42066049|NCT00609973|75875148|FG001|Overall Study|Adverse Event|1|||
42066050|NCT00609973|75875147|FG000|Overall Study|Protocol Violation|4|||
42066051|NCT00609973|75875148|FG001|Overall Study|Protocol Violation|3|||
42066052|NCT00609973|75875147|FG000|Overall Study|Lost to Follow-up|2|||
42066053|NCT00609973|75875148|FG001|Overall Study|Lost to Follow-up|1|||
42175387|NCT00366899|75982385|FG000|Infant Series|Adverse Event|0|||
42175388|NCT00366899|75982386|FG001|Infant Series|Adverse Event|1|||
42175389|NCT00366899|75982385|FG000|Infant Series|Physician Decision|1|||
42175390|NCT00366899|75982386|FG001|Infant Series|Physician Decision|0|||
42175391|NCT00366899|75982385|FG000|Infant Series|Randomized but not consented|1|||
42175392|NCT00366899|75982386|FG001|Infant Series|Randomized but not consented|0|||
42175393|NCT00366899|75982385|FG000|After Infant Series|Lost to Follow-up|4|||
42175394|NCT00366899|75982386|FG001|After Infant Series|Lost to Follow-up|3|||
42175395|NCT00366899|75982385|FG000|After Infant Series|Withdrawal by Subject|1|||
42066054|NCT00609973|75875147|FG000|Overall Study|Withdrawal by Subject|0|||
42066055|NCT00609973|75875148|FG001|Overall Study|Withdrawal by Subject|1|||
42066056|NCT00803049|75875158|FG000|Overall Study|Adverse Event|21|||
42066057|NCT00803049|75875159|FG001|Overall Study|Adverse Event|33|||
42066058|NCT00803049|75875160|FG002|Overall Study|Adverse Event|13|||
42066059|NCT00803049|75875161|FG003|Overall Study|Adverse Event|27|||
42066060|NCT00803049|75875158|FG000|Overall Study|Lack of Efficacy|10|||
42066061|NCT00803049|75875159|FG001|Overall Study|Lack of Efficacy|19|||
42066062|NCT00803049|75875160|FG002|Overall Study|Lack of Efficacy|6|||
42066063|NCT00803049|75875161|FG003|Overall Study|Lack of Efficacy|13|||
42066064|NCT00803049|75875158|FG000|Overall Study|Lost to Follow-up|0|||
42066065|NCT00803049|75875159|FG001|Overall Study|Lost to Follow-up|2|||
42066066|NCT00803049|75875160|FG002|Overall Study|Lost to Follow-up|0|||
42066067|NCT00803049|75875161|FG003|Overall Study|Lost to Follow-up|3|||
42066068|NCT00803049|75875158|FG000|Overall Study|Death|2|||
42066069|NCT00803049|75875159|FG001|Overall Study|Death|1|||
42292231|NCT03739112|76125974|FG001|Overall Study|Randomized but not vaccinated|25|||
42292232|NCT03622593|76125983|FG000|Overall Study|Withdrawal by Subject|11|||
42292233|NCT03622593|76125984|FG001|Overall Study|Withdrawal by Subject|9|||
42066070|NCT00803049|75875160|FG002|Overall Study|Death|0|||
42066071|NCT00803049|75875161|FG003|Overall Study|Death|2|||
42066072|NCT00803049|75875158|FG000|Overall Study|Progressive Disease|6|||
42066073|NCT00803049|75875159|FG001|Overall Study|Progressive Disease|10|||
42066074|NCT00803049|75875160|FG002|Overall Study|Progressive Disease|6|||
42066075|NCT00803049|75875161|FG003|Overall Study|Progressive Disease|6|||
42066076|NCT00803049|75875158|FG000|Overall Study|Withdrawal by Subject|19|||
42066077|NCT00803049|75875159|FG001|Overall Study|Withdrawal by Subject|43|||
42066078|NCT00803049|75875160|FG002|Overall Study|Withdrawal by Subject|16|||
42066079|NCT00803049|75875161|FG003|Overall Study|Withdrawal by Subject|44|||
42066080|NCT00803049|75875158|FG000|Overall Study|Protocol Violation|0|||
42175396|NCT00366899|75982386|FG001|After Infant Series|Withdrawal by Subject|4|||
42175397|NCT00366899|75982385|FG000|After Infant Series|Adverse Event|1|||
42175398|NCT00366899|75982386|FG001|After Infant Series|Adverse Event|2|||
42066081|NCT00803049|75875159|FG001|Overall Study|Protocol Violation|1|||
42066082|NCT00803049|75875160|FG002|Overall Study|Protocol Violation|1|||
42175399|NCT00366899|75982385|FG000|After Infant Series|Protocol Violation|1|||
42175400|NCT00366899|75982386|FG001|After Infant Series|Protocol Violation|0|||
42175401|NCT00366899|75982385|FG000|Toddler Dose|Withdrawal by Subject|1|||
42175402|NCT00366899|75982386|FG001|Toddler Dose|Withdrawal by Subject|1|||
42175403|NCT00366899|75982385|FG000|Toddler Dose|Protocol Violation|1|||
42175404|NCT00366899|75982386|FG001|Toddler Dose|Protocol Violation|0|||
42175405|NCT03254134|75982420|FG000|Overall Study|Not eligible patients|599|||
42175406|NCT03254134|75982421|FG001|Overall Study|Not eligible patients|3630|||
42175407|NCT00037830|75982430|FG000|Overall Study|Adverse Event|2|||
42175408|NCT00037830|75982431|FG001|Overall Study|Adverse Event|0|||
42175409|NCT00037830|75982432|FG002|Overall Study|Adverse Event|0|||
42175410|NCT00037830|75982430|FG000|Overall Study|Withdrawal by Subject|4|||
42175411|NCT00037830|75982431|FG001|Overall Study|Withdrawal by Subject|5|||
42175412|NCT00037830|75982432|FG002|Overall Study|Withdrawal by Subject|1|||
42175413|NCT00037830|75982430|FG000|Overall Study|Protocol Violation|2|||
42175414|NCT00037830|75982431|FG001|Overall Study|Protocol Violation|2|||
42175415|NCT00037830|75982432|FG002|Overall Study|Protocol Violation|0|||
42175416|NCT00037830|75982430|FG000|Overall Study|Unrelated Medical Problem|2|||
42175417|NCT00037830|75982431|FG001|Overall Study|Unrelated Medical Problem|0|||
42175418|NCT00037830|75982432|FG002|Overall Study|Unrelated Medical Problem|0|||
42175419|NCT03242434|75982442|FG000|Overall Study|Death|0|||
42175420|NCT03242434|75982443|FG001|Overall Study|Death|2|||
42175421|NCT02939014|75982452|FG000|Overall Study|Lost to Follow-up|1|||
42175422|NCT02939014|75982453|FG001|Overall Study|Lost to Follow-up|0|||
42292234|NCT03622593|76125985|FG002|Overall Study|Withdrawal by Subject|13|||
42292235|NCT03622593|76125983|FG000|Overall Study|Death|12|||
42292236|NCT03622593|76125984|FG001|Overall Study|Death|9|||
42292237|NCT03622593|76125985|FG002|Overall Study|Death|10|||
42292238|NCT03622593|76125983|FG000|Overall Study|Lost to Follow-up|11|||
42292239|NCT03622593|76125984|FG001|Overall Study|Lost to Follow-up|5|||
42292240|NCT03622593|76125985|FG002|Overall Study|Lost to Follow-up|8|||
42292241|NCT03622593|76125983|FG000|Overall Study|Adverse Event|4|||
42292242|NCT03622593|76125984|FG001|Overall Study|Adverse Event|5|||
42066083|NCT00803049|75875161|FG003|Overall Study|Protocol Violation|0|||
42175423|NCT02939014|75982452|FG000|Overall Study|Death|4|||
42175424|NCT02939014|75982453|FG001|Overall Study|Death|3|||
42175425|NCT00051558|75982462|FG000|Overall Study|Adverse Event|30|||
42175426|NCT00051558|75982463|FG001|Overall Study|Adverse Event|18|||
42175427|NCT00051558|75982462|FG000|Overall Study|Withdrawal by Subject|29|||
42066084|NCT00803049|75875158|FG000|Overall Study|Randomized and Not Treated|0|||
42175428|NCT00051558|75982463|FG001|Overall Study|Withdrawal by Subject|42|||
42066085|NCT00803049|75875159|FG001|Overall Study|Randomized and Not Treated|0|||
42066086|NCT00803049|75875160|FG002|Overall Study|Randomized and Not Treated|0|||
42292243|NCT03622593|76125985|FG002|Overall Study|Adverse Event|6|||
42292244|NCT03622593|76125983|FG000|Overall Study|Physician Decision|2|||
42292245|NCT03622593|76125984|FG001|Overall Study|Physician Decision|1|||
42292246|NCT03622593|76125985|FG002|Overall Study|Physician Decision|6|||
42066087|NCT00803049|75875161|FG003|Overall Study|Randomized and Not Treated|2|||
42066088|NCT00803049|75875158|FG000|Overall Study|Other than Specified Above|3|||
42066089|NCT00803049|75875159|FG001|Overall Study|Other than Specified Above|9|||
42066090|NCT00803049|75875160|FG002|Overall Study|Other than Specified Above|2|||
42066091|NCT00803049|75875161|FG003|Overall Study|Other than Specified Above|5|||
42066092|NCT00890084|75875171|FG000|Overall Study|Adverse Event|16|||
42066093|NCT00890084|75875171|FG000|Overall Study|Lost to Follow-up|126|||
42066094|NCT00802893|75875184|FG000|Overall Study|study terminated|3|||
42066095|NCT00608569|75875205|FG000|Overall Study|Death|4|||
42066096|NCT00608569|75875206|FG001|Overall Study|Death|3|||
42066097|NCT00608569|75875205|FG000|Overall Study|Lost to Follow-up|4|||
42066098|NCT00608569|75875206|FG001|Overall Study|Lost to Follow-up|5|||
42066099|NCT00608569|75875205|FG000|Overall Study|Withdrawal by Subject|1|||
42066100|NCT00608569|75875206|FG001|Overall Study|Withdrawal by Subject|0|||
42066101|NCT00608569|75875205|FG000|Overall Study|Adverse Event|1|||
42066102|NCT00608569|75875206|FG001|Overall Study|Adverse Event|0|||
42066103|NCT00608569|75875205|FG000|Overall Study|Unable to adhere with study requirements|0|||
42066104|NCT00608569|75875206|FG001|Overall Study|Unable to adhere with study requirements|1|||
42066105|NCT00610675|75875212|FG000|Overall Study|Untreated|4|||
42066106|NCT00610675|75875212|FG000|Overall Study|Adverse Event|67|||
42066107|NCT00610675|75875212|FG000|Overall Study|Insufficient Effect|31|||
42066108|NCT00610675|75875212|FG000|Overall Study|Withdrawal by Subject|28|||
42066109|NCT00610675|75875212|FG000|Overall Study|Reasons unrelated to trial|27|||
42066110|NCT00610675|75875212|FG000|Overall Study|Lack of Compliance|7|||
42066111|NCT00610675|75875212|FG000|Overall Study|Lost to Follow-up|31|||
42066112|NCT00610675|75875212|FG000|Overall Study|Other reason (not specified)|25|||
42066113|NCT00888134|75875216|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
42066114|NCT00888134|75875216|FG000|Follow-up|being followed for long-term survival|1|||
42066115|NCT00573157|75875223|FG000|Overall Study|Adverse Event|3|||
42066116|NCT00573157|75875224|FG001|Overall Study|Adverse Event|1|||
42066117|NCT00573157|75875223|FG000|Overall Study|Other|1|||
42066118|NCT00573157|75875224|FG001|Overall Study|Other|1|||
42066119|NCT00802737|75875233|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
42066120|NCT00802737|75875234|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
42066121|NCT00802737|75875235|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
42066122|NCT00802737|75875233|FG000|Overall Study|Death|6|||
42066123|NCT00802737|75875234|FG001|Overall Study|Death|5|||
42066124|NCT00802737|75875235|FG002|Overall Study|Death|1|||
42066125|NCT00802737|75875233|FG000|Overall Study|Adverse Event|1|||
42066126|NCT00802737|75875234|FG001|Overall Study|Adverse Event|0|||
42066127|NCT00802737|75875235|FG002|Overall Study|Adverse Event|0|||
42066128|NCT00802737|75875233|FG000|Overall Study|Received Prohibited Therapy|1|||
42066129|NCT00802737|75875234|FG001|Overall Study|Received Prohibited Therapy|0|||
42066130|NCT00802737|75875235|FG002|Overall Study|Received Prohibited Therapy|0|||
42066131|NCT00802737|75875233|FG000|Overall Study|Ongoing CLL-Treatment|0|||
42066132|NCT00802737|75875234|FG001|Overall Study|Ongoing CLL-Treatment|1|||
42066133|NCT00802737|75875235|FG002|Overall Study|Ongoing CLL-Treatment|0|||
42066134|NCT00802737|75875233|FG000|Overall Study|Participant too Unwell|0|||
42066135|NCT00802737|75875234|FG001|Overall Study|Participant too Unwell|2|||
42066136|NCT00802737|75875235|FG002|Overall Study|Participant too Unwell|0|||
42066137|NCT00588861|75875246|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
42066138|NCT00588861|75875247|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
42066139|NCT00588861|75875246|FG000|6 Months|Patients did not return for follow-up|98|||
42066140|NCT00588861|75875247|FG001|6 Months|Patients did not return for follow-up|73|||
42066141|NCT00588861|75875246|FG000|1 Year|Patients did not return for follow-up|89|||
42066142|NCT00588861|75875247|FG001|1 Year|Patients did not return for follow-up|82|||
42292247|NCT03622593|76125983|FG000|Overall Study|Other|2|||
42292248|NCT03622593|76125984|FG001|Overall Study|Other|2|||
42292249|NCT03622593|76125985|FG002|Overall Study|Other|3|||
42292250|NCT03622593|76125983|FG000|Overall Study|Protocol Violation|0|||
42292251|NCT03622593|76125984|FG001|Overall Study|Protocol Violation|0|||
42066143|NCT00588861|75875246|FG000|2 Years|Patients did not return for follow-up|92|||
42066144|NCT00588861|75875247|FG001|2 Years|Patients did not return for follow-up|87|||
42066145|NCT00588861|75875246|FG000|4 Years|Patients did not return for follow-up|91|||
42066146|NCT00588861|75875247|FG001|4 Years|Patients did not return for follow-up|103|||
42066147|NCT00588861|75875246|FG000|6 Years|Patients did not return for follow-up|104|||
42066148|NCT00588861|75875247|FG001|6 Years|Patients did not return for follow-up|109|||
42066149|NCT00588861|75875246|FG000|8 Years|Patients did not return for follow-up|105|||
42175429|NCT00051558|75982462|FG000|Overall Study|Death|9|||
42292252|NCT03622593|76125985|FG002|Overall Study|Protocol Violation|1|||
42066150|NCT00588861|75875247|FG001|8 Years|Patients did not return for follow-up|114|||
42066151|NCT00588861|75875246|FG000|10 Years|Incomplete due to study termination|107|||
42066152|NCT00588861|75875247|FG001|10 Years|Incomplete due to study termination|114|||
42066153|NCT00887978|75875255|FG000|Overall Study|Adverse Event|18|||
42066154|NCT00887978|75875256|FG001|Overall Study|Adverse Event|5|||
42292253|NCT03622593|76125983|FG000|Overall Study|Pregnancy|0|||
42066155|NCT00887978|75875255|FG000|Overall Study|Clinical Worsening|4|||
42066156|NCT00887978|75875256|FG001|Overall Study|Clinical Worsening|4|||
42066157|NCT00887978|75875255|FG000|Overall Study|Death|2|||
42066158|NCT00887978|75875256|FG001|Overall Study|Death|3|||
42066159|NCT00887978|75875255|FG000|Overall Study|Withdrawal by Subject|1|||
42066160|NCT00887978|75875256|FG001|Overall Study|Withdrawal by Subject|2|||
42066161|NCT00887978|75875255|FG000|Overall Study|Lost to Follow-up|0|||
42066162|NCT00887978|75875256|FG001|Overall Study|Lost to Follow-up|1|||
42066163|NCT00608023|75875265|FG000|Overall Study|Withdrawal by Subject|8|||
42066164|NCT00608023|75875266|FG001|Overall Study|Withdrawal by Subject|10|||
42066165|NCT00608023|75875267|FG002|Overall Study|Withdrawal by Subject|7|||
42066166|NCT00608023|75875265|FG000|Overall Study|Adverse Event|1|||
42066167|NCT00608023|75875266|FG001|Overall Study|Adverse Event|4|||
42066168|NCT00608023|75875267|FG002|Overall Study|Adverse Event|5|||
42066169|NCT00608023|75875265|FG000|Overall Study|Lost to Follow-up|2|||
42066170|NCT00608023|75875266|FG001|Overall Study|Lost to Follow-up|2|||
42066171|NCT00608023|75875267|FG002|Overall Study|Lost to Follow-up|1|||
42066172|NCT00608023|75875265|FG000|Overall Study|Protocol Violation|1|||
42066173|NCT00608023|75875266|FG001|Overall Study|Protocol Violation|3|||
42066174|NCT00608023|75875267|FG002|Overall Study|Protocol Violation|1|||
42066175|NCT00608023|75875265|FG000|Overall Study|Unknown reason|0|||
42066176|NCT00608023|75875266|FG001|Overall Study|Unknown reason|3|||
42066177|NCT00608023|75875267|FG002|Overall Study|Unknown reason|0|||
42066178|NCT00802659|75875282|FG000|Overall Study|Physician Decision|0|||
42066179|NCT00802659|75875283|FG001|Overall Study|Physician Decision|1|||
42066180|NCT00802659|75875284|FG002|Overall Study|Physician Decision|0|||
42066181|NCT00802659|75875285|FG003|Overall Study|Physician Decision|0|||
42066182|NCT00607789|75875297|FG000|Overall Study|Adverse Event|3|||
42066183|NCT00607789|75875298|FG001|Overall Study|Adverse Event|0|||
42066184|NCT00607789|75875297|FG000|Overall Study|Lack of Efficacy|0|||
42066185|NCT00607789|75875298|FG001|Overall Study|Lack of Efficacy|1|||
42066186|NCT00607789|75875297|FG000|Overall Study|Inadequate adherence|3|||
42066187|NCT00607789|75875298|FG001|Overall Study|Inadequate adherence|0|||
42066188|NCT00607789|75875297|FG000|Overall Study|Lost to Follow-up|0|||
42066189|NCT00607789|75875298|FG001|Overall Study|Lost to Follow-up|5|||
42066190|NCT00607789|75875297|FG000|Overall Study|Withdrawal by Subject|1|||
42066191|NCT00607789|75875298|FG001|Overall Study|Withdrawal by Subject|0|||
42066192|NCT00887822|75875306|FG000|Overall Study|Insufficient therapeutic response|53|||
42066193|NCT00887822|75875307|FG001|Overall Study|Insufficient therapeutic response|55|||
42066194|NCT00887822|75875306|FG000|Overall Study|Adverse Event|14|||
42066195|NCT00887822|75875307|FG001|Overall Study|Adverse Event|17|||
42066196|NCT00887822|75875306|FG000|Overall Study|Failure to return|11|||
42066197|NCT00887822|75875307|FG001|Overall Study|Failure to return|11|||
42066198|NCT00887822|75875306|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
42066199|NCT00887822|75875307|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
42066200|NCT00887822|75875306|FG000|Overall Study|Administrative/Other than specified|5|||
42066201|NCT00887822|75875307|FG001|Overall Study|Administrative/Other than specified|4|||
42066202|NCT00887822|75875306|FG000|Overall Study|Death|2|||
42066203|NCT00887822|75875307|FG001|Overall Study|Death|3|||
42066204|NCT00887822|75875306|FG000|Overall Study|Protocol Violation|0|||
42066205|NCT00887822|75875307|FG001|Overall Study|Protocol Violation|1|||
42066206|NCT00887822|75875306|FG000|Overall Study|Randomized but not treated|0|||
42066207|NCT00887822|75875307|FG001|Overall Study|Randomized but not treated|1|||
42066208|NCT00951665|75875319|FG000|Phase 1b|Adverse Event|2|||
42066209|NCT00951665|75875320|FG001|Phase 1b|Adverse Event|1|||
42066210|NCT00951665|75875321|FG002|Phase 1b|Adverse Event|0|||
42066211|NCT00951665|75875322|FG003|Phase 1b|Adverse Event|1|||
42066212|NCT00951665|75875323|FG004|Phase 1b|Adverse Event|0|||
42066213|NCT00951665|75875324|FG005|Phase 1b|Adverse Event|0|||
42066214|NCT00951665|75875319|FG000|Phase 1b|Death|1|||
42066215|NCT00951665|75875320|FG001|Phase 1b|Death|0|||
42066216|NCT00951665|75875321|FG002|Phase 1b|Death|2|||
42066217|NCT00951665|75875322|FG003|Phase 1b|Death|0|||
42066218|NCT00951665|75875323|FG004|Phase 1b|Death|0|||
42357518|NCT01831765|76202930|FG002|Overall Study|Withdrawal criteria|16|||
42066219|NCT00951665|75875324|FG005|Phase 1b|Death|0|||
42066220|NCT00951665|75875319|FG000|Phase 1b|Physician Decision|4|||
42066221|NCT00951665|75875320|FG001|Phase 1b|Physician Decision|0|||
42066222|NCT00951665|75875321|FG002|Phase 1b|Physician Decision|1|||
42066223|NCT00951665|75875322|FG003|Phase 1b|Physician Decision|0|||
42066224|NCT00951665|75875323|FG004|Phase 1b|Physician Decision|0|||
42357519|NCT01831765|76202928|FG000|Overall Study|Lost to Follow-up|2|||
42357520|NCT01831765|76202929|FG001|Overall Study|Lost to Follow-up|3|||
42066225|NCT00951665|75875324|FG005|Phase 1b|Physician Decision|0|||
42066226|NCT00951665|75875319|FG000|Phase 1b|Withdrawal by Subject|0|||
42066227|NCT00951665|75875320|FG001|Phase 1b|Withdrawal by Subject|1|||
42066228|NCT00951665|75875321|FG002|Phase 1b|Withdrawal by Subject|0|||
42066229|NCT00951665|75875322|FG003|Phase 1b|Withdrawal by Subject|0|||
42066230|NCT00951665|75875323|FG004|Phase 1b|Withdrawal by Subject|0|||
42066231|NCT00951665|75875324|FG005|Phase 1b|Withdrawal by Subject|0|||
42066232|NCT00951665|75875319|FG000|Phase 1b|Disease Progression|13|||
42357521|NCT01831765|76202930|FG002|Overall Study|Lost to Follow-up|3|||
42357522|NCT01749800|76202943|FG000|Overall Study|not meeting inclusion criteria|3|||
42357523|NCT01749800|76202944|FG001|Overall Study|not meeting inclusion criteria|0|||
42357524|NCT01749800|76202945|FG002|Overall Study|not meeting inclusion criteria|0|||
42357525|NCT01749800|76202943|FG000|Overall Study|Withdrawal by Subject|0|||
42357526|NCT01749800|76202944|FG001|Overall Study|Withdrawal by Subject|1|||
42357527|NCT01749800|76202945|FG002|Overall Study|Withdrawal by Subject|0|||
42357528|NCT01830595|76202953|FG000|First Period|Withdrawal by Subject|1|||
42357529|NCT01830595|76202954|FG001|First Period|Withdrawal by Subject|3|||
42357530|NCT01830595|76202953|FG000|Washout|Withdrawal by Subject|2|||
42357531|NCT01830595|76202954|FG001|Washout|Withdrawal by Subject|2|||
42175430|NCT00051558|75982463|FG001|Overall Study|Death|15|||
42175431|NCT00051558|75982462|FG000|Overall Study|Lost to Follow-up|4|||
42175432|NCT00051558|75982463|FG001|Overall Study|Lost to Follow-up|13|||
42175433|NCT00051558|75982462|FG000|Overall Study|Protocol Violation|3|||
42175434|NCT00051558|75982463|FG001|Overall Study|Protocol Violation|4|||
42175435|NCT00051558|75982462|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
42175436|NCT00051558|75982463|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
42175437|NCT00051558|75982462|FG000|Overall Study|Sponsor Decision|6|||
42175438|NCT00051558|75982463|FG001|Overall Study|Sponsor Decision|1|||
42175439|NCT00051558|75982462|FG000|Overall Study|Other|2|||
42175440|NCT00051558|75982463|FG001|Overall Study|Other|1|||
42175441|NCT00051558|75982462|FG000|Overall Study|Significant Lab Value|2|||
42175442|NCT00051558|75982463|FG001|Overall Study|Significant Lab Value|0|||
42175443|NCT00051558|75982462|FG000|Overall Study|Physician Decision|5|||
42357532|NCT01748552|76202972|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
42357533|NCT01748552|76202973|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
42066233|NCT00951665|75875320|FG001|Phase 1b|Disease Progression|2|||
42066234|NCT00951665|75875321|FG002|Phase 1b|Disease Progression|14|||
42066235|NCT00951665|75875322|FG003|Phase 1b|Disease Progression|0|||
42066236|NCT00951665|75875323|FG004|Phase 1b|Disease Progression|0|||
42066237|NCT00951665|75875324|FG005|Phase 1b|Disease Progression|0|||
42066238|NCT00951665|75875319|FG000|Phase 1b|Protocol Violation|2|||
42066239|NCT00951665|75875320|FG001|Phase 1b|Protocol Violation|0|||
42066240|NCT00951665|75875321|FG002|Phase 1b|Protocol Violation|0|||
42066241|NCT00951665|75875322|FG003|Phase 1b|Protocol Violation|0|||
42066242|NCT00951665|75875323|FG004|Phase 1b|Protocol Violation|0|||
42066243|NCT00951665|75875324|FG005|Phase 1b|Protocol Violation|0|||
42066244|NCT00951665|75875319|FG000|Phase 2a|Adverse Event|0|||
42066245|NCT00951665|75875320|FG001|Phase 2a|Adverse Event|0|||
42066246|NCT00951665|75875321|FG002|Phase 2a|Adverse Event|0|||
42066247|NCT00951665|75875322|FG003|Phase 2a|Adverse Event|0|||
42066248|NCT00951665|75875323|FG004|Phase 2a|Adverse Event|2|||
42066249|NCT00951665|75875324|FG005|Phase 2a|Adverse Event|0|||
42066250|NCT00951665|75875319|FG000|Phase 2a|Death|0|||
42066251|NCT00951665|75875320|FG001|Phase 2a|Death|0|||
42066252|NCT00951665|75875321|FG002|Phase 2a|Death|0|||
42175444|NCT00051558|75982463|FG001|Overall Study|Physician Decision|0|||
42066253|NCT00951665|75875322|FG003|Phase 2a|Death|0|||
42066254|NCT00951665|75875323|FG004|Phase 2a|Death|1|||
42066255|NCT00951665|75875324|FG005|Phase 2a|Death|1|||
42066256|NCT00951665|75875319|FG000|Phase 2a|Lost to Follow-up|0|||
42066257|NCT00951665|75875320|FG001|Phase 2a|Lost to Follow-up|0|||
42175445|NCT03251482|75982474|FG000|Overall Study|Withdrawal by Subject|0|||
42175446|NCT03251482|75982475|FG001|Overall Study|Withdrawal by Subject|1|||
42175447|NCT03251482|75982476|FG002|Overall Study|Withdrawal by Subject|0|||
42175448|NCT03251482|75982477|FG003|Overall Study|Withdrawal by Subject|0|||
42175449|NCT03251482|75982478|FG004|Overall Study|Withdrawal by Subject|0|||
42066258|NCT00951665|75875321|FG002|Phase 2a|Lost to Follow-up|0|||
42066259|NCT00951665|75875322|FG003|Phase 2a|Lost to Follow-up|0|||
42066260|NCT00951665|75875323|FG004|Phase 2a|Lost to Follow-up|1|||
42175450|NCT03249454|75982490|FG000|Overall Study|Withdrawal by Subject|0|||
42175451|NCT03249454|75982491|FG001|Overall Study|Withdrawal by Subject|0|||
42175452|NCT03249454|75982492|FG002|Overall Study|Withdrawal by Subject|0|||
42175453|NCT03249454|75982493|FG003|Overall Study|Withdrawal by Subject|0|||
42175454|NCT03249454|75982494|FG004|Overall Study|Withdrawal by Subject|0|||
42066261|NCT00951665|75875324|FG005|Phase 2a|Lost to Follow-up|0|||
42066262|NCT00951665|75875319|FG000|Phase 2a|Physician Decision|0|||
42066263|NCT00951665|75875320|FG001|Phase 2a|Physician Decision|0|||
42066264|NCT00951665|75875321|FG002|Phase 2a|Physician Decision|0|||
42357534|NCT01748552|76202974|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
42066265|NCT00951665|75875322|FG003|Phase 2a|Physician Decision|0|||
42066266|NCT00951665|75875323|FG004|Phase 2a|Physician Decision|0|||
42066267|NCT00951665|75875324|FG005|Phase 2a|Physician Decision|1|||
42066268|NCT00951665|75875319|FG000|Phase 2a|Withdrawal by Subject|0|||
42066269|NCT00951665|75875320|FG001|Phase 2a|Withdrawal by Subject|0|||
42066270|NCT00951665|75875321|FG002|Phase 2a|Withdrawal by Subject|0|||
42066271|NCT00951665|75875322|FG003|Phase 2a|Withdrawal by Subject|0|||
42066272|NCT00951665|75875323|FG004|Phase 2a|Withdrawal by Subject|2|||
42066273|NCT00951665|75875324|FG005|Phase 2a|Withdrawal by Subject|0|||
42066274|NCT00951665|75875319|FG000|Phase 2a|Disease Progression|0|||
42066275|NCT00951665|75875320|FG001|Phase 2a|Disease Progression|0|||
42066276|NCT00951665|75875321|FG002|Phase 2a|Disease Progression|0|||
42066277|NCT00951665|75875322|FG003|Phase 2a|Disease Progression|0|||
42066278|NCT00951665|75875323|FG004|Phase 2a|Disease Progression|6|||
42066279|NCT00951665|75875324|FG005|Phase 2a|Disease Progression|5|||
42066280|NCT00801099|75875358|FG000|Overall Study|Lost to Follow-up|101|||
42066281|NCT00887744|75875362|FG000|Overall Study|Adverse Event|3|||
42066282|NCT00887744|75875362|FG000|Overall Study|Death|1|||
42066283|NCT00887744|75875362|FG000|Overall Study|Lost to Follow-up|3|||
42066284|NCT00887744|75875362|FG000|Overall Study|Withdrawal by Subject|18|||
42066285|NCT00887744|75875362|FG000|Overall Study|Various reasons|9|||
42066286|NCT00951509|75875366|FG000|Overall Study|Withdrawal by Subject|2|||
42066287|NCT00610441|75875378|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
42066288|NCT00610441|75875379|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
42066289|NCT00610441|75875380|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
42066290|NCT00610441|75875381|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
42066291|NCT00610441|75875378|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
42066292|NCT00610441|75875379|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
42066293|NCT00610441|75875380|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
42066294|NCT00610441|75875381|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
42066295|NCT00610441|75875378|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
42066296|NCT00610441|75875379|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
42066297|NCT00610441|75875380|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
42066298|NCT00610441|75875381|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
42066299|NCT00610441|75875378|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
42066300|NCT00610441|75875379|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
42066301|NCT00610441|75875380|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
42066302|NCT00610441|75875381|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
42066303|NCT00610441|75875378|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
42066304|NCT00610441|75875379|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
42066305|NCT00610441|75875380|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
42066306|NCT00610441|75875381|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
42066307|NCT00610441|75875378|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
42066308|NCT00610441|75875379|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
42066309|NCT00610441|75875380|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
42066310|NCT00610441|75875381|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
42066311|NCT00610441|75875378|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
42066312|NCT00610441|75875379|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
42066313|NCT00610441|75875380|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
42066314|NCT00610441|75875381|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
42066315|NCT00610441|75875378|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
42066316|NCT00610441|75875379|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
42066317|NCT00610441|75875380|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
42292254|NCT03622593|76125984|FG001|Overall Study|Pregnancy|0|||
42292255|NCT03622593|76125985|FG002|Overall Study|Pregnancy|1|||
42292256|NCT03593655|76125996|FG000|First Product Use Period|Withdrawal by Subject|1|||
42292257|NCT03593655|76125997|FG001|First Product Use Period|Withdrawal by Subject|1|||
42292258|NCT03593655|76125996|FG000|First Product Use Period|Lost to Follow-up|1|||
42292259|NCT03593655|76125997|FG001|First Product Use Period|Lost to Follow-up|3|||
42292260|NCT03593655|76125996|FG000|Second Product Use Period|Withdrawal by Subject|1|||
42292261|NCT03593655|76125997|FG001|Second Product Use Period|Withdrawal by Subject|1|||
42292262|NCT03593655|76125996|FG000|Second Product Use Period|Lost to Follow-up|1|||
42292263|NCT03593655|76125997|FG001|Second Product Use Period|Lost to Follow-up|0|||
42292264|NCT03593655|76125996|FG000|Third Product Use Period|Lost to Follow-up|1|||
42292265|NCT03593655|76125997|FG001|Third Product Use Period|Lost to Follow-up|2|||
42066318|NCT00610441|75875381|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
42066319|NCT00610441|75875378|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
42066320|NCT00610441|75875379|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
42066321|NCT00610441|75875380|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
42066322|NCT00610441|75875381|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
42066323|NCT00799617|75875395|FG000|Main Testosterone Trial|Randomized in error|1|||
42292266|NCT03593655|76125996|FG000|Third Product Use Period|Physician Decision|0|||
42292267|NCT03593655|76125997|FG001|Third Product Use Period|Physician Decision|1|||
42292268|NCT03593655|76125996|FG000|Third Product Use Period|Withdrawal by Subject|0|||
42066324|NCT00799617|75875396|FG001|Main Testosterone Trial|Randomized in error|1|||
42066325|NCT00799617|75875395|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
42066326|NCT00799617|75875396|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
42066327|NCT00799617|75875395|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
42066328|NCT00799617|75875396|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
42066329|NCT00799617|75875395|FG000|Sexual Funtion Trial|No Baseline Data|4|||
42066330|NCT00799617|75875396|FG001|Sexual Funtion Trial|No Baseline Data|7|||
42066331|NCT00799617|75875395|FG000|Physical Function Trial|Lost to Follow-up|6|||
42066332|NCT00799617|75875396|FG001|Physical Function Trial|Lost to Follow-up|11|||
42066333|NCT00799617|75875395|FG000|Vitality Trial|Lost to Follow-up|7|||
42066334|NCT00799617|75875396|FG001|Vitality Trial|Lost to Follow-up|22|||
42066335|NCT00799617|75875395|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
42066336|NCT00799617|75875396|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
42066337|NCT00799617|75875395|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
42066338|NCT00799617|75875396|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
42066339|NCT00799617|75875395|FG000|Bone Trial|Month 12 scan not available|6|||
42066340|NCT00799617|75875396|FG001|Bone Trial|Month 12 scan not available|16|||
42066341|NCT00799617|75875395|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
42066342|NCT00799617|75875396|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
42175455|NCT03249454|75982495|FG005|Overall Study|Withdrawal by Subject|0|||
42175456|NCT03249454|75982496|FG006|Overall Study|Withdrawal by Subject|0|||
42175457|NCT03249454|75982497|FG007|Overall Study|Withdrawal by Subject|0|||
42175458|NCT03249454|75982498|FG008|Overall Study|Withdrawal by Subject|0|||
42175459|NCT03249454|75982499|FG009|Overall Study|Withdrawal by Subject|1|||
42175460|NCT03249454|75982500|FG010|Overall Study|Withdrawal by Subject|1|||
42175461|NCT03732248|75982513|FG000|Overall Study|Withdrawal by Subject|1|||
42175462|NCT03732248|75982514|FG001|Overall Study|Withdrawal by Subject|0|||
42175463|NCT00310037|75982522|FG000|Overall Study|Adverse Event|7|||
42175464|NCT00310037|75982523|FG001|Overall Study|Adverse Event|14|||
42175465|NCT00310037|75982522|FG000|Overall Study|Withdrawal by Subject|4|||
42175466|NCT00310037|75982523|FG001|Overall Study|Withdrawal by Subject|3|||
42175467|NCT00310037|75982522|FG000|Overall Study|Progression|6|||
42175468|NCT00310037|75982523|FG001|Overall Study|Progression|0|||
42175469|NCT00310037|75982522|FG000|Overall Study|Non-protocol treatment|1|||
42175470|NCT00310037|75982523|FG001|Overall Study|Non-protocol treatment|0|||
42175471|NCT00309959|75982529|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
42175472|NCT03238924|75982540|FG000|Overall Study|Withdrawal by Subject|2|||
42175473|NCT03238924|75982541|FG001|Overall Study|Withdrawal by Subject|2|||
42175474|NCT03247816|75982547|FG000|Overall Study|Adverse Event|12|||
42175475|NCT03247816|75982547|FG000|Overall Study|Physician Decision|3|||
42175476|NCT03247816|75982547|FG000|Overall Study|Lack of Efficacy|1|||
42175477|NCT03247816|75982547|FG000|Overall Study|Lost to Follow-up|10|||
42175478|NCT03247816|75982547|FG000|Overall Study|Missing Feraccru stop date|3|||
42175479|NCT00333359|75982565|FG000|Overall Study|Adverse Event|29|||
42175480|NCT00333359|75982566|FG001|Overall Study|Adverse Event|35|||
42175481|NCT00333359|75982565|FG000|Overall Study|Withdrawal by Subject|19|||
42175482|NCT00333359|75982566|FG001|Overall Study|Withdrawal by Subject|37|||
42292269|NCT03593655|76125997|FG001|Third Product Use Period|Withdrawal by Subject|1|||
42292270|NCT03577106|76126006|FG000|Overall Study|Withdrawal by Subject|3|||
42292271|NCT03364231|76126016|FG000|Overall Study|Adverse Event|1|||
42292272|NCT03364231|76126017|FG001|Overall Study|Adverse Event|4|||
42292273|NCT03364231|76126016|FG000|Overall Study|Death|1|||
42292274|NCT03364231|76126017|FG001|Overall Study|Death|0|||
42066343|NCT00799617|75875395|FG000|Anemia Trial|Withdrawal by Subject|3|||
42066344|NCT00799617|75875396|FG001|Anemia Trial|Withdrawal by Subject|3|||
42066345|NCT00607087|75875405|FG000|Overall Study|Withdrawal by Subject|9|||
42175483|NCT00333359|75982565|FG000|Overall Study|Physician Decision|2|||
42175484|NCT00333359|75982566|FG001|Overall Study|Physician Decision|2|||
42175485|NCT00333359|75982565|FG000|Overall Study|Protocol Non-compliance|2|||
42175486|NCT00333359|75982566|FG001|Overall Study|Protocol Non-compliance|8|||
42175487|NCT00333359|75982565|FG000|Overall Study|Lost to Follow-up|15|||
42175488|NCT00333359|75982566|FG001|Overall Study|Lost to Follow-up|25|||
42292275|NCT03364231|76126016|FG000|Overall Study|Investigator Decision|2|||
42292276|NCT03364231|76126017|FG001|Overall Study|Investigator Decision|2|||
42066346|NCT00607087|75875406|FG001|Overall Study|Withdrawal by Subject|4|||
42175489|NCT00333359|75982565|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
42175490|NCT00333359|75982566|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
42175491|NCT00333359|75982565|FG000|Overall Study|Treatment Failure|3|||
42175492|NCT00333359|75982566|FG001|Overall Study|Treatment Failure|8|||
42175493|NCT00333359|75982565|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
42292277|NCT03364231|76126016|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
42292278|NCT03364231|76126017|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
42066347|NCT00607087|75875407|FG002|Overall Study|Withdrawal by Subject|4|||
42066348|NCT00607087|75875405|FG000|Overall Study|Adverse Event|3|||
42066349|NCT00607087|75875406|FG001|Overall Study|Adverse Event|2|||
42175494|NCT00333359|75982566|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
42066350|NCT00607087|75875407|FG002|Overall Study|Adverse Event|3|||
42066351|NCT00607087|75875405|FG000|Overall Study|Other reason|1|||
42066352|NCT00607087|75875406|FG001|Overall Study|Other reason|5|||
42066353|NCT00607087|75875407|FG002|Overall Study|Other reason|2|||
42066354|NCT00607087|75875405|FG000|Overall Study|Poor compliance to protocol|1|||
42066355|NCT00607087|75875406|FG001|Overall Study|Poor compliance to protocol|0|||
42066356|NCT00607087|75875407|FG002|Overall Study|Poor compliance to protocol|1|||
42066357|NCT00607087|75875405|FG000|Overall Study|Lost to Follow-up|1|||
42066358|NCT00607087|75875406|FG001|Overall Study|Lost to Follow-up|0|||
42066359|NCT00607087|75875407|FG002|Overall Study|Lost to Follow-up|0|||
42066360|NCT00607087|75875405|FG000|Period 1|Withdrawal by Subject|7|||
42066361|NCT00607087|75875406|FG001|Period 1|Withdrawal by Subject|2|||
42066362|NCT00607087|75875407|FG002|Period 1|Withdrawal by Subject|3|||
42066363|NCT00607087|75875405|FG000|Period 1|Adverse Event|3|||
42066364|NCT00607087|75875406|FG001|Period 1|Adverse Event|0|||
42066365|NCT00607087|75875407|FG002|Period 1|Adverse Event|0|||
42066366|NCT00607087|75875405|FG000|Period 1|Poor compliance to protocol|1|||
42066367|NCT00607087|75875406|FG001|Period 1|Poor compliance to protocol|0|||
42066368|NCT00607087|75875407|FG002|Period 1|Poor compliance to protocol|0|||
42066369|NCT00607087|75875405|FG000|Period 1|Lost to Follow-up|1|||
42066370|NCT00607087|75875406|FG001|Period 1|Lost to Follow-up|0|||
42066371|NCT00607087|75875407|FG002|Period 1|Lost to Follow-up|0|||
42066372|NCT00607087|75875405|FG000|Period 1|Other reason|0|||
42066373|NCT00607087|75875406|FG001|Period 1|Other reason|4|||
42066374|NCT00607087|75875407|FG002|Period 1|Other reason|2|||
42066375|NCT00607087|75875405|FG000|Period 2|Withdrawal by Subject|0|||
42066376|NCT00607087|75875406|FG001|Period 2|Withdrawal by Subject|1|||
42066377|NCT00607087|75875407|FG002|Period 2|Withdrawal by Subject|1|||
42066378|NCT00607087|75875405|FG000|Period 2|Other reason|1|||
42066379|NCT00607087|75875406|FG001|Period 2|Other reason|1|||
42066380|NCT00607087|75875407|FG002|Period 2|Other reason|0|||
42066381|NCT00607087|75875405|FG000|Period 2|Adverse Event|0|||
42066382|NCT00607087|75875406|FG001|Period 2|Adverse Event|1|||
42066383|NCT00607087|75875407|FG002|Period 2|Adverse Event|3|||
42066384|NCT00607087|75875405|FG000|Period 2|Poor compliance to protocol|0|||
42066385|NCT00607087|75875406|FG001|Period 2|Poor compliance to protocol|0|||
42066386|NCT00607087|75875407|FG002|Period 2|Poor compliance to protocol|1|||
42066387|NCT00607087|75875405|FG000|Period 3|Withdrawal by Subject|2|||
42066388|NCT00607087|75875406|FG001|Period 3|Withdrawal by Subject|1|||
42066389|NCT00607087|75875407|FG002|Period 3|Withdrawal by Subject|0|||
42066390|NCT00607087|75875405|FG000|Period 3|Adverse Event|0|||
42066391|NCT00607087|75875406|FG001|Period 3|Adverse Event|1|||
42066392|NCT00607087|75875407|FG002|Period 3|Adverse Event|0|||
42066393|NCT00610363|75875417|FG000|Overall Study|Non-compliance with protocol|0|||
42066394|NCT00610363|75875418|FG001|Overall Study|Non-compliance with protocol|1|||
42066395|NCT00610363|75875417|FG000|Overall Study|Adverse Event|3|||
42066396|NCT00610363|75875418|FG001|Overall Study|Adverse Event|1|||
42066397|NCT00610363|75875417|FG000|Overall Study|Lack of Efficacy|2|||
42066398|NCT00610363|75875418|FG001|Overall Study|Lack of Efficacy|0|||
42066399|NCT00610363|75875417|FG000|Overall Study|Lost to Follow-up|4|||
42066400|NCT00610363|75875418|FG001|Overall Study|Lost to Follow-up|0|||
42066401|NCT00610363|75875417|FG000|Overall Study|Withdrawal by Subject|1|||
42066402|NCT00610363|75875418|FG001|Overall Study|Withdrawal by Subject|0|||
42066403|NCT00610363|75875417|FG000|Overall Study|Other than specified above|1|||
42066404|NCT00610363|75875418|FG001|Overall Study|Other than specified above|1|||
42066405|NCT00887588|75875427|FG000|Core Period|Death|1|||
42066406|NCT00887588|75875428|FG001|Core Period|Death|1|||
42066407|NCT00887588|75875427|FG000|Core Period|Lost to Follow-up|3|||
42066408|NCT00887588|75875428|FG001|Core Period|Lost to Follow-up|1|||
42066409|NCT00887588|75875427|FG000|Core Period|Withdrawal by Subject|6|||
42066410|NCT00887588|75875428|FG001|Core Period|Withdrawal by Subject|8|||
42066411|NCT00887588|75875427|FG000|Core Period|Adverse Event|9|||
42066412|NCT00887588|75875428|FG001|Core Period|Adverse Event|11|||
42066413|NCT00887588|75875427|FG000|Extension Period|Adverse Event|4|||
42066414|NCT00887588|75875428|FG001|Extension Period|Adverse Event|4|||
42066415|NCT00887588|75875427|FG000|Extension Period|Death|0|||
42066416|NCT00887588|75875428|FG001|Extension Period|Death|1|||
42066417|NCT00887588|75875427|FG000|Extension Period|Protocol deviation|1|||
42066418|NCT00887588|75875428|FG001|Extension Period|Protocol deviation|0|||
42066419|NCT00887588|75875427|FG000|Extension Period|Lost to Follow-up|1|||
42066420|NCT00887588|75875428|FG001|Extension Period|Lost to Follow-up|0|||
42292279|NCT03364231|76126016|FG000|Overall Study|Withdrawal of Subject Consent|1|||
42066421|NCT00945893|75875436|FG000|Overall Study|Lost to Follow-up|2|||
42066422|NCT00945893|75875437|FG001|Overall Study|Lost to Follow-up|8|||
42066423|NCT00945893|75875436|FG000|Overall Study|Withdrawal of consent|1|||
42066424|NCT00945893|75875437|FG001|Overall Study|Withdrawal of consent|2|||
42066425|NCT00799383|75875449|FG000|Overall Study|Protocol Violation|1|||
42066426|NCT00799383|75875450|FG001|Overall Study|Protocol Violation|1|||
42066427|NCT00799383|75875449|FG000|Overall Study|Adverse Event|0|||
42066428|NCT00799383|75875450|FG001|Overall Study|Adverse Event|1|||
42066429|NCT00799383|75875449|FG000|Overall Study|Lost to Follow-up|1|||
42066430|NCT00799383|75875450|FG001|Overall Study|Lost to Follow-up|2|||
42066431|NCT00799383|75875449|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
42066432|NCT00799383|75875450|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
42066433|NCT00799383|75875449|FG000|Overall Study|Withdrawal by Subject|0|||
42066434|NCT00799383|75875450|FG001|Overall Study|Withdrawal by Subject|1|||
42066435|NCT00610207|75875456|FG000|Overall Study|Lost to Follow-up|3|||
42066436|NCT00798759|75875462|FG000|Overall Study|Adverse Event|3|||
42066437|NCT00798759|75875463|FG001|Overall Study|Adverse Event|3|||
42066438|NCT00798759|75875462|FG000|Overall Study|Lost to Follow-up|1|||
42066439|NCT00798759|75875463|FG001|Overall Study|Lost to Follow-up|1|||
42066440|NCT00798759|75875462|FG000|Overall Study|Protocol Violation|4|||
42066441|NCT00798759|75875463|FG001|Overall Study|Protocol Violation|8|||
42066442|NCT00798759|75875462|FG000|Overall Study|Other|0|||
42066443|NCT00798759|75875463|FG001|Overall Study|Other|1|||
42066444|NCT00887432|75875471|FG000|Overall Study|Start Excluded Therapy|3|||
42066445|NCT00887432|75875472|FG001|Overall Study|Start Excluded Therapy|0|||
42066446|NCT00887432|75875471|FG000|Overall Study|Did not complete treatment|6|||
42066447|NCT00887432|75875472|FG001|Overall Study|Did not complete treatment|8|||
42066448|NCT00887432|75875471|FG000|Overall Study|Protocol Violation|2|||
42066449|NCT00887432|75875472|FG001|Overall Study|Protocol Violation|3|||
42066450|NCT00887432|75875471|FG000|Overall Study|Withdrawal by Subject|3|||
42066451|NCT00887432|75875472|FG001|Overall Study|Withdrawal by Subject|2|||
42066452|NCT00887432|75875471|FG000|Overall Study|Lost to Follow-up|1|||
42066453|NCT00887432|75875472|FG001|Overall Study|Lost to Follow-up|0|||
42066454|NCT00887432|75875471|FG000|Overall Study|No reason provided|0|||
42066455|NCT00887432|75875472|FG001|Overall Study|No reason provided|1|||
42066456|NCT00951275|75875478|FG000|Overall Study|Administrative Reason|1|||
42066457|NCT00951275|75875478|FG000|Overall Study|Adverse Event|7|||
42066458|NCT00951275|75875478|FG000|Overall Study|Withdrawal by Subject|4|||
42066459|NCT00951275|75875478|FG000|Overall Study|Protocol Violation|1|||
42292280|NCT03364231|76126017|FG001|Overall Study|Withdrawal of Subject Consent|0|||
42292281|NCT03364231|76126016|FG000|Overall Study|Reason Not Specified|1|||
42292282|NCT03364231|76126017|FG001|Overall Study|Reason Not Specified|0|||
42292283|NCT03364231|76126016|FG000|Overall Study|Disease Progression|0|||
42292284|NCT03364231|76126017|FG001|Overall Study|Disease Progression|6|||
42292285|NCT03303625|76126028|FG000|Overall Study|Withdrawal by Subject|2|||
42292286|NCT03303625|76126029|FG001|Overall Study|Withdrawal by Subject|0|||
42292287|NCT03303625|76126030|FG002|Overall Study|Withdrawal by Subject|0|||
42292288|NCT03303625|76126031|FG003|Overall Study|Withdrawal by Subject|0|||
42066460|NCT00798603|75875482|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
42066461|NCT00798603|75875482|FG000|Overall Study|Withdrawal by Subject|10|||
42066462|NCT00798603|75875482|FG000|Overall Study|Adverse Event|22|||
42066463|NCT00798603|75875482|FG000|Overall Study|Physician Decision|1|||
42066464|NCT00798603|75875482|FG000|Overall Study|Lack of insurance coverage|1|||
42066465|NCT00887354|75875488|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
42066466|NCT00887354|75875489|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
42066467|NCT00887354|75875488|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
42066468|NCT00887354|75875489|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
42066469|NCT00887354|75875488|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
42066470|NCT00887354|75875489|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
42066471|NCT00887354|75875488|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
42066472|NCT00887354|75875489|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
42066473|NCT00887354|75875488|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
42066474|NCT00887354|75875489|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
42066475|NCT00887354|75875488|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
42066476|NCT00887354|75875489|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
42175495|NCT03246724|75982578|FG000|Overall Study|Withdrawal by Subject|5|||
42292289|NCT03299816|76126043|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
42292290|NCT03299816|76126044|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
42016882|NCT01217892|75824441|FG002|Overall Study|Lab value|1|||
42016883|NCT01217892|75824442|FG003|Overall Study|Lab value|0|||
42016884|NCT01217892|75824439|FG000|Overall Study|Subject no longer meets study criteria|5|||
42016885|NCT01217892|75824440|FG001|Overall Study|Subject no longer meets study criteria|2|||
42016886|NCT01217892|75824441|FG002|Overall Study|Subject no longer meets study criteria|4|||
42016887|NCT01217892|75824442|FG003|Overall Study|Subject no longer meets study criteria|8|||
42016888|NCT01217892|75824439|FG000|Overall Study|Incorrect enrollment|0|||
42016889|NCT01217892|75824440|FG001|Overall Study|Incorrect enrollment|1|||
42016890|NCT01217892|75824441|FG002|Overall Study|Incorrect enrollment|1|||
42016891|NCT01217892|75824442|FG003|Overall Study|Incorrect enrollment|0|||
42016892|NCT01217892|75824439|FG000|Overall Study|Poor/Non-Compliance|0|||
42016893|NCT01217892|75824440|FG001|Overall Study|Poor/Non-Compliance|0|||
42066477|NCT00887354|75875488|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
42066478|NCT00887354|75875489|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
42066479|NCT00887354|75875488|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
42066480|NCT00887354|75875489|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
42066481|NCT00887354|75875488|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
42066482|NCT00887354|75875489|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
42066483|NCT00887354|75875488|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
42066484|NCT00887354|75875489|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
42066485|NCT00887354|75875488|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
42066486|NCT00887354|75875489|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
42066487|NCT00887354|75875488|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
42066488|NCT00887354|75875489|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
42066489|NCT00887354|75875488|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
42066490|NCT00887354|75875489|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
42066491|NCT00887354|75875488|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
42066492|NCT00887354|75875489|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
42066493|NCT00887354|75875488|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
42066494|NCT00887354|75875489|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
42066495|NCT00951041|75875498|FG000|Overall Study|Withdrawal by Subject|1|||
42066496|NCT00951041|75875499|FG001|Overall Study|Withdrawal by Subject|1|||
42066497|NCT00951041|75875498|FG000|Overall Study|Lost to Follow-up|1|||
42066498|NCT00951041|75875499|FG001|Overall Study|Lost to Follow-up|0|||
42066499|NCT00951041|75875498|FG000|Overall Study|Other|3|||
42066500|NCT00951041|75875499|FG001|Overall Study|Other|0|||
42066501|NCT02763462|75875506|FG000|Overall Study|Protocol Violation|6|||
42066502|NCT00610129|75875520|FG000|Overall Study|Not treated since patients ineligible|3|||
42066503|NCT00945815|75875524|FG000|Overall Study|Death|3|||
42066504|NCT00945815|75875524|FG000|Overall Study|Not protocol specified|1|||
42066505|NCT00945815|75875524|FG000|Overall Study|Ineligible|3|||
42066506|NCT00945815|75875524|FG000|Overall Study|Did not begin protocol therapy|1|||
42066507|NCT00606307|75875528|FG000|Overall Study|Adverse Event|2|||
42066508|NCT00606307|75875528|FG000|Overall Study|Withdrawal by Subject|2|||
42066509|NCT00606307|75875528|FG000|Overall Study|Disease progression|6|||
42066510|NCT00606307|75875528|FG000|Overall Study|QTc prolongation|1|||
42066511|NCT00798369|75875538|FG000|Overall Study|Subject withdrew consent|0|||
42066512|NCT00798369|75875539|FG001|Overall Study|Subject withdrew consent|0|||
42066513|NCT00798369|75875540|FG002|Overall Study|Subject withdrew consent|1|||
42066514|NCT00798369|75875541|FG003|Overall Study|Subject withdrew consent|1|||
42066515|NCT00798369|75875542|FG004|Overall Study|Subject withdrew consent|0|||
42066516|NCT00798369|75875543|FG005|Overall Study|Subject withdrew consent|2|||
42066517|NCT00798369|75875538|FG000|Overall Study|Lost to Follow-up|1|||
42066518|NCT00798369|75875539|FG001|Overall Study|Lost to Follow-up|1|||
42066519|NCT00798369|75875540|FG002|Overall Study|Lost to Follow-up|1|||
42066520|NCT00798369|75875541|FG003|Overall Study|Lost to Follow-up|0|||
42066521|NCT00798369|75875542|FG004|Overall Study|Lost to Follow-up|1|||
42066522|NCT00798369|75875543|FG005|Overall Study|Lost to Follow-up|0|||
42066523|NCT00798369|75875538|FG000|Overall Study|Adminstrative problems|0|||
42066524|NCT00798369|75875539|FG001|Overall Study|Adminstrative problems|0|||
42066525|NCT00798369|75875540|FG002|Overall Study|Adminstrative problems|0|||
42066526|NCT00798369|75875541|FG003|Overall Study|Adminstrative problems|0|||
42066527|NCT00798369|75875542|FG004|Overall Study|Adminstrative problems|0|||
42066528|NCT00798369|75875543|FG005|Overall Study|Adminstrative problems|1|||
42066529|NCT00950963|75875560|FG000|Overall Study|Lost to Follow-up|29|||
42066530|NCT00950963|75875561|FG001|Overall Study|Lost to Follow-up|24|||
42066531|NCT00608959|75875569|FG000|Part 1|Did not meet eligibility criteria|1|||
42066532|NCT00945659|75875582|FG000|Overall Study|Lost to Follow-up|7|||
42066533|NCT00945659|75875583|FG001|Overall Study|Lost to Follow-up|20|||
42066534|NCT00945659|75875584|FG002|Overall Study|Lost to Follow-up|17|||
42066535|NCT00941603|75875598|FG000|Overall Study|Adverse Event|10|||
42066536|NCT00941603|75875599|FG001|Overall Study|Adverse Event|15|||
42175496|NCT03246724|75982579|FG001|Overall Study|Withdrawal by Subject|2|||
42175497|NCT03246724|75982580|FG002|Overall Study|Withdrawal by Subject|4|||
42175498|NCT03246724|75982581|FG003|Overall Study|Withdrawal by Subject|2|||
42292291|NCT03299816|76126043|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
42016894|NCT01217892|75824441|FG002|Overall Study|Poor/Non-Compliance|1|||
42016895|NCT01217892|75824442|FG003|Overall Study|Poor/Non-Compliance|0|||
42016896|NCT01217814|75824455|FG000|Overall Study|Adverse Event|1|||
42016897|NCT01217814|75824456|FG001|Overall Study|Adverse Event|1|||
42016898|NCT01217814|75824457|FG002|Overall Study|Adverse Event|0|||
42016899|NCT01217814|75824455|FG000|Overall Study|Lack of Efficacy|0|||
42016900|NCT01217814|75824456|FG001|Overall Study|Lack of Efficacy|0|||
42016901|NCT01217814|75824457|FG002|Overall Study|Lack of Efficacy|1|||
42016902|NCT01217190|75824468|FG000|Second Dosing|Withdrawal by Subject|0|||
42016903|NCT01217190|75824469|FG001|Second Dosing|Withdrawal by Subject|2|||
42016904|NCT01136733|75824485|FG000|Phase 1b|Adverse Event|0|||
42016905|NCT01136733|75824486|FG001|Phase 1b|Adverse Event|3|||
42016906|NCT01136733|75824487|FG002|Phase 1b|Adverse Event|1|||
42016907|NCT01136733|75824488|FG003|Phase 1b|Adverse Event|0|||
42016908|NCT01136733|75824489|FG004|Phase 1b|Adverse Event|0|||
42066537|NCT00941603|75875600|FG002|Overall Study|Adverse Event|5|||
42066538|NCT00941603|75875601|FG003|Overall Study|Adverse Event|1|||
42066539|NCT00941603|75875602|FG004|Overall Study|Adverse Event|4|||
42066540|NCT00941603|75875603|FG005|Overall Study|Adverse Event|0|||
42066541|NCT00941603|75875598|FG000|Overall Study|Lost to Follow-up|0|||
42066542|NCT00941603|75875599|FG001|Overall Study|Lost to Follow-up|0|||
42066543|NCT00941603|75875600|FG002|Overall Study|Lost to Follow-up|0|||
42066544|NCT00941603|75875601|FG003|Overall Study|Lost to Follow-up|1|||
42066545|NCT00941603|75875602|FG004|Overall Study|Lost to Follow-up|0|||
42066546|NCT00941603|75875603|FG005|Overall Study|Lost to Follow-up|2|||
42066547|NCT00941603|75875598|FG000|Overall Study|Withdrawal by Subject|0|||
42066548|NCT00941603|75875599|FG001|Overall Study|Withdrawal by Subject|0|||
42066549|NCT00941603|75875600|FG002|Overall Study|Withdrawal by Subject|0|||
42066550|NCT00941603|75875601|FG003|Overall Study|Withdrawal by Subject|2|||
42066551|NCT00941603|75875602|FG004|Overall Study|Withdrawal by Subject|0|||
42066552|NCT00941603|75875603|FG005|Overall Study|Withdrawal by Subject|1|||
42066553|NCT00941603|75875598|FG000|Overall Study|Protocol Violation|0|||
42066554|NCT00941603|75875599|FG001|Overall Study|Protocol Violation|1|||
42066555|NCT00941603|75875600|FG002|Overall Study|Protocol Violation|0|||
42066556|NCT00941603|75875601|FG003|Overall Study|Protocol Violation|0|||
42066557|NCT00941603|75875602|FG004|Overall Study|Protocol Violation|0|||
42066558|NCT00941603|75875603|FG005|Overall Study|Protocol Violation|0|||
42066559|NCT00941603|75875598|FG000|Overall Study|Did not meet protocol eligibility|1|||
42066560|NCT00941603|75875599|FG001|Overall Study|Did not meet protocol eligibility|0|||
42066561|NCT00941603|75875600|FG002|Overall Study|Did not meet protocol eligibility|0|||
42066562|NCT00941603|75875601|FG003|Overall Study|Did not meet protocol eligibility|0|||
42066563|NCT00941603|75875602|FG004|Overall Study|Did not meet protocol eligibility|0|||
42066564|NCT00941603|75875603|FG005|Overall Study|Did not meet protocol eligibility|0|||
42066565|NCT00797823|75875620|FG000|First Period (Initial Randomization)|Physician Decision|1|||
42066566|NCT00797823|75875621|FG001|First Period (Initial Randomization)|Physician Decision|0|||
42066567|NCT00797823|75875622|FG002|First Period (Initial Randomization)|Physician Decision|0|||
42066568|NCT00797667|75875632|FG000|Overall Study|Lack of Efficacy|0|||
42066569|NCT00797667|75875633|FG001|Overall Study|Lack of Efficacy|1|||
42066570|NCT00797667|75875634|FG002|Overall Study|Lack of Efficacy|0|||
42066571|NCT00797667|75875632|FG000|Overall Study|Lost to Follow-up|8|||
42066572|NCT00797667|75875633|FG001|Overall Study|Lost to Follow-up|12|||
42066573|NCT00797667|75875634|FG002|Overall Study|Lost to Follow-up|2|||
42066574|NCT00797667|75875632|FG000|Overall Study|Physician Decision|3|||
42066575|NCT00797667|75875633|FG001|Overall Study|Physician Decision|1|||
42066576|NCT00797667|75875634|FG002|Overall Study|Physician Decision|0|||
42066577|NCT00797667|75875632|FG000|Overall Study|Pregnancy|2|||
42066578|NCT00797667|75875633|FG001|Overall Study|Pregnancy|0|||
42066579|NCT00797667|75875634|FG002|Overall Study|Pregnancy|0|||
42066580|NCT00797667|75875632|FG000|Overall Study|Protocol Violation|2|||
42066581|NCT00797667|75875633|FG001|Overall Study|Protocol Violation|7|||
42066582|NCT00797667|75875634|FG002|Overall Study|Protocol Violation|0|||
42066583|NCT00797667|75875632|FG000|Overall Study|Study Terminated by Sponsor|217|||
42066584|NCT00797667|75875633|FG001|Overall Study|Study Terminated by Sponsor|216|||
42066585|NCT00797667|75875634|FG002|Overall Study|Study Terminated by Sponsor|115|||
42066586|NCT00797667|75875632|FG000|Overall Study|Withdrawal by Subject|9|||
42066587|NCT00797667|75875633|FG001|Overall Study|Withdrawal by Subject|14|||
42066588|NCT00797667|75875634|FG002|Overall Study|Withdrawal by Subject|2|||
42066589|NCT00797667|75875632|FG000|Overall Study|Adverse Event|19|||
42066590|NCT00797667|75875633|FG001|Overall Study|Adverse Event|8|||
42066591|NCT00797667|75875634|FG002|Overall Study|Adverse Event|8|||
42066592|NCT00950807|75875642|FG000|Treatment Period 1|Lack of Efficacy|1|||
42066593|NCT00950807|75875643|FG001|Treatment Period 1|Lack of Efficacy|0|||
42066594|NCT00950807|75875644|FG002|Treatment Period 1|Lack of Efficacy|0|||
42066595|NCT00950807|75875645|FG003|Treatment Period 1|Lack of Efficacy|0|||
42066596|NCT00950807|75875646|FG004|Treatment Period 1|Lack of Efficacy|0|||
42066597|NCT00950807|75875647|FG005|Treatment Period 1|Lack of Efficacy|1|||
42292292|NCT03299816|76126044|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
42292293|NCT03299816|76126043|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
42292294|NCT03299816|76126044|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
42292295|NCT03288493|76126057|FG000|Overall Study|Withdrawal by Subject|4|||
42292296|NCT03288493|76126058|FG001|Overall Study|Withdrawal by Subject|0|||
42066598|NCT00950807|75875648|FG006|Treatment Period 1|Lack of Efficacy|0|||
42066599|NCT00950807|75875649|FG007|Treatment Period 1|Lack of Efficacy|0|||
42066600|NCT00950807|75875650|FG008|Treatment Period 1|Lack of Efficacy|0|||
42066601|NCT00950807|75875651|FG009|Treatment Period 1|Lack of Efficacy|0|||
42066602|NCT00950807|75875642|FG000|Treatment Period 1|Protocol Violation|1|||
42066603|NCT00950807|75875643|FG001|Treatment Period 1|Protocol Violation|0|||
42066604|NCT00950807|75875644|FG002|Treatment Period 1|Protocol Violation|0|||
42066605|NCT00950807|75875645|FG003|Treatment Period 1|Protocol Violation|0|||
42292297|NCT03288493|76126059|FG002|Overall Study|Withdrawal by Subject|0|||
42066606|NCT00950807|75875646|FG004|Treatment Period 1|Protocol Violation|0|||
42066607|NCT00950807|75875647|FG005|Treatment Period 1|Protocol Violation|0|||
42066608|NCT00950807|75875648|FG006|Treatment Period 1|Protocol Violation|0|||
42066609|NCT00950807|75875649|FG007|Treatment Period 1|Protocol Violation|0|||
42066610|NCT00950807|75875650|FG008|Treatment Period 1|Protocol Violation|0|||
42066611|NCT00950807|75875651|FG009|Treatment Period 1|Protocol Violation|0|||
42066612|NCT00950807|75875642|FG000|Treatment Period 1|Lost to Follow-up|0|||
42066613|NCT00950807|75875643|FG001|Treatment Period 1|Lost to Follow-up|0|||
42066614|NCT00950807|75875644|FG002|Treatment Period 1|Lost to Follow-up|1|||
42066615|NCT00950807|75875645|FG003|Treatment Period 1|Lost to Follow-up|0|||
42066616|NCT00950807|75875646|FG004|Treatment Period 1|Lost to Follow-up|0|||
42016909|NCT01136733|75824490|FG005|Phase 1b|Adverse Event|0|||
42016910|NCT01136733|75824491|FG006|Phase 1b|Adverse Event|0|||
42016911|NCT01136733|75824485|FG000|Phase 1b|Participant Choice|0|||
42016912|NCT01136733|75824486|FG001|Phase 1b|Participant Choice|0|||
42066617|NCT00950807|75875647|FG005|Treatment Period 1|Lost to Follow-up|0|||
42066618|NCT00950807|75875648|FG006|Treatment Period 1|Lost to Follow-up|0|||
42066619|NCT00950807|75875649|FG007|Treatment Period 1|Lost to Follow-up|0|||
42066620|NCT00950807|75875650|FG008|Treatment Period 1|Lost to Follow-up|0|||
42066621|NCT00950807|75875651|FG009|Treatment Period 1|Lost to Follow-up|0|||
42066622|NCT00950807|75875642|FG000|Treatment Period 1|Withdrawal by Subject|1|||
42066623|NCT00950807|75875643|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42066624|NCT00950807|75875644|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42066625|NCT00950807|75875645|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42066626|NCT00950807|75875646|FG004|Treatment Period 1|Withdrawal by Subject|1|||
42066627|NCT00950807|75875647|FG005|Treatment Period 1|Withdrawal by Subject|0|||
42066628|NCT00950807|75875648|FG006|Treatment Period 1|Withdrawal by Subject|0|||
42066629|NCT00950807|75875649|FG007|Treatment Period 1|Withdrawal by Subject|0|||
42066630|NCT00950807|75875650|FG008|Treatment Period 1|Withdrawal by Subject|1|||
42066631|NCT00950807|75875651|FG009|Treatment Period 1|Withdrawal by Subject|0|||
42066632|NCT00950807|75875642|FG000|Treatment Period 1|Adverse Event|0|||
42066633|NCT00950807|75875643|FG001|Treatment Period 1|Adverse Event|0|||
42066634|NCT00950807|75875644|FG002|Treatment Period 1|Adverse Event|0|||
42066635|NCT00950807|75875645|FG003|Treatment Period 1|Adverse Event|0|||
42066636|NCT00950807|75875646|FG004|Treatment Period 1|Adverse Event|0|||
42066637|NCT00950807|75875647|FG005|Treatment Period 1|Adverse Event|1|||
42066638|NCT00950807|75875648|FG006|Treatment Period 1|Adverse Event|0|||
42066639|NCT00950807|75875649|FG007|Treatment Period 1|Adverse Event|0|||
42066640|NCT00950807|75875650|FG008|Treatment Period 1|Adverse Event|0|||
42066641|NCT00950807|75875651|FG009|Treatment Period 1|Adverse Event|0|||
42066642|NCT00950807|75875642|FG000|Washout Period 1|Lack of Efficacy|0|||
42066643|NCT00950807|75875643|FG001|Washout Period 1|Lack of Efficacy|0|||
42066644|NCT00950807|75875644|FG002|Washout Period 1|Lack of Efficacy|0|||
42066645|NCT00950807|75875645|FG003|Washout Period 1|Lack of Efficacy|0|||
42066646|NCT00950807|75875646|FG004|Washout Period 1|Lack of Efficacy|0|||
42066647|NCT00950807|75875647|FG005|Washout Period 1|Lack of Efficacy|0|||
42066648|NCT00950807|75875648|FG006|Washout Period 1|Lack of Efficacy|1|||
42066649|NCT00950807|75875649|FG007|Washout Period 1|Lack of Efficacy|0|||
42066650|NCT00950807|75875650|FG008|Washout Period 1|Lack of Efficacy|0|||
42066651|NCT00950807|75875651|FG009|Washout Period 1|Lack of Efficacy|0|||
42066652|NCT00950807|75875642|FG000|Washout Period 1|Withdrawal by Subject|0|||
42066653|NCT00950807|75875643|FG001|Washout Period 1|Withdrawal by Subject|0|||
42066654|NCT00950807|75875644|FG002|Washout Period 1|Withdrawal by Subject|0|||
42066655|NCT00950807|75875645|FG003|Washout Period 1|Withdrawal by Subject|0|||
42066656|NCT00950807|75875646|FG004|Washout Period 1|Withdrawal by Subject|0|||
42357535|NCT01748552|76202975|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
42357536|NCT01748552|76202976|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
42016913|NCT01136733|75824487|FG002|Phase 1b|Participant Choice|1|||
42016914|NCT01136733|75824488|FG003|Phase 1b|Participant Choice|0|||
42016915|NCT01136733|75824489|FG004|Phase 1b|Participant Choice|0|||
42016916|NCT01136733|75824490|FG005|Phase 1b|Participant Choice|0|||
42016917|NCT01136733|75824491|FG006|Phase 1b|Participant Choice|0|||
42016918|NCT01136733|75824485|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
42016919|NCT01136733|75824486|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
42016920|NCT01136733|75824487|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
42016921|NCT01136733|75824488|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
42066657|NCT00950807|75875647|FG005|Washout Period 1|Withdrawal by Subject|0|||
42066658|NCT00950807|75875648|FG006|Washout Period 1|Withdrawal by Subject|0|||
42066659|NCT00950807|75875649|FG007|Washout Period 1|Withdrawal by Subject|0|||
42066660|NCT00950807|75875650|FG008|Washout Period 1|Withdrawal by Subject|1|||
42016922|NCT01136733|75824489|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
42016923|NCT01136733|75824490|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
42016924|NCT01136733|75824491|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
42066661|NCT00950807|75875651|FG009|Washout Period 1|Withdrawal by Subject|0|||
42016925|NCT01136733|75824485|FG000|Phase 1b|Clinical Progression|1|||
42066662|NCT00950807|75875642|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
42066663|NCT00950807|75875643|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
42066664|NCT00950807|75875644|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
42066665|NCT00950807|75875645|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
42066666|NCT00950807|75875646|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
42066667|NCT00950807|75875647|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
42066668|NCT00950807|75875648|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
42066669|NCT00950807|75875649|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
42066670|NCT00950807|75875650|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
42066671|NCT00950807|75875651|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
42066672|NCT00950807|75875642|FG000|Washout Period 1|Adverse Event|2|||
42066673|NCT00950807|75875643|FG001|Washout Period 1|Adverse Event|0|||
42066674|NCT00950807|75875644|FG002|Washout Period 1|Adverse Event|0|||
42066675|NCT00950807|75875645|FG003|Washout Period 1|Adverse Event|1|||
42066676|NCT00950807|75875646|FG004|Washout Period 1|Adverse Event|1|||
42066677|NCT00950807|75875647|FG005|Washout Period 1|Adverse Event|0|||
42066678|NCT00950807|75875648|FG006|Washout Period 1|Adverse Event|0|||
42066679|NCT00950807|75875649|FG007|Washout Period 1|Adverse Event|0|||
42066680|NCT00950807|75875650|FG008|Washout Period 1|Adverse Event|0|||
42066681|NCT00950807|75875651|FG009|Washout Period 1|Adverse Event|0|||
42066682|NCT00950807|75875642|FG000|Treatment Period 2|Lack of Efficacy|1|||
42066683|NCT00950807|75875643|FG001|Treatment Period 2|Lack of Efficacy|0|||
42066684|NCT00950807|75875644|FG002|Treatment Period 2|Lack of Efficacy|0|||
42066685|NCT00950807|75875645|FG003|Treatment Period 2|Lack of Efficacy|0|||
42066686|NCT00950807|75875646|FG004|Treatment Period 2|Lack of Efficacy|0|||
42066687|NCT00950807|75875647|FG005|Treatment Period 2|Lack of Efficacy|0|||
42066688|NCT00950807|75875648|FG006|Treatment Period 2|Lack of Efficacy|0|||
42066689|NCT00950807|75875649|FG007|Treatment Period 2|Lack of Efficacy|0|||
42066690|NCT00950807|75875650|FG008|Treatment Period 2|Lack of Efficacy|0|||
42066691|NCT00950807|75875651|FG009|Treatment Period 2|Lack of Efficacy|0|||
42066692|NCT00950807|75875642|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42066693|NCT00950807|75875643|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42066694|NCT00950807|75875644|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42066695|NCT00950807|75875645|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42066696|NCT00950807|75875646|FG004|Treatment Period 2|Withdrawal by Subject|0|||
42066697|NCT00950807|75875647|FG005|Treatment Period 2|Withdrawal by Subject|0|||
42066698|NCT00950807|75875648|FG006|Treatment Period 2|Withdrawal by Subject|1|||
42066699|NCT00950807|75875649|FG007|Treatment Period 2|Withdrawal by Subject|2|||
42066700|NCT00950807|75875650|FG008|Treatment Period 2|Withdrawal by Subject|0|||
42066701|NCT00950807|75875651|FG009|Treatment Period 2|Withdrawal by Subject|0|||
42066702|NCT00950807|75875642|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
42066703|NCT00950807|75875643|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42066704|NCT00950807|75875644|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42066705|NCT00950807|75875645|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42066706|NCT00950807|75875646|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42066707|NCT00950807|75875647|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42066708|NCT00950807|75875648|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42066709|NCT00950807|75875649|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42066710|NCT00950807|75875650|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42066711|NCT00950807|75875651|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
42066712|NCT00950807|75875642|FG000|Treatment Period 2|Adverse Event|0|||
42066713|NCT00950807|75875643|FG001|Treatment Period 2|Adverse Event|1|||
42066714|NCT00950807|75875644|FG002|Treatment Period 2|Adverse Event|0|||
42066715|NCT00950807|75875645|FG003|Treatment Period 2|Adverse Event|1|||
42066716|NCT00950807|75875646|FG004|Treatment Period 2|Adverse Event|0|||
42066717|NCT00950807|75875647|FG005|Treatment Period 2|Adverse Event|1|||
42066718|NCT00950807|75875648|FG006|Treatment Period 2|Adverse Event|0|||
42066719|NCT00950807|75875649|FG007|Treatment Period 2|Adverse Event|1|||
42066720|NCT00950807|75875650|FG008|Treatment Period 2|Adverse Event|0|||
42066721|NCT00950807|75875651|FG009|Treatment Period 2|Adverse Event|0|||
42066722|NCT00950807|75875642|FG000|Washout Period 2|Lack of Efficacy|1|||
42066723|NCT00950807|75875643|FG001|Washout Period 2|Lack of Efficacy|0|||
42292298|NCT03288493|76126060|FG003|Overall Study|Withdrawal by Subject|0|||
42066724|NCT00950807|75875644|FG002|Washout Period 2|Lack of Efficacy|0|||
42066725|NCT00950807|75875645|FG003|Washout Period 2|Lack of Efficacy|0|||
42066726|NCT00950807|75875646|FG004|Washout Period 2|Lack of Efficacy|0|||
42066727|NCT00950807|75875647|FG005|Washout Period 2|Lack of Efficacy|0|||
42066728|NCT00950807|75875648|FG006|Washout Period 2|Lack of Efficacy|0|||
42066729|NCT00950807|75875649|FG007|Washout Period 2|Lack of Efficacy|0|||
42066730|NCT00950807|75875650|FG008|Washout Period 2|Lack of Efficacy|0|||
42066731|NCT00950807|75875651|FG009|Washout Period 2|Lack of Efficacy|0|||
42066732|NCT00950807|75875642|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
42066733|NCT00950807|75875643|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
42292299|NCT03288493|76126061|FG004|Overall Study|Withdrawal by Subject|0|||
42066734|NCT00950807|75875644|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
42066735|NCT00950807|75875645|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
42066736|NCT00950807|75875646|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
42066737|NCT00950807|75875647|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
42066738|NCT00950807|75875648|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
42066739|NCT00950807|75875649|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
42066740|NCT00950807|75875650|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
42066741|NCT00950807|75875651|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
42066742|NCT00950807|75875642|FG000|Washout Period 2|Adverse Event|3|||
42066743|NCT00950807|75875643|FG001|Washout Period 2|Adverse Event|0|||
42066744|NCT00950807|75875644|FG002|Washout Period 2|Adverse Event|0|||
42066745|NCT00950807|75875645|FG003|Washout Period 2|Adverse Event|1|||
42066746|NCT00950807|75875646|FG004|Washout Period 2|Adverse Event|0|||
42066747|NCT00950807|75875647|FG005|Washout Period 2|Adverse Event|0|||
42066748|NCT00950807|75875648|FG006|Washout Period 2|Adverse Event|0|||
42066749|NCT00950807|75875649|FG007|Washout Period 2|Adverse Event|0|||
42066750|NCT00950807|75875650|FG008|Washout Period 2|Adverse Event|0|||
42066751|NCT00950807|75875651|FG009|Washout Period 2|Adverse Event|0|||
42066752|NCT00950807|75875642|FG000|Treatment Period 3|Withdrawal by Subject|0|||
42066753|NCT00950807|75875643|FG001|Treatment Period 3|Withdrawal by Subject|0|||
42066754|NCT00950807|75875644|FG002|Treatment Period 3|Withdrawal by Subject|0|||
42066755|NCT00950807|75875645|FG003|Treatment Period 3|Withdrawal by Subject|0|||
42066756|NCT00950807|75875646|FG004|Treatment Period 3|Withdrawal by Subject|0|||
42066757|NCT00950807|75875647|FG005|Treatment Period 3|Withdrawal by Subject|0|||
42066758|NCT00950807|75875648|FG006|Treatment Period 3|Withdrawal by Subject|0|||
42066759|NCT00950807|75875649|FG007|Treatment Period 3|Withdrawal by Subject|0|||
42066760|NCT00950807|75875650|FG008|Treatment Period 3|Withdrawal by Subject|0|||
42066761|NCT00950807|75875651|FG009|Treatment Period 3|Withdrawal by Subject|1|||
42066762|NCT00950807|75875642|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
42066763|NCT00950807|75875643|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42066764|NCT00950807|75875644|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42066765|NCT00950807|75875645|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42066766|NCT00950807|75875646|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42066767|NCT00950807|75875647|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42066768|NCT00950807|75875648|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42066769|NCT00950807|75875649|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
42066770|NCT00950807|75875650|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42066771|NCT00950807|75875651|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
42066772|NCT00950807|75875642|FG000|Treatment Period 3|Adverse Event|0|||
42066773|NCT00950807|75875643|FG001|Treatment Period 3|Adverse Event|0|||
42066774|NCT00950807|75875644|FG002|Treatment Period 3|Adverse Event|0|||
42066775|NCT00950807|75875645|FG003|Treatment Period 3|Adverse Event|0|||
42066776|NCT00950807|75875646|FG004|Treatment Period 3|Adverse Event|0|||
42066777|NCT00950807|75875647|FG005|Treatment Period 3|Adverse Event|0|||
42066778|NCT00950807|75875648|FG006|Treatment Period 3|Adverse Event|1|||
42066779|NCT00950807|75875649|FG007|Treatment Period 3|Adverse Event|0|||
42066780|NCT00950807|75875650|FG008|Treatment Period 3|Adverse Event|0|||
42066781|NCT00950807|75875651|FG009|Treatment Period 3|Adverse Event|0|||
42066782|NCT00797511|75875673|FG000|Overall Study|Withdrawal by Subject|1|||
42066783|NCT00608881|75875680|FG000|Overall Study|Death|22|||
42066784|NCT00608881|75875681|FG001|Overall Study|Death|13|||
42066785|NCT00608881|75875680|FG000|Overall Study|Adverse Event|5|||
42066786|NCT00608881|75875681|FG001|Overall Study|Adverse Event|3|||
42066787|NCT00608881|75875680|FG000|Overall Study|Lost to Follow-up|28|||
42066788|NCT00608881|75875681|FG001|Overall Study|Lost to Follow-up|14|||
42066789|NCT00608881|75875680|FG000|Overall Study|Withdrawal by Subject|18|||
42066790|NCT00608881|75875681|FG001|Overall Study|Withdrawal by Subject|29|||
42066791|NCT00608881|75875680|FG000|Overall Study|Physician Decision|5|||
42066792|NCT00608881|75875681|FG001|Overall Study|Physician Decision|5|||
42066793|NCT00608881|75875680|FG000|Overall Study|Institutionalized|1|||
42066794|NCT00608881|75875681|FG001|Overall Study|Institutionalized|2|||
42292300|NCT03288493|76126062|FG005|Overall Study|Withdrawal by Subject|2|||
42292301|NCT03288493|76126063|FG006|Overall Study|Withdrawal by Subject|0|||
42292302|NCT03288493|76126057|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
42292303|NCT03288493|76126058|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
42066795|NCT00945191|75875687|FG000|Overall Study|Did not achieve a complete response|18|||
42066796|NCT00945191|75875687|FG000|Overall Study|Participant relocated to another state|1|||
42066797|NCT00945191|75875687|FG000|Overall Study|Disease progression|3|||
42066798|NCT00945191|75875687|FG000|Overall Study|Serious adverse event or adverse event|1|||
42066799|NCT00945191|75875687|FG000|Overall Study|Investigator's discretion|1|||
42066800|NCT00606931|75875691|FG000|Overall Study|Withdrawal by Subject|3|||
42066801|NCT00792909|75875698|FG000|Overall Study|Withdrawal by Subject|0|||
42066802|NCT00792909|75875699|FG001|Overall Study|Withdrawal by Subject|1|||
42066803|NCT00792909|75875700|FG002|Overall Study|Withdrawal by Subject|0|||
42066804|NCT00944645|75875711|FG000|Period 2|Adverse Event|1|||
42066805|NCT00944645|75875712|FG001|Period 2|Adverse Event|0|||
42066806|NCT00944645|75875711|FG000|Period 2|Lost to Follow-up|0|||
42066807|NCT00944645|75875712|FG001|Period 2|Lost to Follow-up|3|||
42066808|NCT00944645|75875711|FG000|Period 2|Withdrawal by Subject|7|||
42066809|NCT00944645|75875712|FG001|Period 2|Withdrawal by Subject|6|||
42066810|NCT00606229|75875718|FG000|Overall Study|Adverse Event|11|||
42066811|NCT00606229|75875718|FG000|Overall Study|Lack of Efficacy|1|||
42066812|NCT00606229|75875718|FG000|Overall Study|Withdrawal by Subject|4|||
42066813|NCT00606229|75875718|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
42066814|NCT00606229|75875718|FG000|Overall Study|change of residence or other commitments|2|||
42066815|NCT00950651|75875724|FG000|Overall Study|Adverse Event|17|||
42066816|NCT00950651|75875725|FG001|Overall Study|Adverse Event|20|||
42066817|NCT00950651|75875724|FG000|Overall Study|Death|1|||
42066818|NCT00950651|75875725|FG001|Overall Study|Death|0|||
42066819|NCT00950651|75875724|FG000|Overall Study|Lack of Efficacy|2|||
42066820|NCT00950651|75875725|FG001|Overall Study|Lack of Efficacy|2|||
42066821|NCT00950651|75875724|FG000|Overall Study|Protocol Violation|3|||
42066822|NCT00950651|75875725|FG001|Overall Study|Protocol Violation|4|||
42066823|NCT00950651|75875724|FG000|Overall Study|Withdrawal by Subject|8|||
42066824|NCT00950651|75875725|FG001|Overall Study|Withdrawal by Subject|9|||
42066825|NCT00605293|75875733|FG000|Overall Study|Death|2|||
42066826|NCT00605293|75875734|FG001|Overall Study|Death|1|||
42066827|NCT00605293|75875733|FG000|Overall Study|Insufficient Therapeutic Response|2|||
42066828|NCT00605293|75875734|FG001|Overall Study|Insufficient Therapeutic Response|0|||
42066829|NCT00605293|75875733|FG000|Overall Study|Adverse Event|1|||
42066830|NCT00605293|75875734|FG001|Overall Study|Adverse Event|0|||
42066831|NCT00605293|75875733|FG000|Overall Study|Holidays Dialysis Out|1|||
42066832|NCT00605293|75875734|FG001|Overall Study|Holidays Dialysis Out|0|||
42066833|NCT00605293|75875733|FG000|Overall Study|Blood Transfusion|7|||
42066834|NCT00605293|75875734|FG001|Overall Study|Blood Transfusion|1|||
42066835|NCT00605293|75875733|FG000|Overall Study|Renal Transplantation|3|||
42066836|NCT00605293|75875734|FG001|Overall Study|Renal Transplantation|1|||
42066837|NCT00605293|75875733|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
42066838|NCT00605293|75875734|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
42066839|NCT00605293|75875733|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
42066840|NCT00605293|75875734|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
42066841|NCT00605293|75875733|FG000|Overall Study|Principal Investigator Decision|0|||
42066842|NCT00605293|75875734|FG001|Overall Study|Principal Investigator Decision|1|||
42066843|NCT00572533|75875742|FG000|Overall Study|Death|4|||
42066844|NCT00572533|75875743|FG001|Overall Study|Death|1|||
42066845|NCT00572533|75875742|FG000|Overall Study|Received Kidney Transplant|2|||
42066846|NCT00572533|75875743|FG001|Overall Study|Received Kidney Transplant|1|||
42066847|NCT00572533|75875742|FG000|Overall Study|Social Issues|1|||
42066848|NCT00572533|75875743|FG001|Overall Study|Social Issues|0|||
42066849|NCT00572533|75875742|FG000|Overall Study|Transfer out of Facility|0|||
42066850|NCT00572533|75875743|FG001|Overall Study|Transfer out of Facility|1|||
42066851|NCT00949715|75875751|FG000|Overall Study|Physician Decision|1|||
42066852|NCT00949715|75875752|FG001|Overall Study|Physician Decision|0|||
42066853|NCT00949715|75875751|FG000|Overall Study|Lost to Follow-up|1|||
42066854|NCT00949715|75875752|FG001|Overall Study|Lost to Follow-up|0|||
42066855|NCT00949715|75875751|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
42066856|NCT00949715|75875752|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
42066857|NCT00791661|75875760|FG000|7 Day Wash-out|Adverse Event|0|||
42066858|NCT00791661|75875761|FG001|7 Day Wash-out|Adverse Event|0|||
42292304|NCT03288493|76126059|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
42292305|NCT03288493|76126060|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
42292306|NCT03288493|76126061|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
42292307|NCT03288493|76126062|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
42292308|NCT03288493|76126063|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
42066859|NCT00791661|75875762|FG002|7 Day Wash-out|Adverse Event|1|||
42066860|NCT00791661|75875760|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
42066861|NCT00791661|75875761|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
42066862|NCT00791661|75875762|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
42066863|NCT00943787|75875786|FG000|Overall Study|Physician Decision|4|||
42066864|NCT00943787|75875786|FG000|Overall Study|Withdrawal by Subject|3|||
42066865|NCT00949325|75875790|FG000|Overall Study|Adverse Event|0|||
42066866|NCT00949325|75875791|FG001|Overall Study|Adverse Event|2|||
42066867|NCT00949325|75875792|FG002|Overall Study|Adverse Event|0|||
42066868|NCT00943319|75875808|FG000|Overall Study|Death|1|||
42292309|NCT03288493|76126057|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
42292310|NCT03288493|76126058|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
42292311|NCT03288493|76126059|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
42292312|NCT03288493|76126060|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
42292313|NCT03288493|76126061|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
42292314|NCT03288493|76126062|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
42292315|NCT03288493|76126063|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
42292316|NCT03288493|76126057|FG000|Overall Study|Death|2|||
42066869|NCT00790647|75875812|FG000|Overall Study|Adverse Event|1|||
42066870|NCT00790569|75875821|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
42066871|NCT00790569|75875822|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
42066872|NCT00790569|75875823|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
42066873|NCT00790569|75875821|FG000|End of Treatment (6 Month Interview)|Death|0|||
42066874|NCT00790569|75875822|FG001|End of Treatment (6 Month Interview)|Death|2|||
42066875|NCT00790569|75875823|FG002|End of Treatment (6 Month Interview)|Death|1|||
42066876|NCT00790569|75875821|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
42066877|NCT00790569|75875822|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
42066878|NCT00790569|75875823|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
42066879|NCT00790569|75875821|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
42066880|NCT00790569|75875822|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
42066881|NCT00790569|75875823|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
42066882|NCT00790569|75875821|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
42066883|NCT00790569|75875822|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
42066884|NCT00790569|75875823|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
42066885|NCT00790569|75875821|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
42066886|NCT00790569|75875822|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
42066887|NCT00790569|75875823|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
42066888|NCT00939029|75875833|FG000|Overall Study|Withdrawal by Subject|3|||
42066889|NCT00939029|75875834|FG001|Overall Study|Withdrawal by Subject|7|||
42066890|NCT00939029|75875833|FG000|Overall Study|Lost to Follow-up|3|||
42016926|NCT01136733|75824486|FG001|Phase 1b|Clinical Progression|1|||
42016927|NCT01136733|75824487|FG002|Phase 1b|Clinical Progression|0|||
42016928|NCT01136733|75824488|FG003|Phase 1b|Clinical Progression|0|||
42016929|NCT01136733|75824489|FG004|Phase 1b|Clinical Progression|0|||
42016930|NCT01136733|75824490|FG005|Phase 1b|Clinical Progression|0|||
42016931|NCT01136733|75824491|FG006|Phase 1b|Clinical Progression|0|||
42016932|NCT01136733|75824485|FG000|Phase 2|Disease Progression|0|||
42016933|NCT01136733|75824486|FG001|Phase 2|Disease Progression|0|||
42016934|NCT01136733|75824487|FG002|Phase 2|Disease Progression|0|||
42016935|NCT01136733|75824488|FG003|Phase 2|Disease Progression|0|||
42016936|NCT01136733|75824489|FG004|Phase 2|Disease Progression|30|||
42016937|NCT01136733|75824490|FG005|Phase 2|Disease Progression|32|||
42016938|NCT01136733|75824491|FG006|Phase 2|Disease Progression|38|||
42016939|NCT01136733|75824485|FG000|Phase 2|Adverse Event|0|||
42016940|NCT01136733|75824486|FG001|Phase 2|Adverse Event|0|||
42016941|NCT01136733|75824487|FG002|Phase 2|Adverse Event|0|||
42016942|NCT01136733|75824488|FG003|Phase 2|Adverse Event|0|||
42016943|NCT01136733|75824489|FG004|Phase 2|Adverse Event|11|||
42016944|NCT01136733|75824490|FG005|Phase 2|Adverse Event|13|||
42016945|NCT01136733|75824491|FG006|Phase 2|Adverse Event|5|||
42016946|NCT01136733|75824485|FG000|Phase 2|Participant Choice|0|||
42016947|NCT01136733|75824486|FG001|Phase 2|Participant Choice|0|||
42016948|NCT01136733|75824487|FG002|Phase 2|Participant Choice|0|||
42016949|NCT01136733|75824488|FG003|Phase 2|Participant Choice|0|||
42016950|NCT01136733|75824489|FG004|Phase 2|Participant Choice|3|||
42016951|NCT01136733|75824490|FG005|Phase 2|Participant Choice|0|||
42016952|NCT01136733|75824491|FG006|Phase 2|Participant Choice|1|||
42016953|NCT01136733|75824485|FG000|Phase 2|Administrative-Withdrew Consent|0|||
42016954|NCT01136733|75824486|FG001|Phase 2|Administrative-Withdrew Consent|0|||
42016955|NCT01136733|75824487|FG002|Phase 2|Administrative-Withdrew Consent|0|||
42016956|NCT01136733|75824488|FG003|Phase 2|Administrative-Withdrew Consent|0|||
42066891|NCT00939029|75875834|FG001|Overall Study|Lost to Follow-up|4|||
42066892|NCT00939029|75875833|FG000|Overall Study|Adverse Event|0|||
42066893|NCT00939029|75875834|FG001|Overall Study|Adverse Event|1|||
42066894|NCT00587847|75875840|FG000|Overall Study|Lack of Efficacy|5|||
42066895|NCT00587847|75875840|FG000|Overall Study|Adverse Event|2|||
42066896|NCT00784563|75875848|FG000|Years 1 & 2|Withdrawal by Subject|3|||
42066897|NCT00784563|75875849|FG001|Years 1 & 2|Withdrawal by Subject|2|||
42066898|NCT00784563|75875850|FG002|Years 1 & 2|Withdrawal by Subject|0|||
42066899|NCT00784563|75875848|FG000|Years 1 & 2|Adverse Event|0|||
42066900|NCT00784563|75875849|FG001|Years 1 & 2|Adverse Event|3|||
42066901|NCT00784563|75875850|FG002|Years 1 & 2|Adverse Event|0|||
42066902|NCT00784563|75875848|FG000|Year 3|Withdrawal by Subject|0|||
42066903|NCT00784563|75875849|FG001|Year 3|Withdrawal by Subject|0|||
42066904|NCT00784563|75875850|FG002|Year 3|Withdrawal by Subject|2|||
42066905|NCT00784563|75875848|FG000|Year 3|Adverse Event|0|||
42066906|NCT00784563|75875849|FG001|Year 3|Adverse Event|0|||
42066907|NCT00784563|75875850|FG002|Year 3|Adverse Event|1|||
42066908|NCT00938717|75875858|FG000|Overall Study|Adverse Event|10|||
42066909|NCT00938717|75875859|FG001|Overall Study|Adverse Event|41|||
42066910|NCT00938717|75875858|FG000|Overall Study|Protocol Violation|11|||
42066911|NCT00938717|75875859|FG001|Overall Study|Protocol Violation|8|||
42066912|NCT00938717|75875858|FG000|Overall Study|Withdrawal by Subject|26|||
42066913|NCT00938717|75875859|FG001|Overall Study|Withdrawal by Subject|24|||
42066914|NCT00938717|75875858|FG000|Overall Study|Lost to Follow-up|13|||
42066915|NCT00938717|75875859|FG001|Overall Study|Lost to Follow-up|18|||
42066916|NCT00938717|75875858|FG000|Overall Study|Lack of Efficacy|33|||
42066917|NCT00938717|75875859|FG001|Overall Study|Lack of Efficacy|15|||
42066918|NCT00938717|75875858|FG000|Overall Study|Other reason|5|||
42066919|NCT00938717|75875859|FG001|Overall Study|Other reason|2|||
42066920|NCT00587223|75875865|FG000|Overall Study|Adverse Event|1|||
42066921|NCT00938639|75875874|FG000|Overall Study|Moved away from study area|0|||
42066922|NCT00938639|75875875|FG001|Overall Study|Moved away from study area|1|||
42066923|NCT00938639|75875874|FG000|Overall Study|Lost to Follow-up|1|||
42066924|NCT00938639|75875875|FG001|Overall Study|Lost to Follow-up|2|||
42066925|NCT00938639|75875874|FG000|Overall Study|Family issues|1|||
42066926|NCT00938639|75875875|FG001|Overall Study|Family issues|1|||
42066927|NCT00938639|75875874|FG000|Overall Study|Participant noncompliance|1|||
42066928|NCT00938639|75875875|FG001|Overall Study|Participant noncompliance|0|||
42066929|NCT00783705|75875887|FG000|Overall Study|Adverse Event|2|||
42066930|NCT00783705|75875888|FG001|Overall Study|Adverse Event|0|||
42066931|NCT00783705|75875887|FG000|Overall Study|Withdrawal by Subject|3|||
42066932|NCT00783705|75875888|FG001|Overall Study|Withdrawal by Subject|2|||
42066933|NCT00783705|75875887|FG000|Overall Study|Lost to Follow-up|1|||
42066934|NCT00783705|75875888|FG001|Overall Study|Lost to Follow-up|3|||
42066935|NCT00604669|75875894|FG000|Overall Study|lack of information in chart|7|||
42066936|NCT00938327|75875898|FG000|Overall Study|Adverse Event|2|||
42066937|NCT00938327|75875898|FG000|Overall Study|Protocol Violation|1|||
42066938|NCT00938327|75875898|FG000|Overall Study|Withdrawal by Subject|4|||
42066939|NCT00938327|75875898|FG000|Overall Study|Lost to Follow-up|37|||
42066940|NCT00938327|75875898|FG000|Overall Study|2nd dose received outside of the study|7|||
42066941|NCT00938327|75875898|FG000|Overall Study|Vaccine not received as out of stock|9|||
42066942|NCT00887198|75875904|FG000|Randomized Period|Ongoing|42|||
42066943|NCT00887198|75875905|FG001|Randomized Period|Ongoing|0|||
42066944|NCT00887198|75875906|FG002|Randomized Period|Ongoing|0|||
42292317|NCT03288493|76126058|FG001|Overall Study|Death|0|||
42292318|NCT03288493|76126059|FG002|Overall Study|Death|0|||
42292319|NCT03288493|76126060|FG003|Overall Study|Death|0|||
42292320|NCT03288493|76126061|FG004|Overall Study|Death|0|||
42292321|NCT03288493|76126062|FG005|Overall Study|Death|0|||
42292322|NCT03288493|76126063|FG006|Overall Study|Death|0|||
42357537|NCT01748552|76202977|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
42357538|NCT01748552|76202978|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
42292323|NCT03288493|76126057|FG000|Overall Study|other reason not listed above|2|||
42292324|NCT03288493|76126058|FG001|Overall Study|other reason not listed above|0|||
42292325|NCT03288493|76126059|FG002|Overall Study|other reason not listed above|0|||
42292326|NCT03288493|76126060|FG003|Overall Study|other reason not listed above|0|||
42292327|NCT03288493|76126061|FG004|Overall Study|other reason not listed above|0|||
42292328|NCT03288493|76126062|FG005|Overall Study|other reason not listed above|0|||
42292329|NCT03288493|76126063|FG006|Overall Study|other reason not listed above|0|||
42292330|NCT03238300|76126083|FG000|Baseline (Before Intervention)|Physician Decision|0|||
42357539|NCT01748552|76202979|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
42292331|NCT03238300|76126084|FG001|Baseline (Before Intervention)|Physician Decision|1|||
42066945|NCT00887198|75875904|FG000|Randomized Period|Adverse Event|50|||
42066946|NCT00887198|75875905|FG001|Randomized Period|Adverse Event|33|||
42066947|NCT00887198|75875906|FG002|Randomized Period|Adverse Event|0|||
42066948|NCT00887198|75875904|FG000|Randomized Period|Lost to Follow-up|1|||
42066949|NCT00887198|75875905|FG001|Randomized Period|Lost to Follow-up|0|||
42066950|NCT00887198|75875906|FG002|Randomized Period|Lost to Follow-up|0|||
42066951|NCT00887198|75875904|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
42292332|NCT03238300|76126083|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
42292333|NCT03238300|76126084|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
42292334|NCT03238300|76126083|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
42292335|NCT03238300|76126084|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
42292336|NCT03238300|76126083|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
42292337|NCT03238300|76126084|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
42292338|NCT03178045|76126096|FG000|Overall Study|Withdrawal by Subject|5|||
42292339|NCT03178045|76126097|FG001|Overall Study|Withdrawal by Subject|7|||
42292340|NCT03178045|76126096|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
42292341|NCT03178045|76126097|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
42292342|NCT03178045|76126096|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
42292343|NCT03178045|76126097|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
42292344|NCT03113500|76126121|FG000|Overall Study|Withdrawal by Subject|1|||
42292345|NCT02924727|76126142|FG000|Overall Study|Withdrawal by Subject|2|||
42292346|NCT02924727|76126143|FG001|Overall Study|Withdrawal by Subject|4|||
42292347|NCT02924727|76126142|FG000|Overall Study|Lost to Follow-up|2|||
42292348|NCT02924727|76126143|FG001|Overall Study|Lost to Follow-up|5|||
42292349|NCT02924727|76126142|FG000|Overall Study|Death|221|||
42292350|NCT02924727|76126143|FG001|Overall Study|Death|247|||
42357540|NCT01748552|76202980|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
42357541|NCT01748552|76202981|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
42066952|NCT00887198|75875905|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
42066953|NCT00887198|75875906|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
42066954|NCT00887198|75875904|FG000|Randomized Period|Withdrawal by Subject|41|||
42175499|NCT03246724|75982578|FG000|Overall Study|Ineligible on day of surgery|7|||
42175500|NCT03246724|75982579|FG001|Overall Study|Ineligible on day of surgery|2|||
42175501|NCT03246724|75982580|FG002|Overall Study|Ineligible on day of surgery|0|||
42175502|NCT03246724|75982581|FG003|Overall Study|Ineligible on day of surgery|3|||
42175503|NCT03246724|75982578|FG000|Overall Study|Study completed before surgical date|2|||
42175504|NCT03246724|75982579|FG001|Overall Study|Study completed before surgical date|1|||
42175505|NCT03246724|75982580|FG002|Overall Study|Study completed before surgical date|8|||
42175506|NCT03246724|75982581|FG003|Overall Study|Study completed before surgical date|1|||
42175507|NCT03246724|75982578|FG000|Overall Study|Transferred to other arm|0|||
42175508|NCT03246724|75982579|FG001|Overall Study|Transferred to other arm|0|||
42175509|NCT03246724|75982580|FG002|Overall Study|Transferred to other arm|1|||
42175510|NCT03246724|75982581|FG003|Overall Study|Transferred to other arm|0|||
42175511|NCT03246724|75982578|FG000|Overall Study|Unable to obtain medication timely|0|||
42175512|NCT03246724|75982579|FG001|Overall Study|Unable to obtain medication timely|2|||
42175513|NCT03246724|75982580|FG002|Overall Study|Unable to obtain medication timely|2|||
42175514|NCT03246724|75982581|FG003|Overall Study|Unable to obtain medication timely|1|||
42175515|NCT03246724|75982578|FG000|Overall Study|Re-consented to participate|0|||
42175516|NCT03246724|75982579|FG001|Overall Study|Re-consented to participate|0|||
42175517|NCT03246724|75982580|FG002|Overall Study|Re-consented to participate|0|||
42175518|NCT03246724|75982581|FG003|Overall Study|Re-consented to participate|1|||
42175519|NCT03246646|75982593|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
42175520|NCT03246646|75982594|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
42175521|NCT03246646|75982593|FG000|Overall Study|Withdrawal by Subject|3|||
42175522|NCT03246646|75982594|FG001|Overall Study|Withdrawal by Subject|0|||
42175523|NCT03246646|75982593|FG000|Overall Study|Lost to Follow-up|7|||
42175524|NCT03246646|75982594|FG001|Overall Study|Lost to Follow-up|0|||
42175525|NCT01347112|75982602|FG000|Overall Study|Withdrawal by Subject|1|||
42175526|NCT01347112|75982603|FG001|Overall Study|Withdrawal by Subject|7|||
42175527|NCT01347112|75982602|FG000|Overall Study|Lost to Follow-up|3|||
42175528|NCT01347112|75982603|FG001|Overall Study|Lost to Follow-up|5|||
42175529|NCT00308711|75982613|FG000|Overall Study|Withdrawal by Subject|1|||
42175530|NCT00308711|75982614|FG001|Overall Study|Withdrawal by Subject|0|||
42175531|NCT00308711|75982615|FG002|Overall Study|Withdrawal by Subject|1|||
42175532|NCT00308711|75982613|FG000|Overall Study|Protocol Violation|0|||
42175533|NCT00308711|75982614|FG001|Overall Study|Protocol Violation|1|||
42175534|NCT00308711|75982615|FG002|Overall Study|Protocol Violation|1|||
42175535|NCT00308711|75982613|FG000|Overall Study|Lost to Follow-up|0|||
42175536|NCT00308711|75982614|FG001|Overall Study|Lost to Follow-up|1|||
42175537|NCT00308711|75982615|FG002|Overall Study|Lost to Follow-up|0|||
42175538|NCT00308711|75982613|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
42175539|NCT00308711|75982614|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
42175540|NCT00308711|75982615|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
42292351|NCT02924727|76126142|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
42357542|NCT01748552|76202982|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
42175541|NCT00308711|75982613|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
42175542|NCT00308711|75982614|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
42175543|NCT00308711|75982615|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
42175544|NCT00308555|75982625|FG000|Overall Study|Withdrawal by Subject|1|||
42066955|NCT00887198|75875905|FG001|Randomized Period|Withdrawal by Subject|56|||
42066956|NCT00887198|75875906|FG002|Randomized Period|Withdrawal by Subject|0|||
42066957|NCT00887198|75875904|FG000|Randomized Period|Progressive disease|366|||
42066958|NCT00887198|75875905|FG001|Randomized Period|Progressive disease|370|||
42292352|NCT02924727|76126143|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
42292353|NCT02901626|76126153|FG000|Overall Study|Lost to Follow-up|1|||
42292354|NCT02901626|76126154|FG001|Overall Study|Lost to Follow-up|1|||
42292355|NCT02720692|76126193|FG000|Overall Study|Withdrawal by Subject|3|||
42292356|NCT02720692|76126194|FG001|Overall Study|Withdrawal by Subject|0|||
42292357|NCT02720692|76126193|FG000|Overall Study|Physician Decision|1|||
42292358|NCT02720692|76126194|FG001|Overall Study|Physician Decision|0|||
42292359|NCT02720692|76126193|FG000|Overall Study|Lost to Follow-up|8|||
42292360|NCT02720692|76126194|FG001|Overall Study|Lost to Follow-up|3|||
42292361|NCT02720692|76126193|FG000|Overall Study|Subject unable to return for visit|1|||
42292362|NCT02720692|76126194|FG001|Overall Study|Subject unable to return for visit|0|||
42066959|NCT00887198|75875906|FG002|Randomized Period|Progressive disease|0|||
42066960|NCT00887198|75875904|FG000|Randomized Period|Other|42|||
42066961|NCT00887198|75875905|FG001|Randomized Period|Other|30|||
42066962|NCT00887198|75875906|FG002|Randomized Period|Other|0|||
42066963|NCT00887198|75875904|FG000|Randomized Period|Randomized, Not treated|4|||
42066964|NCT00887198|75875905|FG001|Randomized Period|Randomized, Not treated|2|||
42066965|NCT00887198|75875906|FG002|Randomized Period|Randomized, Not treated|0|||
42066966|NCT00887198|75875904|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
42066967|NCT00887198|75875905|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
42066968|NCT00887198|75875906|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
42066969|NCT00887198|75875904|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
42066970|NCT00887198|75875905|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
42066971|NCT00887198|75875906|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
42066972|NCT00887198|75875904|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
42066973|NCT00887198|75875905|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
42066974|NCT00887198|75875906|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
42066975|NCT00887198|75875904|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
42066976|NCT00887198|75875905|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
42066977|NCT00887198|75875906|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
42066978|NCT00887198|75875904|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
42066979|NCT00887198|75875905|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
42066980|NCT00887198|75875906|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
42066981|NCT00887198|75875904|FG000|Cross Over (Placebo to AA)|Other|0|||
42066982|NCT00887198|75875905|FG001|Cross Over (Placebo to AA)|Other|0|||
42066983|NCT00887198|75875906|FG002|Cross Over (Placebo to AA)|Other|19|||
42066984|NCT00782067|75875914|FG000|Overall Study|Adverse Event|35|||
42066985|NCT00782067|75875914|FG000|Overall Study|Subject withdrew consent|11|||
42066986|NCT00782067|75875914|FG000|Overall Study|Lost to Follow-up|2|||
42066987|NCT00782067|75875914|FG000|Overall Study|Administrative problems|14|||
42066988|NCT00782067|75875914|FG000|Overall Study|Death|9|||
42066989|NCT00782067|75875914|FG000|Overall Study|Disease progression|43|||
42066990|NCT00782067|75875914|FG000|Overall Study|Protocol deviation|2|||
42066991|NCT00886340|75875920|FG000|Overall Study|Withdrawal by Subject|0|||
42066992|NCT00886340|75875921|FG001|Overall Study|Withdrawal by Subject|7|||
42066993|NCT00605215|75875930|FG000|Overall Study|Death|0|||
42066994|NCT00605215|75875931|FG001|Overall Study|Death|0|||
42066995|NCT00605215|75875932|FG002|Overall Study|Death|1|||
42066996|NCT00605215|75875930|FG000|Overall Study|Adverse Event|19|||
42292363|NCT02656303|76126203|FG000|Overall Study|Adverse Event|3|||
42016957|NCT01136733|75824489|FG004|Phase 2|Administrative-Withdrew Consent|1|||
42016958|NCT01136733|75824490|FG005|Phase 2|Administrative-Withdrew Consent|0|||
42016959|NCT01136733|75824491|FG006|Phase 2|Administrative-Withdrew Consent|0|||
42016960|NCT01136733|75824485|FG000|Phase 2|Other|0|||
42016961|NCT01136733|75824486|FG001|Phase 2|Other|0|||
42016962|NCT01136733|75824487|FG002|Phase 2|Other|0|||
42016963|NCT01136733|75824488|FG003|Phase 2|Other|0|||
42016964|NCT01136733|75824489|FG004|Phase 2|Other|6|||
42016965|NCT01136733|75824490|FG005|Phase 2|Other|7|||
42016966|NCT01136733|75824491|FG006|Phase 2|Other|6|||
42016967|NCT01136655|75824521|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
42016968|NCT01136655|75824521|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
42016969|NCT01136655|75824521|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
42016970|NCT01136655|75824521|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
42016971|NCT01135017|75824536|FG000|Overall Study|Adverse Event|3|||
42066997|NCT00605215|75875931|FG001|Overall Study|Adverse Event|21|||
42292364|NCT02656303|76126204|FG001|Overall Study|Adverse Event|2|||
42066998|NCT00605215|75875932|FG002|Overall Study|Adverse Event|26|||
42292365|NCT02656303|76126205|FG002|Overall Study|Adverse Event|0|||
42066999|NCT00605215|75875930|FG000|Overall Study|Refusal to sign the re-consent form|8|||
42067000|NCT00605215|75875931|FG001|Overall Study|Refusal to sign the re-consent form|3|||
42067001|NCT00605215|75875932|FG002|Overall Study|Refusal to sign the re-consent form|3|||
42067002|NCT00605215|75875930|FG000|Overall Study|Withdrawal by Subject|39|||
42067003|NCT00605215|75875931|FG001|Overall Study|Withdrawal by Subject|37|||
42067004|NCT00605215|75875932|FG002|Overall Study|Withdrawal by Subject|27|||
42067005|NCT00605215|75875930|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
42067006|NCT00605215|75875931|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
42067007|NCT00605215|75875932|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
42067008|NCT00605215|75875930|FG000|Overall Study|Protocol Violation|3|||
42067009|NCT00605215|75875931|FG001|Overall Study|Protocol Violation|4|||
42067010|NCT00605215|75875932|FG002|Overall Study|Protocol Violation|1|||
42067011|NCT00605215|75875930|FG000|Overall Study|Pregnancy|8|||
42067012|NCT00605215|75875931|FG001|Overall Study|Pregnancy|5|||
42067013|NCT00605215|75875932|FG002|Overall Study|Pregnancy|4|||
42067014|NCT00605215|75875930|FG000|Overall Study|Lost to Follow-up|8|||
42067015|NCT00605215|75875931|FG001|Overall Study|Lost to Follow-up|5|||
42067016|NCT00605215|75875932|FG002|Overall Study|Lost to Follow-up|2|||
42067017|NCT00605215|75875930|FG000|Overall Study|Other than specified|0|||
42067018|NCT00605215|75875931|FG001|Overall Study|Other than specified|2|||
42067019|NCT00605215|75875932|FG002|Overall Study|Other than specified|1|||
42067020|NCT00604279|75875942|FG000|Overall Study|Lack of Efficacy|22|||
42067021|NCT00604279|75875943|FG001|Overall Study|Lack of Efficacy|9|||
42067022|NCT00604279|75875942|FG000|Overall Study|Lost to Follow-up|9|||
42067023|NCT00604279|75875943|FG001|Overall Study|Lost to Follow-up|14|||
42067024|NCT00604279|75875942|FG000|Overall Study|Pregnancy|2|||
42067025|NCT00604279|75875943|FG001|Overall Study|Pregnancy|0|||
42067026|NCT00604279|75875942|FG000|Overall Study|Protocol Violation|3|||
42067027|NCT00604279|75875943|FG001|Overall Study|Protocol Violation|1|||
42067028|NCT00604279|75875942|FG000|Overall Study|Withdrawal by Subject|16|||
42067029|NCT00604279|75875943|FG001|Overall Study|Withdrawal by Subject|5|||
42067030|NCT00604279|75875942|FG000|Overall Study|Adverse Event|4|||
42067031|NCT00604279|75875943|FG001|Overall Study|Adverse Event|5|||
42067032|NCT00604279|75875942|FG000|Overall Study|Other|8|||
42067033|NCT00604279|75875943|FG001|Overall Study|Other|4|||
42067034|NCT00938015|75875949|FG000|Overall Study|Death|2|||
42067035|NCT00938015|75875949|FG000|Overall Study|Lost to Follow-up|32|||
42067036|NCT00938015|75875949|FG000|Overall Study|Adverse Event|32|||
42067037|NCT00938015|75875949|FG000|Overall Study|Non-responder|52|||
42067038|NCT00938015|75875949|FG000|Overall Study|Reason not related to Etanercept|29|||
42067039|NCT00781911|75875955|FG000|Overall Study|Adverse Event|4|||
42067040|NCT00781911|75875956|FG001|Overall Study|Adverse Event|4|||
42067041|NCT00781911|75875955|FG000|Overall Study|Withdrawal by Subject|1|||
42067042|NCT00781911|75875956|FG001|Overall Study|Withdrawal by Subject|2|||
42067043|NCT00781911|75875955|FG000|Overall Study|Physician Decision|0|||
42067044|NCT00781911|75875956|FG001|Overall Study|Physician Decision|2|||
42067045|NCT00781911|75875955|FG000|Overall Study|Sponsor Decision|1|||
42067046|NCT00781911|75875956|FG001|Overall Study|Sponsor Decision|0|||
42067047|NCT00605917|75875964|FG000|Overall Study|Protocol Violation|79|||
42067048|NCT00781599|75876001|FG000|Overall Study|Lost to Follow-up|7|||
42067049|NCT00781599|75876002|FG001|Overall Study|Lost to Follow-up|4|||
42067050|NCT00605839|75876020|FG000|Overall Study|Protocol Violation|1|||
42067051|NCT00605839|75876021|FG001|Overall Study|Protocol Violation|0|||
42067052|NCT00605839|75876022|FG002|Overall Study|Protocol Violation|0|||
42067053|NCT00781365|75876032|FG000|Overall Study|Withdrawal by Subject|13|||
42067054|NCT00781365|75876033|FG001|Overall Study|Withdrawal by Subject|8|||
42067055|NCT00781365|75876032|FG000|Overall Study|Did Not Attend Visit|20|||
42067056|NCT00781365|75876033|FG001|Overall Study|Did Not Attend Visit|28|||
42067057|NCT00781365|75876032|FG000|Overall Study|Language barrier|1|||
42067058|NCT00781365|75876033|FG001|Overall Study|Language barrier|0|||
42067059|NCT00937547|75876042|FG000|Overall Study|misdiagnosis|1|||
42067060|NCT00937547|75876043|FG001|Overall Study|misdiagnosis|6|||
42067061|NCT00937547|75876044|FG002|Overall Study|misdiagnosis|7|||
42067062|NCT00780975|75876052|FG000|Overall Study|Progressive disease|3|||
42067063|NCT00780975|75876052|FG000|Overall Study|Toxicity|5|||
42067064|NCT00780273|75876056|FG000|Overall Study|Death|1|||
42067065|NCT00780273|75876056|FG000|Overall Study|Lost to Follow-up|1|||
42067066|NCT00779259|75876061|FG000|Quinine Alone|Adverse Event|2|||
42067067|NCT00779025|75876079|FG000|Overall Study|Withdrawal by Subject|1|||
42067068|NCT00936065|75876087|FG000|Overall Study|Adverse Event|1|||
42067069|NCT00936065|75876088|FG001|Overall Study|Adverse Event|0|||
42067070|NCT00936065|75876089|FG002|Overall Study|Adverse Event|1|||
42067071|NCT00936065|75876087|FG000|Overall Study|Lack of Efficacy|1|||
42067072|NCT00936065|75876088|FG001|Overall Study|Lack of Efficacy|0|||
42067073|NCT00936065|75876089|FG002|Overall Study|Lack of Efficacy|1|||
42067074|NCT00936065|75876087|FG000|Overall Study|Lost to Follow-up|1|||
42067075|NCT00936065|75876088|FG001|Overall Study|Lost to Follow-up|0|||
42067076|NCT00936065|75876089|FG002|Overall Study|Lost to Follow-up|0|||
42067077|NCT00936065|75876087|FG000|Overall Study|Protocol Violation|1|||
42067078|NCT00936065|75876088|FG001|Overall Study|Protocol Violation|2|||
42067079|NCT00936065|75876089|FG002|Overall Study|Protocol Violation|1|||
42067080|NCT00936065|75876087|FG000|Overall Study|Withdrawal by Subject|0|||
42067081|NCT00936065|75876088|FG001|Overall Study|Withdrawal by Subject|2|||
42067082|NCT00936065|75876089|FG002|Overall Study|Withdrawal by Subject|4|||
42067083|NCT04441788|75876100|FG000|Overall Study|Voluntary Withdrawl|0|||
42067084|NCT04441788|75876101|FG001|Overall Study|Voluntary Withdrawl|1|||
42067085|NCT04441788|75876102|FG002|Overall Study|Voluntary Withdrawl|0|||
42067086|NCT04441788|75876100|FG000|Overall Study|Ineligibility|1|||
42067087|NCT04441788|75876101|FG001|Overall Study|Ineligibility|0|||
42067088|NCT04441788|75876102|FG002|Overall Study|Ineligibility|0|||
42067089|NCT04441788|75876100|FG000|Overall Study|Adverse Event|0|||
42067090|NCT04441788|75876101|FG001|Overall Study|Adverse Event|0|||
42067091|NCT04441788|75876102|FG002|Overall Study|Adverse Event|4|||
42067092|NCT04441788|75876100|FG000|Overall Study|Study Terminated by Sponsor|16|||
42067093|NCT04441788|75876101|FG001|Overall Study|Study Terminated by Sponsor|16|||
42067094|NCT04441788|75876102|FG002|Overall Study|Study Terminated by Sponsor|12|||
42067095|NCT00604825|75876118|FG000|Overall Study|Adverse Event|2|||
42067096|NCT00604825|75876119|FG001|Overall Study|Adverse Event|6|||
42067097|NCT00604825|75876120|FG002|Overall Study|Adverse Event|7|||
42067098|NCT00604825|75876121|FG003|Overall Study|Adverse Event|4|||
42067099|NCT00604825|75876118|FG000|Overall Study|Lost to Follow-up|0|||
42067100|NCT00604825|75876119|FG001|Overall Study|Lost to Follow-up|3|||
42067101|NCT00604825|75876120|FG002|Overall Study|Lost to Follow-up|1|||
42067102|NCT00604825|75876121|FG003|Overall Study|Lost to Follow-up|0|||
42067103|NCT00604825|75876118|FG000|Overall Study|Protocol Violation|0|||
42067104|NCT00604825|75876119|FG001|Overall Study|Protocol Violation|1|||
42067105|NCT00604825|75876120|FG002|Overall Study|Protocol Violation|0|||
42067106|NCT00604825|75876121|FG003|Overall Study|Protocol Violation|0|||
42067107|NCT00604825|75876118|FG000|Overall Study|Withdrawal by Subject|4|||
42067108|NCT00604825|75876119|FG001|Overall Study|Withdrawal by Subject|3|||
42067109|NCT00604825|75876120|FG002|Overall Study|Withdrawal by Subject|5|||
42067110|NCT00604825|75876121|FG003|Overall Study|Withdrawal by Subject|5|||
42067111|NCT00604825|75876118|FG000|Overall Study|Lack of Efficacy|3|||
42067112|NCT00604825|75876119|FG001|Overall Study|Lack of Efficacy|2|||
42067113|NCT00604825|75876120|FG002|Overall Study|Lack of Efficacy|1|||
42067114|NCT00604825|75876121|FG003|Overall Study|Lack of Efficacy|0|||
42067115|NCT00604825|75876118|FG000|Overall Study|Did not meet eligibility criteria|0|||
42067116|NCT00604825|75876119|FG001|Overall Study|Did not meet eligibility criteria|0|||
42067117|NCT00604825|75876120|FG002|Overall Study|Did not meet eligibility criteria|2|||
42067118|NCT00604825|75876121|FG003|Overall Study|Did not meet eligibility criteria|0|||
42067119|NCT00604825|75876118|FG000|Overall Study|Physician Decision|0|||
42067120|NCT00604825|75876119|FG001|Overall Study|Physician Decision|0|||
42067121|NCT00604825|75876120|FG002|Overall Study|Physician Decision|0|||
42067122|NCT00604825|75876121|FG003|Overall Study|Physician Decision|1|||
42067123|NCT00604825|75876118|FG000|Overall Study|Exclusion criterion met|0|||
42067124|NCT00604825|75876119|FG001|Overall Study|Exclusion criterion met|0|||
42067125|NCT00604825|75876120|FG002|Overall Study|Exclusion criterion met|0|||
42067126|NCT00604825|75876121|FG003|Overall Study|Exclusion criterion met|1|||
42067127|NCT00937391|75876133|FG000|Stage 2|Withdrawal by Subject|1|||
42067128|NCT00937157|75876150|FG000|Overall Study|Pregnancy|1|||
42067129|NCT00937157|75876150|FG000|Overall Study|Lost to Follow-up|3|||
42067130|NCT00777153|75876157|FG000|Overall Study|Lost to Follow-up|1|||
42067131|NCT00777153|75876158|FG001|Overall Study|Lost to Follow-up|1|||
42067132|NCT00777153|75876159|FG002|Overall Study|Lost to Follow-up|0|||
42067133|NCT00777153|75876157|FG000|Overall Study|Death|85|||
42067134|NCT00777153|75876158|FG001|Overall Study|Death|73|||
42067135|NCT00777153|75876159|FG002|Overall Study|Death|33|||
42067136|NCT00777153|75876157|FG000|Overall Study|Withdrawal by Subject|3|||
42067137|NCT00777153|75876158|FG001|Overall Study|Withdrawal by Subject|4|||
42067138|NCT00777153|75876159|FG002|Overall Study|Withdrawal by Subject|3|||
42357543|NCT01748552|76202983|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
42067139|NCT00777153|75876157|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
42067140|NCT00777153|75876158|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
42067141|NCT00777153|75876159|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
42067142|NCT00567541|75876173|FG000|Overall Study|Adverse Event|0|||
42067143|NCT00567541|75876174|FG001|Overall Study|Adverse Event|1|||
42067144|NCT00776997|75876180|FG000|Overall Study|Adverse Event|2|||
42067145|NCT00940823|75876186|FG000|Overall Study|Death|8|||
42067146|NCT00940823|75876187|FG001|Overall Study|Death|12|||
42067147|NCT00940823|75876186|FG000|Overall Study|Lost to Follow-up|27|||
42067148|NCT00940823|75876187|FG001|Overall Study|Lost to Follow-up|20|||
42067149|NCT00936611|75876195|FG000|Overall Study|Progressive Disease|3|||
42067150|NCT00936611|75876195|FG000|Overall Study|New Systemic Therapy|22|||
42357544|NCT01748552|76202972|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
42067151|NCT00936611|75876195|FG000|Overall Study|Lost to Follow-up|1|||
42067152|NCT00936611|75876195|FG000|Overall Study|Withdrawal by Subject|2|||
42067153|NCT00936611|75876195|FG000|Overall Study|Still on Follow-up|1|||
42067154|NCT00936611|75876195|FG000|Overall Study|Still on Active Therapy|7|||
42067155|NCT00936611|75876195|FG000|Overall Study|Ineligible for Study Drug|3|||
42067156|NCT00936221|75876218|FG000|Overall Study|Withdrawal by Subject|1|||
42067157|NCT00936221|75876219|FG001|Overall Study|Withdrawal by Subject|1|||
42067158|NCT00776919|75876229|FG000|Overall Study|Withdrawal by Subject|16|||
42067159|NCT00776919|75876230|FG001|Overall Study|Withdrawal by Subject|14|||
42067160|NCT00776919|75876231|FG002|Overall Study|Withdrawal by Subject|15|||
42067161|NCT00776919|75876232|FG003|Overall Study|Withdrawal by Subject|26|||
42067162|NCT00776919|75876229|FG000|Overall Study|Lost to Follow-up|8|||
42067163|NCT00776919|75876230|FG001|Overall Study|Lost to Follow-up|12|||
42067164|NCT00776919|75876231|FG002|Overall Study|Lost to Follow-up|11|||
42067165|NCT00776919|75876232|FG003|Overall Study|Lost to Follow-up|8|||
42067166|NCT00776919|75876229|FG000|Overall Study|Adverse Event|1|||
42067167|NCT00776919|75876230|FG001|Overall Study|Adverse Event|0|||
42067168|NCT00776919|75876231|FG002|Overall Study|Adverse Event|2|||
42067169|NCT00776919|75876232|FG003|Overall Study|Adverse Event|2|||
42067170|NCT00776919|75876229|FG000|Overall Study|Protocol Violation|1|||
42067171|NCT00776919|75876230|FG001|Overall Study|Protocol Violation|2|||
42067172|NCT00776919|75876231|FG002|Overall Study|Protocol Violation|0|||
42067173|NCT00776919|75876232|FG003|Overall Study|Protocol Violation|1|||
42067174|NCT00776919|75876229|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
42067175|NCT00776919|75876230|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
42067176|NCT00776919|75876231|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
42067177|NCT00776919|75876232|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
42067178|NCT00775983|75876259|FG000|Overall Study|Protocol Violation|1|||
42067179|NCT00775983|75876260|FG001|Overall Study|Protocol Violation|2|||
42067180|NCT00775593|75876266|FG000|Overall Study|Unmet eligibility criteria|6|||
42067181|NCT00775593|75876266|FG000|Overall Study|Death|1|||
42067182|NCT00939809|75876270|FG000|Overall Study|Adverse Event|2|||
42067183|NCT00939809|75876270|FG000|Overall Study|Death|1|||
42067184|NCT00934661|75876276|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
42067185|NCT00934661|75876277|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
42067186|NCT00775437|75876283|FG000|Overall Study|Loss of efficacy|2|||
42067187|NCT00775437|75876283|FG000|Overall Study|Withdrawal by Subject|3|||
42067188|NCT00775437|75876283|FG000|Overall Study|Lost to Follow-up|1|||
42067189|NCT00775203|75876289|FG000|Overall Study|Adverse Event|25|||
42067190|NCT00775203|75876290|FG001|Overall Study|Adverse Event|6|||
42067191|NCT00775203|75876289|FG000|Overall Study|Lack of Efficacy|8|||
42067192|NCT00775203|75876290|FG001|Overall Study|Lack of Efficacy|9|||
42067193|NCT00775203|75876289|FG000|Overall Study|Withdrawal by Subject|11|||
42067194|NCT00775203|75876290|FG001|Overall Study|Withdrawal by Subject|9|||
42067195|NCT00775203|75876289|FG000|Overall Study|Lost to Follow-up|11|||
42067196|NCT00775203|75876290|FG001|Overall Study|Lost to Follow-up|15|||
42067197|NCT00775203|75876289|FG000|Overall Study|Administrative reason|2|||
42067198|NCT00775203|75876290|FG001|Overall Study|Administrative reason|0|||
42067199|NCT00775203|75876289|FG000|Overall Study|Noncompliance|4|||
42067200|NCT00775203|75876290|FG001|Overall Study|Noncompliance|2|||
42067201|NCT00775203|75876289|FG000|Overall Study|Protocol Violation|0|||
42067202|NCT00775203|75876290|FG001|Overall Study|Protocol Violation|1|||
42067203|NCT00775203|75876289|FG000|Overall Study|Entered other study|1|||
42067204|NCT00775203|75876290|FG001|Overall Study|Entered other study|0|||
42067205|NCT00775203|75876289|FG000|Overall Study|Physician Decision|0|||
42067206|NCT00775203|75876290|FG001|Overall Study|Physician Decision|1|||
42067207|NCT00568321|75876299|FG000|Overall Study|Adverse Event|1|||
42067208|NCT00568321|75876300|FG001|Overall Study|Adverse Event|0|||
42067209|NCT00568321|75876301|FG002|Overall Study|Adverse Event|0|||
42067210|NCT00568321|75876299|FG000|Overall Study|Lack of Efficacy|8|||
42067211|NCT00568321|75876300|FG001|Overall Study|Lack of Efficacy|5|||
42067212|NCT00568321|75876301|FG002|Overall Study|Lack of Efficacy|6|||
42067213|NCT00568321|75876299|FG000|Overall Study|Lost to Follow-up|0|||
42067214|NCT00568321|75876300|FG001|Overall Study|Lost to Follow-up|0|||
42067215|NCT00568321|75876301|FG002|Overall Study|Lost to Follow-up|1|||
42067216|NCT00568321|75876299|FG000|Overall Study|Withdrawal by Subject|2|||
42067217|NCT00568321|75876300|FG001|Overall Study|Withdrawal by Subject|0|||
42067218|NCT00568321|75876301|FG002|Overall Study|Withdrawal by Subject|0|||
42067219|NCT00568321|75876299|FG000|Overall Study|Protocol Violation|0|||
42067220|NCT00568321|75876300|FG001|Overall Study|Protocol Violation|0|||
42067221|NCT00568321|75876301|FG002|Overall Study|Protocol Violation|1|||
42067222|NCT00568321|75876299|FG000|Overall Study|Randomized, not treated|2|||
42067223|NCT00568321|75876300|FG001|Overall Study|Randomized, not treated|0|||
42067224|NCT00568321|75876301|FG002|Overall Study|Randomized, not treated|1|||
42067225|NCT00774345|75876313|FG000|Pre-treatment|Other reasons|2|||
42067226|NCT00774345|75876314|FG001|Pre-treatment|Other reasons|0|||
42067227|NCT00774345|75876313|FG000|Treatment|Adverse Event|61|||
42067228|NCT00774345|75876314|FG001|Treatment|Adverse Event|15|||
42067229|NCT00774345|75876313|FG000|Treatment|Progressive Disease without histologic transformation|51|||
42067230|NCT00774345|75876314|FG001|Treatment|Progressive Disease without histologic transformation|111|||
42067231|NCT00774345|75876313|FG000|Treatment|Progressive Disease with histologic transformation|4|||
42175545|NCT00308555|75982626|FG001|Overall Study|Withdrawal by Subject|0|||
42175546|NCT00308555|75982625|FG000|Overall Study|Physician Decision|2|||
42175547|NCT00308555|75982626|FG001|Overall Study|Physician Decision|0|||
42175548|NCT00050778|75982635|FG000|Overall Study|Adverse Event|13|||
42175549|NCT00050778|75982636|FG001|Overall Study|Adverse Event|3|||
42175550|NCT00050778|75982637|FG002|Overall Study|Adverse Event|2|||
42175551|NCT00050778|75982635|FG000|Overall Study|Death|0|||
42175552|NCT00050778|75982636|FG001|Overall Study|Death|1|||
42175553|NCT00050778|75982637|FG002|Overall Study|Death|1|||
42175554|NCT00050778|75982635|FG000|Overall Study|Lack of Efficacy|16|||
42175555|NCT00050778|75982636|FG001|Overall Study|Lack of Efficacy|2|||
42292366|NCT02656303|76126203|FG000|Overall Study|Death|12|||
42292367|NCT02656303|76126204|FG001|Overall Study|Death|4|||
42292368|NCT02656303|76126205|FG002|Overall Study|Death|1|||
42292369|NCT02656303|76126203|FG000|Overall Study|Lack of Efficacy|1|||
42292370|NCT02656303|76126204|FG001|Overall Study|Lack of Efficacy|0|||
42292371|NCT02656303|76126205|FG002|Overall Study|Lack of Efficacy|0|||
42292372|NCT02656303|76126203|FG000|Overall Study|Non-Compliance with Study|1|||
42292373|NCT02656303|76126204|FG001|Overall Study|Non-Compliance with Study|1|||
42292374|NCT02656303|76126205|FG002|Overall Study|Non-Compliance with Study|0|||
42292375|NCT02656303|76126203|FG000|Overall Study|Investigator Decision|2|||
42292376|NCT02656303|76126204|FG001|Overall Study|Investigator Decision|1|||
42292377|NCT02656303|76126205|FG002|Overall Study|Investigator Decision|0|||
42292378|NCT02656303|76126203|FG000|Overall Study|Progressive Disease|25|||
42292379|NCT02656303|76126204|FG001|Overall Study|Progressive Disease|14|||
42292380|NCT02656303|76126205|FG002|Overall Study|Progressive Disease|10|||
42292381|NCT02656303|76126203|FG000|Overall Study|Study Terminated by Sponsor|20|||
42292382|NCT02656303|76126204|FG001|Overall Study|Study Terminated by Sponsor|7|||
42292383|NCT02656303|76126205|FG002|Overall Study|Study Terminated by Sponsor|5|||
42292384|NCT02656303|76126203|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
42292385|NCT02656303|76126204|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
42292386|NCT02656303|76126205|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
42292387|NCT02656303|76126203|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
42292388|NCT02656303|76126204|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
42292389|NCT02656303|76126205|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
42292390|NCT02656303|76126203|FG000|Overall Study|Reason not Specified|1|||
42292391|NCT02656303|76126204|FG001|Overall Study|Reason not Specified|1|||
42292392|NCT02656303|76126205|FG002|Overall Study|Reason not Specified|2|||
42292393|NCT02628626|76126215|FG000|Overall Study|Withdrawal by Subject|2|||
42292394|NCT02628626|76126216|FG001|Overall Study|Withdrawal by Subject|2|||
42292395|NCT02527707|76126248|FG000|Overall Study|Adverse Event|1|||
42292396|NCT02527707|76126248|FG000|Overall Study|Adverse Event|1|||
42292397|NCT02453191|76126259|FG000|Overall Study|Withdrawal by Subject|1|||
42292398|NCT02352090|76126267|FG000|Overall Study|general malaise|1|||
42292399|NCT02352090|76126268|FG001|Overall Study|general malaise|0|||
42292400|NCT02352090|76126269|FG002|Overall Study|general malaise|0|||
42292401|NCT02352090|76126267|FG000|Overall Study|non-specified mild side-effects|0|||
42292402|NCT02352090|76126268|FG001|Overall Study|non-specified mild side-effects|0|||
42292403|NCT02352090|76126269|FG002|Overall Study|non-specified mild side-effects|2|||
42292404|NCT02135107|76126279|FG000|Treatment Period|Withdrawal by Subject|11|||
42292405|NCT02135107|76126280|FG001|Treatment Period|Withdrawal by Subject|0|||
42292406|NCT02135107|76126281|FG002|Treatment Period|Withdrawal by Subject|0|||
42016972|NCT01135017|75824537|FG001|Overall Study|Adverse Event|8|||
42016973|NCT01135017|75824536|FG000|Overall Study|Other than above|3|||
42016974|NCT01135017|75824537|FG001|Overall Study|Other than above|4|||
42016975|NCT01134939|75824551|FG000|Overall Study|Adverse Event|9|||
42016976|NCT01134939|75824552|FG001|Overall Study|Adverse Event|3|||
42016977|NCT01134939|75824553|FG002|Overall Study|Adverse Event|4|||
42016978|NCT01134939|75824554|FG003|Overall Study|Adverse Event|5|||
42016979|NCT01134939|75824555|FG004|Overall Study|Adverse Event|5|||
42016980|NCT01134939|75824556|FG005|Overall Study|Adverse Event|5|||
42016981|NCT01134939|75824557|FG006|Overall Study|Adverse Event|1|||
42016982|NCT01134939|75824558|FG007|Overall Study|Adverse Event|0|||
42016983|NCT01134939|75824551|FG000|Overall Study|Lack of Efficacy|2|||
42016984|NCT01134939|75824552|FG001|Overall Study|Lack of Efficacy|5|||
42016985|NCT01134939|75824553|FG002|Overall Study|Lack of Efficacy|1|||
42016986|NCT01134939|75824554|FG003|Overall Study|Lack of Efficacy|0|||
42016987|NCT01134939|75824555|FG004|Overall Study|Lack of Efficacy|3|||
42067232|NCT00774345|75876314|FG001|Treatment|Progressive Disease with histologic transformation|2|||
42292407|NCT02135107|76126282|FG003|Treatment Period|Withdrawal by Subject|0|||
42292408|NCT02135107|76126279|FG000|Treatment Period|Adverse Event|5|||
42292409|NCT02135107|76126280|FG001|Treatment Period|Adverse Event|2|||
42016988|NCT01134939|75824556|FG005|Overall Study|Lack of Efficacy|0|||
42016989|NCT01134939|75824557|FG006|Overall Study|Lack of Efficacy|1|||
42175556|NCT00050778|75982637|FG002|Overall Study|Lack of Efficacy|2|||
42016990|NCT01134939|75824558|FG007|Overall Study|Lack of Efficacy|0|||
42016991|NCT01134939|75824551|FG000|Overall Study|Lost to Follow-up|2|||
42175557|NCT00050778|75982635|FG000|Overall Study|Lost to Follow-up|0|||
42067233|NCT00774345|75876313|FG000|Treatment|Withdrawal by Subject|5|||
42067234|NCT00774345|75876314|FG001|Treatment|Withdrawal by Subject|2|||
42067235|NCT00774345|75876313|FG000|Treatment|Lost to Follow-up|1|||
42067236|NCT00774345|75876314|FG001|Treatment|Lost to Follow-up|1|||
42067237|NCT00774345|75876313|FG000|Treatment|Death|4|||
42067238|NCT00774345|75876314|FG001|Treatment|Death|0|||
42067239|NCT00774345|75876313|FG000|Treatment|Other Reasons|32|||
42067240|NCT00774345|75876314|FG001|Treatment|Other Reasons|26|||
42067241|NCT00773253|75876326|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
42067242|NCT00773253|75876327|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
42067243|NCT00773175|75876337|FG000|Overall Study|Adverse Event|2|||
42067244|NCT00773175|75876338|FG001|Overall Study|Adverse Event|0|||
42067245|NCT00773175|75876337|FG000|Overall Study|Consent Withdrawn|0|||
42067246|NCT00773175|75876338|FG001|Overall Study|Consent Withdrawn|2|||
42067247|NCT00566527|75876352|FG000|Overall Study|Reason not provided|3|||
42067248|NCT00566527|75876353|FG001|Overall Study|Reason not provided|11|||
42067249|NCT00566527|75876354|FG002|Overall Study|Reason not provided|10|||
42067250|NCT00566527|75876352|FG000|Overall Study|Adverse Event|2|||
42067251|NCT00566527|75876353|FG001|Overall Study|Adverse Event|0|||
42067252|NCT00566527|75876354|FG002|Overall Study|Adverse Event|1|||
42067253|NCT00566527|75876352|FG000|Overall Study|Physician Decision|3|||
42067254|NCT00566527|75876353|FG001|Overall Study|Physician Decision|8|||
42067255|NCT00566527|75876354|FG002|Overall Study|Physician Decision|20|||
42067256|NCT00566527|75876352|FG000|Overall Study|Lost to Follow-up|3|||
42067257|NCT00566527|75876353|FG001|Overall Study|Lost to Follow-up|4|||
42067258|NCT00566527|75876354|FG002|Overall Study|Lost to Follow-up|4|||
42067259|NCT00566527|75876352|FG000|Overall Study|Withdrawal by Subject|6|||
42067260|NCT00566527|75876353|FG001|Overall Study|Withdrawal by Subject|43|||
42067261|NCT00566527|75876354|FG002|Overall Study|Withdrawal by Subject|43|||
42067262|NCT00773097|75876364|FG000|Overall Study|Withdrawal by Subject|1|||
42067263|NCT00773097|75876364|FG000|Overall Study|Physician Decision|6|||
42067264|NCT00933335|75876370|FG000|Overall Study|Lost to Follow-up|1|||
42067265|NCT00933335|75876371|FG001|Overall Study|Lost to Follow-up|3|||
42067266|NCT00933335|75876370|FG000|Overall Study|Withdrawal by Subject|0|||
42067267|NCT00933335|75876371|FG001|Overall Study|Withdrawal by Subject|1|||
42067268|NCT00933335|75876370|FG000|Overall Study|Progressive Disease|0|||
42067269|NCT00933335|75876371|FG001|Overall Study|Progressive Disease|11|||
42067270|NCT00933335|75876370|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
42067271|NCT00933335|75876371|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
42067272|NCT00933335|75876370|FG000|Overall Study|Co-morbid Illness|1|||
42067273|NCT00933335|75876371|FG001|Overall Study|Co-morbid Illness|0|||
42067274|NCT00772941|75876383|FG000|Overall Study|CRFs not available|195|||
42067275|NCT00772941|75876383|FG000|Overall Study|Study not completed|16|||
42067276|NCT00772941|75876383|FG000|Overall Study|Missed Visits|374|||
42067277|NCT00772941|75876383|FG000|Overall Study|Poor Compliance|7|||
42067278|NCT00772941|75876383|FG000|Overall Study|GPSP Violation|90|||
42067279|NCT00772707|75876410|FG000|Overall Study|Withdrawn|3|||
42067280|NCT00772629|75876416|FG000|Overall Study|Subject was not vaccinated|1|||
42067281|NCT00772629|75876417|FG001|Overall Study|Subject was not vaccinated|0|||
42067282|NCT00939341|75876423|FG000|Overall Study|Adverse Event|15|||
42067283|NCT00939341|75876423|FG000|Overall Study|Pregnancy|1|||
42067284|NCT00939341|75876423|FG000|Overall Study|Lost to Follow-up|23|||
42067285|NCT00939341|75876423|FG000|Overall Study|Withdrawal by Subject|13|||
42067286|NCT00939341|75876423|FG000|Overall Study|Protocol Violation|6|||
42067287|NCT00939341|75876423|FG000|Overall Study|Incorrect enrolment|8|||
42067288|NCT04292470|75876452|FG000|Overall Study|Withdrawal by Subject|0|||
42067289|NCT04292470|75876453|FG001|Overall Study|Withdrawal by Subject|1|||
42067290|NCT04217590|75876461|FG000|Overall Study|Other|1|||
42067291|NCT04217590|75876462|FG001|Overall Study|Other|1|||
42067292|NCT04217590|75876461|FG000|Overall Study|Withdrawal by Subject|3|||
42067293|NCT04217590|75876462|FG001|Overall Study|Withdrawal by Subject|1|||
42067294|NCT04217590|75876461|FG000|Overall Study|Death|0|||
42067295|NCT04217590|75876462|FG001|Overall Study|Death|1|||
42357545|NCT01748552|76202973|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
42067296|NCT03963232|75876470|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
42067297|NCT03963232|75876471|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
42067298|NCT03963232|75876470|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
42067299|NCT03963232|75876471|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
42067300|NCT03963232|75876470|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
42067301|NCT03963232|75876471|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
42067302|NCT03963232|75876470|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
42067303|NCT03963232|75876471|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
42067304|NCT03963232|75876470|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
42067305|NCT03963232|75876471|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
42067306|NCT03963232|75876470|FG000|Open-Label Treatment Phase|Adverse Event|1|||
42067307|NCT03963232|75876471|FG001|Open-Label Treatment Phase|Adverse Event|2|||
42067308|NCT03963232|75876470|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
42067309|NCT03963232|75876471|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
42067310|NCT03963232|75876470|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
42067311|NCT03963232|75876471|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
42067312|NCT03963232|75876470|FG000|Open-Label Treatment Phase|Pregnancy|1|||
42067313|NCT03963232|75876471|FG001|Open-Label Treatment Phase|Pregnancy|0|||
42175558|NCT00050778|75982636|FG001|Overall Study|Lost to Follow-up|2|||
42175559|NCT00050778|75982637|FG002|Overall Study|Lost to Follow-up|4|||
42175560|NCT00050778|75982635|FG000|Overall Study|Physician Decision|3|||
42175561|NCT00050778|75982636|FG001|Overall Study|Physician Decision|0|||
42175562|NCT00050778|75982637|FG002|Overall Study|Physician Decision|2|||
42175563|NCT00050778|75982635|FG000|Overall Study|Protocol Violation|2|||
42175564|NCT00050778|75982636|FG001|Overall Study|Protocol Violation|0|||
42175565|NCT00050778|75982637|FG002|Overall Study|Protocol Violation|1|||
42175566|NCT00050778|75982635|FG000|Overall Study|Withdrawal by Subject|6|||
42175567|NCT00050778|75982636|FG001|Overall Study|Withdrawal by Subject|8|||
42175568|NCT00050778|75982637|FG002|Overall Study|Withdrawal by Subject|4|||
42175569|NCT00050778|75982635|FG000|Overall Study|Randomized but not treated|4|||
42175570|NCT00050778|75982636|FG001|Overall Study|Randomized but not treated|5|||
42175571|NCT00050778|75982637|FG002|Overall Study|Randomized but not treated|2|||
42175572|NCT00050778|75982635|FG000|Overall Study|Familial and personal reasons|1|||
42175573|NCT00050778|75982636|FG001|Overall Study|Familial and personal reasons|0|||
42175574|NCT00050778|75982637|FG002|Overall Study|Familial and personal reasons|0|||
42175575|NCT00050622|75982647|FG000|Overall Study|Adverse Event|1|||
42175576|NCT00308087|75982673|FG000|Overall Study|Progressive Disease|19|||
42175577|NCT00308087|75982674|FG001|Overall Study|Progressive Disease|21|||
42175578|NCT00308087|75982673|FG000|Overall Study|Study Closure|11|||
42175579|NCT00308087|75982674|FG001|Overall Study|Study Closure|12|||
42175580|NCT00308087|75982673|FG000|Overall Study|Withdrawal by Subject|2|||
42175581|NCT00308087|75982674|FG001|Overall Study|Withdrawal by Subject|1|||
42175582|NCT00308087|75982673|FG000|Overall Study|Other|4|||
42175583|NCT00308087|75982674|FG001|Overall Study|Other|3|||
42175584|NCT00307931|75982680|FG000|Overall Study|Adverse Event|1|||
42175585|NCT02796170|75982686|FG000|Overall Study|Lost to Follow-up|3|||
42175586|NCT02796170|75982687|FG001|Overall Study|Lost to Follow-up|0|||
42175587|NCT00049842|75982695|FG000|Treatment Phase|Adverse Event|47|||
42175588|NCT00049842|75982696|FG001|Treatment Phase|Adverse Event|12|||
42175589|NCT00049842|75982695|FG000|Treatment Phase|Withdrawal by Subject|35|||
42175590|NCT00049842|75982696|FG001|Treatment Phase|Withdrawal by Subject|46|||
42175591|NCT00049842|75982695|FG000|Treatment Phase|Non-compliance with protocol|7|||
42175592|NCT00049842|75982696|FG001|Treatment Phase|Non-compliance with protocol|8|||
42175593|NCT00049842|75982695|FG000|Treatment Phase|Lost to Follow-up|4|||
42175594|NCT00049842|75982696|FG001|Treatment Phase|Lost to Follow-up|8|||
42175595|NCT00049842|75982695|FG000|Treatment Phase|Administrative|0|||
42175596|NCT00049842|75982696|FG001|Treatment Phase|Administrative|3|||
42175597|NCT00049842|75982695|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
42175598|NCT00049842|75982696|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
42175599|NCT00049842|75982695|FG000|Follow-up Phase|Adverse Event|6|||
42175600|NCT00049842|75982696|FG001|Follow-up Phase|Adverse Event|1|||
42175601|NCT00049842|75982695|FG000|Follow-up Phase|Other|1|||
42175602|NCT00049842|75982696|FG001|Follow-up Phase|Other|4|||
42175603|NCT00307151|75982706|FG000|Overall Study|Death|4|||
42175604|NCT00307151|75982707|FG001|Overall Study|Death|3|||
42175605|NCT00307151|75982708|FG002|Overall Study|Death|10|||
42175606|NCT00307151|75982709|FG003|Overall Study|Death|3|||
42175607|NCT00307151|75982706|FG000|Overall Study|Severe debilitation, unable to continue|1|||
42292410|NCT02135107|76126281|FG002|Treatment Period|Adverse Event|0|||
42292411|NCT02135107|76126282|FG003|Treatment Period|Adverse Event|0|||
42292412|NCT02135107|76126279|FG000|Treatment Period|Pregnancy|1|||
42292413|NCT02135107|76126280|FG001|Treatment Period|Pregnancy|0|||
42292414|NCT02135107|76126281|FG002|Treatment Period|Pregnancy|0|||
42292415|NCT02135107|76126282|FG003|Treatment Period|Pregnancy|0|||
42067314|NCT03963232|75876470|FG000|Follow-up Phase|Withdrawal by Subject|7|||
42067315|NCT03963232|75876471|FG001|Follow-up Phase|Withdrawal by Subject|5|||
42067316|NCT03963232|75876470|FG000|Follow-up Phase|Protocol Violation|0|||
42067317|NCT03963232|75876471|FG001|Follow-up Phase|Protocol Violation|2|||
42292416|NCT02135107|76126279|FG000|Treatment Period|Other|115|||
42067318|NCT03963232|75876470|FG000|Follow-up Phase|Adverse Event|0|||
42067319|NCT03963232|75876471|FG001|Follow-up Phase|Adverse Event|1|||
42175608|NCT00307151|75982707|FG001|Overall Study|Severe debilitation, unable to continue|0|||
42175609|NCT00307151|75982708|FG002|Overall Study|Severe debilitation, unable to continue|0|||
42175610|NCT00307151|75982709|FG003|Overall Study|Severe debilitation, unable to continue|0|||
42175611|NCT00307151|75982706|FG000|Overall Study|Subject unable to get to clinic|1|||
42175612|NCT00307151|75982707|FG001|Overall Study|Subject unable to get to clinic|0|||
42175613|NCT00307151|75982708|FG002|Overall Study|Subject unable to get to clinic|6|||
42175614|NCT00307151|75982709|FG003|Overall Study|Subject unable to get to clinic|2|||
42175615|NCT00307151|75982706|FG000|Overall Study|Withdrew consent|0|||
42175616|NCT00307151|75982707|FG001|Overall Study|Withdrew consent|1|||
42175617|NCT00307151|75982708|FG002|Overall Study|Withdrew consent|1|||
42292417|NCT02135107|76126280|FG001|Treatment Period|Other|24|||
42067320|NCT03963232|75876470|FG000|Follow-up Phase|Lost to Follow-up|0|||
42067321|NCT03963232|75876471|FG001|Follow-up Phase|Lost to Follow-up|1|||
42067322|NCT03856593|75876495|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
42067323|NCT03856593|75876496|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
42067324|NCT03785925|75876504|FG000|Overall Study|Withdrawal by Subject|15|||
42067325|NCT03785925|75876504|FG000|Overall Study|Lost to Follow-up|1|||
42067326|NCT03427411|75876515|FG000|Overall Study|Screen failure - platelets too low|0|||
42067327|NCT03427411|75876516|FG001|Overall Study|Screen failure - platelets too low|1|||
42067328|NCT03330106|75876524|FG000|Part A|Withdrawal by Subject|1|||
42067329|NCT03330106|75876525|FG001|Part A|Withdrawal by Subject|1|||
42067330|NCT03330106|75876526|FG002|Part A|Withdrawal by Subject|0|||
42067331|NCT03330106|75876527|FG003|Part A|Withdrawal by Subject|0|||
42067332|NCT03330106|75876524|FG000|Part A|Death|2|||
42067333|NCT03330106|75876525|FG001|Part A|Death|1|||
42067334|NCT03330106|75876526|FG002|Part A|Death|0|||
42067335|NCT03330106|75876527|FG003|Part A|Death|0|||
42067336|NCT03330106|75876524|FG000|Part A|Adverse Event|0|||
42067337|NCT03330106|75876525|FG001|Part A|Adverse Event|1|||
42067338|NCT03330106|75876526|FG002|Part A|Adverse Event|0|||
42067339|NCT03330106|75876527|FG003|Part A|Adverse Event|0|||
42067340|NCT03330106|75876524|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
42067341|NCT03330106|75876525|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
42067342|NCT03330106|75876526|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
42067343|NCT03330106|75876527|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
42067344|NCT03330106|75876524|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
42067345|NCT03330106|75876525|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
42067346|NCT03330106|75876526|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
42067347|NCT03330106|75876527|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
42067348|NCT03330106|75876524|FG000|Part A|Progressive Disease|0|||
42067349|NCT03330106|75876525|FG001|Part A|Progressive Disease|1|||
42067350|NCT03330106|75876526|FG002|Part A|Progressive Disease|0|||
42067351|NCT03330106|75876527|FG003|Part A|Progressive Disease|0|||
42067352|NCT03330106|75876524|FG000|Part B|Lost to Follow-up|0|||
42067353|NCT03330106|75876525|FG001|Part B|Lost to Follow-up|0|||
42067354|NCT03330106|75876526|FG002|Part B|Lost to Follow-up|0|||
42067355|NCT03330106|75876527|FG003|Part B|Lost to Follow-up|1|||
42067356|NCT03330106|75876524|FG000|Part B|Withdrawal by Subject|0|||
42067357|NCT03330106|75876525|FG001|Part B|Withdrawal by Subject|0|||
42067358|NCT03330106|75876526|FG002|Part B|Withdrawal by Subject|4|||
42067359|NCT03330106|75876527|FG003|Part B|Withdrawal by Subject|0|||
42067360|NCT03330106|75876524|FG000|Part B|Death|0|||
42067361|NCT03330106|75876525|FG001|Part B|Death|0|||
42067362|NCT03330106|75876526|FG002|Part B|Death|2|||
42067363|NCT03330106|75876527|FG003|Part B|Death|0|||
42067364|NCT03330106|75876524|FG000|Part B|Clinical Progression|0|||
42067365|NCT03330106|75876525|FG001|Part B|Clinical Progression|0|||
42067366|NCT03330106|75876526|FG002|Part B|Clinical Progression|1|||
42067367|NCT03330106|75876527|FG003|Part B|Clinical Progression|1|||
42067368|NCT03330106|75876524|FG000|Part B|Symptomatic Deterioration|0|||
42067369|NCT03330106|75876525|FG001|Part B|Symptomatic Deterioration|0|||
42067370|NCT03330106|75876526|FG002|Part B|Symptomatic Deterioration|0|||
42067371|NCT03330106|75876527|FG003|Part B|Symptomatic Deterioration|1|||
42067372|NCT03330106|75876524|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
42067373|NCT03330106|75876525|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
42067374|NCT03330106|75876526|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
42067375|NCT03330106|75876527|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
42067376|NCT03330106|75876524|FG000|Part B|Progressive Disease|0|||
42067377|NCT03330106|75876525|FG001|Part B|Progressive Disease|0|||
42067378|NCT03330106|75876526|FG002|Part B|Progressive Disease|11|||
42067379|NCT03330106|75876527|FG003|Part B|Progressive Disease|4|||
42067380|NCT03164564|75876539|FG000|Overall Study|Death|3|||
42067381|NCT03164564|75876540|FG001|Overall Study|Death|0|||
42067382|NCT03164564|75876539|FG000|Overall Study|Withdrawal by Subject|20|||
42067383|NCT03164564|75876540|FG001|Overall Study|Withdrawal by Subject|15|||
42067384|NCT03164564|75876539|FG000|Overall Study|Lost to Follow-up|2|||
42067385|NCT03164564|75876540|FG001|Overall Study|Lost to Follow-up|0|||
42067386|NCT03164564|75876539|FG000|Overall Study|Physician Decision|0|||
42067387|NCT03164564|75876540|FG001|Overall Study|Physician Decision|1|||
42175618|NCT00307151|75982709|FG003|Overall Study|Withdrew consent|3|||
42067388|NCT03164564|75876539|FG000|Overall Study|Adverse Event|0|||
42067389|NCT03164564|75876540|FG001|Overall Study|Adverse Event|1|||
42067390|NCT03164564|75876539|FG000|Overall Study|Ongoing|1586|||
42067391|NCT03164564|75876540|FG001|Overall Study|Ongoing|1586|||
42067392|NCT02821754|75876556|FG000|Overall Study|Procedure not required prior to amendment change|13|||
42067393|NCT02821754|75876557|FG001|Overall Study|Procedure not required prior to amendment change|11|||
42067394|NCT02821754|75876558|FG002|Overall Study|Procedure not required prior to amendment change|0|||
42067395|NCT02821754|75876556|FG000|Overall Study|Participant's Clinical status|2|||
42067396|NCT02821754|75876557|FG001|Overall Study|Participant's Clinical status|0|||
42067397|NCT02821754|75876558|FG002|Overall Study|Participant's Clinical status|0|||
42067398|NCT02821754|75876556|FG000|Overall Study|Participant removed for noncompliance|1|||
42067399|NCT02821754|75876557|FG001|Overall Study|Participant removed for noncompliance|0|||
42067400|NCT02821754|75876558|FG002|Overall Study|Participant removed for noncompliance|0|||
42067401|NCT02821754|75876556|FG000|Overall Study|Drug not available.|0|||
42067402|NCT02821754|75876557|FG001|Overall Study|Drug not available.|0|||
42067403|NCT02821754|75876558|FG002|Overall Study|Drug not available.|1|||
42067404|NCT02821754|75876556|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
42067405|NCT02821754|75876557|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
42067406|NCT02821754|75876558|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
42067407|NCT02708108|75876566|FG000|Overall Study|Death|1|||
42067408|NCT02708108|75876567|FG001|Overall Study|Death|2|||
42067409|NCT02708108|75876566|FG000|Overall Study|Regimen change|1|||
42067410|NCT02708108|75876567|FG001|Overall Study|Regimen change|0|||
42067411|NCT02708108|75876566|FG000|Overall Study|No MRD and no imaging available|0|||
42067412|NCT02708108|75876567|FG001|Overall Study|No MRD and no imaging available|1|||
42067413|NCT02617589|75876576|FG000|Randomization|Request to Discontinue Study Treatment|1|||
42067414|NCT02617589|75876577|FG001|Randomization|Request to Discontinue Study Treatment|3|||
42067415|NCT02617589|75876576|FG000|Randomization|Participant Withdrew Consent|1|||
42067416|NCT02617589|75876577|FG001|Randomization|Participant Withdrew Consent|2|||
42067417|NCT02617589|75876576|FG000|Treatment|Other Reasons|3|||
42067418|NCT02617589|75876577|FG001|Treatment|Other Reasons|3|||
42067419|NCT02617589|75876576|FG000|Treatment|Poor/Non Compliance|1|||
42067420|NCT02617589|75876577|FG001|Treatment|Poor/Non Compliance|1|||
42067421|NCT02617589|75876576|FG000|Treatment|Maximum Clinical Benefit|0|||
42067422|NCT02617589|75876577|FG001|Treatment|Maximum Clinical Benefit|2|||
42067423|NCT02617589|75876576|FG000|Treatment|Participant Withdrew Consent|2|||
42067424|NCT02617589|75876577|FG001|Treatment|Participant Withdrew Consent|6|||
42067425|NCT02617589|75876576|FG000|Treatment|Participant Request to Discontinue|12|||
42067426|NCT02617589|75876577|FG001|Treatment|Participant Request to Discontinue|21|||
42175619|NCT00307151|75982706|FG000|Overall Study|Not willing to adhere to study reqs|2|||
42175620|NCT00307151|75982707|FG001|Overall Study|Not willing to adhere to study reqs|0|||
42175621|NCT00307151|75982708|FG002|Overall Study|Not willing to adhere to study reqs|2|||
42175622|NCT00307151|75982709|FG003|Overall Study|Not willing to adhere to study reqs|2|||
42175623|NCT00307151|75982706|FG000|Overall Study|Clinic unable to contact subject|3|||
42175624|NCT00307151|75982707|FG001|Overall Study|Clinic unable to contact subject|3|||
42175625|NCT00307151|75982708|FG002|Overall Study|Clinic unable to contact subject|1|||
42175626|NCT00307151|75982709|FG003|Overall Study|Clinic unable to contact subject|1|||
42175627|NCT02654132|75982721|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
42175628|NCT02654132|75982722|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
42175629|NCT02654132|75982721|FG000|Treatment Period|Disease progression|43|||
42175630|NCT02654132|75982722|FG001|Treatment Period|Disease progression|38|||
42175631|NCT02654132|75982721|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
42175632|NCT02654132|75982722|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
42175633|NCT02654132|75982721|FG000|Treatment Period|Other reasons|4|||
42175634|NCT02654132|75982722|FG001|Treatment Period|Other reasons|2|||
42175635|NCT02654132|75982721|FG000|Treatment Period|Study drug toxicity|2|||
42175636|NCT02654132|75982722|FG001|Treatment Period|Study drug toxicity|2|||
42175637|NCT02654132|75982721|FG000|Treatment Period|Withdrawal by Subject|2|||
42175638|NCT02654132|75982722|FG001|Treatment Period|Withdrawal by Subject|1|||
42175639|NCT02654132|75982721|FG000|Treatment Period|Maximum Clinical Benefit|0|||
42175640|NCT02654132|75982722|FG001|Treatment Period|Maximum Clinical Benefit|2|||
42175641|NCT02654132|75982721|FG000|Treatment Period|Participant request to discontinue|2|||
42175642|NCT02654132|75982722|FG001|Treatment Period|Participant request to discontinue|0|||
42175643|NCT02654132|75982721|FG000|Treatment Period|Administrative reasons by sponsor|0|||
42175644|NCT02654132|75982722|FG001|Treatment Period|Administrative reasons by sponsor|1|||
42175645|NCT02654132|75982721|FG000|Treatment Period|Death|1|||
42067427|NCT02617589|75876576|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
42067428|NCT02617589|75876577|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
42067429|NCT02617589|75876576|FG000|Treatment|Death|1|||
42067430|NCT02617589|75876577|FG001|Treatment|Death|1|||
42067431|NCT02617589|75876576|FG000|Treatment|Study Drug Toxicity|27|||
42067432|NCT02617589|75876577|FG001|Treatment|Study Drug Toxicity|20|||
42067433|NCT02617589|75876576|FG000|Treatment|Disease Progression|216|||
42067434|NCT02617589|75876577|FG001|Treatment|Disease Progression|136|||
42067435|NCT02471807|75876583|FG000|Overall Study|Death|14|||
42175646|NCT02654132|75982722|FG001|Treatment Period|Death|0|||
42292418|NCT02135107|76126281|FG002|Treatment Period|Other|0|||
42292419|NCT02135107|76126282|FG003|Treatment Period|Other|0|||
42175647|NCT03241342|75982731|FG000|Overall Study|Adverse Event|5|||
42067436|NCT02471807|75876583|FG000|Overall Study|Withdrawal by Subject|2|||
42067437|NCT02471807|75876583|FG000|Overall Study|Explant|5|||
42067438|NCT02471807|75876583|FG000|Overall Study|Lost to Follow-up|1|||
42067439|NCT01899326|75876603|FG000|Overall Study|Withdrawal by Subject|1|||
42067440|NCT01899326|75876603|FG000|Overall Study|Adverse Event|2|||
42067441|NCT01899326|75876603|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
42067442|NCT01572480|75876608|FG000|Participants Enrolled|Withdrawal by Subject|1|||
42067443|NCT01572480|75876608|FG000|Drug Administration|Discontinued drug/Off Study|1|||
42067444|NCT01572480|75876608|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
42067445|NCT01572480|75876608|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
42067446|NCT01126190|75876615|FG000|Double-Blind Phase|Death|0|||
42067447|NCT01126190|75876616|FG001|Double-Blind Phase|Death|1|||
42067448|NCT01126190|75876617|FG002|Double-Blind Phase|Death|0|||
42067449|NCT01126190|75876615|FG000|Double-Blind Phase|Adverse Event|1|||
42067450|NCT01126190|75876616|FG001|Double-Blind Phase|Adverse Event|2|||
42067451|NCT01126190|75876617|FG002|Double-Blind Phase|Adverse Event|0|||
42067452|NCT01126190|75876615|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
42067453|NCT01126190|75876616|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
42067454|NCT01126190|75876617|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
42067455|NCT01126190|75876615|FG000|Double-Blind Phase|Request of Investigator|1|||
42067456|NCT01126190|75876616|FG001|Double-Blind Phase|Request of Investigator|0|||
42067457|NCT01126190|75876617|FG002|Double-Blind Phase|Request of Investigator|0|||
42067458|NCT01126190|75876615|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
42067459|NCT01126190|75876616|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
42067460|NCT01126190|75876617|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
42067461|NCT01126190|75876615|FG000|Double-Blind Phase|Non-compliance|1|||
42067462|NCT01126190|75876616|FG001|Double-Blind Phase|Non-compliance|0|||
42067463|NCT01126190|75876617|FG002|Double-Blind Phase|Non-compliance|0|||
42067464|NCT01126190|75876615|FG000|Double-Blind Phase|Lost to Follow-up|1|||
42067465|NCT01126190|75876616|FG001|Double-Blind Phase|Lost to Follow-up|3|||
42067466|NCT01126190|75876617|FG002|Double-Blind Phase|Lost to Follow-up|0|||
42067467|NCT01126190|75876615|FG000|Open-Label Phase|Death|0|||
42067468|NCT01126190|75876616|FG001|Open-Label Phase|Death|0|||
42067469|NCT01126190|75876617|FG002|Open-Label Phase|Death|1|||
42067470|NCT01126190|75876615|FG000|Open-Label Phase|Adverse Event|0|||
42067471|NCT01126190|75876616|FG001|Open-Label Phase|Adverse Event|0|||
42067472|NCT01126190|75876617|FG002|Open-Label Phase|Adverse Event|4|||
42067473|NCT01126190|75876615|FG000|Open-Label Phase|Withdrawal by Subject|0|||
42067474|NCT01126190|75876616|FG001|Open-Label Phase|Withdrawal by Subject|0|||
42067475|NCT01126190|75876617|FG002|Open-Label Phase|Withdrawal by Subject|6|||
42067476|NCT00939185|75876650|FG000|Overall Study|Adverse Event|3|||
42067477|NCT00939185|75876650|FG000|Overall Study|Lack of Efficacy|1|||
42067478|NCT00939185|75876650|FG000|Overall Study|Lost to Follow-up|6|||
42067479|NCT00939185|75876650|FG000|Overall Study|Other|3|||
42067480|NCT00939185|75876650|FG000|Overall Study|Withdrawal by Subject|2|||
42067481|NCT00939185|75876650|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
42067482|NCT03977155|75876657|FG000|Overall Study|Adverse Event|3|||
42067483|NCT03977155|75876658|FG001|Overall Study|Adverse Event|0|||
42067484|NCT03977155|75876659|FG002|Overall Study|Adverse Event|0|||
42067485|NCT03977155|75876657|FG000|Overall Study|Lost to Follow-up|0|||
42067486|NCT03977155|75876658|FG001|Overall Study|Lost to Follow-up|1|||
42175648|NCT03241342|75982732|FG001|Overall Study|Adverse Event|8|||
42175649|NCT03241342|75982733|FG002|Overall Study|Adverse Event|4|||
42292420|NCT02135107|76126279|FG000|Maintenance Therapy Period|Adverse Event|0|||
42292421|NCT02135107|76126280|FG001|Maintenance Therapy Period|Adverse Event|0|||
42292422|NCT02135107|76126281|FG002|Maintenance Therapy Period|Adverse Event|3|||
42067487|NCT03977155|75876659|FG002|Overall Study|Lost to Follow-up|0|||
42292423|NCT02135107|76126282|FG003|Maintenance Therapy Period|Adverse Event|7|||
42292424|NCT02135107|76126279|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
42292425|NCT02135107|76126280|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
42292426|NCT02135107|76126281|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
42292427|NCT02135107|76126282|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
42292428|NCT02135107|76126279|FG000|Maintenance Therapy Period|Pregnancy|0|||
42292429|NCT02135107|76126280|FG001|Maintenance Therapy Period|Pregnancy|0|||
42067488|NCT03977155|75876657|FG000|Overall Study|Withdrawal by Subject|1|||
42067489|NCT03977155|75876658|FG001|Overall Study|Withdrawal by Subject|1|||
42067490|NCT03977155|75876659|FG002|Overall Study|Withdrawal by Subject|2|||
42067491|NCT03977155|75876657|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
42067492|NCT03977155|75876658|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
42067493|NCT03977155|75876659|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
42067494|NCT00930059|75876684|FG000|Overall Study|Death|1|||
42067495|NCT00930059|75876685|FG001|Overall Study|Death|0|||
42067496|NCT00930059|75876684|FG000|Overall Study|Did not meet entrance criteria|1|||
42067497|NCT00930059|75876685|FG001|Overall Study|Did not meet entrance criteria|1|||
42067498|NCT00930059|75876684|FG000|Overall Study|Withdrawal by Subject|3|||
42067499|NCT00930059|75876685|FG001|Overall Study|Withdrawal by Subject|4|||
42067500|NCT00930059|75876684|FG000|Overall Study|Other|1|||
42067501|NCT00930059|75876685|FG001|Overall Study|Other|0|||
42067502|NCT00930059|75876684|FG000|Overall Study|1 site terminated by sponsor|1|||
42067503|NCT00930059|75876685|FG001|Overall Study|1 site terminated by sponsor|1|||
42067504|NCT00930059|75876684|FG000|Overall Study|Adverse Event|1|||
42067505|NCT00930059|75876685|FG001|Overall Study|Adverse Event|6|||
42067506|NCT00772005|75876704|FG000|Overall Study|Adverse Event|9|||
42067507|NCT00772005|75876705|FG001|Overall Study|Adverse Event|14|||
42067508|NCT00772005|75876706|FG002|Overall Study|Adverse Event|10|||
42067509|NCT00772005|75876707|FG003|Overall Study|Adverse Event|13|||
42067510|NCT00772005|75876704|FG000|Overall Study|Lack of Efficacy|0|||
42067511|NCT00772005|75876705|FG001|Overall Study|Lack of Efficacy|1|||
42067512|NCT00772005|75876706|FG002|Overall Study|Lack of Efficacy|0|||
42067513|NCT00772005|75876707|FG003|Overall Study|Lack of Efficacy|0|||
42067514|NCT00772005|75876704|FG000|Overall Study|Withdrawal by Subject|3|||
42067515|NCT00772005|75876705|FG001|Overall Study|Withdrawal by Subject|7|||
42067516|NCT00772005|75876706|FG002|Overall Study|Withdrawal by Subject|10|||
42067517|NCT00772005|75876707|FG003|Overall Study|Withdrawal by Subject|2|||
42067518|NCT00772005|75876704|FG000|Overall Study|Protocol Violation|2|||
42067519|NCT00772005|75876705|FG001|Overall Study|Protocol Violation|4|||
42067520|NCT00772005|75876706|FG002|Overall Study|Protocol Violation|1|||
42067521|NCT00772005|75876707|FG003|Overall Study|Protocol Violation|6|||
42067522|NCT00772005|75876704|FG000|Overall Study|Lost to Follow-up|7|||
42067523|NCT00772005|75876705|FG001|Overall Study|Lost to Follow-up|3|||
42067524|NCT00772005|75876706|FG002|Overall Study|Lost to Follow-up|6|||
42067525|NCT00772005|75876707|FG003|Overall Study|Lost to Follow-up|3|||
42067526|NCT00772005|75876704|FG000|Overall Study|Non-compliance with study procedures|1|||
42067527|NCT00772005|75876705|FG001|Overall Study|Non-compliance with study procedures|1|||
42067528|NCT00772005|75876706|FG002|Overall Study|Non-compliance with study procedures|0|||
42067529|NCT00772005|75876707|FG003|Overall Study|Non-compliance with study procedures|1|||
42067530|NCT00772005|75876704|FG000|Overall Study|Non-compliance with drug administration|3|||
42067531|NCT00772005|75876705|FG001|Overall Study|Non-compliance with drug administration|0|||
42067532|NCT00772005|75876706|FG002|Overall Study|Non-compliance with drug administration|1|||
42067533|NCT00772005|75876707|FG003|Overall Study|Non-compliance with drug administration|1|||
42067534|NCT00939107|75876719|FG000|Overall Study|Lost to Follow-up|14|||
42067535|NCT00939107|75876720|FG001|Overall Study|Lost to Follow-up|12|||
42067536|NCT00927485|75876728|FG000|Overall Study|Adverse Event|4|||
42067537|NCT00927485|75876729|FG001|Overall Study|Adverse Event|2|||
42067538|NCT00927485|75876728|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
42067539|NCT00927485|75876729|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
42067540|NCT00927251|75876735|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
42067541|NCT00927095|75876742|FG000|Overall Study|Adverse Event|3|||
42067542|NCT00927095|75876743|FG001|Overall Study|Adverse Event|1|||
42067543|NCT00927095|75876744|FG002|Overall Study|Adverse Event|0|||
42067544|NCT00927095|75876742|FG000|Overall Study|Withdrawal by Subject|2|||
42067545|NCT00927095|75876743|FG001|Overall Study|Withdrawal by Subject|1|||
42067546|NCT00927095|75876744|FG002|Overall Study|Withdrawal by Subject|1|||
42067547|NCT00927095|75876742|FG000|Overall Study|Physician Decision|1|||
42067548|NCT00927095|75876743|FG001|Overall Study|Physician Decision|2|||
42067549|NCT00927095|75876744|FG002|Overall Study|Physician Decision|1|||
42067550|NCT00932165|75876752|FG000|Overall Study|Lost to Follow-up|1|||
42067551|NCT04888494|75876759|FG000|Overall Study|Lost to Follow-up|2|||
42067552|NCT04888494|75876760|FG001|Overall Study|Lost to Follow-up|3|||
42067553|NCT04888494|75876759|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
42067554|NCT04888494|75876760|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
42067555|NCT04573972|75876822|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
42067556|NCT04573972|75876823|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
42067557|NCT04391309|75876851|FG000|Overall Study|Death|1|||
42067558|NCT04391309|75876852|FG001|Overall Study|Death|1|||
42067559|NCT04391309|75876851|FG000|Overall Study|Lost to Follow-up|3|||
42067560|NCT04391309|75876852|FG001|Overall Study|Lost to Follow-up|2|||
42067561|NCT04391309|75876851|FG000|Overall Study|Withdrawal by Subject|2|||
42067562|NCT04391309|75876852|FG001|Overall Study|Withdrawal by Subject|2|||
42067563|NCT04202965|75876867|FG000|Overall Study|Adverse Event|3|||
42067564|NCT04202965|75876867|FG000|Overall Study|Did not meet inclusion criteria|1|||
42067565|NCT04056624|75876875|FG000|Overall Study|Withdrawal by Subject|0|||
42067566|NCT04056624|75876876|FG001|Overall Study|Withdrawal by Subject|0|||
42067567|NCT04056624|75876877|FG002|Overall Study|Withdrawal by Subject|1|||
42067568|NCT04056624|75876875|FG000|Overall Study|Protocol Violation|1|||
42067569|NCT04056624|75876876|FG001|Overall Study|Protocol Violation|2|||
42067570|NCT04056624|75876877|FG002|Overall Study|Protocol Violation|0|||
42067571|NCT03870763|75876897|FG000|Overall Study|Study terminated by sponsor|0|||
42175650|NCT03241342|75982731|FG000|Overall Study|Lack of Efficacy|0|||
42175651|NCT03241342|75982732|FG001|Overall Study|Lack of Efficacy|0|||
42175652|NCT03241342|75982733|FG002|Overall Study|Lack of Efficacy|1|||
42175653|NCT03241342|75982731|FG000|Overall Study|noncompliance with study drug|2|||
42175654|NCT03241342|75982732|FG001|Overall Study|noncompliance with study drug|1|||
42175655|NCT03241342|75982733|FG002|Overall Study|noncompliance with study drug|1|||
42175656|NCT03241342|75982731|FG000|Overall Study|sponsor decision|0|||
42175657|NCT03241342|75982732|FG001|Overall Study|sponsor decision|1|||
42175658|NCT03241342|75982733|FG002|Overall Study|sponsor decision|2|||
42175659|NCT03241342|75982731|FG000|Overall Study|not reported|15|||
42175660|NCT03241342|75982732|FG001|Overall Study|not reported|21|||
42175661|NCT03241342|75982733|FG002|Overall Study|not reported|19|||
42175662|NCT00306995|75982748|FG000|Study Part I|Withdrawal by Subject|0|||
42175663|NCT00306995|75982749|FG001|Study Part I|Withdrawal by Subject|0|||
42175664|NCT00306995|75982750|FG002|Study Part I|Withdrawal by Subject|0|||
42175665|NCT00306995|75982751|FG003|Study Part I|Withdrawal by Subject|0|||
42175666|NCT00306995|75982752|FG004|Study Part I|Withdrawal by Subject|0|||
42175667|NCT00306995|75982753|FG005|Study Part I|Withdrawal by Subject|0|||
42175668|NCT00306995|75982754|FG006|Study Part I|Withdrawal by Subject|1|||
42175669|NCT00306995|75982748|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
42175670|NCT00306995|75982749|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
42175671|NCT00306995|75982750|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
42175672|NCT00306995|75982751|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
42175673|NCT00306995|75982752|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
42175674|NCT00306995|75982753|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
42175675|NCT00306995|75982754|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
42292430|NCT02135107|76126281|FG002|Maintenance Therapy Period|Pregnancy|0|||
42292431|NCT02135107|76126282|FG003|Maintenance Therapy Period|Pregnancy|1|||
42292432|NCT02135107|76126279|FG000|Maintenance Therapy Period|Other|0|||
42292433|NCT02135107|76126280|FG001|Maintenance Therapy Period|Other|0|||
42292434|NCT02135107|76126281|FG002|Maintenance Therapy Period|Other|7|||
42292435|NCT02135107|76126282|FG003|Maintenance Therapy Period|Other|8|||
42292436|NCT02030847|76126294|FG000|Overall Study|Death|10|||
42292437|NCT02030847|76126294|FG000|Overall Study|Disease Progression|15|||
42292438|NCT02030847|76126294|FG000|Overall Study|New Cancer Therapy|8|||
42292439|NCT02030847|76126294|FG000|Overall Study|Physician Decision|3|||
42292440|NCT02030847|76126294|FG000|Overall Study|Withdrawal by Subject|1|||
42292441|NCT02030834|76126302|FG000|Overall Study|Death|4|||
42292442|NCT02030834|76126303|FG001|Overall Study|Death|0|||
42292443|NCT02030834|76126304|FG002|Overall Study|Death|0|||
42292444|NCT02030834|76126302|FG000|Overall Study|Manufacturing failure|2|||
42292445|NCT02030834|76126303|FG001|Overall Study|Manufacturing failure|0|||
42292446|NCT02030834|76126304|FG002|Overall Study|Manufacturing failure|1|||
42292447|NCT02030834|76126302|FG000|Overall Study|Disease progression|2|||
42292448|NCT02030834|76126303|FG001|Overall Study|Disease progression|0|||
42292449|NCT02030834|76126304|FG002|Overall Study|Disease progression|2|||
42292450|NCT02030834|76126302|FG000|Overall Study|Lost to Follow-up|1|||
42292451|NCT02030834|76126303|FG001|Overall Study|Lost to Follow-up|0|||
42292452|NCT02030834|76126304|FG002|Overall Study|Lost to Follow-up|0|||
42292453|NCT02030834|76126302|FG000|Overall Study|Withdrawal by Subject|1|||
42292454|NCT02030834|76126303|FG001|Overall Study|Withdrawal by Subject|0|||
42292455|NCT02030834|76126304|FG002|Overall Study|Withdrawal by Subject|0|||
42292456|NCT02030834|76126302|FG000|Overall Study|Lack of funding|1|||
42292457|NCT02030834|76126303|FG001|Overall Study|Lack of funding|0|||
42292458|NCT02030834|76126304|FG002|Overall Study|Lack of funding|0|||
42292459|NCT01982448|76126314|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
42292460|NCT01982448|76126315|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
42292461|NCT01982448|76126314|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
42292462|NCT01982448|76126315|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
42292463|NCT01982448|76126314|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
42292464|NCT01982448|76126315|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
42175676|NCT00121108|75982801|FG000|Overall Study|Lost to Follow-up|10|||
42175677|NCT00121108|75982802|FG001|Overall Study|Lost to Follow-up|22|||
42175678|NCT00121108|75982801|FG000|Overall Study|Withdrawal by Subject|106|||
42175679|NCT00121108|75982802|FG001|Overall Study|Withdrawal by Subject|195|||
42067572|NCT03870763|75876898|FG001|Overall Study|Study terminated by sponsor|2|||
42175680|NCT00121108|75982801|FG000|Overall Study|Death|5|||
42175681|NCT00121108|75982802|FG001|Overall Study|Death|8|||
42292465|NCT01982448|76126314|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
42175682|NCT02387996|75982809|FG000|Overall Study|Disease Progression|167|||
42175683|NCT02387996|75982809|FG000|Overall Study|Study Drug Toxicity|31|||
42292466|NCT01982448|76126315|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
42067573|NCT03870763|75876899|FG002|Overall Study|Study terminated by sponsor|0|||
42067574|NCT03870763|75876897|FG000|Overall Study|Withdrawal by Subject|0|||
42067575|NCT03870763|75876898|FG001|Overall Study|Withdrawal by Subject|1|||
42067576|NCT03870763|75876899|FG002|Overall Study|Withdrawal by Subject|0|||
42067577|NCT03870763|75876897|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
42067578|NCT03870763|75876898|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
42067579|NCT03870763|75876899|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
42067580|NCT03647501|75876909|FG000|Overall Study|Lost to Follow-up|1|||
42067581|NCT03647501|75876910|FG001|Overall Study|Lost to Follow-up|1|||
42067582|NCT03647501|75876909|FG000|Overall Study|Withdrawal by Subject|0|||
42067583|NCT03647501|75876910|FG001|Overall Study|Withdrawal by Subject|1|||
42067584|NCT03587142|75876942|FG000|Overall Study|Lost to Follow-up|5|||
42067585|NCT03587142|75876943|FG001|Overall Study|Lost to Follow-up|3|||
42067586|NCT03587142|75876942|FG000|Overall Study|Did not complete the f4 visit|3|||
42067587|NCT03587142|75876943|FG001|Overall Study|Did not complete the f4 visit|7|||
42067588|NCT03493854|75876951|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
42067589|NCT03493854|75876952|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
42067590|NCT03493854|75876951|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
42067591|NCT03493854|75876952|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
42067592|NCT03493854|75876951|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
42067593|NCT03493854|75876952|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
42067594|NCT03493854|75876951|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
42067595|NCT03493854|75876952|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
42067596|NCT03493854|75876951|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
42067597|NCT03493854|75876952|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
42067598|NCT03493854|75876951|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
42067599|NCT03493854|75876952|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
42067600|NCT03493854|75876951|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
42067601|NCT03493854|75876952|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
42067602|NCT03493854|75876951|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229|||
42067603|NCT03493854|75876952|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228|||
42067604|NCT03493854|75876951|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
42067605|NCT03493854|75876952|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2|||
42067606|NCT03493854|75876951|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
42067607|NCT03493854|75876952|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1|||
42067608|NCT03493854|75876951|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3|||
42067609|NCT03493854|75876952|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
42067610|NCT03493854|75876951|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1|||
42067611|NCT03493854|75876952|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0|||
42067612|NCT03493854|75876951|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
42067613|NCT03493854|75876952|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0|||
42067614|NCT03493854|75876951|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|5|||
42067615|NCT03493854|75876952|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|3|||
42067616|NCT03493854|75876951|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
42067617|NCT03493854|75876952|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1|||
42067618|NCT03493854|75876951|FG000|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18|||
42067619|NCT03493854|75876952|FG001|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16|||
42067620|NCT03188705|75876958|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
42067621|NCT03188705|75876958|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
42175684|NCT02387996|75982809|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
42175685|NCT02387996|75982809|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
42175686|NCT02387996|75982809|FG000|Overall Study|Subject Withdrew Consent|5|||
42292467|NCT01773421|76126329|FG000|Treatment Phase|Other|0|||
42292468|NCT01773421|76126330|FG001|Treatment Phase|Other|0|||
42292469|NCT01773421|76126331|FG002|Treatment Phase|Other|2|||
42067622|NCT03032484|75876963|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
42067623|NCT03032484|75876964|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
42067624|NCT03032484|75876963|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
42067625|NCT03032484|75876964|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
42067626|NCT02975349|75876973|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
42067627|NCT02975349|75876974|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
42067628|NCT02975349|75876975|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
42067629|NCT02975349|75876976|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
42067630|NCT02975349|75876977|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
42067631|NCT02975349|75876978|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
42175687|NCT02387996|75982809|FG000|Overall Study|Lost to Follow-up|1|||
42175688|NCT02387996|75982809|FG000|Overall Study|Poor/Non-Compliance|1|||
42175689|NCT02387996|75982809|FG000|Overall Study|Other Reasons|5|||
42067632|NCT02975349|75876973|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
42067633|NCT02975349|75876974|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42067634|NCT02975349|75876975|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42067635|NCT02975349|75876976|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42067636|NCT02975349|75876977|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42067637|NCT02975349|75876978|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42067638|NCT02975349|75876973|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
42067639|NCT02975349|75876974|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
42067640|NCT02975349|75876975|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
42067641|NCT02975349|75876976|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
42067642|NCT02975349|75876977|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
42067643|NCT02975349|75876978|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
42067644|NCT02975349|75876973|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
42067645|NCT02975349|75876974|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
42067646|NCT02975349|75876975|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
42067647|NCT02975349|75876976|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
42067648|NCT02975349|75876977|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
42067649|NCT02975349|75876978|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
42067650|NCT02975349|75876973|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
42067651|NCT02975349|75876974|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
42067652|NCT02975349|75876975|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
42067653|NCT02975349|75876976|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
42067654|NCT02975349|75876977|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
42067655|NCT02975349|75876978|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
42067656|NCT02975349|75876973|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
42067657|NCT02975349|75876974|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
42067658|NCT02975349|75876975|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
42067659|NCT02975349|75876976|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
42067660|NCT02975349|75876977|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
42067661|NCT02975349|75876978|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
42067662|NCT02975349|75876973|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
42067663|NCT02975349|75876974|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
42067664|NCT02975349|75876975|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
42067665|NCT02975349|75876976|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
42067666|NCT02975349|75876977|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
42067667|NCT02975349|75876978|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
42067668|NCT02975349|75876973|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
42067669|NCT02975349|75876974|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
42067670|NCT02975349|75876975|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
42067671|NCT02975349|75876976|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
42067672|NCT02975349|75876977|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
42067673|NCT02975349|75876978|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
42067674|NCT02975349|75876973|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
42067675|NCT02975349|75876974|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
42067676|NCT02975349|75876975|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
42067677|NCT02975349|75876976|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
42067678|NCT02975349|75876977|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
42067679|NCT02975349|75876978|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
42067680|NCT02520141|75877049|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
42067681|NCT02329847|75877061|FG000|Overall Study|Death|4|||
42067682|NCT02329847|75877062|FG001|Overall Study|Death|4|||
42067683|NCT02329847|75877063|FG002|Overall Study|Death|22|||
42067684|NCT02329847|75877064|FG003|Overall Study|Death|12|||
42067685|NCT02329847|75877065|FG004|Overall Study|Death|20|||
42067686|NCT02329847|75877066|FG005|Overall Study|Death|13|||
42067687|NCT02329847|75877061|FG000|Overall Study|Lost to Follow-up|0|||
42067688|NCT02329847|75877062|FG001|Overall Study|Lost to Follow-up|0|||
42067689|NCT02329847|75877063|FG002|Overall Study|Lost to Follow-up|2|||
42067690|NCT02329847|75877064|FG003|Overall Study|Lost to Follow-up|3|||
42067691|NCT02329847|75877065|FG004|Overall Study|Lost to Follow-up|0|||
42067692|NCT02329847|75877066|FG005|Overall Study|Lost to Follow-up|1|||
42067693|NCT02329847|75877061|FG000|Overall Study|Physician Decision|0|||
42067694|NCT02329847|75877062|FG001|Overall Study|Physician Decision|0|||
42067695|NCT02329847|75877063|FG002|Overall Study|Physician Decision|0|||
42067696|NCT02329847|75877064|FG003|Overall Study|Physician Decision|0|||
42067697|NCT02329847|75877065|FG004|Overall Study|Physician Decision|1|||
42067698|NCT02329847|75877066|FG005|Overall Study|Physician Decision|0|||
42292470|NCT01773421|76126332|FG003|Treatment Phase|Other|0|||
42292471|NCT01773421|76126333|FG004|Treatment Phase|Other|0|||
42067699|NCT02329847|75877061|FG000|Overall Study|Withdrawal by Subject|2|||
42067700|NCT02329847|75877062|FG001|Overall Study|Withdrawal by Subject|1|||
42067701|NCT02329847|75877063|FG002|Overall Study|Withdrawal by Subject|5|||
42067702|NCT02329847|75877064|FG003|Overall Study|Withdrawal by Subject|7|||
42067703|NCT02329847|75877065|FG004|Overall Study|Withdrawal by Subject|8|||
42067704|NCT02329847|75877066|FG005|Overall Study|Withdrawal by Subject|3|||
42067705|NCT02329847|75877061|FG000|Overall Study|Other|1|||
42067706|NCT02329847|75877062|FG001|Overall Study|Other|2|||
42067707|NCT02329847|75877063|FG002|Overall Study|Other|6|||
42067708|NCT02329847|75877064|FG003|Overall Study|Other|13|||
42067709|NCT02329847|75877065|FG004|Overall Study|Other|10|||
42067710|NCT02329847|75877066|FG005|Overall Study|Other|3|||
42067711|NCT02314624|75877087|FG000|Overall Study|No participating patient|16|||
42067712|NCT02314624|75877088|FG001|Overall Study|No participating patient|13|||
42067713|NCT02314624|75877087|FG000|Overall Study|Participant withdrew|7|||
42067714|NCT02314624|75877088|FG001|Overall Study|Participant withdrew|2|||
42067715|NCT02314624|75877087|FG000|Overall Study|Lost to Follow-up|2|||
42067716|NCT02314624|75877088|FG001|Overall Study|Lost to Follow-up|5|||
42067717|NCT02314624|75877087|FG000|Overall Study|Dropped/Excluded by PI|6|||
42067718|NCT02314624|75877088|FG001|Overall Study|Dropped/Excluded by PI|6|||
42067719|NCT01419080|75877117|FG000|Overall Study|Withdrawal by Subject|75|||
42067720|NCT01419080|75877117|FG000|Overall Study|Death|30|||
42067721|NCT01419080|75877117|FG000|Overall Study|Lost to Follow-up|23|||
42067722|NCT01419080|75877117|FG000|Overall Study|Too Ill|3|||
42067723|NCT01164228|75877125|FG000|Overall Study|Progression|24|||
42067724|NCT01164228|75877126|FG001|Overall Study|Progression|25|||
42067725|NCT01164228|75877125|FG000|Overall Study|Adverse Event|13|||
42067726|NCT01164228|75877126|FG001|Overall Study|Adverse Event|7|||
42067727|NCT01164228|75877125|FG000|Overall Study|Death|1|||
42067728|NCT01164228|75877126|FG001|Overall Study|Death|1|||
42067729|NCT01164228|75877125|FG000|Overall Study|Withdrawal by Subject|2|||
42067730|NCT01164228|75877126|FG001|Overall Study|Withdrawal by Subject|0|||
42067731|NCT01164228|75877125|FG000|Overall Study|Physician Decision|1|||
42067732|NCT01164228|75877126|FG001|Overall Study|Physician Decision|2|||
42067733|NCT01164228|75877125|FG000|Overall Study|Symptomatic deterioration|1|||
42067734|NCT01164228|75877126|FG001|Overall Study|Symptomatic deterioration|0|||
42067735|NCT01164228|75877125|FG000|Overall Study|Never started treatment|1|||
42067736|NCT01164228|75877126|FG001|Overall Study|Never started treatment|3|||
42067737|NCT01164228|75877125|FG000|Overall Study|Ineligible|1|||
42067738|NCT01164228|75877126|FG001|Overall Study|Ineligible|0|||
42067739|NCT00554515|75877132|FG000|Overall Study|Withdrawal by Subject|3|||
42067740|NCT00554515|75877132|FG000|Overall Study|Disease progression|52|||
42067741|NCT00554515|75877132|FG000|Overall Study|Physician Decision|18|||
42067742|NCT00554515|75877132|FG000|Overall Study|Withdrawal by Subject|11|||
42067743|NCT00554515|75877132|FG000|Overall Study|Adverse Event|9|||
42067744|NCT00554515|75877132|FG000|Overall Study|Death|2|||
42067745|NCT00554515|75877132|FG000|Overall Study|Achieved Stable Disease|7|||
42067746|NCT00554515|75877132|FG000|Overall Study|Other|1|||
42067747|NCT00554515|75877132|FG000|Overall Study|Misc|15|||
42067748|NCT00049517|75877159|FG000|Induction|Disease progression|0|||
42067749|NCT00049517|75877160|FG001|Induction|Disease progression|0|||
42067750|NCT00049517|75877161|FG002|Induction|Disease progression|0|||
42067751|NCT00049517|75877162|FG003|Induction|Disease progression|0|||
42067752|NCT00049517|75877163|FG004|Induction|Disease progression|18|||
42067753|NCT00049517|75877164|FG005|Induction|Disease progression|11|||
42067754|NCT00049517|75877159|FG000|Induction|Adverse Event|0|||
42067755|NCT00049517|75877160|FG001|Induction|Adverse Event|0|||
42067756|NCT00049517|75877161|FG002|Induction|Adverse Event|0|||
42067757|NCT00049517|75877162|FG003|Induction|Adverse Event|0|||
42175690|NCT02387996|75982809|FG000|Overall Study|Death|1|||
42175691|NCT03212326|75982813|FG000|Overall Study|Physician Decision|4|||
42175692|NCT03229486|75982852|FG000|Overall Study|Protocol Violation|0|||
42067758|NCT00049517|75877163|FG004|Induction|Adverse Event|5|||
42067759|NCT00049517|75877164|FG005|Induction|Adverse Event|7|||
42067760|NCT00049517|75877159|FG000|Induction|Death|0|||
42067761|NCT00049517|75877160|FG001|Induction|Death|0|||
42357546|NCT01748552|76202974|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
42357547|NCT01748552|76202975|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
42067762|NCT00049517|75877161|FG002|Induction|Death|0|||
42067763|NCT00049517|75877162|FG003|Induction|Death|0|||
42067764|NCT00049517|75877163|FG004|Induction|Death|9|||
42067765|NCT00049517|75877164|FG005|Induction|Death|6|||
42067766|NCT00049517|75877159|FG000|Induction|Withdrawal by Subject|0|||
42067767|NCT00049517|75877160|FG001|Induction|Withdrawal by Subject|0|||
42067768|NCT00049517|75877161|FG002|Induction|Withdrawal by Subject|0|||
42067769|NCT00049517|75877162|FG003|Induction|Withdrawal by Subject|0|||
42067770|NCT00049517|75877163|FG004|Induction|Withdrawal by Subject|1|||
42175693|NCT03229486|75982853|FG001|Overall Study|Protocol Violation|1|||
42067771|NCT00049517|75877164|FG005|Induction|Withdrawal by Subject|3|||
42067772|NCT00049517|75877159|FG000|Induction|Alternative therapy|0|||
42067773|NCT00049517|75877160|FG001|Induction|Alternative therapy|0|||
42067774|NCT00049517|75877161|FG002|Induction|Alternative therapy|0|||
42067775|NCT00049517|75877162|FG003|Induction|Alternative therapy|0|||
42067776|NCT00049517|75877163|FG004|Induction|Alternative therapy|2|||
42067777|NCT00049517|75877164|FG005|Induction|Alternative therapy|2|||
42067778|NCT00049517|75877159|FG000|Induction|Other complicating disease|0|||
42067779|NCT00049517|75877160|FG001|Induction|Other complicating disease|0|||
42067780|NCT00049517|75877161|FG002|Induction|Other complicating disease|0|||
42067781|NCT00049517|75877162|FG003|Induction|Other complicating disease|0|||
42067782|NCT00049517|75877163|FG004|Induction|Other complicating disease|3|||
42067783|NCT00049517|75877164|FG005|Induction|Other complicating disease|0|||
42067784|NCT00049517|75877159|FG000|Induction|Reasons not reported|0|||
42067785|NCT00049517|75877160|FG001|Induction|Reasons not reported|0|||
42175694|NCT01779050|75982861|FG000|Overall Study|Withdrawal by Subject|1|||
42175695|NCT01779050|75982862|FG001|Overall Study|Withdrawal by Subject|0|||
42175696|NCT00306527|75982872|FG000|Overall Study|Lost to Follow-up|3|||
42175697|NCT00306527|75982873|FG001|Overall Study|Lost to Follow-up|4|||
42175698|NCT00306527|75982874|FG002|Overall Study|Lost to Follow-up|3|||
42175699|NCT00306527|75982875|FG003|Overall Study|Lost to Follow-up|0|||
42175700|NCT00306527|75982872|FG000|Overall Study|Withdrawal by Subject|2|||
42175701|NCT00306527|75982873|FG001|Overall Study|Withdrawal by Subject|3|||
42067786|NCT00049517|75877161|FG002|Induction|Reasons not reported|0|||
42175702|NCT00306527|75982874|FG002|Overall Study|Withdrawal by Subject|0|||
42175703|NCT00306527|75982875|FG003|Overall Study|Withdrawal by Subject|3|||
42175704|NCT00306527|75982872|FG000|Overall Study|Adverse Event|0|||
42175705|NCT00306527|75982873|FG001|Overall Study|Adverse Event|0|||
42175706|NCT00306527|75982874|FG002|Overall Study|Adverse Event|1|||
42175707|NCT00306527|75982875|FG003|Overall Study|Adverse Event|1|||
42175708|NCT00306527|75982872|FG000|Overall Study|Death|1|||
42175709|NCT00306527|75982873|FG001|Overall Study|Death|0|||
42175710|NCT00306527|75982874|FG002|Overall Study|Death|1|||
42175711|NCT00306527|75982875|FG003|Overall Study|Death|2|||
42175712|NCT00306293|75982889|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
42175713|NCT00306293|75982890|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
42175714|NCT00306293|75982889|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
42175715|NCT00306293|75982890|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
42175716|NCT00306293|75982889|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
42175717|NCT00306293|75982890|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
42175718|NCT00306293|75982889|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
42175719|NCT00306293|75982890|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
42175720|NCT00306293|75982889|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
42175721|NCT00306293|75982890|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
42175722|NCT00306293|75982889|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
42175723|NCT00306293|75982890|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
42175724|NCT00306293|75982889|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
42175725|NCT00306293|75982890|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
42175726|NCT00306293|75982889|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
42175727|NCT00306293|75982890|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
42175728|NCT00294671|75982900|FG000|Overall Study|Lack of Efficacy|11|||
42175729|NCT00294671|75982901|FG001|Overall Study|Lack of Efficacy|23|||
42175730|NCT00294671|75982900|FG000|Overall Study|Liver transplant|7|||
42175731|NCT00294671|75982901|FG001|Overall Study|Liver transplant|9|||
42175732|NCT00294671|75982900|FG000|Overall Study|Drug related adverse event (AE)|4|||
42175733|NCT00294671|75982901|FG001|Overall Study|Drug related adverse event (AE)|2|||
42175734|NCT00294671|75982900|FG000|Overall Study|Non-drug related AE|3|||
42175735|NCT00294671|75982901|FG001|Overall Study|Non-drug related AE|2|||
42175736|NCT00294671|75982900|FG000|Overall Study|Lost to Follow-up|1|||
42175737|NCT00294671|75982901|FG001|Overall Study|Lost to Follow-up|3|||
42175738|NCT00294671|75982900|FG000|Overall Study|Non-compliance|1|||
42175739|NCT00294671|75982901|FG001|Overall Study|Non-compliance|0|||
42175740|NCT00294671|75982900|FG000|Overall Study|Death|0|||
42175741|NCT00294671|75982901|FG001|Overall Study|Death|1|||
42175742|NCT01495598|75982907|FG000|Overall Study|Death during follow up period|2|||
42175743|NCT01495598|75982907|FG000|Overall Study|Death on study|1|||
42175744|NCT01495598|75982907|FG000|Overall Study|Lost to Follow-up|3|||
42292472|NCT01773421|76126334|FG005|Treatment Phase|Other|0|||
42067787|NCT00049517|75877162|FG003|Induction|Reasons not reported|0|||
42067788|NCT00049517|75877163|FG004|Induction|Reasons not reported|22|||
42175745|NCT01495598|75982907|FG000|Overall Study|Physician Decision|8|||
42067789|NCT00049517|75877164|FG005|Induction|Reasons not reported|25|||
42067790|NCT00049517|75877159|FG000|Conditioning/Transplant|Disease progression|14|||
42175746|NCT02937454|75982938|FG000|Overall Study|Adverse Event|0|||
42175747|NCT02937454|75982939|FG001|Overall Study|Adverse Event|1|||
42175748|NCT02937454|75982938|FG000|Overall Study|Death|98|||
42175749|NCT02937454|75982939|FG001|Overall Study|Death|95|||
42175750|NCT02937454|75982938|FG000|Overall Study|Lost to Follow-up|1|||
42175751|NCT02937454|75982939|FG001|Overall Study|Lost to Follow-up|1|||
42175752|NCT02937454|75982938|FG000|Overall Study|Physician Decision|0|||
42292473|NCT01773421|76126335|FG006|Treatment Phase|Other|0|||
42067791|NCT00049517|75877160|FG001|Conditioning/Transplant|Disease progression|6|||
42067792|NCT00049517|75877161|FG002|Conditioning/Transplant|Disease progression|10|||
42067793|NCT00049517|75877162|FG003|Conditioning/Transplant|Disease progression|6|||
42067794|NCT00049517|75877163|FG004|Conditioning/Transplant|Disease progression|0|||
42067795|NCT00049517|75877164|FG005|Conditioning/Transplant|Disease progression|0|||
42067796|NCT00049517|75877159|FG000|Conditioning/Transplant|Adverse Event|2|||
42067797|NCT00049517|75877160|FG001|Conditioning/Transplant|Adverse Event|1|||
42067798|NCT00049517|75877161|FG002|Conditioning/Transplant|Adverse Event|4|||
42067799|NCT00049517|75877162|FG003|Conditioning/Transplant|Adverse Event|8|||
42067800|NCT00049517|75877163|FG004|Conditioning/Transplant|Adverse Event|0|||
42067801|NCT00049517|75877164|FG005|Conditioning/Transplant|Adverse Event|0|||
42067802|NCT00049517|75877159|FG000|Conditioning/Transplant|Death|1|||
42067803|NCT00049517|75877160|FG001|Conditioning/Transplant|Death|0|||
42067804|NCT00049517|75877161|FG002|Conditioning/Transplant|Death|0|||
42067805|NCT00049517|75877162|FG003|Conditioning/Transplant|Death|2|||
42067806|NCT00049517|75877163|FG004|Conditioning/Transplant|Death|0|||
42067807|NCT00049517|75877164|FG005|Conditioning/Transplant|Death|0|||
42067808|NCT00049517|75877159|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
42067809|NCT00049517|75877160|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
42067810|NCT00049517|75877161|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
42067811|NCT00049517|75877162|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
42067812|NCT00049517|75877163|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
42067813|NCT00049517|75877164|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
42067814|NCT00049517|75877159|FG000|Conditioning/Transplant|Alternative therapy|4|||
42067815|NCT00049517|75877160|FG001|Conditioning/Transplant|Alternative therapy|4|||
42067816|NCT00049517|75877161|FG002|Conditioning/Transplant|Alternative therapy|2|||
42067817|NCT00049517|75877162|FG003|Conditioning/Transplant|Alternative therapy|1|||
42067818|NCT00049517|75877163|FG004|Conditioning/Transplant|Alternative therapy|1|||
42067819|NCT00049517|75877164|FG005|Conditioning/Transplant|Alternative therapy|0|||
42067820|NCT00049517|75877159|FG000|Conditioning/Transplant|Other complicating disease|2|||
42067821|NCT00049517|75877160|FG001|Conditioning/Transplant|Other complicating disease|0|||
42067822|NCT00049517|75877161|FG002|Conditioning/Transplant|Other complicating disease|0|||
42067823|NCT00049517|75877162|FG003|Conditioning/Transplant|Other complicating disease|4|||
42067824|NCT00049517|75877163|FG004|Conditioning/Transplant|Other complicating disease|0|||
42067825|NCT00049517|75877164|FG005|Conditioning/Transplant|Other complicating disease|1|||
42067826|NCT00049517|75877159|FG000|Conditioning/Transplant|Reasons not reported|25|||
42067827|NCT00049517|75877160|FG001|Conditioning/Transplant|Reasons not reported|31|||
42067828|NCT00049517|75877161|FG002|Conditioning/Transplant|Reasons not reported|18|||
42067829|NCT00049517|75877162|FG003|Conditioning/Transplant|Reasons not reported|15|||
42067830|NCT00049517|75877163|FG004|Conditioning/Transplant|Reasons not reported|5|||
42067831|NCT00049517|75877164|FG005|Conditioning/Transplant|Reasons not reported|5|||
42067832|NCT00926783|75877174|FG000|Overall Study|Incomplete CFAE Procedures|3|||
42067833|NCT00926783|75877175|FG001|Overall Study|Incomplete CFAE Procedures|3|||
42067834|NCT00929669|75877181|FG000|Overall Study|elevated glucose levels|1|||
42067835|NCT00566995|75877185|FG000|Overall Study|Toxicity|4|||
42067836|NCT00566995|75877185|FG000|Overall Study|Withdrew consent|3|||
42067837|NCT00926393|75877191|FG000|Overall Study|Withdrawal by Subject|1|||
42067838|NCT00926393|75877192|FG001|Overall Study|Withdrawal by Subject|2|||
42067839|NCT00926393|75877191|FG000|Overall Study|Adverse Event|1|||
42067840|NCT00926393|75877192|FG001|Overall Study|Adverse Event|1|||
42067841|NCT00926237|75877198|FG000|Overall Study|Withdrawal by Subject|2|||
42067842|NCT00926237|75877199|FG001|Overall Study|Withdrawal by Subject|1|||
42067843|NCT00931463|75877211|FG000|Overall Study|Death|8|||
42067844|NCT00931463|75877212|FG001|Overall Study|Death|4|||
42067845|NCT00931463|75877211|FG000|Overall Study|Withdrawal by Subject|5|||
42067846|NCT00931463|75877212|FG001|Overall Study|Withdrawal by Subject|0|||
42067847|NCT00931463|75877211|FG000|Overall Study|Lost to Follow-up|4|||
42067848|NCT00931463|75877212|FG001|Overall Study|Lost to Follow-up|1|||
42067849|NCT00929201|75877218|FG000|Period 1|Withdrawal by Subject|0|||
42067850|NCT00929201|75877219|FG001|Period 1|Withdrawal by Subject|1|||
42067851|NCT00926003|75877229|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
42067852|NCT00926003|75877230|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
42067853|NCT00926003|75877231|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
42067854|NCT00926003|75877229|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
42292474|NCT01773421|76126329|FG000|Treatment Phase|Adverse Event|0|||
42292475|NCT01773421|76126330|FG001|Treatment Phase|Adverse Event|0|||
42292476|NCT01773421|76126331|FG002|Treatment Phase|Adverse Event|3|||
42292477|NCT01773421|76126332|FG003|Treatment Phase|Adverse Event|1|||
42067855|NCT00926003|75877230|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
42067856|NCT00926003|75877231|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
42067857|NCT00928889|75877241|FG000|Overall Study|Lost to Follow-up|3|||
42067858|NCT00928889|75877242|FG001|Overall Study|Lost to Follow-up|1|||
42067859|NCT00928889|75877241|FG000|Overall Study|Protocol Violation|0|||
42067860|NCT00928889|75877242|FG001|Overall Study|Protocol Violation|1|||
42067861|NCT00928889|75877241|FG000|Overall Study|Adverse Event|1|||
42067862|NCT00928889|75877242|FG001|Overall Study|Adverse Event|0|||
42067863|NCT00928889|75877241|FG000|Overall Study|Other|1|||
42067864|NCT00928889|75877242|FG001|Overall Study|Other|0|||
42067865|NCT03978091|75877254|FG000|Overall Study|Lost to Follow-up|0|||
42067866|NCT03978091|75877255|FG001|Overall Study|Lost to Follow-up|0|||
42067867|NCT03978091|75877256|FG002|Overall Study|Lost to Follow-up|1|||
42067868|NCT03978091|75877257|FG003|Overall Study|Lost to Follow-up|0|||
42067869|NCT03978091|75877258|FG004|Overall Study|Lost to Follow-up|0|||
42067870|NCT03978091|75877259|FG005|Overall Study|Lost to Follow-up|0|||
42067871|NCT03978091|75877254|FG000|Overall Study|Withdrawal by Subject|0|||
42067872|NCT03978091|75877255|FG001|Overall Study|Withdrawal by Subject|0|||
42067873|NCT03978091|75877256|FG002|Overall Study|Withdrawal by Subject|0|||
42175753|NCT02937454|75982939|FG001|Overall Study|Physician Decision|1|||
42175754|NCT02937454|75982938|FG000|Overall Study|Protocol Violation|6|||
42175755|NCT02937454|75982939|FG001|Overall Study|Protocol Violation|10|||
42175756|NCT02937454|75982938|FG000|Overall Study|Withdrawal by Subject|27|||
42067874|NCT03978091|75877257|FG003|Overall Study|Withdrawal by Subject|1|||
42067875|NCT03978091|75877258|FG004|Overall Study|Withdrawal by Subject|1|||
42067876|NCT03978091|75877259|FG005|Overall Study|Withdrawal by Subject|0|||
42067877|NCT00564733|75877282|FG000|Overall Study|Withdrawal by Subject|4|||
42067878|NCT00564733|75877282|FG000|Overall Study|Ineligible|5|||
42067879|NCT00931385|75877286|FG000|Overall Study|Adverse Event|2|||
42067880|NCT00931385|75877287|FG001|Overall Study|Adverse Event|1|||
42067881|NCT00931385|75877288|FG002|Overall Study|Adverse Event|0|||
42067882|NCT00931385|75877289|FG003|Overall Study|Adverse Event|3|||
42067883|NCT00931385|75877286|FG000|Overall Study|Protocol Violation|0|||
42067884|NCT00931385|75877287|FG001|Overall Study|Protocol Violation|0|||
42067885|NCT00931385|75877288|FG002|Overall Study|Protocol Violation|1|||
42067886|NCT00931385|75877289|FG003|Overall Study|Protocol Violation|0|||
42067887|NCT00931385|75877286|FG000|Overall Study|Withdrawal by Subject|0|||
42067888|NCT00931385|75877287|FG001|Overall Study|Withdrawal by Subject|1|||
42067889|NCT00931385|75877288|FG002|Overall Study|Withdrawal by Subject|0|||
42067890|NCT00931385|75877289|FG003|Overall Study|Withdrawal by Subject|1|||
42067891|NCT00931385|75877286|FG000|Overall Study|Lost to Follow-up|0|||
42067892|NCT00931385|75877287|FG001|Overall Study|Lost to Follow-up|0|||
42067893|NCT00931385|75877288|FG002|Overall Study|Lost to Follow-up|0|||
42067894|NCT00931385|75877289|FG003|Overall Study|Lost to Follow-up|1|||
42067895|NCT00565747|75877305|FG000|Overall Study|No embryo transfer|67|||
42067896|NCT00565747|75877306|FG001|Overall Study|No embryo transfer|73|||
42067897|NCT00563797|75877314|FG000|Overall Study|Lost to Follow-up|7|||
42067898|NCT00563797|75877315|FG001|Overall Study|Lost to Follow-up|2|||
42067899|NCT00771927|75877334|FG000|Overall Study|Adverse Event|100|||
42067900|NCT00771927|75877335|FG001|Overall Study|Adverse Event|105|||
42067901|NCT00771927|75877334|FG000|Overall Study|Lack of Efficacy|70|||
42067902|NCT00771927|75877335|FG001|Overall Study|Lack of Efficacy|42|||
42067903|NCT00771927|75877334|FG000|Overall Study|Lost to Follow-up|46|||
42067904|NCT00771927|75877335|FG001|Overall Study|Lost to Follow-up|46|||
42067905|NCT00771927|75877334|FG000|Overall Study|Withdrawal by Subject|16|||
42067906|NCT00771927|75877335|FG001|Overall Study|Withdrawal by Subject|17|||
42067907|NCT00771927|75877334|FG000|Overall Study|Other reason|23|||
42067908|NCT00771927|75877335|FG001|Overall Study|Other reason|27|||
42067909|NCT00771849|75877343|FG000|Overall Study|Lost to Follow-up|1|||
42067910|NCT00771849|75877344|FG001|Overall Study|Lost to Follow-up|2|||
42067911|NCT00771849|75877343|FG000|Overall Study|Withdrawal by Subject|1|||
42067912|NCT00771849|75877344|FG001|Overall Study|Withdrawal by Subject|1|||
42067913|NCT00771849|75877343|FG000|Overall Study|Not vaccinated|0|||
42067914|NCT00771849|75877344|FG001|Overall Study|Not vaccinated|1|||
42067915|NCT00564889|75877350|FG000|Overall Study|Death|7|||
42067916|NCT00564889|75877350|FG000|Overall Study|Adverse Event|12|||
42067917|NCT00564889|75877350|FG000|Overall Study|Alternative treatment|3|||
42067918|NCT00564889|75877350|FG000|Overall Study|Disease progression|3|||
42067919|NCT00564889|75877350|FG000|Overall Study|Other, not specified|4|||
42067920|NCT00560833|75877368|FG000|Overall Study|Adverse Event|16|||
42067921|NCT00560833|75877369|FG001|Overall Study|Adverse Event|10|||
42067922|NCT00560833|75877370|FG002|Overall Study|Adverse Event|25|||
42067923|NCT00560833|75877371|FG003|Overall Study|Adverse Event|23|||
42292478|NCT01773421|76126333|FG004|Treatment Phase|Adverse Event|0|||
42067924|NCT00560833|75877372|FG004|Overall Study|Adverse Event|35|||
42067925|NCT00560833|75877368|FG000|Overall Study|Lost to Follow-up|0|||
42067926|NCT00560833|75877369|FG001|Overall Study|Lost to Follow-up|0|||
42175757|NCT02937454|75982939|FG001|Overall Study|Withdrawal by Subject|15|||
42292479|NCT01773421|76126334|FG005|Treatment Phase|Adverse Event|0|||
42292480|NCT01773421|76126335|FG006|Treatment Phase|Adverse Event|0|||
42292481|NCT01773421|76126329|FG000|Treatment Phase|Withdrawal by Subject|0|||
42292482|NCT01773421|76126330|FG001|Treatment Phase|Withdrawal by Subject|0|||
42292483|NCT01773421|76126331|FG002|Treatment Phase|Withdrawal by Subject|1|||
42067927|NCT00560833|75877370|FG002|Overall Study|Lost to Follow-up|1|||
42067928|NCT00560833|75877371|FG003|Overall Study|Lost to Follow-up|0|||
42067929|NCT00560833|75877372|FG004|Overall Study|Lost to Follow-up|0|||
42067930|NCT00560833|75877368|FG000|Overall Study|Lack of Efficacy|22|||
42067931|NCT00560833|75877369|FG001|Overall Study|Lack of Efficacy|9|||
42067932|NCT00560833|75877370|FG002|Overall Study|Lack of Efficacy|6|||
42067933|NCT00560833|75877371|FG003|Overall Study|Lack of Efficacy|4|||
42067934|NCT00560833|75877372|FG004|Overall Study|Lack of Efficacy|4|||
42067935|NCT00560833|75877368|FG000|Overall Study|Participant uncooperative|5|||
42067936|NCT00560833|75877369|FG001|Overall Study|Participant uncooperative|5|||
42067937|NCT00560833|75877370|FG002|Overall Study|Participant uncooperative|4|||
42067938|NCT00560833|75877371|FG003|Overall Study|Participant uncooperative|4|||
42067939|NCT00560833|75877372|FG004|Overall Study|Participant uncooperative|2|||
42067940|NCT00560833|75877368|FG000|Overall Study|Other|1|||
42067941|NCT00560833|75877369|FG001|Overall Study|Other|1|||
42067942|NCT00560833|75877370|FG002|Overall Study|Other|3|||
42067943|NCT00560833|75877371|FG003|Overall Study|Other|0|||
42067944|NCT00560833|75877372|FG004|Overall Study|Other|0|||
42067945|NCT00560833|75877368|FG000|Overall Study|Never received drug|0|||
42067946|NCT00560833|75877369|FG001|Overall Study|Never received drug|1|||
42067947|NCT00560833|75877370|FG002|Overall Study|Never received drug|0|||
42067948|NCT00560833|75877371|FG003|Overall Study|Never received drug|0|||
42067949|NCT00560833|75877372|FG004|Overall Study|Never received drug|1|||
42067950|NCT00771615|75877393|FG000|Overall Study|Withdrawal by Subject|0|||
42067951|NCT00771615|75877394|FG001|Overall Study|Withdrawal by Subject|1|||
42067952|NCT00771615|75877395|FG002|Overall Study|Withdrawal by Subject|0|||
42067953|NCT00771615|75877396|FG003|Overall Study|Withdrawal by Subject|0|||
42067954|NCT00771615|75877397|FG004|Overall Study|Withdrawal by Subject|0|||
42067955|NCT00771615|75877398|FG005|Overall Study|Withdrawal by Subject|0|||
42067956|NCT00771615|75877399|FG006|Overall Study|Withdrawal by Subject|0|||
42067957|NCT00771615|75877400|FG007|Overall Study|Withdrawal by Subject|1|||
42067958|NCT00771615|75877401|FG008|Overall Study|Withdrawal by Subject|0|||
42067959|NCT00771615|75877393|FG000|Overall Study|Lost to Follow-up|1|||
42067960|NCT00771615|75877394|FG001|Overall Study|Lost to Follow-up|1|||
42067961|NCT00771615|75877395|FG002|Overall Study|Lost to Follow-up|1|||
42067962|NCT00771615|75877396|FG003|Overall Study|Lost to Follow-up|1|||
42067963|NCT00771615|75877397|FG004|Overall Study|Lost to Follow-up|0|||
42067964|NCT00771615|75877398|FG005|Overall Study|Lost to Follow-up|1|||
42067965|NCT00771615|75877399|FG006|Overall Study|Lost to Follow-up|1|||
42067966|NCT00771615|75877400|FG007|Overall Study|Lost to Follow-up|0|||
42067967|NCT00771615|75877401|FG008|Overall Study|Lost to Follow-up|0|||
42067968|NCT02723604|75877430|FG000|Overall Study|ineligible|1|||
42067969|NCT02723604|75877430|FG000|Overall Study|never received treatment|1|||
42067970|NCT00560755|75877434|FG000|Overall Study|Protocol Violation|15|||
42067971|NCT00560755|75877434|FG000|Overall Study|Withdrawal by Subject|26|||
42067972|NCT00560755|75877434|FG000|Overall Study|Lost to Follow-up|9|||
42067973|NCT00560755|75877434|FG000|Overall Study|Adverse Event|8|||
42067974|NCT00560755|75877434|FG000|Overall Study|Physician Decision|2|||
42067975|NCT00770991|75877441|FG000|Overall Study|Physician Decision|2|||
42067976|NCT00770991|75877442|FG001|Overall Study|Physician Decision|0|||
42067977|NCT00770991|75877441|FG000|Overall Study|Withdrawal by Subject|1|||
42067978|NCT00770991|75877442|FG001|Overall Study|Withdrawal by Subject|0|||
42067979|NCT00770991|75877441|FG000|Overall Study|Adverse Event|1|||
42067980|NCT00770991|75877442|FG001|Overall Study|Adverse Event|5|||
42067981|NCT00770991|75877441|FG000|Overall Study|Pregnancy|1|||
42067982|NCT00770991|75877442|FG001|Overall Study|Pregnancy|0|||
42067983|NCT00925769|75877453|FG000|Overall Study|Major toxicity|1|||
42067984|NCT00925769|75877454|FG001|Overall Study|Major toxicity|0|||
42067985|NCT00925769|75877455|FG002|Overall Study|Major toxicity|1|||
42067986|NCT00925769|75877456|FG003|Overall Study|Major toxicity|1|||
42067987|NCT00925769|75877457|FG004|Overall Study|Major toxicity|0|||
42067988|NCT00925769|75877458|FG005|Overall Study|Major toxicity|0|||
42067989|NCT00925769|75877453|FG000|Overall Study|Disease progression|4|||
42067990|NCT00925769|75877454|FG001|Overall Study|Disease progression|5|||
42067991|NCT00925769|75877455|FG002|Overall Study|Disease progression|3|||
42067992|NCT00925769|75877456|FG003|Overall Study|Disease progression|4|||
42067993|NCT00925769|75877457|FG004|Overall Study|Disease progression|2|||
42067994|NCT00925769|75877458|FG005|Overall Study|Disease progression|3|||
42067995|NCT00925769|75877453|FG000|Overall Study|Death|0|||
42067996|NCT00925769|75877454|FG001|Overall Study|Death|0|||
42067997|NCT00925769|75877455|FG002|Overall Study|Death|1|||
42067998|NCT00925769|75877456|FG003|Overall Study|Death|0|||
42067999|NCT00925769|75877457|FG004|Overall Study|Death|0|||
42068000|NCT00925769|75877458|FG005|Overall Study|Death|0|||
42068001|NCT00925769|75877453|FG000|Overall Study|Physician Decision|1|||
42068002|NCT00925769|75877454|FG001|Overall Study|Physician Decision|0|||
42068003|NCT00925769|75877455|FG002|Overall Study|Physician Decision|0|||
42068004|NCT00925769|75877456|FG003|Overall Study|Physician Decision|0|||
42068005|NCT00925769|75877457|FG004|Overall Study|Physician Decision|0|||
42068006|NCT00925769|75877458|FG005|Overall Study|Physician Decision|0|||
42068007|NCT00925769|75877453|FG000|Overall Study|Missing documentation|0|||
42068008|NCT00925769|75877454|FG001|Overall Study|Missing documentation|1|||
42068009|NCT00925769|75877455|FG002|Overall Study|Missing documentation|0|||
42068010|NCT00925769|75877456|FG003|Overall Study|Missing documentation|0|||
42068011|NCT00925769|75877457|FG004|Overall Study|Missing documentation|0|||
42068012|NCT00925769|75877458|FG005|Overall Study|Missing documentation|0|||
42068013|NCT00925769|75877453|FG000|Overall Study|End of study visit not done|0|||
42068014|NCT00925769|75877454|FG001|Overall Study|End of study visit not done|0|||
42068015|NCT00925769|75877455|FG002|Overall Study|End of study visit not done|1|||
42068016|NCT00925769|75877456|FG003|Overall Study|End of study visit not done|0|||
42068017|NCT00925769|75877457|FG004|Overall Study|End of study visit not done|0|||
42068018|NCT00925769|75877458|FG005|Overall Study|End of study visit not done|0|||
42068019|NCT00925769|75877453|FG000|Overall Study|Participant is unable to swallow drug|0|||
42068020|NCT00925769|75877454|FG001|Overall Study|Participant is unable to swallow drug|0|||
42068021|NCT00925769|75877455|FG002|Overall Study|Participant is unable to swallow drug|0|||
42068022|NCT00925769|75877456|FG003|Overall Study|Participant is unable to swallow drug|1|||
42068023|NCT00925769|75877457|FG004|Overall Study|Participant is unable to swallow drug|0|||
42068024|NCT00925769|75877458|FG005|Overall Study|Participant is unable to swallow drug|0|||
42068025|NCT00925769|75877453|FG000|Overall Study|Adverse Event|0|||
42068026|NCT00925769|75877454|FG001|Overall Study|Adverse Event|0|||
42068027|NCT00925769|75877455|FG002|Overall Study|Adverse Event|0|||
42068028|NCT00925769|75877456|FG003|Overall Study|Adverse Event|0|||
42068029|NCT00925769|75877457|FG004|Overall Study|Adverse Event|1|||
42175758|NCT02937454|75982938|FG000|Overall Study|Other|8|||
42175759|NCT02937454|75982939|FG001|Overall Study|Other|5|||
42175760|NCT03211858|75982958|FG000|Overall Study|Adverse Event|8|||
42175761|NCT03211858|75982959|FG001|Overall Study|Adverse Event|6|||
42175762|NCT03211858|75982958|FG000|Overall Study|Lack of Efficacy|0|||
42175763|NCT03211858|75982959|FG001|Overall Study|Lack of Efficacy|4|||
42175764|NCT03211858|75982958|FG000|Overall Study|Poor compliance to protocol|6|||
42175765|NCT03211858|75982959|FG001|Overall Study|Poor compliance to protocol|2|||
42175766|NCT03211858|75982958|FG000|Overall Study|Non-serious Hypoglycemia|1|||
42175767|NCT03211858|75982959|FG001|Overall Study|Non-serious Hypoglycemia|0|||
42175768|NCT03211858|75982958|FG000|Overall Study|Other than specified above|22|||
42175769|NCT03211858|75982959|FG001|Overall Study|Other than specified above|21|||
42175770|NCT03211156|75982971|FG000|Overall Study|Withdrawal by Subject|0|||
42175771|NCT03211156|75982972|FG001|Overall Study|Withdrawal by Subject|2|||
42175772|NCT03211156|75982971|FG000|Overall Study|Lost to Follow-up|1|||
42175773|NCT03211156|75982972|FG001|Overall Study|Lost to Follow-up|1|||
42175774|NCT03211156|75982971|FG000|Overall Study|Adverse Event|1|||
42175775|NCT03211156|75982972|FG001|Overall Study|Adverse Event|0|||
42175776|NCT04472494|75982980|FG000|Pre-treatment|Other reasons|2|||
42175777|NCT04472494|75982981|FG001|Pre-treatment|Other reasons|0|||
42175778|NCT04472494|75982980|FG000|Treatment|Death|5|||
42175779|NCT04472494|75982981|FG001|Treatment|Death|2|||
42175780|NCT04472494|75982980|FG000|Treatment|Hospital discharge|1|||
42175781|NCT04472494|75982981|FG001|Treatment|Hospital discharge|1|||
42175782|NCT04419506|75982991|FG000|Overall Study|Adverse Event|0|||
42175783|NCT04419506|75982992|FG001|Overall Study|Adverse Event|10|||
42175784|NCT04419506|75982993|FG002|Overall Study|Adverse Event|0|||
42175785|NCT04419506|75982994|FG003|Overall Study|Adverse Event|3|||
42175786|NCT04419506|75982991|FG000|Overall Study|Withdrawal by Subject|0|||
42175787|NCT04419506|75982992|FG001|Overall Study|Withdrawal by Subject|0|||
42175788|NCT04419506|75982993|FG002|Overall Study|Withdrawal by Subject|0|||
42175789|NCT04419506|75982994|FG003|Overall Study|Withdrawal by Subject|1|||
42175790|NCT04419506|75982991|FG000|Overall Study|poor-compliance|0|||
42175791|NCT04419506|75982992|FG001|Overall Study|poor-compliance|0|||
42175792|NCT04419506|75982993|FG002|Overall Study|poor-compliance|0|||
42175793|NCT04419506|75982994|FG003|Overall Study|poor-compliance|1|||
42175794|NCT03236506|75983007|FG000|Overall Study|Death|1|||
42175795|NCT03236506|75983008|FG001|Overall Study|Death|1|||
42175796|NCT03236506|75983009|FG002|Overall Study|Death|1|||
42175797|NCT03236506|75983007|FG000|Overall Study|Withdrawal by Subject|3|||
42175798|NCT03236506|75983008|FG001|Overall Study|Withdrawal by Subject|3|||
42175799|NCT03236506|75983009|FG002|Overall Study|Withdrawal by Subject|4|||
42175800|NCT03236506|75983007|FG000|Overall Study|Did not initiate treatment|2|||
42175801|NCT03236506|75983008|FG001|Overall Study|Did not initiate treatment|1|||
42175802|NCT03236506|75983009|FG002|Overall Study|Did not initiate treatment|2|||
42068030|NCT00925769|75877458|FG005|Overall Study|Adverse Event|0|||
42068031|NCT00770913|75877477|FG000|Overall Study|Adverse Event|1|||
42068032|NCT00770913|75877478|FG001|Overall Study|Adverse Event|3|||
42175803|NCT03227692|75983028|FG000|Overall Study|Protocol Violation|1|||
42175804|NCT03227692|75983029|FG001|Overall Study|Protocol Violation|1|||
42175805|NCT03227692|75983028|FG000|Overall Study|Lost to Follow-up|4|||
42175806|NCT03227692|75983029|FG001|Overall Study|Lost to Follow-up|2|||
42175807|NCT03227692|75983028|FG000|Overall Study|Adverse Event|0|||
42175808|NCT03227692|75983029|FG001|Overall Study|Adverse Event|2|||
42175809|NCT03210220|75983037|FG000|Overall Study|Physician Decision|1|||
42175810|NCT03210220|75983038|FG001|Overall Study|Physician Decision|0|||
42068033|NCT00770913|75877479|FG002|Overall Study|Adverse Event|6|||
42068034|NCT00770913|75877477|FG000|Overall Study|Refusal to continue participation|6|||
42068035|NCT00770913|75877478|FG001|Overall Study|Refusal to continue participation|4|||
42068036|NCT00770913|75877479|FG002|Overall Study|Refusal to continue participation|5|||
42068037|NCT00770913|75877477|FG000|Overall Study|Physician Decision|0|||
42068038|NCT00770913|75877478|FG001|Overall Study|Physician Decision|1|||
42068039|NCT00770913|75877479|FG002|Overall Study|Physician Decision|1|||
42068040|NCT00770913|75877477|FG000|Overall Study|Protocol Violation|3|||
42068041|NCT00770913|75877478|FG001|Overall Study|Protocol Violation|0|||
42068042|NCT00770913|75877479|FG002|Overall Study|Protocol Violation|1|||
42068043|NCT00770913|75877477|FG000|Overall Study|Incorrect drug was allocated|1|||
42068044|NCT00770913|75877478|FG001|Overall Study|Incorrect drug was allocated|0|||
42068045|NCT00770913|75877479|FG002|Overall Study|Incorrect drug was allocated|0|||
42068046|NCT00562861|75877489|FG000|Overall Study|Adverse Event|1|||
42068047|NCT00562861|75877490|FG001|Overall Study|Adverse Event|1|||
42068048|NCT00562861|75877489|FG000|Overall Study|Lack of Efficacy|5|||
42068049|NCT00562861|75877490|FG001|Overall Study|Lack of Efficacy|5|||
42068050|NCT00562861|75877489|FG000|Overall Study|noncompliance, moved|7|||
42068051|NCT00562861|75877490|FG001|Overall Study|noncompliance, moved|2|||
42068052|NCT00562861|75877489|FG000|Overall Study|Lost to Follow-up|7|||
42068053|NCT00562861|75877490|FG001|Overall Study|Lost to Follow-up|3|||
42068054|NCT00770679|75877496|FG000|Overall Study|Lost to Follow-up|3|||
42068055|NCT00770679|75877496|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
42068056|NCT00770601|75877500|FG000|Overall Study|Withdrawal by Subject|1|||
42068057|NCT00770367|75877506|FG000|First Intervention|Withdrawal by Subject|0|||
42068058|NCT00770367|75877507|FG001|First Intervention|Withdrawal by Subject|2|||
42068059|NCT00770367|75877506|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
42068060|NCT00770367|75877507|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
42068061|NCT00770367|75877506|FG000|Second Intervention|Lost to Follow-up|2|||
42068062|NCT00770367|75877507|FG001|Second Intervention|Lost to Follow-up|0|||
42068063|NCT00931307|75877515|FG000|Overall Study|Lack of Efficacy|12|||
42068064|NCT00931307|75877515|FG000|Overall Study|Biomicroscopy|1|||
42068065|NCT00930761|75877521|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
42068066|NCT00930761|75877522|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
42068067|NCT00930761|75877521|FG000|Overall Study|less than 3 music therapy sessions|0|||
42068068|NCT00930761|75877522|FG001|Overall Study|less than 3 music therapy sessions|3|||
42068069|NCT00770289|75877528|FG000|Overall Study|Other|6|||
42068070|NCT00770211|75877539|FG000|Overall Study|Lost to Follow-up|1|||
42068071|NCT00770211|75877540|FG001|Overall Study|Lost to Follow-up|0|||
42068072|NCT00770211|75877539|FG000|Overall Study|Withdrawal by Subject|0|||
42068073|NCT00770211|75877540|FG001|Overall Study|Withdrawal by Subject|2|||
42068074|NCT00928187|75877549|FG000|Overall Study|Death|1|||
42175811|NCT03209518|75983044|FG000|Overall Study|Case Report Forms Uncollected|1|||
42175812|NCT03209518|75983044|FG000|Overall Study|Protocol Deviation|1|||
42175813|NCT03725852|75983050|FG000|Overall Study|Death|1|||
42175814|NCT03725852|75983051|FG001|Overall Study|Death|0|||
42175815|NCT03725852|75983050|FG000|Overall Study|Withdrawal by Subject|1|||
42175816|NCT03725852|75983051|FG001|Overall Study|Withdrawal by Subject|0|||
42175817|NCT03725852|75983050|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
42175818|NCT03725852|75983051|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
42175819|NCT00304031|75983060|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
42175820|NCT00304031|75983061|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
42175821|NCT00304031|75983062|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
42175822|NCT00304031|75983060|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
42292484|NCT01773421|76126332|FG003|Treatment Phase|Withdrawal by Subject|1|||
42292485|NCT01773421|76126333|FG004|Treatment Phase|Withdrawal by Subject|0|||
42292486|NCT01773421|76126334|FG005|Treatment Phase|Withdrawal by Subject|0|||
42068075|NCT00928187|75877550|FG001|Overall Study|Death|2|||
42068076|NCT00928187|75877551|FG002|Overall Study|Death|3|||
42068077|NCT00928187|75877549|FG000|Overall Study|Lost to Follow-up|1|||
42068078|NCT00928187|75877550|FG001|Overall Study|Lost to Follow-up|2|||
42068079|NCT00928187|75877551|FG002|Overall Study|Lost to Follow-up|1|||
42068080|NCT00928187|75877549|FG000|Overall Study|Withdrawal by Subject|0|||
42068081|NCT00928187|75877550|FG001|Overall Study|Withdrawal by Subject|1|||
42068082|NCT00928187|75877551|FG002|Overall Study|Withdrawal by Subject|1|||
42068083|NCT00928187|75877549|FG000|Overall Study|Protocol Violation|0|||
42068084|NCT00928187|75877550|FG001|Overall Study|Protocol Violation|1|||
42068085|NCT00928187|75877551|FG002|Overall Study|Protocol Violation|0|||
42068086|NCT00769119|75877561|FG000|Overall Study|Voluntary discontinuation|0|||
42068087|NCT00769119|75877562|FG001|Overall Study|Voluntary discontinuation|2|||
42068088|NCT00769119|75877561|FG000|Overall Study|Adverse Event|1|||
42292487|NCT01773421|76126335|FG006|Treatment Phase|Withdrawal by Subject|0|||
42068089|NCT00769119|75877562|FG001|Overall Study|Adverse Event|1|||
42068090|NCT00769119|75877561|FG000|Overall Study|Disallowed medication|1|||
42068091|NCT00769119|75877562|FG001|Overall Study|Disallowed medication|0|||
42068092|NCT00927953|75877570|FG000|Overall Study|Death|2|||
42068093|NCT00927953|75877571|FG001|Overall Study|Death|1|||
42068094|NCT00768651|75877578|FG000|Overall Study|Withdrawal by Subject|1|||
42068095|NCT00756717|75877583|FG000|Overall Study|Withdrawal by Subject|2|||
42068096|NCT04987762|75877593|FG000|Overall Study|Study was Terminated by Sponsor|103|||
42068097|NCT04817332|75877620|FG000|Overall Study|Lost to Follow-up|3|||
42068098|NCT04817332|75877621|FG001|Overall Study|Lost to Follow-up|3|||
42068099|NCT04817332|75877620|FG000|Overall Study|Protocol Violation|2|||
42068100|NCT04817332|75877621|FG001|Overall Study|Protocol Violation|0|||
42068101|NCT04797637|75877629|FG000|Overall Study|Lost to Follow-up|23|||
42068102|NCT04797637|75877630|FG001|Overall Study|Lost to Follow-up|32|||
42068103|NCT04797637|75877629|FG000|Overall Study|Withdrawal by Subject|0|||
42068104|NCT04797637|75877630|FG001|Overall Study|Withdrawal by Subject|1|||
42068105|NCT04779489|75877636|FG000|Overall Study|Physician Decision|1|||
42068106|NCT04300296|75877667|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
42068107|NCT04300296|75877668|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
42068108|NCT04300296|75877669|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
42068109|NCT04300296|75877670|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
42068110|NCT04300296|75877671|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
42068111|NCT04300296|75877672|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
42068112|NCT04300296|75877667|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
42068113|NCT04300296|75877668|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
42068114|NCT04300296|75877669|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
42068115|NCT04300296|75877670|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
42068116|NCT04300296|75877671|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
42068117|NCT04300296|75877672|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
42068118|NCT04300296|75877667|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
42068119|NCT04300296|75877668|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
42068120|NCT04300296|75877669|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
42068121|NCT04300296|75877670|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
42068122|NCT04300296|75877671|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
42068123|NCT04300296|75877672|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
42068124|NCT04300296|75877667|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
42068125|NCT04300296|75877668|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
42068126|NCT04300296|75877669|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
42068127|NCT04300296|75877670|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
42068128|NCT04300296|75877671|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
42068129|NCT04300296|75877672|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
42068130|NCT04300296|75877667|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
42068131|NCT04300296|75877668|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
42068132|NCT04300296|75877669|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
42068133|NCT04300296|75877670|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
42068134|NCT04300296|75877671|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
42068135|NCT04300296|75877672|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
42068136|NCT04300296|75877667|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
42068137|NCT04300296|75877668|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
42068138|NCT04300296|75877669|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
42068139|NCT04300296|75877670|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
42068140|NCT04300296|75877671|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
42068141|NCT04300296|75877672|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
42068142|NCT04300296|75877667|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
42068143|NCT04300296|75877668|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
42068144|NCT04300296|75877669|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
42068145|NCT04300296|75877670|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
42068146|NCT04300296|75877671|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
42068147|NCT04300296|75877672|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
42068148|NCT03989440|75877716|FG000|Overall Study|COVID-19 travel restrictions|0|||
42068149|NCT03989440|75877717|FG001|Overall Study|COVID-19 travel restrictions|0|||
42068150|NCT03989440|75877718|FG002|Overall Study|COVID-19 travel restrictions|1|||
42292488|NCT01773421|76126329|FG000|Extension Phase|Other|0|||
42016992|NCT01134939|75824552|FG001|Overall Study|Lost to Follow-up|3|||
42016993|NCT01134939|75824553|FG002|Overall Study|Lost to Follow-up|0|||
42016994|NCT01134939|75824554|FG003|Overall Study|Lost to Follow-up|1|||
42016995|NCT01134939|75824555|FG004|Overall Study|Lost to Follow-up|2|||
42016996|NCT01134939|75824556|FG005|Overall Study|Lost to Follow-up|1|||
42016997|NCT01134939|75824557|FG006|Overall Study|Lost to Follow-up|0|||
42016998|NCT01134939|75824558|FG007|Overall Study|Lost to Follow-up|0|||
42016999|NCT01134939|75824551|FG000|Overall Study|Death|0|||
42017000|NCT01134939|75824552|FG001|Overall Study|Death|1|||
42068151|NCT03989440|75877719|FG003|Overall Study|COVID-19 travel restrictions|0|||
42068152|NCT03989440|75877720|FG004|Overall Study|COVID-19 travel restrictions|0|||
42068153|NCT03989440|75877721|FG005|Overall Study|COVID-19 travel restrictions|0|||
42068154|NCT03989440|75877716|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
42068155|NCT03989440|75877717|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
42068156|NCT03989440|75877718|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
42068157|NCT03989440|75877719|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
42068158|NCT03989440|75877720|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
42068159|NCT03989440|75877721|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
42068160|NCT03908437|75877739|FG000|Overall Study|Death|0|||
42068161|NCT03908437|75877740|FG001|Overall Study|Death|1|||
42068162|NCT03908437|75877739|FG000|Overall Study|Lost to Follow-up|31|||
42068163|NCT03908437|75877740|FG001|Overall Study|Lost to Follow-up|24|||
42068164|NCT03274895|75877765|FG000|Overall Study|Lack of Efficacy|1|||
42068165|NCT03274895|75877766|FG001|Overall Study|Lack of Efficacy|0|||
42068166|NCT03274895|75877765|FG000|Overall Study|Adverse Event|8|||
42068167|NCT03274895|75877766|FG001|Overall Study|Adverse Event|7|||
42068168|NCT03274895|75877765|FG000|Overall Study|Lost to Follow-up|1|||
42068169|NCT03274895|75877766|FG001|Overall Study|Lost to Follow-up|0|||
42068170|NCT03274895|75877765|FG000|Overall Study|Diagnosis not confirmed|3|||
42068171|NCT03274895|75877766|FG001|Overall Study|Diagnosis not confirmed|4|||
42068172|NCT03035201|75877788|FG000|Overall Study|Death|9|||
42068173|NCT03035201|75877789|FG001|Overall Study|Death|12|||
42068174|NCT03035201|75877790|FG002|Overall Study|Death|9|||
42068175|NCT03035201|75877791|FG003|Overall Study|Death|10|||
42068176|NCT03035201|75877788|FG000|Overall Study|Withdrawal by Subject|51|||
42068177|NCT03035201|75877789|FG001|Overall Study|Withdrawal by Subject|49|||
42068178|NCT03035201|75877790|FG002|Overall Study|Withdrawal by Subject|37|||
42068179|NCT03035201|75877791|FG003|Overall Study|Withdrawal by Subject|46|||
42068180|NCT03035201|75877788|FG000|Overall Study|Lost to Follow-up|67|||
42068181|NCT03035201|75877789|FG001|Overall Study|Lost to Follow-up|51|||
42068182|NCT03035201|75877790|FG002|Overall Study|Lost to Follow-up|64|||
42068183|NCT03035201|75877791|FG003|Overall Study|Lost to Follow-up|69|||
42068184|NCT02969915|75877813|FG000|Overall Study|Death|104|||
42068185|NCT02969915|75877814|FG001|Overall Study|Death|125|||
42068186|NCT02969915|75877813|FG000|Overall Study|Lost to Follow-up|108|||
42068187|NCT02969915|75877814|FG001|Overall Study|Lost to Follow-up|112|||
42068188|NCT02969915|75877813|FG000|Overall Study|Censored due to COVID-19|481|||
42068189|NCT02969915|75877814|FG001|Overall Study|Censored due to COVID-19|471|||
42068190|NCT02906332|75877820|FG000|Overall Study|Withdrawal by Subject|1|||
42068191|NCT02827877|75877834|FG000|Overall Study|Withdrawal by Subject|1|||
42068192|NCT02755597|75877840|FG000|Overall Study|Withdrew consent|27|||
42068193|NCT02755597|75877841|FG001|Overall Study|Withdrew consent|11|||
42068194|NCT02755597|75877840|FG000|Overall Study|Lost to Follow-up|1|||
42068195|NCT02755597|75877841|FG001|Overall Study|Lost to Follow-up|0|||
42068196|NCT02755597|75877840|FG000|Overall Study|Death|78|||
42068197|NCT02755597|75877841|FG001|Overall Study|Death|36|||
42068198|NCT02755597|75877840|FG000|Overall Study|Study terminated by Sponsor|67|||
42068199|NCT02755597|75877841|FG001|Overall Study|Study terminated by Sponsor|47|||
42068200|NCT02755597|75877840|FG000|Overall Study|Other, not specified|20|||
42068201|NCT02755597|75877841|FG001|Overall Study|Other, not specified|3|||
42068202|NCT02755597|75877840|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
42068203|NCT02755597|75877841|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
42068204|NCT02598557|75877850|FG000|Overall Study|Withdrawal by Subject|1|||
42068205|NCT02598557|75877851|FG001|Overall Study|Withdrawal by Subject|0|||
42068206|NCT02598557|75877852|FG002|Overall Study|Withdrawal by Subject|1|||
42068207|NCT02598557|75877850|FG000|Overall Study|Participant did not start treatment|2|||
42068208|NCT02598557|75877851|FG001|Overall Study|Participant did not start treatment|1|||
42068209|NCT02598557|75877852|FG002|Overall Study|Participant did not start treatment|1|||
42068210|NCT02598557|75877850|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
42068211|NCT02598557|75877851|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
42068212|NCT02598557|75877852|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
42068213|NCT02598557|75877850|FG000|Overall Study|Adverse Event|1|||
42068214|NCT02598557|75877851|FG001|Overall Study|Adverse Event|1|||
42068215|NCT02598557|75877852|FG002|Overall Study|Adverse Event|0|||
42068216|NCT02340780|75877860|FG000|Overall Study|Ineligible|1|||
42068217|NCT01470417|75877875|FG000|Overall Study|Disease progression|0|||
42068218|NCT01470417|75877876|FG001|Overall Study|Disease progression|2|||
42068219|NCT00820248|75877914|FG000|Overall Study|No treated|4|||
42068220|NCT00820248|75877915|FG001|Overall Study|No treated|1|||
42068221|NCT00668642|75877932|FG000|First Off-cycle|Cancer progression|1|||
42068222|NCT00668642|75877933|FG001|First Off-cycle|Cancer progression|0|||
42068223|NCT00668642|75877932|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
42068224|NCT00668642|75877933|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
42068225|NCT00609791|75877939|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
42068226|NCT00101101|75877952|FG000|Overall Study|never received vaccine|20|||
42068227|NCT03962101|75877956|FG000|Overall Study|Adverse Event|1|||
42068228|NCT03962101|75877956|FG000|Overall Study|Physician Decision|2|||
42068229|NCT03962101|75877956|FG000|Overall Study|Not related to medical events|1|||
42068230|NCT00923351|75877963|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
42068231|NCT00923351|75877964|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
42068232|NCT00923351|75877965|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
42068233|NCT00755937|75877971|FG000|Recruitment|Unknown if infliximab received|164|||
42068234|NCT00755937|75877971|FG000|Observational Follow-up|Lost to Follow-up|148|||
42068235|NCT00755079|75877977|FG000|Overall Study|Lost to Follow-up|1|||
42068236|NCT00755079|75877978|FG001|Overall Study|Lost to Follow-up|3|||
42068237|NCT00755079|75877977|FG000|Overall Study|Adverse Event|0|||
42068238|NCT00755079|75877978|FG001|Overall Study|Adverse Event|1|||
42068239|NCT00755079|75877977|FG000|Overall Study|Withdrawal by Subject|0|||
42068240|NCT00755079|75877978|FG001|Overall Study|Withdrawal by Subject|2|||
42068241|NCT00925301|75877986|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
42068242|NCT00925301|75877987|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
42068243|NCT00925301|75877988|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
42068244|NCT00925301|75877989|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
42068245|NCT00925301|75877986|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
42068246|NCT00925301|75877987|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
42068247|NCT00925301|75877988|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
42068248|NCT00925301|75877989|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
42068249|NCT00925301|75877986|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
42068250|NCT00925301|75877987|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
42068251|NCT00925301|75877988|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
42068252|NCT00925301|75877989|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
42068253|NCT00925301|75877986|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
42068254|NCT00925301|75877987|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
42068255|NCT00925301|75877988|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
42068256|NCT00925301|75877989|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
42068257|NCT00925301|75877986|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
42068258|NCT00925301|75877987|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
42068259|NCT00925301|75877988|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
42068260|NCT00925301|75877989|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
42068261|NCT00925301|75877986|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
42068262|NCT00925301|75877987|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
42068263|NCT00925301|75877988|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
42068264|NCT00925301|75877989|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
42068265|NCT00925301|75877986|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
42068266|NCT00925301|75877987|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
42068267|NCT00925301|75877988|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
42068268|NCT00925301|75877989|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
42068269|NCT00754065|75878002|FG000|Overall Study|Never received treatment|12|||
42068270|NCT00754065|75878003|FG001|Overall Study|Never received treatment|2|||
42068271|NCT00754065|75878002|FG000|Overall Study|Adverse Event|19|||
42068272|NCT00754065|75878003|FG001|Overall Study|Adverse Event|25|||
42068273|NCT00754065|75878002|FG000|Overall Study|Lost to Follow-up|7|||
42068274|NCT00754065|75878003|FG001|Overall Study|Lost to Follow-up|11|||
42068275|NCT00754065|75878002|FG000|Overall Study|Protocol Violation|12|||
42068276|NCT00754065|75878003|FG001|Overall Study|Protocol Violation|10|||
42068277|NCT00754065|75878002|FG000|Overall Study|Withdrawal by Subject|4|||
42068278|NCT00754065|75878003|FG001|Overall Study|Withdrawal by Subject|5|||
42068279|NCT00754065|75878002|FG000|Overall Study|Pregnancy|6|||
42068280|NCT00754065|75878003|FG001|Overall Study|Pregnancy|0|||
42068281|NCT00754065|75878002|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
42068282|NCT00754065|75878003|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
42068283|NCT04138056|75878023|FG000|Primary Study|Lost to Follow-up|3|||
42068284|NCT04138056|75878024|FG001|Primary Study|Lost to Follow-up|4|||
42068285|NCT04138056|75878025|FG002|Primary Study|Lost to Follow-up|1|||
42068286|NCT04138056|75878026|FG003|Primary Study|Lost to Follow-up|1|||
42068287|NCT04138056|75878027|FG004|Primary Study|Lost to Follow-up|4|||
42068288|NCT04138056|75878023|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
42068289|NCT04138056|75878024|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
42068290|NCT04138056|75878025|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
42068291|NCT04138056|75878026|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
42068292|NCT04138056|75878027|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
42068293|NCT04138056|75878023|FG000|Extension Study|Lost to Follow-up|1|||
42068294|NCT04138056|75878024|FG001|Extension Study|Lost to Follow-up|2|||
42068295|NCT04138056|75878025|FG002|Extension Study|Lost to Follow-up|1|||
42068296|NCT04138056|75878026|FG003|Extension Study|Lost to Follow-up|0|||
42068297|NCT04138056|75878027|FG004|Extension Study|Lost to Follow-up|1|||
42068298|NCT00753675|75878073|FG000|Overall Study|other reason|11|||
42068299|NCT00753675|75878074|FG001|Overall Study|other reason|12|||
42068300|NCT00753675|75878075|FG002|Overall Study|other reason|13|||
42068301|NCT00753675|75878073|FG000|Overall Study|Death|1|||
42068302|NCT00753675|75878074|FG001|Overall Study|Death|2|||
42068303|NCT00753675|75878075|FG002|Overall Study|Death|4|||
42068304|NCT00753675|75878073|FG000|Overall Study|Adverse Event|11|||
42068305|NCT00753675|75878074|FG001|Overall Study|Adverse Event|9|||
42068306|NCT00753675|75878075|FG002|Overall Study|Adverse Event|4|||
42068307|NCT00753675|75878073|FG000|Overall Study|Objective progression of disease|35|||
42068308|NCT00753675|75878074|FG001|Overall Study|Objective progression of disease|35|||
42068309|NCT00753675|75878075|FG002|Overall Study|Objective progression of disease|35|||
42068310|NCT00753675|75878073|FG000|Overall Study|Withdrawal by Subject|0|||
42068311|NCT00753675|75878074|FG001|Overall Study|Withdrawal by Subject|1|||
42068312|NCT00753675|75878075|FG002|Overall Study|Withdrawal by Subject|0|||
42068313|NCT00753675|75878073|FG000|Overall Study|Lost to Follow-up|1|||
42068314|NCT00753675|75878074|FG001|Overall Study|Lost to Follow-up|0|||
42068315|NCT00753675|75878075|FG002|Overall Study|Lost to Follow-up|0|||
42068316|NCT00586521|75878083|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
42068317|NCT00923273|75878092|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
42068318|NCT00923273|75878093|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
42068319|NCT00923273|75878094|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
42068320|NCT00923273|75878095|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
42068321|NCT00923273|75878096|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
42068322|NCT00923273|75878092|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
42068323|NCT00923273|75878093|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
42068324|NCT00923273|75878094|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
42068325|NCT00923273|75878095|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
42068326|NCT00923273|75878096|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
42068327|NCT00923195|75878116|FG000|Overall Study|Death|0|||
42068328|NCT00923195|75878117|FG001|Overall Study|Death|1|||
42068329|NCT00753519|75878125|FG000|Overall Study|Withdrawal by Subject|0|||
42068330|NCT00753519|75878126|FG001|Overall Study|Withdrawal by Subject|2|||
42068331|NCT00919061|75878134|FG000|Overall Study|Adverse Event|1|||
42068332|NCT00919061|75878134|FG000|Overall Study|Withdrawal by Subject|1|||
42068333|NCT00747435|75878138|FG000|Overall Study|Lost to Follow-up|2|||
42068334|NCT00747435|75878138|FG000|Overall Study|Withdrawal by Subject|3|||
42068335|NCT00747435|75878138|FG000|Overall Study|Still undergoing follow up|1|||
42068336|NCT00918749|75878145|FG000|Overall Study|Adverse Event|1|||
42068337|NCT00918749|75878146|FG001|Overall Study|Adverse Event|0|||
42068338|NCT00918749|75878147|FG002|Overall Study|Adverse Event|1|||
42068339|NCT00918749|75878145|FG000|Overall Study|Lost to Follow-up|0|||
42068340|NCT00918749|75878146|FG001|Overall Study|Lost to Follow-up|0|||
42068341|NCT00918749|75878147|FG002|Overall Study|Lost to Follow-up|1|||
42068342|NCT00918749|75878145|FG000|Overall Study|Withdrawal by Subject|5|||
42068343|NCT00918749|75878146|FG001|Overall Study|Withdrawal by Subject|3|||
42068344|NCT00918749|75878147|FG002|Overall Study|Withdrawal by Subject|5|||
42068345|NCT00918749|75878145|FG000|Overall Study|No Study Medication Taken|1|||
42068346|NCT00918749|75878146|FG001|Overall Study|No Study Medication Taken|0|||
42068347|NCT00918749|75878147|FG002|Overall Study|No Study Medication Taken|0|||
42068348|NCT00746733|75878155|FG000|Second Intervention|Adverse Event|1|||
42068349|NCT00746733|75878156|FG001|Second Intervention|Adverse Event|0|||
42068350|NCT00746733|75878155|FG000|Third Intervention|Withdrawal by Subject|1|||
42068351|NCT00746733|75878156|FG001|Third Intervention|Withdrawal by Subject|1|||
42068352|NCT00745875|75878171|FG000|Overall Study|Continuing study treatment|4|||
42068353|NCT00745875|75878172|FG001|Overall Study|Continuing study treatment|4|||
42068354|NCT00555217|75878180|FG000|Overall Study|Withdrawal by Subject|35|||
42068355|NCT00555217|75878181|FG001|Overall Study|Withdrawal by Subject|31|||
42068356|NCT00555217|75878180|FG000|Overall Study|Lost to Follow-up|19|||
42068357|NCT00555217|75878181|FG001|Overall Study|Lost to Follow-up|20|||
42068358|NCT00555217|75878180|FG000|Overall Study|close out sites|21|||
42068359|NCT00555217|75878181|FG001|Overall Study|close out sites|17|||
42068360|NCT00745251|75878189|FG000|Overall Study|Adverse Event|1|||
42068361|NCT00745251|75878190|FG001|Overall Study|Adverse Event|2|||
42068362|NCT00745251|75878189|FG000|Overall Study|Withdrawal by Subject|1|||
42068363|NCT00745251|75878190|FG001|Overall Study|Withdrawal by Subject|1|||
42068364|NCT00745095|75878202|FG000|Overall Study|Declined to participate|1|||
42068365|NCT00745095|75878203|FG001|Overall Study|Declined to participate|0|||
42068366|NCT00745095|75878204|FG002|Overall Study|Declined to participate|0|||
42068367|NCT00745095|75878205|FG003|Overall Study|Declined to participate|0|||
42068368|NCT00745095|75878206|FG004|Overall Study|Declined to participate|92|||
42068369|NCT00745095|75878207|FG005|Overall Study|Declined to participate|95|||
42292489|NCT01773421|76126330|FG001|Extension Phase|Other|0|||
42068370|NCT00745095|75878202|FG000|Overall Study|Ineligible due to GFR criteria|0|||
42068371|NCT00745095|75878203|FG001|Overall Study|Ineligible due to GFR criteria|2|||
42068372|NCT00745095|75878204|FG002|Overall Study|Ineligible due to GFR criteria|3|||
42068373|NCT00745095|75878205|FG003|Overall Study|Ineligible due to GFR criteria|3|||
42068374|NCT00745095|75878206|FG004|Overall Study|Ineligible due to GFR criteria|30|||
42068375|NCT00745095|75878207|FG005|Overall Study|Ineligible due to GFR criteria|28|||
42068376|NCT00744939|75878228|FG000|Overall Study|Withdrawal by Subject|9|||
42068377|NCT00744939|75878228|FG000|Overall Study|Protocol Violation|13|||
42068378|NCT00744939|75878228|FG000|Overall Study|Death|24|||
42068379|NCT00744939|75878228|FG000|Overall Study|distance|4|||
42068380|NCT00744939|75878228|FG000|Overall Study|Lost to Follow-up|12|||
42068381|NCT00744939|75878228|FG000|Overall Study|Medical history exclusionary|1|||
42068382|NCT00744939|75878228|FG000|Overall Study|Did not receive Magnevist|7|||
42068383|NCT00744939|75878228|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
42068384|NCT00744939|75878228|FG000|Overall Study|coma|1|||
42068385|NCT00744939|75878228|FG000|Overall Study|incorrect race|1|||
42068386|NCT00744861|75878244|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
42068387|NCT00744861|75878245|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
42068388|NCT00744861|75878246|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
42068389|NCT00744861|75878247|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
42068390|NCT00744861|75878244|FG000|Feasibility Stage 1|Pregnancy|0|||
42068391|NCT00744861|75878245|FG001|Feasibility Stage 1|Pregnancy|1|||
42068392|NCT00744861|75878246|FG002|Feasibility Stage 1|Pregnancy|0|||
42068393|NCT00744861|75878247|FG003|Feasibility Stage 1|Pregnancy|0|||
42068394|NCT00744861|75878244|FG000|Pivotal Stage 2|Adverse Event|0|||
42068395|NCT00744861|75878245|FG001|Pivotal Stage 2|Adverse Event|0|||
42068396|NCT00744861|75878246|FG002|Pivotal Stage 2|Adverse Event|6|||
42068397|NCT00744861|75878247|FG003|Pivotal Stage 2|Adverse Event|11|||
42068398|NCT00744861|75878244|FG000|Pivotal Stage 2|Death|0|||
42068399|NCT00744861|75878245|FG001|Pivotal Stage 2|Death|0|||
42068400|NCT00744861|75878246|FG002|Pivotal Stage 2|Death|0|||
42068401|NCT00744861|75878247|FG003|Pivotal Stage 2|Death|1|||
42068402|NCT00744861|75878244|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
42068403|NCT00744861|75878245|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
42068404|NCT00744861|75878246|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
42068405|NCT00744861|75878247|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
42068406|NCT00744861|75878244|FG000|Pivotal Stage 2|Physician Decision|0|||
42068407|NCT00744861|75878245|FG001|Pivotal Stage 2|Physician Decision|0|||
42068408|NCT00744861|75878246|FG002|Pivotal Stage 2|Physician Decision|3|||
42068409|NCT00744861|75878247|FG003|Pivotal Stage 2|Physician Decision|1|||
42068410|NCT00744861|75878244|FG000|Pivotal Stage 2|Protocol Violation|0|||
42068411|NCT00744861|75878245|FG001|Pivotal Stage 2|Protocol Violation|0|||
42068412|NCT00744861|75878246|FG002|Pivotal Stage 2|Protocol Violation|0|||
42068413|NCT00744861|75878247|FG003|Pivotal Stage 2|Protocol Violation|1|||
42068414|NCT00744861|75878244|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
42068415|NCT00744861|75878245|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
42068416|NCT00744861|75878246|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
42068417|NCT00744861|75878247|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
42068418|NCT00744861|75878244|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
42068419|NCT00744861|75878245|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
42292490|NCT01773421|76126331|FG002|Extension Phase|Other|0|||
42292491|NCT01773421|76126332|FG003|Extension Phase|Other|0|||
42292492|NCT01773421|76126333|FG004|Extension Phase|Other|1|||
42292493|NCT01773421|76126334|FG005|Extension Phase|Other|2|||
42292494|NCT01773421|76126335|FG006|Extension Phase|Other|0|||
42292495|NCT01773421|76126329|FG000|Extension Phase|Adverse Event|0|||
42292496|NCT01773421|76126330|FG001|Extension Phase|Adverse Event|0|||
42292497|NCT01773421|76126331|FG002|Extension Phase|Adverse Event|0|||
42292498|NCT01773421|76126332|FG003|Extension Phase|Adverse Event|0|||
42292499|NCT01773421|76126333|FG004|Extension Phase|Adverse Event|2|||
42292500|NCT01773421|76126334|FG005|Extension Phase|Adverse Event|0|||
42292501|NCT01773421|76126335|FG006|Extension Phase|Adverse Event|0|||
42292502|NCT01747486|76126353|FG000|Stage 1|Physician Decision|3|||
42292503|NCT01747486|76126354|FG001|Stage 1|Physician Decision|0|||
42292504|NCT01747486|76126353|FG000|Stage 1|Withdrawal by Subject|4|||
42068420|NCT00744861|75878246|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
42068421|NCT00744861|75878247|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
42068422|NCT03969589|75878257|FG000|Overall Study|Lost to Follow-up|3|||
42292505|NCT01747486|76126354|FG001|Stage 1|Withdrawal by Subject|3|||
42068423|NCT03969589|75878258|FG001|Overall Study|Lost to Follow-up|2|||
42292506|NCT01747486|76126353|FG000|Stage 1|Disease progression|4|||
42292507|NCT01747486|76126354|FG001|Stage 1|Disease progression|9|||
42068424|NCT03969589|75878257|FG000|Overall Study|Declined Follow-Up|0|||
42068425|NCT03969589|75878258|FG001|Overall Study|Declined Follow-Up|1|||
42068426|NCT00744627|75878266|FG000|Overall Study|Adverse Event|6|||
42068427|NCT00744627|75878267|FG001|Overall Study|Adverse Event|9|||
42068428|NCT00744627|75878266|FG000|Overall Study|Lack of Efficacy|7|||
42292508|NCT01747486|76126353|FG000|Stage 1|Death|1|||
42292509|NCT01747486|76126354|FG001|Stage 1|Death|1|||
42292510|NCT01747486|76126353|FG000|Stage 2|Physician Decision|2|||
42292511|NCT01747486|76126354|FG001|Stage 2|Physician Decision|0|||
42292512|NCT01747486|76126353|FG000|Stage 2|Withdrawal by Subject|1|||
42292513|NCT01747486|76126354|FG001|Stage 2|Withdrawal by Subject|0|||
42292514|NCT01747486|76126353|FG000|Stage 2|New Cancer Therapy|3|||
42292515|NCT01747486|76126354|FG001|Stage 2|New Cancer Therapy|0|||
42292516|NCT01747486|76126353|FG000|Stage 2|Disease Progression|3|||
42292517|NCT01747486|76126354|FG001|Stage 2|Disease Progression|0|||
42292518|NCT01593254|76126366|FG000|Overall Study|Disease progression|2|||
42292519|NCT01593254|76126367|FG001|Overall Study|Disease progression|7|||
42292520|NCT01593254|76126366|FG000|Overall Study|Study drug toxicity|6|||
42292521|NCT01593254|76126367|FG001|Overall Study|Study drug toxicity|20|||
42292522|NCT01593254|76126366|FG000|Overall Study|Death|3|||
42292523|NCT01593254|76126367|FG001|Overall Study|Death|3|||
42292524|NCT01593254|76126366|FG000|Overall Study|AE unrelated to study drug|0|||
42292525|NCT01593254|76126367|FG001|Overall Study|AE unrelated to study drug|1|||
42292526|NCT01593254|76126366|FG000|Overall Study|participant request to discontinue study treatment|1|||
42068429|NCT00744627|75878267|FG001|Overall Study|Lack of Efficacy|3|||
42068430|NCT00744627|75878266|FG000|Overall Study|Noncompliance|0|||
42068431|NCT00744627|75878267|FG001|Overall Study|Noncompliance|1|||
42068432|NCT00744627|75878266|FG000|Overall Study|Protocol Deviations|0|||
42068433|NCT00744627|75878267|FG001|Overall Study|Protocol Deviations|2|||
42068434|NCT00744627|75878266|FG000|Overall Study|Voluntary Withdrawal|9|||
42068435|NCT00744627|75878267|FG001|Overall Study|Voluntary Withdrawal|6|||
42068436|NCT00744627|75878266|FG000|Overall Study|Lost to Follow-up|2|||
42068437|NCT00744627|75878267|FG001|Overall Study|Lost to Follow-up|1|||
42068438|NCT00744627|75878266|FG000|Overall Study|Other|1|||
42068439|NCT00744627|75878267|FG001|Overall Study|Other|0|||
42068440|NCT03959137|75878273|FG000|Overall Study|Protocol Violation|6|||
42068441|NCT00562627|75878280|FG000|Overall Study|Protocol Violation|1|||
42068442|NCT00562627|75878281|FG001|Overall Study|Protocol Violation|1|||
42068443|NCT00562627|75878282|FG002|Overall Study|Protocol Violation|1|||
42068444|NCT00562159|75878292|FG000|Overall Study|Adverse Event|11|||
42068445|NCT00562159|75878293|FG001|Overall Study|Adverse Event|8|||
42068446|NCT00562159|75878292|FG000|Overall Study|Lost to Follow-up|5|||
42068447|NCT00562159|75878293|FG001|Overall Study|Lost to Follow-up|4|||
42068448|NCT00562159|75878292|FG000|Overall Study|Withdrawal by Subject|9|||
42068449|NCT00562159|75878293|FG001|Overall Study|Withdrawal by Subject|8|||
42068450|NCT00562159|75878292|FG000|Overall Study|Protocol Violation|12|||
42068451|NCT00562159|75878293|FG001|Overall Study|Protocol Violation|12|||
42068452|NCT00562159|75878292|FG000|Overall Study|Did not meet protocol eligibility|1|||
42068453|NCT00562159|75878293|FG001|Overall Study|Did not meet protocol eligibility|1|||
42068454|NCT04223778|75878302|FG000|Overall Study|Ongoing|322|||
42068455|NCT04223778|75878303|FG001|Overall Study|Ongoing|326|||
42068456|NCT04223778|75878302|FG000|Overall Study|Death|0|||
42068457|NCT04223778|75878303|FG001|Overall Study|Death|1|||
42068458|NCT04223778|75878302|FG000|Overall Study|Lost to Follow-up|1|||
42068459|NCT04223778|75878303|FG001|Overall Study|Lost to Follow-up|5|||
42068460|NCT04223778|75878302|FG000|Overall Study|Physician Decision|3|||
42068461|NCT04223778|75878303|FG001|Overall Study|Physician Decision|1|||
42068462|NCT04223778|75878302|FG000|Overall Study|Withdrawal by Subject|10|||
42068463|NCT04223778|75878303|FG001|Overall Study|Withdrawal by Subject|1|||
42068464|NCT04223778|75878302|FG000|Overall Study|Lack of Efficacy|0|||
42068465|NCT04223778|75878303|FG001|Overall Study|Lack of Efficacy|2|||
42068466|NCT00921557|75878312|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
42068467|NCT00921557|75878313|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
42068468|NCT00921557|75878314|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
42068469|NCT00921557|75878312|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
42068470|NCT00921557|75878313|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
42068471|NCT00921557|75878314|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
42068472|NCT00921557|75878312|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
42292527|NCT01593254|76126367|FG001|Overall Study|participant request to discontinue study treatment|3|||
42068473|NCT00921557|75878313|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
42068474|NCT00921557|75878314|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
42068475|NCT00921557|75878312|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
42068476|NCT00921557|75878313|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
42068477|NCT00921557|75878314|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
42068478|NCT00921557|75878312|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
42292528|NCT01593254|76126366|FG000|Overall Study|participant withdrew consent|0|||
42068479|NCT00921557|75878313|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
42068480|NCT00921557|75878314|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
42068481|NCT00744471|75878331|FG000|Overall Study|Randomized but not treated|1|||
42068482|NCT00744471|75878332|FG001|Overall Study|Randomized but not treated|1|||
42292529|NCT01593254|76126367|FG001|Overall Study|participant withdrew consent|9|||
42292530|NCT01593254|76126366|FG000|Overall Study|lost to follow up|1|||
42068483|NCT00744471|75878333|FG002|Overall Study|Randomized but not treated|4|||
42068484|NCT00744471|75878334|FG003|Overall Study|Randomized but not treated|0|||
42175823|NCT00304031|75983061|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
42175824|NCT00304031|75983062|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
42175825|NCT00304031|75983060|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
42175826|NCT00304031|75983061|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
42175827|NCT00304031|75983062|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
42175828|NCT00304031|75983060|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
42175829|NCT00304031|75983061|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
42175830|NCT00304031|75983062|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
42175831|NCT00304031|75983060|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
42175832|NCT00304031|75983061|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
42175833|NCT00304031|75983062|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
42175834|NCT00304031|75983060|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
42175835|NCT00304031|75983061|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
42175836|NCT00304031|75983062|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
42175837|NCT00304031|75983060|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
42175838|NCT00304031|75983061|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
42175839|NCT00304031|75983062|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
42175840|NCT00304031|75983060|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
42175841|NCT00304031|75983061|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
42175842|NCT00304031|75983062|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
42175843|NCT00304031|75983060|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
42175844|NCT00304031|75983061|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
42175845|NCT00304031|75983062|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
42175846|NCT00332189|75983077|FG000|Overall Study|Adverse Event|3|||
42175847|NCT00332189|75983077|FG000|Overall Study|Uncooperative/Noncompliant|3|||
42175848|NCT00332189|75983077|FG000|Overall Study|Withdrawal by Subject|9|||
42175849|NCT00332189|75983077|FG000|Overall Study|Lack of Efficacy|4|||
42175850|NCT00332189|75983077|FG000|Overall Study|Moved out of country|2|||
42175851|NCT00331799|75983082|FG000|Overall Study|Withdrawal by Subject|2|||
42175852|NCT00331799|75983082|FG000|Overall Study|Sedation|1|||
42175853|NCT00303719|75983088|FG000|Overall Study|Not evaluable, prior therapies|0|||
42175854|NCT00303719|75983089|FG001|Overall Study|Not evaluable, prior therapies|30|||
42175855|NCT00303719|75983088|FG000|Overall Study|Lost to Follow-up|0|||
42175856|NCT00303719|75983089|FG001|Overall Study|Lost to Follow-up|7|||
42175857|NCT00331409|75983096|FG000|Overall Study|Lack of Efficacy|4|||
42175858|NCT00303485|75983102|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
42175859|NCT00303485|75983103|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
42175860|NCT00303485|75983102|FG000|Overall Study|Failure to return|0|||
42175861|NCT00303485|75983103|FG001|Overall Study|Failure to return|1|||
42175862|NCT00303485|75983102|FG000|Overall Study|Withdrawal by Subject|1|||
42175863|NCT00303485|75983103|FG001|Overall Study|Withdrawal by Subject|0|||
42175864|NCT03235726|75983117|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
42175865|NCT03235726|75983118|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
42175866|NCT03235726|75983119|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
42175867|NCT03235726|75983120|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
42175868|NCT03235726|75983121|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
42175869|NCT03235726|75983122|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
42175870|NCT03235726|75983123|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
42175871|NCT03235726|75983124|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
42175872|NCT03235726|75983125|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
42175873|NCT03235726|75983126|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
42175874|NCT03235726|75983117|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
42175875|NCT03235726|75983118|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
42175876|NCT03235726|75983119|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
42175877|NCT03235726|75983120|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
42175878|NCT03235726|75983121|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
42175879|NCT03235726|75983122|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
42175880|NCT03235726|75983123|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
42068485|NCT00744471|75878331|FG000|Overall Study|Death|0|||
42068486|NCT00744471|75878332|FG001|Overall Study|Death|0|||
42175881|NCT03235726|75983124|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
42175882|NCT03235726|75983125|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
42175883|NCT03235726|75983126|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
42175884|NCT00303953|75983161|FG000|Overall Study|Ineligible|1|||
42068487|NCT00744471|75878333|FG002|Overall Study|Death|0|||
42068488|NCT00744471|75878334|FG003|Overall Study|Death|1|||
42068489|NCT00744471|75878331|FG000|Overall Study|Adverse Event|6|||
42068490|NCT00744471|75878332|FG001|Overall Study|Adverse Event|7|||
42068491|NCT00744471|75878333|FG002|Overall Study|Adverse Event|5|||
42068492|NCT00744471|75878334|FG003|Overall Study|Adverse Event|9|||
42068493|NCT00744471|75878331|FG000|Overall Study|Withdrawal by Subject|9|||
42068494|NCT00744471|75878332|FG001|Overall Study|Withdrawal by Subject|9|||
42068495|NCT00744471|75878333|FG002|Overall Study|Withdrawal by Subject|15|||
42068496|NCT00744471|75878334|FG003|Overall Study|Withdrawal by Subject|12|||
42068497|NCT00744471|75878331|FG000|Overall Study|Protocol Violation|1|||
42068498|NCT00744471|75878332|FG001|Overall Study|Protocol Violation|4|||
42068499|NCT00744471|75878333|FG002|Overall Study|Protocol Violation|1|||
42068500|NCT00744471|75878334|FG003|Overall Study|Protocol Violation|2|||
42068501|NCT00744471|75878331|FG000|Overall Study|Entered extension study|41|||
42068502|NCT00744471|75878332|FG001|Overall Study|Entered extension study|84|||
42068503|NCT00744471|75878333|FG002|Overall Study|Entered extension study|100|||
42068504|NCT00744471|75878334|FG003|Overall Study|Entered extension study|91|||
42068505|NCT00744471|75878331|FG000|Overall Study|Other|2|||
42068506|NCT00744471|75878332|FG001|Overall Study|Other|3|||
42068507|NCT00744471|75878333|FG002|Overall Study|Other|6|||
42068508|NCT00744471|75878334|FG003|Overall Study|Other|2|||
42068509|NCT00744471|75878331|FG000|Overall Study|Lack of Efficacy|83|||
42068510|NCT00744471|75878332|FG001|Overall Study|Lack of Efficacy|37|||
42068511|NCT00744471|75878333|FG002|Overall Study|Lack of Efficacy|19|||
42068512|NCT00744471|75878334|FG003|Overall Study|Lack of Efficacy|31|||
42068513|NCT00744471|75878331|FG000|Overall Study|Lost to Follow-up|0|||
42068514|NCT00744471|75878332|FG001|Overall Study|Lost to Follow-up|0|||
42068515|NCT00744471|75878333|FG002|Overall Study|Lost to Follow-up|2|||
42068516|NCT00744471|75878334|FG003|Overall Study|Lost to Follow-up|0|||
42068517|NCT00744237|75878347|FG000|Overall Study|Lack of Efficacy|1|||
42068518|NCT00744237|75878348|FG001|Overall Study|Lack of Efficacy|1|||
42068519|NCT00744237|75878349|FG002|Overall Study|Lack of Efficacy|0|||
42068520|NCT00744237|75878347|FG000|Overall Study|Withdrawal by Subject|9|||
42068521|NCT00744237|75878348|FG001|Overall Study|Withdrawal by Subject|5|||
42068522|NCT00744237|75878349|FG002|Overall Study|Withdrawal by Subject|3|||
42068523|NCT00744237|75878347|FG000|Overall Study|Lost to Follow-up|1|||
42068524|NCT00744237|75878348|FG001|Overall Study|Lost to Follow-up|1|||
42068525|NCT00744237|75878349|FG002|Overall Study|Lost to Follow-up|1|||
42068526|NCT00744237|75878347|FG000|Overall Study|Protocol Violation|3|||
42068527|NCT00744237|75878348|FG001|Overall Study|Protocol Violation|4|||
42068528|NCT00744237|75878349|FG002|Overall Study|Protocol Violation|3|||
42068529|NCT00744237|75878347|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
42068530|NCT00744237|75878348|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
42175885|NCT00303953|75983161|FG000|Overall Study|Death|1|||
42175886|NCT00303953|75983161|FG000|Overall Study|Adverse Event|4|||
42175887|NCT00303953|75983161|FG000|Overall Study|Lack of Efficacy|12|||
42175888|NCT00303953|75983161|FG000|Overall Study|Physician Decision|1|||
42175889|NCT02935894|75983165|FG000|Overall Study|Subject dismissed|1|||
42175890|NCT03224182|75983171|FG000|Overall Study|Study Drug Not Instilled|6|||
42175891|NCT03224182|75983172|FG001|Overall Study|Study Drug Not Instilled|1|||
42175892|NCT03224182|75983171|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
42175893|NCT03224182|75983172|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
42175894|NCT03224182|75983171|FG000|Overall Study|Withdrew of Consent|4|||
42175895|NCT03224182|75983172|FG001|Overall Study|Withdrew of Consent|2|||
42175896|NCT03224182|75983171|FG000|Overall Study|Investigator Decision|3|||
42175897|NCT03224182|75983172|FG001|Overall Study|Investigator Decision|1|||
42292531|NCT01593254|76126367|FG001|Overall Study|lost to follow up|6|||
42292532|NCT01593254|76126366|FG000|Overall Study|maximum clinical benefit|1|||
42068531|NCT00744237|75878349|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
42068532|NCT00744237|75878347|FG000|Overall Study|Dosing Error|1|||
42068533|NCT00744237|75878348|FG001|Overall Study|Dosing Error|0|||
42068534|NCT00744237|75878349|FG002|Overall Study|Dosing Error|1|||
42068535|NCT00744237|75878347|FG000|Overall Study|Study Drug Error|1|||
42068536|NCT00744237|75878348|FG001|Overall Study|Study Drug Error|0|||
42068537|NCT00744237|75878349|FG002|Overall Study|Study Drug Error|0|||
42292533|NCT01593254|76126367|FG001|Overall Study|maximum clinical benefit|2|||
42068538|NCT00744237|75878347|FG000|Overall Study|Prohibited Concomitant Medication|0|||
42068539|NCT00744237|75878348|FG001|Overall Study|Prohibited Concomitant Medication|0|||
42068540|NCT00744237|75878349|FG002|Overall Study|Prohibited Concomitant Medication|1|||
42068541|NCT00744237|75878347|FG000|Overall Study|Poor Compliance|0|||
42068542|NCT00744237|75878348|FG001|Overall Study|Poor Compliance|2|||
42068543|NCT00744237|75878349|FG002|Overall Study|Poor Compliance|0|||
42068544|NCT00744237|75878347|FG000|Overall Study|Administrative. Site Closed|1|||
42175898|NCT03224182|75983171|FG000|Overall Study|Sponsor Decision|26|||
42175899|NCT03224182|75983172|FG001|Overall Study|Sponsor Decision|12|||
42175900|NCT03224182|75983171|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
42292534|NCT01593254|76126366|FG000|Overall Study|Poor/non compliance|1|||
42068545|NCT00744237|75878348|FG001|Overall Study|Administrative. Site Closed|1|||
42068546|NCT00744237|75878349|FG002|Overall Study|Administrative. Site Closed|1|||
42068547|NCT00744237|75878347|FG000|Overall Study|Adverse Event|9|||
42068548|NCT00744237|75878348|FG001|Overall Study|Adverse Event|13|||
42068549|NCT00744237|75878349|FG002|Overall Study|Adverse Event|5|||
42068550|NCT00743145|75878357|FG000|Overall Study|Withdrawal by Subject|1|||
42068551|NCT00743145|75878357|FG000|Overall Study|Adverse Event|2|||
42068552|NCT00743145|75878357|FG000|Overall Study|Pregnancy|1|||
42068553|NCT00920855|75878374|FG000|Overall Study|Adverse Event|1|||
42068554|NCT00920855|75878375|FG001|Overall Study|Adverse Event|1|||
42068555|NCT00920855|75878376|FG002|Overall Study|Adverse Event|4|||
42068556|NCT00920855|75878374|FG000|Overall Study|Withdrawal by Subject|2|||
42068557|NCT00920855|75878375|FG001|Overall Study|Withdrawal by Subject|1|||
42068558|NCT00920855|75878376|FG002|Overall Study|Withdrawal by Subject|6|||
42068559|NCT00920855|75878374|FG000|Overall Study|Disease progression|2|||
42068560|NCT00920855|75878375|FG001|Overall Study|Disease progression|1|||
42068561|NCT00920855|75878376|FG002|Overall Study|Disease progression|10|||
42068562|NCT00920855|75878374|FG000|Overall Study|Noncompliance to study medication|0|||
42068563|NCT00920855|75878375|FG001|Overall Study|Noncompliance to study medication|0|||
42068564|NCT00920855|75878376|FG002|Overall Study|Noncompliance to study medication|1|||
42068565|NCT00920855|75878374|FG000|Overall Study|Response plateau; started maintenance|0|||
42068566|NCT00920855|75878375|FG001|Overall Study|Response plateau; started maintenance|0|||
42068567|NCT00920855|75878376|FG002|Overall Study|Response plateau; started maintenance|1|||
42068568|NCT00742209|75878390|FG000|Overall Study|Adverse Event|11|||
42068569|NCT00742209|75878391|FG001|Overall Study|Adverse Event|4|||
42068570|NCT00742209|75878392|FG002|Overall Study|Adverse Event|17|||
42068571|NCT00742209|75878393|FG003|Overall Study|Adverse Event|16|||
42175901|NCT03224182|75983172|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
42175902|NCT03224182|75983171|FG000|Overall Study|Lost to Follow-up|1|||
42175903|NCT03224182|75983172|FG001|Overall Study|Lost to Follow-up|0|||
42175904|NCT03224182|75983171|FG000|Overall Study|Participant Had Recurrence|11|||
42175905|NCT03224182|75983172|FG001|Overall Study|Participant Had Recurrence|5|||
42175906|NCT03224182|75983171|FG000|Overall Study|Death|0|||
42175907|NCT03224182|75983172|FG001|Overall Study|Death|1|||
42175908|NCT03224182|75983171|FG000|Overall Study|Reason not Specified|3|||
42175909|NCT03224182|75983172|FG001|Overall Study|Reason not Specified|3|||
42175910|NCT03224182|75983171|FG000|Overall Study|Other|1|||
42175911|NCT03224182|75983172|FG001|Overall Study|Other|0|||
42175912|NCT02935192|75983180|FG000|Overall Study|Withdrawal by Subject|8|||
42175913|NCT02935192|75983181|FG001|Overall Study|Withdrawal by Subject|4|||
42175914|NCT03722264|75983187|FG000|Overall Study|Physician Decision|3|||
42175915|NCT03722030|75983195|FG000|Overall Study|Withdrawal by Subject|1|||
42175916|NCT03722030|75983196|FG001|Overall Study|Withdrawal by Subject|0|||
42175917|NCT03221842|75983203|FG000|Period 1 (Open-label)|Adverse Event|4|||
42175918|NCT03221842|75983204|FG001|Period 1 (Open-label)|Adverse Event|0|||
42175919|NCT03221842|75983203|FG000|Period 1 (Open-label)|Physician Decision|2|||
42175920|NCT03221842|75983204|FG001|Period 1 (Open-label)|Physician Decision|0|||
42175921|NCT03221842|75983203|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
42175922|NCT03221842|75983204|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
42175923|NCT03221842|75983203|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
42175924|NCT03221842|75983204|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
42175925|NCT03221842|75983203|FG000|Period 1 (Open-label)|Other|2|||
42175926|NCT03221842|75983204|FG001|Period 1 (Open-label)|Other|0|||
42175927|NCT03221842|75983203|FG000|Period 2 (Randomized, Blinded)|Death|0|||
42175928|NCT03221842|75983204|FG001|Period 2 (Randomized, Blinded)|Death|1|||
42175929|NCT03221842|75983203|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
42175930|NCT03221842|75983204|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
42175931|NCT03364738|75983214|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
42175932|NCT03364738|75983214|FG000|Overall Study|Withdrawal by Subject|1|||
42175933|NCT03364738|75983214|FG000|Overall Study|Adverse Event|1|||
42175934|NCT00303329|75983221|FG000|Overall Study|Adverse Event|7|||
42175935|NCT00303329|75983222|FG001|Overall Study|Adverse Event|14|||
42068572|NCT00742209|75878394|FG004|Overall Study|Adverse Event|13|||
42175936|NCT00303329|75983221|FG000|Overall Study|Abnormal Laboratory Values|0|||
42292535|NCT01593254|76126367|FG001|Overall Study|Poor/non compliance|1|||
42068573|NCT00742209|75878390|FG000|Overall Study|Participant Withdrew Consent|8|||
42068574|NCT00742209|75878391|FG001|Overall Study|Participant Withdrew Consent|4|||
42068575|NCT00742209|75878392|FG002|Overall Study|Participant Withdrew Consent|14|||
42068576|NCT00742209|75878393|FG003|Overall Study|Participant Withdrew Consent|7|||
42175937|NCT00303329|75983222|FG001|Overall Study|Abnormal Laboratory Values|1|||
42175938|NCT00303329|75983221|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
42175939|NCT00303329|75983222|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42175940|NCT00303329|75983221|FG000|Overall Study|Condition no longer requires study drug|0|||
42175941|NCT00303329|75983222|FG001|Overall Study|Condition no longer requires study drug|8|||
42175942|NCT00303329|75983221|FG000|Overall Study|Protocol Violation|3|||
42175943|NCT00303329|75983222|FG001|Overall Study|Protocol Violation|0|||
42175944|NCT00303329|75983221|FG000|Overall Study|Withdrawal by Subject|9|||
42175945|NCT00303329|75983222|FG001|Overall Study|Withdrawal by Subject|15|||
42175946|NCT00303329|75983221|FG000|Overall Study|Lost to Follow-up|0|||
42175947|NCT00303329|75983222|FG001|Overall Study|Lost to Follow-up|1|||
42175948|NCT00303329|75983221|FG000|Overall Study|Administrative problems|1|||
42175949|NCT00303329|75983222|FG001|Overall Study|Administrative problems|0|||
42175950|NCT00303329|75983221|FG000|Overall Study|Death|2|||
42175951|NCT00303329|75983222|FG001|Overall Study|Death|12|||
42175952|NCT00303329|75983221|FG000|Overall Study|Stopped at end of core|3|||
42175953|NCT00303329|75983222|FG001|Overall Study|Stopped at end of core|9|||
42175954|NCT00303329|75983221|FG000|Overall Study|Stopped at end of extension 1|1|||
42175955|NCT00303329|75983222|FG001|Overall Study|Stopped at end of extension 1|0|||
42175956|NCT00329849|75983230|FG000|Overall Study|Withdrawal by Subject|6|||
42175957|NCT00329849|75983231|FG001|Overall Study|Withdrawal by Subject|4|||
42175958|NCT02934178|75983243|FG000|Received Vaccination 2|Death|0|||
42175959|NCT02934178|75983244|FG001|Received Vaccination 2|Death|1|||
42175960|NCT02934178|75983243|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
42175961|NCT02934178|75983244|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
42292536|NCT01593254|76126366|FG000|Overall Study|Pregnancy|0|||
42292537|NCT01593254|76126367|FG001|Overall Study|Pregnancy|3|||
42292538|NCT01593254|76126366|FG000|Overall Study|participant no longer meets study criteria|1|||
42292539|NCT01593254|76126367|FG001|Overall Study|participant no longer meets study criteria|1|||
42292540|NCT01593254|76126366|FG000|Overall Study|Admin reason by sponsor|7|||
42175962|NCT00329303|75983253|FG000|Overall Study|Lack of Efficacy|1|||
42175963|NCT00329303|75983254|FG001|Overall Study|Lack of Efficacy|0|||
42175964|NCT00329303|75983253|FG000|Overall Study|Decision of the sponsor|0|||
42175965|NCT00329303|75983254|FG001|Overall Study|Decision of the sponsor|1|||
42175966|NCT00329303|75983253|FG000|Overall Study|Patient no longer available|1|||
42175967|NCT00329303|75983254|FG001|Overall Study|Patient no longer available|0|||
42175968|NCT00329303|75983253|FG000|Overall Study|Patient relocated|0|||
42175969|NCT00329303|75983254|FG001|Overall Study|Patient relocated|1|||
42175970|NCT03216850|75983261|FG000|Overall Study|Pre-analytical error|6|||
42175971|NCT00302159|75983265|FG000|Overall Study|pt declined before treatment started|1|||
42175972|NCT00302159|75983265|FG000|Overall Study|pt started Avastin|1|||
42175973|NCT00302081|75983273|FG000|Overall Study|Adverse Event|6|||
42175974|NCT00302081|75983274|FG001|Overall Study|Adverse Event|5|||
42175975|NCT00302081|75983275|FG002|Overall Study|Adverse Event|4|||
42175976|NCT00302081|75983273|FG000|Overall Study|Lost to Follow-up|21|||
42175977|NCT00302081|75983274|FG001|Overall Study|Lost to Follow-up|18|||
42175978|NCT00302081|75983275|FG002|Overall Study|Lost to Follow-up|28|||
42175979|NCT00302081|75983273|FG000|Overall Study|Withdrawal by Subject|8|||
42175980|NCT00302081|75983274|FG001|Overall Study|Withdrawal by Subject|12|||
42175981|NCT00302081|75983275|FG002|Overall Study|Withdrawal by Subject|8|||
42175982|NCT00302081|75983273|FG000|Overall Study|Protocol Violation|5|||
42175983|NCT00302081|75983274|FG001|Overall Study|Protocol Violation|1|||
42175984|NCT00302081|75983275|FG002|Overall Study|Protocol Violation|2|||
42175985|NCT00302081|75983273|FG000|Overall Study|Lack of Efficacy|1|||
42175986|NCT00302081|75983274|FG001|Overall Study|Lack of Efficacy|0|||
42175987|NCT00302081|75983275|FG002|Overall Study|Lack of Efficacy|5|||
42175988|NCT00302081|75983273|FG000|Overall Study|Death|2|||
42175989|NCT00302081|75983274|FG001|Overall Study|Death|1|||
42175990|NCT00302081|75983275|FG002|Overall Study|Death|0|||
42175991|NCT00302081|75983273|FG000|Overall Study|Other|13|||
42175992|NCT00302081|75983274|FG001|Overall Study|Other|6|||
42175993|NCT00302081|75983275|FG002|Overall Study|Other|5|||
42175994|NCT00302003|75983283|FG000|Overall Study|Lack of Efficacy|62|||
42292541|NCT01593254|76126367|FG001|Overall Study|Admin reason by sponsor|3|||
42292542|NCT01593254|76126366|FG000|Overall Study|Imatinib treatment failure|2|||
42292543|NCT01593254|76126367|FG001|Overall Study|Imatinib treatment failure|0|||
42292544|NCT01593254|76126366|FG000|Overall Study|Other Reasons|61|||
42292545|NCT01593254|76126367|FG001|Overall Study|Other Reasons|115|||
42292546|NCT01559818|76126374|FG000|Overall Study|Physician Decision|1|||
42292547|NCT01559818|76126374|FG000|Overall Study|Pregnancy|1|||
42292548|NCT01559818|76126374|FG000|Overall Study|Study terminated by Sponsor|4|||
42175995|NCT00302003|75983283|FG000|Overall Study|Lost to Follow-up|1|||
42017001|NCT01134939|75824553|FG002|Overall Study|Death|0|||
42175996|NCT00302003|75983283|FG000|Overall Study|Physician Decision|2|||
42175997|NCT00302003|75983283|FG000|Overall Study|Withdrawal by Subject|5|||
42175998|NCT00302003|75983283|FG000|Overall Study|Ineligible|9|||
42175999|NCT00302003|75983283|FG000|Overall Study|Protocol Violation|1|||
42176000|NCT00036270|75983289|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
42176001|NCT00036270|75983290|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
42292549|NCT01559818|76126374|FG000|Overall Study|Withdrawal by Subject|1|||
42017002|NCT01134939|75824554|FG003|Overall Study|Death|0|||
42017003|NCT01134939|75824555|FG004|Overall Study|Death|0|||
42176002|NCT00036270|75983289|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
42176003|NCT00036270|75983290|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
42292550|NCT01454934|76126381|FG000|Overall Study|Clinical progression|28|||
42292551|NCT01454934|76126382|FG001|Overall Study|Clinical progression|25|||
42176004|NCT00036270|75983289|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
42176005|NCT00036270|75983290|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
42176006|NCT00036270|75983289|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
42176007|NCT00036270|75983290|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
42176008|NCT00036270|75983289|FG000|Study Treatment to 5 Year Report|Other|277|||
42176009|NCT00036270|75983290|FG001|Study Treatment to 5 Year Report|Other|288|||
42176010|NCT00036270|75983289|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
42176011|NCT00036270|75983290|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
42176012|NCT00036270|75983289|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
42176013|NCT00036270|75983290|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
42176014|NCT00036270|75983289|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
42176015|NCT00036270|75983290|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
42176016|NCT00036270|75983289|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
42176017|NCT00036270|75983290|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
42176018|NCT00036270|75983289|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
42176019|NCT00036270|75983290|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
42292552|NCT01454934|76126381|FG000|Overall Study|Other|6|||
42292553|NCT01454934|76126382|FG001|Overall Study|Other|17|||
42292554|NCT01454934|76126381|FG000|Overall Study|Adverse Event|28|||
42292555|NCT01454934|76126382|FG001|Overall Study|Adverse Event|24|||
42292556|NCT01454934|76126381|FG000|Overall Study|Withdrawn consent|2|||
42292557|NCT01454934|76126382|FG001|Overall Study|Withdrawn consent|5|||
42292558|NCT01454934|76126381|FG000|Overall Study|Withdrawal by Subject|11|||
42292559|NCT01454934|76126382|FG001|Overall Study|Withdrawal by Subject|15|||
42292560|NCT01454934|76126381|FG000|Overall Study|Disease progression|194|||
42292561|NCT01454934|76126382|FG001|Overall Study|Disease progression|181|||
42292562|NCT01454934|76126381|FG000|Overall Study|Lost to Follow-up|0|||
42292563|NCT01454934|76126382|FG001|Overall Study|Lost to Follow-up|1|||
42292564|NCT01454934|76126381|FG000|Overall Study|Not treated|1|||
42357548|NCT01748552|76202976|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
42357549|NCT01748552|76202977|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
42357550|NCT01748552|76202978|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
42357551|NCT01748552|76202979|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
42357552|NCT01748552|76202980|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
42357553|NCT01748552|76202981|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
42357554|NCT01748552|76202982|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
42357555|NCT01748552|76202983|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
42357556|NCT01748162|76203025|FG000|Overall Study|no additional croup episodes to evaluate|2|||
42068577|NCT00742209|75878394|FG004|Overall Study|Participant Withdrew Consent|4|||
42068578|NCT00742209|75878390|FG000|Overall Study|Protocol Violation|6|||
42068579|NCT00742209|75878391|FG001|Overall Study|Protocol Violation|5|||
42068580|NCT00742209|75878392|FG002|Overall Study|Protocol Violation|4|||
42068581|NCT00742209|75878393|FG003|Overall Study|Protocol Violation|5|||
42068582|NCT00742209|75878394|FG004|Overall Study|Protocol Violation|3|||
42068583|NCT00742209|75878390|FG000|Overall Study|Lost to Follow-up|3|||
42068584|NCT00742209|75878391|FG001|Overall Study|Lost to Follow-up|4|||
42068585|NCT00742209|75878392|FG002|Overall Study|Lost to Follow-up|5|||
42068586|NCT00742209|75878393|FG003|Overall Study|Lost to Follow-up|5|||
42068587|NCT00742209|75878394|FG004|Overall Study|Lost to Follow-up|3|||
42068588|NCT00742209|75878390|FG000|Overall Study|Lack of Efficacy|6|||
42068589|NCT00742209|75878391|FG001|Overall Study|Lack of Efficacy|1|||
42068590|NCT00742209|75878392|FG002|Overall Study|Lack of Efficacy|1|||
42068591|NCT00742209|75878393|FG003|Overall Study|Lack of Efficacy|3|||
42068592|NCT00742209|75878394|FG004|Overall Study|Lack of Efficacy|1|||
42068593|NCT00742209|75878390|FG000|Overall Study|Investigator Discretion|0|||
42068594|NCT00742209|75878391|FG001|Overall Study|Investigator Discretion|0|||
42068595|NCT00742209|75878392|FG002|Overall Study|Investigator Discretion|5|||
42068596|NCT00742209|75878393|FG003|Overall Study|Investigator Discretion|1|||
42068597|NCT00742209|75878394|FG004|Overall Study|Investigator Discretion|1|||
42068598|NCT00741819|75878407|FG000|Overall Study|Adverse Event|3|||
42068599|NCT00741819|75878407|FG000|Overall Study|Withdrawal by Subject|3|||
42068600|NCT00741819|75878407|FG000|Overall Study|Death|1|||
42068601|NCT00741819|75878407|FG000|Overall Study|Disease progression|1|||
42068602|NCT00924443|75878413|FG000|Overall Study|Physician Decision|2|||
42292565|NCT01454934|76126382|FG001|Overall Study|Not treated|2|||
42292566|NCT01439282|76126390|FG000|Overall Study|Adverse Event|5|||
42292567|NCT01439282|76126391|FG001|Overall Study|Adverse Event|0|||
42292568|NCT01439282|76126390|FG000|Overall Study|Withdrawal by Subject|2|||
42357557|NCT01748162|76203026|FG001|Overall Study|no additional croup episodes to evaluate|2|||
42357558|NCT01748162|76203025|FG000|Overall Study|participant consented but did not begin|0|||
42357559|NCT01748162|76203026|FG001|Overall Study|participant consented but did not begin|1|||
42176020|NCT00036270|75983289|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
42176021|NCT00036270|75983290|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
42176022|NCT00301067|75983296|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
42176023|NCT00301067|75983297|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
42176024|NCT00301067|75983298|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
42176025|NCT00301067|75983299|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
42176026|NCT00301067|75983296|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
42176027|NCT00301067|75983297|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
42176028|NCT00301067|75983298|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
42176029|NCT00301067|75983299|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
42176030|NCT00301067|75983296|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
42176031|NCT00301067|75983297|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
42176032|NCT00301067|75983298|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
42176033|NCT00301067|75983299|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
42176034|NCT00301067|75983296|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
42176035|NCT00301067|75983297|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
42176036|NCT00301067|75983298|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
42176037|NCT00301067|75983299|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
42176038|NCT00301067|75983296|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
42176039|NCT00301067|75983297|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
42292569|NCT01439282|76126391|FG001|Overall Study|Withdrawal by Subject|0|||
42292570|NCT01439282|76126390|FG000|Overall Study|Other|1|||
42292571|NCT01439282|76126391|FG001|Overall Study|Other|1|||
42292572|NCT01326312|76126401|FG000|Overall Study|Adverse Event|11|||
42292573|NCT01326312|76126402|FG001|Overall Study|Adverse Event|11|||
42292574|NCT01326312|76126403|FG002|Overall Study|Adverse Event|1|||
42292575|NCT01326312|76126401|FG000|Overall Study|Withdrawal by Subject|1|||
42292576|NCT01326312|76126402|FG001|Overall Study|Withdrawal by Subject|2|||
42292577|NCT01326312|76126403|FG002|Overall Study|Withdrawal by Subject|1|||
42292578|NCT01326312|76126401|FG000|Overall Study|Protocol Violation|0|||
42292579|NCT01326312|76126402|FG001|Overall Study|Protocol Violation|1|||
42292580|NCT01326312|76126403|FG002|Overall Study|Protocol Violation|0|||
42176040|NCT00301067|75983298|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
42357560|NCT01748162|76203025|FG000|Overall Study|reasons not available|3|||
42357561|NCT01748162|76203026|FG001|Overall Study|reasons not available|2|||
42357562|NCT01724216|76203032|FG000|Overall Study|Scan was not completed|1|||
42357563|NCT01723904|76203036|FG000|Overall Study|Noncompliant|3|||
42292581|NCT01326312|76126401|FG000|Overall Study|Lack of Efficacy|13|||
42292582|NCT01326312|76126402|FG001|Overall Study|Lack of Efficacy|7|||
42292583|NCT01326312|76126403|FG002|Overall Study|Lack of Efficacy|1|||
42292584|NCT01326312|76126401|FG000|Overall Study|Death|1|||
42292585|NCT01326312|76126402|FG001|Overall Study|Death|0|||
42357564|NCT01723904|76203036|FG000|Overall Study|Adverse Event|5|||
42357565|NCT01723904|76203036|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
42357566|NCT01747772|76203040|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
42357567|NCT01830127|76203050|FG000|Overall Study|Adverse Event|1|||
42357568|NCT01830127|76203051|FG001|Overall Study|Adverse Event|6|||
42068603|NCT00924443|75878413|FG000|Overall Study|Protocol Violation|1|||
42068604|NCT00924287|75878417|FG000|Overall Study|Death|1|||
42068605|NCT00923975|75878421|FG000|Overall Study|Did not meet inclusion criteria|1|||
42068606|NCT00918203|75878457|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
42068607|NCT00918203|75878458|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
42068608|NCT00918203|75878459|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
42068609|NCT00918203|75878457|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
42068610|NCT00918203|75878458|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
42068611|NCT00918203|75878459|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
42068612|NCT00918203|75878457|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
42068613|NCT00918203|75878458|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
42068614|NCT00918203|75878459|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
42068615|NCT00918203|75878457|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
42068616|NCT00918203|75878458|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
42292586|NCT01326312|76126403|FG002|Overall Study|Death|1|||
42292587|NCT01326312|76126401|FG000|Overall Study|progressive disease|0|||
42292588|NCT01326312|76126402|FG001|Overall Study|progressive disease|1|||
42292589|NCT01326312|76126403|FG002|Overall Study|progressive disease|1|||
42292590|NCT01326312|76126401|FG000|Overall Study|Study terminated by Sponsor|8|||
42292591|NCT01326312|76126402|FG001|Overall Study|Study terminated by Sponsor|32|||
42292592|NCT01326312|76126403|FG002|Overall Study|Study terminated by Sponsor|46|||
42357569|NCT01830127|76203050|FG000|Overall Study|Lack of Efficacy|3|||
42357570|NCT01830127|76203051|FG001|Overall Study|Lack of Efficacy|0|||
42357571|NCT01830127|76203050|FG000|Overall Study|Withdrawal by Subject|1|||
42357572|NCT01830127|76203051|FG001|Overall Study|Withdrawal by Subject|1|||
42357573|NCT01830127|76203050|FG000|Overall Study|Other reason not defined above|0|||
42292593|NCT01326312|76126401|FG000|Overall Study|Treatment arm terminated|19|||
42292594|NCT01326312|76126402|FG001|Overall Study|Treatment arm terminated|0|||
42292595|NCT01326312|76126403|FG002|Overall Study|Treatment arm terminated|0|||
42292596|NCT01326312|76126401|FG000|Overall Study|QTc > 500|0|||
42357574|NCT01830127|76203051|FG001|Overall Study|Other reason not defined above|2|||
42357575|NCT01614067|76203059|FG000|Overall Study|Pregnancy|1|||
42357576|NCT01614067|76203060|FG001|Overall Study|Pregnancy|0|||
42357577|NCT01614067|76203059|FG000|Overall Study|Physician Decision|6|||
42357578|NCT01614067|76203060|FG001|Overall Study|Physician Decision|5|||
42357579|NCT01614067|76203059|FG000|Overall Study|Withdrawal by Subject|0|||
42357580|NCT01614067|76203060|FG001|Overall Study|Withdrawal by Subject|1|||
42357581|NCT01614067|76203059|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
42357582|NCT01614067|76203060|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
42357583|NCT01777490|76203070|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
42357584|NCT01777490|76203071|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
42176041|NCT00301067|75983299|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
42176042|NCT00301067|75983296|FG000|Follow up Until Death|Alive at last data cut point|1|||
42176043|NCT00301067|75983297|FG001|Follow up Until Death|Alive at last data cut point|0|||
42176044|NCT00301067|75983298|FG002|Follow up Until Death|Alive at last data cut point|0|||
42176045|NCT00301067|75983299|FG003|Follow up Until Death|Alive at last data cut point|1|||
42176046|NCT00007020|75983310|FG000|Overall Study|Death|16|||
42176047|NCT00007020|75983310|FG000|Overall Study|Lost to Follow-up|13|||
42176048|NCT00007020|75983310|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
42176049|NCT00007020|75983310|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
42176050|NCT00007020|75983310|FG000|Overall Study|Pt cared for by outside physician|4|||
42176051|NCT00007020|75983310|FG000|Overall Study|No evidence of treatment|6|||
42176052|NCT00300755|75983319|FG000|Overall Study|Adverse Event|1|||
42176053|NCT00300755|75983320|FG001|Overall Study|Adverse Event|2|||
42176054|NCT00300755|75983321|FG002|Overall Study|Adverse Event|1|||
42176055|NCT00300755|75983319|FG000|Overall Study|Withdrawal by Subject|0|||
42176056|NCT00300755|75983320|FG001|Overall Study|Withdrawal by Subject|2|||
42176057|NCT00300755|75983321|FG002|Overall Study|Withdrawal by Subject|0|||
42176058|NCT00300755|75983319|FG000|Overall Study|Protocol Violation|0|||
42176059|NCT00300755|75983320|FG001|Overall Study|Protocol Violation|0|||
42176060|NCT00300755|75983321|FG002|Overall Study|Protocol Violation|1|||
42176061|NCT00033540|75983329|FG000|Overall Study|Adverse Event|14|||
42176062|NCT00033540|75983329|FG000|Overall Study|Death|1|||
42176063|NCT00033540|75983329|FG000|Overall Study|Progression|26|||
42176064|NCT00033540|75983329|FG000|Overall Study|Withdrawal by Subject|6|||
42176065|NCT00033540|75983329|FG000|Overall Study|Other|5|||
42292597|NCT01326312|76126402|FG001|Overall Study|QTc > 500|1|||
42176066|NCT00033540|75983329|FG000|Overall Study|Ineligible|3|||
42176067|NCT00033540|75983329|FG000|Overall Study|Never received treatment|2|||
42176068|NCT00300365|75983336|FG000|Overall Study|Lost to Follow-up|1|||
42176069|NCT00300365|75983337|FG001|Overall Study|Lost to Follow-up|0|||
42176070|NCT00300365|75983336|FG000|Overall Study|Physician Decision|2|||
42176071|NCT00300365|75983337|FG001|Overall Study|Physician Decision|0|||
42176072|NCT00300365|75983336|FG000|Overall Study|Withdrawal by Subject|1|||
42176073|NCT00300365|75983337|FG001|Overall Study|Withdrawal by Subject|0|||
42176074|NCT00300365|75983336|FG000|Overall Study|Adverse Event|0|||
42176075|NCT00300365|75983337|FG001|Overall Study|Adverse Event|2|||
42176076|NCT00048048|75983352|FG000|Core Treatment|Withdrawal by Subject|0|||
42176077|NCT00048048|75983353|FG001|Core Treatment|Withdrawal by Subject|0|||
42176078|NCT00048048|75983354|FG002|Core Treatment|Withdrawal by Subject|1|||
42176079|NCT00048048|75983355|FG003|Core Treatment|Withdrawal by Subject|0|||
42176080|NCT00048048|75983356|FG004|Core Treatment|Withdrawal by Subject|0|||
42176081|NCT00048048|75983357|FG005|Core Treatment|Withdrawal by Subject|0|||
42176082|NCT00048048|75983358|FG006|Core Treatment|Withdrawal by Subject|0|||
42176083|NCT00048048|75983359|FG007|Core Treatment|Withdrawal by Subject|0|||
42176084|NCT00048048|75983360|FG008|Core Treatment|Withdrawal by Subject|0|||
42176085|NCT00048048|75983361|FG009|Core Treatment|Withdrawal by Subject|0|||
42292598|NCT01326312|76126403|FG002|Overall Study|QTc > 500|0|||
42292599|NCT01269346|76126425|FG000|Treatment Phase|Disease progression|3|||
42292600|NCT01269346|76126425|FG000|Treatment Phase|Adverse Event|3|||
42292601|NCT01269346|76126425|FG000|Treatment Phase|Withdrawal by Subject|1|||
42292602|NCT01269346|76126425|FG000|Treatment Phase|Other|2|||
42176086|NCT00048048|75983362|FG010|Core Treatment|Withdrawal by Subject|0|||
42176087|NCT00048048|75983363|FG011|Core Treatment|Withdrawal by Subject|0|||
42292603|NCT01269346|76126425|FG000|Extension Phase|Adverse Event|6|||
42292604|NCT01269346|76126425|FG000|Extension Phase|Withdrawal by Subject|4|||
42292605|NCT01269346|76126425|FG000|Extension Phase|Disease progression|22|||
42292606|NCT01269346|76126425|FG000|Extension Phase|Physician decision or participant choice|9|||
42176088|NCT00048048|75983352|FG000|Core Treatment|Adverse Event|0|||
42176089|NCT00048048|75983353|FG001|Core Treatment|Adverse Event|0|||
42357585|NCT01777490|76203072|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
42176090|NCT00048048|75983354|FG002|Core Treatment|Adverse Event|0|||
42176091|NCT00048048|75983355|FG003|Core Treatment|Adverse Event|0|||
42176092|NCT00048048|75983356|FG004|Core Treatment|Adverse Event|0|||
42176093|NCT00048048|75983357|FG005|Core Treatment|Adverse Event|0|||
42176094|NCT00048048|75983358|FG006|Core Treatment|Adverse Event|0|||
42176095|NCT00048048|75983359|FG007|Core Treatment|Adverse Event|1|||
42176096|NCT00048048|75983360|FG008|Core Treatment|Adverse Event|0|||
42176097|NCT00048048|75983361|FG009|Core Treatment|Adverse Event|0|||
42068617|NCT00918203|75878459|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
42068618|NCT00918281|75878471|FG000|Overall Study|Physician Decision|29|||
42068619|NCT02770716|75878480|FG000|Overall Study|Death|101|||
42176098|NCT00048048|75983362|FG010|Core Treatment|Adverse Event|0|||
42176099|NCT00048048|75983363|FG011|Core Treatment|Adverse Event|0|||
42176100|NCT00048048|75983352|FG000|Extension Year 1|Early withdrawals|0|||
42176101|NCT00048048|75983353|FG001|Extension Year 1|Early withdrawals|0|||
42176102|NCT00048048|75983354|FG002|Extension Year 1|Early withdrawals|0|||
42176103|NCT00048048|75983355|FG003|Extension Year 1|Early withdrawals|0|||
42176104|NCT00048048|75983356|FG004|Extension Year 1|Early withdrawals|0|||
42176105|NCT00048048|75983357|FG005|Extension Year 1|Early withdrawals|0|||
42176106|NCT00048048|75983358|FG006|Extension Year 1|Early withdrawals|0|||
42176107|NCT00048048|75983359|FG007|Extension Year 1|Early withdrawals|0|||
42176108|NCT00048048|75983360|FG008|Extension Year 1|Early withdrawals|0|||
42176109|NCT00048048|75983361|FG009|Extension Year 1|Early withdrawals|2|||
42176110|NCT00048048|75983362|FG010|Extension Year 1|Early withdrawals|2|||
42176111|NCT00048048|75983363|FG011|Extension Year 1|Early withdrawals|4|||
42176112|NCT00048048|75983352|FG000|Extension Year 2|Early withdrawals|0|||
42176113|NCT00048048|75983353|FG001|Extension Year 2|Early withdrawals|0|||
42176114|NCT00048048|75983354|FG002|Extension Year 2|Early withdrawals|0|||
42176115|NCT00048048|75983355|FG003|Extension Year 2|Early withdrawals|0|||
42176116|NCT00048048|75983356|FG004|Extension Year 2|Early withdrawals|0|||
42176117|NCT00048048|75983357|FG005|Extension Year 2|Early withdrawals|0|||
42176118|NCT00048048|75983358|FG006|Extension Year 2|Early withdrawals|0|||
42176119|NCT00048048|75983359|FG007|Extension Year 2|Early withdrawals|0|||
42176120|NCT00048048|75983360|FG008|Extension Year 2|Early withdrawals|0|||
42176121|NCT00048048|75983361|FG009|Extension Year 2|Early withdrawals|0|||
42176122|NCT00048048|75983362|FG010|Extension Year 2|Early withdrawals|4|||
42176123|NCT00048048|75983363|FG011|Extension Year 2|Early withdrawals|2|||
42176124|NCT00300053|75983393|FG000|Overall Study|Patient/Caregiver Preference|2|||
42176125|NCT00300053|75983394|FG001|Overall Study|Patient/Caregiver Preference|2|||
42176126|NCT00300053|75983395|FG002|Overall Study|Patient/Caregiver Preference|3|||
42176127|NCT00300053|75983393|FG000|Overall Study|Death|0|||
42176128|NCT00300053|75983394|FG001|Overall Study|Death|0|||
42176129|NCT00300053|75983395|FG002|Overall Study|Death|3|||
42176130|NCT00300053|75983393|FG000|Overall Study|Lost to Follow-up|0|||
42176131|NCT00300053|75983394|FG001|Overall Study|Lost to Follow-up|1|||
42176132|NCT00300053|75983395|FG002|Overall Study|Lost to Follow-up|0|||
42176133|NCT00299975|75983407|FG000|Overall Study|Adverse Event|1|||
42176134|NCT00299975|75983408|FG001|Overall Study|Adverse Event|0|||
42176135|NCT00299975|75983409|FG002|Overall Study|Adverse Event|2|||
42176136|NCT00299975|75983407|FG000|Overall Study|Pregnancy|0|||
42176137|NCT00299975|75983408|FG001|Overall Study|Pregnancy|0|||
42176138|NCT00299975|75983409|FG002|Overall Study|Pregnancy|1|||
42176139|NCT00299975|75983407|FG000|Overall Study|Lack of Efficacy|1|||
42176140|NCT00299975|75983408|FG001|Overall Study|Lack of Efficacy|0|||
42176141|NCT00299975|75983409|FG002|Overall Study|Lack of Efficacy|1|||
42176142|NCT00299975|75983407|FG000|Overall Study|Lost to Follow-up|1|||
42176143|NCT00299975|75983408|FG001|Overall Study|Lost to Follow-up|0|||
42176144|NCT00299975|75983409|FG002|Overall Study|Lost to Follow-up|0|||
42176145|NCT00299975|75983407|FG000|Overall Study|Withdrawal by Subject|0|||
42176146|NCT00299975|75983408|FG001|Overall Study|Withdrawal by Subject|1|||
42176147|NCT00299975|75983409|FG002|Overall Study|Withdrawal by Subject|3|||
42176148|NCT00299975|75983407|FG000|Overall Study|Physician Decision|0|||
42176149|NCT00299975|75983408|FG001|Overall Study|Physician Decision|0|||
42176150|NCT00299975|75983409|FG002|Overall Study|Physician Decision|1|||
42176151|NCT00004980|75983419|FG000|Overall Study|Withdrawal by Subject|1|||
42176152|NCT00004980|75983420|FG001|Overall Study|Withdrawal by Subject|0|||
42176153|NCT00004980|75983419|FG000|Overall Study|memory difficulties|1|||
42176154|NCT00004980|75983420|FG001|Overall Study|memory difficulties|1|||
42176155|NCT00004980|75983419|FG000|Overall Study|Physician Decision|0|||
42176156|NCT00004980|75983420|FG001|Overall Study|Physician Decision|1|||
42176157|NCT00326963|75983426|FG000|Overall Study|Adverse Event|2|||
42176158|NCT00326963|75983426|FG000|Overall Study|Injection site reaction|1|||
42068620|NCT02770716|75878481|FG001|Overall Study|Death|45|||
42176159|NCT00326963|75983426|FG000|Overall Study|Death|1|||
42176160|NCT00326963|75983426|FG000|Overall Study|Failure to return|10|||
42176161|NCT00326963|75983426|FG000|Overall Study|Withdrawal by Subject|10|||
42176162|NCT00326963|75983426|FG000|Overall Study|Refused treatment / did not cooperate|5|||
42176163|NCT00326963|75983426|FG000|Overall Study|Violation of selection criteria at entry|2|||
42176164|NCT00326963|75983426|FG000|Overall Study|Other protocol violation|1|||
42176165|NCT00326963|75983426|FG000|Overall Study|Administrative / other|1|||
42176166|NCT00326885|75983431|FG000|Overall Study|Adverse Event|1|||
42176167|NCT00326885|75983431|FG000|Overall Study|Withdrawal by Subject|3|||
42176168|NCT00326885|75983431|FG000|Overall Study|Physician Decision|1|||
42176169|NCT00326885|75983431|FG000|Overall Study|Hospice withdrew consent|2|||
42176170|NCT00326495|75983436|FG000|Overall Study|Switched to alternative treatment|1|||
42176171|NCT00326495|75983436|FG000|Overall Study|Disease progression before treatment|1|||
42176172|NCT00326495|75983436|FG000|Overall Study|Refused further treatment|2|||
42176173|NCT00326495|75983436|FG000|Overall Study|Subject off study before assessment|1|||
42176174|NCT00326417|75983442|FG000|Overall Study|Withdrawal by Subject|0|||
42176175|NCT00326417|75983443|FG001|Overall Study|Withdrawal by Subject|0|||
42176176|NCT00326417|75983444|FG002|Overall Study|Withdrawal by Subject|1|||
42176177|NCT00326417|75983445|FG003|Overall Study|Withdrawal by Subject|0|||
42176178|NCT00326417|75983442|FG000|Overall Study|Arm Closed|7|||
42176179|NCT00326417|75983443|FG001|Overall Study|Arm Closed|0|||
42176180|NCT00326417|75983444|FG002|Overall Study|Arm Closed|0|||
42176181|NCT00326417|75983445|FG003|Overall Study|Arm Closed|3|||
42176182|NCT00326417|75983442|FG000|Overall Study|Death|7|||
42176183|NCT00326417|75983443|FG001|Overall Study|Death|0|||
42176184|NCT00326417|75983444|FG002|Overall Study|Death|0|||
42176185|NCT00326417|75983445|FG003|Overall Study|Death|0|||
42176186|NCT03825341|75983455|FG000|Overall Study|Withdrawal by Subject|0|||
42176187|NCT03825341|75983456|FG001|Overall Study|Withdrawal by Subject|1|||
42176188|NCT00297479|75983467|FG000|Overall Study|Lost to Follow-up|37|||
42176189|NCT00297479|75983468|FG001|Overall Study|Lost to Follow-up|54|||
42176190|NCT00297479|75983469|FG002|Overall Study|Lost to Follow-up|51|||
42176191|NCT00688870|75983479|FG000|Infant Series|Parent or legal guardian request|4|||
42176192|NCT00688870|75983480|FG001|Infant Series|Parent or legal guardian request|0|||
42176193|NCT00297167|75983490|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
42176194|NCT00297167|75983491|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
42176195|NCT00297167|75983492|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
42176196|NCT00297167|75983490|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
42176197|NCT00297167|75983491|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
42176198|NCT00297167|75983492|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
42176199|NCT03216226|75983501|FG000|Overall Study|Adverse Event|3|||
42176200|NCT03216226|75983502|FG001|Overall Study|Adverse Event|0|||
42176201|NCT03216226|75983501|FG000|Overall Study|Protocol Violation|1|||
42176202|NCT03216226|75983502|FG001|Overall Study|Protocol Violation|3|||
42176203|NCT03216226|75983501|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
42176204|NCT03216226|75983502|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
42176205|NCT03216226|75983501|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
42176206|NCT03216226|75983502|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
42176207|NCT03216226|75983501|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
42176208|NCT03216226|75983502|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
42176209|NCT03215758|75983510|FG000|Overall Study|Technical Problems|1|||
42176210|NCT03215758|75983511|FG001|Overall Study|Technical Problems|0|||
42176211|NCT03215758|75983510|FG000|Overall Study|Protocol deviation|0|||
42176212|NCT03215758|75983511|FG001|Overall Study|Protocol deviation|1|||
42176213|NCT03215758|75983510|FG000|Overall Study|Physician Decision|0|||
42176214|NCT03215758|75983511|FG001|Overall Study|Physician Decision|1|||
42176215|NCT03215758|75983510|FG000|Overall Study|Death|0|||
42176216|NCT03215758|75983511|FG001|Overall Study|Death|1|||
42176217|NCT03215758|75983510|FG000|Overall Study|Adverse Event|1|||
42176218|NCT03215758|75983511|FG001|Overall Study|Adverse Event|2|||
42176219|NCT03215758|75983510|FG000|Overall Study|Subject/Guardian Decision|3|||
42176220|NCT03215758|75983511|FG001|Overall Study|Subject/Guardian Decision|3|||
42176221|NCT00290771|75983519|FG000|Overall Study|Disease progression|95|||
42176222|NCT00290771|75983520|FG001|Overall Study|Disease progression|73|||
42176223|NCT00290771|75983519|FG000|Overall Study|Death|11|||
42176224|NCT00290771|75983520|FG001|Overall Study|Death|10|||
42176225|NCT00290771|75983519|FG000|Overall Study|Adverse Event|12|||
42176226|NCT00290771|75983520|FG001|Overall Study|Adverse Event|6|||
42176227|NCT00290771|75983519|FG000|Overall Study|Withdrawal by Subject|5|||
42176228|NCT00290771|75983520|FG001|Overall Study|Withdrawal by Subject|6|||
42176229|NCT00290771|75983519|FG000|Overall Study|Administrative problems|2|||
42176230|NCT00290771|75983520|FG001|Overall Study|Administrative problems|1|||
42176231|NCT00290771|75983519|FG000|Overall Study|Protocol Violation|2|||
42176232|NCT00290771|75983520|FG001|Overall Study|Protocol Violation|0|||
42176233|NCT00290771|75983519|FG000|Overall Study|Lost to Follow-up|0|||
42176234|NCT00290771|75983520|FG001|Overall Study|Lost to Follow-up|1|||
42176235|NCT00274625|75983529|FG000|Overall Study|Lost to Follow-up|46|||
42176236|NCT00274625|75983530|FG001|Overall Study|Lost to Follow-up|54|||
42176237|NCT00274625|75983529|FG000|Overall Study|Excluded from analysis|14|||
42176238|NCT00274625|75983530|FG001|Overall Study|Excluded from analysis|8|||
42176239|NCT00290693|75983536|FG000|Overall Study|Withdrawal by Subject|2|||
42176240|NCT03214666|75983547|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
42176241|NCT03214666|75983548|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
42176242|NCT03214666|75983549|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
42176243|NCT03214666|75983550|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
42176244|NCT03214666|75983551|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
42176245|NCT03214666|75983552|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
42176246|NCT00274469|75983569|FG000|Overall Study|Death|63|||
42176247|NCT00274469|75983570|FG001|Overall Study|Death|74|||
42176248|NCT00274469|75983569|FG000|Overall Study|Did not consent to OS follow-up|16|||
42176249|NCT00274469|75983570|FG001|Overall Study|Did not consent to OS follow-up|19|||
42176250|NCT03214588|75983579|FG000|Overall Study|Adverse Event|1|||
42176251|NCT03214588|75983580|FG001|Overall Study|Adverse Event|0|||
42176252|NCT03214588|75983581|FG002|Overall Study|Adverse Event|2|||
42176253|NCT03214588|75983579|FG000|Overall Study|Reason Not Specified|0|||
42176254|NCT03214588|75983580|FG001|Overall Study|Reason Not Specified|1|||
42176255|NCT03214588|75983581|FG002|Overall Study|Reason Not Specified|0|||
42176256|NCT03166618|75983591|FG000|Overall Study|Study was Terminated|0|||
42176257|NCT03166618|75983592|FG001|Overall Study|Study was Terminated|1|||
42176258|NCT03162796|75983609|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
42176259|NCT03162796|75983610|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
42176260|NCT03162796|75983611|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
42176261|NCT03162796|75983609|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
42176262|NCT03162796|75983610|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
42176263|NCT03162796|75983611|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
42176264|NCT03162796|75983609|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
42176265|NCT03162796|75983610|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
42176266|NCT03162796|75983611|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
42176267|NCT03162796|75983609|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
42176268|NCT03162796|75983610|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
42176269|NCT03162796|75983611|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
42176270|NCT03162796|75983609|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
42176271|NCT03162796|75983610|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
42176272|NCT03162796|75983611|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
42176273|NCT03162796|75983609|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
42176274|NCT03162796|75983610|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
42176275|NCT03162796|75983611|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
42176276|NCT03162796|75983609|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
42176277|NCT03162796|75983610|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
42176278|NCT03162796|75983611|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
42176279|NCT03162796|75983609|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
42176280|NCT03162796|75983610|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
42176281|NCT03162796|75983611|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
42176282|NCT03162796|75983609|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
42176283|NCT03162796|75983610|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
42176284|NCT03162796|75983611|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
42176285|NCT03162796|75983609|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
42176286|NCT03162796|75983610|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
42292607|NCT01269346|76126425|FG000|Extension Phase|Clinical progression|1|||
42292608|NCT01269346|76126425|FG000|Extension Phase|Started a prohibited con med|1|||
42292609|NCT01268293|76126430|FG000|Overall Study|Disease progression|7|||
42292610|NCT01268293|76126430|FG000|Overall Study|Adverse Event|1|||
42017004|NCT01134939|75824556|FG005|Overall Study|Death|0|||
42017005|NCT01134939|75824557|FG006|Overall Study|Death|0|||
42017006|NCT01134939|75824558|FG007|Overall Study|Death|0|||
42017007|NCT01134939|75824551|FG000|Overall Study|Termination page not available|4|||
42017008|NCT01134939|75824552|FG001|Overall Study|Termination page not available|6|||
42017009|NCT01134939|75824553|FG002|Overall Study|Termination page not available|5|||
42017010|NCT01134939|75824554|FG003|Overall Study|Termination page not available|8|||
42017011|NCT01134939|75824555|FG004|Overall Study|Termination page not available|0|||
42017012|NCT01134939|75824556|FG005|Overall Study|Termination page not available|3|||
42017013|NCT01134939|75824557|FG006|Overall Study|Termination page not available|7|||
42017014|NCT01134939|75824558|FG007|Overall Study|Termination page not available|0|||
42017015|NCT01134783|75824574|FG000|Overall Study|Pregnancy|16|||
42017016|NCT01134783|75824575|FG001|Overall Study|Pregnancy|8|||
42017017|NCT01134783|75824574|FG000|Overall Study|Withdrawal by Subject|15|||
42176287|NCT03162796|75983611|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
42176288|NCT03162796|75983609|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
42176289|NCT03162796|75983610|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
42017018|NCT01134783|75824575|FG001|Overall Study|Withdrawal by Subject|9|||
42068621|NCT02770716|75878480|FG000|Overall Study|Withdrawal by Subject|4|||
42068622|NCT02770716|75878481|FG001|Overall Study|Withdrawal by Subject|2|||
42068623|NCT02770716|75878480|FG000|Overall Study|Lost to Follow-up|1|||
42068624|NCT02770716|75878481|FG001|Overall Study|Lost to Follow-up|0|||
42068625|NCT02770716|75878480|FG000|Overall Study|Various reasons|6|||
42068626|NCT02770716|75878481|FG001|Overall Study|Various reasons|2|||
42068627|NCT00917579|75878487|FG000|Washout >= 2 Weeks|Adverse Event|1|||
42068628|NCT00917579|75878488|FG001|Washout >= 2 Weeks|Adverse Event|0|||
42068629|NCT00917579|75878487|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
42068630|NCT00917579|75878488|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
42068631|NCT00915551|75878496|FG000|Overall Study|Withdrawal by Subject|0|||
42068632|NCT00915551|75878497|FG001|Overall Study|Withdrawal by Subject|1|||
42068633|NCT00915473|75878505|FG000|Screening|Withdrawal by Subject|1|||
42068634|NCT00915473|75878506|FG001|Screening|Withdrawal by Subject|0|||
42068635|NCT00915473|75878505|FG000|4-week Follow Up|Lost to Follow-up|1|||
42068636|NCT00915473|75878506|FG001|4-week Follow Up|Lost to Follow-up|5|||
42068637|NCT00917501|75878514|FG000|Overall Study|Lost to Follow-up|4|||
42068638|NCT00917501|75878515|FG001|Overall Study|Lost to Follow-up|1|||
42068639|NCT00917501|75878514|FG000|Overall Study|Withdrawal by Subject|3|||
42068640|NCT00917501|75878515|FG001|Overall Study|Withdrawal by Subject|1|||
42068641|NCT00917501|75878514|FG000|Overall Study|Lack of Efficacy|1|||
42068642|NCT00917501|75878515|FG001|Overall Study|Lack of Efficacy|2|||
42068643|NCT00917501|75878514|FG000|Overall Study|trouble swollowing capsules|0|||
42068644|NCT00917501|75878515|FG001|Overall Study|trouble swollowing capsules|1|||
42068645|NCT00917267|75878534|FG000|Overall Study|Adverse Event|15|||
42068646|NCT00917267|75878535|FG001|Overall Study|Adverse Event|36|||
42068647|NCT00917267|75878534|FG000|Overall Study|Physician Decision|2|||
42068648|NCT00917267|75878535|FG001|Overall Study|Physician Decision|4|||
42068649|NCT00917267|75878534|FG000|Overall Study|Protocol Violation|9|||
42068650|NCT00917267|75878535|FG001|Overall Study|Protocol Violation|18|||
42068651|NCT00917267|75878534|FG000|Overall Study|Withdrawal by Subject|5|||
42068652|NCT00917267|75878535|FG001|Overall Study|Withdrawal by Subject|12|||
42068653|NCT00917267|75878534|FG000|Overall Study|Lost to follow up|0|||
42068654|NCT00917267|75878535|FG001|Overall Study|Lost to follow up|2|||
42068655|NCT00917267|75878534|FG000|Overall Study|Entry Criteria Not Met|1|||
42068656|NCT00917267|75878535|FG001|Overall Study|Entry Criteria Not Met|0|||
42068657|NCT00917267|75878534|FG000|Overall Study|Sponsor Decision|5|||
42068658|NCT00917267|75878535|FG001|Overall Study|Sponsor Decision|5|||
42068659|NCT00917267|75878534|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
42068660|NCT00917267|75878535|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
42068661|NCT00920699|75878548|FG000|Overall Study|Withdrawal by Subject|2|||
42068662|NCT00920699|75878549|FG001|Overall Study|Withdrawal by Subject|0|||
42068663|NCT00920699|75878550|FG002|Overall Study|Withdrawal by Subject|2|||
42068664|NCT00920699|75878548|FG000|Overall Study|no longer met eligibility|0|||
42068665|NCT00920699|75878549|FG001|Overall Study|no longer met eligibility|1|||
42068666|NCT00920699|75878550|FG002|Overall Study|no longer met eligibility|0|||
42068667|NCT00920699|75878548|FG000|Overall Study|Lost to Follow-up|0|||
42068668|NCT00920699|75878549|FG001|Overall Study|Lost to Follow-up|0|||
42068669|NCT00920699|75878550|FG002|Overall Study|Lost to Follow-up|2|||
42068670|NCT03462576|75878561|FG000|Overall Study|Protocol Violation|5|||
42068671|NCT03462576|75878562|FG001|Overall Study|Protocol Violation|11|||
42068672|NCT03462576|75878563|FG002|Overall Study|Protocol Violation|7|||
42068673|NCT03462576|75878561|FG000|Overall Study|Device Malfunction|0|||
42068674|NCT03462576|75878562|FG001|Overall Study|Device Malfunction|0|||
42068675|NCT03462576|75878563|FG002|Overall Study|Device Malfunction|1|||
42068676|NCT00916721|75878573|FG000|Overall Study|Lost to Follow-up|0|||
42017019|NCT01134783|75824574|FG000|Overall Study|Lost to Follow-up|5|||
42017020|NCT01134783|75824575|FG001|Overall Study|Lost to Follow-up|20|||
42017021|NCT01134705|75824587|FG000|Overall Study|Adverse Event|1|||
42292611|NCT01268293|76126430|FG000|Overall Study|Subject choice|1|||
42292612|NCT01268150|76126434|FG000|Treatment Phase|Progression of disease|18|||
42292613|NCT01268150|76126434|FG000|Treatment Phase|Adverse Event|3|||
42292614|NCT01268150|76126434|FG000|Treatment Phase|Withdrawal by Subject|3|||
42017022|NCT01134705|75824588|FG001|Overall Study|Adverse Event|7|||
42017023|NCT01134705|75824587|FG000|Overall Study|Withdrawal by Subject|6|||
42017024|NCT01134705|75824588|FG001|Overall Study|Withdrawal by Subject|6|||
42017025|NCT01134705|75824587|FG000|Overall Study|Pregnancy|1|||
42068677|NCT00916721|75878574|FG001|Overall Study|Lost to Follow-up|1|||
42068678|NCT00916721|75878573|FG000|Overall Study|Adverse Event|6|||
42292615|NCT01268150|76126434|FG000|Treatment Phase|Other|4|||
42292616|NCT01268150|76126434|FG000|Extension Phase|Adverse Event|3|||
42292617|NCT01268150|76126434|FG000|Extension Phase|Disease progression|18|||
42292618|NCT01268150|76126434|FG000|Extension Phase|Other|6|||
42017026|NCT01134705|75824588|FG001|Overall Study|Pregnancy|0|||
42068679|NCT00916721|75878574|FG001|Overall Study|Adverse Event|3|||
42068680|NCT00916721|75878573|FG000|Overall Study|Withdrawal by Subject|2|||
42068681|NCT00916721|75878574|FG001|Overall Study|Withdrawal by Subject|2|||
42068682|NCT00916721|75878573|FG000|Overall Study|Protocol Violation|2|||
42068683|NCT00916721|75878574|FG001|Overall Study|Protocol Violation|4|||
42068684|NCT00915005|75878582|FG000|Overall Study|Withdrawal by Subject|4|||
42068685|NCT00915005|75878583|FG001|Overall Study|Withdrawal by Subject|4|||
42068686|NCT00915005|75878582|FG000|Overall Study|Patient preferred protons therapy|6|||
42068687|NCT00915005|75878583|FG001|Overall Study|Patient preferred protons therapy|0|||
42068688|NCT00915005|75878582|FG000|Overall Study|Insurance denial|3|||
42068689|NCT00915005|75878583|FG001|Overall Study|Insurance denial|15|||
42068690|NCT01143246|75878591|FG000|Overall Study|Adverse Event|24|||
42068691|NCT01143246|75878592|FG001|Overall Study|Adverse Event|28|||
42068692|NCT01143246|75878591|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
42068693|NCT01143246|75878592|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
42068694|NCT01143246|75878591|FG000|Overall Study|Lost to Follow-up|0|||
42068695|NCT01143246|75878592|FG001|Overall Study|Lost to Follow-up|1|||
42068696|NCT01143246|75878591|FG000|Overall Study|Death|16|||
42068697|NCT01143246|75878592|FG001|Overall Study|Death|15|||
42068698|NCT01143246|75878591|FG000|Overall Study|Reason not Specified|3|||
42068699|NCT01143246|75878592|FG001|Overall Study|Reason not Specified|5|||
42068700|NCT00561925|75878606|FG000|14 Day Lead-In Period|Adverse Event|38|||
42068701|NCT00561925|75878607|FG001|14 Day Lead-In Period|Adverse Event|0|||
42068702|NCT00561925|75878608|FG002|14 Day Lead-In Period|Adverse Event|0|||
42068703|NCT00561925|75878609|FG003|14 Day Lead-In Period|Adverse Event|0|||
42068704|NCT00561925|75878610|FG004|14 Day Lead-In Period|Adverse Event|0|||
42068705|NCT00561925|75878606|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
42068706|NCT00561925|75878607|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
42068707|NCT00561925|75878608|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
42068708|NCT00561925|75878609|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
42068709|NCT00561925|75878610|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
42068710|NCT00561925|75878606|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
42068711|NCT00561925|75878607|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
42068712|NCT00561925|75878608|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
42068713|NCT00561925|75878609|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
42068714|NCT00561925|75878610|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
42068715|NCT00561925|75878606|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
42068716|NCT00561925|75878607|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
42068717|NCT00561925|75878608|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
42068718|NCT00561925|75878609|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
42068719|NCT00561925|75878610|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
42068720|NCT00561925|75878606|FG000|14 Day Lead-In Period|Other|5|||
42068721|NCT00561925|75878607|FG001|14 Day Lead-In Period|Other|0|||
42068722|NCT00561925|75878608|FG002|14 Day Lead-In Period|Other|0|||
42068723|NCT00561925|75878609|FG003|14 Day Lead-In Period|Other|0|||
42068724|NCT00561925|75878610|FG004|14 Day Lead-In Period|Other|0|||
42068725|NCT00561925|75878606|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
42068726|NCT00561925|75878607|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
42068727|NCT00561925|75878608|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
42068728|NCT00561925|75878609|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
42068729|NCT00561925|75878610|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
42068730|NCT00561925|75878606|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
42068731|NCT00561925|75878607|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
42068732|NCT00561925|75878608|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
42068733|NCT00561925|75878609|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
42068734|NCT00561925|75878610|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
42068735|NCT00561925|75878606|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
42068736|NCT00561925|75878607|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
42068737|NCT00561925|75878608|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
42068738|NCT00561925|75878609|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
42068739|NCT00561925|75878610|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
42068740|NCT00561925|75878606|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
42068741|NCT00561925|75878607|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
42068742|NCT00561925|75878608|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
42068743|NCT00561925|75878609|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
42068744|NCT00561925|75878610|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
42068745|NCT00561925|75878606|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
42068746|NCT00561925|75878607|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
42068747|NCT00561925|75878608|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
42068748|NCT00561925|75878609|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
42068749|NCT00561925|75878610|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
42068750|NCT00561925|75878606|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
42068751|NCT00561925|75878607|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
42068752|NCT00561925|75878608|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
42068753|NCT00561925|75878609|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
42068754|NCT00561925|75878610|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
42068755|NCT00561925|75878606|FG000|144-week Double-blind, Double-dummy|Death|0|||
42068756|NCT00561925|75878607|FG001|144-week Double-blind, Double-dummy|Death|6|||
42068757|NCT00561925|75878608|FG002|144-week Double-blind, Double-dummy|Death|3|||
42068758|NCT00561925|75878609|FG003|144-week Double-blind, Double-dummy|Death|0|||
42068759|NCT00561925|75878610|FG004|144-week Double-blind, Double-dummy|Death|0|||
42068760|NCT00561925|75878606|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
42068761|NCT00561925|75878607|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
42068762|NCT00561925|75878608|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
42068763|NCT00561925|75878609|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
42068764|NCT00561925|75878610|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
42068765|NCT00561925|75878606|FG000|144-week Double-blind, Double-dummy|Other|0|||
42068766|NCT00561925|75878607|FG001|144-week Double-blind, Double-dummy|Other|8|||
42068767|NCT00561925|75878608|FG002|144-week Double-blind, Double-dummy|Other|11|||
42068768|NCT00561925|75878609|FG003|144-week Double-blind, Double-dummy|Other|0|||
42068769|NCT00561925|75878610|FG004|144-week Double-blind, Double-dummy|Other|0|||
42068770|NCT00561925|75878606|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
42068771|NCT00561925|75878607|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
42068772|NCT00561925|75878608|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
42068773|NCT00561925|75878609|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
42068774|NCT00561925|75878610|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
42068775|NCT00549445|75878630|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
42068776|NCT00549445|75878631|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
42068777|NCT00601107|75878641|FG000|Overall Study|Adverse Event|0|||
42068778|NCT00601107|75878642|FG001|Overall Study|Adverse Event|1|||
42068779|NCT00601107|75878643|FG002|Overall Study|Adverse Event|3|||
42068780|NCT00601107|75878644|FG003|Overall Study|Adverse Event|0|||
42068781|NCT00601107|75878641|FG000|Overall Study|Withdrawal by Subject|5|||
42068782|NCT00601107|75878642|FG001|Overall Study|Withdrawal by Subject|4|||
42068783|NCT00601107|75878643|FG002|Overall Study|Withdrawal by Subject|7|||
42068784|NCT00601107|75878644|FG003|Overall Study|Withdrawal by Subject|4|||
42068785|NCT00601107|75878641|FG000|Overall Study|Lost to Follow-up|3|||
42068786|NCT00601107|75878642|FG001|Overall Study|Lost to Follow-up|3|||
42068787|NCT00601107|75878643|FG002|Overall Study|Lost to Follow-up|0|||
42068788|NCT00601107|75878644|FG003|Overall Study|Lost to Follow-up|3|||
42068789|NCT00601107|75878641|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
42068790|NCT00601107|75878642|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
42068791|NCT00601107|75878643|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
42068792|NCT00601107|75878644|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
42068793|NCT00601107|75878641|FG000|Overall Study|Worsening of Psoriasis|4|||
42357586|NCT01777490|76203073|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
42357587|NCT01397409|76203095|FG000|Stage 2|Adverse Event|0|||
42357588|NCT01397409|76203096|FG001|Stage 2|Adverse Event|0|||
42357589|NCT01397409|76203097|FG002|Stage 2|Adverse Event|0|||
42357590|NCT01397409|76203098|FG003|Stage 2|Adverse Event|0|||
42017027|NCT01134705|75824587|FG000|Overall Study|Lost to Follow-up|5|||
42017028|NCT01134705|75824588|FG001|Overall Study|Lost to Follow-up|2|||
42017029|NCT01134705|75824587|FG000|Overall Study|Protocol Violation|1|||
42017030|NCT01134705|75824588|FG001|Overall Study|Protocol Violation|1|||
42017031|NCT01134705|75824587|FG000|Overall Study|Other|1|||
42017032|NCT01134705|75824588|FG001|Overall Study|Other|6|||
42017033|NCT00927823|75824594|FG000|Continuous Dosing Period|Death|0|||
42017034|NCT00927823|75824595|FG001|Continuous Dosing Period|Death|0|||
42017035|NCT00927823|75824596|FG002|Continuous Dosing Period|Death|6|||
42017036|NCT00927823|75824597|FG003|Continuous Dosing Period|Death|0|||
42017037|NCT00927823|75824594|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
42017038|NCT00927823|75824595|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
42017039|NCT00927823|75824596|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
42017040|NCT00927823|75824597|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
42017041|NCT00927823|75824594|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
42017042|NCT00927823|75824595|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
42017043|NCT00927823|75824596|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
42017044|NCT00927823|75824597|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
42017045|NCT00927823|75824594|FG000|Continuous Dosing Period|Other|1|||
42017046|NCT00927823|75824595|FG001|Continuous Dosing Period|Other|2|||
42017047|NCT00927823|75824596|FG002|Continuous Dosing Period|Other|9|||
42017048|NCT00927823|75824597|FG003|Continuous Dosing Period|Other|3|||
42017049|NCT01134627|75824616|FG000|Overall Study|Adverse Event|47|||
42017050|NCT01134627|75824617|FG001|Overall Study|Adverse Event|31|||
42017051|NCT01134627|75824616|FG000|Overall Study|Lost to Follow-up|1|||
42017052|NCT01134627|75824617|FG001|Overall Study|Lost to Follow-up|2|||
42017053|NCT01134627|75824616|FG000|Overall Study|Protocol Violation|3|||
42017054|NCT01134627|75824617|FG001|Overall Study|Protocol Violation|5|||
42017055|NCT01134627|75824616|FG000|Overall Study|Lack of Efficacy|2|||
42017056|NCT01134627|75824617|FG001|Overall Study|Lack of Efficacy|12|||
42292619|NCT01267175|76126438|FG000|Overall Study|Withdrawal by Subject|1|||
42292620|NCT01267175|76126438|FG000|Overall Study|Lost to Follow-up|1|||
42292621|NCT01133756|76126449|FG000|Overall Study|Adverse Event|1|||
42292622|NCT01133756|76126450|FG001|Overall Study|Adverse Event|2|||
42292623|NCT01133756|76126451|FG002|Overall Study|Adverse Event|1|||
42292624|NCT01133756|76126449|FG000|Overall Study|Investigator Decision|1|||
42292625|NCT01133756|76126450|FG001|Overall Study|Investigator Decision|0|||
42292626|NCT01133756|76126451|FG002|Overall Study|Investigator Decision|0|||
42292627|NCT01133756|76126449|FG000|Overall Study|Withdrawal by Subject|0|||
42292628|NCT01133756|76126450|FG001|Overall Study|Withdrawal by Subject|1|||
42292629|NCT01133756|76126451|FG002|Overall Study|Withdrawal by Subject|0|||
42292630|NCT01133756|76126449|FG000|Overall Study|Progression of Disease|0|||
42292631|NCT01133756|76126450|FG001|Overall Study|Progression of Disease|0|||
42292632|NCT01133756|76126451|FG002|Overall Study|Progression of Disease|1|||
42292633|NCT01126736|76126464|FG000|Overall Study|Death|2|||
42292634|NCT01126736|76126465|FG001|Overall Study|Death|2|||
42292635|NCT01126736|76126466|FG002|Overall Study|Death|1|||
42292636|NCT01126736|76126467|FG003|Overall Study|Death|19|||
42292637|NCT01126736|76126468|FG004|Overall Study|Death|19|||
42292638|NCT01126736|76126464|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
42292639|NCT01126736|76126465|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
42292640|NCT01126736|76126466|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
42357591|NCT01397409|76203099|FG004|Stage 2|Adverse Event|6|||
42357592|NCT01397409|76203100|FG005|Stage 2|Adverse Event|3|||
42357593|NCT01397409|76203101|FG006|Stage 2|Adverse Event|0|||
42357594|NCT01397409|76203102|FG007|Stage 2|Adverse Event|0|||
42357595|NCT01397409|76203103|FG008|Stage 2|Adverse Event|0|||
42357596|NCT01397409|76203104|FG009|Stage 2|Adverse Event|0|||
42357597|NCT01397409|76203095|FG000|Stage 2|Personal Reasons|0|||
42357598|NCT01397409|76203096|FG001|Stage 2|Personal Reasons|0|||
42357599|NCT01397409|76203097|FG002|Stage 2|Personal Reasons|0|||
42357600|NCT01397409|76203098|FG003|Stage 2|Personal Reasons|0|||
42357601|NCT01397409|76203099|FG004|Stage 2|Personal Reasons|1|||
42357602|NCT01397409|76203100|FG005|Stage 2|Personal Reasons|0|||
42357603|NCT01397409|76203101|FG006|Stage 2|Personal Reasons|0|||
42357604|NCT01397409|76203102|FG007|Stage 2|Personal Reasons|0|||
42357605|NCT01397409|76203103|FG008|Stage 2|Personal Reasons|0|||
42357606|NCT01397409|76203104|FG009|Stage 2|Personal Reasons|0|||
42357607|NCT01397409|76203095|FG000|Stage 2|Other Miscellaneous Reasons|0|||
42357608|NCT01397409|76203096|FG001|Stage 2|Other Miscellaneous Reasons|0|||
42357609|NCT01397409|76203097|FG002|Stage 2|Other Miscellaneous Reasons|0|||
42357610|NCT01397409|76203098|FG003|Stage 2|Other Miscellaneous Reasons|0|||
42357611|NCT01397409|76203099|FG004|Stage 2|Other Miscellaneous Reasons|1|||
42357612|NCT01397409|76203100|FG005|Stage 2|Other Miscellaneous Reasons|1|||
42357613|NCT01397409|76203101|FG006|Stage 2|Other Miscellaneous Reasons|0|||
42357614|NCT01397409|76203102|FG007|Stage 2|Other Miscellaneous Reasons|0|||
42357615|NCT01397409|76203103|FG008|Stage 2|Other Miscellaneous Reasons|0|||
42357616|NCT01397409|76203104|FG009|Stage 2|Other Miscellaneous Reasons|0|||
42357617|NCT01397409|76203095|FG000|Stage 3|Adverse Event|0|||
42357618|NCT01397409|76203096|FG001|Stage 3|Adverse Event|0|||
42357619|NCT01397409|76203097|FG002|Stage 3|Adverse Event|0|||
42357620|NCT01397409|76203098|FG003|Stage 3|Adverse Event|0|||
42357621|NCT01397409|76203099|FG004|Stage 3|Adverse Event|0|||
42357622|NCT01397409|76203100|FG005|Stage 3|Adverse Event|0|||
42357623|NCT01397409|76203101|FG006|Stage 3|Adverse Event|0|||
42357624|NCT01397409|76203102|FG007|Stage 3|Adverse Event|1|||
42357625|NCT01397409|76203103|FG008|Stage 3|Adverse Event|0|||
42357626|NCT01397409|76203104|FG009|Stage 3|Adverse Event|0|||
42357627|NCT01397409|76203095|FG000|Stage 3|Other Miscellaneous Reasons|0|||
42357628|NCT01397409|76203096|FG001|Stage 3|Other Miscellaneous Reasons|0|||
42357629|NCT01397409|76203097|FG002|Stage 3|Other Miscellaneous Reasons|0|||
42357630|NCT01397409|76203098|FG003|Stage 3|Other Miscellaneous Reasons|0|||
42357631|NCT01397409|76203099|FG004|Stage 3|Other Miscellaneous Reasons|0|||
42357632|NCT01397409|76203100|FG005|Stage 3|Other Miscellaneous Reasons|0|||
42357633|NCT01397409|76203101|FG006|Stage 3|Other Miscellaneous Reasons|0|||
42357634|NCT01397409|76203102|FG007|Stage 3|Other Miscellaneous Reasons|1|||
42292641|NCT01126736|76126467|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
42357635|NCT01397409|76203103|FG008|Stage 3|Other Miscellaneous Reasons|0|||
42357636|NCT01397409|76203104|FG009|Stage 3|Other Miscellaneous Reasons|0|||
42357637|NCT01397253|76203129|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
42357638|NCT01397253|76203130|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
42292642|NCT01126736|76126468|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
42357639|NCT01777334|76203138|FG000|Overall Study|Adverse Event|18|||
42357640|NCT01777334|76203139|FG001|Overall Study|Adverse Event|14|||
42357641|NCT01777334|76203138|FG000|Overall Study|Lack of Efficacy|15|||
42357642|NCT01777334|76203139|FG001|Overall Study|Lack of Efficacy|29|||
42357643|NCT01777334|76203138|FG000|Overall Study|Protocol Violation|3|||
42357644|NCT01777334|76203139|FG001|Overall Study|Protocol Violation|7|||
42017057|NCT01134627|75824616|FG000|Overall Study|Withdrawal by Subject|4|||
42017058|NCT01134627|75824617|FG001|Overall Study|Withdrawal by Subject|3|||
42017059|NCT01134627|75824616|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
42357645|NCT01777334|76203138|FG000|Overall Study|Lost to Follow-up|3|||
42357646|NCT01777334|76203139|FG001|Overall Study|Lost to Follow-up|2|||
42357647|NCT01777334|76203138|FG000|Overall Study|Withdrawal by Subject|14|||
42357648|NCT01777334|76203139|FG001|Overall Study|Withdrawal by Subject|11|||
42357649|NCT01383993|76203148|FG000|Overall Study|Adverse Event|1|||
42357650|NCT01383993|76203149|FG001|Overall Study|Adverse Event|1|||
42357651|NCT01383993|76203150|FG002|Overall Study|Adverse Event|0|||
42357652|NCT01383993|76203148|FG000|Overall Study|Withdrawal by Subject|0|||
42357653|NCT01383993|76203149|FG001|Overall Study|Withdrawal by Subject|0|||
42357654|NCT01383993|76203150|FG002|Overall Study|Withdrawal by Subject|1|||
42357655|NCT01383993|76203148|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
42357656|NCT01383993|76203149|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
42357657|NCT01383993|76203150|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
42017060|NCT01134627|75824617|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
42017061|NCT01134627|75824616|FG000|Overall Study|Other|11|||
42017062|NCT01134627|75824617|FG001|Overall Study|Other|14|||
42017063|NCT01134393|75824623|FG000|Overall Study|Adverse Event|18|||
42357658|NCT01396395|76203161|FG000|Overall Study|Withdrawal by Subject|10|||
42068794|NCT00601107|75878642|FG001|Overall Study|Worsening of Psoriasis|1|||
42068795|NCT00601107|75878643|FG002|Overall Study|Worsening of Psoriasis|1|||
42068796|NCT00601107|75878644|FG003|Overall Study|Worsening of Psoriasis|4|||
42068797|NCT00601107|75878641|FG000|Overall Study|Undefined|1|||
42068798|NCT00601107|75878642|FG001|Overall Study|Undefined|0|||
42068799|NCT00601107|75878643|FG002|Overall Study|Undefined|1|||
42068800|NCT00601107|75878644|FG003|Overall Study|Undefined|0|||
42068801|NCT00914927|75878661|FG000|Overall Study|Adverse Event|0|||
42068802|NCT00914927|75878662|FG001|Overall Study|Adverse Event|0|||
42068803|NCT00914927|75878663|FG002|Overall Study|Adverse Event|0|||
42068804|NCT00914927|75878664|FG003|Overall Study|Adverse Event|0|||
42068805|NCT00914927|75878665|FG004|Overall Study|Adverse Event|1|||
42068806|NCT00914927|75878666|FG005|Overall Study|Adverse Event|0|||
42068807|NCT00914927|75878667|FG006|Overall Study|Adverse Event|0|||
42068808|NCT00914927|75878661|FG000|Overall Study|Withdrawal by Subject|0|||
42068809|NCT00914927|75878662|FG001|Overall Study|Withdrawal by Subject|1|||
42068810|NCT00914927|75878663|FG002|Overall Study|Withdrawal by Subject|0|||
42017064|NCT01134393|75824623|FG000|Overall Study|Lack of Efficacy|2|||
42017065|NCT01134393|75824623|FG000|Overall Study|Protocol Violation|12|||
42017066|NCT01134393|75824623|FG000|Overall Study|Lost to Follow-up|3|||
42017067|NCT01134393|75824623|FG000|Overall Study|Withdrawal by Subject|11|||
42017068|NCT01134393|75824623|FG000|Overall Study|Other|6|||
42017069|NCT00922441|75824631|FG000|Overall Study|Protocol Violation|0|||
42017070|NCT00922441|75824632|FG001|Overall Study|Protocol Violation|0|||
42017071|NCT00922441|75824633|FG002|Overall Study|Protocol Violation|2|||
42017072|NCT00922441|75824631|FG000|Overall Study|Withdrawal by Subject|0|||
42017073|NCT00922441|75824632|FG001|Overall Study|Withdrawal by Subject|0|||
42017074|NCT00922441|75824633|FG002|Overall Study|Withdrawal by Subject|1|||
42017075|NCT01217112|75824646|FG000|Overall Study|Adverse Event|0|||
42017076|NCT01217112|75824647|FG001|Overall Study|Adverse Event|2|||
42017077|NCT01217112|75824648|FG002|Overall Study|Adverse Event|0|||
42017078|NCT01217112|75824649|FG003|Overall Study|Adverse Event|2|||
42017079|NCT01217112|75824650|FG004|Overall Study|Adverse Event|0|||
42017080|NCT01217112|75824646|FG000|Overall Study|Withdrawal by Subject|0|||
42017081|NCT01217112|75824647|FG001|Overall Study|Withdrawal by Subject|0|||
42017082|NCT01217112|75824648|FG002|Overall Study|Withdrawal by Subject|1|||
42017083|NCT01217112|75824649|FG003|Overall Study|Withdrawal by Subject|0|||
42017084|NCT01217112|75824650|FG004|Overall Study|Withdrawal by Subject|0|||
42017085|NCT01217112|75824646|FG000|Overall Study|Physician Decision|0|||
42017086|NCT01217112|75824647|FG001|Overall Study|Physician Decision|0|||
42017087|NCT01217112|75824648|FG002|Overall Study|Physician Decision|0|||
42017088|NCT01217112|75824649|FG003|Overall Study|Physician Decision|0|||
42017089|NCT01217112|75824650|FG004|Overall Study|Physician Decision|1|||
42176290|NCT03162796|75983611|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
42176291|NCT03162328|75983624|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
42176292|NCT03162328|75983625|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
42176293|NCT03162328|75983626|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
42176294|NCT03162328|75983624|FG000|Screening Period|Withdrawal by Subject|1|||
42176295|NCT03162328|75983625|FG001|Screening Period|Withdrawal by Subject|0|||
42176296|NCT03162328|75983626|FG002|Screening Period|Withdrawal by Subject|0|||
42176297|NCT03162328|75983624|FG000|Study Period|Withdrawal by Subject|0|||
42176298|NCT03162328|75983625|FG001|Study Period|Withdrawal by Subject|0|||
42176299|NCT03162328|75983626|FG002|Study Period|Withdrawal by Subject|1|||
42176300|NCT00272987|75983640|FG000|Overall Study|Adverse Event|1|||
42176301|NCT00272987|75983641|FG001|Overall Study|Adverse Event|0|||
42176302|NCT00272987|75983642|FG002|Overall Study|Adverse Event|0|||
42176303|NCT00272987|75983640|FG000|Overall Study|Lost to Follow-up|3|||
42176304|NCT00272987|75983641|FG001|Overall Study|Lost to Follow-up|1|||
42176305|NCT00272987|75983642|FG002|Overall Study|Lost to Follow-up|1|||
42176306|NCT00272987|75983640|FG000|Overall Study|Withdrawal by Subject|1|||
42176307|NCT00272987|75983641|FG001|Overall Study|Withdrawal by Subject|0|||
42176308|NCT00272987|75983642|FG002|Overall Study|Withdrawal by Subject|3|||
42017090|NCT01216332|75824664|FG000|Overall Study|Withdrawal by Subject|4|||
42017091|NCT01216332|75824665|FG001|Overall Study|Withdrawal by Subject|0|||
42068811|NCT00914927|75878664|FG003|Overall Study|Withdrawal by Subject|1|||
42017092|NCT00922207|75824674|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
42017093|NCT00922207|75824675|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
42068812|NCT00914927|75878665|FG004|Overall Study|Withdrawal by Subject|0|||
42068813|NCT00914927|75878666|FG005|Overall Study|Withdrawal by Subject|0|||
42176309|NCT00272987|75983640|FG000|Overall Study|Sponsor Terminated study|0|||
42176310|NCT00272987|75983641|FG001|Overall Study|Sponsor Terminated study|1|||
42176311|NCT00272987|75983642|FG002|Overall Study|Sponsor Terminated study|1|||
42176312|NCT00272987|75983640|FG000|Overall Study|Disease progression|1|||
42176313|NCT00272987|75983641|FG001|Overall Study|Disease progression|1|||
42176314|NCT00272987|75983642|FG002|Overall Study|Disease progression|2|||
42176315|NCT00272987|75983640|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
42068814|NCT00914927|75878667|FG006|Overall Study|Withdrawal by Subject|0|||
42068815|NCT00914927|75878661|FG000|Overall Study|Lost to Follow-up|0|||
42068816|NCT00914927|75878662|FG001|Overall Study|Lost to Follow-up|0|||
42068817|NCT00914927|75878663|FG002|Overall Study|Lost to Follow-up|0|||
42068818|NCT00914927|75878664|FG003|Overall Study|Lost to Follow-up|1|||
42068819|NCT00914927|75878665|FG004|Overall Study|Lost to Follow-up|0|||
42068820|NCT00914927|75878666|FG005|Overall Study|Lost to Follow-up|0|||
42068821|NCT00914927|75878667|FG006|Overall Study|Lost to Follow-up|0|||
42068822|NCT00914927|75878661|FG000|Overall Study|Administrative/Other|2|||
42068823|NCT00914927|75878662|FG001|Overall Study|Administrative/Other|1|||
42068824|NCT00914927|75878663|FG002|Overall Study|Administrative/Other|0|||
42068825|NCT00914927|75878664|FG003|Overall Study|Administrative/Other|0|||
42068826|NCT00914927|75878665|FG004|Overall Study|Administrative/Other|1|||
42068827|NCT00914927|75878666|FG005|Overall Study|Administrative/Other|0|||
42068828|NCT00914927|75878667|FG006|Overall Study|Administrative/Other|0|||
42068829|NCT00914849|75878694|FG000|Overall Study|Withdrawal by Subject|1|||
42068830|NCT00914849|75878695|FG001|Overall Study|Withdrawal by Subject|0|||
42068831|NCT00914849|75878694|FG000|Overall Study|Not eligible|0|||
42068832|NCT00914849|75878695|FG001|Overall Study|Not eligible|1|||
42068833|NCT00912743|75878703|FG000|Overall Study|Adverse Event|3|||
42068834|NCT00912743|75878704|FG001|Overall Study|Adverse Event|1|||
42068835|NCT00912743|75878703|FG000|Overall Study|Lack of Efficacy|9|||
42068836|NCT00912743|75878704|FG001|Overall Study|Lack of Efficacy|18|||
42068837|NCT00912743|75878703|FG000|Overall Study|Toxicity|0|||
42068838|NCT00912743|75878704|FG001|Overall Study|Toxicity|1|||
42068839|NCT00912743|75878703|FG000|Overall Study|End of treatment form was not collected|1|||
42068840|NCT00912743|75878704|FG001|Overall Study|End of treatment form was not collected|0|||
42068841|NCT00914459|75878712|FG000|Overall Study|Protocol Violation|0|||
42068842|NCT00914459|75878713|FG001|Overall Study|Protocol Violation|1|||
42068843|NCT00914459|75878712|FG000|Overall Study|Parent/Legal guardian request|1|||
42068844|NCT00914459|75878713|FG001|Overall Study|Parent/Legal guardian request|0|||
42068845|NCT00912509|75878723|FG000|Overall Study|Lost to Follow-up|1|||
42068846|NCT00912509|75878724|FG001|Overall Study|Lost to Follow-up|0|||
42068847|NCT00912509|75878723|FG000|Overall Study|Lack of Efficacy|4|||
42068848|NCT00912509|75878724|FG001|Overall Study|Lack of Efficacy|3|||
42068849|NCT00913835|75878744|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
42068850|NCT00913835|75878745|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
42068851|NCT00913835|75878744|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
42068852|NCT00913835|75878745|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
42068853|NCT00913835|75878744|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
42068854|NCT00913835|75878745|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
42176316|NCT00272987|75983641|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
42176317|NCT00272987|75983642|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
42176318|NCT00272987|75983640|FG000|Overall Study|Death|1|||
42176319|NCT00272987|75983641|FG001|Overall Study|Death|0|||
42176320|NCT00272987|75983642|FG002|Overall Study|Death|0|||
42176321|NCT01730950|75983652|FG000|Overall Study|Protocol Violation|6|||
42176322|NCT01730950|75983653|FG001|Overall Study|Protocol Violation|6|||
42176323|NCT00271505|75983660|FG000|Overall Study|Screen Failure|3|||
42176324|NCT00271505|75983660|FG000|Overall Study|Adverse Event|1|||
42176325|NCT00271505|75983660|FG000|Overall Study|Death|1|||
42176326|NCT01642186|75983668|FG000|Overall Study|Death|0|||
42176327|NCT01642186|75983669|FG001|Overall Study|Death|2|||
42176328|NCT01642186|75983670|FG002|Overall Study|Death|2|||
42176329|NCT01642186|75983668|FG000|Overall Study|Lost to Follow-up|0|||
42176330|NCT01642186|75983669|FG001|Overall Study|Lost to Follow-up|0|||
42176331|NCT01642186|75983670|FG002|Overall Study|Lost to Follow-up|1|||
42176332|NCT00423514|75983680|FG000|Overall Study|Ineligible|1|||
42176333|NCT00423514|75983681|FG001|Overall Study|Ineligible|0|||
42176334|NCT00289991|75983689|FG000|Overall Study|Death|35|||
42176335|NCT00289991|75983690|FG001|Overall Study|Death|38|||
42176336|NCT00289991|75983689|FG000|Overall Study|Adverse Event|15|||
42176337|NCT00289991|75983690|FG001|Overall Study|Adverse Event|13|||
42068855|NCT00913835|75878744|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
42068856|NCT00913835|75878745|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
42068857|NCT00913835|75878744|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
42068858|NCT00913835|75878745|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
42068859|NCT00913523|75878770|FG000|Overall Study|Withdrawal by Subject|3|||
42068860|NCT00913523|75878771|FG001|Overall Study|Withdrawal by Subject|2|||
42068861|NCT00913523|75878772|FG002|Overall Study|Withdrawal by Subject|2|||
42068862|NCT00913523|75878770|FG000|Overall Study|Lost to Follow-up|1|||
42068863|NCT00913523|75878771|FG001|Overall Study|Lost to Follow-up|1|||
42068864|NCT00913523|75878772|FG002|Overall Study|Lost to Follow-up|1|||
42176338|NCT00289991|75983689|FG000|Overall Study|Failure of prophylaxis|1|||
42176339|NCT00289991|75983690|FG001|Overall Study|Failure of prophylaxis|1|||
42176340|NCT00289991|75983689|FG000|Overall Study|Fungal breakthrough infection|0|||
42176341|NCT00289991|75983690|FG001|Overall Study|Fungal breakthrough infection|1|||
42176342|NCT00289991|75983689|FG000|Overall Study|Lost to Follow-up|0|||
42176343|NCT00289991|75983690|FG001|Overall Study|Lost to Follow-up|1|||
42068865|NCT00913523|75878770|FG000|Overall Study|Adverse Event|1|||
42068866|NCT00913523|75878771|FG001|Overall Study|Adverse Event|0|||
42068867|NCT00913523|75878772|FG002|Overall Study|Adverse Event|0|||
42068868|NCT00913523|75878770|FG000|Overall Study|Protocol Violation|5|||
42068869|NCT00913523|75878771|FG001|Overall Study|Protocol Violation|8|||
42068870|NCT00913523|75878772|FG002|Overall Study|Protocol Violation|8|||
42068871|NCT00913523|75878770|FG000|Overall Study|Pregnancy|1|||
42068872|NCT00913523|75878771|FG001|Overall Study|Pregnancy|3|||
42068873|NCT00913523|75878772|FG002|Overall Study|Pregnancy|0|||
42068874|NCT00913523|75878770|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
42068875|NCT00913523|75878771|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
42068876|NCT00913523|75878772|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
42068877|NCT00912197|75878782|FG000|Overall Study|Withdrawal by Subject|3|||
42068878|NCT00912197|75878783|FG001|Overall Study|Withdrawal by Subject|3|||
42068879|NCT00910247|75878791|FG000|Overall Study|Adverse Event|15|||
42068880|NCT00910247|75878791|FG000|Overall Study|Death|2|||
42068881|NCT00910247|75878791|FG000|Overall Study|Lost to Follow-up|10|||
42068882|NCT00910247|75878791|FG000|Overall Study|Physician Decision|3|||
42068883|NCT00910247|75878791|FG000|Overall Study|Protocol Violation|10|||
42068884|NCT00910247|75878791|FG000|Overall Study|Withdrawal by Subject|25|||
42068885|NCT00910247|75878791|FG000|Overall Study|Not collected|4|||
42068886|NCT00659334|75878802|FG000|Overall Study|Screen Failure|8|||
42068887|NCT00659334|75878803|FG001|Overall Study|Screen Failure|5|||
42068888|NCT00659334|75878804|FG002|Overall Study|Screen Failure|0|||
42068889|NCT00659334|75878805|FG003|Overall Study|Screen Failure|0|||
42068890|NCT00659334|75878806|FG004|Overall Study|Screen Failure|0|||
42068891|NCT00659334|75878807|FG005|Overall Study|Screen Failure|0|||
42068892|NCT00659334|75878808|FG006|Overall Study|Screen Failure|1|||
42068893|NCT00910091|75878830|FG000|Pre-assignment|Withdrawal by Subject|0|||
42068894|NCT00910091|75878831|FG001|Pre-assignment|Withdrawal by Subject|2|||
42068895|NCT00910091|75878830|FG000|Treatment and Survival|Withdrawal by Subject|3|||
42068896|NCT00910091|75878831|FG001|Treatment and Survival|Withdrawal by Subject|4|||
42068897|NCT00910091|75878830|FG000|Treatment and Survival|Adverse Event|1|||
42068898|NCT00910091|75878831|FG001|Treatment and Survival|Adverse Event|0|||
42068899|NCT00909857|75878840|FG000|Overall Study|Withdrawal by Subject|6|||
42068900|NCT00909857|75878841|FG001|Overall Study|Withdrawal by Subject|10|||
42068901|NCT00909857|75878840|FG000|Overall Study|Adverse Event|5|||
42068902|NCT00909857|75878841|FG001|Overall Study|Adverse Event|5|||
42068903|NCT00909857|75878840|FG000|Overall Study|Lost to Follow-up|2|||
42068904|NCT00909857|75878841|FG001|Overall Study|Lost to Follow-up|5|||
42068905|NCT00909857|75878840|FG000|Overall Study|Protocol Violation|2|||
42068906|NCT00909857|75878841|FG001|Overall Study|Protocol Violation|1|||
42068907|NCT00909857|75878840|FG000|Overall Study|Pregnancy|1|||
42068908|NCT00909857|75878841|FG001|Overall Study|Pregnancy|0|||
42068909|NCT00909857|75878840|FG000|Overall Study|Other|1|||
42068910|NCT00909857|75878841|FG001|Overall Study|Other|0|||
42068911|NCT00909857|75878840|FG000|Overall Study|Did not receive study medication|19|||
42068912|NCT00909857|75878841|FG001|Overall Study|Did not receive study medication|24|||
42068913|NCT00911807|75878850|FG000|Overall Study|Adverse Event|2|||
42068914|NCT00911807|75878851|FG001|Overall Study|Adverse Event|1|||
42068915|NCT00911807|75878852|FG002|Overall Study|Adverse Event|5|||
42068916|NCT00911807|75878850|FG000|Overall Study|Death|0|||
42068917|NCT00911807|75878851|FG001|Overall Study|Death|0|||
42068918|NCT00911807|75878852|FG002|Overall Study|Death|1|||
42068919|NCT00911807|75878850|FG000|Overall Study|Protocol Violation|6|||
42068920|NCT00911807|75878851|FG001|Overall Study|Protocol Violation|4|||
42068921|NCT00911807|75878852|FG002|Overall Study|Protocol Violation|9|||
42068922|NCT00911807|75878850|FG000|Overall Study|Withdrawal by Subject|8|||
42068923|NCT00911807|75878851|FG001|Overall Study|Withdrawal by Subject|10|||
42068924|NCT00911807|75878852|FG002|Overall Study|Withdrawal by Subject|7|||
42068925|NCT00911807|75878850|FG000|Overall Study|Organizational reasons|1|||
42017094|NCT00922207|75824676|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
42017095|NCT00922207|75824674|FG000|Overall Study|Insufficient Therapeutic Response|0|||
42017096|NCT00922207|75824675|FG001|Overall Study|Insufficient Therapeutic Response|0|||
42017097|NCT00922207|75824676|FG002|Overall Study|Insufficient Therapeutic Response|1|||
42017098|NCT00922207|75824674|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
42017099|NCT00922207|75824675|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
42017100|NCT00922207|75824676|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
42017101|NCT00922207|75824674|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
42068926|NCT00911807|75878851|FG001|Overall Study|Organizational reasons|3|||
42017102|NCT00922207|75824675|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
42068927|NCT00911807|75878852|FG002|Overall Study|Organizational reasons|1|||
42068928|NCT04287920|75878879|FG000|Overall Study|Lost to Follow-up|1|||
42068929|NCT04287920|75878880|FG001|Overall Study|Lost to Follow-up|1|||
42068930|NCT04287920|75878879|FG000|Overall Study|Withdrawal by Subject|0|||
42068931|NCT04287920|75878880|FG001|Overall Study|Withdrawal by Subject|3|||
42068932|NCT00909779|75878888|FG000|Overall Study|Adverse Event|53|||
42068933|NCT00909779|75878889|FG001|Overall Study|Adverse Event|55|||
42068934|NCT00909779|75878888|FG000|Overall Study|Lack of Efficacy|7|||
42068935|NCT00909779|75878889|FG001|Overall Study|Lack of Efficacy|4|||
42068936|NCT00909779|75878888|FG000|Overall Study|Lost to Follow-up|19|||
42068937|NCT00909779|75878889|FG001|Overall Study|Lost to Follow-up|15|||
42068938|NCT00909779|75878888|FG000|Overall Study|Physician Decision|8|||
42068939|NCT00909779|75878889|FG001|Overall Study|Physician Decision|2|||
42068940|NCT00909779|75878888|FG000|Overall Study|Protocol Violation|2|||
42068941|NCT00909779|75878889|FG001|Overall Study|Protocol Violation|5|||
42068942|NCT00909779|75878888|FG000|Overall Study|Withdrawal by Subject|116|||
42068943|NCT00909779|75878889|FG001|Overall Study|Withdrawal by Subject|80|||
42068944|NCT00909779|75878888|FG000|Overall Study|Site Ceasing Operation|2|||
42068945|NCT00909779|75878889|FG001|Overall Study|Site Ceasing Operation|2|||
42068946|NCT00909779|75878888|FG000|Overall Study|Medical Monitor Decision|1|||
42068947|NCT00909779|75878889|FG001|Overall Study|Medical Monitor Decision|0|||
42068948|NCT00909779|75878888|FG000|Overall Study|Noncompliance|1|||
42068949|NCT00909779|75878889|FG001|Overall Study|Noncompliance|1|||
42068950|NCT00909779|75878888|FG000|Overall Study|Randomized in error|1|||
42068951|NCT00909779|75878889|FG001|Overall Study|Randomized in error|1|||
42068952|NCT00910871|75878897|FG000|Overall Study|Adverse Event|5|||
42068953|NCT00910871|75878897|FG000|Overall Study|Death|12|||
42068954|NCT00910871|75878897|FG000|Overall Study|Lost to Follow-up|8|||
42068955|NCT00910871|75878897|FG000|Overall Study|Protocol Violation|11|||
42068956|NCT00910871|75878897|FG000|Overall Study|Withdrawal by Subject|12|||
42068957|NCT00910871|75878897|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
42068958|NCT00910871|75878897|FG000|Overall Study|Undefined|1|||
42068959|NCT02631941|75878922|FG000|Overall Study|Physician Decision|0|||
42068960|NCT02631941|75878923|FG001|Overall Study|Physician Decision|1|||
42068961|NCT02631941|75878924|FG002|Overall Study|Physician Decision|0|||
42068962|NCT02631941|75878925|FG003|Overall Study|Physician Decision|0|||
42068963|NCT02631941|75878926|FG004|Overall Study|Physician Decision|0|||
42068964|NCT02631941|75878927|FG005|Overall Study|Physician Decision|0|||
42068965|NCT02631941|75878928|FG006|Overall Study|Physician Decision|0|||
42068966|NCT02631941|75878929|FG007|Overall Study|Physician Decision|0|||
42068967|NCT02631941|75878930|FG008|Overall Study|Physician Decision|0|||
42068968|NCT02631941|75878931|FG009|Overall Study|Physician Decision|0|||
42068969|NCT02631941|75878922|FG000|Overall Study|Adverse Event|0|||
42068970|NCT02631941|75878923|FG001|Overall Study|Adverse Event|1|||
42068971|NCT02631941|75878924|FG002|Overall Study|Adverse Event|0|||
42068972|NCT02631941|75878925|FG003|Overall Study|Adverse Event|0|||
42068973|NCT02631941|75878926|FG004|Overall Study|Adverse Event|0|||
42068974|NCT02631941|75878927|FG005|Overall Study|Adverse Event|0|||
42068975|NCT02631941|75878928|FG006|Overall Study|Adverse Event|0|||
42068976|NCT02631941|75878929|FG007|Overall Study|Adverse Event|0|||
42068977|NCT02631941|75878930|FG008|Overall Study|Adverse Event|0|||
42068978|NCT02631941|75878931|FG009|Overall Study|Adverse Event|0|||
42068979|NCT02631941|75878922|FG000|Overall Study|Withdrawal by Subject|0|||
42068980|NCT02631941|75878923|FG001|Overall Study|Withdrawal by Subject|0|||
42068981|NCT02631941|75878924|FG002|Overall Study|Withdrawal by Subject|0|||
42068982|NCT02631941|75878925|FG003|Overall Study|Withdrawal by Subject|0|||
42068983|NCT02631941|75878926|FG004|Overall Study|Withdrawal by Subject|1|||
42068984|NCT02631941|75878927|FG005|Overall Study|Withdrawal by Subject|0|||
42068985|NCT02631941|75878928|FG006|Overall Study|Withdrawal by Subject|0|||
42068986|NCT02631941|75878929|FG007|Overall Study|Withdrawal by Subject|1|||
42068987|NCT02631941|75878930|FG008|Overall Study|Withdrawal by Subject|0|||
42068988|NCT02631941|75878931|FG009|Overall Study|Withdrawal by Subject|0|||
42068989|NCT02631941|75878922|FG000|Overall Study|Lost to Follow-up|0|||
42068990|NCT02631941|75878923|FG001|Overall Study|Lost to Follow-up|0|||
42068991|NCT02631941|75878924|FG002|Overall Study|Lost to Follow-up|0|||
42068992|NCT02631941|75878925|FG003|Overall Study|Lost to Follow-up|0|||
42068993|NCT02631941|75878926|FG004|Overall Study|Lost to Follow-up|0|||
42068994|NCT02631941|75878927|FG005|Overall Study|Lost to Follow-up|0|||
42068995|NCT02631941|75878928|FG006|Overall Study|Lost to Follow-up|0|||
42068996|NCT02631941|75878929|FG007|Overall Study|Lost to Follow-up|0|||
42068997|NCT02631941|75878930|FG008|Overall Study|Lost to Follow-up|1|||
42068998|NCT02631941|75878931|FG009|Overall Study|Lost to Follow-up|0|||
42068999|NCT00908375|75878943|FG000|Overall Study|Withdrawal by Subject|2|||
42069000|NCT00908375|75878944|FG001|Overall Study|Withdrawal by Subject|4|||
42069001|NCT00908375|75878943|FG000|Overall Study|Lost to Follow-up|8|||
42069002|NCT00908375|75878944|FG001|Overall Study|Lost to Follow-up|6|||
42069003|NCT00909389|75878950|FG000|Overall Study|Adverse Event|6|||
42069004|NCT00909389|75878950|FG000|Overall Study|Death|4|||
42069005|NCT00909389|75878950|FG000|Overall Study|Poor Compliance|16|||
42069006|NCT00909389|75878950|FG000|Overall Study|Lost to Follow-up|4|||
42069007|NCT00909389|75878950|FG000|Overall Study|No Information|103|||
42069008|NCT00910715|75878957|FG000|Overall Study|Lost to Follow-up|22|||
42069009|NCT00910715|75878958|FG001|Overall Study|Lost to Follow-up|26|||
42292643|NCT01126736|76126464|FG000|Overall Study|Lost to Follow-up|0|||
42069010|NCT00910715|75878959|FG002|Overall Study|Lost to Follow-up|0|||
42069011|NCT00600483|75879021|FG000|Overall Study|Lost to Follow-up|26|||
42069012|NCT00600483|75879022|FG001|Overall Study|Lost to Follow-up|47|||
42069013|NCT00600483|75879021|FG000|Overall Study|Randomized but not treated|10|||
42069014|NCT00600483|75879022|FG001|Overall Study|Randomized but not treated|0|||
42069015|NCT00600171|75879034|FG000|Overall Study|Adverse Event|0|||
42069016|NCT00600171|75879035|FG001|Overall Study|Adverse Event|1|||
42069017|NCT00600171|75879036|FG002|Overall Study|Adverse Event|0|||
42069018|NCT00600171|75879037|FG003|Overall Study|Adverse Event|0|||
42069019|NCT00600171|75879038|FG004|Overall Study|Adverse Event|1|||
42069020|NCT00600171|75879039|FG005|Overall Study|Adverse Event|0|||
42069021|NCT00600171|75879034|FG000|Overall Study|Lack of Efficacy|9|||
42069022|NCT00600171|75879035|FG001|Overall Study|Lack of Efficacy|12|||
42069023|NCT00600171|75879036|FG002|Overall Study|Lack of Efficacy|3|||
42069024|NCT00600171|75879037|FG003|Overall Study|Lack of Efficacy|5|||
42069025|NCT00600171|75879038|FG004|Overall Study|Lack of Efficacy|4|||
42069026|NCT00600171|75879039|FG005|Overall Study|Lack of Efficacy|0|||
42069027|NCT00600171|75879034|FG000|Overall Study|Protocol Violation|1|||
42069028|NCT00600171|75879035|FG001|Overall Study|Protocol Violation|2|||
42069029|NCT00600171|75879036|FG002|Overall Study|Protocol Violation|0|||
42069030|NCT00600171|75879037|FG003|Overall Study|Protocol Violation|1|||
42069031|NCT00600171|75879038|FG004|Overall Study|Protocol Violation|0|||
42069032|NCT00600171|75879039|FG005|Overall Study|Protocol Violation|0|||
42069033|NCT00600171|75879034|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
42069034|NCT00600171|75879035|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
42069035|NCT00600171|75879036|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
42069036|NCT00600171|75879037|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
42069037|NCT00600171|75879038|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
42069038|NCT00600171|75879039|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
42069039|NCT00600171|75879034|FG000|Overall Study|Withdrawal by Subject|3|||
42069040|NCT00600171|75879035|FG001|Overall Study|Withdrawal by Subject|0|||
42069041|NCT00600171|75879036|FG002|Overall Study|Withdrawal by Subject|0|||
42069042|NCT00600171|75879037|FG003|Overall Study|Withdrawal by Subject|1|||
42069043|NCT00600171|75879038|FG004|Overall Study|Withdrawal by Subject|1|||
42069044|NCT00600171|75879039|FG005|Overall Study|Withdrawal by Subject|1|||
42069045|NCT00600171|75879034|FG000|Overall Study|Physician Decision|0|||
42069046|NCT00600171|75879035|FG001|Overall Study|Physician Decision|1|||
42069047|NCT00600171|75879036|FG002|Overall Study|Physician Decision|0|||
42069048|NCT00600171|75879037|FG003|Overall Study|Physician Decision|1|||
42069049|NCT00600171|75879038|FG004|Overall Study|Physician Decision|0|||
42069050|NCT00600171|75879039|FG005|Overall Study|Physician Decision|2|||
42069051|NCT00600171|75879034|FG000|Overall Study|Lost to Follow-up|0|||
42069052|NCT00600171|75879035|FG001|Overall Study|Lost to Follow-up|0|||
42176344|NCT00289991|75983689|FG000|Overall Study|Withdrawal by Subject|2|||
42176345|NCT00289991|75983690|FG001|Overall Study|Withdrawal by Subject|12|||
42176346|NCT00289991|75983689|FG000|Overall Study|Other|5|||
42176347|NCT00289991|75983690|FG001|Overall Study|Other|14|||
42017103|NCT00922207|75824676|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
42017104|NCT00922207|75824674|FG000|Overall Study|Withdrew Consent|2|||
42017105|NCT00922207|75824675|FG001|Overall Study|Withdrew Consent|5|||
42017106|NCT00922207|75824676|FG002|Overall Study|Withdrew Consent|2|||
42017107|NCT00922207|75824674|FG000|Overall Study|Abnormality of Laboratory Test|0|||
42017108|NCT00922207|75824675|FG001|Overall Study|Abnormality of Laboratory Test|1|||
42017109|NCT00922207|75824676|FG002|Overall Study|Abnormality of Laboratory Test|1|||
42017110|NCT01134315|75824686|FG000|Overall Study|Adverse Event|1|||
42017111|NCT01134315|75824687|FG001|Overall Study|Adverse Event|2|||
42017112|NCT01134315|75824686|FG000|Overall Study|Other Reason|8|||
42017113|NCT01134315|75824687|FG001|Overall Study|Other Reason|17|||
42017114|NCT01216176|75824696|FG000|Overall Study|Adverse Event|0|||
42017115|NCT01216176|75824697|FG001|Overall Study|Adverse Event|8|||
42017116|NCT01216176|75824698|FG002|Overall Study|Adverse Event|0|||
42017117|NCT01216176|75824696|FG000|Overall Study|Physician Decision|0|||
42017118|NCT01216176|75824697|FG001|Overall Study|Physician Decision|0|||
42017119|NCT01216176|75824698|FG002|Overall Study|Physician Decision|1|||
42017120|NCT01133847|75824710|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
42017121|NCT01133847|75824711|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
42017122|NCT01133847|75824712|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
42017123|NCT01133847|75824710|FG000|Follow-Up Phase|Lost to Follow-up|1|||
42017124|NCT01133847|75824711|FG001|Follow-Up Phase|Lost to Follow-up|3|||
42017125|NCT01133847|75824712|FG002|Follow-Up Phase|Lost to Follow-up|7|||
42017126|NCT01133379|75824724|FG000|Overall Study|Withdrawal by Subject|0|||
42017127|NCT01133379|75824725|FG001|Overall Study|Withdrawal by Subject|1|||
42017128|NCT01133379|75824726|FG002|Overall Study|Withdrawal by Subject|1|||
42017129|NCT01133379|75824724|FG000|Overall Study|Lost to Follow-up|1|||
42017130|NCT01133379|75824725|FG001|Overall Study|Lost to Follow-up|1|||
42069053|NCT00600171|75879036|FG002|Overall Study|Lost to Follow-up|0|||
42069054|NCT00600171|75879037|FG003|Overall Study|Lost to Follow-up|1|||
42069055|NCT00600171|75879038|FG004|Overall Study|Lost to Follow-up|0|||
42292644|NCT01126736|76126465|FG001|Overall Study|Lost to Follow-up|0|||
42017131|NCT01133379|75824726|FG002|Overall Study|Lost to Follow-up|1|||
42017132|NCT01133067|75824734|FG000|Overall Study|Death|136|||
42069056|NCT00600171|75879039|FG005|Overall Study|Lost to Follow-up|0|||
42069057|NCT04035668|75879058|FG000|Overall Study|Adverse Event|3|||
42069058|NCT04035668|75879059|FG001|Overall Study|Adverse Event|4|||
42069059|NCT04035668|75879060|FG002|Overall Study|Adverse Event|2|||
42069060|NCT04035668|75879058|FG000|Overall Study|Lost to Follow-up|0|||
42069061|NCT04035668|75879059|FG001|Overall Study|Lost to Follow-up|1|||
42069062|NCT04035668|75879060|FG002|Overall Study|Lost to Follow-up|0|||
42069063|NCT04035668|75879058|FG000|Overall Study|Physician Decision|2|||
42069064|NCT04035668|75879059|FG001|Overall Study|Physician Decision|1|||
42069065|NCT04035668|75879060|FG002|Overall Study|Physician Decision|1|||
42069066|NCT04035668|75879058|FG000|Overall Study|Subject Decision|2|||
42069067|NCT04035668|75879059|FG001|Overall Study|Subject Decision|2|||
42069068|NCT04035668|75879060|FG002|Overall Study|Subject Decision|0|||
42069069|NCT00885495|75879080|FG000|Overall Study|Adverse Event|1|||
42069070|NCT00885495|75879081|FG001|Overall Study|Adverse Event|2|||
42069071|NCT00885495|75879080|FG000|Overall Study|Protocol Violation|0|||
42069072|NCT00885495|75879081|FG001|Overall Study|Protocol Violation|1|||
42069073|NCT00885495|75879080|FG000|Overall Study|Withdrawal by Subject|1|||
42069074|NCT00885495|75879081|FG001|Overall Study|Withdrawal by Subject|0|||
42069075|NCT00885105|75879094|FG000|Overall Study|Withdrawal by Subject|0|||
42069076|NCT00885105|75879095|FG001|Overall Study|Withdrawal by Subject|8|||
42069077|NCT00885105|75879094|FG000|Overall Study|Adverse Event|1|||
42069078|NCT00885105|75879095|FG001|Overall Study|Adverse Event|0|||
42069079|NCT00885105|75879094|FG000|Overall Study|Protocol Violation|0|||
42069080|NCT00885105|75879095|FG001|Overall Study|Protocol Violation|2|||
42069081|NCT03945188|75879103|FG000|Overall Study|Protocol Violation|1|||
42069082|NCT03945188|75879104|FG001|Overall Study|Protocol Violation|0|||
42069083|NCT03945188|75879103|FG000|Overall Study|Disease worsening|79|||
42069084|NCT03945188|75879104|FG001|Overall Study|Disease worsening|73|||
42069085|NCT03945188|75879103|FG000|Overall Study|Physician Decision|2|||
42069086|NCT03945188|75879104|FG001|Overall Study|Physician Decision|2|||
42069087|NCT03945188|75879103|FG000|Overall Study|Lack of Efficacy|7|||
42069088|NCT03945188|75879104|FG001|Overall Study|Lack of Efficacy|4|||
42069089|NCT03945188|75879103|FG000|Overall Study|Pregnancy|2|||
42069090|NCT03945188|75879104|FG001|Overall Study|Pregnancy|0|||
42069091|NCT03945188|75879103|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
42069092|NCT03945188|75879104|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
42069093|NCT03945188|75879103|FG000|Overall Study|Adverse Event|10|||
42069094|NCT03945188|75879104|FG001|Overall Study|Adverse Event|5|||
42069095|NCT03945188|75879103|FG000|Overall Study|Other|2|||
42069096|NCT03945188|75879104|FG001|Overall Study|Other|2|||
42069097|NCT03945188|75879103|FG000|Overall Study|Lost to Follow-up|1|||
42069098|NCT03945188|75879104|FG001|Overall Study|Lost to Follow-up|2|||
42069099|NCT00884949|75879110|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
42069100|NCT00884949|75879110|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
42069101|NCT00884793|75879123|FG000|Overall Study|Withdrawal by Subject|1|||
42069102|NCT00884325|75879129|FG000|Overall Study|Lost to Follow-up|1|||
42069103|NCT00884325|75879130|FG001|Overall Study|Lost to Follow-up|2|||
42069104|NCT00884325|75879129|FG000|Overall Study|Lack of Efficacy|0|||
42069105|NCT00884325|75879130|FG001|Overall Study|Lack of Efficacy|1|||
42069106|NCT00884325|75879129|FG000|Overall Study|Withdrawal by Subject|1|||
42069107|NCT00884325|75879130|FG001|Overall Study|Withdrawal by Subject|1|||
42069108|NCT00884325|75879129|FG000|Overall Study|Not provided|1|||
42069109|NCT00884325|75879130|FG001|Overall Study|Not provided|0|||
42069110|NCT00883779|75879138|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
42069111|NCT00883779|75879139|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
42069112|NCT00883779|75879138|FG000|Primary Study Treatment Phase|Disease progression|75|||
42069113|NCT00883779|75879139|FG001|Primary Study Treatment Phase|Disease progression|59|||
42069114|NCT00883779|75879138|FG000|Primary Study Treatment Phase|Adverse Event|16|||
42069115|NCT00883779|75879139|FG001|Primary Study Treatment Phase|Adverse Event|16|||
42069116|NCT00883779|75879138|FG000|Primary Study Treatment Phase|Death|2|||
42069117|NCT00883779|75879139|FG001|Primary Study Treatment Phase|Death|3|||
42069118|NCT00883779|75879138|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
42069119|NCT00883779|75879139|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
42069120|NCT00883779|75879138|FG000|Primary Study Treatment Phase|Other|3|||
42069121|NCT00883779|75879139|FG001|Primary Study Treatment Phase|Other|0|||
42069122|NCT00883779|75879138|FG000|Post-Study Treatment Phase|Adverse Event|2|||
42069123|NCT00883779|75879139|FG001|Post-Study Treatment Phase|Adverse Event|3|||
42069124|NCT00883779|75879138|FG000|Post-Study Treatment Phase|Death|1|||
42069125|NCT00883779|75879139|FG001|Post-Study Treatment Phase|Death|3|||
42069126|NCT00883779|75879138|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
42069127|NCT00883779|75879139|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
42069128|NCT00883779|75879138|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
42069129|NCT00883779|75879139|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
42069130|NCT00883779|75879138|FG000|Post-Study Treatment Phase|Disease progression|103|||
42069131|NCT00883779|75879139|FG001|Post-Study Treatment Phase|Disease progression|122|||
42069132|NCT00883779|75879138|FG000|Post-Study Treatment Phase|Other|3|||
42069133|NCT00883779|75879139|FG001|Post-Study Treatment Phase|Other|0|||
42069134|NCT00883779|75879138|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
42069135|NCT00883779|75879139|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
42069136|NCT00883779|75879138|FG000|Off-study Phase|Death|185|||
42069137|NCT00883779|75879139|FG001|Off-study Phase|Death|174|||
42069138|NCT00883779|75879138|FG000|Off-study Phase|Refused treatment|1|||
42069139|NCT00883779|75879139|FG001|Off-study Phase|Refused treatment|1|||
42069140|NCT00883779|75879138|FG000|Off-study Phase|Failure to return|5|||
42069141|NCT00883779|75879139|FG001|Off-study Phase|Failure to return|6|||
42069142|NCT00883779|75879138|FG000|Off-study Phase|Other|18|||
42069143|NCT00883779|75879139|FG001|Off-study Phase|Other|21|||
42069144|NCT04159701|75879147|FG000|Period 1: Treatment Period|Pregnancy|1|||
42069145|NCT04159701|75879148|FG001|Period 1: Treatment Period|Pregnancy|0|||
42069146|NCT04159701|75879147|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
42069147|NCT04159701|75879148|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
42069148|NCT04159701|75879147|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
42069149|NCT04159701|75879148|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
42069150|NCT04159701|75879147|FG000|Washout Period|site terminated by sponsor|0|||
42069151|NCT04159701|75879148|FG001|Washout Period|site terminated by sponsor|1|||
42069152|NCT04159701|75879147|FG000|Washout Period|study terminated by sponsor|10|||
42069153|NCT04159701|75879148|FG001|Washout Period|study terminated by sponsor|3|||
42069154|NCT04159701|75879147|FG000|Washout Period|Withdrawal by Subject|1|||
42069155|NCT04159701|75879148|FG001|Washout Period|Withdrawal by Subject|0|||
42069156|NCT04159701|75879147|FG000|Washout Period|Inadvertent Enrollment|1|||
42069157|NCT04159701|75879148|FG001|Washout Period|Inadvertent Enrollment|0|||
42069158|NCT04159701|75879147|FG000|Washout Period|Miscellaneous|1|||
42069159|NCT04159701|75879148|FG001|Washout Period|Miscellaneous|0|||
42069160|NCT04159701|75879147|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
42069161|NCT04159701|75879148|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
42069162|NCT04159701|75879147|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
42069163|NCT04159701|75879148|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
42069164|NCT04159701|75879147|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
42069165|NCT04159701|75879148|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
42176348|NCT00289913|75983701|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42292645|NCT01126736|76126466|FG002|Overall Study|Lost to Follow-up|0|||
42069166|NCT04159701|75879147|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
42069167|NCT04159701|75879148|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
42069168|NCT04159701|75879147|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
42069169|NCT04159701|75879148|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
42069170|NCT00880269|75879160|FG000|Overall Study|Protocol Violation|1|||
42069171|NCT00880269|75879161|FG001|Overall Study|Protocol Violation|0|||
42069172|NCT00880269|75879160|FG000|Overall Study|Disease Progression|13|||
42069173|NCT00880269|75879161|FG001|Overall Study|Disease Progression|11|||
42069174|NCT00880269|75879160|FG000|Overall Study|New Cancer Therapy|1|||
42069175|NCT00880269|75879161|FG001|Overall Study|New Cancer Therapy|0|||
42069176|NCT00880269|75879160|FG000|Overall Study|Death|4|||
42069177|NCT00880269|75879161|FG001|Overall Study|Death|2|||
42069178|NCT00880269|75879160|FG000|Overall Study|Lost to Follow-up|0|||
42069179|NCT00880269|75879161|FG001|Overall Study|Lost to Follow-up|1|||
42069180|NCT00880269|75879160|FG000|Overall Study|Withdrawal by Subject|3|||
42069181|NCT00880269|75879161|FG001|Overall Study|Withdrawal by Subject|4|||
42069182|NCT00880269|75879160|FG000|Overall Study|Adverse Event|10|||
42069183|NCT00880269|75879161|FG001|Overall Study|Adverse Event|9|||
42069184|NCT00880191|75879169|FG000|Overall Study|Refused further treatment|4|||
42069185|NCT00880191|75879170|FG001|Overall Study|Refused further treatment|1|||
42069186|NCT00880191|75879169|FG000|Overall Study|Adverse Event|8|||
42069187|NCT00880191|75879170|FG001|Overall Study|Adverse Event|6|||
42069188|NCT00880191|75879169|FG000|Overall Study|Hospitalization/efficacy|1|||
42069189|NCT00880191|75879170|FG001|Overall Study|Hospitalization/efficacy|1|||
42069190|NCT00597519|75879176|FG000|Overall Study|Death|1|||
42069191|NCT00879333|75879182|FG000|Overall Study|Adverse Event|94|||
42069192|NCT00879333|75879183|FG001|Overall Study|Adverse Event|34|||
42069193|NCT00879333|75879182|FG000|Overall Study|Abnormal Laboratory Value|1|||
42069194|NCT00879333|75879183|FG001|Overall Study|Abnormal Laboratory Value|0|||
42069195|NCT00879333|75879182|FG000|Overall Study|Withdrawal by Subject|20|||
42069196|NCT00879333|75879183|FG001|Overall Study|Withdrawal by Subject|7|||
42069197|NCT00879333|75879182|FG000|Overall Study|Lost to Follow-up|2|||
42069198|NCT00879333|75879183|FG001|Overall Study|Lost to Follow-up|1|||
42069199|NCT00879333|75879182|FG000|Overall Study|Administrative Problems|2|||
42069200|NCT00879333|75879183|FG001|Overall Study|Administrative Problems|0|||
42069201|NCT00879333|75879182|FG000|Overall Study|Death|16|||
42069202|NCT00879333|75879183|FG001|Overall Study|Death|5|||
42069203|NCT00879333|75879182|FG000|Overall Study|Disease Progression|292|||
42069204|NCT00879333|75879183|FG001|Overall Study|Disease Progression|169|||
42069205|NCT00879333|75879182|FG000|Overall Study|Protocol Violation|1|||
42069206|NCT00879333|75879183|FG001|Overall Study|Protocol Violation|1|||
42069207|NCT03481556|75879195|FG000|Overall Study|Adverse Event|1|||
42069208|NCT03481556|75879196|FG001|Overall Study|Adverse Event|0|||
42069209|NCT03481556|75879197|FG002|Overall Study|Adverse Event|0|||
42069210|NCT03481556|75879198|FG003|Overall Study|Adverse Event|0|||
42176349|NCT00289913|75983702|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
42176350|NCT00289913|75983703|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42176351|NCT00289913|75983704|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42176352|NCT00289913|75983705|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42176353|NCT00289913|75983701|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
42176354|NCT00289913|75983702|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
42176355|NCT00289913|75983703|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
42176356|NCT00289913|75983704|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
42176357|NCT00289913|75983705|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
42176358|NCT00289913|75983701|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
42176359|NCT00289913|75983702|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
42176360|NCT00289913|75983703|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
42292646|NCT01126736|76126467|FG003|Overall Study|Lost to Follow-up|1|||
42292647|NCT01126736|76126468|FG004|Overall Study|Lost to Follow-up|1|||
42069211|NCT03481556|75879195|FG000|Overall Study|Death|4|||
42069212|NCT03481556|75879196|FG001|Overall Study|Death|2|||
42069213|NCT03481556|75879197|FG002|Overall Study|Death|3|||
42069214|NCT03481556|75879198|FG003|Overall Study|Death|16|||
42069215|NCT03481556|75879195|FG000|Overall Study|Study Terminated by Sponsor|10|||
42069216|NCT03481556|75879196|FG001|Overall Study|Study Terminated by Sponsor|5|||
42069217|NCT03481556|75879197|FG002|Overall Study|Study Terminated by Sponsor|2|||
42069218|NCT03481556|75879198|FG003|Overall Study|Study Terminated by Sponsor|9|||
42069219|NCT00596427|75879216|FG000|Overall Study|Withdrawal by Subject|2|||
42069220|NCT00596427|75879217|FG001|Overall Study|Withdrawal by Subject|2|||
42069221|NCT00596427|75879216|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
42069222|NCT00596427|75879217|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
42069223|NCT00596427|75879216|FG000|Overall Study|Protocol Violation|1|||
42069224|NCT00596427|75879217|FG001|Overall Study|Protocol Violation|0|||
42069225|NCT02732210|75879226|FG000|Overall Study|Site Closed|0|||
42069226|NCT02732210|75879227|FG001|Overall Study|Site Closed|11|||
42069227|NCT02732210|75879226|FG000|Overall Study|Study Ended|13|||
42069228|NCT02732210|75879227|FG001|Overall Study|Study Ended|13|||
42069229|NCT02732210|75879226|FG000|Overall Study|Withdrawal by Subject|28|||
42069230|NCT02732210|75879227|FG001|Overall Study|Withdrawal by Subject|87|||
42069231|NCT02732210|75879226|FG000|Overall Study|Lost to Follow-up|5|||
42069232|NCT02732210|75879227|FG001|Overall Study|Lost to Follow-up|57|||
42069233|NCT02732210|75879226|FG000|Overall Study|Death|4|||
42069234|NCT02732210|75879227|FG001|Overall Study|Death|15|||
42069235|NCT02732210|75879226|FG000|Overall Study|Other|35|||
42069236|NCT02732210|75879227|FG001|Overall Study|Other|103|||
42069237|NCT02732210|75879226|FG000|Overall Study|Missing|0|||
42069238|NCT02732210|75879227|FG001|Overall Study|Missing|8|||
42069239|NCT00595959|75879233|FG000|Overall Study|Withdrawal by Subject|1|||
42069240|NCT00595959|75879233|FG000|Overall Study|Lost to Follow-up|1|||
42069241|NCT00436748|75879271|FG000|Overall Study|Ineligibility Determined|1|||
42069242|NCT00436748|75879272|FG001|Overall Study|Ineligibility Determined|1|||
42069243|NCT00436748|75879271|FG000|Overall Study|Adverse Event|0|||
42069244|NCT00436748|75879272|FG001|Overall Study|Adverse Event|2|||
42069245|NCT00436748|75879271|FG000|Overall Study|Consent Withdrawn|1|||
42069246|NCT00436748|75879272|FG001|Overall Study|Consent Withdrawn|4|||
42069247|NCT00436748|75879271|FG000|Overall Study|Administrative Decision|1|||
42069248|NCT00436748|75879272|FG001|Overall Study|Administrative Decision|0|||
42069249|NCT00436748|75879271|FG000|Overall Study|Lost to Follow-up|0|||
42069250|NCT00436748|75879272|FG001|Overall Study|Lost to Follow-up|1|||
42069251|NCT00436748|75879271|FG000|Overall Study|Protocol-specified Criteria|5|||
42069252|NCT00436748|75879272|FG001|Overall Study|Protocol-specified Criteria|4|||
42069253|NCT00436748|75879271|FG000|Overall Study|Other|3|||
42069254|NCT00436748|75879272|FG001|Overall Study|Other|0|||
42069255|NCT02703272|75879282|FG000|Overall Study|Death|4|||
42069256|NCT02703272|75879283|FG001|Overall Study|Death|9|||
42069257|NCT02703272|75879284|FG002|Overall Study|Death|19|||
42069258|NCT02703272|75879285|FG003|Overall Study|Death|10|||
42069259|NCT02703272|75879282|FG000|Overall Study|Withdrawal by Subject|0|||
42069260|NCT02703272|75879283|FG001|Overall Study|Withdrawal by Subject|0|||
42069261|NCT02703272|75879284|FG002|Overall Study|Withdrawal by Subject|4|||
42069262|NCT02703272|75879285|FG003|Overall Study|Withdrawal by Subject|2|||
42069263|NCT02703272|75879282|FG000|Overall Study|Study Terminated by Sponsor|6|||
42069264|NCT02703272|75879283|FG001|Overall Study|Study Terminated by Sponsor|1|||
42069265|NCT02703272|75879284|FG002|Overall Study|Study Terminated by Sponsor|12|||
42069266|NCT02703272|75879285|FG003|Overall Study|Study Terminated by Sponsor|4|||
42069267|NCT02703272|75879282|FG000|Overall Study|Other|1|||
42069268|NCT02703272|75879283|FG001|Overall Study|Other|0|||
42069269|NCT02703272|75879284|FG002|Overall Study|Other|0|||
42069270|NCT02703272|75879285|FG003|Overall Study|Other|0|||
42069271|NCT02568215|75879325|FG000|Overall Study|Death|1|||
42069272|NCT02568215|75879326|FG001|Overall Study|Death|2|||
42069273|NCT02568215|75879327|FG002|Overall Study|Death|0|||
42069274|NCT02568215|75879325|FG000|Overall Study|Physician Decision|2|||
42069275|NCT02568215|75879326|FG001|Overall Study|Physician Decision|2|||
42069276|NCT02568215|75879327|FG002|Overall Study|Physician Decision|2|||
42069277|NCT02568215|75879325|FG000|Overall Study|Lost to Follow-up|29|||
42069278|NCT02568215|75879326|FG001|Overall Study|Lost to Follow-up|32|||
42069279|NCT02568215|75879327|FG002|Overall Study|Lost to Follow-up|41|||
42069280|NCT02568215|75879325|FG000|Overall Study|Withdrawal by Subject|21|||
42069281|NCT02568215|75879326|FG001|Overall Study|Withdrawal by Subject|19|||
42069282|NCT02568215|75879327|FG002|Overall Study|Withdrawal by Subject|22|||
42069283|NCT02568215|75879325|FG000|Overall Study|Protocol Violation|1|||
42069284|NCT02568215|75879326|FG001|Overall Study|Protocol Violation|1|||
42069285|NCT02568215|75879327|FG002|Overall Study|Protocol Violation|0|||
42069286|NCT02568215|75879325|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
42069287|NCT02568215|75879326|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
42069288|NCT02568215|75879327|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
42069289|NCT02568215|75879325|FG000|Overall Study|Other|0|||
42069290|NCT02568215|75879326|FG001|Overall Study|Other|1|||
42069291|NCT02568215|75879327|FG002|Overall Study|Other|4|||
42069292|NCT00908141|75879364|FG000|Overall Study|Withdrawal by Subject|0|||
42069293|NCT00908141|75879365|FG001|Overall Study|Withdrawal by Subject|1|||
42069294|NCT00906347|75879373|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
42176361|NCT00289913|75983704|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
42176362|NCT00289913|75983705|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
42176363|NCT00289913|75983701|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
42176364|NCT00289913|75983702|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
42069295|NCT00906347|75879374|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
42069296|NCT00906347|75879373|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
42069297|NCT00906347|75879374|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
42069298|NCT00906347|75879373|FG000|Received Study Drug|Refused study drug|1|||
42069299|NCT00906347|75879374|FG001|Received Study Drug|Refused study drug|0|||
42069300|NCT00906347|75879373|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
42069301|NCT00906347|75879374|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
42069302|NCT00906035|75879383|FG000|Overall Study|Withdrawal by Subject|2|||
42069303|NCT00906035|75879384|FG001|Overall Study|Withdrawal by Subject|3|||
42069304|NCT00906035|75879385|FG002|Overall Study|Withdrawal by Subject|0|||
42069305|NCT00905489|75879393|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
42069306|NCT00905489|75879393|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
42069307|NCT00905489|75879393|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
42069308|NCT02704754|75879404|FG000|Overall Study|Lost to Follow-up|1|||
42069309|NCT02704754|75879405|FG001|Overall Study|Lost to Follow-up|1|||
42069310|NCT02704754|75879404|FG000|Overall Study|Lack of Efficacy|1|||
42069311|NCT02704754|75879405|FG001|Overall Study|Lack of Efficacy|0|||
42069312|NCT02704754|75879404|FG000|Overall Study|Withdrawal by Subject|1|||
42069313|NCT02704754|75879405|FG001|Overall Study|Withdrawal by Subject|0|||
42069314|NCT03170882|75879413|FG000|Overall Study|Death|17|||
42069315|NCT03170882|75879414|FG001|Overall Study|Death|29|||
42069316|NCT03170882|75879413|FG000|Overall Study|Lost to Follow-up|0|||
42069317|NCT03170882|75879414|FG001|Overall Study|Lost to Follow-up|1|||
42069318|NCT03170882|75879413|FG000|Overall Study|Withdrawal by Subject|4|||
42069319|NCT03170882|75879414|FG001|Overall Study|Withdrawal by Subject|7|||
42069320|NCT03170882|75879413|FG000|Overall Study|Reason not Specified|28|||
42069321|NCT03170882|75879414|FG001|Overall Study|Reason not Specified|36|||
42069322|NCT00907517|75879425|FG000|Overall Study|Progressive Disease|3|||
42069323|NCT00907517|75879426|FG001|Overall Study|Progressive Disease|3|||
42069324|NCT00907517|75879427|FG002|Overall Study|Progressive Disease|4|||
42069325|NCT00907517|75879428|FG003|Overall Study|Progressive Disease|4|||
42069326|NCT00907517|75879429|FG004|Overall Study|Progressive Disease|4|||
42069327|NCT00907517|75879425|FG000|Overall Study|Symptomatic Deterioration|0|||
42069328|NCT00907517|75879426|FG001|Overall Study|Symptomatic Deterioration|0|||
42069329|NCT00907517|75879427|FG002|Overall Study|Symptomatic Deterioration|0|||
42069330|NCT00907517|75879428|FG003|Overall Study|Symptomatic Deterioration|0|||
42069331|NCT00907517|75879429|FG004|Overall Study|Symptomatic Deterioration|1|||
42069332|NCT00905255|75879443|FG000|Overall Study|Adverse Event|7|||
42069333|NCT00905255|75879444|FG001|Overall Study|Adverse Event|5|||
42069334|NCT00905255|75879443|FG000|Overall Study|Withdrawal by Subject|5|||
42069335|NCT00905255|75879444|FG001|Overall Study|Withdrawal by Subject|4|||
42069336|NCT00905255|75879443|FG000|Overall Study|Familial and Personal Reasons|1|||
42069337|NCT00905255|75879444|FG001|Overall Study|Familial and Personal Reasons|0|||
42069338|NCT00905021|75879451|FG000|Overall Study|Adverse Event|2|||
42069339|NCT00906971|75879458|FG000|Overall Study|Withdrawal by Subject|8|||
42069340|NCT00906971|75879459|FG001|Overall Study|Withdrawal by Subject|2|||
42069341|NCT00906971|75879458|FG000|Overall Study|Lost to Follow-up|0|||
42069342|NCT00906971|75879459|FG001|Overall Study|Lost to Follow-up|1|||
42069343|NCT00903929|75879465|FG000|Overall Study|Withdrawal by Subject|0|||
42069344|NCT00903929|75879466|FG001|Overall Study|Withdrawal by Subject|0|||
42069345|NCT00903929|75879467|FG002|Overall Study|Withdrawal by Subject|1|||
42069346|NCT00903929|75879468|FG003|Overall Study|Withdrawal by Subject|2|||
42069347|NCT00903929|75879465|FG000|Overall Study|Adverse Event|0|||
42069348|NCT00903929|75879466|FG001|Overall Study|Adverse Event|0|||
42069349|NCT00903929|75879467|FG002|Overall Study|Adverse Event|0|||
42069350|NCT00903929|75879468|FG003|Overall Study|Adverse Event|1|||
42069351|NCT00903695|75879475|FG000|Overall Study|medical exclusion after 1st testing|1|||
42069352|NCT00903695|75879476|FG001|Overall Study|medical exclusion after 1st testing|0|||
42069353|NCT00903695|75879475|FG000|Overall Study|lung cancer|1|||
42069354|NCT00903695|75879476|FG001|Overall Study|lung cancer|0|||
42069355|NCT00903617|75879488|FG000|Overall Study|Adverse Event|0|||
42069356|NCT00903617|75879489|FG001|Overall Study|Adverse Event|1|||
42069357|NCT00903617|75879490|FG002|Overall Study|Adverse Event|1|||
42069358|NCT00903617|75879491|FG003|Overall Study|Adverse Event|0|||
42069359|NCT00903617|75879488|FG000|Overall Study|Protocol-defined stopping criteria|0|||
42069360|NCT00903617|75879489|FG001|Overall Study|Protocol-defined stopping criteria|2|||
42069361|NCT00903617|75879490|FG002|Overall Study|Protocol-defined stopping criteria|0|||
42069362|NCT00903617|75879491|FG003|Overall Study|Protocol-defined stopping criteria|0|||
42069363|NCT00903617|75879488|FG000|Overall Study|Lost to Follow-up|2|||
42069364|NCT00903617|75879489|FG001|Overall Study|Lost to Follow-up|0|||
42069365|NCT00903617|75879490|FG002|Overall Study|Lost to Follow-up|1|||
42069366|NCT00903617|75879491|FG003|Overall Study|Lost to Follow-up|1|||
42069367|NCT00903617|75879488|FG000|Overall Study|Withdrawal by Subject|1|||
42069368|NCT00903617|75879489|FG001|Overall Study|Withdrawal by Subject|2|||
42176365|NCT00289913|75983703|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
42176366|NCT00289913|75983704|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
42176367|NCT00289913|75983705|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
42176368|NCT00289913|75983701|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
42069369|NCT00903617|75879490|FG002|Overall Study|Withdrawal by Subject|3|||
42069370|NCT00903617|75879491|FG003|Overall Study|Withdrawal by Subject|0|||
42069371|NCT00903383|75879506|FG000|Overall Study|Adverse Event|1|||
42069372|NCT00903383|75879507|FG001|Overall Study|Adverse Event|2|||
42069373|NCT00903383|75879508|FG002|Overall Study|Adverse Event|3|||
42176369|NCT00289913|75983702|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
42176370|NCT00289913|75983703|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
42176371|NCT00289913|75983704|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
42069374|NCT00903383|75879509|FG003|Overall Study|Adverse Event|1|||
42069375|NCT00903383|75879506|FG000|Overall Study|Physician Decision|1|||
42069376|NCT00903383|75879507|FG001|Overall Study|Physician Decision|2|||
42069377|NCT00903383|75879508|FG002|Overall Study|Physician Decision|0|||
42069378|NCT00903383|75879509|FG003|Overall Study|Physician Decision|0|||
42069379|NCT00903383|75879506|FG000|Overall Study|Lost to Follow-up|0|||
42069380|NCT00903383|75879507|FG001|Overall Study|Lost to Follow-up|0|||
42069381|NCT00903383|75879508|FG002|Overall Study|Lost to Follow-up|0|||
42069382|NCT00903383|75879509|FG003|Overall Study|Lost to Follow-up|1|||
42069383|NCT00903383|75879506|FG000|Overall Study|Decision of Sponsor|1|||
42069384|NCT00903383|75879507|FG001|Overall Study|Decision of Sponsor|0|||
42069385|NCT00903383|75879508|FG002|Overall Study|Decision of Sponsor|0|||
42069386|NCT00903383|75879509|FG003|Overall Study|Decision of Sponsor|0|||
42069387|NCT00903383|75879506|FG000|Overall Study|Withdrawal by Subject|4|||
42069388|NCT00903383|75879507|FG001|Overall Study|Withdrawal by Subject|1|||
42069389|NCT00903383|75879508|FG002|Overall Study|Withdrawal by Subject|0|||
42069390|NCT00903383|75879509|FG003|Overall Study|Withdrawal by Subject|2|||
42357659|NCT01396395|76203162|FG001|Overall Study|Withdrawal by Subject|12|||
42357660|NCT01396395|76203161|FG000|Overall Study|Protocol Violation|3|||
42357661|NCT01396395|76203162|FG001|Overall Study|Protocol Violation|1|||
42017133|NCT01133067|75824734|FG000|Overall Study|Lost to Follow-up|3|||
42069391|NCT00903383|75879506|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
42069392|NCT00903383|75879507|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
42069393|NCT00903383|75879508|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
42069394|NCT00903383|75879509|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
42069395|NCT00903383|75879506|FG000|Overall Study|Patient Decision|0|||
42069396|NCT00903383|75879507|FG001|Overall Study|Patient Decision|0|||
42069397|NCT00903383|75879508|FG002|Overall Study|Patient Decision|0|||
42069398|NCT00903383|75879509|FG003|Overall Study|Patient Decision|1|||
42069399|NCT02314026|75879519|FG000|Overall Study|Protocol Violation|28|||
42069400|NCT01617096|75879529|FG000|Overall Study|Withdrawal by Subject|96|||
42069401|NCT01617096|75879530|FG001|Overall Study|Withdrawal by Subject|81|||
42069402|NCT01617096|75879529|FG000|Overall Study|Lost to Follow-up|37|||
42069403|NCT01617096|75879530|FG001|Overall Study|Lost to Follow-up|32|||
42069404|NCT01617096|75879529|FG000|Overall Study|Physician Decision|10|||
42069405|NCT01617096|75879530|FG001|Overall Study|Physician Decision|18|||
42069406|NCT01617096|75879529|FG000|Overall Study|Death|4|||
42069407|NCT01617096|75879530|FG001|Overall Study|Death|3|||
42069408|NCT01617096|75879529|FG000|Overall Study|Other|1|||
42069409|NCT01617096|75879530|FG001|Overall Study|Other|3|||
42069410|NCT00900731|75879559|FG000|Overall Study|Adverse Event|31|||
42069411|NCT00900731|75879560|FG001|Overall Study|Adverse Event|27|||
42069412|NCT00900731|75879559|FG000|Overall Study|Withdrawal by Subject|8|||
42069413|NCT00900731|75879560|FG001|Overall Study|Withdrawal by Subject|7|||
42069414|NCT00900731|75879559|FG000|Overall Study|Protocol Deviation|8|||
42069415|NCT00900731|75879560|FG001|Overall Study|Protocol Deviation|11|||
42069416|NCT00900731|75879559|FG000|Overall Study|Administrative Problems|5|||
42069417|NCT00900731|75879560|FG001|Overall Study|Administrative Problems|4|||
42069418|NCT00900731|75879559|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
42069419|NCT00900731|75879560|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
42069420|NCT00900731|75879559|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
42069421|NCT00900731|75879560|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
42069422|NCT00900731|75879559|FG000|Overall Study|Lost to Follow-up|2|||
42069423|NCT00900731|75879560|FG001|Overall Study|Lost to Follow-up|3|||
42069424|NCT00900731|75879559|FG000|Overall Study|Lack of Efficacy|1|||
42069425|NCT00900731|75879560|FG001|Overall Study|Lack of Efficacy|3|||
42069426|NCT00900731|75879559|FG000|Overall Study|Death|0|||
42069427|NCT00900731|75879560|FG001|Overall Study|Death|2|||
42069428|NCT03842436|75879566|FG000|Overall Study|Lost to Follow-up|1|||
42069429|NCT00602472|75879606|FG000|Overall Study|Adverse Event|5|||
42069430|NCT00602472|75879607|FG001|Overall Study|Adverse Event|23|||
42357662|NCT01396395|76203161|FG000|Overall Study|Adverse Event|10|||
42017134|NCT01132755|75824738|FG000|Overall Study|Procedure not done due to medical reason|23|||
42017135|NCT01132755|75824738|FG000|Overall Study|Protocol Violation|15|||
42017136|NCT01132755|75824738|FG000|Overall Study|Withdrawal by Subject|4|||
42017137|NCT00919711|75824744|FG000|Overall Study|Withdrawal by Subject|15|||
42017138|NCT00919711|75824745|FG001|Overall Study|Withdrawal by Subject|7|||
42017139|NCT00919711|75824744|FG000|Overall Study|Adverse Event|13|||
42017140|NCT00919711|75824745|FG001|Overall Study|Adverse Event|3|||
42017141|NCT00919711|75824744|FG000|Overall Study|Other|1|||
42017142|NCT00919711|75824745|FG001|Overall Study|Other|2|||
42017143|NCT00919711|75824744|FG000|Overall Study|Administrative Decision|0|||
42017144|NCT00919711|75824745|FG001|Overall Study|Administrative Decision|1|||
42017145|NCT00919711|75824744|FG000|Overall Study|Lost to Follow-up|2|||
42069431|NCT00602472|75879606|FG000|Overall Study|Protocol Violation|4|||
42017146|NCT00919711|75824745|FG001|Overall Study|Lost to Follow-up|0|||
42017147|NCT00919711|75824744|FG000|Overall Study|Death|1|||
42069432|NCT00602472|75879607|FG001|Overall Study|Protocol Violation|19|||
42069433|NCT00602472|75879606|FG000|Overall Study|Withdrawal by Subject|8|||
42069434|NCT00602472|75879607|FG001|Overall Study|Withdrawal by Subject|14|||
42069435|NCT00602472|75879606|FG000|Overall Study|Other incl. lack of efficacy|4|||
42069436|NCT00602472|75879607|FG001|Overall Study|Other incl. lack of efficacy|2|||
42069437|NCT00901901|75879642|FG000|Treatment Period|Adverse Event|120|||
42069438|NCT00901901|75879643|FG001|Treatment Period|Adverse Event|128|||
42069439|NCT00901901|75879642|FG000|Treatment Period|Withdrawal by Subject|26|||
42069440|NCT00901901|75879643|FG001|Treatment Period|Withdrawal by Subject|24|||
42069441|NCT00901901|75879642|FG000|Treatment Period|Physician Decision|2|||
42069442|NCT00901901|75879643|FG001|Treatment Period|Physician Decision|2|||
42069443|NCT00901901|75879642|FG000|Treatment Period|Lost to Follow-up|3|||
42069444|NCT00901901|75879643|FG001|Treatment Period|Lost to Follow-up|5|||
42069445|NCT00901901|75879642|FG000|Treatment Period|Noncompliance with study medication|4|||
42176372|NCT00289913|75983705|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
42176373|NCT00289913|75983701|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
42176374|NCT00289913|75983702|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
42176375|NCT00289913|75983703|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
42017148|NCT00919711|75824745|FG001|Overall Study|Death|0|||
42017149|NCT00919711|75824744|FG000|Overall Study|Noncompliance|1|||
42017150|NCT00919711|75824745|FG001|Overall Study|Noncompliance|0|||
42017151|NCT01131585|75824753|FG000|Overall Study|Adverse Event|0|||
42017152|NCT01131585|75824754|FG001|Overall Study|Adverse Event|2|||
42017153|NCT01131585|75824753|FG000|Overall Study|Abnormal laboratory value|1|||
42017154|NCT01131585|75824754|FG001|Overall Study|Abnormal laboratory value|0|||
42017155|NCT01131585|75824753|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42017156|NCT01131585|75824754|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
42017157|NCT01131585|75824753|FG000|Overall Study|Protocol Violation|2|||
42017158|NCT01131585|75824754|FG001|Overall Study|Protocol Violation|1|||
42017159|NCT01131585|75824753|FG000|Overall Study|Withdrawal by Subject|3|||
42017160|NCT01131585|75824754|FG001|Overall Study|Withdrawal by Subject|3|||
42017161|NCT01131585|75824753|FG000|Overall Study|Lost to Follow-up|0|||
42176376|NCT00289913|75983704|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
42176377|NCT00289913|75983705|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
42176378|NCT00289913|75983701|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
42176379|NCT00289913|75983702|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
42176380|NCT00289913|75983703|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
42176381|NCT00289913|75983704|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
42176382|NCT00289913|75983705|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
42176383|NCT00289913|75983701|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
42017162|NCT01131585|75824754|FG001|Overall Study|Lost to Follow-up|1|||
42017163|NCT01131585|75824753|FG000|Overall Study|Administrative problems|1|||
42017164|NCT01131585|75824754|FG001|Overall Study|Administrative problems|1|||
42017165|NCT01131585|75824753|FG000|Overall Study|Study termination|78|||
42017166|NCT01131585|75824754|FG001|Overall Study|Study termination|32|||
42017167|NCT01131507|75824760|FG000|Overall Study|Adverse Event|1|||
42017168|NCT01131507|75824760|FG000|Overall Study|Lost to Follow-up|1|||
42017169|NCT01131507|75824760|FG000|Overall Study|Withdrawal by Subject|1|||
42017170|NCT01131351|75824766|FG000|Overall Study|Adverse Event|0|||
42017171|NCT01131351|75824767|FG001|Overall Study|Adverse Event|2|||
42176384|NCT00289913|75983702|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
42176385|NCT00289913|75983703|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
42176386|NCT00289913|75983704|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
42176387|NCT00289913|75983705|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
42176388|NCT00289913|75983701|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
42176389|NCT00289913|75983702|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
42176390|NCT00289913|75983703|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
42176391|NCT00289913|75983704|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
42176392|NCT00289913|75983705|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
42176393|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42176394|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42176395|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
42176396|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42176397|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42176398|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
42176399|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
42176400|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
42176401|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
42176402|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
42017172|NCT01131351|75824766|FG000|Overall Study|Protocol Deviation|0|||
42017173|NCT01131351|75824767|FG001|Overall Study|Protocol Deviation|1|||
42017174|NCT00919633|75824777|FG000|Overall Study|Adverse Event|1|||
42069446|NCT00901901|75879643|FG001|Treatment Period|Noncompliance with study medication|1|||
42069447|NCT00901901|75879642|FG000|Treatment Period|Missing|1|||
42069448|NCT00901901|75879643|FG001|Treatment Period|Missing|0|||
42069449|NCT00901901|75879642|FG000|Treatment Period|Never treated|0|||
42069450|NCT00901901|75879643|FG001|Treatment Period|Never treated|3|||
42069451|NCT00901901|75879642|FG000|Treatment Period|Protocol driven decision point|0|||
42069452|NCT00901901|75879643|FG001|Treatment Period|Protocol driven decision point|2|||
42069453|NCT00901901|75879642|FG000|Treatment Period|Study terminated by sponsor|2|||
42069454|NCT00901901|75879643|FG001|Treatment Period|Study terminated by sponsor|0|||
42069455|NCT00901901|75879642|FG000|Treatment Period|Protocol Violation|5|||
42069456|NCT00901901|75879643|FG001|Treatment Period|Protocol Violation|9|||
42069457|NCT00901901|75879642|FG000|Treatment Period|Switch to commercial drug|1|||
42069458|NCT00901901|75879643|FG001|Treatment Period|Switch to commercial drug|1|||
42069459|NCT00901901|75879642|FG000|Treatment Period|Transfer to treatment continuation study|5|||
42069460|NCT00901901|75879643|FG001|Treatment Period|Transfer to treatment continuation study|2|||
42069461|NCT00901901|75879642|FG000|Follow-up Period|Death|181|||
42069462|NCT00901901|75879643|FG001|Follow-up Period|Death|208|||
42069463|NCT00901901|75879642|FG000|Follow-up Period|Protocol driven decision point|47|||
42069464|NCT00901901|75879643|FG001|Follow-up Period|Protocol driven decision point|36|||
42069465|NCT00901901|75879642|FG000|Follow-up Period|Withdrawal by Subject|6|||
42069466|NCT00901901|75879643|FG001|Follow-up Period|Withdrawal by Subject|9|||
42069467|NCT00901901|75879642|FG000|Follow-up Period|Lost to Follow-up|12|||
42069468|NCT00901901|75879643|FG001|Follow-up Period|Lost to Follow-up|8|||
42069469|NCT00901901|75879642|FG000|Follow-up Period|Missing|94|||
42069470|NCT00901901|75879643|FG001|Follow-up Period|Missing|80|||
42069471|NCT02143778|75879651|FG000|Overall Study|Withdrawal by Subject|2|||
42069472|NCT02143778|75879651|FG000|Overall Study|Device malfunction|1|||
42069473|NCT00896363|75879695|FG000|Overall Study|Adverse Event|3|||
42069474|NCT00896363|75879696|FG001|Overall Study|Adverse Event|4|||
42069475|NCT00896363|75879697|FG002|Overall Study|Adverse Event|2|||
42069476|NCT00896363|75879695|FG000|Overall Study|Lack of Efficacy|0|||
42069477|NCT00896363|75879696|FG001|Overall Study|Lack of Efficacy|2|||
42069478|NCT00896363|75879697|FG002|Overall Study|Lack of Efficacy|1|||
42069479|NCT00896363|75879695|FG000|Overall Study|Withdrawal by Subject|3|||
42069480|NCT00896363|75879696|FG001|Overall Study|Withdrawal by Subject|5|||
42069481|NCT00896363|75879697|FG002|Overall Study|Withdrawal by Subject|5|||
42069482|NCT00900029|75879713|FG000|Overall Study|Lost to Follow-up|0|||
42069483|NCT00900029|75879714|FG001|Overall Study|Lost to Follow-up|2|||
42069484|NCT00900029|75879715|FG002|Overall Study|Lost to Follow-up|1|||
42069485|NCT00900029|75879716|FG003|Overall Study|Lost to Follow-up|4|||
42069486|NCT00900029|75879717|FG004|Overall Study|Lost to Follow-up|4|||
42069487|NCT00900029|75879713|FG000|Overall Study|Withdrawal by Subject|2|||
42069488|NCT00900029|75879714|FG001|Overall Study|Withdrawal by Subject|2|||
42069489|NCT00900029|75879715|FG002|Overall Study|Withdrawal by Subject|1|||
42069490|NCT00900029|75879716|FG003|Overall Study|Withdrawal by Subject|1|||
42069491|NCT00900029|75879717|FG004|Overall Study|Withdrawal by Subject|1|||
42069492|NCT00900029|75879713|FG000|Overall Study|Adverse Event|0|||
42069493|NCT00900029|75879714|FG001|Overall Study|Adverse Event|0|||
42069494|NCT00900029|75879715|FG002|Overall Study|Adverse Event|1|||
42069495|NCT00900029|75879716|FG003|Overall Study|Adverse Event|1|||
42069496|NCT00900029|75879717|FG004|Overall Study|Adverse Event|1|||
42069497|NCT00900029|75879713|FG000|Overall Study|Death|1|||
42069498|NCT00900029|75879714|FG001|Overall Study|Death|0|||
42069499|NCT00900029|75879715|FG002|Overall Study|Death|0|||
42069500|NCT00900029|75879716|FG003|Overall Study|Death|1|||
42069501|NCT00900029|75879717|FG004|Overall Study|Death|0|||
42069502|NCT00896051|75879735|FG000|Overall Study|Adverse Event|2|||
42069503|NCT00896051|75879736|FG001|Overall Study|Adverse Event|1|||
42069504|NCT00896051|75879735|FG000|Overall Study|Lost to Follow-up|3|||
42069505|NCT00896051|75879736|FG001|Overall Study|Lost to Follow-up|2|||
42069506|NCT00896051|75879735|FG000|Overall Study|Withdrawal by Subject|3|||
42069507|NCT00896051|75879736|FG001|Overall Study|Withdrawal by Subject|2|||
42069508|NCT00896051|75879735|FG000|Overall Study|Subject noncompliant|1|||
42069509|NCT00896051|75879736|FG001|Overall Study|Subject noncompliant|3|||
42069510|NCT00896051|75879735|FG000|Overall Study|Other|1|||
42069511|NCT00896051|75879736|FG001|Overall Study|Other|1|||
42069512|NCT00894647|75879753|FG000|Overall Study|Adverse Event|5|||
42069513|NCT00894647|75879754|FG001|Overall Study|Adverse Event|4|||
42069514|NCT00894647|75879753|FG000|Overall Study|Withdrawal by Subject|4|||
42069515|NCT00894647|75879754|FG001|Overall Study|Withdrawal by Subject|4|||
42069516|NCT00894647|75879753|FG000|Overall Study|Lost to Follow-up|0|||
42069517|NCT00894647|75879754|FG001|Overall Study|Lost to Follow-up|2|||
42069518|NCT00894647|75879753|FG000|Overall Study|Non-compliance with study procedures|0|||
42176403|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
42069519|NCT00894647|75879754|FG001|Overall Study|Non-compliance with study procedures|2|||
42357663|NCT01396395|76203162|FG001|Overall Study|Adverse Event|2|||
42069520|NCT00894647|75879753|FG000|Overall Study|Other, not due to AE|1|||
42069521|NCT00894647|75879754|FG001|Overall Study|Other, not due to AE|2|||
42069522|NCT00892775|75879762|FG000|Overall Study|Protocol Violation|1|||
42069523|NCT00892775|75879763|FG001|Overall Study|Protocol Violation|0|||
42069524|NCT00892775|75879762|FG000|Overall Study|Subject difficulties with blood drawing|1|||
42069525|NCT00892775|75879763|FG001|Overall Study|Subject difficulties with blood drawing|0|||
42069526|NCT00892775|75879762|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
42069527|NCT00892775|75879763|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
42069528|NCT00892775|75879762|FG000|Overall Study|Migrated/ moved from study area|1|||
42069529|NCT00892775|75879763|FG001|Overall Study|Migrated/ moved from study area|0|||
42069530|NCT00892775|75879762|FG000|Overall Study|Withdrawal by Subject|0|||
42069531|NCT00892775|75879763|FG001|Overall Study|Withdrawal by Subject|1|||
42069532|NCT00892775|75879762|FG000|Overall Study|Lost to Follow-up|1|||
42069533|NCT00892775|75879763|FG001|Overall Study|Lost to Follow-up|0|||
42069534|NCT00895895|75879774|FG000|Period 1|Adverse Event|7|||
42069535|NCT00895895|75879775|FG001|Period 1|Adverse Event|6|||
42069536|NCT00895895|75879776|FG002|Period 1|Adverse Event|4|||
42069537|NCT00895895|75879777|FG003|Period 1|Adverse Event|6|||
42069538|NCT00895895|75879778|FG004|Period 1|Adverse Event|7|||
42069539|NCT00895895|75879774|FG000|Period 1|Death|0|||
42069540|NCT00895895|75879775|FG001|Period 1|Death|0|||
42069541|NCT00895895|75879776|FG002|Period 1|Death|0|||
42069542|NCT00895895|75879777|FG003|Period 1|Death|0|||
42069543|NCT00895895|75879778|FG004|Period 1|Death|1|||
42069544|NCT00895895|75879774|FG000|Period 1|discontinued by sponsor|2|||
42069545|NCT00895895|75879775|FG001|Period 1|discontinued by sponsor|1|||
42069546|NCT00895895|75879776|FG002|Period 1|discontinued by sponsor|2|||
42069547|NCT00895895|75879777|FG003|Period 1|discontinued by sponsor|1|||
42069548|NCT00895895|75879778|FG004|Period 1|discontinued by sponsor|1|||
42069549|NCT00895895|75879774|FG000|Period 1|failed to return|0|||
42069550|NCT00895895|75879775|FG001|Period 1|failed to return|0|||
42069551|NCT00895895|75879776|FG002|Period 1|failed to return|1|||
42069552|NCT00895895|75879777|FG003|Period 1|failed to return|0|||
42069553|NCT00895895|75879778|FG004|Period 1|failed to return|1|||
42069554|NCT00895895|75879774|FG000|Period 1|investigator request|0|||
42069555|NCT00895895|75879775|FG001|Period 1|investigator request|1|||
42069556|NCT00895895|75879776|FG002|Period 1|investigator request|0|||
42069557|NCT00895895|75879777|FG003|Period 1|investigator request|0|||
42069558|NCT00895895|75879778|FG004|Period 1|investigator request|0|||
42069559|NCT00895895|75879774|FG000|Period 1|Lost to Follow-up|2|||
42017175|NCT00919633|75824778|FG001|Overall Study|Adverse Event|9|||
42017176|NCT00919633|75824779|FG002|Overall Study|Adverse Event|12|||
42017177|NCT00919633|75824780|FG003|Overall Study|Adverse Event|10|||
42017178|NCT00919633|75824777|FG000|Overall Study|Death|0|||
42017179|NCT00919633|75824778|FG001|Overall Study|Death|0|||
42017180|NCT00919633|75824779|FG002|Overall Study|Death|2|||
42017181|NCT00919633|75824780|FG003|Overall Study|Death|0|||
42017182|NCT00919633|75824777|FG000|Overall Study|Lack of Efficacy|17|||
42017183|NCT00919633|75824778|FG001|Overall Study|Lack of Efficacy|3|||
42017184|NCT00919633|75824779|FG002|Overall Study|Lack of Efficacy|2|||
42017185|NCT00919633|75824780|FG003|Overall Study|Lack of Efficacy|3|||
42017186|NCT00919633|75824777|FG000|Overall Study|Withdrawal by Subject|1|||
42017187|NCT00919633|75824778|FG001|Overall Study|Withdrawal by Subject|2|||
42017188|NCT00919633|75824779|FG002|Overall Study|Withdrawal by Subject|4|||
42017189|NCT00919633|75824780|FG003|Overall Study|Withdrawal by Subject|3|||
42017190|NCT00919633|75824777|FG000|Overall Study|Lost to Follow-up|3|||
42017191|NCT00919633|75824778|FG001|Overall Study|Lost to Follow-up|1|||
42017192|NCT00919633|75824779|FG002|Overall Study|Lost to Follow-up|0|||
42017193|NCT00919633|75824780|FG003|Overall Study|Lost to Follow-up|2|||
42017194|NCT00919633|75824777|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
42017195|NCT00919633|75824778|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
42017196|NCT00919633|75824779|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
42017197|NCT00919633|75824780|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
42017198|NCT00919633|75824777|FG000|Overall Study|Protocol Violation|0|||
42017199|NCT00919633|75824778|FG001|Overall Study|Protocol Violation|0|||
42017200|NCT00919633|75824779|FG002|Overall Study|Protocol Violation|0|||
42017201|NCT00919633|75824780|FG003|Overall Study|Protocol Violation|1|||
42017202|NCT00919633|75824777|FG000|Overall Study|Physician Decision|0|||
42017203|NCT00919633|75824778|FG001|Overall Study|Physician Decision|0|||
42017204|NCT00919633|75824779|FG002|Overall Study|Physician Decision|0|||
42017205|NCT00919633|75824780|FG003|Overall Study|Physician Decision|1|||
42017206|NCT00919633|75824777|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
42017207|NCT00919633|75824778|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
42017208|NCT00919633|75824779|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
42069560|NCT00895895|75879775|FG001|Period 1|Lost to Follow-up|1|||
42069561|NCT00895895|75879776|FG002|Period 1|Lost to Follow-up|3|||
42069562|NCT00895895|75879777|FG003|Period 1|Lost to Follow-up|2|||
42069563|NCT00895895|75879778|FG004|Period 1|Lost to Follow-up|3|||
42069564|NCT00895895|75879774|FG000|Period 1|Other|1|||
42069565|NCT00895895|75879775|FG001|Period 1|Other|2|||
42069566|NCT00895895|75879776|FG002|Period 1|Other|1|||
42069567|NCT00895895|75879777|FG003|Period 1|Other|1|||
42069568|NCT00895895|75879778|FG004|Period 1|Other|1|||
42069569|NCT00895895|75879774|FG000|Period 1|Protocol Violation|0|||
42069570|NCT00895895|75879775|FG001|Period 1|Protocol Violation|1|||
42069571|NCT00895895|75879776|FG002|Period 1|Protocol Violation|0|||
42069572|NCT00895895|75879777|FG003|Period 1|Protocol Violation|0|||
42069573|NCT00895895|75879778|FG004|Period 1|Protocol Violation|0|||
42069574|NCT00895895|75879774|FG000|Period 1|Withdrawal by Subject|6|||
42069575|NCT00895895|75879775|FG001|Period 1|Withdrawal by Subject|6|||
42292648|NCT01126736|76126464|FG000|Overall Study|Administrative reasons|0|||
42292649|NCT01126736|76126465|FG001|Overall Study|Administrative reasons|0|||
42069576|NCT00895895|75879776|FG002|Period 1|Withdrawal by Subject|8|||
42069577|NCT00895895|75879777|FG003|Period 1|Withdrawal by Subject|2|||
42069578|NCT00895895|75879778|FG004|Period 1|Withdrawal by Subject|4|||
42069579|NCT00895895|75879774|FG000|Period 1|unsatisfactory response-efficacy|2|||
42069580|NCT00895895|75879775|FG001|Period 1|unsatisfactory response-efficacy|0|||
42069581|NCT00895895|75879776|FG002|Period 1|unsatisfactory response-efficacy|0|||
42069582|NCT00895895|75879777|FG003|Period 1|unsatisfactory response-efficacy|0|||
42069583|NCT00895895|75879778|FG004|Period 1|unsatisfactory response-efficacy|0|||
42069584|NCT00895895|75879774|FG000|Period 1|randomized and not treated|1|||
42069585|NCT00895895|75879775|FG001|Period 1|randomized and not treated|3|||
42069586|NCT00895895|75879776|FG002|Period 1|randomized and not treated|1|||
42069587|NCT00895895|75879777|FG003|Period 1|randomized and not treated|1|||
42069588|NCT00895895|75879778|FG004|Period 1|randomized and not treated|2|||
42069589|NCT00895895|75879774|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
42069590|NCT00895895|75879775|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
42069591|NCT00895895|75879776|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
42069592|NCT00895895|75879777|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
42069593|NCT00895895|75879778|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
42069594|NCT00895895|75879774|FG000|After Period 1, Prior to Period 2|Other|0|||
42069595|NCT00895895|75879775|FG001|After Period 1, Prior to Period 2|Other|0|||
42069596|NCT00895895|75879776|FG002|After Period 1, Prior to Period 2|Other|1|||
42069597|NCT00895895|75879777|FG003|After Period 1, Prior to Period 2|Other|0|||
42069598|NCT00895895|75879778|FG004|After Period 1, Prior to Period 2|Other|0|||
42069599|NCT00895895|75879774|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
42069600|NCT00895895|75879775|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
42069601|NCT00895895|75879776|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
42069602|NCT00895895|75879777|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
42069603|NCT00895895|75879778|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
42069604|NCT00895895|75879774|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
42069605|NCT00895895|75879775|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
42069606|NCT00895895|75879776|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
42069607|NCT00895895|75879777|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
42069608|NCT00895895|75879778|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
42069609|NCT00895895|75879774|FG000|Period 2|Adverse Event|3|||
42069610|NCT00895895|75879775|FG001|Period 2|Adverse Event|3|||
42069611|NCT00895895|75879776|FG002|Period 2|Adverse Event|5|||
42069612|NCT00895895|75879777|FG003|Period 2|Adverse Event|2|||
42069613|NCT00895895|75879778|FG004|Period 2|Adverse Event|5|||
42069614|NCT00895895|75879774|FG000|Period 2|Death|0|||
42069615|NCT00895895|75879775|FG001|Period 2|Death|0|||
42069616|NCT00895895|75879776|FG002|Period 2|Death|1|||
42069617|NCT00895895|75879777|FG003|Period 2|Death|0|||
42069618|NCT00895895|75879778|FG004|Period 2|Death|0|||
42069619|NCT00895895|75879774|FG000|Period 2|discontinued by sponsor|44|||
42069620|NCT00895895|75879775|FG001|Period 2|discontinued by sponsor|44|||
42069621|NCT00895895|75879776|FG002|Period 2|discontinued by sponsor|38|||
42069622|NCT00895895|75879777|FG003|Period 2|discontinued by sponsor|46|||
42069623|NCT00895895|75879778|FG004|Period 2|discontinued by sponsor|37|||
42069624|NCT00895895|75879774|FG000|Period 2|failed to return|2|||
42069625|NCT00895895|75879775|FG001|Period 2|failed to return|0|||
42069626|NCT00895895|75879776|FG002|Period 2|failed to return|0|||
42069627|NCT00895895|75879777|FG003|Period 2|failed to return|0|||
42292650|NCT01126736|76126466|FG002|Overall Study|Administrative reasons|0|||
42069628|NCT00895895|75879778|FG004|Period 2|failed to return|0|||
42069629|NCT00895895|75879774|FG000|Period 2|investigator request|2|||
42069630|NCT00895895|75879775|FG001|Period 2|investigator request|0|||
42069631|NCT00895895|75879776|FG002|Period 2|investigator request|0|||
42069632|NCT00895895|75879777|FG003|Period 2|investigator request|0|||
42069633|NCT00895895|75879778|FG004|Period 2|investigator request|0|||
42069634|NCT00895895|75879774|FG000|Period 2|Lost to Follow-up|1|||
42069635|NCT00895895|75879775|FG001|Period 2|Lost to Follow-up|2|||
42069636|NCT00895895|75879776|FG002|Period 2|Lost to Follow-up|1|||
42069637|NCT00895895|75879777|FG003|Period 2|Lost to Follow-up|1|||
42069638|NCT00895895|75879778|FG004|Period 2|Lost to Follow-up|0|||
42069639|NCT00895895|75879774|FG000|Period 2|Other|1|||
42069640|NCT00895895|75879775|FG001|Period 2|Other|1|||
42069641|NCT00895895|75879776|FG002|Period 2|Other|3|||
42069642|NCT00895895|75879777|FG003|Period 2|Other|1|||
42069643|NCT00895895|75879778|FG004|Period 2|Other|1|||
42292651|NCT01126736|76126467|FG003|Overall Study|Administrative reasons|0|||
42292652|NCT01126736|76126468|FG004|Overall Study|Administrative reasons|1|||
42069644|NCT00895895|75879774|FG000|Period 2|Protocol Violation|1|||
42069645|NCT00895895|75879775|FG001|Period 2|Protocol Violation|0|||
42069646|NCT00895895|75879776|FG002|Period 2|Protocol Violation|1|||
42069647|NCT00895895|75879777|FG003|Period 2|Protocol Violation|1|||
42069648|NCT00895895|75879778|FG004|Period 2|Protocol Violation|1|||
42069649|NCT00895895|75879774|FG000|Period 2|Withdrawal by Subject|0|||
42069650|NCT00895895|75879775|FG001|Period 2|Withdrawal by Subject|2|||
42069651|NCT00895895|75879776|FG002|Period 2|Withdrawal by Subject|0|||
42069652|NCT00895895|75879777|FG003|Period 2|Withdrawal by Subject|3|||
42069653|NCT00895895|75879778|FG004|Period 2|Withdrawal by Subject|5|||
42069654|NCT00895895|75879774|FG000|Period 2|unsatisfactory response-efficacy|2|||
42069655|NCT00895895|75879775|FG001|Period 2|unsatisfactory response-efficacy|1|||
42069656|NCT00895895|75879776|FG002|Period 2|unsatisfactory response-efficacy|0|||
42069657|NCT00895895|75879777|FG003|Period 2|unsatisfactory response-efficacy|0|||
42069658|NCT00895895|75879778|FG004|Period 2|unsatisfactory response-efficacy|0|||
42069659|NCT00895661|75879796|FG000|Overall Study|Death|1|||
42069660|NCT00895661|75879796|FG000|Overall Study|reason unknown|2|||
42069661|NCT00895583|75879802|FG000|Overall Study|Adverse Event|28|||
42069662|NCT00895583|75879803|FG001|Overall Study|Adverse Event|4|||
42069663|NCT00895583|75879802|FG000|Overall Study|Death|2|||
42069664|NCT00895583|75879803|FG001|Overall Study|Death|1|||
42069665|NCT00895583|75879802|FG000|Overall Study|Physician Decision|3|||
42069666|NCT00895583|75879803|FG001|Overall Study|Physician Decision|1|||
42069667|NCT00895583|75879802|FG000|Overall Study|Lost to Follow-up|1|||
42069668|NCT00895583|75879803|FG001|Overall Study|Lost to Follow-up|3|||
42069669|NCT00895583|75879802|FG000|Overall Study|Protocol Violation|1|||
42069670|NCT00895583|75879803|FG001|Overall Study|Protocol Violation|0|||
42069671|NCT00895583|75879802|FG000|Overall Study|Withdrawal by Subject|4|||
42069672|NCT00895583|75879803|FG001|Overall Study|Withdrawal by Subject|2|||
42069673|NCT00895583|75879802|FG000|Overall Study|Lack of Efficacy|5|||
42069674|NCT00895583|75879803|FG001|Overall Study|Lack of Efficacy|0|||
42069675|NCT00895583|75879802|FG000|Overall Study|Other|0|||
42069676|NCT00895583|75879803|FG001|Overall Study|Other|1|||
42069677|NCT00894413|75879820|FG000|Overall Study|Physician Decision|0|||
42176404|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
42176405|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
42176406|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
42176407|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
42176408|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
42176409|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
42176410|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
42176411|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
42176412|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
42176413|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
42292653|NCT01126736|76126464|FG000|Overall Study|Progressive disease|0|||
42292654|NCT01126736|76126465|FG001|Overall Study|Progressive disease|0|||
42292655|NCT01126736|76126466|FG002|Overall Study|Progressive disease|0|||
42292656|NCT01126736|76126467|FG003|Overall Study|Progressive disease|2|||
42292657|NCT01126736|76126468|FG004|Overall Study|Progressive disease|1|||
42292658|NCT01126736|76126464|FG000|Overall Study|Withdrawal by Subject|0|||
42292659|NCT01126736|76126465|FG001|Overall Study|Withdrawal by Subject|0|||
42292660|NCT01126736|76126466|FG002|Overall Study|Withdrawal by Subject|0|||
42292661|NCT01126736|76126467|FG003|Overall Study|Withdrawal by Subject|1|||
42357664|NCT01396395|76203161|FG000|Overall Study|Lost to Follow-up|17|||
42017209|NCT00919633|75824780|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
42017210|NCT00919633|75824777|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
42017211|NCT00919633|75824778|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
42017212|NCT00919633|75824779|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
42017213|NCT00919633|75824780|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
42017214|NCT01130883|75824790|FG000|Overall Study|Patient Noncompliance|6|||
42017215|NCT01130883|75824790|FG000|Overall Study|Reason Unknown|1|||
42017216|NCT01130883|75824790|FG000|Overall Study|Adverse Event|3|||
42017217|NCT00926029|75824797|FG000|Overall Study|Lost to Follow-up|2|||
42017218|NCT00926029|75824798|FG001|Overall Study|Lost to Follow-up|1|||
42017219|NCT00926029|75824799|FG002|Overall Study|Lost to Follow-up|1|||
42069678|NCT00894413|75879821|FG001|Overall Study|Physician Decision|2|||
42069679|NCT00894413|75879820|FG000|Overall Study|Adverse Event|0|||
42069680|NCT00894413|75879821|FG001|Overall Study|Adverse Event|2|||
42069681|NCT00894413|75879820|FG000|Overall Study|Withdrawal by Subject|0|||
42069682|NCT00894413|75879821|FG001|Overall Study|Withdrawal by Subject|4|||
42069683|NCT00895037|75879830|FG000|Overall Study|Death|0|||
42069684|NCT00895037|75879831|FG001|Overall Study|Death|2|||
42069685|NCT00895037|75879832|FG002|Overall Study|Death|1|||
42069686|NCT00892151|75879840|FG000|Overall Study|Protocol Violation|1|||
42069687|NCT01706705|75879844|FG000|Overall Study|Death|1|||
42069688|NCT01706705|75879844|FG000|Overall Study|Lack of Efficacy|13|||
42069689|NCT01706705|75879844|FG000|Overall Study|Non-clinical|6|||
42069690|NCT00894803|75879860|FG000|Overall Study|Death|20|||
42069691|NCT00894803|75879861|FG001|Overall Study|Death|4|||
42069692|NCT00894803|75879860|FG000|Overall Study|Lost to Follow-up|0|||
42069693|NCT00894803|75879861|FG001|Overall Study|Lost to Follow-up|1|||
42069694|NCT00601458|75879870|FG000|Overall Study|Dosing Error|1|||
42069695|NCT00601458|75879871|FG001|Overall Study|Dosing Error|0|||
42069696|NCT00601458|75879872|FG002|Overall Study|Dosing Error|0|||
42069697|NCT00601458|75879870|FG000|Overall Study|Incomplete Data|0|||
42069698|NCT00601458|75879871|FG001|Overall Study|Incomplete Data|2|||
42069699|NCT00601458|75879872|FG002|Overall Study|Incomplete Data|0|||
42069700|NCT00601458|75879870|FG000|Overall Study|Protocol Violation|3|||
42069701|NCT00601458|75879871|FG001|Overall Study|Protocol Violation|2|||
42069702|NCT00601458|75879872|FG002|Overall Study|Protocol Violation|1|||
42069703|NCT00601458|75879870|FG000|Overall Study|Early Termination|0|||
42069704|NCT00601458|75879871|FG001|Overall Study|Early Termination|1|||
42069705|NCT00601458|75879872|FG002|Overall Study|Early Termination|1|||
42069706|NCT02141282|75879884|FG000|Overall Study|Adverse event, not related to progression|8|||
42069707|NCT02141282|75879885|FG001|Overall Study|Adverse event, not related to progression|1|||
42069708|NCT02141282|75879886|FG002|Overall Study|Adverse event, not related to progression|3|||
42069709|NCT02141282|75879887|FG003|Overall Study|Adverse event, not related to progression|1|||
42069710|NCT02141282|75879884|FG000|Overall Study|Adverse event, related to progression|1|||
42069711|NCT02141282|75879885|FG001|Overall Study|Adverse event, related to progression|0|||
42069712|NCT02141282|75879886|FG002|Overall Study|Adverse event, related to progression|2|||
42069713|NCT02141282|75879887|FG003|Overall Study|Adverse event, related to progression|0|||
42069714|NCT02141282|75879884|FG000|Overall Study|COVID-19 infection|1|||
42069715|NCT02141282|75879885|FG001|Overall Study|COVID-19 infection|0|||
42069716|NCT02141282|75879886|FG002|Overall Study|COVID-19 infection|0|||
42069717|NCT02141282|75879887|FG003|Overall Study|COVID-19 infection|0|||
42069718|NCT02141282|75879884|FG000|Overall Study|Lost to Follow-up|0|||
42069719|NCT02141282|75879885|FG001|Overall Study|Lost to Follow-up|0|||
42069720|NCT02141282|75879886|FG002|Overall Study|Lost to Follow-up|4|||
42069721|NCT02141282|75879887|FG003|Overall Study|Lost to Follow-up|2|||
42069722|NCT02141282|75879884|FG000|Overall Study|Other, not specified|14|||
42069723|NCT02141282|75879885|FG001|Overall Study|Other, not specified|11|||
42069724|NCT02141282|75879886|FG002|Overall Study|Other, not specified|23|||
42069725|NCT02141282|75879887|FG003|Overall Study|Other, not specified|9|||
42069726|NCT02141282|75879884|FG000|Overall Study|Progressive disease, Richter's|4|||
42069727|NCT02141282|75879885|FG001|Overall Study|Progressive disease, Richter's|1|||
42069728|NCT02141282|75879886|FG002|Overall Study|Progressive disease, Richter's|1|||
42069729|NCT02141282|75879887|FG003|Overall Study|Progressive disease, Richter's|1|||
42069730|NCT02141282|75879884|FG000|Overall Study|Progressive disease per protocol|12|||
42069731|NCT02141282|75879885|FG001|Overall Study|Progressive disease per protocol|7|||
42069732|NCT02141282|75879886|FG002|Overall Study|Progressive disease per protocol|9|||
42069733|NCT02141282|75879887|FG003|Overall Study|Progressive disease per protocol|2|||
42069734|NCT02141282|75879884|FG000|Overall Study|Stem cell transplant|1|||
42069735|NCT02141282|75879885|FG001|Overall Study|Stem cell transplant|0|||
42069736|NCT02141282|75879886|FG002|Overall Study|Stem cell transplant|1|||
42069737|NCT02141282|75879887|FG003|Overall Study|Stem cell transplant|0|||
42069738|NCT02141282|75879884|FG000|Overall Study|Study terminated by Sponsor|0|||
42069739|NCT02141282|75879885|FG001|Overall Study|Study terminated by Sponsor|1|||
42069740|NCT02141282|75879886|FG002|Overall Study|Study terminated by Sponsor|0|||
42069741|NCT02141282|75879887|FG003|Overall Study|Study terminated by Sponsor|0|||
42069742|NCT02141282|75879884|FG000|Overall Study|Subject non-compliance|0|||
42069743|NCT02141282|75879885|FG001|Overall Study|Subject non-compliance|0|||
42069744|NCT02141282|75879886|FG002|Overall Study|Subject non-compliance|1|||
42069745|NCT02141282|75879887|FG003|Overall Study|Subject non-compliance|0|||
42069746|NCT02141282|75879884|FG000|Overall Study|Withdrew consent|2|||
42069747|NCT02141282|75879885|FG001|Overall Study|Withdrew consent|0|||
42069748|NCT02141282|75879886|FG002|Overall Study|Withdrew consent|4|||
42069749|NCT02141282|75879887|FG003|Overall Study|Withdrew consent|0|||
42069750|NCT00003479|75879900|FG000|Overall Study|Not evaluable|3|||
42069751|NCT00891839|75879904|FG000|Overall Study|Adverse Event|2|||
42069752|NCT00891839|75879904|FG000|Overall Study|Withdrawal by Subject|2|||
42069753|NCT00891839|75879904|FG000|Overall Study|Disease progression|3|||
42069754|NCT00600756|75879910|FG000|Analysis After 6 Months|Adverse Event|43|||
42069755|NCT00600756|75879911|FG001|Analysis After 6 Months|Adverse Event|33|||
42069756|NCT00600756|75879910|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
42069757|NCT00600756|75879911|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
42069758|NCT00600756|75879910|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
42069759|NCT00600756|75879911|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
42069760|NCT00600756|75879910|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
42069761|NCT00600756|75879911|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
42069762|NCT00600756|75879910|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
42176414|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
42176415|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
42176416|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
42176417|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
42176418|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
42176419|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
42176420|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
42176421|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
42176422|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
42176423|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
42176424|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
42176425|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
42176426|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
42176427|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
42176428|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
42176429|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
42176430|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
42176431|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
42176432|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
42176433|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
42176434|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
42176435|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
42176436|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
42176437|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
42017220|NCT01130493|75824809|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
42017221|NCT01130493|75824810|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
42017222|NCT01130493|75824811|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
42017223|NCT01130493|75824809|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
42017224|NCT01130493|75824810|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
42017225|NCT01130493|75824811|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
42017226|NCT01130493|75824809|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
42017227|NCT01130493|75824810|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
42176438|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
42176439|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
42176440|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
42176441|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
42176442|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
42176443|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
42176444|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
42176445|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
42176446|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
42176447|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
42176448|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
42176449|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
42176450|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
42017228|NCT01130493|75824811|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
42069763|NCT00600756|75879911|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
42069764|NCT00600756|75879910|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
42069765|NCT00600756|75879911|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
42069766|NCT00600756|75879910|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
42069767|NCT00600756|75879911|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
42069768|NCT00600756|75879910|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
42069769|NCT00600756|75879911|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
42069770|NCT00600756|75879910|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
42069771|NCT00600756|75879911|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
42069772|NCT00600756|75879910|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
42069773|NCT00600756|75879911|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
42069774|NCT00600756|75879910|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
42069775|NCT00600756|75879911|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
42069776|NCT00600756|75879910|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
42069777|NCT00600756|75879911|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
42069778|NCT00600756|75879910|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
42069779|NCT00600756|75879911|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
42069780|NCT00600756|75879910|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
42069781|NCT00600756|75879911|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
42069782|NCT00890825|75879923|FG000|Overall Study|Withdrawal by Subject|1|||
42069783|NCT00890825|75879924|FG001|Overall Study|Withdrawal by Subject|0|||
42069784|NCT00890825|75879923|FG000|Overall Study|Alive at data cut off (DCO)|13|||
42069785|NCT00890825|75879924|FG001|Overall Study|Alive at data cut off (DCO)|14|||
42069786|NCT00890201|75879932|FG000|Overall Study|Protocol Violation|5|||
42069787|NCT00890201|75879933|FG001|Overall Study|Protocol Violation|56|||
42069788|NCT00891527|75879939|FG000|Overall Study|Withdrawal by Subject|2|||
42069789|NCT03861078|75879944|FG000|Overall Study|COVID-19 shut down|4|||
42069790|NCT03861078|75879944|FG000|Overall Study|Lost to Follow-up|1|||
42069791|NCT03861078|75879944|FG000|Overall Study|Protocol Violation|2|||
42069792|NCT03861078|75879944|FG000|Overall Study|lack of venous access|1|||
42069793|NCT04950465|75879955|FG000|Overall Study|Lost to Follow-up|1|||
42069794|NCT04950465|75879956|FG001|Overall Study|Lost to Follow-up|0|||
42069795|NCT04950465|75879957|FG002|Overall Study|Lost to Follow-up|0|||
42069796|NCT04495816|75879979|FG000|Overall Study|Lost to Follow-up|10|||
42069797|NCT04495816|75879980|FG001|Overall Study|Lost to Follow-up|4|||
42069798|NCT04495816|75879979|FG000|Overall Study|Withdrawal by Subject|3|||
42069799|NCT04495816|75879980|FG001|Overall Study|Withdrawal by Subject|5|||
42069800|NCT04267562|75879995|FG000|Assessed for Eligibility|Screen Failure|64|||
42069801|NCT04267562|75879995|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
42069802|NCT04267562|75879995|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
42069803|NCT04267562|75879995|FG000|Assessed for Eligibility|Site closure|6|||
42069804|NCT04267562|75879995|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
42069805|NCT04267562|75879995|FG000|Assessed for Eligibility|Physician Decision|1|||
42069806|NCT03891901|75880006|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
42069807|NCT03891901|75880007|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
42069808|NCT03891901|75880008|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
42069809|NCT03891901|75880009|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
42069810|NCT03891901|75880010|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
42069811|NCT03891901|75880011|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
42069812|NCT03891901|75880012|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
42069813|NCT03891901|75880013|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
42069814|NCT03891901|75880014|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
42069815|NCT03891901|75880006|FG000|Overall Study|Adverse Event|2|||
42069816|NCT03891901|75880007|FG001|Overall Study|Adverse Event|2|||
42069817|NCT03891901|75880008|FG002|Overall Study|Adverse Event|0|||
42069818|NCT03891901|75880009|FG003|Overall Study|Adverse Event|0|||
42069819|NCT03891901|75880010|FG004|Overall Study|Adverse Event|0|||
42069820|NCT03891901|75880011|FG005|Overall Study|Adverse Event|0|||
42069821|NCT03891901|75880012|FG006|Overall Study|Adverse Event|0|||
42069822|NCT03891901|75880013|FG007|Overall Study|Adverse Event|0|||
42069823|NCT03891901|75880014|FG008|Overall Study|Adverse Event|0|||
42069824|NCT03891901|75880006|FG000|Overall Study|Poor venous access|1|||
42069825|NCT03891901|75880007|FG001|Overall Study|Poor venous access|0|||
42069826|NCT03891901|75880008|FG002|Overall Study|Poor venous access|0|||
42069827|NCT03891901|75880009|FG003|Overall Study|Poor venous access|0|||
42069828|NCT03891901|75880010|FG004|Overall Study|Poor venous access|0|||
42069829|NCT03891901|75880011|FG005|Overall Study|Poor venous access|0|||
42069830|NCT03891901|75880012|FG006|Overall Study|Poor venous access|0|||
42069831|NCT03891901|75880013|FG007|Overall Study|Poor venous access|0|||
42069832|NCT03891901|75880014|FG008|Overall Study|Poor venous access|0|||
42069833|NCT03891901|75880006|FG000|Overall Study|Withdrawal by Subject|0|||
42069834|NCT03891901|75880007|FG001|Overall Study|Withdrawal by Subject|2|||
42069835|NCT03891901|75880008|FG002|Overall Study|Withdrawal by Subject|0|||
42069836|NCT03891901|75880009|FG003|Overall Study|Withdrawal by Subject|0|||
42069837|NCT03891901|75880010|FG004|Overall Study|Withdrawal by Subject|0|||
42069838|NCT03891901|75880011|FG005|Overall Study|Withdrawal by Subject|0|||
42069839|NCT03891901|75880012|FG006|Overall Study|Withdrawal by Subject|0|||
42069840|NCT03891901|75880013|FG007|Overall Study|Withdrawal by Subject|0|||
42069841|NCT03891901|75880014|FG008|Overall Study|Withdrawal by Subject|0|||
42069842|NCT03827018|75880026|FG000|Overall Study|Adverse Event|1|||
42069843|NCT03827018|75880027|FG001|Overall Study|Adverse Event|0|||
42069844|NCT03827018|75880026|FG000|Overall Study|Withdrawal by Subject|2|||
42069845|NCT03827018|75880027|FG001|Overall Study|Withdrawal by Subject|2|||
42069846|NCT03827018|75880026|FG000|Overall Study|Lack of Efficacy|0|||
42069847|NCT03827018|75880027|FG001|Overall Study|Lack of Efficacy|1|||
42069848|NCT03575325|75880051|FG000|Overall Study|Death|1|||
42069849|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
42069850|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
42069851|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
42069852|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
42069853|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
42069854|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
42069855|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
42069856|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
42069857|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
42069858|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
42069859|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
42069860|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
42069861|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Death|1|||
42069862|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Death|2|||
42069863|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Death|2|||
42069864|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Death|0|||
42069865|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Death|0|||
42069866|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Death|0|||
42069867|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
42069868|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
42069869|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
42069870|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
42069871|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
42069872|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
42069873|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
42069874|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
42069875|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
42069876|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
42069877|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
42069878|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
42069879|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
42069880|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
42069881|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
42069882|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
42069883|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
42069884|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
42069885|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
42069886|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
42069887|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
42176451|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
42176452|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
42176453|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
42176454|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
42176455|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
42292662|NCT01126736|76126468|FG004|Overall Study|Withdrawal by Subject|1|||
42292663|NCT01126736|76126464|FG000|Overall Study|Other|2|||
42069888|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
42069889|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
42069890|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
42176456|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
42292664|NCT01126736|76126465|FG001|Overall Study|Other|4|||
42069891|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
42069892|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
42069893|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
42069894|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
42069895|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
42069896|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
42069897|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
42069898|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
42069899|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
42069900|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
42069901|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
42069902|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
42069903|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
42176457|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
42176458|NCT00289913|75983701|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
42176459|NCT00289913|75983702|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
42176460|NCT00289913|75983703|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
42176461|NCT00289913|75983704|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
42069904|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
42069905|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
42069906|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
42069907|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
42069908|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
42069909|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Site closure|0|||
42069910|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Site closure|0|||
42069911|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Site closure|1|||
42069912|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Site closure|0|||
42069913|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Site closure|0|||
42069914|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Site closure|0|||
42069915|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
42069916|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
42069917|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
42069918|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
42069919|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
42069920|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
42069921|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
42069922|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
42069923|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
42069924|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
42069925|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
42069926|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
42069927|NCT03439254|75880060|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
42069928|NCT03439254|75880061|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
42069929|NCT03439254|75880062|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
42069930|NCT03439254|75880063|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
42176462|NCT00289913|75983705|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
42176463|NCT00289913|75983701|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42176464|NCT00289913|75983702|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
42176465|NCT00289913|75983703|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42176466|NCT00289913|75983704|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42292665|NCT01126736|76126466|FG002|Overall Study|Other|4|||
42292666|NCT01126736|76126467|FG003|Overall Study|Other|16|||
42292667|NCT01126736|76126468|FG004|Overall Study|Other|15|||
42069931|NCT03439254|75880064|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
42069932|NCT03439254|75880065|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
42069933|NCT03439254|75880060|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
42069934|NCT03439254|75880061|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
42069935|NCT03439254|75880062|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
42069936|NCT03439254|75880063|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
42292668|NCT01111461|76126480|FG000|Overall Study|Adverse Event|32|||
42292669|NCT01111461|76126480|FG000|Overall Study|Participant choice|11|||
42292670|NCT01111461|76126480|FG000|Overall Study|Lost to Follow-up|1|||
42292671|NCT01111461|76126480|FG000|Overall Study|Withdrawal by Subject|1|||
42357665|NCT01396395|76203162|FG001|Overall Study|Lost to Follow-up|11|||
42357666|NCT01396395|76203161|FG000|Overall Study|Other|0|||
42357667|NCT01396395|76203162|FG001|Overall Study|Other|1|||
42357668|NCT01396317|76203172|FG000|Overall Study|Adverse Event|1|||
42357669|NCT01396317|76203173|FG001|Overall Study|Adverse Event|0|||
42357670|NCT01396161|76203188|FG000|Overall Study|Withdrawal by Subject|0|||
42357671|NCT01396161|76203189|FG001|Overall Study|Withdrawal by Subject|0|||
42357672|NCT01396161|76203190|FG002|Overall Study|Withdrawal by Subject|0|||
42017229|NCT01130493|75824809|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
42017230|NCT01130493|75824810|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
42017231|NCT01130493|75824811|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
42017232|NCT01130493|75824809|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
42017233|NCT01130493|75824810|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
42017234|NCT01130493|75824811|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
42017235|NCT01130493|75824809|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
42017236|NCT01130493|75824810|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
42017237|NCT01130493|75824811|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
42017238|NCT01130493|75824809|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
42017239|NCT01130493|75824810|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
42017240|NCT01130493|75824811|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
42017241|NCT01130493|75824809|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
42017242|NCT01130493|75824810|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
42017243|NCT01130493|75824811|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
42017244|NCT01130493|75824809|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
42017245|NCT01130493|75824810|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
42017246|NCT01130493|75824811|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
42017247|NCT01130493|75824809|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
42017248|NCT01130493|75824810|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
42017249|NCT01130493|75824811|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
42017250|NCT01130493|75824809|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
42017251|NCT01130493|75824810|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
42017252|NCT01130493|75824811|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
42017253|NCT01130493|75824809|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
42017254|NCT01130493|75824810|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
42017255|NCT01130493|75824811|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
42017256|NCT01130493|75824809|FG000|Part 2: OLE|Adverse Event|0|||
42017257|NCT01130493|75824810|FG001|Part 2: OLE|Adverse Event|2|||
42017258|NCT01130493|75824811|FG002|Part 2: OLE|Adverse Event|1|||
42017259|NCT01130493|75824809|FG000|Part 2: OLE|Withdrawal by Subject|0|||
42017260|NCT01130493|75824810|FG001|Part 2: OLE|Withdrawal by Subject|1|||
42017261|NCT01130493|75824811|FG002|Part 2: OLE|Withdrawal by Subject|4|||
42017262|NCT01130337|75824822|FG000|Overall Study|Withdrawal by Subject|3|||
42017263|NCT01130337|75824822|FG000|Overall Study|Principal investigator decision|1|||
42017264|NCT01130337|75824822|FG000|Overall Study|Death|1|||
42017265|NCT01130337|75824822|FG000|Overall Study|Disease progression|1|||
42017266|NCT01130337|75824822|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
42017267|NCT01130337|75824822|FG000|Overall Study|Surgical resection (R2)|1|||
42017268|NCT01130103|75824828|FG000|Randomized Treatment|Adverse Event|1|||
42017269|NCT01130103|75824829|FG001|Randomized Treatment|Adverse Event|1|||
42017270|NCT01130103|75824828|FG000|Randomized Treatment|Lost to Follow-up|1|||
42017271|NCT01130103|75824829|FG001|Randomized Treatment|Lost to Follow-up|0|||
42017272|NCT01130103|75824828|FG000|Randomized Treatment|Protocol Violation|3|||
42017273|NCT01130103|75824829|FG001|Randomized Treatment|Protocol Violation|2|||
42017274|NCT01130103|75824828|FG000|Randomized Treatment|Withdrawal by Subject|1|||
42017275|NCT01130103|75824829|FG001|Randomized Treatment|Withdrawal by Subject|2|||
42017276|NCT01130103|75824828|FG000|Maintenance Treatment|Lack of Efficacy|0|||
42357673|NCT01396161|76203191|FG003|Overall Study|Withdrawal by Subject|0|||
42069937|NCT03439254|75880064|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
42069938|NCT03439254|75880065|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
42069939|NCT03439254|75880060|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
42069940|NCT03439254|75880061|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
42069941|NCT03439254|75880062|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
42069942|NCT03439254|75880063|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
42069943|NCT03439254|75880064|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
42069944|NCT03439254|75880065|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
42069945|NCT03439254|75880060|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
42069946|NCT03439254|75880061|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
42069947|NCT03439254|75880062|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
42069948|NCT03439254|75880063|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
42069949|NCT03439254|75880064|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
42069950|NCT03439254|75880065|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
42069951|NCT03439254|75880060|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
42069952|NCT03439254|75880061|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
42069953|NCT03439254|75880062|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
42069954|NCT03439254|75880063|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
42069955|NCT03439254|75880064|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
42069956|NCT03439254|75880065|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
42069957|NCT03439254|75880060|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
42069958|NCT03439254|75880061|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
42357674|NCT01396161|76203192|FG004|Overall Study|Withdrawal by Subject|1|||
42069959|NCT03439254|75880062|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
42069960|NCT03439254|75880063|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
42069961|NCT03439254|75880064|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
42069962|NCT03439254|75880065|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
42069963|NCT03439254|75880060|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
42069964|NCT03439254|75880061|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
42069965|NCT03439254|75880062|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
42069966|NCT03439254|75880063|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
42069967|NCT03439254|75880064|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
42069968|NCT03439254|75880065|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
42069969|NCT03439254|75880060|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
42069970|NCT03439254|75880061|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
42069971|NCT03439254|75880062|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
42069972|NCT03439254|75880063|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
42069973|NCT03439254|75880064|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
42069974|NCT03439254|75880065|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
42069975|NCT03439254|75880060|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
42069976|NCT03439254|75880061|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
42069977|NCT03439254|75880062|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
42069978|NCT03439254|75880063|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
42069979|NCT03439254|75880064|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
42292672|NCT01111461|76126480|FG000|Overall Study|Other|6|||
42292673|NCT01104155|76126486|FG000|Overall Study|Adverse Event|15|||
42292674|NCT01104155|76126487|FG001|Overall Study|Adverse Event|8|||
42292675|NCT01104155|76126486|FG000|Overall Study|Participant choice|6|||
42292676|NCT01104155|76126487|FG001|Overall Study|Participant choice|5|||
42292677|NCT01104155|76126486|FG000|Overall Study|Withdrawal of consent|1|||
42292678|NCT01104155|76126487|FG001|Overall Study|Withdrawal of consent|1|||
42292679|NCT01104155|76126486|FG000|Overall Study|Other|3|||
42292680|NCT01104155|76126487|FG001|Overall Study|Other|4|||
42357675|NCT01396161|76203193|FG005|Overall Study|Withdrawal by Subject|0|||
42069980|NCT03439254|75880065|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
42069981|NCT03439254|75880060|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
42069982|NCT03439254|75880061|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
42069983|NCT03439254|75880062|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
42069984|NCT03439254|75880063|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
42069985|NCT03439254|75880064|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
42069986|NCT03439254|75880065|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
42069987|NCT03434379|75880081|FG000|Global Period|Lost to Follow-up|3|||
42069988|NCT03434379|75880082|FG001|Global Period|Lost to Follow-up|6|||
42069989|NCT03434379|75880083|FG002|Global Period|Lost to Follow-up|0|||
42069990|NCT03434379|75880084|FG003|Global Period|Lost to Follow-up|0|||
42069991|NCT03434379|75880081|FG000|Global Period|Death|115|||
42069992|NCT03434379|75880082|FG001|Global Period|Death|228|||
42069993|NCT03434379|75880083|FG002|Global Period|Death|0|||
42069994|NCT03434379|75880084|FG003|Global Period|Death|0|||
42069995|NCT03434379|75880081|FG000|Global Period|Withdrawal by Subject|20|||
42069996|NCT03434379|75880082|FG001|Global Period|Withdrawal by Subject|21|||
42069997|NCT03434379|75880083|FG002|Global Period|Withdrawal by Subject|0|||
42069998|NCT03434379|75880084|FG003|Global Period|Withdrawal by Subject|0|||
42069999|NCT03434379|75880081|FG000|Global Period|Reason Unspecified|0|||
42070000|NCT03434379|75880082|FG001|Global Period|Reason Unspecified|1|||
42070001|NCT03434379|75880083|FG002|Global Period|Reason Unspecified|0|||
42070002|NCT03434379|75880084|FG003|Global Period|Reason Unspecified|0|||
42070003|NCT03434379|75880081|FG000|Global Period|Study Ended by Sponsor|26|||
42070004|NCT03434379|75880082|FG001|Global Period|Study Ended by Sponsor|80|||
42070005|NCT03434379|75880083|FG002|Global Period|Study Ended by Sponsor|0|||
42070006|NCT03434379|75880084|FG003|Global Period|Study Ended by Sponsor|0|||
42070007|NCT03434379|75880081|FG000|Global Period|Physician Decision|1|||
42070008|NCT03434379|75880082|FG001|Global Period|Physician Decision|0|||
42070009|NCT03434379|75880083|FG002|Global Period|Physician Decision|0|||
42070010|NCT03434379|75880084|FG003|Global Period|Physician Decision|0|||
42070011|NCT03434379|75880081|FG000|China Extension Period|Lost to Follow-up|0|||
42070012|NCT03434379|75880082|FG001|China Extension Period|Lost to Follow-up|0|||
42070013|NCT03434379|75880083|FG002|China Extension Period|Lost to Follow-up|2|||
42070014|NCT03434379|75880084|FG003|China Extension Period|Lost to Follow-up|3|||
42070015|NCT03434379|75880081|FG000|China Extension Period|Death|0|||
42070016|NCT03434379|75880082|FG001|China Extension Period|Death|0|||
42070017|NCT03434379|75880083|FG002|China Extension Period|Death|46|||
42070018|NCT03434379|75880084|FG003|China Extension Period|Death|88|||
42070019|NCT03434379|75880081|FG000|China Extension Period|Withdrawal by Subject|0|||
42070020|NCT03434379|75880082|FG001|China Extension Period|Withdrawal by Subject|0|||
42070021|NCT03434379|75880083|FG002|China Extension Period|Withdrawal by Subject|8|||
42070022|NCT03434379|75880084|FG003|China Extension Period|Withdrawal by Subject|6|||
42070023|NCT03434379|75880081|FG000|China Extension Period|Study Ended by Sponsor|0|||
42070024|NCT03434379|75880082|FG001|China Extension Period|Study Ended by Sponsor|0|||
42070025|NCT03434379|75880083|FG002|China Extension Period|Study Ended by Sponsor|5|||
42070026|NCT03434379|75880084|FG003|China Extension Period|Study Ended by Sponsor|36|||
42070027|NCT03309046|75880098|FG000|Overall Study|Withdrawal by Subject|4|||
42070028|NCT03309046|75880099|FG001|Overall Study|Withdrawal by Subject|17|||
42070029|NCT03228186|75880105|FG000|Overall Study|Patient never started treatment|1|||
42070030|NCT02869633|75880111|FG000|Overall Study|Death|2|||
42070031|NCT02869633|75880112|FG001|Overall Study|Death|1|||
42070032|NCT02869633|75880111|FG000|Overall Study|Patient refused follow-up|1|||
42070033|NCT02869633|75880112|FG001|Overall Study|Patient refused follow-up|0|||
42070034|NCT02869633|75880111|FG000|Overall Study|Provider discretion|1|||
42070035|NCT02869633|75880112|FG001|Overall Study|Provider discretion|0|||
42070036|NCT02869633|75880111|FG000|Overall Study|Investigator decision|1|||
42070037|NCT02869633|75880112|FG001|Overall Study|Investigator decision|0|||
42070038|NCT02869633|75880111|FG000|Overall Study|Lost to Follow-up|0|||
42070039|NCT02869633|75880112|FG001|Overall Study|Lost to Follow-up|1|||
42070040|NCT02869633|75880111|FG000|Overall Study|Not eligible|6|||
42070041|NCT02869633|75880112|FG001|Overall Study|Not eligible|1|||
42070042|NCT02869633|75880111|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
42070043|NCT02869633|75880112|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
42070044|NCT02869633|75880111|FG000|Overall Study|Withdrawal by Subject|0|||
42070045|NCT02869633|75880112|FG001|Overall Study|Withdrawal by Subject|1|||
42070046|NCT02855268|75880122|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
42070047|NCT02855268|75880123|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
42070048|NCT02855268|75880122|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
42070049|NCT02855268|75880123|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
42070050|NCT02855268|75880122|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
42070051|NCT02855268|75880123|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
42070052|NCT02855268|75880122|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
42070053|NCT02855268|75880123|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
42070054|NCT02855268|75880122|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
42070055|NCT02855268|75880123|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
42070056|NCT02855268|75880122|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
42070057|NCT02855268|75880123|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
42070058|NCT02840721|75880138|FG000|Treatment Period|Adverse Event|1|||
42070059|NCT02840721|75880138|FG000|Follow-Up|Lack of Efficacy|1|||
42070060|NCT02840721|75880138|FG000|Follow-Up|Withdrawal by Subject|4|||
42070061|NCT02840721|75880138|FG000|Follow-Up|Withdrawal of Consent|2|||
42070062|NCT02777593|75880147|FG000|Overall Study|Still in study|28|||
42070063|NCT02777593|75880148|FG001|Overall Study|Still in study|71|||
42070064|NCT02777593|75880149|FG002|Overall Study|Still in study|5|||
42070065|NCT02777593|75880150|FG003|Overall Study|Still in study|6|||
42070066|NCT02777593|75880151|FG004|Overall Study|Still in study|6|||
42070067|NCT02777593|75880147|FG000|Overall Study|Death|19|||
42070068|NCT02777593|75880148|FG001|Overall Study|Death|24|||
42070069|NCT02777593|75880149|FG002|Overall Study|Death|0|||
42070070|NCT02777593|75880150|FG003|Overall Study|Death|5|||
42070071|NCT02777593|75880151|FG004|Overall Study|Death|0|||
42070072|NCT02777593|75880147|FG000|Overall Study|Withdrawal by Subject|6|||
42070073|NCT02777593|75880148|FG001|Overall Study|Withdrawal by Subject|3|||
42070074|NCT02777593|75880149|FG002|Overall Study|Withdrawal by Subject|1|||
42070075|NCT02777593|75880150|FG003|Overall Study|Withdrawal by Subject|1|||
42070076|NCT02777593|75880151|FG004|Overall Study|Withdrawal by Subject|0|||
42070077|NCT02777593|75880147|FG000|Overall Study|Lost to Follow-up|4|||
42070078|NCT02777593|75880148|FG001|Overall Study|Lost to Follow-up|12|||
42070079|NCT02777593|75880149|FG002|Overall Study|Lost to Follow-up|4|||
42070080|NCT02777593|75880150|FG003|Overall Study|Lost to Follow-up|0|||
42070081|NCT02777593|75880151|FG004|Overall Study|Lost to Follow-up|0|||
42070082|NCT02777593|75880147|FG000|Overall Study|Physician Decision|2|||
42070083|NCT02777593|75880148|FG001|Overall Study|Physician Decision|2|||
42070084|NCT02777593|75880149|FG002|Overall Study|Physician Decision|0|||
42070085|NCT02777593|75880150|FG003|Overall Study|Physician Decision|0|||
42070086|NCT02777593|75880151|FG004|Overall Study|Physician Decision|0|||
42070087|NCT02777593|75880147|FG000|Overall Study|Discontinued due to Other|3|||
42070088|NCT02777593|75880148|FG001|Overall Study|Discontinued due to Other|0|||
42070089|NCT02777593|75880149|FG002|Overall Study|Discontinued due to Other|0|||
42070090|NCT02777593|75880150|FG003|Overall Study|Discontinued due to Other|0|||
42070091|NCT02777593|75880151|FG004|Overall Study|Discontinued due to Other|0|||
42070092|NCT02701283|75880166|FG000|Overall Study|Death|25|||
42070093|NCT02701283|75880167|FG001|Overall Study|Death|29|||
42070094|NCT02701283|75880168|FG002|Overall Study|Death|19|||
42070095|NCT02701283|75880166|FG000|Overall Study|Lost to Follow-up|3|||
42070096|NCT02701283|75880167|FG001|Overall Study|Lost to Follow-up|8|||
42070097|NCT02701283|75880168|FG002|Overall Study|Lost to Follow-up|1|||
42070098|NCT02701283|75880166|FG000|Overall Study|Withdrawal by Subject|12|||
42070099|NCT02701283|75880167|FG001|Overall Study|Withdrawal by Subject|41|||
42070100|NCT02701283|75880168|FG002|Overall Study|Withdrawal by Subject|1|||
42070101|NCT02701283|75880166|FG000|Overall Study|Missed 2-year visit|22|||
42070102|NCT02701283|75880167|FG001|Overall Study|Missed 2-year visit|27|||
42070103|NCT02701283|75880168|FG002|Overall Study|Missed 2-year visit|0|||
42070104|NCT02701283|75880166|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
42070105|NCT02701283|75880167|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
42070106|NCT02701283|75880168|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
42070107|NCT02399085|75880188|FG000|Overall Study|Adverse Event|16|||
42070108|NCT02399085|75880188|FG000|Overall Study|Death|2|||
42070109|NCT02399085|75880188|FG000|Overall Study|Withdrawal by Subject|8|||
42070110|NCT02399085|75880188|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
42070111|NCT02399085|75880188|FG000|Overall Study|Physician Decision|5|||
42070112|NCT01317160|75880196|FG000|Overall Study|Incorrect inclusion|1|||
42070113|NCT01317160|75880197|FG001|Overall Study|Incorrect inclusion|1|||
42070114|NCT01317160|75880196|FG000|Overall Study|Lost to Follow-up|3|||
42176467|NCT00289913|75983705|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
42176468|NCT00289913|75983701|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
42176469|NCT00289913|75983702|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
42176470|NCT00289913|75983703|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
42357676|NCT01396161|76203194|FG006|Overall Study|Withdrawal by Subject|0|||
42357677|NCT01396161|76203188|FG000|Overall Study|Other|0|||
42357678|NCT01396161|76203189|FG001|Overall Study|Other|0|||
42070115|NCT01317160|75880197|FG001|Overall Study|Lost to Follow-up|3|||
42070116|NCT01317160|75880196|FG000|Overall Study|Withdrawal by Subject|0|||
42070117|NCT01317160|75880197|FG001|Overall Study|Withdrawal by Subject|2|||
42070118|NCT00891371|75880203|FG000|Pre-assignment|Inclusion/exclusion|5|||
42070119|NCT00891371|75880203|FG000|Pre-assignment|Consent withdrawal|1|||
42070120|NCT00891371|75880203|FG000|Treatment|Lack of Efficacy|5|||
42070121|NCT00891371|75880203|FG000|Treatment|Adverse Event|2|||
42070122|NCT00891371|75880203|FG000|Treatment|Death|1|||
42070123|NCT00891371|75880203|FG000|Treatment|Lost to Follow-up|1|||
42357679|NCT01396161|76203190|FG002|Overall Study|Other|0|||
42357680|NCT01396161|76203191|FG003|Overall Study|Other|0|||
42357681|NCT01396161|76203192|FG004|Overall Study|Other|0|||
42357682|NCT01396161|76203193|FG005|Overall Study|Other|0|||
42357683|NCT01396161|76203194|FG006|Overall Study|Other|1|||
42070130|NCT00891293|75880216|FG000|Overall Study|Adverse Event|2|||
42070131|NCT00891293|75880216|FG000|Overall Study|Protocol Violation|2|||
42070132|NCT00891293|75880216|FG000|Overall Study|Laboratory abnormality|4|||
42070133|NCT00891293|75880216|FG000|Overall Study|Lost to Follow-up|7|||
42070134|NCT00891293|75880216|FG000|Overall Study|Subject withdrew consent|7|||
42070135|NCT00891293|75880216|FG000|Overall Study|Sponsor termination|62|||
42070136|NCT00889421|75880220|FG000|Overall Study|Lack of Efficacy|3|||
42070137|NCT00889265|75880224|FG000|Overall Study|Adverse Event|1|||
42070138|NCT00889265|75880224|FG000|Overall Study|Lost to Follow-up|5|||
42070139|NCT00889265|75880224|FG000|Overall Study|Protocol Violation|1|||
42070140|NCT00603746|75880234|FG000|Overall Study|Adverse Event|2|||
42070141|NCT00603746|75880235|FG001|Overall Study|Adverse Event|3|||
42070142|NCT00603746|75880236|FG002|Overall Study|Adverse Event|0|||
42070143|NCT00603746|75880237|FG003|Overall Study|Adverse Event|1|||
42070144|NCT00603746|75880238|FG004|Overall Study|Adverse Event|0|||
42070145|NCT00603746|75880239|FG005|Overall Study|Adverse Event|4|||
42070146|NCT00603746|75880234|FG000|Overall Study|Lack of Efficacy|34|||
42070147|NCT00603746|75880235|FG001|Overall Study|Lack of Efficacy|11|||
42070148|NCT00603746|75880236|FG002|Overall Study|Lack of Efficacy|6|||
42070149|NCT00603746|75880237|FG003|Overall Study|Lack of Efficacy|11|||
42070150|NCT00603746|75880238|FG004|Overall Study|Lack of Efficacy|12|||
42070151|NCT00603746|75880239|FG005|Overall Study|Lack of Efficacy|8|||
42070152|NCT00603746|75880234|FG000|Overall Study|Protocol Violation|0|||
42070153|NCT00603746|75880235|FG001|Overall Study|Protocol Violation|3|||
42070154|NCT00603746|75880236|FG002|Overall Study|Protocol Violation|1|||
42070155|NCT00603746|75880237|FG003|Overall Study|Protocol Violation|0|||
42070156|NCT00603746|75880238|FG004|Overall Study|Protocol Violation|1|||
42070157|NCT00603746|75880239|FG005|Overall Study|Protocol Violation|0|||
42070158|NCT00603746|75880234|FG000|Overall Study|Lost to Follow-up|0|||
42070159|NCT00603746|75880235|FG001|Overall Study|Lost to Follow-up|1|||
42070160|NCT00603746|75880236|FG002|Overall Study|Lost to Follow-up|1|||
42070161|NCT00603746|75880237|FG003|Overall Study|Lost to Follow-up|0|||
42070162|NCT00603746|75880238|FG004|Overall Study|Lost to Follow-up|0|||
42070163|NCT00603746|75880239|FG005|Overall Study|Lost to Follow-up|0|||
42070164|NCT00603746|75880234|FG000|Overall Study|Physician Decision|1|||
42070165|NCT00603746|75880235|FG001|Overall Study|Physician Decision|0|||
42070166|NCT00603746|75880236|FG002|Overall Study|Physician Decision|0|||
42070167|NCT00603746|75880237|FG003|Overall Study|Physician Decision|0|||
42070168|NCT00603746|75880238|FG004|Overall Study|Physician Decision|1|||
42070169|NCT00603746|75880239|FG005|Overall Study|Physician Decision|0|||
42070170|NCT00603746|75880234|FG000|Overall Study|Withdrawal by Subject|1|||
42070171|NCT00603746|75880235|FG001|Overall Study|Withdrawal by Subject|0|||
42070172|NCT00603746|75880236|FG002|Overall Study|Withdrawal by Subject|0|||
42070173|NCT00603746|75880237|FG003|Overall Study|Withdrawal by Subject|1|||
42070174|NCT00603746|75880238|FG004|Overall Study|Withdrawal by Subject|3|||
42070175|NCT00603746|75880239|FG005|Overall Study|Withdrawal by Subject|1|||
42070176|NCT00888329|75880255|FG000|Overall Study|Physician Decision|6|||
42070177|NCT00888329|75880256|FG001|Overall Study|Physician Decision|9|||
42070178|NCT00603590|75880264|FG000|Overall Study|Did not attend study clinic|39|||
42070179|NCT00603590|75880265|FG001|Overall Study|Did not attend study clinic|30|||
42070180|NCT00603590|75880264|FG000|Overall Study|Refused blood test|5|||
42070181|NCT00603590|75880265|FG001|Overall Study|Refused blood test|1|||
42070182|NCT00603590|75880264|FG000|Overall Study|Patient discontinued study drug|22|||
42070183|NCT00603590|75880265|FG001|Overall Study|Patient discontinued study drug|15|||
42070184|NCT00603590|75880264|FG000|Overall Study|Adverse Event|2|||
42070185|NCT00603590|75880265|FG001|Overall Study|Adverse Event|0|||
42070186|NCT00603590|75880264|FG000|Overall Study|Lost to Follow-up|8|||
42070187|NCT00603590|75880265|FG001|Overall Study|Lost to Follow-up|4|||
42070188|NCT00603590|75880264|FG000|Overall Study|Cardiovascular event|0|||
42070189|NCT00603590|75880265|FG001|Overall Study|Cardiovascular event|1|||
42070190|NCT00888173|75880271|FG000|Overall Study|Wrong Primary|1|||
42070191|NCT00888173|75880271|FG000|Overall Study|Ineligible: required test not done|1|||
42070192|NCT00887549|75880284|FG000|Induction Therapy|Adverse Event|8|||
42070193|NCT00887549|75880284|FG000|Induction Therapy|Physician Decision|1|||
42070194|NCT00887549|75880284|FG000|Induction Therapy|Progressive Disease|13|||
42070195|NCT00887549|75880284|FG000|Induction Therapy|Death due to Study Disease|4|||
42070196|NCT00887549|75880284|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
42070197|NCT00887549|75880284|FG000|Maintenance Therapy|Adverse Event|16|||
42070198|NCT00887549|75880284|FG000|Maintenance Therapy|Physician Decision|1|||
42070199|NCT00887549|75880284|FG000|Maintenance Therapy|Progressive Disease|25|||
42070200|NCT00887549|75880284|FG000|Maintenance Therapy|Death due to adverse event|1|||
42070201|NCT00887315|75880290|FG000|Overall Study|Study termination|7|||
42070202|NCT00887315|75880291|FG001|Overall Study|Study termination|4|||
42070203|NCT03608826|75880297|FG000|Overall Study|Death|3|||
42070204|NCT03608826|75880297|FG000|Overall Study|Heart Transplant|3|||
42070205|NCT03608826|75880297|FG000|Overall Study|Physician Decision|4|||
42070206|NCT00887159|75880304|FG000|Overall Study|Disease progression|6|||
42070207|NCT00887159|75880305|FG001|Overall Study|Disease progression|39|||
42070208|NCT00887159|75880306|FG002|Overall Study|Disease progression|33|||
42070209|NCT00887159|75880304|FG000|Overall Study|Adverse Event|3|||
42070210|NCT00887159|75880305|FG001|Overall Study|Adverse Event|4|||
42070211|NCT00887159|75880306|FG002|Overall Study|Adverse Event|17|||
42070212|NCT00887159|75880304|FG000|Overall Study|Death|2|||
42070213|NCT00887159|75880305|FG001|Overall Study|Death|2|||
42070214|NCT00887159|75880306|FG002|Overall Study|Death|0|||
42070215|NCT00887159|75880304|FG000|Overall Study|Withdrawal by Subject|4|||
42070216|NCT00887159|75880305|FG001|Overall Study|Withdrawal by Subject|4|||
42070217|NCT00887159|75880306|FG002|Overall Study|Withdrawal by Subject|2|||
42070218|NCT00887159|75880304|FG000|Overall Study|Alternative therapy|2|||
42070219|NCT00887159|75880305|FG001|Overall Study|Alternative therapy|0|||
42070220|NCT00887159|75880306|FG002|Overall Study|Alternative therapy|0|||
42070221|NCT00887159|75880304|FG000|Overall Study|Physician Decision|1|||
42070222|NCT00887159|75880305|FG001|Overall Study|Physician Decision|1|||
42070223|NCT00887159|75880306|FG002|Overall Study|Physician Decision|0|||
42070224|NCT00887159|75880304|FG000|Overall Study|Sympomatic deterioration|1|||
42070225|NCT00887159|75880305|FG001|Overall Study|Sympomatic deterioration|0|||
42070226|NCT00887159|75880306|FG002|Overall Study|Sympomatic deterioration|0|||
42070227|NCT00887159|75880304|FG000|Overall Study|Treatment delayed|1|||
42070228|NCT00887159|75880305|FG001|Overall Study|Treatment delayed|1|||
42070229|NCT00887159|75880306|FG002|Overall Study|Treatment delayed|0|||
42070230|NCT00887159|75880304|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
42070231|NCT00887159|75880305|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
42070232|NCT00887159|75880306|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
42070233|NCT00887159|75880304|FG000|Overall Study|Received more tx instead of observation|1|||
42070234|NCT00887159|75880305|FG001|Overall Study|Received more tx instead of observation|0|||
42070235|NCT00887159|75880306|FG002|Overall Study|Received more tx instead of observation|0|||
42070236|NCT00887159|75880304|FG000|Overall Study|Ineligible|5|||
42070237|NCT00887159|75880305|FG001|Overall Study|Ineligible|1|||
42070238|NCT00887159|75880306|FG002|Overall Study|Ineligible|0|||
42070239|NCT00887159|75880304|FG000|Overall Study|Never started assigned therapy|3|||
42070240|NCT00887159|75880305|FG001|Overall Study|Never started assigned therapy|3|||
42070241|NCT00887159|75880306|FG002|Overall Study|Never started assigned therapy|4|||
42070242|NCT00886769|75880318|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
42070243|NCT00886769|75880319|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
42070244|NCT00886613|75880328|FG000|Overall Study|Protocol deviation (Part B)|1|||
42070245|NCT00886613|75880329|FG001|Overall Study|Protocol deviation (Part B)|0|||
42070246|NCT00886613|75880330|FG002|Overall Study|Protocol deviation (Part B)|0|||
42070247|NCT00886613|75880328|FG000|Overall Study|Lost to follow-up (Part B)|1|||
42070248|NCT00886613|75880329|FG001|Overall Study|Lost to follow-up (Part B)|0|||
42070249|NCT00886613|75880330|FG002|Overall Study|Lost to follow-up (Part B)|1|||
42070250|NCT00886613|75880328|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
42070251|NCT00886613|75880329|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
42070252|NCT00886613|75880330|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
42070253|NCT00886379|75880346|FG000|Overall Study|Transferred Schools|0|||
42070254|NCT00886379|75880347|FG001|Overall Study|Transferred Schools|0|||
42070255|NCT00886379|75880348|FG002|Overall Study|Transferred Schools|2|||
42070256|NCT00886379|75880349|FG003|Overall Study|Transferred Schools|1|||
42070257|NCT00886379|75880350|FG004|Overall Study|Transferred Schools|1|||
42070258|NCT00886379|75880346|FG000|Overall Study|Final blood draw not obtained|3|||
42070259|NCT00886379|75880347|FG001|Overall Study|Final blood draw not obtained|3|||
42070260|NCT00886379|75880348|FG002|Overall Study|Final blood draw not obtained|4|||
42070261|NCT00886379|75880349|FG003|Overall Study|Final blood draw not obtained|2|||
42070262|NCT00886379|75880350|FG004|Overall Study|Final blood draw not obtained|2|||
42357684|NCT01396083|76203217|FG000|Overall Study|Adverse Event|2|||
42357685|NCT01396083|76203218|FG001|Overall Study|Adverse Event|28|||
42357686|NCT01396083|76203217|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
42070263|NCT00599196|75880362|FG000|Overall Study|Lack of Efficacy|22|||
42070264|NCT00599196|75880362|FG000|Overall Study|Adverse Event|93|||
42070265|NCT00599196|75880362|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
42070266|NCT00599196|75880362|FG000|Overall Study|Subject withdrew consent|43|||
42070267|NCT00599196|75880362|FG000|Overall Study|Study ended per sponsor|197|||
42070268|NCT00599196|75880362|FG000|Overall Study|Lost to Follow-up|17|||
42070269|NCT00599196|75880362|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
42070270|NCT00599196|75880362|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
42070271|NCT00599196|75880362|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
42070272|NCT00599196|75880362|FG000|Overall Study|Other: Pt Moved To Australia|1|||
42070273|NCT00599196|75880362|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
42070274|NCT00599196|75880362|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
42070275|NCT00603512|75880371|FG000|Overall Study|Adverse Event|0|||
42070276|NCT00603512|75880372|FG001|Overall Study|Adverse Event|2|||
42070277|NCT00603512|75880373|FG002|Overall Study|Adverse Event|4|||
42070278|NCT00603512|75880374|FG003|Overall Study|Adverse Event|4|||
42070279|NCT00603512|75880375|FG004|Overall Study|Adverse Event|2|||
42070280|NCT00603512|75880371|FG000|Overall Study|Lack of Efficacy|0|||
42070281|NCT00603512|75880372|FG001|Overall Study|Lack of Efficacy|1|||
42070282|NCT00603512|75880373|FG002|Overall Study|Lack of Efficacy|0|||
42070283|NCT00603512|75880374|FG003|Overall Study|Lack of Efficacy|0|||
42357687|NCT01396083|76203218|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
42357688|NCT01396083|76203217|FG000|Overall Study|Consent withdrawn|4|||
42357689|NCT01396083|76203218|FG001|Overall Study|Consent withdrawn|5|||
42357690|NCT01396083|76203217|FG000|Overall Study|Protocol deviation(s)|0|||
42357691|NCT01396083|76203218|FG001|Overall Study|Protocol deviation(s)|1|||
42357692|NCT01396083|76203217|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42357693|NCT01396083|76203218|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42357694|NCT01396083|76203217|FG000|Overall Study|Administrative problems|1|||
42357695|NCT01396083|76203218|FG001|Overall Study|Administrative problems|0|||
42357696|NCT01396083|76203217|FG000|Overall Study|Lost to Follow-up|1|||
42357697|NCT01396083|76203218|FG001|Overall Study|Lost to Follow-up|0|||
42357698|NCT01723826|76203228|FG000|Overall Study|Adverse Event|4|||
42357699|NCT01723826|76203229|FG001|Overall Study|Adverse Event|1|||
42070284|NCT00603512|75880375|FG004|Overall Study|Lack of Efficacy|1|||
42070285|NCT00603512|75880371|FG000|Overall Study|Other|2|||
42070286|NCT00603512|75880372|FG001|Overall Study|Other|1|||
42070287|NCT00603512|75880373|FG002|Overall Study|Other|0|||
42070288|NCT00603512|75880374|FG003|Overall Study|Other|1|||
42070289|NCT00603512|75880375|FG004|Overall Study|Other|1|||
42070290|NCT00603512|75880371|FG000|Overall Study|Withdrawal by Subject|0|||
42070291|NCT00603512|75880372|FG001|Overall Study|Withdrawal by Subject|0|||
42070292|NCT00603512|75880373|FG002|Overall Study|Withdrawal by Subject|0|||
42070293|NCT00603512|75880374|FG003|Overall Study|Withdrawal by Subject|0|||
42070294|NCT00603512|75880375|FG004|Overall Study|Withdrawal by Subject|1|||
42070295|NCT00603512|75880371|FG000|Overall Study|Randomized but not treated|0|||
42070296|NCT00603512|75880372|FG001|Overall Study|Randomized but not treated|1|||
42070297|NCT00603512|75880373|FG002|Overall Study|Randomized but not treated|1|||
42070298|NCT00603512|75880374|FG003|Overall Study|Randomized but not treated|2|||
42070299|NCT00603512|75880375|FG004|Overall Study|Randomized but not treated|0|||
42070300|NCT04242875|75880387|FG000|Overall Study|Adverse Event|2|||
42070301|NCT00603278|75880401|FG000|Overall Study|Lack of Efficacy|35|||
42070302|NCT00603278|75880402|FG001|Overall Study|Lack of Efficacy|10|||
42070303|NCT00603278|75880403|FG002|Overall Study|Lack of Efficacy|11|||
42070304|NCT00603278|75880404|FG003|Overall Study|Lack of Efficacy|8|||
42070305|NCT00603278|75880405|FG004|Overall Study|Lack of Efficacy|7|||
42070306|NCT00603278|75880406|FG005|Overall Study|Lack of Efficacy|14|||
42070307|NCT00603278|75880401|FG000|Overall Study|Adverse Event|0|||
42070308|NCT00603278|75880402|FG001|Overall Study|Adverse Event|3|||
42070309|NCT00603278|75880403|FG002|Overall Study|Adverse Event|1|||
42070310|NCT00603278|75880404|FG003|Overall Study|Adverse Event|0|||
42070311|NCT00603278|75880405|FG004|Overall Study|Adverse Event|2|||
42070312|NCT00603278|75880406|FG005|Overall Study|Adverse Event|1|||
42070313|NCT00603278|75880401|FG000|Overall Study|Withdrawal by Subject|2|||
42070314|NCT00603278|75880402|FG001|Overall Study|Withdrawal by Subject|3|||
42070315|NCT00603278|75880403|FG002|Overall Study|Withdrawal by Subject|1|||
42070316|NCT00603278|75880404|FG003|Overall Study|Withdrawal by Subject|2|||
42070317|NCT00603278|75880405|FG004|Overall Study|Withdrawal by Subject|1|||
42070318|NCT00603278|75880406|FG005|Overall Study|Withdrawal by Subject|2|||
42070319|NCT00603278|75880401|FG000|Overall Study|Protocol Violation|3|||
42070320|NCT00603278|75880402|FG001|Overall Study|Protocol Violation|0|||
42070321|NCT00603278|75880403|FG002|Overall Study|Protocol Violation|1|||
42070322|NCT00603278|75880404|FG003|Overall Study|Protocol Violation|1|||
42070323|NCT00603278|75880405|FG004|Overall Study|Protocol Violation|0|||
42070324|NCT00603278|75880406|FG005|Overall Study|Protocol Violation|1|||
42070325|NCT00603278|75880401|FG000|Overall Study|Physician Decision|0|||
42070326|NCT00603278|75880402|FG001|Overall Study|Physician Decision|1|||
42070327|NCT00603278|75880403|FG002|Overall Study|Physician Decision|0|||
42070328|NCT00603278|75880404|FG003|Overall Study|Physician Decision|0|||
42070329|NCT00603278|75880405|FG004|Overall Study|Physician Decision|2|||
42070330|NCT00603278|75880406|FG005|Overall Study|Physician Decision|1|||
42070331|NCT00603278|75880401|FG000|Overall Study|Lost to Follow-up|1|||
42070332|NCT00603278|75880402|FG001|Overall Study|Lost to Follow-up|0|||
42070333|NCT00603278|75880403|FG002|Overall Study|Lost to Follow-up|0|||
42070334|NCT00603278|75880404|FG003|Overall Study|Lost to Follow-up|0|||
42357700|NCT01723826|76203230|FG002|Overall Study|Adverse Event|4|||
42357701|NCT01723826|76203231|FG003|Overall Study|Adverse Event|5|||
42357702|NCT01723826|76203228|FG000|Overall Study|Death according to AE eCRF|2|||
42070335|NCT00603278|75880405|FG004|Overall Study|Lost to Follow-up|1|||
42070336|NCT00603278|75880406|FG005|Overall Study|Lost to Follow-up|0|||
42070337|NCT00876447|75880422|FG000|Overall Study|Other miscellaneous reasons|3|||
42070338|NCT00876447|75880423|FG001|Overall Study|Other miscellaneous reasons|8|||
42070339|NCT00876447|75880422|FG000|Overall Study|Site closure|19|||
42070340|NCT00876447|75880423|FG001|Overall Study|Site closure|14|||
42070341|NCT00876447|75880422|FG000|Overall Study|Protocol Violation|9|||
42070342|NCT00876447|75880423|FG001|Overall Study|Protocol Violation|3|||
42292681|NCT01065597|76126493|FG000|Overall Study|Adverse Event|1|||
42292682|NCT01051856|76126499|FG000|Overall Study|Withdrawal by Subject|1|||
42292683|NCT01051856|76126500|FG001|Overall Study|Withdrawal by Subject|0|||
42292684|NCT01029366|76126508|FG000|Overall Study|Withdrawal by Subject|1|||
42292685|NCT01029366|76126509|FG001|Overall Study|Withdrawal by Subject|0|||
42292686|NCT01029366|76126508|FG000|Overall Study|Death|1|||
42292687|NCT01029366|76126509|FG001|Overall Study|Death|1|||
42292688|NCT01029366|76126508|FG000|Overall Study|disease progression|2|||
42292689|NCT01029366|76126509|FG001|Overall Study|disease progression|0|||
42070343|NCT00876447|75880422|FG000|Overall Study|Personal reasons|30|||
42070344|NCT00876447|75880423|FG001|Overall Study|Personal reasons|28|||
42070345|NCT00876447|75880422|FG000|Overall Study|Lost to Follow-up|6|||
42070346|NCT00876447|75880423|FG001|Overall Study|Lost to Follow-up|15|||
42070347|NCT00876447|75880422|FG000|Overall Study|Pregnancy|4|||
42070348|NCT00876447|75880423|FG001|Overall Study|Pregnancy|2|||
42070349|NCT00876447|75880422|FG000|Overall Study|Lack of Efficacy|5|||
42070350|NCT00876447|75880423|FG001|Overall Study|Lack of Efficacy|3|||
42070351|NCT00876447|75880422|FG000|Overall Study|Adverse Event|4|||
42070352|NCT00876447|75880423|FG001|Overall Study|Adverse Event|8|||
42070353|NCT00598650|75880453|FG000|Overall Study|Withdrawal by Subject|3|||
42070354|NCT00598650|75880453|FG000|Overall Study|Adverse Event|18|||
42070355|NCT00598650|75880453|FG000|Overall Study|No treatment for 3 weeks|1|||
42070356|NCT00598650|75880453|FG000|Overall Study|Not eligible|1|||
42070357|NCT00598650|75880453|FG000|Overall Study|Prohibited Concomitant Medication|2|||
42070358|NCT00598650|75880453|FG000|Overall Study|Physician Decision|2|||
42070359|NCT04249076|75880460|FG000|Overall Study|Adverse Event|1|||
42070360|NCT04249076|75880461|FG001|Overall Study|Adverse Event|1|||
42070361|NCT04249076|75880460|FG000|Overall Study|Protocol Violation|1|||
42070362|NCT04249076|75880461|FG001|Overall Study|Protocol Violation|2|||
42070363|NCT04249076|75880460|FG000|Overall Study|Lack of Efficacy|0|||
42070364|NCT04249076|75880461|FG001|Overall Study|Lack of Efficacy|1|||
42070365|NCT04249076|75880460|FG000|Overall Study|Withdrawal by Subject|0|||
42070366|NCT04249076|75880461|FG001|Overall Study|Withdrawal by Subject|1|||
42070367|NCT04150107|75880469|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
42070368|NCT04150107|75880470|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
42070369|NCT04150107|75880469|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
42070370|NCT04150107|75880470|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
42070371|NCT00875979|75880480|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
42070372|NCT00875979|75880481|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
42070373|NCT00875979|75880480|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
42070374|NCT00875979|75880481|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
42070375|NCT00875979|75880480|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
42070376|NCT00875979|75880481|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
42070377|NCT00875979|75880480|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
42176471|NCT00289913|75983704|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
42176472|NCT00289913|75983705|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
42176473|NCT00289913|75983701|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
42176474|NCT00289913|75983702|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
42176475|NCT00289913|75983703|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
42070378|NCT00875979|75880481|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
42070379|NCT00875979|75880480|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
42070380|NCT00875979|75880481|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
42070381|NCT00875979|75880480|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
42070382|NCT00875979|75880481|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
42070383|NCT00875979|75880480|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
42070384|NCT00875979|75880481|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
42070385|NCT00875979|75880480|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
42070386|NCT00875979|75880481|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
42292690|NCT01029366|76126508|FG000|Overall Study|manufacturing failure|0|||
42070387|NCT00875979|75880480|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
42070388|NCT00875979|75880481|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
42292691|NCT01029366|76126509|FG001|Overall Study|manufacturing failure|1|||
42070389|NCT00602420|75880489|FG000|Overall Study|Death|1|||
42070390|NCT00602420|75880490|FG001|Overall Study|Death|4|||
42070391|NCT00602420|75880489|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
42070392|NCT00602420|75880490|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
42070393|NCT00602420|75880489|FG000|Overall Study|Withdrawal by Subject|18|||
42070394|NCT00602420|75880490|FG001|Overall Study|Withdrawal by Subject|17|||
42070395|NCT00602420|75880489|FG000|Overall Study|Adverse Event|1|||
42070396|NCT00602420|75880490|FG001|Overall Study|Adverse Event|0|||
42176476|NCT00289913|75983704|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
42176477|NCT00289913|75983705|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
42176478|NCT00289913|75983701|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
42176479|NCT00289913|75983702|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
42176480|NCT00289913|75983703|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
42176481|NCT00289913|75983704|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
42176482|NCT00289913|75983705|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
42176483|NCT00289913|75983701|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
42176484|NCT00289913|75983702|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
42176485|NCT00289913|75983703|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
42176486|NCT00289913|75983704|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
42176487|NCT00289913|75983705|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
42176488|NCT00289913|75983701|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
42176489|NCT00289913|75983702|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
42176490|NCT00289913|75983703|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
42176491|NCT00289913|75983704|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
42176492|NCT00289913|75983705|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
42176493|NCT00289913|75983701|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
42176494|NCT00289913|75983702|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
42176495|NCT00289913|75983703|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
42176496|NCT00289913|75983704|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
42176497|NCT00289913|75983705|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
42176498|NCT00289913|75983701|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
42176499|NCT00289913|75983702|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
42176500|NCT00289913|75983703|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
42176501|NCT00289913|75983704|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
42176502|NCT00289913|75983705|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
42176503|NCT00289289|75983723|FG000|Overall Study|Withdrawal by Subject|5|||
42176504|NCT00289289|75983724|FG001|Overall Study|Withdrawal by Subject|3|||
42176505|NCT00289289|75983725|FG002|Overall Study|Withdrawal by Subject|15|||
42176506|NCT00289289|75983723|FG000|Overall Study|Lost to Follow-up|1|||
42176507|NCT00289289|75983724|FG001|Overall Study|Lost to Follow-up|0|||
42176508|NCT00289289|75983725|FG002|Overall Study|Lost to Follow-up|1|||
42176509|NCT00289289|75983723|FG000|Overall Study|Death|4|||
42176510|NCT00289289|75983724|FG001|Overall Study|Death|2|||
42176511|NCT00289289|75983725|FG002|Overall Study|Death|5|||
42176512|NCT00289289|75983723|FG000|Overall Study|No implant attempted|0|||
42176513|NCT00289289|75983724|FG001|Overall Study|No implant attempted|0|||
42176514|NCT00289289|75983725|FG002|Overall Study|No implant attempted|1|||
42176515|NCT00289289|75983723|FG000|Overall Study|Physician Decision|1|||
42176516|NCT00289289|75983724|FG001|Overall Study|Physician Decision|0|||
42176517|NCT00289289|75983725|FG002|Overall Study|Physician Decision|6|||
42176518|NCT00289289|75983723|FG000|Overall Study|Non-study device implanted|2|||
42176519|NCT00289289|75983724|FG001|Overall Study|Non-study device implanted|1|||
42176520|NCT00289289|75983725|FG002|Overall Study|Non-study device implanted|3|||
42176521|NCT00289289|75983723|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
42176522|NCT00289289|75983724|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
42176523|NCT00289289|75983725|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
42176524|NCT00289289|75983723|FG000|Overall Study|Other Exit Reason|6|||
42176525|NCT00289289|75983724|FG001|Overall Study|Other Exit Reason|4|||
42176526|NCT00289289|75983725|FG002|Overall Study|Other Exit Reason|12|||
42176527|NCT00270257|75983734|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
42070397|NCT00875667|75880504|FG000|Overall Study|Adverse Event|29|||
42070398|NCT00875667|75880505|FG001|Overall Study|Adverse Event|10|||
42070399|NCT00875667|75880504|FG000|Overall Study|Withdrawal by Subject|17|||
42070400|NCT00875667|75880505|FG001|Overall Study|Withdrawal by Subject|5|||
42070401|NCT00875667|75880504|FG000|Overall Study|Death|7|||
42070402|NCT00875667|75880505|FG001|Overall Study|Death|2|||
42070403|NCT00875667|75880504|FG000|Overall Study|Protocol Violation|2|||
42070404|NCT00875667|75880505|FG001|Overall Study|Protocol Violation|0|||
42070405|NCT00875667|75880504|FG000|Overall Study|Disease Progression|100|||
42070406|NCT00875667|75880505|FG001|Overall Study|Disease Progression|49|||
42070407|NCT00875667|75880504|FG000|Overall Study|Miscellaneous|12|||
42070408|NCT00875667|75880505|FG001|Overall Study|Miscellaneous|6|||
42070409|NCT00875667|75880504|FG000|Overall Study|Randomized but no Study Drug Given|3|||
42070410|NCT00875667|75880505|FG001|Overall Study|Randomized but no Study Drug Given|1|||
42070411|NCT00602030|75880515|FG000|Lead-in Phase|Disease Progression|2|||
42070412|NCT00602030|75880516|FG001|Lead-in Phase|Disease Progression|3|||
42070413|NCT00602030|75880517|FG002|Lead-in Phase|Disease Progression|0|||
42070414|NCT00602030|75880518|FG003|Lead-in Phase|Disease Progression|0|||
42292692|NCT00879086|76126518|FG000|Overall Study|Adverse Event|3|||
42017277|NCT01130103|75824829|FG001|Maintenance Treatment|Lack of Efficacy|1|||
42070415|NCT00602030|75880519|FG004|Lead-in Phase|Disease Progression|0|||
42070416|NCT00602030|75880515|FG000|Lead-in Phase|Adverse Event|0|||
42176528|NCT00270257|75983735|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
42176529|NCT00269633|75983745|FG000|Overall Study|Withdrawal by Subject|1|||
42176530|NCT00269633|75983746|FG001|Overall Study|Withdrawal by Subject|0|||
42176531|NCT00269477|75983756|FG000|Overall Study|Protocol Violation|5|||
42176532|NCT00269477|75983757|FG001|Overall Study|Protocol Violation|5|||
42176533|NCT00269477|75983758|FG002|Overall Study|Protocol Violation|1|||
42176534|NCT00269477|75983759|FG003|Overall Study|Protocol Violation|0|||
42176535|NCT00269477|75983756|FG000|Overall Study|Missed post-vaccination blood draw|0|||
42176536|NCT00269477|75983757|FG001|Overall Study|Missed post-vaccination blood draw|1|||
42176537|NCT00269477|75983758|FG002|Overall Study|Missed post-vaccination blood draw|0|||
42176538|NCT00269477|75983759|FG003|Overall Study|Missed post-vaccination blood draw|0|||
42176539|NCT00269399|75983771|FG000|Overall Study|Lack of Efficacy|27|||
42176540|NCT00269399|75983772|FG001|Overall Study|Lack of Efficacy|10|||
42176541|NCT00269399|75983771|FG000|Overall Study|Adverse Event|10|||
42176542|NCT00269399|75983772|FG001|Overall Study|Adverse Event|4|||
42176543|NCT00269399|75983771|FG000|Overall Study|Withdrawal by Subject|2|||
42176544|NCT00269399|75983772|FG001|Overall Study|Withdrawal by Subject|5|||
42176545|NCT00269399|75983771|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
42176546|NCT00269399|75983772|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
42176547|NCT00269399|75983771|FG000|Overall Study|Other|0|||
42176548|NCT00269399|75983772|FG001|Overall Study|Other|4|||
42176549|NCT00269399|75983771|FG000|Overall Study|Development of exclusion criteria|0|||
42176550|NCT00269399|75983772|FG001|Overall Study|Development of exclusion criteria|1|||
42176551|NCT00269087|75983778|FG000|Overall Study|Adverse Event|20|||
42176552|NCT00269087|75983778|FG000|Overall Study|Withdrawal by Subject|1|||
42176553|NCT00269087|75983778|FG000|Overall Study|Exacerbation of COPD|13|||
42176554|NCT00289133|75983784|FG000|Overall Study|Non-study device implanted|12|||
42176555|NCT00289133|75983785|FG001|Overall Study|Non-study device implanted|0|||
42176556|NCT00289133|75983784|FG000|Overall Study|Protocol Violation|32|||
42176557|NCT00289133|75983785|FG001|Overall Study|Protocol Violation|38|||
42176558|NCT00289133|75983784|FG000|Overall Study|Withdrawal by Subject|9|||
42176559|NCT00289133|75983785|FG001|Overall Study|Withdrawal by Subject|10|||
42176560|NCT00289133|75983784|FG000|Overall Study|Death|5|||
42176561|NCT00289133|75983785|FG001|Overall Study|Death|10|||
42176562|NCT00289133|75983784|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
42176563|NCT00289133|75983785|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
42176564|NCT00289133|75983784|FG000|Overall Study|Physician Decision|41|||
42176565|NCT00289133|75983785|FG001|Overall Study|Physician Decision|45|||
42176566|NCT00289133|75983784|FG000|Overall Study|Revision|8|||
42176567|NCT00289133|75983785|FG001|Overall Study|Revision|6|||
42176568|NCT00289133|75983784|FG000|Overall Study|Lost to Follow-up|92|||
42176569|NCT00289133|75983785|FG001|Overall Study|Lost to Follow-up|115|||
42176570|NCT00288587|75983797|FG000|Overall Study|Death|4|||
42176571|NCT00288587|75983798|FG001|Overall Study|Death|4|||
42176572|NCT00288587|75983797|FG000|Overall Study|Transplant|0|||
42176573|NCT00288587|75983798|FG001|Overall Study|Transplant|3|||
42176574|NCT00288587|75983797|FG000|Overall Study|Adverse Event|0|||
42176575|NCT00288587|75983798|FG001|Overall Study|Adverse Event|1|||
42176576|NCT00288587|75983797|FG000|Overall Study|Physician Decision|0|||
42292693|NCT00879086|76126519|FG001|Overall Study|Adverse Event|15|||
42017278|NCT01130103|75824828|FG000|Maintenance Treatment|Lost to Follow-up|1|||
42017279|NCT01130103|75824829|FG001|Maintenance Treatment|Lost to Follow-up|1|||
42017280|NCT01130103|75824828|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
42017281|NCT01130103|75824829|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
42017282|NCT01129557|75824838|FG000|Overall Study|Adverse Event|1|||
42017283|NCT01129557|75824839|FG001|Overall Study|Adverse Event|2|||
42017284|NCT01129557|75824840|FG002|Overall Study|Adverse Event|2|||
42017285|NCT01129557|75824838|FG000|Overall Study|Novartis terminated study early|3|||
42017286|NCT01129557|75824839|FG001|Overall Study|Novartis terminated study early|3|||
42017287|NCT01129557|75824840|FG002|Overall Study|Novartis terminated study early|2|||
42070417|NCT00602030|75880516|FG001|Lead-in Phase|Adverse Event|2|||
42070418|NCT00602030|75880517|FG002|Lead-in Phase|Adverse Event|0|||
42070419|NCT00602030|75880518|FG003|Lead-in Phase|Adverse Event|0|||
42070420|NCT00602030|75880519|FG004|Lead-in Phase|Adverse Event|0|||
42176577|NCT00288587|75983798|FG001|Overall Study|Physician Decision|2|||
42176578|NCT00288587|75983797|FG000|Overall Study|Severe Aortic Stenosis|1|||
42176579|NCT00288587|75983798|FG001|Overall Study|Severe Aortic Stenosis|0|||
42292694|NCT00879086|76126518|FG000|Overall Study|Participant choice|2|||
42070421|NCT00602030|75880515|FG000|Double-blind Phase|Disease progression|0|||
42070422|NCT00602030|75880516|FG001|Double-blind Phase|Disease progression|0|||
42070423|NCT00602030|75880517|FG002|Double-blind Phase|Disease progression|33|||
42070424|NCT00602030|75880518|FG003|Double-blind Phase|Disease progression|30|||
42070425|NCT00602030|75880519|FG004|Double-blind Phase|Disease progression|0|||
42070426|NCT00602030|75880515|FG000|Double-blind Phase|Adverse Event|0|||
42070427|NCT00602030|75880516|FG001|Double-blind Phase|Adverse Event|0|||
42070428|NCT00602030|75880517|FG002|Double-blind Phase|Adverse Event|9|||
42070429|NCT00602030|75880518|FG003|Double-blind Phase|Adverse Event|18|||
42070430|NCT00602030|75880519|FG004|Double-blind Phase|Adverse Event|0|||
42070431|NCT00602030|75880515|FG000|Double-blind Phase|Consent withdrawal|0|||
42070432|NCT00602030|75880516|FG001|Double-blind Phase|Consent withdrawal|0|||
42070433|NCT00602030|75880517|FG002|Double-blind Phase|Consent withdrawal|4|||
42070434|NCT00602030|75880518|FG003|Double-blind Phase|Consent withdrawal|3|||
42070435|NCT00602030|75880519|FG004|Double-blind Phase|Consent withdrawal|0|||
42070436|NCT00602030|75880515|FG000|Double-blind Phase|Death|0|||
42070437|NCT00602030|75880516|FG001|Double-blind Phase|Death|0|||
42070438|NCT00602030|75880517|FG002|Double-blind Phase|Death|3|||
42070439|NCT00602030|75880518|FG003|Double-blind Phase|Death|3|||
42070440|NCT00602030|75880519|FG004|Double-blind Phase|Death|0|||
42070441|NCT00602030|75880515|FG000|Double-blind Phase|Administrative decision|0|||
42070442|NCT00602030|75880516|FG001|Double-blind Phase|Administrative decision|0|||
42070443|NCT00602030|75880517|FG002|Double-blind Phase|Administrative decision|0|||
42070444|NCT00602030|75880518|FG003|Double-blind Phase|Administrative decision|2|||
42070445|NCT00602030|75880519|FG004|Double-blind Phase|Administrative decision|0|||
42070446|NCT00602030|75880515|FG000|Double-blind Phase|Ineligibility|0|||
42070447|NCT00602030|75880516|FG001|Double-blind Phase|Ineligibility|0|||
42070448|NCT00602030|75880517|FG002|Double-blind Phase|Ineligibility|0|||
42070449|NCT00602030|75880518|FG003|Double-blind Phase|Ineligibility|1|||
42070450|NCT00602030|75880519|FG004|Double-blind Phase|Ineligibility|0|||
42070451|NCT00602030|75880515|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
42070452|NCT00602030|75880516|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
42070453|NCT00602030|75880517|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
42070454|NCT00602030|75880518|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
42070455|NCT00602030|75880519|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
42070456|NCT00602030|75880515|FG000|Double-blind Phase|Reason not specified|0|||
42070457|NCT00602030|75880516|FG001|Double-blind Phase|Reason not specified|0|||
42070458|NCT00602030|75880517|FG002|Double-blind Phase|Reason not specified|4|||
42292695|NCT00879086|76126519|FG001|Overall Study|Participant choice|2|||
42292696|NCT00879086|76126518|FG000|Overall Study|Progression of disease|40|||
42292697|NCT00879086|76126519|FG001|Overall Study|Progression of disease|26|||
42292698|NCT00879086|76126518|FG000|Overall Study|Withdrawal of consent|2|||
42292699|NCT00879086|76126519|FG001|Overall Study|Withdrawal of consent|1|||
42292700|NCT00879086|76126518|FG000|Overall Study|Other|4|||
42292701|NCT00879086|76126519|FG001|Overall Study|Other|6|||
42292702|NCT00879086|76126518|FG000|Overall Study|Death|1|||
42292703|NCT00879086|76126519|FG001|Overall Study|Death|2|||
42292704|NCT00244933|76126535|FG000|Overall Study|Not response evaluable|2|||
42292705|NCT02637557|76126616|FG000|Overall Study|Adverse Event|3|||
42292706|NCT02637557|76126617|FG001|Overall Study|Adverse Event|1|||
42292707|NCT02637557|76126618|FG002|Overall Study|Adverse Event|3|||
42292708|NCT02637557|76126619|FG003|Overall Study|Adverse Event|3|||
42292709|NCT02637557|76126616|FG000|Overall Study|Lost to Follow-up|1|||
42292710|NCT02637557|76126617|FG001|Overall Study|Lost to Follow-up|1|||
42292711|NCT02637557|76126618|FG002|Overall Study|Lost to Follow-up|0|||
42292712|NCT02637557|76126619|FG003|Overall Study|Lost to Follow-up|1|||
42292713|NCT02637557|76126616|FG000|Overall Study|Physician Decision|1|||
42292714|NCT02637557|76126617|FG001|Overall Study|Physician Decision|0|||
42070459|NCT00602030|75880518|FG003|Double-blind Phase|Reason not specified|2|||
42070460|NCT00602030|75880519|FG004|Double-blind Phase|Reason not specified|0|||
42070461|NCT00602030|75880515|FG000|Crossover Phase|Disease Progression|0|||
42070462|NCT00602030|75880516|FG001|Crossover Phase|Disease Progression|0|||
42070463|NCT00602030|75880517|FG002|Crossover Phase|Disease Progression|0|||
42070464|NCT00602030|75880518|FG003|Crossover Phase|Disease Progression|0|||
42070465|NCT00602030|75880519|FG004|Crossover Phase|Disease Progression|11|||
42070466|NCT00602030|75880515|FG000|Crossover Phase|Adverse Event|0|||
42292715|NCT02637557|76126618|FG002|Overall Study|Physician Decision|0|||
42292716|NCT02637557|76126619|FG003|Overall Study|Physician Decision|0|||
42292717|NCT02637557|76126616|FG000|Overall Study|Protocol Violation|2|||
42070467|NCT00602030|75880516|FG001|Crossover Phase|Adverse Event|0|||
42070468|NCT00602030|75880517|FG002|Crossover Phase|Adverse Event|0|||
42070469|NCT00602030|75880518|FG003|Crossover Phase|Adverse Event|0|||
42070470|NCT00602030|75880519|FG004|Crossover Phase|Adverse Event|3|||
42070471|NCT00602030|75880515|FG000|Crossover Phase|Consent withdrawal|0|||
42070472|NCT00602030|75880516|FG001|Crossover Phase|Consent withdrawal|0|||
42292718|NCT02637557|76126617|FG001|Overall Study|Protocol Violation|0|||
42292719|NCT02637557|76126618|FG002|Overall Study|Protocol Violation|2|||
42292720|NCT02637557|76126619|FG003|Overall Study|Protocol Violation|1|||
42070473|NCT00602030|75880517|FG002|Crossover Phase|Consent withdrawal|0|||
42070474|NCT00602030|75880518|FG003|Crossover Phase|Consent withdrawal|0|||
42292721|NCT02637557|76126616|FG000|Overall Study|Withdrawal by Subject|1|||
42292722|NCT02637557|76126617|FG001|Overall Study|Withdrawal by Subject|3|||
42292723|NCT02637557|76126618|FG002|Overall Study|Withdrawal by Subject|4|||
42292724|NCT02637557|76126619|FG003|Overall Study|Withdrawal by Subject|2|||
42292725|NCT02638493|76126632|FG000|Overall Study|Inability to provide semen samples|2|||
42292726|NCT02638493|76126633|FG001|Overall Study|Inability to provide semen samples|0|||
42292727|NCT02638493|76126634|FG002|Overall Study|Inability to provide semen samples|0|||
42292728|NCT02638337|76126644|FG000|Overall Study|Adverse Event|6|||
42292729|NCT02638337|76126645|FG001|Overall Study|Adverse Event|10|||
42292730|NCT02638337|76126644|FG000|Overall Study|Protocol Violation|3|||
42292731|NCT02638337|76126645|FG001|Overall Study|Protocol Violation|0|||
42292732|NCT02638337|76126644|FG000|Overall Study|Withdrawal by Subject|13|||
42292733|NCT02638337|76126645|FG001|Overall Study|Withdrawal by Subject|16|||
42292734|NCT02638337|76126644|FG000|Overall Study|Lost to Follow-up|7|||
42292735|NCT02638337|76126645|FG001|Overall Study|Lost to Follow-up|7|||
42292736|NCT02638337|76126644|FG000|Overall Study|Other - Miscellaneous|4|||
42292737|NCT02638337|76126645|FG001|Overall Study|Other - Miscellaneous|3|||
42292738|NCT02638259|76126653|FG000|Treatment Period 1|Adverse Event|1|||
42070475|NCT00602030|75880519|FG004|Crossover Phase|Consent withdrawal|2|||
42070476|NCT00549757|75880533|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
42070477|NCT00549757|75880534|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
42070478|NCT00549757|75880533|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
42070479|NCT00549757|75880534|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
42070480|NCT00549757|75880533|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
42070481|NCT00549757|75880534|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
42070482|NCT00549757|75880533|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
42070483|NCT00549757|75880534|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
42070484|NCT00549757|75880533|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
42070485|NCT00549757|75880534|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
42070486|NCT00549757|75880533|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
42070487|NCT00549757|75880534|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
42070488|NCT00549757|75880533|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
42070489|NCT00549757|75880534|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
42070490|NCT00549757|75880533|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
42070491|NCT00549757|75880534|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
42070492|NCT00549757|75880533|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
42070493|NCT00549757|75880534|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
42070494|NCT00549757|75880533|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
42070495|NCT00549757|75880534|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
42070496|NCT00549757|75880533|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
42070497|NCT00549757|75880534|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
42070498|NCT00549757|75880533|FG000|Extension Period (in Average 9 Months)|Death|143|||
42070499|NCT00549757|75880534|FG001|Extension Period (in Average 9 Months)|Death|136|||
42070500|NCT00549757|75880533|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
42070501|NCT00549757|75880534|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
42070502|NCT00549757|75880533|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
42070503|NCT00549757|75880534|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
42070504|NCT00549757|75880533|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
42070505|NCT00549757|75880534|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
42070506|NCT00549601|75880549|FG000|Randomized|Protocol Violation|0|||
42070507|NCT00549601|75880550|FG001|Randomized|Protocol Violation|0|||
42070508|NCT00549601|75880551|FG002|Randomized|Protocol Violation|1|||
42176580|NCT00268463|75983806|FG000|Overall Study|study terminated due to low accrual|10|||
42176581|NCT00268463|75983807|FG001|Overall Study|study terminated due to low accrual|12|||
42176582|NCT00288509|75983813|FG000|Treatment Cycle 1|Adverse Event|1|||
42176583|NCT00288509|75983813|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
42292739|NCT02638259|76126654|FG001|Treatment Period 1|Adverse Event|5|||
42292740|NCT02638259|76126653|FG000|Treatment Period 1|Death|0|||
42292741|NCT02638259|76126654|FG001|Treatment Period 1|Death|1|||
42292742|NCT02638259|76126653|FG000|Treatment Period 1|Lack of Efficacy|0|||
42070509|NCT00549601|75880549|FG000|Randomized|Withdrawal by Subject|0|||
42070510|NCT00549601|75880550|FG001|Randomized|Withdrawal by Subject|1|||
42292743|NCT02638259|76126654|FG001|Treatment Period 1|Lack of Efficacy|1|||
42292744|NCT02638259|76126653|FG000|Treatment Period 1|Protocol Violation|0|||
42292745|NCT02638259|76126654|FG001|Treatment Period 1|Protocol Violation|3|||
42292746|NCT02638259|76126653|FG000|Treatment Period 1|Withdrawal by Subject|4|||
42070511|NCT00549601|75880551|FG002|Randomized|Withdrawal by Subject|1|||
42070512|NCT00549601|75880549|FG000|Received Study Drug|Adverse Event|2|||
42070513|NCT00549601|75880550|FG001|Received Study Drug|Adverse Event|5|||
42070514|NCT00549601|75880551|FG002|Received Study Drug|Adverse Event|1|||
42070515|NCT00549601|75880549|FG000|Received Study Drug|Death|0|||
42070516|NCT00549601|75880550|FG001|Received Study Drug|Death|1|||
42070517|NCT00549601|75880551|FG002|Received Study Drug|Death|0|||
42070518|NCT00549601|75880549|FG000|Received Study Drug|Lost to Follow-up|0|||
42070519|NCT00549601|75880550|FG001|Received Study Drug|Lost to Follow-up|1|||
42070520|NCT00549601|75880551|FG002|Received Study Drug|Lost to Follow-up|1|||
42070521|NCT00549601|75880549|FG000|Received Study Drug|Protocol Violation|3|||
42070522|NCT00549601|75880550|FG001|Received Study Drug|Protocol Violation|4|||
42070523|NCT00549601|75880551|FG002|Received Study Drug|Protocol Violation|1|||
42070524|NCT00549601|75880549|FG000|Received Study Drug|Withdrawal by Subject|2|||
42070525|NCT00549601|75880550|FG001|Received Study Drug|Withdrawal by Subject|0|||
42070526|NCT00549601|75880551|FG002|Received Study Drug|Withdrawal by Subject|1|||
42070527|NCT00601640|75880577|FG000|Overall Study|Withdrawal by Subject|3|||
42070528|NCT00601640|75880578|FG001|Overall Study|Withdrawal by Subject|0|||
42070529|NCT00601640|75880579|FG002|Overall Study|Withdrawal by Subject|7|||
42070530|NCT00601640|75880577|FG000|Overall Study|Death|1|||
42070531|NCT00601640|75880578|FG001|Overall Study|Death|0|||
42070532|NCT00601640|75880579|FG002|Overall Study|Death|0|||
42070533|NCT00601640|75880577|FG000|Overall Study|Adverse Event|0|||
42070534|NCT00601640|75880578|FG001|Overall Study|Adverse Event|4|||
42070535|NCT00601640|75880579|FG002|Overall Study|Adverse Event|2|||
42070536|NCT00601640|75880577|FG000|Overall Study|intercurrent illness|1|||
42070537|NCT00601640|75880578|FG001|Overall Study|intercurrent illness|0|||
42070538|NCT00601640|75880579|FG002|Overall Study|intercurrent illness|0|||
42070539|NCT00601640|75880577|FG000|Overall Study|change in eligibility status|0|||
42070540|NCT00601640|75880578|FG001|Overall Study|change in eligibility status|1|||
42070541|NCT00601640|75880579|FG002|Overall Study|change in eligibility status|1|||
42070542|NCT02805725|75880594|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
42070543|NCT02805725|75880595|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
42070544|NCT02805725|75880596|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
42070545|NCT02805725|75880597|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
42292747|NCT02638259|76126654|FG001|Treatment Period 1|Withdrawal by Subject|6|||
42292748|NCT02638259|76126653|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
42292749|NCT02638259|76126654|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
42292750|NCT02638259|76126653|FG000|Treatment Period 2|Adverse Event|5|||
42070546|NCT02805725|75880598|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
42070547|NCT02805725|75880594|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
42070548|NCT02805725|75880595|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
42070549|NCT02805725|75880596|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
42070550|NCT02805725|75880597|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
42070551|NCT02805725|75880598|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
42070552|NCT02805725|75880594|FG000|Phase II|Protocol Violation|0|||
42070553|NCT02805725|75880595|FG001|Phase II|Protocol Violation|0|||
42070554|NCT02805725|75880596|FG002|Phase II|Protocol Violation|0|||
42070555|NCT02805725|75880597|FG003|Phase II|Protocol Violation|0|||
42070556|NCT02805725|75880598|FG004|Phase II|Protocol Violation|6|||
42070557|NCT00546871|75880615|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
42070558|NCT00546871|75880616|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
42070559|NCT00546871|75880615|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
42070560|NCT00546871|75880616|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
42070561|NCT00546871|75880615|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
42070562|NCT00546871|75880616|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
42070563|NCT00546871|75880615|FG000|Study Extension Period|Protocol Violation|1|||
42070564|NCT00546871|75880616|FG001|Study Extension Period|Protocol Violation|0|||
42070565|NCT00546871|75880615|FG000|Study Extension Period|Withdrawal by Subject|0|||
42070566|NCT00546871|75880616|FG001|Study Extension Period|Withdrawal by Subject|1|||
42070567|NCT03951805|75880649|FG000|Overall Study|Adverse Event|1|||
42070568|NCT03951805|75880650|FG001|Overall Study|Adverse Event|0|||
42070569|NCT03951805|75880651|FG002|Overall Study|Adverse Event|0|||
42070570|NCT03951805|75880652|FG003|Overall Study|Adverse Event|0|||
42070571|NCT03944707|75880664|FG000|Overall Study|Adverse Event|0|||
42070572|NCT03944707|75880665|FG001|Overall Study|Adverse Event|2|||
42070573|NCT03944707|75880664|FG000|Overall Study|Study terminated by sponsor|12|||
42292751|NCT02638259|76126654|FG001|Treatment Period 2|Adverse Event|4|||
42070574|NCT03944707|75880665|FG001|Overall Study|Study terminated by sponsor|7|||
42176584|NCT00288509|75983813|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
42176585|NCT00288509|75983813|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
42292752|NCT02638259|76126653|FG000|Treatment Period 2|Withdrawal by Subject|1|||
42070575|NCT03944707|75880664|FG000|Overall Study|Subject decision|0|||
42070576|NCT03944707|75880665|FG001|Overall Study|Subject decision|1|||
42070577|NCT00549055|75880671|FG000|Overall Study|Adverse Event|4|||
42070578|NCT00549055|75880671|FG000|Overall Study|Lack of Efficacy|18|||
42070579|NCT00549055|75880671|FG000|Overall Study|Stabilization|5|||
42070580|NCT00549055|75880671|FG000|Overall Study|Progression to fibrosis|2|||
42070581|NCT00549055|75880671|FG000|Overall Study|Decrease of size|1|||
42070582|NCT00549055|75880671|FG000|Overall Study|Active choroidal neovascula increased|1|||
42070583|NCT00549055|75880671|FG000|Overall Study|Vitreous hemorrhage|1|||
42070584|NCT00549055|75880671|FG000|Overall Study|Growth choroidal neovascularisation|1|||
42070585|NCT00549055|75880671|FG000|Overall Study|Choroidal neovascularization|1|||
42070586|NCT00549055|75880671|FG000|Overall Study|Very low visual acuity (VA)|1|||
42070587|NCT00883116|75880677|FG000|Overall Study|Adverse event unrelated to study drug|5|||
42070588|NCT00883116|75880678|FG001|Overall Study|Adverse event unrelated to study drug|10|||
42070589|NCT00883116|75880677|FG000|Overall Study|Death|6|||
42070590|NCT00883116|75880678|FG001|Overall Study|Death|2|||
42070591|NCT00883116|75880677|FG000|Overall Study|Disease progression|130|||
42292753|NCT02638259|76126654|FG001|Treatment Period 2|Withdrawal by Subject|7|||
42292754|NCT02637323|76126666|FG000|Overall Study|Lost to Follow-up|2|||
42292755|NCT02637323|76126667|FG001|Overall Study|Lost to Follow-up|0|||
42292756|NCT02637323|76126666|FG000|Overall Study|Protocol Violation|0|||
42292757|NCT02637323|76126667|FG001|Overall Study|Protocol Violation|1|||
42292758|NCT03573817|76126676|FG000|Overall Study|Adverse Event|0|||
42292759|NCT03573817|76126677|FG001|Overall Study|Adverse Event|2|||
42292760|NCT03573817|76126676|FG000|Overall Study|Protocol Violation|0|||
42070592|NCT00883116|75880678|FG001|Overall Study|Disease progression|128|||
42070593|NCT00883116|75880677|FG000|Overall Study|Lost to Follow-up|0|||
42070594|NCT00883116|75880678|FG001|Overall Study|Lost to Follow-up|1|||
42070595|NCT00883116|75880677|FG000|Overall Study|Maximum clinical benefit|13|||
42070596|NCT00883116|75880678|FG001|Overall Study|Maximum clinical benefit|46|||
42070597|NCT00883116|75880677|FG000|Overall Study|Not identified|3|||
42070598|NCT00883116|75880678|FG001|Overall Study|Not identified|6|||
42070599|NCT00883116|75880677|FG000|Overall Study|Study drug toxicity|36|||
42070600|NCT00883116|75880678|FG001|Overall Study|Study drug toxicity|16|||
42070601|NCT00883116|75880677|FG000|Overall Study|Withdrawal by Subject|14|||
42070602|NCT00883116|75880678|FG001|Overall Study|Withdrawal by Subject|8|||
42070603|NCT00883116|75880677|FG000|Overall Study|No longer meets study criteria|2|||
42070604|NCT00883116|75880678|FG001|Overall Study|No longer meets study criteria|2|||
42070605|NCT00594399|75880697|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
42070606|NCT00594399|75880698|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
42070607|NCT00594399|75880699|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
42070608|NCT00594399|75880697|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
42070609|NCT00594399|75880698|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
42070610|NCT00594399|75880699|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
42176586|NCT00288509|75983813|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
42176587|NCT00288509|75983813|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
42176588|NCT00288509|75983813|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
42176589|NCT00288509|75983813|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
42176590|NCT00288509|75983813|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
42176591|NCT00288509|75983813|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
42176592|NCT00288509|75983813|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
42176593|NCT00288509|75983813|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
42176594|NCT00288509|75983813|FG000|Treatment Cycle 4|Physician Decision|4|||
42176595|NCT00288509|75983813|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
42176596|NCT00266825|75983819|FG000|Completed Follow-Up|Lost to Follow-up|14|||
42176597|NCT00266825|75983820|FG001|Completed Follow-Up|Lost to Follow-up|19|||
42176598|NCT00266825|75983819|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
42176599|NCT00266825|75983820|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
42176600|NCT00265889|75983828|FG000|Overall Study|Physician Decision|1|||
42176601|NCT00265889|75983828|FG000|Overall Study|Protocol Violation|1|||
42176602|NCT00265889|75983828|FG000|Overall Study|Insurance denied the request|3|||
42292761|NCT03573817|76126677|FG001|Overall Study|Protocol Violation|1|||
42292762|NCT03573817|76126676|FG000|Overall Study|Withdrawal by Subject|1|||
42070611|NCT00594399|75880697|FG000|Initial 3 Month Counseling|Personal issues|2|||
42070612|NCT00594399|75880698|FG001|Initial 3 Month Counseling|Personal issues|0|||
42070613|NCT00594399|75880699|FG002|Initial 3 Month Counseling|Personal issues|0|||
42070614|NCT00594399|75880697|FG000|Initial 3 Month Counseling|Too busy|7|||
42070615|NCT00594399|75880698|FG001|Initial 3 Month Counseling|Too busy|1|||
42070616|NCT00594399|75880699|FG002|Initial 3 Month Counseling|Too busy|0|||
42070617|NCT00594399|75880697|FG000|Initial 3 Month Counseling|Pain|2|||
42070618|NCT00594399|75880698|FG001|Initial 3 Month Counseling|Pain|0|||
42070619|NCT00594399|75880699|FG002|Initial 3 Month Counseling|Pain|0|||
42070620|NCT00594399|75880697|FG000|Initial 3 Month Counseling|Moved|1|||
42070621|NCT00594399|75880698|FG001|Initial 3 Month Counseling|Moved|0|||
42070622|NCT00594399|75880699|FG002|Initial 3 Month Counseling|Moved|0|||
42292763|NCT03573817|76126677|FG001|Overall Study|Withdrawal by Subject|1|||
42070623|NCT00594399|75880697|FG000|Initial 3 Month Counseling|Family illness|1|||
42070624|NCT00594399|75880698|FG001|Initial 3 Month Counseling|Family illness|0|||
42070625|NCT00594399|75880699|FG002|Initial 3 Month Counseling|Family illness|0|||
42070626|NCT00594399|75880697|FG000|Rerandomization Arm 1 Only|Death|2|||
42070627|NCT00594399|75880698|FG001|Rerandomization Arm 1 Only|Death|1|||
42070628|NCT00594399|75880699|FG002|Rerandomization Arm 1 Only|Death|0|||
42070629|NCT00594399|75880697|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
42070630|NCT00594399|75880698|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
42070631|NCT00594399|75880699|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
42070632|NCT00546715|75880709|FG000|Overall Study|Withdrawal by Subject|0|||
42070633|NCT00546715|75880710|FG001|Overall Study|Withdrawal by Subject|1|||
42070634|NCT00546715|75880711|FG002|Overall Study|Withdrawal by Subject|0|||
42070635|NCT00546715|75880712|FG003|Overall Study|Withdrawal by Subject|0|||
42070636|NCT00874029|75880722|FG000|Overall Study|Withdrawal by Subject|10|||
42070637|NCT00874029|75880722|FG000|Overall Study|Pregnancy|4|||
42070638|NCT00874029|75880722|FG000|Overall Study|Physician Decision|1|||
42070639|NCT00874029|75880722|FG000|Overall Study|Adverse Event|1|||
42070640|NCT00874029|75880722|FG000|Overall Study|Lost to Follow-up|5|||
42070641|NCT00546637|75880738|FG000|Overall Study|Adverse Event|46|||
42070642|NCT00546637|75880739|FG001|Overall Study|Adverse Event|20|||
42070643|NCT00546637|75880738|FG000|Overall Study|Lack of Efficacy|5|||
42070644|NCT00546637|75880739|FG001|Overall Study|Lack of Efficacy|5|||
42070645|NCT00546637|75880738|FG000|Overall Study|Lost to Follow-up|2|||
42070646|NCT00546637|75880739|FG001|Overall Study|Lost to Follow-up|2|||
42070647|NCT00546637|75880738|FG000|Overall Study|Other|10|||
42070648|NCT00546637|75880739|FG001|Overall Study|Other|12|||
42070649|NCT00546637|75880738|FG000|Overall Study|Withdrawal by Subject|7|||
42070650|NCT00546637|75880739|FG001|Overall Study|Withdrawal by Subject|9|||
42070651|NCT00546637|75880738|FG000|Overall Study|Randomized, but not treated|3|||
42070652|NCT00546637|75880739|FG001|Overall Study|Randomized, but not treated|1|||
42070653|NCT00546481|75880747|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
42070654|NCT00546481|75880748|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
42070655|NCT00546481|75880749|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
42070656|NCT00546481|75880747|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
42070657|NCT00546481|75880748|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
42070658|NCT00546481|75880749|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
42070659|NCT00546481|75880747|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
42070660|NCT00546481|75880748|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
42070661|NCT00546481|75880749|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
42070662|NCT00546481|75880747|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
42070663|NCT00546481|75880748|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
42070664|NCT00546481|75880749|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
42070665|NCT00546481|75880747|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
42070666|NCT00546481|75880748|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
42070667|NCT00546481|75880749|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
42070668|NCT00546481|75880747|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
42070669|NCT00546481|75880748|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
42070670|NCT00546481|75880749|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
42070671|NCT00546481|75880747|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
42070672|NCT00546481|75880748|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
42070673|NCT00546481|75880749|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
42070674|NCT00546481|75880747|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
42070675|NCT00546481|75880748|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
42070676|NCT00546481|75880749|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
42070677|NCT00546481|75880747|FG000|Maintenance Phase (CERA)|Other Reason|0|||
42070678|NCT00546481|75880748|FG001|Maintenance Phase (CERA)|Other Reason|0|||
42070679|NCT00546481|75880749|FG002|Maintenance Phase (CERA)|Other Reason|1|||
42070680|NCT00880698|75880761|FG000|Overall Study|Death|0|||
42070681|NCT00880698|75880762|FG001|Overall Study|Death|0|||
42070682|NCT00880698|75880763|FG002|Overall Study|Death|1|||
42070683|NCT00880698|75880764|FG003|Overall Study|Death|2|||
42070684|NCT00880698|75880761|FG000|Overall Study|Lost to Follow-up|1|||
42176603|NCT03209362|75983834|FG000|Overall Study|Adverse Event|0|||
42176604|NCT03209362|75983835|FG001|Overall Study|Adverse Event|1|||
42070685|NCT00880698|75880762|FG001|Overall Study|Lost to Follow-up|3|||
42070686|NCT00880698|75880763|FG002|Overall Study|Lost to Follow-up|0|||
42176605|NCT03209362|75983834|FG000|Overall Study|Lost to Follow-up|0|||
42070687|NCT00880698|75880764|FG003|Overall Study|Lost to Follow-up|1|||
42070688|NCT00880620|75880780|FG000|Overall Study|Adverse Event|4|||
42070689|NCT00880620|75880781|FG001|Overall Study|Adverse Event|5|||
42070690|NCT00880620|75880782|FG002|Overall Study|Adverse Event|15|||
42070691|NCT00880620|75880783|FG003|Overall Study|Adverse Event|15|||
42070692|NCT00880620|75880780|FG000|Overall Study|Death|0|||
42070693|NCT00880620|75880781|FG001|Overall Study|Death|0|||
42070694|NCT00880620|75880782|FG002|Overall Study|Death|1|||
42070695|NCT00880620|75880783|FG003|Overall Study|Death|0|||
42070696|NCT00880620|75880780|FG000|Overall Study|Lack of Efficacy|12|||
42070697|NCT00880620|75880781|FG001|Overall Study|Lack of Efficacy|4|||
42070698|NCT00880620|75880782|FG002|Overall Study|Lack of Efficacy|0|||
42070699|NCT00880620|75880783|FG003|Overall Study|Lack of Efficacy|1|||
42070700|NCT00880620|75880780|FG000|Overall Study|Lost to Follow-up|0|||
42070701|NCT00880620|75880781|FG001|Overall Study|Lost to Follow-up|1|||
42070702|NCT00880620|75880782|FG002|Overall Study|Lost to Follow-up|1|||
42070703|NCT00880620|75880783|FG003|Overall Study|Lost to Follow-up|0|||
42070704|NCT00880620|75880780|FG000|Overall Study|Protocol Violation|0|||
42070705|NCT00880620|75880781|FG001|Overall Study|Protocol Violation|1|||
42070706|NCT00880620|75880782|FG002|Overall Study|Protocol Violation|0|||
42070707|NCT00880620|75880783|FG003|Overall Study|Protocol Violation|2|||
42070708|NCT00880620|75880780|FG000|Overall Study|Withdrawal by Subject|4|||
42070709|NCT00880620|75880781|FG001|Overall Study|Withdrawal by Subject|3|||
42070710|NCT00880620|75880782|FG002|Overall Study|Withdrawal by Subject|1|||
42070711|NCT00880620|75880783|FG003|Overall Study|Withdrawal by Subject|3|||
42070712|NCT00880620|75880780|FG000|Overall Study|Noncompliance|0|||
42070713|NCT00880620|75880781|FG001|Overall Study|Noncompliance|0|||
42070714|NCT00880620|75880782|FG002|Overall Study|Noncompliance|1|||
42070715|NCT00880620|75880783|FG003|Overall Study|Noncompliance|1|||
42070716|NCT00880620|75880780|FG000|Overall Study|Other|1|||
42070717|NCT00880620|75880781|FG001|Overall Study|Other|1|||
42176606|NCT03209362|75983835|FG001|Overall Study|Lost to Follow-up|1|||
42176607|NCT03209362|75983834|FG000|Overall Study|Withdrawal by Subject|2|||
42176608|NCT03209362|75983835|FG001|Overall Study|Withdrawal by Subject|0|||
42176609|NCT03209362|75983834|FG000|Overall Study|Other|0|||
42176610|NCT03209362|75983835|FG001|Overall Study|Other|1|||
42176611|NCT02932462|75983843|FG000|Overall Study|Adverse Event|1|||
42176612|NCT02932462|75983844|FG001|Overall Study|Adverse Event|2|||
42176613|NCT02932462|75983843|FG000|Overall Study|Lost to Follow-up|4|||
42176614|NCT02932462|75983844|FG001|Overall Study|Lost to Follow-up|1|||
42176615|NCT02932462|75983843|FG000|Overall Study|Protocol Violation|0|||
42176616|NCT02932462|75983844|FG001|Overall Study|Protocol Violation|5|||
42176617|NCT02932462|75983843|FG000|Overall Study|Withdrawal by Subject|1|||
42176618|NCT02932462|75983844|FG001|Overall Study|Withdrawal by Subject|4|||
42176619|NCT02932462|75983843|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42176620|NCT02932462|75983844|FG001|Overall Study|Non-Compliance With Study Drug|1|||
42176621|NCT02932462|75983843|FG000|Overall Study|Progressive Disease|1|||
42176622|NCT02932462|75983844|FG001|Overall Study|Progressive Disease|0|||
42176623|NCT03206788|75983852|FG000|Overall Study|Withdrawal by Subject|0|||
42176624|NCT03206788|75983853|FG001|Overall Study|Withdrawal by Subject|1|||
42176625|NCT03206788|75983852|FG000|Overall Study|Adverse Event|0|||
42176626|NCT03206788|75983853|FG001|Overall Study|Adverse Event|1|||
42176627|NCT03206788|75983852|FG000|Overall Study|Physician Decision|0|||
42176628|NCT03206788|75983853|FG001|Overall Study|Physician Decision|1|||
42176629|NCT03205150|75983862|FG000|Overall Study|Protocol deviation|1|||
42176630|NCT03205150|75983863|FG001|Overall Study|Protocol deviation|3|||
42176631|NCT03205150|75983864|FG002|Overall Study|Protocol deviation|0|||
42176632|NCT03205150|75983862|FG000|Overall Study|Patient/guardian decision|0|||
42176633|NCT03205150|75983863|FG001|Overall Study|Patient/guardian decision|3|||
42176634|NCT03205150|75983864|FG002|Overall Study|Patient/guardian decision|0|||
42176635|NCT03205150|75983862|FG000|Overall Study|Adverse Event|1|||
42176636|NCT03205150|75983863|FG001|Overall Study|Adverse Event|1|||
42176637|NCT03205150|75983864|FG002|Overall Study|Adverse Event|1|||
42292764|NCT02638103|76126692|FG000|Overall Study|Adverse Event|13|||
42070718|NCT00880620|75880782|FG002|Overall Study|Other|2|||
42070719|NCT00880620|75880783|FG003|Overall Study|Other|2|||
42070720|NCT00881868|75880809|FG000|Overall Study|Adverse Event|0|||
42070721|NCT00881868|75880810|FG001|Overall Study|Adverse Event|1|||
42070722|NCT00881868|75880809|FG000|Overall Study|Lost to Follow-up|2|||
42070723|NCT00881868|75880810|FG001|Overall Study|Lost to Follow-up|1|||
42070724|NCT00881868|75880809|FG000|Overall Study|Physician Decision|4|||
42176638|NCT03205150|75983862|FG000|Overall Study|Lost to Follow-up|0|||
42176639|NCT03205150|75983863|FG001|Overall Study|Lost to Follow-up|0|||
42070725|NCT00881868|75880810|FG001|Overall Study|Physician Decision|0|||
42070726|NCT00881868|75880809|FG000|Overall Study|Protocol Violation|2|||
42070727|NCT00881868|75880810|FG001|Overall Study|Protocol Violation|0|||
42070728|NCT00881712|75880819|FG000|Overall Study|Death|1|||
42176640|NCT03205150|75983864|FG002|Overall Study|Lost to Follow-up|1|||
42176641|NCT02932306|75983875|FG000|Overall Study|Withdrawal by Subject|16|||
42176642|NCT02932306|75983876|FG001|Overall Study|Withdrawal by Subject|25|||
42176643|NCT02932306|75983875|FG000|Overall Study|Adverse Event|3|||
42176644|NCT02932306|75983876|FG001|Overall Study|Adverse Event|0|||
42176645|NCT02932306|75983875|FG000|Overall Study|Pregnancy|2|||
42292765|NCT02638103|76126693|FG001|Overall Study|Adverse Event|12|||
42070729|NCT00881712|75880820|FG001|Overall Study|Death|0|||
42070730|NCT00881712|75880821|FG002|Overall Study|Death|0|||
42070731|NCT00881712|75880819|FG000|Overall Study|Withdrawal by Subject|1|||
42070732|NCT00881712|75880820|FG001|Overall Study|Withdrawal by Subject|0|||
42070733|NCT00881712|75880821|FG002|Overall Study|Withdrawal by Subject|0|||
42070734|NCT03955471|75880829|FG000|Overall Study|Death|22|||
42070735|NCT03955471|75880829|FG000|Overall Study|Lost to Follow-up|1|||
42070736|NCT03955471|75880829|FG000|Overall Study|Withdrawal by Subject|6|||
42070737|NCT03955471|75880829|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
42070738|NCT00880542|75880833|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
42070739|NCT00880542|75880833|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
42070740|NCT00880542|75880833|FG000|REP: Surgical Resection|progressive disease|1|||
42070741|NCT00885534|75880837|FG000|Overall Study|Patient deemed ineligible|1|||
42070742|NCT00885378|75880843|FG000|Overall Study|Lack of Efficacy|2|||
42070743|NCT00885378|75880844|FG001|Overall Study|Lack of Efficacy|2|||
42070744|NCT00885378|75880843|FG000|Overall Study|Withdrawal by Subject|1|||
42070745|NCT00885378|75880844|FG001|Overall Study|Withdrawal by Subject|2|||
42070746|NCT00885378|75880843|FG000|Overall Study|Lost to Follow-up|1|||
42070747|NCT00885378|75880844|FG001|Overall Study|Lost to Follow-up|2|||
42070748|NCT00885378|75880843|FG000|Overall Study|Poor/Noncompliance|2|||
42070749|NCT00885378|75880844|FG001|Overall Study|Poor/Noncompliance|2|||
42070750|NCT00885378|75880843|FG000|Overall Study|Protocol Violation|2|||
42070751|NCT00885378|75880844|FG001|Overall Study|Protocol Violation|0|||
42070752|NCT00545779|75880850|FG000|Overall Study|Violation of selection criteria at entry|8|||
42176646|NCT02932306|75983876|FG001|Overall Study|Pregnancy|0|||
42176647|NCT02932306|75983875|FG000|Overall Study|Protocol Violation|1|||
42176648|NCT02932306|75983876|FG001|Overall Study|Protocol Violation|1|||
42176649|NCT02932306|75983875|FG000|Overall Study|Noncompliance with Study Drug|1|||
42176650|NCT02932306|75983876|FG001|Overall Study|Noncompliance with Study Drug|1|||
42176651|NCT02932306|75983875|FG000|Overall Study|Lost to Follow-up|36|||
42176652|NCT02932306|75983876|FG001|Overall Study|Lost to Follow-up|40|||
42176653|NCT02932306|75983875|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
42176654|NCT02932306|75983876|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
42176655|NCT02932306|75983875|FG000|Overall Study|Lack of Efficacy|0|||
42176656|NCT02932306|75983876|FG001|Overall Study|Lack of Efficacy|2|||
42176657|NCT02932306|75983875|FG000|Overall Study|Worsening condition|2|||
42176658|NCT02932306|75983876|FG001|Overall Study|Worsening condition|0|||
42176659|NCT02932306|75983875|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
42070753|NCT00545779|75880850|FG000|Overall Study|Other protocol violation|1|||
42070754|NCT00545779|75880850|FG000|Overall Study|Did not cooperate|7|||
42070755|NCT00545779|75880850|FG000|Overall Study|Withdrawal by Subject|20|||
42070756|NCT00545779|75880850|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
42070757|NCT00545779|75880850|FG000|Overall Study|Failure to return|3|||
42070758|NCT00597714|75880860|FG000|Overall Study|Death|56|||
42070759|NCT00597714|75880861|FG001|Overall Study|Death|46|||
42070760|NCT00597714|75880862|FG002|Overall Study|Death|0|||
42176660|NCT02932306|75983876|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
42292766|NCT02638103|76126694|FG002|Overall Study|Adverse Event|19|||
42292767|NCT02638103|76126695|FG003|Overall Study|Adverse Event|12|||
42292768|NCT02638103|76126692|FG000|Overall Study|Withdrawal by Subject|43|||
42292769|NCT02638103|76126693|FG001|Overall Study|Withdrawal by Subject|53|||
42292770|NCT02638103|76126694|FG002|Overall Study|Withdrawal by Subject|30|||
42292771|NCT02638103|76126695|FG003|Overall Study|Withdrawal by Subject|61|||
42292772|NCT02638103|76126692|FG000|Overall Study|Protocol Violation|1|||
42292773|NCT02638103|76126693|FG001|Overall Study|Protocol Violation|2|||
42357703|NCT01723826|76203229|FG001|Overall Study|Death according to AE eCRF|3|||
42357704|NCT01723826|76203230|FG002|Overall Study|Death according to AE eCRF|3|||
42357705|NCT01723826|76203231|FG003|Overall Study|Death according to AE eCRF|7|||
42357706|NCT01723826|76203228|FG000|Overall Study|Lost to Follow-up|1|||
42357707|NCT01723826|76203229|FG001|Overall Study|Lost to Follow-up|3|||
42357708|NCT01723826|76203230|FG002|Overall Study|Lost to Follow-up|1|||
42357709|NCT01723826|76203231|FG003|Overall Study|Lost to Follow-up|1|||
42357710|NCT01723826|76203228|FG000|Overall Study|Non-compliance|0|||
42357711|NCT01723826|76203229|FG001|Overall Study|Non-compliance|1|||
42070761|NCT00597714|75880860|FG000|Overall Study|Recipient death|0|||
42070762|NCT00597714|75880861|FG001|Overall Study|Recipient death|0|||
42070763|NCT00597714|75880862|FG002|Overall Study|Recipient death|10|||
42070764|NCT03938857|75880875|FG000|Overall Study|Physician Decision|1|||
42070765|NCT03938857|75880876|FG001|Overall Study|Physician Decision|0|||
42070766|NCT03938857|75880877|FG002|Overall Study|Physician Decision|0|||
42070767|NCT03938857|75880878|FG003|Overall Study|Physician Decision|0|||
42176661|NCT02932228|75983884|FG000|Overall Study|Death|8|||
42176662|NCT02932228|75983885|FG001|Overall Study|Death|23|||
42176663|NCT02932228|75983884|FG000|Overall Study|not eligible upon chart review|2|||
42176664|NCT02932228|75983885|FG001|Overall Study|not eligible upon chart review|5|||
42176665|NCT02931838|75983899|FG000|Overall Study|Reason not provided by investigator|1|||
42292774|NCT02638103|76126694|FG002|Overall Study|Protocol Violation|1|||
42292775|NCT02638103|76126695|FG003|Overall Study|Protocol Violation|4|||
42292776|NCT02638103|76126692|FG000|Overall Study|Pregnancy|2|||
42357712|NCT01723826|76203230|FG002|Overall Study|Non-compliance|3|||
42070768|NCT00884832|75880890|FG000|Overall Study|Withdrawal by Subject|0|||
42070769|NCT00884832|75880891|FG001|Overall Study|Withdrawal by Subject|1|||
42070770|NCT03938545|75880901|FG000|Overall Study|Lost to Follow-up|0|||
42070771|NCT03938545|75880902|FG001|Overall Study|Lost to Follow-up|0|||
42070772|NCT03938545|75880903|FG002|Overall Study|Lost to Follow-up|0|||
42070773|NCT03938545|75880904|FG003|Overall Study|Lost to Follow-up|1|||
42070774|NCT03938545|75880901|FG000|Overall Study|Non-compliance with study drug|0|||
42070775|NCT03938545|75880902|FG001|Overall Study|Non-compliance with study drug|0|||
42070776|NCT03938545|75880903|FG002|Overall Study|Non-compliance with study drug|1|||
42176666|NCT02931838|75983900|FG001|Overall Study|Reason not provided by investigator|0|||
42176667|NCT02931838|75983901|FG002|Overall Study|Reason not provided by investigator|1|||
42176668|NCT02931838|75983902|FG003|Overall Study|Reason not provided by investigator|0|||
42176669|NCT02931838|75983903|FG004|Overall Study|Reason not provided by investigator|0|||
42292777|NCT02638103|76126693|FG001|Overall Study|Pregnancy|3|||
42292778|NCT02638103|76126694|FG002|Overall Study|Pregnancy|0|||
42292779|NCT02638103|76126695|FG003|Overall Study|Pregnancy|1|||
42292780|NCT02638103|76126692|FG000|Overall Study|Non-compliance to Study Procedures|2|||
42292781|NCT02638103|76126693|FG001|Overall Study|Non-compliance to Study Procedures|1|||
42292782|NCT02638103|76126694|FG002|Overall Study|Non-compliance to Study Procedures|1|||
42292783|NCT02638103|76126695|FG003|Overall Study|Non-compliance to Study Procedures|1|||
42292784|NCT02638103|76126692|FG000|Overall Study|Lost to Follow-up|26|||
42292785|NCT02638103|76126693|FG001|Overall Study|Lost to Follow-up|33|||
42292786|NCT02638103|76126694|FG002|Overall Study|Lost to Follow-up|20|||
42292787|NCT02638103|76126695|FG003|Overall Study|Lost to Follow-up|37|||
42292788|NCT02638103|76126692|FG000|Overall Study|Lack of Efficacy|14|||
42292789|NCT02638103|76126693|FG001|Overall Study|Lack of Efficacy|10|||
42292790|NCT02638103|76126694|FG002|Overall Study|Lack of Efficacy|12|||
42292791|NCT02638103|76126695|FG003|Overall Study|Lack of Efficacy|22|||
42292792|NCT02638103|76126692|FG000|Overall Study|Other than specified|5|||
42292793|NCT02638103|76126693|FG001|Overall Study|Other than specified|4|||
42292794|NCT02638103|76126694|FG002|Overall Study|Other than specified|2|||
42292795|NCT02638103|76126695|FG003|Overall Study|Other than specified|4|||
42292796|NCT03551743|76126717|FG000|Overall Study|Adverse Event|1|||
42292797|NCT03551743|76126718|FG001|Overall Study|Adverse Event|0|||
42292798|NCT03551743|76126719|FG002|Overall Study|Adverse Event|0|||
42292799|NCT03551743|76126720|FG003|Overall Study|Adverse Event|0|||
42292800|NCT03551743|76126717|FG000|Overall Study|Withdrawal by Subject|1|||
42176670|NCT02931838|75983904|FG005|Overall Study|Reason not provided by investigator|0|||
42292801|NCT03551743|76126718|FG001|Overall Study|Withdrawal by Subject|0|||
42292802|NCT03551743|76126719|FG002|Overall Study|Withdrawal by Subject|0|||
42292803|NCT03551743|76126720|FG003|Overall Study|Withdrawal by Subject|0|||
42292804|NCT02636699|76126732|FG000|Overall Study|Adverse Event|4|||
42357713|NCT01723826|76203231|FG003|Overall Study|Non-compliance|3|||
42357714|NCT01723826|76203228|FG000|Overall Study|Non-compliance With Study Drug|0|||
42357715|NCT01723826|76203229|FG001|Overall Study|Non-compliance With Study Drug|1|||
42357716|NCT01723826|76203230|FG002|Overall Study|Non-compliance With Study Drug|0|||
42357717|NCT01723826|76203231|FG003|Overall Study|Non-compliance With Study Drug|0|||
42017288|NCT01129011|75824861|FG000|Overall Study|Adverse Event|20|||
42017289|NCT01129011|75824862|FG001|Overall Study|Adverse Event|30|||
42017290|NCT01129011|75824861|FG000|Overall Study|Withdrawal by Subject|24|||
42017291|NCT01129011|75824862|FG001|Overall Study|Withdrawal by Subject|8|||
42017292|NCT01129011|75824861|FG000|Overall Study|Lost to Follow-up|6|||
42017293|NCT01129011|75824862|FG001|Overall Study|Lost to Follow-up|7|||
42017294|NCT01129011|75824861|FG000|Overall Study|Duodenal Ulcer|2|||
42017295|NCT01129011|75824862|FG001|Overall Study|Duodenal Ulcer|8|||
42017296|NCT01129011|75824861|FG000|Overall Study|misc|7|||
42017297|NCT01129011|75824862|FG001|Overall Study|misc|4|||
42017298|NCT00919867|75824874|FG000|First Intervention|Withdrawal by Subject|0|||
42017299|NCT00919867|75824875|FG001|First Intervention|Withdrawal by Subject|0|||
42017300|NCT00919867|75824876|FG002|First Intervention|Withdrawal by Subject|1|||
42017301|NCT00919867|75824877|FG003|First Intervention|Withdrawal by Subject|0|||
42017302|NCT00919867|75824878|FG004|First Intervention|Withdrawal by Subject|0|||
42017303|NCT00919867|75824879|FG005|First Intervention|Withdrawal by Subject|0|||
42017304|NCT00919867|75824874|FG000|First Intervention|Physician Decision|0|||
42017305|NCT00919867|75824875|FG001|First Intervention|Physician Decision|0|||
42017306|NCT00919867|75824876|FG002|First Intervention|Physician Decision|0|||
42017307|NCT00919867|75824877|FG003|First Intervention|Physician Decision|0|||
42017308|NCT00919867|75824878|FG004|First Intervention|Physician Decision|0|||
42017309|NCT00919867|75824879|FG005|First Intervention|Physician Decision|1|||
42292805|NCT02636699|76126733|FG001|Overall Study|Adverse Event|0|||
42292806|NCT02636699|76126732|FG000|Overall Study|Lost to Follow-up|3|||
42292807|NCT02636699|76126733|FG001|Overall Study|Lost to Follow-up|3|||
42292808|NCT02636699|76126732|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
42292809|NCT02636699|76126733|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
42292810|NCT02636699|76126732|FG000|Overall Study|Physician Decision|0|||
42292811|NCT02636699|76126733|FG001|Overall Study|Physician Decision|1|||
42292812|NCT02636699|76126732|FG000|Overall Study|Withdrawal by Subject|13|||
42292813|NCT02636699|76126733|FG001|Overall Study|Withdrawal by Subject|6|||
42292814|NCT02636699|76126732|FG000|Overall Study|Other|3|||
42292815|NCT02636699|76126733|FG001|Overall Study|Other|1|||
42292816|NCT02634983|76126739|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
42292817|NCT02634983|76126740|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
42292818|NCT02633501|76126752|FG000|Overall Study|Adverse Event|0|||
42292819|NCT02633501|76126753|FG001|Overall Study|Adverse Event|0|||
42292820|NCT02633501|76126754|FG002|Overall Study|Adverse Event|1|||
42292821|NCT02633501|76126755|FG003|Overall Study|Adverse Event|0|||
42292822|NCT02633501|76126756|FG004|Overall Study|Adverse Event|1|||
42292823|NCT02633501|76126757|FG005|Overall Study|Adverse Event|1|||
42292824|NCT02633501|76126752|FG000|Overall Study|Withdrawal by Subject|2|||
42292825|NCT02633501|76126753|FG001|Overall Study|Withdrawal by Subject|1|||
42292826|NCT02633501|76126754|FG002|Overall Study|Withdrawal by Subject|2|||
42292827|NCT02633501|76126755|FG003|Overall Study|Withdrawal by Subject|2|||
42292828|NCT02633501|76126756|FG004|Overall Study|Withdrawal by Subject|1|||
42292829|NCT02633501|76126757|FG005|Overall Study|Withdrawal by Subject|3|||
42292830|NCT02633501|76126752|FG000|Overall Study|Various other reasons|0|||
42292831|NCT02633501|76126753|FG001|Overall Study|Various other reasons|2|||
42070777|NCT03938545|75880904|FG003|Overall Study|Non-compliance with study drug|0|||
42070778|NCT03938545|75880901|FG000|Overall Study|Pregnancy|1|||
42070779|NCT03938545|75880902|FG001|Overall Study|Pregnancy|0|||
42070780|NCT03938545|75880903|FG002|Overall Study|Pregnancy|0|||
42070781|NCT03938545|75880904|FG003|Overall Study|Pregnancy|0|||
42070782|NCT03938545|75880901|FG000|Overall Study|Study terminated by sponsor|6|||
42070783|NCT03938545|75880902|FG001|Overall Study|Study terminated by sponsor|4|||
42070784|NCT03938545|75880903|FG002|Overall Study|Study terminated by sponsor|2|||
42070785|NCT03938545|75880904|FG003|Overall Study|Study terminated by sponsor|4|||
42070786|NCT03938545|75880901|FG000|Overall Study|Withdrawal by Subject|0|||
42176671|NCT02931838|75983899|FG000|Overall Study|Poor/non-compliance|0|||
42176672|NCT02931838|75983900|FG001|Overall Study|Poor/non-compliance|0|||
42176673|NCT02931838|75983901|FG002|Overall Study|Poor/non-compliance|1|||
42176674|NCT02931838|75983902|FG003|Overall Study|Poor/non-compliance|0|||
42176675|NCT02931838|75983903|FG004|Overall Study|Poor/non-compliance|0|||
42176676|NCT02931838|75983904|FG005|Overall Study|Poor/non-compliance|0|||
42176677|NCT02931838|75983899|FG000|Overall Study|Lack of Efficacy|5|||
42176678|NCT02931838|75983900|FG001|Overall Study|Lack of Efficacy|4|||
42176679|NCT02931838|75983901|FG002|Overall Study|Lack of Efficacy|0|||
42176680|NCT02931838|75983902|FG003|Overall Study|Lack of Efficacy|0|||
42176681|NCT02931838|75983903|FG004|Overall Study|Lack of Efficacy|0|||
42176682|NCT02931838|75983904|FG005|Overall Study|Lack of Efficacy|1|||
42176683|NCT02931838|75983899|FG000|Overall Study|Lost to Follow-up|1|||
42176684|NCT02931838|75983900|FG001|Overall Study|Lost to Follow-up|0|||
42176685|NCT02931838|75983901|FG002|Overall Study|Lost to Follow-up|1|||
42176686|NCT02931838|75983902|FG003|Overall Study|Lost to Follow-up|1|||
42176687|NCT02931838|75983903|FG004|Overall Study|Lost to Follow-up|2|||
42176688|NCT02931838|75983904|FG005|Overall Study|Lost to Follow-up|0|||
42176689|NCT02931838|75983899|FG000|Overall Study|Subject request to discontinue treatment|4|||
42176690|NCT02931838|75983900|FG001|Overall Study|Subject request to discontinue treatment|3|||
42176691|NCT02931838|75983901|FG002|Overall Study|Subject request to discontinue treatment|3|||
42176692|NCT02931838|75983902|FG003|Overall Study|Subject request to discontinue treatment|0|||
42176693|NCT02931838|75983903|FG004|Overall Study|Subject request to discontinue treatment|1|||
42176694|NCT02931838|75983904|FG005|Overall Study|Subject request to discontinue treatment|0|||
42176695|NCT02931838|75983899|FG000|Overall Study|Withdrawal by Subject|1|||
42176696|NCT02931838|75983900|FG001|Overall Study|Withdrawal by Subject|2|||
42176697|NCT02931838|75983901|FG002|Overall Study|Withdrawal by Subject|0|||
42176698|NCT02931838|75983902|FG003|Overall Study|Withdrawal by Subject|1|||
42176699|NCT02931838|75983903|FG004|Overall Study|Withdrawal by Subject|0|||
42176700|NCT02931838|75983904|FG005|Overall Study|Withdrawal by Subject|0|||
42176701|NCT02931838|75983899|FG000|Overall Study|Adverse Event|2|||
42176702|NCT02931838|75983900|FG001|Overall Study|Adverse Event|1|||
42176703|NCT02931838|75983901|FG002|Overall Study|Adverse Event|2|||
42176704|NCT02931838|75983902|FG003|Overall Study|Adverse Event|1|||
42176705|NCT02931838|75983903|FG004|Overall Study|Adverse Event|3|||
42176706|NCT02931838|75983904|FG005|Overall Study|Adverse Event|1|||
42292832|NCT02633501|76126754|FG002|Overall Study|Various other reasons|4|||
42292833|NCT02633501|76126755|FG003|Overall Study|Various other reasons|1|||
42292834|NCT02633501|76126756|FG004|Overall Study|Various other reasons|7|||
42070787|NCT03938545|75880902|FG001|Overall Study|Withdrawal by Subject|1|||
42176707|NCT03201562|75983926|FG000|Overall Study|Physician Decision|0|||
42176708|NCT03201562|75983927|FG001|Overall Study|Physician Decision|0|||
42176709|NCT03201562|75983928|FG002|Overall Study|Physician Decision|1|||
42176710|NCT03201562|75983926|FG000|Overall Study|Adverse Event|0|||
42070788|NCT03938545|75880903|FG002|Overall Study|Withdrawal by Subject|0|||
42070789|NCT03938545|75880904|FG003|Overall Study|Withdrawal by Subject|0|||
42176711|NCT03201562|75983927|FG001|Overall Study|Adverse Event|0|||
42292835|NCT02633501|76126757|FG005|Overall Study|Various other reasons|11|||
42292836|NCT02633501|76126752|FG000|Overall Study|Lost to Follow-up|0|||
42292837|NCT02633501|76126753|FG001|Overall Study|Lost to Follow-up|0|||
42292838|NCT02633501|76126754|FG002|Overall Study|Lost to Follow-up|0|||
42292839|NCT02633501|76126755|FG003|Overall Study|Lost to Follow-up|1|||
42292840|NCT02633501|76126756|FG004|Overall Study|Lost to Follow-up|2|||
42292841|NCT02633501|76126757|FG005|Overall Study|Lost to Follow-up|0|||
42292842|NCT03591107|76126778|FG000|Overall Study|Same patient in both arms|1|||
42292843|NCT03591107|76126779|FG001|Overall Study|Same patient in both arms|1|||
42292844|NCT03591107|76126778|FG000|Overall Study|Sought care at other clinics|0|||
42292845|NCT03591107|76126779|FG001|Overall Study|Sought care at other clinics|2|||
42292846|NCT03591107|76126778|FG000|Overall Study|Discharged from clinic|0|||
42292847|NCT03591107|76126779|FG001|Overall Study|Discharged from clinic|1|||
42292848|NCT03591107|76126778|FG000|Overall Study|Withdrawal by Subject|0|||
42292849|NCT03591107|76126779|FG001|Overall Study|Withdrawal by Subject|1|||
42292850|NCT02922023|76126792|FG000|Overall Study|Lost to Follow-up|2|||
42292851|NCT02922023|76126793|FG001|Overall Study|Lost to Follow-up|0|||
42292852|NCT01672853|76126802|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
42292853|NCT01672853|76126803|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
42292854|NCT01672853|76126804|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
42292855|NCT01672853|76126802|FG000|Overall Study|Pregnancy|0|||
42292856|NCT01672853|76126803|FG001|Overall Study|Pregnancy|1|||
42292857|NCT01672853|76126804|FG002|Overall Study|Pregnancy|0|||
42292858|NCT01672853|76126802|FG000|Overall Study|Investigator's Discretion|1|||
42292859|NCT01672853|76126803|FG001|Overall Study|Investigator's Discretion|0|||
42292860|NCT01672853|76126804|FG002|Overall Study|Investigator's Discretion|0|||
42292861|NCT01672853|76126802|FG000|Overall Study|Withdrew Consent|5|||
42292862|NCT01672853|76126803|FG001|Overall Study|Withdrew Consent|5|||
42292863|NCT01672853|76126804|FG002|Overall Study|Withdrew Consent|5|||
42070790|NCT03938545|75880901|FG000|Overall Study|Adverse Event|1|||
42070791|NCT03938545|75880902|FG001|Overall Study|Adverse Event|0|||
42070792|NCT03938545|75880903|FG002|Overall Study|Adverse Event|0|||
42070793|NCT03938545|75880904|FG003|Overall Study|Adverse Event|0|||
42070794|NCT00879996|75880916|FG000|Overall Study|Lost to Follow-up|7|||
42070795|NCT00879996|75880917|FG001|Overall Study|Lost to Follow-up|6|||
42070796|NCT00879996|75880916|FG000|Overall Study|non-compliance|6|||
42070797|NCT00879996|75880917|FG001|Overall Study|non-compliance|4|||
42070798|NCT00879996|75880916|FG000|Overall Study|Physician Decision|1|||
42070799|NCT00879996|75880917|FG001|Overall Study|Physician Decision|2|||
42070800|NCT00879996|75880916|FG000|Overall Study|psychiatric problem|0|||
42357718|NCT01723826|76203228|FG000|Overall Study|Other Reason|8|||
42357719|NCT01723826|76203229|FG001|Overall Study|Other Reason|6|||
42357720|NCT01723826|76203230|FG002|Overall Study|Other Reason|12|||
42357721|NCT01723826|76203231|FG003|Overall Study|Other Reason|14|||
42357722|NCT01723826|76203228|FG000|Overall Study|Physician Decision|1|||
42070801|NCT00879996|75880917|FG001|Overall Study|psychiatric problem|1|||
42070802|NCT00879996|75880916|FG000|Overall Study|put on parole|1|||
42070803|NCT00879996|75880917|FG001|Overall Study|put on parole|0|||
42070804|NCT00873093|75880930|FG000|Overall Study|Adverse Event|0|||
42070805|NCT00873093|75880931|FG001|Overall Study|Adverse Event|2|||
42070806|NCT00873093|75880932|FG002|Overall Study|Adverse Event|0|||
42070807|NCT00873093|75880933|FG003|Overall Study|Adverse Event|0|||
42070808|NCT00873093|75880934|FG004|Overall Study|Adverse Event|0|||
42070809|NCT00873093|75880930|FG000|Overall Study|Death|0|||
42070810|NCT00873093|75880931|FG001|Overall Study|Death|3|||
42070811|NCT00873093|75880932|FG002|Overall Study|Death|2|||
42070812|NCT00873093|75880933|FG003|Overall Study|Death|0|||
42070813|NCT00873093|75880934|FG004|Overall Study|Death|0|||
42070814|NCT00873093|75880930|FG000|Overall Study|Physician Decision|0|||
42070815|NCT00873093|75880931|FG001|Overall Study|Physician Decision|17|||
42070816|NCT00873093|75880932|FG002|Overall Study|Physician Decision|10|||
42070817|NCT00873093|75880933|FG003|Overall Study|Physician Decision|10|||
42292864|NCT01672853|76126802|FG000|Overall Study|Adverse Event|4|||
42292865|NCT01672853|76126803|FG001|Overall Study|Adverse Event|6|||
42292866|NCT01672853|76126804|FG002|Overall Study|Adverse Event|8|||
42292867|NCT01672853|76126802|FG000|Overall Study|Lost to Follow-up|0|||
42292868|NCT01672853|76126803|FG001|Overall Study|Lost to Follow-up|1|||
42070818|NCT00873093|75880934|FG004|Overall Study|Physician Decision|2|||
42292869|NCT01672853|76126804|FG002|Overall Study|Lost to Follow-up|0|||
42292870|NCT01672853|76126802|FG000|Overall Study|Randomized but Never Treated|0|||
42292871|NCT01672853|76126803|FG001|Overall Study|Randomized but Never Treated|0|||
42292872|NCT01672853|76126804|FG002|Overall Study|Randomized but Never Treated|1|||
42292873|NCT01603459|76126812|FG000|Overall Study|Adverse Event|5|||
42292874|NCT01603459|76126812|FG000|Overall Study|Withdrawal by Subject|5|||
42292875|NCT01603459|76126812|FG000|Overall Study|Lost to Follow-up|3|||
42070819|NCT00873093|75880930|FG000|Overall Study|Withdrawal by Subject|1|||
42070820|NCT00873093|75880931|FG001|Overall Study|Withdrawal by Subject|4|||
42292876|NCT01603459|76126812|FG000|Overall Study|Predefined discontinuation criteria|3|||
42292877|NCT01603459|76126812|FG000|Overall Study|Non-compliance|1|||
42292878|NCT01603459|76126812|FG000|Overall Study|Administrative reason|1|||
42292879|NCT01678807|76126851|FG000|Overall Study|Adverse Event|4|||
42292880|NCT01678807|76126852|FG001|Overall Study|Adverse Event|4|||
42292881|NCT01678807|76126853|FG002|Overall Study|Adverse Event|0|||
42292882|NCT01678807|76126851|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
42292883|NCT01678807|76126852|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
42292884|NCT01678807|76126853|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
42292885|NCT03073525|76126864|FG000|Overall Study|Withdrawal by Subject|0|||
42292886|NCT03073525|76126865|FG001|Overall Study|Withdrawal by Subject|0|||
42292887|NCT03073525|76126866|FG002|Overall Study|Withdrawal by Subject|3|||
42292888|NCT02631551|76126887|FG000|Overall Study|Adverse Event|1|||
42292889|NCT02631551|76126888|FG001|Overall Study|Adverse Event|2|||
42292890|NCT02631551|76126889|FG002|Overall Study|Adverse Event|4|||
42292891|NCT02631551|76126890|FG003|Overall Study|Adverse Event|0|||
42070821|NCT00873093|75880932|FG002|Overall Study|Withdrawal by Subject|4|||
42070822|NCT00873093|75880933|FG003|Overall Study|Withdrawal by Subject|0|||
42070823|NCT00873093|75880934|FG004|Overall Study|Withdrawal by Subject|0|||
42070824|NCT00873093|75880930|FG000|Overall Study|Ineligible|0|||
42070825|NCT00873093|75880931|FG001|Overall Study|Ineligible|1|||
42070826|NCT00873093|75880932|FG002|Overall Study|Ineligible|0|||
42070827|NCT00873093|75880933|FG003|Overall Study|Ineligible|1|||
42070828|NCT00873093|75880934|FG004|Overall Study|Ineligible|0|||
42070829|NCT00884286|75880958|FG000|Overall Study|Progressive disease|21|||
42292892|NCT02631551|76126887|FG000|Overall Study|Lack of Efficacy|0|||
42292893|NCT02631551|76126888|FG001|Overall Study|Lack of Efficacy|0|||
42292894|NCT02631551|76126889|FG002|Overall Study|Lack of Efficacy|1|||
42292895|NCT02631551|76126890|FG003|Overall Study|Lack of Efficacy|0|||
42292896|NCT02631551|76126887|FG000|Overall Study|Lost to Follow-up|1|||
42292897|NCT02631551|76126888|FG001|Overall Study|Lost to Follow-up|2|||
42292898|NCT02631551|76126889|FG002|Overall Study|Lost to Follow-up|0|||
42292899|NCT02631551|76126890|FG003|Overall Study|Lost to Follow-up|3|||
42292900|NCT02631551|76126887|FG000|Overall Study|Withdrawal by Subject|2|||
42292901|NCT02631551|76126888|FG001|Overall Study|Withdrawal by Subject|2|||
42292902|NCT02631551|76126889|FG002|Overall Study|Withdrawal by Subject|0|||
42292903|NCT02631551|76126890|FG003|Overall Study|Withdrawal by Subject|5|||
42292904|NCT02631551|76126887|FG000|Overall Study|Protocol deviation|3|||
42292905|NCT02631551|76126888|FG001|Overall Study|Protocol deviation|6|||
42292906|NCT02631551|76126889|FG002|Overall Study|Protocol deviation|3|||
42292907|NCT02631551|76126890|FG003|Overall Study|Protocol deviation|0|||
42292908|NCT02631551|76126887|FG000|Overall Study|Non-compliance with study procedures|0|||
42292909|NCT02631551|76126888|FG001|Overall Study|Non-compliance with study procedures|0|||
42292910|NCT02631551|76126889|FG002|Overall Study|Non-compliance with study procedures|1|||
42292911|NCT02631551|76126890|FG003|Overall Study|Non-compliance with study procedures|1|||
42292912|NCT02631551|76126887|FG000|Overall Study|Non-compliance with study drug|1|||
42292913|NCT02631551|76126888|FG001|Overall Study|Non-compliance with study drug|0|||
42292914|NCT02631551|76126889|FG002|Overall Study|Non-compliance with study drug|0|||
42292915|NCT02631551|76126890|FG003|Overall Study|Non-compliance with study drug|0|||
42292916|NCT02631551|76126887|FG000|Overall Study|Other, specific reasons not collected|5|||
42292917|NCT02631551|76126888|FG001|Overall Study|Other, specific reasons not collected|7|||
42292918|NCT02631551|76126889|FG002|Overall Study|Other, specific reasons not collected|2|||
42292919|NCT02631551|76126890|FG003|Overall Study|Other, specific reasons not collected|2|||
42292920|NCT01680991|76126903|FG000|Overall Study|Adverse Event|1|||
42292921|NCT01680991|76126904|FG001|Overall Study|Adverse Event|0|||
42292922|NCT01680991|76126905|FG002|Overall Study|Adverse Event|0|||
42292923|NCT01680991|76126903|FG000|Overall Study|Death|1|||
42292924|NCT01680991|76126904|FG001|Overall Study|Death|0|||
42292925|NCT01680991|76126905|FG002|Overall Study|Death|1|||
42292926|NCT01680991|76126903|FG000|Overall Study|Protocol Violation|0|||
42292927|NCT01680991|76126904|FG001|Overall Study|Protocol Violation|1|||
42292928|NCT01680991|76126905|FG002|Overall Study|Protocol Violation|0|||
42292929|NCT01680991|76126903|FG000|Overall Study|Withdrawal by Subject|5|||
42292930|NCT01680991|76126904|FG001|Overall Study|Withdrawal by Subject|1|||
42292931|NCT01680991|76126905|FG002|Overall Study|Withdrawal by Subject|0|||
42070830|NCT00884286|75880959|FG001|Overall Study|Progressive disease|28|||
42292932|NCT01680991|76126903|FG000|Overall Study|Progressive disease (PD)|0|||
42292933|NCT01680991|76126904|FG001|Overall Study|Progressive disease (PD)|10|||
42292934|NCT01680991|76126905|FG002|Overall Study|Progressive disease (PD)|0|||
42292935|NCT01680991|76126903|FG000|Overall Study|Physician Decision|0|||
42292936|NCT01680991|76126904|FG001|Overall Study|Physician Decision|7|||
42292937|NCT01680991|76126905|FG002|Overall Study|Physician Decision|2|||
42292938|NCT01680991|76126903|FG000|Overall Study|Bad physical condition|0|||
42070831|NCT00884286|75880958|FG000|Overall Study|Toxicity|4|||
42070832|NCT00884286|75880959|FG001|Overall Study|Toxicity|1|||
42070833|NCT00884286|75880958|FG000|Overall Study|Death|2|||
42070834|NCT00884286|75880959|FG001|Overall Study|Death|2|||
42292939|NCT01680991|76126904|FG001|Overall Study|Bad physical condition|0|||
42292940|NCT01680991|76126905|FG002|Overall Study|Bad physical condition|1|||
42292941|NCT01680991|76126903|FG000|Overall Study|PD confirmed in other hospital|1|||
42292942|NCT01680991|76126904|FG001|Overall Study|PD confirmed in other hospital|0|||
42292943|NCT01680991|76126905|FG002|Overall Study|PD confirmed in other hospital|0|||
42292944|NCT02819479|76126915|FG000|Overall Study|Adverse Event|2|||
42292945|NCT04064411|76126922|FG000|Overall Study|Adverse Event|29|||
42292946|NCT04064411|76126923|FG001|Overall Study|Adverse Event|19|||
42292947|NCT04064411|76126922|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
42292948|NCT04064411|76126923|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
42292949|NCT04064411|76126922|FG000|Overall Study|Protocol Deviation|0|||
42292950|NCT04064411|76126923|FG001|Overall Study|Protocol Deviation|2|||
42292951|NCT04064411|76126922|FG000|Overall Study|Withdrawal by Subject|25|||
42292952|NCT04064411|76126923|FG001|Overall Study|Withdrawal by Subject|29|||
42292953|NCT04064411|76126922|FG000|Overall Study|Lost to Follow-up|5|||
42292954|NCT04064411|76126923|FG001|Overall Study|Lost to Follow-up|2|||
42292955|NCT04064411|76126922|FG000|Overall Study|Other than Specified|4|||
42292956|NCT04064411|76126923|FG001|Overall Study|Other than Specified|1|||
42292957|NCT04064411|76126922|FG000|Overall Study|Death|1|||
42292958|NCT04064411|76126923|FG001|Overall Study|Death|0|||
42292959|NCT02629133|76126931|FG000|Overall Study|Lost to Follow-up|3|||
42292960|NCT02629133|76126932|FG001|Overall Study|Lost to Follow-up|1|||
42292961|NCT02629133|76126931|FG000|Overall Study|Withdrawal by Subject|1|||
42292962|NCT02629133|76126932|FG001|Overall Study|Withdrawal by Subject|1|||
42292963|NCT02660359|76126941|FG000|Overall Study|Protocol Deviation|0|||
42292964|NCT02660359|76126942|FG001|Overall Study|Protocol Deviation|0|||
42292965|NCT02660359|76126943|FG002|Overall Study|Protocol Deviation|1|||
42292966|NCT02660359|76126941|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
42292967|NCT02660359|76126942|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
42292968|NCT02660359|76126943|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
42292969|NCT02660359|76126941|FG000|Overall Study|Lack of Efficacy|1|||
42292970|NCT02660359|76126942|FG001|Overall Study|Lack of Efficacy|1|||
42292971|NCT02660359|76126943|FG002|Overall Study|Lack of Efficacy|1|||
42292972|NCT02660359|76126941|FG000|Overall Study|Adverse Event|0|||
42292973|NCT02660359|76126942|FG001|Overall Study|Adverse Event|1|||
42292974|NCT02660359|76126943|FG002|Overall Study|Adverse Event|0|||
42292975|NCT02660359|76126941|FG000|Overall Study|Other|2|||
42292976|NCT02660359|76126942|FG001|Overall Study|Other|1|||
42292977|NCT02660359|76126943|FG002|Overall Study|Other|3|||
42292978|NCT02660359|76126941|FG000|Overall Study|Withdrawal by Subject|7|||
42292979|NCT02660359|76126942|FG001|Overall Study|Withdrawal by Subject|5|||
42292980|NCT02660359|76126943|FG002|Overall Study|Withdrawal by Subject|8|||
42292981|NCT02660359|76126941|FG000|Overall Study|Lost to Follow-up|3|||
42292982|NCT02660359|76126942|FG001|Overall Study|Lost to Follow-up|3|||
42292983|NCT02660359|76126943|FG002|Overall Study|Lost to Follow-up|0|||
42292984|NCT02628743|76126951|FG000|Overall Study|Other|3|||
42292985|NCT02628743|76126951|FG000|Overall Study|Withdrawal by Subject|50|||
42292986|NCT02628743|76126951|FG000|Overall Study|Study Terminated by Sponsor|76|||
42292987|NCT02628743|76126951|FG000|Overall Study|Physician Decision|2|||
42292988|NCT03839459|76126955|FG000|Overall Study|Withdrawal by Subject|2|||
42292989|NCT03839459|76126955|FG000|Overall Study|progression of disease|3|||
42292990|NCT05059301|76126962|FG000|Overall Study|Adverse Event|0|||
42292991|NCT05059301|76126963|FG001|Overall Study|Adverse Event|2|||
42292992|NCT05059301|76126964|FG002|Overall Study|Adverse Event|2|||
42292993|NCT05059301|76126962|FG000|Overall Study|Lost to Follow-up|2|||
42292994|NCT05059301|76126963|FG001|Overall Study|Lost to Follow-up|3|||
42292995|NCT05059301|76126964|FG002|Overall Study|Lost to Follow-up|3|||
42292996|NCT01938430|76126990|FG000|Overall Study|Randomized but Not Treated|0|||
42292997|NCT01938430|76126991|FG001|Overall Study|Randomized but Not Treated|0|||
42292998|NCT01938430|76126992|FG002|Overall Study|Randomized but Not Treated|0|||
42292999|NCT01938430|76126993|FG003|Overall Study|Randomized but Not Treated|0|||
42293000|NCT01938430|76126994|FG004|Overall Study|Randomized but Not Treated|0|||
42293001|NCT01938430|76126995|FG005|Overall Study|Randomized but Not Treated|0|||
42293002|NCT01938430|76126996|FG006|Overall Study|Randomized but Not Treated|0|||
42293003|NCT01938430|76126997|FG007|Overall Study|Randomized but Not Treated|0|||
42293004|NCT01938430|76126998|FG008|Overall Study|Randomized but Not Treated|0|||
42293005|NCT01938430|76126999|FG009|Overall Study|Randomized but Not Treated|0|||
42293006|NCT01938430|76127000|FG010|Overall Study|Randomized but Not Treated|1|||
42293007|NCT01938430|76127001|FG011|Overall Study|Randomized but Not Treated|0|||
42293008|NCT01938430|76127002|FG012|Overall Study|Randomized but Not Treated|0|||
42293009|NCT01938430|76127003|FG013|Overall Study|Randomized but Not Treated|1|||
42293010|NCT01938430|76126990|FG000|Overall Study|Adverse Event|0|||
42293011|NCT01938430|76126991|FG001|Overall Study|Adverse Event|0|||
42293012|NCT01938430|76126992|FG002|Overall Study|Adverse Event|0|||
42070835|NCT00884286|75880958|FG000|Overall Study|Physician Decision|1|||
42293013|NCT01938430|76126993|FG003|Overall Study|Adverse Event|0|||
42293014|NCT01938430|76126994|FG004|Overall Study|Adverse Event|0|||
42293015|NCT01938430|76126995|FG005|Overall Study|Adverse Event|0|||
42293016|NCT01938430|76126996|FG006|Overall Study|Adverse Event|1|||
42293017|NCT01938430|76126997|FG007|Overall Study|Adverse Event|0|||
42293018|NCT01938430|76126998|FG008|Overall Study|Adverse Event|0|||
42293019|NCT01938430|76126999|FG009|Overall Study|Adverse Event|0|||
42293020|NCT01938430|76127000|FG010|Overall Study|Adverse Event|0|||
42293021|NCT01938430|76127001|FG011|Overall Study|Adverse Event|0|||
42293022|NCT01938430|76127002|FG012|Overall Study|Adverse Event|0|||
42293023|NCT01938430|76127003|FG013|Overall Study|Adverse Event|0|||
42293024|NCT01938430|76126990|FG000|Overall Study|Death|1|||
42293025|NCT01938430|76126991|FG001|Overall Study|Death|2|||
42293026|NCT01938430|76126992|FG002|Overall Study|Death|2|||
42293027|NCT01938430|76126993|FG003|Overall Study|Death|1|||
42293028|NCT01938430|76126994|FG004|Overall Study|Death|0|||
42293029|NCT01938430|76126995|FG005|Overall Study|Death|0|||
42293030|NCT01938430|76126996|FG006|Overall Study|Death|1|||
42293031|NCT01938430|76126997|FG007|Overall Study|Death|1|||
42293032|NCT01938430|76126998|FG008|Overall Study|Death|2|||
42293033|NCT01938430|76126999|FG009|Overall Study|Death|3|||
42293034|NCT01938430|76127000|FG010|Overall Study|Death|0|||
42293035|NCT01938430|76127001|FG011|Overall Study|Death|0|||
42293036|NCT01938430|76127002|FG012|Overall Study|Death|0|||
42293037|NCT01938430|76127003|FG013|Overall Study|Death|0|||
42293038|NCT01938430|76126990|FG000|Overall Study|Investigator's Discretion|0|||
42293039|NCT01938430|76126991|FG001|Overall Study|Investigator's Discretion|0|||
42293040|NCT01938430|76126992|FG002|Overall Study|Investigator's Discretion|1|||
42293041|NCT01938430|76126993|FG003|Overall Study|Investigator's Discretion|0|||
42293042|NCT01938430|76126994|FG004|Overall Study|Investigator's Discretion|0|||
42176712|NCT03201562|75983928|FG002|Overall Study|Adverse Event|1|||
42176713|NCT03201562|75983926|FG000|Overall Study|Lost to Follow-up|0|||
42176714|NCT03201562|75983927|FG001|Overall Study|Lost to Follow-up|1|||
42176715|NCT03201562|75983928|FG002|Overall Study|Lost to Follow-up|2|||
42176716|NCT03200860|75983938|FG000|Overall Study|Withdrawal by Subject|1|||
42176717|NCT03200860|75983939|FG001|Overall Study|Withdrawal by Subject|0|||
42176718|NCT03198754|75983947|FG000|Overall Study|Withdrawal by Subject|5|||
42176719|NCT03198754|75983948|FG001|Overall Study|Withdrawal by Subject|4|||
42176720|NCT03198754|75983947|FG000|Overall Study|Lost to Follow-up|4|||
42176721|NCT03198754|75983948|FG001|Overall Study|Lost to Follow-up|3|||
42176722|NCT03198754|75983947|FG000|Overall Study|Ineligible|2|||
42176723|NCT03198754|75983948|FG001|Overall Study|Ineligible|1|||
42176724|NCT03198520|75983954|FG000|Overall Study|Physician Decision|2|||
42176725|NCT03198520|75983954|FG000|Overall Study|Protocol Violation|2|||
42176726|NCT03198520|75983954|FG000|Overall Study|Withdrawal by Subject|1|||
42176727|NCT03198520|75983954|FG000|Overall Study|Study Ended|1|||
42176728|NCT03194464|75983966|FG000|Overall Study|data not usable|2|||
42176729|NCT03192904|75983974|FG000|Overall Study|Physician Decision|3|||
42176730|NCT03192904|75983975|FG001|Overall Study|Physician Decision|1|||
42176731|NCT03192904|75983974|FG000|Overall Study|Lost to Follow-up|0|||
42176732|NCT03192904|75983975|FG001|Overall Study|Lost to Follow-up|1|||
42176733|NCT03188536|75983981|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
42176734|NCT03188536|75983981|FG000|Overall Study|Not participated/met inclusion criteria|1|||
42176735|NCT03187756|75983985|FG000|Overall Study|Termination of study|4|||
42176736|NCT03187132|75983991|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
42176737|NCT03187132|75983992|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
42176738|NCT03187132|75983991|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
42293043|NCT01938430|76126995|FG005|Overall Study|Investigator's Discretion|0|||
42293044|NCT01938430|76126996|FG006|Overall Study|Investigator's Discretion|0|||
42293045|NCT01938430|76126997|FG007|Overall Study|Investigator's Discretion|0|||
42293046|NCT01938430|76126998|FG008|Overall Study|Investigator's Discretion|0|||
42293047|NCT01938430|76126999|FG009|Overall Study|Investigator's Discretion|0|||
42293048|NCT01938430|76127000|FG010|Overall Study|Investigator's Discretion|0|||
42176739|NCT03187132|75983992|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
42176740|NCT03187132|75983991|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
42176741|NCT03187132|75983992|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
42176742|NCT03187132|75983991|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
42176743|NCT03187132|75983992|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
42176744|NCT03187132|75983991|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
42176745|NCT03187132|75983992|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
42293049|NCT01938430|76127001|FG011|Overall Study|Investigator's Discretion|0|||
42293050|NCT01938430|76127002|FG012|Overall Study|Investigator's Discretion|0|||
42293051|NCT01938430|76127003|FG013|Overall Study|Investigator's Discretion|0|||
42293052|NCT01938430|76126990|FG000|Overall Study|Lack of Efficacy|3|||
42293053|NCT01938430|76126991|FG001|Overall Study|Lack of Efficacy|1|||
42293054|NCT01938430|76126992|FG002|Overall Study|Lack of Efficacy|1|||
42293055|NCT01938430|76126993|FG003|Overall Study|Lack of Efficacy|1|||
42293056|NCT01938430|76126994|FG004|Overall Study|Lack of Efficacy|0|||
42293057|NCT01938430|76126995|FG005|Overall Study|Lack of Efficacy|0|||
42293058|NCT01938430|76126996|FG006|Overall Study|Lack of Efficacy|0|||
42293059|NCT01938430|76126997|FG007|Overall Study|Lack of Efficacy|0|||
42176746|NCT03187132|75983991|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
42176747|NCT03187132|75983992|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
42176748|NCT03187132|75983991|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
42176749|NCT03187132|75983992|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
42176750|NCT03187132|75983991|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
42176751|NCT03187132|75983992|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
42293060|NCT01938430|76126998|FG008|Overall Study|Lack of Efficacy|1|||
42293061|NCT01938430|76126999|FG009|Overall Study|Lack of Efficacy|0|||
42293062|NCT01938430|76127000|FG010|Overall Study|Lack of Efficacy|2|||
42176752|NCT03187132|75983991|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
42176753|NCT03187132|75983992|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
42176754|NCT03187132|75983991|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
42176755|NCT03187132|75983992|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
42176756|NCT03187132|75983991|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
42176757|NCT03187132|75983992|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
42357723|NCT01723826|76203229|FG001|Overall Study|Physician Decision|3|||
42357724|NCT01723826|76203230|FG002|Overall Study|Physician Decision|4|||
42357725|NCT01723826|76203231|FG003|Overall Study|Physician Decision|11|||
42357726|NCT01723826|76203228|FG000|Overall Study|Protocol Violation|1|||
42357727|NCT01723826|76203229|FG001|Overall Study|Protocol Violation|1|||
42357728|NCT01723826|76203230|FG002|Overall Study|Protocol Violation|3|||
42293063|NCT01938430|76127001|FG011|Overall Study|Lack of Efficacy|1|||
42293064|NCT01938430|76127002|FG012|Overall Study|Lack of Efficacy|0|||
42293065|NCT01938430|76127003|FG013|Overall Study|Lack of Efficacy|0|||
42293066|NCT01938430|76126990|FG000|Overall Study|Lost to Follow-up|0|||
42293067|NCT01938430|76126991|FG001|Overall Study|Lost to Follow-up|0|||
42293068|NCT01938430|76126992|FG002|Overall Study|Lost to Follow-up|1|||
42293069|NCT01938430|76126993|FG003|Overall Study|Lost to Follow-up|0|||
42357729|NCT01723826|76203231|FG003|Overall Study|Protocol Violation|1|||
42017310|NCT01215942|75824889|FG000|Treatment Period|Adverse Event|15|||
42017311|NCT01215942|75824890|FG001|Treatment Period|Adverse Event|26|||
42017312|NCT01215942|75824889|FG000|Treatment Period|Death|2|||
42017313|NCT01215942|75824890|FG001|Treatment Period|Death|4|||
42017314|NCT01215942|75824889|FG000|Treatment Period|Lack of Efficacy|23|||
42017315|NCT01215942|75824890|FG001|Treatment Period|Lack of Efficacy|62|||
42017316|NCT01215942|75824889|FG000|Treatment Period|Lost to Follow-up|3|||
42017317|NCT01215942|75824890|FG001|Treatment Period|Lost to Follow-up|4|||
42017318|NCT01215942|75824889|FG000|Treatment Period|Withdrawal by Subject|17|||
42017319|NCT01215942|75824890|FG001|Treatment Period|Withdrawal by Subject|40|||
42017320|NCT01215942|75824889|FG000|Treatment Period|Physician Decision|5|||
42017321|NCT01215942|75824890|FG001|Treatment Period|Physician Decision|5|||
42017322|NCT01215942|75824889|FG000|Treatment Period|Protocol Violation|0|||
42017323|NCT01215942|75824890|FG001|Treatment Period|Protocol Violation|1|||
42017324|NCT01215942|75824889|FG000|Treatment Period|Sponsor Decision|349|||
42017325|NCT01215942|75824890|FG001|Treatment Period|Sponsor Decision|530|||
42017326|NCT01215942|75824889|FG000|Post-Treatment Follow-Up Period|Death|0|||
42017327|NCT01215942|75824890|FG001|Post-Treatment Follow-Up Period|Death|1|||
42017328|NCT01215942|75824889|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
42017329|NCT01215942|75824890|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
42017330|NCT01215942|75824889|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
42017331|NCT01215942|75824890|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
42017332|NCT01215942|75824889|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
42017333|NCT01215942|75824890|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
42017334|NCT01215942|75824889|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
42017335|NCT01215942|75824890|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
42017336|NCT01128621|75824909|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
42017337|NCT01128621|75824910|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
42017338|NCT00918463|75824932|FG000|Overall Study|Death|1|||
42017339|NCT00918463|75824932|FG000|Overall Study|Lack of Efficacy|1|||
42017340|NCT01128543|75824936|FG000|Overall Study|Withdrawal by Subject|3|||
42017341|NCT01128543|75824936|FG000|Overall Study|Protocol Violation|1|||
42017342|NCT01128387|75824942|FG000|Overall Study|Physician Decision|0|||
42017343|NCT01128387|75824943|FG001|Overall Study|Physician Decision|1|||
42017344|NCT01214850|75824952|FG000|Overall Study|Withdrawal by Subject|38|||
42017345|NCT01214850|75824953|FG001|Overall Study|Withdrawal by Subject|31|||
42017346|NCT01214850|75824954|FG002|Overall Study|Withdrawal by Subject|28|||
42017347|NCT01214850|75824952|FG000|Overall Study|Lost to Follow-up|124|||
42017348|NCT01214850|75824953|FG001|Overall Study|Lost to Follow-up|98|||
42017349|NCT01214850|75824954|FG002|Overall Study|Lost to Follow-up|123|||
42017350|NCT01214850|75824952|FG000|Overall Study|Protocol Violation|5|||
42017351|NCT01214850|75824953|FG001|Overall Study|Protocol Violation|5|||
42293070|NCT01938430|76126994|FG004|Overall Study|Lost to Follow-up|0|||
42293071|NCT01938430|76126995|FG005|Overall Study|Lost to Follow-up|1|||
42293072|NCT01938430|76126996|FG006|Overall Study|Lost to Follow-up|0|||
42293073|NCT01938430|76126997|FG007|Overall Study|Lost to Follow-up|0|||
42293074|NCT01938430|76126998|FG008|Overall Study|Lost to Follow-up|0|||
42293075|NCT01938430|76126999|FG009|Overall Study|Lost to Follow-up|0|||
42293076|NCT01938430|76127000|FG010|Overall Study|Lost to Follow-up|0|||
42293077|NCT01938430|76127001|FG011|Overall Study|Lost to Follow-up|0|||
42293078|NCT01938430|76127002|FG012|Overall Study|Lost to Follow-up|0|||
42293079|NCT01938430|76127003|FG013|Overall Study|Lost to Follow-up|0|||
42293080|NCT01938430|76126990|FG000|Overall Study|Withdrew Consent|0|||
42293081|NCT01938430|76126991|FG001|Overall Study|Withdrew Consent|0|||
42293082|NCT01938430|76126992|FG002|Overall Study|Withdrew Consent|0|||
42293083|NCT01938430|76126993|FG003|Overall Study|Withdrew Consent|0|||
42293084|NCT01938430|76126994|FG004|Overall Study|Withdrew Consent|0|||
42293085|NCT01938430|76126995|FG005|Overall Study|Withdrew Consent|0|||
42293086|NCT01938430|76126996|FG006|Overall Study|Withdrew Consent|0|||
42293087|NCT01938430|76126997|FG007|Overall Study|Withdrew Consent|0|||
42293088|NCT01938430|76126998|FG008|Overall Study|Withdrew Consent|1|||
42293089|NCT01938430|76126999|FG009|Overall Study|Withdrew Consent|0|||
42293090|NCT01938430|76127000|FG010|Overall Study|Withdrew Consent|0|||
42293091|NCT01938430|76127001|FG011|Overall Study|Withdrew Consent|0|||
42293092|NCT01938430|76127002|FG012|Overall Study|Withdrew Consent|0|||
42293093|NCT01938430|76127003|FG013|Overall Study|Withdrew Consent|0|||
42293094|NCT01937884|76127060|FG000|Overall Study|Withdrawal by Subject|1|||
42293095|NCT01937884|76127061|FG001|Overall Study|Withdrawal by Subject|0|||
42293096|NCT01916824|76127071|FG000|Overall Study|Lost to Follow-up|3|||
42293097|NCT01916824|76127072|FG001|Overall Study|Lost to Follow-up|6|||
42293098|NCT01916824|76127071|FG000|Overall Study|Physician Decision|2|||
42293099|NCT01916824|76127072|FG001|Overall Study|Physician Decision|0|||
42293100|NCT01916824|76127071|FG000|Overall Study|Withdrawal by Subject|2|||
42293101|NCT01916824|76127072|FG001|Overall Study|Withdrawal by Subject|3|||
42293102|NCT01915732|76127080|FG000|Overall Study|Withdrawal by Subject|18|||
42293103|NCT01915732|76127081|FG001|Overall Study|Withdrawal by Subject|18|||
42293104|NCT01915732|76127080|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
42293105|NCT01915732|76127081|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
42293106|NCT01915732|76127080|FG000|Overall Study|Adverse Event|12|||
42293107|NCT01915732|76127081|FG001|Overall Study|Adverse Event|4|||
42293108|NCT01915732|76127080|FG000|Overall Study|Protocol Violation|5|||
42293109|NCT01915732|76127081|FG001|Overall Study|Protocol Violation|5|||
42293110|NCT01915732|76127080|FG000|Overall Study|Lack of Efficacy|6|||
42293111|NCT01915732|76127081|FG001|Overall Study|Lack of Efficacy|11|||
42293112|NCT01915732|76127080|FG000|Overall Study|Lost to Follow-up|22|||
42293113|NCT01915732|76127081|FG001|Overall Study|Lost to Follow-up|26|||
42293114|NCT01915732|76127080|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
42293115|NCT01915732|76127081|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
42293116|NCT01915732|76127080|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
42293117|NCT01915732|76127081|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
42293118|NCT01915732|76127080|FG000|Overall Study|Drug Release Error|1|||
42293119|NCT01915732|76127081|FG001|Overall Study|Drug Release Error|0|||
42293120|NCT01915732|76127080|FG000|Overall Study|Recovered|1|||
42293121|NCT01915732|76127081|FG001|Overall Study|Recovered|0|||
42293122|NCT01915732|76127080|FG000|Overall Study|Pregnancy|1|||
42293123|NCT01915732|76127081|FG001|Overall Study|Pregnancy|0|||
42293124|NCT01915732|76127080|FG000|Overall Study|Poor Perceived Efficacy|1|||
42293125|NCT01915732|76127081|FG001|Overall Study|Poor Perceived Efficacy|0|||
42293126|NCT01915732|76127080|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
42293127|NCT01915732|76127081|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
42293128|NCT01915732|76127080|FG000|Overall Study|Got Well|0|||
42293129|NCT01915732|76127081|FG001|Overall Study|Got Well|1|||
42293130|NCT01915732|76127080|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
42293131|NCT01915732|76127081|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
42176758|NCT03184558|75983998|FG000|Overall Study|Withdrawal by Subject|2|||
42293132|NCT01915732|76127080|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
42293133|NCT01915732|76127081|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
42293134|NCT01915732|76127080|FG000|Overall Study|Job Transfer|0|||
42293135|NCT01915732|76127081|FG001|Overall Study|Job Transfer|1|||
42017352|NCT01214850|75824954|FG002|Overall Study|Protocol Violation|6|||
42293136|NCT01915732|76127080|FG000|Overall Study|Improper Facial Procedure|0|||
42293137|NCT01915732|76127081|FG001|Overall Study|Improper Facial Procedure|1|||
42293138|NCT01915732|76127080|FG000|Overall Study|Poor Conscious Effect|0|||
42293139|NCT01915732|76127081|FG001|Overall Study|Poor Conscious Effect|1|||
42293140|NCT01936948|76127091|FG000|Overall Study|no 30-day follow-up data|0|||
42293141|NCT01936948|76127092|FG001|Overall Study|no 30-day follow-up data|3|||
42293142|NCT01936948|76127093|FG002|Overall Study|no 30-day follow-up data|3|||
42293143|NCT01936948|76127094|FG003|Overall Study|no 30-day follow-up data|3|||
42293144|NCT01936870|76127102|FG000|Overall Study|No Visit After Treatment|176|||
42293145|NCT01936870|76127102|FG000|Overall Study|Protocol Violation|12|||
42293146|NCT01936870|76127102|FG000|Overall Study|No Drug Administration|1|||
42293147|NCT01618864|76127106|FG000|Overall Study|Withdrawal by Subject|2|||
42293148|NCT01618864|76127106|FG000|Overall Study|Lost to Follow-up|2|||
42293149|NCT01618708|76127117|FG000|Overall Study|Adverse Event|10|||
42293150|NCT01618708|76127118|FG001|Overall Study|Adverse Event|10|||
42293151|NCT01618708|76127117|FG000|Overall Study|Lost to Follow-up|3|||
42293152|NCT01618708|76127118|FG001|Overall Study|Lost to Follow-up|3|||
42293153|NCT01618708|76127117|FG000|Overall Study|Withdrawal by Subject|17|||
42293154|NCT01618708|76127118|FG001|Overall Study|Withdrawal by Subject|22|||
42293155|NCT01618708|76127117|FG000|Overall Study|Lack of Efficacy|8|||
42293156|NCT01618708|76127118|FG001|Overall Study|Lack of Efficacy|8|||
42293157|NCT01618708|76127117|FG000|Overall Study|Technical problems|2|||
42293158|NCT01618708|76127118|FG001|Overall Study|Technical problems|0|||
42293159|NCT01618708|76127117|FG000|Overall Study|Other than specified above|1|||
42293160|NCT01618708|76127118|FG001|Overall Study|Other than specified above|1|||
42293161|NCT01618708|76127117|FG000|Overall Study|Randomized but not treated|3|||
42293162|NCT01618708|76127118|FG001|Overall Study|Randomized but not treated|2|||
42293163|NCT00790933|76127134|FG000|Overall Study|Adverse Event|94|||
42293164|NCT00790933|76127135|FG001|Overall Study|Adverse Event|119|||
42293165|NCT00790933|76127136|FG002|Overall Study|Adverse Event|65|||
42293166|NCT00790933|76127137|FG003|Overall Study|Adverse Event|5|||
42293167|NCT00790933|76127138|FG004|Overall Study|Adverse Event|69|||
42293168|NCT00790933|76127134|FG000|Overall Study|Protocol Violation(s)|8|||
42293169|NCT00790933|76127135|FG001|Overall Study|Protocol Violation(s)|18|||
42293170|NCT00790933|76127136|FG002|Overall Study|Protocol Violation(s)|7|||
42293171|NCT00790933|76127137|FG003|Overall Study|Protocol Violation(s)|0|||
42293172|NCT00790933|76127138|FG004|Overall Study|Protocol Violation(s)|12|||
42293173|NCT00790933|76127134|FG000|Overall Study|Lack of Efficacy|192|||
42293174|NCT00790933|76127135|FG001|Overall Study|Lack of Efficacy|176|||
42293175|NCT00790933|76127136|FG002|Overall Study|Lack of Efficacy|130|||
42293176|NCT00790933|76127137|FG003|Overall Study|Lack of Efficacy|1|||
42293177|NCT00790933|76127138|FG004|Overall Study|Lack of Efficacy|121|||
42293178|NCT00790933|76127134|FG000|Overall Study|Study Terminated by Sponsor|0|||
42293179|NCT00790933|76127135|FG001|Overall Study|Study Terminated by Sponsor|0|||
42293180|NCT00790933|76127136|FG002|Overall Study|Study Terminated by Sponsor|1|||
42293181|NCT00790933|76127137|FG003|Overall Study|Study Terminated by Sponsor|0|||
42293182|NCT00790933|76127138|FG004|Overall Study|Study Terminated by Sponsor|0|||
42293183|NCT00790933|76127134|FG000|Overall Study|Withdrawal by Subject|123|||
42293184|NCT00790933|76127135|FG001|Overall Study|Withdrawal by Subject|120|||
42293185|NCT00790933|76127136|FG002|Overall Study|Withdrawal by Subject|52|||
42293186|NCT00790933|76127137|FG003|Overall Study|Withdrawal by Subject|6|||
42293187|NCT00790933|76127138|FG004|Overall Study|Withdrawal by Subject|50|||
42293188|NCT00790933|76127134|FG000|Overall Study|Lost to Follow-up|13|||
42293189|NCT00790933|76127135|FG001|Overall Study|Lost to Follow-up|31|||
42293190|NCT00790933|76127136|FG002|Overall Study|Lost to Follow-up|10|||
42293191|NCT00790933|76127137|FG003|Overall Study|Lost to Follow-up|1|||
42293192|NCT00790933|76127138|FG004|Overall Study|Lost to Follow-up|15|||
42293193|NCT00790933|76127134|FG000|Overall Study|Reason Not Specified|8|||
42293194|NCT00790933|76127135|FG001|Overall Study|Reason Not Specified|16|||
42293195|NCT00790933|76127136|FG002|Overall Study|Reason Not Specified|4|||
42293196|NCT00790933|76127137|FG003|Overall Study|Reason Not Specified|1|||
42293197|NCT00790933|76127138|FG004|Overall Study|Reason Not Specified|9|||
42293198|NCT02161211|76127157|FG000|Overall Study|Lost to Follow-up|21|||
42293199|NCT02161211|76127158|FG001|Overall Study|Lost to Follow-up|27|||
42293200|NCT02161211|76127159|FG002|Overall Study|Lost to Follow-up|21|||
42293201|NCT02161211|76127157|FG000|Overall Study|Dropped|12|||
42293202|NCT02161211|76127158|FG001|Overall Study|Dropped|5|||
42293203|NCT02161211|76127159|FG002|Overall Study|Dropped|9|||
42293204|NCT01676701|76127169|FG000|Overall Study|Protocol Violation|1|||
42293205|NCT01676701|76127170|FG001|Overall Study|Protocol Violation|0|||
42293206|NCT01676701|76127169|FG000|Overall Study|Sponsor Decision|3|||
42017353|NCT01214850|75824952|FG000|Overall Study|Adverse event or death|11|||
42293207|NCT01676701|76127170|FG001|Overall Study|Sponsor Decision|4|||
42293208|NCT01670279|76127181|FG000|Overall Study|Adverse Event|0|||
42293209|NCT01670279|76127182|FG001|Overall Study|Adverse Event|1|||
42293210|NCT01670279|76127183|FG002|Overall Study|Adverse Event|0|||
42293211|NCT01670279|76127184|FG003|Overall Study|Adverse Event|0|||
42293212|NCT01670279|76127181|FG000|Overall Study|Physician Decision|0|||
42293213|NCT01670279|76127182|FG001|Overall Study|Physician Decision|1|||
42293214|NCT01670279|76127183|FG002|Overall Study|Physician Decision|0|||
42293215|NCT01670279|76127184|FG003|Overall Study|Physician Decision|0|||
42293216|NCT01670279|76127181|FG000|Overall Study|Participant met withdrawal criteria|0|||
42293217|NCT01670279|76127182|FG001|Overall Study|Participant met withdrawal criteria|0|||
42293218|NCT01670279|76127183|FG002|Overall Study|Participant met withdrawal criteria|0|||
42293219|NCT01670279|76127184|FG003|Overall Study|Participant met withdrawal criteria|1|||
42293220|NCT02627495|76127192|FG000|Overall Study|Withdrawal by Subject|4|||
42293221|NCT01670045|76127196|FG000|Overall Study|Withdrawal by Subject|3|||
42293222|NCT01670045|76127196|FG000|Overall Study|Adverse Event|1|||
42293223|NCT01670045|76127196|FG000|Overall Study|Death|1|||
42293224|NCT01670045|76127196|FG000|Overall Study|Lost to Follow-up|11|||
42293225|NCT01669421|76127200|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
42293226|NCT01669421|76127200|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
42293227|NCT01671059|76127214|FG000|Overall Study|Adverse Event|4|||
42293228|NCT01671059|76127214|FG000|Overall Study|Lack of Efficacy|1|||
42293229|NCT01669811|76127230|FG000|Overall Study|Investigator decision|0|||
42293230|NCT01669811|76127231|FG001|Overall Study|Investigator decision|1|||
42293231|NCT01669811|76127230|FG000|Overall Study|Withdrawal by Subject|1|||
42293232|NCT01669811|76127231|FG001|Overall Study|Withdrawal by Subject|2|||
42293233|NCT01669811|76127230|FG000|Overall Study|Adverse Event|2|||
42293234|NCT01669811|76127231|FG001|Overall Study|Adverse Event|6|||
42293235|NCT01669811|76127230|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
42293236|NCT01669811|76127231|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
42293237|NCT01669577|76127237|FG000|Overall Study|Death|22|||
42293238|NCT01669577|76127237|FG000|Overall Study|Lost to Follow-up|78|||
42293239|NCT01669577|76127237|FG000|Overall Study|Physician Decision|34|||
42293240|NCT02658175|76127244|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
42293241|NCT02658175|76127245|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
42293242|NCT02658175|76127246|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
42293243|NCT02658175|76127244|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
42293244|NCT02658175|76127245|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
42293245|NCT02658175|76127246|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
42293246|NCT02658175|76127244|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
42293247|NCT02658175|76127245|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
42293248|NCT02658175|76127246|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
42293249|NCT02658175|76127244|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
42293250|NCT02658175|76127245|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
42293251|NCT02658175|76127246|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
42293252|NCT02658175|76127244|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
42293253|NCT02658175|76127245|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
42293254|NCT02658175|76127246|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
42293255|NCT02658175|76127244|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
42293256|NCT02658175|76127245|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
42293257|NCT02658175|76127246|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
42293258|NCT02658175|76127244|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
42293259|NCT02658175|76127245|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
42293260|NCT02658175|76127246|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
42293261|NCT02658175|76127244|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
42293262|NCT02658175|76127245|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
42293263|NCT02658175|76127246|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
42293264|NCT02658175|76127244|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
42293265|NCT02658175|76127245|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
42293266|NCT02658175|76127246|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
42293267|NCT02658175|76127244|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
42293268|NCT02658175|76127245|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
42293269|NCT02658175|76127246|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
42293270|NCT02625623|76127256|FG000|Overall Study|Participants randomized but not treated|9|||
42293271|NCT02625623|76127257|FG001|Overall Study|Participants randomized but not treated|1|||
42293272|NCT02658019|76127265|FG000|Overall Study|Adverse Event|1|||
42293273|NCT02624687|76127271|FG000|Overall Study|Withdrawal by Subject|1|||
42293274|NCT02624687|76127272|FG001|Overall Study|Withdrawal by Subject|1|||
42293275|NCT02624687|76127271|FG000|Overall Study|medical leave from work|0|||
42293276|NCT02624687|76127272|FG001|Overall Study|medical leave from work|1|||
42293277|NCT01675765|76127280|FG000|Overall Study|Progressive disease|4|||
42293278|NCT01675765|76127281|FG001|Overall Study|Progressive disease|4|||
42293279|NCT01675765|76127280|FG000|Overall Study|Adverse Event|1|||
42293280|NCT01675765|76127281|FG001|Overall Study|Adverse Event|2|||
42293281|NCT01675765|76127280|FG000|Overall Study|Withdrawal by Subject|2|||
42357730|NCT01723826|76203228|FG000|Overall Study|Withdrawal by Subject|10|||
42357731|NCT01723826|76203229|FG001|Overall Study|Withdrawal by Subject|17|||
42357732|NCT01723826|76203230|FG002|Overall Study|Withdrawal by Subject|27|||
42070836|NCT00884286|75880959|FG001|Overall Study|Physician Decision|0|||
42070837|NCT00884286|75880958|FG000|Overall Study|Septic shock|1|||
42070838|NCT00884286|75880959|FG001|Overall Study|Septic shock|0|||
42070839|NCT00884286|75880958|FG000|Overall Study|Thrombus in right auricle|1|||
42357733|NCT01723826|76203231|FG003|Overall Study|Withdrawal by Subject|48|||
42070840|NCT00884286|75880959|FG001|Overall Study|Thrombus in right auricle|0|||
42070841|NCT00884286|75880958|FG000|Overall Study|Not treated|2|||
42070842|NCT00884286|75880959|FG001|Overall Study|Not treated|1|||
42070843|NCT00884286|75880958|FG000|Overall Study|Comprised lung carcinoma|0|||
42070844|NCT00884286|75880959|FG001|Overall Study|Comprised lung carcinoma|1|||
42070845|NCT00873015|75880970|FG000|Overall Study|Withdrawal by Subject|0|||
42070846|NCT00873015|75880971|FG001|Overall Study|Withdrawal by Subject|1|||
42070847|NCT00873015|75880972|FG002|Overall Study|Withdrawal by Subject|0|||
42070848|NCT00873015|75880973|FG003|Overall Study|Withdrawal by Subject|0|||
42070849|NCT03921151|75880988|FG000|Overall Study|Withdrawal by Subject|11|||
42070850|NCT03921151|75880989|FG001|Overall Study|Withdrawal by Subject|16|||
42070851|NCT00872001|75881001|FG000|Overall Study|Adverse Event|34|||
42070852|NCT00872001|75881002|FG001|Overall Study|Adverse Event|23|||
42070853|NCT00872001|75881001|FG000|Overall Study|Protocol Defined Clinical Event|5|||
42070854|NCT00872001|75881002|FG001|Overall Study|Protocol Defined Clinical Event|7|||
42070855|NCT00872001|75881001|FG000|Overall Study|Lost to Follow-up|13|||
42070856|NCT00872001|75881002|FG001|Overall Study|Lost to Follow-up|12|||
42070857|NCT00872001|75881001|FG000|Overall Study|Withdrawal by Subject|18|||
42070858|NCT00872001|75881002|FG001|Overall Study|Withdrawal by Subject|30|||
42070859|NCT00872001|75881001|FG000|Overall Study|Protocol Violation|5|||
42070860|NCT00872001|75881002|FG001|Overall Study|Protocol Violation|8|||
42070861|NCT00872001|75881001|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
42070862|NCT00872001|75881002|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
42070863|NCT00872001|75881001|FG000|Overall Study|Administrative|23|||
42070864|NCT00872001|75881002|FG001|Overall Study|Administrative|15|||
42070865|NCT00871923|75881010|FG000|Overall Study|Death|1|||
42070866|NCT00871923|75881010|FG000|Overall Study|Withdrawal by Subject|1|||
42293282|NCT01675765|76127281|FG001|Overall Study|Withdrawal by Subject|0|||
42293283|NCT01675765|76127280|FG000|Overall Study|Death|1|||
42293284|NCT01675765|76127281|FG001|Overall Study|Death|0|||
42293285|NCT01675765|76127280|FG000|Overall Study|Clinical progression|3|||
42293286|NCT01675765|76127281|FG001|Overall Study|Clinical progression|2|||
42293287|NCT02625233|76127289|FG000|Overall Study|Adverse Event|2|||
42293288|NCT02625233|76127290|FG001|Overall Study|Adverse Event|0|||
42293289|NCT02656693|76127299|FG000|Overall Study|Pregnancy|1|||
42293290|NCT02656693|76127300|FG001|Overall Study|Pregnancy|1|||
42293291|NCT02656693|76127301|FG002|Overall Study|Pregnancy|1|||
42293292|NCT02656693|76127299|FG000|Overall Study|Bariatric surgery|0|||
42293293|NCT02656693|76127300|FG001|Overall Study|Bariatric surgery|1|||
42293294|NCT02656693|76127301|FG002|Overall Study|Bariatric surgery|2|||
42293295|NCT02633293|76127309|FG000|Overall Study|Death|56|||
42293296|NCT02633293|76127309|FG000|Overall Study|Progressive Disease|12|||
42293297|NCT02633293|76127309|FG000|Overall Study|Adverse Event|29|||
42293298|NCT02633293|76127309|FG000|Overall Study|Withdrawal by Subject|41|||
42293299|NCT02633293|76127309|FG000|Overall Study|Protocol Violation|1|||
42293300|NCT02633293|76127309|FG000|Overall Study|Lost to Follow-up|1|||
42293301|NCT02633293|76127309|FG000|Overall Study|Study Terminated by Sponsor|24|||
42293302|NCT02633293|76127309|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
42293303|NCT02633293|76127309|FG000|Overall Study|Lung Transplant|5|||
42293304|NCT02633293|76127309|FG000|Overall Study|Lack of Efficacy|2|||
42293305|NCT02633293|76127309|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
42293306|NCT02623829|76127315|FG000|Overall Study|Lost to Follow-up|1|||
42293307|NCT02623829|76127316|FG001|Overall Study|Lost to Follow-up|1|||
42293308|NCT02655679|76127327|FG000|Overall Study|Adverse Event|0|||
42293309|NCT02655679|76127328|FG001|Overall Study|Adverse Event|1|||
42293310|NCT02655679|76127329|FG002|Overall Study|Adverse Event|0|||
42293311|NCT02655679|76127330|FG003|Overall Study|Adverse Event|0|||
42293312|NCT02655679|76127331|FG004|Overall Study|Adverse Event|0|||
42293313|NCT02655679|76127327|FG000|Overall Study|Withdrawal by Subject|1|||
42293314|NCT02655679|76127328|FG001|Overall Study|Withdrawal by Subject|1|||
42293315|NCT02655679|76127329|FG002|Overall Study|Withdrawal by Subject|0|||
42293316|NCT02655679|76127330|FG003|Overall Study|Withdrawal by Subject|3|||
42293317|NCT02655679|76127331|FG004|Overall Study|Withdrawal by Subject|1|||
42293318|NCT02655679|76127327|FG000|Overall Study|Inability to Comply with the Protocol|1|||
42293319|NCT02655679|76127328|FG001|Overall Study|Inability to Comply with the Protocol|0|||
42293320|NCT02655679|76127329|FG002|Overall Study|Inability to Comply with the Protocol|0|||
42357734|NCT01721954|76203243|FG000|Overall Study|Death|58|||
42070867|NCT03922945|75881017|FG000|Overall Study|Adverse Event|1|||
42070868|NCT03922945|75881018|FG001|Overall Study|Adverse Event|1|||
42070869|NCT03922945|75881019|FG002|Overall Study|Adverse Event|2|||
42070870|NCT03922945|75881017|FG000|Overall Study|Lost to Follow-up|13|||
42070871|NCT03922945|75881018|FG001|Overall Study|Lost to Follow-up|9|||
42070872|NCT03922945|75881019|FG002|Overall Study|Lost to Follow-up|20|||
42070873|NCT03922945|75881017|FG000|Overall Study|Lack of Efficacy|2|||
42070874|NCT03922945|75881018|FG001|Overall Study|Lack of Efficacy|0|||
42293321|NCT02655679|76127330|FG003|Overall Study|Inability to Comply with the Protocol|0|||
42293322|NCT02655679|76127331|FG004|Overall Study|Inability to Comply with the Protocol|0|||
42293323|NCT02655679|76127327|FG000|Overall Study|Lost to Follow-up|0|||
42293324|NCT02655679|76127328|FG001|Overall Study|Lost to Follow-up|1|||
42293325|NCT02655679|76127329|FG002|Overall Study|Lost to Follow-up|1|||
42293326|NCT02655679|76127330|FG003|Overall Study|Lost to Follow-up|1|||
42293327|NCT02655679|76127331|FG004|Overall Study|Lost to Follow-up|0|||
42293328|NCT02655679|76127327|FG000|Overall Study|Other Miscellaneous Reasons|1|||
42293329|NCT02655679|76127328|FG001|Overall Study|Other Miscellaneous Reasons|0|||
42293330|NCT02655679|76127329|FG002|Overall Study|Other Miscellaneous Reasons|0|||
42293331|NCT02655679|76127330|FG003|Overall Study|Other Miscellaneous Reasons|0|||
42293332|NCT02655679|76127331|FG004|Overall Study|Other Miscellaneous Reasons|0|||
42293333|NCT02623361|76127346|FG000|Overall Study|Protocol Violation|0|||
42293334|NCT02623361|76127347|FG001|Overall Study|Protocol Violation|1|||
42293335|NCT02623361|76127346|FG000|Overall Study|Withdrawal by Subject|0|||
42293336|NCT02623361|76127347|FG001|Overall Study|Withdrawal by Subject|1|||
42070875|NCT03922945|75881019|FG002|Overall Study|Lack of Efficacy|1|||
42070876|NCT03922945|75881017|FG000|Overall Study|Protocol Non-Compliance|0|||
42070877|NCT03922945|75881018|FG001|Overall Study|Protocol Non-Compliance|0|||
42070878|NCT03922945|75881019|FG002|Overall Study|Protocol Non-Compliance|1|||
42070879|NCT03922945|75881017|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
42070880|NCT03922945|75881018|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
42070881|NCT03922945|75881019|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
42070882|NCT03922945|75881017|FG000|Overall Study|All Other Personal Reasons|1|||
42070883|NCT03922945|75881018|FG001|Overall Study|All Other Personal Reasons|1|||
42070884|NCT03922945|75881019|FG002|Overall Study|All Other Personal Reasons|2|||
42070885|NCT03922477|75881030|FG000|Overall Study|Death|9|||
42070886|NCT03922477|75881030|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
42070887|NCT03922477|75881030|FG000|Overall Study|Physician Decision|1|||
42070888|NCT03922477|75881030|FG000|Overall Study|Withdrawal by Subject|2|||
42070889|NCT00867165|75881036|FG000|Overall Study|Adverse Event|3|||
42070890|NCT00867165|75881037|FG001|Overall Study|Adverse Event|0|||
42070891|NCT00867165|75881036|FG000|Overall Study|Withdrawal by Subject|1|||
42070892|NCT00867165|75881037|FG001|Overall Study|Withdrawal by Subject|0|||
42070893|NCT00867087|75881043|FG000|Overall Study|Other|1|||
42070894|NCT00867087|75881043|FG000|Overall Study|Withdrawal by Subject|4|||
42070895|NCT00867087|75881043|FG000|Overall Study|Death|37|||
42070896|NCT00545233|75881049|FG000|Overall Study|Adverse Event|10|||
42070897|NCT00545233|75881050|FG001|Overall Study|Adverse Event|5|||
42070898|NCT00545233|75881049|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
42070899|NCT00545233|75881050|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
42070900|NCT00545233|75881049|FG000|Overall Study|Protocol Violation|2|||
42070901|NCT00545233|75881050|FG001|Overall Study|Protocol Violation|0|||
42070902|NCT00545233|75881049|FG000|Overall Study|Refused Treatment|9|||
42070903|NCT00545233|75881050|FG001|Overall Study|Refused Treatment|7|||
42070904|NCT00545233|75881049|FG000|Overall Study|Failure to Return|4|||
42070905|NCT00545233|75881050|FG001|Overall Study|Failure to Return|6|||
42070906|NCT00545233|75881049|FG000|Overall Study|Insufficient response|14|||
42070907|NCT00545233|75881050|FG001|Overall Study|Insufficient response|15|||
42070908|NCT00545233|75881049|FG000|Overall Study|Physician Decision|2|||
42070909|NCT00545233|75881050|FG001|Overall Study|Physician Decision|1|||
42070910|NCT02393248|75881082|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070911|NCT02393248|75881083|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
42070912|NCT02393248|75881084|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070913|NCT02393248|75881085|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070914|NCT02393248|75881086|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070915|NCT02393248|75881087|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
42070916|NCT02393248|75881088|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
42070917|NCT02393248|75881089|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070918|NCT02393248|75881090|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070919|NCT02393248|75881091|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070920|NCT02393248|75881092|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070921|NCT02393248|75881093|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070922|NCT02393248|75881094|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070923|NCT02393248|75881095|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070924|NCT02393248|75881096|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42293337|NCT01675531|76127394|FG000|Overall Study|Adverse Event|9|||
42293338|NCT01675531|76127394|FG000|Overall Study|Withdrawal by Subject|7|||
42070925|NCT02393248|75881097|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070926|NCT02393248|75881098|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42176759|NCT03184558|75983998|FG000|Overall Study|Death|16|||
42070927|NCT02393248|75881099|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070928|NCT02393248|75881100|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070929|NCT02393248|75881101|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070930|NCT02393248|75881102|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42293339|NCT01675531|76127394|FG000|Overall Study|Lack of Efficacy|1|||
42293340|NCT01675531|76127394|FG000|Overall Study|Protocol Violation|8|||
42070931|NCT02393248|75881103|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070932|NCT02393248|75881104|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070933|NCT02393248|75881105|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070934|NCT02393248|75881106|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
42070935|NCT02393248|75881082|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070936|NCT02393248|75881083|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
42070937|NCT02393248|75881084|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070938|NCT02393248|75881085|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070939|NCT02393248|75881086|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070940|NCT02393248|75881087|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070941|NCT02393248|75881088|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070942|NCT02393248|75881089|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070943|NCT02393248|75881090|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070944|NCT02393248|75881091|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070945|NCT02393248|75881092|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070946|NCT02393248|75881093|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070947|NCT02393248|75881094|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070948|NCT02393248|75881095|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070949|NCT02393248|75881096|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070950|NCT02393248|75881097|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070951|NCT02393248|75881098|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070952|NCT02393248|75881099|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070953|NCT02393248|75881100|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070954|NCT02393248|75881101|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070955|NCT02393248|75881102|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070956|NCT02393248|75881103|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070957|NCT02393248|75881104|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070958|NCT02393248|75881105|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070959|NCT02393248|75881106|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
42070960|NCT02393248|75881082|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
42070961|NCT02393248|75881083|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
42070962|NCT02393248|75881084|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
42070963|NCT02393248|75881085|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
42070964|NCT02393248|75881086|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
42070965|NCT02393248|75881087|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
42070966|NCT02393248|75881088|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
42070967|NCT02393248|75881089|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
42070968|NCT02393248|75881090|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
42070969|NCT02393248|75881091|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
42070970|NCT02393248|75881092|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
42070971|NCT02393248|75881093|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
42070972|NCT02393248|75881094|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
42070973|NCT02393248|75881095|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
42070974|NCT02393248|75881096|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
42070975|NCT02393248|75881097|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
42070976|NCT02393248|75881098|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
42070977|NCT02393248|75881099|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
42070978|NCT02393248|75881100|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
42070979|NCT02393248|75881101|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
42070980|NCT02393248|75881102|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
42070981|NCT02393248|75881103|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
42070982|NCT02393248|75881104|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
42070983|NCT02393248|75881105|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
42070984|NCT02393248|75881106|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
42070985|NCT02393248|75881082|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
42070986|NCT02393248|75881083|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070987|NCT02393248|75881084|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070988|NCT02393248|75881085|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070989|NCT02393248|75881086|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070990|NCT02393248|75881087|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070991|NCT02393248|75881088|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070992|NCT02393248|75881089|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070993|NCT02393248|75881090|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070994|NCT02393248|75881091|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070995|NCT02393248|75881092|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070996|NCT02393248|75881093|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070997|NCT02393248|75881094|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070998|NCT02393248|75881095|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42070999|NCT02393248|75881096|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42071000|NCT02393248|75881097|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42071001|NCT02393248|75881098|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42071002|NCT02393248|75881099|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42071003|NCT02393248|75881100|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42071004|NCT02393248|75881101|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42071005|NCT02393248|75881102|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42071006|NCT02393248|75881103|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42071007|NCT02393248|75881104|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42071008|NCT02393248|75881105|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42071009|NCT02393248|75881106|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
42071010|NCT02393248|75881082|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071011|NCT02393248|75881083|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071012|NCT02393248|75881084|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071013|NCT02393248|75881085|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071014|NCT02393248|75881086|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071015|NCT02393248|75881087|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
42071016|NCT02393248|75881088|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
42071017|NCT02393248|75881089|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071018|NCT02393248|75881090|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071019|NCT02393248|75881091|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
42071020|NCT02393248|75881092|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071021|NCT02393248|75881093|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071022|NCT02393248|75881094|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071023|NCT02393248|75881095|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071024|NCT02393248|75881096|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071025|NCT02393248|75881097|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071026|NCT02393248|75881098|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071027|NCT02393248|75881099|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071028|NCT02393248|75881100|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071029|NCT02393248|75881101|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071030|NCT02393248|75881102|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071031|NCT02393248|75881103|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071032|NCT02393248|75881104|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071033|NCT02393248|75881105|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071034|NCT02393248|75881106|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
42071035|NCT02393248|75881082|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071036|NCT02393248|75881083|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071037|NCT02393248|75881084|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071038|NCT02393248|75881085|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071039|NCT02393248|75881086|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071040|NCT02393248|75881087|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071041|NCT02393248|75881088|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
42071042|NCT02393248|75881089|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071043|NCT02393248|75881090|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071044|NCT02393248|75881091|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071045|NCT02393248|75881092|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071046|NCT02393248|75881093|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071047|NCT02393248|75881094|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071048|NCT02393248|75881095|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071049|NCT02393248|75881096|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071050|NCT02393248|75881097|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071051|NCT02393248|75881098|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071052|NCT02393248|75881099|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071053|NCT02393248|75881100|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071054|NCT02393248|75881101|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071055|NCT02393248|75881102|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071056|NCT02393248|75881103|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071057|NCT02393248|75881104|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42293341|NCT02532543|76127403|FG000|Overall Study|Lost to Follow-up|0|||
42293342|NCT02532543|76127404|FG001|Overall Study|Lost to Follow-up|0|||
42071058|NCT02393248|75881105|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071059|NCT02393248|75881106|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
42071060|NCT02393248|75881082|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071061|NCT02393248|75881083|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071062|NCT02393248|75881084|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071063|NCT02393248|75881085|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071064|NCT02393248|75881086|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071065|NCT02393248|75881087|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071066|NCT02393248|75881088|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071067|NCT02393248|75881089|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071068|NCT02393248|75881090|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42176760|NCT03184558|75983998|FG000|Overall Study|Lost to Follow-up|2|||
42176761|NCT03184558|75983998|FG000|Overall Study|Other|9|||
42176762|NCT03183778|75984002|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
42176763|NCT03182686|75984008|FG000|Overall Study|Lost to Follow-up|2|||
42176764|NCT03182686|75984009|FG001|Overall Study|Lost to Follow-up|0|||
42176765|NCT03182686|75984008|FG000|Overall Study|Adverse Event|2|||
42176766|NCT03182686|75984009|FG001|Overall Study|Adverse Event|0|||
42176767|NCT03182686|75984008|FG000|Overall Study|Withdrawal by Subject|3|||
42176768|NCT03182686|75984009|FG001|Overall Study|Withdrawal by Subject|0|||
42176769|NCT03181594|75984015|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
42176770|NCT03181594|75984015|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
42176771|NCT03181594|75984015|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
42176772|NCT03181594|75984015|FG000|Initial Study Protocol (12-month FU)|Death|1|||
42176773|NCT03181594|75984015|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
42176774|NCT03181594|75984015|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
42176775|NCT03180736|75984021|FG000|Overall Study|Adverse Event|3|||
42176776|NCT03180736|75984022|FG001|Overall Study|Adverse Event|4|||
42176777|NCT03180736|75984021|FG000|Overall Study|Death|10|||
42176778|NCT03180736|75984022|FG001|Overall Study|Death|7|||
42176779|NCT03180736|75984021|FG000|Overall Study|Withdrawal by Subject|5|||
42176780|NCT03180736|75984022|FG001|Overall Study|Withdrawal by Subject|12|||
42176781|NCT03180736|75984021|FG000|Overall Study|Lost to Follow-up|1|||
42176782|NCT03180736|75984022|FG001|Overall Study|Lost to Follow-up|0|||
42176783|NCT03180736|75984021|FG000|Overall Study|Lack of Efficacy|66|||
42176784|NCT03180736|75984022|FG001|Overall Study|Lack of Efficacy|87|||
42176785|NCT03180736|75984021|FG000|Overall Study|Physician Decision|4|||
42176786|NCT03180736|75984022|FG001|Overall Study|Physician Decision|7|||
42176787|NCT03180736|75984021|FG000|Overall Study|randomized but not treated|2|||
42176788|NCT03180736|75984022|FG001|Overall Study|randomized but not treated|3|||
42176789|NCT03178942|75984035|FG000|Overall Study|Withdrawal by Subject|2|||
42176790|NCT03178942|75984036|FG001|Overall Study|Withdrawal by Subject|0|||
42176791|NCT03178942|75984035|FG000|Overall Study|Lost to Follow-up|1|||
42176792|NCT03178942|75984036|FG001|Overall Study|Lost to Follow-up|2|||
42176793|NCT03175198|75984042|FG000|Overall Study|Adverse Event|480|||
42176794|NCT03175198|75984042|FG000|Overall Study|No actual visit|120|||
42176795|NCT03175198|75984042|FG000|Overall Study|Registration rule not followed|4|||
42176796|NCT03175198|75984042|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
42176797|NCT03175198|75984042|FG000|Overall Study|Other personal reason|509|||
42176798|NCT03175198|75984042|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
42176799|NCT03175198|75984042|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
42176800|NCT03175198|75984042|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
42176801|NCT03175198|75984042|FG000|Overall Study|To conduct invasive treatment of operation|53|||
42176802|NCT03175198|75984042|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
42176803|NCT03175120|75984048|FG000|Overall Study|Adverse Event|2|||
42176804|NCT03175120|75984049|FG001|Overall Study|Adverse Event|2|||
42176805|NCT03175120|75984048|FG000|Overall Study|Protocol Violation|5|||
42176806|NCT03175120|75984049|FG001|Overall Study|Protocol Violation|2|||
42176807|NCT03175120|75984048|FG000|Overall Study|Lost to Follow-up|1|||
42176808|NCT03175120|75984049|FG001|Overall Study|Lost to Follow-up|0|||
42176809|NCT03175120|75984048|FG000|Overall Study|Withdrawal by Subject|2|||
42176810|NCT03175120|75984049|FG001|Overall Study|Withdrawal by Subject|5|||
42176811|NCT03175120|75984048|FG000|Overall Study|Other|2|||
42176812|NCT03175120|75984049|FG001|Overall Study|Other|3|||
42176813|NCT03172702|75984055|FG000|Overall Study|Adverse Event|9|||
42176814|NCT03172702|75984055|FG000|Overall Study|Death|2|||
42176815|NCT03172702|75984055|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
42176816|NCT03172702|75984055|FG000|Overall Study|Withdrawal by Subject|5|||
42176817|NCT03172702|75984055|FG000|Overall Study|Other|2|||
42176818|NCT02795182|75984064|FG000|Overall Study|Death|5|||
42176819|NCT02795182|75984065|FG001|Overall Study|Death|4|||
42176820|NCT02795182|75984066|FG002|Overall Study|Death|4|||
42176821|NCT02795182|75984067|FG003|Overall Study|Death|18|||
42176822|NCT02795182|75984064|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
42071069|NCT02393248|75881091|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071070|NCT02393248|75881092|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071071|NCT02393248|75881093|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
42071072|NCT02393248|75881094|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
42071073|NCT02393248|75881095|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
42071074|NCT02393248|75881096|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
42071075|NCT02393248|75881097|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071076|NCT02393248|75881098|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071077|NCT02393248|75881099|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071078|NCT02393248|75881100|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071079|NCT02393248|75881101|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071080|NCT02393248|75881102|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071081|NCT02393248|75881103|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071082|NCT02393248|75881104|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071083|NCT02393248|75881105|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071084|NCT02393248|75881106|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
42071085|NCT02393248|75881082|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071086|NCT02393248|75881083|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071087|NCT02393248|75881084|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071088|NCT02393248|75881085|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071089|NCT02393248|75881086|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071090|NCT02393248|75881087|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071091|NCT02393248|75881088|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071092|NCT02393248|75881089|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071093|NCT02393248|75881090|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071094|NCT02393248|75881091|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071095|NCT02393248|75881092|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
42071096|NCT02393248|75881093|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
42071097|NCT02393248|75881094|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071098|NCT02393248|75881095|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071099|NCT02393248|75881096|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071100|NCT02393248|75881097|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071101|NCT02393248|75881098|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071102|NCT02393248|75881099|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071103|NCT02393248|75881100|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071104|NCT02393248|75881101|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071105|NCT02393248|75881102|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071106|NCT02393248|75881103|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071107|NCT02393248|75881104|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071108|NCT02393248|75881105|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071109|NCT02393248|75881106|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
42071110|NCT02393248|75881082|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
42071111|NCT02393248|75881083|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
42071112|NCT02393248|75881084|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
42071113|NCT02393248|75881085|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
42071114|NCT02393248|75881086|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
42071115|NCT02393248|75881087|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
42071116|NCT02393248|75881088|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
42071117|NCT02393248|75881089|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
42071118|NCT02393248|75881090|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
42071119|NCT02393248|75881091|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
42071120|NCT02393248|75881092|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
42071121|NCT02393248|75881093|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
42071122|NCT02393248|75881094|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
42071123|NCT02393248|75881095|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
42071124|NCT02393248|75881096|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
42071125|NCT02393248|75881097|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
42071126|NCT02393248|75881098|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
42071127|NCT02393248|75881099|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
42071128|NCT02393248|75881100|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
42071129|NCT02393248|75881101|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
42357735|NCT01721954|76203244|FG001|Overall Study|Death|64|||
42071130|NCT02393248|75881102|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
42071131|NCT02393248|75881103|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
42357736|NCT01721954|76203243|FG000|Overall Study|Withdrawal by Subject|8|||
42357737|NCT01721954|76203244|FG001|Overall Study|Withdrawal by Subject|4|||
42071132|NCT02393248|75881104|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
42071133|NCT02393248|75881105|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
42071134|NCT02393248|75881106|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
42071135|NCT02393248|75881082|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071136|NCT02393248|75881083|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071137|NCT02393248|75881084|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071138|NCT02393248|75881085|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071139|NCT02393248|75881086|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071140|NCT02393248|75881087|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071141|NCT02393248|75881088|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42176823|NCT02795182|75984065|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
42176824|NCT02795182|75984066|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
42176825|NCT02795182|75984067|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
42176826|NCT02795182|75984064|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
42176827|NCT02795182|75984065|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
42176828|NCT02795182|75984066|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
42176829|NCT02795182|75984067|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
42176830|NCT02795182|75984064|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
42176831|NCT02795182|75984065|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
42176832|NCT02795182|75984066|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
42176833|NCT02795182|75984067|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
42176834|NCT02795182|75984064|FG000|Overall Study|Withdrawal by Subject|4|||
42176835|NCT02795182|75984065|FG001|Overall Study|Withdrawal by Subject|0|||
42176836|NCT02795182|75984066|FG002|Overall Study|Withdrawal by Subject|0|||
42176837|NCT02795182|75984067|FG003|Overall Study|Withdrawal by Subject|3|||
42176838|NCT02795182|75984064|FG000|Overall Study|Lost to Follow-up|0|||
42176839|NCT02795182|75984065|FG001|Overall Study|Lost to Follow-up|0|||
42176840|NCT02795182|75984066|FG002|Overall Study|Lost to Follow-up|1|||
42176841|NCT02795182|75984067|FG003|Overall Study|Lost to Follow-up|1|||
42176842|NCT02795182|75984064|FG000|Overall Study|Roll Over to Long Term Extension|3|||
42176843|NCT02795182|75984065|FG001|Overall Study|Roll Over to Long Term Extension|3|||
42176844|NCT02795182|75984066|FG002|Overall Study|Roll Over to Long Term Extension|2|||
42176845|NCT02795182|75984067|FG003|Overall Study|Roll Over to Long Term Extension|5|||
42176846|NCT02795182|75984064|FG000|Overall Study|Progressive Disease|0|||
42176847|NCT02795182|75984065|FG001|Overall Study|Progressive Disease|1|||
42176848|NCT02795182|75984066|FG002|Overall Study|Progressive Disease|0|||
42176849|NCT02795182|75984067|FG003|Overall Study|Progressive Disease|4|||
42176850|NCT02795182|75984064|FG000|Overall Study|Physician Decision|0|||
42176851|NCT02795182|75984065|FG001|Overall Study|Physician Decision|0|||
42176852|NCT02795182|75984066|FG002|Overall Study|Physician Decision|0|||
42176853|NCT02795182|75984067|FG003|Overall Study|Physician Decision|1|||
42176854|NCT03167242|75984096|FG000|Overall Study|Patient/Guardian Decision|0|||
42176855|NCT03167242|75984097|FG001|Overall Study|Patient/Guardian Decision|1|||
42176856|NCT03167242|75984098|FG002|Overall Study|Patient/Guardian Decision|2|||
42176857|NCT03167242|75984099|FG003|Overall Study|Patient/Guardian Decision|1|||
42176858|NCT03167242|75984100|FG004|Overall Study|Patient/Guardian Decision|1|||
42176859|NCT03167242|75984101|FG005|Overall Study|Patient/Guardian Decision|1|||
42176860|NCT03167242|75984102|FG006|Overall Study|Patient/Guardian Decision|0|||
42176861|NCT03167242|75984103|FG007|Overall Study|Patient/Guardian Decision|0|||
42176862|NCT03167242|75984104|FG008|Overall Study|Patient/Guardian Decision|0|||
42176863|NCT03167242|75984105|FG009|Overall Study|Patient/Guardian Decision|0|||
42176864|NCT03167242|75984106|FG010|Overall Study|Patient/Guardian Decision|1|||
42176865|NCT03167242|75984107|FG011|Overall Study|Patient/Guardian Decision|0|||
42176866|NCT03167242|75984096|FG000|Overall Study|Lost to Follow-up|0|||
42176867|NCT03167242|75984097|FG001|Overall Study|Lost to Follow-up|0|||
42176868|NCT03167242|75984098|FG002|Overall Study|Lost to Follow-up|1|||
42176869|NCT03167242|75984099|FG003|Overall Study|Lost to Follow-up|0|||
42176870|NCT03167242|75984100|FG004|Overall Study|Lost to Follow-up|0|||
42357738|NCT01721954|76203243|FG000|Overall Study|Adverse Event|2|||
42017354|NCT01214850|75824953|FG001|Overall Study|Adverse event or death|8|||
42017355|NCT01214850|75824954|FG002|Overall Study|Adverse event or death|3|||
42017356|NCT01214850|75824952|FG000|Overall Study|Inappropriate enrollment|2|||
42017357|NCT01214850|75824953|FG001|Overall Study|Inappropriate enrollment|1|||
42017358|NCT01214850|75824954|FG002|Overall Study|Inappropriate enrollment|0|||
42017359|NCT01214850|75824952|FG000|Overall Study|Administrative reason|1|||
42017360|NCT01214850|75824953|FG001|Overall Study|Administrative reason|0|||
42017361|NCT01214850|75824954|FG002|Overall Study|Administrative reason|0|||
42017362|NCT01214850|75824952|FG000|Overall Study|Unable to classify|2|||
42017363|NCT01214850|75824953|FG001|Overall Study|Unable to classify|1|||
42017364|NCT01214850|75824954|FG002|Overall Study|Unable to classify|1|||
42017365|NCT01128153|75824967|FG000|Overall Study|Adverse Event|1|||
42017366|NCT01128153|75824968|FG001|Overall Study|Adverse Event|3|||
42017367|NCT01128153|75824967|FG000|Overall Study|Condition under investigation worsened|8|||
42176871|NCT03167242|75984101|FG005|Overall Study|Lost to Follow-up|1|||
42176872|NCT03167242|75984102|FG006|Overall Study|Lost to Follow-up|2|||
42176873|NCT03167242|75984103|FG007|Overall Study|Lost to Follow-up|1|||
42176874|NCT03167242|75984104|FG008|Overall Study|Lost to Follow-up|0|||
42071142|NCT02393248|75881089|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071143|NCT02393248|75881090|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071144|NCT02393248|75881091|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071145|NCT02393248|75881092|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071146|NCT02393248|75881093|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
42071147|NCT02393248|75881094|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071148|NCT02393248|75881095|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
42071149|NCT02393248|75881096|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071150|NCT02393248|75881097|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071151|NCT02393248|75881098|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071152|NCT02393248|75881099|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071153|NCT02393248|75881100|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071154|NCT02393248|75881101|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42176875|NCT03167242|75984105|FG009|Overall Study|Lost to Follow-up|0|||
42176876|NCT03167242|75984106|FG010|Overall Study|Lost to Follow-up|1|||
42176877|NCT03167242|75984107|FG011|Overall Study|Lost to Follow-up|1|||
42176878|NCT03167242|75984096|FG000|Overall Study|Reason not provided|0|||
42176879|NCT03167242|75984097|FG001|Overall Study|Reason not provided|0|||
42176880|NCT03167242|75984098|FG002|Overall Study|Reason not provided|0|||
42176881|NCT03167242|75984099|FG003|Overall Study|Reason not provided|0|||
42176882|NCT03167242|75984100|FG004|Overall Study|Reason not provided|0|||
42176883|NCT03167242|75984101|FG005|Overall Study|Reason not provided|0|||
42176884|NCT03167242|75984102|FG006|Overall Study|Reason not provided|0|||
42176885|NCT03167242|75984103|FG007|Overall Study|Reason not provided|0|||
42176886|NCT03167242|75984104|FG008|Overall Study|Reason not provided|1|||
42176887|NCT03167242|75984105|FG009|Overall Study|Reason not provided|0|||
42176888|NCT03167242|75984106|FG010|Overall Study|Reason not provided|0|||
42071155|NCT02393248|75881102|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071156|NCT02393248|75881103|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071157|NCT02393248|75881104|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071158|NCT02393248|75881105|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071159|NCT02393248|75881106|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
42071160|NCT02393248|75881082|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42176889|NCT03167242|75984107|FG011|Overall Study|Reason not provided|0|||
42176890|NCT03286426|75984143|FG000|Overall Study|Physician Decision|3|||
42176891|NCT02882152|75984162|FG000|Overall Study|Lost to Follow-up|1|||
42176892|NCT02882152|75984163|FG001|Overall Study|Lost to Follow-up|0|||
42176893|NCT00286091|75984171|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
42176894|NCT00286091|75984172|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
42176895|NCT00286091|75984171|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
42176896|NCT00286091|75984172|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
42176897|NCT00286091|75984171|FG000|Double-blind Treatment Phase|Death|58|||
42176898|NCT00286091|75984172|FG001|Double-blind Treatment Phase|Death|65|||
42176899|NCT00286091|75984171|FG000|Double-blind Treatment Phase|Adverse Event|28|||
42071161|NCT02393248|75881083|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071162|NCT02393248|75881084|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071163|NCT02393248|75881085|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071164|NCT02393248|75881086|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071165|NCT02393248|75881087|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071166|NCT02393248|75881088|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071167|NCT02393248|75881089|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071168|NCT02393248|75881090|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071169|NCT02393248|75881091|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071170|NCT02393248|75881092|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071171|NCT02393248|75881093|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071172|NCT02393248|75881094|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071173|NCT02393248|75881095|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071174|NCT02393248|75881096|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071175|NCT02393248|75881097|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071176|NCT02393248|75881098|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42176900|NCT00286091|75984172|FG001|Double-blind Treatment Phase|Adverse Event|40|||
42176901|NCT00286091|75984171|FG000|Double-blind Treatment Phase|Disease Progression|22|||
42176902|NCT00286091|75984172|FG001|Double-blind Treatment Phase|Disease Progression|35|||
42176903|NCT00286091|75984171|FG000|Double-blind Treatment Phase|Other|25|||
42176904|NCT00286091|75984172|FG001|Double-blind Treatment Phase|Other|33|||
42176905|NCT00286091|75984171|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
42293343|NCT02532543|76127405|FG002|Overall Study|Lost to Follow-up|1|||
42071177|NCT02393248|75881099|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071178|NCT02393248|75881100|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
42071179|NCT02393248|75881101|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071180|NCT02393248|75881102|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
42071181|NCT02393248|75881103|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
42071182|NCT02393248|75881104|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071183|NCT02393248|75881105|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
42071184|NCT02393248|75881106|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
42071185|NCT02393248|75881082|FG000|Part 3: Combination Therapy|Death|0|||
42071186|NCT02393248|75881083|FG001|Part 3: Combination Therapy|Death|0|||
42071187|NCT02393248|75881084|FG002|Part 3: Combination Therapy|Death|0|||
42071188|NCT02393248|75881085|FG003|Part 3: Combination Therapy|Death|0|||
42071189|NCT02393248|75881086|FG004|Part 3: Combination Therapy|Death|0|||
42071190|NCT02393248|75881087|FG005|Part 3: Combination Therapy|Death|0|||
42071191|NCT02393248|75881088|FG006|Part 3: Combination Therapy|Death|0|||
42071192|NCT02393248|75881089|FG007|Part 3: Combination Therapy|Death|0|||
42071193|NCT02393248|75881090|FG008|Part 3: Combination Therapy|Death|0|||
42071194|NCT02393248|75881091|FG009|Part 3: Combination Therapy|Death|0|||
42071195|NCT02393248|75881092|FG010|Part 3: Combination Therapy|Death|0|||
42071196|NCT02393248|75881093|FG011|Part 3: Combination Therapy|Death|0|||
42071197|NCT02393248|75881094|FG012|Part 3: Combination Therapy|Death|0|||
42071198|NCT02393248|75881095|FG013|Part 3: Combination Therapy|Death|0|||
42071199|NCT02393248|75881096|FG014|Part 3: Combination Therapy|Death|0|||
42176906|NCT00286091|75984172|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
42176907|NCT00286091|75984171|FG000|Double-blind Treatment Phase|Noncompliance|8|||
42176908|NCT00286091|75984172|FG001|Double-blind Treatment Phase|Noncompliance|8|||
42176909|NCT00286091|75984171|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
42071200|NCT02393248|75881097|FG015|Part 3: Combination Therapy|Death|1|||
42071201|NCT02393248|75881098|FG016|Part 3: Combination Therapy|Death|7|||
42071202|NCT02393248|75881099|FG017|Part 3: Combination Therapy|Death|5|||
42071203|NCT02393248|75881100|FG018|Part 3: Combination Therapy|Death|5|||
42071204|NCT02393248|75881101|FG019|Part 3: Combination Therapy|Death|3|||
42071205|NCT02393248|75881102|FG020|Part 3: Combination Therapy|Death|7|||
42176910|NCT00286091|75984172|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
42176911|NCT00286091|75984171|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
42176912|NCT00286091|75984172|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
42176913|NCT00286091|75984171|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
42176914|NCT00286091|75984172|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
42176915|NCT00286091|75984171|FG000|Open-label Treatment Phase|Physician Decision|24|||
42357739|NCT01721954|76203244|FG001|Overall Study|Adverse Event|0|||
42071206|NCT02393248|75881103|FG021|Part 3: Combination Therapy|Death|5|||
42071207|NCT02393248|75881104|FG022|Part 3: Combination Therapy|Death|6|||
42071208|NCT02393248|75881105|FG023|Part 3: Combination Therapy|Death|3|||
42071209|NCT02393248|75881106|FG024|Part 3: Combination Therapy|Death|0|||
42071210|NCT02393248|75881082|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071211|NCT02393248|75881083|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071212|NCT02393248|75881084|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071213|NCT02393248|75881085|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071214|NCT02393248|75881086|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071215|NCT02393248|75881087|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071216|NCT02393248|75881088|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071217|NCT02393248|75881089|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071218|NCT02393248|75881090|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071219|NCT02393248|75881091|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071220|NCT02393248|75881092|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071221|NCT02393248|75881093|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071222|NCT02393248|75881094|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071223|NCT02393248|75881095|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071224|NCT02393248|75881096|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071225|NCT02393248|75881097|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071226|NCT02393248|75881098|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071227|NCT02393248|75881099|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
42071228|NCT02393248|75881100|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
42071229|NCT02393248|75881101|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
42071230|NCT02393248|75881102|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
42071231|NCT02393248|75881103|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
42071232|NCT02393248|75881104|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
42176916|NCT00286091|75984172|FG001|Open-label Treatment Phase|Physician Decision|21|||
42176917|NCT00286091|75984171|FG000|Open-label Treatment Phase|Adverse Event|5|||
42176918|NCT00286091|75984172|FG001|Open-label Treatment Phase|Adverse Event|16|||
42357740|NCT01721954|76203243|FG000|Overall Study|Lost to Follow-up|2|||
42071233|NCT02393248|75881105|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
42071234|NCT02393248|75881106|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
42357741|NCT01721954|76203244|FG001|Overall Study|Lost to Follow-up|1|||
42071235|NCT02393248|75881082|FG000|Part 3: Combination Therapy|Disease Progression|0|||
42071236|NCT02393248|75881083|FG001|Part 3: Combination Therapy|Disease Progression|0|||
42071237|NCT02393248|75881084|FG002|Part 3: Combination Therapy|Disease Progression|0|||
42071238|NCT02393248|75881085|FG003|Part 3: Combination Therapy|Disease Progression|0|||
42071239|NCT02393248|75881086|FG004|Part 3: Combination Therapy|Disease Progression|0|||
42071240|NCT02393248|75881087|FG005|Part 3: Combination Therapy|Disease Progression|0|||
42071241|NCT02393248|75881088|FG006|Part 3: Combination Therapy|Disease Progression|0|||
42071242|NCT02393248|75881089|FG007|Part 3: Combination Therapy|Disease Progression|0|||
42071243|NCT02393248|75881090|FG008|Part 3: Combination Therapy|Disease Progression|0|||
42071244|NCT02393248|75881091|FG009|Part 3: Combination Therapy|Disease Progression|0|||
42071245|NCT02393248|75881092|FG010|Part 3: Combination Therapy|Disease Progression|0|||
42071246|NCT02393248|75881093|FG011|Part 3: Combination Therapy|Disease Progression|0|||
42071247|NCT02393248|75881094|FG012|Part 3: Combination Therapy|Disease Progression|0|||
42071248|NCT02393248|75881095|FG013|Part 3: Combination Therapy|Disease Progression|0|||
42071249|NCT02393248|75881096|FG014|Part 3: Combination Therapy|Disease Progression|0|||
42071250|NCT02393248|75881097|FG015|Part 3: Combination Therapy|Disease Progression|0|||
42071251|NCT02393248|75881098|FG016|Part 3: Combination Therapy|Disease Progression|0|||
42071252|NCT02393248|75881099|FG017|Part 3: Combination Therapy|Disease Progression|0|||
42071253|NCT02393248|75881100|FG018|Part 3: Combination Therapy|Disease Progression|0|||
42071254|NCT02393248|75881101|FG019|Part 3: Combination Therapy|Disease Progression|0|||
42071255|NCT02393248|75881102|FG020|Part 3: Combination Therapy|Disease Progression|2|||
42071256|NCT02393248|75881103|FG021|Part 3: Combination Therapy|Disease Progression|1|||
42071257|NCT02393248|75881104|FG022|Part 3: Combination Therapy|Disease Progression|0|||
42071258|NCT02393248|75881105|FG023|Part 3: Combination Therapy|Disease Progression|0|||
42071259|NCT02393248|75881106|FG024|Part 3: Combination Therapy|Disease Progression|0|||
42071260|NCT02393248|75881082|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071261|NCT02393248|75881083|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071262|NCT02393248|75881084|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071263|NCT02393248|75881085|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071264|NCT02393248|75881086|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071265|NCT02393248|75881087|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071266|NCT02393248|75881088|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071267|NCT02393248|75881089|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071268|NCT02393248|75881090|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071269|NCT02393248|75881091|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071270|NCT02393248|75881092|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071271|NCT02393248|75881093|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071272|NCT02393248|75881094|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071273|NCT02393248|75881095|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071274|NCT02393248|75881096|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071275|NCT02393248|75881097|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071276|NCT02393248|75881098|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071277|NCT02393248|75881099|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071278|NCT02393248|75881100|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071279|NCT02393248|75881101|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071280|NCT02393248|75881102|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
42071281|NCT02393248|75881103|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
42071282|NCT02393248|75881104|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071283|NCT02393248|75881105|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071284|NCT02393248|75881106|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
42071285|NCT02393248|75881082|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071286|NCT02393248|75881083|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071287|NCT02393248|75881084|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071288|NCT02393248|75881085|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071289|NCT02393248|75881086|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42357742|NCT01776554|76203252|FG000|Overall Study|Adverse Event|1|||
42357743|NCT01776554|76203253|FG001|Overall Study|Adverse Event|0|||
42357744|NCT01776554|76203252|FG000|Overall Study|Withdrawal by Subject|3|||
42357745|NCT01776554|76203253|FG001|Overall Study|Withdrawal by Subject|8|||
42357746|NCT01776554|76203252|FG000|Overall Study|Lost to Follow-up|6|||
42071290|NCT02393248|75881087|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071291|NCT02393248|75881088|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071292|NCT02393248|75881089|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42357747|NCT01776554|76203253|FG001|Overall Study|Lost to Follow-up|9|||
42071293|NCT02393248|75881090|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071294|NCT02393248|75881091|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071295|NCT02393248|75881092|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071296|NCT02393248|75881093|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071297|NCT02393248|75881094|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071298|NCT02393248|75881095|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071299|NCT02393248|75881096|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071300|NCT02393248|75881097|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071301|NCT02393248|75881098|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071302|NCT02393248|75881099|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071303|NCT02393248|75881100|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071304|NCT02393248|75881101|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071305|NCT02393248|75881102|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
42071306|NCT02393248|75881103|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071307|NCT02393248|75881104|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071308|NCT02393248|75881105|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071309|NCT02393248|75881106|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
42071310|NCT02393248|75881082|FG000|Part 3: Combination Therapy|Adverse Event|0|||
42071311|NCT02393248|75881083|FG001|Part 3: Combination Therapy|Adverse Event|0|||
42071312|NCT02393248|75881084|FG002|Part 3: Combination Therapy|Adverse Event|0|||
42071313|NCT02393248|75881085|FG003|Part 3: Combination Therapy|Adverse Event|0|||
42071314|NCT02393248|75881086|FG004|Part 3: Combination Therapy|Adverse Event|0|||
42071315|NCT02393248|75881087|FG005|Part 3: Combination Therapy|Adverse Event|0|||
42071316|NCT02393248|75881088|FG006|Part 3: Combination Therapy|Adverse Event|0|||
42071317|NCT02393248|75881089|FG007|Part 3: Combination Therapy|Adverse Event|0|||
42071318|NCT02393248|75881090|FG008|Part 3: Combination Therapy|Adverse Event|0|||
42071319|NCT02393248|75881091|FG009|Part 3: Combination Therapy|Adverse Event|0|||
42071320|NCT02393248|75881092|FG010|Part 3: Combination Therapy|Adverse Event|0|||
42071321|NCT02393248|75881093|FG011|Part 3: Combination Therapy|Adverse Event|0|||
42071322|NCT02393248|75881094|FG012|Part 3: Combination Therapy|Adverse Event|0|||
42071323|NCT02393248|75881095|FG013|Part 3: Combination Therapy|Adverse Event|0|||
42071324|NCT02393248|75881096|FG014|Part 3: Combination Therapy|Adverse Event|0|||
42071325|NCT02393248|75881097|FG015|Part 3: Combination Therapy|Adverse Event|0|||
42071326|NCT02393248|75881098|FG016|Part 3: Combination Therapy|Adverse Event|0|||
42071327|NCT02393248|75881099|FG017|Part 3: Combination Therapy|Adverse Event|0|||
42071328|NCT02393248|75881100|FG018|Part 3: Combination Therapy|Adverse Event|0|||
42071329|NCT02393248|75881101|FG019|Part 3: Combination Therapy|Adverse Event|0|||
42071330|NCT02393248|75881102|FG020|Part 3: Combination Therapy|Adverse Event|0|||
42071331|NCT02393248|75881103|FG021|Part 3: Combination Therapy|Adverse Event|0|||
42071332|NCT02393248|75881104|FG022|Part 3: Combination Therapy|Adverse Event|0|||
42071333|NCT02393248|75881105|FG023|Part 3: Combination Therapy|Adverse Event|1|||
42176919|NCT00286091|75984171|FG000|Open-label Treatment Phase|Other|11|||
42176920|NCT00286091|75984172|FG001|Open-label Treatment Phase|Other|11|||
42176921|NCT00286091|75984171|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
42176922|NCT00286091|75984172|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
42176923|NCT00286091|75984171|FG000|Open-label Treatment Phase|Death|10|||
42176924|NCT00286091|75984172|FG001|Open-label Treatment Phase|Death|7|||
42176925|NCT00286091|75984171|FG000|Open-label Treatment Phase|Disease Progression|9|||
42176926|NCT00286091|75984172|FG001|Open-label Treatment Phase|Disease Progression|3|||
42176927|NCT00286091|75984171|FG000|Open-label Treatment Phase|Noncompliance|3|||
42176928|NCT00286091|75984172|FG001|Open-label Treatment Phase|Noncompliance|1|||
42176929|NCT00286091|75984171|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
42293344|NCT02532543|76127406|FG003|Overall Study|Lost to Follow-up|0|||
42071334|NCT02393248|75881106|FG024|Part 3: Combination Therapy|Adverse Event|0|||
42071335|NCT02393248|75881082|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071336|NCT02393248|75881083|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071337|NCT02393248|75881084|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42176930|NCT00286091|75984172|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
42293345|NCT02532465|76127418|FG000|Overall Study|Protocol Violation|1|||
42293346|NCT02532465|76127419|FG001|Overall Study|Protocol Violation|0|||
42293347|NCT02532465|76127418|FG000|Overall Study|Lack of Efficacy|0|||
42293348|NCT02532465|76127419|FG001|Overall Study|Lack of Efficacy|1|||
42293349|NCT02528331|76127425|FG000|Overall Study|Withdrawal by Subject|2|||
42293350|NCT02654977|76127429|FG000|Overall Study|Death|1|||
42293351|NCT02654977|76127429|FG000|Overall Study|Lost to Follow-up|1|||
42293352|NCT02654977|76127429|FG000|Overall Study|Adverse Event|1|||
42176931|NCT00286091|75984171|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
42176932|NCT00286091|75984172|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
42176933|NCT00286091|75984171|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
42176934|NCT00286091|75984172|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
42176935|NCT00285857|75984180|FG000|Overall Study|Withdrawal by Subject|2|||
42176936|NCT00285857|75984180|FG000|Overall Study|Inadequate initial breast cytology|1|||
42176937|NCT00285857|75984180|FG000|Overall Study|Adverse Event|1|||
42176938|NCT00284141|75984189|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
42176939|NCT00284141|75984189|FG000|Overall Study|Adverse Event|19|||
42176940|NCT00284141|75984189|FG000|Overall Study|Participant's request|9|||
42176941|NCT00284141|75984189|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
42176942|NCT00284141|75984189|FG000|Overall Study|Clinical deterioration / death|2|||
42176943|NCT00284141|75984189|FG000|Overall Study|General decline|1|||
42176944|NCT00284141|75984189|FG000|Overall Study|Pneumonia|1|||
42176945|NCT00284141|75984189|FG000|Overall Study|Did not take study medication|2|||
42176946|NCT00284141|75984189|FG000|Overall Study|Ongoing treatment|2|||
42176947|NCT00265343|75984197|FG000|Overall Study|Adverse Event|10|||
42176948|NCT00265343|75984198|FG001|Overall Study|Adverse Event|7|||
42176949|NCT00265343|75984197|FG000|Overall Study|Withdrawal by Subject|3|||
42176950|NCT00265343|75984198|FG001|Overall Study|Withdrawal by Subject|9|||
42176951|NCT00265343|75984197|FG000|Overall Study|Other|8|||
42176952|NCT00265343|75984198|FG001|Overall Study|Other|3|||
42176953|NCT00283595|75984206|FG000|Overall Study|Withdrawal by Subject|1|||
42176954|NCT00283595|75984207|FG001|Overall Study|Withdrawal by Subject|2|||
42176955|NCT00265109|75984213|FG000|Overall Study|Withdrawal by Subject|5|||
42176956|NCT00265109|75984213|FG000|Overall Study|Adverse Event|1|||
42176957|NCT03235024|75984220|FG000|Overall Study|Adverse Event|2|||
42176958|NCT03235024|75984221|FG001|Overall Study|Adverse Event|2|||
42176959|NCT03235024|75984220|FG000|Overall Study|Death|1|||
42176960|NCT03235024|75984221|FG001|Overall Study|Death|0|||
42176961|NCT03235024|75984220|FG000|Overall Study|Lost to Follow-up|2|||
42176962|NCT03235024|75984221|FG001|Overall Study|Lost to Follow-up|5|||
42176963|NCT03235024|75984220|FG000|Overall Study|Protocol Violation|1|||
42176964|NCT03235024|75984221|FG001|Overall Study|Protocol Violation|0|||
42176965|NCT03235024|75984220|FG000|Overall Study|Withdrawal by Subject|0|||
42176966|NCT03235024|75984221|FG001|Overall Study|Withdrawal by Subject|3|||
42176967|NCT03233308|75984227|FG000|Overall Study|Adverse Event|1|||
42176968|NCT03233308|75984227|FG000|Overall Study|Protocol Violation|1|||
42176969|NCT00283439|75984242|FG000|Overall Study|Adverse Event|0|||
42176970|NCT00283439|75984243|FG001|Overall Study|Adverse Event|0|||
42176971|NCT00283439|75984244|FG002|Overall Study|Adverse Event|0|||
42176972|NCT00283439|75984245|FG003|Overall Study|Adverse Event|1|||
42176973|NCT00283439|75984242|FG000|Overall Study|Death|0|||
42176974|NCT00283439|75984243|FG001|Overall Study|Death|0|||
42176975|NCT00283439|75984244|FG002|Overall Study|Death|1|||
42176976|NCT00283439|75984245|FG003|Overall Study|Death|0|||
42176977|NCT00283439|75984242|FG000|Overall Study|Disease progression|0|||
42176978|NCT00283439|75984243|FG001|Overall Study|Disease progression|1|||
42176979|NCT00283439|75984244|FG002|Overall Study|Disease progression|0|||
42176980|NCT00283439|75984245|FG003|Overall Study|Disease progression|0|||
42176981|NCT00283439|75984242|FG000|Overall Study|Requirement for alternative therapy|1|||
42176982|NCT00283439|75984243|FG001|Overall Study|Requirement for alternative therapy|2|||
42293353|NCT02654977|76127429|FG000|Overall Study|Withdrawal by Subject|1|||
42293354|NCT02654977|76127429|FG000|Overall Study|Lack of Efficacy|3|||
42293355|NCT01362517|76127433|FG000|Overall Study|Protocol Violation|1|||
42293356|NCT01362517|76127433|FG000|Overall Study|Lost to Follow-up|1|||
42293357|NCT01362439|76127440|FG000|Overall Study|Adverse Event|1|||
42293358|NCT01362439|76127440|FG000|Overall Study|Lack of Efficacy|3|||
42293359|NCT01362439|76127440|FG000|Overall Study|Lost to Follow-up|2|||
42176983|NCT00283439|75984244|FG002|Overall Study|Requirement for alternative therapy|5|||
42176984|NCT00283439|75984245|FG003|Overall Study|Requirement for alternative therapy|2|||
42293360|NCT01362439|76127440|FG000|Overall Study|Study medication non-compliant|1|||
42176985|NCT00283439|75984242|FG000|Overall Study|Stem cell transplant|6|||
42176986|NCT00283439|75984243|FG001|Overall Study|Stem cell transplant|6|||
42176987|NCT00283439|75984244|FG002|Overall Study|Stem cell transplant|4|||
42176988|NCT00283439|75984245|FG003|Overall Study|Stem cell transplant|3|||
42176989|NCT00283439|75984242|FG000|Overall Study|Treatment discontinued|0|||
42176990|NCT00283439|75984243|FG001|Overall Study|Treatment discontinued|2|||
42176991|NCT00283439|75984244|FG002|Overall Study|Treatment discontinued|1|||
42176992|NCT00283439|75984245|FG003|Overall Study|Treatment discontinued|3|||
42176993|NCT00283439|75984242|FG000|Overall Study|Other|1|||
42176994|NCT00283439|75984243|FG001|Overall Study|Other|0|||
42176995|NCT00283439|75984244|FG002|Overall Study|Other|0|||
42176996|NCT00283439|75984245|FG003|Overall Study|Other|0|||
42176997|NCT03233230|75984259|FG000|Overall Study|Adverse Event|6|||
42176998|NCT03233230|75984260|FG001|Overall Study|Adverse Event|3|||
42176999|NCT03233230|75984261|FG002|Overall Study|Adverse Event|6|||
42293361|NCT01362439|76127440|FG000|Overall Study|Participant who withdrew consent|8|||
42177000|NCT03233230|75984262|FG003|Overall Study|Adverse Event|3|||
42177001|NCT03233230|75984259|FG000|Overall Study|Protocol Violation|1|||
42177002|NCT03233230|75984260|FG001|Overall Study|Protocol Violation|2|||
42177003|NCT03233230|75984261|FG002|Overall Study|Protocol Violation|1|||
42177004|NCT03233230|75984262|FG003|Overall Study|Protocol Violation|1|||
42177005|NCT03233230|75984259|FG000|Overall Study|Lack of Efficacy|1|||
42177006|NCT03233230|75984260|FG001|Overall Study|Lack of Efficacy|0|||
42177007|NCT03233230|75984261|FG002|Overall Study|Lack of Efficacy|0|||
42177008|NCT03233230|75984262|FG003|Overall Study|Lack of Efficacy|0|||
42177009|NCT03233230|75984259|FG000|Overall Study|Other|5|||
42177010|NCT03233230|75984260|FG001|Overall Study|Other|5|||
42177011|NCT03233230|75984261|FG002|Overall Study|Other|5|||
42177012|NCT03233230|75984262|FG003|Overall Study|Other|3|||
42177013|NCT03233230|75984259|FG000|Overall Study|Withdrawal by Subject|2|||
42177014|NCT03233230|75984260|FG001|Overall Study|Withdrawal by Subject|2|||
42177015|NCT03233230|75984261|FG002|Overall Study|Withdrawal by Subject|0|||
42177016|NCT03233230|75984262|FG003|Overall Study|Withdrawal by Subject|1|||
42177017|NCT03233230|75984259|FG000|Overall Study|Lost to Follow-up|0|||
42293362|NCT02653495|76127447|FG000|Overall Study|Lost to Follow-up|2|||
42293363|NCT02653495|76127448|FG001|Overall Study|Lost to Follow-up|0|||
42293364|NCT02653495|76127447|FG000|Overall Study|Screening Failure|10|||
42293365|NCT02653495|76127448|FG001|Overall Study|Screening Failure|0|||
42293366|NCT01675141|76127454|FG000|Overall Study|Lenalidomide outside NIH|3|||
42293367|NCT01675141|76127454|FG000|Overall Study|Withdrawal by Subject|3|||
42071338|NCT02393248|75881085|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071339|NCT02393248|75881086|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071340|NCT02393248|75881087|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071341|NCT02393248|75881088|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071342|NCT02393248|75881089|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071343|NCT02393248|75881090|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071344|NCT02393248|75881091|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071345|NCT02393248|75881092|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071346|NCT02393248|75881093|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071347|NCT02393248|75881094|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071348|NCT02393248|75881095|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071349|NCT02393248|75881096|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071350|NCT02393248|75881097|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071351|NCT02393248|75881098|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071352|NCT02393248|75881099|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071353|NCT02393248|75881100|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071354|NCT02393248|75881101|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071355|NCT02393248|75881102|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071356|NCT02393248|75881103|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071357|NCT02393248|75881104|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071358|NCT02393248|75881105|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
42071359|NCT02393248|75881106|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
42071360|NCT00601484|75881169|FG000|Overall Study|Adverse Event|0|||
42071361|NCT00601484|75881170|FG001|Overall Study|Adverse Event|1|||
42071362|NCT00601484|75881169|FG000|Overall Study|Lost to Follow-up|4|||
42071363|NCT00601484|75881170|FG001|Overall Study|Lost to Follow-up|3|||
42071364|NCT00601484|75881169|FG000|Overall Study|Lack of Efficacy|0|||
42071365|NCT00601484|75881170|FG001|Overall Study|Lack of Efficacy|2|||
42071366|NCT00601484|75881169|FG000|Overall Study|Withdrawal by Subject|1|||
42071367|NCT00601484|75881170|FG001|Overall Study|Withdrawal by Subject|1|||
42071368|NCT00601484|75881169|FG000|Overall Study|Randomized, but not treated|0|||
42071369|NCT00601484|75881170|FG001|Overall Study|Randomized, but not treated|1|||
42293368|NCT01675141|76127454|FG000|Overall Study|Physician Decision|4|||
42293369|NCT01675141|76127454|FG000|Overall Study|No treatment, per protocol|1|||
42071370|NCT00883896|75881180|FG000|Overall Study|Lost to Follow-up|0|||
42071371|NCT00883896|75881181|FG001|Overall Study|Lost to Follow-up|0|||
42071372|NCT00883896|75881182|FG002|Overall Study|Lost to Follow-up|0|||
42071373|NCT00883896|75881183|FG003|Overall Study|Lost to Follow-up|2|||
42071374|NCT00883896|75881180|FG000|Overall Study|Withdrawal by Subject|5|||
42071375|NCT00883896|75881181|FG001|Overall Study|Withdrawal by Subject|0|||
42071376|NCT00883896|75881182|FG002|Overall Study|Withdrawal by Subject|1|||
42071377|NCT00883896|75881183|FG003|Overall Study|Withdrawal by Subject|3|||
42071378|NCT00883896|75881180|FG000|Overall Study|Lack of Efficacy|0|||
42071379|NCT00883896|75881181|FG001|Overall Study|Lack of Efficacy|0|||
42071380|NCT00883896|75881182|FG002|Overall Study|Lack of Efficacy|0|||
42071381|NCT00883896|75881183|FG003|Overall Study|Lack of Efficacy|2|||
42071382|NCT00883896|75881180|FG000|Overall Study|Other|1|||
42293370|NCT03367819|76127489|FG000|Overall Study|Adverse Event|4|||
42177018|NCT03233230|75984260|FG001|Overall Study|Lost to Follow-up|3|||
42177019|NCT03233230|75984261|FG002|Overall Study|Lost to Follow-up|0|||
42177020|NCT03233230|75984262|FG003|Overall Study|Lost to Follow-up|0|||
42177021|NCT00283049|75984275|FG000|Overall Study|Adverse Event|6|||
42177022|NCT00283049|75984276|FG001|Overall Study|Adverse Event|1|||
42177023|NCT00283049|75984277|FG002|Overall Study|Adverse Event|4|||
42177024|NCT00283049|75984275|FG000|Overall Study|Protocol Violation|3|||
42177025|NCT00283049|75984276|FG001|Overall Study|Protocol Violation|0|||
42177026|NCT00283049|75984277|FG002|Overall Study|Protocol Violation|3|||
42177027|NCT00283049|75984275|FG000|Overall Study|Death|1|||
42177028|NCT00283049|75984276|FG001|Overall Study|Death|1|||
42177029|NCT00283049|75984277|FG002|Overall Study|Death|1|||
42177030|NCT00283049|75984275|FG000|Overall Study|Lack of Efficacy|0|||
42177031|NCT00283049|75984276|FG001|Overall Study|Lack of Efficacy|1|||
42177032|NCT00283049|75984277|FG002|Overall Study|Lack of Efficacy|1|||
42177033|NCT00283049|75984275|FG000|Overall Study|Lost to Follow-up|4|||
42177034|NCT00283049|75984276|FG001|Overall Study|Lost to Follow-up|2|||
42177035|NCT00283049|75984277|FG002|Overall Study|Lost to Follow-up|5|||
42177036|NCT00283049|75984275|FG000|Overall Study|Withdrawal by Subject|26|||
42177037|NCT00283049|75984276|FG001|Overall Study|Withdrawal by Subject|24|||
42177038|NCT00283049|75984277|FG002|Overall Study|Withdrawal by Subject|19|||
42177039|NCT00283049|75984275|FG000|Overall Study|Discontinuation of Study|18|||
42177040|NCT00283049|75984276|FG001|Overall Study|Discontinuation of Study|16|||
42177041|NCT00283049|75984277|FG002|Overall Study|Discontinuation of Study|20|||
42177042|NCT00283049|75984275|FG000|Overall Study|No longer requires study treatment|0|||
42177043|NCT00283049|75984276|FG001|Overall Study|No longer requires study treatment|0|||
42177044|NCT00283049|75984277|FG002|Overall Study|No longer requires study treatment|1|||
42177045|NCT00264875|75984285|FG000|Overall Study|Adverse Event|6|||
42177046|NCT00264875|75984285|FG000|Overall Study|Lost to Follow-up|6|||
42177047|NCT00264875|75984285|FG000|Overall Study|Protocol Violation|11|||
42177048|NCT00264875|75984285|FG000|Overall Study|Withdrawal by Subject|7|||
42177049|NCT03152110|75984289|FG000|Overall Study|Withdrawal by Subject|3|||
42177050|NCT03151408|75984296|FG000|Overall Study|Adverse Event|24|||
42177051|NCT03151408|75984297|FG001|Overall Study|Adverse Event|23|||
42177052|NCT03151408|75984296|FG000|Overall Study|Death|46|||
42071383|NCT00883896|75881181|FG001|Overall Study|Other|0|||
42071384|NCT00883896|75881182|FG002|Overall Study|Other|0|||
42071385|NCT00883896|75881183|FG003|Overall Study|Other|0|||
42071386|NCT00867009|75881193|FG000|Induction Period|Nonserious Adverse Event|5|||
42071387|NCT00867009|75881193|FG000|Induction Period|Serious Adverse Event|10|||
42071388|NCT00867009|75881193|FG000|Induction Period|Death due to serious adverse event|6|||
42071389|NCT00867009|75881193|FG000|Induction Period|Death due to Study Disease|4|||
42071390|NCT00867009|75881193|FG000|Induction Period|Protocol Violation|1|||
42071391|NCT00867009|75881193|FG000|Induction Period|Withdrawal by Subject|8|||
42071392|NCT00867009|75881193|FG000|Induction Period|Physician Decision|3|||
42071393|NCT00867009|75881193|FG000|Induction Period|Progressive Disease (PD)|25|||
42071394|NCT00867009|75881193|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
42071395|NCT00601250|75881199|FG000|Overall Study|Adverse Event|3|||
42071396|NCT00601250|75881200|FG001|Overall Study|Adverse Event|9|||
42071397|NCT00601250|75881199|FG000|Overall Study|Protocol Violation|3|||
42071398|NCT00601250|75881200|FG001|Overall Study|Protocol Violation|2|||
42071399|NCT00601250|75881199|FG000|Overall Study|Lost to Follow-up|2|||
42071400|NCT00601250|75881200|FG001|Overall Study|Lost to Follow-up|6|||
42071401|NCT00601250|75881199|FG000|Overall Study|Withdrawal by Subject|4|||
42071402|NCT00601250|75881200|FG001|Overall Study|Withdrawal by Subject|13|||
42071403|NCT00601250|75881199|FG000|Overall Study|Other incl. lack of efficacy|2|||
42071404|NCT00601250|75881200|FG001|Overall Study|Other incl. lack of efficacy|9|||
42293371|NCT03367819|76127490|FG001|Overall Study|Adverse Event|4|||
42293372|NCT03367819|76127489|FG000|Overall Study|Progressive Disease|15|||
42293373|NCT03367819|76127490|FG001|Overall Study|Progressive Disease|13|||
42293374|NCT03367819|76127489|FG000|Overall Study|Withdrawal by Subject|1|||
42293375|NCT03367819|76127490|FG001|Overall Study|Withdrawal by Subject|0|||
42293376|NCT03367819|76127489|FG000|Overall Study|Other|4|||
42071405|NCT00866775|75881208|FG000|Overall Study|Adverse Event|5|||
42071406|NCT00866775|75881209|FG001|Overall Study|Adverse Event|19|||
42177053|NCT03151408|75984297|FG001|Overall Study|Death|26|||
42177054|NCT03151408|75984296|FG000|Overall Study|Physician Decision|13|||
42177055|NCT03151408|75984297|FG001|Overall Study|Physician Decision|19|||
42177056|NCT03151408|75984296|FG000|Overall Study|Withdrawal by Subject|16|||
42177057|NCT03151408|75984297|FG001|Overall Study|Withdrawal by Subject|20|||
42177058|NCT03151408|75984296|FG000|Overall Study|Progressive disease|45|||
42177059|NCT03151408|75984297|FG001|Overall Study|Progressive disease|61|||
42293377|NCT03367819|76127490|FG001|Overall Study|Other|2|||
42071407|NCT00866775|75881208|FG000|Overall Study|Death|1|||
42071408|NCT00866775|75881209|FG001|Overall Study|Death|0|||
42071409|NCT00866775|75881208|FG000|Overall Study|Lost to Follow-up|0|||
42071410|NCT00866775|75881209|FG001|Overall Study|Lost to Follow-up|4|||
42071411|NCT00866775|75881208|FG000|Overall Study|Physician Decision|0|||
42071412|NCT00866775|75881209|FG001|Overall Study|Physician Decision|3|||
42071413|NCT00866775|75881208|FG000|Overall Study|Protocol Violation|3|||
42071414|NCT00866775|75881209|FG001|Overall Study|Protocol Violation|4|||
42071415|NCT00866775|75881208|FG000|Overall Study|Withdrawal by Subject|4|||
42071416|NCT00866775|75881209|FG001|Overall Study|Withdrawal by Subject|4|||
42071417|NCT00866775|75881208|FG000|Overall Study|met exit criteria|23|||
42071418|NCT00866775|75881209|FG001|Overall Study|met exit criteria|17|||
42071419|NCT00866775|75881208|FG000|Overall Study|discontinued due to communication error|0|||
42071420|NCT00866775|75881209|FG001|Overall Study|discontinued due to communication error|1|||
42071421|NCT03265210|75881219|FG000|Overall Study|Withdrawal by Subject|7|||
42071422|NCT03265210|75881220|FG001|Overall Study|Withdrawal by Subject|9|||
42071423|NCT03265210|75881219|FG000|Overall Study|Lost to Follow-up|2|||
42071424|NCT03265210|75881220|FG001|Overall Study|Lost to Follow-up|0|||
42071425|NCT03265210|75881219|FG000|Overall Study|Physician Decision|2|||
42071426|NCT03265210|75881220|FG001|Overall Study|Physician Decision|0|||
42071427|NCT03265210|75881219|FG000|Overall Study|Adverse Event|1|||
42071428|NCT03265210|75881220|FG001|Overall Study|Adverse Event|0|||
42071429|NCT00543985|75881226|FG000|Overall Study|Withdrawal by Subject|4|||
42071430|NCT00582556|75881241|FG000|Overall Study|Withdrawal by Subject|0|||
42071431|NCT00582556|75881242|FG001|Overall Study|Withdrawal by Subject|1|||
42071432|NCT00582556|75881243|FG002|Overall Study|Withdrawal by Subject|1|||
42071433|NCT00582556|75881241|FG000|Overall Study|Physician Decision|0|||
42071434|NCT00582556|75881242|FG001|Overall Study|Physician Decision|0|||
42071435|NCT00582556|75881243|FG002|Overall Study|Physician Decision|1|||
42071436|NCT00542269|75881255|FG000|Overall Study|Adverse Event|10|||
42071437|NCT00542269|75881256|FG001|Overall Study|Adverse Event|4|||
42071438|NCT00542269|75881257|FG002|Overall Study|Adverse Event|5|||
42071439|NCT00542269|75881255|FG000|Overall Study|Protocol Violation|1|||
42071440|NCT00542269|75881256|FG001|Overall Study|Protocol Violation|1|||
42071441|NCT00542269|75881257|FG002|Overall Study|Protocol Violation|0|||
42071442|NCT00542269|75881255|FG000|Overall Study|Withdrawal by Subject|1|||
42071443|NCT00542269|75881256|FG001|Overall Study|Withdrawal by Subject|0|||
42071444|NCT00542269|75881257|FG002|Overall Study|Withdrawal by Subject|0|||
42071445|NCT00542269|75881255|FG000|Overall Study|Administrative problems|1|||
42071446|NCT00542269|75881256|FG001|Overall Study|Administrative problems|1|||
42071447|NCT00542269|75881257|FG002|Overall Study|Administrative problems|1|||
42071448|NCT00866697|75881269|FG000|Overall Study|Study closed/terminated|156|||
42071449|NCT00866697|75881270|FG001|Overall Study|Study closed/terminated|138|||
42071450|NCT00866697|75881269|FG000|Overall Study|Lost to Follow-up|22|||
42071451|NCT00866697|75881270|FG001|Overall Study|Lost to Follow-up|28|||
42071452|NCT00866697|75881269|FG000|Overall Study|Physician Decision|3|||
42071453|NCT00866697|75881270|FG001|Overall Study|Physician Decision|5|||
42071454|NCT00866697|75881269|FG000|Overall Study|Withdrawal by Subject|33|||
42071455|NCT00866697|75881270|FG001|Overall Study|Withdrawal by Subject|57|||
42071456|NCT00542191|75881276|FG000|Overall Study|Death|3|||
42071457|NCT00600938|75881282|FG000|Core Study|Abnormal test procedure result(s)|3|||
42071458|NCT00600938|75881283|FG001|Core Study|Abnormal test procedure result(s)|2|||
42071459|NCT00600938|75881284|FG002|Core Study|Abnormal test procedure result(s)|0|||
42071460|NCT00600938|75881285|FG003|Core Study|Abnormal test procedure result(s)|0|||
42071461|NCT00600938|75881282|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
42071462|NCT00600938|75881283|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
42071463|NCT00600938|75881284|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
42071464|NCT00600938|75881285|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
42071465|NCT00600938|75881282|FG000|Core Study|Patient withdrew consent|7|||
42071466|NCT00600938|75881283|FG001|Core Study|Patient withdrew consent|12|||
42071467|NCT00600938|75881284|FG002|Core Study|Patient withdrew consent|0|||
42071468|NCT00600938|75881285|FG003|Core Study|Patient withdrew consent|0|||
42071469|NCT00600938|75881282|FG000|Core Study|Lost to Follow-up|3|||
42071470|NCT00600938|75881283|FG001|Core Study|Lost to Follow-up|2|||
42071471|NCT00600938|75881284|FG002|Core Study|Lost to Follow-up|0|||
42071472|NCT00600938|75881285|FG003|Core Study|Lost to Follow-up|0|||
42357748|NCT01776554|76203252|FG000|Overall Study|Administrative Reason|2|||
42357749|NCT01776554|76203253|FG001|Overall Study|Administrative Reason|5|||
42357750|NCT01776554|76203252|FG000|Overall Study|Protocol Violation|1|||
42357751|NCT01776554|76203253|FG001|Overall Study|Protocol Violation|0|||
42071473|NCT00600938|75881282|FG000|Core Study|Death|1|||
42071474|NCT00600938|75881283|FG001|Core Study|Death|1|||
42071475|NCT00600938|75881284|FG002|Core Study|Death|0|||
42071476|NCT00600938|75881285|FG003|Core Study|Death|0|||
42071477|NCT00600938|75881282|FG000|Core Study|Protocol Violation|1|||
42071478|NCT00600938|75881283|FG001|Core Study|Protocol Violation|2|||
42071479|NCT00600938|75881284|FG002|Core Study|Protocol Violation|0|||
42071480|NCT00600938|75881285|FG003|Core Study|Protocol Violation|0|||
42071481|NCT00600938|75881282|FG000|Extension Study|Adverse Event|1|||
42071482|NCT00600938|75881283|FG001|Extension Study|Adverse Event|0|||
42071483|NCT00600938|75881284|FG002|Extension Study|Adverse Event|2|||
42071484|NCT00600938|75881285|FG003|Extension Study|Adverse Event|0|||
42071485|NCT00600938|75881282|FG000|Extension Study|Abnormal test procedure results|0|||
42071486|NCT00600938|75881283|FG001|Extension Study|Abnormal test procedure results|1|||
42071487|NCT00600938|75881284|FG002|Extension Study|Abnormal test procedure results|1|||
42071488|NCT00600938|75881285|FG003|Extension Study|Abnormal test procedure results|1|||
42071489|NCT00600938|75881282|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
42177060|NCT03151408|75984296|FG000|Overall Study|non-compliance by patient|1|||
42177061|NCT03151408|75984297|FG001|Overall Study|non-compliance by patient|0|||
42177062|NCT03151408|75984296|FG000|Overall Study|other reasons|56|||
42177063|NCT03151408|75984297|FG001|Overall Study|other reasons|52|||
42177064|NCT03151408|75984296|FG000|Overall Study|randomized and not treated|2|||
42177065|NCT03151408|75984297|FG001|Overall Study|randomized and not treated|2|||
42071490|NCT00600938|75881283|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
42071491|NCT00600938|75881284|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
42071492|NCT00600938|75881285|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
42071493|NCT00600938|75881282|FG000|Extension Study|Withdrawal by Subject|2|||
42071494|NCT00600938|75881283|FG001|Extension Study|Withdrawal by Subject|2|||
42071495|NCT00600938|75881284|FG002|Extension Study|Withdrawal by Subject|3|||
42071496|NCT00600938|75881285|FG003|Extension Study|Withdrawal by Subject|0|||
42071497|NCT00600938|75881282|FG000|Extension Study|Lost to Follow-up|1|||
42071498|NCT00600938|75881283|FG001|Extension Study|Lost to Follow-up|1|||
42071499|NCT00600938|75881284|FG002|Extension Study|Lost to Follow-up|2|||
42071500|NCT00600938|75881285|FG003|Extension Study|Lost to Follow-up|0|||
42071501|NCT00600938|75881282|FG000|Extension Study|Death|1|||
42177066|NCT00546754|75984305|FG000|Overall Study|Serious Adverse Event|1|||
42177067|NCT00546754|75984306|FG001|Overall Study|Serious Adverse Event|1|||
42177068|NCT00546754|75984305|FG000|Overall Study|Adverse Event|11|||
42177069|NCT00546754|75984306|FG001|Overall Study|Adverse Event|16|||
42177070|NCT00546754|75984305|FG000|Overall Study|Lack of Efficacy|1|||
42177071|NCT00546754|75984306|FG001|Overall Study|Lack of Efficacy|1|||
42071502|NCT00600938|75881283|FG001|Extension Study|Death|0|||
42071503|NCT00600938|75881284|FG002|Extension Study|Death|0|||
42071504|NCT00600938|75881285|FG003|Extension Study|Death|0|||
42071505|NCT00543439|75881326|FG000|Period 1|Adverse Event|0|||
42071506|NCT00543439|75881327|FG001|Period 1|Adverse Event|2|||
42071507|NCT00543439|75881328|FG002|Period 1|Adverse Event|1|||
42071508|NCT00543439|75881326|FG000|Period 1|Withdrawal by Subject|1|||
42071509|NCT00543439|75881327|FG001|Period 1|Withdrawal by Subject|1|||
42071510|NCT00543439|75881328|FG002|Period 1|Withdrawal by Subject|0|||
42071511|NCT00543439|75881326|FG000|Period 1|Physician Decision|0|||
42071512|NCT00543439|75881327|FG001|Period 1|Physician Decision|0|||
42071513|NCT00543439|75881328|FG002|Period 1|Physician Decision|1|||
42071514|NCT00543439|75881326|FG000|Period 2|Protocol Violation|1|||
42071515|NCT00543439|75881327|FG001|Period 2|Protocol Violation|0|||
42071516|NCT00543439|75881328|FG002|Period 2|Protocol Violation|1|||
42071517|NCT00543439|75881326|FG000|Period 2|Adverse Event|0|||
42071518|NCT00543439|75881327|FG001|Period 2|Adverse Event|1|||
42071519|NCT00543439|75881328|FG002|Period 2|Adverse Event|1|||
42071520|NCT00582166|75881345|FG000|Overall Study|Death|1|||
42071521|NCT00582166|75881345|FG000|Overall Study|Ineligible pathology|1|||
42071522|NCT00601172|75881351|FG000|Overall Study|Adverse Event|43|||
42071523|NCT00601172|75881352|FG001|Overall Study|Adverse Event|32|||
42071524|NCT00601172|75881351|FG000|Overall Study|Lack of Efficacy|11|||
42071525|NCT00601172|75881352|FG001|Overall Study|Lack of Efficacy|12|||
42071526|NCT00601172|75881351|FG000|Overall Study|Protocol Violation|2|||
42071527|NCT00601172|75881352|FG001|Overall Study|Protocol Violation|5|||
42071528|NCT00601172|75881351|FG000|Overall Study|Lost to Follow-up|4|||
42071529|NCT00601172|75881352|FG001|Overall Study|Lost to Follow-up|3|||
42071530|NCT00601172|75881351|FG000|Overall Study|Physician Decision|27|||
42071531|NCT00601172|75881352|FG001|Overall Study|Physician Decision|28|||
42071532|NCT00601172|75881351|FG000|Overall Study|Withdrawal by Subject|35|||
42071533|NCT00601172|75881352|FG001|Overall Study|Withdrawal by Subject|27|||
42071534|NCT00601172|75881351|FG000|Overall Study|Did not meet continuation criteria|19|||
42177072|NCT00546754|75984305|FG000|Overall Study|Lost to Follow-up|9|||
42177073|NCT00546754|75984306|FG001|Overall Study|Lost to Follow-up|15|||
42177074|NCT00546754|75984305|FG000|Overall Study|Protocol Violation|3|||
42293378|NCT01597193|76127533|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
42293379|NCT01597193|76127534|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
42071535|NCT00601172|75881352|FG001|Overall Study|Did not meet continuation criteria|20|||
42071536|NCT00582010|75881361|FG000|Overall Study|Death|0|||
42177075|NCT00546754|75984306|FG001|Overall Study|Protocol Violation|0|||
42293380|NCT01597193|76127535|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
42071537|NCT00582010|75881362|FG001|Overall Study|Death|1|||
42071538|NCT00580840|75881372|FG000|Run-in|Adverse Event|17|||
42071539|NCT00580840|75881373|FG001|Run-in|Adverse Event|0|||
42177076|NCT00546754|75984305|FG000|Overall Study|Withdrawal by Subject|6|||
42177077|NCT00546754|75984306|FG001|Overall Study|Withdrawal by Subject|7|||
42177078|NCT00546754|75984305|FG000|Overall Study|Dyspnea|1|||
42177079|NCT00546754|75984306|FG001|Overall Study|Dyspnea|0|||
42071540|NCT00580840|75881374|FG002|Run-in|Adverse Event|0|||
42071541|NCT00580840|75881375|FG003|Run-in|Adverse Event|0|||
42071542|NCT00580840|75881372|FG000|Run-in|Lack of Efficacy|93|||
42071543|NCT00580840|75881373|FG001|Run-in|Lack of Efficacy|0|||
42071544|NCT00580840|75881374|FG002|Run-in|Lack of Efficacy|0|||
42071545|NCT00580840|75881375|FG003|Run-in|Lack of Efficacy|0|||
42071546|NCT00580840|75881372|FG000|Run-in|Loss of Efficacy|1|||
42071547|NCT00580840|75881373|FG001|Run-in|Loss of Efficacy|0|||
42071548|NCT00580840|75881374|FG002|Run-in|Loss of Efficacy|0|||
42071549|NCT00580840|75881375|FG003|Run-in|Loss of Efficacy|0|||
42071550|NCT00580840|75881372|FG000|Run-in|Lost to Follow-up|4|||
42071551|NCT00580840|75881373|FG001|Run-in|Lost to Follow-up|0|||
42071552|NCT00580840|75881374|FG002|Run-in|Lost to Follow-up|0|||
42071553|NCT00580840|75881375|FG003|Run-in|Lost to Follow-up|0|||
42071554|NCT00580840|75881372|FG000|Run-in|Withdrawal by Subject|5|||
42071555|NCT00580840|75881373|FG001|Run-in|Withdrawal by Subject|0|||
42071556|NCT00580840|75881374|FG002|Run-in|Withdrawal by Subject|0|||
42071557|NCT00580840|75881375|FG003|Run-in|Withdrawal by Subject|0|||
42071558|NCT00580840|75881372|FG000|Run-in|Other: Per Sponsor Request|2|||
42071559|NCT00580840|75881373|FG001|Run-in|Other: Per Sponsor Request|0|||
42071560|NCT00580840|75881374|FG002|Run-in|Other: Per Sponsor Request|0|||
42071561|NCT00580840|75881375|FG003|Run-in|Other: Per Sponsor Request|0|||
42071562|NCT00580840|75881372|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
42071563|NCT00580840|75881373|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
42177080|NCT00546754|75984305|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
42177081|NCT00546754|75984306|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
42177082|NCT00546754|75984305|FG000|Overall Study|Hip Replacement|1|||
42177083|NCT00546754|75984306|FG001|Overall Study|Hip Replacement|0|||
42177084|NCT00546754|75984305|FG000|Overall Study|Suicide|1|||
42177085|NCT00546754|75984306|FG001|Overall Study|Suicide|0|||
42177086|NCT00546754|75984305|FG000|Overall Study|Missing Cooperation|1|||
42177087|NCT00546754|75984306|FG001|Overall Study|Missing Cooperation|0|||
42177088|NCT00546754|75984305|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
42177089|NCT00546754|75984306|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
42177090|NCT00546754|75984305|FG000|Overall Study|Patient's Decision|0|||
42177091|NCT00546754|75984306|FG001|Overall Study|Patient's Decision|1|||
42177092|NCT00546754|75984305|FG000|Overall Study|Missing|14|||
42177093|NCT00546754|75984306|FG001|Overall Study|Missing|7|||
42177094|NCT00282347|75984314|FG000|Treatment Period|Death|2|||
42177095|NCT00282347|75984315|FG001|Treatment Period|Death|0|||
42177096|NCT00282347|75984314|FG000|Treatment Period|Lost to Follow-up|2|||
42177097|NCT00282347|75984315|FG001|Treatment Period|Lost to Follow-up|5|||
42177098|NCT00282347|75984314|FG000|Treatment Period|Withdrawal by Subject|1|||
42177099|NCT00282347|75984315|FG001|Treatment Period|Withdrawal by Subject|3|||
42177100|NCT00282347|75984314|FG000|Treatment Period|Physician Decision|0|||
42177101|NCT00282347|75984315|FG001|Treatment Period|Physician Decision|1|||
42177102|NCT00282347|75984314|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
42177103|NCT00282347|75984315|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
42177104|NCT00282347|75984314|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
42177105|NCT00282347|75984315|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
42177106|NCT00282347|75984314|FG000|Safety Follow-up Period|Physician Decision|1|||
42177107|NCT00282347|75984315|FG001|Safety Follow-up Period|Physician Decision|1|||
42177108|NCT00282347|75984314|FG000|Safety Follow-up Period|Protocol Deviation|0|||
42177109|NCT00282347|75984315|FG001|Safety Follow-up Period|Protocol Deviation|2|||
42177110|NCT00282347|75984314|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
42177111|NCT00282347|75984315|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
42177112|NCT00282347|75984314|FG000|B Cell Follow-up Period|Physician Decision|1|||
42177113|NCT00282347|75984315|FG001|B Cell Follow-up Period|Physician Decision|0|||
42177114|NCT00282347|75984314|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
42177115|NCT00282347|75984315|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
42177116|NCT00405964|75984325|FG000|Overall Study|Treatment Failure|17|||
42177117|NCT00405964|75984326|FG001|Overall Study|Treatment Failure|45|||
42177118|NCT00405964|75984325|FG000|Overall Study|Adverse Event|7|||
42177119|NCT00405964|75984326|FG001|Overall Study|Adverse Event|16|||
42177120|NCT00405964|75984325|FG000|Overall Study|Lost to Follow-up|5|||
42177121|NCT00405964|75984326|FG001|Overall Study|Lost to Follow-up|5|||
42177122|NCT00405964|75984325|FG000|Overall Study|Withdrawal by Subject|19|||
42177123|NCT00405964|75984326|FG001|Overall Study|Withdrawal by Subject|23|||
42177124|NCT00405964|75984325|FG000|Overall Study|Protocol Violation|11|||
42177125|NCT00405964|75984326|FG001|Overall Study|Protocol Violation|6|||
42071564|NCT00580840|75881374|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
42177126|NCT00264797|75984334|FG000|Overall Study|Withdrawal by Subject|11|||
42177127|NCT00264797|75984335|FG001|Overall Study|Withdrawal by Subject|11|||
42177128|NCT00264797|75984334|FG000|Overall Study|Lost to Follow-up|9|||
42177129|NCT00264797|75984335|FG001|Overall Study|Lost to Follow-up|17|||
42177130|NCT00264797|75984334|FG000|Overall Study|Moved from area|3|||
42177131|NCT00264797|75984335|FG001|Overall Study|Moved from area|1|||
42177132|NCT00264797|75984334|FG000|Overall Study|Practical Problems|2|||
42177133|NCT00264797|75984335|FG001|Overall Study|Practical Problems|3|||
42071565|NCT00580840|75881375|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
42071566|NCT00580840|75881372|FG000|Run-in|Other: Exclusionary Lab Value|1|||
42177134|NCT00264797|75984334|FG000|Overall Study|Incarceration|4|||
42177135|NCT00264797|75984335|FG001|Overall Study|Incarceration|5|||
42177136|NCT00264797|75984334|FG000|Overall Study|Pressure/advice from Outsiders|1|||
42177137|NCT00264797|75984335|FG001|Overall Study|Pressure/advice from Outsiders|1|||
42177138|NCT00264797|75984334|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
42177139|NCT00264797|75984335|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
42177140|NCT00264797|75984334|FG000|Overall Study|Other|3|||
42177141|NCT00264797|75984335|FG001|Overall Study|Other|4|||
42177142|NCT03148756|75984343|FG000|Overall Study|Study Terminated|0|||
42177143|NCT03148756|75984344|FG001|Overall Study|Study Terminated|1|||
42177144|NCT00282113|75984353|FG000|Overall Study|Removed at parents request|1|||
42177145|NCT00282113|75984354|FG001|Overall Study|Removed at parents request|0|||
42177146|NCT00282113|75984355|FG002|Overall Study|Removed at parents request|0|||
42177147|NCT00281957|75984365|FG000|Overall Study|Adverse Event|7|||
42177148|NCT00281957|75984366|FG001|Overall Study|Adverse Event|2|||
42177149|NCT00281957|75984365|FG000|Overall Study|Death|1|||
42177150|NCT00281957|75984366|FG001|Overall Study|Death|0|||
42177151|NCT00281957|75984365|FG000|Overall Study|Progression/relapse|47|||
42177152|NCT00281957|75984366|FG001|Overall Study|Progression/relapse|35|||
42177153|NCT00281957|75984365|FG000|Overall Study|Not protocol specified|8|||
42177154|NCT00281957|75984366|FG001|Overall Study|Not protocol specified|1|||
42071567|NCT00580840|75881373|FG001|Run-in|Other: Exclusionary Lab Value|0|||
42071568|NCT00580840|75881374|FG002|Run-in|Other: Exclusionary Lab Value|0|||
42071569|NCT00580840|75881375|FG003|Run-in|Other: Exclusionary Lab Value|0|||
42071570|NCT00580840|75881372|FG000|Double-Blind|Adverse Event|0|||
42071571|NCT00580840|75881373|FG001|Double-Blind|Adverse Event|3|||
42071572|NCT00580840|75881374|FG002|Double-Blind|Adverse Event|4|||
42071573|NCT00580840|75881375|FG003|Double-Blind|Adverse Event|1|||
42071574|NCT00580840|75881372|FG000|Double-Blind|Loss of Efficacy|0|||
42071575|NCT00580840|75881373|FG001|Double-Blind|Loss of Efficacy|1|||
42071576|NCT00580840|75881374|FG002|Double-Blind|Loss of Efficacy|2|||
42071577|NCT00580840|75881375|FG003|Double-Blind|Loss of Efficacy|10|||
42071578|NCT00580840|75881372|FG000|Double-Blind|Lost to Follow-up|0|||
42071579|NCT00580840|75881373|FG001|Double-Blind|Lost to Follow-up|1|||
42071580|NCT00580840|75881374|FG002|Double-Blind|Lost to Follow-up|0|||
42071581|NCT00580840|75881375|FG003|Double-Blind|Lost to Follow-up|2|||
42071582|NCT00580840|75881372|FG000|Double-Blind|Withdrawal by Subject|0|||
42071583|NCT00580840|75881373|FG001|Double-Blind|Withdrawal by Subject|1|||
42071584|NCT00580840|75881374|FG002|Double-Blind|Withdrawal by Subject|2|||
42071585|NCT00580840|75881375|FG003|Double-Blind|Withdrawal by Subject|2|||
42071586|NCT00580840|75881372|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
42071587|NCT00580840|75881373|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
42071588|NCT00580840|75881374|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
42071589|NCT00580840|75881375|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
42071590|NCT00580840|75881372|FG000|Double-Blind|Other: Forbidden Medication|0|||
42071591|NCT00580840|75881373|FG001|Double-Blind|Other: Forbidden Medication|0|||
42071592|NCT00580840|75881374|FG002|Double-Blind|Other: Forbidden Medication|1|||
42071593|NCT00580840|75881375|FG003|Double-Blind|Other: Forbidden Medication|0|||
42071594|NCT00879684|75881385|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
42071595|NCT00879684|75881386|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
42071596|NCT00879684|75881387|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
42071597|NCT00879684|75881388|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
42071598|NCT00879684|75881389|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
42071599|NCT00879684|75881390|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
42071600|NCT00879684|75881391|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
42071601|NCT00879684|75881385|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
42071602|NCT00879684|75881386|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
42071603|NCT00879684|75881387|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
42071604|NCT00879684|75881388|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
42071605|NCT00879684|75881389|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
42071606|NCT00879684|75881390|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
42071607|NCT00879684|75881391|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
42177155|NCT00281957|75984365|FG000|Overall Study|Not eligible|1|||
42177156|NCT00281957|75984366|FG001|Overall Study|Not eligible|2|||
42177157|NCT00281957|75984365|FG000|Overall Study|Did not start treatment|3|||
42177158|NCT00281957|75984366|FG001|Overall Study|Did not start treatment|1|||
42071608|NCT00879684|75881385|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
42177159|NCT00281957|75984365|FG000|Overall Study|Refusal unrelated to adverse events|0|||
42177160|NCT00281957|75984366|FG001|Overall Study|Refusal unrelated to adverse events|1|||
42177161|NCT00281099|75984376|FG000|Overall Study|Death|46|||
42177162|NCT00281099|75984377|FG001|Overall Study|Death|57|||
42177163|NCT00281099|75984376|FG000|Overall Study|Lost to Follow-up|10|||
42071609|NCT00879684|75881386|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
42071610|NCT00879684|75881387|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
42071611|NCT00879684|75881388|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
42071612|NCT00879684|75881389|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
42071613|NCT00879684|75881390|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
42071614|NCT00879684|75881391|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
42071615|NCT00879684|75881385|FG000|Stage 1: Dose Escalation|Death|0|||
42071616|NCT00879684|75881386|FG001|Stage 1: Dose Escalation|Death|0|||
42071617|NCT00879684|75881387|FG002|Stage 1: Dose Escalation|Death|1|||
42071618|NCT00879684|75881388|FG003|Stage 1: Dose Escalation|Death|0|||
42071619|NCT00879684|75881389|FG004|Stage 1: Dose Escalation|Death|0|||
42071620|NCT00879684|75881390|FG005|Stage 1: Dose Escalation|Death|0|||
42071621|NCT00879684|75881391|FG006|Stage 1: Dose Escalation|Death|0|||
42071622|NCT00879684|75881385|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
42071623|NCT00879684|75881386|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
42071624|NCT00879684|75881387|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
42071625|NCT00879684|75881388|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
42071626|NCT00879684|75881389|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
42071627|NCT00879684|75881390|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
42071628|NCT00879684|75881391|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
42177164|NCT00281099|75984377|FG001|Overall Study|Lost to Follow-up|19|||
42177165|NCT00281099|75984376|FG000|Overall Study|Withdrawal by Subject|65|||
42177166|NCT00281099|75984377|FG001|Overall Study|Withdrawal by Subject|70|||
42177167|NCT00281099|75984376|FG000|Overall Study|Physician Decision|79|||
42177168|NCT00281099|75984377|FG001|Overall Study|Physician Decision|72|||
42177169|NCT00281099|75984376|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
42177170|NCT00281099|75984377|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
42177171|NCT00262925|75984384|FG000|Overall Study|Lack of Efficacy|3|||
42177172|NCT00262925|75984384|FG000|Overall Study|Adverse Event|4|||
42177173|NCT00262925|75984384|FG000|Overall Study|Death|2|||
42177174|NCT00262925|75984384|FG000|Overall Study|alternative therapy|1|||
42177175|NCT00262925|75984384|FG000|Overall Study|Other|1|||
42177176|NCT03720470|75984394|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
42177177|NCT03720470|75984395|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
42177178|NCT03720470|75984396|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
42177179|NCT03720470|75984397|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
42177180|NCT03720470|75984398|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
42177181|NCT03720470|75984399|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
42177182|NCT03720470|75984394|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
42177183|NCT03720470|75984395|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
42177184|NCT03720470|75984396|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
42177185|NCT03720470|75984397|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
42177186|NCT03720470|75984398|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
42177187|NCT03720470|75984399|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
42177188|NCT03720470|75984394|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
42177189|NCT03720470|75984395|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
42177190|NCT03720470|75984396|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
42177191|NCT03720470|75984397|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
42177192|NCT03720470|75984398|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
42177193|NCT03720470|75984399|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
42071629|NCT00879684|75881385|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
42071630|NCT00879684|75881386|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
42071631|NCT00879684|75881387|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
42071632|NCT00879684|75881388|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
42071633|NCT00879684|75881389|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
42071634|NCT00879684|75881390|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
42071635|NCT00879684|75881391|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
42177194|NCT03720470|75984394|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
42177195|NCT03720470|75984395|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
42177196|NCT03720470|75984396|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
42177197|NCT03720470|75984397|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
42177198|NCT03720470|75984398|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
42177199|NCT03720470|75984399|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
42177200|NCT03720470|75984394|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
42177201|NCT03720470|75984395|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
42177202|NCT03720470|75984396|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
42177203|NCT03720470|75984397|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
42177204|NCT03720470|75984398|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
42177205|NCT03720470|75984399|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
42071636|NCT00879684|75881385|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
42177206|NCT03720470|75984394|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
42293381|NCT01597193|76127536|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
42293382|NCT01597193|76127537|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
42177207|NCT03720470|75984395|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
42177208|NCT03720470|75984396|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
42177209|NCT03720470|75984397|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
42177210|NCT03720470|75984398|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
42177211|NCT03720470|75984399|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
42177212|NCT03720470|75984394|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
42071637|NCT00879684|75881386|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
42071638|NCT00879684|75881387|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
42071639|NCT00879684|75881388|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
42071640|NCT00879684|75881389|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
42071641|NCT00879684|75881390|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
42071642|NCT00879684|75881391|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
42071643|NCT00581776|75881410|FG000|Overall Study|Disease progression or no response|3|||
42071644|NCT00883740|75881414|FG000|First Intervention|Lost to Follow-up|1|||
42071645|NCT00883740|75881415|FG001|First Intervention|Lost to Follow-up|0|||
42071646|NCT00883740|75881414|FG000|First Intervention|No longer willing to participate|2|||
42071647|NCT00883740|75881415|FG001|First Intervention|No longer willing to participate|0|||
42071648|NCT00883740|75881414|FG000|First Intervention|Protocol Violation|3|||
42071649|NCT00883740|75881415|FG001|First Intervention|Protocol Violation|6|||
42071650|NCT00883740|75881414|FG000|First Intervention|Adverse Event|1|||
42071651|NCT00883740|75881415|FG001|First Intervention|Adverse Event|2|||
42071652|NCT00883740|75881414|FG000|Second Intervention|Protocol Violation|1|||
42071653|NCT00883740|75881415|FG001|Second Intervention|Protocol Violation|0|||
42071654|NCT00883740|75881414|FG000|Second Intervention|No longer willing to participate|0|||
42071655|NCT00883740|75881415|FG001|Second Intervention|No longer willing to participate|1|||
42071656|NCT00597012|75881423|FG000|Overall Study|Death|1|||
42071657|NCT00597012|75881424|FG001|Overall Study|Death|1|||
42071658|NCT00597012|75881423|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
42071659|NCT00597012|75881424|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
42071660|NCT00597012|75881423|FG000|Overall Study|Withdrawal by Subject|7|||
42071661|NCT00597012|75881424|FG001|Overall Study|Withdrawal by Subject|4|||
42071662|NCT00597012|75881423|FG000|Overall Study|Ineligible|2|||
42071663|NCT00597012|75881424|FG001|Overall Study|Ineligible|0|||
42071664|NCT00597012|75881423|FG000|Overall Study|Lost to Follow-up|0|||
42071665|NCT00597012|75881424|FG001|Overall Study|Lost to Follow-up|2|||
42071666|NCT00542815|75881435|FG000|Overall Study|Adverse Event|19|||
42071667|NCT00542815|75881436|FG001|Overall Study|Adverse Event|6|||
42071668|NCT00542815|75881437|FG002|Overall Study|Adverse Event|9|||
42071669|NCT00542815|75881435|FG000|Overall Study|Death|10|||
42071670|NCT00542815|75881436|FG001|Overall Study|Death|7|||
42071671|NCT00542815|75881437|FG002|Overall Study|Death|3|||
42071672|NCT00542815|75881435|FG000|Overall Study|Lack of Efficacy|9|||
42071673|NCT00542815|75881436|FG001|Overall Study|Lack of Efficacy|2|||
42071674|NCT00542815|75881437|FG002|Overall Study|Lack of Efficacy|0|||
42071675|NCT00542815|75881435|FG000|Overall Study|Physician Decision|2|||
42071676|NCT00542815|75881436|FG001|Overall Study|Physician Decision|1|||
42071677|NCT00542815|75881437|FG002|Overall Study|Physician Decision|0|||
42071678|NCT00542815|75881435|FG000|Overall Study|Protocol Violation|1|||
42071679|NCT00542815|75881436|FG001|Overall Study|Protocol Violation|1|||
42071680|NCT00542815|75881437|FG002|Overall Study|Protocol Violation|2|||
42071681|NCT00542815|75881435|FG000|Overall Study|Withdrawal by Subject|41|||
42071682|NCT00542815|75881436|FG001|Overall Study|Withdrawal by Subject|5|||
42071683|NCT00542815|75881437|FG002|Overall Study|Withdrawal by Subject|8|||
42071684|NCT00542815|75881435|FG000|Overall Study|Other reasons|24|||
42071685|NCT00542815|75881436|FG001|Overall Study|Other reasons|10|||
42071686|NCT00542815|75881437|FG002|Overall Study|Other reasons|10|||
42071687|NCT00542425|75881450|FG000|Initial 24 Weeks|Administrative reasons|0|||
42071688|NCT00542425|75881451|FG001|Initial 24 Weeks|Administrative reasons|0|||
42071689|NCT00542425|75881452|FG002|Initial 24 Weeks|Administrative reasons|1|||
42071690|NCT00542425|75881453|FG003|Initial 24 Weeks|Administrative reasons|1|||
42071691|NCT00542425|75881454|FG004|Initial 24 Weeks|Administrative reasons|0|||
42071692|NCT00542425|75881450|FG000|Initial 24 Weeks|Adverse Event|0|||
42071693|NCT00542425|75881451|FG001|Initial 24 Weeks|Adverse Event|1|||
42071694|NCT00542425|75881452|FG002|Initial 24 Weeks|Adverse Event|1|||
42071695|NCT00542425|75881453|FG003|Initial 24 Weeks|Adverse Event|3|||
42071696|NCT00542425|75881454|FG004|Initial 24 Weeks|Adverse Event|2|||
42071697|NCT00542425|75881450|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
42071698|NCT00542425|75881451|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
42071699|NCT00542425|75881452|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
42071700|NCT00542425|75881453|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
42071701|NCT00542425|75881454|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
42071702|NCT00542425|75881450|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
42071703|NCT00542425|75881451|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
42293383|NCT01597193|76127538|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
42071704|NCT00542425|75881452|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
42071705|NCT00542425|75881453|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
42071706|NCT00542425|75881454|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
42071707|NCT00542425|75881450|FG000|Initial 24 Weeks|Non-compliance|0|||
42071708|NCT00542425|75881451|FG001|Initial 24 Weeks|Non-compliance|0|||
42071709|NCT00542425|75881452|FG002|Initial 24 Weeks|Non-compliance|0|||
42071710|NCT00542425|75881453|FG003|Initial 24 Weeks|Non-compliance|1|||
42071711|NCT00542425|75881454|FG004|Initial 24 Weeks|Non-compliance|1|||
42071712|NCT00542425|75881450|FG000|Initial 24 Weeks|Protocol Violation|0|||
42071713|NCT00542425|75881451|FG001|Initial 24 Weeks|Protocol Violation|0|||
42071714|NCT00542425|75881452|FG002|Initial 24 Weeks|Protocol Violation|0|||
42071715|NCT00542425|75881453|FG003|Initial 24 Weeks|Protocol Violation|1|||
42071716|NCT00542425|75881454|FG004|Initial 24 Weeks|Protocol Violation|0|||
42071717|NCT00542425|75881450|FG000|Initial 24 Weeks|Refusal of treatment|2|||
42071718|NCT00542425|75881451|FG001|Initial 24 Weeks|Refusal of treatment|2|||
42071719|NCT00542425|75881452|FG002|Initial 24 Weeks|Refusal of treatment|1|||
42071720|NCT00542425|75881453|FG003|Initial 24 Weeks|Refusal of treatment|4|||
42071721|NCT00542425|75881454|FG004|Initial 24 Weeks|Refusal of treatment|1|||
42071722|NCT00542425|75881450|FG000|Initial 24 Weeks|Other|0|||
42071723|NCT00542425|75881451|FG001|Initial 24 Weeks|Other|2|||
42071724|NCT00542425|75881452|FG002|Initial 24 Weeks|Other|1|||
42071725|NCT00542425|75881453|FG003|Initial 24 Weeks|Other|0|||
42071726|NCT00542425|75881454|FG004|Initial 24 Weeks|Other|0|||
42071727|NCT00542425|75881450|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
42071728|NCT00542425|75881451|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
42071729|NCT00542425|75881452|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
42071730|NCT00542425|75881453|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
42071731|NCT00542425|75881454|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
42071732|NCT00542425|75881450|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
42071733|NCT00542425|75881451|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
42071734|NCT00542425|75881452|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
42071735|NCT00542425|75881453|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
42071736|NCT00542425|75881454|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
42071737|NCT00542425|75881450|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
42071738|NCT00542425|75881451|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
42071739|NCT00542425|75881452|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
42071740|NCT00542425|75881453|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
42071741|NCT00542425|75881454|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
42071742|NCT00542425|75881450|FG000|Extended 24 Weeks of Treatment|Other|1|||
42071743|NCT00542425|75881451|FG001|Extended 24 Weeks of Treatment|Other|1|||
42071744|NCT00542425|75881452|FG002|Extended 24 Weeks of Treatment|Other|0|||
42071745|NCT00542425|75881453|FG003|Extended 24 Weeks of Treatment|Other|0|||
42071746|NCT00542425|75881454|FG004|Extended 24 Weeks of Treatment|Other|1|||
42071747|NCT00541099|75881466|FG000|Overall Study|Ineligible|3|||
42071748|NCT00580606|75881472|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
42071749|NCT00580606|75881473|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
42071750|NCT00580606|75881472|FG000|Open Label (OL)|Withdrawal by Subject|4|||
42071751|NCT00580606|75881473|FG001|Open Label (OL)|Withdrawal by Subject|6|||
42071752|NCT00580606|75881472|FG000|Open Label (OL)|Dosing Symptoms|0|||
42071753|NCT00580606|75881473|FG001|Open Label (OL)|Dosing Symptoms|1|||
42071754|NCT00580606|75881472|FG000|Open Label (OL)|Lost to Follow-up|0|||
42071755|NCT00580606|75881473|FG001|Open Label (OL)|Lost to Follow-up|1|||
42071756|NCT00580606|75881472|FG000|Open Label (OL)|Pregnancy|0|||
42071757|NCT00580606|75881473|FG001|Open Label (OL)|Pregnancy|1|||
42177213|NCT03720470|75984395|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
42177214|NCT03720470|75984396|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
42177215|NCT03720470|75984397|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
42357752|NCT01776554|76203252|FG000|Overall Study|Unclassified|4|||
42357753|NCT01776554|76203253|FG001|Overall Study|Unclassified|1|||
42357754|NCT01776008|76203260|FG000|Overall Study|ineligible|2|||
42357755|NCT01746368|76203266|FG000|Overall Study|Lost to Follow-up|2|||
42357756|NCT01746368|76203267|FG001|Overall Study|Lost to Follow-up|0|||
42357757|NCT01746368|76203266|FG000|Overall Study|Withdrawal by Subject|0|||
42357758|NCT01746368|76203267|FG001|Overall Study|Withdrawal by Subject|1|||
42357759|NCT01381575|76203276|FG000|Overall Study|Serious Adverse Event|1|||
42357760|NCT01381575|76203277|FG001|Overall Study|Serious Adverse Event|0|||
42071758|NCT00580606|75881472|FG000|Open Label (OL)|Non-compliance|2|||
42071759|NCT00580606|75881473|FG001|Open Label (OL)|Non-compliance|0|||
42071760|NCT00580606|75881472|FG000|Open Label (OL)|Physician Decision|1|||
42071761|NCT00580606|75881473|FG001|Open Label (OL)|Physician Decision|1|||
42071762|NCT00580606|75881472|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
42071763|NCT00580606|75881473|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
42071764|NCT00579982|75881487|FG000|Overall Study|Adverse Event|4|||
42071765|NCT00579982|75881487|FG000|Overall Study|Protocol Violation|4|||
42071766|NCT00596466|75881491|FG000|Overall Study|Lack of Efficacy|5|||
42357761|NCT01381575|76203278|FG002|Overall Study|Serious Adverse Event|0|||
42357762|NCT01381575|76203276|FG000|Overall Study|Non-Serious Adverse Event|0|||
42357763|NCT01381575|76203277|FG001|Overall Study|Non-Serious Adverse Event|0|||
42357764|NCT01381575|76203278|FG002|Overall Study|Non-Serious Adverse Event|1|||
42357765|NCT01381575|76203276|FG000|Overall Study|Protocol Violation|0|||
42357766|NCT01381575|76203277|FG001|Overall Study|Protocol Violation|1|||
42357767|NCT01381575|76203278|FG002|Overall Study|Protocol Violation|1|||
42357768|NCT01381575|76203276|FG000|Overall Study|Withdrawal by Subject|15|||
42357769|NCT01381575|76203277|FG001|Overall Study|Withdrawal by Subject|9|||
42071767|NCT00596466|75881491|FG000|Overall Study|Adverse Event|4|||
42071768|NCT00596466|75881491|FG000|Overall Study|Withdrawal by Subject|2|||
42071769|NCT00596466|75881491|FG000|Overall Study|Protocol Violation|2|||
42071770|NCT00596466|75881491|FG000|Overall Study|Unpecified|2|||
42071771|NCT00596466|75881491|FG000|Overall Study|Enrolled, not treated|2|||
42071772|NCT00596934|75881495|FG000|Overall Study|Protocol Violation|1|||
42071773|NCT00596934|75881495|FG000|Overall Study|Withdrawal by Subject|1|||
42071774|NCT03911401|75881504|FG000|Overall Study|Adverse Event|1|||
42071775|NCT03911401|75881505|FG001|Overall Study|Adverse Event|2|||
42071776|NCT03911401|75881506|FG002|Overall Study|Adverse Event|5|||
42071777|NCT03911401|75881504|FG000|Overall Study|Lack of Efficacy|1|||
42071778|NCT03911401|75881505|FG001|Overall Study|Lack of Efficacy|1|||
42071779|NCT03911401|75881506|FG002|Overall Study|Lack of Efficacy|8|||
42071780|NCT03911401|75881504|FG000|Overall Study|Physician Decision|0|||
42071781|NCT03911401|75881505|FG001|Overall Study|Physician Decision|0|||
42071782|NCT03911401|75881506|FG002|Overall Study|Physician Decision|1|||
42071783|NCT03911401|75881504|FG000|Overall Study|Withdrawal by Subject|1|||
42071784|NCT03911401|75881505|FG001|Overall Study|Withdrawal by Subject|2|||
42071785|NCT03911401|75881506|FG002|Overall Study|Withdrawal by Subject|0|||
42071786|NCT03911401|75881504|FG000|Overall Study|Withdrawal by parent/guardian|4|||
42071787|NCT03911401|75881505|FG001|Overall Study|Withdrawal by parent/guardian|4|||
42071788|NCT03911401|75881506|FG002|Overall Study|Withdrawal by parent/guardian|11|||
42071789|NCT00579670|75881519|FG000|Overall Study|Death|1|||
42071790|NCT00579670|75881520|FG001|Overall Study|Death|0|||
42071791|NCT00579670|75881521|FG002|Overall Study|Death|0|||
42071792|NCT00579670|75881522|FG003|Overall Study|Death|0|||
42071793|NCT00579670|75881523|FG004|Overall Study|Death|0|||
42071794|NCT00579670|75881519|FG000|Overall Study|Adverse Event|1|||
42071795|NCT00579670|75881520|FG001|Overall Study|Adverse Event|0|||
42071796|NCT00579670|75881521|FG002|Overall Study|Adverse Event|1|||
42071797|NCT00579670|75881522|FG003|Overall Study|Adverse Event|2|||
42071798|NCT00579670|75881523|FG004|Overall Study|Adverse Event|0|||
42071799|NCT00579670|75881519|FG000|Overall Study|Lack of Efficacy|0|||
42071800|NCT00579670|75881520|FG001|Overall Study|Lack of Efficacy|0|||
42071801|NCT00579670|75881521|FG002|Overall Study|Lack of Efficacy|1|||
42071802|NCT00579670|75881522|FG003|Overall Study|Lack of Efficacy|14|||
42071803|NCT00579670|75881523|FG004|Overall Study|Lack of Efficacy|0|||
42071804|NCT00579670|75881519|FG000|Overall Study|Lost to Follow-up|0|||
42071805|NCT00579670|75881520|FG001|Overall Study|Lost to Follow-up|1|||
42071806|NCT00579670|75881521|FG002|Overall Study|Lost to Follow-up|0|||
42071807|NCT00579670|75881522|FG003|Overall Study|Lost to Follow-up|4|||
42071808|NCT00579670|75881523|FG004|Overall Study|Lost to Follow-up|0|||
42071809|NCT00579670|75881519|FG000|Overall Study|Other|0|||
42071810|NCT00579670|75881520|FG001|Overall Study|Other|0|||
42071811|NCT00579670|75881521|FG002|Overall Study|Other|1|||
42177216|NCT03720470|75984398|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
42177217|NCT03720470|75984399|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
42177218|NCT03720470|75984394|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
42177219|NCT03720470|75984395|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
42177220|NCT03720470|75984396|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
42357770|NCT01381575|76203278|FG002|Overall Study|Withdrawal by Subject|7|||
42357771|NCT01381575|76203276|FG000|Overall Study|Migrated/moved from study area|2|||
42357772|NCT01381575|76203277|FG001|Overall Study|Migrated/moved from study area|12|||
42357773|NCT01381575|76203278|FG002|Overall Study|Migrated/moved from study area|2|||
42357774|NCT01381575|76203276|FG000|Overall Study|Lost to Follow-up|8|||
42071812|NCT00579670|75881522|FG003|Overall Study|Other|2|||
42071813|NCT00579670|75881523|FG004|Overall Study|Other|0|||
42357775|NCT01381575|76203277|FG001|Overall Study|Lost to Follow-up|17|||
42357776|NCT01381575|76203278|FG002|Overall Study|Lost to Follow-up|9|||
42071814|NCT00579670|75881519|FG000|Overall Study|Withdrawal by Subject|0|||
42071815|NCT00579670|75881520|FG001|Overall Study|Withdrawal by Subject|0|||
42071816|NCT00579670|75881521|FG002|Overall Study|Withdrawal by Subject|1|||
42071817|NCT00579670|75881522|FG003|Overall Study|Withdrawal by Subject|0|||
42071818|NCT00579670|75881523|FG004|Overall Study|Withdrawal by Subject|0|||
42071819|NCT03909295|75881547|FG000|Overall Study|Adverse Event|2|||
42071820|NCT03909295|75881547|FG000|Overall Study|Study terminated by sponsor|50|||
42177221|NCT03720470|75984397|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
42177222|NCT03720470|75984398|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
42177223|NCT03720470|75984399|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
42177224|NCT03720470|75984394|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
42177225|NCT03720470|75984395|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
42177226|NCT03720470|75984396|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
42177227|NCT03720470|75984397|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
42071821|NCT00599924|75881558|FG000|Overall Study|Lack of Efficacy|3|||
42071822|NCT00599924|75881559|FG001|Overall Study|Lack of Efficacy|5|||
42177228|NCT03720470|75984398|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
42177229|NCT03720470|75984399|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
42177230|NCT03720470|75984394|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
42177231|NCT03720470|75984395|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
42071823|NCT00599924|75881560|FG002|Overall Study|Lack of Efficacy|1|||
42071824|NCT00599924|75881561|FG003|Overall Study|Lack of Efficacy|2|||
42071825|NCT00599924|75881562|FG004|Overall Study|Lack of Efficacy|3|||
42071826|NCT00599924|75881563|FG005|Overall Study|Lack of Efficacy|2|||
42071827|NCT00599924|75881564|FG006|Overall Study|Lack of Efficacy|0|||
42071828|NCT00599924|75881558|FG000|Overall Study|Adverse Event|0|||
42071829|NCT00599924|75881559|FG001|Overall Study|Adverse Event|0|||
42071830|NCT00599924|75881560|FG002|Overall Study|Adverse Event|0|||
42071831|NCT00599924|75881561|FG003|Overall Study|Adverse Event|2|||
42071832|NCT00599924|75881562|FG004|Overall Study|Adverse Event|0|||
42177232|NCT03720470|75984396|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
42177233|NCT03720470|75984397|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
42177234|NCT03720470|75984398|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
42177235|NCT03720470|75984399|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
42177236|NCT03720470|75984394|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
42177237|NCT03720470|75984395|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
42177238|NCT03720470|75984396|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
42177239|NCT03720470|75984397|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
42177240|NCT03720470|75984398|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
42177241|NCT03720470|75984399|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
42177242|NCT03720470|75984394|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
42177243|NCT03720470|75984395|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
42177244|NCT03720470|75984396|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
42177245|NCT03720470|75984397|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
42177246|NCT03720470|75984398|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
42177247|NCT03720470|75984399|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
42177248|NCT03720470|75984394|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
42177249|NCT03720470|75984395|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
42177250|NCT03720470|75984396|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
42177251|NCT03720470|75984397|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
42177252|NCT03720470|75984398|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
42177253|NCT03720470|75984399|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
42177254|NCT03720470|75984394|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
42177255|NCT03720470|75984395|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
42177256|NCT03720470|75984396|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
42177257|NCT03720470|75984397|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
42177258|NCT03720470|75984398|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
42177259|NCT03720470|75984399|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
42293384|NCT01597193|76127539|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
42293385|NCT01597193|76127533|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
42293386|NCT01597193|76127534|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
42293387|NCT01597193|76127535|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
42293388|NCT01597193|76127536|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
42293389|NCT01597193|76127537|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
42293390|NCT01597193|76127538|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
42071833|NCT00599924|75881563|FG005|Overall Study|Adverse Event|0|||
42071834|NCT00599924|75881564|FG006|Overall Study|Adverse Event|2|||
42071835|NCT00599924|75881558|FG000|Overall Study|Death|0|||
42071836|NCT00599924|75881559|FG001|Overall Study|Death|0|||
42177260|NCT03720470|75984394|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
42177261|NCT03720470|75984395|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
42177262|NCT03720470|75984396|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
42177263|NCT03720470|75984397|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
42293391|NCT01597193|76127539|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
42293392|NCT01597193|76127533|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
42071837|NCT00599924|75881560|FG002|Overall Study|Death|0|||
42071838|NCT00599924|75881561|FG003|Overall Study|Death|2|||
42071839|NCT00599924|75881562|FG004|Overall Study|Death|0|||
42071840|NCT00599924|75881563|FG005|Overall Study|Death|2|||
42177264|NCT03720470|75984398|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
42177265|NCT03720470|75984399|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
42177266|NCT03720470|75984394|FG000|Treatment Period: Final 4 Weeks|Other|0|||
42177267|NCT03720470|75984395|FG001|Treatment Period: Final 4 Weeks|Other|1|||
42177268|NCT03720470|75984396|FG002|Treatment Period: Final 4 Weeks|Other|0|||
42177269|NCT03720470|75984397|FG003|Treatment Period: Final 4 Weeks|Other|2|||
42177270|NCT03720470|75984398|FG004|Treatment Period: Final 4 Weeks|Other|1|||
42177271|NCT03720470|75984399|FG005|Treatment Period: Final 4 Weeks|Other|0|||
42177272|NCT00262847|75984422|FG000|Overall Study|Disease Progression|309|||
42177273|NCT00262847|75984423|FG001|Overall Study|Disease Progression|274|||
42177274|NCT00262847|75984424|FG002|Overall Study|Disease Progression|195|||
42177275|NCT00262847|75984422|FG000|Overall Study|Patient Refusal|41|||
42177276|NCT00262847|75984423|FG001|Overall Study|Patient Refusal|52|||
42177277|NCT00262847|75984424|FG002|Overall Study|Patient Refusal|47|||
42177278|NCT00262847|75984422|FG000|Overall Study|Adverse Event|74|||
42177279|NCT00262847|75984423|FG001|Overall Study|Adverse Event|88|||
42177280|NCT00262847|75984424|FG002|Overall Study|Adverse Event|108|||
42177281|NCT00262847|75984422|FG000|Overall Study|Death|8|||
42177282|NCT00262847|75984423|FG001|Overall Study|Death|8|||
42177283|NCT00262847|75984424|FG002|Overall Study|Death|11|||
42177284|NCT00262847|75984422|FG000|Overall Study|Concomitant disease|3|||
42177285|NCT00262847|75984423|FG001|Overall Study|Concomitant disease|2|||
42177286|NCT00262847|75984424|FG002|Overall Study|Concomitant disease|4|||
42177287|NCT00262847|75984422|FG000|Overall Study|Other Reasons|79|||
42177288|NCT00262847|75984423|FG001|Overall Study|Other Reasons|88|||
42177289|NCT00262847|75984424|FG002|Overall Study|Other Reasons|27|||
42177290|NCT00262847|75984422|FG000|Overall Study|Did not receive study treatment|4|||
42177291|NCT00262847|75984423|FG001|Overall Study|Did not receive study treatment|1|||
42177292|NCT00262847|75984424|FG002|Overall Study|Did not receive study treatment|4|||
42177293|NCT00280397|75984435|FG000|Overall Study|Adverse Event|1|||
42177294|NCT00262301|75984444|FG000|Double-blind Phase|Lost to Follow-up|1|||
42177295|NCT00262301|75984445|FG001|Double-blind Phase|Lost to Follow-up|0|||
42177296|NCT00262301|75984446|FG002|Double-blind Phase|Lost to Follow-up|0|||
42071841|NCT00599924|75881564|FG006|Overall Study|Death|1|||
42071842|NCT00599924|75881558|FG000|Overall Study|Protocol Violation|0|||
42071843|NCT00599924|75881559|FG001|Overall Study|Protocol Violation|0|||
42071844|NCT00599924|75881560|FG002|Overall Study|Protocol Violation|0|||
42071845|NCT00599924|75881561|FG003|Overall Study|Protocol Violation|1|||
42071846|NCT00599924|75881562|FG004|Overall Study|Protocol Violation|0|||
42177297|NCT00262301|75984444|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
42177298|NCT00262301|75984445|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
42177299|NCT00262301|75984446|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
42177300|NCT00279305|75984456|FG000|Overall Study|Pregnancy|1|||
42071847|NCT00599924|75881563|FG005|Overall Study|Protocol Violation|0|||
42071848|NCT00599924|75881564|FG006|Overall Study|Protocol Violation|0|||
42071849|NCT00599924|75881558|FG000|Overall Study|Withdrawal by Subject|0|||
42071850|NCT00599924|75881559|FG001|Overall Study|Withdrawal by Subject|0|||
42071851|NCT00599924|75881560|FG002|Overall Study|Withdrawal by Subject|1|||
42071852|NCT00599924|75881561|FG003|Overall Study|Withdrawal by Subject|0|||
42071853|NCT00599924|75881562|FG004|Overall Study|Withdrawal by Subject|1|||
42071854|NCT00599924|75881563|FG005|Overall Study|Withdrawal by Subject|0|||
42071855|NCT00599924|75881564|FG006|Overall Study|Withdrawal by Subject|0|||
42071856|NCT00599924|75881558|FG000|Overall Study|Other|0|||
42071857|NCT00599924|75881559|FG001|Overall Study|Other|0|||
42071858|NCT00599924|75881560|FG002|Overall Study|Other|0|||
42071859|NCT00599924|75881561|FG003|Overall Study|Other|1|||
42071860|NCT00599924|75881562|FG004|Overall Study|Other|2|||
42071861|NCT00599924|75881563|FG005|Overall Study|Other|0|||
42071862|NCT00599924|75881564|FG006|Overall Study|Other|2|||
42071863|NCT00581542|75881587|FG000|Overall Study|they met an exclusion criteria|2|||
42177301|NCT00279305|75984457|FG001|Overall Study|Pregnancy|0|||
42177302|NCT00279305|75984456|FG000|Overall Study|Withdrawal by Subject|2|||
42177303|NCT00279305|75984457|FG001|Overall Study|Withdrawal by Subject|0|||
42177304|NCT00279305|75984456|FG000|Overall Study|Dificulting establishing IV|1|||
42177305|NCT00279305|75984457|FG001|Overall Study|Dificulting establishing IV|0|||
42177306|NCT00279305|75984456|FG000|Overall Study|FDA Safety Alert|4|||
42177307|NCT00279305|75984457|FG001|Overall Study|FDA Safety Alert|1|||
42177308|NCT00278993|75984463|FG000|Overall Study|Adverse Event|24|||
42177309|NCT00278993|75984463|FG000|Overall Study|Withdrawal by Subject|5|||
42177310|NCT00278993|75984463|FG000|Overall Study|Progressive Disease|65|||
42293393|NCT01597193|76127534|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
42071864|NCT00581542|75881588|FG001|Overall Study|they met an exclusion criteria|2|||
42071865|NCT00581542|75881587|FG000|Overall Study|Lost to Follow-up|9|||
42071866|NCT00581542|75881588|FG001|Overall Study|Lost to Follow-up|21|||
42071867|NCT03912337|75881598|FG000|Overall Study|Withdrawal of Consent From Study|1|||
42071868|NCT03912337|75881599|FG001|Overall Study|Withdrawal of Consent From Study|0|||
42071869|NCT03912337|75881598|FG000|Overall Study|Lost to Follow-up|1|||
42071870|NCT03912337|75881599|FG001|Overall Study|Lost to Follow-up|1|||
42177311|NCT00278993|75984463|FG000|Overall Study|Physician Decision|9|||
42177312|NCT00278993|75984463|FG000|Overall Study|Not Otherwise Specified|4|||
42177313|NCT00277355|75984469|FG000|Overall Study|Withdrawal by Subject|3|||
42177314|NCT00277355|75984470|FG001|Overall Study|Withdrawal by Subject|3|||
42177315|NCT00277355|75984469|FG000|Overall Study|Lost to Follow-up|2|||
42177316|NCT00277355|75984470|FG001|Overall Study|Lost to Follow-up|2|||
42177317|NCT00277355|75984469|FG000|Overall Study|Adverse Event|5|||
42177318|NCT00277355|75984470|FG001|Overall Study|Adverse Event|0|||
42177319|NCT00277355|75984469|FG000|Overall Study|Death|3|||
42177320|NCT00277355|75984470|FG001|Overall Study|Death|0|||
42177321|NCT00277355|75984469|FG000|Overall Study|Physician Decision|1|||
42177322|NCT00277355|75984470|FG001|Overall Study|Physician Decision|0|||
42177323|NCT00262223|75984479|FG000|Treatment Phase|Withdrawal by Subject|3|||
42177324|NCT00262223|75984480|FG001|Treatment Phase|Withdrawal by Subject|6|||
42177325|NCT00262223|75984479|FG000|Treatment Phase|Adverse Event|1|||
42177326|NCT00262223|75984480|FG001|Treatment Phase|Adverse Event|2|||
42177327|NCT00262223|75984479|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
42177328|NCT00262223|75984480|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
42177329|NCT00262223|75984479|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
42177330|NCT00262223|75984480|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
42177331|NCT00262223|75984479|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
42177332|NCT00262223|75984480|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
42177333|NCT00276419|75984489|FG000|First Intervention|Adverse Event|1|||
42177334|NCT00276419|75984490|FG001|First Intervention|Adverse Event|0|||
42177335|NCT00276419|75984489|FG000|First Intervention|Withdrawal by Subject|0|||
42177336|NCT00276419|75984490|FG001|First Intervention|Withdrawal by Subject|2|||
42177337|NCT00262067|75984511|FG000|Overall Study|Death|190|||
42177338|NCT00262067|75984512|FG001|Overall Study|Death|89|||
42177339|NCT00262067|75984513|FG002|Overall Study|Death|186|||
42177340|NCT00262067|75984514|FG003|Overall Study|Death|99|||
42177341|NCT00262067|75984511|FG000|Overall Study|Lost to Follow-up|5|||
42177342|NCT00262067|75984512|FG001|Overall Study|Lost to Follow-up|4|||
42177343|NCT00262067|75984513|FG002|Overall Study|Lost to Follow-up|7|||
42177344|NCT00262067|75984514|FG003|Overall Study|Lost to Follow-up|5|||
42177345|NCT00262067|75984511|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
42177346|NCT00262067|75984512|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
42177347|NCT00262067|75984513|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
42177348|NCT00262067|75984514|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
42177349|NCT00262067|75984511|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
42177350|NCT00262067|75984512|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
42177351|NCT00262067|75984513|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
42177352|NCT00262067|75984514|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
42177353|NCT00275561|75984526|FG000|Overall Study|Withdrawal by Subject|0|||
42177354|NCT00275561|75984527|FG001|Overall Study|Withdrawal by Subject|1|||
42177355|NCT00275561|75984526|FG000|Overall Study|Travel|1|||
42177356|NCT00275561|75984527|FG001|Overall Study|Travel|1|||
42177357|NCT00275561|75984526|FG000|Overall Study|Scheduling|1|||
42177358|NCT00275561|75984527|FG001|Overall Study|Scheduling|2|||
42177359|NCT00275561|75984526|FG000|Overall Study|Family Issues|0|||
42177360|NCT00275561|75984527|FG001|Overall Study|Family Issues|2|||
42177361|NCT00274937|75984537|FG000|Overall Study|Physician Decision|10|||
42177362|NCT00274937|75984537|FG000|Overall Study|Withdrawal by Subject|6|||
42177363|NCT00274937|75984537|FG000|Overall Study|Progressive Disease|4|||
42177364|NCT00251693|75984544|FG000|Overall Study|Adverse Event|17|||
42177365|NCT00251693|75984545|FG001|Overall Study|Adverse Event|9|||
42177366|NCT00251693|75984546|FG002|Overall Study|Adverse Event|9|||
42177367|NCT00251693|75984544|FG000|Overall Study|Protocol Violation|2|||
42177368|NCT00251693|75984545|FG001|Overall Study|Protocol Violation|0|||
42177369|NCT00251693|75984546|FG002|Overall Study|Protocol Violation|2|||
42177370|NCT00251693|75984544|FG000|Overall Study|Lost to Follow-up|12|||
42177371|NCT00251693|75984545|FG001|Overall Study|Lost to Follow-up|7|||
42071871|NCT02121652|75881607|FG000|Overall Study|Lost to Follow-up|2|||
42177372|NCT00251693|75984546|FG002|Overall Study|Lost to Follow-up|8|||
42177373|NCT00251693|75984544|FG000|Overall Study|Withdrawal by Subject|11|||
42177374|NCT00251693|75984545|FG001|Overall Study|Withdrawal by Subject|17|||
42177375|NCT00251693|75984546|FG002|Overall Study|Withdrawal by Subject|14|||
42071872|NCT02121652|75881608|FG001|Overall Study|Lost to Follow-up|1|||
42071873|NCT02121652|75881607|FG000|Overall Study|Death|1|||
42071874|NCT02121652|75881608|FG001|Overall Study|Death|0|||
42177376|NCT00251693|75984544|FG000|Overall Study|Lack of Efficacy|0|||
42177377|NCT00251693|75984545|FG001|Overall Study|Lack of Efficacy|1|||
42177378|NCT00251693|75984546|FG002|Overall Study|Lack of Efficacy|0|||
42177379|NCT00251693|75984544|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
42177380|NCT00251693|75984545|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
42177381|NCT00251693|75984546|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
42177382|NCT00251693|75984544|FG000|Overall Study|Noncompliant|0|||
42177383|NCT00251693|75984545|FG001|Overall Study|Noncompliant|0|||
42177384|NCT00251693|75984546|FG002|Overall Study|Noncompliant|2|||
42177385|NCT00251693|75984544|FG000|Overall Study|Possible Barrett's esophagus|3|||
42177386|NCT00251693|75984545|FG001|Overall Study|Possible Barrett's esophagus|5|||
42177387|NCT00251693|75984546|FG002|Overall Study|Possible Barrett's esophagus|2|||
42177388|NCT00251693|75984544|FG000|Overall Study|Subject request/subject unavailable|1|||
42177389|NCT00251693|75984545|FG001|Overall Study|Subject request/subject unavailable|2|||
42177390|NCT00251693|75984546|FG002|Overall Study|Subject request/subject unavailable|0|||
42177391|NCT00251693|75984544|FG000|Overall Study|Abnormal laboratory findings|0|||
42177392|NCT00251693|75984545|FG001|Overall Study|Abnormal laboratory findings|0|||
42177393|NCT00251693|75984546|FG002|Overall Study|Abnormal laboratory findings|1|||
42177394|NCT00250835|75984554|FG000|Overall Study|Withdrawal by Subject|1|||
42177395|NCT03716024|75984564|FG000|Overall Study|Randomized, not Treated|7|||
42177396|NCT03716024|75984565|FG001|Overall Study|Randomized, not Treated|8|||
42071875|NCT02121652|75881607|FG000|Overall Study|Withdrawal by Subject|3|||
42071876|NCT02121652|75881608|FG001|Overall Study|Withdrawal by Subject|3|||
42071877|NCT00595920|75881614|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
42177397|NCT03716024|75984564|FG000|Overall Study|Adverse Event|1|||
42177398|NCT03716024|75984565|FG001|Overall Study|Adverse Event|2|||
42177399|NCT03716024|75984564|FG000|Overall Study|Treatment Failure|1|||
42177400|NCT03716024|75984565|FG001|Overall Study|Treatment Failure|0|||
42177401|NCT03716024|75984564|FG000|Overall Study|Lost to Follow-up|2|||
42177402|NCT03716024|75984565|FG001|Overall Study|Lost to Follow-up|6|||
42177403|NCT03716024|75984564|FG000|Overall Study|Withdrawal by Subject|0|||
42177404|NCT03716024|75984565|FG001|Overall Study|Withdrawal by Subject|1|||
42177405|NCT03716024|75984564|FG000|Overall Study|Missing Reason|0|||
42177406|NCT03716024|75984565|FG001|Overall Study|Missing Reason|1|||
42177407|NCT00250679|75984574|FG000|Overall Study|Adverse Event|12|||
42177408|NCT00250679|75984575|FG001|Overall Study|Adverse Event|15|||
42177409|NCT00250679|75984576|FG002|Overall Study|Adverse Event|16|||
42177410|NCT00250679|75984574|FG000|Overall Study|Protocol Violation|2|||
42177411|NCT00250679|75984575|FG001|Overall Study|Protocol Violation|4|||
42177412|NCT00250679|75984576|FG002|Overall Study|Protocol Violation|3|||
42177413|NCT00250679|75984574|FG000|Overall Study|Withdrawal by Subject|15|||
42177414|NCT00250679|75984575|FG001|Overall Study|Withdrawal by Subject|18|||
42177415|NCT00250679|75984576|FG002|Overall Study|Withdrawal by Subject|15|||
42293394|NCT01597193|76127535|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
42293395|NCT01597193|76127536|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
42293396|NCT01597193|76127537|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
42293397|NCT01597193|76127538|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
42293398|NCT01597193|76127539|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
42293399|NCT01597193|76127533|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
42293400|NCT01597193|76127534|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
42293401|NCT01597193|76127535|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
42071878|NCT00595764|75881620|FG000|Overall Study|Protocol Violation|24|||
42177416|NCT00250679|75984574|FG000|Overall Study|Lost to Follow-up|3|||
42177417|NCT00250679|75984575|FG001|Overall Study|Lost to Follow-up|4|||
42177418|NCT00250679|75984576|FG002|Overall Study|Lost to Follow-up|2|||
42177419|NCT00250679|75984574|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
42177420|NCT00250679|75984575|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
42177421|NCT00250679|75984576|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
42177422|NCT00250679|75984574|FG000|Overall Study|Lack of Efficacy|0|||
42177423|NCT00250679|75984575|FG001|Overall Study|Lack of Efficacy|1|||
42177424|NCT00250679|75984576|FG002|Overall Study|Lack of Efficacy|3|||
42177425|NCT00250679|75984574|FG000|Overall Study|Technical Holter issues|1|||
42177426|NCT00250679|75984575|FG001|Overall Study|Technical Holter issues|0|||
42177427|NCT00250679|75984576|FG002|Overall Study|Technical Holter issues|2|||
42177428|NCT00250679|75984574|FG000|Overall Study|Moved|1|||
42071879|NCT00595764|75881621|FG001|Overall Study|Protocol Violation|19|||
42177429|NCT00250679|75984575|FG001|Overall Study|Moved|1|||
42177430|NCT00250679|75984576|FG002|Overall Study|Moved|0|||
42177431|NCT00250679|75984574|FG000|Overall Study|Non-compliance|1|||
42293402|NCT01597193|76127536|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
42293403|NCT01597193|76127537|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
42293404|NCT01597193|76127538|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
42293405|NCT01597193|76127539|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
42293406|NCT01597193|76127533|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
42293407|NCT01597193|76127534|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
42293408|NCT01597193|76127535|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
42293409|NCT01597193|76127536|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
42071880|NCT00595764|75881620|FG000|Overall Study|Missed Medication >1 week|10|||
42071881|NCT00595764|75881621|FG001|Overall Study|Missed Medication >1 week|17|||
42177432|NCT00250679|75984575|FG001|Overall Study|Non-compliance|1|||
42177433|NCT00250679|75984576|FG002|Overall Study|Non-compliance|0|||
42177434|NCT00250679|75984574|FG000|Overall Study|various single events: hip surgery,diary|3|||
42177435|NCT00250679|75984575|FG001|Overall Study|various single events: hip surgery,diary|1|||
42071882|NCT00595764|75881620|FG000|Overall Study|Missed 3 PM visits|1|||
42071883|NCT00595764|75881621|FG001|Overall Study|Missed 3 PM visits|7|||
42071884|NCT00595764|75881620|FG000|Overall Study|Withdrawal by Subject|4|||
42071885|NCT00595764|75881621|FG001|Overall Study|Withdrawal by Subject|0|||
42071886|NCT00581308|75881641|FG000|Pre Discharge|Lost to Follow-up|1|||
42071887|NCT00581308|75881641|FG000|Pre Discharge|Device Removed|1|||
42071888|NCT00581308|75881641|FG000|Month 1|Lost to Follow-up|3|||
42071889|NCT00581308|75881641|FG000|Month 1|Withdrawal by Subject|2|||
42071890|NCT00581308|75881641|FG000|Month 1|Device Removed|2|||
42071891|NCT00581308|75881641|FG000|Month 1|Uknown|1|||
42071892|NCT00581308|75881641|FG000|Month 6|Lost to Follow-up|1|||
42071893|NCT00581308|75881641|FG000|Month 6|Withdrawal by Subject|2|||
42071894|NCT00581308|75881641|FG000|Month 12|Death|1|||
42071895|NCT00581308|75881641|FG000|Month 12|Lost to Follow-up|14|||
42071896|NCT00581308|75881641|FG000|Month 12|Withdrawal by Subject|3|||
42071897|NCT00581308|75881641|FG000|Month 12|Device Removed|1|||
42071898|NCT00581308|75881641|FG000|Month 12|Other|1|||
42071899|NCT00877890|75881650|FG000|Overall Study|Adverse Event|6|||
42071900|NCT00877890|75881651|FG001|Overall Study|Adverse Event|6|||
42071901|NCT00877890|75881650|FG000|Overall Study|Lost to Follow-up|5|||
42071902|NCT00877890|75881651|FG001|Overall Study|Lost to Follow-up|5|||
42071903|NCT00877890|75881650|FG000|Overall Study|Protocol Violation|0|||
42071904|NCT00877890|75881651|FG001|Overall Study|Protocol Violation|1|||
42071905|NCT00877890|75881650|FG000|Overall Study|Withdrawal of Consent|6|||
42071906|NCT00877890|75881651|FG001|Overall Study|Withdrawal of Consent|12|||
42071907|NCT00877890|75881650|FG000|Overall Study|Investigator Decision|0|||
42071908|NCT00877890|75881651|FG001|Overall Study|Investigator Decision|2|||
42071909|NCT00877890|75881650|FG000|Overall Study|Loss of Glucose Control|3|||
42071910|NCT00877890|75881651|FG001|Overall Study|Loss of Glucose Control|4|||
42071911|NCT03474679|75881661|FG000|Overall Study|Death|7|||
42071912|NCT03474679|75881661|FG000|Overall Study|Withdrawal by Subject|1|||
42071913|NCT03905863|75881667|FG000|Overall Study|Adverse Event|2|||
42071914|NCT03905863|75881668|FG001|Overall Study|Adverse Event|4|||
42071915|NCT03905863|75881667|FG000|Overall Study|Withdrawal by Subject|2|||
42071916|NCT03905863|75881668|FG001|Overall Study|Withdrawal by Subject|2|||
42071917|NCT03905863|75881667|FG000|Overall Study|Physician Decision|0|||
42071918|NCT03905863|75881668|FG001|Overall Study|Physician Decision|3|||
42071919|NCT03905863|75881667|FG000|Overall Study|Lost to Follow-up|1|||
42071920|NCT03905863|75881668|FG001|Overall Study|Lost to Follow-up|0|||
42293410|NCT01597193|76127537|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
42293411|NCT01597193|76127538|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
42293412|NCT01597193|76127539|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
42017368|NCT01128153|75824968|FG001|Overall Study|Condition under investigation worsened|7|||
42017369|NCT01128153|75824967|FG000|Overall Study|Withdrawal by Subject|2|||
42017370|NCT01128153|75824968|FG001|Overall Study|Withdrawal by Subject|3|||
42017371|NCT01128153|75824967|FG000|Overall Study|Incorrect enrolment to study|2|||
42017372|NCT01128153|75824968|FG001|Overall Study|Incorrect enrolment to study|1|||
42017373|NCT01128153|75824967|FG000|Overall Study|Protocol Violation|2|||
42017374|NCT01128153|75824968|FG001|Overall Study|Protocol Violation|0|||
42017375|NCT01128153|75824967|FG000|Overall Study|Developed discontinuation criteria|1|||
42017376|NCT01128153|75824968|FG001|Overall Study|Developed discontinuation criteria|1|||
42017377|NCT00925015|75824977|FG000|Overall Study|Adverse Event|1|||
42017378|NCT00925015|75824978|FG001|Overall Study|Adverse Event|2|||
42017379|NCT00925015|75824979|FG002|Overall Study|Adverse Event|1|||
42017380|NCT00925015|75824977|FG000|Overall Study|Physician Decision|0|||
42017381|NCT00925015|75824978|FG001|Overall Study|Physician Decision|1|||
42017382|NCT00925015|75824979|FG002|Overall Study|Physician Decision|0|||
42017383|NCT00925015|75824977|FG000|Overall Study|Progressive Disease|7|||
42017384|NCT00925015|75824978|FG001|Overall Study|Progressive Disease|3|||
42017385|NCT00925015|75824979|FG002|Overall Study|Progressive Disease|4|||
42017386|NCT00925015|75824977|FG000|Overall Study|Withdrawal by Subject|0|||
42017387|NCT00925015|75824978|FG001|Overall Study|Withdrawal by Subject|0|||
42017388|NCT00925015|75824979|FG002|Overall Study|Withdrawal by Subject|1|||
42071921|NCT03905863|75881667|FG000|Overall Study|Protocol Violation|0|||
42071922|NCT03905863|75881668|FG001|Overall Study|Protocol Violation|2|||
42071923|NCT03905863|75881667|FG000|Overall Study|Death|0|||
42071924|NCT03905863|75881668|FG001|Overall Study|Death|1|||
42071925|NCT04067011|75881677|FG000|Overall Study|Not Treated|8|||
42071926|NCT04067011|75881678|FG001|Overall Study|Not Treated|7|||
42071927|NCT04067011|75881679|FG002|Overall Study|Not Treated|5|||
42071928|NCT04067011|75881677|FG000|Overall Study|Adverse Event|2|||
42071929|NCT04067011|75881678|FG001|Overall Study|Adverse Event|1|||
42071930|NCT04067011|75881679|FG002|Overall Study|Adverse Event|0|||
42071931|NCT04067011|75881677|FG000|Overall Study|Withdrawal by Subject|6|||
42071932|NCT04067011|75881678|FG001|Overall Study|Withdrawal by Subject|2|||
42071933|NCT04067011|75881679|FG002|Overall Study|Withdrawal by Subject|1|||
42071934|NCT04067011|75881677|FG000|Overall Study|Lost to Follow-up|0|||
42071935|NCT04067011|75881678|FG001|Overall Study|Lost to Follow-up|0|||
42017389|NCT01127763|75824991|FG000|Overall Study|Adverse Event|2|||
42017390|NCT01127763|75824991|FG000|Overall Study|Withdrawal by Subject|1|||
42017391|NCT01127763|75824991|FG000|Overall Study|Physician Decision|2|||
42017392|NCT01127607|75825001|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
42017393|NCT01127607|75825002|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
42017394|NCT01127607|75825001|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
42017395|NCT01127607|75825002|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
42017396|NCT00924781|75825029|FG000|Overall Study|Study terminated by sponsor|12|||
42017397|NCT00924781|75825030|FG001|Overall Study|Study terminated by sponsor|10|||
42017398|NCT01127451|75825048|FG000|Overall Study|Other|2|||
42017399|NCT01127451|75825049|FG001|Overall Study|Other|1|||
42017400|NCT01127451|75825048|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
42017401|NCT01127451|75825049|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
42017402|NCT01127451|75825048|FG000|Overall Study|Death|22|||
42017403|NCT01127451|75825049|FG001|Overall Study|Death|17|||
42017404|NCT01127451|75825048|FG000|Overall Study|Lost to Follow-up|3|||
42017405|NCT01127451|75825049|FG001|Overall Study|Lost to Follow-up|0|||
42017406|NCT01127451|75825048|FG000|Overall Study|Administrative Reason by Sponsor|2|||
42017407|NCT01127451|75825049|FG001|Overall Study|Administrative Reason by Sponsor|2|||
42017408|NCT01127373|75825055|FG000|Overall Study|Not Treated|3|||
42017409|NCT01127373|75825055|FG000|Overall Study|Lost to Follow-up|7|||
42017410|NCT01127373|75825055|FG000|Overall Study|Withdrawal by Subject|1|||
42017411|NCT01127373|75825055|FG000|Overall Study|Disease progression|1|||
42017412|NCT01127139|75825059|FG000|Overall Study|Adverse Event|40|||
42017413|NCT01127139|75825059|FG000|Overall Study|Incompliance|12|||
42071936|NCT04067011|75881679|FG002|Overall Study|Lost to Follow-up|1|||
42071937|NCT04067011|75881677|FG000|Overall Study|Physician Decision|1|||
42071938|NCT04067011|75881678|FG001|Overall Study|Physician Decision|1|||
42071939|NCT04067011|75881679|FG002|Overall Study|Physician Decision|0|||
42071940|NCT04067011|75881677|FG000|Overall Study|Other Reasons|2|||
42071941|NCT04067011|75881678|FG001|Overall Study|Other Reasons|0|||
42071942|NCT04067011|75881679|FG002|Overall Study|Other Reasons|1|||
42071943|NCT04067011|75881677|FG000|Overall Study|Missing|0|||
42071944|NCT04067011|75881678|FG001|Overall Study|Missing|2|||
42071945|NCT04067011|75881679|FG002|Overall Study|Missing|0|||
42071946|NCT00539305|75881723|FG000|Overall Study|Adverse Event|1|||
42071947|NCT00539305|75881724|FG001|Overall Study|Adverse Event|0|||
42071948|NCT00539305|75881723|FG000|Overall Study|Substance Use|0|||
42071949|NCT00539305|75881724|FG001|Overall Study|Substance Use|1|||
42071950|NCT00539305|75881723|FG000|Overall Study|Withdrawal by Subject|0|||
42071951|NCT00539305|75881724|FG001|Overall Study|Withdrawal by Subject|1|||
42071952|NCT04469465|75881751|FG000|Overall Study|Adverse Event|2|||
42071953|NCT04469465|75881752|FG001|Overall Study|Adverse Event|1|||
42071954|NCT04469465|75881751|FG000|Overall Study|Ongoing treatment|7|||
42071955|NCT04469465|75881752|FG001|Overall Study|Ongoing treatment|4|||
42071956|NCT04469465|75881751|FG000|Overall Study|Withdrawal by Subject|0|||
42071957|NCT04469465|75881752|FG001|Overall Study|Withdrawal by Subject|1|||
42071958|NCT00877032|75881765|FG000|Overall Study|Did not meet entrance criteria|0|||
42071959|NCT00877032|75881766|FG001|Overall Study|Did not meet entrance criteria|0|||
42071960|NCT00877032|75881767|FG002|Overall Study|Did not meet entrance criteria|0|||
42071961|NCT00877032|75881768|FG003|Overall Study|Did not meet entrance criteria|1|||
42071962|NCT00877032|75881769|FG004|Overall Study|Did not meet entrance criteria|0|||
42071963|NCT00877032|75881770|FG005|Overall Study|Did not meet entrance criteria|0|||
42071964|NCT00877032|75881771|FG006|Overall Study|Did not meet entrance criteria|2|||
42071965|NCT00538681|75881810|FG000|Overall Study|Progressive Disease|7|||
42071966|NCT00538681|75881811|FG001|Overall Study|Progressive Disease|0|||
42071967|NCT00538681|75881812|FG002|Overall Study|Progressive Disease|1|||
42071968|NCT00538681|75881813|FG003|Overall Study|Progressive Disease|0|||
42071969|NCT00538681|75881810|FG000|Overall Study|Sponsor Decision|1|||
42071970|NCT00538681|75881811|FG001|Overall Study|Sponsor Decision|3|||
42071971|NCT00538681|75881812|FG002|Overall Study|Sponsor Decision|8|||
42071972|NCT00538681|75881813|FG003|Overall Study|Sponsor Decision|9|||
42071973|NCT00538681|75881810|FG000|Overall Study|Adverse Event|1|||
42071974|NCT00538681|75881811|FG001|Overall Study|Adverse Event|1|||
42071975|NCT00538681|75881812|FG002|Overall Study|Adverse Event|1|||
42071976|NCT00538681|75881813|FG003|Overall Study|Adverse Event|0|||
42071977|NCT00538681|75881810|FG000|Overall Study|Death|0|||
42071978|NCT00538681|75881811|FG001|Overall Study|Death|0|||
42071979|NCT00538681|75881812|FG002|Overall Study|Death|1|||
42071980|NCT00538681|75881813|FG003|Overall Study|Death|1|||
42071981|NCT00538681|75881810|FG000|Overall Study|Investigator Decision|0|||
42071982|NCT00538681|75881811|FG001|Overall Study|Investigator Decision|0|||
42017414|NCT01127139|75825059|FG000|Overall Study|Lack of Efficacy|4|||
42017415|NCT01127139|75825059|FG000|Overall Study|Reason not specified|1|||
42017416|NCT01214616|75825070|FG000|Overall Study|Progressive disease|2|||
42017417|NCT01214616|75825071|FG001|Overall Study|Progressive disease|2|||
42017418|NCT01214616|75825072|FG002|Overall Study|Progressive disease|2|||
42071983|NCT00538681|75881812|FG002|Overall Study|Investigator Decision|0|||
42071984|NCT00538681|75881813|FG003|Overall Study|Investigator Decision|1|||
42071985|NCT00876018|75881827|FG000|Overall Study|Lost to Follow-up|0|||
42071986|NCT00876018|75881828|FG001|Overall Study|Lost to Follow-up|1|||
42071987|NCT00876018|75881829|FG002|Overall Study|Lost to Follow-up|1|||
42071988|NCT00876018|75881827|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
42071989|NCT00876018|75881828|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
42071990|NCT00876018|75881829|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
42071991|NCT03885934|75881854|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
42071992|NCT03885934|75881855|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
42071993|NCT03885934|75881856|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
42071994|NCT03885934|75881857|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
42071995|NCT03885934|75881858|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
42071996|NCT03885934|75881859|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
42071997|NCT04417894|75881875|FG000|Overall Study|Lost to Follow-up|3|||
42071998|NCT04417894|75881876|FG001|Overall Study|Lost to Follow-up|0|||
42071999|NCT04417894|75881875|FG000|Overall Study|Withdrawal by Subject|7|||
42072000|NCT04417894|75881876|FG001|Overall Study|Withdrawal by Subject|6|||
42072001|NCT04417894|75881875|FG000|Overall Study|Lack of Efficacy|3|||
42072002|NCT04417894|75881876|FG001|Overall Study|Lack of Efficacy|1|||
42072003|NCT00875706|75881889|FG000|Overall Study|Withdrawal by Subject|1|||
42072004|NCT00875706|75881890|FG001|Overall Study|Withdrawal by Subject|0|||
42072005|NCT00875706|75881891|FG002|Overall Study|Withdrawal by Subject|0|||
42072006|NCT04399889|75881902|FG000|Overall Study|Death|5|||
42072007|NCT04399889|75881903|FG001|Overall Study|Death|1|||
42072008|NCT04399889|75881904|FG002|Overall Study|Death|1|||
42072009|NCT00837265|75881919|FG000|Pilot Phase|Withdrawal by Subject|0|||
42072010|NCT00837265|75881920|FG001|Pilot Phase|Withdrawal by Subject|2|||
42072011|NCT00837265|75881921|FG002|Pilot Phase|Withdrawal by Subject|3|||
42072012|NCT00837265|75881922|FG003|Pilot Phase|Withdrawal by Subject|2|||
42072013|NCT00837265|75881923|FG004|Pilot Phase|Withdrawal by Subject|0|||
42072014|NCT00837265|75881924|FG005|Pilot Phase|Withdrawal by Subject|0|||
42072015|NCT00837265|75881925|FG006|Pilot Phase|Withdrawal by Subject|0|||
42072016|NCT00837265|75881919|FG000|Pilot Phase|Decision of the investigator|2|||
42072017|NCT00837265|75881920|FG001|Pilot Phase|Decision of the investigator|1|||
42072018|NCT00837265|75881921|FG002|Pilot Phase|Decision of the investigator|0|||
42072019|NCT00837265|75881922|FG003|Pilot Phase|Decision of the investigator|0|||
42072020|NCT00837265|75881923|FG004|Pilot Phase|Decision of the investigator|0|||
42072021|NCT00837265|75881924|FG005|Pilot Phase|Decision of the investigator|0|||
42072022|NCT00837265|75881925|FG006|Pilot Phase|Decision of the investigator|0|||
42072023|NCT00837265|75881919|FG000|Pilot Phase|Adverse Event|1|||
42072024|NCT00837265|75881920|FG001|Pilot Phase|Adverse Event|0|||
42072025|NCT00837265|75881921|FG002|Pilot Phase|Adverse Event|0|||
42072026|NCT00837265|75881922|FG003|Pilot Phase|Adverse Event|0|||
42072027|NCT00837265|75881923|FG004|Pilot Phase|Adverse Event|0|||
42072028|NCT00837265|75881924|FG005|Pilot Phase|Adverse Event|0|||
42072029|NCT00837265|75881925|FG006|Pilot Phase|Adverse Event|0|||
42072030|NCT00837265|75881919|FG000|Pilot Phase|Disease progression|0|||
42072031|NCT00837265|75881920|FG001|Pilot Phase|Disease progression|0|||
42072032|NCT00837265|75881921|FG002|Pilot Phase|Disease progression|0|||
42072033|NCT00837265|75881922|FG003|Pilot Phase|Disease progression|1|||
42072034|NCT00837265|75881923|FG004|Pilot Phase|Disease progression|0|||
42072035|NCT00837265|75881924|FG005|Pilot Phase|Disease progression|0|||
42072036|NCT00837265|75881925|FG006|Pilot Phase|Disease progression|0|||
42072037|NCT00837265|75881919|FG000|Pilot Phase|Participant left the city|0|||
42072038|NCT00837265|75881920|FG001|Pilot Phase|Participant left the city|0|||
42072039|NCT00837265|75881921|FG002|Pilot Phase|Participant left the city|0|||
42072040|NCT00837265|75881922|FG003|Pilot Phase|Participant left the city|1|||
42072041|NCT00837265|75881923|FG004|Pilot Phase|Participant left the city|0|||
42072042|NCT00837265|75881924|FG005|Pilot Phase|Participant left the city|0|||
42072043|NCT00837265|75881925|FG006|Pilot Phase|Participant left the city|0|||
42072044|NCT00837265|75881919|FG000|Main Phase|Withdrawal by Subject|0|||
42072045|NCT00837265|75881920|FG001|Main Phase|Withdrawal by Subject|0|||
42072046|NCT00837265|75881921|FG002|Main Phase|Withdrawal by Subject|0|||
42072047|NCT00837265|75881922|FG003|Main Phase|Withdrawal by Subject|0|||
42072048|NCT00837265|75881923|FG004|Main Phase|Withdrawal by Subject|4|||
42072049|NCT00837265|75881924|FG005|Main Phase|Withdrawal by Subject|2|||
42072050|NCT00837265|75881925|FG006|Main Phase|Withdrawal by Subject|1|||
42072051|NCT00837265|75881919|FG000|Main Phase|Decision of the investigator|0|||
42072052|NCT00837265|75881920|FG001|Main Phase|Decision of the investigator|0|||
42072053|NCT00837265|75881921|FG002|Main Phase|Decision of the investigator|0|||
42072054|NCT00837265|75881922|FG003|Main Phase|Decision of the investigator|0|||
42072055|NCT00837265|75881923|FG004|Main Phase|Decision of the investigator|0|||
42072056|NCT00837265|75881924|FG005|Main Phase|Decision of the investigator|2|||
42072057|NCT00837265|75881925|FG006|Main Phase|Decision of the investigator|1|||
42072058|NCT00837265|75881919|FG000|Main Phase|Adverse Event|0|||
42072059|NCT00837265|75881920|FG001|Main Phase|Adverse Event|0|||
42072060|NCT00837265|75881921|FG002|Main Phase|Adverse Event|0|||
42072061|NCT00837265|75881922|FG003|Main Phase|Adverse Event|0|||
42072062|NCT00837265|75881923|FG004|Main Phase|Adverse Event|0|||
42072063|NCT00837265|75881924|FG005|Main Phase|Adverse Event|1|||
42072064|NCT00837265|75881925|FG006|Main Phase|Adverse Event|0|||
42072065|NCT00837265|75881919|FG000|Main Phase|Death|0|||
42072066|NCT00837265|75881920|FG001|Main Phase|Death|0|||
42072067|NCT00837265|75881921|FG002|Main Phase|Death|0|||
42072068|NCT00837265|75881922|FG003|Main Phase|Death|0|||
42072069|NCT00837265|75881923|FG004|Main Phase|Death|2|||
42072070|NCT00837265|75881924|FG005|Main Phase|Death|0|||
42072071|NCT00837265|75881925|FG006|Main Phase|Death|1|||
42072072|NCT00837265|75881919|FG000|Main Phase|Lost to Follow-up|0|||
42072073|NCT00837265|75881920|FG001|Main Phase|Lost to Follow-up|0|||
42072074|NCT00837265|75881921|FG002|Main Phase|Lost to Follow-up|0|||
42072075|NCT00837265|75881922|FG003|Main Phase|Lost to Follow-up|0|||
42072076|NCT00837265|75881923|FG004|Main Phase|Lost to Follow-up|1|||
42072077|NCT00837265|75881924|FG005|Main Phase|Lost to Follow-up|0|||
42072078|NCT00837265|75881925|FG006|Main Phase|Lost to Follow-up|0|||
42072079|NCT00837265|75881919|FG000|Main Phase|Principal investigator resignation|0|||
42072080|NCT00837265|75881920|FG001|Main Phase|Principal investigator resignation|0|||
42072081|NCT00837265|75881921|FG002|Main Phase|Principal investigator resignation|0|||
42072082|NCT00837265|75881922|FG003|Main Phase|Principal investigator resignation|0|||
42072083|NCT00837265|75881923|FG004|Main Phase|Principal investigator resignation|2|||
42072084|NCT00837265|75881924|FG005|Main Phase|Principal investigator resignation|0|||
42072085|NCT00837265|75881925|FG006|Main Phase|Principal investigator resignation|0|||
42072086|NCT00837265|75881919|FG000|Main Phase|Participant's personal reason|0|||
42072087|NCT00837265|75881920|FG001|Main Phase|Participant's personal reason|0|||
42072088|NCT00837265|75881921|FG002|Main Phase|Participant's personal reason|0|||
42072089|NCT00837265|75881922|FG003|Main Phase|Participant's personal reason|0|||
42072090|NCT00837265|75881923|FG004|Main Phase|Participant's personal reason|1|||
42072091|NCT00837265|75881924|FG005|Main Phase|Participant's personal reason|0|||
42072092|NCT00837265|75881925|FG006|Main Phase|Participant's personal reason|0|||
42072093|NCT00594516|75881938|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
42072094|NCT00594516|75881939|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
42072095|NCT00594516|75881940|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
42072096|NCT00594516|75881938|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
42072097|NCT00594516|75881939|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
42072098|NCT00594516|75881940|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
42072099|NCT00594516|75881938|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
42072100|NCT00594516|75881939|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
42072101|NCT00594516|75881940|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
42072102|NCT00594516|75881938|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
42072103|NCT00594516|75881939|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
42072104|NCT00594516|75881940|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
42072105|NCT00594516|75881938|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
42072106|NCT00594516|75881939|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
42072107|NCT00594516|75881940|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
42072108|NCT00594516|75881938|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
42072109|NCT00594516|75881939|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
42072110|NCT00594516|75881940|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
42072111|NCT00594516|75881938|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
42072112|NCT00594516|75881939|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
42072113|NCT00594516|75881940|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
42072114|NCT00594516|75881938|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
42072115|NCT00594516|75881939|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
42072116|NCT00594516|75881940|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
42072117|NCT00594516|75881938|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
42072118|NCT00594516|75881939|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
42072119|NCT00594516|75881940|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
42072120|NCT00538291|75881944|FG000|Overall Study|Adverse Event|2|||
42072121|NCT00538291|75881944|FG000|Overall Study|Withdrawal by Subject|1|||
42072122|NCT00594906|75881950|FG000|Overall Study|Physician Decision|1|||
42072123|NCT00594906|75881951|FG001|Overall Study|Physician Decision|0|||
42177436|NCT00250679|75984576|FG002|Overall Study|various single events: hip surgery,diary|1|||
42177437|NCT00261833|75984586|FG000|Overall Study|Death|1|||
42177438|NCT00261833|75984587|FG001|Overall Study|Death|3|||
42072124|NCT00594906|75881950|FG000|Overall Study|Physician Decision|0|||
42072125|NCT00594906|75881951|FG001|Overall Study|Physician Decision|1|||
42072126|NCT00594906|75881950|FG000|Overall Study|Death|0|||
42072127|NCT00594906|75881951|FG001|Overall Study|Death|1|||
42072128|NCT00537979|75881959|FG000|Overall Study|Adverse Event|2|||
42072129|NCT00537979|75881960|FG001|Overall Study|Adverse Event|2|||
42072130|NCT00537979|75881959|FG000|Overall Study|Withdrawal by Subject|1|||
42072131|NCT00537979|75881960|FG001|Overall Study|Withdrawal by Subject|4|||
42072132|NCT00537979|75881959|FG000|Overall Study|Lost to Follow-up|1|||
42072133|NCT00537979|75881960|FG001|Overall Study|Lost to Follow-up|4|||
42177439|NCT00261833|75984586|FG000|Overall Study|Adverse Event|1|||
42072134|NCT00537979|75881959|FG000|Overall Study|Lack of Efficacy|0|||
42072135|NCT00537979|75881960|FG001|Overall Study|Lack of Efficacy|1|||
42072136|NCT00537979|75881959|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
42072137|NCT00537979|75881960|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
42072138|NCT00537979|75881959|FG000|Overall Study|Death|0|||
42072139|NCT00537979|75881960|FG001|Overall Study|Death|3|||
42072140|NCT00537979|75881959|FG000|Overall Study|Kidney transplant|0|||
42072141|NCT00537979|75881960|FG001|Overall Study|Kidney transplant|3|||
42072142|NCT00537979|75881959|FG000|Overall Study|Heart failure|0|||
42072143|NCT00537979|75881960|FG001|Overall Study|Heart failure|1|||
42072144|NCT00537823|75881969|FG000|Overall Study|Adverse Event|2|||
42072145|NCT00537823|75881970|FG001|Overall Study|Adverse Event|0|||
42072146|NCT00537277|75881977|FG000|Overall Study|Adverse Event|1|||
42072147|NCT00537277|75881977|FG000|Overall Study|Lack of Efficacy|2|||
42072148|NCT00537277|75881977|FG000|Overall Study|Lost to Follow-up|12|||
42072149|NCT00537277|75881977|FG000|Overall Study|Protocol Violation|11|||
42072150|NCT00537277|75881977|FG000|Overall Study|Unclassified|4|||
42072151|NCT00537277|75881977|FG000|Overall Study|Inability to tolerate trial medication|4|||
42072152|NCT00537277|75881977|FG000|Overall Study|Non-compliance with trial procedures|15|||
42072153|NCT00537199|75881981|FG000|Overall Study|Study Terminated|1|||
42072154|NCT03898063|75881987|FG000|Overall Study|Withdrawal by Subject|10|||
42072155|NCT03898063|75881988|FG001|Overall Study|Withdrawal by Subject|8|||
42072156|NCT00873912|75881996|FG000|Overall Study|Withdrawal by Subject|1|||
42072157|NCT00873912|75881997|FG001|Overall Study|Withdrawal by Subject|0|||
42072158|NCT00873912|75881996|FG000|Overall Study|Lost to Follow-up|2|||
42072159|NCT00873912|75881997|FG001|Overall Study|Lost to Follow-up|0|||
42072160|NCT03823300|75882009|FG000|Overall Study|Withdrawal by Subject|16|||
42072161|NCT03823300|75882010|FG001|Overall Study|Withdrawal by Subject|22|||
42072162|NCT03823300|75882009|FG000|Overall Study|Death|10|||
42072163|NCT03823300|75882010|FG001|Overall Study|Death|14|||
42072164|NCT03823300|75882009|FG000|Overall Study|Adverse Event|3|||
42072165|NCT03823300|75882010|FG001|Overall Study|Adverse Event|5|||
42072166|NCT03823300|75882009|FG000|Overall Study|Physician Decision|1|||
42072167|NCT03823300|75882010|FG001|Overall Study|Physician Decision|7|||
42072168|NCT03823300|75882009|FG000|Overall Study|Lost to Follow-up|1|||
42072169|NCT03823300|75882010|FG001|Overall Study|Lost to Follow-up|3|||
42072170|NCT03823300|75882009|FG000|Overall Study|Protocol Violation|1|||
42072171|NCT03823300|75882010|FG001|Overall Study|Protocol Violation|1|||
42072172|NCT03823300|75882009|FG000|Overall Study|Lack of Efficacy|1|||
42072173|NCT03823300|75882010|FG001|Overall Study|Lack of Efficacy|1|||
42072174|NCT03823300|75882009|FG000|Overall Study|Not Eligible|0|||
42072175|NCT03823300|75882010|FG001|Overall Study|Not Eligible|1|||
42072176|NCT03823300|75882009|FG000|Overall Study|Other|1|||
42072177|NCT03823300|75882010|FG001|Overall Study|Other|0|||
42072178|NCT00537745|75882016|FG000|Overall Study|Did not meet eligibility criteria|2|||
42072179|NCT00537745|75882016|FG000|Overall Study|Withdrawal by Subject|2|||
42072180|NCT00537745|75882016|FG000|Overall Study|Subject unable to provide Interlock info|1|||
42072181|NCT00874848|75882023|FG000|Overall Study|Adverse Event|13|||
42072182|NCT00874848|75882024|FG001|Overall Study|Adverse Event|2|||
42072183|NCT00874848|75882023|FG000|Overall Study|Progressive neoplastic disease|38|||
42072184|NCT00874848|75882024|FG001|Overall Study|Progressive neoplastic disease|18|||
42072185|NCT00874848|75882023|FG000|Overall Study|Withdrawal by Subject|7|||
42072186|NCT00874848|75882024|FG001|Overall Study|Withdrawal by Subject|4|||
42072187|NCT00874848|75882023|FG000|Overall Study|Noncompliance|1|||
42072188|NCT00874848|75882024|FG001|Overall Study|Noncompliance|1|||
42072189|NCT00874848|75882023|FG000|Overall Study|Failure to comply with protocol|0|||
42072190|NCT00874848|75882024|FG001|Overall Study|Failure to comply with protocol|1|||
42072191|NCT00874848|75882023|FG000|Overall Study|Physician Decision|0|||
42072192|NCT00874848|75882024|FG001|Overall Study|Physician Decision|2|||
42072193|NCT00578812|75882032|FG000|Overall Study|Not treated|6|||
42072194|NCT00578812|75882033|FG001|Overall Study|Not treated|7|||
42072195|NCT04043806|75882040|FG000|Overall Study|Commercial drug is available for participants|13|||
42293413|NCT02649439|76127562|FG000|Overall Study|Switched to alternative treatment|6|||
42072196|NCT04043806|75882040|FG000|Overall Study|Physician Decision|2|||
42072197|NCT04043806|75882040|FG000|Overall Study|Other|12|||
42072198|NCT04043806|75882040|FG000|Overall Study|Adverse Event|2|||
42072199|NCT04043806|75882040|FG000|Overall Study|Lost to Follow-up|6|||
42293414|NCT02649439|76127563|FG001|Overall Study|Switched to alternative treatment|4|||
42293415|NCT02649439|76127562|FG000|Overall Study|Patient decision|1|||
42293416|NCT02649439|76127563|FG001|Overall Study|Patient decision|0|||
42072200|NCT04043806|75882040|FG000|Overall Study|Other non-compliance|2|||
42072201|NCT04043806|75882040|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
42072202|NCT04043806|75882040|FG000|Overall Study|Never Dosed|1|||
42072203|NCT00536809|75882045|FG000|Phase II|Adverse Event|1|||
42072204|NCT00536809|75882045|FG000|Phase II|Referred for surgical resection|1|||
42072205|NCT00536731|75882056|FG000|Overall Study|Adverse Event|3|||
42072206|NCT00536731|75882057|FG001|Overall Study|Adverse Event|2|||
42072207|NCT00536731|75882058|FG002|Overall Study|Adverse Event|3|||
42072208|NCT00536731|75882056|FG000|Overall Study|Withdrawal by Subject|0|||
42072209|NCT00536731|75882057|FG001|Overall Study|Withdrawal by Subject|2|||
42072210|NCT00536731|75882058|FG002|Overall Study|Withdrawal by Subject|0|||
42072211|NCT00536731|75882056|FG000|Overall Study|Intake of prohibited conc. medication|0|||
42072212|NCT00536731|75882057|FG001|Overall Study|Intake of prohibited conc. medication|0|||
42072213|NCT00536731|75882058|FG002|Overall Study|Intake of prohibited conc. medication|1|||
42072214|NCT00536731|75882056|FG000|Overall Study|Safety reasons|0|||
42072215|NCT00536731|75882057|FG001|Overall Study|Safety reasons|0|||
42072216|NCT00536731|75882058|FG002|Overall Study|Safety reasons|1|||
42072217|NCT00536731|75882056|FG000|Overall Study|Other|1|||
42072218|NCT00536731|75882057|FG001|Overall Study|Other|1|||
42072219|NCT00536731|75882058|FG002|Overall Study|Other|0|||
42072220|NCT00536575|75882066|FG000|Overall Study|Withdrawal by Subject|1|||
42072221|NCT00536575|75882066|FG000|Overall Study|Death|1|||
42072222|NCT03214250|75882077|FG000|Overall Study|Death|5|||
42072223|NCT03214250|75882078|FG001|Overall Study|Death|5|||
42072224|NCT03214250|75882079|FG002|Overall Study|Death|7|||
42072225|NCT03214250|75882080|FG003|Overall Study|Death|4|||
42072226|NCT03214250|75882081|FG004|Overall Study|Death|23|||
42072227|NCT03214250|75882082|FG005|Overall Study|Death|23|||
42177440|NCT00261833|75984587|FG001|Overall Study|Adverse Event|4|||
42177441|NCT00261833|75984586|FG000|Overall Study|Withdrawal by Subject|5|||
42177442|NCT00261833|75984587|FG001|Overall Study|Withdrawal by Subject|7|||
42177443|NCT00261833|75984586|FG000|Overall Study|Protocol Violation|0|||
42177444|NCT00261833|75984587|FG001|Overall Study|Protocol Violation|1|||
42177445|NCT00261833|75984586|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
42177446|NCT00261833|75984587|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
42177447|NCT00261833|75984586|FG000|Overall Study|Lung transplantation|1|||
42177448|NCT00261833|75984587|FG001|Overall Study|Lung transplantation|1|||
42177449|NCT00261833|75984586|FG000|Overall Study|Missing reason|1|||
42177450|NCT00261833|75984587|FG001|Overall Study|Missing reason|0|||
42177451|NCT00261833|75984586|FG000|Overall Study|Not interested in being participant|0|||
42177452|NCT00261833|75984587|FG001|Overall Study|Not interested in being participant|1|||
42177453|NCT03713684|75984598|FG000|Overall Study|Adverse Event|1|||
42177454|NCT03713684|75984599|FG001|Overall Study|Adverse Event|3|||
42177455|NCT03713684|75984600|FG002|Overall Study|Adverse Event|1|||
42177456|NCT03713684|75984601|FG003|Overall Study|Adverse Event|0|||
42177457|NCT03713684|75984598|FG000|Overall Study|Poor compliance to protocol|2|||
42177458|NCT03713684|75984599|FG001|Overall Study|Poor compliance to protocol|1|||
42177459|NCT03713684|75984600|FG002|Overall Study|Poor compliance to protocol|0|||
42177460|NCT03713684|75984601|FG003|Overall Study|Poor compliance to protocol|1|||
42177461|NCT03713684|75984598|FG000|Overall Study|Withdrawal by Subject|14|||
42177462|NCT03713684|75984599|FG001|Overall Study|Withdrawal by Subject|6|||
42177463|NCT03713684|75984600|FG002|Overall Study|Withdrawal by Subject|14|||
42177464|NCT03713684|75984601|FG003|Overall Study|Withdrawal by Subject|16|||
42177465|NCT03713684|75984598|FG000|Overall Study|Other than specified|69|||
42177466|NCT03713684|75984599|FG001|Overall Study|Other than specified|77|||
42177467|NCT03713684|75984600|FG002|Overall Study|Other than specified|73|||
42177468|NCT03713684|75984601|FG003|Overall Study|Other than specified|70|||
42177469|NCT03711266|75984611|FG000|Overall Study|Lost to Follow-up|10|||
42177470|NCT03150862|75984623|FG000|Overall Study|Death|2|||
42177471|NCT03150862|75984624|FG001|Overall Study|Death|7|||
42177472|NCT03150862|75984625|FG002|Overall Study|Death|8|||
42177473|NCT03150862|75984626|FG003|Overall Study|Death|27|||
42177474|NCT03150862|75984627|FG004|Overall Study|Death|4|||
42177475|NCT03150862|75984628|FG005|Overall Study|Death|8|||
42177476|NCT03150862|75984629|FG006|Overall Study|Death|6|||
42177477|NCT03150862|75984630|FG007|Overall Study|Death|21|||
42177478|NCT03150862|75984623|FG000|Overall Study|Withdrawal by Subject|1|||
42177479|NCT03150862|75984624|FG001|Overall Study|Withdrawal by Subject|1|||
42177480|NCT03150862|75984625|FG002|Overall Study|Withdrawal by Subject|0|||
42177481|NCT03150862|75984626|FG003|Overall Study|Withdrawal by Subject|3|||
42177482|NCT03150862|75984627|FG004|Overall Study|Withdrawal by Subject|1|||
42017419|NCT01214616|75825073|FG003|Overall Study|Progressive disease|4|||
42017420|NCT01214616|75825070|FG000|Overall Study|Dose limiting toxicity|0|||
42017421|NCT01214616|75825071|FG001|Overall Study|Dose limiting toxicity|2|||
42017422|NCT01214616|75825072|FG002|Overall Study|Dose limiting toxicity|0|||
42017423|NCT01214616|75825073|FG003|Overall Study|Dose limiting toxicity|0|||
42017424|NCT01214616|75825070|FG000|Overall Study|Other adverse events|0|||
42017425|NCT01214616|75825071|FG001|Overall Study|Other adverse events|1|||
42017426|NCT01214616|75825072|FG002|Overall Study|Other adverse events|1|||
42017427|NCT01214616|75825073|FG003|Overall Study|Other adverse events|1|||
42017428|NCT01214616|75825070|FG000|Overall Study|Withdrawal by Subject|1|||
42017429|NCT01214616|75825071|FG001|Overall Study|Withdrawal by Subject|0|||
42072228|NCT03214250|75882083|FG006|Overall Study|Death|24|||
42072229|NCT03214250|75882077|FG000|Overall Study|Lost to Follow-up|0|||
42072230|NCT03214250|75882078|FG001|Overall Study|Lost to Follow-up|0|||
42072231|NCT03214250|75882079|FG002|Overall Study|Lost to Follow-up|0|||
42072232|NCT03214250|75882080|FG003|Overall Study|Lost to Follow-up|1|||
42072233|NCT03214250|75882081|FG004|Overall Study|Lost to Follow-up|1|||
42072234|NCT03214250|75882082|FG005|Overall Study|Lost to Follow-up|2|||
42072235|NCT03214250|75882083|FG006|Overall Study|Lost to Follow-up|0|||
42072236|NCT03214250|75882077|FG000|Overall Study|Other|0|||
42072237|NCT03214250|75882078|FG001|Overall Study|Other|0|||
42072238|NCT03214250|75882079|FG002|Overall Study|Other|0|||
42072239|NCT03214250|75882080|FG003|Overall Study|Other|0|||
42072240|NCT03214250|75882081|FG004|Overall Study|Other|1|||
42072241|NCT03214250|75882082|FG005|Overall Study|Other|1|||
42072242|NCT03214250|75882083|FG006|Overall Study|Other|2|||
42072243|NCT03214250|75882077|FG000|Overall Study|Remains on Study|2|||
42072244|NCT03214250|75882078|FG001|Overall Study|Remains on Study|2|||
42072245|NCT03214250|75882079|FG002|Overall Study|Remains on Study|0|||
42072246|NCT03214250|75882080|FG003|Overall Study|Remains on Study|1|||
42072247|NCT03214250|75882081|FG004|Overall Study|Remains on Study|7|||
42072248|NCT03214250|75882082|FG005|Overall Study|Remains on Study|5|||
42072249|NCT03214250|75882083|FG006|Overall Study|Remains on Study|3|||
42072250|NCT03214250|75882077|FG000|Overall Study|Withdrawal by Subject|0|||
42072251|NCT03214250|75882078|FG001|Overall Study|Withdrawal by Subject|0|||
42072252|NCT03214250|75882079|FG002|Overall Study|Withdrawal by Subject|1|||
42072253|NCT03214250|75882080|FG003|Overall Study|Withdrawal by Subject|2|||
42072254|NCT03214250|75882081|FG004|Overall Study|Withdrawal by Subject|5|||
42072255|NCT03214250|75882082|FG005|Overall Study|Withdrawal by Subject|0|||
42072256|NCT03214250|75882083|FG006|Overall Study|Withdrawal by Subject|2|||
42072257|NCT00874770|75882107|FG000|Overall Study|Lack of Efficacy|2|||
42072258|NCT00874770|75882108|FG001|Overall Study|Lack of Efficacy|0|||
42072259|NCT00874770|75882109|FG002|Overall Study|Lack of Efficacy|0|||
42072260|NCT00874770|75882110|FG003|Overall Study|Lack of Efficacy|2|||
42072261|NCT00874770|75882107|FG000|Overall Study|Adverse Event|1|||
42072262|NCT00874770|75882108|FG001|Overall Study|Adverse Event|1|||
42072263|NCT00874770|75882109|FG002|Overall Study|Adverse Event|4|||
42072264|NCT00874770|75882110|FG003|Overall Study|Adverse Event|2|||
42072265|NCT00874770|75882107|FG000|Overall Study|Lost to Follow-up|1|||
42072266|NCT00874770|75882108|FG001|Overall Study|Lost to Follow-up|0|||
42072267|NCT00874770|75882109|FG002|Overall Study|Lost to Follow-up|0|||
42072268|NCT00874770|75882110|FG003|Overall Study|Lost to Follow-up|1|||
42072269|NCT00874770|75882107|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
42072270|NCT00874770|75882108|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
42072271|NCT00874770|75882109|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
42072272|NCT00874770|75882110|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
42072273|NCT00536263|75882133|FG000|Overall Study|Adverse Event|5|||
42072274|NCT00536263|75882134|FG001|Overall Study|Adverse Event|5|||
42072275|NCT00536263|75882135|FG002|Overall Study|Adverse Event|7|||
42072276|NCT00536263|75882133|FG000|Overall Study|Lost to Follow-up|3|||
42072277|NCT00536263|75882134|FG001|Overall Study|Lost to Follow-up|4|||
42072278|NCT00536263|75882135|FG002|Overall Study|Lost to Follow-up|4|||
42072279|NCT00536263|75882133|FG000|Overall Study|Subject withdrew - not treatment related|2|||
42072280|NCT00536263|75882134|FG001|Overall Study|Subject withdrew - not treatment related|0|||
42177483|NCT03150862|75984628|FG005|Overall Study|Withdrawal by Subject|1|||
42177484|NCT03150862|75984629|FG006|Overall Study|Withdrawal by Subject|1|||
42017430|NCT01214616|75825072|FG002|Overall Study|Withdrawal by Subject|0|||
42017431|NCT01214616|75825073|FG003|Overall Study|Withdrawal by Subject|1|||
42017432|NCT01213836|75825093|FG000|Period 1, First Intervention|Adverse Event|2|||
42017433|NCT01213836|75825094|FG001|Period 1, First Intervention|Adverse Event|1|||
42017434|NCT01213836|75825093|FG000|Period 1, First Intervention|Protocol Violation|0|||
42017435|NCT01213836|75825094|FG001|Period 1, First Intervention|Protocol Violation|1|||
42017436|NCT01213836|75825093|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
42017437|NCT01213836|75825094|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
42017438|NCT01127061|75825105|FG000|Overall Study|Lost to Follow-up|7|||
42072281|NCT00536263|75882135|FG002|Overall Study|Subject withdrew - not treatment related|5|||
42072282|NCT00536263|75882133|FG000|Overall Study|Subject withdrew - treatment related|0|||
42072283|NCT00536263|75882134|FG001|Overall Study|Subject withdrew - treatment related|3|||
42072284|NCT00536263|75882135|FG002|Overall Study|Subject withdrew - treatment related|2|||
42072285|NCT00536263|75882133|FG000|Overall Study|Noncompliance with protocol|0|||
42072286|NCT00536263|75882134|FG001|Overall Study|Noncompliance with protocol|0|||
42072287|NCT00536263|75882135|FG002|Overall Study|Noncompliance with protocol|1|||
42072288|NCT00536263|75882133|FG000|Overall Study|Did not meet protocol eligibility|1|||
42072289|NCT00536263|75882134|FG001|Overall Study|Did not meet protocol eligibility|2|||
42072290|NCT00536263|75882135|FG002|Overall Study|Did not meet protocol eligibility|2|||
42072291|NCT00578344|75882143|FG000|Overall Study|Insurance problems|1|||
42072292|NCT00578344|75882143|FG000|Overall Study|Graft failure|1|||
42072293|NCT00873366|75882147|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
42072294|NCT00873366|75882147|FG000|Overall Study|Off tamoxifen due to side effects|2|||
42072295|NCT00873366|75882147|FG000|Overall Study|Refused to continue DM-BT testing|3|||
42072296|NCT00536107|75882153|FG000|Overall Study|Death|5|||
42072297|NCT00536107|75882154|FG001|Overall Study|Death|1|||
42072298|NCT00536107|75882153|FG000|Overall Study|Incorrect enrolment|1|||
42072299|NCT00536107|75882154|FG001|Overall Study|Incorrect enrolment|0|||
42072300|NCT00536107|75882153|FG000|Overall Study|Withdrawal by Subject|0|||
42072301|NCT00536107|75882154|FG001|Overall Study|Withdrawal by Subject|1|||
42072302|NCT00536107|75882153|FG000|Overall Study|Study Termination|2|||
42072303|NCT00536107|75882154|FG001|Overall Study|Study Termination|4|||
42072304|NCT00885482|75882174|FG000|Overall Study|Pregnancy|1|||
42072305|NCT00885482|75882174|FG000|Overall Study|Lack of Efficacy|1|||
42072306|NCT00885482|75882174|FG000|Overall Study|Death|1|||
42072307|NCT00885482|75882174|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
42072308|NCT00885170|75882198|FG000|Overall Study|Adverse Event|12|||
42072309|NCT00885170|75882199|FG001|Overall Study|Adverse Event|4|||
42072310|NCT00885170|75882198|FG000|Overall Study|Excessive bone loss|6|||
42072311|NCT00885170|75882199|FG001|Overall Study|Excessive bone loss|3|||
42072312|NCT00885170|75882198|FG000|Overall Study|Lost to Follow-up|2|||
42072313|NCT00885170|75882199|FG001|Overall Study|Lost to Follow-up|1|||
42072314|NCT00885170|75882198|FG000|Overall Study|Physician Decision|2|||
42072315|NCT00885170|75882199|FG001|Overall Study|Physician Decision|1|||
42072316|NCT00885170|75882198|FG000|Overall Study|Protocol Violation|3|||
42072317|NCT00885170|75882199|FG001|Overall Study|Protocol Violation|1|||
42072318|NCT00885170|75882198|FG000|Overall Study|Withdrawal by Subject|13|||
42072319|NCT00885170|75882199|FG001|Overall Study|Withdrawal by Subject|13|||
42072320|NCT00866619|75882226|FG000|Overall Study|Adverse Event|112|||
42072321|NCT00866619|75882227|FG001|Overall Study|Adverse Event|106|||
42072322|NCT00866619|75882228|FG002|Overall Study|Adverse Event|47|||
42072323|NCT00866619|75882229|FG003|Overall Study|Adverse Event|44|||
42072324|NCT00866619|75882226|FG000|Overall Study|Protocol Violation|2|||
42072325|NCT00866619|75882227|FG001|Overall Study|Protocol Violation|39|||
42072326|NCT00866619|75882228|FG002|Overall Study|Protocol Violation|2|||
42072327|NCT00866619|75882229|FG003|Overall Study|Protocol Violation|17|||
42072328|NCT00866619|75882226|FG000|Overall Study|Withdrawal by Subject|587|||
42072329|NCT00866619|75882227|FG001|Overall Study|Withdrawal by Subject|295|||
42072330|NCT00866619|75882228|FG002|Overall Study|Withdrawal by Subject|272|||
42072331|NCT00866619|75882229|FG003|Overall Study|Withdrawal by Subject|144|||
42072332|NCT00866619|75882226|FG000|Overall Study|Lost to Follow-up|1145|||
42072333|NCT00866619|75882227|FG001|Overall Study|Lost to Follow-up|830|||
42072334|NCT00866619|75882228|FG002|Overall Study|Lost to Follow-up|568|||
42072335|NCT00866619|75882229|FG003|Overall Study|Lost to Follow-up|425|||
42072336|NCT00884390|75882276|FG000|Overall Study|Adverse Event|0|||
42072337|NCT00884390|75882277|FG001|Overall Study|Adverse Event|1|||
42072338|NCT00884390|75882276|FG000|Overall Study|Lost to Follow-up|0|||
42072339|NCT00884390|75882277|FG001|Overall Study|Lost to Follow-up|1|||
42072340|NCT00884390|75882276|FG000|Overall Study|Physician Decision|2|||
42072341|NCT00884390|75882277|FG001|Overall Study|Physician Decision|1|||
42072342|NCT00884390|75882276|FG000|Overall Study|Protocol Violation|4|||
42072343|NCT00884390|75882277|FG001|Overall Study|Protocol Violation|1|||
42072344|NCT00884390|75882276|FG000|Overall Study|Withdrawal by Subject|4|||
42072345|NCT00884390|75882277|FG001|Overall Study|Withdrawal by Subject|1|||
42177485|NCT03150862|75984630|FG007|Overall Study|Withdrawal by Subject|3|||
42177486|NCT03150862|75984623|FG000|Overall Study|Lost to Follow-up|0|||
42177487|NCT03150862|75984624|FG001|Overall Study|Lost to Follow-up|0|||
42072346|NCT00884390|75882276|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
42072347|NCT00884390|75882277|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
42072348|NCT00884390|75882276|FG000|Overall Study|Other|11|||
42072349|NCT00884390|75882277|FG001|Overall Study|Other|1|||
42072350|NCT00872898|75882314|FG000|Part Two - Double Blind|Adverse Event|4|||
42072351|NCT00872898|75882315|FG001|Part Two - Double Blind|Adverse Event|3|||
42072352|NCT00872898|75882314|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
42072353|NCT00872898|75882315|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
42072354|NCT00872898|75882314|FG000|Part Two - Double Blind|Protocol Violation|1|||
42072355|NCT00872898|75882315|FG001|Part Two - Double Blind|Protocol Violation|0|||
42072356|NCT00872898|75882314|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
42072357|NCT00872898|75882315|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
42072358|NCT00872898|75882314|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
42072359|NCT00872898|75882315|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
42072360|NCT00872898|75882314|FG000|Part Two - Double Blind|Other reasons|2|||
42072361|NCT00872898|75882315|FG001|Part Two - Double Blind|Other reasons|0|||
42072362|NCT00884312|75882326|FG000|Overall Study|Non-fatal Progressive Disease|0|||
42072363|NCT00884312|75882327|FG001|Overall Study|Non-fatal Progressive Disease|8|||
42072364|NCT00884312|75882326|FG000|Overall Study|Fatal Progressive Disease|0|||
42072365|NCT00884312|75882327|FG001|Overall Study|Fatal Progressive Disease|1|||
42072366|NCT00884312|75882326|FG000|Overall Study|Non-fatal Adverse Event|1|||
42072367|NCT00884312|75882327|FG001|Overall Study|Non-fatal Adverse Event|0|||
42072368|NCT00884312|75882326|FG000|Overall Study|Fatal Adverse Event|1|||
42072369|NCT00884312|75882327|FG001|Overall Study|Fatal Adverse Event|4|||
42072370|NCT00884312|75882326|FG000|Overall Study|Withdrawal by Subject|0|||
42072371|NCT00884312|75882327|FG001|Overall Study|Withdrawal by Subject|6|||
42072372|NCT00884312|75882326|FG000|Overall Study|Physician Decision|0|||
42072373|NCT00884312|75882327|FG001|Overall Study|Physician Decision|1|||
42072374|NCT00884312|75882326|FG000|Overall Study|Other|0|||
42072375|NCT00884312|75882327|FG001|Overall Study|Other|4|||
42072376|NCT00884312|75882326|FG000|Overall Study|Did Not Receive Study Drug|0|||
42072377|NCT00884312|75882327|FG001|Overall Study|Did Not Receive Study Drug|1|||
42072378|NCT00534313|75882337|FG000|Short-term Period|Adverse Event|1|||
42072379|NCT00534313|75882338|FG001|Short-term Period|Adverse Event|2|||
42072380|NCT00534313|75882339|FG002|Short-term Period|Adverse Event|1|||
42072381|NCT00534313|75882340|FG003|Short-term Period|Adverse Event|3|||
42072382|NCT00534313|75882337|FG000|Short-term Period|Lack of Efficacy|3|||
42072383|NCT00534313|75882338|FG001|Short-term Period|Lack of Efficacy|4|||
42072384|NCT00534313|75882339|FG002|Short-term Period|Lack of Efficacy|0|||
42072385|NCT00534313|75882340|FG003|Short-term Period|Lack of Efficacy|3|||
42072386|NCT00534313|75882337|FG000|Short-term Period|Participant not meeting study criteria|0|||
42072387|NCT00534313|75882338|FG001|Short-term Period|Participant not meeting study criteria|0|||
42072388|NCT00534313|75882339|FG002|Short-term Period|Participant not meeting study criteria|0|||
42072389|NCT00534313|75882340|FG003|Short-term Period|Participant not meeting study criteria|1|||
42072390|NCT00534313|75882337|FG000|Short-term Period|Participant withdrew consent|2|||
42072391|NCT00534313|75882338|FG001|Short-term Period|Participant withdrew consent|0|||
42072392|NCT00534313|75882339|FG002|Short-term Period|Participant withdrew consent|0|||
42072393|NCT00534313|75882340|FG003|Short-term Period|Participant withdrew consent|2|||
42072394|NCT00534313|75882337|FG000|Short-term Period|Pregnancy|0|||
42072395|NCT00534313|75882338|FG001|Short-term Period|Pregnancy|0|||
42072396|NCT00534313|75882339|FG002|Short-term Period|Pregnancy|1|||
42072397|NCT00534313|75882340|FG003|Short-term Period|Pregnancy|0|||
42072398|NCT00534313|75882337|FG000|Long-term Period|Adverse Event|2|||
42072399|NCT00534313|75882338|FG001|Long-term Period|Adverse Event|1|||
42072400|NCT00534313|75882339|FG002|Long-term Period|Adverse Event|0|||
42072401|NCT00534313|75882340|FG003|Long-term Period|Adverse Event|1|||
42072402|NCT00534313|75882337|FG000|Long-term Period|Lack of Efficacy|14|||
42072403|NCT00534313|75882338|FG001|Long-term Period|Lack of Efficacy|10|||
42072404|NCT00534313|75882339|FG002|Long-term Period|Lack of Efficacy|14|||
42072405|NCT00534313|75882340|FG003|Long-term Period|Lack of Efficacy|12|||
42072406|NCT00534313|75882337|FG000|Long-term Period|Lost to Follow-up|1|||
42072407|NCT00534313|75882338|FG001|Long-term Period|Lost to Follow-up|2|||
42072408|NCT00534313|75882339|FG002|Long-term Period|Lost to Follow-up|0|||
42072409|NCT00534313|75882340|FG003|Long-term Period|Lost to Follow-up|0|||
42072410|NCT00534313|75882337|FG000|Long-term Period|Withdrawal by Subject|2|||
42072411|NCT00534313|75882338|FG001|Long-term Period|Withdrawal by Subject|2|||
42072412|NCT00534313|75882339|FG002|Long-term Period|Withdrawal by Subject|0|||
42072413|NCT00534313|75882340|FG003|Long-term Period|Withdrawal by Subject|0|||
42072414|NCT00534313|75882337|FG000|Long-term Period|No longer meets study criteria|0|||
42072415|NCT00534313|75882338|FG001|Long-term Period|No longer meets study criteria|1|||
42072416|NCT00534313|75882339|FG002|Long-term Period|No longer meets study criteria|0|||
42072417|NCT00534313|75882340|FG003|Long-term Period|No longer meets study criteria|0|||
42072418|NCT00534313|75882337|FG000|Long-term Period|Poor compliance/noncompliance|0|||
42072419|NCT00534313|75882338|FG001|Long-term Period|Poor compliance/noncompliance|1|||
42072420|NCT00534313|75882339|FG002|Long-term Period|Poor compliance/noncompliance|1|||
42072421|NCT00534313|75882340|FG003|Long-term Period|Poor compliance/noncompliance|0|||
42072422|NCT00534313|75882337|FG000|Long-term Period|Administrative reason by sponsor|17|||
42072423|NCT00534313|75882338|FG001|Long-term Period|Administrative reason by sponsor|15|||
42072424|NCT00534313|75882339|FG002|Long-term Period|Administrative reason by sponsor|26|||
42072425|NCT00534313|75882340|FG003|Long-term Period|Administrative reason by sponsor|18|||
42072426|NCT00534313|75882337|FG000|Long-term Period|Other|1|||
42072427|NCT00534313|75882338|FG001|Long-term Period|Other|2|||
42072428|NCT00534313|75882339|FG002|Long-term Period|Other|2|||
42072429|NCT00534313|75882340|FG003|Long-term Period|Other|2|||
42072430|NCT03888391|75882385|FG000|Overall Study|Lost to Follow-up|15|||
42293417|NCT02649439|76127562|FG000|Overall Study|Patient going out of country|1|||
42357777|NCT01858363|76203289|FG000|Overall Study|Death|35|||
42072431|NCT00594204|75882391|FG000|Overall Study|Adverse Event|15|||
42072432|NCT00594204|75882392|FG001|Overall Study|Adverse Event|3|||
42072433|NCT00594204|75882391|FG000|Overall Study|Lost to Follow-up|9|||
42072434|NCT00594204|75882392|FG001|Overall Study|Lost to Follow-up|5|||
42072435|NCT00594204|75882391|FG000|Overall Study|Withdrawal by Subject|23|||
42072436|NCT00594204|75882392|FG001|Overall Study|Withdrawal by Subject|29|||
42072437|NCT00594204|75882391|FG000|Overall Study|Other|4|||
42072438|NCT00594204|75882392|FG001|Overall Study|Other|3|||
42072439|NCT00594204|75882391|FG000|Overall Study|Lack of Efficacy|3|||
42072440|NCT00594204|75882392|FG001|Overall Study|Lack of Efficacy|4|||
42072441|NCT00594204|75882391|FG000|Overall Study|Randomized but not treated|4|||
42072442|NCT00594204|75882392|FG001|Overall Study|Randomized but not treated|1|||
42072443|NCT03888235|75882410|FG000|Overall Study|Lost to Follow-up|1|||
42072444|NCT03888235|75882411|FG001|Overall Study|Lost to Follow-up|1|||
42072445|NCT03888235|75882412|FG002|Overall Study|Lost to Follow-up|0|||
42072446|NCT00866307|75882443|FG000|Induction|Adverse Event|5|||
42072447|NCT00866307|75882444|FG001|Induction|Adverse Event|0|||
42072448|NCT00866307|75882445|FG002|Induction|Adverse Event|0|||
42072449|NCT00866307|75882443|FG000|Induction|Death|2|||
42072450|NCT00866307|75882444|FG001|Induction|Death|0|||
42072451|NCT00866307|75882445|FG002|Induction|Death|0|||
42072452|NCT00866307|75882443|FG000|Induction|Physician Decision|5|||
42072453|NCT00866307|75882444|FG001|Induction|Physician Decision|0|||
42072454|NCT00866307|75882445|FG002|Induction|Physician Decision|0|||
42072455|NCT00866307|75882443|FG000|Induction|Progressive Disease|1|||
42072456|NCT00866307|75882444|FG001|Induction|Progressive Disease|0|||
42072457|NCT00866307|75882445|FG002|Induction|Progressive Disease|0|||
42072458|NCT00866307|75882443|FG000|Induction|Identification of Patients with Day 29 M|3|||
42072459|NCT00866307|75882444|FG001|Induction|Identification of Patients with Day 29 M|0|||
42072460|NCT00866307|75882445|FG002|Induction|Identification of Patients with Day 29 M|0|||
42072461|NCT00866307|75882443|FG000|Induction|Inadequate cytognetic samples th|1|||
42072462|NCT00866307|75882444|FG001|Induction|Inadequate cytognetic samples th|0|||
42072463|NCT00866307|75882445|FG002|Induction|Inadequate cytognetic samples th|0|||
42072464|NCT00866307|75882443|FG000|Induction|Improper post-induction consent|2|||
42072465|NCT00866307|75882444|FG001|Induction|Improper post-induction consent|0|||
42072466|NCT00866307|75882445|FG002|Induction|Improper post-induction consent|0|||
42072467|NCT00866307|75882443|FG000|Induction|Study was closed at the time|1|||
42072468|NCT00866307|75882444|FG001|Induction|Study was closed at the time|0|||
42072469|NCT00866307|75882445|FG002|Induction|Study was closed at the time|0|||
42072470|NCT00866307|75882443|FG000|Consolidation/Maintenance|Adverse Event|0|||
42072471|NCT00866307|75882444|FG001|Consolidation/Maintenance|Adverse Event|0|||
42072472|NCT00866307|75882445|FG002|Consolidation/Maintenance|Adverse Event|8|||
42072473|NCT00866307|75882443|FG000|Consolidation/Maintenance|Death|0|||
42072474|NCT00866307|75882444|FG001|Consolidation/Maintenance|Death|0|||
42072475|NCT00866307|75882445|FG002|Consolidation/Maintenance|Death|1|||
42072476|NCT00866307|75882443|FG000|Consolidation/Maintenance|Physician Decision|0|||
42072477|NCT00866307|75882444|FG001|Consolidation/Maintenance|Physician Decision|3|||
42072478|NCT00866307|75882445|FG002|Consolidation/Maintenance|Physician Decision|2|||
42072479|NCT00866307|75882443|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
42072480|NCT00866307|75882444|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
42072481|NCT00866307|75882445|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
42072482|NCT00866307|75882443|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
42072483|NCT00866307|75882444|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
42072484|NCT00866307|75882445|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
42072485|NCT00866307|75882443|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
42072486|NCT00866307|75882444|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
42072487|NCT00866307|75882445|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
42072488|NCT00866307|75882443|FG000|Consolidation/Maintenance|Therapy error|0|||
42072489|NCT00866307|75882444|FG001|Consolidation/Maintenance|Therapy error|1|||
42072490|NCT00866307|75882445|FG002|Consolidation/Maintenance|Therapy error|0|||
42072491|NCT00866307|75882443|FG000|Consolidation/Maintenance|Non-compliance|0|||
42072492|NCT00866307|75882444|FG001|Consolidation/Maintenance|Non-compliance|0|||
42072493|NCT00866307|75882445|FG002|Consolidation/Maintenance|Non-compliance|1|||
42072494|NCT00866307|75882443|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
42072495|NCT00866307|75882444|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
42072496|NCT00866307|75882445|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
42072497|NCT00531427|75882453|FG000|Overall Study|Withdrawal by Subject|7|||
42072498|NCT00531427|75882454|FG001|Overall Study|Withdrawal by Subject|13|||
42072499|NCT00531427|75882453|FG000|Overall Study|Adverse Event|44|||
42072500|NCT00531427|75882454|FG001|Overall Study|Adverse Event|30|||
42072501|NCT00531427|75882453|FG000|Overall Study|Lost to Follow-up|4|||
42072502|NCT00531427|75882454|FG001|Overall Study|Lost to Follow-up|3|||
42072503|NCT00531427|75882453|FG000|Overall Study|Lack of Efficacy|14|||
42072504|NCT00531427|75882454|FG001|Overall Study|Lack of Efficacy|39|||
42072505|NCT00531427|75882453|FG000|Overall Study|Administrative|4|||
42072506|NCT00531427|75882454|FG001|Overall Study|Administrative|9|||
42072507|NCT00871728|75882461|FG000|Overall Study|Adverse Event|1|||
42072508|NCT00871728|75882461|FG000|Overall Study|Protocol Violation|7|||
42072509|NCT00871728|75882461|FG000|Overall Study|Lost to Follow-up|2|||
42072510|NCT00871728|75882461|FG000|Overall Study|Failed to Visit Hospital|4|||
42072511|NCT00871728|75882461|FG000|Overall Study|Participant Non-compliance|1|||
42072512|NCT00871728|75882461|FG000|Overall Study|Withdrawal of Informed Consent|5|||
42072513|NCT00868998|75882465|FG000|Overall Study|Screen Failure|1|||
42072514|NCT00868998|75882465|FG000|Overall Study|Withdrawal by Subject|1|||
42072515|NCT00868998|75882465|FG000|Overall Study|Progression of disease|2|||
42072516|NCT00868998|75882465|FG000|Overall Study|Death|1|||
42072517|NCT00533845|75882480|FG000|Overall Study|Physician Decision|1|||
42072518|NCT00533845|75882481|FG001|Overall Study|Physician Decision|0|||
42072519|NCT00857649|75882489|FG000|Overall Study|Adverse Event|15|||
42072520|NCT00857649|75882490|FG001|Overall Study|Adverse Event|10|||
42072521|NCT00857649|75882489|FG000|Overall Study|Non-compliance|1|||
42072522|NCT00857649|75882490|FG001|Overall Study|Non-compliance|1|||
42072523|NCT00857649|75882489|FG000|Overall Study|Protocol Violation|2|||
42072524|NCT00857649|75882490|FG001|Overall Study|Protocol Violation|2|||
42072525|NCT00857649|75882489|FG000|Overall Study|Withdrawal of Consent|10|||
42072526|NCT00857649|75882490|FG001|Overall Study|Withdrawal of Consent|7|||
42072527|NCT00857649|75882489|FG000|Overall Study|Nursing Home Placement|2|||
42072528|NCT00857649|75882490|FG001|Overall Study|Nursing Home Placement|9|||
42072529|NCT00857649|75882489|FG000|Overall Study|Other Reasons|1|||
42072530|NCT00857649|75882490|FG001|Overall Study|Other Reasons|3|||
42072531|NCT00857415|75882498|FG000|Overall Study|Image acquisition failure|2|||
42072532|NCT00857415|75882499|FG001|Overall Study|Image acquisition failure|0|||
42072533|NCT00857415|75882498|FG000|Overall Study|Invalid image or not imaged|3|||
42072534|NCT00857415|75882499|FG001|Overall Study|Invalid image or not imaged|0|||
42072535|NCT00857415|75882498|FG000|Overall Study|Subject still living at end of study|110|||
42072536|NCT00857415|75882499|FG001|Overall Study|Subject still living at end of study|0|||
42072537|NCT00857415|75882498|FG000|Overall Study|Deceased with no autopsy|2|||
42072538|NCT00857415|75882499|FG001|Overall Study|Deceased with no autopsy|0|||
42072539|NCT00532441|75882505|FG000|Overall Study|Death|1|||
42072540|NCT00532441|75882506|FG001|Overall Study|Death|0|||
42072541|NCT00857259|75882527|FG000|Overall Study|Protocol Violation|1|||
42072542|NCT00857259|75882528|FG001|Overall Study|Protocol Violation|0|||
42072543|NCT00857259|75882529|FG002|Overall Study|Protocol Violation|1|||
42072544|NCT00868608|75882542|FG000|Overall Study|Withdrawal by Subject|3|||
42072545|NCT00868608|75882543|FG001|Overall Study|Withdrawal by Subject|1|||
42072546|NCT00868608|75882544|FG002|Overall Study|Withdrawal by Subject|0|||
42072547|NCT00868608|75882542|FG000|Overall Study|Lost to Follow-up|3|||
42072548|NCT00868608|75882543|FG001|Overall Study|Lost to Follow-up|0|||
42072549|NCT00868608|75882544|FG002|Overall Study|Lost to Follow-up|1|||
42072550|NCT00868608|75882542|FG000|Overall Study|Death|16|||
42072551|NCT00868608|75882543|FG001|Overall Study|Death|2|||
42072552|NCT00868608|75882544|FG002|Overall Study|Death|4|||
42072553|NCT00868608|75882542|FG000|Overall Study|Other - Unspecified|1|||
42072554|NCT00868608|75882543|FG001|Overall Study|Other - Unspecified|0|||
42072555|NCT00868608|75882544|FG002|Overall Study|Other - Unspecified|0|||
42072556|NCT00856635|75882554|FG000|Overall Study|Lost to Follow-up|2|||
42072557|NCT00856635|75882555|FG001|Overall Study|Lost to Follow-up|5|||
42072558|NCT00856635|75882554|FG000|Overall Study|Pregnancy|1|||
42072559|NCT00856635|75882555|FG001|Overall Study|Pregnancy|0|||
42072560|NCT00856635|75882554|FG000|Overall Study|Withdrawal by Subject|3|||
42072561|NCT00856635|75882555|FG001|Overall Study|Withdrawal by Subject|1|||
42072562|NCT00856635|75882554|FG000|Overall Study|Serious Adverse Event|1|||
42072563|NCT00856635|75882555|FG001|Overall Study|Serious Adverse Event|0|||
42072564|NCT00856635|75882554|FG000|Overall Study|Other|1|||
42072565|NCT00856635|75882555|FG001|Overall Study|Other|0|||
42072566|NCT00856635|75882554|FG000|Overall Study|Discontinued at Randomization|2|||
42072567|NCT00856635|75882555|FG001|Overall Study|Discontinued at Randomization|2|||
42072568|NCT00856557|75882565|FG000|Overall Study|No patients with contextual flags|12|||
42072569|NCT00856557|75882566|FG001|Overall Study|No patients with contextual flags|16|||
42072570|NCT00856323|75882572|FG000|Overall Study|Withdrawal by Subject|2|||
42072571|NCT00856245|75882580|FG000|Overall Study|Was not transplanted|5|||
42072572|NCT00855933|75882586|FG000|Overall Study|Withdrawal by Subject|0|||
42072573|NCT00855933|75882587|FG001|Overall Study|Withdrawal by Subject|1|||
42072574|NCT00871572|75882597|FG000|Overall Study|Adverse Event|0|||
42072575|NCT00871572|75882598|FG001|Overall Study|Adverse Event|2|||
42072576|NCT00871572|75882599|FG002|Overall Study|Adverse Event|0|||
42072577|NCT00871572|75882600|FG003|Overall Study|Adverse Event|3|||
42072578|NCT00871572|75882597|FG000|Overall Study|Investigator Decision|0|||
42072579|NCT00871572|75882598|FG001|Overall Study|Investigator Decision|1|||
42072580|NCT00871572|75882599|FG002|Overall Study|Investigator Decision|0|||
42072581|NCT00871572|75882600|FG003|Overall Study|Investigator Decision|1|||
42072582|NCT00871572|75882597|FG000|Overall Study|Lost to Follow-up|0|||
42072583|NCT00871572|75882598|FG001|Overall Study|Lost to Follow-up|1|||
42072584|NCT00871572|75882599|FG002|Overall Study|Lost to Follow-up|0|||
42072585|NCT00871572|75882600|FG003|Overall Study|Lost to Follow-up|1|||
42072586|NCT00871572|75882597|FG000|Overall Study|Protocol Violation|0|||
42293418|NCT02649439|76127563|FG001|Overall Study|Patient going out of country|0|||
42072587|NCT00871572|75882598|FG001|Overall Study|Protocol Violation|0|||
42072588|NCT00871572|75882599|FG002|Overall Study|Protocol Violation|1|||
42072589|NCT00871572|75882600|FG003|Overall Study|Protocol Violation|1|||
42072590|NCT00871572|75882597|FG000|Overall Study|Sponsor Decision|1|||
42072591|NCT00871572|75882598|FG001|Overall Study|Sponsor Decision|0|||
42072592|NCT00871572|75882599|FG002|Overall Study|Sponsor Decision|0|||
42072593|NCT00871572|75882600|FG003|Overall Study|Sponsor Decision|0|||
42072594|NCT00871572|75882597|FG000|Overall Study|Withdrawal by Subject|1|||
42072595|NCT00871572|75882598|FG001|Overall Study|Withdrawal by Subject|2|||
42072596|NCT00871572|75882599|FG002|Overall Study|Withdrawal by Subject|3|||
42072597|NCT00871572|75882600|FG003|Overall Study|Withdrawal by Subject|1|||
42072598|NCT03885661|75882612|FG000|Overall Study|Withdrawal by Subject|0|||
42072599|NCT03885661|75882613|FG001|Overall Study|Withdrawal by Subject|1|||
42072600|NCT03885661|75882612|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
42072601|NCT03885661|75882613|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
42072602|NCT00868530|75882619|FG000|Overall Study|Adverse Event|3|||
42072603|NCT00868530|75882619|FG000|Overall Study|Lost to Follow-up|1|||
42072604|NCT00598442|75882626|FG000|Overall Study|Adverse Event|3|||
42072605|NCT00598442|75882627|FG001|Overall Study|Adverse Event|0|||
42072606|NCT00598442|75882628|FG002|Overall Study|Adverse Event|0|||
42072607|NCT00598442|75882626|FG000|Overall Study|Death|19|||
42072608|NCT00598442|75882627|FG001|Overall Study|Death|11|||
42072609|NCT00598442|75882628|FG002|Overall Study|Death|11|||
42072610|NCT00598442|75882626|FG000|Overall Study|Lost to Follow-up|4|||
42072611|NCT00598442|75882627|FG001|Overall Study|Lost to Follow-up|3|||
42072612|NCT00598442|75882628|FG002|Overall Study|Lost to Follow-up|3|||
42072613|NCT00598442|75882626|FG000|Overall Study|Physician Decision|2|||
42072614|NCT00598442|75882627|FG001|Overall Study|Physician Decision|1|||
42072615|NCT00598442|75882628|FG002|Overall Study|Physician Decision|1|||
42072616|NCT00598442|75882626|FG000|Overall Study|Withdrawal by Subject|8|||
42072617|NCT00598442|75882627|FG001|Overall Study|Withdrawal by Subject|16|||
42072618|NCT00598442|75882628|FG002|Overall Study|Withdrawal by Subject|6|||
42072619|NCT00598442|75882626|FG000|Overall Study|Noncompliance|0|||
42072620|NCT00598442|75882627|FG001|Overall Study|Noncompliance|2|||
42072621|NCT00598442|75882628|FG002|Overall Study|Noncompliance|1|||
42072622|NCT00598442|75882626|FG000|Overall Study|Relocation|1|||
42072623|NCT00598442|75882627|FG001|Overall Study|Relocation|4|||
42072624|NCT00598442|75882628|FG002|Overall Study|Relocation|0|||
42072625|NCT00598442|75882626|FG000|Overall Study|Renal transplant|0|||
42072626|NCT00598442|75882627|FG001|Overall Study|Renal transplant|0|||
42072627|NCT00598442|75882628|FG002|Overall Study|Renal transplant|1|||
42072628|NCT00598442|75882626|FG000|Overall Study|Site closed by sponsor|5|||
42072629|NCT00598442|75882627|FG001|Overall Study|Site closed by sponsor|2|||
42072630|NCT00598442|75882628|FG002|Overall Study|Site closed by sponsor|1|||
42072631|NCT00598442|75882626|FG000|Overall Study|Started dialysis|1|||
42072632|NCT00598442|75882627|FG001|Overall Study|Started dialysis|0|||
42072633|NCT00598442|75882628|FG002|Overall Study|Started dialysis|0|||
42072634|NCT00593814|75882638|FG000|Overall Study|Death|7|||
42072635|NCT00593814|75882639|FG001|Overall Study|Death|0|||
42072636|NCT00593814|75882638|FG000|Overall Study|Withdrawal by Subject|7|||
42072637|NCT00593814|75882639|FG001|Overall Study|Withdrawal by Subject|0|||
42072638|NCT00593814|75882638|FG000|Overall Study|Lost to Follow-up|7|||
42072639|NCT00593814|75882639|FG001|Overall Study|Lost to Follow-up|0|||
42072640|NCT00593814|75882638|FG000|Overall Study|Physician Decision|3|||
42072641|NCT00593814|75882639|FG001|Overall Study|Physician Decision|0|||
42072642|NCT00855309|75882647|FG000|Overall Study|patient never recieved drug|1|||
42072643|NCT00855309|75882648|FG001|Overall Study|patient never recieved drug|0|||
42072644|NCT00532129|75882654|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
42072645|NCT00532129|75882654|FG000|Treatment Period|Physician Decision|15|||
42072646|NCT00532129|75882654|FG000|Treatment Period|Disease progression|3|||
42072647|NCT00532129|75882654|FG000|Treatment Period|Protocol Violation|1|||
42072648|NCT00532129|75882654|FG000|Treatment Period|Other|5|||
42072649|NCT00532129|75882654|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
42072650|NCT00532129|75882654|FG000|Follow-up Period|Disease progression|57|||
42072651|NCT00532129|75882654|FG000|Follow-up Period|Lost to Follow-up|1|||
42072652|NCT00532129|75882654|FG000|Follow-up Period|Other|6|||
42072653|NCT00854607|75882658|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
42072654|NCT00854373|75882671|FG000|Overall Study|Withdrawal by Subject|1|||
42072655|NCT00854373|75882672|FG001|Overall Study|Withdrawal by Subject|3|||
42072656|NCT00854373|75882671|FG000|Overall Study|Forgot to take study drug|1|||
42072657|NCT00854373|75882672|FG001|Overall Study|Forgot to take study drug|1|||
42177488|NCT03150862|75984625|FG002|Overall Study|Lost to Follow-up|1|||
42177489|NCT03150862|75984626|FG003|Overall Study|Lost to Follow-up|0|||
42177490|NCT03150862|75984627|FG004|Overall Study|Lost to Follow-up|0|||
42072658|NCT00853905|75882680|FG000|Overall Study|Lost to Follow-up|1|||
42072659|NCT00853905|75882681|FG001|Overall Study|Lost to Follow-up|3|||
42072660|NCT00853905|75882680|FG000|Overall Study|Withdrawal by Subject|0|||
42072661|NCT00853905|75882681|FG001|Overall Study|Withdrawal by Subject|1|||
42072662|NCT00853905|75882680|FG000|Overall Study|never had surgery|1|||
42072663|NCT00853905|75882681|FG001|Overall Study|never had surgery|0|||
42072664|NCT00868296|75882692|FG000|Overall Study|Adverse Event|0|||
42072665|NCT00868296|75882693|FG001|Overall Study|Adverse Event|2|||
42072666|NCT00868296|75882692|FG000|Overall Study|Withdrawal by Subject|0|||
42072667|NCT00868296|75882693|FG001|Overall Study|Withdrawal by Subject|1|||
42072668|NCT00867360|75882701|FG000|Overall Study|Withdrawal by Subject|1|||
42072669|NCT00867360|75882702|FG001|Overall Study|Withdrawal by Subject|0|||
42072670|NCT00867360|75882701|FG000|Overall Study|Physician Decision|0|||
42072671|NCT00867360|75882702|FG001|Overall Study|Physician Decision|1|||
42072672|NCT00593736|75882713|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
42072673|NCT00593736|75882714|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
42072674|NCT00593736|75882715|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
42072675|NCT00593736|75882716|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
42072676|NCT00593736|75882713|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
42072677|NCT00593736|75882714|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
42072678|NCT00593736|75882715|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
42072679|NCT00593736|75882716|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
42072680|NCT00593736|75882713|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
42072681|NCT00593736|75882714|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
42072682|NCT00593736|75882715|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
42072683|NCT00593736|75882716|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
42072684|NCT00593736|75882713|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
42072685|NCT00593736|75882714|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
42072686|NCT00593736|75882715|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
42072687|NCT00593736|75882716|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
42072688|NCT00593736|75882713|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
42072689|NCT00593736|75882714|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
42072690|NCT00593736|75882715|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
42072691|NCT00593736|75882716|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
42072692|NCT00593736|75882713|FG000|Screening Period and Placebo Run-in|Various|0|||
42072693|NCT00593736|75882714|FG001|Screening Period and Placebo Run-in|Various|0|||
42072694|NCT00593736|75882715|FG002|Screening Period and Placebo Run-in|Various|0|||
42072695|NCT00593736|75882716|FG003|Screening Period and Placebo Run-in|Various|25|||
42072696|NCT00593736|75882713|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
42072697|NCT00593736|75882714|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
42072698|NCT00593736|75882715|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
42072699|NCT00593736|75882716|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
42072700|NCT00593736|75882713|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
42072701|NCT00593736|75882714|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
42072702|NCT00593736|75882715|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
42072703|NCT00593736|75882716|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
42072704|NCT00593736|75882713|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
42072705|NCT00593736|75882714|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
42072706|NCT00593736|75882715|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
42072707|NCT00593736|75882716|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
42072708|NCT00593736|75882713|FG000|Treatment Period and Placebo Run-out|Various|1|||
42072709|NCT00593736|75882714|FG001|Treatment Period and Placebo Run-out|Various|1|||
42072710|NCT00593736|75882715|FG002|Treatment Period and Placebo Run-out|Various|1|||
42072711|NCT00593736|75882716|FG003|Treatment Period and Placebo Run-out|Various|0|||
42072712|NCT00883688|75882726|FG000|Overall Study|Ineligible|2|||
42072713|NCT03883477|75882732|FG000|Overall Study|Death|1|||
42072714|NCT03883477|75882733|FG001|Overall Study|Death|0|||
42072715|NCT03883477|75882732|FG000|Overall Study|Protocol Violation|0|||
42072716|NCT03883477|75882733|FG001|Overall Study|Protocol Violation|1|||
42072717|NCT00853827|75882741|FG000|Single Blind Period (1 Week)|Other|4|||
42072718|NCT00853827|75882742|FG001|Single Blind Period (1 Week)|Other|0|||
42072719|NCT00853827|75882741|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
42072720|NCT00853827|75882742|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
42072721|NCT00853827|75882741|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
42072722|NCT00853827|75882742|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
42072723|NCT00853827|75882741|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
42072724|NCT00853827|75882742|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
42072725|NCT00853827|75882741|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
42072726|NCT00853827|75882742|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
42072727|NCT00853827|75882741|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
42072728|NCT00853827|75882742|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
42072729|NCT00853827|75882741|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
42072730|NCT00853827|75882742|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
42072731|NCT00853827|75882741|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
42293419|NCT02649439|76127562|FG000|Overall Study|To start finasteride|1|||
42293420|NCT02649439|76127563|FG001|Overall Study|To start finasteride|0|||
42293421|NCT02649439|76127562|FG000|Overall Study|Physician Decision|1|||
42293422|NCT02649439|76127563|FG001|Overall Study|Physician Decision|0|||
42293423|NCT02649439|76127562|FG000|Overall Study|Disease progression on study|12|||
42072732|NCT00853827|75882742|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
42072733|NCT00853827|75882741|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
42072734|NCT00853827|75882742|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
42072735|NCT00853827|75882741|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
42072736|NCT00853827|75882742|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
42072737|NCT00853827|75882741|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
42072738|NCT00853827|75882742|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
42072739|NCT00853827|75882741|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
42072740|NCT00853827|75882742|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
42072741|NCT00853827|75882741|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
42072742|NCT00853827|75882742|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
42072743|NCT00853827|75882741|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
42072744|NCT00853827|75882742|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
42072745|NCT00853827|75882741|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
42072746|NCT00853827|75882742|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
42072747|NCT00853827|75882741|FG000|Double Blind Period (103 Weeks)|Death|1|||
42072748|NCT00853827|75882742|FG001|Double Blind Period (103 Weeks)|Death|6|||
42072749|NCT00853749|75882750|FG000|Overall Study|Lost to Follow-up|0|||
42072750|NCT00853749|75882751|FG001|Overall Study|Lost to Follow-up|1|||
42072751|NCT00592839|75882760|FG000|Overall Study|Withdrawal by Subject|1|||
42072752|NCT00592839|75882761|FG001|Overall Study|Withdrawal by Subject|1|||
42072753|NCT00592839|75882762|FG002|Overall Study|Withdrawal by Subject|3|||
42072754|NCT00592839|75882760|FG000|Overall Study|Protocol Violation|1|||
42072755|NCT00592839|75882761|FG001|Overall Study|Protocol Violation|1|||
42072756|NCT00592839|75882762|FG002|Overall Study|Protocol Violation|2|||
42072757|NCT00592839|75882760|FG000|Overall Study|Adverse Event|0|||
42072758|NCT00592839|75882761|FG001|Overall Study|Adverse Event|1|||
42072759|NCT00592839|75882762|FG002|Overall Study|Adverse Event|0|||
42072760|NCT00592839|75882760|FG000|Overall Study|Lost to Follow-up|0|||
42072761|NCT00592839|75882761|FG001|Overall Study|Lost to Follow-up|1|||
42072762|NCT00592839|75882762|FG002|Overall Study|Lost to Follow-up|1|||
42072763|NCT00598832|75882772|FG000|Overall Study|Lack of Efficacy|3|||
42072764|NCT00598832|75882773|FG001|Overall Study|Lack of Efficacy|7|||
42072765|NCT00598832|75882772|FG000|Overall Study|Adverse Event|6|||
42072766|NCT00598832|75882773|FG001|Overall Study|Adverse Event|2|||
42072767|NCT00598832|75882772|FG000|Overall Study|Withdrawal by Subject|25|||
42072768|NCT00598832|75882773|FG001|Overall Study|Withdrawal by Subject|36|||
42072769|NCT00598832|75882772|FG000|Overall Study|Protocol Violation|0|||
42072770|NCT00598832|75882773|FG001|Overall Study|Protocol Violation|2|||
42072771|NCT00598832|75882772|FG000|Overall Study|Lost to Follow-up|24|||
42072772|NCT00598832|75882773|FG001|Overall Study|Lost to Follow-up|29|||
42072773|NCT00598832|75882772|FG000|Overall Study|Pregnancy|2|||
42072774|NCT00598832|75882773|FG001|Overall Study|Pregnancy|2|||
42072775|NCT00598832|75882772|FG000|Overall Study|Physician Decision|1|||
42072776|NCT00598832|75882773|FG001|Overall Study|Physician Decision|4|||
42072777|NCT00598832|75882772|FG000|Overall Study|Non compliance|1|||
42072778|NCT00598832|75882773|FG001|Overall Study|Non compliance|0|||
42072779|NCT00853593|75882779|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
42072780|NCT00853593|75882779|FG000|Overall Study|Model 4396 lead not attempted|29|||
42072781|NCT00853593|75882779|FG000|Overall Study|Implant not attempted|4|||
42072782|NCT00853125|75882800|FG000|Overall Study|Study participant's donor was CMV +|1|||
42072783|NCT00530023|75882807|FG000|Overall Study|Withdrawal by Subject|0|||
42072784|NCT00530023|75882808|FG001|Overall Study|Withdrawal by Subject|1|||
42072785|NCT00529087|75882817|FG000|Overall Study|Adverse Event|10|||
42072786|NCT00529087|75882818|FG001|Overall Study|Adverse Event|13|||
42072787|NCT00529087|75882819|FG002|Overall Study|Adverse Event|4|||
42072788|NCT00529087|75882817|FG000|Overall Study|Lost to Follow-up|6|||
42072789|NCT00529087|75882818|FG001|Overall Study|Lost to Follow-up|4|||
42072790|NCT00529087|75882819|FG002|Overall Study|Lost to Follow-up|1|||
42072791|NCT00529087|75882817|FG000|Overall Study|Protocol Violation|8|||
42072792|NCT00529087|75882818|FG001|Overall Study|Protocol Violation|7|||
42072793|NCT00529087|75882819|FG002|Overall Study|Protocol Violation|6|||
42072794|NCT00529087|75882817|FG000|Overall Study|Withdrawal by Subject|3|||
42072795|NCT00529087|75882818|FG001|Overall Study|Withdrawal by Subject|3|||
42072796|NCT00529087|75882819|FG002|Overall Study|Withdrawal by Subject|3|||
42293424|NCT02649439|76127563|FG001|Overall Study|Disease progression on study|13|||
42072797|NCT00529087|75882817|FG000|Overall Study|Protocol deviation|1|||
42072798|NCT00529087|75882818|FG001|Overall Study|Protocol deviation|1|||
42293425|NCT02649439|76127562|FG000|Overall Study|Refused further treatment|1|||
42072799|NCT00529087|75882819|FG002|Overall Study|Protocol deviation|2|||
42072800|NCT00870870|75882854|FG000|Overall Study|Withdrawal by Subject|0|||
42072801|NCT00870870|75882855|FG001|Overall Study|Withdrawal by Subject|1|||
42072802|NCT00870870|75882856|FG002|Overall Study|Withdrawal by Subject|1|||
42072803|NCT00870870|75882857|FG003|Overall Study|Withdrawal by Subject|3|||
42072804|NCT00870870|75882854|FG000|Overall Study|Adverse Event|0|||
42072805|NCT00870870|75882855|FG001|Overall Study|Adverse Event|0|||
42072806|NCT00870870|75882856|FG002|Overall Study|Adverse Event|2|||
42072807|NCT00870870|75882857|FG003|Overall Study|Adverse Event|2|||
42072808|NCT03877237|75882874|FG000|Overall Study|Adverse Event|1|||
42072809|NCT03877237|75882875|FG001|Overall Study|Adverse Event|2|||
42072810|NCT03877237|75882874|FG000|Overall Study|Death|3|||
42072811|NCT03877237|75882875|FG001|Overall Study|Death|2|||
42072812|NCT03877237|75882874|FG000|Overall Study|Physician Decision|1|||
42072813|NCT03877237|75882875|FG001|Overall Study|Physician Decision|0|||
42072814|NCT03877237|75882874|FG000|Overall Study|Withdrawal by Subject|0|||
42072815|NCT03877237|75882875|FG001|Overall Study|Withdrawal by Subject|2|||
42072816|NCT00528931|75882881|FG000|Overall Study|Lost to Follow-up|1|||
42072817|NCT00866814|75882886|FG000|Overall Study|Lost to Follow-up|12|||
42072818|NCT00866814|75882886|FG000|Overall Study|Adverse Event|2|||
42072819|NCT00866814|75882886|FG000|Overall Study|Physician Decision|1|||
42072820|NCT00866814|75882886|FG000|Overall Study|Death|1|||
42072821|NCT00866814|75882886|FG000|Overall Study|No longer wished to participate|1|||
42072822|NCT00866814|75882886|FG000|Overall Study|Unable to meet follow-up requirements|2|||
42072823|NCT00866814|75882886|FG000|Overall Study|Moved to area without study site|1|||
42072824|NCT00871494|75882890|FG000|Overall Study|Protocol Violation|5|||
42072825|NCT00871494|75882890|FG000|Overall Study|Lack of Efficacy|4|||
42072826|NCT00871494|75882890|FG000|Overall Study|Adverse Event|4|||
42072827|NCT00871494|75882890|FG000|Overall Study|Lost to Follow-up|1|||
42072828|NCT00529789|75882894|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
42072829|NCT00529789|75882894|FG000|Study Period II/III|Adverse Event|3|||
42072830|NCT00529789|75882894|FG000|Study Period II/III|Lack of Efficacy|2|||
42072831|NCT00529789|75882894|FG000|Study Period II/III|Withdrawal by Subject|1|||
42072832|NCT00529789|75882894|FG000|Study Period II/III|Protocol Violation|3|||
42072833|NCT00529789|75882894|FG000|Study Period II/III|Physician Decision|3|||
42072834|NCT00529789|75882894|FG000|Study Period II/III|Lost to Follow-up|3|||
42072835|NCT00529789|75882894|FG000|Study Period IV|Parent/Caregiver Decision|1|||
42072836|NCT00529789|75882894|FG000|Study Period IV|Adverse Event|1|||
42072837|NCT00529789|75882894|FG000|Study Period IV|Lack of Efficacy|1|||
42072838|NCT00529789|75882894|FG000|Study Period IV|Lost to Follow-up|3|||
42072839|NCT00577642|75882904|FG000|Overall Study|Clinical Disease Progression|1|||
42072840|NCT00866658|75882910|FG000|Overall Study|Adverse Event|5|||
42072841|NCT00866658|75882911|FG001|Overall Study|Adverse Event|14|||
42072842|NCT00866658|75882910|FG000|Overall Study|Lack of Efficacy|2|||
42072843|NCT00866658|75882911|FG001|Overall Study|Lack of Efficacy|1|||
42072844|NCT00866658|75882910|FG000|Overall Study|Withdrawal by Subject|1|||
42072845|NCT00866658|75882911|FG001|Overall Study|Withdrawal by Subject|0|||
42072846|NCT00866658|75882910|FG000|Overall Study|Protocol Violation|1|||
42072847|NCT00866658|75882911|FG001|Overall Study|Protocol Violation|1|||
42072848|NCT00866658|75882910|FG000|Overall Study|Familial and Personal Reasons|4|||
42072849|NCT00866658|75882911|FG001|Overall Study|Familial and Personal Reasons|5|||
42072850|NCT00597584|75882919|FG000|Overall Study|Adverse Event|4|||
42072851|NCT00597584|75882920|FG001|Overall Study|Adverse Event|2|||
42293426|NCT02649439|76127563|FG001|Overall Study|Refused further treatment|0|||
42293427|NCT02649439|76127562|FG000|Overall Study|Refused further follow up|2|||
42293428|NCT02649439|76127563|FG001|Overall Study|Refused further follow up|7|||
42293429|NCT02649439|76127562|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
42293430|NCT02649439|76127563|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
42293431|NCT02649439|76127562|FG000|Overall Study|No treatment, per protocol|1|||
42293432|NCT02649439|76127563|FG001|Overall Study|No treatment, per protocol|0|||
42072852|NCT00597584|75882919|FG000|Overall Study|Death|53|||
42072853|NCT00597584|75882920|FG001|Overall Study|Death|30|||
42072854|NCT00597584|75882919|FG000|Overall Study|Lack of Efficacy|1|||
42072855|NCT00597584|75882920|FG001|Overall Study|Lack of Efficacy|0|||
42072856|NCT00597584|75882919|FG000|Overall Study|Lost to Follow-up|2|||
42072857|NCT00597584|75882920|FG001|Overall Study|Lost to Follow-up|4|||
42072858|NCT00597584|75882919|FG000|Overall Study|Physician Decision|3|||
42072859|NCT00597584|75882920|FG001|Overall Study|Physician Decision|0|||
42072860|NCT00597584|75882919|FG000|Overall Study|Pregnancy|2|||
42072861|NCT00597584|75882920|FG001|Overall Study|Pregnancy|0|||
42072862|NCT00597584|75882919|FG000|Overall Study|Withdrawal by Subject|44|||
42072863|NCT00597584|75882920|FG001|Overall Study|Withdrawal by Subject|12|||
42072864|NCT00597584|75882919|FG000|Overall Study|Discontinued Dialysis|0|||
42072865|NCT00597584|75882920|FG001|Overall Study|Discontinued Dialysis|1|||
42072866|NCT00597584|75882919|FG000|Overall Study|Lost ability to consent|1|||
42072867|NCT00597584|75882920|FG001|Overall Study|Lost ability to consent|1|||
42072868|NCT00597584|75882919|FG000|Overall Study|Never dosed|1|||
42072869|NCT00597584|75882920|FG001|Overall Study|Never dosed|0|||
42072870|NCT00597584|75882919|FG000|Overall Study|Relocation|8|||
42072871|NCT00597584|75882920|FG001|Overall Study|Relocation|6|||
42072872|NCT00597584|75882919|FG000|Overall Study|Renal transplant|9|||
42072873|NCT00597584|75882920|FG001|Overall Study|Renal transplant|7|||
42072874|NCT00529633|75882928|FG000|Overall Study|Withdrawal by Subject|1|||
42072875|NCT00529633|75882929|FG001|Overall Study|Withdrawal by Subject|1|||
42072876|NCT00530335|75882935|FG000|Overall Study|Adverse Event|3|||
42072877|NCT00530335|75882935|FG000|Overall Study|Protocol Violation|1|||
42072878|NCT00530335|75882935|FG000|Overall Study|Withdrawal by Subject|1|||
42072879|NCT00530335|75882935|FG000|Overall Study|Physician Decision|1|||
42072880|NCT00712270|75882942|FG000|Overall Study|Withdrawal by Subject|11|||
42072881|NCT00712270|75882942|FG000|Overall Study|Screen Failure|3|||
42072882|NCT00530257|75882968|FG000|Overall Study|Lost to Follow-up|1|||
42072883|NCT00869778|75882978|FG000|Overall Study|Adverse Event|2|||
42072884|NCT00869778|75882979|FG001|Overall Study|Adverse Event|0|||
42072885|NCT00869778|75882980|FG002|Overall Study|Adverse Event|0|||
42072886|NCT00869778|75882978|FG000|Overall Study|Withdrawal by Subject|3|||
42072887|NCT00869778|75882979|FG001|Overall Study|Withdrawal by Subject|4|||
42072888|NCT00869778|75882980|FG002|Overall Study|Withdrawal by Subject|5|||
42072889|NCT00869778|75882978|FG000|Overall Study|Pregnancy|1|||
42072890|NCT00869778|75882979|FG001|Overall Study|Pregnancy|0|||
42072891|NCT00869778|75882980|FG002|Overall Study|Pregnancy|0|||
42072892|NCT00869778|75882978|FG000|Overall Study|Protocol Violation|5|||
42072893|NCT00869778|75882979|FG001|Overall Study|Protocol Violation|3|||
42072894|NCT00869778|75882980|FG002|Overall Study|Protocol Violation|5|||
42072895|NCT00869778|75882978|FG000|Overall Study|Unblinding|1|||
42072896|NCT00869778|75882979|FG001|Overall Study|Unblinding|0|||
42072897|NCT00869778|75882980|FG002|Overall Study|Unblinding|0|||
42072898|NCT00711958|75883011|FG000|Overall Study|Withdrawal by Subject|6|||
42072899|NCT00711958|75883012|FG001|Overall Study|Withdrawal by Subject|8|||
42072900|NCT00711958|75883011|FG000|Overall Study|Lack of Efficacy|3|||
42072901|NCT00711958|75883012|FG001|Overall Study|Lack of Efficacy|1|||
42072902|NCT00711958|75883011|FG000|Overall Study|Clinical deterioration|1|||
42072903|NCT00711958|75883012|FG001|Overall Study|Clinical deterioration|0|||
42072904|NCT00711958|75883011|FG000|Overall Study|Adverse Event|9|||
42072905|NCT00711958|75883012|FG001|Overall Study|Adverse Event|7|||
42072906|NCT00711958|75883011|FG000|Overall Study|Protocol Violation|1|||
42072907|NCT00711958|75883012|FG001|Overall Study|Protocol Violation|0|||
42072908|NCT00711958|75883011|FG000|Overall Study|Lost to Follow-up|2|||
42072909|NCT00711958|75883012|FG001|Overall Study|Lost to Follow-up|2|||
42072910|NCT00711958|75883011|FG000|Overall Study|Death|10|||
42072911|NCT00711958|75883012|FG001|Overall Study|Death|5|||
42072912|NCT00711958|75883011|FG000|Overall Study|Progression of disease|1|||
42072913|NCT00711958|75883012|FG001|Overall Study|Progression of disease|0|||
42072914|NCT00711880|75883020|FG000|Overall Study|Adverse Event|11|||
42072915|NCT00711880|75883021|FG001|Overall Study|Adverse Event|2|||
42072916|NCT00711880|75883020|FG000|Overall Study|Patient non-compliance|1|||
42072917|NCT00711880|75883021|FG001|Overall Study|Patient non-compliance|0|||
42072918|NCT00711880|75883020|FG000|Overall Study|Lack of Efficacy|1|||
42072919|NCT00711880|75883021|FG001|Overall Study|Lack of Efficacy|5|||
42072920|NCT00528775|75883027|FG000|Overall Study|Other not specified|1|||
42072921|NCT00529399|75883034|FG000|Overall Study|Lost to Follow-up|1|||
42072922|NCT00529399|75883035|FG001|Overall Study|Lost to Follow-up|0|||
42072923|NCT00529399|75883036|FG002|Overall Study|Lost to Follow-up|1|||
42072924|NCT00529399|75883034|FG000|Overall Study|Withdrawal by Subject|1|||
42072925|NCT00529399|75883035|FG001|Overall Study|Withdrawal by Subject|0|||
42072926|NCT00529399|75883036|FG002|Overall Study|Withdrawal by Subject|1|||
42072927|NCT00529399|75883034|FG000|Overall Study|Non-compliant|0|||
42072928|NCT00529399|75883035|FG001|Overall Study|Non-compliant|1|||
42072929|NCT00529399|75883036|FG002|Overall Study|Non-compliant|0|||
42072930|NCT00852969|75883046|FG000|Overall Study|Adverse Event|0|||
42072931|NCT00852969|75883047|FG001|Overall Study|Adverse Event|1|||
42072932|NCT00852969|75883046|FG000|Overall Study|Lost to Follow-up|0|||
42072933|NCT00852969|75883047|FG001|Overall Study|Lost to Follow-up|1|||
42072934|NCT03870997|75883059|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
42072935|NCT03870997|75883060|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
42072936|NCT03870997|75883061|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
42177491|NCT03150862|75984628|FG005|Overall Study|Lost to Follow-up|0|||
42072937|NCT03870997|75883062|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
42072938|NCT03870997|75883063|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
42072939|NCT03870997|75883064|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
42072940|NCT00521365|75883073|FG000|Overall Study|Adverse Event|3|||
42072941|NCT00521365|75883073|FG000|Overall Study|Lost to Follow-up|6|||
42072942|NCT00521365|75883073|FG000|Overall Study|Protocol deviation|2|||
42072943|NCT00521365|75883073|FG000|Overall Study|Drug compliance|3|||
42072944|NCT00521365|75883073|FG000|Overall Study|Usage of not allowed drugs|6|||
42072945|NCT00711802|75883085|FG000|Overall Study|Not treated (no further detail)|2|||
42072946|NCT00711802|75883086|FG001|Overall Study|Not treated (no further detail)|1|||
42072947|NCT00711802|75883087|FG002|Overall Study|Not treated (no further detail)|2|||
42072948|NCT00711802|75883088|FG003|Overall Study|Not treated (no further detail)|0|||
42072949|NCT00711802|75883089|FG004|Overall Study|Not treated (no further detail)|2|||
42072950|NCT00711802|75883090|FG005|Overall Study|Not treated (no further detail)|0|||
42072951|NCT00711802|75883091|FG006|Overall Study|Not treated (no further detail)|0|||
42072952|NCT00711802|75883092|FG007|Overall Study|Not treated (no further detail)|0|||
42072953|NCT00711802|75883085|FG000|Overall Study|Adverse Event|0|||
42072954|NCT00711802|75883086|FG001|Overall Study|Adverse Event|0|||
42072955|NCT00711802|75883087|FG002|Overall Study|Adverse Event|0|||
42072956|NCT00711802|75883088|FG003|Overall Study|Adverse Event|0|||
42072957|NCT00711802|75883089|FG004|Overall Study|Adverse Event|1|||
42072958|NCT00711802|75883090|FG005|Overall Study|Adverse Event|1|||
42072959|NCT00711802|75883091|FG006|Overall Study|Adverse Event|0|||
42072960|NCT00711802|75883092|FG007|Overall Study|Adverse Event|0|||
42072961|NCT00711802|75883085|FG000|Overall Study|Microbiological failure|0|||
42072962|NCT00711802|75883086|FG001|Overall Study|Microbiological failure|1|||
42072963|NCT00711802|75883087|FG002|Overall Study|Microbiological failure|0|||
42072964|NCT00711802|75883088|FG003|Overall Study|Microbiological failure|0|||
42072965|NCT00711802|75883089|FG004|Overall Study|Microbiological failure|0|||
42072966|NCT00711802|75883090|FG005|Overall Study|Microbiological failure|1|||
42072967|NCT00711802|75883091|FG006|Overall Study|Microbiological failure|0|||
42072968|NCT00711802|75883092|FG007|Overall Study|Microbiological failure|0|||
42072969|NCT00711802|75883085|FG000|Overall Study|Protocol Violation|0|||
42072970|NCT00711802|75883086|FG001|Overall Study|Protocol Violation|0|||
42072971|NCT00711802|75883087|FG002|Overall Study|Protocol Violation|0|||
42072972|NCT00711802|75883088|FG003|Overall Study|Protocol Violation|1|||
42072973|NCT00711802|75883089|FG004|Overall Study|Protocol Violation|0|||
42072974|NCT00711802|75883090|FG005|Overall Study|Protocol Violation|0|||
42072975|NCT00711802|75883091|FG006|Overall Study|Protocol Violation|0|||
42072976|NCT00711802|75883092|FG007|Overall Study|Protocol Violation|0|||
42072977|NCT00711802|75883085|FG000|Overall Study|Physician Decision|0|||
42072978|NCT00711802|75883086|FG001|Overall Study|Physician Decision|2|||
42072979|NCT00711802|75883087|FG002|Overall Study|Physician Decision|0|||
42072980|NCT00711802|75883088|FG003|Overall Study|Physician Decision|0|||
42072981|NCT00711802|75883089|FG004|Overall Study|Physician Decision|0|||
42072982|NCT00711802|75883090|FG005|Overall Study|Physician Decision|0|||
42072983|NCT00711802|75883091|FG006|Overall Study|Physician Decision|0|||
42072984|NCT00711802|75883092|FG007|Overall Study|Physician Decision|0|||
42072985|NCT00711802|75883085|FG000|Overall Study|Withdrawal by Subject|0|||
42072986|NCT00711802|75883086|FG001|Overall Study|Withdrawal by Subject|1|||
42072987|NCT00711802|75883087|FG002|Overall Study|Withdrawal by Subject|0|||
42072988|NCT00711802|75883088|FG003|Overall Study|Withdrawal by Subject|1|||
42072989|NCT00711802|75883089|FG004|Overall Study|Withdrawal by Subject|0|||
42072990|NCT00711802|75883090|FG005|Overall Study|Withdrawal by Subject|0|||
42072991|NCT00711802|75883091|FG006|Overall Study|Withdrawal by Subject|0|||
42072992|NCT00711802|75883092|FG007|Overall Study|Withdrawal by Subject|0|||
42072993|NCT00711802|75883085|FG000|Overall Study|Lost to Follow-up|0|||
42072994|NCT00711802|75883086|FG001|Overall Study|Lost to Follow-up|0|||
42177492|NCT03150862|75984629|FG006|Overall Study|Lost to Follow-up|0|||
42177493|NCT03150862|75984630|FG007|Overall Study|Lost to Follow-up|2|||
42072995|NCT00711802|75883087|FG002|Overall Study|Lost to Follow-up|3|||
42072996|NCT00711802|75883088|FG003|Overall Study|Lost to Follow-up|1|||
42072997|NCT00711802|75883089|FG004|Overall Study|Lost to Follow-up|10|||
42072998|NCT00711802|75883090|FG005|Overall Study|Lost to Follow-up|6|||
42072999|NCT00711802|75883091|FG006|Overall Study|Lost to Follow-up|4|||
42073000|NCT00711802|75883092|FG007|Overall Study|Lost to Follow-up|2|||
42073001|NCT00711802|75883085|FG000|Overall Study|Reason not reported|0|||
42073002|NCT00711802|75883086|FG001|Overall Study|Reason not reported|1|||
42073003|NCT00711802|75883087|FG002|Overall Study|Reason not reported|1|||
42073004|NCT00711802|75883088|FG003|Overall Study|Reason not reported|0|||
42073005|NCT00711802|75883089|FG004|Overall Study|Reason not reported|1|||
42177494|NCT03150862|75984623|FG000|Overall Study|Sponsor's decision|0|||
42073006|NCT00711802|75883090|FG005|Overall Study|Reason not reported|0|||
42073007|NCT00711802|75883091|FG006|Overall Study|Reason not reported|1|||
42073008|NCT00711802|75883092|FG007|Overall Study|Reason not reported|0|||
42073009|NCT00851877|75883113|FG000|Phase I-1|Death|1|||
42073010|NCT00851877|75883114|FG001|Phase I-1|Death|0|||
42073011|NCT00851877|75883115|FG002|Phase I-1|Death|0|||
42073012|NCT00851877|75883113|FG000|Phase II|Withdrawal by Subject|0|||
42073013|NCT00851877|75883114|FG001|Phase II|Withdrawal by Subject|0|||
42073014|NCT00851877|75883115|FG002|Phase II|Withdrawal by Subject|3|||
42073015|NCT00882908|75883126|FG000|Overall Study|Adverse Event|0|||
42073016|NCT00882908|75883127|FG001|Overall Study|Adverse Event|0|||
42073017|NCT00882908|75883128|FG002|Overall Study|Adverse Event|1|||
42073018|NCT00882908|75883129|FG003|Overall Study|Adverse Event|0|||
42073019|NCT00882908|75883130|FG004|Overall Study|Adverse Event|1|||
42073020|NCT00882908|75883126|FG000|Overall Study|Lost to Follow-up|3|||
42073021|NCT00882908|75883127|FG001|Overall Study|Lost to Follow-up|5|||
42073022|NCT00882908|75883128|FG002|Overall Study|Lost to Follow-up|3|||
42073023|NCT00882908|75883129|FG003|Overall Study|Lost to Follow-up|1|||
42073024|NCT00882908|75883130|FG004|Overall Study|Lost to Follow-up|2|||
42073025|NCT00882908|75883126|FG000|Overall Study|Protocol Violation|0|||
42073026|NCT00882908|75883127|FG001|Overall Study|Protocol Violation|1|||
42073027|NCT00882908|75883128|FG002|Overall Study|Protocol Violation|0|||
42073028|NCT00882908|75883129|FG003|Overall Study|Protocol Violation|0|||
42073029|NCT00882908|75883130|FG004|Overall Study|Protocol Violation|0|||
42073030|NCT00882908|75883126|FG000|Overall Study|Withdrawal by Subject|0|||
42073031|NCT00882908|75883127|FG001|Overall Study|Withdrawal by Subject|0|||
42073032|NCT00882908|75883128|FG002|Overall Study|Withdrawal by Subject|3|||
42073033|NCT00882908|75883129|FG003|Overall Study|Withdrawal by Subject|5|||
42073034|NCT00882908|75883130|FG004|Overall Study|Withdrawal by Subject|2|||
42073035|NCT00882908|75883126|FG000|Overall Study|Subject reached a virologic endpoint|0|||
42073036|NCT00882908|75883127|FG001|Overall Study|Subject reached a virologic endpoint|0|||
42073037|NCT00882908|75883128|FG002|Overall Study|Subject reached a virologic endpoint|0|||
42073038|NCT00882908|75883129|FG003|Overall Study|Subject reached a virologic endpoint|0|||
42073039|NCT00882908|75883130|FG004|Overall Study|Subject reached a virologic endpoint|1|||
42073040|NCT00882908|75883126|FG000|Overall Study|Study terminated in error|0|||
42073041|NCT00882908|75883127|FG001|Overall Study|Study terminated in error|0|||
42073042|NCT00882908|75883128|FG002|Overall Study|Study terminated in error|0|||
42073043|NCT00882908|75883129|FG003|Overall Study|Study terminated in error|1|||
42073044|NCT00882908|75883130|FG004|Overall Study|Study terminated in error|0|||
42073045|NCT00851799|75883146|FG000|Overall Study|Death|1|||
42073046|NCT00851799|75883147|FG001|Overall Study|Death|0|||
42073047|NCT00851799|75883148|FG002|Overall Study|Death|1|||
42073048|NCT00851799|75883146|FG000|Overall Study|Lost to Follow-up|5|||
42073049|NCT00851799|75883147|FG001|Overall Study|Lost to Follow-up|3|||
42073050|NCT00851799|75883148|FG002|Overall Study|Lost to Follow-up|10|||
42073051|NCT00851799|75883146|FG000|Overall Study|Not able to get to clinic|8|||
42073052|NCT00851799|75883147|FG001|Overall Study|Not able to get to clinic|5|||
42073053|NCT00851799|75883148|FG002|Overall Study|Not able to get to clinic|9|||
42073054|NCT00851799|75883146|FG000|Overall Study|Not willing to adhere to requirements|1|||
42073055|NCT00851799|75883147|FG001|Overall Study|Not willing to adhere to requirements|2|||
42073056|NCT00851799|75883148|FG002|Overall Study|Not willing to adhere to requirements|2|||
42073057|NCT00851799|75883146|FG000|Overall Study|Withdrew consent prior study completion|1|||
42073058|NCT00851799|75883147|FG001|Overall Study|Withdrew consent prior study completion|2|||
42073059|NCT00851799|75883148|FG002|Overall Study|Withdrew consent prior study completion|1|||
42073060|NCT00851799|75883146|FG000|Overall Study|Severe Debilitation|0|||
42073061|NCT00851799|75883147|FG001|Overall Study|Severe Debilitation|1|||
42073062|NCT00851799|75883148|FG002|Overall Study|Severe Debilitation|0|||
42073063|NCT00851799|75883146|FG000|Overall Study|Completed protocol due to pregnancy|0|||
42073064|NCT00851799|75883147|FG001|Overall Study|Completed protocol due to pregnancy|0|||
42073065|NCT00851799|75883148|FG002|Overall Study|Completed protocol due to pregnancy|1|||
42073066|NCT00521053|75883156|FG000|Observation Phase|Disease Progression|55|||
42073067|NCT00521053|75883156|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
42073068|NCT00521053|75883156|FG000|Observation Phase|Death|2|||
42073069|NCT00521053|75883156|FG000|Observation Phase|Adverse Event|1|||
42073070|NCT00521053|75883156|FG000|Observation Phase|Other non-study melanoma treatment|1|||
42073071|NCT00521053|75883156|FG000|Observation Phase|Physician Decision|1|||
42073072|NCT00853047|75883168|FG000|Core Phase|Participant Request|0|||
42073073|NCT00853047|75883169|FG001|Core Phase|Participant Request|0|||
42073074|NCT00853047|75883170|FG002|Core Phase|Participant Request|0|||
42073075|NCT00853047|75883171|FG003|Core Phase|Participant Request|1|||
42073076|NCT00853047|75883172|FG004|Core Phase|Participant Request|0|||
42073077|NCT00853047|75883173|FG005|Core Phase|Participant Request|0|||
42073078|NCT00853047|75883168|FG000|Open-Label Extension Phase|Participant Request|0|||
42073079|NCT00853047|75883169|FG001|Open-Label Extension Phase|Participant Request|0|||
42073080|NCT00853047|75883170|FG002|Open-Label Extension Phase|Participant Request|0|||
42073081|NCT00853047|75883171|FG003|Open-Label Extension Phase|Participant Request|0|||
42073082|NCT00853047|75883172|FG004|Open-Label Extension Phase|Participant Request|0|||
42073083|NCT00853047|75883173|FG005|Open-Label Extension Phase|Participant Request|7|||
42073084|NCT00853047|75883168|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
42073085|NCT00853047|75883169|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
42073086|NCT00853047|75883170|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
42073087|NCT00853047|75883171|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
42073088|NCT00853047|75883172|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
42073089|NCT00853047|75883173|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
42073090|NCT00853047|75883168|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
42073091|NCT00853047|75883169|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
42073092|NCT00853047|75883170|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
42073093|NCT00853047|75883171|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
42073094|NCT00853047|75883172|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
42073095|NCT00853047|75883173|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
42073096|NCT00853047|75883168|FG000|Open-Label Extension Phase|Investigator Decision|0|||
42073097|NCT00853047|75883169|FG001|Open-Label Extension Phase|Investigator Decision|0|||
42073098|NCT00853047|75883170|FG002|Open-Label Extension Phase|Investigator Decision|0|||
42073099|NCT00853047|75883171|FG003|Open-Label Extension Phase|Investigator Decision|0|||
42073100|NCT00853047|75883172|FG004|Open-Label Extension Phase|Investigator Decision|0|||
42073101|NCT00853047|75883173|FG005|Open-Label Extension Phase|Investigator Decision|1|||
42073102|NCT00853047|75883168|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
42073103|NCT00853047|75883169|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
42073104|NCT00853047|75883170|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
42073105|NCT00853047|75883171|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
42073106|NCT00853047|75883172|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
42073107|NCT00853047|75883173|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
42073108|NCT00520975|75883190|FG000|Overall Study|Disease progression|31|||
42073109|NCT00520975|75883191|FG001|Overall Study|Disease progression|23|||
42073110|NCT00520975|75883190|FG000|Overall Study|Adverse Event|7|||
42073111|NCT00520975|75883191|FG001|Overall Study|Adverse Event|10|||
42073112|NCT00520975|75883190|FG000|Overall Study|Death|0|||
42073113|NCT00520975|75883191|FG001|Overall Study|Death|2|||
42073114|NCT00520975|75883190|FG000|Overall Study|Withdrawal by Subject|3|||
42073115|NCT00520975|75883191|FG001|Overall Study|Withdrawal by Subject|5|||
42073116|NCT00520975|75883190|FG000|Overall Study|Other therapy|2|||
42073117|NCT00520975|75883191|FG001|Overall Study|Other therapy|4|||
42073118|NCT00520975|75883190|FG000|Overall Study|Other reasons|4|||
42357778|NCT01858363|76203290|FG001|Overall Study|Death|9|||
42357779|NCT01858363|76203289|FG000|Overall Study|Withdrawal by Subject|28|||
42017439|NCT01127061|75825106|FG001|Overall Study|Lost to Follow-up|10|||
42017440|NCT01127061|75825105|FG000|Overall Study|Physician Decision|3|||
42017441|NCT01127061|75825106|FG001|Overall Study|Physician Decision|3|||
42017442|NCT00924703|75825112|FG000|Overall Study|Withdrawal by Subject|11|||
42017443|NCT00924703|75825112|FG000|Overall Study|Physician Decision|5|||
42017444|NCT00924703|75825112|FG000|Overall Study|Lost to Follow-up|3|||
42017445|NCT00924703|75825112|FG000|Overall Study|Adverse Event|2|||
42017446|NCT00924703|75825112|FG000|Overall Study|Withdrawal by Sponsor|1|||
42017447|NCT01213524|75825118|FG000|Baseline|Withdrawal by Subject|5|||
42017448|NCT01213524|75825118|FG000|Baseline|high breath alcohol levels|1|||
42017449|NCT01213524|75825118|FG000|Baseline|Physician Decision|1|||
42017450|NCT01213524|75825118|FG000|Session 2|Withdrawal by Subject|5|||
42017451|NCT01213524|75825118|FG000|Session 3|Withdrawal by Subject|4|||
42017452|NCT01213524|75825118|FG000|Session 4|Physician Decision|1|||
42017453|NCT01213524|75825118|FG000|Session 4|Withdrawal by Subject|2|||
42017454|NCT01212744|75825129|FG000|Overall Study|Withdrawal by Subject|1|||
42017455|NCT01212588|75825137|FG000|Overall Study|Physician Decision|0|||
42017456|NCT01212588|75825138|FG001|Overall Study|Physician Decision|1|||
42017457|NCT01212588|75825137|FG000|Overall Study|Protocol Violation|1|||
42017458|NCT01212588|75825138|FG001|Overall Study|Protocol Violation|1|||
42017459|NCT00918385|75825146|FG000|Monotherapy|Adverse Event|1|||
42017460|NCT00918385|75825147|FG001|Monotherapy|Adverse Event|6|||
42017461|NCT00918385|75825146|FG000|Monotherapy|Complicating illness|1|||
42017462|NCT00918385|75825147|FG001|Monotherapy|Complicating illness|0|||
42017463|NCT00918385|75825146|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
42017464|NCT00918385|75825147|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
42017465|NCT00918385|75825146|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
42017466|NCT00918385|75825147|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
42017467|NCT00918385|75825146|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
42017468|NCT00918385|75825147|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
42017469|NCT00918385|75825146|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
42017470|NCT00918385|75825147|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
42017471|NCT01211262|75825157|FG000|Overall Study|Progressive Disease|18|||
42017472|NCT01211262|75825158|FG001|Overall Study|Progressive Disease|9|||
42017473|NCT01211262|75825157|FG000|Overall Study|Adverse Event|4|||
42017474|NCT01211262|75825158|FG001|Overall Study|Adverse Event|0|||
42017475|NCT01211262|75825157|FG000|Overall Study|Withdrawal of Consent|1|||
42017476|NCT01211262|75825158|FG001|Overall Study|Withdrawal of Consent|0|||
42017477|NCT01211262|75825157|FG000|Overall Study|Other|0|||
42017478|NCT01211262|75825158|FG001|Overall Study|Other|1|||
42073119|NCT00520975|75883191|FG001|Overall Study|Other reasons|2|||
42073120|NCT00520975|75883190|FG000|Overall Study|Not start protocol therapy|1|||
42073121|NCT00520975|75883191|FG001|Overall Study|Not start protocol therapy|2|||
42073122|NCT00851721|75883199|FG000|Overall Study|planned surgery|1|||
42073123|NCT00851721|75883200|FG001|Overall Study|planned surgery|0|||
42073124|NCT00851721|75883199|FG000|Overall Study|Death|1|||
42073125|NCT00851721|75883200|FG001|Overall Study|Death|0|||
42073126|NCT00851721|75883199|FG000|Overall Study|Adverse Event|0|||
42073127|NCT00851721|75883200|FG001|Overall Study|Adverse Event|1|||
42073128|NCT00520741|75883214|FG000|Overall Study|Adverse Event|16|||
42073129|NCT00520741|75883215|FG001|Overall Study|Adverse Event|56|||
42073130|NCT00520741|75883214|FG000|Overall Study|Lack of Efficacy|11|||
42073131|NCT00520741|75883215|FG001|Overall Study|Lack of Efficacy|30|||
42073132|NCT00520741|75883214|FG000|Overall Study|Withdrawal by Subject|0|||
42073133|NCT00520741|75883215|FG001|Overall Study|Withdrawal by Subject|11|||
42073134|NCT00520741|75883214|FG000|Overall Study|Protocol Violation|2|||
42073135|NCT00520741|75883215|FG001|Overall Study|Protocol Violation|15|||
42073136|NCT00520741|75883214|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
42073137|NCT00520741|75883215|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
42073138|NCT00520741|75883214|FG000|Overall Study|Lost to Follow-up|4|||
42073139|NCT00520741|75883215|FG001|Overall Study|Lost to Follow-up|4|||
42073140|NCT00520741|75883214|FG000|Overall Study|Other reasons for premature termination|0|||
42073141|NCT00520741|75883215|FG001|Overall Study|Other reasons for premature termination|6|||
42073142|NCT00882518|75883225|FG000|Overall Study|Adverse Event|9|||
42073143|NCT00882518|75883226|FG001|Overall Study|Adverse Event|18|||
42073144|NCT00882518|75883225|FG000|Overall Study|Withdrawal by Subject|9|||
42073145|NCT00882518|75883226|FG001|Overall Study|Withdrawal by Subject|13|||
42073146|NCT00882518|75883225|FG000|Overall Study|Lack of Efficacy|12|||
42073147|NCT00882518|75883226|FG001|Overall Study|Lack of Efficacy|9|||
42073148|NCT00882518|75883225|FG000|Overall Study|Severe non-compliance to protocol|3|||
42073149|NCT00882518|75883226|FG001|Overall Study|Severe non-compliance to protocol|1|||
42073150|NCT00882518|75883225|FG000|Overall Study|Incorrect enrolment|4|||
42073151|NCT00882518|75883226|FG001|Overall Study|Incorrect enrolment|2|||
42073152|NCT00882518|75883225|FG000|Overall Study|Central lab closure for National day|1|||
42073153|NCT00882518|75883226|FG001|Overall Study|Central lab closure for National day|0|||
42073154|NCT00882518|75883225|FG000|Overall Study|Allocating random number by mistake|0|||
42073155|NCT00882518|75883226|FG001|Overall Study|Allocating random number by mistake|1|||
42073156|NCT00882362|75883243|FG000|Overall Study|Adverse Event|13|||
42073157|NCT00882362|75883244|FG001|Overall Study|Adverse Event|10|||
42073158|NCT00882362|75883243|FG000|Overall Study|Withdrawal by Subject|13|||
42073159|NCT00882362|75883244|FG001|Overall Study|Withdrawal by Subject|10|||
42073160|NCT00882362|75883243|FG000|Overall Study|Lack of Efficacy|3|||
42073161|NCT00882362|75883244|FG001|Overall Study|Lack of Efficacy|0|||
42073162|NCT00882362|75883243|FG000|Overall Study|Protocol Violation|7|||
42073163|NCT00882362|75883244|FG001|Overall Study|Protocol Violation|2|||
42073164|NCT00882362|75883243|FG000|Overall Study|Pregnancy|1|||
42073165|NCT00882362|75883244|FG001|Overall Study|Pregnancy|0|||
42073166|NCT00882362|75883243|FG000|Overall Study|Physician Decision|5|||
42073167|NCT00882362|75883244|FG001|Overall Study|Physician Decision|1|||
42073168|NCT00882362|75883243|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
42073169|NCT00882362|75883244|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
42073170|NCT00882362|75883243|FG000|Overall Study|change of residence or other commitments|5|||
42073171|NCT00882362|75883244|FG001|Overall Study|change of residence or other commitments|0|||
42073172|NCT00851643|75883256|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
42073173|NCT00851643|75883257|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
42073174|NCT00851643|75883258|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
42073175|NCT00851643|75883259|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
42073176|NCT00851643|75883260|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
42073177|NCT00851643|75883261|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
42073178|NCT00851643|75883256|FG000|Base Study (Up to 12 Months)|Other|0|||
42073179|NCT00851643|75883257|FG001|Base Study (Up to 12 Months)|Other|0|||
42073180|NCT00851643|75883258|FG002|Base Study (Up to 12 Months)|Other|0|||
42073181|NCT00851643|75883259|FG003|Base Study (Up to 12 Months)|Other|0|||
42073182|NCT00851643|75883260|FG004|Base Study (Up to 12 Months)|Other|0|||
42073183|NCT00851643|75883261|FG005|Base Study (Up to 12 Months)|Other|1|||
42073184|NCT00851643|75883256|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
42073185|NCT00851643|75883257|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
42073186|NCT00851643|75883258|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
42177495|NCT03150862|75984624|FG001|Overall Study|Sponsor's decision|0|||
42073187|NCT00851643|75883259|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
42073188|NCT00851643|75883260|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
42073189|NCT00851643|75883261|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
42073190|NCT00851643|75883256|FG000|Extension Study (Up to 36 Months)|Moved|0|||
42073191|NCT00851643|75883257|FG001|Extension Study (Up to 36 Months)|Moved|2|||
42073192|NCT00851643|75883258|FG002|Extension Study (Up to 36 Months)|Moved|1|||
42073193|NCT00851643|75883259|FG003|Extension Study (Up to 36 Months)|Moved|1|||
42073194|NCT00851643|75883260|FG004|Extension Study (Up to 36 Months)|Moved|0|||
42073195|NCT00851643|75883261|FG005|Extension Study (Up to 36 Months)|Moved|1|||
42073196|NCT00529243|75883274|FG000|Overall Study|Adverse Event|1|||
42073197|NCT00529243|75883274|FG000|Overall Study|Death|1|||
42073198|NCT00529243|75883274|FG000|Overall Study|Relocated|1|||
42073199|NCT03728309|75883280|FG000|Overall Study|Randomized but not Treated|0|||
42073200|NCT03728309|75883281|FG001|Overall Study|Randomized but not Treated|1|||
42073201|NCT03728309|75883280|FG000|Overall Study|Adverse Event|0|||
42073202|NCT03728309|75883281|FG001|Overall Study|Adverse Event|1|||
42073203|NCT03728309|75883280|FG000|Overall Study|Withdrawal by Subject|2|||
42073204|NCT03728309|75883281|FG001|Overall Study|Withdrawal by Subject|8|||
42073205|NCT03728309|75883280|FG000|Overall Study|Lost to Follow-up|9|||
42073206|NCT03728309|75883281|FG001|Overall Study|Lost to Follow-up|10|||
42073207|NCT03728309|75883280|FG000|Overall Study|Protocol Deviation|0|||
42073208|NCT03728309|75883281|FG001|Overall Study|Protocol Deviation|1|||
42073209|NCT03728309|75883280|FG000|Overall Study|Due to COVID|1|||
42073210|NCT03728309|75883281|FG001|Overall Study|Due to COVID|3|||
42073211|NCT03683719|75883298|FG000|Overall Study|Lack of Efficacy|1|||
42073212|NCT03683719|75883299|FG001|Overall Study|Lack of Efficacy|3|||
42073213|NCT03683719|75883300|FG002|Overall Study|Lack of Efficacy|4|||
42073214|NCT03683719|75883301|FG003|Overall Study|Lack of Efficacy|0|||
42073215|NCT03683719|75883302|FG004|Overall Study|Lack of Efficacy|4|||
42073216|NCT03683719|75883298|FG000|Overall Study|Adverse Event|6|||
42073217|NCT03683719|75883299|FG001|Overall Study|Adverse Event|6|||
42073218|NCT03683719|75883300|FG002|Overall Study|Adverse Event|0|||
42073219|NCT03683719|75883301|FG003|Overall Study|Adverse Event|1|||
42073220|NCT03683719|75883302|FG004|Overall Study|Adverse Event|3|||
42073221|NCT03683719|75883298|FG000|Overall Study|Withdrawal by Subject|4|||
42073222|NCT03683719|75883299|FG001|Overall Study|Withdrawal by Subject|4|||
42073223|NCT03683719|75883300|FG002|Overall Study|Withdrawal by Subject|3|||
42073224|NCT03683719|75883301|FG003|Overall Study|Withdrawal by Subject|5|||
42073225|NCT03683719|75883302|FG004|Overall Study|Withdrawal by Subject|5|||
42073226|NCT03683719|75883298|FG000|Overall Study|Lost to Follow-up|1|||
42073227|NCT03683719|75883299|FG001|Overall Study|Lost to Follow-up|0|||
42073228|NCT03683719|75883300|FG002|Overall Study|Lost to Follow-up|0|||
42073229|NCT03683719|75883301|FG003|Overall Study|Lost to Follow-up|1|||
42073230|NCT03683719|75883302|FG004|Overall Study|Lost to Follow-up|1|||
42073231|NCT03683719|75883298|FG000|Overall Study|Other personal reasons|0|||
42073232|NCT03683719|75883299|FG001|Overall Study|Other personal reasons|0|||
42073233|NCT03683719|75883300|FG002|Overall Study|Other personal reasons|1|||
42073234|NCT03683719|75883301|FG003|Overall Study|Other personal reasons|0|||
42073235|NCT03683719|75883302|FG004|Overall Study|Other personal reasons|1|||
42073236|NCT00851253|75883316|FG000|Overall Study|Disease Progression|1|||
42073237|NCT00851253|75883317|FG001|Overall Study|Disease Progression|0|||
42073238|NCT00520351|75883325|FG000|First Intervention|Withdrawal by Subject|1|||
42073239|NCT00520351|75883326|FG001|First Intervention|Withdrawal by Subject|1|||
42073240|NCT00850395|75883336|FG000|Overall Study|Death|1|||
42073241|NCT00850395|75883336|FG000|Overall Study|Adverse Event|1|||
42073242|NCT00850395|75883336|FG000|Overall Study|Insufficient clinical response|3|||
42073243|NCT00850395|75883336|FG000|Overall Study|Other|5|||
42073244|NCT00520039|75883342|FG000|Overall Study|Exclusion criteria met at first visit|7|||
42073245|NCT00520039|75883343|FG001|Overall Study|Exclusion criteria met at first visit|5|||
42073246|NCT00577720|75883355|FG000|Overall Study|Adverse Event|2|||
42177496|NCT03150862|75984625|FG002|Overall Study|Sponsor's decision|0|||
42293433|NCT02649439|76127562|FG000|Overall Study|PSA DT makes ineligible|0|||
42293434|NCT02649439|76127563|FG001|Overall Study|PSA DT makes ineligible|1|||
42293435|NCT02649439|76127562|FG000|Overall Study|Rising PSA No Mets|0|||
42293436|NCT02649439|76127563|FG001|Overall Study|Rising PSA No Mets|1|||
42293437|NCT02649439|76127562|FG000|Overall Study|Rising PSA|0|||
42293438|NCT02649439|76127563|FG001|Overall Study|Rising PSA|1|||
42073247|NCT00577720|75883356|FG001|Overall Study|Adverse Event|1|||
42073248|NCT00577720|75883357|FG002|Overall Study|Adverse Event|0|||
42073249|NCT00577720|75883358|FG003|Overall Study|Adverse Event|4|||
42293439|NCT02649439|76127562|FG000|Overall Study|Signed follow up protocol|0|||
42293440|NCT02649439|76127563|FG001|Overall Study|Signed follow up protocol|1|||
42073250|NCT00577720|75883355|FG000|Overall Study|Lost to Follow-up|0|||
42073251|NCT00577720|75883356|FG001|Overall Study|Lost to Follow-up|0|||
42073252|NCT00577720|75883357|FG002|Overall Study|Lost to Follow-up|1|||
42073253|NCT00577720|75883358|FG003|Overall Study|Lost to Follow-up|0|||
42073254|NCT00577720|75883355|FG000|Overall Study|Protocol Violation|0|||
42073255|NCT00577720|75883356|FG001|Overall Study|Protocol Violation|0|||
42073256|NCT00577720|75883357|FG002|Overall Study|Protocol Violation|0|||
42177497|NCT03150862|75984626|FG003|Overall Study|Sponsor's decision|10|||
42073257|NCT00577720|75883358|FG003|Overall Study|Protocol Violation|1|||
42073258|NCT00577720|75883355|FG000|Overall Study|Withdrawal by Subject|2|||
42073259|NCT00577720|75883356|FG001|Overall Study|Withdrawal by Subject|0|||
42177498|NCT03150862|75984627|FG004|Overall Study|Sponsor's decision|3|||
42073260|NCT00577720|75883357|FG002|Overall Study|Withdrawal by Subject|0|||
42073261|NCT00577720|75883358|FG003|Overall Study|Withdrawal by Subject|2|||
42073262|NCT00519649|75883368|FG000|Overall Study|Withdrawal by Subject|1|||
42073263|NCT00512707|75883386|FG000|Overall Study|Lost to Follow-up|5|||
42073264|NCT00512707|75883387|FG001|Overall Study|Lost to Follow-up|11|||
42073265|NCT00512707|75883386|FG000|Overall Study|Developed skin irritation|2|||
42073266|NCT00512707|75883387|FG001|Overall Study|Developed skin irritation|1|||
42073267|NCT00512707|75883386|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
42073268|NCT00512707|75883387|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
42073269|NCT00512707|75883386|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
42073270|NCT00512707|75883387|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
42073271|NCT03471767|75883395|FG000|Overall Study|Withdrawal by Subject|3|||
42073272|NCT03471767|75883396|FG001|Overall Study|Withdrawal by Subject|1|||
42073273|NCT03471767|75883395|FG000|Overall Study|Adverse Event|1|||
42073274|NCT03471767|75883396|FG001|Overall Study|Adverse Event|0|||
42073275|NCT03471767|75883395|FG000|Overall Study|Lost to Follow-up|1|||
42073276|NCT03471767|75883396|FG001|Overall Study|Lost to Follow-up|0|||
42073277|NCT03471767|75883395|FG000|Overall Study|PI Withdrawal|1|||
42073278|NCT03471767|75883396|FG001|Overall Study|PI Withdrawal|3|||
42073279|NCT00849693|75883406|FG000|Acute Treatment Phase|Adverse Event|12|||
42073280|NCT00849693|75883407|FG001|Acute Treatment Phase|Adverse Event|7|||
42073281|NCT00849693|75883408|FG002|Acute Treatment Phase|Adverse Event|6|||
42073282|NCT00849693|75883409|FG003|Acute Treatment Phase|Adverse Event|4|||
42073283|NCT00849693|75883406|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
42073284|NCT00849693|75883407|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
42073285|NCT00849693|75883408|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
42073286|NCT00849693|75883409|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
42073287|NCT00849693|75883406|FG000|Acute Treatment Phase|Protocol Violation|1|||
42073288|NCT00849693|75883407|FG001|Acute Treatment Phase|Protocol Violation|5|||
42073289|NCT00849693|75883408|FG002|Acute Treatment Phase|Protocol Violation|2|||
42073290|NCT00849693|75883409|FG003|Acute Treatment Phase|Protocol Violation|6|||
42073291|NCT00849693|75883406|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
42073292|NCT00849693|75883407|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
42073293|NCT00849693|75883408|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
42073294|NCT00849693|75883409|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
42073295|NCT00849693|75883406|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
42073296|NCT00849693|75883407|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
42073297|NCT00849693|75883408|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
42073298|NCT00849693|75883409|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
42073299|NCT00849693|75883406|FG000|Acute Treatment Phase|Physician Decision|2|||
42073300|NCT00849693|75883407|FG001|Acute Treatment Phase|Physician Decision|1|||
42073301|NCT00849693|75883408|FG002|Acute Treatment Phase|Physician Decision|2|||
42073302|NCT00849693|75883409|FG003|Acute Treatment Phase|Physician Decision|1|||
42073303|NCT00849693|75883406|FG000|Acute Treatment Phase|Sponsor decision|0|||
42073304|NCT00849693|75883407|FG001|Acute Treatment Phase|Sponsor decision|0|||
42073305|NCT00849693|75883408|FG002|Acute Treatment Phase|Sponsor decision|1|||
42073306|NCT00849693|75883409|FG003|Acute Treatment Phase|Sponsor decision|0|||
42073307|NCT00849693|75883406|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
42073308|NCT00849693|75883407|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
42073309|NCT00849693|75883408|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
42357780|NCT01858363|76203290|FG001|Overall Study|Withdrawal by Subject|14|||
42017479|NCT01211184|75825170|FG000|Overall Study|Withdrawal by Subject|0|||
42017480|NCT01211184|75825171|FG001|Overall Study|Withdrawal by Subject|2|||
42017481|NCT01211184|75825172|FG002|Overall Study|Withdrawal by Subject|1|||
42017482|NCT00924469|75825185|FG000|Overall Study|Adverse Event|2|||
42017483|NCT00924469|75825186|FG001|Overall Study|Adverse Event|0|||
42017484|NCT00924469|75825185|FG000|Overall Study|Withdrawal by Subject|0|||
42017485|NCT00924469|75825186|FG001|Overall Study|Withdrawal by Subject|1|||
42017486|NCT00924469|75825185|FG000|Overall Study|Lost to Follow-up|0|||
42017487|NCT00924469|75825186|FG001|Overall Study|Lost to Follow-up|1|||
42017488|NCT00924313|75825192|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
42017489|NCT01209780|75825200|FG000|Overall Study|Adverse Event|0|||
42017490|NCT01209780|75825201|FG001|Overall Study|Adverse Event|1|||
42017491|NCT01209780|75825202|FG002|Overall Study|Adverse Event|0|||
42017492|NCT01209780|75825203|FG003|Overall Study|Adverse Event|0|||
42017493|NCT01209780|75825204|FG004|Overall Study|Adverse Event|0|||
42017494|NCT01209780|75825200|FG000|Overall Study|Withdrawal by Subject|9|||
42017495|NCT01209780|75825201|FG001|Overall Study|Withdrawal by Subject|2|||
42017496|NCT01209780|75825202|FG002|Overall Study|Withdrawal by Subject|1|||
42017497|NCT01209780|75825203|FG003|Overall Study|Withdrawal by Subject|1|||
42017498|NCT01209780|75825204|FG004|Overall Study|Withdrawal by Subject|0|||
42017499|NCT01209780|75825200|FG000|Overall Study|Lost to Follow-up|17|||
42017500|NCT01209780|75825201|FG001|Overall Study|Lost to Follow-up|12|||
42017501|NCT01209780|75825202|FG002|Overall Study|Lost to Follow-up|3|||
42017502|NCT01209780|75825203|FG003|Overall Study|Lost to Follow-up|9|||
42073310|NCT00849693|75883409|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
42073311|NCT00849693|75883406|FG000|Extension Phase|Adverse Event|4|||
42073312|NCT00849693|75883407|FG001|Extension Phase|Adverse Event|6|||
42073313|NCT00849693|75883408|FG002|Extension Phase|Adverse Event|3|||
42073314|NCT00849693|75883409|FG003|Extension Phase|Adverse Event|7|||
42073315|NCT00849693|75883406|FG000|Extension Phase|Lost to Follow-up|7|||
42073316|NCT00849693|75883407|FG001|Extension Phase|Lost to Follow-up|5|||
42073317|NCT00849693|75883408|FG002|Extension Phase|Lost to Follow-up|6|||
42073318|NCT00849693|75883409|FG003|Extension Phase|Lost to Follow-up|6|||
42073319|NCT00849693|75883406|FG000|Extension Phase|Protocol Violation|0|||
42073320|NCT00849693|75883407|FG001|Extension Phase|Protocol Violation|3|||
42073321|NCT00849693|75883408|FG002|Extension Phase|Protocol Violation|2|||
42073322|NCT00849693|75883409|FG003|Extension Phase|Protocol Violation|3|||
42073323|NCT00849693|75883406|FG000|Extension Phase|Withdrawal by Subject|6|||
42073324|NCT00849693|75883407|FG001|Extension Phase|Withdrawal by Subject|9|||
42073325|NCT00849693|75883408|FG002|Extension Phase|Withdrawal by Subject|10|||
42073326|NCT00849693|75883409|FG003|Extension Phase|Withdrawal by Subject|15|||
42073327|NCT00849693|75883406|FG000|Extension Phase|Parent or caregiver decision|9|||
42073328|NCT00849693|75883407|FG001|Extension Phase|Parent or caregiver decision|4|||
42073329|NCT00849693|75883408|FG002|Extension Phase|Parent or caregiver decision|10|||
42073330|NCT00849693|75883409|FG003|Extension Phase|Parent or caregiver decision|5|||
42073331|NCT00849693|75883406|FG000|Extension Phase|Physician Decision|1|||
42073332|NCT00849693|75883407|FG001|Extension Phase|Physician Decision|1|||
42073333|NCT00849693|75883408|FG002|Extension Phase|Physician Decision|2|||
42073334|NCT00849693|75883409|FG003|Extension Phase|Physician Decision|0|||
42073335|NCT00849693|75883406|FG000|Extension Phase|Sponsor decision|1|||
42073336|NCT00849693|75883407|FG001|Extension Phase|Sponsor decision|0|||
42073337|NCT00849693|75883408|FG002|Extension Phase|Sponsor decision|0|||
42073338|NCT00849693|75883409|FG003|Extension Phase|Sponsor decision|1|||
42073339|NCT00849693|75883406|FG000|Extension Phase|Lack of Efficacy|2|||
42073340|NCT00849693|75883407|FG001|Extension Phase|Lack of Efficacy|2|||
42073341|NCT00849693|75883408|FG002|Extension Phase|Lack of Efficacy|2|||
42073342|NCT00849693|75883409|FG003|Extension Phase|Lack of Efficacy|1|||
42073343|NCT00527605|75883433|FG000|Overall Study|Adverse Event|3|||
42073344|NCT00527605|75883434|FG001|Overall Study|Adverse Event|0|||
42073345|NCT00527605|75883433|FG000|Overall Study|Withdrawal by Subject|3|||
42073346|NCT00527605|75883434|FG001|Overall Study|Withdrawal by Subject|7|||
42073347|NCT00527605|75883433|FG000|Overall Study|Lost to Follow-up|6|||
42073348|NCT00527605|75883434|FG001|Overall Study|Lost to Follow-up|2|||
42073349|NCT00527605|75883433|FG000|Overall Study|Protocol Violation|1|||
42073350|NCT00527605|75883434|FG001|Overall Study|Protocol Violation|2|||
42073351|NCT00849381|75883440|FG000|Overall Study|Adverse Event|1|||
42073352|NCT00849381|75883440|FG000|Overall Study|Lost to Follow-up|129|||
42073353|NCT00849381|75883440|FG000|Overall Study|Protocol Violation|5|||
42073354|NCT00849381|75883440|FG000|Overall Study|Withdrawal by Subject|6|||
42073355|NCT00849381|75883440|FG000|Overall Study|Other|4|||
42073356|NCT00711412|75883444|FG000|Induction Treatment|Death|2|||
42073357|NCT00711412|75883444|FG000|Induction Treatment|Adverse Event|1|||
42073358|NCT00711412|75883444|FG000|Induction Treatment|Other|1|||
42073359|NCT00711412|75883444|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
42073360|NCT00711412|75883444|FG000|Evaluated for Combination Treatment|Death|1|||
42073361|NCT00711412|75883444|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
42073362|NCT00711412|75883444|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
42073363|NCT00711412|75883444|FG000|Combination Treatment|Progressive Disease|1|||
42073364|NCT00711412|75883444|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
42073365|NCT00711412|75883444|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
42073366|NCT00711412|75883444|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
42073367|NCT00711412|75883444|FG000|Evaluation for Response and Surgery|Death|1|||
42073368|NCT00711412|75883444|FG000|Survival Follow up Until Death|Other|12|||
42073369|NCT00577408|75883460|FG000|Overall Study|Stopped attending study visits|9|||
42073370|NCT00577408|75883461|FG001|Overall Study|Stopped attending study visits|11|||
42073371|NCT00577408|75883460|FG000|Overall Study|Continued opioid use|3|||
42073372|NCT00577408|75883461|FG001|Overall Study|Continued opioid use|2|||
42073373|NCT00577408|75883460|FG000|Overall Study|Non-compliance with study meds|0|||
42073374|NCT00577408|75883461|FG001|Overall Study|Non-compliance with study meds|3|||
42073375|NCT00577408|75883460|FG000|Overall Study|Refused Oral Naltrexone|0|||
42177499|NCT03150862|75984628|FG005|Overall Study|Sponsor's decision|0|||
42073376|NCT00577408|75883461|FG001|Overall Study|Refused Oral Naltrexone|1|||
42073377|NCT00577408|75883460|FG000|Overall Study|Moved out of state|0|||
42073378|NCT00577408|75883461|FG001|Overall Study|Moved out of state|1|||
42073379|NCT00577408|75883460|FG000|Overall Study|Scheduling Issues|0|||
42073380|NCT00577408|75883461|FG001|Overall Study|Scheduling Issues|3|||
42073381|NCT00577408|75883460|FG000|Overall Study|Death|0|||
42073382|NCT00577408|75883461|FG001|Overall Study|Death|1|||
42073383|NCT00577408|75883460|FG000|Overall Study|Psychiatric hospitalization|0|||
42073384|NCT00577408|75883461|FG001|Overall Study|Psychiatric hospitalization|1|||
42073385|NCT00713596|75883470|FG000|Overall Study|Study was terminated|2|||
42073386|NCT00713596|75883471|FG001|Overall Study|Study was terminated|3|||
42073387|NCT00713596|75883472|FG002|Overall Study|Study was terminated|2|||
42073388|NCT00880568|75883489|FG000|Overall Study|Disease progression|3|||
42073389|NCT00880568|75883490|FG001|Overall Study|Disease progression|3|||
42073390|NCT00880568|75883491|FG002|Overall Study|Disease progression|3|||
42073391|NCT00880568|75883492|FG003|Overall Study|Disease progression|1|||
42073392|NCT00880568|75883493|FG004|Overall Study|Disease progression|3|||
42073393|NCT00880568|75883494|FG005|Overall Study|Disease progression|3|||
42073394|NCT00880568|75883495|FG006|Overall Study|Disease progression|5|||
42073395|NCT00880568|75883496|FG007|Overall Study|Disease progression|0|||
42177500|NCT03150862|75984629|FG006|Overall Study|Sponsor's decision|1|||
42177501|NCT03150862|75984630|FG007|Overall Study|Sponsor's decision|1|||
42177502|NCT03150862|75984623|FG000|Overall Study|Change in Methylation status|0|||
42177503|NCT03150862|75984624|FG001|Overall Study|Change in Methylation status|0|||
42177504|NCT03150862|75984625|FG002|Overall Study|Change in Methylation status|0|||
42177505|NCT03150862|75984626|FG003|Overall Study|Change in Methylation status|0|||
42177506|NCT03150862|75984627|FG004|Overall Study|Change in Methylation status|1|||
42177507|NCT03150862|75984628|FG005|Overall Study|Change in Methylation status|0|||
42293441|NCT02622113|76127578|FG000|Overall Study|Adverse Event|4|||
42293442|NCT02622113|76127579|FG001|Overall Study|Adverse Event|4|||
42293443|NCT02622113|76127578|FG000|Overall Study|Physician Decision|0|||
42293444|NCT02622113|76127579|FG001|Overall Study|Physician Decision|1|||
42293445|NCT02622113|76127578|FG000|Overall Study|Withdrawal by Subject|0|||
42293446|NCT02622113|76127579|FG001|Overall Study|Withdrawal by Subject|2|||
42293447|NCT02622113|76127578|FG000|Overall Study|Stopping Criteria|1|||
42293448|NCT02622113|76127579|FG001|Overall Study|Stopping Criteria|3|||
42293449|NCT02651467|76127588|FG000|Overall Study|Withdrawal by Subject|0|||
42073396|NCT00880568|75883497|FG008|Overall Study|Disease progression|3|||
42073397|NCT00880568|75883489|FG000|Overall Study|Adverse Event|0|||
42073398|NCT00880568|75883490|FG001|Overall Study|Adverse Event|0|||
42073399|NCT00880568|75883491|FG002|Overall Study|Adverse Event|0|||
42073400|NCT00880568|75883492|FG003|Overall Study|Adverse Event|0|||
42073401|NCT00880568|75883493|FG004|Overall Study|Adverse Event|0|||
42073402|NCT00880568|75883494|FG005|Overall Study|Adverse Event|0|||
42073403|NCT00880568|75883495|FG006|Overall Study|Adverse Event|1|||
42073404|NCT00880568|75883496|FG007|Overall Study|Adverse Event|1|||
42073405|NCT00880568|75883497|FG008|Overall Study|Adverse Event|0|||
42073406|NCT00880568|75883489|FG000|Overall Study|Withdrawal by Subject|0|||
42073407|NCT00880568|75883490|FG001|Overall Study|Withdrawal by Subject|0|||
42073408|NCT00880568|75883491|FG002|Overall Study|Withdrawal by Subject|0|||
42073409|NCT00880568|75883492|FG003|Overall Study|Withdrawal by Subject|0|||
42073410|NCT00880568|75883493|FG004|Overall Study|Withdrawal by Subject|0|||
42073411|NCT00880568|75883494|FG005|Overall Study|Withdrawal by Subject|0|||
42073412|NCT00880568|75883495|FG006|Overall Study|Withdrawal by Subject|0|||
42073413|NCT00880568|75883496|FG007|Overall Study|Withdrawal by Subject|1|||
42073414|NCT00880568|75883497|FG008|Overall Study|Withdrawal by Subject|0|||
42073415|NCT00881894|75883524|FG000|Overall Study|Consent withdrawn|0|||
42073416|NCT00881894|75883525|FG001|Overall Study|Consent withdrawn|1|||
42073417|NCT00881894|75883524|FG000|Overall Study|Other reasons for premature termination|1|||
42073418|NCT00881894|75883525|FG001|Overall Study|Other reasons for premature termination|2|||
42073419|NCT00711100|75883531|FG000|Overall Study|Lack of Efficacy|5|||
42073420|NCT00711100|75883531|FG000|Overall Study|Withdrawal by Subject|8|||
42073421|NCT00827931|75883549|FG000|Overall Study|Death|3|||
42073422|NCT00827931|75883550|FG001|Overall Study|Death|5|||
42073423|NCT00827931|75883549|FG000|Overall Study|Adverse Event|1|||
42177508|NCT03150862|75984629|FG006|Overall Study|Change in Methylation status|0|||
42177509|NCT03150862|75984630|FG007|Overall Study|Change in Methylation status|0|||
42293450|NCT02651467|76127589|FG001|Overall Study|Withdrawal by Subject|0|||
42293451|NCT02651467|76127590|FG002|Overall Study|Withdrawal by Subject|2|||
42073424|NCT00827931|75883550|FG001|Overall Study|Adverse Event|0|||
42073425|NCT00827931|75883549|FG000|Overall Study|Lost to Follow-up|1|||
42073426|NCT00827931|75883550|FG001|Overall Study|Lost to Follow-up|0|||
42073427|NCT00827931|75883549|FG000|Overall Study|Withdrawal by Subject|0|||
42073428|NCT00827931|75883550|FG001|Overall Study|Withdrawal by Subject|1|||
42073429|NCT00827931|75883549|FG000|Overall Study|Other|1|||
42073430|NCT00827931|75883550|FG001|Overall Study|Other|0|||
42073431|NCT00526669|75883556|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
42073432|NCT00526669|75883557|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
42073433|NCT00526669|75883556|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
42177510|NCT03150862|75984623|FG000|Overall Study|Roll over in to Long Term Extension|0|||
42177511|NCT03150862|75984624|FG001|Overall Study|Roll over in to Long Term Extension|0|||
42177512|NCT03150862|75984625|FG002|Overall Study|Roll over in to Long Term Extension|0|||
42293452|NCT02651467|76127588|FG000|Overall Study|Other (Not specified)|1|||
42073434|NCT00526669|75883557|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
42293453|NCT02651467|76127589|FG001|Overall Study|Other (Not specified)|0|||
42073435|NCT00526669|75883556|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
42073436|NCT00526669|75883557|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
42073437|NCT00526669|75883556|FG000|Combined Treatment Phase|Death|0|||
42073438|NCT00526669|75883557|FG001|Combined Treatment Phase|Death|2|||
42073439|NCT00710866|75883569|FG000|Overall Study|Protocol Violation|5|||
42073440|NCT00710866|75883570|FG001|Overall Study|Protocol Violation|4|||
42073441|NCT00710866|75883569|FG000|Overall Study|Withdrawal by Subject|2|||
42073442|NCT00710866|75883570|FG001|Overall Study|Withdrawal by Subject|1|||
42073443|NCT00710866|75883569|FG000|Overall Study|Lost to Follow-up|1|||
42073444|NCT00710866|75883570|FG001|Overall Study|Lost to Follow-up|0|||
42073445|NCT00710866|75883569|FG000|Overall Study|Failed to meet eligibility|1|||
42073446|NCT00710866|75883570|FG001|Overall Study|Failed to meet eligibility|1|||
42073447|NCT00827775|75883587|FG000|Overall Study|Withdrawal by Subject|0|||
42073448|NCT00827775|75883588|FG001|Overall Study|Withdrawal by Subject|5|||
42073449|NCT00827541|75883596|FG000|Overall Study|Exitus|1|||
42073450|NCT00827541|75883597|FG001|Overall Study|Exitus|8|||
42073451|NCT00827541|75883596|FG000|Overall Study|Other|1|||
42073452|NCT00827541|75883597|FG001|Overall Study|Other|3|||
42073453|NCT00827541|75883596|FG000|Overall Study|Pathogen not susceptible|1|||
42073454|NCT00827541|75883597|FG001|Overall Study|Pathogen not susceptible|0|||
42073455|NCT00827541|75883596|FG000|Overall Study|Lack of effectiveness|1|||
42073456|NCT00827541|75883597|FG001|Overall Study|Lack of effectiveness|0|||
42073457|NCT00518323|75883607|FG000|Overall Study|Lack of Efficacy|14|||
42073458|NCT00518323|75883608|FG001|Overall Study|Lack of Efficacy|2|||
42073459|NCT00518323|75883609|FG002|Overall Study|Lack of Efficacy|4|||
42073460|NCT00518323|75883610|FG003|Overall Study|Lack of Efficacy|20|||
42073461|NCT00518323|75883607|FG000|Overall Study|Withdrawal by Subject|1|||
42073462|NCT00518323|75883608|FG001|Overall Study|Withdrawal by Subject|2|||
42073463|NCT00518323|75883609|FG002|Overall Study|Withdrawal by Subject|4|||
42073464|NCT00518323|75883610|FG003|Overall Study|Withdrawal by Subject|2|||
42073465|NCT00518323|75883607|FG000|Overall Study|Lost to Follow-up|0|||
42073466|NCT00518323|75883608|FG001|Overall Study|Lost to Follow-up|2|||
42073467|NCT00518323|75883609|FG002|Overall Study|Lost to Follow-up|1|||
42073468|NCT00518323|75883610|FG003|Overall Study|Lost to Follow-up|3|||
42073469|NCT00518323|75883607|FG000|Overall Study|Adverse Event|1|||
42073470|NCT00518323|75883608|FG001|Overall Study|Adverse Event|1|||
42073471|NCT00518323|75883609|FG002|Overall Study|Adverse Event|1|||
42073472|NCT00518323|75883610|FG003|Overall Study|Adverse Event|0|||
42073473|NCT00518323|75883607|FG000|Overall Study|Prohibited medication and others|3|||
42073474|NCT00518323|75883608|FG001|Overall Study|Prohibited medication and others|1|||
42073475|NCT00518323|75883609|FG002|Overall Study|Prohibited medication and others|1|||
42073476|NCT00518323|75883610|FG003|Overall Study|Prohibited medication and others|0|||
42073477|NCT00826449|75883622|FG000|Overall Study|Disease Progression|4|||
42073478|NCT00826449|75883622|FG000|Overall Study|Withdrawal by Subject|1|||
42073479|NCT00825825|75883627|FG000|First Medication Period (14 Days)|Adverse Event|1|||
42073480|NCT00825825|75883628|FG001|First Medication Period (14 Days)|Adverse Event|0|||
42073481|NCT00825825|75883629|FG002|First Medication Period (14 Days)|Adverse Event|0|||
42073482|NCT00825825|75883630|FG003|First Medication Period (14 Days)|Adverse Event|0|||
42073483|NCT00825825|75883631|FG004|First Medication Period (14 Days)|Adverse Event|0|||
42073484|NCT00825825|75883632|FG005|First Medication Period (14 Days)|Adverse Event|1|||
42073485|NCT00825825|75883627|FG000|First Medication Period (14 Days)|Physician Decision|2|||
42073486|NCT00825825|75883628|FG001|First Medication Period (14 Days)|Physician Decision|0|||
42073487|NCT00825825|75883629|FG002|First Medication Period (14 Days)|Physician Decision|1|||
42073488|NCT00825825|75883630|FG003|First Medication Period (14 Days)|Physician Decision|0|||
42073489|NCT00825825|75883631|FG004|First Medication Period (14 Days)|Physician Decision|0|||
42073490|NCT00825825|75883632|FG005|First Medication Period (14 Days)|Physician Decision|1|||
42073491|NCT00825825|75883627|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
42177513|NCT03150862|75984626|FG003|Overall Study|Roll over in to Long Term Extension|0|||
42177514|NCT03150862|75984627|FG004|Overall Study|Roll over in to Long Term Extension|0|||
42073492|NCT00825825|75883628|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
42073493|NCT00825825|75883629|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
42073494|NCT00825825|75883630|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
42177515|NCT03150862|75984628|FG005|Overall Study|Roll over in to Long Term Extension|0|||
42293454|NCT02651467|76127590|FG002|Overall Study|Other (Not specified)|2|||
42073495|NCT00825825|75883631|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
42073496|NCT00825825|75883632|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
42073497|NCT00825825|75883627|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
42073498|NCT00825825|75883628|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
42073499|NCT00825825|75883629|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
42073500|NCT00825825|75883630|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
42073501|NCT00825825|75883631|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
42073502|NCT00825825|75883632|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
42073503|NCT00825825|75883627|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
42073504|NCT00825825|75883628|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
42073505|NCT00825825|75883629|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
42073506|NCT00825825|75883630|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
42073507|NCT00825825|75883631|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
42073508|NCT00825825|75883632|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
42073509|NCT00825825|75883627|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
42073510|NCT00825825|75883628|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
42073511|NCT00825825|75883629|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
42073512|NCT00825825|75883630|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
42073513|NCT00825825|75883631|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
42073514|NCT00825825|75883632|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
42073515|NCT00825825|75883627|FG000|Third Medication Period (14 Days)|poor data quality|0|||
42073516|NCT00825825|75883628|FG001|Third Medication Period (14 Days)|poor data quality|1|||
42073517|NCT00825825|75883629|FG002|Third Medication Period (14 Days)|poor data quality|0|||
42073518|NCT00825825|75883630|FG003|Third Medication Period (14 Days)|poor data quality|0|||
42073519|NCT00825825|75883631|FG004|Third Medication Period (14 Days)|poor data quality|0|||
42073520|NCT00825825|75883632|FG005|Third Medication Period (14 Days)|poor data quality|0|||
42073521|NCT00710710|75883641|FG000|Overall Study|Consent withdrawn|2|||
42073522|NCT00710710|75883642|FG001|Overall Study|Consent withdrawn|2|||
42073523|NCT00710710|75883641|FG000|Overall Study|Protocol Violation|0|||
42073524|NCT00710710|75883642|FG001|Overall Study|Protocol Violation|1|||
42073525|NCT00710710|75883641|FG000|Overall Study|Adverse Event|3|||
42073526|NCT00710710|75883642|FG001|Overall Study|Adverse Event|3|||
42073527|NCT00710710|75883641|FG000|Overall Study|Progressive disease|40|||
42073528|NCT00710710|75883642|FG001|Overall Study|Progressive disease|38|||
42073529|NCT00880334|75883650|FG000|Randomized Phase|Physician Decision|1|||
42073530|NCT00880334|75883651|FG001|Randomized Phase|Physician Decision|0|||
42073531|NCT00880334|75883650|FG000|Randomized Phase|Withdrawal by Subject|2|||
42073532|NCT00880334|75883651|FG001|Randomized Phase|Withdrawal by Subject|1|||
42073533|NCT00880334|75883650|FG000|Randomized Phase|Inadequate Labs|1|||
42073534|NCT00880334|75883651|FG001|Randomized Phase|Inadequate Labs|1|||
42073535|NCT00880334|75883650|FG000|Randomized Phase|Brain Metastasis|0|||
42073536|NCT00880334|75883651|FG001|Randomized Phase|Brain Metastasis|1|||
42073537|NCT00880334|75883650|FG000|Randomized Phase|Crossover Participants|0|||
42073538|NCT00880334|75883651|FG001|Randomized Phase|Crossover Participants|37|||
42073539|NCT00865566|75883663|FG000|Overall Study|Death|1|||
42073540|NCT00865566|75883664|FG001|Overall Study|Death|11|||
42073541|NCT00865566|75883663|FG000|Overall Study|Lost to Follow-up|314|||
42073542|NCT00865566|75883664|FG001|Overall Study|Lost to Follow-up|315|||
42073543|NCT00865566|75883663|FG000|Overall Study|Withdrawal by Subject|45|||
42073544|NCT00865566|75883664|FG001|Overall Study|Withdrawal by Subject|65|||
42073545|NCT00865566|75883663|FG000|Overall Study|Physician Decision|0|||
42073546|NCT00865566|75883664|FG001|Overall Study|Physician Decision|1|||
42073547|NCT00865566|75883663|FG000|Overall Study|Participant relocated|78|||
42073548|NCT00865566|75883664|FG001|Overall Study|Participant relocated|107|||
42073549|NCT00865566|75883663|FG000|Overall Study|Participant unable to adhere|27|||
42073550|NCT00865566|75883664|FG001|Overall Study|Participant unable to adhere|42|||
42073551|NCT00865566|75883663|FG000|Overall Study|Other; N=245 due to early study closure|154|||
42073552|NCT00865566|75883664|FG001|Overall Study|Other; N=245 due to early study closure|139|||
42073553|NCT00865566|75883663|FG000|Overall Study|HIV infection|5|||
42073554|NCT00865566|75883664|FG001|Overall Study|HIV infection|7|||
42073555|NCT03866473|75883672|FG000|Phase 1|Death|1|||
42073556|NCT03866473|75883673|FG001|Phase 1|Death|0|||
42073557|NCT03866473|75883672|FG000|Phase 2|Death|0|||
42073558|NCT03866473|75883673|FG001|Phase 2|Death|2|||
42073559|NCT03866473|75883672|FG000|Phase 2|Dropped|1|||
42073560|NCT03866473|75883673|FG001|Phase 2|Dropped|1|||
42073561|NCT03866473|75883672|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
42073562|NCT03866473|75883673|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
42073563|NCT00525499|75883687|FG000|Overall Study|Lost to Follow-up|2|||
42073564|NCT00525499|75883688|FG001|Overall Study|Lost to Follow-up|4|||
42073565|NCT00525499|75883689|FG002|Overall Study|Lost to Follow-up|1|||
42073566|NCT00525499|75883690|FG003|Overall Study|Lost to Follow-up|4|||
42073567|NCT00525499|75883687|FG000|Overall Study|Adverse Event|0|||
42073568|NCT00525499|75883688|FG001|Overall Study|Adverse Event|1|||
42073569|NCT00525499|75883689|FG002|Overall Study|Adverse Event|0|||
42073570|NCT00525499|75883690|FG003|Overall Study|Adverse Event|1|||
42073571|NCT00525499|75883687|FG000|Overall Study|Withdrawal by Subject|5|||
42073572|NCT00525499|75883688|FG001|Overall Study|Withdrawal by Subject|1|||
42073573|NCT00525499|75883689|FG002|Overall Study|Withdrawal by Subject|5|||
42073574|NCT00525499|75883690|FG003|Overall Study|Withdrawal by Subject|2|||
42073575|NCT00525499|75883687|FG000|Overall Study|Protocol Violation|0|||
42073576|NCT00525499|75883688|FG001|Overall Study|Protocol Violation|1|||
42073577|NCT00525499|75883689|FG002|Overall Study|Protocol Violation|1|||
42073578|NCT00525499|75883690|FG003|Overall Study|Protocol Violation|0|||
42073579|NCT00824655|75883702|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
42073580|NCT00824655|75883703|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
42073581|NCT00824655|75883702|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
42073582|NCT00824655|75883703|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
42073583|NCT00525265|75883713|FG000|Overall Study|Protocol Violation|1|||
42073584|NCT00525265|75883714|FG001|Overall Study|Protocol Violation|0|||
42073585|NCT00880256|75883720|FG000|Overall Study|Lost to Follow-up|28|||
42073586|NCT03865381|75883729|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
42073587|NCT03865381|75883729|FG000|Overall Study|Withdrawal by Subject|2|||
42073588|NCT00865098|75883733|FG000|Overall Study|Progressive disease|1|||
42073589|NCT00880100|75883737|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
42073590|NCT00880100|75883737|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
42073591|NCT00880100|75883737|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
42073592|NCT00518011|75883743|FG000|Overall Study|Death|1|||
42073593|NCT00518011|75883744|FG001|Overall Study|Death|1|||
42073594|NCT00518011|75883743|FG000|Overall Study|Adverse Event|2|||
42073595|NCT00518011|75883744|FG001|Overall Study|Adverse Event|3|||
42073596|NCT00518011|75883743|FG000|Overall Study|Disease Progression|2|||
42073597|NCT00518011|75883744|FG001|Overall Study|Disease Progression|2|||
42073598|NCT00518011|75883743|FG000|Overall Study|Other Reasons|3|||
42073599|NCT00518011|75883744|FG001|Overall Study|Other Reasons|2|||
42073600|NCT00518011|75883743|FG000|Overall Study|Withdrawal by Subject|1|||
42073601|NCT00518011|75883744|FG001|Overall Study|Withdrawal by Subject|0|||
42073602|NCT00865020|75883753|FG000|Overall Study|Withdrawal by Subject|22|||
42073603|NCT00865020|75883754|FG001|Overall Study|Withdrawal by Subject|16|||
42073604|NCT00865020|75883753|FG000|Overall Study|Adverse Event|9|||
42073605|NCT00865020|75883754|FG001|Overall Study|Adverse Event|14|||
42073606|NCT00865020|75883753|FG000|Overall Study|Abnormal test procedure result(s)|6|||
42073607|NCT00865020|75883754|FG001|Overall Study|Abnormal test procedure result(s)|8|||
42073608|NCT00865020|75883753|FG000|Overall Study|Lost to Follow-up|6|||
42073609|NCT00865020|75883754|FG001|Overall Study|Lost to Follow-up|4|||
42073610|NCT00865020|75883753|FG000|Overall Study|Protocol deviation|4|||
42073611|NCT00865020|75883754|FG001|Overall Study|Protocol deviation|1|||
42073612|NCT00865020|75883753|FG000|Overall Study|Administrative problems|0|||
42177516|NCT03150862|75984629|FG006|Overall Study|Roll over in to Long Term Extension|0|||
42177517|NCT03150862|75984630|FG007|Overall Study|Roll over in to Long Term Extension|1|||
42177518|NCT03150862|75984623|FG000|Overall Study|Progressive Disease|0|||
42177519|NCT03150862|75984624|FG001|Overall Study|Progressive Disease|0|||
42177520|NCT03150862|75984625|FG002|Overall Study|Progressive Disease|0|||
42177521|NCT03150862|75984626|FG003|Overall Study|Progressive Disease|0|||
42177522|NCT03150862|75984627|FG004|Overall Study|Progressive Disease|0|||
42177523|NCT03150862|75984628|FG005|Overall Study|Progressive Disease|0|||
42177524|NCT03150862|75984629|FG006|Overall Study|Progressive Disease|0|||
42177525|NCT03150862|75984630|FG007|Overall Study|Progressive Disease|2|||
42177526|NCT00260429|75984659|FG000|Overall Study|failure to follow appointments|1|||
42177527|NCT00260429|75984660|FG001|Overall Study|failure to follow appointments|0|||
42177528|NCT00260429|75984659|FG000|Overall Study|scheduled hand surgery|1|||
42177529|NCT00260429|75984660|FG001|Overall Study|scheduled hand surgery|0|||
42177530|NCT00379288|75984670|FG000|Overall Study|Adverse Event|5|||
42177531|NCT00379288|75984671|FG001|Overall Study|Adverse Event|6|||
42177532|NCT00379288|75984672|FG002|Overall Study|Adverse Event|2|||
42177533|NCT00379288|75984673|FG003|Overall Study|Adverse Event|0|||
42177534|NCT00379288|75984670|FG000|Overall Study|Treatment Failure|0|||
42177535|NCT00379288|75984671|FG001|Overall Study|Treatment Failure|1|||
42177536|NCT00379288|75984672|FG002|Overall Study|Treatment Failure|0|||
42177537|NCT00379288|75984673|FG003|Overall Study|Treatment Failure|1|||
42177538|NCT00379288|75984670|FG000|Overall Study|Lost to Follow-up|3|||
42177539|NCT00379288|75984671|FG001|Overall Study|Lost to Follow-up|3|||
42177540|NCT00379288|75984672|FG002|Overall Study|Lost to Follow-up|2|||
42177541|NCT00379288|75984673|FG003|Overall Study|Lost to Follow-up|0|||
42073613|NCT00865020|75883754|FG001|Overall Study|Administrative problems|2|||
42073614|NCT00865020|75883753|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42177542|NCT00379288|75984670|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
42073615|NCT00865020|75883754|FG001|Overall Study|Abnormal laboratory value(s)|1|||
42073616|NCT00865020|75883753|FG000|Overall Study|Death|0|||
42073617|NCT00865020|75883754|FG001|Overall Study|Death|1|||
42073618|NCT00865020|75883753|FG000|Overall Study|Randomized but discontinued|2|||
42073619|NCT00865020|75883754|FG001|Overall Study|Randomized but discontinued|4|||
42177543|NCT00379288|75984671|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
42073620|NCT00517933|75883762|FG000|Period 1|Death|2|||
42177544|NCT00379288|75984672|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
42073621|NCT00517933|75883763|FG001|Period 1|Death|1|||
42073622|NCT00517933|75883762|FG000|Period 1|Adverse Event|4|||
42073623|NCT00517933|75883763|FG001|Period 1|Adverse Event|4|||
42073624|NCT00517933|75883762|FG000|Period 1|Lost to Follow-up|2|||
42073625|NCT00517933|75883763|FG001|Period 1|Lost to Follow-up|0|||
42073626|NCT00517933|75883762|FG000|Period 1|Underwent lung transplant|0|||
42073627|NCT00517933|75883763|FG001|Period 1|Underwent lung transplant|1|||
42073628|NCT00517933|75883762|FG000|Period 2|Death|2|||
42073629|NCT00517933|75883763|FG001|Period 2|Death|4|||
42073630|NCT00517933|75883762|FG000|Period 2|Adverse Event|2|||
42073631|NCT00517933|75883763|FG001|Period 2|Adverse Event|4|||
42073632|NCT00517933|75883762|FG000|Period 2|Physician Decision|1|||
42073633|NCT00517933|75883763|FG001|Period 2|Physician Decision|0|||
42073634|NCT00517933|75883762|FG000|Period 2|Withdrawal by Subject|1|||
42073635|NCT00517933|75883763|FG001|Period 2|Withdrawal by Subject|3|||
42073636|NCT00517933|75883762|FG000|Period 2|Underwent lung transplant|0|||
42073637|NCT00517933|75883763|FG001|Period 2|Underwent lung transplant|2|||
42073638|NCT00701038|75883774|FG000|Overall Study|study amended pilot group of patients|4|||
42073639|NCT00701038|75883775|FG001|Overall Study|study amended pilot group of patients|4|||
42073640|NCT00857766|75883783|FG000|Overall Study|Adverse Event|13|||
42073641|NCT00857766|75883784|FG001|Overall Study|Adverse Event|12|||
42073642|NCT00857766|75883783|FG000|Overall Study|Protocol Violation|11|||
42073643|NCT00857766|75883784|FG001|Overall Study|Protocol Violation|11|||
42073644|NCT00857766|75883783|FG000|Overall Study|Lost to Follow-up|1|||
42073645|NCT00857766|75883784|FG001|Overall Study|Lost to Follow-up|0|||
42073646|NCT00857766|75883783|FG000|Overall Study|Investigator Discretion|2|||
42073647|NCT00857766|75883784|FG001|Overall Study|Investigator Discretion|3|||
42073648|NCT00857766|75883783|FG000|Overall Study|Participant Withdrew Consent|4|||
42073649|NCT00857766|75883784|FG001|Overall Study|Participant Withdrew Consent|4|||
42073650|NCT00517699|75883790|FG000|Overall Study|Withdrawal by Subject|1|||
42073651|NCT00517699|75883790|FG000|Overall Study|Lack of Efficacy|1|||
42073652|NCT00517699|75883790|FG000|Overall Study|Administrative error|1|||
42073653|NCT00517699|75883790|FG000|Overall Study|Study terminated by Sponsor|2|||
42073654|NCT00857454|75883794|FG000|Overall Study|Withdrawal by Subject|2|||
42073655|NCT00857454|75883794|FG000|Overall Study|Lost to Follow-up|1|||
42073656|NCT00857454|75883794|FG000|Overall Study|Adverse Event|2|||
42073657|NCT00857454|75883794|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
42073658|NCT00857454|75883794|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
42073659|NCT00857454|75883794|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
42073660|NCT00525031|75883800|FG000|Overall Study|Disease Progression|1|||
42073661|NCT00525031|75883801|FG001|Overall Study|Disease Progression|1|||
42073662|NCT00524485|75883808|FG000|Overall Study|Withdrawal by Subject|5|||
42073663|NCT00857220|75883812|FG000|Overall Study|Adverse Event|35|||
42073664|NCT00857220|75883812|FG000|Overall Study|Death|1|||
42073665|NCT00857220|75883812|FG000|Overall Study|Lack of Efficacy|11|||
42073666|NCT00857220|75883812|FG000|Overall Study|Lost to Follow-up|30|||
42073667|NCT00857220|75883812|FG000|Overall Study|Physician Decision|4|||
42073668|NCT00857220|75883812|FG000|Overall Study|Protocol Violation|16|||
42073669|NCT00857220|75883812|FG000|Overall Study|Withdrawal by Subject|67|||
42073670|NCT00857220|75883812|FG000|Overall Study|Clinical Hold|6|||
42073671|NCT00857220|75883812|FG000|Overall Study|Site Closed|5|||
42073672|NCT00857220|75883812|FG000|Overall Study|Miscellaneous|8|||
42073673|NCT00524173|75883818|FG000|Overall Study|Lost to Follow-up|0|||
42073674|NCT00524173|75883819|FG001|Overall Study|Lost to Follow-up|1|||
42073675|NCT00524173|75883818|FG000|Overall Study|Death|1|||
42073676|NCT00524173|75883819|FG001|Overall Study|Death|0|||
42073677|NCT00524173|75883818|FG000|Overall Study|Had not reached endpoint at study close|4|||
42073678|NCT00524173|75883819|FG001|Overall Study|Had not reached endpoint at study close|1|||
42073679|NCT00879710|75883827|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
42073680|NCT00879710|75883828|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
42073681|NCT00879710|75883829|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
42073682|NCT00879710|75883830|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
42073683|NCT00879710|75883827|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
42073684|NCT00879710|75883828|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
42073685|NCT00879710|75883829|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
42073686|NCT00879710|75883830|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
42073687|NCT00597506|75883838|FG000|Overall Study|Subject is being followed for survival|1|||
42073688|NCT00708682|75883851|FG000|Infant Series|Adverse Event|1|||
42293455|NCT02620787|76127619|FG000|Overall Study|Adverse Event|1|||
42073689|NCT00708682|75883851|FG000|Infant Series|Lost to Follow-up|4|||
42073690|NCT00708682|75883851|FG000|Infant Series|Protocol Violation|1|||
42073691|NCT00708682|75883851|FG000|Infant Series|Parent/legal guardian request|6|||
42073692|NCT00708682|75883851|FG000|Infant Series|Failed to return|2|||
42073693|NCT00708682|75883851|FG000|Infant Series|Other|19|||
42073694|NCT00708682|75883851|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
42073695|NCT00708682|75883851|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
42073696|NCT00708682|75883851|FG000|Toddler Dose|Lost to Follow-up|3|||
42073697|NCT00708682|75883851|FG000|Toddler Dose|Failed to Return|4|||
42073698|NCT00712348|75883857|FG000|Overall Study|Withdrawal by Subject|1|||
42073699|NCT00881504|75883861|FG000|Overall Study|Withdrawal by Subject|1|||
42073700|NCT01936831|75883874|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
42073701|NCT01936831|75883875|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
42073702|NCT01936831|75883876|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
42073703|NCT01936831|75883877|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
42073704|NCT01936831|75883878|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
42073705|NCT01936831|75883879|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
42073706|NCT01936831|75883880|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
42073707|NCT01936831|75883881|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
42073708|NCT01936831|75883882|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
42073709|NCT03863353|75883899|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
42073710|NCT03863353|75883900|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
42073711|NCT00523705|75883908|FG000|Overall Study|No time for study.|0|||
42073712|NCT00523705|75883909|FG001|Overall Study|No time for study.|1|||
42073713|NCT00523549|75883922|FG000|Overall Study|Adverse Event|6|||
42073714|NCT00523549|75883923|FG001|Overall Study|Adverse Event|3|||
42073715|NCT00523549|75883922|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42073716|NCT00523549|75883923|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
42073717|NCT00523549|75883922|FG000|Overall Study|Protocol Deviation|3|||
42073718|NCT00523549|75883923|FG001|Overall Study|Protocol Deviation|1|||
42073719|NCT00523549|75883922|FG000|Overall Study|Patient withdrew consent|7|||
42073720|NCT00523549|75883923|FG001|Overall Study|Patient withdrew consent|6|||
42073721|NCT00523549|75883922|FG000|Overall Study|Lost to Follow-up|3|||
42073722|NCT00523549|75883923|FG001|Overall Study|Lost to Follow-up|5|||
42073723|NCT03504085|75883931|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
42073724|NCT03504085|75883932|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
42073725|NCT03504085|75883931|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
42073726|NCT03504085|75883932|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
42073727|NCT00700102|75883940|FG000|Overall Study|Died|394|||
42073728|NCT00700102|75883941|FG001|Overall Study|Died|385|||
42073729|NCT00700102|75883940|FG000|Overall Study|Lost to Follow-up|8|||
42073730|NCT00700102|75883941|FG001|Overall Study|Lost to Follow-up|10|||
42073731|NCT00595478|75883949|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
42073732|NCT00595478|75883950|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
42073733|NCT00595478|75883949|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
42073734|NCT00595478|75883950|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
42073735|NCT00516295|75883959|FG000|Overall Study|Lack of Efficacy|2|||
42073736|NCT00516295|75883960|FG001|Overall Study|Lack of Efficacy|0|||
42073737|NCT00516295|75883961|FG002|Overall Study|Lack of Efficacy|0|||
42073738|NCT00516295|75883959|FG000|Overall Study|Ineligible|1|||
42073739|NCT00516295|75883960|FG001|Overall Study|Ineligible|0|||
42073740|NCT00516295|75883961|FG002|Overall Study|Ineligible|0|||
42073741|NCT03861559|75883971|FG000|Overall Study|Adverse Event|0|||
42073742|NCT03861559|75883972|FG001|Overall Study|Adverse Event|2|||
42073743|NCT03861559|75883971|FG000|Overall Study|Treatment failure|0|||
42073744|NCT03861559|75883972|FG001|Overall Study|Treatment failure|2|||
42073745|NCT03861559|75883971|FG000|Overall Study|Noncompliance|1|||
42073746|NCT03861559|75883972|FG001|Overall Study|Noncompliance|1|||
42073747|NCT03861559|75883971|FG000|Overall Study|Did not meet eligibility requirements|1|||
42073748|NCT03861559|75883972|FG001|Overall Study|Did not meet eligibility requirements|0|||
42073749|NCT00516139|75883978|FG000|Overall Study|Adverse Event|27|||
42073750|NCT00516139|75883978|FG000|Overall Study|Lost to Follow-up|1|||
42073751|NCT00516139|75883978|FG000|Overall Study|Protocol Violation|1|||
42073752|NCT00516139|75883978|FG000|Overall Study|Withdrawal by Subject|8|||
42073753|NCT00516139|75883978|FG000|Overall Study|Lack of Efficacy|1|||
42073754|NCT00515827|75883988|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
42073755|NCT00515827|75883989|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
42073756|NCT00515827|75883988|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
42073757|NCT00515827|75883989|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
42073758|NCT00522457|75883997|FG000|Overall Study|Due to disease progression|16|||
42073759|NCT00522457|75883997|FG000|Overall Study|Adverse Event|2|||
42073760|NCT00856986|75884006|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
42073761|NCT00856986|75884007|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
42073762|NCT00856986|75884008|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
42073763|NCT00856986|75884009|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
42073764|NCT00856986|75884010|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
42073765|NCT00856986|75884006|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
42073766|NCT00856986|75884007|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
42073767|NCT00856986|75884008|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
42073768|NCT00856986|75884009|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
42073769|NCT00856986|75884010|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
42073770|NCT00856986|75884006|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
42073771|NCT00856986|75884007|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
42073772|NCT00856986|75884008|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
42073773|NCT00856986|75884009|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
42073774|NCT00856986|75884010|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
42073775|NCT00856986|75884006|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
42073776|NCT00856986|75884007|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
42073777|NCT00856986|75884008|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
42073778|NCT00856986|75884009|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
42073779|NCT00856986|75884010|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
42073780|NCT00856986|75884006|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
42073781|NCT00856986|75884007|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
42073782|NCT00856986|75884008|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
42073783|NCT00856986|75884009|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
42073784|NCT00856986|75884010|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
42073785|NCT00856986|75884006|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
42073786|NCT00856986|75884007|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
42073787|NCT00856986|75884008|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
42073788|NCT00856986|75884009|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
42073789|NCT00856986|75884010|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
42073790|NCT00856986|75884006|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
42073791|NCT00856986|75884007|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
42073792|NCT00856986|75884008|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
42073793|NCT00856986|75884009|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
42073794|NCT00856986|75884010|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
42073795|NCT00856986|75884006|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
42073796|NCT00856986|75884007|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
42073797|NCT00856986|75884008|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
42073798|NCT00856986|75884009|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
42073799|NCT00856986|75884010|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
42073800|NCT00856986|75884006|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
42073801|NCT00856986|75884007|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
42073802|NCT00856986|75884008|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
42073803|NCT00856986|75884009|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
42073804|NCT00856986|75884010|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
42073805|NCT00856986|75884006|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
42073806|NCT00856986|75884007|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
42073807|NCT00856986|75884008|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
42073808|NCT00856986|75884009|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
42073809|NCT00856986|75884010|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
42073810|NCT00856986|75884006|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
42073811|NCT00856986|75884007|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
42073812|NCT00856986|75884008|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
42073813|NCT00856986|75884009|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
42073814|NCT00856986|75884010|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
42073815|NCT00856986|75884006|FG000|Main Period, Weeks 0-26|Unclassified|7|||
42073816|NCT00856986|75884007|FG001|Main Period, Weeks 0-26|Unclassified|6|||
42073817|NCT00856986|75884008|FG002|Main Period, Weeks 0-26|Unclassified|7|||
42073818|NCT00856986|75884009|FG003|Main Period, Weeks 0-26|Unclassified|0|||
42073819|NCT00856986|75884010|FG004|Main Period, Weeks 0-26|Unclassified|0|||
42073820|NCT00856986|75884006|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
42073821|NCT00856986|75884007|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
42073822|NCT00856986|75884008|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
42073823|NCT00856986|75884009|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
42073824|NCT00856986|75884010|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
42073825|NCT00856986|75884006|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
42073826|NCT00856986|75884007|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
42073827|NCT00856986|75884008|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
42073828|NCT00856986|75884009|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
42073829|NCT00856986|75884010|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
42073830|NCT00856986|75884006|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
42073831|NCT00856986|75884007|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
42073832|NCT00856986|75884008|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
42073833|NCT00856986|75884009|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
42073834|NCT00856986|75884010|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
42073835|NCT00856986|75884006|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
42073836|NCT00856986|75884007|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
42073837|NCT00856986|75884008|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
42073838|NCT00856986|75884009|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
42073839|NCT00856986|75884010|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
42073840|NCT00856986|75884006|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
42073841|NCT00856986|75884007|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
42073842|NCT00856986|75884008|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
42073843|NCT00856986|75884009|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
42073844|NCT00856986|75884010|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
42073845|NCT00856986|75884006|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
42073846|NCT00856986|75884007|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
42073847|NCT00856986|75884008|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
42073848|NCT00856986|75884009|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
42073849|NCT00856986|75884010|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
42073850|NCT00707746|75884024|FG000|Treatment Period|Adverse Event|2|||
42073851|NCT00707746|75884025|FG001|Treatment Period|Adverse Event|4|||
42073852|NCT00707746|75884024|FG000|Treatment Period|Ineligibility|0|||
42073853|NCT00707746|75884025|FG001|Treatment Period|Ineligibility|1|||
42073854|NCT00856908|75884033|FG000|Overall Study|Lost to Follow-up|1|||
42073855|NCT00856908|75884034|FG001|Overall Study|Lost to Follow-up|0|||
42073856|NCT00522379|75884045|FG000|Overall Study|Adverse Event|12|||
42073857|NCT00522379|75884046|FG001|Overall Study|Adverse Event|15|||
42073858|NCT00522379|75884047|FG002|Overall Study|Adverse Event|12|||
42073859|NCT00522379|75884048|FG003|Overall Study|Adverse Event|5|||
42073860|NCT00522379|75884049|FG004|Overall Study|Adverse Event|17|||
42073861|NCT00522379|75884045|FG000|Overall Study|Lack of Efficacy|3|||
42073862|NCT00522379|75884046|FG001|Overall Study|Lack of Efficacy|0|||
42073863|NCT00522379|75884047|FG002|Overall Study|Lack of Efficacy|2|||
42073864|NCT00522379|75884048|FG003|Overall Study|Lack of Efficacy|2|||
42073865|NCT00522379|75884049|FG004|Overall Study|Lack of Efficacy|7|||
42073866|NCT00522379|75884045|FG000|Overall Study|Withdrawal by Subject|2|||
42073867|NCT00522379|75884046|FG001|Overall Study|Withdrawal by Subject|3|||
42073868|NCT00522379|75884047|FG002|Overall Study|Withdrawal by Subject|1|||
42073869|NCT00522379|75884048|FG003|Overall Study|Withdrawal by Subject|2|||
42073870|NCT00522379|75884049|FG004|Overall Study|Withdrawal by Subject|0|||
42073871|NCT00522379|75884045|FG000|Overall Study|Protocol Violation|1|||
42073872|NCT00522379|75884046|FG001|Overall Study|Protocol Violation|1|||
42073873|NCT00522379|75884047|FG002|Overall Study|Protocol Violation|2|||
42073874|NCT00522379|75884048|FG003|Overall Study|Protocol Violation|0|||
42073875|NCT00522379|75884049|FG004|Overall Study|Protocol Violation|0|||
42073876|NCT00522379|75884045|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
42073877|NCT00522379|75884046|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
42073878|NCT00522379|75884047|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
42073879|NCT00522379|75884048|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
42073880|NCT00522379|75884049|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
42073881|NCT00522379|75884045|FG000|Overall Study|Lost to Follow-up|1|||
42073882|NCT00522379|75884046|FG001|Overall Study|Lost to Follow-up|0|||
42073883|NCT00522379|75884047|FG002|Overall Study|Lost to Follow-up|4|||
42073884|NCT00522379|75884048|FG003|Overall Study|Lost to Follow-up|2|||
42073885|NCT00522379|75884049|FG004|Overall Study|Lost to Follow-up|2|||
42073886|NCT00522379|75884045|FG000|Overall Study|Randomization error|0|||
42073887|NCT00522379|75884046|FG001|Overall Study|Randomization error|0|||
42073888|NCT00522379|75884047|FG002|Overall Study|Randomization error|0|||
42073889|NCT00522379|75884048|FG003|Overall Study|Randomization error|0|||
42073890|NCT00522379|75884049|FG004|Overall Study|Randomization error|1|||
42073891|NCT00522379|75884045|FG000|Overall Study|Dispensing error|1|||
42073892|NCT00522379|75884046|FG001|Overall Study|Dispensing error|0|||
42073893|NCT00522379|75884047|FG002|Overall Study|Dispensing error|0|||
42073894|NCT00522379|75884048|FG003|Overall Study|Dispensing error|1|||
42073895|NCT00522379|75884049|FG004|Overall Study|Dispensing error|0|||
42073896|NCT00522379|75884045|FG000|Overall Study|Subject Moved|1|||
42073897|NCT00522379|75884046|FG001|Overall Study|Subject Moved|1|||
42073898|NCT00522379|75884047|FG002|Overall Study|Subject Moved|0|||
42073899|NCT00522379|75884048|FG003|Overall Study|Subject Moved|0|||
42073900|NCT00522379|75884049|FG004|Overall Study|Subject Moved|0|||
42073901|NCT00522379|75884045|FG000|Overall Study|Sponsor Request|0|||
42073902|NCT00522379|75884046|FG001|Overall Study|Sponsor Request|1|||
42073903|NCT00522379|75884047|FG002|Overall Study|Sponsor Request|0|||
42073904|NCT00522379|75884048|FG003|Overall Study|Sponsor Request|0|||
42073905|NCT00522379|75884049|FG004|Overall Study|Sponsor Request|0|||
42073906|NCT00522379|75884045|FG000|Overall Study|Family Problem|0|||
42073907|NCT00522379|75884046|FG001|Overall Study|Family Problem|0|||
42073908|NCT00522379|75884047|FG002|Overall Study|Family Problem|1|||
42073909|NCT00522379|75884048|FG003|Overall Study|Family Problem|0|||
42073910|NCT00522379|75884049|FG004|Overall Study|Family Problem|0|||
42073911|NCT00522379|75884045|FG000|Overall Study|Site Closed|0|||
42073912|NCT00522379|75884046|FG001|Overall Study|Site Closed|0|||
42073913|NCT00522379|75884047|FG002|Overall Study|Site Closed|0|||
42073914|NCT00522379|75884048|FG003|Overall Study|Site Closed|1|||
42073915|NCT00522379|75884049|FG004|Overall Study|Site Closed|0|||
42073916|NCT00522379|75884045|FG000|Overall Study|Subject Withdrawal|0|||
42073917|NCT00522379|75884046|FG001|Overall Study|Subject Withdrawal|0|||
42073918|NCT00522379|75884047|FG002|Overall Study|Subject Withdrawal|0|||
42073919|NCT00522379|75884048|FG003|Overall Study|Subject Withdrawal|1|||
42073920|NCT00522379|75884049|FG004|Overall Study|Subject Withdrawal|0|||
42073921|NCT00856830|75884065|FG000|Irinotecan & Bendamustine|Death|0|||
42073922|NCT00856830|75884066|FG001|Irinotecan & Bendamustine|Death|0|||
42073923|NCT00856830|75884067|FG002|Irinotecan & Bendamustine|Death|0|||
42073924|NCT00856830|75884068|FG003|Irinotecan & Bendamustine|Death|2|||
42073925|NCT00856830|75884065|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
42073926|NCT00856830|75884066|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
42073927|NCT00856830|75884067|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
42073928|NCT00856830|75884068|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
42073929|NCT00522301|75884073|FG000|Overall Study|Withdrawal by Subject|1|||
42073930|NCT00522301|75884073|FG000|Overall Study|Adverse Event|5|||
42073931|NCT00863928|75884079|FG000|Overall Study|Protocol Violation|26|||
42073932|NCT00863928|75884080|FG001|Overall Study|Protocol Violation|0|||
42073933|NCT00863928|75884079|FG000|Overall Study|Withdrawal by Subject|3|||
42073934|NCT00863928|75884080|FG001|Overall Study|Withdrawal by Subject|0|||
42073935|NCT00863928|75884079|FG000|Overall Study|surgery cancellation|4|||
42073936|NCT00863928|75884080|FG001|Overall Study|surgery cancellation|0|||
42073937|NCT00863928|75884079|FG000|Overall Study|medication allergy|3|||
42073938|NCT00863928|75884080|FG001|Overall Study|medication allergy|0|||
42073939|NCT00856518|75884088|FG000|Overall Study|Lost to Follow-up|4|||
42073940|NCT00856518|75884089|FG001|Overall Study|Lost to Follow-up|2|||
42073941|NCT00506389|75884100|FG000|In-treatment Period|Other|3|||
42073942|NCT00506389|75884101|FG001|In-treatment Period|Other|3|||
42073943|NCT00506389|75884102|FG002|In-treatment Period|Other|4|||
42073944|NCT00506389|75884100|FG000|In-treatment Period|Lost to Follow-up|0|||
42073945|NCT00506389|75884101|FG001|In-treatment Period|Lost to Follow-up|0|||
42073946|NCT00506389|75884102|FG002|In-treatment Period|Lost to Follow-up|1|||
42073947|NCT00506389|75884100|FG000|In-treatment Period|Lack of compliance|1|||
42073948|NCT00506389|75884101|FG001|In-treatment Period|Lack of compliance|0|||
42073949|NCT00506389|75884102|FG002|In-treatment Period|Lack of compliance|0|||
42073950|NCT00506389|75884100|FG000|In-treatment Period|Reasons not related to trial|4|||
42073951|NCT00506389|75884101|FG001|In-treatment Period|Reasons not related to trial|1|||
42073952|NCT00506389|75884102|FG002|In-treatment Period|Reasons not related to trial|0|||
42073953|NCT00506389|75884100|FG000|In-treatment Period|Withdrawal by Subject|3|||
42073954|NCT00506389|75884101|FG001|In-treatment Period|Withdrawal by Subject|3|||
42073955|NCT00506389|75884102|FG002|In-treatment Period|Withdrawal by Subject|4|||
42073956|NCT00506389|75884100|FG000|In-treatment Period|Lack of Efficacy|0|||
42073957|NCT00506389|75884101|FG001|In-treatment Period|Lack of Efficacy|2|||
42073958|NCT00506389|75884102|FG002|In-treatment Period|Lack of Efficacy|0|||
42073959|NCT00506389|75884100|FG000|In-treatment Period|Adverse Event|11|||
42073960|NCT00506389|75884101|FG001|In-treatment Period|Adverse Event|5|||
42073961|NCT00506389|75884102|FG002|In-treatment Period|Adverse Event|2|||
42073962|NCT00506389|75884100|FG000|In-treatment Period|Randomized but not treated|4|||
42073963|NCT00506389|75884101|FG001|In-treatment Period|Randomized but not treated|1|||
42073964|NCT00506389|75884102|FG002|In-treatment Period|Randomized but not treated|1|||
42073965|NCT00871338|75884115|FG000|Prior to Booster|Withdrawal by Subject|1|||
42073966|NCT00871338|75884116|FG001|Prior to Booster|Withdrawal by Subject|3|||
42073967|NCT00871338|75884115|FG000|Prior to Booster|Lost to Follow-up|1|||
42073968|NCT00871338|75884116|FG001|Prior to Booster|Lost to Follow-up|0|||
42073969|NCT00824421|75884125|FG000|Overall Study|Adverse Event|6|||
42073970|NCT00824421|75884126|FG001|Overall Study|Adverse Event|6|||
42073971|NCT00824421|75884127|FG002|Overall Study|Adverse Event|6|||
42073972|NCT00824421|75884125|FG000|Overall Study|Death|0|||
42073973|NCT00824421|75884126|FG001|Overall Study|Death|1|||
42073974|NCT00824421|75884127|FG002|Overall Study|Death|0|||
42073975|NCT00824421|75884125|FG000|Overall Study|Lack of Efficacy|5|||
42073976|NCT00824421|75884126|FG001|Overall Study|Lack of Efficacy|7|||
42073977|NCT00824421|75884127|FG002|Overall Study|Lack of Efficacy|4|||
42073978|NCT00824421|75884125|FG000|Overall Study|Lost to Follow-up|2|||
42073979|NCT00824421|75884126|FG001|Overall Study|Lost to Follow-up|3|||
42073980|NCT00824421|75884127|FG002|Overall Study|Lost to Follow-up|0|||
42073981|NCT00824421|75884125|FG000|Overall Study|Pregnancy|1|||
42073982|NCT00824421|75884126|FG001|Overall Study|Pregnancy|0|||
42073983|NCT00824421|75884127|FG002|Overall Study|Pregnancy|1|||
42073984|NCT00824421|75884125|FG000|Overall Study|Withdrawal by Subject|2|||
42073985|NCT00824421|75884126|FG001|Overall Study|Withdrawal by Subject|3|||
42073986|NCT00824421|75884127|FG002|Overall Study|Withdrawal by Subject|3|||
42073987|NCT00824421|75884125|FG000|Overall Study|Randomized but not Treated|1|||
42073988|NCT00824421|75884126|FG001|Overall Study|Randomized but not Treated|1|||
42073989|NCT00824421|75884127|FG002|Overall Study|Randomized but not Treated|0|||
42073990|NCT00824421|75884125|FG000|Overall Study|Other|0|||
42073991|NCT00824421|75884126|FG001|Overall Study|Other|1|||
42073992|NCT00824421|75884127|FG002|Overall Study|Other|0|||
42073993|NCT00514813|75884141|FG000|Overall Study|Study terminated|14|||
42073994|NCT00514813|75884142|FG001|Overall Study|Study terminated|74|||
42073995|NCT00514813|75884143|FG002|Overall Study|Study terminated|40|||
42073996|NCT00514813|75884144|FG003|Overall Study|Study terminated|2|||
42073997|NCT00514813|75884141|FG000|Overall Study|Adverse Event|0|||
42073998|NCT00514813|75884142|FG001|Overall Study|Adverse Event|2|||
42073999|NCT00514813|75884143|FG002|Overall Study|Adverse Event|2|||
42074000|NCT00514813|75884144|FG003|Overall Study|Adverse Event|0|||
42074001|NCT00514813|75884141|FG000|Overall Study|Protocol Violation|1|||
42074002|NCT00514813|75884142|FG001|Overall Study|Protocol Violation|0|||
42074003|NCT00514813|75884143|FG002|Overall Study|Protocol Violation|0|||
42074004|NCT00514813|75884144|FG003|Overall Study|Protocol Violation|0|||
42074005|NCT00514813|75884141|FG000|Overall Study|Withdrawal by Subject|0|||
42074006|NCT00514813|75884142|FG001|Overall Study|Withdrawal by Subject|1|||
42074007|NCT00514813|75884143|FG002|Overall Study|Withdrawal by Subject|0|||
42074008|NCT00514813|75884144|FG003|Overall Study|Withdrawal by Subject|0|||
42074009|NCT00514813|75884141|FG000|Overall Study|Lack of Efficacy|0|||
42074010|NCT00514813|75884142|FG001|Overall Study|Lack of Efficacy|1|||
42074011|NCT00514813|75884143|FG002|Overall Study|Lack of Efficacy|0|||
42074012|NCT00514813|75884144|FG003|Overall Study|Lack of Efficacy|0|||
42074013|NCT00514813|75884141|FG000|Overall Study|Kidney transplant|0|||
42074014|NCT00514813|75884142|FG001|Overall Study|Kidney transplant|6|||
42074015|NCT00514813|75884143|FG002|Overall Study|Kidney transplant|2|||
42074016|NCT00514813|75884144|FG003|Overall Study|Kidney transplant|0|||
42074017|NCT00514813|75884141|FG000|Overall Study|Death|0|||
42074018|NCT00514813|75884142|FG001|Overall Study|Death|2|||
42074019|NCT00514813|75884143|FG002|Overall Study|Death|3|||
42074020|NCT00514813|75884144|FG003|Overall Study|Death|2|||
42074021|NCT00597116|75884156|FG000|Overall Study|Adverse Event|2|||
42074022|NCT00597116|75884157|FG001|Overall Study|Adverse Event|1|||
42074023|NCT00597116|75884156|FG000|Overall Study|Withdrawal by Subject|0|||
42074024|NCT00597116|75884157|FG001|Overall Study|Withdrawal by Subject|2|||
42074025|NCT00597116|75884156|FG000|Overall Study|Physician Decision|0|||
42074026|NCT00597116|75884157|FG001|Overall Study|Physician Decision|1|||
42074027|NCT00597116|75884156|FG000|Overall Study|Death|0|||
42074028|NCT00597116|75884157|FG001|Overall Study|Death|1|||
42074029|NCT00597116|75884156|FG000|Overall Study|Lost to Follow-up|1|||
42074030|NCT00597116|75884157|FG001|Overall Study|Lost to Follow-up|0|||
42074031|NCT00597116|75884156|FG000|Overall Study|Progressive disease|11|||
42074032|NCT00597116|75884157|FG001|Overall Study|Progressive disease|6|||
42074033|NCT00514735|75884165|FG000|Overall Study|Withdrawal by Subject|13|||
42074034|NCT00514735|75884166|FG001|Overall Study|Withdrawal by Subject|5|||
42074035|NCT00514735|75884165|FG000|Overall Study|Death|1|||
42074036|NCT00514735|75884166|FG001|Overall Study|Death|0|||
42074037|NCT00514735|75884165|FG000|Overall Study|Lost to Follow-up|0|||
42074038|NCT00514735|75884166|FG001|Overall Study|Lost to Follow-up|1|||
42074039|NCT03252587|75884178|FG000|Overall Study|Adverse Event|3|||
42074040|NCT03252587|75884179|FG001|Overall Study|Adverse Event|8|||
42074041|NCT03252587|75884180|FG002|Overall Study|Adverse Event|6|||
42074042|NCT03252587|75884181|FG003|Overall Study|Adverse Event|12|||
42074043|NCT03252587|75884178|FG000|Overall Study|Lack of Efficacy|7|||
42074044|NCT03252587|75884179|FG001|Overall Study|Lack of Efficacy|2|||
42074045|NCT03252587|75884180|FG002|Overall Study|Lack of Efficacy|2|||
42074046|NCT03252587|75884181|FG003|Overall Study|Lack of Efficacy|4|||
42074047|NCT03252587|75884178|FG000|Overall Study|Lost to Follow-up|2|||
42074048|NCT03252587|75884179|FG001|Overall Study|Lost to Follow-up|0|||
42074049|NCT03252587|75884180|FG002|Overall Study|Lost to Follow-up|0|||
42074050|NCT03252587|75884181|FG003|Overall Study|Lost to Follow-up|2|||
42074051|NCT03252587|75884178|FG000|Overall Study|Pregnancy|2|||
42074052|NCT03252587|75884179|FG001|Overall Study|Pregnancy|1|||
42074053|NCT03252587|75884180|FG002|Overall Study|Pregnancy|0|||
42074054|NCT03252587|75884181|FG003|Overall Study|Pregnancy|1|||
42074055|NCT03252587|75884178|FG000|Overall Study|Withdrawal by Subject|8|||
42074056|NCT03252587|75884179|FG001|Overall Study|Withdrawal by Subject|4|||
42074057|NCT03252587|75884180|FG002|Overall Study|Withdrawal by Subject|4|||
42074058|NCT03252587|75884181|FG003|Overall Study|Withdrawal by Subject|4|||
42074059|NCT03252587|75884178|FG000|Overall Study|Other Reasons|2|||
42074060|NCT03252587|75884179|FG001|Overall Study|Other Reasons|5|||
42074061|NCT03252587|75884180|FG002|Overall Study|Other Reasons|5|||
42074062|NCT03252587|75884181|FG003|Overall Study|Other Reasons|4|||
42074063|NCT00511147|75884194|FG000|Overall Study|Withdrawal by Subject|1|||
42074064|NCT00511147|75884194|FG000|Overall Study|Disease progression|5|||
42074065|NCT00511147|75884194|FG000|Overall Study|Required platelet transfusion|1|||
42074066|NCT00510835|75884201|FG000|Overall Study|Withdrawal by Subject|6|||
42074067|NCT00510835|75884202|FG001|Overall Study|Withdrawal by Subject|2|||
42074068|NCT00510835|75884203|FG002|Overall Study|Withdrawal by Subject|2|||
42074069|NCT00506077|75884213|FG000|Treatment Period 1|Adverse Event|2|||
42074070|NCT00506077|75884214|FG001|Treatment Period 1|Adverse Event|1|||
42074071|NCT00506077|75884213|FG000|Treatment Period 1|Lost to Follow-up|0|||
42074072|NCT00506077|75884214|FG001|Treatment Period 1|Lost to Follow-up|2|||
42074073|NCT00506077|75884213|FG000|Treatment Period 1|Withdrawal by Subject|2|||
42074074|NCT00506077|75884214|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42074075|NCT00506077|75884213|FG000|Treatment Period 2|Adverse Event|0|||
42074076|NCT00506077|75884214|FG001|Treatment Period 2|Adverse Event|1|||
42074077|NCT00506077|75884213|FG000|Treatment Period 2|Withdrawal by Subject|1|||
42074078|NCT00506077|75884214|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42074079|NCT00505921|75884220|FG000|Overall Study|Ineligible|1|||
42074080|NCT00505921|75884220|FG000|Overall Study|Failed to Mobilize|8|||
42074081|NCT00596960|75884226|FG000|Overall Study|Death|1|||
42074082|NCT00596960|75884227|FG001|Overall Study|Death|2|||
42074083|NCT00596960|75884226|FG000|Overall Study|Lost to Follow-up|6|||
42074084|NCT00596960|75884227|FG001|Overall Study|Lost to Follow-up|5|||
42074085|NCT00596960|75884226|FG000|Overall Study|Withdrawal by Subject|1|||
42074086|NCT00596960|75884227|FG001|Overall Study|Withdrawal by Subject|0|||
42074087|NCT00596960|75884226|FG000|Overall Study|Incarcerated|2|||
42074088|NCT00596960|75884227|FG001|Overall Study|Incarcerated|0|||
42074089|NCT00596960|75884226|FG000|Overall Study|Physician Decision|1|||
42074090|NCT00596960|75884227|FG001|Overall Study|Physician Decision|0|||
42074091|NCT00596960|75884226|FG000|Overall Study|Protocol Violation|0|||
42074092|NCT00596960|75884227|FG001|Overall Study|Protocol Violation|1|||
42074093|NCT00596960|75884226|FG000|Overall Study|No alcohol use data|0|||
42074094|NCT00596960|75884227|FG001|Overall Study|No alcohol use data|1|||
42074095|NCT00505765|75884236|FG000|Overall Study|Withdrawal by Subject|1|||
42074096|NCT00505765|75884237|FG001|Overall Study|Withdrawal by Subject|0|||
42074097|NCT00505765|75884238|FG002|Overall Study|Withdrawal by Subject|0|||
42074098|NCT00505765|75884236|FG000|Overall Study|Adverse Event|1|||
42074099|NCT00505765|75884237|FG001|Overall Study|Adverse Event|2|||
42074100|NCT00505765|75884238|FG002|Overall Study|Adverse Event|0|||
42074101|NCT00505765|75884236|FG000|Overall Study|Noncompliance|0|||
42074102|NCT00505765|75884237|FG001|Overall Study|Noncompliance|1|||
42074103|NCT00505765|75884238|FG002|Overall Study|Noncompliance|3|||
42074104|NCT00505687|75884246|FG000|Overall Study|Important protocol violation|2|||
42074105|NCT00505687|75884246|FG000|Overall Study|Lack of Efficacy|15|||
42074106|NCT00505687|75884246|FG000|Overall Study|Adverse Event|48|||
42074107|NCT00505687|75884246|FG000|Overall Study|Subject withdrew consent|15|||
42074108|NCT00505687|75884246|FG000|Overall Study|Lost to Follow-up|1|||
42074109|NCT00505687|75884246|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
42074110|NCT00505687|75884246|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
42074111|NCT00505687|75884246|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
42074112|NCT00505687|75884246|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
42074113|NCT00505687|75884246|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
42074114|NCT00505687|75884246|FG000|Overall Study|Other: Disease Progression|1|||
42074115|NCT00505687|75884246|FG000|Overall Study|Other: As Per Sponsor|8|||
42074116|NCT00505375|75884252|FG000|Overall Study|Death|1|||
42074117|NCT00505375|75884253|FG001|Overall Study|Death|0|||
42074118|NCT00505375|75884252|FG000|Overall Study|Withdrawal by Subject|2|||
42074119|NCT00505375|75884253|FG001|Overall Study|Withdrawal by Subject|2|||
42074120|NCT00505375|75884252|FG000|Overall Study|Lost to Follow-up|0|||
42074121|NCT00505375|75884253|FG001|Overall Study|Lost to Follow-up|2|||
42074122|NCT00505375|75884252|FG000|Overall Study|Pregnancy|1|||
42074123|NCT00505375|75884253|FG001|Overall Study|Pregnancy|0|||
42074124|NCT00505375|75884252|FG000|Overall Study|Travel issues|0|||
42074125|NCT00505375|75884253|FG001|Overall Study|Travel issues|1|||
42074126|NCT00594932|75884261|FG000|First 3 Months|Withdrawal by Subject|1|||
42074127|NCT00594932|75884262|FG001|First 3 Months|Withdrawal by Subject|3|||
42074128|NCT00594932|75884261|FG000|Final 3 Months|Withdrawal by Subject|4|||
42074129|NCT00594932|75884262|FG001|Final 3 Months|Withdrawal by Subject|3|||
42074130|NCT00504829|75884271|FG000|Overall Study|Protocol Violation|6|||
42074131|NCT00504829|75884272|FG001|Overall Study|Protocol Violation|4|||
42074132|NCT00504829|75884273|FG002|Overall Study|Protocol Violation|10|||
42074133|NCT00504595|75884285|FG000|Overall Study|Lack of Efficacy|1|||
42074134|NCT00504595|75884286|FG001|Overall Study|Lack of Efficacy|0|||
42074135|NCT00504595|75884287|FG002|Overall Study|Lack of Efficacy|0|||
42074136|NCT00504595|75884288|FG003|Overall Study|Lack of Efficacy|0|||
42074137|NCT00504595|75884285|FG000|Overall Study|Other|0|||
42074138|NCT00504595|75884286|FG001|Overall Study|Other|0|||
42074139|NCT00504595|75884287|FG002|Overall Study|Other|2|||
42074140|NCT00504595|75884288|FG003|Overall Study|Other|0|||
42074141|NCT00513409|75884300|FG000|Overall Study|Adverse Event|0|||
42074142|NCT00513409|75884301|FG001|Overall Study|Adverse Event|1|||
42074143|NCT00513409|75884300|FG000|Overall Study|Withdrawal by Subject|0|||
42074144|NCT00513409|75884301|FG001|Overall Study|Withdrawal by Subject|2|||
42074145|NCT00513409|75884300|FG000|Overall Study|Lost to Follow-up|0|||
42074146|NCT00513409|75884301|FG001|Overall Study|Lost to Follow-up|1|||
42074147|NCT00513409|75884300|FG000|Overall Study|Physician Decision|1|||
42074148|NCT00513409|75884301|FG001|Overall Study|Physician Decision|0|||
42074149|NCT00513409|75884300|FG000|Overall Study|Visit 3 not done|1|||
42074150|NCT00513409|75884301|FG001|Overall Study|Visit 3 not done|2|||
42074151|NCT03150095|75884309|FG000|Overall Study|Death|0|||
42074152|NCT03150095|75884310|FG001|Overall Study|Death|1|||
42074153|NCT03150095|75884309|FG000|Overall Study|Lost to Follow-up|1|||
42074154|NCT03150095|75884310|FG001|Overall Study|Lost to Follow-up|1|||
42074155|NCT03150095|75884309|FG000|Overall Study|Withdrawal by Subject|4|||
42074156|NCT03150095|75884310|FG001|Overall Study|Withdrawal by Subject|0|||
42074157|NCT03150095|75884309|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
42074158|NCT03150095|75884310|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
42074159|NCT00705016|75884319|FG000|Overall Study|Adverse Event|6|||
42074160|NCT00705016|75884320|FG001|Overall Study|Adverse Event|11|||
42074161|NCT00705016|75884321|FG002|Overall Study|Adverse Event|10|||
42074162|NCT00705016|75884319|FG000|Overall Study|Death|5|||
42074163|NCT00705016|75884320|FG001|Overall Study|Death|7|||
42074164|NCT00705016|75884321|FG002|Overall Study|Death|5|||
42074165|NCT00705016|75884319|FG000|Overall Study|Protocol Violation|0|||
42074166|NCT00705016|75884320|FG001|Overall Study|Protocol Violation|1|||
42074167|NCT00705016|75884321|FG002|Overall Study|Protocol Violation|1|||
42074168|NCT00705016|75884319|FG000|Overall Study|Withdrawal by Subject|4|||
42074169|NCT00705016|75884320|FG001|Overall Study|Withdrawal by Subject|3|||
42074170|NCT00705016|75884321|FG002|Overall Study|Withdrawal by Subject|2|||
42074171|NCT00705016|75884319|FG000|Overall Study|Progressive Disease|33|||
42074172|NCT00705016|75884320|FG001|Overall Study|Progressive Disease|29|||
42074173|NCT00705016|75884321|FG002|Overall Study|Progressive Disease|33|||
42074174|NCT00705016|75884319|FG000|Overall Study|Symptomatic Deterioration|3|||
42074175|NCT00705016|75884320|FG001|Overall Study|Symptomatic Deterioration|1|||
42074176|NCT00705016|75884321|FG002|Overall Study|Symptomatic Deterioration|1|||
42074177|NCT00705016|75884319|FG000|Overall Study|Other|9|||
42074178|NCT00705016|75884320|FG001|Overall Study|Other|6|||
42074179|NCT00705016|75884321|FG002|Overall Study|Other|6|||
42074180|NCT00595868|75884331|FG000|Overall Study|Lost to Follow-up|45|||
42074181|NCT00595868|75884332|FG001|Overall Study|Lost to Follow-up|50|||
42074182|NCT00856284|75884362|FG000|Overall Study|Hyperglycemic rescue|231|||
42074183|NCT00856284|75884363|FG001|Overall Study|Hyperglycemic rescue|201|||
42074184|NCT00856284|75884364|FG002|Overall Study|Hyperglycemic rescue|235|||
42074185|NCT00856284|75884362|FG000|Overall Study|Adverse Event|60|||
42074186|NCT00856284|75884363|FG001|Overall Study|Adverse Event|74|||
42074187|NCT00856284|75884364|FG002|Overall Study|Adverse Event|82|||
42074188|NCT00856284|75884362|FG000|Overall Study|Major protocol deviation|24|||
42074189|NCT00856284|75884363|FG001|Overall Study|Major protocol deviation|16|||
42074190|NCT00856284|75884364|FG002|Overall Study|Major protocol deviation|15|||
42074191|NCT00856284|75884362|FG000|Overall Study|Lost to Follow-up|20|||
42074192|NCT00856284|75884363|FG001|Overall Study|Lost to Follow-up|22|||
42074193|NCT00856284|75884364|FG002|Overall Study|Lost to Follow-up|28|||
42074194|NCT00856284|75884362|FG000|Overall Study|Voluntary withdrawal|48|||
42074195|NCT00856284|75884363|FG001|Overall Study|Voluntary withdrawal|52|||
42074196|NCT00856284|75884364|FG002|Overall Study|Voluntary withdrawal|62|||
42074197|NCT00856284|75884362|FG000|Overall Study|Pregnancy|1|||
42074198|NCT00856284|75884363|FG001|Overall Study|Pregnancy|2|||
42074199|NCT00856284|75884364|FG002|Overall Study|Pregnancy|0|||
42074200|NCT00856284|75884362|FG000|Overall Study|Investigator discretion|9|||
42074201|NCT00856284|75884363|FG001|Overall Study|Investigator discretion|8|||
42074202|NCT00856284|75884364|FG002|Overall Study|Investigator discretion|10|||
42074203|NCT00856284|75884362|FG000|Overall Study|Other|15|||
42074204|NCT00856284|75884363|FG001|Overall Study|Other|17|||
42074205|NCT00856284|75884364|FG002|Overall Study|Other|14|||
42177545|NCT00379288|75984673|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
42074206|NCT00856284|75884362|FG000|Overall Study|Randomized in error|0|||
42074207|NCT00856284|75884363|FG001|Overall Study|Randomized in error|0|||
42074208|NCT00856284|75884364|FG002|Overall Study|Randomized in error|1|||
42074209|NCT00510289|75884372|FG000|Overall Study|Withdrawal by Subject|7|||
42074210|NCT00510289|75884372|FG000|Overall Study|Refused bone marrow biopsy|2|||
42074211|NCT00510289|75884372|FG000|Overall Study|Lost to Follow-up|1|||
42074212|NCT00510289|75884372|FG000|Overall Study|Progressed prior to starting drug|2|||
42074213|NCT00492115|75884379|FG000|Overall Study|Withdrawal by Subject|3|||
42074214|NCT00492115|75884380|FG001|Overall Study|Withdrawal by Subject|4|||
42074215|NCT00856206|75884388|FG000|Overall Study|Protocol Violation|6|||
42074216|NCT00856206|75884389|FG001|Overall Study|Protocol Violation|18|||
42074217|NCT00856206|75884388|FG000|Overall Study|Adverse Event|10|||
42074218|NCT00856206|75884389|FG001|Overall Study|Adverse Event|46|||
42074219|NCT00856206|75884388|FG000|Overall Study|Lack of Efficacy|1|||
42074220|NCT00856206|75884389|FG001|Overall Study|Lack of Efficacy|2|||
42074221|NCT00856206|75884388|FG000|Overall Study|Withdrawal by Subject|15|||
42074222|NCT00856206|75884389|FG001|Overall Study|Withdrawal by Subject|36|||
42074223|NCT00856206|75884388|FG000|Overall Study|Lost to Follow-up|13|||
42074224|NCT00856206|75884389|FG001|Overall Study|Lost to Follow-up|39|||
42074225|NCT00856206|75884388|FG000|Overall Study|Death|2|||
42074226|NCT00856206|75884389|FG001|Overall Study|Death|2|||
42074227|NCT00856206|75884388|FG000|Overall Study|Decision by the Sponsor|4|||
42074228|NCT00856206|75884389|FG001|Overall Study|Decision by the Sponsor|8|||
42074229|NCT00856206|75884388|FG000|Overall Study|Other than specified above|3|||
42074230|NCT00856206|75884389|FG001|Overall Study|Other than specified above|10|||
42074231|NCT00593112|75884397|FG000|Overall Study|Scan Anxiety|3|||
42074232|NCT00593112|75884398|FG001|Overall Study|Scan Anxiety|0|||
42074233|NCT00593112|75884397|FG000|Overall Study|Abnormal Scan|1|||
42074234|NCT00593112|75884398|FG001|Overall Study|Abnormal Scan|0|||
42074235|NCT00593112|75884397|FG000|Overall Study|Unreadable Scan|1|||
42074236|NCT00593112|75884398|FG001|Overall Study|Unreadable Scan|0|||
42074237|NCT00593112|75884397|FG000|Overall Study|Withdrawal by Subject|5|||
42177546|NCT00379288|75984670|FG000|Overall Study|Subject withdrew-related to study drug|1|||
42177547|NCT00379288|75984671|FG001|Overall Study|Subject withdrew-related to study drug|0|||
42177548|NCT00379288|75984672|FG002|Overall Study|Subject withdrew-related to study drug|0|||
42177549|NCT00379288|75984673|FG003|Overall Study|Subject withdrew-related to study drug|1|||
42177550|NCT00379288|75984670|FG000|Overall Study|Noncompliance with protocol|8|||
42177551|NCT00379288|75984671|FG001|Overall Study|Noncompliance with protocol|6|||
42177552|NCT00379288|75984672|FG002|Overall Study|Noncompliance with protocol|2|||
42177553|NCT00379288|75984673|FG003|Overall Study|Noncompliance with protocol|1|||
42177554|NCT00379288|75984670|FG000|Overall Study|Did not meet protocol eligibility|0|||
42177555|NCT00379288|75984671|FG001|Overall Study|Did not meet protocol eligibility|1|||
42177556|NCT00379288|75984672|FG002|Overall Study|Did not meet protocol eligibility|0|||
42177557|NCT00379288|75984673|FG003|Overall Study|Did not meet protocol eligibility|2|||
42177558|NCT00379288|75984670|FG000|Overall Study|Administrative|2|||
42177559|NCT00379288|75984671|FG001|Overall Study|Administrative|2|||
42177560|NCT00379288|75984672|FG002|Overall Study|Administrative|0|||
42177561|NCT00379288|75984673|FG003|Overall Study|Administrative|1|||
42177562|NCT00243503|75984683|FG000|Overall Study|Adverse Event|11|||
42177563|NCT00243503|75984683|FG000|Overall Study|Withdrawal by Subject|1|||
42177564|NCT00243503|75984683|FG000|Overall Study|Lack of Efficacy|44|||
42177565|NCT00243503|75984683|FG000|Overall Study|Death|1|||
42177566|NCT00243503|75984683|FG000|Overall Study|Other|1|||
42177567|NCT00239837|75984690|FG000|Overall Study|Lost to Follow-up|3|||
42177568|NCT00239837|75984691|FG001|Overall Study|Lost to Follow-up|7|||
42177569|NCT00259649|75984699|FG000|Overall Study|Lost to Follow-up|7|||
42177570|NCT00259649|75984699|FG000|Overall Study|irregular menses|3|||
42177571|NCT03712280|75984707|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
42177572|NCT03712280|75984708|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
42177573|NCT03712280|75984709|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
42177574|NCT03712280|75984710|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
42177575|NCT03712280|75984707|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
42177576|NCT03712280|75984708|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
42177577|NCT03712280|75984709|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
42177578|NCT03712280|75984710|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
42177579|NCT03712280|75984707|FG000|Overall Study|Adverse Event|0|||
42177580|NCT03712280|75984708|FG001|Overall Study|Adverse Event|0|||
42177581|NCT03712280|75984709|FG002|Overall Study|Adverse Event|1|||
42177582|NCT03712280|75984710|FG003|Overall Study|Adverse Event|0|||
42177583|NCT01345240|75984725|FG000|Overall Study|Adverse Event|3|||
42177584|NCT01345240|75984726|FG001|Overall Study|Adverse Event|5|||
42177585|NCT01345240|75984727|FG002|Overall Study|Adverse Event|4|||
42177586|NCT01345240|75984728|FG003|Overall Study|Adverse Event|2|||
42177587|NCT01345240|75984729|FG004|Overall Study|Adverse Event|1|||
42177588|NCT01345240|75984725|FG000|Overall Study|Lost to Follow-up|8|||
42177589|NCT01345240|75984726|FG001|Overall Study|Lost to Follow-up|9|||
42177590|NCT01345240|75984727|FG002|Overall Study|Lost to Follow-up|14|||
42177591|NCT01345240|75984728|FG003|Overall Study|Lost to Follow-up|7|||
42177592|NCT01345240|75984729|FG004|Overall Study|Lost to Follow-up|9|||
42177593|NCT03707912|75984761|FG000|Overall Study|Violation of inclusion criteria|1|||
42177594|NCT03707912|75984762|FG001|Overall Study|Violation of inclusion criteria|0|||
42177595|NCT02883244|75984770|FG000|Overall Study|Lost to Follow-up|0|||
42177596|NCT02883244|75984771|FG001|Overall Study|Lost to Follow-up|1|||
42177597|NCT02882854|75984779|FG000|Overall Study|Lost to Follow-up|1|||
42177598|NCT02882854|75984780|FG001|Overall Study|Lost to Follow-up|2|||
42177599|NCT02882854|75984779|FG000|Overall Study|Physician Decision|0|||
42177600|NCT02882854|75984780|FG001|Overall Study|Physician Decision|1|||
42177601|NCT03707522|75984790|FG000|Overall Study|Lost to Follow-up|24|||
42177602|NCT03707522|75984791|FG001|Overall Study|Lost to Follow-up|27|||
42177603|NCT03707522|75984792|FG002|Overall Study|Lost to Follow-up|41|||
42074238|NCT00593112|75884398|FG001|Overall Study|Withdrawal by Subject|0|||
42074239|NCT00491179|75884406|FG000|Overall Study|Adverse Event|5|||
42074240|NCT00491179|75884407|FG001|Overall Study|Adverse Event|1|||
42074241|NCT00491179|75884406|FG000|Overall Study|Withdrawal by Subject|2|||
42074242|NCT00491179|75884407|FG001|Overall Study|Withdrawal by Subject|1|||
42074243|NCT00503581|75884416|FG000|Overall Study|Study closed|3|||
42074244|NCT00503581|75884417|FG001|Overall Study|Study closed|4|||
42074245|NCT00503581|75884418|FG002|Overall Study|Study closed|2|||
42074246|NCT00703534|75884428|FG000|Overall Study|Adverse Event|14|||
42074247|NCT00703534|75884429|FG001|Overall Study|Adverse Event|3|||
42074248|NCT00703534|75884428|FG000|Overall Study|Withdrawal by Subject|8|||
42074249|NCT00703534|75884429|FG001|Overall Study|Withdrawal by Subject|7|||
42074250|NCT00703534|75884428|FG000|Overall Study|Incorrect Enrollment|6|||
42074251|NCT00703534|75884429|FG001|Overall Study|Incorrect Enrollment|6|||
42074252|NCT00703534|75884428|FG000|Overall Study|Lost to Follow-up|1|||
42074253|NCT00703534|75884429|FG001|Overall Study|Lost to Follow-up|4|||
42074254|NCT00703534|75884428|FG000|Overall Study|Severe Non Compliance|1|||
42074255|NCT00703534|75884429|FG001|Overall Study|Severe Non Compliance|5|||
42074256|NCT00503425|75884435|FG000|Overall Study|Participant files lost|6|||
42074257|NCT00503425|75884435|FG000|Overall Study|Adverse Event|5|||
42074258|NCT00503425|75884435|FG000|Overall Study|Lack of Efficacy|25|||
42074259|NCT00503425|75884435|FG000|Overall Study|Withdrawal by Subject|8|||
42074260|NCT00503425|75884435|FG000|Overall Study|Lost to Follow-up|3|||
42074261|NCT00503425|75884435|FG000|Overall Study|Death|3|||
42074262|NCT00503425|75884435|FG000|Overall Study|Missing Data/Unknown|4|||
42074263|NCT00863772|75884443|FG000|Overall Study|Adverse Event|1|||
42074264|NCT00863772|75884444|FG001|Overall Study|Adverse Event|4|||
42074265|NCT00863772|75884445|FG002|Overall Study|Adverse Event|0|||
42074266|NCT00863772|75884443|FG000|Overall Study|Lack of Efficacy|4|||
42074267|NCT00863772|75884444|FG001|Overall Study|Lack of Efficacy|2|||
42074268|NCT00863772|75884445|FG002|Overall Study|Lack of Efficacy|4|||
42074269|NCT00863772|75884443|FG000|Overall Study|Lost to Follow-up|5|||
42074270|NCT00863772|75884444|FG001|Overall Study|Lost to Follow-up|1|||
42074271|NCT00863772|75884445|FG002|Overall Study|Lost to Follow-up|1|||
42074272|NCT00863772|75884443|FG000|Overall Study|Protocol Violation|2|||
42074273|NCT00863772|75884444|FG001|Overall Study|Protocol Violation|0|||
42074274|NCT00863772|75884445|FG002|Overall Study|Protocol Violation|2|||
42074275|NCT00863772|75884443|FG000|Overall Study|Withdrawal by Subject|4|||
42074276|NCT00863772|75884444|FG001|Overall Study|Withdrawal by Subject|7|||
42074277|NCT00863772|75884445|FG002|Overall Study|Withdrawal by Subject|5|||
42074278|NCT00863772|75884443|FG000|Overall Study|Study terminated by sponsor|44|||
42074279|NCT00863772|75884444|FG001|Overall Study|Study terminated by sponsor|45|||
42074280|NCT00863772|75884445|FG002|Overall Study|Study terminated by sponsor|36|||
42074281|NCT00863772|75884443|FG000|Overall Study|Entered extension study|6|||
42074282|NCT00863772|75884444|FG001|Overall Study|Entered extension study|4|||
42074283|NCT00863772|75884445|FG002|Overall Study|Entered extension study|9|||
42074284|NCT00863772|75884443|FG000|Overall Study|Other|1|||
42074285|NCT00863772|75884444|FG001|Overall Study|Other|2|||
42074286|NCT00863772|75884445|FG002|Overall Study|Other|4|||
42074287|NCT00863772|75884443|FG000|Overall Study|Randomized but not Treated|1|||
42074288|NCT00863772|75884444|FG001|Overall Study|Randomized but not Treated|0|||
42074289|NCT00863772|75884445|FG002|Overall Study|Randomized but not Treated|0|||
42074290|NCT00502801|75884453|FG000|Treatment Period|Withdrawal by Subject|3|||
42074291|NCT00502801|75884453|FG000|Treatment Period|Adverse Event|7|||
42074292|NCT00502801|75884453|FG000|Treatment Period|Death|14|||
42074293|NCT00502801|75884453|FG000|Treatment Period|OTHER|30|||
42074294|NCT00502801|75884453|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
42074295|NCT00502801|75884453|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
42074296|NCT00502801|75884453|FG000|End of Therapy to Test of Cure|Death|3|||
42074297|NCT00502801|75884453|FG000|End of Therapy to Test of Cure|OTHER|2|||
42074298|NCT00824265|75884459|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
42074299|NCT00824265|75884460|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
42074300|NCT00824265|75884459|FG000|Treatment Phase|Protocol Violation|1|||
42074301|NCT00824265|75884460|FG001|Treatment Phase|Protocol Violation|0|||
42074302|NCT00824265|75884459|FG000|Treatment Phase|Lost to Follow-up|1|||
42074303|NCT00824265|75884460|FG001|Treatment Phase|Lost to Follow-up|1|||
42177604|NCT03707522|75984793|FG003|Overall Study|Lost to Follow-up|36|||
42074304|NCT00824265|75884459|FG000|Treatment Phase|Physician Decision|6|||
42074305|NCT00824265|75884460|FG001|Treatment Phase|Physician Decision|12|||
42074306|NCT00824265|75884459|FG000|Treatment Phase|Withdrawal by Subject|6|||
42074307|NCT00824265|75884460|FG001|Treatment Phase|Withdrawal by Subject|15|||
42074308|NCT00824265|75884459|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
42074309|NCT00824265|75884460|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
42074310|NCT00824265|75884459|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
42074311|NCT00824265|75884460|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
42074312|NCT00855894|75884470|FG000|Overall Study|Death|31|||
42074313|NCT00855894|75884470|FG000|Overall Study|Patient's decision|1|||
42074314|NCT00855894|75884470|FG000|Overall Study|Disease progression|1|||
42293456|NCT02620787|76127620|FG001|Overall Study|Adverse Event|0|||
42074315|NCT00855816|75884476|FG000|Overall Study|Withdrawal by Subject|22|||
42074316|NCT00855816|75884477|FG001|Overall Study|Withdrawal by Subject|15|||
42074317|NCT00855816|75884476|FG000|Overall Study|Lost to Follow-up|3|||
42074318|NCT00855816|75884477|FG001|Overall Study|Lost to Follow-up|5|||
42074319|NCT00855816|75884476|FG000|Overall Study|Death|1|||
42074320|NCT00855816|75884477|FG001|Overall Study|Death|0|||
42074321|NCT00855816|75884476|FG000|Overall Study|Became ineligible|0|||
42074322|NCT00855816|75884477|FG001|Overall Study|Became ineligible|1|||
42074323|NCT00855738|75884483|FG000|Overall Study|Lost to Follow-up|2|||
42074324|NCT00855738|75884483|FG000|Overall Study|Adverse Event|1|||
42074325|NCT00855738|75884483|FG000|Overall Study|Subject Defaulted|1|||
42074326|NCT00855738|75884483|FG000|Overall Study|Death|1|||
42074327|NCT05513625|75884511|FG000|Overall Study|Withdrawal by Subject|1|||
42074328|NCT05093790|75884521|FG000|Overall Study|Failure to meet continuation criteria|0|||
42074329|NCT05093790|75884522|FG001|Overall Study|Failure to meet continuation criteria|0|||
42074330|NCT05093790|75884523|FG002|Overall Study|Failure to meet continuation criteria|1|||
42074331|NCT05093790|75884524|FG003|Overall Study|Failure to meet continuation criteria|0|||
42074332|NCT05093790|75884521|FG000|Overall Study|Adverse Event|1|||
42074333|NCT05093790|75884522|FG001|Overall Study|Adverse Event|0|||
42074334|NCT05093790|75884523|FG002|Overall Study|Adverse Event|0|||
42074335|NCT05093790|75884524|FG003|Overall Study|Adverse Event|0|||
42074336|NCT04739306|75884565|FG000|Main Study Period|Adverse Event|6|||
42074337|NCT04739306|75884566|FG001|Main Study Period|Adverse Event|7|||
42074338|NCT04739306|75884565|FG000|Main Study Period|Lost to Follow-up|4|||
42074339|NCT04739306|75884566|FG001|Main Study Period|Lost to Follow-up|6|||
42074340|NCT04739306|75884565|FG000|Main Study Period|Physician Decision|1|||
42074341|NCT04739306|75884566|FG001|Main Study Period|Physician Decision|1|||
42074342|NCT04739306|75884565|FG000|Main Study Period|Withdrawal by Subject|8|||
42074343|NCT04739306|75884566|FG001|Main Study Period|Withdrawal by Subject|6|||
42074344|NCT04739306|75884565|FG000|Main Study Period|Protocol Violation|0|||
42074345|NCT04739306|75884566|FG001|Main Study Period|Protocol Violation|1|||
42074346|NCT04739306|75884565|FG000|Main Study Period|War in Ukraine|1|||
42074347|NCT04739306|75884566|FG001|Main Study Period|War in Ukraine|1|||
42074348|NCT04442490|75884579|FG000|Overall Study|Withdrawal by Subject|18|||
42074349|NCT04442490|75884580|FG001|Overall Study|Withdrawal by Subject|10|||
42074350|NCT04442490|75884579|FG000|Overall Study|Lost to Follow-up|7|||
42074351|NCT04442490|75884580|FG001|Overall Study|Lost to Follow-up|7|||
42074352|NCT04442490|75884579|FG000|Overall Study|Adverse Event|2|||
42074353|NCT04442490|75884580|FG001|Overall Study|Adverse Event|6|||
42074354|NCT04442490|75884579|FG000|Overall Study|Noncompliance|3|||
42074355|NCT04442490|75884580|FG001|Overall Study|Noncompliance|1|||
42074356|NCT04442490|75884579|FG000|Overall Study|Physician Decision|2|||
42074357|NCT04442490|75884580|FG001|Overall Study|Physician Decision|1|||
42074358|NCT04442490|75884579|FG000|Overall Study|Reason not Specified|2|||
42074359|NCT04442490|75884580|FG001|Overall Study|Reason not Specified|1|||
42074360|NCT04442490|75884579|FG000|Overall Study|Randomized but not Treated|3|||
42074361|NCT04442490|75884580|FG001|Overall Study|Randomized but not Treated|3|||
42074362|NCT04375761|75884588|FG000|Overall Study|Death|1|||
42074363|NCT04375761|75884589|FG001|Overall Study|Death|2|||
42074364|NCT04375761|75884588|FG000|Overall Study|Lost to Follow-up|203|||
42074365|NCT04375761|75884589|FG001|Overall Study|Lost to Follow-up|380|||
42074366|NCT04375761|75884588|FG000|Overall Study|Withdrawal by Subject|47|||
42074367|NCT04375761|75884589|FG001|Overall Study|Withdrawal by Subject|98|||
42074368|NCT04375761|75884588|FG000|Overall Study|Noncompliance with study procedure|121|||
42074369|NCT04375761|75884589|FG001|Overall Study|Noncompliance with study procedure|251|||
42074370|NCT04375761|75884588|FG000|Overall Study|Reimbursement not enough|1|||
42074371|NCT04375761|75884589|FG001|Overall Study|Reimbursement not enough|2|||
42074372|NCT04375761|75884588|FG000|Overall Study|Unforeseen family circumstances|1|||
42074373|NCT04375761|75884589|FG001|Overall Study|Unforeseen family circumstances|3|||
42074374|NCT04375761|75884588|FG000|Overall Study|Test too painful|1|||
42074375|NCT04375761|75884589|FG001|Overall Study|Test too painful|1|||
42177605|NCT03150082|75984803|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
42177606|NCT03150082|75984804|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
42177607|NCT03142750|75984832|FG000|Overall Study|Lost to Follow-up|4|||
42177608|NCT03142750|75984833|FG001|Overall Study|Lost to Follow-up|1|||
42074376|NCT04375761|75884588|FG000|Overall Study|Moved|0|||
42177609|NCT03149848|75984843|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
42074377|NCT04375761|75884589|FG001|Overall Study|Moved|2|||
42074378|NCT04375761|75884588|FG000|Overall Study|Nonresponsive|0|||
42074379|NCT04375761|75884589|FG001|Overall Study|Nonresponsive|5|||
42074380|NCT04219189|75884598|FG000|Overall Study|Withdrawal by Subject|1|||
42074381|NCT04219189|75884599|FG001|Overall Study|Withdrawal by Subject|2|||
42074382|NCT04219189|75884598|FG000|Overall Study|Protocol Violation|0|||
42074383|NCT04219189|75884599|FG001|Overall Study|Protocol Violation|1|||
42074384|NCT04219189|75884598|FG000|Overall Study|Lost to Follow-up|0|||
42074385|NCT04219189|75884599|FG001|Overall Study|Lost to Follow-up|1|||
42074386|NCT04219189|75884598|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
42074387|NCT04219189|75884599|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
42074388|NCT04209725|75884607|FG000|Overall Study|Adverse Event|1|||
42074389|NCT04164901|75884613|FG000|Overall Study|Withdrawal by Subject|4|||
42074390|NCT04164901|75884614|FG001|Overall Study|Withdrawal by Subject|4|||
42074391|NCT03739762|75884632|FG000|Overall Study|Lost to Follow-up|1|||
42074392|NCT03739762|75884633|FG001|Overall Study|Lost to Follow-up|1|||
42074393|NCT03739762|75884632|FG000|Overall Study|Withdrawal by Subject|2|||
42074394|NCT03739762|75884633|FG001|Overall Study|Withdrawal by Subject|6|||
42074395|NCT03725605|75884639|FG000|Overall Study|Unsuccessful TIL expansion|2|||
42074396|NCT03650387|75884643|FG000|Overall Study|Withdrawal by Subject|13|||
42074397|NCT03650387|75884643|FG000|Overall Study|Lost to Follow-up|12|||
42074398|NCT03650387|75884643|FG000|Overall Study|Adverse Event (Not related)|1|||
42074399|NCT03650387|75884643|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
42074400|NCT03536754|75884669|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
42074401|NCT03536754|75884670|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
42074402|NCT03536754|75884671|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
42074403|NCT03536754|75884672|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
42074404|NCT03536754|75884673|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
42074405|NCT03536754|75884669|FG000|Open Label Extension|Other|0|||
42074406|NCT03536754|75884670|FG001|Open Label Extension|Other|0|||
42074407|NCT03536754|75884671|FG002|Open Label Extension|Other|0|||
42074408|NCT03536754|75884672|FG003|Open Label Extension|Other|0|||
42074409|NCT03536754|75884673|FG004|Open Label Extension|Other|1|||
42074410|NCT03436862|75884689|FG000|Overall Study|Adverse Event|4|||
42074411|NCT03436862|75884689|FG000|Overall Study|Progressive Disease|2|||
42074412|NCT03173248|75884705|FG000|Overall Study|Death|28|||
42074413|NCT03173248|75884706|FG001|Overall Study|Death|46|||
42074414|NCT03173248|75884705|FG000|Overall Study|Lost to Follow-up|0|||
42074415|NCT03173248|75884706|FG001|Overall Study|Lost to Follow-up|1|||
42074416|NCT03173248|75884705|FG000|Overall Study|Withdrawal by Subject|6|||
42074417|NCT03173248|75884706|FG001|Overall Study|Withdrawal by Subject|4|||
42074418|NCT03173248|75884705|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
42074419|NCT03173248|75884706|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
42074420|NCT03164616|75884715|FG000|Overall Study|Death|250|||
42074421|NCT03164616|75884716|FG001|Overall Study|Death|264|||
42074422|NCT03164616|75884717|FG002|Overall Study|Death|279|||
42074423|NCT03164616|75884715|FG000|Overall Study|Lost to Follow-up|2|||
42074424|NCT03164616|75884716|FG001|Overall Study|Lost to Follow-up|2|||
42074425|NCT03164616|75884717|FG002|Overall Study|Lost to Follow-up|2|||
42074426|NCT03164616|75884715|FG000|Overall Study|Withdrawal by Subject|6|||
42074427|NCT03164616|75884716|FG001|Overall Study|Withdrawal by Subject|7|||
42074428|NCT03164616|75884717|FG002|Overall Study|Withdrawal by Subject|16|||
42074429|NCT02887248|75884761|FG000|Overall Study|Withdrawal by Subject|1|||
42074430|NCT02887248|75884761|FG000|Overall Study|Adverse Event|1|||
42074431|NCT02887248|75884761|FG000|Overall Study|Progressive Disease|1|||
42074432|NCT02879448|75884767|FG000|Overall Study|No implant attempt|17|||
42074433|NCT02879448|75884768|FG001|Overall Study|No implant attempt|28|||
42074434|NCT02879448|75884767|FG000|Overall Study|Withdrawal by Subject|20|||
42074435|NCT02879448|75884768|FG001|Overall Study|Withdrawal by Subject|46|||
42074436|NCT02879448|75884767|FG000|Overall Study|Death|63|||
42074437|NCT02879448|75884768|FG001|Overall Study|Death|85|||
42074438|NCT02879448|75884767|FG000|Overall Study|Lost to Follow-up|3|||
42074439|NCT02879448|75884768|FG001|Overall Study|Lost to Follow-up|4|||
42074440|NCT02879448|75884767|FG000|Overall Study|Missing visit|34|||
42074441|NCT02879448|75884768|FG001|Overall Study|Missing visit|39|||
42074442|NCT02879448|75884767|FG000|Overall Study|Pending evaluation|1|||
42074443|NCT02879448|75884768|FG001|Overall Study|Pending evaluation|0|||
42074444|NCT02859064|75884774|FG000|Overall Study|Progressive Disease|3|||
42074445|NCT02859064|75884774|FG000|Overall Study|Physician Decision|1|||
42074446|NCT02859064|75884774|FG000|Overall Study|Withdrawal by Subject|1|||
42074447|NCT02859064|75884774|FG000|Overall Study|Death|1|||
42074448|NCT02843074|75884778|FG000|Overall Study|Withdrawal by Subject|5|||
42074449|NCT02843074|75884778|FG000|Overall Study|Progressive disease|1|||
42074450|NCT02843074|75884778|FG000|Overall Study|Physician Decision|1|||
42357781|NCT01858363|76203289|FG000|Overall Study|Lost to Follow-up|13|||
42074451|NCT02843074|75884778|FG000|Overall Study|Lost to Follow-up|1|||
42074452|NCT02843074|75884778|FG000|Overall Study|Death|9|||
42074453|NCT02795156|75884786|FG000|Overall Study|Progressive Disease|22|||
42074454|NCT02795156|75884787|FG001|Overall Study|Progressive Disease|7|||
42074455|NCT02795156|75884788|FG002|Overall Study|Progressive Disease|34|||
42074456|NCT02795156|75884789|FG003|Overall Study|Progressive Disease|7|||
42074457|NCT02795156|75884786|FG000|Overall Study|Adverse Event|13|||
42074458|NCT02795156|75884787|FG001|Overall Study|Adverse Event|2|||
42074459|NCT02795156|75884788|FG002|Overall Study|Adverse Event|3|||
42074460|NCT02795156|75884789|FG003|Overall Study|Adverse Event|2|||
42074461|NCT02795156|75884786|FG000|Overall Study|Death|1|||
42074462|NCT02795156|75884787|FG001|Overall Study|Death|1|||
42074463|NCT02795156|75884788|FG002|Overall Study|Death|1|||
42074464|NCT02795156|75884789|FG003|Overall Study|Death|0|||
42074465|NCT02795156|75884786|FG000|Overall Study|Physician Decision|1|||
42074466|NCT02795156|75884787|FG001|Overall Study|Physician Decision|0|||
42074467|NCT02795156|75884788|FG002|Overall Study|Physician Decision|1|||
42074468|NCT02795156|75884789|FG003|Overall Study|Physician Decision|0|||
42074469|NCT02795156|75884786|FG000|Overall Study|Withdrawal by Subject|2|||
42074470|NCT02795156|75884787|FG001|Overall Study|Withdrawal by Subject|0|||
42074471|NCT02795156|75884788|FG002|Overall Study|Withdrawal by Subject|3|||
42074472|NCT02795156|75884789|FG003|Overall Study|Withdrawal by Subject|0|||
42074473|NCT02636582|75884818|FG000|Overall Study|Surgical Pathology|1|||
42074474|NCT02636582|75884819|FG001|Overall Study|Surgical Pathology|0|||
42357782|NCT01858363|76203290|FG001|Overall Study|Lost to Follow-up|3|||
42357783|NCT01877551|76203298|FG000|Overall Study|Physician Decision|0|||
42074475|NCT02435849|75884895|FG000|Overall Study|Death|23|||
42074476|NCT02435849|75884896|FG001|Overall Study|Death|0|||
42074477|NCT02435849|75884895|FG000|Overall Study|Lack of Efficacy|10|||
42074478|NCT02435849|75884896|FG001|Overall Study|Lack of Efficacy|0|||
42074479|NCT02435849|75884895|FG000|Overall Study|New therapy for study indication|8|||
42074480|NCT02435849|75884896|FG001|Overall Study|New therapy for study indication|0|||
42074481|NCT02435849|75884895|FG000|Overall Study|Subject/guardian decision|5|||
42074482|NCT02435849|75884896|FG001|Overall Study|Subject/guardian decision|1|||
42074483|NCT02435849|75884895|FG000|Overall Study|Lost to Follow-up|1|||
42074484|NCT02435849|75884896|FG001|Overall Study|Lost to Follow-up|0|||
42074485|NCT02435849|75884895|FG000|Overall Study|Physician Decision|1|||
42074486|NCT02435849|75884896|FG001|Overall Study|Physician Decision|0|||
42074487|NCT02318784|75884902|FG000|Overall Study|Adverse Event|13|||
42074488|NCT02318784|75884902|FG000|Overall Study|Death|2|||
42074489|NCT02318784|75884902|FG000|Overall Study|Progressive Disease|37|||
42074490|NCT02318784|75884902|FG000|Overall Study|Withdrawal by Subject|10|||
42074491|NCT02195011|75884908|FG000|Overall Study|Adverse Event|4|||
42074492|NCT02195011|75884909|FG001|Overall Study|Adverse Event|0|||
42074493|NCT02195011|75884908|FG000|Overall Study|Progressive Disease|18|||
42074494|NCT02195011|75884909|FG001|Overall Study|Progressive Disease|1|||
42074495|NCT02195011|75884908|FG000|Overall Study|Withdrawal by Subject|3|||
42074496|NCT02195011|75884909|FG001|Overall Study|Withdrawal by Subject|0|||
42074497|NCT02087501|75884915|FG000|Overall Study|Death|7|||
42074498|NCT02087501|75884915|FG000|Overall Study|Open repair of aneurysm|1|||
42074499|NCT02087501|75884915|FG000|Overall Study|Lost to Follow-up|2|||
42074500|NCT01897454|75884921|FG000|Overall Study|Withdrawal by Subject|1|||
42074501|NCT01856023|75884927|FG000|Overall Study|Death|1|||
42074502|NCT01856023|75884928|FG001|Overall Study|Death|2|||
42074503|NCT01856023|75884927|FG000|Overall Study|Adverse Event|2|||
42074504|NCT01856023|75884928|FG001|Overall Study|Adverse Event|1|||
42074505|NCT01856023|75884927|FG000|Overall Study|Lack of Efficacy|5|||
42074506|NCT01856023|75884928|FG001|Overall Study|Lack of Efficacy|5|||
42074507|NCT01856023|75884927|FG000|Overall Study|non compliance, study closure|1|||
42074508|NCT01856023|75884928|FG001|Overall Study|non compliance, study closure|3|||
42074509|NCT01856023|75884927|FG000|Overall Study|Withdrawal by Subject|1|||
42074510|NCT01856023|75884928|FG001|Overall Study|Withdrawal by Subject|1|||
42074511|NCT01364597|75884940|FG000|Overall Study|Adverse Event|4|||
42293457|NCT02620787|76127619|FG000|Overall Study|Eligibility Criteria Not Met|1|||
42293458|NCT02620787|76127620|FG001|Overall Study|Eligibility Criteria Not Met|0|||
42293459|NCT02651155|76127628|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
42293460|NCT02651155|76127629|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
42293461|NCT02651155|76127628|FG000|Overall Study|Voluntary Withdrawal|5|||
42293462|NCT02651155|76127629|FG001|Overall Study|Voluntary Withdrawal|0|||
42293463|NCT02619617|76127635|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
42293464|NCT02619617|76127636|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
42293465|NCT02619617|76127635|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
42293466|NCT02619617|76127636|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
42357784|NCT01877551|76203299|FG001|Overall Study|Physician Decision|1|||
42357785|NCT01396005|76203307|FG000|Overall Study|Withdrawal by Subject|0|||
42357786|NCT01396005|76203308|FG001|Overall Study|Withdrawal by Subject|1|||
42357787|NCT01396005|76203307|FG000|Overall Study|Non-compliance with protocol|0|||
42357788|NCT01396005|76203308|FG001|Overall Study|Non-compliance with protocol|1|||
42357789|NCT01877239|76203316|FG000|Overall Study|Adverse Event|4|||
42074512|NCT01364597|75884941|FG001|Overall Study|Adverse Event|5|||
42074513|NCT01364597|75884942|FG002|Overall Study|Adverse Event|16|||
42074514|NCT01364597|75884943|FG003|Overall Study|Adverse Event|7|||
42074515|NCT01364597|75884940|FG000|Overall Study|Lack of Efficacy|4|||
42074516|NCT01364597|75884941|FG001|Overall Study|Lack of Efficacy|4|||
42074517|NCT01364597|75884942|FG002|Overall Study|Lack of Efficacy|23|||
42074518|NCT01364597|75884943|FG003|Overall Study|Lack of Efficacy|8|||
42074519|NCT01364597|75884940|FG000|Overall Study|Protocol Violation|0|||
42074520|NCT01364597|75884941|FG001|Overall Study|Protocol Violation|0|||
42074521|NCT01364597|75884942|FG002|Overall Study|Protocol Violation|2|||
42074522|NCT01364597|75884943|FG003|Overall Study|Protocol Violation|0|||
42074523|NCT01364597|75884940|FG000|Overall Study|Lost to Follow-up|0|||
42074524|NCT01364597|75884941|FG001|Overall Study|Lost to Follow-up|0|||
42074525|NCT01364597|75884942|FG002|Overall Study|Lost to Follow-up|5|||
42177610|NCT03149848|75984843|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
42177611|NCT03706040|75984853|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
42177612|NCT03706040|75984854|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
42177613|NCT03706040|75984855|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
42177614|NCT03706040|75984856|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
42177615|NCT03706040|75984857|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
42177616|NCT03706040|75984858|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
42177617|NCT03706040|75984859|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
42177618|NCT03706040|75984853|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
42177619|NCT03706040|75984854|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
42177620|NCT03706040|75984855|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
42177621|NCT03706040|75984856|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
42177622|NCT03706040|75984857|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
42177623|NCT03706040|75984858|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
42177624|NCT03706040|75984859|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
42177625|NCT03706040|75984853|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
42177626|NCT03706040|75984854|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
42177627|NCT03706040|75984855|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
42177628|NCT03706040|75984856|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
42177629|NCT03706040|75984857|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
42177630|NCT03706040|75984858|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
42177631|NCT03706040|75984859|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
42177632|NCT03706040|75984853|FG000|Period A (Week 0 to Week 16)|Other|2|||
42177633|NCT03706040|75984854|FG001|Period A (Week 0 to Week 16)|Other|0|||
42177634|NCT03706040|75984855|FG002|Period A (Week 0 to Week 16)|Other|2|||
42177635|NCT03706040|75984856|FG003|Period A (Week 0 to Week 16)|Other|0|||
42177636|NCT03706040|75984857|FG004|Period A (Week 0 to Week 16)|Other|0|||
42177637|NCT03706040|75984858|FG005|Period A (Week 0 to Week 16)|Other|0|||
42177638|NCT03706040|75984859|FG006|Period A (Week 0 to Week 16)|Other|0|||
42177639|NCT03706040|75984853|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
42177640|NCT03706040|75984854|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
42177641|NCT03706040|75984855|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
42177642|NCT03706040|75984856|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
42177643|NCT03706040|75984857|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
42177644|NCT03706040|75984858|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
42177645|NCT03706040|75984859|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
42177646|NCT03706040|75984853|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
42177647|NCT03706040|75984854|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
42177648|NCT03706040|75984855|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
42177649|NCT03706040|75984856|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
42177650|NCT03706040|75984857|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
42177651|NCT03706040|75984858|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
42177652|NCT03706040|75984859|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
42177653|NCT03706040|75984853|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
42177654|NCT03706040|75984854|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
42177655|NCT03706040|75984855|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
42177656|NCT03706040|75984856|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
42177657|NCT03706040|75984857|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
42177658|NCT03706040|75984858|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
42177659|NCT03706040|75984859|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
42177660|NCT03706040|75984853|FG000|Period B (Week 16 to Week 52)|Other|0|||
42177661|NCT03706040|75984854|FG001|Period B (Week 16 to Week 52)|Other|0|||
42177662|NCT03706040|75984855|FG002|Period B (Week 16 to Week 52)|Other|0|||
42177663|NCT03706040|75984856|FG003|Period B (Week 16 to Week 52)|Other|4|||
42177664|NCT03706040|75984857|FG004|Period B (Week 16 to Week 52)|Other|5|||
42177665|NCT03706040|75984858|FG005|Period B (Week 16 to Week 52)|Other|23|||
42177666|NCT03706040|75984859|FG006|Period B (Week 16 to Week 52)|Other|17|||
42177667|NCT03770000|75984880|FG000|Overall Study|Premature discontinuation due to PD|0|||
42177668|NCT03770000|75984881|FG001|Overall Study|Premature discontinuation due to PD|0|||
42177669|NCT03770000|75984882|FG002|Overall Study|Premature discontinuation due to PD|1|||
42357790|NCT01877239|76203316|FG000|Overall Study|Disease Remission|1|||
42357791|NCT01877239|76203316|FG000|Overall Study|Withdrawal by Subject|4|||
42357792|NCT01877239|76203316|FG000|Overall Study|Other|2|||
42177670|NCT03770000|75984883|FG003|Overall Study|Premature discontinuation due to PD|3|||
42177671|NCT03770000|75984884|FG004|Overall Study|Premature discontinuation due to PD|2|||
42177672|NCT03158272|75984903|FG000|Overall Study|Disease progression|3|||
42177673|NCT03158272|75984904|FG001|Overall Study|Disease progression|3|||
42177674|NCT03158272|75984905|FG002|Overall Study|Disease progression|4|||
42177675|NCT03158272|75984906|FG003|Overall Study|Disease progression|6|||
42074526|NCT01364597|75884943|FG003|Overall Study|Lost to Follow-up|3|||
42074527|NCT01364597|75884940|FG000|Overall Study|Withdrawal by Subject|4|||
42074528|NCT01364597|75884941|FG001|Overall Study|Withdrawal by Subject|1|||
42074529|NCT01364597|75884942|FG002|Overall Study|Withdrawal by Subject|18|||
42074530|NCT01364597|75884943|FG003|Overall Study|Withdrawal by Subject|6|||
42074531|NCT01364597|75884940|FG000|Overall Study|Non compliance|1|||
42074532|NCT01364597|75884941|FG001|Overall Study|Non compliance|0|||
42074533|NCT01364597|75884942|FG002|Overall Study|Non compliance|1|||
42074534|NCT01364597|75884943|FG003|Overall Study|Non compliance|0|||
42074535|NCT01364597|75884940|FG000|Overall Study|Lack of compliance|1|||
42074536|NCT01364597|75884941|FG001|Overall Study|Lack of compliance|0|||
42074537|NCT01364597|75884942|FG002|Overall Study|Lack of compliance|0|||
42074538|NCT01364597|75884943|FG003|Overall Study|Lack of compliance|0|||
42074539|NCT01364597|75884940|FG000|Overall Study|End of treatment epilepsy|1|||
42074540|NCT01364597|75884941|FG001|Overall Study|End of treatment epilepsy|0|||
42074541|NCT01364597|75884942|FG002|Overall Study|End of treatment epilepsy|0|||
42074542|NCT01364597|75884943|FG003|Overall Study|End of treatment epilepsy|0|||
42074543|NCT01364597|75884940|FG000|Overall Study|No Seizures|1|||
42074544|NCT01364597|75884941|FG001|Overall Study|No Seizures|0|||
42074545|NCT01364597|75884942|FG002|Overall Study|No Seizures|0|||
42074546|NCT01364597|75884943|FG003|Overall Study|No Seizures|0|||
42074547|NCT01364597|75884940|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
42074548|NCT01364597|75884941|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
42074549|NCT01364597|75884942|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
42074550|NCT01364597|75884943|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
42074551|NCT01364597|75884940|FG000|Overall Study|Cure|1|||
42074552|NCT01364597|75884941|FG001|Overall Study|Cure|0|||
42074553|NCT01364597|75884942|FG002|Overall Study|Cure|0|||
42074554|NCT01364597|75884943|FG003|Overall Study|Cure|0|||
42074555|NCT01364597|75884940|FG000|Overall Study|Patient was moving|0|||
42074556|NCT01364597|75884941|FG001|Overall Study|Patient was moving|1|||
42074557|NCT01364597|75884942|FG002|Overall Study|Patient was moving|0|||
42074558|NCT01364597|75884943|FG003|Overall Study|Patient was moving|0|||
42074559|NCT01364597|75884940|FG000|Overall Study|Seizures resolved|0|||
42074560|NCT01364597|75884941|FG001|Overall Study|Seizures resolved|0|||
42074561|NCT01364597|75884942|FG002|Overall Study|Seizures resolved|1|||
42074562|NCT01364597|75884943|FG003|Overall Study|Seizures resolved|0|||
42074563|NCT01364597|75884940|FG000|Overall Study|Patient became seizure-free after surgery|0|||
42074564|NCT01364597|75884941|FG001|Overall Study|Patient became seizure-free after surgery|0|||
42074565|NCT01364597|75884942|FG002|Overall Study|Patient became seizure-free after surgery|1|||
42074566|NCT01364597|75884943|FG003|Overall Study|Patient became seizure-free after surgery|0|||
42074567|NCT01364597|75884940|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
42074568|NCT01364597|75884941|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
42074569|NCT01364597|75884942|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
42074570|NCT01364597|75884943|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
42074571|NCT01364597|75884940|FG000|Overall Study|Patient cured from Epilepsy|0|||
42074572|NCT01364597|75884941|FG001|Overall Study|Patient cured from Epilepsy|0|||
42074573|NCT01364597|75884942|FG002|Overall Study|Patient cured from Epilepsy|1|||
42074574|NCT01364597|75884943|FG003|Overall Study|Patient cured from Epilepsy|0|||
42074575|NCT01364597|75884940|FG000|Overall Study|Investigator decision|0|||
42074576|NCT01364597|75884941|FG001|Overall Study|Investigator decision|0|||
42074577|NCT01364597|75884942|FG002|Overall Study|Investigator decision|1|||
42074578|NCT01364597|75884943|FG003|Overall Study|Investigator decision|0|||
42074579|NCT01364597|75884940|FG000|Overall Study|Sponsor recommended discontinuation|0|||
42074580|NCT01364597|75884941|FG001|Overall Study|Sponsor recommended discontinuation|0|||
42074581|NCT01364597|75884942|FG002|Overall Study|Sponsor recommended discontinuation|0|||
42074582|NCT01364597|75884943|FG003|Overall Study|Sponsor recommended discontinuation|1|||
42074583|NCT01364597|75884940|FG000|Overall Study|Parents went abroad with the patient|0|||
42074584|NCT01364597|75884941|FG001|Overall Study|Parents went abroad with the patient|0|||
42074585|NCT01364597|75884942|FG002|Overall Study|Parents went abroad with the patient|1|||
42074586|NCT01364597|75884943|FG003|Overall Study|Parents went abroad with the patient|0|||
42074587|NCT01364597|75884940|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
42074588|NCT01364597|75884941|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
42074589|NCT01364597|75884942|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
42074590|NCT01364597|75884943|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
42074591|NCT01364597|75884940|FG000|Overall Study|BRV administration dropout|0|||
42074592|NCT01364597|75884941|FG001|Overall Study|BRV administration dropout|0|||
42074593|NCT01364597|75884942|FG002|Overall Study|BRV administration dropout|1|||
42074594|NCT01364597|75884943|FG003|Overall Study|BRV administration dropout|0|||
42177676|NCT03158272|75984903|FG000|Overall Study|Death|0|||
42074595|NCT01364597|75884940|FG000|Overall Study|Dropout|0|||
42074596|NCT01364597|75884941|FG001|Overall Study|Dropout|0|||
42074597|NCT01364597|75884942|FG002|Overall Study|Dropout|3|||
42074598|NCT01364597|75884943|FG003|Overall Study|Dropout|1|||
42074599|NCT01364597|75884940|FG000|Overall Study|Unreliable subject|0|||
42074600|NCT01364597|75884941|FG001|Overall Study|Unreliable subject|0|||
42074601|NCT01364597|75884942|FG002|Overall Study|Unreliable subject|0|||
42074602|NCT01364597|75884943|FG003|Overall Study|Unreliable subject|1|||
42074603|NCT01364597|75884940|FG000|Overall Study|Other|0|||
42074604|NCT01364597|75884941|FG001|Overall Study|Other|0|||
42074605|NCT01364597|75884942|FG002|Overall Study|Other|0|||
42074606|NCT01364597|75884943|FG003|Overall Study|Other|1|||
42074607|NCT01311648|75884959|FG000|Main Study|Protocol Violation|0|||
42074608|NCT01311648|75884960|FG001|Main Study|Protocol Violation|1|||
42074609|NCT01311648|75884959|FG000|Main Study|Adverse Event|0|||
42074610|NCT01311648|75884960|FG001|Main Study|Adverse Event|1|||
42074611|NCT01311648|75884959|FG000|Main Study|Inhibitor management|0|||
42074612|NCT01311648|75884960|FG001|Main Study|Inhibitor management|17|||
42074613|NCT01311648|75884959|FG000|Main Study|Withdrawal by Subject|0|||
42074614|NCT01311648|75884960|FG001|Main Study|Withdrawal by Subject|2|||
42074615|NCT01311648|75884959|FG000|Extension Study|Physician Decision|0|||
42074616|NCT01311648|75884960|FG001|Extension Study|Physician Decision|1|||
42074617|NCT01311648|75884959|FG000|Extension Study|ITI therapy with marketed product|0|||
42074618|NCT01311648|75884960|FG001|Extension Study|ITI therapy with marketed product|1|||
42074619|NCT01311648|75884959|FG000|Extension Study|Incorrect visit planning|0|||
42074620|NCT01311648|75884960|FG001|Extension Study|Incorrect visit planning|1|||
42074621|NCT01311648|75884959|FG000|Extension Study|Family's decision|0|||
42074622|NCT01311648|75884960|FG001|Extension Study|Family's decision|1|||
42074623|NCT01311648|75884959|FG000|Extension Study|Failure of ITI therapy|0|||
42074624|NCT01311648|75884960|FG001|Extension Study|Failure of ITI therapy|3|||
42074625|NCT01311648|75884959|FG000|Extension Study|Long travel|0|||
42074626|NCT01311648|75884960|FG001|Extension Study|Long travel|1|||
42074627|NCT01311648|75884959|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
42074628|NCT01311648|75884960|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
42074629|NCT01311648|75884959|FG000|Extension Study|Withdrawal by Subject|0|||
42074630|NCT01311648|75884960|FG001|Extension Study|Withdrawal by Subject|1|||
42074631|NCT01311648|75884959|FG000|Extension Study|Inhibitor management|0|||
42074632|NCT01311648|75884960|FG001|Extension Study|Inhibitor management|2|||
42074633|NCT00470704|75884988|FG000|Overall Study|Withdrawal by Subject|4|||
42074634|NCT00470704|75884989|FG001|Overall Study|Withdrawal by Subject|3|||
42074635|NCT00470704|75884988|FG000|Overall Study|Relapse/Progression|37|||
42074636|NCT00470704|75884989|FG001|Overall Study|Relapse/Progression|42|||
42074637|NCT00470704|75884988|FG000|Overall Study|toxicity|0|||
42074638|NCT00470704|75884989|FG001|Overall Study|toxicity|1|||
42074639|NCT00385697|75885000|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
42074640|NCT00385697|75885001|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
42074641|NCT00385697|75885002|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
42074642|NCT00385697|75885003|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
42074643|NCT00385697|75885004|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
42074644|NCT00385697|75885000|FG000|Open-label Segment 1|Lost to Follow-up|1|||
42074645|NCT00385697|75885001|FG001|Open-label Segment 1|Lost to Follow-up|0|||
42074646|NCT00385697|75885002|FG002|Open-label Segment 1|Lost to Follow-up|0|||
42074647|NCT00385697|75885003|FG003|Open-label Segment 1|Lost to Follow-up|0|||
42074648|NCT00385697|75885004|FG004|Open-label Segment 1|Lost to Follow-up|0|||
42074649|NCT00385697|75885000|FG000|Double-blind Segment 2|Adverse Event|0|||
42074650|NCT00385697|75885001|FG001|Double-blind Segment 2|Adverse Event|3|||
42074651|NCT00385697|75885002|FG002|Double-blind Segment 2|Adverse Event|1|||
42074652|NCT00385697|75885003|FG003|Double-blind Segment 2|Adverse Event|0|||
42074653|NCT00385697|75885004|FG004|Double-blind Segment 2|Adverse Event|0|||
42074654|NCT00385697|75885000|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
42074655|NCT00385697|75885001|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
42074656|NCT00385697|75885002|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
42074657|NCT00385697|75885003|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
42074658|NCT00385697|75885004|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
42074659|NCT00385697|75885000|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
42074660|NCT00385697|75885001|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
42074661|NCT00385697|75885002|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
42074662|NCT00385697|75885003|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
42074663|NCT00385697|75885004|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
42074664|NCT00385697|75885000|FG000|Double-blind Segment 2|Other|0|||
42074665|NCT00385697|75885001|FG001|Double-blind Segment 2|Other|2|||
42074666|NCT00385697|75885002|FG002|Double-blind Segment 2|Other|0|||
42074667|NCT00385697|75885003|FG003|Double-blind Segment 2|Other|0|||
42074668|NCT00385697|75885004|FG004|Double-blind Segment 2|Other|0|||
42074669|NCT00490945|75885022|FG000|Overall Study|Adverse Event|0|||
42074670|NCT00490945|75885023|FG001|Overall Study|Adverse Event|1|||
42074671|NCT00490945|75885024|FG002|Overall Study|Adverse Event|0|||
42074672|NCT00490945|75885025|FG003|Overall Study|Adverse Event|0|||
42074673|NCT00490945|75885026|FG004|Overall Study|Adverse Event|0|||
42074674|NCT00879398|75885044|FG000|Overall Study|Visit Stop|399|||
42074675|NCT00879398|75885044|FG000|Overall Study|Lack of Efficacy|64|||
42074676|NCT00879398|75885044|FG000|Overall Study|Adverse Event|41|||
42074677|NCT00879398|75885044|FG000|Overall Study|Other Reasons|171|||
42074678|NCT00696436|75885053|FG000|Overall Study|Adverse Event|7|||
42074679|NCT00696436|75885054|FG001|Overall Study|Adverse Event|9|||
42074680|NCT00696436|75885055|FG002|Overall Study|Adverse Event|8|||
42074681|NCT00696436|75885056|FG003|Overall Study|Adverse Event|6|||
42074682|NCT00696436|75885057|FG004|Overall Study|Adverse Event|4|||
42074683|NCT00696436|75885053|FG000|Overall Study|Protocol Violation|3|||
42074684|NCT00696436|75885054|FG001|Overall Study|Protocol Violation|2|||
42074685|NCT00696436|75885055|FG002|Overall Study|Protocol Violation|2|||
42074686|NCT00696436|75885056|FG003|Overall Study|Protocol Violation|0|||
42074687|NCT00696436|75885057|FG004|Overall Study|Protocol Violation|1|||
42074688|NCT00696436|75885053|FG000|Overall Study|Lost to Follow-up|1|||
42074689|NCT00696436|75885054|FG001|Overall Study|Lost to Follow-up|6|||
42074690|NCT00696436|75885055|FG002|Overall Study|Lost to Follow-up|2|||
42074691|NCT00696436|75885056|FG003|Overall Study|Lost to Follow-up|4|||
42074692|NCT00696436|75885057|FG004|Overall Study|Lost to Follow-up|3|||
42074693|NCT00696436|75885053|FG000|Overall Study|Withdrawal by Subject|4|||
42074694|NCT00696436|75885054|FG001|Overall Study|Withdrawal by Subject|11|||
42074695|NCT00696436|75885055|FG002|Overall Study|Withdrawal by Subject|5|||
42074696|NCT00696436|75885056|FG003|Overall Study|Withdrawal by Subject|7|||
42074697|NCT00696436|75885057|FG004|Overall Study|Withdrawal by Subject|1|||
42074698|NCT00696436|75885053|FG000|Overall Study|Lack of Efficacy|3|||
42074699|NCT00696436|75885054|FG001|Overall Study|Lack of Efficacy|1|||
42074700|NCT00696436|75885055|FG002|Overall Study|Lack of Efficacy|5|||
42074701|NCT00696436|75885056|FG003|Overall Study|Lack of Efficacy|2|||
42074702|NCT00696436|75885057|FG004|Overall Study|Lack of Efficacy|4|||
42074703|NCT00696436|75885053|FG000|Overall Study|Participant Unavailability|2|||
42074704|NCT00696436|75885054|FG001|Overall Study|Participant Unavailability|0|||
42074705|NCT00696436|75885055|FG002|Overall Study|Participant Unavailability|2|||
42074706|NCT00696436|75885056|FG003|Overall Study|Participant Unavailability|1|||
42074707|NCT00696436|75885057|FG004|Overall Study|Participant Unavailability|0|||
42074708|NCT00696436|75885053|FG000|Overall Study|Administrative Error|2|||
42074709|NCT00696436|75885054|FG001|Overall Study|Administrative Error|0|||
42074710|NCT00696436|75885055|FG002|Overall Study|Administrative Error|2|||
42074711|NCT00696436|75885056|FG003|Overall Study|Administrative Error|0|||
42074712|NCT00696436|75885057|FG004|Overall Study|Administrative Error|0|||
42074713|NCT00696436|75885053|FG000|Overall Study|Participant Non-compliance|0|||
42074714|NCT00696436|75885054|FG001|Overall Study|Participant Non-compliance|0|||
42074715|NCT00696436|75885055|FG002|Overall Study|Participant Non-compliance|1|||
42177677|NCT03158272|75984904|FG001|Overall Study|Death|0|||
42177678|NCT03158272|75984905|FG002|Overall Study|Death|1|||
42177679|NCT03158272|75984906|FG003|Overall Study|Death|0|||
42177680|NCT03158272|75984903|FG000|Overall Study|Other reasons|0|||
42177681|NCT03158272|75984904|FG001|Overall Study|Other reasons|0|||
42177682|NCT03158272|75984905|FG002|Overall Study|Other reasons|1|||
42177683|NCT03158272|75984906|FG003|Overall Study|Other reasons|0|||
42177684|NCT03158272|75984903|FG000|Overall Study|Adverse event unrelated to the drug|0|||
42177685|NCT03158272|75984904|FG001|Overall Study|Adverse event unrelated to the drug|1|||
42293467|NCT02650921|76127657|FG000|Overall Study|Withdrawal by Subject|4|||
42293468|NCT02650921|76127657|FG000|Overall Study|Lost to Follow-up|2|||
42074716|NCT00696436|75885056|FG003|Overall Study|Participant Non-compliance|2|||
42074717|NCT00696436|75885057|FG004|Overall Study|Participant Non-compliance|0|||
42074718|NCT00696436|75885053|FG000|Overall Study|Administrative Decision|1|||
42074719|NCT00696436|75885054|FG001|Overall Study|Administrative Decision|0|||
42177686|NCT03158272|75984905|FG002|Overall Study|Adverse event unrelated to the drug|0|||
42177687|NCT03158272|75984906|FG003|Overall Study|Adverse event unrelated to the drug|0|||
42293469|NCT02650921|76127657|FG000|Overall Study|Adverse Event|1|||
42293470|NCT02650921|76127657|FG000|Overall Study|Due to Medical Condition|1|||
42293471|NCT01596335|76127665|FG000|Overall Study|exacerbation of primary disease|5|||
42074720|NCT00696436|75885055|FG002|Overall Study|Administrative Decision|0|||
42074721|NCT00696436|75885056|FG003|Overall Study|Administrative Decision|0|||
42293472|NCT01596335|76127666|FG001|Overall Study|exacerbation of primary disease|9|||
42074722|NCT00696436|75885057|FG004|Overall Study|Administrative Decision|0|||
42074723|NCT00696436|75885053|FG000|Overall Study|Missing|0|||
42074724|NCT00696436|75885054|FG001|Overall Study|Missing|1|||
42074725|NCT00696436|75885055|FG002|Overall Study|Missing|1|||
42074726|NCT00696436|75885056|FG003|Overall Study|Missing|0|||
42074727|NCT00696436|75885057|FG004|Overall Study|Missing|0|||
42074728|NCT00878072|75885069|FG000|Overall Study|Withdrew consent|2|||
42074729|NCT00594854|75885097|FG000|Overall Study|Study terminated|7|||
42177688|NCT03705494|75984920|FG000|Overall Study|Lost to Follow-up|2|||
42293473|NCT02618759|76127674|FG000|Overall Study|Lost to Follow-up|0|||
42293474|NCT02618759|76127675|FG001|Overall Study|Lost to Follow-up|1|||
42293475|NCT02618759|76127674|FG000|Overall Study|Withdrawal by Subject|1|||
42293476|NCT02618759|76127675|FG001|Overall Study|Withdrawal by Subject|0|||
42293477|NCT02618759|76127674|FG000|Overall Study|Other Reasons|1|||
42074730|NCT00594854|75885098|FG001|Overall Study|Study terminated|10|||
42074731|NCT00855582|75885107|FG000|Overall Study|Adverse Event|2|||
42074732|NCT00855582|75885108|FG001|Overall Study|Adverse Event|6|||
42074733|NCT00855582|75885109|FG002|Overall Study|Adverse Event|3|||
42074734|NCT00855582|75885107|FG000|Overall Study|Death|1|||
42074735|NCT00855582|75885108|FG001|Overall Study|Death|0|||
42074736|NCT00855582|75885109|FG002|Overall Study|Death|0|||
42074737|NCT00855582|75885107|FG000|Overall Study|Lack of Efficacy|1|||
42074738|NCT00855582|75885108|FG001|Overall Study|Lack of Efficacy|3|||
42074739|NCT00855582|75885109|FG002|Overall Study|Lack of Efficacy|8|||
42074740|NCT00855582|75885107|FG000|Overall Study|Lost to Follow-up|1|||
42074741|NCT00855582|75885108|FG001|Overall Study|Lost to Follow-up|3|||
42074742|NCT00855582|75885109|FG002|Overall Study|Lost to Follow-up|1|||
42074743|NCT00855582|75885107|FG000|Overall Study|Physician Decision|0|||
42074744|NCT00855582|75885108|FG001|Overall Study|Physician Decision|0|||
42074745|NCT00855582|75885109|FG002|Overall Study|Physician Decision|1|||
42074746|NCT00855582|75885107|FG000|Overall Study|Protocol Violation|6|||
42074747|NCT00855582|75885108|FG001|Overall Study|Protocol Violation|2|||
42074748|NCT00855582|75885109|FG002|Overall Study|Protocol Violation|6|||
42074749|NCT00855582|75885107|FG000|Overall Study|Entry Criteria Not Met|8|||
42074750|NCT00855582|75885108|FG001|Overall Study|Entry Criteria Not Met|6|||
42074751|NCT00855582|75885109|FG002|Overall Study|Entry Criteria Not Met|3|||
42074752|NCT00855582|75885107|FG000|Overall Study|Withdrawal by Subject|7|||
42074753|NCT00855582|75885108|FG001|Overall Study|Withdrawal by Subject|4|||
42074754|NCT00855582|75885109|FG002|Overall Study|Withdrawal by Subject|8|||
42074755|NCT00854724|75885122|FG000|First Intervention|Withdrawal by Subject|1|||
42074756|NCT00854724|75885123|FG001|First Intervention|Withdrawal by Subject|1|||
42074757|NCT00854724|75885122|FG000|Washout|Protocol Violation|1|||
42074758|NCT00854724|75885123|FG001|Washout|Protocol Violation|0|||
42074759|NCT00854724|75885122|FG000|Washout|Withdrawal by Subject|0|||
42074760|NCT00854724|75885123|FG001|Washout|Withdrawal by Subject|1|||
42074761|NCT00854724|75885122|FG000|Second Intervention|Protocol Violation|1|||
42074762|NCT00854724|75885123|FG001|Second Intervention|Protocol Violation|0|||
42074763|NCT00854724|75885122|FG000|Second Intervention|Physician Decision|0|||
42074764|NCT00854724|75885123|FG001|Second Intervention|Physician Decision|1|||
42074765|NCT00698932|75885161|FG000|Overall Study|Adverse Event|0|||
42074766|NCT00698932|75885162|FG001|Overall Study|Adverse Event|2|||
42074767|NCT00698932|75885161|FG000|Overall Study|Incorrect enrollment|0|||
42074768|NCT00698932|75885162|FG001|Overall Study|Incorrect enrollment|2|||
42074769|NCT00698932|75885161|FG000|Overall Study|Study specific discontinuation criteria|3|||
42074770|NCT00698932|75885162|FG001|Overall Study|Study specific discontinuation criteria|4|||
42074771|NCT00698932|75885161|FG000|Overall Study|Withdrawal by Subject|11|||
42074772|NCT00698932|75885162|FG001|Overall Study|Withdrawal by Subject|23|||
42074773|NCT00698932|75885161|FG000|Overall Study|Lost to Follow-up|6|||
42074774|NCT00698932|75885162|FG001|Overall Study|Lost to Follow-up|1|||
42074775|NCT00698932|75885161|FG000|Overall Study|Severe non-compliance to protocol|1|||
42074776|NCT00698932|75885162|FG001|Overall Study|Severe non-compliance to protocol|2|||
42074777|NCT00698932|75885161|FG000|Overall Study|Safety reasons|0|||
42074778|NCT00698932|75885162|FG001|Overall Study|Safety reasons|2|||
42074779|NCT00698932|75885161|FG000|Overall Study|Death|1|||
42074780|NCT00698932|75885162|FG001|Overall Study|Death|0|||
42074781|NCT00823719|75885170|FG000|Overall Study|Adverse Event|1|||
42074782|NCT00823719|75885171|FG001|Overall Study|Adverse Event|2|||
42074783|NCT00823719|75885170|FG000|Overall Study|Physician Decision|1|||
42074784|NCT00823719|75885171|FG001|Overall Study|Physician Decision|4|||
42074785|NCT00823719|75885170|FG000|Overall Study|Withdrawal by Subject|0|||
42074786|NCT00823719|75885171|FG001|Overall Study|Withdrawal by Subject|1|||
42074787|NCT00823719|75885170|FG000|Overall Study|Disease Progression|4|||
42074788|NCT00823719|75885171|FG001|Overall Study|Disease Progression|4|||
42074789|NCT00875420|75885184|FG000|Overall Study|Adverse Event|0|||
42074790|NCT00875420|75885185|FG001|Overall Study|Adverse Event|1|||
42074791|NCT00875420|75885186|FG002|Overall Study|Adverse Event|1|||
42074792|NCT00875420|75885187|FG003|Overall Study|Adverse Event|0|||
42074793|NCT00875420|75885188|FG004|Overall Study|Adverse Event|0|||
42074794|NCT00875420|75885184|FG000|Overall Study|Inability to complete study procedures|1|||
42074795|NCT00875420|75885185|FG001|Overall Study|Inability to complete study procedures|0|||
42074796|NCT00875420|75885186|FG002|Overall Study|Inability to complete study procedures|1|||
42074797|NCT00875420|75885187|FG003|Overall Study|Inability to complete study procedures|1|||
42074798|NCT00875420|75885188|FG004|Overall Study|Inability to complete study procedures|1|||
42074799|NCT00875420|75885184|FG000|Overall Study|Lost to Follow-up|1|||
42074800|NCT00875420|75885185|FG001|Overall Study|Lost to Follow-up|0|||
42074801|NCT00875420|75885186|FG002|Overall Study|Lost to Follow-up|0|||
42074802|NCT00875420|75885187|FG003|Overall Study|Lost to Follow-up|0|||
42074803|NCT00875420|75885188|FG004|Overall Study|Lost to Follow-up|0|||
42074804|NCT00875420|75885184|FG000|Overall Study|Personal reason|0|||
42074805|NCT00875420|75885185|FG001|Overall Study|Personal reason|0|||
42074806|NCT00875420|75885186|FG002|Overall Study|Personal reason|0|||
42074807|NCT00875420|75885187|FG003|Overall Study|Personal reason|0|||
42074808|NCT00875420|75885188|FG004|Overall Study|Personal reason|1|||
42074809|NCT00875420|75885184|FG000|Overall Study|Prohibited medication|0|||
42074810|NCT00875420|75885185|FG001|Overall Study|Prohibited medication|0|||
42074811|NCT00875420|75885186|FG002|Overall Study|Prohibited medication|0|||
42074812|NCT00875420|75885187|FG003|Overall Study|Prohibited medication|1|||
42074813|NCT00875420|75885188|FG004|Overall Study|Prohibited medication|0|||
42074814|NCT00875420|75885184|FG000|Overall Study|Sponsor decision|0|||
42074815|NCT00875420|75885185|FG001|Overall Study|Sponsor decision|1|||
42074816|NCT00875420|75885186|FG002|Overall Study|Sponsor decision|0|||
42074817|NCT00875420|75885187|FG003|Overall Study|Sponsor decision|0|||
42074818|NCT00875420|75885188|FG004|Overall Study|Sponsor decision|0|||
42074819|NCT00875420|75885184|FG000|Overall Study|Withdrawal by Subject|0|||
42074820|NCT00875420|75885185|FG001|Overall Study|Withdrawal by Subject|0|||
42074821|NCT00875420|75885186|FG002|Overall Study|Withdrawal by Subject|1|||
42074822|NCT00875420|75885187|FG003|Overall Study|Withdrawal by Subject|0|||
42074823|NCT00875420|75885188|FG004|Overall Study|Withdrawal by Subject|0|||
42074824|NCT00822237|75885202|FG000|Dose 1 Vaccination|Not vaccinated|3|||
42074825|NCT00822237|75885203|FG001|Dose 1 Vaccination|Not vaccinated|0|||
42074826|NCT00822237|75885202|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
42074827|NCT00822237|75885203|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
42074828|NCT00822237|75885202|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
42074829|NCT00822237|75885203|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
42074830|NCT00822237|75885202|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
42074831|NCT00822237|75885203|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
42074832|NCT00822237|75885202|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
42074833|NCT00822237|75885203|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
42074834|NCT00577096|75885210|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
42074835|NCT00577096|75885211|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
42074836|NCT00577096|75885210|FG000|Short Term Participation|Withdrawal by Subject|3|||
42074837|NCT00577096|75885211|FG001|Short Term Participation|Withdrawal by Subject|5|||
42074838|NCT00577096|75885210|FG000|Short Term Participation|Death|1|||
42074839|NCT00577096|75885211|FG001|Short Term Participation|Death|1|||
42074840|NCT00863304|75885221|FG000|Overall Study|Adverse Event|10|||
42074841|NCT00863304|75885222|FG001|Overall Study|Adverse Event|4|||
42074842|NCT00863304|75885223|FG002|Overall Study|Adverse Event|14|||
42074843|NCT00863304|75885224|FG003|Overall Study|Adverse Event|16|||
42074844|NCT00863304|75885221|FG000|Overall Study|Lost to Follow-up|1|||
42074845|NCT00863304|75885222|FG001|Overall Study|Lost to Follow-up|5|||
42074846|NCT00863304|75885223|FG002|Overall Study|Lost to Follow-up|4|||
42074847|NCT00863304|75885224|FG003|Overall Study|Lost to Follow-up|2|||
42074848|NCT00863304|75885221|FG000|Overall Study|Lack of Efficacy|57|||
42074849|NCT00863304|75885222|FG001|Overall Study|Lack of Efficacy|26|||
42074850|NCT00863304|75885223|FG002|Overall Study|Lack of Efficacy|30|||
42074851|NCT00863304|75885224|FG003|Overall Study|Lack of Efficacy|28|||
42074852|NCT00863304|75885221|FG000|Overall Study|Withdrawal by Subject|19|||
42074853|NCT00863304|75885222|FG001|Overall Study|Withdrawal by Subject|14|||
42074854|NCT00863304|75885223|FG002|Overall Study|Withdrawal by Subject|20|||
42074855|NCT00863304|75885224|FG003|Overall Study|Withdrawal by Subject|18|||
42074856|NCT00863304|75885221|FG000|Overall Study|Other|1|||
42074857|NCT00863304|75885222|FG001|Overall Study|Other|0|||
42074858|NCT00863304|75885223|FG002|Overall Study|Other|0|||
42074859|NCT00863304|75885224|FG003|Overall Study|Other|1|||
42074860|NCT00863304|75885221|FG000|Overall Study|Protocol Violation|2|||
42074861|NCT00863304|75885222|FG001|Overall Study|Protocol Violation|6|||
42074862|NCT00863304|75885223|FG002|Overall Study|Protocol Violation|2|||
42074863|NCT00863304|75885224|FG003|Overall Study|Protocol Violation|0|||
42074864|NCT00863304|75885221|FG000|Overall Study|Randomized, but not Treated|3|||
42074865|NCT00863304|75885222|FG001|Overall Study|Randomized, but not Treated|1|||
42074866|NCT00863304|75885223|FG002|Overall Study|Randomized, but not Treated|4|||
42074867|NCT00863304|75885224|FG003|Overall Study|Randomized, but not Treated|1|||
42293478|NCT02618759|76127675|FG001|Overall Study|Other Reasons|4|||
42293479|NCT02614079|76127690|FG000|Overall Study|Withdrawal by Subject|1|||
42074868|NCT00863304|75885221|FG000|Overall Study|Entered extension study|101|||
42074869|NCT00863304|75885222|FG001|Overall Study|Entered extension study|129|||
42074870|NCT00863304|75885223|FG002|Overall Study|Entered extension study|113|||
42293480|NCT02616029|76127696|FG000|Overall Study|Adverse Event|1|||
42074871|NCT00863304|75885224|FG003|Overall Study|Entered extension study|125|||
42074872|NCT00695110|75885236|FG000|Treatment Period 1|Adverse Event|1|||
42074873|NCT00695110|75885236|FG000|Treatment Period 1|Withdrawal by Subject|2|||
42074874|NCT00695110|75885236|FG000|Treatment Period 3|Withdrawal by Subject|1|||
42177689|NCT03705494|75984921|FG001|Overall Study|Lost to Follow-up|1|||
42074875|NCT00695110|75885236|FG000|Treatment Period 4|Adverse Event|1|||
42074876|NCT00594386|75885243|FG000|Overall Study|Major protocol violation|2|||
42074877|NCT00594386|75885243|FG000|Overall Study|Lack of Efficacy|12|||
42074878|NCT00594386|75885243|FG000|Overall Study|Adverse Event|68|||
42074879|NCT00594386|75885243|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
42074880|NCT00594386|75885243|FG000|Overall Study|Subject withdrew consent|35|||
42293481|NCT02616029|76127697|FG001|Overall Study|Adverse Event|0|||
42074881|NCT00594386|75885243|FG000|Overall Study|Study ended per sponsor|115|||
42074882|NCT00594386|75885243|FG000|Overall Study|Lost to Follow-up|6|||
42074883|NCT00594386|75885243|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
42074884|NCT00594386|75885243|FG000|Overall Study|Other: Subject moved to Seattle|1|||
42074885|NCT00594386|75885243|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
42074886|NCT00594386|75885243|FG000|Overall Study|Other: Study terminated per investigator|2|||
42074887|NCT00594386|75885243|FG000|Overall Study|Other: Sponsor closure of study|1|||
42074888|NCT00594386|75885243|FG000|Overall Study|Other: Site terminated participation|1|||
42074889|NCT00594386|75885243|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
42074890|NCT00594386|75885243|FG000|Overall Study|Other: Loss of drivers license|1|||
42074891|NCT00862992|75885250|FG000|Overall Study|Adverse Event|2|||
42074892|NCT00862992|75885251|FG001|Overall Study|Adverse Event|1|||
42074893|NCT00862992|75885252|FG002|Overall Study|Adverse Event|1|||
42074894|NCT00862992|75885250|FG000|Overall Study|Physician Decision|1|||
42074895|NCT00862992|75885251|FG001|Overall Study|Physician Decision|0|||
42074896|NCT00862992|75885252|FG002|Overall Study|Physician Decision|0|||
42074897|NCT00862992|75885250|FG000|Overall Study|Withdrawal by Subject|0|||
42074898|NCT00862992|75885251|FG001|Overall Study|Withdrawal by Subject|0|||
42074899|NCT00862992|75885252|FG002|Overall Study|Withdrawal by Subject|2|||
42074900|NCT00694096|75885260|FG000|Overall Study|Withdrawal by Subject|5|||
42074901|NCT00854100|75885267|FG000|Overall Study|Inability to complete the study visits|0|||
42074902|NCT00854100|75885268|FG001|Overall Study|Inability to complete the study visits|0|||
42074903|NCT00854100|75885269|FG002|Overall Study|Inability to complete the study visits|1|||
42074904|NCT00854100|75885267|FG000|Overall Study|Lost to Follow-up|2|||
42074905|NCT00854100|75885268|FG001|Overall Study|Lost to Follow-up|0|||
42074906|NCT00854100|75885269|FG002|Overall Study|Lost to Follow-up|3|||
42074907|NCT00854100|75885267|FG000|Overall Study|Withdrawal by Subject|3|||
42074908|NCT00854100|75885268|FG001|Overall Study|Withdrawal by Subject|1|||
42074909|NCT00854100|75885269|FG002|Overall Study|Withdrawal by Subject|2|||
42074910|NCT00854100|75885267|FG000|Overall Study|Protocol Violation|2|||
42074911|NCT00854100|75885268|FG001|Overall Study|Protocol Violation|4|||
42074912|NCT00854100|75885269|FG002|Overall Study|Protocol Violation|3|||
42074913|NCT00854100|75885267|FG000|Overall Study|Adverse Event|2|||
42074914|NCT00854100|75885268|FG001|Overall Study|Adverse Event|1|||
42074915|NCT00854100|75885269|FG002|Overall Study|Adverse Event|2|||
42074916|NCT00509899|75885286|FG000|Overall Study|Progressive disease|1|||
42074917|NCT00509899|75885287|FG001|Overall Study|Progressive disease|3|||
42074918|NCT00509899|75885288|FG002|Overall Study|Progressive disease|5|||
42074919|NCT00509899|75885289|FG003|Overall Study|Progressive disease|1|||
42074920|NCT00509899|75885290|FG004|Overall Study|Progressive disease|0|||
42074921|NCT00509899|75885291|FG005|Overall Study|Progressive disease|1|||
42074922|NCT00509899|75885292|FG006|Overall Study|Progressive disease|0|||
42074923|NCT00509899|75885293|FG007|Overall Study|Progressive disease|0|||
42074924|NCT00509899|75885286|FG000|Overall Study|Unacceptable Toxicity|1|||
42074925|NCT00509899|75885287|FG001|Overall Study|Unacceptable Toxicity|0|||
42074926|NCT00509899|75885288|FG002|Overall Study|Unacceptable Toxicity|0|||
42074927|NCT00509899|75885289|FG003|Overall Study|Unacceptable Toxicity|2|||
42074928|NCT00509899|75885290|FG004|Overall Study|Unacceptable Toxicity|0|||
42074929|NCT00509899|75885291|FG005|Overall Study|Unacceptable Toxicity|0|||
42074930|NCT00509899|75885292|FG006|Overall Study|Unacceptable Toxicity|0|||
42074931|NCT00509899|75885293|FG007|Overall Study|Unacceptable Toxicity|0|||
42074932|NCT00509899|75885286|FG000|Overall Study|Withdrawal by Subject|6|||
42074933|NCT00509899|75885287|FG001|Overall Study|Withdrawal by Subject|2|||
42074934|NCT00509899|75885288|FG002|Overall Study|Withdrawal by Subject|3|||
42074935|NCT00509899|75885289|FG003|Overall Study|Withdrawal by Subject|0|||
42074936|NCT00509899|75885290|FG004|Overall Study|Withdrawal by Subject|3|||
42074937|NCT00509899|75885291|FG005|Overall Study|Withdrawal by Subject|2|||
42074938|NCT00509899|75885292|FG006|Overall Study|Withdrawal by Subject|0|||
42074939|NCT00509899|75885293|FG007|Overall Study|Withdrawal by Subject|0|||
42074940|NCT00509899|75885286|FG000|Overall Study|Physician Decision|4|||
42074941|NCT00509899|75885287|FG001|Overall Study|Physician Decision|2|||
42074942|NCT00509899|75885288|FG002|Overall Study|Physician Decision|7|||
42074943|NCT00509899|75885289|FG003|Overall Study|Physician Decision|0|||
42074944|NCT00509899|75885290|FG004|Overall Study|Physician Decision|1|||
42074945|NCT00509899|75885291|FG005|Overall Study|Physician Decision|4|||
42293482|NCT02616029|76127696|FG000|Overall Study|Death|0|||
42293483|NCT02616029|76127697|FG001|Overall Study|Death|1|||
42074946|NCT00509899|75885292|FG006|Overall Study|Physician Decision|0|||
42074947|NCT00509899|75885293|FG007|Overall Study|Physician Decision|0|||
42074948|NCT00509899|75885286|FG000|Overall Study|Intercurrent Illness|1|||
42074949|NCT00509899|75885287|FG001|Overall Study|Intercurrent Illness|0|||
42074950|NCT00509899|75885288|FG002|Overall Study|Intercurrent Illness|0|||
42074951|NCT00509899|75885289|FG003|Overall Study|Intercurrent Illness|1|||
42293484|NCT02616029|76127696|FG000|Overall Study|Protocol Violation|1|||
42074952|NCT00509899|75885290|FG004|Overall Study|Intercurrent Illness|0|||
42074953|NCT00509899|75885291|FG005|Overall Study|Intercurrent Illness|1|||
42293485|NCT02616029|76127697|FG001|Overall Study|Protocol Violation|0|||
42074954|NCT00509899|75885292|FG006|Overall Study|Intercurrent Illness|0|||
42074955|NCT00509899|75885293|FG007|Overall Study|Intercurrent Illness|0|||
42074956|NCT00509899|75885286|FG000|Overall Study|Death|2|||
42074957|NCT00509899|75885287|FG001|Overall Study|Death|2|||
42074958|NCT00509899|75885288|FG002|Overall Study|Death|3|||
42074959|NCT00509899|75885289|FG003|Overall Study|Death|0|||
42074960|NCT00509899|75885290|FG004|Overall Study|Death|1|||
42074961|NCT00509899|75885291|FG005|Overall Study|Death|1|||
42074962|NCT00509899|75885292|FG006|Overall Study|Death|1|||
42074963|NCT00509899|75885293|FG007|Overall Study|Death|1|||
42074964|NCT00509899|75885286|FG000|Overall Study|Lack of Efficacy|1|||
42074965|NCT00509899|75885287|FG001|Overall Study|Lack of Efficacy|0|||
42074966|NCT00509899|75885288|FG002|Overall Study|Lack of Efficacy|2|||
42074967|NCT00509899|75885289|FG003|Overall Study|Lack of Efficacy|0|||
42074968|NCT00509899|75885290|FG004|Overall Study|Lack of Efficacy|0|||
42074969|NCT00509899|75885291|FG005|Overall Study|Lack of Efficacy|1|||
42074970|NCT00509899|75885292|FG006|Overall Study|Lack of Efficacy|0|||
42074971|NCT00509899|75885293|FG007|Overall Study|Lack of Efficacy|0|||
42074972|NCT00862836|75885307|FG000|Overall Study|Withdrawal by Subject|1|||
42074973|NCT00820755|75885311|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
42074974|NCT00820755|75885312|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
42074975|NCT00820755|75885313|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
42074976|NCT00820755|75885311|FG000|Period 1: Combination Therapy Phase|Death|28|||
42074977|NCT00820755|75885312|FG001|Period 1: Combination Therapy Phase|Death|0|||
42074978|NCT00820755|75885313|FG002|Period 1: Combination Therapy Phase|Death|0|||
42074979|NCT00820755|75885311|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
42074980|NCT00820755|75885312|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
42074981|NCT00820755|75885313|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
42074982|NCT00820755|75885311|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
42074983|NCT00820755|75885312|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
42074984|NCT00820755|75885313|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
42074985|NCT00820755|75885311|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
42074986|NCT00820755|75885312|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
42074987|NCT00820755|75885313|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
42074988|NCT00820755|75885311|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
42074989|NCT00820755|75885312|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
42074990|NCT00820755|75885313|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
42074991|NCT00820755|75885311|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
42074992|NCT00820755|75885312|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
42074993|NCT00820755|75885313|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
42074994|NCT00820755|75885311|FG000|Period 1: Combination Therapy Phase|Other|11|||
42074995|NCT00820755|75885312|FG001|Period 1: Combination Therapy Phase|Other|0|||
42074996|NCT00820755|75885313|FG002|Period 1: Combination Therapy Phase|Other|0|||
42074997|NCT00820755|75885311|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
42074998|NCT00820755|75885312|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
42074999|NCT00820755|75885313|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
42075000|NCT00820599|75885321|FG000|Overall Study|Death|129|||
42075001|NCT00820599|75885321|FG000|Overall Study|Withdrawal by Subject|2|||
42075002|NCT00819741|75885327|FG000|Overall Study|Adverse Event|5|||
42075003|NCT00819741|75885328|FG001|Overall Study|Adverse Event|2|||
42075004|NCT00819741|75885327|FG000|Overall Study|Lack of Efficacy|0|||
42075005|NCT00819741|75885328|FG001|Overall Study|Lack of Efficacy|2|||
42075006|NCT00819741|75885327|FG000|Overall Study|Lost to Follow-up|3|||
42075007|NCT00819741|75885328|FG001|Overall Study|Lost to Follow-up|1|||
42075008|NCT00819741|75885327|FG000|Overall Study|Protocol Violation|3|||
42075009|NCT00819741|75885328|FG001|Overall Study|Protocol Violation|4|||
42075010|NCT00819741|75885327|FG000|Overall Study|Withdrawal by Subject|2|||
42075011|NCT00819741|75885328|FG001|Overall Study|Withdrawal by Subject|2|||
42075012|NCT00819741|75885327|FG000|Overall Study|Unclassified|6|||
42075013|NCT00819741|75885328|FG001|Overall Study|Unclassified|0|||
42075014|NCT00819741|75885327|FG000|Overall Study|Reasons unknown|3|||
42075015|NCT00819741|75885328|FG001|Overall Study|Reasons unknown|3|||
42075016|NCT00862134|75885336|FG000|Overall Study|Death|1|||
42075017|NCT00862134|75885337|FG001|Overall Study|Death|0|||
42075018|NCT00862134|75885336|FG000|Overall Study|Physician Decision|0|||
42357793|NCT01877239|76203316|FG000|Overall Study|Lack of Efficacy|4|||
42075019|NCT00862134|75885337|FG001|Overall Study|Physician Decision|1|||
42075020|NCT00862134|75885336|FG000|Overall Study|Withdrawal by Subject|1|||
42075021|NCT00862134|75885337|FG001|Overall Study|Withdrawal by Subject|2|||
42075022|NCT00862134|75885336|FG000|Overall Study|Sponsor terminated study|5|||
42075023|NCT00862134|75885337|FG001|Overall Study|Sponsor terminated study|7|||
42075024|NCT00862134|75885336|FG000|Overall Study|Adverse Event|2|||
42075025|NCT00862134|75885337|FG001|Overall Study|Adverse Event|2|||
42075026|NCT00862134|75885336|FG000|Overall Study|Withdrew prior to dosing|2|||
42075027|NCT00862134|75885337|FG001|Overall Study|Withdrew prior to dosing|0|||
42075028|NCT00848484|75885345|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
42075029|NCT00848484|75885346|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
42075030|NCT00848484|75885345|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
42075031|NCT00848484|75885346|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
42075032|NCT00848484|75885345|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
42075033|NCT00848484|75885346|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
42075034|NCT00848484|75885345|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
42075035|NCT00848484|75885346|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
42075036|NCT00848484|75885345|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
42075037|NCT00848484|75885346|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
42075038|NCT00509821|75885354|FG000|Study Period 1 (Induction)|Death|0|||
42075039|NCT00509821|75885355|FG001|Study Period 1 (Induction)|Death|1|||
42075040|NCT00509821|75885354|FG000|Study Period 1 (Induction)|Adverse Event|0|||
42075041|NCT00509821|75885355|FG001|Study Period 1 (Induction)|Adverse Event|2|||
42075042|NCT00509821|75885354|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
42075043|NCT00509821|75885355|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
42075044|NCT00508651|75885368|FG000|Overall Study|Lost to Follow-up|3|||
42075045|NCT00508651|75885369|FG001|Overall Study|Lost to Follow-up|1|||
42075046|NCT00508651|75885368|FG000|Overall Study|Withdrawal by Subject|1|||
42075047|NCT00508651|75885369|FG001|Overall Study|Withdrawal by Subject|1|||
42075048|NCT00490555|75885379|FG000|Overall Study|noncompliant with drug administration|0|||
42075049|NCT00490555|75885380|FG001|Overall Study|noncompliant with drug administration|0|||
42075050|NCT00490555|75885381|FG002|Overall Study|noncompliant with drug administration|2|||
42075051|NCT00490555|75885382|FG003|Overall Study|noncompliant with drug administration|0|||
42075052|NCT00501085|75885392|FG000|Overall Study|Lost to Follow-up|195|||
42075053|NCT00501085|75885392|FG000|Overall Study|Withdrawal by Subject|34|||
42075054|NCT00501085|75885392|FG000|Overall Study|Subject Decision|1|||
42075055|NCT00501085|75885392|FG000|Overall Study|Revision Surgery|7|||
42075056|NCT00501085|75885392|FG000|Overall Study|Explantation Surgery|26|||
42075057|NCT00501085|75885392|FG000|Overall Study|Adverse Event|4|||
42075058|NCT00501085|75885392|FG000|Overall Study|Non-Compliance|24|||
42075059|NCT00501085|75885392|FG000|Overall Study|Study closed by sponsor|109|||
42075060|NCT00501085|75885392|FG000|Overall Study|Other loss to follow-up|32|||
42075061|NCT00501007|75885396|FG000|Overall Study|Inclusion criteria not met.|29|||
42075062|NCT00501007|75885397|FG001|Overall Study|Inclusion criteria not met.|25|||
42075063|NCT00873860|75885407|FG000|Overall Study|Lost to Follow-up|1|||
42075064|NCT00873860|75885408|FG001|Overall Study|Lost to Follow-up|0|||
42075065|NCT00873860|75885409|FG002|Overall Study|Lost to Follow-up|0|||
42075066|NCT00873860|75885410|FG003|Overall Study|Lost to Follow-up|1|||
42075067|NCT00873860|75885407|FG000|Overall Study|Withdrawal by Subject|1|||
42075068|NCT00873860|75885408|FG001|Overall Study|Withdrawal by Subject|0|||
42075069|NCT00873860|75885409|FG002|Overall Study|Withdrawal by Subject|2|||
42075070|NCT00873860|75885410|FG003|Overall Study|Withdrawal by Subject|0|||
42075071|NCT00873860|75885407|FG000|Overall Study|Death|1|||
42075072|NCT00873860|75885408|FG001|Overall Study|Death|0|||
42075073|NCT00873860|75885409|FG002|Overall Study|Death|0|||
42075074|NCT00873860|75885410|FG003|Overall Study|Death|0|||
42075075|NCT00873860|75885407|FG000|Overall Study|Other|1|||
42075076|NCT00873860|75885408|FG001|Overall Study|Other|0|||
42075077|NCT00873860|75885409|FG002|Overall Study|Other|1|||
42075078|NCT00873860|75885410|FG003|Overall Study|Other|0|||
42075079|NCT03853291|75885433|FG000|Overall Study|Lost to Follow-up|1|||
42075080|NCT03853291|75885434|FG001|Overall Study|Lost to Follow-up|2|||
42075081|NCT03853291|75885435|FG002|Overall Study|Lost to Follow-up|0|||
42075082|NCT03853291|75885436|FG003|Overall Study|Lost to Follow-up|0|||
42075083|NCT03853291|75885437|FG004|Overall Study|Lost to Follow-up|0|||
42075084|NCT03853291|75885438|FG005|Overall Study|Lost to Follow-up|0|||
42075085|NCT03853291|75885433|FG000|Overall Study|Determined to be ineligible|1|||
42075086|NCT03853291|75885434|FG001|Overall Study|Determined to be ineligible|1|||
42075087|NCT03853291|75885435|FG002|Overall Study|Determined to be ineligible|0|||
42293486|NCT02616029|76127696|FG000|Overall Study|Withdrew Consent|1|||
42293487|NCT02616029|76127697|FG001|Overall Study|Withdrew Consent|0|||
42293488|NCT02616029|76127696|FG000|Overall Study|Enrolled and Never Treated|1|||
42293489|NCT02616029|76127697|FG001|Overall Study|Enrolled and Never Treated|1|||
42293490|NCT02614859|76127705|FG000|Overall Study|Physician Decision|0|||
42075088|NCT03853291|75885436|FG003|Overall Study|Determined to be ineligible|0|||
42075089|NCT03853291|75885437|FG004|Overall Study|Determined to be ineligible|0|||
42075090|NCT03853291|75885438|FG005|Overall Study|Determined to be ineligible|0|||
42075091|NCT03853213|75885451|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
42075092|NCT03853213|75885452|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
42075093|NCT03853213|75885451|FG000|Overall Study|Other (e.g., too busy)|0|||
42075094|NCT03853213|75885452|FG001|Overall Study|Other (e.g., too busy)|2|||
42075095|NCT02666105|75885478|FG000|Overall Study|Death|1|||
42177690|NCT03705494|75984920|FG000|Overall Study|Withdrawal by Subject|5|||
42293491|NCT02614859|76127706|FG001|Overall Study|Physician Decision|1|||
42075096|NCT00819585|75885497|FG000|Core Study|Adverse Event|2|||
42075097|NCT00819585|75885498|FG001|Core Study|Adverse Event|1|||
42075098|NCT00819585|75885499|FG002|Core Study|Adverse Event|1|||
42075099|NCT00819585|75885500|FG003|Core Study|Adverse Event|4|||
42075100|NCT00819585|75885501|FG004|Core Study|Adverse Event|1|||
42075101|NCT00819585|75885502|FG005|Core Study|Adverse Event|0|||
42075102|NCT00819585|75885503|FG006|Core Study|Adverse Event|2|||
42075103|NCT00819585|75885504|FG007|Core Study|Adverse Event|0|||
42075104|NCT00819585|75885505|FG008|Core Study|Adverse Event|0|||
42075105|NCT00819585|75885506|FG009|Core Study|Adverse Event|0|||
42075106|NCT00819585|75885507|FG010|Core Study|Adverse Event|0|||
42075107|NCT00819585|75885497|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
42075108|NCT00819585|75885498|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
42075109|NCT00819585|75885499|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
42075110|NCT00819585|75885500|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
42075111|NCT00819585|75885501|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
42075112|NCT00819585|75885502|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
42075113|NCT00819585|75885503|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
42075114|NCT00819585|75885504|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
42075115|NCT00819585|75885505|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
42075116|NCT00819585|75885506|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
42075117|NCT00819585|75885507|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
42075118|NCT00819585|75885497|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
42075119|NCT00819585|75885498|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
42075120|NCT00819585|75885499|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
42075121|NCT00819585|75885500|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
42075122|NCT00819585|75885501|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
42075123|NCT00819585|75885502|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
42075124|NCT00819585|75885503|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
42075125|NCT00819585|75885504|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
42075126|NCT00819585|75885505|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
42075127|NCT00819585|75885506|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
42075128|NCT00819585|75885507|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
42075129|NCT00819585|75885497|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
42075130|NCT00819585|75885498|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
42075131|NCT00819585|75885499|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
42075132|NCT00819585|75885500|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
42075133|NCT00819585|75885501|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
42075134|NCT00819585|75885502|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
42075135|NCT00819585|75885503|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
42075136|NCT00819585|75885504|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
42075137|NCT00819585|75885505|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
42075138|NCT00819585|75885506|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
42075139|NCT00819585|75885507|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
42075140|NCT00819585|75885497|FG000|Core Study|Subject Withdrew Consent|0|||
42075141|NCT00819585|75885498|FG001|Core Study|Subject Withdrew Consent|3|||
42177691|NCT03705494|75984921|FG001|Overall Study|Withdrawal by Subject|2|||
42177692|NCT01431508|75984927|FG000|Overall Study|Lack of Efficacy|1|||
42177693|NCT01431508|75984927|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
42177694|NCT00654628|75984931|FG000|6-week Active Treatment Period|Adverse Event|9|||
42293492|NCT02615249|76127714|FG000|Overall Study|Withdrawal by Subject|1|||
42357794|NCT01877239|76203316|FG000|Overall Study|Data not available|35|||
42357795|NCT01877083|76203320|FG000|Treatment Phase|Disease Progression|10|||
42075142|NCT00819585|75885499|FG002|Core Study|Subject Withdrew Consent|2|||
42075143|NCT00819585|75885500|FG003|Core Study|Subject Withdrew Consent|1|||
42075144|NCT00819585|75885501|FG004|Core Study|Subject Withdrew Consent|0|||
42293493|NCT02615171|76127721|FG000|Overall Study|Lost to Follow-up|2|||
42293494|NCT02615171|76127722|FG001|Overall Study|Lost to Follow-up|1|||
42293495|NCT02648347|76127730|FG000|Overall Study|Death|174|||
42293496|NCT02648347|76127731|FG001|Overall Study|Death|167|||
42293497|NCT02648347|76127730|FG000|Overall Study|Withdrawal by Subject|16|||
42075145|NCT00819585|75885502|FG005|Core Study|Subject Withdrew Consent|0|||
42075146|NCT00819585|75885503|FG006|Core Study|Subject Withdrew Consent|3|||
42075147|NCT00819585|75885504|FG007|Core Study|Subject Withdrew Consent|0|||
42075148|NCT00819585|75885505|FG008|Core Study|Subject Withdrew Consent|0|||
42075149|NCT00819585|75885506|FG009|Core Study|Subject Withdrew Consent|0|||
42293498|NCT02648347|76127731|FG001|Overall Study|Withdrawal by Subject|9|||
42293499|NCT02648347|76127730|FG000|Overall Study|Lost to Follow-up|18|||
42293500|NCT02648347|76127731|FG001|Overall Study|Lost to Follow-up|21|||
42075150|NCT00819585|75885507|FG010|Core Study|Subject Withdrew Consent|0|||
42075151|NCT00819585|75885497|FG000|Core Study|Lost to Follow-up|2|||
42075152|NCT00819585|75885498|FG001|Core Study|Lost to Follow-up|1|||
42075153|NCT00819585|75885499|FG002|Core Study|Lost to Follow-up|2|||
42075154|NCT00819585|75885500|FG003|Core Study|Lost to Follow-up|0|||
42293501|NCT02648347|76127730|FG000|Overall Study|Missing|1|||
42293502|NCT02648347|76127731|FG001|Overall Study|Missing|0|||
42075155|NCT00819585|75885501|FG004|Core Study|Lost to Follow-up|1|||
42075156|NCT00819585|75885502|FG005|Core Study|Lost to Follow-up|1|||
42075157|NCT00819585|75885503|FG006|Core Study|Lost to Follow-up|1|||
42075158|NCT00819585|75885504|FG007|Core Study|Lost to Follow-up|0|||
42075159|NCT00819585|75885505|FG008|Core Study|Lost to Follow-up|0|||
42075160|NCT00819585|75885506|FG009|Core Study|Lost to Follow-up|0|||
42075161|NCT00819585|75885507|FG010|Core Study|Lost to Follow-up|0|||
42075162|NCT00819585|75885497|FG000|Core Study|Administrative Problems|0|||
42075163|NCT00819585|75885498|FG001|Core Study|Administrative Problems|0|||
42075164|NCT00819585|75885499|FG002|Core Study|Administrative Problems|0|||
42075165|NCT00819585|75885500|FG003|Core Study|Administrative Problems|0|||
42075166|NCT00819585|75885501|FG004|Core Study|Administrative Problems|0|||
42075167|NCT00819585|75885502|FG005|Core Study|Administrative Problems|0|||
42075168|NCT00819585|75885503|FG006|Core Study|Administrative Problems|2|||
42075169|NCT00819585|75885504|FG007|Core Study|Administrative Problems|0|||
42075170|NCT00819585|75885505|FG008|Core Study|Administrative Problems|0|||
42075171|NCT00819585|75885506|FG009|Core Study|Administrative Problems|0|||
42075172|NCT00819585|75885507|FG010|Core Study|Administrative Problems|0|||
42075173|NCT00819585|75885497|FG000|Core Study|Death|0|||
42075174|NCT00819585|75885498|FG001|Core Study|Death|0|||
42075175|NCT00819585|75885499|FG002|Core Study|Death|0|||
42075176|NCT00819585|75885500|FG003|Core Study|Death|0|||
42075177|NCT00819585|75885501|FG004|Core Study|Death|0|||
42075178|NCT00819585|75885502|FG005|Core Study|Death|0|||
42075179|NCT00819585|75885503|FG006|Core Study|Death|1|||
42075180|NCT00819585|75885504|FG007|Core Study|Death|0|||
42075181|NCT00819585|75885505|FG008|Core Study|Death|0|||
42075182|NCT00819585|75885506|FG009|Core Study|Death|0|||
42075183|NCT00819585|75885507|FG010|Core Study|Death|0|||
42075184|NCT00819585|75885497|FG000|Core Study|Protocol Violation|0|||
42075185|NCT00819585|75885498|FG001|Core Study|Protocol Violation|0|||
42075186|NCT00819585|75885499|FG002|Core Study|Protocol Violation|1|||
42075187|NCT00819585|75885500|FG003|Core Study|Protocol Violation|0|||
42075188|NCT00819585|75885501|FG004|Core Study|Protocol Violation|0|||
42075189|NCT00819585|75885502|FG005|Core Study|Protocol Violation|1|||
42075190|NCT00819585|75885503|FG006|Core Study|Protocol Violation|3|||
42075191|NCT00819585|75885504|FG007|Core Study|Protocol Violation|0|||
42075192|NCT00819585|75885505|FG008|Core Study|Protocol Violation|0|||
42075193|NCT00819585|75885506|FG009|Core Study|Protocol Violation|0|||
42075194|NCT00819585|75885507|FG010|Core Study|Protocol Violation|0|||
42075195|NCT00819585|75885497|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
42075196|NCT00819585|75885498|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
42075197|NCT00819585|75885499|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
42075198|NCT00819585|75885500|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
42075199|NCT00819585|75885501|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
42075200|NCT00819585|75885502|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
42075201|NCT00819585|75885503|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
42075202|NCT00819585|75885504|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
42075203|NCT00819585|75885505|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
42075204|NCT00819585|75885506|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
42075205|NCT00819585|75885507|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
42075206|NCT00819585|75885497|FG000|Extension Study|Subject Withdrew Consent|0|||
42075207|NCT00819585|75885498|FG001|Extension Study|Subject Withdrew Consent|0|||
42075208|NCT00819585|75885499|FG002|Extension Study|Subject Withdrew Consent|0|||
42075209|NCT00819585|75885500|FG003|Extension Study|Subject Withdrew Consent|0|||
42075210|NCT00819585|75885501|FG004|Extension Study|Subject Withdrew Consent|0|||
42075211|NCT00819585|75885502|FG005|Extension Study|Subject Withdrew Consent|0|||
42075212|NCT00819585|75885503|FG006|Extension Study|Subject Withdrew Consent|0|||
42075213|NCT00819585|75885504|FG007|Extension Study|Subject Withdrew Consent|0|||
42075214|NCT00819585|75885505|FG008|Extension Study|Subject Withdrew Consent|3|||
42075215|NCT00819585|75885506|FG009|Extension Study|Subject Withdrew Consent|0|||
42075216|NCT00819585|75885507|FG010|Extension Study|Subject Withdrew Consent|1|||
42075217|NCT00819585|75885497|FG000|Extension Study|Lost to Follow-up|0|||
42075218|NCT00819585|75885498|FG001|Extension Study|Lost to Follow-up|0|||
42075219|NCT00819585|75885499|FG002|Extension Study|Lost to Follow-up|0|||
42075220|NCT00819585|75885500|FG003|Extension Study|Lost to Follow-up|0|||
42075221|NCT00819585|75885501|FG004|Extension Study|Lost to Follow-up|0|||
42293503|NCT02614703|76127739|FG000|Overall Study|Withdrawal by Subject|7|||
42293504|NCT02614703|76127740|FG001|Overall Study|Withdrawal by Subject|1|||
42075222|NCT00819585|75885502|FG005|Extension Study|Lost to Follow-up|0|||
42075223|NCT00819585|75885503|FG006|Extension Study|Lost to Follow-up|0|||
42075224|NCT00819585|75885504|FG007|Extension Study|Lost to Follow-up|0|||
42075225|NCT00819585|75885505|FG008|Extension Study|Lost to Follow-up|2|||
42075226|NCT00819585|75885506|FG009|Extension Study|Lost to Follow-up|1|||
42075227|NCT00819585|75885507|FG010|Extension Study|Lost to Follow-up|1|||
42075228|NCT00819585|75885497|FG000|Extension Study|Death|0|||
42075229|NCT00819585|75885498|FG001|Extension Study|Death|0|||
42075230|NCT00819585|75885499|FG002|Extension Study|Death|0|||
42075231|NCT00819585|75885500|FG003|Extension Study|Death|0|||
42075232|NCT00819585|75885501|FG004|Extension Study|Death|0|||
42075233|NCT00819585|75885502|FG005|Extension Study|Death|0|||
42075234|NCT00819585|75885503|FG006|Extension Study|Death|0|||
42075235|NCT00819585|75885504|FG007|Extension Study|Death|0|||
42075236|NCT00819585|75885505|FG008|Extension Study|Death|2|||
42075237|NCT00819585|75885506|FG009|Extension Study|Death|0|||
42075238|NCT00819585|75885507|FG010|Extension Study|Death|0|||
42075239|NCT00508261|75885539|FG000|Overall Study|Other|0|||
42075240|NCT00508261|75885540|FG001|Overall Study|Other|1|||
42075241|NCT00508261|75885541|FG002|Overall Study|Other|1|||
42075242|NCT00508261|75885542|FG003|Overall Study|Other|0|||
42075243|NCT00508261|75885539|FG000|Overall Study|Serious Adverse Event|0|||
42075244|NCT00508261|75885540|FG001|Overall Study|Serious Adverse Event|1|||
42075245|NCT00508261|75885541|FG002|Overall Study|Serious Adverse Event|0|||
42075246|NCT00508261|75885542|FG003|Overall Study|Serious Adverse Event|0|||
42075247|NCT00508261|75885539|FG000|Overall Study|Withdrawal by Subject|3|||
42075248|NCT00508261|75885540|FG001|Overall Study|Withdrawal by Subject|4|||
42075249|NCT00508261|75885541|FG002|Overall Study|Withdrawal by Subject|4|||
42075250|NCT00508261|75885542|FG003|Overall Study|Withdrawal by Subject|0|||
42075251|NCT00508261|75885539|FG000|Overall Study|Migrated/ moved from study area|0|||
42075252|NCT00508261|75885540|FG001|Overall Study|Migrated/ moved from study area|1|||
42075253|NCT00508261|75885541|FG002|Overall Study|Migrated/ moved from study area|0|||
42075254|NCT00508261|75885542|FG003|Overall Study|Migrated/ moved from study area|0|||
42075255|NCT00508261|75885539|FG000|Overall Study|Lost to Follow-up|0|||
42075256|NCT00508261|75885540|FG001|Overall Study|Lost to Follow-up|1|||
42075257|NCT00508261|75885541|FG002|Overall Study|Lost to Follow-up|1|||
42075258|NCT00508261|75885542|FG003|Overall Study|Lost to Follow-up|1|||
42075259|NCT00819039|75885581|FG000|Overall Study|Physician Decision|1|||
42075260|NCT00819039|75885582|FG001|Overall Study|Physician Decision|0|||
42075261|NCT00819039|75885583|FG002|Overall Study|Physician Decision|1|||
42075262|NCT00819039|75885581|FG000|Overall Study|Protocol Violation|1|||
42075263|NCT00819039|75885582|FG001|Overall Study|Protocol Violation|0|||
42075264|NCT00819039|75885583|FG002|Overall Study|Protocol Violation|0|||
42075265|NCT00500539|75885593|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
42075266|NCT00500539|75885593|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
42075267|NCT00500539|75885593|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
42075268|NCT00500539|75885593|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
42075269|NCT00500539|75885593|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
42075270|NCT00500539|75885593|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
42075271|NCT00500539|75885593|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
42075272|NCT00500539|75885593|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
42075273|NCT00500539|75885593|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
42075274|NCT00500539|75885593|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
42075275|NCT00500539|75885593|FG000|Follow-up Period (16 Weeks)|Death|1|||
42075276|NCT00500539|75885593|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
42075277|NCT00500539|75885593|FG000|Follow-up Period (16 Weeks)|Missing|3|||
42075278|NCT00818883|75885602|FG000|Overall Study|Adverse Event|28|||
42075279|NCT00818883|75885603|FG001|Overall Study|Adverse Event|19|||
42075280|NCT00818883|75885602|FG000|Overall Study|Protocol Violation|2|||
42075281|NCT00818883|75885603|FG001|Overall Study|Protocol Violation|2|||
42075282|NCT00818883|75885602|FG000|Overall Study|Lost to Follow-up|3|||
42075283|NCT00818883|75885603|FG001|Overall Study|Lost to Follow-up|2|||
42075284|NCT00818883|75885602|FG000|Overall Study|Withdrawal by Subject|16|||
42075285|NCT00818883|75885603|FG001|Overall Study|Withdrawal by Subject|14|||
42075286|NCT00818883|75885602|FG000|Overall Study|Lack of Efficacy|0|||
42075287|NCT00818883|75885603|FG001|Overall Study|Lack of Efficacy|2|||
42075288|NCT00818883|75885602|FG000|Overall Study|Other|2|||
42075289|NCT00818883|75885603|FG001|Overall Study|Other|7|||
42075290|NCT00508027|75885609|FG000|Dose Level 1|Lost to Follow-up|4|||
42075291|NCT00508027|75885609|FG000|Dose Level 1|Withdrawal by Subject|2|||
42075292|NCT00508027|75885609|FG000|Dose Level 1|Physician Decision|2|||
42075293|NCT00508027|75885609|FG000|Dose Level 2|Lost to Follow-up|2|||
42075294|NCT00508027|75885609|FG000|Dose Level 2|Withdrawal by Subject|2|||
42075295|NCT00500149|75885638|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
42075296|NCT00500149|75885639|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
42075297|NCT00500149|75885638|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
42075298|NCT00500149|75885639|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
42075299|NCT00500149|75885638|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
42075300|NCT00500149|75885639|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
42075301|NCT00500149|75885638|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
42075302|NCT00500149|75885639|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
42075303|NCT00500149|75885638|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
42075304|NCT00500149|75885639|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
42075305|NCT00500149|75885638|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
42075306|NCT00500149|75885639|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
42075307|NCT00500149|75885638|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
42075308|NCT00500149|75885639|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
42075309|NCT00489853|75885645|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
42075310|NCT00489853|75885646|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
42075311|NCT00489853|75885647|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
42075312|NCT00489853|75885645|FG000|Wash-out Period 1|Adverse Event|0|||
42075313|NCT00489853|75885646|FG001|Wash-out Period 1|Adverse Event|1|||
42075314|NCT00489853|75885647|FG002|Wash-out Period 1|Adverse Event|1|||
42075315|NCT00489853|75885645|FG000|Wash-out Period 1|Protocol Violation|0|||
42075316|NCT00489853|75885646|FG001|Wash-out Period 1|Protocol Violation|1|||
42075317|NCT00489853|75885647|FG002|Wash-out Period 1|Protocol Violation|1|||
42075318|NCT00489853|75885645|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
42075319|NCT00489853|75885646|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
42075320|NCT00489853|75885647|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
42075321|NCT00489853|75885645|FG000|Wash-out Period 2|Adverse Event|1|||
42075322|NCT00489853|75885646|FG001|Wash-out Period 2|Adverse Event|1|||
42075323|NCT00489853|75885647|FG002|Wash-out Period 2|Adverse Event|0|||
42075324|NCT00489853|75885645|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
42075325|NCT00489853|75885646|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
42293505|NCT01669343|76127746|FG000|Part A: All Patients|Withdrawal by Subject|7|||
42357796|NCT01877083|76203320|FG000|Treatment Phase|Clinical Progression|1|||
42357797|NCT01877083|76203320|FG000|Treatment Phase|Adverse Event|6|||
42357798|NCT01877083|76203320|FG000|Treatment Phase|Withdrawal by Subject|2|||
42357799|NCT01877083|76203320|FG000|Treatment Phase|Lost to Follow-up|1|||
42357800|NCT01877083|76203320|FG000|Extension Phase|Disease Progression|3|||
42357801|NCT01877083|76203320|FG000|Extension Phase|Adverse Event|2|||
42357802|NCT01380327|76203327|FG000|Overall Study|Lost to Follow-up|0|||
42357803|NCT01380327|76203328|FG001|Overall Study|Lost to Follow-up|1|||
42357804|NCT01380327|76203329|FG002|Overall Study|Lost to Follow-up|1|||
42357805|NCT01380327|76203327|FG000|Overall Study|Protocol Violation|3|||
42357806|NCT01380327|76203328|FG001|Overall Study|Protocol Violation|2|||
42357807|NCT01380327|76203329|FG002|Overall Study|Protocol Violation|3|||
42357808|NCT01380327|76203327|FG000|Overall Study|Withdrawal by Subject|0|||
42357809|NCT01380327|76203328|FG001|Overall Study|Withdrawal by Subject|0|||
42357810|NCT01380327|76203329|FG002|Overall Study|Withdrawal by Subject|1|||
42357811|NCT01380327|76203327|FG000|Overall Study|Housing situation precluded ability to k|0|||
42357812|NCT01380327|76203328|FG001|Overall Study|Housing situation precluded ability to k|0|||
42357813|NCT01380327|76203329|FG002|Overall Study|Housing situation precluded ability to k|1|||
42357814|NCT01380327|76203327|FG000|Overall Study|Questionable onset of epilepsy|0|||
42357815|NCT01380327|76203328|FG001|Overall Study|Questionable onset of epilepsy|0|||
42357816|NCT01380327|76203329|FG002|Overall Study|Questionable onset of epilepsy|1|||
42357817|NCT01829425|76203339|FG000|Overall Study|Withdrawal by Subject|4|||
42075326|NCT00489853|75885647|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
42075327|NCT00489853|75885645|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
42293506|NCT01669343|76127746|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
42293507|NCT01669343|76127746|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
42293508|NCT01669343|76127746|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
42293509|NCT01669343|76127746|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
42293510|NCT01594931|76127756|FG000|Overall Study|Adverse Event|3|||
42293511|NCT01594931|76127757|FG001|Overall Study|Adverse Event|1|||
42293512|NCT01594931|76127758|FG002|Overall Study|Adverse Event|1|||
42293513|NCT01594931|76127756|FG000|Overall Study|Withdrawal by Subject|2|||
42293514|NCT01594931|76127757|FG001|Overall Study|Withdrawal by Subject|1|||
42357818|NCT01829425|76203340|FG001|Overall Study|Withdrawal by Subject|3|||
42357819|NCT01829425|76203339|FG000|Overall Study|Lost to Follow-up|2|||
42357820|NCT01829425|76203340|FG001|Overall Study|Lost to Follow-up|1|||
42075328|NCT00489853|75885646|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
42075329|NCT00489853|75885647|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
42075330|NCT03686423|75885655|FG000|Overall Study|Withdrawal by Subject|9|||
42075331|NCT03686423|75885655|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
42075332|NCT00499681|75885661|FG000|Overall Study|toxicity|0|||
42075333|NCT00499681|75885662|FG001|Overall Study|toxicity|1|||
42075334|NCT00499681|75885661|FG000|Overall Study|disease progression|0|||
42075335|NCT00499681|75885662|FG001|Overall Study|disease progression|1|||
42075336|NCT00875810|75885673|FG000|Overall Study|Withdrawal by Subject|1|||
42075337|NCT00875810|75885673|FG000|Overall Study|Physician Decision|3|||
42075338|NCT00875810|75885673|FG000|Overall Study|Lost to Follow-up|39|||
42075339|NCT00875810|75885673|FG000|Overall Study|Patient enroled but not implanted|2|||
42075340|NCT00875810|75885673|FG000|Overall Study|Device explanted|1|||
42075341|NCT00499603|75885679|FG000|Overall Study|Adverse Event|0|||
42075342|NCT00499603|75885680|FG001|Overall Study|Adverse Event|1|||
42075343|NCT00810069|75885699|FG000|Lead-in Period I|Adverse Event|43|||
42075344|NCT00810069|75885700|FG001|Lead-in Period I|Adverse Event|0|||
42075345|NCT00810069|75885701|FG002|Lead-in Period I|Adverse Event|0|||
42075346|NCT00810069|75885699|FG000|Lead-in Period I|Lack of Efficacy|1|||
42075347|NCT00810069|75885700|FG001|Lead-in Period I|Lack of Efficacy|0|||
42075348|NCT00810069|75885701|FG002|Lead-in Period I|Lack of Efficacy|0|||
42075349|NCT00810069|75885699|FG000|Lead-in Period I|Lost to Follow-up|19|||
42075350|NCT00810069|75885700|FG001|Lead-in Period I|Lost to Follow-up|0|||
42075351|NCT00810069|75885701|FG002|Lead-in Period I|Lost to Follow-up|0|||
42075352|NCT00810069|75885699|FG000|Lead-in Period I|Physician Decision|1|||
42075353|NCT00810069|75885700|FG001|Lead-in Period I|Physician Decision|0|||
42075354|NCT00810069|75885701|FG002|Lead-in Period I|Physician Decision|0|||
42075355|NCT00810069|75885699|FG000|Lead-in Period I|Protocol Violation|1|||
42075356|NCT00810069|75885700|FG001|Lead-in Period I|Protocol Violation|0|||
42075357|NCT00810069|75885701|FG002|Lead-in Period I|Protocol Violation|0|||
42075358|NCT00810069|75885699|FG000|Lead-in Period I|Withdrawal by Subject|46|||
42075359|NCT00810069|75885700|FG001|Lead-in Period I|Withdrawal by Subject|0|||
42075360|NCT00810069|75885701|FG002|Lead-in Period I|Withdrawal by Subject|0|||
42075361|NCT00810069|75885699|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
42075362|NCT00810069|75885700|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
42075363|NCT00810069|75885701|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
42075364|NCT00810069|75885699|FG000|Lead-in Period I|Randomization criteria not met|158|||
42075365|NCT00810069|75885700|FG001|Lead-in Period I|Randomization criteria not met|0|||
42075366|NCT00810069|75885701|FG002|Lead-in Period I|Randomization criteria not met|0|||
42075367|NCT00810069|75885699|FG000|Double-Blind Period II|Adverse Event|0|||
42075368|NCT00810069|75885700|FG001|Double-Blind Period II|Adverse Event|9|||
42075369|NCT00810069|75885701|FG002|Double-Blind Period II|Adverse Event|8|||
42075370|NCT00810069|75885699|FG000|Double-Blind Period II|Lack of Efficacy|0|||
42075371|NCT00810069|75885700|FG001|Double-Blind Period II|Lack of Efficacy|7|||
42075372|NCT00810069|75885701|FG002|Double-Blind Period II|Lack of Efficacy|12|||
42075373|NCT00810069|75885699|FG000|Double-Blind Period II|Lost to Follow-up|0|||
42075374|NCT00810069|75885700|FG001|Double-Blind Period II|Lost to Follow-up|9|||
42075375|NCT00810069|75885701|FG002|Double-Blind Period II|Lost to Follow-up|9|||
42075376|NCT00810069|75885699|FG000|Double-Blind Period II|Physician Decision|0|||
42075377|NCT00810069|75885700|FG001|Double-Blind Period II|Physician Decision|0|||
42075378|NCT00810069|75885701|FG002|Double-Blind Period II|Physician Decision|1|||
42075379|NCT00810069|75885699|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
42075380|NCT00810069|75885700|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
42075381|NCT00810069|75885701|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
42075382|NCT00810069|75885699|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
42075383|NCT00810069|75885700|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
42075384|NCT00810069|75885701|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
42075385|NCT00810069|75885699|FG000|Double-Blind Period II|Clinical relapse|0|||
42075386|NCT00810069|75885700|FG001|Double-Blind Period II|Clinical relapse|3|||
42177695|NCT00654628|75984931|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
42177696|NCT00654628|75984931|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
42177697|NCT00654628|75984931|FG000|6-week Active Treatment Period|Out of window period|1|||
42075387|NCT00810069|75885701|FG002|Double-Blind Period II|Clinical relapse|0|||
42075388|NCT00810069|75885699|FG000|Double-Blind Period II|Protocol Violation|0|||
42075389|NCT00810069|75885700|FG001|Double-Blind Period II|Protocol Violation|7|||
42075390|NCT00810069|75885701|FG002|Double-Blind Period II|Protocol Violation|6|||
42177698|NCT00654628|75984931|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
42177699|NCT00654628|75984931|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
42177700|NCT00536380|75984938|FG000|Overall Study|Adverse Event|0|||
42075391|NCT00489541|75885712|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
42357821|NCT01394991|76203357|FG000|Overall Study|Adverse Event|0|||
42075392|NCT00489541|75885713|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
42075393|NCT00489541|75885712|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
42177701|NCT00536380|75984939|FG001|Overall Study|Adverse Event|2|||
42075394|NCT00489541|75885713|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
42075395|NCT00489541|75885712|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
42075396|NCT00489541|75885713|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
42075397|NCT00489541|75885712|FG000|12-Month Clinical Follow-up|Death|3|||
42075398|NCT00489541|75885713|FG001|12-Month Clinical Follow-up|Death|2|||
42075399|NCT00489541|75885712|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
42075400|NCT00489541|75885713|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
42075401|NCT00489541|75885712|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
42075402|NCT00489541|75885713|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
42075403|NCT00809835|75885723|FG000|Overall Study|Lost to Follow-up|7|||
42075404|NCT00809835|75885724|FG001|Overall Study|Lost to Follow-up|6|||
42075405|NCT00809835|75885725|FG002|Overall Study|Lost to Follow-up|10|||
42075406|NCT00809835|75885726|FG003|Overall Study|Lost to Follow-up|2|||
42075407|NCT00809835|75885723|FG000|Overall Study|Withdrawal by Subject|1|||
42075408|NCT00809835|75885724|FG001|Overall Study|Withdrawal by Subject|1|||
42075409|NCT00809835|75885725|FG002|Overall Study|Withdrawal by Subject|1|||
42075410|NCT00809835|75885726|FG003|Overall Study|Withdrawal by Subject|0|||
42075411|NCT00853242|75885743|FG000|Overall Study|Adverse Event|0|||
42075412|NCT00853242|75885744|FG001|Overall Study|Adverse Event|1|||
42075413|NCT00853242|75885745|FG002|Overall Study|Adverse Event|1|||
42075414|NCT00853242|75885746|FG003|Overall Study|Adverse Event|0|||
42075415|NCT00853242|75885747|FG004|Overall Study|Adverse Event|3|||
42075416|NCT00853242|75885748|FG005|Overall Study|Adverse Event|1|||
42075417|NCT00853242|75885749|FG006|Overall Study|Adverse Event|1|||
42075418|NCT00853242|75885743|FG000|Overall Study|Noncompliant|0|||
42075419|NCT00853242|75885744|FG001|Overall Study|Noncompliant|0|||
42075420|NCT00853242|75885745|FG002|Overall Study|Noncompliant|0|||
42075421|NCT00853242|75885746|FG003|Overall Study|Noncompliant|0|||
42075422|NCT00853242|75885747|FG004|Overall Study|Noncompliant|1|||
42075423|NCT00853242|75885748|FG005|Overall Study|Noncompliant|0|||
42075424|NCT00853242|75885749|FG006|Overall Study|Noncompliant|0|||
42075425|NCT00853242|75885743|FG000|Overall Study|Withdrawal by Subject|1|||
42075426|NCT00853242|75885744|FG001|Overall Study|Withdrawal by Subject|2|||
42075427|NCT00853242|75885745|FG002|Overall Study|Withdrawal by Subject|0|||
42075428|NCT00853242|75885746|FG003|Overall Study|Withdrawal by Subject|4|||
42075429|NCT00853242|75885747|FG004|Overall Study|Withdrawal by Subject|0|||
42075430|NCT00853242|75885748|FG005|Overall Study|Withdrawal by Subject|0|||
42075431|NCT00853242|75885749|FG006|Overall Study|Withdrawal by Subject|2|||
42075432|NCT00853242|75885743|FG000|Overall Study|Other|2|||
42075433|NCT00853242|75885744|FG001|Overall Study|Other|0|||
42075434|NCT00853242|75885745|FG002|Overall Study|Other|2|||
42075435|NCT00853242|75885746|FG003|Overall Study|Other|0|||
42075436|NCT00853242|75885747|FG004|Overall Study|Other|0|||
42075437|NCT00853242|75885748|FG005|Overall Study|Other|1|||
42075438|NCT00853242|75885749|FG006|Overall Study|Other|2|||
42075439|NCT00848250|75885773|FG000|Overall Study|surgery was completed without cardiopulm|0|||
42075440|NCT00848250|75885774|FG001|Overall Study|surgery was completed without cardiopulm|1|||
42075441|NCT00809757|75885784|FG000|Overall Study|Adverse Event|2|||
42075442|NCT00809757|75885785|FG001|Overall Study|Adverse Event|3|||
42075443|NCT00809757|75885786|FG002|Overall Study|Adverse Event|3|||
42075444|NCT00809757|75885784|FG000|Overall Study|Lost to Follow-up|0|||
42075445|NCT00809757|75885785|FG001|Overall Study|Lost to Follow-up|0|||
42075446|NCT00809757|75885786|FG002|Overall Study|Lost to Follow-up|1|||
42075447|NCT00809757|75885784|FG000|Overall Study|Protocol Violation|1|||
42075448|NCT00809757|75885785|FG001|Overall Study|Protocol Violation|1|||
42293515|NCT01594931|76127758|FG002|Overall Study|Withdrawal by Subject|1|||
42293516|NCT01594931|76127756|FG000|Overall Study|Lack of Efficacy|7|||
42075449|NCT00809757|75885786|FG002|Overall Study|Protocol Violation|1|||
42075450|NCT00809757|75885784|FG000|Overall Study|Withdrawal by Subject|2|||
42075451|NCT00809757|75885785|FG001|Overall Study|Withdrawal by Subject|1|||
42075452|NCT00809757|75885786|FG002|Overall Study|Withdrawal by Subject|3|||
42075453|NCT00809757|75885784|FG000|Overall Study|Subject Uncooperative|1|||
42075454|NCT00809757|75885785|FG001|Overall Study|Subject Uncooperative|0|||
42075455|NCT00809757|75885786|FG002|Overall Study|Subject Uncooperative|2|||
42075456|NCT00809757|75885784|FG000|Overall Study|Noncompliance with Medication|0|||
42075457|NCT00809757|75885785|FG001|Overall Study|Noncompliance with Medication|0|||
42075458|NCT00809757|75885786|FG002|Overall Study|Noncompliance with Medication|1|||
42075459|NCT00594464|75885800|FG000|Overall Study|Withdrawal by Subject|1|||
42075460|NCT00594464|75885800|FG000|Overall Study|Delay in operation|2|||
42075461|NCT00809445|75885813|FG000|1 Month Follow-up|Lost contact|1|||
42075462|NCT00809445|75885814|FG001|1 Month Follow-up|Lost contact|2|||
42177702|NCT00536380|75984940|FG002|Overall Study|Adverse Event|2|||
42177703|NCT00536380|75984938|FG000|Overall Study|Lost to Follow-up|0|||
42075463|NCT00809445|75885815|FG002|1 Month Follow-up|Lost contact|1|||
42177704|NCT00536380|75984939|FG001|Overall Study|Lost to Follow-up|0|||
42177705|NCT00536380|75984940|FG002|Overall Study|Lost to Follow-up|1|||
42293517|NCT01594931|76127757|FG001|Overall Study|Lack of Efficacy|2|||
42075464|NCT00809445|75885813|FG000|1 Month Follow-up|Withdrew consent|1|||
42075465|NCT00809445|75885814|FG001|1 Month Follow-up|Withdrew consent|1|||
42075466|NCT00809445|75885815|FG002|1 Month Follow-up|Withdrew consent|1|||
42075467|NCT00809445|75885813|FG000|1 Month Follow-up|Death|0|||
42075468|NCT00809445|75885814|FG001|1 Month Follow-up|Death|1|||
42075469|NCT00809445|75885815|FG002|1 Month Follow-up|Death|1|||
42075470|NCT00809445|75885813|FG000|1 Month Follow-up|Incarcerated|0|||
42075471|NCT00809445|75885814|FG001|1 Month Follow-up|Incarcerated|0|||
42075472|NCT00809445|75885815|FG002|1 Month Follow-up|Incarcerated|1|||
42075473|NCT00809445|75885813|FG000|6 Month Follow-up|Lost contact|16|||
42075474|NCT00809445|75885814|FG001|6 Month Follow-up|Lost contact|14|||
42075475|NCT00809445|75885815|FG002|6 Month Follow-up|Lost contact|14|||
42075476|NCT00809445|75885813|FG000|6 Month Follow-up|Death|2|||
42075477|NCT00809445|75885814|FG001|6 Month Follow-up|Death|1|||
42075478|NCT00809445|75885815|FG002|6 Month Follow-up|Death|1|||
42075479|NCT00809445|75885813|FG000|6 Month Follow-up|Incarcerated|6|||
42075480|NCT00809445|75885814|FG001|6 Month Follow-up|Incarcerated|8|||
42075481|NCT00809445|75885815|FG002|6 Month Follow-up|Incarcerated|8|||
42075482|NCT00809445|75885813|FG000|6 Month Follow-up|Withdrew consent|0|||
42075483|NCT00809445|75885814|FG001|6 Month Follow-up|Withdrew consent|0|||
42075484|NCT00809445|75885815|FG002|6 Month Follow-up|Withdrew consent|1|||
42075485|NCT00593918|75885838|FG000|Overall Study|Withdrawal by Subject|5|||
42075486|NCT00593918|75885839|FG001|Overall Study|Withdrawal by Subject|24|||
42075487|NCT04135196|75885850|FG000|Overall Study|Lost to Follow-up|8|||
42075488|NCT04135196|75885851|FG001|Overall Study|Lost to Follow-up|7|||
42075489|NCT04135196|75885852|FG002|Overall Study|Lost to Follow-up|8|||
42075490|NCT04135196|75885853|FG003|Overall Study|Lost to Follow-up|9|||
42075491|NCT04135196|75885854|FG004|Overall Study|Lost to Follow-up|1|||
42075492|NCT04135196|75885850|FG000|Overall Study|Pregnancy|0|||
42075493|NCT04135196|75885851|FG001|Overall Study|Pregnancy|0|||
42075494|NCT04135196|75885852|FG002|Overall Study|Pregnancy|1|||
42075495|NCT04135196|75885853|FG003|Overall Study|Pregnancy|0|||
42075496|NCT04135196|75885854|FG004|Overall Study|Pregnancy|0|||
42075497|NCT04135196|75885850|FG000|Overall Study|Withdrawal by Subject|0|||
42075498|NCT04135196|75885851|FG001|Overall Study|Withdrawal by Subject|0|||
42075499|NCT04135196|75885852|FG002|Overall Study|Withdrawal by Subject|0|||
42075500|NCT04135196|75885853|FG003|Overall Study|Withdrawal by Subject|0|||
42075501|NCT04135196|75885854|FG004|Overall Study|Withdrawal by Subject|1|||
42075502|NCT00499369|75885871|FG000|Overall Study|Adverse Event|2|||
42075503|NCT00499369|75885872|FG001|Overall Study|Adverse Event|2|||
42075504|NCT00499369|75885873|FG002|Overall Study|Adverse Event|3|||
42075505|NCT00499369|75885874|FG003|Overall Study|Adverse Event|1|||
42075506|NCT00499369|75885875|FG004|Overall Study|Adverse Event|2|||
42075507|NCT00499369|75885871|FG000|Overall Study|Withdrawal by Subject|0|||
42075508|NCT00499369|75885872|FG001|Overall Study|Withdrawal by Subject|1|||
42075509|NCT00499369|75885873|FG002|Overall Study|Withdrawal by Subject|1|||
42075510|NCT00499369|75885874|FG003|Overall Study|Withdrawal by Subject|0|||
42075511|NCT00499369|75885875|FG004|Overall Study|Withdrawal by Subject|0|||
42075512|NCT00499369|75885871|FG000|Overall Study|Progression|10|||
42075513|NCT00499369|75885872|FG001|Overall Study|Progression|12|||
42075514|NCT00499369|75885873|FG002|Overall Study|Progression|9|||
42075515|NCT00499369|75885874|FG003|Overall Study|Progression|6|||
42075516|NCT00499369|75885875|FG004|Overall Study|Progression|10|||
42075517|NCT00499369|75885871|FG000|Overall Study|Death|0|||
42075518|NCT00499369|75885872|FG001|Overall Study|Death|1|||
42075519|NCT00499369|75885873|FG002|Overall Study|Death|0|||
42075520|NCT00499369|75885874|FG003|Overall Study|Death|0|||
42075521|NCT00499369|75885875|FG004|Overall Study|Death|0|||
42075522|NCT00499369|75885871|FG000|Overall Study|Not protocol specified|2|||
42075523|NCT00499369|75885872|FG001|Overall Study|Not protocol specified|0|||
42075524|NCT00499369|75885873|FG002|Overall Study|Not protocol specified|3|||
42075525|NCT00499369|75885874|FG003|Overall Study|Not protocol specified|1|||
42075526|NCT00499369|75885875|FG004|Overall Study|Not protocol specified|0|||
42075527|NCT00499369|75885871|FG000|Overall Study|Ineligible|2|||
42075528|NCT00499369|75885872|FG001|Overall Study|Ineligible|2|||
42075529|NCT00499369|75885873|FG002|Overall Study|Ineligible|1|||
42075530|NCT00499369|75885874|FG003|Overall Study|Ineligible|1|||
42075531|NCT00499369|75885875|FG004|Overall Study|Ineligible|0|||
42075532|NCT00869258|75885887|FG000|Overall Study|Physician Decision|1|||
42177706|NCT00536380|75984938|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
42075533|NCT00693784|75885891|FG000|Overall Study|Lost to Follow-up|2|||
42075534|NCT00693784|75885891|FG000|Overall Study|Withdrawal by Subject|2|||
42075535|NCT00693706|75885897|FG000|Overall Study|Protocol Violation|0|||
42075536|NCT00693706|75885898|FG001|Overall Study|Protocol Violation|1|||
42075537|NCT00488683|75885907|FG000|Overall Study|Withdrawal by Subject|1|||
42075538|NCT00488683|75885908|FG001|Overall Study|Withdrawal by Subject|2|||
42075539|NCT00488683|75885909|FG002|Overall Study|Withdrawal by Subject|2|||
42075540|NCT00488683|75885907|FG000|Overall Study|Lost to Follow-up|5|||
42075541|NCT00488683|75885908|FG001|Overall Study|Lost to Follow-up|3|||
42075542|NCT00488683|75885909|FG002|Overall Study|Lost to Follow-up|0|||
42075543|NCT00488683|75885907|FG000|Overall Study|Protocol Violation|5|||
42075544|NCT00488683|75885908|FG001|Overall Study|Protocol Violation|1|||
42075545|NCT00488683|75885909|FG002|Overall Study|Protocol Violation|0|||
42075546|NCT00488683|75885907|FG000|Overall Study|Unable to Classify|1|||
42075547|NCT00488683|75885908|FG001|Overall Study|Unable to Classify|0|||
42075548|NCT00488683|75885909|FG002|Overall Study|Unable to Classify|0|||
42075549|NCT00693472|75885943|FG000|Part 1|Adverse Event|1|||
42075550|NCT00693472|75885944|FG001|Part 1|Adverse Event|1|||
42075551|NCT00693472|75885945|FG002|Part 1|Adverse Event|0|||
42075552|NCT00693472|75885946|FG003|Part 1|Adverse Event|0|||
42075553|NCT00693472|75885943|FG000|Part 1|Lost to Follow-up|0|||
42075554|NCT00693472|75885944|FG001|Part 1|Lost to Follow-up|1|||
42075555|NCT00693472|75885945|FG002|Part 1|Lost to Follow-up|0|||
42075556|NCT00693472|75885946|FG003|Part 1|Lost to Follow-up|0|||
42075557|NCT00693472|75885943|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
42075558|NCT00693472|75885944|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
42075559|NCT00693472|75885945|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
42075560|NCT00693472|75885946|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
42075561|NCT00693472|75885943|FG000|Part 2|Adverse Event|0|||
42075562|NCT00693472|75885944|FG001|Part 2|Adverse Event|0|||
42075563|NCT00693472|75885945|FG002|Part 2|Adverse Event|1|||
42075564|NCT00693472|75885946|FG003|Part 2|Adverse Event|0|||
42075565|NCT00693472|75885943|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
42075566|NCT00693472|75885944|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
42075567|NCT00693472|75885945|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
42075568|NCT00693472|75885946|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
42075569|NCT00498433|75885959|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
42075570|NCT00498433|75885960|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
42075571|NCT00498433|75885961|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
42075572|NCT00498433|75885959|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
42075573|NCT00498433|75885960|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
42075574|NCT00498433|75885961|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
42075575|NCT00498433|75885959|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
42075576|NCT00498433|75885960|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
42075577|NCT00498433|75885961|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
42075578|NCT00498433|75885959|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
42075579|NCT00498433|75885960|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
42075580|NCT00498433|75885961|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
42075581|NCT00498355|75885978|FG000|Overall Study|Lost to Follow-up|1|||
42075582|NCT04327271|75885985|FG000|Overall Study|Death|1|||
42075583|NCT04327271|75885986|FG001|Overall Study|Death|0|||
42075584|NCT04327271|75885985|FG000|Overall Study|Withdrawal by Subject|1|||
42075585|NCT04327271|75885986|FG001|Overall Study|Withdrawal by Subject|0|||
42075586|NCT04327271|75885985|FG000|Overall Study|randomization error (data capture)|4|||
42075587|NCT04327271|75885986|FG001|Overall Study|randomization error (data capture)|3|||
42075588|NCT00688636|75886003|FG000|Overall Study|Adverse Event|2|||
42075589|NCT00688636|75886004|FG001|Overall Study|Adverse Event|1|||
42075590|NCT00870740|75886016|FG000|Overall Study|Adverse Event|2|||
42075591|NCT00870740|75886017|FG001|Overall Study|Adverse Event|1|||
42075592|NCT00870740|75886018|FG002|Overall Study|Adverse Event|3|||
42075593|NCT00870740|75886019|FG003|Overall Study|Adverse Event|2|||
42075594|NCT00870740|75886020|FG004|Overall Study|Adverse Event|1|||
42075595|NCT00870740|75886021|FG005|Overall Study|Adverse Event|6|||
42075596|NCT00870740|75886016|FG000|Overall Study|Consent Withdrawn|6|||
42075597|NCT00870740|75886017|FG001|Overall Study|Consent Withdrawn|3|||
42075598|NCT00870740|75886018|FG002|Overall Study|Consent Withdrawn|4|||
42075599|NCT00870740|75886019|FG003|Overall Study|Consent Withdrawn|6|||
42075600|NCT00870740|75886020|FG004|Overall Study|Consent Withdrawn|6|||
42075601|NCT00870740|75886021|FG005|Overall Study|Consent Withdrawn|5|||
42075602|NCT00870740|75886016|FG000|Overall Study|Investigator Decision|2|||
42075603|NCT00870740|75886017|FG001|Overall Study|Investigator Decision|0|||
42075604|NCT00870740|75886018|FG002|Overall Study|Investigator Decision|1|||
42075605|NCT00870740|75886019|FG003|Overall Study|Investigator Decision|0|||
42075606|NCT00870740|75886020|FG004|Overall Study|Investigator Decision|0|||
42075607|NCT00870740|75886021|FG005|Overall Study|Investigator Decision|0|||
42075608|NCT00870740|75886016|FG000|Overall Study|Subject Non-compliance|0|||
42075609|NCT00870740|75886017|FG001|Overall Study|Subject Non-compliance|0|||
42075610|NCT00870740|75886018|FG002|Overall Study|Subject Non-compliance|0|||
42177707|NCT00536380|75984939|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
42177708|NCT00536380|75984940|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
42075611|NCT00870740|75886019|FG003|Overall Study|Subject Non-compliance|0|||
42177709|NCT00536380|75984938|FG000|Overall Study|Withdrawal related to study drug|7|||
42075612|NCT00870740|75886020|FG004|Overall Study|Subject Non-compliance|0|||
42075613|NCT00870740|75886021|FG005|Overall Study|Subject Non-compliance|1|||
42075614|NCT00870740|75886016|FG000|Overall Study|Death|0|||
42075615|NCT00870740|75886017|FG001|Overall Study|Death|0|||
42075616|NCT00870740|75886018|FG002|Overall Study|Death|0|||
42075617|NCT00870740|75886019|FG003|Overall Study|Death|0|||
42075618|NCT00870740|75886020|FG004|Overall Study|Death|1|||
42075619|NCT00870740|75886021|FG005|Overall Study|Death|0|||
42075620|NCT00870740|75886016|FG000|Overall Study|Other|2|||
42075621|NCT00870740|75886017|FG001|Overall Study|Other|5|||
42075622|NCT00870740|75886018|FG002|Overall Study|Other|2|||
42075623|NCT00870740|75886019|FG003|Overall Study|Other|4|||
42075624|NCT00870740|75886020|FG004|Overall Study|Other|3|||
42075625|NCT00870740|75886021|FG005|Overall Study|Other|5|||
42075626|NCT00869024|75886048|FG000|Overall Study|Death|2|||
42075627|NCT00869024|75886049|FG001|Overall Study|Death|3|||
42075628|NCT00869024|75886048|FG000|Overall Study|Lost to Follow-up|0|||
42075629|NCT00869024|75886049|FG001|Overall Study|Lost to Follow-up|1|||
42075630|NCT00869024|75886048|FG000|Overall Study|Protocol Violation|0|||
42075631|NCT00869024|75886049|FG001|Overall Study|Protocol Violation|1|||
42075632|NCT00506779|75886057|FG000|Overall Study|Withdrawal by Subject|1|||
42075633|NCT00506779|75886058|FG001|Overall Study|Withdrawal by Subject|0|||
42075634|NCT00506779|75886059|FG002|Overall Study|Withdrawal by Subject|1|||
42075635|NCT00506779|75886060|FG003|Overall Study|Withdrawal by Subject|0|||
42075636|NCT00506779|75886057|FG000|Overall Study|Adverse Event|0|||
42075637|NCT00506779|75886058|FG001|Overall Study|Adverse Event|1|||
42075638|NCT00506779|75886059|FG002|Overall Study|Adverse Event|1|||
42075639|NCT00506779|75886060|FG003|Overall Study|Adverse Event|1|||
42075640|NCT00488293|75886073|FG000|Overall Study|Lost to Follow-up|28|||
42075641|NCT00488293|75886074|FG001|Overall Study|Lost to Follow-up|25|||
42075642|NCT00488293|75886073|FG000|Overall Study|Withdrawal by Subject|5|||
42075643|NCT00488293|75886074|FG001|Overall Study|Withdrawal by Subject|3|||
42075644|NCT00488293|75886073|FG000|Overall Study|Death|2|||
42075645|NCT00488293|75886074|FG001|Overall Study|Death|1|||
42075646|NCT00488293|75886073|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
42075647|NCT00488293|75886074|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
42075648|NCT00868790|75886080|FG000|Period 1|Adverse Event|1|||
42075649|NCT00868790|75886081|FG001|Period 1|Adverse Event|0|||
42075650|NCT00868790|75886082|FG002|Period 1|Adverse Event|0|||
42075651|NCT00868790|75886083|FG003|Period 1|Adverse Event|0|||
42075652|NCT00868790|75886084|FG004|Period 1|Adverse Event|0|||
42075653|NCT00868790|75886085|FG005|Period 1|Adverse Event|0|||
42075654|NCT00868790|75886086|FG006|Period 1|Adverse Event|0|||
42075655|NCT00868790|75886087|FG007|Period 1|Adverse Event|3|||
42075656|NCT00868790|75886088|FG008|Period 1|Adverse Event|1|||
42075657|NCT00868790|75886089|FG009|Period 1|Adverse Event|0|||
42075658|NCT00868790|75886090|FG010|Period 1|Adverse Event|0|||
42075659|NCT00868790|75886091|FG011|Period 1|Adverse Event|0|||
42075660|NCT00868790|75886092|FG012|Period 1|Adverse Event|0|||
42075661|NCT00868790|75886093|FG013|Period 1|Adverse Event|1|||
42075662|NCT00868790|75886080|FG000|Period 1|Protocol Violation|1|||
42075663|NCT00868790|75886081|FG001|Period 1|Protocol Violation|0|||
42075664|NCT00868790|75886082|FG002|Period 1|Protocol Violation|0|||
42075665|NCT00868790|75886083|FG003|Period 1|Protocol Violation|0|||
42075666|NCT00868790|75886084|FG004|Period 1|Protocol Violation|0|||
42075667|NCT00868790|75886085|FG005|Period 1|Protocol Violation|0|||
42075668|NCT00868790|75886086|FG006|Period 1|Protocol Violation|0|||
42075669|NCT00868790|75886087|FG007|Period 1|Protocol Violation|0|||
42075670|NCT00868790|75886088|FG008|Period 1|Protocol Violation|0|||
42075671|NCT00868790|75886089|FG009|Period 1|Protocol Violation|0|||
42075672|NCT00868790|75886090|FG010|Period 1|Protocol Violation|0|||
42075673|NCT00868790|75886091|FG011|Period 1|Protocol Violation|0|||
42177710|NCT00536380|75984939|FG001|Overall Study|Withdrawal related to study drug|5|||
42177711|NCT00536380|75984940|FG002|Overall Study|Withdrawal related to study drug|2|||
42293518|NCT01594931|76127758|FG002|Overall Study|Lack of Efficacy|2|||
42075674|NCT00868790|75886092|FG012|Period 1|Protocol Violation|0|||
42075675|NCT00868790|75886093|FG013|Period 1|Protocol Violation|0|||
42075676|NCT00868790|75886080|FG000|Period 1|Withdrawal by Subject|0|||
42075677|NCT00868790|75886081|FG001|Period 1|Withdrawal by Subject|1|||
42075678|NCT00868790|75886082|FG002|Period 1|Withdrawal by Subject|0|||
42075679|NCT00868790|75886083|FG003|Period 1|Withdrawal by Subject|0|||
42075680|NCT00868790|75886084|FG004|Period 1|Withdrawal by Subject|0|||
42075681|NCT00868790|75886085|FG005|Period 1|Withdrawal by Subject|0|||
42075682|NCT00868790|75886086|FG006|Period 1|Withdrawal by Subject|0|||
42075683|NCT00868790|75886087|FG007|Period 1|Withdrawal by Subject|0|||
42075684|NCT00868790|75886088|FG008|Period 1|Withdrawal by Subject|0|||
42075685|NCT00868790|75886089|FG009|Period 1|Withdrawal by Subject|0|||
42075686|NCT00868790|75886090|FG010|Period 1|Withdrawal by Subject|0|||
42075687|NCT00868790|75886091|FG011|Period 1|Withdrawal by Subject|0|||
42075688|NCT00868790|75886092|FG012|Period 1|Withdrawal by Subject|0|||
42075689|NCT00868790|75886093|FG013|Period 1|Withdrawal by Subject|1|||
42177712|NCT00536380|75984938|FG000|Overall Study|Noncompliance with protocol|3|||
42075690|NCT00868790|75886080|FG000|Period 1|Abnormal Triglycerides|0|||
42075691|NCT00868790|75886081|FG001|Period 1|Abnormal Triglycerides|0|||
42075692|NCT00868790|75886082|FG002|Period 1|Abnormal Triglycerides|0|||
42075693|NCT00868790|75886083|FG003|Period 1|Abnormal Triglycerides|0|||
42075694|NCT00868790|75886084|FG004|Period 1|Abnormal Triglycerides|1|||
42075695|NCT00868790|75886085|FG005|Period 1|Abnormal Triglycerides|0|||
42075696|NCT00868790|75886086|FG006|Period 1|Abnormal Triglycerides|0|||
42075697|NCT00868790|75886087|FG007|Period 1|Abnormal Triglycerides|0|||
42075698|NCT00868790|75886088|FG008|Period 1|Abnormal Triglycerides|0|||
42075699|NCT00868790|75886089|FG009|Period 1|Abnormal Triglycerides|0|||
42075700|NCT00868790|75886090|FG010|Period 1|Abnormal Triglycerides|0|||
42075701|NCT00868790|75886091|FG011|Period 1|Abnormal Triglycerides|0|||
42075702|NCT00868790|75886092|FG012|Period 1|Abnormal Triglycerides|0|||
42075703|NCT00868790|75886093|FG013|Period 1|Abnormal Triglycerides|0|||
42075704|NCT00868790|75886080|FG000|Period 1|Lost to Follow-up|0|||
42075705|NCT00868790|75886081|FG001|Period 1|Lost to Follow-up|0|||
42075706|NCT00868790|75886082|FG002|Period 1|Lost to Follow-up|0|||
42075707|NCT00868790|75886083|FG003|Period 1|Lost to Follow-up|0|||
42075708|NCT00868790|75886084|FG004|Period 1|Lost to Follow-up|0|||
42075709|NCT00868790|75886085|FG005|Period 1|Lost to Follow-up|1|||
42075710|NCT00868790|75886086|FG006|Period 1|Lost to Follow-up|0|||
42075711|NCT00868790|75886087|FG007|Period 1|Lost to Follow-up|0|||
42075712|NCT00868790|75886088|FG008|Period 1|Lost to Follow-up|0|||
42075713|NCT00868790|75886089|FG009|Period 1|Lost to Follow-up|0|||
42075714|NCT00868790|75886090|FG010|Period 1|Lost to Follow-up|0|||
42075715|NCT00868790|75886091|FG011|Period 1|Lost to Follow-up|0|||
42075716|NCT00868790|75886092|FG012|Period 1|Lost to Follow-up|0|||
42075717|NCT00868790|75886093|FG013|Period 1|Lost to Follow-up|0|||
42075718|NCT00868790|75886080|FG000|Period 2|Adverse Event|0|||
42075719|NCT00868790|75886081|FG001|Period 2|Adverse Event|0|||
42075720|NCT00868790|75886082|FG002|Period 2|Adverse Event|0|||
42075721|NCT00868790|75886083|FG003|Period 2|Adverse Event|0|||
42075722|NCT00868790|75886084|FG004|Period 2|Adverse Event|0|||
42075723|NCT00868790|75886085|FG005|Period 2|Adverse Event|0|||
42075724|NCT00868790|75886086|FG006|Period 2|Adverse Event|0|||
42075725|NCT00868790|75886087|FG007|Period 2|Adverse Event|0|||
42075726|NCT00868790|75886088|FG008|Period 2|Adverse Event|1|||
42075727|NCT00868790|75886089|FG009|Period 2|Adverse Event|0|||
42075728|NCT00868790|75886090|FG010|Period 2|Adverse Event|0|||
42075729|NCT00868790|75886091|FG011|Period 2|Adverse Event|0|||
42075730|NCT00868790|75886092|FG012|Period 2|Adverse Event|0|||
42075731|NCT00868790|75886093|FG013|Period 2|Adverse Event|0|||
42075732|NCT00868790|75886080|FG000|Period 2|Lost to Follow-up|0|||
42075733|NCT00868790|75886081|FG001|Period 2|Lost to Follow-up|1|||
42075734|NCT00868790|75886082|FG002|Period 2|Lost to Follow-up|0|||
42075735|NCT00868790|75886083|FG003|Period 2|Lost to Follow-up|0|||
42075736|NCT00868790|75886084|FG004|Period 2|Lost to Follow-up|0|||
42075737|NCT00868790|75886085|FG005|Period 2|Lost to Follow-up|1|||
42075738|NCT00868790|75886086|FG006|Period 2|Lost to Follow-up|0|||
42075739|NCT00868790|75886087|FG007|Period 2|Lost to Follow-up|0|||
42075740|NCT00868790|75886088|FG008|Period 2|Lost to Follow-up|0|||
42075741|NCT00868790|75886089|FG009|Period 2|Lost to Follow-up|0|||
42075742|NCT00868790|75886090|FG010|Period 2|Lost to Follow-up|0|||
42075743|NCT00868790|75886091|FG011|Period 2|Lost to Follow-up|0|||
42075744|NCT00868790|75886092|FG012|Period 2|Lost to Follow-up|0|||
42075745|NCT00868790|75886093|FG013|Period 2|Lost to Follow-up|0|||
42075746|NCT00868790|75886080|FG000|Period 2|Withdrawal by Subject|0|||
42075747|NCT00868790|75886081|FG001|Period 2|Withdrawal by Subject|0|||
42075748|NCT00868790|75886082|FG002|Period 2|Withdrawal by Subject|0|||
42075749|NCT00868790|75886083|FG003|Period 2|Withdrawal by Subject|0|||
42075750|NCT00868790|75886084|FG004|Period 2|Withdrawal by Subject|0|||
42075751|NCT00868790|75886085|FG005|Period 2|Withdrawal by Subject|0|||
42075752|NCT00868790|75886086|FG006|Period 2|Withdrawal by Subject|0|||
42075753|NCT00868790|75886087|FG007|Period 2|Withdrawal by Subject|0|||
42075754|NCT00868790|75886088|FG008|Period 2|Withdrawal by Subject|1|||
42017503|NCT01209780|75825204|FG004|Overall Study|Lost to Follow-up|4|||
42075755|NCT00868790|75886089|FG009|Period 2|Withdrawal by Subject|0|||
42075756|NCT00868790|75886090|FG010|Period 2|Withdrawal by Subject|0|||
42075757|NCT00868790|75886091|FG011|Period 2|Withdrawal by Subject|0|||
42075758|NCT00868790|75886092|FG012|Period 2|Withdrawal by Subject|0|||
42075759|NCT00868790|75886093|FG013|Period 2|Withdrawal by Subject|1|||
42075760|NCT00868790|75886080|FG000|Period 3|Adverse Event|0|||
42177713|NCT00536380|75984939|FG001|Overall Study|Noncompliance with protocol|2|||
42017504|NCT01209780|75825200|FG000|Overall Study|Protocol Violation|0|||
42017505|NCT01209780|75825201|FG001|Overall Study|Protocol Violation|1|||
42017506|NCT01209780|75825202|FG002|Overall Study|Protocol Violation|0|||
42017507|NCT01209780|75825203|FG003|Overall Study|Protocol Violation|0|||
42017508|NCT01209780|75825204|FG004|Overall Study|Protocol Violation|0|||
42017509|NCT01209780|75825200|FG000|Overall Study|Inappropriate enrollment|0|||
42017510|NCT01209780|75825201|FG001|Overall Study|Inappropriate enrollment|2|||
42017511|NCT01209780|75825202|FG002|Overall Study|Inappropriate enrollment|0|||
42017512|NCT01209780|75825203|FG003|Overall Study|Inappropriate enrollment|0|||
42017513|NCT01209780|75825204|FG004|Overall Study|Inappropriate enrollment|1|||
42017514|NCT00916357|75825217|FG000|Period 1|Withdrawal by Subject|1|||
42017515|NCT00916357|75825218|FG001|Period 1|Withdrawal by Subject|0|||
42017516|NCT00916357|75825219|FG002|Period 1|Withdrawal by Subject|0|||
42017517|NCT00916357|75825220|FG003|Period 1|Withdrawal by Subject|0|||
42075761|NCT00868790|75886081|FG001|Period 3|Adverse Event|0|||
42075762|NCT00868790|75886082|FG002|Period 3|Adverse Event|0|||
42075763|NCT00868790|75886083|FG003|Period 3|Adverse Event|0|||
42075764|NCT00868790|75886084|FG004|Period 3|Adverse Event|0|||
42075765|NCT00868790|75886085|FG005|Period 3|Adverse Event|0|||
42075766|NCT00868790|75886086|FG006|Period 3|Adverse Event|0|||
42075767|NCT00868790|75886087|FG007|Period 3|Adverse Event|0|||
42075768|NCT00868790|75886088|FG008|Period 3|Adverse Event|0|||
42075769|NCT00868790|75886089|FG009|Period 3|Adverse Event|1|||
42075770|NCT00868790|75886090|FG010|Period 3|Adverse Event|0|||
42075771|NCT00868790|75886091|FG011|Period 3|Adverse Event|0|||
42075772|NCT00868790|75886092|FG012|Period 3|Adverse Event|0|||
42075773|NCT00868790|75886093|FG013|Period 3|Adverse Event|0|||
42075774|NCT00868790|75886080|FG000|Period 3|Protocol Violation|0|||
42075775|NCT00868790|75886081|FG001|Period 3|Protocol Violation|0|||
42075776|NCT00868790|75886082|FG002|Period 3|Protocol Violation|0|||
42075777|NCT00868790|75886083|FG003|Period 3|Protocol Violation|0|||
42075778|NCT00868790|75886084|FG004|Period 3|Protocol Violation|0|||
42075779|NCT00868790|75886085|FG005|Period 3|Protocol Violation|0|||
42075780|NCT00868790|75886086|FG006|Period 3|Protocol Violation|0|||
42075781|NCT00868790|75886087|FG007|Period 3|Protocol Violation|0|||
42075782|NCT00868790|75886088|FG008|Period 3|Protocol Violation|0|||
42075783|NCT00868790|75886089|FG009|Period 3|Protocol Violation|0|||
42075784|NCT00868790|75886090|FG010|Period 3|Protocol Violation|1|||
42075785|NCT00868790|75886091|FG011|Period 3|Protocol Violation|0|||
42075786|NCT00868790|75886092|FG012|Period 3|Protocol Violation|0|||
42075787|NCT00868790|75886093|FG013|Period 3|Protocol Violation|0|||
42075788|NCT00868790|75886080|FG000|Period 3|Study Terminated by Sponsor|0|||
42075789|NCT00868790|75886081|FG001|Period 3|Study Terminated by Sponsor|0|||
42075790|NCT00868790|75886082|FG002|Period 3|Study Terminated by Sponsor|0|||
42075791|NCT00868790|75886083|FG003|Period 3|Study Terminated by Sponsor|1|||
42075792|NCT00868790|75886084|FG004|Period 3|Study Terminated by Sponsor|0|||
42075793|NCT00868790|75886085|FG005|Period 3|Study Terminated by Sponsor|0|||
42075794|NCT00868790|75886086|FG006|Period 3|Study Terminated by Sponsor|0|||
42075795|NCT00868790|75886087|FG007|Period 3|Study Terminated by Sponsor|0|||
42075796|NCT00868790|75886088|FG008|Period 3|Study Terminated by Sponsor|0|||
42075797|NCT00868790|75886089|FG009|Period 3|Study Terminated by Sponsor|0|||
42075798|NCT00868790|75886090|FG010|Period 3|Study Terminated by Sponsor|0|||
42075799|NCT00868790|75886091|FG011|Period 3|Study Terminated by Sponsor|0|||
42075800|NCT00868790|75886092|FG012|Period 3|Study Terminated by Sponsor|0|||
42075801|NCT00868790|75886093|FG013|Period 3|Study Terminated by Sponsor|0|||
42177714|NCT00536380|75984940|FG002|Overall Study|Noncompliance with protocol|2|||
42177715|NCT00536380|75984938|FG000|Overall Study|Did not meet protocol eligibility|0|||
42177716|NCT00536380|75984939|FG001|Overall Study|Did not meet protocol eligibility|0|||
42177717|NCT00536380|75984940|FG002|Overall Study|Did not meet protocol eligibility|1|||
42177718|NCT00536380|75984938|FG000|Overall Study|Administrative|0|||
42177719|NCT00536380|75984939|FG001|Overall Study|Administrative|0|||
42177720|NCT00536380|75984940|FG002|Overall Study|Administrative|1|||
42177721|NCT00496834|75984950|FG000|Overall Study|Withdrawal by Subject|4|||
42177722|NCT00496834|75984951|FG001|Overall Study|Withdrawal by Subject|6|||
42177723|NCT00496834|75984950|FG000|Overall Study|Contraindicated medication administered|0|||
42177724|NCT00496834|75984951|FG001|Overall Study|Contraindicated medication administered|1|||
42177725|NCT00496834|75984950|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
42177726|NCT00496834|75984951|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
42177727|NCT00496834|75984950|FG000|Overall Study|Adverse Event|5|||
42177728|NCT00496834|75984951|FG001|Overall Study|Adverse Event|3|||
42177729|NCT00496834|75984950|FG000|Overall Study|IP administration violation|2|||
42293519|NCT01594931|76127756|FG000|Overall Study|Lost to Follow-up|4|||
42293520|NCT01594931|76127757|FG001|Overall Study|Lost to Follow-up|3|||
42293521|NCT01594931|76127758|FG002|Overall Study|Lost to Follow-up|3|||
42293522|NCT01594931|76127756|FG000|Overall Study|Protocol Violation|2|||
42293523|NCT01594931|76127757|FG001|Overall Study|Protocol Violation|1|||
42293524|NCT01594931|76127758|FG002|Overall Study|Protocol Violation|0|||
42075802|NCT00868790|75886080|FG000|Period 4|Adverse Event|0|||
42075803|NCT00868790|75886081|FG001|Period 4|Adverse Event|0|||
42075804|NCT00868790|75886082|FG002|Period 4|Adverse Event|0|||
42075805|NCT00868790|75886083|FG003|Period 4|Adverse Event|0|||
42075806|NCT00868790|75886084|FG004|Period 4|Adverse Event|0|||
42075807|NCT00868790|75886085|FG005|Period 4|Adverse Event|0|||
42177730|NCT00496834|75984951|FG001|Overall Study|IP administration violation|0|||
42177731|NCT00496834|75984950|FG000|Overall Study|Lost to Follow-up|2|||
42177732|NCT00496834|75984951|FG001|Overall Study|Lost to Follow-up|0|||
42075808|NCT00868790|75886086|FG006|Period 4|Adverse Event|0|||
42075809|NCT00868790|75886087|FG007|Period 4|Adverse Event|1|||
42075810|NCT00868790|75886088|FG008|Period 4|Adverse Event|0|||
42075811|NCT00868790|75886089|FG009|Period 4|Adverse Event|0|||
42075812|NCT00868790|75886090|FG010|Period 4|Adverse Event|1|||
42177733|NCT00496834|75984950|FG000|Overall Study|Blood Pressure control failure|2|||
42293525|NCT01594931|76127756|FG000|Overall Study|No defiined|11|||
42293526|NCT01594931|76127757|FG001|Overall Study|No defiined|4|||
42075813|NCT00868790|75886091|FG011|Period 4|Adverse Event|0|||
42075814|NCT00868790|75886092|FG012|Period 4|Adverse Event|1|||
42075815|NCT00868790|75886093|FG013|Period 4|Adverse Event|0|||
42075816|NCT00868790|75886080|FG000|Period 4|Lost to Follow-up|0|||
42075817|NCT00868790|75886081|FG001|Period 4|Lost to Follow-up|0|||
42075818|NCT00868790|75886082|FG002|Period 4|Lost to Follow-up|0|||
42075819|NCT00868790|75886083|FG003|Period 4|Lost to Follow-up|0|||
42075820|NCT00868790|75886084|FG004|Period 4|Lost to Follow-up|0|||
42075821|NCT00868790|75886085|FG005|Period 4|Lost to Follow-up|0|||
42075822|NCT00868790|75886086|FG006|Period 4|Lost to Follow-up|0|||
42075823|NCT00868790|75886087|FG007|Period 4|Lost to Follow-up|1|||
42075824|NCT00868790|75886088|FG008|Period 4|Lost to Follow-up|0|||
42075825|NCT00868790|75886089|FG009|Period 4|Lost to Follow-up|0|||
42075826|NCT00868790|75886090|FG010|Period 4|Lost to Follow-up|0|||
42075827|NCT00868790|75886091|FG011|Period 4|Lost to Follow-up|0|||
42075828|NCT00868790|75886092|FG012|Period 4|Lost to Follow-up|0|||
42075829|NCT00868790|75886093|FG013|Period 4|Lost to Follow-up|0|||
42075830|NCT00868790|75886080|FG000|Period 4|Study Terminated by Sponsor|2|||
42075831|NCT00868790|75886081|FG001|Period 4|Study Terminated by Sponsor|0|||
42075832|NCT00868790|75886082|FG002|Period 4|Study Terminated by Sponsor|0|||
42075833|NCT00868790|75886083|FG003|Period 4|Study Terminated by Sponsor|0|||
42075834|NCT00868790|75886084|FG004|Period 4|Study Terminated by Sponsor|0|||
42075835|NCT00868790|75886085|FG005|Period 4|Study Terminated by Sponsor|0|||
42075836|NCT00868790|75886086|FG006|Period 4|Study Terminated by Sponsor|0|||
42075837|NCT00868790|75886087|FG007|Period 4|Study Terminated by Sponsor|1|||
42075838|NCT00868790|75886088|FG008|Period 4|Study Terminated by Sponsor|2|||
42075839|NCT00868790|75886089|FG009|Period 4|Study Terminated by Sponsor|0|||
42075840|NCT00868790|75886090|FG010|Period 4|Study Terminated by Sponsor|2|||
42075841|NCT00868790|75886091|FG011|Period 4|Study Terminated by Sponsor|1|||
42075842|NCT00868790|75886092|FG012|Period 4|Study Terminated by Sponsor|0|||
42075843|NCT00868790|75886093|FG013|Period 4|Study Terminated by Sponsor|1|||
42075844|NCT00868790|75886080|FG000|Period 4|Abnormal ALT/AST|0|||
42075845|NCT00868790|75886081|FG001|Period 4|Abnormal ALT/AST|0|||
42075846|NCT00868790|75886082|FG002|Period 4|Abnormal ALT/AST|1|||
42075847|NCT00868790|75886083|FG003|Period 4|Abnormal ALT/AST|0|||
42075848|NCT00868790|75886084|FG004|Period 4|Abnormal ALT/AST|0|||
42075849|NCT00868790|75886085|FG005|Period 4|Abnormal ALT/AST|0|||
42075850|NCT00868790|75886086|FG006|Period 4|Abnormal ALT/AST|0|||
42075851|NCT00868790|75886087|FG007|Period 4|Abnormal ALT/AST|0|||
42075852|NCT00868790|75886088|FG008|Period 4|Abnormal ALT/AST|0|||
42075853|NCT00868790|75886089|FG009|Period 4|Abnormal ALT/AST|0|||
42075854|NCT00868790|75886090|FG010|Period 4|Abnormal ALT/AST|0|||
42075855|NCT00868790|75886091|FG011|Period 4|Abnormal ALT/AST|0|||
42075856|NCT00868790|75886092|FG012|Period 4|Abnormal ALT/AST|0|||
42075857|NCT00868790|75886093|FG013|Period 4|Abnormal ALT/AST|0|||
42075858|NCT00868790|75886080|FG000|Post-study|Withdrawal by Subject|0|||
42075859|NCT00868790|75886081|FG001|Post-study|Withdrawal by Subject|0|||
42075860|NCT00868790|75886082|FG002|Post-study|Withdrawal by Subject|0|||
42075861|NCT00868790|75886083|FG003|Post-study|Withdrawal by Subject|0|||
42075862|NCT00868790|75886084|FG004|Post-study|Withdrawal by Subject|1|||
42075863|NCT00868790|75886085|FG005|Post-study|Withdrawal by Subject|0|||
42075864|NCT00868790|75886086|FG006|Post-study|Withdrawal by Subject|0|||
42075865|NCT00868790|75886087|FG007|Post-study|Withdrawal by Subject|0|||
42075866|NCT00868790|75886088|FG008|Post-study|Withdrawal by Subject|0|||
42075867|NCT00868790|75886089|FG009|Post-study|Withdrawal by Subject|0|||
42075868|NCT00868790|75886090|FG010|Post-study|Withdrawal by Subject|0|||
42075869|NCT00868790|75886091|FG011|Post-study|Withdrawal by Subject|0|||
42075870|NCT00868790|75886092|FG012|Post-study|Withdrawal by Subject|0|||
42075871|NCT00868790|75886093|FG013|Post-study|Withdrawal by Subject|0|||
42075872|NCT00868790|75886080|FG000|Post-study|Excluded Medication|0|||
42075873|NCT00868790|75886081|FG001|Post-study|Excluded Medication|0|||
42075874|NCT00868790|75886082|FG002|Post-study|Excluded Medication|0|||
42075875|NCT00868790|75886083|FG003|Post-study|Excluded Medication|0|||
42075876|NCT00868790|75886084|FG004|Post-study|Excluded Medication|0|||
42075877|NCT00868790|75886085|FG005|Post-study|Excluded Medication|0|||
42075878|NCT00868790|75886086|FG006|Post-study|Excluded Medication|0|||
42075879|NCT00868790|75886087|FG007|Post-study|Excluded Medication|2|||
42075880|NCT00868790|75886088|FG008|Post-study|Excluded Medication|0|||
42075881|NCT00868790|75886089|FG009|Post-study|Excluded Medication|1|||
42075882|NCT00868790|75886090|FG010|Post-study|Excluded Medication|0|||
42075883|NCT00868790|75886091|FG011|Post-study|Excluded Medication|0|||
42075884|NCT00868790|75886092|FG012|Post-study|Excluded Medication|0|||
42075885|NCT00868790|75886093|FG013|Post-study|Excluded Medication|0|||
42075886|NCT00496483|75886109|FG000|Overall Study|Not dosed|9|||
42075887|NCT00496483|75886109|FG000|Overall Study|Adverse Event|2|||
42075888|NCT00496483|75886109|FG000|Overall Study|Lack of Efficacy|1|||
42075889|NCT03528551|75886119|FG000|Overall Study|Lost to Follow-up|0|||
42075890|NCT03528551|75886120|FG001|Overall Study|Lost to Follow-up|1|||
42075891|NCT03528551|75886121|FG002|Overall Study|Lost to Follow-up|0|||
42075892|NCT03528551|75886119|FG000|Overall Study|Transferred to other arm/group|2|||
42075893|NCT03528551|75886120|FG001|Overall Study|Transferred to other arm/group|3|||
42075894|NCT03528551|75886121|FG002|Overall Study|Transferred to other arm/group|0|||
42075895|NCT03528551|75886119|FG000|Overall Study|Withdrawal by parent/guardian|0|||
42075896|NCT03528551|75886120|FG001|Overall Study|Withdrawal by parent/guardian|5|||
42075897|NCT03528551|75886121|FG002|Overall Study|Withdrawal by parent/guardian|0|||
42075898|NCT03528551|75886119|FG000|Overall Study|Protocol Violation|0|||
42075899|NCT03528551|75886120|FG001|Overall Study|Protocol Violation|3|||
42075900|NCT03528551|75886121|FG002|Overall Study|Protocol Violation|0|||
42075901|NCT03528551|75886119|FG000|Overall Study|Withdrawal by Subject|0|||
42075902|NCT03528551|75886120|FG001|Overall Study|Withdrawal by Subject|7|||
42075903|NCT03528551|75886121|FG002|Overall Study|Withdrawal by Subject|0|||
42075904|NCT00487981|75886130|FG000|Overall Study|Hypothyroidism diagnosis|1|||
42075905|NCT00861744|75886138|FG000|Overall Study|Adverse Event|0|||
42075906|NCT00861744|75886139|FG001|Overall Study|Adverse Event|0|||
42075907|NCT00861744|75886140|FG002|Overall Study|Adverse Event|0|||
42075908|NCT00861744|75886141|FG003|Overall Study|Adverse Event|1|||
42075909|NCT00861744|75886138|FG000|Overall Study|Lost to Follow-up|7|||
42075910|NCT00861744|75886139|FG001|Overall Study|Lost to Follow-up|19|||
42075911|NCT00861744|75886140|FG002|Overall Study|Lost to Follow-up|17|||
42075912|NCT00861744|75886141|FG003|Overall Study|Lost to Follow-up|12|||
42075913|NCT00861744|75886138|FG000|Overall Study|Withdrawal by Subject|10|||
42075914|NCT00861744|75886139|FG001|Overall Study|Withdrawal by Subject|6|||
42075915|NCT00861744|75886140|FG002|Overall Study|Withdrawal by Subject|6|||
42075916|NCT00861744|75886141|FG003|Overall Study|Withdrawal by Subject|19|||
42075917|NCT00861744|75886138|FG000|Overall Study|Protocol Violation|0|||
42075918|NCT00861744|75886139|FG001|Overall Study|Protocol Violation|1|||
42075919|NCT00861744|75886140|FG002|Overall Study|Protocol Violation|0|||
42075920|NCT00861744|75886141|FG003|Overall Study|Protocol Violation|0|||
42075921|NCT00861744|75886138|FG000|Overall Study|Migration from study area|0|||
42075922|NCT00861744|75886139|FG001|Overall Study|Migration from study area|3|||
42075923|NCT00861744|75886140|FG002|Overall Study|Migration from study area|1|||
42075924|NCT00861744|75886141|FG003|Overall Study|Migration from study area|0|||
42075925|NCT00861744|75886138|FG000|Overall Study|Blood draws|0|||
42075926|NCT00861744|75886139|FG001|Overall Study|Blood draws|0|||
42075927|NCT00861744|75886140|FG002|Overall Study|Blood draws|0|||
42075928|NCT00861744|75886141|FG003|Overall Study|Blood draws|1|||
42075929|NCT00603239|75886153|FG000|Overall Study|Adverse Event|4|||
42075930|NCT00603239|75886154|FG001|Overall Study|Adverse Event|1|||
42075931|NCT00603239|75886153|FG000|Overall Study|Entry criteria not met|0|||
42075932|NCT00603239|75886154|FG001|Overall Study|Entry criteria not met|1|||
42075933|NCT00603239|75886153|FG000|Overall Study|Loss of glucose control|3|||
42075934|NCT00603239|75886154|FG001|Overall Study|Loss of glucose control|0|||
42075935|NCT00603239|75886153|FG000|Overall Study|Lost to Follow-up|2|||
42075936|NCT00603239|75886154|FG001|Overall Study|Lost to Follow-up|1|||
42075937|NCT00603239|75886153|FG000|Overall Study|Physician Decision|2|||
42075938|NCT00603239|75886154|FG001|Overall Study|Physician Decision|0|||
42075939|NCT00603239|75886153|FG000|Overall Study|Protocol Violation|2|||
42075940|NCT00603239|75886154|FG001|Overall Study|Protocol Violation|0|||
42075941|NCT00603239|75886153|FG000|Overall Study|Subject decision|2|||
42075942|NCT00603239|75886154|FG001|Overall Study|Subject decision|1|||
42075943|NCT00852930|75886163|FG000|Overall Study|Withdrawal by Subject|1|||
42075944|NCT00852930|75886164|FG001|Overall Study|Withdrawal by Subject|1|||
42075945|NCT00852930|75886165|FG002|Overall Study|Withdrawal by Subject|1|||
42075946|NCT00852930|75886163|FG000|Overall Study|Physician Decision|0|||
42075947|NCT00852930|75886164|FG001|Overall Study|Physician Decision|0|||
42075948|NCT00852930|75886165|FG002|Overall Study|Physician Decision|1|||
42075949|NCT00852540|75886176|FG000|Overall Study|Adverse Event|10|||
42357822|NCT01394991|76203358|FG001|Overall Study|Adverse Event|4|||
42357823|NCT01394991|76203357|FG000|Overall Study|Lack of Efficacy|5|||
42357824|NCT01394991|76203358|FG001|Overall Study|Lack of Efficacy|7|||
42357825|NCT01394991|76203357|FG000|Overall Study|Lost to Follow-up|6|||
42357826|NCT01394991|76203358|FG001|Overall Study|Lost to Follow-up|8|||
42357827|NCT01394991|76203357|FG000|Overall Study|Physician Decision|1|||
42075950|NCT00852540|75886177|FG001|Overall Study|Adverse Event|3|||
42075951|NCT00852540|75886176|FG000|Overall Study|Lack of Efficacy|15|||
42075952|NCT00852540|75886177|FG001|Overall Study|Lack of Efficacy|3|||
42075953|NCT00852540|75886176|FG000|Overall Study|Protocol Violation|1|||
42075954|NCT00852540|75886177|FG001|Overall Study|Protocol Violation|2|||
42075955|NCT00852540|75886176|FG000|Overall Study|Lost to Follow-up|2|||
42075956|NCT00852540|75886177|FG001|Overall Study|Lost to Follow-up|3|||
42075957|NCT00852540|75886176|FG000|Overall Study|Investigator Discretion|2|||
42075958|NCT00852540|75886177|FG001|Overall Study|Investigator Discretion|3|||
42075959|NCT00852540|75886176|FG000|Overall Study|Withdrawal by Subject|3|||
42357828|NCT01394991|76203358|FG001|Overall Study|Physician Decision|3|||
42075960|NCT00852540|75886177|FG001|Overall Study|Withdrawal by Subject|1|||
42075961|NCT00852540|75886176|FG000|Overall Study|Did Not Receive Study Drug|3|||
42075962|NCT00852540|75886177|FG001|Overall Study|Did Not Receive Study Drug|3|||
42075963|NCT00861198|75886184|FG000|Overall Study|SpyGlass Failed|5|||
42075964|NCT00847704|75886188|FG000|Overall Study|Withdrawal by Subject|1|||
42075965|NCT00860574|75886192|FG000|Overall Study|Death|2|||
42075966|NCT00860574|75886192|FG000|Overall Study|Relapse|1|||
42075967|NCT00496015|75886201|FG000|Overall Study|Other|1|||
42075968|NCT00496015|75886202|FG001|Overall Study|Other|0|||
42075969|NCT00496015|75886203|FG002|Overall Study|Other|0|||
42075970|NCT00496015|75886204|FG003|Overall Study|Other|1|||
42075971|NCT00496015|75886205|FG004|Overall Study|Other|0|||
42075972|NCT00487825|75886227|FG000|Overall Study|Adverse Event|2|||
42075973|NCT00487825|75886228|FG001|Overall Study|Adverse Event|2|||
42075974|NCT00487825|75886227|FG000|Overall Study|Lack of Efficacy|1|||
42075975|NCT00487825|75886228|FG001|Overall Study|Lack of Efficacy|1|||
42075976|NCT00487825|75886227|FG000|Overall Study|Other|3|||
42075977|NCT00487825|75886228|FG001|Overall Study|Other|2|||
42075978|NCT00487747|75886234|FG000|Overall Study|Adverse Event|1|||
42075979|NCT00487747|75886234|FG000|Overall Study|Lost to Follow-up|9|||
42075980|NCT00487747|75886234|FG000|Overall Study|Lack of Efficacy|1|||
42075981|NCT00487435|75886238|FG000|Overall Study|Adverse Event|146|||
42075982|NCT00487435|75886238|FG000|Overall Study|Death|2|||
42075983|NCT00487435|75886238|FG000|Overall Study|Lack of Efficacy|33|||
42075984|NCT00487435|75886238|FG000|Overall Study|Lost to Follow-up|54|||
42075985|NCT00487435|75886238|FG000|Overall Study|Pregnancy|2|||
42075986|NCT00487435|75886238|FG000|Overall Study|Withdrawal by Subject|132|||
42075987|NCT00487435|75886238|FG000|Overall Study|Resolution Of Pain|1|||
42075988|NCT00487435|75886238|FG000|Overall Study|Study Medication Non-Compliant|32|||
42075989|NCT00487435|75886238|FG000|Overall Study|Other|83|||
42075990|NCT00487279|75886244|FG000|Overall Study|Death|1|||
42075991|NCT00487279|75886245|FG001|Overall Study|Death|0|||
42075992|NCT00487279|75886244|FG000|Overall Study|Withdrawal by Subject|0|||
42075993|NCT00487279|75886245|FG001|Overall Study|Withdrawal by Subject|2|||
42075994|NCT00495625|75886251|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
42075995|NCT00847626|75886266|FG000|Overall Study|Adverse Event|10|||
42075996|NCT00847626|75886267|FG001|Overall Study|Adverse Event|10|||
42075997|NCT00847626|75886268|FG002|Overall Study|Adverse Event|6|||
42075998|NCT00847626|75886269|FG003|Overall Study|Adverse Event|19|||
42075999|NCT00847626|75886270|FG004|Overall Study|Adverse Event|11|||
42076000|NCT00847626|75886271|FG005|Overall Study|Adverse Event|22|||
42076001|NCT00847626|75886272|FG006|Overall Study|Adverse Event|4|||
42076002|NCT00847626|75886273|FG007|Overall Study|Adverse Event|6|||
42076003|NCT00847626|75886274|FG008|Overall Study|Adverse Event|3|||
42076004|NCT00847626|75886275|FG009|Overall Study|Adverse Event|6|||
42076005|NCT00847626|75886276|FG010|Overall Study|Adverse Event|6|||
42076006|NCT00847626|75886266|FG000|Overall Study|Protocol Violation|2|||
42076007|NCT00847626|75886267|FG001|Overall Study|Protocol Violation|1|||
42076008|NCT00847626|75886268|FG002|Overall Study|Protocol Violation|2|||
42076009|NCT00847626|75886269|FG003|Overall Study|Protocol Violation|1|||
42076010|NCT00847626|75886270|FG004|Overall Study|Protocol Violation|1|||
42076011|NCT00847626|75886271|FG005|Overall Study|Protocol Violation|1|||
42076012|NCT00847626|75886272|FG006|Overall Study|Protocol Violation|1|||
42076013|NCT00847626|75886273|FG007|Overall Study|Protocol Violation|1|||
42076014|NCT00847626|75886274|FG008|Overall Study|Protocol Violation|0|||
42076015|NCT00847626|75886275|FG009|Overall Study|Protocol Violation|1|||
42076016|NCT00847626|75886276|FG010|Overall Study|Protocol Violation|1|||
42076017|NCT00847626|75886266|FG000|Overall Study|Lost to Follow-up|0|||
42076018|NCT00847626|75886267|FG001|Overall Study|Lost to Follow-up|1|||
42076019|NCT00847626|75886268|FG002|Overall Study|Lost to Follow-up|1|||
42076020|NCT00847626|75886269|FG003|Overall Study|Lost to Follow-up|1|||
42076021|NCT00847626|75886270|FG004|Overall Study|Lost to Follow-up|0|||
42177734|NCT00496834|75984951|FG001|Overall Study|Blood Pressure control failure|1|||
42177735|NCT05244122|75984959|FG000|Overall Study|Withdrawal by Subject|318|||
42293527|NCT01594931|76127758|FG002|Overall Study|No defiined|7|||
42293528|NCT01594853|76127768|FG000|Overall Study|Withdrawal by Subject|1|||
42293529|NCT01594853|76127769|FG001|Overall Study|Withdrawal by Subject|1|||
42076022|NCT00847626|75886271|FG005|Overall Study|Lost to Follow-up|3|||
42076023|NCT00847626|75886272|FG006|Overall Study|Lost to Follow-up|1|||
42076024|NCT00847626|75886273|FG007|Overall Study|Lost to Follow-up|3|||
42076025|NCT00847626|75886274|FG008|Overall Study|Lost to Follow-up|1|||
42076026|NCT00847626|75886275|FG009|Overall Study|Lost to Follow-up|0|||
42076027|NCT00847626|75886276|FG010|Overall Study|Lost to Follow-up|1|||
42076028|NCT00847626|75886266|FG000|Overall Study|Withdrawal by Subject|5|||
42076029|NCT00847626|75886267|FG001|Overall Study|Withdrawal by Subject|5|||
42076030|NCT00847626|75886268|FG002|Overall Study|Withdrawal by Subject|3|||
42076031|NCT00847626|75886269|FG003|Overall Study|Withdrawal by Subject|8|||
42076032|NCT00847626|75886270|FG004|Overall Study|Withdrawal by Subject|12|||
42076033|NCT00847626|75886271|FG005|Overall Study|Withdrawal by Subject|9|||
42076034|NCT00847626|75886272|FG006|Overall Study|Withdrawal by Subject|8|||
42076035|NCT00847626|75886273|FG007|Overall Study|Withdrawal by Subject|4|||
42076036|NCT00847626|75886274|FG008|Overall Study|Withdrawal by Subject|4|||
42076037|NCT00847626|75886275|FG009|Overall Study|Withdrawal by Subject|5|||
42076038|NCT00847626|75886276|FG010|Overall Study|Withdrawal by Subject|2|||
42076039|NCT00847626|75886266|FG000|Overall Study|Lack of Efficacy|3|||
42293530|NCT01594853|76127768|FG000|Overall Study|Lost to Follow-up|1|||
42076040|NCT00847626|75886267|FG001|Overall Study|Lack of Efficacy|1|||
42076041|NCT00847626|75886268|FG002|Overall Study|Lack of Efficacy|0|||
42076042|NCT00847626|75886269|FG003|Overall Study|Lack of Efficacy|1|||
42076043|NCT00847626|75886270|FG004|Overall Study|Lack of Efficacy|2|||
42076044|NCT00847626|75886271|FG005|Overall Study|Lack of Efficacy|0|||
42076045|NCT00847626|75886272|FG006|Overall Study|Lack of Efficacy|6|||
42076046|NCT00847626|75886273|FG007|Overall Study|Lack of Efficacy|2|||
42076047|NCT00847626|75886274|FG008|Overall Study|Lack of Efficacy|5|||
42076048|NCT00847626|75886275|FG009|Overall Study|Lack of Efficacy|1|||
42076049|NCT00847626|75886276|FG010|Overall Study|Lack of Efficacy|7|||
42076050|NCT00847626|75886266|FG000|Overall Study|Other|1|||
42076051|NCT00847626|75886267|FG001|Overall Study|Other|5|||
42076052|NCT00847626|75886268|FG002|Overall Study|Other|4|||
42076053|NCT00847626|75886269|FG003|Overall Study|Other|1|||
42076054|NCT00847626|75886270|FG004|Overall Study|Other|2|||
42076055|NCT00847626|75886271|FG005|Overall Study|Other|2|||
42076056|NCT00847626|75886272|FG006|Overall Study|Other|2|||
42076057|NCT00847626|75886273|FG007|Overall Study|Other|3|||
42076058|NCT00847626|75886274|FG008|Overall Study|Other|1|||
42076059|NCT00847626|75886275|FG009|Overall Study|Other|1|||
42076060|NCT00847626|75886276|FG010|Overall Study|Other|3|||
42076061|NCT00851682|75886305|FG000|Overall Study|screen failure|5|||
42076062|NCT00851682|75886306|FG001|Overall Study|screen failure|0|||
42076063|NCT00860262|75886315|FG000|Overall Study|Adverse Event|9|||
42076064|NCT00860262|75886316|FG001|Overall Study|Adverse Event|6|||
42076065|NCT00860262|75886317|FG002|Overall Study|Adverse Event|7|||
42076066|NCT00860262|75886315|FG000|Overall Study|Protocol Violation|0|||
42076067|NCT00860262|75886316|FG001|Overall Study|Protocol Violation|1|||
42076068|NCT00860262|75886317|FG002|Overall Study|Protocol Violation|0|||
42076069|NCT00860262|75886315|FG000|Overall Study|Lost to Follow-up|2|||
42076070|NCT00860262|75886316|FG001|Overall Study|Lost to Follow-up|0|||
42076071|NCT00860262|75886317|FG002|Overall Study|Lost to Follow-up|1|||
42076072|NCT00860262|75886315|FG000|Overall Study|Withdrawal by Subject|4|||
42076073|NCT00860262|75886316|FG001|Overall Study|Withdrawal by Subject|8|||
42076074|NCT00860262|75886317|FG002|Overall Study|Withdrawal by Subject|6|||
42076075|NCT00860262|75886315|FG000|Overall Study|Lack of Efficacy|0|||
42076076|NCT00860262|75886316|FG001|Overall Study|Lack of Efficacy|4|||
42076077|NCT00860262|75886317|FG002|Overall Study|Lack of Efficacy|3|||
42076078|NCT00860262|75886315|FG000|Overall Study|Other|5|||
42177736|NCT00166504|75984980|FG000|Overall Study|Adverse Event|3|||
42177737|NCT00166504|75984981|FG001|Overall Study|Adverse Event|3|||
42177738|NCT00166504|75984980|FG000|Overall Study|Lost to Follow-up|1|||
42177739|NCT00166504|75984981|FG001|Overall Study|Lost to Follow-up|1|||
42177740|NCT00166504|75984980|FG000|Overall Study|Withdrawal by Subject|1|||
42177741|NCT00166504|75984981|FG001|Overall Study|Withdrawal by Subject|0|||
42177742|NCT03137992|75984987|FG000|Washout Period 1|Adverse Event|1|||
42177743|NCT03137992|75984988|FG001|Washout Period 1|Adverse Event|1|||
42177744|NCT03137992|75984989|FG002|Washout Period 1|Adverse Event|0|||
42177745|NCT03137992|75984990|FG003|Washout Period 1|Adverse Event|0|||
42177746|NCT03137992|75984991|FG004|Washout Period 1|Adverse Event|0|||
42177747|NCT03137992|75984992|FG005|Washout Period 1|Adverse Event|1|||
42177748|NCT03137992|75984987|FG000|Washout Period 1|Withdrawal by Subject|0|||
42177749|NCT03137992|75984988|FG001|Washout Period 1|Withdrawal by Subject|1|||
42177750|NCT03137992|75984989|FG002|Washout Period 1|Withdrawal by Subject|1|||
42177751|NCT03137992|75984990|FG003|Washout Period 1|Withdrawal by Subject|0|||
42177752|NCT03137992|75984991|FG004|Washout Period 1|Withdrawal by Subject|0|||
42177753|NCT03137992|75984992|FG005|Washout Period 1|Withdrawal by Subject|0|||
42177754|NCT03137992|75984987|FG000|Washout Period 1|Principal Investigator Discretion|0|||
42177755|NCT03137992|75984988|FG001|Washout Period 1|Principal Investigator Discretion|1|||
42177756|NCT03137992|75984989|FG002|Washout Period 1|Principal Investigator Discretion|0|||
42177757|NCT03137992|75984990|FG003|Washout Period 1|Principal Investigator Discretion|0|||
42177758|NCT03137992|75984991|FG004|Washout Period 1|Principal Investigator Discretion|0|||
42076079|NCT00860262|75886316|FG001|Overall Study|Other|3|||
42076080|NCT00860262|75886317|FG002|Overall Study|Other|1|||
42076081|NCT00860028|75886329|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
42076082|NCT00860028|75886330|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
42076083|NCT00859638|75886340|FG000|Overall Study|Lost to Follow-up|6|||
42076084|NCT00859638|75886341|FG001|Overall Study|Lost to Follow-up|1|||
42076085|NCT00859638|75886340|FG000|Overall Study|Withdrawal by Subject|3|||
42076086|NCT00859638|75886341|FG001|Overall Study|Withdrawal by Subject|2|||
42076087|NCT00859638|75886340|FG000|Overall Study|Ill health|1|||
42076088|NCT00859638|75886341|FG001|Overall Study|Ill health|1|||
42076089|NCT00846846|75886347|FG000|Overall Study|Death|56|||
42076090|NCT00846846|75886347|FG000|Overall Study|Withdrawal by Subject|19|||
42076091|NCT00846768|75886351|FG000|Overall Study|Adverse Event|0|||
42076092|NCT00846768|75886352|FG001|Overall Study|Adverse Event|1|||
42177759|NCT03137992|75984992|FG005|Washout Period 1|Principal Investigator Discretion|0|||
42177760|NCT03137992|75984987|FG000|Washout Period 1|COPD Exacerbation|1|||
42177761|NCT03137992|75984988|FG001|Washout Period 1|COPD Exacerbation|1|||
42076093|NCT00846768|75886353|FG002|Overall Study|Adverse Event|0|||
42076094|NCT00846768|75886354|FG003|Overall Study|Adverse Event|0|||
42076095|NCT00863798|75886367|FG000|Overall Study|Adverse Event|5|||
42076096|NCT00863798|75886368|FG001|Overall Study|Adverse Event|2|||
42076097|NCT00863798|75886369|FG002|Overall Study|Adverse Event|4|||
42076098|NCT00863798|75886367|FG000|Overall Study|Participant failed to return|2|||
42076099|NCT00863798|75886368|FG001|Overall Study|Participant failed to return|1|||
42076100|NCT00863798|75886369|FG002|Overall Study|Participant failed to return|0|||
42076101|NCT00863798|75886367|FG000|Overall Study|Investigator request|1|||
42076102|NCT00863798|75886368|FG001|Overall Study|Investigator request|2|||
42076103|NCT00863798|75886369|FG002|Overall Study|Investigator request|1|||
42076104|NCT00863798|75886367|FG000|Overall Study|Lack of Efficacy|4|||
42076105|NCT00863798|75886368|FG001|Overall Study|Lack of Efficacy|3|||
42076106|NCT00863798|75886369|FG002|Overall Study|Lack of Efficacy|6|||
42076107|NCT00863798|75886367|FG000|Overall Study|Lost to Follow-up|6|||
42076108|NCT00863798|75886368|FG001|Overall Study|Lost to Follow-up|9|||
42076109|NCT00863798|75886369|FG002|Overall Study|Lost to Follow-up|5|||
42076110|NCT00863798|75886367|FG000|Overall Study|Other|2|||
42076111|NCT00863798|75886368|FG001|Overall Study|Other|3|||
42076112|NCT00863798|75886369|FG002|Overall Study|Other|1|||
42076113|NCT00863798|75886367|FG000|Overall Study|Protocol Violation|0|||
42076114|NCT00863798|75886368|FG001|Overall Study|Protocol Violation|1|||
42076115|NCT00863798|75886369|FG002|Overall Study|Protocol Violation|1|||
42076116|NCT00863798|75886367|FG000|Overall Study|Withdrawal by Subject|8|||
42076117|NCT00863798|75886368|FG001|Overall Study|Withdrawal by Subject|7|||
42076118|NCT00863798|75886369|FG002|Overall Study|Withdrawal by Subject|4|||
42076119|NCT00863798|75886367|FG000|Overall Study|Randomized not treated|4|||
42076120|NCT00863798|75886368|FG001|Overall Study|Randomized not treated|2|||
42076121|NCT00863798|75886369|FG002|Overall Study|Randomized not treated|3|||
42076122|NCT00859014|75886377|FG000|Overall Study|Death|4|||
42076123|NCT00859014|75886377|FG000|Overall Study|Lost to Follow-up|1|||
42076124|NCT00593606|75886381|FG000|Overall Study|Adverse Event|13|||
42076125|NCT00593606|75886381|FG000|Overall Study|Withdrawal by Subject|1|||
42076126|NCT00593606|75886381|FG000|Overall Study|Protocol Violation|3|||
42076127|NCT00593606|75886381|FG000|Overall Study|Lost to Follow-up|2|||
42076128|NCT00593606|75886381|FG000|Overall Study|Run-In Failure|5|||
42076129|NCT00593606|75886381|FG000|Overall Study|Screen Failure|3|||
42076130|NCT00870584|75886387|FG000|Overall Study|Adverse Event|3|||
42076131|NCT00870584|75886388|FG001|Overall Study|Adverse Event|3|||
42076132|NCT00870584|75886387|FG000|Overall Study|Withdrawal by Subject|6|||
42076133|NCT00870584|75886388|FG001|Overall Study|Withdrawal by Subject|7|||
42076134|NCT00870584|75886387|FG000|Overall Study|Lost to Follow-up|5|||
42076135|NCT00870584|75886388|FG001|Overall Study|Lost to Follow-up|1|||
42076136|NCT00870584|75886387|FG000|Overall Study|Protocol Deviation|2|||
42076137|NCT00870584|75886388|FG001|Overall Study|Protocol Deviation|2|||
42076138|NCT00870194|75886396|FG000|Overall Study|Adverse Event|10|||
42076139|NCT00870194|75886397|FG001|Overall Study|Adverse Event|5|||
42076140|NCT00870194|75886396|FG000|Overall Study|Lack of Efficacy|0|||
42076141|NCT00870194|75886397|FG001|Overall Study|Lack of Efficacy|1|||
42076142|NCT00870194|75886396|FG000|Overall Study|Lost to Follow-up|2|||
42076143|NCT00870194|75886397|FG001|Overall Study|Lost to Follow-up|0|||
42076144|NCT00870194|75886396|FG000|Overall Study|Physician Decision|3|||
42076145|NCT00870194|75886397|FG001|Overall Study|Physician Decision|1|||
42076146|NCT00870194|75886396|FG000|Overall Study|Protocol Violation|3|||
42076147|NCT00870194|75886397|FG001|Overall Study|Protocol Violation|3|||
42076148|NCT00870194|75886396|FG000|Overall Study|Entry Criteria Not Met|1|||
42076149|NCT00870194|75886397|FG001|Overall Study|Entry Criteria Not Met|2|||
42076150|NCT00870194|75886396|FG000|Overall Study|Subject Decision|7|||
42076151|NCT00870194|75886397|FG001|Overall Study|Subject Decision|2|||
42076152|NCT00690430|75886405|FG000|Core Phase|Abnormal Laboratory value|0|||
42076153|NCT00690430|75886406|FG001|Core Phase|Abnormal Laboratory value|1|||
42076154|NCT00690430|75886407|FG002|Core Phase|Abnormal Laboratory value|0|||
42076155|NCT00690430|75886405|FG000|Core Phase|Adverse Event|5|||
42357829|NCT01394991|76203357|FG000|Overall Study|Protocol Violation|1|||
42357830|NCT01394991|76203358|FG001|Overall Study|Protocol Violation|1|||
42076156|NCT00690430|75886406|FG001|Core Phase|Adverse Event|1|||
42076157|NCT00690430|75886407|FG002|Core Phase|Adverse Event|0|||
42076158|NCT00690430|75886405|FG000|Core Phase|Death|0|||
42076159|NCT00690430|75886406|FG001|Core Phase|Death|2|||
42076160|NCT00690430|75886407|FG002|Core Phase|Death|0|||
42357831|NCT01394991|76203357|FG000|Overall Study|Withdrawal by Subject|20|||
42076161|NCT00690430|75886405|FG000|Core Phase|Protocol Violation|1|||
42076162|NCT00690430|75886406|FG001|Core Phase|Protocol Violation|0|||
42076163|NCT00690430|75886407|FG002|Core Phase|Protocol Violation|0|||
42076164|NCT00690430|75886405|FG000|Core Phase|Withdrawal by Subject|3|||
42076165|NCT00690430|75886406|FG001|Core Phase|Withdrawal by Subject|3|||
42076166|NCT00690430|75886407|FG002|Core Phase|Withdrawal by Subject|0|||
42076167|NCT00690430|75886405|FG000|Core Phase|Subject no longer requires study drug|1|||
42076168|NCT00690430|75886406|FG001|Core Phase|Subject no longer requires study drug|0|||
42076169|NCT00690430|75886407|FG002|Core Phase|Subject no longer requires study drug|0|||
42076170|NCT00690430|75886405|FG000|Core Phase|Lack of Efficacy|8|||
42076171|NCT00690430|75886406|FG001|Core Phase|Lack of Efficacy|10|||
42076172|NCT00690430|75886407|FG002|Core Phase|Lack of Efficacy|0|||
42076173|NCT00690430|75886405|FG000|Core Phase|Administrative Problems|0|||
42076174|NCT00690430|75886406|FG001|Core Phase|Administrative Problems|1|||
42076175|NCT00690430|75886407|FG002|Core Phase|Administrative Problems|0|||
42076176|NCT00690430|75886405|FG000|Core Phase|Early Termination|0|||
42076177|NCT00690430|75886406|FG001|Core Phase|Early Termination|5|||
42357832|NCT01394991|76203358|FG001|Overall Study|Withdrawal by Subject|17|||
42357833|NCT01394991|76203357|FG000|Overall Study|Chemotherapy Termination|10|||
42357834|NCT01394991|76203358|FG001|Overall Study|Chemotherapy Termination|15|||
42357835|NCT01394991|76203357|FG000|Overall Study|Disease Progression|7|||
42357836|NCT01394991|76203358|FG001|Overall Study|Disease Progression|7|||
42357837|NCT01394991|76203357|FG000|Overall Study|Prematurely Termination of Trial|9|||
42357838|NCT01394991|76203358|FG001|Overall Study|Prematurely Termination of Trial|10|||
42357839|NCT01829347|76203366|FG000|VTI-210|Death|5|||
42076178|NCT00690430|75886407|FG002|Core Phase|Early Termination|0|||
42076179|NCT00690430|75886405|FG000|Extension Phase|Lack of Efficacy|3|||
42076180|NCT00690430|75886406|FG001|Extension Phase|Lack of Efficacy|1|||
42076181|NCT00690430|75886407|FG002|Extension Phase|Lack of Efficacy|4|||
42076182|NCT00690430|75886405|FG000|Extension Phase|Abnormal Lab Values|1|||
42076183|NCT00690430|75886406|FG001|Extension Phase|Abnormal Lab Values|0|||
42076184|NCT00690430|75886407|FG002|Extension Phase|Abnormal Lab Values|0|||
42076185|NCT00690430|75886405|FG000|Extension Phase|Abnormal test procedure results|1|||
42076186|NCT00690430|75886406|FG001|Extension Phase|Abnormal test procedure results|0|||
42076187|NCT00690430|75886407|FG002|Extension Phase|Abnormal test procedure results|0|||
42076188|NCT00690430|75886405|FG000|Extension Phase|Administrative Problems|0|||
42076189|NCT00690430|75886406|FG001|Extension Phase|Administrative Problems|1|||
42076190|NCT00690430|75886407|FG002|Extension Phase|Administrative Problems|1|||
42076191|NCT00690430|75886405|FG000|Extension Phase|Adverse Event|2|||
42076192|NCT00690430|75886406|FG001|Extension Phase|Adverse Event|1|||
42076193|NCT00690430|75886407|FG002|Extension Phase|Adverse Event|2|||
42076194|NCT00690430|75886405|FG000|Extension Phase|Death|1|||
42076195|NCT00690430|75886406|FG001|Extension Phase|Death|1|||
42076196|NCT00690430|75886407|FG002|Extension Phase|Death|1|||
42076197|NCT00690430|75886405|FG000|Extension Phase|Withdrawal by Subject|0|||
42076198|NCT00690430|75886406|FG001|Extension Phase|Withdrawal by Subject|0|||
42076199|NCT00690430|75886407|FG002|Extension Phase|Withdrawal by Subject|2|||
42076200|NCT00690430|75886405|FG000|Extension Phase|Early Termination|10|||
42076201|NCT00690430|75886406|FG001|Extension Phase|Early Termination|1|||
42076202|NCT00690430|75886407|FG002|Extension Phase|Early Termination|3|||
42076203|NCT00863330|75886416|FG000|Overall Study|study terminated early due to administra|6|||
42076204|NCT00688324|75886420|FG000|Overall Study|Withdrawal by Subject|2|||
42076205|NCT00688324|75886420|FG000|Overall Study|Physician Decision|5|||
42076206|NCT00688324|75886420|FG000|Overall Study|Lost to Follow-up|1|||
42076207|NCT00862940|75886427|FG000|Overall Study|Adverse Event|15|||
42076208|NCT00862940|75886428|FG001|Overall Study|Adverse Event|12|||
42076209|NCT00862940|75886427|FG000|Overall Study|Lack of Efficacy|1|||
42076210|NCT00862940|75886428|FG001|Overall Study|Lack of Efficacy|3|||
42076211|NCT00862940|75886427|FG000|Overall Study|Protocol Violation|2|||
42076212|NCT00862940|75886428|FG001|Overall Study|Protocol Violation|5|||
42076213|NCT00862940|75886427|FG000|Overall Study|Withdrawal by Subject|4|||
42076214|NCT00862940|75886428|FG001|Overall Study|Withdrawal by Subject|6|||
42076215|NCT00862940|75886427|FG000|Overall Study|Non-compliance|4|||
42076216|NCT00862940|75886428|FG001|Overall Study|Non-compliance|0|||
42076217|NCT00862940|75886427|FG000|Overall Study|Lost to Follow-up|0|||
42076218|NCT00862940|75886428|FG001|Overall Study|Lost to Follow-up|1|||
42076219|NCT00862940|75886427|FG000|Overall Study|Administrative or other reason(s)|4|||
42076220|NCT00862940|75886428|FG001|Overall Study|Administrative or other reason(s)|3|||
42076221|NCT00868166|75886436|FG000|Overall Study|Death|58|||
42357840|NCT01829347|76203367|FG001|VTI-210|Death|3|||
42017518|NCT00916357|75825221|FG004|Period 1|Withdrawal by Subject|0|||
42076222|NCT00868166|75886437|FG001|Overall Study|Death|65|||
42076223|NCT00868166|75886436|FG000|Overall Study|Withdrawal by Subject|33|||
42076224|NCT00868166|75886437|FG001|Overall Study|Withdrawal by Subject|25|||
42357841|NCT01829347|76203366|FG000|VTI-210|Withdrawal by Subject|1|||
42357842|NCT01829347|76203367|FG001|VTI-210|Withdrawal by Subject|0|||
42357843|NCT01829347|76203366|FG000|VTI-210E|Death|2|||
42357844|NCT01829347|76203367|FG001|VTI-210E|Death|1|||
42017519|NCT00916357|75825222|FG005|Period 1|Withdrawal by Subject|0|||
42017520|NCT00916357|75825217|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
42017521|NCT00916357|75825218|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
42017522|NCT00916357|75825219|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
42017523|NCT00916357|75825220|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
42017524|NCT00916357|75825221|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
42017525|NCT00916357|75825222|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
42017526|NCT01209624|75825231|FG000|Overall Study|Death|2|||
42076225|NCT00868166|75886436|FG000|Overall Study|Protocol Violation|1|||
42076226|NCT00868166|75886437|FG001|Overall Study|Protocol Violation|0|||
42076227|NCT00868166|75886436|FG000|Overall Study|Lost to Follow-up|1|||
42076228|NCT00868166|75886437|FG001|Overall Study|Lost to Follow-up|3|||
42076229|NCT00868166|75886436|FG000|Overall Study|Adverse Event|9|||
42076230|NCT00868166|75886437|FG001|Overall Study|Adverse Event|10|||
42076231|NCT00868166|75886436|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
42076232|NCT00868166|75886437|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
42076233|NCT00868166|75886436|FG000|Overall Study|Non-compliance with IMP|1|||
42076234|NCT00868166|75886437|FG001|Overall Study|Non-compliance with IMP|1|||
42076235|NCT00858780|75886443|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
42076236|NCT00858780|75886444|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
42076237|NCT00858780|75886445|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
42076238|NCT00858780|75886446|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
42076239|NCT00858780|75886447|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
42076240|NCT00858780|75886443|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
42076241|NCT00858780|75886444|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
42076242|NCT00858780|75886445|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
42076243|NCT00858780|75886446|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
42076244|NCT00858780|75886447|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
42076245|NCT00858780|75886443|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
42076246|NCT00858780|75886444|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
42076247|NCT00858780|75886445|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
42076248|NCT00858780|75886446|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
42076249|NCT00858780|75886447|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
42076250|NCT00858780|75886443|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
42076251|NCT00858780|75886444|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
42076252|NCT00858780|75886445|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
42076253|NCT00858780|75886446|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
42076254|NCT00858780|75886447|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
42076255|NCT00858780|75886443|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
42076256|NCT00858780|75886444|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
42076257|NCT00858780|75886445|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
42076258|NCT00858780|75886446|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
42076259|NCT00858780|75886447|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
42076260|NCT00858780|75886443|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
42076261|NCT00858780|75886444|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
42076262|NCT00858780|75886445|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
42076263|NCT00858780|75886446|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
42076264|NCT00858780|75886447|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
42076265|NCT00850200|75886457|FG000|Overall Study|Physician Decision|2|||
42076266|NCT00850200|75886457|FG000|Overall Study|Did not recieve treatment|2|||
42076267|NCT00850200|75886457|FG000|Overall Study|Withdrawal by Subject|1|||
42076268|NCT00858234|75886464|FG000|Overall Study|Adverse Event|6|||
42076269|NCT00858234|75886464|FG000|Overall Study|Progressive disease|2|||
42076270|NCT00858234|75886464|FG000|Overall Study|Status unknown|1|||
42076271|NCT00862082|75886470|FG000|Overall Study|Sponsor decision to terminate the study|5|||
42076272|NCT00862082|75886471|FG001|Overall Study|Sponsor decision to terminate the study|0|||
42076273|NCT00862082|75886470|FG000|Overall Study|Withdrawal by Subject|0|||
42076274|NCT00862082|75886471|FG001|Overall Study|Withdrawal by Subject|1|||
42076275|NCT00692770|75886486|FG000|Overall Study|Protocol Violation|2|||
42076276|NCT00692770|75886487|FG001|Overall Study|Protocol Violation|7|||
42076277|NCT00692770|75886486|FG000|Overall Study|Withdrawal by Subject|97|||
42076278|NCT00692770|75886487|FG001|Overall Study|Withdrawal by Subject|36|||
42076279|NCT00692770|75886486|FG000|Overall Study|Adverse Event|136|||
42076280|NCT00692770|75886487|FG001|Overall Study|Adverse Event|41|||
42076281|NCT00692770|75886486|FG000|Overall Study|Death|10|||
42076282|NCT00692770|75886487|FG001|Overall Study|Death|5|||
42076283|NCT00692770|75886486|FG000|Overall Study|Lost to Follow-up|7|||
42076284|NCT00692770|75886487|FG001|Overall Study|Lost to Follow-up|3|||
42076285|NCT00692770|75886486|FG000|Overall Study|Non-compliant with study medication|11|||
42076286|NCT00692770|75886487|FG001|Overall Study|Non-compliant with study medication|5|||
42076287|NCT00692770|75886486|FG000|Overall Study|Progression by clinical judgment|2|||
42076288|NCT00692770|75886487|FG001|Overall Study|Progression by clinical judgment|3|||
42076289|NCT00692770|75886486|FG000|Overall Study|Physician decision not protocol driven|10|||
42076290|NCT00692770|75886487|FG001|Overall Study|Physician decision not protocol driven|14|||
42076291|NCT00692770|75886486|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
42293531|NCT01594853|76127769|FG001|Overall Study|Lost to Follow-up|1|||
42293532|NCT01594853|76127768|FG000|Overall Study|noncompliance with exercise|0|||
42076292|NCT00692770|75886487|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
42076293|NCT00692770|75886486|FG000|Overall Study|Protocol driven decision point|3|||
42076294|NCT00692770|75886487|FG001|Overall Study|Protocol driven decision point|7|||
42076295|NCT00692770|75886486|FG000|Overall Study|Completed all planned assessments|79|||
42076296|NCT00692770|75886487|FG001|Overall Study|Completed all planned assessments|101|||
42076297|NCT00692770|75886486|FG000|Overall Study|Radiological and clinical progression|8|||
42076298|NCT00692770|75886487|FG001|Overall Study|Radiological and clinical progression|8|||
42076299|NCT00692770|75886486|FG000|Overall Study|Clinical endpoint reached|16|||
42076300|NCT00692770|75886487|FG001|Overall Study|Clinical endpoint reached|43|||
42076301|NCT00692770|75886486|FG000|Overall Study|Study terminated by sponsor|2|||
42076302|NCT00692770|75886487|FG001|Overall Study|Study terminated by sponsor|2|||
42076303|NCT00692770|75886486|FG000|Overall Study|Randomized but not treated|3|||
42076304|NCT00692770|75886487|FG001|Overall Study|Randomized but not treated|4|||
42076305|NCT00849108|75886502|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
42076306|NCT00849108|75886503|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
42076307|NCT00849108|75886502|FG000|Cohort 2 Efficacy|Adverse Event|0|||
42076308|NCT00849108|75886503|FG001|Cohort 2 Efficacy|Adverse Event|1|||
42076309|NCT00849108|75886502|FG000|Cohort 2 Efficacy|Other|0|||
42076310|NCT00849108|75886503|FG001|Cohort 2 Efficacy|Other|9|||
42076311|NCT00867308|75886513|FG000|Overall Study|Death|1|||
42076312|NCT00867308|75886514|FG001|Overall Study|Death|0|||
42076313|NCT00867308|75886513|FG000|Overall Study|Adverse Event|1|||
42076314|NCT00867308|75886514|FG001|Overall Study|Adverse Event|4|||
42076315|NCT00867308|75886513|FG000|Overall Study|Lack of Efficacy|6|||
42076316|NCT00867308|75886514|FG001|Overall Study|Lack of Efficacy|12|||
42076317|NCT00867308|75886513|FG000|Overall Study|Withdrawal by Subject|1|||
42076318|NCT00867308|75886514|FG001|Overall Study|Withdrawal by Subject|2|||
42076319|NCT00849186|75886520|FG000|Overall Study|Adverse Event|2|||
42076320|NCT00849186|75886520|FG000|Overall Study|Withdrawal by Subject|1|||
42076321|NCT00849186|75886520|FG000|Overall Study|not treated|6|||
42076322|NCT00849186|75886520|FG000|Overall Study|Other|1|||
42076323|NCT00866918|75886527|FG000|Overall Study|Death|1|||
42076324|NCT00866918|75886528|FG001|Overall Study|Death|5|||
42076325|NCT00866918|75886527|FG000|Overall Study|Lack of Efficacy|1|||
42076326|NCT00866918|75886528|FG001|Overall Study|Lack of Efficacy|1|||
42076327|NCT00866918|75886527|FG000|Overall Study|Physician Decision|10|||
42076328|NCT00866918|75886528|FG001|Overall Study|Physician Decision|2|||
42076329|NCT00866918|75886527|FG000|Overall Study|Ineligible|2|||
42076330|NCT00866918|75886528|FG001|Overall Study|Ineligible|4|||
42076331|NCT00866918|75886527|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
42076332|NCT00866918|75886528|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
42076333|NCT00866918|75886527|FG000|Overall Study|Secondary malignancy|1|||
42076334|NCT00866918|75886528|FG001|Overall Study|Secondary malignancy|0|||
42076335|NCT03158285|75886537|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
42076336|NCT03158285|75886538|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
42076337|NCT03158285|75886539|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
42076338|NCT03158285|75886537|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
42076339|NCT03158285|75886538|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
42076340|NCT03158285|75886539|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
42076341|NCT03158285|75886537|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
42076342|NCT03158285|75886538|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
42076343|NCT03158285|75886539|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
42076344|NCT03158285|75886537|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
42076345|NCT03158285|75886538|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
42076346|NCT03158285|75886539|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
42076347|NCT03158285|75886537|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
42076348|NCT03158285|75886538|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
42076349|NCT03158285|75886539|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
42076350|NCT03158285|75886537|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
42076351|NCT03158285|75886538|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
42076352|NCT03158285|75886539|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
42076353|NCT03158285|75886537|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
42076354|NCT03158285|75886538|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
42177762|NCT03137992|75984989|FG002|Washout Period 1|COPD Exacerbation|1|||
42177763|NCT03137992|75984990|FG003|Washout Period 1|COPD Exacerbation|0|||
42076355|NCT03158285|75886539|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
42076356|NCT03158285|75886537|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
42076357|NCT03158285|75886538|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
42177764|NCT03137992|75984991|FG004|Washout Period 1|COPD Exacerbation|1|||
42076358|NCT03158285|75886539|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
42076359|NCT03158285|75886537|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
42177765|NCT03137992|75984992|FG005|Washout Period 1|COPD Exacerbation|1|||
42076360|NCT03158285|75886538|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
42076361|NCT03158285|75886539|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
42076362|NCT03158285|75886537|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
42076363|NCT03158285|75886538|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
42076364|NCT03158285|75886539|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
42076365|NCT03158285|75886537|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
42076366|NCT03158285|75886538|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
42076367|NCT03158285|75886539|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
42076368|NCT03158285|75886537|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
42076369|NCT03158285|75886538|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
42076370|NCT03158285|75886539|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
42076371|NCT03158285|75886537|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
42076372|NCT03158285|75886538|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
42076373|NCT03158285|75886539|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
42076374|NCT03158285|75886537|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
42076375|NCT03158285|75886538|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
42076376|NCT03158285|75886539|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
42076377|NCT03158285|75886537|FG000|Active Treatment Period: Week 52-100|Death|1|||
42076378|NCT03158285|75886538|FG001|Active Treatment Period: Week 52-100|Death|0|||
42076379|NCT03158285|75886539|FG002|Active Treatment Period: Week 52-100|Death|0|||
42076380|NCT03158285|75886537|FG000|Active Treatment Period: Week 52-100|Other|4|||
42076381|NCT03158285|75886538|FG001|Active Treatment Period: Week 52-100|Other|1|||
42076382|NCT03158285|75886539|FG002|Active Treatment Period: Week 52-100|Other|0|||
42076383|NCT00861692|75886552|FG000|Overall Study|Death|6|||
42076384|NCT00602927|75886558|FG000|Period 1: 13 Days|Protocol Violation|2|||
42076385|NCT00602927|75886559|FG001|Period 1: 13 Days|Protocol Violation|4|||
42076386|NCT00602927|75886558|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
42076387|NCT00602927|75886559|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
42076388|NCT00602927|75886558|FG000|Period 1: 13 Days|Time|1|||
42076389|NCT00602927|75886559|FG001|Period 1: 13 Days|Time|0|||
42076390|NCT00602927|75886558|FG000|Period 1: 13 Days|Claustrophobia|0|||
42076391|NCT00602927|75886559|FG001|Period 1: 13 Days|Claustrophobia|1|||
42076392|NCT00602927|75886558|FG000|Period 2: 14 Days|Protocol Violation|0|||
42076393|NCT00602927|75886559|FG001|Period 2: 14 Days|Protocol Violation|2|||
42076394|NCT00602927|75886558|FG000|Period 3: 13 Days|Protocol Violation|0|||
42076395|NCT00602927|75886559|FG001|Period 3: 13 Days|Protocol Violation|1|||
42076396|NCT00602927|75886558|FG000|Period 3: 13 Days|MRI data quality|2|||
42076397|NCT00602927|75886559|FG001|Period 3: 13 Days|MRI data quality|2|||
42076398|NCT00602537|75886567|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
42076399|NCT00602537|75886568|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
42293533|NCT01594853|76127769|FG001|Overall Study|noncompliance with exercise|1|||
42076400|NCT00602537|75886567|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
42076401|NCT00602537|75886568|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
42076402|NCT00602537|75886567|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
42076403|NCT00602537|75886568|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
42076404|NCT00602537|75886567|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
42076405|NCT00602537|75886568|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
42076406|NCT00602537|75886567|FG000|Follow Up Study Comparison|Adverse Event|1|||
42076407|NCT00602537|75886568|FG001|Follow Up Study Comparison|Adverse Event|0|||
42076408|NCT00602537|75886567|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
42076409|NCT00602537|75886568|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
42076410|NCT00602537|75886567|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
42076411|NCT00602537|75886568|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
42076412|NCT00861614|75886576|FG000|Overall Study|Disease Progression|182|||
42076413|NCT00861614|75886577|FG001|Overall Study|Disease Progression|263|||
42076414|NCT00861614|75886576|FG000|Overall Study|Study Drug Toxicity|79|||
42076415|NCT00861614|75886577|FG001|Overall Study|Study Drug Toxicity|6|||
42076416|NCT00861614|75886576|FG000|Overall Study|Death|32|||
42293534|NCT01668797|76127786|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
42293535|NCT01668797|76127787|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
42076417|NCT00861614|75886577|FG001|Overall Study|Death|19|||
42076418|NCT00861614|75886576|FG000|Overall Study|Adverse Event|27|||
42076419|NCT00861614|75886577|FG001|Overall Study|Adverse Event|23|||
42177766|NCT03137992|75984987|FG000|Washout Period 1|Subject Noncompliance|1|||
42177767|NCT03137992|75984988|FG001|Washout Period 1|Subject Noncompliance|0|||
42293536|NCT01668797|76127788|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
42076420|NCT00861614|75886576|FG000|Overall Study|Withdrawal by Subject|34|||
42076421|NCT00861614|75886577|FG001|Overall Study|Withdrawal by Subject|35|||
42076422|NCT00861614|75886576|FG000|Overall Study|Other|17|||
42076423|NCT00861614|75886577|FG001|Overall Study|Other|22|||
42076424|NCT00485173|75886585|FG000|Overall Study|Death|4|||
42076425|NCT00485173|75886586|FG001|Overall Study|Death|3|||
42076426|NCT00485173|75886585|FG000|Overall Study|Lost to Follow-up|32|||
42076427|NCT00485173|75886586|FG001|Overall Study|Lost to Follow-up|61|||
42076428|NCT00495469|75886599|FG000|Overall Study|Adverse Event|0|||
42076429|NCT00495469|75886600|FG001|Overall Study|Adverse Event|1|||
42076430|NCT00495469|75886601|FG002|Overall Study|Adverse Event|3|||
42076431|NCT00495469|75886602|FG003|Overall Study|Adverse Event|0|||
42076432|NCT00495469|75886603|FG004|Overall Study|Adverse Event|1|||
42076433|NCT00495469|75886604|FG005|Overall Study|Adverse Event|1|||
42076434|NCT00495469|75886605|FG006|Overall Study|Adverse Event|1|||
42076435|NCT00495469|75886599|FG000|Overall Study|Lost to Follow-up|1|||
42076436|NCT00495469|75886600|FG001|Overall Study|Lost to Follow-up|1|||
42076437|NCT00495469|75886601|FG002|Overall Study|Lost to Follow-up|3|||
42076438|NCT00495469|75886602|FG003|Overall Study|Lost to Follow-up|1|||
42076439|NCT00495469|75886603|FG004|Overall Study|Lost to Follow-up|0|||
42076440|NCT00495469|75886604|FG005|Overall Study|Lost to Follow-up|0|||
42076441|NCT00495469|75886605|FG006|Overall Study|Lost to Follow-up|0|||
42076442|NCT00495469|75886599|FG000|Overall Study|Protocol Violation|0|||
42076443|NCT00495469|75886600|FG001|Overall Study|Protocol Violation|0|||
42076444|NCT00495469|75886601|FG002|Overall Study|Protocol Violation|0|||
42076445|NCT00495469|75886602|FG003|Overall Study|Protocol Violation|0|||
42076446|NCT00495469|75886603|FG004|Overall Study|Protocol Violation|1|||
42076447|NCT00495469|75886604|FG005|Overall Study|Protocol Violation|2|||
42076448|NCT00495469|75886605|FG006|Overall Study|Protocol Violation|0|||
42076449|NCT00495469|75886599|FG000|Overall Study|Withdrawal by Subject|5|||
42076450|NCT00495469|75886600|FG001|Overall Study|Withdrawal by Subject|3|||
42076451|NCT00495469|75886601|FG002|Overall Study|Withdrawal by Subject|1|||
42076452|NCT00495469|75886602|FG003|Overall Study|Withdrawal by Subject|3|||
42076453|NCT00495469|75886603|FG004|Overall Study|Withdrawal by Subject|3|||
42076454|NCT00495469|75886604|FG005|Overall Study|Withdrawal by Subject|2|||
42076455|NCT00495469|75886605|FG006|Overall Study|Withdrawal by Subject|3|||
42076456|NCT00495469|75886599|FG000|Overall Study|Lack of Efficacy|0|||
42076457|NCT00495469|75886600|FG001|Overall Study|Lack of Efficacy|0|||
42076458|NCT00495469|75886601|FG002|Overall Study|Lack of Efficacy|0|||
42076459|NCT00495469|75886602|FG003|Overall Study|Lack of Efficacy|0|||
42076460|NCT00495469|75886603|FG004|Overall Study|Lack of Efficacy|0|||
42076461|NCT00495469|75886604|FG005|Overall Study|Lack of Efficacy|0|||
42076462|NCT00495469|75886605|FG006|Overall Study|Lack of Efficacy|1|||
42076463|NCT00495469|75886599|FG000|Overall Study|Liver function test abnormality|0|||
42076464|NCT00495469|75886600|FG001|Overall Study|Liver function test abnormality|1|||
42076465|NCT00495469|75886601|FG002|Overall Study|Liver function test abnormality|0|||
42076466|NCT00495469|75886602|FG003|Overall Study|Liver function test abnormality|0|||
42076467|NCT00495469|75886603|FG004|Overall Study|Liver function test abnormality|0|||
42076468|NCT00495469|75886604|FG005|Overall Study|Liver function test abnormality|0|||
42076469|NCT00495469|75886605|FG006|Overall Study|Liver function test abnormality|0|||
42076470|NCT00495469|75886599|FG000|Overall Study|ST depression at randomisation in ECG|0|||
42076471|NCT00495469|75886600|FG001|Overall Study|ST depression at randomisation in ECG|1|||
42076472|NCT00495469|75886601|FG002|Overall Study|ST depression at randomisation in ECG|0|||
42076473|NCT00495469|75886602|FG003|Overall Study|ST depression at randomisation in ECG|0|||
42076474|NCT00495469|75886603|FG004|Overall Study|ST depression at randomisation in ECG|0|||
42076475|NCT00495469|75886604|FG005|Overall Study|ST depression at randomisation in ECG|0|||
42076476|NCT00495469|75886605|FG006|Overall Study|ST depression at randomisation in ECG|0|||
42076477|NCT00861380|75886635|FG000|Overall Study|Withdrawal Information not recorded|8427|||
42076478|NCT00861380|75886636|FG001|Overall Study|Withdrawal Information not recorded|9112|||
42076479|NCT00861380|75886637|FG002|Overall Study|Withdrawal Information not recorded|8872|||
42076480|NCT00861380|75886638|FG003|Overall Study|Withdrawal Information not recorded|3689|||
42076481|NCT00861380|75886639|FG004|Overall Study|Withdrawal Information not recorded|1812|||
42076482|NCT00861380|75886640|FG005|Overall Study|Withdrawal Information not recorded|6249|||
42076483|NCT00861380|75886641|FG006|Overall Study|Withdrawal Information not recorded|3020|||
42076484|NCT00495391|75886676|FG000|Overall Study|Lack of Efficacy|34|||
42076485|NCT00495391|75886677|FG001|Overall Study|Lack of Efficacy|18|||
42076486|NCT00495391|75886676|FG000|Overall Study|Withdrawal by Subject|2|||
42076487|NCT00495391|75886677|FG001|Overall Study|Withdrawal by Subject|3|||
42076488|NCT00869960|75886683|FG000|Overall Study|Lost to Follow-up|2|||
42076489|NCT00494299|75886689|FG000|Overall Study|Adverse Event|93|||
42076490|NCT00494299|75886690|FG001|Overall Study|Adverse Event|13|||
42076491|NCT00494299|75886689|FG000|Overall Study|Lost to Follow-up|1|||
42076492|NCT00494299|75886690|FG001|Overall Study|Lost to Follow-up|0|||
42076493|NCT00494299|75886689|FG000|Overall Study|Physician Decision|0|||
42076494|NCT00494299|75886690|FG001|Overall Study|Physician Decision|2|||
42076495|NCT00494299|75886689|FG000|Overall Study|Protocol Violation|1|||
42076496|NCT00494299|75886690|FG001|Overall Study|Protocol Violation|2|||
42076497|NCT00494299|75886689|FG000|Overall Study|Withdrawal by Subject|8|||
42076498|NCT00494299|75886690|FG001|Overall Study|Withdrawal by Subject|3|||
42076499|NCT00494299|75886689|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
42076500|NCT00494299|75886690|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
42076501|NCT00494299|75886689|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
42076502|NCT00494299|75886690|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
42076503|NCT00494299|75886689|FG000|Overall Study|Site Closed by Sponsor|6|||
42076504|NCT00494299|75886690|FG001|Overall Study|Site Closed by Sponsor|0|||
42076505|NCT00494299|75886689|FG000|Overall Study|Protocol Driven Decision Point|11|||
42076506|NCT00494299|75886690|FG001|Overall Study|Protocol Driven Decision Point|22|||
42076507|NCT00593684|75886698|FG000|Overall Study|Death|2|||
42076508|NCT00593684|75886699|FG001|Overall Study|Death|1|||
42076509|NCT02963831|75886709|FG000|Overall Study|Progressive Disease|3|||
42076510|NCT02963831|75886710|FG001|Overall Study|Progressive Disease|3|||
42076511|NCT02963831|75886711|FG002|Overall Study|Progressive Disease|16|||
42076512|NCT02963831|75886712|FG003|Overall Study|Progressive Disease|27|||
42076513|NCT02963831|75886709|FG000|Overall Study|Withdrawal by Subject|1|||
42076514|NCT02963831|75886710|FG001|Overall Study|Withdrawal by Subject|0|||
42076515|NCT02963831|75886711|FG002|Overall Study|Withdrawal by Subject|2|||
42076516|NCT02963831|75886712|FG003|Overall Study|Withdrawal by Subject|4|||
42076517|NCT02963831|75886709|FG000|Overall Study|Adverse Event|0|||
42076518|NCT02963831|75886710|FG001|Overall Study|Adverse Event|1|||
42076519|NCT02963831|75886711|FG002|Overall Study|Adverse Event|1|||
42076520|NCT02963831|75886712|FG003|Overall Study|Adverse Event|2|||
42076521|NCT02963831|75886709|FG000|Overall Study|Death|0|||
42076522|NCT02963831|75886710|FG001|Overall Study|Death|0|||
42076523|NCT02963831|75886711|FG002|Overall Study|Death|0|||
42076524|NCT02963831|75886712|FG003|Overall Study|Death|2|||
42076525|NCT00859898|75886727|FG000|Overall Study|Lack of Efficacy|0|||
42076526|NCT00859898|75886728|FG001|Overall Study|Lack of Efficacy|1|||
42076527|NCT00859898|75886729|FG002|Overall Study|Lack of Efficacy|1|||
42076528|NCT00859898|75886727|FG000|Overall Study|Adverse Event|4|||
42076529|NCT00859898|75886728|FG001|Overall Study|Adverse Event|9|||
42076530|NCT00859898|75886729|FG002|Overall Study|Adverse Event|8|||
42076531|NCT00859898|75886727|FG000|Overall Study|Withdrawal by Subject|11|||
42076532|NCT00859898|75886728|FG001|Overall Study|Withdrawal by Subject|8|||
42076533|NCT00859898|75886729|FG002|Overall Study|Withdrawal by Subject|11|||
42076534|NCT00859898|75886727|FG000|Overall Study|Death|0|||
42076535|NCT00859898|75886728|FG001|Overall Study|Death|0|||
42076536|NCT00859898|75886729|FG002|Overall Study|Death|1|||
42076537|NCT00859898|75886727|FG000|Overall Study|Lost to Follow-up|10|||
42076538|NCT00859898|75886728|FG001|Overall Study|Lost to Follow-up|11|||
42076539|NCT00859898|75886729|FG002|Overall Study|Lost to Follow-up|5|||
42076540|NCT00859898|75886727|FG000|Overall Study|poor/non-compliance|2|||
42076541|NCT00859898|75886728|FG001|Overall Study|poor/non-compliance|0|||
42076542|NCT00859898|75886729|FG002|Overall Study|poor/non-compliance|0|||
42076543|NCT00859898|75886727|FG000|Overall Study|No longer meets criteria|0|||
42076544|NCT00859898|75886728|FG001|Overall Study|No longer meets criteria|1|||
42076545|NCT00859898|75886729|FG002|Overall Study|No longer meets criteria|0|||
42076546|NCT00859898|75886727|FG000|Overall Study|non-specified|1|||
42076547|NCT00859898|75886728|FG001|Overall Study|non-specified|1|||
42076548|NCT00859898|75886729|FG002|Overall Study|non-specified|1|||
42076549|NCT00859586|75886738|FG000|Overall Study|Donors|4|||
42076550|NCT00494221|75886745|FG000|Overall Study|Death|15|||
42076551|NCT00494221|75886746|FG001|Overall Study|Death|9|||
42076552|NCT00494221|75886747|FG002|Overall Study|Death|14|||
42076553|NCT00494221|75886745|FG000|Overall Study|Withdrawal by Subject|1|||
42076554|NCT00494221|75886746|FG001|Overall Study|Withdrawal by Subject|2|||
42076555|NCT00494221|75886747|FG002|Overall Study|Withdrawal by Subject|0|||
42076556|NCT00857948|75886759|FG000|Overall Study|Withdrawal by Subject|2|||
42076557|NCT00857948|75886760|FG001|Overall Study|Withdrawal by Subject|0|||
42076558|NCT00857948|75886761|FG002|Overall Study|Withdrawal by Subject|0|||
42076559|NCT00857948|75886762|FG003|Overall Study|Withdrawal by Subject|0|||
42076560|NCT00857948|75886759|FG000|Overall Study|Protocol Violation|1|||
42293537|NCT01668797|76127789|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
42293538|NCT01668797|76127786|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
42293539|NCT01668797|76127787|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
42293540|NCT01668797|76127788|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
42293541|NCT01668797|76127789|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
42293542|NCT01668797|76127786|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
42076561|NCT00857948|75886760|FG001|Overall Study|Protocol Violation|0|||
42076562|NCT00857948|75886761|FG002|Overall Study|Protocol Violation|1|||
42076563|NCT00857948|75886762|FG003|Overall Study|Protocol Violation|0|||
42076564|NCT00866606|75886772|FG000|Overall Study|Lost to Follow-up|3|||
42076565|NCT00866606|75886772|FG000|Overall Study|Adverse Event|1|||
42076566|NCT00857792|75886776|FG000|Overall Study|inadequate image quality for analysis|12|||
42076567|NCT00601835|75886782|FG000|Overall Study|Withdrawal by Subject|9|||
42076568|NCT00601835|75886783|FG001|Overall Study|Withdrawal by Subject|6|||
42076569|NCT00601835|75886782|FG000|Overall Study|Physician Decision|1|||
42076570|NCT00601835|75886783|FG001|Overall Study|Physician Decision|0|||
42076571|NCT00601835|75886782|FG000|Overall Study|Lost to Follow-up|37|||
42076572|NCT00601835|75886783|FG001|Overall Study|Lost to Follow-up|5|||
42076573|NCT00601835|75886782|FG000|Overall Study|Adverse Event|1|||
42076574|NCT00601835|75886783|FG001|Overall Study|Adverse Event|1|||
42076575|NCT00601835|75886782|FG000|Overall Study|Relocate|12|||
42076576|NCT00601835|75886783|FG001|Overall Study|Relocate|2|||
42076577|NCT00857246|75886789|FG000|Induction Regimen|Adverse Event|1|||
42076578|NCT00857246|75886789|FG000|Induction Regimen|disease-related complications|1|||
42076579|NCT00857246|75886789|FG000|Induction Regimen|Withdrawal by Subject|1|||
42076580|NCT00857246|75886789|FG000|Surgery (Curative)|disease progression|6|||
42076581|NCT00857246|75886789|FG000|ChemoRT|Withdrawal by Subject|1|||
42076582|NCT00857246|75886789|FG000|ChemoRT|Adverse Event|2|||
42076583|NCT00856856|75886796|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
42076584|NCT00856856|75886796|FG000|4-year Clinical Follow-up|Missed visit|1|||
42076585|NCT00493285|75886811|FG000|Overall Study|Lost to Follow-up|0|||
42076586|NCT00493285|75886812|FG001|Overall Study|Lost to Follow-up|0|||
42076587|NCT00493285|75886813|FG002|Overall Study|Lost to Follow-up|0|||
42076588|NCT00493285|75886814|FG003|Overall Study|Lost to Follow-up|0|||
42076589|NCT00493285|75886815|FG004|Overall Study|Lost to Follow-up|1|||
42076590|NCT00493285|75886816|FG005|Overall Study|Lost to Follow-up|0|||
42076591|NCT00856778|75886830|FG000|Overall Study|Adverse Event|7|||
42076592|NCT00856778|75886830|FG000|Overall Study|Withdrawal by Subject|10|||
42076593|NCT00856778|75886830|FG000|Overall Study|Study deviation|2|||
42076594|NCT00856778|75886830|FG000|Overall Study|Lost to Follow-up|5|||
42076595|NCT00603473|75886834|FG000|Overall Study|Adverse Event|4|||
42076596|NCT00603473|75886834|FG000|Overall Study|Lack of Efficacy|4|||
42076597|NCT00603473|75886834|FG000|Overall Study|Protocol Violation|1|||
42076598|NCT00486889|75886838|FG000|Overall Study|Death|3|||
42076599|NCT00486889|75886838|FG000|Overall Study|Non-compliant|2|||
42076600|NCT00486889|75886838|FG000|Overall Study|Withdrawal by Subject|6|||
42076601|NCT00486811|75886845|FG000|Overall Study|Adverse Event|28|||
42076602|NCT00486811|75886846|FG001|Overall Study|Adverse Event|60|||
42076603|NCT00486811|75886847|FG002|Overall Study|Adverse Event|135|||
42076604|NCT00486811|75886845|FG000|Overall Study|Lack of Efficacy|34|||
42076605|NCT00486811|75886846|FG001|Overall Study|Lack of Efficacy|14|||
42076606|NCT00486811|75886847|FG002|Overall Study|Lack of Efficacy|7|||
42076607|NCT00486811|75886845|FG000|Overall Study|Lost to Follow-up|4|||
42076608|NCT00486811|75886846|FG001|Overall Study|Lost to Follow-up|6|||
42076609|NCT00486811|75886847|FG002|Overall Study|Lost to Follow-up|4|||
42076610|NCT00486811|75886845|FG000|Overall Study|Withdrawal by Subject|33|||
42076611|NCT00486811|75886846|FG001|Overall Study|Withdrawal by Subject|44|||
42076612|NCT00486811|75886847|FG002|Overall Study|Withdrawal by Subject|58|||
42076613|NCT00486811|75886845|FG000|Overall Study|Study drug non-compliant|5|||
42076614|NCT00486811|75886846|FG001|Overall Study|Study drug non-compliant|6|||
42076615|NCT00486811|75886847|FG002|Overall Study|Study drug non-compliant|3|||
42076616|NCT00486811|75886845|FG000|Overall Study|All other|18|||
42076617|NCT00486811|75886846|FG001|Overall Study|All other|11|||
42076618|NCT00486811|75886847|FG002|Overall Study|All other|7|||
42076619|NCT00486265|75886855|FG000|Overall Study|Adverse Event|1|||
42076620|NCT00486265|75886855|FG000|Overall Study|Lack of Efficacy|8|||
42076621|NCT02151604|75886859|FG000|Overall Study|Lost to Follow-up|3|||
42076622|NCT02151604|75886859|FG000|Overall Study|Withdrawal by Subject|2|||
42076623|NCT02151604|75886859|FG000|Overall Study|Physician Decision|3|||
42076624|NCT02151604|75886859|FG000|Overall Study|Death|1|||
42076625|NCT00466921|75886864|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
42076626|NCT00466921|75886864|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
42076627|NCT00466921|75886864|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
42076628|NCT00466921|75886864|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
42076629|NCT00466921|75886864|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
42076630|NCT00466921|75886864|FG000|Follow up for a Minimum of 1 Year|Death|6|||
42076631|NCT00601523|75886870|FG000|Overall Study|Adverse Event|42|||
42076632|NCT00601523|75886871|FG001|Overall Study|Adverse Event|14|||
42076633|NCT00601523|75886870|FG000|Overall Study|Lack of Efficacy|3|||
42076634|NCT00601523|75886871|FG001|Overall Study|Lack of Efficacy|0|||
42076635|NCT00601523|75886870|FG000|Overall Study|Protocol Violation|5|||
42076636|NCT00601523|75886871|FG001|Overall Study|Protocol Violation|1|||
42076637|NCT00601523|75886870|FG000|Overall Study|Lost to Follow-up|0|||
42076638|NCT00601523|75886871|FG001|Overall Study|Lost to Follow-up|1|||
42076639|NCT00601523|75886870|FG000|Overall Study|Withdrawal by Subject|18|||
42076640|NCT00601523|75886871|FG001|Overall Study|Withdrawal by Subject|9|||
42076641|NCT00601523|75886870|FG000|Overall Study|Other|9|||
42076642|NCT00601523|75886871|FG001|Overall Study|Other|1|||
42076643|NCT00466687|75886877|FG000|Overall Study|Adverse Event|1|||
42076644|NCT00466687|75886877|FG000|Overall Study|Other complicating illness|3|||
42076645|NCT00466687|75886877|FG000|Overall Study|Withdrawal by Subject|1|||
42076646|NCT00466687|75886877|FG000|Overall Study|Disease progression|29|||
42076647|NCT00465985|75886899|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
42076648|NCT00465985|75886900|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
42076649|NCT00465985|75886899|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
42076650|NCT00465985|75886900|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
42076651|NCT00465985|75886899|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
42357845|NCT01829347|76203366|FG000|VTI-210E|Study terminated prematurely|1|||
42076652|NCT00465985|75886900|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
42076653|NCT00465985|75886899|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
42076654|NCT00465985|75886900|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
42076655|NCT00454051|75886911|FG000|Overall Study|Adverse Event|1|||
42076656|NCT00454051|75886912|FG001|Overall Study|Adverse Event|2|||
42076657|NCT00454051|75886911|FG000|Overall Study|Withdrawal by Subject|1|||
42076658|NCT00454051|75886912|FG001|Overall Study|Withdrawal by Subject|0|||
42076659|NCT00454051|75886911|FG000|Overall Study|Protocol Violation|1|||
42076660|NCT00454051|75886912|FG001|Overall Study|Protocol Violation|1|||
42076661|NCT00484939|75886920|FG000|Overall Study|Death|9|||
42076662|NCT00484939|75886921|FG001|Overall Study|Death|13|||
42076663|NCT00484939|75886920|FG000|Overall Study|Adverse Event|22|||
42076664|NCT00484939|75886921|FG001|Overall Study|Adverse Event|12|||
42076665|NCT00484939|75886920|FG000|Overall Study|Patient Withdrew Consent|19|||
42076666|NCT00484939|75886921|FG001|Overall Study|Patient Withdrew Consent|10|||
42076667|NCT00484939|75886920|FG000|Overall Study|Protocol Violation|3|||
42076668|NCT00484939|75886921|FG001|Overall Study|Protocol Violation|3|||
42076669|NCT00484939|75886920|FG000|Overall Study|Lost to Follow-up|0|||
42076670|NCT00484939|75886921|FG001|Overall Study|Lost to Follow-up|3|||
42076671|NCT00484939|75886920|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
42076672|NCT00484939|75886921|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
42076673|NCT00484939|75886920|FG000|Overall Study|Disease progression|67|||
42076674|NCT00484939|75886921|FG001|Overall Study|Disease progression|88|||
42076675|NCT00484939|75886920|FG000|Overall Study|Screen Failure|2|||
42076676|NCT00484939|75886921|FG001|Overall Study|Screen Failure|2|||
42076677|NCT00484939|75886920|FG000|Overall Study|Reason Not Specified|11|||
42076678|NCT00484939|75886921|FG001|Overall Study|Reason Not Specified|6|||
42076679|NCT00453973|75886929|FG000|Overall Study|Adverse Event|4|||
42076680|NCT00453973|75886930|FG001|Overall Study|Adverse Event|9|||
42076681|NCT00453973|75886929|FG000|Overall Study|Withdrawal by Subject|7|||
42076682|NCT00453973|75886930|FG001|Overall Study|Withdrawal by Subject|6|||
42076683|NCT00453973|75886929|FG000|Overall Study|PI Decision|0|||
42076684|NCT00453973|75886930|FG001|Overall Study|PI Decision|2|||
42076685|NCT00453973|75886929|FG000|Overall Study|Relocation|1|||
42076686|NCT00453973|75886930|FG001|Overall Study|Relocation|0|||
42076687|NCT00453973|75886929|FG000|Overall Study|Renal transplant|1|||
42076688|NCT00453973|75886930|FG001|Overall Study|Renal transplant|1|||
42076689|NCT00453973|75886929|FG000|Overall Study|Site closed by sponsor|3|||
42076690|NCT00453973|75886930|FG001|Overall Study|Site closed by sponsor|0|||
42076691|NCT00453973|75886929|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
42076692|NCT00453973|75886930|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
42076693|NCT00465361|75886936|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
42076694|NCT00464815|75886942|FG000|Overall Study|Withdrawal by Subject|6|||
42076695|NCT00464815|75886943|FG001|Overall Study|Withdrawal by Subject|3|||
42076696|NCT00464737|75886952|FG000|Overall Study|Adverse Event|12|||
42076697|NCT00464737|75886953|FG001|Overall Study|Adverse Event|17|||
42076698|NCT00464737|75886954|FG002|Overall Study|Adverse Event|33|||
42076699|NCT00464737|75886952|FG000|Overall Study|Lack of Efficacy|7|||
42076700|NCT00464737|75886953|FG001|Overall Study|Lack of Efficacy|7|||
42076701|NCT00464737|75886954|FG002|Overall Study|Lack of Efficacy|4|||
42076702|NCT00464737|75886952|FG000|Overall Study|Withdrawal by Subject|5|||
42076703|NCT00464737|75886953|FG001|Overall Study|Withdrawal by Subject|3|||
42076704|NCT00464737|75886954|FG002|Overall Study|Withdrawal by Subject|5|||
42076705|NCT00464737|75886952|FG000|Overall Study|Protocol Violation|1|||
42076706|NCT00464737|75886953|FG001|Overall Study|Protocol Violation|1|||
42076707|NCT00464737|75886954|FG002|Overall Study|Protocol Violation|5|||
42076708|NCT00464737|75886952|FG000|Overall Study|Non-compliance|0|||
42076709|NCT00464737|75886953|FG001|Overall Study|Non-compliance|1|||
42076710|NCT00464737|75886954|FG002|Overall Study|Non-compliance|1|||
42076711|NCT00464737|75886952|FG000|Overall Study|Lost to Follow-up|5|||
42076712|NCT00464737|75886953|FG001|Overall Study|Lost to Follow-up|2|||
42076713|NCT00464737|75886954|FG002|Overall Study|Lost to Follow-up|5|||
42076714|NCT00464737|75886952|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
42076715|NCT00464737|75886953|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
42076716|NCT00464737|75886954|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
42076717|NCT00464737|75886952|FG000|Overall Study|Other: Subject left town; family illness|1|||
42076718|NCT00464737|75886953|FG001|Overall Study|Other: Subject left town; family illness|0|||
42293543|NCT01668797|76127787|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
42076719|NCT00464737|75886954|FG002|Overall Study|Other: Subject left town; family illness|0|||
42293544|NCT01668797|76127788|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
42076720|NCT00464737|75886952|FG000|Overall Study|Other: Study demands too great|0|||
42076721|NCT00464737|75886953|FG001|Overall Study|Other: Study demands too great|1|||
42076722|NCT00464737|75886954|FG002|Overall Study|Other: Study demands too great|0|||
42076723|NCT00464737|75886952|FG000|Overall Study|Other: Personal family reasons|0|||
42076724|NCT00464737|75886953|FG001|Overall Study|Other: Personal family reasons|0|||
42076725|NCT00464737|75886954|FG002|Overall Study|Other: Personal family reasons|1|||
42076726|NCT00464737|75886952|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
42076727|NCT00464737|75886953|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
42076728|NCT00464737|75886954|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
42076729|NCT00453349|75886964|FG000|Randomized|Adverse Event|12|||
42076730|NCT00453349|75886965|FG001|Randomized|Adverse Event|11|||
42076731|NCT00453349|75886964|FG000|Randomized|Lack of Efficacy|2|||
42076732|NCT00453349|75886965|FG001|Randomized|Lack of Efficacy|1|||
42076733|NCT00453349|75886964|FG000|Randomized|Lost to Follow-up|7|||
42076734|NCT00453349|75886965|FG001|Randomized|Lost to Follow-up|5|||
42076735|NCT00453349|75886964|FG000|Randomized|Protocol Violation|1|||
42076736|NCT00453349|75886965|FG001|Randomized|Protocol Violation|1|||
42076737|NCT00453349|75886964|FG000|Randomized|Withdrawal by Subject|3|||
42076738|NCT00453349|75886965|FG001|Randomized|Withdrawal by Subject|5|||
42076739|NCT00453349|75886964|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
42076740|NCT00453349|75886965|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
42076741|NCT00453349|75886964|FG000|Completed Study|Adverse Event|12|||
42076742|NCT00453349|75886965|FG001|Completed Study|Adverse Event|11|||
42076743|NCT00453349|75886964|FG000|Completed Study|Lack of Efficacy|2|||
42076744|NCT00453349|75886965|FG001|Completed Study|Lack of Efficacy|1|||
42076745|NCT00453349|75886964|FG000|Completed Study|Lost to Follow-up|7|||
42076746|NCT00453349|75886965|FG001|Completed Study|Lost to Follow-up|5|||
42076747|NCT00453349|75886964|FG000|Completed Study|Protocol Violation|1|||
42076748|NCT00453349|75886965|FG001|Completed Study|Protocol Violation|1|||
42076749|NCT00453349|75886964|FG000|Completed Study|Withdrawal by Subject|3|||
42076750|NCT00453349|75886965|FG001|Completed Study|Withdrawal by Subject|5|||
42076751|NCT00453349|75886964|FG000|Completed Study|Lost to follow up after study treatment|2|||
42076752|NCT00453349|75886965|FG001|Completed Study|Lost to follow up after study treatment|11|||
42076753|NCT00464269|75886975|FG000|Overall Study|Lack of Efficacy|1|||
42076754|NCT00464269|75886976|FG001|Overall Study|Lack of Efficacy|0|||
42076755|NCT00464269|75886977|FG002|Overall Study|Lack of Efficacy|0|||
42076756|NCT00464269|75886978|FG003|Overall Study|Lack of Efficacy|0|||
42076757|NCT00464269|75886975|FG000|Overall Study|Lost to Follow-up|0|||
42076758|NCT00464269|75886976|FG001|Overall Study|Lost to Follow-up|4|||
42076759|NCT00464269|75886977|FG002|Overall Study|Lost to Follow-up|0|||
42076760|NCT00464269|75886978|FG003|Overall Study|Lost to Follow-up|1|||
42076761|NCT00464269|75886975|FG000|Overall Study|Withdrawal by Subject|0|||
42076762|NCT00464269|75886976|FG001|Overall Study|Withdrawal by Subject|2|||
42076763|NCT00464269|75886977|FG002|Overall Study|Withdrawal by Subject|1|||
42076764|NCT00464269|75886978|FG003|Overall Study|Withdrawal by Subject|1|||
42076765|NCT00464269|75886975|FG000|Overall Study|Other reason|3|||
42076766|NCT00464269|75886976|FG001|Overall Study|Other reason|3|||
42076767|NCT00464269|75886977|FG002|Overall Study|Other reason|1|||
42076768|NCT00464269|75886978|FG003|Overall Study|Other reason|1|||
42076769|NCT00464269|75886975|FG000|Overall Study|AE, serious fatal|0|||
42076770|NCT00464269|75886976|FG001|Overall Study|AE, serious fatal|0|||
42076771|NCT00464269|75886977|FG002|Overall Study|AE, serious fatal|1|||
42076772|NCT00464269|75886978|FG003|Overall Study|AE, serious fatal|1|||
42076773|NCT00464269|75886975|FG000|Overall Study|SAE, non-fatal|0|||
42076774|NCT00464269|75886976|FG001|Overall Study|SAE, non-fatal|0|||
42076775|NCT00464269|75886977|FG002|Overall Study|SAE, non-fatal|0|||
42076776|NCT00464269|75886978|FG003|Overall Study|SAE, non-fatal|1|||
42076777|NCT00464269|75886975|FG000|Overall Study|AE, non-serious non-fatal|2|||
42076778|NCT00464269|75886976|FG001|Overall Study|AE, non-serious non-fatal|8|||
42076779|NCT00464269|75886977|FG002|Overall Study|AE, non-serious non-fatal|3|||
42076780|NCT00464269|75886978|FG003|Overall Study|AE, non-serious non-fatal|4|||
42076781|NCT00464269|75886975|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
42076782|NCT00464269|75886976|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
42076783|NCT00464269|75886977|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
42076784|NCT00464269|75886978|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
42076785|NCT00484315|75886992|FG000|12-Month Clinical Follow-up|Death|6|||
42076786|NCT00484315|75886993|FG001|12-Month Clinical Follow-up|Death|2|||
42076787|NCT00484315|75886992|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
42076788|NCT00484315|75886993|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
42076789|NCT00484315|75886992|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
42076790|NCT00484315|75886993|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
42076791|NCT00484315|75886992|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
42076792|NCT00484315|75886993|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
42076793|NCT00484315|75886992|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
42076794|NCT00484315|75886993|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
42076795|NCT00484315|75886992|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
42076796|NCT00484315|75886993|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
42076797|NCT00484315|75886992|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
42076798|NCT00484315|75886993|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
42076799|NCT00463801|75886999|FG000|Overall Study|Protocol Violation|1|||
42076800|NCT00463801|75886999|FG000|Overall Study|Lack of Efficacy|2|||
42076801|NCT00463801|75886999|FG000|Overall Study|Adverse Event|4|||
42076802|NCT00463801|75886999|FG000|Overall Study|Lost to Follow-up|5|||
42076803|NCT00463801|75886999|FG000|Overall Study|No longer require therapy|1|||
42076804|NCT00463567|75887010|FG000|Overall Study|Adverse Event|29|||
42076805|NCT00463567|75887011|FG001|Overall Study|Adverse Event|26|||
42177768|NCT03137992|75984989|FG002|Washout Period 1|Subject Noncompliance|0|||
42177769|NCT03137992|75984990|FG003|Washout Period 1|Subject Noncompliance|0|||
42177770|NCT03137992|75984991|FG004|Washout Period 1|Subject Noncompliance|1|||
42177771|NCT03137992|75984992|FG005|Washout Period 1|Subject Noncompliance|0|||
42177772|NCT03137992|75984987|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
42177773|NCT03137992|75984988|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
42177774|NCT03137992|75984989|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
42177775|NCT03137992|75984990|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
42177776|NCT03137992|75984991|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
42177777|NCT03137992|75984992|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
42177778|NCT03137992|75984987|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
42177779|NCT03137992|75984988|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
42293545|NCT01668797|76127789|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
42293546|NCT01668797|76127786|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
42293547|NCT01668797|76127787|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
42293548|NCT01668797|76127788|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
42293549|NCT01668797|76127789|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
42076806|NCT00463567|75887012|FG002|Overall Study|Adverse Event|17|||
42076807|NCT00463567|75887013|FG003|Overall Study|Adverse Event|46|||
42076808|NCT00463567|75887014|FG004|Overall Study|Adverse Event|10|||
42076809|NCT00463567|75887015|FG005|Overall Study|Adverse Event|10|||
42076810|NCT00463567|75887016|FG006|Overall Study|Adverse Event|4|||
42076811|NCT00463567|75887010|FG000|Overall Study|Withdrawal by Subject|29|||
42076812|NCT00463567|75887011|FG001|Overall Study|Withdrawal by Subject|22|||
42076813|NCT00463567|75887012|FG002|Overall Study|Withdrawal by Subject|20|||
42076814|NCT00463567|75887013|FG003|Overall Study|Withdrawal by Subject|37|||
42076815|NCT00463567|75887014|FG004|Overall Study|Withdrawal by Subject|6|||
42076816|NCT00463567|75887015|FG005|Overall Study|Withdrawal by Subject|5|||
42076817|NCT00463567|75887016|FG006|Overall Study|Withdrawal by Subject|1|||
42076818|NCT00463567|75887010|FG000|Overall Study|Protocol Deviation|13|||
42076819|NCT00463567|75887011|FG001|Overall Study|Protocol Deviation|9|||
42076820|NCT00463567|75887012|FG002|Overall Study|Protocol Deviation|14|||
42076821|NCT00463567|75887013|FG003|Overall Study|Protocol Deviation|11|||
42076822|NCT00463567|75887014|FG004|Overall Study|Protocol Deviation|1|||
42076823|NCT00463567|75887015|FG005|Overall Study|Protocol Deviation|1|||
42076824|NCT00463567|75887016|FG006|Overall Study|Protocol Deviation|2|||
42076825|NCT00463567|75887010|FG000|Overall Study|Lost to Follow-up|12|||
42076826|NCT00463567|75887011|FG001|Overall Study|Lost to Follow-up|6|||
42076827|NCT00463567|75887012|FG002|Overall Study|Lost to Follow-up|13|||
42076828|NCT00463567|75887013|FG003|Overall Study|Lost to Follow-up|8|||
42076829|NCT00463567|75887014|FG004|Overall Study|Lost to Follow-up|1|||
42076830|NCT00463567|75887015|FG005|Overall Study|Lost to Follow-up|1|||
42076831|NCT00463567|75887016|FG006|Overall Study|Lost to Follow-up|1|||
42076832|NCT00463567|75887010|FG000|Overall Study|Administrative problems|5|||
42076833|NCT00463567|75887011|FG001|Overall Study|Administrative problems|3|||
42076834|NCT00463567|75887012|FG002|Overall Study|Administrative problems|6|||
42076835|NCT00463567|75887013|FG003|Overall Study|Administrative problems|9|||
42076836|NCT00463567|75887014|FG004|Overall Study|Administrative problems|3|||
42076837|NCT00463567|75887015|FG005|Overall Study|Administrative problems|2|||
42076838|NCT00463567|75887016|FG006|Overall Study|Administrative problems|2|||
42076839|NCT00463567|75887010|FG000|Overall Study|Lack of Efficacy|4|||
42076840|NCT00463567|75887011|FG001|Overall Study|Lack of Efficacy|9|||
42076841|NCT00463567|75887012|FG002|Overall Study|Lack of Efficacy|9|||
42177780|NCT03137992|75984989|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
42177781|NCT03137992|75984990|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
42177782|NCT03137992|75984991|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
42293550|NCT01668797|76127786|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
42293551|NCT01668797|76127787|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
42076842|NCT00463567|75887013|FG003|Overall Study|Lack of Efficacy|17|||
42076843|NCT00463567|75887014|FG004|Overall Study|Lack of Efficacy|1|||
42076844|NCT00463567|75887015|FG005|Overall Study|Lack of Efficacy|0|||
42076845|NCT00463567|75887016|FG006|Overall Study|Lack of Efficacy|1|||
42076846|NCT00463567|75887010|FG000|Overall Study|Abnormal lab value(s)|1|||
42076847|NCT00463567|75887011|FG001|Overall Study|Abnormal lab value(s)|1|||
42293552|NCT01668797|76127788|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
42076848|NCT00463567|75887012|FG002|Overall Study|Abnormal lab value(s)|2|||
42076849|NCT00463567|75887013|FG003|Overall Study|Abnormal lab value(s)|1|||
42076850|NCT00463567|75887014|FG004|Overall Study|Abnormal lab value(s)|1|||
42076851|NCT00463567|75887015|FG005|Overall Study|Abnormal lab value(s)|0|||
42076852|NCT00463567|75887016|FG006|Overall Study|Abnormal lab value(s)|0|||
42177783|NCT03137992|75984992|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
42076853|NCT00463567|75887010|FG000|Overall Study|Abnormal test procedure result(s)|1|||
42076854|NCT00463567|75887011|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42076855|NCT00463567|75887012|FG002|Overall Study|Abnormal test procedure result(s)|6|||
42076856|NCT00463567|75887013|FG003|Overall Study|Abnormal test procedure result(s)|2|||
42076857|NCT00463567|75887014|FG004|Overall Study|Abnormal test procedure result(s)|0|||
42076858|NCT00463567|75887015|FG005|Overall Study|Abnormal test procedure result(s)|2|||
42076859|NCT00463567|75887016|FG006|Overall Study|Abnormal test procedure result(s)|0|||
42076860|NCT00463567|75887010|FG000|Overall Study|Death|1|||
42076861|NCT00463567|75887011|FG001|Overall Study|Death|0|||
42076862|NCT00463567|75887012|FG002|Overall Study|Death|2|||
42076863|NCT00463567|75887013|FG003|Overall Study|Death|0|||
42076864|NCT00463567|75887014|FG004|Overall Study|Death|0|||
42076865|NCT00463567|75887015|FG005|Overall Study|Death|0|||
42076866|NCT00463567|75887016|FG006|Overall Study|Death|0|||
42076867|NCT00484159|75887041|FG000|Overall Study|Lost to Follow-up|1|||
42076868|NCT00484159|75887042|FG001|Overall Study|Lost to Follow-up|1|||
42076869|NCT00484159|75887043|FG002|Overall Study|Lost to Follow-up|0|||
42076870|NCT00462865|75887051|FG000|Overall Study|Adverse Event|1|||
42076871|NCT03839641|75887057|FG000|Overall Study|Withdrawal by Subject|1|||
42076872|NCT03839641|75887058|FG001|Overall Study|Withdrawal by Subject|1|||
42076873|NCT00462709|75887066|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
42076874|NCT00462709|75887066|FG000|Overall Study|Lost to Follow-up|10|||
42076875|NCT00462709|75887066|FG000|Overall Study|Withdrawal by Subject|8|||
42076876|NCT00462709|75887066|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
42076877|NCT00462709|75887066|FG000|Overall Study|Death|2|||
42076878|NCT00462709|75887066|FG000|Overall Study|Logistical reasons|2|||
42076879|NCT00462709|75887066|FG000|Overall Study|Physician Decision|1|||
42076880|NCT00462709|75887066|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
42076881|NCT00461305|75887072|FG000|Treatment|Adverse Event|26|||
42076882|NCT00461305|75887073|FG001|Treatment|Adverse Event|3|||
42357846|NCT01829347|76203367|FG001|VTI-210E|Study terminated prematurely|5|||
42357847|NCT01394523|76203376|FG000|Overall Study|Unable to place block|1|||
42357848|NCT01394523|76203377|FG001|Overall Study|Unable to place block|0|||
42357849|NCT01394523|76203378|FG002|Overall Study|Unable to place block|0|||
42357850|NCT01857973|76203386|FG000|Overall Study|Subject did not meet required BG range|3|||
42357851|NCT01857973|76203386|FG000|Overall Study|drop out after 3 failed attempts|1|||
42357852|NCT01857973|76203386|FG000|Overall Study|Physician Decision|1|||
42357853|NCT01857583|76203394|FG000|Overall Study|Adverse Event|0|||
42357854|NCT01857583|76203395|FG001|Overall Study|Adverse Event|0|||
42357855|NCT01857583|76203396|FG002|Overall Study|Adverse Event|1|||
42357856|NCT01857583|76203397|FG003|Overall Study|Adverse Event|1|||
42357857|NCT01857583|76203394|FG000|Overall Study|Death|0|||
42357858|NCT01857583|76203395|FG001|Overall Study|Death|1|||
42357859|NCT01857583|76203396|FG002|Overall Study|Death|1|||
42076883|NCT00461305|75887072|FG000|Treatment|Lost to Follow-up|4|||
42076884|NCT00461305|75887073|FG001|Treatment|Lost to Follow-up|2|||
42076885|NCT00461305|75887072|FG000|Treatment|Protocol Violation|13|||
42076886|NCT00461305|75887073|FG001|Treatment|Protocol Violation|2|||
42076887|NCT00461305|75887072|FG000|Treatment|Withdrawal by Subject|48|||
42076888|NCT00461305|75887073|FG001|Treatment|Withdrawal by Subject|2|||
42076889|NCT00461305|75887072|FG000|Treatment|Never dispensed|5|||
42076890|NCT00461305|75887073|FG001|Treatment|Never dispensed|0|||
42076891|NCT00461305|75887072|FG000|Treatment|Study drug not taken|1|||
42076892|NCT00461305|75887073|FG001|Treatment|Study drug not taken|0|||
42076893|NCT00461305|75887072|FG000|Treatment|Partially missing diary|2|||
42076894|NCT00461305|75887073|FG001|Treatment|Partially missing diary|0|||
42076895|NCT00461305|75887072|FG000|Treatment|Other (missing drug etc)|2|||
42076896|NCT00461305|75887073|FG001|Treatment|Other (missing drug etc)|0|||
42076897|NCT00461305|75887072|FG000|Continued Treatment|Adverse Event|26|||
42076898|NCT00461305|75887073|FG001|Continued Treatment|Adverse Event|0|||
42076899|NCT00461305|75887072|FG000|Continued Treatment|Lost to Follow-up|4|||
42076900|NCT00461305|75887073|FG001|Continued Treatment|Lost to Follow-up|0|||
42076901|NCT00461305|75887072|FG000|Continued Treatment|Protocol Violation|13|||
42076902|NCT00461305|75887073|FG001|Continued Treatment|Protocol Violation|0|||
42076903|NCT00461305|75887072|FG000|Continued Treatment|Withdrawal by Subject|48|||
42076904|NCT00461305|75887073|FG001|Continued Treatment|Withdrawal by Subject|0|||
42177784|NCT03137992|75984987|FG000|Period 2 (Visit 3)|Adverse Event|0|||
42177785|NCT03137992|75984988|FG001|Period 2 (Visit 3)|Adverse Event|1|||
42177786|NCT03137992|75984989|FG002|Period 2 (Visit 3)|Adverse Event|0|||
42357860|NCT01857583|76203397|FG003|Overall Study|Death|0|||
42076905|NCT00461305|75887072|FG000|Continued Treatment|Partially missing diary|2|||
42076906|NCT00461305|75887073|FG001|Continued Treatment|Partially missing diary|0|||
42076907|NCT00461305|75887072|FG000|Continued Treatment|Other (missing drug etc)|2|||
42076908|NCT00461305|75887073|FG001|Continued Treatment|Other (missing drug etc)|0|||
42076909|NCT00856544|75887084|FG000|Overall Study|Randomized but not treated|3|||
42076910|NCT00856544|75887085|FG001|Overall Study|Randomized but not treated|0|||
42076911|NCT00856544|75887086|FG002|Overall Study|Randomized but not treated|0|||
42076912|NCT00856544|75887087|FG003|Overall Study|Randomized but not treated|0|||
42076913|NCT00856544|75887084|FG000|Overall Study|Death|0|||
42076914|NCT00856544|75887085|FG001|Overall Study|Death|2|||
42076915|NCT00856544|75887086|FG002|Overall Study|Death|0|||
42076916|NCT00856544|75887087|FG003|Overall Study|Death|0|||
42076917|NCT00856544|75887084|FG000|Overall Study|Adverse Event|20|||
42076918|NCT00856544|75887085|FG001|Overall Study|Adverse Event|29|||
42076919|NCT00856544|75887086|FG002|Overall Study|Adverse Event|2|||
42177787|NCT03137992|75984990|FG003|Period 2 (Visit 3)|Adverse Event|0|||
42177788|NCT03137992|75984991|FG004|Period 2 (Visit 3)|Adverse Event|0|||
42177789|NCT03137992|75984992|FG005|Period 2 (Visit 3)|Adverse Event|0|||
42177790|NCT03137992|75984987|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
42177791|NCT03137992|75984988|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
42177792|NCT03137992|75984989|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
42177793|NCT03137992|75984990|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
42177794|NCT03137992|75984991|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
42177795|NCT03137992|75984992|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
42177796|NCT03137992|75984987|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
42177797|NCT03137992|75984988|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
42177798|NCT03137992|75984989|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
42177799|NCT03137992|75984990|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
42177800|NCT03137992|75984991|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
42177801|NCT03137992|75984992|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
42177802|NCT03137992|75984987|FG000|Washout Period 2|COPD Exacerbation|1|||
42177803|NCT03137992|75984988|FG001|Washout Period 2|COPD Exacerbation|1|||
42177804|NCT03137992|75984989|FG002|Washout Period 2|COPD Exacerbation|0|||
42177805|NCT03137992|75984990|FG003|Washout Period 2|COPD Exacerbation|0|||
42177806|NCT03137992|75984991|FG004|Washout Period 2|COPD Exacerbation|1|||
42177807|NCT03137992|75984992|FG005|Washout Period 2|COPD Exacerbation|0|||
42177808|NCT03137992|75984987|FG000|Washout Period 2|Subject Non-compliance|0|||
42177809|NCT03137992|75984988|FG001|Washout Period 2|Subject Non-compliance|1|||
42177810|NCT03137992|75984989|FG002|Washout Period 2|Subject Non-compliance|0|||
42177811|NCT03137992|75984990|FG003|Washout Period 2|Subject Non-compliance|0|||
42177812|NCT03137992|75984991|FG004|Washout Period 2|Subject Non-compliance|0|||
42177813|NCT03137992|75984992|FG005|Washout Period 2|Subject Non-compliance|0|||
42177814|NCT03137992|75984987|FG000|Washout Period 2|Adverse Event|0|||
42177815|NCT03137992|75984988|FG001|Washout Period 2|Adverse Event|0|||
42177816|NCT03137992|75984989|FG002|Washout Period 2|Adverse Event|0|||
42177817|NCT03137992|75984990|FG003|Washout Period 2|Adverse Event|1|||
42177818|NCT03137992|75984991|FG004|Washout Period 2|Adverse Event|1|||
42177819|NCT03137992|75984992|FG005|Washout Period 2|Adverse Event|0|||
42177820|NCT03137992|75984987|FG000|Washout Period 2|Withdrawal by Subject|1|||
42177821|NCT03137992|75984988|FG001|Washout Period 2|Withdrawal by Subject|0|||
42177822|NCT03137992|75984989|FG002|Washout Period 2|Withdrawal by Subject|0|||
42177823|NCT03137992|75984990|FG003|Washout Period 2|Withdrawal by Subject|0|||
42177824|NCT03137992|75984991|FG004|Washout Period 2|Withdrawal by Subject|1|||
42177825|NCT03137992|75984992|FG005|Washout Period 2|Withdrawal by Subject|0|||
42177826|NCT03137992|75984987|FG000|Washout Period 2|Sponsor Decision|0|||
42177827|NCT03137992|75984988|FG001|Washout Period 2|Sponsor Decision|0|||
42177828|NCT03137992|75984989|FG002|Washout Period 2|Sponsor Decision|0|||
42177829|NCT03137992|75984990|FG003|Washout Period 2|Sponsor Decision|0|||
42177830|NCT03137992|75984991|FG004|Washout Period 2|Sponsor Decision|0|||
42177831|NCT03137992|75984992|FG005|Washout Period 2|Sponsor Decision|1|||
42177832|NCT03137992|75984987|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
42177833|NCT03137992|75984988|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
42293553|NCT01668797|76127789|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
42293554|NCT01668797|76127786|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
42293555|NCT01668797|76127787|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
42293556|NCT01668797|76127788|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
42177834|NCT03137992|75984989|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
42177835|NCT03137992|75984990|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
42177836|NCT03137992|75984991|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
42177837|NCT03137992|75984992|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
42177838|NCT03137992|75984987|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
42177839|NCT03137992|75984988|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
42177840|NCT03137992|75984989|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
42293557|NCT01668797|76127789|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
42076920|NCT00856544|75887087|FG003|Overall Study|Adverse Event|3|||
42177841|NCT03137992|75984990|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
42177842|NCT03137992|75984991|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
42177843|NCT03137992|75984992|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
42177844|NCT03137992|75984987|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
42076921|NCT00856544|75887084|FG000|Overall Study|Lack of Efficacy|16|||
42076922|NCT00856544|75887085|FG001|Overall Study|Lack of Efficacy|12|||
42177845|NCT03137992|75984988|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
42177846|NCT03137992|75984989|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
42357861|NCT01857583|76203394|FG000|Overall Study|Physician Decision|0|||
42076923|NCT00856544|75887086|FG002|Overall Study|Lack of Efficacy|3|||
42076924|NCT00856544|75887087|FG003|Overall Study|Lack of Efficacy|3|||
42076925|NCT00856544|75887084|FG000|Overall Study|Other|9|||
42076926|NCT00856544|75887085|FG001|Overall Study|Other|16|||
42076927|NCT00856544|75887086|FG002|Overall Study|Other|1|||
42076928|NCT00856544|75887087|FG003|Overall Study|Other|6|||
42076929|NCT00856544|75887084|FG000|Overall Study|Lost to Follow-up|1|||
42076930|NCT00856544|75887085|FG001|Overall Study|Lost to Follow-up|2|||
42076931|NCT00856544|75887086|FG002|Overall Study|Lost to Follow-up|2|||
42076932|NCT00856544|75887087|FG003|Overall Study|Lost to Follow-up|0|||
42076933|NCT00856544|75887084|FG000|Overall Study|Withdrawal by Subject|8|||
42076934|NCT00856544|75887085|FG001|Overall Study|Withdrawal by Subject|5|||
42076935|NCT00856544|75887086|FG002|Overall Study|Withdrawal by Subject|0|||
42076936|NCT00856544|75887087|FG003|Overall Study|Withdrawal by Subject|1|||
42076937|NCT00856388|75887109|FG000|Overall Study|Other|1|||
42076938|NCT00848354|75887116|FG000|Phase 1|Adverse Event|5|||
42076939|NCT00848354|75887117|FG001|Phase 1|Adverse Event|4|||
42076940|NCT00848354|75887116|FG000|Phase 1|Discontinuation of study by sponsor|2|||
42076941|NCT00848354|75887117|FG001|Phase 1|Discontinuation of study by sponsor|1|||
42076942|NCT00848354|75887116|FG000|Phase 1|Failed to return|0|||
42076943|NCT00848354|75887117|FG001|Phase 1|Failed to return|1|||
42076944|NCT00848354|75887116|FG000|Phase 1|Lost to Follow-up|1|||
42076945|NCT00848354|75887117|FG001|Phase 1|Lost to Follow-up|1|||
42076946|NCT00848354|75887116|FG000|Phase 1|Unspecified Reason|1|||
42076947|NCT00848354|75887117|FG001|Phase 1|Unspecified Reason|1|||
42076948|NCT00848354|75887116|FG000|Phase 1|Protocol Violation|1|||
42076949|NCT00848354|75887117|FG001|Phase 1|Protocol Violation|1|||
42076950|NCT00848354|75887116|FG000|Phase 1|Withdrawal by Subject|2|||
42076951|NCT00848354|75887117|FG001|Phase 1|Withdrawal by Subject|4|||
42076952|NCT00848354|75887116|FG000|Phase 1|Lack of Efficacy|0|||
42076953|NCT00848354|75887117|FG001|Phase 1|Lack of Efficacy|1|||
42076954|NCT00848354|75887116|FG000|Phase 2 Year 1|Adverse Event|7|||
42076955|NCT00848354|75887117|FG001|Phase 2 Year 1|Adverse Event|2|||
42076956|NCT00848354|75887116|FG000|Phase 2 Year 1|Death|1|||
42076957|NCT00848354|75887117|FG001|Phase 2 Year 1|Death|0|||
42076958|NCT00848354|75887116|FG000|Phase 2 Year 1|Failed to Return|1|||
42076959|NCT00848354|75887117|FG001|Phase 2 Year 1|Failed to Return|1|||
42076960|NCT00848354|75887116|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
42076961|NCT00848354|75887117|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
42076962|NCT00848354|75887116|FG000|Phase 2 Year 1|Unspecified Reason|3|||
42076963|NCT00848354|75887117|FG001|Phase 2 Year 1|Unspecified Reason|0|||
42076964|NCT00848354|75887116|FG000|Phase 2 Year 1|Protocol Violation|4|||
42076965|NCT00848354|75887117|FG001|Phase 2 Year 1|Protocol Violation|1|||
42076966|NCT00848354|75887116|FG000|Phase 2 Year 1|Subject Request|1|||
42076967|NCT00848354|75887117|FG001|Phase 2 Year 1|Subject Request|2|||
42076968|NCT00848354|75887116|FG000|Phase 2 Year 2|Adverse Event|12|||
42076969|NCT00848354|75887117|FG001|Phase 2 Year 2|Adverse Event|2|||
42076970|NCT00848354|75887116|FG000|Phase 2 Year 2|Death|2|||
42076971|NCT00848354|75887117|FG001|Phase 2 Year 2|Death|0|||
42177847|NCT03137992|75984990|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
42177848|NCT03137992|75984991|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
42177849|NCT03137992|75984992|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
42177850|NCT03137992|75984987|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
42177851|NCT03137992|75984988|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
42177852|NCT03137992|75984989|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
42177853|NCT03137992|75984990|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
42177854|NCT03137992|75984991|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
42177855|NCT03137992|75984992|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
42177856|NCT03137992|75984987|FG000|Part 2 (Open-label Extension)|Per study team|1|||
42177857|NCT03137992|75984988|FG001|Part 2 (Open-label Extension)|Per study team|0|||
42177858|NCT03137992|75984989|FG002|Part 2 (Open-label Extension)|Per study team|0|||
42177859|NCT03137992|75984990|FG003|Part 2 (Open-label Extension)|Per study team|0|||
42177860|NCT03137992|75984991|FG004|Part 2 (Open-label Extension)|Per study team|0|||
42177861|NCT03137992|75984992|FG005|Part 2 (Open-label Extension)|Per study team|0|||
42076972|NCT00848354|75887116|FG000|Phase 2 Year 2|Failed to return|3|||
42177862|NCT03137992|75984987|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
42076973|NCT00848354|75887117|FG001|Phase 2 Year 2|Failed to return|0|||
42076974|NCT00848354|75887116|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
42076975|NCT00848354|75887117|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
42076976|NCT00848354|75887116|FG000|Phase 2 Year 2|Unspecified Reason|1|||
42076977|NCT00848354|75887117|FG001|Phase 2 Year 2|Unspecified Reason|0|||
42076978|NCT00848354|75887116|FG000|Phase 2 Year 2|Protocol Violation|1|||
42076979|NCT00848354|75887117|FG001|Phase 2 Year 2|Protocol Violation|1|||
42076980|NCT00848354|75887116|FG000|Phase 2 Year 2|Subject Request|1|||
42076981|NCT00848354|75887117|FG001|Phase 2 Year 2|Subject Request|1|||
42076982|NCT00848354|75887116|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
42076983|NCT00848354|75887117|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
42076984|NCT00848198|75887127|FG000|Overall Study|Incomplete Case Report Forms|15|||
42076985|NCT00848120|75887135|FG000|Overall Study|Adverse Event|1|||
42076986|NCT00600821|75887141|FG000|Overall Study|Death|45|||
42076987|NCT00600821|75887142|FG001|Overall Study|Death|46|||
42076988|NCT00600821|75887141|FG000|Overall Study|Lost to Follow-up|2|||
42076989|NCT00600821|75887142|FG001|Overall Study|Lost to Follow-up|2|||
42076990|NCT00600821|75887141|FG000|Overall Study|Withdrawal by Subject|1|||
42076991|NCT00600821|75887142|FG001|Overall Study|Withdrawal by Subject|1|||
42076992|NCT00600821|75887141|FG000|Overall Study|Terminated by sponsor|8|||
42076993|NCT00600821|75887142|FG001|Overall Study|Terminated by sponsor|6|||
42076994|NCT00600821|75887141|FG000|Overall Study|Objective progression or relapse|0|||
42076995|NCT00600821|75887142|FG001|Overall Study|Objective progression or relapse|1|||
42076996|NCT00600821|75887141|FG000|Overall Study|Randomized but not treated|0|||
42076997|NCT00600821|75887142|FG001|Overall Study|Randomized but not treated|1|||
42076998|NCT00600821|75887141|FG000|Overall Study|Other|2|||
42076999|NCT00600821|75887142|FG001|Overall Study|Other|3|||
42077000|NCT00592904|75887154|FG000|Overall Study|Adverse Event|15|||
42077001|NCT00592904|75887155|FG001|Overall Study|Adverse Event|25|||
42077002|NCT00592904|75887156|FG002|Overall Study|Adverse Event|13|||
42077003|NCT00592904|75887157|FG003|Overall Study|Adverse Event|5|||
42077004|NCT00592904|75887154|FG000|Overall Study|Protocol Violation|1|||
42077005|NCT00592904|75887155|FG001|Overall Study|Protocol Violation|1|||
42077006|NCT00592904|75887156|FG002|Overall Study|Protocol Violation|0|||
42077007|NCT00592904|75887157|FG003|Overall Study|Protocol Violation|1|||
42077008|NCT00592904|75887154|FG000|Overall Study|Withdrawal by Subject|4|||
42077009|NCT00592904|75887155|FG001|Overall Study|Withdrawal by Subject|16|||
42077010|NCT00592904|75887156|FG002|Overall Study|Withdrawal by Subject|1|||
42077011|NCT00592904|75887157|FG003|Overall Study|Withdrawal by Subject|2|||
42077012|NCT00592904|75887154|FG000|Overall Study|Lack of Efficacy|2|||
42077013|NCT00592904|75887155|FG001|Overall Study|Lack of Efficacy|7|||
42077014|NCT00592904|75887156|FG002|Overall Study|Lack of Efficacy|2|||
42077015|NCT00592904|75887157|FG003|Overall Study|Lack of Efficacy|3|||
42077016|NCT00592904|75887154|FG000|Overall Study|Physician Decision|0|||
42077017|NCT00592904|75887155|FG001|Overall Study|Physician Decision|3|||
42077018|NCT00592904|75887156|FG002|Overall Study|Physician Decision|1|||
42077019|NCT00592904|75887157|FG003|Overall Study|Physician Decision|0|||
42077020|NCT00592904|75887154|FG000|Overall Study|Other|3|||
42077021|NCT00592904|75887155|FG001|Overall Study|Other|3|||
42077022|NCT00592904|75887156|FG002|Overall Study|Other|0|||
42077023|NCT00592904|75887157|FG003|Overall Study|Other|0|||
42077024|NCT00855920|75887170|FG000|Overall Study|Protocol Violation|0|||
42077025|NCT00855920|75887171|FG001|Overall Study|Protocol Violation|0|||
42077026|NCT00855920|75887172|FG002|Overall Study|Protocol Violation|2|||
42077027|NCT00855920|75887170|FG000|Overall Study|Adverse Event|2|||
42077028|NCT00855920|75887171|FG001|Overall Study|Adverse Event|1|||
42077029|NCT00855920|75887172|FG002|Overall Study|Adverse Event|1|||
42077030|NCT00855920|75887170|FG000|Overall Study|Lack of Efficacy|2|||
42077031|NCT00855920|75887171|FG001|Overall Study|Lack of Efficacy|2|||
42077032|NCT00855920|75887172|FG002|Overall Study|Lack of Efficacy|2|||
42077033|NCT00855920|75887170|FG000|Overall Study|Withdrawal by Subject|2|||
42077034|NCT00855920|75887171|FG001|Overall Study|Withdrawal by Subject|3|||
42077035|NCT00855920|75887172|FG002|Overall Study|Withdrawal by Subject|2|||
42077036|NCT00855920|75887170|FG000|Overall Study|Lost to Follow-up|1|||
42077037|NCT00855920|75887171|FG001|Overall Study|Lost to Follow-up|0|||
42077038|NCT00855920|75887172|FG002|Overall Study|Lost to Follow-up|2|||
42077039|NCT00855920|75887170|FG000|Overall Study|Death|0|||
42077040|NCT00855920|75887171|FG001|Overall Study|Death|1|||
42077041|NCT00855920|75887172|FG002|Overall Study|Death|0|||
42077042|NCT00855920|75887170|FG000|Overall Study|Decision by the sponsor|0|||
42077043|NCT00855920|75887171|FG001|Overall Study|Decision by the sponsor|1|||
42077044|NCT00855920|75887172|FG002|Overall Study|Decision by the sponsor|1|||
42077045|NCT00855920|75887170|FG000|Overall Study|Other than specified above|1|||
42077046|NCT00855920|75887171|FG001|Overall Study|Other than specified above|1|||
42077047|NCT00855920|75887172|FG002|Overall Study|Other than specified above|1|||
42077048|NCT00848042|75887183|FG000|Overall Study|Death|1|||
42077049|NCT00848042|75887184|FG001|Overall Study|Death|2|||
42077050|NCT00848042|75887185|FG002|Overall Study|Death|0|||
42077051|NCT00848042|75887183|FG000|Overall Study|Other Therapy|3|||
42077052|NCT00848042|75887184|FG001|Overall Study|Other Therapy|0|||
42077053|NCT00848042|75887185|FG002|Overall Study|Other Therapy|0|||
42077054|NCT00847886|75887195|FG000|Overall Study|Adverse Event|0|||
42077055|NCT00847886|75887196|FG001|Overall Study|Adverse Event|1|||
42077056|NCT00847808|75887202|FG000|Overall Study|Adverse Event|7|||
42077057|NCT00847808|75887202|FG000|Overall Study|Protocol Violation|1|||
42077058|NCT00847808|75887202|FG000|Overall Study|Lost to Follow-up|1|||
42077059|NCT00847808|75887202|FG000|Overall Study|Withdrawal by Subject|4|||
42077060|NCT00847808|75887202|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
42077061|NCT00847808|75887202|FG000|Overall Study|Participant Took Excluded Medication|1|||
42077062|NCT00600353|75887208|FG000|Overall Study|history of malignancy within 5 years|1|||
42077063|NCT00600353|75887209|FG001|Overall Study|history of malignancy within 5 years|0|||
42077064|NCT00600353|75887208|FG000|Overall Study|History of prepartive regimen|0|||
42077065|NCT00600353|75887209|FG001|Overall Study|History of prepartive regimen|1|||
42077066|NCT00691210|75887223|FG000|Overall Study|Progression of Disease|0|||
42077067|NCT00691210|75887224|FG001|Overall Study|Progression of Disease|0|||
42077068|NCT00691210|75887225|FG002|Overall Study|Progression of Disease|0|||
42077069|NCT00691210|75887226|FG003|Overall Study|Progression of Disease|2|||
42077070|NCT00691210|75887227|FG004|Overall Study|Progression of Disease|0|||
42077071|NCT00691210|75887228|FG005|Overall Study|Progression of Disease|0|||
42077072|NCT00691210|75887229|FG006|Overall Study|Progression of Disease|0|||
42077073|NCT00691210|75887230|FG007|Overall Study|Progression of Disease|0|||
42077074|NCT00691210|75887223|FG000|Overall Study|Lack of Efficacy|0|||
42077075|NCT00691210|75887224|FG001|Overall Study|Lack of Efficacy|0|||
42077076|NCT00691210|75887225|FG002|Overall Study|Lack of Efficacy|0|||
42077077|NCT00691210|75887226|FG003|Overall Study|Lack of Efficacy|1|||
42077078|NCT00691210|75887227|FG004|Overall Study|Lack of Efficacy|0|||
42077079|NCT00691210|75887228|FG005|Overall Study|Lack of Efficacy|1|||
42077080|NCT00691210|75887229|FG006|Overall Study|Lack of Efficacy|0|||
42077081|NCT00691210|75887230|FG007|Overall Study|Lack of Efficacy|0|||
42077082|NCT00691132|75887250|FG000|Overall Study|Adverse Event|2|||
42077083|NCT00691132|75887251|FG001|Overall Study|Adverse Event|3|||
42077084|NCT00691132|75887250|FG000|Overall Study|Withdrawal by Subject|10|||
42077085|NCT00691132|75887251|FG001|Overall Study|Withdrawal by Subject|10|||
42077086|NCT00855218|75887273|FG000|Overall Study|Adverse Event|43|||
42077087|NCT00855218|75887274|FG001|Overall Study|Adverse Event|27|||
42077088|NCT00855218|75887273|FG000|Overall Study|Withdrawal by Subject|10|||
42077089|NCT00855218|75887274|FG001|Overall Study|Withdrawal by Subject|6|||
42077090|NCT00855218|75887273|FG000|Overall Study|Physician Decision|18|||
42077091|NCT00855218|75887274|FG001|Overall Study|Physician Decision|11|||
42077092|NCT00855218|75887273|FG000|Overall Study|Lost to Follow-up|0|||
42077093|NCT00855218|75887274|FG001|Overall Study|Lost to Follow-up|1|||
42077094|NCT00855218|75887273|FG000|Overall Study|Protocol Violation|5|||
42077095|NCT00855218|75887274|FG001|Overall Study|Protocol Violation|9|||
42077096|NCT00855218|75887273|FG000|Overall Study|non-compliant with study drug|3|||
42077097|NCT00855218|75887274|FG001|Overall Study|non-compliant with study drug|1|||
42077098|NCT00855218|75887273|FG000|Overall Study|patient convenience|2|||
42077099|NCT00855218|75887274|FG001|Overall Study|patient convenience|0|||
42077100|NCT00855218|75887273|FG000|Overall Study|technical problems|2|||
42077101|NCT00855218|75887274|FG001|Overall Study|technical problems|1|||
42077102|NCT00855218|75887273|FG000|Overall Study|Still treated with study medication|0|||
42077103|NCT00855218|75887274|FG001|Overall Study|Still treated with study medication|1|||
42077104|NCT00855218|75887273|FG000|Overall Study|Untreatable disease progression|54|||
42077105|NCT00855218|75887274|FG001|Overall Study|Untreatable disease progression|67|||
42077106|NCT00855218|75887273|FG000|Overall Study|Second malignancy|0|||
42077107|NCT00855218|75887274|FG001|Overall Study|Second malignancy|1|||
42077108|NCT00855218|75887273|FG000|Overall Study|Progression measurement proven|7|||
42077109|NCT00855218|75887274|FG001|Overall Study|Progression measurement proven|15|||
42077110|NCT00855218|75887273|FG000|Overall Study|Clinical endpoint reached|10|||
42077111|NCT00855218|75887274|FG001|Overall Study|Clinical endpoint reached|13|||
42077112|NCT01063348|75887282|FG000|Overall Study|Lost to Follow-up|3|||
42077113|NCT01063348|75887283|FG001|Overall Study|Lost to Follow-up|10|||
42077114|NCT00855062|75887291|FG000|Step1|Early Study Closure|5|||
42077115|NCT00855062|75887292|FG001|Step1|Early Study Closure|7|||
42077116|NCT00855062|75887291|FG000|Step1|Adverse Event|1|||
42077117|NCT00855062|75887292|FG001|Step1|Adverse Event|1|||
42177863|NCT03137992|75984988|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
42177864|NCT03137992|75984989|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
42177865|NCT03137992|75984990|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
42177866|NCT03137992|75984991|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
42177867|NCT03137992|75984992|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
42177868|NCT03704636|75985000|FG000|Overall Study|Inadequate Venous Flow|3|||
42177869|NCT05096312|75985015|FG000|Overall Study|Lost to Follow-up|2|||
42177870|NCT05096312|75985016|FG001|Overall Study|Lost to Follow-up|4|||
42177871|NCT05096312|75985015|FG000|Overall Study|Adverse Event|1|||
42177872|NCT05096312|75985016|FG001|Overall Study|Adverse Event|0|||
42077118|NCT00855062|75887291|FG000|Step1|Protocol Violation|1|||
42077119|NCT00855062|75887292|FG001|Step1|Protocol Violation|0|||
42077120|NCT00855062|75887291|FG000|Step1|Pregnancy|1|||
42077121|NCT00855062|75887292|FG001|Step1|Pregnancy|0|||
42077122|NCT00855062|75887291|FG000|Step1|Withdrawal by Subject|2|||
42177873|NCT04908488|75985024|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
42077123|NCT00855062|75887292|FG001|Step1|Withdrawal by Subject|3|||
42077124|NCT00855062|75887291|FG000|Step2|Early Study Closure|6|||
42077125|NCT00855062|75887292|FG001|Step2|Early Study Closure|2|||
42077126|NCT00855062|75887291|FG000|Step2|Adverse Event|0|||
42077127|NCT00855062|75887292|FG001|Step2|Adverse Event|3|||
42077128|NCT00855062|75887291|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
42077129|NCT00855062|75887292|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
42077130|NCT00854906|75887298|FG000|Overall Study|One person had no ocular history|1|||
42077131|NCT00854828|75887309|FG000|Overall Study|Death|1|||
42077132|NCT00854828|75887310|FG001|Overall Study|Death|0|||
42077133|NCT00854828|75887311|FG002|Overall Study|Death|0|||
42077134|NCT00854828|75887312|FG003|Overall Study|Death|0|||
42077135|NCT00854828|75887309|FG000|Overall Study|Withdrawal by Subject|1|||
42077136|NCT00854828|75887310|FG001|Overall Study|Withdrawal by Subject|1|||
42077137|NCT00854828|75887311|FG002|Overall Study|Withdrawal by Subject|0|||
42077138|NCT00854828|75887312|FG003|Overall Study|Withdrawal by Subject|9|||
42077139|NCT00854828|75887309|FG000|Overall Study|Missed 24mo visit|1|||
42077140|NCT00854828|75887310|FG001|Overall Study|Missed 24mo visit|1|||
42077141|NCT00854828|75887311|FG002|Overall Study|Missed 24mo visit|8|||
42077142|NCT00854828|75887312|FG003|Overall Study|Missed 24mo visit|8|||
42077143|NCT00847730|75887322|FG000|Overall Study|Multiple interruptions in therapy|8|||
42077144|NCT00600119|75887332|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
42077145|NCT00600119|75887333|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
42077146|NCT00600119|75887334|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
42077147|NCT00600119|75887335|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
42077148|NCT00600119|75887336|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
42077149|NCT00600119|75887337|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
42077150|NCT00600119|75887332|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
42077151|NCT00600119|75887333|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
42077152|NCT00600119|75887334|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
42077153|NCT00600119|75887335|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
42077154|NCT00600119|75887336|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
42077155|NCT00600119|75887337|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
42077156|NCT00600119|75887332|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
42077157|NCT00600119|75887333|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
42077158|NCT00600119|75887334|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
42077159|NCT00600119|75887335|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
42017527|NCT01209624|75825231|FG000|Overall Study|Adverse Event|13|||
42077160|NCT00600119|75887336|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
42077161|NCT00600119|75887337|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
42077162|NCT00600119|75887332|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
42077163|NCT00600119|75887333|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
42077164|NCT00600119|75887334|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
42077165|NCT00600119|75887335|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
42077166|NCT00600119|75887336|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
42077167|NCT00600119|75887337|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
42017528|NCT01209624|75825231|FG000|Overall Study|Lack of Efficacy|17|||
42017529|NCT01209624|75825231|FG000|Overall Study|Lost to Follow-up|290|||
42017530|NCT01209624|75825231|FG000|Overall Study|Other|4|||
42017531|NCT00916279|75825235|FG000|Overall Study|Death|2|||
42017532|NCT00916279|75825235|FG000|Overall Study|Lost to Follow-up|2|||
42017533|NCT01209078|75825244|FG000|Overall Study|Adverse Event|5|||
42017534|NCT01209078|75825245|FG001|Overall Study|Adverse Event|0|||
42017535|NCT01209078|75825244|FG000|Overall Study|Lost to Follow-up|4|||
42017536|NCT01209078|75825245|FG001|Overall Study|Lost to Follow-up|0|||
42017537|NCT01209078|75825244|FG000|Overall Study|Physician Decision|5|||
42017538|NCT01209078|75825245|FG001|Overall Study|Physician Decision|2|||
42017539|NCT01209078|75825244|FG000|Overall Study|Withdrawal by Subject|2|||
42017540|NCT01209078|75825245|FG001|Overall Study|Withdrawal by Subject|1|||
42017541|NCT01207596|75825253|FG000|Overall Study|Physician Decision|4|||
42017542|NCT01207596|75825253|FG000|Overall Study|Lack of Efficacy|1|||
42017543|NCT01207596|75825253|FG000|Overall Study|Adverse Event|3|||
42017544|NCT01207596|75825253|FG000|Overall Study|Withdrawal by Subject|1|||
42017545|NCT00915343|75825257|FG000|Part B - Open Label Period|Treatment switch|0|||
42017546|NCT00915343|75825258|FG001|Part B - Open Label Period|Treatment switch|0|||
42017547|NCT00915343|75825259|FG002|Part B - Open Label Period|Treatment switch|1|||
42017548|NCT00915343|75825257|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
42017549|NCT00915343|75825258|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
42017550|NCT00915343|75825259|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
42017551|NCT00911989|75825271|FG000|Overall Study|Adverse Event|1|||
42017552|NCT00910273|75825277|FG000|Overall Study|Lack of Efficacy|6|||
42017553|NCT00910273|75825278|FG001|Overall Study|Lack of Efficacy|9|||
42017554|NCT00910273|75825277|FG000|Overall Study|Adverse Event|1|||
42017555|NCT00910273|75825278|FG001|Overall Study|Adverse Event|1|||
42017556|NCT00910273|75825277|FG000|Overall Study|Withdrawal by Subject|1|||
42017557|NCT00910273|75825278|FG001|Overall Study|Withdrawal by Subject|0|||
42017558|NCT00910273|75825277|FG000|Overall Study|Discontinuation of study by sponsor|8|||
42017559|NCT00910273|75825278|FG001|Overall Study|Discontinuation of study by sponsor|2|||
42077168|NCT00600119|75887332|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
42077169|NCT00600119|75887333|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
42077170|NCT00600119|75887334|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
42077171|NCT00600119|75887335|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
42077172|NCT00600119|75887336|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
42077173|NCT00600119|75887337|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
42077174|NCT00600119|75887332|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
42077175|NCT00600119|75887333|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
42077176|NCT00600119|75887334|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
42077177|NCT00600119|75887335|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
42077178|NCT00600119|75887336|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
42077179|NCT00600119|75887337|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
42077180|NCT00600119|75887332|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
42077181|NCT00600119|75887333|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
42077182|NCT00600119|75887334|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
42077183|NCT00600119|75887335|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
42077184|NCT00600119|75887336|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
42077185|NCT00600119|75887337|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
42077186|NCT00600119|75887332|FG000|Double-blind Treatment Period|Other|0|||
42077187|NCT00600119|75887333|FG001|Double-blind Treatment Period|Other|0|||
42077188|NCT00600119|75887334|FG002|Double-blind Treatment Period|Other|0|||
42077189|NCT00600119|75887335|FG003|Double-blind Treatment Period|Other|0|||
42077190|NCT00600119|75887336|FG004|Double-blind Treatment Period|Other|2|||
42077191|NCT00600119|75887337|FG005|Double-blind Treatment Period|Other|1|||
42077192|NCT00600119|75887332|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
42077193|NCT00600119|75887333|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
42077194|NCT00600119|75887334|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
42077195|NCT00600119|75887335|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
42077196|NCT00600119|75887336|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
42077197|NCT00600119|75887337|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
42077198|NCT00600119|75887332|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
42077199|NCT00600119|75887333|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
42077200|NCT00600119|75887334|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
42077201|NCT00600119|75887335|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
42077202|NCT00600119|75887336|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
42077203|NCT00600119|75887337|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
42077204|NCT00600119|75887332|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
42077205|NCT00600119|75887333|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
42077206|NCT00600119|75887334|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
42077207|NCT00600119|75887335|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
42077208|NCT00600119|75887336|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
42077209|NCT00600119|75887337|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
42077210|NCT00600119|75887332|FG000|Double-blind Treatment Period|Physician Decision|2|||
42077211|NCT00600119|75887333|FG001|Double-blind Treatment Period|Physician Decision|0|||
42077212|NCT00600119|75887334|FG002|Double-blind Treatment Period|Physician Decision|0|||
42077213|NCT00600119|75887335|FG003|Double-blind Treatment Period|Physician Decision|0|||
42077214|NCT00600119|75887336|FG004|Double-blind Treatment Period|Physician Decision|0|||
42077215|NCT00600119|75887337|FG005|Double-blind Treatment Period|Physician Decision|0|||
42077216|NCT00600119|75887332|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
42077217|NCT00600119|75887333|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
42077218|NCT00600119|75887334|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
42077219|NCT00600119|75887335|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
42077220|NCT00600119|75887336|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
42077221|NCT00600119|75887337|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
42077222|NCT00600119|75887332|FG000|Double-blind Treatment Period|Adverse Event|1|||
42077223|NCT00600119|75887333|FG001|Double-blind Treatment Period|Adverse Event|1|||
42077224|NCT00600119|75887334|FG002|Double-blind Treatment Period|Adverse Event|0|||
42077225|NCT00600119|75887335|FG003|Double-blind Treatment Period|Adverse Event|1|||
42077226|NCT00600119|75887336|FG004|Double-blind Treatment Period|Adverse Event|2|||
42077227|NCT00600119|75887337|FG005|Double-blind Treatment Period|Adverse Event|10|||
42077228|NCT00600119|75887332|FG000|Follow-up Period|Adverse Event|0|||
42077229|NCT00600119|75887333|FG001|Follow-up Period|Adverse Event|0|||
42077230|NCT00600119|75887334|FG002|Follow-up Period|Adverse Event|0|||
42077231|NCT00600119|75887335|FG003|Follow-up Period|Adverse Event|0|||
42293558|NCT01668797|76127786|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
42357862|NCT01857583|76203395|FG001|Overall Study|Physician Decision|0|||
42077232|NCT00600119|75887336|FG004|Follow-up Period|Adverse Event|0|||
42077233|NCT00600119|75887337|FG005|Follow-up Period|Adverse Event|1|||
42077234|NCT00600119|75887332|FG000|Follow-up Period|Other|1|||
42077235|NCT00600119|75887333|FG001|Follow-up Period|Other|0|||
42077236|NCT00600119|75887334|FG002|Follow-up Period|Other|0|||
42077237|NCT00600119|75887335|FG003|Follow-up Period|Other|0|||
42077238|NCT00600119|75887336|FG004|Follow-up Period|Other|0|||
42077239|NCT00600119|75887337|FG005|Follow-up Period|Other|0|||
42077240|NCT00866294|75887354|FG000|Overall Study|Adverse Event|12|||
42077241|NCT00866294|75887355|FG001|Overall Study|Adverse Event|13|||
42077242|NCT00866294|75887356|FG002|Overall Study|Adverse Event|9|||
42077243|NCT00866294|75887354|FG000|Overall Study|Lack of Efficacy|7|||
42077244|NCT00866294|75887355|FG001|Overall Study|Lack of Efficacy|1|||
42077245|NCT00866294|75887356|FG002|Overall Study|Lack of Efficacy|0|||
42077246|NCT00866294|75887354|FG000|Overall Study|Protocol Violation|2|||
42077247|NCT00866294|75887355|FG001|Overall Study|Protocol Violation|0|||
42077248|NCT00866294|75887356|FG002|Overall Study|Protocol Violation|0|||
42077249|NCT00866294|75887354|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
42077250|NCT00866294|75887355|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
42077251|NCT00866294|75887356|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
42077252|NCT00866294|75887354|FG000|Overall Study|Lost to Follow-up|1|||
42077253|NCT00866294|75887355|FG001|Overall Study|Lost to Follow-up|3|||
42077254|NCT00866294|75887356|FG002|Overall Study|Lost to Follow-up|0|||
42077255|NCT00866294|75887354|FG000|Overall Study|Physician Decision|6|||
42077256|NCT00866294|75887355|FG001|Overall Study|Physician Decision|2|||
42077257|NCT00866294|75887356|FG002|Overall Study|Physician Decision|1|||
42077258|NCT00854360|75887376|FG000|Overall Study|Adverse Event|0|||
42077259|NCT00854360|75887377|FG001|Overall Study|Adverse Event|1|||
42077260|NCT00854360|75887378|FG002|Overall Study|Adverse Event|2|||
42077261|NCT00854360|75887379|FG003|Overall Study|Adverse Event|6|||
42077262|NCT00854360|75887376|FG000|Overall Study|Withdrawal by Subject|0|||
42077263|NCT00854360|75887377|FG001|Overall Study|Withdrawal by Subject|0|||
42077264|NCT00854360|75887378|FG002|Overall Study|Withdrawal by Subject|0|||
42077265|NCT00854360|75887379|FG003|Overall Study|Withdrawal by Subject|1|||
42077266|NCT00854360|75887376|FG000|Overall Study|Pregnancy|0|||
42077267|NCT00854360|75887377|FG001|Overall Study|Pregnancy|1|||
42077268|NCT00854360|75887378|FG002|Overall Study|Pregnancy|0|||
42077269|NCT00854360|75887379|FG003|Overall Study|Pregnancy|0|||
42077270|NCT00854360|75887376|FG000|Overall Study|Lack of Efficacy|2|||
42077271|NCT00854360|75887377|FG001|Overall Study|Lack of Efficacy|1|||
42077272|NCT00854360|75887378|FG002|Overall Study|Lack of Efficacy|0|||
42077273|NCT00854360|75887379|FG003|Overall Study|Lack of Efficacy|0|||
42077274|NCT00854360|75887376|FG000|Overall Study|Other|0|||
42077275|NCT00854360|75887377|FG001|Overall Study|Other|0|||
42077276|NCT00854360|75887378|FG002|Overall Study|Other|0|||
42077277|NCT00854360|75887379|FG003|Overall Study|Other|3|||
42077278|NCT00853970|75887391|FG000|Overall Study|Withdrawal by Subject|2|||
42077279|NCT00853970|75887392|FG001|Overall Study|Withdrawal by Subject|1|||
42077280|NCT00853970|75887391|FG000|Overall Study|Cancelled surgery|4|||
42077281|NCT00853970|75887392|FG001|Overall Study|Cancelled surgery|2|||
42077282|NCT00865904|75887420|FG000|Overall Study|Randomized but not Treated|2|||
42077283|NCT00865904|75887421|FG001|Overall Study|Randomized but not Treated|0|||
42077284|NCT00865904|75887422|FG002|Overall Study|Randomized but not Treated|0|||
42077285|NCT00865904|75887423|FG003|Overall Study|Randomized but not Treated|1|||
42077286|NCT00865904|75887424|FG004|Overall Study|Randomized but not Treated|1|||
42077287|NCT00599339|75887440|FG000|Overall Study|Adverse Event|79|||
42077288|NCT00599339|75887440|FG000|Overall Study|Withdrawal by Subject|137|||
42077289|NCT00599339|75887440|FG000|Overall Study|Other Reason|179|||
42077290|NCT00599339|75887440|FG000|Overall Study|Lost to Follow-up|221|||
42077291|NCT00599339|75887440|FG000|Overall Study|No valid data consent|36|||
42077292|NCT00599339|75887440|FG000|Overall Study|Study Termination Status Unknown|12|||
42077293|NCT00599027|75887464|FG000|Overall Study|Withdrawal by Subject|1|||
42077294|NCT00599027|75887465|FG001|Overall Study|Withdrawal by Subject|1|||
42077295|NCT00599027|75887464|FG000|Overall Study|Adverse Event|0|||
42077296|NCT00599027|75887465|FG001|Overall Study|Adverse Event|1|||
42077297|NCT00599027|75887464|FG000|Overall Study|Treatment Failure|0|||
42077298|NCT00599027|75887465|FG001|Overall Study|Treatment Failure|1|||
42077299|NCT02881151|75887480|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
42077300|NCT00689728|75887488|FG000|Double-Blind Treatment|Adverse Event|1|||
42077301|NCT00689728|75887489|FG001|Double-Blind Treatment|Adverse Event|0|||
42077302|NCT00689728|75887490|FG002|Double-Blind Treatment|Adverse Event|0|||
42077303|NCT00689728|75887488|FG000|Double-Blind Treatment|Protocol Violation|0|||
42077304|NCT00689728|75887489|FG001|Double-Blind Treatment|Protocol Violation|0|||
42077305|NCT00689728|75887490|FG002|Double-Blind Treatment|Protocol Violation|1|||
42077306|NCT00689728|75887488|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
42077307|NCT00689728|75887489|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
42077308|NCT00689728|75887490|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
42077309|NCT00689728|75887488|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
42077310|NCT00689728|75887489|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
42077311|NCT00689728|75887490|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
42077312|NCT00689728|75887488|FG000|Rescue|Adverse Event|0|||
42077313|NCT00689728|75887489|FG001|Rescue|Adverse Event|1|||
42077314|NCT00689728|75887490|FG002|Rescue|Adverse Event|0|||
42077315|NCT00689728|75887488|FG000|Rescue|Withdrawal by Subject|1|||
42077316|NCT00689728|75887489|FG001|Rescue|Withdrawal by Subject|1|||
42077317|NCT00689728|75887490|FG002|Rescue|Withdrawal by Subject|1|||
42077318|NCT00689728|75887488|FG000|Optional Follow-Up|Adverse Event|1|||
42077319|NCT00689728|75887489|FG001|Optional Follow-Up|Adverse Event|0|||
42077320|NCT00689728|75887490|FG002|Optional Follow-Up|Adverse Event|0|||
42077321|NCT00689728|75887488|FG000|Optional Follow-Up|Lack of Efficacy|0|||
42077322|NCT00689728|75887489|FG001|Optional Follow-Up|Lack of Efficacy|1|||
42077323|NCT00689728|75887490|FG002|Optional Follow-Up|Lack of Efficacy|1|||
42077324|NCT00689728|75887488|FG000|Optional Follow-Up|Lost to Follow-up|0|||
42077325|NCT00689728|75887489|FG001|Optional Follow-Up|Lost to Follow-up|1|||
42077326|NCT00689728|75887490|FG002|Optional Follow-Up|Lost to Follow-up|1|||
42077327|NCT00689728|75887488|FG000|Optional Follow-Up|Protocol Violation|0|||
42077328|NCT00689728|75887489|FG001|Optional Follow-Up|Protocol Violation|0|||
42077329|NCT00689728|75887490|FG002|Optional Follow-Up|Protocol Violation|1|||
42077330|NCT00689728|75887488|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
42077331|NCT00689728|75887489|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
42077332|NCT00689728|75887490|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
42077333|NCT00691054|75887519|FG000|Overall Study|Withdrawal by Subject|1|||
42077334|NCT00598871|75887527|FG000|Overall Study|Adverse Event|0|||
42077335|NCT00598871|75887528|FG001|Overall Study|Adverse Event|1|||
42077336|NCT00690820|75887536|FG000|Period 1|Withdrawal by Subject|0|||
42077337|NCT00690820|75887537|FG001|Period 1|Withdrawal by Subject|1|||
42077338|NCT00689338|75887543|FG000|Overall Study|Death|65|||
42077339|NCT00689338|75887543|FG000|Overall Study|Adverse Event|13|||
42077340|NCT00689338|75887543|FG000|Overall Study|Insufficient Clinical Response|1|||
42077341|NCT00689338|75887543|FG000|Overall Study|Lack of Efficacy|6|||
42077342|NCT00689338|75887543|FG000|Overall Study|Other|8|||
42077343|NCT00689338|75887543|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
42077344|NCT00689338|75887543|FG000|Overall Study|Lost to Follow-up|5|||
42077345|NCT00689338|75887543|FG000|Overall Study|Withdrawal by Subject|3|||
42077346|NCT00689338|75887543|FG000|Overall Study|Protocol Violation|15|||
42077347|NCT00686998|75887550|FG000|Overall Study|Adverse Event|3|||
42077348|NCT00686998|75887551|FG001|Overall Study|Adverse Event|2|||
42077349|NCT00686998|75887552|FG002|Overall Study|Adverse Event|1|||
42077350|NCT00686998|75887550|FG000|Overall Study|Withdrawal by Subject|2|||
42077351|NCT00686998|75887551|FG001|Overall Study|Withdrawal by Subject|1|||
42077352|NCT00686998|75887552|FG002|Overall Study|Withdrawal by Subject|2|||
42077353|NCT00686998|75887550|FG000|Overall Study|Lack of Efficacy|7|||
42077354|NCT00686998|75887551|FG001|Overall Study|Lack of Efficacy|5|||
42077355|NCT00686998|75887552|FG002|Overall Study|Lack of Efficacy|0|||
42077356|NCT00686998|75887550|FG000|Overall Study|Other|0|||
42077357|NCT00686998|75887551|FG001|Overall Study|Other|0|||
42077358|NCT00686998|75887552|FG002|Overall Study|Other|1|||
42077359|NCT00686998|75887550|FG000|Overall Study|Safety Reasons|1|||
42077360|NCT00686998|75887551|FG001|Overall Study|Safety Reasons|0|||
42077361|NCT00686998|75887552|FG002|Overall Study|Safety Reasons|0|||
42077362|NCT00848718|75887573|FG000|Overall Study|Adverse Event|2|||
42077363|NCT00848718|75887574|FG001|Overall Study|Adverse Event|2|||
42077364|NCT00848718|75887575|FG002|Overall Study|Adverse Event|1|||
42077365|NCT00848718|75887576|FG003|Overall Study|Adverse Event|1|||
42077366|NCT00848718|75887577|FG004|Overall Study|Adverse Event|1|||
42077367|NCT00848718|75887578|FG005|Overall Study|Adverse Event|0|||
42077368|NCT00848718|75887579|FG006|Overall Study|Adverse Event|0|||
42077369|NCT00848718|75887580|FG007|Overall Study|Adverse Event|1|||
42077370|NCT00848718|75887581|FG008|Overall Study|Adverse Event|1|||
42077371|NCT00848718|75887582|FG009|Overall Study|Adverse Event|0|||
42077372|NCT00848718|75887583|FG010|Overall Study|Adverse Event|0|||
42077373|NCT00848718|75887584|FG011|Overall Study|Adverse Event|0|||
42077374|NCT00848718|75887585|FG012|Overall Study|Adverse Event|2|||
42077375|NCT00848718|75887573|FG000|Overall Study|Lack of Efficacy|0|||
42077376|NCT00848718|75887574|FG001|Overall Study|Lack of Efficacy|0|||
42077377|NCT00848718|75887575|FG002|Overall Study|Lack of Efficacy|1|||
42077378|NCT00848718|75887576|FG003|Overall Study|Lack of Efficacy|0|||
42077379|NCT00848718|75887577|FG004|Overall Study|Lack of Efficacy|0|||
42077380|NCT00848718|75887578|FG005|Overall Study|Lack of Efficacy|0|||
42077381|NCT00848718|75887579|FG006|Overall Study|Lack of Efficacy|1|||
42077382|NCT00848718|75887580|FG007|Overall Study|Lack of Efficacy|0|||
42077383|NCT00848718|75887581|FG008|Overall Study|Lack of Efficacy|0|||
42077384|NCT00848718|75887582|FG009|Overall Study|Lack of Efficacy|0|||
42077385|NCT00848718|75887583|FG010|Overall Study|Lack of Efficacy|0|||
42077386|NCT00848718|75887584|FG011|Overall Study|Lack of Efficacy|0|||
42077387|NCT00848718|75887585|FG012|Overall Study|Lack of Efficacy|0|||
42077388|NCT00848718|75887573|FG000|Overall Study|Physician Decision|0|||
42077389|NCT00848718|75887574|FG001|Overall Study|Physician Decision|1|||
42077390|NCT00848718|75887575|FG002|Overall Study|Physician Decision|0|||
42077391|NCT00848718|75887576|FG003|Overall Study|Physician Decision|0|||
42077392|NCT00848718|75887577|FG004|Overall Study|Physician Decision|1|||
42077393|NCT00848718|75887578|FG005|Overall Study|Physician Decision|1|||
42077394|NCT00848718|75887579|FG006|Overall Study|Physician Decision|0|||
42077395|NCT00848718|75887580|FG007|Overall Study|Physician Decision|0|||
42077396|NCT00848718|75887581|FG008|Overall Study|Physician Decision|1|||
42077397|NCT00848718|75887582|FG009|Overall Study|Physician Decision|2|||
42077398|NCT00848718|75887583|FG010|Overall Study|Physician Decision|0|||
42077399|NCT00848718|75887584|FG011|Overall Study|Physician Decision|0|||
42077400|NCT00848718|75887585|FG012|Overall Study|Physician Decision|1|||
42077401|NCT00848718|75887573|FG000|Overall Study|Progressive disease before treatment|1|||
42077402|NCT00848718|75887574|FG001|Overall Study|Progressive disease before treatment|5|||
42077403|NCT00848718|75887575|FG002|Overall Study|Progressive disease before treatment|1|||
42077404|NCT00848718|75887576|FG003|Overall Study|Progressive disease before treatment|3|||
42077405|NCT00848718|75887577|FG004|Overall Study|Progressive disease before treatment|4|||
42077406|NCT00848718|75887578|FG005|Overall Study|Progressive disease before treatment|4|||
42077407|NCT00848718|75887579|FG006|Overall Study|Progressive disease before treatment|2|||
42077408|NCT00848718|75887580|FG007|Overall Study|Progressive disease before treatment|1|||
42077409|NCT00848718|75887581|FG008|Overall Study|Progressive disease before treatment|2|||
42077410|NCT00848718|75887582|FG009|Overall Study|Progressive disease before treatment|7|||
42077411|NCT00848718|75887583|FG010|Overall Study|Progressive disease before treatment|3|||
42077412|NCT00848718|75887584|FG011|Overall Study|Progressive disease before treatment|6|||
42077413|NCT00848718|75887585|FG012|Overall Study|Progressive disease before treatment|2|||
42077414|NCT00848718|75887573|FG000|Overall Study|Protocol Violation|0|||
42077415|NCT00848718|75887574|FG001|Overall Study|Protocol Violation|1|||
42077416|NCT00848718|75887575|FG002|Overall Study|Protocol Violation|0|||
42077417|NCT00848718|75887576|FG003|Overall Study|Protocol Violation|0|||
42077418|NCT00848718|75887577|FG004|Overall Study|Protocol Violation|0|||
42077419|NCT00848718|75887578|FG005|Overall Study|Protocol Violation|0|||
42077420|NCT00848718|75887579|FG006|Overall Study|Protocol Violation|0|||
42077421|NCT00848718|75887580|FG007|Overall Study|Protocol Violation|1|||
42077422|NCT00848718|75887581|FG008|Overall Study|Protocol Violation|0|||
42077423|NCT00848718|75887582|FG009|Overall Study|Protocol Violation|0|||
42077424|NCT00848718|75887583|FG010|Overall Study|Protocol Violation|0|||
42077425|NCT00848718|75887584|FG011|Overall Study|Protocol Violation|0|||
42077426|NCT00848718|75887585|FG012|Overall Study|Protocol Violation|1|||
42077427|NCT00848718|75887573|FG000|Overall Study|Withdrawal by Subject|1|||
42077428|NCT00848718|75887574|FG001|Overall Study|Withdrawal by Subject|0|||
42077429|NCT00848718|75887575|FG002|Overall Study|Withdrawal by Subject|0|||
42077430|NCT00848718|75887576|FG003|Overall Study|Withdrawal by Subject|1|||
42077431|NCT00848718|75887577|FG004|Overall Study|Withdrawal by Subject|0|||
42077432|NCT00848718|75887578|FG005|Overall Study|Withdrawal by Subject|0|||
42077433|NCT00848718|75887579|FG006|Overall Study|Withdrawal by Subject|0|||
42077434|NCT00848718|75887580|FG007|Overall Study|Withdrawal by Subject|0|||
42077435|NCT00848718|75887581|FG008|Overall Study|Withdrawal by Subject|0|||
42077436|NCT00848718|75887582|FG009|Overall Study|Withdrawal by Subject|0|||
42077437|NCT00848718|75887583|FG010|Overall Study|Withdrawal by Subject|1|||
42077438|NCT00848718|75887584|FG011|Overall Study|Withdrawal by Subject|0|||
42077439|NCT00848718|75887585|FG012|Overall Study|Withdrawal by Subject|0|||
42077440|NCT00848718|75887573|FG000|Overall Study|Progressive disease during treatment|3|||
42077441|NCT00848718|75887574|FG001|Overall Study|Progressive disease during treatment|0|||
42077442|NCT00848718|75887575|FG002|Overall Study|Progressive disease during treatment|3|||
42077443|NCT00848718|75887576|FG003|Overall Study|Progressive disease during treatment|0|||
42077444|NCT00848718|75887577|FG004|Overall Study|Progressive disease during treatment|0|||
42077445|NCT00848718|75887578|FG005|Overall Study|Progressive disease during treatment|0|||
42077446|NCT00848718|75887579|FG006|Overall Study|Progressive disease during treatment|0|||
42077447|NCT00848718|75887580|FG007|Overall Study|Progressive disease during treatment|2|||
42077448|NCT00848718|75887581|FG008|Overall Study|Progressive disease during treatment|0|||
42077449|NCT00848718|75887582|FG009|Overall Study|Progressive disease during treatment|0|||
42077450|NCT00848718|75887583|FG010|Overall Study|Progressive disease during treatment|0|||
42077451|NCT00848718|75887584|FG011|Overall Study|Progressive disease during treatment|0|||
42077452|NCT00848718|75887585|FG012|Overall Study|Progressive disease during treatment|2|||
42077453|NCT00883337|75887622|FG000|Core Treatment Period|Adverse Event|9|||
42077454|NCT00883337|75887623|FG001|Core Treatment Period|Adverse Event|12|||
42077455|NCT00883337|75887624|FG002|Core Treatment Period|Adverse Event|22|||
42077456|NCT00883337|75887622|FG000|Core Treatment Period|Lack of Efficacy|7|||
42077457|NCT00883337|75887623|FG001|Core Treatment Period|Lack of Efficacy|4|||
42077458|NCT00883337|75887624|FG002|Core Treatment Period|Lack of Efficacy|2|||
42077459|NCT00883337|75887622|FG000|Core Treatment Period|Lost to Follow-up|1|||
42077460|NCT00883337|75887623|FG001|Core Treatment Period|Lost to Follow-up|1|||
42077461|NCT00883337|75887624|FG002|Core Treatment Period|Lost to Follow-up|0|||
42077462|NCT00883337|75887622|FG000|Core Treatment Period|Withdrawal by Subject|2|||
42077463|NCT00883337|75887623|FG001|Core Treatment Period|Withdrawal by Subject|2|||
42077464|NCT00883337|75887624|FG002|Core Treatment Period|Withdrawal by Subject|6|||
42077465|NCT00883337|75887622|FG000|Core Treatment Period|Wish to be pregnant|1|||
42077466|NCT00883337|75887623|FG001|Core Treatment Period|Wish to be pregnant|2|||
42077467|NCT00883337|75887624|FG002|Core Treatment Period|Wish to be pregnant|1|||
42077468|NCT00883337|75887622|FG000|Core Treatment Period|Poor compliance to protocol|0|||
42077469|NCT00883337|75887623|FG001|Core Treatment Period|Poor compliance to protocol|0|||
42077470|NCT00883337|75887624|FG002|Core Treatment Period|Poor compliance to protocol|1|||
42077471|NCT00883337|75887622|FG000|Core Treatment Period|Other than above|0|||
42077472|NCT00883337|75887623|FG001|Core Treatment Period|Other than above|1|||
42077473|NCT00883337|75887624|FG002|Core Treatment Period|Other than above|1|||
42077474|NCT00883337|75887622|FG000|Extension Treatment Period|Adverse Event|8|||
42077475|NCT00883337|75887623|FG001|Extension Treatment Period|Adverse Event|5|||
42077476|NCT00883337|75887624|FG002|Extension Treatment Period|Adverse Event|5|||
42077477|NCT00883337|75887622|FG000|Extension Treatment Period|Lack of Efficacy|8|||
42077478|NCT00883337|75887623|FG001|Extension Treatment Period|Lack of Efficacy|8|||
42017560|NCT00910273|75825277|FG000|Overall Study|Protocol Violation|1|||
42017561|NCT00910273|75825278|FG001|Overall Study|Protocol Violation|0|||
42017562|NCT00910273|75825277|FG000|Overall Study|Lost to Follow-up|1|||
42017563|NCT00910273|75825278|FG001|Overall Study|Lost to Follow-up|1|||
42077479|NCT00883337|75887624|FG002|Extension Treatment Period|Lack of Efficacy|8|||
42077480|NCT00883337|75887622|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
42077481|NCT00883337|75887623|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
42077482|NCT00883337|75887624|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
42077483|NCT00883337|75887622|FG000|Extension Treatment Period|Lost to Follow-up|1|||
42077484|NCT00883337|75887623|FG001|Extension Treatment Period|Lost to Follow-up|0|||
42077485|NCT00883337|75887624|FG002|Extension Treatment Period|Lost to Follow-up|0|||
42077486|NCT00883337|75887622|FG000|Extension Treatment Period|Other than above|10|||
42077487|NCT00883337|75887623|FG001|Extension Treatment Period|Other than above|9|||
42077488|NCT00883337|75887624|FG002|Extension Treatment Period|Other than above|5|||
42077489|NCT00838110|75887640|FG000|Overall Study|Death|0|||
42077490|NCT00838110|75887641|FG001|Overall Study|Death|0|||
42077491|NCT00838110|75887642|FG002|Overall Study|Death|1|||
42077492|NCT00838110|75887643|FG003|Overall Study|Death|2|||
42077493|NCT00838110|75887640|FG000|Overall Study|Adverse Event|11|||
42077494|NCT00838110|75887641|FG001|Overall Study|Adverse Event|10|||
42077495|NCT00838110|75887642|FG002|Overall Study|Adverse Event|8|||
42077496|NCT00838110|75887643|FG003|Overall Study|Adverse Event|7|||
42077497|NCT00838110|75887640|FG000|Overall Study|Withdrawal by Subject|5|||
42077498|NCT00838110|75887641|FG001|Overall Study|Withdrawal by Subject|6|||
42077499|NCT00838110|75887642|FG002|Overall Study|Withdrawal by Subject|3|||
42077500|NCT00838110|75887643|FG003|Overall Study|Withdrawal by Subject|4|||
42077501|NCT00838110|75887640|FG000|Overall Study|Other|3|||
42077502|NCT00838110|75887641|FG001|Overall Study|Other|3|||
42077503|NCT00838110|75887642|FG002|Overall Study|Other|3|||
42077504|NCT00838110|75887643|FG003|Overall Study|Other|2|||
42077505|NCT00838110|75887640|FG000|Overall Study|Protocol Violation|0|||
42077506|NCT00838110|75887641|FG001|Overall Study|Protocol Violation|2|||
42077507|NCT00838110|75887642|FG002|Overall Study|Protocol Violation|1|||
42077508|NCT00838110|75887643|FG003|Overall Study|Protocol Violation|1|||
42077509|NCT00838110|75887640|FG000|Overall Study|Lost to Follow-up|3|||
42077510|NCT00838110|75887641|FG001|Overall Study|Lost to Follow-up|0|||
42077511|NCT00838110|75887642|FG002|Overall Study|Lost to Follow-up|0|||
42077512|NCT00838110|75887643|FG003|Overall Study|Lost to Follow-up|0|||
42077513|NCT00838110|75887640|FG000|Overall Study|Did not meet eligibility criteria|0|||
42077514|NCT00838110|75887641|FG001|Overall Study|Did not meet eligibility criteria|0|||
42077515|NCT00838110|75887642|FG002|Overall Study|Did not meet eligibility criteria|1|||
42077516|NCT00838110|75887643|FG003|Overall Study|Did not meet eligibility criteria|2|||
42177874|NCT04908488|75985025|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
42357863|NCT01857583|76203396|FG002|Overall Study|Physician Decision|0|||
42017564|NCT00910039|75825284|FG000|Overall Study|Physician Decision|1|||
42017565|NCT00909181|75825292|FG000|Overall Study|Lost to Follow-up|39|||
42017566|NCT00909181|75825293|FG001|Overall Study|Lost to Follow-up|18|||
42017567|NCT00909181|75825294|FG002|Overall Study|Lost to Follow-up|33|||
42017568|NCT01286987|75825317|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
42017569|NCT01286987|75825318|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
42077517|NCT00838110|75887640|FG000|Overall Study|Randomized but not treated|0|||
42077518|NCT00838110|75887641|FG001|Overall Study|Randomized but not treated|1|||
42077519|NCT00838110|75887642|FG002|Overall Study|Randomized but not treated|0|||
42077520|NCT00838110|75887643|FG003|Overall Study|Randomized but not treated|0|||
42077521|NCT00837876|75887653|FG000|Overall Study|Death|2|||
42077522|NCT00837876|75887653|FG000|Overall Study|Adverse Event|7|||
42077523|NCT00837876|75887653|FG000|Overall Study|Physician Decision|1|||
42077524|NCT00837876|75887653|FG000|Overall Study|Withdrawal by Subject|3|||
42077525|NCT00837876|75887653|FG000|Overall Study|disease progression|24|||
42077526|NCT00686920|75887659|FG000|Overall Study|Death|45|||
42077527|NCT00686920|75887660|FG001|Overall Study|Death|14|||
42077528|NCT00686920|75887659|FG000|Overall Study|Liver Transplant|23|||
42017570|NCT01286987|75825319|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
42357864|NCT01857583|76203397|FG003|Overall Study|Physician Decision|1|||
42077529|NCT00686920|75887660|FG001|Overall Study|Liver Transplant|8|||
42077530|NCT00686920|75887659|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
42077531|NCT00686920|75887660|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
42077532|NCT00686920|75887659|FG000|Overall Study|Withdrawal by Subject|23|||
42077533|NCT00686920|75887660|FG001|Overall Study|Withdrawal by Subject|5|||
42077534|NCT00686920|75887659|FG000|Overall Study|Protocol Violation|2|||
42077535|NCT00686920|75887660|FG001|Overall Study|Protocol Violation|1|||
42077536|NCT00686920|75887659|FG000|Overall Study|Adverse Event|10|||
42077537|NCT00686920|75887660|FG001|Overall Study|Adverse Event|2|||
42077538|NCT00686920|75887659|FG000|Overall Study|Personal Reason|0|||
42077539|NCT00686920|75887660|FG001|Overall Study|Personal Reason|1|||
42077540|NCT00686920|75887659|FG000|Overall Study|Lost to Follow-up|15|||
42077541|NCT00686920|75887660|FG001|Overall Study|Lost to Follow-up|3|||
42077542|NCT00686920|75887659|FG000|Overall Study|Moved to Another State|1|||
42077543|NCT00686920|75887660|FG001|Overall Study|Moved to Another State|0|||
42077544|NCT00686920|75887659|FG000|Overall Study|Transferred to Nursing Home|1|||
42077545|NCT00686920|75887660|FG001|Overall Study|Transferred to Nursing Home|0|||
42077546|NCT00686920|75887659|FG000|Overall Study|Noncompliance|9|||
42077547|NCT00686920|75887660|FG001|Overall Study|Noncompliance|0|||
42077548|NCT00686920|75887659|FG000|Overall Study|Principal Investigator Decision|2|||
42077549|NCT00686920|75887660|FG001|Overall Study|Principal Investigator Decision|0|||
42077550|NCT00845832|75887669|FG000|Treatment Period|Adverse Event|0|||
42077551|NCT00845832|75887670|FG001|Treatment Period|Adverse Event|2|||
42077552|NCT00845832|75887671|FG002|Treatment Period|Adverse Event|0|||
42077553|NCT00845832|75887669|FG000|Treatment Period|Protocol Violation|1|||
42077554|NCT00845832|75887670|FG001|Treatment Period|Protocol Violation|1|||
42077555|NCT00845832|75887671|FG002|Treatment Period|Protocol Violation|0|||
42077556|NCT00845832|75887669|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
42077557|NCT00845832|75887670|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
42177875|NCT04908488|75985024|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
42177876|NCT04908488|75985025|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
42177877|NCT04876274|75985036|FG000|Overall Study|Lost to Follow-up|9|||
42177878|NCT04876274|75985037|FG001|Overall Study|Lost to Follow-up|12|||
42177879|NCT04865354|75985045|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
42177880|NCT04865354|75985046|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
42177881|NCT04865354|75985045|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
42177882|NCT04865354|75985046|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
42177883|NCT04865354|75985045|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
42177884|NCT04865354|75985046|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
42177885|NCT04860518|75985057|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
42177886|NCT04860518|75985058|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
42177887|NCT03110380|75985066|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
42177888|NCT03110380|75985067|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
42177889|NCT03110380|75985068|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
42177890|NCT03110380|75985069|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
42177891|NCT03110380|75985066|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
42177892|NCT03110380|75985067|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
42177893|NCT03110380|75985068|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
42177894|NCT03110380|75985069|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
42177895|NCT03110380|75985066|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
42177896|NCT03110380|75985067|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
42177897|NCT03110380|75985068|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
42177898|NCT03110380|75985069|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
42177899|NCT03110380|75985066|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
42177900|NCT03110380|75985067|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
42177901|NCT03110380|75985068|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
42177902|NCT03110380|75985069|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
42177903|NCT03110380|75985066|FG000|Double-Blind Treatment Phase|Death|2|||
42177904|NCT03110380|75985067|FG001|Double-Blind Treatment Phase|Death|1|||
42177905|NCT03110380|75985068|FG002|Double-Blind Treatment Phase|Death|0|||
42177906|NCT03110380|75985069|FG003|Double-Blind Treatment Phase|Death|0|||
42177907|NCT03110380|75985066|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
42357865|NCT01857583|76203394|FG000|Overall Study|Withdrawal by Subject|1|||
42077558|NCT00845832|75887671|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
42077559|NCT00845832|75887669|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
42077560|NCT00845832|75887670|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
42077561|NCT00845832|75887671|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
42077562|NCT00591864|75887679|FG000|Overall Study|Incomplete Imaging|5|||
42177908|NCT03110380|75985067|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
42177909|NCT03110380|75985068|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
42357866|NCT01857583|76203395|FG001|Overall Study|Withdrawal by Subject|0|||
42077563|NCT00885755|75887687|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
42077564|NCT00885755|75887688|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
42077565|NCT00885755|75887689|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
42077566|NCT00885755|75887687|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
42077567|NCT00885755|75887688|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
42077568|NCT00885755|75887689|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
42077569|NCT00885755|75887687|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
42077570|NCT00885755|75887688|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
42077571|NCT00885755|75887689|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
42077572|NCT00885755|75887687|FG000|Part I: Trastuzumab+Taxane|Death|0|||
42077573|NCT00885755|75887688|FG001|Part I: Trastuzumab+Taxane|Death|0|||
42077574|NCT00885755|75887689|FG002|Part I: Trastuzumab+Taxane|Death|1|||
42077575|NCT00885755|75887687|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
42077576|NCT00885755|75887688|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
42077577|NCT00885755|75887689|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
42077578|NCT00837486|75887699|FG000|Blinded-treatment Phase|Physician Decision|1|||
42077579|NCT00837486|75887700|FG001|Blinded-treatment Phase|Physician Decision|0|||
42077580|NCT00837486|75887699|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
42077581|NCT00837486|75887700|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
42077582|NCT00837486|75887699|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
42077583|NCT00837486|75887700|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
42077584|NCT00837486|75887699|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
42077585|NCT00837486|75887700|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
42077586|NCT00845676|75887708|FG000|Overall Study|Virologic breakthrough at week 20|1|||
42077587|NCT00845676|75887708|FG000|Overall Study|Adverse Event|1|||
42077588|NCT00883181|75887713|FG000|Overall Study|Hematological Adverse Event|26|||
42077589|NCT00883181|75887713|FG000|Overall Study|Non-hematological Adverse Event|55|||
42077590|NCT00883181|75887713|FG000|Overall Study|Disease Progression|94|||
42077591|NCT00883181|75887713|FG000|Overall Study|Administrative Reason|24|||
42077592|NCT00883181|75887713|FG000|Overall Study|Withdrawal by Subject|4|||
42077593|NCT00883181|75887713|FG000|Overall Study|Death|31|||
42077594|NCT00883181|75887713|FG000|Overall Study|Other|38|||
42077595|NCT00883181|75887713|FG000|Overall Study|Protocol Deviation|3|||
42077596|NCT00883181|75887713|FG000|Overall Study|Noncompliance|3|||
42077597|NCT00845520|75887733|FG000|Overall Study|Death|1|||
42077598|NCT00845520|75887734|FG001|Overall Study|Death|2|||
42077599|NCT00845520|75887735|FG002|Overall Study|Death|0|||
42077600|NCT00845520|75887733|FG000|Overall Study|Lost to Follow-up|1|||
42077601|NCT00845520|75887734|FG001|Overall Study|Lost to Follow-up|0|||
42077602|NCT00845520|75887735|FG002|Overall Study|Lost to Follow-up|0|||
42077603|NCT00845520|75887733|FG000|Overall Study|Adverse Event|0|||
42077604|NCT00845520|75887734|FG001|Overall Study|Adverse Event|0|||
42077605|NCT00845520|75887735|FG002|Overall Study|Adverse Event|1|||
42077606|NCT00844896|75887751|FG000|Overall Study|Lost to Follow-up|12|||
42077607|NCT00844896|75887752|FG001|Overall Study|Lost to Follow-up|16|||
42077608|NCT00844896|75887751|FG000|Overall Study|Parents did not have time to complete|0|||
42077609|NCT00844896|75887752|FG001|Overall Study|Parents did not have time to complete|1|||
42077610|NCT00827502|75887759|FG000|Overall Study|randomized but not treated|11|||
42077611|NCT00827502|75887759|FG000|Overall Study|Adverse Event|1|||
42077612|NCT00827502|75887759|FG000|Overall Study|Lost to Follow-up|4|||
42077613|NCT00827502|75887759|FG000|Overall Study|Withdrawal by Subject|5|||
42077614|NCT00837330|75887765|FG000|Overall Study|Lost to Follow-up|1|||
42077615|NCT00837330|75887766|FG001|Overall Study|Lost to Follow-up|3|||
42077616|NCT00837096|75887774|FG000|Overall Study|Physician Decision|1|||
42077617|NCT00837096|75887775|FG001|Overall Study|Physician Decision|1|||
42077618|NCT00837096|75887774|FG000|Overall Study|Not reported|9|||
42077619|NCT00837096|75887775|FG001|Overall Study|Not reported|8|||
42077620|NCT00885677|75887783|FG000|Overall Study|Death|40|||
42293559|NCT01668797|76127787|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
42293560|NCT01668797|76127788|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
42293561|NCT01668797|76127789|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
42293562|NCT01668797|76127786|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
42293563|NCT01668797|76127787|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
42077621|NCT00885677|75887784|FG001|Overall Study|Death|34|||
42077622|NCT00885677|75887783|FG000|Overall Study|Lost to Follow-up|15|||
42077623|NCT00885677|75887784|FG001|Overall Study|Lost to Follow-up|13|||
42077624|NCT00885677|75887783|FG000|Overall Study|Protocol Violation|54|||
42077625|NCT00885677|75887784|FG001|Overall Study|Protocol Violation|54|||
42077626|NCT00885677|75887783|FG000|Overall Study|premature study closure|41|||
42077627|NCT00885677|75887784|FG001|Overall Study|premature study closure|44|||
42077628|NCT00885677|75887783|FG000|Overall Study|device/lead revision or replacement|7|||
42077629|NCT00885677|75887784|FG001|Overall Study|device/lead revision or replacement|6|||
42077630|NCT00885677|75887783|FG000|Overall Study|Heart transplantation|1|||
42077631|NCT00885677|75887784|FG001|Overall Study|Heart transplantation|0|||
42077632|NCT00885677|75887783|FG000|Overall Study|Inclusion/exclusion not met|25|||
42077633|NCT00885677|75887784|FG001|Overall Study|Inclusion/exclusion not met|27|||
42077634|NCT00885365|75887792|FG000|4 Weeks ON Treatment|Adverse Event|2|||
42077635|NCT00885365|75887793|FG001|4 Weeks ON Treatment|Adverse Event|4|||
42077636|NCT00885365|75887792|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
42077637|NCT00885365|75887793|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
42077638|NCT00885365|75887792|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
42077639|NCT00885365|75887793|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
42077640|NCT00827112|75887801|FG000|Overall Study|Adverse Event|2|||
42077641|NCT00827112|75887802|FG001|Overall Study|Adverse Event|0|||
42077642|NCT00827112|75887801|FG000|Overall Study|Lack of Efficacy|2|||
42077643|NCT00827112|75887802|FG001|Overall Study|Lack of Efficacy|0|||
42077644|NCT00827112|75887801|FG000|Overall Study|Lost to Follow-up|3|||
42077645|NCT00827112|75887802|FG001|Overall Study|Lost to Follow-up|2|||
42077646|NCT00827112|75887801|FG000|Overall Study|Pregnancy|0|||
42077647|NCT00827112|75887802|FG001|Overall Study|Pregnancy|1|||
42077648|NCT00827112|75887801|FG000|Overall Study|Protocol Violation|0|||
42077649|NCT00827112|75887802|FG001|Overall Study|Protocol Violation|2|||
42077650|NCT00827112|75887801|FG000|Overall Study|Withdrawal by Subject|2|||
42077651|NCT00827112|75887802|FG001|Overall Study|Withdrawal by Subject|1|||
42077652|NCT00827112|75887801|FG000|Overall Study|Randomized but not treated|5|||
42077653|NCT00827112|75887802|FG001|Overall Study|Randomized but not treated|3|||
42077654|NCT00827112|75887801|FG000|Overall Study|Other|1|||
42077655|NCT00827112|75887802|FG001|Overall Study|Other|3|||
42077656|NCT00689104|75887812|FG000|Overall Study|Eligibility criterion not met|5|||
42077657|NCT00689104|75887813|FG001|Overall Study|Eligibility criterion not met|8|||
42077658|NCT00689104|75887814|FG002|Overall Study|Eligibility criterion not met|0|||
42077659|NCT00689104|75887815|FG003|Overall Study|Eligibility criterion not met|4|||
42077660|NCT00689104|75887812|FG000|Overall Study|Adverse Event|13|||
42077661|NCT00689104|75887813|FG001|Overall Study|Adverse Event|25|||
42077662|NCT00689104|75887814|FG002|Overall Study|Adverse Event|16|||
42077663|NCT00689104|75887815|FG003|Overall Study|Adverse Event|24|||
42077664|NCT00689104|75887812|FG000|Overall Study|Lack of Efficacy|5|||
42077665|NCT00689104|75887813|FG001|Overall Study|Lack of Efficacy|6|||
42077666|NCT00689104|75887814|FG002|Overall Study|Lack of Efficacy|2|||
42077667|NCT00689104|75887815|FG003|Overall Study|Lack of Efficacy|3|||
42077668|NCT00689104|75887812|FG000|Overall Study|Withdrawal by Subject|12|||
42077669|NCT00689104|75887813|FG001|Overall Study|Withdrawal by Subject|11|||
42077670|NCT00689104|75887814|FG002|Overall Study|Withdrawal by Subject|18|||
42077671|NCT00689104|75887815|FG003|Overall Study|Withdrawal by Subject|11|||
42077672|NCT00689104|75887812|FG000|Overall Study|Lost to Follow-up|4|||
42077673|NCT00689104|75887813|FG001|Overall Study|Lost to Follow-up|3|||
42077674|NCT00689104|75887814|FG002|Overall Study|Lost to Follow-up|2|||
42077675|NCT00689104|75887815|FG003|Overall Study|Lost to Follow-up|5|||
42077676|NCT00689104|75887812|FG000|Overall Study|Protocol Violation|2|||
42077677|NCT00689104|75887813|FG001|Overall Study|Protocol Violation|3|||
42077678|NCT00689104|75887814|FG002|Overall Study|Protocol Violation|5|||
42077679|NCT00689104|75887815|FG003|Overall Study|Protocol Violation|3|||
42077680|NCT00689104|75887812|FG000|Overall Study|Randomized but never received study drug|2|||
42077681|NCT00689104|75887813|FG001|Overall Study|Randomized but never received study drug|1|||
42077682|NCT00689104|75887814|FG002|Overall Study|Randomized but never received study drug|1|||
42077683|NCT00689104|75887815|FG003|Overall Study|Randomized but never received study drug|0|||
42077684|NCT00689104|75887812|FG000|Overall Study|Physician Decision|1|||
42077685|NCT00689104|75887813|FG001|Overall Study|Physician Decision|0|||
42077686|NCT00689104|75887814|FG002|Overall Study|Physician Decision|0|||
42077687|NCT00689104|75887815|FG003|Overall Study|Physician Decision|0|||
42077688|NCT00689104|75887812|FG000|Overall Study|Non-compliance with study procedures|0|||
42077689|NCT00689104|75887813|FG001|Overall Study|Non-compliance with study procedures|0|||
42077690|NCT00689104|75887814|FG002|Overall Study|Non-compliance with study procedures|1|||
42077691|NCT00689104|75887815|FG003|Overall Study|Non-compliance with study procedures|0|||
42077692|NCT00689026|75887827|FG000|Overall Study|Withdrawal by Subject|13|||
42077693|NCT00689026|75887828|FG001|Overall Study|Withdrawal by Subject|6|||
42077694|NCT00598559|75887837|FG000|Overall Study|Adverse Event|11|||
42077695|NCT00598559|75887838|FG001|Overall Study|Adverse Event|7|||
42077696|NCT00598559|75887839|FG002|Overall Study|Adverse Event|0|||
42077697|NCT00598559|75887837|FG000|Overall Study|Withdrawal by Subject|2|||
42077698|NCT00598559|75887838|FG001|Overall Study|Withdrawal by Subject|2|||
42077699|NCT00598559|75887839|FG002|Overall Study|Withdrawal by Subject|0|||
42077700|NCT00598559|75887837|FG000|Overall Study|Protocol Non-compliance|1|||
42077701|NCT00598559|75887838|FG001|Overall Study|Protocol Non-compliance|0|||
42077702|NCT00598559|75887839|FG002|Overall Study|Protocol Non-compliance|0|||
42077703|NCT00598559|75887837|FG000|Overall Study|Early discharge from hospital|9|||
42077704|NCT00598559|75887838|FG001|Overall Study|Early discharge from hospital|12|||
42077705|NCT00598559|75887839|FG002|Overall Study|Early discharge from hospital|3|||
42077706|NCT00598559|75887837|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
42077707|NCT00598559|75887838|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
42077708|NCT00598559|75887839|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
42077709|NCT00686686|75887847|FG000|Overall Study|Non-compliance|1|||
42077710|NCT00686686|75887847|FG000|Overall Study|Adverse Event|2|||
42077711|NCT00686686|75887847|FG000|Overall Study|Lost to Follow-up|3|||
42077712|NCT04160195|75887853|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
42077713|NCT04160195|75887854|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
42077714|NCT00686374|75887862|FG000|Overall Study|Lack of Efficacy|10|||
42077715|NCT00686374|75887862|FG000|Overall Study|Adverse Event|8|||
42077716|NCT00686374|75887862|FG000|Overall Study|Withdrew consent|5|||
42077717|NCT00686374|75887862|FG000|Overall Study|Lost to Follow-up|1|||
42077718|NCT00686374|75887862|FG000|Overall Study|Missing reason|33|||
42077719|NCT00686374|75887862|FG000|Overall Study|Other, not specified|4|||
42077720|NCT00571948|75887868|FG000|Overall Study|Lost to Follow-up|2|||
42077721|NCT00571948|75887869|FG001|Overall Study|Lost to Follow-up|0|||
42077722|NCT00571948|75887868|FG000|Overall Study|Withdrawal by Subject|1|||
42077723|NCT00571948|75887869|FG001|Overall Study|Withdrawal by Subject|2|||
42077724|NCT00571948|75887868|FG000|Overall Study|Protocol Violation|3|||
42077725|NCT00571948|75887869|FG001|Overall Study|Protocol Violation|3|||
42077726|NCT00571948|75887868|FG000|Overall Study|infant refused study meal|3|||
42077727|NCT00571948|75887869|FG001|Overall Study|infant refused study meal|4|||
42077728|NCT00571948|75887868|FG000|Overall Study|Parent were afraid of blood colection|2|||
42077729|NCT00571948|75887869|FG001|Overall Study|Parent were afraid of blood colection|5|||
42077730|NCT00684424|75887875|FG000|Overall Study|Adverse Event|1|||
42077731|NCT00684424|75887875|FG000|Overall Study|Lost to Follow-up|2|||
42077732|NCT00684424|75887875|FG000|Overall Study|Other|2|||
42077733|NCT00685750|75887887|FG000|Overall Study|Tumor sampling failure|0|||
42077734|NCT00685750|75887888|FG001|Overall Study|Tumor sampling failure|0|||
42077735|NCT00685750|75887889|FG002|Overall Study|Tumor sampling failure|1|||
42077736|NCT00685750|75887890|FG003|Overall Study|Tumor sampling failure|0|||
42077737|NCT00685750|75887891|FG004|Overall Study|Tumor sampling failure|0|||
42077738|NCT00685750|75887892|FG005|Overall Study|Tumor sampling failure|0|||
42077739|NCT00685750|75887893|FG006|Overall Study|Tumor sampling failure|0|||
42077740|NCT00685750|75887887|FG000|Overall Study|Patient didn't receive the treatment|0|||
42077741|NCT00685750|75887888|FG001|Overall Study|Patient didn't receive the treatment|0|||
42077742|NCT00685750|75887889|FG002|Overall Study|Patient didn't receive the treatment|0|||
42077743|NCT00685750|75887890|FG003|Overall Study|Patient didn't receive the treatment|0|||
42077744|NCT00685750|75887891|FG004|Overall Study|Patient didn't receive the treatment|0|||
42077745|NCT00685750|75887892|FG005|Overall Study|Patient didn't receive the treatment|0|||
42077746|NCT00685750|75887893|FG006|Overall Study|Patient didn't receive the treatment|1|||
42077747|NCT00685750|75887887|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42077748|NCT00685750|75887888|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
42077749|NCT00685750|75887889|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
42077750|NCT00685750|75887890|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
42077751|NCT00685750|75887891|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
42077752|NCT00685750|75887892|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
42077753|NCT00685750|75887893|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
42077754|NCT00576628|75887913|FG000|Overall Study|Adverse Event|11|||
42077755|NCT00576628|75887913|FG000|Overall Study|Death|2|||
42077756|NCT00576628|75887913|FG000|Overall Study|Failure to return|1|||
42077757|NCT00576628|75887913|FG000|Overall Study|Refused Treatment|8|||
42077758|NCT00576628|75887913|FG000|Overall Study|Pregnancy|1|||
42077759|NCT00576628|75887913|FG000|Overall Study|RBC transfusion|1|||
42077760|NCT00576628|75887913|FG000|Overall Study|Progression of Kidney Disease|1|||
42077761|NCT00576628|75887913|FG000|Overall Study|Progression of Renal Failure|1|||
42077762|NCT00576628|75887913|FG000|Overall Study|The patient move into other town|1|||
42077763|NCT00576628|75887913|FG000|Overall Study|Transplantation|1|||
42077764|NCT00576628|75887913|FG000|Overall Study|Dialysis|15|||
42077765|NCT00683878|75887921|FG000|Overall Study|Lack of Efficacy|3|||
42077766|NCT00683878|75887922|FG001|Overall Study|Lack of Efficacy|0|||
42077767|NCT00683878|75887923|FG002|Overall Study|Lack of Efficacy|1|||
42077768|NCT00683878|75887921|FG000|Overall Study|Adverse Event|4|||
42077769|NCT00683878|75887922|FG001|Overall Study|Adverse Event|3|||
42077770|NCT00683878|75887923|FG002|Overall Study|Adverse Event|3|||
42077771|NCT00683878|75887921|FG000|Overall Study|Withdrawal by Subject|9|||
42077772|NCT00683878|75887922|FG001|Overall Study|Withdrawal by Subject|8|||
42077773|NCT00683878|75887923|FG002|Overall Study|Withdrawal by Subject|6|||
42077774|NCT00683878|75887921|FG000|Overall Study|Death|0|||
42077775|NCT00683878|75887922|FG001|Overall Study|Death|1|||
42077776|NCT00683878|75887923|FG002|Overall Study|Death|0|||
42077777|NCT00683878|75887921|FG000|Overall Study|Lost to Follow-up|4|||
42077778|NCT00683878|75887922|FG001|Overall Study|Lost to Follow-up|2|||
42077779|NCT00683878|75887923|FG002|Overall Study|Lost to Follow-up|4|||
42077780|NCT00683878|75887921|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
42077781|NCT00683878|75887922|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
42077782|NCT00683878|75887923|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
42077783|NCT00884741|75887934|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
42077784|NCT00884741|75887935|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
42077785|NCT00884741|75887936|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
42077786|NCT00884741|75887937|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
42077787|NCT00884741|75887934|FG000|Step 1 Registration: Tissue Screening|Death|3|||
42077788|NCT00884741|75887935|FG001|Step 1 Registration: Tissue Screening|Death|0|||
42077789|NCT00884741|75887936|FG002|Step 1 Registration: Tissue Screening|Death|0|||
42077790|NCT00884741|75887937|FG003|Step 1 Registration: Tissue Screening|Death|0|||
42077791|NCT00884741|75887934|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
42077792|NCT00884741|75887935|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
42077793|NCT00884741|75887936|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
42077794|NCT00884741|75887937|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
42077795|NCT00884741|75887934|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
42077796|NCT00884741|75887935|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
42077797|NCT00884741|75887936|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
42077798|NCT00884741|75887937|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
42077799|NCT00884741|75887934|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
42077800|NCT00884741|75887935|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
42077801|NCT00884741|75887936|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
42077802|NCT00884741|75887937|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
42077803|NCT00884741|75887934|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
42077804|NCT00884741|75887935|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
42077805|NCT00884741|75887936|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
42077806|NCT00884741|75887937|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
42077807|NCT00884741|75887934|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
42077808|NCT00884741|75887935|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
42077809|NCT00884741|75887936|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
42077810|NCT00884741|75887937|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
42077811|NCT00884741|75887934|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
42077812|NCT00884741|75887935|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
42077813|NCT00884741|75887936|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
42077814|NCT00884741|75887937|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
42077815|NCT00884741|75887934|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
42077816|NCT00884741|75887935|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
42077817|NCT00884741|75887936|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
42077818|NCT00884741|75887937|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
42077819|NCT00884741|75887934|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
42077820|NCT00884741|75887935|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
42077821|NCT00884741|75887936|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
42077822|NCT00884741|75887937|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
42077823|NCT00884741|75887934|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
42077824|NCT00884741|75887935|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
42077825|NCT00884741|75887936|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
42077826|NCT00884741|75887937|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
42077827|NCT00884741|75887934|FG000|Randomization|Protocol Violation|0|||
42077828|NCT00884741|75887935|FG001|Randomization|Protocol Violation|0|||
42077829|NCT00884741|75887936|FG002|Randomization|Protocol Violation|8|||
42077830|NCT00884741|75887937|FG003|Randomization|Protocol Violation|8|||
42077831|NCT00880763|75887948|FG000|Extension Period (Part 2)|Adverse Event|0|||
42077832|NCT00880763|75887949|FG001|Extension Period (Part 2)|Adverse Event|0|||
42077833|NCT00880763|75887950|FG002|Extension Period (Part 2)|Adverse Event|1|||
42077834|NCT00880763|75887951|FG003|Extension Period (Part 2)|Adverse Event|1|||
42177910|NCT03110380|75985069|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
42177911|NCT03110380|75985066|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
42077835|NCT00880763|75887948|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
42077836|NCT00880763|75887949|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
42077837|NCT00880763|75887950|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
42077838|NCT00880763|75887951|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
42077839|NCT00880763|75887948|FG000|Extension Period (Part 2)|Physician Decision|0|||
42077840|NCT00880763|75887949|FG001|Extension Period (Part 2)|Physician Decision|1|||
42077841|NCT00880763|75887950|FG002|Extension Period (Part 2)|Physician Decision|1|||
42177912|NCT03110380|75985067|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
42177913|NCT03110380|75985068|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
42177914|NCT03110380|75985069|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
42077842|NCT00880763|75887951|FG003|Extension Period (Part 2)|Physician Decision|0|||
42177915|NCT03110380|75985066|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
42077843|NCT00880763|75887948|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
42077844|NCT00880763|75887949|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
42077845|NCT00880763|75887950|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
42077846|NCT00880763|75887951|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
42077847|NCT00884273|75887963|FG000|Overall Study|Adverse Event|0|||
42077848|NCT00884273|75887964|FG001|Overall Study|Adverse Event|2|||
42077849|NCT00884273|75887963|FG000|Overall Study|Protocol Violation|1|||
42177916|NCT03110380|75985067|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
42177917|NCT03110380|75985068|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
42177918|NCT03110380|75985069|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
42177919|NCT03110380|75985066|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
42177920|NCT03110380|75985067|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
42177921|NCT03110380|75985068|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
42177922|NCT03110380|75985069|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
42177923|NCT03110380|75985066|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
42177924|NCT03110380|75985067|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
42177925|NCT03110380|75985068|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
42177926|NCT03110380|75985069|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
42177927|NCT03110380|75985066|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
42177928|NCT03110380|75985067|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
42177929|NCT03110380|75985068|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
42177930|NCT03110380|75985069|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
42177931|NCT04851314|75985079|FG000|Overall Study|Unable to complete research set-up procedures|0|||
42177932|NCT04851314|75985080|FG001|Overall Study|Unable to complete research set-up procedures|2|||
42177933|NCT04851314|75985079|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
42177934|NCT04851314|75985080|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
42177935|NCT04848662|75985088|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
42177936|NCT04848662|75985089|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
42177937|NCT03701516|75985095|FG000|Period 1|Lost to Follow-up|0|||
42177938|NCT03701516|75985096|FG001|Period 1|Lost to Follow-up|1|||
42177939|NCT03701516|75985095|FG000|Period 1|Adverse Event|0|||
42177940|NCT03701516|75985096|FG001|Period 1|Adverse Event|2|||
42177941|NCT03701516|75985095|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
42177942|NCT03701516|75985096|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
42177943|NCT03701516|75985095|FG000|Period 1|Non Compliance to Protocol|2|||
42177944|NCT03701516|75985096|FG001|Period 1|Non Compliance to Protocol|1|||
42177945|NCT03701516|75985095|FG000|Period 1|Withdrawal by Subject|0|||
42177946|NCT03701516|75985096|FG001|Period 1|Withdrawal by Subject|1|||
42177947|NCT03701516|75985095|FG000|Period 2|failed to meet all eligibility creiteria|1|||
42177948|NCT03701516|75985096|FG001|Period 2|failed to meet all eligibility creiteria|0|||
42177949|NCT03701516|75985095|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
42177950|NCT03701516|75985096|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
42177951|NCT03700892|75985104|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
42177952|NCT03700892|75985105|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
42177953|NCT03700892|75985106|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
42177954|NCT03700736|75985117|FG000|Overall Study|Pregnancy|1|||
42177955|NCT03700736|75985118|FG001|Overall Study|Pregnancy|1|||
42177956|NCT03700736|75985117|FG000|Overall Study|Withdrawal by Subject|2|||
42177957|NCT03700736|75985118|FG001|Overall Study|Withdrawal by Subject|6|||
42177958|NCT04737278|75985129|FG000|Overall Study|Lost to Follow-up|1|||
42293564|NCT01668797|76127788|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
42293565|NCT01668797|76127789|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
42293566|NCT01668797|76127786|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
42293567|NCT01668797|76127787|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
42293568|NCT01668797|76127788|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
42293569|NCT01668797|76127789|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
42293570|NCT01668797|76127786|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
42357867|NCT01857583|76203396|FG002|Overall Study|Withdrawal by Subject|1|||
42357868|NCT01857583|76203397|FG003|Overall Study|Withdrawal by Subject|2|||
42077850|NCT00884273|75887964|FG001|Overall Study|Protocol Violation|3|||
42077851|NCT00884273|75887963|FG000|Overall Study|Practical reasons|1|||
42077852|NCT00884273|75887964|FG001|Overall Study|Practical reasons|0|||
42077853|NCT00884117|75887970|FG000|Overall Study|Adverse Event|2|||
42077854|NCT00884117|75887970|FG000|Overall Study|Withdrawal by Subject|89|||
42077855|NCT00884117|75887970|FG000|Overall Study|Death|3|||
42077856|NCT00884117|75887970|FG000|Overall Study|Lost to Follow-up|143|||
42077857|NCT00884117|75887970|FG000|Overall Study|Other|12|||
42077858|NCT00884039|75887989|FG000|Overall Study|Withdrawal by Subject|0|||
42077859|NCT00884039|75887990|FG001|Overall Study|Withdrawal by Subject|1|||
42077860|NCT00884039|75887989|FG000|Overall Study|Lack of Efficacy|2|||
42077861|NCT00884039|75887990|FG001|Overall Study|Lack of Efficacy|0|||
42077862|NCT00835770|75887998|FG000|Overall Study|MS Relapse|17|||
42077863|NCT00835770|75887999|FG001|Overall Study|MS Relapse|23|||
42077864|NCT00835770|75887998|FG000|Overall Study|MS Progression|14|||
42077865|NCT00835770|75887999|FG001|Overall Study|MS Progression|9|||
42077866|NCT00835770|75887998|FG000|Overall Study|Adverse Event|113|||
42077867|NCT00835770|75887999|FG001|Overall Study|Adverse Event|124|||
42077868|NCT00835770|75887998|FG000|Overall Study|Lost to Follow-up|22|||
42077869|NCT00835770|75887999|FG001|Overall Study|Lost to Follow-up|19|||
42077870|NCT00835770|75887998|FG000|Overall Study|Consent Withdrawn|144|||
42077871|NCT00835770|75887999|FG001|Overall Study|Consent Withdrawn|156|||
42077872|NCT00835770|75887998|FG000|Overall Study|Investigator Decision|42|||
42077873|NCT00835770|75887999|FG001|Overall Study|Investigator Decision|42|||
42077874|NCT00835770|75887998|FG000|Overall Study|Participant Non-Compliance|11|||
42077875|NCT00835770|75887999|FG001|Overall Study|Participant Non-Compliance|9|||
42077876|NCT00835770|75887998|FG000|Overall Study|Death|4|||
42077877|NCT00835770|75887999|FG001|Overall Study|Death|6|||
42077878|NCT00835770|75887998|FG000|Overall Study|Other|115|||
42077879|NCT00835770|75887999|FG001|Overall Study|Other|104|||
42077880|NCT00835770|75887998|FG000|Overall Study|Other|2|||
42077881|NCT00835770|75887999|FG001|Overall Study|Other|1|||
42077882|NCT00880685|75888011|FG000|Memantine 10mg|Lost to Follow-up|2|||
42077883|NCT00880685|75888011|FG000|Memantine 20mg|Withdrawal by Subject|1|||
42077884|NCT00835380|75888018|FG000|Overall Study|Withdrawal by Subject|2|||
42077885|NCT00880607|75888024|FG000|Overall Study|Physician Decision|2|||
42077886|NCT00880607|75888025|FG001|Overall Study|Physician Decision|2|||
42077887|NCT00880607|75888024|FG000|Overall Study|Protocol Violation|2|||
42077888|NCT00880607|75888025|FG001|Overall Study|Protocol Violation|1|||
42077889|NCT00880607|75888024|FG000|Overall Study|surgery did not extend past L1 level|3|||
42077890|NCT00880607|75888025|FG001|Overall Study|surgery did not extend past L1 level|0|||
42077891|NCT00835068|75888035|FG000|Overall Study|Death|1|||
42077892|NCT00835068|75888036|FG001|Overall Study|Death|0|||
42077893|NCT00835068|75888035|FG000|Overall Study|Adverse Event|0|||
42077894|NCT00835068|75888036|FG001|Overall Study|Adverse Event|1|||
42077895|NCT00835068|75888035|FG000|Overall Study|Other|8|||
42077896|NCT00835068|75888036|FG001|Overall Study|Other|0|||
42077897|NCT00835068|75888035|FG000|Overall Study|Withdrawal by Subject|1|||
42077898|NCT00835068|75888036|FG001|Overall Study|Withdrawal by Subject|0|||
42077899|NCT00834912|75888048|FG000|Treatment Period 1|Adverse Event|0|||
42077900|NCT00834912|75888049|FG001|Treatment Period 1|Adverse Event|1|||
42077901|NCT00834912|75888050|FG002|Treatment Period 1|Adverse Event|0|||
42077902|NCT00834912|75888051|FG003|Treatment Period 1|Adverse Event|1|||
42077903|NCT00834912|75888052|FG004|Treatment Period 1|Adverse Event|0|||
42077904|NCT00834912|75888053|FG005|Treatment Period 1|Adverse Event|0|||
42077905|NCT00834912|75888048|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42077906|NCT00834912|75888049|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42077907|NCT00834912|75888050|FG002|Treatment Period 2|Withdrawal by Subject|1|||
42077908|NCT00834912|75888051|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42077909|NCT00834912|75888052|FG004|Treatment Period 2|Withdrawal by Subject|1|||
42077910|NCT00834912|75888053|FG005|Treatment Period 2|Withdrawal by Subject|0|||
42077911|NCT00883493|75888063|FG000|Overall Study|Adverse Event|11|||
42077912|NCT00883493|75888064|FG001|Overall Study|Adverse Event|12|||
42077913|NCT00883493|75888063|FG000|Overall Study|Lack of Efficacy|4|||
42077914|NCT00883493|75888064|FG001|Overall Study|Lack of Efficacy|3|||
42077915|NCT00883493|75888063|FG000|Overall Study|Lost to Follow-up|7|||
42077916|NCT00883493|75888064|FG001|Overall Study|Lost to Follow-up|6|||
42077917|NCT00883493|75888063|FG000|Overall Study|Withdrawal by Subject|11|||
42077918|NCT00883493|75888064|FG001|Overall Study|Withdrawal by Subject|20|||
42077919|NCT00883493|75888063|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
42077920|NCT00883493|75888064|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
42077921|NCT00883493|75888063|FG000|Overall Study|Study specific disc. criteria|2|||
42077922|NCT00883493|75888064|FG001|Overall Study|Study specific disc. criteria|0|||
42077923|NCT00883493|75888063|FG000|Overall Study|Other|5|||
42077924|NCT00883493|75888064|FG001|Overall Study|Other|3|||
42077925|NCT04887922|75888079|FG000|1st Randomization|Decided not to have surgery|0|||
42077926|NCT04887922|75888080|FG001|1st Randomization|Decided not to have surgery|1|||
42077927|NCT04887922|75888081|FG002|1st Randomization|Decided not to have surgery|0|||
42077928|NCT04887922|75888082|FG003|1st Randomization|Decided not to have surgery|0|||
42077929|NCT04887922|75888083|FG004|1st Randomization|Decided not to have surgery|0|||
42077930|NCT04771403|75888106|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
42077931|NCT04771403|75888107|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
42077932|NCT04771403|75888106|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
42077933|NCT04771403|75888107|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
42077934|NCT04771403|75888106|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
42077935|NCT04771403|75888107|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
42077936|NCT04771403|75888106|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
42077937|NCT04771403|75888107|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
42077938|NCT04771403|75888106|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
42077939|NCT04771403|75888107|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
42077940|NCT04771403|75888106|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
42077941|NCT04771403|75888107|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
42077942|NCT04771403|75888106|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
42077943|NCT04771403|75888107|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
42077944|NCT04771403|75888106|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
42077945|NCT04771403|75888107|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
42077946|NCT04698525|75888116|FG000|Overall Study|Lost to Follow-up|1|||
42077947|NCT04698525|75888117|FG001|Overall Study|Lost to Follow-up|2|||
42077948|NCT04698525|75888116|FG000|Overall Study|Three suffered of Covid-19|2|||
42077949|NCT04698525|75888117|FG001|Overall Study|Three suffered of Covid-19|1|||
42077950|NCT04510675|75888131|FG000|Overall Study|Withdrawal by Subject|5|||
42077951|NCT04228783|75888153|FG000|Overall Study|Adverse Event|1|||
42077952|NCT04228783|75888154|FG001|Overall Study|Adverse Event|0|||
42077953|NCT04228783|75888155|FG002|Overall Study|Adverse Event|2|||
42077954|NCT04228783|75888156|FG003|Overall Study|Adverse Event|0|||
42077955|NCT04228783|75888157|FG004|Overall Study|Adverse Event|0|||
42077956|NCT04228783|75888158|FG005|Overall Study|Adverse Event|1|||
42077957|NCT04228783|75888153|FG000|Overall Study|Death|0|||
42077958|NCT04228783|75888154|FG001|Overall Study|Death|0|||
42077959|NCT04228783|75888155|FG002|Overall Study|Death|0|||
42077960|NCT04228783|75888156|FG003|Overall Study|Death|0|||
42077961|NCT04228783|75888157|FG004|Overall Study|Death|1|||
42077962|NCT04228783|75888158|FG005|Overall Study|Death|0|||
42077963|NCT04228783|75888153|FG000|Overall Study|Lost to Follow-up|36|||
42077964|NCT04228783|75888154|FG001|Overall Study|Lost to Follow-up|36|||
42077965|NCT04228783|75888155|FG002|Overall Study|Lost to Follow-up|28|||
42077966|NCT04228783|75888156|FG003|Overall Study|Lost to Follow-up|6|||
42077967|NCT04228783|75888157|FG004|Overall Study|Lost to Follow-up|14|||
42077968|NCT04228783|75888158|FG005|Overall Study|Lost to Follow-up|3|||
42077969|NCT04228783|75888153|FG000|Overall Study|Physician Decision|1|||
42077970|NCT04228783|75888154|FG001|Overall Study|Physician Decision|2|||
42077971|NCT04228783|75888155|FG002|Overall Study|Physician Decision|0|||
42077972|NCT04228783|75888156|FG003|Overall Study|Physician Decision|0|||
42077973|NCT04228783|75888157|FG004|Overall Study|Physician Decision|0|||
42077974|NCT04228783|75888158|FG005|Overall Study|Physician Decision|0|||
42077975|NCT04228783|75888153|FG000|Overall Study|Protocol Violation|0|||
42077976|NCT04228783|75888154|FG001|Overall Study|Protocol Violation|0|||
42077977|NCT04228783|75888155|FG002|Overall Study|Protocol Violation|0|||
42077978|NCT04228783|75888156|FG003|Overall Study|Protocol Violation|1|||
42077979|NCT04228783|75888157|FG004|Overall Study|Protocol Violation|0|||
42077980|NCT04228783|75888158|FG005|Overall Study|Protocol Violation|0|||
42077981|NCT04228783|75888153|FG000|Overall Study|Withdrawal by Subject|6|||
42077982|NCT04228783|75888154|FG001|Overall Study|Withdrawal by Subject|10|||
42077983|NCT04228783|75888155|FG002|Overall Study|Withdrawal by Subject|19|||
42077984|NCT04228783|75888156|FG003|Overall Study|Withdrawal by Subject|1|||
42077985|NCT04228783|75888157|FG004|Overall Study|Withdrawal by Subject|2|||
42077986|NCT04228783|75888158|FG005|Overall Study|Withdrawal by Subject|0|||
42077987|NCT04228783|75888153|FG000|Overall Study|Other|4|||
42077988|NCT04228783|75888154|FG001|Overall Study|Other|3|||
42077989|NCT04228783|75888155|FG002|Overall Study|Other|2|||
42077990|NCT04228783|75888156|FG003|Overall Study|Other|1|||
42077991|NCT04228783|75888157|FG004|Overall Study|Other|0|||
42077992|NCT04228783|75888158|FG005|Overall Study|Other|0|||
42077993|NCT03950674|75888174|FG000|Overall Study|Death|3|||
42077994|NCT03950674|75888175|FG001|Overall Study|Death|7|||
42077995|NCT03950674|75888174|FG000|Overall Study|Ongoing in Study|22|||
42077996|NCT03950674|75888175|FG001|Overall Study|Ongoing in Study|8|||
42077997|NCT03702621|75888184|FG000|Overall Study|Physician Decision|6|||
42077998|NCT03702621|75888185|FG001|Overall Study|Physician Decision|6|||
42077999|NCT03577990|75888193|FG000|Overall Study|Lost to Follow-up|4|||
42078000|NCT03577990|75888194|FG001|Overall Study|Lost to Follow-up|6|||
42078001|NCT03577990|75888193|FG000|Overall Study|Withdrawal by Subject|4|||
42078002|NCT03577990|75888194|FG001|Overall Study|Withdrawal by Subject|7|||
42078003|NCT03565497|75888204|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
42078004|NCT03565497|75888205|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
42078005|NCT03565497|75888206|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
42078006|NCT03565497|75888204|FG000|Overall Study|Lost to Follow-up|1|||
42078007|NCT03565497|75888205|FG001|Overall Study|Lost to Follow-up|1|||
42078008|NCT03565497|75888206|FG002|Overall Study|Lost to Follow-up|2|||
42078009|NCT03565497|75888204|FG000|Overall Study|Withdrawal by Subject|1|||
42078010|NCT03565497|75888205|FG001|Overall Study|Withdrawal by Subject|1|||
42078011|NCT03565497|75888206|FG002|Overall Study|Withdrawal by Subject|1|||
42078012|NCT03362931|75888214|FG000|Overall Study|Adverse Event|1|||
42078013|NCT03362931|75888214|FG000|Overall Study|Death|2|||
42078014|NCT03360019|75888221|FG000|Overall Study|Withdrawal by Subject|2|||
42078015|NCT03360019|75888222|FG001|Overall Study|Withdrawal by Subject|0|||
42078016|NCT03360019|75888223|FG002|Overall Study|Withdrawal by Subject|0|||
42078017|NCT03360019|75888221|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
42078018|NCT03360019|75888222|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
42078019|NCT03360019|75888223|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
42078020|NCT03245008|75888240|FG000|Overall Study|Adverse Event|15|||
42078021|NCT03245008|75888241|FG001|Overall Study|Adverse Event|18|||
42078022|NCT03245008|75888242|FG002|Overall Study|Adverse Event|15|||
42078023|NCT03245008|75888243|FG003|Overall Study|Adverse Event|0|||
42078024|NCT03245008|75888244|FG004|Overall Study|Adverse Event|1|||
42078025|NCT03245008|75888240|FG000|Overall Study|Lack of Efficacy|0|||
42078026|NCT03245008|75888241|FG001|Overall Study|Lack of Efficacy|1|||
42078027|NCT03245008|75888242|FG002|Overall Study|Lack of Efficacy|0|||
42078028|NCT03245008|75888243|FG003|Overall Study|Lack of Efficacy|0|||
42078029|NCT03245008|75888244|FG004|Overall Study|Lack of Efficacy|0|||
42078030|NCT03245008|75888240|FG000|Overall Study|Lost to Follow-up|4|||
42078031|NCT03245008|75888241|FG001|Overall Study|Lost to Follow-up|1|||
42078032|NCT03245008|75888242|FG002|Overall Study|Lost to Follow-up|0|||
42078033|NCT03245008|75888243|FG003|Overall Study|Lost to Follow-up|0|||
42078034|NCT03245008|75888244|FG004|Overall Study|Lost to Follow-up|1|||
42078035|NCT03245008|75888240|FG000|Overall Study|Physician Decision|1|||
42078036|NCT03245008|75888241|FG001|Overall Study|Physician Decision|3|||
42078037|NCT03245008|75888242|FG002|Overall Study|Physician Decision|4|||
42078038|NCT03245008|75888243|FG003|Overall Study|Physician Decision|0|||
42078039|NCT03245008|75888244|FG004|Overall Study|Physician Decision|0|||
42078040|NCT03245008|75888240|FG000|Overall Study|Protocol Violation|0|||
42078041|NCT03245008|75888241|FG001|Overall Study|Protocol Violation|1|||
42078042|NCT03245008|75888242|FG002|Overall Study|Protocol Violation|0|||
42078043|NCT03245008|75888243|FG003|Overall Study|Protocol Violation|0|||
42078044|NCT03245008|75888244|FG004|Overall Study|Protocol Violation|0|||
42078045|NCT03245008|75888240|FG000|Overall Study|Withdrawal by Subject|20|||
42078046|NCT03245008|75888241|FG001|Overall Study|Withdrawal by Subject|19|||
42078047|NCT03245008|75888242|FG002|Overall Study|Withdrawal by Subject|11|||
42078048|NCT03245008|75888243|FG003|Overall Study|Withdrawal by Subject|0|||
42078049|NCT03245008|75888244|FG004|Overall Study|Withdrawal by Subject|0|||
42078050|NCT03245008|75888240|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
42078051|NCT03245008|75888241|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
42078052|NCT03245008|75888242|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
42078053|NCT03245008|75888243|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
42078054|NCT03245008|75888244|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
42078055|NCT03245008|75888240|FG000|Overall Study|Failure to meet randomization criteria|0|||
42078056|NCT03245008|75888241|FG001|Overall Study|Failure to meet randomization criteria|1|||
42078057|NCT03245008|75888242|FG002|Overall Study|Failure to meet randomization criteria|0|||
42078058|NCT03245008|75888243|FG003|Overall Study|Failure to meet randomization criteria|1|||
42078059|NCT03245008|75888244|FG004|Overall Study|Failure to meet randomization criteria|0|||
42078060|NCT03203473|75888266|FG000|Induction Phase|Never started primary treatment|2|||
42078061|NCT03203473|75888267|FG001|Induction Phase|Never started primary treatment|0|||
42078062|NCT03203473|75888268|FG002|Induction Phase|Never started primary treatment|0|||
42078063|NCT03203473|75888266|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
42078064|NCT03203473|75888267|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
42078065|NCT03203473|75888268|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
42078066|NCT03203473|75888266|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
42078067|NCT03203473|75888267|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
42078068|NCT03203473|75888268|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
42078069|NCT03203473|75888266|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
42078070|NCT03203473|75888267|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
42078071|NCT03203473|75888268|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
42078072|NCT03203473|75888266|FG000|Arm Allocation Phase|started salvage therapy|0|||
42078073|NCT03203473|75888267|FG001|Arm Allocation Phase|started salvage therapy|5|||
42078074|NCT03203473|75888268|FG002|Arm Allocation Phase|started salvage therapy|0|||
42078075|NCT03203473|75888266|FG000|Arm Allocation Phase|Disease progression|0|||
42078076|NCT03203473|75888267|FG001|Arm Allocation Phase|Disease progression|0|||
42078077|NCT03203473|75888268|FG002|Arm Allocation Phase|Disease progression|37|||
42078078|NCT03203473|75888266|FG000|Arm Allocation Phase|Adverse Event|0|||
42078079|NCT03203473|75888267|FG001|Arm Allocation Phase|Adverse Event|0|||
42078080|NCT03203473|75888268|FG002|Arm Allocation Phase|Adverse Event|11|||
42078081|NCT03203473|75888266|FG000|Arm Allocation Phase|Physician Decision|0|||
42078082|NCT03203473|75888267|FG001|Arm Allocation Phase|Physician Decision|0|||
42078083|NCT03203473|75888268|FG002|Arm Allocation Phase|Physician Decision|3|||
42078084|NCT03203473|75888266|FG000|Arm Allocation Phase|Death|0|||
42078085|NCT03203473|75888267|FG001|Arm Allocation Phase|Death|0|||
42078086|NCT03203473|75888268|FG002|Arm Allocation Phase|Death|1|||
42078087|NCT03203473|75888266|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
42078088|NCT03203473|75888267|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
42078089|NCT03203473|75888268|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
42078090|NCT03203473|75888266|FG000|Arm Allocation Phase|Intercurrent illness|0|||
42078091|NCT03203473|75888267|FG001|Arm Allocation Phase|Intercurrent illness|0|||
42078092|NCT03203473|75888268|FG002|Arm Allocation Phase|Intercurrent illness|1|||
42078093|NCT03203473|75888266|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
42078094|NCT03203473|75888267|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
42078095|NCT03203473|75888268|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
42078096|NCT03158051|75888281|FG000|Overall Study|Lost to Follow-up|41|||
42078097|NCT03158051|75888282|FG001|Overall Study|Lost to Follow-up|47|||
42078098|NCT03158051|75888281|FG000|Overall Study|Physician Decision|6|||
42078099|NCT03158051|75888282|FG001|Overall Study|Physician Decision|7|||
42078100|NCT03158051|75888281|FG000|Overall Study|Withdrawal by Subject|24|||
42078101|NCT03158051|75888282|FG001|Overall Study|Withdrawal by Subject|15|||
42078102|NCT03158051|75888281|FG000|Overall Study|Death|0|||
42078103|NCT03158051|75888282|FG001|Overall Study|Death|1|||
42078104|NCT02971761|75888297|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
42078105|NCT02600507|75888304|FG000|Overall Study|Adverse Event|3|||
42078106|NCT02600507|75888305|FG001|Overall Study|Adverse Event|15|||
42078107|NCT02600507|75888306|FG002|Overall Study|Adverse Event|5|||
42078108|NCT02600507|75888304|FG000|Overall Study|Lack of Efficacy|3|||
42078109|NCT02600507|75888305|FG001|Overall Study|Lack of Efficacy|8|||
42078110|NCT02600507|75888306|FG002|Overall Study|Lack of Efficacy|5|||
42078111|NCT02600507|75888304|FG000|Overall Study|Lost to Follow-up|3|||
42078112|NCT02600507|75888305|FG001|Overall Study|Lost to Follow-up|5|||
42078113|NCT02600507|75888306|FG002|Overall Study|Lost to Follow-up|2|||
42078114|NCT02600507|75888304|FG000|Overall Study|Protocol Violation|12|||
42078115|NCT02600507|75888305|FG001|Overall Study|Protocol Violation|4|||
42078116|NCT02600507|75888306|FG002|Overall Study|Protocol Violation|4|||
42078117|NCT02600507|75888304|FG000|Overall Study|Physician Decision|1|||
42078118|NCT02600507|75888305|FG001|Overall Study|Physician Decision|0|||
42078119|NCT02600507|75888306|FG002|Overall Study|Physician Decision|1|||
42078120|NCT02600507|75888304|FG000|Overall Study|Withdrawal by Subject|7|||
42078121|NCT02600507|75888305|FG001|Overall Study|Withdrawal by Subject|11|||
42078122|NCT02600507|75888306|FG002|Overall Study|Withdrawal by Subject|7|||
42078123|NCT02600507|75888304|FG000|Overall Study|Other|0|||
42078124|NCT02600507|75888305|FG001|Overall Study|Other|1|||
42078125|NCT02600507|75888306|FG002|Overall Study|Other|1|||
42078126|NCT02578680|75888316|FG000|Overall Study|Death|124|||
42078127|NCT02578680|75888317|FG001|Overall Study|Death|104|||
42078128|NCT02578680|75888316|FG000|Overall Study|Protocol Violation|1|||
42078129|NCT02578680|75888317|FG001|Overall Study|Protocol Violation|1|||
42078130|NCT02578680|75888316|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
42078131|NCT02578680|75888317|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
42078132|NCT02578680|75888316|FG000|Overall Study|Withdrawal by Subject|8|||
42078133|NCT02578680|75888317|FG001|Overall Study|Withdrawal by Subject|5|||
42078134|NCT02578680|75888316|FG000|Overall Study|Ongoing in Study|276|||
42078135|NCT02578680|75888317|FG001|Overall Study|Ongoing in Study|96|||
42078136|NCT02385266|75888325|FG000|Overall Study|Withdrawal by Subject|1|||
42078137|NCT02385266|75888326|FG001|Overall Study|Withdrawal by Subject|3|||
42078138|NCT02379988|75888332|FG000|Overall Study|Not eligible|1|||
42078139|NCT02006069|75888347|FG000|Overall Study|MPP other programming|239|||
42078140|NCT02006069|75888348|FG001|Overall Study|MPP other programming|0|||
42078141|NCT02006069|75888347|FG000|Overall Study|RV only pacing|0|||
42078142|NCT02006069|75888348|FG001|Overall Study|RV only pacing|3|||
42078143|NCT01985867|75888356|FG000|Overall Study|Lost to Follow-up|3|||
42078144|NCT01985867|75888357|FG001|Overall Study|Lost to Follow-up|4|||
42078145|NCT01985867|75888356|FG000|Overall Study|Adverse Event|3|||
42078146|NCT01985867|75888357|FG001|Overall Study|Adverse Event|2|||
42078147|NCT01985867|75888356|FG000|Overall Study|Lack of Efficacy|1|||
42078148|NCT01985867|75888357|FG001|Overall Study|Lack of Efficacy|0|||
42078149|NCT01367002|75888365|FG000|Overall Study|Withdrawal by Subject|1|||
42078150|NCT01367002|75888366|FG001|Overall Study|Withdrawal by Subject|0|||
42078151|NCT01367002|75888365|FG000|Overall Study|Physician Decision|0|||
42078152|NCT01367002|75888366|FG001|Overall Study|Physician Decision|2|||
42078153|NCT00858273|75888374|FG000|Overall Study|Protocol Violation|3|||
42078154|NCT00858273|75888375|FG001|Overall Study|Protocol Violation|5|||
42078155|NCT00844428|75888406|FG000|Screening Period|Screen Failure|3|||
42078156|NCT00844428|75888406|FG000|Extension Treatment Period|Death|1|||
42078157|NCT00844428|75888406|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
42078158|NCT00834834|75888412|FG000|Overall Study|Withdrawal by Subject|4|||
42078159|NCT00834834|75888413|FG001|Overall Study|Withdrawal by Subject|3|||
42078160|NCT00834366|75888421|FG000|Treatment Period 1|Adverse Event|1|||
42078161|NCT00834366|75888422|FG001|Treatment Period 1|Adverse Event|1|||
42078162|NCT00844194|75888430|FG000|Overall Study|Adverse Event|17|||
42078163|NCT00844194|75888431|FG001|Overall Study|Adverse Event|5|||
42078164|NCT00844194|75888430|FG000|Overall Study|Protocol Violation|1|||
42078165|NCT00844194|75888431|FG001|Overall Study|Protocol Violation|1|||
42078166|NCT00844194|75888430|FG000|Overall Study|Lost to Follow-up|1|||
42078167|NCT00844194|75888431|FG001|Overall Study|Lost to Follow-up|1|||
42078168|NCT00844194|75888430|FG000|Overall Study|Withdrawal by Subject|2|||
42078169|NCT00844194|75888431|FG001|Overall Study|Withdrawal by Subject|1|||
42078170|NCT00844194|75888430|FG000|Overall Study|Lack of Efficacy|3|||
42078171|NCT00844194|75888431|FG001|Overall Study|Lack of Efficacy|0|||
42078172|NCT00844194|75888430|FG000|Overall Study|Other reason (not specified)|1|||
42078173|NCT00844194|75888431|FG001|Overall Study|Other reason (not specified)|0|||
42078174|NCT00826176|75888443|FG000|Overall Study|Lost to Follow-up|1|||
42078175|NCT00826176|75888444|FG001|Overall Study|Lost to Follow-up|0|||
42078176|NCT00826176|75888443|FG000|Overall Study|Subject Withdrew Consent|3|||
42078177|NCT00826176|75888444|FG001|Overall Study|Subject Withdrew Consent|0|||
42078178|NCT00826176|75888443|FG000|Overall Study|Administrative|9|||
42078179|NCT00826176|75888444|FG001|Overall Study|Administrative|0|||
42078180|NCT00878969|75888453|FG000|Overall Study|Physician Decision|5|||
42078181|NCT00878969|75888454|FG001|Overall Study|Physician Decision|3|||
42078182|NCT00878969|75888455|FG002|Overall Study|Physician Decision|2|||
42078183|NCT00878969|75888453|FG000|Overall Study|Withdrawal by Subject|1|||
42078184|NCT00878969|75888454|FG001|Overall Study|Withdrawal by Subject|6|||
42078185|NCT00878969|75888455|FG002|Overall Study|Withdrawal by Subject|3|||
42078186|NCT00878969|75888453|FG000|Overall Study|kidney transplant|2|||
42078187|NCT00878969|75888454|FG001|Overall Study|kidney transplant|3|||
42078188|NCT00878969|75888455|FG002|Overall Study|kidney transplant|2|||
42078189|NCT00878969|75888453|FG000|Overall Study|Adverse Event|3|||
42078190|NCT00878969|75888454|FG001|Overall Study|Adverse Event|1|||
42078191|NCT00878969|75888455|FG002|Overall Study|Adverse Event|2|||
42078192|NCT00878969|75888453|FG000|Overall Study|Lost to Follow-up|2|||
42078193|NCT00878969|75888454|FG001|Overall Study|Lost to Follow-up|1|||
42078194|NCT00878969|75888455|FG002|Overall Study|Lost to Follow-up|0|||
42078195|NCT00878969|75888453|FG000|Overall Study|Protocol Violation|2|||
42078196|NCT00878969|75888454|FG001|Overall Study|Protocol Violation|0|||
42078197|NCT00878969|75888455|FG002|Overall Study|Protocol Violation|0|||
42078198|NCT00878969|75888453|FG000|Overall Study|Death|0|||
42078199|NCT00878969|75888454|FG001|Overall Study|Death|0|||
42078200|NCT00878969|75888455|FG002|Overall Study|Death|2|||
42078201|NCT00878969|75888453|FG000|Overall Study|Pregnancy|0|||
42078202|NCT00878969|75888454|FG001|Overall Study|Pregnancy|1|||
42078203|NCT00878969|75888455|FG002|Overall Study|Pregnancy|0|||
42078204|NCT00843726|75888469|FG000|Overall Study|Death|1|||
42078205|NCT00843726|75888470|FG001|Overall Study|Death|0|||
42078206|NCT00843726|75888469|FG000|Overall Study|Withdrawal by Subject|0|||
42078207|NCT00843726|75888470|FG001|Overall Study|Withdrawal by Subject|1|||
42078208|NCT00843492|75888479|FG000|Overall Study|Adverse Event|0|||
42078209|NCT00843492|75888480|FG001|Overall Study|Adverse Event|3|||
42078210|NCT00843492|75888479|FG000|Overall Study|Lost to Follow-up|4|||
42078211|NCT00843492|75888480|FG001|Overall Study|Lost to Follow-up|4|||
42078212|NCT00843492|75888479|FG000|Overall Study|Withdrawal by Subject|0|||
42078213|NCT00843492|75888480|FG001|Overall Study|Withdrawal by Subject|4|||
42078214|NCT00843492|75888479|FG000|Overall Study|Immobilization Stopped|1|||
42078215|NCT00843492|75888480|FG001|Overall Study|Immobilization Stopped|0|||
42078216|NCT00843492|75888479|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
42078217|NCT00843492|75888480|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
42078218|NCT00843492|75888479|FG000|Overall Study|Orthopedic Surgery|0|||
42078219|NCT00843492|75888480|FG001|Overall Study|Orthopedic Surgery|2|||
42078220|NCT00843492|75888479|FG000|Overall Study|Visit Not Performed|1|||
42078221|NCT00843492|75888480|FG001|Overall Study|Visit Not Performed|0|||
42078222|NCT00843492|75888479|FG000|Overall Study|Deep-vein Thrombosis|1|||
42078223|NCT00843492|75888480|FG001|Overall Study|Deep-vein Thrombosis|0|||
42078224|NCT00833976|75888486|FG000|Overall Study|Withdrawal by Subject|5|||
42078225|NCT00833976|75888486|FG000|Overall Study|Lost to Follow-up|4|||
42078226|NCT00833976|75888486|FG000|Overall Study|Did not meet eligibility criteria|41|||
42078227|NCT00833976|75888486|FG000|Overall Study|Physician Decision|1|||
42078228|NCT00833898|75888492|FG000|Overall Study|Withdrawal by Subject|33|||
42078229|NCT00833898|75888493|FG001|Overall Study|Withdrawal by Subject|27|||
42078230|NCT00833898|75888492|FG000|Overall Study|Lost to Follow-up|7|||
42078231|NCT00833898|75888493|FG001|Overall Study|Lost to Follow-up|7|||
42078232|NCT00833898|75888492|FG000|Overall Study|Patient did not receive transplant|0|||
42078233|NCT00833898|75888493|FG001|Overall Study|Patient did not receive transplant|2|||
42078234|NCT00825162|75888502|FG000|Overall Study|Withdrawal by Subject|11|||
42078235|NCT00825162|75888503|FG001|Overall Study|Withdrawal by Subject|13|||
42078236|NCT00825162|75888504|FG002|Overall Study|Withdrawal by Subject|3|||
42078237|NCT00825162|75888502|FG000|Overall Study|Lost to Follow-up|9|||
42078238|NCT00825162|75888503|FG001|Overall Study|Lost to Follow-up|6|||
42078239|NCT00825162|75888504|FG002|Overall Study|Lost to Follow-up|3|||
42078240|NCT00825162|75888502|FG000|Overall Study|Physician Decision|2|||
42078241|NCT00825162|75888503|FG001|Overall Study|Physician Decision|0|||
42078242|NCT00825162|75888504|FG002|Overall Study|Physician Decision|0|||
42078243|NCT00825162|75888502|FG000|Overall Study|Move away from the study area|1|||
42078244|NCT00825162|75888503|FG001|Overall Study|Move away from the study area|0|||
42078245|NCT00825162|75888504|FG002|Overall Study|Move away from the study area|0|||
42078246|NCT00825162|75888502|FG000|Overall Study|Unable to attend the study visit|5|||
42078247|NCT00825162|75888503|FG001|Overall Study|Unable to attend the study visit|2|||
42078248|NCT00825162|75888504|FG002|Overall Study|Unable to attend the study visit|0|||
42078249|NCT00824850|75888519|FG000|Overall Study|Withdrawal by Subject|0|||
42078250|NCT00824850|75888520|FG001|Overall Study|Withdrawal by Subject|1|||
42078251|NCT00596687|75888534|FG000|Overall Study|< 24 hours of insulin treatment|8|||
42078252|NCT00596687|75888535|FG001|Overall Study|< 24 hours of insulin treatment|6|||
42078253|NCT00596687|75888534|FG000|Overall Study|continuous insulin infusion during TPN|2|||
42078254|NCT00596687|75888535|FG001|Overall Study|continuous insulin infusion during TPN|1|||
42078255|NCT00596687|75888534|FG000|Overall Study|Withdrawal by Subject|3|||
42078256|NCT00596687|75888535|FG001|Overall Study|Withdrawal by Subject|1|||
42078257|NCT00596687|75888534|FG000|Overall Study|cancelled surgery|1|||
42078258|NCT00596687|75888535|FG001|Overall Study|cancelled surgery|1|||
42078259|NCT00824772|75888541|FG000|Overall Study|Withdrawal by Subject|8|||
42078260|NCT00824616|75888547|FG000|Overall Study|Adverse Event|2|||
42078261|NCT00824616|75888548|FG001|Overall Study|Adverse Event|1|||
42078262|NCT00824616|75888547|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
42078263|NCT00824616|75888548|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
42078264|NCT00824616|75888547|FG000|Overall Study|Hyperglycemia|1|||
42177959|NCT04737278|75985130|FG001|Overall Study|Lost to Follow-up|1|||
42177960|NCT04737278|75985129|FG000|Overall Study|Withdrawal by Subject|1|||
42177961|NCT04737278|75985130|FG001|Overall Study|Withdrawal by Subject|0|||
42177962|NCT04737278|75985129|FG000|Overall Study|Protocol Violation|1|||
42177963|NCT04737278|75985130|FG001|Overall Study|Protocol Violation|1|||
42177964|NCT04737278|75985129|FG000|Overall Study|failure to complete questionnaire|1|||
42177965|NCT04737278|75985130|FG001|Overall Study|failure to complete questionnaire|1|||
42177966|NCT04725500|75985136|FG000|Screening|Screen Failure|26|||
42177967|NCT04725500|75985136|FG000|Screening|Withdrawal by Subject|1|||
42177968|NCT04725500|75985136|FG000|2 Week Take Home|Screen Fail|5|||
42177969|NCT04684394|75985142|FG000|Overall Study|Death|1|||
42177970|NCT04684394|75985143|FG001|Overall Study|Death|2|||
42177971|NCT04684394|75985142|FG000|Overall Study|Lost to Follow-up|1|||
42177972|NCT04684394|75985143|FG001|Overall Study|Lost to Follow-up|0|||
42177973|NCT04684394|75985142|FG000|Overall Study|Withdrawal by Subject|2|||
42177974|NCT04684394|75985143|FG001|Overall Study|Withdrawal by Subject|0|||
42177975|NCT04684394|75985142|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
42177976|NCT04684394|75985143|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
42177977|NCT04674644|75985149|FG000|Overall Study|with missing data|37|||
42177978|NCT04668950|75985156|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
42177979|NCT04668950|75985157|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
42177980|NCT04668950|75985156|FG000|Overall Study|Could not confirm started study medication|15|||
42177981|NCT04668950|75985157|FG001|Overall Study|Could not confirm started study medication|15|||
42177982|NCT04668950|75985156|FG000|Overall Study|Could not confirm baseline status|6|||
42177983|NCT04668950|75985157|FG001|Overall Study|Could not confirm baseline status|2|||
42177984|NCT04668950|75985156|FG000|Overall Study|Drop out and did not start medication|15|||
42177985|NCT04668950|75985157|FG001|Overall Study|Drop out and did not start medication|17|||
42177986|NCT04668950|75985156|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
42177987|NCT04668950|75985157|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
42177988|NCT04668950|75985156|FG000|Overall Study|Other|2|||
42177989|NCT04668950|75985157|FG001|Overall Study|Other|4|||
42177990|NCT03078478|75985165|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
42177991|NCT03078478|75985166|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
42177992|NCT03078478|75985165|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
42177993|NCT03078478|75985166|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
42078265|NCT00824616|75888548|FG001|Overall Study|Hyperglycemia|1|||
42177994|NCT03078478|75985165|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
42177995|NCT03078478|75985166|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
42078266|NCT00824616|75888547|FG000|Overall Study|Lack of Efficacy|2|||
42078267|NCT00824616|75888548|FG001|Overall Study|Lack of Efficacy|1|||
42078268|NCT00824616|75888547|FG000|Overall Study|Lost to Follow-up|0|||
42078269|NCT00824616|75888548|FG001|Overall Study|Lost to Follow-up|1|||
42078270|NCT00824616|75888547|FG000|Overall Study|Withdrawal by Subject|1|||
42078271|NCT00824616|75888548|FG001|Overall Study|Withdrawal by Subject|1|||
42078272|NCT00824382|75888558|FG000|Overall Study|Adverse Event|4|||
42078273|NCT00824382|75888559|FG001|Overall Study|Adverse Event|1|||
42078274|NCT00824382|75888560|FG002|Overall Study|Adverse Event|1|||
42078275|NCT00824382|75888561|FG003|Overall Study|Adverse Event|4|||
42078276|NCT00824382|75888558|FG000|Overall Study|Protocol Violation|1|||
42078277|NCT00824382|75888559|FG001|Overall Study|Protocol Violation|0|||
42078278|NCT00824382|75888560|FG002|Overall Study|Protocol Violation|0|||
42078279|NCT00824382|75888561|FG003|Overall Study|Protocol Violation|1|||
42078280|NCT00824382|75888558|FG000|Overall Study|Investigator's decision|0|||
42078281|NCT00824382|75888559|FG001|Overall Study|Investigator's decision|1|||
42078282|NCT00824382|75888560|FG002|Overall Study|Investigator's decision|2|||
42078283|NCT00824382|75888561|FG003|Overall Study|Investigator's decision|0|||
42078284|NCT00833040|75888573|FG000|Overall Study|Adverse Event|0|||
42078285|NCT00833040|75888574|FG001|Overall Study|Adverse Event|0|||
42078286|NCT00833040|75888575|FG002|Overall Study|Adverse Event|0|||
42078287|NCT00833040|75888576|FG003|Overall Study|Adverse Event|0|||
42078288|NCT00833040|75888577|FG004|Overall Study|Adverse Event|0|||
42078289|NCT00833040|75888578|FG005|Overall Study|Adverse Event|1|||
42078290|NCT00843024|75888587|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
42078291|NCT00843024|75888588|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
42078292|NCT00843024|75888589|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
42078293|NCT00843024|75888590|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
42078294|NCT00843024|75888591|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
42078295|NCT00843024|75888592|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
42078296|NCT00843024|75888587|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
42078297|NCT00843024|75888588|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
42078298|NCT00843024|75888589|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
42078299|NCT00843024|75888590|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
42078300|NCT00843024|75888591|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
42078301|NCT00843024|75888592|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
42078302|NCT00843024|75888587|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
42078303|NCT00843024|75888588|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
42078304|NCT00843024|75888589|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
42078305|NCT00843024|75888590|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
42078306|NCT00843024|75888591|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
42078307|NCT00843024|75888592|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
42078308|NCT00843024|75888587|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
42078309|NCT00843024|75888588|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
42078310|NCT00843024|75888589|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
42078311|NCT00843024|75888590|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
42078312|NCT00843024|75888591|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
42078313|NCT00843024|75888592|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
42078314|NCT00843024|75888587|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
42078315|NCT00843024|75888588|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
42078316|NCT00843024|75888589|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
42078317|NCT00843024|75888590|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
42078318|NCT00843024|75888591|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
42078319|NCT00843024|75888592|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
42078320|NCT00843024|75888587|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
42078321|NCT00843024|75888588|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
42078322|NCT00843024|75888589|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
42078323|NCT00843024|75888590|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
42078324|NCT00843024|75888591|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
42078325|NCT00843024|75888592|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
42078326|NCT00843024|75888587|FG000|Single-blind Placebo Run-In Phase|Other|0|||
42078327|NCT00843024|75888588|FG001|Single-blind Placebo Run-In Phase|Other|1|||
42078328|NCT00843024|75888589|FG002|Single-blind Placebo Run-In Phase|Other|0|||
42078329|NCT00843024|75888590|FG003|Single-blind Placebo Run-In Phase|Other|0|||
42078330|NCT00843024|75888591|FG004|Single-blind Placebo Run-In Phase|Other|0|||
42357869|NCT01829191|76203409|FG000|Overall Study|Relocation|0|||
42078331|NCT00843024|75888592|FG005|Single-blind Placebo Run-In Phase|Other|0|||
42078332|NCT00843024|75888587|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
42078333|NCT00843024|75888588|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
42078334|NCT00843024|75888589|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
42357870|NCT01829191|76203410|FG001|Overall Study|Relocation|1|||
42357871|NCT01829191|76203409|FG000|Overall Study|Lens discomfort|0|||
42357872|NCT01829191|76203410|FG001|Overall Study|Lens discomfort|3|||
42357873|NCT01829191|76203409|FG000|Overall Study|Lens handling difficulty|1|||
42078335|NCT00843024|75888590|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
42078336|NCT00843024|75888591|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
42078337|NCT00843024|75888592|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
42078338|NCT00843024|75888587|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
42078339|NCT00843024|75888588|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
42078340|NCT00843024|75888589|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
42078341|NCT00843024|75888590|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
42078342|NCT00843024|75888591|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
42078343|NCT00843024|75888592|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
42078344|NCT00843024|75888587|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
42078345|NCT00843024|75888588|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
42078346|NCT00843024|75888589|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
42078347|NCT00843024|75888590|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
42078348|NCT00843024|75888591|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
42078349|NCT00843024|75888592|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
42078350|NCT00843024|75888587|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
42078351|NCT00843024|75888588|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
42078352|NCT00843024|75888589|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
42078353|NCT00843024|75888590|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
42078354|NCT00843024|75888591|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
42078355|NCT00843024|75888592|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
42078356|NCT00843024|75888587|FG000|Double-blind Treatment Phase|Physician Decision|0|||
42078357|NCT00843024|75888588|FG001|Double-blind Treatment Phase|Physician Decision|0|||
42078358|NCT00843024|75888589|FG002|Double-blind Treatment Phase|Physician Decision|0|||
42078359|NCT00843024|75888590|FG003|Double-blind Treatment Phase|Physician Decision|3|||
42078360|NCT00843024|75888591|FG004|Double-blind Treatment Phase|Physician Decision|1|||
42078361|NCT00843024|75888592|FG005|Double-blind Treatment Phase|Physician Decision|1|||
42078362|NCT00843024|75888587|FG000|Double-blind Treatment Phase|Adverse Event|0|||
42078363|NCT00843024|75888588|FG001|Double-blind Treatment Phase|Adverse Event|0|||
42078364|NCT00843024|75888589|FG002|Double-blind Treatment Phase|Adverse Event|0|||
42078365|NCT00843024|75888590|FG003|Double-blind Treatment Phase|Adverse Event|0|||
42078366|NCT00843024|75888591|FG004|Double-blind Treatment Phase|Adverse Event|1|||
42078367|NCT00843024|75888592|FG005|Double-blind Treatment Phase|Adverse Event|1|||
42078368|NCT00843024|75888587|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
42078369|NCT00843024|75888588|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
42078370|NCT00843024|75888589|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
42078371|NCT00843024|75888590|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
42078372|NCT00843024|75888591|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
42078373|NCT00843024|75888592|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
42078374|NCT00832650|75888608|FG000|Overall Study|Randomized but not treated|0|||
42078375|NCT00832650|75888609|FG001|Overall Study|Randomized but not treated|0|||
42078376|NCT00832650|75888610|FG002|Overall Study|Randomized but not treated|1|||
42078377|NCT00595517|75888618|FG000|Overall Study|Adverse Event|6|||
42078378|NCT00595517|75888618|FG000|Overall Study|Withdrawal by Subject|4|||
42078379|NCT00595517|75888618|FG000|Overall Study|Protocol Violation|2|||
42078380|NCT00595517|75888618|FG000|Overall Study|Recurrence of ulcer|5|||
42078381|NCT00595517|75888618|FG000|Overall Study|usage of prohibited treatment|1|||
42078382|NCT00595517|75888618|FG000|Overall Study|No intention to attend regularly|1|||
42078383|NCT00823836|75888624|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
42078384|NCT00823836|75888625|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
42078385|NCT00823836|75888624|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
42078386|NCT00823836|75888625|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
42078387|NCT00823836|75888624|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
42078388|NCT00823836|75888625|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
42078389|NCT00823836|75888624|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
42078390|NCT00823836|75888625|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
42078391|NCT00823836|75888624|FG000|Long-term Phase|Adverse Event|3|||
42078392|NCT00823836|75888625|FG001|Long-term Phase|Adverse Event|2|||
42078393|NCT00823836|75888624|FG000|Long-term Phase|Physician Decision|1|||
42078394|NCT00823836|75888625|FG001|Long-term Phase|Physician Decision|2|||
42078395|NCT00823836|75888624|FG000|Long-term Phase|Withdrawal by Subject|1|||
42078396|NCT00823836|75888625|FG001|Long-term Phase|Withdrawal by Subject|1|||
42078397|NCT00879437|75888634|FG000|Overall Study|Protocol Violation|0|||
42078398|NCT00879437|75888635|FG001|Overall Study|Protocol Violation|1|||
42078399|NCT00879437|75888634|FG000|Overall Study|Death|1|||
42078400|NCT00879437|75888635|FG001|Overall Study|Death|0|||
42078401|NCT00877799|75888648|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
42078402|NCT00877799|75888649|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
42078403|NCT00877799|75888650|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
42078404|NCT00877799|75888651|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
42078405|NCT00877799|75888652|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
42078406|NCT00877799|75888648|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
42078407|NCT00877799|75888649|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
42078408|NCT00877799|75888650|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
42078409|NCT00877799|75888651|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
42078410|NCT00877799|75888652|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
42078411|NCT00877799|75888648|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
42078412|NCT00877799|75888649|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
42078413|NCT00877799|75888650|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
42078414|NCT00877799|75888651|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
42078415|NCT00877799|75888652|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
42078416|NCT00877799|75888648|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
42078417|NCT00877799|75888649|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
42078418|NCT00877799|75888650|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
42078419|NCT00877799|75888651|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
42078420|NCT00877799|75888652|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
42078421|NCT00877799|75888648|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
42078422|NCT00877799|75888649|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
42078423|NCT00877799|75888650|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
42078424|NCT00877799|75888651|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
42078425|NCT00877799|75888652|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
42078426|NCT00595127|75888663|FG000|Overall Study|Death|6|||
42078427|NCT00595127|75888663|FG000|Overall Study|Relapsed|3|||
42078428|NCT00595127|75888663|FG000|Overall Study|joined another trial|1|||
42078429|NCT00877487|75888667|FG000|Open-label Treatment Phase|Adverse Event|1|||
42078430|NCT00877487|75888668|FG001|Open-label Treatment Phase|Adverse Event|0|||
42078431|NCT00877487|75888667|FG000|Open-label Treatment Phase|Protocol Violation|3|||
42078432|NCT00877487|75888668|FG001|Open-label Treatment Phase|Protocol Violation|0|||
42078433|NCT00877487|75888667|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
42078434|NCT00877487|75888668|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
42078435|NCT00877487|75888667|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
42078436|NCT00877487|75888668|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
42078437|NCT00877487|75888667|FG000|Open-label Treatment Phase|Out of country for business|1|||
42078438|NCT00877487|75888668|FG001|Open-label Treatment Phase|Out of country for business|0|||
42078439|NCT00877487|75888667|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
42078440|NCT00877487|75888668|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
42078441|NCT00877487|75888667|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
42078442|NCT00877487|75888668|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
42078443|NCT00877487|75888667|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
42078444|NCT00877487|75888668|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
42078445|NCT00877487|75888667|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
42078446|NCT00877487|75888668|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
42078447|NCT00878501|75888677|FG000|Overall Study|Adverse Event|11|||
42078448|NCT00878501|75888678|FG001|Overall Study|Adverse Event|3|||
42078449|NCT00878501|75888679|FG002|Overall Study|Adverse Event|3|||
42078450|NCT00878501|75888677|FG000|Overall Study|Lack of Efficacy|2|||
42078451|NCT00878501|75888678|FG001|Overall Study|Lack of Efficacy|1|||
42078452|NCT00878501|75888679|FG002|Overall Study|Lack of Efficacy|0|||
42078453|NCT00878501|75888677|FG000|Overall Study|Withdrawal by Subject|2|||
42078454|NCT00878501|75888678|FG001|Overall Study|Withdrawal by Subject|1|||
42078455|NCT00878501|75888679|FG002|Overall Study|Withdrawal by Subject|2|||
42078456|NCT00878501|75888677|FG000|Overall Study|Protocol Violation|0|||
42078457|NCT00878501|75888678|FG001|Overall Study|Protocol Violation|0|||
42078458|NCT00878501|75888679|FG002|Overall Study|Protocol Violation|1|||
42078459|NCT00878501|75888677|FG000|Overall Study|Incorrect enrolment|1|||
42078460|NCT00878501|75888678|FG001|Overall Study|Incorrect enrolment|2|||
42078461|NCT00878501|75888679|FG002|Overall Study|Incorrect enrolment|0|||
42078462|NCT00878501|75888677|FG000|Overall Study|Intake of prohibited concom. medication|0|||
42078463|NCT00878501|75888678|FG001|Overall Study|Intake of prohibited concom. medication|0|||
42078464|NCT00878501|75888679|FG002|Overall Study|Intake of prohibited concom. medication|1|||
42078465|NCT00878501|75888677|FG000|Overall Study|Mis-randomisation of patient|1|||
42078466|NCT00878501|75888678|FG001|Overall Study|Mis-randomisation of patient|0|||
42078467|NCT00878501|75888679|FG002|Overall Study|Mis-randomisation of patient|0|||
42078468|NCT00878501|75888677|FG000|Overall Study|Administrative|0|||
42078469|NCT00878501|75888678|FG001|Overall Study|Administrative|0|||
42078470|NCT00878501|75888679|FG002|Overall Study|Administrative|1|||
42078471|NCT00882713|75888687|FG000|Overall Study|Adverse Event|2|||
42078472|NCT00882713|75888687|FG000|Overall Study|Death|3|||
42078473|NCT00882713|75888687|FG000|Overall Study|Administrative reasons|4|||
42078474|NCT00882713|75888687|FG000|Overall Study|refused treatment/withdrew consent|4|||
42078475|NCT00882713|75888687|FG000|Overall Study|Blood transfusion|2|||
42078476|NCT00882713|75888687|FG000|Overall Study|Insufficient therapeutic response|3|||
42078477|NCT00882713|75888687|FG000|Overall Study|Failure to return|2|||
42078478|NCT00882713|75888687|FG000|Overall Study|Other - Reasons|2|||
42078479|NCT00809133|75888706|FG000|Overall Study|Progressive disease|2|||
42078480|NCT00809133|75888707|FG001|Overall Study|Progressive disease|5|||
42078481|NCT00809133|75888708|FG002|Overall Study|Progressive disease|5|||
42078482|NCT00809133|75888709|FG003|Overall Study|Progressive disease|3|||
42078483|NCT00809133|75888710|FG004|Overall Study|Progressive disease|4|||
42078484|NCT00809133|75888711|FG005|Overall Study|Progressive disease|1|||
42078485|NCT00809133|75888712|FG006|Overall Study|Progressive disease|3|||
42078486|NCT00809133|75888713|FG007|Overall Study|Progressive disease|3|||
42078487|NCT00809133|75888714|FG008|Overall Study|Progressive disease|3|||
42078488|NCT00809133|75888715|FG009|Overall Study|Progressive disease|9|||
42078489|NCT00809133|75888716|FG010|Overall Study|Progressive disease|5|||
42078490|NCT00809133|75888717|FG011|Overall Study|Progressive disease|7|||
42078491|NCT00809133|75888718|FG012|Overall Study|Progressive disease|5|||
42078492|NCT00809133|75888719|FG013|Overall Study|Progressive disease|4|||
42078493|NCT00809133|75888706|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42078494|NCT00809133|75888707|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42078495|NCT00809133|75888708|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42078496|NCT00809133|75888709|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42078497|NCT00809133|75888710|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42078498|NCT00809133|75888711|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
42078499|NCT00809133|75888712|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
42078500|NCT00809133|75888713|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
42078501|NCT00809133|75888714|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42078502|NCT00809133|75888715|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42078503|NCT00809133|75888716|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42078504|NCT00809133|75888717|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42078505|NCT00809133|75888718|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42078506|NCT00809133|75888719|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
42078507|NCT00809133|75888706|FG000|Overall Study|Other adverse event|1|||
42078508|NCT00809133|75888707|FG001|Overall Study|Other adverse event|1|||
42078509|NCT00809133|75888708|FG002|Overall Study|Other adverse event|1|||
42078510|NCT00809133|75888709|FG003|Overall Study|Other adverse event|0|||
42078511|NCT00809133|75888710|FG004|Overall Study|Other adverse event|0|||
42078512|NCT00809133|75888711|FG005|Overall Study|Other adverse event|3|||
42078513|NCT00809133|75888712|FG006|Overall Study|Other adverse event|2|||
42078514|NCT00809133|75888713|FG007|Overall Study|Other adverse event|4|||
42078515|NCT00809133|75888714|FG008|Overall Study|Other adverse event|0|||
42078516|NCT00809133|75888715|FG009|Overall Study|Other adverse event|0|||
42078517|NCT00809133|75888716|FG010|Overall Study|Other adverse event|1|||
42078518|NCT00809133|75888717|FG011|Overall Study|Other adverse event|1|||
42078519|NCT00809133|75888718|FG012|Overall Study|Other adverse event|0|||
42078520|NCT00809133|75888719|FG013|Overall Study|Other adverse event|1|||
42078521|NCT00809133|75888706|FG000|Overall Study|Lost to Follow-up|0|||
42078522|NCT00809133|75888707|FG001|Overall Study|Lost to Follow-up|0|||
42078523|NCT00809133|75888708|FG002|Overall Study|Lost to Follow-up|0|||
42078524|NCT00809133|75888709|FG003|Overall Study|Lost to Follow-up|0|||
42078525|NCT00809133|75888710|FG004|Overall Study|Lost to Follow-up|0|||
42078526|NCT00809133|75888711|FG005|Overall Study|Lost to Follow-up|1|||
42078527|NCT00809133|75888712|FG006|Overall Study|Lost to Follow-up|0|||
42078528|NCT00809133|75888713|FG007|Overall Study|Lost to Follow-up|0|||
42078529|NCT00809133|75888714|FG008|Overall Study|Lost to Follow-up|0|||
42078530|NCT00809133|75888715|FG009|Overall Study|Lost to Follow-up|0|||
42078531|NCT00809133|75888716|FG010|Overall Study|Lost to Follow-up|0|||
42078532|NCT00809133|75888717|FG011|Overall Study|Lost to Follow-up|0|||
42078533|NCT00809133|75888718|FG012|Overall Study|Lost to Follow-up|0|||
42078534|NCT00809133|75888719|FG013|Overall Study|Lost to Follow-up|0|||
42078535|NCT00809133|75888706|FG000|Overall Study|Consent withdrawn|0|||
42078536|NCT00809133|75888707|FG001|Overall Study|Consent withdrawn|0|||
42078537|NCT00809133|75888708|FG002|Overall Study|Consent withdrawn|0|||
42078538|NCT00809133|75888709|FG003|Overall Study|Consent withdrawn|0|||
42078539|NCT00809133|75888710|FG004|Overall Study|Consent withdrawn|1|||
42078540|NCT00809133|75888711|FG005|Overall Study|Consent withdrawn|0|||
42078541|NCT00809133|75888712|FG006|Overall Study|Consent withdrawn|0|||
42078542|NCT00809133|75888713|FG007|Overall Study|Consent withdrawn|0|||
42078543|NCT00809133|75888714|FG008|Overall Study|Consent withdrawn|0|||
42078544|NCT00809133|75888715|FG009|Overall Study|Consent withdrawn|0|||
42078545|NCT00809133|75888716|FG010|Overall Study|Consent withdrawn|0|||
42078546|NCT00809133|75888717|FG011|Overall Study|Consent withdrawn|0|||
42078547|NCT00809133|75888718|FG012|Overall Study|Consent withdrawn|0|||
42078548|NCT00809133|75888719|FG013|Overall Study|Consent withdrawn|0|||
42078549|NCT00809133|75888706|FG000|Overall Study|Other not mentioned above|0|||
42078550|NCT00809133|75888707|FG001|Overall Study|Other not mentioned above|1|||
42078551|NCT00809133|75888708|FG002|Overall Study|Other not mentioned above|0|||
42078552|NCT00809133|75888709|FG003|Overall Study|Other not mentioned above|0|||
42078553|NCT00809133|75888710|FG004|Overall Study|Other not mentioned above|0|||
42078554|NCT00809133|75888711|FG005|Overall Study|Other not mentioned above|1|||
42078555|NCT00809133|75888712|FG006|Overall Study|Other not mentioned above|0|||
42078556|NCT00809133|75888713|FG007|Overall Study|Other not mentioned above|0|||
42078557|NCT00809133|75888714|FG008|Overall Study|Other not mentioned above|0|||
42078558|NCT00809133|75888715|FG009|Overall Study|Other not mentioned above|0|||
42078559|NCT00809133|75888716|FG010|Overall Study|Other not mentioned above|0|||
42078560|NCT00809133|75888717|FG011|Overall Study|Other not mentioned above|0|||
42078561|NCT00809133|75888718|FG012|Overall Study|Other not mentioned above|0|||
42078562|NCT00809133|75888719|FG013|Overall Study|Other not mentioned above|0|||
42078563|NCT00882557|75888764|FG000|Overall Study|Withdrawal by Subject|1|||
42078564|NCT00882557|75888765|FG001|Overall Study|Withdrawal by Subject|0|||
42078565|NCT00882557|75888764|FG000|Overall Study|Trouble with Vein Access|1|||
42078566|NCT00882557|75888765|FG001|Overall Study|Trouble with Vein Access|0|||
42078567|NCT00882557|75888764|FG000|Overall Study|Randomized Not Treated|0|||
42078568|NCT00882557|75888765|FG001|Overall Study|Randomized Not Treated|1|||
42078569|NCT00808899|75888771|FG000|Overall Study|Death|1|||
42078570|NCT00808899|75888771|FG000|Overall Study|Physician Decision|3|||
42078571|NCT00808665|75888777|FG000|Overall Study|Withdrawal by Subject|1|||
42078572|NCT00808665|75888778|FG001|Overall Study|Withdrawal by Subject|0|||
42078573|NCT00808665|75888777|FG000|Overall Study|only required minimally invasive surgery|1|||
42078574|NCT00808665|75888778|FG001|Overall Study|only required minimally invasive surgery|0|||
42078575|NCT00808665|75888777|FG000|Overall Study|surgery cancelled|1|||
42078576|NCT00808665|75888778|FG001|Overall Study|surgery cancelled|0|||
42078577|NCT00808665|75888777|FG000|Overall Study|required an additional procedure|0|||
42078578|NCT00808665|75888778|FG001|Overall Study|required an additional procedure|1|||
42078579|NCT00808665|75888777|FG000|Overall Study|Physician Decision|3|||
42078580|NCT00808665|75888778|FG001|Overall Study|Physician Decision|1|||
42078581|NCT00808665|75888777|FG000|Overall Study|Medication stopped by resident|0|||
42078582|NCT00808665|75888778|FG001|Overall Study|Medication stopped by resident|1|||
42078583|NCT00808509|75888786|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
42078584|NCT00808509|75888787|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
42078585|NCT00808509|75888786|FG000|Randomized Phase|Reduced methotrexate dose|1|||
42078586|NCT00808509|75888787|FG001|Randomized Phase|Reduced methotrexate dose|2|||
42078587|NCT00808509|75888786|FG000|Randomized Phase|Patient refused rescue therapy|0|||
42078588|NCT00808509|75888787|FG001|Randomized Phase|Patient refused rescue therapy|3|||
42177996|NCT03078478|75985165|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
42177997|NCT03078478|75985166|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
42177998|NCT03078478|75985165|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
42177999|NCT03078478|75985166|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
42178000|NCT03078478|75985165|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
42178001|NCT03078478|75985166|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
42178002|NCT03078478|75985165|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
42178003|NCT03078478|75985166|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
42178004|NCT03078478|75985165|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
42178005|NCT03078478|75985166|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
42178006|NCT02879578|75985175|FG000|Overall Study|Adverse Event|1|||
42178007|NCT02879578|75985176|FG001|Overall Study|Adverse Event|2|||
42178008|NCT02879578|75985177|FG002|Overall Study|Adverse Event|14|||
42178009|NCT02879578|75985175|FG000|Overall Study|Protocol Violation|0|||
42178010|NCT02879578|75985176|FG001|Overall Study|Protocol Violation|1|||
42178011|NCT02879578|75985177|FG002|Overall Study|Protocol Violation|1|||
42178012|NCT02879578|75985175|FG000|Overall Study|Withdrawal by Subject|8|||
42178013|NCT02879578|75985176|FG001|Overall Study|Withdrawal by Subject|6|||
42178014|NCT02879578|75985177|FG002|Overall Study|Withdrawal by Subject|9|||
42178015|NCT02879578|75985175|FG000|Overall Study|Lost to Follow-up|1|||
42178016|NCT02879578|75985176|FG001|Overall Study|Lost to Follow-up|0|||
42178017|NCT02879578|75985177|FG002|Overall Study|Lost to Follow-up|4|||
42178018|NCT02879578|75985175|FG000|Overall Study|Physician Decision|0|||
42178019|NCT02879578|75985176|FG001|Overall Study|Physician Decision|0|||
42178020|NCT02879578|75985177|FG002|Overall Study|Physician Decision|4|||
42178021|NCT00045942|75985194|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
42178022|NCT00045942|75985195|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
42178023|NCT00045942|75985196|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
42178024|NCT00045942|75985197|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
42178025|NCT00045942|75985198|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
42178026|NCT00045942|75985199|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
42178027|NCT00045942|75985200|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
42178028|NCT00045942|75985201|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
42178029|NCT00045942|75985202|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
42178030|NCT00045942|75985194|FG000|PKC412A2104 (Core)|Adverse Event|5|||
42078589|NCT00807885|75888804|FG000|Overall Study|Lost to Follow-up|0|||
42078590|NCT00807885|75888805|FG001|Overall Study|Lost to Follow-up|0|||
42078591|NCT00807885|75888806|FG002|Overall Study|Lost to Follow-up|0|||
42078592|NCT00807885|75888807|FG003|Overall Study|Lost to Follow-up|0|||
42078593|NCT00807885|75888808|FG004|Overall Study|Lost to Follow-up|0|||
42078594|NCT00807885|75888809|FG005|Overall Study|Lost to Follow-up|1|||
42078595|NCT00807885|75888810|FG006|Overall Study|Lost to Follow-up|0|||
42078596|NCT00807885|75888811|FG007|Overall Study|Lost to Follow-up|0|||
42078597|NCT00807885|75888812|FG008|Overall Study|Lost to Follow-up|0|||
42078598|NCT00807573|75888832|FG000|Overall Study|Withdrawal by Subject|1|||
42078599|NCT00807573|75888832|FG000|Overall Study|Adverse Event|1|||
42078600|NCT00842712|75888843|FG000|Safety Run-in Part|Adverse Event|0|||
42078601|NCT00842712|75888844|FG001|Safety Run-in Part|Adverse Event|1|||
42078602|NCT00842712|75888845|FG002|Safety Run-in Part|Adverse Event|0|||
42078603|NCT00842712|75888846|FG003|Safety Run-in Part|Adverse Event|0|||
42078604|NCT00842712|75888847|FG004|Safety Run-in Part|Adverse Event|0|||
42078605|NCT00842712|75888848|FG005|Safety Run-in Part|Adverse Event|0|||
42357874|NCT01829191|76203410|FG001|Overall Study|Lens handling difficulty|4|||
42357875|NCT01829191|76203409|FG000|Overall Study|Protocol Violation|4|||
42357876|NCT01829191|76203410|FG001|Overall Study|Protocol Violation|1|||
42357877|NCT01829191|76203409|FG000|Overall Study|Withdrawal by Subject|2|||
42357878|NCT01829191|76203410|FG001|Overall Study|Withdrawal by Subject|3|||
42357879|NCT01829191|76203409|FG000|Overall Study|Lost to Follow-up|0|||
42078606|NCT00842712|75888849|FG006|Safety Run-in Part|Adverse Event|0|||
42078607|NCT00842712|75888843|FG000|Safety Run-in Part|Progressive disease|3|||
42078608|NCT00842712|75888844|FG001|Safety Run-in Part|Progressive disease|1|||
42078609|NCT00842712|75888845|FG002|Safety Run-in Part|Progressive disease|0|||
42078610|NCT00842712|75888846|FG003|Safety Run-in Part|Progressive disease|1|||
42078611|NCT00842712|75888847|FG004|Safety Run-in Part|Progressive disease|0|||
42078612|NCT00842712|75888848|FG005|Safety Run-in Part|Progressive disease|0|||
42078613|NCT00842712|75888849|FG006|Safety Run-in Part|Progressive disease|0|||
42078614|NCT00842712|75888843|FG000|Randomized Part|Randomized but not treated|0|||
42078615|NCT00842712|75888844|FG001|Randomized Part|Randomized but not treated|0|||
42078616|NCT00842712|75888845|FG002|Randomized Part|Randomized but not treated|0|||
42078617|NCT00842712|75888846|FG003|Randomized Part|Randomized but not treated|0|||
42078618|NCT00842712|75888847|FG004|Randomized Part|Randomized but not treated|0|||
42078619|NCT00842712|75888848|FG005|Randomized Part|Randomized but not treated|1|||
42078620|NCT00842712|75888849|FG006|Randomized Part|Randomized but not treated|4|||
42078621|NCT00842712|75888843|FG000|Randomized Part|Ongoing at cut-off date|0|||
42078622|NCT00842712|75888844|FG001|Randomized Part|Ongoing at cut-off date|0|||
42078623|NCT00842712|75888845|FG002|Randomized Part|Ongoing at cut-off date|0|||
42078624|NCT00842712|75888846|FG003|Randomized Part|Ongoing at cut-off date|0|||
42078625|NCT00842712|75888847|FG004|Randomized Part|Ongoing at cut-off date|0|||
42078626|NCT00842712|75888848|FG005|Randomized Part|Ongoing at cut-off date|0|||
42078627|NCT00842712|75888849|FG006|Randomized Part|Ongoing at cut-off date|2|||
42078628|NCT00842244|75888865|FG000|Overall Study|Death|3|||
42078629|NCT00842244|75888865|FG000|Overall Study|Withdrawal by Subject|1|||
42078630|NCT00842244|75888865|FG000|Overall Study|Other|17|||
42078631|NCT00832416|75888876|FG000|Overall Study|Lack of Efficacy|17|||
42078632|NCT00832416|75888877|FG001|Overall Study|Lack of Efficacy|15|||
42078633|NCT00832416|75888878|FG002|Overall Study|Lack of Efficacy|13|||
42078634|NCT00832416|75888879|FG003|Overall Study|Lack of Efficacy|52|||
42078635|NCT00832416|75888876|FG000|Overall Study|Withdrawal by Subject|5|||
42078636|NCT00832416|75888877|FG001|Overall Study|Withdrawal by Subject|7|||
42078637|NCT00832416|75888878|FG002|Overall Study|Withdrawal by Subject|2|||
42293571|NCT01668797|76127787|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
42293572|NCT01668797|76127788|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
42293573|NCT01668797|76127789|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
42293574|NCT01668797|76127786|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
42293575|NCT01668797|76127787|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
42293576|NCT01668797|76127788|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
42293577|NCT01668797|76127789|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
42293578|NCT01668797|76127786|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
42293579|NCT01668797|76127787|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
42293580|NCT01668797|76127788|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
42293581|NCT01668797|76127789|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
42357880|NCT01829191|76203410|FG001|Overall Study|Lost to Follow-up|1|||
42078638|NCT00832416|75888879|FG003|Overall Study|Withdrawal by Subject|10|||
42078639|NCT00832416|75888876|FG000|Overall Study|Physician Decision|2|||
42078640|NCT00832416|75888877|FG001|Overall Study|Physician Decision|12|||
42078641|NCT00832416|75888878|FG002|Overall Study|Physician Decision|5|||
42078642|NCT00832416|75888879|FG003|Overall Study|Physician Decision|10|||
42078643|NCT00832416|75888876|FG000|Overall Study|Administrative|0|||
42078644|NCT00832416|75888877|FG001|Overall Study|Administrative|0|||
42078645|NCT00832416|75888878|FG002|Overall Study|Administrative|0|||
42293582|NCT01668797|76127786|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
42078646|NCT00832416|75888879|FG003|Overall Study|Administrative|1|||
42078647|NCT00832416|75888876|FG000|Overall Study|Adverse Event|21|||
42078648|NCT00832416|75888877|FG001|Overall Study|Adverse Event|19|||
42078649|NCT00832416|75888878|FG002|Overall Study|Adverse Event|41|||
42078650|NCT00832416|75888879|FG003|Overall Study|Adverse Event|10|||
42078651|NCT00832416|75888876|FG000|Overall Study|Death|1|||
42078652|NCT00832416|75888877|FG001|Overall Study|Death|0|||
42078653|NCT00832416|75888878|FG002|Overall Study|Death|0|||
42078654|NCT00832416|75888879|FG003|Overall Study|Death|0|||
42078655|NCT00841776|75888891|FG000|Overall Study|Lack of Efficacy|0|||
42078656|NCT00841776|75888892|FG001|Overall Study|Lack of Efficacy|1|||
42078657|NCT00841776|75888891|FG000|Overall Study|Lost to Follow-up|2|||
42078658|NCT00841776|75888892|FG001|Overall Study|Lost to Follow-up|1|||
42078659|NCT00841776|75888891|FG000|Overall Study|Withdrawal by Subject|0|||
42078660|NCT00841776|75888892|FG001|Overall Study|Withdrawal by Subject|1|||
42078661|NCT00683800|75888900|FG000|Overall Study|Adverse Event|195|||
42078662|NCT00683800|75888901|FG001|Overall Study|Adverse Event|102|||
42078663|NCT00683800|75888900|FG000|Overall Study|Death|0|||
42078664|NCT00683800|75888901|FG001|Overall Study|Death|1|||
42078665|NCT00683800|75888900|FG000|Overall Study|Lost to Follow-up|57|||
42078666|NCT00683800|75888901|FG001|Overall Study|Lost to Follow-up|44|||
42078667|NCT00683800|75888900|FG000|Overall Study|Other|5|||
42078668|NCT00683800|75888901|FG001|Overall Study|Other|2|||
42078669|NCT00683800|75888900|FG000|Overall Study|Protocol Violation|13|||
42078670|NCT00683800|75888901|FG001|Overall Study|Protocol Violation|16|||
42078671|NCT00683800|75888900|FG000|Overall Study|Withdrawal by Subject|66|||
42078672|NCT00683800|75888901|FG001|Overall Study|Withdrawal by Subject|64|||
42078673|NCT00683800|75888900|FG000|Overall Study|Lack of Efficacy|61|||
42078674|NCT00683800|75888901|FG001|Overall Study|Lack of Efficacy|104|||
42078675|NCT00683800|75888900|FG000|Overall Study|Randomized, not treated|35|||
42078676|NCT00683800|75888901|FG001|Overall Study|Randomized, not treated|33|||
42078677|NCT00683644|75888909|FG000|Overall Study|Withdrawal by Subject|4|||
42078678|NCT00683644|75888910|FG001|Overall Study|Withdrawal by Subject|2|||
42078679|NCT00683644|75888909|FG000|Overall Study|Lost to Follow-up|1|||
42078680|NCT00683644|75888910|FG001|Overall Study|Lost to Follow-up|4|||
42078681|NCT00683644|75888909|FG000|Overall Study|Adverse Event|1|||
42078682|NCT00683644|75888910|FG001|Overall Study|Adverse Event|2|||
42078683|NCT00683644|75888909|FG000|Overall Study|Low copper, other health problems,|7|||
42078684|NCT00683644|75888910|FG001|Overall Study|Low copper, other health problems,|6|||
42078685|NCT00685360|75888923|FG000|Overall Study|Lost to Follow-up|0|||
42078686|NCT00685360|75888924|FG001|Overall Study|Lost to Follow-up|1|||
42078687|NCT00685360|75888925|FG002|Overall Study|Lost to Follow-up|2|||
42078688|NCT00685360|75888923|FG000|Overall Study|Adverse Event|4|||
42078689|NCT00685360|75888924|FG001|Overall Study|Adverse Event|6|||
42078690|NCT00685360|75888925|FG002|Overall Study|Adverse Event|4|||
42078691|NCT00685360|75888923|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
42078692|NCT00685360|75888924|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
42078693|NCT00685360|75888925|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
42078694|NCT00685360|75888923|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
42078695|NCT00685360|75888924|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
42078696|NCT00685360|75888925|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
42078697|NCT00685360|75888923|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
42078698|NCT00685360|75888924|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
42078699|NCT00685360|75888925|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
42078700|NCT00685360|75888923|FG000|Overall Study|Protocol Deviation|0|||
42078701|NCT00685360|75888924|FG001|Overall Study|Protocol Deviation|1|||
42078702|NCT00685360|75888925|FG002|Overall Study|Protocol Deviation|1|||
42078703|NCT00684814|75888933|FG000|Washout Period of 7 Days|Adverse Event|1|||
42078704|NCT00684814|75888934|FG001|Washout Period of 7 Days|Adverse Event|2|||
42078705|NCT00684814|75888933|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
42078706|NCT00684814|75888934|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
42078707|NCT00684814|75888933|FG000|Second Intervention|Adverse Event|1|||
42078708|NCT00684814|75888934|FG001|Second Intervention|Adverse Event|0|||
42078709|NCT00576472|75888955|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078710|NCT00576472|75888956|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078711|NCT00576472|75888957|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078712|NCT00576472|75888958|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
42078713|NCT00576472|75888959|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078714|NCT00576472|75888960|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078715|NCT00576472|75888961|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078716|NCT00576472|75888962|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078717|NCT00576472|75888963|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078718|NCT00576472|75888964|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078719|NCT00576472|75888965|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078720|NCT00576472|75888966|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078721|NCT00576472|75888967|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078722|NCT00576472|75888968|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078723|NCT00576472|75888969|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
42078724|NCT00576472|75888955|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
42078725|NCT00576472|75888956|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
42078726|NCT00576472|75888957|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
42078727|NCT00576472|75888958|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
42078728|NCT00576472|75888959|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
42078729|NCT00576472|75888960|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
42078730|NCT00576472|75888961|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
42078731|NCT00576472|75888962|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
42078732|NCT00576472|75888963|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
42078733|NCT00576472|75888964|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
42078734|NCT00576472|75888965|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
42078735|NCT00576472|75888966|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
42078736|NCT00576472|75888967|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
42078737|NCT00576472|75888968|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
42078738|NCT00576472|75888969|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
42078739|NCT00576472|75888955|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078740|NCT00576472|75888956|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078741|NCT00576472|75888957|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078742|NCT00576472|75888958|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
42078743|NCT00576472|75888959|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078744|NCT00576472|75888960|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078745|NCT00576472|75888961|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078746|NCT00576472|75888962|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078747|NCT00576472|75888963|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078748|NCT00576472|75888964|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078749|NCT00576472|75888965|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078750|NCT00576472|75888966|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078751|NCT00576472|75888967|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078752|NCT00576472|75888968|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078753|NCT00576472|75888969|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
42078754|NCT00576472|75888955|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
42078755|NCT00576472|75888956|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
42078756|NCT00576472|75888957|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
42078757|NCT00576472|75888958|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
42078758|NCT00576472|75888959|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
42078759|NCT00576472|75888960|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
42078760|NCT00576472|75888961|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
42078761|NCT00576472|75888962|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
42078762|NCT00576472|75888963|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
42078763|NCT00576472|75888964|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
42078764|NCT00576472|75888965|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
42078765|NCT00576472|75888966|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
42078766|NCT00576472|75888967|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
42078767|NCT00576472|75888968|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
42078768|NCT00576472|75888969|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
42078769|NCT00576472|75888955|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078770|NCT00576472|75888956|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078771|NCT00576472|75888957|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078772|NCT00576472|75888958|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
42078773|NCT00576472|75888959|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078774|NCT00576472|75888960|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078775|NCT00576472|75888961|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078776|NCT00576472|75888962|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078777|NCT00576472|75888963|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078778|NCT00576472|75888964|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078779|NCT00576472|75888965|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078780|NCT00576472|75888966|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078781|NCT00576472|75888967|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078782|NCT00576472|75888968|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078783|NCT00576472|75888969|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
42078784|NCT00576472|75888955|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078785|NCT00576472|75888956|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
42178031|NCT00045942|75985195|FG001|PKC412A2104 (Core)|Adverse Event|0|||
42078786|NCT00576472|75888957|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078787|NCT00576472|75888958|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078788|NCT00576472|75888959|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078789|NCT00576472|75888960|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078790|NCT00576472|75888961|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
42078791|NCT00576472|75888962|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078792|NCT00576472|75888963|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078793|NCT00576472|75888964|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078794|NCT00576472|75888965|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078795|NCT00576472|75888966|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078796|NCT00576472|75888967|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078797|NCT00576472|75888968|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078798|NCT00576472|75888969|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
42078799|NCT00576472|75888955|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
42078800|NCT00576472|75888956|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
42078801|NCT00576472|75888957|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
42078802|NCT00576472|75888958|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
42078803|NCT00576472|75888959|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
42078804|NCT00576472|75888960|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
42078805|NCT00576472|75888961|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
42078806|NCT00576472|75888962|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
42078807|NCT00576472|75888963|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
42078808|NCT00576472|75888964|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
42078809|NCT00576472|75888965|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
42078810|NCT00576472|75888966|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
42078811|NCT00576472|75888967|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
42078812|NCT00576472|75888968|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
42078813|NCT00576472|75888969|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
42078814|NCT00576472|75888955|FG000|MPH Cross Over Phase|Physician Decision|0|||
42078815|NCT00576472|75888956|FG001|MPH Cross Over Phase|Physician Decision|0|||
42078816|NCT00576472|75888957|FG002|MPH Cross Over Phase|Physician Decision|0|||
42078817|NCT00576472|75888958|FG003|MPH Cross Over Phase|Physician Decision|0|||
42078818|NCT00576472|75888959|FG004|MPH Cross Over Phase|Physician Decision|0|||
42078819|NCT00576472|75888960|FG005|MPH Cross Over Phase|Physician Decision|0|||
42078820|NCT00576472|75888961|FG006|MPH Cross Over Phase|Physician Decision|4|||
42078821|NCT00576472|75888962|FG007|MPH Cross Over Phase|Physician Decision|0|||
42078822|NCT00576472|75888963|FG008|MPH Cross Over Phase|Physician Decision|0|||
42078823|NCT00576472|75888964|FG009|MPH Cross Over Phase|Physician Decision|0|||
42178032|NCT00045942|75985196|FG002|PKC412A2104 (Core)|Adverse Event|0|||
42178033|NCT00045942|75985197|FG003|PKC412A2104 (Core)|Adverse Event|0|||
42178034|NCT00045942|75985198|FG004|PKC412A2104 (Core)|Adverse Event|0|||
42178035|NCT00045942|75985199|FG005|PKC412A2104 (Core)|Adverse Event|0|||
42178036|NCT00045942|75985200|FG006|PKC412A2104 (Core)|Adverse Event|0|||
42178037|NCT00045942|75985201|FG007|PKC412A2104 (Core)|Adverse Event|0|||
42178038|NCT00045942|75985202|FG008|PKC412A2104 (Core)|Adverse Event|0|||
42178039|NCT00045942|75985194|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
42178040|NCT00045942|75985195|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
42178041|NCT00045942|75985196|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
42178042|NCT00045942|75985197|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
42178043|NCT00045942|75985198|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
42178044|NCT00045942|75985199|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
42178045|NCT00045942|75985200|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
42178046|NCT00045942|75985201|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
42078824|NCT00576472|75888965|FG010|MPH Cross Over Phase|Physician Decision|0|||
42078825|NCT00576472|75888966|FG011|MPH Cross Over Phase|Physician Decision|0|||
42078826|NCT00576472|75888967|FG012|MPH Cross Over Phase|Physician Decision|0|||
42078827|NCT00576472|75888968|FG013|MPH Cross Over Phase|Physician Decision|0|||
42078828|NCT00576472|75888969|FG014|MPH Cross Over Phase|Physician Decision|0|||
42078829|NCT00576472|75888955|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
42078830|NCT00576472|75888956|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
42078831|NCT00576472|75888957|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
42178047|NCT00045942|75985202|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
42178048|NCT00045942|75985194|FG000|PKC412A2104 (Core)|Death|1|||
42293583|NCT01668797|76127787|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
42293584|NCT01668797|76127788|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
42078832|NCT00576472|75888958|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
42078833|NCT00576472|75888959|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
42078834|NCT00576472|75888960|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
42078835|NCT00576472|75888961|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
42078836|NCT00576472|75888962|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
42078837|NCT00576472|75888963|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
42078838|NCT00576472|75888964|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
42078839|NCT00576472|75888965|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
42178049|NCT00045942|75985195|FG001|PKC412A2104 (Core)|Death|0|||
42178050|NCT00045942|75985196|FG002|PKC412A2104 (Core)|Death|0|||
42178051|NCT00045942|75985197|FG003|PKC412A2104 (Core)|Death|0|||
42178052|NCT00045942|75985198|FG004|PKC412A2104 (Core)|Death|0|||
42078840|NCT00576472|75888966|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
42078841|NCT00576472|75888967|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
42078842|NCT00576472|75888968|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
42078843|NCT00576472|75888969|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
42078844|NCT00576472|75888955|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078845|NCT00576472|75888956|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078846|NCT00576472|75888957|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078847|NCT00576472|75888958|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078848|NCT00576472|75888959|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078849|NCT00576472|75888960|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078850|NCT00576472|75888961|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078851|NCT00576472|75888962|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078852|NCT00576472|75888963|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078853|NCT00576472|75888964|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078854|NCT00576472|75888965|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078855|NCT00576472|75888966|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078856|NCT00576472|75888967|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078857|NCT00576472|75888968|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
42078858|NCT00576472|75888969|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
42078859|NCT00576472|75888955|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
42078860|NCT00576472|75888956|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
42078861|NCT00576472|75888957|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
42078862|NCT00576472|75888958|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
42078863|NCT00576472|75888959|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
42078864|NCT00576472|75888960|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
42078865|NCT00576472|75888961|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
42078866|NCT00576472|75888962|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
42078867|NCT00576472|75888963|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
42078868|NCT00576472|75888964|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
42078869|NCT00576472|75888965|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
42078870|NCT00576472|75888966|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
42078871|NCT00576472|75888967|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
42078872|NCT00576472|75888968|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
42078873|NCT00576472|75888969|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
42078874|NCT00576472|75888955|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
42078875|NCT00576472|75888956|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
42078876|NCT00576472|75888957|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
42078877|NCT00576472|75888958|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
42078878|NCT00576472|75888959|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
42078879|NCT00576472|75888960|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
42078880|NCT00576472|75888961|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
42078881|NCT00576472|75888962|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
42078882|NCT00576472|75888963|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
42078883|NCT00576472|75888964|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
42078884|NCT00576472|75888965|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
42078885|NCT00576472|75888966|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
42078886|NCT00576472|75888967|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
42078887|NCT00576472|75888968|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
42078888|NCT00576472|75888969|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
42078889|NCT00576472|75888955|FG000|MPH Home Maintenance Phase|Side effects|0|||
42078890|NCT00576472|75888956|FG001|MPH Home Maintenance Phase|Side effects|0|||
42078891|NCT00576472|75888957|FG002|MPH Home Maintenance Phase|Side effects|0|||
42078892|NCT00576472|75888958|FG003|MPH Home Maintenance Phase|Side effects|0|||
42078893|NCT00576472|75888959|FG004|MPH Home Maintenance Phase|Side effects|0|||
42078894|NCT00576472|75888960|FG005|MPH Home Maintenance Phase|Side effects|0|||
42078895|NCT00576472|75888961|FG006|MPH Home Maintenance Phase|Side effects|0|||
42293585|NCT01668797|76127789|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
42078896|NCT00576472|75888962|FG007|MPH Home Maintenance Phase|Side effects|0|||
42078897|NCT00576472|75888963|FG008|MPH Home Maintenance Phase|Side effects|0|||
42078898|NCT00576472|75888964|FG009|MPH Home Maintenance Phase|Side effects|0|||
42078899|NCT00576472|75888965|FG010|MPH Home Maintenance Phase|Side effects|0|||
42078900|NCT00576472|75888966|FG011|MPH Home Maintenance Phase|Side effects|0|||
42078901|NCT00576472|75888967|FG012|MPH Home Maintenance Phase|Side effects|0|||
42078902|NCT00576472|75888968|FG013|MPH Home Maintenance Phase|Side effects|0|||
42078903|NCT00576472|75888969|FG014|MPH Home Maintenance Phase|Side effects|8|||
42078904|NCT00576472|75888955|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078905|NCT00576472|75888956|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42178053|NCT00045942|75985199|FG005|PKC412A2104 (Core)|Death|0|||
42293586|NCT01668797|76127786|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
42078906|NCT00576472|75888957|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078907|NCT00576472|75888958|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078908|NCT00576472|75888959|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078909|NCT00576472|75888960|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078910|NCT00576472|75888961|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078911|NCT00576472|75888962|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078912|NCT00576472|75888963|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078913|NCT00576472|75888964|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078914|NCT00576472|75888965|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078915|NCT00576472|75888966|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078916|NCT00576472|75888967|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078917|NCT00576472|75888968|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
42078918|NCT00576472|75888969|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
42078919|NCT00576472|75888955|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
42078920|NCT00576472|75888956|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
42078921|NCT00576472|75888957|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
42078922|NCT00576472|75888958|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
42078923|NCT00576472|75888959|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
42078924|NCT00576472|75888960|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
42078925|NCT00576472|75888961|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
42078926|NCT00576472|75888962|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
42078927|NCT00576472|75888963|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
42078928|NCT00576472|75888964|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
42078929|NCT00576472|75888965|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
42078930|NCT00576472|75888966|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
42078931|NCT00576472|75888967|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
42078932|NCT00576472|75888968|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
42078933|NCT00576472|75888969|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
42078934|NCT00576472|75888955|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078935|NCT00576472|75888956|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078936|NCT00576472|75888957|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078937|NCT00576472|75888958|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078938|NCT00576472|75888959|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078939|NCT00576472|75888960|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078940|NCT00576472|75888961|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078941|NCT00576472|75888962|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078942|NCT00576472|75888963|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078943|NCT00576472|75888964|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078944|NCT00576472|75888965|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078945|NCT00576472|75888966|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078946|NCT00576472|75888967|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078947|NCT00576472|75888968|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
42078948|NCT00576472|75888969|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
42078949|NCT00823212|75889002|FG000|Overall Study|Death|8|||
42078950|NCT00823212|75889003|FG001|Overall Study|Death|10|||
42078951|NCT00823212|75889002|FG000|Overall Study|Withdrawal by Subject|6|||
42078952|NCT00823212|75889003|FG001|Overall Study|Withdrawal by Subject|1|||
42078953|NCT00823212|75889002|FG000|Overall Study|Incarcerated|0|||
42078954|NCT00823212|75889003|FG001|Overall Study|Incarcerated|1|||
42078955|NCT00823212|75889002|FG000|Overall Study|Missed 12-month visit|21|||
42078956|NCT00823212|75889003|FG001|Overall Study|Missed 12-month visit|21|||
42078957|NCT00807495|75889016|FG000|Overall Study|Adverse Event|6|||
42078958|NCT00807495|75889017|FG001|Overall Study|Adverse Event|3|||
42078959|NCT00807495|75889018|FG002|Overall Study|Adverse Event|1|||
42078960|NCT00807495|75889019|FG003|Overall Study|Adverse Event|1|||
42078961|NCT00807495|75889020|FG004|Overall Study|Adverse Event|2|||
42078962|NCT00807495|75889016|FG000|Overall Study|Withdrawal by Patient|2|||
42293587|NCT01668797|76127787|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
42078963|NCT00807495|75889017|FG001|Overall Study|Withdrawal by Patient|0|||
42078964|NCT00807495|75889018|FG002|Overall Study|Withdrawal by Patient|1|||
42078965|NCT00807495|75889019|FG003|Overall Study|Withdrawal by Patient|0|||
42078966|NCT00807495|75889020|FG004|Overall Study|Withdrawal by Patient|0|||
42078967|NCT00807495|75889016|FG000|Overall Study|Reason Not Specified|0|||
42078968|NCT00807495|75889017|FG001|Overall Study|Reason Not Specified|3|||
42078969|NCT00807495|75889018|FG002|Overall Study|Reason Not Specified|2|||
42078970|NCT00807495|75889019|FG003|Overall Study|Reason Not Specified|0|||
42078971|NCT00807495|75889020|FG004|Overall Study|Reason Not Specified|3|||
42078972|NCT05074433|75889036|FG000|Overall Study|Adverse Event|0|||
42293588|NCT01668797|76127788|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
42078973|NCT05074433|75889037|FG001|Overall Study|Adverse Event|2|||
42078974|NCT05074433|75889038|FG002|Overall Study|Adverse Event|0|||
42078975|NCT05074433|75889039|FG003|Overall Study|Adverse Event|1|||
42078976|NCT05074433|75889036|FG000|Overall Study|Sponsor Request|0|||
42078977|NCT05074433|75889037|FG001|Overall Study|Sponsor Request|1|||
42078978|NCT05074433|75889038|FG002|Overall Study|Sponsor Request|1|||
42078979|NCT05074433|75889039|FG003|Overall Study|Sponsor Request|0|||
42078980|NCT05074433|75889036|FG000|Overall Study|Death|1|||
42078981|NCT05074433|75889037|FG001|Overall Study|Death|0|||
42078982|NCT05074433|75889038|FG002|Overall Study|Death|0|||
42078983|NCT05074433|75889039|FG003|Overall Study|Death|0|||
42078984|NCT05074433|75889036|FG000|Overall Study|Lost to Follow-up|0|||
42078985|NCT05074433|75889037|FG001|Overall Study|Lost to Follow-up|0|||
42078986|NCT05074433|75889038|FG002|Overall Study|Lost to Follow-up|2|||
42078987|NCT05074433|75889039|FG003|Overall Study|Lost to Follow-up|0|||
42078988|NCT05074433|75889036|FG000|Overall Study|Subject Decision|8|||
42078989|NCT05074433|75889037|FG001|Overall Study|Subject Decision|6|||
42078990|NCT05074433|75889038|FG002|Overall Study|Subject Decision|4|||
42078991|NCT05074433|75889039|FG003|Overall Study|Subject Decision|5|||
42078992|NCT04922021|75889063|FG000|Overall Study|Withdrawal by Subject|4|||
42078993|NCT04922021|75889064|FG001|Overall Study|Withdrawal by Subject|10|||
42078994|NCT04922021|75889063|FG000|Overall Study|Adverse Event|2|||
42078995|NCT04922021|75889064|FG001|Overall Study|Adverse Event|2|||
42078996|NCT04922021|75889063|FG000|Overall Study|Lack of Efficacy|0|||
42078997|NCT04922021|75889064|FG001|Overall Study|Lack of Efficacy|1|||
42078998|NCT04922021|75889063|FG000|Overall Study|Multiple reasons|1|||
42078999|NCT04922021|75889064|FG001|Overall Study|Multiple reasons|0|||
42079000|NCT04233580|75889115|FG000|Overall Study|Adverse Event|3|||
42079001|NCT04233580|75889116|FG001|Overall Study|Adverse Event|3|||
42079002|NCT04233580|75889115|FG000|Overall Study|Withdrawal by Subject|2|||
42079003|NCT04233580|75889116|FG001|Overall Study|Withdrawal by Subject|1|||
42079004|NCT04016805|75889136|FG000|Overall Study|Sponsor's Discretion|30|||
42079005|NCT04016805|75889137|FG001|Overall Study|Sponsor's Discretion|6|||
42079006|NCT04016805|75889138|FG002|Overall Study|Sponsor's Discretion|5|||
42079007|NCT03982199|75889148|FG000|Overall Study|Site terminated by sponsor|14|||
42079008|NCT03982199|75889149|FG001|Overall Study|Site terminated by sponsor|17|||
42079009|NCT03982199|75889148|FG000|Overall Study|Lost to Follow-up|137|||
42079010|NCT03982199|75889149|FG001|Overall Study|Lost to Follow-up|142|||
42293589|NCT01668797|76127789|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
42293590|NCT01668797|76127786|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
42293591|NCT01668797|76127787|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
42293592|NCT01668797|76127788|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
42293593|NCT01668797|76127789|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
42293594|NCT01668797|76127786|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
42293595|NCT01668797|76127787|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
42293596|NCT01668797|76127788|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
42293597|NCT01668797|76127789|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
42293598|NCT01668797|76127786|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
42293599|NCT01668797|76127787|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
42293600|NCT01668797|76127788|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
42293601|NCT01668797|76127789|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
42293602|NCT01668797|76127786|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
42293603|NCT01668797|76127787|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
42293604|NCT01668797|76127788|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
42293605|NCT01668797|76127789|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
42293606|NCT01668797|76127786|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
42293607|NCT01668797|76127787|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
42293608|NCT01668797|76127788|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
42079011|NCT03982199|75889148|FG000|Overall Study|Physician Decision|38|||
42079012|NCT03982199|75889149|FG001|Overall Study|Physician Decision|33|||
42079013|NCT03982199|75889148|FG000|Overall Study|Withdrawal by Subject|514|||
42079014|NCT03982199|75889149|FG001|Overall Study|Withdrawal by Subject|496|||
42079015|NCT03982199|75889148|FG000|Overall Study|Adverse Event|10|||
42178054|NCT00045942|75985200|FG006|PKC412A2104 (Core)|Death|0|||
42079016|NCT03982199|75889149|FG001|Overall Study|Adverse Event|14|||
42079017|NCT03982199|75889148|FG000|Overall Study|Technical Problems|9|||
42079018|NCT03982199|75889149|FG001|Overall Study|Technical Problems|8|||
42178055|NCT00045942|75985201|FG007|PKC412A2104 (Core)|Death|0|||
42079019|NCT03982199|75889148|FG000|Overall Study|Death|40|||
42079020|NCT03982199|75889149|FG001|Overall Study|Death|40|||
42079021|NCT03982199|75889148|FG000|Overall Study|Study terminated by sponsor|2|||
42079022|NCT03982199|75889149|FG001|Overall Study|Study terminated by sponsor|1|||
42293609|NCT01668797|76127789|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
42079023|NCT03982199|75889148|FG000|Overall Study|Other|76|||
42079024|NCT03982199|75889149|FG001|Overall Study|Other|81|||
42079025|NCT03982199|75889148|FG000|Overall Study|Ongoing|743|||
42079026|NCT03982199|75889149|FG001|Overall Study|Ongoing|799|||
42079027|NCT03982199|75889148|FG000|Overall Study|Randomized but not vaccinated|18|||
42079028|NCT03982199|75889149|FG001|Overall Study|Randomized but not vaccinated|15|||
42079029|NCT03828448|75889155|FG000|Overall Study|Sponsor's Discretion|34|||
42079030|NCT03580369|75889167|FG000|Overall Study|No treatment due to mis-randomization|1|||
42079031|NCT03580369|75889168|FG001|Overall Study|No treatment due to mis-randomization|0|||
42079032|NCT03580369|75889169|FG002|Overall Study|No treatment due to mis-randomization|0|||
42079033|NCT03580369|75889170|FG003|Overall Study|No treatment due to mis-randomization|0|||
42079034|NCT03580369|75889171|FG004|Overall Study|No treatment due to mis-randomization|3|||
42079035|NCT03580369|75889172|FG005|Overall Study|No treatment due to mis-randomization|0|||
42079036|NCT03580369|75889173|FG006|Overall Study|No treatment due to mis-randomization|0|||
42079037|NCT03580369|75889174|FG007|Overall Study|No treatment due to mis-randomization|0|||
42079038|NCT03580369|75889167|FG000|Overall Study|Reason unknown|0|||
42079039|NCT03580369|75889168|FG001|Overall Study|Reason unknown|0|||
42079040|NCT03580369|75889169|FG002|Overall Study|Reason unknown|1|||
42079041|NCT03580369|75889170|FG003|Overall Study|Reason unknown|0|||
42079042|NCT03580369|75889171|FG004|Overall Study|Reason unknown|0|||
42079043|NCT03580369|75889172|FG005|Overall Study|Reason unknown|0|||
42079044|NCT03580369|75889173|FG006|Overall Study|Reason unknown|0|||
42079045|NCT03580369|75889174|FG007|Overall Study|Reason unknown|0|||
42079046|NCT03580369|75889167|FG000|Overall Study|Technical problems|0|||
42079047|NCT03580369|75889168|FG001|Overall Study|Technical problems|0|||
42079048|NCT03580369|75889169|FG002|Overall Study|Technical problems|0|||
42079049|NCT03580369|75889170|FG003|Overall Study|Technical problems|0|||
42079050|NCT03580369|75889171|FG004|Overall Study|Technical problems|1|||
42079051|NCT03580369|75889172|FG005|Overall Study|Technical problems|0|||
42079052|NCT03580369|75889173|FG006|Overall Study|Technical problems|2|||
42079053|NCT03580369|75889174|FG007|Overall Study|Technical problems|0|||
42079054|NCT03580369|75889167|FG000|Overall Study|Pregnancy|2|||
42079055|NCT03580369|75889168|FG001|Overall Study|Pregnancy|0|||
42079056|NCT03580369|75889169|FG002|Overall Study|Pregnancy|3|||
42079057|NCT03580369|75889170|FG003|Overall Study|Pregnancy|0|||
42079058|NCT03580369|75889171|FG004|Overall Study|Pregnancy|2|||
42079059|NCT03580369|75889172|FG005|Overall Study|Pregnancy|0|||
42079060|NCT03580369|75889173|FG006|Overall Study|Pregnancy|0|||
42079061|NCT03580369|75889174|FG007|Overall Study|Pregnancy|0|||
42079062|NCT03580369|75889167|FG000|Overall Study|Lost to Follow-up|2|||
42079063|NCT03580369|75889168|FG001|Overall Study|Lost to Follow-up|0|||
42079064|NCT03580369|75889169|FG002|Overall Study|Lost to Follow-up|2|||
42079065|NCT03580369|75889170|FG003|Overall Study|Lost to Follow-up|0|||
42079066|NCT03580369|75889171|FG004|Overall Study|Lost to Follow-up|3|||
42079067|NCT03580369|75889172|FG005|Overall Study|Lost to Follow-up|0|||
42079068|NCT03580369|75889173|FG006|Overall Study|Lost to Follow-up|1|||
42079069|NCT03580369|75889174|FG007|Overall Study|Lost to Follow-up|0|||
42079070|NCT03580369|75889167|FG000|Overall Study|Physician Decision|4|||
42079071|NCT03580369|75889168|FG001|Overall Study|Physician Decision|0|||
42079072|NCT03580369|75889169|FG002|Overall Study|Physician Decision|4|||
42079073|NCT03580369|75889170|FG003|Overall Study|Physician Decision|1|||
42079074|NCT03580369|75889171|FG004|Overall Study|Physician Decision|1|||
42079075|NCT03580369|75889172|FG005|Overall Study|Physician Decision|0|||
42079076|NCT03580369|75889173|FG006|Overall Study|Physician Decision|0|||
42079077|NCT03580369|75889174|FG007|Overall Study|Physician Decision|0|||
42079078|NCT03580369|75889167|FG000|Overall Study|Lack of Efficacy|3|||
42079079|NCT03580369|75889168|FG001|Overall Study|Lack of Efficacy|0|||
42079080|NCT03580369|75889169|FG002|Overall Study|Lack of Efficacy|7|||
42079081|NCT03580369|75889170|FG003|Overall Study|Lack of Efficacy|0|||
42079082|NCT03580369|75889171|FG004|Overall Study|Lack of Efficacy|2|||
42079083|NCT03580369|75889172|FG005|Overall Study|Lack of Efficacy|0|||
42079084|NCT03580369|75889173|FG006|Overall Study|Lack of Efficacy|3|||
42079085|NCT03580369|75889174|FG007|Overall Study|Lack of Efficacy|0|||
42079086|NCT03580369|75889167|FG000|Overall Study|Protocol Violation|6|||
42079087|NCT03580369|75889168|FG001|Overall Study|Protocol Violation|0|||
42079088|NCT03580369|75889169|FG002|Overall Study|Protocol Violation|6|||
42079089|NCT03580369|75889170|FG003|Overall Study|Protocol Violation|1|||
42079090|NCT03580369|75889171|FG004|Overall Study|Protocol Violation|8|||
42079091|NCT03580369|75889172|FG005|Overall Study|Protocol Violation|2|||
42079092|NCT03580369|75889173|FG006|Overall Study|Protocol Violation|1|||
42079093|NCT03580369|75889174|FG007|Overall Study|Protocol Violation|0|||
42079094|NCT03580369|75889167|FG000|Overall Study|Adverse Event|7|||
42079095|NCT03580369|75889168|FG001|Overall Study|Adverse Event|0|||
42079096|NCT03580369|75889169|FG002|Overall Study|Adverse Event|14|||
42079097|NCT03580369|75889170|FG003|Overall Study|Adverse Event|1|||
42079098|NCT03580369|75889171|FG004|Overall Study|Adverse Event|6|||
42079099|NCT03580369|75889172|FG005|Overall Study|Adverse Event|0|||
42079100|NCT03580369|75889173|FG006|Overall Study|Adverse Event|1|||
42079101|NCT03580369|75889174|FG007|Overall Study|Adverse Event|0|||
42079102|NCT03580369|75889167|FG000|Overall Study|Withdrawal by Subject|19|||
42079103|NCT03580369|75889168|FG001|Overall Study|Withdrawal by Subject|0|||
42079104|NCT03580369|75889169|FG002|Overall Study|Withdrawal by Subject|17|||
42079105|NCT03580369|75889170|FG003|Overall Study|Withdrawal by Subject|0|||
42079106|NCT03580369|75889171|FG004|Overall Study|Withdrawal by Subject|16|||
42079107|NCT03580369|75889172|FG005|Overall Study|Withdrawal by Subject|1|||
42079108|NCT03580369|75889173|FG006|Overall Study|Withdrawal by Subject|7|||
42079109|NCT03580369|75889174|FG007|Overall Study|Withdrawal by Subject|0|||
42079110|NCT03215810|75889211|FG000|Overall Study|Still responding to nivolumab|1|||
42079111|NCT03215810|75889211|FG000|Overall Study|Insufficient TIL growth|1|||
42079112|NCT03215810|75889211|FG000|Overall Study|Decline in performance status|1|||
42079113|NCT03215810|75889211|FG000|Overall Study|Withdrawal by Subject|1|||
42079114|NCT02634710|75889246|FG000|Overall Study|Death|4|||
42079115|NCT02540993|75889261|FG000|Overall Study|Lost to Follow-up|5|||
42079116|NCT02540993|75889262|FG001|Overall Study|Lost to Follow-up|3|||
42079117|NCT02540993|75889261|FG000|Overall Study|Withdrawal by Subject|4|||
42079118|NCT02540993|75889262|FG001|Overall Study|Withdrawal by Subject|6|||
42079119|NCT02540993|75889261|FG000|Overall Study|GCP violations|33|||
42079120|NCT02540993|75889262|FG001|Overall Study|GCP violations|27|||
42079121|NCT02449239|75889297|FG000|Induction Phase|Lack of Efficacy|64|||
42079122|NCT02449239|75889297|FG000|Induction Phase|Adverse Event|1|||
42357881|NCT01829191|76203409|FG000|Overall Study|Subject was fit for ortho - k|0|||
42357882|NCT01829191|76203410|FG001|Overall Study|Subject was fit for ortho - k|1|||
42079123|NCT02449239|75889297|FG000|Induction Phase|Lost to Follow-up|1|||
42079124|NCT02449239|75889297|FG000|Induction Phase|Protocol Violation|1|||
42079125|NCT02449239|75889297|FG000|Induction Phase|Physician Decision|1|||
42079126|NCT02449239|75889297|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
42079127|NCT02449239|75889297|FG000|Induction Phase|Withdrawal by Subject|1|||
42079128|NCT02449239|75889297|FG000|Maintenance Month 3|Lack of Efficacy|14|||
42079129|NCT02449239|75889297|FG000|Maintenance Month 6|Lack of Efficacy|10|||
42079130|NCT02449239|75889297|FG000|Maintenance Month 6|Adverse Event|2|||
42079131|NCT02449239|75889297|FG000|Maintenance Month 6|Physician Decision|1|||
42079132|NCT02449239|75889297|FG000|Maintenance Month 9|Lack of Efficacy|2|||
42079133|NCT02449239|75889297|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
42079134|NCT02449239|75889297|FG000|Maintenance Month 12|Lack of Efficacy|5|||
42079135|NCT02449239|75889297|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
42079136|NCT02449239|75889297|FG000|Maintenance Month 12|Subject moved from area|1|||
42079137|NCT02449239|75889297|FG000|Maintenance Month 15|Lack of Efficacy|1|||
42079138|NCT02449239|75889297|FG000|Maintenance Month 21|Lack of Efficacy|1|||
42079139|NCT02449239|75889297|FG000|Maintenance Month 21|Sponsor decision|1|||
42079140|NCT01292928|75889301|FG000|Overall Study|Death|8|||
42079141|NCT01292928|75889301|FG000|Overall Study|Withdrawal by Subject|8|||
42079142|NCT01292928|75889301|FG000|Overall Study|Lost to Follow-up|6|||
42079143|NCT01292928|75889301|FG000|Overall Study|Physician Decision|2|||
42079144|NCT00581828|75889320|FG000|Overall Study|Protocol Violation|1|||
42079145|NCT00220337|75889369|FG000|Overall Study|Adverse Event|70|||
42079146|NCT00220337|75889369|FG000|Overall Study|Lack of Efficacy|17|||
42079147|NCT00220337|75889369|FG000|Overall Study|Withdrawal by Subject|68|||
42079148|NCT00220337|75889369|FG000|Overall Study|Protocol Violation|2|||
42079149|NCT00220337|75889369|FG000|Overall Study|Lost to Follow-up|5|||
42079150|NCT00220337|75889369|FG000|Overall Study|Other|12|||
42079151|NCT00220337|75889369|FG000|Overall Study|Unsatisfactory compliance|5|||
42079152|NCT00576316|75889373|FG000|Overall Study|Adverse Event|9|||
42079153|NCT00576316|75889373|FG000|Overall Study|Withdrawal by Subject|2|||
42079154|NCT00576316|75889373|FG000|Overall Study|Protocol Violation|9|||
42178056|NCT00045942|75985202|FG008|PKC412A2104 (Core)|Death|0|||
42178057|NCT00045942|75985194|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
42178058|NCT00045942|75985195|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
42178059|NCT00045942|75985196|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
42178060|NCT00045942|75985197|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
42079155|NCT00823134|75889377|FG000|Overall Study|Invalid measurement|1|||
42079156|NCT00831792|75889382|FG000|Overall Study|Not Eligible|3|||
42079157|NCT00831792|75889382|FG000|Overall Study|Adverse Event|1|||
42079158|NCT00831792|75889382|FG000|Overall Study|Death|1|||
42079159|NCT00831792|75889382|FG000|Overall Study|Lack of Efficacy|1|||
42079160|NCT00575380|75889388|FG000|Overall Study|Withdrawal by Subject|1|||
42079161|NCT00575380|75889389|FG001|Overall Study|Withdrawal by Subject|0|||
42079162|NCT00575380|75889388|FG000|Overall Study|Adverse Event|0|||
42079163|NCT00575380|75889389|FG001|Overall Study|Adverse Event|1|||
42178061|NCT00045942|75985198|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
42178062|NCT00045942|75985199|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
42178063|NCT00045942|75985200|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
42079164|NCT00575380|75889388|FG000|Overall Study|Various|0|||
42079165|NCT00575380|75889389|FG001|Overall Study|Various|2|||
42079166|NCT00840996|75889397|FG000|Overall Study|Withdrawal by Subject|1|||
42079167|NCT00840996|75889398|FG001|Overall Study|Withdrawal by Subject|0|||
42079168|NCT00680914|75889406|FG000|Overall Study|Consent withdrawal|6|||
42079169|NCT00680914|75889407|FG001|Overall Study|Consent withdrawal|3|||
42079170|NCT00680914|75889406|FG000|Overall Study|Lost to Follow-up|4|||
42079171|NCT00680914|75889407|FG001|Overall Study|Lost to Follow-up|0|||
42079172|NCT00680914|75889406|FG000|Overall Study|serious adverse event (SAE)|0|||
42079173|NCT00680914|75889407|FG001|Overall Study|serious adverse event (SAE)|1|||
42079174|NCT00680836|75889415|FG000|Overall Study|Withdrawal by Subject|3|||
42079175|NCT00680836|75889416|FG001|Overall Study|Withdrawal by Subject|0|||
42357883|NCT00211185|76203415|FG000|Overall Study|Death|2|||
42079176|NCT00680836|75889415|FG000|Overall Study|Lost to Follow-up|3|||
42079177|NCT00680836|75889416|FG001|Overall Study|Lost to Follow-up|1|||
42079178|NCT00680836|75889415|FG000|Overall Study|Physician Decision|2|||
42079179|NCT00680836|75889416|FG001|Overall Study|Physician Decision|1|||
42079180|NCT00679432|75889427|FG000|Overall Study|Adverse Event|5|||
42079181|NCT00679432|75889428|FG001|Overall Study|Adverse Event|6|||
42079182|NCT00679432|75889429|FG002|Overall Study|Adverse Event|10|||
42079183|NCT00679432|75889430|FG003|Overall Study|Adverse Event|7|||
42079184|NCT00679432|75889427|FG000|Overall Study|Protocol Violation|1|||
42079185|NCT00679432|75889428|FG001|Overall Study|Protocol Violation|1|||
42079186|NCT00679432|75889429|FG002|Overall Study|Protocol Violation|2|||
42079187|NCT00679432|75889430|FG003|Overall Study|Protocol Violation|1|||
42079188|NCT00679432|75889427|FG000|Overall Study|Withdrawal by Subject|8|||
42079189|NCT00679432|75889428|FG001|Overall Study|Withdrawal by Subject|11|||
42079190|NCT00679432|75889429|FG002|Overall Study|Withdrawal by Subject|10|||
42079191|NCT00679432|75889430|FG003|Overall Study|Withdrawal by Subject|9|||
42079192|NCT00679432|75889427|FG000|Overall Study|Lost to Follow-up|1|||
42079193|NCT00679432|75889428|FG001|Overall Study|Lost to Follow-up|5|||
42079194|NCT00679432|75889429|FG002|Overall Study|Lost to Follow-up|4|||
42079195|NCT00679432|75889430|FG003|Overall Study|Lost to Follow-up|2|||
42079196|NCT00679432|75889427|FG000|Overall Study|Physician Decision|3|||
42079197|NCT00679432|75889428|FG001|Overall Study|Physician Decision|2|||
42079198|NCT00679432|75889429|FG002|Overall Study|Physician Decision|2|||
42079199|NCT00679432|75889430|FG003|Overall Study|Physician Decision|2|||
42079200|NCT00679432|75889427|FG000|Overall Study|Sponsor decision|1|||
42079201|NCT00679432|75889428|FG001|Overall Study|Sponsor decision|0|||
42079202|NCT00679432|75889429|FG002|Overall Study|Sponsor decision|0|||
42079203|NCT00679432|75889430|FG003|Overall Study|Sponsor decision|0|||
42079204|NCT00679432|75889427|FG000|Overall Study|Lack of Efficacy|13|||
42079205|NCT00679432|75889428|FG001|Overall Study|Lack of Efficacy|9|||
42079206|NCT00679432|75889429|FG002|Overall Study|Lack of Efficacy|14|||
42079207|NCT00679432|75889430|FG003|Overall Study|Lack of Efficacy|8|||
42079208|NCT00679432|75889427|FG000|Overall Study|Infectious colitis, normal histology|5|||
42079209|NCT00679432|75889428|FG001|Overall Study|Infectious colitis, normal histology|4|||
42079210|NCT00679432|75889429|FG002|Overall Study|Infectious colitis, normal histology|8|||
42079211|NCT00679432|75889430|FG003|Overall Study|Infectious colitis, normal histology|3|||
42079212|NCT00679432|75889427|FG000|Overall Study|Randomization error, return to prior Rx|0|||
42079213|NCT00679432|75889428|FG001|Overall Study|Randomization error, return to prior Rx|0|||
42079214|NCT00679432|75889429|FG002|Overall Study|Randomization error, return to prior Rx|3|||
42079215|NCT00679432|75889430|FG003|Overall Study|Randomization error, return to prior Rx|0|||
42079216|NCT00679354|75889440|FG000|Overall Study|Death|3|||
42079217|NCT00679354|75889440|FG000|Overall Study|Lack of Efficacy|22|||
42079218|NCT00679354|75889440|FG000|Overall Study|Physician Decision|4|||
42079219|NCT00679354|75889440|FG000|Overall Study|Ineligible|1|||
42079220|NCT00822900|75889447|FG000|Overall Study|Withdrawal by Subject|14|||
42079221|NCT00822900|75889448|FG001|Overall Study|Withdrawal by Subject|14|||
42079222|NCT00822900|75889447|FG000|Overall Study|Lost to Follow-up|9|||
42079223|NCT00822900|75889448|FG001|Overall Study|Lost to Follow-up|9|||
42079224|NCT00822900|75889447|FG000|Overall Study|Death|83|||
42079225|NCT00822900|75889448|FG001|Overall Study|Death|69|||
42357884|NCT00211185|76203415|FG000|Overall Study|Disease progression|7|||
42357885|NCT00211185|76203415|FG000|Overall Study|Withdrawal by Subject|6|||
42079226|NCT00822900|75889447|FG000|Overall Study|Became a ward of the state|2|||
42079227|NCT00822900|75889448|FG001|Overall Study|Became a ward of the state|1|||
42079228|NCT00682786|75889456|FG000|Overall Study|Withdrawal by Subject|2|||
42079229|NCT00682786|75889457|FG001|Overall Study|Withdrawal by Subject|2|||
42079230|NCT00682786|75889456|FG000|Overall Study|Did not receive irinotecan|0|||
42079231|NCT00682786|75889457|FG001|Overall Study|Did not receive irinotecan|1|||
42079232|NCT00840450|75889469|FG000|Overall Study|Adverse Event|1|||
42079233|NCT00840450|75889469|FG000|Overall Study|Lack of Efficacy|2|||
42079234|NCT00840294|75889475|FG000|Overall Study|Withdrawal by Subject|2|||
42079235|NCT00840294|75889476|FG001|Overall Study|Withdrawal by Subject|1|||
42079236|NCT00840294|75889475|FG000|Overall Study|Protocol Violation|1|||
42079237|NCT00840294|75889476|FG001|Overall Study|Protocol Violation|3|||
42079238|NCT00840294|75889475|FG000|Overall Study|Illness|0|||
42079239|NCT00840294|75889476|FG001|Overall Study|Illness|1|||
42079240|NCT00680368|75889482|FG000|Overall Study|not supervised, not eligible|15|||
42079241|NCT00680056|75889490|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
42079242|NCT00680056|75889491|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
42079243|NCT00680056|75889490|FG000|Second Intervention|Protocol Violation|3|||
42079244|NCT00680056|75889491|FG001|Second Intervention|Protocol Violation|1|||
42079245|NCT00680992|75889501|FG000|Overall Study|Complete Resection (as per protocol)|25|||
42079246|NCT00680992|75889502|FG001|Overall Study|Complete Resection (as per protocol)|121|||
42079247|NCT00680992|75889503|FG002|Overall Study|Complete Resection (as per protocol)|0|||
42079248|NCT00680992|75889501|FG000|Overall Study|Administrative Decision|83|||
42079249|NCT00680992|75889502|FG001|Overall Study|Administrative Decision|42|||
42079250|NCT00680992|75889503|FG002|Overall Study|Administrative Decision|5|||
42079251|NCT00680992|75889501|FG000|Overall Study|End of Trial|32|||
42079252|NCT00680992|75889502|FG001|Overall Study|End of Trial|12|||
42079253|NCT00680992|75889503|FG002|Overall Study|End of Trial|3|||
42079254|NCT00680992|75889501|FG000|Overall Study|Withdrawal by Subject|33|||
42079255|NCT00680992|75889502|FG001|Overall Study|Withdrawal by Subject|11|||
42079256|NCT00680992|75889503|FG002|Overall Study|Withdrawal by Subject|1|||
42079257|NCT00680992|75889501|FG000|Overall Study|Adverse Event|21|||
42079258|NCT00680992|75889502|FG001|Overall Study|Adverse Event|19|||
42079259|NCT00680992|75889503|FG002|Overall Study|Adverse Event|1|||
42079260|NCT00680992|75889501|FG000|Overall Study|Other|19|||
42079261|NCT00680992|75889502|FG001|Overall Study|Other|14|||
42079262|NCT00680992|75889503|FG002|Overall Study|Other|1|||
42079263|NCT00680992|75889501|FG000|Overall Study|Disease Progression|21|||
42079264|NCT00680992|75889502|FG001|Overall Study|Disease Progression|9|||
42079265|NCT00680992|75889503|FG002|Overall Study|Disease Progression|0|||
42079266|NCT00680992|75889501|FG000|Overall Study|Lost to Follow-up|12|||
42079267|NCT00680992|75889502|FG001|Overall Study|Lost to Follow-up|14|||
42079268|NCT00680992|75889503|FG002|Overall Study|Lost to Follow-up|0|||
42079269|NCT00680992|75889501|FG000|Overall Study|Noncompliance|4|||
42079270|NCT00680992|75889502|FG001|Overall Study|Noncompliance|6|||
42079271|NCT00680992|75889503|FG002|Overall Study|Noncompliance|0|||
42079272|NCT00680992|75889501|FG000|Overall Study|Requirement for Alternative Therapy|8|||
42079273|NCT00680992|75889502|FG001|Overall Study|Requirement for Alternative Therapy|2|||
42079274|NCT00680992|75889503|FG002|Overall Study|Requirement for Alternative Therapy|0|||
42079275|NCT00680992|75889501|FG000|Overall Study|Pregnancy|5|||
42079276|NCT00680992|75889502|FG001|Overall Study|Pregnancy|0|||
42079277|NCT00680992|75889503|FG002|Overall Study|Pregnancy|1|||
42079278|NCT00680992|75889501|FG000|Overall Study|Death|5|||
42079279|NCT00680992|75889502|FG001|Overall Study|Death|1|||
42079280|NCT00680992|75889503|FG002|Overall Study|Death|0|||
42079281|NCT00680992|75889501|FG000|Overall Study|Ineligibility Determined|0|||
42079282|NCT00680992|75889502|FG001|Overall Study|Ineligibility Determined|1|||
42079283|NCT00680992|75889503|FG002|Overall Study|Ineligibility Determined|0|||
42079284|NCT00805389|75889517|FG000|Overall Study|Adverse Event|0|||
42079285|NCT00805389|75889518|FG001|Overall Study|Adverse Event|0|||
42079286|NCT00805389|75889519|FG002|Overall Study|Adverse Event|1|||
42079287|NCT00805389|75889520|FG003|Overall Study|Adverse Event|2|||
42079288|NCT00805389|75889521|FG004|Overall Study|Adverse Event|0|||
42079289|NCT00805389|75889517|FG000|Overall Study|Lost to Follow-up|4|||
42079290|NCT00805389|75889518|FG001|Overall Study|Lost to Follow-up|3|||
42079291|NCT00805389|75889519|FG002|Overall Study|Lost to Follow-up|6|||
42079292|NCT00805389|75889520|FG003|Overall Study|Lost to Follow-up|10|||
42079293|NCT00805389|75889521|FG004|Overall Study|Lost to Follow-up|9|||
42079294|NCT00805389|75889517|FG000|Overall Study|Protocol Violation|0|||
42079295|NCT00805389|75889518|FG001|Overall Study|Protocol Violation|0|||
42079296|NCT00805389|75889519|FG002|Overall Study|Protocol Violation|1|||
42079297|NCT00805389|75889520|FG003|Overall Study|Protocol Violation|0|||
42079298|NCT00805389|75889521|FG004|Overall Study|Protocol Violation|0|||
42079299|NCT00805389|75889517|FG000|Overall Study|Withdrawal by Subject|3|||
42079300|NCT00805389|75889518|FG001|Overall Study|Withdrawal by Subject|2|||
42079301|NCT00805389|75889519|FG002|Overall Study|Withdrawal by Subject|4|||
42357886|NCT00211185|76203415|FG000|Overall Study|Physician Decision|5|||
42357887|NCT00210639|76203421|FG000|Overall Study|Lost to Follow-up|37|||
42079302|NCT00805389|75889520|FG003|Overall Study|Withdrawal by Subject|5|||
42357888|NCT00210639|76203422|FG001|Overall Study|Lost to Follow-up|29|||
42079303|NCT00805389|75889521|FG004|Overall Study|Withdrawal by Subject|4|||
42079304|NCT00678886|75889545|FG000|Overall Study|Withdrawal by Subject|0|||
42079305|NCT00678886|75889546|FG001|Overall Study|Withdrawal by Subject|0|||
42079306|NCT00678886|75889547|FG002|Overall Study|Withdrawal by Subject|4|||
42079307|NCT00678886|75889548|FG003|Overall Study|Withdrawal by Subject|6|||
42079308|NCT00678886|75889545|FG000|Overall Study|Physician Decision|0|||
42079309|NCT00678886|75889546|FG001|Overall Study|Physician Decision|0|||
42079310|NCT00678886|75889547|FG002|Overall Study|Physician Decision|1|||
42079311|NCT00678886|75889548|FG003|Overall Study|Physician Decision|1|||
42079312|NCT00678886|75889545|FG000|Overall Study|Lost to Follow-up|0|||
42079313|NCT00678886|75889546|FG001|Overall Study|Lost to Follow-up|0|||
42079314|NCT00678886|75889547|FG002|Overall Study|Lost to Follow-up|3|||
42079315|NCT00678886|75889548|FG003|Overall Study|Lost to Follow-up|2|||
42079316|NCT00678886|75889545|FG000|Overall Study|Other|0|||
42079317|NCT00678886|75889546|FG001|Overall Study|Other|0|||
42079318|NCT00678886|75889547|FG002|Overall Study|Other|1|||
42079319|NCT00678886|75889548|FG003|Overall Study|Other|0|||
42079320|NCT00804843|75889559|FG000|Overall Study|Protocol Violation|1|||
42079321|NCT00804843|75889560|FG001|Overall Study|Protocol Violation|0|||
42079322|NCT00804843|75889559|FG000|Overall Study|Adverse Event|8|||
42079323|NCT00804843|75889560|FG001|Overall Study|Adverse Event|5|||
42079324|NCT00804843|75889559|FG000|Overall Study|Withdrawal by Subject|1|||
42079325|NCT00804843|75889560|FG001|Overall Study|Withdrawal by Subject|2|||
42079326|NCT00822120|75889569|FG000|Initial Registration|Adverse Event|1|||
42079327|NCT00822120|75889570|FG001|Initial Registration|Adverse Event|0|||
42079328|NCT00822120|75889571|FG002|Initial Registration|Adverse Event|0|||
42079329|NCT00822120|75889572|FG003|Initial Registration|Adverse Event|0|||
42079330|NCT00822120|75889573|FG004|Initial Registration|Adverse Event|0|||
42079331|NCT00822120|75889574|FG005|Initial Registration|Adverse Event|0|||
42079332|NCT00822120|75889569|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
42079333|NCT00822120|75889570|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
42079334|NCT00822120|75889571|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
42079335|NCT00822120|75889572|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
42079336|NCT00822120|75889573|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
42079337|NCT00822120|75889574|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
42079338|NCT00822120|75889569|FG000|Initial Registration|Reasons not Protocol Specified|2|||
42079339|NCT00822120|75889570|FG001|Initial Registration|Reasons not Protocol Specified|0|||
42079340|NCT00822120|75889571|FG002|Initial Registration|Reasons not Protocol Specified|0|||
42079341|NCT00822120|75889572|FG003|Initial Registration|Reasons not Protocol Specified|0|||
42079342|NCT00822120|75889573|FG004|Initial Registration|Reasons not Protocol Specified|0|||
42079343|NCT00822120|75889574|FG005|Initial Registration|Reasons not Protocol Specified|0|||
42079344|NCT00822120|75889569|FG000|Initial Registration|Ineligible|22|||
42079345|NCT00822120|75889570|FG001|Initial Registration|Ineligible|1|||
42079346|NCT00822120|75889571|FG002|Initial Registration|Ineligible|0|||
42079347|NCT00822120|75889572|FG003|Initial Registration|Ineligible|0|||
42079348|NCT00822120|75889573|FG004|Initial Registration|Ineligible|0|||
42079349|NCT00822120|75889574|FG005|Initial Registration|Ineligible|0|||
42079350|NCT00822120|75889569|FG000|PET-directed Therapy|Adverse Event|0|||
42079351|NCT00822120|75889570|FG001|PET-directed Therapy|Adverse Event|0|||
42079352|NCT00822120|75889571|FG002|PET-directed Therapy|Adverse Event|0|||
42079353|NCT00822120|75889572|FG003|PET-directed Therapy|Adverse Event|1|||
42079354|NCT00822120|75889573|FG004|PET-directed Therapy|Adverse Event|0|||
42079355|NCT00822120|75889574|FG005|PET-directed Therapy|Adverse Event|0|||
42079356|NCT00822120|75889569|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
42079357|NCT00822120|75889570|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
42079358|NCT00822120|75889571|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
42079359|NCT00822120|75889572|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
42079360|NCT00822120|75889573|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
42079361|NCT00822120|75889574|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
42079362|NCT00822120|75889569|FG000|PET-directed Therapy|Death|0|||
42079363|NCT00822120|75889570|FG001|PET-directed Therapy|Death|0|||
42079364|NCT00822120|75889571|FG002|PET-directed Therapy|Death|0|||
42357889|NCT00210639|76203421|FG000|Overall Study|Withdrawal by Subject|8|||
42357890|NCT00210639|76203422|FG001|Overall Study|Withdrawal by Subject|1|||
42357891|NCT00210639|76203421|FG000|Overall Study|Other|18|||
42357892|NCT00210639|76203422|FG001|Overall Study|Other|12|||
42357893|NCT01829113|76203430|FG000|Overall Study|Disease Progression|37|||
42357894|NCT01829113|76203431|FG001|Overall Study|Disease Progression|48|||
42357895|NCT01829113|76203430|FG000|Overall Study|Adverse Event|14|||
42357896|NCT01829113|76203431|FG001|Overall Study|Adverse Event|10|||
42357897|NCT01829113|76203430|FG000|Overall Study|Withdrawal by Subject|17|||
42357898|NCT01829113|76203431|FG001|Overall Study|Withdrawal by Subject|10|||
42357899|NCT01829113|76203430|FG000|Overall Study|Death|4|||
42357900|NCT01829113|76203431|FG001|Overall Study|Death|6|||
42357901|NCT01829113|76203430|FG000|Overall Study|Sponsor Decision|1|||
42357902|NCT01829113|76203431|FG001|Overall Study|Sponsor Decision|1|||
42357903|NCT01829113|76203430|FG000|Overall Study|No Study Treatment Received|3|||
42079365|NCT00822120|75889572|FG003|PET-directed Therapy|Death|2|||
42079366|NCT00822120|75889573|FG004|PET-directed Therapy|Death|0|||
42079367|NCT00822120|75889574|FG005|PET-directed Therapy|Death|0|||
42079368|NCT00822120|75889569|FG000|PET-directed Therapy|Protocol Violation|0|||
42079369|NCT00822120|75889570|FG001|PET-directed Therapy|Protocol Violation|0|||
42079370|NCT00822120|75889571|FG002|PET-directed Therapy|Protocol Violation|0|||
42079371|NCT00822120|75889572|FG003|PET-directed Therapy|Protocol Violation|6|||
42079372|NCT00822120|75889573|FG004|PET-directed Therapy|Protocol Violation|0|||
42079373|NCT00822120|75889574|FG005|PET-directed Therapy|Protocol Violation|0|||
42079374|NCT00804687|75889595|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
42357904|NCT01829113|76203431|FG001|Overall Study|No Study Treatment Received|2|||
42357905|NCT01829113|76203430|FG000|Overall Study|Physician Decision|1|||
42079375|NCT00804687|75889596|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
42079376|NCT00804687|75889597|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
42079377|NCT00804687|75889598|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
42079378|NCT00804687|75889599|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
42079379|NCT00804687|75889600|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
42079380|NCT00804687|75889595|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
42079381|NCT00804687|75889596|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
42079382|NCT00804687|75889597|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
42079383|NCT00804687|75889598|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
42079384|NCT00804687|75889599|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
42079385|NCT00804687|75889600|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
42079386|NCT00804687|75889595|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
42079387|NCT00804687|75889596|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
42079388|NCT00804687|75889597|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
42079389|NCT00804687|75889598|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
42079390|NCT00804687|75889599|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
42079391|NCT00804687|75889600|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
42079392|NCT00804687|75889595|FG000|Period 5: Treatment Period|Positive drug test|1|||
42079393|NCT00804687|75889596|FG001|Period 5: Treatment Period|Positive drug test|0|||
42079394|NCT00804687|75889597|FG002|Period 5: Treatment Period|Positive drug test|0|||
42079395|NCT00804687|75889598|FG003|Period 5: Treatment Period|Positive drug test|0|||
42079396|NCT00804687|75889599|FG004|Period 5: Treatment Period|Positive drug test|0|||
42079397|NCT00804687|75889600|FG005|Period 5: Treatment Period|Positive drug test|0|||
42079398|NCT00678652|75889612|FG000|Overall Study|Protocol Violation|2|||
42079399|NCT00678652|75889613|FG001|Overall Study|Protocol Violation|0|||
42079400|NCT00678652|75889614|FG002|Overall Study|Protocol Violation|0|||
42079401|NCT00678652|75889615|FG003|Overall Study|Protocol Violation|0|||
42079402|NCT00678652|75889612|FG000|Overall Study|Pregnancy|0|||
42079403|NCT00678652|75889613|FG001|Overall Study|Pregnancy|0|||
42079404|NCT00678652|75889614|FG002|Overall Study|Pregnancy|1|||
42079405|NCT00678652|75889615|FG003|Overall Study|Pregnancy|0|||
42079406|NCT00678652|75889612|FG000|Overall Study|Relocation|1|||
42079407|NCT00678652|75889613|FG001|Overall Study|Relocation|0|||
42079408|NCT00678652|75889614|FG002|Overall Study|Relocation|0|||
42079409|NCT00678652|75889615|FG003|Overall Study|Relocation|0|||
42079410|NCT00840060|75889636|FG000|Overall Study|Withdrawal by Subject|1|||
42079411|NCT00840060|75889637|FG001|Overall Study|Withdrawal by Subject|0|||
42079412|NCT00840060|75889636|FG000|Overall Study|Change in emotional/behavioral status|0|||
42079413|NCT00840060|75889637|FG001|Overall Study|Change in emotional/behavioral status|1|||
42079414|NCT00574912|75889643|FG000|Overall Study|Could not place IV lines.|3|||
42079415|NCT00574912|75889643|FG000|Overall Study|scheduling conflicts|3|||
42079416|NCT00574912|75889643|FG000|Overall Study|Physician Decision|2|||
42079417|NCT00674128|75889657|FG000|Overall Study|Withdrawal by Subject|25|||
42079418|NCT00674128|75889658|FG001|Overall Study|Withdrawal by Subject|23|||
42079419|NCT00804141|75889664|FG000|Overall Study|Adverse Event|157|||
42079420|NCT00804141|75889664|FG000|Overall Study|Death|4|||
42079421|NCT00804141|75889664|FG000|Overall Study|Failed to return|96|||
42079422|NCT00804141|75889664|FG000|Overall Study|Investigator request|8|||
42079423|NCT00804141|75889664|FG000|Overall Study|Protocol Violation|85|||
42079424|NCT00804141|75889664|FG000|Overall Study|Withdrawal by Subject|131|||
42079425|NCT00804141|75889664|FG000|Overall Study|Lack of Efficacy|46|||
42079426|NCT00804141|75889664|FG000|Overall Study|Other than specified|30|||
42079427|NCT00804141|75889664|FG000|Overall Study|Enrolled but not treated|6|||
42079428|NCT00677092|75889668|FG000|Overall Study|Adverse Event|1|||
42079429|NCT00677092|75889668|FG000|Overall Study|Lost to Follow-up|1|||
42079430|NCT00677092|75889668|FG000|Overall Study|Withdrawal by Subject|3|||
42079431|NCT00677092|75889668|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
42079432|NCT00677014|75889676|FG000|Overall Study|Lost to Follow-up|20|||
42079433|NCT00677014|75889677|FG001|Overall Study|Lost to Follow-up|12|||
42079434|NCT00677014|75889678|FG002|Overall Study|Lost to Follow-up|24|||
42079435|NCT00677014|75889676|FG000|Overall Study|Death|6|||
42079436|NCT00677014|75889677|FG001|Overall Study|Death|15|||
42079437|NCT00677014|75889678|FG002|Overall Study|Death|7|||
42079438|NCT00677014|75889676|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
42079439|NCT00677014|75889677|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
42079440|NCT00677014|75889678|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
42079441|NCT00839436|75889689|FG000|Overall Study|Developed exclusionary condition|1|||
42079442|NCT00839436|75889690|FG001|Overall Study|Developed exclusionary condition|0|||
42079443|NCT00839436|75889691|FG002|Overall Study|Developed exclusionary condition|0|||
42079444|NCT00839436|75889689|FG000|Overall Study|Withdrawal by Subject|0|||
42079445|NCT00839436|75889690|FG001|Overall Study|Withdrawal by Subject|1|||
42079446|NCT00839436|75889691|FG002|Overall Study|Withdrawal by Subject|0|||
42079447|NCT00839436|75889689|FG000|Overall Study|Study drug no longer available|0|||
42079448|NCT00839436|75889690|FG001|Overall Study|Study drug no longer available|0|||
42079449|NCT00839436|75889691|FG002|Overall Study|Study drug no longer available|1|||
42079450|NCT00675766|75889703|FG000|Overall Study|Lost to Follow-up|6|||
42079451|NCT00675766|75889704|FG001|Overall Study|Lost to Follow-up|5|||
42079452|NCT00675766|75889705|FG002|Overall Study|Lost to Follow-up|21|||
42079453|NCT00675766|75889706|FG003|Overall Study|Lost to Follow-up|26|||
42079454|NCT00673894|75889718|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
42079455|NCT00673894|75889719|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
42079456|NCT00673894|75889718|FG000|First Intervention 4 Weeks|Adverse Event|1|||
42079457|NCT00673894|75889719|FG001|First Intervention 4 Weeks|Adverse Event|0|||
42079458|NCT00674986|75889727|FG000|Overall Study|Adverse Event|2|||
42079459|NCT00674986|75889728|FG001|Overall Study|Adverse Event|1|||
42079460|NCT00674986|75889727|FG000|Overall Study|Subject withdrew consent|12|||
42079461|NCT00674986|75889728|FG001|Overall Study|Subject withdrew consent|19|||
42079462|NCT00674986|75889727|FG000|Overall Study|Lost to Follow-up|25|||
42079463|NCT00674986|75889728|FG001|Overall Study|Lost to Follow-up|53|||
42079464|NCT00674986|75889727|FG000|Overall Study|Other reasons|4|||
42079465|NCT00674986|75889728|FG001|Overall Study|Other reasons|8|||
42079466|NCT00673660|75889735|FG000|Overall Study|Lost to Follow-up|107|||
42079467|NCT00672958|75889746|FG000|Overall Study|Adverse Event|11|||
42079468|NCT00672958|75889747|FG001|Overall Study|Adverse Event|9|||
42079469|NCT00672958|75889746|FG000|Overall Study|Lack of Efficacy|6|||
42079470|NCT00672958|75889747|FG001|Overall Study|Lack of Efficacy|11|||
42079471|NCT00672958|75889746|FG000|Overall Study|Non-compliance with study drug|2|||
42079472|NCT00672958|75889747|FG001|Overall Study|Non-compliance with study drug|3|||
42079473|NCT00672958|75889746|FG000|Overall Study|Protocol deviations|11|||
42079474|NCT00672958|75889747|FG001|Overall Study|Protocol deviations|5|||
42079475|NCT00672958|75889746|FG000|Overall Study|Voluntary withdrawal|12|||
42079476|NCT00672958|75889747|FG001|Overall Study|Voluntary withdrawal|8|||
42079477|NCT00672958|75889746|FG000|Overall Study|Lost to Follow-up|22|||
42079478|NCT00672958|75889747|FG001|Overall Study|Lost to Follow-up|17|||
42079479|NCT00672958|75889746|FG000|Overall Study|Reason not specified|0|||
42079480|NCT00672958|75889747|FG001|Overall Study|Reason not specified|3|||
42079481|NCT00672646|75889756|FG000|Overall Study|Lost to Follow-up|0|||
42079482|NCT00672646|75889757|FG001|Overall Study|Lost to Follow-up|1|||
42079483|NCT00672646|75889758|FG002|Overall Study|Lost to Follow-up|2|||
42079484|NCT00672646|75889756|FG000|Overall Study|Withdrawal by Subject|0|||
42079485|NCT00672646|75889757|FG001|Overall Study|Withdrawal by Subject|0|||
42079486|NCT00672646|75889758|FG002|Overall Study|Withdrawal by Subject|1|||
42079487|NCT00672490|75889768|FG000|Overall Study|Withdrawal by Subject|8|||
42079488|NCT00672490|75889769|FG001|Overall Study|Withdrawal by Subject|8|||
42079489|NCT00672490|75889768|FG000|Overall Study|Lack of Compliance|2|||
42079490|NCT00672490|75889769|FG001|Overall Study|Lack of Compliance|7|||
42079491|NCT00672490|75889768|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
42079492|NCT00672490|75889769|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
42079493|NCT00672490|75889768|FG000|Overall Study|Adverse Event|5|||
42079494|NCT00672490|75889769|FG001|Overall Study|Adverse Event|8|||
42079495|NCT00672490|75889768|FG000|Overall Study|Violation of Concomitant Medicine|1|||
42079496|NCT00672490|75889769|FG001|Overall Study|Violation of Concomitant Medicine|0|||
42079497|NCT00672490|75889768|FG000|Overall Study|Intolerance|0|||
42079498|NCT00672490|75889769|FG001|Overall Study|Intolerance|2|||
42079499|NCT00672490|75889768|FG000|Overall Study|Lost to Follow-up|1|||
42079500|NCT00672490|75889769|FG001|Overall Study|Lost to Follow-up|5|||
42079501|NCT00672490|75889768|FG000|Overall Study|No reason was provided|6|||
42079502|NCT00672490|75889769|FG001|Overall Study|No reason was provided|2|||
42079503|NCT00670930|75889777|FG000|Overall Study|Adminstrative Problem|0|||
42079504|NCT00670930|75889778|FG001|Overall Study|Adminstrative Problem|1|||
42079505|NCT00670930|75889777|FG000|Overall Study|Lost to Follow-up|1|||
42079506|NCT00670930|75889778|FG001|Overall Study|Lost to Follow-up|0|||
42079507|NCT00670540|75889784|FG000|Overall Study|ineligible|17|||
42079508|NCT00670540|75889784|FG000|Overall Study|not living in France|348|||
42079509|NCT00670540|75889784|FG000|Overall Study|refused to participate|189|||
42079510|NCT00670540|75889784|FG000|Overall Study|controls randomised for no follow up|2770|||
42079511|NCT00670540|75889784|FG000|Overall Study|missing information inclusion criteria|1|||
42079512|NCT00591786|75889798|FG000|Overall Study|Withdrawal of Informed Consent|0|||
42079513|NCT00591786|75889799|FG001|Overall Study|Withdrawal of Informed Consent|0|||
42079514|NCT00591786|75889800|FG002|Overall Study|Withdrawal of Informed Consent|1|||
42293610|NCT01668797|76127786|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
42293611|NCT01668797|76127787|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
42293612|NCT01668797|76127788|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
42079515|NCT00591786|75889801|FG003|Overall Study|Withdrawal of Informed Consent|0|||
42079516|NCT00591786|75889802|FG004|Overall Study|Withdrawal of Informed Consent|0|||
42079517|NCT00591786|75889803|FG005|Overall Study|Withdrawal of Informed Consent|0|||
42079518|NCT00591786|75889804|FG006|Overall Study|Withdrawal of Informed Consent|0|||
42079519|NCT00591786|75889805|FG007|Overall Study|Withdrawal of Informed Consent|0|||
42079520|NCT00591786|75889806|FG008|Overall Study|Withdrawal of Informed Consent|0|||
42079521|NCT00591786|75889807|FG009|Overall Study|Withdrawal of Informed Consent|0|||
42079522|NCT00674362|75889831|FG000|Double Blind|Adverse Event|6|||
42079523|NCT00674362|75889832|FG001|Double Blind|Adverse Event|6|||
42079524|NCT00674362|75889831|FG000|Double Blind|Lack of Efficacy|2|||
42079525|NCT00674362|75889832|FG001|Double Blind|Lack of Efficacy|6|||
42079526|NCT00674362|75889831|FG000|Double Blind|Loss of efficacy|0|||
42079527|NCT00674362|75889832|FG001|Double Blind|Loss of efficacy|1|||
42079528|NCT00674362|75889831|FG000|Double Blind|Withdrawal by Subject|4|||
42079529|NCT00674362|75889832|FG001|Double Blind|Withdrawal by Subject|3|||
42079530|NCT00674362|75889831|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
42079531|NCT00674362|75889832|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
42079532|NCT00674362|75889831|FG000|Double Blind|Other: Surgery|0|||
42079533|NCT00674362|75889832|FG001|Double Blind|Other: Surgery|1|||
42079534|NCT00674362|75889831|FG000|Open Label|Adverse Event|1|||
42079535|NCT00674362|75889832|FG001|Open Label|Adverse Event|0|||
42079536|NCT00674362|75889831|FG000|Open Label|Other: Subject moved to extension study|1|||
42079537|NCT00674362|75889832|FG001|Open Label|Other: Subject moved to extension study|0|||
42079538|NCT00820950|75889844|FG000|Overall Study|Scheduling Conflict|0|||
42079539|NCT00820950|75889845|FG001|Overall Study|Scheduling Conflict|0|||
42079540|NCT00820950|75889846|FG002|Overall Study|Scheduling Conflict|0|||
42079541|NCT00820950|75889847|FG003|Overall Study|Scheduling Conflict|0|||
42079542|NCT00820950|75889848|FG004|Overall Study|Scheduling Conflict|0|||
42079543|NCT00820950|75889849|FG005|Overall Study|Scheduling Conflict|0|||
42079544|NCT00820950|75889850|FG006|Overall Study|Scheduling Conflict|1|||
42079545|NCT00820950|75889851|FG007|Overall Study|Scheduling Conflict|1|||
42079546|NCT00820950|75889852|FG008|Overall Study|Scheduling Conflict|0|||
42079547|NCT00820950|75889853|FG009|Overall Study|Scheduling Conflict|0|||
42079548|NCT00820950|75889844|FG000|Overall Study|Protocol Violation|1|||
42079549|NCT00820950|75889845|FG001|Overall Study|Protocol Violation|1|||
42079550|NCT00820950|75889846|FG002|Overall Study|Protocol Violation|0|||
42079551|NCT00820950|75889847|FG003|Overall Study|Protocol Violation|0|||
42079552|NCT00820950|75889848|FG004|Overall Study|Protocol Violation|0|||
42079553|NCT00820950|75889849|FG005|Overall Study|Protocol Violation|0|||
42079554|NCT00820950|75889850|FG006|Overall Study|Protocol Violation|0|||
42079555|NCT00820950|75889851|FG007|Overall Study|Protocol Violation|0|||
42079556|NCT00820950|75889852|FG008|Overall Study|Protocol Violation|0|||
42079557|NCT00820950|75889853|FG009|Overall Study|Protocol Violation|0|||
42079558|NCT00670306|75889893|FG000|Overall Study|Adverse Event|8|||
42079559|NCT00670306|75889893|FG000|Overall Study|Lack of Efficacy|10|||
42079560|NCT00670306|75889893|FG000|Overall Study|Withdrawal by Subject|9|||
42079561|NCT00670306|75889893|FG000|Overall Study|Physician Decision|1|||
42079562|NCT00670306|75889893|FG000|Overall Study|Lost to Follow-up|8|||
42079563|NCT00670306|75889893|FG000|Overall Study|incl/excl criterias did not meet|19|||
42079564|NCT00672256|75889897|FG000|Overall Study|PI dropped, bad data|44|||
42079565|NCT00591630|75889905|FG000|Overall Study|Death|0|||
42079566|NCT00591630|75889906|FG001|Overall Study|Death|0|||
42079567|NCT00591630|75889907|FG002|Overall Study|Death|1|||
42079568|NCT00591630|75889908|FG003|Overall Study|Death|0|||
42079569|NCT00670228|75889920|FG000|Overall Study|Adverse Event|1|||
42079570|NCT00670228|75889921|FG001|Overall Study|Adverse Event|0|||
42079571|NCT00670228|75889920|FG000|Overall Study|Death or MACE|0|||
42079572|NCT00670228|75889921|FG001|Overall Study|Death or MACE|1|||
42079573|NCT00670228|75889920|FG000|Overall Study|Not treated|2|||
42079574|NCT00670228|75889921|FG001|Overall Study|Not treated|2|||
42079575|NCT00670228|75889920|FG000|Overall Study|Not meeting the selection criteria|2|||
42079576|NCT00670228|75889921|FG001|Overall Study|Not meeting the selection criteria|0|||
42079577|NCT00570778|75889927|FG000|Overall Study|Protocol deviation|2|||
42079578|NCT00570778|75889928|FG001|Overall Study|Protocol deviation|1|||
42079579|NCT00570778|75889929|FG002|Overall Study|Protocol deviation|2|||
42079580|NCT00570778|75889930|FG003|Overall Study|Protocol deviation|2|||
42079581|NCT00570778|75889927|FG000|Overall Study|Adverse Event|0|||
42079582|NCT00570778|75889928|FG001|Overall Study|Adverse Event|1|||
42079583|NCT00570778|75889929|FG002|Overall Study|Adverse Event|4|||
42079584|NCT00570778|75889930|FG003|Overall Study|Adverse Event|1|||
42178064|NCT00045942|75985201|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
42178065|NCT00045942|75985202|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
42079585|NCT00570778|75889927|FG000|Overall Study|Subject withdrew consent|0|||
42079586|NCT00570778|75889928|FG001|Overall Study|Subject withdrew consent|1|||
42178066|NCT00045942|75985194|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
42079587|NCT00570778|75889929|FG002|Overall Study|Subject withdrew consent|0|||
42079588|NCT00570778|75889930|FG003|Overall Study|Subject withdrew consent|1|||
42079589|NCT00570778|75889927|FG000|Overall Study|Abnormal test procedure|1|||
42079590|NCT00570778|75889928|FG001|Overall Study|Abnormal test procedure|0|||
42079591|NCT00570778|75889929|FG002|Overall Study|Abnormal test procedure|0|||
42079592|NCT00570778|75889930|FG003|Overall Study|Abnormal test procedure|0|||
42079593|NCT00570778|75889927|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42079594|NCT00570778|75889928|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42079595|NCT00570778|75889929|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
42079596|NCT00570778|75889930|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
42079597|NCT00570778|75889927|FG000|Overall Study|Lost to Follow-up|0|||
42079598|NCT00570778|75889928|FG001|Overall Study|Lost to Follow-up|0|||
42079599|NCT00570778|75889929|FG002|Overall Study|Lost to Follow-up|1|||
42079600|NCT00570778|75889930|FG003|Overall Study|Lost to Follow-up|0|||
42079601|NCT00570778|75889927|FG000|Overall Study|Subject no longer requires study drug|0|||
42079602|NCT00570778|75889928|FG001|Overall Study|Subject no longer requires study drug|1|||
42079603|NCT00570778|75889929|FG002|Overall Study|Subject no longer requires study drug|0|||
42079604|NCT00570778|75889930|FG003|Overall Study|Subject no longer requires study drug|0|||
42079605|NCT00668746|75889942|FG000|Overall Study|Lost to Follow-up|2|||
42079606|NCT00668746|75889943|FG001|Overall Study|Lost to Follow-up|1|||
42079607|NCT00878189|75889961|FG000|Overall Study|Death|0|||
42079608|NCT00878189|75889962|FG001|Overall Study|Death|1|||
42079609|NCT00878189|75889963|FG002|Overall Study|Death|0|||
42079610|NCT00878189|75889964|FG003|Overall Study|Death|1|||
42079611|NCT00878189|75889965|FG004|Overall Study|Death|0|||
42079612|NCT00878189|75889966|FG005|Overall Study|Death|0|||
42079613|NCT00878189|75889967|FG006|Overall Study|Death|0|||
42079614|NCT00878189|75889968|FG007|Overall Study|Death|0|||
42079615|NCT00878189|75889969|FG008|Overall Study|Death|1|||
42079616|NCT00878189|75889961|FG000|Overall Study|Participant Refused to Follow-up|0|||
42079617|NCT00878189|75889962|FG001|Overall Study|Participant Refused to Follow-up|0|||
42079618|NCT00878189|75889963|FG002|Overall Study|Participant Refused to Follow-up|0|||
42079619|NCT00878189|75889964|FG003|Overall Study|Participant Refused to Follow-up|0|||
42079620|NCT00878189|75889965|FG004|Overall Study|Participant Refused to Follow-up|0|||
42079621|NCT00878189|75889966|FG005|Overall Study|Participant Refused to Follow-up|4|||
42079622|NCT00878189|75889967|FG006|Overall Study|Participant Refused to Follow-up|0|||
42079623|NCT00878189|75889968|FG007|Overall Study|Participant Refused to Follow-up|0|||
42079624|NCT00878189|75889969|FG008|Overall Study|Participant Refused to Follow-up|0|||
42079625|NCT00878189|75889961|FG000|Overall Study|Other|3|||
42079626|NCT00878189|75889962|FG001|Overall Study|Other|2|||
42079627|NCT00878189|75889963|FG002|Overall Study|Other|4|||
42079628|NCT00878189|75889964|FG003|Overall Study|Other|7|||
42079629|NCT00878189|75889965|FG004|Overall Study|Other|4|||
42079630|NCT00878189|75889966|FG005|Overall Study|Other|18|||
42079631|NCT00878189|75889967|FG006|Overall Study|Other|15|||
42079632|NCT00878189|75889968|FG007|Overall Study|Other|3|||
42079633|NCT00878189|75889969|FG008|Overall Study|Other|4|||
42079634|NCT00878189|75889961|FG000|Overall Study|Lost to Follow-up|0|||
42079635|NCT00878189|75889962|FG001|Overall Study|Lost to Follow-up|0|||
42079636|NCT00878189|75889963|FG002|Overall Study|Lost to Follow-up|0|||
42079637|NCT00878189|75889964|FG003|Overall Study|Lost to Follow-up|0|||
42079638|NCT00878189|75889965|FG004|Overall Study|Lost to Follow-up|0|||
42079639|NCT00878189|75889966|FG005|Overall Study|Lost to Follow-up|1|||
42079640|NCT00878189|75889967|FG006|Overall Study|Lost to Follow-up|1|||
42079641|NCT00878189|75889968|FG007|Overall Study|Lost to Follow-up|0|||
42079642|NCT00878189|75889969|FG008|Overall Study|Lost to Follow-up|0|||
42079643|NCT00878189|75889961|FG000|Overall Study|Objection Progression or Relapse|0|||
42079644|NCT00878189|75889962|FG001|Overall Study|Objection Progression or Relapse|0|||
42079645|NCT00878189|75889963|FG002|Overall Study|Objection Progression or Relapse|0|||
42079646|NCT00878189|75889964|FG003|Overall Study|Objection Progression or Relapse|0|||
42079647|NCT00878189|75889965|FG004|Overall Study|Objection Progression or Relapse|0|||
42079648|NCT00878189|75889966|FG005|Overall Study|Objection Progression or Relapse|0|||
42293613|NCT01668797|76127789|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
42293614|NCT01668797|76127786|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
42079649|NCT00878189|75889967|FG006|Overall Study|Objection Progression or Relapse|0|||
42079650|NCT00878189|75889968|FG007|Overall Study|Objection Progression or Relapse|0|||
42079651|NCT00878189|75889969|FG008|Overall Study|Objection Progression or Relapse|3|||
42079652|NCT00668200|75890003|FG000|Overall Study|Withdrawal by Subject|2|||
42079653|NCT00668200|75890003|FG000|Overall Study|Lost to Follow-up|1|||
42079654|NCT00838578|75890007|FG000|Overall Study|Protocol Violation|2|||
42079655|NCT00829296|75890017|FG000|Overall Study|Adverse Event|5|||
42079656|NCT00829296|75890018|FG001|Overall Study|Adverse Event|4|||
42079657|NCT00881621|75890024|FG000|Overall Study|Physician Decision|34|||
42079658|NCT00818766|75890030|FG000|Overall Study|Could not be Contacted on Day 28|11|||
42079659|NCT00818766|75890031|FG001|Overall Study|Could not be Contacted on Day 28|10|||
42079660|NCT00818766|75890030|FG000|Overall Study|Death|1|||
42079661|NCT00818766|75890031|FG001|Overall Study|Death|0|||
42079662|NCT00818766|75890030|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
42079663|NCT00818766|75890031|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
42079664|NCT00667888|75890039|FG000|Overall Study|Death|1|||
42079665|NCT00667888|75890040|FG001|Overall Study|Death|1|||
42079666|NCT00667888|75890039|FG000|Overall Study|Withdrawal by Subject|6|||
42079667|NCT00667888|75890040|FG001|Overall Study|Withdrawal by Subject|3|||
42079668|NCT00667888|75890039|FG000|Overall Study|Proceed with other treatment|3|||
42079669|NCT00667888|75890040|FG001|Overall Study|Proceed with other treatment|3|||
42079670|NCT00667888|75890039|FG000|Overall Study|Ineligible after SIM|0|||
42079671|NCT00667888|75890040|FG001|Overall Study|Ineligible after SIM|2|||
42079672|NCT00594815|75890046|FG000|Overall Study|Never Treated|3|||
42079673|NCT00594815|75890046|FG000|Overall Study|Withdrawal by Subject|2|||
42079674|NCT00594815|75890046|FG000|Overall Study|Toxicity|4|||
42079675|NCT00820170|75890055|FG000|Overall Study|Adverse Event|0|||
42079676|NCT00820170|75890056|FG001|Overall Study|Adverse Event|0|||
42079677|NCT00820170|75890057|FG002|Overall Study|Adverse Event|0|||
42079678|NCT00820170|75890058|FG003|Overall Study|Adverse Event|0|||
42079679|NCT00820170|75890059|FG004|Overall Study|Adverse Event|2|||
42079680|NCT00820170|75890055|FG000|Overall Study|Progressive Disease|0|||
42079681|NCT00820170|75890056|FG001|Overall Study|Progressive Disease|0|||
42079682|NCT00820170|75890057|FG002|Overall Study|Progressive Disease|0|||
42079683|NCT00820170|75890058|FG003|Overall Study|Progressive Disease|0|||
42079684|NCT00820170|75890059|FG004|Overall Study|Progressive Disease|2|||
42079685|NCT00818454|75890076|FG000|Treatment Period 1|Adverse Event|0|||
42079686|NCT00818454|75890077|FG001|Treatment Period 1|Adverse Event|1|||
42079687|NCT00818454|75890078|FG002|Treatment Period 1|Adverse Event|0|||
42079688|NCT00818454|75890079|FG003|Treatment Period 1|Adverse Event|0|||
42079689|NCT00818454|75890076|FG000|Treatment Period 1|Other|3|||
42079690|NCT00818454|75890077|FG001|Treatment Period 1|Other|0|||
42079691|NCT00818454|75890078|FG002|Treatment Period 1|Other|0|||
42079692|NCT00818454|75890079|FG003|Treatment Period 1|Other|0|||
42079693|NCT00818454|75890076|FG000|Washout Period of 1 Week|Adverse Event|1|||
42079694|NCT00818454|75890077|FG001|Washout Period of 1 Week|Adverse Event|1|||
42079695|NCT00818454|75890078|FG002|Washout Period of 1 Week|Adverse Event|0|||
42079696|NCT00818454|75890079|FG003|Washout Period of 1 Week|Adverse Event|0|||
42079697|NCT00818454|75890076|FG000|Washout Period of 1 Week|Protocol Violation|2|||
42079698|NCT00818454|75890077|FG001|Washout Period of 1 Week|Protocol Violation|0|||
42079699|NCT00818454|75890078|FG002|Washout Period of 1 Week|Protocol Violation|0|||
42079700|NCT00818454|75890079|FG003|Washout Period of 1 Week|Protocol Violation|0|||
42079701|NCT00818454|75890076|FG000|Washout Period of 1 Week|Other|1|||
42079702|NCT00818454|75890077|FG001|Washout Period of 1 Week|Other|2|||
42079703|NCT00818454|75890078|FG002|Washout Period of 1 Week|Other|0|||
42079704|NCT00818454|75890079|FG003|Washout Period of 1 Week|Other|0|||
42079705|NCT00818454|75890076|FG000|Treatment Period 2|Other|2|||
42079706|NCT00818454|75890077|FG001|Treatment Period 2|Other|1|||
42079707|NCT00818454|75890078|FG002|Treatment Period 2|Other|0|||
42079708|NCT00818454|75890079|FG003|Treatment Period 2|Other|0|||
42079709|NCT00818454|75890076|FG000|Treatment Period 3|Adverse Event|0|||
42079710|NCT00818454|75890077|FG001|Treatment Period 3|Adverse Event|0|||
42079711|NCT00818454|75890078|FG002|Treatment Period 3|Adverse Event|0|||
42079712|NCT00818454|75890079|FG003|Treatment Period 3|Adverse Event|1|||
42079713|NCT00828984|75890092|FG000|Overall Study|Adverse Event|2|||
42079714|NCT00828984|75890093|FG001|Overall Study|Adverse Event|3|||
42079715|NCT00828984|75890094|FG002|Overall Study|Adverse Event|0|||
42079716|NCT00828984|75890092|FG000|Overall Study|Lost to Follow-up|5|||
42079717|NCT00828984|75890093|FG001|Overall Study|Lost to Follow-up|3|||
42079718|NCT00828984|75890094|FG002|Overall Study|Lost to Follow-up|1|||
42079719|NCT00828984|75890092|FG000|Overall Study|Withdrawal by Subject|4|||
42079720|NCT00828984|75890093|FG001|Overall Study|Withdrawal by Subject|4|||
42079721|NCT00828984|75890094|FG002|Overall Study|Withdrawal by Subject|4|||
42079722|NCT00828984|75890092|FG000|Overall Study|Ineligable|1|||
42079723|NCT00828984|75890093|FG001|Overall Study|Ineligable|2|||
42079724|NCT00828984|75890094|FG002|Overall Study|Ineligable|0|||
42079725|NCT00828984|75890092|FG000|Overall Study|Medical Contraindication|0|||
42079726|NCT00828984|75890093|FG001|Overall Study|Medical Contraindication|1|||
42079727|NCT00828984|75890094|FG002|Overall Study|Medical Contraindication|0|||
42079728|NCT00828984|75890092|FG000|Overall Study|Noncompliant|1|||
42079729|NCT00828984|75890093|FG001|Overall Study|Noncompliant|2|||
42079730|NCT00828984|75890094|FG002|Overall Study|Noncompliant|3|||
42079731|NCT00828984|75890092|FG000|Overall Study|ConMed|1|||
42079732|NCT00828984|75890093|FG001|Overall Study|ConMed|1|||
42079733|NCT00828984|75890094|FG002|Overall Study|ConMed|1|||
42079734|NCT00828750|75890102|FG000|Overall Study|Lack of Efficacy|3|||
42079735|NCT00828750|75890102|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
42079736|NCT00667810|75890111|FG000|Overall Study|Adverse Event|13|||
42079737|NCT00667810|75890112|FG001|Overall Study|Adverse Event|14|||
42079738|NCT00667810|75890113|FG002|Overall Study|Adverse Event|19|||
42079739|NCT00667810|75890114|FG003|Overall Study|Adverse Event|1|||
42079740|NCT00667810|75890111|FG000|Overall Study|Death|1|||
42079741|NCT00667810|75890112|FG001|Overall Study|Death|1|||
42079742|NCT00667810|75890113|FG002|Overall Study|Death|3|||
42079743|NCT00667810|75890114|FG003|Overall Study|Death|0|||
42079744|NCT00667810|75890111|FG000|Overall Study|Lack of Efficacy|1|||
42079745|NCT00667810|75890112|FG001|Overall Study|Lack of Efficacy|0|||
42079746|NCT00667810|75890113|FG002|Overall Study|Lack of Efficacy|2|||
42079747|NCT00667810|75890114|FG003|Overall Study|Lack of Efficacy|0|||
42079748|NCT00667810|75890111|FG000|Overall Study|Lost to Follow-up|1|||
42079749|NCT00667810|75890112|FG001|Overall Study|Lost to Follow-up|4|||
42079750|NCT00667810|75890113|FG002|Overall Study|Lost to Follow-up|2|||
42079751|NCT00667810|75890114|FG003|Overall Study|Lost to Follow-up|0|||
42079752|NCT00667810|75890111|FG000|Overall Study|Physician Decision|1|||
42079753|NCT00667810|75890112|FG001|Overall Study|Physician Decision|1|||
42079754|NCT00667810|75890113|FG002|Overall Study|Physician Decision|2|||
42079755|NCT00667810|75890114|FG003|Overall Study|Physician Decision|0|||
42079756|NCT00667810|75890111|FG000|Overall Study|Protocol Violation|0|||
42079757|NCT00667810|75890112|FG001|Overall Study|Protocol Violation|2|||
42079758|NCT00667810|75890113|FG002|Overall Study|Protocol Violation|0|||
42079759|NCT00667810|75890114|FG003|Overall Study|Protocol Violation|0|||
42079760|NCT00667810|75890111|FG000|Overall Study|Withdrawal by Subject|14|||
42079761|NCT00667810|75890112|FG001|Overall Study|Withdrawal by Subject|20|||
42079762|NCT00667810|75890113|FG002|Overall Study|Withdrawal by Subject|29|||
42079763|NCT00667810|75890114|FG003|Overall Study|Withdrawal by Subject|1|||
42079764|NCT00667810|75890111|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
42079765|NCT00667810|75890112|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
42079766|NCT00667810|75890113|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
42079767|NCT00667810|75890114|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
42079768|NCT00667810|75890111|FG000|Overall Study|Failed to Return|0|||
42079769|NCT00667810|75890112|FG001|Overall Study|Failed to Return|0|||
42079770|NCT00667810|75890113|FG002|Overall Study|Failed to Return|2|||
42079771|NCT00667810|75890114|FG003|Overall Study|Failed to Return|0|||
42079772|NCT00667810|75890111|FG000|Overall Study|Loss of Caregiver|0|||
42079773|NCT00667810|75890112|FG001|Overall Study|Loss of Caregiver|1|||
42079774|NCT00667810|75890113|FG002|Overall Study|Loss of Caregiver|3|||
42079775|NCT00667810|75890114|FG003|Overall Study|Loss of Caregiver|0|||
42079776|NCT00667810|75890111|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
42079777|NCT00667810|75890112|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
42079778|NCT00667810|75890113|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
42079779|NCT00667810|75890114|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
42079780|NCT00667810|75890111|FG000|Overall Study|Other|6|||
42079781|NCT00667810|75890112|FG001|Overall Study|Other|6|||
42079782|NCT00667810|75890113|FG002|Overall Study|Other|5|||
42079783|NCT00667810|75890114|FG003|Overall Study|Other|0|||
42079784|NCT00819390|75890133|FG000|Overall Study|Lost to Follow-up|1|||
42079785|NCT00819390|75890134|FG001|Overall Study|Lost to Follow-up|1|||
42079786|NCT00819390|75890135|FG002|Overall Study|Lost to Follow-up|0|||
42079787|NCT00819390|75890136|FG003|Overall Study|Lost to Follow-up|0|||
42079788|NCT00819390|75890133|FG000|Overall Study|Withdrawal by Subject|2|||
42079789|NCT00819390|75890134|FG001|Overall Study|Withdrawal by Subject|0|||
42079790|NCT00819390|75890135|FG002|Overall Study|Withdrawal by Subject|0|||
42079791|NCT00819390|75890136|FG003|Overall Study|Withdrawal by Subject|0|||
42079792|NCT00819390|75890133|FG000|Overall Study|Adverse Event|0|||
42079793|NCT00819390|75890134|FG001|Overall Study|Adverse Event|0|||
42079794|NCT00819390|75890135|FG002|Overall Study|Adverse Event|1|||
42079795|NCT00819390|75890136|FG003|Overall Study|Adverse Event|0|||
42079796|NCT00876395|75890151|FG000|Overall Study|Untreated|8|||
42079797|NCT00876395|75890152|FG001|Overall Study|Untreated|1|||
42079798|NCT00876395|75890151|FG000|Overall Study|Adverse Event|63|||
42079799|NCT00876395|75890152|FG001|Overall Study|Adverse Event|11|||
42079800|NCT00876395|75890151|FG000|Overall Study|Abnormal test procedure result(s)|1|||
42079801|NCT00876395|75890152|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42079802|NCT00876395|75890151|FG000|Overall Study|Disease progression|259|||
42079803|NCT00876395|75890152|FG001|Overall Study|Disease progression|162|||
42293615|NCT01668797|76127787|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
42079804|NCT00876395|75890151|FG000|Overall Study|New cancer therapy|25|||
42079805|NCT00876395|75890152|FG001|Overall Study|New cancer therapy|7|||
42079806|NCT00876395|75890151|FG000|Overall Study|Protocol Violation|5|||
42079807|NCT00876395|75890152|FG001|Overall Study|Protocol Violation|2|||
42079808|NCT00876395|75890151|FG000|Overall Study|Withdrawal by Subject|66|||
42079809|NCT00876395|75890152|FG001|Overall Study|Withdrawal by Subject|33|||
42079810|NCT00876395|75890151|FG000|Overall Study|Lost to Follow-up|2|||
42079811|NCT00876395|75890152|FG001|Overall Study|Lost to Follow-up|0|||
42079812|NCT00876395|75890151|FG000|Overall Study|Administrative problems|39|||
42079813|NCT00876395|75890152|FG001|Overall Study|Administrative problems|23|||
42079814|NCT00876395|75890151|FG000|Overall Study|Death|12|||
42079815|NCT00876395|75890152|FG001|Overall Study|Death|0|||
42079816|NCT00594659|75890166|FG000|Overall Study|Lost to Follow-up|13|||
42079817|NCT00594659|75890167|FG001|Overall Study|Lost to Follow-up|9|||
42079818|NCT00594659|75890168|FG002|Overall Study|Lost to Follow-up|7|||
42079819|NCT00667732|75890178|FG000|Run -In (8 Weeks)|Adverse Event|4|||
42079820|NCT00667732|75890179|FG001|Run -In (8 Weeks)|Adverse Event|0|||
42079821|NCT00667732|75890180|FG002|Run -In (8 Weeks)|Adverse Event|0|||
42079822|NCT00667732|75890178|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
42079823|NCT00667732|75890179|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
42079824|NCT00667732|75890180|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
42079825|NCT00667732|75890178|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
42079826|NCT00667732|75890179|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
42079827|NCT00667732|75890180|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
42079828|NCT00671788|75890190|FG000|Overall Study|Adverse Event|8|||
42079829|NCT00671788|75890190|FG000|Overall Study|Refused further treatment|3|||
42079830|NCT00671788|75890190|FG000|Overall Study|Ineligible|1|||
42079831|NCT00671788|75890190|FG000|Overall Study|MD Decision|1|||
42079832|NCT00671788|75890190|FG000|Overall Study|Other|1|||
42079833|NCT00875615|75890194|FG000|Overall Study|Withdrawal by Subject|1|||
42079834|NCT00597701|75890200|FG000|Overall Study|Withdrawal by Subject|5|||
42079835|NCT00597701|75890201|FG001|Overall Study|Withdrawal by Subject|5|||
42079836|NCT00597701|75890200|FG000|Overall Study|Death|0|||
42079837|NCT00597701|75890201|FG001|Overall Study|Death|1|||
42079838|NCT00597701|75890200|FG000|Overall Study|Physician Decision|2|||
42079839|NCT00597701|75890201|FG001|Overall Study|Physician Decision|0|||
42079840|NCT00597701|75890200|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
42079841|NCT00597701|75890201|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
42079842|NCT00671554|75890207|FG000|Overall Study|Disease progression|3|||
42079843|NCT00667576|75890217|FG000|Overall Study|Withdrawal by Subject|1|||
42079844|NCT00667576|75890218|FG001|Overall Study|Withdrawal by Subject|0|||
42079845|NCT00667576|75890219|FG002|Overall Study|Withdrawal by Subject|1|||
42079846|NCT00667576|75890220|FG003|Overall Study|Withdrawal by Subject|1|||
42079847|NCT00667576|75890221|FG004|Overall Study|Withdrawal by Subject|1|||
42079848|NCT00667576|75890217|FG000|Overall Study|Adverse Event|1|||
42079849|NCT00667576|75890218|FG001|Overall Study|Adverse Event|1|||
42079850|NCT00667576|75890219|FG002|Overall Study|Adverse Event|0|||
42079851|NCT00667576|75890220|FG003|Overall Study|Adverse Event|0|||
42079852|NCT00667576|75890221|FG004|Overall Study|Adverse Event|0|||
42079853|NCT00667576|75890217|FG000|Overall Study|Lost to Follow-up|0|||
42079854|NCT00667576|75890218|FG001|Overall Study|Lost to Follow-up|0|||
42079855|NCT00667576|75890219|FG002|Overall Study|Lost to Follow-up|1|||
42079856|NCT00667576|75890220|FG003|Overall Study|Lost to Follow-up|0|||
42079857|NCT00667576|75890221|FG004|Overall Study|Lost to Follow-up|0|||
42079858|NCT00667576|75890217|FG000|Overall Study|Protocol Violation|0|||
42079859|NCT00667576|75890218|FG001|Overall Study|Protocol Violation|0|||
42079860|NCT00667576|75890219|FG002|Overall Study|Protocol Violation|0|||
42079861|NCT00667576|75890220|FG003|Overall Study|Protocol Violation|1|||
42079862|NCT00667576|75890221|FG004|Overall Study|Protocol Violation|0|||
42079863|NCT00667576|75890217|FG000|Overall Study|Physician Decision|0|||
42079864|NCT00667576|75890218|FG001|Overall Study|Physician Decision|0|||
42079865|NCT00667576|75890219|FG002|Overall Study|Physician Decision|0|||
42079866|NCT00667576|75890220|FG003|Overall Study|Physician Decision|1|||
42079867|NCT00667576|75890221|FG004|Overall Study|Physician Decision|0|||
42079868|NCT00667576|75890217|FG000|Overall Study|Missed Visit|0|||
42079869|NCT00667576|75890218|FG001|Overall Study|Missed Visit|0|||
42079870|NCT00667576|75890219|FG002|Overall Study|Missed Visit|0|||
42079871|NCT00667576|75890220|FG003|Overall Study|Missed Visit|1|||
42079872|NCT00667576|75890221|FG004|Overall Study|Missed Visit|0|||
42079873|NCT00666718|75890235|FG000|Overall Study|Adverse Event|0|||
42293616|NCT01668797|76127788|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
42079874|NCT00666718|75890236|FG001|Overall Study|Adverse Event|1|||
42079875|NCT00666718|75890235|FG000|Overall Study|Death|1|||
42079876|NCT00666718|75890236|FG001|Overall Study|Death|0|||
42178067|NCT00045942|75985195|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
42178068|NCT00045942|75985196|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
42293617|NCT01668797|76127789|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
42079877|NCT00666718|75890235|FG000|Overall Study|Lost to Follow-up|1|||
42079878|NCT00666718|75890236|FG001|Overall Study|Lost to Follow-up|0|||
42178069|NCT00045942|75985197|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
42079879|NCT00666718|75890235|FG000|Overall Study|Entry Criteria Not Met|2|||
42079880|NCT00666718|75890236|FG001|Overall Study|Entry Criteria Not Met|0|||
42079881|NCT00666718|75890235|FG000|Overall Study|Protocol Violation|1|||
42079882|NCT00666718|75890236|FG001|Overall Study|Protocol Violation|3|||
42079883|NCT00666718|75890235|FG000|Overall Study|Withdrawal by Subject|7|||
42079884|NCT00666718|75890236|FG001|Overall Study|Withdrawal by Subject|12|||
42079885|NCT00666718|75890235|FG000|Overall Study|Physician Decision|0|||
42079886|NCT00666718|75890236|FG001|Overall Study|Physician Decision|2|||
42079887|NCT00667420|75890242|FG000|Overall Study|Adverse Event|2|||
42079888|NCT00667420|75890242|FG000|Overall Study|Lack of Efficacy|5|||
42079889|NCT00667420|75890242|FG000|Overall Study|Physician Decision|1|||
42079890|NCT00667420|75890242|FG000|Overall Study|Withdrawal by Subject|2|||
42079891|NCT00853658|75890250|FG000|Overall Study|Death|713|||
42079892|NCT00853658|75890251|FG001|Overall Study|Death|768|||
42079893|NCT00853658|75890252|FG002|Overall Study|Death|753|||
42079894|NCT00853658|75890250|FG000|Overall Study|Lost to Follow-up|11|||
42079895|NCT00853658|75890251|FG001|Overall Study|Lost to Follow-up|6|||
42079896|NCT00853658|75890252|FG002|Overall Study|Lost to Follow-up|11|||
42079897|NCT00853658|75890250|FG000|Overall Study|H.A. Request|26|||
42079898|NCT00853658|75890251|FG001|Overall Study|H.A. Request|23|||
42079899|NCT00853658|75890252|FG002|Overall Study|H.A. Request|19|||
42079900|NCT00853658|75890250|FG000|Overall Study|IRB request|0|||
42079901|NCT00853658|75890251|FG001|Overall Study|IRB request|0|||
42079902|NCT00853658|75890252|FG002|Overall Study|IRB request|2|||
42079903|NCT00853658|75890250|FG000|Overall Study|Vital Status known (alive) at study end|2|||
42079904|NCT00853658|75890251|FG001|Overall Study|Vital Status known (alive) at study end|3|||
42079905|NCT00853658|75890252|FG002|Overall Study|Vital Status known (alive) at study end|3|||
42079906|NCT00853658|75890250|FG000|Overall Study|Vital Status unknown at study end|1|||
42079907|NCT00853658|75890251|FG001|Overall Study|Vital Status unknown at study end|1|||
42079908|NCT00853658|75890252|FG002|Overall Study|Vital Status unknown at study end|0|||
42079909|NCT00853658|75890250|FG000|Overall Study|Vital Status at study end N/A|8|||
42079910|NCT00853658|75890251|FG001|Overall Study|Vital Status at study end N/A|10|||
42079911|NCT00853658|75890252|FG002|Overall Study|Vital Status at study end N/A|10|||
42079912|NCT00853658|75890250|FG000|Overall Study|Patient's request|21|||
42079913|NCT00853658|75890251|FG001|Overall Study|Patient's request|17|||
42079914|NCT00853658|75890252|FG002|Overall Study|Patient's request|11|||
42079915|NCT00853658|75890250|FG000|Overall Study|Missing study completion information|5|||
42079916|NCT00853658|75890251|FG001|Overall Study|Missing study completion information|4|||
42079917|NCT00853658|75890252|FG002|Overall Study|Missing study completion information|6|||
42079918|NCT00666562|75890263|FG000|Overall Study|Withdrawal by Subject|0|||
42079919|NCT00666562|75890264|FG001|Overall Study|Withdrawal by Subject|1|||
42079920|NCT00666562|75890265|FG002|Overall Study|Withdrawal by Subject|0|||
42079921|NCT00666562|75890263|FG000|Overall Study|Concomitant Medication|0|||
42079922|NCT00666562|75890264|FG001|Overall Study|Concomitant Medication|1|||
42079923|NCT00666562|75890265|FG002|Overall Study|Concomitant Medication|0|||
42079924|NCT00666328|75890280|FG000|Overall Study|Death|2|||
42079925|NCT00666328|75890280|FG000|Overall Study|Lost to Follow-up|2|||
42079926|NCT00666328|75890280|FG000|Overall Study|No longer met eligibility criteria|1|||
42079927|NCT00853580|75890288|FG000|Overall Study|Lost to Follow-up|3|||
42079928|NCT00853580|75890289|FG001|Overall Study|Lost to Follow-up|5|||
42079929|NCT00853580|75890288|FG000|Overall Study|Protocol Violation|2|||
42079930|NCT00853580|75890289|FG001|Overall Study|Protocol Violation|1|||
42079931|NCT00853580|75890288|FG000|Overall Study|Withdrawal by Subject|2|||
42079932|NCT00853580|75890289|FG001|Overall Study|Withdrawal by Subject|8|||
42079933|NCT00853580|75890288|FG000|Overall Study|Commenced contraindicated therapy|0|||
42079934|NCT00853580|75890289|FG001|Overall Study|Commenced contraindicated therapy|2|||
42079935|NCT00865514|75890295|FG000|Overall Study|Infusion cost exceeded funding|2|||
42079936|NCT00865280|75890302|FG000|Overall Study|Withdrawal by Subject|4|||
42079937|NCT00865280|75890303|FG001|Overall Study|Withdrawal by Subject|1|||
42079938|NCT00865280|75890302|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
42079939|NCT00865280|75890303|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
42079940|NCT00865280|75890302|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
42079941|NCT00865280|75890303|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
42079942|NCT00865280|75890302|FG000|Overall Study|Exclusion Condition|1|||
42079943|NCT00865280|75890303|FG001|Overall Study|Exclusion Condition|0|||
42079944|NCT00865280|75890302|FG000|Overall Study|Adverse Event|0|||
42079945|NCT00865280|75890303|FG001|Overall Study|Adverse Event|1|||
42079946|NCT00865124|75890312|FG000|Overall Study|Physician Decision|2|||
42079947|NCT00865124|75890313|FG001|Overall Study|Physician Decision|1|||
42079948|NCT00865124|75890314|FG002|Overall Study|Physician Decision|0|||
42079949|NCT00865124|75890312|FG000|Overall Study|Withdrawn consent|2|||
42079950|NCT00865124|75890313|FG001|Overall Study|Withdrawn consent|0|||
42079951|NCT00865124|75890314|FG002|Overall Study|Withdrawn consent|0|||
42079952|NCT00871715|75890325|FG000|Overall Study|Withdrawal by Subject|6|||
42079953|NCT00871715|75890326|FG001|Overall Study|Withdrawal by Subject|10|||
42079954|NCT00871715|75890327|FG002|Overall Study|Withdrawal by Subject|15|||
42079955|NCT00871715|75890325|FG000|Overall Study|Physician Decision|6|||
42079956|NCT00871715|75890326|FG001|Overall Study|Physician Decision|0|||
42079957|NCT00871715|75890327|FG002|Overall Study|Physician Decision|2|||
42079958|NCT00871715|75890325|FG000|Overall Study|Lost to Follow-up|3|||
42079959|NCT00871715|75890326|FG001|Overall Study|Lost to Follow-up|6|||
42079960|NCT00871715|75890327|FG002|Overall Study|Lost to Follow-up|9|||
42079961|NCT00819234|75890336|FG000|Overall Study|Withdrawal by Subject|8|||
42079962|NCT00819234|75890337|FG001|Overall Study|Withdrawal by Subject|13|||
42079963|NCT00819234|75890338|FG002|Overall Study|Withdrawal by Subject|6|||
42079964|NCT00819234|75890339|FG003|Overall Study|Withdrawal by Subject|3|||
42079965|NCT00819234|75890340|FG004|Overall Study|Withdrawal by Subject|0|||
42079966|NCT00819234|75890341|FG005|Overall Study|Withdrawal by Subject|4|||
42079967|NCT00819234|75890342|FG006|Overall Study|Withdrawal by Subject|4|||
42079968|NCT00819234|75890343|FG007|Overall Study|Withdrawal by Subject|8|||
42079969|NCT00819234|75890344|FG008|Overall Study|Withdrawal by Subject|5|||
42079970|NCT00819234|75890345|FG009|Overall Study|Withdrawal by Subject|3|||
42079971|NCT00819234|75890336|FG000|Overall Study|Adverse Event|0|||
42079972|NCT00819234|75890337|FG001|Overall Study|Adverse Event|0|||
42079973|NCT00819234|75890338|FG002|Overall Study|Adverse Event|1|||
42079974|NCT00819234|75890339|FG003|Overall Study|Adverse Event|0|||
42079975|NCT00819234|75890340|FG004|Overall Study|Adverse Event|0|||
42079976|NCT00819234|75890341|FG005|Overall Study|Adverse Event|2|||
42079977|NCT00819234|75890342|FG006|Overall Study|Adverse Event|0|||
42079978|NCT00819234|75890343|FG007|Overall Study|Adverse Event|0|||
42079979|NCT00819234|75890344|FG008|Overall Study|Adverse Event|0|||
42079980|NCT00819234|75890345|FG009|Overall Study|Adverse Event|0|||
42079981|NCT00819234|75890336|FG000|Overall Study|Physician Decision|0|||
42079982|NCT00819234|75890337|FG001|Overall Study|Physician Decision|0|||
42079983|NCT00819234|75890338|FG002|Overall Study|Physician Decision|0|||
42079984|NCT00819234|75890339|FG003|Overall Study|Physician Decision|1|||
42079985|NCT00819234|75890340|FG004|Overall Study|Physician Decision|0|||
42079986|NCT00819234|75890341|FG005|Overall Study|Physician Decision|0|||
42079987|NCT00819234|75890342|FG006|Overall Study|Physician Decision|0|||
42079988|NCT00819234|75890343|FG007|Overall Study|Physician Decision|0|||
42079989|NCT00819234|75890344|FG008|Overall Study|Physician Decision|0|||
42079990|NCT00819234|75890345|FG009|Overall Study|Physician Decision|2|||
42079991|NCT00819234|75890336|FG000|Overall Study|Protocol Violation|0|||
42079992|NCT00819234|75890337|FG001|Overall Study|Protocol Violation|0|||
42079993|NCT00819234|75890338|FG002|Overall Study|Protocol Violation|1|||
42079994|NCT00819234|75890339|FG003|Overall Study|Protocol Violation|0|||
42079995|NCT00819234|75890340|FG004|Overall Study|Protocol Violation|0|||
42178070|NCT00045942|75985198|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
42178071|NCT00045942|75985199|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
42178072|NCT00045942|75985200|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
42178073|NCT00045942|75985201|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
42178074|NCT00045942|75985202|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
42178075|NCT00045942|75985194|FG000|PKC412A2104E1|Lack of Efficacy|0|||
42178076|NCT00045942|75985195|FG001|PKC412A2104E1|Lack of Efficacy|11|||
42178077|NCT00045942|75985196|FG002|PKC412A2104E1|Lack of Efficacy|11|||
42178078|NCT00045942|75985197|FG003|PKC412A2104E1|Lack of Efficacy|23|||
42178079|NCT00045942|75985198|FG004|PKC412A2104E1|Lack of Efficacy|17|||
42178080|NCT00045942|75985199|FG005|PKC412A2104E1|Lack of Efficacy|0|||
42178081|NCT00045942|75985200|FG006|PKC412A2104E1|Lack of Efficacy|0|||
42178082|NCT00045942|75985201|FG007|PKC412A2104E1|Lack of Efficacy|0|||
42178083|NCT00045942|75985202|FG008|PKC412A2104E1|Lack of Efficacy|0|||
42178084|NCT00045942|75985194|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
42178085|NCT00045942|75985195|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
42178086|NCT00045942|75985196|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
42178087|NCT00045942|75985197|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
42178088|NCT00045942|75985198|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
42178089|NCT00045942|75985199|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
42178090|NCT00045942|75985200|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
42178091|NCT00045942|75985201|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
42178092|NCT00045942|75985202|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
42293618|NCT01668797|76127786|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
42293619|NCT01668797|76127787|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
42293620|NCT01668797|76127788|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
42357906|NCT01829113|76203431|FG001|Overall Study|Physician Decision|1|||
42079996|NCT00819234|75890341|FG005|Overall Study|Protocol Violation|0|||
42079997|NCT00819234|75890342|FG006|Overall Study|Protocol Violation|0|||
42079998|NCT00819234|75890343|FG007|Overall Study|Protocol Violation|0|||
42079999|NCT00819234|75890344|FG008|Overall Study|Protocol Violation|0|||
42080000|NCT00819234|75890345|FG009|Overall Study|Protocol Violation|0|||
42080001|NCT00819234|75890336|FG000|Overall Study|Lost to Follow-up|2|||
42080002|NCT00819234|75890337|FG001|Overall Study|Lost to Follow-up|2|||
42080003|NCT00819234|75890338|FG002|Overall Study|Lost to Follow-up|0|||
42080004|NCT00819234|75890339|FG003|Overall Study|Lost to Follow-up|2|||
42080005|NCT00819234|75890340|FG004|Overall Study|Lost to Follow-up|1|||
42080006|NCT00819234|75890341|FG005|Overall Study|Lost to Follow-up|1|||
42080007|NCT00819234|75890342|FG006|Overall Study|Lost to Follow-up|1|||
42080008|NCT00819234|75890343|FG007|Overall Study|Lost to Follow-up|1|||
42080009|NCT00819234|75890344|FG008|Overall Study|Lost to Follow-up|1|||
42080010|NCT00819234|75890345|FG009|Overall Study|Lost to Follow-up|2|||
42080011|NCT00871403|75890403|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
42080012|NCT00871403|75890404|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
42080013|NCT00871403|75890405|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
42080014|NCT00871403|75890403|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
42080015|NCT00871403|75890404|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
42080016|NCT00871403|75890405|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
42080017|NCT00871403|75890403|FG000|Combination Treatment Phase|Adverse Event|0|||
42080018|NCT00871403|75890404|FG001|Combination Treatment Phase|Adverse Event|17|||
42080019|NCT00871403|75890405|FG002|Combination Treatment Phase|Adverse Event|2|||
42080020|NCT00871403|75890403|FG000|Combination Treatment Phase|Disease Progression|0|||
42080021|NCT00871403|75890404|FG001|Combination Treatment Phase|Disease Progression|8|||
42080022|NCT00871403|75890405|FG002|Combination Treatment Phase|Disease Progression|5|||
42080023|NCT00871403|75890403|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
42080024|NCT00871403|75890404|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
42080025|NCT00871403|75890405|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
42080026|NCT00871403|75890403|FG000|Combination Treatment Phase|Physician Decision|0|||
42080027|NCT00871403|75890404|FG001|Combination Treatment Phase|Physician Decision|1|||
42080028|NCT00871403|75890405|FG002|Combination Treatment Phase|Physician Decision|3|||
42080029|NCT00871403|75890403|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
42080030|NCT00871403|75890404|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
42080031|NCT00871403|75890405|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
42080032|NCT00871403|75890403|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
42080033|NCT00871403|75890404|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
42080034|NCT00871403|75890405|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
42080035|NCT00853112|75890419|FG000|Overall Study|Randomized but not treated|0|||
42080036|NCT00853112|75890420|FG001|Overall Study|Randomized but not treated|1|||
42080037|NCT00853112|75890421|FG002|Overall Study|Randomized but not treated|0|||
42080038|NCT00853112|75890422|FG003|Overall Study|Randomized but not treated|2|||
42080039|NCT00853112|75890423|FG004|Overall Study|Randomized but not treated|0|||
42080040|NCT00853112|75890424|FG005|Overall Study|Randomized but not treated|0|||
42080041|NCT00853112|75890425|FG006|Overall Study|Randomized but not treated|1|||
42080042|NCT00460603|75890453|FG000|Phase 1|Death|1|||
42080043|NCT00460603|75890454|FG001|Phase 1|Death|0|||
42080044|NCT00460603|75890455|FG002|Phase 1|Death|0|||
42080045|NCT00460603|75890456|FG003|Phase 1|Death|2|||
42080046|NCT00460603|75890457|FG004|Phase 1|Death|0|||
42080047|NCT00460603|75890458|FG005|Phase 1|Death|0|||
42080048|NCT00460603|75890459|FG006|Phase 1|Death|0|||
42080049|NCT00460603|75890460|FG007|Phase 1|Death|0|||
42080050|NCT00460603|75890461|FG008|Phase 1|Death|1|||
42080051|NCT00460603|75890462|FG009|Phase 1|Death|0|||
42080052|NCT00460603|75890463|FG010|Phase 1|Death|0|||
42080053|NCT00460603|75890464|FG011|Phase 1|Death|0|||
42080054|NCT00460603|75890453|FG000|Phase 1|Adverse Event|3|||
42080055|NCT00460603|75890454|FG001|Phase 1|Adverse Event|1|||
42080056|NCT00460603|75890455|FG002|Phase 1|Adverse Event|1|||
42178093|NCT00045942|75985194|FG000|PKC412A2104E1|Adverse Event|0|||
42178094|NCT00045942|75985195|FG001|PKC412A2104E1|Adverse Event|1|||
42293621|NCT01668797|76127789|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
42293622|NCT01668797|76127786|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
42293623|NCT01668797|76127787|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
42293624|NCT01668797|76127788|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
42293625|NCT01668797|76127789|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
42080057|NCT00460603|75890456|FG003|Phase 1|Adverse Event|2|||
42080058|NCT00460603|75890457|FG004|Phase 1|Adverse Event|0|||
42080059|NCT00460603|75890458|FG005|Phase 1|Adverse Event|0|||
42080060|NCT00460603|75890459|FG006|Phase 1|Adverse Event|3|||
42080061|NCT00460603|75890460|FG007|Phase 1|Adverse Event|0|||
42080062|NCT00460603|75890461|FG008|Phase 1|Adverse Event|4|||
42080063|NCT00460603|75890462|FG009|Phase 1|Adverse Event|0|||
42080064|NCT00460603|75890463|FG010|Phase 1|Adverse Event|0|||
42080065|NCT00460603|75890464|FG011|Phase 1|Adverse Event|0|||
42080066|NCT00460603|75890453|FG000|Phase 1|Lack of Efficacy|1|||
42080067|NCT00460603|75890454|FG001|Phase 1|Lack of Efficacy|0|||
42080068|NCT00460603|75890455|FG002|Phase 1|Lack of Efficacy|1|||
42080069|NCT00460603|75890456|FG003|Phase 1|Lack of Efficacy|2|||
42080070|NCT00460603|75890457|FG004|Phase 1|Lack of Efficacy|2|||
42080071|NCT00460603|75890458|FG005|Phase 1|Lack of Efficacy|2|||
42080072|NCT00460603|75890459|FG006|Phase 1|Lack of Efficacy|2|||
42080073|NCT00460603|75890460|FG007|Phase 1|Lack of Efficacy|2|||
42080074|NCT00460603|75890461|FG008|Phase 1|Lack of Efficacy|11|||
42080075|NCT00460603|75890462|FG009|Phase 1|Lack of Efficacy|0|||
42080076|NCT00460603|75890463|FG010|Phase 1|Lack of Efficacy|0|||
42178095|NCT00045942|75985196|FG002|PKC412A2104E1|Adverse Event|1|||
42080077|NCT00460603|75890464|FG011|Phase 1|Lack of Efficacy|0|||
42080078|NCT00460603|75890453|FG000|Phase 1|Withdrawal by Subject|1|||
42080079|NCT00460603|75890454|FG001|Phase 1|Withdrawal by Subject|2|||
42080080|NCT00460603|75890455|FG002|Phase 1|Withdrawal by Subject|1|||
42080081|NCT00460603|75890456|FG003|Phase 1|Withdrawal by Subject|1|||
42017571|NCT01286987|75825320|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
42017572|NCT01286987|75825321|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
42017573|NCT01286987|75825322|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
42017574|NCT01286987|75825323|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
42080082|NCT00460603|75890457|FG004|Phase 1|Withdrawal by Subject|3|||
42080083|NCT00460603|75890458|FG005|Phase 1|Withdrawal by Subject|0|||
42080084|NCT00460603|75890459|FG006|Phase 1|Withdrawal by Subject|1|||
42080085|NCT00460603|75890460|FG007|Phase 1|Withdrawal by Subject|0|||
42080086|NCT00460603|75890461|FG008|Phase 1|Withdrawal by Subject|2|||
42080087|NCT00460603|75890462|FG009|Phase 1|Withdrawal by Subject|0|||
42080088|NCT00460603|75890463|FG010|Phase 1|Withdrawal by Subject|0|||
42080089|NCT00460603|75890464|FG011|Phase 1|Withdrawal by Subject|0|||
42080090|NCT00460603|75890453|FG000|Phase 1|Other|0|||
42080091|NCT00460603|75890454|FG001|Phase 1|Other|3|||
42080092|NCT00460603|75890455|FG002|Phase 1|Other|1|||
42080093|NCT00460603|75890456|FG003|Phase 1|Other|1|||
42080094|NCT00460603|75890457|FG004|Phase 1|Other|1|||
42080095|NCT00460603|75890458|FG005|Phase 1|Other|2|||
42080096|NCT00460603|75890459|FG006|Phase 1|Other|0|||
42080097|NCT00460603|75890460|FG007|Phase 1|Other|1|||
42080098|NCT00460603|75890461|FG008|Phase 1|Other|0|||
42080099|NCT00460603|75890462|FG009|Phase 1|Other|0|||
42080100|NCT00460603|75890463|FG010|Phase 1|Other|0|||
42080101|NCT00460603|75890464|FG011|Phase 1|Other|0|||
42080102|NCT00460603|75890453|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
42080103|NCT00460603|75890454|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
42080104|NCT00460603|75890455|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
42080105|NCT00460603|75890456|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
42080106|NCT00460603|75890457|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
42080107|NCT00460603|75890458|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
42080108|NCT00460603|75890459|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
42080109|NCT00460603|75890460|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
42080110|NCT00460603|75890461|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
42080111|NCT00460603|75890462|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
42080112|NCT00460603|75890463|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
42080113|NCT00460603|75890464|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
42080114|NCT00460603|75890453|FG000|Phase 2|Adverse Event|0|||
42080115|NCT00460603|75890454|FG001|Phase 2|Adverse Event|0|||
42080116|NCT00460603|75890455|FG002|Phase 2|Adverse Event|0|||
42080117|NCT00460603|75890456|FG003|Phase 2|Adverse Event|0|||
42080118|NCT00460603|75890457|FG004|Phase 2|Adverse Event|0|||
42080119|NCT00460603|75890458|FG005|Phase 2|Adverse Event|0|||
42080120|NCT00460603|75890459|FG006|Phase 2|Adverse Event|0|||
42080121|NCT00460603|75890460|FG007|Phase 2|Adverse Event|0|||
42080122|NCT00460603|75890461|FG008|Phase 2|Adverse Event|0|||
42080123|NCT00460603|75890462|FG009|Phase 2|Adverse Event|12|||
42080124|NCT00460603|75890463|FG010|Phase 2|Adverse Event|9|||
42080125|NCT00460603|75890464|FG011|Phase 2|Adverse Event|10|||
42080126|NCT00460603|75890453|FG000|Phase 2|Death|0|||
42080127|NCT00460603|75890454|FG001|Phase 2|Death|0|||
42080128|NCT00460603|75890455|FG002|Phase 2|Death|0|||
42080129|NCT00460603|75890456|FG003|Phase 2|Death|0|||
42080130|NCT00460603|75890457|FG004|Phase 2|Death|0|||
42080131|NCT00460603|75890458|FG005|Phase 2|Death|0|||
42080132|NCT00460603|75890459|FG006|Phase 2|Death|0|||
42080133|NCT00460603|75890460|FG007|Phase 2|Death|0|||
42178096|NCT00045942|75985197|FG003|PKC412A2104E1|Adverse Event|3|||
42178097|NCT00045942|75985198|FG004|PKC412A2104E1|Adverse Event|6|||
42178098|NCT00045942|75985199|FG005|PKC412A2104E1|Adverse Event|0|||
42178099|NCT00045942|75985200|FG006|PKC412A2104E1|Adverse Event|0|||
42178100|NCT00045942|75985201|FG007|PKC412A2104E1|Adverse Event|0|||
42178101|NCT00045942|75985202|FG008|PKC412A2104E1|Adverse Event|0|||
42017575|NCT01286987|75825324|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
42017576|NCT01286987|75825325|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
42017577|NCT01286987|75825326|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
42017578|NCT01286987|75825327|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
42080134|NCT00460603|75890461|FG008|Phase 2|Death|0|||
42080135|NCT00460603|75890462|FG009|Phase 2|Death|4|||
42080136|NCT00460603|75890463|FG010|Phase 2|Death|2|||
42080137|NCT00460603|75890464|FG011|Phase 2|Death|2|||
42080138|NCT00460603|75890453|FG000|Phase 2|Protocol Violation|0|||
42080139|NCT00460603|75890454|FG001|Phase 2|Protocol Violation|0|||
42080140|NCT00460603|75890455|FG002|Phase 2|Protocol Violation|0|||
42080141|NCT00460603|75890456|FG003|Phase 2|Protocol Violation|0|||
42080142|NCT00460603|75890457|FG004|Phase 2|Protocol Violation|0|||
42080143|NCT00460603|75890458|FG005|Phase 2|Protocol Violation|0|||
42080144|NCT00460603|75890459|FG006|Phase 2|Protocol Violation|0|||
42080145|NCT00460603|75890460|FG007|Phase 2|Protocol Violation|0|||
42080146|NCT00460603|75890461|FG008|Phase 2|Protocol Violation|0|||
42080147|NCT00460603|75890462|FG009|Phase 2|Protocol Violation|1|||
42080148|NCT00460603|75890463|FG010|Phase 2|Protocol Violation|1|||
42080149|NCT00460603|75890464|FG011|Phase 2|Protocol Violation|0|||
42080150|NCT00460603|75890453|FG000|Phase 2|Lost to Follow-up|0|||
42080151|NCT00460603|75890454|FG001|Phase 2|Lost to Follow-up|0|||
42080152|NCT00460603|75890455|FG002|Phase 2|Lost to Follow-up|0|||
42080153|NCT00460603|75890456|FG003|Phase 2|Lost to Follow-up|0|||
42080154|NCT00460603|75890457|FG004|Phase 2|Lost to Follow-up|0|||
42080155|NCT00460603|75890458|FG005|Phase 2|Lost to Follow-up|0|||
42080156|NCT00460603|75890459|FG006|Phase 2|Lost to Follow-up|0|||
42080157|NCT00460603|75890460|FG007|Phase 2|Lost to Follow-up|0|||
42080158|NCT00460603|75890461|FG008|Phase 2|Lost to Follow-up|0|||
42080159|NCT00460603|75890462|FG009|Phase 2|Lost to Follow-up|1|||
42080160|NCT00460603|75890463|FG010|Phase 2|Lost to Follow-up|0|||
42080161|NCT00460603|75890464|FG011|Phase 2|Lost to Follow-up|0|||
42080162|NCT00460603|75890453|FG000|Phase 2|Other|0|||
42080163|NCT00460603|75890454|FG001|Phase 2|Other|0|||
42080164|NCT00460603|75890455|FG002|Phase 2|Other|0|||
42080165|NCT00460603|75890456|FG003|Phase 2|Other|0|||
42080166|NCT00460603|75890457|FG004|Phase 2|Other|0|||
42080167|NCT00460603|75890458|FG005|Phase 2|Other|0|||
42080168|NCT00460603|75890459|FG006|Phase 2|Other|0|||
42080169|NCT00460603|75890460|FG007|Phase 2|Other|0|||
42080170|NCT00460603|75890461|FG008|Phase 2|Other|0|||
42080171|NCT00460603|75890462|FG009|Phase 2|Other|6|||
42080172|NCT00460603|75890463|FG010|Phase 2|Other|16|||
42080173|NCT00460603|75890464|FG011|Phase 2|Other|7|||
42080174|NCT00460603|75890453|FG000|Phase 2|Objective Progression or Relapse|0|||
42080175|NCT00460603|75890454|FG001|Phase 2|Objective Progression or Relapse|0|||
42080176|NCT00460603|75890455|FG002|Phase 2|Objective Progression or Relapse|0|||
42080177|NCT00460603|75890456|FG003|Phase 2|Objective Progression or Relapse|0|||
42080178|NCT00460603|75890457|FG004|Phase 2|Objective Progression or Relapse|0|||
42080179|NCT00460603|75890458|FG005|Phase 2|Objective Progression or Relapse|0|||
42080180|NCT00460603|75890459|FG006|Phase 2|Objective Progression or Relapse|0|||
42080181|NCT00460603|75890460|FG007|Phase 2|Objective Progression or Relapse|0|||
42080182|NCT00460603|75890461|FG008|Phase 2|Objective Progression or Relapse|0|||
42080183|NCT00460603|75890462|FG009|Phase 2|Objective Progression or Relapse|9|||
42080184|NCT00460603|75890463|FG010|Phase 2|Objective Progression or Relapse|10|||
42080185|NCT00460603|75890464|FG011|Phase 2|Objective Progression or Relapse|17|||
42080186|NCT00460603|75890453|FG000|Phase 2|Global Deterioration of Health Status|0|||
42080187|NCT00460603|75890454|FG001|Phase 2|Global Deterioration of Health Status|0|||
42080188|NCT00460603|75890455|FG002|Phase 2|Global Deterioration of Health Status|0|||
42080189|NCT00460603|75890456|FG003|Phase 2|Global Deterioration of Health Status|0|||
42080190|NCT00460603|75890457|FG004|Phase 2|Global Deterioration of Health Status|0|||
42080191|NCT00460603|75890458|FG005|Phase 2|Global Deterioration of Health Status|0|||
42080192|NCT00460603|75890459|FG006|Phase 2|Global Deterioration of Health Status|0|||
42080193|NCT00460603|75890460|FG007|Phase 2|Global Deterioration of Health Status|0|||
42080194|NCT00460603|75890461|FG008|Phase 2|Global Deterioration of Health Status|0|||
42080195|NCT00460603|75890462|FG009|Phase 2|Global Deterioration of Health Status|0|||
42080196|NCT00460603|75890463|FG010|Phase 2|Global Deterioration of Health Status|1|||
42080197|NCT00460603|75890464|FG011|Phase 2|Global Deterioration of Health Status|0|||
42080198|NCT00460603|75890453|FG000|Phase 2|Withdrawal by Subject|0|||
42080199|NCT00460603|75890454|FG001|Phase 2|Withdrawal by Subject|0|||
42080200|NCT00460603|75890455|FG002|Phase 2|Withdrawal by Subject|0|||
42080201|NCT00460603|75890456|FG003|Phase 2|Withdrawal by Subject|0|||
42080202|NCT00460603|75890457|FG004|Phase 2|Withdrawal by Subject|0|||
42080203|NCT00460603|75890458|FG005|Phase 2|Withdrawal by Subject|0|||
42080204|NCT00460603|75890459|FG006|Phase 2|Withdrawal by Subject|0|||
42080205|NCT00460603|75890460|FG007|Phase 2|Withdrawal by Subject|0|||
42293626|NCT01668797|76127786|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
42293627|NCT01668797|76127787|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
42293628|NCT01668797|76127788|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
42080206|NCT00460603|75890461|FG008|Phase 2|Withdrawal by Subject|0|||
42080207|NCT00460603|75890462|FG009|Phase 2|Withdrawal by Subject|5|||
42080208|NCT00460603|75890463|FG010|Phase 2|Withdrawal by Subject|4|||
42080209|NCT00460603|75890464|FG011|Phase 2|Withdrawal by Subject|5|||
42080210|NCT00460603|75890453|FG000|Phase 2|Randomized, but not treated|0|||
42080211|NCT00460603|75890454|FG001|Phase 2|Randomized, but not treated|0|||
42080212|NCT00460603|75890455|FG002|Phase 2|Randomized, but not treated|0|||
42080213|NCT00460603|75890456|FG003|Phase 2|Randomized, but not treated|0|||
42080214|NCT00460603|75890457|FG004|Phase 2|Randomized, but not treated|0|||
42080215|NCT00460603|75890458|FG005|Phase 2|Randomized, but not treated|0|||
42080216|NCT00460603|75890459|FG006|Phase 2|Randomized, but not treated|0|||
42080217|NCT00460603|75890460|FG007|Phase 2|Randomized, but not treated|0|||
42080218|NCT00460603|75890461|FG008|Phase 2|Randomized, but not treated|0|||
42080219|NCT00460603|75890462|FG009|Phase 2|Randomized, but not treated|3|||
42080220|NCT00460603|75890463|FG010|Phase 2|Randomized, but not treated|0|||
42080221|NCT00460603|75890464|FG011|Phase 2|Randomized, but not treated|0|||
42080222|NCT00662038|75890490|FG000|Overall Study|Reason not specified|3|||
42080223|NCT00662038|75890490|FG000|Overall Study|Withdrawn consent|22|||
42080224|NCT00662038|75890490|FG000|Overall Study|Withdrawal by Subject|83|||
42080225|NCT00662038|75890490|FG000|Overall Study|Sponsor decision|1|||
42080226|NCT00662038|75890490|FG000|Overall Study|Physician Decision|19|||
42080227|NCT00662038|75890490|FG000|Overall Study|Lung transplantation|44|||
42080228|NCT00662038|75890490|FG000|Overall Study|Lost to Follow-up|1|||
42080229|NCT00662038|75890490|FG000|Overall Study|Death|95|||
42080230|NCT00662038|75890490|FG000|Overall Study|Adverse Event|358|||
42080231|NCT00662038|75890490|FG000|Overall Study|Continued treatment|5|||
42080232|NCT00459979|75890494|FG000|Overall Study|Withdrawal by Subject|1|||
42080233|NCT00459979|75890494|FG000|Overall Study|Protocol Violation|1|||
42080234|NCT00851786|75890500|FG000|Overall Study|Withdrawal by Subject|0|||
42080235|NCT00851786|75890501|FG001|Overall Study|Withdrawal by Subject|1|||
42080236|NCT00851786|75890500|FG000|Overall Study|Protocol Violation|0|||
42080237|NCT00851786|75890501|FG001|Overall Study|Protocol Violation|1|||
42080238|NCT00851786|75890500|FG000|Overall Study|Lost to Follow-up|1|||
42080239|NCT00851786|75890501|FG001|Overall Study|Lost to Follow-up|0|||
42080240|NCT00851786|75890500|FG000|Overall Study|Incarceration|1|||
42080241|NCT00851786|75890501|FG001|Overall Study|Incarceration|0|||
42080242|NCT00851786|75890500|FG000|Overall Study|Site Closure|1|||
42080243|NCT00851786|75890501|FG001|Overall Study|Site Closure|0|||
42080244|NCT00851786|75890500|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
42080245|NCT00851786|75890501|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
42080246|NCT00665626|75890509|FG000|Overall Study|Lack of Efficacy|8|||
42080247|NCT00665626|75890510|FG001|Overall Study|Lack of Efficacy|5|||
42080248|NCT00665626|75890509|FG000|Overall Study|Lost to Follow-up|0|||
42080249|NCT00665626|75890510|FG001|Overall Study|Lost to Follow-up|2|||
42080250|NCT00665626|75890509|FG000|Overall Study|Withdrawal by Subject|0|||
42080251|NCT00665626|75890510|FG001|Overall Study|Withdrawal by Subject|1|||
42080252|NCT00665626|75890509|FG000|Overall Study|Protocol Violation|0|||
42080253|NCT00665626|75890510|FG001|Overall Study|Protocol Violation|2|||
42080254|NCT00665626|75890509|FG000|Overall Study|Adverse Event|1|||
42080255|NCT00665626|75890510|FG001|Overall Study|Adverse Event|9|||
42080256|NCT00665626|75890509|FG000|Overall Study|Due to exclusion criteria|0|||
42080257|NCT00665626|75890510|FG001|Overall Study|Due to exclusion criteria|1|||
42080258|NCT00665626|75890509|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
42080259|NCT00665626|75890510|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
42080260|NCT00665626|75890509|FG000|Overall Study|Unably to comply with dosing regimen|0|||
42080261|NCT00665626|75890510|FG001|Overall Study|Unably to comply with dosing regimen|1|||
42080262|NCT00665626|75890509|FG000|Overall Study|Death|1|||
42080263|NCT00665626|75890510|FG001|Overall Study|Death|0|||
42080264|NCT00828672|75890518|FG000|Study Treatment|Lost to Follow-up|1|||
42080265|NCT00828672|75890519|FG001|Study Treatment|Lost to Follow-up|0|||
42080266|NCT00828672|75890518|FG000|Study Treatment|Adverse Event|0|||
42080267|NCT00828672|75890519|FG001|Study Treatment|Adverse Event|1|||
42080268|NCT00828672|75890518|FG000|Study Treatment|Complete response, no surgery|1|||
42080269|NCT00828672|75890519|FG001|Study Treatment|Complete response, no surgery|1|||
42080270|NCT00828672|75890518|FG000|Post-surgery (<30 Days)|No central review materials|0|||
42080271|NCT00828672|75890519|FG001|Post-surgery (<30 Days)|No central review materials|1|||
42080272|NCT00873119|75890527|FG000|Overall Study|Patient request|4|||
42080273|NCT00873119|75890528|FG001|Overall Study|Patient request|2|||
42080274|NCT00873119|75890527|FG000|Overall Study|Adverse Event|8|||
42080275|NCT00873119|75890528|FG001|Overall Study|Adverse Event|0|||
42080276|NCT00873119|75890527|FG000|Overall Study|Progressive disease|26|||
42080277|NCT00873119|75890528|FG001|Overall Study|Progressive disease|18|||
42080278|NCT00873119|75890527|FG000|Overall Study|Death|2|||
42080279|NCT00873119|75890528|FG001|Overall Study|Death|1|||
42357907|NCT01857271|76203439|FG000|Overall Study|Lost to Follow-up|1|||
42080280|NCT00873119|75890527|FG000|Overall Study|Other|2|||
42080281|NCT00873119|75890528|FG001|Overall Study|Other|5|||
42080282|NCT00873119|75890527|FG000|Overall Study|Not treated|2|||
42080283|NCT00873119|75890528|FG001|Overall Study|Not treated|0|||
42080284|NCT00661726|75890534|FG000|Overall Study|Adverse Event|1|||
42080285|NCT00865046|75890541|FG000|Overall Study|Lost to Follow-up|1|||
42080286|NCT00865046|75890542|FG001|Overall Study|Lost to Follow-up|4|||
42080287|NCT00865046|75890543|FG002|Overall Study|Lost to Follow-up|0|||
42080288|NCT00865046|75890541|FG000|Overall Study|Death|0|||
42080289|NCT00865046|75890542|FG001|Overall Study|Death|1|||
42080290|NCT00865046|75890543|FG002|Overall Study|Death|1|||
42080291|NCT00865046|75890541|FG000|Overall Study|Withdrawal by Subject|5|||
42080292|NCT00865046|75890542|FG001|Overall Study|Withdrawal by Subject|0|||
42080293|NCT00865046|75890543|FG002|Overall Study|Withdrawal by Subject|0|||
42080294|NCT00828516|75890551|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
42080295|NCT00665392|75890555|FG000|Overall Study|not treated|1|||
42080296|NCT00851630|75890562|FG000|Overall Study|Death|2|||
42080297|NCT00851630|75890563|FG001|Overall Study|Death|1|||
42080298|NCT00851630|75890562|FG000|Overall Study|Clinical failure|0|||
42080299|NCT00851630|75890563|FG001|Overall Study|Clinical failure|1|||
42080300|NCT00459667|75890572|FG000|Overall Study|Adverse Event|9|||
42080301|NCT00459667|75890573|FG001|Overall Study|Adverse Event|12|||
42080302|NCT00459667|75890574|FG002|Overall Study|Adverse Event|8|||
42080303|NCT00459667|75890572|FG000|Overall Study|Lost to Follow-up|5|||
42080304|NCT00459667|75890573|FG001|Overall Study|Lost to Follow-up|9|||
42080305|NCT00459667|75890574|FG002|Overall Study|Lost to Follow-up|3|||
42080306|NCT00459667|75890572|FG000|Overall Study|Pregnancy|1|||
42080307|NCT00459667|75890573|FG001|Overall Study|Pregnancy|1|||
42080308|NCT00459667|75890574|FG002|Overall Study|Pregnancy|1|||
42080309|NCT00459667|75890572|FG000|Overall Study|Protocol Violation|1|||
42080310|NCT00459667|75890573|FG001|Overall Study|Protocol Violation|0|||
42080311|NCT00459667|75890574|FG002|Overall Study|Protocol Violation|0|||
42080312|NCT00459667|75890572|FG000|Overall Study|Withdrawal by Subject|3|||
42080313|NCT00459667|75890573|FG001|Overall Study|Withdrawal by Subject|5|||
42080314|NCT00459667|75890574|FG002|Overall Study|Withdrawal by Subject|5|||
42080315|NCT00459667|75890572|FG000|Overall Study|Other disease modifying treatment|1|||
42080316|NCT00459667|75890573|FG001|Overall Study|Other disease modifying treatment|2|||
42080317|NCT00459667|75890574|FG002|Overall Study|Other disease modifying treatment|1|||
42080318|NCT00459667|75890572|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
42080319|NCT00459667|75890573|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
42080320|NCT00459667|75890574|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
42080321|NCT00459667|75890572|FG000|Overall Study|No treatment administered|6|||
42080322|NCT00459667|75890573|FG001|Overall Study|No treatment administered|3|||
42080323|NCT00459667|75890574|FG002|Overall Study|No treatment administered|1|||
42080324|NCT00828204|75890584|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
42080325|NCT00828204|75890585|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
42080326|NCT00828204|75890584|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
42080327|NCT00828204|75890585|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
42080328|NCT00828204|75890584|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
42080329|NCT00828204|75890585|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
42080330|NCT00828204|75890584|FG000|Main Study: After Study Restart|Adverse Event|0|||
42080331|NCT00828204|75890585|FG001|Main Study: After Study Restart|Adverse Event|2|||
42080332|NCT00828204|75890584|FG000|Main Study: After Study Restart|Noncompliance|0|||
42080333|NCT00828204|75890585|FG001|Main Study: After Study Restart|Noncompliance|1|||
42080334|NCT00828204|75890584|FG000|Extension Study|Lost to Follow-up|0|||
42080335|NCT00828204|75890585|FG001|Extension Study|Lost to Follow-up|1|||
42080336|NCT00828204|75890584|FG000|Extension Study|Physician Decision|0|||
42080337|NCT00828204|75890585|FG001|Extension Study|Physician Decision|2|||
42080338|NCT00851552|75890592|FG000|Overall Study|Death|2|||
42080339|NCT00851552|75890592|FG000|Overall Study|Adverse Event|1|||
42080340|NCT00851552|75890592|FG000|Overall Study|Disease Progression|4|||
42080341|NCT00459355|75890598|FG000|Overall Study|Subject no longer met inc criteria|20|||
42080342|NCT00459355|75890599|FG001|Overall Study|Subject no longer met inc criteria|18|||
42080343|NCT00459043|75890611|FG000|Overall Study|Withdrawal by Subject|1|||
42080344|NCT00459043|75890612|FG001|Overall Study|Withdrawal by Subject|0|||
42080345|NCT00817206|75890620|FG000|Overall Study|Adverse Event|10|||
42080346|NCT00817206|75890621|FG001|Overall Study|Adverse Event|3|||
42080347|NCT00817206|75890620|FG000|Overall Study|Protocol Violation|0|||
42080348|NCT00817206|75890621|FG001|Overall Study|Protocol Violation|2|||
42080349|NCT00817206|75890620|FG000|Overall Study|Lost to Follow-up|0|||
42080350|NCT00817206|75890621|FG001|Overall Study|Lost to Follow-up|1|||
42080351|NCT00817206|75890620|FG000|Overall Study|Death|2|||
42080352|NCT00817206|75890621|FG001|Overall Study|Death|0|||
42080353|NCT00817206|75890620|FG000|Overall Study|Withdrawal by Subject|7|||
42080354|NCT00817206|75890621|FG001|Overall Study|Withdrawal by Subject|3|||
42080355|NCT00817206|75890620|FG000|Overall Study|Physician Decision|2|||
42080356|NCT00817206|75890621|FG001|Overall Study|Physician Decision|0|||
42080357|NCT00665002|75890627|FG000|Overall Study|Progression/relapse during treatment|11|||
42080358|NCT00665002|75890627|FG000|Overall Study|Cytogenetic resistance|1|||
42080359|NCT03847987|75890633|FG000|Overall Study|Lost to Follow-up|1|||
42080360|NCT03847987|75890634|FG001|Overall Study|Lost to Follow-up|0|||
42080361|NCT03847987|75890633|FG000|Overall Study|Adverse Event|2|||
42080362|NCT03847987|75890634|FG001|Overall Study|Adverse Event|0|||
42080363|NCT00660010|75890651|FG000|Overall Study|Withdrawal by Subject|2|||
42080364|NCT00660010|75890651|FG000|Overall Study|Lost to Follow-up|3|||
42080365|NCT00660010|75890651|FG000|Overall Study|Adverse Event|1|||
42080366|NCT00660010|75890651|FG000|Overall Study|Noncompliance with visit schedule|3|||
42080367|NCT00873041|75890658|FG000|Core Study|Adverse Event|2|||
42080368|NCT00873041|75890659|FG001|Core Study|Adverse Event|3|||
42080369|NCT00873041|75890660|FG002|Core Study|Adverse Event|1|||
42080370|NCT00873041|75890658|FG000|Core Study|Withdrawal by Subject|1|||
42080371|NCT00873041|75890659|FG001|Core Study|Withdrawal by Subject|2|||
42080372|NCT00873041|75890660|FG002|Core Study|Withdrawal by Subject|2|||
42080373|NCT00873041|75890658|FG000|Core Study|Lost to Follow-up|3|||
42080374|NCT00873041|75890659|FG001|Core Study|Lost to Follow-up|1|||
42080375|NCT00873041|75890660|FG002|Core Study|Lost to Follow-up|0|||
42080376|NCT00873041|75890658|FG000|Core Study|Abnormal laboratory value|0|||
42080377|NCT00873041|75890659|FG001|Core Study|Abnormal laboratory value|0|||
42080378|NCT00873041|75890660|FG002|Core Study|Abnormal laboratory value|1|||
42080379|NCT00873041|75890658|FG000|Core Study|Protocol deviation|1|||
42080380|NCT00873041|75890659|FG001|Core Study|Protocol deviation|0|||
42178102|NCT00045942|75985194|FG000|PKC412A2104E1|Death|0|||
42178103|NCT00045942|75985195|FG001|PKC412A2104E1|Death|4|||
42178104|NCT00045942|75985196|FG002|PKC412A2104E1|Death|1|||
42178105|NCT00045942|75985197|FG003|PKC412A2104E1|Death|1|||
42178106|NCT00045942|75985198|FG004|PKC412A2104E1|Death|1|||
42178107|NCT00045942|75985199|FG005|PKC412A2104E1|Death|0|||
42178108|NCT00045942|75985200|FG006|PKC412A2104E1|Death|0|||
42178109|NCT00045942|75985201|FG007|PKC412A2104E1|Death|0|||
42178110|NCT00045942|75985202|FG008|PKC412A2104E1|Death|0|||
42178111|NCT00045942|75985194|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
42178112|NCT00045942|75985195|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
42178113|NCT00045942|75985196|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
42178114|NCT00045942|75985197|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
42178115|NCT00045942|75985198|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
42178116|NCT00045942|75985199|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
42178117|NCT00045942|75985200|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
42178118|NCT00045942|75985201|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
42178119|NCT00045942|75985202|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
42178120|NCT00045942|75985194|FG000|PKC412A2104E2|Lost to Follow-up|0|||
42178121|NCT00045942|75985195|FG001|PKC412A2104E2|Lost to Follow-up|0|||
42178122|NCT00045942|75985196|FG002|PKC412A2104E2|Lost to Follow-up|0|||
42178123|NCT00045942|75985197|FG003|PKC412A2104E2|Lost to Follow-up|0|||
42178124|NCT00045942|75985198|FG004|PKC412A2104E2|Lost to Follow-up|0|||
42178125|NCT00045942|75985199|FG005|PKC412A2104E2|Lost to Follow-up|0|||
42178126|NCT00045942|75985200|FG006|PKC412A2104E2|Lost to Follow-up|0|||
42178127|NCT00045942|75985201|FG007|PKC412A2104E2|Lost to Follow-up|3|||
42178128|NCT00045942|75985202|FG008|PKC412A2104E2|Lost to Follow-up|0|||
42178129|NCT00045942|75985194|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
42178130|NCT00045942|75985195|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
42178131|NCT00045942|75985196|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
42178132|NCT00045942|75985197|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
42178133|NCT00045942|75985198|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
42178134|NCT00045942|75985199|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
42080381|NCT00873041|75890660|FG002|Core Study|Protocol deviation|1|||
42080382|NCT00873041|75890658|FG000|Extension Study|Adverse Event|1|||
42178135|NCT00045942|75985200|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
42178136|NCT00045942|75985201|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
42178137|NCT00045942|75985202|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
42178138|NCT00045942|75985194|FG000|PKC412A2104E2|Lack of Efficacy|0|||
42178139|NCT00045942|75985195|FG001|PKC412A2104E2|Lack of Efficacy|0|||
42178140|NCT00045942|75985196|FG002|PKC412A2104E2|Lack of Efficacy|0|||
42080383|NCT00873041|75890659|FG001|Extension Study|Adverse Event|0|||
42080384|NCT00873041|75890660|FG002|Extension Study|Adverse Event|1|||
42080385|NCT00873041|75890658|FG000|Extension Study|Administrative reasons|0|||
42080386|NCT00873041|75890659|FG001|Extension Study|Administrative reasons|0|||
42080387|NCT00873041|75890660|FG002|Extension Study|Administrative reasons|1|||
42080388|NCT00458341|75890677|FG000|Cycle 1|Adverse Event|1|||
42080389|NCT00458341|75890678|FG001|Cycle 1|Adverse Event|0|||
42178141|NCT00045942|75985197|FG003|PKC412A2104E2|Lack of Efficacy|0|||
42080390|NCT00816036|75890686|FG000|Overall Study|Death|47|||
42080391|NCT00816036|75890687|FG001|Overall Study|Death|28|||
42080392|NCT00816036|75890686|FG000|Overall Study|Lost to Follow-up|75|||
42080393|NCT00816036|75890687|FG001|Overall Study|Lost to Follow-up|57|||
42080394|NCT00816036|75890686|FG000|Overall Study|Withdrawal by Subject|54|||
42080395|NCT00816036|75890687|FG001|Overall Study|Withdrawal by Subject|23|||
42080396|NCT00664534|75890695|FG000|Overall Study|Adverse Event|2|||
42080397|NCT00664534|75890696|FG001|Overall Study|Adverse Event|3|||
42080398|NCT00664534|75890695|FG000|Overall Study|Lost to Follow-up|6|||
42080399|NCT00664534|75890696|FG001|Overall Study|Lost to Follow-up|10|||
42080400|NCT00664534|75890695|FG000|Overall Study|Protocol Violation|10|||
42080401|NCT00664534|75890696|FG001|Overall Study|Protocol Violation|8|||
42080402|NCT00664534|75890695|FG000|Overall Study|Withdrawal by Subject|7|||
42080403|NCT00664534|75890696|FG001|Overall Study|Withdrawal by Subject|6|||
42080404|NCT00664534|75890695|FG000|Overall Study|Physician Decision|8|||
42080405|NCT00664534|75890696|FG001|Overall Study|Physician Decision|0|||
42080406|NCT00664534|75890695|FG000|Overall Study|Sponsor decision|8|||
42080407|NCT00664534|75890696|FG001|Overall Study|Sponsor decision|6|||
42080408|NCT00594035|75890704|FG000|Overall Study|Lost to Follow-up|1|||
42080409|NCT00594035|75890705|FG001|Overall Study|Lost to Follow-up|1|||
42080410|NCT00594035|75890704|FG000|Overall Study|Withdrawal by Subject|1|||
42080411|NCT00594035|75890705|FG001|Overall Study|Withdrawal by Subject|0|||
42080412|NCT00594035|75890704|FG000|Overall Study|Subject transferred to nursing home|0|||
42080413|NCT00594035|75890705|FG001|Overall Study|Subject transferred to nursing home|1|||
42080414|NCT00594035|75890704|FG000|Overall Study|Subject couldn't return due to job|0|||
42080415|NCT00594035|75890705|FG001|Overall Study|Subject couldn't return due to job|1|||
42080416|NCT00570310|75890713|FG000|Overall Study|Adverse Event|1|||
42080417|NCT00570310|75890714|FG001|Overall Study|Adverse Event|2|||
42080418|NCT00570310|75890713|FG000|Overall Study|Lack of Efficacy|1|||
42080419|NCT00570310|75890714|FG001|Overall Study|Lack of Efficacy|4|||
42293629|NCT01668797|76127789|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
42293630|NCT01668797|76127786|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
42293631|NCT01668797|76127787|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
42293632|NCT01668797|76127788|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
42293633|NCT01668797|76127789|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
42017579|NCT01286987|75825328|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
42017580|NCT01286987|75825329|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
42017581|NCT01286987|75825330|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
42017582|NCT01286987|75825331|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
42017583|NCT01286987|75825317|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
42017584|NCT01286987|75825318|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
42017585|NCT01286987|75825319|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
42017586|NCT01286987|75825320|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
42017587|NCT01286987|75825321|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
42017588|NCT01286987|75825322|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
42017589|NCT01286987|75825323|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
42017590|NCT01286987|75825324|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
42017591|NCT01286987|75825325|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
42017592|NCT01286987|75825326|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
42017593|NCT01286987|75825327|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
42017594|NCT01286987|75825328|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
42017595|NCT01286987|75825329|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
42017596|NCT01286987|75825330|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
42017597|NCT01286987|75825331|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
42017598|NCT01286987|75825317|FG000|Part 1: Dose Escalation|Physician Decision|0|||
42017599|NCT01286987|75825318|FG001|Part 1: Dose Escalation|Physician Decision|0|||
42017600|NCT01286987|75825319|FG002|Part 1: Dose Escalation|Physician Decision|0|||
42017601|NCT01286987|75825320|FG003|Part 1: Dose Escalation|Physician Decision|0|||
42017602|NCT01286987|75825321|FG004|Part 1: Dose Escalation|Physician Decision|1|||
42017603|NCT01286987|75825322|FG005|Part 1: Dose Escalation|Physician Decision|0|||
42017604|NCT01286987|75825323|FG006|Part 1: Dose Escalation|Physician Decision|0|||
42017605|NCT01286987|75825324|FG007|Part 1: Dose Escalation|Physician Decision|0|||
42017606|NCT01286987|75825325|FG008|Part 1: Dose Escalation|Physician Decision|0|||
42080420|NCT00664066|75890720|FG000|Overall Study|Study terminated|3|||
42080421|NCT00814710|75890726|FG000|Overall Study|Adverse Event|1|||
42080422|NCT00814710|75890727|FG001|Overall Study|Adverse Event|0|||
42080423|NCT00814710|75890726|FG000|Overall Study|Lost to Follow-up|7|||
42080424|NCT00814710|75890727|FG001|Overall Study|Lost to Follow-up|3|||
42080425|NCT00871169|75890733|FG000|Overall Study|Protocol Violation|1|||
42080426|NCT00871169|75890733|FG000|Overall Study|Patient did not receive study treatment|2|||
42080427|NCT00814632|75890737|FG000|Overall Study|Lack of Efficacy|2|||
42080428|NCT00851318|75890745|FG000|Overall Study|Withdrawal by Subject|7|||
42080429|NCT00851318|75890746|FG001|Overall Study|Withdrawal by Subject|1|||
42080430|NCT00851318|75890747|FG002|Overall Study|Withdrawal by Subject|5|||
42080431|NCT00851318|75890748|FG003|Overall Study|Withdrawal by Subject|3|||
42080432|NCT00851318|75890745|FG000|Overall Study|Adverse Event|13|||
42080433|NCT00851318|75890746|FG001|Overall Study|Adverse Event|2|||
42080434|NCT00851318|75890747|FG002|Overall Study|Adverse Event|9|||
42080435|NCT00851318|75890748|FG003|Overall Study|Adverse Event|12|||
42080436|NCT00851318|75890745|FG000|Overall Study|Pregnancy|0|||
42080437|NCT00851318|75890746|FG001|Overall Study|Pregnancy|0|||
42080438|NCT00851318|75890747|FG002|Overall Study|Pregnancy|1|||
42080439|NCT00851318|75890748|FG003|Overall Study|Pregnancy|1|||
42080440|NCT00851318|75890745|FG000|Overall Study|Lack of Efficacy|8|||
42080441|NCT00851318|75890746|FG001|Overall Study|Lack of Efficacy|2|||
42080442|NCT00851318|75890747|FG002|Overall Study|Lack of Efficacy|4|||
42080443|NCT00851318|75890748|FG003|Overall Study|Lack of Efficacy|2|||
42080444|NCT00851318|75890745|FG000|Overall Study|Non-compliance with Study Procedures|2|||
42080445|NCT00851318|75890746|FG001|Overall Study|Non-compliance with Study Procedures|0|||
42080446|NCT00851318|75890747|FG002|Overall Study|Non-compliance with Study Procedures|1|||
42080447|NCT00851318|75890748|FG003|Overall Study|Non-compliance with Study Procedures|0|||
42080448|NCT00851318|75890745|FG000|Overall Study|Physician Decision|0|||
42080449|NCT00851318|75890746|FG001|Overall Study|Physician Decision|0|||
42080450|NCT00851318|75890747|FG002|Overall Study|Physician Decision|1|||
42080451|NCT00851318|75890748|FG003|Overall Study|Physician Decision|1|||
42080452|NCT00593957|75890761|FG000|Overall Study|Physician Decision|0|||
42080453|NCT00593957|75890762|FG001|Overall Study|Physician Decision|1|||
42080454|NCT00593957|75890763|FG002|Overall Study|Physician Decision|2|||
42080455|NCT00870233|75890785|FG000|Overall Study|Withdrawal by Subject|18|||
42080456|NCT00870233|75890785|FG000|Overall Study|Did not undergo laparotomy|3|||
42080457|NCT00870233|75890785|FG000|Overall Study|Incompatible internet browser|2|||
42080458|NCT00870233|75890785|FG000|Overall Study|Death|1|||
42080459|NCT00851084|75890792|FG000|Overall Study|Randomized but not treated|1|||
42080460|NCT00851084|75890793|FG001|Overall Study|Randomized but not treated|0|||
42080461|NCT00851084|75890792|FG000|Overall Study|Adverse Event|26|||
42080462|NCT00851084|75890793|FG001|Overall Study|Adverse Event|36|||
42080463|NCT00851084|75890792|FG000|Overall Study|Disease progression|52|||
42080464|NCT00851084|75890793|FG001|Overall Study|Disease progression|47|||
42080465|NCT00851084|75890792|FG000|Overall Study|Poor compliance to protocol|1|||
42080466|NCT00851084|75890793|FG001|Overall Study|Poor compliance to protocol|1|||
42080467|NCT00851084|75890792|FG000|Overall Study|Physician Decision|13|||
42080468|NCT00851084|75890793|FG001|Overall Study|Physician Decision|14|||
42080469|NCT00851084|75890792|FG000|Overall Study|Consent withdrawn|0|||
42080470|NCT00851084|75890793|FG001|Overall Study|Consent withdrawn|2|||
42080471|NCT00851084|75890792|FG000|Overall Study|Withdrawal by Subject|11|||
42080472|NCT00851084|75890793|FG001|Overall Study|Withdrawal by Subject|12|||
42080473|NCT00851084|75890792|FG000|Overall Study|Metastatic surgery|6|||
42080474|NCT00851084|75890793|FG001|Overall Study|Metastatic surgery|6|||
42080475|NCT00851084|75890792|FG000|Overall Study|Other|7|||
42080476|NCT00851084|75890793|FG001|Overall Study|Other|1|||
42080477|NCT00845858|75890804|FG000|Overall Study|Withdrawal by Subject|5|||
42080478|NCT00845858|75890805|FG001|Overall Study|Withdrawal by Subject|1|||
42080479|NCT00845858|75890806|FG002|Overall Study|Withdrawal by Subject|1|||
42080480|NCT00845858|75890804|FG000|Overall Study|Adverse Event|3|||
42080481|NCT00845858|75890805|FG001|Overall Study|Adverse Event|8|||
42080482|NCT00845858|75890806|FG002|Overall Study|Adverse Event|4|||
42080483|NCT00845858|75890804|FG000|Overall Study|Protocol Violation|0|||
42080484|NCT00845858|75890805|FG001|Overall Study|Protocol Violation|0|||
42080485|NCT00845858|75890806|FG002|Overall Study|Protocol Violation|1|||
42080486|NCT00845858|75890804|FG000|Overall Study|not eligible|0|||
42080487|NCT00845858|75890805|FG001|Overall Study|not eligible|3|||
42080488|NCT00845858|75890806|FG002|Overall Study|not eligible|2|||
42080489|NCT00850538|75890817|FG000|Overall Study|unable/unwilling to complete MRI|13|||
42080490|NCT00850538|75890817|FG000|Overall Study|specimen missed due to scheduling error|14|||
42080491|NCT00850538|75890817|FG000|Overall Study|specimen unusable|7|||
42080492|NCT00850538|75890817|FG000|Overall Study|Withdrawal by Subject|3|||
42080493|NCT00850538|75890817|FG000|Overall Study|radiology error|2|||
42080494|NCT00850538|75890817|FG000|Overall Study|Protocol Violation|2|||
42080495|NCT00850460|75890823|FG000|Overall Study|Lost to Follow-up|4|||
42080496|NCT00850460|75890824|FG001|Overall Study|Lost to Follow-up|4|||
42080497|NCT00661492|75890832|FG000|Overall Study|Adverse Event|16|||
42178142|NCT00045942|75985198|FG004|PKC412A2104E2|Lack of Efficacy|0|||
42178143|NCT00045942|75985199|FG005|PKC412A2104E2|Lack of Efficacy|3|||
42080498|NCT00661492|75890833|FG001|Overall Study|Adverse Event|13|||
42080499|NCT00661492|75890832|FG000|Overall Study|Disease Progression|44|||
42080500|NCT00661492|75890833|FG001|Overall Study|Disease Progression|14|||
42080501|NCT00661492|75890832|FG000|Overall Study|Patient Request|6|||
42080502|NCT00661492|75890833|FG001|Overall Study|Patient Request|1|||
42080503|NCT00661492|75890832|FG000|Overall Study|Investigator Request|1|||
42080504|NCT00661492|75890833|FG001|Overall Study|Investigator Request|0|||
42080505|NCT00661492|75890832|FG000|Overall Study|Lost to Follow-up|0|||
42080506|NCT00661492|75890833|FG001|Overall Study|Lost to Follow-up|1|||
42080507|NCT00661492|75890832|FG000|Overall Study|Other|1|||
42080508|NCT00661492|75890833|FG001|Overall Study|Other|0|||
42080509|NCT00850070|75890841|FG000|Overall Study|Lack of Efficacy|1|||
42080510|NCT00850070|75890842|FG001|Overall Study|Lack of Efficacy|1|||
42080511|NCT00850070|75890841|FG000|Overall Study|Adverse Event|2|||
42080512|NCT00850070|75890842|FG001|Overall Study|Adverse Event|0|||
42080513|NCT00592358|75890853|FG000|Overall Study|Withdrawal by Subject|2|||
42080514|NCT00592358|75890853|FG000|Overall Study|Adverse Event|1|||
42080515|NCT00592358|75890853|FG000|Overall Study|Lack of Efficacy|2|||
42080516|NCT00592358|75890853|FG000|Overall Study|Inability to swallow pills|1|||
42080517|NCT00814320|75890859|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
42080518|NCT00814320|75890860|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
42080519|NCT00814320|75890859|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
42080520|NCT00814320|75890860|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
42080521|NCT00814320|75890859|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
42080522|NCT00814320|75890860|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
42293634|NCT02613221|76127796|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
42293635|NCT02613221|76127796|FG000|Overall Study|Adverse Event|2|||
42293636|NCT02613221|76127796|FG000|Overall Study|Voluntary Discontinuation|1|||
42293637|NCT02613221|76127796|FG000|Overall Study|Delayed Treatment|1|||
42293638|NCT02613221|76127796|FG000|Overall Study|Enrolled but Not Treated|1|||
42293639|NCT01362049|76127804|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
42293640|NCT01362049|76127805|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
42293641|NCT01362049|76127806|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
42080523|NCT00814320|75890859|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
42080524|NCT00814320|75890860|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
42293642|NCT01362049|76127807|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
42293643|NCT01362049|76127804|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
42080525|NCT00814320|75890859|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
42080526|NCT00814320|75890860|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
42080527|NCT00814320|75890859|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
42080528|NCT00814320|75890860|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
42293644|NCT01362049|76127805|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
42293645|NCT01362049|76127806|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
42293646|NCT01362049|76127807|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
42293647|NCT02612909|76127839|FG000|Phase 2|Withdrawal by Subject|2|||
42293648|NCT02612909|76127840|FG001|Phase 2|Withdrawal by Subject|5|||
42293649|NCT02612909|76127841|FG002|Phase 2|Withdrawal by Subject|0|||
42293650|NCT02612909|76127842|FG003|Phase 2|Withdrawal by Subject|0|||
42293651|NCT02612909|76127843|FG004|Phase 2|Withdrawal by Subject|0|||
42293652|NCT02612909|76127839|FG000|Phase 2|Pregnancy|0|||
42293653|NCT02612909|76127840|FG001|Phase 2|Pregnancy|0|||
42293654|NCT02612909|76127841|FG002|Phase 2|Pregnancy|1|||
42293655|NCT02612909|76127842|FG003|Phase 2|Pregnancy|0|||
42293656|NCT02612909|76127843|FG004|Phase 2|Pregnancy|0|||
42357908|NCT01745120|76203445|FG000|Overall Study|Investigator decision|1|||
42080529|NCT00814320|75890859|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
42080530|NCT00814320|75890860|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
42080531|NCT00814320|75890859|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
42080532|NCT00814320|75890860|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
42080533|NCT00814320|75890859|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
42178144|NCT00045942|75985200|FG006|PKC412A2104E2|Lack of Efficacy|2|||
42293657|NCT02612909|76127839|FG000|Phase 3|Withdrawal by Subject|0|||
42293658|NCT02612909|76127840|FG001|Phase 3|Withdrawal by Subject|0|||
42293659|NCT02612909|76127841|FG002|Phase 3|Withdrawal by Subject|0|||
42293660|NCT02612909|76127842|FG003|Phase 3|Withdrawal by Subject|1|||
42293661|NCT02612909|76127843|FG004|Phase 3|Withdrawal by Subject|0|||
42293662|NCT02612285|76127857|FG000|Overall Study|Withdrawal by Subject|1|||
42080534|NCT00814320|75890860|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
42080535|NCT00814320|75890859|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
42080536|NCT00814320|75890860|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
42080537|NCT00869999|75890883|FG000|Overall Study|Withdrawal by Subject|1|||
42080538|NCT00869999|75890883|FG000|Overall Study|removed prior to starting therapy|1|||
42080539|NCT00570232|75890887|FG000|Overall Study|Adverse Event|10|||
42080540|NCT00570232|75890887|FG000|Overall Study|discontinued due to medical condition|3|||
42080541|NCT00570232|75890887|FG000|Overall Study|discontinued due to recurrence|8|||
42080542|NCT00570232|75890887|FG000|Overall Study|discontinued due to noncompliance|2|||
42080543|NCT00809328|75890891|FG000|Overall Study|Lack of Efficacy|18|||
42080544|NCT00809328|75890891|FG000|Overall Study|Adverse Event|6|||
42080545|NCT00809328|75890891|FG000|Overall Study|Protocol Violation|3|||
42080546|NCT00809328|75890891|FG000|Overall Study|Withdrawal by Subject|2|||
42080547|NCT00868517|75890898|FG000|Overall Study|Withdrawal by Subject|3|||
42080548|NCT00868517|75890899|FG001|Overall Study|Withdrawal by Subject|3|||
42080549|NCT00868517|75890900|FG002|Overall Study|Withdrawal by Subject|2|||
42080550|NCT00868517|75890898|FG000|Overall Study|Protocol Violation|1|||
42080551|NCT00868517|75890899|FG001|Overall Study|Protocol Violation|1|||
42293663|NCT02609633|76127863|FG000|Overall Study|Consent Withdrawn|0|||
42293664|NCT02609633|76127864|FG001|Overall Study|Consent Withdrawn|1|||
42293665|NCT02609633|76127863|FG000|Overall Study|Protocol Deviation|1|||
42080552|NCT00868517|75890900|FG002|Overall Study|Protocol Violation|0|||
42080553|NCT00868439|75890910|FG000|Overall Study|Adverse Event|4|||
42080554|NCT00868439|75890911|FG001|Overall Study|Adverse Event|3|||
42080555|NCT00868439|75890910|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
42080556|NCT00868439|75890911|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
42080557|NCT00868439|75890910|FG000|Overall Study|Death|0|||
42080558|NCT00868439|75890911|FG001|Overall Study|Death|1|||
42080559|NCT00868439|75890910|FG000|Overall Study|Protocol Violation|1|||
42080560|NCT00868439|75890911|FG001|Overall Study|Protocol Violation|1|||
42080561|NCT00868439|75890910|FG000|Overall Study|Physician Decision|1|||
42080562|NCT00868439|75890911|FG001|Overall Study|Physician Decision|0|||
42080563|NCT00868439|75890910|FG000|Overall Study|Withdrawal by Subject|0|||
42293666|NCT02609633|76127864|FG001|Overall Study|Protocol Deviation|0|||
42293667|NCT02609633|76127863|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
42293668|NCT02609633|76127864|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
42293669|NCT02609633|76127863|FG000|Overall Study|Reason not Specified|2|||
42293670|NCT02609633|76127864|FG001|Overall Study|Reason not Specified|1|||
42293671|NCT01597375|76127886|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
42293672|NCT01597375|76127887|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
42293673|NCT01597375|76127886|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
42293674|NCT01597375|76127887|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
42293675|NCT01597375|76127886|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
42293676|NCT01597375|76127887|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
42293677|NCT01597375|76127886|FG000|Washout (2 Weeks)|Adverse Event|1|||
42293678|NCT01597375|76127887|FG001|Washout (2 Weeks)|Adverse Event|0|||
42293679|NCT01597375|76127886|FG000|Second Intervention|Failed to react at both Aspirin|1|||
42293680|NCT01597375|76127887|FG001|Second Intervention|Failed to react at both Aspirin|1|||
42293681|NCT02527161|76127894|FG000|Overall Study|Failed MRI|52|||
42293682|NCT02527161|76127894|FG000|Overall Study|Withdrawal by Subject|19|||
42293683|NCT02527161|76127894|FG000|Overall Study|Delay in or unfit for surgery|16|||
42293684|NCT02527161|76127894|FG000|Overall Study|MRI contraindication|6|||
42293685|NCT02527161|76127894|FG000|Overall Study|Consent violation|4|||
42293686|NCT02527161|76127894|FG000|Overall Study|Only Recruited to Part A|27|||
42293687|NCT02527161|76127894|FG000|Overall Study|Physician Decision|1|||
42293688|NCT02527161|76127894|FG000|Overall Study|Adverse Event|1|||
42293689|NCT02527161|76127894|FG000|Overall Study|Lost to Follow-up|6|||
42080564|NCT00868439|75890911|FG001|Overall Study|Withdrawal by Subject|1|||
42080565|NCT00814164|75890917|FG000|Overall Study|Progression|7|||
42080566|NCT00814164|75890917|FG000|Overall Study|not stated|7|||
42080567|NCT00814164|75890917|FG000|Overall Study|Death|5|||
42080568|NCT00659230|75890923|FG000|Overall Study|Lost to Follow-up|2|||
42080569|NCT00659230|75890924|FG001|Overall Study|Lost to Follow-up|5|||
42080570|NCT00659230|75890923|FG000|Overall Study|Lost source documentation|5|||
42080571|NCT00659230|75890924|FG001|Overall Study|Lost source documentation|4|||
42293690|NCT02609399|76127901|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
42293691|NCT02609399|76127902|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
42293692|NCT02609399|76127901|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
42293693|NCT02609399|76127902|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
42293694|NCT02609399|76127901|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
42293695|NCT02609399|76127902|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
42293696|NCT02720185|76127910|FG000|Overall Study|Lost to Follow-up|1|||
42293697|NCT02526693|76127933|FG000|Overall Study|Physician Decision|3|||
42080572|NCT00659230|75890923|FG000|Overall Study|Did not return post-randomization|2|||
42080573|NCT00659230|75890924|FG001|Overall Study|Did not return post-randomization|3|||
42080574|NCT00809094|75890932|FG000|Overall Study|Lost to Follow-up|0|||
42080575|NCT00809094|75890933|FG001|Overall Study|Lost to Follow-up|1|||
42080576|NCT00658996|75890939|FG000|First Intervention|Positive slit lamp finding|1|||
42080577|NCT00658996|75890940|FG001|First Intervention|Positive slit lamp finding|0|||
42080578|NCT00658996|75890939|FG000|First Intervention|Lack of lenses|0|||
42080579|NCT00658996|75890940|FG001|First Intervention|Lack of lenses|1|||
42080580|NCT00658996|75890939|FG000|Crossover Period|Physician Decision|1|||
42080581|NCT00658996|75890940|FG001|Crossover Period|Physician Decision|0|||
42080582|NCT00658996|75890939|FG000|Crossover Period|Ineligible|1|||
42080583|NCT00658996|75890940|FG001|Crossover Period|Ineligible|1|||
42080584|NCT00658996|75890939|FG000|Second Intervention|Developed a stye on upper lid|1|||
42080585|NCT00658996|75890940|FG001|Second Intervention|Developed a stye on upper lid|0|||
42080586|NCT00658996|75890939|FG000|Second Intervention|Positive slit lamp finding|0|||
42080587|NCT00658996|75890940|FG001|Second Intervention|Positive slit lamp finding|1|||
42080588|NCT00867815|75890946|FG000|Overall Study|Lost to Follow-up|1|||
42080589|NCT00452413|75890953|FG000|Overall Study|Progressive Disease|4|||
42080590|NCT00452413|75890954|FG001|Overall Study|Progressive Disease|11|||
42293698|NCT02526693|76127934|FG001|Overall Study|Physician Decision|1|||
42293699|NCT02710669|76127952|FG000|Overall Study|Physician Decision|2|||
42293700|NCT02710669|76127953|FG001|Overall Study|Physician Decision|1|||
42293701|NCT02710669|76127954|FG002|Overall Study|Physician Decision|0|||
42293702|NCT02710669|76127952|FG000|Overall Study|Institutional delays (including COVID)|2|||
42293703|NCT02710669|76127953|FG001|Overall Study|Institutional delays (including COVID)|2|||
42293704|NCT02710669|76127954|FG002|Overall Study|Institutional delays (including COVID)|0|||
42293705|NCT02710669|76127952|FG000|Overall Study|arrived in afib/aflutter|10|||
42293706|NCT02710669|76127953|FG001|Overall Study|arrived in afib/aflutter|8|||
42293707|NCT02710669|76127954|FG002|Overall Study|arrived in afib/aflutter|2|||
42293708|NCT02610725|76127962|FG000|Overall Study|Lost to Follow-up|197|||
42293709|NCT02610725|76127962|FG000|Overall Study|self-reported contraindication|9|||
42293710|NCT02684461|76127969|FG000|Overall Study|Adverse Event|1|||
42293711|NCT02684461|76127970|FG001|Overall Study|Adverse Event|0|||
42293712|NCT02684461|76127971|FG002|Overall Study|Adverse Event|0|||
42293713|NCT02684461|76127969|FG000|Overall Study|Lack of Efficacy|1|||
42293714|NCT02684461|76127970|FG001|Overall Study|Lack of Efficacy|2|||
42293715|NCT02684461|76127971|FG002|Overall Study|Lack of Efficacy|0|||
42293716|NCT02647645|76127996|FG000|Overall Study|Lost to Follow-up|2|||
42293717|NCT02647645|76127997|FG001|Overall Study|Lost to Follow-up|1|||
42293718|NCT02531373|76128012|FG000|Overall Study|Lack of Efficacy|0|||
42293719|NCT02531373|76128013|FG001|Overall Study|Lack of Efficacy|0|||
42293720|NCT02531373|76128014|FG002|Overall Study|Lack of Efficacy|0|||
42293721|NCT02531373|76128015|FG003|Overall Study|Lack of Efficacy|0|||
42293722|NCT02531373|76128016|FG004|Overall Study|Lack of Efficacy|3|||
42293723|NCT02531373|76128017|FG005|Overall Study|Lack of Efficacy|2|||
42293724|NCT02531373|76128018|FG006|Overall Study|Lack of Efficacy|4|||
42293725|NCT02531373|76128019|FG007|Overall Study|Lack of Efficacy|8|||
42293726|NCT02531373|76128020|FG008|Overall Study|Lack of Efficacy|5|||
42293727|NCT02531373|76128012|FG000|Overall Study|Lost to Follow-up|0|||
42293728|NCT02531373|76128013|FG001|Overall Study|Lost to Follow-up|0|||
42293729|NCT02531373|76128014|FG002|Overall Study|Lost to Follow-up|0|||
42293730|NCT02531373|76128015|FG003|Overall Study|Lost to Follow-up|0|||
42293731|NCT02531373|76128016|FG004|Overall Study|Lost to Follow-up|0|||
42293732|NCT02531373|76128017|FG005|Overall Study|Lost to Follow-up|2|||
42293733|NCT02531373|76128018|FG006|Overall Study|Lost to Follow-up|2|||
42293734|NCT02531373|76128019|FG007|Overall Study|Lost to Follow-up|0|||
42293735|NCT02531373|76128020|FG008|Overall Study|Lost to Follow-up|0|||
42293736|NCT02531373|76128012|FG000|Overall Study|Physician Decision|0|||
42293737|NCT02531373|76128013|FG001|Overall Study|Physician Decision|0|||
42293738|NCT02531373|76128014|FG002|Overall Study|Physician Decision|0|||
42293739|NCT02531373|76128015|FG003|Overall Study|Physician Decision|0|||
42293740|NCT02531373|76128016|FG004|Overall Study|Physician Decision|2|||
42293741|NCT02531373|76128017|FG005|Overall Study|Physician Decision|1|||
42293742|NCT02531373|76128018|FG006|Overall Study|Physician Decision|0|||
42293743|NCT02531373|76128019|FG007|Overall Study|Physician Decision|0|||
42293744|NCT02531373|76128020|FG008|Overall Study|Physician Decision|0|||
42293745|NCT02531373|76128012|FG000|Overall Study|Protocol Violation|0|||
42293746|NCT02531373|76128013|FG001|Overall Study|Protocol Violation|0|||
42293747|NCT02531373|76128014|FG002|Overall Study|Protocol Violation|0|||
42293748|NCT02531373|76128015|FG003|Overall Study|Protocol Violation|0|||
42293749|NCT02531373|76128016|FG004|Overall Study|Protocol Violation|0|||
42293750|NCT02531373|76128017|FG005|Overall Study|Protocol Violation|1|||
42293751|NCT02531373|76128018|FG006|Overall Study|Protocol Violation|1|||
42293752|NCT02531373|76128019|FG007|Overall Study|Protocol Violation|0|||
42293753|NCT02531373|76128020|FG008|Overall Study|Protocol Violation|1|||
42293754|NCT02531373|76128012|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42293755|NCT02531373|76128013|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
42293756|NCT02531373|76128014|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
42293757|NCT02531373|76128015|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
42293758|NCT02531373|76128016|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
42293759|NCT02531373|76128017|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
42293760|NCT02531373|76128018|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
42293761|NCT02531373|76128019|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
42080591|NCT00452413|75890955|FG002|Overall Study|Progressive Disease|30|||
42293762|NCT02531373|76128020|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
42293763|NCT02531373|76128012|FG000|Overall Study|Withdrawal by Subject|0|||
42293764|NCT02531373|76128013|FG001|Overall Study|Withdrawal by Subject|0|||
42293765|NCT02531373|76128014|FG002|Overall Study|Withdrawal by Subject|0|||
42293766|NCT02531373|76128015|FG003|Overall Study|Withdrawal by Subject|0|||
42293767|NCT02531373|76128016|FG004|Overall Study|Withdrawal by Subject|3|||
42293768|NCT02531373|76128017|FG005|Overall Study|Withdrawal by Subject|0|||
42293769|NCT02531373|76128018|FG006|Overall Study|Withdrawal by Subject|0|||
42293770|NCT02531373|76128019|FG007|Overall Study|Withdrawal by Subject|0|||
42293771|NCT02531373|76128020|FG008|Overall Study|Withdrawal by Subject|0|||
42293772|NCT02606279|76128043|FG000|Overall Study|Lost to Follow-up|0|||
42293773|NCT02606279|76128044|FG001|Overall Study|Lost to Follow-up|1|||
42293774|NCT02643355|76128058|FG000|Overall Study|Withdrawal by Subject|1|||
42080592|NCT00452413|75890953|FG000|Overall Study|Withdrawal by Subject|0|||
42080593|NCT00452413|75890954|FG001|Overall Study|Withdrawal by Subject|1|||
42080594|NCT00452413|75890955|FG002|Overall Study|Withdrawal by Subject|4|||
42080595|NCT00452413|75890953|FG000|Overall Study|Adverse Event|0|||
42080596|NCT00452413|75890954|FG001|Overall Study|Adverse Event|0|||
42080597|NCT00452413|75890955|FG002|Overall Study|Adverse Event|5|||
42080598|NCT00452413|75890953|FG000|Overall Study|Physician Decision|0|||
42080599|NCT00452413|75890954|FG001|Overall Study|Physician Decision|0|||
42080600|NCT00452413|75890955|FG002|Overall Study|Physician Decision|4|||
42080601|NCT00452413|75890953|FG000|Overall Study|Death due to study disease|0|||
42080602|NCT00452413|75890954|FG001|Overall Study|Death due to study disease|0|||
42080603|NCT00452413|75890955|FG002|Overall Study|Death due to study disease|2|||
42080604|NCT00452413|75890953|FG000|Overall Study|Death due to adverse event (AE)|0|||
42080605|NCT00452413|75890954|FG001|Overall Study|Death due to adverse event (AE)|0|||
42080606|NCT00452413|75890955|FG002|Overall Study|Death due to adverse event (AE)|1|||
42080607|NCT00452413|75890953|FG000|Overall Study|On treatment|0|||
42080608|NCT00452413|75890954|FG001|Overall Study|On treatment|0|||
42080609|NCT00452413|75890955|FG002|Overall Study|On treatment|3|||
42080610|NCT00867503|75890964|FG000|Overall Study|Withdrawal by Subject|1|||
42080611|NCT00867113|75890970|FG000|Treatment Period|Adverse Event|15|||
42080612|NCT00867113|75890970|FG000|Treatment Period|Death|2|||
42293775|NCT02643355|76128059|FG001|Overall Study|Withdrawal by Subject|3|||
42293776|NCT02643355|76128058|FG000|Overall Study|Protocol Violation|0|||
42293777|NCT02643355|76128059|FG001|Overall Study|Protocol Violation|2|||
42293778|NCT02604017|76128067|FG000|Overall Study|Withdrew Consent|0|||
42293779|NCT02604017|76128068|FG001|Overall Study|Withdrew Consent|2|||
42293780|NCT02604017|76128067|FG000|Overall Study|Lost to Follow-up|5|||
42293781|NCT02604017|76128068|FG001|Overall Study|Lost to Follow-up|6|||
42293782|NCT02604017|76128067|FG000|Overall Study|Other|1|||
42293783|NCT02604017|76128068|FG001|Overall Study|Other|0|||
42293784|NCT02640547|76128074|FG000|Overall Study|Failure to Return|1|||
42080613|NCT00867113|75890970|FG000|Treatment Period|Withdrawal by Subject|19|||
42080614|NCT00867113|75890970|FG000|Treatment Period|Lost to Follow-up|3|||
42080615|NCT00867113|75890970|FG000|Treatment Period|Administrative problems|1|||
42080616|NCT00867113|75890970|FG000|Treatment Period|Disease progression/relapse|1|||
42080617|NCT00867113|75890970|FG000|Treatment Period|Protocol Violation|4|||
42080618|NCT00867113|75890970|FG000|Post Treatment After Survival Follow-up|Death|1|||
42080619|NCT00867113|75890970|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
42080620|NCT00867113|75890970|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
42080621|NCT00867113|75890970|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
42080622|NCT00451555|75890977|FG000|Overall Study|Protocol Violation|2|||
42080623|NCT00451555|75890978|FG001|Overall Study|Protocol Violation|2|||
42293785|NCT02640547|76128074|FG000|Overall Study|Withdrawal by Subject|1|||
42293786|NCT02640547|76128074|FG000|Overall Study|Death|6|||
42293787|NCT02640547|76128074|FG000|Overall Study|Miscellaneous|3|||
42293788|NCT02530905|76128088|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
42293789|NCT02530905|76128089|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
42293790|NCT02530905|76128090|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
42080624|NCT00451555|75890977|FG000|Overall Study|Adverse Event|3|||
42080625|NCT00451555|75890978|FG001|Overall Study|Adverse Event|1|||
42080626|NCT00451555|75890977|FG000|Overall Study|Withdrawal by Subject|6|||
42080627|NCT00451555|75890978|FG001|Overall Study|Withdrawal by Subject|0|||
42080628|NCT00451555|75890977|FG000|Overall Study|Physician Decision|2|||
42080629|NCT00451555|75890978|FG001|Overall Study|Physician Decision|1|||
42080630|NCT00808236|75890995|FG000|Overall Study|Was not resuscitated|50|||
42080631|NCT00808236|75890996|FG001|Overall Study|Was not resuscitated|56|||
42080632|NCT00808236|75890995|FG000|Overall Study|Pre-defined exclusion|13|||
42080633|NCT00808236|75890996|FG001|Overall Study|Pre-defined exclusion|3|||
42080634|NCT00808236|75890995|FG000|Overall Study|Lost to Follow-up|1|||
42293791|NCT02530671|76128114|FG000|Overall Study|Lost to Follow-up|2|||
42293792|NCT02530671|76128115|FG001|Overall Study|Lost to Follow-up|0|||
42357909|NCT01745120|76203446|FG001|Overall Study|Investigator decision|0|||
42357910|NCT01828567|76203457|FG000|Overall Study|Lost to Follow-up|27|||
42357911|NCT01828567|76203458|FG001|Overall Study|Lost to Follow-up|9|||
42357912|NCT01828567|76203457|FG000|Overall Study|Excluded - did not meet criteria|4|||
42357913|NCT01828567|76203458|FG001|Overall Study|Excluded - did not meet criteria|1|||
42357914|NCT01721486|76203466|FG000|Overall Study|Protocol Violation|1|||
42357915|NCT01721486|76203467|FG001|Overall Study|Protocol Violation|0|||
42357916|NCT01721486|76203466|FG000|Overall Study|Physician Decision|0|||
42357917|NCT01721486|76203467|FG001|Overall Study|Physician Decision|1|||
42357918|NCT01775930|76203473|FG000|Overall Study|Futility stopping boundary met|1|||
42357919|NCT01856569|76203477|FG000|Overall Study|Other|1|||
42357920|NCT01856569|76203477|FG000|Overall Study|Changed Site/Structure|1|||
42357921|NCT01856569|76203477|FG000|Overall Study|Lost to Follow-up|3|||
42357922|NCT01856569|76203477|FG000|Overall Study|Did not met inclusion criteria|8|||
42357923|NCT01721408|76203483|FG000|Overall Study|Adverse Event|6|||
42357924|NCT01721408|76203484|FG001|Overall Study|Adverse Event|1|||
42357925|NCT01721408|76203483|FG000|Overall Study|Death|1|||
42357926|NCT01721408|76203484|FG001|Overall Study|Death|0|||
42357927|NCT01721408|76203483|FG000|Overall Study|Insufficient clinical response|15|||
42357928|NCT01721408|76203484|FG001|Overall Study|Insufficient clinical response|6|||
42357929|NCT01721408|76203483|FG000|Overall Study|No longer willing to participate study|9|||
42357930|NCT01721408|76203484|FG001|Overall Study|No longer willing to participate study|10|||
42357931|NCT01721408|76203483|FG000|Overall Study|Protocol Violation|0|||
42357932|NCT01721408|76203484|FG001|Overall Study|Protocol Violation|2|||
42293793|NCT02530671|76128114|FG000|Overall Study|Withdrawal by Subject|1|||
42293794|NCT02530671|76128115|FG001|Overall Study|Withdrawal by Subject|0|||
42293795|NCT02603393|76128123|FG000|Overall Study|Patient/guardian decision|32|||
42293796|NCT02603393|76128124|FG001|Overall Study|Patient/guardian decision|18|||
42357933|NCT01721408|76203483|FG000|Overall Study|Other|3|||
42357934|NCT01721408|76203484|FG001|Overall Study|Other|3|||
42080635|NCT00808236|75890996|FG001|Overall Study|Lost to Follow-up|1|||
42080636|NCT00808236|75890995|FG000|Overall Study|Physician Decision|0|||
42293797|NCT02603393|76128123|FG000|Overall Study|Adverse Event|17|||
42080637|NCT00808236|75890996|FG001|Overall Study|Physician Decision|1|||
42080638|NCT00808236|75890995|FG000|Overall Study|Death|18|||
42080639|NCT00808236|75890996|FG001|Overall Study|Death|30|||
42080640|NCT00867035|75891004|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
42178145|NCT00045942|75985201|FG007|PKC412A2104E2|Lack of Efficacy|2|||
42293798|NCT02603393|76128124|FG001|Overall Study|Adverse Event|15|||
42357935|NCT01721408|76203483|FG000|Overall Study|Lost to Follow-up|1|||
42357936|NCT01721408|76203484|FG001|Overall Study|Lost to Follow-up|2|||
42357937|NCT01721408|76203483|FG000|Overall Study|Does not meet entrance criteria|1|||
42357938|NCT01721408|76203484|FG001|Overall Study|Does not meet entrance criteria|0|||
42357939|NCT01744496|76203492|FG000|Titration Period|Adverse Event|2|||
42357940|NCT01744496|76203493|FG001|Titration Period|Adverse Event|1|||
42357941|NCT01744496|76203492|FG000|Titration Period|Personal reasons|0|||
42357942|NCT01744496|76203493|FG001|Titration Period|Personal reasons|1|||
42357943|NCT01744496|76203492|FG000|Maintenance Period|Adverse Event|1|||
42357944|NCT01744496|76203493|FG001|Maintenance Period|Adverse Event|3|||
42357945|NCT01744496|76203492|FG000|Maintenance Period|Protocol Violation|1|||
42357946|NCT01744496|76203493|FG001|Maintenance Period|Protocol Violation|0|||
42357947|NCT01744496|76203492|FG000|Maintenance Period|Withdrawal by Subject|1|||
42357948|NCT01744496|76203493|FG001|Maintenance Period|Withdrawal by Subject|1|||
42357949|NCT01744496|76203492|FG000|Maintenance Period|Subject left town|1|||
42357950|NCT01744496|76203493|FG001|Maintenance Period|Subject left town|0|||
42293799|NCT02603393|76128123|FG000|Overall Study|Technical problems|4|||
42293800|NCT02603393|76128124|FG001|Overall Study|Technical problems|7|||
42293801|NCT02603393|76128123|FG000|Overall Study|Lack of Efficacy|7|||
42293802|NCT02603393|76128124|FG001|Overall Study|Lack of Efficacy|2|||
42357951|NCT01721330|76203501|FG000|Overall Study|Withdrawal by Subject|0|||
42357952|NCT01721330|76203502|FG001|Overall Study|Withdrawal by Subject|1|||
42357953|NCT01828021|76203518|FG000|Overall Study|Adverse Event|5|||
42357954|NCT01828021|76203518|FG000|Overall Study|Lack of Efficacy|17|||
42357955|NCT01828021|76203518|FG000|Overall Study|Withdrawal by Subject|2|||
42293803|NCT02603393|76128123|FG000|Overall Study|Death|3|||
42293804|NCT02603393|76128124|FG001|Overall Study|Death|4|||
42080641|NCT00867035|75891005|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
42080642|NCT00867035|75891004|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
42080643|NCT00867035|75891005|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
42080644|NCT00663208|75891018|FG000|Treatment Period|Lost to Follow-up|0|||
42080645|NCT00663208|75891019|FG001|Treatment Period|Lost to Follow-up|1|||
42080646|NCT00663208|75891020|FG002|Treatment Period|Lost to Follow-up|0|||
42080647|NCT00663208|75891021|FG003|Treatment Period|Lost to Follow-up|0|||
42080648|NCT00663208|75891022|FG004|Treatment Period|Lost to Follow-up|0|||
42080649|NCT00663208|75891023|FG005|Treatment Period|Lost to Follow-up|0|||
42080650|NCT00663208|75891024|FG006|Treatment Period|Lost to Follow-up|0|||
42080651|NCT00663208|75891018|FG000|Follow-up Period|Lost to Follow-up|2|||
42080652|NCT00663208|75891019|FG001|Follow-up Period|Lost to Follow-up|0|||
42080653|NCT00663208|75891020|FG002|Follow-up Period|Lost to Follow-up|3|||
42080654|NCT00663208|75891021|FG003|Follow-up Period|Lost to Follow-up|2|||
42080655|NCT00663208|75891022|FG004|Follow-up Period|Lost to Follow-up|0|||
42080656|NCT00663208|75891023|FG005|Follow-up Period|Lost to Follow-up|0|||
42080657|NCT00663208|75891024|FG006|Follow-up Period|Lost to Follow-up|0|||
42080658|NCT00663208|75891018|FG000|Follow-up Period|Other reason|1|||
42080659|NCT00663208|75891019|FG001|Follow-up Period|Other reason|0|||
42080660|NCT00663208|75891020|FG002|Follow-up Period|Other reason|0|||
42178146|NCT00045942|75985202|FG008|PKC412A2104E2|Lack of Efficacy|6|||
42178147|NCT00045942|75985194|FG000|PKC412A2104E2|Adverse Event|0|||
42178148|NCT00045942|75985195|FG001|PKC412A2104E2|Adverse Event|0|||
42178149|NCT00045942|75985196|FG002|PKC412A2104E2|Adverse Event|0|||
42178150|NCT00045942|75985197|FG003|PKC412A2104E2|Adverse Event|0|||
42178151|NCT00045942|75985198|FG004|PKC412A2104E2|Adverse Event|0|||
42178152|NCT00045942|75985199|FG005|PKC412A2104E2|Adverse Event|4|||
42178153|NCT00045942|75985200|FG006|PKC412A2104E2|Adverse Event|3|||
42293805|NCT02603393|76128123|FG000|Overall Study|Physician Decision|3|||
42293806|NCT02603393|76128124|FG001|Overall Study|Physician Decision|3|||
42293807|NCT02603393|76128123|FG000|Overall Study|Protocol deviation|2|||
42080661|NCT00663208|75891021|FG003|Follow-up Period|Other reason|0|||
42178154|NCT00045942|75985201|FG007|PKC412A2104E2|Adverse Event|1|||
42178155|NCT00045942|75985202|FG008|PKC412A2104E2|Adverse Event|0|||
42178156|NCT00045942|75985194|FG000|PKC412A2104E2|Death|0|||
42080662|NCT00663208|75891022|FG004|Follow-up Period|Other reason|0|||
42293808|NCT02603393|76128124|FG001|Overall Study|Protocol deviation|3|||
42293809|NCT02603393|76128123|FG000|Overall Study|Lost to Follow-up|1|||
42178157|NCT00045942|75985195|FG001|PKC412A2104E2|Death|0|||
42178158|NCT00045942|75985196|FG002|PKC412A2104E2|Death|0|||
42293810|NCT02603393|76128124|FG001|Overall Study|Lost to Follow-up|2|||
42357956|NCT01828021|76203518|FG000|Overall Study|Ileal obstruction, unrelated|1|||
42080663|NCT00663208|75891023|FG005|Follow-up Period|Other reason|0|||
42080664|NCT00663208|75891024|FG006|Follow-up Period|Other reason|1|||
42080665|NCT00810810|75891046|FG000|Overall Study|Withdrawal by Subject|0|||
42080666|NCT00810810|75891047|FG001|Overall Study|Withdrawal by Subject|8|||
42080667|NCT00810810|75891048|FG002|Overall Study|Withdrawal by Subject|10|||
42080668|NCT00810810|75891049|FG003|Overall Study|Withdrawal by Subject|8|||
42080669|NCT00810810|75891046|FG000|Overall Study|Physician Decision|0|||
42080670|NCT00810810|75891047|FG001|Overall Study|Physician Decision|3|||
42080671|NCT00810810|75891048|FG002|Overall Study|Physician Decision|1|||
42080672|NCT00810810|75891049|FG003|Overall Study|Physician Decision|5|||
42080673|NCT00661258|75891061|FG000|Overall Study|Death|1|||
42080674|NCT00661258|75891062|FG001|Overall Study|Death|0|||
42080675|NCT00661258|75891061|FG000|Overall Study|caught by police and in detox center|2|||
42080676|NCT00661258|75891062|FG001|Overall Study|caught by police and in detox center|1|||
42080677|NCT00871871|75891070|FG000|Part I|Adverse Event|0|||
42080678|NCT00871871|75891071|FG001|Part I|Adverse Event|2|||
42080679|NCT00871871|75891072|FG002|Part I|Adverse Event|0|||
42080680|NCT00871871|75891073|FG003|Part I|Adverse Event|0|||
42080681|NCT00871871|75891070|FG000|Part I|Withdrawal by Subject|3|||
42080682|NCT00871871|75891071|FG001|Part I|Withdrawal by Subject|0|||
42080683|NCT00871871|75891072|FG002|Part I|Withdrawal by Subject|0|||
42080684|NCT00871871|75891073|FG003|Part I|Withdrawal by Subject|0|||
42080685|NCT00871871|75891070|FG000|Part I|Laboratory abnormality|0|||
42080686|NCT00871871|75891071|FG001|Part I|Laboratory abnormality|1|||
42080687|NCT00871871|75891072|FG002|Part I|Laboratory abnormality|0|||
42080688|NCT00871871|75891073|FG003|Part I|Laboratory abnormality|0|||
42080689|NCT00871871|75891070|FG000|Part II|Lack of Efficacy|0|||
42080690|NCT00871871|75891071|FG001|Part II|Lack of Efficacy|0|||
42080691|NCT00871871|75891072|FG002|Part II|Lack of Efficacy|1|||
42080692|NCT00871871|75891073|FG003|Part II|Lack of Efficacy|0|||
42080693|NCT00871871|75891070|FG000|Part II|Withdrawal by Subject|0|||
42080694|NCT00871871|75891071|FG001|Part II|Withdrawal by Subject|0|||
42080695|NCT00871871|75891072|FG002|Part II|Withdrawal by Subject|2|||
42080696|NCT00871871|75891073|FG003|Part II|Withdrawal by Subject|1|||
42080697|NCT00871871|75891070|FG000|Part II|Adverse Event|0|||
42080698|NCT00871871|75891071|FG001|Part II|Adverse Event|0|||
42357957|NCT01827943|76203522|FG000|Overall Study|Protocol Violation|8|||
42357958|NCT01827943|76203522|FG000|Overall Study|Never treated because of an rapid progression|1|||
42357959|NCT00217971|76203528|FG000|Overall Study|Adverse Event|1|||
42357960|NCT00217971|76203529|FG001|Overall Study|Adverse Event|1|||
42357961|NCT00217971|76203528|FG000|Overall Study|Lost to Follow-up|15|||
42357962|NCT00217971|76203529|FG001|Overall Study|Lost to Follow-up|19|||
42357963|NCT00217971|76203528|FG000|Overall Study|Physician Decision|0|||
42357964|NCT00217971|76203529|FG001|Overall Study|Physician Decision|1|||
42357965|NCT00217971|76203528|FG000|Overall Study|Withdrawal by Subject|7|||
42357966|NCT00217971|76203529|FG001|Overall Study|Withdrawal by Subject|12|||
42357967|NCT00217971|76203528|FG000|Overall Study|non compliant|1|||
42357968|NCT00217971|76203529|FG001|Overall Study|non compliant|0|||
42357969|NCT00217581|76203535|FG000|Overall Study|Withdrawal by Subject|1|||
42357970|NCT01856257|76203543|FG000|Overall Study|Death|2|||
42357971|NCT01856257|76203544|FG001|Overall Study|Death|0|||
42357972|NCT01856257|76203545|FG002|Overall Study|Death|0|||
42357973|NCT01856257|76203546|FG003|Overall Study|Death|0|||
42357974|NCT01856257|76203543|FG000|Overall Study|Physician Decision|0|||
42357975|NCT01856257|76203544|FG001|Overall Study|Physician Decision|0|||
42357976|NCT01856257|76203545|FG002|Overall Study|Physician Decision|0|||
42357977|NCT01856257|76203546|FG003|Overall Study|Physician Decision|1|||
42357978|NCT01856257|76203543|FG000|Overall Study|Withdrawal by Subject|1|||
42357979|NCT01856257|76203544|FG001|Overall Study|Withdrawal by Subject|1|||
42357980|NCT01856257|76203545|FG002|Overall Study|Withdrawal by Subject|0|||
42357981|NCT01856257|76203546|FG003|Overall Study|Withdrawal by Subject|0|||
42357982|NCT01856257|76203543|FG000|Overall Study|Donor complication|0|||
42357983|NCT01856257|76203544|FG001|Overall Study|Donor complication|0|||
42357984|NCT01856257|76203545|FG002|Overall Study|Donor complication|0|||
42080699|NCT00871871|75891072|FG002|Part II|Adverse Event|1|||
42080700|NCT00871871|75891073|FG003|Part II|Adverse Event|2|||
42080701|NCT00871871|75891070|FG000|Part II|Protocol Violation|0|||
42080702|NCT00871871|75891071|FG001|Part II|Protocol Violation|0|||
42080703|NCT00871871|75891072|FG002|Part II|Protocol Violation|0|||
42080704|NCT00871871|75891073|FG003|Part II|Protocol Violation|1|||
42080705|NCT00849680|75891091|FG000|Overall Study|Adverse Event|0|||
42178159|NCT00045942|75985197|FG003|PKC412A2104E2|Death|0|||
42357985|NCT01856257|76203546|FG003|Overall Study|Donor complication|1|||
42357986|NCT00215943|76203557|FG000|Overall Study|Disease Progression|3|||
42080706|NCT00849680|75891092|FG001|Overall Study|Adverse Event|0|||
42080707|NCT00849680|75891093|FG002|Overall Study|Adverse Event|0|||
42080708|NCT00849680|75891094|FG003|Overall Study|Adverse Event|0|||
42357987|NCT00215943|76203558|FG001|Overall Study|Disease Progression|5|||
42080709|NCT00849680|75891095|FG004|Overall Study|Adverse Event|0|||
42178160|NCT00045942|75985198|FG004|PKC412A2104E2|Death|0|||
42178161|NCT00045942|75985199|FG005|PKC412A2104E2|Death|1|||
42080710|NCT00849680|75891096|FG005|Overall Study|Adverse Event|0|||
42080711|NCT00849680|75891097|FG006|Overall Study|Adverse Event|2|||
42080712|NCT00849680|75891098|FG007|Overall Study|Adverse Event|0|||
42080713|NCT00849680|75891091|FG000|Overall Study|Lost to Follow-up|7|||
42080714|NCT00849680|75891092|FG001|Overall Study|Lost to Follow-up|3|||
42080715|NCT00849680|75891093|FG002|Overall Study|Lost to Follow-up|12|||
42080716|NCT00849680|75891094|FG003|Overall Study|Lost to Follow-up|11|||
42080717|NCT00849680|75891095|FG004|Overall Study|Lost to Follow-up|8|||
42080718|NCT00849680|75891096|FG005|Overall Study|Lost to Follow-up|11|||
42080719|NCT00849680|75891097|FG006|Overall Study|Lost to Follow-up|12|||
42080720|NCT00849680|75891098|FG007|Overall Study|Lost to Follow-up|5|||
42080721|NCT00849680|75891091|FG000|Overall Study|Subject moved|1|||
42178162|NCT00045942|75985200|FG006|PKC412A2104E2|Death|2|||
42293811|NCT02603393|76128123|FG000|Overall Study|Non-compliance with study treatment|1|||
42293812|NCT02603393|76128124|FG001|Overall Study|Non-compliance with study treatment|0|||
42293813|NCT02603393|76128123|FG000|Overall Study|Sponsor decision|1|||
42293814|NCT02603393|76128124|FG001|Overall Study|Sponsor decision|0|||
42293815|NCT02642653|76128132|FG000|Overall Study|Adverse Event|2|||
42293816|NCT02642653|76128133|FG001|Overall Study|Adverse Event|0|||
42293817|NCT01659567|76128139|FG000|Overall Study|Lack of Efficacy|22|||
42293818|NCT01659567|76128139|FG000|Overall Study|Switched to Pegferon|6|||
42080722|NCT00849680|75891092|FG001|Overall Study|Subject moved|0|||
42080723|NCT00849680|75891093|FG002|Overall Study|Subject moved|3|||
42080724|NCT00849680|75891094|FG003|Overall Study|Subject moved|1|||
42080725|NCT00849680|75891095|FG004|Overall Study|Subject moved|0|||
42080726|NCT00849680|75891096|FG005|Overall Study|Subject moved|2|||
42080727|NCT00849680|75891097|FG006|Overall Study|Subject moved|2|||
42080728|NCT00849680|75891098|FG007|Overall Study|Subject moved|2|||
42080729|NCT00849680|75891091|FG000|Overall Study|Withdrawal by Subject|2|||
42080730|NCT00849680|75891092|FG001|Overall Study|Withdrawal by Subject|0|||
42080731|NCT00849680|75891093|FG002|Overall Study|Withdrawal by Subject|0|||
42080732|NCT00849680|75891094|FG003|Overall Study|Withdrawal by Subject|2|||
42080733|NCT00849680|75891095|FG004|Overall Study|Withdrawal by Subject|2|||
42080734|NCT00849680|75891096|FG005|Overall Study|Withdrawal by Subject|2|||
42080735|NCT00849680|75891097|FG006|Overall Study|Withdrawal by Subject|1|||
42080736|NCT00849680|75891098|FG007|Overall Study|Withdrawal by Subject|1|||
42080737|NCT00849680|75891091|FG000|Overall Study|Subject unable to comply with protocol|1|||
42080738|NCT00849680|75891092|FG001|Overall Study|Subject unable to comply with protocol|0|||
42080739|NCT00849680|75891093|FG002|Overall Study|Subject unable to comply with protocol|0|||
42080740|NCT00849680|75891094|FG003|Overall Study|Subject unable to comply with protocol|0|||
42080741|NCT00849680|75891095|FG004|Overall Study|Subject unable to comply with protocol|0|||
42080742|NCT00849680|75891096|FG005|Overall Study|Subject unable to comply with protocol|0|||
42080743|NCT00849680|75891097|FG006|Overall Study|Subject unable to comply with protocol|0|||
42080744|NCT00849680|75891098|FG007|Overall Study|Subject unable to comply with protocol|0|||
42293819|NCT01659567|76128139|FG000|Overall Study|Adverse Event|12|||
42293820|NCT01659567|76128139|FG000|Overall Study|Good result at early stage of treatment|5|||
42293821|NCT01659567|76128139|FG000|Overall Study|Withdrawal by Subject|64|||
42293822|NCT01659567|76128139|FG000|Overall Study|Progression of the main disease|1|||
42293823|NCT01659567|76128139|FG000|Overall Study|Other|13|||
42293824|NCT02605967|76128155|FG000|Overall Study|subject / guardian decision|1|||
42293825|NCT02605967|76128156|FG001|Overall Study|subject / guardian decision|2|||
42293826|NCT02605967|76128155|FG000|Overall Study|Physician Decision|10|||
42293827|NCT02605967|76128156|FG001|Overall Study|Physician Decision|1|||
42293828|NCT02605967|76128155|FG000|Overall Study|Death|4|||
42293829|NCT02605967|76128156|FG001|Overall Study|Death|2|||
42293830|NCT02605967|76128155|FG000|Overall Study|Adverse Event|1|||
42293831|NCT02605967|76128156|FG001|Overall Study|Adverse Event|0|||
42293832|NCT02605967|76128155|FG000|Overall Study|progressive disease|66|||
42293833|NCT02605967|76128156|FG001|Overall Study|progressive disease|35|||
42293834|NCT01668173|76128166|FG000|Overall Study|Adverse Event|3|||
42293835|NCT01668173|76128166|FG000|Overall Study|Trial suspension|4|||
42293836|NCT02600351|76128183|FG000|Overall Study|Lack of Efficacy|3|||
42293837|NCT02600351|76128184|FG001|Overall Study|Lack of Efficacy|0|||
42080745|NCT00810342|75891118|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
42080746|NCT00810342|75891119|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
42080747|NCT00810342|75891118|FG000|Month 1 Follow-up|Pregnancy|1|||
42080748|NCT00810342|75891119|FG001|Month 1 Follow-up|Pregnancy|0|||
42080749|NCT00810342|75891118|FG000|6-month Follow-up|Lost to Follow-up|18|||
42178163|NCT00045942|75985201|FG007|PKC412A2104E2|Death|0|||
42293838|NCT02600351|76128185|FG002|Overall Study|Lack of Efficacy|5|||
42293839|NCT02600351|76128186|FG003|Overall Study|Lack of Efficacy|2|||
42080750|NCT00810342|75891119|FG001|6-month Follow-up|Lost to Follow-up|6|||
42293840|NCT02600351|76128183|FG000|Overall Study|Lost to Follow-up|1|||
42080751|NCT00810342|75891118|FG000|6-month Follow-up|Pregnancy|6|||
42080752|NCT00810342|75891119|FG001|6-month Follow-up|Pregnancy|2|||
42080753|NCT00810342|75891118|FG000|12-month Followup|Pregnancy|9|||
42293841|NCT02600351|76128184|FG001|Overall Study|Lost to Follow-up|0|||
42080754|NCT00810342|75891119|FG001|12-month Followup|Pregnancy|10|||
42080755|NCT00810342|75891118|FG000|12-month Followup|Lost to Follow-up|3|||
42080756|NCT00810342|75891119|FG001|12-month Followup|Lost to Follow-up|1|||
42080757|NCT00849524|75891127|FG000|Overall Study|Lack of Efficacy|3|||
42080758|NCT00808080|75891131|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
42080759|NCT00866723|75891136|FG000|Overall Study|Withdrawal by Subject|1|||
42080760|NCT00866723|75891136|FG000|Overall Study|Disease Progression|4|||
42080761|NCT00849212|75891140|FG000|Overall Study|Lack of Efficacy|1|||
42080762|NCT00849212|75891140|FG000|Overall Study|Withdrawal by Subject|3|||
42080763|NCT00849212|75891140|FG000|Overall Study|Adverse Event|2|||
42080764|NCT00849212|75891140|FG000|Overall Study|Miscellaneous|1|||
42080765|NCT00810264|75891144|FG000|Overall Study|Lost to Follow-up|191|||
42080766|NCT00810264|75891144|FG000|Overall Study|Withdrawal by subject or physician|721|||
42080767|NCT00810264|75891144|FG000|Overall Study|Death|641|||
42080768|NCT00849056|75891154|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
42080769|NCT00849056|75891155|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
42080770|NCT00849056|75891154|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
42080771|NCT00849056|75891155|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
42080772|NCT00849056|75891154|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
42080773|NCT00849056|75891155|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
42080774|NCT00849056|75891154|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
42080775|NCT00849056|75891155|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
42080776|NCT00849056|75891154|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
42080777|NCT00849056|75891155|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
42080778|NCT00849056|75891154|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
42080779|NCT00849056|75891155|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
42080780|NCT00849056|75891154|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
42080781|NCT00849056|75891155|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
42080782|NCT00849056|75891154|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
42080783|NCT00849056|75891155|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
42080784|NCT00849056|75891154|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
42293842|NCT02600351|76128185|FG002|Overall Study|Lost to Follow-up|0|||
42293843|NCT02600351|76128186|FG003|Overall Study|Lost to Follow-up|0|||
42293844|NCT02600351|76128183|FG000|Overall Study|Randomized but Not Treated|1|||
42293845|NCT02600351|76128184|FG001|Overall Study|Randomized but Not Treated|0|||
42293846|NCT02600351|76128185|FG002|Overall Study|Randomized but Not Treated|1|||
42293847|NCT02600351|76128186|FG003|Overall Study|Randomized but Not Treated|3|||
42293848|NCT02640235|76128200|FG000|Overall Study|Withdrawal by Subject|7|||
42293849|NCT02640235|76128201|FG001|Overall Study|Withdrawal by Subject|6|||
42293850|NCT02640235|76128200|FG000|Overall Study|Lost to Follow-up|4|||
42293851|NCT02640235|76128201|FG001|Overall Study|Lost to Follow-up|3|||
42357988|NCT00215943|76203557|FG000|Overall Study|Alternate therapy|0|||
42357989|NCT00215943|76203558|FG001|Overall Study|Alternate therapy|1|||
42357990|NCT00215943|76203557|FG000|Overall Study|Adverse Event|3|||
42357991|NCT00215943|76203558|FG001|Overall Study|Adverse Event|6|||
42357992|NCT00215943|76203557|FG000|Overall Study|Other disease|0|||
42357993|NCT00215943|76203558|FG001|Overall Study|Other disease|1|||
42357994|NCT00215943|76203557|FG000|Overall Study|Other complications|3|||
42357995|NCT00215943|76203558|FG001|Overall Study|Other complications|1|||
42357996|NCT01827319|76203564|FG000|Overall Study|Lost to Follow-up|3|||
42357997|NCT01827163|76203568|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
42357998|NCT01827163|76203568|FG000|Overall Study|Adverse Event|9|||
42357999|NCT00215553|76203579|FG000|Overall Study|Adverse Event|0|||
42358000|NCT00215553|76203580|FG001|Overall Study|Adverse Event|1|||
42358001|NCT00215553|76203581|FG002|Overall Study|Adverse Event|2|||
42358002|NCT00215553|76203582|FG003|Overall Study|Adverse Event|1|||
42358003|NCT00215553|76203583|FG004|Overall Study|Adverse Event|2|||
42358004|NCT00215553|76203584|FG005|Overall Study|Adverse Event|6|||
42358005|NCT00215553|76203585|FG006|Overall Study|Adverse Event|0|||
42358006|NCT00214461|76203605|FG000|Overall Study|Adverse Event|0|||
42358007|NCT00214461|76203606|FG001|Overall Study|Adverse Event|0|||
42358008|NCT00214461|76203607|FG002|Overall Study|Adverse Event|1|||
42358009|NCT00214461|76203608|FG003|Overall Study|Adverse Event|1|||
42358010|NCT00214461|76203605|FG000|Overall Study|Withdrawal by Subject|0|||
42080785|NCT00849056|75891155|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
42080786|NCT00849056|75891154|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
42293852|NCT02640235|76128200|FG000|Overall Study|Death|2|||
42293853|NCT02640235|76128201|FG001|Overall Study|Death|3|||
42293854|NCT02640235|76128200|FG000|Overall Study|Other|1|||
42293855|NCT02640235|76128201|FG001|Overall Study|Other|2|||
42358011|NCT00214461|76203606|FG001|Overall Study|Withdrawal by Subject|0|||
42178164|NCT00045942|75985202|FG008|PKC412A2104E2|Death|0|||
42293856|NCT02599961|76128207|FG000|Overall Study|Withdrawal by Subject|1|||
42358012|NCT00214461|76203607|FG002|Overall Study|Withdrawal by Subject|1|||
42358013|NCT00214461|76203608|FG003|Overall Study|Withdrawal by Subject|0|||
42358014|NCT00214383|76203620|FG000|Overall Study|Lost to Follow-up|16|||
42293857|NCT02599961|76128207|FG000|Overall Study|Subject Non-Compliance|2|||
42293858|NCT02599961|76128207|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
42293859|NCT02599961|76128207|FG000|Overall Study|Other, Not Specified|3|||
42293860|NCT02640157|76128232|FG000|Overall Study|Adverse Event|2|||
42293861|NCT02640157|76128233|FG001|Overall Study|Adverse Event|2|||
42293862|NCT02640157|76128234|FG002|Overall Study|Adverse Event|1|||
42293863|NCT02640157|76128232|FG000|Overall Study|Withdrew consent|2|||
42358015|NCT00214383|76203621|FG001|Overall Study|Lost to Follow-up|26|||
42358016|NCT00212355|76203627|FG000|Overall Study|Adverse Event|1|||
42358017|NCT00212355|76203627|FG000|Overall Study|Withdrawal by Subject|1|||
42358018|NCT00212355|76203627|FG000|Overall Study|A change of address|1|||
42358019|NCT00211887|76203634|FG000|Overall Study|Adverse Event|8|||
42358020|NCT00211887|76203635|FG001|Overall Study|Adverse Event|4|||
42358021|NCT00211887|76203636|FG002|Overall Study|Adverse Event|6|||
42358022|NCT00211887|76203634|FG000|Overall Study|Death|1|||
42358023|NCT00211887|76203635|FG001|Overall Study|Death|1|||
42358024|NCT00211887|76203636|FG002|Overall Study|Death|1|||
42358025|NCT00211887|76203634|FG000|Overall Study|Lost to Follow-up|28|||
42358026|NCT00211887|76203635|FG001|Overall Study|Lost to Follow-up|13|||
42358027|NCT00211887|76203636|FG002|Overall Study|Lost to Follow-up|9|||
42358028|NCT00211887|76203634|FG000|Overall Study|Non-medical reason|31|||
42358029|NCT00211887|76203635|FG001|Overall Study|Non-medical reason|14|||
42358030|NCT00211887|76203636|FG002|Overall Study|Non-medical reason|8|||
42358031|NCT00211887|76203634|FG000|Overall Study|Other medical reason|15|||
42358032|NCT00211887|76203635|FG001|Overall Study|Other medical reason|11|||
42358033|NCT00211887|76203636|FG002|Overall Study|Other medical reason|7|||
42358034|NCT00211887|76203634|FG000|Overall Study|Side effects|19|||
42358035|NCT00211887|76203635|FG001|Overall Study|Side effects|13|||
42358036|NCT00211887|76203636|FG002|Overall Study|Side effects|5|||
42358037|NCT01855945|76203656|FG000|Overall Study|Adverse Event|0|||
42358038|NCT01855945|76203657|FG001|Overall Study|Adverse Event|0|||
42358039|NCT01855945|76203658|FG002|Overall Study|Adverse Event|0|||
42358040|NCT01855945|76203659|FG003|Overall Study|Adverse Event|0|||
42358041|NCT01855945|76203660|FG004|Overall Study|Adverse Event|0|||
42358042|NCT01855945|76203661|FG005|Overall Study|Adverse Event|0|||
42358043|NCT01855945|76203662|FG006|Overall Study|Adverse Event|1|||
42358044|NCT01855945|76203663|FG007|Overall Study|Adverse Event|0|||
42358045|NCT01855945|76203664|FG008|Overall Study|Adverse Event|0|||
42358046|NCT01855945|76203665|FG009|Overall Study|Adverse Event|0|||
42358047|NCT01855945|76203666|FG010|Overall Study|Adverse Event|0|||
42358048|NCT01855945|76203667|FG011|Overall Study|Adverse Event|0|||
42358049|NCT01855945|76203656|FG000|Overall Study|Death|0|||
42358050|NCT01855945|76203657|FG001|Overall Study|Death|0|||
42358051|NCT01855945|76203658|FG002|Overall Study|Death|0|||
42358052|NCT01855945|76203659|FG003|Overall Study|Death|0|||
42358053|NCT01855945|76203660|FG004|Overall Study|Death|0|||
42358054|NCT01855945|76203661|FG005|Overall Study|Death|0|||
42358055|NCT01855945|76203662|FG006|Overall Study|Death|2|||
42358056|NCT01855945|76203663|FG007|Overall Study|Death|0|||
42358057|NCT01855945|76203664|FG008|Overall Study|Death|0|||
42358058|NCT01855945|76203665|FG009|Overall Study|Death|0|||
42080787|NCT00849056|75891155|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
42080788|NCT00849056|75891154|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
42080789|NCT00849056|75891155|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
42080790|NCT00849056|75891154|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
42080791|NCT00849056|75891155|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
42080792|NCT00849056|75891154|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
42080793|NCT00849056|75891155|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
42080794|NCT00849056|75891154|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
42080795|NCT00849056|75891155|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
42178165|NCT04386616|75985229|FG000|Overall Study|Death|22|||
42178166|NCT04386616|75985230|FG001|Overall Study|Death|22|||
42178167|NCT04386616|75985231|FG002|Overall Study|Death|21|||
42178168|NCT04386616|75985229|FG000|Overall Study|Lost to Follow-up|5|||
42358059|NCT01855945|76203666|FG010|Overall Study|Death|0|||
42358060|NCT01855945|76203667|FG011|Overall Study|Death|0|||
42358061|NCT01855945|76203656|FG000|Overall Study|Lost to Follow-up|11|||
42358062|NCT01855945|76203657|FG001|Overall Study|Lost to Follow-up|10|||
42358063|NCT01855945|76203658|FG002|Overall Study|Lost to Follow-up|7|||
42080796|NCT00849056|75891154|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
42080797|NCT00849056|75891155|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
42293864|NCT02640157|76128233|FG001|Overall Study|Withdrew consent|0|||
42358064|NCT01855945|76203659|FG003|Overall Study|Lost to Follow-up|3|||
42358065|NCT01855945|76203660|FG004|Overall Study|Lost to Follow-up|0|||
42358066|NCT01855945|76203661|FG005|Overall Study|Lost to Follow-up|3|||
42358067|NCT01855945|76203662|FG006|Overall Study|Lost to Follow-up|4|||
42358068|NCT01855945|76203663|FG007|Overall Study|Lost to Follow-up|7|||
42358069|NCT01855945|76203664|FG008|Overall Study|Lost to Follow-up|2|||
42358070|NCT01855945|76203665|FG009|Overall Study|Lost to Follow-up|0|||
42293865|NCT02640157|76128234|FG002|Overall Study|Withdrew consent|2|||
42293866|NCT02640157|76128232|FG000|Overall Study|Lost to Follow-up|9|||
42293867|NCT02640157|76128233|FG001|Overall Study|Lost to Follow-up|2|||
42293868|NCT02640157|76128234|FG002|Overall Study|Lost to Follow-up|7|||
42293869|NCT02640157|76128232|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
42293870|NCT02640157|76128233|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
42293871|NCT02640157|76128234|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
42293872|NCT01673347|76128243|FG000|Overall Study|failure of allograft|7|||
42293873|NCT02528253|76128252|FG000|Overall Study|Adverse Event|3|||
42293874|NCT02528253|76128253|FG001|Overall Study|Adverse Event|4|||
42293875|NCT02528253|76128254|FG002|Overall Study|Adverse Event|4|||
42293876|NCT02528253|76128255|FG003|Overall Study|Adverse Event|8|||
42293877|NCT02528253|76128256|FG004|Overall Study|Adverse Event|18|||
42293878|NCT02528253|76128252|FG000|Overall Study|Death|2|||
42293879|NCT02528253|76128253|FG001|Overall Study|Death|2|||
42293880|NCT02528253|76128254|FG002|Overall Study|Death|1|||
42293881|NCT02528253|76128255|FG003|Overall Study|Death|0|||
42293882|NCT02528253|76128256|FG004|Overall Study|Death|1|||
42293883|NCT02528253|76128252|FG000|Overall Study|Insufficient clinical response|7|||
42293884|NCT02528253|76128253|FG001|Overall Study|Insufficient clinical response|10|||
42293885|NCT02528253|76128254|FG002|Overall Study|Insufficient clinical response|13|||
42293886|NCT02528253|76128255|FG003|Overall Study|Insufficient clinical response|12|||
42293887|NCT02528253|76128256|FG004|Overall Study|Insufficient clinical response|16|||
42293888|NCT02528253|76128252|FG000|Overall Study|Lost to Follow-up|16|||
42293889|NCT02528253|76128253|FG001|Overall Study|Lost to Follow-up|9|||
42293890|NCT02528253|76128254|FG002|Overall Study|Lost to Follow-up|31|||
42293891|NCT02528253|76128255|FG003|Overall Study|Lost to Follow-up|16|||
42293892|NCT02528253|76128256|FG004|Overall Study|Lost to Follow-up|34|||
42293893|NCT02528253|76128252|FG000|Overall Study|Other|21|||
42293894|NCT02528253|76128253|FG001|Overall Study|Other|22|||
42293895|NCT02528253|76128254|FG002|Overall Study|Other|58|||
42293896|NCT02528253|76128255|FG003|Overall Study|Other|52|||
42293897|NCT02528253|76128256|FG004|Overall Study|Other|76|||
42293898|NCT02528253|76128252|FG000|Overall Study|Withdrawal by Subject|25|||
42293899|NCT02528253|76128253|FG001|Overall Study|Withdrawal by Subject|20|||
42293900|NCT02528253|76128254|FG002|Overall Study|Withdrawal by Subject|29|||
42293901|NCT02528253|76128255|FG003|Overall Study|Withdrawal by Subject|48|||
42293902|NCT02528253|76128256|FG004|Overall Study|Withdrawal by Subject|73|||
42293903|NCT02528253|76128252|FG000|Overall Study|Protocol Violation|1|||
42293904|NCT02528253|76128253|FG001|Overall Study|Protocol Violation|2|||
42293905|NCT02528253|76128254|FG002|Overall Study|Protocol Violation|4|||
42293906|NCT02528253|76128255|FG003|Overall Study|Protocol Violation|0|||
42293907|NCT02528253|76128256|FG004|Overall Study|Protocol Violation|4|||
42293908|NCT02528253|76128252|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
42293909|NCT02528253|76128253|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
42293910|NCT02528253|76128254|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
42293911|NCT02528253|76128255|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
42293912|NCT02528253|76128256|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
42293913|NCT01672957|76128287|FG000|Overall Study|Protocol Violation|48|||
42293914|NCT01672957|76128287|FG000|Overall Study|Death|2|||
42293915|NCT01672957|76128287|FG000|Overall Study|ICF Signed After Transplantation|5|||
42293916|NCT02525133|76128293|FG000|Overall Study|Adverse Event|0|||
42293917|NCT02525133|76128294|FG001|Overall Study|Adverse Event|1|||
42293918|NCT02525133|76128293|FG000|Overall Study|Death|0|||
42293919|NCT02525133|76128294|FG001|Overall Study|Death|1|||
42293920|NCT02525133|76128293|FG000|Overall Study|did not meet randomization criteria|1|||
42293921|NCT02525133|76128294|FG001|Overall Study|did not meet randomization criteria|0|||
42293922|NCT02525133|76128293|FG000|Overall Study|Lost to Follow-up|5|||
42293923|NCT02525133|76128294|FG001|Overall Study|Lost to Follow-up|1|||
42293924|NCT02525133|76128293|FG000|Overall Study|randomized not enrolled|3|||
42293925|NCT02525133|76128294|FG001|Overall Study|randomized not enrolled|0|||
42293926|NCT02525133|76128293|FG000|Overall Study|Withdrawal by Subject|1|||
42293927|NCT02525133|76128294|FG001|Overall Study|Withdrawal by Subject|0|||
42293928|NCT01659255|76128321|FG000|Overall Study|Adverse Event|0|||
42293929|NCT01659255|76128322|FG001|Overall Study|Adverse Event|0|||
42178169|NCT04386616|75985230|FG001|Overall Study|Lost to Follow-up|8|||
42178170|NCT04386616|75985231|FG002|Overall Study|Lost to Follow-up|6|||
42178171|NCT04386616|75985229|FG000|Overall Study|Withdrawal by Subject|2|||
42178172|NCT04386616|75985230|FG001|Overall Study|Withdrawal by Subject|4|||
42178173|NCT04386616|75985231|FG002|Overall Study|Withdrawal by Subject|1|||
42293930|NCT01659255|76128323|FG002|Overall Study|Adverse Event|0|||
42293931|NCT01659255|76128324|FG003|Overall Study|Adverse Event|0|||
42293932|NCT01659255|76128325|FG004|Overall Study|Adverse Event|0|||
42293933|NCT01659255|76128326|FG005|Overall Study|Adverse Event|1|||
42178174|NCT04386616|75985229|FG000|Overall Study|Adverse Event|1|||
42293934|NCT01659255|76128327|FG006|Overall Study|Adverse Event|1|||
42293935|NCT01659255|76128328|FG007|Overall Study|Adverse Event|0|||
42178175|NCT04386616|75985230|FG001|Overall Study|Adverse Event|1|||
42293936|NCT01659255|76128329|FG008|Overall Study|Adverse Event|0|||
42293937|NCT01659255|76128330|FG009|Overall Study|Adverse Event|1|||
42293938|NCT01659255|76128331|FG010|Overall Study|Adverse Event|0|||
42293939|NCT01659255|76128332|FG011|Overall Study|Adverse Event|1|||
42293940|NCT01659255|76128333|FG012|Overall Study|Adverse Event|0|||
42293941|NCT01659255|76128334|FG013|Overall Study|Adverse Event|2|||
42293942|NCT01659255|76128335|FG014|Overall Study|Adverse Event|0|||
42293943|NCT01659255|76128336|FG015|Overall Study|Adverse Event|1|||
42293944|NCT01659255|76128337|FG016|Overall Study|Adverse Event|0|||
42293945|NCT01659255|76128321|FG000|Overall Study|Death|0|||
42293946|NCT01659255|76128322|FG001|Overall Study|Death|1|||
42293947|NCT01659255|76128323|FG002|Overall Study|Death|0|||
42293948|NCT01659255|76128324|FG003|Overall Study|Death|0|||
42293949|NCT01659255|76128325|FG004|Overall Study|Death|0|||
42293950|NCT01659255|76128326|FG005|Overall Study|Death|0|||
42293951|NCT01659255|76128327|FG006|Overall Study|Death|0|||
42293952|NCT01659255|76128328|FG007|Overall Study|Death|1|||
42293953|NCT01659255|76128329|FG008|Overall Study|Death|1|||
42293954|NCT01659255|76128330|FG009|Overall Study|Death|0|||
42293955|NCT01659255|76128331|FG010|Overall Study|Death|0|||
42293956|NCT01659255|76128332|FG011|Overall Study|Death|0|||
42293957|NCT01659255|76128333|FG012|Overall Study|Death|1|||
42293958|NCT01659255|76128334|FG013|Overall Study|Death|1|||
42293959|NCT01659255|76128335|FG014|Overall Study|Death|2|||
42293960|NCT01659255|76128336|FG015|Overall Study|Death|1|||
42293961|NCT01659255|76128337|FG016|Overall Study|Death|0|||
42293962|NCT01659255|76128321|FG000|Overall Study|Progressive Disease|2|||
42293963|NCT01659255|76128322|FG001|Overall Study|Progressive Disease|0|||
42293964|NCT01659255|76128323|FG002|Overall Study|Progressive Disease|0|||
42293965|NCT01659255|76128324|FG003|Overall Study|Progressive Disease|0|||
42293966|NCT01659255|76128325|FG004|Overall Study|Progressive Disease|0|||
42293967|NCT01659255|76128326|FG005|Overall Study|Progressive Disease|0|||
42293968|NCT01659255|76128327|FG006|Overall Study|Progressive Disease|0|||
42293969|NCT01659255|76128328|FG007|Overall Study|Progressive Disease|1|||
42293970|NCT01659255|76128329|FG008|Overall Study|Progressive Disease|0|||
42293971|NCT01659255|76128330|FG009|Overall Study|Progressive Disease|2|||
42293972|NCT01659255|76128331|FG010|Overall Study|Progressive Disease|2|||
42293973|NCT01659255|76128332|FG011|Overall Study|Progressive Disease|3|||
42293974|NCT01659255|76128333|FG012|Overall Study|Progressive Disease|5|||
42293975|NCT01659255|76128334|FG013|Overall Study|Progressive Disease|13|||
42293976|NCT01659255|76128335|FG014|Overall Study|Progressive Disease|6|||
42293977|NCT01659255|76128336|FG015|Overall Study|Progressive Disease|2|||
42293978|NCT01659255|76128337|FG016|Overall Study|Progressive Disease|3|||
42293979|NCT01659255|76128321|FG000|Overall Study|Withdrew Consent|0|||
42293980|NCT01659255|76128322|FG001|Overall Study|Withdrew Consent|0|||
42293981|NCT01659255|76128323|FG002|Overall Study|Withdrew Consent|0|||
42293982|NCT01659255|76128324|FG003|Overall Study|Withdrew Consent|0|||
42293983|NCT01659255|76128325|FG004|Overall Study|Withdrew Consent|0|||
42293984|NCT01659255|76128326|FG005|Overall Study|Withdrew Consent|0|||
42293985|NCT01659255|76128327|FG006|Overall Study|Withdrew Consent|0|||
42293986|NCT01659255|76128328|FG007|Overall Study|Withdrew Consent|0|||
42293987|NCT01659255|76128329|FG008|Overall Study|Withdrew Consent|0|||
42293988|NCT01659255|76128330|FG009|Overall Study|Withdrew Consent|0|||
42293989|NCT01659255|76128331|FG010|Overall Study|Withdrew Consent|1|||
42293990|NCT01659255|76128332|FG011|Overall Study|Withdrew Consent|0|||
42293991|NCT01659255|76128333|FG012|Overall Study|Withdrew Consent|0|||
42293992|NCT01659255|76128334|FG013|Overall Study|Withdrew Consent|1|||
42293993|NCT01659255|76128335|FG014|Overall Study|Withdrew Consent|0|||
42293994|NCT01659255|76128336|FG015|Overall Study|Withdrew Consent|0|||
42293995|NCT01659255|76128337|FG016|Overall Study|Withdrew Consent|0|||
42293996|NCT01659255|76128321|FG000|Overall Study|Investigator Decision|0|||
42293997|NCT01659255|76128322|FG001|Overall Study|Investigator Decision|0|||
42293998|NCT01659255|76128323|FG002|Overall Study|Investigator Decision|0|||
42293999|NCT01659255|76128324|FG003|Overall Study|Investigator Decision|0|||
42294000|NCT01659255|76128325|FG004|Overall Study|Investigator Decision|0|||
42294001|NCT01659255|76128326|FG005|Overall Study|Investigator Decision|0|||
42294002|NCT01659255|76128327|FG006|Overall Study|Investigator Decision|0|||
42294003|NCT01659255|76128328|FG007|Overall Study|Investigator Decision|0|||
42294004|NCT01659255|76128329|FG008|Overall Study|Investigator Decision|0|||
42294005|NCT01659255|76128330|FG009|Overall Study|Investigator Decision|0|||
42080798|NCT00849056|75891154|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
42294006|NCT01659255|76128331|FG010|Overall Study|Investigator Decision|0|||
42294007|NCT01659255|76128332|FG011|Overall Study|Investigator Decision|0|||
42294008|NCT01659255|76128333|FG012|Overall Study|Investigator Decision|1|||
42294009|NCT01659255|76128334|FG013|Overall Study|Investigator Decision|1|||
42294010|NCT01659255|76128335|FG014|Overall Study|Investigator Decision|0|||
42294011|NCT01659255|76128336|FG015|Overall Study|Investigator Decision|0|||
42294012|NCT01659255|76128337|FG016|Overall Study|Investigator Decision|0|||
42080799|NCT00849056|75891155|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
42080800|NCT00837434|75891163|FG000|Overall Study|Physician Decision|3|||
42080801|NCT00837434|75891164|FG001|Overall Study|Physician Decision|0|||
42080802|NCT00837434|75891163|FG000|Overall Study|Lost to Follow-up|1|||
42080803|NCT00837434|75891164|FG001|Overall Study|Lost to Follow-up|1|||
42080804|NCT00837434|75891163|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
42080805|NCT00837434|75891164|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
42080806|NCT00837434|75891163|FG000|Overall Study|Noncompliant|2|||
42080807|NCT00837434|75891164|FG001|Overall Study|Noncompliant|0|||
42080808|NCT00837434|75891163|FG000|Overall Study|Baseline assessments not done in time|1|||
42080809|NCT00837434|75891164|FG001|Overall Study|Baseline assessments not done in time|0|||
42080810|NCT00837434|75891163|FG000|Overall Study|Unable to obtain study drug|1|||
42080811|NCT00837434|75891164|FG001|Overall Study|Unable to obtain study drug|0|||
42080812|NCT00827918|75891173|FG000|Overall Study|Adverse Event|4|||
42080813|NCT00827918|75891174|FG001|Overall Study|Adverse Event|0|||
42080814|NCT00827918|75891175|FG002|Overall Study|Adverse Event|0|||
42080815|NCT00827918|75891173|FG000|Overall Study|Lack of Efficacy|16|||
42080816|NCT00827918|75891174|FG001|Overall Study|Lack of Efficacy|4|||
42080817|NCT00827918|75891175|FG002|Overall Study|Lack of Efficacy|15|||
42080818|NCT00827918|75891173|FG000|Overall Study|Physician Decision|1|||
42080819|NCT00827918|75891174|FG001|Overall Study|Physician Decision|0|||
42080820|NCT00827918|75891175|FG002|Overall Study|Physician Decision|0|||
42080821|NCT00827918|75891173|FG000|Overall Study|Pregnancy|0|||
42080822|NCT00827918|75891174|FG001|Overall Study|Pregnancy|1|||
42080823|NCT00827918|75891175|FG002|Overall Study|Pregnancy|0|||
42080824|NCT00827918|75891173|FG000|Overall Study|Progressive Disease|1|||
42080825|NCT00827918|75891174|FG001|Overall Study|Progressive Disease|1|||
42080826|NCT00827918|75891175|FG002|Overall Study|Progressive Disease|0|||
42080827|NCT00827918|75891173|FG000|Overall Study|Protocol Violation|0|||
42080828|NCT00827918|75891174|FG001|Overall Study|Protocol Violation|1|||
42080829|NCT00827918|75891175|FG002|Overall Study|Protocol Violation|0|||
42080830|NCT00827918|75891173|FG000|Overall Study|Withdrawal by Subject|6|||
42080831|NCT00827918|75891174|FG001|Overall Study|Withdrawal by Subject|2|||
42080832|NCT00827918|75891175|FG002|Overall Study|Withdrawal by Subject|6|||
42080833|NCT00813150|75891185|FG000|Treatment Period|Adverse Event|16|||
42080834|NCT00813150|75891186|FG001|Treatment Period|Adverse Event|15|||
42080835|NCT00813150|75891185|FG000|Treatment Period|Death|2|||
42080836|NCT00813150|75891186|FG001|Treatment Period|Death|0|||
42080837|NCT00813150|75891185|FG000|Treatment Period|Progressive disease|1|||
42080838|NCT00813150|75891186|FG001|Treatment Period|Progressive disease|0|||
42080839|NCT00813150|75891185|FG000|Treatment Period|Complete response|0|||
42080840|NCT00813150|75891186|FG001|Treatment Period|Complete response|1|||
42080841|NCT00813150|75891185|FG000|Treatment Period|Stable disease|1|||
42080842|NCT00813150|75891186|FG001|Treatment Period|Stable disease|2|||
42080843|NCT00813150|75891185|FG000|Treatment Period|Protocol Violation|3|||
42080844|NCT00813150|75891186|FG001|Treatment Period|Protocol Violation|4|||
42080845|NCT00813150|75891185|FG000|Treatment Period|Withdrawal by Subject|5|||
42080846|NCT00813150|75891186|FG001|Treatment Period|Withdrawal by Subject|3|||
42080847|NCT00813150|75891185|FG000|Treatment Period|Non compliance|0|||
42080848|NCT00813150|75891186|FG001|Treatment Period|Non compliance|1|||
42080849|NCT00813150|75891185|FG000|Treatment Period|Reason not specified|3|||
42080850|NCT00813150|75891186|FG001|Treatment Period|Reason not specified|4|||
42080851|NCT00813150|75891185|FG000|Treatment Period|Data not available|1|||
42080852|NCT00813150|75891186|FG001|Treatment Period|Data not available|2|||
42080853|NCT00813150|75891185|FG000|Long Term Follow-up|Death|0|||
42080854|NCT00813150|75891186|FG001|Long Term Follow-up|Death|4|||
42080855|NCT00813150|75891185|FG000|Long Term Follow-up|Other|0|||
42080856|NCT00813150|75891186|FG001|Long Term Follow-up|Other|3|||
42080857|NCT00813150|75891185|FG000|Long Term Follow-up|Lost to Follow-up|2|||
42080858|NCT00813150|75891186|FG001|Long Term Follow-up|Lost to Follow-up|0|||
42080859|NCT00813150|75891185|FG000|Long Term Follow-up|Progression/Relapse|22|||
42080860|NCT00813150|75891186|FG001|Long Term Follow-up|Progression/Relapse|24|||
42080861|NCT00807846|75891194|FG000|Overall Study|Adverse Event|5|||
42080862|NCT00807846|75891195|FG001|Overall Study|Adverse Event|0|||
42080863|NCT00807846|75891194|FG000|Overall Study|Lack of Efficacy|2|||
42294013|NCT01659255|76128321|FG000|Overall Study|Sponsor's Decision|0|||
42294014|NCT01659255|76128322|FG001|Overall Study|Sponsor's Decision|0|||
42294015|NCT01659255|76128323|FG002|Overall Study|Sponsor's Decision|0|||
42294016|NCT01659255|76128324|FG003|Overall Study|Sponsor's Decision|0|||
42080864|NCT00807846|75891195|FG001|Overall Study|Lack of Efficacy|0|||
42080865|NCT00807846|75891194|FG000|Overall Study|Protocol Violation|2|||
42080866|NCT00807846|75891195|FG001|Overall Study|Protocol Violation|1|||
42080867|NCT00807846|75891194|FG000|Overall Study|Withdrawal by Subject|2|||
42080868|NCT00807846|75891195|FG001|Overall Study|Withdrawal by Subject|1|||
42080869|NCT00807846|75891194|FG000|Overall Study|Other|1|||
42080870|NCT00807846|75891195|FG001|Overall Study|Other|2|||
42080871|NCT00810108|75891203|FG000|Overall Study|Withdrawal by Subject|1|||
42080872|NCT00810108|75891204|FG001|Overall Study|Withdrawal by Subject|0|||
42080873|NCT00827606|75891211|FG000|Overall Study|Protocol Violation|4|||
42080874|NCT00827606|75891212|FG001|Overall Study|Protocol Violation|3|||
42080875|NCT00827606|75891211|FG000|Overall Study|Lost to Follow-up|3|||
42080876|NCT00827606|75891212|FG001|Overall Study|Lost to Follow-up|1|||
42080877|NCT00827606|75891211|FG000|Overall Study|Withdrawal by Subject|7|||
42080878|NCT00827606|75891212|FG001|Overall Study|Withdrawal by Subject|6|||
42080879|NCT00827606|75891211|FG000|Overall Study|Pregnancy|0|||
42080880|NCT00827606|75891212|FG001|Overall Study|Pregnancy|1|||
42080881|NCT00827606|75891211|FG000|Overall Study|Other|5|||
42080882|NCT00827606|75891212|FG001|Overall Study|Other|13|||
42080883|NCT00827606|75891211|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
42080884|NCT00827606|75891212|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
42080885|NCT00827606|75891211|FG000|Overall Study|Adverse Event|4|||
42080886|NCT00827606|75891212|FG001|Overall Study|Adverse Event|2|||
42080887|NCT00663052|75891226|FG000|Overall Study|Adverse Event|6|||
42294017|NCT01659255|76128325|FG004|Overall Study|Sponsor's Decision|0|||
42294018|NCT01659255|76128326|FG005|Overall Study|Sponsor's Decision|0|||
42178176|NCT04386616|75985231|FG002|Overall Study|Adverse Event|0|||
42178177|NCT00045708|75985251|FG000|Phase 1|early progressive disease|0|||
42178178|NCT00045708|75985252|FG001|Phase 1|early progressive disease|1|||
42178179|NCT00045708|75985253|FG002|Phase 1|early progressive disease|0|||
42178180|NCT00045630|75985270|FG000|Overall Study|Adverse Event|1|||
42358071|NCT01855945|76203666|FG010|Overall Study|Lost to Follow-up|0|||
42358072|NCT01855945|76203667|FG011|Overall Study|Lost to Follow-up|2|||
42358073|NCT01855945|76203656|FG000|Overall Study|Other - Unclassified|1|||
42358074|NCT01855945|76203657|FG001|Overall Study|Other - Unclassified|1|||
42358075|NCT01855945|76203658|FG002|Overall Study|Other - Unclassified|1|||
42358076|NCT01855945|76203659|FG003|Overall Study|Other - Unclassified|0|||
42358077|NCT01855945|76203660|FG004|Overall Study|Other - Unclassified|0|||
42358078|NCT01855945|76203661|FG005|Overall Study|Other - Unclassified|0|||
42358079|NCT01855945|76203662|FG006|Overall Study|Other - Unclassified|2|||
42178181|NCT00045630|75985270|FG000|Overall Study|Refusal unrelated to adverse event|1|||
42178182|NCT00045630|75985270|FG000|Overall Study|Progression/relapse|1|||
42178183|NCT00045630|75985270|FG000|Overall Study|Death|1|||
42178184|NCT00045630|75985270|FG000|Overall Study|Ineligible|2|||
42294019|NCT01659255|76128327|FG006|Overall Study|Sponsor's Decision|1|||
42294020|NCT01659255|76128328|FG007|Overall Study|Sponsor's Decision|0|||
42294021|NCT01659255|76128329|FG008|Overall Study|Sponsor's Decision|0|||
42294022|NCT01659255|76128330|FG009|Overall Study|Sponsor's Decision|0|||
42294023|NCT01659255|76128331|FG010|Overall Study|Sponsor's Decision|0|||
42294024|NCT01659255|76128332|FG011|Overall Study|Sponsor's Decision|0|||
42358080|NCT01855945|76203663|FG007|Overall Study|Other - Unclassified|1|||
42358081|NCT01855945|76203664|FG008|Overall Study|Other - Unclassified|0|||
42358082|NCT01855945|76203665|FG009|Overall Study|Other - Unclassified|0|||
42358083|NCT01855945|76203666|FG010|Overall Study|Other - Unclassified|1|||
42294025|NCT01659255|76128333|FG012|Overall Study|Sponsor's Decision|0|||
42358084|NCT01855945|76203667|FG011|Overall Study|Other - Unclassified|0|||
42358085|NCT01855945|76203656|FG000|Overall Study|Withdrawal by Subject|4|||
42358086|NCT01855945|76203657|FG001|Overall Study|Withdrawal by Subject|0|||
42358087|NCT01855945|76203658|FG002|Overall Study|Withdrawal by Subject|4|||
42358088|NCT01855945|76203659|FG003|Overall Study|Withdrawal by Subject|1|||
42080888|NCT00663052|75891227|FG001|Overall Study|Adverse Event|3|||
42080889|NCT00663052|75891226|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
42080890|NCT00663052|75891227|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
42080891|NCT00663052|75891226|FG000|Overall Study|Protocol Violation|1|||
42294026|NCT01659255|76128334|FG013|Overall Study|Sponsor's Decision|0|||
42294027|NCT01659255|76128335|FG014|Overall Study|Sponsor's Decision|0|||
42294028|NCT01659255|76128336|FG015|Overall Study|Sponsor's Decision|0|||
42294029|NCT01659255|76128337|FG016|Overall Study|Sponsor's Decision|0|||
42358089|NCT01855945|76203660|FG004|Overall Study|Withdrawal by Subject|1|||
42358090|NCT01855945|76203661|FG005|Overall Study|Withdrawal by Subject|0|||
42358091|NCT01855945|76203662|FG006|Overall Study|Withdrawal by Subject|1|||
42358092|NCT01855945|76203663|FG007|Overall Study|Withdrawal by Subject|0|||
42080892|NCT00663052|75891227|FG001|Overall Study|Protocol Violation|0|||
42080893|NCT00663052|75891226|FG000|Overall Study|Withdrawal by Subject|2|||
42080894|NCT00663052|75891227|FG001|Overall Study|Withdrawal by Subject|5|||
42080895|NCT00663052|75891226|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
42080896|NCT00663052|75891227|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
42080897|NCT00663052|75891226|FG000|Overall Study|Other|0|||
42080898|NCT00663052|75891227|FG001|Overall Study|Other|1|||
42080899|NCT00826748|75891236|FG000|Overall Study|Withdrawal by Subject|0|||
42080900|NCT00826748|75891237|FG001|Overall Study|Withdrawal by Subject|0|||
42080901|NCT00826748|75891238|FG002|Overall Study|Withdrawal by Subject|2|||
42080902|NCT00826748|75891236|FG000|Overall Study|Physician Decision|0|||
42080903|NCT00826748|75891237|FG001|Overall Study|Physician Decision|0|||
42080904|NCT00826748|75891238|FG002|Overall Study|Physician Decision|1|||
42080905|NCT00826748|75891236|FG000|Overall Study|Samples Did Not pass QC|0|||
42080906|NCT00826748|75891237|FG001|Overall Study|Samples Did Not pass QC|0|||
42080907|NCT00826748|75891238|FG002|Overall Study|Samples Did Not pass QC|1|||
42080908|NCT00806988|75891248|FG000|Overall Study|Death|15|||
42080909|NCT00806988|75891249|FG001|Overall Study|Death|16|||
42080910|NCT00806988|75891248|FG000|Overall Study|Withdrawal by Subject|8|||
42080911|NCT00806988|75891249|FG001|Overall Study|Withdrawal by Subject|8|||
42080912|NCT00806988|75891248|FG000|Overall Study|Lost to Follow-up|4|||
42080913|NCT00806988|75891249|FG001|Overall Study|Lost to Follow-up|19|||
42080914|NCT00807144|75891257|FG000|Overall Study|Lost to Follow-up|0|||
42080915|NCT00807144|75891258|FG001|Overall Study|Lost to Follow-up|1|||
42080916|NCT00591006|75891264|FG000|Overall Study|Withdrawal by Subject|0|||
42080917|NCT00591006|75891265|FG001|Overall Study|Withdrawal by Subject|0|||
42080918|NCT00591006|75891266|FG002|Overall Study|Withdrawal by Subject|0|||
42080919|NCT00591006|75891267|FG003|Overall Study|Withdrawal by Subject|0|||
42080920|NCT00591006|75891268|FG004|Overall Study|Withdrawal by Subject|0|||
42080921|NCT00591006|75891269|FG005|Overall Study|Withdrawal by Subject|0|||
42294030|NCT01659255|76128321|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294031|NCT01659255|76128322|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294032|NCT01659255|76128323|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294033|NCT01659255|76128324|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294034|NCT01659255|76128325|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294035|NCT01659255|76128326|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294036|NCT01659255|76128327|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294037|NCT01659255|76128328|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294038|NCT01659255|76128329|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294039|NCT01659255|76128330|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294040|NCT01659255|76128331|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294041|NCT01659255|76128332|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294042|NCT01659255|76128333|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294043|NCT01659255|76128334|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42080922|NCT00591006|75891270|FG006|Overall Study|Withdrawal by Subject|0|||
42080923|NCT00591006|75891271|FG007|Overall Study|Withdrawal by Subject|0|||
42080924|NCT00591006|75891272|FG008|Overall Study|Withdrawal by Subject|0|||
42080925|NCT00591006|75891273|FG009|Overall Study|Withdrawal by Subject|0|||
42080926|NCT00591006|75891274|FG010|Overall Study|Withdrawal by Subject|0|||
42080927|NCT00591006|75891275|FG011|Overall Study|Withdrawal by Subject|0|||
42080928|NCT00591006|75891276|FG012|Overall Study|Withdrawal by Subject|0|||
42080929|NCT00591006|75891277|FG013|Overall Study|Withdrawal by Subject|0|||
42080930|NCT00591006|75891278|FG014|Overall Study|Withdrawal by Subject|0|||
42080931|NCT00591006|75891279|FG015|Overall Study|Withdrawal by Subject|1|||
42080932|NCT00591006|75891280|FG016|Overall Study|Withdrawal by Subject|0|||
42080933|NCT00591006|75891281|FG017|Overall Study|Withdrawal by Subject|0|||
42358093|NCT01855945|76203664|FG008|Overall Study|Withdrawal by Subject|0|||
42080934|NCT00591006|75891282|FG018|Overall Study|Withdrawal by Subject|0|||
42080935|NCT00591006|75891283|FG019|Overall Study|Withdrawal by Subject|0|||
42080936|NCT00591006|75891284|FG020|Overall Study|Withdrawal by Subject|0|||
42080937|NCT00591006|75891285|FG021|Overall Study|Withdrawal by Subject|0|||
42080938|NCT00591006|75891286|FG022|Overall Study|Withdrawal by Subject|0|||
42080939|NCT00591006|75891287|FG023|Overall Study|Withdrawal by Subject|1|||
42080940|NCT00591006|75891264|FG000|Overall Study|Adverse Event|0|||
42080941|NCT00591006|75891265|FG001|Overall Study|Adverse Event|0|||
42080942|NCT00591006|75891266|FG002|Overall Study|Adverse Event|0|||
42080943|NCT00591006|75891267|FG003|Overall Study|Adverse Event|0|||
42080944|NCT00591006|75891268|FG004|Overall Study|Adverse Event|0|||
42080945|NCT00591006|75891269|FG005|Overall Study|Adverse Event|0|||
42080946|NCT00591006|75891270|FG006|Overall Study|Adverse Event|0|||
42080947|NCT00591006|75891271|FG007|Overall Study|Adverse Event|0|||
42080948|NCT00591006|75891272|FG008|Overall Study|Adverse Event|0|||
42080949|NCT00591006|75891273|FG009|Overall Study|Adverse Event|0|||
42080950|NCT00591006|75891274|FG010|Overall Study|Adverse Event|0|||
42080951|NCT00591006|75891275|FG011|Overall Study|Adverse Event|0|||
42080952|NCT00591006|75891276|FG012|Overall Study|Adverse Event|0|||
42178185|NCT00003702|75985276|FG000|Overall Study|Ineligible cell types|2|||
42178186|NCT00003702|75985277|FG001|Overall Study|Ineligible cell types|2|||
42178187|NCT00003702|75985276|FG000|Overall Study|Did not meet criteria for persistence|8|||
42294044|NCT01659255|76128335|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294045|NCT01659255|76128336|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
42294046|NCT01659255|76128337|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
42294047|NCT01659255|76128321|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
42294048|NCT01659255|76128322|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
42294049|NCT01659255|76128323|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
42294050|NCT01659255|76128324|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
42294051|NCT01659255|76128325|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
42178188|NCT00003702|75985277|FG001|Overall Study|Did not meet criteria for persistence|5|||
42178189|NCT00003702|75985276|FG000|Overall Study|WHO score > 6|2|||
42178190|NCT00003702|75985277|FG001|Overall Study|WHO score > 6|1|||
42178191|NCT00003702|75985276|FG000|Overall Study|Inadequate documentation of disease|1|||
42178192|NCT00003702|75985277|FG001|Overall Study|Inadequate documentation of disease|3|||
42178193|NCT00031590|75985284|FG000|Overall Study|Adverse Event|1|||
42178194|NCT00031590|75985284|FG000|Overall Study|Withdrawal by parents|2|||
42178195|NCT00239681|75985291|FG000|Overall Study|Adverse Event|100|||
42178196|NCT00239681|75985292|FG001|Overall Study|Adverse Event|99|||
42178197|NCT00239681|75985291|FG000|Overall Study|Withdrawal by Subject|458|||
42178198|NCT00239681|75985292|FG001|Overall Study|Withdrawal by Subject|489|||
42178199|NCT00239681|75985291|FG000|Overall Study|Lost to Follow-up|28|||
42178200|NCT00239681|75985292|FG001|Overall Study|Lost to Follow-up|22|||
42178201|NCT00239681|75985291|FG000|Overall Study|Protocol Violation|4|||
42178202|NCT00239681|75985292|FG001|Overall Study|Protocol Violation|4|||
42178203|NCT00239681|75985291|FG000|Overall Study|Physician Decision|13|||
42178204|NCT00239681|75985292|FG001|Overall Study|Physician Decision|17|||
42178205|NCT00239681|75985291|FG000|Overall Study|No information chacked on CaseReportForm|90|||
42178206|NCT00239681|75985292|FG001|Overall Study|No information chacked on CaseReportForm|84|||
42178207|NCT02878330|75985300|FG000|Overall Study|Death|3|||
42178208|NCT02878330|75985301|FG001|Overall Study|Death|2|||
42178209|NCT02878330|75985300|FG000|Overall Study|Lost to Follow-up|11|||
42178210|NCT02878330|75985301|FG001|Overall Study|Lost to Follow-up|26|||
42178211|NCT02878330|75985300|FG000|Overall Study|Withdrawal by Subject|11|||
42178212|NCT02878330|75985301|FG001|Overall Study|Withdrawal by Subject|21|||
42178213|NCT02878330|75985300|FG000|Overall Study|Other|4|||
42178214|NCT02878330|75985301|FG001|Overall Study|Other|7|||
42178215|NCT00238433|75985308|FG000|Overall Study|Screen failure|1|||
42178216|NCT00238433|75985308|FG000|Overall Study|Lost to Follow-up|1|||
42178217|NCT00238433|75985308|FG000|Overall Study|Death|1|||
42178218|NCT00045162|75985315|FG000|Overall Study|Ineligible|12|||
42178219|NCT00045162|75985316|FG001|Overall Study|Ineligible|8|||
42178220|NCT00045162|75985315|FG000|Overall Study|Not treated|7|||
42178221|NCT00045162|75985316|FG001|Overall Study|Not treated|2|||
42178222|NCT00045162|75985315|FG000|Overall Study|Adverse Event|55|||
42178223|NCT00045162|75985316|FG001|Overall Study|Adverse Event|50|||
42178224|NCT00045162|75985315|FG000|Overall Study|Lack of Efficacy|32|||
42080953|NCT00591006|75891277|FG013|Overall Study|Adverse Event|0|||
42080954|NCT00591006|75891278|FG014|Overall Study|Adverse Event|0|||
42080955|NCT00591006|75891279|FG015|Overall Study|Adverse Event|0|||
42178225|NCT00045162|75985316|FG001|Overall Study|Lack of Efficacy|29|||
42294052|NCT01659255|76128326|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
42080956|NCT00591006|75891280|FG016|Overall Study|Adverse Event|0|||
42178226|NCT00045162|75985315|FG000|Overall Study|Death|10|||
42178227|NCT00045162|75985316|FG001|Overall Study|Death|10|||
42178228|NCT00045162|75985315|FG000|Overall Study|Withdrawal by Subject|5|||
42178229|NCT00045162|75985316|FG001|Overall Study|Withdrawal by Subject|3|||
42080957|NCT00591006|75891281|FG017|Overall Study|Adverse Event|0|||
42080958|NCT00591006|75891282|FG018|Overall Study|Adverse Event|0|||
42178230|NCT00045162|75985315|FG000|Overall Study|Other|21|||
42080959|NCT00591006|75891283|FG019|Overall Study|Adverse Event|0|||
42080960|NCT00591006|75891284|FG020|Overall Study|Adverse Event|0|||
42080961|NCT00591006|75891285|FG021|Overall Study|Adverse Event|0|||
42080962|NCT00591006|75891286|FG022|Overall Study|Adverse Event|1|||
42080963|NCT00591006|75891287|FG023|Overall Study|Adverse Event|0|||
42080964|NCT00844844|75891304|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
42080965|NCT00844844|75891304|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
42080966|NCT00844844|75891304|FG000|Extension Treatment Period|Adverse Event|2|||
42080967|NCT00844844|75891304|FG000|Post Treatment Period|Withdrawal by Subject|1|||
42080968|NCT00660790|75891308|FG000|Baseline to 3 Months|Death|1|||
42080969|NCT00660790|75891308|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
42080970|NCT00660790|75891308|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
42080971|NCT00836810|75891314|FG000|Overall Study|New diagnosis|1|||
42080972|NCT00836810|75891315|FG001|Overall Study|New diagnosis|0|||
42080973|NCT00658684|75891324|FG000|Overall Study|Adverse Event|10|||
42080974|NCT00658684|75891325|FG001|Overall Study|Adverse Event|8|||
42178231|NCT00045162|75985316|FG001|Overall Study|Other|16|||
42178232|NCT02748616|75985322|FG000|Overall Study|Lost to Follow-up|1|||
42178233|NCT02748616|75985322|FG000|Overall Study|Withdrawal by Subject|2|||
42178234|NCT02748616|75985322|FG000|Overall Study|Physician Decision|2|||
42178235|NCT02748616|75985322|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
42178236|NCT00238121|75985328|FG000|Overall Study|Withdrawal by Subject|1|||
42178237|NCT00238121|75985329|FG001|Overall Study|Withdrawal by Subject|1|||
42178238|NCT00238121|75985328|FG000|Overall Study|Adverse Event|2|||
42178239|NCT00238121|75985329|FG001|Overall Study|Adverse Event|1|||
42178240|NCT03139552|75985334|FG000|Overall Study|unable to attend tasting due to schedule|3|||
42178241|NCT03804918|75985345|FG000|Overall Study|Participant did not use the app|1|||
42178242|NCT03139240|75985353|FG000|Overall Study|Lost to Follow-up|0|||
42178243|NCT03139240|75985354|FG001|Overall Study|Lost to Follow-up|1|||
42178244|NCT03139240|75985355|FG002|Overall Study|Lost to Follow-up|1|||
42178245|NCT03139240|75985356|FG003|Overall Study|Lost to Follow-up|0|||
42178246|NCT00237809|75985368|FG000|Overall Study|Lost to Follow-up|11|||
42178247|NCT00237809|75985369|FG001|Overall Study|Lost to Follow-up|10|||
42178248|NCT00237809|75985370|FG002|Overall Study|Lost to Follow-up|9|||
42178249|NCT00237809|75985371|FG003|Overall Study|Lost to Follow-up|9|||
42178250|NCT00003498|75985381|FG000|Overall Study|Not evaluable.|4|||
42178251|NCT00003492|75985385|FG000|Overall Study|Not evaluable|6|||
42178252|NCT03136198|75985391|FG000|Overall Study|Withdrawal by Subject|0|||
42178253|NCT03136198|75985392|FG001|Overall Study|Withdrawal by Subject|1|||
42178254|NCT00042666|75985398|FG000|Overall Study|Adverse Event|2|||
42178255|NCT00042666|75985398|FG000|Overall Study|Death|4|||
42178256|NCT00042666|75985398|FG000|Overall Study|Protocol Violation|1|||
42178257|NCT00042666|75985398|FG000|Overall Study|Participant/Physician Perception|1|||
42178258|NCT00042666|75985398|FG000|Overall Study|Progressive Disease|41|||
42178259|NCT00042666|75985398|FG000|Overall Study|Other|1|||
42178260|NCT00042666|75985398|FG000|Overall Study|Other|4|||
42178261|NCT00042432|75985405|FG000|Overall Study|Adverse Event|4|||
42178262|NCT00042432|75985406|FG001|Overall Study|Adverse Event|1|||
42178263|NCT00042432|75985405|FG000|Overall Study|Withdrawal by Subject|1|||
42178264|NCT00042432|75985406|FG001|Overall Study|Withdrawal by Subject|3|||
42178265|NCT00042432|75985405|FG000|Overall Study|Death|0|||
42178266|NCT00042432|75985406|FG001|Overall Study|Death|2|||
42178267|NCT00042432|75985405|FG000|Overall Study|Ineligibility determined|1|||
42178268|NCT00042432|75985406|FG001|Overall Study|Ineligibility determined|0|||
42178269|NCT00042432|75985405|FG000|Overall Study|Initiation of maintenance dialysis|1|||
42178270|NCT00042432|75985406|FG001|Overall Study|Initiation of maintenance dialysis|1|||
42178271|NCT00042432|75985405|FG000|Overall Study|Other|2|||
42178272|NCT00042432|75985406|FG001|Overall Study|Other|0|||
42178273|NCT00003474|75985412|FG000|Overall Study|Not Evaluable|14|||
42178274|NCT01542736|75985416|FG000|Overall Study|Death|1|||
42178275|NCT01346410|75985420|FG000|Overall Study|Death|1|||
42178276|NCT00003456|75985424|FG000|Overall Study|Not evaluable|8|||
42178277|NCT02719522|75985428|FG000|Overall Study|Implant Failure|4|||
42178278|NCT02719522|75985428|FG000|Overall Study|Death|2|||
42178279|NCT02719522|75985428|FG000|Overall Study|Lost to Follow-up|5|||
42178280|NCT00237185|75985434|FG000|Core|Adverse Event|3|||
42358094|NCT01855945|76203665|FG009|Overall Study|Withdrawal by Subject|2|||
42358095|NCT01855945|76203666|FG010|Overall Study|Withdrawal by Subject|4|||
42358096|NCT01855945|76203667|FG011|Overall Study|Withdrawal by Subject|1|||
42358097|NCT01855789|76203730|FG000|1) Baseline up to Week 24|Adverse Event|37|||
42178281|NCT00237185|75985435|FG001|Core|Adverse Event|4|||
42178282|NCT00237185|75985434|FG000|Core|Abnormal laboratory value|0|||
42178283|NCT00237185|75985435|FG001|Core|Abnormal laboratory value|4|||
42080975|NCT00658684|75891326|FG002|Overall Study|Adverse Event|2|||
42178284|NCT00237185|75985434|FG000|Core|Abnormal test procedure results|1|||
42178285|NCT00237185|75985435|FG001|Core|Abnormal test procedure results|0|||
42178286|NCT00237185|75985434|FG000|Core|Lack of Efficacy|30|||
42178287|NCT00237185|75985435|FG001|Core|Lack of Efficacy|23|||
42080976|NCT00658684|75891327|FG003|Overall Study|Adverse Event|0|||
42178288|NCT00237185|75985434|FG000|Core|Protocol Violation|1|||
42080977|NCT00658684|75891324|FG000|Overall Study|Withdrawal by Subject|6|||
42080978|NCT00658684|75891325|FG001|Overall Study|Withdrawal by Subject|4|||
42080979|NCT00658684|75891326|FG002|Overall Study|Withdrawal by Subject|1|||
42080980|NCT00658684|75891327|FG003|Overall Study|Withdrawal by Subject|1|||
42080981|NCT00658684|75891324|FG000|Overall Study|Lack of Efficacy|1|||
42080982|NCT00658684|75891325|FG001|Overall Study|Lack of Efficacy|1|||
42080983|NCT00658684|75891326|FG002|Overall Study|Lack of Efficacy|0|||
42178289|NCT00237185|75985435|FG001|Core|Protocol Violation|1|||
42178290|NCT00237185|75985434|FG000|Core|Withdrawal by Subject|4|||
42178291|NCT00237185|75985435|FG001|Core|Withdrawal by Subject|4|||
42178292|NCT00237185|75985434|FG000|Core|Administrative problems|0|||
42178293|NCT00237185|75985435|FG001|Core|Administrative problems|1|||
42178294|NCT00237185|75985434|FG000|Core|Death|4|||
42178295|NCT00237185|75985435|FG001|Core|Death|0|||
42178296|NCT00237185|75985434|FG000|Core|Determined ineligible post randomization|1|||
42178297|NCT00237185|75985435|FG001|Core|Determined ineligible post randomization|0|||
42178298|NCT00237185|75985434|FG000|Extension|Adverse Event|1|||
42178299|NCT00237185|75985435|FG001|Extension|Adverse Event|0|||
42178300|NCT00237185|75985434|FG000|Extension|Abnormal laboratory value|0|||
42178301|NCT00237185|75985435|FG001|Extension|Abnormal laboratory value|1|||
42178302|NCT00237185|75985434|FG000|Extension|Lack of Efficacy|9|||
42178303|NCT00237185|75985435|FG001|Extension|Lack of Efficacy|14|||
42178304|NCT00237185|75985434|FG000|Extension|Condition no longer required study drug|0|||
42080984|NCT00658684|75891327|FG003|Overall Study|Lack of Efficacy|0|||
42294053|NCT01659255|76128327|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
42294054|NCT01659255|76128328|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
42294055|NCT01659255|76128329|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
42294056|NCT01659255|76128330|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
42294057|NCT01659255|76128331|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
42294058|NCT01659255|76128332|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
42294059|NCT01659255|76128333|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
42294060|NCT01659255|76128334|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
42294061|NCT01659255|76128335|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
42294062|NCT01659255|76128336|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
42080985|NCT00658684|75891324|FG000|Overall Study|Protocol Violation|1|||
42080986|NCT00658684|75891325|FG001|Overall Study|Protocol Violation|1|||
42080987|NCT00658684|75891326|FG002|Overall Study|Protocol Violation|0|||
42080988|NCT00658684|75891327|FG003|Overall Study|Protocol Violation|0|||
42080989|NCT00658684|75891324|FG000|Overall Study|Pregnancy|1|||
42080990|NCT00658684|75891325|FG001|Overall Study|Pregnancy|1|||
42080991|NCT00658684|75891326|FG002|Overall Study|Pregnancy|0|||
42080992|NCT00658684|75891327|FG003|Overall Study|Pregnancy|0|||
42080993|NCT00660400|75891337|FG000|Overall Study|Lack of insurance approval|1|||
42080994|NCT00660400|75891337|FG000|Overall Study|Suboptimal organ function|1|||
42080995|NCT00660400|75891337|FG000|Overall Study|Intracranial hemorrhage|1|||
42080996|NCT00660400|75891337|FG000|Overall Study|Withdrawal by Subject|1|||
42080997|NCT00826514|75891343|FG000|Overall Study|Adverse Event|1|||
42080998|NCT00826514|75891344|FG001|Overall Study|Adverse Event|1|||
42080999|NCT00826514|75891343|FG000|Overall Study|Lack of Efficacy|0|||
42081000|NCT00826514|75891344|FG001|Overall Study|Lack of Efficacy|1|||
42178305|NCT00237185|75985435|FG001|Extension|Condition no longer required study drug|1|||
42178306|NCT00237185|75985434|FG000|Extension|Withdrawal by Subject|3|||
42178307|NCT00237185|75985435|FG001|Extension|Withdrawal by Subject|2|||
42178308|NCT00237185|75985434|FG000|Extension|Lost to Follow-up|1|||
42178309|NCT00237185|75985435|FG001|Extension|Lost to Follow-up|0|||
42178310|NCT00237185|75985434|FG000|Extension|Administrative problems|1|||
42178311|NCT00237185|75985435|FG001|Extension|Administrative problems|0|||
42178312|NCT00237185|75985434|FG000|Extension|Death|1|||
42178313|NCT00237185|75985435|FG001|Extension|Death|1|||
42178314|NCT00003222|75985443|FG000|Overall Study|Physician Decision|0|||
42178315|NCT00003222|75985444|FG001|Overall Study|Physician Decision|1|||
42294063|NCT01659255|76128337|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
42081001|NCT00826514|75891343|FG000|Overall Study|Withdrawal by Subject|2|||
42178316|NCT02877082|75985450|FG000|Overall Study|Trial was closed early|5|||
42178317|NCT02875834|75985458|FG000|Open-label Phase|Withdrawal by Subject|3|||
42178318|NCT02875834|75985459|FG001|Open-label Phase|Withdrawal by Subject|0|||
42178319|NCT02875834|75985460|FG002|Open-label Phase|Withdrawal by Subject|0|||
42081002|NCT00826514|75891344|FG001|Overall Study|Withdrawal by Subject|3|||
42178320|NCT02875834|75985461|FG003|Open-label Phase|Withdrawal by Subject|0|||
42178321|NCT02875834|75985458|FG000|Open-label Phase|(Not collected)|4|||
42081003|NCT00826280|75891353|FG000|Overall Study|Randomized but drug not received|1|||
42081004|NCT00826280|75891354|FG001|Overall Study|Randomized but drug not received|0|||
42081005|NCT00826280|75891355|FG002|Overall Study|Randomized but drug not received|1|||
42081006|NCT00826280|75891353|FG000|Overall Study|Adverse Event|1|||
42081007|NCT00826280|75891354|FG001|Overall Study|Adverse Event|3|||
42178322|NCT02875834|75985459|FG001|Open-label Phase|(Not collected)|0|||
42178323|NCT02875834|75985460|FG002|Open-label Phase|(Not collected)|0|||
42081008|NCT00826280|75891355|FG002|Overall Study|Adverse Event|0|||
42081009|NCT00826280|75891353|FG000|Overall Study|Lost to Follow-up|0|||
42081010|NCT00826280|75891354|FG001|Overall Study|Lost to Follow-up|1|||
42081011|NCT00826280|75891355|FG002|Overall Study|Lost to Follow-up|0|||
42081012|NCT00826280|75891353|FG000|Overall Study|Sponsor discontinued subject or study|1|||
42081013|NCT00826280|75891354|FG001|Overall Study|Sponsor discontinued subject or study|0|||
42081014|NCT00826280|75891355|FG002|Overall Study|Sponsor discontinued subject or study|0|||
42081015|NCT00826280|75891353|FG000|Overall Study|Reversible ischemic defect not present|43|||
42081016|NCT00826280|75891354|FG001|Overall Study|Reversible ischemic defect not present|40|||
42081017|NCT00826280|75891355|FG002|Overall Study|Reversible ischemic defect not present|44|||
42081018|NCT00826280|75891353|FG000|Overall Study|Interpretation Failure|1|||
42081019|NCT00826280|75891354|FG001|Overall Study|Interpretation Failure|0|||
42081020|NCT00826280|75891355|FG002|Overall Study|Interpretation Failure|0|||
42081021|NCT00826280|75891353|FG000|Overall Study|Machine Failure|1|||
42081022|NCT00826280|75891354|FG001|Overall Study|Machine Failure|1|||
42081023|NCT00826280|75891355|FG002|Overall Study|Machine Failure|0|||
42081024|NCT00826280|75891353|FG000|Overall Study|One or more non-interpretable scan|0|||
42081025|NCT00826280|75891354|FG001|Overall Study|One or more non-interpretable scan|1|||
42081026|NCT00826280|75891355|FG002|Overall Study|One or more non-interpretable scan|1|||
42081027|NCT00864851|75891366|FG000|Overall Study|Withdrawal by Subject|0|||
42081028|NCT00864851|75891367|FG001|Overall Study|Withdrawal by Subject|1|||
42081029|NCT00864851|75891368|FG002|Overall Study|Withdrawal by Subject|0|||
42081030|NCT00864851|75891366|FG000|Overall Study|Physician Decision|1|||
42081031|NCT00864851|75891367|FG001|Overall Study|Physician Decision|0|||
42081032|NCT00864851|75891368|FG002|Overall Study|Physician Decision|0|||
42081033|NCT00864851|75891366|FG000|Overall Study|Death|1|||
42081034|NCT00864851|75891367|FG001|Overall Study|Death|0|||
42081035|NCT00864851|75891368|FG002|Overall Study|Death|0|||
42081036|NCT00864851|75891366|FG000|Overall Study|Patient uncooperative|1|||
42081037|NCT00864851|75891367|FG001|Overall Study|Patient uncooperative|0|||
42081038|NCT00864851|75891368|FG002|Overall Study|Patient uncooperative|0|||
42081039|NCT00857207|75891380|FG000|Overall Study|Withdrawal by Subject|13|||
42081040|NCT00857207|75891381|FG001|Overall Study|Withdrawal by Subject|0|||
42081041|NCT00857207|75891380|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
42081042|NCT00857207|75891381|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
42081043|NCT00857207|75891380|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
42081044|NCT00857207|75891381|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
42081045|NCT00836498|75891390|FG000|Overall Study|Adverse Event|1|||
42081046|NCT00836498|75891391|FG001|Overall Study|Adverse Event|0|||
42081047|NCT00836498|75891390|FG000|Overall Study|Lost to Follow-up|1|||
42081048|NCT00836498|75891391|FG001|Overall Study|Lost to Follow-up|0|||
42081049|NCT00836498|75891390|FG000|Overall Study|Withdrawal by Subject|2|||
42081050|NCT00836498|75891391|FG001|Overall Study|Withdrawal by Subject|1|||
42081051|NCT00856973|75891401|FG000|Overall Study|Adverse Event|5|||
42081052|NCT00856973|75891402|FG001|Overall Study|Adverse Event|5|||
42081053|NCT00856973|75891403|FG002|Overall Study|Adverse Event|3|||
42081054|NCT00856973|75891401|FG000|Overall Study|Lost to Follow-up|6|||
42081055|NCT00856973|75891402|FG001|Overall Study|Lost to Follow-up|3|||
42081056|NCT00856973|75891403|FG002|Overall Study|Lost to Follow-up|5|||
42081057|NCT00856973|75891401|FG000|Overall Study|Physician Decision|0|||
42081058|NCT00856973|75891402|FG001|Overall Study|Physician Decision|3|||
42081059|NCT00856973|75891403|FG002|Overall Study|Physician Decision|1|||
42081060|NCT00856973|75891401|FG000|Overall Study|Protocol Violation|1|||
42081061|NCT00856973|75891402|FG001|Overall Study|Protocol Violation|2|||
42081062|NCT00856973|75891403|FG002|Overall Study|Protocol Violation|1|||
42081063|NCT00856973|75891401|FG000|Overall Study|Withdrawal by Subject|13|||
42081064|NCT00856973|75891402|FG001|Overall Study|Withdrawal by Subject|16|||
42081065|NCT00856973|75891403|FG002|Overall Study|Withdrawal by Subject|15|||
42081066|NCT00856973|75891401|FG000|Overall Study|Other|11|||
42081067|NCT00856973|75891402|FG001|Overall Study|Other|12|||
42178324|NCT02875834|75985461|FG003|Open-label Phase|(Not collected)|0|||
42178325|NCT02875834|75985458|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
42178326|NCT02875834|75985459|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
42178327|NCT02875834|75985460|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
42081068|NCT00856973|75891403|FG002|Overall Study|Other|13|||
42081069|NCT00844532|75891415|FG000|Overall Study|Death|16|||
42081070|NCT00844532|75891415|FG000|Overall Study|Withdrawal by Subject|16|||
42081071|NCT00844532|75891415|FG000|Overall Study|Lost to Follow-up|7|||
42081072|NCT00805194|75891421|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
42081073|NCT00805194|75891422|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
42081074|NCT00805194|75891421|FG000|Overall Study|Worsening or AE of underlying disease|64|||
42081075|NCT00805194|75891422|FG001|Overall Study|Worsening or AE of underlying disease|70|||
42081076|NCT00805194|75891421|FG000|Overall Study|Other AE|84|||
42081077|NCT00805194|75891422|FG001|Overall Study|Other AE|73|||
42178328|NCT02875834|75985461|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
42081078|NCT00805194|75891421|FG000|Overall Study|Protocol Violation|9|||
42081079|NCT00805194|75891422|FG001|Overall Study|Protocol Violation|9|||
42081080|NCT00805194|75891421|FG000|Overall Study|Lost to Follow-up|5|||
42081081|NCT00805194|75891422|FG001|Overall Study|Lost to Follow-up|5|||
42081082|NCT00805194|75891421|FG000|Overall Study|Withdrawal by Subject|60|||
42081083|NCT00805194|75891422|FG001|Overall Study|Withdrawal by Subject|42|||
42081084|NCT00805194|75891421|FG000|Overall Study|Not treated|3|||
42081085|NCT00805194|75891422|FG001|Overall Study|Not treated|4|||
42081086|NCT00805194|75891421|FG000|Overall Study|Reasons other than stated above|20|||
42081087|NCT00805194|75891422|FG001|Overall Study|Reasons other than stated above|16|||
42081088|NCT00836186|75891433|FG000|Overall Study|Blood could not be drawn|1|||
42081089|NCT00657046|75891441|FG000|Overall Study|Adverse Event|1|||
42081090|NCT00657046|75891442|FG001|Overall Study|Adverse Event|1|||
42081091|NCT00657046|75891443|FG002|Overall Study|Adverse Event|0|||
42081092|NCT00657046|75891441|FG000|Overall Study|Protocol Violation|2|||
42081093|NCT00657046|75891442|FG001|Overall Study|Protocol Violation|2|||
42081094|NCT00657046|75891443|FG002|Overall Study|Protocol Violation|0|||
42081095|NCT00657046|75891441|FG000|Overall Study|Withdrawal by Subject|1|||
42081096|NCT00657046|75891442|FG001|Overall Study|Withdrawal by Subject|0|||
42081097|NCT00657046|75891443|FG002|Overall Study|Withdrawal by Subject|0|||
42081098|NCT00657046|75891441|FG000|Overall Study|Death|0|||
42081099|NCT00657046|75891442|FG001|Overall Study|Death|0|||
42081100|NCT00657046|75891443|FG002|Overall Study|Death|1|||
42081101|NCT00657046|75891441|FG000|Overall Study|Surgery|0|||
42081102|NCT00657046|75891442|FG001|Overall Study|Surgery|0|||
42081103|NCT00657046|75891443|FG002|Overall Study|Surgery|1|||
42081104|NCT00856661|75891453|FG000|Overall Study|Death|15|||
42081105|NCT00856661|75891454|FG001|Overall Study|Death|18|||
42081106|NCT00856661|75891453|FG000|Overall Study|Protocol Violation|2|||
42081107|NCT00856661|75891454|FG001|Overall Study|Protocol Violation|1|||
42081108|NCT00856661|75891453|FG000|Overall Study|Withdrawal by Subject|1|||
42081109|NCT00856661|75891454|FG001|Overall Study|Withdrawal by Subject|2|||
42081110|NCT00856661|75891453|FG000|Overall Study|Lost to Follow-up|1|||
42081111|NCT00856661|75891454|FG001|Overall Study|Lost to Follow-up|3|||
42081112|NCT00856661|75891453|FG000|Overall Study|Physician Judgement|8|||
42081113|NCT00856661|75891454|FG001|Overall Study|Physician Judgement|5|||
42081114|NCT00844376|75891460|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
42081115|NCT00844376|75891461|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
42081116|NCT00658606|75891469|FG000|Overall Study|Adverse Event|2|||
42081117|NCT00658606|75891470|FG001|Overall Study|Adverse Event|1|||
42081118|NCT00658606|75891469|FG000|Overall Study|Lack of Efficacy|6|||
42081119|NCT00658606|75891470|FG001|Overall Study|Lack of Efficacy|3|||
42081120|NCT00658606|75891469|FG000|Overall Study|Lost to Follow-up|1|||
42081121|NCT00658606|75891470|FG001|Overall Study|Lost to Follow-up|0|||
42081122|NCT00658606|75891469|FG000|Overall Study|Withdrawal by Subject|7|||
42081123|NCT00658606|75891470|FG001|Overall Study|Withdrawal by Subject|16|||
42081124|NCT00658606|75891469|FG000|Overall Study|Lack of Compliance|0|||
42081125|NCT00658606|75891470|FG001|Overall Study|Lack of Compliance|3|||
42081126|NCT00589290|75891476|FG000|Overall Study|Withdrawal by Subject|1|||
42081127|NCT00843518|75891484|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
42081128|NCT00843518|75891485|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
42081129|NCT00843518|75891484|FG000|Period 2 (Double-blind Treatment)|Death|0|||
42081130|NCT00843518|75891485|FG001|Period 2 (Double-blind Treatment)|Death|1|||
42081131|NCT00843518|75891484|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
42081132|NCT00843518|75891485|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
42081133|NCT00843518|75891484|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
42081134|NCT00843518|75891485|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
42081135|NCT00843518|75891484|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
42081136|NCT00843518|75891485|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
42081137|NCT00843518|75891484|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
42178329|NCT02875834|75985458|FG000|Randomized Treatment Phase|Protocol Violation|0|||
42178330|NCT02875834|75985459|FG001|Randomized Treatment Phase|Protocol Violation|2|||
42358098|NCT01855789|76203731|FG001|1) Baseline up to Week 24|Adverse Event|0|||
42081138|NCT00843518|75891485|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
42081139|NCT00843518|75891484|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
42081140|NCT00843518|75891485|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
42081141|NCT00843284|75891495|FG000|Overall Study|Adverse Event|39|||
42081142|NCT00843284|75891495|FG000|Overall Study|Lack of Efficacy|5|||
42081143|NCT00843284|75891495|FG000|Overall Study|Lost to Follow-up|11|||
42081144|NCT00843284|75891495|FG000|Overall Study|Other|10|||
42081145|NCT00843284|75891495|FG000|Overall Study|Withdrawal by Subject|4|||
42081146|NCT00843284|75891495|FG000|Overall Study|Death|3|||
42081147|NCT00652834|75891512|FG000|Overall Study|Withdrawal by Subject|3|||
42081148|NCT00652834|75891512|FG000|Overall Study|Lost to Follow-up|2|||
42081149|NCT00825812|75891520|FG000|Overall Study|Never entered follow up|0|||
42081150|NCT00825812|75891521|FG001|Overall Study|Never entered follow up|0|||
42081151|NCT00825812|75891522|FG002|Overall Study|Never entered follow up|0|||
42081152|NCT00825812|75891523|FG003|Overall Study|Never entered follow up|1|||
42081153|NCT00825812|75891520|FG000|Overall Study|Adverse Event|0|||
42081154|NCT00825812|75891521|FG001|Overall Study|Adverse Event|0|||
42081155|NCT00825812|75891522|FG002|Overall Study|Adverse Event|0|||
42081156|NCT00825812|75891523|FG003|Overall Study|Adverse Event|1|||
42081157|NCT00825812|75891520|FG000|Overall Study|Subject withdrew consent|0|||
42081158|NCT00825812|75891521|FG001|Overall Study|Subject withdrew consent|0|||
42081159|NCT00825812|75891522|FG002|Overall Study|Subject withdrew consent|3|||
42081160|NCT00825812|75891523|FG003|Overall Study|Subject withdrew consent|2|||
42081161|NCT00825812|75891520|FG000|Overall Study|Non-compliance with protocol|0|||
42081162|NCT00825812|75891521|FG001|Overall Study|Non-compliance with protocol|0|||
42081163|NCT00825812|75891522|FG002|Overall Study|Non-compliance with protocol|0|||
42081164|NCT00825812|75891523|FG003|Overall Study|Non-compliance with protocol|1|||
42081165|NCT00825812|75891520|FG000|Overall Study|Administrative|0|||
42081166|NCT00825812|75891521|FG001|Overall Study|Administrative|1|||
42081167|NCT00825812|75891522|FG002|Overall Study|Administrative|3|||
42081168|NCT00825812|75891523|FG003|Overall Study|Administrative|5|||
42081169|NCT00824720|75891536|FG000|Overall Study|failed plug insertion|3|||
42081170|NCT00824720|75891537|FG001|Overall Study|failed plug insertion|1|||
42081171|NCT00824720|75891538|FG002|Overall Study|failed plug insertion|0|||
42358099|NCT01855789|76203732|FG002|1) Baseline up to Week 24|Adverse Event|0|||
42358100|NCT01855789|76203733|FG003|1) Baseline up to Week 24|Adverse Event|0|||
42358101|NCT01855789|76203730|FG000|1) Baseline up to Week 24|Death|2|||
42358102|NCT01855789|76203731|FG001|1) Baseline up to Week 24|Death|0|||
42358103|NCT01855789|76203732|FG002|1) Baseline up to Week 24|Death|0|||
42358104|NCT01855789|76203733|FG003|1) Baseline up to Week 24|Death|0|||
42358105|NCT01855789|76203730|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
42358106|NCT01855789|76203731|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
42358107|NCT01855789|76203732|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
42081172|NCT00824720|75891536|FG000|Overall Study|Protocol Violation|0|||
42081173|NCT00824720|75891537|FG001|Overall Study|Protocol Violation|0|||
42081174|NCT00824720|75891538|FG002|Overall Study|Protocol Violation|1|||
42081175|NCT03704064|75891548|FG000|Overall Study|Lost to Follow-up|8|||
42081176|NCT03704064|75891549|FG001|Overall Study|Lost to Follow-up|4|||
42081177|NCT03704064|75891548|FG000|Overall Study|Withdrawal by Subject|1|||
42081178|NCT03704064|75891549|FG001|Overall Study|Withdrawal by Subject|1|||
42081179|NCT03704064|75891548|FG000|Overall Study|No longer available for study visits|0|||
42081180|NCT03704064|75891549|FG001|Overall Study|No longer available for study visits|1|||
42081181|NCT03704064|75891548|FG000|Overall Study|Censoring event|1|||
42081182|NCT03704064|75891549|FG001|Overall Study|Censoring event|0|||
42081183|NCT00824564|75891557|FG000|Overall Study|Lost to Follow-up|5|||
42081184|NCT00824564|75891558|FG001|Overall Study|Lost to Follow-up|7|||
42081185|NCT00824564|75891557|FG000|Overall Study|Withdrawal by Subject|1|||
42081186|NCT00824564|75891558|FG001|Overall Study|Withdrawal by Subject|1|||
42081187|NCT00824564|75891557|FG000|Overall Study|Other|1|||
42081188|NCT00824564|75891558|FG001|Overall Study|Other|2|||
42081189|NCT00824564|75891557|FG000|Overall Study|Randomized, but not treated|1|||
42081190|NCT00824564|75891558|FG001|Overall Study|Randomized, but not treated|0|||
42081191|NCT00658528|75891566|FG000|Overall Study|Adverse Event|5|||
42081192|NCT00658528|75891567|FG001|Overall Study|Adverse Event|7|||
42081193|NCT00658528|75891566|FG000|Overall Study|Lost to Follow-up|14|||
42081194|NCT00658528|75891567|FG001|Overall Study|Lost to Follow-up|22|||
42081195|NCT00658528|75891566|FG000|Overall Study|Withdrawal by Subject|8|||
42081196|NCT00658528|75891567|FG001|Overall Study|Withdrawal by Subject|6|||
42081197|NCT00658528|75891566|FG000|Overall Study|Withdrawal of consent|5|||
42081198|NCT00658528|75891567|FG001|Overall Study|Withdrawal of consent|6|||
42081199|NCT00658528|75891566|FG000|Overall Study|Other|8|||
42081200|NCT00658528|75891567|FG001|Overall Study|Other|4|||
42178331|NCT02875834|75985460|FG002|Randomized Treatment Phase|Protocol Violation|0|||
42178332|NCT02875834|75985461|FG003|Randomized Treatment Phase|Protocol Violation|0|||
42081201|NCT00856583|75891575|FG000|Overall Study|Lack of Efficacy|389|||
42081202|NCT00856583|75891576|FG001|Overall Study|Lack of Efficacy|377|||
42081203|NCT00856583|75891575|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
42081204|NCT00856583|75891576|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
42081205|NCT00856583|75891575|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
42081206|NCT00856583|75891576|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
42081207|NCT00856583|75891575|FG000|Overall Study|Non-compliance|305|||
42081208|NCT00856583|75891576|FG001|Overall Study|Non-compliance|262|||
42081209|NCT00856583|75891575|FG000|Overall Study|Withdrawal by Subject|1092|||
42081210|NCT00856583|75891576|FG001|Overall Study|Withdrawal by Subject|919|||
42081211|NCT00856583|75891575|FG000|Overall Study|Physician Decision|59|||
42358108|NCT01855789|76203733|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
42081212|NCT00856583|75891576|FG001|Overall Study|Physician Decision|82|||
42081213|NCT00856583|75891575|FG000|Overall Study|Pregnancy|14|||
42081214|NCT00856583|75891576|FG001|Overall Study|Pregnancy|5|||
42081215|NCT00856583|75891575|FG000|Overall Study|Other|92|||
42081216|NCT00856583|75891576|FG001|Overall Study|Other|104|||
42081217|NCT00856583|75891575|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
42081218|NCT00856583|75891576|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
42081219|NCT00856349|75891582|FG000|Overall Study|Death|418|||
42081220|NCT00856349|75891582|FG000|Overall Study|Withdrawal by Subject|116|||
42081221|NCT00856349|75891582|FG000|Overall Study|Lost to Follow-up|91|||
42081222|NCT00856349|75891582|FG000|Overall Study|Protocol Violation|38|||
42081223|NCT00856349|75891582|FG000|Overall Study|Physician Decision|13|||
42081224|NCT00856349|75891582|FG000|Overall Study|Subject relocation|104|||
42081225|NCT00856349|75891582|FG000|Overall Study|Device explant|33|||
42081226|NCT00856349|75891582|FG000|Overall Study|Site closure|78|||
42178333|NCT02875834|75985458|FG000|Randomized Treatment Phase|(Not collected)|0|||
42178334|NCT02875834|75985459|FG001|Randomized Treatment Phase|(Not collected)|9|||
42178335|NCT02875834|75985460|FG002|Randomized Treatment Phase|(Not collected)|10|||
42178336|NCT02875834|75985461|FG003|Randomized Treatment Phase|(Not collected)|9|||
42178337|NCT02875366|75985473|FG000|Overall Study|Adverse Event|0|||
42178338|NCT02875366|75985474|FG001|Overall Study|Adverse Event|2|||
42178339|NCT02875366|75985473|FG000|Overall Study|Noncompliance|0|||
42178340|NCT02875366|75985474|FG001|Overall Study|Noncompliance|1|||
42178341|NCT00002850|75985483|FG000|Overall Study|Death|4|||
42178342|NCT00002850|75985484|FG001|Overall Study|Death|1|||
42178343|NCT00002850|75985485|FG002|Overall Study|Death|3|||
42178344|NCT00002850|75985483|FG000|Overall Study|Protocol Violation|1|||
42178345|NCT00002850|75985484|FG001|Overall Study|Protocol Violation|0|||
42178346|NCT00002850|75985485|FG002|Overall Study|Protocol Violation|1|||
42178347|NCT00002850|75985483|FG000|Overall Study|Withdrawal by Subject|0|||
42178348|NCT00002850|75985484|FG001|Overall Study|Withdrawal by Subject|1|||
42178349|NCT00002850|75985485|FG002|Overall Study|Withdrawal by Subject|0|||
42178350|NCT00002766|75985495|FG000|Overall Study|Withdrawal by Subject|0|||
42178351|NCT00002766|75985496|FG001|Overall Study|Withdrawal by Subject|1|||
42178352|NCT00002766|75985495|FG000|Overall Study|Patient Not Treated|1|||
42178353|NCT00002766|75985496|FG001|Overall Study|Patient Not Treated|2|||
42178354|NCT00002766|75985495|FG000|Overall Study|Adverse Event|1|||
42178355|NCT00002766|75985496|FG001|Overall Study|Adverse Event|1|||
42178356|NCT00002766|75985495|FG000|Overall Study|Protocol Violation|1|||
42178357|NCT00002766|75985496|FG001|Overall Study|Protocol Violation|0|||
42178358|NCT02306122|75985509|FG000|Initial Physician Randomization|Physician Decision|0|||
42178359|NCT02306122|75985510|FG001|Initial Physician Randomization|Physician Decision|0|||
42178360|NCT02306122|75985511|FG002|Initial Physician Randomization|Physician Decision|0|||
42178361|NCT02306122|75985512|FG003|Initial Physician Randomization|Physician Decision|0|||
42178362|NCT02306122|75985513|FG004|Initial Physician Randomization|Physician Decision|0|||
42178363|NCT02306122|75985514|FG005|Initial Physician Randomization|Physician Decision|0|||
42178364|NCT02306122|75985515|FG006|Initial Physician Randomization|Physician Decision|0|||
42178365|NCT02306122|75985516|FG007|Initial Physician Randomization|Physician Decision|0|||
42178366|NCT02306122|75985517|FG008|Initial Physician Randomization|Physician Decision|1|||
42178367|NCT02306122|75985518|FG009|Initial Physician Randomization|Physician Decision|0|||
42178368|NCT02306122|75985519|FG010|Initial Physician Randomization|Physician Decision|0|||
42178369|NCT00001962|75985537|FG000|Overall Study|Lack of Efficacy|18|||
42178370|NCT00001962|75985537|FG000|Overall Study|Lack of Accrual|6|||
42178371|NCT00001962|75985537|FG000|Overall Study|Death|1|||
42178372|NCT00001962|75985537|FG000|Overall Study|Lost to Follow-up|2|||
42178373|NCT00001962|75985537|FG000|Overall Study|Adverse Event|1|||
42178374|NCT00028002|75985541|FG000|Overall Study|Withdrawal by Subject|3|||
42178375|NCT00028002|75985541|FG000|Overall Study|Ineligible|8|||
42178376|NCT00256997|75985548|FG000|Overall Study|Protocol Violation|1|||
42178377|NCT00256997|75985549|FG001|Overall Study|Protocol Violation|4|||
42178378|NCT00256997|75985548|FG000|Overall Study|Lack of Efficacy|1|||
42178379|NCT00256997|75985549|FG001|Overall Study|Lack of Efficacy|4|||
42178380|NCT00256997|75985548|FG000|Overall Study|Death|2|||
42178381|NCT00256997|75985549|FG001|Overall Study|Death|0|||
42178382|NCT00256997|75985548|FG000|Overall Study|Adverse Event|4|||
42178383|NCT00256997|75985549|FG001|Overall Study|Adverse Event|0|||
42178384|NCT00256997|75985548|FG000|Overall Study|Lost to Follow-up|3|||
42178385|NCT00256997|75985549|FG001|Overall Study|Lost to Follow-up|5|||
42178386|NCT00256997|75985548|FG000|Overall Study|Withdrawal by Subject|13|||
42081227|NCT00856349|75891582|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
42081228|NCT00803244|75891590|FG000|Overall Study|Adverse Event|1|||
42178387|NCT00256997|75985549|FG001|Overall Study|Withdrawal by Subject|3|||
42178388|NCT00256997|75985548|FG000|Overall Study|Started but not treated|2|||
42178389|NCT00256997|75985549|FG001|Overall Study|Started but not treated|0|||
42081229|NCT00803244|75891591|FG001|Overall Study|Adverse Event|2|||
42081230|NCT00803244|75891590|FG000|Overall Study|Withdrawal by Subject|2|||
42178390|NCT00256997|75985548|FG000|Overall Study|Other|5|||
42081231|NCT00803244|75891591|FG001|Overall Study|Withdrawal by Subject|3|||
42081232|NCT00803244|75891590|FG000|Overall Study|Any other reason not above-mentioned|4|||
42081233|NCT00803244|75891591|FG001|Overall Study|Any other reason not above-mentioned|10|||
42081234|NCT00804570|75891599|FG000|Overall Study|Adverse Event|14|||
42081235|NCT00804570|75891600|FG001|Overall Study|Adverse Event|7|||
42081236|NCT00804570|75891599|FG000|Overall Study|Lack of Efficacy|0|||
42081237|NCT00804570|75891600|FG001|Overall Study|Lack of Efficacy|1|||
42081238|NCT00804570|75891599|FG000|Overall Study|Lost to Follow-up|18|||
42081239|NCT00804570|75891600|FG001|Overall Study|Lost to Follow-up|21|||
42081240|NCT00804570|75891599|FG000|Overall Study|Entry criteria not met|5|||
42081241|NCT00804570|75891600|FG001|Overall Study|Entry criteria not met|5|||
42081242|NCT00804570|75891599|FG000|Overall Study|Protocol Violation|12|||
42081243|NCT00804570|75891600|FG001|Overall Study|Protocol Violation|16|||
42081244|NCT00804570|75891599|FG000|Overall Study|Physician Decision|1|||
42081245|NCT00804570|75891600|FG001|Overall Study|Physician Decision|2|||
42081246|NCT00804570|75891599|FG000|Overall Study|Sponsor decision|1|||
42081247|NCT00804570|75891600|FG001|Overall Study|Sponsor decision|4|||
42081248|NCT00804570|75891599|FG000|Overall Study|Withdrawal by Subject|21|||
42081249|NCT00804570|75891600|FG001|Overall Study|Withdrawal by Subject|38|||
42081250|NCT00824408|75891612|FG000|Run-in Phase|Progressive disease|4|||
42081251|NCT00824408|75891613|FG001|Run-in Phase|Progressive disease|4|||
42358109|NCT01855789|76203730|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
42358110|NCT01855789|76203731|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
42358111|NCT01855789|76203732|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
42358112|NCT01855789|76203733|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
42081252|NCT00824408|75891614|FG002|Run-in Phase|Progressive disease|0|||
42081253|NCT00824408|75891615|FG003|Run-in Phase|Progressive disease|0|||
42081254|NCT00824408|75891616|FG004|Run-in Phase|Progressive disease|0|||
42081255|NCT00824408|75891612|FG000|Run-in Phase|Adverse Event|1|||
42081256|NCT00824408|75891613|FG001|Run-in Phase|Adverse Event|1|||
42081257|NCT00824408|75891614|FG002|Run-in Phase|Adverse Event|0|||
42081258|NCT00824408|75891615|FG003|Run-in Phase|Adverse Event|0|||
42081259|NCT00824408|75891616|FG004|Run-in Phase|Adverse Event|0|||
42081260|NCT00824408|75891612|FG000|Run-in Phase|Refused to continue medication|1|||
42178391|NCT00256997|75985549|FG001|Overall Study|Other|8|||
42178392|NCT00256997|75985548|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
42178393|NCT00256997|75985549|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
42178394|NCT00256997|75985548|FG000|Overall Study|Participant Non-compliant|3|||
42178395|NCT00256997|75985549|FG001|Overall Study|Participant Non-compliant|6|||
42178396|NCT00256997|75985548|FG000|Overall Study|Investigator Withdrew Participant|2|||
42178397|NCT00256997|75985549|FG001|Overall Study|Investigator Withdrew Participant|1|||
42178398|NCT00027846|75985559|FG000|Overall Study|Lost to Follow-up|0|||
42178399|NCT00027846|75985560|FG001|Overall Study|Lost to Follow-up|41|||
42178400|NCT00027846|75985561|FG002|Overall Study|Lost to Follow-up|9|||
42178401|NCT00027846|75985559|FG000|Overall Study|Withdrawal by Subject|0|||
42178402|NCT00027846|75985560|FG001|Overall Study|Withdrawal by Subject|14|||
42178403|NCT00027846|75985561|FG002|Overall Study|Withdrawal by Subject|7|||
42178404|NCT00027846|75985559|FG000|Overall Study|Ineligible for study|2|||
42178405|NCT00027846|75985560|FG001|Overall Study|Ineligible for study|6|||
42178406|NCT00027846|75985561|FG002|Overall Study|Ineligible for study|14|||
42178407|NCT00027846|75985559|FG000|Overall Study|Entry into another COG therapeutic study|0|||
42178408|NCT00027846|75985560|FG001|Overall Study|Entry into another COG therapeutic study|5|||
42178409|NCT00027846|75985561|FG002|Overall Study|Entry into another COG therapeutic study|2|||
42178410|NCT00027846|75985559|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
42178411|NCT00027846|75985560|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
42178412|NCT00027846|75985561|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
42178413|NCT00027378|75985573|FG000|Overall Study|Physician Decision|0|||
42178414|NCT00027378|75985574|FG001|Overall Study|Physician Decision|3|||
42358113|NCT01855789|76203730|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
42358114|NCT01855789|76203731|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
42081261|NCT00824408|75891613|FG001|Run-in Phase|Refused to continue medication|0|||
42081262|NCT00824408|75891614|FG002|Run-in Phase|Refused to continue medication|0|||
42081263|NCT00824408|75891615|FG003|Run-in Phase|Refused to continue medication|0|||
42081264|NCT00824408|75891616|FG004|Run-in Phase|Refused to continue medication|0|||
42358115|NCT01855789|76203732|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
42081265|NCT00824408|75891612|FG000|Run-in Phase|Other reason not defined above|0|||
42178415|NCT00235391|75985586|FG000|Overall Study|Adverse Event|4|||
42178416|NCT00235391|75985587|FG001|Overall Study|Adverse Event|5|||
42178417|NCT00235391|75985588|FG002|Overall Study|Adverse Event|10|||
42178418|NCT00235391|75985589|FG003|Overall Study|Adverse Event|72|||
42178419|NCT00235391|75985590|FG004|Overall Study|Adverse Event|5|||
42358116|NCT01855789|76203733|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
42081266|NCT00824408|75891613|FG001|Run-in Phase|Other reason not defined above|1|||
42081267|NCT00824408|75891614|FG002|Run-in Phase|Other reason not defined above|0|||
42081268|NCT00824408|75891615|FG003|Run-in Phase|Other reason not defined above|0|||
42081269|NCT00824408|75891616|FG004|Run-in Phase|Other reason not defined above|0|||
42081270|NCT00824408|75891612|FG000|Randomized Phase|Not treated|0|||
42081271|NCT00824408|75891613|FG001|Randomized Phase|Not treated|0|||
42081272|NCT00824408|75891614|FG002|Randomized Phase|Not treated|1|||
42081273|NCT00824408|75891615|FG003|Randomized Phase|Not treated|1|||
42081274|NCT00824408|75891616|FG004|Randomized Phase|Not treated|1|||
42081275|NCT00824408|75891612|FG000|Randomized Phase|Progressive disease|0|||
42081276|NCT00824408|75891613|FG001|Randomized Phase|Progressive disease|0|||
42081277|NCT00824408|75891614|FG002|Randomized Phase|Progressive disease|25|||
42081278|NCT00824408|75891615|FG003|Randomized Phase|Progressive disease|36|||
42081279|NCT00824408|75891616|FG004|Randomized Phase|Progressive disease|34|||
42081280|NCT00824408|75891612|FG000|Randomized Phase|Adverse Event|0|||
42081281|NCT00824408|75891613|FG001|Randomized Phase|Adverse Event|0|||
42081282|NCT00824408|75891614|FG002|Randomized Phase|Adverse Event|4|||
42081283|NCT00824408|75891615|FG003|Randomized Phase|Adverse Event|5|||
42081284|NCT00824408|75891616|FG004|Randomized Phase|Adverse Event|5|||
42081285|NCT00824408|75891612|FG000|Randomized Phase|Refused to continue medication|0|||
42081286|NCT00824408|75891613|FG001|Randomized Phase|Refused to continue medication|0|||
42081287|NCT00824408|75891614|FG002|Randomized Phase|Refused to continue medication|2|||
42081288|NCT00824408|75891615|FG003|Randomized Phase|Refused to continue medication|2|||
42081289|NCT00824408|75891616|FG004|Randomized Phase|Refused to continue medication|2|||
42081290|NCT00824408|75891612|FG000|Randomized Phase|Other reason not defined above|0|||
42081291|NCT00824408|75891613|FG001|Randomized Phase|Other reason not defined above|0|||
42081292|NCT00824408|75891614|FG002|Randomized Phase|Other reason not defined above|4|||
42081293|NCT00824408|75891615|FG003|Randomized Phase|Other reason not defined above|2|||
42081294|NCT00824408|75891616|FG004|Randomized Phase|Other reason not defined above|4|||
42081295|NCT00866333|75891637|FG000|Overall Study|Withdrawal of consent|0|||
42081296|NCT00866333|75891638|FG001|Overall Study|Withdrawal of consent|1|||
42081297|NCT00866333|75891639|FG002|Overall Study|Withdrawal of consent|2|||
42081298|NCT00866333|75891637|FG000|Overall Study|Reason not Specified|3|||
42081299|NCT00866333|75891638|FG001|Overall Study|Reason not Specified|1|||
42081300|NCT00866333|75891639|FG002|Overall Study|Reason not Specified|1|||
42081301|NCT00866333|75891637|FG000|Overall Study|Study Terminated by Sponsor|2|||
42081302|NCT00866333|75891638|FG001|Overall Study|Study Terminated by Sponsor|5|||
42081303|NCT00866333|75891639|FG002|Overall Study|Study Terminated by Sponsor|9|||
42081304|NCT00834080|75891647|FG000|Overall Study|Adverse Event|7|||
42081305|NCT00834080|75891647|FG000|Overall Study|Lost to Follow-up|7|||
42081306|NCT00834080|75891647|FG000|Overall Study|Withdrawal by Subject|5|||
42081307|NCT00834080|75891647|FG000|Overall Study|Other - Pregnancy|1|||
42081308|NCT00834080|75891647|FG000|Overall Study|Other - False positive tests of the UDS|1|||
42081309|NCT00834080|75891647|FG000|Overall Study|Physician Decision|1|||
42081310|NCT00834080|75891647|FG000|Overall Study|Subject Relocated|1|||
42081311|NCT00823472|75891653|FG000|Overall Study|Physician Decision|24|||
42081312|NCT00823472|75891654|FG001|Overall Study|Physician Decision|28|||
42081313|NCT00856193|75891660|FG000|Period 2|Abnormal test procedure results|0|||
42081314|NCT00856193|75891661|FG001|Period 2|Abnormal test procedure results|1|||
42081315|NCT00856193|75891660|FG000|Period 2|Lost to Follow-up|0|||
42358117|NCT01855789|76203730|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
42358118|NCT01855789|76203731|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
42358119|NCT01855789|76203732|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
42358120|NCT01855789|76203733|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
42358121|NCT01855789|76203730|FG000|1) Baseline up to Week 24|Physician Decision|4|||
42358122|NCT01855789|76203731|FG001|1) Baseline up to Week 24|Physician Decision|0|||
42081316|NCT00856193|75891661|FG001|Period 2|Lost to Follow-up|1|||
42081317|NCT00652366|75891672|FG000|Overall Study|Adverse Event|8|||
42081318|NCT00652366|75891673|FG001|Overall Study|Adverse Event|4|||
42081319|NCT00652366|75891674|FG002|Overall Study|Adverse Event|7|||
42081320|NCT00652366|75891675|FG003|Overall Study|Adverse Event|17|||
42081321|NCT00652366|75891676|FG004|Overall Study|Adverse Event|13|||
42081322|NCT00652366|75891672|FG000|Overall Study|Death|5|||
42081323|NCT00652366|75891673|FG001|Overall Study|Death|4|||
42081324|NCT00652366|75891674|FG002|Overall Study|Death|1|||
42081325|NCT00652366|75891675|FG003|Overall Study|Death|8|||
42081326|NCT00652366|75891676|FG004|Overall Study|Death|5|||
42081327|NCT00652366|75891672|FG000|Overall Study|Lack of Efficacy|84|||
42081328|NCT00652366|75891673|FG001|Overall Study|Lack of Efficacy|58|||
42081329|NCT00652366|75891674|FG002|Overall Study|Lack of Efficacy|53|||
42081330|NCT00652366|75891675|FG003|Overall Study|Lack of Efficacy|133|||
42081331|NCT00652366|75891676|FG004|Overall Study|Lack of Efficacy|13|||
42081332|NCT00652366|75891672|FG000|Overall Study|Violation of Selection Criteria|0|||
42081333|NCT00652366|75891673|FG001|Overall Study|Violation of Selection Criteria|0|||
42081334|NCT00652366|75891674|FG002|Overall Study|Violation of Selection Criteria|1|||
42081335|NCT00652366|75891675|FG003|Overall Study|Violation of Selection Criteria|0|||
42081336|NCT00652366|75891676|FG004|Overall Study|Violation of Selection Criteria|0|||
42081337|NCT00652366|75891672|FG000|Overall Study|Protocol Violation|1|||
42081338|NCT00652366|75891673|FG001|Overall Study|Protocol Violation|0|||
42081339|NCT00652366|75891674|FG002|Overall Study|Protocol Violation|0|||
42081340|NCT00652366|75891675|FG003|Overall Study|Protocol Violation|0|||
42081341|NCT00652366|75891676|FG004|Overall Study|Protocol Violation|0|||
42081342|NCT00652366|75891672|FG000|Overall Study|Refused treatment|3|||
42081343|NCT00652366|75891673|FG001|Overall Study|Refused treatment|7|||
42081344|NCT00652366|75891674|FG002|Overall Study|Refused treatment|6|||
42081345|NCT00652366|75891675|FG003|Overall Study|Refused treatment|17|||
42081346|NCT00652366|75891676|FG004|Overall Study|Refused treatment|5|||
42081347|NCT00652366|75891672|FG000|Overall Study|Other|5|||
42081348|NCT00652366|75891673|FG001|Overall Study|Other|2|||
42081349|NCT00652366|75891674|FG002|Overall Study|Other|3|||
42081350|NCT00652366|75891675|FG003|Overall Study|Other|4|||
42081351|NCT00652366|75891676|FG004|Overall Study|Other|0|||
42081352|NCT00841568|75891690|FG000|Overall Study|Adverse Event|1|||
42081353|NCT00841568|75891690|FG000|Overall Study|Death|1|||
42081354|NCT00841568|75891690|FG000|Overall Study|Withdrawal by Subject|2|||
42081355|NCT00841568|75891690|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
42081356|NCT00855959|75891698|FG000|Overall Study|Adverse Event|2|||
42081357|NCT00855959|75891698|FG000|Overall Study|Lost to Follow-up|2|||
42081358|NCT00855959|75891698|FG000|Overall Study|Withdrawal by Subject|3|||
42081359|NCT00855959|75891698|FG000|Overall Study|Pregnancy|1|||
42081360|NCT00855959|75891698|FG000|Overall Study|Incorrect enrolment|1|||
42081361|NCT00841100|75891702|FG000|Phase 1 (28 Days)|Adverse Event|1|||
42081362|NCT00841100|75891702|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
42081363|NCT00651820|75891706|FG000|Overall Study|Lost to Follow-up|2|||
42081364|NCT00866177|75891712|FG000|Overall Study|Withdrawal by Subject|1|||
42081365|NCT00866177|75891712|FG000|Overall Study|Not Treated|151|||
42081366|NCT00833924|75891716|FG000|Overall Study|Death|21|||
42081367|NCT00833924|75891716|FG000|Overall Study|Conversion|2|||
42081368|NCT00833924|75891716|FG000|Overall Study|Lost to Follow-up|2|||
42081369|NCT00833924|75891716|FG000|Overall Study|Withdrawal by Subject|13|||
42081370|NCT00833924|75891716|FG000|Overall Study|In study follow-up|71|||
42081371|NCT00840086|75891720|FG000|Overall Study|Adverse Event|1|||
42081372|NCT00840086|75891720|FG000|Overall Study|Protocol Violation|2|||
42081373|NCT00840086|75891720|FG000|Overall Study|Lost to Follow-up|1|||
42081374|NCT00822926|75891729|FG000|Second Injection Visit|Lost to Follow-up|1|||
42081375|NCT00822926|75891730|FG001|Second Injection Visit|Lost to Follow-up|0|||
42081376|NCT00822926|75891729|FG000|Second Injection Visit|Withdrawal by Subject|0|||
42081377|NCT00822926|75891730|FG001|Second Injection Visit|Withdrawal by Subject|1|||
42081378|NCT00822770|75891741|FG000|Overall Study|Not treated|1|||
42081379|NCT00822770|75891742|FG001|Overall Study|Not treated|0|||
42081380|NCT00822770|75891741|FG000|Overall Study|Complication/Incomplete treatment|1|||
42081381|NCT00822770|75891742|FG001|Overall Study|Complication/Incomplete treatment|0|||
42081382|NCT00822770|75891741|FG000|Overall Study|Death|1|||
42081383|NCT00822770|75891742|FG001|Overall Study|Death|1|||
42081384|NCT00822692|75891750|FG000|Overall Study|Lost to Follow-up|17|||
42081385|NCT00822692|75891751|FG001|Overall Study|Lost to Follow-up|25|||
42081386|NCT00806442|75891757|FG000|Overall Study|Lost to Follow-up|3|||
42081387|NCT00806442|75891758|FG001|Overall Study|Lost to Follow-up|2|||
42081388|NCT00806442|75891757|FG000|Overall Study|Withdrawal by Subject|1|||
42081389|NCT00806442|75891758|FG001|Overall Study|Withdrawal by Subject|5|||
42081390|NCT00821678|75891768|FG000|Overall Study|Withdrawal by Subject|8|||
42081391|NCT00821678|75891769|FG001|Overall Study|Withdrawal by Subject|0|||
42081392|NCT00821678|75891768|FG000|Overall Study|Lost to Follow-up|13|||
42081393|NCT00821678|75891769|FG001|Overall Study|Lost to Follow-up|12|||
42081394|NCT00821678|75891768|FG000|Overall Study|Death|0|||
42081395|NCT00821678|75891769|FG001|Overall Study|Death|2|||
42081396|NCT00839852|75891777|FG000|Overall Study|Adverse Event|10|||
42081397|NCT00839852|75891777|FG000|Overall Study|Insufficient Therapeutic Response|3|||
42081398|NCT00839852|75891777|FG000|Overall Study|Protocol Violation|9|||
42081399|NCT00839852|75891777|FG000|Overall Study|Withdrawal of Consent|16|||
42081400|NCT00839852|75891777|FG000|Overall Study|Lost to Follow-up|7|||
42081401|NCT00839852|75891777|FG000|Overall Study|Lack of Compliance While in Jail|1|||
42081402|NCT00839852|75891777|FG000|Overall Study|Pregnancy|1|||
42081403|NCT00833690|75891784|FG000|Overall Study|Withdrawal by Subject|1|||
42081404|NCT00833690|75891785|FG001|Overall Study|Withdrawal by Subject|0|||
42081405|NCT00833690|75891786|FG002|Overall Study|Withdrawal by Subject|0|||
42081406|NCT00833690|75891784|FG000|Overall Study|Discontinued study drug|3|||
42081407|NCT00833690|75891785|FG001|Overall Study|Discontinued study drug|2|||
42081408|NCT00833690|75891786|FG002|Overall Study|Discontinued study drug|0|||
42081409|NCT00820898|75891794|FG000|Overall Study|Inelgible - wrong primary site|1|||
42081410|NCT00865709|75891806|FG000|Treatment|Adverse Event|9|||
42081411|NCT00865709|75891807|FG001|Treatment|Adverse Event|6|||
42081412|NCT00865709|75891806|FG000|Treatment|Withdrawal by Subject|10|||
42081413|NCT00865709|75891807|FG001|Treatment|Withdrawal by Subject|7|||
42081414|NCT00865709|75891806|FG000|Treatment|Physician Decision|3|||
42081415|NCT00865709|75891807|FG001|Treatment|Physician Decision|2|||
42081416|NCT00865709|75891806|FG000|Treatment|Surgery|8|||
42081417|NCT00865709|75891807|FG001|Treatment|Surgery|3|||
42081418|NCT00839306|75891817|FG000|Overall Study|Adverse Event|3|||
42081419|NCT00839306|75891818|FG001|Overall Study|Adverse Event|5|||
42081420|NCT00839306|75891817|FG000|Overall Study|Lost to Follow-up|6|||
42081421|NCT00839306|75891818|FG001|Overall Study|Lost to Follow-up|9|||
42081422|NCT00839306|75891817|FG000|Overall Study|Withdrawal by Subject|5|||
42081423|NCT00839306|75891818|FG001|Overall Study|Withdrawal by Subject|7|||
42081424|NCT00839306|75891817|FG000|Overall Study|Lack of Efficacy|5|||
42081425|NCT00839306|75891818|FG001|Overall Study|Lack of Efficacy|4|||
42081426|NCT00839306|75891817|FG000|Overall Study|Other|6|||
42081427|NCT00839306|75891818|FG001|Overall Study|Other|18|||
42081428|NCT00839072|75891825|FG000|First Intervention Period|Withdrawal by Subject|1|||
42081429|NCT00839072|75891826|FG001|First Intervention Period|Withdrawal by Subject|0|||
42081430|NCT00839072|75891825|FG000|First Intervention Period|Adverse Event|1|||
42081431|NCT00839072|75891826|FG001|First Intervention Period|Adverse Event|1|||
42081432|NCT00839072|75891825|FG000|Second Intervention Period|Withdrawal by Subject|1|||
42081433|NCT00839072|75891826|FG001|Second Intervention Period|Withdrawal by Subject|0|||
42081434|NCT00855803|75891832|FG000|Overall Study|Death|2|||
42081435|NCT00855803|75891832|FG000|Overall Study|Lost to Follow-up|2|||
42081436|NCT00855803|75891832|FG000|Overall Study|Technical inability to undergo procedure|2|||
42081437|NCT00855803|75891832|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
42081438|NCT00855803|75891832|FG000|Overall Study|Withdrawal by Subject|3|||
42081439|NCT00855803|75891832|FG000|Overall Study|Physician Decision|3|||
42081440|NCT00838916|75891838|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
42081441|NCT00838916|75891839|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
42081442|NCT00838916|75891838|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
42081443|NCT00838916|75891839|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
42081444|NCT00838916|75891838|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
42081445|NCT00838916|75891839|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
42081446|NCT00838916|75891838|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
42081447|NCT00838916|75891839|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
42081448|NCT00838916|75891838|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
42081449|NCT00838916|75891839|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
42081450|NCT00838916|75891838|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
42081451|NCT00838916|75891839|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
42081452|NCT00838916|75891838|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
42081453|NCT00838916|75891839|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
42081454|NCT00838916|75891838|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
42081455|NCT00838916|75891839|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
42081456|NCT00838916|75891838|FG000|Treatment Period (156 Weeks)|Missing|3|||
42081457|NCT00838916|75891839|FG001|Treatment Period (156 Weeks)|Missing|1|||
42081458|NCT00838916|75891838|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
42081459|NCT00838916|75891839|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
42081460|NCT00838916|75891838|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
42081461|NCT00838916|75891839|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
42081462|NCT00838916|75891838|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
42081463|NCT00838916|75891839|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
42081464|NCT00838916|75891838|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
42081465|NCT00838916|75891839|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
42081466|NCT00838916|75891838|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
42081467|NCT00838916|75891839|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
42081468|NCT00838916|75891838|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
42081469|NCT00838916|75891839|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
42081470|NCT00838916|75891838|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
42081471|NCT00838916|75891839|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
42081472|NCT00838916|75891838|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
42081473|NCT00838916|75891839|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
42081474|NCT00838916|75891838|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
42081475|NCT00838916|75891839|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
42081476|NCT00838916|75891838|FG000|Follow-up Period (8 Weeks)|Missing|3|||
42081477|NCT00838916|75891839|FG001|Follow-up Period (8 Weeks)|Missing|0|||
42081478|NCT00838682|75891847|FG000|Overall Study|Lost to Follow-up|21|||
42081479|NCT00838682|75891848|FG001|Overall Study|Lost to Follow-up|14|||
42081480|NCT00838682|75891847|FG000|Overall Study|detection of exclusion criteria|4|||
42081481|NCT00838682|75891848|FG001|Overall Study|detection of exclusion criteria|3|||
42081482|NCT00838682|75891847|FG000|Overall Study|Protocol Violation|0|||
42081483|NCT00838682|75891848|FG001|Overall Study|Protocol Violation|1|||
42081484|NCT00838682|75891847|FG000|Overall Study|Withdrawal by Subject|0|||
42081485|NCT00838682|75891848|FG001|Overall Study|Withdrawal by Subject|1|||
42081486|NCT00820040|75891854|FG000|Overall Study|Death|1|||
42081487|NCT00820040|75891854|FG000|Overall Study|Sponsor terminated study|1|||
42081488|NCT00820040|75891854|FG000|Overall Study|Screen failure|1|||
42081489|NCT00803712|75891860|FG000|Overall Study|Noncompliance|3|||
42081490|NCT00803712|75891861|FG001|Overall Study|Noncompliance|0|||
42081491|NCT00803712|75891860|FG000|Overall Study|Adverse Event|5|||
42081492|NCT00803712|75891861|FG001|Overall Study|Adverse Event|0|||
42081493|NCT00803712|75891860|FG000|Overall Study|Death|8|||
42081494|NCT00803712|75891861|FG001|Overall Study|Death|7|||
42081495|NCT00803712|75891860|FG000|Overall Study|Lost to Follow-up|3|||
42081496|NCT00803712|75891861|FG001|Overall Study|Lost to Follow-up|1|||
42081497|NCT00803712|75891860|FG000|Overall Study|Withdrawal by Subject|2|||
42081498|NCT00803712|75891861|FG001|Overall Study|Withdrawal by Subject|4|||
42081499|NCT00803712|75891860|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
42081500|NCT00803712|75891861|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
42081501|NCT00803712|75891860|FG000|Overall Study|Protocol criteria (other)|0|||
42081502|NCT00803712|75891861|FG001|Overall Study|Protocol criteria (other)|2|||
42081503|NCT00803712|75891860|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
42081504|NCT00803712|75891861|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
42081505|NCT00803712|75891860|FG000|Overall Study|Administrative decision|2|||
42081506|NCT00803712|75891861|FG001|Overall Study|Administrative decision|3|||
42081507|NCT00803712|75891860|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
42081508|NCT00803712|75891861|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
42081509|NCT00591344|75891869|FG000|Overall Study|Transportation issues|1|||
42081510|NCT00591344|75891870|FG001|Overall Study|Transportation issues|0|||
42081511|NCT00591344|75891869|FG000|Overall Study|Moved out of state|1|||
42081512|NCT00591344|75891870|FG001|Overall Study|Moved out of state|0|||
42081513|NCT00591344|75891869|FG000|Overall Study|Medical complications|1|||
42081514|NCT00591344|75891870|FG001|Overall Study|Medical complications|3|||
42081515|NCT00591344|75891869|FG000|Overall Study|Underwent DBS|2|||
42081516|NCT00591344|75891870|FG001|Overall Study|Underwent DBS|2|||
42081517|NCT00591344|75891869|FG000|Overall Study|Death|0|||
42081518|NCT00591344|75891870|FG001|Overall Study|Death|1|||
42081519|NCT00591344|75891869|FG000|Overall Study|Lost to Follow-up|0|||
42081520|NCT00591344|75891870|FG001|Overall Study|Lost to Follow-up|1|||
42081521|NCT00591344|75891869|FG000|Overall Study|Did not want to come off medication|0|||
42081522|NCT00591344|75891870|FG001|Overall Study|Did not want to come off medication|1|||
42081523|NCT00803634|75891882|FG000|Overall Study|Withdrew Consent|1|||
42081524|NCT00803634|75891883|FG001|Overall Study|Withdrew Consent|0|||
42081525|NCT00803634|75891882|FG000|Overall Study|Lost to Follow-up|2|||
42081526|NCT00803634|75891883|FG001|Overall Study|Lost to Follow-up|3|||
42081527|NCT00803634|75891882|FG000|Overall Study|Death|3|||
42081528|NCT00803634|75891883|FG001|Overall Study|Death|2|||
42081529|NCT00838526|75891892|FG000|Overall Study|Adverse Event|3|||
42081530|NCT00838526|75891893|FG001|Overall Study|Adverse Event|12|||
42081531|NCT00838526|75891892|FG000|Overall Study|Lost to Follow-up|4|||
42081532|NCT00838526|75891893|FG001|Overall Study|Lost to Follow-up|12|||
42081533|NCT00838526|75891892|FG000|Overall Study|Withdrawal by Subject|4|||
42081534|NCT00838526|75891893|FG001|Overall Study|Withdrawal by Subject|5|||
42081535|NCT00838526|75891892|FG000|Overall Study|Lack of Efficacy|2|||
42081536|NCT00838526|75891893|FG001|Overall Study|Lack of Efficacy|3|||
42081537|NCT00838526|75891892|FG000|Overall Study|Other|11|||
42081538|NCT00838526|75891893|FG001|Overall Study|Other|7|||
42081539|NCT00818246|75891912|FG000|Overall Study|Impossible to match pictures|5|||
42081540|NCT00818168|75891916|FG000|Overall Study|Lack of Efficacy|18|||
42081541|NCT00818168|75891916|FG000|Overall Study|Pregnancy|2|||
42081542|NCT00818168|75891916|FG000|Overall Study|Withdrawal by Subject|16|||
42081543|NCT00818168|75891916|FG000|Overall Study|Lost to Follow-up|7|||
42081544|NCT00818168|75891916|FG000|Overall Study|Adverse Event|19|||
42081545|NCT00818168|75891916|FG000|Overall Study|Reason for Non-completion Not reported|6|||
42081546|NCT00818168|75891916|FG000|Overall Study|Participant Moved|2|||
42081547|NCT00817778|75891922|FG000|Overall Study|Adverse Event|1|||
42081548|NCT00817778|75891923|FG001|Overall Study|Adverse Event|0|||
42081549|NCT00817778|75891922|FG000|Overall Study|Withdrawal by Subject|1|||
42081550|NCT00817778|75891923|FG001|Overall Study|Withdrawal by Subject|1|||
42081551|NCT00817778|75891922|FG000|Overall Study|Protocol Violation|0|||
42081552|NCT00817778|75891923|FG001|Overall Study|Protocol Violation|1|||
42081553|NCT00817778|75891922|FG000|Overall Study|Study-specific discontinuation criteria|0|||
42081554|NCT00817778|75891923|FG001|Overall Study|Study-specific discontinuation criteria|1|||
42081555|NCT00817778|75891922|FG000|Overall Study|Poor venous access|1|||
42081556|NCT00817778|75891923|FG001|Overall Study|Poor venous access|0|||
42081557|NCT00813098|75891932|FG000|Overall Study|Adverse Event|2|||
42081558|NCT00813098|75891933|FG001|Overall Study|Adverse Event|4|||
42081559|NCT00813098|75891934|FG002|Overall Study|Adverse Event|1|||
42081560|NCT00813098|75891932|FG000|Overall Study|Withdrawal by Subject|0|||
42081561|NCT00813098|75891933|FG001|Overall Study|Withdrawal by Subject|1|||
42081562|NCT00813098|75891934|FG002|Overall Study|Withdrawal by Subject|0|||
42081563|NCT00813098|75891932|FG000|Overall Study|Inability to complete study procedures|1|||
42081564|NCT00813098|75891933|FG001|Overall Study|Inability to complete study procedures|0|||
42081565|NCT00813098|75891934|FG002|Overall Study|Inability to complete study procedures|0|||
42081566|NCT00813098|75891932|FG000|Overall Study|Lost to Follow-up|0|||
42081567|NCT00813098|75891933|FG001|Overall Study|Lost to Follow-up|1|||
42081568|NCT00813098|75891934|FG002|Overall Study|Lost to Follow-up|0|||
42081569|NCT00813098|75891932|FG000|Overall Study|Protocol Violation|0|||
42081570|NCT00813098|75891933|FG001|Overall Study|Protocol Violation|0|||
42081571|NCT00813098|75891934|FG002|Overall Study|Protocol Violation|1|||
42081572|NCT00813098|75891932|FG000|Overall Study|Principal Investigator decision|0|||
42081573|NCT00813098|75891933|FG001|Overall Study|Principal Investigator decision|1|||
42081574|NCT00813098|75891934|FG002|Overall Study|Principal Investigator decision|0|||
42081575|NCT00813098|75891932|FG000|Overall Study|Withdrew Consent|0|||
42081576|NCT00813098|75891933|FG001|Overall Study|Withdrew Consent|1|||
42081577|NCT00813098|75891934|FG002|Overall Study|Withdrew Consent|0|||
42081578|NCT00796653|75891946|FG000|Overall Study|Adverse Event|19|||
42081579|NCT00796653|75891947|FG001|Overall Study|Adverse Event|16|||
42081580|NCT00796653|75891948|FG002|Overall Study|Adverse Event|16|||
42081581|NCT00796653|75891949|FG003|Overall Study|Adverse Event|16|||
42081582|NCT00796653|75891946|FG000|Overall Study|Lost to Follow-up|2|||
42081583|NCT00796653|75891947|FG001|Overall Study|Lost to Follow-up|1|||
42081584|NCT00796653|75891948|FG002|Overall Study|Lost to Follow-up|2|||
42081585|NCT00796653|75891949|FG003|Overall Study|Lost to Follow-up|3|||
42081586|NCT00796653|75891946|FG000|Overall Study|Withdrawal by Subject|16|||
42081587|NCT00796653|75891947|FG001|Overall Study|Withdrawal by Subject|8|||
42081588|NCT00796653|75891948|FG002|Overall Study|Withdrawal by Subject|8|||
42081589|NCT00796653|75891949|FG003|Overall Study|Withdrawal by Subject|13|||
42081590|NCT00796653|75891946|FG000|Overall Study|Lack of Efficacy|8|||
42081591|NCT00796653|75891947|FG001|Overall Study|Lack of Efficacy|1|||
42081592|NCT00796653|75891948|FG002|Overall Study|Lack of Efficacy|3|||
42081593|NCT00796653|75891949|FG003|Overall Study|Lack of Efficacy|2|||
42081594|NCT00796653|75891946|FG000|Overall Study|Non compliance with protocol|2|||
42081595|NCT00796653|75891947|FG001|Overall Study|Non compliance with protocol|2|||
42081596|NCT00796653|75891948|FG002|Overall Study|Non compliance with protocol|0|||
42081597|NCT00796653|75891949|FG003|Overall Study|Non compliance with protocol|2|||
42081598|NCT00796653|75891946|FG000|Overall Study|Other reason not described above|4|||
42081599|NCT00796653|75891947|FG001|Overall Study|Other reason not described above|9|||
42081600|NCT00796653|75891948|FG002|Overall Study|Other reason not described above|7|||
42081601|NCT00796653|75891949|FG003|Overall Study|Other reason not described above|4|||
42081602|NCT00806286|75891970|FG000|Overall Study|Adverse Event|5|||
42081603|NCT00806286|75891971|FG001|Overall Study|Adverse Event|2|||
42081604|NCT00806286|75891972|FG002|Overall Study|Adverse Event|0|||
42081605|NCT00806286|75891970|FG000|Overall Study|Disease progression|31|||
42081606|NCT00806286|75891971|FG001|Overall Study|Disease progression|38|||
42081607|NCT00806286|75891972|FG002|Overall Study|Disease progression|1|||
42081608|NCT00806286|75891970|FG000|Overall Study|Death|1|||
42081609|NCT00806286|75891971|FG001|Overall Study|Death|6|||
42081610|NCT00806286|75891972|FG002|Overall Study|Death|0|||
42081611|NCT00806286|75891970|FG000|Overall Study|Lost to Follow-up|0|||
42081612|NCT00806286|75891971|FG001|Overall Study|Lost to Follow-up|1|||
42081613|NCT00806286|75891972|FG002|Overall Study|Lost to Follow-up|0|||
42081614|NCT00806286|75891970|FG000|Overall Study|Withdrawal by Subject|8|||
42081615|NCT00806286|75891971|FG001|Overall Study|Withdrawal by Subject|3|||
42081616|NCT00806286|75891972|FG002|Overall Study|Withdrawal by Subject|1|||
42081617|NCT00806286|75891970|FG000|Overall Study|Physician Decision|2|||
42081618|NCT00806286|75891971|FG001|Overall Study|Physician Decision|2|||
42081619|NCT00806286|75891972|FG002|Overall Study|Physician Decision|0|||
42081620|NCT00806286|75891970|FG000|Overall Study|Due to a variety of reasons|7|||
42081621|NCT00806286|75891971|FG001|Overall Study|Due to a variety of reasons|2|||
42081622|NCT00806286|75891972|FG002|Overall Study|Due to a variety of reasons|1|||
42081623|NCT00590538|75891980|FG000|Overall Study|Study terminated before completed|2|||
42081624|NCT00796419|75891986|FG000|Overall Study|Death|0|||
42081625|NCT00796419|75891987|FG001|Overall Study|Death|1|||
42081626|NCT00796107|75891993|FG000|Overall Study|Lack of Efficacy|1|||
42081627|NCT00796107|75891993|FG000|Overall Study|Progressive Disease|5|||
42081628|NCT00795951|75891997|FG000|Overall Study|Lost to Follow-up|1|||
42081629|NCT00795951|75891997|FG000|Overall Study|Withdrawal by Subject|1|||
42081630|NCT00795717|75892004|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
42081631|NCT00795717|75892005|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
42081632|NCT00795717|75892004|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
42081633|NCT00795717|75892005|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
42081634|NCT00795717|75892004|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
42081635|NCT00795717|75892005|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
42081636|NCT00795717|75892004|FG000|Phase II|too busy|0|||
42081637|NCT00795717|75892005|FG001|Phase II|too busy|1|||
42081638|NCT00805740|75892014|FG000|Overall Study|Death|7|||
42081639|NCT00805740|75892015|FG001|Overall Study|Death|4|||
42081640|NCT00805740|75892014|FG000|Overall Study|Withdrawal by Subject|1|||
42081641|NCT00805740|75892015|FG001|Overall Study|Withdrawal by Subject|0|||
42081642|NCT00805740|75892014|FG000|Overall Study|Lost to Follow-up|1|||
42081643|NCT00805740|75892015|FG001|Overall Study|Lost to Follow-up|0|||
42081644|NCT00805740|75892014|FG000|Overall Study|Randomized, but not treated|2|||
42081645|NCT00805740|75892015|FG001|Overall Study|Randomized, but not treated|0|||
42081646|NCT00795639|75892023|FG000|Overall Study|Death|1|||
42081647|NCT00795639|75892024|FG001|Overall Study|Death|6|||
42081648|NCT00795639|75892023|FG000|Overall Study|Withdrawal by Subject|1|||
42081649|NCT00795639|75892024|FG001|Overall Study|Withdrawal by Subject|3|||
42081650|NCT00795639|75892023|FG000|Overall Study|Pregnancy|1|||
42081651|NCT00795639|75892024|FG001|Overall Study|Pregnancy|0|||
42081652|NCT00795639|75892023|FG000|Overall Study|Adverse Event|5|||
42081653|NCT00795639|75892024|FG001|Overall Study|Adverse Event|2|||
42081654|NCT00795639|75892023|FG000|Overall Study|Other|0|||
42081655|NCT00795639|75892024|FG001|Overall Study|Other|2|||
42081656|NCT00795639|75892023|FG000|Overall Study|Terminated by sponsor|13|||
42081657|NCT00795639|75892024|FG001|Overall Study|Terminated by sponsor|12|||
42178420|NCT00235391|75985591|FG005|Overall Study|Adverse Event|2|||
42178421|NCT00235391|75985586|FG000|Overall Study|Abnormal laboratory value(s)|3|||
42178422|NCT00235391|75985587|FG001|Overall Study|Abnormal laboratory value(s)|5|||
42178423|NCT00235391|75985588|FG002|Overall Study|Abnormal laboratory value(s)|4|||
42178424|NCT00235391|75985589|FG003|Overall Study|Abnormal laboratory value(s)|27|||
42178425|NCT00235391|75985590|FG004|Overall Study|Abnormal laboratory value(s)|1|||
42178426|NCT00235391|75985591|FG005|Overall Study|Abnormal laboratory value(s)|2|||
42178427|NCT00235391|75985586|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42178428|NCT00235391|75985587|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42178429|NCT00235391|75985588|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
42178430|NCT00235391|75985589|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
42178431|NCT00235391|75985590|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
42178432|NCT00235391|75985591|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
42178433|NCT00235391|75985586|FG000|Overall Study|Condition no longer requires treatment|3|||
42178434|NCT00235391|75985587|FG001|Overall Study|Condition no longer requires treatment|0|||
42178435|NCT00235391|75985588|FG002|Overall Study|Condition no longer requires treatment|0|||
42178436|NCT00235391|75985589|FG003|Overall Study|Condition no longer requires treatment|11|||
42178437|NCT00235391|75985590|FG004|Overall Study|Condition no longer requires treatment|1|||
42178438|NCT00235391|75985591|FG005|Overall Study|Condition no longer requires treatment|0|||
42178439|NCT00235391|75985586|FG000|Overall Study|Protocol deviation|0|||
42178440|NCT00235391|75985587|FG001|Overall Study|Protocol deviation|0|||
42178441|NCT00235391|75985588|FG002|Overall Study|Protocol deviation|1|||
42178442|NCT00235391|75985589|FG003|Overall Study|Protocol deviation|11|||
42178443|NCT00235391|75985590|FG004|Overall Study|Protocol deviation|0|||
42178444|NCT00235391|75985591|FG005|Overall Study|Protocol deviation|0|||
42178445|NCT00235391|75985586|FG000|Overall Study|Withdrawal by Subject|2|||
42178446|NCT00235391|75985587|FG001|Overall Study|Withdrawal by Subject|3|||
42178447|NCT00235391|75985588|FG002|Overall Study|Withdrawal by Subject|3|||
42178448|NCT00235391|75985589|FG003|Overall Study|Withdrawal by Subject|61|||
42178449|NCT00235391|75985590|FG004|Overall Study|Withdrawal by Subject|5|||
42178450|NCT00235391|75985591|FG005|Overall Study|Withdrawal by Subject|0|||
42178451|NCT00235391|75985586|FG000|Overall Study|Lost to Follow-up|0|||
42178452|NCT00235391|75985587|FG001|Overall Study|Lost to Follow-up|3|||
42178453|NCT00235391|75985588|FG002|Overall Study|Lost to Follow-up|3|||
42178454|NCT00235391|75985589|FG003|Overall Study|Lost to Follow-up|16|||
42178455|NCT00235391|75985590|FG004|Overall Study|Lost to Follow-up|0|||
42178456|NCT00235391|75985591|FG005|Overall Study|Lost to Follow-up|0|||
42178457|NCT00235391|75985586|FG000|Overall Study|Administrative problems|0|||
42178458|NCT00235391|75985587|FG001|Overall Study|Administrative problems|0|||
42081658|NCT00795639|75892023|FG000|Overall Study|Randomized and not treated|0|||
42178459|NCT00235391|75985588|FG002|Overall Study|Administrative problems|0|||
42178460|NCT00235391|75985589|FG003|Overall Study|Administrative problems|1|||
42178461|NCT00235391|75985590|FG004|Overall Study|Administrative problems|0|||
42178462|NCT00235391|75985591|FG005|Overall Study|Administrative problems|0|||
42178463|NCT00235391|75985586|FG000|Overall Study|Death|0|||
42178464|NCT00235391|75985587|FG001|Overall Study|Death|0|||
42178465|NCT00235391|75985588|FG002|Overall Study|Death|1|||
42178466|NCT00235391|75985589|FG003|Overall Study|Death|4|||
42081659|NCT00795639|75892024|FG001|Overall Study|Randomized and not treated|1|||
42081660|NCT00589602|75892030|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
42081661|NCT00794157|75892039|FG000|Overall Study|Adverse Event|4|||
42081662|NCT00794157|75892040|FG001|Overall Study|Adverse Event|1|||
42081663|NCT00794157|75892041|FG002|Overall Study|Adverse Event|8|||
42081664|NCT00794157|75892039|FG000|Overall Study|Subject withdrew consent|2|||
42081665|NCT00794157|75892040|FG001|Overall Study|Subject withdrew consent|0|||
42081666|NCT00794157|75892041|FG002|Overall Study|Subject withdrew consent|3|||
42081667|NCT00794157|75892039|FG000|Overall Study|Lost to Follow-up|2|||
42081668|NCT00794157|75892040|FG001|Overall Study|Lost to Follow-up|0|||
42081669|NCT00794157|75892041|FG002|Overall Study|Lost to Follow-up|1|||
42081670|NCT00794157|75892039|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42081671|NCT00794157|75892040|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42081672|NCT00794157|75892041|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
42081673|NCT00794157|75892039|FG000|Overall Study|Administrative problems|1|||
42081674|NCT00794157|75892040|FG001|Overall Study|Administrative problems|7|||
42081675|NCT00794157|75892041|FG002|Overall Study|Administrative problems|4|||
42081676|NCT00794157|75892039|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42081677|NCT00794157|75892040|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42081678|NCT00794157|75892041|FG002|Overall Study|Abnormal test procedure result(s)|0|||
42081679|NCT00794157|75892039|FG000|Overall Study|Protocol deviation|0|||
42081680|NCT00794157|75892040|FG001|Overall Study|Protocol deviation|1|||
42081681|NCT00794157|75892041|FG002|Overall Study|Protocol deviation|1|||
42081682|NCT00588237|75892049|FG000|Overall Study|Evaluable for toxicity only|3|||
42081683|NCT00588237|75892049|FG000|Overall Study|Patien not treated|1|||
42081684|NCT00790023|75892056|FG000|Overall Study|Adverse Event|2|||
42081685|NCT00790023|75892057|FG001|Overall Study|Adverse Event|1|||
42081686|NCT00790023|75892058|FG002|Overall Study|Adverse Event|4|||
42081687|NCT00790023|75892056|FG000|Overall Study|Protocol Violation|2|||
42081688|NCT00790023|75892057|FG001|Overall Study|Protocol Violation|4|||
42081689|NCT00790023|75892058|FG002|Overall Study|Protocol Violation|2|||
42081690|NCT00790023|75892056|FG000|Overall Study|Withdrawal by Subject|2|||
42081691|NCT00790023|75892057|FG001|Overall Study|Withdrawal by Subject|0|||
42081692|NCT00790023|75892058|FG002|Overall Study|Withdrawal by Subject|6|||
42081693|NCT00790023|75892056|FG000|Overall Study|Lost to Follow-up|0|||
42081694|NCT00790023|75892057|FG001|Overall Study|Lost to Follow-up|0|||
42081695|NCT00790023|75892058|FG002|Overall Study|Lost to Follow-up|1|||
42081696|NCT00790023|75892056|FG000|Overall Study|Other|5|||
42081697|NCT00790023|75892057|FG001|Overall Study|Other|5|||
42081698|NCT00790023|75892058|FG002|Overall Study|Other|8|||
42081699|NCT00588822|75892067|FG000|Overall Study|progression of disease|8|||
42081700|NCT00589914|75892073|FG000|Overall Study|Adverse Event|19|||
42081701|NCT00589914|75892074|FG001|Overall Study|Adverse Event|10|||
42081702|NCT00589914|75892073|FG000|Overall Study|Death|2|||
42081703|NCT00589914|75892074|FG001|Overall Study|Death|0|||
42081704|NCT00589914|75892073|FG000|Overall Study|Lack of Efficacy|40|||
42081705|NCT00589914|75892074|FG001|Overall Study|Lack of Efficacy|43|||
42081706|NCT00589914|75892073|FG000|Overall Study|Lost to Follow-up|11|||
42081707|NCT00589914|75892074|FG001|Overall Study|Lost to Follow-up|18|||
42081708|NCT00589914|75892073|FG000|Overall Study|Pregnancy|1|||
42081709|NCT00589914|75892074|FG001|Overall Study|Pregnancy|0|||
42081710|NCT00589914|75892073|FG000|Overall Study|Withdrawal by Subject|55|||
42081711|NCT00589914|75892074|FG001|Overall Study|Withdrawal by Subject|49|||
42081712|NCT00589914|75892073|FG000|Overall Study|Other|22|||
42081713|NCT00589914|75892074|FG001|Overall Study|Other|17|||
42081714|NCT00789555|75892083|FG000|Overall Study|Protocol Amendment|78|||
42081715|NCT00789555|75892084|FG001|Overall Study|Protocol Amendment|76|||
42081716|NCT00789555|75892085|FG002|Overall Study|Protocol Amendment|80|||
42081717|NCT00789555|75892083|FG000|Overall Study|Adverse Event|17|||
42081718|NCT00789555|75892084|FG001|Overall Study|Adverse Event|7|||
42081719|NCT00789555|75892085|FG002|Overall Study|Adverse Event|10|||
42081720|NCT00789555|75892083|FG000|Overall Study|Lost to Follow-up|9|||
42081721|NCT00789555|75892084|FG001|Overall Study|Lost to Follow-up|10|||
42081722|NCT00789555|75892085|FG002|Overall Study|Lost to Follow-up|18|||
42081723|NCT00789555|75892083|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
42081724|NCT00789555|75892084|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
42081725|NCT00789555|75892085|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
42081726|NCT00789555|75892083|FG000|Overall Study|Treatment failure|11|||
42081727|NCT00789555|75892084|FG001|Overall Study|Treatment failure|8|||
42081728|NCT00789555|75892085|FG002|Overall Study|Treatment failure|12|||
42081729|NCT00789555|75892083|FG000|Overall Study|Protocol Violation|6|||
42081730|NCT00789555|75892084|FG001|Overall Study|Protocol Violation|9|||
42081731|NCT00789555|75892085|FG002|Overall Study|Protocol Violation|13|||
42081732|NCT00451321|75892101|FG000|Overall Study|Lost to Follow-up|3|||
42081733|NCT00451321|75892102|FG001|Overall Study|Lost to Follow-up|3|||
42081734|NCT00451321|75892103|FG002|Overall Study|Lost to Follow-up|1|||
42081735|NCT00451321|75892104|FG003|Overall Study|Lost to Follow-up|3|||
42081736|NCT00451321|75892105|FG004|Overall Study|Lost to Follow-up|0|||
42081737|NCT00451321|75892106|FG005|Overall Study|Lost to Follow-up|1|||
42081738|NCT00451321|75892107|FG006|Overall Study|Lost to Follow-up|0|||
42081739|NCT00451321|75892108|FG007|Overall Study|Lost to Follow-up|0|||
42081740|NCT00451321|75892101|FG000|Overall Study|Withdrawal by Subject|3|||
42081741|NCT00451321|75892102|FG001|Overall Study|Withdrawal by Subject|1|||
42081742|NCT00451321|75892103|FG002|Overall Study|Withdrawal by Subject|0|||
42081743|NCT00451321|75892104|FG003|Overall Study|Withdrawal by Subject|4|||
42081744|NCT00451321|75892105|FG004|Overall Study|Withdrawal by Subject|0|||
42081745|NCT00451321|75892106|FG005|Overall Study|Withdrawal by Subject|0|||
42081746|NCT00451321|75892107|FG006|Overall Study|Withdrawal by Subject|0|||
42081747|NCT00451321|75892108|FG007|Overall Study|Withdrawal by Subject|0|||
42081748|NCT00451321|75892101|FG000|Overall Study|Study closed/terminated|1|||
42081749|NCT00451321|75892102|FG001|Overall Study|Study closed/terminated|1|||
42081750|NCT00451321|75892103|FG002|Overall Study|Study closed/terminated|17|||
42081751|NCT00451321|75892104|FG003|Overall Study|Study closed/terminated|5|||
42081752|NCT00451321|75892105|FG004|Overall Study|Study closed/terminated|7|||
42081753|NCT00451321|75892106|FG005|Overall Study|Study closed/terminated|7|||
42081754|NCT00451321|75892107|FG006|Overall Study|Study closed/terminated|5|||
42081755|NCT00451321|75892108|FG007|Overall Study|Study closed/terminated|3|||
42081756|NCT00451321|75892101|FG000|Overall Study|Sponsor decision to amend protocol|0|||
42081757|NCT00451321|75892102|FG001|Overall Study|Sponsor decision to amend protocol|0|||
42081758|NCT00451321|75892103|FG002|Overall Study|Sponsor decision to amend protocol|0|||
42081759|NCT00451321|75892104|FG003|Overall Study|Sponsor decision to amend protocol|0|||
42081760|NCT00451321|75892105|FG004|Overall Study|Sponsor decision to amend protocol|0|||
42081761|NCT00451321|75892106|FG005|Overall Study|Sponsor decision to amend protocol|1|||
42081762|NCT00451321|75892107|FG006|Overall Study|Sponsor decision to amend protocol|1|||
42081763|NCT00451321|75892108|FG007|Overall Study|Sponsor decision to amend protocol|3|||
42081764|NCT00802464|75892134|FG000|Month 0 - Month 8|Adverse Event|0|||
42081765|NCT00802464|75892135|FG001|Month 0 - Month 8|Adverse Event|1|||
42081766|NCT00802464|75892136|FG002|Month 0 - Month 8|Adverse Event|1|||
42081767|NCT00802464|75892137|FG003|Month 0 - Month 8|Adverse Event|2|||
42081768|NCT00802464|75892134|FG000|Month 0 - Month 8|Protocol Violation|0|||
42081769|NCT00802464|75892135|FG001|Month 0 - Month 8|Protocol Violation|0|||
42081770|NCT00802464|75892136|FG002|Month 0 - Month 8|Protocol Violation|1|||
42081771|NCT00802464|75892137|FG003|Month 0 - Month 8|Protocol Violation|0|||
42081772|NCT00802464|75892134|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
42081773|NCT00802464|75892135|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
42081774|NCT00802464|75892136|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
42081775|NCT00802464|75892137|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
42081776|NCT00802464|75892134|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
42081777|NCT00802464|75892135|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
42081778|NCT00802464|75892136|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
42081779|NCT00802464|75892137|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
42081780|NCT00802464|75892134|FG000|Month 0 - Month 8|Other|0|||
42081781|NCT00802464|75892135|FG001|Month 0 - Month 8|Other|0|||
42081782|NCT00802464|75892136|FG002|Month 0 - Month 8|Other|1|||
42081783|NCT00802464|75892137|FG003|Month 0 - Month 8|Other|0|||
42081784|NCT00802464|75892134|FG000|Month 8 - Month 14|Adverse Event|0|||
42081785|NCT00802464|75892135|FG001|Month 8 - Month 14|Adverse Event|1|||
42081786|NCT00802464|75892136|FG002|Month 8 - Month 14|Adverse Event|0|||
42081787|NCT00802464|75892137|FG003|Month 8 - Month 14|Adverse Event|0|||
42081788|NCT00802464|75892134|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
42081789|NCT00802464|75892135|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
42081790|NCT00802464|75892136|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
42081791|NCT00802464|75892137|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
42081792|NCT00802464|75892134|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
42081793|NCT00802464|75892135|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
42081794|NCT00802464|75892136|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
42081795|NCT00802464|75892137|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
42081796|NCT00450619|75892151|FG000|Overall Study|refused treatment after randomization|2|||
42081797|NCT00450619|75892152|FG001|Overall Study|refused treatment after randomization|0|||
42081798|NCT00450619|75892151|FG000|Overall Study|did not progress; refused further trmt|1|||
42081799|NCT00450619|75892152|FG001|Overall Study|did not progress; refused further trmt|1|||
42081800|NCT00450619|75892151|FG000|Overall Study|Adverse Event|1|||
42081801|NCT00450619|75892152|FG001|Overall Study|Adverse Event|0|||
42081802|NCT00802074|75892165|FG000|Overall Study|Adverse Event|1|||
42081803|NCT00802074|75892166|FG001|Overall Study|Adverse Event|1|||
42081804|NCT00802074|75892167|FG002|Overall Study|Adverse Event|1|||
42081805|NCT00802074|75892168|FG003|Overall Study|Adverse Event|0|||
42081806|NCT00802074|75892169|FG004|Overall Study|Adverse Event|0|||
42081807|NCT00802074|75892170|FG005|Overall Study|Adverse Event|0|||
42081808|NCT00802074|75892165|FG000|Overall Study|Withdrawal by Subject|1|||
42081809|NCT00802074|75892166|FG001|Overall Study|Withdrawal by Subject|0|||
42081810|NCT00802074|75892167|FG002|Overall Study|Withdrawal by Subject|0|||
42081811|NCT00802074|75892168|FG003|Overall Study|Withdrawal by Subject|0|||
42081812|NCT00802074|75892169|FG004|Overall Study|Withdrawal by Subject|0|||
42081813|NCT00802074|75892170|FG005|Overall Study|Withdrawal by Subject|0|||
42081814|NCT00450385|75892187|FG000|Overall Study|Death|3|||
42081815|NCT00450385|75892187|FG000|Overall Study|Protocol Violation|1|||
42081816|NCT00450385|75892187|FG000|Overall Study|Withdrawal by Subject|2|||
42081817|NCT00450385|75892187|FG000|Overall Study|Lack of Efficacy|2|||
42081818|NCT00450385|75892187|FG000|Overall Study|Adverse Event|1|||
42081819|NCT00450385|75892187|FG000|Overall Study|Physician Decision|1|||
42081820|NCT00450385|75892187|FG000|Overall Study|Other|3|||
42081821|NCT00588354|75892194|FG000|Baseline to 2 Weeks|Adverse Event|1|||
42081822|NCT00588354|75892195|FG001|Baseline to 2 Weeks|Adverse Event|0|||
42081823|NCT00588354|75892194|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
42081824|NCT00588354|75892195|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
42081825|NCT00588354|75892194|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
42081826|NCT00588354|75892195|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
42081827|NCT00449761|75892202|FG000|Overall Study|Disease progression|12|||
42081828|NCT00449761|75892202|FG000|Overall Study|Death|5|||
42081829|NCT00449761|75892202|FG000|Overall Study|New cancer therapy|1|||
42081830|NCT00800982|75892209|FG000|Overall Study|Lost to Follow-up|1|||
42081831|NCT00800982|75892210|FG001|Overall Study|Lost to Follow-up|2|||
42081832|NCT00800982|75892209|FG000|Overall Study|Withdrawal by Subject|0|||
42081833|NCT00800982|75892210|FG001|Overall Study|Withdrawal by Subject|1|||
42081834|NCT00800982|75892209|FG000|Overall Study|Patient moved out of state|1|||
42081835|NCT00800982|75892210|FG001|Overall Study|Patient moved out of state|0|||
42178467|NCT00235391|75985590|FG004|Overall Study|Death|0|||
42178468|NCT00235391|75985591|FG005|Overall Study|Death|0|||
42178469|NCT00234533|75985635|FG000|Overall Study|Withdrawal by Subject|6|||
42178470|NCT00234533|75985635|FG000|Overall Study|Adverse Event|2|||
42178471|NCT00234533|75985635|FG000|Overall Study|Enrolled but not treated|3|||
42178472|NCT00026208|75985642|FG000|Overall Study|Complications of auto accident|1|||
42178473|NCT00026208|75985643|FG001|Overall Study|Complications of auto accident|0|||
42178474|NCT00025662|75985649|FG000|Overall Study|Withdrawal by Subject|2|||
42178475|NCT00025662|75985649|FG000|Overall Study|Technical failure of manipulation|1|||
42178476|NCT00025506|75985653|FG000|Overall Study|Ineligible: clerical error|1|||
42178477|NCT00025506|75985653|FG000|Overall Study|Ineligible: wrong cell type|5|||
42178478|NCT00025506|75985653|FG000|Overall Study|Ineligible: inadequate pathology|2|||
42178479|NCT00025506|75985653|FG000|Overall Study|Never Treated|2|||
42178480|NCT00024258|75985662|FG000|Overall Study|Withdrawal by Subject|1|||
42178481|NCT00024258|75985662|FG000|Overall Study|Disease Progression|8|||
42178482|NCT00023712|75985668|FG000|Overall Study|Not platinum sensitive|1|||
42178483|NCT00023712|75985669|FG001|Overall Study|Not platinum sensitive|0|||
42178484|NCT00023712|75985668|FG000|Overall Study|Never treated|1|||
42178485|NCT00023712|75985669|FG001|Overall Study|Never treated|1|||
42178486|NCT00023322|75985685|FG000|Overall Study|Lost to Follow-up|1|||
42178487|NCT04640168|75985691|FG000|Overall Study|Withdrawal by Subject|8|||
42178488|NCT04640168|75985692|FG001|Overall Study|Withdrawal by Subject|7|||
42178489|NCT04640168|75985691|FG000|Overall Study|Lost to Follow-up|1|||
42178490|NCT04640168|75985692|FG001|Overall Study|Lost to Follow-up|0|||
42178491|NCT04640168|75985691|FG000|Overall Study|Enrolled but not treated|12|||
42178492|NCT04640168|75985692|FG001|Overall Study|Enrolled but not treated|12|||
42178493|NCT00022698|75985700|FG000|Overall Study|Adverse Event|5|||
42178494|NCT00022698|75985701|FG001|Overall Study|Adverse Event|9|||
42178495|NCT00022698|75985700|FG000|Overall Study|Death|0|||
42178496|NCT00022698|75985701|FG001|Overall Study|Death|2|||
42178497|NCT00022698|75985700|FG000|Overall Study|Failure to return|0|||
42178498|NCT00022698|75985701|FG001|Overall Study|Failure to return|1|||
42178499|NCT00022698|75985700|FG000|Overall Study|Refused treatment|0|||
42178500|NCT00022698|75985701|FG001|Overall Study|Refused treatment|2|||
42178501|NCT00022698|75985700|FG000|Overall Study|Insufficient therapeutic response|2|||
42178502|NCT00022698|75985701|FG001|Overall Study|Insufficient therapeutic response|14|||
42178503|NCT00022698|75985700|FG000|Overall Study|Administrative /other|1|||
42178504|NCT00022698|75985701|FG001|Overall Study|Administrative /other|7|||
42178505|NCT05261126|75985718|FG000|Overall Study|Death|0|||
42081836|NCT00830960|75892222|FG000|Overall Study|Death|5|||
42081837|NCT00830960|75892223|FG001|Overall Study|Death|4|||
42081838|NCT00830960|75892224|FG002|Overall Study|Death|3|||
42081839|NCT00830960|75892225|FG003|Overall Study|Death|2|||
42178506|NCT05261126|75985719|FG001|Overall Study|Death|0|||
42178507|NCT05261126|75985720|FG002|Overall Study|Death|1|||
42178508|NCT05261126|75985721|FG003|Overall Study|Death|0|||
42178509|NCT05261126|75985722|FG004|Overall Study|Death|0|||
42178510|NCT05261126|75985718|FG000|Overall Study|Lost to Follow-up|0|||
42178511|NCT05261126|75985719|FG001|Overall Study|Lost to Follow-up|0|||
42178512|NCT05261126|75985720|FG002|Overall Study|Lost to Follow-up|0|||
42178513|NCT05261126|75985721|FG003|Overall Study|Lost to Follow-up|0|||
42178514|NCT05261126|75985722|FG004|Overall Study|Lost to Follow-up|1|||
42178515|NCT05261126|75985718|FG000|Overall Study|Physician Decision|1|||
42081840|NCT00830960|75892226|FG004|Overall Study|Death|6|||
42081841|NCT00830960|75892227|FG005|Overall Study|Death|1|||
42081842|NCT00830960|75892222|FG000|Overall Study|Lost to Follow-up|1|||
42081843|NCT00830960|75892223|FG001|Overall Study|Lost to Follow-up|1|||
42081844|NCT00830960|75892224|FG002|Overall Study|Lost to Follow-up|1|||
42081845|NCT00830960|75892225|FG003|Overall Study|Lost to Follow-up|0|||
42081846|NCT00830960|75892226|FG004|Overall Study|Lost to Follow-up|0|||
42081847|NCT00830960|75892227|FG005|Overall Study|Lost to Follow-up|1|||
42081848|NCT00830960|75892222|FG000|Overall Study|Withdrawal by Subject|19|||
42081849|NCT00830960|75892223|FG001|Overall Study|Withdrawal by Subject|19|||
42081850|NCT00830960|75892224|FG002|Overall Study|Withdrawal by Subject|18|||
42081851|NCT00830960|75892225|FG003|Overall Study|Withdrawal by Subject|23|||
42081852|NCT00830960|75892226|FG004|Overall Study|Withdrawal by Subject|16|||
42081853|NCT00830960|75892227|FG005|Overall Study|Withdrawal by Subject|21|||
42081854|NCT00830960|75892222|FG000|Overall Study|Sponsor Decision|1|||
42081855|NCT00830960|75892223|FG001|Overall Study|Sponsor Decision|2|||
42081856|NCT00830960|75892224|FG002|Overall Study|Sponsor Decision|3|||
42081857|NCT00830960|75892225|FG003|Overall Study|Sponsor Decision|4|||
42081858|NCT00830960|75892226|FG004|Overall Study|Sponsor Decision|5|||
42081859|NCT00830960|75892227|FG005|Overall Study|Sponsor Decision|7|||
42081860|NCT00830960|75892222|FG000|Overall Study|No study drug received|7|||
42081861|NCT00830960|75892223|FG001|Overall Study|No study drug received|2|||
42081862|NCT00830960|75892224|FG002|Overall Study|No study drug received|4|||
42081863|NCT00830960|75892225|FG003|Overall Study|No study drug received|3|||
42081864|NCT00830960|75892226|FG004|Overall Study|No study drug received|5|||
42081865|NCT00830960|75892227|FG005|Overall Study|No study drug received|7|||
42081866|NCT00830804|75892264|FG000|Overall Study|Lost to Follow-up|4|||
42081867|NCT00830804|75892264|FG000|Overall Study|Death|1|||
42081868|NCT00830804|75892264|FG000|Overall Study|Unable to get to clinic|7|||
42081869|NCT00830804|75892264|FG000|Overall Study|Consent withdrawn|2|||
42081870|NCT00830804|75892264|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
42081871|NCT00789477|75892274|FG000|Overall Study|Withdrawal by Subject|2|||
42081872|NCT00789477|75892275|FG001|Overall Study|Withdrawal by Subject|1|||
42081873|NCT00789477|75892276|FG002|Overall Study|Withdrawal by Subject|3|||
42081874|NCT00789477|75892277|FG003|Overall Study|Withdrawal by Subject|2|||
42081875|NCT00789477|75892278|FG004|Overall Study|Withdrawal by Subject|3|||
42081876|NCT00789477|75892274|FG000|Overall Study|Protocol Violation|1|||
42081877|NCT00789477|75892275|FG001|Overall Study|Protocol Violation|0|||
42081878|NCT00789477|75892276|FG002|Overall Study|Protocol Violation|0|||
42081879|NCT00789477|75892277|FG003|Overall Study|Protocol Violation|1|||
42081880|NCT00789477|75892278|FG004|Overall Study|Protocol Violation|0|||
42081881|NCT00789477|75892274|FG000|Overall Study|Adverse Event|3|||
42081882|NCT00789477|75892275|FG001|Overall Study|Adverse Event|3|||
42081883|NCT00789477|75892276|FG002|Overall Study|Adverse Event|1|||
42081884|NCT00789477|75892277|FG003|Overall Study|Adverse Event|0|||
42081885|NCT00789477|75892278|FG004|Overall Study|Adverse Event|0|||
42081886|NCT00789477|75892274|FG000|Overall Study|Death|1|||
42081887|NCT00789477|75892275|FG001|Overall Study|Death|1|||
42081888|NCT00789477|75892276|FG002|Overall Study|Death|2|||
42081889|NCT00789477|75892277|FG003|Overall Study|Death|2|||
42081890|NCT00789477|75892278|FG004|Overall Study|Death|0|||
42081891|NCT00789477|75892274|FG000|Overall Study|Lost to Follow-up|0|||
42081892|NCT00789477|75892275|FG001|Overall Study|Lost to Follow-up|1|||
42081893|NCT00789477|75892276|FG002|Overall Study|Lost to Follow-up|4|||
42081894|NCT00789477|75892277|FG003|Overall Study|Lost to Follow-up|2|||
42081895|NCT00789477|75892278|FG004|Overall Study|Lost to Follow-up|4|||
42081896|NCT00789477|75892274|FG000|Overall Study|Lack of Efficacy|2|||
42081897|NCT00789477|75892275|FG001|Overall Study|Lack of Efficacy|0|||
42178516|NCT05261126|75985719|FG001|Overall Study|Physician Decision|0|||
42178517|NCT05261126|75985720|FG002|Overall Study|Physician Decision|0|||
42294064|NCT02637037|76128377|FG000|Overall Study|Positive drug screen at admission|1|||
42081898|NCT00789477|75892276|FG002|Overall Study|Lack of Efficacy|0|||
42294065|NCT02637037|76128378|FG001|Overall Study|Positive drug screen at admission|0|||
42294066|NCT02637037|76128377|FG000|Overall Study|Withdrawal by Subject|2|||
42294067|NCT02637037|76128378|FG001|Overall Study|Withdrawal by Subject|1|||
42081899|NCT00789477|75892277|FG003|Overall Study|Lack of Efficacy|0|||
42294068|NCT02637037|76128377|FG000|Overall Study|Adverse Event|1|||
42081900|NCT00789477|75892278|FG004|Overall Study|Lack of Efficacy|0|||
42178518|NCT05261126|75985721|FG003|Overall Study|Physician Decision|0|||
42178519|NCT05261126|75985722|FG004|Overall Study|Physician Decision|0|||
42294069|NCT02637037|76128378|FG001|Overall Study|Adverse Event|0|||
42294070|NCT02637895|76128398|FG000|Overall Study|Lost to Follow-up|4|||
42081901|NCT00789477|75892274|FG000|Overall Study|Other|2|||
42178520|NCT05261126|75985718|FG000|Overall Study|Screen Failure|0|||
42178521|NCT05261126|75985719|FG001|Overall Study|Screen Failure|0|||
42294071|NCT02637895|76128399|FG001|Overall Study|Lost to Follow-up|0|||
42294072|NCT02637895|76128398|FG000|Overall Study|Protocol Violation|0|||
42294073|NCT02637895|76128399|FG001|Overall Study|Protocol Violation|1|||
42081902|NCT00789477|75892275|FG001|Overall Study|Other|0|||
42081903|NCT00789477|75892276|FG002|Overall Study|Other|1|||
42081904|NCT00789477|75892277|FG003|Overall Study|Other|3|||
42081905|NCT00789477|75892278|FG004|Overall Study|Other|0|||
42081906|NCT00796614|75892296|FG000|Overall Study|Adverse Event|1|||
42081907|NCT00796614|75892297|FG001|Overall Study|Adverse Event|2|||
42081908|NCT00796614|75892298|FG002|Overall Study|Adverse Event|0|||
42081909|NCT00796614|75892299|FG003|Overall Study|Adverse Event|0|||
42081910|NCT00796614|75892296|FG000|Overall Study|Protocol Violation|0|||
42081911|NCT00796614|75892297|FG001|Overall Study|Protocol Violation|0|||
42081912|NCT00796614|75892298|FG002|Overall Study|Protocol Violation|2|||
42081913|NCT00796614|75892299|FG003|Overall Study|Protocol Violation|0|||
42081914|NCT00796614|75892296|FG000|Overall Study|Lost to Follow-up|2|||
42081915|NCT00796614|75892297|FG001|Overall Study|Lost to Follow-up|2|||
42081916|NCT00796614|75892298|FG002|Overall Study|Lost to Follow-up|1|||
42081917|NCT00796614|75892299|FG003|Overall Study|Lost to Follow-up|0|||
42081918|NCT00796614|75892296|FG000|Overall Study|Withdrawal by Subject|1|||
42081919|NCT00796614|75892297|FG001|Overall Study|Withdrawal by Subject|0|||
42081920|NCT00796614|75892298|FG002|Overall Study|Withdrawal by Subject|0|||
42081921|NCT00796614|75892299|FG003|Overall Study|Withdrawal by Subject|1|||
42081922|NCT00796614|75892296|FG000|Overall Study|Other than stated|1|||
42081923|NCT00796614|75892297|FG001|Overall Study|Other than stated|0|||
42081924|NCT00796614|75892298|FG002|Overall Study|Other than stated|0|||
42081925|NCT00796614|75892299|FG003|Overall Study|Other than stated|0|||
42081926|NCT00448747|75892311|FG000|Overall Study|collapsed veins|1|||
42081927|NCT00448747|75892312|FG001|Overall Study|collapsed veins|0|||
42081928|NCT00830180|75892328|FG000|Overall Study|Adverse Event|6|||
42081929|NCT00830180|75892328|FG000|Overall Study|Death|11|||
42081930|NCT00830180|75892328|FG000|Overall Study|Insufficient clinical response|1|||
42081931|NCT00830180|75892328|FG000|Overall Study|Withdrawal by Subject|5|||
42081932|NCT00830180|75892328|FG000|Overall Study|Progressive disease|2|||
42081933|NCT00830180|75892328|FG000|Overall Study|Other - Unspecified|1|||
42081934|NCT00789321|75892336|FG000|Overall Study|Adverse Event|0|||
42081935|NCT00789321|75892337|FG001|Overall Study|Adverse Event|1|||
42081936|NCT00811928|75892345|FG000|Overall Study|AEs and SAEs Including Death|7|||
42081937|NCT00811928|75892346|FG001|Overall Study|AEs and SAEs Including Death|11|||
42081938|NCT00811928|75892345|FG000|Overall Study|Withdrawal by Subject|18|||
42081939|NCT00811928|75892346|FG001|Overall Study|Withdrawal by Subject|12|||
42081940|NCT00811928|75892345|FG000|Overall Study|Did Not Take Study Drug|3|||
42081941|NCT00811928|75892346|FG001|Overall Study|Did Not Take Study Drug|0|||
42081942|NCT00811928|75892345|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
42081943|NCT00811928|75892346|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
42081944|NCT00811928|75892345|FG000|Overall Study|Investigator Decision|2|||
42081945|NCT00811928|75892346|FG001|Overall Study|Investigator Decision|1|||
42081946|NCT00811928|75892345|FG000|Overall Study|Poor Compliance|2|||
42081947|NCT00811928|75892346|FG001|Overall Study|Poor Compliance|5|||
42081948|NCT00788775|75892354|FG000|Overall Study|Progressive Disease|8|||
42081949|NCT00788775|75892355|FG001|Overall Study|Progressive Disease|6|||
42081950|NCT00788775|75892354|FG000|Overall Study|Withdrawal by Subject|0|||
42081951|NCT00788775|75892355|FG001|Overall Study|Withdrawal by Subject|2|||
42081952|NCT00788775|75892354|FG000|Overall Study|Patient Non-Compliance|1|||
42178522|NCT05261126|75985720|FG002|Overall Study|Screen Failure|0|||
42178523|NCT05261126|75985721|FG003|Overall Study|Screen Failure|0|||
42178524|NCT05261126|75985722|FG004|Overall Study|Screen Failure|1|||
42178525|NCT05261126|75985718|FG000|Overall Study|Withdrawal by Subject|1|||
42081953|NCT00788775|75892355|FG001|Overall Study|Patient Non-Compliance|0|||
42081954|NCT00788775|75892354|FG000|Overall Study|Patient's measurable disease resected.|1|||
42294074|NCT02637895|76128398|FG000|Overall Study|Lack of Efficacy|1|||
42294075|NCT02637895|76128399|FG001|Overall Study|Lack of Efficacy|0|||
42081955|NCT00788775|75892355|FG001|Overall Study|Patient's measurable disease resected.|0|||
42294076|NCT02637895|76128398|FG000|Overall Study|Withdrawal by Subject|1|||
42294077|NCT02637895|76128399|FG001|Overall Study|Withdrawal by Subject|1|||
42081956|NCT00448669|75892363|FG000|Overall Study|Lost to Follow-up|52|||
42081957|NCT00448669|75892364|FG001|Overall Study|Lost to Follow-up|63|||
42081958|NCT00448669|75892363|FG000|Overall Study|Withdrawal by Subject|90|||
42081959|NCT00448669|75892364|FG001|Overall Study|Withdrawal by Subject|74|||
42081960|NCT00448669|75892363|FG000|Overall Study|Relocated|49|||
42081961|NCT00448669|75892364|FG001|Overall Study|Relocated|36|||
42178526|NCT05261126|75985719|FG001|Overall Study|Withdrawal by Subject|0|||
42081962|NCT00448669|75892363|FG000|Overall Study|Were withdrawn by investigator|10|||
42081963|NCT00448669|75892364|FG001|Overall Study|Were withdrawn by investigator|6|||
42081964|NCT00448669|75892363|FG000|Overall Study|Death|2|||
42081965|NCT00448669|75892364|FG001|Overall Study|Death|4|||
42294078|NCT02637895|76128398|FG000|Overall Study|Abnormal baseline lab|0|||
42081966|NCT00448669|75892363|FG000|Overall Study|Had other reasons|5|||
42081967|NCT00448669|75892364|FG001|Overall Study|Had other reasons|6|||
42081968|NCT00448669|75892363|FG000|Overall Study|HIV-infected at enrollment|1|||
42081969|NCT00448669|75892364|FG001|Overall Study|HIV-infected at enrollment|2|||
42081970|NCT00448669|75892363|FG000|Overall Study|Never started drug|9|||
42081971|NCT00448669|75892364|FG001|Overall Study|Never started drug|7|||
42081972|NCT00591734|75892372|FG000|Overall Study|Lack of Efficacy|35|||
42081973|NCT00591734|75892372|FG000|Overall Study|Adverse Event|5|||
42081974|NCT00591734|75892372|FG000|Overall Study|Physician Decision|5|||
42081975|NCT00591734|75892372|FG000|Overall Study|Intercurrent Illness|8|||
42081976|NCT00788697|75892376|FG000|Overall Study|No study drug administered|12|||
42081977|NCT00788697|75892376|FG000|Overall Study|Training Patients|74|||
42081978|NCT00788697|75892376|FG000|Overall Study|no truth standard procedure available|5|||
42081979|NCT00788697|75892376|FG000|Overall Study|Technically inadequate truth standard|1|||
42081980|NCT00788697|75892376|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
42081981|NCT00848549|75892390|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
42081982|NCT00848549|75892391|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
42081983|NCT00848549|75892390|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
42081984|NCT00848549|75892391|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
42081985|NCT00848549|75892390|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
42081986|NCT00848549|75892391|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
42081987|NCT00848549|75892390|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
42081988|NCT00848549|75892391|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
42081989|NCT00848549|75892390|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
42081990|NCT00848549|75892391|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
42081991|NCT00848549|75892390|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
42081992|NCT00848549|75892391|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
42081993|NCT00848549|75892390|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
42081994|NCT00848549|75892391|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
42081995|NCT00848549|75892390|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
42081996|NCT00848549|75892391|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
42081997|NCT00848549|75892390|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
42081998|NCT00848549|75892391|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
42081999|NCT00848549|75892390|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
42082000|NCT00848549|75892391|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
42082001|NCT00848549|75892390|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
42082002|NCT00848549|75892391|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
42082003|NCT00848549|75892390|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
42082004|NCT00848549|75892391|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
42082005|NCT00848549|75892390|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
42082006|NCT00848549|75892391|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
42082007|NCT00848549|75892390|FG000|E2090-E044-314 (Extension Study)|Other|5|||
42082008|NCT00848549|75892391|FG001|E2090-E044-314 (Extension Study)|Other|6|||
42082009|NCT00788151|75892401|FG000|Overall Study|Other adverse event|0|||
42082010|NCT00788151|75892402|FG001|Overall Study|Other adverse event|2|||
42082011|NCT00788151|75892401|FG000|Overall Study|Protocol Violation|0|||
42082012|NCT00788151|75892402|FG001|Overall Study|Protocol Violation|1|||
42082013|NCT00788151|75892401|FG000|Overall Study|Withdrawal by Subject|13|||
42082014|NCT00788151|75892402|FG001|Overall Study|Withdrawal by Subject|6|||
42082015|NCT00788151|75892401|FG000|Overall Study|Enrolled but not treated|1|||
42082016|NCT00788151|75892402|FG001|Overall Study|Enrolled but not treated|1|||
42082017|NCT00788073|75892410|FG000|STX209 Then Placebo|Adverse Event|1|||
42082018|NCT00788073|75892411|FG001|STX209 Then Placebo|Adverse Event|0|||
42082019|NCT00788073|75892410|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
42082020|NCT00788073|75892411|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
42082021|NCT00788073|75892410|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
42082022|NCT00788073|75892411|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
42082023|NCT00788073|75892410|FG000|STX209 Then Placebo|unable to return due to travel|0|||
42082024|NCT00788073|75892411|FG001|STX209 Then Placebo|unable to return due to travel|1|||
42082025|NCT00788073|75892410|FG000|Placebo Then STX209|Adverse Event|2|||
42082026|NCT00788073|75892411|FG001|Placebo Then STX209|Adverse Event|0|||
42082027|NCT00788073|75892410|FG000|Placebo Then STX209|Protocol Violation|0|||
42082028|NCT00788073|75892411|FG001|Placebo Then STX209|Protocol Violation|1|||
42082029|NCT00848393|75892420|FG000|Overall Study|Protocol Violation|0|||
42082030|NCT00848393|75892421|FG001|Overall Study|Protocol Violation|0|||
42082031|NCT00848393|75892422|FG002|Overall Study|Protocol Violation|1|||
42082032|NCT00848393|75892420|FG000|Overall Study|surgical complications unrelated to stud|0|||
42082033|NCT00848393|75892421|FG001|Overall Study|surgical complications unrelated to stud|0|||
42082034|NCT00848393|75892422|FG002|Overall Study|surgical complications unrelated to stud|2|||
42082035|NCT00815516|75892436|FG000|Overall Study|Death|3|||
42082036|NCT00815516|75892437|FG001|Overall Study|Death|1|||
42082037|NCT00815516|75892436|FG000|Overall Study|Physician Decision|1|||
42082038|NCT00815516|75892437|FG001|Overall Study|Physician Decision|0|||
42082039|NCT00787917|75892445|FG000|Blinded Treatment|Adverse Event|1|||
42082040|NCT00787917|75892446|FG001|Blinded Treatment|Adverse Event|0|||
42082041|NCT00787917|75892445|FG000|Blinded Treatment|Lack of Efficacy|1|||
42082042|NCT00787917|75892446|FG001|Blinded Treatment|Lack of Efficacy|0|||
42082043|NCT00787917|75892445|FG000|Blinded Treatment|Administrative problems|3|||
42082044|NCT00787917|75892446|FG001|Blinded Treatment|Administrative problems|2|||
42082045|NCT00787917|75892445|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
42082046|NCT00787917|75892446|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
42082047|NCT00787917|75892445|FG000|Open Label|Administrative problems|3|||
42082048|NCT00787917|75892446|FG001|Open Label|Administrative problems|0|||
42082049|NCT00814892|75892454|FG000|Overall Study|Disease Progression|1|||
42082050|NCT00814892|75892454|FG000|Overall Study|Study Termination|1|||
42082051|NCT00787839|75892458|FG000|Overall Study|Failure to have the OGTT was most common|404|||
42082052|NCT00829244|75892481|FG000|Overall Study|Adverse Event|1|||
42082053|NCT00829244|75892482|FG001|Overall Study|Adverse Event|3|||
42082054|NCT00829244|75892481|FG000|Overall Study|Protocol Violation|1|||
42082055|NCT00829244|75892482|FG001|Overall Study|Protocol Violation|0|||
42082056|NCT00829244|75892481|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
42082057|NCT00829244|75892482|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
42082058|NCT00829244|75892481|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
42082059|NCT00829244|75892482|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
42082060|NCT00829244|75892481|FG000|Overall Study|No fertilization|2|||
42082061|NCT00829244|75892482|FG001|Overall Study|No fertilization|2|||
42082062|NCT00829244|75892481|FG000|Overall Study|All embryos discarded|0|||
42082063|NCT00829244|75892482|FG001|Overall Study|All embryos discarded|3|||
42082064|NCT00829244|75892481|FG000|Overall Study|No embryo cleavage|0|||
42082065|NCT00829244|75892482|FG001|Overall Study|No embryo cleavage|2|||
42082066|NCT00787605|75892490|FG000|Overall Study|Administrative Problems|3|||
42082067|NCT00787605|75892491|FG001|Overall Study|Administrative Problems|0|||
42082068|NCT00787605|75892490|FG000|Overall Study|Adverse Event|14|||
42082069|NCT00787605|75892491|FG001|Overall Study|Adverse Event|25|||
42082070|NCT00787605|75892490|FG000|Overall Study|Lost to Follow-up|3|||
42082071|NCT00787605|75892491|FG001|Overall Study|Lost to Follow-up|6|||
42082072|NCT00787605|75892490|FG000|Overall Study|Protocol Violation|7|||
42082073|NCT00787605|75892491|FG001|Overall Study|Protocol Violation|3|||
42082074|NCT00787605|75892490|FG000|Overall Study|Withdrawal by Subject|6|||
42082075|NCT00787605|75892491|FG001|Overall Study|Withdrawal by Subject|13|||
42082076|NCT00787605|75892490|FG000|Overall Study|Lack of Efficacy|13|||
42082077|NCT00787605|75892491|FG001|Overall Study|Lack of Efficacy|9|||
42082078|NCT00448591|75892497|FG000|Overall Study|Withdrawal by Subject|178|||
42082079|NCT00448591|75892497|FG000|Overall Study|Progressive Disease|1382|||
42082080|NCT00448591|75892497|FG000|Overall Study|Adverse Event|382|||
42082081|NCT00448591|75892497|FG000|Overall Study|Protocol Violation|41|||
42082082|NCT00448591|75892497|FG000|Overall Study|Lost to Follow-up|19|||
42082083|NCT00448591|75892497|FG000|Overall Study|Treatment Regimen Completed|70|||
42082084|NCT00448591|75892497|FG000|Overall Study|Other|154|||
42082085|NCT00448591|75892497|FG000|Overall Study|Termination of Study|70|||
42082086|NCT00651664|75892513|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
42082087|NCT00651664|75892514|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
42082088|NCT00651664|75892515|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
42082089|NCT00651664|75892516|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
42082090|NCT00651664|75892517|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
42082091|NCT00651664|75892518|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
42082092|NCT00651664|75892519|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
42082093|NCT00651664|75892520|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
42082094|NCT00651664|75892521|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
42082095|NCT00651664|75892522|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
42082096|NCT00651664|75892513|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
42082097|NCT00651664|75892514|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
42082098|NCT00651664|75892515|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
42082099|NCT00651664|75892516|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
42082100|NCT00651664|75892517|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
42082101|NCT00651664|75892518|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
42082102|NCT00651664|75892519|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
42082103|NCT00651664|75892520|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
42082104|NCT00651664|75892521|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
42082105|NCT00651664|75892522|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
42082106|NCT00651664|75892513|FG000|Overall Study|Progressive Disease|3|||
42082107|NCT00651664|75892514|FG001|Overall Study|Progressive Disease|3|||
42082108|NCT00651664|75892515|FG002|Overall Study|Progressive Disease|3|||
42082109|NCT00651664|75892516|FG003|Overall Study|Progressive Disease|12|||
42082110|NCT00651664|75892517|FG004|Overall Study|Progressive Disease|4|||
42082111|NCT00651664|75892518|FG005|Overall Study|Progressive Disease|1|||
42082112|NCT00651664|75892519|FG006|Overall Study|Progressive Disease|3|||
42082113|NCT00651664|75892520|FG007|Overall Study|Progressive Disease|6|||
42082114|NCT00651664|75892521|FG008|Overall Study|Progressive Disease|5|||
42082115|NCT00651664|75892522|FG009|Overall Study|Progressive Disease|5|||
42082116|NCT00651664|75892513|FG000|Overall Study|Patient Declined Further Treatment|0|||
42082117|NCT00651664|75892514|FG001|Overall Study|Patient Declined Further Treatment|0|||
42082118|NCT00651664|75892515|FG002|Overall Study|Patient Declined Further Treatment|0|||
42082119|NCT00651664|75892516|FG003|Overall Study|Patient Declined Further Treatment|1|||
42082120|NCT00651664|75892517|FG004|Overall Study|Patient Declined Further Treatment|1|||
42082121|NCT00651664|75892518|FG005|Overall Study|Patient Declined Further Treatment|1|||
42082122|NCT00651664|75892519|FG006|Overall Study|Patient Declined Further Treatment|0|||
42082123|NCT00651664|75892520|FG007|Overall Study|Patient Declined Further Treatment|0|||
42082124|NCT00651664|75892521|FG008|Overall Study|Patient Declined Further Treatment|0|||
42082125|NCT00651664|75892522|FG009|Overall Study|Patient Declined Further Treatment|1|||
42082126|NCT00651664|75892513|FG000|Overall Study|Symptomatic Deterioration|0|||
42082127|NCT00651664|75892514|FG001|Overall Study|Symptomatic Deterioration|0|||
42082128|NCT00651664|75892515|FG002|Overall Study|Symptomatic Deterioration|0|||
42082129|NCT00651664|75892516|FG003|Overall Study|Symptomatic Deterioration|1|||
42082130|NCT00651664|75892517|FG004|Overall Study|Symptomatic Deterioration|0|||
42082131|NCT00651664|75892518|FG005|Overall Study|Symptomatic Deterioration|0|||
42082132|NCT00651664|75892519|FG006|Overall Study|Symptomatic Deterioration|1|||
42082133|NCT00651664|75892520|FG007|Overall Study|Symptomatic Deterioration|0|||
42082134|NCT00651664|75892521|FG008|Overall Study|Symptomatic Deterioration|1|||
42082135|NCT00651664|75892522|FG009|Overall Study|Symptomatic Deterioration|0|||
42082136|NCT00651664|75892513|FG000|Overall Study|Reason not Specified|0|||
42082137|NCT00651664|75892514|FG001|Overall Study|Reason not Specified|0|||
42082138|NCT00651664|75892515|FG002|Overall Study|Reason not Specified|0|||
42082139|NCT00651664|75892516|FG003|Overall Study|Reason not Specified|0|||
42082140|NCT00651664|75892517|FG004|Overall Study|Reason not Specified|0|||
42082141|NCT00651664|75892518|FG005|Overall Study|Reason not Specified|0|||
42082142|NCT00651664|75892519|FG006|Overall Study|Reason not Specified|1|||
42082143|NCT00651664|75892520|FG007|Overall Study|Reason not Specified|0|||
42082144|NCT00651664|75892521|FG008|Overall Study|Reason not Specified|0|||
42082145|NCT00651664|75892522|FG009|Overall Study|Reason not Specified|0|||
42082146|NCT00787527|75892548|FG000|Overall Study|Toxicity|3|||
42082147|NCT00787137|75892559|FG000|Overall Study|Study Termination|0|||
42082148|NCT00787137|75892560|FG001|Overall Study|Study Termination|0|||
42082149|NCT00787137|75892561|FG002|Overall Study|Study Termination|1|||
42082150|NCT00448435|75892569|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
42082151|NCT00448435|75892570|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
42082152|NCT00448279|75892581|FG000|Overall Study|Lost to Follow-up|2|||
42082153|NCT00448279|75892582|FG001|Overall Study|Lost to Follow-up|2|||
42082154|NCT00448279|75892581|FG000|Overall Study|Adverse Event|1|||
42082155|NCT00448279|75892582|FG001|Overall Study|Adverse Event|1|||
42082156|NCT00448279|75892581|FG000|Overall Study|Disease progression|16|||
42082157|NCT00448279|75892582|FG001|Overall Study|Disease progression|18|||
42082158|NCT00448279|75892581|FG000|Overall Study|Withdrawal by Subject|4|||
42082159|NCT00448279|75892582|FG001|Overall Study|Withdrawal by Subject|3|||
42082160|NCT00448279|75892581|FG000|Overall Study|Other|6|||
42082161|NCT00448279|75892582|FG001|Overall Study|Other|4|||
42082162|NCT00448279|75892581|FG000|Overall Study|Protocol Violation|0|||
42082163|NCT00448279|75892582|FG001|Overall Study|Protocol Violation|1|||
42082164|NCT00448123|75892590|FG000|Overall Study|Lost to Follow-up|9|||
42082165|NCT00448123|75892591|FG001|Overall Study|Lost to Follow-up|6|||
42082166|NCT00448123|75892590|FG000|Overall Study|Physician Decision|6|||
42082167|NCT00448123|75892591|FG001|Overall Study|Physician Decision|6|||
42082168|NCT00447499|75892600|FG000|Overall Study|Adverse Event|1|||
42082169|NCT00447499|75892600|FG000|Overall Study|Patient Decision|4|||
42178527|NCT05261126|75985720|FG002|Overall Study|Withdrawal by Subject|1|||
42294079|NCT02637895|76128399|FG001|Overall Study|Abnormal baseline lab|1|||
42294080|NCT02522481|76128406|FG000|Overall Study|discontinued|1|||
42082170|NCT00447499|75892600|FG000|Overall Study|Sponsor Decision|1|||
42082171|NCT00447499|75892600|FG000|Overall Study|Physician Decision|1|||
42082172|NCT00800436|75892613|FG000|Overall Study|Withdrawal by Subject|0|||
42082173|NCT00800436|75892614|FG001|Overall Study|Withdrawal by Subject|0|||
42082174|NCT00800436|75892615|FG002|Overall Study|Withdrawal by Subject|1|||
42082175|NCT00800436|75892616|FG003|Overall Study|Withdrawal by Subject|1|||
42082176|NCT00800436|75892617|FG004|Overall Study|Withdrawal by Subject|0|||
42082177|NCT00800436|75892618|FG005|Overall Study|Withdrawal by Subject|0|||
42082178|NCT00800436|75892619|FG006|Overall Study|Withdrawal by Subject|0|||
42082179|NCT00655564|75892635|FG000|Overall Study|Adverse Event|1|||
42082180|NCT00655564|75892635|FG000|Overall Study|Lost to Follow-up|1|||
42082181|NCT00655564|75892635|FG000|Overall Study|Desired Alternate Therapy|1|||
42082182|NCT00447421|75892640|FG000|Overall Study|Lack of Efficacy|1|||
42082183|NCT00447421|75892640|FG000|Overall Study|Adverse Event|3|||
42082184|NCT00447421|75892640|FG000|Overall Study|Sponsor Decision|2|||
42082185|NCT00651118|75892648|FG000|Overall Study|Adverse Event|4|||
42082186|NCT00651118|75892649|FG001|Overall Study|Adverse Event|0|||
42082187|NCT00651118|75892650|FG002|Overall Study|Adverse Event|1|||
42082188|NCT00651118|75892651|FG003|Overall Study|Adverse Event|1|||
42082189|NCT00651118|75892648|FG000|Overall Study|Protocol Violation|2|||
42082190|NCT00651118|75892649|FG001|Overall Study|Protocol Violation|2|||
42082191|NCT00651118|75892650|FG002|Overall Study|Protocol Violation|6|||
42082192|NCT00651118|75892651|FG003|Overall Study|Protocol Violation|2|||
42082193|NCT00651118|75892648|FG000|Overall Study|Lost to Follow-up|2|||
42082194|NCT00651118|75892649|FG001|Overall Study|Lost to Follow-up|0|||
42082195|NCT00651118|75892650|FG002|Overall Study|Lost to Follow-up|1|||
42082196|NCT00651118|75892651|FG003|Overall Study|Lost to Follow-up|2|||
42082197|NCT00651118|75892648|FG000|Overall Study|administrative|1|||
42082198|NCT00651118|75892649|FG001|Overall Study|administrative|4|||
42082199|NCT00651118|75892650|FG002|Overall Study|administrative|2|||
42082200|NCT00651118|75892651|FG003|Overall Study|administrative|1|||
42082201|NCT00651118|75892648|FG000|Overall Study|Withdrawal by Subject|0|||
42082202|NCT00651118|75892649|FG001|Overall Study|Withdrawal by Subject|1|||
42082203|NCT00651118|75892650|FG002|Overall Study|Withdrawal by Subject|1|||
42082204|NCT00651118|75892651|FG003|Overall Study|Withdrawal by Subject|1|||
42082205|NCT00447265|75892664|FG000|Overall Study|Physician Decision|1|||
42082206|NCT00447265|75892665|FG001|Overall Study|Physician Decision|0|||
42082207|NCT00657358|75892669|FG000|Overall Study|Lack of Efficacy|6|||
42082208|NCT00457639|75892674|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
42082209|NCT00457639|75892675|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
42082210|NCT00457639|75892674|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
42082211|NCT00457639|75892675|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
42082212|NCT00457639|75892674|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
42082213|NCT00457639|75892675|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
42082214|NCT00800202|75892683|FG000|Overall Study|Adverse Event|7|||
42082215|NCT00800202|75892684|FG001|Overall Study|Adverse Event|6|||
42082216|NCT00800202|75892683|FG000|Overall Study|Death|1|||
42082217|NCT00800202|75892684|FG001|Overall Study|Death|0|||
42082218|NCT00800202|75892683|FG000|Overall Study|Other|5|||
42082219|NCT00800202|75892684|FG001|Overall Study|Other|0|||
42082220|NCT00800202|75892683|FG000|Overall Study|Disease Progression|54|||
42082221|NCT00800202|75892684|FG001|Overall Study|Disease Progression|18|||
42082222|NCT00655486|75892690|FG000|Overall Study|Adverse Event|10|||
42082223|NCT00655486|75892690|FG000|Overall Study|Lack of Efficacy|8|||
42082224|NCT00655486|75892690|FG000|Overall Study|Withdrawal by Subject|4|||
42082225|NCT00655486|75892690|FG000|Overall Study|Protocol Violation|1|||
42082226|NCT00655486|75892690|FG000|Overall Study|Unsatisfactory compliance|2|||
42082227|NCT00655486|75892690|FG000|Overall Study|Other: Pregnancy|1|||
42082228|NCT00655486|75892690|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
42082229|NCT00655486|75892690|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
42082230|NCT00457249|75892696|FG000|Overall Study|Lost to Follow-up|3|||
42082231|NCT00457249|75892697|FG001|Overall Study|Lost to Follow-up|0|||
42082232|NCT00457249|75892696|FG000|Overall Study|Protocol Violation|4|||
42082233|NCT00457249|75892697|FG001|Overall Study|Protocol Violation|1|||
42082234|NCT00457249|75892696|FG000|Overall Study|Withdrawal by Subject|3|||
42082235|NCT00457249|75892697|FG001|Overall Study|Withdrawal by Subject|1|||
42178528|NCT05261126|75985721|FG003|Overall Study|Withdrawal by Subject|1|||
42178529|NCT05261126|75985722|FG004|Overall Study|Withdrawal by Subject|0|||
42178530|NCT05261126|75985718|FG000|Overall Study|Not Recorded|0|||
42294081|NCT02522481|76128406|FG000|Overall Study|Not dosed|2|||
42294082|NCT02522403|76128419|FG000|Overall Study|Lost to Follow-up|2|||
42178531|NCT05261126|75985719|FG001|Overall Study|Not Recorded|0|||
42294083|NCT02522403|76128420|FG001|Overall Study|Lost to Follow-up|2|||
42294084|NCT02522403|76128419|FG000|Overall Study|Withdrawal by Subject|2|||
42294085|NCT02522403|76128420|FG001|Overall Study|Withdrawal by Subject|4|||
42294086|NCT02522325|76128426|FG000|Overall Study|Adverse Event|0|||
42082236|NCT00457249|75892696|FG000|Overall Study|Serious Adverse Events|2|||
42082237|NCT00457249|75892697|FG001|Overall Study|Serious Adverse Events|0|||
42082238|NCT00457015|75892707|FG000|Overall Study|Left study site against medical advice|0|||
42082239|NCT00457015|75892708|FG001|Overall Study|Left study site against medical advice|1|||
42082240|NCT00654940|75892716|FG000|Period 1|Adverse Event|0|||
42082241|NCT00654940|75892717|FG001|Period 1|Adverse Event|1|||
42082242|NCT00654940|75892716|FG000|Period 1|Intolerable Pain Level|1|||
42082243|NCT00654940|75892717|FG001|Period 1|Intolerable Pain Level|0|||
42082244|NCT00588666|75892729|FG000|Overall Study|Adverse Event|4|||
42082245|NCT00793182|75892744|FG000|Overall Study|Adverse Event|0|||
42082246|NCT00793182|75892745|FG001|Overall Study|Adverse Event|1|||
42082247|NCT00793104|75892751|FG000|Overall Study|Lost to Follow-up|1|||
42082248|NCT00446797|75892757|FG000|Overall Study|Lack of Efficacy|0|||
42082249|NCT00446797|75892758|FG001|Overall Study|Lack of Efficacy|2|||
42082250|NCT00446797|75892757|FG000|Overall Study|Lost to Follow-up|5|||
42082251|NCT00446797|75892758|FG001|Overall Study|Lost to Follow-up|3|||
42082252|NCT00446797|75892757|FG000|Overall Study|Withdrawal by Subject|2|||
42082253|NCT00446797|75892758|FG001|Overall Study|Withdrawal by Subject|2|||
42082254|NCT00446797|75892757|FG000|Overall Study|Protocol Violation|1|||
42082255|NCT00446797|75892758|FG001|Overall Study|Protocol Violation|3|||
42082256|NCT00446797|75892757|FG000|Overall Study|subject entered at another site|0|||
42082257|NCT00446797|75892758|FG001|Overall Study|subject entered at another site|1|||
42082258|NCT00446797|75892757|FG000|Overall Study|did not meet entrance criteria|0|||
42082259|NCT00446797|75892758|FG001|Overall Study|did not meet entrance criteria|1|||
42082260|NCT00855335|75892769|FG000|Overall Study|Lost to Follow-up|0|||
42082261|NCT00855335|75892770|FG001|Overall Study|Lost to Follow-up|0|||
42082262|NCT00855335|75892771|FG002|Overall Study|Lost to Follow-up|3|||
42082263|NCT00855335|75892772|FG003|Overall Study|Lost to Follow-up|1|||
42082264|NCT00855335|75892773|FG004|Overall Study|Lost to Follow-up|0|||
42082265|NCT00855335|75892769|FG000|Overall Study|Withdrawal by Subject|0|||
42082266|NCT00855335|75892770|FG001|Overall Study|Withdrawal by Subject|0|||
42082267|NCT00855335|75892771|FG002|Overall Study|Withdrawal by Subject|0|||
42082268|NCT00855335|75892772|FG003|Overall Study|Withdrawal by Subject|1|||
42082269|NCT00855335|75892773|FG004|Overall Study|Withdrawal by Subject|0|||
42082270|NCT00855335|75892769|FG000|Overall Study|Adverse Event|2|||
42082271|NCT00855335|75892770|FG001|Overall Study|Adverse Event|0|||
42082272|NCT00855335|75892771|FG002|Overall Study|Adverse Event|0|||
42082273|NCT00855335|75892772|FG003|Overall Study|Adverse Event|0|||
42082274|NCT00855335|75892773|FG004|Overall Study|Adverse Event|0|||
42082275|NCT00855335|75892769|FG000|Overall Study|Physician Decision|1|||
42082276|NCT00855335|75892770|FG001|Overall Study|Physician Decision|1|||
42082277|NCT00855335|75892771|FG002|Overall Study|Physician Decision|0|||
42082278|NCT00855335|75892772|FG003|Overall Study|Physician Decision|0|||
42082279|NCT00855335|75892773|FG004|Overall Study|Physician Decision|0|||
42082280|NCT00855335|75892769|FG000|Overall Study|Other|2|||
42082281|NCT00855335|75892770|FG001|Overall Study|Other|1|||
42082282|NCT00855335|75892771|FG002|Overall Study|Other|2|||
42082283|NCT00855335|75892772|FG003|Overall Study|Other|5|||
42082284|NCT00855335|75892773|FG004|Overall Study|Other|1|||
42082285|NCT00799422|75892798|FG000|First Week of Wear|Lost to Follow-up|0|||
42082286|NCT00799422|75892799|FG001|First Week of Wear|Lost to Follow-up|0|||
42082287|NCT00799422|75892800|FG002|First Week of Wear|Lost to Follow-up|1|||
42082288|NCT00799422|75892801|FG003|First Week of Wear|Lost to Follow-up|0|||
42082289|NCT00799422|75892802|FG004|First Week of Wear|Lost to Follow-up|0|||
42082290|NCT00799422|75892803|FG005|First Week of Wear|Lost to Follow-up|0|||
42082291|NCT00799422|75892798|FG000|First Week of Wear|Adverse Event|0|||
42082292|NCT00799422|75892799|FG001|First Week of Wear|Adverse Event|0|||
42082293|NCT00799422|75892800|FG002|First Week of Wear|Adverse Event|0|||
42082294|NCT00799422|75892801|FG003|First Week of Wear|Adverse Event|1|||
42082295|NCT00799422|75892802|FG004|First Week of Wear|Adverse Event|0|||
42082296|NCT00799422|75892803|FG005|First Week of Wear|Adverse Event|0|||
42178532|NCT05261126|75985720|FG002|Overall Study|Not Recorded|0|||
42178533|NCT05261126|75985721|FG003|Overall Study|Not Recorded|1|||
42178534|NCT05261126|75985722|FG004|Overall Study|Not Recorded|0|||
42178535|NCT05116683|75985734|FG000|Overall Study|Physician Decision|4|||
42178536|NCT04585815|75985748|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
42294087|NCT02522325|76128427|FG001|Overall Study|Adverse Event|1|||
42294088|NCT01672879|76128436|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
42082297|NCT00593489|75892813|FG000|Allocation|did not attend workshop; allocation not|2|||
42082298|NCT00593489|75892814|FG001|Allocation|did not attend workshop; allocation not|1|||
42082299|NCT00446641|75892824|FG000|Overall Study|Withdrawal by Subject|8|||
42082300|NCT00446641|75892825|FG001|Overall Study|Withdrawal by Subject|3|||
42082301|NCT00446641|75892824|FG000|Overall Study|poor compliance|8|||
42082302|NCT00446641|75892825|FG001|Overall Study|poor compliance|6|||
42082303|NCT00446641|75892824|FG000|Overall Study|Lost to Follow-up|1|||
42082304|NCT00446641|75892825|FG001|Overall Study|Lost to Follow-up|1|||
42082305|NCT00646282|75892833|FG000|Overall Study|Protocol terminated|4|||
42082306|NCT00646282|75892834|FG001|Overall Study|Protocol terminated|4|||
42082307|NCT00792636|75892843|FG000|Overall Study|Protocol Violation|17|||
42082308|NCT00792636|75892844|FG001|Overall Study|Protocol Violation|23|||
42082309|NCT00792636|75892845|FG002|Overall Study|Protocol Violation|20|||
42082310|NCT00792636|75892843|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
42178537|NCT04585815|75985749|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
42082311|NCT00792636|75892844|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
42082312|NCT00792636|75892845|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
42082313|NCT00792636|75892843|FG000|Overall Study|Lost to Follow-up|13|||
42082314|NCT00792636|75892844|FG001|Overall Study|Lost to Follow-up|19|||
42082315|NCT00792636|75892845|FG002|Overall Study|Lost to Follow-up|14|||
42082316|NCT00792636|75892843|FG000|Overall Study|Withdrew Consent|10|||
42082317|NCT00792636|75892844|FG001|Overall Study|Withdrew Consent|13|||
42082318|NCT00792636|75892845|FG002|Overall Study|Withdrew Consent|9|||
42082319|NCT00792636|75892843|FG000|Overall Study|Lack of Efficacy|3|||
42082320|NCT00792636|75892844|FG001|Overall Study|Lack of Efficacy|4|||
42082321|NCT00792636|75892845|FG002|Overall Study|Lack of Efficacy|13|||
42082322|NCT00792636|75892843|FG000|Overall Study|Adverse Event|4|||
42082323|NCT00792636|75892844|FG001|Overall Study|Adverse Event|2|||
42082324|NCT00792636|75892845|FG002|Overall Study|Adverse Event|3|||
42082325|NCT00792636|75892843|FG000|Overall Study|Investigator Discretion|2|||
42082326|NCT00792636|75892844|FG001|Overall Study|Investigator Discretion|0|||
42082327|NCT00792636|75892845|FG002|Overall Study|Investigator Discretion|2|||
42178538|NCT04585815|75985748|FG000|Sub-study A- Treatment Phase|Death|0|||
42178539|NCT04585815|75985749|FG001|Sub-study A- Treatment Phase|Death|1|||
42178540|NCT04585815|75985748|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
42178541|NCT04585815|75985749|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
42178542|NCT04585815|75985748|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
42178543|NCT04585815|75985749|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
42178544|NCT04585815|75985748|FG000|Sub-study A- Treatment Phase|Other|1|||
42178545|NCT04585815|75985749|FG001|Sub-study A- Treatment Phase|Other|0|||
42178546|NCT04585815|75985748|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
42178547|NCT04585815|75985749|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
42178548|NCT04585815|75985748|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
42178549|NCT04585815|75985749|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
42178550|NCT04570436|75985757|FG000|Overall Study|Adverse Event|0|||
42178551|NCT04570436|75985758|FG001|Overall Study|Adverse Event|0|||
42178552|NCT04570436|75985759|FG002|Overall Study|Adverse Event|1|||
42178553|NCT04570436|75985760|FG003|Overall Study|Adverse Event|0|||
42178554|NCT04570436|75985761|FG004|Overall Study|Adverse Event|0|||
42178555|NCT04570436|75985762|FG005|Overall Study|Adverse Event|0|||
42294089|NCT01672879|76128437|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
42294090|NCT01672879|76128438|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
42294091|NCT01672879|76128436|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
42294092|NCT01672879|76128437|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
42294093|NCT01672879|76128438|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
42294094|NCT01672879|76128436|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
42082328|NCT00446563|75892857|FG000|Overall Study|Adverse Event|4|||
42178556|NCT04570436|75985763|FG006|Overall Study|Adverse Event|0|||
42178557|NCT04570436|75985764|FG007|Overall Study|Adverse Event|0|||
42178558|NCT04570436|75985765|FG008|Overall Study|Adverse Event|0|||
42178559|NCT04570436|75985766|FG009|Overall Study|Adverse Event|0|||
42178560|NCT04570436|75985757|FG000|Overall Study|Physician Decision|1|||
42178561|NCT04570436|75985758|FG001|Overall Study|Physician Decision|0|||
42178562|NCT04570436|75985759|FG002|Overall Study|Physician Decision|0|||
42294095|NCT01672879|76128437|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
42082329|NCT00446563|75892858|FG001|Overall Study|Adverse Event|3|||
42082330|NCT00446563|75892857|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42082331|NCT00446563|75892858|FG001|Overall Study|Abnormal laboratory value(s)|1|||
42082332|NCT00446563|75892857|FG000|Overall Study|Abnormal test procedure result(s)|1|||
42082333|NCT00446563|75892858|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42082334|NCT00446563|75892857|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42082335|NCT00446563|75892858|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
42082336|NCT00446563|75892857|FG000|Overall Study|Withdrawal by Subject|2|||
42082337|NCT00446563|75892858|FG001|Overall Study|Withdrawal by Subject|1|||
42082338|NCT00446563|75892857|FG000|Overall Study|Administrative problems|0|||
42082339|NCT00446563|75892858|FG001|Overall Study|Administrative problems|1|||
42178563|NCT04570436|75985760|FG003|Overall Study|Physician Decision|0|||
42294096|NCT01672879|76128438|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
42294097|NCT01672879|76128436|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
42294098|NCT01672879|76128437|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
42294099|NCT01672879|76128438|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
42294100|NCT01672879|76128436|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
42294101|NCT01672879|76128437|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
42294102|NCT01672879|76128438|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
42294103|NCT01672879|76128436|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
42294104|NCT01672879|76128437|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
42178564|NCT04570436|75985761|FG004|Overall Study|Physician Decision|0|||
42294105|NCT01672879|76128438|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
42294106|NCT01672879|76128436|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
42294107|NCT01672879|76128437|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
42082340|NCT00650806|75892868|FG000|Overall Study|Adverse Event|0|||
42082341|NCT00650806|75892869|FG001|Overall Study|Adverse Event|5|||
42082342|NCT00650806|75892870|FG002|Overall Study|Adverse Event|3|||
42082343|NCT00650806|75892871|FG003|Overall Study|Adverse Event|4|||
42082344|NCT00650806|75892868|FG000|Overall Study|Lost to Follow-up|7|||
42082345|NCT00650806|75892869|FG001|Overall Study|Lost to Follow-up|6|||
42082346|NCT00650806|75892870|FG002|Overall Study|Lost to Follow-up|11|||
42082347|NCT00650806|75892871|FG003|Overall Study|Lost to Follow-up|10|||
42082348|NCT00650806|75892868|FG000|Overall Study|Protocol Violation|0|||
42082349|NCT00650806|75892869|FG001|Overall Study|Protocol Violation|0|||
42082350|NCT00650806|75892870|FG002|Overall Study|Protocol Violation|0|||
42082351|NCT00650806|75892871|FG003|Overall Study|Protocol Violation|1|||
42082352|NCT00650806|75892868|FG000|Overall Study|Pregnancy|0|||
42082353|NCT00650806|75892869|FG001|Overall Study|Pregnancy|0|||
42082354|NCT00650806|75892870|FG002|Overall Study|Pregnancy|0|||
42082355|NCT00650806|75892871|FG003|Overall Study|Pregnancy|1|||
42082356|NCT00650806|75892868|FG000|Overall Study|Withdrawal by Subject|7|||
42082357|NCT00650806|75892869|FG001|Overall Study|Withdrawal by Subject|5|||
42082358|NCT00650806|75892870|FG002|Overall Study|Withdrawal by Subject|8|||
42082359|NCT00650806|75892871|FG003|Overall Study|Withdrawal by Subject|6|||
42082360|NCT00650806|75892868|FG000|Overall Study|Noncompliance with study drug regimen|1|||
42082361|NCT00650806|75892869|FG001|Overall Study|Noncompliance with study drug regimen|1|||
42082362|NCT00650806|75892870|FG002|Overall Study|Noncompliance with study drug regimen|0|||
42082363|NCT00650806|75892871|FG003|Overall Study|Noncompliance with study drug regimen|0|||
42082364|NCT00650806|75892868|FG000|Overall Study|Study terminated by sponsor|2|||
42082365|NCT00650806|75892869|FG001|Overall Study|Study terminated by sponsor|3|||
42082366|NCT00650806|75892870|FG002|Overall Study|Study terminated by sponsor|5|||
42082367|NCT00650806|75892871|FG003|Overall Study|Study terminated by sponsor|4|||
42082368|NCT00650806|75892868|FG000|Overall Study|Other|1|||
42082369|NCT00650806|75892869|FG001|Overall Study|Other|1|||
42082370|NCT00650806|75892870|FG002|Overall Study|Other|2|||
42082371|NCT00650806|75892871|FG003|Overall Study|Other|0|||
42082372|NCT00863057|75892887|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
42082373|NCT00863057|75892888|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
42082374|NCT00863057|75892889|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
42082375|NCT00863057|75892890|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
42082376|NCT00863057|75892887|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
42082377|NCT00863057|75892888|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
42082378|NCT00863057|75892889|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
42082379|NCT00863057|75892890|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
42082380|NCT00863057|75892887|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
42082381|NCT00863057|75892888|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
42082382|NCT00863057|75892889|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
42082383|NCT00863057|75892890|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
42082384|NCT00863057|75892887|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
42082385|NCT00863057|75892888|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
42082386|NCT00863057|75892889|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
42082387|NCT00863057|75892890|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
42082388|NCT00829166|75892908|FG000|Overall Study|Death|305|||
42082389|NCT00829166|75892909|FG001|Overall Study|Death|333|||
42082390|NCT00829166|75892908|FG000|Overall Study|Lost to Follow-up|5|||
42082391|NCT00829166|75892909|FG001|Overall Study|Lost to Follow-up|4|||
42082392|NCT00829166|75892908|FG000|Overall Study|Physician's Decision|4|||
42082393|NCT00829166|75892909|FG001|Overall Study|Physician's Decision|3|||
42082394|NCT00829166|75892908|FG000|Overall Study|Subject's Decision|41|||
42082395|NCT00829166|75892909|FG001|Overall Study|Subject's Decision|55|||
42082396|NCT00829166|75892908|FG000|Overall Study|Sponsor's Decision|137|||
42082397|NCT00829166|75892909|FG001|Overall Study|Sponsor's Decision|98|||
42082398|NCT00829166|75892908|FG000|Overall Study|Reason Not Specified|3|||
42082399|NCT00829166|75892909|FG001|Overall Study|Reason Not Specified|3|||
42358123|NCT01855789|76203732|FG002|1) Baseline up to Week 24|Physician Decision|0|||
42358124|NCT01855789|76203733|FG003|1) Baseline up to Week 24|Physician Decision|0|||
42082400|NCT00799266|75892918|FG000|Overall Study|Adverse Event|0|||
42082401|NCT00799266|75892919|FG001|Overall Study|Adverse Event|1|||
42082402|NCT00799266|75892918|FG000|Overall Study|Subject withdrew consent|3|||
42082403|NCT00799266|75892919|FG001|Overall Study|Subject withdrew consent|0|||
42082404|NCT00650104|75892925|FG000|Overall Study|Adverse Event|17|||
42082405|NCT00650104|75892925|FG000|Overall Study|Death|2|||
42082406|NCT00650104|75892925|FG000|Overall Study|Withdrawal by Subject|11|||
42082407|NCT00650104|75892925|FG000|Overall Study|Physician Decision|7|||
42082408|NCT00650104|75892925|FG000|Overall Study|Lost to Follow-up|1|||
42082409|NCT00650104|75892925|FG000|Overall Study|Non-compliance|2|||
42082410|NCT00650104|75892925|FG000|Overall Study|Sponsor Terminated Dosing|1|||
42082411|NCT00654238|75892929|FG000|Overall Study|Screen Failures|4|||
42082412|NCT00862979|75892936|FG000|Overall Study|Adverse Event|6|||
42082413|NCT00862979|75892937|FG001|Overall Study|Adverse Event|3|||
42082414|NCT00862979|75892936|FG000|Overall Study|Protocol Violation|0|||
42082415|NCT00862979|75892937|FG001|Overall Study|Protocol Violation|1|||
42082416|NCT00862979|75892936|FG000|Overall Study|Patient withdrew consent|2|||
42082417|NCT00862979|75892937|FG001|Overall Study|Patient withdrew consent|1|||
42082418|NCT00862979|75892936|FG000|Overall Study|Administrative problems|0|||
42082419|NCT00862979|75892937|FG001|Overall Study|Administrative problems|1|||
42082420|NCT00862979|75892936|FG000|Overall Study|Death|0|||
42082421|NCT00862979|75892937|FG001|Overall Study|Death|1|||
42082422|NCT00483379|75892945|FG000|Treatment Period|Adverse Event|1|||
42082423|NCT00483379|75892946|FG001|Treatment Period|Adverse Event|0|||
42082424|NCT00483379|75892945|FG000|Treatment Period|Withdrawal by Subject|1|||
42082425|NCT00483379|75892946|FG001|Treatment Period|Withdrawal by Subject|0|||
42082426|NCT00446251|75892954|FG000|Overall Study|On-study Transplants|2|||
42082427|NCT00446251|75892954|FG000|Overall Study|Rituximab Infusion Reaction|2|||
42082428|NCT00446251|75892954|FG000|Overall Study|Lost to Follow-up|1|||
42082429|NCT00796224|75892960|FG000|Overall Study|Adverse Event|1|||
42082430|NCT00796224|75892961|FG001|Overall Study|Adverse Event|0|||
42082431|NCT00796224|75892960|FG000|Overall Study|Protocol Violation|0|||
42082432|NCT00796224|75892961|FG001|Overall Study|Protocol Violation|1|||
42082433|NCT00791934|75892969|FG000|Overall Study|Withdrawal by Subject|2|||
42082434|NCT00791934|75892969|FG000|Overall Study|Did not consent for extended follow-up|13|||
42082435|NCT00848081|75892975|FG000|Overall Study|Adverse Event|6|||
42082436|NCT00848081|75892976|FG001|Overall Study|Adverse Event|7|||
42082437|NCT00848081|75892975|FG000|Overall Study|Protocol Violation|8|||
42082438|NCT00848081|75892976|FG001|Overall Study|Protocol Violation|5|||
42082439|NCT00848081|75892975|FG000|Overall Study|Lost to Follow-up|1|||
42082440|NCT00848081|75892976|FG001|Overall Study|Lost to Follow-up|0|||
42082441|NCT00848081|75892975|FG000|Overall Study|Physician Decision|0|||
42082442|NCT00848081|75892976|FG001|Overall Study|Physician Decision|3|||
42082443|NCT00848081|75892975|FG000|Overall Study|Withdrawal by Subject|5|||
42082444|NCT00848081|75892976|FG001|Overall Study|Withdrawal by Subject|3|||
42082445|NCT00654004|75892984|FG000|Overall Study|Lost to Follow-up|1|||
42082446|NCT00654004|75892985|FG001|Overall Study|Lost to Follow-up|0|||
42178565|NCT04570436|75985762|FG005|Overall Study|Physician Decision|0|||
42178566|NCT04570436|75985763|FG006|Overall Study|Physician Decision|0|||
42178567|NCT04570436|75985764|FG007|Overall Study|Physician Decision|0|||
42178568|NCT04570436|75985765|FG008|Overall Study|Physician Decision|0|||
42178569|NCT04570436|75985766|FG009|Overall Study|Physician Decision|0|||
42178570|NCT04563845|75985800|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178571|NCT04563845|75985801|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178572|NCT04563845|75985802|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178573|NCT04563845|75985803|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42082447|NCT00791778|75892993|FG000|Double-blind Treatment|Adverse Event|49|||
42178574|NCT04563845|75985804|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178575|NCT04563845|75985805|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178576|NCT04563845|75985806|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178577|NCT04563845|75985807|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
42178578|NCT04563845|75985808|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178579|NCT04563845|75985809|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178580|NCT04563845|75985810|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178581|NCT04563845|75985811|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178582|NCT04563845|75985812|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178583|NCT04563845|75985813|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
42178584|NCT04563845|75985800|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178585|NCT04563845|75985801|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178586|NCT04563845|75985802|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178587|NCT04563845|75985803|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178588|NCT04563845|75985804|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
42178589|NCT04563845|75985805|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178590|NCT04563845|75985806|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42082448|NCT00791778|75892994|FG001|Double-blind Treatment|Adverse Event|9|||
42082449|NCT00791778|75892993|FG000|Double-blind Treatment|Physician Decision|6|||
42082450|NCT00791778|75892994|FG001|Double-blind Treatment|Physician Decision|26|||
42082451|NCT00791778|75892993|FG000|Double-blind Treatment|Protocol Violation|0|||
42082452|NCT00791778|75892994|FG001|Double-blind Treatment|Protocol Violation|4|||
42082453|NCT00791778|75892993|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
42082454|NCT00791778|75892994|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
42082455|NCT00791778|75892993|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
42082456|NCT00791778|75892994|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
42082457|NCT00791778|75892993|FG000|Follow-up|Withdrawal by Subject|3|||
42082458|NCT00791778|75892994|FG001|Follow-up|Withdrawal by Subject|0|||
42082459|NCT00791778|75892993|FG000|Follow-up|Lost to Follow-up|2|||
42082460|NCT00791778|75892994|FG001|Follow-up|Lost to Follow-up|1|||
42082461|NCT00798174|75893000|FG000|Overall Study|inability to implant azygos coil|3|||
42082462|NCT00798174|75893001|FG001|Overall Study|inability to implant azygos coil|3|||
42082463|NCT00798174|75893000|FG000|Overall Study|Inability to sedate for DFT testing|1|||
42082464|NCT00798174|75893001|FG001|Overall Study|Inability to sedate for DFT testing|0|||
42082465|NCT00798096|75893005|FG000|Overall Study|Ongoing|2|||
42082466|NCT00795600|75893011|FG000|Overall Study|Adverse Event|1|||
42082467|NCT00795600|75893012|FG001|Overall Study|Adverse Event|1|||
42082468|NCT00795600|75893011|FG000|Overall Study|Protocol Violation|1|||
42178591|NCT04563845|75985807|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178592|NCT04563845|75985808|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178593|NCT04563845|75985809|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178594|NCT04563845|75985810|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178595|NCT04563845|75985811|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178596|NCT04563845|75985812|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178597|NCT04563845|75985813|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
42178598|NCT04517253|75985844|FG000|Overall Study|Adverse Event|1|||
42178599|NCT04517253|75985845|FG001|Overall Study|Adverse Event|0|||
42178600|NCT04517253|75985846|FG002|Overall Study|Adverse Event|0|||
42178601|NCT04517253|75985844|FG000|Overall Study|Death|0|||
42178602|NCT04517253|75985845|FG001|Overall Study|Death|1|||
42178603|NCT04517253|75985846|FG002|Overall Study|Death|0|||
42178604|NCT04433767|75985856|FG000|Overall Study|Adverse Event|1|||
42178605|NCT04419467|75985863|FG000|Overall Study|Not treated with IP|0|||
42178606|NCT04419467|75985864|FG001|Overall Study|Not treated with IP|0|||
42178607|NCT04419467|75985865|FG002|Overall Study|Not treated with IP|2|||
42178608|NCT04419467|75985863|FG000|Overall Study|Adverse Event|0|||
42178609|NCT04419467|75985864|FG001|Overall Study|Adverse Event|2|||
42178610|NCT04419467|75985865|FG002|Overall Study|Adverse Event|0|||
42178611|NCT04419467|75985863|FG000|Overall Study|Death|1|||
42178612|NCT04419467|75985864|FG001|Overall Study|Death|0|||
42178613|NCT04419467|75985865|FG002|Overall Study|Death|0|||
42178614|NCT04419467|75985863|FG000|Overall Study|Lost to Follow-up|0|||
42178615|NCT04419467|75985864|FG001|Overall Study|Lost to Follow-up|1|||
42178616|NCT04419467|75985865|FG002|Overall Study|Lost to Follow-up|2|||
42178617|NCT04419467|75985863|FG000|Overall Study|Withdrawal by Subject|0|||
42178618|NCT04419467|75985864|FG001|Overall Study|Withdrawal by Subject|0|||
42178619|NCT04419467|75985865|FG002|Overall Study|Withdrawal by Subject|4|||
42178620|NCT04419467|75985863|FG000|Overall Study|Pandemic related|0|||
42178621|NCT04419467|75985864|FG001|Overall Study|Pandemic related|0|||
42178622|NCT04419467|75985865|FG002|Overall Study|Pandemic related|1|||
42178623|NCT04419467|75985863|FG000|Overall Study|Reason not known|1|||
42178624|NCT04419467|75985864|FG001|Overall Study|Reason not known|0|||
42178625|NCT04419467|75985865|FG002|Overall Study|Reason not known|0|||
42178626|NCT04382326|75985884|FG000|Overall Study|Adverse Event, not serious|1|||
42178627|NCT04382326|75985885|FG001|Overall Study|Adverse Event, not serious|2|||
42178628|NCT04382326|75985884|FG000|Overall Study|Other|1|||
42178629|NCT04382326|75985885|FG001|Overall Study|Other|0|||
42178630|NCT04382326|75985884|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
42178631|NCT04382326|75985885|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
42178632|NCT04382326|75985884|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
42178633|NCT04382326|75985885|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
42178634|NCT04382326|75985884|FG000|Overall Study|Protocol Violation|29|||
42178635|NCT04382326|75985885|FG001|Overall Study|Protocol Violation|23|||
42178636|NCT04382326|75985884|FG000|Overall Study|Physician Decision|0|||
42178637|NCT04382326|75985885|FG001|Overall Study|Physician Decision|1|||
42178638|NCT04382326|75985884|FG000|Overall Study|Lost to Follow-up|48|||
42178639|NCT04382326|75985885|FG001|Overall Study|Lost to Follow-up|63|||
42178640|NCT04382326|75985884|FG000|Overall Study|Adverse Event, non-fatal|1|||
42178641|NCT04382326|75985885|FG001|Overall Study|Adverse Event, non-fatal|1|||
42178642|NCT04359901|75985893|FG000|Overall Study|Withdrawal by Subject|0|||
42178643|NCT04359901|75985894|FG001|Overall Study|Withdrawal by Subject|1|||
42178644|NCT04359901|75985893|FG000|Overall Study|Death|6|||
42178645|NCT04359901|75985894|FG001|Overall Study|Death|2|||
42178646|NCT03945591|75985909|FG000|Overall Study|Participant not transplanted|1|||
42294108|NCT01672879|76128438|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
42178647|NCT03945591|75985909|FG000|Overall Study|Change in treatment plan|3|||
42178648|NCT03945591|75985909|FG000|Overall Study|Adverse Event|1|||
42178649|NCT03744676|75985913|FG000|Pre-Treatment Phase|Death|7|||
42178650|NCT03744676|75985913|FG000|Pre-Treatment Phase|Disease related complications|2|||
42178651|NCT03744676|75985913|FG000|Pre-Treatment Phase|No longer meets eligibility criteria for other reasons|4|||
42178652|NCT03744676|75985913|FG000|Pre-Treatment Phase|Other reasons|8|||
42178653|NCT03744676|75985913|FG000|Treatment Phase|Ongoing in study|18|||
42178654|NCT03744676|75985913|FG000|Treatment Phase|Death|31|||
42178655|NCT03744676|75985913|FG000|Treatment Phase|Withdrawal of consent|8|||
42178656|NCT03744676|75985913|FG000|Treatment Phase|Other reasons|6|||
42178657|NCT03732820|75985919|FG000|Overall Study|Death|168|||
42082469|NCT00795600|75893012|FG001|Overall Study|Protocol Violation|2|||
42082470|NCT00795600|75893011|FG000|Overall Study|Withdrawal by Subject|1|||
42082471|NCT00795600|75893012|FG001|Overall Study|Withdrawal by Subject|0|||
42082472|NCT00795600|75893011|FG000|Overall Study|Unclassified|1|||
42082473|NCT00795600|75893012|FG001|Overall Study|Unclassified|1|||
42082474|NCT00795132|75893018|FG000|Overall Study|Death|1|||
42082475|NCT00795132|75893018|FG000|Overall Study|Relapse|2|||
42082476|NCT00647296|75893034|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
42082477|NCT00647296|75893035|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
42082478|NCT00647296|75893036|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
42082479|NCT00647296|75893037|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
42082480|NCT00647296|75893034|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
42082481|NCT00647296|75893035|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
42082482|NCT00647296|75893036|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
42082483|NCT00647296|75893037|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
42082484|NCT00647296|75893034|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
42082485|NCT00647296|75893035|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
42082486|NCT00647296|75893036|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
42082487|NCT00647296|75893037|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
42082488|NCT00647296|75893034|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
42082489|NCT00647296|75893035|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
42082490|NCT00647296|75893036|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
42082491|NCT00647296|75893037|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
42082492|NCT00647296|75893034|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
42082493|NCT00647296|75893035|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
42082494|NCT00647296|75893036|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
42082495|NCT00647296|75893037|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
42082496|NCT00647296|75893034|FG000|Part 2: 4-week Placebo Washout|Death|3|||
42082497|NCT00647296|75893035|FG001|Part 2: 4-week Placebo Washout|Death|0|||
42082498|NCT00647296|75893036|FG002|Part 2: 4-week Placebo Washout|Death|0|||
42082499|NCT00647296|75893037|FG003|Part 2: 4-week Placebo Washout|Death|0|||
42082500|NCT00647296|75893034|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
42082501|NCT00647296|75893035|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
42082502|NCT00647296|75893036|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
42082503|NCT00647296|75893037|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
42082504|NCT00647296|75893034|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
42082505|NCT00647296|75893035|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
42082506|NCT00647296|75893036|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
42082507|NCT00647296|75893037|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
42082508|NCT00647296|75893034|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
42082509|NCT00647296|75893035|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
42082510|NCT00647296|75893036|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
42082511|NCT00647296|75893037|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
42082512|NCT00647296|75893034|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
42082513|NCT00647296|75893035|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
42082514|NCT00647296|75893036|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
42082515|NCT00647296|75893037|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
42082516|NCT00647296|75893034|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
42082517|NCT00647296|75893035|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
42082518|NCT00647296|75893036|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
42082519|NCT00647296|75893037|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
42082520|NCT00644878|75893059|FG000|Overall Study|Adverse Event|2|||
42082521|NCT00644878|75893059|FG000|Overall Study|Abnormal laboratory value|3|||
42082522|NCT00644878|75893059|FG000|Overall Study|Protocol deviation|2|||
42082523|NCT00644878|75893059|FG000|Overall Study|Treatment duration completed as per protocol|11|||
42082524|NCT00646906|75893067|FG000|Crossover Period 1|Withdrawal by Subject|1|||
42082525|NCT00646906|75893068|FG001|Crossover Period 1|Withdrawal by Subject|0|||
42082526|NCT00646906|75893069|FG002|Crossover Period 1|Withdrawal by Subject|0|||
42082527|NCT00646906|75893070|FG003|Crossover Period 1|Withdrawal by Subject|0|||
42082528|NCT00646906|75893071|FG004|Crossover Period 1|Withdrawal by Subject|0|||
42082529|NCT00646906|75893072|FG005|Crossover Period 1|Withdrawal by Subject|1|||
42082530|NCT00646906|75893073|FG006|Crossover Period 1|Withdrawal by Subject|0|||
42082531|NCT00646906|75893067|FG000|Crossover Period 2|Withdrawal by Subject|0|||
42082532|NCT00646906|75893068|FG001|Crossover Period 2|Withdrawal by Subject|1|||
42082533|NCT00646906|75893069|FG002|Crossover Period 2|Withdrawal by Subject|2|||
42082534|NCT00646906|75893070|FG003|Crossover Period 2|Withdrawal by Subject|1|||
42082535|NCT00646906|75893071|FG004|Crossover Period 2|Withdrawal by Subject|0|||
42082536|NCT00646906|75893072|FG005|Crossover Period 2|Withdrawal by Subject|0|||
42082537|NCT00646906|75893073|FG006|Crossover Period 2|Withdrawal by Subject|0|||
42082538|NCT00646906|75893067|FG000|Crossover Period 2|Physician Decision|0|||
42082539|NCT00646906|75893068|FG001|Crossover Period 2|Physician Decision|0|||
42082540|NCT00646906|75893069|FG002|Crossover Period 2|Physician Decision|0|||
42082541|NCT00646906|75893070|FG003|Crossover Period 2|Physician Decision|0|||
42082542|NCT00646906|75893071|FG004|Crossover Period 2|Physician Decision|0|||
42082543|NCT00646906|75893072|FG005|Crossover Period 2|Physician Decision|0|||
42082544|NCT00646906|75893073|FG006|Crossover Period 2|Physician Decision|1|||
42082545|NCT00642772|75893086|FG000|Overall Study|Lost to Follow-up|3|||
42082546|NCT00642772|75893086|FG000|Overall Study|Withdrawal by Subject|7|||
42082547|NCT00446095|75893095|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
42082548|NCT00446095|75893096|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
42082549|NCT00446095|75893097|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
42082550|NCT00446095|75893098|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
42082551|NCT00446095|75893099|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
42082552|NCT00446095|75893095|FG000|Phase II (8 Weeks)|Adverse Event|0|||
42082553|NCT00446095|75893096|FG001|Phase II (8 Weeks)|Adverse Event|1|||
42082554|NCT00446095|75893097|FG002|Phase II (8 Weeks)|Adverse Event|1|||
42178658|NCT03732820|75985920|FG001|Overall Study|Death|203|||
42178659|NCT03732820|75985919|FG000|Overall Study|Other|2|||
42178660|NCT03732820|75985920|FG001|Overall Study|Other|2|||
42178661|NCT03732820|75985919|FG000|Overall Study|Failure to meet randomisation criteria|1|||
42178662|NCT03732820|75985920|FG001|Overall Study|Failure to meet randomisation criteria|1|||
42178663|NCT03732820|75985919|FG000|Overall Study|Patient decision|14|||
42178664|NCT03732820|75985920|FG001|Overall Study|Patient decision|10|||
42178665|NCT03732820|75985919|FG000|Overall Study|Screen failure|0|||
42178666|NCT03732820|75985920|FG001|Overall Study|Screen failure|1|||
42178667|NCT03732820|75985919|FG000|Overall Study|Patients ongoing study at data cut off|210|||
42178668|NCT03732820|75985920|FG001|Overall Study|Patients ongoing study at data cut off|178|||
42178669|NCT03732820|75985919|FG000|Overall Study|Lost to Follow-up|4|||
42178670|NCT03732820|75985920|FG001|Overall Study|Lost to Follow-up|2|||
42178671|NCT03605667|75985928|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
42178672|NCT03605667|75985929|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
42178673|NCT03605667|75985928|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
42178674|NCT03605667|75985929|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
42178675|NCT03605667|75985928|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
42178676|NCT03605667|75985929|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
42178677|NCT03605667|75985928|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
42178678|NCT03605667|75985929|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
42178679|NCT03605667|75985928|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
42178680|NCT03605667|75985929|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
42178681|NCT03605667|75985928|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
42178682|NCT03605667|75985929|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
42178683|NCT03605667|75985928|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
42178684|NCT03605667|75985929|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
42178685|NCT03605667|75985928|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
42178686|NCT03605667|75985929|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
42178687|NCT03605667|75985928|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
42178688|NCT03605667|75985929|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
42178689|NCT03605667|75985928|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
42178690|NCT03605667|75985929|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
42178691|NCT03605667|75985928|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
42178692|NCT03605667|75985929|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
42178693|NCT03605667|75985928|FG000|OLE Phase (48 Weeks)|Other|6|||
42178694|NCT03605667|75985929|FG001|OLE Phase (48 Weeks)|Other|8|||
42178695|NCT03605667|75985928|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
42178696|NCT03605667|75985929|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
42294109|NCT01672879|76128436|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
42294110|NCT01672879|76128437|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
42178697|NCT03605667|75985928|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
42082555|NCT00446095|75893098|FG003|Phase II (8 Weeks)|Adverse Event|0|||
42082556|NCT00446095|75893099|FG004|Phase II (8 Weeks)|Adverse Event|0|||
42082557|NCT00446095|75893095|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
42082558|NCT00446095|75893096|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
42082559|NCT00446095|75893097|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
42082560|NCT00446095|75893098|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
42082561|NCT00446095|75893099|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
42082562|NCT00446095|75893095|FG000|Phase II (8 Weeks)|Physician Decision|1|||
42082563|NCT00446095|75893096|FG001|Phase II (8 Weeks)|Physician Decision|0|||
42082564|NCT00446095|75893097|FG002|Phase II (8 Weeks)|Physician Decision|0|||
42082565|NCT00446095|75893098|FG003|Phase II (8 Weeks)|Physician Decision|0|||
42082566|NCT00446095|75893099|FG004|Phase II (8 Weeks)|Physician Decision|0|||
42082567|NCT00446095|75893095|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
42082568|NCT00446095|75893096|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
42082569|NCT00446095|75893097|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
42082570|NCT00446095|75893098|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
42082571|NCT00446095|75893099|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
42082572|NCT00446095|75893095|FG000|Phase II (8 Weeks)|Ongoing|0|||
42082573|NCT00446095|75893096|FG001|Phase II (8 Weeks)|Ongoing|0|||
42082574|NCT00446095|75893097|FG002|Phase II (8 Weeks)|Ongoing|1|||
42082575|NCT00446095|75893098|FG003|Phase II (8 Weeks)|Ongoing|0|||
42082576|NCT00446095|75893099|FG004|Phase II (8 Weeks)|Ongoing|0|||
42082577|NCT00446095|75893095|FG000|Phase I (28 Days)|Adverse Event|0|||
42082578|NCT00446095|75893096|FG001|Phase I (28 Days)|Adverse Event|0|||
42082579|NCT00446095|75893097|FG002|Phase I (28 Days)|Adverse Event|0|||
42294111|NCT01672879|76128438|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
42294112|NCT01672879|76128436|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
42294113|NCT01672879|76128437|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
42294114|NCT01672879|76128438|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
42294115|NCT01672879|76128436|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
42294116|NCT01672879|76128437|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
42294117|NCT01672879|76128438|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
42294118|NCT01672879|76128436|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
42294119|NCT01672879|76128437|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
42294120|NCT01672879|76128438|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
42294121|NCT01672879|76128436|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
42294122|NCT01672879|76128437|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
42294123|NCT01672879|76128438|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
42294124|NCT01672879|76128436|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
42082580|NCT00446095|75893098|FG003|Phase I (28 Days)|Adverse Event|1|||
42082581|NCT00446095|75893099|FG004|Phase I (28 Days)|Adverse Event|0|||
42082582|NCT00446095|75893095|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
42082583|NCT00446095|75893096|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
42082584|NCT00446095|75893097|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
42082585|NCT00446095|75893098|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
42082586|NCT00446095|75893099|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
42082587|NCT00829010|75893115|FG000|Overall Study|Adverse Event|1|||
42082588|NCT00829010|75893116|FG001|Overall Study|Adverse Event|0|||
42082589|NCT00829010|75893117|FG002|Overall Study|Adverse Event|0|||
42082590|NCT00829010|75893118|FG003|Overall Study|Adverse Event|0|||
42082591|NCT00829010|75893119|FG004|Overall Study|Adverse Event|0|||
42082592|NCT00829010|75893115|FG000|Overall Study|Withdrawal by Subject|0|||
42082593|NCT00829010|75893116|FG001|Overall Study|Withdrawal by Subject|1|||
42082594|NCT00829010|75893117|FG002|Overall Study|Withdrawal by Subject|1|||
42082595|NCT00829010|75893118|FG003|Overall Study|Withdrawal by Subject|0|||
42082596|NCT00829010|75893119|FG004|Overall Study|Withdrawal by Subject|2|||
42082597|NCT00829010|75893115|FG000|Overall Study|Lost to Follow-up|1|||
42082598|NCT00829010|75893116|FG001|Overall Study|Lost to Follow-up|0|||
42082599|NCT00829010|75893117|FG002|Overall Study|Lost to Follow-up|2|||
42082600|NCT00829010|75893118|FG003|Overall Study|Lost to Follow-up|0|||
42082601|NCT00829010|75893119|FG004|Overall Study|Lost to Follow-up|0|||
42082602|NCT00829010|75893115|FG000|Overall Study|Fatality|5|||
42082603|NCT00829010|75893116|FG001|Overall Study|Fatality|4|||
42082604|NCT00829010|75893117|FG002|Overall Study|Fatality|0|||
42082605|NCT00829010|75893118|FG003|Overall Study|Fatality|3|||
42082606|NCT00829010|75893119|FG004|Overall Study|Fatality|0|||
42082607|NCT00829010|75893115|FG000|Overall Study|Migrated/Moved from study area|3|||
42082608|NCT00829010|75893116|FG001|Overall Study|Migrated/Moved from study area|4|||
42082609|NCT00829010|75893117|FG002|Overall Study|Migrated/Moved from study area|0|||
42082610|NCT00829010|75893118|FG003|Overall Study|Migrated/Moved from study area|5|||
42082611|NCT00829010|75893119|FG004|Overall Study|Migrated/Moved from study area|0|||
42082612|NCT00644332|75893131|FG000|Overall Study|Adverse Event|11|||
42082613|NCT00644332|75893131|FG000|Overall Study|Withdrawal by Subject|6|||
42082614|NCT00644332|75893131|FG000|Overall Study|Completion Status Unknown|2|||
42082615|NCT00644332|75893131|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
42082616|NCT00644332|75893131|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
42178698|NCT03605667|75985929|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
42178699|NCT03605667|75985928|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
42294125|NCT01672879|76128437|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
42082617|NCT00445939|75893138|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
42082618|NCT00445939|75893139|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
42082619|NCT00445939|75893140|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
42082620|NCT00445939|75893141|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
42082621|NCT00445939|75893138|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
42082622|NCT00445939|75893139|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
42082623|NCT00445939|75893140|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
42178700|NCT03605667|75985929|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
42178701|NCT03605667|75985928|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
42358125|NCT01855789|76203730|FG000|1) Baseline up to Week 24|Pregnancy|1|||
42358126|NCT01855789|76203731|FG001|1) Baseline up to Week 24|Pregnancy|0|||
42358127|NCT01855789|76203732|FG002|1) Baseline up to Week 24|Pregnancy|0|||
42358128|NCT01855789|76203733|FG003|1) Baseline up to Week 24|Pregnancy|0|||
42358129|NCT01855789|76203730|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
42358130|NCT01855789|76203731|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
42358131|NCT01855789|76203732|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
42358132|NCT01855789|76203733|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
42358133|NCT01855789|76203730|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
42358134|NCT01855789|76203731|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
42358135|NCT01855789|76203732|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
42358136|NCT01855789|76203733|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
42358137|NCT01855789|76203730|FG000|1) Baseline up to Week 24|Other|4|||
42358138|NCT01855789|76203731|FG001|1) Baseline up to Week 24|Other|0|||
42358139|NCT01855789|76203732|FG002|1) Baseline up to Week 24|Other|0|||
42358140|NCT01855789|76203733|FG003|1) Baseline up to Week 24|Other|0|||
42178702|NCT03605667|75985929|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
42178703|NCT03605667|75985928|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
42178704|NCT03605667|75985929|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
42178705|NCT03605667|75985928|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
42178706|NCT03605667|75985929|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
42178707|NCT03605667|75985928|FG000|OLE Phase (48 Weeks)|Death|0|||
42178708|NCT03605667|75985929|FG001|OLE Phase (48 Weeks)|Death|2|||
42178709|NCT03605667|75985928|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
42178710|NCT03605667|75985929|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
42178711|NCT03600350|75985941|FG000|Overall Study|Death|1|||
42178712|NCT03600350|75985941|FG000|Overall Study|On Follow Up|18|||
42178713|NCT03382561|75985947|FG000|Overall Study|Disease progression|47|||
42178714|NCT03382561|75985948|FG001|Overall Study|Disease progression|6|||
42178715|NCT03382561|75985947|FG000|Overall Study|Adverse Event|10|||
42178716|NCT03382561|75985948|FG001|Overall Study|Adverse Event|2|||
42178717|NCT03382561|75985947|FG000|Overall Study|Death|8|||
42178718|NCT03382561|75985948|FG001|Overall Study|Death|3|||
42178719|NCT03382561|75985947|FG000|Overall Study|Withdrawal by Subject|6|||
42358141|NCT01855789|76203730|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
42358142|NCT01855789|76203731|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
42358143|NCT01855789|76203732|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
42358144|NCT01855789|76203733|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
42358145|NCT01855789|76203730|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
42358146|NCT01855789|76203731|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
42082624|NCT00445939|75893141|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
42082625|NCT00482053|75893161|FG000|Inter-treatment Period|Disease progression|1|||
42082626|NCT00455923|75893167|FG000|Overall Study|Pregnancy|0|||
42082627|NCT00455923|75893168|FG001|Overall Study|Pregnancy|2|||
42082628|NCT00455923|75893167|FG000|Overall Study|Other|3|||
42082629|NCT00455923|75893168|FG001|Overall Study|Other|1|||
42082630|NCT00642616|75893178|FG000|Overall Study|Adverse Event|2|||
42082631|NCT00642616|75893179|FG001|Overall Study|Adverse Event|0|||
42082632|NCT00642616|75893180|FG002|Overall Study|Adverse Event|1|||
42082633|NCT00642616|75893181|FG003|Overall Study|Adverse Event|0|||
42082634|NCT00642616|75893178|FG000|Overall Study|Study Terminated by Sponsor|7|||
42082635|NCT00642616|75893179|FG001|Overall Study|Study Terminated by Sponsor|6|||
42082636|NCT00642616|75893180|FG002|Overall Study|Study Terminated by Sponsor|4|||
42082637|NCT00642616|75893181|FG003|Overall Study|Study Terminated by Sponsor|5|||
42082638|NCT00642616|75893178|FG000|Overall Study|Withdrawal by Subject|0|||
42082639|NCT00642616|75893179|FG001|Overall Study|Withdrawal by Subject|1|||
42082640|NCT00642616|75893180|FG002|Overall Study|Withdrawal by Subject|1|||
42082641|NCT00642616|75893181|FG003|Overall Study|Withdrawal by Subject|1|||
42082642|NCT00642616|75893178|FG000|Overall Study|Protocol Violation|0|||
42082643|NCT00642616|75893179|FG001|Overall Study|Protocol Violation|0|||
42082644|NCT00642616|75893180|FG002|Overall Study|Protocol Violation|2|||
42082645|NCT00642616|75893181|FG003|Overall Study|Protocol Violation|0|||
42082646|NCT00642616|75893178|FG000|Overall Study|Physician Decision|0|||
42082647|NCT00642616|75893179|FG001|Overall Study|Physician Decision|0|||
42082648|NCT00642616|75893180|FG002|Overall Study|Physician Decision|1|||
42178720|NCT03382561|75985948|FG001|Overall Study|Withdrawal by Subject|5|||
42178721|NCT03382561|75985947|FG000|Overall Study|Alternative therapy|2|||
42358147|NCT01855789|76203732|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
42358148|NCT01855789|76203733|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
42358149|NCT01855789|76203730|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
42358150|NCT01855789|76203731|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
42358151|NCT01855789|76203732|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
42358152|NCT01855789|76203733|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
42358153|NCT01855789|76203730|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
42358154|NCT01855789|76203731|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
42358155|NCT01855789|76203732|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
42358156|NCT01855789|76203733|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
42358157|NCT01855789|76203730|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
42358158|NCT01855789|76203731|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
42358159|NCT01855789|76203732|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
42358160|NCT01855789|76203733|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
42358161|NCT01855789|76203730|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
42082649|NCT00642616|75893181|FG003|Overall Study|Physician Decision|1|||
42082650|NCT03844945|75893197|FG000|Overall Study|Adverse Event|1|||
42082651|NCT03844945|75893198|FG001|Overall Study|Adverse Event|1|||
42082652|NCT03844945|75893199|FG002|Overall Study|Adverse Event|4|||
42082653|NCT03844945|75893200|FG003|Overall Study|Adverse Event|0|||
42082654|NCT03844945|75893197|FG000|Overall Study|Withdrawal by Subject|0|||
42082655|NCT03844945|75893198|FG001|Overall Study|Withdrawal by Subject|0|||
42082656|NCT03844945|75893199|FG002|Overall Study|Withdrawal by Subject|1|||
42082657|NCT03844945|75893200|FG003|Overall Study|Withdrawal by Subject|0|||
42082658|NCT03844945|75893197|FG000|Overall Study|Lack of Efficacy|0|||
42082659|NCT03844945|75893198|FG001|Overall Study|Lack of Efficacy|0|||
42082660|NCT03844945|75893199|FG002|Overall Study|Lack of Efficacy|0|||
42082661|NCT03844945|75893200|FG003|Overall Study|Lack of Efficacy|1|||
42082662|NCT00445549|75893210|FG000|Overall Study|progressive disease|12|||
42082663|NCT00445003|75893217|FG000|Overall Study|Death|1|||
42082664|NCT00445003|75893218|FG001|Overall Study|Death|2|||
42082665|NCT00445003|75893219|FG002|Overall Study|Death|1|||
42082666|NCT00445003|75893217|FG000|Overall Study|Missed Visit|3|||
42082667|NCT00445003|75893218|FG001|Overall Study|Missed Visit|5|||
42082668|NCT00445003|75893219|FG002|Overall Study|Missed Visit|1|||
42082669|NCT00445003|75893217|FG000|Overall Study|Dropped|1|||
42082670|NCT00445003|75893218|FG001|Overall Study|Dropped|3|||
42082671|NCT00445003|75893219|FG002|Overall Study|Dropped|2|||
42082672|NCT00811070|75893233|FG000|Overall Study|Death|0|||
42082673|NCT00811070|75893234|FG001|Overall Study|Death|0|||
42082674|NCT00811070|75893235|FG002|Overall Study|Death|0|||
42082675|NCT00811070|75893236|FG003|Overall Study|Death|2|||
42082676|NCT00811070|75893237|FG004|Overall Study|Death|5|||
42082677|NCT00811070|75893238|FG005|Overall Study|Death|0|||
42082678|NCT00811070|75893233|FG000|Overall Study|Other|1|||
42082679|NCT00811070|75893234|FG001|Overall Study|Other|0|||
42082680|NCT00811070|75893235|FG002|Overall Study|Other|0|||
42082681|NCT00811070|75893236|FG003|Overall Study|Other|0|||
42082682|NCT00811070|75893237|FG004|Overall Study|Other|0|||
42082683|NCT00811070|75893238|FG005|Overall Study|Other|0|||
42082684|NCT00811070|75893233|FG000|Overall Study|Withdrawal by Subject|0|||
42082685|NCT00811070|75893234|FG001|Overall Study|Withdrawal by Subject|1|||
42082686|NCT00811070|75893235|FG002|Overall Study|Withdrawal by Subject|0|||
42082687|NCT00811070|75893236|FG003|Overall Study|Withdrawal by Subject|0|||
42082688|NCT00811070|75893237|FG004|Overall Study|Withdrawal by Subject|0|||
42082689|NCT00811070|75893238|FG005|Overall Study|Withdrawal by Subject|0|||
42082690|NCT00811070|75893233|FG000|Overall Study|Physician Decision|0|||
42178722|NCT03382561|75985948|FG001|Overall Study|Alternative therapy|8|||
42178723|NCT03382561|75985947|FG000|Overall Study|Never started treatment|3|||
42178724|NCT03382561|75985948|FG001|Overall Study|Never started treatment|6|||
42178725|NCT03382561|75985947|FG000|Overall Study|Lack of Efficacy|0|||
42178726|NCT03382561|75985948|FG001|Overall Study|Lack of Efficacy|1|||
42082691|NCT00811070|75893234|FG001|Overall Study|Physician Decision|0|||
42178727|NCT03382561|75985947|FG000|Overall Study|Physician Decision|0|||
42358162|NCT01855789|76203731|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
42358163|NCT01855789|76203732|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
42358164|NCT01855789|76203733|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
42082692|NCT00811070|75893235|FG002|Overall Study|Physician Decision|0|||
42358165|NCT01855789|76203730|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
42082693|NCT00811070|75893236|FG003|Overall Study|Physician Decision|0|||
42082694|NCT00811070|75893237|FG004|Overall Study|Physician Decision|0|||
42082695|NCT00811070|75893238|FG005|Overall Study|Physician Decision|1|||
42082696|NCT00642460|75893256|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
42082697|NCT00642460|75893257|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
42082698|NCT00642460|75893258|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
42082699|NCT00642460|75893259|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
42178728|NCT03382561|75985948|FG001|Overall Study|Physician Decision|1|||
42082700|NCT00642460|75893260|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
42082701|NCT00642460|75893261|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
42082702|NCT00642460|75893256|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
42082703|NCT00642460|75893257|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
42082704|NCT00642460|75893258|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
42082705|NCT00642460|75893259|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
42082706|NCT00642460|75893260|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
42082707|NCT00642460|75893261|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
42082708|NCT00642460|75893256|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
42082709|NCT00642460|75893257|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
42082710|NCT00642460|75893258|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
42082711|NCT00642460|75893259|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
42082712|NCT00642460|75893260|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
42082713|NCT00642460|75893261|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
42082714|NCT00642460|75893256|FG000|Part II: Open-Label Up to Week 92|Death|0|||
42082715|NCT00642460|75893257|FG001|Part II: Open-Label Up to Week 92|Death|1|||
42082716|NCT00642460|75893258|FG002|Part II: Open-Label Up to Week 92|Death|0|||
42082717|NCT00642460|75893259|FG003|Part II: Open-Label Up to Week 92|Death|2|||
42082718|NCT00642460|75893260|FG004|Part II: Open-Label Up to Week 92|Death|0|||
42082719|NCT00642460|75893261|FG005|Part II: Open-Label Up to Week 92|Death|0|||
42082720|NCT00642460|75893256|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
42082721|NCT00642460|75893257|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
42082722|NCT00642460|75893258|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
42082723|NCT00642460|75893259|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
42082724|NCT00642460|75893260|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
42082725|NCT00642460|75893261|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
42178729|NCT03382561|75985947|FG000|Overall Study|Other complicating disease|0|||
42178730|NCT03382561|75985948|FG001|Overall Study|Other complicating disease|1|||
42178731|NCT03201445|75985975|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
42178732|NCT03201445|75985976|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
42178733|NCT03201445|75985975|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
42178734|NCT03201445|75985976|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
42178735|NCT03201445|75985975|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
42178736|NCT03201445|75985976|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
42294126|NCT01672879|76128438|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
42358166|NCT01855789|76203731|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
42358167|NCT01855789|76203732|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
42358168|NCT01855789|76203733|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
42358169|NCT01855789|76203730|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
42358170|NCT01855789|76203731|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
42358171|NCT01855789|76203732|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
42358172|NCT01855789|76203733|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
42358173|NCT01855789|76203730|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
42358174|NCT01855789|76203731|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
42358175|NCT01855789|76203732|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
42358176|NCT01855789|76203733|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
42358177|NCT01855789|76203730|FG000|2) Week 24 up to End of Study|Other|0|||
42358178|NCT01855789|76203731|FG001|2) Week 24 up to End of Study|Other|0|||
42358179|NCT01855789|76203732|FG002|2) Week 24 up to End of Study|Other|0|||
42358180|NCT01855789|76203733|FG003|2) Week 24 up to End of Study|Other|1|||
42294127|NCT02601209|76128454|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
42294128|NCT02601209|76128455|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
42294129|NCT02601209|76128456|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
42294130|NCT02601209|76128457|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
42294131|NCT02601209|76128458|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
42294132|NCT02601209|76128459|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
42294133|NCT02601209|76128460|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
42082726|NCT00642460|75893256|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
42082727|NCT00642460|75893257|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
42082728|NCT00642460|75893258|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
42082729|NCT00642460|75893259|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
42082730|NCT00642460|75893260|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
42294134|NCT02601209|76128461|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
42082731|NCT00642460|75893261|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
42082732|NCT00642460|75893256|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
42082733|NCT00642460|75893257|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
42082734|NCT00642460|75893258|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
42082735|NCT00642460|75893259|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
42082736|NCT00642460|75893260|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
42082737|NCT00642460|75893261|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
42082738|NCT00642460|75893256|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
42082739|NCT00642460|75893257|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
42082740|NCT00642460|75893258|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
42082741|NCT00642460|75893259|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
42082742|NCT00642460|75893260|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
42082743|NCT00642460|75893261|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
42082744|NCT00642460|75893256|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
42082745|NCT00642460|75893257|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
42082746|NCT00642460|75893258|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
42082747|NCT00642460|75893259|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
42082748|NCT00642460|75893260|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
42082749|NCT00642460|75893261|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
42082750|NCT00642460|75893256|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
42082751|NCT00642460|75893257|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
42082752|NCT00642460|75893258|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
42082753|NCT00642460|75893259|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
42082754|NCT00642460|75893260|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
42082755|NCT00642460|75893261|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
42082756|NCT00642460|75893256|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
42082757|NCT00642460|75893257|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
42082758|NCT00642460|75893258|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
42082759|NCT00642460|75893259|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
42082760|NCT00642460|75893260|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
42082761|NCT00642460|75893261|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
42082762|NCT00642460|75893256|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
42082763|NCT00642460|75893257|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
42082764|NCT00642460|75893258|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
42082765|NCT00642460|75893259|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
42082766|NCT00642460|75893260|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
42082767|NCT00642460|75893261|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
42082768|NCT00642460|75893256|FG000|Part III: Open-Label Up to Week 260|Other|0|||
42082769|NCT00642460|75893257|FG001|Part III: Open-Label Up to Week 260|Other|0|||
42082770|NCT00642460|75893258|FG002|Part III: Open-Label Up to Week 260|Other|0|||
42082771|NCT00642460|75893259|FG003|Part III: Open-Label Up to Week 260|Other|0|||
42082772|NCT00642460|75893260|FG004|Part III: Open-Label Up to Week 260|Other|2|||
42082773|NCT00642460|75893261|FG005|Part III: Open-Label Up to Week 260|Other|2|||
42082774|NCT00642460|75893256|FG000|Part III: Open-Label Up to Week 260|Death|0|||
42082775|NCT00642460|75893257|FG001|Part III: Open-Label Up to Week 260|Death|0|||
42082776|NCT00642460|75893258|FG002|Part III: Open-Label Up to Week 260|Death|0|||
42082777|NCT00642460|75893259|FG003|Part III: Open-Label Up to Week 260|Death|0|||
42082778|NCT00642460|75893260|FG004|Part III: Open-Label Up to Week 260|Death|0|||
42082779|NCT00642460|75893261|FG005|Part III: Open-Label Up to Week 260|Death|3|||
42082780|NCT00642460|75893256|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
42082781|NCT00642460|75893257|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
42082782|NCT00642460|75893258|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
42082783|NCT00642460|75893259|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
42082784|NCT00642460|75893260|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
42082785|NCT00642460|75893261|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
42082786|NCT00642460|75893256|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
42082787|NCT00642460|75893257|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
42082788|NCT00642460|75893258|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
42082789|NCT00642460|75893259|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
42082790|NCT00642460|75893260|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
42082791|NCT00642460|75893261|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
42082792|NCT00814658|75893273|FG000|Overall Study|Lost to Follow-up|0|||
42082793|NCT00814658|75893274|FG001|Overall Study|Lost to Follow-up|1|||
42082794|NCT00814658|75893273|FG000|Overall Study|Physician Decision|1|||
42294135|NCT02601209|76128462|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
42294136|NCT02601209|76128454|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
42294137|NCT02601209|76128455|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
42294138|NCT02601209|76128456|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
42082795|NCT00814658|75893274|FG001|Overall Study|Physician Decision|0|||
42082796|NCT00814658|75893273|FG000|Overall Study|Adverse Event|3|||
42082797|NCT00814658|75893274|FG001|Overall Study|Adverse Event|3|||
42082798|NCT00642304|75893290|FG000|Overall Study|Adverse Event|1|||
42082799|NCT00642304|75893290|FG000|Overall Study|Death|1|||
42082800|NCT00642304|75893290|FG000|Overall Study|Blood transfusion|2|||
42082801|NCT00642304|75893290|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
42082802|NCT00642304|75893290|FG000|Overall Study|Transplantation|1|||
42082803|NCT00814580|75893296|FG000|Overall Study|Adverse Event|6|||
42082804|NCT00814580|75893297|FG001|Overall Study|Adverse Event|15|||
42082805|NCT00814580|75893296|FG000|Overall Study|Lack of Efficacy|18|||
42082806|NCT00814580|75893297|FG001|Overall Study|Lack of Efficacy|25|||
42082807|NCT00814580|75893296|FG000|Overall Study|Protocol Violation|2|||
42082808|NCT00814580|75893297|FG001|Overall Study|Protocol Violation|0|||
42082809|NCT00814580|75893296|FG000|Overall Study|Withdrawal by Subject|2|||
42082810|NCT00814580|75893297|FG001|Overall Study|Withdrawal by Subject|2|||
42082811|NCT00814580|75893296|FG000|Overall Study|Other|1|||
42082812|NCT00814580|75893297|FG001|Overall Study|Other|3|||
42082813|NCT00814580|75893296|FG000|Overall Study|Did Not Take Drug|2|||
42082814|NCT00814580|75893297|FG001|Overall Study|Did Not Take Drug|2|||
42082815|NCT00643162|75893317|FG000|Overall Study|Withdrawal by Subject|1|||
42082816|NCT00643162|75893318|FG001|Overall Study|Withdrawal by Subject|1|||
42082817|NCT00643006|75893326|FG000|Overall Study|Lost to Follow-up|5|||
42082818|NCT00643006|75893327|FG001|Overall Study|Lost to Follow-up|4|||
42082819|NCT00814502|75893337|FG000|Overall Study|Adverse Event|1|||
42082820|NCT00814502|75893338|FG001|Overall Study|Adverse Event|0|||
42082821|NCT00814502|75893337|FG000|Overall Study|Withdrawal by Subject|0|||
42082822|NCT00814502|75893338|FG001|Overall Study|Withdrawal by Subject|2|||
42082823|NCT00653224|75893348|FG000|Overall Study|Adverse Event|2|||
42082824|NCT00653224|75893349|FG001|Overall Study|Adverse Event|1|||
42082825|NCT00653224|75893348|FG000|Overall Study|Lack of Efficacy|1|||
42082826|NCT00653224|75893349|FG001|Overall Study|Lack of Efficacy|2|||
42358181|NCT01610791|76203739|FG000|Overall Study|Lost to Follow-up|7|||
42358182|NCT01610791|76203739|FG000|Overall Study|Adverse Event|6|||
42082827|NCT00653224|75893348|FG000|Overall Study|Loss of efficacy|1|||
42082828|NCT00653224|75893349|FG001|Overall Study|Loss of efficacy|0|||
42178737|NCT03201445|75985975|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
42178738|NCT03201445|75985976|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
42178739|NCT03201445|75985975|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
42178740|NCT03201445|75985976|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
42178741|NCT03201445|75985975|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
42178742|NCT03201445|75985976|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
42178743|NCT03201445|75985975|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
42178744|NCT03201445|75985976|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
42178745|NCT02839720|75986001|FG000|Overall Study|Adverse Event|2|||
42178746|NCT02839720|75986001|FG000|Overall Study|Non-compliance|2|||
42178747|NCT02839720|75986001|FG000|Overall Study|Intercurrent Illness|1|||
42178748|NCT02839720|75986001|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
42178749|NCT02642042|75986011|FG000|Overall Study|Adverse Event|22|||
42178750|NCT02642042|75986011|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
42178751|NCT02642042|75986011|FG000|Overall Study|Progression/Relapse|28|||
42178752|NCT02642042|75986011|FG000|Overall Study|Death|1|||
42178753|NCT02642042|75986011|FG000|Overall Study|Not Protocol Specified|2|||
42178754|NCT02608268|75986045|FG000|Overall Study|Adverse Event|0|||
42178755|NCT02608268|75986046|FG001|Overall Study|Adverse Event|0|||
42178756|NCT02608268|75986047|FG002|Overall Study|Adverse Event|1|||
42178757|NCT02608268|75986048|FG003|Overall Study|Adverse Event|0|||
42178758|NCT02608268|75986049|FG004|Overall Study|Adverse Event|0|||
42178759|NCT02608268|75986050|FG005|Overall Study|Adverse Event|0|||
42178760|NCT02608268|75986051|FG006|Overall Study|Adverse Event|0|||
42082829|NCT00653224|75893348|FG000|Overall Study|Lost to Follow-up|1|||
42082830|NCT00653224|75893349|FG001|Overall Study|Lost to Follow-up|0|||
42082831|NCT00653224|75893348|FG000|Overall Study|Other|2|||
42082832|NCT00653224|75893349|FG001|Overall Study|Other|4|||
42178761|NCT02608268|75986052|FG007|Overall Study|Adverse Event|0|||
42178762|NCT02608268|75986053|FG008|Overall Study|Adverse Event|0|||
42178763|NCT02608268|75986054|FG009|Overall Study|Adverse Event|0|||
42178764|NCT02608268|75986055|FG010|Overall Study|Adverse Event|0|||
42082833|NCT00444925|75893358|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
42082834|NCT00444925|75893359|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
42082835|NCT00444925|75893360|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
42082836|NCT00444925|75893358|FG000|Double-blind Treatment Period|Death|2|||
42082837|NCT00444925|75893359|FG001|Double-blind Treatment Period|Death|0|||
42178765|NCT02608268|75986056|FG011|Overall Study|Adverse Event|0|||
42178766|NCT02608268|75986057|FG012|Overall Study|Adverse Event|2|||
42082838|NCT00444925|75893360|FG002|Double-blind Treatment Period|Death|0|||
42082839|NCT00444925|75893358|FG000|Double-blind Treatment Period|Adverse Event|6|||
42358183|NCT01610791|76203739|FG000|Overall Study|Physician Decision|1|||
42082840|NCT00444925|75893359|FG001|Double-blind Treatment Period|Adverse Event|28|||
42082841|NCT00444925|75893360|FG002|Double-blind Treatment Period|Adverse Event|44|||
42082842|NCT00444925|75893358|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
42082843|NCT00444925|75893359|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
42082844|NCT00444925|75893360|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
42082845|NCT00444925|75893358|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
42082846|NCT00444925|75893359|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
42082847|NCT00444925|75893360|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
42082848|NCT00444925|75893358|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
42082849|NCT00444925|75893359|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
42082850|NCT00444925|75893360|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
42082851|NCT00444925|75893358|FG000|Double-blind Treatment Period|Other|7|||
42082852|NCT00444925|75893359|FG001|Double-blind Treatment Period|Other|7|||
42082853|NCT00444925|75893360|FG002|Double-blind Treatment Period|Other|12|||
42082854|NCT00641056|75893370|FG000|Overall Study|Adverse Event|12|||
42082855|NCT00641056|75893371|FG001|Overall Study|Adverse Event|2|||
42082856|NCT00641056|75893370|FG000|Overall Study|Lost to Follow-up|2|||
42082857|NCT00641056|75893371|FG001|Overall Study|Lost to Follow-up|1|||
42082858|NCT00641056|75893370|FG000|Overall Study|Physician Decision|3|||
42082859|NCT00641056|75893371|FG001|Overall Study|Physician Decision|1|||
42082860|NCT00641056|75893370|FG000|Overall Study|Protocol Violation|2|||
42082861|NCT00641056|75893371|FG001|Overall Study|Protocol Violation|0|||
42082862|NCT00641056|75893370|FG000|Overall Study|Entry Criteria Not Met|3|||
42082863|NCT00641056|75893371|FG001|Overall Study|Entry Criteria Not Met|0|||
42082864|NCT00641056|75893370|FG000|Overall Study|Subject Decision|6|||
42082865|NCT00641056|75893371|FG001|Overall Study|Subject Decision|19|||
42082866|NCT00641056|75893370|FG000|Overall Study|Sponsor Decision|1|||
42082867|NCT00641056|75893371|FG001|Overall Study|Sponsor Decision|2|||
42082868|NCT00814346|75893383|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
42082869|NCT00814346|75893384|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
42082870|NCT00814346|75893383|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
42082871|NCT00814346|75893384|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
42082872|NCT00814346|75893383|FG000|Open Phase (17 Months)|Adverse Event|5|||
42082873|NCT00814346|75893384|FG001|Open Phase (17 Months)|Adverse Event|0|||
42082874|NCT00814346|75893383|FG000|Open Phase (17 Months)|Consent|2|||
42082875|NCT00814346|75893384|FG001|Open Phase (17 Months)|Consent|0|||
42082876|NCT00814346|75893383|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
42082877|NCT00814346|75893384|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
42082878|NCT00814346|75893383|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
42082879|NCT00814346|75893384|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
42082880|NCT00569374|75893403|FG000|Overall Study|Withdrawal by Subject|4|||
42082881|NCT00828464|75893407|FG000|Overall Study|Withdrawal by Subject|1|||
42082882|NCT00810602|75893411|FG000|Overall Study|Withdrawal by Subject|8|||
42082883|NCT00810602|75893412|FG001|Overall Study|Withdrawal by Subject|3|||
42082884|NCT00791700|75893420|FG000|Overall Study|Insufficient clinical response|1|||
42082885|NCT00791700|75893421|FG001|Overall Study|Insufficient clinical response|4|||
42082886|NCT00791700|75893422|FG002|Overall Study|Insufficient clinical response|1|||
42082887|NCT00791700|75893423|FG003|Overall Study|Insufficient clinical response|8|||
42178767|NCT02608268|75986058|FG013|Overall Study|Adverse Event|0|||
42178768|NCT02608268|75986059|FG014|Overall Study|Adverse Event|0|||
42178769|NCT02608268|75986060|FG015|Overall Study|Adverse Event|0|||
42178770|NCT02608268|75986061|FG016|Overall Study|Adverse Event|0|||
42294139|NCT02601209|76128457|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
42294140|NCT02601209|76128458|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
42294141|NCT02601209|76128459|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
42294142|NCT02601209|76128460|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
42294143|NCT02601209|76128461|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
42294144|NCT02601209|76128462|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
42082888|NCT00791700|75893420|FG000|Overall Study|No longer willing to participate|1|||
42082889|NCT00791700|75893421|FG001|Overall Study|No longer willing to participate|1|||
42082890|NCT00791700|75893422|FG002|Overall Study|No longer willing to participate|0|||
42082891|NCT00791700|75893423|FG003|Overall Study|No longer willing to participate|8|||
42082892|NCT00791700|75893420|FG000|Overall Study|Non-compliance with study treatment|0|||
42082893|NCT00791700|75893421|FG001|Overall Study|Non-compliance with study treatment|2|||
42082894|NCT00791700|75893422|FG002|Overall Study|Non-compliance with study treatment|0|||
42082895|NCT00791700|75893423|FG003|Overall Study|Non-compliance with study treatment|4|||
42082896|NCT00791700|75893420|FG000|Overall Study|Withdrawn due to pregnancy|0|||
42082897|NCT00791700|75893421|FG001|Overall Study|Withdrawn due to pregnancy|0|||
42082898|NCT00791700|75893422|FG002|Overall Study|Withdrawn due to pregnancy|0|||
42178771|NCT02608268|75986062|FG017|Overall Study|Adverse Event|0|||
42082899|NCT00791700|75893423|FG003|Overall Study|Withdrawn due to pregnancy|1|||
42082900|NCT00791700|75893420|FG000|Overall Study|Other|0|||
42082901|NCT00791700|75893421|FG001|Overall Study|Other|1|||
42082902|NCT00791700|75893422|FG002|Overall Study|Other|0|||
42082903|NCT00791700|75893423|FG003|Overall Study|Other|1|||
42082904|NCT00791700|75893420|FG000|Overall Study|Death|0|||
42082905|NCT00791700|75893421|FG001|Overall Study|Death|0|||
42082906|NCT00791700|75893422|FG002|Overall Study|Death|0|||
42082907|NCT00791700|75893423|FG003|Overall Study|Death|1|||
42082908|NCT00791700|75893420|FG000|Overall Study|Lost to Follow-up|4|||
42082909|NCT00791700|75893421|FG001|Overall Study|Lost to Follow-up|3|||
42082910|NCT00791700|75893422|FG002|Overall Study|Lost to Follow-up|4|||
42082911|NCT00791700|75893423|FG003|Overall Study|Lost to Follow-up|6|||
42082912|NCT00791700|75893420|FG000|Overall Study|Adverse Event|0|||
42082913|NCT00791700|75893421|FG001|Overall Study|Adverse Event|0|||
42082914|NCT00791700|75893422|FG002|Overall Study|Adverse Event|1|||
42082915|NCT00791700|75893423|FG003|Overall Study|Adverse Event|1|||
42082916|NCT00810368|75893446|FG000|Overall Study|Lost to Follow-up|4|||
42082917|NCT00810368|75893447|FG001|Overall Study|Lost to Follow-up|2|||
42082918|NCT00810368|75893446|FG000|Overall Study|Lack of Efficacy|2|||
42082919|NCT00810368|75893447|FG001|Overall Study|Lack of Efficacy|0|||
42082920|NCT00628108|75893457|FG000|Overall Study|Adverse Event|0|||
42082921|NCT00628108|75893458|FG001|Overall Study|Adverse Event|3|||
42082922|NCT00628108|75893457|FG000|Overall Study|Withdrawal by Subject|1|||
42082923|NCT00628108|75893458|FG001|Overall Study|Withdrawal by Subject|0|||
42082924|NCT00628030|75893466|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
42082925|NCT00628030|75893467|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
42082926|NCT00628030|75893466|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
42082927|NCT00628030|75893467|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
42082928|NCT00628030|75893466|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
42178772|NCT02608268|75986063|FG018|Overall Study|Adverse Event|0|||
42178773|NCT02608268|75986064|FG019|Overall Study|Adverse Event|0|||
42178774|NCT02608268|75986065|FG020|Overall Study|Adverse Event|1|||
42178775|NCT02608268|75986066|FG021|Overall Study|Adverse Event|1|||
42178776|NCT02608268|75986067|FG022|Overall Study|Adverse Event|0|||
42178777|NCT02608268|75986068|FG023|Overall Study|Adverse Event|0|||
42178778|NCT02608268|75986069|FG024|Overall Study|Adverse Event|1|||
42178779|NCT02608268|75986070|FG025|Overall Study|Adverse Event|0|||
42178780|NCT02608268|75986071|FG026|Overall Study|Adverse Event|0|||
42178781|NCT02608268|75986072|FG027|Overall Study|Adverse Event|0|||
42178782|NCT02608268|75986073|FG028|Overall Study|Adverse Event|1|||
42178783|NCT02608268|75986074|FG029|Overall Study|Adverse Event|0|||
42178784|NCT02608268|75986045|FG000|Overall Study|Death|1|||
42178785|NCT02608268|75986046|FG001|Overall Study|Death|0|||
42178786|NCT02608268|75986047|FG002|Overall Study|Death|0|||
42178787|NCT02608268|75986048|FG003|Overall Study|Death|0|||
42294145|NCT01659021|76128478|FG000|Main Study|Adverse Event|2|||
42294146|NCT01659021|76128479|FG001|Main Study|Adverse Event|3|||
42294147|NCT01659021|76128478|FG000|Main Study|Lost to Follow-up|1|||
42294148|NCT01659021|76128479|FG001|Main Study|Lost to Follow-up|0|||
42294149|NCT01659021|76128478|FG000|Main Study|Unknown Reasons|2|||
42294150|NCT01659021|76128479|FG001|Main Study|Unknown Reasons|1|||
42082929|NCT00628030|75893467|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
42082930|NCT00591578|75893476|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
42082931|NCT00591578|75893477|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
42082932|NCT00591578|75893478|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
42082933|NCT00591578|75893476|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
42082934|NCT00591578|75893477|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
42082935|NCT00591578|75893478|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
42082936|NCT00591578|75893476|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
42082937|NCT00591578|75893477|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
42178788|NCT02608268|75986049|FG004|Overall Study|Death|0|||
42294151|NCT01659021|76128478|FG000|Main Study|Physician Decision|34|||
42294152|NCT01659021|76128479|FG001|Main Study|Physician Decision|16|||
42294153|NCT01659021|76128478|FG000|Main Study|Withdrawal by Subject|19|||
42082938|NCT00591578|75893478|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
42082939|NCT00591578|75893476|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
42082940|NCT00591578|75893477|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
42082941|NCT00591578|75893478|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
42082942|NCT00591578|75893476|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
42082943|NCT00591578|75893477|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
42082944|NCT00591578|75893478|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
42082945|NCT00591578|75893476|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
42178789|NCT02608268|75986050|FG005|Overall Study|Death|0|||
42178790|NCT02608268|75986051|FG006|Overall Study|Death|0|||
42178791|NCT02608268|75986052|FG007|Overall Study|Death|0|||
42178792|NCT02608268|75986053|FG008|Overall Study|Death|1|||
42294154|NCT01659021|76128479|FG001|Main Study|Withdrawal by Subject|16|||
42294155|NCT01659021|76128478|FG000|Main Study|Study Terminated by Sponsor|16|||
42082946|NCT00591578|75893477|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
42082947|NCT00591578|75893478|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
42082948|NCT00591578|75893476|FG000|Double-Blind Treatment Phase|Other|4|||
42082949|NCT00591578|75893477|FG001|Double-Blind Treatment Phase|Other|9|||
42082950|NCT00591578|75893478|FG002|Double-Blind Treatment Phase|Other|4|||
42082951|NCT00591578|75893476|FG000|Open-Label Extension Phase|Adverse Event|3|||
42082952|NCT00591578|75893477|FG001|Open-Label Extension Phase|Adverse Event|5|||
42082953|NCT00591578|75893478|FG002|Open-Label Extension Phase|Adverse Event|0|||
42082954|NCT00591578|75893476|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
42082955|NCT00591578|75893477|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
42082956|NCT00591578|75893478|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
42082957|NCT00591578|75893476|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
42082958|NCT00591578|75893477|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
42082959|NCT00591578|75893478|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
42082960|NCT00591578|75893476|FG000|Open-Label Extension Phase|Other|1|||
42082961|NCT00591578|75893477|FG001|Open-Label Extension Phase|Other|0|||
42082962|NCT00591578|75893478|FG002|Open-Label Extension Phase|Other|0|||
42082963|NCT00797862|75893490|FG000|Overall Study|Adverse Event|86|||
42082964|NCT00797862|75893491|FG001|Overall Study|Adverse Event|44|||
42082965|NCT00797862|75893492|FG002|Overall Study|Adverse Event|58|||
42082966|NCT00797862|75893490|FG000|Overall Study|Abnormal Test Procedure Result|0|||
42082967|NCT00797862|75893491|FG001|Overall Study|Abnormal Test Procedure Result|1|||
42082968|NCT00797862|75893492|FG002|Overall Study|Abnormal Test Procedure Result|1|||
42082969|NCT00797862|75893490|FG000|Overall Study|Lack of Efficacy|1|||
42082970|NCT00797862|75893491|FG001|Overall Study|Lack of Efficacy|7|||
42082971|NCT00797862|75893492|FG002|Overall Study|Lack of Efficacy|6|||
42082972|NCT00797862|75893490|FG000|Overall Study|No longer required study medication|1|||
42082973|NCT00797862|75893491|FG001|Overall Study|No longer required study medication|0|||
42082974|NCT00797862|75893492|FG002|Overall Study|No longer required study medication|0|||
42082975|NCT00797862|75893490|FG000|Overall Study|Withdrawal by Subject|14|||
42082976|NCT00797862|75893491|FG001|Overall Study|Withdrawal by Subject|7|||
42082977|NCT00797862|75893492|FG002|Overall Study|Withdrawal by Subject|7|||
42082978|NCT00797862|75893490|FG000|Overall Study|Lost to Follow-up|11|||
42082979|NCT00797862|75893491|FG001|Overall Study|Lost to Follow-up|0|||
42082980|NCT00797862|75893492|FG002|Overall Study|Lost to Follow-up|5|||
42082981|NCT00797862|75893490|FG000|Overall Study|Administrative Problem|4|||
42082982|NCT00797862|75893491|FG001|Overall Study|Administrative Problem|0|||
42082983|NCT00797862|75893492|FG002|Overall Study|Administrative Problem|0|||
42082984|NCT00797862|75893490|FG000|Overall Study|Protocol Violation|4|||
42082985|NCT00797862|75893491|FG001|Overall Study|Protocol Violation|6|||
42082986|NCT00797862|75893492|FG002|Overall Study|Protocol Violation|8|||
42082987|NCT00797862|75893490|FG000|Overall Study|Mis-randomized|3|||
42082988|NCT00797862|75893491|FG001|Overall Study|Mis-randomized|3|||
42082989|NCT00797862|75893492|FG002|Overall Study|Mis-randomized|1|||
42082990|NCT00794820|75893500|FG000|Overall Study|Adverse Event|11|||
42082991|NCT00794820|75893500|FG000|Overall Study|Secondary Malignancies|2|||
42082992|NCT00794820|75893500|FG000|Overall Study|Resistant Disease|2|||
42082993|NCT00794820|75893500|FG000|Overall Study|Ineligible/Screen Failure|1|||
42082994|NCT00455533|75893506|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
42082995|NCT00455533|75893507|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
42082996|NCT00455533|75893508|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
42082997|NCT00455533|75893506|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
42082998|NCT00455533|75893507|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
42082999|NCT00455533|75893508|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
42083000|NCT00455533|75893506|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
42083001|NCT00455533|75893507|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
42083002|NCT00455533|75893508|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
42083003|NCT00455533|75893506|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
42083004|NCT00455533|75893507|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
42083005|NCT00455533|75893508|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
42083006|NCT00455533|75893506|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
42083007|NCT00455533|75893507|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
42083008|NCT00455533|75893508|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
42083009|NCT00455533|75893506|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
42083010|NCT00455533|75893507|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
42083011|NCT00455533|75893508|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
42083012|NCT00455533|75893506|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
42083013|NCT00455533|75893507|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
42083014|NCT00455533|75893508|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
42083015|NCT00455533|75893506|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
42083016|NCT00455533|75893507|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
42083017|NCT00455533|75893508|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
42083018|NCT00455533|75893506|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
42083019|NCT00455533|75893507|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
42083020|NCT00455533|75893508|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
42083021|NCT00455533|75893506|FG000|Period Two: Randomized Period|Death|0|||
42083022|NCT00455533|75893507|FG001|Period Two: Randomized Period|Death|0|||
42083023|NCT00455533|75893508|FG002|Period Two: Randomized Period|Death|3|||
42083024|NCT00455533|75893506|FG000|Period Two: Randomized Period|Disease Progression|0|||
42083025|NCT00455533|75893507|FG001|Period Two: Randomized Period|Disease Progression|1|||
42083026|NCT00455533|75893508|FG002|Period Two: Randomized Period|Disease Progression|1|||
42083027|NCT00455533|75893506|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
42083028|NCT00455533|75893507|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
42083029|NCT00455533|75893508|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
42083030|NCT00455533|75893506|FG000|Period Two: Randomized Period|Other - need reasons|0|||
42083031|NCT00455533|75893507|FG001|Period Two: Randomized Period|Other - need reasons|1|||
42083032|NCT00455533|75893508|FG002|Period Two: Randomized Period|Other - need reasons|0|||
42083033|NCT00455533|75893506|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
42083034|NCT00455533|75893507|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
42083035|NCT00455533|75893508|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
42083036|NCT00455533|75893506|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
42083037|NCT00455533|75893507|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
42083038|NCT00455533|75893508|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
42083039|NCT00627094|75893518|FG000|Overall Study|Adverse Event|8|||
42083040|NCT00627094|75893519|FG001|Overall Study|Adverse Event|7|||
42083041|NCT00627094|75893518|FG000|Overall Study|Lost to Follow-up|1|||
42083042|NCT00627094|75893519|FG001|Overall Study|Lost to Follow-up|0|||
42083043|NCT00627094|75893518|FG000|Overall Study|Withdrawal by Subject|1|||
42083044|NCT00627094|75893519|FG001|Overall Study|Withdrawal by Subject|1|||
42358184|NCT01610791|76203739|FG000|Overall Study|Adverse event and Investigator decision|1|||
42358185|NCT01610791|76203739|FG000|Overall Study|Death|1|||
42358186|NCT01610791|76203739|FG000|Overall Study|Not determined|5|||
42358187|NCT01876381|76203743|FG000|Overall Study|Lack of Efficacy|5|||
42358188|NCT01876381|76203743|FG000|Overall Study|Physician Decision|1|||
42358189|NCT01876381|76203743|FG000|Overall Study|Withdrawal by Subject|1|||
42358190|NCT01855399|76203758|FG000|6 Month|Lost to Follow-up|12|||
42358191|NCT01855399|76203759|FG001|6 Month|Lost to Follow-up|9|||
42358192|NCT01855399|76203758|FG000|6 Month|Withdrawal by Subject|8|||
42358193|NCT01855399|76203759|FG001|6 Month|Withdrawal by Subject|6|||
42358194|NCT01855399|76203758|FG000|12 Month|Lost to Follow-up|7|||
42358195|NCT01855399|76203759|FG001|12 Month|Lost to Follow-up|11|||
42358196|NCT01875991|76203767|FG000|Overall Study|Withdrawal by Subject|6|||
42358197|NCT01875991|76203768|FG001|Overall Study|Withdrawal by Subject|6|||
42083045|NCT00627094|75893518|FG000|Overall Study|ulcer healed|1|||
42083046|NCT00627094|75893519|FG001|Overall Study|ulcer healed|7|||
42083047|NCT00627094|75893518|FG000|Overall Study|Other reason|1|||
42294156|NCT01659021|76128479|FG001|Main Study|Study Terminated by Sponsor|1|||
42294157|NCT01659021|76128478|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
42083048|NCT00627094|75893519|FG001|Overall Study|Other reason|0|||
42083049|NCT00642850|75893527|FG000|Overall Study|Death|7|||
42083050|NCT00642850|75893527|FG000|Overall Study|Adverse Event|2|||
42083051|NCT00642850|75893527|FG000|Overall Study|Lack of Efficacy|1|||
42083052|NCT00642850|75893527|FG000|Overall Study|Protocol Violation|2|||
42083053|NCT00642850|75893527|FG000|Overall Study|Kidney transplantation|8|||
42083054|NCT00642850|75893527|FG000|Overall Study|Blood transfusion|6|||
42083055|NCT00642850|75893527|FG000|Overall Study|Other reasons|7|||
42083056|NCT00455455|75893531|FG000|Washout|Withdrawal by Subject|0|||
42083057|NCT00455455|75893532|FG001|Washout|Withdrawal by Subject|1|||
42083058|NCT00455455|75893531|FG000|Washout|Withdrawal by Subject|1|||
42083059|NCT00455455|75893532|FG001|Washout|Withdrawal by Subject|0|||
42083060|NCT03840811|75893544|FG000|Overall Study|Lost to Follow-up|0|||
42083061|NCT03840811|75893545|FG001|Overall Study|Lost to Follow-up|0|||
42083062|NCT03840811|75893546|FG002|Overall Study|Lost to Follow-up|1|||
42083063|NCT00640510|75893556|FG000|Overall Study|Lack of Efficacy|0|||
42294158|NCT01659021|76128479|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
42294159|NCT01659021|76128478|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
42294160|NCT01659021|76128479|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
42294161|NCT04654468|76128519|FG000|Overall Study|Death|1|||
42294162|NCT04654468|76128519|FG000|Overall Study|Ongoing in the Study|50|||
42294163|NCT04478266|76128525|FG000|Overall Study|Adverse Event|20|||
42083064|NCT00640510|75893557|FG001|Overall Study|Lack of Efficacy|1|||
42083065|NCT00640510|75893556|FG000|Overall Study|Protocol Violation|1|||
42294164|NCT04478266|76128526|FG001|Overall Study|Adverse Event|21|||
42358198|NCT01875991|76203767|FG000|Overall Study|Sponsor Decision|1|||
42358199|NCT01875991|76203768|FG001|Overall Study|Sponsor Decision|0|||
42358200|NCT01855243|76203780|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
42358201|NCT01855243|76203781|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
42083066|NCT00640510|75893557|FG001|Overall Study|Protocol Violation|0|||
42083067|NCT00640510|75893556|FG000|Overall Study|Physician Decision|0|||
42083068|NCT00640510|75893557|FG001|Overall Study|Physician Decision|1|||
42083069|NCT00813800|75893563|FG000|Overall Study|Screen Failure after Consent|2|||
42083070|NCT00813800|75893563|FG000|Overall Study|Adverse Event|1|||
42083071|NCT00813800|75893563|FG000|Overall Study|Worsening of depression|2|||
42083072|NCT00813800|75893563|FG000|Overall Study|Physician Decision|1|||
42083073|NCT00627016|75893569|FG000|Overall Study|Adverse Event|1|||
42083074|NCT00627016|75893570|FG001|Overall Study|Adverse Event|1|||
42083075|NCT00627016|75893569|FG000|Overall Study|Protocol Violation|0|||
42083076|NCT00627016|75893570|FG001|Overall Study|Protocol Violation|2|||
42083077|NCT00627016|75893569|FG000|Overall Study|Lost to Follow-up|0|||
42083078|NCT00627016|75893570|FG001|Overall Study|Lost to Follow-up|1|||
42083079|NCT00627016|75893569|FG000|Overall Study|Withdrawal by Subject|2|||
42083080|NCT00627016|75893570|FG001|Overall Study|Withdrawal by Subject|1|||
42083081|NCT00627016|75893569|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
42083082|NCT00627016|75893570|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
42083083|NCT00627016|75893569|FG000|Overall Study|Lack of Efficacy|1|||
42083084|NCT00627016|75893570|FG001|Overall Study|Lack of Efficacy|0|||
42083085|NCT00627016|75893569|FG000|Overall Study|Placed on Excluded Drugs|1|||
42083086|NCT00627016|75893570|FG001|Overall Study|Placed on Excluded Drugs|0|||
42083087|NCT00627016|75893569|FG000|Overall Study|Pregnancy|1|||
42083088|NCT00627016|75893570|FG001|Overall Study|Pregnancy|0|||
42083089|NCT00794664|75893578|FG000|Treatment Period|Withdrawal by Subject|0|||
42083090|NCT00794664|75893579|FG001|Treatment Period|Withdrawal by Subject|2|||
42083091|NCT00794664|75893578|FG000|Treatment Period|Protocol non-compliance|0|||
42083092|NCT00794664|75893579|FG001|Treatment Period|Protocol non-compliance|1|||
42083093|NCT00794664|75893578|FG000|Treatment Period|Other|0|||
42083094|NCT00794664|75893579|FG001|Treatment Period|Other|1|||
42083095|NCT00794664|75893578|FG000|Treatment Period|Adverse Event|1|||
42083096|NCT00794664|75893579|FG001|Treatment Period|Adverse Event|8|||
42083097|NCT00794664|75893578|FG000|Follow-up Period|Other|1|||
42083098|NCT00794664|75893579|FG001|Follow-up Period|Other|2|||
42178793|NCT02608268|75986054|FG009|Overall Study|Death|1|||
42294165|NCT04478266|76128525|FG000|Overall Study|Progressive disease|146|||
42294166|NCT04478266|76128526|FG001|Overall Study|Progressive disease|168|||
42358202|NCT01855243|76203782|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
42358203|NCT01825837|76203794|FG000|PART I|Withdrawal by Subject|0|||
42294167|NCT04478266|76128525|FG000|Overall Study|Poor compliance to protocol|1|||
42294168|NCT04478266|76128526|FG001|Overall Study|Poor compliance to protocol|0|||
42294169|NCT04478266|76128525|FG000|Overall Study|Withdrawal by Subject|19|||
42294170|NCT04478266|76128526|FG001|Overall Study|Withdrawal by Subject|16|||
42294171|NCT04478266|76128525|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
42294172|NCT04478266|76128526|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
42358204|NCT01825837|76203795|FG001|PART I|Withdrawal by Subject|0|||
42358205|NCT01825837|76203796|FG002|PART I|Withdrawal by Subject|0|||
42358206|NCT01825837|76203797|FG003|PART I|Withdrawal by Subject|6|||
42358207|NCT01825837|76203794|FG000|PART I|Patient non-compliance|0|||
42358208|NCT01825837|76203795|FG001|PART I|Patient non-compliance|0|||
42358209|NCT01825837|76203796|FG002|PART I|Patient non-compliance|0|||
42358210|NCT01825837|76203797|FG003|PART I|Patient non-compliance|1|||
42358211|NCT01825837|76203794|FG000|PART I|Treatment failure|0|||
42358212|NCT01825837|76203795|FG001|PART I|Treatment failure|0|||
42358213|NCT01825837|76203796|FG002|PART I|Treatment failure|0|||
42358214|NCT01825837|76203797|FG003|PART I|Treatment failure|7|||
42358215|NCT01825837|76203794|FG000|PART I|reason unspecified|0|||
42358216|NCT01825837|76203795|FG001|PART I|reason unspecified|0|||
42358217|NCT01825837|76203796|FG002|PART I|reason unspecified|0|||
42358218|NCT01825837|76203797|FG003|PART I|reason unspecified|3|||
42083099|NCT00794664|75893578|FG000|Follow-up Period|Withdrawal by Subject|0|||
42083100|NCT00794664|75893579|FG001|Follow-up Period|Withdrawal by Subject|2|||
42083101|NCT00794664|75893578|FG000|Follow-up Period|Protocol non-compliance|0|||
42083102|NCT00794664|75893579|FG001|Follow-up Period|Protocol non-compliance|1|||
42358219|NCT01825837|76203794|FG000|PART II|Withdrawal by Subject|3|||
42083103|NCT00444535|75893585|FG000|Overall Study|Withdrawal by Subject|5|||
42083104|NCT00444535|75893585|FG000|Overall Study|Physician Decision|5|||
42083105|NCT00444535|75893585|FG000|Overall Study|progressive disease|1|||
42358220|NCT01825837|76203795|FG001|PART II|Withdrawal by Subject|3|||
42358221|NCT01825837|76203796|FG002|PART II|Withdrawal by Subject|7|||
42358222|NCT01825837|76203797|FG003|PART II|Withdrawal by Subject|0|||
42358223|NCT01825837|76203794|FG000|PART II|Patient non-compliance|5|||
42358224|NCT01825837|76203795|FG001|PART II|Patient non-compliance|2|||
42358225|NCT01825837|76203796|FG002|PART II|Patient non-compliance|4|||
42358226|NCT01825837|76203797|FG003|PART II|Patient non-compliance|0|||
42083106|NCT00444535|75893585|FG000|Overall Study|Adverse Event|2|||
42083107|NCT00847613|75893593|FG000|Overall Study|Ongoing at cut-off date|250|||
42083108|NCT00847613|75893594|FG001|Overall Study|Ongoing at cut-off date|265|||
42083109|NCT00847613|75893595|FG002|Overall Study|Ongoing at cut-off date|64|||
42083110|NCT00847613|75893596|FG003|Overall Study|Ongoing at cut-off date|64|||
42083111|NCT00847613|75893593|FG000|Overall Study|Death|1|||
42083112|NCT00847613|75893594|FG001|Overall Study|Death|1|||
42083113|NCT00847613|75893595|FG002|Overall Study|Death|0|||
42083114|NCT00847613|75893596|FG003|Overall Study|Death|0|||
42083115|NCT00847613|75893593|FG000|Overall Study|Adverse Event|36|||
42083116|NCT00847613|75893594|FG001|Overall Study|Adverse Event|26|||
42083117|NCT00847613|75893595|FG002|Overall Study|Adverse Event|5|||
42083118|NCT00847613|75893596|FG003|Overall Study|Adverse Event|6|||
42083119|NCT00847613|75893593|FG000|Overall Study|Lack of Efficacy|7|||
42083120|NCT00847613|75893594|FG001|Overall Study|Lack of Efficacy|3|||
42178794|NCT02608268|75986055|FG010|Overall Study|Death|0|||
42358227|NCT01825837|76203794|FG000|PART II|Adverse Event|3|||
42358228|NCT01825837|76203795|FG001|PART II|Adverse Event|3|||
42358229|NCT01825837|76203796|FG002|PART II|Adverse Event|1|||
42358230|NCT01825837|76203797|FG003|PART II|Adverse Event|0|||
42358231|NCT01825837|76203794|FG000|PART II|Treatment failure|6|||
42358232|NCT01825837|76203795|FG001|PART II|Treatment failure|4|||
42358233|NCT01825837|76203796|FG002|PART II|Treatment failure|5|||
42358234|NCT01825837|76203797|FG003|PART II|Treatment failure|0|||
42358235|NCT01825837|76203794|FG000|PART II|reason unspecified|2|||
42358236|NCT01825837|76203795|FG001|PART II|reason unspecified|2|||
42358237|NCT01825837|76203796|FG002|PART II|reason unspecified|2|||
42358238|NCT01825837|76203797|FG003|PART II|reason unspecified|0|||
42358239|NCT01854697|76203810|FG000|Overall Study|Adverse Event|1|||
42358240|NCT01854697|76203811|FG001|Overall Study|Adverse Event|0|||
42358241|NCT01854697|76203812|FG002|Overall Study|Adverse Event|0|||
42358242|NCT01854697|76203813|FG003|Overall Study|Adverse Event|0|||
42358243|NCT01854697|76203814|FG004|Overall Study|Adverse Event|1|||
42358244|NCT01854697|76203810|FG000|Overall Study|Lost to Follow-up|4|||
42358245|NCT01854697|76203811|FG001|Overall Study|Lost to Follow-up|1|||
42358246|NCT01854697|76203812|FG002|Overall Study|Lost to Follow-up|1|||
42358247|NCT01854697|76203813|FG003|Overall Study|Lost to Follow-up|2|||
42358248|NCT01854697|76203814|FG004|Overall Study|Lost to Follow-up|0|||
42358249|NCT01854697|76203810|FG000|Overall Study|To enter another AbbVie study|1|||
42358250|NCT01854697|76203811|FG001|Overall Study|To enter another AbbVie study|0|||
42358251|NCT01854697|76203812|FG002|Overall Study|To enter another AbbVie study|0|||
42358252|NCT01854697|76203813|FG003|Overall Study|To enter another AbbVie study|0|||
42358253|NCT01854697|76203814|FG004|Overall Study|To enter another AbbVie study|1|||
42358254|NCT01854697|76203810|FG000|Overall Study|Withdrew Consent|0|||
42358255|NCT01854697|76203811|FG001|Overall Study|Withdrew Consent|1|||
42358256|NCT01854697|76203812|FG002|Overall Study|Withdrew Consent|0|||
42358257|NCT01854697|76203813|FG003|Overall Study|Withdrew Consent|1|||
42358258|NCT01854697|76203814|FG004|Overall Study|Withdrew Consent|0|||
42358259|NCT01854697|76203810|FG000|Overall Study|Other|0|||
42358260|NCT01854697|76203811|FG001|Overall Study|Other|1|||
42358261|NCT01854697|76203812|FG002|Overall Study|Other|1|||
42358262|NCT01854697|76203813|FG003|Overall Study|Other|0|||
42358263|NCT01854697|76203814|FG004|Overall Study|Other|0|||
42358264|NCT01824979|76203826|FG000|Overall Study|Withdrawal by Subject|5|||
42358265|NCT01824979|76203827|FG001|Overall Study|Withdrawal by Subject|0|||
42358266|NCT01824979|76203826|FG000|Overall Study|Physician Decision|2|||
42083121|NCT00847613|75893595|FG002|Overall Study|Lack of Efficacy|3|||
42083122|NCT00847613|75893596|FG003|Overall Study|Lack of Efficacy|1|||
42083123|NCT00847613|75893593|FG000|Overall Study|Study terminated by Sponsor|1|||
42083124|NCT00847613|75893594|FG001|Overall Study|Study terminated by Sponsor|0|||
42083125|NCT00847613|75893595|FG002|Overall Study|Study terminated by Sponsor|2|||
42083126|NCT00847613|75893596|FG003|Overall Study|Study terminated by Sponsor|1|||
42083127|NCT00847613|75893593|FG000|Overall Study|Lost to Follow-up|5|||
42083128|NCT00847613|75893594|FG001|Overall Study|Lost to Follow-up|0|||
42083129|NCT00847613|75893595|FG002|Overall Study|Lost to Follow-up|0|||
42083130|NCT00847613|75893596|FG003|Overall Study|Lost to Follow-up|3|||
42083131|NCT00847613|75893593|FG000|Overall Study|Protocol Violation|6|||
42083132|NCT00847613|75893594|FG001|Overall Study|Protocol Violation|6|||
42083133|NCT00847613|75893595|FG002|Overall Study|Protocol Violation|3|||
42083134|NCT00847613|75893596|FG003|Overall Study|Protocol Violation|1|||
42083135|NCT00847613|75893593|FG000|Overall Study|Pregnancy|1|||
42083136|NCT00847613|75893594|FG001|Overall Study|Pregnancy|1|||
42083137|NCT00847613|75893595|FG002|Overall Study|Pregnancy|0|||
42083138|NCT00847613|75893596|FG003|Overall Study|Pregnancy|0|||
42358267|NCT01824979|76203827|FG001|Overall Study|Physician Decision|0|||
42358268|NCT01824979|76203826|FG000|Overall Study|Protocol Violation|6|||
42358269|NCT01824979|76203827|FG001|Overall Study|Protocol Violation|13|||
42358270|NCT01824823|76203835|FG000|Overall Study|Lack of Efficacy|1|||
42358271|NCT01824823|76203836|FG001|Overall Study|Lack of Efficacy|1|||
42358272|NCT01824823|76203835|FG000|Overall Study|Off-treatment reason not submitted|1|||
42358273|NCT01824823|76203836|FG001|Overall Study|Off-treatment reason not submitted|0|||
42083139|NCT00847613|75893593|FG000|Overall Study|Site closure|1|||
42083140|NCT00847613|75893594|FG001|Overall Study|Site closure|0|||
42083141|NCT00847613|75893595|FG002|Overall Study|Site closure|0|||
42083142|NCT00847613|75893596|FG003|Overall Study|Site closure|1|||
42083143|NCT00847613|75893593|FG000|Overall Study|Withdrawal by Subject|8|||
42083144|NCT00847613|75893594|FG001|Overall Study|Withdrawal by Subject|11|||
42083145|NCT00847613|75893595|FG002|Overall Study|Withdrawal by Subject|2|||
42083146|NCT00847613|75893596|FG003|Overall Study|Withdrawal by Subject|2|||
42083147|NCT00847613|75893593|FG000|Overall Study|Participant moved|4|||
42083148|NCT00847613|75893594|FG001|Overall Study|Participant moved|1|||
42083149|NCT00847613|75893595|FG002|Overall Study|Participant moved|0|||
42083150|NCT00847613|75893596|FG003|Overall Study|Participant moved|0|||
42083151|NCT00847613|75893593|FG000|Overall Study|Sponsor request|0|||
42083152|NCT00847613|75893594|FG001|Overall Study|Sponsor request|1|||
42083153|NCT00847613|75893595|FG002|Overall Study|Sponsor request|0|||
42083154|NCT00847613|75893596|FG003|Overall Study|Sponsor request|0|||
42083155|NCT00847613|75893593|FG000|Overall Study|Randomized, but not treated|0|||
42083156|NCT00847613|75893594|FG001|Overall Study|Randomized, but not treated|3|||
42083157|NCT00847613|75893595|FG002|Overall Study|Randomized, but not treated|0|||
42083158|NCT00847613|75893596|FG003|Overall Study|Randomized, but not treated|0|||
42083159|NCT00847613|75893593|FG000|Overall Study|Other|1|||
42083160|NCT00847613|75893594|FG001|Overall Study|Other|1|||
42083161|NCT00847613|75893595|FG002|Overall Study|Other|2|||
42083162|NCT00847613|75893596|FG003|Overall Study|Other|0|||
42083163|NCT00794196|75893615|FG000|Overall Study|Lost to Follow-up|5|||
42083164|NCT00794196|75893616|FG001|Overall Study|Lost to Follow-up|23|||
42083165|NCT00807092|75893624|FG000|Overall Study|Adverse Event|0|||
42083166|NCT00807092|75893625|FG001|Overall Study|Adverse Event|1|||
42083167|NCT00807092|75893624|FG000|Overall Study|Protocol Violation|0|||
42083168|NCT00807092|75893625|FG001|Overall Study|Protocol Violation|2|||
42083169|NCT00807092|75893624|FG000|Overall Study|Withdrawal by Subject|1|||
42083170|NCT00807092|75893625|FG001|Overall Study|Withdrawal by Subject|0|||
42083171|NCT00807092|75893624|FG000|Overall Study|CGMS data collection failed|0|||
42083172|NCT00807092|75893625|FG001|Overall Study|CGMS data collection failed|1|||
42083173|NCT00794118|75893631|FG000|Overall Study|Lost to Follow-up|16|||
42083174|NCT00794118|75893631|FG000|Overall Study|Withdrawal by Subject|9|||
42083175|NCT00794118|75893631|FG000|Overall Study|Changed hospital center|2|||
42083176|NCT00640042|75893635|FG000|Enrollment|Did not receive study drug|83|||
42083177|NCT00807014|75893641|FG000|Overall Study|Participant Considered Disease Cured|13|||
42083178|NCT00807014|75893642|FG001|Overall Study|Participant Considered Disease Cured|2|||
42083179|NCT00807014|75893641|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
42178795|NCT02608268|75986056|FG011|Overall Study|Death|0|||
42178796|NCT02608268|75986057|FG012|Overall Study|Death|0|||
42178797|NCT02608268|75986058|FG013|Overall Study|Death|0|||
42178798|NCT02608268|75986059|FG014|Overall Study|Death|0|||
42178799|NCT02608268|75986060|FG015|Overall Study|Death|1|||
42178800|NCT02608268|75986061|FG016|Overall Study|Death|0|||
42178801|NCT02608268|75986062|FG017|Overall Study|Death|1|||
42178802|NCT02608268|75986063|FG018|Overall Study|Death|0|||
42178803|NCT02608268|75986064|FG019|Overall Study|Death|1|||
42178804|NCT02608268|75986065|FG020|Overall Study|Death|1|||
42178805|NCT02608268|75986066|FG021|Overall Study|Death|0|||
42178806|NCT02608268|75986067|FG022|Overall Study|Death|0|||
42178807|NCT02608268|75986068|FG023|Overall Study|Death|0|||
42178808|NCT02608268|75986069|FG024|Overall Study|Death|1|||
42178809|NCT02608268|75986070|FG025|Overall Study|Death|2|||
42178810|NCT02608268|75986071|FG026|Overall Study|Death|0|||
42178811|NCT02608268|75986072|FG027|Overall Study|Death|1|||
42178812|NCT02608268|75986073|FG028|Overall Study|Death|4|||
42178813|NCT02608268|75986074|FG029|Overall Study|Death|0|||
42083180|NCT00807014|75893642|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
42178814|NCT02608268|75986045|FG000|Overall Study|Physician Decision|0|||
42178815|NCT02608268|75986046|FG001|Overall Study|Physician Decision|0|||
42083181|NCT00807014|75893641|FG000|Overall Study|Protocol Violation|2|||
42083182|NCT00807014|75893642|FG001|Overall Study|Protocol Violation|8|||
42083183|NCT00807014|75893641|FG000|Overall Study|Adverse Event|0|||
42083184|NCT00807014|75893642|FG001|Overall Study|Adverse Event|2|||
42083185|NCT00807014|75893641|FG000|Overall Study|Lost to Follow-up|9|||
42083186|NCT00807014|75893642|FG001|Overall Study|Lost to Follow-up|7|||
42178816|NCT02608268|75986047|FG002|Overall Study|Physician Decision|0|||
42178817|NCT02608268|75986048|FG003|Overall Study|Physician Decision|0|||
42178818|NCT02608268|75986049|FG004|Overall Study|Physician Decision|0|||
42178819|NCT02608268|75986050|FG005|Overall Study|Physician Decision|0|||
42178820|NCT02608268|75986051|FG006|Overall Study|Physician Decision|0|||
42178821|NCT02608268|75986052|FG007|Overall Study|Physician Decision|0|||
42083187|NCT00807014|75893641|FG000|Overall Study|Recovery|1|||
42083188|NCT00807014|75893642|FG001|Overall Study|Recovery|0|||
42083189|NCT00807014|75893641|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
42083190|NCT00807014|75893642|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
42083191|NCT00592631|75893650|FG000|Overall Study|Lost to Follow-up|0|||
42083192|NCT00592631|75893651|FG001|Overall Study|Lost to Follow-up|2|||
42083193|NCT00791388|75893662|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
42083194|NCT00791388|75893663|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
42083195|NCT00791388|75893664|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
42083196|NCT00791388|75893665|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
42083197|NCT00791388|75893666|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
42083198|NCT00791388|75893662|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
42083199|NCT00791388|75893663|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
42083200|NCT00791388|75893664|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
42083201|NCT00791388|75893665|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
42083202|NCT00791388|75893666|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
42083203|NCT00791388|75893662|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
42083204|NCT00791388|75893663|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
42083205|NCT00791388|75893664|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
42083206|NCT00791388|75893665|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
42083207|NCT00791388|75893666|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
42083208|NCT00794040|75893680|FG000|Overall Study|Withdrawal by Subject|3|||
42083209|NCT00794040|75893681|FG001|Overall Study|Withdrawal by Subject|4|||
42083210|NCT00794040|75893680|FG000|Overall Study|Physician Decision|0|||
42083211|NCT00794040|75893681|FG001|Overall Study|Physician Decision|1|||
42083212|NCT00813488|75893687|FG000|Titration Period 1|Adverse Event|6|||
42083213|NCT00813488|75893688|FG001|Titration Period 1|Adverse Event|1|||
42083214|NCT00813488|75893687|FG000|Titration Period 1|Lack of Efficacy|9|||
42083215|NCT00813488|75893688|FG001|Titration Period 1|Lack of Efficacy|7|||
42083216|NCT00813488|75893687|FG000|Titration Period 1|Withdrawal by Subject|2|||
42083217|NCT00813488|75893688|FG001|Titration Period 1|Withdrawal by Subject|2|||
42083218|NCT00813488|75893687|FG000|Titration Period 1|Protocol Violation|4|||
42083219|NCT00813488|75893688|FG001|Titration Period 1|Protocol Violation|3|||
42083220|NCT00813488|75893687|FG000|Titration Period 1|Non-compliance to study medication|4|||
42083221|NCT00813488|75893688|FG001|Titration Period 1|Non-compliance to study medication|1|||
42083222|NCT00813488|75893687|FG000|Titration Period 1|Non-compliance to study procedures|2|||
42083223|NCT00813488|75893688|FG001|Titration Period 1|Non-compliance to study procedures|2|||
42083224|NCT00813488|75893687|FG000|Titration Period 1|Technical Difficulties|0|||
42083225|NCT00813488|75893688|FG001|Titration Period 1|Technical Difficulties|1|||
42083226|NCT00813488|75893687|FG000|Titration Period 2|Adverse Event|2|||
42083227|NCT00813488|75893688|FG001|Titration Period 2|Adverse Event|3|||
42083228|NCT00813488|75893687|FG000|Titration Period 2|Lack of Efficacy|8|||
42083229|NCT00813488|75893688|FG001|Titration Period 2|Lack of Efficacy|4|||
42083230|NCT00813488|75893687|FG000|Titration Period 2|Protocol Violation|3|||
42083231|NCT00813488|75893688|FG001|Titration Period 2|Protocol Violation|2|||
42083232|NCT00813488|75893687|FG000|Titration Period 2|Lost to Follow-up|1|||
42083233|NCT00813488|75893688|FG001|Titration Period 2|Lost to Follow-up|0|||
42083234|NCT00813488|75893687|FG000|Titration Period 2|Non-compliance with study procedures|2|||
42083235|NCT00813488|75893688|FG001|Titration Period 2|Non-compliance with study procedures|1|||
42083236|NCT00813488|75893687|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
42083237|NCT00813488|75893688|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
42083238|NCT00813488|75893687|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
42083239|NCT00813488|75893688|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
42083240|NCT00813488|75893687|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
42083241|NCT00813488|75893688|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
42083242|NCT00813488|75893687|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
42083243|NCT00813488|75893688|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
42083244|NCT00813488|75893687|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
42083245|NCT00813488|75893688|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
42083246|NCT00813488|75893687|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
42083247|NCT00813488|75893688|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
42178822|NCT02608268|75986053|FG008|Overall Study|Physician Decision|0|||
42178823|NCT02608268|75986054|FG009|Overall Study|Physician Decision|0|||
42178824|NCT02608268|75986055|FG010|Overall Study|Physician Decision|1|||
42178825|NCT02608268|75986056|FG011|Overall Study|Physician Decision|0|||
42083248|NCT00813488|75893687|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
42083249|NCT00813488|75893688|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
42083250|NCT00813488|75893687|FG000|Double-blind Treatment Period 2|Other|1|||
42083251|NCT00813488|75893688|FG001|Double-blind Treatment Period 2|Other|0|||
42083252|NCT00813488|75893687|FG000|Open-label Extension|Adverse Event|1|||
42083253|NCT00813488|75893688|FG001|Open-label Extension|Adverse Event|2|||
42083254|NCT00813488|75893687|FG000|Open-label Extension|Lack of Efficacy|3|||
42083255|NCT00813488|75893688|FG001|Open-label Extension|Lack of Efficacy|0|||
42083256|NCT00813488|75893687|FG000|Open-label Extension|Withdrawal by Subject|0|||
42083257|NCT00813488|75893688|FG001|Open-label Extension|Withdrawal by Subject|2|||
42083258|NCT00813488|75893687|FG000|Open-label Extension|Protocol Violation|1|||
42083259|NCT00813488|75893688|FG001|Open-label Extension|Protocol Violation|2|||
42083260|NCT00813488|75893687|FG000|Open-label Extension|Non-compliance study medication|4|||
42083261|NCT00813488|75893688|FG001|Open-label Extension|Non-compliance study medication|0|||
42083262|NCT00813488|75893687|FG000|Open-label Extension|Non-compliance study procedures|2|||
42083263|NCT00813488|75893688|FG001|Open-label Extension|Non-compliance study procedures|1|||
42083264|NCT00813488|75893687|FG000|Open-label Extension|Other|1|||
42083265|NCT00813488|75893688|FG001|Open-label Extension|Other|0|||
42083266|NCT00797316|75893700|FG000|Overall Study|Administrative problems|1|||
42083267|NCT00797316|75893701|FG001|Overall Study|Administrative problems|0|||
42083268|NCT00797316|75893700|FG000|Overall Study|Adverse Event|5|||
42083269|NCT00797316|75893701|FG001|Overall Study|Adverse Event|3|||
42083270|NCT00797316|75893700|FG000|Overall Study|Lost to Follow-up|4|||
42083271|NCT00797316|75893701|FG001|Overall Study|Lost to Follow-up|8|||
42083272|NCT00797316|75893700|FG000|Overall Study|Protocol Deviation|1|||
42083273|NCT00797316|75893701|FG001|Overall Study|Protocol Deviation|2|||
42083274|NCT00797316|75893700|FG000|Overall Study|Patient withdrew consent|12|||
42083275|NCT00797316|75893701|FG001|Overall Study|Patient withdrew consent|6|||
42083276|NCT00797316|75893700|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42083277|NCT00797316|75893701|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
42083278|NCT00587964|75893707|FG000|Overall Study|Withdrawal by Subject|1|||
42083279|NCT00587964|75893707|FG000|Overall Study|Lost to Follow-up|1|||
42083280|NCT00587964|75893707|FG000|Overall Study|Patient found to be ineligible|1|||
42083281|NCT00587964|75893707|FG000|Overall Study|Patient did not receive intervention|5|||
42083282|NCT00587964|75893707|FG000|Overall Study|Progression of Disease|4|||
42083283|NCT00590954|75893711|FG000|Overall Study|Inevaluable|2|||
42083284|NCT00791076|75893717|FG000|Overall Study|Study was terminated,PI left institution|8|||
42083285|NCT00590720|75893725|FG000|Overall Study|Lost to Follow-up|1|||
42083286|NCT00590720|75893726|FG001|Overall Study|Lost to Follow-up|0|||
42083287|NCT00590720|75893725|FG000|Overall Study|Withdrawal by Subject|0|||
42083288|NCT00590720|75893726|FG001|Overall Study|Withdrawal by Subject|1|||
42083289|NCT00625378|75893734|FG000|Overall Study|Adverse Event|22|||
42083290|NCT00625378|75893735|FG001|Overall Study|Adverse Event|0|||
42083291|NCT00625378|75893734|FG000|Overall Study|Withdrawal by Subject|16|||
42083292|NCT00625378|75893735|FG001|Overall Study|Withdrawal by Subject|0|||
42083293|NCT00625378|75893734|FG000|Overall Study|Death|38|||
42083294|NCT00625378|75893735|FG001|Overall Study|Death|0|||
42083295|NCT00625378|75893734|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
42083296|NCT00625378|75893735|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
42083297|NCT00625378|75893734|FG000|Overall Study|Lost to Follow-up|17|||
42083298|NCT00625378|75893735|FG001|Overall Study|Lost to Follow-up|0|||
42083299|NCT00625378|75893734|FG000|Overall Study|Non-compliant with study medication|3|||
42083300|NCT00625378|75893735|FG001|Overall Study|Non-compliant with study medication|0|||
42083301|NCT00625378|75893734|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
42083302|NCT00625378|75893735|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
42083303|NCT00625378|75893734|FG000|Overall Study|Medical decision|1|||
42083304|NCT00625378|75893735|FG001|Overall Study|Medical decision|0|||
42083305|NCT00625378|75893734|FG000|Overall Study|Multiple toxicities|1|||
42083306|NCT00625378|75893735|FG001|Overall Study|Multiple toxicities|0|||
42083307|NCT00625378|75893734|FG000|Overall Study|New cancer|1|||
42083308|NCT00625378|75893735|FG001|Overall Study|New cancer|0|||
42083309|NCT00625378|75893734|FG000|Overall Study|PTA program|2|||
42083310|NCT00625378|75893735|FG001|Overall Study|PTA program|0|||
42083311|NCT00625378|75893734|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
42083312|NCT00625378|75893735|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
42083313|NCT00625378|75893734|FG000|Overall Study|Sponsor decision|1|||
42178826|NCT02608268|75986057|FG012|Overall Study|Physician Decision|0|||
42178827|NCT02608268|75986058|FG013|Overall Study|Physician Decision|1|||
42083314|NCT00625378|75893735|FG001|Overall Study|Sponsor decision|0|||
42083315|NCT00625378|75893734|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
42083316|NCT00625378|75893735|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
42083317|NCT00625378|75893734|FG000|Overall Study|Switch to commercial drug|6|||
42083318|NCT00625378|75893735|FG001|Overall Study|Switch to commercial drug|1|||
42083319|NCT00625378|75893734|FG000|Overall Study|Missing|2|||
42083320|NCT00625378|75893735|FG001|Overall Study|Missing|0|||
42083321|NCT00625378|75893734|FG000|Overall Study|End of treatment not available|2|||
42083322|NCT00625378|75893735|FG001|Overall Study|End of treatment not available|0|||
42083323|NCT00625378|75893734|FG000|Overall Study|Never treated|2|||
42083324|NCT00625378|75893735|FG001|Overall Study|Never treated|0|||
42083325|NCT00806624|75893744|FG000|Overall Study|Adverse Event|2|||
42083326|NCT00806624|75893745|FG001|Overall Study|Adverse Event|8|||
42083327|NCT00806624|75893746|FG002|Overall Study|Adverse Event|0|||
42083328|NCT00806624|75893744|FG000|Overall Study|Death|0|||
42083329|NCT00806624|75893745|FG001|Overall Study|Death|1|||
42083330|NCT00806624|75893746|FG002|Overall Study|Death|1|||
42083331|NCT00806624|75893744|FG000|Overall Study|Lost to Follow-up|1|||
42083332|NCT00806624|75893745|FG001|Overall Study|Lost to Follow-up|0|||
42083333|NCT00806624|75893746|FG002|Overall Study|Lost to Follow-up|1|||
42083334|NCT00806624|75893744|FG000|Overall Study|Withdrawal by Subject|6|||
42083335|NCT00806624|75893745|FG001|Overall Study|Withdrawal by Subject|3|||
42083336|NCT00806624|75893746|FG002|Overall Study|Withdrawal by Subject|3|||
42083337|NCT00806624|75893744|FG000|Overall Study|discontinued before start of treatment|0|||
42083338|NCT00806624|75893745|FG001|Overall Study|discontinued before start of treatment|0|||
42083339|NCT00806624|75893746|FG002|Overall Study|discontinued before start of treatment|1|||
42083340|NCT00806546|75893754|FG000|Overall Study|Enrolled, not treated|35|||
42083341|NCT00806546|75893754|FG000|Overall Study|Lost to Follow-up|32|||
42083342|NCT00806546|75893754|FG000|Overall Study|Adverse Event|74|||
42083343|NCT00806546|75893754|FG000|Overall Study|Withdrawal by Subject|75|||
42083344|NCT00806546|75893754|FG000|Overall Study|Protocol Violation|49|||
42083345|NCT00806546|75893754|FG000|Overall Study|Various|42|||
42083346|NCT00624832|75893762|FG000|Overall Study|Adverse Event|0|||
42083347|NCT00624832|75893763|FG001|Overall Study|Adverse Event|1|||
42083348|NCT00624832|75893764|FG002|Overall Study|Adverse Event|0|||
42083349|NCT00624832|75893765|FG003|Overall Study|Adverse Event|1|||
42083350|NCT00624832|75893762|FG000|Overall Study|Abnormal Laboratory Value|2|||
42083351|NCT00624832|75893763|FG001|Overall Study|Abnormal Laboratory Value|0|||
42083352|NCT00624832|75893764|FG002|Overall Study|Abnormal Laboratory Value|0|||
42083353|NCT00624832|75893765|FG003|Overall Study|Abnormal Laboratory Value|0|||
42083354|NCT00633880|75893777|FG000|Open Label Titration|Lack of Efficacy|1|||
42083355|NCT00633880|75893778|FG001|Open Label Titration|Lack of Efficacy|0|||
42083356|NCT00633880|75893779|FG002|Open Label Titration|Lack of Efficacy|0|||
42083357|NCT00633880|75893777|FG000|Open Label Titration|Adverse Event|13|||
42083358|NCT00633880|75893778|FG001|Open Label Titration|Adverse Event|0|||
42083359|NCT00633880|75893779|FG002|Open Label Titration|Adverse Event|0|||
42083360|NCT00633880|75893777|FG000|Open Label Titration|Treatment Failure|55|||
42083361|NCT00633880|75893778|FG001|Open Label Titration|Treatment Failure|0|||
42083362|NCT00633880|75893779|FG002|Open Label Titration|Treatment Failure|0|||
42083363|NCT00633880|75893777|FG000|Open Label Titration|Protocol Violation|6|||
42083364|NCT00633880|75893778|FG001|Open Label Titration|Protocol Violation|0|||
42083365|NCT00633880|75893779|FG002|Open Label Titration|Protocol Violation|0|||
42083366|NCT00633880|75893777|FG000|Open Label Titration|Physician Decision|1|||
42083367|NCT00633880|75893778|FG001|Open Label Titration|Physician Decision|0|||
42083368|NCT00633880|75893779|FG002|Open Label Titration|Physician Decision|0|||
42083369|NCT00633880|75893777|FG000|Open Label Titration|Withdrawal by Subject|4|||
42083370|NCT00633880|75893778|FG001|Open Label Titration|Withdrawal by Subject|0|||
42083371|NCT00633880|75893779|FG002|Open Label Titration|Withdrawal by Subject|0|||
42083372|NCT00590564|75893786|FG000|Overall Study|Withdrawal by Subject|4|||
42083373|NCT00590564|75893786|FG000|Overall Study|Lost to Follow-up|6|||
42083374|NCT00590564|75893786|FG000|Overall Study|Protocol Violation|1|||
42083375|NCT00590564|75893786|FG000|Overall Study|Patient Found to be Ineligible|1|||
42083376|NCT00590564|75893786|FG000|Overall Study|Patient Non-compliance|6|||
42083377|NCT00631696|75893792|FG000|Overall Study|Entered, not randomized to treatment|1|||
42083378|NCT00631696|75893793|FG001|Overall Study|Entered, not randomized to treatment|1|||
42083379|NCT00631696|75893792|FG000|Overall Study|Discontinued after database release date|1|||
42083380|NCT00631696|75893793|FG001|Overall Study|Discontinued after database release date|0|||
42083381|NCT00631696|75893792|FG000|Overall Study|Follow up after database release date|1|||
42083382|NCT00631696|75893793|FG001|Overall Study|Follow up after database release date|0|||
42083383|NCT00631696|75893792|FG000|Overall Study|Lost to Follow-up|7|||
42083384|NCT00631696|75893793|FG001|Overall Study|Lost to Follow-up|10|||
42083385|NCT00631696|75893792|FG000|Overall Study|Withdrawal by Subject|2|||
42083386|NCT00631696|75893793|FG001|Overall Study|Withdrawal by Subject|9|||
42083387|NCT00631696|75893792|FG000|Overall Study|Other|8|||
42083388|NCT00631696|75893793|FG001|Overall Study|Other|8|||
42083389|NCT00631696|75893792|FG000|Overall Study|Protocol Violation|9|||
42083390|NCT00631696|75893793|FG001|Overall Study|Protocol Violation|9|||
42083391|NCT00631696|75893792|FG000|Overall Study|Study terminated by sponsor|3|||
42178828|NCT02608268|75986059|FG014|Overall Study|Physician Decision|0|||
42083392|NCT00631696|75893793|FG001|Overall Study|Study terminated by sponsor|3|||
42083393|NCT00631696|75893792|FG000|Overall Study|Adverse Event|5|||
42083394|NCT00631696|75893793|FG001|Overall Study|Adverse Event|0|||
42178829|NCT02608268|75986060|FG015|Overall Study|Physician Decision|0|||
42178830|NCT02608268|75986061|FG016|Overall Study|Physician Decision|0|||
42083395|NCT00631540|75893799|FG000|Overall Study|Withdrawal by Subject|5|||
42083396|NCT00631540|75893799|FG000|Overall Study|Death|4|||
42083397|NCT00631540|75893799|FG000|Overall Study|Lost to Follow-up|2|||
42083398|NCT00631540|75893799|FG000|Overall Study|Core Lab Data Unavailable|3|||
42083399|NCT00630916|75893803|FG000|Overall Study|Death|110|||
42083400|NCT00630916|75893803|FG000|Overall Study|Explant|8|||
42083401|NCT00630916|75893803|FG000|Overall Study|Lost to Follow-up|5|||
42083402|NCT00630916|75893803|FG000|Overall Study|Withdrawal by Subject|30|||
42083403|NCT00630916|75893803|FG000|Overall Study|Protocol Violation|7|||
42083404|NCT00630916|75893803|FG000|Overall Study|Physician Decision|47|||
42083405|NCT00630916|75893803|FG000|Overall Study|Lack of Efficacy|3|||
42083406|NCT00630292|75893807|FG000|Overall Study|Withdrawal by Subject|1|||
42178831|NCT02608268|75986062|FG017|Overall Study|Physician Decision|0|||
42178832|NCT02608268|75986063|FG018|Overall Study|Physician Decision|0|||
42178833|NCT02608268|75986064|FG019|Overall Study|Physician Decision|0|||
42178834|NCT02608268|75986065|FG020|Overall Study|Physician Decision|0|||
42178835|NCT02608268|75986066|FG021|Overall Study|Physician Decision|0|||
42178836|NCT02608268|75986067|FG022|Overall Study|Physician Decision|1|||
42178837|NCT02608268|75986068|FG023|Overall Study|Physician Decision|1|||
42178838|NCT02608268|75986069|FG024|Overall Study|Physician Decision|1|||
42178839|NCT02608268|75986070|FG025|Overall Study|Physician Decision|0|||
42178840|NCT02608268|75986071|FG026|Overall Study|Physician Decision|0|||
42178841|NCT02608268|75986072|FG027|Overall Study|Physician Decision|2|||
42178842|NCT02608268|75986073|FG028|Overall Study|Physician Decision|1|||
42178843|NCT02608268|75986074|FG029|Overall Study|Physician Decision|1|||
42178844|NCT02608268|75986045|FG000|Overall Study|Progressive disease|12|||
42178845|NCT02608268|75986046|FG001|Overall Study|Progressive disease|8|||
42178846|NCT02608268|75986047|FG002|Overall Study|Progressive disease|13|||
42178847|NCT02608268|75986048|FG003|Overall Study|Progressive disease|5|||
42178848|NCT02608268|75986049|FG004|Overall Study|Progressive disease|2|||
42178849|NCT02608268|75986050|FG005|Overall Study|Progressive disease|4|||
42178850|NCT02608268|75986051|FG006|Overall Study|Progressive disease|6|||
42178851|NCT02608268|75986052|FG007|Overall Study|Progressive disease|2|||
42178852|NCT02608268|75986053|FG008|Overall Study|Progressive disease|5|||
42178853|NCT02608268|75986054|FG009|Overall Study|Progressive disease|6|||
42178854|NCT02608268|75986055|FG010|Overall Study|Progressive disease|5|||
42178855|NCT02608268|75986056|FG011|Overall Study|Progressive disease|5|||
42083407|NCT00626548|75893813|FG000|Overall Study|Adverse Event|164|||
42083408|NCT00626548|75893814|FG001|Overall Study|Adverse Event|44|||
42083409|NCT00626548|75893813|FG000|Overall Study|Withdrawal by Subject|42|||
42083410|NCT00626548|75893814|FG001|Overall Study|Withdrawal by Subject|46|||
42083411|NCT00626548|75893813|FG000|Overall Study|Protocol Violation|4|||
42083412|NCT00626548|75893814|FG001|Overall Study|Protocol Violation|11|||
42083413|NCT00626548|75893813|FG000|Overall Study|Lost to Follow-up|2|||
42083414|NCT00626548|75893814|FG001|Overall Study|Lost to Follow-up|2|||
42083415|NCT00626548|75893813|FG000|Overall Study|Other termination reason|493|||
42083416|NCT00626548|75893814|FG001|Overall Study|Other termination reason|613|||
42083417|NCT00847379|75893823|FG000|Overall Study|Study terminated by Sponsor|59|||
42083418|NCT00847379|75893824|FG001|Overall Study|Study terminated by Sponsor|57|||
42083419|NCT00847379|75893825|FG002|Overall Study|Study terminated by Sponsor|57|||
42083420|NCT00847301|75893835|FG000|Overall Study|Adverse Event|35|||
42083421|NCT00847301|75893835|FG000|Overall Study|Switch to other anticoagulants|16|||
42083422|NCT00847301|75893835|FG000|Overall Study|Lost to Follow-up|1|||
42083423|NCT00847301|75893835|FG000|Overall Study|No prescription after hospital discharge|1|||
42083424|NCT00847301|75893835|FG000|Overall Study|Other reason not defined above|1|||
42083425|NCT00624520|75893841|FG000|Overall Study|Withdrawal by Subject|12|||
42083426|NCT00624520|75893842|FG001|Overall Study|Withdrawal by Subject|7|||
42083427|NCT00624520|75893841|FG000|Overall Study|Death|0|||
42083428|NCT00624520|75893842|FG001|Overall Study|Death|1|||
42083429|NCT00847145|75893856|FG000|Overall Study|AE or Death|0|||
42083430|NCT00847145|75893857|FG001|Overall Study|AE or Death|1|||
42083431|NCT00847145|75893858|FG002|Overall Study|AE or Death|1|||
42083432|NCT00847145|75893859|FG003|Overall Study|AE or Death|0|||
42083433|NCT00847145|75893860|FG004|Overall Study|AE or Death|0|||
42083434|NCT00847145|75893861|FG005|Overall Study|AE or Death|0|||
42083435|NCT00847145|75893862|FG006|Overall Study|AE or Death|0|||
42083436|NCT00847145|75893863|FG007|Overall Study|AE or Death|0|||
42083437|NCT00847145|75893856|FG000|Overall Study|Withdrawal by Subject|3|||
42083438|NCT00847145|75893857|FG001|Overall Study|Withdrawal by Subject|4|||
42083439|NCT00847145|75893858|FG002|Overall Study|Withdrawal by Subject|6|||
42083440|NCT00847145|75893859|FG003|Overall Study|Withdrawal by Subject|1|||
42083441|NCT00847145|75893860|FG004|Overall Study|Withdrawal by Subject|0|||
42083442|NCT00847145|75893861|FG005|Overall Study|Withdrawal by Subject|0|||
42083443|NCT00847145|75893862|FG006|Overall Study|Withdrawal by Subject|1|||
42083444|NCT00847145|75893863|FG007|Overall Study|Withdrawal by Subject|1|||
42083445|NCT00847145|75893856|FG000|Overall Study|Lost to Follow-up|3|||
42083446|NCT00847145|75893857|FG001|Overall Study|Lost to Follow-up|1|||
42083447|NCT00847145|75893858|FG002|Overall Study|Lost to Follow-up|1|||
42083448|NCT00847145|75893859|FG003|Overall Study|Lost to Follow-up|0|||
42178856|NCT02608268|75986057|FG012|Overall Study|Progressive disease|4|||
42178857|NCT02608268|75986058|FG013|Overall Study|Progressive disease|11|||
42178858|NCT02608268|75986059|FG014|Overall Study|Progressive disease|6|||
42083449|NCT00847145|75893860|FG004|Overall Study|Lost to Follow-up|4|||
42083450|NCT00847145|75893861|FG005|Overall Study|Lost to Follow-up|4|||
42178859|NCT02608268|75986060|FG015|Overall Study|Progressive disease|3|||
42178860|NCT02608268|75986061|FG016|Overall Study|Progressive disease|5|||
42083451|NCT00847145|75893862|FG006|Overall Study|Lost to Follow-up|8|||
42083452|NCT00847145|75893863|FG007|Overall Study|Lost to Follow-up|2|||
42083453|NCT00847145|75893856|FG000|Overall Study|Inappropriate enrollment|0|||
42083454|NCT00847145|75893857|FG001|Overall Study|Inappropriate enrollment|0|||
42083455|NCT00847145|75893858|FG002|Overall Study|Inappropriate enrollment|0|||
42083456|NCT00847145|75893859|FG003|Overall Study|Inappropriate enrollment|0|||
42083457|NCT00847145|75893860|FG004|Overall Study|Inappropriate enrollment|1|||
42083458|NCT00847145|75893861|FG005|Overall Study|Inappropriate enrollment|0|||
42083459|NCT00847145|75893862|FG006|Overall Study|Inappropriate enrollment|0|||
42083460|NCT00847145|75893863|FG007|Overall Study|Inappropriate enrollment|0|||
42083461|NCT00847145|75893856|FG000|Overall Study|Protocol Violation|0|||
42083462|NCT00847145|75893857|FG001|Overall Study|Protocol Violation|0|||
42083463|NCT00847145|75893858|FG002|Overall Study|Protocol Violation|3|||
42083464|NCT00847145|75893859|FG003|Overall Study|Protocol Violation|0|||
42083465|NCT00847145|75893860|FG004|Overall Study|Protocol Violation|1|||
42083466|NCT00847145|75893861|FG005|Overall Study|Protocol Violation|0|||
42083467|NCT00847145|75893862|FG006|Overall Study|Protocol Violation|0|||
42083468|NCT00847145|75893863|FG007|Overall Study|Protocol Violation|1|||
42083469|NCT00846521|75893890|FG000|Overall Study|Withdrawal by Subject|5|||
42083470|NCT00846521|75893890|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
42083471|NCT00846521|75893890|FG000|Overall Study|Protocol Violation|1|||
42083472|NCT00862823|75893894|FG000|First Intervention|Withdrawal by Subject|1|||
42083473|NCT00862823|75893895|FG001|First Intervention|Withdrawal by Subject|1|||
42083474|NCT00790842|75893903|FG000|Dose Level 1|Adverse Event|1|||
42083475|NCT00790842|75893904|FG001|Dose Level 1|Adverse Event|0|||
42083476|NCT00790842|75893905|FG002|Dose Level 1|Adverse Event|0|||
42083477|NCT00790842|75893906|FG003|Dose Level 1|Adverse Event|2|||
42083478|NCT00790842|75893907|FG004|Dose Level 1|Adverse Event|0|||
42083479|NCT00790842|75893908|FG005|Dose Level 1|Adverse Event|0|||
42083480|NCT00790842|75893909|FG006|Dose Level 1|Adverse Event|0|||
42083481|NCT00790842|75893910|FG007|Dose Level 1|Adverse Event|1|||
42083482|NCT00790842|75893911|FG008|Dose Level 1|Adverse Event|0|||
42083483|NCT00790842|75893912|FG009|Dose Level 1|Adverse Event|0|||
42083484|NCT00790842|75893913|FG010|Dose Level 1|Adverse Event|0|||
42083485|NCT00790842|75893903|FG000|Dose Level 1|Physician Decision|1|||
42083486|NCT00790842|75893904|FG001|Dose Level 1|Physician Decision|0|||
42083487|NCT00790842|75893905|FG002|Dose Level 1|Physician Decision|0|||
42083488|NCT00790842|75893906|FG003|Dose Level 1|Physician Decision|0|||
42083489|NCT00790842|75893907|FG004|Dose Level 1|Physician Decision|0|||
42083490|NCT00790842|75893908|FG005|Dose Level 1|Physician Decision|0|||
42083491|NCT00790842|75893909|FG006|Dose Level 1|Physician Decision|0|||
42083492|NCT00790842|75893910|FG007|Dose Level 1|Physician Decision|1|||
42083493|NCT00790842|75893911|FG008|Dose Level 1|Physician Decision|0|||
42083494|NCT00790842|75893912|FG009|Dose Level 1|Physician Decision|0|||
42083495|NCT00790842|75893913|FG010|Dose Level 1|Physician Decision|0|||
42083496|NCT00790842|75893903|FG000|Dose Level 1|Withdrawal by Subject|1|||
42083497|NCT00790842|75893904|FG001|Dose Level 1|Withdrawal by Subject|0|||
42083498|NCT00790842|75893905|FG002|Dose Level 1|Withdrawal by Subject|0|||
42083499|NCT00790842|75893906|FG003|Dose Level 1|Withdrawal by Subject|0|||
42083500|NCT00790842|75893907|FG004|Dose Level 1|Withdrawal by Subject|0|||
42083501|NCT00790842|75893908|FG005|Dose Level 1|Withdrawal by Subject|0|||
42083502|NCT00790842|75893909|FG006|Dose Level 1|Withdrawal by Subject|0|||
42083503|NCT00790842|75893910|FG007|Dose Level 1|Withdrawal by Subject|0|||
42083504|NCT00790842|75893911|FG008|Dose Level 1|Withdrawal by Subject|0|||
42083505|NCT00790842|75893912|FG009|Dose Level 1|Withdrawal by Subject|0|||
42083506|NCT00790842|75893913|FG010|Dose Level 1|Withdrawal by Subject|0|||
42083507|NCT00790842|75893903|FG000|Dose Level 2|Death|0|||
42083508|NCT00790842|75893904|FG001|Dose Level 2|Death|1|||
42083509|NCT00790842|75893905|FG002|Dose Level 2|Death|0|||
42083510|NCT00790842|75893906|FG003|Dose Level 2|Death|0|||
42083511|NCT00790842|75893907|FG004|Dose Level 2|Death|1|||
42083512|NCT00790842|75893908|FG005|Dose Level 2|Death|0|||
42083513|NCT00790842|75893909|FG006|Dose Level 2|Death|0|||
42083514|NCT00790842|75893910|FG007|Dose Level 2|Death|0|||
42083515|NCT00790842|75893911|FG008|Dose Level 2|Death|0|||
42083516|NCT00790842|75893912|FG009|Dose Level 2|Death|0|||
42083517|NCT00790842|75893913|FG010|Dose Level 2|Death|0|||
42083518|NCT00790842|75893903|FG000|Dose Level 2|Physician Decision|0|||
42083519|NCT00790842|75893904|FG001|Dose Level 2|Physician Decision|1|||
42083520|NCT00790842|75893905|FG002|Dose Level 2|Physician Decision|0|||
42083521|NCT00790842|75893906|FG003|Dose Level 2|Physician Decision|0|||
42083522|NCT00790842|75893907|FG004|Dose Level 2|Physician Decision|0|||
42083523|NCT00790842|75893908|FG005|Dose Level 2|Physician Decision|0|||
42083524|NCT00790842|75893909|FG006|Dose Level 2|Physician Decision|0|||
42083525|NCT00790842|75893910|FG007|Dose Level 2|Physician Decision|0|||
42083526|NCT00790842|75893911|FG008|Dose Level 2|Physician Decision|0|||
42083527|NCT00790842|75893912|FG009|Dose Level 2|Physician Decision|0|||
42083528|NCT00790842|75893913|FG010|Dose Level 2|Physician Decision|0|||
42083529|NCT00790842|75893903|FG000|Dose Level 2|Withdrawal by Subject|0|||
42083530|NCT00790842|75893904|FG001|Dose Level 2|Withdrawal by Subject|1|||
42083531|NCT00790842|75893905|FG002|Dose Level 2|Withdrawal by Subject|0|||
42083532|NCT00790842|75893906|FG003|Dose Level 2|Withdrawal by Subject|0|||
42083533|NCT00790842|75893907|FG004|Dose Level 2|Withdrawal by Subject|0|||
42083534|NCT00790842|75893908|FG005|Dose Level 2|Withdrawal by Subject|0|||
42083535|NCT00790842|75893909|FG006|Dose Level 2|Withdrawal by Subject|0|||
42083536|NCT00790842|75893910|FG007|Dose Level 2|Withdrawal by Subject|0|||
42083537|NCT00790842|75893911|FG008|Dose Level 2|Withdrawal by Subject|0|||
42083538|NCT00790842|75893912|FG009|Dose Level 2|Withdrawal by Subject|0|||
42083539|NCT00790842|75893913|FG010|Dose Level 2|Withdrawal by Subject|0|||
42083540|NCT00790842|75893903|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
42083541|NCT00790842|75893904|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
42083542|NCT00790842|75893905|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
42083543|NCT00790842|75893906|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
42083544|NCT00790842|75893907|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
42083545|NCT00790842|75893908|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
42083546|NCT00790842|75893909|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
42083547|NCT00790842|75893910|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
42083548|NCT00790842|75893911|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
42083549|NCT00790842|75893912|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
42083550|NCT00790842|75893913|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
42083551|NCT00790842|75893903|FG000|Dose Level 3|Adverse Event|0|||
42083552|NCT00790842|75893904|FG001|Dose Level 3|Adverse Event|0|||
42083553|NCT00790842|75893905|FG002|Dose Level 3|Adverse Event|1|||
42083554|NCT00790842|75893906|FG003|Dose Level 3|Adverse Event|0|||
42083555|NCT00790842|75893907|FG004|Dose Level 3|Adverse Event|0|||
42083556|NCT00790842|75893908|FG005|Dose Level 3|Adverse Event|0|||
42083557|NCT00790842|75893909|FG006|Dose Level 3|Adverse Event|0|||
42083558|NCT00790842|75893910|FG007|Dose Level 3|Adverse Event|0|||
42083559|NCT00790842|75893911|FG008|Dose Level 3|Adverse Event|0|||
42083560|NCT00790842|75893912|FG009|Dose Level 3|Adverse Event|0|||
42083561|NCT00790842|75893913|FG010|Dose Level 3|Adverse Event|0|||
42083562|NCT00790842|75893903|FG000|Dose Level 3|Withdrawal by Subject|0|||
42083563|NCT00790842|75893904|FG001|Dose Level 3|Withdrawal by Subject|0|||
42083564|NCT00790842|75893905|FG002|Dose Level 3|Withdrawal by Subject|3|||
42083565|NCT00790842|75893906|FG003|Dose Level 3|Withdrawal by Subject|0|||
42083566|NCT00790842|75893907|FG004|Dose Level 3|Withdrawal by Subject|0|||
42083567|NCT00790842|75893908|FG005|Dose Level 3|Withdrawal by Subject|0|||
42083568|NCT00790842|75893909|FG006|Dose Level 3|Withdrawal by Subject|0|||
42083569|NCT00790842|75893910|FG007|Dose Level 3|Withdrawal by Subject|0|||
42083570|NCT00790842|75893911|FG008|Dose Level 3|Withdrawal by Subject|0|||
42083571|NCT00790842|75893912|FG009|Dose Level 3|Withdrawal by Subject|2|||
42083572|NCT00790842|75893913|FG010|Dose Level 3|Withdrawal by Subject|0|||
42083573|NCT00790842|75893903|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
42083574|NCT00790842|75893904|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
42083575|NCT00790842|75893905|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
42083576|NCT00790842|75893906|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
42083577|NCT00790842|75893907|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
42083578|NCT00790842|75893908|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
42083579|NCT00790842|75893909|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
42083580|NCT00790842|75893910|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
42083581|NCT00790842|75893911|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
42083582|NCT00790842|75893912|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
42083583|NCT00790842|75893913|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
42083584|NCT00790842|75893903|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
42083585|NCT00790842|75893904|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
42083586|NCT00790842|75893905|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
42178861|NCT02608268|75986062|FG017|Overall Study|Progressive disease|5|||
42017607|NCT01286987|75825326|FG009|Part 1: Dose Escalation|Physician Decision|0|||
42017608|NCT01286987|75825327|FG010|Part 1: Dose Escalation|Physician Decision|0|||
42017609|NCT01286987|75825328|FG011|Part 1: Dose Escalation|Physician Decision|0|||
42017610|NCT01286987|75825329|FG012|Part 1: Dose Escalation|Physician Decision|0|||
42017611|NCT01286987|75825330|FG013|Part 1: Dose Escalation|Physician Decision|0|||
42017612|NCT01286987|75825331|FG014|Part 1: Dose Escalation|Physician Decision|0|||
42017613|NCT01286987|75825317|FG000|Part 2: Dose Expansion|Death|0|||
42017614|NCT01286987|75825318|FG001|Part 2: Dose Expansion|Death|0|||
42017615|NCT01286987|75825319|FG002|Part 2: Dose Expansion|Death|0|||
42017616|NCT01286987|75825320|FG003|Part 2: Dose Expansion|Death|0|||
42017617|NCT01286987|75825321|FG004|Part 2: Dose Expansion|Death|0|||
42083587|NCT00790842|75893906|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
42083588|NCT00790842|75893907|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
42083589|NCT00790842|75893908|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
42083590|NCT00790842|75893909|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
42083591|NCT00790842|75893910|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
42083592|NCT00790842|75893911|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
42083593|NCT00790842|75893912|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
42083594|NCT00790842|75893913|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
42083595|NCT00790842|75893903|FG000|Dose Level 4|Adverse Event|0|||
42083596|NCT00790842|75893904|FG001|Dose Level 4|Adverse Event|0|||
42083597|NCT00790842|75893905|FG002|Dose Level 4|Adverse Event|0|||
42083598|NCT00790842|75893906|FG003|Dose Level 4|Adverse Event|0|||
42083599|NCT00790842|75893907|FG004|Dose Level 4|Adverse Event|0|||
42083600|NCT00790842|75893908|FG005|Dose Level 4|Adverse Event|0|||
42083601|NCT00790842|75893909|FG006|Dose Level 4|Adverse Event|1|||
42083602|NCT00790842|75893910|FG007|Dose Level 4|Adverse Event|0|||
42083603|NCT00790842|75893911|FG008|Dose Level 4|Adverse Event|0|||
42083604|NCT00790842|75893912|FG009|Dose Level 4|Adverse Event|0|||
42083605|NCT00790842|75893913|FG010|Dose Level 4|Adverse Event|0|||
42083606|NCT00790842|75893903|FG000|Dose Level 4|Physician Decision|0|||
42083607|NCT00790842|75893904|FG001|Dose Level 4|Physician Decision|0|||
42083608|NCT00790842|75893905|FG002|Dose Level 4|Physician Decision|0|||
42083609|NCT00790842|75893906|FG003|Dose Level 4|Physician Decision|0|||
42083610|NCT00790842|75893907|FG004|Dose Level 4|Physician Decision|0|||
42083611|NCT00790842|75893908|FG005|Dose Level 4|Physician Decision|0|||
42083612|NCT00790842|75893909|FG006|Dose Level 4|Physician Decision|1|||
42083613|NCT00790842|75893910|FG007|Dose Level 4|Physician Decision|0|||
42083614|NCT00790842|75893911|FG008|Dose Level 4|Physician Decision|0|||
42083615|NCT00790842|75893912|FG009|Dose Level 4|Physician Decision|0|||
42083616|NCT00790842|75893913|FG010|Dose Level 4|Physician Decision|1|||
42083617|NCT00790842|75893903|FG000|Dose Level 4|Withdrawal by Subject|0|||
42083618|NCT00790842|75893904|FG001|Dose Level 4|Withdrawal by Subject|0|||
42083619|NCT00790842|75893905|FG002|Dose Level 4|Withdrawal by Subject|0|||
42083620|NCT00790842|75893906|FG003|Dose Level 4|Withdrawal by Subject|0|||
42083621|NCT00790842|75893907|FG004|Dose Level 4|Withdrawal by Subject|0|||
42083622|NCT00790842|75893908|FG005|Dose Level 4|Withdrawal by Subject|0|||
42083623|NCT00790842|75893909|FG006|Dose Level 4|Withdrawal by Subject|0|||
42083624|NCT00790842|75893910|FG007|Dose Level 4|Withdrawal by Subject|0|||
42083625|NCT00790842|75893911|FG008|Dose Level 4|Withdrawal by Subject|0|||
42083626|NCT00790842|75893912|FG009|Dose Level 4|Withdrawal by Subject|0|||
42017618|NCT01286987|75825322|FG005|Part 2: Dose Expansion|Death|0|||
42017619|NCT01286987|75825323|FG006|Part 2: Dose Expansion|Death|0|||
42017620|NCT01286987|75825324|FG007|Part 2: Dose Expansion|Death|0|||
42017621|NCT01286987|75825325|FG008|Part 2: Dose Expansion|Death|0|||
42017622|NCT01286987|75825326|FG009|Part 2: Dose Expansion|Death|0|||
42017623|NCT01286987|75825327|FG010|Part 2: Dose Expansion|Death|0|||
42017624|NCT01286987|75825328|FG011|Part 2: Dose Expansion|Death|0|||
42017625|NCT01286987|75825329|FG012|Part 2: Dose Expansion|Death|1|||
42017626|NCT01286987|75825330|FG013|Part 2: Dose Expansion|Death|1|||
42017627|NCT01286987|75825331|FG014|Part 2: Dose Expansion|Death|0|||
42017628|NCT01286987|75825317|FG000|Part 2: Dose Expansion|Physician Decision|0|||
42017629|NCT01286987|75825318|FG001|Part 2: Dose Expansion|Physician Decision|0|||
42017630|NCT01286987|75825319|FG002|Part 2: Dose Expansion|Physician Decision|0|||
42017631|NCT01286987|75825320|FG003|Part 2: Dose Expansion|Physician Decision|0|||
42017632|NCT01286987|75825321|FG004|Part 2: Dose Expansion|Physician Decision|0|||
42017633|NCT01286987|75825322|FG005|Part 2: Dose Expansion|Physician Decision|0|||
42017634|NCT01286987|75825323|FG006|Part 2: Dose Expansion|Physician Decision|0|||
42017635|NCT01286987|75825324|FG007|Part 2: Dose Expansion|Physician Decision|0|||
42017636|NCT01286987|75825325|FG008|Part 2: Dose Expansion|Physician Decision|0|||
42017637|NCT01286987|75825326|FG009|Part 2: Dose Expansion|Physician Decision|0|||
42017638|NCT01286987|75825327|FG010|Part 2: Dose Expansion|Physician Decision|1|||
42017639|NCT01286987|75825328|FG011|Part 2: Dose Expansion|Physician Decision|1|||
42017640|NCT01286987|75825329|FG012|Part 2: Dose Expansion|Physician Decision|0|||
42017641|NCT01286987|75825330|FG013|Part 2: Dose Expansion|Physician Decision|1|||
42083627|NCT00790842|75893913|FG010|Dose Level 4|Withdrawal by Subject|1|||
42083628|NCT00790842|75893903|FG000|Expansion Cohort|Adverse Event|0|||
42083629|NCT00790842|75893904|FG001|Expansion Cohort|Adverse Event|0|||
42083630|NCT00790842|75893905|FG002|Expansion Cohort|Adverse Event|0|||
42083631|NCT00790842|75893906|FG003|Expansion Cohort|Adverse Event|0|||
42083632|NCT00790842|75893907|FG004|Expansion Cohort|Adverse Event|0|||
42083633|NCT00790842|75893908|FG005|Expansion Cohort|Adverse Event|0|||
42083634|NCT00790842|75893909|FG006|Expansion Cohort|Adverse Event|1|||
42083635|NCT00790842|75893910|FG007|Expansion Cohort|Adverse Event|0|||
42083636|NCT00790842|75893911|FG008|Expansion Cohort|Adverse Event|0|||
42083637|NCT00790842|75893912|FG009|Expansion Cohort|Adverse Event|0|||
42083638|NCT00790842|75893913|FG010|Expansion Cohort|Adverse Event|0|||
42083639|NCT00790842|75893903|FG000|Expansion Cohort|Death|0|||
42083640|NCT00790842|75893904|FG001|Expansion Cohort|Death|0|||
42083641|NCT00790842|75893905|FG002|Expansion Cohort|Death|2|||
42083642|NCT00790842|75893906|FG003|Expansion Cohort|Death|0|||
42083643|NCT00790842|75893907|FG004|Expansion Cohort|Death|0|||
42178862|NCT02608268|75986063|FG018|Overall Study|Progressive disease|5|||
42178863|NCT02608268|75986064|FG019|Overall Study|Progressive disease|2|||
42178864|NCT02608268|75986065|FG020|Overall Study|Progressive disease|10|||
42178865|NCT02608268|75986066|FG021|Overall Study|Progressive disease|4|||
42178866|NCT02608268|75986067|FG022|Overall Study|Progressive disease|5|||
42178867|NCT02608268|75986068|FG023|Overall Study|Progressive disease|5|||
42178868|NCT02608268|75986069|FG024|Overall Study|Progressive disease|3|||
42178869|NCT02608268|75986070|FG025|Overall Study|Progressive disease|11|||
42178870|NCT02608268|75986071|FG026|Overall Study|Progressive disease|16|||
42178871|NCT02608268|75986072|FG027|Overall Study|Progressive disease|11|||
42178872|NCT02608268|75986073|FG028|Overall Study|Progressive disease|10|||
42178873|NCT02608268|75986074|FG029|Overall Study|Progressive disease|15|||
42178874|NCT02608268|75986045|FG000|Overall Study|Subject/guardian decision|1|||
42178875|NCT02608268|75986046|FG001|Overall Study|Subject/guardian decision|1|||
42178876|NCT02608268|75986047|FG002|Overall Study|Subject/guardian decision|2|||
42178877|NCT02608268|75986048|FG003|Overall Study|Subject/guardian decision|0|||
42178878|NCT02608268|75986049|FG004|Overall Study|Subject/guardian decision|0|||
42178879|NCT02608268|75986050|FG005|Overall Study|Subject/guardian decision|0|||
42178880|NCT02608268|75986051|FG006|Overall Study|Subject/guardian decision|0|||
42294173|NCT04478266|76128525|FG000|Overall Study|Study terminated by sponsor|33|||
42294174|NCT04478266|76128526|FG001|Overall Study|Study terminated by sponsor|35|||
42294175|NCT04478266|76128525|FG000|Overall Study|Other: unspecified|5|||
42294176|NCT04478266|76128526|FG001|Overall Study|Other: unspecified|7|||
42294177|NCT04478266|76128525|FG000|Overall Study|Randomized but not treated|1|||
42294178|NCT04478266|76128526|FG001|Overall Study|Randomized but not treated|1|||
42294179|NCT04233216|76128538|FG000|Overall Study|Lost to Follow-up|0|||
42294180|NCT04233216|76128539|FG001|Overall Study|Lost to Follow-up|0|||
42294181|NCT04233216|76128540|FG002|Overall Study|Lost to Follow-up|2|||
42294182|NCT04233216|76128541|FG003|Overall Study|Lost to Follow-up|0|||
42294183|NCT04233216|76128538|FG000|Overall Study|Physician Decision|0|||
42294184|NCT04233216|76128539|FG001|Overall Study|Physician Decision|1|||
42294185|NCT04233216|76128540|FG002|Overall Study|Physician Decision|0|||
42294186|NCT04233216|76128541|FG003|Overall Study|Physician Decision|0|||
42294187|NCT04233216|76128538|FG000|Overall Study|Withdrawal by Subject|0|||
42294188|NCT04233216|76128539|FG001|Overall Study|Withdrawal by Subject|1|||
42294189|NCT04233216|76128540|FG002|Overall Study|Withdrawal by Subject|1|||
42294190|NCT04233216|76128541|FG003|Overall Study|Withdrawal by Subject|0|||
42294191|NCT04233216|76128538|FG000|Overall Study|Ongoing participation in study|7|||
42294192|NCT04233216|76128539|FG001|Overall Study|Ongoing participation in study|12|||
42294193|NCT04233216|76128540|FG002|Overall Study|Ongoing participation in study|4|||
42294194|NCT04233216|76128541|FG003|Overall Study|Ongoing participation in study|7|||
42294195|NCT04173507|76128552|FG000|Overall Study|On Treatment|3|||
42294196|NCT04173507|76128552|FG000|Overall Study|Adverse Event|3|||
42294197|NCT04173507|76128552|FG000|Overall Study|Progression/Relapse|34|||
42294198|NCT04173507|76128552|FG000|Overall Study|Death|2|||
42294199|NCT03971474|76128558|FG000|Overall Study|Adverse Event|11|||
42294200|NCT03971474|76128559|FG001|Overall Study|Adverse Event|7|||
42294201|NCT03971474|76128558|FG000|Overall Study|Refusal unrelated to adverse event|5|||
42294202|NCT03971474|76128559|FG001|Overall Study|Refusal unrelated to adverse event|1|||
42083644|NCT00790842|75893908|FG005|Expansion Cohort|Death|0|||
42083645|NCT00790842|75893909|FG006|Expansion Cohort|Death|0|||
42083646|NCT00790842|75893910|FG007|Expansion Cohort|Death|0|||
42178881|NCT02608268|75986052|FG007|Overall Study|Subject/guardian decision|0|||
42178882|NCT02608268|75986053|FG008|Overall Study|Subject/guardian decision|2|||
42294203|NCT03971474|76128558|FG000|Overall Study|Progression/relapse|40|||
42294204|NCT03971474|76128559|FG001|Overall Study|Progression/relapse|47|||
42083647|NCT00790842|75893911|FG008|Expansion Cohort|Death|0|||
42083648|NCT00790842|75893912|FG009|Expansion Cohort|Death|0|||
42083649|NCT00790842|75893913|FG010|Expansion Cohort|Death|0|||
42083650|NCT00790842|75893903|FG000|Expansion Cohort|Physician Decision|0|||
42083651|NCT00790842|75893904|FG001|Expansion Cohort|Physician Decision|0|||
42083652|NCT00790842|75893905|FG002|Expansion Cohort|Physician Decision|1|||
42083653|NCT00790842|75893906|FG003|Expansion Cohort|Physician Decision|0|||
42083654|NCT00790842|75893907|FG004|Expansion Cohort|Physician Decision|0|||
42083655|NCT00790842|75893908|FG005|Expansion Cohort|Physician Decision|0|||
42083656|NCT00790842|75893909|FG006|Expansion Cohort|Physician Decision|0|||
42083657|NCT00790842|75893910|FG007|Expansion Cohort|Physician Decision|0|||
42178883|NCT02608268|75986054|FG009|Overall Study|Subject/guardian decision|2|||
42178884|NCT02608268|75986055|FG010|Overall Study|Subject/guardian decision|0|||
42178885|NCT02608268|75986056|FG011|Overall Study|Subject/guardian decision|1|||
42178886|NCT02608268|75986057|FG012|Overall Study|Subject/guardian decision|0|||
42178887|NCT02608268|75986058|FG013|Overall Study|Subject/guardian decision|1|||
42178888|NCT02608268|75986059|FG014|Overall Study|Subject/guardian decision|0|||
42178889|NCT02608268|75986060|FG015|Overall Study|Subject/guardian decision|1|||
42178890|NCT02608268|75986061|FG016|Overall Study|Subject/guardian decision|0|||
42178891|NCT02608268|75986062|FG017|Overall Study|Subject/guardian decision|0|||
42178892|NCT02608268|75986063|FG018|Overall Study|Subject/guardian decision|1|||
42178893|NCT02608268|75986064|FG019|Overall Study|Subject/guardian decision|0|||
42178894|NCT02608268|75986065|FG020|Overall Study|Subject/guardian decision|0|||
42178895|NCT02608268|75986066|FG021|Overall Study|Subject/guardian decision|0|||
42178896|NCT02608268|75986067|FG022|Overall Study|Subject/guardian decision|1|||
42178897|NCT02608268|75986068|FG023|Overall Study|Subject/guardian decision|0|||
42178898|NCT02608268|75986069|FG024|Overall Study|Subject/guardian decision|0|||
42178899|NCT02608268|75986070|FG025|Overall Study|Subject/guardian decision|1|||
42178900|NCT02608268|75986071|FG026|Overall Study|Subject/guardian decision|1|||
42178901|NCT02608268|75986072|FG027|Overall Study|Subject/guardian decision|1|||
42178902|NCT02608268|75986073|FG028|Overall Study|Subject/guardian decision|1|||
42178903|NCT02608268|75986074|FG029|Overall Study|Subject/guardian decision|0|||
42178904|NCT02510261|75986187|FG000|Overall Study|Adverse Event|5|||
42294205|NCT03971474|76128558|FG000|Overall Study|Death|6|||
42294206|NCT03971474|76128559|FG001|Overall Study|Death|3|||
42294207|NCT03971474|76128558|FG000|Overall Study|Other - not protocol specified|5|||
42083658|NCT00790842|75893911|FG008|Expansion Cohort|Physician Decision|0|||
42083659|NCT00790842|75893912|FG009|Expansion Cohort|Physician Decision|0|||
42178905|NCT02510261|75986188|FG001|Overall Study|Adverse Event|8|||
42178906|NCT02510261|75986189|FG002|Overall Study|Adverse Event|0|||
42178907|NCT02510261|75986187|FG000|Overall Study|Physician Decision|1|||
42178908|NCT02510261|75986188|FG001|Overall Study|Physician Decision|5|||
42178909|NCT02510261|75986189|FG002|Overall Study|Physician Decision|0|||
42178910|NCT02510261|75986187|FG000|Overall Study|Death|19|||
42178911|NCT02510261|75986188|FG001|Overall Study|Death|19|||
42178912|NCT02510261|75986189|FG002|Overall Study|Death|0|||
42178913|NCT02510261|75986187|FG000|Overall Study|Withdrawal by Subject|3|||
42178914|NCT02510261|75986188|FG001|Overall Study|Withdrawal by Subject|10|||
42178915|NCT02510261|75986189|FG002|Overall Study|Withdrawal by Subject|3|||
42178916|NCT02506192|75986200|FG000|Overall Study|Withdrawal by Subject|1|||
42178917|NCT02506192|75986201|FG001|Overall Study|Withdrawal by Subject|1|||
42178918|NCT02395666|75986209|FG000|Overall Study|Physician Decision|3|||
42083660|NCT00790842|75893913|FG010|Expansion Cohort|Physician Decision|0|||
42083661|NCT00790842|75893903|FG000|Expansion Cohort|Withdrawal by Subject|0|||
42083662|NCT00790842|75893904|FG001|Expansion Cohort|Withdrawal by Subject|0|||
42083663|NCT00790842|75893905|FG002|Expansion Cohort|Withdrawal by Subject|3|||
42083664|NCT00790842|75893906|FG003|Expansion Cohort|Withdrawal by Subject|0|||
42083665|NCT00790842|75893907|FG004|Expansion Cohort|Withdrawal by Subject|0|||
42083666|NCT00790842|75893908|FG005|Expansion Cohort|Withdrawal by Subject|0|||
42083667|NCT00790842|75893909|FG006|Expansion Cohort|Withdrawal by Subject|0|||
42083668|NCT00790842|75893910|FG007|Expansion Cohort|Withdrawal by Subject|0|||
42083669|NCT00790842|75893911|FG008|Expansion Cohort|Withdrawal by Subject|0|||
42178919|NCT02395666|75986210|FG001|Overall Study|Physician Decision|0|||
42178920|NCT02395666|75986209|FG000|Overall Study|Lost to Follow-up|1|||
42178921|NCT02395666|75986210|FG001|Overall Study|Lost to Follow-up|0|||
42294208|NCT03971474|76128559|FG001|Overall Study|Other - not protocol specified|4|||
42294209|NCT03971474|76128558|FG000|Overall Study|On treatment|0|||
42083670|NCT00790842|75893912|FG009|Expansion Cohort|Withdrawal by Subject|0|||
42083671|NCT00790842|75893913|FG010|Expansion Cohort|Withdrawal by Subject|0|||
42083672|NCT00790842|75893903|FG000|Expansion Cohort|Study Closure|0|||
42083673|NCT00790842|75893904|FG001|Expansion Cohort|Study Closure|0|||
42083674|NCT00790842|75893905|FG002|Expansion Cohort|Study Closure|1|||
42178922|NCT02395666|75986209|FG000|Overall Study|Withdrawal by Subject|2|||
42178923|NCT02395666|75986210|FG001|Overall Study|Withdrawal by Subject|1|||
42178924|NCT02257528|75986220|FG000|Overall Study|Never received study treatment|1|||
42083675|NCT00790842|75893906|FG003|Expansion Cohort|Study Closure|0|||
42083676|NCT00790842|75893907|FG004|Expansion Cohort|Study Closure|0|||
42083677|NCT00790842|75893908|FG005|Expansion Cohort|Study Closure|0|||
42083678|NCT00790842|75893909|FG006|Expansion Cohort|Study Closure|0|||
42083679|NCT00790842|75893910|FG007|Expansion Cohort|Study Closure|0|||
42083680|NCT00790842|75893911|FG008|Expansion Cohort|Study Closure|0|||
42083681|NCT00790842|75893912|FG009|Expansion Cohort|Study Closure|0|||
42083682|NCT00790842|75893913|FG010|Expansion Cohort|Study Closure|0|||
42083683|NCT00574288|75893968|FG000|Overall Study|Adverse Event|2|||
42083684|NCT00574288|75893969|FG001|Overall Study|Adverse Event|0|||
42083685|NCT00574288|75893970|FG002|Overall Study|Adverse Event|0|||
42083686|NCT00574288|75893971|FG003|Overall Study|Adverse Event|0|||
42083687|NCT00574288|75893972|FG004|Overall Study|Adverse Event|1|||
42178925|NCT02223819|75986224|FG000|Overall Study|Lost to Follow-up|2|||
42178926|NCT02048813|75986239|FG000|Overall Study|Still on treatment|279|||
42178927|NCT02048813|75986240|FG001|Overall Study|Still on treatment|0|||
42178928|NCT02048813|75986239|FG000|Overall Study|Adverse Event|40|||
42178929|NCT02048813|75986240|FG001|Overall Study|Adverse Event|38|||
42178930|NCT02048813|75986239|FG000|Overall Study|Disease progression|13|||
42178931|NCT02048813|75986240|FG001|Overall Study|Disease progression|3|||
42178932|NCT02048813|75986239|FG000|Overall Study|Withdrawal by Subject|7|||
42178933|NCT02048813|75986240|FG001|Overall Study|Withdrawal by Subject|8|||
42178934|NCT02048813|75986239|FG000|Overall Study|Death|2|||
42178935|NCT02048813|75986240|FG001|Overall Study|Death|1|||
42178936|NCT02048813|75986239|FG000|Overall Study|Complication|2|||
42178937|NCT02048813|75986240|FG001|Overall Study|Complication|2|||
42178938|NCT02048813|75986239|FG000|Overall Study|Non-protocol therapy|0|||
42178939|NCT02048813|75986240|FG001|Overall Study|Non-protocol therapy|1|||
42178940|NCT02048813|75986239|FG000|Overall Study|Second primary cancer|2|||
42178941|NCT02048813|75986240|FG001|Overall Study|Second primary cancer|0|||
42178942|NCT02048813|75986239|FG000|Overall Study|Insurance|2|||
42178943|NCT02048813|75986240|FG001|Overall Study|Insurance|0|||
42178944|NCT02048813|75986239|FG000|Overall Study|Wound infection/healing|2|||
42178945|NCT02048813|75986240|FG001|Overall Study|Wound infection/healing|0|||
42178946|NCT02048813|75986239|FG000|Overall Study|Missed appointment|3|||
42178947|NCT02048813|75986240|FG001|Overall Study|Missed appointment|0|||
42178948|NCT02048813|75986239|FG000|Overall Study|Never started treatment|2|||
42178949|NCT02048813|75986240|FG001|Overall Study|Never started treatment|17|||
42178950|NCT02030067|75986259|FG000|Overall Study|Disease Progression|1|||
42178951|NCT02030067|75986260|FG001|Overall Study|Disease Progression|1|||
42178952|NCT02030067|75986261|FG002|Overall Study|Disease Progression|2|||
42178953|NCT02030067|75986262|FG003|Overall Study|Disease Progression|2|||
42178954|NCT02030067|75986263|FG004|Overall Study|Disease Progression|3|||
42178955|NCT02030067|75986264|FG005|Overall Study|Disease Progression|2|||
42178956|NCT02030067|75986265|FG006|Overall Study|Disease Progression|3|||
42178957|NCT02030067|75986266|FG007|Overall Study|Disease Progression|3|||
42178958|NCT02030067|75986267|FG008|Overall Study|Disease Progression|4|||
42294210|NCT03971474|76128559|FG001|Overall Study|On treatment|7|||
42083688|NCT00574288|75893973|FG005|Overall Study|Adverse Event|0|||
42083689|NCT00574288|75893974|FG006|Overall Study|Adverse Event|0|||
42083690|NCT00574288|75893968|FG000|Overall Study|Death|0|||
42083691|NCT00574288|75893969|FG001|Overall Study|Death|0|||
42083692|NCT00574288|75893970|FG002|Overall Study|Death|0|||
42083693|NCT00574288|75893971|FG003|Overall Study|Death|0|||
42083694|NCT00574288|75893972|FG004|Overall Study|Death|0|||
42083695|NCT00574288|75893973|FG005|Overall Study|Death|25|||
42083696|NCT00574288|75893974|FG006|Overall Study|Death|21|||
42083697|NCT00574288|75893968|FG000|Overall Study|Lost to Follow-up|0|||
42083698|NCT00574288|75893969|FG001|Overall Study|Lost to Follow-up|0|||
42083699|NCT00574288|75893970|FG002|Overall Study|Lost to Follow-up|0|||
42083700|NCT00574288|75893971|FG003|Overall Study|Lost to Follow-up|0|||
42083701|NCT00574288|75893972|FG004|Overall Study|Lost to Follow-up|0|||
42083702|NCT00574288|75893973|FG005|Overall Study|Lost to Follow-up|1|||
42083703|NCT00574288|75893974|FG006|Overall Study|Lost to Follow-up|2|||
42083704|NCT00574288|75893968|FG000|Overall Study|Study Terminated By Sponsor|0|||
42083705|NCT00574288|75893969|FG001|Overall Study|Study Terminated By Sponsor|0|||
42083706|NCT00574288|75893970|FG002|Overall Study|Study Terminated By Sponsor|0|||
42294211|NCT03901079|76128566|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
42083707|NCT00574288|75893971|FG003|Overall Study|Study Terminated By Sponsor|0|||
42083708|NCT00574288|75893972|FG004|Overall Study|Study Terminated By Sponsor|0|||
42083709|NCT00574288|75893973|FG005|Overall Study|Study Terminated By Sponsor|0|||
42083710|NCT00574288|75893974|FG006|Overall Study|Study Terminated By Sponsor|5|||
42083711|NCT00574288|75893968|FG000|Overall Study|Progressive Disease|17|||
42083712|NCT00574288|75893969|FG001|Overall Study|Progressive Disease|2|||
42083713|NCT00574288|75893970|FG002|Overall Study|Progressive Disease|3|||
42083714|NCT00574288|75893971|FG003|Overall Study|Progressive Disease|2|||
42178959|NCT02030067|75986268|FG009|Overall Study|Disease Progression|3|||
42178960|NCT02030067|75986269|FG010|Overall Study|Disease Progression|7|||
42083715|NCT00574288|75893972|FG004|Overall Study|Progressive Disease|1|||
42083716|NCT00574288|75893973|FG005|Overall Study|Progressive Disease|0|||
42083717|NCT00574288|75893974|FG006|Overall Study|Progressive Disease|0|||
42178961|NCT02030067|75986270|FG011|Overall Study|Disease Progression|2|||
42083718|NCT00574288|75893968|FG000|Overall Study|Other|1|||
42083719|NCT00574288|75893969|FG001|Overall Study|Other|1|||
42083720|NCT00574288|75893970|FG002|Overall Study|Other|0|||
42083721|NCT00574288|75893971|FG003|Overall Study|Other|0|||
42083722|NCT00574288|75893972|FG004|Overall Study|Other|0|||
42083723|NCT00574288|75893973|FG005|Overall Study|Other|0|||
42083724|NCT00574288|75893974|FG006|Overall Study|Other|0|||
42083725|NCT00790452|75894002|FG000|Overall Study|Drug supply issue|1|||
42083726|NCT00790452|75894003|FG001|Overall Study|Drug supply issue|0|||
42083727|NCT00626392|75894015|FG000|Run-in Period|Adverse Event|0|||
42083728|NCT00626392|75894016|FG001|Run-in Period|Adverse Event|0|||
42083729|NCT00626392|75894017|FG002|Run-in Period|Adverse Event|1|||
42083730|NCT00626392|75894018|FG003|Run-in Period|Adverse Event|0|||
42083731|NCT00626392|75894019|FG004|Run-in Period|Adverse Event|1|||
42083732|NCT00626392|75894020|FG005|Run-in Period|Adverse Event|0|||
42083733|NCT00626392|75894015|FG000|Run-in Period|Withdrawal by Subject|0|||
42083734|NCT00626392|75894016|FG001|Run-in Period|Withdrawal by Subject|1|||
42083735|NCT00626392|75894017|FG002|Run-in Period|Withdrawal by Subject|1|||
42083736|NCT00626392|75894018|FG003|Run-in Period|Withdrawal by Subject|1|||
42083737|NCT00626392|75894019|FG004|Run-in Period|Withdrawal by Subject|3|||
42083738|NCT00626392|75894020|FG005|Run-in Period|Withdrawal by Subject|1|||
42083739|NCT00626392|75894015|FG000|Run-in Period|Noncompliance|1|||
42083740|NCT00626392|75894016|FG001|Run-in Period|Noncompliance|0|||
42083741|NCT00626392|75894017|FG002|Run-in Period|Noncompliance|1|||
42083742|NCT00626392|75894018|FG003|Run-in Period|Noncompliance|0|||
42083743|NCT00626392|75894019|FG004|Run-in Period|Noncompliance|0|||
42083744|NCT00626392|75894020|FG005|Run-in Period|Noncompliance|0|||
42083745|NCT00626392|75894015|FG000|Coadministration Period|Adverse Event|3|||
42083746|NCT00626392|75894016|FG001|Coadministration Period|Adverse Event|1|||
42083747|NCT00626392|75894017|FG002|Coadministration Period|Adverse Event|7|||
42083748|NCT00626392|75894018|FG003|Coadministration Period|Adverse Event|4|||
42083749|NCT00626392|75894019|FG004|Coadministration Period|Adverse Event|3|||
42083750|NCT00626392|75894020|FG005|Coadministration Period|Adverse Event|4|||
42083751|NCT00626392|75894015|FG000|Coadministration Period|Withdrawal by Subject|1|||
42083752|NCT00626392|75894016|FG001|Coadministration Period|Withdrawal by Subject|1|||
42083753|NCT00626392|75894017|FG002|Coadministration Period|Withdrawal by Subject|0|||
42083754|NCT00626392|75894018|FG003|Coadministration Period|Withdrawal by Subject|1|||
42178962|NCT02030067|75986271|FG012|Overall Study|Disease Progression|59|||
42178963|NCT02030067|75986259|FG000|Overall Study|Withdrawal by Subject|0|||
42178964|NCT02030067|75986260|FG001|Overall Study|Withdrawal by Subject|0|||
42178965|NCT02030067|75986261|FG002|Overall Study|Withdrawal by Subject|0|||
42178966|NCT02030067|75986262|FG003|Overall Study|Withdrawal by Subject|1|||
42178967|NCT02030067|75986263|FG004|Overall Study|Withdrawal by Subject|0|||
42178968|NCT02030067|75986264|FG005|Overall Study|Withdrawal by Subject|0|||
42178969|NCT02030067|75986265|FG006|Overall Study|Withdrawal by Subject|0|||
42178970|NCT02030067|75986266|FG007|Overall Study|Withdrawal by Subject|1|||
42178971|NCT02030067|75986267|FG008|Overall Study|Withdrawal by Subject|0|||
42178972|NCT02030067|75986268|FG009|Overall Study|Withdrawal by Subject|0|||
42178973|NCT02030067|75986269|FG010|Overall Study|Withdrawal by Subject|3|||
42178974|NCT02030067|75986270|FG011|Overall Study|Withdrawal by Subject|0|||
42178975|NCT02030067|75986271|FG012|Overall Study|Withdrawal by Subject|6|||
42178976|NCT02030067|75986259|FG000|Overall Study|Physician Decision|0|||
42178977|NCT02030067|75986260|FG001|Overall Study|Physician Decision|0|||
42178978|NCT02030067|75986261|FG002|Overall Study|Physician Decision|0|||
42178979|NCT02030067|75986262|FG003|Overall Study|Physician Decision|0|||
42178980|NCT02030067|75986263|FG004|Overall Study|Physician Decision|0|||
42178981|NCT02030067|75986264|FG005|Overall Study|Physician Decision|0|||
42178982|NCT02030067|75986265|FG006|Overall Study|Physician Decision|0|||
42178983|NCT02030067|75986266|FG007|Overall Study|Physician Decision|0|||
42178984|NCT02030067|75986267|FG008|Overall Study|Physician Decision|0|||
42178985|NCT02030067|75986268|FG009|Overall Study|Physician Decision|0|||
42178986|NCT02030067|75986269|FG010|Overall Study|Physician Decision|1|||
42178987|NCT02030067|75986270|FG011|Overall Study|Physician Decision|0|||
42178988|NCT02030067|75986271|FG012|Overall Study|Physician Decision|3|||
42178989|NCT02030067|75986259|FG000|Overall Study|other reasons|0|||
42178990|NCT02030067|75986260|FG001|Overall Study|other reasons|0|||
42178991|NCT02030067|75986261|FG002|Overall Study|other reasons|0|||
42178992|NCT02030067|75986262|FG003|Overall Study|other reasons|0|||
42083755|NCT00626392|75894019|FG004|Coadministration Period|Withdrawal by Subject|0|||
42083756|NCT00626392|75894020|FG005|Coadministration Period|Withdrawal by Subject|1|||
42083757|NCT00626392|75894015|FG000|Coadministration Period|Protocol Violation|0|||
42083758|NCT00626392|75894016|FG001|Coadministration Period|Protocol Violation|1|||
42083759|NCT00626392|75894017|FG002|Coadministration Period|Protocol Violation|0|||
42083760|NCT00626392|75894018|FG003|Coadministration Period|Protocol Violation|1|||
42178993|NCT02030067|75986263|FG004|Overall Study|other reasons|0|||
42178994|NCT02030067|75986264|FG005|Overall Study|other reasons|1|||
42178995|NCT02030067|75986265|FG006|Overall Study|other reasons|0|||
42178996|NCT02030067|75986266|FG007|Overall Study|other reasons|0|||
42083761|NCT00626392|75894019|FG004|Coadministration Period|Protocol Violation|1|||
42083762|NCT00626392|75894020|FG005|Coadministration Period|Protocol Violation|0|||
42083763|NCT00626392|75894015|FG000|Coadministration Period|Other|0|||
42083764|NCT00626392|75894016|FG001|Coadministration Period|Other|2|||
42083765|NCT00626392|75894017|FG002|Coadministration Period|Other|3|||
42083766|NCT00626392|75894018|FG003|Coadministration Period|Other|1|||
42083767|NCT00626392|75894019|FG004|Coadministration Period|Other|1|||
42083768|NCT00626392|75894020|FG005|Coadministration Period|Other|1|||
42083769|NCT00624286|75894028|FG000|Overall Study|Protocol Deviation|7|||
42083770|NCT00624286|75894029|FG001|Overall Study|Protocol Deviation|9|||
42083771|NCT00624286|75894028|FG000|Overall Study|Adverse Event|6|||
42083772|NCT00624286|75894029|FG001|Overall Study|Adverse Event|3|||
42083773|NCT00624286|75894028|FG000|Overall Study|Withdrawal by Subject|5|||
42083774|NCT00624286|75894029|FG001|Overall Study|Withdrawal by Subject|4|||
42083775|NCT00624286|75894028|FG000|Overall Study|Lost to Follow-up|3|||
42083776|NCT00624286|75894029|FG001|Overall Study|Lost to Follow-up|2|||
42083777|NCT00624286|75894028|FG000|Overall Study|Administrative problems|3|||
42083778|NCT00624286|75894029|FG001|Overall Study|Administrative problems|0|||
42083779|NCT00624286|75894028|FG000|Overall Study|Lack of Efficacy|1|||
42083780|NCT00624286|75894029|FG001|Overall Study|Lack of Efficacy|6|||
42083781|NCT00624286|75894028|FG000|Overall Study|Not stated|0|||
42083782|NCT00624286|75894029|FG001|Overall Study|Not stated|1|||
42083783|NCT00624286|75894028|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42083784|NCT00624286|75894029|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42358274|NCT01875367|76203844|FG000|Overall Study|Not complete at least 2 questionaries|4|||
42358275|NCT01875367|76203845|FG001|Overall Study|Not complete at least 2 questionaries|2|||
42358276|NCT01875367|76203844|FG000|Overall Study|Not receive study treatment|1|||
42358277|NCT01875367|76203845|FG001|Overall Study|Not receive study treatment|0|||
42358278|NCT01853839|76203855|FG000|Overall Study|Violated inclusion criteria|2|||
42358279|NCT01853839|76203855|FG000|Overall Study|Not meet ITT population definition|58|||
42083785|NCT00624286|75894028|FG000|Overall Study|Death|0|||
42083786|NCT00624286|75894029|FG001|Overall Study|Death|1|||
42083787|NCT00624052|75894039|FG000|Overall Study|Adverse Event|7|||
42083788|NCT00624052|75894040|FG001|Overall Study|Adverse Event|6|||
42358280|NCT01853839|76203855|FG000|Overall Study|End of treatment visit too early|33|||
42358281|NCT01853839|76203855|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
42358282|NCT01874665|76203865|FG000|Overall Study|Adverse Event|6|||
42358283|NCT01874665|76203866|FG001|Overall Study|Adverse Event|2|||
42358284|NCT01874665|76203865|FG000|Overall Study|Withdrawal by Subject|4|||
42358285|NCT01874665|76203866|FG001|Overall Study|Withdrawal by Subject|1|||
42358286|NCT01874665|76203865|FG000|Overall Study|Physician Decision|3|||
42358287|NCT01874665|76203866|FG001|Overall Study|Physician Decision|0|||
42358288|NCT01874665|76203865|FG000|Overall Study|Clinical Progressive Disease|4|||
42358289|NCT01874665|76203866|FG001|Overall Study|Clinical Progressive Disease|3|||
42358290|NCT01874665|76203865|FG000|Overall Study|Study Terminated by Sponsor|0|||
42358291|NCT01874665|76203866|FG001|Overall Study|Study Terminated by Sponsor|2|||
42358292|NCT01874665|76203865|FG000|Overall Study|Documented Progressive Disease|11|||
42358293|NCT01874665|76203866|FG001|Overall Study|Documented Progressive Disease|7|||
42358294|NCT01874665|76203865|FG000|Overall Study|Other|2|||
42083789|NCT00624052|75894041|FG002|Overall Study|Adverse Event|0|||
42083790|NCT00624052|75894042|FG003|Overall Study|Adverse Event|3|||
42083791|NCT00624052|75894039|FG000|Overall Study|Lack of Efficacy|1|||
42083792|NCT00624052|75894040|FG001|Overall Study|Lack of Efficacy|1|||
42083793|NCT00624052|75894041|FG002|Overall Study|Lack of Efficacy|0|||
42083794|NCT00624052|75894042|FG003|Overall Study|Lack of Efficacy|0|||
42083795|NCT00624052|75894039|FG000|Overall Study|Lost to Follow-up|2|||
42083796|NCT00624052|75894040|FG001|Overall Study|Lost to Follow-up|3|||
42083797|NCT00624052|75894041|FG002|Overall Study|Lost to Follow-up|1|||
42083798|NCT00624052|75894042|FG003|Overall Study|Lost to Follow-up|0|||
42083799|NCT00624052|75894039|FG000|Overall Study|Non compliant with the protocol|2|||
42083800|NCT00624052|75894040|FG001|Overall Study|Non compliant with the protocol|1|||
42358295|NCT01874665|76203866|FG001|Overall Study|Other|0|||
42083801|NCT00624052|75894041|FG002|Overall Study|Non compliant with the protocol|1|||
42083802|NCT00624052|75894042|FG003|Overall Study|Non compliant with the protocol|1|||
42083803|NCT00624052|75894039|FG000|Overall Study|Consent withdrawn|3|||
42083804|NCT00624052|75894040|FG001|Overall Study|Consent withdrawn|1|||
42083805|NCT00624052|75894041|FG002|Overall Study|Consent withdrawn|1|||
42083806|NCT00624052|75894042|FG003|Overall Study|Consent withdrawn|0|||
42083807|NCT00624052|75894039|FG000|Overall Study|Changed job/ran out if meds|0|||
42083808|NCT00624052|75894040|FG001|Overall Study|Changed job/ran out if meds|2|||
42083809|NCT00624052|75894041|FG002|Overall Study|Changed job/ran out if meds|0|||
42083810|NCT00624052|75894042|FG003|Overall Study|Changed job/ran out if meds|0|||
42358296|NCT01874431|76203881|FG000|Overall Study|Physician Decision|0|||
42083811|NCT00785577|75894061|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
42358297|NCT01874431|76203882|FG001|Overall Study|Physician Decision|0|||
42358298|NCT01874431|76203883|FG002|Overall Study|Physician Decision|1|||
42083812|NCT00785577|75894062|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
42083813|NCT00785577|75894063|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
42083814|NCT00785577|75894064|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
42083815|NCT00785577|75894065|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
42083816|NCT00785577|75894061|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
42083817|NCT00785577|75894062|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
42083818|NCT00785577|75894063|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
42083819|NCT00785577|75894064|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
42083820|NCT00785577|75894065|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
42083821|NCT00785577|75894061|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
42358299|NCT01874431|76203884|FG003|Overall Study|Physician Decision|0|||
42358300|NCT01874431|76203885|FG004|Overall Study|Physician Decision|0|||
42358301|NCT01874431|76203886|FG005|Overall Study|Physician Decision|0|||
42358302|NCT01874431|76203887|FG006|Overall Study|Physician Decision|0|||
42358303|NCT01874431|76203888|FG007|Overall Study|Physician Decision|0|||
42358304|NCT01874431|76203881|FG000|Overall Study|Adverse Event|5|||
42358305|NCT01874431|76203882|FG001|Overall Study|Adverse Event|4|||
42083822|NCT00785577|75894062|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
42083823|NCT00785577|75894063|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
42083824|NCT00785577|75894064|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
42083825|NCT00785577|75894065|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
42083826|NCT00785577|75894061|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
42358306|NCT01874431|76203883|FG002|Overall Study|Adverse Event|6|||
42358307|NCT01874431|76203884|FG003|Overall Study|Adverse Event|5|||
42358308|NCT01874431|76203885|FG004|Overall Study|Adverse Event|2|||
42358309|NCT01874431|76203886|FG005|Overall Study|Adverse Event|8|||
42358310|NCT01874431|76203887|FG006|Overall Study|Adverse Event|2|||
42358311|NCT01874431|76203888|FG007|Overall Study|Adverse Event|3|||
42358312|NCT01874431|76203881|FG000|Overall Study|Protocol Violation|1|||
42358313|NCT01874431|76203882|FG001|Overall Study|Protocol Violation|1|||
42358314|NCT01874431|76203883|FG002|Overall Study|Protocol Violation|1|||
42358315|NCT01874431|76203884|FG003|Overall Study|Protocol Violation|0|||
42358316|NCT01874431|76203885|FG004|Overall Study|Protocol Violation|3|||
42358317|NCT01874431|76203886|FG005|Overall Study|Protocol Violation|2|||
42358318|NCT01874431|76203887|FG006|Overall Study|Protocol Violation|1|||
42358319|NCT01874431|76203888|FG007|Overall Study|Protocol Violation|1|||
42358320|NCT01874431|76203881|FG000|Overall Study|Non-compliance|0|||
42358321|NCT01874431|76203882|FG001|Overall Study|Non-compliance|0|||
42358322|NCT01874431|76203883|FG002|Overall Study|Non-compliance|0|||
42358323|NCT01874431|76203884|FG003|Overall Study|Non-compliance|0|||
42358324|NCT01874431|76203885|FG004|Overall Study|Non-compliance|1|||
42358325|NCT01874431|76203886|FG005|Overall Study|Non-compliance|0|||
42358326|NCT01874431|76203887|FG006|Overall Study|Non-compliance|1|||
42083827|NCT00785577|75894062|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
42083828|NCT00785577|75894063|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
42083829|NCT00785577|75894064|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
42083830|NCT00785577|75894065|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
42083831|NCT00785577|75894061|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
42083832|NCT00785577|75894062|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
42083833|NCT00785577|75894063|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
42083834|NCT00785577|75894064|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
42083835|NCT00785577|75894065|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
42083836|NCT00785577|75894061|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
42083837|NCT00785577|75894062|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
42083838|NCT00785577|75894063|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
42083839|NCT00785577|75894064|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
42083840|NCT00785577|75894065|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
42083841|NCT00785577|75894061|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
42083842|NCT00785577|75894062|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
42083843|NCT00785577|75894063|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
42358327|NCT01874431|76203888|FG007|Overall Study|Non-compliance|0|||
42358328|NCT01874431|76203881|FG000|Overall Study|Logistical difficulties|0|||
42083844|NCT00785577|75894064|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
42358329|NCT01874431|76203882|FG001|Overall Study|Logistical difficulties|0|||
42358330|NCT01874431|76203883|FG002|Overall Study|Logistical difficulties|0|||
42358331|NCT01874431|76203884|FG003|Overall Study|Logistical difficulties|0|||
42358332|NCT01874431|76203885|FG004|Overall Study|Logistical difficulties|0|||
42358333|NCT01874431|76203886|FG005|Overall Study|Logistical difficulties|0|||
42358334|NCT01874431|76203887|FG006|Overall Study|Logistical difficulties|1|||
42358335|NCT01874431|76203888|FG007|Overall Study|Logistical difficulties|0|||
42358336|NCT01874431|76203881|FG000|Overall Study|Withdrawal by Subject|0|||
42358337|NCT01874431|76203882|FG001|Overall Study|Withdrawal by Subject|0|||
42358338|NCT01874431|76203883|FG002|Overall Study|Withdrawal by Subject|1|||
42358339|NCT01874431|76203884|FG003|Overall Study|Withdrawal by Subject|2|||
42083845|NCT00785577|75894065|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
42083846|NCT00785577|75894061|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
42083847|NCT00785577|75894062|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
42083848|NCT00785577|75894063|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
42083849|NCT00785577|75894064|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
42083850|NCT00785577|75894065|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
42083851|NCT00785577|75894061|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
42083852|NCT00785577|75894062|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
42083853|NCT00785577|75894063|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
42083854|NCT00785577|75894064|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
42358340|NCT01874431|76203885|FG004|Overall Study|Withdrawal by Subject|1|||
42358341|NCT01874431|76203886|FG005|Overall Study|Withdrawal by Subject|1|||
42358342|NCT01874431|76203887|FG006|Overall Study|Withdrawal by Subject|3|||
42358343|NCT01874431|76203888|FG007|Overall Study|Withdrawal by Subject|0|||
42358344|NCT01874431|76203881|FG000|Overall Study|Sponsor decision|0|||
42358345|NCT01874431|76203882|FG001|Overall Study|Sponsor decision|0|||
42358346|NCT01874431|76203883|FG002|Overall Study|Sponsor decision|0|||
42358347|NCT01874431|76203884|FG003|Overall Study|Sponsor decision|0|||
42358348|NCT01874431|76203885|FG004|Overall Study|Sponsor decision|1|||
42358349|NCT01874431|76203886|FG005|Overall Study|Sponsor decision|0|||
42358350|NCT01874431|76203887|FG006|Overall Study|Sponsor decision|0|||
42358351|NCT01874431|76203888|FG007|Overall Study|Sponsor decision|0|||
42358352|NCT01874431|76203881|FG000|Overall Study|Lost to Follow-up|0|||
42358353|NCT01874431|76203882|FG001|Overall Study|Lost to Follow-up|0|||
42358354|NCT01874431|76203883|FG002|Overall Study|Lost to Follow-up|1|||
42358355|NCT01874431|76203884|FG003|Overall Study|Lost to Follow-up|0|||
42358356|NCT01874431|76203885|FG004|Overall Study|Lost to Follow-up|0|||
42358357|NCT01874431|76203886|FG005|Overall Study|Lost to Follow-up|0|||
42358358|NCT01874431|76203887|FG006|Overall Study|Lost to Follow-up|0|||
42358359|NCT01874431|76203888|FG007|Overall Study|Lost to Follow-up|0|||
42358360|NCT01824355|76203906|FG000|Overall Study|Adverse Event|2|||
42358361|NCT01824355|76203906|FG000|Overall Study|unevaluable reference method results per|1|||
42358362|NCT01823341|76203914|FG000|Overall Study|Failed run-in|7|||
42358363|NCT01823341|76203914|FG000|Overall Study|Withdrawal by Subject|7|||
42358364|NCT01823341|76203914|FG000|Overall Study|Adverse Event|1|||
42358365|NCT01853137|76203923|FG000|Overall Study|Lost to Follow-up|4|||
42358366|NCT01853137|76203924|FG001|Overall Study|Lost to Follow-up|1|||
42358367|NCT01823107|76203931|FG000|Overall Study|Withdrawal by Subject|1|||
42358368|NCT01874275|76203937|FG000|Overall Study|Lost to Follow-up|1|||
42358369|NCT01874275|76203938|FG001|Overall Study|Lost to Follow-up|0|||
42358370|NCT01873729|76203950|FG000|Overall Study|Withdrawal by Subject|1|||
42358371|NCT01873495|76203954|FG000|Overall Study|Withdrawal by Subject|1|||
42358372|NCT01873495|76203954|FG000|Overall Study|Physician Decision|3|||
42358373|NCT01873495|76203954|FG000|Overall Study|Adverse Event|1|||
42358374|NCT01873495|76203954|FG000|Overall Study|Removed for Transplantation|1|||
42358375|NCT01873495|76203954|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
42083855|NCT00785577|75894065|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
42083856|NCT00785577|75894061|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
42083857|NCT00785577|75894062|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
42083858|NCT00785577|75894063|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
42083859|NCT00785577|75894064|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
42083860|NCT00785577|75894065|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
42083861|NCT00789828|75894089|FG000|Core Period (48 Weeks)|Administrative problems|0|||
42083862|NCT00789828|75894090|FG001|Core Period (48 Weeks)|Administrative problems|1|||
42083863|NCT00789828|75894089|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
42083864|NCT00789828|75894090|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
42083865|NCT00789828|75894089|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
42083866|NCT00789828|75894090|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
42083867|NCT00789828|75894089|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
42083868|NCT00789828|75894090|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
42083869|NCT00789828|75894089|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
42083870|NCT00789828|75894090|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
42083871|NCT00789828|75894089|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
42358376|NCT01852825|76203961|FG000|Overall Study|Withdrawal by Subject|2|||
42358377|NCT01852825|76203962|FG001|Overall Study|Withdrawal by Subject|0|||
42358378|NCT01852825|76203963|FG002|Overall Study|Withdrawal by Subject|0|||
42358379|NCT01822561|76203971|FG000|Overall Study|Withdrawal by Subject|2|||
42358380|NCT01852591|76203996|FG000|Overall Study|Withdrawal by Subject|2|||
42358381|NCT01852591|76203996|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
42358382|NCT01852045|76204003|FG000|Overall Study|Adverse Event|1|||
42358383|NCT01852045|76204004|FG001|Overall Study|Adverse Event|0|||
42358384|NCT01852045|76204005|FG002|Overall Study|Adverse Event|0|||
42358385|NCT01852045|76204003|FG000|Overall Study|Lack of Efficacy|3|||
42358386|NCT01852045|76204004|FG001|Overall Study|Lack of Efficacy|0|||
42358387|NCT01852045|76204005|FG002|Overall Study|Lack of Efficacy|0|||
42358388|NCT01852045|76204003|FG000|Overall Study|Lost to Follow-up|0|||
42358389|NCT01852045|76204004|FG001|Overall Study|Lost to Follow-up|1|||
42358390|NCT01852045|76204005|FG002|Overall Study|Lost to Follow-up|1|||
42358391|NCT01852045|76204003|FG000|Overall Study|Withdrawal by Subject|1|||
42358392|NCT01852045|76204004|FG001|Overall Study|Withdrawal by Subject|0|||
42358393|NCT01852045|76204005|FG002|Overall Study|Withdrawal by Subject|1|||
42358394|NCT01852045|76204003|FG000|Overall Study|Other Miscellaneous Reasons|1|||
42358395|NCT01852045|76204004|FG001|Overall Study|Other Miscellaneous Reasons|3|||
42358396|NCT01852045|76204005|FG002|Overall Study|Other Miscellaneous Reasons|2|||
42358397|NCT01821937|76204024|FG000|Overall Study|Adverse Event|0|||
42358398|NCT01821937|76204025|FG001|Overall Study|Adverse Event|3|||
42358399|NCT01821625|76204033|FG000|Overall Study|Withdrawal by Subject|2|||
42358400|NCT01821625|76204033|FG000|Overall Study|Lack of Efficacy|2|||
42358401|NCT01821625|76204033|FG000|Overall Study|Adverse Event|1|||
42358402|NCT01821625|76204033|FG000|Overall Study|Medical contraindication|1|||
42358403|NCT01821391|76204039|FG000|Overall Study|Adverse Event|1|||
42358404|NCT01821391|76204040|FG001|Overall Study|Adverse Event|0|||
42083872|NCT00789828|75894090|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
42083873|NCT00789828|75894089|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
42083874|NCT00789828|75894090|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
42083875|NCT00789828|75894089|FG000|Open-label Extension Period (4 Years)|Death|1|||
42083876|NCT00789828|75894090|FG001|Open-label Extension Period (4 Years)|Death|0|||
42083877|NCT00789828|75894089|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
42083878|NCT00789828|75894090|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
42083879|NCT00789828|75894089|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
42083880|NCT00789828|75894090|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
42083881|NCT00790296|75894101|FG000|Overall Study|Did not meet study eligibility criteria|1|||
42083882|NCT00790296|75894102|FG001|Overall Study|Did not meet study eligibility criteria|1|||
42083883|NCT00790296|75894101|FG000|Overall Study|Adverse Event|0|||
42083884|NCT00790296|75894102|FG001|Overall Study|Adverse Event|1|||
42083885|NCT00623194|75894108|FG000|Overall Study|Lack of Efficacy|1|||
42083886|NCT00623194|75894108|FG000|Overall Study|Protocol Violation|3|||
42083887|NCT00623194|75894108|FG000|Overall Study|Unclassified|1|||
42083888|NCT00784368|75894115|FG000|Overall Study|Physician Decision|0|||
42083889|NCT00784368|75894116|FG001|Overall Study|Physician Decision|0|||
42083890|NCT00784368|75894117|FG002|Overall Study|Physician Decision|6|||
42083891|NCT00784368|75894115|FG000|Overall Study|Lack of Efficacy|2|||
42083892|NCT00784368|75894116|FG001|Overall Study|Lack of Efficacy|0|||
42083893|NCT00784368|75894117|FG002|Overall Study|Lack of Efficacy|1|||
42083894|NCT00784368|75894115|FG000|Overall Study|Adverse Event|6|||
42083895|NCT00784368|75894116|FG001|Overall Study|Adverse Event|9|||
42083896|NCT00784368|75894117|FG002|Overall Study|Adverse Event|2|||
42083897|NCT00784368|75894115|FG000|Overall Study|Diagnosis of fever|0|||
42083898|NCT00784368|75894116|FG001|Overall Study|Diagnosis of fever|0|||
42083899|NCT00784368|75894117|FG002|Overall Study|Diagnosis of fever|1|||
42083900|NCT00784368|75894115|FG000|Overall Study|Worsening of complications|0|||
42083901|NCT00784368|75894116|FG001|Overall Study|Worsening of complications|0|||
42083902|NCT00784368|75894117|FG002|Overall Study|Worsening of complications|1|||
42083903|NCT00784368|75894115|FG000|Overall Study|Worsening of symptoms|0|||
42083904|NCT00784368|75894116|FG001|Overall Study|Worsening of symptoms|1|||
42083905|NCT00784368|75894117|FG002|Overall Study|Worsening of symptoms|0|||
42083906|NCT00784368|75894115|FG000|Overall Study|Withdrawal of informed consent|0|||
42083907|NCT00784368|75894116|FG001|Overall Study|Withdrawal of informed consent|1|||
42083908|NCT00784368|75894117|FG002|Overall Study|Withdrawal of informed consent|0|||
42083909|NCT00622726|75894130|FG000|March, 2008 to August, 2010|Death|5|||
42083910|NCT00622726|75894131|FG001|March, 2008 to August, 2010|Death|2|||
42083911|NCT00622726|75894130|FG000|August, 2010 to April, 2013|Death|1|||
42358405|NCT01873417|76204048|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
42358406|NCT01873417|76204048|FG000|Overall Study|Adverse Event|24|||
42358407|NCT01873417|76204048|FG000|Overall Study|Lost to Follow-up|2|||
42358408|NCT01873417|76204048|FG000|Overall Study|Withdrawal by Subject|2|||
42083912|NCT00622726|75894131|FG001|August, 2010 to April, 2013|Death|5|||
42083913|NCT00623428|75894143|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
42083914|NCT00623428|75894144|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
42083915|NCT00623428|75894143|FG000|Treatment Period|Death|0|||
42083916|NCT00623428|75894144|FG001|Treatment Period|Death|1|||
42358409|NCT01873417|76204048|FG000|Overall Study|Physician Decision|3|||
42358410|NCT01872715|76204052|FG000|Overall Study|Adverse Event|1|||
42358411|NCT01872715|76204052|FG000|Overall Study|Protocol Violation|1|||
42083917|NCT00623428|75894143|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
42083918|NCT00623428|75894144|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
42083919|NCT00623428|75894143|FG000|Treatment Period|Insufficient therapeutic response|0|||
42083920|NCT00623428|75894144|FG001|Treatment Period|Insufficient therapeutic response|2|||
42083921|NCT00623428|75894143|FG000|Treatment Period|Other|0|||
42083922|NCT00623428|75894144|FG001|Treatment Period|Other|1|||
42083923|NCT00623428|75894143|FG000|Treatment Period|Withdrawal by Subject|0|||
42294212|NCT03845296|76128572|FG000|Overall Study|On Treatment|2|||
42294213|NCT03845296|76128573|FG001|Overall Study|On Treatment|1|||
42294214|NCT03845296|76128572|FG000|Overall Study|Adverse Event|4|||
42294215|NCT03845296|76128573|FG001|Overall Study|Adverse Event|11|||
42294216|NCT03845296|76128572|FG000|Overall Study|Refusal unrelated to adverse event|0|||
42083924|NCT00623428|75894144|FG001|Treatment Period|Withdrawal by Subject|1|||
42083925|NCT00623428|75894143|FG000|Follow-up Period|Relapse post-treatment|11|||
42083926|NCT00623428|75894144|FG001|Follow-up Period|Relapse post-treatment|3|||
42083927|NCT00623428|75894143|FG000|Follow-up Period|Failure to return|10|||
42083928|NCT00623428|75894144|FG001|Follow-up Period|Failure to return|2|||
42083929|NCT00623428|75894143|FG000|Follow-up Period|Patient withdrew consent|5|||
42083930|NCT00623428|75894144|FG001|Follow-up Period|Patient withdrew consent|4|||
42083931|NCT00623428|75894143|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
42083932|NCT00623428|75894144|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
42083933|NCT00623428|75894143|FG000|Follow-up Period|Did not cooperate|0|||
42083934|NCT00623428|75894144|FG001|Follow-up Period|Did not cooperate|3|||
42083935|NCT00623428|75894143|FG000|Follow-up Period|Reason not specified|1|||
42083936|NCT00623428|75894144|FG001|Follow-up Period|Reason not specified|1|||
42083937|NCT00623428|75894143|FG000|Follow-up Period|Death|0|||
42083938|NCT00623428|75894144|FG001|Follow-up Period|Death|1|||
42083939|NCT00784134|75894152|FG000|Overall Study|Lost to Follow-up|3|||
42083940|NCT00784134|75894153|FG001|Overall Study|Lost to Follow-up|6|||
42083941|NCT00776100|75894161|FG000|Overall Study|Disease Progression|1|||
42083942|NCT00776100|75894162|FG001|Overall Study|Disease Progression|0|||
42083943|NCT00783432|75894170|FG000|Overall Study|Adverse Event|22|||
42083944|NCT00783432|75894171|FG001|Overall Study|Adverse Event|17|||
42083945|NCT00783432|75894170|FG000|Overall Study|Lack of Efficacy|20|||
42083946|NCT00783432|75894171|FG001|Overall Study|Lack of Efficacy|21|||
42083947|NCT00783432|75894170|FG000|Overall Study|Lost to Follow-up|11|||
42083948|NCT00783432|75894171|FG001|Overall Study|Lost to Follow-up|6|||
42083949|NCT00783432|75894170|FG000|Overall Study|Withdrawal by Subject|23|||
42083950|NCT00783432|75894171|FG001|Overall Study|Withdrawal by Subject|20|||
42083951|NCT00783432|75894170|FG000|Overall Study|subject moved|3|||
42083952|NCT00783432|75894171|FG001|Overall Study|subject moved|5|||
42083953|NCT00783432|75894170|FG000|Overall Study|Protocol Violation|6|||
42083954|NCT00783432|75894171|FG001|Overall Study|Protocol Violation|9|||
42083955|NCT00783198|75894180|FG000|Overall Study|Adverse Event|15|||
42083956|NCT00783198|75894181|FG001|Overall Study|Adverse Event|19|||
42294217|NCT03845296|76128573|FG001|Overall Study|Refusal unrelated to adverse event|1|||
42294218|NCT03845296|76128572|FG000|Overall Study|Progression/relapse|14|||
42294219|NCT03845296|76128573|FG001|Overall Study|Progression/relapse|18|||
42294220|NCT03845296|76128572|FG000|Overall Study|Death|4|||
42083957|NCT00783198|75894182|FG002|Overall Study|Adverse Event|3|||
42083958|NCT00783198|75894180|FG000|Overall Study|Lost to Follow-up|11|||
42083959|NCT00783198|75894181|FG001|Overall Study|Lost to Follow-up|1|||
42083960|NCT00783198|75894182|FG002|Overall Study|Lost to Follow-up|7|||
42083961|NCT00783198|75894180|FG000|Overall Study|Withdrawal by Subject|22|||
42083962|NCT00783198|75894181|FG001|Overall Study|Withdrawal by Subject|14|||
42294221|NCT03845296|76128573|FG001|Overall Study|Death|0|||
42294222|NCT03845296|76128572|FG000|Overall Study|Other - not protocol specified|1|||
42294223|NCT03845296|76128573|FG001|Overall Study|Other - not protocol specified|3|||
42083963|NCT00783198|75894182|FG002|Overall Study|Withdrawal by Subject|20|||
42083964|NCT00783198|75894180|FG000|Overall Study|Noncompliance with protocol|7|||
42083965|NCT00783198|75894181|FG001|Overall Study|Noncompliance with protocol|7|||
42083966|NCT00783198|75894182|FG002|Overall Study|Noncompliance with protocol|10|||
42083967|NCT00783198|75894180|FG000|Overall Study|Did not meet protocol eligibility|0|||
42083968|NCT00783198|75894181|FG001|Overall Study|Did not meet protocol eligibility|1|||
42178997|NCT02030067|75986267|FG008|Overall Study|other reasons|2|||
42083969|NCT00783198|75894182|FG002|Overall Study|Did not meet protocol eligibility|0|||
42083970|NCT00783198|75894180|FG000|Overall Study|Administrative|2|||
42083971|NCT00783198|75894181|FG001|Overall Study|Administrative|1|||
42083972|NCT00783198|75894182|FG002|Overall Study|Administrative|2|||
42083973|NCT00789360|75894192|FG000|Overall Study|Protocol Violation|3|||
42083974|NCT00789360|75894193|FG001|Overall Study|Protocol Violation|1|||
42083975|NCT00782496|75894202|FG000|Overall Study|Lost to Follow-up|14|||
42083976|NCT00782496|75894203|FG001|Overall Study|Lost to Follow-up|15|||
42083977|NCT00782418|75894210|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
42083978|NCT00782418|75894211|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
42083979|NCT00782418|75894212|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
42083980|NCT00782418|75894213|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
42083981|NCT00782418|75894214|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
42083982|NCT00782418|75894215|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
42083983|NCT00782418|75894216|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
42083984|NCT00782418|75894210|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
42083985|NCT00782418|75894211|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
42083986|NCT00782418|75894212|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
42083987|NCT00782418|75894213|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
42083988|NCT00782418|75894214|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
42083989|NCT00782418|75894215|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
42083990|NCT00782418|75894216|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
42083991|NCT00782340|75894233|FG000|Open Label Titration|Adverse Event|12|||
42083992|NCT00782340|75894234|FG001|Open Label Titration|Adverse Event|0|||
42083993|NCT00782340|75894235|FG002|Open Label Titration|Adverse Event|0|||
42083994|NCT00782340|75894233|FG000|Open Label Titration|Treatment failure|50|||
42083995|NCT00782340|75894234|FG001|Open Label Titration|Treatment failure|0|||
42083996|NCT00782340|75894235|FG002|Open Label Titration|Treatment failure|0|||
42083997|NCT00782340|75894233|FG000|Open Label Titration|Protocol Violation|5|||
42083998|NCT00782340|75894234|FG001|Open Label Titration|Protocol Violation|0|||
42083999|NCT00782340|75894235|FG002|Open Label Titration|Protocol Violation|0|||
42084000|NCT00782340|75894233|FG000|Open Label Titration|Withdrawal by Subject|5|||
42084001|NCT00782340|75894234|FG001|Open Label Titration|Withdrawal by Subject|0|||
42084002|NCT00782340|75894235|FG002|Open Label Titration|Withdrawal by Subject|0|||
42084003|NCT00782340|75894233|FG000|Open Label Titration|Enrollment capped|16|||
42084004|NCT00782340|75894234|FG001|Open Label Titration|Enrollment capped|0|||
42084005|NCT00782340|75894235|FG002|Open Label Titration|Enrollment capped|0|||
42084006|NCT00782340|75894233|FG000|Open Label Titration|Did not meet responder criteria|2|||
42084007|NCT00782340|75894234|FG001|Open Label Titration|Did not meet responder criteria|0|||
42084008|NCT00782340|75894235|FG002|Open Label Titration|Did not meet responder criteria|0|||
42084009|NCT00782340|75894233|FG000|Open Label Titration|Lost to Follow-up|5|||
42084010|NCT00782340|75894234|FG001|Open Label Titration|Lost to Follow-up|0|||
42084011|NCT00782340|75894235|FG002|Open Label Titration|Lost to Follow-up|0|||
42084012|NCT00782340|75894233|FG000|Open Label Titration|Randomized in error|6|||
42084013|NCT00782340|75894234|FG001|Open Label Titration|Randomized in error|0|||
42084014|NCT00782340|75894235|FG002|Open Label Titration|Randomized in error|0|||
42084015|NCT00774852|75894244|FG000|Overall Study|Adverse Event|9|||
42084016|NCT00774852|75894245|FG001|Overall Study|Adverse Event|6|||
42084017|NCT00774852|75894244|FG000|Overall Study|Death|2|||
42084018|NCT00774852|75894245|FG001|Overall Study|Death|1|||
42084019|NCT00774852|75894244|FG000|Overall Study|Lack of Efficacy|3|||
42084020|NCT00774852|75894245|FG001|Overall Study|Lack of Efficacy|7|||
42084021|NCT00774852|75894244|FG000|Overall Study|Lost to Follow-up|9|||
42084022|NCT00774852|75894245|FG001|Overall Study|Lost to Follow-up|5|||
42084023|NCT00774852|75894244|FG000|Overall Study|Physician Decision|2|||
42084024|NCT00774852|75894245|FG001|Overall Study|Physician Decision|6|||
42084025|NCT00774852|75894244|FG000|Overall Study|Pregnancy|1|||
42084026|NCT00774852|75894245|FG001|Overall Study|Pregnancy|2|||
42084027|NCT00774852|75894244|FG000|Overall Study|Withdrawal by Subject|2|||
42084028|NCT00774852|75894245|FG001|Overall Study|Withdrawal by Subject|2|||
42084029|NCT00774852|75894244|FG000|Overall Study|Non-responder|15|||
42084030|NCT00774852|75894245|FG001|Overall Study|Non-responder|11|||
42084031|NCT00774852|75894244|FG000|Overall Study|Subject non-compliance|0|||
42084032|NCT00774852|75894245|FG001|Overall Study|Subject non-compliance|1|||
42084033|NCT00774852|75894244|FG000|Overall Study|Protocol Violation|1|||
42084034|NCT00774852|75894245|FG001|Overall Study|Protocol Violation|0|||
42084035|NCT00774852|75894244|FG000|Overall Study|Subject received prohibited medication|1|||
42084036|NCT00774852|75894245|FG001|Overall Study|Subject received prohibited medication|0|||
42084037|NCT00774306|75894265|FG000|Overall Study|Adverse Event|3|||
42084038|NCT00774306|75894266|FG001|Overall Study|Adverse Event|0|||
42084039|NCT00774306|75894267|FG002|Overall Study|Adverse Event|0|||
42084040|NCT00774306|75894268|FG003|Overall Study|Adverse Event|0|||
42084041|NCT00774306|75894265|FG000|Overall Study|Protocol Violation|2|||
42084042|NCT00774306|75894266|FG001|Overall Study|Protocol Violation|0|||
42084043|NCT00774306|75894267|FG002|Overall Study|Protocol Violation|3|||
42084044|NCT00774306|75894268|FG003|Overall Study|Protocol Violation|0|||
42084045|NCT00774306|75894265|FG000|Overall Study|Withdrawal by Subject|6|||
42084046|NCT00774306|75894266|FG001|Overall Study|Withdrawal by Subject|1|||
42084047|NCT00774306|75894267|FG002|Overall Study|Withdrawal by Subject|1|||
42084048|NCT00774306|75894268|FG003|Overall Study|Withdrawal by Subject|0|||
42084049|NCT00774306|75894265|FG000|Overall Study|Lost to Follow-up|6|||
42084050|NCT00774306|75894266|FG001|Overall Study|Lost to Follow-up|0|||
42084051|NCT00774306|75894267|FG002|Overall Study|Lost to Follow-up|4|||
42084052|NCT00774306|75894268|FG003|Overall Study|Lost to Follow-up|5|||
42084053|NCT00774306|75894265|FG000|Overall Study|Death|1|||
42084054|NCT00774306|75894266|FG001|Overall Study|Death|1|||
42084055|NCT00774306|75894267|FG002|Overall Study|Death|0|||
42084056|NCT00774306|75894268|FG003|Overall Study|Death|0|||
42084057|NCT00781326|75894278|FG000|Phase I|Adverse Event|1|||
42084058|NCT00781326|75894278|FG000|Phase I|Withdrawal by Subject|1|||
42084059|NCT00781326|75894278|FG000|Phase I|Physician Decision|2|||
42084060|NCT00787800|75894284|FG000|Overall Study|Withdrawal by Subject|3|||
42084061|NCT00787800|75894285|FG001|Overall Study|Withdrawal by Subject|5|||
42084062|NCT00787800|75894284|FG000|Overall Study|Death|0|||
42084063|NCT00787800|75894285|FG001|Overall Study|Death|2|||
42084064|NCT00773838|75894292|FG000|Overall Study|Adverse Event|29|||
42084065|NCT00773838|75894292|FG000|Overall Study|Lost to Follow-up|1|||
42084066|NCT00773838|75894292|FG000|Overall Study|Physician Decision|8|||
42084067|NCT00773838|75894292|FG000|Overall Study|Progressive Disease|82|||
42084068|NCT00773838|75894292|FG000|Overall Study|Protocol Violation|2|||
42084069|NCT00773838|75894292|FG000|Overall Study|Withdrawal by Subject|21|||
42084070|NCT00787644|75894298|FG000|Overall Study|Lost to Follow-up|1|||
42084071|NCT00787644|75894299|FG001|Overall Study|Lost to Follow-up|1|||
42084072|NCT00787644|75894298|FG000|Overall Study|Withdrawal by Subject|1|||
42084073|NCT00787644|75894299|FG001|Overall Study|Withdrawal by Subject|1|||
42084074|NCT00787566|75894308|FG000|Overall Study|AE related to chemotherapy|0|||
42084075|NCT00787566|75894309|FG001|Overall Study|AE related to chemotherapy|1|||
42084076|NCT00787566|75894310|FG002|Overall Study|AE related to chemotherapy|0|||
42084077|NCT00787254|75894320|FG000|Overall Study|Adverse Event|24|||
42084078|NCT00787254|75894321|FG001|Overall Study|Adverse Event|23|||
42084079|NCT00787254|75894320|FG000|Overall Study|Protocol Violation|26|||
42084080|NCT00787254|75894321|FG001|Overall Study|Protocol Violation|23|||
42084081|NCT00787254|75894320|FG000|Overall Study|Withdrawal by Subject|16|||
42084082|NCT00787254|75894321|FG001|Overall Study|Withdrawal by Subject|11|||
42084083|NCT00787254|75894320|FG000|Overall Study|Lack of Efficacy|4|||
42084084|NCT00787254|75894321|FG001|Overall Study|Lack of Efficacy|15|||
42084085|NCT00787254|75894320|FG000|Overall Study|NSAIDs discontinuation|1|||
42084086|NCT00787254|75894321|FG001|Overall Study|NSAIDs discontinuation|2|||
42084087|NCT00787254|75894320|FG000|Overall Study|Institution closed|1|||
42084088|NCT00787254|75894321|FG001|Overall Study|Institution closed|0|||
42084089|NCT00787254|75894320|FG000|Overall Study|Physician Decision|4|||
42084090|NCT00787254|75894321|FG001|Overall Study|Physician Decision|8|||
42084091|NCT00625846|75894331|FG000|Overall Study|Withdrawal by Subject|2|||
42084092|NCT00625846|75894332|FG001|Overall Study|Withdrawal by Subject|0|||
42084093|NCT00625846|75894333|FG002|Overall Study|Withdrawal by Subject|1|||
42084094|NCT00625846|75894334|FG003|Overall Study|Withdrawal by Subject|2|||
42084095|NCT00773292|75894348|FG000|Treatment 48 Weeks|Adverse Event|1|||
42084096|NCT00773292|75894348|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
42084097|NCT00786864|75894354|FG000|Overall Study|Lost to Follow-up|0|||
42084098|NCT00786864|75894355|FG001|Overall Study|Lost to Follow-up|1|||
42084099|NCT00786864|75894354|FG000|Overall Study|Sustained serious back injury|1|||
42084100|NCT00786864|75894355|FG001|Overall Study|Sustained serious back injury|0|||
42084101|NCT00621322|75894367|FG000|Overall Study|Lost to Follow-up|0|||
42084102|NCT00621322|75894368|FG001|Overall Study|Lost to Follow-up|0|||
42084103|NCT00621322|75894369|FG002|Overall Study|Lost to Follow-up|0|||
42084104|NCT00621322|75894370|FG003|Overall Study|Lost to Follow-up|0|||
42084105|NCT00621322|75894371|FG004|Overall Study|Lost to Follow-up|1|||
42084106|NCT00621322|75894372|FG005|Overall Study|Lost to Follow-up|0|||
42084107|NCT00621322|75894367|FG000|Overall Study|Physician Decision|0|||
42084108|NCT00621322|75894368|FG001|Overall Study|Physician Decision|0|||
42084109|NCT00621322|75894369|FG002|Overall Study|Physician Decision|1|||
42084110|NCT00621322|75894370|FG003|Overall Study|Physician Decision|1|||
42084111|NCT00621322|75894371|FG004|Overall Study|Physician Decision|0|||
42084112|NCT00621322|75894372|FG005|Overall Study|Physician Decision|0|||
42084113|NCT00621322|75894367|FG000|Overall Study|Withdrawal by Subject|0|||
42084114|NCT00621322|75894368|FG001|Overall Study|Withdrawal by Subject|0|||
42084115|NCT00621322|75894369|FG002|Overall Study|Withdrawal by Subject|0|||
42084116|NCT00621322|75894370|FG003|Overall Study|Withdrawal by Subject|1|||
42084117|NCT00621322|75894371|FG004|Overall Study|Withdrawal by Subject|0|||
42084118|NCT00621322|75894372|FG005|Overall Study|Withdrawal by Subject|2|||
42084119|NCT00621322|75894367|FG000|Overall Study|Migrated/moved from study area|1|||
42084120|NCT00621322|75894368|FG001|Overall Study|Migrated/moved from study area|0|||
42084121|NCT00621322|75894369|FG002|Overall Study|Migrated/moved from study area|1|||
42084122|NCT00621322|75894370|FG003|Overall Study|Migrated/moved from study area|1|||
42084123|NCT00621322|75894371|FG004|Overall Study|Migrated/moved from study area|0|||
42084124|NCT00621322|75894372|FG005|Overall Study|Migrated/moved from study area|2|||
42084125|NCT00853385|75894391|FG000|Overall Study|Death|0|||
42084126|NCT00853385|75894392|FG001|Overall Study|Death|0|||
42084127|NCT00853385|75894393|FG002|Overall Study|Death|0|||
42084128|NCT00853385|75894394|FG003|Overall Study|Death|0|||
42084129|NCT00853385|75894395|FG004|Overall Study|Death|1|||
42084130|NCT00853385|75894391|FG000|Overall Study|Adverse Event|24|||
42084131|NCT00853385|75894392|FG001|Overall Study|Adverse Event|24|||
42084132|NCT00853385|75894393|FG002|Overall Study|Adverse Event|2|||
42084133|NCT00853385|75894394|FG003|Overall Study|Adverse Event|5|||
42084134|NCT00853385|75894395|FG004|Overall Study|Adverse Event|22|||
42084135|NCT00853385|75894391|FG000|Overall Study|Lack of Efficacy|6|||
42084136|NCT00853385|75894392|FG001|Overall Study|Lack of Efficacy|7|||
42017642|NCT01286987|75825331|FG014|Part 2: Dose Expansion|Physician Decision|0|||
42017643|NCT01286987|75825317|FG000|Part 2: Dose Expansion|Other|0|||
42017644|NCT01286987|75825318|FG001|Part 2: Dose Expansion|Other|0|||
42017645|NCT01286987|75825319|FG002|Part 2: Dose Expansion|Other|0|||
42017646|NCT01286987|75825320|FG003|Part 2: Dose Expansion|Other|0|||
42017647|NCT01286987|75825321|FG004|Part 2: Dose Expansion|Other|0|||
42017648|NCT01286987|75825322|FG005|Part 2: Dose Expansion|Other|0|||
42017649|NCT01286987|75825323|FG006|Part 2: Dose Expansion|Other|0|||
42017650|NCT01286987|75825324|FG007|Part 2: Dose Expansion|Other|0|||
42017651|NCT01286987|75825325|FG008|Part 2: Dose Expansion|Other|0|||
42017652|NCT01286987|75825326|FG009|Part 2: Dose Expansion|Other|0|||
42017653|NCT01286987|75825327|FG010|Part 2: Dose Expansion|Other|0|||
42017654|NCT01286987|75825328|FG011|Part 2: Dose Expansion|Other|0|||
42017655|NCT01286987|75825329|FG012|Part 2: Dose Expansion|Other|0|||
42017656|NCT01286987|75825330|FG013|Part 2: Dose Expansion|Other|1|||
42017657|NCT01286987|75825331|FG014|Part 2: Dose Expansion|Other|0|||
42017658|NCT01286987|75825317|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
42017659|NCT01286987|75825318|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
42017660|NCT01286987|75825319|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
42017661|NCT01286987|75825320|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
42017662|NCT01286987|75825321|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
42017663|NCT01286987|75825322|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
42017664|NCT01286987|75825323|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
42017665|NCT01286987|75825324|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
42017666|NCT01286987|75825325|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
42017667|NCT01286987|75825326|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
42017668|NCT01286987|75825327|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
42017669|NCT01286987|75825328|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
42017670|NCT01286987|75825329|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
42017671|NCT01286987|75825330|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
42017672|NCT01286987|75825331|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
42017673|NCT01286987|75825317|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
42017674|NCT01286987|75825318|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
42017675|NCT01286987|75825319|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
42017676|NCT01286987|75825320|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
42017677|NCT01286987|75825321|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
42017678|NCT01286987|75825322|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
42017679|NCT01286987|75825323|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
42017680|NCT01286987|75825324|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
42017681|NCT01286987|75825325|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
42017682|NCT01286987|75825326|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
42017683|NCT01286987|75825327|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
42017684|NCT01286987|75825328|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
42017685|NCT01286987|75825329|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
42017686|NCT01286987|75825330|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
42017687|NCT01286987|75825331|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
42017688|NCT01286987|75825317|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017689|NCT01286987|75825318|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017690|NCT01286987|75825319|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017691|NCT01286987|75825320|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017692|NCT01286987|75825321|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017693|NCT01286987|75825322|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017694|NCT01286987|75825323|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017695|NCT01286987|75825324|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017696|NCT01286987|75825325|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42084137|NCT00853385|75894393|FG002|Overall Study|Lack of Efficacy|3|||
42084138|NCT00853385|75894394|FG003|Overall Study|Lack of Efficacy|3|||
42084139|NCT00853385|75894395|FG004|Overall Study|Lack of Efficacy|6|||
42084140|NCT00853385|75894391|FG000|Overall Study|Lost to Follow-up|2|||
42084141|NCT00853385|75894392|FG001|Overall Study|Lost to Follow-up|1|||
42084142|NCT00853385|75894393|FG002|Overall Study|Lost to Follow-up|0|||
42084143|NCT00853385|75894394|FG003|Overall Study|Lost to Follow-up|0|||
42084144|NCT00853385|75894395|FG004|Overall Study|Lost to Follow-up|0|||
42084145|NCT00853385|75894391|FG000|Overall Study|Withdrawal by Subject|4|||
42084146|NCT00853385|75894392|FG001|Overall Study|Withdrawal by Subject|2|||
42084147|NCT00853385|75894393|FG002|Overall Study|Withdrawal by Subject|0|||
42084148|NCT00853385|75894394|FG003|Overall Study|Withdrawal by Subject|1|||
42084149|NCT00853385|75894395|FG004|Overall Study|Withdrawal by Subject|1|||
42084150|NCT00853385|75894391|FG000|Overall Study|Other|18|||
42084151|NCT00853385|75894392|FG001|Overall Study|Other|9|||
42084152|NCT00853385|75894393|FG002|Overall Study|Other|4|||
42084153|NCT00853385|75894394|FG003|Overall Study|Other|4|||
42084154|NCT00853385|75894395|FG004|Overall Study|Other|12|||
42084155|NCT00622336|75894417|FG000|Treatment Phase|Progression of Disease|181|||
42084156|NCT00622336|75894417|FG000|Treatment Phase|Adverse Event|46|||
42084157|NCT00622336|75894417|FG000|Treatment Phase|Other|40|||
42084158|NCT00622336|75894417|FG000|Treatment Phase|Death|14|||
42084159|NCT00622336|75894417|FG000|Treatment Phase|Lack of therapeutic effect|13|||
42084160|NCT00622336|75894417|FG000|Treatment Phase|Withdrawal by Subject|13|||
42084161|NCT00622336|75894417|FG000|Treatment Phase|Lost to Follow-up|2|||
42084162|NCT00622336|75894417|FG000|Extension Phase|Adverse Event|2|||
42084163|NCT00622336|75894417|FG000|Extension Phase|Progressive Disease|6|||
42084164|NCT00622336|75894417|FG000|Extension Phase|Lack of therapeutic effect|2|||
42084165|NCT00622336|75894417|FG000|Extension Phase|Withdrawal by Subject|1|||
42084166|NCT00622336|75894417|FG000|Extension Phase|Lost to Follow-up|1|||
42084167|NCT00622336|75894417|FG000|Extension Phase|Other|9|||
42084168|NCT00779766|75894425|FG000|Month 24|Serious Adverse Event|2|||
42084169|NCT00779766|75894426|FG001|Month 24|Serious Adverse Event|3|||
42084170|NCT00779766|75894425|FG000|Month 24|Adverse Event|3|||
42084171|NCT00779766|75894426|FG001|Month 24|Adverse Event|3|||
42084172|NCT00779766|75894425|FG000|Month 24|Protocol Violation|3|||
42084173|NCT00779766|75894426|FG001|Month 24|Protocol Violation|1|||
42084174|NCT00779766|75894425|FG000|Month 24|Withdrawal by Subject|159|||
42084175|NCT00779766|75894426|FG001|Month 24|Withdrawal by Subject|127|||
42084176|NCT00779766|75894425|FG000|Month 24|Migrated/moved from study area|138|||
42084177|NCT00779766|75894426|FG001|Month 24|Migrated/moved from study area|162|||
42084178|NCT00779766|75894425|FG000|Month 24|Lost to Follow-up|9|||
42084179|NCT00779766|75894426|FG001|Month 24|Lost to Follow-up|9|||
42084180|NCT00779766|75894425|FG000|Month 24|Other|18|||
42084181|NCT00779766|75894426|FG001|Month 24|Other|27|||
42084182|NCT00779766|75894425|FG000|Month 48|Withdrawal by Subject|68|||
42084183|NCT00779766|75894426|FG001|Month 48|Withdrawal by Subject|63|||
42084184|NCT00779766|75894425|FG000|Month 48|Migrated/moved from study area|76|||
42084185|NCT00779766|75894426|FG001|Month 48|Migrated/moved from study area|75|||
42084186|NCT00779766|75894425|FG000|Month 48|Lost to Follow-up|29|||
42084187|NCT00779766|75894426|FG001|Month 48|Lost to Follow-up|30|||
42084188|NCT00779766|75894425|FG000|Month 48|Other|1|||
42084189|NCT00779766|75894426|FG001|Month 48|Other|0|||
42084190|NCT00779766|75894425|FG000|Month 72|Withdrawal by Subject|55|||
42084191|NCT00779766|75894426|FG001|Month 72|Withdrawal by Subject|71|||
42084192|NCT00779766|75894425|FG000|Month 72|Migrated/moved from study area|124|||
42084193|NCT00779766|75894426|FG001|Month 72|Migrated/moved from study area|109|||
42084194|NCT00779766|75894425|FG000|Month 72|Lost to Follow-up|6|||
42084195|NCT00779766|75894426|FG001|Month 72|Lost to Follow-up|8|||
42084196|NCT00779766|75894425|FG000|Month 72|Other|0|||
42084197|NCT00779766|75894426|FG001|Month 72|Other|1|||
42084198|NCT00846365|75894436|FG000|Overall Study|Adverse Event|20|||
42084199|NCT00846365|75894437|FG001|Overall Study|Adverse Event|30|||
42084200|NCT00846365|75894438|FG002|Overall Study|Adverse Event|11|||
42084201|NCT00846365|75894436|FG000|Overall Study|Protocol Violation|5|||
42084202|NCT00846365|75894437|FG001|Overall Study|Protocol Violation|4|||
42084203|NCT00846365|75894438|FG002|Overall Study|Protocol Violation|0|||
42084204|NCT00846365|75894436|FG000|Overall Study|Lost to Follow-up|8|||
42084205|NCT00846365|75894437|FG001|Overall Study|Lost to Follow-up|2|||
42084206|NCT00846365|75894438|FG002|Overall Study|Lost to Follow-up|5|||
42178998|NCT02030067|75986268|FG009|Overall Study|other reasons|0|||
42084207|NCT00846365|75894436|FG000|Overall Study|Withdrawal by Subject|11|||
42084208|NCT00846365|75894437|FG001|Overall Study|Withdrawal by Subject|11|||
42084209|NCT00846365|75894438|FG002|Overall Study|Withdrawal by Subject|9|||
42084210|NCT00846365|75894436|FG000|Overall Study|Pregnancy|1|||
42084211|NCT00846365|75894437|FG001|Overall Study|Pregnancy|0|||
42084212|NCT00846365|75894438|FG002|Overall Study|Pregnancy|0|||
42084213|NCT00846365|75894436|FG000|Overall Study|Lack of Efficacy|1|||
42084214|NCT00846365|75894437|FG001|Overall Study|Lack of Efficacy|1|||
42084215|NCT00846365|75894438|FG002|Overall Study|Lack of Efficacy|2|||
42084216|NCT00846365|75894436|FG000|Overall Study|Other|9|||
42084217|NCT00846365|75894437|FG001|Overall Study|Other|1|||
42084218|NCT00846365|75894438|FG002|Overall Study|Other|6|||
42084219|NCT00779142|75894446|FG000|Overall Study|Screen Failures|3|||
42084220|NCT00622180|75894451|FG000|Overall Study|Lost to Follow-up|1|||
42084221|NCT00622180|75894452|FG001|Overall Study|Lost to Follow-up|2|||
42084222|NCT00773136|75894458|FG000|Overall Study|Physician Decision|2|||
42084223|NCT00853307|75894465|FG000|Overall Study|Adverse Event|1|||
42084224|NCT00853307|75894466|FG001|Overall Study|Adverse Event|2|||
42084225|NCT00853307|75894465|FG000|Overall Study|Withdrawal by Subject|1|||
42084226|NCT00853307|75894466|FG001|Overall Study|Withdrawal by Subject|2|||
42084227|NCT00853307|75894465|FG000|Overall Study|Reason Not Specified|0|||
42084228|NCT00853307|75894466|FG001|Overall Study|Reason Not Specified|1|||
42084229|NCT00778830|75894474|FG000|Overall Study|Ongoing at data cut-off|0|||
42084230|NCT00778830|75894475|FG001|Overall Study|Ongoing at data cut-off|1|||
42084231|NCT00772668|75894481|FG000|Overall Study|Physician Decision|3|||
42084232|NCT00786474|75894488|FG000|Overall Study|Death|5|||
42358412|NCT01872715|76204052|FG000|Overall Study|Withdrawal by Subject|2|||
42358413|NCT01871545|76204068|FG000|Overall Study|Death|2|||
42358414|NCT01871545|76204069|FG001|Overall Study|Death|0|||
42358415|NCT01871545|76204068|FG000|Overall Study|Lack of Efficacy|11|||
42358416|NCT01871545|76204069|FG001|Overall Study|Lack of Efficacy|2|||
42358417|NCT01871545|76204068|FG000|Overall Study|Physician Decision|4|||
42358418|NCT01871545|76204069|FG001|Overall Study|Physician Decision|0|||
42358419|NCT01871545|76204068|FG000|Overall Study|Withdrawal by Subject|0|||
42358420|NCT01871545|76204069|FG001|Overall Study|Withdrawal by Subject|1|||
42358421|NCT01613599|76204078|FG000|Overall Study|Death|9|||
42084233|NCT00786474|75894489|FG001|Overall Study|Death|4|||
42084234|NCT00786474|75894488|FG000|Overall Study|Withdrawal by Subject|23|||
42084235|NCT00786474|75894489|FG001|Overall Study|Withdrawal by Subject|31|||
42084236|NCT00786474|75894488|FG000|Overall Study|Lost to Follow-up|3|||
42084237|NCT00786474|75894489|FG001|Overall Study|Lost to Follow-up|3|||
42084238|NCT00786474|75894488|FG000|Overall Study|Physician Decision|2|||
42084239|NCT00786474|75894489|FG001|Overall Study|Physician Decision|1|||
42084240|NCT00786474|75894488|FG000|Overall Study|Other|4|||
42084241|NCT00786474|75894489|FG001|Overall Study|Other|4|||
42084242|NCT00784875|75894499|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
42084243|NCT00784875|75894500|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
42084244|NCT00784875|75894501|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
42084245|NCT00784875|75894502|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
42084246|NCT00784875|75894499|FG000|Period A - Baseline|Adverse Event|0|||
42084247|NCT00784875|75894500|FG001|Period A - Baseline|Adverse Event|0|||
42084248|NCT00784875|75894501|FG002|Period A - Baseline|Adverse Event|0|||
42084249|NCT00784875|75894502|FG003|Period A - Baseline|Adverse Event|8|||
42084250|NCT00784875|75894499|FG000|Period A - Baseline|Protocol Violation|0|||
42084251|NCT00784875|75894500|FG001|Period A - Baseline|Protocol Violation|0|||
42084252|NCT00784875|75894501|FG002|Period A - Baseline|Protocol Violation|0|||
42084253|NCT00784875|75894502|FG003|Period A - Baseline|Protocol Violation|25|||
42084254|NCT00784875|75894499|FG000|Period A - Baseline|Withdrawal by Subject|0|||
42084255|NCT00784875|75894500|FG001|Period A - Baseline|Withdrawal by Subject|0|||
42084256|NCT00784875|75894501|FG002|Period A - Baseline|Withdrawal by Subject|0|||
42084257|NCT00784875|75894502|FG003|Period A - Baseline|Withdrawal by Subject|27|||
42084258|NCT00784875|75894499|FG000|Period A - Baseline|Physician Decision|0|||
42084259|NCT00784875|75894500|FG001|Period A - Baseline|Physician Decision|0|||
42084260|NCT00784875|75894501|FG002|Period A - Baseline|Physician Decision|0|||
42084261|NCT00784875|75894502|FG003|Period A - Baseline|Physician Decision|2|||
42084262|NCT00784875|75894499|FG000|Period A - Baseline|Sponsor Decision|0|||
42294224|NCT03841448|76128581|FG000|Double Blind Treatment Period|Death|1|||
42294225|NCT03841448|76128582|FG001|Double Blind Treatment Period|Death|1|||
42294226|NCT03841448|76128583|FG002|Double Blind Treatment Period|Death|0|||
42294227|NCT03841448|76128584|FG003|Double Blind Treatment Period|Death|0|||
42294228|NCT03841448|76128581|FG000|Open-Label Extension Period|Participants Stopped Participation in the Study|0|||
42294229|NCT03841448|76128582|FG001|Open-Label Extension Period|Participants Stopped Participation in the Study|0|||
42294230|NCT03841448|76128583|FG002|Open-Label Extension Period|Participants Stopped Participation in the Study|1|||
42294231|NCT03841448|76128584|FG003|Open-Label Extension Period|Participants Stopped Participation in the Study|1|||
42294232|NCT03841448|76128581|FG000|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|0|||
42294233|NCT03841448|76128582|FG001|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|0|||
42358422|NCT01613599|76204078|FG000|Overall Study|Lost to Follow-up|5|||
42358423|NCT01613599|76204078|FG000|Overall Study|Withdrawal by Subject|8|||
42084263|NCT00784875|75894500|FG001|Period A - Baseline|Sponsor Decision|0|||
42084264|NCT00784875|75894501|FG002|Period A - Baseline|Sponsor Decision|0|||
42084265|NCT00784875|75894502|FG003|Period A - Baseline|Sponsor Decision|113|||
42084266|NCT00784875|75894499|FG000|Period A - Baseline|Lost to Follow-up|0|||
42084267|NCT00784875|75894500|FG001|Period A - Baseline|Lost to Follow-up|0|||
42358424|NCT01613599|76204078|FG000|Overall Study|Reason not specified|3|||
42084268|NCT00784875|75894501|FG002|Period A - Baseline|Lost to Follow-up|0|||
42084269|NCT00784875|75894502|FG003|Period A - Baseline|Lost to Follow-up|2|||
42084270|NCT00784875|75894499|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
42084271|NCT00784875|75894500|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
42084272|NCT00784875|75894501|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
42084273|NCT00784875|75894502|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
42084274|NCT00784875|75894499|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
42084275|NCT00784875|75894500|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
42084276|NCT00784875|75894501|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
42084277|NCT00784875|75894502|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
42084278|NCT00784875|75894499|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
42084279|NCT00784875|75894500|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
42084280|NCT00784875|75894501|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
42084281|NCT00784875|75894502|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
42084282|NCT00784875|75894499|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
42084283|NCT00784875|75894500|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
42084284|NCT00784875|75894501|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
42084285|NCT00784875|75894502|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
42084286|NCT00784875|75894499|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
42017697|NCT01286987|75825326|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017698|NCT01286987|75825327|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
42017699|NCT01286987|75825328|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017700|NCT01286987|75825329|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017701|NCT01286987|75825330|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017702|NCT01286987|75825331|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
42017703|NCT01286753|75825374|FG000|Overall Study|Adverse Event|7|||
42017704|NCT01286753|75825375|FG001|Overall Study|Adverse Event|6|||
42017705|NCT01286753|75825374|FG000|Overall Study|Progression|11|||
42017706|NCT01286753|75825375|FG001|Overall Study|Progression|13|||
42017707|NCT01286753|75825374|FG000|Overall Study|Refused Treatment|1|||
42017708|NCT01286753|75825375|FG001|Overall Study|Refused Treatment|0|||
42017709|NCT01286753|75825374|FG000|Overall Study|Withdrawal of Consent|0|||
42017710|NCT01286753|75825375|FG001|Overall Study|Withdrawal of Consent|2|||
42017711|NCT01286753|75825374|FG000|Overall Study|Discontinued to Join Extension Study|6|||
42017712|NCT01286753|75825375|FG001|Overall Study|Discontinued to Join Extension Study|4|||
42017713|NCT01286753|75825374|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
42084287|NCT00784875|75894500|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
42084288|NCT00784875|75894501|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
42084289|NCT00784875|75894502|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
42084290|NCT00784875|75894499|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
42084291|NCT00784875|75894500|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
42084292|NCT00784875|75894501|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
42084293|NCT00784875|75894502|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
42084294|NCT00784875|75894499|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
42084295|NCT00784875|75894500|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
42084296|NCT00784875|75894501|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
42084297|NCT00784875|75894502|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
42084298|NCT00784875|75894499|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
42084299|NCT00784875|75894500|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
42084300|NCT00784875|75894501|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
42084301|NCT00784875|75894502|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
42084302|NCT00784875|75894499|FG000|Period C|Adverse Event|1|||
42084303|NCT00784875|75894500|FG001|Period C|Adverse Event|0|||
42084304|NCT00784875|75894501|FG002|Period C|Adverse Event|4|||
42084305|NCT00784875|75894502|FG003|Period C|Adverse Event|2|||
42084306|NCT00784875|75894499|FG000|Period C|Protocol Violation|0|||
42084307|NCT00784875|75894500|FG001|Period C|Protocol Violation|0|||
42084308|NCT00784875|75894501|FG002|Period C|Protocol Violation|1|||
42084309|NCT00784875|75894502|FG003|Period C|Protocol Violation|2|||
42084310|NCT00784875|75894499|FG000|Period C|Lack of Efficacy|0|||
42084311|NCT00784875|75894500|FG001|Period C|Lack of Efficacy|0|||
42084312|NCT00784875|75894501|FG002|Period C|Lack of Efficacy|1|||
42084313|NCT00784875|75894502|FG003|Period C|Lack of Efficacy|0|||
42084314|NCT00784875|75894499|FG000|Period C|Withdrawal by Subject|1|||
42084315|NCT00784875|75894500|FG001|Period C|Withdrawal by Subject|1|||
42084316|NCT00784875|75894501|FG002|Period C|Withdrawal by Subject|2|||
42084317|NCT00784875|75894502|FG003|Period C|Withdrawal by Subject|0|||
42017714|NCT01286753|75825375|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
42017715|NCT01286129|75825384|FG000|Overall Study|Withdrawal by Subject|4|||
42084318|NCT00784875|75894499|FG000|Period C|Physician Decision|0|||
42084319|NCT00784875|75894500|FG001|Period C|Physician Decision|0|||
42084320|NCT00784875|75894501|FG002|Period C|Physician Decision|1|||
42084321|NCT00784875|75894502|FG003|Period C|Physician Decision|1|||
42084322|NCT00784875|75894499|FG000|Period C|Sponsor Decision|5|||
42358425|NCT01850641|76204082|FG000|Overall Study|Physician Decision|1|||
42358426|NCT01850641|76204082|FG000|Overall Study|Decrease in serum phosphorus|1|||
42358427|NCT01850641|76204082|FG000|Overall Study|Decrease in serum calcium|2|||
42358428|NCT01850641|76204082|FG000|Overall Study|Increase in serum ferritin|1|||
42358429|NCT01850563|76204088|FG000|Overall Study|Not eligible|3|||
42358430|NCT01850563|76204089|FG001|Overall Study|Not eligible|0|||
42358431|NCT04999839|76204141|FG000|Overall Study|Adverse Event|1|||
42358432|NCT04999839|76204142|FG001|Overall Study|Adverse Event|1|||
42358433|NCT04999839|76204143|FG002|Overall Study|Adverse Event|1|||
42294234|NCT03841448|76128583|FG002|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|7|||
42294235|NCT03841448|76128584|FG003|Open-Label Extension Period|Ongoing in the Study at the Time of Data Cut-off (i.e., Primary Completion Date)|19|||
42294236|NCT03382782|76128595|FG000|Cohort 1|Withdrawal by Subject|11|||
42294237|NCT03382782|76128596|FG001|Cohort 1|Withdrawal by Subject|5|||
42294238|NCT03382782|76128597|FG002|Cohort 1|Withdrawal by Subject|0|||
42294239|NCT03382782|76128595|FG000|Cohort 2|Withdrawal by Subject|1|||
42294240|NCT03382782|76128596|FG001|Cohort 2|Withdrawal by Subject|1|||
42294241|NCT03382782|76128597|FG002|Cohort 2|Withdrawal by Subject|0|||
42294242|NCT03382782|76128595|FG000|Cohort 3|Withdrawal by Subject|1|||
42294243|NCT03382782|76128596|FG001|Cohort 3|Withdrawal by Subject|2|||
42294244|NCT03382782|76128597|FG002|Cohort 3|Withdrawal by Subject|0|||
42178999|NCT02030067|75986269|FG010|Overall Study|other reasons|0|||
42358434|NCT04999839|76204144|FG003|Overall Study|Adverse Event|1|||
42358435|NCT04999839|76204145|FG004|Overall Study|Adverse Event|1|||
42358436|NCT04999839|76204141|FG000|Overall Study|Lost to Follow-up|2|||
42294245|NCT02876328|76128644|FG000|Overall Study|Death|2|||
42294246|NCT02876328|76128645|FG001|Overall Study|Death|1|||
42294247|NCT02876328|76128646|FG002|Overall Study|Death|3|||
42294248|NCT02876328|76128647|FG003|Overall Study|Death|0|||
42294249|NCT02876328|76128648|FG004|Overall Study|Death|0|||
42294250|NCT02876328|76128649|FG005|Overall Study|Death|0|||
42294251|NCT02876328|76128650|FG006|Overall Study|Death|1|||
42179000|NCT02030067|75986270|FG011|Overall Study|other reasons|0|||
42179001|NCT02030067|75986271|FG012|Overall Study|other reasons|4|||
42179002|NCT02030067|75986259|FG000|Overall Study|Adverse Event|0|||
42179003|NCT02030067|75986260|FG001|Overall Study|Adverse Event|0|||
42179004|NCT02030067|75986261|FG002|Overall Study|Adverse Event|0|||
42294252|NCT02876328|76128651|FG007|Overall Study|Death|3|||
42294253|NCT02876328|76128652|FG008|Overall Study|Death|0|||
42294254|NCT02876328|76128653|FG009|Overall Study|Death|1|||
42294255|NCT02876328|76128654|FG010|Overall Study|Death|1|||
42294256|NCT02876328|76128655|FG011|Overall Study|Death|0|||
42179005|NCT02030067|75986262|FG003|Overall Study|Adverse Event|0|||
42179006|NCT02030067|75986263|FG004|Overall Study|Adverse Event|0|||
42179007|NCT02030067|75986264|FG005|Overall Study|Adverse Event|0|||
42179008|NCT02030067|75986265|FG006|Overall Study|Adverse Event|0|||
42017716|NCT01286129|75825385|FG001|Overall Study|Withdrawal by Subject|1|||
42017717|NCT01286129|75825384|FG000|Overall Study|Could not comply with study requirements|4|||
42017718|NCT01286129|75825385|FG001|Overall Study|Could not comply with study requirements|4|||
42084323|NCT00784875|75894500|FG001|Period C|Sponsor Decision|5|||
42084324|NCT00784875|75894501|FG002|Period C|Sponsor Decision|4|||
42084325|NCT00784875|75894502|FG003|Period C|Sponsor Decision|2|||
42084326|NCT00784875|75894499|FG000|Period D|Adverse Event|0|||
42084327|NCT00784875|75894500|FG001|Period D|Adverse Event|2|||
42084328|NCT00784875|75894501|FG002|Period D|Adverse Event|2|||
42084329|NCT00784875|75894502|FG003|Period D|Adverse Event|0|||
42084330|NCT00784875|75894499|FG000|Period D|Protocol Violation|1|||
42179009|NCT02030067|75986266|FG007|Overall Study|Adverse Event|0|||
42179010|NCT02030067|75986267|FG008|Overall Study|Adverse Event|0|||
42179011|NCT02030067|75986268|FG009|Overall Study|Adverse Event|0|||
42179012|NCT02030067|75986269|FG010|Overall Study|Adverse Event|0|||
42179013|NCT02030067|75986270|FG011|Overall Study|Adverse Event|1|||
42179014|NCT02030067|75986271|FG012|Overall Study|Adverse Event|8|||
42179015|NCT02003209|75986303|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
42179016|NCT02003209|75986304|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
42179017|NCT01708941|75986314|FG000|Overall Study|Adverse Event|4|||
42179018|NCT01708941|75986315|FG001|Overall Study|Adverse Event|6|||
42179019|NCT01708941|75986316|FG002|Overall Study|Adverse Event|1|||
42179020|NCT01708941|75986317|FG003|Overall Study|Adverse Event|0|||
42179021|NCT01708941|75986314|FG000|Overall Study|Death|1|||
42179022|NCT01708941|75986315|FG001|Overall Study|Death|1|||
42179023|NCT01708941|75986316|FG002|Overall Study|Death|2|||
42179024|NCT01708941|75986317|FG003|Overall Study|Death|14|||
42179025|NCT01708941|75986314|FG000|Overall Study|Withdrawal by Subject|1|||
42179026|NCT01708941|75986315|FG001|Overall Study|Withdrawal by Subject|0|||
42179027|NCT01708941|75986316|FG002|Overall Study|Withdrawal by Subject|3|||
42179028|NCT01708941|75986317|FG003|Overall Study|Withdrawal by Subject|4|||
42179029|NCT01708941|75986314|FG000|Overall Study|Disease progression|9|||
42179030|NCT01708941|75986315|FG001|Overall Study|Disease progression|10|||
42179031|NCT01708941|75986316|FG002|Overall Study|Disease progression|8|||
42179032|NCT01708941|75986317|FG003|Overall Study|Disease progression|0|||
42179033|NCT01708941|75986314|FG000|Overall Study|Alternative therapy|0|||
42179034|NCT01708941|75986315|FG001|Overall Study|Alternative therapy|0|||
42179035|NCT01708941|75986316|FG002|Overall Study|Alternative therapy|2|||
42179036|NCT01708941|75986317|FG003|Overall Study|Alternative therapy|0|||
42179037|NCT01708941|75986314|FG000|Overall Study|Ineligible and never started treatment|1|||
42179038|NCT01708941|75986315|FG001|Overall Study|Ineligible and never started treatment|0|||
42179039|NCT01708941|75986316|FG002|Overall Study|Ineligible and never started treatment|1|||
42179040|NCT01708941|75986317|FG003|Overall Study|Ineligible and never started treatment|0|||
42179041|NCT01708941|75986314|FG000|Overall Study|Never started treatment|2|||
42179042|NCT01708941|75986315|FG001|Overall Study|Never started treatment|1|||
42179043|NCT01708941|75986316|FG002|Overall Study|Never started treatment|0|||
42294257|NCT02876328|76128656|FG012|Overall Study|Death|0|||
42294258|NCT02876328|76128657|FG013|Overall Study|Death|0|||
42179044|NCT01708941|75986317|FG003|Overall Study|Never started treatment|0|||
42179045|NCT01708941|75986314|FG000|Overall Study|Ineligible|0|||
42179046|NCT01708941|75986315|FG001|Overall Study|Ineligible|0|||
42294259|NCT02876328|76128658|FG014|Overall Study|Death|0|||
42017719|NCT01285349|75825396|FG000|Overall Study|Lost to Follow-up|27|||
42017720|NCT01285349|75825397|FG001|Overall Study|Lost to Follow-up|20|||
42017721|NCT01285349|75825398|FG002|Overall Study|Lost to Follow-up|27|||
42017722|NCT01284959|75825410|FG000|Overall Study|Withdrawal by Subject|1|||
42017723|NCT01284959|75825411|FG001|Overall Study|Withdrawal by Subject|0|||
42179047|NCT01708941|75986316|FG002|Overall Study|Ineligible|2|||
42084331|NCT00784875|75894500|FG001|Period D|Protocol Violation|0|||
42084332|NCT00784875|75894501|FG002|Period D|Protocol Violation|0|||
42084333|NCT00784875|75894502|FG003|Period D|Protocol Violation|0|||
42084334|NCT00784875|75894499|FG000|Period D|Withdrawal by Subject|2|||
42084335|NCT00784875|75894500|FG001|Period D|Withdrawal by Subject|0|||
42084336|NCT00784875|75894501|FG002|Period D|Withdrawal by Subject|2|||
42084337|NCT00784875|75894502|FG003|Period D|Withdrawal by Subject|0|||
42084338|NCT00784875|75894499|FG000|Period D|Physician Decision|0|||
42084339|NCT00784875|75894500|FG001|Period D|Physician Decision|1|||
42084340|NCT00784875|75894501|FG002|Period D|Physician Decision|0|||
42084341|NCT00784875|75894502|FG003|Period D|Physician Decision|0|||
42084342|NCT00784875|75894499|FG000|Period D|Sponsor Decision|1|||
42084343|NCT00784875|75894500|FG001|Period D|Sponsor Decision|1|||
42084344|NCT00784875|75894501|FG002|Period D|Sponsor Decision|1|||
42084345|NCT00784875|75894502|FG003|Period D|Sponsor Decision|0|||
42084346|NCT00784875|75894499|FG000|Period D|Lost to Follow-up|1|||
42084347|NCT00784875|75894500|FG001|Period D|Lost to Follow-up|0|||
42084348|NCT00784875|75894501|FG002|Period D|Lost to Follow-up|1|||
42084349|NCT00784875|75894502|FG003|Period D|Lost to Follow-up|1|||
42084350|NCT00592553|75894528|FG000|Overall Study|Protocol Noncompliance|1|||
42084351|NCT00592553|75894529|FG001|Overall Study|Protocol Noncompliance|0|||
42084352|NCT00592553|75894530|FG002|Overall Study|Protocol Noncompliance|0|||
42084353|NCT00853229|75894540|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
42084354|NCT00853229|75894541|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
42084355|NCT00853151|75894553|FG000|Overall Study|Adverse Event|1|||
42084356|NCT00853151|75894554|FG001|Overall Study|Adverse Event|4|||
42084357|NCT00853151|75894555|FG002|Overall Study|Adverse Event|2|||
42084358|NCT00853151|75894556|FG003|Overall Study|Adverse Event|0|||
42084359|NCT00853151|75894553|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
42084360|NCT00853151|75894554|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42084361|NCT00853151|75894555|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42084362|NCT00853151|75894556|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
42084363|NCT00853151|75894553|FG000|Overall Study|Lost to Follow-up|2|||
42084364|NCT00853151|75894554|FG001|Overall Study|Lost to Follow-up|0|||
42084365|NCT00853151|75894555|FG002|Overall Study|Lost to Follow-up|3|||
42084366|NCT00853151|75894556|FG003|Overall Study|Lost to Follow-up|0|||
42084367|NCT00853151|75894553|FG000|Overall Study|Death|1|||
42084368|NCT00853151|75894554|FG001|Overall Study|Death|0|||
42084369|NCT00853151|75894555|FG002|Overall Study|Death|0|||
42084370|NCT00853151|75894556|FG003|Overall Study|Death|1|||
42084371|NCT00853151|75894553|FG000|Overall Study|Protocol Violation|0|||
42084372|NCT00853151|75894554|FG001|Overall Study|Protocol Violation|0|||
42084373|NCT00853151|75894555|FG002|Overall Study|Protocol Violation|0|||
42084374|NCT00853151|75894556|FG003|Overall Study|Protocol Violation|1|||
42084375|NCT00853151|75894553|FG000|Overall Study|Withdrawal by Subject|5|||
42179048|NCT01708941|75986317|FG003|Overall Study|Ineligible|0|||
42179049|NCT00234065|75986338|FG000|Overall Study|Adverse Event|268|||
42179050|NCT00234065|75986339|FG001|Overall Study|Adverse Event|166|||
42179051|NCT00234065|75986338|FG000|Overall Study|Withdrawal by Subject|73|||
42179052|NCT00234065|75986339|FG001|Overall Study|Withdrawal by Subject|56|||
42179053|NCT00234065|75986338|FG000|Overall Study|Physician Decision|23|||
42179054|NCT00234065|75986339|FG001|Overall Study|Physician Decision|22|||
42179055|NCT00234065|75986338|FG000|Overall Study|Not Classified|111|||
42179056|NCT00234065|75986339|FG001|Overall Study|Not Classified|112|||
42179057|NCT00233987|75986345|FG000|Overall Study|Withdrawal by Subject|1|||
42179058|NCT00233987|75986345|FG000|Overall Study|Lack of Efficacy|2|||
42179059|NCT00233987|75986345|FG000|Overall Study|Reason Under Review|1|||
42179060|NCT00233987|75986345|FG000|Overall Study|Other - Not Protocol Specified|5|||
42179061|NCT00233987|75986345|FG000|Overall Study|Eligible but No Treatment Received|2|||
42179062|NCT00233987|75986345|FG000|Overall Study|Ineligible|4|||
42179063|NCT04623242|75986354|FG000|Overall Study|Withdrawal by Subject|7|||
42084376|NCT00853151|75894554|FG001|Overall Study|Withdrawal by Subject|4|||
42084377|NCT00853151|75894555|FG002|Overall Study|Withdrawal by Subject|2|||
42179064|NCT04623242|75986355|FG001|Overall Study|Withdrawal by Subject|12|||
42358437|NCT04999839|76204142|FG001|Overall Study|Lost to Follow-up|0|||
42358438|NCT04999839|76204143|FG002|Overall Study|Lost to Follow-up|2|||
42358439|NCT04999839|76204144|FG003|Overall Study|Lost to Follow-up|4|||
42358440|NCT04999839|76204145|FG004|Overall Study|Lost to Follow-up|1|||
42084378|NCT00853151|75894556|FG003|Overall Study|Withdrawal by Subject|1|||
42084379|NCT00853151|75894553|FG000|Overall Study|Physician Decision|0|||
42084380|NCT00853151|75894554|FG001|Overall Study|Physician Decision|2|||
42084381|NCT00853151|75894555|FG002|Overall Study|Physician Decision|1|||
42084382|NCT00853151|75894556|FG003|Overall Study|Physician Decision|0|||
42084383|NCT00853151|75894553|FG000|Overall Study|Sponsor Decision|0|||
42084384|NCT00853151|75894554|FG001|Overall Study|Sponsor Decision|3|||
42179065|NCT04623242|75986356|FG002|Overall Study|Withdrawal by Subject|5|||
42358441|NCT04999839|76204141|FG000|Overall Study|Withdrawal by Subject|6|||
42179066|NCT04623242|75986357|FG003|Overall Study|Withdrawal by Subject|7|||
42179067|NCT04623242|75986358|FG004|Overall Study|Withdrawal by Subject|0|||
42358442|NCT04999839|76204142|FG001|Overall Study|Withdrawal by Subject|5|||
42358443|NCT04999839|76204143|FG002|Overall Study|Withdrawal by Subject|3|||
42358444|NCT04999839|76204144|FG003|Overall Study|Withdrawal by Subject|2|||
42358445|NCT04999839|76204145|FG004|Overall Study|Withdrawal by Subject|2|||
42358446|NCT04999839|76204141|FG000|Overall Study|Lack of Efficacy|0|||
42179068|NCT04623242|75986354|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
42179069|NCT04623242|75986355|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
42179070|NCT04623242|75986356|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
42179071|NCT04623242|75986357|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
42179072|NCT04623242|75986358|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
42179073|NCT04623242|75986354|FG000|Overall Study|Subject unblinded to mutation status|0|||
42179074|NCT04623242|75986355|FG001|Overall Study|Subject unblinded to mutation status|0|||
42179075|NCT04623242|75986356|FG002|Overall Study|Subject unblinded to mutation status|0|||
42179076|NCT04623242|75986357|FG003|Overall Study|Subject unblinded to mutation status|13|||
42179077|NCT04623242|75986358|FG004|Overall Study|Subject unblinded to mutation status|0|||
42179078|NCT00233363|75986375|FG000|Overall Study|Adverse Event|1|||
42179079|NCT00233363|75986376|FG001|Overall Study|Adverse Event|2|||
42179080|NCT00233363|75986375|FG000|Overall Study|Lack of Efficacy|0|||
42179081|NCT00233363|75986376|FG001|Overall Study|Lack of Efficacy|2|||
42179082|NCT00233363|75986375|FG000|Overall Study|Withdrawal by Subject|1|||
42179083|NCT00233363|75986376|FG001|Overall Study|Withdrawal by Subject|1|||
42179084|NCT00233363|75986375|FG000|Overall Study|Aggravation of complication|1|||
42179085|NCT00233363|75986376|FG001|Overall Study|Aggravation of complication|0|||
42179086|NCT01147666|75986397|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
42179087|NCT01147666|75986398|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
42179088|NCT01147666|75986399|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
42179089|NCT01147666|75986400|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
42179090|NCT01147666|75986401|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
42179091|NCT01147666|75986402|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
42179092|NCT01147666|75986403|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
42179093|NCT01147666|75986404|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
42179094|NCT01147666|75986405|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
42179095|NCT01147666|75986406|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
42179096|NCT01147666|75986407|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
42179097|NCT01147666|75986408|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
42179098|NCT01147666|75986409|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
42179099|NCT01147666|75986410|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
42179100|NCT01147666|75986411|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
42179101|NCT01147666|75986397|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
42179102|NCT01147666|75986398|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
42179103|NCT01147666|75986399|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
42179104|NCT01147666|75986400|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
42179105|NCT01147666|75986401|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
42179106|NCT01147666|75986402|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
42179107|NCT01147666|75986403|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
42179108|NCT01147666|75986404|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
42179109|NCT01147666|75986405|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
42179110|NCT01147666|75986406|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
42179111|NCT01147666|75986407|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
42179112|NCT01147666|75986408|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
42179113|NCT01147666|75986409|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
42179114|NCT01147666|75986410|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
42179115|NCT01147666|75986411|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
42179116|NCT01147666|75986397|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
42179117|NCT01147666|75986398|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
42179118|NCT01147666|75986399|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
42358447|NCT04999839|76204142|FG001|Overall Study|Lack of Efficacy|1|||
42358448|NCT04999839|76204143|FG002|Overall Study|Lack of Efficacy|0|||
42358449|NCT04999839|76204144|FG003|Overall Study|Lack of Efficacy|0|||
42084385|NCT00853151|75894555|FG002|Overall Study|Sponsor Decision|0|||
42084386|NCT00853151|75894556|FG003|Overall Study|Sponsor Decision|0|||
42084387|NCT00853073|75894571|FG000|Overall Study|Withdrawal by Subject|3|||
42084388|NCT00853073|75894572|FG001|Overall Study|Withdrawal by Subject|2|||
42084389|NCT00846053|75894580|FG000|Overall Study|Physician Decision|3|||
42084390|NCT00846053|75894581|FG001|Overall Study|Physician Decision|0|||
42084391|NCT00845897|75894592|FG000|Overall Study|Lost to Follow-up|1|||
42084392|NCT00845897|75894593|FG001|Overall Study|Lost to Follow-up|1|||
42084393|NCT00845897|75894594|FG002|Overall Study|Lost to Follow-up|0|||
42084394|NCT00845897|75894592|FG000|Overall Study|Withdrawal by Subject|0|||
42084395|NCT00845897|75894593|FG001|Overall Study|Withdrawal by Subject|3|||
42084396|NCT00845897|75894594|FG002|Overall Study|Withdrawal by Subject|2|||
42084397|NCT00845897|75894592|FG000|Overall Study|Ulcer did not heal|1|||
42084398|NCT00845897|75894593|FG001|Overall Study|Ulcer did not heal|0|||
42084399|NCT00845897|75894594|FG002|Overall Study|Ulcer did not heal|1|||
42084400|NCT00845897|75894592|FG000|Overall Study|Too ill to participate|0|||
42084401|NCT00845897|75894593|FG001|Overall Study|Too ill to participate|1|||
42084402|NCT00845897|75894594|FG002|Overall Study|Too ill to participate|0|||
42084403|NCT00862277|75894605|FG000|Overall Study|Protocol Violation|1|||
42084404|NCT00862277|75894606|FG001|Overall Study|Protocol Violation|2|||
42084405|NCT00862277|75894607|FG002|Overall Study|Protocol Violation|5|||
42084406|NCT00852995|75894620|FG000|Overall Study|Adverse Event|1|||
42084407|NCT00852995|75894621|FG001|Overall Study|Adverse Event|0|||
42084408|NCT00852995|75894622|FG002|Overall Study|Adverse Event|4|||
42084409|NCT00852995|75894623|FG003|Overall Study|Adverse Event|0|||
42084410|NCT00852995|75894624|FG004|Overall Study|Adverse Event|0|||
42084411|NCT00852995|75894620|FG000|Overall Study|Lost to Follow-up|0|||
42179119|NCT01147666|75986400|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
42179120|NCT01147666|75986401|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
42179121|NCT01147666|75986402|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
42179122|NCT01147666|75986403|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
42179123|NCT01147666|75986404|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
42179124|NCT01147666|75986405|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
42179125|NCT01147666|75986406|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
42179126|NCT01147666|75986407|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
42179127|NCT01147666|75986408|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
42179128|NCT01147666|75986409|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
42179129|NCT01147666|75986410|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
42179130|NCT01147666|75986411|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
42084412|NCT00852995|75894621|FG001|Overall Study|Lost to Follow-up|1|||
42084413|NCT00852995|75894622|FG002|Overall Study|Lost to Follow-up|1|||
42084414|NCT00852995|75894623|FG003|Overall Study|Lost to Follow-up|0|||
42084415|NCT00852995|75894624|FG004|Overall Study|Lost to Follow-up|0|||
42084416|NCT00852995|75894620|FG000|Overall Study|Withdrawal by Subject|4|||
42084417|NCT00852995|75894621|FG001|Overall Study|Withdrawal by Subject|0|||
42084418|NCT00852995|75894622|FG002|Overall Study|Withdrawal by Subject|0|||
42084419|NCT00852995|75894623|FG003|Overall Study|Withdrawal by Subject|1|||
42084420|NCT00852995|75894624|FG004|Overall Study|Withdrawal by Subject|2|||
42084421|NCT00852995|75894620|FG000|Overall Study|Non-Compliance|0|||
42084422|NCT00852995|75894621|FG001|Overall Study|Non-Compliance|0|||
42084423|NCT00852995|75894622|FG002|Overall Study|Non-Compliance|0|||
42084424|NCT00852995|75894623|FG003|Overall Study|Non-Compliance|2|||
42084425|NCT00852995|75894624|FG004|Overall Study|Non-Compliance|0|||
42084426|NCT00852995|75894620|FG000|Overall Study|Progressive Disease|1|||
42084427|NCT00852995|75894621|FG001|Overall Study|Progressive Disease|0|||
42084428|NCT00852995|75894622|FG002|Overall Study|Progressive Disease|0|||
42084429|NCT00852995|75894623|FG003|Overall Study|Progressive Disease|2|||
42084430|NCT00852995|75894624|FG004|Overall Study|Progressive Disease|1|||
42084431|NCT00852995|75894620|FG000|Overall Study|Physician Decision|1|||
42084432|NCT00852995|75894621|FG001|Overall Study|Physician Decision|0|||
42084433|NCT00852995|75894622|FG002|Overall Study|Physician Decision|0|||
42084434|NCT00852995|75894623|FG003|Overall Study|Physician Decision|0|||
42084435|NCT00852995|75894624|FG004|Overall Study|Physician Decision|0|||
42084436|NCT00852995|75894620|FG000|Overall Study|Protocol Violation|0|||
42084437|NCT00852995|75894621|FG001|Overall Study|Protocol Violation|0|||
42084438|NCT00852995|75894622|FG002|Overall Study|Protocol Violation|0|||
42084439|NCT00852995|75894623|FG003|Overall Study|Protocol Violation|0|||
42084440|NCT00852995|75894624|FG004|Overall Study|Protocol Violation|1|||
42084441|NCT00852995|75894620|FG000|Overall Study|Moved Out of Area|1|||
42084442|NCT00852995|75894621|FG001|Overall Study|Moved Out of Area|0|||
42084443|NCT00852995|75894622|FG002|Overall Study|Moved Out of Area|0|||
42084444|NCT00852995|75894623|FG003|Overall Study|Moved Out of Area|0|||
42084445|NCT00852995|75894624|FG004|Overall Study|Moved Out of Area|0|||
42084446|NCT00592319|75894643|FG000|Overall Study|Lost to Follow-up|0|||
42084447|NCT00592319|75894644|FG001|Overall Study|Lost to Follow-up|3|||
42084448|NCT00862121|75894654|FG000|Overall Study|Adverse Event|1|||
42084449|NCT00862121|75894655|FG001|Overall Study|Adverse Event|2|||
42084450|NCT00862121|75894654|FG000|Overall Study|Lack of Efficacy|0|||
42084451|NCT00862121|75894655|FG001|Overall Study|Lack of Efficacy|3|||
42084452|NCT00862121|75894654|FG000|Overall Study|Protocol Violation|0|||
42084453|NCT00862121|75894655|FG001|Overall Study|Protocol Violation|1|||
42084454|NCT00862121|75894654|FG000|Overall Study|Exclusion criterion violation|0|||
42084455|NCT00862121|75894655|FG001|Overall Study|Exclusion criterion violation|1|||
42084456|NCT00862121|75894654|FG000|Overall Study|Incorrect randomisation|0|||
42084457|NCT00862121|75894655|FG001|Overall Study|Incorrect randomisation|1|||
42179131|NCT01147666|75986397|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
42084458|NCT00784719|75894668|FG000|Overall Study|Adverse Event|0|||
42084459|NCT00784719|75894669|FG001|Overall Study|Adverse Event|2|||
42179132|NCT01147666|75986398|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42294260|NCT02876328|76128659|FG015|Overall Study|Death|0|||
42084460|NCT00784719|75894670|FG002|Overall Study|Adverse Event|0|||
42084461|NCT00784719|75894671|FG003|Overall Study|Adverse Event|0|||
42084462|NCT00784719|75894672|FG004|Overall Study|Adverse Event|1|||
42084463|NCT00784719|75894673|FG005|Overall Study|Adverse Event|1|||
42084464|NCT00784719|75894674|FG006|Overall Study|Adverse Event|1|||
42084465|NCT00784719|75894668|FG000|Overall Study|Lost to Follow-up|0|||
42084466|NCT00784719|75894669|FG001|Overall Study|Lost to Follow-up|0|||
42084467|NCT00784719|75894670|FG002|Overall Study|Lost to Follow-up|0|||
42084468|NCT00784719|75894671|FG003|Overall Study|Lost to Follow-up|0|||
42084469|NCT00784719|75894672|FG004|Overall Study|Lost to Follow-up|1|||
42084470|NCT00784719|75894673|FG005|Overall Study|Lost to Follow-up|1|||
42084471|NCT00784719|75894674|FG006|Overall Study|Lost to Follow-up|0|||
42084472|NCT00784719|75894668|FG000|Overall Study|Other|2|||
42084473|NCT00784719|75894669|FG001|Overall Study|Other|1|||
42084474|NCT00784719|75894670|FG002|Overall Study|Other|1|||
42084475|NCT00784719|75894671|FG003|Overall Study|Other|0|||
42084476|NCT00784719|75894672|FG004|Overall Study|Other|2|||
42084477|NCT00784719|75894673|FG005|Overall Study|Other|1|||
42084478|NCT00784719|75894674|FG006|Overall Study|Other|3|||
42084479|NCT00784719|75894668|FG000|Overall Study|Withdrawal by Subject|1|||
42084480|NCT00784719|75894669|FG001|Overall Study|Withdrawal by Subject|0|||
42084481|NCT00784719|75894670|FG002|Overall Study|Withdrawal by Subject|0|||
42084482|NCT00784719|75894671|FG003|Overall Study|Withdrawal by Subject|0|||
42084483|NCT00784719|75894672|FG004|Overall Study|Withdrawal by Subject|2|||
42084484|NCT00784719|75894673|FG005|Overall Study|Withdrawal by Subject|0|||
42084485|NCT00784719|75894674|FG006|Overall Study|Withdrawal by Subject|1|||
42084486|NCT00852917|75894694|FG000|Overall Study|Adverse Event|13|||
42084487|NCT00852917|75894695|FG001|Overall Study|Adverse Event|20|||
42084488|NCT00852917|75894696|FG002|Overall Study|Adverse Event|35|||
42084489|NCT00852917|75894697|FG003|Overall Study|Adverse Event|17|||
42084490|NCT00852917|75894694|FG000|Overall Study|Lack of Efficacy|21|||
42084491|NCT00852917|75894695|FG001|Overall Study|Lack of Efficacy|11|||
42084492|NCT00852917|75894696|FG002|Overall Study|Lack of Efficacy|11|||
42084493|NCT00852917|75894697|FG003|Overall Study|Lack of Efficacy|47|||
42084494|NCT00852917|75894694|FG000|Overall Study|Withdrawal by Subject|4|||
42084495|NCT00852917|75894695|FG001|Overall Study|Withdrawal by Subject|8|||
42084496|NCT00852917|75894696|FG002|Overall Study|Withdrawal by Subject|10|||
42084497|NCT00852917|75894697|FG003|Overall Study|Withdrawal by Subject|9|||
42084498|NCT00852917|75894694|FG000|Overall Study|Physician Decision|6|||
42084499|NCT00852917|75894695|FG001|Overall Study|Physician Decision|7|||
42084500|NCT00852917|75894696|FG002|Overall Study|Physician Decision|2|||
42084501|NCT00852917|75894697|FG003|Overall Study|Physician Decision|19|||
42084502|NCT00852917|75894694|FG000|Overall Study|Death|0|||
42084503|NCT00852917|75894695|FG001|Overall Study|Death|0|||
42084504|NCT00852917|75894696|FG002|Overall Study|Death|0|||
42084505|NCT00852917|75894697|FG003|Overall Study|Death|1|||
42084506|NCT00845429|75894710|FG000|Overall Study|Protocol Violation|5|||
42084507|NCT00845429|75894711|FG001|Overall Study|Protocol Violation|4|||
42084508|NCT00845429|75894712|FG002|Overall Study|Protocol Violation|7|||
42084509|NCT00845429|75894710|FG000|Overall Study|Lost to Follow-up|7|||
42084510|NCT00845429|75894711|FG001|Overall Study|Lost to Follow-up|9|||
42084511|NCT00845429|75894712|FG002|Overall Study|Lost to Follow-up|10|||
42084512|NCT00845429|75894710|FG000|Overall Study|Withdrawal by Subject|2|||
42084513|NCT00845429|75894711|FG001|Overall Study|Withdrawal by Subject|2|||
42084514|NCT00845429|75894712|FG002|Overall Study|Withdrawal by Subject|2|||
42084515|NCT00845429|75894710|FG000|Overall Study|Serious adverse event|0|||
42084516|NCT00845429|75894711|FG001|Overall Study|Serious adverse event|0|||
42084517|NCT00845429|75894712|FG002|Overall Study|Serious adverse event|1|||
42084518|NCT00593333|75894722|FG000|Overall Study|Lost to Follow-up|10|||
42084519|NCT00593333|75894723|FG001|Overall Study|Lost to Follow-up|11|||
42084520|NCT00844883|75894729|FG000|Overall Study|Bridged to liver transplant|3|||
42358450|NCT04999839|76204145|FG004|Overall Study|Lack of Efficacy|0|||
42084521|NCT00844883|75894729|FG000|Overall Study|Bridged to resection|1|||
42084522|NCT00851903|75894733|FG000|Overall Study|Withdrawal by Subject|2|||
42084523|NCT00587457|75894740|FG000|Overall Study|Adverse Event|1|||
42084524|NCT00587457|75894741|FG001|Overall Study|Adverse Event|2|||
42084525|NCT00587457|75894742|FG002|Overall Study|Adverse Event|1|||
42084526|NCT00587457|75894740|FG000|Overall Study|Disease progression|2|||
42084527|NCT00587457|75894741|FG001|Overall Study|Disease progression|0|||
42084528|NCT00587457|75894742|FG002|Overall Study|Disease progression|2|||
42084529|NCT00587457|75894740|FG000|Overall Study|Initiation of alternative therapy|0|||
42084530|NCT00587457|75894741|FG001|Overall Study|Initiation of alternative therapy|1|||
42084531|NCT00587457|75894742|FG002|Overall Study|Initiation of alternative therapy|0|||
42084532|NCT00587457|75894740|FG000|Overall Study|Undefined|0|||
42084533|NCT00587457|75894741|FG001|Overall Study|Undefined|0|||
42084534|NCT00587457|75894742|FG002|Overall Study|Undefined|1|||
42084535|NCT00587457|75894740|FG000|Overall Study|Development of neutralizing Abs|0|||
42084536|NCT00587457|75894741|FG001|Overall Study|Development of neutralizing Abs|0|||
42084537|NCT00587457|75894742|FG002|Overall Study|Development of neutralizing Abs|1|||
42084538|NCT00851747|75894753|FG000|Overall Study|Physician Decision|6|||
42084539|NCT00851747|75894754|FG001|Overall Study|Physician Decision|6|||
42084540|NCT00851747|75894755|FG002|Overall Study|Physician Decision|6|||
42084541|NCT00767325|75894762|FG000|Overall Study|Lack of Efficacy|2|||
42084542|NCT00767325|75894762|FG000|Overall Study|Adverse Event|7|||
42084543|NCT00767325|75894762|FG000|Overall Study|Lost to Follow-up|3|||
42084544|NCT00767325|75894762|FG000|Overall Study|No longer met study criteria|2|||
42084545|NCT00767325|75894762|FG000|Overall Study|Missed visit due to family reasons|1|||
42084546|NCT00851591|75894768|FG000|Overall Study|Withdrawal by Subject|2|||
42084547|NCT00851591|75894769|FG001|Overall Study|Withdrawal by Subject|0|||
42084548|NCT00861341|75894775|FG000|Overall Study|Withdrawal by Subject|2|||
42084549|NCT00766467|75894781|FG000|Overall Study|Withdrawal by Subject|7|||
42084550|NCT00766467|75894782|FG001|Overall Study|Withdrawal by Subject|2|||
42084551|NCT00766467|75894781|FG000|Overall Study|Adverse Event|1|||
42084552|NCT00766467|75894782|FG001|Overall Study|Adverse Event|1|||
42084553|NCT00766467|75894781|FG000|Overall Study|Protocol Violation|2|||
42084554|NCT00766467|75894782|FG001|Overall Study|Protocol Violation|4|||
42084555|NCT00766467|75894781|FG000|Overall Study|Tumor Progression on Study|0|||
42084556|NCT00766467|75894782|FG001|Overall Study|Tumor Progression on Study|1|||
42084557|NCT00766467|75894781|FG000|Overall Study|Physician Decision|1|||
42084558|NCT00766467|75894782|FG001|Overall Study|Physician Decision|0|||
42084559|NCT00850499|75894790|FG000|Overall Study|Adverse Event|3|||
42084560|NCT00850499|75894791|FG001|Overall Study|Adverse Event|1|||
42084561|NCT00850499|75894790|FG000|Overall Study|Lack of Efficacy|0|||
42084562|NCT00850499|75894791|FG001|Overall Study|Lack of Efficacy|1|||
42084563|NCT00860951|75894797|FG000|Overall Study|Withdrawal by Subject|2|||
42084564|NCT00860951|75894797|FG000|Overall Study|Lost to Follow-up|5|||
42084565|NCT00844805|75894815|FG000|Treatment Phase|Adverse Event|5|||
42084566|NCT00844805|75894816|FG001|Treatment Phase|Adverse Event|1|||
42084567|NCT00844805|75894817|FG002|Treatment Phase|Adverse Event|0|||
42084568|NCT00844805|75894818|FG003|Treatment Phase|Adverse Event|0|||
42084569|NCT00844805|75894815|FG000|Treatment Phase|Withdrawal by Subject|3|||
42084570|NCT00844805|75894816|FG001|Treatment Phase|Withdrawal by Subject|4|||
42084571|NCT00844805|75894817|FG002|Treatment Phase|Withdrawal by Subject|0|||
42084572|NCT00844805|75894818|FG003|Treatment Phase|Withdrawal by Subject|0|||
42084573|NCT00844805|75894815|FG000|Treatment Phase|Noncompliance With Protocol|1|||
42084574|NCT00844805|75894816|FG001|Treatment Phase|Noncompliance With Protocol|0|||
42084575|NCT00844805|75894817|FG002|Treatment Phase|Noncompliance With Protocol|0|||
42084576|NCT00844805|75894818|FG003|Treatment Phase|Noncompliance With Protocol|0|||
42084577|NCT00844805|75894815|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
42084578|NCT00844805|75894816|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
42084579|NCT00844805|75894817|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
42084580|NCT00844805|75894818|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
42084581|NCT00844805|75894815|FG000|Follow-Up Phase|Adverse Event|0|||
42084582|NCT00844805|75894816|FG001|Follow-Up Phase|Adverse Event|0|||
42179133|NCT01147666|75986399|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42179134|NCT01147666|75986400|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
42179135|NCT01147666|75986401|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42179136|NCT01147666|75986402|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42179137|NCT01147666|75986403|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42179138|NCT01147666|75986404|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42179139|NCT01147666|75986405|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42179140|NCT01147666|75986406|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42179141|NCT01147666|75986407|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
42179142|NCT01147666|75986408|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42179143|NCT01147666|75986409|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42179144|NCT01147666|75986410|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42179145|NCT01147666|75986411|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
42179146|NCT01147666|75986397|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
42179147|NCT01147666|75986398|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
42179148|NCT01147666|75986399|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
42084583|NCT00844805|75894817|FG002|Follow-Up Phase|Adverse Event|1|||
42084584|NCT00844805|75894818|FG003|Follow-Up Phase|Adverse Event|0|||
42084585|NCT00844805|75894815|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
42084586|NCT00844805|75894816|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
42084587|NCT00844805|75894817|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
42179149|NCT01147666|75986400|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
42179150|NCT01147666|75986401|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
42179151|NCT01147666|75986402|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
42084588|NCT00844805|75894818|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
42084589|NCT00844805|75894815|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
42084590|NCT00844805|75894816|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
42084591|NCT00844805|75894817|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
42084592|NCT00844805|75894818|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
42084593|NCT00844805|75894815|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
42084594|NCT00844805|75894816|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
42084595|NCT00844805|75894817|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
42084596|NCT00844805|75894818|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
42084597|NCT00844805|75894815|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
42084598|NCT00844805|75894816|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
42084599|NCT00844805|75894817|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
42084600|NCT00844805|75894818|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
42084601|NCT00765999|75894829|FG000|Overall Study|Adverse Event|203|||
42084602|NCT00765999|75894829|FG000|Overall Study|Insufficient Therapeutic Response|100|||
42084603|NCT00765999|75894829|FG000|Overall Study|Protocol Violation|95|||
42084604|NCT00765999|75894829|FG000|Overall Study|Consent Withdrawn|202|||
42084605|NCT00765999|75894829|FG000|Overall Study|Lost to Follow-up|131|||
42084606|NCT00765999|75894829|FG000|Overall Study|Study Terminated by Sponsor|2|||
42084607|NCT00765999|75894829|FG000|Overall Study|Other Miscellaneous Reasons|51|||
42084608|NCT00765843|75894838|FG000|Overall Study|Lost to Follow-up|1|||
42084609|NCT00765843|75894839|FG001|Overall Study|Lost to Follow-up|3|||
42084610|NCT00765843|75894840|FG002|Overall Study|Lost to Follow-up|2|||
42084611|NCT00765843|75894838|FG000|Overall Study|did not return to receive intervention|0|||
42084612|NCT00765843|75894839|FG001|Overall Study|did not return to receive intervention|1|||
42084613|NCT00765843|75894840|FG002|Overall Study|did not return to receive intervention|0|||
42084614|NCT00765843|75894838|FG000|Overall Study|Adverse Event|0|||
42084615|NCT00765843|75894839|FG001|Overall Study|Adverse Event|0|||
42084616|NCT00765843|75894840|FG002|Overall Study|Adverse Event|1|||
42084617|NCT00765063|75894848|FG000|Overall Study|Lack of Efficacy|5|||
42084618|NCT00765063|75894848|FG000|Overall Study|Withdrawal by Subject|1|||
42084619|NCT00765063|75894848|FG000|Overall Study|Other|16|||
42084620|NCT00765063|75894848|FG000|Overall Study|Protocol Violation|6|||
42084621|NCT00765063|75894848|FG000|Overall Study|Adverse Event|4|||
42084622|NCT00764751|75894854|FG000|Overall Study|Adverse Event|1|||
42084623|NCT00764751|75894855|FG001|Overall Study|Adverse Event|1|||
42084624|NCT00764751|75894854|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
42084625|NCT00764751|75894855|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
42084626|NCT00764673|75894866|FG000|Overall Study|Death|1|||
42084627|NCT00764673|75894866|FG000|Overall Study|Lost to Follow-up|3|||
42084628|NCT00764673|75894866|FG000|Overall Study|Withdrawal by Subject|6|||
42084629|NCT00764673|75894866|FG000|Overall Study|Revision of Device|2|||
42084630|NCT00764517|75894872|FG000|Overall Study|Adverse Event|9|||
42084631|NCT00764517|75894873|FG001|Overall Study|Adverse Event|3|||
42084632|NCT00764517|75894872|FG000|Overall Study|Death|3|||
42084633|NCT00764517|75894873|FG001|Overall Study|Death|11|||
42084634|NCT00764517|75894872|FG000|Overall Study|Physician Decision|3|||
42084635|NCT00764517|75894873|FG001|Overall Study|Physician Decision|0|||
42084636|NCT00764361|75894881|FG000|Overall Study|Withdrawal by Subject|2|||
42084637|NCT00764361|75894882|FG001|Overall Study|Withdrawal by Subject|3|||
42084638|NCT00764361|75894881|FG000|Overall Study|Adverse Event|0|||
42084639|NCT00764361|75894882|FG001|Overall Study|Adverse Event|1|||
42084640|NCT00763971|75894891|FG000|Overall Study|Adverse Event|5|||
42084641|NCT00763971|75894892|FG001|Overall Study|Adverse Event|2|||
42084642|NCT00763971|75894893|FG002|Overall Study|Adverse Event|4|||
42084643|NCT00763971|75894891|FG000|Overall Study|Protocol Violation|3|||
42084644|NCT00763971|75894892|FG001|Overall Study|Protocol Violation|3|||
42084645|NCT00763971|75894893|FG002|Overall Study|Protocol Violation|2|||
42084646|NCT00763971|75894891|FG000|Overall Study|Withdrawal by Subject|4|||
42084647|NCT00763971|75894892|FG001|Overall Study|Withdrawal by Subject|5|||
42084648|NCT00763971|75894893|FG002|Overall Study|Withdrawal by Subject|5|||
42084649|NCT00763971|75894891|FG000|Overall Study|Lost to Follow-up|0|||
42084650|NCT00763971|75894892|FG001|Overall Study|Lost to Follow-up|1|||
42084651|NCT00763971|75894893|FG002|Overall Study|Lost to Follow-up|0|||
42084652|NCT00763971|75894891|FG000|Overall Study|Lack of Efficacy|11|||
42084653|NCT00763971|75894892|FG001|Overall Study|Lack of Efficacy|22|||
42084654|NCT00763971|75894893|FG002|Overall Study|Lack of Efficacy|54|||
42084655|NCT00763971|75894891|FG000|Overall Study|Unable to swallow capsule|2|||
42084656|NCT00763971|75894892|FG001|Overall Study|Unable to swallow capsule|1|||
42084657|NCT00763971|75894893|FG002|Overall Study|Unable to swallow capsule|1|||
42084658|NCT00763971|75894891|FG000|Overall Study|Personal reason|3|||
42084659|NCT00763971|75894892|FG001|Overall Study|Personal reason|0|||
42084660|NCT00763971|75894893|FG002|Overall Study|Personal reason|0|||
42084661|NCT00763971|75894891|FG000|Overall Study|Exclusion criteria met|1|||
42084662|NCT00763971|75894892|FG001|Overall Study|Exclusion criteria met|0|||
42084663|NCT00763971|75894893|FG002|Overall Study|Exclusion criteria met|0|||
42084664|NCT00763971|75894891|FG000|Overall Study|Sponsor decision|1|||
42084665|NCT00763971|75894892|FG001|Overall Study|Sponsor decision|0|||
42084666|NCT00763971|75894893|FG002|Overall Study|Sponsor decision|0|||
42084667|NCT00763971|75894891|FG000|Overall Study|Due to holiday season|2|||
42084668|NCT00763971|75894892|FG001|Overall Study|Due to holiday season|0|||
42084669|NCT00763971|75894893|FG002|Overall Study|Due to holiday season|1|||
42084670|NCT00763971|75894891|FG000|Overall Study|Randomization error|0|||
42084671|NCT00763971|75894892|FG001|Overall Study|Randomization error|0|||
42084672|NCT00763971|75894893|FG002|Overall Study|Randomization error|1|||
42084673|NCT00763971|75894891|FG000|Overall Study|Medical monitor decision|0|||
42084674|NCT00763971|75894892|FG001|Overall Study|Medical monitor decision|0|||
42084675|NCT00763971|75894893|FG002|Overall Study|Medical monitor decision|1|||
42084676|NCT00763971|75894891|FG000|Overall Study|Moved to another country|0|||
42084677|NCT00763971|75894892|FG001|Overall Study|Moved to another country|1|||
42084678|NCT00763971|75894893|FG002|Overall Study|Moved to another country|0|||
42084679|NCT00763971|75894891|FG000|Overall Study|Subject wanted dose reduction|0|||
42084680|NCT00763971|75894892|FG001|Overall Study|Subject wanted dose reduction|1|||
42084681|NCT00763971|75894893|FG002|Overall Study|Subject wanted dose reduction|0|||
42084682|NCT00763971|75894891|FG000|Overall Study|Lack of availability|0|||
42084683|NCT00763971|75894892|FG001|Overall Study|Lack of availability|1|||
42084684|NCT00763971|75894893|FG002|Overall Study|Lack of availability|0|||
42084685|NCT00763971|75894891|FG000|Overall Study|Performed final visit on phone|0|||
42084686|NCT00763971|75894892|FG001|Overall Study|Performed final visit on phone|1|||
42084687|NCT00763971|75894893|FG002|Overall Study|Performed final visit on phone|0|||
42084688|NCT00763971|75894891|FG000|Overall Study|Participation in 489-326 required|1|||
42084689|NCT00763971|75894892|FG001|Overall Study|Participation in 489-326 required|0|||
42084690|NCT00763971|75894893|FG002|Overall Study|Participation in 489-326 required|0|||
42084691|NCT00763815|75894903|FG000|Overall Study|Adverse Event|14|||
42084692|NCT00763815|75894904|FG001|Overall Study|Adverse Event|29|||
42084693|NCT00763815|75894903|FG000|Overall Study|Lack of Efficacy|10|||
42084694|NCT00763815|75894904|FG001|Overall Study|Lack of Efficacy|11|||
42084695|NCT00763815|75894903|FG000|Overall Study|Poor Compliance to Protocol|6|||
42084696|NCT00763815|75894904|FG001|Overall Study|Poor Compliance to Protocol|6|||
42084697|NCT00763815|75894903|FG000|Overall Study|Lost to Follow-up|2|||
42084698|NCT00763815|75894904|FG001|Overall Study|Lost to Follow-up|4|||
42084699|NCT00763815|75894903|FG000|Overall Study|Early Termination|1|||
42084700|NCT00763815|75894904|FG001|Overall Study|Early Termination|0|||
42084701|NCT00763815|75894903|FG000|Overall Study|Familial and Personal Reasons|9|||
42084702|NCT00763815|75894904|FG001|Overall Study|Familial and Personal Reasons|16|||
42084703|NCT00763815|75894903|FG000|Overall Study|Physician Decision|1|||
42084704|NCT00763815|75894904|FG001|Overall Study|Physician Decision|0|||
42084705|NCT00763815|75894903|FG000|Overall Study|Withdrawal by Subject|7|||
42084706|NCT00763815|75894904|FG001|Overall Study|Withdrawal by Subject|12|||
42084707|NCT00763815|75894903|FG000|Overall Study|Protocol Violation|2|||
42084708|NCT00763815|75894904|FG001|Overall Study|Protocol Violation|5|||
42084709|NCT00763815|75894903|FG000|Overall Study|Sponsor's Decision|0|||
42084710|NCT00763815|75894904|FG001|Overall Study|Sponsor's Decision|1|||
42084711|NCT00763269|75894912|FG000|Overall Study|Lost to Follow-up|12|||
42084712|NCT00763269|75894913|FG001|Overall Study|Lost to Follow-up|13|||
42084713|NCT00763035|75894919|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
42084714|NCT00763035|75894920|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
42084715|NCT00763035|75894919|FG000|First Intervention|Adverse Event|0|||
42084716|NCT00763035|75894920|FG001|First Intervention|Adverse Event|1|||
42084717|NCT00763035|75894919|FG000|Second Intervention|Adverse Event|1|||
42084718|NCT00763035|75894920|FG001|Second Intervention|Adverse Event|0|||
42084719|NCT00763035|75894919|FG000|Second Intervention|Physician Decision|2|||
42084720|NCT00763035|75894920|FG001|Second Intervention|Physician Decision|0|||
42084721|NCT00844649|75894928|FG000|Overall Study|Progressive Disease|196|||
42084722|NCT00844649|75894929|FG001|Overall Study|Progressive Disease|245|||
42084723|NCT00844649|75894928|FG000|Overall Study|Adverse Event|128|||
42084724|NCT00844649|75894929|FG001|Overall Study|Adverse Event|73|||
42084725|NCT00844649|75894928|FG000|Overall Study|Physician Decision|25|||
42084726|NCT00844649|75894929|FG001|Overall Study|Physician Decision|18|||
42084727|NCT00844649|75894928|FG000|Overall Study|Protocol Violation|10|||
42179152|NCT01147666|75986403|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
42179153|NCT01147666|75986404|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
42294261|NCT02876328|76128660|FG016|Overall Study|Death|1|||
42084728|NCT00844649|75894929|FG001|Overall Study|Protocol Violation|6|||
42084729|NCT00844649|75894928|FG000|Overall Study|Withdrawal by Subject|28|||
42084730|NCT00844649|75894929|FG001|Overall Study|Withdrawal by Subject|39|||
42084731|NCT00844649|75894928|FG000|Overall Study|Other|7|||
42084732|NCT00844649|75894929|FG001|Overall Study|Other|10|||
42084733|NCT00844649|75894928|FG000|Overall Study|Withdrew prior to starting treatment|11|||
42294262|NCT02876328|76128661|FG017|Overall Study|Death|1|||
42084734|NCT00844649|75894929|FG001|Overall Study|Withdrew prior to starting treatment|27|||
42084735|NCT00762723|75894940|FG000|Overall Study|Study Terminated slow enrollement|5|||
42084736|NCT00762723|75894941|FG001|Overall Study|Study Terminated slow enrollement|5|||
42084737|NCT00762723|75894942|FG002|Overall Study|Study Terminated slow enrollement|3|||
42084738|NCT00850343|75894954|FG000|Overall Study|Withdrawal by Subject|11|||
42084739|NCT00850343|75894955|FG001|Overall Study|Withdrawal by Subject|0|||
42084740|NCT00850343|75894956|FG002|Overall Study|Withdrawal by Subject|3|||
42084741|NCT00850343|75894957|FG003|Overall Study|Withdrawal by Subject|2|||
42084742|NCT00850343|75894954|FG000|Overall Study|Adverse Event|15|||
42084743|NCT00850343|75894955|FG001|Overall Study|Adverse Event|2|||
42084744|NCT00850343|75894956|FG002|Overall Study|Adverse Event|6|||
42084745|NCT00850343|75894957|FG003|Overall Study|Adverse Event|6|||
42084746|NCT00850343|75894954|FG000|Overall Study|Pregnancy|0|||
42358451|NCT04999839|76204141|FG000|Overall Study|Physician Decision|0|||
42084747|NCT00850343|75894955|FG001|Overall Study|Pregnancy|0|||
42084748|NCT00850343|75894956|FG002|Overall Study|Pregnancy|0|||
42084749|NCT00850343|75894957|FG003|Overall Study|Pregnancy|1|||
42084750|NCT00850343|75894954|FG000|Overall Study|Lack of Efficacy|17|||
42084751|NCT00850343|75894955|FG001|Overall Study|Lack of Efficacy|0|||
42084752|NCT00850343|75894956|FG002|Overall Study|Lack of Efficacy|3|||
42084753|NCT00850343|75894957|FG003|Overall Study|Lack of Efficacy|2|||
42084754|NCT00850343|75894954|FG000|Overall Study|Non-compliance with Study Procedures|1|||
42084755|NCT00850343|75894955|FG001|Overall Study|Non-compliance with Study Procedures|0|||
42084756|NCT00850343|75894956|FG002|Overall Study|Non-compliance with Study Procedures|1|||
42084757|NCT00850343|75894957|FG003|Overall Study|Non-compliance with Study Procedures|1|||
42084758|NCT00850343|75894954|FG000|Overall Study|Physician Decision|2|||
42084759|NCT00850343|75894955|FG001|Overall Study|Physician Decision|1|||
42084760|NCT00850343|75894956|FG002|Overall Study|Physician Decision|1|||
42084761|NCT00850343|75894957|FG003|Overall Study|Physician Decision|1|||
42084762|NCT00849875|75894970|FG000|Overall Study|Death|28|||
42084763|NCT00849875|75894970|FG000|Overall Study|Ongoing (unknown completion status)|11|||
42084764|NCT00849875|75894970|FG000|Overall Study|Others|6|||
42084765|NCT00849875|75894970|FG000|Overall Study|Lost to Follow-up|2|||
42084766|NCT00844415|75894981|FG000|Overall Study|Withdrawal by Subject|1|||
42084767|NCT00843635|75894989|FG000|Overall Study|Adverse Event|2|||
42084768|NCT00843635|75894990|FG001|Overall Study|Adverse Event|2|||
42084769|NCT00843635|75894991|FG002|Overall Study|Adverse Event|0|||
42084770|NCT00843167|75895005|FG000|Treatment Period|Adverse Event|1|||
42084771|NCT00843167|75895006|FG001|Treatment Period|Adverse Event|5|||
42084772|NCT00843167|75895005|FG000|Treatment Period|Withdrawal by Subject|2|||
42084773|NCT00843167|75895006|FG001|Treatment Period|Withdrawal by Subject|3|||
42084774|NCT00849017|75895019|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
42084775|NCT00849017|75895020|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
42084776|NCT00849017|75895021|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
42084777|NCT00849017|75895019|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
42084778|NCT00849017|75895020|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
42084779|NCT00849017|75895021|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
42084780|NCT00849017|75895019|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
42084781|NCT00849017|75895020|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
42084782|NCT00849017|75895021|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
42084783|NCT00849017|75895019|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
42084784|NCT00849017|75895020|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
42179154|NCT01147666|75986405|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
42179155|NCT01147666|75986406|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
42179156|NCT01147666|75986407|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
42179157|NCT01147666|75986408|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
42179158|NCT01147666|75986409|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
42179159|NCT01147666|75986410|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
42179160|NCT01147666|75986411|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
42179161|NCT01147666|75986397|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42179162|NCT01147666|75986398|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42358452|NCT04999839|76204142|FG001|Overall Study|Physician Decision|0|||
42358453|NCT04999839|76204143|FG002|Overall Study|Physician Decision|0|||
42084785|NCT00849017|75895021|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
42084786|NCT00849017|75895019|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
42084787|NCT00849017|75895020|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
42084788|NCT00849017|75895021|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
42084789|NCT00849017|75895019|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
42084790|NCT00849017|75895020|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
42084791|NCT00849017|75895021|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
42179163|NCT01147666|75986399|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42084792|NCT00849017|75895019|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
42084793|NCT00849017|75895020|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
42084794|NCT00849017|75895021|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
42179164|NCT01147666|75986400|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
42179165|NCT01147666|75986401|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42179166|NCT01147666|75986402|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42179167|NCT01147666|75986403|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42179168|NCT01147666|75986404|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42179169|NCT01147666|75986405|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42179170|NCT01147666|75986406|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42179171|NCT01147666|75986407|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
42179172|NCT01147666|75986408|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42179173|NCT01147666|75986409|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42179174|NCT01147666|75986410|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42179175|NCT01147666|75986411|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
42179176|NCT01147666|75986397|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42179177|NCT01147666|75986398|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42084795|NCT00849017|75895019|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
42084796|NCT00849017|75895020|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
42084797|NCT00849017|75895021|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
42084798|NCT00849017|75895019|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
42084799|NCT00849017|75895020|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
42084800|NCT00849017|75895021|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
42084801|NCT00849017|75895019|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
42084802|NCT00849017|75895020|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
42084803|NCT00849017|75895021|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
42084804|NCT00849017|75895019|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
42084805|NCT00849017|75895020|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
42084806|NCT00849017|75895021|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
42084807|NCT00849017|75895019|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
42084808|NCT00849017|75895020|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
42084809|NCT00849017|75895021|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
42084810|NCT00849017|75895019|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
42084811|NCT00849017|75895020|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
42084812|NCT00849017|75895021|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
42084813|NCT00849017|75895019|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
42084814|NCT00849017|75895020|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
42084815|NCT00849017|75895021|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
42084816|NCT00849017|75895019|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
42084817|NCT00849017|75895020|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
42084818|NCT00849017|75895021|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
42084819|NCT00849017|75895019|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
42084820|NCT00849017|75895020|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
42084821|NCT00849017|75895021|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
42084822|NCT00849017|75895019|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
42084823|NCT00849017|75895020|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
42084824|NCT00849017|75895021|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
42084825|NCT00849017|75895019|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
42084826|NCT00849017|75895020|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
42084827|NCT00849017|75895021|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
42084828|NCT00849017|75895019|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
42084829|NCT00849017|75895020|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
42084830|NCT00849017|75895021|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
42084831|NCT00842543|75895037|FG000|Overall Study|Withdrawal by Subject|2|||
42084832|NCT00842543|75895038|FG001|Overall Study|Withdrawal by Subject|0|||
42084833|NCT00842543|75895039|FG002|Overall Study|Withdrawal by Subject|3|||
42084834|NCT00842543|75895040|FG003|Overall Study|Withdrawal by Subject|4|||
42084835|NCT00785928|75895059|FG000|Treatment Phase|Adverse Event|1|||
42084836|NCT00785928|75895060|FG001|Treatment Phase|Adverse Event|1|||
42084837|NCT00785928|75895061|FG002|Treatment Phase|Adverse Event|2|||
42084838|NCT00785928|75895062|FG003|Treatment Phase|Adverse Event|0|||
42084839|NCT00785928|75895063|FG004|Treatment Phase|Adverse Event|0|||
42179178|NCT01147666|75986399|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42179179|NCT01147666|75986400|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42294263|NCT02876328|76128662|FG018|Overall Study|Death|0|||
42084840|NCT00785928|75895064|FG005|Treatment Phase|Adverse Event|0|||
42084841|NCT00785928|75895065|FG006|Treatment Phase|Adverse Event|2|||
42084842|NCT00785928|75895059|FG000|Treatment Phase|Inadequate Response|0|||
42084843|NCT00785928|75895060|FG001|Treatment Phase|Inadequate Response|1|||
42084844|NCT00785928|75895061|FG002|Treatment Phase|Inadequate Response|0|||
42084845|NCT00785928|75895062|FG003|Treatment Phase|Inadequate Response|0|||
42084846|NCT00785928|75895063|FG004|Treatment Phase|Inadequate Response|0|||
42084847|NCT00785928|75895064|FG005|Treatment Phase|Inadequate Response|0|||
42084848|NCT00785928|75895065|FG006|Treatment Phase|Inadequate Response|0|||
42084849|NCT00785928|75895059|FG000|Treatment Phase|Lack of Efficacy|0|||
42084850|NCT00785928|75895060|FG001|Treatment Phase|Lack of Efficacy|1|||
42084851|NCT00785928|75895061|FG002|Treatment Phase|Lack of Efficacy|1|||
42084852|NCT00785928|75895062|FG003|Treatment Phase|Lack of Efficacy|0|||
42084853|NCT00785928|75895063|FG004|Treatment Phase|Lack of Efficacy|0|||
42084854|NCT00785928|75895064|FG005|Treatment Phase|Lack of Efficacy|0|||
42084855|NCT00785928|75895065|FG006|Treatment Phase|Lack of Efficacy|0|||
42084856|NCT00785928|75895059|FG000|Treatment Phase|Physician Decision|0|||
42084857|NCT00785928|75895060|FG001|Treatment Phase|Physician Decision|0|||
42084858|NCT00785928|75895061|FG002|Treatment Phase|Physician Decision|0|||
42084859|NCT00785928|75895062|FG003|Treatment Phase|Physician Decision|0|||
42084860|NCT00785928|75895063|FG004|Treatment Phase|Physician Decision|1|||
42084861|NCT00785928|75895064|FG005|Treatment Phase|Physician Decision|0|||
42084862|NCT00785928|75895065|FG006|Treatment Phase|Physician Decision|0|||
42084863|NCT00785928|75895059|FG000|Treatment Phase|Sponsor Decision|1|||
42084864|NCT00785928|75895060|FG001|Treatment Phase|Sponsor Decision|0|||
42084865|NCT00785928|75895061|FG002|Treatment Phase|Sponsor Decision|0|||
42084866|NCT00785928|75895062|FG003|Treatment Phase|Sponsor Decision|0|||
42084867|NCT00785928|75895063|FG004|Treatment Phase|Sponsor Decision|0|||
42084868|NCT00785928|75895064|FG005|Treatment Phase|Sponsor Decision|0|||
42084869|NCT00785928|75895065|FG006|Treatment Phase|Sponsor Decision|1|||
42084870|NCT00785928|75895059|FG000|Treatment Phase|Withdrawal by Subject|1|||
42084871|NCT00785928|75895060|FG001|Treatment Phase|Withdrawal by Subject|2|||
42084872|NCT00785928|75895061|FG002|Treatment Phase|Withdrawal by Subject|0|||
42084873|NCT00785928|75895062|FG003|Treatment Phase|Withdrawal by Subject|0|||
42084874|NCT00785928|75895063|FG004|Treatment Phase|Withdrawal by Subject|1|||
42084875|NCT00785928|75895064|FG005|Treatment Phase|Withdrawal by Subject|0|||
42084876|NCT00785928|75895065|FG006|Treatment Phase|Withdrawal by Subject|0|||
42084877|NCT00842309|75895105|FG000|Overall Study|Withdrawal by Subject|3|||
42084878|NCT00842309|75895106|FG001|Overall Study|Withdrawal by Subject|1|||
42084879|NCT00842153|75895114|FG000|Overall Study|Adverse Event|0|||
42358454|NCT04999839|76204144|FG003|Overall Study|Physician Decision|0|||
42084880|NCT00842153|75895115|FG001|Overall Study|Adverse Event|1|||
42084881|NCT00842153|75895114|FG000|Overall Study|Lost to Follow-up|1|||
42084882|NCT00842153|75895115|FG001|Overall Study|Lost to Follow-up|2|||
42084883|NCT00762411|75895123|FG000|Initial Treatment|Death|7|||
42084884|NCT00762411|75895124|FG001|Initial Treatment|Death|6|||
42084885|NCT00762411|75895123|FG000|Initial Treatment|Adverse Event|132|||
42084886|NCT00762411|75895124|FG001|Initial Treatment|Adverse Event|40|||
42084887|NCT00762411|75895123|FG000|Initial Treatment|Protocol Violation|4|||
42084888|NCT00762411|75895124|FG001|Initial Treatment|Protocol Violation|1|||
42084889|NCT00762411|75895123|FG000|Initial Treatment|Withdrawal by Subject|65|||
42084890|NCT00762411|75895124|FG001|Initial Treatment|Withdrawal by Subject|52|||
42084891|NCT00762411|75895123|FG000|Initial Treatment|Physician Decision|1|||
42084892|NCT00762411|75895124|FG001|Initial Treatment|Physician Decision|0|||
42084893|NCT00762411|75895123|FG000|Initial Treatment|Sponsor Decision|293|||
42084894|NCT00762411|75895124|FG001|Initial Treatment|Sponsor Decision|401|||
42084895|NCT00762411|75895123|FG000|Initial Treatment|Lost to Follow-up|5|||
42084896|NCT00762411|75895124|FG001|Initial Treatment|Lost to Follow-up|0|||
42084897|NCT00762411|75895123|FG000|Initial Treatment|Caregiver Decision|21|||
42084898|NCT00762411|75895124|FG001|Initial Treatment|Caregiver Decision|16|||
42358455|NCT04999839|76204145|FG004|Overall Study|Physician Decision|1|||
42084899|NCT00762411|75895123|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
42084900|NCT00762411|75895124|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
42084901|NCT00762411|75895123|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
42084902|NCT00762411|75895124|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
42084903|NCT00762411|75895123|FG000|Delayed Start|Adverse Event|0|||
42084904|NCT00762411|75895124|FG001|Delayed Start|Adverse Event|4|||
42084905|NCT00762411|75895123|FG000|Delayed Start|Protocol Violation|0|||
42084906|NCT00762411|75895124|FG001|Delayed Start|Protocol Violation|1|||
42084907|NCT00762411|75895123|FG000|Delayed Start|Sponsor Decision|16|||
42084908|NCT00762411|75895124|FG001|Delayed Start|Sponsor Decision|20|||
42084909|NCT00762411|75895123|FG000|Delayed Start|Caregiver Decision|1|||
42084910|NCT00762411|75895124|FG001|Delayed Start|Caregiver Decision|1|||
42084911|NCT00762411|75895123|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
42084912|NCT00762411|75895124|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
42084913|NCT00762411|75895123|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
42084914|NCT00762411|75895124|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
42084915|NCT00762411|75895123|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
42084916|NCT00762411|75895124|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
42084917|NCT00762411|75895123|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
42084918|NCT00762411|75895124|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
42084919|NCT00762411|75895123|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
42084920|NCT00762411|75895124|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
42084921|NCT00762411|75895123|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
42179180|NCT01147666|75986401|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42179181|NCT01147666|75986402|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42179182|NCT01147666|75986403|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42179183|NCT01147666|75986404|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42179184|NCT01147666|75986405|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42179185|NCT01147666|75986406|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42179186|NCT01147666|75986407|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42179187|NCT01147666|75986408|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
42179188|NCT01147666|75986409|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
42084922|NCT00762411|75895124|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
42084923|NCT00761865|75895136|FG000|Overall Study|Lost to Follow-up|8|||
42084924|NCT00761865|75895137|FG001|Overall Study|Lost to Follow-up|7|||
42084925|NCT00841763|75895145|FG000|Overall Study|Withdrawal by Subject|60|||
42084926|NCT00841763|75895146|FG001|Overall Study|Withdrawal by Subject|17|||
42084927|NCT00841763|75895147|FG002|Overall Study|Withdrawal by Subject|4|||
42084928|NCT00841763|75895148|FG003|Overall Study|Withdrawal by Subject|1|||
42084929|NCT00841763|75895145|FG000|Overall Study|Adverse Event|9|||
42084930|NCT00841763|75895146|FG001|Overall Study|Adverse Event|10|||
42084931|NCT00841763|75895147|FG002|Overall Study|Adverse Event|3|||
42084932|NCT00841763|75895148|FG003|Overall Study|Adverse Event|2|||
42084933|NCT00841763|75895145|FG000|Overall Study|Lost to Follow-up|63|||
42084934|NCT00841763|75895146|FG001|Overall Study|Lost to Follow-up|25|||
42084935|NCT00841763|75895147|FG002|Overall Study|Lost to Follow-up|0|||
42084936|NCT00841763|75895148|FG003|Overall Study|Lost to Follow-up|0|||
42084937|NCT00841763|75895145|FG000|Overall Study|Protocol Violation|20|||
42084938|NCT00841763|75895146|FG001|Overall Study|Protocol Violation|3|||
42084939|NCT00841763|75895147|FG002|Overall Study|Protocol Violation|1|||
42084940|NCT00841763|75895148|FG003|Overall Study|Protocol Violation|0|||
42084941|NCT00841763|75895145|FG000|Overall Study|Administrative Reasons|3|||
42084942|NCT00841763|75895146|FG001|Overall Study|Administrative Reasons|1|||
42179189|NCT01147666|75986410|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
42179190|NCT01147666|75986411|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
42179191|NCT01147666|75986397|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
42179192|NCT01147666|75986398|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
42179193|NCT01147666|75986399|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
42179194|NCT01147666|75986400|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
42179195|NCT01147666|75986401|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
42179196|NCT01147666|75986402|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
42179197|NCT01147666|75986403|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
42179198|NCT01147666|75986404|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
42179199|NCT01147666|75986405|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
42179200|NCT01147666|75986406|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
42179201|NCT01147666|75986407|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
42179202|NCT01147666|75986408|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
42179203|NCT01147666|75986409|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
42179204|NCT01147666|75986410|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
42179205|NCT01147666|75986411|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
42179206|NCT01147666|75986397|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
42179207|NCT01147666|75986398|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
42179208|NCT01147666|75986399|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
42179209|NCT01147666|75986400|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
42084943|NCT00841763|75895147|FG002|Overall Study|Administrative Reasons|0|||
42179210|NCT01147666|75986401|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
42179211|NCT01147666|75986402|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
42179212|NCT01147666|75986403|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
42084944|NCT00841763|75895148|FG003|Overall Study|Administrative Reasons|0|||
42084945|NCT00841763|75895145|FG000|Overall Study|Unable to Classify|7|||
42084946|NCT00841763|75895146|FG001|Overall Study|Unable to Classify|1|||
42084947|NCT00841763|75895147|FG002|Overall Study|Unable to Classify|0|||
42084948|NCT00841763|75895148|FG003|Overall Study|Unable to Classify|0|||
42084949|NCT00838331|75895193|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
42084950|NCT00785538|75895201|FG000|Treatment Period|Adverse Event|1|||
42084951|NCT00785538|75895202|FG001|Treatment Period|Adverse Event|2|||
42084952|NCT00785538|75895203|FG002|Treatment Period|Adverse Event|2|||
42084953|NCT00785538|75895204|FG003|Treatment Period|Adverse Event|0|||
42084954|NCT00785538|75895201|FG000|Treatment Period|Withdrawal by Subject|0|||
42084955|NCT00785538|75895202|FG001|Treatment Period|Withdrawal by Subject|0|||
42084956|NCT00785538|75895203|FG002|Treatment Period|Withdrawal by Subject|0|||
42084957|NCT00785538|75895204|FG003|Treatment Period|Withdrawal by Subject|1|||
42084958|NCT00860405|75895217|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
42084959|NCT00860405|75895218|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
42084960|NCT00838097|75895224|FG000|Overall Study|Ineligibility determined|6|||
42084961|NCT00838097|75895224|FG000|Overall Study|Adverse Event|2|||
42084962|NCT00838097|75895224|FG000|Overall Study|Withdrawal by Subject|3|||
42084963|NCT00838097|75895224|FG000|Overall Study|Requirement for alternative therapy|2|||
42084964|NCT00838097|75895224|FG000|Overall Study|Physician Decision|4|||
42084965|NCT00838097|75895224|FG000|Overall Study|Lost to Follow-up|11|||
42084966|NCT00838097|75895224|FG000|Overall Study|Death|6|||
42084967|NCT00838097|75895224|FG000|Overall Study|Protocol-specified criteria|142|||
42084968|NCT00840827|75895228|FG000|Overall Study|Adverse Event|1|||
42084969|NCT00840827|75895228|FG000|Overall Study|Lack of Efficacy|4|||
42084970|NCT00840827|75895228|FG000|Overall Study|Physician Decision|1|||
42084971|NCT00860249|75895235|FG000|Overall Study|trial was terminated prior to completion|21|||
42084972|NCT00860249|75895236|FG001|Overall Study|trial was terminated prior to completion|18|||
42084973|NCT00860249|75895237|FG002|Overall Study|trial was terminated prior to completion|21|||
42084974|NCT00840749|75895247|FG000|Overall Study|Death|1|||
42084975|NCT00840749|75895248|FG001|Overall Study|Death|2|||
42084976|NCT00840749|75895247|FG000|Overall Study|not treated on study arm|11|||
42084977|NCT00840749|75895248|FG001|Overall Study|not treated on study arm|11|||
42084978|NCT00840749|75895247|FG000|Overall Study|study closed|19|||
42084979|NCT00840749|75895248|FG001|Overall Study|study closed|14|||
42084980|NCT00859937|75895256|FG000|Overall Study|Protocol Violation|1|||
42084981|NCT00859937|75895257|FG001|Overall Study|Protocol Violation|0|||
42084982|NCT00592007|75895263|FG000|Overall Study|Withdrawal by Subject|1|||
42179213|NCT01147666|75986404|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
42084983|NCT00592007|75895263|FG000|Overall Study|patient ineligible (out of lab range)|1|||
42084984|NCT00837473|75895267|FG000|Overall Study|Lost to Follow-up|1|||
42084985|NCT00837473|75895267|FG000|Overall Study|Withdrawal by Subject|2|||
42084986|NCT00839423|75895275|FG000|Overall Study|Adverse Event|4|||
42084987|NCT00839423|75895276|FG001|Overall Study|Adverse Event|3|||
42084988|NCT00839423|75895277|FG002|Overall Study|Adverse Event|7|||
42084989|NCT00839423|75895278|FG003|Overall Study|Adverse Event|16|||
42084990|NCT00839423|75895275|FG000|Overall Study|Lack of Efficacy|6|||
42084991|NCT00839423|75895276|FG001|Overall Study|Lack of Efficacy|6|||
42084992|NCT00839423|75895277|FG002|Overall Study|Lack of Efficacy|3|||
42084993|NCT00839423|75895278|FG003|Overall Study|Lack of Efficacy|2|||
42084994|NCT00839423|75895275|FG000|Overall Study|Non-compliance|0|||
42084995|NCT00839423|75895276|FG001|Overall Study|Non-compliance|0|||
42084996|NCT00839423|75895277|FG002|Overall Study|Non-compliance|0|||
42084997|NCT00839423|75895278|FG003|Overall Study|Non-compliance|1|||
42084998|NCT00839423|75895275|FG000|Overall Study|Protocol Violation|0|||
42084999|NCT00839423|75895276|FG001|Overall Study|Protocol Violation|1|||
42085000|NCT00839423|75895277|FG002|Overall Study|Protocol Violation|2|||
42085001|NCT00839423|75895278|FG003|Overall Study|Protocol Violation|0|||
42085002|NCT00839423|75895275|FG000|Overall Study|Withdrawal of consent|4|||
42085003|NCT00839423|75895276|FG001|Overall Study|Withdrawal of consent|0|||
42085004|NCT00839423|75895277|FG002|Overall Study|Withdrawal of consent|4|||
42085005|NCT00839423|75895278|FG003|Overall Study|Withdrawal of consent|1|||
42294264|NCT02876328|76128663|FG019|Overall Study|Death|0|||
42085006|NCT00839423|75895275|FG000|Overall Study|Lost to Follow-up|1|||
42085007|NCT00839423|75895276|FG001|Overall Study|Lost to Follow-up|0|||
42085008|NCT00839423|75895277|FG002|Overall Study|Lost to Follow-up|1|||
42085009|NCT00839423|75895278|FG003|Overall Study|Lost to Follow-up|0|||
42085010|NCT00839423|75895275|FG000|Overall Study|Administrative or other reasons|3|||
42085011|NCT00839423|75895276|FG001|Overall Study|Administrative or other reasons|0|||
42294265|NCT02876328|76128664|FG020|Overall Study|Death|0|||
42085012|NCT00839423|75895277|FG002|Overall Study|Administrative or other reasons|1|||
42085013|NCT00839423|75895278|FG003|Overall Study|Administrative or other reasons|0|||
42085014|NCT00837161|75895288|FG000|Overall Study|refused hysterectomy|2|||
42085015|NCT00859547|75895292|FG000|Overall Study|Lost to Follow-up|1|||
42085016|NCT00859547|75895292|FG000|Overall Study|Parent withdrew consent|1|||
42085017|NCT00859469|75895296|FG000|Overall Study|Adverse Event|2|||
42085018|NCT00859469|75895296|FG000|Overall Study|Lack of Efficacy|9|||
42085019|NCT00859469|75895296|FG000|Overall Study|Withdrawal by Subject|1|||
42294266|NCT02876328|76128665|FG021|Overall Study|Death|1|||
42085020|NCT00859469|75895296|FG000|Overall Study|Death|16|||
42085021|NCT00859313|75895300|FG000|Overall Study|Lack of Efficacy|2|||
42085022|NCT00859313|75895300|FG000|Overall Study|Adverse Event|1|||
42085023|NCT00859313|75895300|FG000|Overall Study|staff error|1|||
42085024|NCT00771810|75895307|FG000|Overall Study|Adverse Event|3|||
42085025|NCT00771810|75895308|FG001|Overall Study|Adverse Event|0|||
42085026|NCT00771810|75895309|FG002|Overall Study|Adverse Event|2|||
42085027|NCT00771810|75895307|FG000|Overall Study|Lost to Follow-up|0|||
42085028|NCT00771810|75895308|FG001|Overall Study|Lost to Follow-up|0|||
42085029|NCT00771810|75895309|FG002|Overall Study|Lost to Follow-up|1|||
42085030|NCT00771810|75895307|FG000|Overall Study|Physician Decision|1|||
42085031|NCT00771810|75895308|FG001|Overall Study|Physician Decision|2|||
42085032|NCT00771810|75895309|FG002|Overall Study|Physician Decision|2|||
42085033|NCT00771810|75895307|FG000|Overall Study|Protocol Violation|0|||
42085034|NCT00771810|75895308|FG001|Overall Study|Protocol Violation|1|||
42085035|NCT00771810|75895309|FG002|Overall Study|Protocol Violation|1|||
42085036|NCT00771810|75895307|FG000|Overall Study|Withdrawal by Subject|1|||
42085037|NCT00771810|75895308|FG001|Overall Study|Withdrawal by Subject|2|||
42085038|NCT00771810|75895309|FG002|Overall Study|Withdrawal by Subject|0|||
42085039|NCT00771810|75895307|FG000|Overall Study|Other|0|||
42085040|NCT00771810|75895308|FG001|Overall Study|Other|0|||
42085041|NCT00771810|75895309|FG002|Overall Study|Other|1|||
42085042|NCT00836927|75895323|FG000|Overall Study|Progressive disease|2|||
42085043|NCT00836927|75895324|FG001|Overall Study|Progressive disease|0|||
42085044|NCT00836927|75895325|FG002|Overall Study|Progressive disease|0|||
42085045|NCT00836927|75895326|FG003|Overall Study|Progressive disease|1|||
42179214|NCT01147666|75986405|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
42179215|NCT01147666|75986406|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
42179216|NCT01147666|75986407|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
42179217|NCT01147666|75986408|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
42085046|NCT00836927|75895327|FG004|Overall Study|Progressive disease|1|||
42085047|NCT00836927|75895323|FG000|Overall Study|Withdrawal by Subject|1|||
42085048|NCT00836927|75895324|FG001|Overall Study|Withdrawal by Subject|0|||
42085049|NCT00836927|75895325|FG002|Overall Study|Withdrawal by Subject|0|||
42085050|NCT00836927|75895326|FG003|Overall Study|Withdrawal by Subject|0|||
42085051|NCT00836927|75895327|FG004|Overall Study|Withdrawal by Subject|0|||
42085052|NCT00771030|75895348|FG000|Overall Study|Adverse Event|0|||
42085053|NCT00771030|75895349|FG001|Overall Study|Adverse Event|1|||
42085054|NCT00771030|75895350|FG002|Overall Study|Adverse Event|0|||
42085055|NCT00771030|75895351|FG003|Overall Study|Adverse Event|0|||
42085056|NCT00771030|75895352|FG004|Overall Study|Adverse Event|0|||
42085057|NCT00771030|75895353|FG005|Overall Study|Adverse Event|0|||
42085058|NCT00771030|75895354|FG006|Overall Study|Adverse Event|0|||
42085059|NCT00768300|75895377|FG000|Overall Study|Randomized but not treated|1|||
42085060|NCT00768300|75895378|FG001|Overall Study|Randomized but not treated|1|||
42085061|NCT00768300|75895377|FG000|Overall Study|Adverse Event|10|||
42085062|NCT00768300|75895378|FG001|Overall Study|Adverse Event|2|||
42085063|NCT00768300|75895377|FG000|Overall Study|Protocol Violation|6|||
42085064|NCT00768300|75895378|FG001|Overall Study|Protocol Violation|1|||
42085065|NCT00768300|75895377|FG000|Overall Study|Withdrawal by Subject|13|||
42085066|NCT00768300|75895378|FG001|Overall Study|Withdrawal by Subject|7|||
42085067|NCT00768300|75895377|FG000|Overall Study|Physician Decision|2|||
42085068|NCT00768300|75895378|FG001|Overall Study|Physician Decision|3|||
42085069|NCT00768300|75895377|FG000|Overall Study|Study discontinued by Sponsor|271|||
42085070|NCT00768300|75895378|FG001|Overall Study|Study discontinued by Sponsor|140|||
42085071|NCT00768300|75895377|FG000|Overall Study|Death|21|||
42085072|NCT00768300|75895378|FG001|Overall Study|Death|5|||
42085073|NCT00768300|75895377|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
42085074|NCT00768300|75895378|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
42085075|NCT00768300|75895377|FG000|Overall Study|Screen failure following randomization|1|||
42085076|NCT00768300|75895378|FG001|Overall Study|Screen failure following randomization|0|||
42085077|NCT00768300|75895377|FG000|Overall Study|Received lung transplant|1|||
42085078|NCT00768300|75895378|FG001|Overall Study|Received lung transplant|1|||
42085079|NCT00768300|75895377|FG000|Overall Study|Lost to Follow-up|0|||
42179218|NCT01147666|75986409|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
42085080|NCT00768300|75895378|FG001|Overall Study|Lost to Follow-up|1|||
42085081|NCT00768300|75895377|FG000|Overall Study|Began prohibited concomitant medication|0|||
42085082|NCT00768300|75895378|FG001|Overall Study|Began prohibited concomitant medication|1|||
42085083|NCT00768300|75895377|FG000|Overall Study|Treated but never dosed with Study drug|1|||
42085084|NCT00768300|75895378|FG001|Overall Study|Treated but never dosed with Study drug|0|||
42085085|NCT00768300|75895377|FG000|Overall Study|Missing data|1|||
42085086|NCT00768300|75895378|FG001|Overall Study|Missing data|0|||
42085087|NCT00768222|75895386|FG000|Overall Study|Lost to Follow-up|1|||
42085088|NCT00768222|75895387|FG001|Overall Study|Lost to Follow-up|1|||
42085089|NCT00768222|75895386|FG000|Overall Study|Withdrawal by Subject|3|||
42085090|NCT00768222|75895387|FG001|Overall Study|Withdrawal by Subject|1|||
42085091|NCT00768222|75895386|FG000|Overall Study|Protocol Violation|0|||
42085092|NCT00768222|75895387|FG001|Overall Study|Protocol Violation|2|||
42085093|NCT00768144|75895393|FG000|Overall Study|Adverse Event|13|||
42085094|NCT00768144|75895393|FG000|Overall Study|Progressive Disease|21|||
42085095|NCT00768144|75895393|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
42085096|NCT00768144|75895393|FG000|Overall Study|Pt Withdrew Consent|1|||
42085097|NCT00784836|75895397|FG000|Overall Study|Early Study Termination|3|||
42085098|NCT00784758|75895403|FG000|Overall Study|Withdrawal by Subject|3|||
42085099|NCT00784758|75895404|FG001|Overall Study|Withdrawal by Subject|0|||
42085100|NCT00784758|75895403|FG000|Overall Study|Adverse Event|1|||
42085101|NCT00784758|75895404|FG001|Overall Study|Adverse Event|0|||
42085102|NCT00768066|75895415|FG000|Overall Study|Did not receive study product injection.|3|||
42085103|NCT00768066|75895416|FG001|Overall Study|Did not receive study product injection.|3|||
42085104|NCT00768066|75895417|FG002|Overall Study|Did not receive study product injection.|0|||
42085105|NCT00767676|75895425|FG000|Overall Study|Investigator error|54|||
42085106|NCT00767520|75895431|FG000|Overall Study|Participants still on treatment|11|||
42085107|NCT00767520|75895432|FG001|Overall Study|Participants still on treatment|15|||
42085108|NCT00767520|75895431|FG000|Overall Study|Randomized in error and Never treated|0|||
42085109|NCT00767520|75895432|FG001|Overall Study|Randomized in error and Never treated|2|||
42085110|NCT00838565|75895444|FG000|Overall Study|Withdrawal by Subject|0|||
42085111|NCT00838565|75895445|FG001|Overall Study|Withdrawal by Subject|0|||
42085112|NCT00838565|75895446|FG002|Overall Study|Withdrawal by Subject|1|||
42085113|NCT00838565|75895447|FG003|Overall Study|Withdrawal by Subject|0|||
42085114|NCT00838565|75895448|FG004|Overall Study|Withdrawal by Subject|0|||
42085115|NCT00838565|75895449|FG005|Overall Study|Withdrawal by Subject|2|||
42085116|NCT00838565|75895444|FG000|Overall Study|Other|0|||
42085117|NCT00838565|75895445|FG001|Overall Study|Other|2|||
42085118|NCT00838565|75895446|FG002|Overall Study|Other|0|||
42085119|NCT00838565|75895447|FG003|Overall Study|Other|0|||
42085120|NCT00838565|75895448|FG004|Overall Study|Other|0|||
42085121|NCT00838565|75895449|FG005|Overall Study|Other|0|||
42085122|NCT00838565|75895444|FG000|Overall Study|Randomized but not Treated|0|||
42085123|NCT00838565|75895445|FG001|Overall Study|Randomized but not Treated|1|||
42085124|NCT00838565|75895446|FG002|Overall Study|Randomized but not Treated|0|||
42085125|NCT00838565|75895447|FG003|Overall Study|Randomized but not Treated|0|||
42085126|NCT00838565|75895448|FG004|Overall Study|Randomized but not Treated|0|||
42085127|NCT00838565|75895449|FG005|Overall Study|Randomized but not Treated|0|||
42085128|NCT00858845|75895470|FG000|Overall Study|Patient underwent heart transplant.|0|||
42085129|NCT00858845|75895471|FG001|Overall Study|Patient underwent heart transplant.|1|||
42085130|NCT00770562|75895479|FG000|Overall Study|Did not take treatment|1|||
42085131|NCT00770562|75895480|FG001|Overall Study|Did not take treatment|1|||
42085132|NCT00836693|75895489|FG000|Overall Study|Adverse Event|4|||
42085133|NCT00836693|75895490|FG001|Overall Study|Adverse Event|1|||
42085134|NCT00836693|75895489|FG000|Overall Study|Sponsor Decision|0|||
42085135|NCT00836693|75895490|FG001|Overall Study|Sponsor Decision|1|||
42085136|NCT00836693|75895489|FG000|Overall Study|Physician Decision|2|||
42085137|NCT00836693|75895490|FG001|Overall Study|Physician Decision|0|||
42085138|NCT00836693|75895489|FG000|Overall Study|Withdrawal by Subject|9|||
42085139|NCT00836693|75895490|FG001|Overall Study|Withdrawal by Subject|4|||
42085140|NCT00836693|75895489|FG000|Overall Study|Protocol Violation|1|||
42085141|NCT00836693|75895490|FG001|Overall Study|Protocol Violation|0|||
42085142|NCT00836693|75895489|FG000|Overall Study|Lost to Follow-up|1|||
42085143|NCT00836693|75895490|FG001|Overall Study|Lost to Follow-up|0|||
42085144|NCT00770484|75895498|FG000|Overall Study|Withdrawal by Subject|1|||
42085145|NCT00770484|75895499|FG001|Overall Study|Withdrawal by Subject|0|||
42085146|NCT00835679|75895509|FG000|Overall Study|Withdrawal by Subject|1|||
42085147|NCT00835679|75895510|FG001|Overall Study|Withdrawal by Subject|0|||
42085148|NCT00835679|75895511|FG002|Overall Study|Withdrawal by Subject|0|||
42085149|NCT00835679|75895512|FG003|Overall Study|Withdrawal by Subject|0|||
42085150|NCT00766506|75895528|FG000|Overall Study|Use rescue medication after 3 hours|3|||
42085151|NCT00766506|75895529|FG001|Overall Study|Use rescue medication after 3 hours|0|||
42085152|NCT00766506|75895528|FG000|Overall Study|Other|2|||
42085153|NCT00766506|75895529|FG001|Overall Study|Other|2|||
42085154|NCT00770328|75895537|FG000|Overall Study|Adverse Event|11|||
42085155|NCT00770328|75895538|FG001|Overall Study|Adverse Event|2|||
42085156|NCT00770328|75895537|FG000|Overall Study|Lost to Follow-up|2|||
42085157|NCT00770328|75895538|FG001|Overall Study|Lost to Follow-up|2|||
42085158|NCT00766038|75895546|FG000|Overall Study|Lost to Follow-up|15|||
42085159|NCT00766038|75895547|FG001|Overall Study|Lost to Follow-up|14|||
42085160|NCT00765882|75895558|FG000|Overall Study|Adverse Event|10|||
42085161|NCT00765882|75895559|FG001|Overall Study|Adverse Event|21|||
42085162|NCT00765882|75895560|FG002|Overall Study|Adverse Event|20|||
42085163|NCT00765882|75895558|FG000|Overall Study|Lack of Efficacy|4|||
42085164|NCT00765882|75895559|FG001|Overall Study|Lack of Efficacy|0|||
42085165|NCT00765882|75895560|FG002|Overall Study|Lack of Efficacy|1|||
42085166|NCT00765882|75895558|FG000|Overall Study|Protocol Violation|4|||
42085167|NCT00765882|75895559|FG001|Overall Study|Protocol Violation|3|||
42085168|NCT00765882|75895560|FG002|Overall Study|Protocol Violation|1|||
42085169|NCT00765882|75895558|FG000|Overall Study|Withdrawal by Subject|2|||
42085170|NCT00765882|75895559|FG001|Overall Study|Withdrawal by Subject|6|||
42085171|NCT00765882|75895560|FG002|Overall Study|Withdrawal by Subject|6|||
42085172|NCT00765882|75895558|FG000|Overall Study|Lost to Follow-up|1|||
42085173|NCT00765882|75895559|FG001|Overall Study|Lost to Follow-up|9|||
42085174|NCT00765882|75895560|FG002|Overall Study|Lost to Follow-up|6|||
42085175|NCT00765882|75895558|FG000|Overall Study|Other Reason|3|||
42085176|NCT00765882|75895559|FG001|Overall Study|Other Reason|1|||
42085177|NCT00765882|75895560|FG002|Overall Study|Other Reason|2|||
42085178|NCT00769860|75895570|FG000|Overall Study|Withdrawal by Subject|2|||
42085179|NCT00769860|75895571|FG001|Overall Study|Withdrawal by Subject|0|||
42085180|NCT00858143|75895577|FG000|Overall Study|Adverse Event|16|||
42085181|NCT00858143|75895577|FG000|Overall Study|Lack of Efficacy|4|||
42085182|NCT00858143|75895577|FG000|Overall Study|Death|7|||
42085183|NCT00858143|75895577|FG000|Overall Study|Other|23|||
42085184|NCT00828113|75895583|FG000|Overall Study|Withdrawal by Subject|27|||
42085185|NCT00828113|75895584|FG001|Overall Study|Withdrawal by Subject|26|||
42085186|NCT00828113|75895583|FG000|Overall Study|Lost to Follow-up|3|||
42085187|NCT00828113|75895584|FG001|Overall Study|Lost to Follow-up|5|||
42085188|NCT00769704|75895592|FG000|Overall Study|Lost to Follow-up|3|||
42085189|NCT00769704|75895593|FG001|Overall Study|Lost to Follow-up|2|||
42085190|NCT00769704|75895592|FG000|Overall Study|Death|95|||
42085191|NCT00769704|75895593|FG001|Overall Study|Death|190|||
42085192|NCT00769704|75895592|FG000|Overall Study|Withdrawal by Subject|12|||
42085193|NCT00769704|75895593|FG001|Overall Study|Withdrawal by Subject|5|||
42085194|NCT00769704|75895592|FG000|Overall Study|Other|1|||
42085195|NCT00769704|75895593|FG001|Overall Study|Other|2|||
42085196|NCT00818753|75895603|FG000|Overall Study|Protocol Violation|1|||
42085197|NCT00818753|75895604|FG001|Overall Study|Protocol Violation|0|||
42085198|NCT00818753|75895605|FG002|Overall Study|Protocol Violation|0|||
42085199|NCT00818753|75895603|FG000|Overall Study|Other reason (not specified)|0|||
42085200|NCT00818753|75895604|FG001|Overall Study|Other reason (not specified)|0|||
42085201|NCT00818753|75895605|FG002|Overall Study|Other reason (not specified)|1|||
42085202|NCT00818753|75895603|FG000|Overall Study|Randomised and not treated|2|||
42085203|NCT00818753|75895604|FG001|Overall Study|Randomised and not treated|0|||
42085204|NCT00818753|75895605|FG002|Overall Study|Randomised and not treated|0|||
42085205|NCT00765726|75895613|FG000|Overall Study|Withdrawal by Subject|1|||
42085206|NCT00765726|75895613|FG000|Overall Study|Discontinuation of study by sponsor|8|||
42085207|NCT00765336|75895619|FG000|Overall Study|Protocol Violation|4|||
42085208|NCT00765336|75895620|FG001|Overall Study|Protocol Violation|2|||
42085209|NCT00765336|75895619|FG000|Overall Study|Withdrawal by Subject|6|||
42085210|NCT00765336|75895620|FG001|Overall Study|Withdrawal by Subject|4|||
42085211|NCT00765336|75895619|FG000|Overall Study|Lost to Follow-up|7|||
42085212|NCT00765336|75895620|FG001|Overall Study|Lost to Follow-up|9|||
42085213|NCT00765336|75895619|FG000|Overall Study|Adverse Event|2|||
42085214|NCT00765336|75895620|FG001|Overall Study|Adverse Event|1|||
42085215|NCT00818519|75895628|FG000|Overall Study|Adverse Event|2|||
42085216|NCT00818519|75895629|FG001|Overall Study|Adverse Event|2|||
42085217|NCT00818519|75895628|FG000|Overall Study|Lost to Follow-up|4|||
42085218|NCT00818519|75895629|FG001|Overall Study|Lost to Follow-up|6|||
42085219|NCT00818519|75895628|FG000|Overall Study|Protocol Violation|2|||
42085220|NCT00818519|75895629|FG001|Overall Study|Protocol Violation|1|||
42085221|NCT00818519|75895628|FG000|Overall Study|Pregnancy|0|||
42085222|NCT00818519|75895629|FG001|Overall Study|Pregnancy|1|||
42294267|NCT02876328|76128666|FG022|Overall Study|Death|0|||
42294268|NCT02876328|76128667|FG023|Overall Study|Death|0|||
42294269|NCT02876328|76128644|FG000|Overall Study|Withdrawal by Subject|0|||
42294270|NCT02876328|76128645|FG001|Overall Study|Withdrawal by Subject|2|||
42294271|NCT02876328|76128646|FG002|Overall Study|Withdrawal by Subject|3|||
42294272|NCT02876328|76128647|FG003|Overall Study|Withdrawal by Subject|3|||
42017724|NCT01284959|75825412|FG002|Overall Study|Withdrawal by Subject|0|||
42017725|NCT01284959|75825410|FG000|Overall Study|Adverse Event|0|||
42017726|NCT01284959|75825411|FG001|Overall Study|Adverse Event|0|||
42017727|NCT01284959|75825412|FG002|Overall Study|Adverse Event|1|||
42017728|NCT01284491|75825420|FG000|Overall Study|Study termination|13|||
42017729|NCT01283009|75825428|FG000|Overall Study|Death|83|||
42017730|NCT01283009|75825429|FG001|Overall Study|Death|78|||
42017731|NCT01283009|75825428|FG000|Overall Study|Study ended early|23|||
42017732|NCT01283009|75825429|FG001|Overall Study|Study ended early|26|||
42017733|NCT01283009|75825428|FG000|Overall Study|Withdrawal by Subject|10|||
42017734|NCT01283009|75825429|FG001|Overall Study|Withdrawal by Subject|8|||
42017735|NCT01283009|75825428|FG000|Overall Study|Physician Decision|1|||
42017736|NCT01283009|75825429|FG001|Overall Study|Physician Decision|1|||
42017737|NCT01283009|75825428|FG000|Overall Study|Lost to Follow-up|1|||
42085223|NCT00818519|75895628|FG000|Overall Study|Withdrawal by Subject|4|||
42085224|NCT00818519|75895629|FG001|Overall Study|Withdrawal by Subject|9|||
42085225|NCT00818519|75895628|FG000|Overall Study|participant recovered completely|1|||
42085226|NCT00818519|75895629|FG001|Overall Study|participant recovered completely|0|||
42294273|NCT02876328|76128648|FG004|Overall Study|Withdrawal by Subject|0|||
42085227|NCT00818519|75895628|FG000|Overall Study|participant will leave for long tme|1|||
42085228|NCT00818519|75895629|FG001|Overall Study|participant will leave for long tme|0|||
42085229|NCT00827567|75895635|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
42085230|NCT00765102|75895639|FG000|Overall Study|Progressive disease|18|||
42085231|NCT00765102|75895639|FG000|Overall Study|Adverse Event|6|||
42085232|NCT00765102|75895639|FG000|Overall Study|Physician Decision|4|||
42085233|NCT00765102|75895639|FG000|Overall Study|Withdrawal by Subject|2|||
42085234|NCT00765102|75895639|FG000|Overall Study|Protocol Violation|1|||
42085235|NCT00809354|75895655|FG000|Overall Study|Adverse Event|32|||
42085236|NCT00809354|75895656|FG001|Overall Study|Adverse Event|45|||
42085237|NCT00809354|75895657|FG002|Overall Study|Adverse Event|37|||
42085238|NCT00809354|75895658|FG003|Overall Study|Adverse Event|53|||
42085239|NCT00809354|75895659|FG004|Overall Study|Adverse Event|26|||
42085240|NCT00809354|75895660|FG005|Overall Study|Adverse Event|33|||
42085241|NCT00809354|75895661|FG006|Overall Study|Adverse Event|44|||
42085242|NCT00809354|75895662|FG007|Overall Study|Adverse Event|40|||
42085243|NCT00809354|75895663|FG008|Overall Study|Adverse Event|46|||
42085244|NCT00809354|75895664|FG009|Overall Study|Adverse Event|26|||
42085245|NCT00809354|75895655|FG000|Overall Study|Lack of Efficacy|23|||
42085246|NCT00809354|75895656|FG001|Overall Study|Lack of Efficacy|23|||
42085247|NCT00809354|75895657|FG002|Overall Study|Lack of Efficacy|22|||
42085248|NCT00809354|75895658|FG003|Overall Study|Lack of Efficacy|15|||
42085249|NCT00809354|75895659|FG004|Overall Study|Lack of Efficacy|40|||
42085250|NCT00809354|75895660|FG005|Overall Study|Lack of Efficacy|19|||
42085251|NCT00809354|75895661|FG006|Overall Study|Lack of Efficacy|21|||
42179219|NCT01147666|75986410|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
42179220|NCT01147666|75986411|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
42179221|NCT01147666|75986397|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179222|NCT01147666|75986398|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179223|NCT01147666|75986399|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179224|NCT01147666|75986400|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
42085252|NCT00809354|75895662|FG007|Overall Study|Lack of Efficacy|15|||
42085253|NCT00809354|75895663|FG008|Overall Study|Lack of Efficacy|18|||
42179225|NCT01147666|75986401|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42085254|NCT00809354|75895664|FG009|Overall Study|Lack of Efficacy|38|||
42085255|NCT00809354|75895655|FG000|Overall Study|Lost to Follow-up|10|||
42085256|NCT00809354|75895656|FG001|Overall Study|Lost to Follow-up|11|||
42085257|NCT00809354|75895657|FG002|Overall Study|Lost to Follow-up|8|||
42085258|NCT00809354|75895658|FG003|Overall Study|Lost to Follow-up|13|||
42085259|NCT00809354|75895659|FG004|Overall Study|Lost to Follow-up|6|||
42085260|NCT00809354|75895660|FG005|Overall Study|Lost to Follow-up|2|||
42085261|NCT00809354|75895661|FG006|Overall Study|Lost to Follow-up|0|||
42085262|NCT00809354|75895662|FG007|Overall Study|Lost to Follow-up|5|||
42085263|NCT00809354|75895663|FG008|Overall Study|Lost to Follow-up|4|||
42085264|NCT00809354|75895664|FG009|Overall Study|Lost to Follow-up|0|||
42085265|NCT00809354|75895655|FG000|Overall Study|Protocol Violation|7|||
42085266|NCT00809354|75895656|FG001|Overall Study|Protocol Violation|14|||
42085267|NCT00809354|75895657|FG002|Overall Study|Protocol Violation|14|||
42085268|NCT00809354|75895658|FG003|Overall Study|Protocol Violation|12|||
42085269|NCT00809354|75895659|FG004|Overall Study|Protocol Violation|14|||
42085270|NCT00809354|75895660|FG005|Overall Study|Protocol Violation|6|||
42085271|NCT00809354|75895661|FG006|Overall Study|Protocol Violation|4|||
42085272|NCT00809354|75895662|FG007|Overall Study|Protocol Violation|6|||
42085273|NCT00809354|75895663|FG008|Overall Study|Protocol Violation|9|||
42179226|NCT01147666|75986402|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179227|NCT01147666|75986403|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179228|NCT01147666|75986404|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179229|NCT01147666|75986405|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179230|NCT01147666|75986406|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179231|NCT01147666|75986407|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42085274|NCT00809354|75895664|FG009|Overall Study|Protocol Violation|3|||
42085275|NCT00809354|75895655|FG000|Overall Study|Withdrawal by Subject|32|||
42085276|NCT00809354|75895656|FG001|Overall Study|Withdrawal by Subject|27|||
42085277|NCT00809354|75895657|FG002|Overall Study|Withdrawal by Subject|31|||
42085278|NCT00809354|75895658|FG003|Overall Study|Withdrawal by Subject|33|||
42179232|NCT01147666|75986408|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179233|NCT01147666|75986409|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179234|NCT01147666|75986410|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179235|NCT01147666|75986411|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
42179236|NCT01147666|75986397|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
42179237|NCT01147666|75986398|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
42179238|NCT01147666|75986399|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
42179239|NCT01147666|75986400|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
42179240|NCT01147666|75986401|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
42179241|NCT01147666|75986402|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
42179242|NCT01147666|75986403|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
42179243|NCT01147666|75986404|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
42179244|NCT01147666|75986405|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
42179245|NCT01147666|75986406|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
42179246|NCT01147666|75986407|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
42179247|NCT01147666|75986408|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
42179248|NCT01147666|75986409|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
42179249|NCT01147666|75986410|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
42179250|NCT01147666|75986411|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
42179251|NCT01147666|75986397|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179252|NCT01147666|75986398|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179253|NCT01147666|75986399|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42294274|NCT02876328|76128649|FG005|Overall Study|Withdrawal by Subject|1|||
42294275|NCT02876328|76128650|FG006|Overall Study|Withdrawal by Subject|0|||
42294276|NCT02876328|76128651|FG007|Overall Study|Withdrawal by Subject|1|||
42294277|NCT02876328|76128652|FG008|Overall Study|Withdrawal by Subject|1|||
42294278|NCT02876328|76128653|FG009|Overall Study|Withdrawal by Subject|2|||
42294279|NCT02876328|76128654|FG010|Overall Study|Withdrawal by Subject|0|||
42294280|NCT02876328|76128655|FG011|Overall Study|Withdrawal by Subject|0|||
42294281|NCT02876328|76128656|FG012|Overall Study|Withdrawal by Subject|0|||
42294282|NCT02876328|76128657|FG013|Overall Study|Withdrawal by Subject|0|||
42294283|NCT02876328|76128658|FG014|Overall Study|Withdrawal by Subject|0|||
42085279|NCT00809354|75895659|FG004|Overall Study|Withdrawal by Subject|34|||
42085280|NCT00809354|75895660|FG005|Overall Study|Withdrawal by Subject|29|||
42085281|NCT00809354|75895661|FG006|Overall Study|Withdrawal by Subject|27|||
42085282|NCT00809354|75895662|FG007|Overall Study|Withdrawal by Subject|19|||
42085283|NCT00809354|75895663|FG008|Overall Study|Withdrawal by Subject|18|||
42085284|NCT00809354|75895664|FG009|Overall Study|Withdrawal by Subject|20|||
42085285|NCT00809354|75895655|FG000|Overall Study|Other|10|||
42085286|NCT00809354|75895656|FG001|Overall Study|Other|2|||
42085287|NCT00809354|75895657|FG002|Overall Study|Other|7|||
42085288|NCT00809354|75895658|FG003|Overall Study|Other|10|||
42085289|NCT00809354|75895659|FG004|Overall Study|Other|5|||
42085290|NCT00809354|75895660|FG005|Overall Study|Other|3|||
42085291|NCT00809354|75895661|FG006|Overall Study|Other|2|||
42085292|NCT00809354|75895662|FG007|Overall Study|Other|3|||
42085293|NCT00809354|75895663|FG008|Overall Study|Other|4|||
42085294|NCT00809354|75895664|FG009|Overall Study|Other|3|||
42085295|NCT00809354|75895655|FG000|Overall Study|Study terminated by sponsor|138|||
42085296|NCT00809354|75895656|FG001|Overall Study|Study terminated by sponsor|134|||
42085297|NCT00809354|75895657|FG002|Overall Study|Study terminated by sponsor|129|||
42085298|NCT00809354|75895658|FG003|Overall Study|Study terminated by sponsor|120|||
42085299|NCT00809354|75895659|FG004|Overall Study|Study terminated by sponsor|126|||
42085300|NCT00809354|75895660|FG005|Overall Study|Study terminated by sponsor|133|||
42085301|NCT00809354|75895661|FG006|Overall Study|Study terminated by sponsor|124|||
42085302|NCT00809354|75895662|FG007|Overall Study|Study terminated by sponsor|148|||
42085303|NCT00809354|75895663|FG008|Overall Study|Study terminated by sponsor|127|||
42085304|NCT00809354|75895664|FG009|Overall Study|Study terminated by sponsor|135|||
42085305|NCT00809354|75895655|FG000|Overall Study|Withdrawn due to pregnancy|0|||
42085306|NCT00809354|75895656|FG001|Overall Study|Withdrawn due to pregnancy|1|||
42085307|NCT00809354|75895657|FG002|Overall Study|Withdrawn due to pregnancy|0|||
42085308|NCT00809354|75895658|FG003|Overall Study|Withdrawn due to pregnancy|0|||
42085309|NCT00809354|75895659|FG004|Overall Study|Withdrawn due to pregnancy|0|||
42085310|NCT00809354|75895660|FG005|Overall Study|Withdrawn due to pregnancy|0|||
42085311|NCT00809354|75895661|FG006|Overall Study|Withdrawn due to pregnancy|0|||
42085312|NCT00809354|75895662|FG007|Overall Study|Withdrawn due to pregnancy|0|||
42085313|NCT00809354|75895663|FG008|Overall Study|Withdrawn due to pregnancy|0|||
42085314|NCT00809354|75895664|FG009|Overall Study|Withdrawn due to pregnancy|0|||
42085315|NCT00809354|75895655|FG000|Overall Study|Randomized but not Treated|3|||
42085316|NCT00809354|75895656|FG001|Overall Study|Randomized but not Treated|1|||
42085317|NCT00809354|75895657|FG002|Overall Study|Randomized but not Treated|6|||
42085318|NCT00809354|75895658|FG003|Overall Study|Randomized but not Treated|0|||
42085319|NCT00809354|75895659|FG004|Overall Study|Randomized but not Treated|5|||
42085320|NCT00809354|75895660|FG005|Overall Study|Randomized but not Treated|0|||
42085321|NCT00809354|75895661|FG006|Overall Study|Randomized but not Treated|1|||
42085322|NCT00809354|75895662|FG007|Overall Study|Randomized but not Treated|1|||
42085323|NCT00809354|75895663|FG008|Overall Study|Randomized but not Treated|2|||
42085324|NCT00809354|75895664|FG009|Overall Study|Randomized but not Treated|1|||
42085325|NCT00809354|75895655|FG000|Overall Study|Death|0|||
42085326|NCT00809354|75895656|FG001|Overall Study|Death|0|||
42085327|NCT00809354|75895657|FG002|Overall Study|Death|0|||
42085328|NCT00809354|75895658|FG003|Overall Study|Death|0|||
42085329|NCT00809354|75895659|FG004|Overall Study|Death|0|||
42085330|NCT00809354|75895660|FG005|Overall Study|Death|0|||
42085331|NCT00809354|75895661|FG006|Overall Study|Death|0|||
42085332|NCT00809354|75895662|FG007|Overall Study|Death|1|||
42085333|NCT00809354|75895663|FG008|Overall Study|Death|0|||
42085334|NCT00809354|75895664|FG009|Overall Study|Death|0|||
42085335|NCT00834899|75895693|FG000|Overall Study|Withdrawal by Subject|1|||
42085336|NCT00834899|75895694|FG001|Overall Study|Withdrawal by Subject|1|||
42085337|NCT00764946|75895703|FG000|Overall Study|Lack of Efficacy|1|||
42085338|NCT00764946|75895704|FG001|Overall Study|Lack of Efficacy|0|||
42085339|NCT00764946|75895705|FG002|Overall Study|Lack of Efficacy|0|||
42085340|NCT00764946|75895703|FG000|Overall Study|Lost to Follow-up|3|||
42085341|NCT00764946|75895704|FG001|Overall Study|Lost to Follow-up|4|||
42085342|NCT00764946|75895705|FG002|Overall Study|Lost to Follow-up|0|||
42085343|NCT00764946|75895703|FG000|Overall Study|Physician Decision|2|||
42085344|NCT00764946|75895704|FG001|Overall Study|Physician Decision|4|||
42085345|NCT00764946|75895705|FG002|Overall Study|Physician Decision|0|||
42085346|NCT00764946|75895703|FG000|Overall Study|Adverse Event|3|||
42085347|NCT00764946|75895704|FG001|Overall Study|Adverse Event|2|||
42085348|NCT00764946|75895705|FG002|Overall Study|Adverse Event|1|||
42085349|NCT00764946|75895703|FG000|Overall Study|Withdrawal by Subject|3|||
42085350|NCT00764946|75895704|FG001|Overall Study|Withdrawal by Subject|6|||
42085351|NCT00764946|75895705|FG002|Overall Study|Withdrawal by Subject|2|||
42085352|NCT00764946|75895703|FG000|Overall Study|Never Treated|1|||
42085353|NCT00764946|75895704|FG001|Overall Study|Never Treated|1|||
42085354|NCT00764946|75895705|FG002|Overall Study|Never Treated|1|||
42085355|NCT00764868|75895719|FG000|Overall Study|Adverse Event|18|||
42085356|NCT00764868|75895719|FG000|Overall Study|Withdrawal by Subject|31|||
42085357|NCT00764868|75895719|FG000|Overall Study|Non-compliance|16|||
42085358|NCT00764868|75895719|FG000|Overall Study|Lost to Follow-up|25|||
42085359|NCT00764868|75895719|FG000|Overall Study|Lack of Efficacy|5|||
42085360|NCT00764868|75895719|FG000|Overall Study|Subject moved|7|||
42085361|NCT00764868|75895719|FG000|Overall Study|Pregnancy|3|||
42085362|NCT00764868|75895719|FG000|Overall Study|Prohibited medication|1|||
42085363|NCT00764868|75895719|FG000|Overall Study|Out of town|1|||
42085364|NCT00764868|75895719|FG000|Overall Study|Misuse and compliance of study drug|1|||
42085365|NCT00764868|75895719|FG000|Overall Study|Subject sent to boarding school|1|||
42085366|NCT00764868|75895719|FG000|Overall Study|Met an exclusion criteria|1|||
42085367|NCT00764868|75895719|FG000|Overall Study|Positive drug screen|2|||
42085368|NCT00764868|75895719|FG000|Overall Study|Sponsor requested withdrawal|1|||
42085369|NCT00764790|75895726|FG000|Overall Study|Protocol Violation|0|||
42085370|NCT00764790|75895727|FG001|Overall Study|Protocol Violation|0|||
42085371|NCT00764790|75895728|FG002|Overall Study|Protocol Violation|1|||
42085372|NCT00764790|75895726|FG000|Overall Study|Withdrawal by Subject|10|||
42085373|NCT00764790|75895727|FG001|Overall Study|Withdrawal by Subject|12|||
42085374|NCT00764790|75895728|FG002|Overall Study|Withdrawal by Subject|6|||
42085375|NCT00764790|75895726|FG000|Overall Study|Lost to Follow-up|28|||
42085376|NCT00764790|75895727|FG001|Overall Study|Lost to Follow-up|29|||
42085377|NCT00764790|75895728|FG002|Overall Study|Lost to Follow-up|23|||
42085378|NCT00756444|75895738|FG000|Overall Study|Adverse Event|1|||
42179254|NCT01147666|75986400|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
42179255|NCT01147666|75986401|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179256|NCT01147666|75986402|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179257|NCT01147666|75986403|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179258|NCT01147666|75986404|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179259|NCT01147666|75986405|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179260|NCT01147666|75986406|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179261|NCT01147666|75986407|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
42179262|NCT01147666|75986408|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179263|NCT01147666|75986409|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179264|NCT01147666|75986410|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179265|NCT01147666|75986411|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
42179266|NCT01147666|75986397|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42179267|NCT01147666|75986398|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42179268|NCT01147666|75986399|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42358456|NCT04999839|76204141|FG000|Overall Study|Sponsor request|0|||
42358457|NCT04999839|76204142|FG001|Overall Study|Sponsor request|1|||
42085379|NCT00756444|75895739|FG001|Overall Study|Adverse Event|1|||
42085380|NCT00756444|75895738|FG000|Overall Study|Withdrawal by Subject|6|||
42085381|NCT00756444|75895739|FG001|Overall Study|Withdrawal by Subject|8|||
42085382|NCT00756444|75895738|FG000|Overall Study|Lost to Follow-up|0|||
42085383|NCT00756444|75895739|FG001|Overall Study|Lost to Follow-up|1|||
42085384|NCT00756444|75895738|FG000|Overall Study|Death|5|||
42085385|NCT00756444|75895739|FG001|Overall Study|Death|4|||
42085386|NCT00756444|75895738|FG000|Overall Study|Disease Progression|2|||
42085387|NCT00756444|75895739|FG001|Overall Study|Disease Progression|7|||
42085388|NCT00756444|75895738|FG000|Overall Study|Ineligibility Determined|1|||
42085389|NCT00756444|75895739|FG001|Overall Study|Ineligibility Determined|0|||
42085390|NCT00769002|75895750|FG000|Overall Study|Study was not completed, no data|9|||
42085391|NCT00769002|75895751|FG001|Overall Study|Study was not completed, no data|9|||
42085392|NCT00753012|75895758|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
42085393|NCT00753012|75895759|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
42085394|NCT00753012|75895758|FG000|Overall Study|Adverse Event|2|||
42085395|NCT00753012|75895759|FG001|Overall Study|Adverse Event|0|||
42085396|NCT00753012|75895758|FG000|Overall Study|Withdrawal by Subject|0|||
42085397|NCT00753012|75895759|FG001|Overall Study|Withdrawal by Subject|1|||
42085398|NCT00753012|75895758|FG000|Overall Study|Lost to Follow-up|4|||
42085399|NCT00753012|75895759|FG001|Overall Study|Lost to Follow-up|0|||
42085400|NCT00753012|75895758|FG000|Overall Study|Confounded endpoint data|1|||
42085401|NCT00753012|75895759|FG001|Overall Study|Confounded endpoint data|0|||
42085402|NCT00806156|75895768|FG000|Overall Study|Death|35|||
42085403|NCT00806156|75895769|FG001|Overall Study|Death|95|||
42085404|NCT00806156|75895768|FG000|Overall Study|Did not meet eligibility criteria|1|||
42085405|NCT00806156|75895769|FG001|Overall Study|Did not meet eligibility criteria|0|||
42085406|NCT00806156|75895768|FG000|Overall Study|Study terminated by Sponsor|2|||
42085407|NCT00806156|75895769|FG001|Overall Study|Study terminated by Sponsor|40|||
42085408|NCT00806156|75895768|FG000|Overall Study|Consent withdrawn by subject|1|||
42085409|NCT00806156|75895769|FG001|Overall Study|Consent withdrawn by subject|3|||
42085410|NCT00806156|75895768|FG000|Overall Study|Lost to Follow-up|0|||
42085411|NCT00806156|75895769|FG001|Overall Study|Lost to Follow-up|1|||
42085412|NCT00764478|75895790|FG000|Overall Study|Adverse Event|1|||
42085413|NCT00764478|75895791|FG001|Overall Study|Adverse Event|1|||
42085414|NCT00764478|75895792|FG002|Overall Study|Adverse Event|1|||
42085415|NCT00764478|75895790|FG000|Overall Study|Withdrawal by Subject|7|||
42085416|NCT00764478|75895791|FG001|Overall Study|Withdrawal by Subject|12|||
42085417|NCT00764478|75895792|FG002|Overall Study|Withdrawal by Subject|1|||
42085418|NCT00764478|75895790|FG000|Overall Study|Lost to Follow-up|7|||
42085419|NCT00764478|75895791|FG001|Overall Study|Lost to Follow-up|8|||
42085420|NCT00764478|75895792|FG002|Overall Study|Lost to Follow-up|5|||
42085421|NCT00764478|75895790|FG000|Overall Study|Protocol Violation|0|||
42085422|NCT00764478|75895791|FG001|Overall Study|Protocol Violation|1|||
42085423|NCT00764478|75895792|FG002|Overall Study|Protocol Violation|1|||
42085424|NCT00805766|75895800|FG000|Screening Period|Adverse Event|1|||
42085425|NCT00805766|75895800|FG000|Screening Period|Lack of Efficacy|2|||
42085426|NCT00805766|75895800|FG000|Screening Period|Pregnancy|1|||
42085427|NCT00805766|75895800|FG000|Screening Period|Responder|2|||
42085428|NCT00805766|75895800|FG000|Increased Dose Period|Adverse Event|4|||
42085429|NCT00805766|75895800|FG000|Increased Dose Period|Lack of Efficacy|7|||
42085430|NCT00805766|75895800|FG000|Increased Dose Period|Pregnancy|1|||
42085431|NCT00805766|75895800|FG000|Increased Dose Period|Withdrawal by Subject|1|||
42085432|NCT00805532|75895810|FG000|Overall Study|invalid data|0|||
42085433|NCT00805532|75895811|FG001|Overall Study|invalid data|1|||
42085434|NCT00764322|75895821|FG000|Overall Study|Withdrawal by Subject|11|||
42085435|NCT00764322|75895821|FG000|Overall Study|No CYP2D6 genotyping|9|||
42085436|NCT00752856|75895840|FG000|Overall Study|randomized but did not do viral kinetics|0|||
42085437|NCT00752856|75895841|FG001|Overall Study|randomized but did not do viral kinetics|1|||
42085438|NCT00755196|75895847|FG000|Overall Study|Lost to Follow-up|1|||
42085439|NCT00755196|75895847|FG000|Overall Study|Lack of Efficiency|1|||
42179269|NCT01147666|75986400|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42085440|NCT00805142|75895854|FG000|Titration Period|Adverse Event|3|||
42085441|NCT00805142|75895855|FG001|Titration Period|Adverse Event|3|||
42085442|NCT00805142|75895854|FG000|Titration Period|Lack of Efficacy|1|||
42085443|NCT00805142|75895855|FG001|Titration Period|Lack of Efficacy|1|||
42085444|NCT00805142|75895854|FG000|Titration Period|Lost to Follow-up|0|||
42085445|NCT00805142|75895855|FG001|Titration Period|Lost to Follow-up|1|||
42085446|NCT00805142|75895854|FG000|Titration Period|Disease Progression|2|||
42085447|NCT00805142|75895855|FG001|Titration Period|Disease Progression|1|||
42085448|NCT00805142|75895854|FG000|Titration Period|Withdrawal of consent|0|||
42085449|NCT00805142|75895855|FG001|Titration Period|Withdrawal of consent|1|||
42085450|NCT00805142|75895854|FG000|Titration Period|Other|0|||
42085451|NCT00805142|75895855|FG001|Titration Period|Other|3|||
42179270|NCT01147666|75986401|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42179271|NCT01147666|75986402|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42179272|NCT01147666|75986403|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42179273|NCT01147666|75986404|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42179274|NCT01147666|75986405|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42179275|NCT01147666|75986406|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42179276|NCT01147666|75986407|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42179277|NCT01147666|75986408|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42179278|NCT01147666|75986409|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
42179279|NCT01147666|75986410|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42085452|NCT00805142|75895854|FG000|Maintenance Period|Adverse Event|0|||
42085453|NCT00805142|75895855|FG001|Maintenance Period|Adverse Event|1|||
42085454|NCT00805142|75895854|FG000|Maintenance Period|Other|0|||
42179280|NCT01147666|75986411|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
42085455|NCT00805142|75895855|FG001|Maintenance Period|Other|1|||
42085456|NCT00761631|75895872|FG000|Overall Study|Parent/legal guardian request|8|||
42085457|NCT00761631|75895873|FG001|Overall Study|Parent/legal guardian request|3|||
42085458|NCT00761631|75895874|FG002|Overall Study|Parent/legal guardian request|8|||
42085459|NCT00761631|75895875|FG003|Overall Study|Parent/legal guardian request|0|||
42085460|NCT00761631|75895876|FG004|Overall Study|Parent/legal guardian request|5|||
42085461|NCT00761631|75895877|FG005|Overall Study|Parent/legal guardian request|0|||
42085462|NCT00761631|75895872|FG000|Overall Study|Lost to Follow-up|2|||
42085463|NCT00761631|75895873|FG001|Overall Study|Lost to Follow-up|4|||
42085464|NCT00761631|75895874|FG002|Overall Study|Lost to Follow-up|7|||
42085465|NCT00761631|75895875|FG003|Overall Study|Lost to Follow-up|1|||
42085466|NCT00761631|75895876|FG004|Overall Study|Lost to Follow-up|6|||
42085467|NCT00761631|75895877|FG005|Overall Study|Lost to Follow-up|1|||
42085468|NCT00761631|75895872|FG000|Overall Study|Protocol Violation|2|||
42085469|NCT00761631|75895873|FG001|Overall Study|Protocol Violation|0|||
42085470|NCT00761631|75895874|FG002|Overall Study|Protocol Violation|0|||
42085471|NCT00761631|75895875|FG003|Overall Study|Protocol Violation|1|||
42085472|NCT00761631|75895876|FG004|Overall Study|Protocol Violation|5|||
42085473|NCT00761631|75895877|FG005|Overall Study|Protocol Violation|1|||
42085474|NCT00761631|75895872|FG000|Overall Study|Randomized, not treated|1|||
42085475|NCT00761631|75895873|FG001|Overall Study|Randomized, not treated|0|||
42085476|NCT00761631|75895874|FG002|Overall Study|Randomized, not treated|0|||
42085477|NCT00761631|75895875|FG003|Overall Study|Randomized, not treated|0|||
42085478|NCT00761631|75895876|FG004|Overall Study|Randomized, not treated|0|||
42085479|NCT00761631|75895877|FG005|Overall Study|Randomized, not treated|0|||
42085480|NCT00761631|75895872|FG000|Overall Study|Failed to return|1|||
42085481|NCT00761631|75895873|FG001|Overall Study|Failed to return|0|||
42085482|NCT00761631|75895874|FG002|Overall Study|Failed to return|1|||
42085483|NCT00761631|75895875|FG003|Overall Study|Failed to return|1|||
42085484|NCT00761631|75895876|FG004|Overall Study|Failed to return|5|||
42085485|NCT00761631|75895877|FG005|Overall Study|Failed to return|2|||
42085486|NCT00761631|75895872|FG000|Overall Study|Physician Decision|1|||
42085487|NCT00761631|75895873|FG001|Overall Study|Physician Decision|0|||
42085488|NCT00761631|75895874|FG002|Overall Study|Physician Decision|0|||
42085489|NCT00761631|75895875|FG003|Overall Study|Physician Decision|0|||
42085490|NCT00761631|75895876|FG004|Overall Study|Physician Decision|0|||
42085491|NCT00761631|75895877|FG005|Overall Study|Physician Decision|0|||
42085492|NCT00761631|75895872|FG000|Overall Study|Other|0|||
42085493|NCT00761631|75895873|FG001|Overall Study|Other|0|||
42085494|NCT00761631|75895874|FG002|Overall Study|Other|0|||
42085495|NCT00761631|75895875|FG003|Overall Study|Other|0|||
42179281|NCT01147666|75986397|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42085496|NCT00761631|75895876|FG004|Overall Study|Other|1|||
42179282|NCT01147666|75986398|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42085497|NCT00761631|75895877|FG005|Overall Study|Other|1|||
42179283|NCT01147666|75986399|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42085498|NCT00763698|75895900|FG000|Overall Study|Unsuccessful Implant|5|||
42085499|NCT00763698|75895900|FG000|Overall Study|Death|4|||
42085500|NCT00763698|75895900|FG000|Overall Study|Withdrawal by Subject|1|||
42085501|NCT00763386|75895907|FG000|Overall Study|Adverse Event|43|||
42085502|NCT00763386|75895908|FG001|Overall Study|Adverse Event|33|||
42085503|NCT00763386|75895907|FG000|Overall Study|Death|1|||
42085504|NCT00763386|75895908|FG001|Overall Study|Death|2|||
42085505|NCT00763386|75895907|FG000|Overall Study|Lost to Follow-up|3|||
42085506|NCT00763386|75895908|FG001|Overall Study|Lost to Follow-up|3|||
42085507|NCT00763386|75895907|FG000|Overall Study|Withdrawal by Subject|0|||
42085508|NCT00763386|75895908|FG001|Overall Study|Withdrawal by Subject|1|||
42085509|NCT00763386|75895907|FG000|Overall Study|CRF missing|0|||
42085510|NCT00763386|75895908|FG001|Overall Study|CRF missing|1|||
42085511|NCT00763386|75895907|FG000|Overall Study|Study Prosthesis Removed|1|||
42085512|NCT00763386|75895908|FG001|Overall Study|Study Prosthesis Removed|0|||
42085513|NCT00761319|75895916|FG000|Overall Study|Protocol Violation|21|||
42085514|NCT00761319|75895917|FG001|Overall Study|Protocol Violation|14|||
42085515|NCT00761319|75895916|FG000|Overall Study|Adverse Event|11|||
42085516|NCT00761319|75895917|FG001|Overall Study|Adverse Event|7|||
42085517|NCT00761319|75895916|FG000|Overall Study|Withdrawal by Subject|8|||
42085518|NCT00761319|75895917|FG001|Overall Study|Withdrawal by Subject|7|||
42085519|NCT00761319|75895916|FG000|Overall Study|Noncompliance|4|||
42085520|NCT00761319|75895917|FG001|Overall Study|Noncompliance|3|||
42085521|NCT00761319|75895916|FG000|Overall Study|Lost to Follow-up|1|||
42179284|NCT01147666|75986400|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42179285|NCT01147666|75986401|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42085522|NCT00761319|75895917|FG001|Overall Study|Lost to Follow-up|1|||
42085523|NCT00761319|75895916|FG000|Overall Study|Nonspecified|2|||
42085524|NCT00761319|75895917|FG001|Overall Study|Nonspecified|2|||
42085525|NCT00761319|75895916|FG000|Overall Study|Missing|1|||
42085526|NCT00761319|75895917|FG001|Overall Study|Missing|0|||
42085527|NCT00762996|75895923|FG000|Period One|Protocol Violation|0|||
42085528|NCT00762996|75895924|FG001|Period One|Protocol Violation|0|||
42085529|NCT00762996|75895925|FG002|Period One|Protocol Violation|1|||
42085530|NCT00762996|75895926|FG003|Period One|Protocol Violation|0|||
42085531|NCT00762996|75895923|FG000|Period One|ineligible|0|||
42085532|NCT00762996|75895924|FG001|Period One|ineligible|0|||
42085533|NCT00762996|75895925|FG002|Period One|ineligible|1|||
42085534|NCT00762996|75895926|FG003|Period One|ineligible|1|||
42085535|NCT00762996|75895923|FG000|Period One|Adverse Event|0|||
42085536|NCT00762996|75895924|FG001|Period One|Adverse Event|0|||
42085537|NCT00762996|75895925|FG002|Period One|Adverse Event|1|||
42085538|NCT00762996|75895926|FG003|Period One|Adverse Event|0|||
42085539|NCT00762996|75895923|FG000|Period One|Withdrawal by Subject|0|||
42085540|NCT00762996|75895924|FG001|Period One|Withdrawal by Subject|0|||
42085541|NCT00762996|75895925|FG002|Period One|Withdrawal by Subject|1|||
42085542|NCT00762996|75895926|FG003|Period One|Withdrawal by Subject|0|||
42085543|NCT00762606|75895936|FG000|Overall Study|Lost to Follow-up|18|||
42085544|NCT00762606|75895937|FG001|Overall Study|Lost to Follow-up|13|||
42085545|NCT00818441|75895945|FG000|Overall Study|Death|69|||
42085546|NCT00818441|75895946|FG001|Overall Study|Death|26|||
42085547|NCT00818441|75895945|FG000|Overall Study|Other|5|||
42085548|NCT00818441|75895946|FG001|Overall Study|Other|0|||
42085549|NCT00818441|75895945|FG000|Overall Study|Lost to Follow-up|2|||
42085550|NCT00818441|75895946|FG001|Overall Study|Lost to Follow-up|1|||
42085551|NCT00818441|75895945|FG000|Overall Study|Withdrawal by Subject|2|||
42085552|NCT00818441|75895946|FG001|Overall Study|Withdrawal by Subject|0|||
42085553|NCT00818441|75895945|FG000|Overall Study|Adverse Event|0|||
42085554|NCT00818441|75895946|FG001|Overall Study|Adverse Event|1|||
42085555|NCT00818441|75895945|FG000|Overall Study|Study terminated by sponsor|11|||
42294284|NCT02876328|76128659|FG015|Overall Study|Withdrawal by Subject|0|||
42085556|NCT00818441|75895946|FG001|Overall Study|Study terminated by sponsor|2|||
42085557|NCT00826943|75895953|FG000|Overall Study|Withdrawal by Subject|0|||
42085558|NCT00826943|75895954|FG001|Overall Study|Withdrawal by Subject|0|||
42085559|NCT00826943|75895955|FG002|Overall Study|Withdrawal by Subject|0|||
42085560|NCT00826943|75895956|FG003|Overall Study|Withdrawal by Subject|0|||
42085561|NCT00826943|75895957|FG004|Overall Study|Withdrawal by Subject|1|||
42085562|NCT00826943|75895958|FG005|Overall Study|Withdrawal by Subject|0|||
42085563|NCT00834041|75895968|FG000|Overall Study|Withdrawal by Subject|1|||
42085564|NCT00834041|75895969|FG001|Overall Study|Withdrawal by Subject|0|||
42085565|NCT00834041|75895968|FG000|Overall Study|Lost to Follow-up|0|||
42085566|NCT00834041|75895969|FG001|Overall Study|Lost to Follow-up|1|||
42085567|NCT00760929|75895979|FG000|Overall Study|Adverse Event|2|||
42294285|NCT02876328|76128660|FG016|Overall Study|Withdrawal by Subject|1|||
42085568|NCT00760929|75895980|FG001|Overall Study|Adverse Event|0|||
42085569|NCT00760929|75895981|FG002|Overall Study|Adverse Event|6|||
42085570|NCT00760929|75895982|FG003|Overall Study|Adverse Event|10|||
42085571|NCT00760929|75895979|FG000|Overall Study|Lack of Efficacy|0|||
42085572|NCT00760929|75895980|FG001|Overall Study|Lack of Efficacy|2|||
42085573|NCT00760929|75895981|FG002|Overall Study|Lack of Efficacy|1|||
42085574|NCT00760929|75895982|FG003|Overall Study|Lack of Efficacy|0|||
42085575|NCT00760929|75895979|FG000|Overall Study|Withdrawal by Subject|1|||
42085576|NCT00760929|75895980|FG001|Overall Study|Withdrawal by Subject|0|||
42085577|NCT00760929|75895981|FG002|Overall Study|Withdrawal by Subject|9|||
42085578|NCT00760929|75895982|FG003|Overall Study|Withdrawal by Subject|1|||
42294286|NCT02876328|76128661|FG017|Overall Study|Withdrawal by Subject|3|||
42085579|NCT00760929|75895979|FG000|Overall Study|Lost to Follow-up|0|||
42085580|NCT00760929|75895980|FG001|Overall Study|Lost to Follow-up|0|||
42085581|NCT00760929|75895981|FG002|Overall Study|Lost to Follow-up|1|||
42179286|NCT01147666|75986402|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42179287|NCT01147666|75986403|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42179288|NCT01147666|75986404|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42179289|NCT01147666|75986405|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42179290|NCT01147666|75986406|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42179291|NCT01147666|75986407|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42179292|NCT01147666|75986408|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42179293|NCT01147666|75986409|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
42085582|NCT00760929|75895982|FG003|Overall Study|Lost to Follow-up|0|||
42085583|NCT00760929|75895979|FG000|Overall Study|Progression of Disease|21|||
42085584|NCT00760929|75895980|FG001|Overall Study|Progression of Disease|26|||
42085585|NCT00760929|75895981|FG002|Overall Study|Progression of Disease|38|||
42085586|NCT00760929|75895982|FG003|Overall Study|Progression of Disease|42|||
42085587|NCT00760929|75895979|FG000|Overall Study|Other|2|||
42085588|NCT00760929|75895980|FG001|Overall Study|Other|0|||
42085589|NCT00760929|75895981|FG002|Overall Study|Other|2|||
42085590|NCT00760929|75895982|FG003|Overall Study|Other|1|||
42085591|NCT00760929|75895979|FG000|Overall Study|Death|0|||
42085592|NCT00760929|75895980|FG001|Overall Study|Death|0|||
42085593|NCT00760929|75895981|FG002|Overall Study|Death|1|||
42085594|NCT00760929|75895982|FG003|Overall Study|Death|0|||
42085595|NCT00760929|75895979|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
42085596|NCT00760929|75895980|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
42085597|NCT00760929|75895981|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
42085598|NCT00760929|75895982|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
42085599|NCT00818207|75895993|FG000|Overall Study|Adverse Event|6|||
42085600|NCT00818207|75895994|FG001|Overall Study|Adverse Event|0|||
42085601|NCT00818207|75895993|FG000|Overall Study|Lost to Follow-up|160|||
42085602|NCT00818207|75895994|FG001|Overall Study|Lost to Follow-up|146|||
42085603|NCT00818207|75895993|FG000|Overall Study|Multiple reasons|11|||
42085604|NCT00818207|75895994|FG001|Overall Study|Multiple reasons|12|||
42085605|NCT00818207|75895993|FG000|Overall Study|Withdrawal by Subject|42|||
42085606|NCT00818207|75895994|FG001|Overall Study|Withdrawal by Subject|104|||
42085607|NCT00818207|75895993|FG000|Overall Study|Death|3|||
42085608|NCT00818207|75895994|FG001|Overall Study|Death|5|||
42085609|NCT00760617|75896003|FG000|Overall Study|Adverse Event|5|||
42085610|NCT00760617|75896004|FG001|Overall Study|Adverse Event|2|||
42085611|NCT00760617|75896005|FG002|Overall Study|Adverse Event|0|||
42085612|NCT00760617|75896003|FG000|Overall Study|Lost to Follow-up|0|||
42085613|NCT00760617|75896004|FG001|Overall Study|Lost to Follow-up|0|||
42085614|NCT00760617|75896005|FG002|Overall Study|Lost to Follow-up|5|||
42085615|NCT00760383|75896015|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
42085616|NCT00760383|75896016|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
42085617|NCT00759915|75896024|FG000|Overall Study|Withdrawal by Subject|1|||
42085618|NCT00759915|75896025|FG001|Overall Study|Withdrawal by Subject|0|||
42085619|NCT00759915|75896024|FG000|Overall Study|Adverse Event|0|||
42085620|NCT00759915|75896025|FG001|Overall Study|Adverse Event|1|||
42085621|NCT00759759|75896033|FG000|Overall Study|didn't return for period 2|1|||
42085622|NCT00759759|75896034|FG001|Overall Study|didn't return for period 2|0|||
42085623|NCT00759759|75896033|FG000|Overall Study|Didn't receive drug in period 2|1|||
42085624|NCT00759759|75896034|FG001|Overall Study|Didn't receive drug in period 2|0|||
42085625|NCT00759759|75896033|FG000|Overall Study|Withdrawal by Subject|2|||
42085626|NCT00759759|75896034|FG001|Overall Study|Withdrawal by Subject|1|||
42085627|NCT00759681|75896042|FG000|Overall Study|Death|2|||
42085628|NCT00759681|75896043|FG001|Overall Study|Death|5|||
42085629|NCT00759681|75896042|FG000|Overall Study|Lost to Follow-up|8|||
42085630|NCT00759681|75896043|FG001|Overall Study|Lost to Follow-up|5|||
42179294|NCT01147666|75986410|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
42179295|NCT01147666|75986411|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
42179296|NCT00256295|75986473|FG000|Overall Study|Withdrawal by Subject|3|||
42179297|NCT00256295|75986473|FG000|Overall Study|Death|1|||
42179298|NCT02877004|75986480|FG000|Overall Study|Pregnancy|0|||
42085631|NCT00826241|75896050|FG000|Overall Study|Withdrawal from Follow-up|1|||
42085632|NCT00826241|75896050|FG000|Overall Study|Withdrew consent|2|||
42085633|NCT00826241|75896050|FG000|Overall Study|Death|4|||
42085634|NCT00826241|75896050|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
42085635|NCT00826241|75896050|FG000|Overall Study|Non-compliance|1|||
42085636|NCT00826241|75896050|FG000|Overall Study|Progression of disease|1|||
42085637|NCT00826241|75896050|FG000|Overall Study|Patient refused follow-up|3|||
42085638|NCT00826241|75896050|FG000|Overall Study|Lost to Follow-up|9|||
42085639|NCT00826241|75896050|FG000|Overall Study|Could not obtain records|1|||
42085640|NCT00826241|75896050|FG000|Overall Study|Screen failure|2|||
42085641|NCT00826241|75896050|FG000|Overall Study|Pt unable to proceed to registration|1|||
42179299|NCT02877004|75986481|FG001|Overall Study|Pregnancy|0|||
42179300|NCT02877004|75986482|FG002|Overall Study|Pregnancy|1|||
42179301|NCT04617860|75986512|FG000|Overall Study|Adverse Event|0|||
42179302|NCT04617860|75986513|FG001|Overall Study|Adverse Event|2|||
42179303|NCT04617860|75986514|FG002|Overall Study|Adverse Event|2|||
42085642|NCT00826241|75896050|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
42085643|NCT00758589|75896058|FG000|Overall Study|Adverse Event|3|||
42085644|NCT00758589|75896059|FG001|Overall Study|Adverse Event|2|||
42085645|NCT00758589|75896060|FG002|Overall Study|Adverse Event|5|||
42085646|NCT00758589|75896061|FG003|Overall Study|Adverse Event|4|||
42085647|NCT00758589|75896058|FG000|Overall Study|Withdrawal by Subject|0|||
42085648|NCT00758589|75896059|FG001|Overall Study|Withdrawal by Subject|1|||
42085649|NCT00758589|75896060|FG002|Overall Study|Withdrawal by Subject|1|||
42179304|NCT04617860|75986512|FG000|Overall Study|Withdrawal by Subject|0|||
42179305|NCT04617860|75986513|FG001|Overall Study|Withdrawal by Subject|0|||
42085650|NCT00758589|75896061|FG003|Overall Study|Withdrawal by Subject|1|||
42085651|NCT00758589|75896058|FG000|Overall Study|Palm stopped to work|0|||
42085652|NCT00758589|75896059|FG001|Overall Study|Palm stopped to work|0|||
42085653|NCT00758589|75896060|FG002|Overall Study|Palm stopped to work|0|||
42085654|NCT00758589|75896061|FG003|Overall Study|Palm stopped to work|1|||
42179306|NCT04617860|75986514|FG002|Overall Study|Withdrawal by Subject|2|||
42179307|NCT04617860|75986512|FG000|Overall Study|Physician Decision|0|||
42179308|NCT04617860|75986513|FG001|Overall Study|Physician Decision|1|||
42179309|NCT04617860|75986514|FG002|Overall Study|Physician Decision|0|||
42179310|NCT04617860|75986512|FG000|Overall Study|Sponsor Decision|0|||
42179311|NCT04617860|75986513|FG001|Overall Study|Sponsor Decision|3|||
42179312|NCT04617860|75986514|FG002|Overall Study|Sponsor Decision|1|||
42179313|NCT04617860|75986512|FG000|Overall Study|Termination of Study by Sponsor|8|||
42179314|NCT04617860|75986513|FG001|Overall Study|Termination of Study by Sponsor|4|||
42179315|NCT04617860|75986514|FG002|Overall Study|Termination of Study by Sponsor|13|||
42179316|NCT04608500|75986526|FG000|Overall Study|Adverse Event|2|||
42179317|NCT04608500|75986527|FG001|Overall Study|Adverse Event|0|||
42179318|NCT04608500|75986526|FG000|Overall Study|Lost to Follow-up|15|||
42085655|NCT00833417|75896073|FG000|Overall Study|Adverse Event|5|||
42085656|NCT00833417|75896074|FG001|Overall Study|Adverse Event|16|||
42085657|NCT00833417|75896073|FG000|Overall Study|Death|1|||
42085658|NCT00833417|75896074|FG001|Overall Study|Death|3|||
42085659|NCT00833417|75896073|FG000|Overall Study|Lost to Follow-up|1|||
42085660|NCT00833417|75896074|FG001|Overall Study|Lost to Follow-up|2|||
42085661|NCT00833417|75896073|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
42085662|NCT00833417|75896074|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
42085663|NCT00833417|75896073|FG000|Overall Study|Patient Decision to Withdraw|4|||
42085664|NCT00833417|75896074|FG001|Overall Study|Patient Decision to Withdraw|23|||
42085665|NCT00833417|75896073|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
42085666|NCT00833417|75896074|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
42085667|NCT00833417|75896073|FG000|Overall Study|Disease Progression|18|||
42085668|NCT00833417|75896074|FG001|Overall Study|Disease Progression|17|||
42085669|NCT00833417|75896073|FG000|Overall Study|Reason Not Specified|0|||
42085670|NCT00833417|75896074|FG001|Overall Study|Reason Not Specified|1|||
42085671|NCT00762372|75896084|FG000|Overall Study|Adverse Event|1|||
42085672|NCT00762372|75896085|FG001|Overall Study|Adverse Event|0|||
42085673|NCT00762372|75896086|FG002|Overall Study|Adverse Event|0|||
42085674|NCT00833261|75896100|FG000|Overall Study|Withdrawal by Subject|4|||
42085675|NCT00833105|75896104|FG000|Overall Study|Withdrawal by Subject|1|||
42085676|NCT00833105|75896104|FG000|Overall Study|Adverse Event|2|||
42085677|NCT00833027|75896110|FG000|Overall Study|Adverse Event|33|||
42179319|NCT04608500|75986527|FG001|Overall Study|Lost to Follow-up|9|||
42179320|NCT04608500|75986526|FG000|Overall Study|Participant request|11|||
42179321|NCT04608500|75986527|FG001|Overall Study|Participant request|7|||
42179322|NCT04608500|75986526|FG000|Overall Study|Protocol Violation|1|||
42294287|NCT02876328|76128662|FG018|Overall Study|Withdrawal by Subject|0|||
42085678|NCT00833027|75896110|FG000|Overall Study|Death|1|||
42085679|NCT00833027|75896110|FG000|Overall Study|Lack of Efficacy|12|||
42085680|NCT00833027|75896110|FG000|Overall Study|Lost to Follow-up|24|||
42085681|NCT00833027|75896110|FG000|Overall Study|Protocol Violation|115|||
42085682|NCT00833027|75896110|FG000|Overall Study|Withdrawal by Subject|16|||
42179323|NCT04608500|75986527|FG001|Overall Study|Protocol Violation|0|||
42179324|NCT04608500|75986526|FG000|Overall Study|Other|6|||
42179325|NCT04608500|75986527|FG001|Overall Study|Other|2|||
42179326|NCT04585646|75986533|FG000|First Intervention|Physician Decision|1|||
42294288|NCT02876328|76128663|FG019|Overall Study|Withdrawal by Subject|0|||
42294289|NCT02876328|76128664|FG020|Overall Study|Withdrawal by Subject|1|||
42294290|NCT02876328|76128665|FG021|Overall Study|Withdrawal by Subject|0|||
42085683|NCT00833027|75896110|FG000|Overall Study|Missing|10|||
42179327|NCT04585646|75986534|FG001|First Intervention|Physician Decision|0|||
42179328|NCT04585646|75986533|FG000|First Intervention|Lost to Follow-up|0|||
42179329|NCT04585646|75986534|FG001|First Intervention|Lost to Follow-up|3|||
42179330|NCT04585646|75986533|FG000|First Intervention|Withdrawal by Subject|0|||
42179331|NCT04585646|75986534|FG001|First Intervention|Withdrawal by Subject|1|||
42179332|NCT04584788|75986550|FG000|Overall Study|Physician Decision|8|||
42085684|NCT00752622|75896114|FG000|Induction Phase|Adverse Event|3|||
42179333|NCT04584788|75986550|FG000|Overall Study|Withdrawal by Subject|1|||
42179334|NCT04584788|75986550|FG000|Overall Study|Adverse Event|3|||
42085685|NCT00752622|75896114|FG000|Induction Phase|Other|3|||
42085686|NCT00752622|75896114|FG000|Induction Phase|Non-responder|14|||
42085687|NCT00752622|75896114|FG000|Induction Phase|Withdrawal by Subject|1|||
42085688|NCT00752622|75896114|FG000|Induction Phase|Premature study termination|14|||
42085689|NCT00752622|75896114|FG000|Observational Phase|Premature Study Termination|36|||
42085690|NCT00752622|75896114|FG000|Observational Phase|Non-responder|2|||
42085691|NCT00752622|75896114|FG000|Observational Phase|Withdrawal by Subject|2|||
42085692|NCT00752622|75896114|FG000|Observational Phase|Adverse Event|1|||
42085693|NCT00752622|75896114|FG000|Observational Phase|Other|2|||
42085694|NCT00752622|75896114|FG000|Interventional Phase|Non-responder|2|||
42085695|NCT00752622|75896114|FG000|Interventional Phase|Physician Decision|1|||
42085696|NCT00752622|75896114|FG000|Interventional Phase|Premature Study Termination|5|||
42085697|NCT00754650|75896119|FG000|Overall Study|Disease Progression|2|||
42085698|NCT00761748|75896123|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
42085699|NCT00761748|75896124|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
42085700|NCT00761748|75896123|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
42085701|NCT00761748|75896124|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
42085702|NCT00825305|75896132|FG000|Overall Study|Adverse Event|1|||
42085703|NCT00825305|75896133|FG001|Overall Study|Adverse Event|1|||
42085704|NCT00825305|75896132|FG000|Overall Study|Withdrawal by Subject|6|||
42085705|NCT00825305|75896133|FG001|Overall Study|Withdrawal by Subject|12|||
42085706|NCT00825305|75896132|FG000|Overall Study|Inappropriate inclusion|1|||
42085707|NCT00825305|75896133|FG001|Overall Study|Inappropriate inclusion|0|||
42085708|NCT00825305|75896132|FG000|Overall Study|Protocol Violation|9|||
42085709|NCT00825305|75896133|FG001|Overall Study|Protocol Violation|9|||
42085710|NCT00825305|75896132|FG000|Overall Study|Can not be classified|0|||
42085711|NCT00825305|75896133|FG001|Overall Study|Can not be classified|1|||
42085712|NCT00754572|75896139|FG000|Overall Study|Adverse Event|19|||
42085713|NCT00754572|75896139|FG000|Overall Study|Other|39|||
42085714|NCT00754572|75896139|FG000|Overall Study|Protocol Violation|3|||
42085715|NCT00754572|75896139|FG000|Overall Study|Withdrawal by Subject|3|||
42085716|NCT00754572|75896139|FG000|Overall Study|Lack of Efficacy|2|||
42085717|NCT00754572|75896139|FG000|Overall Study|Death|1|||
42085718|NCT00754572|75896139|FG000|Overall Study|Administrative Reason|3|||
42085719|NCT00754572|75896139|FG000|Overall Study|Lost to Follow-up|1|||
42085720|NCT00824993|75896145|FG000|Overall Study|Withdrawal by Subject|1|||
42085721|NCT00824993|75896146|FG001|Overall Study|Withdrawal by Subject|1|||
42085722|NCT00824993|75896145|FG000|Overall Study|Malignancy Relapse|9|||
42294291|NCT02876328|76128666|FG022|Overall Study|Withdrawal by Subject|0|||
42085723|NCT00824993|75896146|FG001|Overall Study|Malignancy Relapse|10|||
42085724|NCT00824993|75896145|FG000|Overall Study|Rapid Bone Loss|0|||
42179335|NCT04575038|75986556|FG000|Overall Study|Withdrawal by Subject|1|||
42179336|NCT04575038|75986557|FG001|Overall Study|Withdrawal by Subject|1|||
42085725|NCT00824993|75896146|FG001|Overall Study|Rapid Bone Loss|1|||
42085726|NCT00824993|75896145|FG000|Overall Study|Non-Compliant|2|||
42179337|NCT03066622|75986565|FG000|Overall Study|Lost to Follow-up|24|||
42179338|NCT03066622|75986566|FG001|Overall Study|Lost to Follow-up|25|||
42179339|NCT03066622|75986565|FG000|Overall Study|Withdrawal by Subject|2|||
42085727|NCT00824993|75896146|FG001|Overall Study|Non-Compliant|1|||
42085728|NCT00824993|75896145|FG000|Overall Study|Insurance Issue|2|||
42085729|NCT00824993|75896146|FG001|Overall Study|Insurance Issue|1|||
42085730|NCT00824993|75896145|FG000|Overall Study|Death|0|||
42085731|NCT00824993|75896146|FG001|Overall Study|Death|3|||
42085732|NCT00832091|75896154|FG000|Overall Study|Adverse Event|1|||
42085733|NCT00832091|75896155|FG001|Overall Study|Adverse Event|1|||
42085734|NCT00832091|75896154|FG000|Overall Study|Protocol Violation|1|||
42085735|NCT00832091|75896155|FG001|Overall Study|Protocol Violation|0|||
42085736|NCT00832091|75896154|FG000|Overall Study|Withdrawal by Subject|2|||
42085737|NCT00832091|75896155|FG001|Overall Study|Withdrawal by Subject|1|||
42179340|NCT03066622|75986566|FG001|Overall Study|Withdrawal by Subject|1|||
42179341|NCT04501952|75986598|FG000|Overall Study|Adverse Event|0|||
42179342|NCT04501952|75986599|FG001|Overall Study|Adverse Event|3|||
42179343|NCT04501952|75986598|FG000|Overall Study|Investigator's Discretion|0|||
42179344|NCT04501952|75986599|FG001|Overall Study|Investigator's Discretion|1|||
42179345|NCT04501952|75986598|FG000|Overall Study|Protocol Violation|1|||
42179346|NCT04501952|75986599|FG001|Overall Study|Protocol Violation|1|||
42179347|NCT04501952|75986598|FG000|Overall Study|Withdrew Consent|5|||
42179348|NCT04501952|75986599|FG001|Overall Study|Withdrew Consent|4|||
42179349|NCT04501952|75986598|FG000|Overall Study|Lost to Follow-up|7|||
42179350|NCT04501952|75986599|FG001|Overall Study|Lost to Follow-up|2|||
42179351|NCT04501952|75986598|FG000|Overall Study|Randomized and Never Treated|13|||
42179352|NCT04501952|75986599|FG001|Overall Study|Randomized and Never Treated|9|||
42179353|NCT02930122|75986617|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
42179354|NCT02930122|75986618|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
42179355|NCT03697460|75986625|FG000|Overall Study|Withdrawal by Subject|3|||
42179356|NCT00070018|75986629|FG000|Overall Study|Adverse Event|2|||
42179357|NCT00070018|75986629|FG000|Overall Study|Lack of Efficacy|1|||
42179358|NCT00070018|75986629|FG000|Overall Study|Withdrawal by Subject|1|||
42179359|NCT00231413|75986640|FG000|Overall Study|Non-serious AE|0|||
42179360|NCT00231413|75986641|FG001|Overall Study|Non-serious AE|0|||
42179361|NCT00231413|75986642|FG002|Overall Study|Non-serious AE|1|||
42179362|NCT00231413|75986643|FG003|Overall Study|Non-serious AE|0|||
42179363|NCT00231413|75986644|FG004|Overall Study|Non-serious AE|0|||
42179364|NCT00231413|75986645|FG005|Overall Study|Non-serious AE|0|||
42179365|NCT00231413|75986646|FG006|Overall Study|Non-serious AE|1|||
42179366|NCT00231413|75986640|FG000|Overall Study|Withdrawal by Subject|3|||
42179367|NCT00231413|75986641|FG001|Overall Study|Withdrawal by Subject|1|||
42179368|NCT00231413|75986642|FG002|Overall Study|Withdrawal by Subject|4|||
42179369|NCT00231413|75986643|FG003|Overall Study|Withdrawal by Subject|2|||
42179370|NCT00231413|75986644|FG004|Overall Study|Withdrawal by Subject|2|||
42179371|NCT00231413|75986645|FG005|Overall Study|Withdrawal by Subject|0|||
42179372|NCT00231413|75986646|FG006|Overall Study|Withdrawal by Subject|3|||
42179373|NCT00231413|75986640|FG000|Overall Study|Migrated/moved from study area|0|||
42179374|NCT00231413|75986641|FG001|Overall Study|Migrated/moved from study area|0|||
42179375|NCT00231413|75986642|FG002|Overall Study|Migrated/moved from study area|1|||
42179376|NCT00231413|75986643|FG003|Overall Study|Migrated/moved from study area|0|||
42179377|NCT00231413|75986644|FG004|Overall Study|Migrated/moved from study area|0|||
42179378|NCT00231413|75986645|FG005|Overall Study|Migrated/moved from study area|1|||
42179379|NCT00231413|75986646|FG006|Overall Study|Migrated/moved from study area|0|||
42179380|NCT00231413|75986640|FG000|Overall Study|Lost to Follow-up|4|||
42179381|NCT00231413|75986641|FG001|Overall Study|Lost to Follow-up|4|||
42179382|NCT00231413|75986642|FG002|Overall Study|Lost to Follow-up|1|||
42179383|NCT00231413|75986643|FG003|Overall Study|Lost to Follow-up|1|||
42179384|NCT00231413|75986644|FG004|Overall Study|Lost to Follow-up|1|||
42179385|NCT00231413|75986645|FG005|Overall Study|Lost to Follow-up|4|||
42179386|NCT00231413|75986646|FG006|Overall Study|Lost to Follow-up|0|||
42179387|NCT00231413|75986640|FG000|Overall Study|Pregnancy|1|||
42179388|NCT00231413|75986641|FG001|Overall Study|Pregnancy|0|||
42179389|NCT00231413|75986642|FG002|Overall Study|Pregnancy|0|||
42017738|NCT01283009|75825429|FG001|Overall Study|Lost to Follow-up|0|||
42017739|NCT01283009|75825428|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
42017740|NCT01283009|75825429|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
42017741|NCT01282463|75825438|FG000|Overall Study|Lost to Follow-up|1|||
42017742|NCT01282463|75825439|FG001|Overall Study|Lost to Follow-up|0|||
42017743|NCT01282463|75825440|FG002|Overall Study|Lost to Follow-up|0|||
42017744|NCT01282463|75825438|FG000|Overall Study|Withdrawal by Subject|6|||
42017745|NCT01282463|75825439|FG001|Overall Study|Withdrawal by Subject|2|||
42017746|NCT01282463|75825440|FG002|Overall Study|Withdrawal by Subject|3|||
42017747|NCT01282463|75825438|FG000|Overall Study|"Never Treated Death"|0|||
42017748|NCT01282463|75825439|FG001|Overall Study|"Never Treated Death"|1|||
42017749|NCT01282463|75825440|FG002|Overall Study|"Never Treated Death"|0|||
42017750|NCT01282463|75825438|FG000|Overall Study|"Never Treated PD"|0|||
42085738|NCT00832091|75896154|FG000|Overall Study|Prohibited Medication|1|||
42085739|NCT00832091|75896155|FG001|Overall Study|Prohibited Medication|0|||
42085740|NCT00761514|75896161|FG000|Overall Study|Adverse Event|1|||
42085741|NCT00761514|75896161|FG000|Overall Study|Withdrawal by Subject|2|||
42085742|NCT00761514|75896161|FG000|Overall Study|Lost to Follow-up|1|||
42085743|NCT00761514|75896161|FG000|Overall Study|Health insurance didn't cover study drug|1|||
42085744|NCT00761514|75896161|FG000|Overall Study|Problem complying with study visit|1|||
42085745|NCT00761514|75896161|FG000|Overall Study|Unable to pay for medications|1|||
42085746|NCT00831779|75896167|FG000|Overall Study|Lost to Follow-up|1|||
42085747|NCT00831779|75896168|FG001|Overall Study|Lost to Follow-up|0|||
42085748|NCT00831779|75896167|FG000|Overall Study|No longer met criteria|0|||
42085749|NCT00831779|75896168|FG001|Overall Study|No longer met criteria|1|||
42085750|NCT00758043|75896178|FG000|Overall Study|Adverse Event|1|||
42085751|NCT00758043|75896179|FG001|Overall Study|Adverse Event|20|||
42085752|NCT00758043|75896180|FG002|Overall Study|Adverse Event|12|||
42085753|NCT00758043|75896181|FG003|Overall Study|Adverse Event|62|||
42085754|NCT00758043|75896178|FG000|Overall Study|Lack of Efficacy|0|||
42085755|NCT00758043|75896179|FG001|Overall Study|Lack of Efficacy|6|||
42085756|NCT00758043|75896180|FG002|Overall Study|Lack of Efficacy|18|||
42085757|NCT00758043|75896181|FG003|Overall Study|Lack of Efficacy|12|||
42085758|NCT00758043|75896178|FG000|Overall Study|Refused Further Treatment|0|||
42085759|NCT00758043|75896179|FG001|Overall Study|Refused Further Treatment|11|||
42085760|NCT00758043|75896180|FG002|Overall Study|Refused Further Treatment|5|||
42085761|NCT00758043|75896181|FG003|Overall Study|Refused Further Treatment|8|||
42085762|NCT00758043|75896178|FG000|Overall Study|Lost to Follow-up|0|||
42085763|NCT00758043|75896179|FG001|Overall Study|Lost to Follow-up|2|||
42085764|NCT00758043|75896180|FG002|Overall Study|Lost to Follow-up|2|||
42085765|NCT00758043|75896181|FG003|Overall Study|Lost to Follow-up|5|||
42085766|NCT00758043|75896178|FG000|Overall Study|Withdrawal by Subject|0|||
42085767|NCT00758043|75896179|FG001|Overall Study|Withdrawal by Subject|1|||
42085768|NCT00758043|75896180|FG002|Overall Study|Withdrawal by Subject|1|||
42085769|NCT00758043|75896181|FG003|Overall Study|Withdrawal by Subject|4|||
42085770|NCT00758043|75896178|FG000|Overall Study|Required Prohibited Medication|0|||
42085771|NCT00758043|75896179|FG001|Overall Study|Required Prohibited Medication|0|||
42085772|NCT00758043|75896180|FG002|Overall Study|Required Prohibited Medication|1|||
42085773|NCT00758043|75896181|FG003|Overall Study|Required Prohibited Medication|3|||
42085774|NCT00758043|75896178|FG000|Overall Study|Non-Compliant With study Drug|0|||
42085775|NCT00758043|75896179|FG001|Overall Study|Non-Compliant With study Drug|0|||
42085776|NCT00758043|75896180|FG002|Overall Study|Non-Compliant With study Drug|0|||
42085777|NCT00758043|75896181|FG003|Overall Study|Non-Compliant With study Drug|1|||
42085778|NCT00758043|75896178|FG000|Overall Study|Other Reasons|0|||
42085779|NCT00758043|75896179|FG001|Overall Study|Other Reasons|1|||
42085780|NCT00758043|75896180|FG002|Overall Study|Other Reasons|0|||
42085781|NCT00758043|75896181|FG003|Overall Study|Other Reasons|5|||
42085782|NCT00831701|75896199|FG000|Overall Study|Withdrawal by Subject|2|||
42085783|NCT00831701|75896200|FG001|Overall Study|Withdrawal by Subject|0|||
42179390|NCT00231413|75986643|FG003|Overall Study|Pregnancy|0|||
42179391|NCT00231413|75986644|FG004|Overall Study|Pregnancy|0|||
42179392|NCT00231413|75986645|FG005|Overall Study|Pregnancy|0|||
42179393|NCT00231413|75986646|FG006|Overall Study|Pregnancy|0|||
42179394|NCT04494646|75986664|FG000|Overall Study|Adverse Event|0|||
42179395|NCT04494646|75986665|FG001|Overall Study|Adverse Event|1|||
42179396|NCT04494646|75986664|FG000|Overall Study|Withdrawal by Subject|0|||
42179397|NCT04494646|75986665|FG001|Overall Study|Withdrawal by Subject|1|||
42179398|NCT00231179|75986673|FG000|Overall Study|Lost to Follow-up|21|||
42179399|NCT00231179|75986674|FG001|Overall Study|Lost to Follow-up|21|||
42179400|NCT00231179|75986673|FG000|Overall Study|Withdrawal by Subject|3|||
42179401|NCT00231179|75986674|FG001|Overall Study|Withdrawal by Subject|3|||
42179402|NCT03135028|75986680|FG000|Overall Study|Death|6|||
42179403|NCT03135028|75986680|FG000|Overall Study|Study Terminated by Sponsor|2|||
42085784|NCT00831701|75896199|FG000|Overall Study|Stone expulsion before first medication|2|||
42179404|NCT03135028|75986680|FG000|Overall Study|Withdrew Consent|1|||
42179405|NCT00228917|75986692|FG000|Overall Study|Migrated/moved from study area|0|||
42179406|NCT00228917|75986693|FG001|Overall Study|Migrated/moved from study area|0|||
42179407|NCT00228917|75986694|FG002|Overall Study|Migrated/moved from study area|0|||
42179408|NCT00228917|75986695|FG003|Overall Study|Migrated/moved from study area|0|||
42179409|NCT00228917|75986696|FG004|Overall Study|Migrated/moved from study area|0|||
42179410|NCT00228917|75986697|FG005|Overall Study|Migrated/moved from study area|2|||
42085785|NCT00831701|75896200|FG001|Overall Study|Stone expulsion before first medication|2|||
42085786|NCT00831701|75896199|FG000|Overall Study|Lost to Follow-up|1|||
42085787|NCT00831701|75896200|FG001|Overall Study|Lost to Follow-up|3|||
42085788|NCT00752895|75896208|FG000|Overall Study|Withdrawal by Subject|8|||
42085789|NCT00752895|75896209|FG001|Overall Study|Withdrawal by Subject|3|||
42085790|NCT00831389|75896217|FG000|Overall Study|Withdrawal by Subject|0|||
42085791|NCT00831389|75896218|FG001|Overall Study|Withdrawal by Subject|1|||
42085792|NCT00831311|75896226|FG000|Overall Study|Definitive Contraindication|3|||
42179411|NCT00228917|75986698|FG006|Overall Study|Migrated/moved from study area|0|||
42179412|NCT00228917|75986699|FG007|Overall Study|Migrated/moved from study area|0|||
42179413|NCT00227903|75986715|FG000|Overall Study|Withdrawal by Subject|2|||
42179414|NCT00227903|75986716|FG001|Overall Study|Withdrawal by Subject|5|||
42179415|NCT00227903|75986715|FG000|Overall Study|Subject moved out of area|1|||
42179416|NCT00227903|75986716|FG001|Overall Study|Subject moved out of area|2|||
42179417|NCT00227903|75986715|FG000|Overall Study|Lost to Follow-up|1|||
42179418|NCT00227903|75986716|FG001|Overall Study|Lost to Follow-up|3|||
42179419|NCT00227903|75986715|FG000|Overall Study|Miscarriage|1|||
42179420|NCT00227903|75986716|FG001|Overall Study|Miscarriage|0|||
42179421|NCT04411628|75986726|FG000|Overall Study|Withdrawal by Subject|1|||
42085793|NCT00831311|75896227|FG001|Overall Study|Definitive Contraindication|3|||
42085794|NCT00831311|75896226|FG000|Overall Study|Lost to Follow-up|3|||
42085795|NCT00831311|75896227|FG001|Overall Study|Lost to Follow-up|0|||
42085796|NCT00831311|75896226|FG000|Overall Study|Physician Decision|0|||
42085797|NCT00831311|75896227|FG001|Overall Study|Physician Decision|1|||
42085798|NCT00831311|75896226|FG000|Overall Study|Withdrawal by Subject|6|||
42085799|NCT00831311|75896227|FG001|Overall Study|Withdrawal by Subject|4|||
42085800|NCT00831233|75896236|FG000|Overall Study|Adverse Event|0|||
42085801|NCT00831233|75896237|FG001|Overall Study|Adverse Event|1|||
42085802|NCT00831233|75896236|FG000|Overall Study|Protocol Violation|1|||
42085803|NCT00831233|75896237|FG001|Overall Study|Protocol Violation|0|||
42085804|NCT00831233|75896236|FG000|Overall Study|Selection Criteria Not Met|2|||
42085805|NCT00831233|75896237|FG001|Overall Study|Selection Criteria Not Met|0|||
42085806|NCT00761280|75896254|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
42085807|NCT00761280|75896255|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
42085808|NCT00761280|75896254|FG000|Randomization to First Dose|Sponsor decision|1|||
42085809|NCT00761280|75896255|FG001|Randomization to First Dose|Sponsor decision|0|||
42085810|NCT00761280|75896254|FG000|Randomization to First Dose|Other|1|||
42085811|NCT00761280|75896255|FG001|Randomization to First Dose|Other|0|||
42085812|NCT00761280|75896254|FG000|First Dose to End of Study|End of trial|5|||
42085813|NCT00761280|75896255|FG001|First Dose to End of Study|End of trial|5|||
42085814|NCT00761280|75896254|FG000|First Dose to End of Study|Progressive disease|5|||
42085815|NCT00761280|75896255|FG001|First Dose to End of Study|Progressive disease|3|||
42085816|NCT00761280|75896254|FG000|First Dose to End of Study|Sponsor decision|1|||
42085817|NCT00761280|75896255|FG001|First Dose to End of Study|Sponsor decision|2|||
42085818|NCT00761280|75896254|FG000|First Dose to End of Study|Death|1|||
42085819|NCT00761280|75896255|FG001|First Dose to End of Study|Death|0|||
42085820|NCT00761280|75896254|FG000|First Dose to End of Study|Lost to Follow-up|0|||
42085821|NCT00761280|75896255|FG001|First Dose to End of Study|Lost to Follow-up|1|||
42085822|NCT00824369|75896267|FG000|Overall Study|Nolonger willing to participate in study|1|||
42085823|NCT00824369|75896268|FG001|Overall Study|Nolonger willing to participate in study|0|||
42085824|NCT00824369|75896269|FG002|Overall Study|Nolonger willing to participate in study|1|||
42085825|NCT00824369|75896270|FG003|Overall Study|Nolonger willing to participate in study|2|||
42085826|NCT00824369|75896271|FG004|Overall Study|Nolonger willing to participate in study|0|||
42085827|NCT00824369|75896272|FG005|Overall Study|Nolonger willing to participate in study|1|||
42085828|NCT00824369|75896267|FG000|Overall Study|Lost to Follow-up|0|||
42085829|NCT00824369|75896268|FG001|Overall Study|Lost to Follow-up|0|||
42085830|NCT00824369|75896269|FG002|Overall Study|Lost to Follow-up|0|||
42085831|NCT00824369|75896270|FG003|Overall Study|Lost to Follow-up|0|||
42085832|NCT00824369|75896271|FG004|Overall Study|Lost to Follow-up|1|||
42085833|NCT00824369|75896272|FG005|Overall Study|Lost to Follow-up|0|||
42179422|NCT04411628|75986727|FG001|Overall Study|Withdrawal by Subject|1|||
42179423|NCT04411628|75986728|FG002|Overall Study|Withdrawal by Subject|2|||
42179424|NCT04411628|75986729|FG003|Overall Study|Withdrawal by Subject|0|||
42179425|NCT04411628|75986726|FG000|Overall Study|Lost to Follow-up|0|||
42179426|NCT04411628|75986727|FG001|Overall Study|Lost to Follow-up|1|||
42179427|NCT04411628|75986728|FG002|Overall Study|Lost to Follow-up|0|||
42179428|NCT04411628|75986729|FG003|Overall Study|Lost to Follow-up|0|||
42085834|NCT00824291|75896288|FG000|Overall Study|Adverse Event|15|||
42085835|NCT00824291|75896289|FG001|Overall Study|Adverse Event|6|||
42085836|NCT00824291|75896288|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
42179429|NCT00227591|75986742|FG000|Overall Study|Withdrawal by Subject|1|||
42085837|NCT00824291|75896289|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
42085838|NCT00824291|75896288|FG000|Overall Study|Lost to Follow-up|11|||
42085839|NCT00824291|75896289|FG001|Overall Study|Lost to Follow-up|9|||
42085840|NCT00824291|75896288|FG000|Overall Study|Non-compliance|1|||
42085841|NCT00824291|75896289|FG001|Overall Study|Non-compliance|1|||
42085842|NCT00824291|75896288|FG000|Overall Study|Protocol Violation|4|||
42179430|NCT04512482|75986748|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
42085843|NCT00824291|75896289|FG001|Overall Study|Protocol Violation|1|||
42085844|NCT00824291|75896288|FG000|Overall Study|Withdrawal by Subject|14|||
42179431|NCT04512482|75986749|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
42179432|NCT00226811|75986755|FG000|Overall Study|Death|8|||
42179433|NCT00226811|75986755|FG000|Overall Study|Adverse Event|11|||
42179434|NCT00226811|75986755|FG000|Overall Study|Lack of Efficacy|55|||
42179435|NCT00226811|75986755|FG000|Overall Study|Withdrawal by Subject|2|||
42179436|NCT00226655|75986759|FG000|Overall Study|Death|13|||
42179437|NCT00226655|75986759|FG000|Overall Study|Withdrawal by Subject|15|||
42179438|NCT00226655|75986759|FG000|Overall Study|Adverse Event|35|||
42085845|NCT00824291|75896289|FG001|Overall Study|Withdrawal by Subject|8|||
42085846|NCT00824291|75896288|FG000|Overall Study|Lack of Efficacy|7|||
42085847|NCT00824291|75896289|FG001|Overall Study|Lack of Efficacy|8|||
42085848|NCT00824291|75896288|FG000|Overall Study|Participant on prohibited medication|1|||
42085849|NCT00824291|75896289|FG001|Overall Study|Participant on prohibited medication|0|||
42085850|NCT00804986|75896301|FG000|Overall Study|Adverse Event|0|||
42085851|NCT00804986|75896302|FG001|Overall Study|Adverse Event|1|||
42085852|NCT00804986|75896303|FG002|Overall Study|Adverse Event|2|||
42085853|NCT00804986|75896304|FG003|Overall Study|Adverse Event|1|||
42179439|NCT00226655|75986759|FG000|Overall Study|Physician Decision|6|||
42179440|NCT00226655|75986759|FG000|Overall Study|Clinical deterioration|10|||
42179441|NCT03124108|75986775|FG000|Overall Study|Adverse Event|0|||
42179442|NCT03124108|75986776|FG001|Overall Study|Adverse Event|1|||
42179443|NCT03124108|75986777|FG002|Overall Study|Adverse Event|0|||
42179444|NCT04475588|75986789|FG000|Overall Study|Adverse Event|2|||
42179445|NCT04475588|75986790|FG001|Overall Study|Adverse Event|0|||
42179446|NCT04353596|75986799|FG000|Overall Study|Protocol Violation|4|||
42179447|NCT04353596|75986800|FG001|Overall Study|Protocol Violation|4|||
42085854|NCT00804986|75896305|FG004|Overall Study|Adverse Event|3|||
42085855|NCT00804986|75896306|FG005|Overall Study|Adverse Event|0|||
42085856|NCT00804986|75896301|FG000|Overall Study|Lack of Efficacy|0|||
42085857|NCT00804986|75896302|FG001|Overall Study|Lack of Efficacy|0|||
42085858|NCT00804986|75896303|FG002|Overall Study|Lack of Efficacy|0|||
42085859|NCT00804986|75896304|FG003|Overall Study|Lack of Efficacy|1|||
42085860|NCT00804986|75896305|FG004|Overall Study|Lack of Efficacy|0|||
42085861|NCT00804986|75896306|FG005|Overall Study|Lack of Efficacy|3|||
42085862|NCT00804986|75896301|FG000|Overall Study|Lost to Follow-up|0|||
42085863|NCT00804986|75896302|FG001|Overall Study|Lost to Follow-up|0|||
42085864|NCT00804986|75896303|FG002|Overall Study|Lost to Follow-up|0|||
42085865|NCT00804986|75896304|FG003|Overall Study|Lost to Follow-up|1|||
42085866|NCT00804986|75896305|FG004|Overall Study|Lost to Follow-up|1|||
42085867|NCT00804986|75896306|FG005|Overall Study|Lost to Follow-up|3|||
42085868|NCT00804986|75896301|FG000|Overall Study|Protocol Violation|0|||
42085869|NCT00804986|75896302|FG001|Overall Study|Protocol Violation|1|||
42085870|NCT00804986|75896303|FG002|Overall Study|Protocol Violation|0|||
42085871|NCT00804986|75896304|FG003|Overall Study|Protocol Violation|1|||
42085872|NCT00804986|75896305|FG004|Overall Study|Protocol Violation|0|||
42085873|NCT00804986|75896306|FG005|Overall Study|Protocol Violation|0|||
42085874|NCT00804986|75896301|FG000|Overall Study|Withdrawal by Subject|0|||
42085875|NCT00804986|75896302|FG001|Overall Study|Withdrawal by Subject|3|||
42085876|NCT00804986|75896303|FG002|Overall Study|Withdrawal by Subject|0|||
42085877|NCT00804986|75896304|FG003|Overall Study|Withdrawal by Subject|3|||
42085878|NCT00804986|75896305|FG004|Overall Study|Withdrawal by Subject|5|||
42085879|NCT00804986|75896306|FG005|Overall Study|Withdrawal by Subject|3|||
42085880|NCT00804986|75896301|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
42085881|NCT00804986|75896302|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
42085882|NCT00804986|75896303|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
42085883|NCT00804986|75896304|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
42085884|NCT00804986|75896305|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
42085885|NCT00804986|75896306|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
42085886|NCT00804986|75896301|FG000|Overall Study|Sponsor Decision|0|||
42085887|NCT00804986|75896302|FG001|Overall Study|Sponsor Decision|1|||
42179448|NCT04353596|75986799|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
42179449|NCT04353596|75986800|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
42085888|NCT00804986|75896303|FG002|Overall Study|Sponsor Decision|0|||
42294292|NCT02876328|76128667|FG023|Overall Study|Withdrawal by Subject|0|||
42294293|NCT02876328|76128644|FG000|Overall Study|Missed 12 Month Visit|15|||
42085889|NCT00804986|75896304|FG003|Overall Study|Sponsor Decision|0|||
42085890|NCT00804986|75896305|FG004|Overall Study|Sponsor Decision|0|||
42085891|NCT00804986|75896306|FG005|Overall Study|Sponsor Decision|0|||
42085892|NCT00804986|75896301|FG000|Overall Study|Physician Decision|1|||
42085893|NCT00804986|75896302|FG001|Overall Study|Physician Decision|0|||
42085894|NCT00804986|75896303|FG002|Overall Study|Physician Decision|0|||
42085895|NCT00804986|75896304|FG003|Overall Study|Physician Decision|0|||
42085896|NCT00804986|75896305|FG004|Overall Study|Physician Decision|0|||
42085897|NCT00804986|75896306|FG005|Overall Study|Physician Decision|0|||
42179450|NCT04350788|75986808|FG000|Overall Study|Lost to Follow-up|6|||
42179451|NCT04350788|75986809|FG001|Overall Study|Lost to Follow-up|2|||
42179452|NCT04350788|75986808|FG000|Overall Study|Withdrawal by Subject|2|||
42179453|NCT04350788|75986809|FG001|Overall Study|Withdrawal by Subject|4|||
42085898|NCT00752232|75896327|FG000|Overall Study|Protocol Violation|0|||
42085899|NCT00752232|75896328|FG001|Overall Study|Protocol Violation|0|||
42085900|NCT00752232|75896329|FG002|Overall Study|Protocol Violation|0|||
42085901|NCT00752232|75896330|FG003|Overall Study|Protocol Violation|0|||
42294294|NCT02876328|76128645|FG001|Overall Study|Missed 12 Month Visit|10|||
42358458|NCT04999839|76204143|FG002|Overall Study|Sponsor request|0|||
42358459|NCT04999839|76204144|FG003|Overall Study|Sponsor request|0|||
42358460|NCT04999839|76204145|FG004|Overall Study|Sponsor request|0|||
42358461|NCT04999839|76204141|FG000|Overall Study|Other|0|||
42358462|NCT04999839|76204142|FG001|Overall Study|Other|0|||
42358463|NCT04999839|76204143|FG002|Overall Study|Other|1|||
42358464|NCT04999839|76204144|FG003|Overall Study|Other|0|||
42358465|NCT04999839|76204145|FG004|Overall Study|Other|0|||
42358466|NCT04696146|76204189|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
42358467|NCT04696146|76204190|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
42358468|NCT04696146|76204189|FG000|Overall Study|Off hours issue with product|1|||
42358469|NCT04696146|76204190|FG001|Overall Study|Off hours issue with product|0|||
42358470|NCT04658940|76204196|FG000|Overall Study|Withdrawal by Subject|1|||
42358471|NCT04629066|76204202|FG000|Overall Study|Lost to Follow-up|3|||
42358472|NCT04629066|76204203|FG001|Overall Study|Lost to Follow-up|2|||
42358473|NCT04598269|76204211|FG000|Overall Study|Adverse Event|0|||
42358474|NCT04598269|76204212|FG001|Overall Study|Adverse Event|3|||
42358475|NCT04598269|76204211|FG000|Overall Study|Withdrawal by Subject|1|||
42358476|NCT04598269|76204212|FG001|Overall Study|Withdrawal by Subject|4|||
42358477|NCT04598269|76204211|FG000|Overall Study|Lost to Follow-up|1|||
42358478|NCT04598269|76204212|FG001|Overall Study|Lost to Follow-up|0|||
42358479|NCT04598269|76204211|FG000|Overall Study|Not Treated|2|||
42358480|NCT04598269|76204212|FG001|Overall Study|Not Treated|0|||
42358481|NCT04591015|76204220|FG000|Overall Study|Death|6|||
42358482|NCT04591015|76204221|FG001|Overall Study|Death|4|||
42358483|NCT04591015|76204220|FG000|Overall Study|Withdrawal by Subject|6|||
42358484|NCT04591015|76204221|FG001|Overall Study|Withdrawal by Subject|3|||
42358485|NCT04591015|76204220|FG000|Overall Study|Lost to Follow-up|16|||
42358486|NCT04591015|76204221|FG001|Overall Study|Lost to Follow-up|11|||
42358487|NCT04566692|76204229|FG000|Overall Study|Adverse Event|2|||
42358488|NCT04566692|76204230|FG001|Overall Study|Adverse Event|0|||
42085902|NCT00752232|75896331|FG004|Overall Study|Protocol Violation|0|||
42085903|NCT00752232|75896332|FG005|Overall Study|Protocol Violation|1|||
42294295|NCT02876328|76128646|FG002|Overall Study|Missed 12 Month Visit|11|||
42294296|NCT02876328|76128647|FG003|Overall Study|Missed 12 Month Visit|6|||
42294297|NCT02876328|76128648|FG004|Overall Study|Missed 12 Month Visit|10|||
42294298|NCT02876328|76128649|FG005|Overall Study|Missed 12 Month Visit|14|||
42294299|NCT02876328|76128650|FG006|Overall Study|Missed 12 Month Visit|3|||
42294300|NCT02876328|76128651|FG007|Overall Study|Missed 12 Month Visit|8|||
42294301|NCT02876328|76128652|FG008|Overall Study|Missed 12 Month Visit|9|||
42294302|NCT02876328|76128653|FG009|Overall Study|Missed 12 Month Visit|5|||
42294303|NCT02876328|76128654|FG010|Overall Study|Missed 12 Month Visit|4|||
42294304|NCT02876328|76128655|FG011|Overall Study|Missed 12 Month Visit|1|||
42294305|NCT02876328|76128656|FG012|Overall Study|Missed 12 Month Visit|5|||
42294306|NCT02876328|76128657|FG013|Overall Study|Missed 12 Month Visit|4|||
42085904|NCT00752232|75896333|FG006|Overall Study|Protocol Violation|0|||
42085905|NCT00752232|75896327|FG000|Overall Study|Caregiver request|2|||
42294307|NCT02876328|76128658|FG014|Overall Study|Missed 12 Month Visit|4|||
42358489|NCT04566692|76204229|FG000|Overall Study|Withdrawal by Subject|1|||
42358490|NCT04566692|76204230|FG001|Overall Study|Withdrawal by Subject|1|||
42358491|NCT04533412|76204245|FG000|Overall Study|Withdrawal by Subject|1|||
42294308|NCT02876328|76128659|FG015|Overall Study|Missed 12 Month Visit|4|||
42358492|NCT04533412|76204246|FG001|Overall Study|Withdrawal by Subject|1|||
42358493|NCT04533412|76204245|FG000|Overall Study|Lost to Follow-up|1|||
42358494|NCT04533412|76204246|FG001|Overall Study|Lost to Follow-up|4|||
42358495|NCT04515147|76204258|FG000|Overall Study|Withdrawal by Subject|1|||
42358496|NCT04515147|76204259|FG001|Overall Study|Withdrawal by Subject|0|||
42179454|NCT04350788|75986808|FG000|Overall Study|Protocol Violation|4|||
42179455|NCT04350788|75986809|FG001|Overall Study|Protocol Violation|0|||
42179456|NCT03852316|75986820|FG000|Overall Study|Protocol Violation|1|||
42179457|NCT03852316|75986820|FG000|Overall Study|Withdrawal by Subject|2|||
42179458|NCT03852316|75986820|FG000|Overall Study|Enrolled but Device not Utilized|1|||
42179459|NCT04335812|75986826|FG000|Overall Study|Withdrawal by Subject|1|||
42179460|NCT04335812|75986827|FG001|Overall Study|Withdrawal by Subject|3|||
42179461|NCT04335812|75986826|FG000|Overall Study|Lost to Follow-up|12|||
42085906|NCT00752232|75896328|FG001|Overall Study|Caregiver request|0|||
42085907|NCT00752232|75896329|FG002|Overall Study|Caregiver request|0|||
42085908|NCT00752232|75896330|FG003|Overall Study|Caregiver request|0|||
42085909|NCT00752232|75896331|FG004|Overall Study|Caregiver request|1|||
42085910|NCT00752232|75896332|FG005|Overall Study|Caregiver request|0|||
42085911|NCT00752232|75896333|FG006|Overall Study|Caregiver request|0|||
42085912|NCT00752232|75896327|FG000|Overall Study|Investigator request|0|||
42085913|NCT00752232|75896328|FG001|Overall Study|Investigator request|0|||
42085914|NCT00752232|75896329|FG002|Overall Study|Investigator request|0|||
42085915|NCT00752232|75896330|FG003|Overall Study|Investigator request|0|||
42085916|NCT00752232|75896331|FG004|Overall Study|Investigator request|1|||
42085917|NCT00752232|75896332|FG005|Overall Study|Investigator request|0|||
42085918|NCT00752232|75896333|FG006|Overall Study|Investigator request|0|||
42085919|NCT00752232|75896327|FG000|Overall Study|Subject request|0|||
42085920|NCT00752232|75896328|FG001|Overall Study|Subject request|0|||
42085921|NCT00752232|75896329|FG002|Overall Study|Subject request|1|||
42085922|NCT00752232|75896330|FG003|Overall Study|Subject request|0|||
42085923|NCT00752232|75896331|FG004|Overall Study|Subject request|0|||
42085924|NCT00752232|75896332|FG005|Overall Study|Subject request|0|||
42085925|NCT00752232|75896333|FG006|Overall Study|Subject request|0|||
42085926|NCT00752232|75896327|FG000|Overall Study|Group home admission|0|||
42085927|NCT00752232|75896328|FG001|Overall Study|Group home admission|0|||
42085928|NCT00752232|75896329|FG002|Overall Study|Group home admission|0|||
42085929|NCT00752232|75896330|FG003|Overall Study|Group home admission|1|||
42085930|NCT00752232|75896331|FG004|Overall Study|Group home admission|0|||
42085931|NCT00752232|75896332|FG005|Overall Study|Group home admission|0|||
42179462|NCT04335812|75986827|FG001|Overall Study|Lost to Follow-up|12|||
42294309|NCT02876328|76128660|FG016|Overall Study|Missed 12 Month Visit|3|||
42294310|NCT02876328|76128661|FG017|Overall Study|Missed 12 Month Visit|6|||
42294311|NCT02876328|76128662|FG018|Overall Study|Missed 12 Month Visit|2|||
42294312|NCT02876328|76128663|FG019|Overall Study|Missed 12 Month Visit|2|||
42294313|NCT02876328|76128664|FG020|Overall Study|Missed 12 Month Visit|11|||
42294314|NCT02876328|76128665|FG021|Overall Study|Missed 12 Month Visit|7|||
42294315|NCT02876328|76128666|FG022|Overall Study|Missed 12 Month Visit|1|||
42294316|NCT02876328|76128667|FG023|Overall Study|Missed 12 Month Visit|0|||
42294317|NCT02577354|76128713|FG000|Overall Study|Lack of Efficacy|4|||
42294318|NCT02577354|76128714|FG001|Overall Study|Lack of Efficacy|4|||
42085932|NCT00752232|75896333|FG006|Overall Study|Group home admission|0|||
42085933|NCT00752232|75896327|FG000|Overall Study|Caregiver could not attend the subject|0|||
42085934|NCT00752232|75896328|FG001|Overall Study|Caregiver could not attend the subject|0|||
42179463|NCT04335812|75986826|FG000|Overall Study|Did not engage in the intervention|22|||
42179464|NCT04335812|75986827|FG001|Overall Study|Did not engage in the intervention|18|||
42179465|NCT03127384|75986833|FG000|Overall Study|Lost to Follow-up|4|||
42294319|NCT02577354|76128713|FG000|Overall Study|Lost to Follow-up|3|||
42085935|NCT00752232|75896329|FG002|Overall Study|Caregiver could not attend the subject|0|||
42179466|NCT03127384|75986833|FG000|Overall Study|Subject request|2|||
42294320|NCT02577354|76128714|FG001|Overall Study|Lost to Follow-up|1|||
42085936|NCT00752232|75896330|FG003|Overall Study|Caregiver could not attend the subject|0|||
42294321|NCT02577354|76128713|FG000|Overall Study|Missed Visit|4|||
42085937|NCT00752232|75896331|FG004|Overall Study|Caregiver could not attend the subject|1|||
42085938|NCT00752232|75896332|FG005|Overall Study|Caregiver could not attend the subject|0|||
42085939|NCT00752232|75896333|FG006|Overall Study|Caregiver could not attend the subject|0|||
42085940|NCT00760266|75896352|FG000|Overall Study|Adverse Event|13|||
42085941|NCT00760266|75896353|FG001|Overall Study|Adverse Event|7|||
42085942|NCT00760266|75896352|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42085943|NCT00760266|75896353|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42085944|NCT00760266|75896352|FG000|Overall Study|Abnormal test procedure result(s)|1|||
42085945|NCT00760266|75896353|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42085946|NCT00760266|75896352|FG000|Overall Study|Lack of Efficacy|2|||
42085947|NCT00760266|75896353|FG001|Overall Study|Lack of Efficacy|2|||
42085948|NCT00760266|75896352|FG000|Overall Study|Protocol deviation|2|||
42085949|NCT00760266|75896353|FG001|Overall Study|Protocol deviation|4|||
42085950|NCT00760266|75896352|FG000|Overall Study|Patient withdrew consent|3|||
42085951|NCT00760266|75896353|FG001|Overall Study|Patient withdrew consent|3|||
42085952|NCT00760266|75896352|FG000|Overall Study|Lost to Follow-up|2|||
42085953|NCT00760266|75896353|FG001|Overall Study|Lost to Follow-up|1|||
42085954|NCT00760266|75896352|FG000|Overall Study|Administrative Problems|0|||
42085955|NCT00760266|75896353|FG001|Overall Study|Administrative Problems|1|||
42085956|NCT00753714|75896361|FG000|Overall Study|Lack of Efficacy|21|||
42085957|NCT00753714|75896362|FG001|Overall Study|Lack of Efficacy|34|||
42085958|NCT00753714|75896361|FG000|Overall Study|Adverse Event|26|||
42085959|NCT00753714|75896362|FG001|Overall Study|Adverse Event|18|||
42085960|NCT00753714|75896361|FG000|Overall Study|Protocol Violation|1|||
42085961|NCT00753714|75896362|FG001|Overall Study|Protocol Violation|0|||
42085962|NCT00753714|75896361|FG000|Overall Study|Lost to Follow-up|0|||
42085963|NCT00753714|75896362|FG001|Overall Study|Lost to Follow-up|1|||
42085964|NCT00753714|75896361|FG000|Overall Study|Withdrawal by Subject|2|||
42085965|NCT00753714|75896362|FG001|Overall Study|Withdrawal by Subject|1|||
42085966|NCT00753714|75896361|FG000|Overall Study|Death|3|||
42085967|NCT00753714|75896362|FG001|Overall Study|Death|3|||
42085968|NCT00753714|75896361|FG000|Overall Study|Other|7|||
42085969|NCT00753714|75896362|FG001|Overall Study|Other|5|||
42085970|NCT00759954|75896373|FG000|Overall Study|Personal reason|1|||
42085971|NCT00759954|75896374|FG001|Overall Study|Personal reason|0|||
42085972|NCT00759954|75896373|FG000|Overall Study|Adverse Event|1|||
42085973|NCT00759954|75896374|FG001|Overall Study|Adverse Event|2|||
42085974|NCT00804908|75896383|FG000|Overall Study|Other|115|||
42085975|NCT00804908|75896384|FG001|Overall Study|Other|116|||
42085976|NCT00804908|75896385|FG002|Overall Study|Other|114|||
42085977|NCT00808808|75896396|FG000|Overall Study|Vaccinated; survey not completed|131|||
42179467|NCT04398134|75986860|FG000|Overall Study|Adverse Event|0|||
42294322|NCT02577354|76128714|FG001|Overall Study|Missed Visit|3|||
42085978|NCT00808808|75896397|FG001|Overall Study|Vaccinated; survey not completed|169|||
42085979|NCT00808808|75896398|FG002|Overall Study|Vaccinated; survey not completed|302|||
42085980|NCT00808808|75896396|FG000|Overall Study|Employee was not vaccinated.|2686|||
42085981|NCT00808808|75896397|FG001|Overall Study|Employee was not vaccinated.|2268|||
42085982|NCT00808808|75896398|FG002|Overall Study|Employee was not vaccinated.|2255|||
42085983|NCT00589784|75896414|FG000|Overall Study|Withdrawal by Subject|0|||
42085984|NCT00589784|75896415|FG001|Overall Study|Withdrawal by Subject|6|||
42085985|NCT00589784|75896414|FG000|Overall Study|Patient inevaluable|1|||
42085986|NCT00589784|75896415|FG001|Overall Study|Patient inevaluable|0|||
42085987|NCT00589784|75896414|FG000|Overall Study|Adverse Event|0|||
42179468|NCT04398134|75986861|FG001|Overall Study|Adverse Event|0|||
42179469|NCT04398134|75986862|FG002|Overall Study|Adverse Event|1|||
42179470|NCT04398134|75986863|FG003|Overall Study|Adverse Event|0|||
42179471|NCT04398134|75986860|FG000|Overall Study|Withdrawal by Subject|2|||
42179472|NCT04398134|75986861|FG001|Overall Study|Withdrawal by Subject|0|||
42179473|NCT04398134|75986862|FG002|Overall Study|Withdrawal by Subject|0|||
42179474|NCT04398134|75986863|FG003|Overall Study|Withdrawal by Subject|1|||
42179475|NCT04398134|75986860|FG000|Overall Study|Study Terminated by Sponsor|30|||
42179476|NCT04398134|75986861|FG001|Overall Study|Study Terminated by Sponsor|11|||
42179477|NCT04398134|75986862|FG002|Overall Study|Study Terminated by Sponsor|32|||
42179478|NCT04398134|75986863|FG003|Overall Study|Study Terminated by Sponsor|11|||
42179479|NCT03122860|75986879|FG000|Overall Study|Discontinued Before Treatment|1|||
42085988|NCT00589784|75896415|FG001|Overall Study|Adverse Event|4|||
42085989|NCT00759876|75896420|FG000|Overall Study|Sponsor terminated study early|36|||
42085990|NCT00823979|75896427|FG000|Overall Study|Lack of Efficacy|13|||
42179480|NCT03122860|75986880|FG001|Overall Study|Discontinued Before Treatment|1|||
42179481|NCT03122860|75986881|FG002|Overall Study|Discontinued Before Treatment|2|||
42179482|NCT03122860|75986882|FG003|Overall Study|Discontinued Before Treatment|0|||
42294323|NCT02577354|76128713|FG000|Overall Study|Adverse Event|4|||
42085991|NCT00823979|75896428|FG001|Overall Study|Lack of Efficacy|16|||
42085992|NCT00823979|75896429|FG002|Overall Study|Lack of Efficacy|9|||
42085993|NCT00823979|75896427|FG000|Overall Study|Lost to Follow-up|2|||
42085994|NCT00823979|75896428|FG001|Overall Study|Lost to Follow-up|1|||
42085995|NCT00823979|75896429|FG002|Overall Study|Lost to Follow-up|0|||
42085996|NCT00823979|75896427|FG000|Overall Study|Withdrawal by Subject|2|||
42085997|NCT00823979|75896428|FG001|Overall Study|Withdrawal by Subject|3|||
42085998|NCT00823979|75896429|FG002|Overall Study|Withdrawal by Subject|2|||
42179483|NCT03122860|75986883|FG004|Overall Study|Discontinued Before Treatment|1|||
42179484|NCT03122860|75986884|FG005|Overall Study|Discontinued Before Treatment|0|||
42179485|NCT03122860|75986879|FG000|Overall Study|Adverse Event|1|||
42085999|NCT00823979|75896427|FG000|Overall Study|Protocol Violation|1|||
42086000|NCT00823979|75896428|FG001|Overall Study|Protocol Violation|1|||
42086001|NCT00823979|75896429|FG002|Overall Study|Protocol Violation|0|||
42086002|NCT00823979|75896427|FG000|Overall Study|Pregnancy|0|||
42086003|NCT00823979|75896428|FG001|Overall Study|Pregnancy|1|||
42086004|NCT00823979|75896429|FG002|Overall Study|Pregnancy|0|||
42086005|NCT00823979|75896427|FG000|Overall Study|Adverse Event|0|||
42086006|NCT00823979|75896428|FG001|Overall Study|Adverse Event|2|||
42086007|NCT00823979|75896429|FG002|Overall Study|Adverse Event|4|||
42086008|NCT00823979|75896427|FG000|Overall Study|Other|2|||
42086009|NCT00823979|75896428|FG001|Overall Study|Other|0|||
42086010|NCT00823979|75896429|FG002|Overall Study|Other|1|||
42179486|NCT03122860|75986880|FG001|Overall Study|Adverse Event|0|||
42179487|NCT03122860|75986881|FG002|Overall Study|Adverse Event|1|||
42179488|NCT03122860|75986882|FG003|Overall Study|Adverse Event|1|||
42179489|NCT03122860|75986883|FG004|Overall Study|Adverse Event|0|||
42179490|NCT03122860|75986884|FG005|Overall Study|Adverse Event|0|||
42179491|NCT03122860|75986879|FG000|Overall Study|Lost to Follow-up|5|||
42179492|NCT03122860|75986880|FG001|Overall Study|Lost to Follow-up|2|||
42179493|NCT03122860|75986881|FG002|Overall Study|Lost to Follow-up|3|||
42179494|NCT03122860|75986882|FG003|Overall Study|Lost to Follow-up|3|||
42179495|NCT03122860|75986883|FG004|Overall Study|Lost to Follow-up|5|||
42179496|NCT03122860|75986884|FG005|Overall Study|Lost to Follow-up|4|||
42179497|NCT03122860|75986879|FG000|Overall Study|Subject Non-Compliance|0|||
42179498|NCT03122860|75986880|FG001|Overall Study|Subject Non-Compliance|0|||
42179499|NCT03122860|75986881|FG002|Overall Study|Subject Non-Compliance|1|||
42179500|NCT03122860|75986882|FG003|Overall Study|Subject Non-Compliance|0|||
42179501|NCT03122860|75986883|FG004|Overall Study|Subject Non-Compliance|0|||
42179502|NCT03122860|75986884|FG005|Overall Study|Subject Non-Compliance|0|||
42179503|NCT03122860|75986879|FG000|Overall Study|Withdrawal by Subject|3|||
42179504|NCT03122860|75986880|FG001|Overall Study|Withdrawal by Subject|2|||
42179505|NCT03122860|75986881|FG002|Overall Study|Withdrawal by Subject|5|||
42179506|NCT03122860|75986882|FG003|Overall Study|Withdrawal by Subject|7|||
42179507|NCT03122860|75986883|FG004|Overall Study|Withdrawal by Subject|9|||
42179508|NCT03122860|75986884|FG005|Overall Study|Withdrawal by Subject|8|||
42179509|NCT03798366|75986901|FG000|Overall Study|Lost to Follow-up|0|||
42179510|NCT03798366|75986902|FG001|Overall Study|Lost to Follow-up|1|||
42179511|NCT04327388|75986911|FG000|Overall Study|Adverse Event|17|||
42086011|NCT00823979|75896427|FG000|Overall Study|Randomized but not Treated|4|||
42086012|NCT00823979|75896428|FG001|Overall Study|Randomized but not Treated|3|||
42086013|NCT00823979|75896429|FG002|Overall Study|Randomized but not Treated|1|||
42086014|NCT00823979|75896427|FG000|Overall Study|Study Terminated by Sponsor|5|||
42086015|NCT00823979|75896428|FG001|Overall Study|Study Terminated by Sponsor|5|||
42086016|NCT00823979|75896429|FG002|Overall Study|Study Terminated by Sponsor|7|||
42179512|NCT04327388|75986912|FG001|Overall Study|Adverse Event|18|||
42086017|NCT00823901|75896439|FG000|Overall Study|Adverse Event|1|||
42086018|NCT00823901|75896440|FG001|Overall Study|Adverse Event|1|||
42086019|NCT00823901|75896439|FG000|Overall Study|Lack of Efficacy|1|||
42086020|NCT00823901|75896440|FG001|Overall Study|Lack of Efficacy|0|||
42086021|NCT00823901|75896439|FG000|Overall Study|Lost to Follow-up|2|||
42086022|NCT00823901|75896440|FG001|Overall Study|Lost to Follow-up|1|||
42086023|NCT00823823|75896448|FG000|Overall Study|Lost to Follow-up|3|||
42086024|NCT00823823|75896449|FG001|Overall Study|Lost to Follow-up|1|||
42086025|NCT00823823|75896448|FG000|Overall Study|Protocol Violation|5|||
42179513|NCT04327388|75986913|FG002|Overall Study|Adverse Event|9|||
42179514|NCT04327388|75986911|FG000|Overall Study|Other|1|||
42179515|NCT04327388|75986912|FG001|Overall Study|Other|2|||
42179516|NCT04327388|75986913|FG002|Overall Study|Other|0|||
42179517|NCT04327388|75986911|FG000|Overall Study|Randomized and not treated|2|||
42179518|NCT04327388|75986912|FG001|Overall Study|Randomized and not treated|0|||
42179519|NCT04327388|75986913|FG002|Overall Study|Randomized and not treated|2|||
42086026|NCT00823823|75896449|FG001|Overall Study|Protocol Violation|5|||
42086027|NCT00759564|75896469|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
42086028|NCT00759564|75896470|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
42086029|NCT00759564|75896471|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
42086030|NCT00759564|75896472|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
42179520|NCT03796728|75986921|FG000|Overall Study|Lost to Follow-up|8|||
42179521|NCT03796728|75986921|FG000|Overall Study|Reason not Specified|16|||
42179522|NCT04323800|75986927|FG000|Overall Study|Withdrawal by Subject|4|||
42179523|NCT04323800|75986928|FG001|Overall Study|Withdrawal by Subject|4|||
42086031|NCT00759564|75896473|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
42294324|NCT02577354|76128714|FG001|Overall Study|Adverse Event|5|||
42086032|NCT00816023|75896509|FG000|Overall Study|Lost to Follow-up|1|||
42179524|NCT04323800|75986927|FG000|Overall Study|Incomplete transfusion|1|||
42179525|NCT04323800|75986928|FG001|Overall Study|Incomplete transfusion|0|||
42086033|NCT00816023|75896510|FG001|Overall Study|Lost to Follow-up|1|||
42086034|NCT00816023|75896511|FG002|Overall Study|Lost to Follow-up|0|||
42086035|NCT00816023|75896512|FG003|Overall Study|Lost to Follow-up|0|||
42086036|NCT00816023|75896509|FG000|Overall Study|Withdrawal by Subject|1|||
42086037|NCT00816023|75896510|FG001|Overall Study|Withdrawal by Subject|0|||
42086038|NCT00816023|75896511|FG002|Overall Study|Withdrawal by Subject|0|||
42086039|NCT00816023|75896512|FG003|Overall Study|Withdrawal by Subject|0|||
42086040|NCT00816023|75896509|FG000|Overall Study|Physician Decision|0|||
42086041|NCT00816023|75896510|FG001|Overall Study|Physician Decision|0|||
42086042|NCT00816023|75896511|FG002|Overall Study|Physician Decision|1|||
42086043|NCT00816023|75896512|FG003|Overall Study|Physician Decision|0|||
42086044|NCT00816023|75896509|FG000|Overall Study|assessments complete prior to window|1|||
42086045|NCT00816023|75896510|FG001|Overall Study|assessments complete prior to window|1|||
42086046|NCT00816023|75896511|FG002|Overall Study|assessments complete prior to window|2|||
42086047|NCT00816023|75896512|FG003|Overall Study|assessments complete prior to window|1|||
42086048|NCT00816023|75896509|FG000|Overall Study|Randomized Not Treated|6|||
42086049|NCT00816023|75896510|FG001|Overall Study|Randomized Not Treated|4|||
42179526|NCT04323800|75986927|FG000|Overall Study|Other|0|||
42179527|NCT04323800|75986928|FG001|Overall Study|Other|1|||
42179528|NCT04323800|75986927|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
42179529|NCT04323800|75986928|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
42179530|NCT04321460|75986936|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
42179531|NCT04321460|75986937|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
42179532|NCT03122548|75986943|FG000|Overall Study|Death|2|||
42179533|NCT03122548|75986943|FG000|Overall Study|Progression - subject went into hospice|1|||
42179534|NCT03122548|75986943|FG000|Overall Study|Study Terminated by Sponsor|2|||
42179535|NCT04459598|75986949|FG000|Overall Study|Adverse Event|1|||
42179536|NCT04459598|75986950|FG001|Overall Study|Adverse Event|1|||
42179537|NCT02929498|75986959|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
42179538|NCT02929498|75986960|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
42179539|NCT02929498|75986961|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
42179540|NCT02929498|75986959|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
42179541|NCT02929498|75986960|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
42179542|NCT02929498|75986961|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
42294325|NCT02477696|76128732|FG000|Overall Study|Death|89|||
42179543|NCT03792672|75986967|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
42179544|NCT03792672|75986968|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
42179545|NCT03792672|75986969|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
42179546|NCT03792672|75986970|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
42179547|NCT03792672|75986971|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
42179548|NCT03792672|75986972|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
42179549|NCT03792672|75986967|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
42179550|NCT03792672|75986968|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
42179551|NCT03792672|75986969|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
42294326|NCT02477696|76128733|FG001|Overall Study|Death|106|||
42017751|NCT01282463|75825439|FG001|Overall Study|"Never Treated PD"|1|||
42017752|NCT01282463|75825440|FG002|Overall Study|"Never Treated PD"|0|||
42017753|NCT01282463|75825438|FG000|Overall Study|Protocol Violation|0|||
42017754|NCT01282463|75825439|FG001|Overall Study|Protocol Violation|0|||
42017755|NCT01282463|75825440|FG002|Overall Study|Protocol Violation|1|||
42017756|NCT01282463|75825438|FG000|Overall Study|Physician Decision|1|||
42017757|NCT01282463|75825439|FG001|Overall Study|Physician Decision|0|||
42017758|NCT01282463|75825440|FG002|Overall Study|Physician Decision|0|||
42017759|NCT01282229|75825456|FG000|Overall Study|Protocol Violation|2|||
42017760|NCT01281917|75825474|FG000|Overall Study|Withdrawal by Subject|1|||
42017761|NCT01281839|75825480|FG000|Overall Study|Lost to Follow-up|6|||
42017762|NCT01281839|75825481|FG001|Overall Study|Lost to Follow-up|3|||
42179552|NCT03792672|75986970|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
42179553|NCT03792672|75986971|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
42294327|NCT02477696|76128732|FG000|Overall Study|Lost to Follow-up|7|||
42017763|NCT01281839|75825480|FG000|Overall Study|Withdrawal by Subject|4|||
42086050|NCT00816023|75896511|FG002|Overall Study|Randomized Not Treated|6|||
42086051|NCT00816023|75896512|FG003|Overall Study|Randomized Not Treated|11|||
42086052|NCT00759174|75896524|FG000|Overall Study|Other|0|||
42086053|NCT00759174|75896525|FG001|Overall Study|Other|2|||
42086054|NCT00815633|75896532|FG000|Overall Study|study terminated|1|||
42086055|NCT00830765|75896538|FG000|Overall Study|Protocol Violation|3|||
42086056|NCT00830765|75896539|FG001|Overall Study|Protocol Violation|2|||
42086057|NCT00830375|75896545|FG000|Overall Study|Lost to Follow-up|1|||
42086058|NCT00803270|75896551|FG000|Overall Study|Lost to Follow-up|1|||
42086059|NCT00803270|75896552|FG001|Overall Study|Lost to Follow-up|2|||
42086060|NCT00751998|75896558|FG000|Overall Study|Lost to Follow-up|7|||
42086061|NCT00751998|75896558|FG000|Overall Study|Death|11|||
42179554|NCT03792672|75986972|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
42179555|NCT03792672|75986967|FG000|Treatment Period 4 (2 Days)|Other|1|||
42179556|NCT03792672|75986968|FG001|Treatment Period 4 (2 Days)|Other|0|||
42179557|NCT03792672|75986969|FG002|Treatment Period 4 (2 Days)|Other|0|||
42179558|NCT03792672|75986970|FG003|Treatment Period 4 (2 Days)|Other|0|||
42179559|NCT03792672|75986971|FG004|Treatment Period 4 (2 Days)|Other|0|||
42179560|NCT03792672|75986972|FG005|Treatment Period 4 (2 Days)|Other|0|||
42179561|NCT03120676|75986987|FG000|Overall Study|Not treated|1|||
42179562|NCT03120520|75986995|FG000|Overall Study|Lost to Follow-up|1|||
42179563|NCT03120520|75986996|FG001|Overall Study|Lost to Follow-up|1|||
42179564|NCT03120520|75986997|FG002|Overall Study|Lost to Follow-up|1|||
42179565|NCT03120520|75986998|FG003|Overall Study|Lost to Follow-up|1|||
42179566|NCT03120520|75986995|FG000|Overall Study|Withdrawal by Subject|3|||
42179567|NCT03120520|75986996|FG001|Overall Study|Withdrawal by Subject|2|||
42179568|NCT03120520|75986997|FG002|Overall Study|Withdrawal by Subject|3|||
42179569|NCT03120520|75986998|FG003|Overall Study|Withdrawal by Subject|2|||
42179570|NCT03120520|75986995|FG000|Overall Study|Other|0|||
42179571|NCT03120520|75986996|FG001|Overall Study|Other|1|||
42017764|NCT01281839|75825481|FG001|Overall Study|Withdrawal by Subject|10|||
42017765|NCT01281839|75825480|FG000|Overall Study|Reason not specified|0|||
42017766|NCT01281839|75825481|FG001|Overall Study|Reason not specified|1|||
42017767|NCT01281137|75825489|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
42017768|NCT01281137|75825490|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
42017769|NCT01281137|75825489|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
42017770|NCT01281137|75825490|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
42017771|NCT01281137|75825489|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
42017772|NCT01281137|75825490|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
42017773|NCT01281137|75825489|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
42017774|NCT01281137|75825490|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
42017775|NCT01281137|75825489|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
42017776|NCT01281137|75825490|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
42017777|NCT01280981|75825514|FG000|Overall Study|Withdrawal by Subject|11|||
42017778|NCT01280981|75825514|FG000|Overall Study|Protocol Violation|2|||
42017779|NCT01280981|75825514|FG000|Overall Study|Lack of Efficacy|13|||
42017780|NCT01280981|75825514|FG000|Overall Study|Lost to Follow-up|3|||
42017781|NCT01280981|75825514|FG000|Overall Study|Adverse Event|6|||
42017782|NCT01280981|75825514|FG000|Overall Study|Irregular or discontinued menses|3|||
42017783|NCT01280981|75825514|FG000|Overall Study|Failed to return|45|||
42017784|NCT01280981|75825514|FG000|Overall Study|Non-compliance with protocol|3|||
42017785|NCT01280981|75825514|FG000|Overall Study|Withdrawal of consent|3|||
42017786|NCT01280981|75825514|FG000|Overall Study|Elective surgery|2|||
42017787|NCT01280981|75825514|FG000|Overall Study|Study site closure|1|||
42017788|NCT01280903|75825520|FG000|Overall Study|Lost to Follow-up|23|||
42017789|NCT01280903|75825521|FG001|Overall Study|Lost to Follow-up|16|||
42017790|NCT01280591|75825531|FG000|Overall Study|Withdrawal by Subject|0|||
42017791|NCT01280591|75825532|FG001|Overall Study|Withdrawal by Subject|0|||
42017792|NCT01280591|75825533|FG002|Overall Study|Withdrawal by Subject|0|||
42017793|NCT01280591|75825534|FG003|Overall Study|Withdrawal by Subject|2|||
42017794|NCT01280591|75825531|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
42017795|NCT01280591|75825532|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
42086062|NCT00751998|75896558|FG000|Overall Study|Withdrawal by Subject|2|||
42086063|NCT00803738|75896564|FG000|Overall Study|Adverse Event|3|||
42179572|NCT03120520|75986997|FG002|Overall Study|Other|0|||
42179573|NCT03120520|75986998|FG003|Overall Study|Other|0|||
42179574|NCT03787212|75987008|FG000|Period 1|Study Termination|2|||
42086064|NCT00803738|75896565|FG001|Overall Study|Adverse Event|5|||
42086065|NCT00803738|75896564|FG000|Overall Study|Lost to Follow-up|4|||
42086066|NCT00803738|75896565|FG001|Overall Study|Lost to Follow-up|4|||
42086067|NCT00803738|75896564|FG000|Overall Study|Protocol Violation|18|||
42086068|NCT00803738|75896565|FG001|Overall Study|Protocol Violation|10|||
42086069|NCT00803738|75896564|FG000|Overall Study|Withdrawal by Subject|1|||
42086070|NCT00803738|75896565|FG001|Overall Study|Withdrawal by Subject|4|||
42086071|NCT00803738|75896564|FG000|Overall Study|Lack of Efficacy|10|||
42086072|NCT00803738|75896565|FG001|Overall Study|Lack of Efficacy|16|||
42086073|NCT00803738|75896564|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
42086074|NCT00803738|75896565|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
42179575|NCT03787212|75987009|FG001|Period 1|Study Termination|2|||
42179576|NCT03125200|75987022|FG000|Overall Study|Study Termination|0|||
42179577|NCT03125200|75987023|FG001|Overall Study|Study Termination|0|||
42179578|NCT03125200|75987024|FG002|Overall Study|Study Termination|0|||
42086075|NCT00803738|75896564|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
42086076|NCT00803738|75896565|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
42086077|NCT00758706|75896573|FG000|Overall Study|Adverse Event|4|||
42179579|NCT03125200|75987025|FG003|Overall Study|Study Termination|1|||
42179580|NCT03125200|75987026|FG004|Overall Study|Study Termination|1|||
42179581|NCT03125200|75987027|FG005|Overall Study|Study Termination|2|||
42179582|NCT03125200|75987028|FG006|Overall Study|Study Termination|1|||
42179583|NCT03125200|75987022|FG000|Overall Study|Clinical Progression|0|||
42017796|NCT01280591|75825533|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
42086078|NCT00758706|75896574|FG001|Overall Study|Adverse Event|4|||
42086079|NCT00591266|75896583|FG000|Overall Study|Adverse Event|2|||
42086080|NCT00591266|75896584|FG001|Overall Study|Adverse Event|2|||
42086081|NCT00591266|75896585|FG002|Overall Study|Adverse Event|3|||
42086082|NCT00591266|75896583|FG000|Overall Study|Lost to Follow-up|0|||
42086083|NCT00591266|75896584|FG001|Overall Study|Lost to Follow-up|1|||
42179584|NCT03125200|75987023|FG001|Overall Study|Clinical Progression|0|||
42179585|NCT03125200|75987024|FG002|Overall Study|Clinical Progression|0|||
42179586|NCT03125200|75987025|FG003|Overall Study|Clinical Progression|1|||
42179587|NCT03125200|75987026|FG004|Overall Study|Clinical Progression|0|||
42017797|NCT01280591|75825534|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
42017798|NCT01280357|75825544|FG000|Overall Study|Excluded no internal monitoring|14|||
42017799|NCT01280357|75825544|FG000|Overall Study|IInsufficient data/No data supplied|12|||
42017800|NCT01274351|75825551|FG000|Overall Study|Lost to Follow-up|1|||
42017801|NCT01274351|75825551|FG000|Overall Study|patient not compliant with the protocol|1|||
42017802|NCT01274351|75825551|FG000|Overall Study|Pregnancy|1|||
42017803|NCT01274351|75825551|FG000|Overall Study|Death|2|||
42017804|NCT01274351|75825551|FG000|Overall Study|Withdrawal by Subject|3|||
42017805|NCT01274351|75825551|FG000|Overall Study|Adverse Event|8|||
42017806|NCT01274351|75825551|FG000|Overall Study|progression of disease|3|||
42017807|NCT01274351|75825551|FG000|Overall Study|hospitalization|1|||
42017808|NCT01271933|75825555|FG000|Single-Blind Phase|Lack of Efficacy|37|||
42017809|NCT01271933|75825556|FG001|Single-Blind Phase|Lack of Efficacy|0|||
42017810|NCT01271933|75825557|FG002|Single-Blind Phase|Lack of Efficacy|0|||
42017811|NCT01271933|75825555|FG000|Single-Blind Phase|Lost to Follow-up|10|||
42017812|NCT01271933|75825556|FG001|Single-Blind Phase|Lost to Follow-up|0|||
42017813|NCT01271933|75825557|FG002|Single-Blind Phase|Lost to Follow-up|0|||
42017814|NCT01271933|75825555|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
42017815|NCT01271933|75825556|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
42017816|NCT01271933|75825557|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
42017817|NCT01271933|75825555|FG000|Single-Blind Phase|Protocol Violation|3|||
42017818|NCT01271933|75825556|FG001|Single-Blind Phase|Protocol Violation|0|||
42017819|NCT01271933|75825557|FG002|Single-Blind Phase|Protocol Violation|0|||
42017820|NCT01271933|75825555|FG000|Single-Blind Phase|Adverse Event|52|||
42017821|NCT01271933|75825556|FG001|Single-Blind Phase|Adverse Event|0|||
42017822|NCT01271933|75825557|FG002|Single-Blind Phase|Adverse Event|0|||
42017823|NCT01271933|75825555|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
42017824|NCT01271933|75825556|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
42017825|NCT01271933|75825557|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
42017826|NCT01271933|75825555|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
42017827|NCT01271933|75825556|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
42017828|NCT01271933|75825557|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
42017829|NCT01271933|75825555|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
42017830|NCT01271933|75825556|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
42086084|NCT00591266|75896585|FG002|Overall Study|Lost to Follow-up|0|||
42086085|NCT00591266|75896583|FG000|Overall Study|Protocol Violation|0|||
42086086|NCT00591266|75896584|FG001|Overall Study|Protocol Violation|0|||
42086087|NCT00591266|75896585|FG002|Overall Study|Protocol Violation|1|||
42179588|NCT03125200|75987027|FG005|Overall Study|Clinical Progression|1|||
42179589|NCT03125200|75987028|FG006|Overall Study|Clinical Progression|0|||
42086088|NCT00591266|75896583|FG000|Overall Study|Withdrawal by Subject|6|||
42086089|NCT00591266|75896584|FG001|Overall Study|Withdrawal by Subject|2|||
42086090|NCT00591266|75896585|FG002|Overall Study|Withdrawal by Subject|5|||
42086091|NCT00591266|75896583|FG000|Overall Study|Lack of Efficacy|0|||
42086092|NCT00591266|75896584|FG001|Overall Study|Lack of Efficacy|2|||
42086093|NCT00591266|75896585|FG002|Overall Study|Lack of Efficacy|0|||
42086094|NCT00591266|75896583|FG000|Overall Study|Other|1|||
42086095|NCT00591266|75896584|FG001|Overall Study|Other|4|||
42086096|NCT00591266|75896585|FG002|Overall Study|Other|5|||
42086097|NCT00758394|75896597|FG000|2nd Intervention Order|Lost to Follow-up|0|||
42086098|NCT00758394|75896598|FG001|2nd Intervention Order|Lost to Follow-up|1|||
42086099|NCT00758394|75896599|FG002|2nd Intervention Order|Lost to Follow-up|0|||
42086100|NCT00758394|75896600|FG003|2nd Intervention Order|Lost to Follow-up|0|||
42086101|NCT00758394|75896597|FG000|3rd Intervention|Lost to Follow-up|1|||
42086102|NCT00758394|75896598|FG001|3rd Intervention|Lost to Follow-up|0|||
42086103|NCT00758394|75896599|FG002|3rd Intervention|Lost to Follow-up|0|||
42086104|NCT00758394|75896600|FG003|3rd Intervention|Lost to Follow-up|1|||
42086105|NCT04450394|75896613|FG000|Overall Study|Adverse Event|2|||
42086106|NCT04450394|75896614|FG001|Overall Study|Adverse Event|0|||
42086107|NCT04450394|75896615|FG002|Overall Study|Adverse Event|0|||
42086108|NCT04450394|75896613|FG000|Overall Study|Death|0|||
42086109|NCT04450394|75896614|FG001|Overall Study|Death|1|||
42086110|NCT04450394|75896615|FG002|Overall Study|Death|0|||
42086111|NCT04450394|75896613|FG000|Overall Study|Lost to Follow-up|0|||
42179590|NCT03125200|75987022|FG000|Overall Study|Progressive Disease|2|||
42179591|NCT03125200|75987023|FG001|Overall Study|Progressive Disease|1|||
42179592|NCT03125200|75987024|FG002|Overall Study|Progressive Disease|2|||
42179593|NCT03125200|75987025|FG003|Overall Study|Progressive Disease|1|||
42179594|NCT03125200|75987026|FG004|Overall Study|Progressive Disease|2|||
42179595|NCT03125200|75987027|FG005|Overall Study|Progressive Disease|0|||
42086112|NCT04450394|75896614|FG001|Overall Study|Lost to Follow-up|3|||
42086113|NCT04450394|75896615|FG002|Overall Study|Lost to Follow-up|0|||
42086114|NCT04450394|75896613|FG000|Overall Study|Physician Decision|0|||
42086115|NCT04450394|75896614|FG001|Overall Study|Physician Decision|1|||
42086116|NCT04450394|75896615|FG002|Overall Study|Physician Decision|0|||
42086117|NCT04450394|75896613|FG000|Overall Study|Protocol Violation|2|||
42086118|NCT04450394|75896614|FG001|Overall Study|Protocol Violation|0|||
42086119|NCT04450394|75896615|FG002|Overall Study|Protocol Violation|0|||
42086120|NCT04450394|75896613|FG000|Overall Study|Withdrawal by Subject|6|||
42086121|NCT04450394|75896614|FG001|Overall Study|Withdrawal by Subject|9|||
42086122|NCT04450394|75896615|FG002|Overall Study|Withdrawal by Subject|0|||
42086123|NCT00758160|75896622|FG000|Overall Study|No Longer Requires Study Medication|4|||
42086124|NCT00758160|75896622|FG000|Overall Study|Administration Problems|3|||
42086125|NCT00758160|75896622|FG000|Overall Study|Adverse Event|15|||
42086126|NCT00758160|75896622|FG000|Overall Study|Lack of Efficacy|10|||
42086127|NCT00758160|75896622|FG000|Overall Study|Lost to Follow-up|14|||
42086128|NCT00758160|75896622|FG000|Overall Study|Protocol Violation|12|||
42179596|NCT03125200|75987028|FG006|Overall Study|Progressive Disease|1|||
42179597|NCT03125200|75987022|FG000|Overall Study|Lack of Efficacy|0|||
42179598|NCT03125200|75987023|FG001|Overall Study|Lack of Efficacy|0|||
42179599|NCT03125200|75987024|FG002|Overall Study|Lack of Efficacy|0|||
42179600|NCT03125200|75987025|FG003|Overall Study|Lack of Efficacy|1|||
42086129|NCT00758160|75896622|FG000|Overall Study|Withdrawal by Subject|8|||
42086130|NCT00757848|75896632|FG000|Overall Study|Voluntary discontinuation|1|||
42086131|NCT00757848|75896633|FG001|Overall Study|Voluntary discontinuation|0|||
42086132|NCT00757848|75896632|FG000|Overall Study|Adverse Event|1|||
42086133|NCT00757848|75896633|FG001|Overall Study|Adverse Event|2|||
42086134|NCT00757848|75896632|FG000|Overall Study|Incorrect enrolment|1|||
42179601|NCT03125200|75987026|FG004|Overall Study|Lack of Efficacy|0|||
42179602|NCT03125200|75987027|FG005|Overall Study|Lack of Efficacy|0|||
42086135|NCT00757848|75896633|FG001|Overall Study|Incorrect enrolment|0|||
42086136|NCT00751296|75896639|FG000|Overall Study|Adverse Event|2|||
42086137|NCT00751140|75896643|FG000|Overall Study|benign angioma excluded from analysis|1|||
42086138|NCT00751881|75896654|FG000|Core Treatment Period|Not treated|1|||
42086139|NCT00751881|75896655|FG001|Core Treatment Period|Not treated|1|||
42086140|NCT00751881|75896656|FG002|Core Treatment Period|Not treated|2|||
42086141|NCT00751881|75896654|FG000|Core Treatment Period|Adverse Event|26|||
42086142|NCT00751881|75896655|FG001|Core Treatment Period|Adverse Event|54|||
42086143|NCT00751881|75896656|FG002|Core Treatment Period|Adverse Event|58|||
42086144|NCT00751881|75896654|FG000|Core Treatment Period|Lack of Efficacy|37|||
42179603|NCT03125200|75987028|FG006|Overall Study|Lack of Efficacy|0|||
42358497|NCT04515147|76204260|FG002|Overall Study|Withdrawal by Subject|10|||
42086145|NCT00751881|75896655|FG001|Core Treatment Period|Lack of Efficacy|30|||
42086146|NCT00751881|75896656|FG002|Core Treatment Period|Lack of Efficacy|20|||
42086147|NCT00751881|75896654|FG000|Core Treatment Period|Poor compliance to protocol|15|||
42086148|NCT00751881|75896655|FG001|Core Treatment Period|Poor compliance to protocol|3|||
42086149|NCT00751881|75896656|FG002|Core Treatment Period|Poor compliance to protocol|4|||
42086150|NCT00751881|75896654|FG000|Core Treatment Period|Lost to Follow-up|6|||
42179604|NCT03125200|75987022|FG000|Overall Study|Toxicity|0|||
42086151|NCT00751881|75896655|FG001|Core Treatment Period|Lost to Follow-up|4|||
42086152|NCT00751881|75896656|FG002|Core Treatment Period|Lost to Follow-up|3|||
42086153|NCT00751881|75896654|FG000|Core Treatment Period|Other: protocol deviation|3|||
42086154|NCT00751881|75896655|FG001|Core Treatment Period|Other: protocol deviation|3|||
42086155|NCT00751881|75896656|FG002|Core Treatment Period|Other: protocol deviation|7|||
42086156|NCT00751881|75896654|FG000|Core Treatment Period|Other: wish to parent|5|||
42086157|NCT00751881|75896655|FG001|Core Treatment Period|Other: wish to parent|7|||
42086158|NCT00751881|75896656|FG002|Core Treatment Period|Other: wish to parent|4|||
42086159|NCT00751881|75896654|FG000|Core Treatment Period|Other: personal/family constraints|6|||
42086160|NCT00751881|75896655|FG001|Core Treatment Period|Other: personal/family constraints|7|||
42086161|NCT00751881|75896656|FG002|Core Treatment Period|Other: personal/family constraints|10|||
42086162|NCT00751881|75896654|FG000|Core Treatment Period|Other: MS treatment change|6|||
42086163|NCT00751881|75896655|FG001|Core Treatment Period|Other: MS treatment change|4|||
42086164|NCT00751881|75896656|FG002|Core Treatment Period|Other: MS treatment change|4|||
42086165|NCT00751881|75896654|FG000|Core Treatment Period|Other: tolerability complaints|2|||
42086166|NCT00751881|75896655|FG001|Core Treatment Period|Other: tolerability complaints|0|||
42086167|NCT00751881|75896656|FG002|Core Treatment Period|Other: tolerability complaints|0|||
42086168|NCT00751881|75896654|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
42086169|NCT00751881|75896655|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
42086170|NCT00751881|75896656|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
42086171|NCT00751881|75896654|FG000|Extension Study Period|Adverse Event|18|||
42086172|NCT00751881|75896655|FG001|Extension Study Period|Adverse Event|20|||
42086173|NCT00751881|75896656|FG002|Extension Study Period|Adverse Event|21|||
42086174|NCT00751881|75896654|FG000|Extension Study Period|Lack of Efficacy|14|||
42086175|NCT00751881|75896655|FG001|Extension Study Period|Lack of Efficacy|10|||
42086176|NCT00751881|75896656|FG002|Extension Study Period|Lack of Efficacy|20|||
42086177|NCT00751881|75896654|FG000|Extension Study Period|Lost to Follow-up|4|||
42086178|NCT00751881|75896655|FG001|Extension Study Period|Lost to Follow-up|9|||
42086179|NCT00751881|75896656|FG002|Extension Study Period|Lost to Follow-up|6|||
42086180|NCT00751881|75896654|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
42086181|NCT00751881|75896655|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
42086182|NCT00751881|75896656|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
42086183|NCT00751881|75896654|FG000|Extension Study Period|Other than specified above|26|||
42086184|NCT00751881|75896655|FG001|Extension Study Period|Other than specified above|30|||
42086185|NCT00751881|75896656|FG002|Extension Study Period|Other than specified above|18|||
42086186|NCT00747474|75896670|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
42086187|NCT00747474|75896671|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
42086188|NCT00747474|75896672|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
42086189|NCT00747474|75896673|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
42086190|NCT00747474|75896674|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
42086191|NCT00747474|75896675|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
42086192|NCT00747474|75896676|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
42086193|NCT00747474|75896677|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
42086194|NCT00747474|75896678|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
42086195|NCT00747474|75896679|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
42086196|NCT00747474|75896680|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
42086197|NCT00747474|75896681|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
42086198|NCT00830063|75896690|FG000|Overall Study|Adverse Event|7|||
42086199|NCT00830063|75896691|FG001|Overall Study|Adverse Event|13|||
42086200|NCT00830063|75896692|FG002|Overall Study|Adverse Event|16|||
42086201|NCT00830063|75896693|FG003|Overall Study|Adverse Event|13|||
42086202|NCT00830063|75896690|FG000|Overall Study|Death|1|||
42086203|NCT00830063|75896691|FG001|Overall Study|Death|0|||
42086204|NCT00830063|75896692|FG002|Overall Study|Death|0|||
42086205|NCT00830063|75896693|FG003|Overall Study|Death|0|||
42179605|NCT03125200|75987023|FG001|Overall Study|Toxicity|0|||
42179606|NCT03125200|75987024|FG002|Overall Study|Toxicity|0|||
42179607|NCT03125200|75987025|FG003|Overall Study|Toxicity|1|||
42179608|NCT03125200|75987026|FG004|Overall Study|Toxicity|0|||
42179609|NCT03125200|75987027|FG005|Overall Study|Toxicity|0|||
42086206|NCT00830063|75896690|FG000|Overall Study|Lost to Follow-up|0|||
42086207|NCT00830063|75896691|FG001|Overall Study|Lost to Follow-up|0|||
42179610|NCT03125200|75987028|FG006|Overall Study|Toxicity|0|||
42179611|NCT03125200|75987022|FG000|Overall Study|Consent Withdrawn by Subject|0|||
42179612|NCT03125200|75987023|FG001|Overall Study|Consent Withdrawn by Subject|1|||
42086208|NCT00830063|75896692|FG002|Overall Study|Lost to Follow-up|3|||
42086209|NCT00830063|75896693|FG003|Overall Study|Lost to Follow-up|1|||
42179613|NCT03125200|75987024|FG002|Overall Study|Consent Withdrawn by Subject|0|||
42179614|NCT03125200|75987025|FG003|Overall Study|Consent Withdrawn by Subject|0|||
42179615|NCT03125200|75987026|FG004|Overall Study|Consent Withdrawn by Subject|1|||
42179616|NCT03125200|75987027|FG005|Overall Study|Consent Withdrawn by Subject|0|||
42179617|NCT03125200|75987028|FG006|Overall Study|Consent Withdrawn by Subject|1|||
42179618|NCT03132220|75987049|FG000|Overall Study|Lost to Follow-up|17|||
42179619|NCT03132220|75987050|FG001|Overall Study|Lost to Follow-up|8|||
42179620|NCT03132220|75987049|FG000|Overall Study|Withdrawal by Subject|1|||
42179621|NCT03132220|75987050|FG001|Overall Study|Withdrawal by Subject|4|||
42179622|NCT03119662|75987058|FG000|Overall Study|Withdrawal by Subject|0|||
42179623|NCT03119662|75987059|FG001|Overall Study|Withdrawal by Subject|1|||
42179624|NCT02728804|75987065|FG000|Overall Study|Ineligible|3|||
42179625|NCT02728804|75987065|FG000|Overall Study|Did not complete baseline questionnaire|9|||
42179626|NCT02728804|75987065|FG000|Overall Study|Death|99|||
42179627|NCT02699554|75987081|FG000|Overall Study|Lost to Follow-up|9|||
42179628|NCT03783780|75987095|FG000|Overall Study|Withdrawn prior to completion|1|||
42086210|NCT00830063|75896690|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
42086211|NCT00830063|75896691|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
42179629|NCT03783702|75987102|FG000|Overall Study|Lost to Follow-up|6|||
42179630|NCT03783702|75987103|FG001|Overall Study|Lost to Follow-up|8|||
42086212|NCT00830063|75896692|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
42086213|NCT00830063|75896693|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
42086214|NCT00830063|75896690|FG000|Overall Study|Lack of Efficacy|51|||
42086215|NCT00830063|75896691|FG001|Overall Study|Lack of Efficacy|23|||
42086216|NCT00830063|75896692|FG002|Overall Study|Lack of Efficacy|25|||
42086217|NCT00830063|75896693|FG003|Overall Study|Lack of Efficacy|32|||
42086218|NCT00830063|75896690|FG000|Overall Study|Other|5|||
42086219|NCT00830063|75896691|FG001|Overall Study|Other|5|||
42086220|NCT00830063|75896692|FG002|Overall Study|Other|8|||
42086221|NCT00830063|75896693|FG003|Overall Study|Other|6|||
42086222|NCT00830063|75896690|FG000|Overall Study|Withdrawal by Subject|16|||
42086223|NCT00830063|75896691|FG001|Overall Study|Withdrawal by Subject|10|||
42179631|NCT03783702|75987102|FG000|Overall Study|Protocol Violation|1|||
42179632|NCT03783702|75987103|FG001|Overall Study|Protocol Violation|3|||
42179633|NCT03575572|75987111|FG000|Overall Study|Withdrawal by Subject|2|||
42179634|NCT03575572|75987111|FG000|Overall Study|Physician Decision|2|||
42179635|NCT03116698|75987137|FG000|Overall Study|Adverse Event|1|||
42179636|NCT03116698|75987138|FG001|Overall Study|Adverse Event|1|||
42179637|NCT03116698|75987139|FG002|Overall Study|Adverse Event|1|||
42179638|NCT03116698|75987140|FG003|Overall Study|Adverse Event|0|||
42179639|NCT03116698|75987137|FG000|Overall Study|Withdrawal by Subject|1|||
42179640|NCT03116698|75987138|FG001|Overall Study|Withdrawal by Subject|4|||
42179641|NCT03116698|75987139|FG002|Overall Study|Withdrawal by Subject|5|||
42086224|NCT00830063|75896692|FG002|Overall Study|Withdrawal by Subject|16|||
42086225|NCT00830063|75896693|FG003|Overall Study|Withdrawal by Subject|13|||
42086226|NCT00830063|75896690|FG000|Overall Study|Protocol Violation|1|||
42086227|NCT00830063|75896691|FG001|Overall Study|Protocol Violation|0|||
42086228|NCT00830063|75896692|FG002|Overall Study|Protocol Violation|3|||
42086229|NCT00830063|75896693|FG003|Overall Study|Protocol Violation|2|||
42086230|NCT00830063|75896690|FG000|Overall Study|Randomized But Not Treated|0|||
42086231|NCT00830063|75896691|FG001|Overall Study|Randomized But Not Treated|2|||
42086232|NCT00830063|75896692|FG002|Overall Study|Randomized But Not Treated|0|||
42086233|NCT00830063|75896693|FG003|Overall Study|Randomized But Not Treated|2|||
42086234|NCT00750438|75896707|FG000|Overall Study|Protocol Violation|4|||
42086235|NCT00750438|75896708|FG001|Overall Study|Protocol Violation|1|||
42086236|NCT00750438|75896707|FG000|Overall Study|Physician Decision|2|||
42086237|NCT00750438|75896708|FG001|Overall Study|Physician Decision|2|||
42086238|NCT00750438|75896707|FG000|Overall Study|Withdrawal by Subject|1|||
42086239|NCT00750438|75896708|FG001|Overall Study|Withdrawal by Subject|1|||
42179642|NCT03116698|75987140|FG003|Overall Study|Withdrawal by Subject|2|||
42358498|NCT04515147|76204261|FG003|Overall Study|Withdrawal by Subject|18|||
42358499|NCT04515147|76204262|FG004|Overall Study|Withdrawal by Subject|1|||
42086240|NCT00586326|75896714|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
42086241|NCT00586326|75896714|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
42179643|NCT03116698|75987137|FG000|Overall Study|Lost to Follow-up|2|||
42179644|NCT03116698|75987138|FG001|Overall Study|Lost to Follow-up|0|||
42179645|NCT03116698|75987139|FG002|Overall Study|Lost to Follow-up|0|||
42179646|NCT03116698|75987140|FG003|Overall Study|Lost to Follow-up|0|||
42086242|NCT00586326|75896714|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
42086243|NCT00586326|75896714|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
42086244|NCT00586326|75896714|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
42086245|NCT00586326|75896714|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
42086246|NCT00586326|75896714|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
42086247|NCT00586326|75896714|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
42086248|NCT00586326|75896714|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
42086249|NCT00586326|75896714|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
42358500|NCT04515147|76204263|FG005|Overall Study|Withdrawal by Subject|8|||
42358501|NCT04515147|76204258|FG000|Overall Study|Lost to Follow-up|0|||
42358502|NCT04515147|76204259|FG001|Overall Study|Lost to Follow-up|1|||
42179647|NCT03116698|75987137|FG000|Overall Study|Physician Decision|1|||
42179648|NCT03116698|75987138|FG001|Overall Study|Physician Decision|1|||
42086250|NCT00586326|75896714|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
42358503|NCT04515147|76204260|FG002|Overall Study|Lost to Follow-up|5|||
42179649|NCT03116698|75987139|FG002|Overall Study|Physician Decision|0|||
42179650|NCT03116698|75987140|FG003|Overall Study|Physician Decision|0|||
42179651|NCT03116698|75987137|FG000|Overall Study|Protocol Violation|1|||
42179652|NCT03116698|75987138|FG001|Overall Study|Protocol Violation|0|||
42179653|NCT03116698|75987139|FG002|Overall Study|Protocol Violation|0|||
42179654|NCT03116698|75987140|FG003|Overall Study|Protocol Violation|0|||
42179655|NCT03116698|75987137|FG000|Overall Study|Death|0|||
42179656|NCT03116698|75987138|FG001|Overall Study|Death|0|||
42179657|NCT03116698|75987139|FG002|Overall Study|Death|2|||
42179658|NCT03116698|75987140|FG003|Overall Study|Death|0|||
42179659|NCT03116152|75987152|FG000|Overall Study|Disease Progression|49|||
42179660|NCT03116152|75987153|FG001|Overall Study|Disease Progression|47|||
42179661|NCT03116152|75987152|FG000|Overall Study|Death|5|||
42179662|NCT03116152|75987153|FG001|Overall Study|Death|2|||
42179663|NCT03116152|75987152|FG000|Overall Study|Adverse Event|21|||
42179664|NCT03116152|75987153|FG001|Overall Study|Adverse Event|7|||
42179665|NCT03116152|75987152|FG000|Overall Study|Protocol Violation|2|||
42179666|NCT03116152|75987153|FG001|Overall Study|Protocol Violation|2|||
42179667|NCT03116152|75987152|FG000|Overall Study|Withdrawal by Subject|0|||
42179668|NCT03116152|75987153|FG001|Overall Study|Withdrawal by Subject|1|||
42179669|NCT03116152|75987152|FG000|Overall Study|Physician Decision|3|||
42179670|NCT03116152|75987153|FG001|Overall Study|Physician Decision|2|||
42358504|NCT04515147|76204261|FG003|Overall Study|Lost to Follow-up|6|||
42358505|NCT04515147|76204262|FG004|Overall Study|Lost to Follow-up|2|||
42358506|NCT04515147|76204263|FG005|Overall Study|Lost to Follow-up|1|||
42358507|NCT04515147|76204258|FG000|Overall Study|Adverse Event|0|||
42358508|NCT04515147|76204259|FG001|Overall Study|Adverse Event|0|||
42358509|NCT04515147|76204260|FG002|Overall Study|Adverse Event|0|||
42358510|NCT04515147|76204261|FG003|Overall Study|Adverse Event|2|||
42358511|NCT04515147|76204262|FG004|Overall Study|Adverse Event|0|||
42086251|NCT00586326|75896714|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
42086252|NCT00586326|75896714|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
42086253|NCT00586326|75896714|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
42086254|NCT00586326|75896714|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
42086255|NCT00586326|75896714|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
42086256|NCT00586326|75896714|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
42086257|NCT00751101|75896724|FG000|Overall Study|Withdrawal by Subject|1|||
42086258|NCT00751101|75896725|FG001|Overall Study|Withdrawal by Subject|0|||
42179671|NCT03116152|75987152|FG000|Overall Study|other|11|||
42179672|NCT03116152|75987153|FG001|Overall Study|other|34|||
42358512|NCT04515147|76204263|FG005|Overall Study|Adverse Event|0|||
42179673|NCT00226499|75987164|FG000|Overall Study|Adverse Event|10|||
42179674|NCT00226499|75987165|FG001|Overall Study|Adverse Event|6|||
42179675|NCT00226499|75987166|FG002|Overall Study|Adverse Event|3|||
42358513|NCT04515147|76204258|FG000|Overall Study|Miscellaneous|0|||
42358514|NCT04515147|76204259|FG001|Overall Study|Miscellaneous|0|||
42358515|NCT04515147|76204260|FG002|Overall Study|Miscellaneous|0|||
42358516|NCT04515147|76204261|FG003|Overall Study|Miscellaneous|1|||
42179676|NCT00226499|75987164|FG000|Overall Study|Others|1064|||
42179677|NCT00226499|75987165|FG001|Overall Study|Others|1066|||
42086259|NCT00751101|75896724|FG000|Overall Study|No HFS / Never Started Patch/|0|||
42086260|NCT00751101|75896725|FG001|Overall Study|No HFS / Never Started Patch/|4|||
42086261|NCT00751101|75896724|FG000|Overall Study|Never began capecitabine|1|||
42086262|NCT00751101|75896725|FG001|Overall Study|Never began capecitabine|0|||
42086263|NCT00751101|75896724|FG000|Overall Study|Physician Decision|0|||
42086264|NCT00751101|75896725|FG001|Overall Study|Physician Decision|1|||
42086265|NCT00750204|75896737|FG000|Overall Study|study halted prematurely|1|||
42086266|NCT00750204|75896738|FG001|Overall Study|study halted prematurely|1|||
42086267|NCT00751023|75896746|FG000|Overall Study|Lost to Follow-up|11|||
42086268|NCT00751023|75896747|FG001|Overall Study|Lost to Follow-up|7|||
42086269|NCT00591773|75896756|FG000|Overall Study|Adverse Event|9|||
42086270|NCT00591773|75896757|FG001|Overall Study|Adverse Event|9|||
42086271|NCT00591773|75896758|FG002|Overall Study|Adverse Event|6|||
42086272|NCT00591773|75896756|FG000|Overall Study|Protocol Violation|2|||
42086273|NCT00591773|75896757|FG001|Overall Study|Protocol Violation|3|||
42086274|NCT00591773|75896758|FG002|Overall Study|Protocol Violation|0|||
42086275|NCT00591773|75896756|FG000|Overall Study|Lost to Follow-up|1|||
42086276|NCT00591773|75896757|FG001|Overall Study|Lost to Follow-up|4|||
42086277|NCT00591773|75896758|FG002|Overall Study|Lost to Follow-up|1|||
42086278|NCT00591773|75896756|FG000|Overall Study|Withdrawal by Subject|2|||
42086279|NCT00591773|75896757|FG001|Overall Study|Withdrawal by Subject|5|||
42086280|NCT00591773|75896758|FG002|Overall Study|Withdrawal by Subject|3|||
42086281|NCT00591773|75896756|FG000|Overall Study|Lack of Efficacy|1|||
42086282|NCT00591773|75896757|FG001|Overall Study|Lack of Efficacy|2|||
42086283|NCT00591773|75896758|FG002|Overall Study|Lack of Efficacy|2|||
42086284|NCT00591773|75896756|FG000|Overall Study|Other|1|||
42086285|NCT00591773|75896757|FG001|Overall Study|Other|1|||
42086286|NCT00591773|75896758|FG002|Overall Study|Other|4|||
42086287|NCT00750867|75896766|FG000|Overall Study|Adverse Event|2|||
42086288|NCT00744042|75896770|FG000|Overall Study|Withdrawal by Subject|1|||
42086289|NCT00829829|75896783|FG000|Overall Study|Protocol Violation|0|||
42086290|NCT00829829|75896784|FG001|Overall Study|Protocol Violation|3|||
42086291|NCT00829829|75896785|FG002|Overall Study|Protocol Violation|0|||
42179678|NCT00226499|75987166|FG002|Overall Study|Others|356|||
42179679|NCT01400776|75987180|FG000|Overall Study|Adverse Event|7|||
42179680|NCT01400776|75987181|FG001|Overall Study|Adverse Event|2|||
42179681|NCT01400776|75987182|FG002|Overall Study|Adverse Event|9|||
42179682|NCT01400776|75987183|FG003|Overall Study|Adverse Event|2|||
42179683|NCT01400776|75987180|FG000|Overall Study|Lost to Follow-up|1|||
42179684|NCT01400776|75987181|FG001|Overall Study|Lost to Follow-up|0|||
42179685|NCT01400776|75987182|FG002|Overall Study|Lost to Follow-up|4|||
42179686|NCT01400776|75987183|FG003|Overall Study|Lost to Follow-up|1|||
42179687|NCT01400776|75987180|FG000|Overall Study|Withdrew Consent|4|||
42179688|NCT01400776|75987181|FG001|Overall Study|Withdrew Consent|2|||
42179689|NCT01400776|75987182|FG002|Overall Study|Withdrew Consent|6|||
42179690|NCT01400776|75987183|FG003|Overall Study|Withdrew Consent|1|||
42179691|NCT01400776|75987180|FG000|Overall Study|Protocol Deviation|6|||
42179692|NCT01400776|75987181|FG001|Overall Study|Protocol Deviation|1|||
42179693|NCT01400776|75987182|FG002|Overall Study|Protocol Deviation|5|||
42179694|NCT01400776|75987183|FG003|Overall Study|Protocol Deviation|2|||
42179695|NCT01400776|75987180|FG000|Overall Study|Reason not Specified|3|||
42179696|NCT01400776|75987181|FG001|Overall Study|Reason not Specified|0|||
42179697|NCT01400776|75987182|FG002|Overall Study|Reason not Specified|4|||
42179698|NCT01400776|75987183|FG003|Overall Study|Reason not Specified|3|||
42179699|NCT03131596|75987195|FG000|Overall Study|Protocol Violation|3|||
42179700|NCT03131596|75987196|FG001|Overall Study|Protocol Violation|3|||
42179701|NCT03131596|75987195|FG000|Overall Study|Lost to Follow-up|3|||
42179702|NCT03131596|75987196|FG001|Overall Study|Lost to Follow-up|0|||
42179703|NCT00255047|75987210|FG000|Overall Study|Serious Adverse Events|2|||
42179704|NCT00255047|75987211|FG001|Overall Study|Serious Adverse Events|1|||
42179705|NCT00255047|75987212|FG002|Overall Study|Serious Adverse Events|2|||
42179706|NCT00255047|75987213|FG003|Overall Study|Serious Adverse Events|1|||
42086292|NCT00829829|75896783|FG000|Overall Study|Adverse Event|4|||
42086293|NCT00829829|75896784|FG001|Overall Study|Adverse Event|4|||
42086294|NCT00829829|75896785|FG002|Overall Study|Adverse Event|3|||
42086295|NCT00829829|75896783|FG000|Overall Study|Withdrawal by Subject|8|||
42086296|NCT00829829|75896784|FG001|Overall Study|Withdrawal by Subject|4|||
42086297|NCT00829829|75896785|FG002|Overall Study|Withdrawal by Subject|2|||
42086298|NCT00829829|75896783|FG000|Overall Study|Decision by the Sponsor|1|||
42086299|NCT00829829|75896784|FG001|Overall Study|Decision by the Sponsor|0|||
42179707|NCT00255047|75987210|FG000|Overall Study|Adverse Event|0|||
42179708|NCT00255047|75987211|FG001|Overall Study|Adverse Event|3|||
42179709|NCT00255047|75987212|FG002|Overall Study|Adverse Event|2|||
42179710|NCT00255047|75987213|FG003|Overall Study|Adverse Event|1|||
42179711|NCT00255047|75987210|FG000|Overall Study|Protocol Violation|13|||
42179712|NCT00255047|75987211|FG001|Overall Study|Protocol Violation|13|||
42179713|NCT00255047|75987212|FG002|Overall Study|Protocol Violation|16|||
42179714|NCT00255047|75987213|FG003|Overall Study|Protocol Violation|20|||
42179715|NCT00255047|75987210|FG000|Overall Study|Lost to Follow-up|9|||
42179716|NCT00255047|75987211|FG001|Overall Study|Lost to Follow-up|8|||
42086300|NCT00829829|75896785|FG002|Overall Study|Decision by the Sponsor|2|||
42086301|NCT00829829|75896783|FG000|Overall Study|Lost to Follow-up|7|||
42086302|NCT00829829|75896784|FG001|Overall Study|Lost to Follow-up|3|||
42086303|NCT00829829|75896785|FG002|Overall Study|Lost to Follow-up|3|||
42179717|NCT00255047|75987212|FG002|Overall Study|Lost to Follow-up|5|||
42179718|NCT00255047|75987213|FG003|Overall Study|Lost to Follow-up|6|||
42179719|NCT00255047|75987210|FG000|Overall Study|Withdrawal by Subject|24|||
42179720|NCT00255047|75987211|FG001|Overall Study|Withdrawal by Subject|23|||
42179721|NCT00255047|75987212|FG002|Overall Study|Withdrawal by Subject|25|||
42179722|NCT00255047|75987213|FG003|Overall Study|Withdrawal by Subject|18|||
42086304|NCT00829829|75896783|FG000|Overall Study|Other than specified above|2|||
42086305|NCT00829829|75896784|FG001|Overall Study|Other than specified above|2|||
42086306|NCT00829829|75896785|FG002|Overall Study|Other than specified above|1|||
42086307|NCT00823199|75896794|FG000|Overall Study|Withdrawal by Subject|2|||
42086308|NCT00829439|75896799|FG000|Overall Study|Adverse Event|0|||
42086309|NCT00829439|75896800|FG001|Overall Study|Adverse Event|0|||
42086310|NCT00829439|75896801|FG002|Overall Study|Adverse Event|1|||
42086311|NCT00829439|75896802|FG003|Overall Study|Adverse Event|0|||
42086312|NCT00749775|75896806|FG000|Overall Study|Protocol Violation|24|||
42086313|NCT00749775|75896806|FG000|Overall Study|Lost to Follow-up|36|||
42086314|NCT00749775|75896806|FG000|Overall Study|No visit after first day of treatment|44|||
42086315|NCT00749775|75896806|FG000|Overall Study|No drug administration|3|||
42086316|NCT00829283|75896822|FG000|Overall Study|Lost to Follow-up|7|||
42086317|NCT00829283|75896823|FG001|Overall Study|Lost to Follow-up|25|||
42086318|NCT00821873|75896829|FG000|Overall Study|Lost to Follow-up|4|||
42086319|NCT00749463|75896836|FG000|Overall Study|Adverse Event|0|||
42086320|NCT00749463|75896837|FG001|Overall Study|Adverse Event|4|||
42086321|NCT00749463|75896838|FG002|Overall Study|Adverse Event|1|||
42086322|NCT00749463|75896836|FG000|Overall Study|Withdrawal by Subject|1|||
42086323|NCT00749463|75896837|FG001|Overall Study|Withdrawal by Subject|0|||
42086324|NCT00749463|75896838|FG002|Overall Study|Withdrawal by Subject|0|||
42086325|NCT00821327|75896846|FG000|Overall Study|Adverse Event|13|||
42086326|NCT00821327|75896846|FG000|Overall Study|Patient Request|1|||
42086327|NCT00821327|75896846|FG000|Overall Study|Investigator Request|2|||
42086328|NCT00821327|75896846|FG000|Overall Study|Sponsor Request|1|||
42086329|NCT00821327|75896846|FG000|Overall Study|Disease Progression|13|||
42086330|NCT00821327|75896846|FG000|Overall Study|Other/Unknown|5|||
42086331|NCT00821093|75896852|FG000|Overall Study|Adverse Event|20|||
42086332|NCT00821093|75896853|FG001|Overall Study|Adverse Event|12|||
42086333|NCT00821093|75896852|FG000|Overall Study|Withdrawal by Subject|9|||
42086334|NCT00821093|75896853|FG001|Overall Study|Withdrawal by Subject|13|||
42086335|NCT00821093|75896852|FG000|Overall Study|Lost to Follow-up|9|||
42086336|NCT00821093|75896853|FG001|Overall Study|Lost to Follow-up|3|||
42086337|NCT00821093|75896852|FG000|Overall Study|Protocol deviation|3|||
42086338|NCT00821093|75896853|FG001|Overall Study|Protocol deviation|6|||
42086339|NCT00821093|75896852|FG000|Overall Study|Abnormal laboratory value(s)|2|||
42086340|NCT00821093|75896853|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42086341|NCT00821093|75896852|FG000|Overall Study|Lack of Efficacy|2|||
42086342|NCT00821093|75896853|FG001|Overall Study|Lack of Efficacy|2|||
42086343|NCT00821093|75896852|FG000|Overall Study|Death|2|||
42086344|NCT00821093|75896853|FG001|Overall Study|Death|1|||
42086345|NCT00821093|75896852|FG000|Overall Study|Abnormal test procedure result(s)|1|||
42086346|NCT00821093|75896853|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42086347|NCT00821093|75896852|FG000|Overall Study|Administrative problems|1|||
42086348|NCT00821093|75896853|FG001|Overall Study|Administrative problems|2|||
42086349|NCT00821015|75896859|FG000|Overall Study|Lost to Follow-up|12|||
42086350|NCT00814463|75896863|FG000|Overall Study|Lost to Follow-up|1|||
42086351|NCT00743652|75896873|FG000|Overall Study|Parent/Legal Guardian Request|3|||
42086352|NCT00743652|75896874|FG001|Overall Study|Parent/Legal Guardian Request|2|||
42086353|NCT00743652|75896875|FG002|Overall Study|Parent/Legal Guardian Request|2|||
42086354|NCT00743652|75896876|FG003|Overall Study|Parent/Legal Guardian Request|2|||
42086355|NCT00743652|75896877|FG004|Overall Study|Parent/Legal Guardian Request|0|||
42086356|NCT00743652|75896873|FG000|Overall Study|Adverse Event|3|||
42086357|NCT00743652|75896874|FG001|Overall Study|Adverse Event|0|||
42179723|NCT00225251|75987225|FG000|Overall Study|Withdrawal by Subject|1|||
42086358|NCT00743652|75896875|FG002|Overall Study|Adverse Event|0|||
42086359|NCT00743652|75896876|FG003|Overall Study|Adverse Event|0|||
42086360|NCT00743652|75896877|FG004|Overall Study|Adverse Event|0|||
42086361|NCT00743652|75896873|FG000|Overall Study|Death|2|||
42086362|NCT00743652|75896874|FG001|Overall Study|Death|0|||
42086363|NCT00743652|75896875|FG002|Overall Study|Death|0|||
42179724|NCT00225251|75987226|FG001|Overall Study|Withdrawal by Subject|1|||
42179725|NCT00254501|75987234|FG000|Overall Study|Lost to Follow-up|1|||
42179726|NCT00254501|75987235|FG001|Overall Study|Lost to Follow-up|1|||
42179727|NCT00253643|75987247|FG000|Overall Study|Withdrawal by Subject|0|||
42179728|NCT00253643|75987248|FG001|Overall Study|Withdrawal by Subject|0|||
42179729|NCT00253643|75987249|FG002|Overall Study|Withdrawal by Subject|1|||
42179730|NCT00253643|75987250|FG003|Overall Study|Withdrawal by Subject|1|||
42179731|NCT00253643|75987247|FG000|Overall Study|Non-Compliance|0|||
42179732|NCT00253643|75987248|FG001|Overall Study|Non-Compliance|0|||
42179733|NCT00253643|75987249|FG002|Overall Study|Non-Compliance|0|||
42179734|NCT00253643|75987250|FG003|Overall Study|Non-Compliance|2|||
42179735|NCT00221195|75987262|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
42179736|NCT00221195|75987263|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
42179737|NCT00221195|75987262|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
42179738|NCT00221195|75987263|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
42179739|NCT00221195|75987262|FG000|Washout Period (Months 7-9)|Death|0|||
42179740|NCT00221195|75987263|FG001|Washout Period (Months 7-9)|Death|1|||
42179741|NCT00221195|75987262|FG000|Therapy 2 (Months 10-15)|Death|1|||
42179742|NCT00221195|75987263|FG001|Therapy 2 (Months 10-15)|Death|0|||
42179743|NCT00221195|75987262|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
42179744|NCT00221195|75987263|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
42086364|NCT00743652|75896876|FG003|Overall Study|Death|0|||
42086365|NCT00743652|75896877|FG004|Overall Study|Death|0|||
42179745|NCT00220805|75987272|FG000|Overall Study|Adverse Event|1|||
42179746|NCT00220805|75987273|FG001|Overall Study|Adverse Event|3|||
42179747|NCT00220805|75987272|FG000|Overall Study|Withdrawal by Subject|3|||
42179748|NCT00220805|75987273|FG001|Overall Study|Withdrawal by Subject|0|||
42179749|NCT00220805|75987272|FG000|Overall Study|Lack of Efficacy|1|||
42179750|NCT00220805|75987273|FG001|Overall Study|Lack of Efficacy|0|||
42179751|NCT00220805|75987272|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
42179752|NCT00220805|75987273|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
42179753|NCT00220727|75987281|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
42179754|NCT00220727|75987282|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
42179755|NCT03971357|75987292|FG000|Overall Study|Lack of Efficacy|0|||
42179756|NCT03971357|75987293|FG001|Overall Study|Lack of Efficacy|1|||
42179757|NCT04310566|75987299|FG000|Period 1|Study Termination due to COVID-19|15|||
42179758|NCT04310566|75987300|FG001|Period 1|Study Termination due to COVID-19|17|||
42179759|NCT04310566|75987299|FG000|Period 1|Protocol Violation|0|||
42179760|NCT04310566|75987300|FG001|Period 1|Protocol Violation|1|||
42179761|NCT04310566|75987299|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
42179762|NCT04310566|75987300|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
42358517|NCT04515147|76204262|FG004|Overall Study|Miscellaneous|0|||
42358518|NCT04515147|76204263|FG005|Overall Study|Miscellaneous|1|||
42358519|NCT04479618|76204285|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
42086366|NCT00743652|75896873|FG000|Overall Study|Investigator Request|0|||
42086367|NCT00743652|75896874|FG001|Overall Study|Investigator Request|0|||
42086368|NCT00743652|75896875|FG002|Overall Study|Investigator Request|0|||
42086369|NCT00743652|75896876|FG003|Overall Study|Investigator Request|2|||
42086370|NCT00743652|75896877|FG004|Overall Study|Investigator Request|0|||
42086371|NCT00743652|75896873|FG000|Overall Study|Other|1|||
42086372|NCT00743652|75896874|FG001|Overall Study|Other|1|||
42086373|NCT00743652|75896875|FG002|Overall Study|Other|0|||
42086374|NCT00743652|75896876|FG003|Overall Study|Other|0|||
42086375|NCT00743652|75896877|FG004|Overall Study|Other|0|||
42086376|NCT00743652|75896873|FG000|Overall Study|Lost to Follow-up|1|||
42086377|NCT00743652|75896874|FG001|Overall Study|Lost to Follow-up|0|||
42086378|NCT00743652|75896875|FG002|Overall Study|Lost to Follow-up|0|||
42086379|NCT00743652|75896876|FG003|Overall Study|Lost to Follow-up|0|||
42086380|NCT00743652|75896877|FG004|Overall Study|Lost to Follow-up|0|||
42086381|NCT00748215|75896895|FG000|Overall Study|Withdrawal by Subject|7|||
42086382|NCT00748215|75896896|FG001|Overall Study|Withdrawal by Subject|7|||
42086383|NCT00748215|75896895|FG000|Overall Study|Treatment change|2|||
42086384|NCT00748215|75896896|FG001|Overall Study|Treatment change|1|||
42179763|NCT04310566|75987299|FG000|Period 1|Lost to Follow-up|1|||
42179764|NCT04310566|75987300|FG001|Period 1|Lost to Follow-up|0|||
42179765|NCT04310566|75987299|FG000|Period 1|Withdrawal by Subject|0|||
42179766|NCT04310566|75987300|FG001|Period 1|Withdrawal by Subject|1|||
42179767|NCT04310566|75987299|FG000|Period 2|Study Termination|7|||
42179768|NCT04310566|75987300|FG001|Period 2|Study Termination|5|||
42086385|NCT00748215|75896895|FG000|Overall Study|Change in patient condition|0|||
42086386|NCT00748215|75896896|FG001|Overall Study|Change in patient condition|3|||
42086387|NCT00748215|75896895|FG000|Overall Study|Non-compliant|0|||
42086388|NCT00748215|75896896|FG001|Overall Study|Non-compliant|2|||
42179769|NCT00252239|75987310|FG000|Overall Study|Withdrawal by Subject|1|||
42358520|NCT04479618|76204286|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
42358521|NCT04479618|76204287|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
42358522|NCT04479618|76204285|FG000|Overall Study|Lack of Efficacy|1|||
42358523|NCT04479618|76204286|FG001|Overall Study|Lack of Efficacy|0|||
42358524|NCT04479618|76204287|FG002|Overall Study|Lack of Efficacy|0|||
42358525|NCT04479618|76204285|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
42358526|NCT04479618|76204286|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
42358527|NCT04479618|76204287|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
42358528|NCT04479618|76204285|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
42358529|NCT04479618|76204286|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
42358530|NCT04479618|76204287|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
42086389|NCT00748215|75896895|FG000|Overall Study|Adverse Event|0|||
42086390|NCT00748215|75896896|FG001|Overall Study|Adverse Event|5|||
42086391|NCT00749892|75896902|FG000|Overall Study|Withdrawal by Subject|3|||
42086392|NCT00749580|75896908|FG000|Overall Study|Lost to Follow-up|4|||
42086393|NCT00749580|75896909|FG001|Overall Study|Lost to Follow-up|8|||
42086394|NCT00749580|75896908|FG000|Overall Study|Adverse Event|0|||
42086395|NCT00749580|75896909|FG001|Overall Study|Adverse Event|1|||
42086396|NCT00747006|75896918|FG000|Overall Study|Adverse Event|1|||
42086397|NCT00747006|75896919|FG001|Overall Study|Adverse Event|0|||
42086398|NCT00747006|75896920|FG002|Overall Study|Adverse Event|0|||
42086399|NCT00747006|75896918|FG000|Overall Study|Lost to Follow-up|0|||
42086400|NCT00747006|75896919|FG001|Overall Study|Lost to Follow-up|1|||
42086401|NCT00747006|75896920|FG002|Overall Study|Lost to Follow-up|0|||
42086402|NCT00747006|75896918|FG000|Overall Study|Physician Decision|2|||
42086403|NCT00747006|75896919|FG001|Overall Study|Physician Decision|0|||
42086404|NCT00747006|75896920|FG002|Overall Study|Physician Decision|1|||
42086405|NCT00743340|75896931|FG000|Overall Study|Study medication non-compliance|1|||
42086406|NCT00743340|75896931|FG000|Overall Study|Lost to Follow-up|1|||
42086407|NCT00743340|75896931|FG000|Overall Study|Withdrawal from the Study|5|||
42086408|NCT00743340|75896931|FG000|Overall Study|Protocol Violation|1|||
42358531|NCT04479618|76204285|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
42358532|NCT04479618|76204286|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
42358533|NCT04479618|76204287|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
42358534|NCT04479618|76204285|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
42358535|NCT04479618|76204286|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
42358536|NCT04479618|76204287|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
42358537|NCT04476043|76204302|FG000|Overall Study|Withdrawal by Subject|1|||
42358538|NCT04476043|76204303|FG001|Overall Study|Withdrawal by Subject|3|||
42358539|NCT04476043|76204304|FG002|Overall Study|Withdrawal by Subject|4|||
42358540|NCT04476043|76204305|FG003|Overall Study|Withdrawal by Subject|1|||
42358541|NCT04476043|76204302|FG000|Overall Study|Lost to Follow-up|1|||
42358542|NCT04476043|76204303|FG001|Overall Study|Lost to Follow-up|1|||
42086409|NCT00743340|75896931|FG000|Overall Study|Virologic failure|8|||
42086410|NCT00743340|75896931|FG000|Overall Study|Pregnancy|1|||
42086411|NCT00743340|75896931|FG000|Overall Study|Rolled over to other Gilead Study|23|||
42086412|NCT00743340|75896931|FG000|Overall Study|Participant Relocated|1|||
42086413|NCT00749190|75896942|FG000|Overall Study|Adverse Event|0|||
42086414|NCT00749190|75896943|FG001|Overall Study|Adverse Event|2|||
42086415|NCT00749190|75896944|FG002|Overall Study|Adverse Event|0|||
42086416|NCT00749190|75896945|FG003|Overall Study|Adverse Event|4|||
42086417|NCT00749190|75896946|FG004|Overall Study|Adverse Event|0|||
42086418|NCT00749190|75896947|FG005|Overall Study|Adverse Event|3|||
42086419|NCT00749190|75896948|FG006|Overall Study|Adverse Event|0|||
42086420|NCT00749190|75896942|FG000|Overall Study|Lack of Efficacy|3|||
42086421|NCT00749190|75896943|FG001|Overall Study|Lack of Efficacy|1|||
42086422|NCT00749190|75896944|FG002|Overall Study|Lack of Efficacy|1|||
42086423|NCT00749190|75896945|FG003|Overall Study|Lack of Efficacy|0|||
42086424|NCT00749190|75896946|FG004|Overall Study|Lack of Efficacy|0|||
42086425|NCT00749190|75896947|FG005|Overall Study|Lack of Efficacy|1|||
42179770|NCT00252239|75987311|FG001|Overall Study|Withdrawal by Subject|0|||
42179771|NCT00252239|75987312|FG002|Overall Study|Withdrawal by Subject|0|||
42086426|NCT00749190|75896948|FG006|Overall Study|Lack of Efficacy|0|||
42086427|NCT00749190|75896942|FG000|Overall Study|Withdrawal by Subject|2|||
42086428|NCT00749190|75896943|FG001|Overall Study|Withdrawal by Subject|1|||
42086429|NCT00749190|75896944|FG002|Overall Study|Withdrawal by Subject|0|||
42086430|NCT00749190|75896945|FG003|Overall Study|Withdrawal by Subject|0|||
42086431|NCT00749190|75896946|FG004|Overall Study|Withdrawal by Subject|0|||
42086432|NCT00749190|75896947|FG005|Overall Study|Withdrawal by Subject|1|||
42179772|NCT00252239|75987313|FG003|Overall Study|Withdrawal by Subject|1|||
42086433|NCT00749190|75896948|FG006|Overall Study|Withdrawal by Subject|0|||
42086434|NCT00749190|75896942|FG000|Overall Study|Protocol Violation|0|||
42086435|NCT00749190|75896943|FG001|Overall Study|Protocol Violation|1|||
42086436|NCT00749190|75896944|FG002|Overall Study|Protocol Violation|0|||
42086437|NCT00749190|75896945|FG003|Overall Study|Protocol Violation|0|||
42086438|NCT00749190|75896946|FG004|Overall Study|Protocol Violation|0|||
42086439|NCT00749190|75896947|FG005|Overall Study|Protocol Violation|0|||
42086440|NCT00749190|75896948|FG006|Overall Study|Protocol Violation|1|||
42086441|NCT00749190|75896942|FG000|Overall Study|Other reason not defined above|0|||
42086442|NCT00749190|75896943|FG001|Overall Study|Other reason not defined above|0|||
42086443|NCT00749190|75896944|FG002|Overall Study|Other reason not defined above|0|||
42086444|NCT00749190|75896945|FG003|Overall Study|Other reason not defined above|1|||
42086445|NCT00749190|75896946|FG004|Overall Study|Other reason not defined above|0|||
42086446|NCT00749190|75896947|FG005|Overall Study|Other reason not defined above|0|||
42086447|NCT00749190|75896948|FG006|Overall Study|Other reason not defined above|0|||
42086448|NCT00748566|75896969|FG000|Overall Study|Adverse Event|49|||
42086449|NCT00748566|75896969|FG000|Overall Study|Death|1|||
42086450|NCT00748566|75896969|FG000|Overall Study|Lack of Efficacy|12|||
42086451|NCT00748566|75896969|FG000|Overall Study|Lost to Follow-up|1|||
42086452|NCT00748566|75896969|FG000|Overall Study|Protocol Violation|13|||
42086453|NCT00748566|75896969|FG000|Overall Study|Withdrawal by Subject|22|||
42086454|NCT00748566|75896969|FG000|Overall Study|Study terminated by sponsor|5|||
42358543|NCT04476043|76204304|FG002|Overall Study|Lost to Follow-up|2|||
42358544|NCT04476043|76204305|FG003|Overall Study|Lost to Follow-up|1|||
42086455|NCT00748566|75896969|FG000|Overall Study|Other|9|||
42086456|NCT00743106|75896975|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
42086457|NCT00743106|75896976|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
42086458|NCT00738699|75896984|FG000|Overall Study|Withdrawal by Subject|5|||
42086459|NCT00738699|75896985|FG001|Overall Study|Withdrawal by Subject|0|||
42086460|NCT00738699|75896984|FG000|Overall Study|Lost to Follow-up|1|||
42086461|NCT00738699|75896985|FG001|Overall Study|Lost to Follow-up|0|||
42086462|NCT00738699|75896984|FG000|Overall Study|Death|144|||
42086463|NCT00738699|75896985|FG001|Overall Study|Death|68|||
42086464|NCT00738699|75896984|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
42086465|NCT00738699|75896985|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
42086466|NCT00738699|75896984|FG000|Overall Study|Other|2|||
42086467|NCT00738699|75896985|FG001|Overall Study|Other|0|||
42086468|NCT00814307|75896995|FG000|Overall Study|Randomized but not treated|1|||
42086469|NCT00814307|75896996|FG001|Overall Study|Randomized but not treated|0|||
42086470|NCT00814307|75896997|FG002|Overall Study|Randomized but not treated|0|||
42086471|NCT00814307|75896998|FG003|Overall Study|Randomized but not treated|0|||
42086472|NCT00814307|75896995|FG000|Overall Study|Adverse Event|3|||
42086473|NCT00814307|75896996|FG001|Overall Study|Adverse Event|9|||
42086474|NCT00814307|75896997|FG002|Overall Study|Adverse Event|3|||
42086475|NCT00814307|75896998|FG003|Overall Study|Adverse Event|2|||
42086476|NCT00814307|75896995|FG000|Overall Study|Lack of Efficacy|1|||
42086477|NCT00814307|75896996|FG001|Overall Study|Lack of Efficacy|1|||
42086478|NCT00814307|75896997|FG002|Overall Study|Lack of Efficacy|3|||
42086479|NCT00814307|75896998|FG003|Overall Study|Lack of Efficacy|4|||
42086480|NCT00814307|75896995|FG000|Overall Study|Other|1|||
42086481|NCT00814307|75896996|FG001|Overall Study|Other|2|||
42086482|NCT00814307|75896997|FG002|Overall Study|Other|0|||
42086483|NCT00814307|75896998|FG003|Overall Study|Other|1|||
42086484|NCT00814307|75896995|FG000|Overall Study|Protocol Violation|2|||
42086485|NCT00814307|75896996|FG001|Overall Study|Protocol Violation|8|||
42086486|NCT00814307|75896997|FG002|Overall Study|Protocol Violation|1|||
42086487|NCT00814307|75896998|FG003|Overall Study|Protocol Violation|1|||
42086488|NCT00814307|75896995|FG000|Overall Study|Withdrawal by Subject|4|||
42086489|NCT00814307|75896996|FG001|Overall Study|Withdrawal by Subject|6|||
42086490|NCT00814307|75896997|FG002|Overall Study|Withdrawal by Subject|0|||
42086491|NCT00814307|75896998|FG003|Overall Study|Withdrawal by Subject|2|||
42086492|NCT00814307|75896995|FG000|Overall Study|Death|0|||
42086493|NCT00814307|75896996|FG001|Overall Study|Death|1|||
42358545|NCT04476043|76204302|FG000|Overall Study|Adverse Event|2|||
42086494|NCT00814307|75896997|FG002|Overall Study|Death|0|||
42086495|NCT00814307|75896998|FG003|Overall Study|Death|0|||
42358546|NCT04476043|76204303|FG001|Overall Study|Adverse Event|0|||
42086496|NCT00748098|75897010|FG000|First Treatment Intervention Period|Adverse Event|1|||
42086497|NCT00748098|75897011|FG001|First Treatment Intervention Period|Adverse Event|1|||
42086498|NCT00748098|75897010|FG000|First Treatment Intervention Period|Protocol Violation|1|||
42358547|NCT04476043|76204304|FG002|Overall Study|Adverse Event|1|||
42086499|NCT00748098|75897011|FG001|First Treatment Intervention Period|Protocol Violation|0|||
42086500|NCT00748098|75897010|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
42086501|NCT00748098|75897011|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
42086502|NCT00748098|75897010|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
42086503|NCT00748098|75897011|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
42086504|NCT00748098|75897010|FG000|First Taper Period|Protocol Violation|1|||
42086505|NCT00748098|75897011|FG001|First Taper Period|Protocol Violation|0|||
42086506|NCT00748098|75897010|FG000|First Taper Period|Withdrawal by Subject|2|||
42086507|NCT00748098|75897011|FG001|First Taper Period|Withdrawal by Subject|0|||
42086508|NCT00748098|75897010|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
42086509|NCT00748098|75897011|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
42086510|NCT00748098|75897010|FG000|1-Week Washout Period|Adverse Event|0|||
42086511|NCT00748098|75897011|FG001|1-Week Washout Period|Adverse Event|1|||
42086512|NCT00748098|75897010|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
42086513|NCT00748098|75897011|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
42086514|NCT00748098|75897010|FG000|Second Treatment Intervention Period|Adverse Event|4|||
42086515|NCT00748098|75897011|FG001|Second Treatment Intervention Period|Adverse Event|1|||
42086516|NCT00748098|75897010|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
42086517|NCT00748098|75897011|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
42086518|NCT00748098|75897010|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
42086519|NCT00748098|75897011|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
42086520|NCT00813995|75897020|FG000|Overall Study|Clinical adverse event|9|||
42086521|NCT00813995|75897021|FG001|Overall Study|Clinical adverse event|3|||
42086522|NCT00813995|75897020|FG000|Overall Study|Laboratory adverse event|0|||
42086523|NCT00813995|75897021|FG001|Overall Study|Laboratory adverse event|2|||
42086524|NCT00813995|75897020|FG000|Overall Study|Lack of Efficacy|1|||
42086525|NCT00813995|75897021|FG001|Overall Study|Lack of Efficacy|0|||
42086526|NCT00813995|75897020|FG000|Overall Study|Lost to Follow-up|4|||
42086527|NCT00813995|75897021|FG001|Overall Study|Lost to Follow-up|2|||
42086528|NCT00813995|75897020|FG000|Overall Study|Other reason|2|||
42086529|NCT00813995|75897021|FG001|Overall Study|Other reason|2|||
42086530|NCT00813995|75897020|FG000|Overall Study|Protocol Violation|3|||
42086531|NCT00813995|75897021|FG001|Overall Study|Protocol Violation|2|||
42086532|NCT00813995|75897020|FG000|Overall Study|Subject moved|4|||
42086533|NCT00813995|75897021|FG001|Overall Study|Subject moved|0|||
42086534|NCT00813995|75897020|FG000|Overall Study|Withdrawal by Subject|0|||
42086535|NCT00813995|75897021|FG001|Overall Study|Withdrawal by Subject|5|||
42086536|NCT00737529|75897031|FG000|Overall Study|Disease Progression|95|||
42086537|NCT00737529|75897031|FG000|Overall Study|Adverse Event|24|||
42358548|NCT04476043|76204305|FG003|Overall Study|Adverse Event|0|||
42358549|NCT04476043|76204302|FG000|Overall Study|Protocol Violation|0|||
42358550|NCT04476043|76204303|FG001|Overall Study|Protocol Violation|1|||
42358551|NCT04476043|76204304|FG002|Overall Study|Protocol Violation|0|||
42358552|NCT04476043|76204305|FG003|Overall Study|Protocol Violation|0|||
42358553|NCT04418765|76204318|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
42179773|NCT00252239|75987310|FG000|Overall Study|Lost to Follow-up|0|||
42179774|NCT00252239|75987311|FG001|Overall Study|Lost to Follow-up|0|||
42179775|NCT00252239|75987312|FG002|Overall Study|Lost to Follow-up|2|||
42086538|NCT00737529|75897031|FG000|Overall Study|Withdrawal by Subject|5|||
42086539|NCT00737529|75897031|FG000|Overall Study|Death|4|||
42086540|NCT00737529|75897031|FG000|Overall Study|Protocol Violation|1|||
42086541|NCT00737529|75897031|FG000|Overall Study|Other|4|||
42086542|NCT00813917|75897037|FG000|Overall Study|Adverse Event|0|||
42179776|NCT00252239|75987313|FG003|Overall Study|Lost to Follow-up|0|||
42179777|NCT03103906|75987325|FG000|Overall Study|Adverse Event|2|||
42179778|NCT03103906|75987326|FG001|Overall Study|Adverse Event|3|||
42179779|NCT03103906|75987325|FG000|Overall Study|Other|2|||
42179780|NCT03103906|75987326|FG001|Overall Study|Other|0|||
42179781|NCT04799158|75987336|FG000|Run-In Period|Adverse Event|6|||
42179782|NCT04799158|75987337|FG001|Run-In Period|Adverse Event|0|||
42179783|NCT04799158|75987338|FG002|Run-In Period|Adverse Event|0|||
42179784|NCT04799158|75987339|FG003|Run-In Period|Adverse Event|0|||
42086543|NCT00813917|75897038|FG001|Overall Study|Adverse Event|1|||
42358554|NCT04418765|76204319|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
42086544|NCT00813917|75897037|FG000|Overall Study|Withdrawal by Subject|3|||
42086545|NCT00813917|75897038|FG001|Overall Study|Withdrawal by Subject|4|||
42086546|NCT00813917|75897037|FG000|Overall Study|Lost to Follow-up|3|||
42086547|NCT00813917|75897038|FG001|Overall Study|Lost to Follow-up|1|||
42086548|NCT00737061|75897044|FG000|Waiting Period|Lost to Follow-up|6|||
42086549|NCT00737061|75897044|FG000|Waiting Period|Withdrawal by Subject|1|||
42086550|NCT00737061|75897044|FG000|Waiting Period|Bilateral placement failure|34|||
42086551|NCT00737061|75897044|FG000|Waiting Period|Deemed patent following HSG|26|||
42086552|NCT00737061|75897044|FG000|Waiting Period|Alternative contraception failure|3|||
42086553|NCT00737061|75897044|FG000|Waiting Period|Elected surgical tubal ligation|5|||
42086554|NCT00737061|75897044|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
42179785|NCT04799158|75987340|FG004|Run-In Period|Adverse Event|0|||
42179786|NCT04799158|75987336|FG000|Run-In Period|Lost to Follow-up|4|||
42179787|NCT04799158|75987337|FG001|Run-In Period|Lost to Follow-up|0|||
42086555|NCT00737061|75897044|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
42086556|NCT00737061|75897044|FG000|1 Year Wearing Period|Discontinued reilance|3|||
42086557|NCT00737061|75897044|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
42179788|NCT04799158|75987338|FG002|Run-In Period|Lost to Follow-up|0|||
42179789|NCT04799158|75987339|FG003|Run-In Period|Lost to Follow-up|0|||
42179790|NCT04799158|75987340|FG004|Run-In Period|Lost to Follow-up|0|||
42179791|NCT04799158|75987336|FG000|Run-In Period|Significant Protocol Deviation|1|||
42179792|NCT04799158|75987337|FG001|Run-In Period|Significant Protocol Deviation|0|||
42179793|NCT04799158|75987338|FG002|Run-In Period|Significant Protocol Deviation|0|||
42179794|NCT04799158|75987339|FG003|Run-In Period|Significant Protocol Deviation|0|||
42179795|NCT04799158|75987340|FG004|Run-In Period|Significant Protocol Deviation|0|||
42086558|NCT00585975|75897050|FG000|Overall Study|Withdrawal by Subject|3|||
42086559|NCT00585975|75897051|FG001|Overall Study|Withdrawal by Subject|3|||
42086560|NCT00585975|75897050|FG000|Overall Study|Lost to Follow-up|2|||
42179796|NCT04799158|75987336|FG000|Run-In Period|Withdrawal by Subject|11|||
42179797|NCT04799158|75987337|FG001|Run-In Period|Withdrawal by Subject|0|||
42179798|NCT04799158|75987338|FG002|Run-In Period|Withdrawal by Subject|0|||
42179799|NCT04799158|75987339|FG003|Run-In Period|Withdrawal by Subject|0|||
42179800|NCT04799158|75987340|FG004|Run-In Period|Withdrawal by Subject|0|||
42179801|NCT04799158|75987336|FG000|Run-In Period|Miscellaneous|3|||
42179802|NCT04799158|75987337|FG001|Run-In Period|Miscellaneous|0|||
42179803|NCT04799158|75987338|FG002|Run-In Period|Miscellaneous|0|||
42179804|NCT04799158|75987339|FG003|Run-In Period|Miscellaneous|0|||
42179805|NCT04799158|75987340|FG004|Run-In Period|Miscellaneous|0|||
42179806|NCT04799158|75987336|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
42179807|NCT04799158|75987337|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
42179808|NCT04799158|75987338|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
42179809|NCT04799158|75987339|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
42179810|NCT04799158|75987340|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
42179811|NCT04799158|75987336|FG000|On-Demand Treatment Period|Adverse Event|0|||
42179812|NCT04799158|75987337|FG001|On-Demand Treatment Period|Adverse Event|1|||
42179813|NCT04799158|75987338|FG002|On-Demand Treatment Period|Adverse Event|0|||
42179814|NCT04799158|75987339|FG003|On-Demand Treatment Period|Adverse Event|0|||
42179815|NCT04799158|75987340|FG004|On-Demand Treatment Period|Adverse Event|1|||
42179816|NCT04799158|75987336|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
42179817|NCT04799158|75987337|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
42179818|NCT04799158|75987338|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
42017831|NCT01271933|75825557|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
42086561|NCT00585975|75897051|FG001|Overall Study|Lost to Follow-up|1|||
42086562|NCT00585975|75897050|FG000|Overall Study|Enrollment met/over-enrolled|10|||
42086563|NCT00585975|75897051|FG001|Overall Study|Enrollment met/over-enrolled|9|||
42086564|NCT00585585|75897057|FG000|Overall Study|Adverse Event|1|||
42086565|NCT00734097|75897061|FG000|Screening|Protocol Violation|12|||
42086566|NCT00734097|75897061|FG000|Screening|Withdrawal by Subject|5|||
42086567|NCT00734097|75897061|FG000|Screening|Lost to Follow-up|2|||
42086568|NCT00734097|75897061|FG000|Screening|Unconfirmed pregnancy|1|||
42086569|NCT00734097|75897061|FG000|Open Label|Lost to Follow-up|7|||
42086570|NCT00734097|75897061|FG000|Open Label|Withdrawal by Subject|5|||
42086571|NCT00734097|75897061|FG000|Open Label|Protocol Violation|4|||
42086572|NCT00819767|75897067|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42179819|NCT04799158|75987339|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
42179820|NCT04799158|75987340|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
42179821|NCT04799158|75987336|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
42179822|NCT04799158|75987337|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
42017832|NCT01271933|75825555|FG000|Double-Blind Phase|Randomized but not treated|0|||
42017833|NCT01271933|75825556|FG001|Double-Blind Phase|Randomized but not treated|0|||
42017834|NCT01271933|75825557|FG002|Double-Blind Phase|Randomized but not treated|1|||
42017835|NCT01271933|75825555|FG000|Double-Blind Phase|Lack of Efficacy|0|||
42017836|NCT01271933|75825556|FG001|Double-Blind Phase|Lack of Efficacy|6|||
42017837|NCT01271933|75825557|FG002|Double-Blind Phase|Lack of Efficacy|9|||
42017838|NCT01271933|75825555|FG000|Double-Blind Phase|Lost to Follow-up|0|||
42017839|NCT01271933|75825556|FG001|Double-Blind Phase|Lost to Follow-up|1|||
42017840|NCT01271933|75825557|FG002|Double-Blind Phase|Lost to Follow-up|1|||
42017841|NCT01271933|75825555|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
42017842|NCT01271933|75825556|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
42017843|NCT01271933|75825557|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
42017844|NCT01271933|75825555|FG000|Double-Blind Phase|Adverse Event|0|||
42017845|NCT01271933|75825556|FG001|Double-Blind Phase|Adverse Event|3|||
42017846|NCT01271933|75825557|FG002|Double-Blind Phase|Adverse Event|0|||
42017847|NCT01271933|75825555|FG000|Double-Blind Phase|Participant request-personal reason|0|||
42017848|NCT01271933|75825556|FG001|Double-Blind Phase|Participant request-personal reason|1|||
42086573|NCT00819767|75897068|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42179823|NCT04799158|75987338|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
42294328|NCT02477696|76128733|FG001|Overall Study|Lost to Follow-up|5|||
42086574|NCT00733005|75897076|FG000|Overall Study|Adverse Event|0|||
42086575|NCT00733005|75897077|FG001|Overall Study|Adverse Event|1|||
42086576|NCT00733005|75897076|FG000|Overall Study|Treatment Failure|0|||
42086577|NCT00733005|75897077|FG001|Overall Study|Treatment Failure|1|||
42179824|NCT04799158|75987339|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
42179825|NCT04799158|75987340|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
42179826|NCT04799158|75987336|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
42179827|NCT04799158|75987337|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
42179828|NCT04799158|75987338|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
42179829|NCT04799158|75987339|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
42179830|NCT04799158|75987340|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
42179831|NCT04799158|75987336|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
42179832|NCT04799158|75987337|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
42179833|NCT04799158|75987338|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
42179834|NCT04799158|75987339|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
42179835|NCT04799158|75987340|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
42179836|NCT04799158|75987336|FG000|On-Demand Treatment Period|Miscellaneous|0|||
42179837|NCT04799158|75987337|FG001|On-Demand Treatment Period|Miscellaneous|0|||
42179838|NCT04799158|75987338|FG002|On-Demand Treatment Period|Miscellaneous|0|||
42179839|NCT04799158|75987339|FG003|On-Demand Treatment Period|Miscellaneous|0|||
42179840|NCT04799158|75987340|FG004|On-Demand Treatment Period|Miscellaneous|1|||
42179841|NCT01319422|75987353|FG000|Overall Study|Withdrawal by Subject|1|||
42179842|NCT01319422|75987354|FG001|Overall Study|Withdrawal by Subject|0|||
42179843|NCT03102034|75987362|FG000|Overall Study|Withdrawal by Subject|1|||
42179844|NCT03102034|75987363|FG001|Overall Study|Withdrawal by Subject|0|||
42179845|NCT03774576|75987369|FG000|Period 2|Adverse Event|1|||
42179846|NCT02928952|75987380|FG000|Overall Study|Lost to Follow-up|5|||
42179847|NCT02928952|75987381|FG001|Overall Study|Lost to Follow-up|5|||
42179848|NCT02928952|75987380|FG000|Overall Study|Withdrawal by Subject|5|||
42179849|NCT02928952|75987381|FG001|Overall Study|Withdrawal by Subject|1|||
42179850|NCT02928952|75987380|FG000|Overall Study|Physician Decision|0|||
42179851|NCT02928952|75987381|FG001|Overall Study|Physician Decision|1|||
42179852|NCT03773796|75987387|FG000|Overall Study|Adverse Event|1|||
42179853|NCT03773796|75987387|FG000|Overall Study|Withdrawal by Subject|1|||
42179854|NCT03773796|75987387|FG000|Overall Study|Lack of Efficacy|1|||
42179855|NCT02927938|75987395|FG000|Overall Study|Death|0|||
42086578|NCT00733005|75897076|FG000|Overall Study|Withdrawal by Subject|0|||
42086579|NCT00733005|75897077|FG001|Overall Study|Withdrawal by Subject|1|||
42086580|NCT00733005|75897076|FG000|Overall Study|Protocol Violation|2|||
42086581|NCT00733005|75897077|FG001|Overall Study|Protocol Violation|0|||
42086582|NCT00812981|75897085|FG000|Overall Study|Other|0|||
42086583|NCT00812981|75897086|FG001|Overall Study|Other|1|||
42086584|NCT00732615|75897094|FG000|Overall Study|Withdrawal by Subject|3|||
42086585|NCT00732615|75897095|FG001|Overall Study|Withdrawal by Subject|1|||
42086586|NCT00732615|75897094|FG000|Overall Study|Lost to Follow-up|0|||
42086587|NCT00732615|75897095|FG001|Overall Study|Lost to Follow-up|1|||
42086588|NCT00732615|75897094|FG000|Overall Study|Adverse Event|0|||
42086589|NCT00732615|75897095|FG001|Overall Study|Adverse Event|2|||
42086590|NCT00732615|75897094|FG000|Overall Study|Physician Decision|3|||
42086591|NCT00732615|75897095|FG001|Overall Study|Physician Decision|0|||
42086592|NCT00732615|75897094|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
42086593|NCT00732615|75897095|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
42086594|NCT00732381|75897104|FG000|Overall Study|Adverse Event|1|||
42086595|NCT00732381|75897105|FG001|Overall Study|Adverse Event|0|||
42086596|NCT00732381|75897104|FG000|Overall Study|Treatment Failure|1|||
42086597|NCT00732381|75897105|FG001|Overall Study|Treatment Failure|1|||
42086598|NCT00732303|75897111|FG000|Overall Study|Study Terminated|2|||
42086599|NCT00813761|75897117|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
42086600|NCT00813761|75897118|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
42086601|NCT00813761|75897119|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
42086602|NCT00813761|75897120|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
42086603|NCT00813761|75897117|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
42086604|NCT00813761|75897118|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
42179856|NCT02927938|75987396|FG001|Overall Study|Death|1|||
42179857|NCT02927938|75987397|FG002|Overall Study|Death|0|||
42179858|NCT02927938|75987398|FG003|Overall Study|Death|4|||
42179859|NCT02927938|75987395|FG000|Overall Study|Early Study Termination|1|||
42179860|NCT02927938|75987396|FG001|Overall Study|Early Study Termination|5|||
42179861|NCT02927938|75987397|FG002|Overall Study|Early Study Termination|4|||
42179862|NCT02927938|75987398|FG003|Overall Study|Early Study Termination|3|||
42179863|NCT03765138|75987406|FG000|Overall Study|Lost to Follow-up|1|||
42179864|NCT03768726|75987413|FG000|Treatment Phase|Adverse Event|2|||
42179865|NCT03768726|75987414|FG001|Treatment Phase|Adverse Event|2|||
42086605|NCT00813761|75897119|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
42086606|NCT00813761|75897120|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
42086607|NCT00813761|75897117|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
42086608|NCT00813761|75897118|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
42086609|NCT00813761|75897119|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
42086610|NCT00813761|75897120|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
42086611|NCT00813761|75897117|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
42086612|NCT00813761|75897118|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
42086613|NCT00813761|75897119|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
42179866|NCT03768726|75987413|FG000|Treatment Phase|Lost to Follow-up|1|||
42179867|NCT03768726|75987414|FG001|Treatment Phase|Lost to Follow-up|0|||
42179868|NCT03768726|75987413|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
42179869|NCT03768726|75987414|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
42179870|NCT03768726|75987413|FG000|Treatment Phase|Withdrawal by Subject|3|||
42179871|NCT03768726|75987414|FG001|Treatment Phase|Withdrawal by Subject|1|||
42179872|NCT03768726|75987413|FG000|Follow-Up|Adverse Event|2|||
42179873|NCT03768726|75987414|FG001|Follow-Up|Adverse Event|2|||
42179874|NCT03768726|75987413|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
42179875|NCT03768726|75987414|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
42179876|NCT03768726|75987413|FG000|Follow-Up|Withdrawal by Subject|2|||
42179877|NCT03768726|75987414|FG001|Follow-Up|Withdrawal by Subject|0|||
42179878|NCT03768726|75987413|FG000|Follow-Up|Other|1|||
42179879|NCT03768726|75987414|FG001|Follow-Up|Other|0|||
42179880|NCT03769896|75987422|FG000|Open-label Phase|Lack of Efficacy|5|||
42179881|NCT03769896|75987423|FG001|Open-label Phase|Lack of Efficacy|0|||
42179882|NCT03769896|75987422|FG000|Open-label Phase|Adverse Event|3|||
42179883|NCT03769896|75987423|FG001|Open-label Phase|Adverse Event|0|||
42179884|NCT03769896|75987422|FG000|Open-label Phase|Withdrawal by Subject|1|||
42179885|NCT03769896|75987423|FG001|Open-label Phase|Withdrawal by Subject|0|||
42179886|NCT05047601|75987433|FG000|Overall Study|Lost to Follow-up|9|||
42179887|NCT05047601|75987434|FG001|Overall Study|Lost to Follow-up|11|||
42179888|NCT05047601|75987435|FG002|Overall Study|Lost to Follow-up|7|||
42179889|NCT05047601|75987433|FG000|Overall Study|Withdrawal by Subject|25|||
42179890|NCT05047601|75987434|FG001|Overall Study|Withdrawal by Subject|36|||
42179891|NCT05047601|75987435|FG002|Overall Study|Withdrawal by Subject|23|||
42179892|NCT05047601|75987433|FG000|Overall Study|Other|10|||
42179893|NCT05047601|75987434|FG001|Overall Study|Other|6|||
42179894|NCT05047601|75987435|FG002|Overall Study|Other|5|||
42179895|NCT04658784|75987445|FG000|6-month Follow-up|Lost to Follow-up|2|||
42179896|NCT04658784|75987446|FG001|6-month Follow-up|Lost to Follow-up|5|||
42179897|NCT04606394|75987452|FG000|Overall Study|Withdrawal by Subject|3|||
42179898|NCT04606394|75987452|FG000|Overall Study|Exclusion criteria screen failure|12|||
42179899|NCT04585451|75987466|FG000|Overall Study|Withdrawal by Subject|26|||
42179900|NCT04585451|75987467|FG001|Overall Study|Withdrawal by Subject|0|||
42179901|NCT04362189|75987492|FG000|Overall Study|Lost to Follow-up|0|||
42179902|NCT04362189|75987493|FG001|Overall Study|Lost to Follow-up|1|||
42179903|NCT04362189|75987492|FG000|Overall Study|Withdrawal by Subject|1|||
42179904|NCT04362189|75987493|FG001|Overall Study|Withdrawal by Subject|0|||
42179905|NCT04362189|75987492|FG000|Overall Study|FDA Clinical Hold|7|||
42179906|NCT04362189|75987493|FG001|Overall Study|FDA Clinical Hold|2|||
42179907|NCT04362189|75987492|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
42179908|NCT04362189|75987493|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
42086614|NCT00813761|75897120|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
42086615|NCT00813761|75897117|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
42179909|NCT04362189|75987492|FG000|Overall Study|Adverse Event|0|||
42179910|NCT04362189|75987493|FG001|Overall Study|Adverse Event|2|||
42179911|NCT04362189|75987492|FG000|Overall Study|Death|4|||
42179912|NCT04362189|75987493|FG001|Overall Study|Death|1|||
42086616|NCT00813761|75897118|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
42179913|NCT04181788|75987567|FG000|TREATMENT|Adverse Event|0|||
42179914|NCT04181788|75987568|FG001|TREATMENT|Adverse Event|2|||
42179915|NCT04181788|75987569|FG002|TREATMENT|Adverse Event|1|||
42179916|NCT04181788|75987570|FG003|TREATMENT|Adverse Event|0|||
42179917|NCT04181788|75987571|FG004|TREATMENT|Adverse Event|1|||
42179918|NCT04181788|75987572|FG005|TREATMENT|Adverse Event|3|||
42179919|NCT04181788|75987567|FG000|TREATMENT|Death|0|||
42179920|NCT04181788|75987568|FG001|TREATMENT|Death|0|||
42179921|NCT04181788|75987569|FG002|TREATMENT|Death|0|||
42179922|NCT04181788|75987570|FG003|TREATMENT|Death|0|||
42086617|NCT00813761|75897119|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
42179923|NCT04181788|75987571|FG004|TREATMENT|Death|8|||
42179924|NCT04181788|75987572|FG005|TREATMENT|Death|8|||
42086618|NCT00813761|75897120|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
42086619|NCT00813761|75897117|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
42086620|NCT00813761|75897118|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
42086621|NCT00813761|75897119|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
42086622|NCT00813761|75897120|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
42086623|NCT00813761|75897117|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
42086624|NCT00813761|75897118|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
42086625|NCT00813761|75897119|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
42086626|NCT00813761|75897120|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
42179925|NCT04181788|75987567|FG000|TREATMENT|Physician Decision|0|||
42179926|NCT04181788|75987568|FG001|TREATMENT|Physician Decision|0|||
42179927|NCT04181788|75987569|FG002|TREATMENT|Physician Decision|0|||
42179928|NCT04181788|75987570|FG003|TREATMENT|Physician Decision|0|||
42179929|NCT04181788|75987571|FG004|TREATMENT|Physician Decision|0|||
42179930|NCT04181788|75987572|FG005|TREATMENT|Physician Decision|1|||
42179931|NCT04181788|75987567|FG000|TREATMENT|Progressive disease|3|||
42179932|NCT04181788|75987568|FG001|TREATMENT|Progressive disease|3|||
42179933|NCT04181788|75987569|FG002|TREATMENT|Progressive disease|5|||
42179934|NCT04181788|75987570|FG003|TREATMENT|Progressive disease|7|||
42179935|NCT04181788|75987571|FG004|TREATMENT|Progressive disease|20|||
42179936|NCT04181788|75987572|FG005|TREATMENT|Progressive disease|38|||
42179937|NCT04181788|75987567|FG000|TREATMENT|Global deterioration of health status|0|||
42179938|NCT04181788|75987568|FG001|TREATMENT|Global deterioration of health status|2|||
42179939|NCT04181788|75987569|FG002|TREATMENT|Global deterioration of health status|0|||
42179940|NCT04181788|75987570|FG003|TREATMENT|Global deterioration of health status|0|||
42179941|NCT04181788|75987571|FG004|TREATMENT|Global deterioration of health status|2|||
42179942|NCT04181788|75987572|FG005|TREATMENT|Global deterioration of health status|8|||
42179943|NCT04181788|75987567|FG000|TREATMENT|Withdrawal by Subject|1|||
42179944|NCT04181788|75987568|FG001|TREATMENT|Withdrawal by Subject|2|||
42179945|NCT04181788|75987569|FG002|TREATMENT|Withdrawal by Subject|0|||
42179946|NCT04181788|75987570|FG003|TREATMENT|Withdrawal by Subject|0|||
42179947|NCT04181788|75987571|FG004|TREATMENT|Withdrawal by Subject|3|||
42179948|NCT04181788|75987572|FG005|TREATMENT|Withdrawal by Subject|5|||
42179949|NCT04181788|75987567|FG000|TREATMENT|Other unspecified|0|||
42179950|NCT04181788|75987568|FG001|TREATMENT|Other unspecified|0|||
42179951|NCT04181788|75987569|FG002|TREATMENT|Other unspecified|0|||
42179952|NCT04181788|75987570|FG003|TREATMENT|Other unspecified|0|||
42179953|NCT04181788|75987571|FG004|TREATMENT|Other unspecified|0|||
42179954|NCT04181788|75987572|FG005|TREATMENT|Other unspecified|2|||
42017849|NCT01271933|75825557|FG002|Double-Blind Phase|Participant request-personal reason|0|||
42017850|NCT01269125|75825570|FG000|Overall Study|Adverse Event|3|||
42017851|NCT01269125|75825571|FG001|Overall Study|Adverse Event|5|||
42017852|NCT01269125|75825572|FG002|Overall Study|Adverse Event|0|||
42017853|NCT01269125|75825570|FG000|Overall Study|Lost to Follow-up|4|||
42017854|NCT01269125|75825571|FG001|Overall Study|Lost to Follow-up|0|||
42017855|NCT01269125|75825572|FG002|Overall Study|Lost to Follow-up|0|||
42017856|NCT01268891|75825582|FG000|Overall Study|Adverse Event|3|||
42017857|NCT01268891|75825583|FG001|Overall Study|Adverse Event|7|||
42017858|NCT01268891|75825582|FG000|Overall Study|Lack of Efficacy|1|||
42017859|NCT01268891|75825583|FG001|Overall Study|Lack of Efficacy|0|||
42017860|NCT01268891|75825582|FG000|Overall Study|Withdrawal of Consent|3|||
42017861|NCT01268891|75825583|FG001|Overall Study|Withdrawal of Consent|1|||
42017862|NCT01268891|75825582|FG000|Overall Study|Administrative or other reason(s)|1|||
42017863|NCT01268891|75825583|FG001|Overall Study|Administrative or other reason(s)|0|||
42017864|NCT01268501|75825589|FG000|Overall Study|Lost to Follow-up|1|||
42017865|NCT01268501|75825589|FG000|Overall Study|Withdrawal by Subject|3|||
42017866|NCT01268501|75825589|FG000|Overall Study|Unacceptable Subjective Vision|3|||
42017867|NCT01268501|75825589|FG000|Overall Study|Handling Difficulties|2|||
42017868|NCT01268267|75825593|FG000|Overall Study|Protocol Violation|1|||
42017869|NCT01267253|75825598|FG000|Overall Study|Ineligible - required test not done|1|||
42017870|NCT01267253|75825598|FG000|Overall Study|Inevaluable-never received study treatme|2|||
42017871|NCT01266317|75825602|FG000|Overall Study|Withdrawal by Subject|2|||
42017872|NCT01266161|75825608|FG000|Overall Study|Ineligible|1|||
42017873|NCT01266161|75825609|FG001|Overall Study|Ineligible|0|||
42017874|NCT01266161|75825608|FG000|Overall Study|Lack of Efficacy|0|||
42017875|NCT01266161|75825609|FG001|Overall Study|Lack of Efficacy|1|||
42017876|NCT01266161|75825608|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
42017877|NCT01266161|75825609|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
42017878|NCT01265849|75825618|FG000|Overall Study|Randomized//Treatment not initiated|1|||
42017879|NCT01265849|75825619|FG001|Overall Study|Randomized//Treatment not initiated|4|||
42086627|NCT00813761|75897117|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
42086628|NCT00813761|75897118|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
42179955|NCT04181788|75987567|FG000|TREATMENT|Ongoing|0|||
42179956|NCT04181788|75987568|FG001|TREATMENT|Ongoing|3|||
42179957|NCT04181788|75987569|FG002|TREATMENT|Ongoing|0|||
42179958|NCT04181788|75987570|FG003|TREATMENT|Ongoing|5|||
42179959|NCT04181788|75987571|FG004|TREATMENT|Ongoing|7|||
42179960|NCT04181788|75987572|FG005|TREATMENT|Ongoing|15|||
42179961|NCT04181788|75987567|FG000|FOLLOW-UP|Death|0|||
42179962|NCT04181788|75987568|FG001|FOLLOW-UP|Death|0|||
42179963|NCT04181788|75987569|FG002|FOLLOW-UP|Death|1|||
42086629|NCT00813761|75897119|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
42086630|NCT00813761|75897120|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
42086631|NCT00813761|75897117|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
42086632|NCT00813761|75897118|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
42086633|NCT00813761|75897119|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
42086634|NCT00813761|75897120|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
42086635|NCT00813761|75897117|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
42086636|NCT00813761|75897118|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
42086637|NCT00813761|75897119|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
42086638|NCT00813761|75897120|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
42179964|NCT04181788|75987570|FG003|FOLLOW-UP|Death|2|||
42179965|NCT04181788|75987571|FG004|FOLLOW-UP|Death|8|||
42086639|NCT00813761|75897117|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
42086640|NCT00813761|75897118|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
42086641|NCT00813761|75897119|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
42179966|NCT04181788|75987572|FG005|FOLLOW-UP|Death|20|||
42179967|NCT04181788|75987567|FG000|FOLLOW-UP|Lost to Follow-up|0|||
42179968|NCT04181788|75987568|FG001|FOLLOW-UP|Lost to Follow-up|0|||
42179969|NCT04181788|75987569|FG002|FOLLOW-UP|Lost to Follow-up|0|||
42179970|NCT04181788|75987570|FG003|FOLLOW-UP|Lost to Follow-up|0|||
42179971|NCT04181788|75987571|FG004|FOLLOW-UP|Lost to Follow-up|0|||
42179972|NCT04181788|75987572|FG005|FOLLOW-UP|Lost to Follow-up|2|||
42179973|NCT04181788|75987567|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
42179974|NCT04181788|75987568|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
42086642|NCT00813761|75897120|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
42086643|NCT00813761|75897117|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
42086644|NCT00813761|75897118|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
42086645|NCT00813761|75897119|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
42086646|NCT00813761|75897120|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
42086647|NCT00732069|75897136|FG000|Washout After First Study Drug|Adverse Event|1|||
42086648|NCT00732069|75897137|FG001|Washout After First Study Drug|Adverse Event|0|||
42086649|NCT00732069|75897138|FG002|Washout After First Study Drug|Adverse Event|0|||
42086650|NCT00732069|75897139|FG003|Washout After First Study Drug|Adverse Event|0|||
42086651|NCT00732069|75897140|FG004|Washout After First Study Drug|Adverse Event|0|||
42086652|NCT00732069|75897141|FG005|Washout After First Study Drug|Adverse Event|0|||
42086653|NCT00731679|75897151|FG000|Overall Study|Adverse Event|7|||
42086654|NCT00731679|75897152|FG001|Overall Study|Adverse Event|8|||
42086655|NCT00731679|75897151|FG000|Overall Study|Withdrawal by Subject|8|||
42086656|NCT00731679|75897152|FG001|Overall Study|Withdrawal by Subject|8|||
42086657|NCT00731679|75897151|FG000|Overall Study|Lost to Follow-up|7|||
42086658|NCT00731679|75897152|FG001|Overall Study|Lost to Follow-up|8|||
42086659|NCT00731679|75897151|FG000|Overall Study|Noncompliance|0|||
42086660|NCT00731679|75897152|FG001|Overall Study|Noncompliance|1|||
42086661|NCT00731679|75897151|FG000|Overall Study|Pregnancy|0|||
42086662|NCT00731679|75897152|FG001|Overall Study|Pregnancy|1|||
42086663|NCT00731133|75897158|FG000|Overall Study|Withdrawal by Subject|10|||
42086664|NCT00730275|75897166|FG000|Overall Study|Withdrawal by Subject|0|||
42086665|NCT00730275|75897167|FG001|Overall Study|Withdrawal by Subject|0|||
42086666|NCT00730275|75897168|FG002|Overall Study|Withdrawal by Subject|0|||
42086667|NCT00730275|75897169|FG003|Overall Study|Withdrawal by Subject|1|||
42086668|NCT00730041|75897187|FG000|Overall Study|Lost to Follow-up|0|||
42086669|NCT00730041|75897188|FG001|Overall Study|Lost to Follow-up|2|||
42086670|NCT00729651|75897196|FG000|Overall Study|Withdrawal by Subject|5|||
42086671|NCT00729651|75897197|FG001|Overall Study|Withdrawal by Subject|6|||
42086672|NCT00729651|75897196|FG000|Overall Study|Lost to Follow-up|5|||
42086673|NCT00729651|75897197|FG001|Overall Study|Lost to Follow-up|4|||
42179975|NCT04181788|75987569|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
42179976|NCT04181788|75987570|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
42086674|NCT00729651|75897196|FG000|Overall Study|Protocol Violation|0|||
42086675|NCT00729651|75897197|FG001|Overall Study|Protocol Violation|1|||
42086676|NCT00729651|75897196|FG000|Overall Study|Adverse Event|7|||
42086677|NCT00729651|75897197|FG001|Overall Study|Adverse Event|3|||
42086678|NCT00729651|75897196|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
42086679|NCT00729651|75897197|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
42086680|NCT00729651|75897196|FG000|Overall Study|Subject's private reason|2|||
42086681|NCT00729651|75897197|FG001|Overall Study|Subject's private reason|0|||
42086682|NCT00729183|75897205|FG000|Overall Study|Adverse Event|11|||
42086683|NCT00729183|75897206|FG001|Overall Study|Adverse Event|5|||
42086684|NCT00729183|75897205|FG000|Overall Study|Lack of Efficacy|0|||
42086685|NCT00729183|75897206|FG001|Overall Study|Lack of Efficacy|1|||
42086686|NCT00729183|75897205|FG000|Overall Study|Lost to Follow-up|3|||
42179977|NCT04181788|75987571|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
42179978|NCT04181788|75987572|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
42086687|NCT00729183|75897206|FG001|Overall Study|Lost to Follow-up|1|||
42086688|NCT00729183|75897205|FG000|Overall Study|Physician Decision|1|||
42086689|NCT00729183|75897206|FG001|Overall Study|Physician Decision|1|||
42086690|NCT00729183|75897205|FG000|Overall Study|Protocol Violation|1|||
42086691|NCT00729183|75897206|FG001|Overall Study|Protocol Violation|0|||
42086692|NCT00729183|75897205|FG000|Overall Study|Withdrawal by Subject|9|||
42086693|NCT00729183|75897206|FG001|Overall Study|Withdrawal by Subject|7|||
42179979|NCT04181788|75987567|FG000|FOLLOW-UP|Other unspecified|0|||
42086694|NCT00811733|75897214|FG000|Overall Study|Investigator Discretion|10|||
42086695|NCT00811733|75897215|FG001|Overall Study|Investigator Discretion|8|||
42086696|NCT00811733|75897214|FG000|Overall Study|Withdrawal by Subject|1|||
42086697|NCT00811733|75897215|FG001|Overall Study|Withdrawal by Subject|2|||
42086698|NCT00728949|75897223|FG000|Overall Study|Adverse Event|8|||
42086699|NCT00728949|75897224|FG001|Overall Study|Adverse Event|0|||
42086700|NCT00728949|75897223|FG000|Overall Study|Withdrawal by Subject|2|||
42086701|NCT00728949|75897224|FG001|Overall Study|Withdrawal by Subject|2|||
42086702|NCT00728949|75897223|FG000|Overall Study|Abnormal Lab Results|0|||
42086703|NCT00728949|75897224|FG001|Overall Study|Abnormal Lab Results|2|||
42086704|NCT00728949|75897223|FG000|Overall Study|On treatment at cutoff date|1|||
42086705|NCT00728949|75897224|FG001|Overall Study|On treatment at cutoff date|0|||
42086706|NCT00728481|75897232|FG000|Overall Study|Withdrawal by Subject|0|||
42086707|NCT00728481|75897233|FG001|Overall Study|Withdrawal by Subject|1|||
42086708|NCT00728481|75897232|FG000|Overall Study|Adverse Event|0|||
42086709|NCT00728481|75897233|FG001|Overall Study|Adverse Event|1|||
42086710|NCT00728481|75897232|FG000|Overall Study|Study medication non-compliance|0|||
42086711|NCT00728481|75897233|FG001|Overall Study|Study medication non-compliance|2|||
42086712|NCT00728481|75897232|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
42086713|NCT00728481|75897233|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
42086714|NCT00811655|75897239|FG000|Overall Study|Physician Decision|1|||
42086715|NCT00727311|75897243|FG000|Overall Study|Did not receive drug|316|||
42086716|NCT00727311|75897243|FG000|Overall Study|Missing end of therapy data|205|||
42086717|NCT00727311|75897243|FG000|Overall Study|Adverse Event|58|||
42086718|NCT00727311|75897243|FG000|Overall Study|Lack of Efficacy|242|||
42086719|NCT00727311|75897243|FG000|Overall Study|Lost to Follow-up|73|||
42086720|NCT00727311|75897243|FG000|Overall Study|Withdrawal by Subject|77|||
42086721|NCT00727311|75897243|FG000|Overall Study|Other|97|||
42086722|NCT00727311|75897243|FG000|Overall Study|Multiple reasons|39|||
42086723|NCT00726999|75897249|FG000|Overall Study|Physician Decision|0|||
42086724|NCT00726999|75897250|FG001|Overall Study|Physician Decision|1|||
42179980|NCT04181788|75987568|FG001|FOLLOW-UP|Other unspecified|1|||
42179981|NCT04181788|75987569|FG002|FOLLOW-UP|Other unspecified|0|||
42179982|NCT04181788|75987570|FG003|FOLLOW-UP|Other unspecified|0|||
42179983|NCT04181788|75987571|FG004|FOLLOW-UP|Other unspecified|0|||
42179984|NCT04181788|75987572|FG005|FOLLOW-UP|Other unspecified|3|||
42179985|NCT04181788|75987567|FG000|FOLLOW-UP|Ongoing|0|||
42179986|NCT04181788|75987568|FG001|FOLLOW-UP|Ongoing|0|||
42179987|NCT04181788|75987569|FG002|FOLLOW-UP|Ongoing|1|||
42179988|NCT04181788|75987570|FG003|FOLLOW-UP|Ongoing|3|||
42179989|NCT04181788|75987571|FG004|FOLLOW-UP|Ongoing|2|||
42179990|NCT04181788|75987572|FG005|FOLLOW-UP|Ongoing|2|||
42179991|NCT04120194|75987595|FG000|Overall Study|Lost to Follow-up|11|||
42179992|NCT04120194|75987596|FG001|Overall Study|Lost to Follow-up|8|||
42179993|NCT04120194|75987595|FG000|Overall Study|Adverse Event|4|||
42086725|NCT00726999|75897249|FG000|Overall Study|Withdrawal by Subject|2|||
42086726|NCT00726999|75897250|FG001|Overall Study|Withdrawal by Subject|0|||
42086727|NCT00726999|75897249|FG000|Overall Study|Protocol Violation|1|||
42086728|NCT00726999|75897250|FG001|Overall Study|Protocol Violation|0|||
42086729|NCT00585351|75897264|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
42086730|NCT00585351|75897265|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
42086731|NCT00585351|75897266|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
42179994|NCT04120194|75987596|FG001|Overall Study|Adverse Event|5|||
42179995|NCT04120194|75987595|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
42179996|NCT04120194|75987596|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
42179997|NCT04120194|75987595|FG000|Overall Study|Miscellaneous|4|||
42179998|NCT04120194|75987596|FG001|Overall Study|Miscellaneous|5|||
42179999|NCT04050670|75987602|FG000|Period 3|Physician Decision|0|||
42180000|NCT04050670|75987603|FG001|Period 3|Physician Decision|1|||
42180001|NCT04050670|75987604|FG002|Period 3|Physician Decision|0|||
42180002|NCT04016714|75987627|FG000|Overall Study|Death|1|||
42180003|NCT04016714|75987628|FG001|Overall Study|Death|0|||
42086732|NCT00585351|75897267|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
42086733|NCT00585351|75897268|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
42086734|NCT00585351|75897269|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
42086735|NCT00585351|75897270|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
42180004|NCT04016714|75987627|FG000|Overall Study|Lost to Follow-up|3|||
42180005|NCT04016714|75987628|FG001|Overall Study|Lost to Follow-up|1|||
42180006|NCT04016714|75987627|FG000|Overall Study|Physician Decision|3|||
42180007|NCT04016714|75987628|FG001|Overall Study|Physician Decision|3|||
42086736|NCT00585351|75897271|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
42086737|NCT00585351|75897264|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
42086738|NCT00585351|75897265|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
42086739|NCT00585351|75897266|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
42086740|NCT00585351|75897267|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
42086741|NCT00585351|75897268|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
42086742|NCT00585351|75897269|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
42086743|NCT00585351|75897270|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
42086744|NCT00585351|75897271|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
42086745|NCT00585351|75897264|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
42086746|NCT00585351|75897265|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
42180008|NCT04016714|75987627|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
42180009|NCT04016714|75987628|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
42180010|NCT03997409|75987637|FG000|Overall Study|Protocol Violation|1|||
42180011|NCT03997409|75987638|FG001|Overall Study|Protocol Violation|1|||
42180012|NCT03997409|75987639|FG002|Overall Study|Protocol Violation|0|||
42180013|NCT03997409|75987637|FG000|Overall Study|Withdrawal by Subject|3|||
42180014|NCT03997409|75987638|FG001|Overall Study|Withdrawal by Subject|0|||
42180015|NCT03997409|75987639|FG002|Overall Study|Withdrawal by Subject|0|||
42180016|NCT03997409|75987637|FG000|Overall Study|Lost to Follow-up|0|||
42180017|NCT03997409|75987638|FG001|Overall Study|Lost to Follow-up|0|||
42180018|NCT03997409|75987639|FG002|Overall Study|Lost to Follow-up|1|||
42180019|NCT03946124|75987647|FG000|Overall Study|Withdrawal by Subject|19|||
42180020|NCT03812029|75987656|FG000|Overall Study|Protocol Violation|1|||
42180021|NCT03812029|75987657|FG001|Overall Study|Protocol Violation|0|||
42180022|NCT03812029|75987658|FG002|Overall Study|Protocol Violation|0|||
42180023|NCT03812029|75987659|FG003|Overall Study|Protocol Violation|1|||
42180024|NCT03812029|75987660|FG004|Overall Study|Protocol Violation|0|||
42180025|NCT03812029|75987656|FG000|Overall Study|Withdrawal by Subject|1|||
42180026|NCT03812029|75987657|FG001|Overall Study|Withdrawal by Subject|0|||
42180027|NCT03812029|75987658|FG002|Overall Study|Withdrawal by Subject|0|||
42180028|NCT03812029|75987659|FG003|Overall Study|Withdrawal by Subject|2|||
42180029|NCT03812029|75987660|FG004|Overall Study|Withdrawal by Subject|2|||
42180030|NCT03812029|75987656|FG000|Overall Study|Stopping rules|0|||
42180031|NCT03812029|75987657|FG001|Overall Study|Stopping rules|1|||
42180032|NCT03812029|75987658|FG002|Overall Study|Stopping rules|0|||
42180033|NCT03812029|75987659|FG003|Overall Study|Stopping rules|0|||
42180034|NCT03812029|75987660|FG004|Overall Study|Stopping rules|0|||
42180035|NCT03812029|75987656|FG000|Overall Study|Adverse Event|0|||
42180036|NCT03812029|75987657|FG001|Overall Study|Adverse Event|9|||
42180037|NCT03812029|75987658|FG002|Overall Study|Adverse Event|0|||
42180038|NCT03812029|75987659|FG003|Overall Study|Adverse Event|3|||
42180039|NCT03812029|75987660|FG004|Overall Study|Adverse Event|5|||
42180040|NCT03812029|75987656|FG000|Overall Study|Lost to Follow-up|0|||
42086747|NCT00585351|75897266|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
42086748|NCT00585351|75897267|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
42180041|NCT03812029|75987657|FG001|Overall Study|Lost to Follow-up|0|||
42180042|NCT03812029|75987658|FG002|Overall Study|Lost to Follow-up|0|||
42180043|NCT03812029|75987659|FG003|Overall Study|Lost to Follow-up|0|||
42180044|NCT03812029|75987660|FG004|Overall Study|Lost to Follow-up|3|||
42180045|NCT03747575|75987678|FG000|Overall Study|Withdrawal by Subject|6|||
42180046|NCT03747575|75987679|FG001|Overall Study|Withdrawal by Subject|3|||
42180047|NCT03747575|75987678|FG000|Overall Study|Lost to Follow-up|3|||
42180048|NCT03747575|75987679|FG001|Overall Study|Lost to Follow-up|3|||
42180049|NCT03747575|75987678|FG000|Overall Study|Adverse Event|0|||
42086749|NCT00585351|75897268|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
42086750|NCT00585351|75897269|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
42180050|NCT03747575|75987679|FG001|Overall Study|Adverse Event|1|||
42180051|NCT03657043|75987688|FG000|Overall Study|Withdrawal by Subject|1|||
42180052|NCT03657043|75987689|FG001|Overall Study|Withdrawal by Subject|1|||
42180053|NCT03657043|75987690|FG002|Overall Study|Withdrawal by Subject|0|||
42180054|NCT03657043|75987691|FG003|Overall Study|Withdrawal by Subject|0|||
42180055|NCT03657043|75987692|FG004|Overall Study|Withdrawal by Subject|4|||
42180056|NCT03657043|75987688|FG000|Overall Study|Study closure by Sponsor|0|||
42180057|NCT03657043|75987689|FG001|Overall Study|Study closure by Sponsor|2|||
42180058|NCT03657043|75987690|FG002|Overall Study|Study closure by Sponsor|0|||
42180059|NCT03657043|75987691|FG003|Overall Study|Study closure by Sponsor|0|||
42180060|NCT03657043|75987692|FG004|Overall Study|Study closure by Sponsor|17|||
42180061|NCT03657043|75987688|FG000|Overall Study|Lost to Follow-up|0|||
42180062|NCT03657043|75987689|FG001|Overall Study|Lost to Follow-up|0|||
42180063|NCT03657043|75987690|FG002|Overall Study|Lost to Follow-up|0|||
42180064|NCT03657043|75987691|FG003|Overall Study|Lost to Follow-up|0|||
42180065|NCT03657043|75987692|FG004|Overall Study|Lost to Follow-up|4|||
42180066|NCT03657043|75987688|FG000|Overall Study|Death|6|||
42180067|NCT03657043|75987689|FG001|Overall Study|Death|5|||
42180068|NCT03657043|75987690|FG002|Overall Study|Death|0|||
42180069|NCT03657043|75987691|FG003|Overall Study|Death|0|||
42180070|NCT03657043|75987692|FG004|Overall Study|Death|53|||
42180071|NCT03657043|75987688|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
42180072|NCT03657043|75987689|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
42180073|NCT03657043|75987690|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
42180074|NCT03657043|75987691|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
42086751|NCT00585351|75897270|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
42086752|NCT00585351|75897271|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
42086753|NCT00585351|75897264|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
42086754|NCT00585351|75897265|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
42180075|NCT03657043|75987692|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
42180076|NCT03657043|75987688|FG000|Overall Study|Adverse Event|0|||
42180077|NCT03657043|75987689|FG001|Overall Study|Adverse Event|0|||
42180078|NCT03657043|75987690|FG002|Overall Study|Adverse Event|0|||
42180079|NCT03657043|75987691|FG003|Overall Study|Adverse Event|0|||
42180080|NCT03657043|75987692|FG004|Overall Study|Adverse Event|2|||
42180081|NCT03657043|75987688|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
42180082|NCT03657043|75987689|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
42180083|NCT03657043|75987690|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
42180084|NCT03657043|75987691|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
42180085|NCT03657043|75987692|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
42180086|NCT03657043|75987688|FG000|Overall Study|Withdrawal - declined follow-up|0|||
42180087|NCT03657043|75987689|FG001|Overall Study|Withdrawal - declined follow-up|0|||
42180088|NCT03657043|75987690|FG002|Overall Study|Withdrawal - declined follow-up|0|||
42180089|NCT03657043|75987691|FG003|Overall Study|Withdrawal - declined follow-up|0|||
42180090|NCT03657043|75987692|FG004|Overall Study|Withdrawal - declined follow-up|1|||
42180091|NCT03646669|75987702|FG000|Overall Study|Withdrawal by Subject|5|||
42086755|NCT00585351|75897266|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
42086756|NCT00585351|75897267|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
42086757|NCT00585351|75897268|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
42086758|NCT00585351|75897269|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
42086759|NCT00585351|75897270|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
42086760|NCT00585351|75897271|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
42086761|NCT00585351|75897264|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
42086762|NCT00585351|75897265|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
42086763|NCT00585351|75897266|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
42086764|NCT00585351|75897267|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
42086765|NCT00585351|75897268|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
42086766|NCT00585351|75897269|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
42086767|NCT00585351|75897270|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
42086768|NCT00585351|75897271|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
42086769|NCT00585351|75897264|FG000|Enrollment Period (Intervention)|Death|0|||
42086770|NCT00585351|75897265|FG001|Enrollment Period (Intervention)|Death|0|||
42086771|NCT00585351|75897266|FG002|Enrollment Period (Intervention)|Death|0|||
42086772|NCT00585351|75897267|FG003|Enrollment Period (Intervention)|Death|0|||
42086773|NCT00585351|75897268|FG004|Enrollment Period (Intervention)|Death|1|||
42086774|NCT00585351|75897269|FG005|Enrollment Period (Intervention)|Death|0|||
42086775|NCT00585351|75897270|FG006|Enrollment Period (Intervention)|Death|1|||
42086776|NCT00585351|75897271|FG007|Enrollment Period (Intervention)|Death|0|||
42086777|NCT00585351|75897264|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
42086778|NCT00585351|75897265|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
42086779|NCT00585351|75897266|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
42086780|NCT00585351|75897267|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
42086781|NCT00585351|75897268|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
42086782|NCT00585351|75897269|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
42086783|NCT00585351|75897270|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
42086784|NCT00585351|75897271|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
42086785|NCT00726609|75897285|FG000|Overall Study|Adverse Event|10|||
42086786|NCT00726609|75897285|FG000|Overall Study|Withdrawal by Subject|2|||
42180092|NCT03646669|75987703|FG001|Overall Study|Withdrawal by Subject|0|||
42180093|NCT03619876|75987711|FG000|Overall Study|Withdrawal by Subject|1|||
42180094|NCT03619876|75987712|FG001|Overall Study|Withdrawal by Subject|2|||
42180095|NCT03619876|75987711|FG000|Overall Study|Withdrawal due to incidental finding|0|||
42180096|NCT03619876|75987712|FG001|Overall Study|Withdrawal due to incidental finding|2|||
42180097|NCT03526861|75987734|FG000|Initial Treatment Period|Not dosed|1|||
42180098|NCT03526861|75987735|FG001|Initial Treatment Period|Not dosed|1|||
42086787|NCT00726609|75897285|FG000|Overall Study|Lack of Efficacy|25|||
42086788|NCT00726609|75897285|FG000|Overall Study|Other|16|||
42086789|NCT00726609|75897285|FG000|Overall Study|Missing|42|||
42086790|NCT00726609|75897285|FG000|Overall Study|Other|3|||
42086791|NCT00726453|75897291|FG000|Primary Enrollment Group|Death|18|||
42086792|NCT00726453|75897292|FG001|Primary Enrollment Group|Death|0|||
42086793|NCT00726453|75897291|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
42086794|NCT00726453|75897292|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
42086795|NCT00726453|75897291|FG000|38 mm Length Group|Death|0|||
42086796|NCT00726453|75897292|FG001|38 mm Length Group|Death|3|||
42086797|NCT00726063|75897299|FG000|Overall Study|Adverse Event|9|||
42086798|NCT00726063|75897300|FG001|Overall Study|Adverse Event|7|||
42086799|NCT00808028|75897310|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
42180099|NCT03526861|75987736|FG002|Initial Treatment Period|Not dosed|1|||
42180100|NCT03526861|75987737|FG003|Initial Treatment Period|Not dosed|0|||
42358555|NCT04418765|76204320|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
42086800|NCT00808028|75897311|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
42086801|NCT00808028|75897312|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
42086802|NCT00808028|75897313|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
42086803|NCT00808028|75897310|FG000|Stage 1 (6 Months)|Other|1|||
42086804|NCT00808028|75897311|FG001|Stage 1 (6 Months)|Other|0|||
42086805|NCT00808028|75897312|FG002|Stage 1 (6 Months)|Other|2|||
42086806|NCT00808028|75897313|FG003|Stage 1 (6 Months)|Other|4|||
42086807|NCT00808028|75897310|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
42086808|NCT00808028|75897311|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
42086809|NCT00808028|75897312|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
42086810|NCT00808028|75897313|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
42086811|NCT00808028|75897310|FG000|Stage 1 (6 Months)|Adverse Event|0|||
42086812|NCT00808028|75897311|FG001|Stage 1 (6 Months)|Adverse Event|0|||
42086813|NCT00808028|75897312|FG002|Stage 1 (6 Months)|Adverse Event|1|||
42086814|NCT00808028|75897313|FG003|Stage 1 (6 Months)|Adverse Event|2|||
42086815|NCT00808028|75897310|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
42086816|NCT00808028|75897311|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
42086817|NCT00808028|75897312|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
42086818|NCT00808028|75897313|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
42086819|NCT00808028|75897310|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
42086820|NCT00808028|75897311|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
42086821|NCT00808028|75897312|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
42086822|NCT00808028|75897313|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
42086823|NCT00808028|75897310|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
42086824|NCT00808028|75897311|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
42086825|NCT00808028|75897312|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
42086826|NCT00808028|75897313|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
42086827|NCT00808028|75897310|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
42086828|NCT00808028|75897311|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
42086829|NCT00808028|75897312|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
42086830|NCT00808028|75897313|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
42086831|NCT00808028|75897310|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
42086832|NCT00808028|75897311|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
42086833|NCT00808028|75897312|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
42086834|NCT00808028|75897313|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
42086835|NCT00808028|75897310|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
42086836|NCT00808028|75897311|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
42086837|NCT00808028|75897312|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
42086838|NCT00808028|75897313|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
42086839|NCT00808028|75897310|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
42086840|NCT00808028|75897311|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
42086841|NCT00808028|75897312|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
42358556|NCT04418765|76204318|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
42086842|NCT00808028|75897313|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
42086843|NCT00808028|75897310|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
42086844|NCT00808028|75897311|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
42086845|NCT00808028|75897312|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
42086846|NCT00808028|75897313|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
42086847|NCT00808028|75897310|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
42086848|NCT00808028|75897311|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
42086849|NCT00808028|75897312|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
42086850|NCT00808028|75897313|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
42086851|NCT00808028|75897310|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
42086852|NCT00808028|75897311|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
42086853|NCT00808028|75897312|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
42086854|NCT00808028|75897313|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
42086855|NCT00808028|75897310|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
42180101|NCT03526861|75987738|FG004|Initial Treatment Period|Not dosed|0|||
42180102|NCT03526861|75987739|FG005|Initial Treatment Period|Not dosed|0|||
42180103|NCT03526861|75987740|FG006|Initial Treatment Period|Not dosed|0|||
42180104|NCT03526861|75987741|FG007|Initial Treatment Period|Not dosed|0|||
42180105|NCT03526861|75987742|FG008|Initial Treatment Period|Not dosed|0|||
42180106|NCT03526861|75987734|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
42180107|NCT03526861|75987735|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
42180108|NCT03526861|75987736|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
42180109|NCT03526861|75987737|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180110|NCT03526861|75987738|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180111|NCT03526861|75987739|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180112|NCT03526861|75987740|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180113|NCT03526861|75987741|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180114|NCT03526861|75987742|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180115|NCT03526861|75987734|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
42180116|NCT03526861|75987735|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
42180117|NCT03526861|75987736|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
42180118|NCT03526861|75987737|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
42180119|NCT03526861|75987738|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
42180120|NCT03526861|75987739|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
42180121|NCT03526861|75987740|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
42180122|NCT03526861|75987741|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
42180123|NCT03526861|75987742|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
42180124|NCT03526861|75987734|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180125|NCT03526861|75987735|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180126|NCT03526861|75987736|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180127|NCT03526861|75987737|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
42180128|NCT03526861|75987738|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
42180129|NCT03526861|75987739|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180130|NCT03526861|75987740|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
42180131|NCT03526861|75987741|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180132|NCT03526861|75987742|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180133|NCT03526861|75987734|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
42180134|NCT03526861|75987735|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
42086856|NCT00808028|75897311|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
42086857|NCT00808028|75897312|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
42086858|NCT00808028|75897313|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
42086859|NCT00809783|75897336|FG000|Overall Study|Death|1|||
42086860|NCT00809783|75897337|FG001|Overall Study|Death|0|||
42086861|NCT00809783|75897338|FG002|Overall Study|Death|0|||
42086862|NCT00809783|75897336|FG000|Overall Study|Adverse Event|34|||
42086863|NCT00809783|75897337|FG001|Overall Study|Adverse Event|52|||
42086864|NCT00809783|75897338|FG002|Overall Study|Adverse Event|71|||
42086865|NCT00809783|75897336|FG000|Overall Study|Lack of Efficacy|39|||
42086866|NCT00809783|75897337|FG001|Overall Study|Lack of Efficacy|52|||
42086867|NCT00809783|75897338|FG002|Overall Study|Lack of Efficacy|63|||
42086868|NCT00809783|75897336|FG000|Overall Study|Lost to Follow-up|0|||
42086869|NCT00809783|75897337|FG001|Overall Study|Lost to Follow-up|3|||
42086870|NCT00809783|75897338|FG002|Overall Study|Lost to Follow-up|4|||
42086871|NCT00809783|75897336|FG000|Overall Study|Withdrawal by Subject|47|||
42086872|NCT00809783|75897337|FG001|Overall Study|Withdrawal by Subject|72|||
42086873|NCT00809783|75897338|FG002|Overall Study|Withdrawal by Subject|64|||
42086874|NCT00809783|75897336|FG000|Overall Study|Protocol Violation|2|||
42086875|NCT00809783|75897337|FG001|Overall Study|Protocol Violation|6|||
42086876|NCT00809783|75897338|FG002|Overall Study|Protocol Violation|5|||
42086877|NCT00809783|75897336|FG000|Overall Study|Randomized, but not treated|3|||
42086878|NCT00809783|75897337|FG001|Overall Study|Randomized, but not treated|0|||
42086879|NCT00809783|75897338|FG002|Overall Study|Randomized, but not treated|2|||
42086880|NCT00809783|75897336|FG000|Overall Study|Study Terminated by Sponsor|378|||
42086881|NCT00809783|75897337|FG001|Overall Study|Study Terminated by Sponsor|626|||
42086882|NCT00809783|75897338|FG002|Overall Study|Study Terminated by Sponsor|565|||
42086883|NCT00809783|75897336|FG000|Overall Study|Other|21|||
42086884|NCT00809783|75897337|FG001|Overall Study|Other|21|||
42086885|NCT00809783|75897338|FG002|Overall Study|Other|16|||
42180135|NCT03526861|75987736|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
42180136|NCT03526861|75987737|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
42180137|NCT03526861|75987738|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
42180138|NCT03526861|75987739|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
42180139|NCT03526861|75987740|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
42180140|NCT03526861|75987741|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
42180141|NCT03526861|75987742|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
42086886|NCT00809471|75897349|FG000|Overall Study|Protocol non-compliance|15|||
42086887|NCT00809471|75897350|FG001|Overall Study|Protocol non-compliance|15|||
42086888|NCT00809471|75897351|FG002|Overall Study|Protocol non-compliance|6|||
42086889|NCT00809471|75897349|FG000|Overall Study|Lost to Follow-up|4|||
42086890|NCT00809471|75897350|FG001|Overall Study|Lost to Follow-up|2|||
42086891|NCT00809471|75897351|FG002|Overall Study|Lost to Follow-up|9|||
42086892|NCT00809471|75897349|FG000|Overall Study|Adverse Event|0|||
42086893|NCT00809471|75897350|FG001|Overall Study|Adverse Event|2|||
42180142|NCT03526861|75987734|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180143|NCT03526861|75987735|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180144|NCT03526861|75987736|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180145|NCT03526861|75987737|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
42180146|NCT03526861|75987738|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180147|NCT03526861|75987739|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180148|NCT03526861|75987740|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180149|NCT03526861|75987741|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180150|NCT03526861|75987742|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180151|NCT03526861|75987734|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180152|NCT03526861|75987735|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180153|NCT03526861|75987736|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180154|NCT03526861|75987737|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180155|NCT03526861|75987738|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180156|NCT03526861|75987739|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180157|NCT03526861|75987740|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180158|NCT03526861|75987741|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
42180159|NCT03526861|75987742|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
42180160|NCT03526861|75987734|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
42180161|NCT03526861|75987735|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
42180162|NCT03526861|75987736|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
42180163|NCT03526861|75987737|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
42180164|NCT03526861|75987738|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
42180165|NCT03526861|75987739|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
42180166|NCT03526861|75987740|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
42180167|NCT03526861|75987741|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
42180168|NCT03526861|75987742|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
42358557|NCT04418765|76204319|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
42086894|NCT00809471|75897351|FG002|Overall Study|Adverse Event|2|||
42086895|NCT00809471|75897349|FG000|Overall Study|Requirement for restricted medication|1|||
42180169|NCT03526861|75987734|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180170|NCT03526861|75987735|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180171|NCT03526861|75987736|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180172|NCT03526861|75987737|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180173|NCT03526861|75987738|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180174|NCT03526861|75987739|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180175|NCT03526861|75987740|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180176|NCT03526861|75987741|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
42180177|NCT03526861|75987742|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
42180178|NCT03510884|75987766|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
42180179|NCT03510884|75987767|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
42180180|NCT03510884|75987768|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
42180181|NCT03510884|75987769|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
42180182|NCT03510884|75987766|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
42180183|NCT03510884|75987767|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
42180184|NCT03510884|75987768|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
42180185|NCT03510884|75987769|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
42180186|NCT03510884|75987766|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
42180187|NCT03510884|75987767|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
42180188|NCT03510884|75987768|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
42086896|NCT00809471|75897350|FG001|Overall Study|Requirement for restricted medication|1|||
42086897|NCT00809471|75897351|FG002|Overall Study|Requirement for restricted medication|0|||
42180189|NCT03510884|75987769|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
42180190|NCT03510884|75987766|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
42180191|NCT03510884|75987767|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
42180192|NCT03510884|75987768|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
42086898|NCT00807248|75897363|FG000|Overall Study|Adverse Event|1|||
42086899|NCT00807248|75897364|FG001|Overall Study|Adverse Event|2|||
42086900|NCT00807248|75897365|FG002|Overall Study|Adverse Event|2|||
42086901|NCT00807248|75897366|FG003|Overall Study|Adverse Event|6|||
42086902|NCT00807248|75897363|FG000|Overall Study|Lack of Efficacy|14|||
42086903|NCT00807248|75897364|FG001|Overall Study|Lack of Efficacy|4|||
42086904|NCT00807248|75897365|FG002|Overall Study|Lack of Efficacy|8|||
42086905|NCT00807248|75897366|FG003|Overall Study|Lack of Efficacy|3|||
42086906|NCT00807248|75897363|FG000|Overall Study|Protocol Violation|0|||
42086907|NCT00807248|75897364|FG001|Overall Study|Protocol Violation|1|||
42086908|NCT00807248|75897365|FG002|Overall Study|Protocol Violation|1|||
42086909|NCT00807248|75897366|FG003|Overall Study|Protocol Violation|0|||
42086910|NCT00807248|75897363|FG000|Overall Study|Withdrawal of Consent|5|||
42086911|NCT00807248|75897364|FG001|Overall Study|Withdrawal of Consent|5|||
42086912|NCT00807248|75897365|FG002|Overall Study|Withdrawal of Consent|5|||
42086913|NCT00807248|75897366|FG003|Overall Study|Withdrawal of Consent|5|||
42086914|NCT00807248|75897363|FG000|Overall Study|Lost to Follow-up|1|||
42086915|NCT00807248|75897364|FG001|Overall Study|Lost to Follow-up|0|||
42086916|NCT00807248|75897365|FG002|Overall Study|Lost to Follow-up|0|||
42086917|NCT00807248|75897366|FG003|Overall Study|Lost to Follow-up|0|||
42086918|NCT00807248|75897363|FG000|Overall Study|Other Reason|0|||
42086919|NCT00807248|75897364|FG001|Overall Study|Other Reason|0|||
42086920|NCT00807248|75897365|FG002|Overall Study|Other Reason|2|||
42086921|NCT00807248|75897366|FG003|Overall Study|Other Reason|0|||
42086922|NCT00589628|75897378|FG000|Overall Study|Lost to Follow-up|0|||
42086923|NCT00589628|75897379|FG001|Overall Study|Lost to Follow-up|1|||
42086924|NCT00588848|75897387|FG000|Overall Study|Physician Decision|0|||
42086925|NCT00588848|75897388|FG001|Overall Study|Physician Decision|3|||
42086926|NCT00797108|75897399|FG000|Overall Study|Adverse Event|1|||
42086927|NCT00797108|75897400|FG001|Overall Study|Adverse Event|0|||
42086928|NCT00797108|75897401|FG002|Overall Study|Adverse Event|3|||
42180193|NCT03510884|75987769|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
42086929|NCT00797108|75897399|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
42086930|NCT00797108|75897400|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
42086931|NCT00797108|75897401|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
42086932|NCT00797108|75897399|FG000|Overall Study|Global Deterioration of Health Status|0|||
42086933|NCT00797108|75897400|FG001|Overall Study|Global Deterioration of Health Status|1|||
42086934|NCT00797108|75897401|FG002|Overall Study|Global Deterioration of Health Status|0|||
42086935|NCT00797108|75897399|FG000|Overall Study|Lack of Efficacy|1|||
42086936|NCT00797108|75897400|FG001|Overall Study|Lack of Efficacy|0|||
42086937|NCT00797108|75897401|FG002|Overall Study|Lack of Efficacy|1|||
42086938|NCT00797108|75897399|FG000|Overall Study|Other|0|||
42086939|NCT00797108|75897400|FG001|Overall Study|Other|0|||
42086940|NCT00797108|75897401|FG002|Overall Study|Other|2|||
42086941|NCT00797108|75897399|FG000|Overall Study|Randomized but not Treated|2|||
42086942|NCT00797108|75897400|FG001|Overall Study|Randomized but not Treated|0|||
42086943|NCT00797108|75897401|FG002|Overall Study|Randomized but not Treated|0|||
42086944|NCT00742560|75897414|FG000|Overall Study|Adverse Event|0|||
42086945|NCT00742560|75897415|FG001|Overall Study|Adverse Event|0|||
42086946|NCT00742560|75897416|FG002|Overall Study|Adverse Event|1|||
42086947|NCT00742560|75897417|FG003|Overall Study|Adverse Event|1|||
42086948|NCT00742560|75897418|FG004|Overall Study|Adverse Event|1|||
42086949|NCT00742560|75897414|FG000|Overall Study|Death|0|||
42086950|NCT00742560|75897415|FG001|Overall Study|Death|2|||
42086951|NCT00742560|75897416|FG002|Overall Study|Death|0|||
42086952|NCT00742560|75897417|FG003|Overall Study|Death|2|||
42086953|NCT00742560|75897418|FG004|Overall Study|Death|3|||
42086954|NCT00742560|75897414|FG000|Overall Study|Subject's Decision|1|||
42086955|NCT00742560|75897415|FG001|Overall Study|Subject's Decision|0|||
42086956|NCT00742560|75897416|FG002|Overall Study|Subject's Decision|2|||
42086957|NCT00742560|75897417|FG003|Overall Study|Subject's Decision|3|||
42086958|NCT00742560|75897418|FG004|Overall Study|Subject's Decision|3|||
42086959|NCT00742560|75897414|FG000|Overall Study|Investigator's Decision|0|||
42086960|NCT00742560|75897415|FG001|Overall Study|Investigator's Decision|0|||
42086961|NCT00742560|75897416|FG002|Overall Study|Investigator's Decision|4|||
42086962|NCT00742560|75897417|FG003|Overall Study|Investigator's Decision|1|||
42086963|NCT00742560|75897418|FG004|Overall Study|Investigator's Decision|0|||
42086964|NCT00742560|75897414|FG000|Overall Study|Disease Progression|1|||
42086965|NCT00742560|75897415|FG001|Overall Study|Disease Progression|0|||
42086966|NCT00742560|75897416|FG002|Overall Study|Disease Progression|5|||
42086967|NCT00742560|75897417|FG003|Overall Study|Disease Progression|17|||
42086968|NCT00742560|75897418|FG004|Overall Study|Disease Progression|16|||
42086969|NCT00742560|75897414|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
42086970|NCT00742560|75897415|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
42086971|NCT00742560|75897416|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
42086972|NCT00742560|75897417|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
42086973|NCT00742560|75897418|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
42086974|NCT00742560|75897414|FG000|Overall Study|Other|0|||
42086975|NCT00742560|75897415|FG001|Overall Study|Other|1|||
42086976|NCT00742560|75897416|FG002|Overall Study|Other|8|||
42086977|NCT00742560|75897417|FG003|Overall Study|Other|9|||
42086978|NCT00742560|75897418|FG004|Overall Study|Other|9|||
42086979|NCT00742560|75897414|FG000|Overall Study|MIssing|0|||
42086980|NCT00742560|75897415|FG001|Overall Study|MIssing|0|||
42086981|NCT00742560|75897416|FG002|Overall Study|MIssing|0|||
42086982|NCT00742560|75897417|FG003|Overall Study|MIssing|0|||
42086983|NCT00742560|75897418|FG004|Overall Study|MIssing|1|||
42086984|NCT00740220|75897449|FG000|Overall Study|screen failures (non-COPD patients)|9|||
42086985|NCT00796718|75897453|FG000|Overall Study|Adverse Event|2|||
42086986|NCT00796718|75897453|FG000|Overall Study|Exclusion Criteria|1|||
42180194|NCT03510884|75987766|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
42180195|NCT03510884|75987767|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
42180196|NCT03510884|75987768|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
42180197|NCT03510884|75987769|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
42180198|NCT03510884|75987766|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
42180199|NCT03510884|75987767|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
42180200|NCT03510884|75987768|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
42086987|NCT00796718|75897453|FG000|Overall Study|Lost to Follow-up|5|||
42086988|NCT00796718|75897453|FG000|Overall Study|Withdrawal by Informed Consent|1|||
42180201|NCT03510884|75987769|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
42086989|NCT00809159|75897461|FG000|Part 1|Adverse Event|1|||
42086990|NCT00809159|75897462|FG001|Part 1|Adverse Event|1|||
42086991|NCT00809159|75897463|FG002|Part 1|Adverse Event|0|||
42180202|NCT03510884|75987766|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
42086992|NCT00809159|75897464|FG003|Part 1|Adverse Event|0|||
42086993|NCT00809159|75897465|FG004|Part 1|Adverse Event|0|||
42086994|NCT00809159|75897466|FG005|Part 1|Adverse Event|0|||
42086995|NCT00809159|75897461|FG000|Part 1|Lost to Follow-up|1|||
42086996|NCT00809159|75897462|FG001|Part 1|Lost to Follow-up|0|||
42086997|NCT00809159|75897463|FG002|Part 1|Lost to Follow-up|0|||
42086998|NCT00809159|75897464|FG003|Part 1|Lost to Follow-up|0|||
42086999|NCT00809159|75897465|FG004|Part 1|Lost to Follow-up|0|||
42087000|NCT00809159|75897466|FG005|Part 1|Lost to Follow-up|0|||
42087001|NCT00809159|75897461|FG000|Part 1|Withdrawal by Subject|3|||
42087002|NCT00809159|75897462|FG001|Part 1|Withdrawal by Subject|1|||
42087003|NCT00809159|75897463|FG002|Part 1|Withdrawal by Subject|0|||
42180203|NCT03510884|75987767|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
42180204|NCT03510884|75987768|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
42180205|NCT03510884|75987769|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
42180206|NCT03510884|75987766|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
42180207|NCT03510884|75987767|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
42180208|NCT03510884|75987768|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
42180209|NCT03510884|75987769|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
42180210|NCT03510884|75987766|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
42180211|NCT03510884|75987767|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
42180212|NCT03510884|75987768|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
42180213|NCT03510884|75987769|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
42180214|NCT03510884|75987766|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
42180215|NCT03510884|75987767|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
42180216|NCT03510884|75987768|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
42180217|NCT03510884|75987769|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
42180218|NCT03488472|75987803|FG000|Overall Study|disease progression additional mets|1|||
42180219|NCT03456453|75987809|FG000|Overall Study|Withdrawal by Subject|2|||
42180220|NCT03456453|75987810|FG001|Overall Study|Withdrawal by Subject|0|||
42180221|NCT03456453|75987809|FG000|Overall Study|Not released to community|1|||
42180222|NCT03456453|75987810|FG001|Overall Study|Not released to community|5|||
42087004|NCT00809159|75897464|FG003|Part 1|Withdrawal by Subject|0|||
42087005|NCT00809159|75897465|FG004|Part 1|Withdrawal by Subject|0|||
42358558|NCT04418765|76204320|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
42358559|NCT04418765|76204318|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
42358560|NCT04418765|76204319|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
42358561|NCT04418765|76204320|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
42358562|NCT04418765|76204318|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
42358563|NCT04418765|76204319|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
42087006|NCT00809159|75897466|FG005|Part 1|Withdrawal by Subject|0|||
42087007|NCT00809159|75897461|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
42087008|NCT00809159|75897462|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
42087009|NCT00809159|75897463|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
42087010|NCT00809159|75897464|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
42087011|NCT00809159|75897465|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
42087012|NCT00809159|75897466|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
42087013|NCT00809159|75897461|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
42087014|NCT00809159|75897462|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
42087015|NCT00809159|75897463|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
42087016|NCT00809159|75897464|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
42087017|NCT00809159|75897465|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
42087018|NCT00809159|75897466|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
42087019|NCT00809159|75897461|FG000|Part 1 and 2|Administrative problems|0|||
42087020|NCT00809159|75897462|FG001|Part 1 and 2|Administrative problems|0|||
42087021|NCT00809159|75897463|FG002|Part 1 and 2|Administrative problems|0|||
42087022|NCT00809159|75897464|FG003|Part 1 and 2|Administrative problems|1|||
42087023|NCT00809159|75897465|FG004|Part 1 and 2|Administrative problems|0|||
42180223|NCT03456453|75987809|FG000|Overall Study|Lost to Follow-up|0|||
42180224|NCT03456453|75987810|FG001|Overall Study|Lost to Follow-up|2|||
42180225|NCT03455829|75987821|FG000|Overall Study|Death|2|||
42180226|NCT03455829|75987822|FG001|Overall Study|Death|3|||
42180227|NCT03455829|75987823|FG002|Overall Study|Death|2|||
42180228|NCT03455829|75987824|FG003|Overall Study|Death|4|||
42180229|NCT03455829|75987825|FG004|Overall Study|Death|2|||
42180230|NCT03455829|75987821|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
42180231|NCT03455829|75987822|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
42087024|NCT00809159|75897466|FG005|Part 1 and 2|Administrative problems|0|||
42087025|NCT00809159|75897461|FG000|Part 1 and 2|Adverse Event|0|||
42087026|NCT00809159|75897462|FG001|Part 1 and 2|Adverse Event|0|||
42180232|NCT03455829|75987823|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
42294329|NCT02477696|76128732|FG000|Overall Study|Withdrawal by Subject|37|||
42294330|NCT02477696|76128733|FG001|Overall Study|Withdrawal by Subject|34|||
42294331|NCT02477696|76128732|FG000|Overall Study|Physician Decision|7|||
42294332|NCT02477696|76128733|FG001|Overall Study|Physician Decision|9|||
42294333|NCT02477696|76128732|FG000|Overall Study|Study terminated by sponsor|103|||
42294334|NCT02477696|76128733|FG001|Overall Study|Study terminated by sponsor|99|||
42294335|NCT02477696|76128732|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
42294336|NCT02477696|76128733|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
42294337|NCT02477696|76128732|FG000|Overall Study|Missing/Unknown|2|||
42294338|NCT02477696|76128733|FG001|Overall Study|Missing/Unknown|0|||
42294339|NCT02468232|76128743|FG000|Core Part of Study|Adverse Event|0|||
42180233|NCT03455829|75987824|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
42180234|NCT03455829|75987825|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
42180235|NCT03455829|75987821|FG000|Overall Study|Disease progression|0|||
42087027|NCT00809159|75897463|FG002|Part 1 and 2|Adverse Event|1|||
42180236|NCT03455829|75987822|FG001|Overall Study|Disease progression|0|||
42180237|NCT03455829|75987823|FG002|Overall Study|Disease progression|0|||
42180238|NCT03455829|75987824|FG003|Overall Study|Disease progression|1|||
42180239|NCT03455829|75987825|FG004|Overall Study|Disease progression|1|||
42180240|NCT03441334|75987839|FG000|Overall Study|Withdrawal by Subject|1|||
42180241|NCT03441334|75987840|FG001|Overall Study|Withdrawal by Subject|0|||
42180242|NCT03429244|75987871|FG000|Overall Study|Withdrawal by Subject|2|||
42180243|NCT03429244|75987872|FG001|Overall Study|Withdrawal by Subject|1|||
42180244|NCT03429244|75987873|FG002|Overall Study|Withdrawal by Subject|1|||
42180245|NCT03250117|75987886|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
42180246|NCT03250117|75987887|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
42180247|NCT03250117|75987888|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
42180248|NCT03250117|75987889|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
42180249|NCT03230838|75987895|FG000|Overall Study|Withdrawal by Subject|3|||
42180250|NCT03230838|75987896|FG001|Overall Study|Withdrawal by Subject|0|||
42180251|NCT03230838|75987895|FG000|Overall Study|Temperature excursion|1|||
42180252|NCT03230838|75987896|FG001|Overall Study|Temperature excursion|0|||
42180253|NCT03217136|75987904|FG000|Overall Study|Lost to Follow-up|2|||
42180254|NCT03217136|75987905|FG001|Overall Study|Lost to Follow-up|1|||
42180255|NCT03217136|75987904|FG000|Overall Study|Site Randomized Participant in Error|0|||
42180256|NCT03217136|75987905|FG001|Overall Study|Site Randomized Participant in Error|1|||
42180257|NCT03217136|75987904|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
42180258|NCT03217136|75987905|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
42180259|NCT03217136|75987904|FG000|Overall Study|Dispensing Error|1|||
42180260|NCT03217136|75987905|FG001|Overall Study|Dispensing Error|0|||
42180261|NCT03217136|75987904|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
42180262|NCT03217136|75987905|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
42180263|NCT03179761|75987913|FG000|Overall Study|Death|2|||
42180264|NCT03179761|75987914|FG001|Overall Study|Death|5|||
42180265|NCT03179761|75987913|FG000|Overall Study|Lost to Follow-up|2|||
42180266|NCT03179761|75987914|FG001|Overall Study|Lost to Follow-up|2|||
42087028|NCT00809159|75897464|FG003|Part 1 and 2|Adverse Event|0|||
42087029|NCT00809159|75897465|FG004|Part 1 and 2|Adverse Event|1|||
42087030|NCT00809159|75897466|FG005|Part 1 and 2|Adverse Event|1|||
42087031|NCT00809159|75897461|FG000|Part 1 and 2|Lost to Follow-up|0|||
42087032|NCT00809159|75897462|FG001|Part 1 and 2|Lost to Follow-up|0|||
42087033|NCT00809159|75897463|FG002|Part 1 and 2|Lost to Follow-up|1|||
42087034|NCT00809159|75897464|FG003|Part 1 and 2|Lost to Follow-up|1|||
42087035|NCT00809159|75897465|FG004|Part 1 and 2|Lost to Follow-up|0|||
42087036|NCT00809159|75897466|FG005|Part 1 and 2|Lost to Follow-up|0|||
42087037|NCT00809159|75897461|FG000|Part 1 and 2|Withdrawal by Subject|0|||
42180267|NCT03179761|75987913|FG000|Overall Study|Protocol Violation|1|||
42180268|NCT03179761|75987914|FG001|Overall Study|Protocol Violation|0|||
42087038|NCT00809159|75897462|FG001|Part 1 and 2|Withdrawal by Subject|0|||
42087039|NCT00809159|75897463|FG002|Part 1 and 2|Withdrawal by Subject|4|||
42087040|NCT00809159|75897464|FG003|Part 1 and 2|Withdrawal by Subject|0|||
42180269|NCT03179761|75987913|FG000|Overall Study|Withdrawal by Subject|1|||
42180270|NCT03179761|75987914|FG001|Overall Study|Withdrawal by Subject|4|||
42180271|NCT03179761|75987913|FG000|Overall Study|Investigator Request|0|||
42180272|NCT03179761|75987914|FG001|Overall Study|Investigator Request|2|||
42180273|NCT03155841|75987922|FG000|Overall Study|Protocol Violation|3|||
42180274|NCT03155841|75987923|FG001|Overall Study|Protocol Violation|4|||
42180275|NCT03114891|75987933|FG000|First Treatment Round|Lost to Follow-up|0|||
42180276|NCT03114891|75987934|FG001|First Treatment Round|Lost to Follow-up|1|||
42180277|NCT03114891|75987935|FG002|First Treatment Round|Lost to Follow-up|1|||
42180278|NCT03114891|75987936|FG003|First Treatment Round|Lost to Follow-up|0|||
42180279|NCT03114891|75987933|FG000|First Treatment Round|Withdrawal by Subject|0|||
42180280|NCT03114891|75987934|FG001|First Treatment Round|Withdrawal by Subject|2|||
42180281|NCT03114891|75987935|FG002|First Treatment Round|Withdrawal by Subject|0|||
42180282|NCT03114891|75987936|FG003|First Treatment Round|Withdrawal by Subject|1|||
42180283|NCT03114891|75987933|FG000|3 Week Break|Lost to Follow-up|1|||
42180284|NCT03114891|75987934|FG001|3 Week Break|Lost to Follow-up|0|||
42180285|NCT03114891|75987935|FG002|3 Week Break|Lost to Follow-up|0|||
42358564|NCT04418765|76204320|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
42087041|NCT00809159|75897465|FG004|Part 1 and 2|Withdrawal by Subject|0|||
42087042|NCT00809159|75897466|FG005|Part 1 and 2|Withdrawal by Subject|1|||
42180286|NCT03114891|75987936|FG003|3 Week Break|Lost to Follow-up|1|||
42180287|NCT03114891|75987933|FG000|3 Week Break|Withdrawal by Subject|0|||
42180288|NCT03114891|75987934|FG001|3 Week Break|Withdrawal by Subject|1|||
42087043|NCT00745368|75897480|FG000|Overall Study|Unable to provide sample|3|||
42087044|NCT00589472|75897484|FG000|Overall Study|Adverse Event|1|||
42087045|NCT00811577|75897490|FG000|Overall Study|Lost to Follow-up|7|||
42087046|NCT00811577|75897491|FG001|Overall Study|Lost to Follow-up|1|||
42087047|NCT00811577|75897490|FG000|Overall Study|Withdrawal by Subject|3|||
42087048|NCT00811577|75897491|FG001|Overall Study|Withdrawal by Subject|0|||
42087049|NCT00802178|75897540|FG000|Overall Study|Lack of Efficacy|36|||
42087050|NCT00802178|75897540|FG000|Overall Study|Insufficient tolerability (IT)|17|||
42087051|NCT00802178|75897540|FG000|Overall Study|Withdrawal by Subject|18|||
42087052|NCT00802178|75897540|FG000|Overall Study|Other|32|||
42087053|NCT00802178|75897540|FG000|Overall Study|Lack of efficacy and patient wish|1|||
42087054|NCT00802178|75897540|FG000|Overall Study|IT and patient wish|8|||
42087055|NCT00802178|75897540|FG000|Overall Study|Patients wish and other reason|1|||
42087056|NCT00744978|75897546|FG000|Period 1|Lost to Follow-up|1|||
42087057|NCT00744978|75897547|FG001|Period 1|Lost to Follow-up|0|||
42087058|NCT00744978|75897546|FG000|Period 1|Withdrawal by Subject|0|||
42087059|NCT00744978|75897547|FG001|Period 1|Withdrawal by Subject|2|||
42087060|NCT00744978|75897546|FG000|Period 1|Other|0|||
42087061|NCT00744978|75897547|FG001|Period 1|Other|2|||
42087062|NCT00744978|75897546|FG000|Period 1|Adverse Event|4|||
42087063|NCT00744978|75897547|FG001|Period 1|Adverse Event|0|||
42087064|NCT00744978|75897546|FG000|Period 1|Randomized but not Treated|1|||
42087065|NCT00744978|75897547|FG001|Period 1|Randomized but not Treated|1|||
42087066|NCT00744978|75897546|FG000|Period 2|Adverse Event|0|||
42087067|NCT00744978|75897547|FG001|Period 2|Adverse Event|1|||
42087068|NCT00739908|75897555|FG000|Overall Study|Adverse Event|5|||
42358565|NCT04418765|76204318|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
42087069|NCT00739908|75897556|FG001|Overall Study|Adverse Event|6|||
42087070|NCT00739908|75897555|FG000|Overall Study|Withdrawal by Subject|4|||
42087071|NCT00739908|75897556|FG001|Overall Study|Withdrawal by Subject|2|||
42087072|NCT00739908|75897555|FG000|Overall Study|Lost to Follow-up|14|||
42087073|NCT00739908|75897556|FG001|Overall Study|Lost to Follow-up|9|||
42087074|NCT00739908|75897555|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
42087075|NCT00739908|75897556|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
42087076|NCT00739908|75897555|FG000|Overall Study|Non-Compliance With Study Medication|0|||
42087077|NCT00739908|75897556|FG001|Overall Study|Non-Compliance With Study Medication|3|||
42087078|NCT00739908|75897555|FG000|Overall Study|Lack of Efficacy|0|||
42087079|NCT00739908|75897556|FG001|Overall Study|Lack of Efficacy|1|||
42087080|NCT00739908|75897555|FG000|Overall Study|Relocation|0|||
42087081|NCT00739908|75897556|FG001|Overall Study|Relocation|1|||
42087082|NCT00739596|75897566|FG000|Overall Study|Adverse Event|12|||
42087083|NCT00739596|75897567|FG001|Overall Study|Adverse Event|6|||
42087084|NCT00739596|75897566|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
42087085|NCT00739596|75897567|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
42087086|NCT00739596|75897566|FG000|Overall Study|Patient Withdrew Consent|8|||
42087087|NCT00739596|75897567|FG001|Overall Study|Patient Withdrew Consent|8|||
42087088|NCT00739596|75897566|FG000|Overall Study|Lost to Follow-up|0|||
42087089|NCT00739596|75897567|FG001|Overall Study|Lost to Follow-up|2|||
42087090|NCT00739596|75897566|FG000|Overall Study|Protocol Deviation|1|||
42087091|NCT00739596|75897567|FG001|Overall Study|Protocol Deviation|1|||
42087092|NCT00742326|75897575|FG000|Overall Study|Physician Decision|0|||
42087093|NCT00742326|75897576|FG001|Overall Study|Physician Decision|1|||
42087094|NCT00741936|75897584|FG000|Overall Study|Lost to Follow-up|1|||
42087095|NCT00741936|75897585|FG001|Overall Study|Lost to Follow-up|1|||
42087096|NCT00741936|75897584|FG000|Overall Study|Adverse Event|3|||
42087097|NCT00741936|75897585|FG001|Overall Study|Adverse Event|4|||
42180289|NCT03114891|75987935|FG002|3 Week Break|Withdrawal by Subject|0|||
42180290|NCT03114891|75987936|FG003|3 Week Break|Withdrawal by Subject|0|||
42180291|NCT03114891|75987933|FG000|Second Treatment Round|Lost to Follow-up|1|||
42087098|NCT00741936|75897584|FG000|Overall Study|Pregnancy|0|||
42087099|NCT00741936|75897585|FG001|Overall Study|Pregnancy|1|||
42087100|NCT00741936|75897584|FG000|Overall Study|Protocol Violation|2|||
42180292|NCT03114891|75987934|FG001|Second Treatment Round|Lost to Follow-up|0|||
42087101|NCT00741936|75897585|FG001|Overall Study|Protocol Violation|0|||
42087102|NCT00741936|75897584|FG000|Overall Study|Lack of Efficacy|0|||
42087103|NCT00741936|75897585|FG001|Overall Study|Lack of Efficacy|2|||
42087104|NCT00741936|75897584|FG000|Overall Study|Low compliance|3|||
42180293|NCT03114891|75987935|FG002|Second Treatment Round|Lost to Follow-up|0|||
42087105|NCT00741936|75897585|FG001|Overall Study|Low compliance|0|||
42087106|NCT00811187|75897593|FG000|Overall Study|Unable to place device / procedure abort|3|||
42087107|NCT00811187|75897594|FG001|Overall Study|Unable to place device / procedure abort|3|||
42087108|NCT00591149|75897600|FG000|Overall Study|Adverse Event|4|||
42087109|NCT00591149|75897600|FG000|Overall Study|Withdrawal by Subject|1|||
42087110|NCT00735072|75897606|FG000|Overall Study|interrupted study med during ARV change|1|||
42087111|NCT00735072|75897607|FG001|Overall Study|interrupted study med during ARV change|0|||
42180294|NCT03114891|75987936|FG003|Second Treatment Round|Lost to Follow-up|0|||
42180295|NCT03114891|75987933|FG000|Second Treatment Round|Physician Decision|1|||
42180296|NCT03114891|75987934|FG001|Second Treatment Round|Physician Decision|0|||
42180297|NCT03114891|75987935|FG002|Second Treatment Round|Physician Decision|0|||
42180298|NCT03114891|75987936|FG003|Second Treatment Round|Physician Decision|0|||
42180299|NCT03057847|75987978|FG000|Overall Study|Lost to Follow-up|16|||
42180300|NCT02946463|75987993|FG000|Primary Evaluation Period|Physician Decision|0|||
42180301|NCT02946463|75987994|FG001|Primary Evaluation Period|Physician Decision|1|||
42180302|NCT02946463|75987993|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
42180303|NCT02946463|75987994|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
42180304|NCT02860039|75988025|FG000|Overall Study|Death|4|||
42180305|NCT02860039|75988026|FG001|Overall Study|Death|0|||
42180306|NCT02860039|75988025|FG000|Overall Study|Lost to Follow-up|2|||
42180307|NCT02860039|75988026|FG001|Overall Study|Lost to Follow-up|2|||
42180308|NCT02860039|75988025|FG000|Overall Study|Protocol Violation|3|||
42180309|NCT02860039|75988026|FG001|Overall Study|Protocol Violation|1|||
42180310|NCT02860039|75988025|FG000|Overall Study|Withdrawal by Subject|1|||
42180311|NCT02860039|75988026|FG001|Overall Study|Withdrawal by Subject|0|||
42180312|NCT02860039|75988025|FG000|Overall Study|Not otherwise eligible|1|||
42180313|NCT02860039|75988026|FG001|Overall Study|Not otherwise eligible|1|||
42180314|NCT02761694|75988056|FG000|Overall Study|Lack of Efficacy|0|||
42180315|NCT02761694|75988057|FG001|Overall Study|Lack of Efficacy|0|||
42180316|NCT02761694|75988058|FG002|Overall Study|Lack of Efficacy|0|||
42180317|NCT02761694|75988059|FG003|Overall Study|Lack of Efficacy|0|||
42087112|NCT00735072|75897606|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
42087113|NCT00735072|75897607|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
42087114|NCT00810641|75897618|FG000|Overall Study|Withdrawal by Subject|0|||
42087115|NCT00810641|75897619|FG001|Overall Study|Withdrawal by Subject|1|||
42087116|NCT00810641|75897620|FG002|Overall Study|Withdrawal by Subject|2|||
42087117|NCT00793598|75897633|FG000|Overall Study|Patient Request|0|||
42087118|NCT00793598|75897634|FG001|Overall Study|Patient Request|1|||
42087119|NCT00793598|75897635|FG002|Overall Study|Patient Request|0|||
42087120|NCT00793598|75897636|FG003|Overall Study|Patient Request|0|||
42087121|NCT00793598|75897637|FG004|Overall Study|Patient Request|0|||
42087122|NCT00793598|75897638|FG005|Overall Study|Patient Request|0|||
42087123|NCT00793598|75897639|FG006|Overall Study|Patient Request|0|||
42087124|NCT00793598|75897640|FG007|Overall Study|Patient Request|0|||
42087125|NCT00793598|75897633|FG000|Overall Study|Protocol Violation|0|||
42087126|NCT00793598|75897634|FG001|Overall Study|Protocol Violation|0|||
42180318|NCT02761694|75988060|FG004|Overall Study|Lack of Efficacy|0|||
42180319|NCT02761694|75988061|FG005|Overall Study|Lack of Efficacy|0|||
42180320|NCT02761694|75988062|FG006|Overall Study|Lack of Efficacy|6|||
42180321|NCT02761694|75988063|FG007|Overall Study|Lack of Efficacy|0|||
42180322|NCT02761694|75988064|FG008|Overall Study|Lack of Efficacy|0|||
42180323|NCT02761694|75988065|FG009|Overall Study|Lack of Efficacy|1|||
42180324|NCT02761694|75988066|FG010|Overall Study|Lack of Efficacy|1|||
42180325|NCT02761694|75988067|FG011|Overall Study|Lack of Efficacy|4|||
42180326|NCT02761694|75988056|FG000|Overall Study|Death|0|||
42180327|NCT02761694|75988057|FG001|Overall Study|Death|0|||
42180328|NCT02761694|75988058|FG002|Overall Study|Death|0|||
42180329|NCT02761694|75988059|FG003|Overall Study|Death|0|||
42180330|NCT02761694|75988060|FG004|Overall Study|Death|0|||
42180331|NCT02761694|75988061|FG005|Overall Study|Death|0|||
42180332|NCT02761694|75988062|FG006|Overall Study|Death|2|||
42180333|NCT02761694|75988063|FG007|Overall Study|Death|0|||
42180334|NCT02761694|75988064|FG008|Overall Study|Death|2|||
42180335|NCT02761694|75988065|FG009|Overall Study|Death|2|||
42180336|NCT02761694|75988066|FG010|Overall Study|Death|1|||
42180337|NCT02761694|75988067|FG011|Overall Study|Death|0|||
42180338|NCT02761694|75988056|FG000|Overall Study|Physician Decision|0|||
42180339|NCT02761694|75988057|FG001|Overall Study|Physician Decision|0|||
42180340|NCT02761694|75988058|FG002|Overall Study|Physician Decision|0|||
42180341|NCT02761694|75988059|FG003|Overall Study|Physician Decision|0|||
42180342|NCT02761694|75988060|FG004|Overall Study|Physician Decision|0|||
42180343|NCT02761694|75988061|FG005|Overall Study|Physician Decision|0|||
42180344|NCT02761694|75988062|FG006|Overall Study|Physician Decision|1|||
42180345|NCT02761694|75988063|FG007|Overall Study|Physician Decision|0|||
42180346|NCT02761694|75988064|FG008|Overall Study|Physician Decision|0|||
42180347|NCT02761694|75988065|FG009|Overall Study|Physician Decision|0|||
42180348|NCT02761694|75988066|FG010|Overall Study|Physician Decision|0|||
42180349|NCT02761694|75988067|FG011|Overall Study|Physician Decision|0|||
42180350|NCT02761694|75988056|FG000|Overall Study|Withdrawal by Subject|0|||
42180351|NCT02761694|75988057|FG001|Overall Study|Withdrawal by Subject|0|||
42180352|NCT02761694|75988058|FG002|Overall Study|Withdrawal by Subject|0|||
42180353|NCT02761694|75988059|FG003|Overall Study|Withdrawal by Subject|1|||
42180354|NCT02761694|75988060|FG004|Overall Study|Withdrawal by Subject|0|||
42180355|NCT02761694|75988061|FG005|Overall Study|Withdrawal by Subject|0|||
42180356|NCT02761694|75988062|FG006|Overall Study|Withdrawal by Subject|4|||
42087127|NCT00793598|75897635|FG002|Overall Study|Protocol Violation|0|||
42087128|NCT00793598|75897636|FG003|Overall Study|Protocol Violation|0|||
42087129|NCT00793598|75897637|FG004|Overall Study|Protocol Violation|0|||
42087130|NCT00793598|75897638|FG005|Overall Study|Protocol Violation|0|||
42087131|NCT00793598|75897639|FG006|Overall Study|Protocol Violation|0|||
42087132|NCT00793598|75897640|FG007|Overall Study|Protocol Violation|1|||
42087133|NCT00793598|75897633|FG000|Overall Study|Subject not dosed|0|||
42087134|NCT00793598|75897634|FG001|Overall Study|Subject not dosed|0|||
42087135|NCT00793598|75897635|FG002|Overall Study|Subject not dosed|0|||
42087136|NCT00793598|75897636|FG003|Overall Study|Subject not dosed|0|||
42087137|NCT00793598|75897637|FG004|Overall Study|Subject not dosed|0|||
42087138|NCT00793598|75897638|FG005|Overall Study|Subject not dosed|1|||
42087139|NCT00793598|75897639|FG006|Overall Study|Subject not dosed|0|||
42087140|NCT00793598|75897640|FG007|Overall Study|Subject not dosed|0|||
42087141|NCT00796562|75897662|FG000|Overall Study|Death|49|||
42087142|NCT00801632|75897666|FG000|Overall Study|Re-transplant|1|||
42087143|NCT00806819|75897672|FG000|Overall Study|progressive disease (modified RECIST )|217|||
42087144|NCT00806819|75897673|FG001|Overall Study|progressive disease (modified RECIST )|216|||
42087145|NCT00806819|75897672|FG000|Overall Study|Worsening or AE of underlying disease|18|||
42180357|NCT02761694|75988063|FG007|Overall Study|Withdrawal by Subject|0|||
42180358|NCT02761694|75988064|FG008|Overall Study|Withdrawal by Subject|2|||
42180359|NCT02761694|75988065|FG009|Overall Study|Withdrawal by Subject|1|||
42180360|NCT02761694|75988066|FG010|Overall Study|Withdrawal by Subject|0|||
42180361|NCT02761694|75988067|FG011|Overall Study|Withdrawal by Subject|0|||
42017880|NCT01265849|75825620|FG002|Overall Study|Randomized//Treatment not initiated|0|||
42017881|NCT01265849|75825618|FG000|Overall Study|Physician Decision|1|||
42017882|NCT01265849|75825619|FG001|Overall Study|Physician Decision|2|||
42017883|NCT01265849|75825620|FG002|Overall Study|Physician Decision|0|||
42017884|NCT01265849|75825618|FG000|Overall Study|Lost to Follow-up|18|||
42017885|NCT01265849|75825619|FG001|Overall Study|Lost to Follow-up|15|||
42017886|NCT01265849|75825620|FG002|Overall Study|Lost to Follow-up|5|||
42017887|NCT01265849|75825618|FG000|Overall Study|Not otherwise specified|1|||
42017888|NCT01265849|75825619|FG001|Overall Study|Not otherwise specified|6|||
42017889|NCT01265849|75825620|FG002|Overall Study|Not otherwise specified|1|||
42017890|NCT01265849|75825618|FG000|Overall Study|Withdrawal by Subject|25|||
42017891|NCT01265849|75825619|FG001|Overall Study|Withdrawal by Subject|34|||
42017892|NCT01265849|75825620|FG002|Overall Study|Withdrawal by Subject|13|||
42017893|NCT01265615|75825636|FG000|Overall Study|Protocol Violation|2|||
42017894|NCT01265615|75825637|FG001|Overall Study|Protocol Violation|2|||
42017895|NCT01265615|75825638|FG002|Overall Study|Protocol Violation|4|||
42180362|NCT02761694|75988056|FG000|Overall Study|Lost to Follow-up|0|||
42180363|NCT02761694|75988057|FG001|Overall Study|Lost to Follow-up|0|||
42180364|NCT02761694|75988058|FG002|Overall Study|Lost to Follow-up|0|||
42180365|NCT02761694|75988059|FG003|Overall Study|Lost to Follow-up|0|||
42180366|NCT02761694|75988060|FG004|Overall Study|Lost to Follow-up|0|||
42180367|NCT02761694|75988061|FG005|Overall Study|Lost to Follow-up|0|||
42180368|NCT02761694|75988062|FG006|Overall Study|Lost to Follow-up|1|||
42087146|NCT00806819|75897673|FG001|Overall Study|Worsening or AE of underlying disease|25|||
42087147|NCT00806819|75897672|FG000|Overall Study|Other AE|38|||
42087148|NCT00806819|75897673|FG001|Overall Study|Other AE|40|||
42087149|NCT00806819|75897672|FG000|Overall Study|Protocol Violation|9|||
42087150|NCT00806819|75897673|FG001|Overall Study|Protocol Violation|4|||
42087151|NCT00806819|75897672|FG000|Overall Study|Lost to Follow-up|1|||
42087152|NCT00806819|75897673|FG001|Overall Study|Lost to Follow-up|0|||
42087153|NCT00806819|75897672|FG000|Overall Study|Withdrawal by Subject|32|||
42087154|NCT00806819|75897673|FG001|Overall Study|Withdrawal by Subject|29|||
42087155|NCT00806819|75897672|FG000|Overall Study|Not treated|6|||
42180369|NCT02761694|75988063|FG007|Overall Study|Lost to Follow-up|0|||
42180370|NCT02761694|75988064|FG008|Overall Study|Lost to Follow-up|0|||
42180371|NCT02761694|75988065|FG009|Overall Study|Lost to Follow-up|0|||
42180372|NCT02761694|75988066|FG010|Overall Study|Lost to Follow-up|0|||
42180373|NCT02761694|75988067|FG011|Overall Study|Lost to Follow-up|1|||
42180374|NCT02761694|75988056|FG000|Overall Study|Adverse Event|0|||
42180375|NCT02761694|75988057|FG001|Overall Study|Adverse Event|0|||
42180376|NCT02761694|75988058|FG002|Overall Study|Adverse Event|0|||
42180377|NCT02761694|75988059|FG003|Overall Study|Adverse Event|0|||
42180378|NCT02761694|75988060|FG004|Overall Study|Adverse Event|0|||
42180379|NCT02761694|75988061|FG005|Overall Study|Adverse Event|0|||
42180380|NCT02761694|75988062|FG006|Overall Study|Adverse Event|1|||
42180381|NCT02761694|75988063|FG007|Overall Study|Adverse Event|0|||
42180382|NCT02761694|75988064|FG008|Overall Study|Adverse Event|1|||
42180383|NCT02761694|75988065|FG009|Overall Study|Adverse Event|0|||
42180384|NCT02761694|75988066|FG010|Overall Study|Adverse Event|0|||
42180385|NCT02761694|75988067|FG011|Overall Study|Adverse Event|1|||
42180386|NCT02761694|75988056|FG000|Overall Study|Other|4|||
42180387|NCT02761694|75988057|FG001|Overall Study|Other|4|||
42180388|NCT02761694|75988058|FG002|Overall Study|Other|1|||
42180389|NCT02761694|75988059|FG003|Overall Study|Other|2|||
42180390|NCT02761694|75988060|FG004|Overall Study|Other|3|||
42180391|NCT02761694|75988061|FG005|Overall Study|Other|3|||
42087156|NCT00806819|75897673|FG001|Overall Study|Not treated|3|||
42087157|NCT00806819|75897672|FG000|Overall Study|Reasons other than stated above|25|||
42087158|NCT00806819|75897673|FG001|Overall Study|Reasons other than stated above|41|||
42087159|NCT00801242|75897680|FG000|Overall Study|Adverse Event|10|||
42087160|NCT00801242|75897680|FG000|Overall Study|Withdrawal by Subject|13|||
42087161|NCT00801242|75897680|FG000|Overall Study|Protocol Violation|5|||
42087162|NCT00801242|75897680|FG000|Overall Study|Physician Decision|3|||
42087163|NCT00801242|75897680|FG000|Overall Study|Lost to Follow-up|1|||
42087164|NCT00801242|75897680|FG000|Overall Study|Miscellaneous reasons|20|||
42087165|NCT00800540|75897693|FG000|Period One: 6 Weeks|Noncompliance|1|||
42087166|NCT00800540|75897694|FG001|Period One: 6 Weeks|Noncompliance|0|||
42087167|NCT00800540|75897693|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
42087168|NCT00800540|75897694|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
42180392|NCT02761694|75988062|FG006|Overall Study|Other|18|||
42180393|NCT02761694|75988063|FG007|Overall Study|Other|8|||
42180394|NCT02761694|75988064|FG008|Overall Study|Other|0|||
42180395|NCT02761694|75988065|FG009|Overall Study|Other|1|||
42180396|NCT02761694|75988066|FG010|Overall Study|Other|1|||
42180397|NCT02761694|75988067|FG011|Overall Study|Other|0|||
42180398|NCT02574481|75988110|FG000|Overall Study|Withdrawal by Subject|29|||
42180399|NCT02574481|75988111|FG001|Overall Study|Withdrawal by Subject|15|||
42180400|NCT02574481|75988112|FG002|Overall Study|Withdrawal by Subject|4|||
42180401|NCT02574481|75988113|FG003|Overall Study|Withdrawal by Subject|1|||
42180402|NCT02574481|75988110|FG000|Overall Study|Adverse Event|5|||
42358566|NCT04418765|76204319|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
42087169|NCT00800540|75897693|FG000|Period 2: 6 Weeks|Adverse Event|0|||
42087170|NCT00800540|75897694|FG001|Period 2: 6 Weeks|Adverse Event|1|||
42087171|NCT00800384|75897702|FG000|Overall Study|Withdrawal by Subject|24|||
42087172|NCT00800384|75897703|FG001|Overall Study|Withdrawal by Subject|17|||
42087173|NCT00800384|75897702|FG000|Overall Study|Lost to Follow-up|17|||
42087174|NCT00800384|75897703|FG001|Overall Study|Lost to Follow-up|26|||
42087175|NCT00796328|75897710|FG000|Overall Study|experienced hypotension requiring tx|6|||
42180403|NCT02574481|75988111|FG001|Overall Study|Adverse Event|1|||
42087176|NCT00588692|75897716|FG000|Overall Study|Withdrawal by Subject|4|||
42087177|NCT00588692|75897717|FG001|Overall Study|Withdrawal by Subject|2|||
42087178|NCT00588692|75897716|FG000|Overall Study|Hip Surgery|0|||
42180404|NCT02574481|75988112|FG002|Overall Study|Adverse Event|1|||
42180405|NCT02574481|75988113|FG003|Overall Study|Adverse Event|0|||
42180406|NCT02574481|75988110|FG000|Overall Study|Visit Missed|15|||
42180407|NCT02574481|75988111|FG001|Overall Study|Visit Missed|7|||
42087179|NCT00588692|75897717|FG001|Overall Study|Hip Surgery|1|||
42180408|NCT02574481|75988112|FG002|Overall Study|Visit Missed|5|||
42180409|NCT02574481|75988113|FG003|Overall Study|Visit Missed|0|||
42180410|NCT02574481|75988110|FG000|Overall Study|Other|7|||
42180411|NCT02574481|75988111|FG001|Overall Study|Other|2|||
42180412|NCT02574481|75988112|FG002|Overall Study|Other|0|||
42180413|NCT02574481|75988113|FG003|Overall Study|Other|0|||
42180414|NCT02574481|75988110|FG000|Overall Study|Death|48|||
42180415|NCT02574481|75988111|FG001|Overall Study|Death|26|||
42180416|NCT02574481|75988112|FG002|Overall Study|Death|12|||
42180417|NCT02574481|75988113|FG003|Overall Study|Death|4|||
42180418|NCT02574481|75988110|FG000|Overall Study|Physician Decision|5|||
42180419|NCT02574481|75988111|FG001|Overall Study|Physician Decision|2|||
42180420|NCT02574481|75988112|FG002|Overall Study|Physician Decision|0|||
42180421|NCT02574481|75988113|FG003|Overall Study|Physician Decision|0|||
42180422|NCT02574481|75988110|FG000|Overall Study|Lost to Follow-up|5|||
42087180|NCT00588692|75897716|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
42087181|NCT00588692|75897717|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
42087182|NCT00588692|75897716|FG000|Overall Study|Cancer|1|||
42087183|NCT00588692|75897717|FG001|Overall Study|Cancer|0|||
42180423|NCT02574481|75988111|FG001|Overall Study|Lost to Follow-up|1|||
42180424|NCT02574481|75988112|FG002|Overall Study|Lost to Follow-up|3|||
42180425|NCT02574481|75988113|FG003|Overall Study|Lost to Follow-up|0|||
42180426|NCT02438722|75988128|FG000|Overall Study|Adverse Event|12|||
42180427|NCT02438722|75988129|FG001|Overall Study|Adverse Event|9|||
42180428|NCT02438722|75988128|FG000|Overall Study|Refusal unrelated to AE|2|||
42180429|NCT02438722|75988129|FG001|Overall Study|Refusal unrelated to AE|5|||
42180430|NCT02438722|75988128|FG000|Overall Study|Disease progression/relapse|46|||
42180431|NCT02438722|75988129|FG001|Overall Study|Disease progression/relapse|51|||
42180432|NCT02438722|75988128|FG000|Overall Study|Death|0|||
42180433|NCT02438722|75988129|FG001|Overall Study|Death|3|||
42180434|NCT02438722|75988128|FG000|Overall Study|Physician Decision|2|||
42180435|NCT02438722|75988129|FG001|Overall Study|Physician Decision|2|||
42180436|NCT02438722|75988128|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
42087184|NCT00588692|75897716|FG000|Overall Study|Death|1|||
42087185|NCT00588692|75897717|FG001|Overall Study|Death|0|||
42087186|NCT00588146|75897725|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
42087187|NCT00588146|75897726|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
42087188|NCT00795704|75897734|FG000|Overall Study|Withdrawal by Subject|3|||
42087189|NCT00795704|75897735|FG001|Overall Study|Withdrawal by Subject|2|||
42087190|NCT00795704|75897734|FG000|Overall Study|Adverse Event|1|||
42087191|NCT00795704|75897735|FG001|Overall Study|Adverse Event|1|||
42087192|NCT00444457|75897745|FG000|Infant Series|Other|0|||
42087193|NCT00444457|75897746|FG001|Infant Series|Other|1|||
42087194|NCT00444457|75897747|FG002|Infant Series|Other|0|||
42087195|NCT00444457|75897748|FG003|Infant Series|Other|0|||
42087196|NCT00444457|75897745|FG000|Infant Series|Parent or legal guardian request|18|||
42087197|NCT00444457|75897746|FG001|Infant Series|Parent or legal guardian request|29|||
42087198|NCT00444457|75897747|FG002|Infant Series|Parent or legal guardian request|34|||
42087199|NCT00444457|75897748|FG003|Infant Series|Parent or legal guardian request|14|||
42087200|NCT00444457|75897745|FG000|Infant Series|Lost to Follow-up|10|||
42087201|NCT00444457|75897746|FG001|Infant Series|Lost to Follow-up|11|||
42087202|NCT00444457|75897747|FG002|Infant Series|Lost to Follow-up|7|||
42087203|NCT00444457|75897748|FG003|Infant Series|Lost to Follow-up|6|||
42087204|NCT00444457|75897745|FG000|Infant Series|Protocol Violation|16|||
42087205|NCT00444457|75897746|FG001|Infant Series|Protocol Violation|8|||
42087206|NCT00444457|75897747|FG002|Infant Series|Protocol Violation|6|||
42087207|NCT00444457|75897748|FG003|Infant Series|Protocol Violation|3|||
42087208|NCT00444457|75897745|FG000|Infant Series|Failed to return|5|||
42087209|NCT00444457|75897746|FG001|Infant Series|Failed to return|4|||
42087210|NCT00444457|75897747|FG002|Infant Series|Failed to return|4|||
42087211|NCT00444457|75897748|FG003|Infant Series|Failed to return|2|||
42087212|NCT00444457|75897745|FG000|Infant Series|Investigator request|4|||
42087213|NCT00444457|75897746|FG001|Infant Series|Investigator request|3|||
42087214|NCT00444457|75897747|FG002|Infant Series|Investigator request|3|||
42087215|NCT00444457|75897748|FG003|Infant Series|Investigator request|2|||
42087216|NCT00444457|75897745|FG000|Infant Series|Other|0|||
42087217|NCT00444457|75897746|FG001|Infant Series|Other|2|||
42180437|NCT02438722|75988129|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
42294340|NCT02468232|76128744|FG001|Core Part of Study|Adverse Event|1|||
42087218|NCT00444457|75897747|FG002|Infant Series|Other|4|||
42087219|NCT00444457|75897748|FG003|Infant Series|Other|0|||
42087220|NCT00444457|75897745|FG000|Infant Series|Adverse Event|1|||
42087221|NCT00444457|75897746|FG001|Infant Series|Adverse Event|2|||
42087222|NCT00444457|75897747|FG002|Infant Series|Adverse Event|2|||
42087223|NCT00444457|75897748|FG003|Infant Series|Adverse Event|0|||
42180438|NCT02438722|75988128|FG000|Overall Study|Withdrawal by Subject|0|||
42180439|NCT02438722|75988129|FG001|Overall Study|Withdrawal by Subject|1|||
42180440|NCT02438722|75988128|FG000|Overall Study|On protocol treatment|15|||
42087224|NCT00444457|75897745|FG000|Infant Series|Death|0|||
42087225|NCT00444457|75897746|FG001|Infant Series|Death|1|||
42087226|NCT00444457|75897747|FG002|Infant Series|Death|1|||
42087227|NCT00444457|75897748|FG003|Infant Series|Death|1|||
42180441|NCT02438722|75988129|FG001|Overall Study|On protocol treatment|14|||
42180442|NCT02438722|75988128|FG000|Overall Study|Did not receive protocol treatment|5|||
42180443|NCT02438722|75988129|FG001|Overall Study|Did not receive protocol treatment|0|||
42087228|NCT00444457|75897745|FG000|After Infant Series|Other|0|||
42087229|NCT00444457|75897746|FG001|After Infant Series|Other|1|||
42087230|NCT00444457|75897747|FG002|After Infant Series|Other|1|||
42087231|NCT00444457|75897748|FG003|After Infant Series|Other|1|||
42087232|NCT00444457|75897745|FG000|After Infant Series|Parent or legal guardian request|4|||
42087233|NCT00444457|75897746|FG001|After Infant Series|Parent or legal guardian request|11|||
42087234|NCT00444457|75897747|FG002|After Infant Series|Parent or legal guardian request|6|||
42087235|NCT00444457|75897748|FG003|After Infant Series|Parent or legal guardian request|3|||
42087236|NCT00444457|75897745|FG000|After Infant Series|Failed to return|7|||
42087237|NCT00444457|75897746|FG001|After Infant Series|Failed to return|6|||
42087238|NCT00444457|75897747|FG002|After Infant Series|Failed to return|5|||
42087239|NCT00444457|75897748|FG003|After Infant Series|Failed to return|1|||
42087240|NCT00444457|75897745|FG000|After Infant Series|Lost to Follow-up|5|||
42087241|NCT00444457|75897746|FG001|After Infant Series|Lost to Follow-up|5|||
42087242|NCT00444457|75897747|FG002|After Infant Series|Lost to Follow-up|5|||
42180444|NCT02376829|75988146|FG000|Overall Study|Withdrawal by Subject|27|||
42180445|NCT02376829|75988147|FG001|Overall Study|Withdrawal by Subject|44|||
42180446|NCT02297438|75988156|FG000|Overall Study|Death|79|||
42180447|NCT02297438|75988157|FG001|Overall Study|Death|86|||
42180448|NCT02297438|75988156|FG000|Overall Study|Lost to Follow-up|9|||
42180449|NCT02297438|75988157|FG001|Overall Study|Lost to Follow-up|7|||
42087243|NCT00444457|75897748|FG003|After Infant Series|Lost to Follow-up|2|||
42087244|NCT00444457|75897745|FG000|After Infant Series|Protocol Violation|2|||
42087245|NCT00444457|75897746|FG001|After Infant Series|Protocol Violation|4|||
42087246|NCT00444457|75897747|FG002|After Infant Series|Protocol Violation|2|||
42087247|NCT00444457|75897748|FG003|After Infant Series|Protocol Violation|2|||
42087248|NCT00444457|75897745|FG000|After Infant Series|Adverse Event|2|||
42087249|NCT00444457|75897746|FG001|After Infant Series|Adverse Event|2|||
42087250|NCT00444457|75897747|FG002|After Infant Series|Adverse Event|0|||
42087251|NCT00444457|75897748|FG003|After Infant Series|Adverse Event|0|||
42087252|NCT00444457|75897745|FG000|After Infant Series|Investigator request|0|||
42087253|NCT00444457|75897746|FG001|After Infant Series|Investigator request|0|||
42087254|NCT00444457|75897747|FG002|After Infant Series|Investigator request|0|||
42087255|NCT00444457|75897748|FG003|After Infant Series|Investigator request|1|||
42180450|NCT02297438|75988156|FG000|Overall Study|Withdrawal by Subject|7|||
42180451|NCT02297438|75988157|FG001|Overall Study|Withdrawal by Subject|0|||
42180452|NCT02297438|75988156|FG000|Overall Study|Other|9|||
42180453|NCT02297438|75988157|FG001|Overall Study|Other|5|||
42180454|NCT02297438|75988156|FG000|Overall Study|Ongoing|65|||
42180455|NCT02297438|75988157|FG001|Overall Study|Ongoing|73|||
42180456|NCT02297139|75988165|FG000|Overall Study|Disease progression|0|||
42180457|NCT02297139|75988166|FG001|Overall Study|Disease progression|1|||
42180458|NCT02297139|75988165|FG000|Overall Study|Study drug toxicity|0|||
42180459|NCT02297139|75988166|FG001|Overall Study|Study drug toxicity|4|||
42180460|NCT02297139|75988165|FG000|Overall Study|Participant request to discontinue study treatment|0|||
42180461|NCT02297139|75988166|FG001|Overall Study|Participant request to discontinue study treatment|1|||
42180462|NCT02297139|75988165|FG000|Overall Study|Maximum clinical benefit|1|||
42180463|NCT02297139|75988166|FG001|Overall Study|Maximum clinical benefit|0|||
42180464|NCT02297139|75988165|FG000|Overall Study|Administrative reason by sponsor|0|||
42180465|NCT02297139|75988166|FG001|Overall Study|Administrative reason by sponsor|2|||
42180466|NCT02297139|75988165|FG000|Overall Study|Other reasons|0|||
42180467|NCT02297139|75988166|FG001|Overall Study|Other reasons|8|||
42180468|NCT02100722|75988183|FG000|Overall Study|Withdrawal pre-procedure|4|||
42180469|NCT02100722|75988184|FG001|Overall Study|Withdrawal pre-procedure|9|||
42180470|NCT02100722|75988183|FG000|Overall Study|Withdrawal post-procedure|0|||
42180471|NCT02100722|75988184|FG001|Overall Study|Withdrawal post-procedure|3|||
42180472|NCT02100722|75988183|FG000|Overall Study|Lost to Follow-up|2|||
42087256|NCT00444457|75897745|FG000|After Infant Series|Other|0|||
42180473|NCT02100722|75988184|FG001|Overall Study|Lost to Follow-up|2|||
42180474|NCT02100722|75988183|FG000|Overall Study|Continuing on study|751|||
42180475|NCT02100722|75988184|FG001|Overall Study|Continuing on study|729|||
42180476|NCT02028988|75988200|FG000|Overall Study|Withdrawal by Subject|2|||
42180477|NCT02004236|75988207|FG000|Overall Study|Lack of Efficacy|0|||
42180478|NCT02004236|75988208|FG001|Overall Study|Lack of Efficacy|0|||
42180479|NCT02004236|75988209|FG002|Overall Study|Lack of Efficacy|16|||
42180480|NCT01642251|75988239|FG000|Overall Study|Progressive disease|0|||
42180481|NCT01642251|75988240|FG001|Overall Study|Progressive disease|0|||
42180482|NCT01642251|75988241|FG002|Overall Study|Progressive disease|3|||
42180483|NCT01642251|75988242|FG003|Overall Study|Progressive disease|3|||
42180484|NCT01642251|75988239|FG000|Overall Study|Adverse Event|0|||
42180485|NCT01642251|75988240|FG001|Overall Study|Adverse Event|0|||
42087257|NCT00444457|75897746|FG001|After Infant Series|Other|1|||
42087258|NCT00444457|75897747|FG002|After Infant Series|Other|0|||
42087259|NCT00444457|75897748|FG003|After Infant Series|Other|0|||
42180486|NCT01642251|75988241|FG002|Overall Study|Adverse Event|5|||
42180487|NCT01642251|75988242|FG003|Overall Study|Adverse Event|4|||
42180488|NCT01642251|75988239|FG000|Overall Study|Death|0|||
42180489|NCT01642251|75988240|FG001|Overall Study|Death|0|||
42180490|NCT01642251|75988241|FG002|Overall Study|Death|1|||
42180491|NCT01642251|75988242|FG003|Overall Study|Death|3|||
42180492|NCT01642251|75988239|FG000|Overall Study|Withdrawal by Subject|0|||
42180493|NCT01642251|75988240|FG001|Overall Study|Withdrawal by Subject|0|||
42180494|NCT01642251|75988241|FG002|Overall Study|Withdrawal by Subject|1|||
42180495|NCT01642251|75988242|FG003|Overall Study|Withdrawal by Subject|3|||
42180496|NCT01642251|75988239|FG000|Overall Study|Alternative therapy|0|||
42180497|NCT01642251|75988240|FG001|Overall Study|Alternative therapy|0|||
42180498|NCT01642251|75988241|FG002|Overall Study|Alternative therapy|0|||
42180499|NCT01642251|75988242|FG003|Overall Study|Alternative therapy|2|||
42180500|NCT01642251|75988239|FG000|Overall Study|Other complicating disease|0|||
42180501|NCT01642251|75988240|FG001|Overall Study|Other complicating disease|0|||
42087260|NCT00444457|75897745|FG000|Toddler Dose|Lost to Follow-up|4|||
42087261|NCT00444457|75897746|FG001|Toddler Dose|Lost to Follow-up|1|||
42087262|NCT00444457|75897747|FG002|Toddler Dose|Lost to Follow-up|1|||
42087263|NCT00444457|75897748|FG003|Toddler Dose|Lost to Follow-up|3|||
42087264|NCT00444457|75897745|FG000|Toddler Dose|Failed to return|2|||
42087265|NCT00444457|75897746|FG001|Toddler Dose|Failed to return|2|||
42087266|NCT00444457|75897747|FG002|Toddler Dose|Failed to return|1|||
42087267|NCT00444457|75897748|FG003|Toddler Dose|Failed to return|3|||
42087268|NCT00444457|75897745|FG000|Toddler Dose|Parent or legal guardian request|0|||
42087269|NCT00444457|75897746|FG001|Toddler Dose|Parent or legal guardian request|3|||
42087270|NCT00444457|75897747|FG002|Toddler Dose|Parent or legal guardian request|2|||
42087271|NCT00444457|75897748|FG003|Toddler Dose|Parent or legal guardian request|1|||
42087272|NCT00444457|75897745|FG000|Toddler Dose|Protocol Violation|1|||
42087273|NCT00444457|75897746|FG001|Toddler Dose|Protocol Violation|0|||
42087274|NCT00444457|75897747|FG002|Toddler Dose|Protocol Violation|0|||
42087275|NCT00444457|75897748|FG003|Toddler Dose|Protocol Violation|1|||
42087276|NCT00799058|75897772|FG000|Overall Study|Withdrawal by Subject|2|||
42087277|NCT00799058|75897773|FG001|Overall Study|Withdrawal by Subject|2|||
42087278|NCT00799058|75897774|FG002|Overall Study|Withdrawal by Subject|2|||
42087279|NCT00799058|75897772|FG000|Overall Study|Lost to Follow-up|1|||
42180502|NCT01642251|75988241|FG002|Overall Study|Other complicating disease|1|||
42180503|NCT01642251|75988242|FG003|Overall Study|Other complicating disease|0|||
42180504|NCT01642251|75988239|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
42180505|NCT01642251|75988240|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
42180506|NCT01642251|75988241|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
42180507|NCT01642251|75988242|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
42180508|NCT01606137|75988251|FG000|Overall Study|Adverse Event|85|||
42180509|NCT01606137|75988251|FG000|Overall Study|Withdrawal by Subject|74|||
42180510|NCT01606137|75988251|FG000|Overall Study|Lack of Efficacy|56|||
42180511|NCT01606137|75988251|FG000|Overall Study|Lost to Follow-up|15|||
42180512|NCT01606137|75988251|FG000|Overall Study|Protocol Violation|1|||
42087280|NCT00799058|75897773|FG001|Overall Study|Lost to Follow-up|2|||
42087281|NCT00799058|75897774|FG002|Overall Study|Lost to Follow-up|1|||
42087282|NCT00799058|75897772|FG000|Overall Study|Adverse Event|0|||
42087283|NCT00799058|75897773|FG001|Overall Study|Adverse Event|2|||
42087284|NCT00799058|75897774|FG002|Overall Study|Adverse Event|0|||
42087285|NCT00799058|75897772|FG000|Overall Study|Pregnancy|1|||
42087286|NCT00799058|75897773|FG001|Overall Study|Pregnancy|0|||
42087287|NCT00799058|75897774|FG002|Overall Study|Pregnancy|0|||
42087288|NCT00799058|75897772|FG000|Overall Study|Not adherent|3|||
42087289|NCT00799058|75897773|FG001|Overall Study|Not adherent|2|||
42087290|NCT00799058|75897774|FG002|Overall Study|Not adherent|1|||
42087291|NCT00799058|75897772|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
42087292|NCT00799058|75897773|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
42087293|NCT00799058|75897774|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
42180513|NCT01606137|75988251|FG000|Overall Study|Patient non-compliance|9|||
42180514|NCT01606137|75988251|FG000|Overall Study|Death|1|||
42180515|NCT01606137|75988251|FG000|Overall Study|Decreased/no pain|4|||
42180516|NCT01606137|75988251|FG000|Overall Study|Issues with driving|4|||
42180517|NCT01606137|75988251|FG000|Overall Study|multiple sclerosis less stable|1|||
42087294|NCT00799058|75897772|FG000|Overall Study|IP dispensing error|1|||
42087295|NCT00799058|75897773|FG001|Overall Study|IP dispensing error|0|||
42087296|NCT00799058|75897774|FG002|Overall Study|IP dispensing error|0|||
42087297|NCT00799058|75897772|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
42180518|NCT01606137|75988251|FG000|Overall Study|Increased bilirubin|1|||
42180519|NCT01606137|75988251|FG000|Overall Study|Spray causes nausea|1|||
42180520|NCT01606137|75988251|FG000|Overall Study|Not enough improvement|4|||
42087298|NCT00799058|75897773|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
42294341|NCT02468232|76128745|FG002|Core Part of Study|Adverse Event|0|||
42294342|NCT02468232|76128746|FG003|Core Part of Study|Adverse Event|0|||
42294343|NCT02468232|76128743|FG000|Core Part of Study|Death|20|||
42294344|NCT02468232|76128744|FG001|Core Part of Study|Death|17|||
42294345|NCT02468232|76128745|FG002|Core Part of Study|Death|0|||
42294346|NCT02468232|76128746|FG003|Core Part of Study|Death|0|||
42087299|NCT00799058|75897774|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
42087300|NCT00799058|75897772|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
42087301|NCT00799058|75897773|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
42087302|NCT00799058|75897774|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
42087303|NCT00799058|75897772|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
42087304|NCT00799058|75897773|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
42087305|NCT00799058|75897774|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
42087306|NCT00799058|75897772|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
42087307|NCT00799058|75897773|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
42087308|NCT00799058|75897774|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
42087309|NCT00725985|75897787|FG000|ITP- Treatment Disposition|Adverse Event|20|||
42087310|NCT00725985|75897788|FG001|ITP- Treatment Disposition|Adverse Event|10|||
42087311|NCT00725985|75897789|FG002|ITP- Treatment Disposition|Adverse Event|5|||
42087312|NCT00725985|75897790|FG003|ITP- Treatment Disposition|Adverse Event|0|||
42087313|NCT00725985|75897791|FG004|ITP- Treatment Disposition|Adverse Event|0|||
42087314|NCT00725985|75897792|FG005|ITP- Treatment Disposition|Adverse Event|0|||
42087315|NCT00725985|75897793|FG006|ITP- Treatment Disposition|Adverse Event|0|||
42087316|NCT00725985|75897794|FG007|ITP- Treatment Disposition|Adverse Event|0|||
42087317|NCT00725985|75897795|FG008|ITP- Treatment Disposition|Adverse Event|0|||
42087318|NCT00725985|75897796|FG009|ITP- Treatment Disposition|Adverse Event|0|||
42087319|NCT00725985|75897797|FG010|ITP- Treatment Disposition|Adverse Event|0|||
42087320|NCT00725985|75897798|FG011|ITP- Treatment Disposition|Adverse Event|0|||
42087321|NCT00725985|75897787|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
42087322|NCT00725985|75897788|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
42087323|NCT00725985|75897789|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
42087324|NCT00725985|75897790|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
42087325|NCT00725985|75897791|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
42087326|NCT00725985|75897792|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
42087327|NCT00725985|75897793|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
42087328|NCT00725985|75897794|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
42087329|NCT00725985|75897795|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
42087330|NCT00725985|75897796|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
42087331|NCT00725985|75897797|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
42087332|NCT00725985|75897798|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
42294347|NCT02468232|76128743|FG000|Core Part of Study|Technical Problems|1|||
42294348|NCT02468232|76128744|FG001|Core Part of Study|Technical Problems|1|||
42294349|NCT02468232|76128745|FG002|Core Part of Study|Technical Problems|0|||
42180521|NCT01606137|75988251|FG000|Overall Study|Wanted to try another treatment|1|||
42180522|NCT01606137|75988251|FG000|Overall Study|Patient leaving country|1|||
42180523|NCT01606137|75988251|FG000|Overall Study|Personal reasons|1|||
42180524|NCT01606137|75988251|FG000|Overall Study|Unable to tolerate study med. taste|1|||
42180525|NCT01606137|75988251|FG000|Overall Study|Patient moving|1|||
42180526|NCT01606137|75988251|FG000|Overall Study|Unable to collect consistent data|1|||
42180527|NCT01532518|75988258|FG000|Overall Study|Withdrawal by Subject|0|||
42180528|NCT01532518|75988259|FG001|Overall Study|Withdrawal by Subject|0|||
42180529|NCT01532518|75988260|FG002|Overall Study|Withdrawal by Subject|1|||
42180530|NCT00844285|75988288|FG000|Overall Study|Other|0|||
42180531|NCT00844285|75988289|FG001|Overall Study|Other|1|||
42180532|NCT00844285|75988290|FG002|Overall Study|Other|0|||
42180533|NCT00844285|75988288|FG000|Overall Study|Other than specified|95|||
42180534|NCT00844285|75988289|FG001|Overall Study|Other than specified|129|||
42180535|NCT00844285|75988290|FG002|Overall Study|Other than specified|12|||
42180536|NCT00844285|75988288|FG000|Overall Study|Site closure|256|||
42180537|NCT00844285|75988289|FG001|Overall Study|Site closure|450|||
42087333|NCT00725985|75897787|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
42087334|NCT00725985|75897788|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
42087335|NCT00725985|75897789|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
42087336|NCT00725985|75897790|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
42087337|NCT00725985|75897791|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
42087338|NCT00725985|75897792|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
42087339|NCT00725985|75897793|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
42087340|NCT00725985|75897794|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
42087341|NCT00725985|75897795|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
42087342|NCT00725985|75897796|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
42180538|NCT00844285|75988290|FG002|Overall Study|Site closure|50|||
42180539|NCT00844285|75988288|FG000|Overall Study|Follow-up < 8 years|16|||
42180540|NCT00844285|75988289|FG001|Overall Study|Follow-up < 8 years|23|||
42180541|NCT00844285|75988290|FG002|Overall Study|Follow-up < 8 years|4|||
42180542|NCT00844285|75988288|FG000|Overall Study|Protocol Violation|26|||
42180543|NCT00844285|75988289|FG001|Overall Study|Protocol Violation|28|||
42180544|NCT00844285|75988290|FG002|Overall Study|Protocol Violation|54|||
42180545|NCT00844285|75988288|FG000|Overall Study|Death|22|||
42180546|NCT00844285|75988289|FG001|Overall Study|Death|21|||
42180547|NCT00844285|75988290|FG002|Overall Study|Death|8|||
42180548|NCT00844285|75988288|FG000|Overall Study|Withdrew Consent|344|||
42180549|NCT00844285|75988289|FG001|Overall Study|Withdrew Consent|466|||
42180550|NCT00844285|75988290|FG002|Overall Study|Withdrew Consent|70|||
42180551|NCT00844285|75988288|FG000|Overall Study|Lost to Follow-up|330|||
42180552|NCT00844285|75988289|FG001|Overall Study|Lost to Follow-up|486|||
42180553|NCT00844285|75988290|FG002|Overall Study|Lost to Follow-up|74|||
42180554|NCT00711646|75988318|FG000|Overall Study|Adverse Event|6|||
42180555|NCT00711646|75988319|FG001|Overall Study|Adverse Event|1|||
42180556|NCT00711646|75988318|FG000|Overall Study|Withdrawal by Subject|4|||
42180557|NCT00711646|75988319|FG001|Overall Study|Withdrawal by Subject|0|||
42180558|NCT00711646|75988318|FG000|Overall Study|Protocol Violation|0|||
42180559|NCT00711646|75988319|FG001|Overall Study|Protocol Violation|1|||
42180560|NCT00711646|75988318|FG000|Overall Study|Lost to Follow-up|1|||
42180561|NCT00711646|75988319|FG001|Overall Study|Lost to Follow-up|0|||
42180562|NCT00711646|75988318|FG000|Overall Study|administrative decision|0|||
42180563|NCT00711646|75988319|FG001|Overall Study|administrative decision|1|||
42180564|NCT00711646|75988318|FG000|Overall Study|patient non-compliance|1|||
42180565|NCT00711646|75988319|FG001|Overall Study|patient non-compliance|0|||
42180566|NCT00640133|75988345|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
42180567|NCT00640133|75988346|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
42180568|NCT00640133|75988345|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
42180569|NCT00640133|75988346|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
42180570|NCT00640133|75988345|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
42087343|NCT00725985|75897797|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
42087344|NCT00725985|75897798|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
42180571|NCT00640133|75988346|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
42087345|NCT00725985|75897787|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
42087346|NCT00725985|75897788|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
42180572|NCT00379340|75988359|FG000|Overall Study|Death|0|||
42180573|NCT00379340|75988360|FG001|Overall Study|Death|0|||
42180574|NCT00379340|75988361|FG002|Overall Study|Death|0|||
42180575|NCT00379340|75988362|FG003|Overall Study|Death|2|||
42180576|NCT00379340|75988363|FG004|Overall Study|Death|0|||
42180577|NCT00379340|75988359|FG000|Overall Study|Lack of Efficacy|6|||
42180578|NCT00379340|75988360|FG001|Overall Study|Lack of Efficacy|1|||
42180579|NCT00379340|75988361|FG002|Overall Study|Lack of Efficacy|0|||
42180580|NCT00379340|75988362|FG003|Overall Study|Lack of Efficacy|4|||
42180581|NCT00379340|75988363|FG004|Overall Study|Lack of Efficacy|3|||
42087347|NCT00725985|75897789|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
42087348|NCT00725985|75897790|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
42087349|NCT00725985|75897791|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
42087350|NCT00725985|75897792|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
42087351|NCT00725985|75897793|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
42087352|NCT00725985|75897794|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
42180582|NCT00379340|75988359|FG000|Overall Study|Physician Decision|6|||
42180583|NCT00379340|75988360|FG001|Overall Study|Physician Decision|2|||
42180584|NCT00379340|75988361|FG002|Overall Study|Physician Decision|1|||
42180585|NCT00379340|75988362|FG003|Overall Study|Physician Decision|2|||
42087353|NCT00725985|75897795|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
42087354|NCT00725985|75897796|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
42087355|NCT00725985|75897797|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
42087356|NCT00725985|75897798|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
42087357|NCT00725985|75897787|FG000|ITP- Treatment Disposition|Other|50|||
42087358|NCT00725985|75897788|FG001|ITP- Treatment Disposition|Other|38|||
42087359|NCT00725985|75897789|FG002|ITP- Treatment Disposition|Other|24|||
42087360|NCT00725985|75897790|FG003|ITP- Treatment Disposition|Other|0|||
42087361|NCT00725985|75897791|FG004|ITP- Treatment Disposition|Other|0|||
42087362|NCT00725985|75897792|FG005|ITP- Treatment Disposition|Other|0|||
42180586|NCT00379340|75988363|FG004|Overall Study|Physician Decision|3|||
42180587|NCT00379340|75988359|FG000|Overall Study|Withdrawal by Subject|0|||
42180588|NCT00379340|75988360|FG001|Overall Study|Withdrawal by Subject|0|||
42180589|NCT00379340|75988361|FG002|Overall Study|Withdrawal by Subject|0|||
42180590|NCT00379340|75988362|FG003|Overall Study|Withdrawal by Subject|1|||
42180591|NCT00379340|75988363|FG004|Overall Study|Withdrawal by Subject|0|||
42180592|NCT00379340|75988359|FG000|Overall Study|Refusal of further protocol therapy|1|||
42180593|NCT00379340|75988360|FG001|Overall Study|Refusal of further protocol therapy|0|||
42180594|NCT00379340|75988361|FG002|Overall Study|Refusal of further protocol therapy|1|||
42180595|NCT00379340|75988362|FG003|Overall Study|Refusal of further protocol therapy|1|||
42180596|NCT00379340|75988363|FG004|Overall Study|Refusal of further protocol therapy|7|||
42180597|NCT00379340|75988359|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
42180598|NCT00379340|75988360|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
42180599|NCT00379340|75988361|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
42180600|NCT00379340|75988362|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
42180601|NCT00379340|75988363|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
42180602|NCT00379340|75988359|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
42180603|NCT00379340|75988360|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
42180604|NCT00379340|75988361|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
42180605|NCT00379340|75988362|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
42180606|NCT00379340|75988363|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
42180607|NCT00301808|75988376|FG000|Overall Study|Adverse Event|5|||
42180608|NCT00301808|75988376|FG000|Overall Study|Death|3|||
42180609|NCT00301808|75988376|FG000|Overall Study|Lack of Efficacy|4|||
42180610|NCT04979858|75988404|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
42180611|NCT04979858|75988405|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
42180612|NCT04030598|75988453|FG000|Overall Study|Voluntary Withdrawal|0|||
42180613|NCT04030598|75988454|FG001|Overall Study|Voluntary Withdrawal|1|||
42180614|NCT04030598|75988455|FG002|Overall Study|Voluntary Withdrawal|0|||
42180615|NCT03777436|75988474|FG000|Placebo-controlled Phase|Adverse Event|8|||
42180616|NCT03777436|75988475|FG001|Placebo-controlled Phase|Adverse Event|10|||
42180617|NCT03777436|75988476|FG002|Placebo-controlled Phase|Adverse Event|0|||
42180618|NCT03777436|75988474|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
42180619|NCT03777436|75988475|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
42180620|NCT03777436|75988476|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
42180621|NCT03777436|75988474|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
42180622|NCT03777436|75988475|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
42180623|NCT03777436|75988476|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
42180624|NCT03777436|75988474|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
42180625|NCT03777436|75988475|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
42358567|NCT04418765|76204320|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
42087363|NCT00725985|75897793|FG006|ITP- Treatment Disposition|Other|0|||
42087364|NCT00725985|75897794|FG007|ITP- Treatment Disposition|Other|0|||
42087365|NCT00725985|75897795|FG008|ITP- Treatment Disposition|Other|0|||
42358568|NCT04418765|76204318|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
42087366|NCT00725985|75897796|FG009|ITP- Treatment Disposition|Other|0|||
42087367|NCT00725985|75897797|FG010|ITP- Treatment Disposition|Other|0|||
42087368|NCT00725985|75897798|FG011|ITP- Treatment Disposition|Other|0|||
42180626|NCT03777436|75988476|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
42180627|NCT03777436|75988474|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
42087369|NCT00725985|75897787|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
42087370|NCT00725985|75897788|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
42180628|NCT03777436|75988475|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
42180629|NCT03777436|75988476|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
42180630|NCT03777436|75988474|FG000|Placebo-controlled Phase|Physician Decision|0|||
42180631|NCT03777436|75988475|FG001|Placebo-controlled Phase|Physician Decision|1|||
42180632|NCT03777436|75988476|FG002|Placebo-controlled Phase|Physician Decision|0|||
42180633|NCT03777436|75988474|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
42180634|NCT03777436|75988475|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
42180635|NCT03777436|75988476|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
42180636|NCT03777436|75988474|FG000|Apremilast Extension Phase|Adverse Event|0|||
42180637|NCT03777436|75988475|FG001|Apremilast Extension Phase|Adverse Event|0|||
42180638|NCT03777436|75988476|FG002|Apremilast Extension Phase|Adverse Event|6|||
42180639|NCT03777436|75988474|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
42180640|NCT03777436|75988475|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
42180641|NCT03777436|75988476|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
42180642|NCT03777436|75988474|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
42180643|NCT03777436|75988475|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
42180644|NCT03777436|75988476|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
42180645|NCT03777436|75988474|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
42180646|NCT03777436|75988475|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
42180647|NCT03777436|75988476|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
42180648|NCT03777436|75988474|FG000|Apremilast Extension Phase|Miscellaneous|0|||
42180649|NCT03777436|75988475|FG001|Apremilast Extension Phase|Miscellaneous|0|||
42180650|NCT03777436|75988476|FG002|Apremilast Extension Phase|Miscellaneous|1|||
42180651|NCT03156023|75988492|FG000|Overall Study|Withdrawal by Subject|1|||
42180652|NCT03156023|75988493|FG001|Overall Study|Withdrawal by Subject|0|||
42180653|NCT03156023|75988494|FG002|Overall Study|Withdrawal by Subject|2|||
42180654|NCT03156023|75988495|FG003|Overall Study|Withdrawal by Subject|1|||
42180655|NCT03156023|75988496|FG004|Overall Study|Withdrawal by Subject|1|||
42180656|NCT03156023|75988492|FG000|Overall Study|Lost to Follow-up|0|||
42180657|NCT03156023|75988493|FG001|Overall Study|Lost to Follow-up|0|||
42180658|NCT03156023|75988494|FG002|Overall Study|Lost to Follow-up|0|||
42180659|NCT03156023|75988495|FG003|Overall Study|Lost to Follow-up|0|||
42180660|NCT03156023|75988496|FG004|Overall Study|Lost to Follow-up|1|||
42180661|NCT03025880|75988514|FG000|Overall Study|Adverse Event|1|||
42180662|NCT03025880|75988515|FG001|Overall Study|Adverse Event|0|||
42180663|NCT03025880|75988514|FG000|Overall Study|Death|1|||
42180664|NCT03025880|75988515|FG001|Overall Study|Death|1|||
42294350|NCT02468232|76128746|FG003|Core Part of Study|Technical Problems|0|||
42294351|NCT02468232|76128743|FG000|OLE Part of Study|Adverse Event|0|||
42087371|NCT00725985|75897789|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
42087372|NCT00725985|75897790|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
42087373|NCT00725985|75897791|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
42087374|NCT00725985|75897792|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
42087375|NCT00725985|75897793|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
42087376|NCT00725985|75897794|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
42087377|NCT00725985|75897795|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
42087378|NCT00725985|75897796|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
42087379|NCT00725985|75897797|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
42087380|NCT00725985|75897798|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
42087381|NCT00725985|75897787|FG000|OLMP (Up to 96 Weeks)|Death|0|||
42087382|NCT00725985|75897788|FG001|OLMP (Up to 96 Weeks)|Death|0|||
42087383|NCT00725985|75897789|FG002|OLMP (Up to 96 Weeks)|Death|0|||
42087384|NCT00725985|75897790|FG003|OLMP (Up to 96 Weeks)|Death|0|||
42087385|NCT00725985|75897791|FG004|OLMP (Up to 96 Weeks)|Death|1|||
42087386|NCT00725985|75897792|FG005|OLMP (Up to 96 Weeks)|Death|0|||
42087387|NCT00725985|75897793|FG006|OLMP (Up to 96 Weeks)|Death|0|||
42087388|NCT00725985|75897794|FG007|OLMP (Up to 96 Weeks)|Death|0|||
42087389|NCT00725985|75897795|FG008|OLMP (Up to 96 Weeks)|Death|0|||
42087390|NCT00725985|75897796|FG009|OLMP (Up to 96 Weeks)|Death|0|||
42087391|NCT00725985|75897797|FG010|OLMP (Up to 96 Weeks)|Death|0|||
42087392|NCT00725985|75897798|FG011|OLMP (Up to 96 Weeks)|Death|0|||
42087393|NCT00725985|75897787|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
42087394|NCT00725985|75897788|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
42087395|NCT00725985|75897789|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
42087396|NCT00725985|75897790|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
42087397|NCT00725985|75897791|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
42087398|NCT00725985|75897792|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
42087399|NCT00725985|75897793|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
42087400|NCT00725985|75897794|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
42180665|NCT03025880|75988514|FG000|Overall Study|Withdrawal by Subject|0|||
42180666|NCT03025880|75988515|FG001|Overall Study|Withdrawal by Subject|1|||
42180667|NCT03025880|75988514|FG000|Overall Study|Physician Decision|0|||
42180668|NCT03025880|75988515|FG001|Overall Study|Physician Decision|1|||
42294352|NCT02468232|76128744|FG001|OLE Part of Study|Adverse Event|0|||
42294353|NCT02468232|76128745|FG002|OLE Part of Study|Adverse Event|4|||
42087401|NCT00725985|75897795|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
42087402|NCT00725985|75897796|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
42087403|NCT00725985|75897797|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
42087404|NCT00725985|75897798|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
42087405|NCT00725985|75897787|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
42087406|NCT00725985|75897788|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
42087407|NCT00725985|75897789|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
42087408|NCT00725985|75897790|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
42087409|NCT00725985|75897791|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
42087410|NCT00725985|75897792|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
42087411|NCT00725985|75897793|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
42087412|NCT00725985|75897794|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
42087413|NCT00725985|75897795|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
42087414|NCT00725985|75897796|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
42087415|NCT00725985|75897797|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
42087416|NCT00725985|75897798|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
42087417|NCT00725985|75897787|FG000|OLMP (Up to 96 Weeks)|Other|0|||
42087418|NCT00725985|75897788|FG001|OLMP (Up to 96 Weeks)|Other|0|||
42087419|NCT00725985|75897789|FG002|OLMP (Up to 96 Weeks)|Other|0|||
42087420|NCT00725985|75897790|FG003|OLMP (Up to 96 Weeks)|Other|15|||
42087421|NCT00725985|75897791|FG004|OLMP (Up to 96 Weeks)|Other|20|||
42087422|NCT00725985|75897792|FG005|OLMP (Up to 96 Weeks)|Other|44|||
42087423|NCT00725985|75897793|FG006|OLMP (Up to 96 Weeks)|Other|0|||
42087424|NCT00725985|75897794|FG007|OLMP (Up to 96 Weeks)|Other|0|||
42087425|NCT00725985|75897795|FG008|OLMP (Up to 96 Weeks)|Other|0|||
42087426|NCT00725985|75897796|FG009|OLMP (Up to 96 Weeks)|Other|0|||
42087427|NCT00725985|75897797|FG010|OLMP (Up to 96 Weeks)|Other|0|||
42087428|NCT00725985|75897798|FG011|OLMP (Up to 96 Weeks)|Other|0|||
42087429|NCT00725985|75897787|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
42087430|NCT00725985|75897788|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
42087431|NCT00725985|75897789|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
42087432|NCT00725985|75897790|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
42087433|NCT00725985|75897791|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
42087434|NCT00725985|75897792|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
42087435|NCT00725985|75897793|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
42087436|NCT00725985|75897794|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
42180669|NCT03025880|75988514|FG000|Overall Study|Progressive Disease|12|||
42180670|NCT03025880|75988515|FG001|Overall Study|Progressive Disease|19|||
42180671|NCT02027376|75988532|FG000|Overall Study|Death|1|||
42180672|NCT02027376|75988533|FG001|Overall Study|Death|0|||
42180673|NCT02027376|75988534|FG002|Overall Study|Death|0|||
42180674|NCT01924533|75988546|FG000|Overall Study|Death|181|||
42180675|NCT01924533|75988547|FG001|Overall Study|Death|200|||
42180676|NCT01924533|75988546|FG000|Overall Study|Lost to Follow-up|0|||
42180677|NCT01924533|75988547|FG001|Overall Study|Lost to Follow-up|1|||
42180678|NCT01924533|75988546|FG000|Overall Study|Withdrawal by Subject|7|||
42180679|NCT01924533|75988547|FG001|Overall Study|Withdrawal by Subject|3|||
42180680|NCT01924533|75988546|FG000|Overall Study|Other Eligibility criteria|1|||
42180681|NCT01924533|75988547|FG001|Overall Study|Other Eligibility criteria|1|||
42180682|NCT01606436|75988553|FG000|Overall Study|Withdrawal by Subject|0|||
42180683|NCT01606436|75988554|FG001|Overall Study|Withdrawal by Subject|0|||
42180684|NCT01606436|75988555|FG002|Overall Study|Withdrawal by Subject|1|||
42180685|NCT01606436|75988556|FG003|Overall Study|Withdrawal by Subject|1|||
42180686|NCT01606436|75988557|FG004|Overall Study|Withdrawal by Subject|1|||
42180687|NCT01606436|75988558|FG005|Overall Study|Withdrawal by Subject|0|||
42180688|NCT01606436|75988553|FG000|Overall Study|Adverse Event|0|||
42180689|NCT01606436|75988554|FG001|Overall Study|Adverse Event|0|||
42180690|NCT01606436|75988555|FG002|Overall Study|Adverse Event|1|||
42180691|NCT01606436|75988556|FG003|Overall Study|Adverse Event|0|||
42180692|NCT01606436|75988557|FG004|Overall Study|Adverse Event|0|||
42180693|NCT01606436|75988558|FG005|Overall Study|Adverse Event|0|||
42180694|NCT01606436|75988553|FG000|Overall Study|Sponsor Decision|0|||
42180695|NCT01606436|75988554|FG001|Overall Study|Sponsor Decision|0|||
42180696|NCT01606436|75988555|FG002|Overall Study|Sponsor Decision|0|||
42180697|NCT01606436|75988556|FG003|Overall Study|Sponsor Decision|1|||
42180698|NCT01606436|75988557|FG004|Overall Study|Sponsor Decision|0|||
42180699|NCT01606436|75988558|FG005|Overall Study|Sponsor Decision|0|||
42180700|NCT00219557|75988578|FG000|Phase 1|Lack of Efficacy|3|||
42180701|NCT00219557|75988579|FG001|Phase 1|Lack of Efficacy|0|||
42180702|NCT00219557|75988580|FG002|Phase 1|Lack of Efficacy|0|||
42180703|NCT00219557|75988578|FG000|Phase 1|Adverse Event|2|||
42180704|NCT00219557|75988579|FG001|Phase 1|Adverse Event|0|||
42180705|NCT00219557|75988580|FG002|Phase 1|Adverse Event|0|||
42180706|NCT00219557|75988578|FG000|Phase 1|Withdrawal by Subject|1|||
42087437|NCT00725985|75897795|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
42087438|NCT00725985|75897796|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
42087439|NCT00725985|75897797|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
42087440|NCT00725985|75897798|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
42180707|NCT00219557|75988579|FG001|Phase 1|Withdrawal by Subject|0|||
42180708|NCT00219557|75988580|FG002|Phase 1|Withdrawal by Subject|0|||
42087441|NCT00725985|75897787|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
42087442|NCT00725985|75897788|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
42087443|NCT00725985|75897789|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
42087444|NCT00725985|75897790|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
42087445|NCT00725985|75897791|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
42087446|NCT00725985|75897792|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
42087447|NCT00725985|75897793|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
42087448|NCT00725985|75897794|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
42087449|NCT00725985|75897795|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
42087450|NCT00725985|75897796|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
42087451|NCT00725985|75897797|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
42087452|NCT00725985|75897798|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
42087453|NCT00725985|75897787|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
42087454|NCT00725985|75897788|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
42180709|NCT00219557|75988578|FG000|Phase 1|Started chemotherapy at other institute|1|||
42180710|NCT00219557|75988579|FG001|Phase 1|Started chemotherapy at other institute|0|||
42087455|NCT00725985|75897789|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
42180711|NCT00219557|75988580|FG002|Phase 1|Started chemotherapy at other institute|0|||
42180712|NCT00219557|75988578|FG000|Phase 2|Lack of Efficacy|0|||
42180713|NCT00219557|75988579|FG001|Phase 2|Lack of Efficacy|21|||
42180714|NCT00219557|75988580|FG002|Phase 2|Lack of Efficacy|15|||
42180715|NCT00219557|75988578|FG000|Phase 2|Adverse Event|0|||
42180716|NCT00219557|75988579|FG001|Phase 2|Adverse Event|22|||
42180717|NCT00219557|75988580|FG002|Phase 2|Adverse Event|2|||
42087456|NCT00725985|75897790|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
42087457|NCT00725985|75897791|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
42180718|NCT00219557|75988578|FG000|Phase 2|Death|0|||
42180719|NCT00219557|75988579|FG001|Phase 2|Death|8|||
42180720|NCT00219557|75988580|FG002|Phase 2|Death|2|||
42180721|NCT00219557|75988578|FG000|Phase 2|Other|0|||
42180722|NCT00219557|75988579|FG001|Phase 2|Other|8|||
42180723|NCT00219557|75988580|FG002|Phase 2|Other|6|||
42180724|NCT00219557|75988578|FG000|Phase 2|Withdrawal by Subject|0|||
42180725|NCT00219557|75988579|FG001|Phase 2|Withdrawal by Subject|9|||
42180726|NCT00219557|75988580|FG002|Phase 2|Withdrawal by Subject|5|||
42180727|NCT00219557|75988578|FG000|Phase 2|Treatment not received|0|||
42180728|NCT00219557|75988579|FG001|Phase 2|Treatment not received|1|||
42180729|NCT00219557|75988580|FG002|Phase 2|Treatment not received|3|||
42180730|NCT00251927|75988595|FG000|Overall Study|Adverse Event|3|||
42180731|NCT00251927|75988596|FG001|Overall Study|Adverse Event|15|||
42180732|NCT00251927|75988595|FG000|Overall Study|Lack of Efficacy|22|||
42180733|NCT00251927|75988596|FG001|Overall Study|Lack of Efficacy|16|||
42180734|NCT00251927|75988595|FG000|Overall Study|Lost to Follow-up|22|||
42180735|NCT00251927|75988596|FG001|Overall Study|Lost to Follow-up|8|||
42180736|NCT00251927|75988595|FG000|Overall Study|Protocol Violation|1|||
42294354|NCT02468232|76128746|FG003|OLE Part of Study|Adverse Event|5|||
42294355|NCT02468232|76128743|FG000|OLE Part of Study|Death|0|||
42294356|NCT02468232|76128744|FG001|OLE Part of Study|Death|0|||
42294357|NCT02468232|76128745|FG002|OLE Part of Study|Death|4|||
42294358|NCT02468232|76128746|FG003|OLE Part of Study|Death|2|||
42087458|NCT00725985|75897792|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
42087459|NCT00725985|75897793|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
42087460|NCT00725985|75897794|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
42087461|NCT00725985|75897795|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
42087462|NCT00725985|75897796|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
42087463|NCT00725985|75897797|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
42087464|NCT00725985|75897798|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
42087465|NCT00725985|75897787|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
42087466|NCT00725985|75897788|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
42087467|NCT00725985|75897789|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
42180737|NCT00251927|75988596|FG001|Overall Study|Protocol Violation|2|||
42294359|NCT02468232|76128743|FG000|OLE Part of Study|Physician Decision|0|||
42294360|NCT02468232|76128744|FG001|OLE Part of Study|Physician Decision|0|||
42294361|NCT02468232|76128745|FG002|OLE Part of Study|Physician Decision|4|||
42180738|NCT00251927|75988595|FG000|Overall Study|Pregnancy|2|||
42180739|NCT00251927|75988596|FG001|Overall Study|Pregnancy|0|||
42180740|NCT00251927|75988595|FG000|Overall Study|Withdrawal by Subject|40|||
42180741|NCT00251927|75988596|FG001|Overall Study|Withdrawal by Subject|25|||
42180742|NCT00251927|75988595|FG000|Overall Study|Study-specific discont. achieved|13|||
42180743|NCT00251927|75988596|FG001|Overall Study|Study-specific discont. achieved|2|||
42180744|NCT00251927|75988595|FG000|Overall Study|Study procedure non-compliance|5|||
42294362|NCT02468232|76128746|FG003|OLE Part of Study|Physician Decision|0|||
42087468|NCT00725985|75897790|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
42180745|NCT00251927|75988596|FG001|Overall Study|Study procedure non-compliance|6|||
42180746|NCT00165503|75988603|FG000|Overall Study|Death|1|||
42087469|NCT00725985|75897791|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
42180747|NCT00165503|75988603|FG000|Overall Study|Lost to Follow-up|12|||
42180748|NCT00165503|75988603|FG000|Overall Study|Unresectable|3|||
42087470|NCT00725985|75897792|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
42087471|NCT00725985|75897793|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
42087472|NCT00725985|75897794|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
42180749|NCT00162773|75988607|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
42180750|NCT00209339|75988611|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
42180751|NCT00209339|75988611|FG000|At 12 Months Follow-up|Death|1|||
42180752|NCT00209339|75988611|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
42180753|NCT00209339|75988611|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
42180754|NCT00209339|75988611|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
42180755|NCT00209339|75988611|FG000|At 24 Months Follow-up|Death|1|||
42180756|NCT00209339|75988611|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
42180757|NCT00209339|75988611|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
42087473|NCT00725985|75897795|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
42087474|NCT00725985|75897796|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
42087475|NCT00725985|75897797|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
42087476|NCT00725985|75897798|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
42087477|NCT00793910|75897826|FG000|Overall Study|discarded study pills|0|||
42087478|NCT00793910|75897827|FG001|Overall Study|discarded study pills|1|||
42087479|NCT00793910|75897826|FG000|Overall Study|did not pick up medications|1|||
42087480|NCT00793910|75897827|FG001|Overall Study|did not pick up medications|1|||
42087481|NCT00793910|75897826|FG000|Overall Study|ineligible based on entry criteria|2|||
42087482|NCT00793910|75897827|FG001|Overall Study|ineligible based on entry criteria|3|||
42180758|NCT00209339|75988611|FG000|At 4 Years Follow-up|Death|1|||
42180759|NCT00209339|75988611|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
42180760|NCT00209339|75988611|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
42180761|NCT00209339|75988611|FG000|At 5 Years Follow-up|Death|1|||
42180762|NCT03823391|75988617|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
42180763|NCT03823391|75988618|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
42180764|NCT03823391|75988617|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
42180765|NCT03823391|75988618|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
42180766|NCT00209027|75988628|FG000|Overall Study|study terminated|10|||
42180767|NCT00209027|75988629|FG001|Overall Study|study terminated|0|||
42180768|NCT00208325|75988639|FG000|Overall Study|Death|18|||
42180769|NCT00208325|75988640|FG001|Overall Study|Death|19|||
42180770|NCT00208325|75988641|FG002|Overall Study|Death|7|||
42087483|NCT00793910|75897826|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
42087484|NCT00793910|75897827|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
42087485|NCT00793910|75897826|FG000|Overall Study|Withdrawal by Subject|0|||
42087486|NCT00793910|75897827|FG001|Overall Study|Withdrawal by Subject|1|||
42087487|NCT00444145|75897833|FG000|Overall Study|Withdrawal by Subject|2|||
42087488|NCT00444145|75897833|FG000|Overall Study|Lost to Follow-up|1|||
42087489|NCT00444145|75897833|FG000|Overall Study|non-compliant|11|||
42087490|NCT00444145|75897833|FG000|Overall Study|Screen Failures|5|||
42087491|NCT00725283|75897837|FG000|Overall Study|Missing Code|3|||
42087492|NCT00725283|75897837|FG000|Overall Study|Death|5|||
42087493|NCT00725283|75897837|FG000|Overall Study|Other|6|||
42087494|NCT00725283|75897837|FG000|Overall Study|Withdrawal by Subject|10|||
42087495|NCT00444067|75897843|FG000|Overall Study|Lost to Follow-up|0|||
42087496|NCT00444067|75897844|FG001|Overall Study|Lost to Follow-up|1|||
42087497|NCT00789854|75897853|FG000|Overall Study|Adverse Event|28|||
42087498|NCT00789854|75897854|FG001|Overall Study|Adverse Event|23|||
42087499|NCT00789854|75897855|FG002|Overall Study|Adverse Event|18|||
42087500|NCT00789854|75897853|FG000|Overall Study|Lost to Follow-up|1|||
42087501|NCT00789854|75897854|FG001|Overall Study|Lost to Follow-up|1|||
42087502|NCT00789854|75897855|FG002|Overall Study|Lost to Follow-up|4|||
42087503|NCT00789854|75897853|FG000|Overall Study|Withdrawal by Subject|9|||
42180771|NCT00208325|75988642|FG003|Overall Study|Death|5|||
42180772|NCT00208325|75988639|FG000|Overall Study|Withdrawal by Subject|0|||
42180773|NCT00208325|75988640|FG001|Overall Study|Withdrawal by Subject|1|||
42180774|NCT00208325|75988641|FG002|Overall Study|Withdrawal by Subject|0|||
42180775|NCT00208325|75988642|FG003|Overall Study|Withdrawal by Subject|0|||
42180776|NCT00208325|75988639|FG000|Overall Study|Revision|4|||
42180777|NCT00208325|75988640|FG001|Overall Study|Revision|1|||
42180778|NCT00208325|75988641|FG002|Overall Study|Revision|0|||
42087504|NCT00789854|75897854|FG001|Overall Study|Withdrawal by Subject|6|||
42087505|NCT00789854|75897855|FG002|Overall Study|Withdrawal by Subject|17|||
42087506|NCT00789854|75897853|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
42087507|NCT00789854|75897854|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
42087508|NCT00789854|75897855|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
42087509|NCT00789854|75897853|FG000|Overall Study|Severe non-compliance to the protocol|3|||
42087510|NCT00789854|75897854|FG001|Overall Study|Severe non-compliance to the protocol|0|||
42087511|NCT00789854|75897855|FG002|Overall Study|Severe non-compliance to the protocol|0|||
42087512|NCT00789854|75897853|FG000|Overall Study|Safety reasons|0|||
42087513|NCT00789854|75897854|FG001|Overall Study|Safety reasons|0|||
42087514|NCT00789854|75897855|FG002|Overall Study|Safety reasons|2|||
42087515|NCT00789854|75897853|FG000|Overall Study|Other|6|||
42087516|NCT00789854|75897854|FG001|Overall Study|Other|0|||
42087517|NCT00789854|75897855|FG002|Overall Study|Other|5|||
42087518|NCT00725205|75897863|FG000|Overall Study|Adverse Event|22|||
42087519|NCT00725205|75897863|FG000|Overall Study|Investigator Discontinued|1|||
42087520|NCT00725205|75897863|FG000|Overall Study|Non-compliance With Protocol|14|||
42087521|NCT00725205|75897863|FG000|Overall Study|Other|8|||
42087522|NCT00725205|75897863|FG000|Overall Study|Protocol Defined Clinical Event|1|||
42087523|NCT00725205|75897863|FG000|Overall Study|Treatment Failure|41|||
42087524|NCT00443755|75897869|FG000|Overall Study|Withdrawal by Subject|2|||
42087525|NCT00443755|75897870|FG001|Overall Study|Withdrawal by Subject|1|||
42087526|NCT00724971|75897876|FG000|Overall Study|Adverse Event|5|||
42087527|NCT00724971|75897876|FG000|Overall Study|Withdrawal by Subject|1|||
42087528|NCT00443599|75897882|FG000|Overall Study|Physician Decision|2|||
42087529|NCT00443599|75897883|FG001|Overall Study|Physician Decision|1|||
42087530|NCT00443599|75897882|FG000|Overall Study|Death|1|||
42087531|NCT00443599|75897883|FG001|Overall Study|Death|1|||
42087532|NCT00443599|75897882|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
42087533|NCT00443599|75897883|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
42087534|NCT00455143|75897889|FG000|Overall Study|Physician Decision|1|||
42087535|NCT00455143|75897889|FG000|Overall Study|Withdrawal by Subject|1|||
42087536|NCT00455143|75897889|FG000|Overall Study|Staff was not avail to follow patient|2|||
42087537|NCT00455143|75897889|FG000|Overall Study|No longer met Inclusion Criteria|1|||
42087538|NCT00455143|75897889|FG000|Overall Study|Surgical time, staff not available|1|||
42087539|NCT00454987|75897897|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
42087540|NCT00454987|75897898|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
42087541|NCT00454987|75897899|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
42087542|NCT00454987|75897897|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
42087543|NCT00454987|75897898|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
42087544|NCT00454987|75897899|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
42087545|NCT00454987|75897897|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
42087546|NCT00454987|75897898|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
42087547|NCT00454987|75897899|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
42087548|NCT00724893|75897910|FG000|Overall Study|Adverse Event|76|||
42087549|NCT00724893|75897911|FG001|Overall Study|Adverse Event|142|||
42087550|NCT00724893|75897910|FG000|Overall Study|Withdrawal by Subject|0|||
42087551|NCT00724893|75897911|FG001|Overall Study|Withdrawal by Subject|1|||
42087552|NCT00724893|75897910|FG000|Overall Study|Lack of virologic response|94|||
42087553|NCT00724893|75897911|FG001|Overall Study|Lack of virologic response|202|||
42087554|NCT00724893|75897910|FG000|Overall Study|Reason not specified|193|||
42087555|NCT00724893|75897911|FG001|Overall Study|Reason not specified|7|||
42087556|NCT00724893|75897910|FG000|Overall Study|Patient choice|0|||
42087557|NCT00724893|75897911|FG001|Overall Study|Patient choice|26|||
42087558|NCT00724893|75897910|FG000|Overall Study|Geographic reasons|0|||
42087559|NCT00724893|75897911|FG001|Overall Study|Geographic reasons|11|||
42087560|NCT00724893|75897910|FG000|Overall Study|Incarceration|0|||
42087561|NCT00724893|75897911|FG001|Overall Study|Incarceration|9|||
42087562|NCT00724893|75897910|FG000|Overall Study|Substance abuse|0|||
42087563|NCT00724893|75897911|FG001|Overall Study|Substance abuse|3|||
42087564|NCT00724893|75897910|FG000|Overall Study|Financial reasons|0|||
42087565|NCT00724893|75897911|FG001|Overall Study|Financial reasons|2|||
42087566|NCT00724893|75897910|FG000|Overall Study|Assigned shorter treatment|0|||
42087567|NCT00724893|75897911|FG001|Overall Study|Assigned shorter treatment|2|||
42087568|NCT00724893|75897910|FG000|Overall Study|Lost to Follow-up|0|||
42087569|NCT00724893|75897911|FG001|Overall Study|Lost to Follow-up|52|||
42087570|NCT00724893|75897910|FG000|Overall Study|Unknown, missing data|1|||
42087571|NCT00724893|75897911|FG001|Overall Study|Unknown, missing data|1|||
42087572|NCT00789698|75897936|FG000|Overall Study|Lack of Efficacy|10|||
42087573|NCT00789698|75897937|FG001|Overall Study|Lack of Efficacy|4|||
42087574|NCT00789698|75897938|FG002|Overall Study|Lack of Efficacy|5|||
42180779|NCT00208325|75988642|FG003|Overall Study|Revision|4|||
42180780|NCT00208325|75988639|FG000|Overall Study|Lost to Follow-up|1|||
42087575|NCT00789698|75897939|FG003|Overall Study|Lack of Efficacy|18|||
42087576|NCT00789698|75897936|FG000|Overall Study|Adverse Event|5|||
42087577|NCT00789698|75897937|FG001|Overall Study|Adverse Event|5|||
42087578|NCT00789698|75897938|FG002|Overall Study|Adverse Event|3|||
42087579|NCT00789698|75897939|FG003|Overall Study|Adverse Event|4|||
42087580|NCT00789698|75897936|FG000|Overall Study|Lost to Follow-up|5|||
42087581|NCT00789698|75897937|FG001|Overall Study|Lost to Follow-up|5|||
42087582|NCT00789698|75897938|FG002|Overall Study|Lost to Follow-up|2|||
42087583|NCT00789698|75897939|FG003|Overall Study|Lost to Follow-up|9|||
42294363|NCT02468232|76128743|FG000|OLE Part of Study|Subject/Guardian decision|0|||
42087584|NCT00789698|75897936|FG000|Overall Study|Protocol Violation|6|||
42087585|NCT00789698|75897937|FG001|Overall Study|Protocol Violation|1|||
42087586|NCT00789698|75897938|FG002|Overall Study|Protocol Violation|2|||
42087587|NCT00789698|75897939|FG003|Overall Study|Protocol Violation|1|||
42087588|NCT00789698|75897936|FG000|Overall Study|Withdrawal by Subject|14|||
42087589|NCT00789698|75897937|FG001|Overall Study|Withdrawal by Subject|15|||
42087590|NCT00789698|75897938|FG002|Overall Study|Withdrawal by Subject|12|||
42087591|NCT00789698|75897939|FG003|Overall Study|Withdrawal by Subject|19|||
42087592|NCT00789698|75897936|FG000|Overall Study|Administrative|0|||
42087593|NCT00789698|75897937|FG001|Overall Study|Administrative|3|||
42087594|NCT00789698|75897938|FG002|Overall Study|Administrative|3|||
42087595|NCT00789698|75897939|FG003|Overall Study|Administrative|1|||
42087596|NCT00724815|75897950|FG000|Overall Study|Randomized, not treated|31|||
42087597|NCT00724815|75897951|FG001|Overall Study|Randomized, not treated|30|||
42087598|NCT00724815|75897950|FG000|Overall Study|Adverse Event|5|||
42087599|NCT00724815|75897951|FG001|Overall Study|Adverse Event|3|||
42087600|NCT00724815|75897950|FG000|Overall Study|Lost to Follow-up|4|||
42180781|NCT00208325|75988640|FG001|Overall Study|Lost to Follow-up|0|||
42180782|NCT00208325|75988641|FG002|Overall Study|Lost to Follow-up|2|||
42180783|NCT00208325|75988642|FG003|Overall Study|Lost to Follow-up|0|||
42180784|NCT00208325|75988639|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
42180785|NCT00208325|75988640|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
42180786|NCT00208325|75988641|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
42180787|NCT00208325|75988642|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
42180788|NCT00208325|75988639|FG000|Overall Study|Does not wish to Continue in Study|5|||
42180789|NCT00208325|75988640|FG001|Overall Study|Does not wish to Continue in Study|8|||
42180790|NCT00208325|75988641|FG002|Overall Study|Does not wish to Continue in Study|3|||
42180791|NCT00208325|75988642|FG003|Overall Study|Does not wish to Continue in Study|2|||
42180792|NCT00208325|75988639|FG000|Overall Study|Other|2|||
42180793|NCT00208325|75988640|FG001|Overall Study|Other|1|||
42180794|NCT00208325|75988641|FG002|Overall Study|Other|1|||
42180795|NCT00208325|75988642|FG003|Overall Study|Other|0|||
42180796|NCT00208325|75988639|FG000|Overall Study|Mis-Randomized|17|||
42180797|NCT00208325|75988640|FG001|Overall Study|Mis-Randomized|20|||
42180798|NCT00208325|75988641|FG002|Overall Study|Mis-Randomized|0|||
42180799|NCT00208325|75988642|FG003|Overall Study|Mis-Randomized|0|||
42180800|NCT00160667|75988655|FG000|Overall Study|Adverse Event|3|||
42180801|NCT00160667|75988656|FG001|Overall Study|Adverse Event|1|||
42180802|NCT00160667|75988657|FG002|Overall Study|Adverse Event|4|||
42180803|NCT00160667|75988655|FG000|Overall Study|Withdrawal by Subject|2|||
42180804|NCT00160667|75988656|FG001|Overall Study|Withdrawal by Subject|0|||
42180805|NCT00160667|75988657|FG002|Overall Study|Withdrawal by Subject|1|||
42180806|NCT00160667|75988655|FG000|Overall Study|Lack of Efficacy|0|||
42180807|NCT00160667|75988656|FG001|Overall Study|Lack of Efficacy|1|||
42180808|NCT00160667|75988657|FG002|Overall Study|Lack of Efficacy|0|||
42180809|NCT00160667|75988655|FG000|Overall Study|Protocol Violation|0|||
42180810|NCT00160667|75988656|FG001|Overall Study|Protocol Violation|1|||
42180811|NCT00160667|75988657|FG002|Overall Study|Protocol Violation|0|||
42087601|NCT00724815|75897951|FG001|Overall Study|Lost to Follow-up|1|||
42087602|NCT00724815|75897950|FG000|Overall Study|Other Various|3|||
42087603|NCT00724815|75897951|FG001|Overall Study|Other Various|5|||
42087604|NCT00454909|75897960|FG000|Overall Study|Withdrawal by Subject|1|||
42087605|NCT00454909|75897961|FG001|Overall Study|Withdrawal by Subject|0|||
42087606|NCT00454909|75897962|FG002|Overall Study|Withdrawal by Subject|0|||
42087607|NCT00454909|75897960|FG000|Overall Study|Migrated/moved from study area|0|||
42087608|NCT00454909|75897961|FG001|Overall Study|Migrated/moved from study area|0|||
42087609|NCT00454909|75897962|FG002|Overall Study|Migrated/moved from study area|1|||
42087610|NCT00454909|75897960|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
42087611|NCT00454909|75897961|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
42087612|NCT00454909|75897962|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
42087613|NCT00454909|75897960|FG000|Overall Study|Others|1|||
42087614|NCT00454909|75897961|FG001|Overall Study|Others|0|||
42180812|NCT00160667|75988655|FG000|Overall Study|Patient decision|0|||
42180813|NCT00160667|75988656|FG001|Overall Study|Patient decision|0|||
42180814|NCT00160667|75988657|FG002|Overall Study|Patient decision|1|||
42087615|NCT00454909|75897962|FG002|Overall Study|Others|0|||
42087616|NCT00798590|75897973|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
42087617|NCT00798590|75897974|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
42087618|NCT00481195|75897982|FG000|Overall Study|Adverse Event|16|||
42087619|NCT00481195|75897983|FG001|Overall Study|Adverse Event|11|||
42180815|NCT00206375|75988669|FG000|Overall Study|Lost to Follow-up|1|||
42180816|NCT00206375|75988670|FG001|Overall Study|Lost to Follow-up|0|||
42180817|NCT00206375|75988671|FG002|Overall Study|Lost to Follow-up|0|||
42180818|NCT00206375|75988669|FG000|Overall Study|Withdrawal by Subject|2|||
42087620|NCT00481195|75897982|FG000|Overall Study|Lack of Efficacy|1|||
42180819|NCT00206375|75988670|FG001|Overall Study|Withdrawal by Subject|1|||
42087621|NCT00481195|75897983|FG001|Overall Study|Lack of Efficacy|3|||
42087622|NCT00481195|75897982|FG000|Overall Study|Lost to Follow-up|4|||
42087623|NCT00481195|75897983|FG001|Overall Study|Lost to Follow-up|6|||
42087624|NCT00481195|75897982|FG000|Overall Study|Physician Decision|3|||
42087625|NCT00481195|75897983|FG001|Overall Study|Physician Decision|1|||
42087626|NCT00481195|75897982|FG000|Overall Study|Protocol Violation|10|||
42087627|NCT00481195|75897983|FG001|Overall Study|Protocol Violation|7|||
42087628|NCT00481195|75897982|FG000|Overall Study|Withdrawal by Subject|3|||
42087629|NCT00481195|75897983|FG001|Overall Study|Withdrawal by Subject|9|||
42087630|NCT00481195|75897982|FG000|Overall Study|Miscellaneous|2|||
42087631|NCT00481195|75897983|FG001|Overall Study|Miscellaneous|2|||
42087632|NCT00454363|75898000|FG000|Overall Study|Adverse Event|1|||
42087633|NCT00454363|75898001|FG001|Overall Study|Adverse Event|2|||
42180820|NCT00206375|75988671|FG002|Overall Study|Withdrawal by Subject|3|||
42180821|NCT00206375|75988669|FG000|Overall Study|Study terminated due to lack of funds|0|||
42180822|NCT00206375|75988670|FG001|Overall Study|Study terminated due to lack of funds|1|||
42180823|NCT00206375|75988671|FG002|Overall Study|Study terminated due to lack of funds|1|||
42358569|NCT04418765|76204319|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
42087634|NCT00454363|75898000|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
42087635|NCT00454363|75898001|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
42087636|NCT00454207|75898008|FG000|Overall Study|Adverse Event|3|||
42087637|NCT00454207|75898009|FG001|Overall Study|Adverse Event|1|||
42087638|NCT00454207|75898008|FG000|Overall Study|Lack of Efficacy|1|||
42087639|NCT00454207|75898009|FG001|Overall Study|Lack of Efficacy|0|||
42087640|NCT00454207|75898008|FG000|Overall Study|Protocol Violation|0|||
42087641|NCT00454207|75898009|FG001|Overall Study|Protocol Violation|1|||
42087642|NCT00738894|75898029|FG000|Overall Study|Lost to Follow-up|23|||
42087643|NCT00738894|75898030|FG001|Overall Study|Lost to Follow-up|13|||
42087644|NCT00738894|75898029|FG000|Overall Study|Withdrawal by Subject|10|||
42087645|NCT00738894|75898030|FG001|Overall Study|Withdrawal by Subject|15|||
42087646|NCT00738894|75898029|FG000|Overall Study|Physician Decision|4|||
42087647|NCT00738894|75898030|FG001|Overall Study|Physician Decision|5|||
42087648|NCT00738894|75898029|FG000|Overall Study|Death|2|||
42087649|NCT00738894|75898030|FG001|Overall Study|Death|0|||
42087650|NCT00480493|75898038|FG000|Overall Study|moved|2|||
42087651|NCT00480493|75898039|FG001|Overall Study|moved|7|||
42087652|NCT00734994|75898047|FG000|Overall Study|Withdrawal by Subject|1|||
42087653|NCT00798434|75898054|FG000|Double-Blind|Adverse Event|22|||
42087654|NCT00798434|75898055|FG001|Double-Blind|Adverse Event|46|||
42087655|NCT00798434|75898054|FG000|Double-Blind|Death|0|||
42087656|NCT00798434|75898055|FG001|Double-Blind|Death|1|||
42087657|NCT00798434|75898054|FG000|Double-Blind|Lost to Follow-up|1|||
42087658|NCT00798434|75898055|FG001|Double-Blind|Lost to Follow-up|0|||
42087659|NCT00798434|75898054|FG000|Double-Blind|Lack of Efficacy|8|||
42087660|NCT00798434|75898055|FG001|Double-Blind|Lack of Efficacy|12|||
42087661|NCT00798434|75898054|FG000|Double-Blind|Withdrawal by Subject|17|||
42087662|NCT00798434|75898055|FG001|Double-Blind|Withdrawal by Subject|14|||
42087663|NCT00798434|75898054|FG000|Double-Blind|Protocol Violation|1|||
42087664|NCT00798434|75898055|FG001|Double-Blind|Protocol Violation|4|||
42087665|NCT00798434|75898054|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
42087666|NCT00798434|75898055|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
42087667|NCT00798434|75898054|FG000|Double-Blind|Other|1|||
42087668|NCT00798434|75898055|FG001|Double-Blind|Other|0|||
42087669|NCT00798434|75898054|FG000|Double-Blind|Not Treated|3|||
42087670|NCT00798434|75898055|FG001|Double-Blind|Not Treated|6|||
42087671|NCT00798434|75898054|FG000|Open-Label|Adverse Event|33|||
42087672|NCT00798434|75898055|FG001|Open-Label|Adverse Event|11|||
42087673|NCT00798434|75898054|FG000|Open-Label|Lack of Efficacy|5|||
42087674|NCT00798434|75898055|FG001|Open-Label|Lack of Efficacy|11|||
42087675|NCT00798434|75898054|FG000|Open-Label|Withdrawal by Subject|2|||
42087676|NCT00798434|75898055|FG001|Open-Label|Withdrawal by Subject|7|||
42087677|NCT00798434|75898054|FG000|Open-Label|Protocol Violation|1|||
42087678|NCT00798434|75898055|FG001|Open-Label|Protocol Violation|0|||
42087679|NCT00798434|75898054|FG000|Open-Label|Other|1|||
42087680|NCT00798434|75898055|FG001|Open-Label|Other|2|||
42087681|NCT00798434|75898054|FG000|Open-Label|Not Treated|0|||
42087682|NCT00798434|75898055|FG001|Open-Label|Not Treated|1|||
42087683|NCT00724503|75898068|FG000|Overall Study|Lost to Follow-up|4|||
42087684|NCT00724503|75898069|FG001|Overall Study|Lost to Follow-up|8|||
42087685|NCT00724503|75898068|FG000|Overall Study|Withdrawal by Subject|11|||
42087686|NCT00724503|75898069|FG001|Overall Study|Withdrawal by Subject|23|||
42087687|NCT00724503|75898068|FG000|Overall Study|Death|190|||
42087688|NCT00724503|75898069|FG001|Overall Study|Death|182|||
42087689|NCT00724503|75898068|FG000|Overall Study|Adverse Event|1|||
42087690|NCT00724503|75898069|FG001|Overall Study|Adverse Event|0|||
42087691|NCT00724503|75898068|FG000|Overall Study|Not otherwise specified|4|||
42087692|NCT00724503|75898069|FG001|Overall Study|Not otherwise specified|7|||
42087693|NCT00791648|75898079|FG000|Overall Study|Physician Decision|0|||
42087694|NCT00791648|75898080|FG001|Overall Study|Physician Decision|1|||
42087695|NCT00791648|75898079|FG000|Overall Study|Withdrawal by Subject|0|||
42087696|NCT00791648|75898080|FG001|Overall Study|Withdrawal by Subject|1|||
42087697|NCT00791492|75898088|FG000|Overall Study|Withdrawal by Subject|1|||
42087698|NCT00791492|75898089|FG001|Overall Study|Withdrawal by Subject|2|||
42087699|NCT00791492|75898088|FG000|Overall Study|Liver transplantation|5|||
42087700|NCT00791492|75898089|FG001|Overall Study|Liver transplantation|1|||
42087701|NCT00723957|75898097|FG000|Overall Study|Adverse event unrelated to study drug|1|||
42087702|NCT00723957|75898098|FG001|Overall Study|Adverse event unrelated to study drug|4|||
42087703|NCT00723957|75898097|FG000|Overall Study|Death|3|||
42087704|NCT00723957|75898098|FG001|Overall Study|Death|4|||
42087705|NCT00723957|75898097|FG000|Overall Study|Disease progression|27|||
42087706|NCT00723957|75898098|FG001|Overall Study|Disease progression|25|||
42087707|NCT00723957|75898097|FG000|Overall Study|Maximum clinical benefit|4|||
42087708|NCT00723957|75898098|FG001|Overall Study|Maximum clinical benefit|5|||
42087709|NCT00723957|75898097|FG000|Overall Study|Investigator decision|1|||
42087710|NCT00723957|75898098|FG001|Overall Study|Investigator decision|1|||
42087711|NCT00723957|75898097|FG000|Overall Study|Study drug toxicity|4|||
42087712|NCT00723957|75898098|FG001|Overall Study|Study drug toxicity|6|||
42087713|NCT00723957|75898097|FG000|Overall Study|Withdrawal by Subject|7|||
42087714|NCT00723957|75898098|FG001|Overall Study|Withdrawal by Subject|5|||
42087715|NCT00723957|75898097|FG000|Overall Study|Reason not analyzed|1|||
42087716|NCT00723957|75898098|FG001|Overall Study|Reason not analyzed|0|||
42087717|NCT00723957|75898097|FG000|Overall Study|Never received treatment|3|||
42087718|NCT00723957|75898098|FG001|Overall Study|Never received treatment|3|||
42087719|NCT00723801|75898106|FG000|Overall Study|Lost to Follow-up|1|||
42087720|NCT00723801|75898107|FG001|Overall Study|Lost to Follow-up|2|||
42087721|NCT00723801|75898106|FG000|Overall Study|Protocol Violation|2|||
42087722|NCT00723801|75898107|FG001|Overall Study|Protocol Violation|1|||
42087723|NCT00797966|75898117|FG000|Phase A|Lost to Follow-up|0|||
42087724|NCT00797966|75898118|FG001|Phase A|Lost to Follow-up|0|||
42087725|NCT00797966|75898119|FG002|Phase A|Lost to Follow-up|0|||
42087726|NCT00797966|75898120|FG003|Phase A|Lost to Follow-up|0|||
42087727|NCT00797966|75898121|FG004|Phase A|Lost to Follow-up|33|||
42087728|NCT00797966|75898122|FG005|Phase A|Lost to Follow-up|0|||
42087729|NCT00797966|75898117|FG000|Phase A|Adverse Event|0|||
42087730|NCT00797966|75898118|FG001|Phase A|Adverse Event|0|||
42087731|NCT00797966|75898119|FG002|Phase A|Adverse Event|0|||
42087732|NCT00797966|75898120|FG003|Phase A|Adverse Event|0|||
42087733|NCT00797966|75898121|FG004|Phase A|Adverse Event|46|||
42087734|NCT00797966|75898122|FG005|Phase A|Adverse Event|0|||
42180824|NCT00160199|75988681|FG000|Overall Study|Adverse Event|5|||
42180825|NCT00160199|75988682|FG001|Overall Study|Adverse Event|14|||
42180826|NCT00160199|75988681|FG000|Overall Study|Lack of Efficacy|0|||
42180827|NCT00160199|75988682|FG001|Overall Study|Lack of Efficacy|1|||
42180828|NCT00160199|75988681|FG000|Overall Study|Lost to Follow-up|7|||
42180829|NCT00160199|75988682|FG001|Overall Study|Lost to Follow-up|7|||
42180830|NCT00160199|75988681|FG000|Overall Study|Withdrawal by Subject|4|||
42180831|NCT00160199|75988682|FG001|Overall Study|Withdrawal by Subject|6|||
42180832|NCT00160199|75988681|FG000|Overall Study|Administrative|0|||
42180833|NCT00160199|75988682|FG001|Overall Study|Administrative|1|||
42180834|NCT00160199|75988681|FG000|Overall Study|Protocol Violation|8|||
42180835|NCT00160199|75988682|FG001|Overall Study|Protocol Violation|8|||
42180836|NCT00157157|75988688|FG000|Overall Study|Withdrawal by Subject|6|||
42180837|NCT00157157|75988688|FG000|Overall Study|Physician Decision|1|||
42180838|NCT00157157|75988688|FG000|Overall Study|Lost to Follow-up|1|||
42180839|NCT00157157|75988688|FG000|Overall Study|Enrolled in another study|1|||
42180840|NCT00157157|75988688|FG000|Overall Study|Met exclusion criteria|1|||
42180841|NCT00157157|75988688|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
42180842|NCT00203411|75988699|FG000|Follow-up|Progressive Disease|4|||
42180843|NCT00203021|75988706|FG000|Overall Study|Death|4|||
42087735|NCT00797966|75898117|FG000|Phase A|Met withdrawal criteria|0|||
42087736|NCT00797966|75898118|FG001|Phase A|Met withdrawal criteria|0|||
42087737|NCT00797966|75898119|FG002|Phase A|Met withdrawal criteria|0|||
42087738|NCT00797966|75898120|FG003|Phase A|Met withdrawal criteria|0|||
42087739|NCT00797966|75898121|FG004|Phase A|Met withdrawal criteria|4|||
42087740|NCT00797966|75898122|FG005|Phase A|Met withdrawal criteria|0|||
42087741|NCT00797966|75898117|FG000|Phase A|Physician Decision|0|||
42087742|NCT00797966|75898118|FG001|Phase A|Physician Decision|0|||
42087743|NCT00797966|75898119|FG002|Phase A|Physician Decision|0|||
42087744|NCT00797966|75898120|FG003|Phase A|Physician Decision|0|||
42180844|NCT00203021|75988707|FG001|Overall Study|Death|1|||
42180845|NCT00203021|75988706|FG000|Overall Study|Adverse Event|10|||
42180846|NCT00203021|75988707|FG001|Overall Study|Adverse Event|5|||
42180847|NCT00203021|75988706|FG000|Overall Study|Withdrawal by Subject|45|||
42087745|NCT00797966|75898121|FG004|Phase A|Physician Decision|13|||
42087746|NCT00797966|75898122|FG005|Phase A|Physician Decision|0|||
42087747|NCT00797966|75898117|FG000|Phase A|Withdrawal by Subject|0|||
42087748|NCT00797966|75898118|FG001|Phase A|Withdrawal by Subject|0|||
42087749|NCT00797966|75898119|FG002|Phase A|Withdrawal by Subject|0|||
42180848|NCT00203021|75988707|FG001|Overall Study|Withdrawal by Subject|48|||
42180849|NCT00203021|75988706|FG000|Overall Study|Lost to Follow-up|9|||
42087750|NCT00797966|75898120|FG003|Phase A|Withdrawal by Subject|0|||
42087751|NCT00797966|75898121|FG004|Phase A|Withdrawal by Subject|33|||
42087752|NCT00797966|75898122|FG005|Phase A|Withdrawal by Subject|0|||
42087753|NCT00797966|75898117|FG000|Phase A|Protocol deviation|0|||
42087754|NCT00797966|75898118|FG001|Phase A|Protocol deviation|0|||
42180850|NCT00203021|75988707|FG001|Overall Study|Lost to Follow-up|7|||
42180851|NCT00203021|75988706|FG000|Overall Study|Other than specified|11|||
42180852|NCT00203021|75988707|FG001|Overall Study|Other than specified|16|||
42180853|NCT00201851|75988716|FG000|Overall Study|Lost to Follow-up|2|||
42180854|NCT00201851|75988717|FG001|Overall Study|Lost to Follow-up|1|||
42180855|NCT00201851|75988718|FG002|Overall Study|Lost to Follow-up|0|||
42087755|NCT00797966|75898119|FG002|Phase A|Protocol deviation|0|||
42087756|NCT00797966|75898120|FG003|Phase A|Protocol deviation|0|||
42087757|NCT00797966|75898121|FG004|Phase A|Protocol deviation|56|||
42087758|NCT00797966|75898122|FG005|Phase A|Protocol deviation|0|||
42087759|NCT00797966|75898117|FG000|Phase B|Lost to Follow-up|0|||
42087760|NCT00797966|75898118|FG001|Phase B|Lost to Follow-up|1|||
42180856|NCT00201851|75988716|FG000|Overall Study|Ineligible post enrollment|6|||
42180857|NCT00201851|75988717|FG001|Overall Study|Ineligible post enrollment|1|||
42180858|NCT00201851|75988718|FG002|Overall Study|Ineligible post enrollment|1|||
42180859|NCT00200057|75988726|FG000|Overall Study|Lack of Efficacy|3|||
42180860|NCT00200057|75988726|FG000|Overall Study|Exited due to terminal illness of PI|2|||
42180861|NCT00200057|75988726|FG000|Overall Study|Withdrawal by Subject|1|||
42180862|NCT00200057|75988726|FG000|Overall Study|Change in medical condition|1|||
42180863|NCT00200057|75988726|FG000|Overall Study|Infection|1|||
42180864|NCT00200057|75988726|FG000|Overall Study|Death|1|||
42180865|NCT03129100|75988735|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
42180866|NCT03129100|75988736|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
42180867|NCT03129100|75988737|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
42180868|NCT03129100|75988738|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
42180869|NCT03129100|75988739|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
42180870|NCT03129100|75988740|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
42180871|NCT03129100|75988741|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
42180872|NCT03129100|75988742|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
42180873|NCT03129100|75988743|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
42180874|NCT03129100|75988744|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
42180875|NCT03129100|75988745|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
42180876|NCT03129100|75988746|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
42180877|NCT03129100|75988747|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
42180878|NCT03129100|75988748|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
42180879|NCT03129100|75988749|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
42180880|NCT03129100|75988750|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
42180881|NCT03129100|75988751|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
42180882|NCT03129100|75988752|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
42180883|NCT03129100|75988753|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
42180884|NCT03129100|75988754|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
42180885|NCT03129100|75988755|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
42180886|NCT03129100|75988756|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
42180887|NCT03129100|75988757|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
42087761|NCT00797966|75898119|FG002|Phase B|Lost to Follow-up|3|||
42087762|NCT00797966|75898120|FG003|Phase B|Lost to Follow-up|0|||
42087763|NCT00797966|75898121|FG004|Phase B|Lost to Follow-up|0|||
42087764|NCT00797966|75898122|FG005|Phase B|Lost to Follow-up|0|||
42087765|NCT00797966|75898117|FG000|Phase B|Adverse Event|2|||
42087766|NCT00797966|75898118|FG001|Phase B|Adverse Event|1|||
42087767|NCT00797966|75898119|FG002|Phase B|Adverse Event|3|||
42087768|NCT00797966|75898120|FG003|Phase B|Adverse Event|1|||
42087769|NCT00797966|75898121|FG004|Phase B|Adverse Event|0|||
42087770|NCT00797966|75898122|FG005|Phase B|Adverse Event|0|||
42087771|NCT00797966|75898117|FG000|Phase B|Met Withdrawal Criteria|3|||
42087772|NCT00797966|75898118|FG001|Phase B|Met Withdrawal Criteria|3|||
42087773|NCT00797966|75898119|FG002|Phase B|Met Withdrawal Criteria|6|||
42087774|NCT00797966|75898120|FG003|Phase B|Met Withdrawal Criteria|1|||
42087775|NCT00797966|75898121|FG004|Phase B|Met Withdrawal Criteria|0|||
42180888|NCT03129100|75988758|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
42180889|NCT03129100|75988759|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
42180890|NCT03129100|75988760|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
42180891|NCT03129100|75988735|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
42180892|NCT03129100|75988736|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180893|NCT03129100|75988737|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180894|NCT03129100|75988738|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180895|NCT03129100|75988739|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42087776|NCT00797966|75898122|FG005|Phase B|Met Withdrawal Criteria|0|||
42087777|NCT00797966|75898117|FG000|Phase B|Physician Decision|1|||
42087778|NCT00797966|75898118|FG001|Phase B|Physician Decision|0|||
42180896|NCT03129100|75988740|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180897|NCT03129100|75988741|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42087779|NCT00797966|75898119|FG002|Phase B|Physician Decision|3|||
42087780|NCT00797966|75898120|FG003|Phase B|Physician Decision|1|||
42087781|NCT00797966|75898121|FG004|Phase B|Physician Decision|0|||
42087782|NCT00797966|75898122|FG005|Phase B|Physician Decision|0|||
42087783|NCT00797966|75898117|FG000|Phase B|Withdrawal by Subject|1|||
42087784|NCT00797966|75898118|FG001|Phase B|Withdrawal by Subject|4|||
42087785|NCT00797966|75898119|FG002|Phase B|Withdrawal by Subject|3|||
42087786|NCT00797966|75898120|FG003|Phase B|Withdrawal by Subject|3|||
42087787|NCT00797966|75898121|FG004|Phase B|Withdrawal by Subject|0|||
42087788|NCT00797966|75898122|FG005|Phase B|Withdrawal by Subject|0|||
42087789|NCT00797966|75898117|FG000|Phase B|Protocol Deviation|4|||
42087790|NCT00797966|75898118|FG001|Phase B|Protocol Deviation|8|||
42087791|NCT00797966|75898119|FG002|Phase B|Protocol Deviation|2|||
42087792|NCT00797966|75898120|FG003|Phase B|Protocol Deviation|6|||
42087793|NCT00797966|75898121|FG004|Phase B|Protocol Deviation|0|||
42087794|NCT00797966|75898122|FG005|Phase B|Protocol Deviation|0|||
42087795|NCT00797966|75898117|FG000|Phase B|Lack of Efficacy|0|||
42087796|NCT00797966|75898118|FG001|Phase B|Lack of Efficacy|1|||
42087797|NCT00797966|75898119|FG002|Phase B|Lack of Efficacy|1|||
42087798|NCT00797966|75898120|FG003|Phase B|Lack of Efficacy|4|||
42087799|NCT00797966|75898121|FG004|Phase B|Lack of Efficacy|0|||
42087800|NCT00797966|75898122|FG005|Phase B|Lack of Efficacy|0|||
42087801|NCT00797966|75898117|FG000|Phase A+|Lost to Follow-up|0|||
42087802|NCT00797966|75898118|FG001|Phase A+|Lost to Follow-up|0|||
42087803|NCT00797966|75898119|FG002|Phase A+|Lost to Follow-up|0|||
42087804|NCT00797966|75898120|FG003|Phase A+|Lost to Follow-up|0|||
42087805|NCT00797966|75898121|FG004|Phase A+|Lost to Follow-up|0|||
42087806|NCT00797966|75898122|FG005|Phase A+|Lost to Follow-up|9|||
42087807|NCT00797966|75898117|FG000|Phase A+|Met withdrawal criteria|0|||
42087808|NCT00797966|75898118|FG001|Phase A+|Met withdrawal criteria|0|||
42087809|NCT00797966|75898119|FG002|Phase A+|Met withdrawal criteria|0|||
42087810|NCT00797966|75898120|FG003|Phase A+|Met withdrawal criteria|0|||
42087811|NCT00797966|75898121|FG004|Phase A+|Met withdrawal criteria|0|||
42087812|NCT00797966|75898122|FG005|Phase A+|Met withdrawal criteria|5|||
42087813|NCT00797966|75898117|FG000|Phase A+|Withdrawal by Subject|0|||
42087814|NCT00797966|75898118|FG001|Phase A+|Withdrawal by Subject|0|||
42087815|NCT00797966|75898119|FG002|Phase A+|Withdrawal by Subject|0|||
42087816|NCT00797966|75898120|FG003|Phase A+|Withdrawal by Subject|0|||
42087817|NCT00797966|75898121|FG004|Phase A+|Withdrawal by Subject|0|||
42087818|NCT00797966|75898122|FG005|Phase A+|Withdrawal by Subject|6|||
42087819|NCT00797966|75898117|FG000|Phase A+|Adverse Event|0|||
42087820|NCT00797966|75898118|FG001|Phase A+|Adverse Event|0|||
42087821|NCT00797966|75898119|FG002|Phase A+|Adverse Event|0|||
42087822|NCT00797966|75898120|FG003|Phase A+|Adverse Event|0|||
42087823|NCT00797966|75898121|FG004|Phase A+|Adverse Event|0|||
42087824|NCT00797966|75898122|FG005|Phase A+|Adverse Event|4|||
42087825|NCT00797966|75898117|FG000|Phase A+|Protocol deviation|0|||
42087826|NCT00797966|75898118|FG001|Phase A+|Protocol deviation|0|||
42087827|NCT00797966|75898119|FG002|Phase A+|Protocol deviation|0|||
42087828|NCT00797966|75898120|FG003|Phase A+|Protocol deviation|0|||
42087829|NCT00797966|75898121|FG004|Phase A+|Protocol deviation|0|||
42087830|NCT00797966|75898122|FG005|Phase A+|Protocol deviation|4|||
42087831|NCT00723489|75898138|FG000|Overall Study|Physician Decision|0|||
42087832|NCT00723489|75898139|FG001|Overall Study|Physician Decision|1|||
42087833|NCT00723489|75898140|FG002|Overall Study|Physician Decision|0|||
42087834|NCT00723489|75898141|FG003|Overall Study|Physician Decision|0|||
42087835|NCT00723489|75898138|FG000|Overall Study|Pregnancy|0|||
42087836|NCT00723489|75898139|FG001|Overall Study|Pregnancy|0|||
42180898|NCT03129100|75988742|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180899|NCT03129100|75988743|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180900|NCT03129100|75988744|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42087837|NCT00723489|75898140|FG002|Overall Study|Pregnancy|0|||
42087838|NCT00723489|75898141|FG003|Overall Study|Pregnancy|1|||
42087839|NCT00723489|75898138|FG000|Overall Study|Withdrawal by Subject|0|||
42087840|NCT00723489|75898139|FG001|Overall Study|Withdrawal by Subject|0|||
42087841|NCT00723489|75898140|FG002|Overall Study|Withdrawal by Subject|0|||
42087842|NCT00723489|75898141|FG003|Overall Study|Withdrawal by Subject|1|||
42087843|NCT00723489|75898138|FG000|Overall Study|Seropositive at baseline|1|||
42087844|NCT00723489|75898139|FG001|Overall Study|Seropositive at baseline|0|||
42087845|NCT00723489|75898140|FG002|Overall Study|Seropositive at baseline|0|||
42087846|NCT00723489|75898141|FG003|Overall Study|Seropositive at baseline|0|||
42087847|NCT00723489|75898138|FG000|Overall Study|Prohibited Medication|0|||
42087848|NCT00723489|75898139|FG001|Overall Study|Prohibited Medication|0|||
42087849|NCT00723489|75898140|FG002|Overall Study|Prohibited Medication|0|||
42087850|NCT00723489|75898141|FG003|Overall Study|Prohibited Medication|1|||
42294364|NCT02468232|76128744|FG001|OLE Part of Study|Subject/Guardian decision|0|||
42087851|NCT00723489|75898138|FG000|Overall Study|Samples Collected Out of Window|0|||
42087852|NCT00723489|75898139|FG001|Overall Study|Samples Collected Out of Window|3|||
42087853|NCT00723489|75898140|FG002|Overall Study|Samples Collected Out of Window|0|||
42087854|NCT00723489|75898141|FG003|Overall Study|Samples Collected Out of Window|0|||
42087855|NCT00587990|75898154|FG000|Overall Study|Death|0|||
42087856|NCT00587990|75898155|FG001|Overall Study|Death|0|||
42087857|NCT00587990|75898156|FG002|Overall Study|Death|1|||
42087858|NCT00723255|75898164|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
42087859|NCT00723255|75898164|FG000|Overall Study|Ineligible: Second primary|1|||
42087860|NCT00723255|75898164|FG000|Overall Study|Ineligible: Wrong Primary|2|||
42087861|NCT00791258|75898180|FG000|Overall Study|Adverse Event|87|||
42087862|NCT00791258|75898180|FG000|Overall Study|Lost to Follow-up|18|||
42087863|NCT00791258|75898180|FG000|Overall Study|Protocol Violation|109|||
42087864|NCT00791258|75898180|FG000|Overall Study|Withdrawal by Subject|40|||
42087865|NCT00791258|75898180|FG000|Overall Study|Did not take medication for >3 days|1|||
42087866|NCT00791258|75898180|FG000|Overall Study|subject left area|2|||
42087867|NCT00791258|75898180|FG000|Overall Study|non-compliance|3|||
42087868|NCT00791258|75898180|FG000|Overall Study|Subject incarcerated|1|||
42087869|NCT00791258|75898180|FG000|Overall Study|Subject required restricted medication|1|||
42087870|NCT00791258|75898180|FG000|Overall Study|Lack of Efficacy|1|||
42087871|NCT00808067|75898186|FG000|Overall Study|Major/minor bleed|30|||
42087872|NCT00808067|75898187|FG001|Overall Study|Major/minor bleed|44|||
42087873|NCT00808067|75898186|FG000|Overall Study|Outcome event - other|33|||
42087874|NCT00808067|75898187|FG001|Overall Study|Outcome event - other|25|||
42087875|NCT00808067|75898186|FG000|Overall Study|Adverse Event|111|||
42087876|NCT00808067|75898187|FG001|Overall Study|Adverse Event|121|||
42087877|NCT00808067|75898186|FG000|Overall Study|Hospitalization (not including surgery)|18|||
42087878|NCT00808067|75898187|FG001|Overall Study|Hospitalization (not including surgery)|17|||
42087879|NCT00808067|75898186|FG000|Overall Study|Hospitalization due to surgery|37|||
42087880|NCT00808067|75898187|FG001|Overall Study|Hospitalization due to surgery|40|||
42087881|NCT00808067|75898186|FG000|Overall Study|Reduced creatinine clearance|53|||
42087882|NCT00808067|75898187|FG001|Overall Study|Reduced creatinine clearance|55|||
42087883|NCT00808067|75898186|FG000|Overall Study|Elevated LFT results|7|||
42087884|NCT00808067|75898187|FG001|Overall Study|Elevated LFT results|3|||
42087885|NCT00808067|75898186|FG000|Overall Study|Patient refused to take study medication|65|||
42087886|NCT00808067|75898187|FG001|Overall Study|Patient refused to take study medication|76|||
42087887|NCT00808067|75898186|FG000|Overall Study|Missing|1|||
42180901|NCT03129100|75988745|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180902|NCT03129100|75988746|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180903|NCT03129100|75988747|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180904|NCT03129100|75988748|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180905|NCT03129100|75988749|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180906|NCT03129100|75988750|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180907|NCT03129100|75988751|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180908|NCT03129100|75988752|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180909|NCT03129100|75988753|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180910|NCT03129100|75988754|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180911|NCT03129100|75988755|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180912|NCT03129100|75988756|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180913|NCT03129100|75988757|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180914|NCT03129100|75988758|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180915|NCT03129100|75988759|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180916|NCT03129100|75988760|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
42180917|NCT03129100|75988735|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
42180918|NCT03129100|75988736|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
42087888|NCT00808067|75898187|FG001|Overall Study|Missing|0|||
42087889|NCT00808067|75898186|FG000|Overall Study|Death|1|||
42087890|NCT00808067|75898187|FG001|Overall Study|Death|1|||
42087891|NCT00808067|75898186|FG000|Overall Study|Procedure|6|||
42087892|NCT00808067|75898187|FG001|Overall Study|Procedure|7|||
42087893|NCT00808067|75898186|FG000|Overall Study|Withdrawal by Subject|21|||
42087894|NCT00808067|75898187|FG001|Overall Study|Withdrawal by Subject|25|||
42087895|NCT00808067|75898186|FG000|Overall Study|Site closed|4|||
42087896|NCT00808067|75898187|FG001|Overall Study|Site closed|3|||
42087897|NCT00808067|75898186|FG000|Overall Study|Physician Decision|47|||
42087898|NCT00808067|75898187|FG001|Overall Study|Physician Decision|38|||
42087899|NCT00808067|75898186|FG000|Overall Study|Protocol Violation|3|||
42087900|NCT00808067|75898187|FG001|Overall Study|Protocol Violation|11|||
42087901|NCT00808067|75898186|FG000|Overall Study|Patient elected|7|||
42087902|NCT00808067|75898187|FG001|Overall Study|Patient elected|9|||
42087903|NCT00808067|75898186|FG000|Overall Study|Site closed for cause|19|||
42087904|NCT00808067|75898187|FG001|Overall Study|Site closed for cause|19|||
42087905|NCT00808067|75898186|FG000|Overall Study|Other reason not defined above|5|||
42087906|NCT00808067|75898187|FG001|Overall Study|Other reason not defined above|5|||
42087907|NCT00808067|75898186|FG000|Overall Study|Excluded from analysis|13|||
42087908|NCT00808067|75898187|FG001|Overall Study|Excluded from analysis|19|||
42180919|NCT03129100|75988737|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42087909|NCT00723021|75898193|FG000|Intervention Period 4|Adverse Event|0|||
42087910|NCT00723021|75898194|FG001|Intervention Period 4|Adverse Event|0|||
42087911|NCT00723021|75898195|FG002|Intervention Period 4|Adverse Event|0|||
42087912|NCT00723021|75898196|FG003|Intervention Period 4|Adverse Event|0|||
42087913|NCT00723021|75898197|FG004|Intervention Period 4|Adverse Event|1|||
42087914|NCT00721227|75898218|FG000|Overall Study|Lost to Follow-up|3|||
42087915|NCT00721227|75898219|FG001|Overall Study|Lost to Follow-up|0|||
42087916|NCT00721227|75898218|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
42087917|NCT00721227|75898219|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
42087918|NCT00807599|75898227|FG000|Overall Study|Not treated on protocol study|0|||
42087919|NCT00807599|75898228|FG001|Overall Study|Not treated on protocol study|0|||
42087920|NCT00807599|75898229|FG002|Overall Study|Not treated on protocol study|2|||
42087921|NCT00807599|75898227|FG000|Overall Study|Adverse Event|0|||
42087922|NCT00807599|75898228|FG001|Overall Study|Adverse Event|0|||
42087923|NCT00807599|75898229|FG002|Overall Study|Adverse Event|5|||
42087924|NCT00807599|75898227|FG000|Overall Study|Inadequate response to induction|0|||
42087925|NCT00807599|75898228|FG001|Overall Study|Inadequate response to induction|0|||
42087926|NCT00807599|75898229|FG002|Overall Study|Inadequate response to induction|9|||
42087927|NCT00807599|75898227|FG000|Overall Study|Withdrawal by Subject|0|||
42087928|NCT00807599|75898228|FG001|Overall Study|Withdrawal by Subject|0|||
42087929|NCT00807599|75898229|FG002|Overall Study|Withdrawal by Subject|1|||
42294365|NCT02468232|76128745|FG002|OLE Part of Study|Subject/Guardian decision|2|||
42294366|NCT02468232|76128746|FG003|OLE Part of Study|Subject/Guardian decision|5|||
42294367|NCT01804816|76128756|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
42087930|NCT00721149|75898235|FG000|Overall Study|Physician Decision|1|||
42087931|NCT00788372|75898239|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
42087932|NCT00788372|75898239|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
42087933|NCT00788372|75898239|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
42087934|NCT00788372|75898239|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
42087935|NCT00788372|75898239|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
42087936|NCT00788372|75898239|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
42087937|NCT00788372|75898239|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
42087938|NCT00738582|75898243|FG000|Combination Therapy|Completed Combination Therapy|1|||
42087939|NCT00738582|75898244|FG001|Combination Therapy|Completed Combination Therapy|0|||
42087940|NCT00738582|75898243|FG000|Combination Therapy|Physician Decision|1|||
42087941|NCT00738582|75898244|FG001|Combination Therapy|Physician Decision|0|||
42087942|NCT00738582|75898243|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
42087943|NCT00738582|75898244|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
42087944|NCT00738582|75898243|FG000|Combination Therapy|Other|5|||
42087945|NCT00738582|75898244|FG001|Combination Therapy|Other|0|||
42087946|NCT00738582|75898243|FG000|Combination Therapy|Adverse Event|16|||
42087947|NCT00738582|75898244|FG001|Combination Therapy|Adverse Event|0|||
42087948|NCT00738582|75898243|FG000|Combination Therapy|Progressive Disease|9|||
42087949|NCT00738582|75898244|FG001|Combination Therapy|Progressive Disease|0|||
42087950|NCT00738582|75898243|FG000|Maintenance Therapy|Other|0|||
42087951|NCT00738582|75898244|FG001|Maintenance Therapy|Other|2|||
42087952|NCT00738582|75898243|FG000|Maintenance Therapy|Adverse Event|0|||
42087953|NCT00738582|75898244|FG001|Maintenance Therapy|Adverse Event|6|||
42087954|NCT00738582|75898243|FG000|Maintenance Therapy|Progressive Disease|0|||
42087955|NCT00738582|75898244|FG001|Maintenance Therapy|Progressive Disease|47|||
42087956|NCT00738582|75898243|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
42087957|NCT00738582|75898244|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
42087958|NCT00720759|75898255|FG000|Overall Study|Lost to Follow-up|0|||
42087959|NCT00720759|75898256|FG001|Overall Study|Lost to Follow-up|1|||
42087960|NCT00720759|75898257|FG002|Overall Study|Lost to Follow-up|1|||
42087961|NCT00720759|75898258|FG003|Overall Study|Lost to Follow-up|0|||
42180920|NCT03129100|75988738|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180921|NCT03129100|75988739|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180922|NCT03129100|75988740|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180923|NCT03129100|75988741|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180924|NCT03129100|75988742|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180925|NCT03129100|75988743|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180926|NCT03129100|75988744|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42087962|NCT00720213|75898268|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
42087963|NCT00720213|75898269|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
42087964|NCT00720213|75898270|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
42087965|NCT00810407|75898278|FG000|Overall Study|Protocol Violation|3|||
42087966|NCT00810407|75898278|FG000|Overall Study|No Visit After First Day of Treatment|3|||
42087967|NCT00720057|75898284|FG000|Overall Study|Lost to Follow-up|0|||
42087968|NCT00720057|75898285|FG001|Overall Study|Lost to Follow-up|2|||
42180927|NCT03129100|75988745|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42087969|NCT00720057|75898284|FG000|Overall Study|Protocol Violation|1|||
42294368|NCT01804816|76128756|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
42294369|NCT01803555|76128765|FG000|Overall Study|Adverse Event|3|||
42180928|NCT03129100|75988746|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42087970|NCT00720057|75898285|FG001|Overall Study|Protocol Violation|0|||
42087971|NCT00720057|75898284|FG000|Overall Study|Withdrawal by Subject|0|||
42087972|NCT00720057|75898285|FG001|Overall Study|Withdrawal by Subject|1|||
42087973|NCT00790868|75898293|FG000|Overall Study|Withdrawal by Subject|4|||
42087974|NCT00790868|75898294|FG001|Overall Study|Withdrawal by Subject|5|||
42087975|NCT00790868|75898293|FG000|Overall Study|Lost to Follow-up|2|||
42087976|NCT00790868|75898294|FG001|Overall Study|Lost to Follow-up|12|||
42087977|NCT00719901|75898302|FG000|Overall Study|Adverse Event|5|||
42087978|NCT00719901|75898302|FG000|Overall Study|Withdrawal by Subject|1|||
42087979|NCT00719901|75898302|FG000|Overall Study|Alternate Treatment|1|||
42180929|NCT03129100|75988747|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42087980|NCT00719901|75898302|FG000|Overall Study|Disease Progression|3|||
42087981|NCT00719901|75898302|FG000|Overall Study|Availability of Study Drug|1|||
42087982|NCT00807365|75898306|FG000|Overall Study|Study Terminated|5|||
42087983|NCT00719355|75898312|FG000|Overall Study|Death|0|||
42087984|NCT00719355|75898313|FG001|Overall Study|Death|1|||
42087985|NCT00719355|75898312|FG000|Overall Study|Medical|14|||
42087986|NCT00719355|75898313|FG001|Overall Study|Medical|5|||
42087987|NCT00719355|75898312|FG000|Overall Study|Compliance|4|||
42087988|NCT00719355|75898313|FG001|Overall Study|Compliance|6|||
42087989|NCT00719355|75898312|FG000|Overall Study|Moved|0|||
42087990|NCT00719355|75898313|FG001|Overall Study|Moved|1|||
42087991|NCT00590759|75898319|FG000|Overall Study|Death|52|||
42087992|NCT00590759|75898319|FG000|Overall Study|Lost to Follow-up|28|||
42087993|NCT00734604|75898329|FG000|Overall Study|Adverse Event|0|||
42087994|NCT00734604|75898330|FG001|Overall Study|Adverse Event|2|||
42180930|NCT03129100|75988748|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180931|NCT03129100|75988749|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180932|NCT03129100|75988750|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180933|NCT03129100|75988751|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180934|NCT03129100|75988752|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180935|NCT03129100|75988753|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180936|NCT03129100|75988754|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180937|NCT03129100|75988755|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180938|NCT03129100|75988756|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180939|NCT03129100|75988757|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180940|NCT03129100|75988758|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180941|NCT03129100|75988759|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180942|NCT03129100|75988760|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
42180943|NCT03129100|75988735|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
42180944|NCT03129100|75988736|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
42180945|NCT03129100|75988737|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180946|NCT03129100|75988738|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180947|NCT03129100|75988739|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180948|NCT03129100|75988740|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180949|NCT03129100|75988741|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180950|NCT03129100|75988742|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180951|NCT03129100|75988743|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180952|NCT03129100|75988744|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180953|NCT03129100|75988745|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180954|NCT03129100|75988746|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180955|NCT03129100|75988747|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180956|NCT03129100|75988748|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180957|NCT03129100|75988749|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180958|NCT03129100|75988750|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42358570|NCT04418765|76204320|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
42358571|NCT04418765|76204318|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
42358572|NCT04418765|76204319|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
42358573|NCT04418765|76204320|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
42087995|NCT00734604|75898331|FG002|Overall Study|Adverse Event|0|||
42087996|NCT00734604|75898332|FG003|Overall Study|Adverse Event|2|||
42087997|NCT00734604|75898333|FG004|Overall Study|Adverse Event|1|||
42087998|NCT00734604|75898334|FG005|Overall Study|Adverse Event|1|||
42180959|NCT03129100|75988751|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180960|NCT03129100|75988752|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180961|NCT03129100|75988753|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42358574|NCT04418765|76204318|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
42180962|NCT03129100|75988754|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42087999|NCT00734604|75898329|FG000|Overall Study|Serious Adverse Event|1|||
42088000|NCT00734604|75898330|FG001|Overall Study|Serious Adverse Event|0|||
42088001|NCT00734604|75898331|FG002|Overall Study|Serious Adverse Event|1|||
42088002|NCT00734604|75898332|FG003|Overall Study|Serious Adverse Event|2|||
42088003|NCT00734604|75898333|FG004|Overall Study|Serious Adverse Event|0|||
42088004|NCT00734604|75898334|FG005|Overall Study|Serious Adverse Event|1|||
42088005|NCT00734604|75898329|FG000|Overall Study|Lost to Follow-up|1|||
42088006|NCT00734604|75898330|FG001|Overall Study|Lost to Follow-up|2|||
42088007|NCT00734604|75898331|FG002|Overall Study|Lost to Follow-up|2|||
42088008|NCT00734604|75898332|FG003|Overall Study|Lost to Follow-up|4|||
42088009|NCT00734604|75898333|FG004|Overall Study|Lost to Follow-up|2|||
42088010|NCT00734604|75898334|FG005|Overall Study|Lost to Follow-up|3|||
42088011|NCT00734604|75898329|FG000|Overall Study|Physician Decision|0|||
42088012|NCT00734604|75898330|FG001|Overall Study|Physician Decision|1|||
42088013|NCT00734604|75898331|FG002|Overall Study|Physician Decision|1|||
42088014|NCT00734604|75898332|FG003|Overall Study|Physician Decision|0|||
42088015|NCT00734604|75898333|FG004|Overall Study|Physician Decision|0|||
42088016|NCT00734604|75898334|FG005|Overall Study|Physician Decision|0|||
42088017|NCT00734604|75898329|FG000|Overall Study|Protocol Violation|0|||
42088018|NCT00734604|75898330|FG001|Overall Study|Protocol Violation|2|||
42088019|NCT00734604|75898331|FG002|Overall Study|Protocol Violation|0|||
42088020|NCT00734604|75898332|FG003|Overall Study|Protocol Violation|0|||
42088021|NCT00734604|75898333|FG004|Overall Study|Protocol Violation|1|||
42088022|NCT00734604|75898334|FG005|Overall Study|Protocol Violation|0|||
42088023|NCT00734604|75898329|FG000|Overall Study|Sponsor Decision|1|||
42088024|NCT00734604|75898330|FG001|Overall Study|Sponsor Decision|2|||
42088025|NCT00734604|75898331|FG002|Overall Study|Sponsor Decision|1|||
42088026|NCT00734604|75898332|FG003|Overall Study|Sponsor Decision|0|||
42088027|NCT00734604|75898333|FG004|Overall Study|Sponsor Decision|2|||
42088028|NCT00734604|75898334|FG005|Overall Study|Sponsor Decision|0|||
42088029|NCT00734604|75898329|FG000|Overall Study|Withdrawal by Subject|0|||
42088030|NCT00734604|75898330|FG001|Overall Study|Withdrawal by Subject|2|||
42088031|NCT00734604|75898331|FG002|Overall Study|Withdrawal by Subject|0|||
42088032|NCT00734604|75898332|FG003|Overall Study|Withdrawal by Subject|1|||
42088033|NCT00734604|75898333|FG004|Overall Study|Withdrawal by Subject|2|||
42088034|NCT00734604|75898334|FG005|Overall Study|Withdrawal by Subject|1|||
42088035|NCT00734604|75898329|FG000|Overall Study|Lack of Efficacy|0|||
42088036|NCT00734604|75898330|FG001|Overall Study|Lack of Efficacy|1|||
42088037|NCT00734604|75898331|FG002|Overall Study|Lack of Efficacy|1|||
42358575|NCT04418765|76204319|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
42358576|NCT04418765|76204320|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
42358577|NCT04418765|76204318|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
42358578|NCT04418765|76204319|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
42358579|NCT04418765|76204320|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
42358580|NCT04418765|76204318|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
42358581|NCT04418765|76204319|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
42358582|NCT04418765|76204320|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
42358583|NCT04418765|76204318|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
42358584|NCT04418765|76204319|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
42358585|NCT04418765|76204320|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
42358586|NCT04418765|76204318|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
42358587|NCT04418765|76204319|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
42358588|NCT04418765|76204320|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
42358589|NCT04418765|76204318|FG000|Extension Period (48 Weeks)|Other than specified|0|||
42358590|NCT04418765|76204319|FG001|Extension Period (48 Weeks)|Other than specified|5|||
42294370|NCT01803555|76128766|FG001|Overall Study|Adverse Event|2|||
42294371|NCT01803555|76128765|FG000|Overall Study|Withdrawal by Subject|3|||
42294372|NCT01803555|76128766|FG001|Overall Study|Withdrawal by Subject|3|||
42294373|NCT01803555|76128765|FG000|Overall Study|Non-compliance|1|||
42358591|NCT04418765|76204320|FG002|Extension Period (48 Weeks)|Other than specified|2|||
42358592|NCT04266795|76204338|FG000|Overall Study|Adverse Event|10|||
42358593|NCT04266795|76204339|FG001|Overall Study|Adverse Event|19|||
42358594|NCT04266795|76204338|FG000|Overall Study|Death|7|||
42294374|NCT01803555|76128766|FG001|Overall Study|Non-compliance|1|||
42294375|NCT01803555|76128765|FG000|Overall Study|Protocol Violation|3|||
42294376|NCT01803555|76128766|FG001|Overall Study|Protocol Violation|5|||
42294377|NCT01803555|76128765|FG000|Overall Study|Lost to Follow-up|0|||
42358595|NCT04266795|76204339|FG001|Overall Study|Death|8|||
42358596|NCT04266795|76204338|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
42358597|NCT04266795|76204339|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
42358598|NCT04266795|76204338|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
42358599|NCT04266795|76204339|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
42358600|NCT04266795|76204338|FG000|Overall Study|Progressive Disease|12|||
42088038|NCT00734604|75898332|FG003|Overall Study|Lack of Efficacy|0|||
42088039|NCT00734604|75898333|FG004|Overall Study|Lack of Efficacy|0|||
42088040|NCT00734604|75898334|FG005|Overall Study|Lack of Efficacy|0|||
42088041|NCT00590681|75898345|FG000|Overall Study|Withdrawal by Subject|7|||
42088042|NCT00590681|75898345|FG000|Overall Study|Adverse Event|8|||
42088043|NCT00590681|75898345|FG000|Overall Study|Death|3|||
42088044|NCT00590681|75898345|FG000|Overall Study|Lost to Follow-up|1|||
42294378|NCT01803555|76128766|FG001|Overall Study|Lost to Follow-up|2|||
42088045|NCT00590681|75898345|FG000|Overall Study|disease progression|1|||
42088046|NCT00727272|75898349|FG000|Washout Period A|Adverse Event|0|||
42088047|NCT00727272|75898350|FG001|Washout Period A|Adverse Event|0|||
42088048|NCT00727272|75898351|FG002|Washout Period A|Adverse Event|1|||
42088049|NCT00727272|75898349|FG000|Washout Period B|Withdrawal by Subject|0|||
42088050|NCT00727272|75898350|FG001|Washout Period B|Withdrawal by Subject|0|||
42088051|NCT00727272|75898351|FG002|Washout Period B|Withdrawal by Subject|1|||
42088052|NCT00805025|75898361|FG000|Overall Study|Screened but not enrolled/treated|42|||
42088053|NCT00805025|75898361|FG000|Overall Study|Adverse Event|4|||
42088054|NCT00805025|75898361|FG000|Overall Study|Withdrawal by Subject|2|||
42088055|NCT00805025|75898361|FG000|Overall Study|Physician Decision|1|||
42088056|NCT00734214|75898367|FG000|Overall Study|Withdrawal by Subject|3|||
42088057|NCT00734214|75898368|FG001|Overall Study|Withdrawal by Subject|4|||
42088058|NCT00734214|75898367|FG000|Overall Study|MD withdrawal|1|||
42088059|NCT00734214|75898368|FG001|Overall Study|MD withdrawal|0|||
42088060|NCT00787202|75898379|FG000|Overall Study|Adverse Event|3|||
42088061|NCT00787202|75898380|FG001|Overall Study|Adverse Event|2|||
42088062|NCT00787202|75898381|FG002|Overall Study|Adverse Event|0|||
42088063|NCT00787202|75898382|FG003|Overall Study|Adverse Event|0|||
42294379|NCT01803555|76128765|FG000|Overall Study|Other than specified|3|||
42294380|NCT01803555|76128766|FG001|Overall Study|Other than specified|5|||
42294381|NCT01112306|76128772|FG000|Overall Study|Death|175|||
42294382|NCT01112306|76128772|FG000|Overall Study|Lost to Follow-up|9|||
42294383|NCT01112306|76128772|FG000|Overall Study|Withdrawal by Subject|31|||
42294384|NCT01112306|76128772|FG000|Overall Study|Other|70|||
42294385|NCT02524665|76128776|FG000|Overall Study|Lost to Follow-up|1|||
42294386|NCT02638129|76128783|FG000|Overall Study|Study terminated|28|||
42294387|NCT02638129|76128784|FG001|Overall Study|Study terminated|30|||
42088064|NCT00787202|75898383|FG004|Overall Study|Adverse Event|2|||
42294388|NCT01658943|76128792|FG000|Overall Study|Adverse Event|6|||
42294389|NCT01658943|76128793|FG001|Overall Study|Adverse Event|13|||
42294390|NCT01658943|76128792|FG000|Overall Study|Withdrawal by Subject|9|||
42294391|NCT01658943|76128793|FG001|Overall Study|Withdrawal by Subject|2|||
42294392|NCT01658943|76128792|FG000|Overall Study|Progression/Relapse|39|||
42294393|NCT01658943|76128793|FG001|Overall Study|Progression/Relapse|40|||
42294394|NCT01658943|76128792|FG000|Overall Study|Death|4|||
42294395|NCT01658943|76128793|FG001|Overall Study|Death|2|||
42294396|NCT01658943|76128792|FG000|Overall Study|not protocol specified|4|||
42294397|NCT01658943|76128793|FG001|Overall Study|not protocol specified|1|||
42294398|NCT01658943|76128792|FG000|Overall Study|Not eligible|7|||
42294399|NCT01658943|76128793|FG001|Overall Study|Not eligible|9|||
42294400|NCT01658943|76128792|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
42294401|NCT01658943|76128793|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
42294402|NCT02600819|76128799|FG000|GEN Phase|Adverse Event|2|||
42294403|NCT02600819|76128800|FG001|GEN Phase|Adverse Event|0|||
42294404|NCT02600819|76128799|FG000|GEN Phase|Death|2|||
42294405|NCT02600819|76128800|FG001|GEN Phase|Death|0|||
42294406|NCT02600819|76128799|FG000|GEN Phase|Investigator's Discretion|4|||
42294407|NCT02600819|76128800|FG001|GEN Phase|Investigator's Discretion|0|||
42294408|NCT02600819|76128799|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
42294409|NCT02600819|76128800|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
42294410|NCT02600819|76128799|FG000|GEN Phase|Withdrew Consent|5|||
42294411|NCT02600819|76128800|FG001|GEN Phase|Withdrew Consent|0|||
42294412|NCT02600819|76128799|FG000|GEN Phase|Lost to Follow-up|2|||
42088065|NCT00787202|75898379|FG000|Overall Study|Lack of Efficacy|5|||
42088066|NCT00787202|75898380|FG001|Overall Study|Lack of Efficacy|6|||
42088067|NCT00787202|75898381|FG002|Overall Study|Lack of Efficacy|5|||
42088068|NCT00787202|75898382|FG003|Overall Study|Lack of Efficacy|2|||
42088069|NCT00787202|75898383|FG004|Overall Study|Lack of Efficacy|1|||
42088070|NCT00787202|75898379|FG000|Overall Study|Lost to Follow-up|1|||
42088071|NCT00787202|75898380|FG001|Overall Study|Lost to Follow-up|0|||
42088072|NCT00787202|75898381|FG002|Overall Study|Lost to Follow-up|0|||
42088073|NCT00787202|75898382|FG003|Overall Study|Lost to Follow-up|0|||
42088074|NCT00787202|75898383|FG004|Overall Study|Lost to Follow-up|0|||
42088075|NCT00787202|75898379|FG000|Overall Study|Withdrawal by Subject|2|||
42088076|NCT00787202|75898380|FG001|Overall Study|Withdrawal by Subject|2|||
42088077|NCT00787202|75898381|FG002|Overall Study|Withdrawal by Subject|2|||
42088078|NCT00787202|75898382|FG003|Overall Study|Withdrawal by Subject|0|||
42088079|NCT00787202|75898383|FG004|Overall Study|Withdrawal by Subject|0|||
42088080|NCT00787202|75898379|FG000|Overall Study|Protocol Violation|2|||
42088081|NCT00787202|75898380|FG001|Overall Study|Protocol Violation|1|||
42088082|NCT00787202|75898381|FG002|Overall Study|Protocol Violation|0|||
42088083|NCT00787202|75898382|FG003|Overall Study|Protocol Violation|0|||
42088084|NCT00787202|75898383|FG004|Overall Study|Protocol Violation|1|||
42088085|NCT00787202|75898379|FG000|Overall Study|Randomized, not treated|1|||
42088086|NCT00787202|75898380|FG001|Overall Study|Randomized, not treated|0|||
42088087|NCT00787202|75898381|FG002|Overall Study|Randomized, not treated|0|||
42088088|NCT00787202|75898382|FG003|Overall Study|Randomized, not treated|0|||
42088089|NCT00787202|75898383|FG004|Overall Study|Randomized, not treated|0|||
42088090|NCT04033367|75898401|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
42088091|NCT04033367|75898402|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
42088092|NCT04033367|75898401|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
42088093|NCT04033367|75898402|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
42088094|NCT04033367|75898401|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
42088095|NCT04033367|75898402|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
42088096|NCT04033367|75898401|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
42294413|NCT02600819|76128800|FG001|GEN Phase|Lost to Follow-up|0|||
42294414|NCT02597933|76128808|FG000|Overall Study|Withdrawal by Subject|7|||
42294415|NCT02597933|76128809|FG001|Overall Study|Withdrawal by Subject|5|||
42294416|NCT02597933|76128808|FG000|Overall Study|Protocol Violation|2|||
42294417|NCT02597933|76128809|FG001|Overall Study|Protocol Violation|2|||
42294418|NCT02597933|76128808|FG000|Overall Study|Adverse Event|20|||
42294419|NCT02597933|76128809|FG001|Overall Study|Adverse Event|28|||
42294420|NCT02597933|76128808|FG000|Overall Study|Not treated|2|||
42294421|NCT02597933|76128809|FG001|Overall Study|Not treated|2|||
42294422|NCT02597933|76128808|FG000|Overall Study|Other than stated above|7|||
42294423|NCT02597933|76128809|FG001|Overall Study|Other than stated above|14|||
42294424|NCT02597855|76128817|FG000|Overall Study|Lost to Follow-up|2|||
42294425|NCT02597855|76128818|FG001|Overall Study|Lost to Follow-up|1|||
42294426|NCT02604407|76128827|FG000|Overall Study|Adverse Event|0|||
42294427|NCT02604407|76128828|FG001|Overall Study|Adverse Event|7|||
42294428|NCT02604407|76128829|FG002|Overall Study|Adverse Event|5|||
42294429|NCT02604407|76128827|FG000|Overall Study|Protocol Violation|2|||
42294430|NCT02604407|76128828|FG001|Overall Study|Protocol Violation|0|||
42294431|NCT02604407|76128829|FG002|Overall Study|Protocol Violation|0|||
42294432|NCT02604407|76128827|FG000|Overall Study|Withdrawal by Subject|3|||
42294433|NCT02604407|76128828|FG001|Overall Study|Withdrawal by Subject|3|||
42294434|NCT02604407|76128829|FG002|Overall Study|Withdrawal by Subject|5|||
42294435|NCT02604407|76128827|FG000|Overall Study|Lost to Follow-up|2|||
42294436|NCT02604407|76128828|FG001|Overall Study|Lost to Follow-up|1|||
42294437|NCT02604407|76128829|FG002|Overall Study|Lost to Follow-up|2|||
42088097|NCT04033367|75898402|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
42088098|NCT00733980|75898414|FG000|Overall Study|Adverse Event|5|||
42294438|NCT02604407|76128827|FG000|Overall Study|Lack of Efficacy|1|||
42294439|NCT02604407|76128828|FG001|Overall Study|Lack of Efficacy|0|||
42294440|NCT02604407|76128829|FG002|Overall Study|Lack of Efficacy|0|||
42294441|NCT02604407|76128827|FG000|Overall Study|Other|3|||
42294442|NCT02604407|76128828|FG001|Overall Study|Other|1|||
42088099|NCT00733980|75898415|FG001|Overall Study|Adverse Event|2|||
42088100|NCT00733980|75898414|FG000|Overall Study|Lack of Efficacy|0|||
42294443|NCT02604407|76128829|FG002|Overall Study|Other|4|||
42358601|NCT04266795|76204339|FG001|Overall Study|Progressive Disease|9|||
42358602|NCT04266795|76204338|FG000|Overall Study|Withdrawal by Patient|5|||
42358603|NCT04266795|76204339|FG001|Overall Study|Withdrawal by Patient|6|||
42358604|NCT04266795|76204338|FG000|Overall Study|Disease Relapse|3|||
42358605|NCT04266795|76204339|FG001|Overall Study|Disease Relapse|6|||
42358606|NCT04266795|76204338|FG000|Overall Study|Reason not Specified|12|||
42358607|NCT04266795|76204339|FG001|Overall Study|Reason not Specified|10|||
42088101|NCT00733980|75898415|FG001|Overall Study|Lack of Efficacy|1|||
42088102|NCT00733980|75898414|FG000|Overall Study|Protocol Violation|2|||
42088103|NCT00733980|75898415|FG001|Overall Study|Protocol Violation|1|||
42088104|NCT00733980|75898414|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
42358608|NCT04266795|76204338|FG000|Overall Study|Participants Ongoing on Treatment|25|||
42358609|NCT04266795|76204339|FG001|Overall Study|Participants Ongoing on Treatment|23|||
42358610|NCT04212169|76204349|FG000|Overall Study|Adverse Event|0|||
42358611|NCT04212169|76204350|FG001|Overall Study|Adverse Event|0|||
42358612|NCT04212169|76204351|FG002|Overall Study|Adverse Event|0|||
42088105|NCT00733980|75898415|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
42088106|NCT00733980|75898414|FG000|Overall Study|Lost to Follow-up|6|||
42088107|NCT00733980|75898415|FG001|Overall Study|Lost to Follow-up|11|||
42088108|NCT00733980|75898414|FG000|Overall Study|Physician Decision|2|||
42088109|NCT00733980|75898415|FG001|Overall Study|Physician Decision|3|||
42088110|NCT00733980|75898414|FG000|Overall Study|Withdrawal by Subject|6|||
42358613|NCT04212169|76204352|FG003|Overall Study|Adverse Event|2|||
42358614|NCT04212169|76204349|FG000|Overall Study|Lost to Follow-up|1|||
42358615|NCT04212169|76204350|FG001|Overall Study|Lost to Follow-up|0|||
42358616|NCT04212169|76204351|FG002|Overall Study|Lost to Follow-up|0|||
42358617|NCT04212169|76204352|FG003|Overall Study|Lost to Follow-up|2|||
42358618|NCT04212169|76204349|FG000|Overall Study|Withdrawal by Subject|10|||
42358619|NCT04212169|76204350|FG001|Overall Study|Withdrawal by Subject|2|||
42358620|NCT04212169|76204351|FG002|Overall Study|Withdrawal by Subject|5|||
42358621|NCT04212169|76204352|FG003|Overall Study|Withdrawal by Subject|7|||
42358622|NCT04212169|76204349|FG000|Overall Study|Other reason, unspecified|3|||
42358623|NCT04212169|76204350|FG001|Overall Study|Other reason, unspecified|1|||
42358624|NCT04212169|76204351|FG002|Overall Study|Other reason, unspecified|0|||
42358625|NCT04212169|76204352|FG003|Overall Study|Other reason, unspecified|2|||
42358626|NCT04109313|76204381|FG000|Overall Study|Pregnancy|1|||
42088111|NCT00733980|75898415|FG001|Overall Study|Withdrawal by Subject|2|||
42088112|NCT00806585|75898427|FG000|Overall Study|Study terminated by Sponsor|0|||
42088113|NCT00806585|75898428|FG001|Overall Study|Study terminated by Sponsor|0|||
42088114|NCT00806585|75898429|FG002|Overall Study|Study terminated by Sponsor|1|||
42180963|NCT03129100|75988755|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180964|NCT03129100|75988756|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180965|NCT03129100|75988757|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180966|NCT03129100|75988758|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180967|NCT03129100|75988759|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180968|NCT03129100|75988760|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
42180969|NCT03129100|75988735|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180970|NCT03129100|75988736|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
42180971|NCT03129100|75988737|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180972|NCT03129100|75988738|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180973|NCT03129100|75988739|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180974|NCT03129100|75988740|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180975|NCT03129100|75988741|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180976|NCT03129100|75988742|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180977|NCT03129100|75988743|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
42088115|NCT00806585|75898430|FG003|Overall Study|Study terminated by Sponsor|2|||
42180978|NCT03129100|75988744|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180979|NCT03129100|75988745|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180980|NCT03129100|75988746|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180981|NCT03129100|75988747|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180982|NCT03129100|75988748|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180983|NCT03129100|75988749|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180984|NCT03129100|75988750|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180985|NCT03129100|75988751|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
42358627|NCT04109313|76204381|FG000|Overall Study|Adverse Event|11|||
42358628|NCT04109313|76204381|FG000|Overall Study|Lack of Efficacy|11|||
42358629|NCT04109313|76204381|FG000|Overall Study|Lost to Follow-up|1|||
42358630|NCT04109313|76204381|FG000|Overall Study|Physician Decision|2|||
42088116|NCT00806585|75898431|FG004|Overall Study|Study terminated by Sponsor|0|||
42088117|NCT00806585|75898427|FG000|Overall Study|Protocol Violation|3|||
42180986|NCT03129100|75988752|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
42358631|NCT04109313|76204381|FG000|Overall Study|Subject Decision|13|||
42358632|NCT04109313|76204381|FG000|Overall Study|Covid-19 situation|2|||
42358633|NCT04089865|76204390|FG000|Overall Study|Withdrawal by Subject|2|||
42358634|NCT04089865|76204391|FG001|Overall Study|Withdrawal by Subject|2|||
42180987|NCT03129100|75988753|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180988|NCT03129100|75988754|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180989|NCT03129100|75988755|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180990|NCT03129100|75988756|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180991|NCT03129100|75988757|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180992|NCT03129100|75988758|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180993|NCT03129100|75988759|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180994|NCT03129100|75988760|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
42180995|NCT03129100|75988735|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42180996|NCT03129100|75988736|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42180997|NCT03129100|75988737|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
42180998|NCT03129100|75988738|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
42180999|NCT03129100|75988739|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181000|NCT03129100|75988740|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
42181001|NCT03129100|75988741|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181002|NCT03129100|75988742|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181003|NCT03129100|75988743|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181004|NCT03129100|75988744|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42088118|NCT00806585|75898428|FG001|Overall Study|Protocol Violation|1|||
42088119|NCT00806585|75898429|FG002|Overall Study|Protocol Violation|2|||
42088120|NCT00806585|75898430|FG003|Overall Study|Protocol Violation|0|||
42088121|NCT00806585|75898431|FG004|Overall Study|Protocol Violation|0|||
42088122|NCT00806585|75898427|FG000|Overall Study|Physician Decision|0|||
42088123|NCT00806585|75898428|FG001|Overall Study|Physician Decision|2|||
42088124|NCT00806585|75898429|FG002|Overall Study|Physician Decision|3|||
42088125|NCT00806585|75898430|FG003|Overall Study|Physician Decision|0|||
42181005|NCT03129100|75988745|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181006|NCT03129100|75988746|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181007|NCT03129100|75988747|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181008|NCT03129100|75988748|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181009|NCT03129100|75988749|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181010|NCT03129100|75988750|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181011|NCT03129100|75988751|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181012|NCT03129100|75988752|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181013|NCT03129100|75988753|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42088126|NCT00806585|75898431|FG004|Overall Study|Physician Decision|1|||
42088127|NCT00806585|75898427|FG000|Overall Study|Lost to Follow-up|2|||
42088128|NCT00806585|75898428|FG001|Overall Study|Lost to Follow-up|1|||
42088129|NCT00806585|75898429|FG002|Overall Study|Lost to Follow-up|2|||
42088130|NCT00806585|75898430|FG003|Overall Study|Lost to Follow-up|2|||
42088131|NCT00806585|75898431|FG004|Overall Study|Lost to Follow-up|5|||
42088132|NCT00806585|75898427|FG000|Overall Study|Lack of Efficacy|1|||
42088133|NCT00806585|75898428|FG001|Overall Study|Lack of Efficacy|0|||
42088134|NCT00806585|75898429|FG002|Overall Study|Lack of Efficacy|0|||
42088135|NCT00806585|75898430|FG003|Overall Study|Lack of Efficacy|0|||
42088136|NCT00806585|75898431|FG004|Overall Study|Lack of Efficacy|0|||
42088137|NCT00806585|75898427|FG000|Overall Study|Adverse Event|1|||
42088138|NCT00806585|75898428|FG001|Overall Study|Adverse Event|5|||
42088139|NCT00806585|75898429|FG002|Overall Study|Adverse Event|3|||
42088140|NCT00806585|75898430|FG003|Overall Study|Adverse Event|4|||
42088141|NCT00806585|75898431|FG004|Overall Study|Adverse Event|2|||
42088142|NCT00806585|75898427|FG000|Overall Study|Withdrawal by Subject|10|||
42088143|NCT00806585|75898428|FG001|Overall Study|Withdrawal by Subject|8|||
42088144|NCT00806585|75898429|FG002|Overall Study|Withdrawal by Subject|9|||
42088145|NCT00806585|75898430|FG003|Overall Study|Withdrawal by Subject|3|||
42088146|NCT00806585|75898431|FG004|Overall Study|Withdrawal by Subject|11|||
42088147|NCT00806585|75898427|FG000|Overall Study|Completion status unknown|15|||
42088148|NCT00806585|75898428|FG001|Overall Study|Completion status unknown|14|||
42088149|NCT00806585|75898429|FG002|Overall Study|Completion status unknown|12|||
42088150|NCT00806585|75898430|FG003|Overall Study|Completion status unknown|4|||
42088151|NCT00806585|75898431|FG004|Overall Study|Completion status unknown|12|||
42088152|NCT00480025|75898445|FG000|Overall Study|Protocol Violation|12|||
42088153|NCT00480025|75898446|FG001|Overall Study|Protocol Violation|7|||
42088154|NCT00480025|75898445|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
42088155|NCT00480025|75898446|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
42088156|NCT00480025|75898445|FG000|Overall Study|Disease Progression / Recurrence|449|||
42181014|NCT03129100|75988754|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181015|NCT03129100|75988755|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42088157|NCT00480025|75898446|FG001|Overall Study|Disease Progression / Recurrence|224|||
42088158|NCT00480025|75898445|FG000|Overall Study|Adverse Event|44|||
42088159|NCT00480025|75898446|FG001|Overall Study|Adverse Event|12|||
42088160|NCT00480025|75898445|FG000|Overall Study|Other|70|||
42088161|NCT00480025|75898446|FG001|Overall Study|Other|29|||
42088162|NCT00480025|75898445|FG000|Overall Study|SAE including intercurrent illness|76|||
42088163|NCT00480025|75898446|FG001|Overall Study|SAE including intercurrent illness|42|||
42088164|NCT00806351|75898460|FG000|Overall Study|Death|5|||
42088165|NCT00806351|75898461|FG001|Overall Study|Death|4|||
42088166|NCT00733902|75898471|FG000|Overall Study|Death|0|||
42088167|NCT00733902|75898472|FG001|Overall Study|Death|0|||
42088168|NCT00733902|75898473|FG002|Overall Study|Death|0|||
42088169|NCT00733902|75898474|FG003|Overall Study|Death|1|||
42088170|NCT00733902|75898471|FG000|Overall Study|Adverse Event|3|||
42088171|NCT00733902|75898472|FG001|Overall Study|Adverse Event|4|||
42088172|NCT00733902|75898473|FG002|Overall Study|Adverse Event|7|||
42088173|NCT00733902|75898474|FG003|Overall Study|Adverse Event|11|||
42088174|NCT00733902|75898471|FG000|Overall Study|Lack of Efficacy|56|||
42088175|NCT00733902|75898472|FG001|Overall Study|Lack of Efficacy|21|||
42088176|NCT00733902|75898473|FG002|Overall Study|Lack of Efficacy|34|||
42088177|NCT00733902|75898474|FG003|Overall Study|Lack of Efficacy|23|||
42088178|NCT00733902|75898471|FG000|Overall Study|Protocol Violation|4|||
42088179|NCT00733902|75898472|FG001|Overall Study|Protocol Violation|6|||
42088180|NCT00733902|75898473|FG002|Overall Study|Protocol Violation|3|||
42088181|NCT00733902|75898474|FG003|Overall Study|Protocol Violation|3|||
42088182|NCT00733902|75898471|FG000|Overall Study|Withdrawal by Subject|10|||
42088183|NCT00733902|75898472|FG001|Overall Study|Withdrawal by Subject|5|||
42088184|NCT00733902|75898473|FG002|Overall Study|Withdrawal by Subject|4|||
42088185|NCT00733902|75898474|FG003|Overall Study|Withdrawal by Subject|16|||
42088186|NCT00733902|75898471|FG000|Overall Study|Entered extension study|89|||
42088187|NCT00733902|75898472|FG001|Overall Study|Entered extension study|124|||
42088188|NCT00733902|75898473|FG002|Overall Study|Entered extension study|111|||
42088189|NCT00733902|75898474|FG003|Overall Study|Entered extension study|109|||
42088190|NCT00733902|75898471|FG000|Overall Study|Randomized but not treated|2|||
42088191|NCT00733902|75898472|FG001|Overall Study|Randomized but not treated|2|||
42088192|NCT00733902|75898473|FG002|Overall Study|Randomized but not treated|2|||
42088193|NCT00733902|75898474|FG003|Overall Study|Randomized but not treated|1|||
42088194|NCT00790790|75898487|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
42088195|NCT00790790|75898488|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
42088196|NCT00790790|75898489|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
42088197|NCT00790790|75898487|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
42088198|NCT00790790|75898488|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
42088199|NCT00790790|75898489|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
42088200|NCT00790790|75898487|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
42088201|NCT00790790|75898488|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
42088202|NCT00790790|75898489|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
42088203|NCT00790790|75898487|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
42088204|NCT00790790|75898488|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
42088205|NCT00790790|75898489|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
42088206|NCT00790790|75898487|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
42088207|NCT00790790|75898488|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
42088208|NCT00790790|75898489|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
42088209|NCT00719043|75898509|FG000|Overall Study|Adverse Event|5|||
42088210|NCT00719043|75898510|FG001|Overall Study|Adverse Event|1|||
42088211|NCT00719043|75898511|FG002|Overall Study|Adverse Event|2|||
42088212|NCT00719043|75898512|FG003|Overall Study|Adverse Event|2|||
42088213|NCT00719043|75898513|FG004|Overall Study|Adverse Event|1|||
42088214|NCT00719043|75898514|FG005|Overall Study|Adverse Event|4|||
42088215|NCT00719043|75898515|FG006|Overall Study|Adverse Event|4|||
42088216|NCT00719043|75898509|FG000|Overall Study|Lost to Follow-up|14|||
42088217|NCT00719043|75898510|FG001|Overall Study|Lost to Follow-up|10|||
42088218|NCT00719043|75898511|FG002|Overall Study|Lost to Follow-up|8|||
42088219|NCT00719043|75898512|FG003|Overall Study|Lost to Follow-up|9|||
42088220|NCT00719043|75898513|FG004|Overall Study|Lost to Follow-up|10|||
42088221|NCT00719043|75898514|FG005|Overall Study|Lost to Follow-up|9|||
42088222|NCT00719043|75898515|FG006|Overall Study|Lost to Follow-up|9|||
42088223|NCT00719043|75898509|FG000|Overall Study|Protocol Violation|0|||
42358635|NCT04089865|76204392|FG002|Overall Study|Withdrawal by Subject|7|||
42358636|NCT04089865|76204393|FG003|Overall Study|Withdrawal by Subject|2|||
42358637|NCT04017832|76204421|FG000|Overall Study|Withdrawal by Subject|13|||
42088224|NCT00719043|75898510|FG001|Overall Study|Protocol Violation|0|||
42088225|NCT00719043|75898511|FG002|Overall Study|Protocol Violation|0|||
42088226|NCT00719043|75898512|FG003|Overall Study|Protocol Violation|0|||
42088227|NCT00719043|75898513|FG004|Overall Study|Protocol Violation|0|||
42088228|NCT00719043|75898514|FG005|Overall Study|Protocol Violation|1|||
42088229|NCT00719043|75898515|FG006|Overall Study|Protocol Violation|0|||
42088230|NCT00719043|75898509|FG000|Overall Study|Other|1|||
42088231|NCT00719043|75898510|FG001|Overall Study|Other|0|||
42088232|NCT00719043|75898511|FG002|Overall Study|Other|1|||
42358638|NCT04017832|76204422|FG001|Overall Study|Withdrawal by Subject|12|||
42088233|NCT00719043|75898512|FG003|Overall Study|Other|2|||
42358639|NCT04017832|76204423|FG002|Overall Study|Withdrawal by Subject|21|||
42088234|NCT00719043|75898513|FG004|Overall Study|Other|0|||
42088235|NCT00719043|75898514|FG005|Overall Study|Other|2|||
42088236|NCT00719043|75898515|FG006|Overall Study|Other|1|||
42181016|NCT03129100|75988756|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181017|NCT03129100|75988757|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181018|NCT03129100|75988758|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181019|NCT03129100|75988759|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42294444|NCT02593097|76128839|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
42294445|NCT02593097|76128840|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
42294446|NCT02593097|76128839|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
42294447|NCT02593097|76128840|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
42294448|NCT02593097|76128839|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
42294449|NCT02593097|76128840|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
42294450|NCT02593097|76128839|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
42294451|NCT02593097|76128840|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
42294452|NCT02593097|76128839|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
42294453|NCT02593097|76128840|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
42294454|NCT01657461|76128848|FG000|Overall Study|Death|9|||
42294455|NCT01657461|76128849|FG001|Overall Study|Death|12|||
42294456|NCT01657461|76128848|FG000|Overall Study|Lost to Follow-up|0|||
42294457|NCT01657461|76128849|FG001|Overall Study|Lost to Follow-up|3|||
42294458|NCT01657461|76128848|FG000|Overall Study|Physician Decision|0|||
42294459|NCT01657461|76128849|FG001|Overall Study|Physician Decision|2|||
42294460|NCT01657461|76128848|FG000|Overall Study|Withdrawal by Subject|1|||
42294461|NCT01657461|76128849|FG001|Overall Study|Withdrawal by Subject|3|||
42294462|NCT02592551|76128858|FG000|Overall Study|Not evaluable|1|||
42294463|NCT02592551|76128859|FG001|Overall Study|Not evaluable|3|||
42294464|NCT02592551|76128860|FG002|Overall Study|Not evaluable|0|||
42294465|NCT02595749|76128871|FG000|Overall Study|Withdrawal by Subject|12|||
42294466|NCT02595749|76128872|FG001|Overall Study|Withdrawal by Subject|7|||
42294467|NCT01657305|76128878|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
42294468|NCT01657305|76128878|FG000|Overall Study|Withdrawal by Subject|4|||
42294469|NCT01657305|76128878|FG000|Overall Study|Adverse Event|1|||
42294470|NCT01657305|76128878|FG000|Overall Study|Lost to Follow-up|1|||
42294471|NCT01657305|76128878|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
42294472|NCT02634307|76128921|FG000|Overall Study|Adverse Event|50|||
42294473|NCT02634307|76128922|FG001|Overall Study|Adverse Event|24|||
42294474|NCT02634307|76128923|FG002|Overall Study|Adverse Event|14|||
42294475|NCT02634307|76128921|FG000|Overall Study|Lost to Follow-up|21|||
42294476|NCT02634307|76128922|FG001|Overall Study|Lost to Follow-up|5|||
42294477|NCT02634307|76128923|FG002|Overall Study|Lost to Follow-up|6|||
42294478|NCT02634307|76128921|FG000|Overall Study|Pregnancy|5|||
42294479|NCT02634307|76128922|FG001|Overall Study|Pregnancy|1|||
42294480|NCT02634307|76128923|FG002|Overall Study|Pregnancy|3|||
42294481|NCT02634307|76128921|FG000|Overall Study|Withdrawal by Subject|38|||
42294482|NCT02634307|76128922|FG001|Overall Study|Withdrawal by Subject|24|||
42294483|NCT02634307|76128923|FG002|Overall Study|Withdrawal by Subject|18|||
42294484|NCT02634307|76128921|FG000|Overall Study|Non-Compliance with Study Drug|0|||
42294485|NCT02634307|76128922|FG001|Overall Study|Non-Compliance with Study Drug|2|||
42294486|NCT02634307|76128923|FG002|Overall Study|Non-Compliance with Study Drug|2|||
42294487|NCT02634307|76128921|FG000|Overall Study|Lack of Efficacy|1|||
42294488|NCT02634307|76128922|FG001|Overall Study|Lack of Efficacy|5|||
42294489|NCT02634307|76128923|FG002|Overall Study|Lack of Efficacy|3|||
42294490|NCT02634307|76128921|FG000|Overall Study|Physician Decision|7|||
42294491|NCT02634307|76128922|FG001|Overall Study|Physician Decision|5|||
42294492|NCT02634307|76128923|FG002|Overall Study|Physician Decision|5|||
42294493|NCT02634307|76128921|FG000|Overall Study|Reason not Specified|3|||
42294494|NCT02634307|76128922|FG001|Overall Study|Reason not Specified|5|||
42294495|NCT02634307|76128923|FG002|Overall Study|Reason not Specified|10|||
42294496|NCT01365273|76128933|FG000|Overall Study|Lost to Follow-up|1|||
42358640|NCT04017832|76204424|FG003|Overall Study|Withdrawal by Subject|7|||
42088237|NCT00719043|75898509|FG000|Overall Study|Withdrawal by Subject|12|||
42088238|NCT00719043|75898510|FG001|Overall Study|Withdrawal by Subject|14|||
42088239|NCT00719043|75898511|FG002|Overall Study|Withdrawal by Subject|9|||
42088240|NCT00719043|75898512|FG003|Overall Study|Withdrawal by Subject|10|||
42358641|NCT04017832|76204421|FG000|Overall Study|Lost to Follow-up|0|||
42358642|NCT04017832|76204422|FG001|Overall Study|Lost to Follow-up|3|||
42358643|NCT04017832|76204423|FG002|Overall Study|Lost to Follow-up|3|||
42088241|NCT00719043|75898513|FG004|Overall Study|Withdrawal by Subject|16|||
42358644|NCT04017832|76204424|FG003|Overall Study|Lost to Follow-up|1|||
42088242|NCT00719043|75898514|FG005|Overall Study|Withdrawal by Subject|18|||
42181020|NCT03129100|75988760|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
42181021|NCT03129100|75988735|FG000|Period2 Extension Period (Group A and B)|Death|0|||
42294497|NCT01365273|76128934|FG001|Overall Study|Lost to Follow-up|0|||
42294498|NCT01365273|76128933|FG000|Overall Study|Protocol Violation|0|||
42294499|NCT01365273|76128934|FG001|Overall Study|Protocol Violation|1|||
42088243|NCT00719043|75898515|FG006|Overall Study|Withdrawal by Subject|14|||
42088244|NCT00786422|75898543|FG000|Rivaroxaban Treatment|Death|2|||
42088245|NCT00786422|75898543|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
42088246|NCT00786422|75898543|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
42088247|NCT00786422|75898543|FG000|Rivaroxaban Treatment|Physician Decision|1|||
42088248|NCT00786422|75898543|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
42088249|NCT00786422|75898543|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
42088250|NCT00786422|75898543|FG000|Rivaroxaban Treatment|Adverse Event|2|||
42088251|NCT00786422|75898543|FG000|Follow-up Period|Death|1|||
42088252|NCT00786422|75898543|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
42088253|NCT00718887|75898551|FG000|Overall Study|Withdrawal by Subject|3|||
42088254|NCT00718887|75898552|FG001|Overall Study|Withdrawal by Subject|2|||
42088255|NCT00718887|75898551|FG000|Overall Study|Not identified|2|||
42088256|NCT00718887|75898552|FG001|Overall Study|Not identified|7|||
42088257|NCT00786188|75898566|FG000|Overall Study|Adverse Event|3|||
42088258|NCT00786188|75898567|FG001|Overall Study|Adverse Event|1|||
42088259|NCT00786188|75898566|FG000|Overall Study|Withdrawal by Subject|2|||
42088260|NCT00786188|75898567|FG001|Overall Study|Withdrawal by Subject|0|||
42088261|NCT00790556|75898575|FG000|Treatment Period 1|Physician Decision|1|||
42181022|NCT03129100|75988736|FG001|Period2 Extension Period (Group A and B)|Death|0|||
42181023|NCT03129100|75988737|FG002|Period2 Extension Period (Group A and B)|Death|1|||
42181024|NCT03129100|75988738|FG003|Period2 Extension Period (Group A and B)|Death|0|||
42181025|NCT03129100|75988739|FG004|Period2 Extension Period (Group A and B)|Death|0|||
42181026|NCT03129100|75988740|FG005|Period2 Extension Period (Group A and B)|Death|0|||
42181027|NCT03129100|75988741|FG006|Period2 Extension Period (Group A and B)|Death|0|||
42088262|NCT00790556|75898576|FG001|Treatment Period 1|Physician Decision|0|||
42088263|NCT00790556|75898575|FG000|Treatment Period 1|Withdrawal by Subject|1|||
42088264|NCT00790556|75898576|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42088265|NCT00733824|75898587|FG000|Phase I|Withdrawal by Subject|1|||
42088266|NCT00733824|75898588|FG001|Phase I|Withdrawal by Subject|0|||
42088267|NCT00733824|75898589|FG002|Phase I|Withdrawal by Subject|0|||
42088268|NCT00733824|75898590|FG003|Phase I|Withdrawal by Subject|0|||
42088269|NCT00733824|75898591|FG004|Phase I|Withdrawal by Subject|0|||
42088270|NCT00718809|75898607|FG000|Overall Study|Disease progression|9|||
42088271|NCT00718809|75898608|FG001|Overall Study|Disease progression|7|||
42088272|NCT00718809|75898607|FG000|Overall Study|Adverse Event|1|||
42088273|NCT00718809|75898608|FG001|Overall Study|Adverse Event|1|||
42088274|NCT00718809|75898607|FG000|Overall Study|Withdrawal by Subject|0|||
42088275|NCT00718809|75898608|FG001|Overall Study|Withdrawal by Subject|1|||
42088276|NCT00718809|75898607|FG000|Overall Study|Lost to Follow-up|1|||
42088277|NCT00718809|75898608|FG001|Overall Study|Lost to Follow-up|0|||
42088278|NCT00718809|75898607|FG000|Overall Study|Noncompliance|1|||
42088279|NCT00718809|75898608|FG001|Overall Study|Noncompliance|0|||
42088280|NCT00585039|75898616|FG000|Overall Study|medication spilled|2|||
42088281|NCT00585039|75898617|FG001|Overall Study|medication spilled|0|||
42088282|NCT00806195|75898629|FG000|Overall Study|Death|6|||
42088283|NCT00806195|75898630|FG001|Overall Study|Death|0|||
42088284|NCT00806195|75898631|FG002|Overall Study|Death|1|||
42088285|NCT00806195|75898632|FG003|Overall Study|Death|0|||
42088286|NCT00806195|75898629|FG000|Overall Study|Adverse Event|25|||
42088287|NCT00806195|75898630|FG001|Overall Study|Adverse Event|5|||
42088288|NCT00806195|75898631|FG002|Overall Study|Adverse Event|11|||
42088289|NCT00806195|75898632|FG003|Overall Study|Adverse Event|2|||
42088290|NCT00806195|75898629|FG000|Overall Study|Withdrawal by Subject|119|||
42088291|NCT00806195|75898630|FG001|Overall Study|Withdrawal by Subject|31|||
42088292|NCT00806195|75898631|FG002|Overall Study|Withdrawal by Subject|76|||
42088293|NCT00806195|75898632|FG003|Overall Study|Withdrawal by Subject|35|||
42088294|NCT00806195|75898629|FG000|Overall Study|Lost to Follow-up|217|||
42088295|NCT00806195|75898630|FG001|Overall Study|Lost to Follow-up|66|||
42088296|NCT00806195|75898631|FG002|Overall Study|Lost to Follow-up|90|||
42088297|NCT00806195|75898632|FG003|Overall Study|Lost to Follow-up|34|||
42088298|NCT00806195|75898629|FG000|Overall Study|Inappropriate Enrollment|0|||
42088299|NCT00806195|75898630|FG001|Overall Study|Inappropriate Enrollment|1|||
42088300|NCT00806195|75898631|FG002|Overall Study|Inappropriate Enrollment|0|||
42358645|NCT04017832|76204421|FG000|Overall Study|Physician Decision|1|||
42358646|NCT04017832|76204422|FG001|Overall Study|Physician Decision|1|||
42358647|NCT04017832|76204423|FG002|Overall Study|Physician Decision|1|||
42358648|NCT04017832|76204424|FG003|Overall Study|Physician Decision|1|||
42358649|NCT04017832|76204421|FG000|Overall Study|Death|2|||
42358650|NCT04017832|76204422|FG001|Overall Study|Death|2|||
42088301|NCT00806195|75898632|FG003|Overall Study|Inappropriate Enrollment|0|||
42088302|NCT00806195|75898629|FG000|Overall Study|Administrative Reason|113|||
42088303|NCT00806195|75898630|FG001|Overall Study|Administrative Reason|35|||
42088304|NCT00806195|75898631|FG002|Overall Study|Administrative Reason|66|||
42088305|NCT00806195|75898632|FG003|Overall Study|Administrative Reason|26|||
42088306|NCT00806195|75898629|FG000|Overall Study|Protocol Violation|34|||
42088307|NCT00806195|75898630|FG001|Overall Study|Protocol Violation|24|||
42088308|NCT00806195|75898631|FG002|Overall Study|Protocol Violation|26|||
42088309|NCT00806195|75898632|FG003|Overall Study|Protocol Violation|9|||
42088310|NCT00733746|75898644|FG000|Overall Study|Ineligible|5|||
42088311|NCT00718419|75898650|FG000|Overall Study|Adverse Event|2|||
42294500|NCT01365273|76128933|FG000|Overall Study|Physician Decision|1|||
42294501|NCT01365273|76128934|FG001|Overall Study|Physician Decision|0|||
42294502|NCT02595437|76128940|FG000|Triferic Via IV|Withdrawal by Subject|1|||
42181028|NCT03129100|75988742|FG007|Period2 Extension Period (Group A and B)|Death|0|||
42181029|NCT03129100|75988743|FG008|Period2 Extension Period (Group A and B)|Death|0|||
42181030|NCT03129100|75988744|FG009|Period2 Extension Period (Group A and B)|Death|0|||
42181031|NCT03129100|75988745|FG010|Period2 Extension Period (Group A and B)|Death|0|||
42181032|NCT03129100|75988746|FG011|Period2 Extension Period (Group A and B)|Death|0|||
42181033|NCT03129100|75988747|FG012|Period2 Extension Period (Group A and B)|Death|0|||
42181034|NCT03129100|75988748|FG013|Period2 Extension Period (Group A and B)|Death|0|||
42181035|NCT03129100|75988749|FG014|Period2 Extension Period (Group A and B)|Death|0|||
42181036|NCT03129100|75988750|FG015|Period2 Extension Period (Group A and B)|Death|0|||
42181037|NCT03129100|75988751|FG016|Period2 Extension Period (Group A and B)|Death|0|||
42181038|NCT03129100|75988752|FG017|Period2 Extension Period (Group A and B)|Death|0|||
42181039|NCT03129100|75988753|FG018|Period2 Extension Period (Group A and B)|Death|0|||
42181040|NCT03129100|75988754|FG019|Period2 Extension Period (Group A and B)|Death|0|||
42181041|NCT03129100|75988755|FG020|Period2 Extension Period (Group A and B)|Death|0|||
42181042|NCT03129100|75988756|FG021|Period2 Extension Period (Group A and B)|Death|0|||
42181043|NCT03129100|75988757|FG022|Period2 Extension Period (Group A and B)|Death|0|||
42181044|NCT03129100|75988758|FG023|Period2 Extension Period (Group A and B)|Death|0|||
42181045|NCT03129100|75988759|FG024|Period2 Extension Period (Group A and B)|Death|0|||
42181046|NCT03129100|75988760|FG025|Period2 Extension Period (Group A and B)|Death|0|||
42181047|NCT03129100|75988735|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181048|NCT03129100|75988736|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181049|NCT03129100|75988737|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
42181050|NCT03129100|75988738|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
42181051|NCT03129100|75988739|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
42181052|NCT03129100|75988740|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
42181053|NCT03129100|75988741|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
42181054|NCT03129100|75988742|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181055|NCT03129100|75988743|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181056|NCT03129100|75988744|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181057|NCT03129100|75988745|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181058|NCT03129100|75988746|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181059|NCT03129100|75988747|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42294503|NCT02594735|76128961|FG000|Overall Study|Adverse Event|1|||
42294504|NCT02634151|76128969|FG000|Overall Study|Withdrawal by Subject|1|||
42294505|NCT02634151|76128970|FG001|Overall Study|Withdrawal by Subject|0|||
42294506|NCT02634151|76128969|FG000|Overall Study|Non-Compliance|0|||
42294507|NCT02634151|76128970|FG001|Overall Study|Non-Compliance|1|||
42294508|NCT02634151|76128969|FG000|Overall Study|Other|0|||
42088312|NCT00718419|75898651|FG001|Overall Study|Adverse Event|1|||
42088313|NCT00718419|75898650|FG000|Overall Study|Physician Decision|1|||
42088314|NCT00718419|75898651|FG001|Overall Study|Physician Decision|6|||
42088315|NCT00718419|75898650|FG000|Overall Study|Sponsor decision|0|||
42088316|NCT00718419|75898651|FG001|Overall Study|Sponsor decision|1|||
42088317|NCT00718419|75898650|FG000|Overall Study|Withdrawal by Subject|0|||
42088318|NCT00718419|75898651|FG001|Overall Study|Withdrawal by Subject|5|||
42088319|NCT00718419|75898650|FG000|Overall Study|Progressive Disease|7|||
42088320|NCT00718419|75898651|FG001|Overall Study|Progressive Disease|25|||
42088321|NCT00718419|75898650|FG000|Overall Study|Death Due to Progressive Disease|2|||
42088322|NCT00718419|75898651|FG001|Overall Study|Death Due to Progressive Disease|0|||
42088323|NCT00718419|75898650|FG000|Overall Study|Death Due to Study Drug Related|0|||
42088324|NCT00718419|75898651|FG001|Overall Study|Death Due to Study Drug Related|1|||
42088325|NCT00718419|75898650|FG000|Overall Study|Death Due to Adverse Events|1|||
42088326|NCT00718419|75898651|FG001|Overall Study|Death Due to Adverse Events|0|||
42088327|NCT00717249|75898659|FG000|Overall Study|Lens Discomfort|4|||
42088328|NCT00717249|75898660|FG001|Overall Study|Lens Discomfort|1|||
42088329|NCT00717249|75898659|FG000|Overall Study|Unsatisfactory visual Response|0|||
42088330|NCT00717249|75898660|FG001|Overall Study|Unsatisfactory visual Response|2|||
42088331|NCT00717249|75898659|FG000|Overall Study|Adverse Event|4|||
42088332|NCT00717249|75898660|FG001|Overall Study|Adverse Event|2|||
42088333|NCT00717249|75898659|FG000|Overall Study|Lost to Follow-up|2|||
42088334|NCT00717249|75898660|FG001|Overall Study|Lost to Follow-up|0|||
42088335|NCT00717249|75898659|FG000|Overall Study|Withdrawal by Subject|1|||
42294509|NCT02634151|76128970|FG001|Overall Study|Other|1|||
42294510|NCT01655823|76128981|FG000|Overall Study|Lost to Follow-up|0|||
42088336|NCT00717249|75898660|FG001|Overall Study|Withdrawal by Subject|2|||
42088337|NCT00717249|75898659|FG000|Overall Study|Pregnancy|6|||
42088338|NCT00717249|75898660|FG001|Overall Study|Pregnancy|3|||
42294511|NCT01655823|76128982|FG001|Overall Study|Lost to Follow-up|1|||
42088339|NCT00717249|75898659|FG000|Overall Study|Protocol Violation|0|||
42088340|NCT00717249|75898660|FG001|Overall Study|Protocol Violation|2|||
42088341|NCT00717249|75898659|FG000|Overall Study|Subject became Ineligible|1|||
42088342|NCT00717249|75898660|FG001|Overall Study|Subject became Ineligible|1|||
42088343|NCT00717249|75898659|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
42088344|NCT00717249|75898660|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
42088345|NCT00717249|75898659|FG000|Overall Study|Gastric Surgery|0|||
42088346|NCT00717249|75898660|FG001|Overall Study|Gastric Surgery|1|||
42088347|NCT00717249|75898659|FG000|Overall Study|Diagnosed with Diabetes|1|||
42181060|NCT03129100|75988748|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181061|NCT03129100|75988749|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181062|NCT03129100|75988750|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181063|NCT03129100|75988751|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181064|NCT03129100|75988752|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181065|NCT03129100|75988753|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181066|NCT03129100|75988754|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181067|NCT03129100|75988755|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181068|NCT03129100|75988756|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181069|NCT03129100|75988757|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181070|NCT03129100|75988758|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181071|NCT03129100|75988759|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181072|NCT03129100|75988760|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
42181073|NCT03129100|75988735|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181074|NCT03129100|75988736|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181075|NCT03129100|75988737|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
42181076|NCT03129100|75988738|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42088348|NCT00717249|75898660|FG001|Overall Study|Diagnosed with Diabetes|0|||
42088349|NCT00717249|75898659|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
42088350|NCT00717249|75898660|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
42088351|NCT00717249|75898659|FG000|Overall Study|Subject relocated|1|||
42088352|NCT00717249|75898660|FG001|Overall Study|Subject relocated|0|||
42088353|NCT00717249|75898659|FG000|Overall Study|Headaches|1|||
42181077|NCT03129100|75988739|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181078|NCT03129100|75988740|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42088354|NCT00717249|75898660|FG001|Overall Study|Headaches|0|||
42088355|NCT00727194|75898666|FG000|Screening Period|Low QMG scores|0|||
42088356|NCT00727194|75898667|FG001|Screening Period|Low QMG scores|0|||
42088357|NCT00727194|75898668|FG002|Screening Period|Low QMG scores|6|||
42088358|NCT00727194|75898666|FG000|Screening Period|Lacked AChR antibodies|0|||
42088359|NCT00727194|75898667|FG001|Screening Period|Lacked AChR antibodies|0|||
42088360|NCT00727194|75898668|FG002|Screening Period|Lacked AChR antibodies|5|||
42088361|NCT00727194|75898666|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
42088362|NCT00727194|75898667|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
42088363|NCT00727194|75898668|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
42088364|NCT00727194|75898666|FG000|Screening Period|Severe infections|0|||
42088365|NCT00727194|75898667|FG001|Screening Period|Severe infections|0|||
42088366|NCT00727194|75898668|FG002|Screening Period|Severe infections|2|||
42088367|NCT00727194|75898666|FG000|Screening Period|History of thymoma|0|||
42088368|NCT00727194|75898667|FG001|Screening Period|History of thymoma|0|||
42088369|NCT00727194|75898668|FG002|Screening Period|History of thymoma|1|||
42181079|NCT03129100|75988741|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181080|NCT03129100|75988742|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181081|NCT03129100|75988743|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181082|NCT03129100|75988744|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42088370|NCT00727194|75898666|FG000|Treatment Period 2|Lack of Efficacy|0|||
42088371|NCT00727194|75898667|FG001|Treatment Period 2|Lack of Efficacy|1|||
42088372|NCT00727194|75898668|FG002|Treatment Period 2|Lack of Efficacy|0|||
42181083|NCT03129100|75988745|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42088373|NCT00717093|75898684|FG000|Overall Study|Adverse Event|19|||
42181084|NCT03129100|75988746|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181085|NCT03129100|75988747|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181086|NCT03129100|75988748|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181087|NCT03129100|75988749|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181088|NCT03129100|75988750|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181089|NCT03129100|75988751|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181090|NCT03129100|75988752|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181091|NCT03129100|75988753|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42088374|NCT00717093|75898685|FG001|Overall Study|Adverse Event|9|||
42088375|NCT00717093|75898684|FG000|Overall Study|Lack of Efficacy|3|||
42088376|NCT00717093|75898685|FG001|Overall Study|Lack of Efficacy|13|||
42088377|NCT00717093|75898684|FG000|Overall Study|Lost to Follow-up|9|||
42088378|NCT00717093|75898685|FG001|Overall Study|Lost to Follow-up|6|||
42088379|NCT00717093|75898684|FG000|Overall Study|Withdrawal by Subject|12|||
42088380|NCT00717093|75898685|FG001|Overall Study|Withdrawal by Subject|19|||
42088381|NCT00717093|75898684|FG000|Overall Study|Other|0|||
42088382|NCT00717093|75898685|FG001|Overall Study|Other|1|||
42088383|NCT00717093|75898684|FG000|Overall Study|Randomized but not treated|1|||
42088384|NCT00717093|75898685|FG001|Overall Study|Randomized but not treated|0|||
42088385|NCT00716859|75898693|FG000|Overall Study|Adverse Event|4|||
42088386|NCT00716859|75898694|FG001|Overall Study|Adverse Event|1|||
42181092|NCT03129100|75988754|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181093|NCT03129100|75988755|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181094|NCT03129100|75988756|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42088387|NCT00716859|75898693|FG000|Overall Study|Lack of Efficacy|3|||
42088388|NCT00716859|75898694|FG001|Overall Study|Lack of Efficacy|0|||
42088389|NCT00716859|75898693|FG000|Overall Study|Withdrawal by Subject|1|||
42181095|NCT03129100|75988757|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181096|NCT03129100|75988758|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181097|NCT03129100|75988759|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181098|NCT03129100|75988760|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
42181099|NCT03129100|75988735|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181100|NCT03129100|75988736|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181101|NCT03129100|75988737|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
42181102|NCT03129100|75988738|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181103|NCT03129100|75988739|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181104|NCT03129100|75988740|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181105|NCT03129100|75988741|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181106|NCT03129100|75988742|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181107|NCT03129100|75988743|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181108|NCT03129100|75988744|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181109|NCT03129100|75988745|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181110|NCT03129100|75988746|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181111|NCT03129100|75988747|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181112|NCT03129100|75988748|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181113|NCT03129100|75988749|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181114|NCT03129100|75988750|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181115|NCT03129100|75988751|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181116|NCT03129100|75988752|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181117|NCT03129100|75988753|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181118|NCT03129100|75988754|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42088390|NCT00716859|75898694|FG001|Overall Study|Withdrawal by Subject|3|||
42088391|NCT00716859|75898693|FG000|Overall Study|Not treated|1|||
42088392|NCT00716859|75898694|FG001|Overall Study|Not treated|1|||
42294512|NCT01655823|76128983|FG002|Overall Study|Lost to Follow-up|0|||
42088393|NCT00589121|75898702|FG000|Overall Study|Protocol Violation|2|||
42088394|NCT00589121|75898703|FG001|Overall Study|Protocol Violation|6|||
42088395|NCT00589121|75898702|FG000|Overall Study|No protocol treatment received|0|||
42088396|NCT00589121|75898703|FG001|Overall Study|No protocol treatment received|1|||
42088397|NCT00590135|75898712|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
42088398|NCT00589667|75898717|FG000|Overall Study|Adverse Event|2|||
42088399|NCT00589667|75898717|FG000|Overall Study|Withdrawal by Subject|1|||
42088400|NCT00737568|75898723|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
42088401|NCT00737568|75898724|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
42088402|NCT00737568|75898723|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
42088403|NCT00737568|75898724|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
42088404|NCT00737568|75898723|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
42088405|NCT00737568|75898724|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
42088406|NCT00737568|75898723|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
42181119|NCT03129100|75988755|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42294513|NCT01655823|76128984|FG003|Overall Study|Lost to Follow-up|0|||
42294514|NCT01655823|76128985|FG004|Overall Study|Lost to Follow-up|1|||
42294515|NCT01655823|76128981|FG000|Overall Study|Withdrawal by Subject|0|||
42294516|NCT01655823|76128982|FG001|Overall Study|Withdrawal by Subject|1|||
42088407|NCT00737568|75898724|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
42088408|NCT00737568|75898723|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
42088409|NCT00737568|75898724|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
42088410|NCT00737568|75898723|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
42088411|NCT00737568|75898724|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
42088412|NCT00737568|75898723|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
42088413|NCT00737568|75898724|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
42088414|NCT00737568|75898723|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
42088415|NCT00737568|75898724|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
42088416|NCT00737568|75898723|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
42294517|NCT01655823|76128983|FG002|Overall Study|Withdrawal by Subject|0|||
42294518|NCT01655823|76128984|FG003|Overall Study|Withdrawal by Subject|1|||
42294519|NCT01655823|76128985|FG004|Overall Study|Withdrawal by Subject|0|||
42294520|NCT01360645|76128999|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
42294521|NCT01360645|76129000|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
42294522|NCT01360645|76129001|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
42294523|NCT01360645|76129002|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
42294524|NCT01360645|76128999|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
42294525|NCT01360645|76129000|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
42294526|NCT01360645|76129001|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
42294527|NCT01360645|76129002|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
42294528|NCT01360645|76128999|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
42088417|NCT00737568|75898724|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
42088418|NCT00737100|75898733|FG000|Overall Study|Adverse Event|6|||
42088419|NCT00737100|75898734|FG001|Overall Study|Adverse Event|5|||
42088420|NCT00737100|75898735|FG002|Overall Study|Adverse Event|3|||
42088421|NCT00737100|75898733|FG000|Overall Study|Lost to Follow-up|0|||
42088422|NCT00737100|75898734|FG001|Overall Study|Lost to Follow-up|1|||
42088423|NCT00737100|75898735|FG002|Overall Study|Lost to Follow-up|0|||
42088424|NCT00737100|75898733|FG000|Overall Study|Withdrawal by Subject|0|||
42088425|NCT00737100|75898734|FG001|Overall Study|Withdrawal by Subject|0|||
42088426|NCT00737100|75898735|FG002|Overall Study|Withdrawal by Subject|3|||
42088427|NCT00737100|75898733|FG000|Overall Study|Reason discontinued not explained above|1|||
42088428|NCT00737100|75898734|FG001|Overall Study|Reason discontinued not explained above|1|||
42088429|NCT00737100|75898735|FG002|Overall Study|Reason discontinued not explained above|1|||
42088430|NCT00732498|75898745|FG000|Overall Study|Ineligible|1|||
42088431|NCT00732498|75898745|FG000|Overall Study|Adverse Event|2|||
42088432|NCT00732498|75898745|FG000|Overall Study|Physician Decision|3|||
42088433|NCT00726882|75898749|FG000|Overall Study|Withdrawal by Subject|5|||
42088434|NCT00726882|75898749|FG000|Overall Study|Lost to Follow-up|7|||
42088435|NCT00726882|75898749|FG000|Overall Study|Other|10|||
42088436|NCT00790400|75898757|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
42088437|NCT00790400|75898758|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
42088438|NCT00790400|75898757|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
42088439|NCT00790400|75898758|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
42088440|NCT00790400|75898757|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
42088441|NCT00790400|75898758|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
42088442|NCT00790400|75898757|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
42088443|NCT00790400|75898758|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
42088444|NCT00790400|75898757|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
42088445|NCT00790400|75898758|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
42088446|NCT00790400|75898757|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
42088447|NCT00790400|75898758|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
42088448|NCT00790400|75898757|FG000|Double-blind Period (Core Phase)|Death|1|||
42181120|NCT03129100|75988756|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181121|NCT03129100|75988757|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181122|NCT03129100|75988758|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181123|NCT03129100|75988759|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181124|NCT03129100|75988760|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
42181125|NCT03129100|75988735|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181126|NCT03129100|75988736|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181127|NCT03129100|75988737|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
42181128|NCT03129100|75988738|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181129|NCT03129100|75988739|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181130|NCT03129100|75988740|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181131|NCT03129100|75988741|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42358651|NCT04017832|76204423|FG002|Overall Study|Death|1|||
42088449|NCT00790400|75898758|FG001|Double-blind Period (Core Phase)|Death|0|||
42088450|NCT00790400|75898757|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
42088451|NCT00790400|75898758|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
42088452|NCT00790400|75898757|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
42088453|NCT00790400|75898758|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
42088454|NCT00790400|75898757|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
42088455|NCT00790400|75898758|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
42088456|NCT00790400|75898757|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
42088457|NCT00790400|75898758|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
42088458|NCT00790400|75898757|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
42088459|NCT00790400|75898758|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
42088460|NCT00790400|75898757|FG000|Everolimus Period (Core or Extension)|Death|1|||
42088461|NCT00790400|75898758|FG001|Everolimus Period (Core or Extension)|Death|0|||
42088462|NCT00790400|75898757|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
42088463|NCT00790400|75898758|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
42088464|NCT00790400|75898757|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
42088465|NCT00790400|75898758|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
42088466|NCT00790400|75898757|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
42088467|NCT00790400|75898758|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
42088468|NCT00786032|75898767|FG000|Overall Study|Death|4|||
42088469|NCT00786032|75898767|FG000|Overall Study|Withdrawal by Subject|14|||
42088470|NCT00786032|75898767|FG000|Overall Study|Did not complete in the timeframe|6|||
42088471|NCT00785486|75898773|FG000|Midazolam Alone|Withdrawal by Subject|1|||
42088472|NCT00589979|75898796|FG000|Run-In Period|Adverse Event|5|||
42088473|NCT00589979|75898797|FG001|Run-In Period|Adverse Event|0|||
42088474|NCT00589979|75898798|FG002|Run-In Period|Adverse Event|0|||
42088475|NCT00589979|75898796|FG000|Run-In Period|Protocol Violation|3|||
42088476|NCT00589979|75898797|FG001|Run-In Period|Protocol Violation|0|||
42088477|NCT00589979|75898798|FG002|Run-In Period|Protocol Violation|0|||
42088478|NCT00589979|75898796|FG000|Run-In Period|Did not qualify for randomization|54|||
42088479|NCT00589979|75898797|FG001|Run-In Period|Did not qualify for randomization|0|||
42088480|NCT00589979|75898798|FG002|Run-In Period|Did not qualify for randomization|0|||
42088481|NCT00589979|75898796|FG000|Run-In Period|Withdrawal by Subject|10|||
42181132|NCT03129100|75988742|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181133|NCT03129100|75988743|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181134|NCT03129100|75988744|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181135|NCT03129100|75988745|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181136|NCT03129100|75988746|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181137|NCT03129100|75988747|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181138|NCT03129100|75988748|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181139|NCT03129100|75988749|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181140|NCT03129100|75988750|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181141|NCT03129100|75988751|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181142|NCT03129100|75988752|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181143|NCT03129100|75988753|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181144|NCT03129100|75988754|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181145|NCT03129100|75988755|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181146|NCT03129100|75988756|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181147|NCT03129100|75988757|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181148|NCT03129100|75988758|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181149|NCT03129100|75988759|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181150|NCT03129100|75988760|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
42181151|NCT03129100|75988735|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181152|NCT03129100|75988736|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181153|NCT03129100|75988737|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181154|NCT03129100|75988738|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181155|NCT03129100|75988739|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
42181156|NCT03129100|75988740|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
42181157|NCT03129100|75988741|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
42358652|NCT04017832|76204424|FG003|Overall Study|Death|0|||
42358653|NCT03952806|76204440|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
42088482|NCT00589979|75898797|FG001|Run-In Period|Withdrawal by Subject|0|||
42088483|NCT00589979|75898798|FG002|Run-In Period|Withdrawal by Subject|0|||
42088484|NCT00589979|75898796|FG000|Run-In Period|Informed Consent Withdrawn|4|||
42088485|NCT00589979|75898797|FG001|Run-In Period|Informed Consent Withdrawn|0|||
42088486|NCT00589979|75898798|FG002|Run-In Period|Informed Consent Withdrawn|0|||
42088487|NCT00589979|75898796|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
42358654|NCT03952806|76204441|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
42358655|NCT03952806|76204440|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
42088488|NCT00589979|75898797|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
42088489|NCT00589979|75898798|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
42088490|NCT00589979|75898796|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
42088491|NCT00589979|75898797|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
42088492|NCT00589979|75898798|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
42088493|NCT00589979|75898796|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
42088494|NCT00589979|75898797|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
42088495|NCT00589979|75898798|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
42088496|NCT00589979|75898796|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
42088497|NCT00589979|75898797|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
42088498|NCT00589979|75898798|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
42088499|NCT00589979|75898796|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
42088500|NCT00589979|75898797|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
42088501|NCT00589979|75898798|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
42088502|NCT00589979|75898796|FG000|Double-Blind Treatment Period 2|Other|0|||
42088503|NCT00589979|75898797|FG001|Double-Blind Treatment Period 2|Other|0|||
42088504|NCT00589979|75898798|FG002|Double-Blind Treatment Period 2|Other|1|||
42088505|NCT00589979|75898796|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
42088506|NCT00589979|75898797|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
42088507|NCT00589979|75898798|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
42088508|NCT00589979|75898796|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
42088509|NCT00589979|75898797|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
42088510|NCT00589979|75898798|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
42088511|NCT00797732|75898812|FG000|Overall Study|Withdrawal by Subject|3|||
42088512|NCT00797732|75898813|FG001|Overall Study|Withdrawal by Subject|3|||
42088513|NCT00797732|75898814|FG002|Overall Study|Withdrawal by Subject|0|||
42088514|NCT00797732|75898812|FG000|Overall Study|Lost to Follow-up|1|||
42088515|NCT00797732|75898813|FG001|Overall Study|Lost to Follow-up|0|||
42088516|NCT00797732|75898814|FG002|Overall Study|Lost to Follow-up|0|||
42181158|NCT03129100|75988742|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181159|NCT03129100|75988743|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181160|NCT03129100|75988744|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181161|NCT03129100|75988745|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181162|NCT03129100|75988746|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181163|NCT03129100|75988747|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181164|NCT03129100|75988748|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181165|NCT03129100|75988749|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181166|NCT03129100|75988750|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181167|NCT03129100|75988751|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181168|NCT03129100|75988752|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181169|NCT03129100|75988753|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181170|NCT03129100|75988754|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181171|NCT03129100|75988755|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181172|NCT03129100|75988756|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181173|NCT03129100|75988757|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181174|NCT03129100|75988758|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181175|NCT03129100|75988759|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181176|NCT03129100|75988760|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
42181177|NCT03129100|75988735|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181178|NCT03129100|75988736|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181179|NCT03129100|75988737|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181180|NCT03129100|75988738|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181181|NCT03129100|75988739|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181182|NCT03129100|75988740|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181183|NCT03129100|75988741|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181184|NCT03129100|75988742|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181185|NCT03129100|75988743|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181186|NCT03129100|75988744|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
42181187|NCT03129100|75988745|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42294529|NCT01360645|76129000|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
42294530|NCT01360645|76129001|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
42088517|NCT00797732|75898812|FG000|Overall Study|Death|1|||
42088518|NCT00797732|75898813|FG001|Overall Study|Death|0|||
42088519|NCT00797732|75898814|FG002|Overall Study|Death|0|||
42088520|NCT00797732|75898812|FG000|Overall Study|Not meet inclusion criteria|0|||
42088521|NCT00797732|75898813|FG001|Overall Study|Not meet inclusion criteria|0|||
42181188|NCT03129100|75988746|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42088522|NCT00797732|75898814|FG002|Overall Study|Not meet inclusion criteria|7|||
42088523|NCT00797732|75898812|FG000|Overall Study|Excluded due to time constraints|0|||
42088524|NCT00797732|75898813|FG001|Overall Study|Excluded due to time constraints|0|||
42088525|NCT00797732|75898814|FG002|Overall Study|Excluded due to time constraints|24|||
42088526|NCT00797732|75898812|FG000|Overall Study|Refused to Participate|0|||
42088527|NCT00797732|75898813|FG001|Overall Study|Refused to Participate|0|||
42088528|NCT00797732|75898814|FG002|Overall Study|Refused to Participate|123|||
42088529|NCT00790088|75898820|FG000|Overall Study|Protocol Violation|11|||
42088530|NCT00790088|75898820|FG000|Overall Study|Withdrawal by Subject|17|||
42088531|NCT00790088|75898820|FG000|Overall Study|Lost to Follow-up|7|||
42088532|NCT00790088|75898820|FG000|Overall Study|Physician Decision|4|||
42088533|NCT00736944|75898826|FG000|Induction|Death|1|||
42088534|NCT00736944|75898826|FG000|Definitive Treatment|Physician Decision|1|||
42088535|NCT00736476|75898835|FG000|Overall Study|Adverse Event|1|||
42088536|NCT00736476|75898836|FG001|Overall Study|Adverse Event|0|||
42088537|NCT00715299|75898848|FG000|Overall Study|Withdrawal by Subject|1|||
42088538|NCT00715299|75898848|FG000|Overall Study|Adverse Event|3|||
42088539|NCT00715299|75898848|FG000|Overall Study|failed the pre-screen exercise test|2|||
42088540|NCT00730236|75898852|FG000|Overall Study|Adverse Event|4|||
42088541|NCT00730236|75898852|FG000|Overall Study|Withdrawal by Subject|1|||
42088542|NCT00730236|75898852|FG000|Overall Study|Non-compliance|1|||
42088543|NCT00714285|75898860|FG000|Overall Study|Lost to Follow-up|0|||
42088544|NCT00714285|75898861|FG001|Overall Study|Lost to Follow-up|2|||
42088545|NCT00714285|75898862|FG002|Overall Study|Lost to Follow-up|0|||
42088546|NCT00714285|75898863|FG003|Overall Study|Lost to Follow-up|1|||
42088547|NCT00714285|75898860|FG000|Overall Study|Migrated/moved from study area|0|||
42088548|NCT00714285|75898861|FG001|Overall Study|Migrated/moved from study area|1|||
42088549|NCT00714285|75898862|FG002|Overall Study|Migrated/moved from study area|0|||
42088550|NCT00714285|75898863|FG003|Overall Study|Migrated/moved from study area|0|||
42088551|NCT00776984|75898877|FG000|Overall Study|Adverse Event|8|||
42088552|NCT00776984|75898878|FG001|Overall Study|Adverse Event|2|||
42088553|NCT00776984|75898877|FG000|Overall Study|Protocol Violation|4|||
42088554|NCT00776984|75898878|FG001|Overall Study|Protocol Violation|2|||
42088555|NCT00776984|75898877|FG000|Overall Study|Lost to Follow-up|2|||
42088556|NCT00776984|75898878|FG001|Overall Study|Lost to Follow-up|0|||
42088557|NCT00776984|75898877|FG000|Overall Study|Withdrawal by Subject|12|||
42088558|NCT00776984|75898878|FG001|Overall Study|Withdrawal by Subject|7|||
42088559|NCT00776984|75898877|FG000|Overall Study|Lack of Efficacy|0|||
42088560|NCT00776984|75898878|FG001|Overall Study|Lack of Efficacy|1|||
42088561|NCT00776984|75898877|FG000|Overall Study|Other|5|||
42088562|NCT00776984|75898878|FG001|Overall Study|Other|9|||
42088563|NCT00714051|75898886|FG000|Overall Study|Withdrawal by Subject|1|||
42088564|NCT00714051|75898887|FG001|Overall Study|Withdrawal by Subject|0|||
42181189|NCT03129100|75988747|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181190|NCT03129100|75988748|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181191|NCT03129100|75988749|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181192|NCT03129100|75988750|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42088565|NCT00714051|75898886|FG000|Overall Study|Death|0|||
42088566|NCT00714051|75898887|FG001|Overall Study|Death|1|||
42088567|NCT00784784|75898895|FG000|Overall Study|Withdrawal by Subject|2|||
42088568|NCT00784784|75898896|FG001|Overall Study|Withdrawal by Subject|2|||
42088569|NCT00801983|75898904|FG000|Period 1|Lost to Follow-up|2|||
42088570|NCT00801983|75898905|FG001|Period 1|Lost to Follow-up|0|||
42294531|NCT01360645|76129002|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
42088571|NCT00801983|75898904|FG000|Period 1|Withdrawal by Subject|2|||
42017896|NCT01265615|75825639|FG003|Overall Study|Protocol Violation|3|||
42017897|NCT01264835|75825649|FG000|Overall Study|Lost to Follow-up|1|||
42017898|NCT01264679|75825653|FG000|Overall Study|Participation in Another Clinical Trial|1|||
42017899|NCT01264679|75825653|FG000|Overall Study|Physician Decision|1|||
42017900|NCT01264679|75825653|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
42017901|NCT01264679|75825653|FG000|Overall Study|Withdrawal by Subject|1|||
42017902|NCT01263665|75825658|FG000|Overall Study|Withdrew Consent|1|||
42017903|NCT01263665|75825658|FG000|Overall Study|Lost to Follow-up|3|||
42017904|NCT01263665|75825658|FG000|Overall Study|Death|2|||
42017905|NCT01263665|75825658|FG000|Overall Study|Amputation above the ankle|1|||
42088572|NCT00801983|75898905|FG001|Period 1|Withdrawal by Subject|8|||
42088573|NCT00801983|75898904|FG000|Period 2|Withdrawal by Subject|2|||
42088574|NCT00801983|75898905|FG001|Period 2|Withdrawal by Subject|1|||
42088575|NCT00587288|75898913|FG000|Overall Study|Adverse Event|0|||
42088576|NCT00587288|75898914|FG001|Overall Study|Adverse Event|1|||
42088577|NCT00587288|75898913|FG000|Overall Study|Lack of Efficacy|2|||
42088578|NCT00587288|75898914|FG001|Overall Study|Lack of Efficacy|8|||
42088579|NCT00587288|75898913|FG000|Overall Study|Protocol Violation|1|||
42088580|NCT00587288|75898914|FG001|Overall Study|Protocol Violation|0|||
42088581|NCT00800735|75898922|FG000|Overall Study|Administrative/Other|2|||
42088582|NCT00800735|75898922|FG000|Overall Study|Insufficient Therapeutic Response|2|||
42088583|NCT00800735|75898922|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
42088584|NCT00800735|75898922|FG000|Overall Study|Withdrew Consent|3|||
42088585|NCT00730158|75898928|FG000|Overall Study|Withdrawal by Subject|1|||
42088586|NCT00730158|75898929|FG001|Overall Study|Withdrawal by Subject|1|||
42088587|NCT00784550|75898941|FG000|Overall Study|Adverse Event|12|||
42088588|NCT00784550|75898942|FG001|Overall Study|Adverse Event|10|||
42088589|NCT00784550|75898941|FG000|Overall Study|Lack of Efficacy|0|||
42088590|NCT00784550|75898942|FG001|Overall Study|Lack of Efficacy|1|||
42088591|NCT00784550|75898941|FG000|Overall Study|Protocol Violation|10|||
42088592|NCT00784550|75898942|FG001|Overall Study|Protocol Violation|10|||
42088593|NCT00784550|75898941|FG000|Overall Study|Lost to Follow-up|8|||
42088594|NCT00784550|75898942|FG001|Overall Study|Lost to Follow-up|5|||
42088595|NCT00784550|75898941|FG000|Overall Study|Physician Decision|2|||
42088596|NCT00784550|75898942|FG001|Overall Study|Physician Decision|3|||
42088597|NCT00784550|75898941|FG000|Overall Study|Withdrawal by Subject|4|||
42088598|NCT00784550|75898942|FG001|Overall Study|Withdrawal by Subject|13|||
42088599|NCT00729690|75898951|FG000|Overall Study|IT Catheter Malfunction|0|||
42088600|NCT00729690|75898952|FG001|Overall Study|IT Catheter Malfunction|2|||
42088601|NCT00729690|75898953|FG002|Overall Study|IT Catheter Malfunction|2|||
42088602|NCT00784238|75898961|FG000|Overall Study|Adverse Event|14|||
42088603|NCT00784238|75898961|FG000|Overall Study|Death|2|||
42088604|NCT00784238|75898961|FG000|Overall Study|Lack of Efficacy|33|||
42088605|NCT00784238|75898961|FG000|Overall Study|Lost to Follow-up|29|||
42088606|NCT00784238|75898961|FG000|Overall Study|Pregnancy|1|||
42088607|NCT00784238|75898961|FG000|Overall Study|Withdrawal by Subject|26|||
42088608|NCT00784238|75898961|FG000|Overall Study|Other|14|||
42088609|NCT00729612|75898968|FG000|Overall Study|Non evaluable for response|10|||
42088610|NCT00585546|75898972|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
42088611|NCT00585546|75898972|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
42088612|NCT00768248|75898978|FG000|Overall Study|Research coordinator didn't collect data|1|||
42088613|NCT00768248|75898979|FG001|Overall Study|Research coordinator didn't collect data|1|||
42088614|NCT00775268|75898987|FG000|Baseline|Drug not synthesize dose|1|||
42088615|NCT00775268|75898988|FG001|Baseline|Drug not synthesize dose|0|||
42088616|NCT00775268|75898987|FG000|Baseline|Not treated-ineligible per CT|0|||
42088617|NCT00775268|75898988|FG001|Baseline|Not treated-ineligible per CT|1|||
42088618|NCT00775268|75898987|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
42088619|NCT00775268|75898988|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
42088620|NCT00775268|75898987|FG000|After Completion|Participant missed scan appointment|1|||
42088621|NCT00775268|75898988|FG001|After Completion|Participant missed scan appointment|0|||
42088622|NCT00775190|75899007|FG000|Overall Study|Lost to Follow-up|2|||
42088623|NCT00775190|75899008|FG001|Overall Study|Lost to Follow-up|3|||
42088624|NCT00775190|75899007|FG000|Overall Study|Withdrawal by Subject|1|||
42181193|NCT03129100|75988751|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181194|NCT03129100|75988752|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181195|NCT03129100|75988753|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42294532|NCT01360645|76128999|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
42294533|NCT01360645|76129000|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
42088625|NCT00775190|75899008|FG001|Overall Study|Withdrawal by Subject|2|||
42088626|NCT00775190|75899007|FG000|Overall Study|Protocol Violation|1|||
42088627|NCT00775190|75899008|FG001|Overall Study|Protocol Violation|0|||
42088628|NCT00479557|75899021|FG000|Overall Study|Death|0|||
42088629|NCT00479557|75899022|FG001|Overall Study|Death|0|||
42088630|NCT00479557|75899023|FG002|Overall Study|Death|0|||
42088631|NCT00479557|75899024|FG003|Overall Study|Death|0|||
42088632|NCT00479557|75899025|FG004|Overall Study|Death|0|||
42088633|NCT00479557|75899026|FG005|Overall Study|Death|1|||
42088634|NCT00479557|75899027|FG006|Overall Study|Death|0|||
42088635|NCT00479557|75899021|FG000|Overall Study|Lack of Efficacy|1|||
42088636|NCT00479557|75899022|FG001|Overall Study|Lack of Efficacy|0|||
42088637|NCT00479557|75899023|FG002|Overall Study|Lack of Efficacy|0|||
42088638|NCT00479557|75899024|FG003|Overall Study|Lack of Efficacy|0|||
42088639|NCT00479557|75899025|FG004|Overall Study|Lack of Efficacy|0|||
42088640|NCT00479557|75899026|FG005|Overall Study|Lack of Efficacy|0|||
42088641|NCT00479557|75899027|FG006|Overall Study|Lack of Efficacy|0|||
42088642|NCT00479557|75899021|FG000|Overall Study|Lost to Follow-up|0|||
42088643|NCT00479557|75899022|FG001|Overall Study|Lost to Follow-up|2|||
42088644|NCT00479557|75899023|FG002|Overall Study|Lost to Follow-up|0|||
42088645|NCT00479557|75899024|FG003|Overall Study|Lost to Follow-up|2|||
42088646|NCT00479557|75899025|FG004|Overall Study|Lost to Follow-up|0|||
42088647|NCT00479557|75899026|FG005|Overall Study|Lost to Follow-up|0|||
42088648|NCT00479557|75899027|FG006|Overall Study|Lost to Follow-up|0|||
42088649|NCT00479557|75899021|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
42088650|NCT00479557|75899022|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
42088651|NCT00479557|75899023|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
42088652|NCT00479557|75899024|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
42088653|NCT00479557|75899025|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
42088654|NCT00479557|75899026|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
42088655|NCT00479557|75899027|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
42088656|NCT00479557|75899021|FG000|Overall Study|AE not related to Study Drug|1|||
42088657|NCT00479557|75899022|FG001|Overall Study|AE not related to Study Drug|3|||
42088658|NCT00479557|75899023|FG002|Overall Study|AE not related to Study Drug|0|||
42088659|NCT00479557|75899024|FG003|Overall Study|AE not related to Study Drug|0|||
42088660|NCT00479557|75899025|FG004|Overall Study|AE not related to Study Drug|2|||
42088661|NCT00479557|75899026|FG005|Overall Study|AE not related to Study Drug|2|||
42088662|NCT00479557|75899027|FG006|Overall Study|AE not related to Study Drug|1|||
42088663|NCT00479557|75899021|FG000|Overall Study|Caregiver Request|2|||
42088664|NCT00479557|75899022|FG001|Overall Study|Caregiver Request|2|||
42088665|NCT00479557|75899023|FG002|Overall Study|Caregiver Request|2|||
42088666|NCT00479557|75899024|FG003|Overall Study|Caregiver Request|0|||
42088667|NCT00479557|75899025|FG004|Overall Study|Caregiver Request|1|||
42088668|NCT00479557|75899026|FG005|Overall Study|Caregiver Request|2|||
42088669|NCT00479557|75899027|FG006|Overall Study|Caregiver Request|0|||
42181196|NCT03129100|75988754|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181197|NCT03129100|75988755|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181198|NCT03129100|75988756|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181199|NCT03129100|75988757|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181200|NCT03129100|75988758|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181201|NCT03129100|75988759|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42181202|NCT03129100|75988760|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
42088670|NCT00479557|75899021|FG000|Overall Study|Investigator Request|0|||
42088671|NCT00479557|75899022|FG001|Overall Study|Investigator Request|0|||
42088672|NCT00479557|75899023|FG002|Overall Study|Investigator Request|1|||
42088673|NCT00479557|75899024|FG003|Overall Study|Investigator Request|0|||
42088674|NCT00479557|75899025|FG004|Overall Study|Investigator Request|0|||
42088675|NCT00479557|75899026|FG005|Overall Study|Investigator Request|0|||
42088676|NCT00479557|75899027|FG006|Overall Study|Investigator Request|0|||
42088677|NCT00479557|75899021|FG000|Overall Study|Subject Request|3|||
42088678|NCT00479557|75899022|FG001|Overall Study|Subject Request|0|||
42088679|NCT00479557|75899023|FG002|Overall Study|Subject Request|1|||
42088680|NCT00479557|75899024|FG003|Overall Study|Subject Request|1|||
42088681|NCT00479557|75899025|FG004|Overall Study|Subject Request|1|||
42088682|NCT00479557|75899026|FG005|Overall Study|Subject Request|4|||
42088683|NCT00479557|75899027|FG006|Overall Study|Subject Request|1|||
42088684|NCT00479557|75899021|FG000|Overall Study|Other|2|||
42181203|NCT03129100|75988735|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181204|NCT03129100|75988736|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181205|NCT03129100|75988737|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181206|NCT03129100|75988738|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181207|NCT03129100|75988739|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181208|NCT03129100|75988740|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181209|NCT03129100|75988741|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181210|NCT03129100|75988742|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181211|NCT03129100|75988743|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181212|NCT03129100|75988744|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181213|NCT03129100|75988745|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42088685|NCT00479557|75899022|FG001|Overall Study|Other|3|||
42088686|NCT00479557|75899023|FG002|Overall Study|Other|1|||
42088687|NCT00479557|75899024|FG003|Overall Study|Other|0|||
42088688|NCT00479557|75899025|FG004|Overall Study|Other|0|||
42088689|NCT00479557|75899026|FG005|Overall Study|Other|3|||
42088690|NCT00479557|75899027|FG006|Overall Study|Other|0|||
42088691|NCT00774800|75899049|FG000|Intervention 4|Withdrawal by Subject|1|||
42088692|NCT00439309|75899061|FG000|Follow-Up|Death|1|||
42088693|NCT00439309|75899062|FG001|Follow-Up|Death|0|||
42088694|NCT00439309|75899061|FG000|Follow-Up|Lost to Follow-up|2|||
42088695|NCT00439309|75899062|FG001|Follow-Up|Lost to Follow-up|0|||
42088696|NCT00439309|75899061|FG000|Follow-Up|Withdrawal by Subject|0|||
42088697|NCT00439309|75899062|FG001|Follow-Up|Withdrawal by Subject|1|||
42088698|NCT00439309|75899061|FG000|Follow-Up|Late response by subject|0|||
42088699|NCT00439309|75899062|FG001|Follow-Up|Late response by subject|1|||
42088700|NCT00479167|75899068|FG000|Overall Study|Withdrawal by Subject|1|||
42088701|NCT00725712|75899075|FG000|Overall Study|Withdrawal by Subject|2|||
42088702|NCT00725712|75899076|FG001|Overall Study|Withdrawal by Subject|1|||
42088703|NCT00725712|75899075|FG000|Overall Study|Protocol Violation|1|||
42088704|NCT00725712|75899076|FG001|Overall Study|Protocol Violation|0|||
42088705|NCT00725712|75899075|FG000|Overall Study|Progressive disease|37|||
42181214|NCT03129100|75988746|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
42181215|NCT03129100|75988747|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181216|NCT03129100|75988748|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181217|NCT03129100|75988749|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181218|NCT03129100|75988750|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181219|NCT03129100|75988751|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181220|NCT03129100|75988752|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181221|NCT03129100|75988753|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181222|NCT03129100|75988754|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181223|NCT03129100|75988755|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181224|NCT03129100|75988756|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181225|NCT03129100|75988757|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181226|NCT03129100|75988758|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181227|NCT03129100|75988759|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181228|NCT03129100|75988760|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
42181229|NCT03129100|75988735|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181230|NCT03129100|75988736|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181231|NCT03129100|75988737|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181232|NCT03129100|75988738|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181233|NCT03129100|75988739|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181234|NCT03129100|75988740|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181235|NCT03129100|75988741|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181236|NCT03129100|75988742|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181237|NCT03129100|75988743|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181238|NCT03129100|75988744|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181239|NCT03129100|75988745|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181240|NCT03129100|75988746|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
42181241|NCT03129100|75988747|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
42181242|NCT03129100|75988748|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
42181243|NCT03129100|75988749|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
42181244|NCT03129100|75988750|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42088706|NCT00725712|75899076|FG001|Overall Study|Progressive disease|16|||
42088707|NCT00725712|75899075|FG000|Overall Study|Clinical progression not based on RECIST|0|||
42088708|NCT00725712|75899076|FG001|Overall Study|Clinical progression not based on RECIST|3|||
42181245|NCT03129100|75988751|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181246|NCT03129100|75988752|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181247|NCT03129100|75988753|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181248|NCT03129100|75988754|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181249|NCT03129100|75988755|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181250|NCT03129100|75988756|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181251|NCT03129100|75988757|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181252|NCT03129100|75988758|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181253|NCT03129100|75988759|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181254|NCT03129100|75988760|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
42181255|NCT03129100|75988735|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181256|NCT03129100|75988736|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42294534|NCT01360645|76129001|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
42088709|NCT00725712|75899075|FG000|Overall Study|Adverse Event|5|||
42088710|NCT00725712|75899076|FG001|Overall Study|Adverse Event|5|||
42294535|NCT01360645|76129002|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
42294536|NCT01360645|76128999|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
42294537|NCT01360645|76129000|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
42294538|NCT01360645|76129001|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
42294539|NCT01360645|76129002|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
42294540|NCT01360645|76128999|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
42088711|NCT00725712|75899075|FG000|Overall Study|Death|2|||
42088712|NCT00725712|75899076|FG001|Overall Study|Death|0|||
42088713|NCT00725712|75899075|FG000|Overall Study|Other: Death|1|||
42088714|NCT00725712|75899076|FG001|Overall Study|Other: Death|0|||
42181257|NCT03129100|75988737|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42294541|NCT01360645|76129000|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
42088715|NCT00725712|75899075|FG000|Overall Study|Hospitalized, unable to continue|0|||
42088716|NCT00725712|75899076|FG001|Overall Study|Hospitalized, unable to continue|1|||
42088717|NCT00729378|75899088|FG000|Baseline|Did not complete study measurements|72|||
42088718|NCT00729378|75899089|FG001|Baseline|Did not complete study measurements|33|||
42088719|NCT00729378|75899088|FG000|Baseline|Withdrawal by Subject|66|||
42088720|NCT00729378|75899089|FG001|Baseline|Withdrawal by Subject|59|||
42088721|NCT00729378|75899088|FG000|12-months|Lost to Follow-up|100|||
42088722|NCT00729378|75899089|FG001|12-months|Lost to Follow-up|65|||
42088723|NCT00729378|75899088|FG000|24-months|Lost to Follow-up|72|||
42088724|NCT00729378|75899089|FG001|24-months|Lost to Follow-up|51|||
42088725|NCT00729378|75899088|FG000|36-months|Lost to Follow-up|15|||
42088726|NCT00729378|75899089|FG001|36-months|Lost to Follow-up|6|||
42088727|NCT00478933|75899098|FG000|Overall Study|Protocol Violation|22|||
42088728|NCT00478933|75899098|FG000|Overall Study|Informed consent not verified|3|||
42088729|NCT00478933|75899098|FG000|Overall Study|Inadequate data available|53|||
42088730|NCT00725322|75899124|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
42088731|NCT00725322|75899125|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
42088732|NCT00725322|75899124|FG000|Washout (28 Days)|Protocol Violation|0|||
42088733|NCT00725322|75899125|FG001|Washout (28 Days)|Protocol Violation|1|||
42088734|NCT00725010|75899131|FG000|Overall Study|Toxicity|9|||
42088735|NCT00725010|75899131|FG000|Overall Study|Tumor Progression|7|||
42088736|NCT00725010|75899131|FG000|Overall Study|Withdrawal by Subject|2|||
42088737|NCT00725010|75899131|FG000|Overall Study|Death|1|||
42088738|NCT00725010|75899131|FG000|Overall Study|Lost to Follow-up|1|||
42088739|NCT00725010|75899131|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
42088740|NCT00725010|75899131|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
42088741|NCT00725010|75899131|FG000|Overall Study|No further documentation|1|||
42181258|NCT03129100|75988738|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181259|NCT03129100|75988739|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42358656|NCT03952806|76204441|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
42358657|NCT03952806|76204440|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
42358658|NCT03952806|76204441|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
42358659|NCT03952806|76204440|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
42358660|NCT03952806|76204441|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
42181260|NCT03129100|75988740|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181261|NCT03129100|75988741|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181262|NCT03129100|75988742|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181263|NCT03129100|75988743|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181264|NCT03129100|75988744|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181265|NCT03129100|75988745|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181266|NCT03129100|75988746|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
42181267|NCT03129100|75988747|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181268|NCT03129100|75988748|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
42181269|NCT03129100|75988749|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
42181270|NCT03129100|75988750|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181271|NCT03129100|75988751|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181272|NCT03129100|75988752|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181273|NCT03129100|75988753|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181274|NCT03129100|75988754|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42358661|NCT03952806|76204440|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
42358662|NCT03952806|76204441|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
42358663|NCT03952806|76204440|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
42358664|NCT03952806|76204441|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
42358665|NCT03952806|76204440|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
42358666|NCT03952806|76204441|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
42358667|NCT03952806|76204440|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
42358668|NCT03952806|76204441|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
42358669|NCT03952806|76204440|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
42358670|NCT03952806|76204441|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
42358671|NCT03952806|76204440|FG000|OLE Phase (48 Weeks)|Other|16|||
42358672|NCT03952806|76204441|FG001|OLE Phase (48 Weeks)|Other|13|||
42358673|NCT03924947|76204466|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
42358674|NCT03924947|76204467|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
42358675|NCT03924947|76204468|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
42358676|NCT03924947|76204469|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
42358677|NCT03924947|76204470|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
42088742|NCT00725010|75899131|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
42088743|NCT00767000|75899142|FG000|54-week Study|Adverse Event|4|||
42088744|NCT00767000|75899143|FG001|54-week Study|Adverse Event|6|||
42088745|NCT00767000|75899144|FG002|54-week Study|Adverse Event|6|||
42088746|NCT00767000|75899145|FG003|54-week Study|Adverse Event|8|||
42088747|NCT00767000|75899146|FG004|54-week Study|Adverse Event|4|||
42088748|NCT00767000|75899142|FG000|54-week Study|Creaninine/creatinine clearance|2|||
42088749|NCT00767000|75899143|FG001|54-week Study|Creaninine/creatinine clearance|1|||
42088750|NCT00767000|75899144|FG002|54-week Study|Creaninine/creatinine clearance|2|||
42088751|NCT00767000|75899145|FG003|54-week Study|Creaninine/creatinine clearance|2|||
42088752|NCT00767000|75899146|FG004|54-week Study|Creaninine/creatinine clearance|4|||
42181275|NCT03129100|75988755|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181276|NCT03129100|75988756|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181277|NCT03129100|75988757|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181278|NCT03129100|75988758|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181279|NCT03129100|75988759|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181280|NCT03129100|75988760|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
42181281|NCT03129100|75988735|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181282|NCT03129100|75988736|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181283|NCT03129100|75988737|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181284|NCT03129100|75988738|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181285|NCT03129100|75988739|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181286|NCT03129100|75988740|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181287|NCT03129100|75988741|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181288|NCT03129100|75988742|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181289|NCT03129100|75988743|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181290|NCT03129100|75988744|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181291|NCT03129100|75988745|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181292|NCT03129100|75988746|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42088753|NCT00767000|75899142|FG000|54-week Study|Hyperglycemia|0|||
42181293|NCT03129100|75988747|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181294|NCT03129100|75988748|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181295|NCT03129100|75988749|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181296|NCT03129100|75988750|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
42181297|NCT03129100|75988751|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181298|NCT03129100|75988752|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181299|NCT03129100|75988753|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181300|NCT03129100|75988754|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181301|NCT03129100|75988755|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181302|NCT03129100|75988756|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181303|NCT03129100|75988757|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181304|NCT03129100|75988758|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181305|NCT03129100|75988759|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181306|NCT03129100|75988760|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
42181307|NCT03129100|75988735|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181308|NCT03129100|75988736|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181309|NCT03129100|75988737|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181310|NCT03129100|75988738|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181311|NCT03129100|75988739|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42294542|NCT01360645|76129001|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
42294543|NCT01360645|76129002|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
42088754|NCT00767000|75899143|FG001|54-week Study|Hyperglycemia|0|||
42088755|NCT00767000|75899144|FG002|54-week Study|Hyperglycemia|1|||
42088756|NCT00767000|75899145|FG003|54-week Study|Hyperglycemia|0|||
42088757|NCT00767000|75899146|FG004|54-week Study|Hyperglycemia|1|||
42088758|NCT00767000|75899142|FG000|54-week Study|Hypoglycemia|0|||
42088759|NCT00767000|75899143|FG001|54-week Study|Hypoglycemia|1|||
42088760|NCT00767000|75899144|FG002|54-week Study|Hypoglycemia|0|||
42088761|NCT00767000|75899145|FG003|54-week Study|Hypoglycemia|0|||
42088762|NCT00767000|75899146|FG004|54-week Study|Hypoglycemia|0|||
42088763|NCT00767000|75899142|FG000|54-week Study|Interruption of study medication|0|||
42088764|NCT00767000|75899143|FG001|54-week Study|Interruption of study medication|0|||
42088765|NCT00767000|75899144|FG002|54-week Study|Interruption of study medication|1|||
42088766|NCT00767000|75899145|FG003|54-week Study|Interruption of study medication|0|||
42088767|NCT00767000|75899146|FG004|54-week Study|Interruption of study medication|0|||
42088768|NCT00767000|75899142|FG000|54-week Study|Lack of Efficacy|2|||
42181312|NCT03129100|75988740|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181313|NCT03129100|75988741|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42294544|NCT01360645|76128999|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
42294545|NCT01360645|76129000|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
42294546|NCT01360645|76129001|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
42294547|NCT01360645|76129002|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
42088769|NCT00767000|75899143|FG001|54-week Study|Lack of Efficacy|0|||
42088770|NCT00767000|75899144|FG002|54-week Study|Lack of Efficacy|1|||
42088771|NCT00767000|75899145|FG003|54-week Study|Lack of Efficacy|0|||
42181314|NCT03129100|75988742|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181315|NCT03129100|75988743|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181316|NCT03129100|75988744|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181317|NCT03129100|75988745|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181318|NCT03129100|75988746|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181319|NCT03129100|75988747|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
42181320|NCT03129100|75988748|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181321|NCT03129100|75988749|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
42181322|NCT03129100|75988750|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
42181323|NCT03129100|75988751|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181324|NCT03129100|75988752|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181325|NCT03129100|75988753|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181326|NCT03129100|75988754|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181327|NCT03129100|75988755|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181328|NCT03129100|75988756|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181329|NCT03129100|75988757|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181330|NCT03129100|75988758|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42294548|NCT01360645|76128999|FG000|Phase B (6 Weeks)|Adverse Event|0|||
42088772|NCT00767000|75899146|FG004|54-week Study|Lack of Efficacy|5|||
42088773|NCT00767000|75899142|FG000|54-week Study|Lost to Follow-up|4|||
42088774|NCT00767000|75899143|FG001|54-week Study|Lost to Follow-up|0|||
42088775|NCT00767000|75899144|FG002|54-week Study|Lost to Follow-up|1|||
42088776|NCT00767000|75899145|FG003|54-week Study|Lost to Follow-up|4|||
42088777|NCT00767000|75899146|FG004|54-week Study|Lost to Follow-up|2|||
42088778|NCT00767000|75899142|FG000|54-week Study|Physician Decision|4|||
42088779|NCT00767000|75899143|FG001|54-week Study|Physician Decision|0|||
42088780|NCT00767000|75899144|FG002|54-week Study|Physician Decision|1|||
42088781|NCT00767000|75899145|FG003|54-week Study|Physician Decision|1|||
42088782|NCT00767000|75899146|FG004|54-week Study|Physician Decision|1|||
42088783|NCT00767000|75899142|FG000|54-week Study|Progressive disease|0|||
42088784|NCT00767000|75899143|FG001|54-week Study|Progressive disease|0|||
42088785|NCT00767000|75899144|FG002|54-week Study|Progressive disease|1|||
42088786|NCT00767000|75899145|FG003|54-week Study|Progressive disease|0|||
42088787|NCT00767000|75899146|FG004|54-week Study|Progressive disease|0|||
42088788|NCT00767000|75899142|FG000|54-week Study|Protocol Violation|0|||
42088789|NCT00767000|75899143|FG001|54-week Study|Protocol Violation|0|||
42088790|NCT00767000|75899144|FG002|54-week Study|Protocol Violation|1|||
42088791|NCT00767000|75899145|FG003|54-week Study|Protocol Violation|2|||
42088792|NCT00767000|75899146|FG004|54-week Study|Protocol Violation|0|||
42088793|NCT00767000|75899142|FG000|54-week Study|Withdrawal by Subject|2|||
42088794|NCT00767000|75899143|FG001|54-week Study|Withdrawal by Subject|3|||
42088795|NCT00767000|75899144|FG002|54-week Study|Withdrawal by Subject|5|||
42088796|NCT00767000|75899145|FG003|54-week Study|Withdrawal by Subject|11|||
42088797|NCT00767000|75899146|FG004|54-week Study|Withdrawal by Subject|13|||
42088798|NCT00767000|75899142|FG000|54-week Study|Study terminated by sponsor|90|||
42088799|NCT00767000|75899143|FG001|54-week Study|Study terminated by sponsor|102|||
42088800|NCT00767000|75899144|FG002|54-week Study|Study terminated by sponsor|89|||
42088801|NCT00767000|75899145|FG003|54-week Study|Study terminated by sponsor|196|||
42088802|NCT00767000|75899146|FG004|54-week Study|Study terminated by sponsor|194|||
42088803|NCT00767000|75899142|FG000|54-week Study|Reason not reported|0|||
42088804|NCT00767000|75899143|FG001|54-week Study|Reason not reported|0|||
42088805|NCT00767000|75899144|FG002|54-week Study|Reason not reported|0|||
42088806|NCT00767000|75899145|FG003|54-week Study|Reason not reported|1|||
42088807|NCT00767000|75899146|FG004|54-week Study|Reason not reported|0|||
42088808|NCT00767000|75899142|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
42088809|NCT00767000|75899143|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
42088810|NCT00767000|75899144|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
42088811|NCT00767000|75899145|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
42088812|NCT00767000|75899146|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
42088813|NCT00724932|75899160|FG000|Overall Study|Lost to Follow-up|1|||
42088814|NCT00724932|75899161|FG001|Overall Study|Lost to Follow-up|0|||
42181331|NCT03129100|75988759|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181332|NCT03129100|75988760|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
42181333|NCT03129100|75988735|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181334|NCT03129100|75988736|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181335|NCT03129100|75988737|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42294549|NCT01360645|76129000|FG001|Phase B (6 Weeks)|Adverse Event|6|||
42294550|NCT01360645|76129001|FG002|Phase B (6 Weeks)|Adverse Event|0|||
42088815|NCT00724932|75899160|FG000|Overall Study|Not treated|4|||
42088816|NCT00724932|75899161|FG001|Overall Study|Not treated|3|||
42294551|NCT01360645|76129002|FG003|Phase B (6 Weeks)|Adverse Event|0|||
42088817|NCT00766532|75899169|FG000|Overall Study|Protocol Violation|2|||
42088818|NCT00774566|75899175|FG000|Overall Study|Protocol Violation|18|||
42088819|NCT00774566|75899176|FG001|Overall Study|Protocol Violation|15|||
42181336|NCT03129100|75988738|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181337|NCT03129100|75988739|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181338|NCT03129100|75988740|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181339|NCT03129100|75988741|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42088820|NCT00766376|75899182|FG000|Overall Study|Withdrawal by Subject|27|||
42088821|NCT00587054|75899186|FG000|Overall Study|Patient not treated|9|||
42088822|NCT00766142|75899190|FG000|Overall Study|Protocol Violation|4|||
42088823|NCT00724854|75899196|FG000|Overall Study|Lack of Efficacy|187|||
42088824|NCT00724854|75899197|FG001|Overall Study|Lack of Efficacy|13|||
42088825|NCT00724854|75899196|FG000|Overall Study|Lost to Follow-up|87|||
42088826|NCT00724854|75899197|FG001|Overall Study|Lost to Follow-up|10|||
42088827|NCT00724854|75899196|FG000|Overall Study|Adverse Event|62|||
42088828|NCT00724854|75899197|FG001|Overall Study|Adverse Event|4|||
42088829|NCT00724854|75899196|FG000|Overall Study|Other|42|||
42088830|NCT00724854|75899197|FG001|Overall Study|Other|3|||
42088831|NCT00724854|75899196|FG000|Overall Study|Death|11|||
42088832|NCT00724854|75899197|FG001|Overall Study|Death|0|||
42088833|NCT00724854|75899196|FG000|Overall Study|Change of treatment|7|||
42088834|NCT00724854|75899197|FG001|Overall Study|Change of treatment|0|||
42088835|NCT00724854|75899196|FG000|Overall Study|Withdrawal by Subject|5|||
42088836|NCT00724854|75899197|FG001|Overall Study|Withdrawal by Subject|0|||
42088837|NCT00724854|75899196|FG000|Overall Study|Adverse event + lack of efficacy|2|||
42088838|NCT00724854|75899197|FG001|Overall Study|Adverse event + lack of efficacy|1|||
42088839|NCT00728988|75899206|FG000|Overall Study|Not Treated|2|||
42088840|NCT00728988|75899207|FG001|Overall Study|Not Treated|2|||
42088841|NCT00728988|75899206|FG000|Overall Study|Death|1|||
42088842|NCT00728988|75899207|FG001|Overall Study|Death|1|||
42181340|NCT03129100|75988742|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181341|NCT03129100|75988743|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181342|NCT03129100|75988744|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181343|NCT03129100|75988745|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181344|NCT03129100|75988746|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181345|NCT03129100|75988747|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181346|NCT03129100|75988748|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181347|NCT03129100|75988749|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181348|NCT03129100|75988750|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181349|NCT03129100|75988751|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181350|NCT03129100|75988752|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
42181351|NCT03129100|75988753|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181352|NCT03129100|75988754|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
42181353|NCT03129100|75988755|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181354|NCT03129100|75988756|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181355|NCT03129100|75988757|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181356|NCT03129100|75988758|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181357|NCT03129100|75988759|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181358|NCT03129100|75988760|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
42181359|NCT03129100|75988735|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42088843|NCT00728988|75899206|FG000|Overall Study|Adverse Event|3|||
42088844|NCT00728988|75899207|FG001|Overall Study|Adverse Event|2|||
42088845|NCT00728988|75899206|FG000|Overall Study|Other|85|||
42088846|NCT00728988|75899207|FG001|Overall Study|Other|77|||
42088847|NCT00728988|75899206|FG000|Overall Study|Withdrawal by Subject|2|||
42088848|NCT00728988|75899207|FG001|Overall Study|Withdrawal by Subject|6|||
42088849|NCT00728754|75899216|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
42088850|NCT00728754|75899217|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
42088851|NCT00728754|75899216|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
42088852|NCT00728754|75899217|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
42181360|NCT03129100|75988736|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181361|NCT03129100|75988737|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42088853|NCT00728754|75899216|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
42088854|NCT00728754|75899217|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
42088855|NCT00728130|75899223|FG000|Overall Study|Withdrawal by Subject|1|||
42088856|NCT00728130|75899223|FG000|Overall Study|Paperwork not completed in time|1|||
42088857|NCT00728130|75899223|FG000|Overall Study|Physician Decision|1|||
42088858|NCT00735696|75899227|FG000|Overall Study|Withdrawal by Subject|1|||
42088859|NCT00735696|75899227|FG000|Overall Study|Enrolled but never Treated|1|||
42088860|NCT00478231|75899236|FG000|Overall Study|Death|7|||
42181362|NCT03129100|75988738|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181363|NCT03129100|75988739|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181364|NCT03129100|75988740|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42088861|NCT00478231|75899236|FG000|Overall Study|Lack of Efficacy|47|||
42088862|NCT00478231|75899236|FG000|Overall Study|Lost to Follow-up|7|||
42088863|NCT00478231|75899236|FG000|Overall Study|Withdrawal by Subject|6|||
42181365|NCT03129100|75988741|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181366|NCT03129100|75988742|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181367|NCT03129100|75988743|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181368|NCT03129100|75988744|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181369|NCT03129100|75988745|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181370|NCT03129100|75988746|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181371|NCT03129100|75988747|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42088864|NCT00478231|75899236|FG000|Overall Study|Other|9|||
42088865|NCT00478231|75899236|FG000|Overall Study|Adverse Event|5|||
42088866|NCT00478231|75899236|FG000|Overall Study|Randomized, not treated|3|||
42088867|NCT00474175|75899243|FG000|Overall Study|Lack of Efficacy|0|||
42088868|NCT00474175|75899244|FG001|Overall Study|Lack of Efficacy|0|||
42088869|NCT00474175|75899245|FG002|Overall Study|Lack of Efficacy|1|||
42088870|NCT00474175|75899243|FG000|Overall Study|Withdrawal by Subject|0|||
42088871|NCT00474175|75899244|FG001|Overall Study|Withdrawal by Subject|1|||
42181372|NCT03129100|75988748|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181373|NCT03129100|75988749|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181374|NCT03129100|75988750|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181375|NCT03129100|75988751|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181376|NCT03129100|75988752|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181377|NCT03129100|75988753|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42088872|NCT00474175|75899245|FG002|Overall Study|Withdrawal by Subject|1|||
42088873|NCT00474175|75899243|FG000|Overall Study|Ineligible|1|||
42088874|NCT00474175|75899244|FG001|Overall Study|Ineligible|3|||
42088875|NCT00474175|75899245|FG002|Overall Study|Ineligible|1|||
42088876|NCT00474175|75899243|FG000|Overall Study|Protocol Violation|0|||
42088877|NCT00474175|75899244|FG001|Overall Study|Protocol Violation|2|||
42088878|NCT00474175|75899245|FG002|Overall Study|Protocol Violation|1|||
42088879|NCT00474175|75899243|FG000|Overall Study|Administrative|0|||
42088880|NCT00474175|75899244|FG001|Overall Study|Administrative|1|||
42088881|NCT00474175|75899245|FG002|Overall Study|Administrative|0|||
42088882|NCT00443209|75899276|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
42088883|NCT00443209|75899277|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
42088884|NCT00443209|75899276|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
42088885|NCT00443209|75899277|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
42088886|NCT00443209|75899276|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
42088887|NCT00443209|75899277|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
42181378|NCT03129100|75988754|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181379|NCT03129100|75988755|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
42181380|NCT03129100|75988756|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181381|NCT03129100|75988757|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181382|NCT03129100|75988758|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181383|NCT03129100|75988759|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181384|NCT03129100|75988760|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
42181385|NCT03129100|75988735|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
42181386|NCT03129100|75988736|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
42181387|NCT03129100|75988737|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
42181388|NCT03129100|75988738|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
42181389|NCT03129100|75988739|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
42181390|NCT03129100|75988740|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
42181391|NCT03129100|75988741|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
42181392|NCT03129100|75988742|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
42181393|NCT03129100|75988743|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
42181394|NCT03129100|75988744|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
42181395|NCT03129100|75988745|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
42181396|NCT03129100|75988746|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
42181397|NCT03129100|75988747|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
42181398|NCT03129100|75988748|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
42181399|NCT03129100|75988749|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
42181400|NCT03129100|75988750|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
42181401|NCT03129100|75988751|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
42088888|NCT00443209|75899276|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
42181402|NCT03129100|75988752|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
42181403|NCT03129100|75988753|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
42181404|NCT03129100|75988754|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
42181405|NCT03129100|75988755|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
42294552|NCT01360645|76128999|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
42088889|NCT00443209|75899277|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
42181406|NCT03129100|75988756|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
42088890|NCT00443209|75899276|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
42088891|NCT00443209|75899277|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
42088892|NCT00443209|75899276|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
42181407|NCT03129100|75988757|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
42181408|NCT03129100|75988758|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
42088893|NCT00443209|75899277|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
42088894|NCT00443209|75899276|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
42181409|NCT03129100|75988759|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
42181410|NCT03129100|75988760|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
42181411|NCT03129100|75988735|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181412|NCT03129100|75988736|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181413|NCT03129100|75988737|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181414|NCT03129100|75988738|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181415|NCT03129100|75988739|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181416|NCT03129100|75988740|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181417|NCT03129100|75988741|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181418|NCT03129100|75988742|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181419|NCT03129100|75988743|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181420|NCT03129100|75988744|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181421|NCT03129100|75988745|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181422|NCT03129100|75988746|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181423|NCT03129100|75988747|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181424|NCT03129100|75988748|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181425|NCT03129100|75988749|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181426|NCT03129100|75988750|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181427|NCT03129100|75988751|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181428|NCT03129100|75988752|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181429|NCT03129100|75988753|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181430|NCT03129100|75988754|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181431|NCT03129100|75988755|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
42181432|NCT03129100|75988756|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42088895|NCT00443209|75899277|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
42088896|NCT00443209|75899276|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
42088897|NCT00443209|75899277|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
42181433|NCT03129100|75988757|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181434|NCT03129100|75988758|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181435|NCT03129100|75988759|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181436|NCT03129100|75988760|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
42181437|NCT03129100|75988735|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
42181438|NCT03129100|75988736|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
42181439|NCT03129100|75988737|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
42181440|NCT03129100|75988738|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
42088898|NCT00443209|75899276|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
42088899|NCT00443209|75899277|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
42088900|NCT00443209|75899276|FG000|Months 1 to 12 Treatment Period|Missing|2|||
42088901|NCT00443209|75899277|FG001|Months 1 to 12 Treatment Period|Missing|1|||
42088902|NCT00443209|75899276|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
42088903|NCT00443209|75899277|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
42088904|NCT00443209|75899276|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
42088905|NCT00443209|75899277|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
42088906|NCT00443209|75899276|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
42088907|NCT00443209|75899277|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
42088908|NCT00443209|75899276|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
42088909|NCT00443209|75899277|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
42088910|NCT00443209|75899276|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
42088911|NCT00443209|75899277|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
42088912|NCT00443209|75899276|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
42088913|NCT00443209|75899277|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
42088914|NCT00443209|75899276|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
42088915|NCT00443209|75899277|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
42088916|NCT00439231|75899283|FG000|Overall Study|Lack of Efficacy|28|||
42088917|NCT00437983|75899289|FG000|Overall Study|Adverse Event|6|||
42088918|NCT00437983|75899290|FG001|Overall Study|Adverse Event|6|||
42088919|NCT00437983|75899289|FG000|Overall Study|Protocol Violation|2|||
42181441|NCT03129100|75988739|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
42181442|NCT03129100|75988740|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
42181443|NCT03129100|75988741|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
42181444|NCT03129100|75988742|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
42088920|NCT00437983|75899290|FG001|Overall Study|Protocol Violation|1|||
42181445|NCT03129100|75988743|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
42181446|NCT03129100|75988744|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
42181447|NCT03129100|75988745|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
42181448|NCT03129100|75988746|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
42088921|NCT00437983|75899289|FG000|Overall Study|Withdrawal by Subject|5|||
42088922|NCT00437983|75899290|FG001|Overall Study|Withdrawal by Subject|6|||
42088923|NCT00783692|75899299|FG000|Induction Phase|Adverse Event|7|||
42088924|NCT00783692|75899300|FG001|Induction Phase|Adverse Event|9|||
42088925|NCT00783692|75899301|FG002|Induction Phase|Adverse Event|24|||
42088926|NCT00783692|75899302|FG003|Induction Phase|Adverse Event|0|||
42088927|NCT00783692|75899303|FG004|Induction Phase|Adverse Event|0|||
42088928|NCT00783692|75899304|FG005|Induction Phase|Adverse Event|0|||
42088929|NCT00783692|75899305|FG006|Induction Phase|Adverse Event|0|||
42088930|NCT00783692|75899299|FG000|Induction Phase|Protocol Violation|0|||
42088931|NCT00783692|75899300|FG001|Induction Phase|Protocol Violation|0|||
42088932|NCT00783692|75899301|FG002|Induction Phase|Protocol Violation|1|||
42088933|NCT00783692|75899302|FG003|Induction Phase|Protocol Violation|0|||
42088934|NCT00783692|75899303|FG004|Induction Phase|Protocol Violation|0|||
42088935|NCT00783692|75899304|FG005|Induction Phase|Protocol Violation|0|||
42088936|NCT00783692|75899305|FG006|Induction Phase|Protocol Violation|0|||
42088937|NCT00783692|75899299|FG000|Induction Phase|Lack of Efficacy|1|||
42088938|NCT00783692|75899300|FG001|Induction Phase|Lack of Efficacy|3|||
42088939|NCT00783692|75899301|FG002|Induction Phase|Lack of Efficacy|28|||
42088940|NCT00783692|75899302|FG003|Induction Phase|Lack of Efficacy|0|||
42088941|NCT00783692|75899303|FG004|Induction Phase|Lack of Efficacy|0|||
42088942|NCT00783692|75899304|FG005|Induction Phase|Lack of Efficacy|0|||
42088943|NCT00783692|75899305|FG006|Induction Phase|Lack of Efficacy|0|||
42088944|NCT00783692|75899299|FG000|Induction Phase|Withdrawal by Subject|3|||
42088945|NCT00783692|75899300|FG001|Induction Phase|Withdrawal by Subject|9|||
42088946|NCT00783692|75899301|FG002|Induction Phase|Withdrawal by Subject|16|||
42088947|NCT00783692|75899302|FG003|Induction Phase|Withdrawal by Subject|0|||
42088948|NCT00783692|75899303|FG004|Induction Phase|Withdrawal by Subject|0|||
42088949|NCT00783692|75899304|FG005|Induction Phase|Withdrawal by Subject|0|||
42181449|NCT03129100|75988747|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
42088950|NCT00783692|75899305|FG006|Induction Phase|Withdrawal by Subject|0|||
42088951|NCT00783692|75899299|FG000|Induction Phase|Lost to Follow-up|0|||
42088952|NCT00783692|75899300|FG001|Induction Phase|Lost to Follow-up|0|||
42088953|NCT00783692|75899301|FG002|Induction Phase|Lost to Follow-up|3|||
42088954|NCT00783692|75899302|FG003|Induction Phase|Lost to Follow-up|0|||
42088955|NCT00783692|75899303|FG004|Induction Phase|Lost to Follow-up|0|||
42088956|NCT00783692|75899304|FG005|Induction Phase|Lost to Follow-up|0|||
42088957|NCT00783692|75899305|FG006|Induction Phase|Lost to Follow-up|0|||
42088958|NCT00783692|75899299|FG000|Induction Phase|Other|0|||
42088959|NCT00783692|75899300|FG001|Induction Phase|Other|0|||
42088960|NCT00783692|75899301|FG002|Induction Phase|Other|2|||
42181450|NCT03129100|75988748|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
42181451|NCT03129100|75988749|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
42181452|NCT03129100|75988750|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
42181453|NCT03129100|75988751|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
42181454|NCT03129100|75988752|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
42181455|NCT03129100|75988753|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
42181456|NCT03129100|75988754|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
42181457|NCT03129100|75988755|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
42181458|NCT03129100|75988756|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
42181459|NCT03129100|75988757|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
42181460|NCT03129100|75988758|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
42181461|NCT03129100|75988759|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
42181462|NCT03129100|75988760|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
42181463|NCT03129100|75988735|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181464|NCT03129100|75988736|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181465|NCT03129100|75988737|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181466|NCT03129100|75988738|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181467|NCT03129100|75988739|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42088961|NCT00783692|75899302|FG003|Induction Phase|Other|0|||
42088962|NCT00783692|75899303|FG004|Induction Phase|Other|0|||
42181468|NCT03129100|75988740|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181469|NCT03129100|75988741|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181470|NCT03129100|75988742|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181471|NCT03129100|75988743|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181472|NCT03129100|75988744|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181473|NCT03129100|75988745|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42088963|NCT00783692|75899304|FG005|Induction Phase|Other|0|||
42088964|NCT00783692|75899305|FG006|Induction Phase|Other|0|||
42088965|NCT00783692|75899299|FG000|Maintenance Phase|Adverse Event|7|||
42088966|NCT00783692|75899300|FG001|Maintenance Phase|Adverse Event|0|||
42088967|NCT00783692|75899301|FG002|Maintenance Phase|Adverse Event|0|||
42088968|NCT00783692|75899302|FG003|Maintenance Phase|Adverse Event|15|||
42088969|NCT00783692|75899303|FG004|Maintenance Phase|Adverse Event|12|||
42088970|NCT00783692|75899304|FG005|Maintenance Phase|Adverse Event|9|||
42088971|NCT00783692|75899305|FG006|Maintenance Phase|Adverse Event|38|||
42088972|NCT00783692|75899299|FG000|Maintenance Phase|Protocol Violation|0|||
42088973|NCT00783692|75899300|FG001|Maintenance Phase|Protocol Violation|0|||
42088974|NCT00783692|75899301|FG002|Maintenance Phase|Protocol Violation|0|||
42088975|NCT00783692|75899302|FG003|Maintenance Phase|Protocol Violation|1|||
42088976|NCT00783692|75899303|FG004|Maintenance Phase|Protocol Violation|2|||
42088977|NCT00783692|75899304|FG005|Maintenance Phase|Protocol Violation|3|||
42088978|NCT00783692|75899305|FG006|Maintenance Phase|Protocol Violation|4|||
42088979|NCT00783692|75899299|FG000|Maintenance Phase|Lack of Efficacy|79|||
42088980|NCT00783692|75899300|FG001|Maintenance Phase|Lack of Efficacy|0|||
42088981|NCT00783692|75899301|FG002|Maintenance Phase|Lack of Efficacy|0|||
42088982|NCT00783692|75899302|FG003|Maintenance Phase|Lack of Efficacy|64|||
42088983|NCT00783692|75899303|FG004|Maintenance Phase|Lack of Efficacy|58|||
42088984|NCT00783692|75899304|FG005|Maintenance Phase|Lack of Efficacy|48|||
42088985|NCT00783692|75899305|FG006|Maintenance Phase|Lack of Efficacy|177|||
42088986|NCT00783692|75899299|FG000|Maintenance Phase|Withdrawal by Subject|7|||
42088987|NCT00783692|75899300|FG001|Maintenance Phase|Withdrawal by Subject|0|||
42088988|NCT00783692|75899301|FG002|Maintenance Phase|Withdrawal by Subject|0|||
42088989|NCT00783692|75899302|FG003|Maintenance Phase|Withdrawal by Subject|7|||
42088990|NCT00783692|75899303|FG004|Maintenance Phase|Withdrawal by Subject|6|||
42088991|NCT00783692|75899304|FG005|Maintenance Phase|Withdrawal by Subject|9|||
42088992|NCT00783692|75899305|FG006|Maintenance Phase|Withdrawal by Subject|24|||
42088993|NCT00783692|75899299|FG000|Maintenance Phase|Lost to Follow-up|2|||
42088994|NCT00783692|75899300|FG001|Maintenance Phase|Lost to Follow-up|0|||
42088995|NCT00783692|75899301|FG002|Maintenance Phase|Lost to Follow-up|0|||
42088996|NCT00783692|75899302|FG003|Maintenance Phase|Lost to Follow-up|1|||
42088997|NCT00783692|75899303|FG004|Maintenance Phase|Lost to Follow-up|3|||
42088998|NCT00783692|75899304|FG005|Maintenance Phase|Lost to Follow-up|2|||
42088999|NCT00783692|75899305|FG006|Maintenance Phase|Lost to Follow-up|5|||
42089000|NCT00783692|75899299|FG000|Maintenance Phase|Other|0|||
42089001|NCT00783692|75899300|FG001|Maintenance Phase|Other|0|||
42181474|NCT03129100|75988746|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42089002|NCT00783692|75899301|FG002|Maintenance Phase|Other|0|||
42089003|NCT00783692|75899302|FG003|Maintenance Phase|Other|1|||
42089004|NCT00783692|75899303|FG004|Maintenance Phase|Other|0|||
42181475|NCT03129100|75988747|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42089005|NCT00783692|75899304|FG005|Maintenance Phase|Other|1|||
42089006|NCT00783692|75899305|FG006|Maintenance Phase|Other|1|||
42089007|NCT04992273|75899320|FG000|Overall Study|Lost to Follow-up|0|||
42089008|NCT04992273|75899321|FG001|Overall Study|Lost to Follow-up|1|||
42089009|NCT00783302|75899328|FG000|Overall Study|Lost to Follow-up|17|||
42181476|NCT03129100|75988748|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181477|NCT03129100|75988749|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181478|NCT03129100|75988750|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181479|NCT03129100|75988751|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181480|NCT03129100|75988752|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181481|NCT03129100|75988753|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181482|NCT03129100|75988754|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181483|NCT03129100|75988755|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181484|NCT03129100|75988756|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181485|NCT03129100|75988757|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181486|NCT03129100|75988758|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
42181487|NCT03129100|75988759|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
42181488|NCT03129100|75988760|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
42181489|NCT03129100|75988735|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181490|NCT03129100|75988736|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181491|NCT03129100|75988737|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181492|NCT03129100|75988738|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181493|NCT03129100|75988739|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42089010|NCT00783302|75899328|FG000|Overall Study|Technical Problems|11|||
42089011|NCT00783302|75899328|FG000|Overall Study|Protocol Violation|3|||
42089012|NCT00783302|75899328|FG000|Overall Study|Physician Decision|1|||
42089013|NCT00783302|75899328|FG000|Overall Study|Withdrawal by Subject|3|||
42089014|NCT00783224|75899350|FG000|Overall Study|Adverse Event|0|||
42089015|NCT00783224|75899351|FG001|Overall Study|Adverse Event|0|||
42089016|NCT00783224|75899352|FG002|Overall Study|Adverse Event|1|||
42089017|NCT00783224|75899353|FG003|Overall Study|Adverse Event|0|||
42089018|NCT00783224|75899350|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
42089019|NCT00783224|75899351|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
42089020|NCT00783224|75899352|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
42089021|NCT00783224|75899353|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
42089022|NCT00783224|75899350|FG000|Overall Study|Inappropriate as a study subject|0|||
42089023|NCT00783224|75899351|FG001|Overall Study|Inappropriate as a study subject|0|||
42089024|NCT00783224|75899352|FG002|Overall Study|Inappropriate as a study subject|0|||
42089025|NCT00783224|75899353|FG003|Overall Study|Inappropriate as a study subject|1|||
42089026|NCT00782834|75899362|FG000|Treatment Phase|fibrous tumor not GIST|1|||
42089027|NCT00584805|75899366|FG000|Overall Study|No longer at risk of exposure|39|||
42089028|NCT00584805|75899366|FG000|Overall Study|Relocation|36|||
42089029|NCT00584805|75899366|FG000|Overall Study|Withdrawal by Subject|18|||
42089030|NCT00584805|75899366|FG000|Overall Study|Non-compliance|1|||
42089031|NCT00584805|75899366|FG000|Overall Study|Lost to follow up|3|||
42089032|NCT00584805|75899366|FG000|Overall Study|Screen failures|2|||
42089033|NCT00765674|75899376|FG000|Overall Study|Adverse Event|7|||
42181494|NCT03129100|75988740|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181495|NCT03129100|75988741|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181496|NCT03129100|75988742|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181497|NCT03129100|75988743|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181498|NCT03129100|75988744|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181499|NCT03129100|75988745|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181500|NCT03129100|75988746|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181501|NCT03129100|75988747|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181502|NCT03129100|75988748|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181503|NCT03129100|75988749|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181504|NCT03129100|75988750|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181505|NCT03129100|75988751|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181506|NCT03129100|75988752|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181507|NCT03129100|75988753|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181508|NCT03129100|75988754|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181509|NCT03129100|75988755|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181510|NCT03129100|75988756|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181511|NCT03129100|75988757|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
42181512|NCT03129100|75988758|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
42294553|NCT01360645|76129000|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
42089034|NCT00765674|75899377|FG001|Overall Study|Adverse Event|2|||
42089035|NCT00765674|75899378|FG002|Overall Study|Adverse Event|8|||
42089036|NCT00765674|75899379|FG003|Overall Study|Adverse Event|11|||
42089037|NCT00765674|75899376|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
42294554|NCT01360645|76129001|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
42294555|NCT01360645|76129002|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
42089038|NCT00765674|75899377|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
42089039|NCT00765674|75899378|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
42181513|NCT03129100|75988759|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
42181514|NCT03129100|75988760|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
42181515|NCT03129100|75988735|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181516|NCT03129100|75988736|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181517|NCT03129100|75988737|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181518|NCT03129100|75988738|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181519|NCT03129100|75988739|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181520|NCT03129100|75988740|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181521|NCT03129100|75988741|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181522|NCT03129100|75988742|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181523|NCT03129100|75988743|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181524|NCT03129100|75988744|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181525|NCT03129100|75988745|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181526|NCT03129100|75988746|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181527|NCT03129100|75988747|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181528|NCT03129100|75988748|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181529|NCT03129100|75988749|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181530|NCT03129100|75988750|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181531|NCT03129100|75988751|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181532|NCT03129100|75988752|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181533|NCT03129100|75988753|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181534|NCT03129100|75988754|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181535|NCT03129100|75988755|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181536|NCT03129100|75988756|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181537|NCT03129100|75988757|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181538|NCT03129100|75988758|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181539|NCT03129100|75988759|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
42181540|NCT03129100|75988760|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
42181541|NCT03129100|75988735|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181542|NCT03129100|75988736|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181543|NCT03129100|75988737|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181544|NCT03129100|75988738|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181545|NCT03129100|75988739|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181546|NCT03129100|75988740|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181547|NCT03129100|75988741|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181548|NCT03129100|75988742|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181549|NCT03129100|75988743|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181550|NCT03129100|75988744|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181551|NCT03129100|75988745|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181552|NCT03129100|75988746|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181553|NCT03129100|75988747|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181554|NCT03129100|75988748|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181555|NCT03129100|75988749|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181556|NCT03129100|75988750|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181557|NCT03129100|75988751|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181558|NCT03129100|75988752|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42089040|NCT00765674|75899379|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
42089041|NCT00765674|75899376|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
42089042|NCT00765674|75899377|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
42089043|NCT00765674|75899378|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
42089044|NCT00765674|75899379|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
42089045|NCT00765674|75899376|FG000|Overall Study|Lack of Efficacy|2|||
42089046|NCT00765674|75899377|FG001|Overall Study|Lack of Efficacy|3|||
42089047|NCT00765674|75899378|FG002|Overall Study|Lack of Efficacy|1|||
42089048|NCT00765674|75899379|FG003|Overall Study|Lack of Efficacy|2|||
42089049|NCT00765674|75899376|FG000|Overall Study|Protocol Violation|2|||
42089050|NCT00765674|75899377|FG001|Overall Study|Protocol Violation|0|||
42089051|NCT00765674|75899378|FG002|Overall Study|Protocol Violation|1|||
42089052|NCT00765674|75899379|FG003|Overall Study|Protocol Violation|0|||
42089053|NCT00765674|75899376|FG000|Overall Study|Withdrawal by Subject|5|||
42089054|NCT00765674|75899377|FG001|Overall Study|Withdrawal by Subject|7|||
42181559|NCT03129100|75988753|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42089055|NCT00765674|75899378|FG002|Overall Study|Withdrawal by Subject|3|||
42089056|NCT00765674|75899379|FG003|Overall Study|Withdrawal by Subject|8|||
42089057|NCT00765674|75899376|FG000|Overall Study|Lost to Follow-up|4|||
42089058|NCT00765674|75899377|FG001|Overall Study|Lost to Follow-up|6|||
42089059|NCT00765674|75899378|FG002|Overall Study|Lost to Follow-up|2|||
42089060|NCT00765674|75899379|FG003|Overall Study|Lost to Follow-up|1|||
42089061|NCT00765674|75899376|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
42089062|NCT00765674|75899377|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
42181560|NCT03129100|75988754|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181561|NCT03129100|75988755|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181562|NCT03129100|75988756|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181563|NCT03129100|75988757|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181564|NCT03129100|75988758|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181565|NCT03129100|75988759|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
42181566|NCT03129100|75988760|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
42181567|NCT03129100|75988735|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
42181568|NCT03129100|75988736|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
42181569|NCT03129100|75988737|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
42181570|NCT03129100|75988738|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
42181571|NCT03129100|75988739|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
42181572|NCT03129100|75988740|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
42089063|NCT00765674|75899378|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
42089064|NCT00765674|75899379|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
42089065|NCT00765362|75899389|FG000|Overall Study|Death|9|||
42089066|NCT00765362|75899389|FG000|Overall Study|Adverse Event|2|||
42089067|NCT00765362|75899389|FG000|Overall Study|Protocol Violation|18|||
42089068|NCT00765362|75899389|FG000|Overall Study|Withdrawal by Subject|13|||
42089069|NCT00765362|75899389|FG000|Overall Study|Lost to Follow-up|95|||
42089070|NCT00586898|75899393|FG000|Overall Study|Adverse Event|1|||
42089071|NCT00586898|75899393|FG000|Overall Study|Patiemt Non-compliance|1|||
42089072|NCT00586898|75899393|FG000|Overall Study|Evaluable for Toxicity Only|5|||
42089073|NCT04912245|75899397|FG000|Overall Study|Withdrawal by Subject|21|||
42089074|NCT04912245|75899398|FG001|Overall Study|Withdrawal by Subject|4|||
42089075|NCT04912245|75899397|FG000|Overall Study|Lost to Follow-up|5|||
42089076|NCT04912245|75899398|FG001|Overall Study|Lost to Follow-up|11|||
42089077|NCT00796991|75899405|FG000|Overall Study|Adverse Event|0|||
42089078|NCT00796991|75899406|FG001|Overall Study|Adverse Event|0|||
42089079|NCT00796991|75899407|FG002|Overall Study|Adverse Event|1|||
42089080|NCT00796991|75899405|FG000|Overall Study|Death|2|||
42089081|NCT00796991|75899406|FG001|Overall Study|Death|0|||
42089082|NCT00796991|75899407|FG002|Overall Study|Death|0|||
42089083|NCT00796991|75899405|FG000|Overall Study|Disease Progression|10|||
42089084|NCT00796991|75899406|FG001|Overall Study|Disease Progression|9|||
42089085|NCT00796991|75899407|FG002|Overall Study|Disease Progression|7|||
42089086|NCT00796991|75899405|FG000|Overall Study|Study Drug Toxicity|3|||
42089087|NCT00796991|75899406|FG001|Overall Study|Study Drug Toxicity|3|||
42089088|NCT00796991|75899407|FG002|Overall Study|Study Drug Toxicity|5|||
42089089|NCT00796991|75899405|FG000|Overall Study|Withdrawal by Subject|0|||
42089090|NCT00796991|75899406|FG001|Overall Study|Withdrawal by Subject|0|||
42089091|NCT00796991|75899407|FG002|Overall Study|Withdrawal by Subject|1|||
42089092|NCT00799487|75899418|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
42089093|NCT00799487|75899419|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
42089094|NCT00799487|75899420|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
42089095|NCT00799487|75899418|FG000|Dose Adjustment Period|Adverse Event|2|||
42089096|NCT00799487|75899419|FG001|Dose Adjustment Period|Adverse Event|0|||
42089097|NCT00799487|75899420|FG002|Dose Adjustment Period|Adverse Event|0|||
42089098|NCT00799487|75899418|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
42089099|NCT00799487|75899419|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
42089100|NCT00799487|75899420|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
42089101|NCT00799487|75899418|FG000|Dose Adjustment Period|Investigator Discretion|2|||
42089102|NCT00799487|75899419|FG001|Dose Adjustment Period|Investigator Discretion|0|||
42089103|NCT00799487|75899420|FG002|Dose Adjustment Period|Investigator Discretion|0|||
42089104|NCT00799487|75899418|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
42089105|NCT00799487|75899419|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
42181573|NCT03129100|75988741|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
42089106|NCT00799487|75899420|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
42089107|NCT00799487|75899418|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
42089108|NCT00799487|75899419|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
42089109|NCT00799487|75899420|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
42089110|NCT00799487|75899418|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
42089111|NCT00799487|75899419|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
42089112|NCT00799487|75899420|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
42089113|NCT00799487|75899418|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
42089114|NCT00799487|75899419|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
42089115|NCT00799487|75899420|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
42089116|NCT00799487|75899418|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
42089117|NCT00799487|75899419|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
42089118|NCT00799487|75899420|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
42089119|NCT00799487|75899418|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
42089120|NCT00799487|75899419|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
42089121|NCT00799487|75899420|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
42089122|NCT00799487|75899418|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
42089123|NCT00799487|75899419|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
42089124|NCT00799487|75899420|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
42089125|NCT00799487|75899418|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
42089126|NCT00799487|75899419|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
42181574|NCT03129100|75988742|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
42181575|NCT03129100|75988743|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
42089127|NCT00799487|75899420|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
42089128|NCT00584727|75899431|FG000|First Intervention|Discontinuation|0|||
42181576|NCT03129100|75988744|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
42181577|NCT03129100|75988745|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
42181578|NCT03129100|75988746|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
42181579|NCT03129100|75988747|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
42181580|NCT03129100|75988748|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
42181581|NCT03129100|75988749|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
42181582|NCT03129100|75988750|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
42181583|NCT03129100|75988751|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
42181584|NCT03129100|75988752|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
42181585|NCT03129100|75988753|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
42181586|NCT03129100|75988754|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
42181587|NCT03129100|75988755|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
42181588|NCT03129100|75988756|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
42181589|NCT03129100|75988757|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
42181590|NCT03129100|75988758|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
42181591|NCT03129100|75988759|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
42181592|NCT03129100|75988760|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
42181593|NCT03101020|75988799|FG000|Overall Study|Lack of time to participate|1|||
42181594|NCT03101020|75988800|FG001|Overall Study|Lack of time to participate|0|||
42181595|NCT03101020|75988799|FG000|Overall Study|Ran over by a car|0|||
42181596|NCT03101020|75988800|FG001|Overall Study|Ran over by a car|1|||
42181597|NCT03101020|75988799|FG000|Overall Study|Withdrawal by Subject|0|||
42181598|NCT03101020|75988800|FG001|Overall Study|Withdrawal by Subject|2|||
42181599|NCT03100942|75988810|FG000|Randomized Treatment Period|Withdrew Consent|4|||
42181600|NCT03100942|75988811|FG001|Randomized Treatment Period|Withdrew Consent|5|||
42181601|NCT03100942|75988812|FG002|Randomized Treatment Period|Withdrew Consent|3|||
42181602|NCT03100942|75988813|FG003|Randomized Treatment Period|Withdrew Consent|3|||
42181603|NCT03100942|75988814|FG004|Randomized Treatment Period|Withdrew Consent|0|||
42181604|NCT03100942|75988815|FG005|Randomized Treatment Period|Withdrew Consent|0|||
42181605|NCT03100942|75988816|FG006|Randomized Treatment Period|Withdrew Consent|0|||
42089129|NCT00584727|75899432|FG001|First Intervention|Discontinuation|0|||
42089130|NCT00584727|75899433|FG002|First Intervention|Discontinuation|1|||
42089131|NCT00584727|75899434|FG003|First Intervention|Discontinuation|0|||
42089132|NCT00584727|75899435|FG004|First Intervention|Discontinuation|0|||
42089133|NCT00584727|75899436|FG005|First Intervention|Discontinuation|0|||
42089134|NCT00584727|75899431|FG000|Third Intervention|Protocol Violation|0|||
42089135|NCT00584727|75899432|FG001|Third Intervention|Protocol Violation|0|||
42089136|NCT00584727|75899433|FG002|Third Intervention|Protocol Violation|1|||
42089137|NCT00584727|75899434|FG003|Third Intervention|Protocol Violation|0|||
42089138|NCT00584727|75899435|FG004|Third Intervention|Protocol Violation|4|||
42089139|NCT00584727|75899436|FG005|Third Intervention|Protocol Violation|2|||
42089140|NCT00799409|75899450|FG000|Overall Study|Withdrawal by Subject|1|||
42181606|NCT03100942|75988810|FG000|Randomized Treatment Period|Adverse Event|5|||
42181607|NCT03100942|75988811|FG001|Randomized Treatment Period|Adverse Event|2|||
42181608|NCT03100942|75988812|FG002|Randomized Treatment Period|Adverse Event|1|||
42181609|NCT03100942|75988813|FG003|Randomized Treatment Period|Adverse Event|0|||
42181610|NCT03100942|75988814|FG004|Randomized Treatment Period|Adverse Event|0|||
42181611|NCT03100942|75988815|FG005|Randomized Treatment Period|Adverse Event|0|||
42181612|NCT03100942|75988816|FG006|Randomized Treatment Period|Adverse Event|0|||
42181613|NCT03100942|75988810|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
42181614|NCT03100942|75988811|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
42089141|NCT00799409|75899451|FG001|Overall Study|Withdrawal by Subject|0|||
42089142|NCT00799409|75899452|FG002|Overall Study|Withdrawal by Subject|0|||
42089143|NCT00799409|75899450|FG000|Overall Study|Lost to Follow-up|1|||
42089144|NCT00799409|75899451|FG001|Overall Study|Lost to Follow-up|0|||
42089145|NCT00799409|75899452|FG002|Overall Study|Lost to Follow-up|0|||
42089146|NCT00799409|75899450|FG000|Overall Study|Optimal Dose Not Achieved|2|||
42181615|NCT03100942|75988812|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
42181616|NCT03100942|75988813|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
42181617|NCT03100942|75988814|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
42181618|NCT03100942|75988815|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
42181619|NCT03100942|75988816|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
42181620|NCT03100942|75988810|FG000|Randomized Treatment Period|Protocol Violation|0|||
42181621|NCT03100942|75988811|FG001|Randomized Treatment Period|Protocol Violation|1|||
42181622|NCT03100942|75988812|FG002|Randomized Treatment Period|Protocol Violation|1|||
42181623|NCT03100942|75988813|FG003|Randomized Treatment Period|Protocol Violation|1|||
42181624|NCT03100942|75988814|FG004|Randomized Treatment Period|Protocol Violation|0|||
42181625|NCT03100942|75988815|FG005|Randomized Treatment Period|Protocol Violation|0|||
42181626|NCT03100942|75988816|FG006|Randomized Treatment Period|Protocol Violation|0|||
42358678|NCT03924947|76204471|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
42358679|NCT03845985|76204496|FG000|Overall Study|Lost to Follow-up|2|||
42358680|NCT03845985|76204497|FG001|Overall Study|Lost to Follow-up|1|||
42089147|NCT00799409|75899451|FG001|Overall Study|Optimal Dose Not Achieved|0|||
42181627|NCT03100942|75988810|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
42181628|NCT03100942|75988811|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
42181629|NCT03100942|75988812|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
42181630|NCT03100942|75988813|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
42181631|NCT03100942|75988814|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
42181632|NCT03100942|75988815|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
42181633|NCT03100942|75988816|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
42181634|NCT03100942|75988810|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
42181635|NCT03100942|75988811|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
42181636|NCT03100942|75988812|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
42181637|NCT03100942|75988813|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
42181638|NCT03100942|75988814|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
42181639|NCT03100942|75988815|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
42181640|NCT03100942|75988816|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
42181641|NCT03100942|75988810|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
42181642|NCT03100942|75988811|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
42181643|NCT03100942|75988812|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
42181644|NCT03100942|75988813|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
42181645|NCT03100942|75988814|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
42181646|NCT03100942|75988815|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
42181647|NCT03100942|75988816|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
42181648|NCT03099694|75988831|FG000|Overall Study|Withdrawal by Subject|11|||
42181649|NCT03099694|75988832|FG001|Overall Study|Withdrawal by Subject|13|||
42181650|NCT03099694|75988831|FG000|Overall Study|Lost to Follow-up|9|||
42181651|NCT03099694|75988832|FG001|Overall Study|Lost to Follow-up|5|||
42181652|NCT03099538|75988839|FG000|Overall Study|Lack of Efficacy|3|||
42181653|NCT03099304|75988848|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
42181654|NCT03099304|75988849|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
42089148|NCT00799409|75899452|FG002|Overall Study|Optimal Dose Not Achieved|0|||
42089149|NCT00799409|75899450|FG000|Overall Study|Failure to follow study protocol)|1|||
42089150|NCT00799409|75899451|FG001|Overall Study|Failure to follow study protocol)|0|||
42089151|NCT00799409|75899452|FG002|Overall Study|Failure to follow study protocol)|0|||
42089152|NCT00799409|75899450|FG000|Overall Study|Did not attend lab school day 1|1|||
42089153|NCT00799409|75899451|FG001|Overall Study|Did not attend lab school day 1|0|||
42089154|NCT00799409|75899452|FG002|Overall Study|Did not attend lab school day 1|0|||
42089155|NCT00799409|75899450|FG000|Overall Study|medication compliance|1|||
42089156|NCT00799409|75899451|FG001|Overall Study|medication compliance|0|||
42181655|NCT03099304|75988850|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
42181656|NCT03099304|75988851|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
42181657|NCT03099304|75988852|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
42181658|NCT03099304|75988853|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
42181659|NCT03099304|75988848|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
42181660|NCT03099304|75988849|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
42181661|NCT03099304|75988850|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
42181662|NCT03099304|75988851|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
42181663|NCT03099304|75988852|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
42358681|NCT03845985|76204496|FG000|Overall Study|Physician Decision|1|||
42358682|NCT03845985|76204497|FG001|Overall Study|Physician Decision|0|||
42358683|NCT03845985|76204496|FG000|Overall Study|Withdrawal by Subject|4|||
42358684|NCT03845985|76204497|FG001|Overall Study|Withdrawal by Subject|1|||
42358685|NCT03745651|76204506|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
42358686|NCT03745651|76204507|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
42358687|NCT03745651|76204508|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
42358688|NCT03745651|76204509|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
42358689|NCT03745651|76204510|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
42181664|NCT03099304|75988853|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
42181665|NCT03099304|75988848|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
42181666|NCT03099304|75988849|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
42181667|NCT03099304|75988850|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
42181668|NCT03099304|75988851|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
42181669|NCT03099304|75988852|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
42181670|NCT03099304|75988853|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
42181671|NCT03099304|75988848|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
42181672|NCT03099304|75988849|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
42181673|NCT03099304|75988850|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
42181674|NCT03099304|75988851|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
42181675|NCT03099304|75988852|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
42089157|NCT00799409|75899452|FG002|Overall Study|medication compliance|0|||
42089158|NCT00782210|75899463|FG000|Overall Study|Adverse Event|21|||
42089159|NCT00782210|75899464|FG001|Overall Study|Adverse Event|17|||
42089160|NCT00782210|75899465|FG002|Overall Study|Adverse Event|16|||
42089161|NCT00782210|75899463|FG000|Overall Study|Lost to Follow-up|2|||
42089162|NCT00782210|75899464|FG001|Overall Study|Lost to Follow-up|1|||
42089163|NCT00782210|75899465|FG002|Overall Study|Lost to Follow-up|2|||
42089164|NCT00782210|75899463|FG000|Overall Study|Withdrawal by Subject|11|||
42089165|NCT00782210|75899464|FG001|Overall Study|Withdrawal by Subject|8|||
42089166|NCT00782210|75899465|FG002|Overall Study|Withdrawal by Subject|11|||
42089167|NCT00782210|75899463|FG000|Overall Study|Non compliance with protocol|0|||
42089168|NCT00782210|75899464|FG001|Overall Study|Non compliance with protocol|3|||
42089169|NCT00782210|75899465|FG002|Overall Study|Non compliance with protocol|2|||
42089170|NCT00782210|75899463|FG000|Overall Study|Lack of Efficacy|13|||
42089171|NCT00782210|75899464|FG001|Overall Study|Lack of Efficacy|4|||
42089172|NCT00782210|75899465|FG002|Overall Study|Lack of Efficacy|1|||
42089173|NCT00782210|75899463|FG000|Overall Study|Other reason not described above|3|||
42089174|NCT00782210|75899464|FG001|Overall Study|Other reason not described above|2|||
42089175|NCT00782210|75899465|FG002|Overall Study|Other reason not described above|3|||
42089176|NCT01558115|75899482|FG000|Overall Study|Withdrawal by Subject|3|||
42089177|NCT01558115|75899482|FG000|Overall Study|Study closed due to poor enrollment|4|||
42089178|NCT00764660|75899496|FG000|Overall Study|Adverse Event|6|||
42089179|NCT00764660|75899497|FG001|Overall Study|Adverse Event|3|||
42089180|NCT00764660|75899496|FG000|Overall Study|Lost to Follow-up|3|||
42089181|NCT00764660|75899497|FG001|Overall Study|Lost to Follow-up|4|||
42089182|NCT00764660|75899496|FG000|Overall Study|Withdrawal by Subject|7|||
42089183|NCT00764660|75899497|FG001|Overall Study|Withdrawal by Subject|3|||
42089184|NCT00764660|75899496|FG000|Overall Study|Noncompliance With Protocol|5|||
42181676|NCT03099304|75988853|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
42181677|NCT03099304|75988848|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
42181678|NCT03099304|75988849|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
42181679|NCT03099304|75988850|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
42181680|NCT03099304|75988851|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
42181681|NCT03099304|75988852|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
42181682|NCT03099304|75988853|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
42181683|NCT03099304|75988848|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
42181684|NCT03099304|75988849|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
42181685|NCT03099304|75988850|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
42089185|NCT00764660|75899497|FG001|Overall Study|Noncompliance With Protocol|1|||
42089186|NCT00764660|75899496|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
42089187|NCT00764660|75899497|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
42089188|NCT00584415|75899503|FG000|Overall Study|Adverse Event|7|||
42089189|NCT00764504|75899511|FG000|Overall Study|Death|12|||
42089190|NCT00764504|75899512|FG001|Overall Study|Death|6|||
42089191|NCT00764504|75899513|FG002|Overall Study|Death|13|||
42089192|NCT00764504|75899511|FG000|Overall Study|Revision of Device|12|||
42089193|NCT00764504|75899512|FG001|Overall Study|Revision of Device|23|||
42089194|NCT00764504|75899513|FG002|Overall Study|Revision of Device|14|||
42089195|NCT00764504|75899511|FG000|Overall Study|Physician Decision|1|||
42089196|NCT00764504|75899512|FG001|Overall Study|Physician Decision|0|||
42089197|NCT00764504|75899513|FG002|Overall Study|Physician Decision|0|||
42089198|NCT00764504|75899511|FG000|Overall Study|Withdrawal by Subject|1|||
42089199|NCT00764504|75899512|FG001|Overall Study|Withdrawal by Subject|7|||
42181686|NCT03099304|75988851|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
42181687|NCT03099304|75988852|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
42181688|NCT03099304|75988853|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
42181689|NCT03099304|75988848|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
42181690|NCT03099304|75988849|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
42181691|NCT03099304|75988850|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
42181692|NCT03099304|75988851|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
42181693|NCT03099304|75988852|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
42181694|NCT03099304|75988853|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
42181695|NCT03099304|75988848|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
42181696|NCT03099304|75988849|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
42089200|NCT00764504|75899513|FG002|Overall Study|Withdrawal by Subject|4|||
42089201|NCT00764504|75899511|FG000|Overall Study|Lost to Follow-up|40|||
42089202|NCT00764504|75899512|FG001|Overall Study|Lost to Follow-up|34|||
42089203|NCT00764504|75899513|FG002|Overall Study|Lost to Follow-up|72|||
42089204|NCT00763958|75899523|FG000|Overall Study|did not meet final criteria|4|||
42089205|NCT00763958|75899524|FG001|Overall Study|did not meet final criteria|4|||
42089206|NCT00763958|75899523|FG000|Overall Study|Lost to Follow-up|10|||
42089207|NCT00763958|75899524|FG001|Overall Study|Lost to Follow-up|2|||
42089208|NCT00763958|75899523|FG000|Overall Study|Believed they were receiving placebo|0|||
42089209|NCT00763958|75899524|FG001|Overall Study|Believed they were receiving placebo|5|||
42089210|NCT00763256|75899533|FG000|Overall Study|Didn't return for appointments|7|||
42089211|NCT00763256|75899534|FG001|Overall Study|Didn't return for appointments|10|||
42089212|NCT00762788|75899546|FG000|Overall Study|Lost to Follow-up|26|||
42089213|NCT00762788|75899547|FG001|Overall Study|Lost to Follow-up|37|||
42089214|NCT00762788|75899548|FG002|Overall Study|Lost to Follow-up|21|||
42089215|NCT00762788|75899549|FG003|Overall Study|Lost to Follow-up|26|||
42089216|NCT00762788|75899550|FG004|Overall Study|Lost to Follow-up|13|||
42089217|NCT00762788|75899551|FG005|Overall Study|Lost to Follow-up|21|||
42089218|NCT00583947|75899567|FG000|Cross-over Period|Adverse Event|2|||
42089219|NCT00583947|75899568|FG001|Cross-over Period|Adverse Event|0|||
42089220|NCT00583947|75899567|FG000|Cross-over Period|Withdrawal by Subject|2|||
42089221|NCT00583947|75899568|FG001|Cross-over Period|Withdrawal by Subject|0|||
42089222|NCT00583947|75899567|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
42089223|NCT00583947|75899568|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
42089224|NCT00583947|75899567|FG000|Cross-over Period|Other|1|||
42089225|NCT00583947|75899568|FG001|Cross-over Period|Other|1|||
42089226|NCT00772928|75899578|FG000|Overall Study|Lost to Follow-up|9|||
42089227|NCT00772928|75899579|FG001|Overall Study|Lost to Follow-up|6|||
42089228|NCT00772928|75899578|FG000|Overall Study|Protocol Violation|10|||
42089229|NCT00772928|75899579|FG001|Overall Study|Protocol Violation|12|||
42089230|NCT00772928|75899578|FG000|Overall Study|Withdrawal by Subject|25|||
42089231|NCT00772928|75899579|FG001|Overall Study|Withdrawal by Subject|22|||
42089232|NCT00772928|75899578|FG000|Overall Study|Did not receive vaccine|0|||
42089233|NCT00772928|75899579|FG001|Overall Study|Did not receive vaccine|1|||
42089234|NCT00762476|75899587|FG000|Overall Study|Adverse Event|7|||
42089235|NCT00762476|75899588|FG001|Overall Study|Adverse Event|1|||
42089236|NCT00762476|75899587|FG000|Overall Study|Lost to Follow-up|2|||
42181697|NCT03099304|75988850|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
42181698|NCT03099304|75988851|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
42181699|NCT03099304|75988852|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
42089237|NCT00762476|75899588|FG001|Overall Study|Lost to Follow-up|0|||
42089238|NCT00762476|75899587|FG000|Overall Study|Protocol Violation|5|||
42089239|NCT00762476|75899588|FG001|Overall Study|Protocol Violation|6|||
42089240|NCT00762476|75899587|FG000|Overall Study|Physician Decision|2|||
42089241|NCT00762476|75899588|FG001|Overall Study|Physician Decision|14|||
42089242|NCT00762476|75899587|FG000|Overall Study|Withdrawal by Subject|6|||
42089243|NCT00762476|75899588|FG001|Overall Study|Withdrawal by Subject|12|||
42089244|NCT00762476|75899587|FG000|Overall Study|antibiotic use|0|||
42089245|NCT00762476|75899588|FG001|Overall Study|antibiotic use|1|||
42089246|NCT00762476|75899587|FG000|Overall Study|non-compliance with study visits|0|||
42089247|NCT00762476|75899588|FG001|Overall Study|non-compliance with study visits|2|||
42089248|NCT00762476|75899587|FG000|Overall Study|Seasonal allergies|1|||
42089249|NCT00762476|75899588|FG001|Overall Study|Seasonal allergies|0|||
42089250|NCT00762164|75899597|FG000|Overall Study|Lost to Follow-up|1|||
42089251|NCT00762164|75899598|FG001|Overall Study|Lost to Follow-up|1|||
42089252|NCT00762164|75899597|FG000|Overall Study|Discontinued medication|2|||
42089253|NCT00762164|75899598|FG001|Overall Study|Discontinued medication|0|||
42181700|NCT03099304|75988853|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
42181701|NCT03099304|75988848|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
42181702|NCT03099304|75988849|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
42181703|NCT03099304|75988850|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
42181704|NCT03099304|75988851|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
42181705|NCT03099304|75988852|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
42181706|NCT03099304|75988853|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
42181707|NCT03099304|75988848|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
42181708|NCT03099304|75988849|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
42181709|NCT03099304|75988850|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
42181710|NCT03099304|75988851|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
42181711|NCT03099304|75988852|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
42181712|NCT03099304|75988853|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
42181713|NCT03099304|75988848|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
42181714|NCT03099304|75988849|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
42181715|NCT03099304|75988850|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
42181716|NCT03099304|75988851|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
42181717|NCT03099304|75988852|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
42181718|NCT03099304|75988853|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
42181719|NCT03099304|75988848|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
42181720|NCT03099304|75988849|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
42181721|NCT03099304|75988850|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
42181722|NCT03099304|75988851|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
42181723|NCT03099304|75988852|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
42181724|NCT03099304|75988853|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
42181725|NCT03099304|75988848|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
42181726|NCT03099304|75988849|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
42181727|NCT03099304|75988850|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
42181728|NCT03099304|75988851|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
42181729|NCT03099304|75988852|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
42181730|NCT03099304|75988853|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
42181731|NCT03099304|75988848|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
42181732|NCT03099304|75988849|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
42181733|NCT03099304|75988850|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
42181734|NCT03099304|75988851|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
42181735|NCT03099304|75988852|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
42181736|NCT03099304|75988853|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
42181737|NCT03099304|75988848|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
42181738|NCT03099304|75988849|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
42181739|NCT03099304|75988850|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
42181740|NCT03099304|75988851|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
42181741|NCT03099304|75988852|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
42181742|NCT03099304|75988853|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
42181743|NCT03099304|75988848|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
42181744|NCT03099304|75988849|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
42181745|NCT03099304|75988850|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
42181746|NCT03099304|75988851|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
42181747|NCT03099304|75988852|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
42181748|NCT03099304|75988853|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
42181749|NCT03099304|75988848|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
42181750|NCT03099304|75988849|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
42089254|NCT00762164|75899597|FG000|Overall Study|Withdrawal by Subject|0|||
42089255|NCT00762164|75899598|FG001|Overall Study|Withdrawal by Subject|1|||
42089256|NCT00762086|75899606|FG000|Overall Study|Adverse Event|2|||
42089257|NCT00762086|75899607|FG001|Overall Study|Adverse Event|0|||
42181751|NCT03099304|75988850|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
42089258|NCT00762086|75899606|FG000|Overall Study|Lost to Follow-up|0|||
42089259|NCT00762086|75899607|FG001|Overall Study|Lost to Follow-up|2|||
42089260|NCT00762086|75899606|FG000|Overall Study|Non compliance|1|||
42089261|NCT00762086|75899607|FG001|Overall Study|Non compliance|0|||
42089262|NCT00762086|75899606|FG000|Overall Study|Withdrawal by Subject|2|||
42089263|NCT00762086|75899607|FG001|Overall Study|Withdrawal by Subject|2|||
42089264|NCT00762086|75899606|FG000|Overall Study|Ineligible to participate in the study|1|||
42089265|NCT00762086|75899607|FG001|Overall Study|Ineligible to participate in the study|0|||
42089266|NCT00761774|75899613|FG000|Overall Study|Adverse Event|17|||
42089267|NCT00761774|75899613|FG000|Overall Study|Lack of Efficacy|37|||
42089268|NCT00761774|75899613|FG000|Overall Study|Lost to Follow-up|2|||
42089269|NCT00761774|75899613|FG000|Overall Study|Withdrawal by Subject|9|||
42089270|NCT00761774|75899613|FG000|Overall Study|Non-compliance|4|||
42089271|NCT00761774|75899613|FG000|Overall Study|End of study|2|||
42089272|NCT00761774|75899613|FG000|Overall Study|Reclassification of seizures|1|||
42089273|NCT00761774|75899613|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
42089274|NCT00761774|75899613|FG000|Overall Study|Sponsor decision|1|||
42089275|NCT00761774|75899613|FG000|Overall Study|Investigator clinical judgement|1|||
42089276|NCT00761774|75899613|FG000|Overall Study|Patient moved out of study area|1|||
42089277|NCT00761774|75899613|FG000|Overall Study|Coordinator leaving site|1|||
42089278|NCT00761774|75899613|FG000|Overall Study|Subject IP non-compliance|1|||
42089279|NCT00761774|75899613|FG000|Overall Study|IP stopped by hospital physician|1|||
42089280|NCT00583791|75899619|FG000|Overall Study|Other|67|||
42089281|NCT00583791|75899619|FG000|Overall Study|Death|6|||
42089282|NCT00781274|75899623|FG000|Overall Study|Withdrawal by Subject|2|||
42089283|NCT00780416|75899629|FG000|Overall Study|Physician Decision|3|||
42089284|NCT00780416|75899630|FG001|Overall Study|Physician Decision|3|||
42089285|NCT00780416|75899629|FG000|Overall Study|Protocol Violation|1|||
42089286|NCT00780416|75899630|FG001|Overall Study|Protocol Violation|0|||
42089287|NCT00780416|75899629|FG000|Overall Study|Withdrawal by Subject|8|||
42089288|NCT00780416|75899630|FG001|Overall Study|Withdrawal by Subject|6|||
42089289|NCT00761462|75899638|FG000|Treatment|Subjects never received study medication|23|||
42089290|NCT00761462|75899639|FG001|Treatment|Subjects never received study medication|12|||
42089291|NCT00761462|75899638|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
42089292|NCT00761462|75899639|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
42089293|NCT00761462|75899638|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
42089294|NCT00761462|75899639|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
42089295|NCT00761462|75899638|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
42089296|NCT00761462|75899639|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
42089297|NCT00761306|75899645|FG000|Overall Study|Adverse Event|5|||
42089298|NCT00761306|75899645|FG000|Overall Study|Lack of Efficacy|4|||
42089299|NCT00761306|75899645|FG000|Overall Study|Protocol Violation|2|||
42089300|NCT00761306|75899645|FG000|Overall Study|Withdrawal of Consent|3|||
42089301|NCT00761306|75899645|FG000|Overall Study|Lost to Follow-up|1|||
42089302|NCT00761306|75899645|FG000|Overall Study|Administrative or Other Reasons|5|||
42089303|NCT00772538|75899651|FG000|Overall Study|Adverse Event|6|||
42089304|NCT00772538|75899652|FG001|Overall Study|Adverse Event|6|||
42089305|NCT00772538|75899651|FG000|Overall Study|Protocol Violation|3|||
42089306|NCT00772538|75899652|FG001|Overall Study|Protocol Violation|3|||
42089307|NCT00772538|75899651|FG000|Overall Study|Lost to Follow-up|1|||
42089308|NCT00772538|75899652|FG001|Overall Study|Lost to Follow-up|1|||
42089309|NCT00772538|75899651|FG000|Overall Study|Withdrawal by Subject|3|||
42089310|NCT00772538|75899652|FG001|Overall Study|Withdrawal by Subject|8|||
42089311|NCT00772538|75899651|FG000|Overall Study|Lack of Efficacy|0|||
42089312|NCT00772538|75899652|FG001|Overall Study|Lack of Efficacy|1|||
42181752|NCT03099304|75988851|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
42181753|NCT03099304|75988852|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
42181754|NCT03099304|75988853|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
42181755|NCT03097588|75988880|FG000|Overall Study|Adverse Event|1|||
42181756|NCT01631214|75988886|FG000|Overall Study|Withdrawal by Subject|276|||
42181757|NCT01631214|75988887|FG001|Overall Study|Withdrawal by Subject|290|||
42181758|NCT01631214|75988886|FG000|Overall Study|Death|113|||
42181759|NCT01631214|75988887|FG001|Overall Study|Death|106|||
42181760|NCT01631214|75988886|FG000|Overall Study|Lost to Follow-up|54|||
42181761|NCT01631214|75988887|FG001|Overall Study|Lost to Follow-up|40|||
42181762|NCT01631214|75988886|FG000|Overall Study|Adverse Event|45|||
42181763|NCT01631214|75988887|FG001|Overall Study|Adverse Event|45|||
42181764|NCT01631214|75988886|FG000|Overall Study|Other|22|||
42181765|NCT01631214|75988887|FG001|Overall Study|Other|19|||
42089313|NCT00772538|75899651|FG000|Overall Study|Other|7|||
42089314|NCT00772538|75899652|FG001|Overall Study|Other|7|||
42181766|NCT01631214|75988886|FG000|Overall Study|Noncompliance|16|||
42181767|NCT01631214|75988887|FG001|Overall Study|Noncompliance|15|||
42294556|NCT01360645|76128999|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
42089315|NCT00761150|75899661|FG000|Open-label Period|Adverse Event|36|||
42089316|NCT00761150|75899662|FG001|Open-label Period|Adverse Event|0|||
42181768|NCT01631214|75988886|FG000|Overall Study|Requirement for Alternative Therapy|8|||
42089317|NCT00761150|75899663|FG002|Open-label Period|Adverse Event|0|||
42181769|NCT01631214|75988887|FG001|Overall Study|Requirement for Alternative Therapy|3|||
42089318|NCT00761150|75899661|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
42089319|NCT00761150|75899662|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
42089320|NCT00761150|75899663|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
42089321|NCT00761150|75899661|FG000|Open-label Period|Lost to Follow-up|7|||
42089322|NCT00761150|75899662|FG001|Open-label Period|Lost to Follow-up|0|||
42089323|NCT00761150|75899663|FG002|Open-label Period|Lost to Follow-up|0|||
42089324|NCT00761150|75899661|FG000|Open-label Period|Lack of Efficacy|4|||
42089325|NCT00761150|75899662|FG001|Open-label Period|Lack of Efficacy|0|||
42089326|NCT00761150|75899663|FG002|Open-label Period|Lack of Efficacy|0|||
42089327|NCT00761150|75899661|FG000|Open-label Period|Withdrawal by Subject|5|||
42089328|NCT00761150|75899662|FG001|Open-label Period|Withdrawal by Subject|0|||
42089329|NCT00761150|75899663|FG002|Open-label Period|Withdrawal by Subject|0|||
42089330|NCT00761150|75899661|FG000|Open-label Period|Noncompliance|2|||
42089331|NCT00761150|75899662|FG001|Open-label Period|Noncompliance|0|||
42089332|NCT00761150|75899663|FG002|Open-label Period|Noncompliance|0|||
42089333|NCT00761150|75899661|FG000|Open-label Period|Other|5|||
42089334|NCT00761150|75899662|FG001|Open-label Period|Other|0|||
42181770|NCT01631214|75988886|FG000|Overall Study|Protocol Deviation|4|||
42181771|NCT01631214|75988887|FG001|Overall Study|Protocol Deviation|3|||
42181772|NCT01631214|75988886|FG000|Overall Study|Ineligibility determined|5|||
42181773|NCT01631214|75988887|FG001|Overall Study|Ineligibility determined|2|||
42181774|NCT01631214|75988886|FG000|Overall Study|Administrative Decision|1|||
42181775|NCT01631214|75988887|FG001|Overall Study|Administrative Decision|0|||
42181776|NCT03093454|75988897|FG000|Overall Study|Withdrawal by Subject|1|||
42181777|NCT03093454|75988898|FG001|Overall Study|Withdrawal by Subject|1|||
42181778|NCT03093454|75988897|FG000|Overall Study|Scheduling conflict|3|||
42181779|NCT03093454|75988898|FG001|Overall Study|Scheduling conflict|1|||
42181780|NCT03093454|75988897|FG000|Overall Study|Physician Decision|2|||
42181781|NCT03093454|75988898|FG001|Overall Study|Physician Decision|1|||
42181782|NCT00468130|75988919|FG000|Overall Study|Adverse Event|2|||
42181783|NCT00468130|75988920|FG001|Overall Study|Adverse Event|1|||
42181784|NCT00468130|75988919|FG000|Overall Study|Withdrawal by Subject|0|||
42181785|NCT00468130|75988920|FG001|Overall Study|Withdrawal by Subject|1|||
42181786|NCT00911820|75988930|FG000|Overall Study|RECIST progression|12|||
42181787|NCT00911820|75988931|FG001|Overall Study|RECIST progression|8|||
42181788|NCT00911820|75988930|FG000|Overall Study|Adverse Event|8|||
42181789|NCT00911820|75988931|FG001|Overall Study|Adverse Event|8|||
42181790|NCT00911820|75988930|FG000|Overall Study|Clinical Progression|7|||
42181791|NCT00911820|75988931|FG001|Overall Study|Clinical Progression|5|||
42181792|NCT00911820|75988930|FG000|Overall Study|Physician Decision|5|||
42181793|NCT00911820|75988931|FG001|Overall Study|Physician Decision|9|||
42181794|NCT00911820|75988930|FG000|Overall Study|Decline in Performance Status|4|||
42181795|NCT00911820|75988931|FG001|Overall Study|Decline in Performance Status|2|||
42181796|NCT00911820|75988930|FG000|Overall Study|Withdrawal by Subject|3|||
42181797|NCT00911820|75988931|FG001|Overall Study|Withdrawal by Subject|4|||
42181798|NCT00911820|75988930|FG000|Overall Study|Death|1|||
42181799|NCT00911820|75988931|FG001|Overall Study|Death|2|||
42181800|NCT00911820|75988930|FG000|Overall Study|Pursue surgery|1|||
42181801|NCT00911820|75988931|FG001|Overall Study|Pursue surgery|1|||
42181802|NCT00911820|75988930|FG000|Overall Study|Pursue Radiation|1|||
42181803|NCT00911820|75988931|FG001|Overall Study|Pursue Radiation|0|||
42181804|NCT00911820|75988930|FG000|Overall Study|Still on Therapy|2|||
42181805|NCT00911820|75988931|FG001|Overall Study|Still on Therapy|2|||
42181806|NCT00911820|75988930|FG000|Overall Study|Pathology Not Confirmed|1|||
42181807|NCT00911820|75988931|FG001|Overall Study|Pathology Not Confirmed|0|||
42181808|NCT00911820|75988930|FG000|Overall Study|Withdraw before Receive Treatment|0|||
42181809|NCT00911820|75988931|FG001|Overall Study|Withdraw before Receive Treatment|2|||
42089335|NCT00761150|75899663|FG002|Open-label Period|Other|0|||
42089336|NCT00761150|75899661|FG000|Double-blind Period|Lack of Efficacy|0|||
42089337|NCT00761150|75899662|FG001|Double-blind Period|Lack of Efficacy|2|||
42089338|NCT00761150|75899663|FG002|Double-blind Period|Lack of Efficacy|19|||
42089339|NCT00761150|75899661|FG000|Double-blind Period|Adverse Event|0|||
42089340|NCT00761150|75899662|FG001|Double-blind Period|Adverse Event|3|||
42089341|NCT00761150|75899663|FG002|Double-blind Period|Adverse Event|3|||
42181810|NCT00246324|75988946|FG000|Overall Study|Withdrawal by Subject|1|||
42181811|NCT04234984|75988952|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
42089342|NCT00761150|75899661|FG000|Double-blind Period|Withdrawal by Subject|0|||
42181812|NCT04234984|75988952|FG000|Follow-up at the Second Time Point|Death|1|||
42181813|NCT04234984|75988952|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
42181814|NCT03922750|75988966|FG000|Overall Study|Unclassified|0|||
42181815|NCT03922750|75988967|FG001|Overall Study|Unclassified|0|||
42181816|NCT03922750|75988968|FG002|Overall Study|Unclassified|1|||
42181817|NCT03922750|75988966|FG000|Overall Study|Adverse Event|0|||
42089343|NCT00761150|75899662|FG001|Double-blind Period|Withdrawal by Subject|3|||
42181818|NCT03922750|75988967|FG001|Overall Study|Adverse Event|1|||
42089344|NCT00761150|75899663|FG002|Double-blind Period|Withdrawal by Subject|2|||
42089345|NCT00761150|75899661|FG000|Double-blind Period|Lost to Follow-up|0|||
42181819|NCT03922750|75988968|FG002|Overall Study|Adverse Event|0|||
42181820|NCT04634253|75988990|FG000|Overall Study|Adverse Event|1|||
42181821|NCT04634253|75988991|FG001|Overall Study|Adverse Event|1|||
42181822|NCT04634253|75988992|FG002|Overall Study|Adverse Event|0|||
42089346|NCT00761150|75899662|FG001|Double-blind Period|Lost to Follow-up|2|||
42089347|NCT00761150|75899663|FG002|Double-blind Period|Lost to Follow-up|1|||
42089348|NCT00761150|75899661|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
42089349|NCT00761150|75899662|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
42089350|NCT00761150|75899663|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
42089351|NCT00761150|75899661|FG000|Double-blind Period|Noncompliance|0|||
42089352|NCT00761150|75899662|FG001|Double-blind Period|Noncompliance|1|||
42089353|NCT00761150|75899663|FG002|Double-blind Period|Noncompliance|0|||
42089354|NCT00761150|75899661|FG000|Double-blind Period|Other|0|||
42089355|NCT00761150|75899662|FG001|Double-blind Period|Other|3|||
42089356|NCT00761150|75899663|FG002|Double-blind Period|Other|3|||
42089357|NCT00760994|75899673|FG000|Overall Study|Lost to Follow-up|4|||
42089358|NCT00760994|75899674|FG001|Overall Study|Lost to Follow-up|4|||
42089359|NCT00760994|75899675|FG002|Overall Study|Lost to Follow-up|3|||
42089360|NCT00583557|75899685|FG000|Overall Study|Withdrawal by Subject|18|||
42089361|NCT00583557|75899685|FG000|Overall Study|Adverse Event|9|||
42089362|NCT00583557|75899685|FG000|Overall Study|Lack of Efficacy|31|||
42089363|NCT00583557|75899685|FG000|Overall Study|Lack of Compliance|5|||
42089364|NCT00583557|75899685|FG000|Overall Study|Other|5|||
42089365|NCT00583557|75899685|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
42089366|NCT00586820|75899691|FG000|Overall Study|Unsuccessful PCI|1|||
42089367|NCT00586820|75899692|FG001|Overall Study|Unsuccessful PCI|0|||
42089368|NCT00760838|75899700|FG000|Overall Study|Adverse Event|1|||
42089369|NCT00760838|75899701|FG001|Overall Study|Adverse Event|1|||
42089370|NCT00760838|75899700|FG000|Overall Study|Lack of Efficacy|1|||
42089371|NCT00760838|75899701|FG001|Overall Study|Lack of Efficacy|0|||
42089372|NCT00760838|75899700|FG000|Overall Study|Lost to Follow-up|2|||
42089373|NCT00760838|75899701|FG001|Overall Study|Lost to Follow-up|0|||
42089374|NCT00760838|75899700|FG000|Overall Study|Withdrawal by Subject|1|||
42089375|NCT00760838|75899701|FG001|Overall Study|Withdrawal by Subject|1|||
42089376|NCT00586664|75899710|FG000|Overall Study|Withdrawal by Subject|3|||
42089377|NCT00586664|75899711|FG001|Overall Study|Withdrawal by Subject|7|||
42089378|NCT00586664|75899712|FG002|Overall Study|Withdrawal by Subject|1|||
42089379|NCT00586664|75899710|FG000|Overall Study|Exclusion criteria met|2|||
42089380|NCT00586664|75899711|FG001|Overall Study|Exclusion criteria met|0|||
42089381|NCT00586664|75899712|FG002|Overall Study|Exclusion criteria met|0|||
42089382|NCT00437281|75899740|FG000|Overall Study|Adverse Event|0|||
42089383|NCT00437281|75899741|FG001|Overall Study|Adverse Event|0|||
42089384|NCT00437281|75899742|FG002|Overall Study|Adverse Event|0|||
42089385|NCT00437281|75899743|FG003|Overall Study|Adverse Event|1|||
42089386|NCT00437281|75899744|FG004|Overall Study|Adverse Event|0|||
42089387|NCT00437281|75899745|FG005|Overall Study|Adverse Event|1|||
42089388|NCT00437281|75899746|FG006|Overall Study|Adverse Event|0|||
42089389|NCT00437281|75899747|FG007|Overall Study|Adverse Event|0|||
42089390|NCT00437281|75899748|FG008|Overall Study|Adverse Event|0|||
42089391|NCT00437281|75899749|FG009|Overall Study|Adverse Event|1|||
42089392|NCT00437281|75899750|FG010|Overall Study|Adverse Event|0|||
42089393|NCT00437281|75899751|FG011|Overall Study|Adverse Event|0|||
42089394|NCT00437281|75899752|FG012|Overall Study|Adverse Event|0|||
42089395|NCT00437281|75899753|FG013|Overall Study|Adverse Event|1|||
42089396|NCT00437281|75899754|FG014|Overall Study|Adverse Event|1|||
42089397|NCT00437281|75899755|FG015|Overall Study|Adverse Event|0|||
42089398|NCT00437281|75899756|FG016|Overall Study|Adverse Event|0|||
42089399|NCT00437281|75899757|FG017|Overall Study|Adverse Event|0|||
42089400|NCT00437281|75899758|FG018|Overall Study|Adverse Event|1|||
42181823|NCT04634253|75988990|FG000|Overall Study|Physician Decision|0|||
42181824|NCT04634253|75988991|FG001|Overall Study|Physician Decision|1|||
42089401|NCT00437281|75899759|FG019|Overall Study|Adverse Event|0|||
42089402|NCT00437281|75899740|FG000|Overall Study|Lost to Follow-up|0|||
42089403|NCT00437281|75899741|FG001|Overall Study|Lost to Follow-up|0|||
42089404|NCT00437281|75899742|FG002|Overall Study|Lost to Follow-up|0|||
42089405|NCT00437281|75899743|FG003|Overall Study|Lost to Follow-up|0|||
42089406|NCT00437281|75899744|FG004|Overall Study|Lost to Follow-up|0|||
42089407|NCT00437281|75899745|FG005|Overall Study|Lost to Follow-up|0|||
42089408|NCT00437281|75899746|FG006|Overall Study|Lost to Follow-up|0|||
42089409|NCT00437281|75899747|FG007|Overall Study|Lost to Follow-up|0|||
42089410|NCT00437281|75899748|FG008|Overall Study|Lost to Follow-up|0|||
42089411|NCT00437281|75899749|FG009|Overall Study|Lost to Follow-up|0|||
42089412|NCT00437281|75899750|FG010|Overall Study|Lost to Follow-up|0|||
42181825|NCT04634253|75988992|FG002|Overall Study|Physician Decision|0|||
42181826|NCT04634253|75988990|FG000|Overall Study|Withdrawal by Subject|1|||
42181827|NCT04634253|75988991|FG001|Overall Study|Withdrawal by Subject|0|||
42181828|NCT04634253|75988992|FG002|Overall Study|Withdrawal by Subject|3|||
42181829|NCT04209634|75989059|FG000|Overall Study|Ongoing|10|||
42181830|NCT03915951|75989065|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
42181831|NCT03915951|75989066|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
42089413|NCT00437281|75899751|FG011|Overall Study|Lost to Follow-up|0|||
42089414|NCT00437281|75899752|FG012|Overall Study|Lost to Follow-up|0|||
42181832|NCT03915951|75989065|FG000|Overall Study|Adverse Event|12|||
42181833|NCT03915951|75989066|FG001|Overall Study|Adverse Event|6|||
42089415|NCT00437281|75899753|FG013|Overall Study|Lost to Follow-up|0|||
42089416|NCT00437281|75899754|FG014|Overall Study|Lost to Follow-up|0|||
42089417|NCT00437281|75899755|FG015|Overall Study|Lost to Follow-up|0|||
42089418|NCT00437281|75899756|FG016|Overall Study|Lost to Follow-up|0|||
42089419|NCT00437281|75899757|FG017|Overall Study|Lost to Follow-up|0|||
42089420|NCT00437281|75899758|FG018|Overall Study|Lost to Follow-up|0|||
42089421|NCT00437281|75899759|FG019|Overall Study|Lost to Follow-up|1|||
42089422|NCT00741039|75899833|FG000|Overall Study|Patient non-compliance|2|||
42089423|NCT00741039|75899834|FG001|Overall Study|Patient non-compliance|0|||
42089424|NCT00772382|75899840|FG000|Overall Study|Adverse Event|19|||
42089425|NCT00772382|75899840|FG000|Overall Study|Death|6|||
42089426|NCT00772382|75899840|FG000|Overall Study|Lack of Efficacy|4|||
42089427|NCT00772382|75899840|FG000|Overall Study|Physician Decision|5|||
42089428|NCT00772382|75899840|FG000|Overall Study|Protocol Violation|1|||
42089429|NCT00772382|75899840|FG000|Overall Study|Withdrawal by Subject|10|||
42089430|NCT00772382|75899840|FG000|Overall Study|Other Reasons|10|||
42089431|NCT00798707|75899847|FG000|Overall Study|Adverse Event|6|||
42089432|NCT00798707|75899848|FG001|Overall Study|Adverse Event|8|||
42089433|NCT00798707|75899849|FG002|Overall Study|Adverse Event|8|||
42089434|NCT00798707|75899847|FG000|Overall Study|Failed to return|2|||
42294557|NCT01360645|76129000|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
42294558|NCT01360645|76129001|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
42294559|NCT01360645|76129002|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
42294560|NCT01360645|76128999|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
42294561|NCT01360645|76129000|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
42294562|NCT01360645|76129001|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
42294563|NCT01360645|76129002|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
42294564|NCT01360645|76128999|FG000|Phase A+|Lost to Follow-up|0|||
42294565|NCT01360645|76129000|FG001|Phase A+|Lost to Follow-up|0|||
42358690|NCT03745651|76204511|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
42017906|NCT01263665|75825658|FG000|Overall Study|Surgical Bypass|2|||
42017907|NCT01263509|75825664|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
42017908|NCT01263509|75825665|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
42017909|NCT01263509|75825666|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
42017910|NCT01263509|75825667|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
42017911|NCT01263509|75825664|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
42017912|NCT01263509|75825665|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
42017913|NCT01263509|75825666|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
42017914|NCT01263509|75825667|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
42017915|NCT01263509|75825664|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
42017916|NCT01263509|75825665|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
42017917|NCT01263509|75825666|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
42017918|NCT01263509|75825667|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
42017919|NCT01263509|75825664|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
42017920|NCT01263509|75825665|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
42017921|NCT01263509|75825666|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
42017922|NCT01263509|75825667|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
42017923|NCT01263509|75825664|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
42017924|NCT01263509|75825665|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
42017925|NCT01263509|75825666|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
42017926|NCT01263509|75825667|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
42017927|NCT01263197|75825675|FG000|First Intervention (Period 1)|Adverse Event|0|||
42017928|NCT01263197|75825676|FG001|First Intervention (Period 1)|Adverse Event|0|||
42017929|NCT01263197|75825677|FG002|First Intervention (Period 1)|Adverse Event|0|||
42017930|NCT01263197|75825678|FG003|First Intervention (Period 1)|Adverse Event|0|||
42017931|NCT01263197|75825679|FG004|First Intervention (Period 1)|Adverse Event|0|||
42017932|NCT01263197|75825680|FG005|First Intervention (Period 1)|Adverse Event|1|||
42017933|NCT01263197|75825675|FG000|Washout Period 1|Protocol Violation|0|||
42017934|NCT01263197|75825676|FG001|Washout Period 1|Protocol Violation|0|||
42017935|NCT01263197|75825677|FG002|Washout Period 1|Protocol Violation|0|||
42017936|NCT01263197|75825678|FG003|Washout Period 1|Protocol Violation|0|||
42089435|NCT00798707|75899848|FG001|Overall Study|Failed to return|2|||
42089436|NCT00798707|75899849|FG002|Overall Study|Failed to return|0|||
42089437|NCT00798707|75899847|FG000|Overall Study|Investigator|0|||
42089438|NCT00798707|75899848|FG001|Overall Study|Investigator|1|||
42089439|NCT00798707|75899849|FG002|Overall Study|Investigator|2|||
42358691|NCT03745651|76204512|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
42358692|NCT03745651|76204506|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
42358693|NCT03745651|76204507|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
42089440|NCT00798707|75899847|FG000|Overall Study|Lack of Efficacy|2|||
42181834|NCT03915951|75989065|FG000|Overall Study|Disease progression (radiological)|17|||
42181835|NCT03915951|75989066|FG001|Overall Study|Disease progression (radiological)|15|||
42181836|NCT03915951|75989065|FG000|Overall Study|Disease progression (clinical)|4|||
42181837|NCT03915951|75989066|FG001|Overall Study|Disease progression (clinical)|1|||
42181838|NCT03915951|75989065|FG000|Overall Study|Patient decision|0|||
42089441|NCT00798707|75899848|FG001|Overall Study|Lack of Efficacy|2|||
42089442|NCT00798707|75899849|FG002|Overall Study|Lack of Efficacy|1|||
42089443|NCT00798707|75899847|FG000|Overall Study|Lost to Follow-up|5|||
42089444|NCT00798707|75899848|FG001|Overall Study|Lost to Follow-up|6|||
42089445|NCT00798707|75899849|FG002|Overall Study|Lost to Follow-up|6|||
42089446|NCT00798707|75899847|FG000|Overall Study|Other|0|||
42089447|NCT00798707|75899848|FG001|Overall Study|Other|1|||
42089448|NCT00798707|75899849|FG002|Overall Study|Other|0|||
42089449|NCT00798707|75899847|FG000|Overall Study|Protocol Violation|4|||
42089450|NCT00798707|75899848|FG001|Overall Study|Protocol Violation|0|||
42089451|NCT00798707|75899849|FG002|Overall Study|Protocol Violation|2|||
42089452|NCT00798707|75899847|FG000|Overall Study|Withdrawal by Subject|3|||
42089453|NCT00798707|75899848|FG001|Overall Study|Withdrawal by Subject|8|||
42089454|NCT00798707|75899849|FG002|Overall Study|Withdrawal by Subject|2|||
42089455|NCT00798707|75899847|FG000|Overall Study|Randomized not treated|4|||
42089456|NCT00798707|75899848|FG001|Overall Study|Randomized not treated|5|||
42089457|NCT00798707|75899849|FG002|Overall Study|Randomized not treated|1|||
42089458|NCT00760214|75899860|FG000|Overall Study|Adverse Event|8|||
42089459|NCT00760214|75899861|FG001|Overall Study|Adverse Event|9|||
42089460|NCT00760214|75899862|FG002|Overall Study|Adverse Event|12|||
42089461|NCT00760214|75899860|FG000|Overall Study|Protocol Violation|3|||
42089462|NCT00760214|75899861|FG001|Overall Study|Protocol Violation|0|||
42089463|NCT00760214|75899862|FG002|Overall Study|Protocol Violation|3|||
42089464|NCT00760214|75899860|FG000|Overall Study|Lost to Follow-up|0|||
42089465|NCT00760214|75899861|FG001|Overall Study|Lost to Follow-up|0|||
42089466|NCT00760214|75899862|FG002|Overall Study|Lost to Follow-up|1|||
42089467|NCT00760214|75899860|FG000|Overall Study|Withdrawal by Subject|12|||
42089468|NCT00760214|75899861|FG001|Overall Study|Withdrawal by Subject|14|||
42089469|NCT00760214|75899862|FG002|Overall Study|Withdrawal by Subject|13|||
42089470|NCT00760214|75899860|FG000|Overall Study|Lack of Efficacy|3|||
42089471|NCT00760214|75899861|FG001|Overall Study|Lack of Efficacy|2|||
42089472|NCT00760214|75899862|FG002|Overall Study|Lack of Efficacy|4|||
42089473|NCT00760214|75899860|FG000|Overall Study|Pregnancy|0|||
42089474|NCT00760214|75899861|FG001|Overall Study|Pregnancy|0|||
42089475|NCT00760214|75899862|FG002|Overall Study|Pregnancy|1|||
42089476|NCT00760214|75899860|FG000|Overall Study|Physician Decision|1|||
42089477|NCT00760214|75899861|FG001|Overall Study|Physician Decision|1|||
42089478|NCT00760214|75899862|FG002|Overall Study|Physician Decision|1|||
42089479|NCT00760214|75899860|FG000|Overall Study|Other|3|||
42089480|NCT00760214|75899861|FG001|Overall Study|Other|4|||
42089481|NCT00760214|75899862|FG002|Overall Study|Other|6|||
42181839|NCT03915951|75989066|FG001|Overall Study|Patient decision|4|||
42181840|NCT03915951|75989065|FG000|Overall Study|Investigator decision|0|||
42181841|NCT03915951|75989066|FG001|Overall Study|Investigator decision|1|||
42181842|NCT03915951|75989065|FG000|Overall Study|Consent withdrawn|1|||
42089482|NCT00802841|75899872|FG000|Overall Study|Administrative problems|1|||
42089483|NCT00802841|75899873|FG001|Overall Study|Administrative problems|0|||
42089484|NCT00802841|75899872|FG000|Overall Study|Lost to Follow-up|2|||
42089485|NCT00802841|75899873|FG001|Overall Study|Lost to Follow-up|1|||
42089486|NCT00802841|75899872|FG000|Overall Study|Death|1|||
42089487|NCT00802841|75899873|FG001|Overall Study|Death|2|||
42089488|NCT00802841|75899872|FG000|Overall Study|Adverse Event|8|||
42181843|NCT03915951|75989066|FG001|Overall Study|Consent withdrawn|1|||
42181844|NCT03915951|75989065|FG000|Overall Study|Death|0|||
42089489|NCT00802841|75899873|FG001|Overall Study|Adverse Event|2|||
42089490|NCT00802841|75899872|FG000|Overall Study|Disease progression|7|||
42089491|NCT00802841|75899873|FG001|Overall Study|Disease progression|3|||
42089492|NCT00802841|75899872|FG000|Overall Study|Withdrawal by Subject|9|||
42089493|NCT00802841|75899873|FG001|Overall Study|Withdrawal by Subject|5|||
42089494|NCT00802841|75899872|FG000|Overall Study|Protocol deviation|2|||
42181845|NCT03915951|75989066|FG001|Overall Study|Death|3|||
42181846|NCT03725982|75989104|FG000|First Intervention|Withdrawal by Subject|0|||
42089495|NCT00802841|75899873|FG001|Overall Study|Protocol deviation|6|||
42089496|NCT00802841|75899872|FG000|Overall Study|Treatment duration completed|66|||
42089497|NCT00802841|75899873|FG001|Overall Study|Treatment duration completed|76|||
42089498|NCT00772148|75899883|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
42089499|NCT00772148|75899884|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
42089500|NCT00772148|75899883|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
42089501|NCT00772148|75899884|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
42089502|NCT00772148|75899883|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
42089503|NCT00772148|75899884|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
42089504|NCT00772148|75899883|FG000|Maintenance Phase (Week 52)|Death|2|||
42089505|NCT00772148|75899884|FG001|Maintenance Phase (Week 52)|Death|2|||
42089506|NCT00772148|75899883|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
42089507|NCT00772148|75899884|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
42089508|NCT00772148|75899883|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
42089509|NCT00772148|75899884|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
42089510|NCT00772148|75899883|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
42089511|NCT00772148|75899884|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
42089512|NCT00759902|75899892|FG000|Overall Study|Adverse Event|0|||
42089513|NCT00759902|75899893|FG001|Overall Study|Adverse Event|1|||
42089514|NCT00772070|75899901|FG000|Overall Study|Lost to Follow-up|0|||
42089515|NCT00772070|75899902|FG001|Overall Study|Lost to Follow-up|8|||
42089516|NCT00772070|75899901|FG000|Overall Study|Withdrawal by Subject|0|||
42089517|NCT00772070|75899902|FG001|Overall Study|Withdrawal by Subject|2|||
42089518|NCT00772070|75899901|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
42089519|NCT00772070|75899902|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
42089520|NCT00796757|75899908|FG000|Overall Study|Withdrawal by Subject|14|||
42089521|NCT00796757|75899908|FG000|Overall Study|Death|61|||
42089522|NCT00796757|75899908|FG000|Overall Study|Protocol Violation|1|||
42089523|NCT00796757|75899908|FG000|Overall Study|Participant noncompliance|1|||
42089524|NCT00796757|75899908|FG000|Overall Study|Investigator's decision|2|||
42089525|NCT00796757|75899908|FG000|Overall Study|Other|7|||
42089526|NCT00759356|75899914|FG000|Overall Study|Adverse Event|0|||
42089527|NCT00759356|75899915|FG001|Overall Study|Adverse Event|1|||
42181847|NCT03725982|75989105|FG001|First Intervention|Withdrawal by Subject|1|||
42181848|NCT03725982|75989104|FG000|First Intervention|Physician Decision|1|||
42181849|NCT03725982|75989105|FG001|First Intervention|Physician Decision|1|||
42181850|NCT03354273|75989171|FG000|Overall Study|Adverse Event|5|||
42181851|NCT03354273|75989171|FG000|Overall Study|Screen Failure|21|||
42294566|NCT01360645|76129001|FG002|Phase A+|Lost to Follow-up|0|||
42294567|NCT01360645|76129002|FG003|Phase A+|Lost to Follow-up|7|||
42294568|NCT01360645|76128999|FG000|Phase A+|Adverse Event|0|||
42294569|NCT01360645|76129000|FG001|Phase A+|Adverse Event|0|||
42294570|NCT01360645|76129001|FG002|Phase A+|Adverse Event|0|||
42294571|NCT01360645|76129002|FG003|Phase A+|Adverse Event|2|||
42294572|NCT01360645|76128999|FG000|Phase A+|Met Withdrawal Criteria|0|||
42294573|NCT01360645|76129000|FG001|Phase A+|Met Withdrawal Criteria|0|||
42294574|NCT01360645|76129001|FG002|Phase A+|Met Withdrawal Criteria|0|||
42294575|NCT01360645|76129002|FG003|Phase A+|Met Withdrawal Criteria|4|||
42294576|NCT01360645|76128999|FG000|Phase A+|Physician Decision|0|||
42294577|NCT01360645|76129000|FG001|Phase A+|Physician Decision|0|||
42294578|NCT01360645|76129001|FG002|Phase A+|Physician Decision|0|||
42294579|NCT01360645|76129002|FG003|Phase A+|Physician Decision|2|||
42294580|NCT01360645|76128999|FG000|Phase A+|Withdrawal by Subject|0|||
42294581|NCT01360645|76129000|FG001|Phase A+|Withdrawal by Subject|0|||
42294582|NCT01360645|76129001|FG002|Phase A+|Withdrawal by Subject|0|||
42294583|NCT01360645|76129002|FG003|Phase A+|Withdrawal by Subject|5|||
42294584|NCT01360645|76128999|FG000|Phase A+|Protocol Deviation|0|||
42294585|NCT01360645|76129000|FG001|Phase A+|Protocol Deviation|0|||
42294586|NCT01360645|76129001|FG002|Phase A+|Protocol Deviation|0|||
42294587|NCT01360645|76129002|FG003|Phase A+|Protocol Deviation|4|||
42294588|NCT04336163|76129014|FG000|Overall Study|Lost to Follow-up|55|||
42294589|NCT04336163|76129015|FG001|Overall Study|Lost to Follow-up|0|||
42294590|NCT02633527|76129026|FG000|Overall Study|Failed to meet eligibility|0|||
42294591|NCT02633527|76129027|FG001|Overall Study|Failed to meet eligibility|1|||
42294592|NCT02633527|76129028|FG002|Overall Study|Failed to meet eligibility|1|||
42294593|NCT02633527|76129029|FG003|Overall Study|Failed to meet eligibility|0|||
42294594|NCT02633527|76129030|FG004|Overall Study|Failed to meet eligibility|1|||
42089528|NCT00759356|75899914|FG000|Overall Study|Withdrawal by Subject|0|||
42089529|NCT00759356|75899915|FG001|Overall Study|Withdrawal by Subject|2|||
42089530|NCT00759356|75899914|FG000|Overall Study|Subject was unable to return|1|||
42089531|NCT00759356|75899915|FG001|Overall Study|Subject was unable to return|0|||
42089532|NCT00721734|75899926|FG000|Overall Study|Progressive Disease|3|||
42089533|NCT00721734|75899927|FG001|Overall Study|Progressive Disease|10|||
42089534|NCT00721734|75899928|FG002|Overall Study|Progressive Disease|4|||
42294595|NCT02633527|76129026|FG000|Overall Study|Adverse Event|0|||
42294596|NCT02633527|76129027|FG001|Overall Study|Adverse Event|4|||
42181852|NCT03354273|75989171|FG000|Overall Study|Withdrawal by Subject|34|||
42181853|NCT03354273|75989171|FG000|Overall Study|Technical Problems|30|||
42181854|NCT03354273|75989171|FG000|Overall Study|Lost to Follow-up|4|||
42181855|NCT03354273|75989171|FG000|Overall Study|Investigator Decision|3|||
42181856|NCT03354273|75989171|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
42181857|NCT03354273|75989171|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
42181858|NCT03354273|75989171|FG000|Overall Study|COVID-19 Restrictions|9|||
42181859|NCT03354273|75989171|FG000|Overall Study|Other|5|||
42181860|NCT02759185|75989195|FG000|Stage 1|Adverse Event|0|||
42181861|NCT02759185|75989196|FG001|Stage 1|Adverse Event|1|||
42181862|NCT02759185|75989197|FG002|Stage 1|Adverse Event|3|||
42181863|NCT02759185|75989198|FG003|Stage 1|Adverse Event|0|||
42181864|NCT02759185|75989199|FG004|Stage 1|Adverse Event|0|||
42181865|NCT02759185|75989200|FG005|Stage 1|Adverse Event|0|||
42181866|NCT02759185|75989201|FG006|Stage 1|Adverse Event|0|||
42181867|NCT02759185|75989195|FG000|Stage 1|Withdrawal by Subject|1|||
42181868|NCT02759185|75989196|FG001|Stage 1|Withdrawal by Subject|0|||
42181869|NCT02759185|75989197|FG002|Stage 1|Withdrawal by Subject|0|||
42181870|NCT02759185|75989198|FG003|Stage 1|Withdrawal by Subject|0|||
42181871|NCT02759185|75989199|FG004|Stage 1|Withdrawal by Subject|0|||
42181872|NCT02759185|75989200|FG005|Stage 1|Withdrawal by Subject|0|||
42181873|NCT02759185|75989201|FG006|Stage 1|Withdrawal by Subject|0|||
42181874|NCT02759185|75989195|FG000|Stage 2|Adverse Event|0|||
42181875|NCT02759185|75989196|FG001|Stage 2|Adverse Event|0|||
42181876|NCT02759185|75989197|FG002|Stage 2|Adverse Event|0|||
42181877|NCT02759185|75989198|FG003|Stage 2|Adverse Event|0|||
42181878|NCT02759185|75989199|FG004|Stage 2|Adverse Event|1|||
42181879|NCT02759185|75989200|FG005|Stage 2|Adverse Event|2|||
42181880|NCT02759185|75989201|FG006|Stage 2|Adverse Event|0|||
42181881|NCT02759185|75989195|FG000|Stage 2|Withdrawal by Subject|0|||
42181882|NCT02759185|75989196|FG001|Stage 2|Withdrawal by Subject|0|||
42181883|NCT02759185|75989197|FG002|Stage 2|Withdrawal by Subject|0|||
42181884|NCT02759185|75989198|FG003|Stage 2|Withdrawal by Subject|0|||
42181885|NCT02759185|75989199|FG004|Stage 2|Withdrawal by Subject|1|||
42181886|NCT02759185|75989200|FG005|Stage 2|Withdrawal by Subject|1|||
42181887|NCT02759185|75989201|FG006|Stage 2|Withdrawal by Subject|1|||
42089535|NCT00721734|75899929|FG003|Overall Study|Progressive Disease|5|||
42089536|NCT00721734|75899930|FG004|Overall Study|Progressive Disease|2|||
42089537|NCT00721734|75899926|FG000|Overall Study|Adverse Event|3|||
42089538|NCT00721734|75899927|FG001|Overall Study|Adverse Event|1|||
42089539|NCT00721734|75899928|FG002|Overall Study|Adverse Event|4|||
42089540|NCT00721734|75899929|FG003|Overall Study|Adverse Event|0|||
42089541|NCT00721734|75899930|FG004|Overall Study|Adverse Event|3|||
42089542|NCT00721734|75899926|FG000|Overall Study|Withdrawal by Subject|2|||
42089543|NCT00721734|75899927|FG001|Overall Study|Withdrawal by Subject|1|||
42089544|NCT00721734|75899928|FG002|Overall Study|Withdrawal by Subject|0|||
42089545|NCT00721734|75899929|FG003|Overall Study|Withdrawal by Subject|0|||
42089546|NCT00721734|75899930|FG004|Overall Study|Withdrawal by Subject|1|||
42089547|NCT00721734|75899926|FG000|Overall Study|Other|0|||
42089548|NCT00721734|75899927|FG001|Overall Study|Other|0|||
42089549|NCT00721734|75899928|FG002|Overall Study|Other|0|||
42089550|NCT00721734|75899929|FG003|Overall Study|Other|1|||
42089551|NCT00721734|75899930|FG004|Overall Study|Other|0|||
42089552|NCT00798317|75899944|FG000|Overall Study|Physician Decision|0|||
42089553|NCT00798317|75899945|FG001|Overall Study|Physician Decision|1|||
42089554|NCT00798317|75899944|FG000|Overall Study|Withdrawal by Subject|5|||
42089555|NCT00798317|75899945|FG001|Overall Study|Withdrawal by Subject|4|||
42089556|NCT00798317|75899944|FG000|Overall Study|Lost to Follow-up|2|||
42089557|NCT00798317|75899945|FG001|Overall Study|Lost to Follow-up|2|||
42089558|NCT00798317|75899944|FG000|Overall Study|Adverse Event|2|||
42089559|NCT00798317|75899945|FG001|Overall Study|Adverse Event|0|||
42089560|NCT00798317|75899944|FG000|Overall Study|Death|1|||
42181888|NCT01844518|75989234|FG000|Overall Study|Adverse Event|7|||
42181889|NCT01844518|75989235|FG001|Overall Study|Adverse Event|1|||
42181890|NCT01844518|75989234|FG000|Overall Study|Lack of Efficacy|17|||
42181891|NCT01844518|75989235|FG001|Overall Study|Lack of Efficacy|5|||
42181892|NCT01844518|75989234|FG000|Overall Study|Participant's request to discontinue|4|||
42294597|NCT02633527|76129028|FG002|Overall Study|Adverse Event|3|||
42089561|NCT00798317|75899945|FG001|Overall Study|Death|0|||
42089562|NCT00779402|75899953|FG000|Treatment Phase 1|Disease Progression|1|||
42089563|NCT00779402|75899954|FG001|Treatment Phase 1|Disease Progression|0|||
42089564|NCT00779402|75899953|FG000|Treatment Phase 1|Adverse Event|2|||
42089565|NCT00779402|75899954|FG001|Treatment Phase 1|Adverse Event|0|||
42089566|NCT00779402|75899953|FG000|Treatment Phase 1|Protocol Violation|1|||
42181893|NCT01844518|75989235|FG001|Overall Study|Participant's request to discontinue|1|||
42181894|NCT01844518|75989234|FG000|Overall Study|Poor/Non-compliance|1|||
42181895|NCT01844518|75989235|FG001|Overall Study|Poor/Non-compliance|0|||
42181896|NCT01844518|75989234|FG000|Overall Study|No Longer Met Study Criteria|2|||
42181897|NCT01844518|75989235|FG001|Overall Study|No Longer Met Study Criteria|0|||
42181898|NCT01844518|75989234|FG000|Overall Study|Withdrawal by Subject|9|||
42089567|NCT00779402|75899954|FG001|Treatment Phase 1|Protocol Violation|0|||
42089568|NCT00779402|75899953|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
42089569|NCT00779402|75899954|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
42089570|NCT00779402|75899953|FG000|Treatment Phase 1|Lost to Follow-up|0|||
42089571|NCT00779402|75899954|FG001|Treatment Phase 1|Lost to Follow-up|1|||
42089572|NCT00779402|75899953|FG000|Treatment Phase 1|Death|0|||
42089573|NCT00779402|75899954|FG001|Treatment Phase 1|Death|1|||
42089574|NCT00779402|75899953|FG000|Treatment Phase 1|Intercurrent Illness|1|||
42089575|NCT00779402|75899954|FG001|Treatment Phase 1|Intercurrent Illness|1|||
42089576|NCT00779402|75899953|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
42089577|NCT00779402|75899954|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
42181899|NCT01844518|75989235|FG001|Overall Study|Withdrawal by Subject|0|||
42181900|NCT01844518|75989234|FG000|Overall Study|Pregnancy|1|||
42181901|NCT01844518|75989235|FG001|Overall Study|Pregnancy|0|||
42181902|NCT01039584|75989304|FG000|Overall Study|Withdrawal by Subject|4|||
42181903|NCT01039584|75989305|FG001|Overall Study|Withdrawal by Subject|2|||
42181904|NCT01039584|75989306|FG002|Overall Study|Withdrawal by Subject|1|||
42181905|NCT01039584|75989304|FG000|Overall Study|Protocol Violation|10|||
42181906|NCT01039584|75989305|FG001|Overall Study|Protocol Violation|4|||
42181907|NCT01039584|75989306|FG002|Overall Study|Protocol Violation|6|||
42181908|NCT01039584|75989304|FG000|Overall Study|Lost to Follow-up|5|||
42181909|NCT01039584|75989305|FG001|Overall Study|Lost to Follow-up|3|||
42089578|NCT00779402|75899953|FG000|Treatment Phase 1|Other|4|||
42089579|NCT00779402|75899954|FG001|Treatment Phase 1|Other|2|||
42181910|NCT01039584|75989306|FG002|Overall Study|Lost to Follow-up|4|||
42181911|NCT01039584|75989304|FG000|Overall Study|Negative Baseline culture for Candida|59|||
42181912|NCT01039584|75989305|FG001|Overall Study|Negative Baseline culture for Candida|59|||
42181913|NCT01039584|75989306|FG002|Overall Study|Negative Baseline culture for Candida|24|||
42181914|NCT01039584|75989304|FG000|Overall Study|Lack of Efficacy|7|||
42181915|NCT01039584|75989305|FG001|Overall Study|Lack of Efficacy|6|||
42181916|NCT01039584|75989306|FG002|Overall Study|Lack of Efficacy|10|||
42089580|NCT00779402|75899953|FG000|Treatment Phase 1|Closure of Study|3|||
42089581|NCT00779402|75899954|FG001|Treatment Phase 1|Closure of Study|2|||
42089582|NCT00779402|75899953|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
42089583|NCT00779402|75899954|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
42089584|NCT00779402|75899953|FG000|Surveillance Phase|Protocol Violation|0|||
42181917|NCT01039584|75989304|FG000|Overall Study|other|1|||
42181918|NCT01039584|75989305|FG001|Overall Study|other|3|||
42089585|NCT00779402|75899954|FG001|Surveillance Phase|Protocol Violation|1|||
42089586|NCT00779402|75899953|FG000|Surveillance Phase|Patient refused to continue|22|||
42089587|NCT00779402|75899954|FG001|Surveillance Phase|Patient refused to continue|14|||
42089588|NCT00779402|75899953|FG000|Surveillance Phase|Lost to Follow-up|2|||
42089589|NCT00779402|75899954|FG001|Surveillance Phase|Lost to Follow-up|1|||
42089590|NCT00779402|75899953|FG000|Surveillance Phase|Death|0|||
42089591|NCT00779402|75899954|FG001|Surveillance Phase|Death|1|||
42089592|NCT00779402|75899953|FG000|Surveillance Phase|Intercurrent Illness|2|||
42089593|NCT00779402|75899954|FG001|Surveillance Phase|Intercurrent Illness|0|||
42089594|NCT00779402|75899953|FG000|Surveillance Phase|Other|5|||
42089595|NCT00779402|75899954|FG001|Surveillance Phase|Other|5|||
42089596|NCT00779402|75899953|FG000|Surveillance Phase|Withdrawal by Subject|4|||
42089597|NCT00779402|75899954|FG001|Surveillance Phase|Withdrawal by Subject|1|||
42089598|NCT00779402|75899953|FG000|Surveillance Phase|Closure of study|5|||
42089599|NCT00779402|75899954|FG001|Surveillance Phase|Closure of study|6|||
42089600|NCT00779402|75899953|FG000|Surveillance Phase|Completed Protocol Visits|3|||
42089601|NCT00779402|75899954|FG001|Surveillance Phase|Completed Protocol Visits|2|||
42089602|NCT00779402|75899953|FG000|Long-term Follow-up|Patient refused to continue|2|||
42089603|NCT00779402|75899954|FG001|Long-term Follow-up|Patient refused to continue|0|||
42089604|NCT00779402|75899953|FG000|Long-term Follow-up|Other|5|||
42089605|NCT00779402|75899954|FG001|Long-term Follow-up|Other|0|||
42089606|NCT00779402|75899953|FG000|Long-term Follow-up|Closure of Study|8|||
42089607|NCT00779402|75899954|FG001|Long-term Follow-up|Closure of Study|4|||
42089608|NCT00779402|75899953|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
42089609|NCT00779402|75899954|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
42089610|NCT00771914|75899964|FG000|Overall Study|Physician Decision|0|||
42089611|NCT00771914|75899965|FG001|Overall Study|Physician Decision|0|||
42089612|NCT00771914|75899966|FG002|Overall Study|Physician Decision|0|||
42089613|NCT00771914|75899967|FG003|Overall Study|Physician Decision|1|||
42089614|NCT00771914|75899964|FG000|Overall Study|Lost to Follow-up|0|||
42089615|NCT00771914|75899965|FG001|Overall Study|Lost to Follow-up|0|||
42089616|NCT00771914|75899966|FG002|Overall Study|Lost to Follow-up|0|||
42089617|NCT00771914|75899967|FG003|Overall Study|Lost to Follow-up|1|||
42089618|NCT00779324|75899979|FG000|Overall Study|Lost to Follow-up|2|||
42089619|NCT00779324|75899980|FG001|Overall Study|Lost to Follow-up|1|||
42089620|NCT00779324|75899979|FG000|Overall Study|Withdrawal by Subject|4|||
42089621|NCT00779324|75899980|FG001|Overall Study|Withdrawal by Subject|2|||
42089622|NCT00779324|75899979|FG000|Overall Study|Missed visit|1|||
42089623|NCT00779324|75899980|FG001|Overall Study|Missed visit|1|||
42089624|NCT00779246|75899988|FG000|Overall Study|Missing sufficient data for analysis|33|||
42181919|NCT01039584|75989306|FG002|Overall Study|other|1|||
42181920|NCT01039584|75989304|FG000|Overall Study|Pap smear with significant pathology|10|||
42181921|NCT01039584|75989305|FG001|Overall Study|Pap smear with significant pathology|10|||
42181922|NCT01039584|75989306|FG002|Overall Study|Pap smear with significant pathology|3|||
42181923|NCT01039584|75989304|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
42181924|NCT01039584|75989305|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
42181925|NCT01039584|75989306|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
42181926|NCT00920387|75989316|FG000|Stage 1|Adverse Event|1|||
42181927|NCT00920387|75989317|FG001|Stage 1|Adverse Event|0|||
42181928|NCT00920387|75989318|FG002|Stage 1|Adverse Event|0|||
42181929|NCT00679783|75989343|FG000|Overall Study|Adverse Event|0|||
42181930|NCT00679783|75989344|FG001|Overall Study|Adverse Event|0|||
42181931|NCT00679783|75989345|FG002|Overall Study|Adverse Event|0|||
42089625|NCT00779246|75899989|FG001|Overall Study|Missing sufficient data for analysis|53|||
42089626|NCT00771758|75899998|FG000|Overall Study|Adverse Event|2|||
42089627|NCT00771758|75899999|FG001|Overall Study|Adverse Event|8|||
42089628|NCT00771758|75900000|FG002|Overall Study|Adverse Event|1|||
42089629|NCT00771758|75899998|FG000|Overall Study|Lack of Efficacy|0|||
42089630|NCT00771758|75899999|FG001|Overall Study|Lack of Efficacy|2|||
42181932|NCT00679783|75989346|FG003|Overall Study|Adverse Event|3|||
42089631|NCT00771758|75900000|FG002|Overall Study|Lack of Efficacy|1|||
42089632|NCT00771758|75899998|FG000|Overall Study|Lost to Follow-up|1|||
42089633|NCT00771758|75899999|FG001|Overall Study|Lost to Follow-up|0|||
42089634|NCT00771758|75900000|FG002|Overall Study|Lost to Follow-up|0|||
42181933|NCT00679783|75989347|FG004|Overall Study|Adverse Event|0|||
42089635|NCT00771758|75899998|FG000|Overall Study|Protocol Violation|1|||
42089636|NCT00771758|75899999|FG001|Overall Study|Protocol Violation|0|||
42089637|NCT00771758|75900000|FG002|Overall Study|Protocol Violation|0|||
42089638|NCT00771758|75899998|FG000|Overall Study|Withdrawal by Subject|1|||
42089639|NCT00771758|75899999|FG001|Overall Study|Withdrawal by Subject|0|||
42089640|NCT00771758|75900000|FG002|Overall Study|Withdrawal by Subject|0|||
42089641|NCT00771758|75899998|FG000|Overall Study|Other|3|||
42089642|NCT00771758|75899999|FG001|Overall Study|Other|2|||
42089643|NCT00771758|75900000|FG002|Overall Study|Other|0|||
42089644|NCT00758498|75900028|FG000|Overall Study|Adverse Event|2|||
42089645|NCT00758498|75900029|FG001|Overall Study|Adverse Event|2|||
42089646|NCT00758498|75900030|FG002|Overall Study|Adverse Event|3|||
42089647|NCT00758498|75900028|FG000|Overall Study|Subject legally detained out of state|1|||
42089648|NCT00758498|75900029|FG001|Overall Study|Subject legally detained out of state|0|||
42089649|NCT00758498|75900030|FG002|Overall Study|Subject legally detained out of state|0|||
42089650|NCT00758498|75900028|FG000|Overall Study|Withdrawal by Subject|0|||
42089651|NCT00758498|75900029|FG001|Overall Study|Withdrawal by Subject|0|||
42089652|NCT00758498|75900030|FG002|Overall Study|Withdrawal by Subject|1|||
42089653|NCT00758498|75900028|FG000|Overall Study|Noncompliance to study procedures|0|||
42089654|NCT00758498|75900029|FG001|Overall Study|Noncompliance to study procedures|0|||
42089655|NCT00758498|75900030|FG002|Overall Study|Noncompliance to study procedures|1|||
42089656|NCT00798161|75900045|FG000|Overall Study|Adverse Event|3|||
42089657|NCT00798161|75900046|FG001|Overall Study|Adverse Event|4|||
42089658|NCT00798161|75900047|FG002|Overall Study|Adverse Event|6|||
42089659|NCT00798161|75900048|FG003|Overall Study|Adverse Event|6|||
42089660|NCT00798161|75900049|FG004|Overall Study|Adverse Event|5|||
42089661|NCT00798161|75900050|FG005|Overall Study|Adverse Event|2|||
42089662|NCT00798161|75900051|FG006|Overall Study|Adverse Event|4|||
42089663|NCT00798161|75900045|FG000|Overall Study|Protocol Violation|2|||
42089664|NCT00798161|75900046|FG001|Overall Study|Protocol Violation|1|||
42089665|NCT00798161|75900047|FG002|Overall Study|Protocol Violation|3|||
42089666|NCT00798161|75900048|FG003|Overall Study|Protocol Violation|3|||
42089667|NCT00798161|75900049|FG004|Overall Study|Protocol Violation|3|||
42089668|NCT00798161|75900050|FG005|Overall Study|Protocol Violation|2|||
42089669|NCT00798161|75900051|FG006|Overall Study|Protocol Violation|0|||
42089670|NCT00798161|75900045|FG000|Overall Study|Lost to Follow-up|1|||
42089671|NCT00798161|75900046|FG001|Overall Study|Lost to Follow-up|3|||
42089672|NCT00798161|75900047|FG002|Overall Study|Lost to Follow-up|4|||
42089673|NCT00798161|75900048|FG003|Overall Study|Lost to Follow-up|3|||
42089674|NCT00798161|75900049|FG004|Overall Study|Lost to Follow-up|4|||
42089675|NCT00798161|75900050|FG005|Overall Study|Lost to Follow-up|0|||
42089676|NCT00798161|75900051|FG006|Overall Study|Lost to Follow-up|0|||
42089677|NCT00798161|75900045|FG000|Overall Study|Withdrawal by Subject|5|||
42089678|NCT00798161|75900046|FG001|Overall Study|Withdrawal by Subject|4|||
42089679|NCT00798161|75900047|FG002|Overall Study|Withdrawal by Subject|5|||
42089680|NCT00798161|75900048|FG003|Overall Study|Withdrawal by Subject|4|||
42089681|NCT00798161|75900049|FG004|Overall Study|Withdrawal by Subject|2|||
42089682|NCT00798161|75900050|FG005|Overall Study|Withdrawal by Subject|3|||
42089683|NCT00798161|75900051|FG006|Overall Study|Withdrawal by Subject|1|||
42089684|NCT00798161|75900045|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
42089685|NCT00798161|75900046|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
42181934|NCT00679783|75989348|FG005|Overall Study|Adverse Event|0|||
42181935|NCT00679783|75989349|FG006|Overall Study|Adverse Event|1|||
42181936|NCT00679783|75989343|FG000|Overall Study|Lack of Efficacy|0|||
42181937|NCT00679783|75989344|FG001|Overall Study|Lack of Efficacy|1|||
42181938|NCT00679783|75989345|FG002|Overall Study|Lack of Efficacy|0|||
42181939|NCT00679783|75989346|FG003|Overall Study|Lack of Efficacy|2|||
42181940|NCT00679783|75989347|FG004|Overall Study|Lack of Efficacy|0|||
42181941|NCT00679783|75989348|FG005|Overall Study|Lack of Efficacy|0|||
42181942|NCT00679783|75989349|FG006|Overall Study|Lack of Efficacy|0|||
42181943|NCT00679783|75989343|FG000|Overall Study|Withdrawal by Subject|0|||
42181944|NCT00679783|75989344|FG001|Overall Study|Withdrawal by Subject|0|||
42181945|NCT00679783|75989345|FG002|Overall Study|Withdrawal by Subject|1|||
42181946|NCT00679783|75989346|FG003|Overall Study|Withdrawal by Subject|1|||
42089686|NCT00798161|75900047|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
42089687|NCT00798161|75900048|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
42089688|NCT00798161|75900049|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
42089689|NCT00798161|75900050|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
42089690|NCT00798161|75900051|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
42089691|NCT00588341|75900067|FG000|Overall Study|Withdrawal by Subject|3|||
42089692|NCT00588341|75900067|FG000|Overall Study|Not treated due to metastatic disease|1|||
42089693|NCT00588341|75900067|FG000|Overall Study|Patient ineligible|1|||
42089694|NCT00802529|75900073|FG000|Overall Study|Lost to Follow-up|0|||
42089695|NCT00802529|75900074|FG001|Overall Study|Lost to Follow-up|1|||
42181947|NCT00679783|75989347|FG004|Overall Study|Withdrawal by Subject|0|||
42181948|NCT00679783|75989348|FG005|Overall Study|Withdrawal by Subject|0|||
42181949|NCT00679783|75989349|FG006|Overall Study|Withdrawal by Subject|0|||
42181950|NCT00679783|75989343|FG000|Overall Study|Not Captured|0|||
42181951|NCT00679783|75989344|FG001|Overall Study|Not Captured|0|||
42181952|NCT00679783|75989345|FG002|Overall Study|Not Captured|0|||
42181953|NCT00679783|75989346|FG003|Overall Study|Not Captured|5|||
42181954|NCT00679783|75989347|FG004|Overall Study|Not Captured|0|||
42181955|NCT00679783|75989348|FG005|Overall Study|Not Captured|0|||
42181956|NCT00679783|75989349|FG006|Overall Study|Not Captured|0|||
42181957|NCT00679783|75989343|FG000|Overall Study|Ongoing at data cut-off|2|||
42181958|NCT00679783|75989344|FG001|Overall Study|Ongoing at data cut-off|2|||
42181959|NCT00679783|75989345|FG002|Overall Study|Ongoing at data cut-off|0|||
42181960|NCT00679783|75989346|FG003|Overall Study|Ongoing at data cut-off|9|||
42181961|NCT00679783|75989347|FG004|Overall Study|Ongoing at data cut-off|1|||
42181962|NCT00679783|75989348|FG005|Overall Study|Ongoing at data cut-off|0|||
42181963|NCT00679783|75989349|FG006|Overall Study|Ongoing at data cut-off|0|||
42181964|NCT03896490|75989371|FG000|Overall Study|Withdrawal by Subject|1|||
42181965|NCT03896490|75989372|FG001|Overall Study|Withdrawal by Subject|1|||
42181966|NCT03617172|75989380|FG000|Overall Study|Lost to Follow-up|1|||
42181967|NCT03617172|75989381|FG001|Overall Study|Lost to Follow-up|0|||
42181968|NCT03760146|75989393|FG000|Overall Study|Adverse Event|11|||
42089696|NCT00758264|75900083|FG000|Active Phase|Withdrawal by Subject|0|||
42089697|NCT00758264|75900084|FG001|Active Phase|Withdrawal by Subject|0|||
42089698|NCT00758264|75900085|FG002|Active Phase|Withdrawal by Subject|1|||
42089699|NCT00758264|75900083|FG000|Active Phase|Lost to Follow-up|1|||
42089700|NCT00758264|75900084|FG001|Active Phase|Lost to Follow-up|0|||
42089701|NCT00758264|75900085|FG002|Active Phase|Lost to Follow-up|0|||
42089702|NCT00758264|75900083|FG000|Active Phase|Other|0|||
42181969|NCT03760146|75989394|FG001|Overall Study|Adverse Event|8|||
42181970|NCT03760146|75989395|FG002|Overall Study|Adverse Event|0|||
42181971|NCT03760146|75989396|FG003|Overall Study|Adverse Event|0|||
42181972|NCT03760146|75989397|FG004|Overall Study|Adverse Event|0|||
42181973|NCT03760146|75989398|FG005|Overall Study|Adverse Event|0|||
42089703|NCT00758264|75900084|FG001|Active Phase|Other|0|||
42089704|NCT00758264|75900085|FG002|Active Phase|Other|4|||
42089705|NCT00588731|75900095|FG000|Overall Study|Withdrawal by Subject|3|||
42089706|NCT00588731|75900096|FG001|Overall Study|Withdrawal by Subject|2|||
42089707|NCT00757172|75900102|FG000|Overall Study|Withdrawal by Subject|4|||
42089708|NCT00757172|75900102|FG000|Overall Study|Physician Decision|3|||
42089709|NCT00757172|75900102|FG000|Overall Study|Progression|4|||
42089710|NCT00797225|75900110|FG000|Weeks 1 to 12|Adverse Event|0|||
42089711|NCT00797225|75900111|FG001|Weeks 1 to 12|Adverse Event|0|||
42089712|NCT00797225|75900112|FG002|Weeks 1 to 12|Adverse Event|1|||
42181974|NCT03760146|75989393|FG000|Overall Study|Death|1|||
42181975|NCT03760146|75989394|FG001|Overall Study|Death|0|||
42181976|NCT03760146|75989395|FG002|Overall Study|Death|0|||
42181977|NCT03760146|75989396|FG003|Overall Study|Death|0|||
42181978|NCT03760146|75989397|FG004|Overall Study|Death|0|||
42181979|NCT03760146|75989398|FG005|Overall Study|Death|0|||
42181980|NCT03760146|75989393|FG000|Overall Study|Lost to Follow-up|41|||
42181981|NCT03760146|75989394|FG001|Overall Study|Lost to Follow-up|28|||
42181982|NCT03760146|75989395|FG002|Overall Study|Lost to Follow-up|9|||
42181983|NCT03760146|75989396|FG003|Overall Study|Lost to Follow-up|2|||
42181984|NCT03760146|75989397|FG004|Overall Study|Lost to Follow-up|14|||
42181985|NCT03760146|75989398|FG005|Overall Study|Lost to Follow-up|8|||
42181986|NCT03760146|75989393|FG000|Overall Study|No longer met eligibility criteria|3|||
42181987|NCT03760146|75989394|FG001|Overall Study|No longer met eligibility criteria|9|||
42181988|NCT03760146|75989395|FG002|Overall Study|No longer met eligibility criteria|0|||
42181989|NCT03760146|75989396|FG003|Overall Study|No longer met eligibility criteria|0|||
42181990|NCT03760146|75989397|FG004|Overall Study|No longer met eligibility criteria|1|||
42089713|NCT00797225|75900113|FG003|Weeks 1 to 12|Adverse Event|0|||
42089714|NCT00797225|75900114|FG004|Weeks 1 to 12|Adverse Event|0|||
42089715|NCT00797225|75900115|FG005|Weeks 1 to 12|Adverse Event|0|||
42089716|NCT00797225|75900116|FG006|Weeks 1 to 12|Adverse Event|0|||
42089717|NCT00797225|75900117|FG007|Weeks 1 to 12|Adverse Event|0|||
42089718|NCT00797225|75900110|FG000|Weeks 1 to 12|Non-compliance|0|||
42181991|NCT03760146|75989398|FG005|Overall Study|No longer met eligibility criteria|0|||
42181992|NCT03760146|75989393|FG000|Overall Study|Protocol Violation|21|||
42181993|NCT03760146|75989394|FG001|Overall Study|Protocol Violation|13|||
42181994|NCT03760146|75989395|FG002|Overall Study|Protocol Violation|1|||
42181995|NCT03760146|75989396|FG003|Overall Study|Protocol Violation|0|||
42181996|NCT03760146|75989397|FG004|Overall Study|Protocol Violation|1|||
42089719|NCT00797225|75900111|FG001|Weeks 1 to 12|Non-compliance|1|||
42089720|NCT00797225|75900112|FG002|Weeks 1 to 12|Non-compliance|0|||
42181997|NCT03760146|75989398|FG005|Overall Study|Protocol Violation|0|||
42181998|NCT03760146|75989393|FG000|Overall Study|Withdrawal by Subject|19|||
42181999|NCT03760146|75989394|FG001|Overall Study|Withdrawal by Subject|20|||
42182000|NCT03760146|75989395|FG002|Overall Study|Withdrawal by Subject|1|||
42089721|NCT00797225|75900113|FG003|Weeks 1 to 12|Non-compliance|0|||
42089722|NCT00797225|75900114|FG004|Weeks 1 to 12|Non-compliance|0|||
42089723|NCT00797225|75900115|FG005|Weeks 1 to 12|Non-compliance|0|||
42182001|NCT03760146|75989396|FG003|Overall Study|Withdrawal by Subject|0|||
42089724|NCT00797225|75900116|FG006|Weeks 1 to 12|Non-compliance|0|||
42089725|NCT00797225|75900117|FG007|Weeks 1 to 12|Non-compliance|0|||
42089726|NCT00797225|75900110|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
42089727|NCT00797225|75900111|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
42089728|NCT00797225|75900112|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
42089729|NCT00797225|75900113|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
42182002|NCT03760146|75989397|FG004|Overall Study|Withdrawal by Subject|1|||
42182003|NCT03760146|75989398|FG005|Overall Study|Withdrawal by Subject|0|||
42182004|NCT03877068|75989418|FG000|Overall Study|Physician Decision|9|||
42182005|NCT03877068|75989419|FG001|Overall Study|Physician Decision|3|||
42182006|NCT03760068|75989429|FG000|Overall Study|Withdrawal by Subject|7|||
42182007|NCT03760068|75989430|FG001|Overall Study|Withdrawal by Subject|8|||
42182008|NCT03760068|75989429|FG000|Overall Study|Adverse Event|1|||
42182009|NCT03760068|75989430|FG001|Overall Study|Adverse Event|2|||
42182010|NCT03760068|75989429|FG000|Overall Study|Administrative Decision by Sponsor|0|||
42182011|NCT03760068|75989430|FG001|Overall Study|Administrative Decision by Sponsor|2|||
42182012|NCT03760068|75989429|FG000|Overall Study|Physician Decision|1|||
42182013|NCT03760068|75989430|FG001|Overall Study|Physician Decision|2|||
42182014|NCT03760068|75989429|FG000|Overall Study|Lost to Follow-up|4|||
42182015|NCT03760068|75989430|FG001|Overall Study|Lost to Follow-up|9|||
42182016|NCT03760068|75989429|FG000|Overall Study|Subject Moved Out of State|1|||
42182017|NCT03760068|75989430|FG001|Overall Study|Subject Moved Out of State|0|||
42182018|NCT03759600|75989437|FG000|Overall Study|Adverse Event|2|||
42182019|NCT03759600|75989437|FG000|Overall Study|Progressive Disease|15|||
42182020|NCT03759600|75989437|FG000|Overall Study|Site Terminated by Sponsor|3|||
42182021|NCT04724733|75989444|FG000|Overall Study|Lost to Follow-up|1|||
42182022|NCT04724733|75989445|FG001|Overall Study|Lost to Follow-up|1|||
42182023|NCT04724733|75989446|FG002|Overall Study|Lost to Follow-up|1|||
42182024|NCT04635839|75989456|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
42182025|NCT04635839|75989457|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
42182026|NCT04493502|75989465|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
42182027|NCT04493502|75989466|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
42182028|NCT04493502|75989465|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
42182029|NCT04493502|75989466|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
42182030|NCT04493502|75989465|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
42182031|NCT04493502|75989466|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
42182032|NCT04493502|75989465|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
42089730|NCT00797225|75900114|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
42089731|NCT00797225|75900115|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
42089732|NCT00797225|75900116|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
42089733|NCT00797225|75900117|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
42089734|NCT00797225|75900110|FG000|Weeks 1 to 12|Sponsor Decision|1|||
42089735|NCT00797225|75900111|FG001|Weeks 1 to 12|Sponsor Decision|0|||
42089736|NCT00797225|75900112|FG002|Weeks 1 to 12|Sponsor Decision|0|||
42089737|NCT00797225|75900113|FG003|Weeks 1 to 12|Sponsor Decision|0|||
42089738|NCT00797225|75900114|FG004|Weeks 1 to 12|Sponsor Decision|0|||
42089739|NCT00797225|75900115|FG005|Weeks 1 to 12|Sponsor Decision|0|||
42182033|NCT04493502|75989466|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
42182034|NCT04493502|75989465|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
42182035|NCT04493502|75989466|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
42182036|NCT04493502|75989465|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
42182037|NCT04493502|75989466|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
42182038|NCT04493502|75989465|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
42182039|NCT04493502|75989466|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
42089740|NCT00797225|75900116|FG006|Weeks 1 to 12|Sponsor Decision|0|||
42089741|NCT00797225|75900117|FG007|Weeks 1 to 12|Sponsor Decision|0|||
42089742|NCT00797225|75900110|FG000|Weeks 13 to 24|Non-compliance|0|||
42089743|NCT00797225|75900111|FG001|Weeks 13 to 24|Non-compliance|2|||
42089744|NCT00797225|75900112|FG002|Weeks 13 to 24|Non-compliance|0|||
42182040|NCT04493502|75989465|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
42182041|NCT04493502|75989466|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
42182042|NCT04493502|75989465|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
42182043|NCT04493502|75989466|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
42182044|NCT04493502|75989465|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
42182045|NCT04493502|75989466|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
42089745|NCT00797225|75900113|FG003|Weeks 13 to 24|Non-compliance|0|||
42089746|NCT00797225|75900114|FG004|Weeks 13 to 24|Non-compliance|0|||
42182046|NCT04493502|75989465|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
42182047|NCT04493502|75989466|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
42182048|NCT04493502|75989465|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
42182049|NCT04493502|75989466|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
42182050|NCT04493502|75989465|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
42182051|NCT04493502|75989466|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
42182052|NCT04147858|75989477|FG000|Overall Study|Adverse Event|6|||
42182053|NCT04147858|75989478|FG001|Overall Study|Adverse Event|6|||
42182054|NCT04147858|75989479|FG002|Overall Study|Adverse Event|6|||
42182055|NCT04147858|75989477|FG000|Overall Study|Lack of Efficacy|3|||
42182056|NCT04147858|75989478|FG001|Overall Study|Lack of Efficacy|3|||
42182057|NCT04147858|75989479|FG002|Overall Study|Lack of Efficacy|1|||
42182058|NCT04147858|75989477|FG000|Overall Study|Lost to Follow-up|1|||
42182059|NCT04147858|75989478|FG001|Overall Study|Lost to Follow-up|6|||
42182060|NCT04147858|75989479|FG002|Overall Study|Lost to Follow-up|2|||
42182061|NCT04147858|75989477|FG000|Overall Study|Withdrawal by Subject|3|||
42182062|NCT04147858|75989478|FG001|Overall Study|Withdrawal by Subject|4|||
42182063|NCT04147858|75989479|FG002|Overall Study|Withdrawal by Subject|10|||
42182064|NCT04147858|75989477|FG000|Overall Study|Subject Noncompliance, Other|4|||
42182065|NCT04147858|75989478|FG001|Overall Study|Subject Noncompliance, Other|3|||
42182066|NCT04147858|75989479|FG002|Overall Study|Subject Noncompliance, Other|1|||
42182067|NCT04146896|75989489|FG000|Overall Study|Adverse Event|5|||
42182068|NCT04146896|75989490|FG001|Overall Study|Adverse Event|8|||
42182069|NCT04146896|75989489|FG000|Overall Study|Lack of Efficacy|3|||
42182070|NCT04146896|75989490|FG001|Overall Study|Lack of Efficacy|2|||
42182071|NCT04146896|75989489|FG000|Overall Study|Lost to Follow-up|0|||
42182072|NCT04146896|75989490|FG001|Overall Study|Lost to Follow-up|1|||
42182073|NCT04146896|75989489|FG000|Overall Study|Non-compliance|5|||
42089747|NCT00797225|75900115|FG005|Weeks 13 to 24|Non-compliance|0|||
42089748|NCT00797225|75900116|FG006|Weeks 13 to 24|Non-compliance|0|||
42089749|NCT00797225|75900117|FG007|Weeks 13 to 24|Non-compliance|0|||
42089750|NCT00797225|75900110|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
42089751|NCT00797225|75900111|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
42089752|NCT00797225|75900112|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
42089753|NCT00797225|75900113|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
42089754|NCT00797225|75900114|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
42089755|NCT00797225|75900115|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
42089756|NCT00797225|75900116|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
42089757|NCT00797225|75900117|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
42089758|NCT00797225|75900110|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
42089759|NCT00797225|75900111|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
42089760|NCT00797225|75900112|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
42089761|NCT00797225|75900113|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
42089762|NCT00797225|75900114|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
42089763|NCT00797225|75900115|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
42089764|NCT00797225|75900116|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
42089765|NCT00797225|75900117|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
42089766|NCT00797225|75900110|FG000|Weeks 13 to 24|Adverse Event|0|||
42089767|NCT00797225|75900111|FG001|Weeks 13 to 24|Adverse Event|1|||
42089768|NCT00797225|75900112|FG002|Weeks 13 to 24|Adverse Event|0|||
42089769|NCT00797225|75900113|FG003|Weeks 13 to 24|Adverse Event|0|||
42182074|NCT04146896|75989490|FG001|Overall Study|Non-compliance|4|||
42182075|NCT04146896|75989489|FG000|Overall Study|Withdrawal by Subject|3|||
42182076|NCT04146896|75989490|FG001|Overall Study|Withdrawal by Subject|5|||
42182077|NCT04146896|75989489|FG000|Overall Study|Randomized in error|1|||
42182078|NCT04146896|75989490|FG001|Overall Study|Randomized in error|2|||
42089770|NCT00797225|75900114|FG004|Weeks 13 to 24|Adverse Event|0|||
42182079|NCT04072887|75989502|FG000|Overall Study|Withdrawal by Subject|3|||
42294598|NCT02633527|76129029|FG003|Overall Study|Adverse Event|1|||
42089771|NCT00797225|75900115|FG005|Weeks 13 to 24|Adverse Event|0|||
42089772|NCT00797225|75900116|FG006|Weeks 13 to 24|Adverse Event|1|||
42089773|NCT00797225|75900117|FG007|Weeks 13 to 24|Adverse Event|0|||
42089774|NCT00797225|75900110|FG000|Weeks 13 to 24|Sponsor Decision|0|||
42089775|NCT00797225|75900111|FG001|Weeks 13 to 24|Sponsor Decision|0|||
42089776|NCT00797225|75900112|FG002|Weeks 13 to 24|Sponsor Decision|0|||
42089777|NCT00797225|75900113|FG003|Weeks 13 to 24|Sponsor Decision|0|||
42089778|NCT00797225|75900114|FG004|Weeks 13 to 24|Sponsor Decision|0|||
42182080|NCT04072887|75989503|FG001|Overall Study|Withdrawal by Subject|8|||
42182081|NCT04072887|75989504|FG002|Overall Study|Withdrawal by Subject|1|||
42089779|NCT00797225|75900115|FG005|Weeks 13 to 24|Sponsor Decision|0|||
42089780|NCT00797225|75900116|FG006|Weeks 13 to 24|Sponsor Decision|1|||
42089781|NCT00797225|75900117|FG007|Weeks 13 to 24|Sponsor Decision|0|||
42089782|NCT00778700|75900137|FG000|Overall Study|Adverse Event|6|||
42089783|NCT00778700|75900138|FG001|Overall Study|Adverse Event|1|||
42089784|NCT00778700|75900139|FG002|Overall Study|Adverse Event|3|||
42089785|NCT00778700|75900140|FG003|Overall Study|Adverse Event|5|||
42089786|NCT00778700|75900137|FG000|Overall Study|Protocol Violation|1|||
42089787|NCT00778700|75900138|FG001|Overall Study|Protocol Violation|1|||
42089788|NCT00778700|75900139|FG002|Overall Study|Protocol Violation|0|||
42089789|NCT00778700|75900140|FG003|Overall Study|Protocol Violation|0|||
42089790|NCT00778700|75900137|FG000|Overall Study|Subject Withdrew Consent|6|||
42089791|NCT00778700|75900138|FG001|Overall Study|Subject Withdrew Consent|4|||
42089792|NCT00778700|75900139|FG002|Overall Study|Subject Withdrew Consent|1|||
42089793|NCT00778700|75900140|FG003|Overall Study|Subject Withdrew Consent|4|||
42089794|NCT00778700|75900137|FG000|Overall Study|Lost to Follow-up|3|||
42089795|NCT00778700|75900138|FG001|Overall Study|Lost to Follow-up|1|||
42089796|NCT00778700|75900139|FG002|Overall Study|Lost to Follow-up|0|||
42182082|NCT04072887|75989505|FG003|Overall Study|Withdrawal by Subject|3|||
42182083|NCT04072887|75989506|FG004|Overall Study|Withdrawal by Subject|3|||
42182084|NCT04072887|75989507|FG005|Overall Study|Withdrawal by Subject|13|||
42182085|NCT04072887|75989502|FG000|Overall Study|Adverse Event|2|||
42182086|NCT04072887|75989503|FG001|Overall Study|Adverse Event|4|||
42182087|NCT04072887|75989504|FG002|Overall Study|Adverse Event|1|||
42182088|NCT04072887|75989505|FG003|Overall Study|Adverse Event|4|||
42182089|NCT04072887|75989506|FG004|Overall Study|Adverse Event|0|||
42182090|NCT04072887|75989507|FG005|Overall Study|Adverse Event|1|||
42182091|NCT04072887|75989502|FG000|Overall Study|Physician Decision|2|||
42182092|NCT04072887|75989503|FG001|Overall Study|Physician Decision|0|||
42182093|NCT04072887|75989504|FG002|Overall Study|Physician Decision|0|||
42182094|NCT04072887|75989505|FG003|Overall Study|Physician Decision|0|||
42182095|NCT04072887|75989506|FG004|Overall Study|Physician Decision|0|||
42182096|NCT04072887|75989507|FG005|Overall Study|Physician Decision|1|||
42182097|NCT04072887|75989502|FG000|Overall Study|Lost to Follow-up|1|||
42182098|NCT04072887|75989503|FG001|Overall Study|Lost to Follow-up|3|||
42182099|NCT04072887|75989504|FG002|Overall Study|Lost to Follow-up|0|||
42182100|NCT04072887|75989505|FG003|Overall Study|Lost to Follow-up|0|||
42182101|NCT04072887|75989506|FG004|Overall Study|Lost to Follow-up|0|||
42182102|NCT04072887|75989507|FG005|Overall Study|Lost to Follow-up|0|||
42182103|NCT04072887|75989502|FG000|Overall Study|Death|0|||
42182104|NCT04072887|75989503|FG001|Overall Study|Death|2|||
42182105|NCT04072887|75989504|FG002|Overall Study|Death|0|||
42182106|NCT04072887|75989505|FG003|Overall Study|Death|2|||
42182107|NCT04072887|75989506|FG004|Overall Study|Death|3|||
42182108|NCT04072887|75989507|FG005|Overall Study|Death|0|||
42182109|NCT03516812|75989600|FG000|Overall Study|Adverse Event|4|||
42182110|NCT03516812|75989600|FG000|Overall Study|Lack of Efficacy|2|||
42182111|NCT03440047|75989604|FG000|Overall Study|Withdrawal by Subject|2|||
42182112|NCT03122119|75989635|FG000|Overall Study|Did not meet eligibility critria|1|||
42182113|NCT02613169|75989641|FG000|Overall Study|Withdrawal by Subject|4|||
42182114|NCT02613169|75989642|FG001|Overall Study|Withdrawal by Subject|1|||
42182115|NCT02613169|75989641|FG000|Overall Study|Lost to Follow-up|0|||
42182116|NCT02613169|75989642|FG001|Overall Study|Lost to Follow-up|5|||
42182117|NCT02613169|75989641|FG000|Overall Study|HIV|0|||
42182118|NCT02613169|75989642|FG001|Overall Study|HIV|2|||
42182119|NCT02613169|75989641|FG000|Overall Study|No TB infection endpoint|14|||
42182120|NCT02613169|75989642|FG001|Overall Study|No TB infection endpoint|9|||
42182121|NCT01974765|75989648|FG000|Overall Study|Withdrawal by Subject|1|||
42182122|NCT01974765|75989648|FG000|Overall Study|Death|1|||
42182123|NCT01974765|75989648|FG000|Overall Study|Adverse Event|2|||
42182124|NCT01725217|75989655|FG000|Overall Study|Withdrawal by Subject|1|||
42182125|NCT01725217|75989656|FG001|Overall Study|Withdrawal by Subject|0|||
42089797|NCT00778700|75900140|FG003|Overall Study|Lost to Follow-up|1|||
42182126|NCT01725217|75989657|FG002|Overall Study|Withdrawal by Subject|0|||
42182127|NCT01344057|75989683|FG000|Overall Study|Premature Withdrawal|1|||
42182128|NCT00886782|75989690|FG000|Overall Study|Disease progression|3|||
42182129|NCT00886782|75989691|FG001|Overall Study|Disease progression|3|||
42089798|NCT00778700|75900137|FG000|Overall Study|Reason not Specified|2|||
42089799|NCT00778700|75900138|FG001|Overall Study|Reason not Specified|0|||
42089800|NCT00778700|75900139|FG002|Overall Study|Reason not Specified|1|||
42182130|NCT00886782|75989692|FG002|Overall Study|Disease progression|3|||
42182131|NCT00886782|75989690|FG000|Overall Study|Study drug toxicity|0|||
42182132|NCT00886782|75989691|FG001|Overall Study|Study drug toxicity|0|||
42182133|NCT00886782|75989692|FG002|Overall Study|Study drug toxicity|1|||
42182134|NCT00886782|75989690|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
42182135|NCT00886782|75989691|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
42182136|NCT00886782|75989692|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
42089801|NCT00778700|75900140|FG003|Overall Study|Reason not Specified|3|||
42182137|NCT00583024|75989700|FG000|Overall Study|Lost to Follow-up|4|||
42294599|NCT02633527|76129030|FG004|Overall Study|Adverse Event|5|||
42182138|NCT03435640|75989715|FG000|Overall Study|Withdrawal by Subject|0|||
42182139|NCT03435640|75989716|FG001|Overall Study|Withdrawal by Subject|1|||
42182140|NCT03435640|75989717|FG002|Overall Study|Withdrawal by Subject|0|||
42358694|NCT03745651|76204508|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
42358695|NCT03745651|76204509|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42358696|NCT03745651|76204510|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42358697|NCT03745651|76204511|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42358698|NCT03745651|76204512|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42358699|NCT03745651|76204506|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
42089802|NCT00778700|75900137|FG000|Overall Study|Other|0|||
42089803|NCT00778700|75900138|FG001|Overall Study|Other|0|||
42182141|NCT03435640|75989718|FG003|Overall Study|Withdrawal by Subject|2|||
42182142|NCT03435640|75989719|FG004|Overall Study|Withdrawal by Subject|0|||
42089804|NCT00778700|75900139|FG002|Overall Study|Other|1|||
42089805|NCT00778700|75900140|FG003|Overall Study|Other|0|||
42089806|NCT00793403|75900154|FG000|Overall Study|Other|73|||
42089807|NCT00793325|75900158|FG000|Overall Study|Protocol Violation|18|||
42089808|NCT00793325|75900158|FG000|Overall Study|Lost to Follow-up|1|||
42089809|NCT00778622|75900184|FG000|Overall Study|Adverse Event|5|||
42089810|NCT00778622|75900185|FG001|Overall Study|Adverse Event|4|||
42089811|NCT00778622|75900186|FG002|Overall Study|Adverse Event|7|||
42089812|NCT00778622|75900184|FG000|Overall Study|Withdrawal by Subject|4|||
42089813|NCT00778622|75900185|FG001|Overall Study|Withdrawal by Subject|5|||
42089814|NCT00778622|75900186|FG002|Overall Study|Withdrawal by Subject|5|||
42089815|NCT00778622|75900184|FG000|Overall Study|Lost to Follow-up|3|||
42089816|NCT00778622|75900185|FG001|Overall Study|Lost to Follow-up|3|||
42089817|NCT00778622|75900186|FG002|Overall Study|Lost to Follow-up|2|||
42089818|NCT00778622|75900184|FG000|Overall Study|Protocol Violation|0|||
42089819|NCT00778622|75900185|FG001|Overall Study|Protocol Violation|3|||
42089820|NCT00778622|75900186|FG002|Overall Study|Protocol Violation|0|||
42089821|NCT00778622|75900184|FG000|Overall Study|Lack of Efficacy|2|||
42089822|NCT00778622|75900185|FG001|Overall Study|Lack of Efficacy|0|||
42089823|NCT00778622|75900186|FG002|Overall Study|Lack of Efficacy|0|||
42089824|NCT00778622|75900184|FG000|Overall Study|immigration|1|||
42089825|NCT00778622|75900185|FG001|Overall Study|immigration|0|||
42089826|NCT00778622|75900186|FG002|Overall Study|immigration|0|||
42089827|NCT00778622|75900184|FG000|Overall Study|Other|1|||
42089828|NCT00778622|75900185|FG001|Overall Study|Other|0|||
42089829|NCT00778622|75900186|FG002|Overall Study|Other|1|||
42089830|NCT00777920|75900198|FG000|Overall Study|Adverse Event|39|||
42089831|NCT00777920|75900198|FG000|Overall Study|Withdrawal of Consent|4|||
42089832|NCT00777920|75900198|FG000|Overall Study|Lost to Follow-up|1|||
42089833|NCT00777920|75900198|FG000|Overall Study|Investigator's discretion|1|||
42089834|NCT00777920|75900198|FG000|Overall Study|Clinical status did not improve|1|||
42089835|NCT00777920|75900198|FG000|Overall Study|Other, not specified|4|||
42089836|NCT04236141|75900204|FG000|Overall Study|Death|18|||
42089837|NCT04236141|75900205|FG001|Overall Study|Death|10|||
42089838|NCT04236141|75900204|FG000|Overall Study|Withdrawal by Participant|1|||
42089839|NCT04236141|75900205|FG001|Overall Study|Withdrawal by Participant|0|||
42089840|NCT04236141|75900204|FG000|Overall Study|Reason not Specified|1|||
42089841|NCT04236141|75900205|FG001|Overall Study|Reason not Specified|0|||
42089842|NCT04236141|75900204|FG000|Overall Study|Study terminated by Sponsor|8|||
42089843|NCT04236141|75900205|FG001|Overall Study|Study terminated by Sponsor|4|||
42089844|NCT00796445|75900213|FG000|Overall Study|Protocol Violation|5|||
42089845|NCT00796445|75900214|FG001|Overall Study|Protocol Violation|3|||
42089846|NCT00796445|75900213|FG000|Overall Study|Adverse event, serious fatal|10|||
42182143|NCT03435640|75989720|FG005|Overall Study|Withdrawal by Subject|0|||
42182144|NCT03435640|75989721|FG006|Overall Study|Withdrawal by Subject|3|||
42182145|NCT03435640|75989722|FG007|Overall Study|Withdrawal by Subject|0|||
42182146|NCT03435640|75989723|FG008|Overall Study|Withdrawal by Subject|0|||
42182147|NCT03435640|75989724|FG009|Overall Study|Withdrawal by Subject|2|||
42089847|NCT00796445|75900214|FG001|Overall Study|Adverse event, serious fatal|5|||
42089848|NCT00796445|75900213|FG000|Overall Study|Adverse event, non-fatal|4|||
42089849|NCT00796445|75900214|FG001|Overall Study|Adverse event, non-fatal|0|||
42089850|NCT00796445|75900213|FG000|Overall Study|Disease progression/recurrence|537|||
42089851|NCT00796445|75900214|FG001|Overall Study|Disease progression/recurrence|268|||
42089852|NCT00796445|75900213|FG000|Overall Study|Other|10|||
42089853|NCT00796445|75900214|FG001|Overall Study|Other|7|||
42089854|NCT00796445|75900213|FG000|Overall Study|Withdrawal by Subject|18|||
42089855|NCT00796445|75900214|FG001|Overall Study|Withdrawal by Subject|9|||
42089856|NCT00796445|75900213|FG000|Overall Study|Invalid Informed Consent Form|1|||
42089857|NCT00796445|75900214|FG001|Overall Study|Invalid Informed Consent Form|0|||
42089858|NCT03939819|75900230|FG000|Overall Study|Death|2|||
42182148|NCT03435640|75989725|FG010|Overall Study|Withdrawal by Subject|3|||
42182149|NCT03435640|75989715|FG000|Overall Study|Lost to Follow-up|0|||
42182150|NCT03435640|75989716|FG001|Overall Study|Lost to Follow-up|0|||
42182151|NCT03435640|75989717|FG002|Overall Study|Lost to Follow-up|1|||
42182152|NCT03435640|75989718|FG003|Overall Study|Lost to Follow-up|0|||
42182153|NCT03435640|75989719|FG004|Overall Study|Lost to Follow-up|0|||
42182154|NCT03435640|75989720|FG005|Overall Study|Lost to Follow-up|0|||
42182155|NCT03435640|75989721|FG006|Overall Study|Lost to Follow-up|0|||
42182156|NCT03435640|75989722|FG007|Overall Study|Lost to Follow-up|0|||
42182157|NCT03435640|75989723|FG008|Overall Study|Lost to Follow-up|0|||
42182158|NCT03435640|75989724|FG009|Overall Study|Lost to Follow-up|0|||
42182159|NCT03435640|75989725|FG010|Overall Study|Lost to Follow-up|0|||
42182160|NCT00655876|75989753|FG000|Overall Study|Protocol Violation|9|||
42182161|NCT00655876|75989754|FG001|Overall Study|Protocol Violation|7|||
42182162|NCT03092752|75989760|FG000|Overall Study|Aged <40 years|14209|||
42182163|NCT03092752|75989760|FG000|Overall Study|At least one claim with T2DM|61299|||
42182164|NCT03092752|75989760|FG000|Overall Study|Having no claim of study drugs|29282|||
42182165|NCT03092752|75989760|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
42182166|NCT03092752|75989760|FG000|Overall Study|<6 month history|245900|||
42182167|NCT03750552|75989783|FG000|Overall Study|Adverse Event|5|||
42182168|NCT03750552|75989784|FG001|Overall Study|Adverse Event|1|||
42182169|NCT03750552|75989783|FG000|Overall Study|Withdrawal by Subject|1|||
42182170|NCT03750552|75989784|FG001|Overall Study|Withdrawal by Subject|1|||
42182171|NCT03750552|75989783|FG000|Overall Study|Other|2|||
42182172|NCT03750552|75989784|FG001|Overall Study|Other|0|||
42182173|NCT03750240|75989791|FG000|Overall Study|Technical Difficulties|2|||
42182174|NCT03091738|75989795|FG000|Overall Study|Adverse Event|1|||
42182175|NCT03091738|75989795|FG000|Overall Study|Lost to Follow-up|1|||
42182176|NCT03193216|75989801|FG000|Overall Study|Lost to Follow-up|1|||
42182177|NCT03193216|75989802|FG001|Overall Study|Lost to Follow-up|0|||
42182178|NCT03193216|75989801|FG000|Overall Study|Withdrawal by Subject|5|||
42182179|NCT03193216|75989802|FG001|Overall Study|Withdrawal by Subject|0|||
42182180|NCT03193216|75989801|FG000|Overall Study|Physician Decision|4|||
42182181|NCT03193216|75989802|FG001|Overall Study|Physician Decision|0|||
42182182|NCT03091348|75989810|FG000|Overall Study|Lost to Follow-up|2|||
42182183|NCT03091348|75989811|FG001|Overall Study|Lost to Follow-up|1|||
42182184|NCT03751098|75989818|FG000|Overall Study|Withdrawal by Subject|0|||
42182185|NCT03751098|75989819|FG001|Overall Study|Withdrawal by Subject|1|||
42182186|NCT03751020|75989830|FG000|Overall Study|Withdrawal by Subject|2|||
42182187|NCT03751020|75989831|FG001|Overall Study|Withdrawal by Subject|0|||
42182188|NCT03751020|75989832|FG002|Overall Study|Withdrawal by Subject|0|||
42182189|NCT03751020|75989830|FG000|Overall Study|Lost to Follow-up|7|||
42182190|NCT03751020|75989831|FG001|Overall Study|Lost to Follow-up|4|||
42182191|NCT03751020|75989832|FG002|Overall Study|Lost to Follow-up|10|||
42182192|NCT03090100|75989842|FG000|Overall Study|Adverse Event|9|||
42182193|NCT03090100|75989843|FG001|Overall Study|Adverse Event|11|||
42182194|NCT03090100|75989842|FG000|Overall Study|Pregnancy|1|||
42182195|NCT03090100|75989843|FG001|Overall Study|Pregnancy|1|||
42182196|NCT03090100|75989842|FG000|Overall Study|Lack of Efficacy|2|||
42182197|NCT03090100|75989843|FG001|Overall Study|Lack of Efficacy|7|||
42182198|NCT03090100|75989842|FG000|Overall Study|Lost to Follow-up|2|||
42182199|NCT03090100|75989843|FG001|Overall Study|Lost to Follow-up|2|||
42182200|NCT03090100|75989842|FG000|Overall Study|Withdrawal by Subject|7|||
42089859|NCT03939819|75900231|FG001|Overall Study|Death|0|||
42089860|NCT00756938|75900240|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
42089861|NCT00756938|75900241|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
42089862|NCT00756938|75900242|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
42089863|NCT00756938|75900243|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
42089864|NCT00756938|75900240|FG000|12-week Base Study|Protocol Violation|0|||
42089865|NCT00756938|75900241|FG001|12-week Base Study|Protocol Violation|0|||
42089866|NCT00756938|75900242|FG002|12-week Base Study|Protocol Violation|1|||
42089867|NCT00756938|75900243|FG003|12-week Base Study|Protocol Violation|0|||
42089868|NCT00756938|75900240|FG000|12-week Base Study|Lost to Follow-up|1|||
42182201|NCT03090100|75989843|FG001|Overall Study|Withdrawal by Subject|19|||
42089869|NCT00756938|75900241|FG001|12-week Base Study|Lost to Follow-up|0|||
42089870|NCT00756938|75900242|FG002|12-week Base Study|Lost to Follow-up|0|||
42182202|NCT03090100|75989842|FG000|Overall Study|Protocol Violation|2|||
42182203|NCT03090100|75989843|FG001|Overall Study|Protocol Violation|6|||
42182204|NCT03090100|75989842|FG000|Overall Study|Non-compliance|2|||
42182205|NCT03090100|75989843|FG001|Overall Study|Non-compliance|0|||
42182206|NCT03090100|75989842|FG000|Overall Study|Other|2|||
42182207|NCT03090100|75989843|FG001|Overall Study|Other|2|||
42089871|NCT00756938|75900243|FG003|12-week Base Study|Lost to Follow-up|0|||
42089872|NCT00756938|75900240|FG000|Optional Extension|Lack of Efficacy|0|||
42182208|NCT03089944|75989849|FG000|Overall Study|Lost to Follow-up|8|||
42182209|NCT03089944|75989849|FG000|Overall Study|Withdrew Consent|2|||
42182210|NCT03089944|75989849|FG000|Overall Study|Adverse Event|1|||
42182211|NCT03089944|75989849|FG000|Overall Study|Other|1|||
42182212|NCT03739866|75989872|FG000|Overall Study|Lost to Follow-up|0|||
42182213|NCT03739866|75989873|FG001|Overall Study|Lost to Follow-up|0|||
42182214|NCT03739866|75989874|FG002|Overall Study|Lost to Follow-up|0|||
42182215|NCT03739866|75989875|FG003|Overall Study|Lost to Follow-up|1|||
42182216|NCT03739866|75989876|FG004|Overall Study|Lost to Follow-up|0|||
42182217|NCT03739866|75989877|FG005|Overall Study|Lost to Follow-up|0|||
42182218|NCT03739866|75989878|FG006|Overall Study|Lost to Follow-up|0|||
42182219|NCT03739866|75989879|FG007|Overall Study|Lost to Follow-up|0|||
42182220|NCT03739866|75989872|FG000|Overall Study|Enrolled but not treated|0|||
42182221|NCT03739866|75989873|FG001|Overall Study|Enrolled but not treated|0|||
42182222|NCT03739866|75989874|FG002|Overall Study|Enrolled but not treated|1|||
42182223|NCT03739866|75989875|FG003|Overall Study|Enrolled but not treated|0|||
42182224|NCT03739866|75989876|FG004|Overall Study|Enrolled but not treated|1|||
42182225|NCT03739866|75989877|FG005|Overall Study|Enrolled but not treated|0|||
42182226|NCT03739866|75989878|FG006|Overall Study|Enrolled but not treated|0|||
42089873|NCT00756938|75900241|FG001|Optional Extension|Lack of Efficacy|0|||
42089874|NCT00756938|75900242|FG002|Optional Extension|Lack of Efficacy|0|||
42089875|NCT00756938|75900243|FG003|Optional Extension|Lack of Efficacy|1|||
42182227|NCT03739866|75989879|FG007|Overall Study|Enrolled but not treated|0|||
42089876|NCT00756938|75900240|FG000|Optional Extension|End of Study|0|||
42089877|NCT00756938|75900241|FG001|Optional Extension|End of Study|0|||
42089878|NCT00756938|75900242|FG002|Optional Extension|End of Study|0|||
42182228|NCT03739242|75989903|FG000|Overall Study|Withdrawal by Subject|1|||
42182229|NCT03739242|75989904|FG001|Overall Study|Withdrawal by Subject|1|||
42182230|NCT03739242|75989903|FG000|Overall Study|Protocol Violation|0|||
42182231|NCT03739242|75989904|FG001|Overall Study|Protocol Violation|1|||
42182232|NCT02849626|75989961|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
42182233|NCT02849626|75989962|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
42182234|NCT02849626|75989963|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
42182235|NCT02849626|75989964|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
42182236|NCT02849626|75989961|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
42182237|NCT02849626|75989962|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
42182238|NCT02849626|75989963|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
42089879|NCT00756938|75900243|FG003|Optional Extension|End of Study|11|||
42089880|NCT00756938|75900240|FG000|Optional Extension|Protocol-specific criteria met|0|||
42089881|NCT00756938|75900241|FG001|Optional Extension|Protocol-specific criteria met|0|||
42089882|NCT00756938|75900242|FG002|Optional Extension|Protocol-specific criteria met|0|||
42089883|NCT00756938|75900243|FG003|Optional Extension|Protocol-specific criteria met|9|||
42089884|NCT00756938|75900240|FG000|Optional Extension|Physician Decision|0|||
42089885|NCT00756938|75900241|FG001|Optional Extension|Physician Decision|0|||
42089886|NCT00756938|75900242|FG002|Optional Extension|Physician Decision|0|||
42089887|NCT00756938|75900243|FG003|Optional Extension|Physician Decision|3|||
42089888|NCT00756938|75900240|FG000|Optional Extension|Lost to Follow-up|0|||
42089889|NCT00756938|75900241|FG001|Optional Extension|Lost to Follow-up|0|||
42089890|NCT00756938|75900242|FG002|Optional Extension|Lost to Follow-up|0|||
42089891|NCT00756938|75900243|FG003|Optional Extension|Lost to Follow-up|1|||
42089892|NCT00756938|75900240|FG000|Optional Extension|Protocol Violation|0|||
42089893|NCT00756938|75900241|FG001|Optional Extension|Protocol Violation|0|||
42089894|NCT00756938|75900242|FG002|Optional Extension|Protocol Violation|0|||
42089895|NCT00756938|75900243|FG003|Optional Extension|Protocol Violation|1|||
42089896|NCT00756938|75900240|FG000|Optional Extension|Withdrawal by Subject|0|||
42089897|NCT00756938|75900241|FG001|Optional Extension|Withdrawal by Subject|0|||
42089898|NCT00756938|75900242|FG002|Optional Extension|Withdrawal by Subject|0|||
42089899|NCT00756938|75900243|FG003|Optional Extension|Withdrawal by Subject|10|||
42089900|NCT00756938|75900240|FG000|Optional Extension|Adverse Event|0|||
42089901|NCT00756938|75900241|FG001|Optional Extension|Adverse Event|0|||
42089902|NCT00756938|75900242|FG002|Optional Extension|Adverse Event|0|||
42182239|NCT02849626|75989964|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
42182240|NCT02849626|75989961|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
42182241|NCT02849626|75989962|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
42182242|NCT02849626|75989963|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
42182243|NCT02849626|75989964|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
42182244|NCT02849626|75989961|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
42182245|NCT02849626|75989962|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
42182246|NCT02849626|75989963|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
42182247|NCT02849626|75989964|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
42089903|NCT00756938|75900243|FG003|Optional Extension|Adverse Event|1|||
42089904|NCT00796367|75900264|FG000|Overall Study|Adverse Event|6|||
42089905|NCT00796367|75900265|FG001|Overall Study|Adverse Event|4|||
42089906|NCT00796367|75900266|FG002|Overall Study|Adverse Event|7|||
42089907|NCT00796367|75900264|FG000|Overall Study|Lost to Follow-up|5|||
42089908|NCT00796367|75900265|FG001|Overall Study|Lost to Follow-up|4|||
42089909|NCT00796367|75900266|FG002|Overall Study|Lost to Follow-up|21|||
42089910|NCT00796367|75900264|FG000|Overall Study|Withdrawal by Subject|9|||
42089911|NCT00796367|75900265|FG001|Overall Study|Withdrawal by Subject|11|||
42089912|NCT00796367|75900266|FG002|Overall Study|Withdrawal by Subject|12|||
42089913|NCT00796367|75900264|FG000|Overall Study|Lack of Efficacy|2|||
42089914|NCT00796367|75900265|FG001|Overall Study|Lack of Efficacy|1|||
42089915|NCT00796367|75900266|FG002|Overall Study|Lack of Efficacy|0|||
42089916|NCT00796367|75900264|FG000|Overall Study|non compliance|3|||
42089917|NCT00796367|75900265|FG001|Overall Study|non compliance|1|||
42089918|NCT00796367|75900266|FG002|Overall Study|non compliance|1|||
42089919|NCT00796367|75900264|FG000|Overall Study|Pregnancy|1|||
42089920|NCT00796367|75900265|FG001|Overall Study|Pregnancy|0|||
42089921|NCT00796367|75900266|FG002|Overall Study|Pregnancy|1|||
42089922|NCT00796367|75900264|FG000|Overall Study|Requirement for restricted medication|2|||
42089923|NCT00796367|75900265|FG001|Overall Study|Requirement for restricted medication|0|||
42089924|NCT00796367|75900266|FG002|Overall Study|Requirement for restricted medication|2|||
42089925|NCT00796367|75900264|FG000|Overall Study|other|2|||
42089926|NCT00796367|75900265|FG001|Overall Study|other|4|||
42089927|NCT00796367|75900266|FG002|Overall Study|other|3|||
42089928|NCT00770588|75900276|FG000|Overall Study|Adverse Event|9|||
42089929|NCT00770588|75900277|FG001|Overall Study|Adverse Event|2|||
42089930|NCT00770588|75900276|FG000|Overall Study|Death caused by progression of disease|70|||
42089931|NCT00770588|75900277|FG001|Overall Study|Death caused by progression of disease|91|||
42089932|NCT00770588|75900276|FG000|Overall Study|Lost to Follow-up|1|||
42089933|NCT00770588|75900277|FG001|Overall Study|Lost to Follow-up|1|||
42089934|NCT00770588|75900276|FG000|Overall Study|Withdrawal by Subject|1|||
42089935|NCT00770588|75900277|FG001|Overall Study|Withdrawal by Subject|1|||
42089936|NCT00777608|75900286|FG000|Overall Study|Lost to Follow-up|1|||
42089937|NCT00777608|75900287|FG001|Overall Study|Lost to Follow-up|1|||
42089938|NCT00777608|75900286|FG000|Overall Study|Withdrawal by Subject|1|||
42089939|NCT00777608|75900287|FG001|Overall Study|Withdrawal by Subject|3|||
42089940|NCT00777608|75900286|FG000|Overall Study|Protocol Violation|1|||
42089941|NCT00777608|75900287|FG001|Overall Study|Protocol Violation|0|||
42089942|NCT00777608|75900286|FG000|Overall Study|Investigator Decision|1|||
42089943|NCT00777608|75900287|FG001|Overall Study|Investigator Decision|2|||
42089944|NCT00792935|75900295|FG000|Overall Study|Adverse Event|2|||
42089945|NCT00792935|75900296|FG001|Overall Study|Adverse Event|1|||
42089946|NCT00792935|75900295|FG000|Overall Study|Lost to Follow-up|0|||
42089947|NCT00792935|75900296|FG001|Overall Study|Lost to Follow-up|1|||
42089948|NCT00792935|75900295|FG000|Overall Study|Protocol Violation|2|||
42089949|NCT00792935|75900296|FG001|Overall Study|Protocol Violation|0|||
42089950|NCT00792935|75900295|FG000|Overall Study|Withdrawal by Subject|0|||
42089951|NCT00792935|75900296|FG001|Overall Study|Withdrawal by Subject|1|||
42089952|NCT00770510|75900302|FG000|Overall Study|Lost to Follow-up|2|||
42089953|NCT00770510|75900302|FG000|Overall Study|Pregnancy|1|||
42089954|NCT00770510|75900302|FG000|Overall Study|Withdrawal by Subject|2|||
42089955|NCT00770432|75900316|FG000|Overall Study|Other|4|||
42089956|NCT00770432|75900317|FG001|Overall Study|Other|6|||
42089957|NCT00770432|75900316|FG000|Overall Study|Non-compliance|0|||
42089958|NCT00770432|75900317|FG001|Overall Study|Non-compliance|1|||
42089959|NCT00792701|75900325|FG000|Overall Study|Adverse Event|0|||
42182248|NCT02849626|75989961|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
42182249|NCT02849626|75989962|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
42182250|NCT02849626|75989963|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
42182251|NCT02849626|75989964|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
42182252|NCT02849626|75989961|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
42182253|NCT02849626|75989962|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
42182254|NCT02849626|75989963|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
42182255|NCT02849626|75989964|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
42182256|NCT02849626|75989961|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
42358700|NCT03745651|76204507|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
42089960|NCT00792701|75900326|FG001|Overall Study|Adverse Event|22|||
42089961|NCT00792701|75900325|FG000|Overall Study|Ineligible|1|||
42089962|NCT00792701|75900326|FG001|Overall Study|Ineligible|3|||
42089963|NCT00792701|75900325|FG000|Overall Study|Withdrawal by Subject|1|||
42089964|NCT00792701|75900326|FG001|Overall Study|Withdrawal by Subject|19|||
42089965|NCT00792701|75900325|FG000|Overall Study|Not protocol specified|17|||
42089966|NCT00792701|75900326|FG001|Overall Study|Not protocol specified|0|||
42089967|NCT00777296|75900338|FG000|Overall Study|Adverse Event|0|||
42089968|NCT00777296|75900339|FG001|Overall Study|Adverse Event|1|||
42089969|NCT00777296|75900340|FG002|Overall Study|Adverse Event|0|||
42089970|NCT00777296|75900341|FG003|Overall Study|Adverse Event|1|||
42089971|NCT00777296|75900338|FG000|Overall Study|Withdrawal by Subject|1|||
42089972|NCT00777296|75900339|FG001|Overall Study|Withdrawal by Subject|0|||
42089973|NCT00777296|75900340|FG002|Overall Study|Withdrawal by Subject|0|||
42089974|NCT00777296|75900341|FG003|Overall Study|Withdrawal by Subject|0|||
42089975|NCT00777296|75900338|FG000|Overall Study|CRF form not completed|0|||
42089976|NCT00777296|75900339|FG001|Overall Study|CRF form not completed|0|||
42089977|NCT00777296|75900340|FG002|Overall Study|CRF form not completed|2|||
42089978|NCT00777296|75900341|FG003|Overall Study|CRF form not completed|0|||
42089979|NCT00756470|75900363|FG000|Overall Study|Withdrawal by Subject|1|||
42089980|NCT00756470|75900363|FG000|Overall Study|Adverse Event|4|||
42089981|NCT00792623|75900367|FG000|Overall Study|Adverse Event|2|||
42089982|NCT00792623|75900367|FG000|Overall Study|Withdrawal by Subject|5|||
42089983|NCT00756314|75900374|FG000|Overall Study|Lost to Follow-up|2|||
42089984|NCT00756314|75900375|FG001|Overall Study|Lost to Follow-up|59|||
42089985|NCT00727506|75900387|FG000|Overall Study|Adverse Event|0|||
42089986|NCT00727506|75900388|FG001|Overall Study|Adverse Event|0|||
42089987|NCT00727506|75900389|FG002|Overall Study|Adverse Event|4|||
42089988|NCT00727506|75900390|FG003|Overall Study|Adverse Event|4|||
42089989|NCT00727506|75900391|FG004|Overall Study|Adverse Event|1|||
42089990|NCT00727506|75900392|FG005|Overall Study|Adverse Event|8|||
42089991|NCT00727506|75900387|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
42089992|NCT00727506|75900388|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42089993|NCT00727506|75900389|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
42089994|NCT00727506|75900390|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42089995|NCT00727506|75900391|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42089996|NCT00727506|75900392|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
42089997|NCT00727506|75900387|FG000|Overall Study|Progressive disease|4|||
42089998|NCT00727506|75900388|FG001|Overall Study|Progressive disease|7|||
42089999|NCT00727506|75900389|FG002|Overall Study|Progressive disease|9|||
42090000|NCT00727506|75900390|FG003|Overall Study|Progressive disease|28|||
42090001|NCT00727506|75900391|FG004|Overall Study|Progressive disease|38|||
42090002|NCT00727506|75900392|FG005|Overall Study|Progressive disease|28|||
42090003|NCT00727506|75900387|FG000|Overall Study|Refused to continue medication|0|||
42090004|NCT00727506|75900388|FG001|Overall Study|Refused to continue medication|1|||
42090005|NCT00727506|75900389|FG002|Overall Study|Refused to continue medication|2|||
42090006|NCT00727506|75900390|FG003|Overall Study|Refused to continue medication|3|||
42090007|NCT00727506|75900391|FG004|Overall Study|Refused to continue medication|1|||
42090008|NCT00727506|75900392|FG005|Overall Study|Refused to continue medication|2|||
42090009|NCT00727506|75900387|FG000|Overall Study|Other reason not described above|0|||
42090010|NCT00727506|75900388|FG001|Overall Study|Other reason not described above|0|||
42090011|NCT00727506|75900389|FG002|Overall Study|Other reason not described above|1|||
42090012|NCT00727506|75900390|FG003|Overall Study|Other reason not described above|4|||
42090013|NCT00727506|75900391|FG004|Overall Study|Other reason not described above|1|||
42090014|NCT00727506|75900392|FG005|Overall Study|Other reason not described above|1|||
42182257|NCT02849626|75989962|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
42182258|NCT02849626|75989963|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
42182259|NCT02849626|75989964|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
42182260|NCT02849626|75989961|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
42182261|NCT02849626|75989962|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
42182262|NCT02849626|75989963|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
42090015|NCT00789815|75900414|FG000|Overall Study|Protocol Violation|6|||
42090016|NCT00789815|75900415|FG001|Overall Study|Protocol Violation|1|||
42090017|NCT00789815|75900414|FG000|Overall Study|Intubation due to massive bleeding|1|||
42090018|NCT00789815|75900415|FG001|Overall Study|Intubation due to massive bleeding|0|||
42090019|NCT00721578|75900421|FG000|Overall Study|Death|1|||
42090020|NCT00721578|75900422|FG001|Overall Study|Death|1|||
42090021|NCT00721578|75900421|FG000|Overall Study|Withdrawal by Subject|1|||
42090022|NCT00721578|75900422|FG001|Overall Study|Withdrawal by Subject|1|||
42090023|NCT00789737|75900430|FG000|Overall Study|Withdrawal by Subject|13|||
42090024|NCT00789737|75900431|FG001|Overall Study|Withdrawal by Subject|22|||
42090025|NCT00789737|75900430|FG000|Overall Study|Lost to Follow-up|10|||
42090026|NCT00789737|75900431|FG001|Overall Study|Lost to Follow-up|14|||
42090027|NCT00789737|75900430|FG000|Overall Study|Adverse Event|8|||
42090028|NCT00789737|75900431|FG001|Overall Study|Adverse Event|8|||
42090029|NCT00789737|75900430|FG000|Overall Study|Protocol Violation|3|||
42182263|NCT02849626|75989964|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
42090030|NCT00789737|75900431|FG001|Overall Study|Protocol Violation|0|||
42090031|NCT00789737|75900430|FG000|Overall Study|Lack of Efficacy|3|||
42090032|NCT00789737|75900431|FG001|Overall Study|Lack of Efficacy|0|||
42090033|NCT00789737|75900430|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
42090034|NCT00789737|75900431|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
42090035|NCT00789737|75900430|FG000|Overall Study|Other|11|||
42090036|NCT00789737|75900431|FG001|Overall Study|Other|7|||
42090037|NCT00792467|75900437|FG000|Overall Study|progression of disease|17|||
42090038|NCT00792467|75900437|FG000|Overall Study|Adverse Event|1|||
42090039|NCT00792467|75900437|FG000|Overall Study|patient request|1|||
42090040|NCT00792467|75900437|FG000|Overall Study|Lost to Follow-up|1|||
42090041|NCT00792467|75900437|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
42090042|NCT00792467|75900437|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
42090043|NCT00585468|75900442|FG000|First Intervention|Withdrawal by Subject|1|||
42090044|NCT00585468|75900443|FG001|First Intervention|Withdrawal by Subject|1|||
42090045|NCT00724152|75900456|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
42090046|NCT00724152|75900457|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
42090047|NCT00724152|75900458|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
42090048|NCT00724152|75900456|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
42090049|NCT00724152|75900457|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
42090050|NCT00724152|75900458|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
42090051|NCT00721110|75900472|FG000|Overall Study|Ultram use|1|||
42090052|NCT00721110|75900473|FG001|Overall Study|Ultram use|0|||
42090053|NCT00721110|75900474|FG002|Overall Study|Ultram use|0|||
42182264|NCT02849626|75989961|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
42182265|NCT02849626|75989962|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
42182266|NCT02849626|75989963|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
42182267|NCT02849626|75989964|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
42182268|NCT02849626|75989961|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
42182269|NCT02849626|75989962|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
42182270|NCT02849626|75989963|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
42182271|NCT02849626|75989964|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
42182272|NCT02849626|75989961|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
42182273|NCT02849626|75989962|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
42182274|NCT02849626|75989963|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
42182275|NCT02849626|75989964|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
42294600|NCT02633527|76129026|FG000|Overall Study|Lost to Follow-up|1|||
42090054|NCT00721110|75900475|FG003|Overall Study|Ultram use|0|||
42090055|NCT00721110|75900472|FG000|Overall Study|vertical incision|0|||
42090056|NCT00721110|75900473|FG001|Overall Study|vertical incision|0|||
42090057|NCT00721110|75900474|FG002|Overall Study|vertical incision|1|||
42090058|NCT00721110|75900475|FG003|Overall Study|vertical incision|0|||
42090059|NCT00791999|75900489|FG000|Overall Study|Protocol planed withdrawal|14|||
42090060|NCT00791999|75900490|FG001|Overall Study|Protocol planed withdrawal|11|||
42090061|NCT00791999|75900491|FG002|Overall Study|Protocol planed withdrawal|11|||
42090062|NCT00791999|75900492|FG003|Overall Study|Protocol planed withdrawal|45|||
42090063|NCT00791999|75900489|FG000|Overall Study|Withdrawal by Subject|0|||
42090064|NCT00791999|75900490|FG001|Overall Study|Withdrawal by Subject|1|||
42090065|NCT00791999|75900491|FG002|Overall Study|Withdrawal by Subject|0|||
42090066|NCT00791999|75900492|FG003|Overall Study|Withdrawal by Subject|2|||
42090067|NCT00791999|75900489|FG000|Overall Study|Protocol Violation|3|||
42090068|NCT00791999|75900490|FG001|Overall Study|Protocol Violation|0|||
42090069|NCT00791999|75900491|FG002|Overall Study|Protocol Violation|1|||
42090070|NCT00791999|75900492|FG003|Overall Study|Protocol Violation|0|||
42090071|NCT00791999|75900489|FG000|Overall Study|Adverse Event|3|||
42090072|NCT00791999|75900490|FG001|Overall Study|Adverse Event|3|||
42090073|NCT00791999|75900491|FG002|Overall Study|Adverse Event|7|||
42090074|NCT00791999|75900492|FG003|Overall Study|Adverse Event|3|||
42090075|NCT00791999|75900489|FG000|Overall Study|Lack of Efficacy|0|||
42090076|NCT00791999|75900490|FG001|Overall Study|Lack of Efficacy|1|||
42090077|NCT00791999|75900491|FG002|Overall Study|Lack of Efficacy|0|||
42090078|NCT00791999|75900492|FG003|Overall Study|Lack of Efficacy|2|||
42090079|NCT00791999|75900489|FG000|Overall Study|Reason other than those above|1|||
42090080|NCT00791999|75900490|FG001|Overall Study|Reason other than those above|0|||
42090081|NCT00791999|75900491|FG002|Overall Study|Reason other than those above|1|||
42090082|NCT00791999|75900492|FG003|Overall Study|Reason other than those above|0|||
42090083|NCT00585078|75900506|FG000|Overall Study|Withdrawal by Subject|4|||
42090084|NCT00585078|75900506|FG000|Overall Study|Poor performance status|1|||
42090085|NCT00585078|75900506|FG000|Overall Study|Disease Progression|24|||
42090086|NCT00585078|75900506|FG000|Overall Study|Adverse Event|10|||
42090087|NCT00585078|75900506|FG000|Overall Study|Death|1|||
42090088|NCT00720876|75900510|FG000|Overall Study|found to be ineligible after starting tx|2|||
42090089|NCT00723840|75900514|FG000|Overall Study|Lost to Follow-up|2|||
42090090|NCT00723840|75900514|FG000|Overall Study|Failure to return|18|||
42090091|NCT00723840|75900514|FG000|Overall Study|Withdrawal by Subject|55|||
42090092|NCT00723840|75900514|FG000|Overall Study|Serious Adverse Events|3|||
42090093|NCT00723840|75900514|FG000|Overall Study|Other Medical Event|2|||
42090094|NCT00723840|75900514|FG000|Overall Study|Unspecified reason|2|||
42090095|NCT00789581|75900527|FG000|AC Therapy|Adverse Event|2|||
42090096|NCT00789581|75900528|FG001|AC Therapy|Adverse Event|3|||
42090097|NCT00789581|75900527|FG000|AC Therapy|Withdrawal by Subject|4|||
42090098|NCT00789581|75900528|FG001|AC Therapy|Withdrawal by Subject|7|||
42090099|NCT00789581|75900527|FG000|AC Therapy|Disease recurrence|3|||
42090100|NCT00789581|75900528|FG001|AC Therapy|Disease recurrence|1|||
42090101|NCT00789581|75900527|FG000|AC Therapy|Intercurrent Illness|1|||
42090102|NCT00789581|75900528|FG001|AC Therapy|Intercurrent Illness|0|||
42090103|NCT00789581|75900527|FG000|AC Therapy|Never Treated|1|||
42090104|NCT00789581|75900528|FG001|AC Therapy|Never Treated|4|||
42090105|NCT00789581|75900527|FG000|AC Therapy|Other|0|||
42090106|NCT00789581|75900528|FG001|AC Therapy|Other|2|||
42090107|NCT00789581|75900527|FG000|Adjuvant Therapy|Never treated|2|||
42090108|NCT00789581|75900528|FG001|Adjuvant Therapy|Never treated|2|||
42090109|NCT00789581|75900527|FG000|Adjuvant Therapy|Adverse Event|20|||
42090110|NCT00789581|75900528|FG001|Adjuvant Therapy|Adverse Event|44|||
42090111|NCT00789581|75900527|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
42090112|NCT00789581|75900528|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
42090113|NCT00789581|75900527|FG000|Adjuvant Therapy|Disease recurrence|2|||
42090114|NCT00789581|75900528|FG001|Adjuvant Therapy|Disease recurrence|1|||
42090115|NCT00789581|75900527|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
42090116|NCT00789581|75900528|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
42090117|NCT00789581|75900527|FG000|Adjuvant Therapy|Protocol Violation|1|||
42182276|NCT03735498|75989982|FG000|Overall Study|Withdrawal by Subject|5|||
42182277|NCT03735498|75989982|FG000|Overall Study|one participant only completed 5 of 6 sessions|1|||
42182278|NCT02659540|75989988|FG000|Overall Study|Adverse Event|3|||
42182279|NCT02659540|75989989|FG001|Overall Study|Adverse Event|2|||
42182280|NCT02659540|75989988|FG000|Overall Study|Death|1|||
42182281|NCT02659540|75989989|FG001|Overall Study|Death|0|||
42090118|NCT00789581|75900528|FG001|Adjuvant Therapy|Protocol Violation|1|||
42182282|NCT02659540|75989988|FG000|Overall Study|Progressive disease|2|||
42182283|NCT02659540|75989989|FG001|Overall Study|Progressive disease|6|||
42182284|NCT01097746|75989995|FG000|Overall Study|Adverse Event|4|||
42182285|NCT01097746|75989995|FG000|Overall Study|taken off study before any treatment given|1|||
42182286|NCT03733470|75990025|FG000|Overall Study|PI Decision|1|||
42182287|NCT03733470|75990026|FG001|Overall Study|PI Decision|1|||
42182288|NCT03732534|75990032|FG000|Overall Study|Study terminated by Sponsor|6|||
42182289|NCT03087058|75990038|FG000|Overall Study|Withdrawal by Subject|2|||
42182290|NCT03087058|75990039|FG001|Overall Study|Withdrawal by Subject|0|||
42182291|NCT03087058|75990040|FG002|Overall Study|Withdrawal by Subject|0|||
42182292|NCT03726996|75990047|FG000|Overall Study|Parent's decision|2|||
42090119|NCT00789581|75900527|FG000|Adjuvant Therapy|Other|0|||
42090120|NCT00789581|75900528|FG001|Adjuvant Therapy|Other|1|||
42090121|NCT00717756|75900535|FG000|Overall Study|Withdrawal by Subject|1|||
42090122|NCT00717522|75900539|FG000|Overall Study|Disease Progression|5|||
42090123|NCT00717522|75900539|FG000|Overall Study|Adverse Event|1|||
42090124|NCT00717522|75900539|FG000|Overall Study|Death|1|||
42090125|NCT00791921|75900545|FG000|Overall Study|Protocol planed|24|||
42090126|NCT00791921|75900546|FG001|Overall Study|Protocol planed|88|||
42090127|NCT00791921|75900545|FG000|Overall Study|Withdrawal by Subject|1|||
42090128|NCT00791921|75900546|FG001|Overall Study|Withdrawal by Subject|2|||
42090129|NCT00791921|75900545|FG000|Overall Study|Adverse Event|8|||
42090130|NCT00791921|75900546|FG001|Overall Study|Adverse Event|2|||
42090131|NCT00791921|75900545|FG000|Overall Study|Lack of Efficacy|0|||
42090132|NCT00791921|75900546|FG001|Overall Study|Lack of Efficacy|2|||
42090133|NCT00791921|75900545|FG000|Overall Study|Lack of study drug administration|1|||
42090134|NCT00791921|75900546|FG001|Overall Study|Lack of study drug administration|1|||
42090135|NCT00791921|75900545|FG000|Overall Study|Reason other than those above|0|||
42090136|NCT00791921|75900546|FG001|Overall Study|Reason other than those above|1|||
42090137|NCT00582933|75900552|FG000|Overall Study|Physician Decision|3|||
42090138|NCT00791765|75900558|FG000|Weeks 1 to 12|Adverse Event|0|||
42090139|NCT00791765|75900559|FG001|Weeks 1 to 12|Adverse Event|1|||
42090140|NCT00791765|75900558|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
42182293|NCT03726996|75990047|FG000|Overall Study|Study early termination|2|||
42182294|NCT03882970|75990055|FG000|Overall Study|Adverse Event|5|||
42182295|NCT03882970|75990056|FG001|Overall Study|Adverse Event|7|||
42182296|NCT03882970|75990057|FG002|Overall Study|Adverse Event|3|||
42182297|NCT03882970|75990058|FG003|Overall Study|Adverse Event|1|||
42090141|NCT00791765|75900559|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
42090142|NCT00791765|75900558|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
42090143|NCT00791765|75900559|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
42090144|NCT00791765|75900558|FG000|Weeks 1 to 12|Physician Decision|1|||
42090145|NCT00791765|75900559|FG001|Weeks 1 to 12|Physician Decision|0|||
42090146|NCT00791765|75900558|FG000|Weeks 1 to 12|Disease progression|3|||
42294601|NCT02633527|76129027|FG001|Overall Study|Lost to Follow-up|2|||
42090147|NCT00791765|75900559|FG001|Weeks 1 to 12|Disease progression|0|||
42090148|NCT00791765|75900558|FG000|Weeks 1 to 12|Ineligibility determined|0|||
42294602|NCT02633527|76129028|FG002|Overall Study|Lost to Follow-up|5|||
42090149|NCT00791765|75900559|FG001|Weeks 1 to 12|Ineligibility determined|3|||
42090150|NCT00791765|75900558|FG000|Weeks 13 to 24|Protocol deviation|2|||
42182298|NCT03882970|75990055|FG000|Overall Study|Death|1|||
42182299|NCT03882970|75990056|FG001|Overall Study|Death|2|||
42090151|NCT00791765|75900559|FG001|Weeks 13 to 24|Protocol deviation|0|||
42090152|NCT00791765|75900558|FG000|Weeks 13 to 24|Adverse Event|0|||
42090153|NCT00791765|75900559|FG001|Weeks 13 to 24|Adverse Event|3|||
42090154|NCT00791765|75900558|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
42090155|NCT00791765|75900559|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
42090156|NCT00791765|75900558|FG000|Weeks 13 to 24|Disease progression|0|||
42090157|NCT00791765|75900559|FG001|Weeks 13 to 24|Disease progression|1|||
42090158|NCT00791765|75900558|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
42090159|NCT00791765|75900559|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
42090160|NCT00791765|75900558|FG000|Weeks 13 to 24|Other|0|||
42090161|NCT00791765|75900559|FG001|Weeks 13 to 24|Other|1|||
42090162|NCT00789191|75900567|FG000|Overall Study|Adverse Event|2|||
42090163|NCT00789191|75900568|FG001|Overall Study|Adverse Event|4|||
42090164|NCT00789191|75900567|FG000|Overall Study|Lack of Efficacy|0|||
42090165|NCT00789191|75900568|FG001|Overall Study|Lack of Efficacy|5|||
42090166|NCT00789191|75900567|FG000|Overall Study|Protocol Violation|5|||
42090167|NCT00789191|75900568|FG001|Overall Study|Protocol Violation|3|||
42182300|NCT03882970|75990057|FG002|Overall Study|Death|1|||
42182301|NCT03882970|75990058|FG003|Overall Study|Death|1|||
42182302|NCT03882970|75990055|FG000|Overall Study|Lost to Follow-up|8|||
42182303|NCT03882970|75990056|FG001|Overall Study|Lost to Follow-up|9|||
42182304|NCT03882970|75990057|FG002|Overall Study|Lost to Follow-up|5|||
42182305|NCT03882970|75990058|FG003|Overall Study|Lost to Follow-up|5|||
42182306|NCT03882970|75990055|FG000|Overall Study|Physician Decision|0|||
42182307|NCT03882970|75990056|FG001|Overall Study|Physician Decision|2|||
42090168|NCT00789191|75900567|FG000|Overall Study|Withdrawal Criteria|2|||
42090169|NCT00789191|75900568|FG001|Overall Study|Withdrawal Criteria|4|||
42090170|NCT00789191|75900567|FG000|Overall Study|Unclassified|5|||
42090171|NCT00789191|75900568|FG001|Overall Study|Unclassified|3|||
42090172|NCT00789035|75900579|FG000|Overall Study|Adverse Event|0|||
42090173|NCT00789035|75900580|FG001|Overall Study|Adverse Event|2|||
42090174|NCT00789035|75900581|FG002|Overall Study|Adverse Event|0|||
42090175|NCT00789035|75900582|FG003|Overall Study|Adverse Event|1|||
42090176|NCT00789035|75900583|FG004|Overall Study|Adverse Event|3|||
42090177|NCT00789035|75900579|FG000|Overall Study|Lack of Efficacy|3|||
42090178|NCT00789035|75900580|FG001|Overall Study|Lack of Efficacy|0|||
42090179|NCT00789035|75900581|FG002|Overall Study|Lack of Efficacy|0|||
42090180|NCT00789035|75900582|FG003|Overall Study|Lack of Efficacy|0|||
42090181|NCT00789035|75900583|FG004|Overall Study|Lack of Efficacy|2|||
42090182|NCT00789035|75900579|FG000|Overall Study|Protocol Violation|1|||
42090183|NCT00789035|75900580|FG001|Overall Study|Protocol Violation|0|||
42090184|NCT00789035|75900581|FG002|Overall Study|Protocol Violation|0|||
42090185|NCT00789035|75900582|FG003|Overall Study|Protocol Violation|0|||
42090186|NCT00789035|75900583|FG004|Overall Study|Protocol Violation|0|||
42090187|NCT00789035|75900579|FG000|Overall Study|Withdrawal by Subject|0|||
42090188|NCT00789035|75900580|FG001|Overall Study|Withdrawal by Subject|2|||
42090189|NCT00789035|75900581|FG002|Overall Study|Withdrawal by Subject|0|||
42090190|NCT00789035|75900582|FG003|Overall Study|Withdrawal by Subject|0|||
42090191|NCT00789035|75900583|FG004|Overall Study|Withdrawal by Subject|0|||
42090192|NCT00789035|75900579|FG000|Overall Study|Other reason not defined above|2|||
42090193|NCT00789035|75900580|FG001|Overall Study|Other reason not defined above|3|||
42090194|NCT00789035|75900581|FG002|Overall Study|Other reason not defined above|1|||
42090195|NCT00789035|75900582|FG003|Overall Study|Other reason not defined above|0|||
42090196|NCT00789035|75900583|FG004|Overall Study|Other reason not defined above|1|||
42090197|NCT03326193|75900607|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
42090198|NCT03326193|75900607|FG000|Overall Study|Death|19|||
42090199|NCT03326193|75900607|FG000|Overall Study|Withdrawal by Subject|8|||
42090200|NCT00437203|75900630|FG000|Overall Study|Death|0|||
42090201|NCT00437203|75900631|FG001|Overall Study|Death|0|||
42182308|NCT03882970|75990057|FG002|Overall Study|Physician Decision|2|||
42182309|NCT03882970|75990058|FG003|Overall Study|Physician Decision|2|||
42182310|NCT03882970|75990055|FG000|Overall Study|Protocol Violation|2|||
42090202|NCT00437203|75900632|FG002|Overall Study|Death|1|||
42090203|NCT00437203|75900633|FG003|Overall Study|Death|0|||
42090204|NCT00437203|75900634|FG004|Overall Study|Death|0|||
42182311|NCT03882970|75990056|FG001|Overall Study|Protocol Violation|0|||
42182312|NCT03882970|75990057|FG002|Overall Study|Protocol Violation|0|||
42182313|NCT03882970|75990058|FG003|Overall Study|Protocol Violation|0|||
42090205|NCT00437203|75900635|FG005|Overall Study|Death|0|||
42090206|NCT00437203|75900636|FG006|Overall Study|Death|0|||
42090207|NCT00437203|75900637|FG007|Overall Study|Death|1|||
42182314|NCT03882970|75990055|FG000|Overall Study|Withdrawal by Subject|8|||
42090208|NCT00437203|75900638|FG008|Overall Study|Death|0|||
42090209|NCT00437203|75900639|FG009|Overall Study|Death|1|||
42090210|NCT00437203|75900630|FG000|Overall Study|Adverse Event|1|||
42090211|NCT00437203|75900631|FG001|Overall Study|Adverse Event|1|||
42090212|NCT00437203|75900632|FG002|Overall Study|Adverse Event|0|||
42090213|NCT00437203|75900633|FG003|Overall Study|Adverse Event|0|||
42090214|NCT00437203|75900634|FG004|Overall Study|Adverse Event|0|||
42090215|NCT00437203|75900635|FG005|Overall Study|Adverse Event|0|||
42090216|NCT00437203|75900636|FG006|Overall Study|Adverse Event|0|||
42090217|NCT00437203|75900637|FG007|Overall Study|Adverse Event|1|||
42090218|NCT00437203|75900638|FG008|Overall Study|Adverse Event|0|||
42182315|NCT03882970|75990056|FG001|Overall Study|Withdrawal by Subject|17|||
42182316|NCT03882970|75990057|FG002|Overall Study|Withdrawal by Subject|7|||
42090219|NCT00437203|75900639|FG009|Overall Study|Adverse Event|1|||
42182317|NCT03882970|75990058|FG003|Overall Study|Withdrawal by Subject|22|||
42182318|NCT03882970|75990055|FG000|Overall Study|Personal Reason|2|||
42182319|NCT03882970|75990056|FG001|Overall Study|Personal Reason|3|||
42182320|NCT03882970|75990057|FG002|Overall Study|Personal Reason|1|||
42090220|NCT00437203|75900630|FG000|Overall Study|Study terminated by sponsor|0|||
42090221|NCT00437203|75900631|FG001|Overall Study|Study terminated by sponsor|0|||
42090222|NCT00437203|75900632|FG002|Overall Study|Study terminated by sponsor|0|||
42090223|NCT00437203|75900633|FG003|Overall Study|Study terminated by sponsor|0|||
42090224|NCT00437203|75900634|FG004|Overall Study|Study terminated by sponsor|0|||
42090225|NCT00437203|75900635|FG005|Overall Study|Study terminated by sponsor|0|||
42182321|NCT03882970|75990058|FG003|Overall Study|Personal Reason|3|||
42182322|NCT03730480|75990072|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
42182323|NCT03668808|75990077|FG000|First Intervention|Withdrawal by Subject|2|||
42182324|NCT03668808|75990078|FG001|First Intervention|Withdrawal by Subject|2|||
42182325|NCT02982954|75990090|FG000|Overall Study|Death|55|||
42182326|NCT02982954|75990091|FG001|Overall Study|Death|29|||
42182327|NCT02982954|75990092|FG002|Overall Study|Death|15|||
42182328|NCT02982954|75990093|FG003|Overall Study|Death|20|||
42182329|NCT02982954|75990090|FG000|Overall Study|Lost to Follow-up|2|||
42182330|NCT02982954|75990091|FG001|Overall Study|Lost to Follow-up|1|||
42090226|NCT00437203|75900636|FG006|Overall Study|Study terminated by sponsor|0|||
42090227|NCT00437203|75900637|FG007|Overall Study|Study terminated by sponsor|0|||
42090228|NCT00437203|75900638|FG008|Overall Study|Study terminated by sponsor|1|||
42090229|NCT00437203|75900639|FG009|Overall Study|Study terminated by sponsor|0|||
42090230|NCT00437203|75900630|FG000|Overall Study|Objective progression or relapse|5|||
42090231|NCT00437203|75900631|FG001|Overall Study|Objective progression or relapse|6|||
42090232|NCT00437203|75900632|FG002|Overall Study|Objective progression or relapse|2|||
42090233|NCT00437203|75900633|FG003|Overall Study|Objective progression or relapse|3|||
42090234|NCT00437203|75900634|FG004|Overall Study|Objective progression or relapse|3|||
42090235|NCT00437203|75900635|FG005|Overall Study|Objective progression or relapse|3|||
42090236|NCT00437203|75900636|FG006|Overall Study|Objective progression or relapse|6|||
42090237|NCT00437203|75900637|FG007|Overall Study|Objective progression or relapse|1|||
42090238|NCT00437203|75900638|FG008|Overall Study|Objective progression or relapse|2|||
42090239|NCT00437203|75900639|FG009|Overall Study|Objective progression or relapse|2|||
42090240|NCT00437203|75900630|FG000|Overall Study|Other|0|||
42090241|NCT00437203|75900631|FG001|Overall Study|Other|1|||
42090242|NCT00437203|75900632|FG002|Overall Study|Other|0|||
42090243|NCT00437203|75900633|FG003|Overall Study|Other|0|||
42090244|NCT00437203|75900634|FG004|Overall Study|Other|0|||
42090245|NCT00437203|75900635|FG005|Overall Study|Other|0|||
42090246|NCT00437203|75900636|FG006|Overall Study|Other|1|||
42090247|NCT00437203|75900637|FG007|Overall Study|Other|0|||
42090248|NCT00437203|75900638|FG008|Overall Study|Other|0|||
42090249|NCT00437203|75900639|FG009|Overall Study|Other|0|||
42090250|NCT00753272|75900672|FG000|Overall Study|Adverse Event|878|||
42090251|NCT00753272|75900673|FG001|Overall Study|Adverse Event|869|||
42182331|NCT02982954|75990092|FG002|Overall Study|Lost to Follow-up|0|||
42182332|NCT02982954|75990093|FG003|Overall Study|Lost to Follow-up|0|||
42182333|NCT02982954|75990090|FG000|Overall Study|Participant withdrew consent|7|||
42182334|NCT02982954|75990091|FG001|Overall Study|Participant withdrew consent|5|||
42182335|NCT02982954|75990092|FG002|Overall Study|Participant withdrew consent|1|||
42090252|NCT00753272|75900672|FG000|Overall Study|Protocol Violation|28|||
42090253|NCT00753272|75900673|FG001|Overall Study|Protocol Violation|46|||
42090254|NCT00753272|75900672|FG000|Overall Study|Withdrawal by Subject|2481|||
42090255|NCT00753272|75900673|FG001|Overall Study|Withdrawal by Subject|2407|||
42090256|NCT00753272|75900672|FG000|Overall Study|Lost to Follow-up|491|||
42090257|NCT00753272|75900673|FG001|Overall Study|Lost to Follow-up|497|||
42090258|NCT00753272|75900672|FG000|Overall Study|Other|1104|||
42182336|NCT02982954|75990093|FG003|Overall Study|Participant withdrew consent|1|||
42182337|NCT02982954|75990090|FG000|Overall Study|Other reasons|42|||
42182338|NCT02982954|75990091|FG001|Overall Study|Other reasons|17|||
42090259|NCT00753272|75900673|FG001|Overall Study|Other|1088|||
42090260|NCT00437125|75900682|FG000|Overall Study|Adverse Event|12|||
42090261|NCT00437125|75900682|FG000|Overall Study|Death|1|||
42090262|NCT00437125|75900682|FG000|Overall Study|Clinical Relapse|1|||
42090263|NCT00437125|75900682|FG000|Overall Study|Lack of Efficacy|1|||
42090264|NCT00437125|75900682|FG000|Overall Study|Lost to Follow-up|1|||
42182339|NCT02982954|75990092|FG002|Overall Study|Other reasons|12|||
42182340|NCT02982954|75990093|FG003|Overall Study|Other reasons|3|||
42182341|NCT02982954|75990090|FG000|Overall Study|Premature site closure|0|||
42182342|NCT02982954|75990091|FG001|Overall Study|Premature site closure|0|||
42182343|NCT02982954|75990092|FG002|Overall Study|Premature site closure|0|||
42182344|NCT02982954|75990093|FG003|Overall Study|Premature site closure|1|||
42182345|NCT03724968|75990105|FG000|Overall Study|Insurance issues|0|||
42182346|NCT03724968|75990106|FG001|Overall Study|Insurance issues|1|||
42182347|NCT03724968|75990105|FG000|Overall Study|Study closed|0|||
42182348|NCT03724968|75990106|FG001|Overall Study|Study closed|1|||
42182349|NCT03724812|75990112|FG000|Overall Study|Missed Visit|1|||
42182350|NCT03724812|75990112|FG000|Overall Study|Death|2|||
42182351|NCT03724812|75990112|FG000|Overall Study|Withdrawal by Subject|1|||
42182352|NCT03722784|75990119|FG000|Overall Study|Withdrawal by Subject|1|||
42182353|NCT03722784|75990120|FG001|Overall Study|Withdrawal by Subject|0|||
42182354|NCT03722784|75990119|FG000|Overall Study|Physician Decision|1|||
42182355|NCT03722784|75990120|FG001|Overall Study|Physician Decision|1|||
42182356|NCT03722784|75990119|FG000|Overall Study|Protocol Violation|0|||
42182357|NCT03722784|75990120|FG001|Overall Study|Protocol Violation|1|||
42182358|NCT03722238|75990129|FG000|Overall Study|Protocol Violation|1|||
42182359|NCT03722238|75990130|FG001|Overall Study|Protocol Violation|0|||
42182360|NCT03722238|75990129|FG000|Overall Study|Physician Decision|1|||
42182361|NCT03722238|75990130|FG001|Overall Study|Physician Decision|0|||
42182362|NCT03722238|75990129|FG000|Overall Study|Death|1|||
42182363|NCT03722238|75990130|FG001|Overall Study|Death|0|||
42090265|NCT00437125|75900682|FG000|Overall Study|Withdrawal by Subject|13|||
42090266|NCT00437125|75900682|FG000|Overall Study|Withdrawal by Caregiver|2|||
42090267|NCT00437125|75900682|FG000|Overall Study|Physician Decision|1|||
42090268|NCT00582309|75900698|FG000|Overall Study|Protocol Violation|0|||
42090269|NCT00582309|75900699|FG001|Overall Study|Protocol Violation|0|||
42090270|NCT00582309|75900700|FG002|Overall Study|Protocol Violation|2|||
42090271|NCT00443053|75900710|FG000|Overall Study|Adverse Event|2|||
42090272|NCT00443053|75900711|FG001|Overall Study|Adverse Event|1|||
42090273|NCT00443053|75900710|FG000|Overall Study|Withdrawal by Subject|9|||
42090274|NCT00443053|75900711|FG001|Overall Study|Withdrawal by Subject|18|||
42090275|NCT00443053|75900710|FG000|Overall Study|Lost to Follow-up|4|||
42090276|NCT00443053|75900711|FG001|Overall Study|Lost to Follow-up|5|||
42090277|NCT00443053|75900710|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
42090278|NCT00443053|75900711|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
42090279|NCT00443053|75900710|FG000|Overall Study|Noncompliance|2|||
42090280|NCT00443053|75900711|FG001|Overall Study|Noncompliance|1|||
42090281|NCT00443053|75900710|FG000|Overall Study|Other|3|||
42090282|NCT00443053|75900711|FG001|Overall Study|Other|4|||
42090283|NCT00443053|75900710|FG000|Overall Study|Physician Decision|0|||
42090284|NCT00443053|75900711|FG001|Overall Study|Physician Decision|4|||
42090285|NCT00720798|75900717|FG000|Overall Study|Adverse Event|304|||
42090286|NCT00720798|75900717|FG000|Overall Study|Death|39|||
42182364|NCT03722238|75990129|FG000|Overall Study|Lost to Follow-up|6|||
42182365|NCT03722238|75990130|FG001|Overall Study|Lost to Follow-up|0|||
42182366|NCT03722238|75990129|FG000|Overall Study|Partial missing data|44|||
42182367|NCT03722238|75990130|FG001|Overall Study|Partial missing data|1|||
42090287|NCT00720798|75900717|FG000|Overall Study|Insufficient Therapeutic Response|129|||
42182368|NCT03722238|75990129|FG000|Overall Study|Withdrawal by Subject|2|||
42182369|NCT03722238|75990130|FG001|Overall Study|Withdrawal by Subject|0|||
42182370|NCT03722238|75990129|FG000|Overall Study|Other|4|||
42182371|NCT03722238|75990130|FG001|Overall Study|Other|0|||
42182372|NCT03722238|75990129|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
42182373|NCT03722238|75990130|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
42182374|NCT03722238|75990129|FG000|Overall Study|Did not meet risk classification group criteria|90|||
42182375|NCT03722238|75990130|FG001|Overall Study|Did not meet risk classification group criteria|0|||
42182376|NCT03722238|75990129|FG000|Overall Study|Did not sign consent|17|||
42182377|NCT03722238|75990130|FG001|Overall Study|Did not sign consent|0|||
42182378|NCT03722238|75990129|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
42182379|NCT03722238|75990130|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
42182380|NCT03722238|75990129|FG000|Overall Study|Not willing to purchase study medication|142|||
42294603|NCT02633527|76129029|FG003|Overall Study|Lost to Follow-up|5|||
42090288|NCT00720798|75900717|FG000|Overall Study|Protocol Violation|4|||
42090289|NCT00720798|75900717|FG000|Overall Study|Refused Treatment|151|||
42090290|NCT00720798|75900717|FG000|Overall Study|Failure to Return|46|||
42182381|NCT03722238|75990130|FG001|Overall Study|Not willing to purchase study medication|0|||
42182382|NCT03722238|75990129|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
42182383|NCT03722238|75990130|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
42090291|NCT00720798|75900717|FG000|Overall Study|Reason not Specified|83|||
42182384|NCT02927080|75990146|FG000|Overall Study|Withdrawal by Subject|0|||
42182385|NCT02927080|75990147|FG001|Overall Study|Withdrawal by Subject|0|||
42182386|NCT02927080|75990148|FG002|Overall Study|Withdrawal by Subject|0|||
42182387|NCT02927080|75990149|FG003|Overall Study|Withdrawal by Subject|0|||
42182388|NCT02927080|75990150|FG004|Overall Study|Withdrawal by Subject|1|||
42090292|NCT00756002|75900727|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
42090293|NCT00756002|75900728|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
42090294|NCT00756002|75900727|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
42090295|NCT00756002|75900728|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
42294604|NCT02633527|76129030|FG004|Overall Study|Lost to Follow-up|4|||
42294605|NCT02633527|76129026|FG000|Overall Study|Withdrawal by Subject|0|||
42294606|NCT02633527|76129027|FG001|Overall Study|Withdrawal by Subject|3|||
42294607|NCT02633527|76129028|FG002|Overall Study|Withdrawal by Subject|5|||
42294608|NCT02633527|76129029|FG003|Overall Study|Withdrawal by Subject|4|||
42294609|NCT02633527|76129030|FG004|Overall Study|Withdrawal by Subject|4|||
42294610|NCT02633527|76129026|FG000|Overall Study|Protocol Violation|0|||
42294611|NCT02633527|76129027|FG001|Overall Study|Protocol Violation|1|||
42294612|NCT02633527|76129028|FG002|Overall Study|Protocol Violation|1|||
42294613|NCT02633527|76129029|FG003|Overall Study|Protocol Violation|1|||
42294614|NCT02633527|76129030|FG004|Overall Study|Protocol Violation|1|||
42294615|NCT02633527|76129026|FG000|Overall Study|Physician Decision|0|||
42294616|NCT02633527|76129027|FG001|Overall Study|Physician Decision|0|||
42294617|NCT02633527|76129028|FG002|Overall Study|Physician Decision|0|||
42294618|NCT02633527|76129029|FG003|Overall Study|Physician Decision|0|||
42090296|NCT00756002|75900727|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
42090297|NCT00756002|75900728|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
42090298|NCT00756002|75900727|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
42090299|NCT00756002|75900728|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
42090300|NCT00756002|75900727|FG000|Double-Blind Treatment Period|Other|2|||
42090301|NCT00756002|75900728|FG001|Double-Blind Treatment Period|Other|2|||
42090302|NCT00717366|75900736|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
42090303|NCT00717366|75900737|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
42182389|NCT02927080|75990151|FG005|Overall Study|Withdrawal by Subject|0|||
42182390|NCT02927080|75990152|FG006|Overall Study|Withdrawal by Subject|1|||
42182391|NCT02927080|75990153|FG007|Overall Study|Withdrawal by Subject|1|||
42182392|NCT02927080|75990154|FG008|Overall Study|Withdrawal by Subject|0|||
42294619|NCT02633527|76129030|FG004|Overall Study|Physician Decision|1|||
42182393|NCT02927080|75990155|FG009|Overall Study|Withdrawal by Subject|2|||
42182394|NCT02927080|75990146|FG000|Overall Study|Willingness to comply with protocol|0|||
42294620|NCT02633527|76129026|FG000|Overall Study|Administrative reason|1|||
42182395|NCT02927080|75990147|FG001|Overall Study|Willingness to comply with protocol|0|||
42090304|NCT00717366|75900736|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
42090305|NCT00717366|75900737|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
42090306|NCT00717366|75900736|FG000|Core Study Period (20 Weeks)|Death|0|||
42182396|NCT02927080|75990148|FG002|Overall Study|Willingness to comply with protocol|0|||
42182397|NCT02927080|75990149|FG003|Overall Study|Willingness to comply with protocol|0|||
42182398|NCT02927080|75990150|FG004|Overall Study|Willingness to comply with protocol|0|||
42182399|NCT02927080|75990151|FG005|Overall Study|Willingness to comply with protocol|0|||
42182400|NCT02927080|75990152|FG006|Overall Study|Willingness to comply with protocol|0|||
42182401|NCT02927080|75990153|FG007|Overall Study|Willingness to comply with protocol|0|||
42182402|NCT02927080|75990154|FG008|Overall Study|Willingness to comply with protocol|0|||
42182403|NCT02927080|75990155|FG009|Overall Study|Willingness to comply with protocol|1|||
42182404|NCT02927080|75990146|FG000|Overall Study|Study terminated by Sponsor|0|||
42182405|NCT02927080|75990147|FG001|Overall Study|Study terminated by Sponsor|0|||
42182406|NCT02927080|75990148|FG002|Overall Study|Study terminated by Sponsor|0|||
42182407|NCT02927080|75990149|FG003|Overall Study|Study terminated by Sponsor|0|||
42182408|NCT02927080|75990150|FG004|Overall Study|Study terminated by Sponsor|0|||
42182409|NCT02927080|75990151|FG005|Overall Study|Study terminated by Sponsor|0|||
42182410|NCT02927080|75990152|FG006|Overall Study|Study terminated by Sponsor|6|||
42182411|NCT02927080|75990153|FG007|Overall Study|Study terminated by Sponsor|7|||
42182412|NCT02927080|75990154|FG008|Overall Study|Study terminated by Sponsor|2|||
42182413|NCT02927080|75990155|FG009|Overall Study|Study terminated by Sponsor|3|||
42182414|NCT02927080|75990146|FG000|Overall Study|Adverse Event|0|||
42182415|NCT02927080|75990147|FG001|Overall Study|Adverse Event|1|||
42182416|NCT02927080|75990148|FG002|Overall Study|Adverse Event|0|||
42182417|NCT02927080|75990149|FG003|Overall Study|Adverse Event|0|||
42182418|NCT02927080|75990150|FG004|Overall Study|Adverse Event|0|||
42182419|NCT02927080|75990151|FG005|Overall Study|Adverse Event|0|||
42182420|NCT02927080|75990152|FG006|Overall Study|Adverse Event|0|||
42182421|NCT02927080|75990153|FG007|Overall Study|Adverse Event|1|||
42182422|NCT02927080|75990154|FG008|Overall Study|Adverse Event|0|||
42182423|NCT02927080|75990155|FG009|Overall Study|Adverse Event|1|||
42182424|NCT02927080|75990146|FG000|Overall Study|Other|0|||
42182425|NCT02927080|75990147|FG001|Overall Study|Other|0|||
42182426|NCT02927080|75990148|FG002|Overall Study|Other|0|||
42182427|NCT02927080|75990149|FG003|Overall Study|Other|0|||
42182428|NCT02927080|75990150|FG004|Overall Study|Other|0|||
42182429|NCT02927080|75990151|FG005|Overall Study|Other|0|||
42182430|NCT02927080|75990152|FG006|Overall Study|Other|1|||
42182431|NCT02927080|75990153|FG007|Overall Study|Other|0|||
42182432|NCT02927080|75990154|FG008|Overall Study|Other|1|||
42182433|NCT02927080|75990155|FG009|Overall Study|Other|0|||
42182434|NCT02374476|75990202|FG000|VT Induced Ablation|Screening Failures|36|||
42294621|NCT02633527|76129027|FG001|Overall Study|Administrative reason|0|||
42294622|NCT02633527|76129028|FG002|Overall Study|Administrative reason|0|||
42294623|NCT02633527|76129029|FG003|Overall Study|Administrative reason|1|||
42090307|NCT00717366|75900737|FG001|Core Study Period (20 Weeks)|Death|1|||
42090308|NCT00717366|75900736|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
42090309|NCT00717366|75900737|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
42090310|NCT00717366|75900736|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
42090311|NCT00717366|75900737|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
42090312|NCT00717366|75900736|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
42090313|NCT00717366|75900737|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
42090314|NCT00717366|75900736|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
42090315|NCT00717366|75900737|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
42090316|NCT00723606|75900756|FG000|Overall Study|Adverse Event|2|||
42182435|NCT02374476|75990203|FG001|VT Induced Ablation|Screening Failures|0|||
42182436|NCT02374476|75990204|FG002|VT Induced Ablation|Screening Failures|0|||
42182437|NCT02374476|75990202|FG000|Arm Assignment|Withdrawal by Subject|0|||
42182438|NCT02374476|75990203|FG001|Arm Assignment|Withdrawal by Subject|0|||
42182439|NCT02374476|75990204|FG002|Arm Assignment|Withdrawal by Subject|1|||
42182440|NCT02918292|75990211|FG000|Study Enrollment Prior to Transplant|Death|1|||
42182441|NCT02918292|75990211|FG000|Study Follow up After Transplant|Death|6|||
42182442|NCT03720210|75990215|FG000|Overall Study|Lost to Follow-up|1|||
42182443|NCT03719586|75990223|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
42182444|NCT03719586|75990224|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
42182445|NCT03719586|75990225|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
42182446|NCT03719586|75990226|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
42182447|NCT03353350|75990252|FG000|30-week Core Treatment Period|Protocol Violation|1|||
42182448|NCT03353350|75990253|FG001|30-week Core Treatment Period|Protocol Violation|1|||
42182449|NCT03353350|75990254|FG002|30-week Core Treatment Period|Protocol Violation|1|||
42182450|NCT03353350|75990255|FG003|30-week Core Treatment Period|Protocol Violation|0|||
42294624|NCT02633527|76129030|FG004|Overall Study|Administrative reason|0|||
42294625|NCT02633527|76129026|FG000|Overall Study|Multiple reasons|1|||
42182451|NCT03353350|75990252|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
42182452|NCT03353350|75990253|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
42182453|NCT03353350|75990254|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
42294626|NCT02633527|76129027|FG001|Overall Study|Multiple reasons|0|||
42294627|NCT02633527|76129028|FG002|Overall Study|Multiple reasons|2|||
42294628|NCT02633527|76129029|FG003|Overall Study|Multiple reasons|2|||
42294629|NCT02633527|76129030|FG004|Overall Study|Multiple reasons|1|||
42294630|NCT01667549|76129047|FG000|Overall Study|Withdrawal by Subject|3|||
42294631|NCT01667549|76129048|FG001|Overall Study|Withdrawal by Subject|5|||
42294632|NCT01667549|76129049|FG002|Overall Study|Withdrawal by Subject|7|||
42294633|NCT01667549|76129050|FG003|Overall Study|Withdrawal by Subject|6|||
42294634|NCT01667549|76129051|FG004|Overall Study|Withdrawal by Subject|1|||
42294635|NCT01672801|76129090|FG000|Overall Study|Screen Failure|0|||
42294636|NCT01672801|76129091|FG001|Overall Study|Screen Failure|1|||
42358701|NCT03745651|76204508|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
42358702|NCT03745651|76204509|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
42358703|NCT03745651|76204510|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
42358704|NCT03745651|76204511|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
42358705|NCT03745651|76204512|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
42358706|NCT03745651|76204506|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42358707|NCT03745651|76204507|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
42358708|NCT03745651|76204508|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42358709|NCT03745651|76204509|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42358710|NCT03745651|76204510|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42358711|NCT03745651|76204511|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42358712|NCT03745651|76204512|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42358713|NCT03745651|76204506|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
42294637|NCT01655901|76129097|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
42294638|NCT01655901|76129098|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
42294639|NCT01655901|76129099|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
42294640|NCT01655901|76129100|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
42294641|NCT01655901|76129101|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
42294642|NCT01655901|76129102|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
42294643|NCT01656759|76129113|FG000|Overall Study|Protocol Violation|2|||
42294644|NCT01656759|76129114|FG001|Overall Study|Protocol Violation|3|||
42358714|NCT03745651|76204507|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
42358715|NCT03745651|76204508|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
42358716|NCT03745651|76204509|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42358717|NCT03745651|76204510|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42358718|NCT03745651|76204511|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42358719|NCT03745651|76204512|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42358720|NCT03745651|76204506|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
42358721|NCT03745651|76204507|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
42358722|NCT03745651|76204508|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
42358723|NCT03745651|76204509|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
42358724|NCT03745651|76204510|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
42090317|NCT00723606|75900757|FG001|Overall Study|Adverse Event|5|||
42090318|NCT00723606|75900756|FG000|Overall Study|Other|2|||
42090319|NCT00723606|75900757|FG001|Overall Study|Other|0|||
42090320|NCT00723606|75900756|FG000|Overall Study|Withdrawal by Subject|0|||
42090321|NCT00723606|75900757|FG001|Overall Study|Withdrawal by Subject|2|||
42090322|NCT00442351|75900765|FG000|Overall Study|Administrative|6|||
42090323|NCT00442351|75900766|FG001|Overall Study|Administrative|5|||
42090324|NCT00442351|75900765|FG000|Overall Study|Did not meet protocol eligibility|1|||
42182454|NCT03353350|75990255|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
42182455|NCT03353350|75990252|FG000|30-week Core Treatment Period|Adverse Event|0|||
42182456|NCT03353350|75990253|FG001|30-week Core Treatment Period|Adverse Event|4|||
42182457|NCT03353350|75990254|FG002|30-week Core Treatment Period|Adverse Event|2|||
42182458|NCT03353350|75990255|FG003|30-week Core Treatment Period|Adverse Event|3|||
42182459|NCT03353350|75990252|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
42182460|NCT03353350|75990253|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
42182461|NCT03353350|75990254|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
42182462|NCT03353350|75990255|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
42182463|NCT03353350|75990252|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
42294645|NCT02631577|76129122|FG000|Overall Study|Death|1|||
42090325|NCT00442351|75900766|FG001|Overall Study|Did not meet protocol eligibility|0|||
42294646|NCT02631577|76129123|FG001|Overall Study|Death|7|||
42090326|NCT00442351|75900765|FG000|Overall Study|Other|0|||
42182464|NCT03353350|75990253|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
42182465|NCT03353350|75990254|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
42182466|NCT03353350|75990255|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
42182467|NCT03353350|75990252|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
42182468|NCT03353350|75990253|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
42182469|NCT03353350|75990254|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
42182470|NCT03353350|75990255|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
42182471|NCT03353350|75990252|FG000|26-week Treatment Extension Period|Adverse Event|1|||
42182472|NCT03353350|75990253|FG001|26-week Treatment Extension Period|Adverse Event|0|||
42182473|NCT03353350|75990254|FG002|26-week Treatment Extension Period|Adverse Event|0|||
42182474|NCT03353350|75990255|FG003|26-week Treatment Extension Period|Adverse Event|1|||
42182475|NCT03353350|75990252|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
42182476|NCT03353350|75990253|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
42182477|NCT03353350|75990254|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
42182478|NCT03353350|75990255|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
42182479|NCT03032068|75990269|FG000|Overall Study|Adverse Event|1|||
42182480|NCT02674516|75990289|FG000|Overall Study|Lost to Follow-up|3|||
42182481|NCT02674516|75990290|FG001|Overall Study|Lost to Follow-up|0|||
42182482|NCT02674516|75990289|FG000|Overall Study|Protocol Violation|0|||
42090327|NCT00442351|75900766|FG001|Overall Study|Other|1|||
42090328|NCT00436501|75900774|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
42182483|NCT02674516|75990290|FG001|Overall Study|Protocol Violation|4|||
42182484|NCT02674516|75990289|FG000|Overall Study|Knowledge of study hypothesis|1|||
42182485|NCT02674516|75990290|FG001|Overall Study|Knowledge of study hypothesis|0|||
42182486|NCT02463448|75990296|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
42182487|NCT02463448|75990296|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
42182488|NCT02463448|75990296|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
42182489|NCT02463448|75990296|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
42182490|NCT03794544|75990304|FG000|Overall Study|Withdrawal by Subject|1|||
42182491|NCT03794544|75990305|FG001|Overall Study|Withdrawal by Subject|1|||
42182492|NCT03794544|75990306|FG002|Overall Study|Withdrawal by Subject|0|||
42182493|NCT03794544|75990307|FG003|Overall Study|Withdrawal by Subject|0|||
42182494|NCT03794544|75990304|FG000|Overall Study|Death|0|||
42182495|NCT03794544|75990305|FG001|Overall Study|Death|0|||
42090329|NCT00436501|75900775|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
42090330|NCT00436501|75900774|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
42090331|NCT00436501|75900775|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
42090332|NCT00755846|75900788|FG000|Overall Study|Adverse Event|0|||
42090333|NCT00755846|75900789|FG001|Overall Study|Adverse Event|0|||
42090334|NCT00755846|75900790|FG002|Overall Study|Adverse Event|0|||
42090335|NCT00755846|75900791|FG003|Overall Study|Adverse Event|1|||
42090336|NCT00755846|75900792|FG004|Overall Study|Adverse Event|3|||
42090337|NCT00755846|75900793|FG005|Overall Study|Adverse Event|2|||
42090338|NCT00755846|75900788|FG000|Overall Study|Protocol Violation|1|||
42090339|NCT00755846|75900789|FG001|Overall Study|Protocol Violation|1|||
42090340|NCT00755846|75900790|FG002|Overall Study|Protocol Violation|1|||
42090341|NCT00755846|75900791|FG003|Overall Study|Protocol Violation|1|||
42090342|NCT00755846|75900792|FG004|Overall Study|Protocol Violation|1|||
42090343|NCT00755846|75900793|FG005|Overall Study|Protocol Violation|1|||
42090344|NCT00755846|75900788|FG000|Overall Study|Lost to Follow-up|0|||
42090345|NCT00755846|75900789|FG001|Overall Study|Lost to Follow-up|2|||
42090346|NCT00755846|75900790|FG002|Overall Study|Lost to Follow-up|1|||
42182496|NCT03794544|75990306|FG002|Overall Study|Death|0|||
42182497|NCT03794544|75990307|FG003|Overall Study|Death|1|||
42182498|NCT03794544|75990304|FG000|Overall Study|Lost to Follow-up|0|||
42182499|NCT03794544|75990305|FG001|Overall Study|Lost to Follow-up|1|||
42294647|NCT02631577|76129122|FG000|Overall Study|Withdrawal by Subject|0|||
42294648|NCT02631577|76129123|FG001|Overall Study|Withdrawal by Subject|3|||
42294649|NCT01667081|76129131|FG000|Overall Study|Death|43|||
42294650|NCT01667081|76129132|FG001|Overall Study|Death|3|||
42294651|NCT01667081|76129131|FG000|Overall Study|Lost to Follow-up|99|||
42294652|NCT01667081|76129132|FG001|Overall Study|Lost to Follow-up|48|||
42294653|NCT01667081|76129131|FG000|Overall Study|Physician Decision|16|||
42294654|NCT01667081|76129132|FG001|Overall Study|Physician Decision|2|||
42294655|NCT01667081|76129131|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
42294656|NCT01667081|76129132|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
42294657|NCT01667081|76129131|FG000|Overall Study|Withdrawal by Subject|90|||
42090347|NCT00755846|75900791|FG003|Overall Study|Lost to Follow-up|0|||
42182500|NCT03794544|75990306|FG002|Overall Study|Lost to Follow-up|1|||
42182501|NCT03794544|75990307|FG003|Overall Study|Lost to Follow-up|0|||
42182502|NCT03794544|75990304|FG000|Overall Study|Other|0|||
42090348|NCT00755846|75900792|FG004|Overall Study|Lost to Follow-up|4|||
42294658|NCT01667081|76129132|FG001|Overall Study|Withdrawal by Subject|35|||
42090349|NCT00755846|75900793|FG005|Overall Study|Lost to Follow-up|2|||
42090350|NCT00755846|75900788|FG000|Overall Study|Withdrawal by Subject|2|||
42090351|NCT00755846|75900789|FG001|Overall Study|Withdrawal by Subject|3|||
42090352|NCT00755846|75900790|FG002|Overall Study|Withdrawal by Subject|5|||
42090353|NCT00755846|75900791|FG003|Overall Study|Withdrawal by Subject|2|||
42090354|NCT00755846|75900792|FG004|Overall Study|Withdrawal by Subject|0|||
42090355|NCT00755846|75900793|FG005|Overall Study|Withdrawal by Subject|1|||
42090356|NCT00755846|75900788|FG000|Overall Study|Hyperglycemic Rescue|21|||
42090357|NCT00755846|75900789|FG001|Overall Study|Hyperglycemic Rescue|7|||
42182503|NCT03794544|75990305|FG001|Overall Study|Other|1|||
42182504|NCT03794544|75990306|FG002|Overall Study|Other|0|||
42182505|NCT03794544|75990307|FG003|Overall Study|Other|0|||
42182506|NCT01804270|75990319|FG000|Overall Study|Withdrawal by Subject|1|||
42182507|NCT01804270|75990320|FG001|Overall Study|Withdrawal by Subject|1|||
42182508|NCT03107026|75990329|FG000|Overall Study|Adverse Event|2|||
42182509|NCT03107026|75990330|FG001|Overall Study|Adverse Event|14|||
42182510|NCT03107026|75990331|FG002|Overall Study|Adverse Event|23|||
42182511|NCT03107026|75990329|FG000|Overall Study|Lost to Follow-up|12|||
42182512|NCT03107026|75990330|FG001|Overall Study|Lost to Follow-up|12|||
42182513|NCT03107026|75990331|FG002|Overall Study|Lost to Follow-up|13|||
42182514|NCT03107026|75990329|FG000|Overall Study|Protocol Violation|1|||
42182515|NCT03107026|75990330|FG001|Overall Study|Protocol Violation|2|||
42182516|NCT03107026|75990331|FG002|Overall Study|Protocol Violation|0|||
42182517|NCT03107026|75990329|FG000|Overall Study|Pregnancy|1|||
42182518|NCT03107026|75990330|FG001|Overall Study|Pregnancy|0|||
42182519|NCT03107026|75990331|FG002|Overall Study|Pregnancy|0|||
42182520|NCT03107026|75990329|FG000|Overall Study|Withdrawal by Subject|13|||
42182521|NCT03107026|75990330|FG001|Overall Study|Withdrawal by Subject|5|||
42182522|NCT03107026|75990331|FG002|Overall Study|Withdrawal by Subject|17|||
42182523|NCT03107026|75990329|FG000|Overall Study|non compliance with study visits|1|||
42182524|NCT03107026|75990330|FG001|Overall Study|non compliance with study visits|2|||
42294659|NCT04545619|76129149|FG000|Overall Study|due to equipment challenges|1|||
42294660|NCT02518971|76129155|FG000|Overall Study|Lost to Follow-up|0|||
42294661|NCT02518971|76129156|FG001|Overall Study|Lost to Follow-up|1|||
42294662|NCT02518971|76129155|FG000|Overall Study|Physician Decision|6|||
42090358|NCT00755846|75900790|FG002|Overall Study|Hyperglycemic Rescue|5|||
42294663|NCT02518971|76129156|FG001|Overall Study|Physician Decision|6|||
42294664|NCT02518971|76129155|FG000|Overall Study|Protocol Violation|6|||
42294665|NCT02518971|76129156|FG001|Overall Study|Protocol Violation|4|||
42294666|NCT02518971|76129155|FG000|Overall Study|Withdrawal by Subject|4|||
42294667|NCT02518971|76129156|FG001|Overall Study|Withdrawal by Subject|5|||
42294668|NCT02518971|76129155|FG000|Overall Study|Side effects|1|||
42294669|NCT02518971|76129156|FG001|Overall Study|Side effects|0|||
42294670|NCT02518971|76129155|FG000|Overall Study|medication lost in mail|0|||
42294671|NCT02518971|76129156|FG001|Overall Study|medication lost in mail|1|||
42294672|NCT02518971|76129155|FG000|Overall Study|eligibility criteria no longer met|6|||
42294673|NCT02518971|76129156|FG001|Overall Study|eligibility criteria no longer met|3|||
42090359|NCT00755846|75900791|FG003|Overall Study|Hyperglycemic Rescue|8|||
42090360|NCT00755846|75900792|FG004|Overall Study|Hyperglycemic Rescue|8|||
42182525|NCT03107026|75990331|FG002|Overall Study|non compliance with study visits|0|||
42182526|NCT03107026|75990329|FG000|Overall Study|non-compliance with study drug|2|||
42182527|NCT03107026|75990330|FG001|Overall Study|non-compliance with study drug|2|||
42182528|NCT03107026|75990331|FG002|Overall Study|non-compliance with study drug|3|||
42182529|NCT03107026|75990329|FG000|Overall Study|Physician Decision|0|||
42182530|NCT03107026|75990330|FG001|Overall Study|Physician Decision|1|||
42182531|NCT03107026|75990331|FG002|Overall Study|Physician Decision|0|||
42182532|NCT03717480|75990339|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
42182533|NCT00005044|75990345|FG000|Overall Study|Protocol Violation|37|||
42182534|NCT00005044|75990346|FG001|Overall Study|Protocol Violation|46|||
42182535|NCT00005044|75990345|FG000|Overall Study|Withdrawal by Subject|1|||
42182536|NCT00005044|75990346|FG001|Overall Study|Withdrawal by Subject|5|||
42182537|NCT00005044|75990345|FG000|Overall Study|No protocol treatment|0|||
42182538|NCT00005044|75990346|FG001|Overall Study|No protocol treatment|1|||
42294674|NCT01365039|76129165|FG000|Overall Study|Study related symptoms and complaints|1|||
42294675|NCT01365039|76129166|FG001|Overall Study|Study related symptoms and complaints|0|||
42090361|NCT00755846|75900793|FG005|Overall Study|Hyperglycemic Rescue|7|||
42182539|NCT03084796|75990358|FG000|Overall Study|Adverse Event|4|||
42182540|NCT03084796|75990359|FG001|Overall Study|Adverse Event|5|||
42182541|NCT03084796|75990360|FG002|Overall Study|Adverse Event|6|||
42182542|NCT03084796|75990361|FG003|Overall Study|Adverse Event|2|||
42182543|NCT03084796|75990362|FG004|Overall Study|Adverse Event|3|||
42090362|NCT00755846|75900788|FG000|Overall Study|Physician Decision|1|||
42182544|NCT03084796|75990363|FG005|Overall Study|Adverse Event|5|||
42182545|NCT03084796|75990358|FG000|Overall Study|Withdrawal by Subject|3|||
42182546|NCT03084796|75990359|FG001|Overall Study|Withdrawal by Subject|5|||
42182547|NCT03084796|75990360|FG002|Overall Study|Withdrawal by Subject|2|||
42294676|NCT01364727|76129173|FG000|Overall Study|Not Eligible|2|||
42294677|NCT02633215|76129181|FG000|Overall Study|Lost to Follow-up|2|||
42090363|NCT00755846|75900789|FG001|Overall Study|Physician Decision|3|||
42090364|NCT00755846|75900790|FG002|Overall Study|Physician Decision|0|||
42090365|NCT00755846|75900791|FG003|Overall Study|Physician Decision|1|||
42090366|NCT00755846|75900792|FG004|Overall Study|Physician Decision|0|||
42090367|NCT00755846|75900793|FG005|Overall Study|Physician Decision|1|||
42090368|NCT00755846|75900788|FG000|Overall Study|Administrative Error|0|||
42090369|NCT00755846|75900789|FG001|Overall Study|Administrative Error|1|||
42090370|NCT00755846|75900790|FG002|Overall Study|Administrative Error|0|||
42090371|NCT00755846|75900791|FG003|Overall Study|Administrative Error|0|||
42090372|NCT00755846|75900792|FG004|Overall Study|Administrative Error|0|||
42090373|NCT00755846|75900793|FG005|Overall Study|Administrative Error|0|||
42090374|NCT00755846|75900788|FG000|Overall Study|Participant Non-compliance|0|||
42090375|NCT00755846|75900789|FG001|Overall Study|Participant Non-compliance|0|||
42090376|NCT00755846|75900790|FG002|Overall Study|Participant Non-compliance|0|||
42090377|NCT00755846|75900791|FG003|Overall Study|Participant Non-compliance|0|||
42090378|NCT00755846|75900792|FG004|Overall Study|Participant Non-compliance|1|||
42090379|NCT00755846|75900793|FG005|Overall Study|Participant Non-compliance|0|||
42090380|NCT03850093|75900810|FG000|Overall Study|Withdrawal by Subject|1|||
42090381|NCT03850093|75900811|FG001|Overall Study|Withdrawal by Subject|0|||
42090382|NCT03850093|75900812|FG002|Overall Study|Withdrawal by Subject|2|||
42090383|NCT00442117|75900822|FG000|Overall Study|Adverse Event|3|||
42090384|NCT00442117|75900823|FG001|Overall Study|Adverse Event|2|||
42090385|NCT00442117|75900822|FG000|Overall Study|Lack of Efficacy|2|||
42090386|NCT00442117|75900823|FG001|Overall Study|Lack of Efficacy|6|||
42090387|NCT00442117|75900822|FG000|Overall Study|Lost to Follow-up|1|||
42090388|NCT00442117|75900823|FG001|Overall Study|Lost to Follow-up|2|||
42090389|NCT00442117|75900822|FG000|Overall Study|Withdrawal by Subject|2|||
42182548|NCT03084796|75990361|FG003|Overall Study|Withdrawal by Subject|1|||
42182549|NCT03084796|75990362|FG004|Overall Study|Withdrawal by Subject|3|||
42182550|NCT03084796|75990363|FG005|Overall Study|Withdrawal by Subject|0|||
42182551|NCT03084796|75990358|FG000|Overall Study|Protocol Violation|0|||
42182552|NCT03084796|75990359|FG001|Overall Study|Protocol Violation|0|||
42182553|NCT03084796|75990360|FG002|Overall Study|Protocol Violation|1|||
42182554|NCT03084796|75990361|FG003|Overall Study|Protocol Violation|0|||
42182555|NCT03084796|75990362|FG004|Overall Study|Protocol Violation|1|||
42182556|NCT03084796|75990363|FG005|Overall Study|Protocol Violation|1|||
42182557|NCT03084796|75990358|FG000|Overall Study|Lack of Efficacy|0|||
42182558|NCT03084796|75990359|FG001|Overall Study|Lack of Efficacy|0|||
42182559|NCT03084796|75990360|FG002|Overall Study|Lack of Efficacy|1|||
42182560|NCT03084796|75990361|FG003|Overall Study|Lack of Efficacy|0|||
42182561|NCT03084796|75990362|FG004|Overall Study|Lack of Efficacy|1|||
42182562|NCT03084796|75990363|FG005|Overall Study|Lack of Efficacy|0|||
42182563|NCT03084796|75990358|FG000|Overall Study|Lost to Follow-up|0|||
42182564|NCT03084796|75990359|FG001|Overall Study|Lost to Follow-up|0|||
42182565|NCT03084796|75990360|FG002|Overall Study|Lost to Follow-up|1|||
42182566|NCT03084796|75990361|FG003|Overall Study|Lost to Follow-up|1|||
42182567|NCT03084796|75990362|FG004|Overall Study|Lost to Follow-up|3|||
42182568|NCT03084796|75990363|FG005|Overall Study|Lost to Follow-up|1|||
42182569|NCT03084796|75990358|FG000|Overall Study|Randomization error|0|||
42182570|NCT03084796|75990359|FG001|Overall Study|Randomization error|0|||
42182571|NCT03084796|75990360|FG002|Overall Study|Randomization error|1|||
42182572|NCT03084796|75990361|FG003|Overall Study|Randomization error|0|||
42182573|NCT03084796|75990362|FG004|Overall Study|Randomization error|0|||
42182574|NCT03084796|75990363|FG005|Overall Study|Randomization error|0|||
42182575|NCT03717012|75990379|FG000|Overall Study|Due to trial termination|1|||
42182576|NCT03717012|75990380|FG001|Overall Study|Due to trial termination|2|||
42182577|NCT03717012|75990379|FG000|Overall Study|Protocol Violation|0|||
42090390|NCT00442117|75900823|FG001|Overall Study|Withdrawal by Subject|2|||
42090391|NCT00442117|75900822|FG000|Overall Study|Major Deviation|25|||
42090392|NCT00442117|75900823|FG001|Overall Study|Major Deviation|20|||
42090393|NCT00442117|75900822|FG000|Overall Study|Non compliance with protocol|3|||
42090394|NCT00442117|75900823|FG001|Overall Study|Non compliance with protocol|5|||
42090395|NCT00442117|75900822|FG000|Overall Study|Met Withdrawal Criteria|2|||
42090396|NCT00442117|75900823|FG001|Overall Study|Met Withdrawal Criteria|1|||
42090397|NCT00752726|75900831|FG000|Overall Study|Lost to Follow-up|2|||
42090398|NCT00752726|75900832|FG001|Overall Study|Lost to Follow-up|1|||
42090399|NCT00752726|75900831|FG000|Overall Study|Adverse Event|3|||
42090400|NCT00752726|75900832|FG001|Overall Study|Adverse Event|0|||
42090401|NCT00752726|75900831|FG000|Overall Study|Withdrawal by Subject|5|||
42090402|NCT00752726|75900832|FG001|Overall Study|Withdrawal by Subject|10|||
42090403|NCT00752726|75900831|FG000|Overall Study|Other Reason|1|||
42090404|NCT00752726|75900832|FG001|Overall Study|Other Reason|2|||
42090405|NCT00755222|75900840|FG000|Overall Study|Withdrawal by Subject|4|||
42090406|NCT00755222|75900841|FG001|Overall Study|Withdrawal by Subject|2|||
42090407|NCT00755222|75900840|FG000|Overall Study|Adverse Event|2|||
42090408|NCT00755222|75900841|FG001|Overall Study|Adverse Event|0|||
42182578|NCT03717012|75990380|FG001|Overall Study|Protocol Violation|2|||
42182579|NCT03717012|75990379|FG000|Overall Study|Adverse Event|0|||
42182580|NCT03717012|75990380|FG001|Overall Study|Adverse Event|1|||
42090409|NCT00755222|75900840|FG000|Overall Study|Protocol Violation|2|||
42090410|NCT00755222|75900841|FG001|Overall Study|Protocol Violation|0|||
42090411|NCT00441727|75900850|FG000|Overall Study|Protocol Violation|19|||
42090412|NCT00441727|75900851|FG001|Overall Study|Protocol Violation|28|||
42090413|NCT00441727|75900852|FG002|Overall Study|Protocol Violation|32|||
42090414|NCT00441727|75900850|FG000|Overall Study|Adverse Event|26|||
42090415|NCT00441727|75900851|FG001|Overall Study|Adverse Event|33|||
42090416|NCT00441727|75900852|FG002|Overall Study|Adverse Event|28|||
42090417|NCT00441727|75900850|FG000|Overall Study|Lack of Efficacy|7|||
42090418|NCT00441727|75900851|FG001|Overall Study|Lack of Efficacy|8|||
42090419|NCT00441727|75900852|FG002|Overall Study|Lack of Efficacy|48|||
42090420|NCT00441727|75900850|FG000|Overall Study|Withdrawal by Subject|40|||
42090421|NCT00441727|75900851|FG001|Overall Study|Withdrawal by Subject|34|||
42090422|NCT00441727|75900852|FG002|Overall Study|Withdrawal by Subject|47|||
42090423|NCT00441727|75900850|FG000|Overall Study|Lost to Follow-up|5|||
42090424|NCT00441727|75900851|FG001|Overall Study|Lost to Follow-up|6|||
42090425|NCT00441727|75900852|FG002|Overall Study|Lost to Follow-up|5|||
42090426|NCT00441727|75900850|FG000|Overall Study|Safety Reasons|3|||
42090427|NCT00441727|75900851|FG001|Overall Study|Safety Reasons|1|||
42090428|NCT00441727|75900852|FG002|Overall Study|Safety Reasons|3|||
42090429|NCT00441727|75900850|FG000|Overall Study|Various reason specified|6|||
42090430|NCT00441727|75900851|FG001|Overall Study|Various reason specified|8|||
42090431|NCT00441727|75900852|FG002|Overall Study|Various reason specified|5|||
42090432|NCT00770120|75900874|FG000|Overall Study|Progression|31|||
42090433|NCT00770120|75900874|FG000|Overall Study|Adverse Event|11|||
42090434|NCT00770120|75900874|FG000|Overall Study|Not Protocol Specified|11|||
42090435|NCT00770120|75900874|FG000|Overall Study|Death|3|||
42090436|NCT00770120|75900874|FG000|Overall Study|Withdrawal by Subject|2|||
42090437|NCT00770120|75900874|FG000|Overall Study|Ineligible|1|||
42090438|NCT00770120|75900874|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
42090439|NCT00770120|75900874|FG000|Overall Study|Reason under Review|1|||
42090440|NCT00436345|75900881|FG000|Overall Study|ICU resident beyond follow-up period|3|||
42090441|NCT00436345|75900882|FG001|Overall Study|ICU resident beyond follow-up period|0|||
42090442|NCT00769184|75900889|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
42090443|NCT00769184|75900890|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
42090444|NCT00769184|75900889|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
42090445|NCT00769184|75900890|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
42182581|NCT03717012|75990379|FG000|Overall Study|Lung transplant|0|||
42182582|NCT03717012|75990380|FG001|Overall Study|Lung transplant|1|||
42182583|NCT03078556|75990393|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
42182584|NCT03078556|75990394|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
42182585|NCT03078556|75990395|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
42182586|NCT03078556|75990396|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
42182587|NCT03078556|75990393|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
42090446|NCT00769184|75900889|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
42090447|NCT00769184|75900890|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
42090448|NCT00768560|75900904|FG000|Intervention Set 1|Adverse Event|0|||
42090449|NCT00768560|75900905|FG001|Intervention Set 1|Adverse Event|1|||
42090450|NCT00768560|75900906|FG002|Intervention Set 1|Adverse Event|0|||
42090451|NCT00768560|75900907|FG003|Intervention Set 1|Adverse Event|0|||
42090452|NCT00768560|75900908|FG004|Intervention Set 1|Adverse Event|0|||
42090453|NCT00768560|75900909|FG005|Intervention Set 1|Adverse Event|0|||
42090454|NCT00468559|75900919|FG000|Open-label Treatment Phase|Adverse Event|5|||
42090455|NCT00468559|75900920|FG001|Open-label Treatment Phase|Adverse Event|0|||
42182588|NCT03078556|75990394|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
42090456|NCT00468559|75900921|FG002|Open-label Treatment Phase|Adverse Event|0|||
42090457|NCT00468559|75900919|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
42090458|NCT00468559|75900920|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
42090459|NCT00468559|75900921|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
42090460|NCT00468559|75900919|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
42090461|NCT00468559|75900920|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
42090462|NCT00468559|75900921|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
42090463|NCT00468559|75900919|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
42090464|NCT00468559|75900920|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
42090465|NCT00468559|75900921|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
42090466|NCT00468559|75900919|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
42090467|NCT00468559|75900920|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
42090468|NCT00468559|75900921|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
42182589|NCT03078556|75990395|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
42182590|NCT03078556|75990396|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
42090469|NCT00754442|75900931|FG000|Overall Study|Withdrawal by Subject|5|||
42090470|NCT00754442|75900932|FG001|Overall Study|Withdrawal by Subject|3|||
42090471|NCT00754052|75900941|FG000|Overall Study|Study terminated by Sponsor|5|||
42090472|NCT00754052|75900942|FG001|Overall Study|Study terminated by Sponsor|3|||
42090473|NCT00747812|75900950|FG000|Overall Study|Research Site Staff Relocation|5|||
42090474|NCT00747812|75900951|FG001|Overall Study|Research Site Staff Relocation|3|||
42090475|NCT02927067|75900959|FG000|Overall Study|Withdrawn Consent|20|||
42090476|NCT02927067|75900960|FG001|Overall Study|Withdrawn Consent|12|||
42090477|NCT02927067|75900959|FG000|Overall Study|Death|18|||
42090478|NCT02927067|75900960|FG001|Overall Study|Death|31|||
42090479|NCT02927067|75900959|FG000|Overall Study|Adverse Event|13|||
42090480|NCT02927067|75900960|FG001|Overall Study|Adverse Event|10|||
42090481|NCT02927067|75900959|FG000|Overall Study|Noncompliance|5|||
42090482|NCT02927067|75900960|FG001|Overall Study|Noncompliance|2|||
42090483|NCT02927067|75900959|FG000|Overall Study|Reason not Specified|4|||
42090484|NCT02927067|75900960|FG001|Overall Study|Reason not Specified|6|||
42090485|NCT01751685|75900970|FG000|6-mo Followup|Missed study visit|1|||
42090486|NCT01751685|75900971|FG001|6-mo Followup|Missed study visit|0|||
42090487|NCT01751685|75900970|FG000|6-mo Followup|Withdrawal by Subject|2|||
42090488|NCT01751685|75900971|FG001|6-mo Followup|Withdrawal by Subject|2|||
42090489|NCT01751685|75900970|FG000|6-mo Followup|Lost to Follow-up|0|||
42090490|NCT01751685|75900971|FG001|6-mo Followup|Lost to Follow-up|1|||
42090491|NCT01751685|75900970|FG000|12-mo Followup|Lost to Follow-up|5|||
42090492|NCT01751685|75900971|FG001|12-mo Followup|Lost to Follow-up|0|||
42090493|NCT00586508|75900979|FG000|Overall Study|Progressive disease|52|||
42090494|NCT00586508|75900980|FG001|Overall Study|Progressive disease|8|||
42182591|NCT03078556|75990393|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
42182592|NCT03078556|75990394|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
42182593|NCT03078556|75990395|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
42182594|NCT03078556|75990396|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
42182595|NCT03078556|75990393|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
42182596|NCT03078556|75990394|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
42182597|NCT03078556|75990395|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
42182598|NCT03078556|75990396|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
42182599|NCT03714672|75990425|FG000|Overall Study|Adverse Event|0|||
42182600|NCT03714672|75990426|FG001|Overall Study|Adverse Event|0|||
42182601|NCT03714672|75990427|FG002|Overall Study|Adverse Event|3|||
42182602|NCT03714672|75990428|FG003|Overall Study|Adverse Event|0|||
42182603|NCT03714672|75990425|FG000|Overall Study|Physician Decision|0|||
42182604|NCT03714672|75990426|FG001|Overall Study|Physician Decision|1|||
42182605|NCT03714672|75990427|FG002|Overall Study|Physician Decision|0|||
42182606|NCT03714672|75990428|FG003|Overall Study|Physician Decision|0|||
42182607|NCT03714672|75990425|FG000|Overall Study|Other Reason|1|||
42182608|NCT03714672|75990426|FG001|Overall Study|Other Reason|2|||
42182609|NCT03714672|75990427|FG002|Overall Study|Other Reason|1|||
42182610|NCT03714672|75990428|FG003|Overall Study|Other Reason|1|||
42182611|NCT03714672|75990425|FG000|Overall Study|Lost to Follow-up|1|||
42182612|NCT03714672|75990426|FG001|Overall Study|Lost to Follow-up|1|||
42182613|NCT03714672|75990427|FG002|Overall Study|Lost to Follow-up|0|||
42182614|NCT03714672|75990428|FG003|Overall Study|Lost to Follow-up|0|||
42182615|NCT03083470|75990444|FG000|Overall Study|Lost to Follow-up|0|||
42182616|NCT03083470|75990445|FG001|Overall Study|Lost to Follow-up|0|||
42182617|NCT03083470|75990446|FG002|Overall Study|Lost to Follow-up|0|||
42182618|NCT03083470|75990447|FG003|Overall Study|Lost to Follow-up|0|||
42182619|NCT03083470|75990448|FG004|Overall Study|Lost to Follow-up|1|||
42182620|NCT03083470|75990444|FG000|Overall Study|Withdrawal by Subject|0|||
42182621|NCT03083470|75990445|FG001|Overall Study|Withdrawal by Subject|0|||
42182622|NCT03083470|75990446|FG002|Overall Study|Withdrawal by Subject|0|||
42182623|NCT03083470|75990447|FG003|Overall Study|Withdrawal by Subject|0|||
42182624|NCT03083470|75990448|FG004|Overall Study|Withdrawal by Subject|1|||
42182625|NCT05405244|75990460|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
42182626|NCT05405244|75990461|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
42182627|NCT05405244|75990460|FG000|Washout (2 Weeks)|Adverse Event|2|||
42182628|NCT05405244|75990461|FG001|Washout (2 Weeks)|Adverse Event|0|||
42182629|NCT05405244|75990460|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
42294678|NCT02633215|76129182|FG001|Overall Study|Lost to Follow-up|3|||
42182630|NCT05405244|75990461|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
42294679|NCT01364649|76129190|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
42090495|NCT00586508|75900979|FG000|Overall Study|Death|0|||
42090496|NCT00586508|75900980|FG001|Overall Study|Death|1|||
42090497|NCT00586508|75900979|FG000|Overall Study|Adverse Event|12|||
42090498|NCT00586508|75900980|FG001|Overall Study|Adverse Event|4|||
42090499|NCT00586508|75900979|FG000|Overall Study|Withdrawal by Subject|4|||
42182631|NCT03074500|75990474|FG000|Overall Study|Lost to Follow-up|1|||
42182632|NCT03074500|75990475|FG001|Overall Study|Lost to Follow-up|0|||
42182633|NCT03074500|75990476|FG002|Overall Study|Lost to Follow-up|0|||
42182634|NCT03074500|75990474|FG000|Overall Study|Lack of Efficacy|0|||
42182635|NCT03074500|75990475|FG001|Overall Study|Lack of Efficacy|1|||
42358725|NCT03745651|76204511|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
42358726|NCT03745651|76204512|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
42358727|NCT03745651|76204506|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
42358728|NCT03745651|76204507|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
42358729|NCT03745651|76204508|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
42358730|NCT03745651|76204509|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
42358731|NCT03745651|76204510|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
42358732|NCT03745651|76204511|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
42358733|NCT03745651|76204512|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
42358734|NCT03745651|76204506|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
42358735|NCT03745651|76204507|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
42358736|NCT03745651|76204508|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
42358737|NCT03745651|76204509|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
42358738|NCT03745651|76204510|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
42358739|NCT03745651|76204511|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
42358740|NCT03745651|76204512|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
42358741|NCT03745651|76204506|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
42358742|NCT03745651|76204507|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
42358743|NCT03745651|76204508|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
42358744|NCT03745651|76204509|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
42294680|NCT01364649|76129191|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
42294681|NCT01364649|76129190|FG000|Overall Study|Lack of Efficacy|6|||
42294682|NCT01364649|76129191|FG001|Overall Study|Lack of Efficacy|0|||
42294683|NCT01364649|76129190|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
42294684|NCT01364649|76129191|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
42294685|NCT01364649|76129190|FG000|Overall Study|Protocol Deviations|4|||
42294686|NCT01364649|76129191|FG001|Overall Study|Protocol Deviations|8|||
42294687|NCT01364649|76129190|FG000|Overall Study|Withdrawal of Consent|9|||
42294688|NCT01364649|76129191|FG001|Overall Study|Withdrawal of Consent|7|||
42294689|NCT01364649|76129190|FG000|Overall Study|Lost to Follow-up|12|||
42294690|NCT01364649|76129191|FG001|Overall Study|Lost to Follow-up|13|||
42294691|NCT01364649|76129190|FG000|Overall Study|Other|4|||
42294692|NCT01364649|76129191|FG001|Overall Study|Other|1|||
42294693|NCT02588261|76129199|FG000|Overall Study|Study Terminated by Sponsor|157|||
42294694|NCT02588261|76129200|FG001|Overall Study|Study Terminated by Sponsor|142|||
42294695|NCT02588261|76129199|FG000|Overall Study|Protocol Deviation|1|||
42294696|NCT02588261|76129200|FG001|Overall Study|Protocol Deviation|0|||
42294697|NCT02588261|76129199|FG000|Overall Study|Death|1|||
42294698|NCT02588261|76129200|FG001|Overall Study|Death|2|||
42294699|NCT02588261|76129199|FG000|Overall Study|Withdrawal by Subject|12|||
42294700|NCT02588261|76129200|FG001|Overall Study|Withdrawal by Subject|8|||
42294701|NCT02588261|76129199|FG000|Overall Study|Noncompliance with Study Drug|0|||
42294702|NCT02588261|76129200|FG001|Overall Study|Noncompliance with Study Drug|1|||
42294703|NCT02588261|76129199|FG000|Overall Study|Miscellaneous|5|||
42294704|NCT02588261|76129200|FG001|Overall Study|Miscellaneous|4|||
42294705|NCT02588261|76129199|FG000|Overall Study|Progressive Disease|61|||
42294706|NCT02588261|76129200|FG001|Overall Study|Progressive Disease|82|||
42294707|NCT02588261|76129199|FG000|Overall Study|Adverse Event|29|||
42090500|NCT00586508|75900980|FG001|Overall Study|Withdrawal by Subject|0|||
42090501|NCT00581919|75900986|FG000|Overall Study|Adverse Event|8|||
42090502|NCT00581919|75900986|FG000|Overall Study|Death|1|||
42090503|NCT00581919|75900986|FG000|Overall Study|Disease Progression|10|||
42090504|NCT00581919|75900986|FG000|Overall Study|Physician Decision|1|||
42090505|NCT00581919|75900986|FG000|Overall Study|Other Complicating Disease|1|||
42090506|NCT00581919|75900986|FG000|Overall Study|Started Non-Protocol Therapy|2|||
42090507|NCT00581919|75900986|FG000|Overall Study|Withdrawal by Subject|1|||
42090508|NCT00723528|75900994|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
42090509|NCT00723528|75900995|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
42090510|NCT00723528|75900996|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
42090511|NCT00723528|75900997|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
42090512|NCT00723528|75900998|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
42182636|NCT03074500|75990476|FG002|Overall Study|Lack of Efficacy|0|||
42294708|NCT02588261|76129200|FG001|Overall Study|Adverse Event|24|||
42294709|NCT02588261|76129199|FG000|Overall Study|Lost to Follow-up|1|||
42294710|NCT02588261|76129200|FG001|Overall Study|Lost to Follow-up|0|||
42294711|NCT01359449|76129208|FG000|Overall Study|Lost to Follow-up|1|||
42090513|NCT00723528|75900999|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
42294712|NCT01359449|76129209|FG001|Overall Study|Lost to Follow-up|0|||
42294713|NCT01359449|76129208|FG000|Overall Study|Protocol Violation|0|||
42294714|NCT01359449|76129209|FG001|Overall Study|Protocol Violation|2|||
42294715|NCT01359449|76129208|FG000|Overall Study|Withdrawal by Subject|3|||
42294716|NCT01359449|76129209|FG001|Overall Study|Withdrawal by Subject|2|||
42294717|NCT01672723|76129215|FG000|First Intervention|Adverse Event|3|||
42090514|NCT00723528|75901000|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
42090515|NCT00723528|75900994|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
42090516|NCT00723528|75900995|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
42090517|NCT00723528|75900996|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
42090518|NCT00723528|75900997|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
42090519|NCT00723528|75900998|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
42090520|NCT00723528|75900999|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
42090521|NCT00723528|75901000|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
42090522|NCT00723528|75900994|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
42090523|NCT00723528|75900995|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
42090524|NCT00723528|75900996|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
42090525|NCT00723528|75900997|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
42090526|NCT00723528|75900998|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
42090527|NCT00723528|75900999|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
42090528|NCT00723528|75901000|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
42090529|NCT00723528|75900994|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
42090530|NCT00723528|75900995|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
42090531|NCT00723528|75900996|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
42090532|NCT00723528|75900997|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
42090533|NCT00723528|75900998|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
42090534|NCT00723528|75900999|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
42182637|NCT03074500|75990474|FG000|Overall Study|Adverse Event|0|||
42182638|NCT03074500|75990475|FG001|Overall Study|Adverse Event|0|||
42182639|NCT03074500|75990476|FG002|Overall Study|Adverse Event|1|||
42182640|NCT03715530|75990489|FG000|Overall Study|Lost to Follow-up|3|||
42182641|NCT03715530|75990490|FG001|Overall Study|Lost to Follow-up|1|||
42182642|NCT03715530|75990491|FG002|Overall Study|Lost to Follow-up|2|||
42182643|NCT03077698|75990501|FG000|Progestin Monotherapy|Stable Disease|8|||
42182644|NCT03077698|75990502|FG001|Progestin Monotherapy|Stable Disease|0|||
42182645|NCT03077698|75990501|FG000|Progestin Monotherapy|Adverse Event|1|||
42182646|NCT03077698|75990502|FG001|Progestin Monotherapy|Adverse Event|0|||
42182647|NCT03077698|75990501|FG000|Progestin Monotherapy|Death|1|||
42182648|NCT03077698|75990502|FG001|Progestin Monotherapy|Death|0|||
42182649|NCT03077698|75990501|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
42182650|NCT03077698|75990502|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
42182651|NCT03077698|75990501|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
42182652|NCT03077698|75990502|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
42182653|NCT03077698|75990501|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
42182654|NCT03077698|75990502|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
42182655|NCT03077698|75990501|FG000|Safety Follow Up|Withdrawal by Subject|2|||
42182656|NCT03077698|75990502|FG001|Safety Follow Up|Withdrawal by Subject|1|||
42182657|NCT03077698|75990501|FG000|Safety Follow Up|Transfer of care to hospice|1|||
42182658|NCT03077698|75990502|FG001|Safety Follow Up|Transfer of care to hospice|0|||
42182659|NCT03079102|75990520|FG000|Overall Study|Physician Decision|0|||
42182660|NCT03079102|75990521|FG001|Overall Study|Physician Decision|1|||
42182661|NCT02434354|75990527|FG000|Overall Study|screen fail|3|||
42182662|NCT03076996|75990531|FG000|Overall Study|Withdrawal by Subject|2|||
42182663|NCT03076996|75990531|FG000|Overall Study|Lost to Follow-up|3|||
42182664|NCT03076996|75990531|FG000|Overall Study|Literacy precluded participation|1|||
42182665|NCT03078868|75990535|FG000|Overall Study|Physician Decision|3|||
42182666|NCT04524598|75990543|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
42182667|NCT04524598|75990544|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
42182668|NCT04524598|75990545|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
42182669|NCT04524598|75990546|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
42182670|NCT04524598|75990547|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
42182671|NCT04524598|75990543|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
42182672|NCT04524598|75990544|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
42182673|NCT04524598|75990545|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
42294718|NCT01672723|76129216|FG001|First Intervention|Adverse Event|0|||
42294719|NCT02632747|76129224|FG000|Wash-out Period|Adverse Event|1|||
42294720|NCT02632747|76129225|FG001|Wash-out Period|Adverse Event|0|||
42294721|NCT02520531|76129244|FG000|Overall Study|Revision of study device components|2|||
42294722|NCT02520531|76129245|FG001|Overall Study|Revision of study device components|2|||
42294723|NCT02520531|76129244|FG000|Overall Study|Death|1|||
42294724|NCT02520531|76129245|FG001|Overall Study|Death|2|||
42294725|NCT02520531|76129244|FG000|Overall Study|Lost to Follow-up|1|||
42090535|NCT00723528|75901000|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
42182674|NCT04524598|75990546|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
42294726|NCT02520531|76129245|FG001|Overall Study|Lost to Follow-up|1|||
42294727|NCT02520531|76129244|FG000|Overall Study|Meet exclusion criterion|0|||
42182675|NCT04524598|75990547|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
42182676|NCT04524598|75990543|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
42182677|NCT04524598|75990544|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
42182678|NCT04524598|75990545|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
42182679|NCT04524598|75990546|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
42182680|NCT04524598|75990547|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
42182681|NCT04524598|75990543|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
42182682|NCT04524598|75990544|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
42182683|NCT04524598|75990545|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
42182684|NCT04524598|75990546|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
42182685|NCT04524598|75990547|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
42182686|NCT04524598|75990543|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
42182687|NCT04524598|75990544|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
42182688|NCT04524598|75990545|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
42182689|NCT04524598|75990546|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
42182690|NCT04524598|75990547|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
42182691|NCT04524598|75990543|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
42090536|NCT00723528|75900994|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
42090537|NCT00723528|75900995|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
42182692|NCT04524598|75990544|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
42182693|NCT04524598|75990545|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
42182694|NCT04524598|75990546|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
42182695|NCT04524598|75990547|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
42182696|NCT04524598|75990543|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
42182697|NCT04524598|75990544|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
42182698|NCT04524598|75990545|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
42182699|NCT04524598|75990546|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
42182700|NCT04524598|75990547|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
42182701|NCT03075904|75990561|FG000|Overall Study|Physician Decision|3|||
42090538|NCT00723528|75900996|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
42090539|NCT00723528|75900997|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
42090540|NCT00723528|75900998|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
42090541|NCT00723528|75900999|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
42090542|NCT00723528|75901000|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
42090543|NCT00723528|75900994|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
42182702|NCT03075904|75990561|FG000|Overall Study|Need for Medication not Permitted|1|||
42182703|NCT03073798|75990565|FG000|Overall Study|Adverse Event|1|||
42182704|NCT03073798|75990565|FG000|Overall Study|Withdrawal by Subject|1|||
42182705|NCT03075826|75990570|FG000|Overall Study|Withdrawal by Subject|1|||
42182706|NCT03075826|75990570|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
42182707|NCT02865850|75990585|FG000|Overall Study|Death|15|||
42182708|NCT02865850|75990586|FG001|Overall Study|Death|19|||
42182709|NCT02865850|75990585|FG000|Overall Study|Withdrawal by Subject|3|||
42182710|NCT02865850|75990586|FG001|Overall Study|Withdrawal by Subject|2|||
42182711|NCT02865850|75990585|FG000|Overall Study|Lost to Follow-up|3|||
42090544|NCT00723528|75900995|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
42090545|NCT00723528|75900996|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
42090546|NCT00723528|75900997|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
42090547|NCT00723528|75900998|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
42090548|NCT00723528|75900999|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
42090549|NCT00723528|75901000|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
42090550|NCT00723528|75900994|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
42090551|NCT00723528|75900995|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
42090552|NCT00723528|75900996|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
42090553|NCT00723528|75900997|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
42090554|NCT00723528|75900998|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
42090555|NCT00723528|75900999|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
42090556|NCT00723528|75901000|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
42090557|NCT00723528|75900994|FG000|Period 2: After Controlled Period|Other|0|||
42090558|NCT00723528|75900995|FG001|Period 2: After Controlled Period|Other|0|||
42090559|NCT00723528|75900996|FG002|Period 2: After Controlled Period|Other|0|||
42182712|NCT02865850|75990586|FG001|Overall Study|Lost to Follow-up|2|||
42182713|NCT03711162|75990595|FG000|Overall Study|Adverse Event|5|||
42182714|NCT03711162|75990596|FG001|Overall Study|Adverse Event|2|||
42090560|NCT00723528|75900997|FG003|Period 2: After Controlled Period|Other|0|||
42090561|NCT00723528|75900998|FG004|Period 2: After Controlled Period|Other|1|||
42090562|NCT00723528|75900999|FG005|Period 2: After Controlled Period|Other|4|||
42182715|NCT03711162|75990597|FG002|Overall Study|Adverse Event|4|||
42182716|NCT03711162|75990595|FG000|Overall Study|Death|11|||
42182717|NCT03711162|75990596|FG001|Overall Study|Death|7|||
42182718|NCT03711162|75990597|FG002|Overall Study|Death|8|||
42182719|NCT03711162|75990595|FG000|Overall Study|Lost to Follow-up|1|||
42182720|NCT03711162|75990596|FG001|Overall Study|Lost to Follow-up|0|||
42182721|NCT03711162|75990597|FG002|Overall Study|Lost to Follow-up|1|||
42182722|NCT03711162|75990595|FG000|Overall Study|Study Terminated by Sponsor|139|||
42182723|NCT03711162|75990596|FG001|Overall Study|Study Terminated by Sponsor|152|||
42182724|NCT03711162|75990597|FG002|Overall Study|Study Terminated by Sponsor|146|||
42182725|NCT03711162|75990595|FG000|Overall Study|Withdrawal by Subject|17|||
42182726|NCT03711162|75990596|FG001|Overall Study|Withdrawal by Subject|10|||
42182727|NCT03711162|75990597|FG002|Overall Study|Withdrawal by Subject|10|||
42182728|NCT03711162|75990595|FG000|Overall Study|Miscellaneous|1|||
42182729|NCT03711162|75990596|FG001|Overall Study|Miscellaneous|2|||
42090563|NCT00723528|75901000|FG006|Period 2: After Controlled Period|Other|0|||
42090564|NCT00723528|75900994|FG000|Period 2: After Controlled Period|Adverse Event|0|||
42090565|NCT00723528|75900995|FG001|Period 2: After Controlled Period|Adverse Event|0|||
42090566|NCT00723528|75900996|FG002|Period 2: After Controlled Period|Adverse Event|0|||
42090567|NCT00723528|75900997|FG003|Period 2: After Controlled Period|Adverse Event|0|||
42090568|NCT00723528|75900998|FG004|Period 2: After Controlled Period|Adverse Event|1|||
42090569|NCT00723528|75900999|FG005|Period 2: After Controlled Period|Adverse Event|0|||
42090570|NCT00723528|75901000|FG006|Period 2: After Controlled Period|Adverse Event|1|||
42090571|NCT00723528|75900994|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
42090572|NCT00723528|75900995|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
42090573|NCT00723528|75900996|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
42090574|NCT00723528|75900997|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
42090575|NCT00723528|75900998|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
42090576|NCT00723528|75900999|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
42090577|NCT00723528|75901000|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
42090578|NCT00723528|75900994|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
42090579|NCT00723528|75900995|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
42090580|NCT00723528|75900996|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
42182730|NCT03711162|75990597|FG002|Overall Study|Miscellaneous|2|||
42182731|NCT03711162|75990595|FG000|Overall Study|Not Treated|1|||
42182732|NCT03711162|75990596|FG001|Overall Study|Not Treated|0|||
42182733|NCT03711162|75990597|FG002|Overall Study|Not Treated|1|||
42182734|NCT03711162|75990595|FG000|Overall Study|Physician Decision|0|||
42182735|NCT03711162|75990596|FG001|Overall Study|Physician Decision|2|||
42182736|NCT03711162|75990597|FG002|Overall Study|Physician Decision|0|||
42182737|NCT03711162|75990595|FG000|Overall Study|Lack of Efficacy|0|||
42182738|NCT03711162|75990596|FG001|Overall Study|Lack of Efficacy|0|||
42182739|NCT03711162|75990597|FG002|Overall Study|Lack of Efficacy|2|||
42090581|NCT00723528|75900997|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
42090582|NCT00723528|75900998|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
42090583|NCT00723528|75900999|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
42090584|NCT00723528|75901000|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
42090585|NCT00751790|75901016|FG000|Overall Study|Lost to Follow-up|1|||
42090586|NCT00751790|75901016|FG000|Overall Study|Death|3|||
42090587|NCT00751790|75901016|FG000|Overall Study|Withdrawal by Subject|1|||
42182740|NCT03711162|75990595|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
42182741|NCT03711162|75990596|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
42182742|NCT03711162|75990597|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
42182743|NCT03072160|75990613|FG000|Overall Study|Adverse Event|3|||
42182744|NCT03072160|75990614|FG001|Overall Study|Adverse Event|1|||
42182745|NCT03072160|75990613|FG000|Overall Study|Refused further treatment|6|||
42182746|NCT03072160|75990614|FG001|Overall Study|Refused further treatment|1|||
42182747|NCT03072160|75990613|FG000|Overall Study|Physician Decision|1|||
42182748|NCT03072160|75990614|FG001|Overall Study|Physician Decision|0|||
42182749|NCT03072160|75990613|FG000|Overall Study|Disease progression on study|1|||
42182750|NCT03072160|75990614|FG001|Overall Study|Disease progression on study|1|||
42090588|NCT00723450|75901022|FG000|Open-Label Phase|Adverse Event|26|||
42090589|NCT00723450|75901023|FG001|Open-Label Phase|Adverse Event|0|||
42090590|NCT00723450|75901024|FG002|Open-Label Phase|Adverse Event|0|||
42090591|NCT00723450|75901022|FG000|Open-Label Phase|Lack of Efficacy|18|||
42182751|NCT03072160|75990613|FG000|Overall Study|No contact|0|||
42182752|NCT03072160|75990614|FG001|Overall Study|No contact|1|||
42182753|NCT00407602|75990652|FG000|Overall Study|Death - unrelated to device|1|||
42182754|NCT00407602|75990652|FG000|Overall Study|Device explanted|5|||
42090592|NCT00723450|75901023|FG001|Open-Label Phase|Lack of Efficacy|0|||
42090593|NCT00723450|75901024|FG002|Open-Label Phase|Lack of Efficacy|0|||
42090594|NCT00723450|75901022|FG000|Open-Label Phase|Protocol Violation|35|||
42090595|NCT00723450|75901023|FG001|Open-Label Phase|Protocol Violation|0|||
42090596|NCT00723450|75901024|FG002|Open-Label Phase|Protocol Violation|0|||
42090597|NCT00723450|75901022|FG000|Open-Label Phase|Lost to Follow-up|7|||
42090598|NCT00723450|75901023|FG001|Open-Label Phase|Lost to Follow-up|0|||
42090599|NCT00723450|75901024|FG002|Open-Label Phase|Lost to Follow-up|0|||
42090600|NCT00723450|75901022|FG000|Open-Label Phase|Physician Decision|2|||
42090601|NCT00723450|75901023|FG001|Open-Label Phase|Physician Decision|0|||
42090602|NCT00723450|75901024|FG002|Open-Label Phase|Physician Decision|0|||
42090603|NCT00723450|75901022|FG000|Open-Label Phase|Withdrawal by Subject|37|||
42090604|NCT00723450|75901023|FG001|Open-Label Phase|Withdrawal by Subject|0|||
42090605|NCT00723450|75901024|FG002|Open-Label Phase|Withdrawal by Subject|0|||
42090606|NCT00723450|75901022|FG000|Randomized Phase|Adverse Event|0|||
42090607|NCT00723450|75901023|FG001|Randomized Phase|Adverse Event|26|||
42182755|NCT00407602|75990652|FG000|Overall Study|Withdrawal by Subject|1|||
42182756|NCT03057496|75990659|FG000|Overall Study|Withdrawal by Subject|8|||
42182757|NCT03057496|75990659|FG000|Overall Study|Lost to Follow-up|5|||
42182758|NCT03057496|75990659|FG000|Overall Study|Did not use device during home trial|3|||
42182759|NCT03057496|75990659|FG000|Overall Study|Device failure|2|||
42182760|NCT03708744|75990669|FG000|Overall Study|Withdrawal by Subject|0|||
42182761|NCT03708744|75990670|FG001|Overall Study|Withdrawal by Subject|0|||
42182762|NCT03708744|75990671|FG002|Overall Study|Withdrawal by Subject|1|||
42182763|NCT03708744|75990672|FG003|Overall Study|Withdrawal by Subject|0|||
42182764|NCT02574286|75990686|FG000|Overall Study|Adverse Event|3|||
42182765|NCT02574286|75990686|FG000|Overall Study|Withdrawal by Subject|2|||
42182766|NCT02083354|75990694|FG000|Overall Study|Withdrawal by Subject|9|||
42182767|NCT02083354|75990694|FG000|Overall Study|Lost to Follow-up|1|||
42182768|NCT02083354|75990694|FG000|Overall Study|Adverse Event|3|||
42090608|NCT00723450|75901024|FG002|Randomized Phase|Adverse Event|17|||
42090609|NCT00723450|75901022|FG000|Randomized Phase|Lack of Efficacy|0|||
42090610|NCT00723450|75901023|FG001|Randomized Phase|Lack of Efficacy|11|||
42090611|NCT00723450|75901024|FG002|Randomized Phase|Lack of Efficacy|11|||
42090612|NCT00723450|75901022|FG000|Randomized Phase|Protocol Violation|0|||
42090613|NCT00723450|75901023|FG001|Randomized Phase|Protocol Violation|9|||
42090614|NCT00723450|75901024|FG002|Randomized Phase|Protocol Violation|13|||
42090615|NCT00723450|75901022|FG000|Randomized Phase|Lost to Follow-up|0|||
42090616|NCT00723450|75901023|FG001|Randomized Phase|Lost to Follow-up|2|||
42090617|NCT00723450|75901024|FG002|Randomized Phase|Lost to Follow-up|3|||
42090618|NCT00723450|75901022|FG000|Randomized Phase|Physician Decision|0|||
42090619|NCT00723450|75901023|FG001|Randomized Phase|Physician Decision|3|||
42090620|NCT00723450|75901024|FG002|Randomized Phase|Physician Decision|1|||
42182769|NCT02083354|75990694|FG000|Overall Study|Disease progression|46|||
42182770|NCT02083354|75990694|FG000|Overall Study|Study closed/terminated|5|||
42182771|NCT04230486|75990698|FG000|Overall Study|Screen Failure|1|||
42182772|NCT01399918|75990704|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
42182773|NCT00112840|75990711|FG000|Overall Study|Physician Decision|1|||
42182774|NCT00112840|75990712|FG001|Overall Study|Physician Decision|0|||
42182775|NCT00112840|75990713|FG002|Overall Study|Physician Decision|0|||
42182776|NCT00112840|75990711|FG000|Overall Study|Withdrawal by Subject|1|||
42182777|NCT00112840|75990712|FG001|Overall Study|Withdrawal by Subject|0|||
42182778|NCT00112840|75990713|FG002|Overall Study|Withdrawal by Subject|1|||
42182779|NCT00112840|75990711|FG000|Overall Study|Protocol Violation|0|||
42182780|NCT00112840|75990712|FG001|Overall Study|Protocol Violation|0|||
42182781|NCT00112840|75990713|FG002|Overall Study|Protocol Violation|5|||
42182782|NCT02197572|75990726|FG000|Overall Study|Progressive Disease|28|||
42182783|NCT02197572|75990726|FG000|Overall Study|Withdrawal by Subject|9|||
42182784|NCT02197572|75990726|FG000|Overall Study|Adverse Event|3|||
42182785|NCT02197572|75990726|FG000|Overall Study|Reason Not Specified|4|||
42182786|NCT03176784|75990734|FG000|Overall Study|Lost to Follow-up|77|||
42182787|NCT03176784|75990735|FG001|Overall Study|Lost to Follow-up|79|||
42182788|NCT03176784|75990736|FG002|Overall Study|Lost to Follow-up|79|||
42090621|NCT00723450|75901022|FG000|Randomized Phase|Withdrawal by Subject|0|||
42090622|NCT00723450|75901023|FG001|Randomized Phase|Withdrawal by Subject|14|||
42090623|NCT00723450|75901024|FG002|Randomized Phase|Withdrawal by Subject|22|||
42090624|NCT00751400|75901033|FG000|Overall Study|Lost to Follow-up|10|||
42182789|NCT03176784|75990737|FG003|Overall Study|Lost to Follow-up|49|||
42182790|NCT03176784|75990734|FG000|Overall Study|Withdrawal by Subject|28|||
42090625|NCT00585312|75901039|FG000|Overall Study|Adverse Event|3|||
42090626|NCT00585312|75901040|FG001|Overall Study|Adverse Event|0|||
42090627|NCT00585312|75901039|FG000|Overall Study|Lack of Efficacy|6|||
42090628|NCT00585312|75901040|FG001|Overall Study|Lack of Efficacy|11|||
42090629|NCT00585312|75901039|FG000|Overall Study|Lost to Follow-up|1|||
42090630|NCT00585312|75901040|FG001|Overall Study|Lost to Follow-up|1|||
42090631|NCT00585312|75901039|FG000|Overall Study|Reason not specified|2|||
42090632|NCT00585312|75901040|FG001|Overall Study|Reason not specified|0|||
42090633|NCT00585312|75901039|FG000|Overall Study|Withdrawal by Subject|5|||
42182791|NCT03176784|75990735|FG001|Overall Study|Withdrawal by Subject|34|||
42182792|NCT03176784|75990736|FG002|Overall Study|Withdrawal by Subject|34|||
42182793|NCT03176784|75990737|FG003|Overall Study|Withdrawal by Subject|21|||
42182794|NCT03049852|75990750|FG000|Overall Study|Lost to Follow-up|0|||
42182795|NCT03049852|75990751|FG001|Overall Study|Lost to Follow-up|1|||
42182796|NCT03049852|75990752|FG002|Overall Study|Lost to Follow-up|0|||
42182797|NCT05091528|75990764|FG000|Overall Study|Study Termination by Sponsor|0|||
42182798|NCT05091528|75990765|FG001|Overall Study|Study Termination by Sponsor|1|||
42182799|NCT05091528|75990766|FG002|Overall Study|Study Termination by Sponsor|0|||
42182800|NCT05091528|75990767|FG003|Overall Study|Study Termination by Sponsor|1|||
42182801|NCT01317004|75990790|FG000|Overall Study|Withdrawal by Subject|1|||
42182802|NCT01317004|75990791|FG001|Overall Study|Withdrawal by Subject|4|||
42182803|NCT01317004|75990790|FG000|Overall Study|Protocol Violation|0|||
42182804|NCT01317004|75990791|FG001|Overall Study|Protocol Violation|2|||
42182805|NCT01317004|75990790|FG000|Overall Study|Adverse Event|3|||
42182806|NCT01317004|75990791|FG001|Overall Study|Adverse Event|3|||
42182807|NCT01343056|75990801|FG000|Overall Study|Lost to Follow-up|7|||
42182808|NCT01343056|75990802|FG001|Overall Study|Lost to Follow-up|5|||
42182809|NCT01343056|75990803|FG002|Overall Study|Lost to Follow-up|3|||
42182810|NCT01343056|75990804|FG003|Overall Study|Lost to Follow-up|9|||
42182811|NCT01316692|75990818|FG000|Overall Study|Adverse Event|5|||
42182812|NCT01316692|75990818|FG000|Overall Study|Disease Progression|7|||
42182813|NCT01316380|75990825|FG000|Overall Study|Adverse Event|0|||
42182814|NCT01316380|75990826|FG001|Overall Study|Adverse Event|2|||
42182815|NCT01316380|75990827|FG002|Overall Study|Adverse Event|1|||
42182816|NCT01316380|75990825|FG000|Overall Study|Protocol Violation|0|||
42182817|NCT01316380|75990826|FG001|Overall Study|Protocol Violation|0|||
42182818|NCT01316380|75990827|FG002|Overall Study|Protocol Violation|1|||
42182819|NCT01316380|75990825|FG000|Overall Study|Withdrawal by Subject|1|||
42182820|NCT01316380|75990826|FG001|Overall Study|Withdrawal by Subject|2|||
42182821|NCT01316380|75990827|FG002|Overall Study|Withdrawal by Subject|0|||
42090634|NCT00585312|75901040|FG001|Overall Study|Withdrawal by Subject|1|||
42182822|NCT01316380|75990825|FG000|Overall Study|Other|0|||
42182823|NCT01316380|75990826|FG001|Overall Study|Other|1|||
42182824|NCT01316380|75990827|FG002|Overall Study|Other|1|||
42182825|NCT01316380|75990825|FG000|Overall Study|Not treated|1|||
42182826|NCT01316380|75990826|FG001|Overall Study|Not treated|0|||
42182827|NCT01316380|75990827|FG002|Overall Study|Not treated|0|||
42182828|NCT01316224|75990835|FG000|Overall Study|Protocol Violation|3|||
42182829|NCT01316224|75990835|FG000|Overall Study|Adverse Event|3|||
42182830|NCT01316224|75990835|FG000|Overall Study|Lack of Efficacy|1|||
42182831|NCT01316224|75990835|FG000|Overall Study|Withdrawal by Subject|1|||
42182832|NCT01316224|75990835|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
42182833|NCT01316224|75990835|FG000|Overall Study|Other|1|||
42182834|NCT04315298|75990858|FG000|Overall Study|Withdrawal by Subject|0|||
42182835|NCT04315298|75990859|FG001|Overall Study|Withdrawal by Subject|0|||
42182836|NCT04315298|75990860|FG002|Overall Study|Withdrawal by Subject|0|||
42182837|NCT04315298|75990861|FG003|Overall Study|Withdrawal by Subject|2|||
42182838|NCT04315298|75990862|FG004|Overall Study|Withdrawal by Subject|2|||
42182839|NCT04315298|75990863|FG005|Overall Study|Withdrawal by Subject|2|||
42182840|NCT04315298|75990864|FG006|Overall Study|Withdrawal by Subject|0|||
42182841|NCT04315298|75990865|FG007|Overall Study|Withdrawal by Subject|1|||
42182842|NCT04315298|75990866|FG008|Overall Study|Withdrawal by Subject|1|||
42182843|NCT04315298|75990867|FG009|Overall Study|Withdrawal by Subject|1|||
42182844|NCT04315298|75990868|FG010|Overall Study|Withdrawal by Subject|0|||
42182845|NCT04315298|75990869|FG011|Overall Study|Withdrawal by Subject|0|||
42182846|NCT04315298|75990870|FG012|Overall Study|Withdrawal by Subject|0|||
42294728|NCT02520531|76129245|FG001|Overall Study|Meet exclusion criterion|1|||
42294729|NCT02520531|76129244|FG000|Overall Study|Withdrawal by Subject|1|||
42294730|NCT02520531|76129245|FG001|Overall Study|Withdrawal by Subject|0|||
42294731|NCT02520531|76129244|FG000|Overall Study|Not study device|1|||
42294732|NCT02520531|76129245|FG001|Overall Study|Not study device|0|||
42294733|NCT01671319|76129251|FG000|Overall Study|Withdrawal by Subject|1|||
42358745|NCT03745651|76204510|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
42090635|NCT00585312|75901039|FG000|Overall Study|Study terminated by the sponsor|34|||
42182847|NCT04315298|75990871|FG013|Overall Study|Withdrawal by Subject|0|||
42182848|NCT04315298|75990872|FG014|Overall Study|Withdrawal by Subject|0|||
42294734|NCT01670539|76129255|FG000|Overall Study|Death|3|||
42294735|NCT01670539|76129256|FG001|Overall Study|Death|5|||
42090636|NCT00585312|75901040|FG001|Overall Study|Study terminated by the sponsor|31|||
42090637|NCT00753506|75901048|FG000|Overall Study|Withdrawal by Subject|4|||
42090638|NCT00753506|75901049|FG001|Overall Study|Withdrawal by Subject|1|||
42090639|NCT00753506|75901048|FG000|Overall Study|Lost to Follow-up|2|||
42090640|NCT00753506|75901049|FG001|Overall Study|Lost to Follow-up|0|||
42090641|NCT00753506|75901048|FG000|Overall Study|Other reason|1|||
42090642|NCT00753506|75901049|FG001|Overall Study|Other reason|1|||
42090643|NCT00720096|75901057|FG000|Overall Study|Withdrawal by Subject|0|||
42090644|NCT00720096|75901058|FG001|Overall Study|Withdrawal by Subject|2|||
42090645|NCT00723294|75901064|FG000|Overall Study|Lobular histology|2|||
42090646|NCT00723294|75901064|FG000|Overall Study|>25% intraductal component|1|||
42090647|NCT00723294|75901064|FG000|Overall Study|No MRI tumor enhancement|1|||
42090648|NCT00723294|75901064|FG000|Overall Study|1.0-Tesla MRI|1|||
42090649|NCT00723294|75901064|FG000|Overall Study|No cryoabalation|2|||
42090650|NCT00723294|75901064|FG000|Overall Study|Did not undergo surgery|1|||
42090651|NCT00723294|75901064|FG000|Overall Study|Treated prior to registration|1|||
42090652|NCT00723294|75901064|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
42090653|NCT00723294|75901064|FG000|Overall Study|Benign lesion|1|||
42090654|NCT00723294|75901064|FG000|Overall Study|Withdrawal by Subject|1|||
42090655|NCT00723294|75901064|FG000|Overall Study|No treatment due to probe failure|1|||
42090656|NCT00747344|75901070|FG000|Controlled Period|Adverse Event|3|||
42090657|NCT00747344|75901071|FG001|Controlled Period|Adverse Event|0|||
42090658|NCT00747344|75901072|FG002|Controlled Period|Adverse Event|0|||
42090659|NCT00747344|75901073|FG003|Controlled Period|Adverse Event|0|||
42090660|NCT00747344|75901070|FG000|Controlled Period|Lack of Efficacy|2|||
42090661|NCT00747344|75901071|FG001|Controlled Period|Lack of Efficacy|1|||
42090662|NCT00747344|75901072|FG002|Controlled Period|Lack of Efficacy|0|||
42090663|NCT00747344|75901073|FG003|Controlled Period|Lack of Efficacy|0|||
42090664|NCT00747344|75901070|FG000|Controlled Period|Other|0|||
42294736|NCT01670539|76129255|FG000|Overall Study|Withdrawal by Subject|3|||
42294737|NCT01670539|76129256|FG001|Overall Study|Withdrawal by Subject|0|||
42294738|NCT02516163|76129263|FG000|Overall Study|Withdrawal by Subject|1|||
42294739|NCT02516163|76129263|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
42294740|NCT02516163|76129263|FG000|Overall Study|Unfit/delay in surgery|3|||
42294741|NCT02516163|76129263|FG000|Overall Study|Use of incorrect measurement technique|5|||
42294742|NCT02516163|76129263|FG000|Overall Study|Data not recorded|2|||
42358746|NCT03745651|76204511|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
42358747|NCT03745651|76204512|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
42358748|NCT03745651|76204506|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
42358749|NCT03745651|76204507|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
42358750|NCT03745651|76204508|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
42358751|NCT03745651|76204509|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
42358752|NCT03745651|76204510|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
42358753|NCT03745651|76204511|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
42358754|NCT03745651|76204512|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
42358755|NCT03745651|76204506|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
42090665|NCT00747344|75901071|FG001|Controlled Period|Other|3|||
42090666|NCT00747344|75901072|FG002|Controlled Period|Other|0|||
42090667|NCT00747344|75901073|FG003|Controlled Period|Other|0|||
42090668|NCT00747344|75901070|FG000|After Controlled Period|Adverse Event|0|||
42090669|NCT00747344|75901071|FG001|After Controlled Period|Adverse Event|0|||
42090670|NCT00747344|75901072|FG002|After Controlled Period|Adverse Event|0|||
42294743|NCT02516163|76129263|FG000|Overall Study|MRI contraindication exclusion|6|||
42294744|NCT02589665|76129271|FG000|Induction Period|Did not receive drug|0|||
42294745|NCT02589665|76129272|FG001|Induction Period|Did not receive drug|0|||
42294746|NCT02589665|76129273|FG002|Induction Period|Did not receive drug|0|||
42294747|NCT02589665|76129274|FG003|Induction Period|Did not receive drug|1|||
42090671|NCT00747344|75901073|FG003|After Controlled Period|Adverse Event|1|||
42090672|NCT00580983|75901081|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
42090673|NCT00753896|75901085|FG000|Overall Study|Adverse Event|4|||
42090674|NCT00753896|75901085|FG000|Overall Study|Death|1|||
42090675|NCT00753896|75901085|FG000|Overall Study|Lost to Follow-up|2|||
42090676|NCT00753896|75901085|FG000|Overall Study|Protocol Violation|1|||
42090677|NCT00753896|75901085|FG000|Overall Study|Withdrawal by Subject|4|||
42090678|NCT00753896|75901085|FG000|Overall Study|Entry Criteria Not Met|4|||
42090679|NCT00743444|75901089|FG000|First Intervention|Catheter placement problems|0|||
42090680|NCT00743444|75901090|FG001|First Intervention|Catheter placement problems|1|||
42090681|NCT00743444|75901089|FG000|Washout Period|Adverse Event|0|||
42090682|NCT00743444|75901090|FG001|Washout Period|Adverse Event|1|||
42090683|NCT00743366|75901096|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
42090684|NCT00743366|75901097|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
42090685|NCT00721968|75901105|FG000|Overall Study|Lost to Follow-up|2|||
42294748|NCT02589665|76129275|FG004|Induction Period|Did not receive drug|0|||
42294749|NCT02589665|76129276|FG005|Induction Period|Did not receive drug|0|||
42182849|NCT04315298|75990873|FG015|Overall Study|Withdrawal by Subject|0|||
42182850|NCT04315298|75990874|FG016|Overall Study|Withdrawal by Subject|0|||
42182851|NCT04315298|75990875|FG017|Overall Study|Withdrawal by Subject|0|||
42182852|NCT04315298|75990876|FG018|Overall Study|Withdrawal by Subject|0|||
42182853|NCT04315298|75990858|FG000|Overall Study|Physician Decision|0|||
42182854|NCT04315298|75990859|FG001|Overall Study|Physician Decision|0|||
42358756|NCT03745651|76204507|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
42090686|NCT00721968|75901106|FG001|Overall Study|Lost to Follow-up|0|||
42090687|NCT00743288|75901112|FG000|Overall Study|Adverse Event|1|||
42182855|NCT04315298|75990860|FG002|Overall Study|Physician Decision|0|||
42182856|NCT04315298|75990861|FG003|Overall Study|Physician Decision|0|||
42182857|NCT04315298|75990862|FG004|Overall Study|Physician Decision|1|||
42182858|NCT04315298|75990863|FG005|Overall Study|Physician Decision|0|||
42182859|NCT04315298|75990864|FG006|Overall Study|Physician Decision|0|||
42182860|NCT04315298|75990865|FG007|Overall Study|Physician Decision|0|||
42182861|NCT04315298|75990866|FG008|Overall Study|Physician Decision|0|||
42182862|NCT04315298|75990867|FG009|Overall Study|Physician Decision|0|||
42182863|NCT04315298|75990868|FG010|Overall Study|Physician Decision|0|||
42182864|NCT04315298|75990869|FG011|Overall Study|Physician Decision|0|||
42182865|NCT04315298|75990870|FG012|Overall Study|Physician Decision|0|||
42182866|NCT04315298|75990871|FG013|Overall Study|Physician Decision|0|||
42182867|NCT04315298|75990872|FG014|Overall Study|Physician Decision|0|||
42182868|NCT04315298|75990873|FG015|Overall Study|Physician Decision|0|||
42182869|NCT04315298|75990874|FG016|Overall Study|Physician Decision|0|||
42182870|NCT04315298|75990875|FG017|Overall Study|Physician Decision|0|||
42182871|NCT04315298|75990876|FG018|Overall Study|Physician Decision|0|||
42182872|NCT04315298|75990858|FG000|Overall Study|Lost to Follow-up|5|||
42182873|NCT04315298|75990859|FG001|Overall Study|Lost to Follow-up|10|||
42182874|NCT04315298|75990860|FG002|Overall Study|Lost to Follow-up|6|||
42182875|NCT04315298|75990861|FG003|Overall Study|Lost to Follow-up|8|||
42182876|NCT04315298|75990862|FG004|Overall Study|Lost to Follow-up|12|||
42182877|NCT04315298|75990863|FG005|Overall Study|Lost to Follow-up|13|||
42182878|NCT04315298|75990864|FG006|Overall Study|Lost to Follow-up|9|||
42182879|NCT04315298|75990865|FG007|Overall Study|Lost to Follow-up|16|||
42182880|NCT04315298|75990866|FG008|Overall Study|Lost to Follow-up|14|||
42182881|NCT04315298|75990867|FG009|Overall Study|Lost to Follow-up|0|||
42294750|NCT02589665|76129277|FG006|Induction Period|Did not receive drug|0|||
42294751|NCT02589665|76129278|FG007|Induction Period|Did not receive drug|0|||
42294752|NCT02589665|76129279|FG008|Induction Period|Did not receive drug|0|||
42294753|NCT02589665|76129280|FG009|Induction Period|Did not receive drug|0|||
42294754|NCT02589665|76129271|FG000|Induction Period|Adverse Event|3|||
42294755|NCT02589665|76129272|FG001|Induction Period|Adverse Event|0|||
42294756|NCT02589665|76129273|FG002|Induction Period|Adverse Event|2|||
42294757|NCT02589665|76129274|FG003|Induction Period|Adverse Event|2|||
42294758|NCT02589665|76129275|FG004|Induction Period|Adverse Event|0|||
42294759|NCT02589665|76129276|FG005|Induction Period|Adverse Event|0|||
42294760|NCT02589665|76129277|FG006|Induction Period|Adverse Event|0|||
42358757|NCT03745651|76204508|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
42358758|NCT03745651|76204509|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
42090688|NCT00743288|75901113|FG001|Overall Study|Adverse Event|1|||
42090689|NCT00743288|75901114|FG002|Overall Study|Adverse Event|2|||
42090690|NCT00743288|75901115|FG003|Overall Study|Adverse Event|2|||
42090691|NCT00743288|75901116|FG004|Overall Study|Adverse Event|1|||
42090692|NCT00743288|75901117|FG005|Overall Study|Adverse Event|1|||
42090693|NCT00743288|75901118|FG006|Overall Study|Adverse Event|2|||
42090694|NCT00743288|75901112|FG000|Overall Study|Withdrawal by Subject|0|||
42090695|NCT00743288|75901113|FG001|Overall Study|Withdrawal by Subject|0|||
42090696|NCT00743288|75901114|FG002|Overall Study|Withdrawal by Subject|1|||
42090697|NCT00743288|75901115|FG003|Overall Study|Withdrawal by Subject|0|||
42090698|NCT00743288|75901116|FG004|Overall Study|Withdrawal by Subject|0|||
42090699|NCT00743288|75901117|FG005|Overall Study|Withdrawal by Subject|1|||
42090700|NCT00743288|75901118|FG006|Overall Study|Withdrawal by Subject|1|||
42090701|NCT00743288|75901112|FG000|Overall Study|Progressive disease (PD)|2|||
42090702|NCT00743288|75901113|FG001|Overall Study|Progressive disease (PD)|0|||
42090703|NCT00743288|75901114|FG002|Overall Study|Progressive disease (PD)|1|||
42090704|NCT00743288|75901115|FG003|Overall Study|Progressive disease (PD)|4|||
42090705|NCT00743288|75901116|FG004|Overall Study|Progressive disease (PD)|5|||
42090706|NCT00743288|75901117|FG005|Overall Study|Progressive disease (PD)|3|||
42090707|NCT00743288|75901118|FG006|Overall Study|Progressive disease (PD)|6|||
42182882|NCT04315298|75990868|FG010|Overall Study|Lost to Follow-up|2|||
42182883|NCT04315298|75990869|FG011|Overall Study|Lost to Follow-up|1|||
42182884|NCT04315298|75990870|FG012|Overall Study|Lost to Follow-up|0|||
42182885|NCT04315298|75990871|FG013|Overall Study|Lost to Follow-up|0|||
42182886|NCT04315298|75990872|FG014|Overall Study|Lost to Follow-up|0|||
42182887|NCT04315298|75990873|FG015|Overall Study|Lost to Follow-up|2|||
42294761|NCT02589665|76129278|FG007|Induction Period|Adverse Event|0|||
42294762|NCT02589665|76129279|FG008|Induction Period|Adverse Event|0|||
42294763|NCT02589665|76129280|FG009|Induction Period|Adverse Event|0|||
42294764|NCT02589665|76129271|FG000|Induction Period|Withdrawal by Subject|0|||
42358759|NCT03745651|76204510|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
42358760|NCT03745651|76204511|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
42358761|NCT03745651|76204512|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
42358762|NCT03745651|76204506|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358763|NCT03745651|76204507|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358764|NCT03745651|76204508|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358765|NCT03745651|76204509|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358766|NCT03745651|76204510|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358767|NCT03745651|76204511|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
42358768|NCT03745651|76204512|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358769|NCT03745651|76204506|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
42358770|NCT03745651|76204507|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
42358771|NCT03745651|76204508|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
42358772|NCT03745651|76204509|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
42358773|NCT03745651|76204510|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
42358774|NCT03745651|76204511|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
42358775|NCT03745651|76204512|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
42358776|NCT03745651|76204506|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
42358777|NCT03745651|76204507|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
42358778|NCT03745651|76204508|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
42358779|NCT03745651|76204509|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
42358780|NCT03745651|76204510|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
42358781|NCT03745651|76204511|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
42358782|NCT03745651|76204512|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
42358783|NCT03745638|76204531|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
42358784|NCT03745638|76204532|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
42182888|NCT04315298|75990874|FG016|Overall Study|Lost to Follow-up|0|||
42182889|NCT04315298|75990875|FG017|Overall Study|Lost to Follow-up|0|||
42182890|NCT04315298|75990876|FG018|Overall Study|Lost to Follow-up|0|||
42182891|NCT04315298|75990858|FG000|Overall Study|Death|24|||
42182892|NCT04315298|75990859|FG001|Overall Study|Death|60|||
42182893|NCT04315298|75990860|FG002|Overall Study|Death|49|||
42182894|NCT04315298|75990861|FG003|Overall Study|Death|59|||
42182895|NCT04315298|75990862|FG004|Overall Study|Death|70|||
42182896|NCT04315298|75990863|FG005|Overall Study|Death|114|||
42182897|NCT04315298|75990864|FG006|Overall Study|Death|9|||
42182898|NCT04315298|75990865|FG007|Overall Study|Death|12|||
42182899|NCT04315298|75990866|FG008|Overall Study|Death|21|||
42182900|NCT04315298|75990867|FG009|Overall Study|Death|16|||
42182901|NCT04315298|75990868|FG010|Overall Study|Death|40|||
42182902|NCT04315298|75990869|FG011|Overall Study|Death|40|||
42182903|NCT04315298|75990870|FG012|Overall Study|Death|3|||
42182904|NCT04315298|75990871|FG013|Overall Study|Death|4|||
42182905|NCT04315298|75990872|FG014|Overall Study|Death|6|||
42182906|NCT04315298|75990873|FG015|Overall Study|Death|4|||
42182907|NCT04315298|75990874|FG016|Overall Study|Death|3|||
42182908|NCT04315298|75990875|FG017|Overall Study|Death|1|||
42182909|NCT04315298|75990876|FG018|Overall Study|Death|0|||
42294765|NCT02589665|76129272|FG001|Induction Period|Withdrawal by Subject|1|||
42294766|NCT02589665|76129273|FG002|Induction Period|Withdrawal by Subject|0|||
42294767|NCT02589665|76129274|FG003|Induction Period|Withdrawal by Subject|1|||
42294768|NCT02589665|76129275|FG004|Induction Period|Withdrawal by Subject|0|||
42294769|NCT02589665|76129276|FG005|Induction Period|Withdrawal by Subject|0|||
42294770|NCT02589665|76129277|FG006|Induction Period|Withdrawal by Subject|0|||
42294771|NCT02589665|76129278|FG007|Induction Period|Withdrawal by Subject|0|||
42294772|NCT02589665|76129279|FG008|Induction Period|Withdrawal by Subject|0|||
42294773|NCT02589665|76129280|FG009|Induction Period|Withdrawal by Subject|0|||
42294774|NCT02589665|76129271|FG000|Induction Period|Protocol Violation|0|||
42294775|NCT02589665|76129272|FG001|Induction Period|Protocol Violation|1|||
42294776|NCT02589665|76129273|FG002|Induction Period|Protocol Violation|0|||
42182910|NCT04308668|75990945|FG000|Overall Study|Lost to Follow-up|32|||
42294777|NCT02589665|76129274|FG003|Induction Period|Protocol Violation|0|||
42294778|NCT02589665|76129275|FG004|Induction Period|Protocol Violation|0|||
42182911|NCT04308668|75990946|FG001|Overall Study|Lost to Follow-up|38|||
42182912|NCT04308668|75990945|FG000|Overall Study|Withdrawal by Subject|4|||
42182913|NCT04308668|75990946|FG001|Overall Study|Withdrawal by Subject|4|||
42182914|NCT04451330|75990954|FG000|Overall Study|Adverse Event|1|||
42182915|NCT04451330|75990955|FG001|Overall Study|Adverse Event|2|||
42182916|NCT04451330|75990954|FG000|Overall Study|Lost to Follow-up|5|||
42182917|NCT04451330|75990955|FG001|Overall Study|Lost to Follow-up|0|||
42182918|NCT04451330|75990954|FG000|Overall Study|Withdrawal by Subject|3|||
42358785|NCT03745638|76204533|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
42358786|NCT03745638|76204534|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
42090708|NCT00743288|75901112|FG000|Overall Study|Worsening of condition (Not PD)|0|||
42090709|NCT00743288|75901113|FG001|Overall Study|Worsening of condition (Not PD)|2|||
42090710|NCT00743288|75901114|FG002|Overall Study|Worsening of condition (Not PD)|1|||
42090711|NCT00743288|75901115|FG003|Overall Study|Worsening of condition (Not PD)|1|||
42294779|NCT02589665|76129276|FG005|Induction Period|Protocol Violation|0|||
42182919|NCT04451330|75990955|FG001|Overall Study|Withdrawal by Subject|1|||
42182920|NCT04451330|75990954|FG000|Overall Study|Withdrawal by parent/guardian|1|||
42182921|NCT04451330|75990955|FG001|Overall Study|Withdrawal by parent/guardian|0|||
42182922|NCT04451330|75990954|FG000|Overall Study|Other than specified|0|||
42294780|NCT02589665|76129277|FG006|Induction Period|Protocol Violation|0|||
42294781|NCT02589665|76129278|FG007|Induction Period|Protocol Violation|0|||
42294782|NCT02589665|76129279|FG008|Induction Period|Protocol Violation|0|||
42294783|NCT02589665|76129280|FG009|Induction Period|Protocol Violation|0|||
42294784|NCT02589665|76129271|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42294785|NCT02589665|76129272|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42294786|NCT02589665|76129273|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42294787|NCT02589665|76129274|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42090712|NCT00743288|75901116|FG004|Overall Study|Worsening of condition (Not PD)|0|||
42090713|NCT00743288|75901117|FG005|Overall Study|Worsening of condition (Not PD)|0|||
42358787|NCT03745638|76204535|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
42358788|NCT03745638|76204536|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
42358789|NCT03745638|76204537|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
42358790|NCT03745638|76204531|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
42358791|NCT03745638|76204532|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42358792|NCT03745638|76204533|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42182923|NCT04451330|75990955|FG001|Overall Study|Other than specified|1|||
42182924|NCT02493426|75990961|FG000|Overall Study|Withdrawal by Subject|0|||
42182925|NCT02493426|75990962|FG001|Overall Study|Withdrawal by Subject|1|||
42182926|NCT04448756|75990971|FG000|Overall Study|Adverse Event|0|||
42182927|NCT04448756|75990972|FG001|Overall Study|Adverse Event|1|||
42182928|NCT04448756|75990973|FG002|Overall Study|Adverse Event|0|||
42182929|NCT04448756|75990971|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
42182930|NCT04448756|75990972|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
42182931|NCT04448756|75990973|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
42358793|NCT03745638|76204534|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42358794|NCT03745638|76204535|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42358795|NCT03745638|76204536|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42090714|NCT00743288|75901118|FG006|Overall Study|Worsening of condition (Not PD)|0|||
42090715|NCT00750308|75901129|FG000|First Treatment|Adverse Event|0|||
42182932|NCT04448756|75990971|FG000|Overall Study|Withdrawal by Subject|0|||
42182933|NCT04448756|75990972|FG001|Overall Study|Withdrawal by Subject|3|||
42182934|NCT04448756|75990973|FG002|Overall Study|Withdrawal by Subject|1|||
42182935|NCT04448756|75990971|FG000|Overall Study|Death|2|||
42182936|NCT04448756|75990972|FG001|Overall Study|Death|1|||
42182937|NCT04448756|75990973|FG002|Overall Study|Death|0|||
42182938|NCT04274192|75990983|FG000|Overall Study|Protocol Violation|1|||
42182939|NCT04274192|75990984|FG001|Overall Study|Protocol Violation|0|||
42182940|NCT04387136|75990994|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
42182941|NCT04387136|75990995|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
42182942|NCT04252586|75991001|FG000|Overall Study|Withdrawal by parent/guardian|3|||
42182943|NCT04252586|75991001|FG000|Overall Study|Adverse Event|1|||
42182944|NCT04252586|75991001|FG000|Overall Study|Death|2|||
42182945|NCT04252586|75991001|FG000|Overall Study|Study terminated by sponsor|4|||
42182946|NCT04252586|75991001|FG000|Overall Study|Sponsor request|10|||
42182947|NCT04252586|75991001|FG000|Overall Study|Did not complete treatment period|1|||
42182948|NCT04247828|75991006|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
42294788|NCT02589665|76129275|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
42294789|NCT02589665|76129276|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
42090716|NCT00750308|75901130|FG001|First Treatment|Adverse Event|1|||
42090717|NCT00750308|75901131|FG002|First Treatment|Adverse Event|0|||
42090718|NCT00750308|75901132|FG003|First Treatment|Adverse Event|0|||
42090719|NCT00750308|75901133|FG004|First Treatment|Adverse Event|0|||
42090720|NCT00750308|75901134|FG005|First Treatment|Adverse Event|0|||
42294790|NCT02589665|76129277|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
42358796|NCT03745638|76204537|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
42358797|NCT03745638|76204531|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
42358798|NCT03745638|76204532|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
42182949|NCT04507776|75991010|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
42090721|NCT00750308|75901135|FG006|First Treatment|Adverse Event|0|||
42358799|NCT03745638|76204533|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
42358800|NCT03745638|76204534|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42358801|NCT03745638|76204535|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42358802|NCT03745638|76204536|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42358803|NCT03745638|76204537|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
42358804|NCT03745638|76204531|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
42358805|NCT03745638|76204532|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
42358806|NCT03745638|76204533|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
42358807|NCT03745638|76204534|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
42358808|NCT03745638|76204535|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
42358809|NCT03745638|76204536|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
42358810|NCT03745638|76204537|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
42358811|NCT03745638|76204531|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
42358812|NCT03745638|76204532|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
42358813|NCT03745638|76204533|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
42358814|NCT03745638|76204534|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
42358815|NCT03745638|76204535|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
42358816|NCT03745638|76204536|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
42182950|NCT04386902|75991019|FG000|Overall Study|Withdrawal by Subject|5|||
42182951|NCT04386902|75991019|FG000|Overall Study|Technical problems in the recording|5|||
42182952|NCT04232540|75991025|FG000|Overall Study|Lost to Follow-up|1|||
42182953|NCT04232540|75991026|FG001|Overall Study|Lost to Follow-up|0|||
42182954|NCT04504032|75991034|FG000|Overall Study|Adverse Event|1|||
42182955|NCT04504032|75991035|FG001|Overall Study|Adverse Event|2|||
42182956|NCT04504032|75991034|FG000|Overall Study|Lost to Follow-up|6|||
42182957|NCT04504032|75991035|FG001|Overall Study|Lost to Follow-up|9|||
42182958|NCT04504032|75991034|FG000|Overall Study|Protocol Violation|2|||
42182959|NCT04504032|75991035|FG001|Overall Study|Protocol Violation|0|||
42182960|NCT04504032|75991034|FG000|Overall Study|Study terminated by sponsor|1|||
42182961|NCT04504032|75991035|FG001|Overall Study|Study terminated by sponsor|2|||
42182962|NCT04504032|75991034|FG000|Overall Study|Withdrawal by Subject|9|||
42182963|NCT04504032|75991035|FG001|Overall Study|Withdrawal by Subject|11|||
42182964|NCT04504032|75991034|FG000|Overall Study|Disease progression prior to dosing|15|||
42182965|NCT04504032|75991035|FG001|Overall Study|Disease progression prior to dosing|3|||
42182966|NCT04504032|75991034|FG000|Overall Study|Drug supply issues|1|||
42182967|NCT04504032|75991035|FG001|Overall Study|Drug supply issues|1|||
42182968|NCT04504032|75991034|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
42182969|NCT04504032|75991035|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
42182970|NCT04439240|75991041|FG000|Overall Study|Ineligible|2|||
42182971|NCT04439240|75991041|FG000|Overall Study|Never started treatment|2|||
42182972|NCT04439240|75991041|FG000|Overall Study|Adverse Event|12|||
42182973|NCT04439240|75991041|FG000|Overall Study|Death|2|||
42182974|NCT04439240|75991041|FG000|Overall Study|Disease progression|25|||
42182975|NCT04439240|75991041|FG000|Overall Study|Other diseases|2|||
42182976|NCT04439240|75991041|FG000|Overall Study|Withdrawal by Subject|3|||
42182977|NCT04439240|75991041|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
42182978|NCT04439240|75991041|FG000|Overall Study|Symptomatic decline|1|||
42182979|NCT04439240|75991041|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
42182980|NCT04439240|75991041|FG000|Overall Study|Clinical progression|1|||
42182981|NCT04605588|75991047|FG000|Overall Study|Withdrawal by Subject|1|||
42182982|NCT04605588|75991048|FG001|Overall Study|Withdrawal by Subject|0|||
42182983|NCT04885296|75991054|FG000|Period 1|Covid-19 Related|1|||
42182984|NCT04885296|75991055|FG001|Period 1|Covid-19 Related|0|||
42182985|NCT04885296|75991054|FG000|Period 1|Adverse Event|0|||
42182986|NCT04885296|75991055|FG001|Period 1|Adverse Event|1|||
42182987|NCT04885296|75991054|FG000|Period 1|Withdrawal by Subject|1|||
42182988|NCT04885296|75991055|FG001|Period 1|Withdrawal by Subject|1|||
42182989|NCT04885296|75991054|FG000|Period 1|Test Article No Longer Available|1|||
42182990|NCT04885296|75991055|FG001|Period 1|Test Article No Longer Available|0|||
42182991|NCT04885296|75991054|FG000|Period 1|Dispensed Study lens in Error|1|||
42182992|NCT04885296|75991055|FG001|Period 1|Dispensed Study lens in Error|0|||
42182993|NCT04885296|75991054|FG000|Period 1|Lost to Follow-up|1|||
42182994|NCT04885296|75991055|FG001|Period 1|Lost to Follow-up|0|||
42182995|NCT04885296|75991054|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
42182996|NCT04885296|75991055|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
42182997|NCT04602000|75991066|FG000|Overall Study|Withdrawal by Subject|3|||
42182998|NCT04602000|75991067|FG001|Overall Study|Withdrawal by Subject|6|||
42182999|NCT04602000|75991068|FG002|Overall Study|Withdrawal by Subject|3|||
42183000|NCT04602000|75991069|FG003|Overall Study|Withdrawal by Subject|27|||
42183001|NCT04602000|75991070|FG004|Overall Study|Withdrawal by Subject|39|||
42183002|NCT04602000|75991066|FG000|Overall Study|Physician Decision|1|||
42183003|NCT04602000|75991067|FG001|Overall Study|Physician Decision|0|||
42183004|NCT04602000|75991068|FG002|Overall Study|Physician Decision|0|||
42183005|NCT04602000|75991069|FG003|Overall Study|Physician Decision|2|||
42183006|NCT04602000|75991070|FG004|Overall Study|Physician Decision|2|||
42183007|NCT04602000|75991066|FG000|Overall Study|Death|0|||
42183008|NCT04602000|75991067|FG001|Overall Study|Death|1|||
42183009|NCT04602000|75991068|FG002|Overall Study|Death|0|||
42183010|NCT04602000|75991069|FG003|Overall Study|Death|1|||
42183011|NCT04602000|75991070|FG004|Overall Study|Death|2|||
42183012|NCT04602000|75991066|FG000|Overall Study|Lost to Follow-up|0|||
42183013|NCT04602000|75991067|FG001|Overall Study|Lost to Follow-up|0|||
42183014|NCT04602000|75991068|FG002|Overall Study|Lost to Follow-up|0|||
42183015|NCT04602000|75991069|FG003|Overall Study|Lost to Follow-up|3|||
42183016|NCT04602000|75991070|FG004|Overall Study|Lost to Follow-up|4|||
42183017|NCT04602000|75991066|FG000|Overall Study|Other|4|||
42183018|NCT04602000|75991067|FG001|Overall Study|Other|1|||
42183019|NCT04602000|75991068|FG002|Overall Study|Other|2|||
42183020|NCT04602000|75991069|FG003|Overall Study|Other|5|||
42183021|NCT04602000|75991070|FG004|Overall Study|Other|4|||
42183022|NCT04602000|75991066|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
42183023|NCT04602000|75991067|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
42183024|NCT04602000|75991068|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
42183025|NCT04602000|75991069|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
42183026|NCT04602000|75991070|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
42183027|NCT03041116|75991086|FG000|Double-blind|Death|0|||
42183028|NCT03041116|75991087|FG001|Double-blind|Death|2|||
42294791|NCT02589665|76129278|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42294792|NCT02589665|76129279|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42294793|NCT02589665|76129280|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42294794|NCT02589665|76129271|FG000|Maintenance Period|Withdrawal by Subject|0|||
42294795|NCT02589665|76129272|FG001|Maintenance Period|Withdrawal by Subject|0|||
42294796|NCT02589665|76129273|FG002|Maintenance Period|Withdrawal by Subject|0|||
42294797|NCT02589665|76129274|FG003|Maintenance Period|Withdrawal by Subject|0|||
42294798|NCT02589665|76129275|FG004|Maintenance Period|Withdrawal by Subject|4|||
42294799|NCT02589665|76129276|FG005|Maintenance Period|Withdrawal by Subject|2|||
42294800|NCT02589665|76129277|FG006|Maintenance Period|Withdrawal by Subject|4|||
42294801|NCT02589665|76129278|FG007|Maintenance Period|Withdrawal by Subject|0|||
42294802|NCT02589665|76129279|FG008|Maintenance Period|Withdrawal by Subject|0|||
42294803|NCT02589665|76129280|FG009|Maintenance Period|Withdrawal by Subject|0|||
42090722|NCT00750308|75901136|FG007|First Treatment|Adverse Event|0|||
42090723|NCT00750308|75901137|FG008|First Treatment|Adverse Event|0|||
42090724|NCT00750308|75901138|FG009|First Treatment|Adverse Event|0|||
42090725|NCT00750308|75901139|FG010|First Treatment|Adverse Event|1|||
42090726|NCT00750308|75901140|FG011|First Treatment|Adverse Event|1|||
42090727|NCT00750308|75901129|FG000|First Treatment|Withdrawal by Subject|0|||
42090728|NCT00750308|75901130|FG001|First Treatment|Withdrawal by Subject|0|||
42090729|NCT00750308|75901131|FG002|First Treatment|Withdrawal by Subject|0|||
42090730|NCT00750308|75901132|FG003|First Treatment|Withdrawal by Subject|1|||
42090731|NCT00750308|75901133|FG004|First Treatment|Withdrawal by Subject|0|||
42090732|NCT00750308|75901134|FG005|First Treatment|Withdrawal by Subject|0|||
42090733|NCT00750308|75901135|FG006|First Treatment|Withdrawal by Subject|0|||
42090734|NCT00750308|75901136|FG007|First Treatment|Withdrawal by Subject|1|||
42090735|NCT00750308|75901137|FG008|First Treatment|Withdrawal by Subject|0|||
42090736|NCT00750308|75901138|FG009|First Treatment|Withdrawal by Subject|0|||
42090737|NCT00750308|75901139|FG010|First Treatment|Withdrawal by Subject|0|||
42090738|NCT00750308|75901140|FG011|First Treatment|Withdrawal by Subject|0|||
42090739|NCT00750308|75901129|FG000|Second Treatment|Adverse Event|0|||
42090740|NCT00750308|75901130|FG001|Second Treatment|Adverse Event|0|||
42090741|NCT00750308|75901131|FG002|Second Treatment|Adverse Event|0|||
42090742|NCT00750308|75901132|FG003|Second Treatment|Adverse Event|0|||
42090743|NCT00750308|75901133|FG004|Second Treatment|Adverse Event|0|||
42090744|NCT00750308|75901134|FG005|Second Treatment|Adverse Event|1|||
42090745|NCT00750308|75901135|FG006|Second Treatment|Adverse Event|0|||
42090746|NCT00750308|75901136|FG007|Second Treatment|Adverse Event|0|||
42090747|NCT00750308|75901137|FG008|Second Treatment|Adverse Event|1|||
42090748|NCT00750308|75901138|FG009|Second Treatment|Adverse Event|0|||
42090749|NCT00750308|75901139|FG010|Second Treatment|Adverse Event|0|||
42090750|NCT00750308|75901140|FG011|Second Treatment|Adverse Event|0|||
42090751|NCT00750308|75901129|FG000|Second Treatment|Withdrawal by Subject|0|||
42090752|NCT00750308|75901130|FG001|Second Treatment|Withdrawal by Subject|0|||
42294804|NCT02589665|76129271|FG000|Maintenance Period|Lack of Efficacy|0|||
42090753|NCT00750308|75901131|FG002|Second Treatment|Withdrawal by Subject|0|||
42183029|NCT03041116|75991086|FG000|Double-blind|Withdrawal by Subject|0|||
42090754|NCT00750308|75901132|FG003|Second Treatment|Withdrawal by Subject|0|||
42183030|NCT03041116|75991087|FG001|Double-blind|Withdrawal by Subject|4|||
42090755|NCT00750308|75901133|FG004|Second Treatment|Withdrawal by Subject|1|||
42183031|NCT03041116|75991086|FG000|Open-label|Death|1|||
42183032|NCT03041116|75991087|FG001|Open-label|Death|0|||
42183033|NCT03041116|75991086|FG000|Open-label|Termination of the study by Sponsor|39|||
42183034|NCT03041116|75991087|FG001|Open-label|Termination of the study by Sponsor|37|||
42358817|NCT03745638|76204537|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
42358818|NCT03745638|76204531|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42358819|NCT03745638|76204532|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
42358820|NCT03745638|76204533|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42358821|NCT03745638|76204534|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42358822|NCT03745638|76204535|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42358823|NCT03745638|76204536|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42358824|NCT03745638|76204537|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
42090756|NCT00750308|75901134|FG005|Second Treatment|Withdrawal by Subject|0|||
42183035|NCT03041116|75991086|FG000|Open-label|Withdrawal by Subject|1|||
42183036|NCT03041116|75991087|FG001|Open-label|Withdrawal by Subject|0|||
42183037|NCT04860258|75991104|FG000|Overall Study|Withdrawal by Subject|0|||
42183038|NCT04860258|75991105|FG001|Overall Study|Withdrawal by Subject|0|||
42183039|NCT04860258|75991106|FG002|Overall Study|Withdrawal by Subject|4|||
42183040|NCT04860258|75991107|FG003|Overall Study|Withdrawal by Subject|1|||
42183041|NCT04860258|75991108|FG004|Overall Study|Withdrawal by Subject|4|||
42183042|NCT04860258|75991109|FG005|Overall Study|Withdrawal by Subject|1|||
42183043|NCT04860258|75991110|FG006|Overall Study|Withdrawal by Subject|0|||
42183044|NCT03041038|75991128|FG000|Overall Study|Withdrawal by Subject|4|||
42183045|NCT03041038|75991129|FG001|Overall Study|Withdrawal by Subject|0|||
42183046|NCT03041038|75991128|FG000|Overall Study|Lost to Follow-up|1|||
42183047|NCT03041038|75991129|FG001|Overall Study|Lost to Follow-up|1|||
42183048|NCT03041038|75991128|FG000|Overall Study|Protocol Violation|1|||
42183049|NCT03041038|75991129|FG001|Overall Study|Protocol Violation|1|||
42183050|NCT04382066|75991140|FG000|Overall Study|Adverse Event|1|||
42183051|NCT04382066|75991141|FG001|Overall Study|Adverse Event|0|||
42183052|NCT04382066|75991142|FG002|Overall Study|Adverse Event|0|||
42183053|NCT04382066|75991140|FG000|Overall Study|Death|1|||
42183054|NCT04382066|75991141|FG001|Overall Study|Death|0|||
42183055|NCT04382066|75991142|FG002|Overall Study|Death|1|||
42183056|NCT04435184|75991158|FG000|Overall Study|follow-up blood draws missing|3|||
42183057|NCT04435184|75991159|FG001|Overall Study|follow-up blood draws missing|5|||
42183058|NCT03693404|75991167|FG000|Overall Study|Withdrawal by Subject|1|||
42183059|NCT03693404|75991168|FG001|Overall Study|Withdrawal by Subject|0|||
42183060|NCT03693404|75991167|FG000|Overall Study|Lost to Follow-up|0|||
42294805|NCT02589665|76129272|FG001|Maintenance Period|Lack of Efficacy|0|||
42294806|NCT02589665|76129273|FG002|Maintenance Period|Lack of Efficacy|0|||
42294807|NCT02589665|76129274|FG003|Maintenance Period|Lack of Efficacy|0|||
42294808|NCT02589665|76129275|FG004|Maintenance Period|Lack of Efficacy|2|||
42294809|NCT02589665|76129276|FG005|Maintenance Period|Lack of Efficacy|1|||
42294810|NCT02589665|76129277|FG006|Maintenance Period|Lack of Efficacy|0|||
42294811|NCT02589665|76129278|FG007|Maintenance Period|Lack of Efficacy|0|||
42294812|NCT02589665|76129279|FG008|Maintenance Period|Lack of Efficacy|0|||
42090757|NCT00750308|75901135|FG006|Second Treatment|Withdrawal by Subject|0|||
42090758|NCT00750308|75901136|FG007|Second Treatment|Withdrawal by Subject|0|||
42090759|NCT00750308|75901137|FG008|Second Treatment|Withdrawal by Subject|0|||
42090760|NCT00750308|75901138|FG009|Second Treatment|Withdrawal by Subject|0|||
42090761|NCT00750308|75901139|FG010|Second Treatment|Withdrawal by Subject|0|||
42090762|NCT00750308|75901140|FG011|Second Treatment|Withdrawal by Subject|0|||
42090763|NCT00750308|75901129|FG000|Third Treatment|Withdrawal by Subject|0|||
42090764|NCT00750308|75901130|FG001|Third Treatment|Withdrawal by Subject|1|||
42090765|NCT00750308|75901131|FG002|Third Treatment|Withdrawal by Subject|0|||
42090766|NCT00750308|75901132|FG003|Third Treatment|Withdrawal by Subject|0|||
42090767|NCT00750308|75901133|FG004|Third Treatment|Withdrawal by Subject|0|||
42090768|NCT00750308|75901134|FG005|Third Treatment|Withdrawal by Subject|0|||
42090769|NCT00750308|75901135|FG006|Third Treatment|Withdrawal by Subject|0|||
42090770|NCT00750308|75901136|FG007|Third Treatment|Withdrawal by Subject|0|||
42090771|NCT00750308|75901137|FG008|Third Treatment|Withdrawal by Subject|0|||
42090772|NCT00750308|75901138|FG009|Third Treatment|Withdrawal by Subject|0|||
42183061|NCT03693404|75991168|FG001|Overall Study|Lost to Follow-up|5|||
42183062|NCT03693404|75991167|FG000|Overall Study|Excluded from Analysis|0|||
42294813|NCT02589665|76129280|FG009|Maintenance Period|Lack of Efficacy|0|||
42294814|NCT02589665|76129271|FG000|Maintenance Period|Adverse Event|0|||
42358825|NCT03745638|76204531|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
42358826|NCT03745638|76204532|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
42090773|NCT00750308|75901139|FG010|Third Treatment|Withdrawal by Subject|0|||
42090774|NCT00750308|75901140|FG011|Third Treatment|Withdrawal by Subject|0|||
42183063|NCT03693404|75991168|FG001|Overall Study|Excluded from Analysis|1|||
42183064|NCT03696108|75991176|FG000|Overall Study|Physician Decision|1|||
42183065|NCT03696108|75991177|FG001|Overall Study|Physician Decision|0|||
42090775|NCT00750152|75901156|FG000|Overall Study|Adverse Event|2|||
42090776|NCT00750152|75901157|FG001|Overall Study|Adverse Event|1|||
42294815|NCT02589665|76129272|FG001|Maintenance Period|Adverse Event|0|||
42294816|NCT02589665|76129273|FG002|Maintenance Period|Adverse Event|0|||
42294817|NCT02589665|76129274|FG003|Maintenance Period|Adverse Event|0|||
42294818|NCT02589665|76129275|FG004|Maintenance Period|Adverse Event|0|||
42090777|NCT00750152|75901156|FG000|Overall Study|Lost to Follow-up|8|||
42090778|NCT00750152|75901157|FG001|Overall Study|Lost to Follow-up|13|||
42090779|NCT00750152|75901156|FG000|Overall Study|Withdrawal by Subject|3|||
42090780|NCT00750152|75901157|FG001|Overall Study|Withdrawal by Subject|3|||
42090781|NCT00750152|75901156|FG000|Overall Study|Physician Decision|1|||
42090782|NCT00750152|75901157|FG001|Overall Study|Physician Decision|1|||
42090783|NCT00750152|75901156|FG000|Overall Study|Non-compliance|0|||
42090784|NCT00750152|75901157|FG001|Overall Study|Non-compliance|1|||
42090785|NCT00750152|75901156|FG000|Overall Study|Termination by sponsor|1|||
42090786|NCT00750152|75901157|FG001|Overall Study|Termination by sponsor|0|||
42090787|NCT00750152|75901156|FG000|Overall Study|Other|7|||
42090788|NCT00750152|75901157|FG001|Overall Study|Other|8|||
42090789|NCT00749996|75901165|FG000|Overall Study|Lost to Follow-up|7|||
42090790|NCT00749996|75901166|FG001|Overall Study|Lost to Follow-up|4|||
42090791|NCT00749996|75901165|FG000|Overall Study|Withdrawal by Subject|5|||
42090792|NCT00749996|75901166|FG001|Overall Study|Withdrawal by Subject|4|||
42090793|NCT00749996|75901165|FG000|Overall Study|Protocol Violation|2|||
42090794|NCT00749996|75901166|FG001|Overall Study|Protocol Violation|3|||
42090795|NCT00749996|75901165|FG000|Overall Study|Physician Decision|2|||
42294819|NCT02589665|76129276|FG005|Maintenance Period|Adverse Event|0|||
42294820|NCT02589665|76129277|FG006|Maintenance Period|Adverse Event|2|||
42294821|NCT02589665|76129278|FG007|Maintenance Period|Adverse Event|0|||
42294822|NCT02589665|76129279|FG008|Maintenance Period|Adverse Event|0|||
42294823|NCT02589665|76129280|FG009|Maintenance Period|Adverse Event|0|||
42294824|NCT02589665|76129271|FG000|Maintenance Period|Lost to Follow-up|0|||
42090796|NCT00749996|75901166|FG001|Overall Study|Physician Decision|0|||
42090797|NCT00749996|75901165|FG000|Overall Study|Pregnancy|0|||
42090798|NCT00749996|75901166|FG001|Overall Study|Pregnancy|2|||
42090799|NCT00749996|75901165|FG000|Overall Study|Adverse Event|1|||
42090800|NCT00749996|75901166|FG001|Overall Study|Adverse Event|0|||
42090801|NCT00749996|75901165|FG000|Overall Study|Death|1|||
42090802|NCT00749996|75901166|FG001|Overall Study|Death|0|||
42090803|NCT00749684|75901172|FG000|Overall Study|Death|1|||
42090804|NCT00749684|75901172|FG000|Overall Study|Adverse Event|27|||
42090805|NCT00749684|75901172|FG000|Overall Study|Participant's Wish|10|||
42090806|NCT00749684|75901172|FG000|Overall Study|Not Documented|1|||
42090807|NCT00749684|75901172|FG000|Overall Study|Progressive Desease|31|||
42090808|NCT00749684|75901172|FG000|Overall Study|Therapy according to protocol + AE|2|||
42090809|NCT00749684|75901172|FG000|Overall Study|AE+discontinuation on participants wish|1|||
42090810|NCT00749684|75901172|FG000|Overall Study|Missing|9|||
42090811|NCT00746798|75901180|FG000|Overall Study|Protocol Violation|0|||
42090812|NCT00746798|75901181|FG001|Overall Study|Protocol Violation|1|||
42090813|NCT00746798|75901182|FG002|Overall Study|Protocol Violation|0|||
42090814|NCT00746798|75901183|FG003|Overall Study|Protocol Violation|0|||
42090815|NCT00746798|75901180|FG000|Overall Study|Withdrawal by Subject|0|||
42090816|NCT00746798|75901181|FG001|Overall Study|Withdrawal by Subject|1|||
42183066|NCT03696108|75991176|FG000|Overall Study|Withdrawal by Subject|3|||
42183067|NCT03696108|75991177|FG001|Overall Study|Withdrawal by Subject|6|||
42183068|NCT04218110|75991187|FG000|Overall Study|Withdrawal by Subject|0|||
42183069|NCT04218110|75991188|FG001|Overall Study|Withdrawal by Subject|0|||
42183070|NCT04218110|75991189|FG002|Overall Study|Withdrawal by Subject|0|||
42183071|NCT04218110|75991190|FG003|Overall Study|Withdrawal by Subject|1|||
42183072|NCT04214600|75991202|FG000|Overall Study|Lost to Follow-up|9|||
42294825|NCT02589665|76129272|FG001|Maintenance Period|Lost to Follow-up|0|||
42294826|NCT02589665|76129273|FG002|Maintenance Period|Lost to Follow-up|0|||
42358827|NCT03745638|76204533|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
42358828|NCT03745638|76204534|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42090817|NCT00746798|75901182|FG002|Overall Study|Withdrawal by Subject|1|||
42090818|NCT00746798|75901183|FG003|Overall Study|Withdrawal by Subject|0|||
42090819|NCT00746798|75901180|FG000|Overall Study|Death|0|||
42183073|NCT04214600|75991203|FG001|Overall Study|Lost to Follow-up|14|||
42358829|NCT03745638|76204535|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42090820|NCT00746798|75901181|FG001|Overall Study|Death|0|||
42090821|NCT00746798|75901182|FG002|Overall Study|Death|2|||
42183074|NCT04210310|75991212|FG000|Overall Study|Lost to Follow-up|32|||
42294827|NCT02589665|76129274|FG003|Maintenance Period|Lost to Follow-up|0|||
42294828|NCT02589665|76129275|FG004|Maintenance Period|Lost to Follow-up|0|||
42090822|NCT00746798|75901183|FG003|Overall Study|Death|0|||
42090823|NCT00746798|75901180|FG000|Overall Study|Participant unable to return for visit|1|||
42090824|NCT00746798|75901181|FG001|Overall Study|Participant unable to return for visit|0|||
42090825|NCT00746798|75901182|FG002|Overall Study|Participant unable to return for visit|0|||
42090826|NCT00746798|75901183|FG003|Overall Study|Participant unable to return for visit|0|||
42090827|NCT00716274|75901196|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
42090828|NCT00716274|75901197|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
42090829|NCT00716274|75901198|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
42090830|NCT00716274|75901199|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
42090831|NCT00716274|75901200|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
42090832|NCT00716274|75901201|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
42090833|NCT00716274|75901196|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
42090834|NCT00716274|75901197|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
42090835|NCT00716274|75901198|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
42090836|NCT00716274|75901199|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
42090837|NCT00716274|75901200|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
42090838|NCT00716274|75901201|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
42090839|NCT00716274|75901196|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
42090840|NCT00716274|75901197|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
42090841|NCT00716274|75901198|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
42090842|NCT00716274|75901199|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
42090843|NCT00716274|75901200|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
42090844|NCT00716274|75901201|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
42090845|NCT00716274|75901196|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
42090846|NCT00716274|75901197|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
42090847|NCT00716274|75901198|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
42090848|NCT00716274|75901199|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
42090849|NCT00716274|75901200|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
42090850|NCT00716274|75901201|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
42090851|NCT00716274|75901196|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
42090852|NCT00716274|75901197|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
42090853|NCT00716274|75901198|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
42090854|NCT00716274|75901199|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
42090855|NCT00716274|75901200|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
42090856|NCT00716274|75901201|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
42090857|NCT00716274|75901196|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
42090858|NCT00716274|75901197|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
42090859|NCT00716274|75901198|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
42090860|NCT00716274|75901199|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
42090861|NCT00716274|75901200|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
42090862|NCT00716274|75901201|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
42090863|NCT00716274|75901196|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
42090864|NCT00716274|75901197|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
42090865|NCT00716274|75901198|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
42090866|NCT00716274|75901199|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
42090867|NCT00716274|75901200|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
42090868|NCT00716274|75901201|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
42090869|NCT00716274|75901196|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
42090870|NCT00716274|75901197|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
42090871|NCT00716274|75901198|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
42090872|NCT00716274|75901199|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
42090873|NCT00716274|75901200|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
42090874|NCT00716274|75901201|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
42090875|NCT00716274|75901196|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
42183075|NCT04210310|75991213|FG001|Overall Study|Lost to Follow-up|1|||
42183076|NCT04209530|75991221|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
42183077|NCT04209530|75991222|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
42183078|NCT04209530|75991221|FG000|Overall Study|Withdrawal by Subject|0|||
42183079|NCT04209530|75991222|FG001|Overall Study|Withdrawal by Subject|1|||
42183080|NCT04349098|75991230|FG000|Overall Study|Death|16|||
42183081|NCT04349098|75991231|FG001|Overall Study|Death|8|||
42183082|NCT04349098|75991230|FG000|Overall Study|Lost to Follow-up|11|||
42183083|NCT04349098|75991231|FG001|Overall Study|Lost to Follow-up|8|||
42183084|NCT04349098|75991230|FG000|Overall Study|Withdrawal by Subject|8|||
42183085|NCT04349098|75991231|FG001|Overall Study|Withdrawal by Subject|5|||
42183086|NCT04349098|75991230|FG000|Overall Study|Other|3|||
42183087|NCT04349098|75991231|FG001|Overall Study|Other|5|||
42183088|NCT04208750|75991239|FG000|Overall Study|Lost to Follow-up|16|||
42183089|NCT04208750|75991240|FG001|Overall Study|Lost to Follow-up|15|||
42183090|NCT04381988|75991248|FG000|Overall Study|The study was terminated|4|||
42090876|NCT00716274|75901197|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
42090877|NCT00716274|75901198|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
42090878|NCT00716274|75901199|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
42090879|NCT00716274|75901200|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
42090880|NCT00716274|75901201|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
42090881|NCT00716274|75901196|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
42090882|NCT00716274|75901197|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
42090883|NCT00716274|75901198|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
42090884|NCT00716274|75901199|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
42090885|NCT00716274|75901200|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
42090886|NCT00716274|75901201|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
42090887|NCT00746564|75901218|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
42090888|NCT01298193|75901224|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
42090889|NCT01298193|75901224|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
42090890|NCT01298193|75901224|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
42090891|NCT01298193|75901224|FG000|Efficacy Phase (Second Cycle)|Death|1|||
42090892|NCT00719862|75901233|FG000|Overall Study|Adverse Event|1|||
42090893|NCT00719862|75901234|FG001|Overall Study|Adverse Event|2|||
42090894|NCT00719862|75901233|FG000|Overall Study|Lack of Efficacy|3|||
42090895|NCT00719862|75901234|FG001|Overall Study|Lack of Efficacy|0|||
42090896|NCT00719862|75901233|FG000|Overall Study|Non-Compliance|1|||
42090897|NCT00719862|75901234|FG001|Overall Study|Non-Compliance|0|||
42090898|NCT00719862|75901233|FG000|Overall Study|Withdrawal by Subject|1|||
42090899|NCT00719862|75901234|FG001|Overall Study|Withdrawal by Subject|0|||
42090900|NCT00719862|75901233|FG000|Overall Study|Lost to Follow-up|0|||
42090901|NCT00719862|75901234|FG001|Overall Study|Lost to Follow-up|1|||
42090902|NCT00719862|75901233|FG000|Overall Study|Other|2|||
42090903|NCT00719862|75901234|FG001|Overall Study|Other|3|||
42090904|NCT00742508|75901242|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
42090905|NCT00742508|75901243|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
42090906|NCT00742508|75901242|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
42183091|NCT04381988|75991249|FG001|Overall Study|The study was terminated|0|||
42183092|NCT04333498|75991257|FG000|Overall Study|Lost to Follow-up|1|||
42183093|NCT04333498|75991258|FG001|Overall Study|Lost to Follow-up|0|||
42183094|NCT04333498|75991257|FG000|Overall Study|Lost to Follow-up|0|||
42183095|NCT04333498|75991258|FG001|Overall Study|Lost to Follow-up|1|||
42183096|NCT03355664|75991266|FG000|Overall Study|Adverse Event|1|||
42183097|NCT03355664|75991267|FG001|Overall Study|Adverse Event|2|||
42183098|NCT03355664|75991266|FG000|Overall Study|Lost to Follow-up|11|||
42183099|NCT03355664|75991267|FG001|Overall Study|Lost to Follow-up|7|||
42183100|NCT03355664|75991266|FG000|Overall Study|Protocol Violation|1|||
42183101|NCT03355664|75991267|FG001|Overall Study|Protocol Violation|2|||
42183102|NCT03355664|75991266|FG000|Overall Study|Withdrawal by Subject|2|||
42183103|NCT03355664|75991267|FG001|Overall Study|Withdrawal by Subject|1|||
42183104|NCT04170686|75991275|FG000|Screening|Physician Decision|12|||
42183105|NCT04170686|75991276|FG001|Screening|Physician Decision|13|||
42183106|NCT04170686|75991275|FG000|Randomization and Treatment|Lost to Follow-up|26|||
42183107|NCT04170686|75991276|FG001|Randomization and Treatment|Lost to Follow-up|15|||
42183108|NCT03695094|75991284|FG000|Overall Study|Adverse Event|1|||
42183109|NCT03695094|75991285|FG001|Overall Study|Adverse Event|1|||
42183110|NCT03695094|75991284|FG000|Overall Study|Withdrawal by Subject|1|||
42183111|NCT03695094|75991285|FG001|Overall Study|Withdrawal by Subject|0|||
42183112|NCT04497948|75991293|FG000|Overall Study|Death|2|||
42183113|NCT04495374|75991303|FG000|Overall Study|Protocol Violation|2|||
42183114|NCT04495374|75991304|FG001|Overall Study|Protocol Violation|1|||
42183115|NCT04794270|75991310|FG000|Period 1|Non Compliance|1|||
42183116|NCT04794270|75991311|FG001|Period 1|Non Compliance|0|||
42358830|NCT03745638|76204536|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42090907|NCT00742508|75901243|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
42090908|NCT00742508|75901242|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
42090909|NCT00742508|75901243|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
42090910|NCT00742508|75901242|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
42090911|NCT00742508|75901243|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
42090912|NCT00742508|75901242|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
42090913|NCT00742508|75901243|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
42090914|NCT00719706|75901251|FG000|Overall Study|Adverse Event|5|||
42090915|NCT00719706|75901252|FG001|Overall Study|Adverse Event|4|||
42090916|NCT00719706|75901251|FG000|Overall Study|Withdrawal by Subject|1|||
42090917|NCT00719706|75901252|FG001|Overall Study|Withdrawal by Subject|2|||
42090918|NCT00719706|75901251|FG000|Overall Study|Protocol Violation|3|||
42090919|NCT00719706|75901252|FG001|Overall Study|Protocol Violation|0|||
42090920|NCT00742274|75901260|FG000|Overall Study|Death|1|||
42183117|NCT04794270|75991310|FG000|Period 1|Adverse Event|1|||
42183118|NCT04794270|75991311|FG001|Period 1|Adverse Event|0|||
42183119|NCT04794270|75991310|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
42183120|NCT04794270|75991311|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
42183121|NCT04567186|75991317|FG000|Period 1|COVID-19 related|1|||
42183122|NCT04567186|75991318|FG001|Period 1|COVID-19 related|0|||
42090921|NCT00742274|75901261|FG001|Overall Study|Death|0|||
42090922|NCT00742274|75901260|FG000|Overall Study|Withdrawal by Subject|1|||
42090923|NCT00742274|75901261|FG001|Overall Study|Withdrawal by Subject|2|||
42090924|NCT00742274|75901260|FG000|Overall Study|Removed for medical reasons|1|||
42090925|NCT00742274|75901261|FG001|Overall Study|Removed for medical reasons|1|||
42090926|NCT00719472|75901267|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
42090927|NCT00719472|75901267|FG000|Enrolled in Study|Subject decision to withdraw|8|||
42090928|NCT00719472|75901267|FG000|Enrolled in Study|Various Reasons|17|||
42090929|NCT00719472|75901267|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
42090930|NCT00719472|75901267|FG000|Received Cycle 1 Treatment|Death|5|||
42090931|NCT00719472|75901267|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
42090932|NCT00719472|75901267|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
42090933|NCT00719472|75901267|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
42090934|NCT00719472|75901267|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
42090935|NCT00719472|75901267|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
42183123|NCT04567186|75991317|FG000|Period 1|Protocol Violation|0|||
42183124|NCT04567186|75991318|FG001|Period 1|Protocol Violation|1|||
42183125|NCT04567186|75991317|FG000|Period 1|Adverse Event|0|||
42183126|NCT04567186|75991318|FG001|Period 1|Adverse Event|2|||
42183127|NCT04567186|75991317|FG000|Period 2|COVID-19 Related|0|||
42183128|NCT04567186|75991318|FG001|Period 2|COVID-19 Related|1|||
42183129|NCT04567186|75991317|FG000|Period 2|Protocol Violation|0|||
42183130|NCT04567186|75991318|FG001|Period 2|Protocol Violation|1|||
42183131|NCT04567186|75991317|FG000|Period 2|Lost to Follow-up|0|||
42183132|NCT04567186|75991318|FG001|Period 2|Lost to Follow-up|1|||
42183133|NCT04567186|75991317|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
42183134|NCT04567186|75991318|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
42183135|NCT04168190|75991329|FG000|Overall Study|Lost to Follow-up|0|||
42183136|NCT04168190|75991330|FG001|Overall Study|Lost to Follow-up|1|||
42294829|NCT02589665|76129276|FG005|Maintenance Period|Lost to Follow-up|1|||
42294830|NCT02589665|76129277|FG006|Maintenance Period|Lost to Follow-up|0|||
42294831|NCT02589665|76129278|FG007|Maintenance Period|Lost to Follow-up|0|||
42294832|NCT02589665|76129279|FG008|Maintenance Period|Lost to Follow-up|0|||
42183137|NCT04168190|75991331|FG002|Overall Study|Lost to Follow-up|0|||
42183138|NCT04168190|75991332|FG003|Overall Study|Lost to Follow-up|7|||
42183139|NCT04168190|75991333|FG004|Overall Study|Lost to Follow-up|5|||
42183140|NCT04168190|75991329|FG000|Overall Study|Withdrawal by Subject|1|||
42183141|NCT04168190|75991330|FG001|Overall Study|Withdrawal by Subject|0|||
42183142|NCT04168190|75991331|FG002|Overall Study|Withdrawal by Subject|0|||
42183143|NCT04168190|75991332|FG003|Overall Study|Withdrawal by Subject|2|||
42183144|NCT04168190|75991333|FG004|Overall Study|Withdrawal by Subject|4|||
42183145|NCT04168190|75991329|FG000|Overall Study|Death|0|||
42183146|NCT04168190|75991330|FG001|Overall Study|Death|0|||
42183147|NCT04168190|75991331|FG002|Overall Study|Death|0|||
42183148|NCT04168190|75991332|FG003|Overall Study|Death|1|||
42183149|NCT04168190|75991333|FG004|Overall Study|Death|0|||
42183150|NCT04732338|75991347|FG000|Overall Study|Lost to Follow-up|3|||
42183151|NCT04732338|75991348|FG001|Overall Study|Lost to Follow-up|3|||
42183152|NCT04194008|75991354|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
42183153|NCT04194008|75991354|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
42183154|NCT04194008|75991354|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
42183155|NCT04194008|75991354|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
42183156|NCT04194008|75991354|FG000|Treatment Phase With Nerivio|Missing data|4|||
42183157|NCT04194008|75991354|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
42183158|NCT04189952|75991367|FG000|Follow-up Period|Death|1|||
42183159|NCT04189952|75991367|FG000|Follow-up Period|Withdrawal by Subject|1|||
42183160|NCT04716426|75991373|FG000|Overall Study|Vaccination|1|||
42183161|NCT04716426|75991374|FG001|Overall Study|Vaccination|1|||
42183162|NCT04716426|75991373|FG000|Overall Study|Contamination|1|||
42294833|NCT02589665|76129280|FG009|Maintenance Period|Lost to Follow-up|0|||
42090936|NCT00719472|75901267|FG000|Received Cycle 2 Treatment|Death|6|||
42090937|NCT00719472|75901267|FG000|Received Cycle 2 Treatment|Disease progression|3|||
42090938|NCT00719472|75901267|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
42090939|NCT00719472|75901267|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
42183163|NCT04716426|75991374|FG001|Overall Study|Contamination|0|||
42183164|NCT03694548|75991382|FG000|Part A Survey|Protocol Violation|3|||
42183165|NCT03694548|75991383|FG001|Part A Survey|Protocol Violation|3|||
42183166|NCT03694548|75991384|FG002|Part A Survey|Protocol Violation|0|||
42183167|NCT03694548|75991382|FG000|Part B Yoga Program|Protocol Violation|0|||
42183168|NCT03694548|75991383|FG001|Part B Yoga Program|Protocol Violation|0|||
42183169|NCT03694548|75991384|FG002|Part B Yoga Program|Protocol Violation|3|||
42183170|NCT03694548|75991382|FG000|Part B Yoga Program|Did not attend intervention|0|||
42183171|NCT03694548|75991383|FG001|Part B Yoga Program|Did not attend intervention|0|||
42183172|NCT03694548|75991384|FG002|Part B Yoga Program|Did not attend intervention|8|||
42183173|NCT04166630|75991396|FG000|Overall Study|Withdrawal by Subject|0|||
42183174|NCT04166630|75991397|FG001|Overall Study|Withdrawal by Subject|1|||
42183175|NCT04164758|75991406|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
42183176|NCT04164758|75991407|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
42183177|NCT04164758|75991408|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
42183178|NCT04164758|75991406|FG000|Overall Study|Adverse Event|0|||
42183179|NCT04164758|75991407|FG001|Overall Study|Adverse Event|1|||
42183180|NCT04164758|75991408|FG002|Overall Study|Adverse Event|0|||
42183181|NCT04178720|75991418|FG000|Overall Study|Withdrawal by Subject|2|||
42183182|NCT04178720|75991419|FG001|Overall Study|Withdrawal by Subject|0|||
42183183|NCT04178720|75991418|FG000|Overall Study|Relocation|0|||
42183184|NCT04178720|75991419|FG001|Overall Study|Relocation|1|||
42183185|NCT04177862|75991430|FG000|Overall Study|Protocol Violation|2|||
42183186|NCT04177862|75991431|FG001|Overall Study|Protocol Violation|7|||
42183187|NCT04173572|75991440|FG000|Overall Study|Withdrawal by Subject|1|||
42090940|NCT00719472|75901267|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
42090941|NCT00719472|75901267|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
42090942|NCT00579501|75901271|FG000|Overall Study|Death|1|||
42090943|NCT00579501|75901271|FG000|Overall Study|End of neoadjuvant therapy|25|||
42183188|NCT04173572|75991441|FG001|Overall Study|Withdrawal by Subject|5|||
42183189|NCT04173572|75991440|FG000|Overall Study|Lost to Follow-up|3|||
42183190|NCT04173572|75991441|FG001|Overall Study|Lost to Follow-up|1|||
42183191|NCT04157738|75991449|FG000|Overall Study|Moved out of state|0|||
42183192|NCT04157738|75991450|FG001|Overall Study|Moved out of state|2|||
42183193|NCT04157738|75991449|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
42183194|NCT04157738|75991450|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
42090944|NCT00579501|75901271|FG000|Overall Study|toxicity|1|||
42090945|NCT00579501|75901271|FG000|Overall Study|Secondary lesion|1|||
42090946|NCT00579501|75901271|FG000|Overall Study|Radiation therapy before surgery|1|||
42090947|NCT00741338|75901277|FG000|Overall Study|Adverse Event|0|||
42090948|NCT00741338|75901278|FG001|Overall Study|Adverse Event|1|||
42090949|NCT00746330|75901288|FG000|Period 1|Abnormal test procedure result|0|||
42090950|NCT00746330|75901289|FG001|Period 1|Abnormal test procedure result|0|||
42090951|NCT00746330|75901290|FG002|Period 1|Abnormal test procedure result|1|||
42090952|NCT00746330|75901291|FG003|Period 1|Abnormal test procedure result|0|||
42090953|NCT00746252|75901304|FG000|Overall Study|weight gain >7.5 %|1|||
42090954|NCT00746252|75901305|FG001|Overall Study|weight gain >7.5 %|2|||
42090955|NCT00718770|75901311|FG000|Overall Study|Adverse Event|1|||
42090956|NCT00718770|75901311|FG000|Overall Study|Lack of Efficacy|1|||
42090957|NCT00718770|75901311|FG000|Overall Study|Lack of Efficacy|1|||
42090958|NCT00718770|75901311|FG000|Overall Study|Adverse Event|1|||
42090959|NCT00718770|75901311|FG000|Overall Study|Lack of Efficacy|1|||
42090960|NCT00718770|75901311|FG000|Overall Study|Adverse Event|1|||
42183195|NCT04156646|75991458|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
42183196|NCT04156646|75991459|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
42183197|NCT04150250|75991470|FG000|Overall Study|Lost to Follow-up|0|||
42183198|NCT04150250|75991471|FG001|Overall Study|Lost to Follow-up|2|||
42183199|NCT04537806|75991479|FG000|Overall Study|Randomized but not treated|1|||
42183200|NCT04537806|75991480|FG001|Overall Study|Randomized but not treated|0|||
42183201|NCT04537806|75991479|FG000|Overall Study|Adverse Event|1|||
42183202|NCT04537806|75991480|FG001|Overall Study|Adverse Event|1|||
42183203|NCT04015232|75991488|FG000|Overall Study|Withdrawal by Subject|7|||
42183204|NCT04015232|75991489|FG001|Overall Study|Withdrawal by Subject|4|||
42090961|NCT00718770|75901311|FG000|Overall Study|Lack of Efficacy|1|||
42183205|NCT04015232|75991488|FG000|Overall Study|Protocol Violation|1|||
42183206|NCT04015232|75991489|FG001|Overall Study|Protocol Violation|0|||
42183207|NCT04015232|75991488|FG000|Overall Study|Medical Grounds|3|||
42183208|NCT04015232|75991489|FG001|Overall Study|Medical Grounds|3|||
42183209|NCT04533204|75991501|FG000|Overall Study|Unable to understand training instructions|1|||
42294834|NCT02589665|76129271|FG000|Maintenance Period|Physician Decision|0|||
42294835|NCT02589665|76129272|FG001|Maintenance Period|Physician Decision|0|||
42294836|NCT02589665|76129273|FG002|Maintenance Period|Physician Decision|0|||
42090962|NCT00718770|75901311|FG000|Overall Study|Adverse Event|1|||
42090963|NCT00746096|75901317|FG000|Overall Study|Adverse Event|1|||
42090964|NCT00746096|75901318|FG001|Overall Study|Adverse Event|0|||
42090965|NCT00746096|75901317|FG000|Overall Study|Withdrawal by Subject|5|||
42183210|NCT04533204|75991502|FG001|Overall Study|Unable to understand training instructions|1|||
42183211|NCT04465422|75991510|FG000|Overall Study|Lost to Follow-up|0|||
42183212|NCT04465422|75991511|FG001|Overall Study|Lost to Follow-up|2|||
42183213|NCT04014062|75991521|FG000|Period I: Dosing|Medical Grounds|4|||
42183214|NCT04014062|75991522|FG001|Period I: Dosing|Medical Grounds|5|||
42183215|NCT04014062|75991521|FG000|Period I: Dosing|Withdrawal by Subject|3|||
42183216|NCT04014062|75991522|FG001|Period I: Dosing|Withdrawal by Subject|1|||
42183217|NCT04531098|75991536|FG000|Stage I|Adverse Event|0|||
42090966|NCT00746096|75901318|FG001|Overall Study|Withdrawal by Subject|1|||
42183218|NCT04531098|75991537|FG001|Stage I|Adverse Event|0|||
42183219|NCT04531098|75991538|FG002|Stage I|Adverse Event|3|||
42090967|NCT00746096|75901317|FG000|Overall Study|Lost to Follow-up|2|||
42183220|NCT04531098|75991536|FG000|Stage I|Protocol Violation|0|||
42183221|NCT04531098|75991537|FG001|Stage I|Protocol Violation|0|||
42183222|NCT04531098|75991538|FG002|Stage I|Protocol Violation|5|||
42183223|NCT04531098|75991536|FG000|Stage I|Withdrawal by Subject|0|||
42183224|NCT04531098|75991537|FG001|Stage I|Withdrawal by Subject|5|||
42183225|NCT04531098|75991538|FG002|Stage I|Withdrawal by Subject|10|||
42183226|NCT04531098|75991536|FG000|Stage II|Adverse Event|1|||
42183227|NCT04531098|75991537|FG001|Stage II|Adverse Event|2|||
42183228|NCT04531098|75991538|FG002|Stage II|Adverse Event|0|||
42183229|NCT04531098|75991536|FG000|Stage II|Protocol Violation|1|||
42183230|NCT04531098|75991537|FG001|Stage II|Protocol Violation|2|||
42090968|NCT00746096|75901318|FG001|Overall Study|Lost to Follow-up|1|||
42090969|NCT00746096|75901317|FG000|Overall Study|Protocol Violation|1|||
42090970|NCT00746096|75901318|FG001|Overall Study|Protocol Violation|0|||
42090971|NCT00746096|75901317|FG000|Overall Study|No study drug treatment|1|||
42090972|NCT00746096|75901318|FG001|Overall Study|No study drug treatment|1|||
42090973|NCT00715026|75901324|FG000|Overall Study|Withdrawal by Subject|5|||
42090974|NCT00715026|75901324|FG000|Overall Study|Lost to Follow-up|3|||
42090975|NCT00715026|75901324|FG000|Overall Study|Protocol Violation|1|||
42090976|NCT00715026|75901324|FG000|Overall Study|Surgery done on non-study consented hip|1|||
42090977|NCT00714948|75901328|FG000|Overall Study|Adverse Event|2|||
42090978|NCT00714870|75901334|FG000|Overall Study|Lost to Follow-up|22|||
42090979|NCT00714870|75901335|FG001|Overall Study|Lost to Follow-up|5|||
42090980|NCT00714870|75901334|FG000|Overall Study|patient unable to come b/c back pain|1|||
42090981|NCT00714870|75901335|FG001|Overall Study|patient unable to come b/c back pain|0|||
42090982|NCT00714870|75901334|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
42090983|NCT00714870|75901335|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
42090984|NCT00714714|75901341|FG000|Overall Study|Adverse Event|1|||
42090985|NCT00441337|75901351|FG000|Overall Study|Disease Progression|6|||
42090986|NCT00441337|75901352|FG001|Overall Study|Disease Progression|6|||
42090987|NCT00441337|75901353|FG002|Overall Study|Disease Progression|4|||
42090988|NCT00441337|75901354|FG003|Overall Study|Disease Progression|18|||
42090989|NCT00441337|75901351|FG000|Overall Study|Lost to Follow-up|0|||
42090990|NCT00441337|75901352|FG001|Overall Study|Lost to Follow-up|0|||
42090991|NCT00441337|75901353|FG002|Overall Study|Lost to Follow-up|0|||
42090992|NCT00441337|75901354|FG003|Overall Study|Lost to Follow-up|1|||
42090993|NCT00441337|75901351|FG000|Overall Study|Sponsor Decision|0|||
42090994|NCT00441337|75901352|FG001|Overall Study|Sponsor Decision|0|||
42090995|NCT00441337|75901353|FG002|Overall Study|Sponsor Decision|1|||
42090996|NCT00441337|75901354|FG003|Overall Study|Sponsor Decision|2|||
42090997|NCT00441337|75901351|FG000|Overall Study|Did not meet inclusion criteria|0|||
42090998|NCT00441337|75901352|FG001|Overall Study|Did not meet inclusion criteria|0|||
42090999|NCT00441337|75901353|FG002|Overall Study|Did not meet inclusion criteria|1|||
42091000|NCT00441337|75901354|FG003|Overall Study|Did not meet inclusion criteria|0|||
42091001|NCT00578877|75901374|FG000|Overall Study|Lost to Follow-up|8|||
42091002|NCT00578877|75901375|FG001|Overall Study|Lost to Follow-up|10|||
42091003|NCT00578877|75901374|FG000|Overall Study|early discontinue|61|||
42091004|NCT00578877|75901375|FG001|Overall Study|early discontinue|101|||
42091005|NCT00578877|75901374|FG000|Overall Study|did not provide follow-up data|12|||
42091006|NCT00578877|75901375|FG001|Overall Study|did not provide follow-up data|17|||
42091007|NCT00468481|75901383|FG000|Overall Study|Adverse Event|13|||
42091008|NCT00468481|75901384|FG001|Overall Study|Adverse Event|3|||
42091009|NCT00468481|75901383|FG000|Overall Study|Lost to Follow-up|25|||
42091010|NCT00468481|75901384|FG001|Overall Study|Lost to Follow-up|8|||
42091011|NCT00468481|75901383|FG000|Overall Study|Pregnancy|2|||
42091012|NCT00468481|75901384|FG001|Overall Study|Pregnancy|0|||
42091013|NCT00468481|75901383|FG000|Overall Study|Protocol Violation|18|||
42091014|NCT00468481|75901384|FG001|Overall Study|Protocol Violation|8|||
42091015|NCT00468481|75901383|FG000|Overall Study|Withdrawal by Subject|12|||
42091016|NCT00468481|75901384|FG001|Overall Study|Withdrawal by Subject|3|||
42183231|NCT04531098|75991538|FG002|Stage II|Protocol Violation|0|||
42183232|NCT04531098|75991536|FG000|Stage II|Withdrawal by Subject|3|||
42183233|NCT04531098|75991537|FG001|Stage II|Withdrawal by Subject|1|||
42183234|NCT04531098|75991538|FG002|Stage II|Withdrawal by Subject|0|||
42091017|NCT00468481|75901383|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
42091018|NCT00468481|75901384|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
42091019|NCT00468481|75901383|FG000|Overall Study|Prohibited Medication|1|||
42183235|NCT04531098|75991536|FG000|Stage II|Moved from study area|8|||
42183236|NCT04531098|75991537|FG001|Stage II|Moved from study area|5|||
42091020|NCT00468481|75901384|FG001|Overall Study|Prohibited Medication|1|||
42091021|NCT00468481|75901383|FG000|Overall Study|Egg Donor|1|||
42091022|NCT00468481|75901384|FG001|Overall Study|Egg Donor|0|||
42183237|NCT04531098|75991538|FG002|Stage II|Moved from study area|0|||
42183238|NCT04144166|75991546|FG000|Overall Study|Discharged before study start|1|||
42091023|NCT00468481|75901383|FG000|Overall Study|Moved out of area|4|||
42091024|NCT00468481|75901384|FG001|Overall Study|Moved out of area|1|||
42183239|NCT04144166|75991546|FG000|Overall Study|Pregnancy|1|||
42091025|NCT00468481|75901383|FG000|Overall Study|Non-Compliance|5|||
42183240|NCT04144166|75991546|FG000|Overall Study|Nail polish could not be removed from finger|1|||
42183241|NCT04142450|75991555|FG000|Overall Study|Screen Failure|1|||
42183242|NCT04142450|75991555|FG000|Overall Study|Lost to Follow-up|1|||
42183243|NCT04529850|75991559|FG000|Overall Study|Death|2|||
42183244|NCT04529850|75991559|FG000|Overall Study|Physician Decision|1|||
42183245|NCT04529850|75991559|FG000|Overall Study|Withdrawal by Subject|2|||
42183246|NCT04225676|75991563|FG000|Overall Study|Physician Decision|1|||
42183247|NCT04225676|75991563|FG000|Overall Study|Lack of Efficacy|1|||
42183248|NCT04225676|75991563|FG000|Overall Study|Study terminated by sponsor|3|||
42183249|NCT04142216|75991571|FG000|Overall Study|Hospitalization|0|||
42183250|NCT04142216|75991572|FG001|Overall Study|Hospitalization|2|||
42183251|NCT04142216|75991571|FG000|Overall Study|Death|3|||
42183252|NCT04142216|75991572|FG001|Overall Study|Death|1|||
42183253|NCT04142216|75991571|FG000|Overall Study|Referral to another hemodialysis unit|3|||
42183254|NCT04142216|75991572|FG001|Overall Study|Referral to another hemodialysis unit|2|||
42183255|NCT04142216|75991571|FG000|Overall Study|Use of clove|0|||
42183256|NCT04142216|75991572|FG001|Overall Study|Use of clove|1|||
42183257|NCT04140890|75991580|FG000|Overall Study|Withdrawal by Subject|0|||
42183258|NCT04140890|75991581|FG001|Overall Study|Withdrawal by Subject|1|||
42183259|NCT03700320|75991592|FG000|Overall Study|Adverse Event|5|||
42183260|NCT03700320|75991593|FG001|Overall Study|Adverse Event|31|||
42183261|NCT03700320|75991592|FG000|Overall Study|Lack of Efficacy|2|||
42183262|NCT03700320|75991593|FG001|Overall Study|Lack of Efficacy|5|||
42183263|NCT03700320|75991592|FG000|Overall Study|Withdrawal by Subject|29|||
42183264|NCT03700320|75991593|FG001|Overall Study|Withdrawal by Subject|75|||
42183265|NCT03700320|75991592|FG000|Overall Study|Lost to Follow-up|16|||
42183266|NCT03700320|75991593|FG001|Overall Study|Lost to Follow-up|23|||
42183267|NCT03700320|75991592|FG000|Overall Study|Pregnancy|2|||
42183268|NCT03700320|75991593|FG001|Overall Study|Pregnancy|4|||
42183269|NCT03700320|75991592|FG000|Overall Study|Protocol Deviation|7|||
42183270|NCT03700320|75991593|FG001|Overall Study|Protocol Deviation|31|||
42183271|NCT03700320|75991592|FG000|Overall Study|Non-compliance with Study Drug|1|||
42183272|NCT03700320|75991593|FG001|Overall Study|Non-compliance with Study Drug|3|||
42183273|NCT03700320|75991592|FG000|Overall Study|Reason not Specified|0|||
42183274|NCT03700320|75991593|FG001|Overall Study|Reason not Specified|1|||
42183275|NCT04139018|75991601|FG000|Overall Study|Screen fail|1|||
42183276|NCT04139018|75991602|FG001|Overall Study|Screen fail|0|||
42183277|NCT04139018|75991601|FG000|Overall Study|Withdrawal by Subject|2|||
42183278|NCT04139018|75991602|FG001|Overall Study|Withdrawal by Subject|0|||
42183279|NCT04139018|75991601|FG000|Overall Study|Lost to Follow-up|0|||
42183280|NCT04139018|75991602|FG001|Overall Study|Lost to Follow-up|1|||
42183281|NCT04527978|75991610|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
42183282|NCT04527978|75991611|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
42183283|NCT04136444|75991622|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
42183284|NCT04136444|75991623|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
42183285|NCT04425252|75991637|FG000|Overall Study|Withdrawal by Subject|2|||
42183286|NCT04425252|75991638|FG001|Overall Study|Withdrawal by Subject|1|||
42183287|NCT04425252|75991637|FG000|Overall Study|Lost to Follow-up|1|||
42091026|NCT00468481|75901384|FG001|Overall Study|Non-Compliance|0|||
42091027|NCT00468481|75901383|FG000|Overall Study|Other|6|||
42091028|NCT00468481|75901384|FG001|Overall Study|Other|0|||
42091029|NCT00714168|75901392|FG000|Overall Study|Pregnancy|5|||
42091030|NCT00714168|75901393|FG001|Overall Study|Pregnancy|4|||
42091031|NCT00714168|75901392|FG000|Overall Study|Lost to Follow-up|32|||
42091032|NCT00714168|75901393|FG001|Overall Study|Lost to Follow-up|50|||
42091033|NCT00714168|75901392|FG000|Overall Study|Relocation|4|||
42091034|NCT00714168|75901393|FG001|Overall Study|Relocation|3|||
42091035|NCT00714168|75901392|FG000|Overall Study|Non-study medical condition|3|||
42091036|NCT00714168|75901393|FG001|Overall Study|Non-study medical condition|2|||
42091037|NCT00713700|75901399|FG000|Overall Study|Lost to Follow-up|3|||
42091038|NCT00713700|75901399|FG000|Overall Study|Withdrawal by Subject|1|||
42091039|NCT00468169|75901405|FG000|Overall Study|Withdrawal by Subject|1|||
42091040|NCT00468169|75901406|FG001|Overall Study|Withdrawal by Subject|0|||
42091041|NCT00435487|75901416|FG000|Overall Study|Death|3|||
42091042|NCT00435487|75901417|FG001|Overall Study|Death|4|||
42091043|NCT00435487|75901416|FG000|Overall Study|Adverse Event|0|||
42091044|NCT00435487|75901417|FG001|Overall Study|Adverse Event|3|||
42183288|NCT04425252|75991638|FG001|Overall Study|Lost to Follow-up|0|||
42183289|NCT04425252|75991637|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
42091045|NCT00435487|75901416|FG000|Overall Study|Lost to Follow-up|2|||
42091046|NCT00435487|75901417|FG001|Overall Study|Lost to Follow-up|2|||
42091047|NCT00435487|75901416|FG000|Overall Study|Other|5|||
42091048|NCT00435487|75901417|FG001|Overall Study|Other|2|||
42091049|NCT00435487|75901416|FG000|Overall Study|Withdrawal by Subject|2|||
42183290|NCT04425252|75991638|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
42183291|NCT03696576|75991649|FG000|Overall Study|Soreness of throat after therapy|1|||
42183292|NCT03696576|75991650|FG001|Overall Study|Soreness of throat after therapy|1|||
42183293|NCT03696576|75991649|FG000|Overall Study|Lost to Follow-up|2|||
42183294|NCT03696576|75991650|FG001|Overall Study|Lost to Follow-up|4|||
42183295|NCT04003610|75991659|FG000|Overall Study|Lost to Follow-up|0|||
42183296|NCT04003610|75991660|FG001|Overall Study|Lost to Follow-up|1|||
42183297|NCT04003610|75991661|FG002|Overall Study|Lost to Follow-up|0|||
42183298|NCT04003610|75991659|FG000|Overall Study|Death|0|||
42183299|NCT04003610|75991660|FG001|Overall Study|Death|0|||
42183300|NCT04003610|75991661|FG002|Overall Study|Death|3|||
42183301|NCT04003610|75991659|FG000|Overall Study|Study Terminated by Sponsor|0|||
42183302|NCT04003610|75991660|FG001|Overall Study|Study Terminated by Sponsor|0|||
42183303|NCT04003610|75991661|FG002|Overall Study|Study Terminated by Sponsor|3|||
42183304|NCT03999554|75991675|FG000|Overall Study|Lost to Follow-up|4|||
42183305|NCT03999554|75991676|FG001|Overall Study|Lost to Follow-up|5|||
42183306|NCT03999554|75991677|FG002|Overall Study|Lost to Follow-up|4|||
42183307|NCT03999554|75991678|FG003|Overall Study|Lost to Follow-up|5|||
42183308|NCT03999554|75991679|FG004|Overall Study|Lost to Follow-up|8|||
42183309|NCT03999554|75991675|FG000|Overall Study|Protocol Violation|0|||
42183310|NCT03999554|75991676|FG001|Overall Study|Protocol Violation|0|||
42183311|NCT03999554|75991677|FG002|Overall Study|Protocol Violation|5|||
42183312|NCT03999554|75991678|FG003|Overall Study|Protocol Violation|0|||
42183313|NCT03999554|75991679|FG004|Overall Study|Protocol Violation|0|||
42183314|NCT03999554|75991675|FG000|Overall Study|Pregnancy|0|||
42183315|NCT03999554|75991676|FG001|Overall Study|Pregnancy|0|||
42183316|NCT03999554|75991677|FG002|Overall Study|Pregnancy|1|||
42183317|NCT03999554|75991678|FG003|Overall Study|Pregnancy|0|||
42183318|NCT03999554|75991679|FG004|Overall Study|Pregnancy|0|||
42183319|NCT03999554|75991675|FG000|Overall Study|Withdrawal by Subject|2|||
42183320|NCT03999554|75991676|FG001|Overall Study|Withdrawal by Subject|2|||
42183321|NCT03999554|75991677|FG002|Overall Study|Withdrawal by Subject|2|||
42183322|NCT03999554|75991678|FG003|Overall Study|Withdrawal by Subject|1|||
42183323|NCT03999554|75991679|FG004|Overall Study|Withdrawal by Subject|1|||
42183324|NCT03999554|75991675|FG000|Overall Study|failure to comply with protocol requirements|0|||
42183325|NCT03999554|75991676|FG001|Overall Study|failure to comply with protocol requirements|0|||
42183326|NCT03999554|75991677|FG002|Overall Study|failure to comply with protocol requirements|0|||
42183327|NCT03999554|75991678|FG003|Overall Study|failure to comply with protocol requirements|1|||
42183328|NCT03999554|75991679|FG004|Overall Study|failure to comply with protocol requirements|0|||
42183329|NCT04129346|75991694|FG000|Overall Study|Death|1|||
42183330|NCT04129346|75991695|FG001|Overall Study|Death|0|||
42183331|NCT04526574|75991703|FG000|Overall Study|Protocol Violation|3|||
42183332|NCT04526574|75991704|FG001|Overall Study|Protocol Violation|1|||
42183333|NCT04526574|75991703|FG000|Overall Study|Withdrawal by Subject|12|||
42183334|NCT04526574|75991704|FG001|Overall Study|Withdrawal by Subject|9|||
42183335|NCT04526574|75991703|FG000|Overall Study|Other|1|||
42183336|NCT04526574|75991704|FG001|Overall Study|Other|2|||
42183337|NCT04526574|75991703|FG000|Overall Study|Adverse Event|1|||
42183338|NCT04526574|75991704|FG001|Overall Study|Adverse Event|1|||
42183339|NCT04526574|75991703|FG000|Overall Study|Death|2|||
42183340|NCT04526574|75991704|FG001|Overall Study|Death|3|||
42183341|NCT04526574|75991703|FG000|Overall Study|Lost to Follow-up|9|||
42183342|NCT04526574|75991704|FG001|Overall Study|Lost to Follow-up|9|||
42091050|NCT00435487|75901417|FG001|Overall Study|Withdrawal by Subject|1|||
42091051|NCT00435487|75901416|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
42091052|NCT00435487|75901417|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
42091053|NCT00435487|75901416|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
42091054|NCT00435487|75901417|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
42091055|NCT00579345|75901431|FG000|Overall Study|Withdrawal by Subject|2|||
42091056|NCT00579345|75901432|FG001|Overall Study|Withdrawal by Subject|0|||
42183343|NCT04526574|75991703|FG000|Overall Study|No longer meets eligibility criteria|8|||
42183344|NCT04526574|75991704|FG001|Overall Study|No longer meets eligibility criteria|8|||
42183345|NCT03993392|75991714|FG000|Overall Study|Withdrawal by Subject|3|||
42294837|NCT02589665|76129274|FG003|Maintenance Period|Physician Decision|0|||
42183346|NCT03993392|75991714|FG000|Overall Study|Lost to Follow-up|2|||
42183347|NCT03993392|75991714|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
42183348|NCT04422990|75991721|FG000|Overall Study|Withdrawal by Subject|0|||
42183349|NCT04422990|75991722|FG001|Overall Study|Withdrawal by Subject|1|||
42183350|NCT04422990|75991721|FG000|Overall Study|Travel|3|||
42183351|NCT04422990|75991722|FG001|Overall Study|Travel|0|||
42183352|NCT04377308|75991733|FG000|Overall Study|Withdrawal by Subject|0|||
42183353|NCT04377308|75991734|FG001|Overall Study|Withdrawal by Subject|1|||
42183354|NCT04447404|75991742|FG000|Overall Study|Death|2|||
42183355|NCT04447404|75991743|FG001|Overall Study|Death|0|||
42183356|NCT03988166|75991749|FG000|Overall Study|Lost to Follow-up|2|||
42183357|NCT03988166|75991749|FG000|Overall Study|Death|1|||
42183358|NCT03988088|75991758|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
42183359|NCT03988088|75991759|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
42183360|NCT03988088|75991760|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
42183361|NCT03988088|75991761|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
42183362|NCT03988088|75991758|FG000|Open-Label Addendum|Lost to Follow-up|0|||
42183363|NCT03988088|75991759|FG001|Open-Label Addendum|Lost to Follow-up|0|||
42183364|NCT03988088|75991760|FG002|Open-Label Addendum|Lost to Follow-up|1|||
42183365|NCT03988088|75991761|FG003|Open-Label Addendum|Lost to Follow-up|0|||
42183366|NCT03987932|75991772|FG000|Overall Study|Lost to Follow-up|2|||
42183367|NCT03987932|75991773|FG001|Overall Study|Lost to Follow-up|1|||
42183368|NCT03987932|75991774|FG002|Overall Study|Lost to Follow-up|1|||
42183369|NCT03987932|75991772|FG000|Overall Study|Non-study related elective surgery|0|||
42183370|NCT03987932|75991773|FG001|Overall Study|Non-study related elective surgery|0|||
42183371|NCT03987932|75991774|FG002|Overall Study|Non-study related elective surgery|1|||
42183372|NCT03987620|75991784|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
42183373|NCT03987620|75991785|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
42183374|NCT03987620|75991784|FG000|Overall Study|Adverse Event|3|||
42183375|NCT03987620|75991785|FG001|Overall Study|Adverse Event|0|||
42183376|NCT03987620|75991784|FG000|Overall Study|Lost to Follow-up|1|||
42183377|NCT03987620|75991785|FG001|Overall Study|Lost to Follow-up|2|||
42183378|NCT03987620|75991784|FG000|Overall Study|Physician Decision|0|||
42183379|NCT03987620|75991785|FG001|Overall Study|Physician Decision|1|||
42183380|NCT03987620|75991784|FG000|Overall Study|Pregnancy|1|||
42183381|NCT03987620|75991785|FG001|Overall Study|Pregnancy|0|||
42183382|NCT03987620|75991784|FG000|Overall Study|Withdrawal by Subject|7|||
42091057|NCT00579345|75901433|FG002|Overall Study|Withdrawal by Subject|0|||
42091058|NCT00579345|75901434|FG003|Overall Study|Withdrawal by Subject|0|||
42091059|NCT00579345|75901435|FG004|Overall Study|Withdrawal by Subject|0|||
42091060|NCT00579345|75901436|FG005|Overall Study|Withdrawal by Subject|0|||
42091061|NCT00579345|75901437|FG006|Overall Study|Withdrawal by Subject|0|||
42091062|NCT00579345|75901438|FG007|Overall Study|Withdrawal by Subject|1|||
42091063|NCT00579345|75901431|FG000|Overall Study|Lost to Follow-up|1|||
42091064|NCT00579345|75901432|FG001|Overall Study|Lost to Follow-up|0|||
42183383|NCT03987620|75991785|FG001|Overall Study|Withdrawal by Subject|1|||
42183384|NCT03987620|75991784|FG000|Overall Study|Other|2|||
42183385|NCT03987620|75991785|FG001|Overall Study|Other|5|||
42183386|NCT04376060|75991791|FG000|Overall Study|Physician Decision|1|||
42183387|NCT04413552|75991805|FG000|Overall Study|Adverse Event|0|||
42183388|NCT04413552|75991806|FG001|Overall Study|Adverse Event|0|||
42294838|NCT02589665|76129275|FG004|Maintenance Period|Physician Decision|0|||
42294839|NCT02589665|76129276|FG005|Maintenance Period|Physician Decision|1|||
42294840|NCT02589665|76129277|FG006|Maintenance Period|Physician Decision|0|||
42294841|NCT02589665|76129278|FG007|Maintenance Period|Physician Decision|0|||
42294842|NCT02589665|76129279|FG008|Maintenance Period|Physician Decision|0|||
42294843|NCT02589665|76129280|FG009|Maintenance Period|Physician Decision|0|||
42294844|NCT02589665|76129271|FG000|Maintenance Period|Reason Not Collected|0|||
42294845|NCT02589665|76129272|FG001|Maintenance Period|Reason Not Collected|0|||
42294846|NCT02589665|76129273|FG002|Maintenance Period|Reason Not Collected|0|||
42294847|NCT02589665|76129274|FG003|Maintenance Period|Reason Not Collected|0|||
42294848|NCT02589665|76129275|FG004|Maintenance Period|Reason Not Collected|0|||
42294849|NCT02589665|76129276|FG005|Maintenance Period|Reason Not Collected|1|||
42294850|NCT02589665|76129277|FG006|Maintenance Period|Reason Not Collected|1|||
42294851|NCT02589665|76129278|FG007|Maintenance Period|Reason Not Collected|0|||
42183389|NCT04413552|75991807|FG002|Overall Study|Adverse Event|0|||
42183390|NCT04413552|75991808|FG003|Overall Study|Adverse Event|0|||
42183391|NCT04413552|75991809|FG004|Overall Study|Adverse Event|0|||
42183392|NCT04413552|75991810|FG005|Overall Study|Adverse Event|0|||
42183393|NCT04413552|75991811|FG006|Overall Study|Adverse Event|1|||
42183394|NCT04413552|75991812|FG007|Overall Study|Adverse Event|0|||
42183395|NCT04413552|75991813|FG008|Overall Study|Adverse Event|0|||
42183396|NCT04413552|75991814|FG009|Overall Study|Adverse Event|0|||
42358831|NCT03745638|76204537|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
42091065|NCT00579345|75901433|FG002|Overall Study|Lost to Follow-up|0|||
42091066|NCT00579345|75901434|FG003|Overall Study|Lost to Follow-up|0|||
42091067|NCT00579345|75901435|FG004|Overall Study|Lost to Follow-up|0|||
42183397|NCT03987074|75991845|FG000|Overall Study|Withdrew Consent|1|||
42183398|NCT03987074|75991846|FG001|Overall Study|Withdrew Consent|1|||
42183399|NCT03987074|75991847|FG002|Overall Study|Withdrew Consent|0|||
42183400|NCT03987074|75991848|FG003|Overall Study|Withdrew Consent|2|||
42183401|NCT03987074|75991849|FG004|Overall Study|Withdrew Consent|1|||
42183402|NCT03987074|75991845|FG000|Overall Study|Adverse Event|2|||
42183403|NCT03987074|75991846|FG001|Overall Study|Adverse Event|1|||
42183404|NCT03987074|75991847|FG002|Overall Study|Adverse Event|0|||
42183405|NCT03987074|75991848|FG003|Overall Study|Adverse Event|0|||
42294852|NCT02589665|76129279|FG008|Maintenance Period|Reason Not Collected|0|||
42183406|NCT03987074|75991849|FG004|Overall Study|Adverse Event|1|||
42183407|NCT03987074|75991845|FG000|Overall Study|Lost to Follow-up|0|||
42294853|NCT02589665|76129280|FG009|Maintenance Period|Reason Not Collected|0|||
42091068|NCT00579345|75901436|FG005|Overall Study|Lost to Follow-up|0|||
42091069|NCT00579345|75901437|FG006|Overall Study|Lost to Follow-up|0|||
42091070|NCT00579345|75901438|FG007|Overall Study|Lost to Follow-up|0|||
42091071|NCT00579345|75901431|FG000|Overall Study|Adverse Event|0|||
42091072|NCT00579345|75901432|FG001|Overall Study|Adverse Event|0|||
42091073|NCT00579345|75901433|FG002|Overall Study|Adverse Event|1|||
42091074|NCT00579345|75901434|FG003|Overall Study|Adverse Event|0|||
42091075|NCT00579345|75901435|FG004|Overall Study|Adverse Event|0|||
42091076|NCT00579345|75901436|FG005|Overall Study|Adverse Event|0|||
42091077|NCT00579345|75901437|FG006|Overall Study|Adverse Event|0|||
42091078|NCT00579345|75901438|FG007|Overall Study|Adverse Event|0|||
42091079|NCT00579345|75901431|FG000|Overall Study|Protocol Violation|1|||
42091080|NCT00579345|75901432|FG001|Overall Study|Protocol Violation|0|||
42183408|NCT03987074|75991846|FG001|Overall Study|Lost to Follow-up|0|||
42183409|NCT03987074|75991847|FG002|Overall Study|Lost to Follow-up|1|||
42183410|NCT03987074|75991848|FG003|Overall Study|Lost to Follow-up|1|||
42183411|NCT03987074|75991849|FG004|Overall Study|Lost to Follow-up|0|||
42183412|NCT03987074|75991845|FG000|Overall Study|Investigator's Discretion|0|||
42183413|NCT03987074|75991846|FG001|Overall Study|Investigator's Discretion|0|||
42183414|NCT03987074|75991847|FG002|Overall Study|Investigator's Discretion|0|||
42183415|NCT03987074|75991848|FG003|Overall Study|Investigator's Discretion|1|||
42183416|NCT03987074|75991849|FG004|Overall Study|Investigator's Discretion|0|||
42183417|NCT04439214|75991861|FG000|Overall Study|Adverse Event|13|||
42183418|NCT04439214|75991861|FG000|Overall Study|Disease progression|16|||
42183419|NCT04439214|75991861|FG000|Overall Study|Death|1|||
42183420|NCT04439214|75991861|FG000|Overall Study|Withdrawal by Subject|2|||
42183421|NCT04439214|75991861|FG000|Overall Study|Declining health|1|||
42183422|NCT04439214|75991861|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
42183423|NCT04439214|75991861|FG000|Overall Study|Ineligible|5|||
42183424|NCT03696342|75991867|FG000|Overall Study|Lost to Follow-up|1|||
42183425|NCT03696342|75991868|FG001|Overall Study|Lost to Follow-up|0|||
42183426|NCT04411680|75991876|FG000|Treatment Period|Adverse Event|3|||
42183427|NCT04411680|75991877|FG001|Treatment Period|Adverse Event|0|||
42183428|NCT04411680|75991876|FG000|Treatment Period|Discharged from hospital|18|||
42183429|NCT04411680|75991877|FG001|Treatment Period|Discharged from hospital|7|||
42183430|NCT04411680|75991876|FG000|Treatment Period|Missed 1 or more doses|8|||
42183431|NCT04411680|75991877|FG001|Treatment Period|Missed 1 or more doses|0|||
42183432|NCT04411680|75991876|FG000|Treatment Period|Transferred to another hospital|0|||
42183433|NCT04411680|75991877|FG001|Treatment Period|Transferred to another hospital|1|||
42183434|NCT04411680|75991876|FG000|Follow up Period|Withdrawal by Subject|2|||
42091081|NCT00579345|75901433|FG002|Overall Study|Protocol Violation|0|||
42091082|NCT00579345|75901434|FG003|Overall Study|Protocol Violation|0|||
42091083|NCT00579345|75901435|FG004|Overall Study|Protocol Violation|0|||
42091084|NCT00579345|75901436|FG005|Overall Study|Protocol Violation|0|||
42183435|NCT04411680|75991877|FG001|Follow up Period|Withdrawal by Subject|0|||
42183436|NCT04411680|75991876|FG000|Follow up Period|Lost to Follow-up|5|||
42183437|NCT04411680|75991877|FG001|Follow up Period|Lost to Follow-up|6|||
42183438|NCT04411680|75991876|FG000|Follow up Period|Death|11|||
42183439|NCT04411680|75991877|FG001|Follow up Period|Death|8|||
42183440|NCT04410198|75991883|FG000|Overall Study|Death|10|||
42183441|NCT04410198|75991883|FG000|Overall Study|Withdrawal by Subject|7|||
42183442|NCT04410198|75991883|FG000|Overall Study|Transferred/Relocation|4|||
42183443|NCT04410198|75991883|FG000|Overall Study|Kidney Transplant|9|||
42183444|NCT04410198|75991883|FG000|Overall Study|Adverse Event|4|||
42183445|NCT04410198|75991883|FG000|Overall Study|Physician Decision|2|||
42183446|NCT04410198|75991883|FG000|Overall Study|Other than specified|1|||
42183447|NCT04161144|75991889|FG000|Overall Study|Withdrawal by Subject|0|||
42183448|NCT04161144|75991890|FG001|Overall Study|Withdrawal by Subject|1|||
42294854|NCT02589665|76129271|FG000|Induction Extension Period|Adverse Event|0|||
42294855|NCT02589665|76129272|FG001|Induction Extension Period|Adverse Event|0|||
42294856|NCT02589665|76129273|FG002|Induction Extension Period|Adverse Event|0|||
42294857|NCT02589665|76129274|FG003|Induction Extension Period|Adverse Event|0|||
42091085|NCT00579345|75901437|FG006|Overall Study|Protocol Violation|0|||
42091086|NCT00579345|75901438|FG007|Overall Study|Protocol Violation|1|||
42091087|NCT00579345|75901431|FG000|Overall Study|Death|1|||
42091088|NCT00579345|75901432|FG001|Overall Study|Death|1|||
42183449|NCT04161144|75991889|FG000|Overall Study|Protocol Violation|1|||
42183450|NCT04161144|75991890|FG001|Overall Study|Protocol Violation|0|||
42183451|NCT03984812|75991907|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
42183452|NCT03984812|75991908|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
42183453|NCT03984812|75991909|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
42183454|NCT03984812|75991910|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
42183455|NCT03984812|75991911|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
42091089|NCT00579345|75901433|FG002|Overall Study|Death|1|||
42183456|NCT03984812|75991912|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
42183457|NCT03984812|75991913|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
42183458|NCT03984812|75991914|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
42294858|NCT02589665|76129275|FG004|Induction Extension Period|Adverse Event|0|||
42183459|NCT03984812|75991915|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
42183460|NCT03984812|75991916|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
42091090|NCT00579345|75901434|FG003|Overall Study|Death|1|||
42091091|NCT00579345|75901435|FG004|Overall Study|Death|0|||
42091092|NCT00579345|75901436|FG005|Overall Study|Death|0|||
42091093|NCT00579345|75901437|FG006|Overall Study|Death|0|||
42091094|NCT00579345|75901438|FG007|Overall Study|Death|0|||
42091095|NCT00795821|75901486|FG000|Acute Treatment Phase|Adverse Event|23|||
42091096|NCT00795821|75901487|FG001|Acute Treatment Phase|Adverse Event|4|||
42091097|NCT00795821|75901486|FG000|Acute Treatment Phase|Death|1|||
42091098|NCT00795821|75901487|FG001|Acute Treatment Phase|Death|0|||
42183461|NCT03984812|75991917|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
42183462|NCT04160988|75991944|FG000|Overall Study|poor image quality|28|||
42183463|NCT04153188|75991965|FG000|Overall Study|Lost to Follow-up|1|||
42183464|NCT04153188|75991966|FG001|Overall Study|Lost to Follow-up|1|||
42183465|NCT04153188|75991965|FG000|Overall Study|Withdrawal by Subject|2|||
42183466|NCT04153188|75991966|FG001|Overall Study|Withdrawal by Subject|0|||
42183467|NCT04153188|75991965|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
42183468|NCT04153188|75991966|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
42183469|NCT04113746|75991974|FG000|Overall Study|Lost to Follow-up|4|||
42183470|NCT04113746|75991975|FG001|Overall Study|Lost to Follow-up|4|||
42183471|NCT03611010|75991985|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
42183472|NCT03611010|75991986|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
42183473|NCT03611010|75991987|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
42183474|NCT03611010|75991988|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
42183475|NCT04357782|75992003|FG000|Overall Study|Discharged from hospital|1|||
42183476|NCT04357782|75992004|FG001|Overall Study|Discharged from hospital|0|||
42183477|NCT04357782|75992003|FG000|Overall Study|Death|0|||
42183478|NCT04357782|75992004|FG001|Overall Study|Death|2|||
42183479|NCT03980522|75992015|FG000|Treatment Period|Adverse Event|1|||
42183480|NCT03980522|75992016|FG001|Treatment Period|Adverse Event|0|||
42183481|NCT03980522|75992017|FG002|Treatment Period|Adverse Event|0|||
42183482|NCT03980522|75992018|FG003|Treatment Period|Adverse Event|0|||
42183483|NCT03980522|75992019|FG004|Treatment Period|Adverse Event|0|||
42183484|NCT04402866|75992037|FG000|Overall Study|Discontinued Prior to Treatment|0|||
42183485|NCT04402866|75992038|FG001|Overall Study|Discontinued Prior to Treatment|0|||
42183486|NCT04402866|75992039|FG002|Overall Study|Discontinued Prior to Treatment|0|||
42183487|NCT04402866|75992040|FG003|Overall Study|Discontinued Prior to Treatment|0|||
42183488|NCT04402866|75992041|FG004|Overall Study|Discontinued Prior to Treatment|2|||
42183489|NCT04402866|75992042|FG005|Overall Study|Discontinued Prior to Treatment|3|||
42183490|NCT04402866|75992037|FG000|Overall Study|Adverse Event|2|||
42183491|NCT04402866|75992038|FG001|Overall Study|Adverse Event|1|||
42183492|NCT04402866|75992039|FG002|Overall Study|Adverse Event|0|||
42183493|NCT04402866|75992040|FG003|Overall Study|Adverse Event|0|||
42183494|NCT04402866|75992041|FG004|Overall Study|Adverse Event|13|||
42183495|NCT04402866|75992042|FG005|Overall Study|Adverse Event|8|||
42183496|NCT04402866|75992037|FG000|Overall Study|Miscellaneous|0|||
42183497|NCT04402866|75992038|FG001|Overall Study|Miscellaneous|0|||
42183498|NCT04402866|75992039|FG002|Overall Study|Miscellaneous|1|||
42183499|NCT04402866|75992040|FG003|Overall Study|Miscellaneous|0|||
42183500|NCT04402866|75992041|FG004|Overall Study|Miscellaneous|0|||
42183501|NCT04402866|75992042|FG005|Overall Study|Miscellaneous|0|||
42183502|NCT04402866|75992037|FG000|Overall Study|Lost to Follow-up|0|||
42183503|NCT04402866|75992038|FG001|Overall Study|Lost to Follow-up|0|||
42183504|NCT04402866|75992039|FG002|Overall Study|Lost to Follow-up|0|||
42183505|NCT04402866|75992040|FG003|Overall Study|Lost to Follow-up|0|||
42183506|NCT04402866|75992041|FG004|Overall Study|Lost to Follow-up|0|||
42183507|NCT04402866|75992042|FG005|Overall Study|Lost to Follow-up|1|||
42183508|NCT04402866|75992037|FG000|Overall Study|Withdrawal by Subject|0|||
42091099|NCT00795821|75901486|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
42183509|NCT04402866|75992038|FG001|Overall Study|Withdrawal by Subject|0|||
42183510|NCT04402866|75992039|FG002|Overall Study|Withdrawal by Subject|0|||
42183511|NCT04402866|75992040|FG003|Overall Study|Withdrawal by Subject|0|||
42183512|NCT04402866|75992041|FG004|Overall Study|Withdrawal by Subject|0|||
42183513|NCT04402866|75992042|FG005|Overall Study|Withdrawal by Subject|2|||
42183514|NCT04400682|75992054|FG000|Period 1|Withdrawal by Subject|1|||
42183515|NCT04400682|75992055|FG001|Period 1|Withdrawal by Subject|4|||
42183516|NCT03066778|75992063|FG000|Overall Study|Death|195|||
42183517|NCT03066778|75992064|FG001|Overall Study|Death|205|||
42183518|NCT03066778|75992063|FG000|Overall Study|Withdrawal by Subject|5|||
42183519|NCT03066778|75992064|FG001|Overall Study|Withdrawal by Subject|7|||
42183520|NCT04348656|75992073|FG000|Overall Study|Withdrawal by Subject|2|||
42183521|NCT04348656|75992074|FG001|Overall Study|Withdrawal by Subject|0|||
42183522|NCT04348656|75992073|FG000|Overall Study|Lost to Follow-up|11|||
42091100|NCT00795821|75901487|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
42091101|NCT00795821|75901486|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
42091102|NCT00795821|75901487|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
42091103|NCT00795821|75901486|FG000|Acute Treatment Phase|Physician Decision|1|||
42183523|NCT04348656|75992074|FG001|Overall Study|Lost to Follow-up|6|||
42183524|NCT04348500|75992089|FG000|Overall Study|Death|2|||
42183525|NCT04348500|75992090|FG001|Overall Study|Death|2|||
42183526|NCT04348500|75992089|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
42183527|NCT04348500|75992090|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
42183528|NCT04347954|75992099|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
42183529|NCT04347954|75992100|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
42183530|NCT04347954|75992101|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
42183531|NCT04347954|75992099|FG000|Overall Study|Lost to Follow-up|0|||
42183532|NCT04347954|75992100|FG001|Overall Study|Lost to Follow-up|1|||
42183533|NCT04347954|75992101|FG002|Overall Study|Lost to Follow-up|0|||
42183534|NCT03065530|75992113|FG000|Overall Study|Lack of Efficacy|1|||
42183535|NCT03065530|75992114|FG001|Overall Study|Lack of Efficacy|1|||
42183536|NCT03065530|75992115|FG002|Overall Study|Lack of Efficacy|0|||
42183537|NCT03065530|75992116|FG003|Overall Study|Lack of Efficacy|1|||
42183538|NCT03065530|75992113|FG000|Overall Study|Protocol Violation|1|||
42183539|NCT03065530|75992114|FG001|Overall Study|Protocol Violation|0|||
42183540|NCT03065530|75992115|FG002|Overall Study|Protocol Violation|1|||
42183541|NCT03065530|75992116|FG003|Overall Study|Protocol Violation|1|||
42183542|NCT03979820|75992138|FG000|Overall Study|Protocol Violation|1|||
42183543|NCT03979820|75992139|FG001|Overall Study|Protocol Violation|0|||
42294859|NCT02589665|76129276|FG005|Induction Extension Period|Adverse Event|0|||
42294860|NCT02589665|76129277|FG006|Induction Extension Period|Adverse Event|0|||
42294861|NCT02589665|76129278|FG007|Induction Extension Period|Adverse Event|0|||
42294862|NCT02589665|76129279|FG008|Induction Extension Period|Adverse Event|4|||
42294863|NCT02589665|76129280|FG009|Induction Extension Period|Adverse Event|0|||
42294864|NCT02589665|76129271|FG000|Induction Extension Period|Lack of Efficacy|0|||
42294865|NCT02589665|76129272|FG001|Induction Extension Period|Lack of Efficacy|0|||
42294866|NCT02589665|76129273|FG002|Induction Extension Period|Lack of Efficacy|0|||
42294867|NCT02589665|76129274|FG003|Induction Extension Period|Lack of Efficacy|0|||
42091104|NCT00795821|75901487|FG001|Acute Treatment Phase|Physician Decision|1|||
42091105|NCT00795821|75901486|FG000|Acute Treatment Phase|Protocol Violation|1|||
42091106|NCT00795821|75901487|FG001|Acute Treatment Phase|Protocol Violation|2|||
42091107|NCT00795821|75901486|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
42091108|NCT00795821|75901487|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
42091109|NCT00795821|75901486|FG000|Long-term Extension Phase|Adverse Event|25|||
42091110|NCT00795821|75901487|FG001|Long-term Extension Phase|Adverse Event|32|||
42091111|NCT00795821|75901486|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
42091112|NCT00795821|75901487|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
42091113|NCT00795821|75901486|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
42091114|NCT00795821|75901487|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
42091115|NCT00795821|75901486|FG000|Long-term Extension Phase|Physician Decision|1|||
42091116|NCT00795821|75901487|FG001|Long-term Extension Phase|Physician Decision|2|||
42091117|NCT00795821|75901486|FG000|Long-term Extension Phase|Protocol Violation|3|||
42091118|NCT00795821|75901487|FG001|Long-term Extension Phase|Protocol Violation|5|||
42091119|NCT00795821|75901486|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
42091120|NCT00795821|75901487|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
42091121|NCT00795821|75901486|FG000|Taper Phase|Adverse Event|2|||
42091122|NCT00795821|75901487|FG001|Taper Phase|Adverse Event|0|||
42091123|NCT00795821|75901486|FG000|Taper Phase|Lost to Follow-up|1|||
42091124|NCT00795821|75901487|FG001|Taper Phase|Lost to Follow-up|0|||
42091125|NCT00795821|75901486|FG000|Taper Phase|Physician Decision|2|||
42091126|NCT00795821|75901487|FG001|Taper Phase|Physician Decision|0|||
42091127|NCT00795821|75901486|FG000|Taper Phase|Withdrawal by Subject|4|||
42091128|NCT00795821|75901487|FG001|Taper Phase|Withdrawal by Subject|0|||
42091129|NCT00578643|75901503|FG000|Overall Study|Death|1|||
42091130|NCT00578643|75901503|FG000|Overall Study|Lost to Follow-up|1|||
42091131|NCT00578565|75901507|FG000|Overall Study|Adverse Event|3|||
42091132|NCT00741260|75901519|FG000|Overall Study|Disease Progression|3|||
42091133|NCT00741260|75901520|FG001|Overall Study|Disease Progression|5|||
42091134|NCT00741260|75901521|FG002|Overall Study|Disease Progression|3|||
42091135|NCT00741260|75901522|FG003|Overall Study|Disease Progression|3|||
42091136|NCT00741260|75901523|FG004|Overall Study|Disease Progression|5|||
42091137|NCT00741260|75901524|FG005|Overall Study|Disease Progression|37|||
42091138|NCT00741260|75901525|FG006|Overall Study|Disease Progression|4|||
42183544|NCT03979820|75992140|FG002|Overall Study|Protocol Violation|0|||
42294868|NCT02589665|76129275|FG004|Induction Extension Period|Lack of Efficacy|0|||
42091139|NCT00741260|75901519|FG000|Overall Study|Death|0|||
42091140|NCT00741260|75901520|FG001|Overall Study|Death|1|||
42183545|NCT03979820|75992141|FG003|Overall Study|Protocol Violation|0|||
42183546|NCT03979820|75992138|FG000|Overall Study|Withdrawal by Subject|0|||
42183547|NCT03979820|75992139|FG001|Overall Study|Withdrawal by Subject|0|||
42294869|NCT02589665|76129276|FG005|Induction Extension Period|Lack of Efficacy|0|||
42294870|NCT02589665|76129277|FG006|Induction Extension Period|Lack of Efficacy|0|||
42183548|NCT03979820|75992140|FG002|Overall Study|Withdrawal by Subject|1|||
42183549|NCT03979820|75992141|FG003|Overall Study|Withdrawal by Subject|0|||
42183550|NCT03979820|75992138|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
42183551|NCT03979820|75992139|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
42183552|NCT03979820|75992140|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
42183553|NCT03979820|75992141|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
42183554|NCT03647488|75992158|FG000|Overall Study|Progressive disease|10|||
42183555|NCT03647488|75992159|FG001|Overall Study|Progressive disease|0|||
42183556|NCT03647488|75992160|FG002|Overall Study|Progressive disease|0|||
42183557|NCT03647488|75992158|FG000|Overall Study|Adverse Event|5|||
42183558|NCT03647488|75992159|FG001|Overall Study|Adverse Event|0|||
42183559|NCT03647488|75992160|FG002|Overall Study|Adverse Event|0|||
42183560|NCT03647488|75992158|FG000|Overall Study|Clinical progression|2|||
42183561|NCT03647488|75992159|FG001|Overall Study|Clinical progression|0|||
42183562|NCT03647488|75992160|FG002|Overall Study|Clinical progression|0|||
42183563|NCT03647488|75992158|FG000|Overall Study|Participant refused to take investigational product|1|||
42183564|NCT03647488|75992159|FG001|Overall Study|Participant refused to take investigational product|0|||
42183565|NCT03647488|75992160|FG002|Overall Study|Participant refused to take investigational product|0|||
42183566|NCT03693950|75992168|FG000|Overall Study|Withdrawal by Subject|1|||
42183567|NCT03693950|75992169|FG001|Overall Study|Withdrawal by Subject|0|||
42183568|NCT04110314|75992181|FG000|Overall Study|Did not meet inclusion criteria|35255|||
42183569|NCT04110314|75992182|FG001|Overall Study|Did not meet inclusion criteria|35104|||
42183570|NCT04110314|75992183|FG002|Overall Study|Did not meet inclusion criteria|35636|||
42183571|NCT04110314|75992184|FG003|Overall Study|Did not meet inclusion criteria|35135|||
42183572|NCT04110314|75992185|FG004|Overall Study|Did not meet inclusion criteria|35247|||
42183573|NCT04110314|75992186|FG005|Overall Study|Did not meet inclusion criteria|35727|||
42183574|NCT04098458|75992198|FG000|Overall Study|Death|1|||
42183575|NCT04098458|75992198|FG000|Overall Study|did not meet study inclusion criteria|3|||
42183576|NCT03447262|75992203|FG000|Overall Study|Adverse Event|7|||
42183577|NCT03447262|75992203|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
42183578|NCT03447262|75992203|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
42183579|NCT03447262|75992203|FG000|Overall Study|Death|2|||
42183580|NCT03447262|75992203|FG000|Overall Study|Study Termination by Sponsor|455|||
42183581|NCT03447262|75992203|FG000|Overall Study|Other|4|||
42183582|NCT04094870|75992212|FG000|Overall Study|Lost to Follow-up|1|||
42183583|NCT04094870|75992213|FG001|Overall Study|Lost to Follow-up|1|||
42183584|NCT04399356|75992228|FG000|Overall Study|Lost to Follow-up|1|||
42183585|NCT04399356|75992229|FG001|Overall Study|Lost to Follow-up|1|||
42183586|NCT04399356|75992228|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
42183587|NCT04399356|75992229|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
42183588|NCT04399356|75992228|FG000|Overall Study|Withdrawal by Subject|1|||
42183589|NCT04399356|75992229|FG001|Overall Study|Withdrawal by Subject|0|||
42183590|NCT03692676|75992239|FG000|Overall Study|exclude patients with prior use|4424|||
42183591|NCT03692676|75992240|FG001|Overall Study|exclude patients with prior use|24726|||
42183592|NCT03692676|75992241|FG002|Overall Study|exclude patients with prior use|0|||
42183593|NCT03692676|75992242|FG003|Overall Study|exclude patients with prior use|0|||
42183594|NCT03692676|75992239|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
42183595|NCT03692676|75992240|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
42183596|NCT03692676|75992241|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
42183597|NCT03692676|75992242|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
42183598|NCT03692676|75992239|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
42183599|NCT03692676|75992240|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
42183600|NCT03692676|75992241|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
42183601|NCT03692676|75992242|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
42183602|NCT03692676|75992239|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
42183603|NCT03692676|75992240|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
42183604|NCT03692676|75992241|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
42183605|NCT03692676|75992242|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
42183606|NCT03692676|75992239|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
42183607|NCT03692676|75992240|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
42183608|NCT03692676|75992241|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
42183609|NCT03692676|75992242|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
42183610|NCT03692676|75992239|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
42183611|NCT03692676|75992240|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
42183612|NCT03692676|75992241|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
42358832|NCT03745638|76204531|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
42183613|NCT03692676|75992242|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
42183614|NCT03692676|75992239|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
42183615|NCT03692676|75992240|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
42183616|NCT03692676|75992241|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
42183617|NCT03692676|75992242|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
42183618|NCT03692676|75992239|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
42183619|NCT03692676|75992240|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
42183620|NCT03692676|75992241|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
42183621|NCT03692676|75992242|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
42183622|NCT03692676|75992239|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
42183623|NCT03692676|75992240|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
42183624|NCT03692676|75992241|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
42183625|NCT03692676|75992242|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
42183626|NCT03692676|75992239|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
42091141|NCT00741260|75901521|FG002|Overall Study|Death|0|||
42091142|NCT00741260|75901522|FG003|Overall Study|Death|1|||
42091143|NCT00741260|75901523|FG004|Overall Study|Death|2|||
42183627|NCT03692676|75992240|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
42183628|NCT03692676|75992241|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
42183629|NCT03692676|75992242|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
42183630|NCT03692676|75992239|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
42183631|NCT03692676|75992240|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
42183632|NCT03692676|75992241|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
42183633|NCT03692676|75992242|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
42183634|NCT03692676|75992239|FG000|Overall Study|Other|0|||
42183635|NCT03692676|75992240|FG001|Overall Study|Other|805|||
42183636|NCT03692676|75992241|FG002|Overall Study|Other|758|||
42183637|NCT03692676|75992242|FG003|Overall Study|Other|277|||
42183638|NCT03692676|75992239|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
42183639|NCT03692676|75992240|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
42183640|NCT03692676|75992241|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
42183641|NCT03692676|75992242|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
42183642|NCT03691428|75992254|FG000|Overall Study|Withdrawal by Subject|6|||
42183643|NCT03691428|75992255|FG001|Overall Study|Withdrawal by Subject|8|||
42183644|NCT04122534|75992261|FG000|Overall Study|Lost to Follow-up|4|||
42091144|NCT00741260|75901524|FG005|Overall Study|Death|2|||
42091145|NCT00741260|75901525|FG006|Overall Study|Death|1|||
42091146|NCT00741260|75901519|FG000|Overall Study|Withdrawal by Subject|0|||
42091147|NCT00741260|75901520|FG001|Overall Study|Withdrawal by Subject|0|||
42091148|NCT00741260|75901521|FG002|Overall Study|Withdrawal by Subject|0|||
42091149|NCT00741260|75901522|FG003|Overall Study|Withdrawal by Subject|0|||
42091150|NCT00741260|75901523|FG004|Overall Study|Withdrawal by Subject|1|||
42091151|NCT00741260|75901524|FG005|Overall Study|Withdrawal by Subject|3|||
42091152|NCT00741260|75901525|FG006|Overall Study|Withdrawal by Subject|1|||
42091153|NCT00741260|75901519|FG000|Overall Study|Physician Decision|1|||
42091154|NCT00741260|75901520|FG001|Overall Study|Physician Decision|1|||
42091155|NCT00741260|75901521|FG002|Overall Study|Physician Decision|0|||
42091156|NCT00741260|75901522|FG003|Overall Study|Physician Decision|0|||
42091157|NCT00741260|75901523|FG004|Overall Study|Physician Decision|0|||
42091158|NCT00741260|75901524|FG005|Overall Study|Physician Decision|0|||
42091159|NCT00741260|75901525|FG006|Overall Study|Physician Decision|0|||
42091160|NCT00741260|75901519|FG000|Overall Study|Other|2|||
42091161|NCT00741260|75901520|FG001|Overall Study|Other|1|||
42091162|NCT00741260|75901521|FG002|Overall Study|Other|1|||
42091163|NCT00741260|75901522|FG003|Overall Study|Other|2|||
42091164|NCT00741260|75901523|FG004|Overall Study|Other|1|||
42183645|NCT04091360|75992271|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
42183646|NCT04091360|75992272|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
42183647|NCT04091360|75992273|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
42183648|NCT04091360|75992274|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
42294871|NCT02589665|76129278|FG007|Induction Extension Period|Lack of Efficacy|0|||
42091165|NCT00741260|75901524|FG005|Overall Study|Other|3|||
42091166|NCT00741260|75901525|FG006|Overall Study|Other|1|||
42091167|NCT00740870|75901546|FG000|Overall Study|Not Catheterized|4|||
42091168|NCT00740870|75901546|FG000|Overall Study|Further testing contraindicated implant|17|||
42091169|NCT00740792|75901557|FG000|Overall Study|Adverse Event|3|||
42183649|NCT04091360|75992275|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
42183650|NCT04091360|75992276|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
42183651|NCT04091360|75992277|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
42183652|NCT04091360|75992278|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
42183653|NCT04091360|75992279|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
42183654|NCT04091360|75992280|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
42183655|NCT04091360|75992271|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
42183656|NCT04091360|75992272|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
42183657|NCT04091360|75992273|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
42183658|NCT04091360|75992274|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
42183659|NCT04091360|75992275|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
42183660|NCT04091360|75992276|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
42183661|NCT04091360|75992277|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
42183662|NCT04091360|75992278|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
42183663|NCT04091360|75992279|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
42183664|NCT04091360|75992280|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
42183665|NCT04091360|75992271|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
42183666|NCT04091360|75992272|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
42183667|NCT04091360|75992273|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
42183668|NCT04091360|75992274|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
42183669|NCT04091360|75992275|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
42183670|NCT04091360|75992276|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
42183671|NCT04091360|75992277|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
42183672|NCT04091360|75992278|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
42183673|NCT04091360|75992279|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
42183674|NCT04091360|75992280|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
42183675|NCT04346628|75992304|FG000|Overall Study|Lost to Follow-up|4|||
42183676|NCT04346628|75992305|FG001|Overall Study|Lost to Follow-up|4|||
42183677|NCT04346628|75992304|FG000|Overall Study|Withdrew (had personal reasons)|2|||
42183678|NCT04346628|75992305|FG001|Overall Study|Withdrew (had personal reasons)|5|||
42183679|NCT04346628|75992304|FG000|Overall Study|Withdrew (medication intolerant)|0|||
42183680|NCT04346628|75992305|FG001|Overall Study|Withdrew (medication intolerant)|3|||
42183681|NCT04346628|75992304|FG000|Overall Study|Withdrew (declined intervention)|0|||
42183682|NCT04346628|75992305|FG001|Overall Study|Withdrew (declined intervention)|1|||
42183683|NCT03681470|75992311|FG000|Overall Study|Lack of Efficacy|3|||
42183684|NCT03681470|75992311|FG000|Overall Study|Lost to Follow-up|1|||
42183685|NCT03681470|75992311|FG000|Overall Study|Protocol Violation|3|||
42183686|NCT03681470|75992311|FG000|Overall Study|Withdrawal by Subject|1|||
42183687|NCT04343976|75992317|FG000|Overall Study|Withdrawal by Subject|0|||
42183688|NCT04343976|75992318|FG001|Overall Study|Withdrawal by Subject|1|||
42183689|NCT03322540|75992326|FG000|Overall Study|Death|21|||
42183690|NCT03322540|75992327|FG001|Overall Study|Death|28|||
42183691|NCT03322540|75992326|FG000|Overall Study|Lost to Follow-up|0|||
42183692|NCT03322540|75992327|FG001|Overall Study|Lost to Follow-up|1|||
42183693|NCT03322540|75992326|FG000|Overall Study|Physician Decision|7|||
42183694|NCT03322540|75992327|FG001|Overall Study|Physician Decision|6|||
42294872|NCT02589665|76129279|FG008|Induction Extension Period|Lack of Efficacy|3|||
42091170|NCT00740792|75901558|FG001|Overall Study|Adverse Event|1|||
42091171|NCT00740792|75901559|FG002|Overall Study|Adverse Event|1|||
42091172|NCT00740792|75901560|FG003|Overall Study|Adverse Event|3|||
42091173|NCT00740792|75901557|FG000|Overall Study|Lack of Efficacy|1|||
42091174|NCT00740792|75901558|FG001|Overall Study|Lack of Efficacy|1|||
42091175|NCT00740792|75901559|FG002|Overall Study|Lack of Efficacy|0|||
42091176|NCT00740792|75901560|FG003|Overall Study|Lack of Efficacy|3|||
42091177|NCT00740792|75901557|FG000|Overall Study|Lost to Follow-up|2|||
42091178|NCT00740792|75901558|FG001|Overall Study|Lost to Follow-up|1|||
42091179|NCT00740792|75901559|FG002|Overall Study|Lost to Follow-up|0|||
42091180|NCT00740792|75901560|FG003|Overall Study|Lost to Follow-up|0|||
42091181|NCT00740792|75901557|FG000|Overall Study|Protocol Violation|0|||
42091182|NCT00740792|75901558|FG001|Overall Study|Protocol Violation|1|||
42091183|NCT00740792|75901559|FG002|Overall Study|Protocol Violation|0|||
42091184|NCT00740792|75901560|FG003|Overall Study|Protocol Violation|2|||
42091185|NCT00740792|75901557|FG000|Overall Study|Withdrawal by Subject|1|||
42091186|NCT00740792|75901558|FG001|Overall Study|Withdrawal by Subject|1|||
42091187|NCT00740792|75901559|FG002|Overall Study|Withdrawal by Subject|0|||
42091188|NCT00740792|75901560|FG003|Overall Study|Withdrawal by Subject|0|||
42091189|NCT00740792|75901557|FG000|Overall Study|administrative|3|||
42091190|NCT00740792|75901558|FG001|Overall Study|administrative|3|||
42091191|NCT00740792|75901559|FG002|Overall Study|administrative|8|||
42091192|NCT00740792|75901560|FG003|Overall Study|administrative|2|||
42091193|NCT00740714|75901573|FG000|Overall Study|Withdrawal by Subject|17|||
42183695|NCT03322540|75992326|FG000|Overall Study|Withdrawal by Subject|3|||
42183696|NCT03322540|75992327|FG001|Overall Study|Withdrawal by Subject|1|||
42183697|NCT03322540|75992326|FG000|Overall Study|Study terminated by sponsor|0|||
42183698|NCT03322540|75992327|FG001|Overall Study|Study terminated by sponsor|1|||
42183699|NCT04339296|75992337|FG000|Overall Study|Refuse to participate after allocation|1|||
42183700|NCT04339296|75992338|FG001|Overall Study|Refuse to participate after allocation|1|||
42183701|NCT04339296|75992337|FG000|Overall Study|Withdrew after completion of baseline|2|||
42183702|NCT04339296|75992338|FG001|Overall Study|Withdrew after completion of baseline|1|||
42183703|NCT04339296|75992337|FG000|Overall Study|Lost to Follow-up|0|||
42183704|NCT04339296|75992338|FG001|Overall Study|Lost to Follow-up|4|||
42183705|NCT04339296|75992337|FG000|Overall Study|Discontinued intervention|5|||
42183706|NCT04339296|75992338|FG001|Overall Study|Discontinued intervention|3|||
42183707|NCT02025556|75992347|FG000|Overall Study|Adverse Event|0|||
42183708|NCT02025556|75992348|FG001|Overall Study|Adverse Event|4|||
42183709|NCT02025556|75992349|FG002|Overall Study|Adverse Event|2|||
42183710|NCT02025556|75992347|FG000|Overall Study|Lack of Efficacy|2|||
42183711|NCT02025556|75992348|FG001|Overall Study|Lack of Efficacy|1|||
42183712|NCT02025556|75992349|FG002|Overall Study|Lack of Efficacy|0|||
42183713|NCT02025556|75992347|FG000|Overall Study|Protocol Violation|2|||
42183714|NCT02025556|75992348|FG001|Overall Study|Protocol Violation|1|||
42183715|NCT02025556|75992349|FG002|Overall Study|Protocol Violation|0|||
42183716|NCT02025556|75992347|FG000|Overall Study|Withdrawal by Subject|0|||
42183717|NCT02025556|75992348|FG001|Overall Study|Withdrawal by Subject|3|||
42183718|NCT02025556|75992349|FG002|Overall Study|Withdrawal by Subject|6|||
42183719|NCT02025556|75992347|FG000|Overall Study|Lost to Follow-up|2|||
42183720|NCT02025556|75992348|FG001|Overall Study|Lost to Follow-up|4|||
42183721|NCT02025556|75992349|FG002|Overall Study|Lost to Follow-up|0|||
42183722|NCT02025556|75992347|FG000|Overall Study|Reason not reported|0|||
42183723|NCT02025556|75992348|FG001|Overall Study|Reason not reported|0|||
42183724|NCT02025556|75992349|FG002|Overall Study|Reason not reported|1|||
42183725|NCT04334460|75992359|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
42183726|NCT04334460|75992360|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
42183727|NCT04334460|75992359|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
42183728|NCT04334460|75992360|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
42183729|NCT04334148|75992369|FG000|Overall Study|positive nasal swab at baseline|0|||
42183730|NCT04334148|75992370|FG001|Overall Study|positive nasal swab at baseline|1|||
42183731|NCT04399122|75992378|FG000|Overall Study|Lost to Follow-up|2|||
42183732|NCT04399122|75992379|FG001|Overall Study|Lost to Follow-up|0|||
42091194|NCT00740714|75901574|FG001|Overall Study|Withdrawal by Subject|19|||
42091195|NCT00740714|75901575|FG002|Overall Study|Withdrawal by Subject|29|||
42091196|NCT00788957|75901587|FG000|Part 1|Death|8|||
42091197|NCT00788957|75901588|FG001|Part 1|Death|0|||
42091198|NCT00788957|75901589|FG002|Part 1|Death|0|||
42091199|NCT00788957|75901590|FG003|Part 1|Death|0|||
42091200|NCT00788957|75901591|FG004|Part 1|Death|0|||
42091201|NCT00788957|75901592|FG005|Part 1|Death|0|||
42091202|NCT00788957|75901587|FG000|Part 1|Lost to Follow-up|1|||
42091203|NCT00788957|75901588|FG001|Part 1|Lost to Follow-up|0|||
42091204|NCT00788957|75901589|FG002|Part 1|Lost to Follow-up|0|||
42091205|NCT00788957|75901590|FG003|Part 1|Lost to Follow-up|0|||
42091206|NCT00788957|75901591|FG004|Part 1|Lost to Follow-up|0|||
42091207|NCT00788957|75901592|FG005|Part 1|Lost to Follow-up|0|||
42091208|NCT00788957|75901587|FG000|Part 2|Withdrawal by Subject|0|||
42091209|NCT00788957|75901588|FG001|Part 2|Withdrawal by Subject|9|||
42183733|NCT04399122|75992378|FG000|Overall Study|Withdrawal by Subject|1|||
42091210|NCT00788957|75901589|FG002|Part 2|Withdrawal by Subject|5|||
42091211|NCT00788957|75901590|FG003|Part 2|Withdrawal by Subject|3|||
42091212|NCT00788957|75901591|FG004|Part 2|Withdrawal by Subject|0|||
42091213|NCT00788957|75901592|FG005|Part 2|Withdrawal by Subject|0|||
42091214|NCT00788957|75901587|FG000|Part 2|Death|0|||
42091215|NCT00788957|75901588|FG001|Part 2|Death|32|||
42091216|NCT00788957|75901589|FG002|Part 2|Death|35|||
42091217|NCT00788957|75901590|FG003|Part 2|Death|37|||
42091218|NCT00788957|75901591|FG004|Part 2|Death|0|||
42091219|NCT00788957|75901592|FG005|Part 2|Death|0|||
42091220|NCT00788957|75901587|FG000|Part 2|Lost to Follow-up|0|||
42183734|NCT04399122|75992379|FG001|Overall Study|Withdrawal by Subject|0|||
42183735|NCT04398732|75992400|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
42183736|NCT04398030|75992406|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
42294873|NCT02589665|76129280|FG009|Induction Extension Period|Lack of Efficacy|0|||
42091221|NCT00788957|75901588|FG001|Part 2|Lost to Follow-up|0|||
42091222|NCT00788957|75901589|FG002|Part 2|Lost to Follow-up|3|||
42091223|NCT00788957|75901590|FG003|Part 2|Lost to Follow-up|0|||
42091224|NCT00788957|75901591|FG004|Part 2|Lost to Follow-up|0|||
42091225|NCT00788957|75901592|FG005|Part 2|Lost to Follow-up|0|||
42091226|NCT00788957|75901587|FG000|Part 2|On-study at time of data cut-off|0|||
42091227|NCT00788957|75901588|FG001|Part 2|On-study at time of data cut-off|1|||
42183737|NCT04398030|75992407|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
42183738|NCT04398030|75992406|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
42183739|NCT04398030|75992407|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
42183740|NCT03064438|75992415|FG000|Overall Study|Lost to Follow-up|1|||
42091228|NCT00788957|75901589|FG002|Part 2|On-study at time of data cut-off|1|||
42091229|NCT00788957|75901590|FG003|Part 2|On-study at time of data cut-off|1|||
42091230|NCT00788957|75901591|FG004|Part 2|On-study at time of data cut-off|0|||
42091231|NCT00788957|75901592|FG005|Part 2|On-study at time of data cut-off|0|||
42091232|NCT00788957|75901587|FG000|Part 3|Withdrawal by Subject|0|||
42091233|NCT00788957|75901588|FG001|Part 3|Withdrawal by Subject|0|||
42091234|NCT00788957|75901589|FG002|Part 3|Withdrawal by Subject|0|||
42091235|NCT00788957|75901590|FG003|Part 3|Withdrawal by Subject|0|||
42091236|NCT00788957|75901591|FG004|Part 3|Withdrawal by Subject|0|||
42183741|NCT03064438|75992416|FG001|Overall Study|Lost to Follow-up|0|||
42183742|NCT03064438|75992415|FG000|Overall Study|Withdrawal by Subject|0|||
42183743|NCT03064438|75992416|FG001|Overall Study|Withdrawal by Subject|1|||
42183744|NCT04327986|75992422|FG000|Overall Study|Physician Decision|2|||
42183745|NCT04327986|75992423|FG001|Overall Study|Physician Decision|0|||
42183746|NCT04327986|75992424|FG002|Overall Study|Physician Decision|0|||
42183747|NCT04327986|75992422|FG000|Overall Study|Death|1|||
42183748|NCT04327986|75992423|FG001|Overall Study|Death|0|||
42183749|NCT04327986|75992424|FG002|Overall Study|Death|0|||
42183750|NCT04322682|75992430|FG000|Overall Study|Withdrawal by Subject|33|||
42091237|NCT00788957|75901592|FG005|Part 3|Withdrawal by Subject|2|||
42091238|NCT00788957|75901587|FG000|Part 3|Death|0|||
42091239|NCT00788957|75901588|FG001|Part 3|Death|0|||
42091240|NCT00788957|75901589|FG002|Part 3|Death|0|||
42091241|NCT00788957|75901590|FG003|Part 3|Death|0|||
42091242|NCT00788957|75901591|FG004|Part 3|Death|8|||
42091243|NCT00788957|75901592|FG005|Part 3|Death|9|||
42091244|NCT00788957|75901587|FG000|Part 3|On-study at time of data cut-off|0|||
42091245|NCT00788957|75901588|FG001|Part 3|On-study at time of data cut-off|0|||
42091246|NCT00788957|75901589|FG002|Part 3|On-study at time of data cut-off|0|||
42091247|NCT00788957|75901590|FG003|Part 3|On-study at time of data cut-off|0|||
42091248|NCT00788957|75901591|FG004|Part 3|On-study at time of data cut-off|1|||
42091249|NCT00788957|75901592|FG005|Part 3|On-study at time of data cut-off|0|||
42091250|NCT00740636|75901611|FG000|Overall Study|Adverse Event|0|||
42183751|NCT04322682|75992431|FG001|Overall Study|Withdrawal by Subject|47|||
42183752|NCT04322682|75992430|FG000|Overall Study|Death|5|||
42183753|NCT04322682|75992431|FG001|Overall Study|Death|9|||
42183754|NCT04322682|75992430|FG000|Overall Study|Lost to Follow-up|4|||
42183755|NCT04322682|75992431|FG001|Overall Study|Lost to Follow-up|8|||
42183756|NCT04322682|75992430|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
42183757|NCT04322682|75992431|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
42183758|NCT04322526|75992439|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
42183759|NCT04322526|75992440|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
42183760|NCT04322526|75992439|FG000|Washout (1 Week)|Lost to Follow-up|1|||
42183761|NCT04322526|75992440|FG001|Washout (1 Week)|Lost to Follow-up|2|||
42183762|NCT04115358|75992449|FG000|Overall Study|exfoliation|0|||
42183763|NCT04115358|75992450|FG001|Overall Study|exfoliation|0|||
42091251|NCT00740636|75901612|FG001|Overall Study|Adverse Event|2|||
42091252|NCT00740636|75901611|FG000|Overall Study|Patient Ineligible|0|||
42091253|NCT00740636|75901612|FG001|Overall Study|Patient Ineligible|1|||
42091254|NCT00740636|75901611|FG000|Overall Study|Patient Not Treated|0|||
42091255|NCT00740636|75901612|FG001|Overall Study|Patient Not Treated|1|||
42091256|NCT00740636|75901611|FG000|Overall Study|Progressive Disease|1|||
42091257|NCT00740636|75901612|FG001|Overall Study|Progressive Disease|0|||
42091258|NCT00740636|75901611|FG000|Overall Study|Death|1|||
42091259|NCT00740636|75901612|FG001|Overall Study|Death|0|||
42091260|NCT00735254|75901622|FG000|Overall Study|Protocol Violation|1|||
42091261|NCT00735254|75901623|FG001|Overall Study|Protocol Violation|1|||
42091262|NCT00735254|75901624|FG002|Overall Study|Protocol Violation|1|||
42091263|NCT00735254|75901625|FG003|Overall Study|Protocol Violation|0|||
42091264|NCT00795509|75901635|FG000|Overall Study|Protocol Violation|31|||
42091265|NCT00787787|75901639|FG000|Overall Study|Lack of Efficacy|4|||
42183764|NCT04115358|75992451|FG002|Overall Study|exfoliation|1|||
42183765|NCT04109118|75992460|FG000|Overall Study|Lost to Follow-up|3|||
42183766|NCT04105998|75992467|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
42183767|NCT04105998|75992468|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
42183768|NCT04397718|75992476|FG000|Overall Study|Death|7|||
42091266|NCT00787787|75901639|FG000|Overall Study|Adverse Event|3|||
42091267|NCT00787319|75901643|FG000|Overall Study|Lost to Follow-up|2|||
42091268|NCT00787319|75901643|FG000|Overall Study|Withdrawal by Subject|15|||
42091269|NCT00787319|75901643|FG000|Overall Study|Adverse Event|3|||
42091270|NCT00787319|75901643|FG000|Overall Study|Objective progression or relapse|30|||
42091271|NCT00787319|75901643|FG000|Overall Study|Lack of Efficacy|1|||
42091272|NCT00787319|75901643|FG000|Overall Study|Budget exhausted/exceeded|1|||
42091273|NCT00787319|75901643|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
42091274|NCT00787319|75901643|FG000|Overall Study|No health insurance reimbursement|2|||
42183769|NCT04397718|75992477|FG001|Overall Study|Death|11|||
42183770|NCT04397718|75992476|FG000|Overall Study|Lost to Follow-up|0|||
42183771|NCT04397718|75992477|FG001|Overall Study|Lost to Follow-up|4|||
42183772|NCT04105218|75992485|FG000|Overall Study|Withdrawal by Subject|3|||
42183773|NCT04105218|75992486|FG001|Overall Study|Withdrawal by Subject|2|||
42183774|NCT04105218|75992485|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
42183775|NCT04105218|75992486|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
42183776|NCT04105218|75992485|FG000|Overall Study|Failed screening tests|2|||
42183777|NCT04105218|75992486|FG001|Overall Study|Failed screening tests|1|||
42183778|NCT04317690|75992497|FG000|Overall Study|did not have complete information for primary outcome|0|||
42183779|NCT04317690|75992498|FG001|Overall Study|did not have complete information for primary outcome|4|||
42183780|NCT04317690|75992499|FG002|Overall Study|did not have complete information for primary outcome|0|||
42183781|NCT04317690|75992500|FG003|Overall Study|did not have complete information for primary outcome|2|||
42183782|NCT04317690|75992501|FG004|Overall Study|did not have complete information for primary outcome|0|||
42183783|NCT03721276|75992528|FG000|Overall Study|Lost to Follow-up|5|||
42183784|NCT03721276|75992529|FG001|Overall Study|Lost to Follow-up|3|||
42183785|NCT03721276|75992528|FG000|Overall Study|Adverse Event|0|||
42183786|NCT03721276|75992529|FG001|Overall Study|Adverse Event|1|||
42183787|NCT03269344|75992544|FG000|Overall Study|Protocol Violation|4|||
42183788|NCT03269344|75992545|FG001|Overall Study|Protocol Violation|3|||
42183789|NCT04389840|75992557|FG000|Overall Study|Adverse Event|0|||
42183790|NCT04389840|75992558|FG001|Overall Study|Adverse Event|0|||
42183791|NCT04389840|75992559|FG002|Overall Study|Adverse Event|0|||
42183792|NCT04389840|75992560|FG003|Overall Study|Adverse Event|1|||
42183793|NCT04389840|75992561|FG004|Overall Study|Adverse Event|0|||
42183794|NCT04389840|75992562|FG005|Overall Study|Adverse Event|0|||
42183795|NCT04389840|75992557|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
42183796|NCT04389840|75992558|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
42183797|NCT04389840|75992559|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
42183798|NCT04389840|75992560|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
42183799|NCT04389840|75992561|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
42183800|NCT04389840|75992562|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
42183801|NCT04389840|75992557|FG000|Overall Study|Death|0|||
42183802|NCT04389840|75992558|FG001|Overall Study|Death|1|||
42183803|NCT04389840|75992559|FG002|Overall Study|Death|0|||
42183804|NCT04389840|75992560|FG003|Overall Study|Death|0|||
42183805|NCT04389840|75992561|FG004|Overall Study|Death|0|||
42183806|NCT04389840|75992562|FG005|Overall Study|Death|0|||
42183807|NCT04307940|75992585|FG000|Overall Study|Adverse Event|1|||
42183808|NCT04307940|75992586|FG001|Overall Study|Adverse Event|0|||
42183809|NCT04307940|75992587|FG002|Overall Study|Adverse Event|0|||
42183810|NCT04307940|75992585|FG000|Overall Study|Withdrawal by Subject|2|||
42183811|NCT04307940|75992586|FG001|Overall Study|Withdrawal by Subject|3|||
42183812|NCT04307940|75992587|FG002|Overall Study|Withdrawal by Subject|1|||
42183813|NCT04307940|75992585|FG000|Overall Study|Lost to Follow-up|2|||
42091275|NCT00787319|75901643|FG000|Overall Study|Stabilized disease findings|3|||
42091276|NCT00787319|75901643|FG000|Overall Study|Inactive disease|5|||
42091277|NCT00794963|75901649|FG000|Overall Study|Withdrawal by Subject|1|||
42091278|NCT00794963|75901650|FG001|Overall Study|Withdrawal by Subject|4|||
42091279|NCT00794573|75901658|FG000|Overall Study|Death|3|||
42091280|NCT00794573|75901659|FG001|Overall Study|Death|0|||
42091281|NCT00794573|75901658|FG000|Overall Study|Withdrawal by Subject|9|||
42183814|NCT04307940|75992586|FG001|Overall Study|Lost to Follow-up|0|||
42183815|NCT04307940|75992587|FG002|Overall Study|Lost to Follow-up|1|||
42183816|NCT02054104|75992597|FG000|Overall Study|Did not want to continue due to college classes|1|||
42183817|NCT02054104|75992598|FG001|Overall Study|Did not want to continue due to college classes|0|||
42091282|NCT00794573|75901659|FG001|Overall Study|Withdrawal by Subject|12|||
42091283|NCT00794573|75901658|FG000|Overall Study|Lost to Follow-up|26|||
42091284|NCT00794573|75901659|FG001|Overall Study|Lost to Follow-up|33|||
42091285|NCT00584844|75901665|FG000|Overall Study|Withdrawal by Subject|59|||
42091286|NCT00584844|75901665|FG000|Overall Study|Screen Failure|20|||
42091287|NCT00739934|75901673|FG000|Voriconazole IV|Adverse Event|6|||
42294874|NCT02589665|76129271|FG000|Induction Extension Period|Withdrawal by Subject|0|||
42183818|NCT02054104|75992597|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
42294875|NCT02589665|76129272|FG001|Induction Extension Period|Withdrawal by Subject|0|||
42294876|NCT02589665|76129273|FG002|Induction Extension Period|Withdrawal by Subject|0|||
42294877|NCT02589665|76129274|FG003|Induction Extension Period|Withdrawal by Subject|0|||
42091288|NCT00739934|75901673|FG000|Voriconazole Oral|Other|3|||
42091289|NCT00739310|75901682|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
42091290|NCT00739310|75901682|FG000|Overall Study|Withdrawal by Subject|1|||
42091291|NCT00739310|75901682|FG000|Overall Study|Lost to Follow-up|2|||
42091292|NCT00734630|75901689|FG000|Overall Study|Lack of Efficacy|4|||
42091293|NCT00734630|75901690|FG001|Overall Study|Lack of Efficacy|4|||
42183819|NCT02054104|75992598|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
42183820|NCT02054104|75992597|FG000|Overall Study|No evidence of immunologic response|2|||
42183821|NCT02054104|75992598|FG001|Overall Study|No evidence of immunologic response|2|||
42183822|NCT02054104|75992597|FG000|Overall Study|Disease Progression On Study|4|||
42183823|NCT02054104|75992598|FG001|Overall Study|Disease Progression On Study|5|||
42183824|NCT02054104|75992597|FG000|Overall Study|Diagnosis of lymphoma|0|||
42183825|NCT02054104|75992598|FG001|Overall Study|Diagnosis of lymphoma|1|||
42183826|NCT02054104|75992597|FG000|Overall Study|Inconclusive response|0|||
42183827|NCT02054104|75992598|FG001|Overall Study|Inconclusive response|1|||
42183828|NCT04090242|75992606|FG000|Overall Study|Withdrawal by Subject|1|||
42183829|NCT04090242|75992607|FG001|Overall Study|Withdrawal by Subject|0|||
42183830|NCT04090164|75992616|FG000|Overall Study|incomplete data on file|245|||
42183831|NCT04090164|75992617|FG001|Overall Study|incomplete data on file|0|||
42183832|NCT04292730|75992637|FG000|Overall Study|Lost to Follow-up|8|||
42183833|NCT04292730|75992638|FG001|Overall Study|Lost to Follow-up|12|||
42183834|NCT04292730|75992639|FG002|Overall Study|Lost to Follow-up|12|||
42091294|NCT00734630|75901689|FG000|Overall Study|Withdrawal by Subject|7|||
42091295|NCT00734630|75901690|FG001|Overall Study|Withdrawal by Subject|9|||
42091296|NCT00734630|75901689|FG000|Overall Study|Lost to Follow-up|13|||
42183835|NCT04292730|75992640|FG003|Overall Study|Lost to Follow-up|48|||
42183836|NCT04292730|75992637|FG000|Overall Study|Death|2|||
42183837|NCT04292730|75992638|FG001|Overall Study|Death|2|||
42183838|NCT04292730|75992639|FG002|Overall Study|Death|4|||
42091297|NCT00734630|75901690|FG001|Overall Study|Lost to Follow-up|7|||
42091298|NCT00734630|75901689|FG000|Overall Study|Protocol Violation|0|||
42091299|NCT00734630|75901690|FG001|Overall Study|Protocol Violation|3|||
42091300|NCT00734630|75901689|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
42091301|NCT00734630|75901690|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
42091302|NCT00734630|75901689|FG000|Overall Study|Adverse Event|3|||
42091303|NCT00734630|75901690|FG001|Overall Study|Adverse Event|6|||
42091304|NCT00734630|75901689|FG000|Overall Study|Randomized in Error|0|||
42091305|NCT00734630|75901690|FG001|Overall Study|Randomized in Error|1|||
42091306|NCT00734630|75901689|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
42091307|NCT00734630|75901690|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
42091308|NCT00734630|75901689|FG000|Overall Study|Poor Compliance|1|||
42091309|NCT00734630|75901690|FG001|Overall Study|Poor Compliance|1|||
42091310|NCT00584454|75901696|FG000|Overall Study|Adverse Event|1|||
42183839|NCT04292730|75992640|FG003|Overall Study|Death|12|||
42183840|NCT04292730|75992637|FG000|Overall Study|Withdrew Consent|2|||
42091311|NCT00584454|75901696|FG000|Overall Study|Relocation|1|||
42091312|NCT00584454|75901696|FG000|Overall Study|Clinical Hold|2|||
42091313|NCT00578175|75901703|FG000|Overall Study|Adverse Event|0|||
42091314|NCT00578175|75901704|FG001|Overall Study|Adverse Event|1|||
42091315|NCT00578175|75901705|FG002|Overall Study|Adverse Event|1|||
42091316|NCT00578175|75901703|FG000|Overall Study|Other reasons|70|||
42183841|NCT04292730|75992638|FG001|Overall Study|Withdrew Consent|2|||
42183842|NCT04292730|75992639|FG002|Overall Study|Withdrew Consent|5|||
42183843|NCT04292730|75992640|FG003|Overall Study|Withdrew Consent|6|||
42183844|NCT04292730|75992637|FG000|Overall Study|Non-Compliance with Study Drug|0|||
42183845|NCT04292730|75992638|FG001|Overall Study|Non-Compliance with Study Drug|1|||
42183846|NCT04292730|75992639|FG002|Overall Study|Non-Compliance with Study Drug|0|||
42183847|NCT04292730|75992640|FG003|Overall Study|Non-Compliance with Study Drug|0|||
42183848|NCT04292730|75992637|FG000|Overall Study|Protocol Violation|0|||
42183849|NCT04292730|75992638|FG001|Overall Study|Protocol Violation|0|||
42183850|NCT04292730|75992639|FG002|Overall Study|Protocol Violation|1|||
42183851|NCT04292730|75992640|FG003|Overall Study|Protocol Violation|0|||
42183852|NCT04292730|75992637|FG000|Overall Study|Randomized but not Treated|8|||
42183853|NCT04292730|75992638|FG001|Overall Study|Randomized but not Treated|4|||
42091317|NCT00578175|75901704|FG001|Overall Study|Other reasons|42|||
42091318|NCT00578175|75901705|FG002|Overall Study|Other reasons|23|||
42294878|NCT02589665|76129275|FG004|Induction Extension Period|Withdrawal by Subject|0|||
42294879|NCT02589665|76129276|FG005|Induction Extension Period|Withdrawal by Subject|0|||
42294880|NCT02589665|76129277|FG006|Induction Extension Period|Withdrawal by Subject|0|||
42091319|NCT00435409|75901717|FG000|Overall Study|Protocol Violation|1|||
42183854|NCT04292730|75992639|FG002|Overall Study|Randomized but not Treated|0|||
42183855|NCT04292730|75992640|FG003|Overall Study|Randomized but not Treated|14|||
42183856|NCT02861014|75992649|FG000|Primary Analysis|Adverse Event|7|||
42183857|NCT02861014|75992649|FG000|Primary Analysis|Death|1|||
42183858|NCT02861014|75992649|FG000|Primary Analysis|Lack of Efficacy|3|||
42183859|NCT02861014|75992649|FG000|Primary Analysis|Physician Decision|2|||
42294881|NCT02589665|76129278|FG007|Induction Extension Period|Withdrawal by Subject|2|||
42294882|NCT02589665|76129279|FG008|Induction Extension Period|Withdrawal by Subject|3|||
42091320|NCT00435409|75901718|FG001|Overall Study|Protocol Violation|2|||
42091321|NCT00435409|75901719|FG002|Overall Study|Protocol Violation|0|||
42091322|NCT00435409|75901717|FG000|Overall Study|Lost to Follow-up|1|||
42091323|NCT00435409|75901718|FG001|Overall Study|Lost to Follow-up|2|||
42091324|NCT00435409|75901719|FG002|Overall Study|Lost to Follow-up|0|||
42183860|NCT02861014|75992649|FG000|Primary Analysis|Pregnancy|4|||
42183861|NCT02861014|75992649|FG000|Primary Analysis|Protocol Violation|2|||
42183862|NCT02861014|75992649|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
42183863|NCT02861014|75992649|FG000|Primary Analysis|Withdrawal by Subject|14|||
42183864|NCT02861014|75992649|FG000|Primary Analysis|Commercial ocrelizumab|3|||
42183865|NCT02861014|75992649|FG000|Safety Follow-up|Adverse Event|1|||
42183866|NCT02861014|75992649|FG000|Safety Follow-up|Pregnancy|1|||
42183867|NCT02861014|75992649|FG000|Safety Follow-up|Withdrawal by Subject|9|||
42183868|NCT02861014|75992649|FG000|Safety Follow-up|Study terminated by sponsor|1|||
42183869|NCT02861014|75992649|FG000|Safety Follow-up|Physician Decision|1|||
42183870|NCT02861014|75992649|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
42183871|NCT02861014|75992649|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
42183872|NCT04382586|75992657|FG000|Overall Study|Death|3|||
42183873|NCT04382586|75992658|FG001|Overall Study|Death|4|||
42183874|NCT04382586|75992657|FG000|Overall Study|Lost to Follow-up|11|||
42183875|NCT04382586|75992658|FG001|Overall Study|Lost to Follow-up|8|||
42183876|NCT04382586|75992657|FG000|Overall Study|Withdrawal by Subject|3|||
42183877|NCT04382586|75992658|FG001|Overall Study|Withdrawal by Subject|1|||
42183878|NCT04382586|75992657|FG000|Overall Study|Physician Decision|0|||
42183879|NCT04382586|75992658|FG001|Overall Study|Physician Decision|3|||
42183880|NCT04480710|75992668|FG000|Overall Study|Adverse Event|0|||
42183881|NCT04480710|75992669|FG001|Overall Study|Adverse Event|2|||
42183882|NCT04480710|75992670|FG002|Overall Study|Adverse Event|0|||
42183883|NCT04480710|75992671|FG003|Overall Study|Adverse Event|0|||
42183884|NCT04480710|75992668|FG000|Overall Study|Withdrawal by Subject|0|||
42183885|NCT04480710|75992669|FG001|Overall Study|Withdrawal by Subject|1|||
42183886|NCT04480710|75992670|FG002|Overall Study|Withdrawal by Subject|0|||
42183887|NCT04480710|75992671|FG003|Overall Study|Withdrawal by Subject|0|||
42183888|NCT04480710|75992668|FG000|Overall Study|Physician Decision|0|||
42183889|NCT04480710|75992669|FG001|Overall Study|Physician Decision|0|||
42183890|NCT04480710|75992670|FG002|Overall Study|Physician Decision|1|||
42183891|NCT04480710|75992671|FG003|Overall Study|Physician Decision|0|||
42183892|NCT04268316|75992690|FG000|Overall Study|Withdrawal by Subject|2|||
42183893|NCT04268316|75992691|FG001|Overall Study|Withdrawal by Subject|1|||
42183894|NCT04268316|75992692|FG002|Overall Study|Withdrawal by Subject|0|||
42183895|NCT01971970|75992702|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
42183896|NCT01971970|75992703|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
42183897|NCT01971970|75992702|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
42183898|NCT01971970|75992703|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
42183899|NCT01971970|75992702|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
42183900|NCT01971970|75992703|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
42183901|NCT01971970|75992702|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
42183902|NCT01971970|75992703|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
42183903|NCT01971970|75992702|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
42183904|NCT01971970|75992703|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
42183905|NCT01971970|75992702|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
42091325|NCT00435409|75901717|FG000|Overall Study|Death|8|||
42091326|NCT00435409|75901718|FG001|Overall Study|Death|6|||
42091327|NCT00435409|75901719|FG002|Overall Study|Death|6|||
42091328|NCT00435409|75901717|FG000|Overall Study|Objective progression or relapse|158|||
42091329|NCT00435409|75901718|FG001|Overall Study|Objective progression or relapse|93|||
42091330|NCT00435409|75901719|FG002|Overall Study|Objective progression or relapse|58|||
42091331|NCT00435409|75901717|FG000|Overall Study|Global deterioration of health status|0|||
42091332|NCT00435409|75901718|FG001|Overall Study|Global deterioration of health status|0|||
42091333|NCT00435409|75901719|FG002|Overall Study|Global deterioration of health status|4|||
42091334|NCT00435409|75901717|FG000|Overall Study|Withdrawal by Subject|8|||
42091335|NCT00435409|75901718|FG001|Overall Study|Withdrawal by Subject|7|||
42091336|NCT00435409|75901719|FG002|Overall Study|Withdrawal by Subject|1|||
42091337|NCT00435409|75901717|FG000|Overall Study|Other|45|||
42183906|NCT01971970|75992703|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
42183907|NCT01971970|75992702|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
42183908|NCT01971970|75992703|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
42183909|NCT04079790|75992718|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
42183910|NCT04079790|75992719|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
42294883|NCT02589665|76129280|FG009|Induction Extension Period|Withdrawal by Subject|0|||
42294884|NCT02589665|76129271|FG000|Induction Extension Period|Physician Decision|0|||
42294885|NCT02589665|76129272|FG001|Induction Extension Period|Physician Decision|0|||
42294886|NCT02589665|76129273|FG002|Induction Extension Period|Physician Decision|0|||
42294887|NCT02589665|76129274|FG003|Induction Extension Period|Physician Decision|0|||
42091338|NCT00435409|75901718|FG001|Overall Study|Other|30|||
42091339|NCT00435409|75901719|FG002|Overall Study|Other|1|||
42091340|NCT00435409|75901717|FG000|Overall Study|Adverse Event|0|||
42091341|NCT00435409|75901718|FG001|Overall Study|Adverse Event|0|||
42183911|NCT04079790|75992720|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
42183912|NCT04079790|75992721|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
42183913|NCT04079790|75992718|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
42183914|NCT04079790|75992719|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
42183915|NCT04079790|75992720|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
42183916|NCT04079790|75992721|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
42183917|NCT04079790|75992718|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
42183918|NCT04079790|75992719|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
42183919|NCT04079790|75992720|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
42183920|NCT04079790|75992721|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
42183921|NCT04259346|75992749|FG000|Overall Study|Lost to Follow-up|1|||
42183922|NCT04259346|75992750|FG001|Overall Study|Lost to Follow-up|3|||
42183923|NCT04259346|75992749|FG000|Overall Study|Protocol Violation|1|||
42183924|NCT04259346|75992750|FG001|Overall Study|Protocol Violation|0|||
42183925|NCT04259346|75992749|FG000|Overall Study|Withdrawal by Subject|1|||
42183926|NCT04259346|75992750|FG001|Overall Study|Withdrawal by Subject|0|||
42183927|NCT04259346|75992749|FG000|Overall Study|Adverse Event|1|||
42183928|NCT04259346|75992750|FG001|Overall Study|Adverse Event|1|||
42183929|NCT04230876|75992758|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
42183930|NCT04230876|75992759|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
42183931|NCT04228302|75992771|FG000|Overall Study|Adverse Event|0|||
42183932|NCT04228302|75992772|FG001|Overall Study|Adverse Event|0|||
42183933|NCT04228302|75992773|FG002|Overall Study|Adverse Event|0|||
42183934|NCT04228302|75992774|FG003|Overall Study|Adverse Event|0|||
42183935|NCT04228302|75992775|FG004|Overall Study|Adverse Event|1|||
42183936|NCT04228302|75992776|FG005|Overall Study|Adverse Event|0|||
42183937|NCT01348100|75992797|FG000|Overall Study|Subject Withdrew Consent|0|||
42183938|NCT01348100|75992798|FG001|Overall Study|Subject Withdrew Consent|0|||
42183939|NCT01348100|75992799|FG002|Overall Study|Subject Withdrew Consent|2|||
42183940|NCT01348100|75992800|FG003|Overall Study|Subject Withdrew Consent|0|||
42183941|NCT01348100|75992801|FG004|Overall Study|Subject Withdrew Consent|1|||
42183942|NCT01348100|75992802|FG005|Overall Study|Subject Withdrew Consent|0|||
42183943|NCT01348100|75992803|FG006|Overall Study|Subject Withdrew Consent|1|||
42091342|NCT00435409|75901719|FG002|Overall Study|Adverse Event|8|||
42183944|NCT01348100|75992797|FG000|Overall Study|Protocol Deviation|0|||
42183945|NCT01348100|75992798|FG001|Overall Study|Protocol Deviation|0|||
42183946|NCT01348100|75992799|FG002|Overall Study|Protocol Deviation|0|||
42183947|NCT01348100|75992800|FG003|Overall Study|Protocol Deviation|1|||
42183948|NCT01348100|75992801|FG004|Overall Study|Protocol Deviation|0|||
42183949|NCT01348100|75992802|FG005|Overall Study|Protocol Deviation|0|||
42183950|NCT01348100|75992803|FG006|Overall Study|Protocol Deviation|0|||
42183951|NCT01348100|75992797|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
42294888|NCT02589665|76129275|FG004|Induction Extension Period|Physician Decision|0|||
42294889|NCT02589665|76129276|FG005|Induction Extension Period|Physician Decision|0|||
42294890|NCT02589665|76129277|FG006|Induction Extension Period|Physician Decision|0|||
42091343|NCT00435409|75901717|FG000|Overall Study|Sponsor decision|0|||
42091344|NCT00435409|75901718|FG001|Overall Study|Sponsor decision|3|||
42091345|NCT00435409|75901719|FG002|Overall Study|Sponsor decision|0|||
42091346|NCT00467857|75901736|FG000|Overall Study|Adverse Event|1|||
42091347|NCT00467857|75901737|FG001|Overall Study|Adverse Event|0|||
42091348|NCT00467857|75901736|FG000|Overall Study|Withdrew consent|2|||
42091349|NCT00467857|75901737|FG001|Overall Study|Withdrew consent|0|||
42091350|NCT00467857|75901736|FG000|Overall Study|Death|0|||
42091351|NCT00467857|75901737|FG001|Overall Study|Death|1|||
42091352|NCT00467857|75901736|FG000|Overall Study|Discharged from court service|0|||
42091353|NCT00467857|75901737|FG001|Overall Study|Discharged from court service|1|||
42091354|NCT00467857|75901736|FG000|Overall Study|Emergency care required|0|||
42091355|NCT00467857|75901737|FG001|Overall Study|Emergency care required|1|||
42091356|NCT00467857|75901736|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
42183952|NCT01348100|75992798|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
42183953|NCT01348100|75992799|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
42183954|NCT01348100|75992800|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
42183955|NCT01348100|75992801|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
42183956|NCT01348100|75992802|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
42183957|NCT01348100|75992803|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
42183958|NCT01348100|75992797|FG000|Overall Study|Lost to Follow-up|0|||
42183959|NCT01348100|75992798|FG001|Overall Study|Lost to Follow-up|0|||
42294891|NCT02589665|76129278|FG007|Induction Extension Period|Physician Decision|0|||
42294892|NCT02589665|76129279|FG008|Induction Extension Period|Physician Decision|1|||
42091357|NCT00467857|75901737|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
42091358|NCT00467857|75901736|FG000|Overall Study|Discontinuation reason missing|0|||
42091359|NCT00467857|75901737|FG001|Overall Study|Discontinuation reason missing|3|||
42091360|NCT00435019|75901745|FG000|Overall Study|Adverse Event|1|||
42091361|NCT00435019|75901746|FG001|Overall Study|Adverse Event|0|||
42091362|NCT00435019|75901745|FG000|Overall Study|Lack of Efficacy|1|||
42091363|NCT00435019|75901746|FG001|Overall Study|Lack of Efficacy|2|||
42091364|NCT00435019|75901745|FG000|Overall Study|Protocol Violation|3|||
42183960|NCT01348100|75992799|FG002|Overall Study|Lost to Follow-up|0|||
42183961|NCT01348100|75992800|FG003|Overall Study|Lost to Follow-up|0|||
42183962|NCT01348100|75992801|FG004|Overall Study|Lost to Follow-up|0|||
42183963|NCT01348100|75992802|FG005|Overall Study|Lost to Follow-up|0|||
42183964|NCT01348100|75992803|FG006|Overall Study|Lost to Follow-up|1|||
42183965|NCT01348100|75992797|FG000|Overall Study|Administrative Problems|0|||
42183966|NCT01348100|75992798|FG001|Overall Study|Administrative Problems|0|||
42183967|NCT01348100|75992799|FG002|Overall Study|Administrative Problems|0|||
42183968|NCT01348100|75992800|FG003|Overall Study|Administrative Problems|0|||
42183969|NCT01348100|75992801|FG004|Overall Study|Administrative Problems|0|||
42183970|NCT01348100|75992802|FG005|Overall Study|Administrative Problems|1|||
42183971|NCT01348100|75992803|FG006|Overall Study|Administrative Problems|1|||
42183972|NCT03676634|75992824|FG000|Overall Study|Red blood cell loss|1|||
42183973|NCT03676634|75992824|FG000|Overall Study|Out-of-limit pulse|2|||
42183974|NCT03675776|75992831|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
42183975|NCT03675776|75992832|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
42183976|NCT03675776|75992833|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
42183977|NCT03675776|75992831|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
42183978|NCT03675776|75992832|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
42183979|NCT03675776|75992833|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
42183980|NCT03673670|75992847|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
42183981|NCT03673670|75992848|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
42183982|NCT03673670|75992849|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
42183983|NCT03673670|75992850|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
42183984|NCT03673670|75992851|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
42183985|NCT03673670|75992852|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
42183986|NCT03673670|75992847|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
42183987|NCT03673670|75992848|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
42183988|NCT03673670|75992849|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
42183989|NCT03673670|75992850|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
42183990|NCT03673670|75992851|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
42183991|NCT03673670|75992852|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
42183992|NCT03673670|75992847|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
42183993|NCT03673670|75992848|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
42183994|NCT03673670|75992849|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
42183995|NCT03673670|75992850|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
42183996|NCT03673670|75992851|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
42183997|NCT03673670|75992852|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
42183998|NCT03673670|75992847|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
42183999|NCT03673670|75992848|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
42184000|NCT03673670|75992849|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
42184001|NCT03673670|75992850|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
42091365|NCT00435019|75901746|FG001|Overall Study|Protocol Violation|1|||
42091366|NCT00435019|75901745|FG000|Overall Study|Personal reasons for withdrawal|8|||
42091367|NCT00435019|75901746|FG001|Overall Study|Personal reasons for withdrawal|7|||
42091368|NCT00577863|75901754|FG000|Overall Study|Adverse Event|4|||
42091369|NCT00577863|75901755|FG001|Overall Study|Adverse Event|2|||
42091370|NCT00577863|75901754|FG000|Overall Study|Death|1|||
42091371|NCT00577863|75901755|FG001|Overall Study|Death|0|||
42091372|NCT00577863|75901754|FG000|Overall Study|Lost to Follow-up|2|||
42091373|NCT00577863|75901755|FG001|Overall Study|Lost to Follow-up|2|||
42091374|NCT00577863|75901754|FG000|Overall Study|Entry Criteria Exclusion|1|||
42091375|NCT00577863|75901755|FG001|Overall Study|Entry Criteria Exclusion|0|||
42091376|NCT00577863|75901754|FG000|Overall Study|Withdrawal by Subject|0|||
42184002|NCT03673670|75992851|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
42184003|NCT03673670|75992852|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
42184004|NCT03673670|75992847|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
42184005|NCT03673670|75992848|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
42294893|NCT02589665|76129280|FG009|Induction Extension Period|Physician Decision|0|||
42184006|NCT03673670|75992849|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
42184007|NCT03673670|75992850|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
42184008|NCT03673670|75992851|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
42184009|NCT03673670|75992852|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
42294894|NCT02589665|76129271|FG000|Induction Extension Period|Reason Not Collected|0|||
42294895|NCT02589665|76129272|FG001|Induction Extension Period|Reason Not Collected|0|||
42091377|NCT00577863|75901755|FG001|Overall Study|Withdrawal by Subject|2|||
42091378|NCT00577863|75901754|FG000|Overall Study|Sponsor Decision|2|||
42091379|NCT00577863|75901755|FG001|Overall Study|Sponsor Decision|7|||
42091380|NCT00577863|75901754|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
42184010|NCT03673670|75992847|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
42184011|NCT03673670|75992848|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
42184012|NCT03673670|75992849|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
42184013|NCT03673670|75992850|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
42184014|NCT03673670|75992851|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
42184015|NCT03673670|75992852|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
42184016|NCT03673670|75992847|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
42184017|NCT03673670|75992848|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
42184018|NCT03673670|75992849|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
42184019|NCT03673670|75992850|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
42184020|NCT03673670|75992851|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
42184021|NCT03673670|75992852|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
42184022|NCT04369742|75992871|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
42091381|NCT00577863|75901755|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
42091382|NCT00794417|75901765|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
42091383|NCT00794417|75901766|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
42091384|NCT00794417|75901767|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
42091385|NCT00794417|75901768|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
42091386|NCT00794417|75901765|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
42091387|NCT00794417|75901766|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
42184023|NCT04369742|75992872|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
42184024|NCT04369742|75992871|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
42184025|NCT04369742|75992872|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
42184026|NCT04369430|75992880|FG000|Overall Study|Adverse Event|2|||
42184027|NCT04369430|75992881|FG001|Overall Study|Adverse Event|3|||
42184028|NCT04369430|75992880|FG000|Overall Study|Death|1|||
42184029|NCT04369430|75992881|FG001|Overall Study|Death|0|||
42184030|NCT04369430|75992880|FG000|Overall Study|Withdrawal by Subject|4|||
42184031|NCT04369430|75992881|FG001|Overall Study|Withdrawal by Subject|3|||
42184032|NCT04369430|75992880|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
42184033|NCT04369430|75992881|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
42184034|NCT04369430|75992880|FG000|Overall Study|Lost to Follow-up|0|||
42184035|NCT04369430|75992881|FG001|Overall Study|Lost to Follow-up|1|||
42184036|NCT04363736|75992889|FG000|Overall Study|Withdrawal by Subject|1|||
42184037|NCT04363736|75992890|FG001|Overall Study|Withdrawal by Subject|0|||
42294896|NCT02589665|76129273|FG002|Induction Extension Period|Reason Not Collected|0|||
42294897|NCT02589665|76129274|FG003|Induction Extension Period|Reason Not Collected|0|||
42294898|NCT02589665|76129275|FG004|Induction Extension Period|Reason Not Collected|0|||
42294899|NCT02589665|76129276|FG005|Induction Extension Period|Reason Not Collected|0|||
42294900|NCT02589665|76129277|FG006|Induction Extension Period|Reason Not Collected|0|||
42294901|NCT02589665|76129278|FG007|Induction Extension Period|Reason Not Collected|0|||
42294902|NCT02589665|76129279|FG008|Induction Extension Period|Reason Not Collected|1|||
42294903|NCT02589665|76129280|FG009|Induction Extension Period|Reason Not Collected|0|||
42294904|NCT02589665|76129271|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42294905|NCT02589665|76129272|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42294906|NCT02589665|76129273|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42091388|NCT00794417|75901767|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
42091389|NCT00794417|75901768|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
42091390|NCT00794417|75901765|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
42091391|NCT00794417|75901766|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
42091392|NCT00794417|75901767|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
42091393|NCT00794417|75901768|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
42091394|NCT00794417|75901765|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
42091395|NCT00794417|75901766|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
42091396|NCT00794417|75901767|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
42091397|NCT00794417|75901768|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
42091398|NCT00794417|75901765|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
42091399|NCT00794417|75901766|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
42091400|NCT00794417|75901767|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
42091401|NCT00794417|75901768|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
42091402|NCT00794417|75901765|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
42091403|NCT00794417|75901766|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
42091404|NCT00794417|75901767|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
42091405|NCT00794417|75901768|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
42091406|NCT00790907|75901783|FG000|Overall Study|Adverse Event|9|||
42091407|NCT00790907|75901784|FG001|Overall Study|Adverse Event|7|||
42091408|NCT00790907|75901785|FG002|Overall Study|Adverse Event|6|||
42184038|NCT04363736|75992889|FG000|Overall Study|Lost to Follow-up|10|||
42184039|NCT04363736|75992890|FG001|Overall Study|Lost to Follow-up|7|||
42184040|NCT04363736|75992889|FG000|Overall Study|Death|8|||
42184041|NCT04363736|75992890|FG001|Overall Study|Death|6|||
42184042|NCT04362176|75992898|FG000|Overall Study|Lost to Follow-up|5|||
42184043|NCT04362176|75992899|FG001|Overall Study|Lost to Follow-up|8|||
42184044|NCT04362176|75992898|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
42184045|NCT04362176|75992899|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
42184046|NCT04079816|75992905|FG000|Overall Study|Request of Subject|2|||
42184047|NCT04079816|75992905|FG000|Overall Study|Unable to draw samples|1|||
42184048|NCT04079114|75992909|FG000|Overall Study|Study prematuely terminated.|166|||
42184049|NCT03055936|75992917|FG000|Overall Study|Adverse Event|0|||
42184050|NCT03055936|75992918|FG001|Overall Study|Adverse Event|1|||
42184051|NCT03055936|75992919|FG002|Overall Study|Adverse Event|1|||
42184052|NCT03055936|75992920|FG003|Overall Study|Adverse Event|1|||
42184053|NCT03055936|75992917|FG000|Overall Study|Personal reason|2|||
42184054|NCT03055936|75992918|FG001|Overall Study|Personal reason|0|||
42184055|NCT03055936|75992919|FG002|Overall Study|Personal reason|1|||
42184056|NCT03055936|75992920|FG003|Overall Study|Personal reason|0|||
42184057|NCT03891524|75992962|FG000|Overall Study|Death|0|||
42184058|NCT03891524|75992963|FG001|Overall Study|Death|0|||
42184059|NCT03891524|75992964|FG002|Overall Study|Death|0|||
42184060|NCT03891524|75992965|FG003|Overall Study|Death|0|||
42184061|NCT03891524|75992966|FG004|Overall Study|Death|0|||
42184062|NCT03891524|75992967|FG005|Overall Study|Death|0|||
42184063|NCT03891524|75992968|FG006|Overall Study|Death|0|||
42184064|NCT03891524|75992969|FG007|Overall Study|Death|1|||
42184065|NCT03891524|75992962|FG000|Overall Study|Withdrawal by Subject|0|||
42184066|NCT03891524|75992963|FG001|Overall Study|Withdrawal by Subject|1|||
42184067|NCT03891524|75992964|FG002|Overall Study|Withdrawal by Subject|2|||
42184068|NCT03891524|75992965|FG003|Overall Study|Withdrawal by Subject|1|||
42184069|NCT03891524|75992966|FG004|Overall Study|Withdrawal by Subject|2|||
42184070|NCT03891524|75992967|FG005|Overall Study|Withdrawal by Subject|2|||
42184071|NCT03891524|75992968|FG006|Overall Study|Withdrawal by Subject|2|||
42184072|NCT03891524|75992969|FG007|Overall Study|Withdrawal by Subject|1|||
42184073|NCT03055624|75993004|FG000|Overall Study|Study closed|9|||
42184074|NCT01346176|75993011|FG000|Recruited|Protocol Violation|1|||
42184075|NCT01346176|75993012|FG001|Recruited|Protocol Violation|0|||
42184076|NCT01346176|75993013|FG002|Recruited|Protocol Violation|0|||
42184077|NCT01346176|75993011|FG000|Completed Advance Directive|Death|3|||
42184078|NCT01346176|75993012|FG001|Completed Advance Directive|Death|2|||
42184079|NCT01346176|75993013|FG002|Completed Advance Directive|Death|2|||
42184080|NCT01346176|75993011|FG000|Completed Advance Directive|Became Ineligible|3|||
42184081|NCT01346176|75993012|FG001|Completed Advance Directive|Became Ineligible|0|||
42184082|NCT01346176|75993013|FG002|Completed Advance Directive|Became Ineligible|1|||
42091409|NCT00790907|75901783|FG000|Overall Study|Physician Decision|304|||
42091410|NCT00790907|75901784|FG001|Overall Study|Physician Decision|271|||
42091411|NCT00790907|75901785|FG002|Overall Study|Physician Decision|255|||
42091412|NCT00790907|75901783|FG000|Overall Study|Withdrawal by Subject|1|||
42091413|NCT00790907|75901784|FG001|Overall Study|Withdrawal by Subject|7|||
42091414|NCT00790907|75901785|FG002|Overall Study|Withdrawal by Subject|5|||
42091415|NCT00790907|75901783|FG000|Overall Study|Bleeding Event|11|||
42091416|NCT00790907|75901784|FG001|Overall Study|Bleeding Event|16|||
42091417|NCT00790907|75901785|FG002|Overall Study|Bleeding Event|21|||
42091418|NCT00790907|75901783|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
42091419|NCT00790907|75901784|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
42091420|NCT00790907|75901785|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
42091421|NCT00790907|75901783|FG000|Overall Study|Qualifying Condition Not Present|29|||
42184083|NCT01346176|75993011|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
42184084|NCT01346176|75993012|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
42184085|NCT01346176|75993013|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
42184086|NCT01346176|75993011|FG000|Completed Satisfaction Survey|Death|3|||
42184087|NCT01346176|75993012|FG001|Completed Satisfaction Survey|Death|0|||
42184088|NCT01346176|75993013|FG002|Completed Satisfaction Survey|Death|2|||
42184089|NCT01346176|75993011|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
42184090|NCT01346176|75993012|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
42184091|NCT01346176|75993013|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
42091422|NCT00790907|75901784|FG001|Overall Study|Qualifying Condition Not Present|14|||
42091423|NCT00790907|75901785|FG002|Overall Study|Qualifying Condition Not Present|16|||
42091424|NCT00790907|75901783|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
42091425|NCT00790907|75901784|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
42091426|NCT00790907|75901785|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
42091427|NCT00790907|75901783|FG000|Overall Study|Did Not Receive Study Drug|10|||
42184092|NCT04075604|75993024|FG000|Overall Study|Adverse Event|0|||
42184093|NCT04075604|75993025|FG001|Overall Study|Adverse Event|0|||
42184094|NCT04075604|75993026|FG002|Overall Study|Adverse Event|3|||
42184095|NCT04075604|75993024|FG000|Overall Study|Participant request to discontinue study treatment|0|||
42184096|NCT04075604|75993025|FG001|Overall Study|Participant request to discontinue study treatment|0|||
42184097|NCT04075604|75993026|FG002|Overall Study|Participant request to discontinue study treatment|1|||
42184098|NCT04075604|75993024|FG000|Overall Study|Participant withdrew consent|0|||
42184099|NCT04075604|75993025|FG001|Overall Study|Participant withdrew consent|0|||
42184100|NCT04075604|75993026|FG002|Overall Study|Participant withdrew consent|1|||
42184101|NCT04075604|75993024|FG000|Overall Study|Other reasons|1|||
42184102|NCT04075604|75993025|FG001|Overall Study|Other reasons|0|||
42184103|NCT04075604|75993026|FG002|Overall Study|Other reasons|0|||
42184104|NCT04075604|75993024|FG000|Overall Study|Disease progression|0|||
42184105|NCT04075604|75993025|FG001|Overall Study|Disease progression|1|||
42184106|NCT04075604|75993026|FG002|Overall Study|Disease progression|0|||
42184107|NCT04075604|75993024|FG000|Overall Study|Study drug toxicity|0|||
42184108|NCT04075604|75993025|FG001|Overall Study|Study drug toxicity|5|||
42184109|NCT04075604|75993026|FG002|Overall Study|Study drug toxicity|1|||
42091428|NCT00790907|75901784|FG001|Overall Study|Did Not Receive Study Drug|0|||
42091429|NCT00790907|75901785|FG002|Overall Study|Did Not Receive Study Drug|0|||
42091430|NCT00793871|75901803|FG000|Overall Study|Death|50|||
42091431|NCT00793871|75901803|FG000|Overall Study|Lost to Follow-up|3|||
42091432|NCT00793871|75901803|FG000|Overall Study|Study terminated by the Sponsor|7|||
42091433|NCT00577707|75901811|FG000|Overall Study|Withdrawal by Subject|3|||
42091434|NCT00713349|75901815|FG000|Overall Study|Protocol Violation|1|||
42091435|NCT00712959|75901823|FG000|Overall Study|Protocol Violation|3|||
42091436|NCT00712959|75901824|FG001|Overall Study|Protocol Violation|1|||
42091437|NCT00712959|75901823|FG000|Overall Study|Lost to Follow-up|13|||
42091438|NCT00712959|75901824|FG001|Overall Study|Lost to Follow-up|2|||
42091439|NCT00712959|75901823|FG000|Overall Study|Withdrawal by Subject|3|||
42091440|NCT00712959|75901824|FG001|Overall Study|Withdrawal by Subject|0|||
42091441|NCT00712725|75901838|FG000|Overall Study|Adverse Event|1|||
42184110|NCT03796208|75993036|FG000|Overall Study|Withdrawal by Subject|3|||
42184111|NCT03796208|75993037|FG001|Overall Study|Withdrawal by Subject|0|||
42184112|NCT03796208|75993036|FG000|Overall Study|Loss of pregnancy|1|||
42184113|NCT03796208|75993037|FG001|Overall Study|Loss of pregnancy|1|||
42184114|NCT03796208|75993036|FG000|Overall Study|Changed prenatal clinics|0|||
42184115|NCT03796208|75993037|FG001|Overall Study|Changed prenatal clinics|5|||
42091442|NCT00712725|75901839|FG001|Overall Study|Adverse Event|0|||
42091443|NCT00712725|75901840|FG002|Overall Study|Adverse Event|0|||
42091444|NCT00712725|75901841|FG003|Overall Study|Adverse Event|1|||
42091445|NCT00712725|75901842|FG004|Overall Study|Adverse Event|0|||
42091446|NCT00712725|75901843|FG005|Overall Study|Adverse Event|0|||
42091447|NCT00712725|75901844|FG006|Overall Study|Adverse Event|0|||
42091448|NCT00712725|75901845|FG007|Overall Study|Adverse Event|0|||
42091449|NCT00712725|75901838|FG000|Overall Study|Lost to Follow-up|3|||
42091450|NCT00712725|75901839|FG001|Overall Study|Lost to Follow-up|2|||
42091451|NCT00712725|75901840|FG002|Overall Study|Lost to Follow-up|1|||
42091452|NCT00712725|75901841|FG003|Overall Study|Lost to Follow-up|1|||
42091453|NCT00712725|75901842|FG004|Overall Study|Lost to Follow-up|2|||
42091454|NCT00712725|75901843|FG005|Overall Study|Lost to Follow-up|2|||
42091455|NCT00712725|75901844|FG006|Overall Study|Lost to Follow-up|3|||
42091456|NCT00712725|75901845|FG007|Overall Study|Lost to Follow-up|1|||
42091457|NCT00712725|75901838|FG000|Overall Study|Physician Decision|2|||
42091458|NCT00712725|75901839|FG001|Overall Study|Physician Decision|0|||
42091459|NCT00712725|75901840|FG002|Overall Study|Physician Decision|0|||
42091460|NCT00712725|75901841|FG003|Overall Study|Physician Decision|0|||
42091461|NCT00712725|75901842|FG004|Overall Study|Physician Decision|1|||
42091462|NCT00712725|75901843|FG005|Overall Study|Physician Decision|0|||
42091463|NCT00712725|75901844|FG006|Overall Study|Physician Decision|2|||
42184116|NCT03796208|75993036|FG000|Overall Study|Lost to Follow-up|20|||
42184117|NCT03796208|75993037|FG001|Overall Study|Lost to Follow-up|16|||
42184118|NCT01318876|75993043|FG000|Day 8 Survey|email address invalid|96|||
42184119|NCT01318876|75993043|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
42184120|NCT01318876|75993043|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
42184121|NCT03668600|75993047|FG000|Overall Study|Study Terminated by the Sponsor|157|||
42358833|NCT03745638|76204532|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
42091464|NCT00712725|75901845|FG007|Overall Study|Physician Decision|0|||
42091465|NCT00712725|75901838|FG000|Overall Study|Pregnancy|0|||
42091466|NCT00712725|75901839|FG001|Overall Study|Pregnancy|1|||
42091467|NCT00712725|75901840|FG002|Overall Study|Pregnancy|0|||
42091468|NCT00712725|75901841|FG003|Overall Study|Pregnancy|0|||
42091469|NCT00712725|75901842|FG004|Overall Study|Pregnancy|1|||
42091470|NCT00712725|75901843|FG005|Overall Study|Pregnancy|0|||
42091471|NCT00712725|75901844|FG006|Overall Study|Pregnancy|2|||
42184122|NCT03668600|75993047|FG000|Overall Study|Protocol Violation|1|||
42184123|NCT03668600|75993047|FG000|Overall Study|Pregnancy|1|||
42184124|NCT03668600|75993047|FG000|Overall Study|Lost to Follow-up|7|||
42184125|NCT03668600|75993047|FG000|Overall Study|Withdrawal by Subject|56|||
42184126|NCT03668600|75993047|FG000|Overall Study|Lack of Efficacy|7|||
42184127|NCT03668600|75993047|FG000|Overall Study|Adverse Event|1|||
42184128|NCT04073186|75993051|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
42184129|NCT04073186|75993051|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
42184130|NCT04073186|75993051|FG000|First Wearing Cycle|Protocol Violation|1|||
42184131|NCT04073186|75993051|FG000|First Wearing Cycle|Lens Discomfort|2|||
42184132|NCT04073186|75993051|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
42184133|NCT04073186|75993051|FG000|Second Wearing Cycle|Adverse Event|1|||
42184134|NCT03054064|75993056|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
42184135|NCT03054064|75993056|FG000|Overall Study|Investigator Decision|2|||
42184136|NCT03054064|75993056|FG000|Overall Study|Bladder Issue|1|||
42184137|NCT03054064|75993056|FG000|Overall Study|High Blood Pressure|1|||
42184138|NCT03054064|75993056|FG000|Overall Study|Change in Status|1|||
42184139|NCT03053518|75993060|FG000|Overall Study|Withdrawal by Subject|3|||
42184140|NCT03053518|75993060|FG000|Overall Study|Lost to Follow-up|2|||
42184141|NCT03053518|75993060|FG000|Overall Study|Ineligible|5|||
42184142|NCT04015336|75993064|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
42184143|NCT04071158|75993087|FG000|Overall Study|Lost to Follow-up|1|||
42184144|NCT04071158|75993088|FG001|Overall Study|Lost to Follow-up|2|||
42184145|NCT04071158|75993089|FG002|Overall Study|Lost to Follow-up|3|||
42184146|NCT04071158|75993090|FG003|Overall Study|Lost to Follow-up|3|||
42184147|NCT04071158|75993091|FG004|Overall Study|Lost to Follow-up|5|||
42294907|NCT02589665|76129274|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42091472|NCT00712725|75901845|FG007|Overall Study|Pregnancy|0|||
42091473|NCT00712725|75901838|FG000|Overall Study|Protocol Violation|2|||
42091474|NCT00712725|75901839|FG001|Overall Study|Protocol Violation|0|||
42091475|NCT00712725|75901840|FG002|Overall Study|Protocol Violation|1|||
42091476|NCT00712725|75901841|FG003|Overall Study|Protocol Violation|3|||
42091477|NCT00712725|75901842|FG004|Overall Study|Protocol Violation|2|||
42091478|NCT00712725|75901843|FG005|Overall Study|Protocol Violation|0|||
42091479|NCT00712725|75901844|FG006|Overall Study|Protocol Violation|1|||
42091480|NCT00712725|75901845|FG007|Overall Study|Protocol Violation|1|||
42091481|NCT00712725|75901838|FG000|Overall Study|Withdrawal by Subject|2|||
42091482|NCT00712725|75901839|FG001|Overall Study|Withdrawal by Subject|1|||
42091483|NCT00712725|75901840|FG002|Overall Study|Withdrawal by Subject|1|||
42091484|NCT00712725|75901841|FG003|Overall Study|Withdrawal by Subject|2|||
42091485|NCT00712725|75901842|FG004|Overall Study|Withdrawal by Subject|1|||
42091486|NCT00712725|75901843|FG005|Overall Study|Withdrawal by Subject|1|||
42091487|NCT00712725|75901844|FG006|Overall Study|Withdrawal by Subject|1|||
42091488|NCT00712725|75901845|FG007|Overall Study|Withdrawal by Subject|2|||
42091489|NCT00712725|75901838|FG000|Overall Study|Lack of Qualifying Event|16|||
42091490|NCT00712725|75901839|FG001|Overall Study|Lack of Qualifying Event|2|||
42091491|NCT00712725|75901840|FG002|Overall Study|Lack of Qualifying Event|6|||
42091492|NCT00712725|75901841|FG003|Overall Study|Lack of Qualifying Event|8|||
42091493|NCT00712725|75901842|FG004|Overall Study|Lack of Qualifying Event|11|||
42091494|NCT00712725|75901843|FG005|Overall Study|Lack of Qualifying Event|13|||
42091495|NCT00712725|75901844|FG006|Overall Study|Lack of Qualifying Event|11|||
42091496|NCT00712725|75901845|FG007|Overall Study|Lack of Qualifying Event|6|||
42091497|NCT00712725|75901838|FG000|Overall Study|Protocol Specified Criteria|3|||
42091498|NCT00712725|75901839|FG001|Overall Study|Protocol Specified Criteria|0|||
42091499|NCT00712725|75901840|FG002|Overall Study|Protocol Specified Criteria|1|||
42091500|NCT00712725|75901841|FG003|Overall Study|Protocol Specified Criteria|2|||
42091501|NCT00712725|75901842|FG004|Overall Study|Protocol Specified Criteria|1|||
42091502|NCT00712725|75901843|FG005|Overall Study|Protocol Specified Criteria|0|||
42091503|NCT00712725|75901844|FG006|Overall Study|Protocol Specified Criteria|2|||
42091504|NCT00712725|75901845|FG007|Overall Study|Protocol Specified Criteria|1|||
42184148|NCT04071158|75993087|FG000|Overall Study|Randomized but not treated|2|||
42184149|NCT04071158|75993088|FG001|Overall Study|Randomized but not treated|2|||
42184150|NCT04071158|75993089|FG002|Overall Study|Randomized but not treated|0|||
42184151|NCT04071158|75993090|FG003|Overall Study|Randomized but not treated|0|||
42184152|NCT04071158|75993091|FG004|Overall Study|Randomized but not treated|0|||
42184153|NCT01317940|75993115|FG000|Overall Study|Death|1|||
42294908|NCT02589665|76129275|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42091505|NCT00712335|75901868|FG000|Overall Study|Withdrawal by Subject|0|||
42184154|NCT01317940|75993116|FG001|Overall Study|Death|0|||
42184155|NCT01317940|75993117|FG002|Overall Study|Death|1|||
42091506|NCT00712335|75901869|FG001|Overall Study|Withdrawal by Subject|7|||
42091507|NCT00712335|75901870|FG002|Overall Study|Withdrawal by Subject|2|||
42091508|NCT00712335|75901871|FG003|Overall Study|Withdrawal by Subject|3|||
42091509|NCT00712335|75901872|FG004|Overall Study|Withdrawal by Subject|0|||
42184156|NCT01317940|75993118|FG003|Overall Study|Death|0|||
42184157|NCT01317940|75993119|FG004|Overall Study|Death|0|||
42184158|NCT01317940|75993120|FG005|Overall Study|Death|0|||
42184159|NCT01317940|75993115|FG000|Overall Study|Lost to Follow-up|0|||
42294909|NCT02589665|76129276|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42091510|NCT00712335|75901868|FG000|Overall Study|Lost to Follow-up|2|||
42091511|NCT00712335|75901869|FG001|Overall Study|Lost to Follow-up|5|||
42091512|NCT00712335|75901870|FG002|Overall Study|Lost to Follow-up|0|||
42091513|NCT00712335|75901871|FG003|Overall Study|Lost to Follow-up|1|||
42091514|NCT00712335|75901872|FG004|Overall Study|Lost to Follow-up|0|||
42091515|NCT00712335|75901868|FG000|Overall Study|Protocol Violation|1|||
42091516|NCT00712335|75901869|FG001|Overall Study|Protocol Violation|2|||
42091517|NCT00712335|75901870|FG002|Overall Study|Protocol Violation|1|||
42091518|NCT00712335|75901871|FG003|Overall Study|Protocol Violation|0|||
42091519|NCT00712335|75901872|FG004|Overall Study|Protocol Violation|0|||
42091520|NCT00712335|75901868|FG000|Overall Study|Lack of Efficacy|0|||
42091521|NCT00712335|75901869|FG001|Overall Study|Lack of Efficacy|0|||
42091522|NCT00712335|75901870|FG002|Overall Study|Lack of Efficacy|1|||
42091523|NCT00712335|75901871|FG003|Overall Study|Lack of Efficacy|1|||
42091524|NCT00712335|75901872|FG004|Overall Study|Lack of Efficacy|0|||
42091525|NCT00712335|75901868|FG000|Overall Study|Other Reason|0|||
42091526|NCT00712335|75901869|FG001|Overall Study|Other Reason|3|||
42091527|NCT00712335|75901870|FG002|Overall Study|Other Reason|1|||
42091528|NCT00712335|75901871|FG003|Overall Study|Other Reason|0|||
42091529|NCT00712335|75901872|FG004|Overall Study|Other Reason|0|||
42091530|NCT00577629|75901884|FG000|Treatment Period|Death|1|||
42091531|NCT00577629|75901884|FG000|Long Term Follow-Up|Death|15|||
42091532|NCT00577629|75901884|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
42091533|NCT00577629|75901884|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
42091534|NCT00577629|75901884|FG000|Long Term Follow-Up|Physician Decision|1|||
42091535|NCT00710385|75901890|FG000|Overall Study|Did not qualify|1|||
42091536|NCT00710385|75901890|FG000|Overall Study|Withdrawal by Subject|1|||
42091537|NCT00710385|75901890|FG000|Overall Study|Undisclosed back pain|1|||
42091538|NCT00710385|75901890|FG000|Overall Study|Physician Decision|1|||
42091539|NCT00710385|75901890|FG000|Overall Study|Undisclosed excessive methadone use|1|||
42091540|NCT00701415|75901902|FG000|Overall Study|Adverse Event|0|||
42091541|NCT00701415|75901903|FG001|Overall Study|Adverse Event|1|||
42091542|NCT00701415|75901902|FG000|Overall Study|Social/family issues and needle phobia|1|||
42091543|NCT00701415|75901903|FG001|Overall Study|Social/family issues and needle phobia|0|||
42091544|NCT00700011|75901911|FG000|Overall Study|Death|0|||
42091545|NCT00700011|75901912|FG001|Overall Study|Death|1|||
42091546|NCT00707031|75901920|FG000|Overall Study|Adverse Event|45|||
42091547|NCT00707031|75901921|FG001|Overall Study|Adverse Event|45|||
42091548|NCT00707031|75901920|FG000|Overall Study|Lack of Efficacy|19|||
42091549|NCT00707031|75901921|FG001|Overall Study|Lack of Efficacy|6|||
42091550|NCT00707031|75901920|FG000|Overall Study|Lost to Follow-up|2|||
42091551|NCT00707031|75901921|FG001|Overall Study|Lost to Follow-up|1|||
42091552|NCT00707031|75901920|FG000|Overall Study|Protocol Violation|1|||
42091553|NCT00707031|75901921|FG001|Overall Study|Protocol Violation|0|||
42091554|NCT00707031|75901920|FG000|Overall Study|Withdrawal by Subject|7|||
42091555|NCT00707031|75901921|FG001|Overall Study|Withdrawal by Subject|8|||
42091556|NCT00707031|75901920|FG000|Overall Study|Poor Compliance to Protocol|7|||
42091557|NCT00707031|75901921|FG001|Overall Study|Poor Compliance to Protocol|13|||
42091558|NCT00707031|75901920|FG000|Overall Study|Familial or Personal Reasons|12|||
42091559|NCT00707031|75901921|FG001|Overall Study|Familial or Personal Reasons|15|||
42091560|NCT00707031|75901920|FG000|Overall Study|Serious Noncompliance|2|||
42091561|NCT00707031|75901921|FG001|Overall Study|Serious Noncompliance|3|||
42091562|NCT00707031|75901920|FG000|Overall Study|Sponsor Decision|9|||
42091563|NCT00707031|75901921|FG001|Overall Study|Sponsor Decision|8|||
42091564|NCT00711477|75901930|FG000|Overall Study|Adverse Event|3|||
42091565|NCT00711477|75901931|FG001|Overall Study|Adverse Event|1|||
42184160|NCT01317940|75993116|FG001|Overall Study|Lost to Follow-up|0|||
42294910|NCT02589665|76129277|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42294911|NCT02589665|76129278|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42294912|NCT02589665|76129279|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
42091566|NCT00711477|75901930|FG000|Overall Study|Lost to Follow-up|0|||
42091567|NCT00711477|75901931|FG001|Overall Study|Lost to Follow-up|1|||
42091568|NCT00711477|75901930|FG000|Overall Study|Noncompliance|0|||
42091569|NCT00711477|75901931|FG001|Overall Study|Noncompliance|1|||
42184161|NCT01317940|75993117|FG002|Overall Study|Lost to Follow-up|1|||
42184162|NCT01317940|75993118|FG003|Overall Study|Lost to Follow-up|1|||
42184163|NCT01317940|75993119|FG004|Overall Study|Lost to Follow-up|1|||
42184164|NCT01317940|75993120|FG005|Overall Study|Lost to Follow-up|0|||
42184165|NCT01317940|75993115|FG000|Overall Study|Change in therapy plan|0|||
42091570|NCT00699699|75901939|FG000|Overall Study|Adverse Event|36|||
42091571|NCT00699699|75901939|FG000|Overall Study|Individual different reasons|21|||
42091572|NCT00734474|75901952|FG000|Overall Study|Entry Criteria Not Met|0|||
42091573|NCT00734474|75901953|FG001|Overall Study|Entry Criteria Not Met|0|||
42091574|NCT00734474|75901954|FG002|Overall Study|Entry Criteria Not Met|5|||
42091575|NCT00734474|75901955|FG003|Overall Study|Entry Criteria Not Met|0|||
42091576|NCT00734474|75901956|FG004|Overall Study|Entry Criteria Not Met|3|||
42091577|NCT00734474|75901957|FG005|Overall Study|Entry Criteria Not Met|1|||
42184166|NCT01317940|75993116|FG001|Overall Study|Change in therapy plan|0|||
42184167|NCT01317940|75993117|FG002|Overall Study|Change in therapy plan|3|||
42184168|NCT01317940|75993118|FG003|Overall Study|Change in therapy plan|0|||
42184169|NCT01317940|75993119|FG004|Overall Study|Change in therapy plan|0|||
42184170|NCT01317940|75993120|FG005|Overall Study|Change in therapy plan|0|||
42184171|NCT01345786|75993139|FG000|Overall Study|Adverse Event|0|||
42184172|NCT01345786|75993140|FG001|Overall Study|Adverse Event|1|||
42184173|NCT01345786|75993141|FG002|Overall Study|Adverse Event|3|||
42358834|NCT03745638|76204533|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
42091578|NCT00734474|75901958|FG006|Overall Study|Entry Criteria Not Met|0|||
42091579|NCT00734474|75901959|FG007|Overall Study|Entry Criteria Not Met|1|||
42091580|NCT00734474|75901960|FG008|Overall Study|Entry Criteria Not Met|1|||
42091581|NCT00734474|75901952|FG000|Overall Study|Lost to Follow-up|1|||
42091582|NCT00734474|75901953|FG001|Overall Study|Lost to Follow-up|0|||
42091583|NCT00734474|75901954|FG002|Overall Study|Lost to Follow-up|13|||
42091584|NCT00734474|75901955|FG003|Overall Study|Lost to Follow-up|0|||
42091585|NCT00734474|75901956|FG004|Overall Study|Lost to Follow-up|11|||
42091586|NCT00734474|75901957|FG005|Overall Study|Lost to Follow-up|1|||
42091587|NCT00734474|75901958|FG006|Overall Study|Lost to Follow-up|0|||
42091588|NCT00734474|75901959|FG007|Overall Study|Lost to Follow-up|9|||
42091589|NCT00734474|75901960|FG008|Overall Study|Lost to Follow-up|4|||
42091590|NCT00734474|75901952|FG000|Overall Study|Withdrawal by Subject|2|||
42091591|NCT00734474|75901953|FG001|Overall Study|Withdrawal by Subject|1|||
42091592|NCT00734474|75901954|FG002|Overall Study|Withdrawal by Subject|18|||
42091593|NCT00734474|75901955|FG003|Overall Study|Withdrawal by Subject|0|||
42091594|NCT00734474|75901956|FG004|Overall Study|Withdrawal by Subject|24|||
42091595|NCT00734474|75901957|FG005|Overall Study|Withdrawal by Subject|2|||
42091596|NCT00734474|75901958|FG006|Overall Study|Withdrawal by Subject|0|||
42091597|NCT00734474|75901959|FG007|Overall Study|Withdrawal by Subject|36|||
42091598|NCT00734474|75901960|FG008|Overall Study|Withdrawal by Subject|21|||
42091599|NCT00734474|75901952|FG000|Overall Study|Physician Decision|0|||
42091600|NCT00734474|75901953|FG001|Overall Study|Physician Decision|0|||
42091601|NCT00734474|75901954|FG002|Overall Study|Physician Decision|4|||
42091602|NCT00734474|75901955|FG003|Overall Study|Physician Decision|1|||
42091603|NCT00734474|75901956|FG004|Overall Study|Physician Decision|11|||
42091604|NCT00734474|75901957|FG005|Overall Study|Physician Decision|0|||
42091605|NCT00734474|75901958|FG006|Overall Study|Physician Decision|0|||
42091606|NCT00734474|75901959|FG007|Overall Study|Physician Decision|9|||
42091607|NCT00734474|75901960|FG008|Overall Study|Physician Decision|9|||
42091608|NCT00734474|75901952|FG000|Overall Study|Adverse Event|4|||
42091609|NCT00734474|75901953|FG001|Overall Study|Adverse Event|4|||
42091610|NCT00734474|75901954|FG002|Overall Study|Adverse Event|63|||
42091611|NCT00734474|75901955|FG003|Overall Study|Adverse Event|1|||
42091612|NCT00734474|75901956|FG004|Overall Study|Adverse Event|64|||
42184174|NCT01345786|75993142|FG003|Overall Study|Adverse Event|1|||
42184175|NCT01345786|75993139|FG000|Overall Study|Subject withdrew consent|2|||
42184176|NCT01345786|75993140|FG001|Overall Study|Subject withdrew consent|2|||
42184177|NCT01345786|75993141|FG002|Overall Study|Subject withdrew consent|1|||
42184178|NCT01345786|75993142|FG003|Overall Study|Subject withdrew consent|0|||
42184179|NCT01345786|75993139|FG000|Overall Study|Noncompliance with protocol|1|||
42294913|NCT02589665|76129280|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
42294914|NCT02589665|76129271|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
42294915|NCT02589665|76129272|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
42294916|NCT02589665|76129273|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
42294917|NCT02589665|76129274|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
42294918|NCT02589665|76129275|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
42294919|NCT02589665|76129276|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
42294920|NCT02589665|76129277|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
42294921|NCT02589665|76129278|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
42294922|NCT02589665|76129279|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
42294923|NCT02589665|76129280|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
42294924|NCT02589665|76129271|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
42294925|NCT02589665|76129272|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
42294926|NCT02589665|76129273|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
42294927|NCT02589665|76129274|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
42091613|NCT00734474|75901957|FG005|Overall Study|Adverse Event|0|||
42091614|NCT00734474|75901958|FG006|Overall Study|Adverse Event|1|||
42091615|NCT00734474|75901959|FG007|Overall Study|Adverse Event|65|||
42091616|NCT00734474|75901960|FG008|Overall Study|Adverse Event|39|||
42091617|NCT00734474|75901952|FG000|Overall Study|Protocol Violation|0|||
42091618|NCT00734474|75901953|FG001|Overall Study|Protocol Violation|0|||
42091619|NCT00734474|75901954|FG002|Overall Study|Protocol Violation|4|||
42091620|NCT00734474|75901955|FG003|Overall Study|Protocol Violation|0|||
42091621|NCT00734474|75901956|FG004|Overall Study|Protocol Violation|3|||
42091622|NCT00734474|75901957|FG005|Overall Study|Protocol Violation|0|||
42091623|NCT00734474|75901958|FG006|Overall Study|Protocol Violation|0|||
42184180|NCT01345786|75993140|FG001|Overall Study|Noncompliance with protocol|0|||
42184181|NCT01345786|75993141|FG002|Overall Study|Noncompliance with protocol|1|||
42184182|NCT01345786|75993142|FG003|Overall Study|Noncompliance with protocol|0|||
42184183|NCT01345786|75993139|FG000|Overall Study|Administrative|3|||
42184184|NCT01345786|75993140|FG001|Overall Study|Administrative|5|||
42184185|NCT01345786|75993141|FG002|Overall Study|Administrative|0|||
42184186|NCT01345786|75993142|FG003|Overall Study|Administrative|0|||
42184187|NCT01345786|75993139|FG000|Overall Study|Lost to Follow-up|0|||
42184188|NCT01345786|75993140|FG001|Overall Study|Lost to Follow-up|0|||
42184189|NCT01345786|75993141|FG002|Overall Study|Lost to Follow-up|0|||
42184190|NCT01345786|75993142|FG003|Overall Study|Lost to Follow-up|2|||
42184191|NCT01317550|75993156|FG000|Overall Study|Withdrawal by Subject|1|||
42184192|NCT01317550|75993157|FG001|Overall Study|Withdrawal by Subject|0|||
42184193|NCT01317550|75993158|FG002|Overall Study|Withdrawal by Subject|0|||
42184194|NCT01317550|75993159|FG003|Overall Study|Withdrawal by Subject|0|||
42184195|NCT01317550|75993156|FG000|Overall Study|Lack of compliance study med|1|||
42184196|NCT01317550|75993157|FG001|Overall Study|Lack of compliance study med|0|||
42184197|NCT01317550|75993158|FG002|Overall Study|Lack of compliance study med|0|||
42294928|NCT02589665|76129275|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
42294929|NCT02589665|76129276|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
42294930|NCT02589665|76129277|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
42294931|NCT02589665|76129278|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
42294932|NCT02589665|76129279|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
42294933|NCT02589665|76129280|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
42091624|NCT00734474|75901959|FG007|Overall Study|Protocol Violation|3|||
42091625|NCT00734474|75901960|FG008|Overall Study|Protocol Violation|1|||
42091626|NCT00734474|75901952|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
42091627|NCT00734474|75901953|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
42091628|NCT00734474|75901954|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
42091629|NCT00734474|75901955|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
42017937|NCT01263197|75825679|FG004|Washout Period 1|Protocol Violation|1|||
42017938|NCT01263197|75825680|FG005|Washout Period 1|Protocol Violation|0|||
42017939|NCT01263197|75825675|FG000|Washout Period 2|Physician Decision|0|||
42017940|NCT01263197|75825676|FG001|Washout Period 2|Physician Decision|0|||
42017941|NCT01263197|75825677|FG002|Washout Period 2|Physician Decision|0|||
42017942|NCT01263197|75825678|FG003|Washout Period 2|Physician Decision|0|||
42017943|NCT01263197|75825679|FG004|Washout Period 2|Physician Decision|0|||
42017944|NCT01263197|75825680|FG005|Washout Period 2|Physician Decision|1|||
42017945|NCT01263197|75825675|FG000|Washout Period 2|Protocol Violation|0|||
42017946|NCT01263197|75825676|FG001|Washout Period 2|Protocol Violation|0|||
42091630|NCT00734474|75901956|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
42091631|NCT00734474|75901957|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
42091632|NCT00734474|75901958|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
42091633|NCT00734474|75901959|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
42091634|NCT00734474|75901960|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
42091635|NCT00734474|75901952|FG000|Overall Study|Sponsor Decision|0|||
42091636|NCT00734474|75901953|FG001|Overall Study|Sponsor Decision|0|||
42091637|NCT00734474|75901954|FG002|Overall Study|Sponsor Decision|0|||
42091638|NCT00734474|75901955|FG003|Overall Study|Sponsor Decision|0|||
42017947|NCT01263197|75825677|FG002|Washout Period 2|Protocol Violation|0|||
42017948|NCT01263197|75825678|FG003|Washout Period 2|Protocol Violation|1|||
42017949|NCT01263197|75825679|FG004|Washout Period 2|Protocol Violation|0|||
42017950|NCT01263197|75825680|FG005|Washout Period 2|Protocol Violation|0|||
42017951|NCT01263197|75825675|FG000|Third Intervention (Period 3)|Adverse Event|0|||
42017952|NCT01263197|75825676|FG001|Third Intervention (Period 3)|Adverse Event|1|||
42017953|NCT01263197|75825677|FG002|Third Intervention (Period 3)|Adverse Event|0|||
42017954|NCT01263197|75825678|FG003|Third Intervention (Period 3)|Adverse Event|0|||
42017955|NCT01263197|75825679|FG004|Third Intervention (Period 3)|Adverse Event|0|||
42017956|NCT01263197|75825680|FG005|Third Intervention (Period 3)|Adverse Event|0|||
42017957|NCT01263119|75825694|FG000|Period 1|Protocol Violation|2|||
42017958|NCT01263119|75825694|FG000|Period 2|Adverse Event|2|||
42017959|NCT01262651|75825704|FG000|Overall Study|Adverse Event|40|||
42017960|NCT01262651|75825705|FG001|Overall Study|Adverse Event|35|||
42017961|NCT01262651|75825704|FG000|Overall Study|Withdrawal by Subject|15|||
42017962|NCT01262651|75825705|FG001|Overall Study|Withdrawal by Subject|11|||
42017963|NCT01262651|75825704|FG000|Overall Study|Withdrawal by Investigator|2|||
42017964|NCT01262651|75825705|FG001|Overall Study|Withdrawal by Investigator|2|||
42017965|NCT01262651|75825704|FG000|Overall Study|Met Withdrawal Criteria|1|||
42091639|NCT00734474|75901956|FG004|Overall Study|Sponsor Decision|2|||
42091640|NCT00734474|75901957|FG005|Overall Study|Sponsor Decision|0|||
42091641|NCT00734474|75901958|FG006|Overall Study|Sponsor Decision|0|||
42091642|NCT00734474|75901959|FG007|Overall Study|Sponsor Decision|0|||
42091643|NCT00734474|75901960|FG008|Overall Study|Sponsor Decision|0|||
42091644|NCT00734474|75901952|FG000|Overall Study|Death|0|||
42091645|NCT00734474|75901953|FG001|Overall Study|Death|0|||
42091646|NCT00734474|75901954|FG002|Overall Study|Death|1|||
42091647|NCT00734474|75901955|FG003|Overall Study|Death|0|||
42091648|NCT00734474|75901956|FG004|Overall Study|Death|0|||
42091649|NCT00734474|75901957|FG005|Overall Study|Death|0|||
42091650|NCT00734474|75901958|FG006|Overall Study|Death|0|||
42091651|NCT00734474|75901959|FG007|Overall Study|Death|2|||
42091652|NCT00734474|75901960|FG008|Overall Study|Death|1|||
42091653|NCT00734474|75901952|FG000|Overall Study|Lack of Efficacy|0|||
42091654|NCT00734474|75901953|FG001|Overall Study|Lack of Efficacy|0|||
42091655|NCT00734474|75901954|FG002|Overall Study|Lack of Efficacy|4|||
42091656|NCT00734474|75901955|FG003|Overall Study|Lack of Efficacy|0|||
42091657|NCT00734474|75901956|FG004|Overall Study|Lack of Efficacy|0|||
42091658|NCT00734474|75901957|FG005|Overall Study|Lack of Efficacy|0|||
42091659|NCT00734474|75901958|FG006|Overall Study|Lack of Efficacy|0|||
42091660|NCT00734474|75901959|FG007|Overall Study|Lack of Efficacy|4|||
42091661|NCT00734474|75901960|FG008|Overall Study|Lack of Efficacy|6|||
42091662|NCT00583362|75901986|FG000|Overall Study|Adverse Event|44|||
42358835|NCT03745638|76204534|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
42358836|NCT03745638|76204535|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
42091663|NCT00583362|75901986|FG000|Overall Study|Lack of Efficacy|22|||
42091664|NCT00583362|75901986|FG000|Overall Study|Lost to Follow-up|4|||
42091665|NCT00583362|75901986|FG000|Overall Study|Non-compliance with study drug|28|||
42184198|NCT01317550|75993159|FG003|Overall Study|Lack of compliance study med|0|||
42184199|NCT01317472|75993171|FG000|Overall Study|Withdrawal by Subject|1|||
42184200|NCT01317472|75993172|FG001|Overall Study|Withdrawal by Subject|0|||
42184201|NCT01317472|75993171|FG000|Overall Study|Unrelated hospitalization|1|||
42184202|NCT01317472|75993172|FG001|Overall Study|Unrelated hospitalization|0|||
42184203|NCT01345630|75993180|FG000|Overall Study|Adverse Event|22|||
42184204|NCT01345630|75993181|FG001|Overall Study|Adverse Event|23|||
42184205|NCT01345630|75993180|FG000|Overall Study|Lost to Follow-up|17|||
42184206|NCT01345630|75993181|FG001|Overall Study|Lost to Follow-up|16|||
42184207|NCT01345630|75993180|FG000|Overall Study|Protocol Violation|4|||
42184208|NCT01345630|75993181|FG001|Overall Study|Protocol Violation|1|||
42184209|NCT01345630|75993180|FG000|Overall Study|Medication error without associated AE|0|||
42294934|NCT02589665|76129271|FG000|Maintenance Extension Period|Adverse Event|0|||
42294935|NCT02589665|76129272|FG001|Maintenance Extension Period|Adverse Event|0|||
42294936|NCT02589665|76129273|FG002|Maintenance Extension Period|Adverse Event|0|||
42294937|NCT02589665|76129274|FG003|Maintenance Extension Period|Adverse Event|0|||
42294938|NCT02589665|76129275|FG004|Maintenance Extension Period|Adverse Event|0|||
42294939|NCT02589665|76129276|FG005|Maintenance Extension Period|Adverse Event|0|||
42294940|NCT02589665|76129277|FG006|Maintenance Extension Period|Adverse Event|0|||
42294941|NCT02589665|76129278|FG007|Maintenance Extension Period|Adverse Event|0|||
42294942|NCT02589665|76129279|FG008|Maintenance Extension Period|Adverse Event|0|||
42294943|NCT02589665|76129280|FG009|Maintenance Extension Period|Adverse Event|2|||
42294944|NCT02589665|76129271|FG000|Maintenance Extension Period|Non-responder|0|||
42294945|NCT02589665|76129272|FG001|Maintenance Extension Period|Non-responder|0|||
42294946|NCT02589665|76129273|FG002|Maintenance Extension Period|Non-responder|0|||
42294947|NCT02589665|76129274|FG003|Maintenance Extension Period|Non-responder|0|||
42294948|NCT02589665|76129275|FG004|Maintenance Extension Period|Non-responder|0|||
42294949|NCT02589665|76129276|FG005|Maintenance Extension Period|Non-responder|0|||
42294950|NCT02589665|76129277|FG006|Maintenance Extension Period|Non-responder|0|||
42294951|NCT02589665|76129278|FG007|Maintenance Extension Period|Non-responder|0|||
42294952|NCT02589665|76129279|FG008|Maintenance Extension Period|Non-responder|0|||
42294953|NCT02589665|76129280|FG009|Maintenance Extension Period|Non-responder|1|||
42294954|NCT01905397|76129306|FG000|Overall Study|Death|0|||
42358837|NCT03745638|76204536|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
42358838|NCT03745638|76204537|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
42358839|NCT03745638|76204531|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
42358840|NCT03745638|76204532|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
42358841|NCT03745638|76204533|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
42358842|NCT03745638|76204534|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
42294955|NCT01905397|76129307|FG001|Overall Study|Death|1|||
42294956|NCT01905397|76129306|FG000|Overall Study|Withdrawal by Subject|2|||
42294957|NCT01905397|76129307|FG001|Overall Study|Withdrawal by Subject|0|||
42294958|NCT01905397|76129306|FG000|Overall Study|Surgery canceled/aborted|9|||
42091666|NCT00583362|75901986|FG000|Overall Study|Pregnancy|7|||
42184210|NCT01345630|75993181|FG001|Overall Study|Medication error without associated AE|1|||
42294959|NCT01905397|76129307|FG001|Overall Study|Surgery canceled/aborted|5|||
42091667|NCT00583362|75901986|FG000|Overall Study|Miscommunication of visit window|5|||
42091668|NCT00583362|75901986|FG000|Overall Study|Current site closed|7|||
42091669|NCT00583362|75901986|FG000|Overall Study|Subject not dosed in LBSL99|1|||
42091670|NCT00583362|75901986|FG000|Overall Study|Subject moved out of the country/state|2|||
42091671|NCT00583362|75901986|FG000|Overall Study|Missed visits due to staff changes|1|||
42091672|NCT00583362|75901986|FG000|Overall Study|Misunderstanding of protocol|1|||
42184211|NCT01345630|75993180|FG000|Overall Study|Study terminated by sponsor|254|||
42184212|NCT01345630|75993181|FG001|Overall Study|Study terminated by sponsor|285|||
42184213|NCT01345630|75993180|FG000|Overall Study|Other reasons|6|||
42184214|NCT01345630|75993181|FG001|Overall Study|Other reasons|8|||
42184215|NCT01345630|75993180|FG000|Overall Study|Withdrawn due to pregnancy|1|||
42184216|NCT01345630|75993181|FG001|Overall Study|Withdrawn due to pregnancy|2|||
42184217|NCT01345630|75993180|FG000|Overall Study|No longer willing to participate|9|||
42184218|NCT01345630|75993181|FG001|Overall Study|No longer willing to participate|12|||
42184219|NCT01345630|75993180|FG000|Overall Study|Insufficient clinical response|48|||
42184220|NCT01345630|75993181|FG001|Overall Study|Insufficient clinical response|11|||
42184221|NCT03693612|75993198|FG000|Overall Study|Lost to Follow-up|0|||
42184222|NCT03693612|75993199|FG001|Overall Study|Lost to Follow-up|0|||
42184223|NCT03693612|75993200|FG002|Overall Study|Lost to Follow-up|0|||
42184224|NCT03693612|75993201|FG003|Overall Study|Lost to Follow-up|0|||
42184225|NCT03693612|75993202|FG004|Overall Study|Lost to Follow-up|1|||
42184226|NCT03693612|75993203|FG005|Overall Study|Lost to Follow-up|0|||
42184227|NCT03693612|75993204|FG006|Overall Study|Lost to Follow-up|0|||
42091673|NCT00583362|75901986|FG000|Overall Study|Behavioral problems and non-compliance|1|||
42091674|NCT00583362|75901986|FG000|Overall Study|Sponsor request due to missed doses|1|||
42091675|NCT00583362|75901986|FG000|Overall Study|Physician Decision|19|||
42091676|NCT00583362|75901986|FG000|Overall Study|Protocol Violation|2|||
42184228|NCT03693612|75993198|FG000|Overall Study|Withdrawal by Subject|0|||
42184229|NCT03693612|75993199|FG001|Overall Study|Withdrawal by Subject|0|||
42294960|NCT01905397|76129306|FG000|Overall Study|Incision < 7 cm|2|||
42294961|NCT01905397|76129307|FG001|Overall Study|Incision < 7 cm|0|||
42294962|NCT01905397|76129306|FG000|Overall Study|Wrong treatment|1|||
42294963|NCT01905397|76129307|FG001|Overall Study|Wrong treatment|1|||
42294964|NCT01905397|76129306|FG000|Overall Study|Device not applied|3|||
42294965|NCT01905397|76129307|FG001|Overall Study|Device not applied|0|||
42294966|NCT01905397|76129306|FG000|Overall Study|Dressing not applied in operating room|1|||
42294967|NCT01905397|76129307|FG001|Overall Study|Dressing not applied in operating room|0|||
42294968|NCT01905397|76129306|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
42294969|NCT01905397|76129307|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
42294970|NCT01362595|76129313|FG000|Overall Study|Screen failure|10|||
42294971|NCT01362595|76129313|FG000|Overall Study|Withdrawal by Subject|2|||
42294972|NCT02519595|76129320|FG000|Overall Study|Protocol Violation|8|||
42294973|NCT02519595|76129321|FG001|Overall Study|Protocol Violation|22|||
42294974|NCT02519595|76129322|FG002|Overall Study|Protocol Violation|16|||
42294975|NCT00660673|76129334|FG000|Overall Study|Adverse Event|84|||
42294976|NCT00660673|76129334|FG000|Overall Study|Lack of Efficacy|7|||
42294977|NCT00660673|76129334|FG000|Overall Study|Withdrawal by Subject|22|||
42294978|NCT00660673|76129334|FG000|Overall Study|Administrative|2|||
42294979|NCT00660673|76129334|FG000|Overall Study|Protocol Violation|2|||
42294980|NCT02630563|76129349|FG000|Overall Study|Administrative|1|||
42294981|NCT02588339|76129363|FG000|Overall Study|Withdrawal by Subject|1|||
42294982|NCT02588339|76129363|FG000|Overall Study|GVHD Progression prior to treatment|2|||
42294983|NCT02629159|76129370|FG000|Overall Study|Adverse Event|17|||
42294984|NCT02629159|76129371|FG001|Overall Study|Adverse Event|20|||
42294985|NCT02629159|76129372|FG002|Overall Study|Adverse Event|22|||
42091677|NCT00583362|75901986|FG000|Overall Study|Withdrawal by Subject|57|||
42091678|NCT00577473|75901992|FG000|Overall Study|Protocol Violation|1|||
42091679|NCT00577473|75901993|FG001|Overall Study|Protocol Violation|4|||
42091680|NCT00577473|75901992|FG000|Overall Study|Adverse Event|8|||
42091681|NCT00577473|75901993|FG001|Overall Study|Adverse Event|5|||
42091682|NCT00577473|75901992|FG000|Overall Study|Withdrawal by Subject|2|||
42091683|NCT00577473|75901993|FG001|Overall Study|Withdrawal by Subject|6|||
42294986|NCT02629159|76129370|FG000|Overall Study|Withdrawal by Subject|22|||
42294987|NCT02629159|76129371|FG001|Overall Study|Withdrawal by Subject|11|||
42294988|NCT02629159|76129372|FG002|Overall Study|Withdrawal by Subject|15|||
42294989|NCT02629159|76129370|FG000|Overall Study|Lost to Follow-up|7|||
42294990|NCT02629159|76129371|FG001|Overall Study|Lost to Follow-up|4|||
42294991|NCT02629159|76129372|FG002|Overall Study|Lost to Follow-up|5|||
42294992|NCT02629159|76129370|FG000|Overall Study|Lack of Efficacy|4|||
42294993|NCT02629159|76129371|FG001|Overall Study|Lack of Efficacy|0|||
42294994|NCT02629159|76129372|FG002|Overall Study|Lack of Efficacy|1|||
42294995|NCT02629159|76129370|FG000|Overall Study|Other|6|||
42294996|NCT02629159|76129371|FG001|Overall Study|Other|4|||
42294997|NCT02629159|76129372|FG002|Overall Study|Other|8|||
42091684|NCT00577473|75901992|FG000|Overall Study|Physician Decision|2|||
42091685|NCT00577473|75901993|FG001|Overall Study|Physician Decision|2|||
42091686|NCT00577473|75901992|FG000|Overall Study|Lack of Efficacy|8|||
42184230|NCT03693612|75993200|FG002|Overall Study|Withdrawal by Subject|1|||
42184231|NCT03693612|75993201|FG003|Overall Study|Withdrawal by Subject|0|||
42294998|NCT02628769|76129383|FG000|First Intervention|Adverse Event|1|||
42294999|NCT02628769|76129384|FG001|First Intervention|Adverse Event|0|||
42295000|NCT02628769|76129383|FG000|First Intervention|Withdrawal by Subject|0|||
42295001|NCT02628769|76129384|FG001|First Intervention|Withdrawal by Subject|1|||
42184232|NCT03693612|75993202|FG004|Overall Study|Withdrawal by Subject|2|||
42184233|NCT03693612|75993203|FG005|Overall Study|Withdrawal by Subject|0|||
42184234|NCT03693612|75993204|FG006|Overall Study|Withdrawal by Subject|0|||
42184235|NCT03693612|75993198|FG000|Overall Study|Study Terminated by Sponsor|0|||
42184236|NCT03693612|75993199|FG001|Overall Study|Study Terminated by Sponsor|1|||
42184237|NCT03693612|75993200|FG002|Overall Study|Study Terminated by Sponsor|0|||
42184238|NCT03693612|75993201|FG003|Overall Study|Study Terminated by Sponsor|0|||
42184239|NCT03693612|75993202|FG004|Overall Study|Study Terminated by Sponsor|3|||
42184240|NCT03693612|75993203|FG005|Overall Study|Study Terminated by Sponsor|0|||
42184241|NCT03693612|75993204|FG006|Overall Study|Study Terminated by Sponsor|0|||
42184242|NCT04223232|75993220|FG000|Overall Study|Withdrawal by Subject|1|||
42184243|NCT04206384|75993224|FG000|Overall Study|Withdrawal by Subject|8|||
42184244|NCT04206384|75993224|FG000|Overall Study|Adverse Event|2|||
42184245|NCT04051944|75993230|FG000|Overall Study|Study ending|1|||
42184246|NCT04051944|75993231|FG001|Overall Study|Study ending|1|||
42184247|NCT04051944|75993230|FG000|Overall Study|Early study termination by participant|1|||
42184248|NCT04051944|75993231|FG001|Overall Study|Early study termination by participant|0|||
42184249|NCT04051944|75993230|FG000|Overall Study|Withdrawal by Subject|2|||
42184250|NCT04051944|75993231|FG001|Overall Study|Withdrawal by Subject|2|||
42184251|NCT04051944|75993230|FG000|Overall Study|Lack of Efficacy|3|||
42184252|NCT04051944|75993231|FG001|Overall Study|Lack of Efficacy|0|||
42184253|NCT04051944|75993230|FG000|Overall Study|Adverse event, non- fatal|1|||
42184254|NCT04051944|75993231|FG001|Overall Study|Adverse event, non- fatal|1|||
42184255|NCT04050618|75993239|FG000|First Intervention|Withdrawal by Subject|2|||
42184256|NCT04050618|75993240|FG001|First Intervention|Withdrawal by Subject|0|||
42184257|NCT04050618|75993239|FG000|Second Intervention|Withdrawal by Subject|1|||
42184258|NCT04050618|75993240|FG001|Second Intervention|Withdrawal by Subject|0|||
42184259|NCT04067492|75993257|FG000|Overall Study|Lost to Follow-up|0|||
42184260|NCT04067492|75993258|FG001|Overall Study|Lost to Follow-up|0|||
42184261|NCT04067492|75993259|FG002|Overall Study|Lost to Follow-up|0|||
42184262|NCT04067492|75993260|FG003|Overall Study|Lost to Follow-up|0|||
42184263|NCT04067492|75993261|FG004|Overall Study|Lost to Follow-up|0|||
42184264|NCT04067492|75993262|FG005|Overall Study|Lost to Follow-up|1|||
42184265|NCT04067492|75993257|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
42184266|NCT04067492|75993258|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
42184267|NCT04067492|75993259|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
42184268|NCT04067492|75993260|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
42184269|NCT04067492|75993261|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
42184270|NCT04067492|75993262|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
42184271|NCT04067492|75993257|FG000|Overall Study|COVID-19 epidemiological situation|0|||
42184272|NCT04067492|75993258|FG001|Overall Study|COVID-19 epidemiological situation|0|||
42184273|NCT04067492|75993259|FG002|Overall Study|COVID-19 epidemiological situation|0|||
42184274|NCT04067492|75993260|FG003|Overall Study|COVID-19 epidemiological situation|1|||
42184275|NCT04067492|75993261|FG004|Overall Study|COVID-19 epidemiological situation|0|||
42184276|NCT04067492|75993262|FG005|Overall Study|COVID-19 epidemiological situation|0|||
42184277|NCT04375878|75993280|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
42184278|NCT04375878|75993281|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
42184279|NCT04375878|75993282|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
42184280|NCT04375878|75993283|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
42184281|NCT04375878|75993284|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
42184282|NCT04375878|75993285|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
42184283|NCT04375878|75993280|FG000|Crossover First and Second Interventions|Adverse Event|0|||
42184284|NCT04375878|75993281|FG001|Crossover First and Second Interventions|Adverse Event|0|||
42091687|NCT00577473|75901993|FG001|Overall Study|Lack of Efficacy|7|||
42091688|NCT00785291|75902002|FG000|Overall Study|Never began treatment|8|||
42091689|NCT00785291|75902003|FG001|Overall Study|Never began treatment|4|||
42091690|NCT00785291|75902004|FG002|Overall Study|Never began treatment|4|||
42091691|NCT00785291|75902002|FG000|Overall Study|Adverse Event|39|||
42091692|NCT00785291|75902003|FG001|Overall Study|Adverse Event|70|||
42091693|NCT00785291|75902004|FG002|Overall Study|Adverse Event|56|||
42091694|NCT00785291|75902002|FG000|Overall Study|Death|7|||
42091695|NCT00785291|75902003|FG001|Overall Study|Death|4|||
42184285|NCT04375878|75993282|FG002|Crossover First and Second Interventions|Adverse Event|1|||
42184286|NCT04375878|75993283|FG003|Crossover First and Second Interventions|Adverse Event|0|||
42091696|NCT00785291|75902004|FG002|Overall Study|Death|3|||
42091697|NCT00785291|75902002|FG000|Overall Study|Withdrawal by Subject|35|||
42184287|NCT04375878|75993284|FG004|Crossover First and Second Interventions|Adverse Event|0|||
42184288|NCT04375878|75993285|FG005|Crossover First and Second Interventions|Adverse Event|0|||
42184289|NCT04375878|75993280|FG000|Extension Phase|Withdrawal by Subject|0|||
42184290|NCT04375878|75993281|FG001|Extension Phase|Withdrawal by Subject|0|||
42091698|NCT00785291|75902003|FG001|Overall Study|Withdrawal by Subject|36|||
42091699|NCT00785291|75902004|FG002|Overall Study|Withdrawal by Subject|17|||
42184291|NCT04375878|75993282|FG002|Extension Phase|Withdrawal by Subject|0|||
42184292|NCT04375878|75993283|FG003|Extension Phase|Withdrawal by Subject|0|||
42184293|NCT04375878|75993284|FG004|Extension Phase|Withdrawal by Subject|1|||
42184294|NCT04375878|75993285|FG005|Extension Phase|Withdrawal by Subject|0|||
42184295|NCT04189224|75993305|FG000|Period 2|Adverse Event|0|||
42184296|NCT04189224|75993306|FG001|Period 2|Adverse Event|1|||
42184297|NCT04186806|75993314|FG000|Period 1: 7 Days|Adverse Event|1|||
42184298|NCT04186806|75993315|FG001|Period 1: 7 Days|Adverse Event|0|||
42184299|NCT04041414|75993324|FG000|Overall Study|Lost to Follow-up|1|||
42184300|NCT04041414|75993325|FG001|Overall Study|Lost to Follow-up|2|||
42184301|NCT04370028|75993334|FG000|Overall Study|Withdrawal by Subject|695|||
42184302|NCT04370028|75993334|FG000|Overall Study|Protocol Violation|9|||
42184303|NCT04370028|75993334|FG000|Overall Study|Adverse Event|3|||
42184304|NCT04037748|75993347|FG000|Treatment Period 1|Withdrawal by Subject|3|||
42184305|NCT04037748|75993348|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42295002|NCT02628769|76129383|FG000|Second Intervention|Adverse Event|2|||
42295003|NCT02628769|76129384|FG001|Second Intervention|Adverse Event|0|||
42091700|NCT00785291|75902002|FG000|Overall Study|Alternative Therapy|12|||
42184306|NCT04037748|75993347|FG000|Treatment Period 1|Adverse Event|1|||
42184307|NCT04037748|75993348|FG001|Treatment Period 1|Adverse Event|1|||
42184308|NCT04037748|75993347|FG000|Treatment Period 1|Protocol Violation|4|||
42184309|NCT04037748|75993348|FG001|Treatment Period 1|Protocol Violation|5|||
42184310|NCT04037748|75993347|FG000|Treatment Period 2|Adverse Event|0|||
42184311|NCT04037748|75993348|FG001|Treatment Period 2|Adverse Event|1|||
42184312|NCT04037748|75993347|FG000|Treatment Period 2|Protocol Violation|2|||
42184313|NCT04037748|75993348|FG001|Treatment Period 2|Protocol Violation|0|||
42184314|NCT04036110|75993357|FG000|Overall Study|Lost to Follow-up|3|||
42184315|NCT04036110|75993358|FG001|Overall Study|Lost to Follow-up|2|||
42184316|NCT04036110|75993359|FG002|Overall Study|Lost to Follow-up|1|||
42184317|NCT04036110|75993357|FG000|Overall Study|Study Suspended|4|||
42184318|NCT04036110|75993358|FG001|Overall Study|Study Suspended|5|||
42184319|NCT04036110|75993359|FG002|Overall Study|Study Suspended|1|||
42184320|NCT03053050|75993370|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
42184321|NCT03053050|75993371|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
42184322|NCT03053050|75993372|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
42184323|NCT03053050|75993373|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
42184324|NCT03053050|75993370|FG000|Randomized Phase|Withdrew Consent|16|||
42184325|NCT03053050|75993371|FG001|Randomized Phase|Withdrew Consent|8|||
42184326|NCT03053050|75993372|FG002|Randomized Phase|Withdrew Consent|9|||
42184327|NCT03053050|75993373|FG003|Randomized Phase|Withdrew Consent|0|||
42184328|NCT03053050|75993370|FG000|Randomized Phase|Investigator's Discretion|6|||
42184329|NCT03053050|75993371|FG001|Randomized Phase|Investigator's Discretion|6|||
42184330|NCT03053050|75993372|FG002|Randomized Phase|Investigator's Discretion|3|||
42184331|NCT03053050|75993373|FG003|Randomized Phase|Investigator's Discretion|0|||
42184332|NCT03053050|75993370|FG000|Randomized Phase|Lost to Follow-up|5|||
42184333|NCT03053050|75993371|FG001|Randomized Phase|Lost to Follow-up|1|||
42091701|NCT00785291|75902003|FG001|Overall Study|Alternative Therapy|6|||
42091702|NCT00785291|75902004|FG002|Overall Study|Alternative Therapy|7|||
42091703|NCT00785291|75902002|FG000|Overall Study|Complicating illness|6|||
42091704|NCT00785291|75902003|FG001|Overall Study|Complicating illness|4|||
42091705|NCT00785291|75902004|FG002|Overall Study|Complicating illness|4|||
42091706|NCT00785291|75902002|FG000|Overall Study|Other Medical Reasons|29|||
42091707|NCT00785291|75902003|FG001|Overall Study|Other Medical Reasons|25|||
42091708|NCT00785291|75902004|FG002|Overall Study|Other Medical Reasons|15|||
42091709|NCT00705939|75902015|FG000|Overall Study|Protocol Violation|0|||
42091710|NCT00705939|75902016|FG001|Overall Study|Protocol Violation|0|||
42091711|NCT00705939|75902017|FG002|Overall Study|Protocol Violation|1|||
42091712|NCT00705939|75902015|FG000|Overall Study|Withdrawal by Subject|0|||
42091713|NCT00705939|75902016|FG001|Overall Study|Withdrawal by Subject|1|||
42091714|NCT00705939|75902017|FG002|Overall Study|Withdrawal by Subject|3|||
42091715|NCT00705939|75902015|FG000|Overall Study|Physician Decision|0|||
42091716|NCT00705939|75902016|FG001|Overall Study|Physician Decision|1|||
42184334|NCT03053050|75993372|FG002|Randomized Phase|Lost to Follow-up|1|||
42091717|NCT00705939|75902017|FG002|Overall Study|Physician Decision|0|||
42184335|NCT03053050|75993373|FG003|Randomized Phase|Lost to Follow-up|0|||
42295004|NCT02628769|76129383|FG000|Second Intervention|Physician Decision|0|||
42091718|NCT00785213|75902026|FG000|Quinine Sulfate Alone|Adverse Event|4|||
42184336|NCT03053050|75993370|FG000|Randomized Phase|Adverse Event|0|||
42184337|NCT03053050|75993371|FG001|Randomized Phase|Adverse Event|1|||
42091719|NCT00785213|75902026|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
42184338|NCT03053050|75993372|FG002|Randomized Phase|Adverse Event|0|||
42184339|NCT03053050|75993373|FG003|Randomized Phase|Adverse Event|0|||
42091720|NCT00577317|75902035|FG000|Overall Study|Study Terminated|0|||
42184340|NCT03053050|75993370|FG000|Randomized Phase|Randomized but Never Treated|2|||
42184341|NCT03053050|75993371|FG001|Randomized Phase|Randomized but Never Treated|2|||
42295005|NCT02628769|76129384|FG001|Second Intervention|Physician Decision|1|||
42091721|NCT00577317|75902036|FG001|Overall Study|Study Terminated|2|||
42184342|NCT03053050|75993372|FG002|Randomized Phase|Randomized but Never Treated|2|||
42184343|NCT03053050|75993373|FG003|Randomized Phase|Randomized but Never Treated|0|||
42184344|NCT03053050|75993370|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
42184345|NCT03053050|75993371|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
42184346|NCT03053050|75993372|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
42184347|NCT03053050|75993373|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
42184348|NCT03053050|75993370|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
42184349|NCT03053050|75993371|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
42184350|NCT03053050|75993372|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
42184351|NCT03053050|75993373|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
42184352|NCT03053050|75993370|FG000|Open-label Phase|Withdrew Consent|0|||
42184353|NCT03053050|75993371|FG001|Open-label Phase|Withdrew Consent|0|||
42184354|NCT03053050|75993372|FG002|Open-label Phase|Withdrew Consent|0|||
42184355|NCT03053050|75993373|FG003|Open-label Phase|Withdrew Consent|6|||
42184356|NCT03053050|75993370|FG000|Open-label Phase|Investigator's Discretion|0|||
42184357|NCT03053050|75993371|FG001|Open-label Phase|Investigator's Discretion|0|||
42184358|NCT03053050|75993372|FG002|Open-label Phase|Investigator's Discretion|0|||
42184359|NCT03053050|75993373|FG003|Open-label Phase|Investigator's Discretion|4|||
42184360|NCT04369950|75993384|FG000|Overall Study|Protocol Violation|2|||
42184361|NCT04369950|75993385|FG001|Overall Study|Protocol Violation|2|||
42184362|NCT04035564|75993393|FG000|Overall Study|Protocol Violation|1|||
42184363|NCT04035564|75993394|FG001|Overall Study|Protocol Violation|2|||
42184364|NCT04035564|75993393|FG000|Overall Study|No laboratory available|2|||
42184365|NCT04035564|75993394|FG001|Overall Study|No laboratory available|2|||
42184366|NCT04035564|75993393|FG000|Overall Study|Guardian declined consent|1|||
42184367|NCT04035564|75993394|FG001|Overall Study|Guardian declined consent|2|||
42184368|NCT02955602|75993403|FG000|Overall Study|Adverse Event|0|||
42184369|NCT02955602|75993404|FG001|Overall Study|Adverse Event|3|||
42184370|NCT02955602|75993405|FG002|Overall Study|Adverse Event|0|||
42184371|NCT02955602|75993403|FG000|Overall Study|Withdrawal of informed consent|1|||
42184372|NCT02955602|75993404|FG001|Overall Study|Withdrawal of informed consent|3|||
42358843|NCT03745638|76204535|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
42358844|NCT03745638|76204536|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
42358845|NCT03745638|76204537|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
42091722|NCT00734162|75902046|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
42017966|NCT01262651|75825705|FG001|Overall Study|Met Withdrawal Criteria|0|||
42017967|NCT01262573|75825713|FG000|Overall Study|Withdrawal by Subject|0|||
42017968|NCT01262573|75825714|FG001|Overall Study|Withdrawal by Subject|1|||
42017969|NCT01262027|75825720|FG000|Overall Study|Adverse Event|1|||
42017970|NCT01262027|75825720|FG000|Overall Study|Withdrawal by Subject|3|||
42017971|NCT01262027|75825720|FG000|Overall Study|Protocol Violation|1|||
42017972|NCT01261793|75825727|FG000|Overall Study|Lack of Efficacy|44|||
42017973|NCT01261793|75825728|FG001|Overall Study|Lack of Efficacy|37|||
42017974|NCT01261793|75825729|FG002|Overall Study|Lack of Efficacy|32|||
42091723|NCT00734162|75902047|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
42091724|NCT00734162|75902048|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
42091725|NCT00734162|75902049|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
42091726|NCT00734162|75902046|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
42091727|NCT00734162|75902047|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
42091728|NCT00734162|75902048|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
42091729|NCT00734162|75902049|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
42091730|NCT00734162|75902046|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
42184373|NCT02955602|75993405|FG002|Overall Study|Withdrawal of informed consent|2|||
42184374|NCT02955602|75993403|FG000|Overall Study|Lost to Follow-up|0|||
42184375|NCT02955602|75993404|FG001|Overall Study|Lost to Follow-up|0|||
42184376|NCT02955602|75993405|FG002|Overall Study|Lost to Follow-up|1|||
42184377|NCT02955602|75993403|FG000|Overall Study|Other|0|||
42184378|NCT02955602|75993404|FG001|Overall Study|Other|1|||
42184379|NCT02955602|75993405|FG002|Overall Study|Other|3|||
42184380|NCT04179786|75993413|FG000|Overall Study|Withdrawal by Subject|8|||
42184381|NCT04175808|75993417|FG000|Part A|Miscellaneous|2|||
42184382|NCT04175808|75993418|FG001|Part A|Miscellaneous|0|||
42184383|NCT04175808|75993419|FG002|Part A|Miscellaneous|0|||
42184384|NCT04175808|75993420|FG003|Part A|Miscellaneous|0|||
42358846|NCT03745638|76204531|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
42184385|NCT04175808|75993421|FG004|Part A|Miscellaneous|0|||
42184386|NCT04175808|75993422|FG005|Part A|Miscellaneous|0|||
42184387|NCT04175808|75993423|FG006|Part A|Miscellaneous|0|||
42184388|NCT04057196|75993439|FG000|Overall Study|Withdrawal by Subject|3|||
42184389|NCT04057196|75993439|FG000|Overall Study|Death|3|||
42184390|NCT04027686|75993445|FG000|Overall Study|Lost to Follow-up|2|||
42184391|NCT04027686|75993446|FG001|Overall Study|Lost to Follow-up|0|||
42184392|NCT04027686|75993445|FG000|Overall Study|Withdrawal by Subject|0|||
42184393|NCT04027686|75993446|FG001|Overall Study|Withdrawal by Subject|1|||
42184394|NCT03052426|75993459|FG000|Overall Study|Withdrawal by Subject|0|||
42184395|NCT03052426|75993460|FG001|Overall Study|Withdrawal by Subject|1|||
42184396|NCT03052426|75993461|FG002|Overall Study|Withdrawal by Subject|0|||
42184397|NCT03052426|75993459|FG000|Overall Study|Lost to Follow-up|2|||
42184398|NCT03052426|75993460|FG001|Overall Study|Lost to Follow-up|0|||
42184399|NCT03052426|75993461|FG002|Overall Study|Lost to Follow-up|1|||
42184400|NCT03688880|75993476|FG000|Overall Study|Withdrawal by Subject|0|||
42184401|NCT03688880|75993477|FG001|Overall Study|Withdrawal by Subject|2|||
42184402|NCT03688880|75993476|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
42184403|NCT03688880|75993477|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
42184404|NCT03688880|75993476|FG000|Overall Study|Lost to Follow-up|4|||
42184405|NCT03688880|75993477|FG001|Overall Study|Lost to Follow-up|7|||
42184406|NCT03688880|75993476|FG000|Overall Study|Adverse Event|0|||
42184407|NCT03688880|75993477|FG001|Overall Study|Adverse Event|2|||
42184408|NCT03688880|75993476|FG000|Overall Study|Device deficiencies|0|||
42184409|NCT03688880|75993477|FG001|Overall Study|Device deficiencies|2|||
42184410|NCT03688880|75993476|FG000|Overall Study|Other|10|||
42184411|NCT03688880|75993477|FG001|Overall Study|Other|16|||
42184412|NCT03051178|75993483|FG000|Overall Study|Withdrawal by Subject|5|||
42184413|NCT03051100|75993489|FG000|Overall Study|Withdrawal by Subject|1|||
42184414|NCT03051100|75993490|FG001|Overall Study|Withdrawal by Subject|0|||
42184415|NCT01343368|75993498|FG000|Overall Study|Death|1|||
42184416|NCT01343368|75993499|FG001|Overall Study|Death|0|||
42184417|NCT01343368|75993498|FG000|Overall Study|Lost to Follow-up|1|||
42184418|NCT01343368|75993499|FG001|Overall Study|Lost to Follow-up|0|||
42184419|NCT02955212|75993507|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
42184420|NCT02955212|75993508|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
42184421|NCT02955212|75993507|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
42184422|NCT02955212|75993508|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
42184423|NCT02955212|75993507|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
42184424|NCT02955212|75993508|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
42184425|NCT02955212|75993507|FG000|Period 1: Double-blind Treatment Period|Other|3|||
42184426|NCT02955212|75993508|FG001|Period 1: Double-blind Treatment Period|Other|2|||
42184427|NCT02955212|75993507|FG000|Period 2: Open-label Extension|Adverse Event|11|||
42184428|NCT02955212|75993508|FG001|Period 2: Open-label Extension|Adverse Event|7|||
42184429|NCT02955212|75993507|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
42184430|NCT02955212|75993508|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
42184431|NCT02955212|75993507|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
42184432|NCT02955212|75993508|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
42184433|NCT02955212|75993507|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
42184434|NCT02955212|75993508|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
42184435|NCT02955212|75993507|FG000|Period 2: Open-label Extension|Other|2|||
42184436|NCT02955212|75993508|FG001|Period 2: Open-label Extension|Other|4|||
42184437|NCT03050398|75993515|FG000|Overall Study|Study terminated by sponsor|8|||
42184438|NCT03662750|75993519|FG000|Overall Study|Withdrawal by Subject|1|||
42184439|NCT04052204|75993523|FG000|Overall Study|Death|1|||
42184440|NCT04052204|75993524|FG001|Overall Study|Death|0|||
42184441|NCT04052204|75993525|FG002|Overall Study|Death|0|||
42184442|NCT04052204|75993523|FG000|Overall Study|Progressive disease|1|||
42184443|NCT04052204|75993524|FG001|Overall Study|Progressive disease|0|||
42184444|NCT04052204|75993525|FG002|Overall Study|Progressive disease|0|||
42184445|NCT04052204|75993523|FG000|Overall Study|Other|1|||
42184446|NCT04052204|75993524|FG001|Overall Study|Other|0|||
42184447|NCT04052204|75993525|FG002|Overall Study|Other|0|||
42184448|NCT04050722|75993531|FG000|Overall Study|Withdrawal by Subject|1|||
42184449|NCT04050722|75993532|FG001|Overall Study|Withdrawal by Subject|0|||
42184450|NCT04049552|75993538|FG000|Overall Study|Lost to Follow-up|1|||
42184451|NCT03048058|75993546|FG000|Overall Study|Lost to Follow-up|4|||
42184452|NCT03048058|75993547|FG001|Overall Study|Lost to Follow-up|0|||
42184453|NCT03048058|75993546|FG000|Overall Study|Withdrawal by Subject|0|||
42184454|NCT03048058|75993547|FG001|Overall Study|Withdrawal by Subject|4|||
42184455|NCT03047980|75993553|FG000|Overall Study|Adverse Event|1|||
42184456|NCT04048382|75993559|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
42184457|NCT04048382|75993560|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
42184458|NCT04048382|75993559|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
42184459|NCT04048382|75993560|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
42184460|NCT04048382|75993559|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
42184461|NCT04048382|75993560|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
42184462|NCT04047446|75993568|FG000|Overall Study|Physician Decision|1|||
42295006|NCT02626819|76129392|FG000|Overall Study|Lost to Follow-up|3|||
42184463|NCT04047446|75993569|FG001|Overall Study|Physician Decision|0|||
42184464|NCT03655106|75993577|FG000|Overall Study|Withdrawal by Subject|3|||
42017975|NCT01261793|75825727|FG000|Overall Study|Protocol Violation|3|||
42184465|NCT03655106|75993578|FG001|Overall Study|Withdrawal by Subject|2|||
42184466|NCT03655106|75993577|FG000|Overall Study|Lost to Follow-up|2|||
42184467|NCT03655106|75993578|FG001|Overall Study|Lost to Follow-up|1|||
42184468|NCT03655106|75993577|FG000|Overall Study|Duplicate Enrollment|1|||
42184469|NCT03655106|75993578|FG001|Overall Study|Duplicate Enrollment|1|||
42184470|NCT03655106|75993577|FG000|Overall Study|Protocol Violation|3|||
42184471|NCT03655106|75993578|FG001|Overall Study|Protocol Violation|0|||
42184472|NCT03630302|75993584|FG000|Surgery|hardware issue prevented LFP recordings|1|||
42184473|NCT03630302|75993584|FG000|3 Month Visit|Adverse Event|2|||
42184474|NCT03630302|75993584|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
42184475|NCT04041440|75993590|FG000|Overall Study|Withdrawal by Subject|0|||
42184476|NCT04041440|75993591|FG001|Overall Study|Withdrawal by Subject|1|||
42184477|NCT04041440|75993590|FG000|Overall Study|Lost to Follow-up|0|||
42184478|NCT04041440|75993591|FG001|Overall Study|Lost to Follow-up|1|||
42184479|NCT03654560|75993600|FG000|Overall Study|Death|3|||
42184480|NCT03654560|75993601|FG001|Overall Study|Death|1|||
42184481|NCT03654560|75993600|FG000|Overall Study|Lost to Follow-up|1|||
42184482|NCT03654560|75993601|FG001|Overall Study|Lost to Follow-up|0|||
42184483|NCT03629054|75993609|FG000|Period 2 (4 Days)|Not treated|0|||
42184484|NCT03629054|75993610|FG001|Period 2 (4 Days)|Not treated|1|||
42184485|NCT03628898|75993616|FG000|Overall Study|Device deficiency|1|||
42184486|NCT03628508|75993620|FG000|Overall Study|Lost to Follow-up|1|||
42184487|NCT03045328|75993624|FG000|Overall Study|Withdrawal by Subject|2|||
42184488|NCT02154490|75993630|FG000|Overall Study|No tissue submitted|23|||
42184489|NCT02154490|75993630|FG000|Overall Study|No biomarker results|167|||
42184490|NCT02154490|75993630|FG000|Overall Study|Not assigned to a sub-study|270|||
42184491|NCT02154490|75993630|FG000|Overall Study|Did not register to a sub-study|749|||
42184492|NCT03627494|75993646|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
42184493|NCT03627494|75993647|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
42184494|NCT03627494|75993648|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
42295007|NCT02626819|76129393|FG001|Overall Study|Lost to Follow-up|2|||
42295008|NCT02626819|76129392|FG000|Overall Study|Withdrawal by Subject|1|||
42295009|NCT02626819|76129393|FG001|Overall Study|Withdrawal by Subject|0|||
42295010|NCT02626819|76129392|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
42295011|NCT02626819|76129393|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
42091731|NCT00734162|75902047|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
42091732|NCT00734162|75902048|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
42091733|NCT00734162|75902049|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
42091734|NCT00734162|75902046|FG000|Open-Label Phase|Withdrew Consent|1|||
42091735|NCT00734162|75902047|FG001|Open-Label Phase|Withdrew Consent|0|||
42091736|NCT00734162|75902048|FG002|Open-Label Phase|Withdrew Consent|1|||
42091737|NCT00734162|75902049|FG003|Open-Label Phase|Withdrew Consent|1|||
42091738|NCT00734162|75902046|FG000|Open-Label Phase|Lost to Follow-up|1|||
42091739|NCT00734162|75902047|FG001|Open-Label Phase|Lost to Follow-up|2|||
42091740|NCT00734162|75902048|FG002|Open-Label Phase|Lost to Follow-up|0|||
42091741|NCT00734162|75902049|FG003|Open-Label Phase|Lost to Follow-up|1|||
42091742|NCT00734162|75902046|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
42184495|NCT03627494|75993649|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
42358847|NCT03745638|76204532|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
42358848|NCT03745638|76204533|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
42358849|NCT03745638|76204534|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
42358850|NCT03745638|76204535|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
42358851|NCT03745638|76204536|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
42358852|NCT03745638|76204537|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
42358853|NCT03745638|76204531|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
42358854|NCT03745638|76204532|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
42358855|NCT03745638|76204533|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
42358856|NCT03745638|76204534|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
42358857|NCT03745638|76204535|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
42358858|NCT03745638|76204536|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
42358859|NCT03745638|76204537|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
42358860|NCT03745638|76204531|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
42358861|NCT03745638|76204532|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
42295012|NCT02630251|76129403|FG000|Overall Study|Physician Decision|0|||
42358862|NCT03745638|76204533|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
42358863|NCT03745638|76204534|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
42358864|NCT03745638|76204535|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
42358865|NCT03745638|76204536|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
42358866|NCT03745638|76204537|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
42295013|NCT02630251|76129404|FG001|Overall Study|Physician Decision|0|||
42184496|NCT03627494|75993650|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
42184497|NCT03627494|75993651|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
42295014|NCT02630251|76129405|FG002|Overall Study|Physician Decision|1|||
42184498|NCT03627494|75993652|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
42184499|NCT03627494|75993653|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
42184500|NCT03627494|75993654|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
42184501|NCT03627494|75993655|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
42184502|NCT03627494|75993656|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
42184503|NCT03627494|75993657|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
42184504|NCT03627494|75993646|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
42184505|NCT03627494|75993647|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
42184506|NCT03627494|75993648|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
42184507|NCT03627494|75993649|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
42184508|NCT03627494|75993650|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
42184509|NCT03627494|75993651|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
42184510|NCT03627494|75993652|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
42184511|NCT03627494|75993653|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
42184512|NCT03627494|75993654|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
42184513|NCT03627494|75993655|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
42184514|NCT03627494|75993656|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
42184515|NCT03627494|75993657|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
42184516|NCT03627494|75993646|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
42184517|NCT03627494|75993647|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
42184518|NCT03627494|75993648|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
42184519|NCT03627494|75993649|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
42184520|NCT03627494|75993650|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
42184521|NCT03627494|75993651|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
42184522|NCT03627494|75993652|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
42184523|NCT03627494|75993653|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
42184524|NCT03627494|75993654|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
42184525|NCT03627494|75993655|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
42184526|NCT03627494|75993656|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
42184527|NCT03627494|75993657|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
42184528|NCT03627416|75993698|FG000|Overall Study|Adverse Event|0|||
42184529|NCT03627416|75993699|FG001|Overall Study|Adverse Event|1|||
42184530|NCT00097539|75993712|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
42184531|NCT00097539|75993713|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
42184532|NCT00097539|75993714|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
42184533|NCT00097539|75993715|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
42184534|NCT00097539|75993716|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
42184535|NCT00097539|75993717|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
42184536|NCT00097539|75993718|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
42184537|NCT00097539|75993712|FG000|Overall Study|Withdrawal by Subject|925|||
42184538|NCT00097539|75993713|FG001|Overall Study|Withdrawal by Subject|323|||
42184539|NCT00097539|75993714|FG002|Overall Study|Withdrawal by Subject|346|||
42184540|NCT00097539|75993715|FG003|Overall Study|Withdrawal by Subject|217|||
42184541|NCT00097539|75993716|FG004|Overall Study|Withdrawal by Subject|68|||
42295015|NCT02630251|76129406|FG003|Overall Study|Physician Decision|0|||
42295016|NCT02518113|76129420|FG000|Overall Study|Adverse Event|1|||
42295017|NCT02518113|76129421|FG001|Overall Study|Adverse Event|0|||
42295018|NCT02518113|76129422|FG002|Overall Study|Adverse Event|1|||
42295019|NCT02518113|76129423|FG003|Overall Study|Adverse Event|0|||
42295020|NCT02518113|76129420|FG000|Overall Study|Death|1|||
42295021|NCT02518113|76129421|FG001|Overall Study|Death|2|||
42295022|NCT02518113|76129422|FG002|Overall Study|Death|0|||
42295023|NCT02518113|76129423|FG003|Overall Study|Death|0|||
42295024|NCT02518113|76129420|FG000|Overall Study|Physician Decision|0|||
42295025|NCT02518113|76129421|FG001|Overall Study|Physician Decision|1|||
42295026|NCT02518113|76129422|FG002|Overall Study|Physician Decision|0|||
42295027|NCT02518113|76129423|FG003|Overall Study|Physician Decision|0|||
42295028|NCT02518113|76129420|FG000|Overall Study|Progressive Disease|1|||
42295029|NCT02518113|76129421|FG001|Overall Study|Progressive Disease|2|||
42295030|NCT02518113|76129422|FG002|Overall Study|Progressive Disease|3|||
42295031|NCT02518113|76129423|FG003|Overall Study|Progressive Disease|0|||
42295032|NCT02629861|76129439|FG000|Overall Study|Adverse Event|7|||
42295033|NCT02629861|76129440|FG001|Overall Study|Adverse Event|5|||
42295034|NCT02629861|76129441|FG002|Overall Study|Adverse Event|4|||
42295035|NCT02629861|76129439|FG000|Overall Study|Withdrawal by Subject|5|||
42295036|NCT02629861|76129440|FG001|Overall Study|Withdrawal by Subject|8|||
42295037|NCT02629861|76129441|FG002|Overall Study|Withdrawal by Subject|13|||
42295038|NCT02629861|76129439|FG000|Overall Study|Protocol Violation|2|||
42295039|NCT02629861|76129440|FG001|Overall Study|Protocol Violation|3|||
42295040|NCT02629861|76129441|FG002|Overall Study|Protocol Violation|7|||
42295041|NCT02629861|76129439|FG000|Overall Study|Lost to Follow-up|12|||
42295042|NCT02629861|76129440|FG001|Overall Study|Lost to Follow-up|9|||
42295043|NCT02629861|76129441|FG002|Overall Study|Lost to Follow-up|4|||
42295044|NCT02629861|76129439|FG000|Overall Study|Other|1|||
42295045|NCT02629861|76129440|FG001|Overall Study|Other|1|||
42295046|NCT02629861|76129441|FG002|Overall Study|Other|0|||
42295047|NCT02629861|76129439|FG000|Overall Study|Pregnancy|2|||
42184542|NCT00097539|75993717|FG005|Overall Study|Withdrawal by Subject|229|||
42184543|NCT00097539|75993718|FG006|Overall Study|Withdrawal by Subject|3|||
42184544|NCT00097539|75993712|FG000|Overall Study|Participant Non-compliant|2140|||
42184545|NCT00097539|75993713|FG001|Overall Study|Participant Non-compliant|567|||
42184546|NCT00097539|75993714|FG002|Overall Study|Participant Non-compliant|1067|||
42184547|NCT00097539|75993715|FG003|Overall Study|Participant Non-compliant|353|||
42184548|NCT00097539|75993716|FG004|Overall Study|Participant Non-compliant|136|||
42184549|NCT00097539|75993717|FG005|Overall Study|Participant Non-compliant|543|||
42184550|NCT00097539|75993718|FG006|Overall Study|Participant Non-compliant|18|||
42184551|NCT00097539|75993712|FG000|Overall Study|Lack of Efficacy|249|||
42184552|NCT00097539|75993713|FG001|Overall Study|Lack of Efficacy|122|||
42184553|NCT00097539|75993714|FG002|Overall Study|Lack of Efficacy|202|||
42184554|NCT00097539|75993715|FG003|Overall Study|Lack of Efficacy|105|||
42184555|NCT00097539|75993716|FG004|Overall Study|Lack of Efficacy|45|||
42184556|NCT00097539|75993717|FG005|Overall Study|Lack of Efficacy|228|||
42184557|NCT00097539|75993718|FG006|Overall Study|Lack of Efficacy|5|||
42184558|NCT00097539|75993712|FG000|Overall Study|Adverse Event|78|||
42184559|NCT00097539|75993713|FG001|Overall Study|Adverse Event|133|||
42184560|NCT00097539|75993714|FG002|Overall Study|Adverse Event|37|||
42184561|NCT00097539|75993715|FG003|Overall Study|Adverse Event|27|||
42184562|NCT00097539|75993716|FG004|Overall Study|Adverse Event|30|||
42184563|NCT00097539|75993717|FG005|Overall Study|Adverse Event|59|||
42184564|NCT00097539|75993718|FG006|Overall Study|Adverse Event|1|||
42184565|NCT00097539|75993712|FG000|Overall Study|Death|2|||
42184566|NCT00097539|75993713|FG001|Overall Study|Death|7|||
42184567|NCT00097539|75993714|FG002|Overall Study|Death|0|||
42184568|NCT00097539|75993715|FG003|Overall Study|Death|0|||
42184569|NCT00097539|75993716|FG004|Overall Study|Death|1|||
42184570|NCT00097539|75993717|FG005|Overall Study|Death|3|||
42184571|NCT00097539|75993718|FG006|Overall Study|Death|0|||
42184572|NCT00097539|75993712|FG000|Overall Study|Reasons Other Than Above|3602|||
42184573|NCT00097539|75993713|FG001|Overall Study|Reasons Other Than Above|1382|||
42184574|NCT00097539|75993714|FG002|Overall Study|Reasons Other Than Above|1757|||
42184575|NCT00097539|75993715|FG003|Overall Study|Reasons Other Than Above|692|||
42295048|NCT02629861|76129440|FG001|Overall Study|Pregnancy|1|||
42295049|NCT02629861|76129441|FG002|Overall Study|Pregnancy|0|||
42295050|NCT02482935|76129449|FG000|Period 1|Withdrawal by Subject|1|||
42295051|NCT02482935|76129450|FG001|Period 1|Withdrawal by Subject|0|||
42295052|NCT02513823|76129456|FG000|Overall Study|Lost to Follow-up|4|||
42295053|NCT02513823|76129456|FG000|Overall Study|Physician Decision|1|||
42295054|NCT02513745|76129462|FG000|Overall Study|Criteria at time of surgery not met.|3|||
42295055|NCT02513745|76129463|FG001|Overall Study|Criteria at time of surgery not met.|3|||
42295056|NCT02477553|76129471|FG000|Overall Study|Screening up-to-date|12|||
42295057|NCT02477553|76129472|FG001|Overall Study|Screening up-to-date|13|||
42295058|NCT02477553|76129471|FG000|Overall Study|No MD visit|1|||
42295059|NCT02477553|76129472|FG001|Overall Study|No MD visit|1|||
42295060|NCT02477553|76129471|FG000|Overall Study|Workup consistent w/CRC|1|||
42295061|NCT02477553|76129472|FG001|Overall Study|Workup consistent w/CRC|1|||
42295062|NCT02477553|76129471|FG000|Overall Study|Technical issues with intervention|2|||
42295063|NCT02477553|76129472|FG001|Overall Study|Technical issues with intervention|0|||
42295064|NCT02477553|76129471|FG000|Overall Study|Elevated risk for CRC|2|||
42295065|NCT02477553|76129472|FG001|Overall Study|Elevated risk for CRC|2|||
42295066|NCT02477553|76129471|FG000|Overall Study|MD advised against screening|1|||
42295067|NCT02477553|76129472|FG001|Overall Study|MD advised against screening|3|||
42295068|NCT02477553|76129471|FG000|Overall Study|patient deceased|1|||
42295069|NCT02477553|76129472|FG001|Overall Study|patient deceased|0|||
42295070|NCT01665911|76129478|FG000|Overall Study|Protocol Violation|4|||
42295071|NCT01665911|76129478|FG000|Overall Study|Withdrawal by Subject|1|||
42295072|NCT01665911|76129478|FG000|Overall Study|Adverse Event|1|||
42295073|NCT02452359|76129483|FG000|Overall Study|Adverse Event|1|||
42295074|NCT02452359|76129483|FG000|Overall Study|Lost to Follow-up|15|||
42295075|NCT02452359|76129483|FG000|Overall Study|Pregnancy|1|||
42295076|NCT02452359|76129483|FG000|Overall Study|Withdrawal by Subject|4|||
42295077|NCT02476617|76129487|FG000|Overall Study|Adverse Event|1|||
42295078|NCT02476617|76129487|FG000|Overall Study|Lost to Follow-up|1|||
42295079|NCT01665599|76129504|FG000|Overall Study|Adverse Event|1|||
42295080|NCT01665599|76129504|FG000|Overall Study|Consent Withdrawn|1|||
42295081|NCT01665599|76129504|FG000|Overall Study|Investigator/Sponsor decision|1|||
42295082|NCT01665599|76129504|FG000|Overall Study|Death|1|||
42295083|NCT01665599|76129504|FG000|Overall Study|Lost to Follow-up|2|||
42295084|NCT01665599|76129504|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
42295085|NCT01665599|76129504|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
42295086|NCT01671085|76129510|FG000|Overall Study|Withdrawal by Subject|1|||
42295087|NCT01671085|76129511|FG001|Overall Study|Withdrawal by Subject|0|||
42295088|NCT02510001|76129526|FG000|Overall Study|Early disease progression|0|||
42295089|NCT02510001|76129527|FG001|Overall Study|Early disease progression|0|||
42295090|NCT02510001|76129528|FG002|Overall Study|Early disease progression|0|||
42295091|NCT02510001|76129529|FG003|Overall Study|Early disease progression|1|||
42295092|NCT02510001|76129530|FG004|Overall Study|Early disease progression|1|||
42295093|NCT02510001|76129531|FG005|Overall Study|Early disease progression|1|||
42295094|NCT02510001|76129532|FG006|Overall Study|Early disease progression|0|||
42295095|NCT02510001|76129533|FG007|Overall Study|Early disease progression|0|||
42295096|NCT02510001|76129526|FG000|Overall Study|Adverse Event|0|||
42295097|NCT02510001|76129527|FG001|Overall Study|Adverse Event|0|||
42295098|NCT02510001|76129528|FG002|Overall Study|Adverse Event|0|||
42295099|NCT02510001|76129529|FG003|Overall Study|Adverse Event|1|||
42358867|NCT03745638|76204531|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358868|NCT03745638|76204532|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358869|NCT03745638|76204533|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358870|NCT03745638|76204534|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358871|NCT03745638|76204535|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358872|NCT03745638|76204536|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
42358873|NCT03745638|76204537|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
42358874|NCT03745638|76204531|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
42358875|NCT03745638|76204532|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
42358876|NCT03745638|76204533|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
42358877|NCT03745638|76204534|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
42358878|NCT03745638|76204535|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
42358879|NCT03745638|76204536|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
42184576|NCT00097539|75993716|FG004|Overall Study|Reasons Other Than Above|361|||
42184577|NCT00097539|75993717|FG005|Overall Study|Reasons Other Than Above|1244|||
42184578|NCT00097539|75993718|FG006|Overall Study|Reasons Other Than Above|34|||
42184579|NCT00097539|75993712|FG000|Overall Study|Reason not Specified|111|||
42184580|NCT00097539|75993713|FG001|Overall Study|Reason not Specified|49|||
42184581|NCT00097539|75993714|FG002|Overall Study|Reason not Specified|53|||
42184582|NCT00097539|75993715|FG003|Overall Study|Reason not Specified|21|||
42184583|NCT00097539|75993716|FG004|Overall Study|Reason not Specified|11|||
42184584|NCT00097539|75993717|FG005|Overall Study|Reason not Specified|40|||
42184585|NCT00097539|75993718|FG006|Overall Study|Reason not Specified|2|||
42184586|NCT03925324|75993736|FG000|Overall Study|Death|1|||
42184587|NCT03925324|75993737|FG001|Overall Study|Death|1|||
42184588|NCT03042910|75993743|FG000|Overall Study|Adverse Event|1|||
42184589|NCT03042910|75993743|FG000|Overall Study|Disease Progression|2|||
42184590|NCT03042910|75993743|FG000|Overall Study|Withdrawal by Subject|3|||
42184591|NCT03042910|75993743|FG000|Overall Study|Enrolled but not treated|1|||
42184592|NCT03059446|75993747|FG000|Overall Study|Adverse Event|11|||
42184593|NCT03059446|75993747|FG000|Overall Study|Withdrawal of Consent|16|||
42184594|NCT03059446|75993747|FG000|Overall Study|Lost to Follow-up|3|||
42184595|NCT03059446|75993747|FG000|Overall Study|Protocol Violation|1|||
42184596|NCT03059446|75993747|FG000|Overall Study|Study Terminated by Sponsor|131|||
42184597|NCT03059446|75993747|FG000|Overall Study|Reason not Specified|5|||
42184598|NCT00090519|75993753|FG000|Overall Study|Adverse Event|5|||
42184599|NCT00090519|75993754|FG001|Overall Study|Adverse Event|4|||
42184600|NCT00090519|75993753|FG000|Overall Study|Death|9|||
42184601|NCT00090519|75993754|FG001|Overall Study|Death|9|||
42184602|NCT00090519|75993753|FG000|Overall Study|Lost to Follow-up|26|||
42184603|NCT00090519|75993754|FG001|Overall Study|Lost to Follow-up|29|||
42184604|NCT00090519|75993753|FG000|Overall Study|Withdrawal by Subject|28|||
42184605|NCT00090519|75993754|FG001|Overall Study|Withdrawal by Subject|29|||
42184606|NCT00090519|75993753|FG000|Overall Study|Physician Decision|2|||
42184607|NCT00090519|75993754|FG001|Overall Study|Physician Decision|3|||
42184608|NCT00090519|75993753|FG000|Overall Study|Sponsor Decision|3|||
42184609|NCT00090519|75993754|FG001|Overall Study|Sponsor Decision|1|||
42184610|NCT00096993|75993784|FG000|Overall Study|Death|1|||
42184611|NCT00096993|75993785|FG001|Overall Study|Death|0|||
42184612|NCT00096993|75993784|FG000|Overall Study|Disease progression|56|||
42184613|NCT00096993|75993785|FG001|Overall Study|Disease progression|53|||
42184614|NCT00096993|75993784|FG000|Overall Study|Adverse Event|2|||
42184615|NCT00096993|75993785|FG001|Overall Study|Adverse Event|8|||
42184616|NCT00096993|75993784|FG000|Overall Study|Subject's decision|3|||
42184617|NCT00096993|75993785|FG001|Overall Study|Subject's decision|1|||
42184618|NCT00096993|75993784|FG000|Overall Study|Physician Decision|2|||
42295100|NCT02510001|76129530|FG004|Overall Study|Adverse Event|2|||
42184619|NCT00096993|75993785|FG001|Overall Study|Physician Decision|1|||
42184620|NCT00096993|75993784|FG000|Overall Study|Non-compliance|0|||
42184621|NCT00096993|75993785|FG001|Overall Study|Non-compliance|1|||
42184622|NCT00096993|75993784|FG000|Overall Study|Other unspecified|1|||
42184623|NCT00096993|75993785|FG001|Overall Study|Other unspecified|1|||
42295101|NCT02510001|76129531|FG005|Overall Study|Adverse Event|1|||
42295102|NCT02510001|76129532|FG006|Overall Study|Adverse Event|2|||
42184624|NCT03040336|75993793|FG000|Overall Study|Death|1|||
42184625|NCT03040336|75993794|FG001|Overall Study|Death|0|||
42184626|NCT03040336|75993793|FG000|Overall Study|Withdrawal by Subject|2|||
42184627|NCT03040336|75993794|FG001|Overall Study|Withdrawal by Subject|3|||
42184628|NCT00072189|75993801|FG000|Overall Study|Withdrawal by Subject|1|||
42184629|NCT03040024|75993808|FG000|Overall Study|Adverse Event|0|||
42184630|NCT03040024|75993809|FG001|Overall Study|Adverse Event|1|||
42184631|NCT03040024|75993810|FG002|Overall Study|Adverse Event|0|||
42184632|NCT03040024|75993808|FG000|Overall Study|Death|0|||
42184633|NCT03040024|75993809|FG001|Overall Study|Death|1|||
42184634|NCT03040024|75993810|FG002|Overall Study|Death|0|||
42184635|NCT03040024|75993808|FG000|Overall Study|Physician Decision|0|||
42184636|NCT03040024|75993809|FG001|Overall Study|Physician Decision|0|||
42184637|NCT03040024|75993810|FG002|Overall Study|Physician Decision|1|||
42184638|NCT03039790|75993838|FG000|Overall Study|Lost to Follow-up|2|||
42184639|NCT03039790|75993839|FG001|Overall Study|Lost to Follow-up|0|||
42184640|NCT03039790|75993840|FG002|Overall Study|Lost to Follow-up|1|||
42184641|NCT03039790|75993841|FG003|Overall Study|Lost to Follow-up|1|||
42184642|NCT03039790|75993842|FG004|Overall Study|Lost to Follow-up|0|||
42184643|NCT03039790|75993843|FG005|Overall Study|Lost to Follow-up|1|||
42184644|NCT03039790|75993844|FG006|Overall Study|Lost to Follow-up|1|||
42184645|NCT03039790|75993845|FG007|Overall Study|Lost to Follow-up|1|||
42184646|NCT03039790|75993846|FG008|Overall Study|Lost to Follow-up|0|||
42184647|NCT03039790|75993847|FG009|Overall Study|Lost to Follow-up|1|||
42184648|NCT03039790|75993848|FG010|Overall Study|Lost to Follow-up|1|||
42184649|NCT03039790|75993849|FG011|Overall Study|Lost to Follow-up|0|||
42184650|NCT03039790|75993850|FG012|Overall Study|Lost to Follow-up|1|||
42184651|NCT03039790|75993851|FG013|Overall Study|Lost to Follow-up|0|||
42184652|NCT03039790|75993852|FG014|Overall Study|Lost to Follow-up|3|||
42184653|NCT03039790|75993853|FG015|Overall Study|Lost to Follow-up|1|||
42184654|NCT03039790|75993854|FG016|Overall Study|Lost to Follow-up|2|||
42184655|NCT03039790|75993855|FG017|Overall Study|Lost to Follow-up|2|||
42184656|NCT03039790|75993856|FG018|Overall Study|Lost to Follow-up|1|||
42184657|NCT03039790|75993857|FG019|Overall Study|Lost to Follow-up|3|||
42184658|NCT03039790|75993838|FG000|Overall Study|Withdrawal of Consent|1|||
42184659|NCT03039790|75993839|FG001|Overall Study|Withdrawal of Consent|0|||
42184660|NCT03039790|75993840|FG002|Overall Study|Withdrawal of Consent|0|||
42295103|NCT02510001|76129533|FG007|Overall Study|Adverse Event|5|||
42295104|NCT02510001|76129526|FG000|Overall Study|Physician Decision|0|||
42295105|NCT02510001|76129527|FG001|Overall Study|Physician Decision|0|||
42295106|NCT02510001|76129528|FG002|Overall Study|Physician Decision|0|||
42295107|NCT02510001|76129529|FG003|Overall Study|Physician Decision|0|||
42295108|NCT02510001|76129530|FG004|Overall Study|Physician Decision|1|||
42295109|NCT02510001|76129531|FG005|Overall Study|Physician Decision|0|||
42295110|NCT02510001|76129532|FG006|Overall Study|Physician Decision|0|||
42295111|NCT02510001|76129533|FG007|Overall Study|Physician Decision|0|||
42295112|NCT02510001|76129526|FG000|Overall Study|Withdrawal by Subject|0|||
42295113|NCT02510001|76129527|FG001|Overall Study|Withdrawal by Subject|0|||
42295114|NCT02510001|76129528|FG002|Overall Study|Withdrawal by Subject|0|||
42295115|NCT02510001|76129529|FG003|Overall Study|Withdrawal by Subject|0|||
42295116|NCT02510001|76129530|FG004|Overall Study|Withdrawal by Subject|0|||
42295117|NCT02510001|76129531|FG005|Overall Study|Withdrawal by Subject|0|||
42295118|NCT02510001|76129532|FG006|Overall Study|Withdrawal by Subject|0|||
42295119|NCT02510001|76129533|FG007|Overall Study|Withdrawal by Subject|2|||
42295120|NCT02452047|76129572|FG000|Overall Study|Adverse Event|0|||
42295121|NCT02452047|76129573|FG001|Overall Study|Adverse Event|1|||
42295122|NCT02452047|76129574|FG002|Overall Study|Adverse Event|1|||
42295123|NCT02452047|76129572|FG000|Overall Study|Death|1|||
42295124|NCT02452047|76129573|FG001|Overall Study|Death|3|||
42295125|NCT02452047|76129574|FG002|Overall Study|Death|1|||
42295126|NCT02452047|76129572|FG000|Overall Study|Physician Decision|1|||
42295127|NCT02452047|76129573|FG001|Overall Study|Physician Decision|0|||
42295128|NCT02452047|76129574|FG002|Overall Study|Physician Decision|0|||
42295129|NCT02452047|76129572|FG000|Overall Study|Lost to Follow-up|1|||
42295130|NCT02452047|76129573|FG001|Overall Study|Lost to Follow-up|1|||
42295131|NCT02452047|76129574|FG002|Overall Study|Lost to Follow-up|0|||
42295132|NCT02452047|76129572|FG000|Overall Study|Withdrawal by Subject|1|||
42295133|NCT02452047|76129573|FG001|Overall Study|Withdrawal by Subject|0|||
42295134|NCT02452047|76129574|FG002|Overall Study|Withdrawal by Subject|0|||
42358880|NCT03745638|76204537|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
42358881|NCT03745638|76204531|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
42017976|NCT01261793|75825728|FG001|Overall Study|Protocol Violation|5|||
42184661|NCT03039790|75993841|FG003|Overall Study|Withdrawal of Consent|1|||
42184662|NCT03039790|75993842|FG004|Overall Study|Withdrawal of Consent|0|||
42184663|NCT03039790|75993843|FG005|Overall Study|Withdrawal of Consent|0|||
42184664|NCT03039790|75993844|FG006|Overall Study|Withdrawal of Consent|0|||
42295135|NCT02475369|76129582|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
42295136|NCT02475369|76129583|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
42295137|NCT02474589|76129596|FG000|Overall Study|Adverse Event|6|||
42184665|NCT03039790|75993845|FG007|Overall Study|Withdrawal of Consent|0|||
42184666|NCT03039790|75993846|FG008|Overall Study|Withdrawal of Consent|0|||
42295138|NCT02474589|76129597|FG001|Overall Study|Adverse Event|2|||
42358882|NCT03745638|76204532|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
42358883|NCT03745638|76204533|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
42358884|NCT03745638|76204534|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
42358885|NCT03745638|76204535|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
42358886|NCT03745638|76204536|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
42358887|NCT03745638|76204537|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
42358888|NCT03699475|76204567|FG000|Overall Study|Death|1|||
42358889|NCT03668613|76204573|FG000|Overall Study|Adverse Event|0|||
42358890|NCT03668613|76204574|FG001|Overall Study|Adverse Event|2|||
42358891|NCT03668613|76204573|FG000|Overall Study|Lack of Efficacy|0|||
42358892|NCT03668613|76204574|FG001|Overall Study|Lack of Efficacy|1|||
42358893|NCT03650413|76204581|FG000|Overall Study|Adverse Event|1|||
42184667|NCT03039790|75993847|FG009|Overall Study|Withdrawal of Consent|1|||
42184668|NCT03039790|75993848|FG010|Overall Study|Withdrawal of Consent|0|||
42184669|NCT03039790|75993849|FG011|Overall Study|Withdrawal of Consent|0|||
42184670|NCT03039790|75993850|FG012|Overall Study|Withdrawal of Consent|2|||
42184671|NCT03039790|75993851|FG013|Overall Study|Withdrawal of Consent|0|||
42184672|NCT03039790|75993852|FG014|Overall Study|Withdrawal of Consent|1|||
42184673|NCT03039790|75993853|FG015|Overall Study|Withdrawal of Consent|5|||
42184674|NCT03039790|75993854|FG016|Overall Study|Withdrawal of Consent|3|||
42184675|NCT03039790|75993855|FG017|Overall Study|Withdrawal of Consent|0|||
42184676|NCT03039790|75993856|FG018|Overall Study|Withdrawal of Consent|2|||
42184677|NCT03039790|75993857|FG019|Overall Study|Withdrawal of Consent|5|||
42184678|NCT03039790|75993838|FG000|Overall Study|Death|0|||
42184679|NCT03039790|75993839|FG001|Overall Study|Death|0|||
42184680|NCT03039790|75993840|FG002|Overall Study|Death|0|||
42184681|NCT03039790|75993841|FG003|Overall Study|Death|0|||
42184682|NCT03039790|75993842|FG004|Overall Study|Death|0|||
42184683|NCT03039790|75993843|FG005|Overall Study|Death|0|||
42184684|NCT03039790|75993844|FG006|Overall Study|Death|0|||
42184685|NCT03039790|75993845|FG007|Overall Study|Death|0|||
42184686|NCT03039790|75993846|FG008|Overall Study|Death|0|||
42184687|NCT03039790|75993847|FG009|Overall Study|Death|0|||
42184688|NCT03039790|75993848|FG010|Overall Study|Death|0|||
42184689|NCT03039790|75993849|FG011|Overall Study|Death|0|||
42184690|NCT03039790|75993850|FG012|Overall Study|Death|0|||
42184691|NCT03039790|75993851|FG013|Overall Study|Death|0|||
42184692|NCT03039790|75993852|FG014|Overall Study|Death|0|||
42184693|NCT03039790|75993853|FG015|Overall Study|Death|1|||
42184694|NCT03039790|75993854|FG016|Overall Study|Death|3|||
42184695|NCT03039790|75993855|FG017|Overall Study|Death|0|||
42184696|NCT03039790|75993856|FG018|Overall Study|Death|2|||
42184697|NCT03039790|75993857|FG019|Overall Study|Death|0|||
42184698|NCT03039790|75993838|FG000|Overall Study|Reason, not Specified|1|||
42184699|NCT03039790|75993839|FG001|Overall Study|Reason, not Specified|0|||
42184700|NCT03039790|75993840|FG002|Overall Study|Reason, not Specified|0|||
42184701|NCT03039790|75993841|FG003|Overall Study|Reason, not Specified|0|||
42184702|NCT03039790|75993842|FG004|Overall Study|Reason, not Specified|0|||
42184703|NCT03039790|75993843|FG005|Overall Study|Reason, not Specified|0|||
42184704|NCT03039790|75993844|FG006|Overall Study|Reason, not Specified|0|||
42184705|NCT03039790|75993845|FG007|Overall Study|Reason, not Specified|0|||
42184706|NCT03039790|75993846|FG008|Overall Study|Reason, not Specified|0|||
42184707|NCT03039790|75993847|FG009|Overall Study|Reason, not Specified|0|||
42184708|NCT03039790|75993848|FG010|Overall Study|Reason, not Specified|0|||
42184709|NCT03039790|75993849|FG011|Overall Study|Reason, not Specified|0|||
42184710|NCT03039790|75993850|FG012|Overall Study|Reason, not Specified|0|||
42184711|NCT03039790|75993851|FG013|Overall Study|Reason, not Specified|0|||
42184712|NCT03039790|75993852|FG014|Overall Study|Reason, not Specified|0|||
42091743|NCT00734162|75902047|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
42184713|NCT03039790|75993853|FG015|Overall Study|Reason, not Specified|0|||
42184714|NCT03039790|75993854|FG016|Overall Study|Reason, not Specified|2|||
42184715|NCT03039790|75993855|FG017|Overall Study|Reason, not Specified|0|||
42184716|NCT03039790|75993856|FG018|Overall Study|Reason, not Specified|1|||
42184717|NCT03039790|75993857|FG019|Overall Study|Reason, not Specified|0|||
42184718|NCT03038620|75993930|FG000|Overall Study|Lost to Follow-up|18|||
42184719|NCT03038620|75993931|FG001|Overall Study|Lost to Follow-up|23|||
42184720|NCT03038620|75993930|FG000|Overall Study|Withdrawal by Subject|0|||
42184721|NCT03038620|75993931|FG001|Overall Study|Withdrawal by Subject|15|||
42295139|NCT02474589|76129596|FG000|Overall Study|Lost to Follow-up|6|||
42295140|NCT02474589|76129597|FG001|Overall Study|Lost to Follow-up|1|||
42295141|NCT02474589|76129596|FG000|Overall Study|Protocol Violation|4|||
42295142|NCT02474589|76129597|FG001|Overall Study|Protocol Violation|1|||
42295143|NCT02474589|76129596|FG000|Overall Study|Withdrawal by Subject|4|||
42295144|NCT02474589|76129597|FG001|Overall Study|Withdrawal by Subject|0|||
42295145|NCT02474589|76129596|FG000|Overall Study|Inability to complete study procedures|5|||
42295146|NCT02474589|76129597|FG001|Overall Study|Inability to complete study procedures|1|||
42295147|NCT02586233|76129610|FG000|Overall Study|Randomized but did not receive treatment|0|||
42184722|NCT03038620|75993930|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
42184723|NCT03038620|75993931|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
42358894|NCT03650413|76204581|FG000|Overall Study|Lack of Efficacy|17|||
42358895|NCT03650413|76204581|FG000|Overall Study|Other|9|||
42358896|NCT03650413|76204581|FG000|Overall Study|Physician Decision|2|||
42358897|NCT03650413|76204581|FG000|Overall Study|Study Terminated By Sponsor|16|||
42358898|NCT03650413|76204581|FG000|Overall Study|Withdrawal by Subject|16|||
42358899|NCT03596242|76204591|FG000|Overall Study|Lost to Follow-up|2|||
42358900|NCT03596242|76204592|FG001|Overall Study|Lost to Follow-up|2|||
42358901|NCT03514017|76204598|FG000|Overall Study|Death|1|||
42358902|NCT03514017|76204598|FG000|Overall Study|Adverse Event|1|||
42358903|NCT03471078|76204604|FG000|Overall Study|Withdrawal by Subject|9|||
42358904|NCT03471078|76204605|FG001|Overall Study|Withdrawal by Subject|1|||
42358905|NCT03471078|76204604|FG000|Overall Study|Adverse Event|4|||
42358906|NCT03471078|76204605|FG001|Overall Study|Adverse Event|1|||
42358907|NCT03471078|76204604|FG000|Overall Study|Physician Decision|3|||
42295148|NCT02586233|76129611|FG001|Overall Study|Randomized but did not receive treatment|1|||
42295149|NCT02586233|76129612|FG002|Overall Study|Randomized but did not receive treatment|0|||
42295150|NCT02586233|76129613|FG003|Overall Study|Randomized but did not receive treatment|0|||
42295151|NCT02586233|76129614|FG004|Overall Study|Randomized but did not receive treatment|0|||
42295152|NCT02586233|76129615|FG005|Overall Study|Randomized but did not receive treatment|2|||
42295153|NCT02586233|76129616|FG006|Overall Study|Randomized but did not receive treatment|2|||
42295154|NCT02586233|76129610|FG000|Overall Study|Death|0|||
42295155|NCT02586233|76129611|FG001|Overall Study|Death|1|||
42295156|NCT02586233|76129612|FG002|Overall Study|Death|0|||
42184724|NCT01350934|75993952|FG000|Base Study|Adverse Event|6|||
42184725|NCT01350934|75993953|FG001|Base Study|Adverse Event|0|||
42184726|NCT01350934|75993952|FG000|Base Study|Lost to Follow-up|1|||
42184727|NCT01350934|75993953|FG001|Base Study|Lost to Follow-up|0|||
42184728|NCT01350934|75993952|FG000|Base Study|Protocol Violation|1|||
42184729|NCT01350934|75993953|FG001|Base Study|Protocol Violation|1|||
42184730|NCT01350934|75993952|FG000|Base Study|Withdrawal by Subject|1|||
42017977|NCT01261793|75825729|FG002|Overall Study|Protocol Violation|6|||
42017978|NCT01261793|75825727|FG000|Overall Study|Lost to Follow-up|10|||
42017979|NCT01261793|75825728|FG001|Overall Study|Lost to Follow-up|3|||
42017980|NCT01261793|75825729|FG002|Overall Study|Lost to Follow-up|7|||
42295157|NCT02586233|76129613|FG003|Overall Study|Death|0|||
42295158|NCT02586233|76129614|FG004|Overall Study|Death|2|||
42295159|NCT02586233|76129615|FG005|Overall Study|Death|0|||
42295160|NCT02586233|76129616|FG006|Overall Study|Death|0|||
42295161|NCT02474355|76129636|FG000|Overall Study|Other|43|||
42295162|NCT02474355|76129636|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
42295163|NCT02474355|76129636|FG000|Overall Study|Lost to Follow-up|98|||
42295164|NCT02474355|76129636|FG000|Overall Study|Withdrawal by Subject|124|||
42295165|NCT02474355|76129636|FG000|Overall Study|Death|1361|||
42295166|NCT02474199|76129642|FG000|Overall Study|Lost to Follow-up|1|||
42295167|NCT02474199|76129643|FG001|Overall Study|Lost to Follow-up|0|||
42295168|NCT02474199|76129644|FG002|Overall Study|Lost to Follow-up|0|||
42295169|NCT02474199|76129645|FG003|Overall Study|Lost to Follow-up|0|||
42295170|NCT02474199|76129642|FG000|Overall Study|Withdrawal by Subject|1|||
42295171|NCT02474199|76129643|FG001|Overall Study|Withdrawal by Subject|2|||
42295172|NCT02474199|76129644|FG002|Overall Study|Withdrawal by Subject|0|||
42295173|NCT02474199|76129645|FG003|Overall Study|Withdrawal by Subject|1|||
42295174|NCT02474199|76129642|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
42295175|NCT02474199|76129643|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
42295176|NCT02474199|76129644|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
42295177|NCT02474199|76129645|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
42295178|NCT02474199|76129642|FG000|Overall Study|Did not meet eligibility criteria|0|||
42358908|NCT03471078|76204605|FG001|Overall Study|Physician Decision|2|||
42017981|NCT01261793|75825727|FG000|Overall Study|Withdrawal by Subject|12|||
42017982|NCT01261793|75825728|FG001|Overall Study|Withdrawal by Subject|14|||
42017983|NCT01261793|75825729|FG002|Overall Study|Withdrawal by Subject|14|||
42017984|NCT01261793|75825727|FG000|Overall Study|Death|3|||
42017985|NCT01261793|75825728|FG001|Overall Study|Death|1|||
42358909|NCT03471078|76204604|FG000|Overall Study|Death|2|||
42184731|NCT01350934|75993953|FG001|Base Study|Withdrawal by Subject|2|||
42184732|NCT01350934|75993952|FG000|Base Study|Non-Compliance With Study Drug|2|||
42295179|NCT02474199|76129643|FG001|Overall Study|Did not meet eligibility criteria|0|||
42295180|NCT02474199|76129644|FG002|Overall Study|Did not meet eligibility criteria|2|||
42358910|NCT03471078|76204605|FG001|Overall Study|Death|0|||
42017986|NCT01261793|75825729|FG002|Overall Study|Death|0|||
42184733|NCT01350934|75993953|FG001|Base Study|Non-Compliance With Study Drug|0|||
42295181|NCT02474199|76129645|FG003|Overall Study|Did not meet eligibility criteria|2|||
42295182|NCT02450487|76129652|FG000|Overall Study|Lost to Follow-up|3|||
42295183|NCT02473965|76129659|FG000|Overall Study|Adverse Event|6|||
42295184|NCT02473965|76129660|FG001|Overall Study|Adverse Event|4|||
42358911|NCT03471078|76204604|FG000|Overall Study|Other|3|||
42358912|NCT03471078|76204605|FG001|Overall Study|Other|2|||
42358913|NCT03308188|76204643|FG000|Overall Study|Withdrawal by Subject|0|||
42358914|NCT03308188|76204644|FG001|Overall Study|Withdrawal by Subject|3|||
42358915|NCT03308188|76204643|FG000|Overall Study|Death|0|||
42358916|NCT03308188|76204644|FG001|Overall Study|Death|1|||
42358917|NCT03113968|76204665|FG000|Overall Study|Withdrawal by Subject|31|||
42358918|NCT03113968|76204666|FG001|Overall Study|Withdrawal by Subject|4|||
42358919|NCT02864251|76204675|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
42358920|NCT02864251|76204676|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
42358921|NCT02864251|76204677|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
42358922|NCT02864251|76204675|FG000|Pre-Treatment|Withdrawal by Participant|0|||
42358923|NCT02864251|76204676|FG001|Pre-Treatment|Withdrawal by Participant|0|||
42358924|NCT02864251|76204677|FG002|Pre-Treatment|Withdrawal by Participant|4|||
42358925|NCT02864251|76204675|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
42091744|NCT00734162|75902048|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
42091745|NCT00734162|75902049|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
42091746|NCT00790751|75902067|FG000|Overall Study|Protocol non-compliance|16|||
42091747|NCT00790751|75902068|FG001|Overall Study|Protocol non-compliance|16|||
42091748|NCT00790751|75902069|FG002|Overall Study|Protocol non-compliance|10|||
42091749|NCT00790751|75902070|FG003|Overall Study|Protocol non-compliance|11|||
42091750|NCT00790751|75902067|FG000|Overall Study|Lost to Follow-up|4|||
42091751|NCT00790751|75902068|FG001|Overall Study|Lost to Follow-up|9|||
42091752|NCT00790751|75902069|FG002|Overall Study|Lost to Follow-up|4|||
42091753|NCT00790751|75902070|FG003|Overall Study|Lost to Follow-up|5|||
42091754|NCT00790751|75902067|FG000|Overall Study|Adverse Event|5|||
42091755|NCT00790751|75902068|FG001|Overall Study|Adverse Event|3|||
42091756|NCT00790751|75902069|FG002|Overall Study|Adverse Event|5|||
42091757|NCT00790751|75902070|FG003|Overall Study|Adverse Event|4|||
42091758|NCT00790751|75902067|FG000|Overall Study|Requirement for restricted medication|0|||
42091759|NCT00790751|75902068|FG001|Overall Study|Requirement for restricted medication|2|||
42091760|NCT00790751|75902069|FG002|Overall Study|Requirement for restricted medication|0|||
42184734|NCT01350934|75993952|FG000|Extension Study|Adverse Event|2|||
42184735|NCT01350934|75993953|FG001|Extension Study|Adverse Event|1|||
42184736|NCT01350934|75993952|FG000|Extension Study|Lost to Follow-up|2|||
42184737|NCT01350934|75993953|FG001|Extension Study|Lost to Follow-up|0|||
42184738|NCT01350934|75993952|FG000|Extension Study|Protocol Violation|1|||
42184739|NCT01350934|75993953|FG001|Extension Study|Protocol Violation|1|||
42184740|NCT01350934|75993952|FG000|Extension Study|Lack of Efficacy|0|||
42184741|NCT01350934|75993953|FG001|Extension Study|Lack of Efficacy|1|||
42184742|NCT01350934|75993952|FG000|Extension Study|Withdrawal by Subject|0|||
42184743|NCT01350934|75993953|FG001|Extension Study|Withdrawal by Subject|1|||
42184744|NCT03622580|75993977|FG000|Overall Study|Death|16|||
42184745|NCT03622580|75993978|FG001|Overall Study|Death|21|||
42184746|NCT03622580|75993979|FG002|Overall Study|Death|13|||
42184747|NCT03622580|75993977|FG000|Overall Study|Adverse Event|6|||
42184748|NCT03622580|75993978|FG001|Overall Study|Adverse Event|6|||
42184749|NCT03622580|75993979|FG002|Overall Study|Adverse Event|5|||
42184750|NCT03622580|75993977|FG000|Overall Study|Withdrawal by Subject|12|||
42184751|NCT03622580|75993978|FG001|Overall Study|Withdrawal by Subject|7|||
42184752|NCT03622580|75993979|FG002|Overall Study|Withdrawal by Subject|19|||
42184753|NCT03622580|75993977|FG000|Overall Study|Lost to Follow-up|12|||
42295185|NCT02473965|76129659|FG000|Overall Study|MG worsening|4|||
42295186|NCT02473965|76129660|FG001|Overall Study|MG worsening|1|||
42295187|NCT02473965|76129659|FG000|Overall Study|Withdrawal by Subject|2|||
42295188|NCT02473965|76129660|FG001|Overall Study|Withdrawal by Subject|3|||
42295189|NCT02473965|76129659|FG000|Overall Study|Physician Decision|0|||
42295190|NCT02473965|76129660|FG001|Overall Study|Physician Decision|2|||
42295191|NCT02472795|76129671|FG000|Overall Study|Adverse Event|0|||
42295192|NCT02472795|76129672|FG001|Overall Study|Adverse Event|1|||
42295193|NCT02472795|76129673|FG002|Overall Study|Adverse Event|0|||
42295194|NCT02472795|76129674|FG003|Overall Study|Adverse Event|0|||
42295195|NCT02472795|76129675|FG004|Overall Study|Adverse Event|2|||
42358926|NCT02864251|76204676|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
42358927|NCT02864251|76204677|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
42358928|NCT02864251|76204675|FG000|Pre-Treatment|Other Reasons|0|||
42295196|NCT02472795|76129671|FG000|Overall Study|Withdrawal by Subject|0|||
42358929|NCT02864251|76204676|FG001|Pre-Treatment|Other Reasons|1|||
42358930|NCT02864251|76204677|FG002|Pre-Treatment|Other Reasons|1|||
42017987|NCT01261793|75825727|FG000|Overall Study|Adverse Event|9|||
42017988|NCT01261793|75825728|FG001|Overall Study|Adverse Event|24|||
42017989|NCT01261793|75825729|FG002|Overall Study|Adverse Event|19|||
42017990|NCT01261793|75825727|FG000|Overall Study|Patient non-availability|1|||
42017991|NCT01261793|75825728|FG001|Overall Study|Patient non-availability|1|||
42017992|NCT01261793|75825729|FG002|Overall Study|Patient non-availability|1|||
42017993|NCT01261793|75825727|FG000|Overall Study|Suspected pregnancy|1|||
42017994|NCT01261793|75825728|FG001|Overall Study|Suspected pregnancy|1|||
42017995|NCT01261793|75825729|FG002|Overall Study|Suspected pregnancy|0|||
42017996|NCT01261793|75825727|FG000|Overall Study|Patient non-compliance|1|||
42295197|NCT02472795|76129672|FG001|Overall Study|Withdrawal by Subject|0|||
42295198|NCT02472795|76129673|FG002|Overall Study|Withdrawal by Subject|0|||
42295199|NCT02472795|76129674|FG003|Overall Study|Withdrawal by Subject|0|||
42295200|NCT02472795|76129675|FG004|Overall Study|Withdrawal by Subject|1|||
42295201|NCT02507349|76129689|FG000|Overall Study|Death|12|||
42295202|NCT02507349|76129690|FG001|Overall Study|Death|16|||
42295203|NCT02507349|76129689|FG000|Overall Study|Withdrawal by Subject|1|||
42295204|NCT02507349|76129690|FG001|Overall Study|Withdrawal by Subject|1|||
42295205|NCT02507349|76129689|FG000|Overall Study|Lost to Follow-up|174|||
42295206|NCT02507349|76129690|FG001|Overall Study|Lost to Follow-up|144|||
42295207|NCT02506881|76129700|FG000|First Intervention (Day 1)|Protocol Violation|0|||
42295208|NCT02506881|76129701|FG001|First Intervention (Day 1)|Protocol Violation|0|||
42295209|NCT02506881|76129702|FG002|First Intervention (Day 1)|Protocol Violation|1|||
42295210|NCT02506881|76129703|FG003|First Intervention (Day 1)|Protocol Violation|0|||
42295211|NCT02506881|76129700|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
42295212|NCT02506881|76129701|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
42295213|NCT02506881|76129702|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
42295214|NCT02506881|76129703|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
42295215|NCT02506881|76129700|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
42295216|NCT02506881|76129701|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
42295217|NCT02506881|76129702|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
42295218|NCT02506881|76129703|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
42295219|NCT02506257|76129727|FG000|Overall Study|Adverse Event|0|||
42091761|NCT00790751|75902070|FG003|Overall Study|Requirement for restricted medication|0|||
42091762|NCT00790751|75902067|FG000|Overall Study|Death|0|||
42091763|NCT00790751|75902068|FG001|Overall Study|Death|0|||
42091764|NCT00790751|75902069|FG002|Overall Study|Death|1|||
42091765|NCT00790751|75902070|FG003|Overall Study|Death|0|||
42091766|NCT00790751|75902067|FG000|Overall Study|Physician Decision|0|||
42091767|NCT00790751|75902068|FG001|Overall Study|Physician Decision|0|||
42091768|NCT00790751|75902069|FG002|Overall Study|Physician Decision|0|||
42091769|NCT00790751|75902070|FG003|Overall Study|Physician Decision|1|||
42091770|NCT00784979|75902080|FG000|Overall Study|incomplete data|6|||
42091771|NCT00738920|75902087|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
42091772|NCT00738920|75902088|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
42091773|NCT00738920|75902089|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
42091774|NCT00738920|75902087|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
42295220|NCT02506257|76129728|FG001|Overall Study|Adverse Event|2|||
42295221|NCT02506257|76129729|FG002|Overall Study|Adverse Event|3|||
42295222|NCT02506257|76129730|FG003|Overall Study|Adverse Event|0|||
42295223|NCT02506257|76129727|FG000|Overall Study|Protocol Violation|0|||
42295224|NCT02506257|76129728|FG001|Overall Study|Protocol Violation|0|||
42295225|NCT02506257|76129729|FG002|Overall Study|Protocol Violation|1|||
42295226|NCT02506257|76129730|FG003|Overall Study|Protocol Violation|0|||
42295227|NCT02506101|76129742|FG000|Overall Study|Transportation issues|1|||
42295228|NCT02506101|76129743|FG001|Overall Study|Transportation issues|0|||
42295229|NCT02506101|76129742|FG000|Overall Study|No enrollment and staff unavailability|1|||
42091775|NCT00738920|75902088|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
42091776|NCT00738920|75902089|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
42091777|NCT00738920|75902087|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
42091778|NCT00738920|75902088|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
42091779|NCT00738920|75902089|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
42091780|NCT00738920|75902087|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
42091781|NCT00738920|75902088|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
42091782|NCT00738920|75902089|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
42091783|NCT00738920|75902087|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
42091784|NCT00738920|75902088|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
42091785|NCT00738920|75902089|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
42091786|NCT00738920|75902087|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
42091787|NCT00738920|75902088|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
42091788|NCT00738920|75902089|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
42091789|NCT00738920|75902087|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
42091790|NCT00738920|75902088|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
42091791|NCT00738920|75902089|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
42295230|NCT02506101|76129743|FG001|Overall Study|No enrollment and staff unavailability|0|||
42295231|NCT01671007|76129758|FG000|Overall Study|Other reasons than listed|166|||
42295232|NCT01671007|76129759|FG001|Overall Study|Other reasons than listed|373|||
42358931|NCT02864251|76204675|FG000|Treatment|Disease Progression|109|||
42091792|NCT00738920|75902087|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
42091793|NCT00738920|75902088|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
42184754|NCT03622580|75993978|FG001|Overall Study|Lost to Follow-up|9|||
42184755|NCT03622580|75993979|FG002|Overall Study|Lost to Follow-up|9|||
42184756|NCT03622580|75993977|FG000|Overall Study|Protocol Violation|1|||
42184757|NCT03622580|75993978|FG001|Overall Study|Protocol Violation|0|||
42184758|NCT03622580|75993979|FG002|Overall Study|Protocol Violation|1|||
42184759|NCT03622580|75993977|FG000|Overall Study|Physician Decision|3|||
42184760|NCT03622580|75993978|FG001|Overall Study|Physician Decision|0|||
42184761|NCT03622580|75993979|FG002|Overall Study|Physician Decision|1|||
42184762|NCT03622580|75993977|FG000|Overall Study|Pregnancy|0|||
42184763|NCT03622580|75993978|FG001|Overall Study|Pregnancy|1|||
42184764|NCT03622580|75993979|FG002|Overall Study|Pregnancy|0|||
42184765|NCT03622580|75993977|FG000|Overall Study|Lack of Efficacy|0|||
42184766|NCT03622580|75993978|FG001|Overall Study|Lack of Efficacy|0|||
42184767|NCT03622580|75993979|FG002|Overall Study|Lack of Efficacy|1|||
42184768|NCT03622580|75993977|FG000|Overall Study|Other|2|||
42184769|NCT03622580|75993978|FG001|Overall Study|Other|0|||
42184770|NCT03622580|75993979|FG002|Overall Study|Other|3|||
42184771|NCT00461032|75993990|FG000|Overall Study|Adverse Event|5|||
42184772|NCT00461032|75993991|FG001|Overall Study|Adverse Event|6|||
42184773|NCT00461032|75993990|FG000|Overall Study|Lack of Efficacy|5|||
42184774|NCT00461032|75993991|FG001|Overall Study|Lack of Efficacy|1|||
42184775|NCT00461032|75993990|FG000|Overall Study|Lost to Follow-up|7|||
42184776|NCT00461032|75993991|FG001|Overall Study|Lost to Follow-up|12|||
42184777|NCT00461032|75993990|FG000|Overall Study|Protocol Violation|4|||
42184778|NCT00461032|75993991|FG001|Overall Study|Protocol Violation|4|||
42184779|NCT00461032|75993990|FG000|Overall Study|Withdrawal by Subject|7|||
42184780|NCT00461032|75993991|FG001|Overall Study|Withdrawal by Subject|15|||
42184781|NCT00461032|75993990|FG000|Overall Study|Patient Moved or Relocated|2|||
42184782|NCT00461032|75993991|FG001|Overall Study|Patient Moved or Relocated|1|||
42184783|NCT00461032|75993990|FG000|Overall Study|Other|7|||
42184784|NCT00461032|75993991|FG001|Overall Study|Other|5|||
42184785|NCT00090142|75993997|FG000|Treatment Period I|Lost to Follow-up|1|||
42184786|NCT00090142|75993998|FG001|Treatment Period I|Lost to Follow-up|2|||
42184787|NCT00090142|75993997|FG000|Treatment Period I|Protocol Violation|2|||
42184788|NCT00090142|75993998|FG001|Treatment Period I|Protocol Violation|0|||
42184789|NCT00090142|75993997|FG000|Treatment Period I|Withdrawal by Subject|2|||
42184790|NCT00090142|75993998|FG001|Treatment Period I|Withdrawal by Subject|0|||
42184791|NCT00090142|75993997|FG000|Treatment Period I|Other|0|||
42184792|NCT00090142|75993998|FG001|Treatment Period I|Other|1|||
42184793|NCT00090142|75993997|FG000|Treatment Period II|Other|1|||
42184794|NCT00090142|75993998|FG001|Treatment Period II|Other|0|||
42184795|NCT03622112|75994015|FG000|Overall Study|Withdrawal by Subject|6|||
42184796|NCT03622112|75994016|FG001|Overall Study|Withdrawal by Subject|2|||
42184797|NCT03622112|75994017|FG002|Overall Study|Withdrawal by Subject|4|||
42184798|NCT03622112|75994018|FG003|Overall Study|Withdrawal by Subject|2|||
42184799|NCT03622112|75994019|FG004|Overall Study|Withdrawal by Subject|1|||
42184800|NCT03622112|75994020|FG005|Overall Study|Withdrawal by Subject|2|||
42184801|NCT03622112|75994021|FG006|Overall Study|Withdrawal by Subject|2|||
42184802|NCT03622112|75994015|FG000|Overall Study|Death|0|||
42295233|NCT01671007|76129760|FG002|Overall Study|Other reasons than listed|197|||
42091794|NCT00738920|75902089|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
42091795|NCT00738920|75902087|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
42091796|NCT00738920|75902088|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
42091797|NCT00738920|75902089|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
42091798|NCT00738920|75902087|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
42091799|NCT00738920|75902088|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
42091800|NCT00738920|75902089|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
42091801|NCT00582972|75902097|FG000|Overall Study|Protocol Violation|2|||
42091802|NCT04319718|75902104|FG000|Overall Study|Adverse Event|0|||
42091803|NCT04319718|75902105|FG001|Overall Study|Adverse Event|2|||
42091804|NCT04319718|75902104|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
42091805|NCT04319718|75902105|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
42091806|NCT04372602|75902113|FG000|Overall Study|Withdrawal by Subject|1|||
42184803|NCT03622112|75994016|FG001|Overall Study|Death|0|||
42184804|NCT03622112|75994017|FG002|Overall Study|Death|0|||
42184805|NCT03622112|75994018|FG003|Overall Study|Death|1|||
42184806|NCT03622112|75994019|FG004|Overall Study|Death|0|||
42184807|NCT03622112|75994020|FG005|Overall Study|Death|0|||
42184808|NCT03622112|75994021|FG006|Overall Study|Death|0|||
42184809|NCT03622112|75994015|FG000|Overall Study|Lost to Follow-up|1|||
42184810|NCT03622112|75994016|FG001|Overall Study|Lost to Follow-up|1|||
42184811|NCT03622112|75994017|FG002|Overall Study|Lost to Follow-up|0|||
42184812|NCT03622112|75994018|FG003|Overall Study|Lost to Follow-up|0|||
42184813|NCT03622112|75994019|FG004|Overall Study|Lost to Follow-up|0|||
42184814|NCT03622112|75994020|FG005|Overall Study|Lost to Follow-up|0|||
42184815|NCT03622112|75994021|FG006|Overall Study|Lost to Follow-up|0|||
42295234|NCT01671007|76129761|FG003|Overall Study|Other reasons than listed|228|||
42184816|NCT03622112|75994015|FG000|Overall Study|Study-specific withdrawal criteria|10|||
42184817|NCT03622112|75994016|FG001|Overall Study|Study-specific withdrawal criteria|8|||
42184818|NCT03622112|75994017|FG002|Overall Study|Study-specific withdrawal criteria|7|||
42184819|NCT03622112|75994018|FG003|Overall Study|Study-specific withdrawal criteria|6|||
42184820|NCT03622112|75994019|FG004|Overall Study|Study-specific withdrawal criteria|4|||
42184821|NCT03622112|75994020|FG005|Overall Study|Study-specific withdrawal criteria|18|||
42184822|NCT03622112|75994021|FG006|Overall Study|Study-specific withdrawal criteria|4|||
42091807|NCT04372602|75902114|FG001|Overall Study|Withdrawal by Subject|1|||
42091808|NCT04372602|75902113|FG000|Overall Study|Adverse Event|0|||
42091809|NCT04372602|75902114|FG001|Overall Study|Adverse Event|1|||
42091810|NCT04372602|75902113|FG000|Overall Study|Transitioned to comfort care|0|||
42091811|NCT04372602|75902114|FG001|Overall Study|Transitioned to comfort care|1|||
42091812|NCT00733304|75902123|FG000|Overall Study|Adverse Event|3|||
42091813|NCT00733304|75902124|FG001|Overall Study|Adverse Event|0|||
42091814|NCT00733304|75902125|FG002|Overall Study|Adverse Event|0|||
42091815|NCT00733304|75902123|FG000|Overall Study|Lack of Efficacy|0|||
42091816|NCT00733304|75902124|FG001|Overall Study|Lack of Efficacy|0|||
42091817|NCT00733304|75902125|FG002|Overall Study|Lack of Efficacy|2|||
42091818|NCT00733304|75902123|FG000|Overall Study|Lost to Follow-up|0|||
42091819|NCT00733304|75902124|FG001|Overall Study|Lost to Follow-up|1|||
42091820|NCT00733304|75902125|FG002|Overall Study|Lost to Follow-up|0|||
42091821|NCT00733304|75902123|FG000|Overall Study|Physician Decision|3|||
42091822|NCT00733304|75902124|FG001|Overall Study|Physician Decision|1|||
42091823|NCT00733304|75902125|FG002|Overall Study|Physician Decision|3|||
42091824|NCT00733304|75902123|FG000|Overall Study|Withdrawal by Subject|1|||
42184823|NCT03622112|75994015|FG000|Overall Study|Protocol Violation|2|||
42184824|NCT03622112|75994016|FG001|Overall Study|Protocol Violation|0|||
42184825|NCT03622112|75994017|FG002|Overall Study|Protocol Violation|1|||
42184826|NCT03622112|75994018|FG003|Overall Study|Protocol Violation|1|||
42184827|NCT03622112|75994019|FG004|Overall Study|Protocol Violation|0|||
42184828|NCT03622112|75994020|FG005|Overall Study|Protocol Violation|0|||
42184829|NCT03622112|75994021|FG006|Overall Study|Protocol Violation|0|||
42184830|NCT03622112|75994015|FG000|Overall Study|Adverse Event|6|||
42184831|NCT03622112|75994016|FG001|Overall Study|Adverse Event|8|||
42184832|NCT03622112|75994017|FG002|Overall Study|Adverse Event|4|||
42184833|NCT03622112|75994018|FG003|Overall Study|Adverse Event|11|||
42184834|NCT03622112|75994019|FG004|Overall Study|Adverse Event|4|||
42184835|NCT03622112|75994020|FG005|Overall Study|Adverse Event|20|||
42184836|NCT03622112|75994021|FG006|Overall Study|Adverse Event|2|||
42184837|NCT03622112|75994015|FG000|Overall Study|Reason not specified|0|||
42184838|NCT03622112|75994016|FG001|Overall Study|Reason not specified|1|||
42184839|NCT03622112|75994017|FG002|Overall Study|Reason not specified|0|||
42184840|NCT03622112|75994018|FG003|Overall Study|Reason not specified|1|||
42184841|NCT03622112|75994019|FG004|Overall Study|Reason not specified|1|||
42184842|NCT03622112|75994020|FG005|Overall Study|Reason not specified|2|||
42184843|NCT03622112|75994021|FG006|Overall Study|Reason not specified|1|||
42184844|NCT04032158|75994039|FG000|Overall Study|Study Termination|2|||
42184845|NCT04032158|75994040|FG001|Overall Study|Study Termination|1|||
42184846|NCT03620708|75994049|FG000|Overall Study|Lost to Follow-up|1|||
42295235|NCT01671007|76129762|FG004|Overall Study|Other reasons than listed|14|||
42295236|NCT01671007|76129763|FG005|Overall Study|Other reasons than listed|71|||
42295237|NCT01671007|76129764|FG006|Overall Study|Other reasons than listed|17|||
42091825|NCT00733304|75902124|FG001|Overall Study|Withdrawal by Subject|1|||
42295238|NCT01671007|76129765|FG007|Overall Study|Other reasons than listed|66|||
42295239|NCT01671007|76129766|FG008|Overall Study|Other reasons than listed|0|||
42295240|NCT01671007|76129758|FG000|Overall Study|Withdrawal by Subject|36|||
42295241|NCT01671007|76129759|FG001|Overall Study|Withdrawal by Subject|59|||
42091826|NCT00733304|75902125|FG002|Overall Study|Withdrawal by Subject|0|||
42091827|NCT00711243|75902139|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
42091828|NCT00711243|75902140|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
42091829|NCT00711243|75902141|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
42091830|NCT00711243|75902142|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
42091831|NCT00711243|75902143|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
42091832|NCT00711243|75902144|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
42091833|NCT00711243|75902139|FG000|Reached First Response/4 Cycles|Death|0|||
42091834|NCT00711243|75902140|FG001|Reached First Response/4 Cycles|Death|0|||
42091835|NCT00711243|75902141|FG002|Reached First Response/4 Cycles|Death|0|||
42091836|NCT00711243|75902142|FG003|Reached First Response/4 Cycles|Death|0|||
42091837|NCT00711243|75902143|FG004|Reached First Response/4 Cycles|Death|0|||
42091838|NCT00711243|75902144|FG005|Reached First Response/4 Cycles|Death|2|||
42184847|NCT03620708|75994050|FG001|Overall Study|Lost to Follow-up|1|||
42184848|NCT03620708|75994051|FG002|Overall Study|Lost to Follow-up|2|||
42184849|NCT03620708|75994049|FG000|Overall Study|Withdrawal by Subject|0|||
42184850|NCT03620708|75994050|FG001|Overall Study|Withdrawal by Subject|0|||
42184851|NCT03620708|75994051|FG002|Overall Study|Withdrawal by Subject|1|||
42184852|NCT03654326|75994061|FG000|Overall Study|Withdrawal by Subject|5|||
42184853|NCT03654326|75994062|FG001|Overall Study|Withdrawal by Subject|3|||
42184854|NCT03654326|75994061|FG000|Overall Study|Physician Decision|0|||
42184855|NCT03654326|75994062|FG001|Overall Study|Physician Decision|1|||
42184856|NCT03654326|75994061|FG000|Overall Study|Unable to adhere to study schedule|0|||
42184857|NCT03654326|75994062|FG001|Overall Study|Unable to adhere to study schedule|1|||
42184858|NCT03654326|75994061|FG000|Overall Study|Lost to Follow-up|1|||
42184859|NCT03654326|75994062|FG001|Overall Study|Lost to Follow-up|1|||
42184860|NCT04025684|75994072|FG000|Overall Study|Withdrawal by Subject|1|||
42184861|NCT04025684|75994073|FG001|Overall Study|Withdrawal by Subject|1|||
42184862|NCT04025684|75994074|FG002|Overall Study|Withdrawal by Subject|0|||
42184863|NCT04025684|75994075|FG003|Overall Study|Withdrawal by Subject|0|||
42184864|NCT04025684|75994072|FG000|Overall Study|Multiple reasons|1|||
42184865|NCT04025684|75994073|FG001|Overall Study|Multiple reasons|3|||
42184866|NCT04025684|75994074|FG002|Overall Study|Multiple reasons|0|||
42184867|NCT04025684|75994075|FG003|Overall Study|Multiple reasons|1|||
42184868|NCT03617588|75994087|FG000|Overall Study|Withdrawal by Subject|1|||
42184869|NCT03617588|75994088|FG001|Overall Study|Withdrawal by Subject|0|||
42184870|NCT03616106|75994100|FG000|Overall Study|Removed by PI|6|||
42358932|NCT02864251|76204676|FG001|Treatment|Disease Progression|52|||
42017997|NCT01261793|75825728|FG001|Overall Study|Patient non-compliance|0|||
42017998|NCT01261793|75825729|FG002|Overall Study|Patient non-compliance|1|||
42017999|NCT01261793|75825727|FG000|Overall Study|Patient pregnant|1|||
42018000|NCT01261793|75825728|FG001|Overall Study|Patient pregnant|0|||
42018001|NCT01261793|75825729|FG002|Overall Study|Patient pregnant|0|||
42018002|NCT01261793|75825727|FG000|Overall Study|Outside the study area|0|||
42018003|NCT01261793|75825728|FG001|Overall Study|Outside the study area|2|||
42018004|NCT01261793|75825729|FG002|Overall Study|Outside the study area|1|||
42091839|NCT00711243|75902139|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
42091840|NCT00711243|75902140|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
42091841|NCT00711243|75902141|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
42091842|NCT00711243|75902142|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
42091843|NCT00711243|75902143|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
42091844|NCT00711243|75902144|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
42091845|NCT00711243|75902139|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
42091846|NCT00711243|75902140|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
42091847|NCT00711243|75902141|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
42091848|NCT00711243|75902142|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
42091849|NCT00711243|75902143|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
42091850|NCT00711243|75902144|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
42091851|NCT00711243|75902139|FG000|Treated Cycle 5 After First Response|Death|0|||
42091852|NCT00711243|75902140|FG001|Treated Cycle 5 After First Response|Death|0|||
42091853|NCT00711243|75902141|FG002|Treated Cycle 5 After First Response|Death|0|||
42091854|NCT00711243|75902142|FG003|Treated Cycle 5 After First Response|Death|0|||
42091855|NCT00711243|75902143|FG004|Treated Cycle 5 After First Response|Death|0|||
42091856|NCT00711243|75902144|FG005|Treated Cycle 5 After First Response|Death|2|||
42091857|NCT00711243|75902139|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
42091858|NCT00711243|75902140|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
42091859|NCT00711243|75902141|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
42091860|NCT00711243|75902142|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
42091861|NCT00711243|75902143|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
42091862|NCT00711243|75902144|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
42091863|NCT00711243|75902139|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
42091864|NCT00711243|75902140|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
42091865|NCT00711243|75902141|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
42091866|NCT00711243|75902142|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
42091867|NCT00711243|75902143|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
42091868|NCT00711243|75902144|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
42091869|NCT00733226|75902162|FG000|Overall Study|Withdrawal by Subject|1|||
42091870|NCT00733226|75902163|FG001|Overall Study|Withdrawal by Subject|0|||
42091871|NCT00733226|75902162|FG000|Overall Study|Lost to Follow-up|2|||
42091872|NCT00733226|75902163|FG001|Overall Study|Lost to Follow-up|0|||
42091873|NCT00733226|75902162|FG000|Overall Study|moved to another place|2|||
42091874|NCT00733226|75902163|FG001|Overall Study|moved to another place|0|||
42091875|NCT00732992|75902171|FG000|Overall Study|Adverse Event|1|||
42091876|NCT00732992|75902172|FG001|Overall Study|Adverse Event|1|||
42091877|NCT00732992|75902171|FG000|Overall Study|Objective Progression or Relapse|3|||
42091878|NCT00732992|75902172|FG001|Overall Study|Objective Progression or Relapse|5|||
42184871|NCT03616106|75994101|FG001|Overall Study|Removed by PI|0|||
42184872|NCT03616106|75994100|FG000|Overall Study|Withdrawal by Subject|1|||
42184873|NCT03616106|75994101|FG001|Overall Study|Withdrawal by Subject|1|||
42184874|NCT03616106|75994100|FG000|Overall Study|Lost to Follow-up|7|||
42184875|NCT03616106|75994101|FG001|Overall Study|Lost to Follow-up|0|||
42018005|NCT01261793|75825727|FG000|Overall Study|Lack of efficacy & patient not available|0|||
42184876|NCT04019054|75994108|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
42184877|NCT04019054|75994109|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
42184878|NCT04019054|75994108|FG000|Overall Study|Withdrawal by Subject|3|||
42184879|NCT04019054|75994109|FG001|Overall Study|Withdrawal by Subject|1|||
42184880|NCT00071799|75994117|FG000|Overall Study|Adverse Event|19|||
42184881|NCT00071799|75994118|FG001|Overall Study|Adverse Event|10|||
42184882|NCT00071799|75994117|FG000|Overall Study|Protocol Violation|1|||
42184883|NCT00071799|75994118|FG001|Overall Study|Protocol Violation|7|||
42184884|NCT00071799|75994117|FG000|Overall Study|Lost to Follow-up|1|||
42184885|NCT00071799|75994118|FG001|Overall Study|Lost to Follow-up|1|||
42184886|NCT00071799|75994117|FG000|Overall Study|Withdrawal by Subject|15|||
42184887|NCT00071799|75994118|FG001|Overall Study|Withdrawal by Subject|37|||
42184888|NCT00071799|75994117|FG000|Overall Study|Physician Decision|0|||
42184889|NCT00071799|75994118|FG001|Overall Study|Physician Decision|2|||
42184890|NCT00071799|75994117|FG000|Overall Study|Lack of Efficacy|11|||
42184891|NCT00071799|75994118|FG001|Overall Study|Lack of Efficacy|18|||
42018006|NCT01261793|75825728|FG001|Overall Study|Lack of efficacy & patient not available|1|||
42018007|NCT01261793|75825729|FG002|Overall Study|Lack of efficacy & patient not available|0|||
42018008|NCT01261793|75825727|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
42018009|NCT01261793|75825728|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
42018010|NCT01261793|75825729|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
42184892|NCT00071799|75994117|FG000|Overall Study|Disease Progression|23|||
42184893|NCT00071799|75994118|FG001|Overall Study|Disease Progression|20|||
42184894|NCT00071799|75994117|FG000|Overall Study|Different Central+Local Pathology Review|0|||
42184895|NCT00071799|75994118|FG001|Overall Study|Different Central+Local Pathology Review|1|||
42184896|NCT00071799|75994117|FG000|Overall Study|Not Documented|0|||
42184897|NCT00071799|75994118|FG001|Overall Study|Not Documented|2|||
42184898|NCT03615482|75994132|FG000|Overall Study|Death|1|||
42184899|NCT03615482|75994133|FG001|Overall Study|Death|0|||
42184900|NCT03615482|75994132|FG000|Overall Study|Lost to Follow-up|7|||
42184901|NCT03615482|75994133|FG001|Overall Study|Lost to Follow-up|7|||
42184902|NCT03615482|75994132|FG000|Overall Study|Physician Decision|2|||
42184903|NCT03615482|75994133|FG001|Overall Study|Physician Decision|3|||
42184904|NCT03615482|75994132|FG000|Overall Study|Withdrawal by Subject|7|||
42184905|NCT03615482|75994133|FG001|Overall Study|Withdrawal by Subject|7|||
42184906|NCT00090363|75994142|FG000|Overall Study|Lost to Follow-up|1|||
42184907|NCT00090363|75994143|FG001|Overall Study|Lost to Follow-up|2|||
42184908|NCT00090363|75994144|FG002|Overall Study|Lost to Follow-up|1|||
42184909|NCT00090363|75994142|FG000|Overall Study|Withdrawal by Subject|7|||
42184910|NCT00090363|75994143|FG001|Overall Study|Withdrawal by Subject|7|||
42018011|NCT01261793|75825727|FG000|Overall Study|Randomization error|0|||
42018012|NCT01261793|75825728|FG001|Overall Study|Randomization error|1|||
42018013|NCT01261793|75825729|FG002|Overall Study|Randomization error|0|||
42018014|NCT01261793|75825727|FG000|Overall Study|Patient unable to start IV line|0|||
42018015|NCT01261793|75825728|FG001|Overall Study|Patient unable to start IV line|0|||
42018016|NCT01261793|75825729|FG002|Overall Study|Patient unable to start IV line|1|||
42018017|NCT01261325|75825740|FG000|Overall Study|Lack of Efficacy|1|||
42018018|NCT01261325|75825741|FG001|Overall Study|Lack of Efficacy|1|||
42018019|NCT01261325|75825742|FG002|Overall Study|Lack of Efficacy|0|||
42018020|NCT01261325|75825740|FG000|Overall Study|Withdrawal by Subject|2|||
42018021|NCT01261325|75825741|FG001|Overall Study|Withdrawal by Subject|2|||
42018022|NCT01261325|75825742|FG002|Overall Study|Withdrawal by Subject|4|||
42018023|NCT01261325|75825740|FG000|Overall Study|SAE, non-fatal|1|||
42018024|NCT01261325|75825741|FG001|Overall Study|SAE, non-fatal|5|||
42091879|NCT00732992|75902171|FG000|Overall Study|Global Deterioration of Health Status|1|||
42091880|NCT00732992|75902172|FG001|Overall Study|Global Deterioration of Health Status|0|||
42091881|NCT00732992|75902171|FG000|Overall Study|Withdrawal by Subject|1|||
42091882|NCT00732992|75902172|FG001|Overall Study|Withdrawal by Subject|0|||
42091883|NCT00732758|75902181|FG000|Overall Study|Lost to Follow-up|8|||
42091884|NCT00732758|75902182|FG001|Overall Study|Lost to Follow-up|16|||
42091885|NCT00699153|75902190|FG000|Overall Study|Lost to Follow-up|1|||
42091886|NCT00699153|75902191|FG001|Overall Study|Lost to Follow-up|0|||
42091887|NCT00699153|75902190|FG000|Overall Study|Adverse Event|0|||
42091888|NCT00699153|75902191|FG001|Overall Study|Adverse Event|2|||
42091889|NCT00699153|75902190|FG000|Overall Study|Protocol Violation|1|||
42091890|NCT00699153|75902191|FG001|Overall Study|Protocol Violation|0|||
42091891|NCT00699153|75902190|FG000|Overall Study|Travel Problem|1|||
42091892|NCT00699153|75902191|FG001|Overall Study|Travel Problem|0|||
42091893|NCT00698997|75902199|FG000|Overall Study|Lost to Follow-up|3|||
42091894|NCT00698997|75902200|FG001|Overall Study|Lost to Follow-up|0|||
42184911|NCT00090363|75994144|FG002|Overall Study|Withdrawal by Subject|6|||
42184912|NCT00090363|75994142|FG000|Overall Study|Study-specific discontinuation criteria|75|||
42184913|NCT00090363|75994143|FG001|Overall Study|Study-specific discontinuation criteria|74|||
42184914|NCT00090363|75994144|FG002|Overall Study|Study-specific discontinuation criteria|62|||
42018025|NCT01261325|75825742|FG002|Overall Study|SAE, non-fatal|1|||
42091895|NCT00698997|75902199|FG000|Overall Study|Withdrawal by Subject|7|||
42091896|NCT00698997|75902200|FG001|Overall Study|Withdrawal by Subject|27|||
42091897|NCT00711087|75902209|FG000|Overall Study|Lost to Follow-up|1|||
42091898|NCT00711087|75902210|FG001|Overall Study|Lost to Follow-up|0|||
42091899|NCT00738530|75902218|FG000|Overall Study|Death|220|||
42091900|NCT00738530|75902219|FG001|Overall Study|Death|224|||
42091901|NCT00738530|75902218|FG000|Overall Study|Lost to Follow-up|8|||
42184915|NCT00090363|75994142|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42184916|NCT00090363|75994143|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
42184917|NCT00090363|75994144|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
42184918|NCT00090363|75994142|FG000|Overall Study|Consent expired|7|||
42184919|NCT00090363|75994143|FG001|Overall Study|Consent expired|10|||
42184920|NCT00090363|75994144|FG002|Overall Study|Consent expired|9|||
42184921|NCT00090363|75994142|FG000|Overall Study|Reasons not specified|2|||
42091902|NCT00738530|75902219|FG001|Overall Study|Lost to Follow-up|6|||
42091903|NCT00738530|75902218|FG000|Overall Study|Withdrawal by Subject|6|||
42091904|NCT00738530|75902219|FG001|Overall Study|Withdrawal by Subject|8|||
42091905|NCT00711009|75902227|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
42091906|NCT00711009|75902228|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
42091907|NCT00711009|75902227|FG000|Overall Study|Withdrawal by Subject|4|||
42091908|NCT00711009|75902228|FG001|Overall Study|Withdrawal by Subject|2|||
42091909|NCT00711009|75902227|FG000|Overall Study|Lost to Follow-up|3|||
42091910|NCT00711009|75902228|FG001|Overall Study|Lost to Follow-up|9|||
42184922|NCT00090363|75994143|FG001|Overall Study|Reasons not specified|1|||
42184923|NCT00090363|75994144|FG002|Overall Study|Reasons not specified|1|||
42184924|NCT00090363|75994142|FG000|Overall Study|Continuing on study off treatment|14|||
42184925|NCT00090363|75994143|FG001|Overall Study|Continuing on study off treatment|13|||
42184926|NCT00090363|75994144|FG002|Overall Study|Continuing on study off treatment|16|||
42184927|NCT03652610|75994154|FG000|Overall Study|Lost to Follow-up|1|||
42184928|NCT03652610|75994155|FG001|Overall Study|Lost to Follow-up|0|||
42184929|NCT03652610|75994154|FG000|Overall Study|Withdrawal by Subject|3|||
42184930|NCT03652610|75994155|FG001|Overall Study|Withdrawal by Subject|5|||
42184931|NCT03615404|75994161|FG000|Overall Study|Death|1|||
42184932|NCT03615404|75994161|FG000|Overall Study|vaccine did not pass quality assurance|1|||
42184933|NCT03614156|75994168|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
42184934|NCT03614156|75994169|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
42184935|NCT03614156|75994170|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
42184936|NCT03614156|75994171|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
42184937|NCT03614156|75994168|FG000|Open-Label Treatment Period|Adverse Event|7|||
42184938|NCT03614156|75994169|FG001|Open-Label Treatment Period|Adverse Event|0|||
42184939|NCT03614156|75994170|FG002|Open-Label Treatment Period|Adverse Event|0|||
42184940|NCT03614156|75994171|FG003|Open-Label Treatment Period|Adverse Event|0|||
42184941|NCT03614156|75994168|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
42184942|NCT03614156|75994169|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
42184943|NCT03614156|75994170|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
42184944|NCT03614156|75994171|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
42184945|NCT03614156|75994168|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
42184946|NCT03614156|75994169|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
42184947|NCT03614156|75994170|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
42184948|NCT03614156|75994171|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
42184949|NCT03614156|75994168|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
42184950|NCT03614156|75994169|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
42184951|NCT03614156|75994170|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
42184952|NCT03614156|75994171|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
42295242|NCT01671007|76129760|FG002|Overall Study|Withdrawal by Subject|53|||
42295243|NCT01671007|76129761|FG003|Overall Study|Withdrawal by Subject|58|||
42295244|NCT01671007|76129762|FG004|Overall Study|Withdrawal by Subject|4|||
42091911|NCT00711009|75902227|FG000|Overall Study|Participant Noncompliant|0|||
42091912|NCT00711009|75902228|FG001|Overall Study|Participant Noncompliant|1|||
42091913|NCT00711009|75902227|FG000|Overall Study|Virologic Failure|2|||
42091914|NCT00711009|75902228|FG001|Overall Study|Virologic Failure|1|||
42091915|NCT00711009|75902227|FG000|Overall Study|Pregnancy|1|||
42091916|NCT00711009|75902228|FG001|Overall Study|Pregnancy|0|||
42091917|NCT00711009|75902227|FG000|Overall Study|Site closing|0|||
42091918|NCT00711009|75902228|FG001|Overall Study|Site closing|1|||
42091919|NCT00711009|75902227|FG000|Overall Study|Dose adjustment|1|||
42091920|NCT00711009|75902228|FG001|Overall Study|Dose adjustment|0|||
42184953|NCT03614156|75994168|FG000|Open-Label Treatment Period|Protocol Violation|2|||
42184954|NCT03614156|75994169|FG001|Open-Label Treatment Period|Protocol Violation|0|||
42184955|NCT03614156|75994170|FG002|Open-Label Treatment Period|Protocol Violation|0|||
42184956|NCT03614156|75994171|FG003|Open-Label Treatment Period|Protocol Violation|0|||
42184957|NCT03614156|75994168|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
42184958|NCT03614156|75994169|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
42184959|NCT03614156|75994170|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
42184960|NCT03614156|75994171|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
42184961|NCT03614156|75994168|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
42184962|NCT03614156|75994169|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
42184963|NCT03614156|75994170|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
42184964|NCT03614156|75994171|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
42184965|NCT03614156|75994168|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
42184966|NCT03614156|75994169|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
42184967|NCT03614156|75994170|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
42184968|NCT03614156|75994171|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
42184969|NCT03614156|75994168|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
42184970|NCT03614156|75994169|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
42184971|NCT03614156|75994170|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
42184972|NCT03614156|75994171|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
42184973|NCT03614156|75994168|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
42184974|NCT03614156|75994169|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
42091921|NCT00577005|75902236|FG000|Overall Study|Lost to Follow-up|3|||
42091922|NCT00577005|75902237|FG001|Overall Study|Lost to Follow-up|2|||
42091923|NCT00577005|75902236|FG000|Overall Study|Withdrawal by Subject|2|||
42091924|NCT00577005|75902237|FG001|Overall Study|Withdrawal by Subject|1|||
42091925|NCT00576927|75902248|FG000|Clinical Assessment|Lack of Efficacy|24|||
42091926|NCT00576927|75902248|FG000|Clinical Assessment|Death|1|||
42295245|NCT01671007|76129763|FG005|Overall Study|Withdrawal by Subject|15|||
42295246|NCT01671007|76129764|FG006|Overall Study|Withdrawal by Subject|1|||
42295247|NCT01671007|76129765|FG007|Overall Study|Withdrawal by Subject|19|||
42295248|NCT01671007|76129766|FG008|Overall Study|Withdrawal by Subject|0|||
42295249|NCT01671007|76129758|FG000|Overall Study|Lost to Follow-up|93|||
42295250|NCT01671007|76129759|FG001|Overall Study|Lost to Follow-up|142|||
42295251|NCT01671007|76129760|FG002|Overall Study|Lost to Follow-up|91|||
42295252|NCT01671007|76129761|FG003|Overall Study|Lost to Follow-up|63|||
42358933|NCT02864251|76204677|FG002|Treatment|Disease Progression|101|||
42091927|NCT00576927|75902248|FG000|Clinical Assessment|Withdrawal by Subject|10|||
42091928|NCT00576927|75902248|FG000|Clinical Assessment|Physician Decision|1|||
42091929|NCT00576927|75902248|FG000|Baseline|Physician Decision|9|||
42091930|NCT00576927|75902248|FG000|Baseline|Medication Change by PCP of subject|1|||
42091931|NCT00576927|75902248|FG000|Baseline|Withdrawal by Subject|3|||
42091932|NCT00576927|75902248|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
42091933|NCT00576927|75902248|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
42091934|NCT00576927|75902248|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
42091935|NCT00576927|75902248|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
42091936|NCT00576927|75902248|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
42091937|NCT00698841|75902254|FG000|Overall Study|Withdrawal by Subject|2|||
42091938|NCT00698841|75902254|FG000|Overall Study|Adverse Event|3|||
42091939|NCT00698841|75902254|FG000|Overall Study|Disease progression|7|||
42091940|NCT00698841|75902254|FG000|Overall Study|Failure to meet eligibility criteria|2|||
42091941|NCT00698841|75902254|FG000|Overall Study|Study drug toxicity|2|||
42091942|NCT00698841|75902254|FG000|Overall Study|Other|2|||
42091943|NCT00577395|75902260|FG000|Overall Study|Study was terminated early by Sponsor|7|||
42091944|NCT00577395|75902261|FG001|Overall Study|Study was terminated early by Sponsor|6|||
42091945|NCT00738374|75902270|FG000|Induction Treatment Phase|Adverse Event|14|||
42091946|NCT00738374|75902271|FG001|Induction Treatment Phase|Adverse Event|0|||
42091947|NCT00738374|75902272|FG002|Induction Treatment Phase|Adverse Event|0|||
42091948|NCT00738374|75902273|FG003|Induction Treatment Phase|Adverse Event|0|||
42091949|NCT00738374|75902270|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
42091950|NCT00738374|75902271|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
42091951|NCT00738374|75902272|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
42091952|NCT00738374|75902273|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
42091953|NCT00738374|75902270|FG000|Induction Treatment Phase|Physician Decision|2|||
42184975|NCT03614156|75994170|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
42184976|NCT03614156|75994171|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
42184977|NCT03614156|75994168|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
42091954|NCT00738374|75902271|FG001|Induction Treatment Phase|Physician Decision|0|||
42091955|NCT00738374|75902272|FG002|Induction Treatment Phase|Physician Decision|0|||
42091956|NCT00738374|75902273|FG003|Induction Treatment Phase|Physician Decision|0|||
42184978|NCT03614156|75994169|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
42091957|NCT00738374|75902270|FG000|Induction Treatment Phase|Protocol Violation|2|||
42091958|NCT00738374|75902271|FG001|Induction Treatment Phase|Protocol Violation|0|||
42091959|NCT00738374|75902272|FG002|Induction Treatment Phase|Protocol Violation|0|||
42184979|NCT03614156|75994170|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
42295253|NCT01671007|76129762|FG004|Overall Study|Lost to Follow-up|7|||
42295254|NCT01671007|76129763|FG005|Overall Study|Lost to Follow-up|20|||
42091960|NCT00738374|75902273|FG003|Induction Treatment Phase|Protocol Violation|0|||
42091961|NCT00738374|75902270|FG000|Induction Treatment Phase|Non-compliance|1|||
42184980|NCT03614156|75994171|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
42184981|NCT03614156|75994168|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
42184982|NCT03614156|75994169|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
42184983|NCT03614156|75994170|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
42184984|NCT03614156|75994171|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
42184985|NCT03614156|75994168|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
42184986|NCT03614156|75994169|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
42184987|NCT03614156|75994170|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
42184988|NCT03614156|75994171|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
42184989|NCT03614156|75994168|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
42184990|NCT03614156|75994169|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
42184991|NCT03614156|75994170|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
42184992|NCT03614156|75994171|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
42184993|NCT03614156|75994168|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
42184994|NCT03614156|75994169|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
42184995|NCT03614156|75994170|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
42184996|NCT03614156|75994171|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
42184997|NCT03614156|75994168|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
42184998|NCT03614156|75994169|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
42184999|NCT03614156|75994170|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
42185000|NCT03614156|75994171|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
42185001|NCT03614078|75994183|FG000|Overall Study|Withdrawal by Subject|2|||
42091962|NCT00738374|75902271|FG001|Induction Treatment Phase|Non-compliance|0|||
42091963|NCT00738374|75902272|FG002|Induction Treatment Phase|Non-compliance|0|||
42091964|NCT00738374|75902273|FG003|Induction Treatment Phase|Non-compliance|0|||
42091965|NCT00738374|75902270|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
42091966|NCT00738374|75902271|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
42185002|NCT03614078|75994184|FG001|Overall Study|Withdrawal by Subject|2|||
42185003|NCT03614078|75994185|FG002|Overall Study|Withdrawal by Subject|3|||
42185004|NCT03614078|75994183|FG000|Overall Study|Participant Did Not Return for Visit|0|||
42185005|NCT03614078|75994184|FG001|Overall Study|Participant Did Not Return for Visit|1|||
42185006|NCT03614078|75994185|FG002|Overall Study|Participant Did Not Return for Visit|0|||
42185007|NCT03614078|75994183|FG000|Overall Study|High Neutrophils|0|||
42185008|NCT03614078|75994184|FG001|Overall Study|High Neutrophils|0|||
42185009|NCT03614078|75994185|FG002|Overall Study|High Neutrophils|2|||
42185010|NCT03614078|75994183|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
42185011|NCT03614078|75994184|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
42185012|NCT03614078|75994185|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
42185013|NCT03614078|75994183|FG000|Overall Study|Exacerbation of Psoriasis|0|||
42185014|NCT03614078|75994184|FG001|Overall Study|Exacerbation of Psoriasis|1|||
42185015|NCT03614078|75994185|FG002|Overall Study|Exacerbation of Psoriasis|0|||
42185016|NCT03614078|75994183|FG000|Overall Study|Adverse Event|0|||
42185017|NCT03614078|75994184|FG001|Overall Study|Adverse Event|2|||
42185018|NCT03614078|75994185|FG002|Overall Study|Adverse Event|0|||
42185019|NCT03614078|75994183|FG000|Overall Study|Dizziness and Rash|0|||
42185020|NCT03614078|75994184|FG001|Overall Study|Dizziness and Rash|1|||
42185021|NCT03614078|75994185|FG002|Overall Study|Dizziness and Rash|0|||
42185022|NCT03613454|75994195|FG000|Overall Study|Protocol Violation|1|||
42185023|NCT03613454|75994196|FG001|Overall Study|Protocol Violation|0|||
42185024|NCT03613454|75994195|FG000|Overall Study|Protocol Violation|0|||
42091967|NCT00738374|75902272|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
42091968|NCT00738374|75902273|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
42091969|NCT00738374|75902270|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
42091970|NCT00738374|75902271|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
42185025|NCT03613454|75994196|FG001|Overall Study|Protocol Violation|1|||
42091971|NCT00738374|75902272|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
42091972|NCT00738374|75902273|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
42091973|NCT00738374|75902270|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
42185026|NCT03581786|75994204|FG000|Overall Study|Death|17|||
42185027|NCT03581786|75994205|FG001|Overall Study|Death|12|||
42185028|NCT03581786|75994204|FG000|Overall Study|Withdrawal by Subject|2|||
42185029|NCT03581786|75994205|FG001|Overall Study|Withdrawal by Subject|4|||
42185030|NCT03581786|75994204|FG000|Overall Study|Lost to Follow-up|1|||
42185031|NCT03581786|75994205|FG001|Overall Study|Lost to Follow-up|0|||
42185032|NCT03581786|75994204|FG000|Overall Study|reason other than specified above|0|||
42185033|NCT03581786|75994205|FG001|Overall Study|reason other than specified above|1|||
42185034|NCT03581786|75994204|FG000|Overall Study|Ongoing in the study|123|||
42185035|NCT03581786|75994205|FG001|Overall Study|Ongoing in the study|129|||
42185036|NCT03580382|75994213|FG000|Overall Study|Early Termination of Study|0|||
42185037|NCT03580382|75994214|FG001|Overall Study|Early Termination of Study|3|||
42185038|NCT03579290|75994219|FG000|Overall Study|Lost to Follow-up|9|||
42185039|NCT03611582|75994225|FG000|Overall Study|Adverse Event|26|||
42185040|NCT03611582|75994226|FG001|Overall Study|Adverse Event|6|||
42185041|NCT03611582|75994225|FG000|Overall Study|Protocol Violation|0|||
42185042|NCT03611582|75994226|FG001|Overall Study|Protocol Violation|1|||
42185043|NCT03611582|75994225|FG000|Overall Study|Pregnancy|1|||
42185044|NCT03611582|75994226|FG001|Overall Study|Pregnancy|2|||
42185045|NCT03611582|75994225|FG000|Overall Study|Lack of Efficacy|0|||
42185046|NCT03611582|75994226|FG001|Overall Study|Lack of Efficacy|1|||
42185047|NCT03611582|75994225|FG000|Overall Study|At the discretion of the investigator|1|||
42185048|NCT03611582|75994226|FG001|Overall Study|At the discretion of the investigator|0|||
42185049|NCT03611582|75994225|FG000|Overall Study|Safety concern as judged by the investigator|1|||
42185050|NCT03611582|75994226|FG001|Overall Study|Safety concern as judged by the investigator|2|||
42185051|NCT03611582|75994225|FG000|Overall Study|Withdrawal by Subject|4|||
42185052|NCT03611582|75994226|FG001|Overall Study|Withdrawal by Subject|3|||
42185053|NCT03611582|75994225|FG000|Overall Study|Lost to Follow-up|18|||
42185054|NCT03611582|75994226|FG001|Overall Study|Lost to Follow-up|7|||
42185055|NCT03611582|75994225|FG000|Overall Study|other|17|||
42185056|NCT03611582|75994226|FG001|Overall Study|other|16|||
42185057|NCT04015518|75994237|FG000|Overall Study|Adverse Event|6|||
42185058|NCT04015518|75994238|FG001|Overall Study|Adverse Event|1|||
42185059|NCT04015518|75994239|FG002|Overall Study|Adverse Event|1|||
42185060|NCT04015518|75994240|FG003|Overall Study|Adverse Event|3|||
42185061|NCT04015518|75994241|FG004|Overall Study|Adverse Event|3|||
42185062|NCT04015518|75994237|FG000|Overall Study|Lack of Efficacy|1|||
42185063|NCT04015518|75994238|FG001|Overall Study|Lack of Efficacy|0|||
42185064|NCT04015518|75994239|FG002|Overall Study|Lack of Efficacy|1|||
42185065|NCT04015518|75994240|FG003|Overall Study|Lack of Efficacy|0|||
42185066|NCT04015518|75994241|FG004|Overall Study|Lack of Efficacy|4|||
42185067|NCT04015518|75994237|FG000|Overall Study|Lost to Follow-up|0|||
42185068|NCT04015518|75994238|FG001|Overall Study|Lost to Follow-up|0|||
42185069|NCT04015518|75994239|FG002|Overall Study|Lost to Follow-up|0|||
42185070|NCT04015518|75994240|FG003|Overall Study|Lost to Follow-up|0|||
42185071|NCT04015518|75994241|FG004|Overall Study|Lost to Follow-up|1|||
42185072|NCT04015518|75994237|FG000|Overall Study|Withdrawal by Subject|0|||
42185073|NCT04015518|75994238|FG001|Overall Study|Withdrawal by Subject|1|||
42185074|NCT04015518|75994239|FG002|Overall Study|Withdrawal by Subject|0|||
42185075|NCT04015518|75994240|FG003|Overall Study|Withdrawal by Subject|1|||
42185076|NCT04015518|75994241|FG004|Overall Study|Withdrawal by Subject|1|||
42185077|NCT04015518|75994237|FG000|Overall Study|Patient did not come for consecutive visits|0|||
42185078|NCT04015518|75994238|FG001|Overall Study|Patient did not come for consecutive visits|1|||
42185079|NCT04015518|75994239|FG002|Overall Study|Patient did not come for consecutive visits|0|||
42091974|NCT00738374|75902271|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
42091975|NCT00738374|75902272|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
42091976|NCT00738374|75902273|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
42091977|NCT00738374|75902270|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
42091978|NCT00738374|75902271|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
42091979|NCT00738374|75902272|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
42091980|NCT00738374|75902273|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
42091981|NCT00738374|75902270|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
42091982|NCT00738374|75902271|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
42091983|NCT00738374|75902272|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
42091984|NCT00738374|75902273|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
42091985|NCT00738374|75902270|FG000|Maintenance Treatment/Observation Phase|Other|0|||
42185080|NCT04015518|75994240|FG003|Overall Study|Patient did not come for consecutive visits|0|||
42185081|NCT04015518|75994241|FG004|Overall Study|Patient did not come for consecutive visits|0|||
42185082|NCT04015518|75994237|FG000|Overall Study|not willing to travel due to Covid-19|0|||
42185083|NCT04015518|75994238|FG001|Overall Study|not willing to travel due to Covid-19|0|||
42185084|NCT04015518|75994239|FG002|Overall Study|not willing to travel due to Covid-19|1|||
42185085|NCT04015518|75994240|FG003|Overall Study|not willing to travel due to Covid-19|0|||
42185086|NCT04015518|75994241|FG004|Overall Study|not willing to travel due to Covid-19|0|||
42185087|NCT04015518|75994237|FG000|Overall Study|Patient wants to discontinue treatment|0|||
42185088|NCT04015518|75994238|FG001|Overall Study|Patient wants to discontinue treatment|0|||
42185089|NCT04015518|75994239|FG002|Overall Study|Patient wants to discontinue treatment|0|||
42185090|NCT04015518|75994240|FG003|Overall Study|Patient wants to discontinue treatment|1|||
42185091|NCT04015518|75994241|FG004|Overall Study|Patient wants to discontinue treatment|0|||
42185092|NCT04015518|75994237|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
42185093|NCT04015518|75994238|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
42185094|NCT04015518|75994239|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
42091986|NCT00738374|75902271|FG001|Maintenance Treatment/Observation Phase|Other|1|||
42091987|NCT00738374|75902272|FG002|Maintenance Treatment/Observation Phase|Other|0|||
42091988|NCT00738374|75902273|FG003|Maintenance Treatment/Observation Phase|Other|0|||
42091989|NCT00697593|75902282|FG000|Overall Study|Adverse Event|3|||
42091990|NCT00697593|75902282|FG000|Overall Study|Protocol Violation|1|||
42091991|NCT00697593|75902282|FG000|Overall Study|Lack of Efficacy|3|||
42185095|NCT04015518|75994240|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
42185096|NCT04015518|75994241|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
42185097|NCT04015518|75994237|FG000|Overall Study|Pregnancy|0|||
42185098|NCT04015518|75994238|FG001|Overall Study|Pregnancy|0|||
42185099|NCT04015518|75994239|FG002|Overall Study|Pregnancy|0|||
42185100|NCT04015518|75994240|FG003|Overall Study|Pregnancy|0|||
42185101|NCT04015518|75994241|FG004|Overall Study|Pregnancy|1|||
42185102|NCT04015518|75994237|FG000|Overall Study|Personal reasons|1|||
42185103|NCT04015518|75994238|FG001|Overall Study|Personal reasons|0|||
42185104|NCT04015518|75994239|FG002|Overall Study|Personal reasons|0|||
42185105|NCT04015518|75994240|FG003|Overall Study|Personal reasons|0|||
42185106|NCT04015518|75994241|FG004|Overall Study|Personal reasons|1|||
42185107|NCT04015518|75994237|FG000|Overall Study|Withdrew consent|1|||
42185108|NCT04015518|75994238|FG001|Overall Study|Withdrew consent|0|||
42185109|NCT04015518|75994239|FG002|Overall Study|Withdrew consent|0|||
42185110|NCT04015518|75994240|FG003|Overall Study|Withdrew consent|0|||
42185111|NCT04015518|75994241|FG004|Overall Study|Withdrew consent|0|||
42185112|NCT04015518|75994237|FG000|Overall Study|Prostate carcinoma|1|||
42185113|NCT04015518|75994238|FG001|Overall Study|Prostate carcinoma|0|||
42185114|NCT04015518|75994239|FG002|Overall Study|Prostate carcinoma|0|||
42185115|NCT04015518|75994240|FG003|Overall Study|Prostate carcinoma|0|||
42185116|NCT04015518|75994241|FG004|Overall Study|Prostate carcinoma|0|||
42185117|NCT04015518|75994237|FG000|Overall Study|Could not keep appointments due to work|1|||
42185118|NCT04015518|75994238|FG001|Overall Study|Could not keep appointments due to work|0|||
42185119|NCT04015518|75994239|FG002|Overall Study|Could not keep appointments due to work|0|||
42185120|NCT04015518|75994240|FG003|Overall Study|Could not keep appointments due to work|0|||
42185121|NCT04015518|75994241|FG004|Overall Study|Could not keep appointments due to work|0|||
42185122|NCT03577730|75994258|FG000|Overall Study|Physician Decision|3|||
42185123|NCT03577730|75994259|FG001|Overall Study|Physician Decision|1|||
42185124|NCT03577730|75994258|FG000|Overall Study|Did not receive allocated intervention|1|||
42185125|NCT03577730|75994259|FG001|Overall Study|Did not receive allocated intervention|0|||
42185126|NCT03608774|75994267|FG000|Overall Study|Lost to Follow-up|5|||
42185127|NCT03608774|75994268|FG001|Overall Study|Lost to Follow-up|5|||
42185128|NCT03608774|75994267|FG000|Overall Study|Withdrawal by Subject|1|||
42185129|NCT03608774|75994268|FG001|Overall Study|Withdrawal by Subject|0|||
42185130|NCT03608774|75994267|FG000|Overall Study|Protocol Violation|1|||
42185131|NCT03608774|75994268|FG001|Overall Study|Protocol Violation|0|||
42185132|NCT03608774|75994267|FG000|Overall Study|Not eligible at enrollment|0|||
42185133|NCT03608774|75994268|FG001|Overall Study|Not eligible at enrollment|1|||
42185134|NCT03608774|75994267|FG000|Overall Study|Health related event|0|||
42185135|NCT03608774|75994268|FG001|Overall Study|Health related event|1|||
42185136|NCT04021524|75994276|FG000|Overall Study|Change in surgical intervention|0|||
42185137|NCT04021524|75994277|FG001|Overall Study|Change in surgical intervention|1|||
42185138|NCT03607682|75994283|FG000|Overall Study|Withdrawal by Subject|1|||
42185139|NCT03607682|75994283|FG000|Overall Study|Disease progression|1|||
42185140|NCT03606668|75994287|FG000|Overall Study|Screen Failure|1|||
42091992|NCT00697593|75902282|FG000|Overall Study|Suspension of the study by sponsor|12|||
42091993|NCT00697515|75902286|FG000|Dose Optimization Period|Adverse Event|4|||
42091994|NCT00697515|75902287|FG001|Dose Optimization Period|Adverse Event|0|||
42091995|NCT00697515|75902286|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
42091996|NCT00697515|75902287|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
42091997|NCT00697515|75902286|FG000|Dose Optimization Period|Lost to Follow-up|2|||
42185141|NCT03606668|75994287|FG000|Overall Study|Lost to Follow-up|1|||
42185142|NCT03601052|75994291|FG000|Overall Study|Lost to Follow-up|2|||
42185143|NCT03600740|75994300|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
42185144|NCT03600428|75994306|FG000|Overall Study|Not eligible|0|||
42185145|NCT03600428|75994307|FG001|Overall Study|Not eligible|1|||
42185146|NCT03600428|75994306|FG000|Overall Study|Lost to Follow-up|5|||
42185147|NCT03600428|75994307|FG001|Overall Study|Lost to Follow-up|4|||
42185148|NCT03575702|75994315|FG000|Overall Study|Withdrawal by Subject|1|||
42185149|NCT03575702|75994316|FG001|Overall Study|Withdrawal by Subject|1|||
42185150|NCT03575702|75994315|FG000|Overall Study|Lost to Follow-up|1|||
42185151|NCT03575702|75994316|FG001|Overall Study|Lost to Follow-up|2|||
42185152|NCT03575702|75994315|FG000|Overall Study|Protocol Violation|0|||
42185153|NCT03575702|75994316|FG001|Overall Study|Protocol Violation|1|||
42185154|NCT03575702|75994315|FG000|Overall Study|Patient non compliance|4|||
42185155|NCT03575702|75994316|FG001|Overall Study|Patient non compliance|0|||
42091998|NCT00697515|75902287|FG001|Dose Optimization Period|Lost to Follow-up|0|||
42091999|NCT00697515|75902286|FG000|Dose Optimization Period|sponsor request|2|||
42092000|NCT00697515|75902287|FG001|Dose Optimization Period|sponsor request|0|||
42092001|NCT00697515|75902286|FG000|Dose Optimization Period|called to active duty|1|||
42092002|NCT00697515|75902287|FG001|Dose Optimization Period|called to active duty|0|||
42092003|NCT00697515|75902286|FG000|Dose Optimization Period|elevated QTc|1|||
42092004|NCT00697515|75902287|FG001|Dose Optimization Period|elevated QTc|0|||
42092005|NCT00697515|75902286|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
42092006|NCT00697515|75902287|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
42092007|NCT00697515|75902286|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
42185156|NCT03573908|75994324|FG000|Treatment Period|Adverse Event|4|||
42185157|NCT03573908|75994325|FG001|Treatment Period|Adverse Event|9|||
42185158|NCT03573908|75994326|FG002|Treatment Period|Adverse Event|0|||
42185159|NCT03573908|75994327|FG003|Treatment Period|Adverse Event|0|||
42185160|NCT03573908|75994328|FG004|Treatment Period|Adverse Event|0|||
42185161|NCT03573908|75994324|FG000|Treatment Period|Protocol Violation|1|||
42185162|NCT03573908|75994325|FG001|Treatment Period|Protocol Violation|0|||
42185163|NCT03573908|75994326|FG002|Treatment Period|Protocol Violation|0|||
42185164|NCT03573908|75994327|FG003|Treatment Period|Protocol Violation|0|||
42185165|NCT03573908|75994328|FG004|Treatment Period|Protocol Violation|0|||
42185166|NCT03573908|75994324|FG000|Treatment Period|Withdrawal by Subject|7|||
42185167|NCT03573908|75994325|FG001|Treatment Period|Withdrawal by Subject|5|||
42185168|NCT03573908|75994326|FG002|Treatment Period|Withdrawal by Subject|0|||
42185169|NCT03573908|75994327|FG003|Treatment Period|Withdrawal by Subject|0|||
42185170|NCT03573908|75994328|FG004|Treatment Period|Withdrawal by Subject|0|||
42185171|NCT03573908|75994324|FG000|Treatment Period|Lost to Follow-up|7|||
42185172|NCT03573908|75994325|FG001|Treatment Period|Lost to Follow-up|6|||
42185173|NCT03573908|75994326|FG002|Treatment Period|Lost to Follow-up|0|||
42185174|NCT03573908|75994327|FG003|Treatment Period|Lost to Follow-up|0|||
42185175|NCT03573908|75994328|FG004|Treatment Period|Lost to Follow-up|0|||
42185176|NCT03573908|75994324|FG000|Treatment Period|Pregnancy|1|||
42185177|NCT03573908|75994325|FG001|Treatment Period|Pregnancy|0|||
42185178|NCT03573908|75994326|FG002|Treatment Period|Pregnancy|0|||
42185179|NCT03573908|75994327|FG003|Treatment Period|Pregnancy|0|||
42185180|NCT03573908|75994328|FG004|Treatment Period|Pregnancy|0|||
42185181|NCT03573908|75994324|FG000|Treatment Period|Other, Not Specified|4|||
42092008|NCT00697515|75902287|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
42092009|NCT00697515|75902286|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
42092010|NCT00697515|75902287|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
42092011|NCT00697515|75902286|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
42092012|NCT00697515|75902287|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
42092013|NCT00738062|75902296|FG000|Open Label Treatment|Lack of Efficacy|5|||
42092014|NCT00738062|75902297|FG001|Open Label Treatment|Lack of Efficacy|0|||
42092015|NCT00738062|75902298|FG002|Open Label Treatment|Lack of Efficacy|0|||
42092016|NCT00738062|75902296|FG000|Open Label Treatment|Adverse Event|11|||
42092017|NCT00738062|75902297|FG001|Open Label Treatment|Adverse Event|0|||
42092018|NCT00738062|75902298|FG002|Open Label Treatment|Adverse Event|0|||
42092019|NCT00738062|75902296|FG000|Open Label Treatment|Protocol Violation|2|||
42092020|NCT00738062|75902297|FG001|Open Label Treatment|Protocol Violation|0|||
42092021|NCT00738062|75902298|FG002|Open Label Treatment|Protocol Violation|0|||
42092022|NCT00738062|75902296|FG000|Open Label Treatment|Withdrawal by Subject|9|||
42092023|NCT00738062|75902297|FG001|Open Label Treatment|Withdrawal by Subject|0|||
42092024|NCT00738062|75902298|FG002|Open Label Treatment|Withdrawal by Subject|0|||
42092025|NCT00738062|75902296|FG000|Open Label Treatment|Investigator Decision|1|||
42092026|NCT00738062|75902297|FG001|Open Label Treatment|Investigator Decision|0|||
42092027|NCT00738062|75902298|FG002|Open Label Treatment|Investigator Decision|0|||
42092028|NCT00738062|75902296|FG000|Open-Label Extension|Adverse Event|5|||
42185182|NCT03573908|75994325|FG001|Treatment Period|Other, Not Specified|6|||
42185183|NCT03573908|75994326|FG002|Treatment Period|Other, Not Specified|0|||
42185184|NCT03573908|75994327|FG003|Treatment Period|Other, Not Specified|0|||
42185185|NCT03573908|75994328|FG004|Treatment Period|Other, Not Specified|0|||
42185186|NCT03573908|75994324|FG000|Randomized Withdrawal Period|Adverse Event|0|||
42092029|NCT00738062|75902297|FG001|Open-Label Extension|Adverse Event|0|||
42092030|NCT00738062|75902298|FG002|Open-Label Extension|Adverse Event|0|||
42092031|NCT00738062|75902296|FG000|Open-Label Extension|Physician Decision|1|||
42185187|NCT03573908|75994325|FG001|Randomized Withdrawal Period|Adverse Event|0|||
42295255|NCT01671007|76129764|FG006|Overall Study|Lost to Follow-up|2|||
42295256|NCT01671007|76129765|FG007|Overall Study|Lost to Follow-up|28|||
42092032|NCT00738062|75902297|FG001|Open-Label Extension|Physician Decision|0|||
42185188|NCT03573908|75994326|FG002|Randomized Withdrawal Period|Adverse Event|3|||
42185189|NCT03573908|75994327|FG003|Randomized Withdrawal Period|Adverse Event|0|||
42295257|NCT01671007|76129766|FG008|Overall Study|Lost to Follow-up|0|||
42092033|NCT00738062|75902298|FG002|Open-Label Extension|Physician Decision|0|||
42092034|NCT00738062|75902296|FG000|Open-Label Extension|Lack of Efficacy|2|||
42092035|NCT00738062|75902297|FG001|Open-Label Extension|Lack of Efficacy|0|||
42092036|NCT00738062|75902298|FG002|Open-Label Extension|Lack of Efficacy|0|||
42092037|NCT00738062|75902296|FG000|Open-Label Extension|Withdrawal by Subject|6|||
42092038|NCT00738062|75902297|FG001|Open-Label Extension|Withdrawal by Subject|0|||
42092039|NCT00738062|75902298|FG002|Open-Label Extension|Withdrawal by Subject|0|||
42092040|NCT00738062|75902296|FG000|Open-Label Extension|Protocol Violation|1|||
42092041|NCT00738062|75902297|FG001|Open-Label Extension|Protocol Violation|0|||
42092042|NCT00738062|75902298|FG002|Open-Label Extension|Protocol Violation|0|||
42092043|NCT00738062|75902296|FG000|Open-Label Extension|Study Terminated|2|||
42092044|NCT00738062|75902297|FG001|Open-Label Extension|Study Terminated|0|||
42092045|NCT00738062|75902298|FG002|Open-Label Extension|Study Terminated|0|||
42185190|NCT03573908|75994328|FG004|Randomized Withdrawal Period|Adverse Event|0|||
42185191|NCT03573908|75994324|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42185192|NCT03573908|75994325|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42185193|NCT03573908|75994326|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42185194|NCT03573908|75994327|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
42185195|NCT03573908|75994328|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
42185196|NCT03573908|75994324|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
42185197|NCT03573908|75994325|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
42185198|NCT03573908|75994326|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
42185199|NCT03573908|75994327|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
42185200|NCT03573908|75994328|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
42185201|NCT03573908|75994324|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
42185202|NCT03573908|75994325|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
42185203|NCT03573908|75994326|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
42185204|NCT03573908|75994327|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
42185205|NCT03573908|75994328|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
42185206|NCT03573830|75994339|FG000|Overall Study|Dropped without completing treatment|0|||
42185207|NCT03573830|75994340|FG001|Overall Study|Dropped without completing treatment|7|||
42185208|NCT03573830|75994339|FG000|Overall Study|Lost to Follow-up|4|||
42185209|NCT03573830|75994340|FG001|Overall Study|Lost to Follow-up|0|||
42185210|NCT03595904|75994347|FG000|Overall Study|Protocol Violation|3|||
42185211|NCT03595904|75994348|FG001|Overall Study|Protocol Violation|1|||
42295258|NCT01671007|76129758|FG000|Overall Study|No end of study case report form|3|||
42295259|NCT01671007|76129759|FG001|Overall Study|No end of study case report form|1|||
42295260|NCT01671007|76129760|FG002|Overall Study|No end of study case report form|0|||
42185212|NCT03595904|75994347|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
42185213|NCT03595904|75994348|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
42185214|NCT03595904|75994347|FG000|Overall Study|Insurance complications|1|||
42185215|NCT03595904|75994348|FG001|Overall Study|Insurance complications|0|||
42185216|NCT03595904|75994347|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
42185217|NCT03595904|75994348|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
42185218|NCT03595280|75994357|FG000|Overall Study|Lost to Follow-up|6|||
42185219|NCT03595280|75994358|FG001|Overall Study|Lost to Follow-up|9|||
42185220|NCT03595280|75994359|FG002|Overall Study|Lost to Follow-up|15|||
42185221|NCT03593876|75994367|FG000|Overall Study|Withdrawal by Subject|1|||
42185222|NCT03593876|75994367|FG000|Overall Study|Discharged home before intervention completion|2|||
42185223|NCT00071487|75994375|FG000|52-Week Double-Blind Period|Adverse Event|5|||
42185224|NCT00071487|75994376|FG001|52-Week Double-Blind Period|Adverse Event|8|||
42185225|NCT00071487|75994377|FG002|52-Week Double-Blind Period|Adverse Event|4|||
42185226|NCT00071487|75994378|FG003|52-Week Double-Blind Period|Adverse Event|8|||
42185227|NCT00071487|75994375|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
42185228|NCT00071487|75994376|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
42185229|NCT00071487|75994377|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
42185230|NCT00071487|75994378|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
42185231|NCT00071487|75994375|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
42185232|NCT00071487|75994376|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
42185233|NCT00071487|75994377|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
42295261|NCT01671007|76129761|FG003|Overall Study|No end of study case report form|2|||
42295262|NCT01671007|76129762|FG004|Overall Study|No end of study case report form|0|||
42295263|NCT01671007|76129763|FG005|Overall Study|No end of study case report form|0|||
42295264|NCT01671007|76129764|FG006|Overall Study|No end of study case report form|0|||
42092046|NCT04245345|75902307|FG000|Overall Study|Death|1|||
42295265|NCT01671007|76129765|FG007|Overall Study|No end of study case report form|0|||
42092047|NCT04245345|75902307|FG000|Overall Study|Exited prior to implant|5|||
42092048|NCT04245345|75902307|FG000|Overall Study|Exited prior to 1-month|9|||
42092049|NCT04245345|75902307|FG000|Overall Study|Missed 1-month visit|3|||
42185234|NCT00071487|75994378|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
42092050|NCT04245345|75902307|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
42092051|NCT04245345|75902307|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
42092052|NCT00698685|75902313|FG000|Overall Study|Sister withdrew as donor|1|||
42092053|NCT00698685|75902313|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
42092054|NCT00737672|75902319|FG000|Overall Study|Graft Abandonment|48|||
42092055|NCT00737672|75902320|FG001|Overall Study|Graft Abandonment|56|||
42092056|NCT00737672|75902319|FG000|Overall Study|Death|23|||
42092057|NCT00737672|75902320|FG001|Overall Study|Death|22|||
42092058|NCT00737672|75902319|FG000|Overall Study|Withdrawal by Subject|1|||
42092059|NCT00737672|75902320|FG001|Overall Study|Withdrawal by Subject|2|||
42092060|NCT00737672|75902319|FG000|Overall Study|Lost to Follow-up|1|||
42092061|NCT00737672|75902320|FG001|Overall Study|Lost to Follow-up|0|||
42092062|NCT00737672|75902319|FG000|Overall Study|Miscellaneous|7|||
42092063|NCT00737672|75902320|FG001|Overall Study|Miscellaneous|1|||
42092064|NCT00737672|75902319|FG000|Overall Study|Physician Decision|0|||
42092065|NCT00737672|75902320|FG001|Overall Study|Physician Decision|2|||
42092066|NCT00737438|75902326|FG000|Overall Study|Withdrawal by Subject|2|||
42092067|NCT00737438|75902326|FG000|Overall Study|Patient ineligible|1|||
42092068|NCT00737282|75902332|FG000|Overall Study|Study prematurely terminated|175|||
42092069|NCT03884478|75902341|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
42092070|NCT03884478|75902342|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
42092071|NCT03884478|75902343|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
42092072|NCT03884478|75902341|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
42185235|NCT00071487|75994375|FG000|52-Week Double-Blind Period|Physician Decision|1|||
42185236|NCT00071487|75994376|FG001|52-Week Double-Blind Period|Physician Decision|0|||
42185237|NCT00071487|75994377|FG002|52-Week Double-Blind Period|Physician Decision|0|||
42185238|NCT00071487|75994378|FG003|52-Week Double-Blind Period|Physician Decision|0|||
42185239|NCT00071487|75994375|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
42185240|NCT00071487|75994376|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
42185241|NCT00071487|75994377|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
42185242|NCT00071487|75994378|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
42185243|NCT00071487|75994375|FG000|52-Week Double-Blind Period|Pregnancy|0|||
42185244|NCT00071487|75994376|FG001|52-Week Double-Blind Period|Pregnancy|1|||
42185245|NCT00071487|75994377|FG002|52-Week Double-Blind Period|Pregnancy|0|||
42185246|NCT00071487|75994378|FG003|52-Week Double-Blind Period|Pregnancy|0|||
42185247|NCT00071487|75994375|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
42185248|NCT00071487|75994376|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
42185249|NCT00071487|75994377|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
42185250|NCT00071487|75994378|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
42185251|NCT00071487|75994375|FG000|52-Week Double-Blind Period|Death|0|||
42185252|NCT00071487|75994376|FG001|52-Week Double-Blind Period|Death|1|||
42185253|NCT00071487|75994377|FG002|52-Week Double-Blind Period|Death|0|||
42185254|NCT00071487|75994378|FG003|52-Week Double-Blind Period|Death|0|||
42185255|NCT00071487|75994375|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
42185256|NCT00071487|75994376|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
42185257|NCT00071487|75994377|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
42185258|NCT00071487|75994378|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
42185259|NCT00071487|75994375|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
42185260|NCT00071487|75994376|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
42185261|NCT00071487|75994377|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
42185262|NCT00071487|75994378|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
42185263|NCT00071487|75994375|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
42185264|NCT00071487|75994376|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
42185265|NCT00071487|75994377|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
42185266|NCT00071487|75994378|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
42185267|NCT00071487|75994375|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
42295266|NCT01671007|76129766|FG008|Overall Study|No end of study case report form|0|||
42295267|NCT01671007|76129758|FG000|Overall Study|Not eligible|23|||
42295268|NCT01671007|76129759|FG001|Overall Study|Not eligible|76|||
42295269|NCT01671007|76129760|FG002|Overall Study|Not eligible|25|||
42295270|NCT01671007|76129761|FG003|Overall Study|Not eligible|17|||
42295271|NCT01671007|76129762|FG004|Overall Study|Not eligible|0|||
42092073|NCT03884478|75902342|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
42092074|NCT03884478|75902343|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
42092075|NCT03884478|75902341|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
42092076|NCT03884478|75902342|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
42092077|NCT03884478|75902343|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
42092078|NCT03884478|75902341|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
42185268|NCT00071487|75994376|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
42295272|NCT01671007|76129763|FG005|Overall Study|Not eligible|6|||
42092079|NCT03884478|75902342|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
42185269|NCT00071487|75994377|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
42185270|NCT00071487|75994378|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
42185271|NCT00071487|75994375|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
42185272|NCT00071487|75994376|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
42185273|NCT00071487|75994377|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
42185274|NCT00071487|75994378|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
42185275|NCT00071487|75994375|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
42185276|NCT00071487|75994376|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
42185277|NCT00071487|75994377|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
42185278|NCT00071487|75994378|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
42185279|NCT00071487|75994375|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
42185280|NCT00071487|75994376|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
42185281|NCT00071487|75994377|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
42185282|NCT00071487|75994378|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
42185283|NCT03591146|75994395|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
42185284|NCT03591146|75994396|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
42185285|NCT03591146|75994397|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
42185286|NCT03591146|75994398|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
42185287|NCT03591146|75994399|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
42185288|NCT03591146|75994395|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
42185289|NCT03591146|75994396|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
42185290|NCT03591146|75994397|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
42185291|NCT03591146|75994398|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
42185292|NCT03591146|75994399|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
42185293|NCT03591146|75994395|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
42185294|NCT03591146|75994396|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
42185295|NCT03591146|75994397|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
42185296|NCT03591146|75994398|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
42185297|NCT03591146|75994399|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
42185298|NCT03591146|75994395|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
42185299|NCT03591146|75994396|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
42185300|NCT03591146|75994397|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
42185301|NCT03591146|75994398|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
42185302|NCT03591146|75994399|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
42185303|NCT00096447|75994411|FG000|Overall Study|Never treated|1|||
42185304|NCT03590366|75994422|FG000|Overall Study|Adverse Event|0|||
42185305|NCT03590366|75994423|FG001|Overall Study|Adverse Event|3|||
42185306|NCT03590366|75994422|FG000|Overall Study|Lost to Follow-up|3|||
42185307|NCT03590366|75994423|FG001|Overall Study|Lost to Follow-up|3|||
42185308|NCT03590366|75994422|FG000|Overall Study|Withdrawal by Subject|0|||
42185309|NCT03590366|75994423|FG001|Overall Study|Withdrawal by Subject|2|||
42185310|NCT03588572|75994431|FG000|Visitation 1|Lack of Efficacy|1|||
42185311|NCT03588572|75994432|FG001|Visitation 1|Lack of Efficacy|1|||
42185312|NCT03588572|75994431|FG000|Visitation 2|Lost to Follow-up|1|||
42185313|NCT03588572|75994432|FG001|Visitation 2|Lost to Follow-up|1|||
42185314|NCT03588572|75994431|FG000|Visitation 2|Lack of Efficacy|0|||
42185315|NCT03588572|75994432|FG001|Visitation 2|Lack of Efficacy|1|||
42185316|NCT03588572|75994431|FG000|Visitation 2|Withdrawal by Subject|1|||
42185317|NCT03588572|75994432|FG001|Visitation 2|Withdrawal by Subject|0|||
42185318|NCT03588572|75994431|FG000|Visitation 3|Lost to Follow-up|1|||
42092080|NCT03884478|75902343|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
42092081|NCT00582816|75902364|FG000|Overall Study|Engraftment Failure|3|||
42092082|NCT00737048|75902371|FG000|Overall Study|Physician Decision|0|||
42092083|NCT00737048|75902372|FG001|Overall Study|Physician Decision|0|||
42092084|NCT00737048|75902373|FG002|Overall Study|Physician Decision|1|||
42092085|NCT00737048|75902371|FG000|Overall Study|Adverse Event|0|||
42092086|NCT00737048|75902372|FG001|Overall Study|Adverse Event|1|||
42092087|NCT00737048|75902373|FG002|Overall Study|Adverse Event|0|||
42092088|NCT00737048|75902371|FG000|Overall Study|Worsening of the symptoms|3|||
42092089|NCT00737048|75902372|FG001|Overall Study|Worsening of the symptoms|5|||
42092090|NCT00737048|75902373|FG002|Overall Study|Worsening of the symptoms|3|||
42092091|NCT00731822|75902383|FG000|Overall Study|Adverse Event|2|||
42092092|NCT00731822|75902384|FG001|Overall Study|Adverse Event|1|||
42185319|NCT03588572|75994432|FG001|Visitation 3|Lost to Follow-up|1|||
42185320|NCT03588572|75994431|FG000|Visitation 3|Physician Decision|1|||
42185321|NCT03588572|75994432|FG001|Visitation 3|Physician Decision|1|||
42185322|NCT03588572|75994431|FG000|Visitation 3|Withdrawal by Subject|1|||
42185323|NCT03588572|75994432|FG001|Visitation 3|Withdrawal by Subject|0|||
42185324|NCT00090285|75994440|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
42185325|NCT00090285|75994441|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
42185326|NCT00090285|75994442|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
42185327|NCT00090285|75994443|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
42092093|NCT00731822|75902383|FG000|Overall Study|Protocol Violation|1|||
42092094|NCT00731822|75902384|FG001|Overall Study|Protocol Violation|0|||
42092095|NCT00731822|75902383|FG000|Overall Study|Lost to Follow-up|1|||
42185328|NCT00090285|75994444|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
42185329|NCT00090285|75994445|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
42185330|NCT00090285|75994440|FG000|Base Study Vaccination Period|Adverse Event|2|||
42185331|NCT00090285|75994441|FG001|Base Study Vaccination Period|Adverse Event|4|||
42185332|NCT00090285|75994442|FG002|Base Study Vaccination Period|Adverse Event|0|||
42185333|NCT00090285|75994443|FG003|Base Study Vaccination Period|Adverse Event|0|||
42185334|NCT00090285|75994444|FG004|Base Study Vaccination Period|Adverse Event|0|||
42185335|NCT00090285|75994445|FG005|Base Study Vaccination Period|Adverse Event|0|||
42185336|NCT00090285|75994440|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
42185337|NCT00090285|75994441|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
42185338|NCT00090285|75994442|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
42185339|NCT00090285|75994443|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
42185340|NCT00090285|75994444|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
42185341|NCT00090285|75994445|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
42185342|NCT00090285|75994440|FG000|Base Study Vaccination Period|Protocol Violation|2|||
42185343|NCT00090285|75994441|FG001|Base Study Vaccination Period|Protocol Violation|3|||
42185344|NCT00090285|75994442|FG002|Base Study Vaccination Period|Protocol Violation|0|||
42185345|NCT00090285|75994443|FG003|Base Study Vaccination Period|Protocol Violation|0|||
42185346|NCT00090285|75994444|FG004|Base Study Vaccination Period|Protocol Violation|0|||
42185347|NCT00090285|75994445|FG005|Base Study Vaccination Period|Protocol Violation|0|||
42185348|NCT00090285|75994440|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
42185349|NCT00090285|75994441|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
42185350|NCT00090285|75994442|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
42185351|NCT00090285|75994443|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
42185352|NCT00090285|75994444|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
42185353|NCT00090285|75994445|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
42185354|NCT00090285|75994440|FG000|Base Study Vaccination Period|Uncooperative|2|||
42185355|NCT00090285|75994441|FG001|Base Study Vaccination Period|Uncooperative|2|||
42185356|NCT00090285|75994442|FG002|Base Study Vaccination Period|Uncooperative|0|||
42185357|NCT00090285|75994443|FG003|Base Study Vaccination Period|Uncooperative|0|||
42185358|NCT00090285|75994444|FG004|Base Study Vaccination Period|Uncooperative|0|||
42185359|NCT00090285|75994445|FG005|Base Study Vaccination Period|Uncooperative|0|||
42185360|NCT00090285|75994440|FG000|Base Study Vaccination Period|Moved|20|||
42185361|NCT00090285|75994441|FG001|Base Study Vaccination Period|Moved|21|||
42185362|NCT00090285|75994442|FG002|Base Study Vaccination Period|Moved|0|||
42185363|NCT00090285|75994443|FG003|Base Study Vaccination Period|Moved|0|||
42185364|NCT00090285|75994444|FG004|Base Study Vaccination Period|Moved|0|||
42185365|NCT00090285|75994445|FG005|Base Study Vaccination Period|Moved|0|||
42185366|NCT00090285|75994440|FG000|Base Study Vaccination Period|Site Terminated|1|||
42185367|NCT00090285|75994441|FG001|Base Study Vaccination Period|Site Terminated|0|||
42185368|NCT00090285|75994442|FG002|Base Study Vaccination Period|Site Terminated|0|||
42185369|NCT00090285|75994443|FG003|Base Study Vaccination Period|Site Terminated|0|||
42185370|NCT00090285|75994444|FG004|Base Study Vaccination Period|Site Terminated|0|||
42185371|NCT00090285|75994445|FG005|Base Study Vaccination Period|Site Terminated|0|||
42185372|NCT00090285|75994440|FG000|Base Study Vaccination Period|Other|2|||
42185373|NCT00090285|75994441|FG001|Base Study Vaccination Period|Other|2|||
42185374|NCT00090285|75994442|FG002|Base Study Vaccination Period|Other|0|||
42185375|NCT00090285|75994443|FG003|Base Study Vaccination Period|Other|0|||
42185376|NCT00090285|75994444|FG004|Base Study Vaccination Period|Other|0|||
42185377|NCT00090285|75994445|FG005|Base Study Vaccination Period|Other|0|||
42185378|NCT00090285|75994440|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
42092096|NCT00731822|75902384|FG001|Overall Study|Lost to Follow-up|0|||
42092097|NCT00731666|75902390|FG000|Overall Study|Adverse Event|2|||
42092098|NCT00731666|75902390|FG000|Overall Study|Lost to Follow-up|8|||
42092099|NCT00731666|75902390|FG000|Overall Study|Withdrawal by Subject|2|||
42092100|NCT00731120|75902397|FG000|Overall Study|Adverse Event|7|||
42092101|NCT00731120|75902398|FG001|Overall Study|Adverse Event|6|||
42092102|NCT00731120|75902399|FG002|Overall Study|Adverse Event|8|||
42092103|NCT00731120|75902397|FG000|Overall Study|Lack of Efficacy|4|||
42092104|NCT00731120|75902398|FG001|Overall Study|Lack of Efficacy|5|||
42092105|NCT00731120|75902399|FG002|Overall Study|Lack of Efficacy|4|||
42092106|NCT00731120|75902397|FG000|Overall Study|Noncompliance with Study Drug|3|||
42092107|NCT00731120|75902398|FG001|Overall Study|Noncompliance with Study Drug|3|||
42185379|NCT00090285|75994441|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
42185380|NCT00090285|75994442|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
42185381|NCT00090285|75994443|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
42185382|NCT00090285|75994444|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
42185383|NCT00090285|75994445|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
42092108|NCT00731120|75902399|FG002|Overall Study|Noncompliance with Study Drug|1|||
42092109|NCT00731120|75902397|FG000|Overall Study|Protocol Deviations|1|||
42092110|NCT00731120|75902398|FG001|Overall Study|Protocol Deviations|6|||
42092111|NCT00731120|75902399|FG002|Overall Study|Protocol Deviations|1|||
42092112|NCT00731120|75902397|FG000|Overall Study|Withdrawal of Consent|13|||
42092113|NCT00731120|75902398|FG001|Overall Study|Withdrawal of Consent|8|||
42092114|NCT00731120|75902399|FG002|Overall Study|Withdrawal of Consent|4|||
42092115|NCT00731120|75902397|FG000|Overall Study|Lost to Follow-up|10|||
42092116|NCT00731120|75902398|FG001|Overall Study|Lost to Follow-up|15|||
42092117|NCT00731120|75902399|FG002|Overall Study|Lost to Follow-up|17|||
42092118|NCT00731120|75902397|FG000|Overall Study|Other|4|||
42092119|NCT00731120|75902398|FG001|Overall Study|Other|0|||
42092120|NCT00731120|75902399|FG002|Overall Study|Other|1|||
42092121|NCT00731042|75902409|FG000|Second Intervention|Did not meet inclusion criteria|0|||
42092122|NCT00731042|75902410|FG001|Second Intervention|Did not meet inclusion criteria|2|||
42092123|NCT00726986|75902416|FG000|Induction Phase|Adverse Event|4|||
42092124|NCT00726986|75902416|FG000|Induction Phase|Withdrawal by Subject|2|||
42092125|NCT00726986|75902416|FG000|Induction Phase|Death|2|||
42092126|NCT00726986|75902416|FG000|Induction Phase|Lack of Efficacy|5|||
42185384|NCT00090285|75994440|FG000|Base Study Vaccination Period|HIV positive|1|||
42185385|NCT00090285|75994441|FG001|Base Study Vaccination Period|HIV positive|1|||
42185386|NCT00090285|75994442|FG002|Base Study Vaccination Period|HIV positive|0|||
42185387|NCT00090285|75994443|FG003|Base Study Vaccination Period|HIV positive|0|||
42185388|NCT00090285|75994444|FG004|Base Study Vaccination Period|HIV positive|0|||
42185389|NCT00090285|75994445|FG005|Base Study Vaccination Period|HIV positive|0|||
42185390|NCT00090285|75994440|FG000|Base Study Follow-up Period|Adverse Event|3|||
42185391|NCT00090285|75994441|FG001|Base Study Follow-up Period|Adverse Event|10|||
42185392|NCT00090285|75994442|FG002|Base Study Follow-up Period|Adverse Event|0|||
42295273|NCT01671007|76129764|FG006|Overall Study|Not eligible|1|||
42295274|NCT01671007|76129765|FG007|Overall Study|Not eligible|19|||
42295275|NCT01671007|76129766|FG008|Overall Study|Not eligible|0|||
42295276|NCT02505945|76129779|FG000|Overall Study|Withdrawal by Subject|13|||
42295277|NCT02505945|76129780|FG001|Overall Study|Withdrawal by Subject|2|||
42295278|NCT02505945|76129779|FG000|Overall Study|Adverse Event|1|||
42295279|NCT02505945|76129780|FG001|Overall Study|Adverse Event|0|||
42295280|NCT02505945|76129779|FG000|Overall Study|Physician Decision|2|||
42295281|NCT02505945|76129780|FG001|Overall Study|Physician Decision|1|||
42295282|NCT02505945|76129779|FG000|Overall Study|Lost to Follow-up|6|||
42295283|NCT02505945|76129780|FG001|Overall Study|Lost to Follow-up|1|||
42295284|NCT02505867|76129788|FG000|Overall Study|Lack of Efficacy|6|||
42295285|NCT02505867|76129789|FG001|Overall Study|Lack of Efficacy|6|||
42185393|NCT00090285|75994443|FG003|Base Study Follow-up Period|Adverse Event|0|||
42185394|NCT00090285|75994444|FG004|Base Study Follow-up Period|Adverse Event|0|||
42185395|NCT00090285|75994445|FG005|Base Study Follow-up Period|Adverse Event|0|||
42185396|NCT00090285|75994440|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
42185397|NCT00090285|75994441|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
42185398|NCT00090285|75994442|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
42185399|NCT00090285|75994443|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
42185400|NCT00090285|75994444|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
42185401|NCT00090285|75994445|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
42185402|NCT00090285|75994440|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
42185403|NCT00090285|75994441|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
42185404|NCT00090285|75994442|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
42185405|NCT00090285|75994443|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
42185406|NCT00090285|75994444|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
42185407|NCT00090285|75994445|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
42185408|NCT00090285|75994440|FG000|Base Study Follow-up Period|Moved|41|||
42185409|NCT00090285|75994441|FG001|Base Study Follow-up Period|Moved|36|||
42185410|NCT00090285|75994442|FG002|Base Study Follow-up Period|Moved|0|||
42185411|NCT00090285|75994443|FG003|Base Study Follow-up Period|Moved|0|||
42185412|NCT00090285|75994444|FG004|Base Study Follow-up Period|Moved|0|||
42185413|NCT00090285|75994445|FG005|Base Study Follow-up Period|Moved|0|||
42185414|NCT00090285|75994440|FG000|Base Study Follow-up Period|Other|2|||
42295286|NCT02472639|76129797|FG000|Overall Study|Physician Decision|4|||
42295287|NCT02472639|76129798|FG001|Overall Study|Physician Decision|3|||
42295288|NCT02472405|76129804|FG000|Overall Study|Lost to Follow-up|9|||
42295289|NCT02472405|76129804|FG000|Overall Study|Adverse Event|1|||
42295290|NCT02448771|76129810|FG000|Overall Study|Disease Progression|30|||
42295291|NCT02448771|76129810|FG000|Overall Study|Unacceptable Toxicity|1|||
42295292|NCT02448771|76129810|FG000|Overall Study|Physician Decision|3|||
42295293|NCT02448771|76129810|FG000|Overall Study|Started new therapy|2|||
42295294|NCT02504541|76129815|FG000|Overall Study|Adverse Event|4|||
42295295|NCT02504541|76129815|FG000|Overall Study|Withdrawal by Subject|4|||
42295296|NCT02504541|76129815|FG000|Overall Study|Lost to Follow-up|1|||
42092127|NCT00726986|75902416|FG000|Induction Phase|Secondary Disease|2|||
42092128|NCT00726986|75902416|FG000|Maintenance Phase|Adverse Event|1|||
42092129|NCT00726986|75902416|FG000|Maintenance Phase|Lack of Efficacy|2|||
42092130|NCT00696657|75902429|FG000|Overall Study|Protocol Violation|0|||
42185415|NCT00090285|75994441|FG001|Base Study Follow-up Period|Other|0|||
42295297|NCT02504541|76129815|FG000|Overall Study|Met Stopping Criteria|1|||
42092131|NCT00696657|75902430|FG001|Overall Study|Protocol Violation|0|||
42092132|NCT00696657|75902431|FG002|Overall Study|Protocol Violation|0|||
42092133|NCT00696657|75902432|FG003|Overall Study|Protocol Violation|0|||
42092134|NCT00696657|75902433|FG004|Overall Study|Protocol Violation|0|||
42092135|NCT00696657|75902434|FG005|Overall Study|Protocol Violation|1|||
42092136|NCT00696657|75902435|FG006|Overall Study|Protocol Violation|0|||
42092137|NCT00696657|75902436|FG007|Overall Study|Protocol Violation|0|||
42092138|NCT00696657|75902437|FG008|Overall Study|Protocol Violation|1|||
42092139|NCT00696657|75902429|FG000|Overall Study|Lack of Efficacy|0|||
42092140|NCT00696657|75902430|FG001|Overall Study|Lack of Efficacy|1|||
42092141|NCT00696657|75902431|FG002|Overall Study|Lack of Efficacy|0|||
42092142|NCT00696657|75902432|FG003|Overall Study|Lack of Efficacy|0|||
42092143|NCT00696657|75902433|FG004|Overall Study|Lack of Efficacy|0|||
42092144|NCT00696657|75902434|FG005|Overall Study|Lack of Efficacy|0|||
42092145|NCT00696657|75902435|FG006|Overall Study|Lack of Efficacy|0|||
42092146|NCT00696657|75902436|FG007|Overall Study|Lack of Efficacy|0|||
42092147|NCT00696657|75902437|FG008|Overall Study|Lack of Efficacy|0|||
42092148|NCT00696657|75902429|FG000|Overall Study|Withdrawal criteria|1|||
42092149|NCT00696657|75902430|FG001|Overall Study|Withdrawal criteria|3|||
42092150|NCT00696657|75902431|FG002|Overall Study|Withdrawal criteria|2|||
42092151|NCT00696657|75902432|FG003|Overall Study|Withdrawal criteria|2|||
42092152|NCT00696657|75902433|FG004|Overall Study|Withdrawal criteria|0|||
42092153|NCT00696657|75902434|FG005|Overall Study|Withdrawal criteria|0|||
42092154|NCT00696657|75902435|FG006|Overall Study|Withdrawal criteria|1|||
42092155|NCT00696657|75902436|FG007|Overall Study|Withdrawal criteria|1|||
42092156|NCT00696657|75902437|FG008|Overall Study|Withdrawal criteria|2|||
42092157|NCT00696657|75902429|FG000|Overall Study|Unclassified|0|||
42092158|NCT00696657|75902430|FG001|Overall Study|Unclassified|1|||
42092159|NCT00696657|75902431|FG002|Overall Study|Unclassified|3|||
42092160|NCT00696657|75902432|FG003|Overall Study|Unclassified|2|||
42092161|NCT00696657|75902433|FG004|Overall Study|Unclassified|4|||
42092162|NCT00696657|75902434|FG005|Overall Study|Unclassified|2|||
42092163|NCT00696657|75902435|FG006|Overall Study|Unclassified|0|||
42092164|NCT00696657|75902436|FG007|Overall Study|Unclassified|0|||
42092165|NCT00696657|75902437|FG008|Overall Study|Unclassified|1|||
42092166|NCT00696657|75902429|FG000|Overall Study|Adverse Event|0|||
42092167|NCT00696657|75902430|FG001|Overall Study|Adverse Event|0|||
42092168|NCT00696657|75902431|FG002|Overall Study|Adverse Event|3|||
42092169|NCT00696657|75902432|FG003|Overall Study|Adverse Event|7|||
42092170|NCT00696657|75902433|FG004|Overall Study|Adverse Event|6|||
42092171|NCT00696657|75902434|FG005|Overall Study|Adverse Event|9|||
42092172|NCT00696657|75902435|FG006|Overall Study|Adverse Event|14|||
42185416|NCT00090285|75994442|FG002|Base Study Follow-up Period|Other|0|||
42185417|NCT00090285|75994443|FG003|Base Study Follow-up Period|Other|0|||
42185418|NCT00090285|75994444|FG004|Base Study Follow-up Period|Other|0|||
42185419|NCT00090285|75994445|FG005|Base Study Follow-up Period|Other|0|||
42185420|NCT00090285|75994440|FG000|Base Study Follow-up Period|Protocol Violation|1|||
42185421|NCT00090285|75994441|FG001|Base Study Follow-up Period|Protocol Violation|0|||
42185422|NCT00090285|75994442|FG002|Base Study Follow-up Period|Protocol Violation|0|||
42185423|NCT00090285|75994443|FG003|Base Study Follow-up Period|Protocol Violation|0|||
42185424|NCT00090285|75994444|FG004|Base Study Follow-up Period|Protocol Violation|0|||
42185425|NCT00090285|75994445|FG005|Base Study Follow-up Period|Protocol Violation|0|||
42185426|NCT00090285|75994440|FG000|Base Study Follow-up Period|Uncooperative|3|||
42295298|NCT02504541|76129815|FG000|Overall Study|Protocol Violation|2|||
42018026|NCT01261325|75825740|FG000|Overall Study|AE, non-serious non-fatal|9|||
42018027|NCT01261325|75825741|FG001|Overall Study|AE, non-serious non-fatal|15|||
42018028|NCT01261325|75825742|FG002|Overall Study|AE, non-serious non-fatal|13|||
42018029|NCT01261325|75825740|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
42018030|NCT01261325|75825741|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
42018031|NCT01261325|75825742|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
42018032|NCT01261325|75825740|FG000|Overall Study|Non Compliance|2|||
42018033|NCT01261325|75825741|FG001|Overall Study|Non Compliance|0|||
42018034|NCT01261325|75825742|FG002|Overall Study|Non Compliance|0|||
42018035|NCT01261325|75825740|FG000|Overall Study|Patient Randomized by Mistake|0|||
42018036|NCT01261325|75825741|FG001|Overall Study|Patient Randomized by Mistake|1|||
42018037|NCT01261325|75825742|FG002|Overall Study|Patient Randomized by Mistake|0|||
42092173|NCT00696657|75902436|FG007|Overall Study|Adverse Event|2|||
42092174|NCT00696657|75902437|FG008|Overall Study|Adverse Event|5|||
42092175|NCT00730886|75902459|FG000|Overall Study|Lost to Follow-up|1|||
42092176|NCT00730886|75902460|FG001|Overall Study|Lost to Follow-up|0|||
42092177|NCT00730886|75902459|FG000|Overall Study|Physician Decision|1|||
42092178|NCT00730886|75902460|FG001|Overall Study|Physician Decision|0|||
42092179|NCT00726752|75902466|FG000|Overall Study|Lack of Efficacy|6|||
42092180|NCT00730028|75902484|FG000|Overall Study|Adverse Event|23|||
42092181|NCT00730028|75902485|FG001|Overall Study|Adverse Event|26|||
42092182|NCT00730028|75902486|FG002|Overall Study|Adverse Event|16|||
42092183|NCT00730028|75902487|FG003|Overall Study|Adverse Event|20|||
42092184|NCT00730028|75902488|FG004|Overall Study|Adverse Event|43|||
42185427|NCT00090285|75994441|FG001|Base Study Follow-up Period|Uncooperative|4|||
42185428|NCT00090285|75994442|FG002|Base Study Follow-up Period|Uncooperative|0|||
42185429|NCT00090285|75994443|FG003|Base Study Follow-up Period|Uncooperative|0|||
42185430|NCT00090285|75994444|FG004|Base Study Follow-up Period|Uncooperative|0|||
42185431|NCT00090285|75994445|FG005|Base Study Follow-up Period|Uncooperative|0|||
42185432|NCT00090285|75994440|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
42185433|NCT00090285|75994441|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
42185434|NCT00090285|75994442|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
42185435|NCT00090285|75994443|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
42185436|NCT00090285|75994444|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
42185437|NCT00090285|75994445|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
42185438|NCT00090285|75994440|FG000|Extension 1|Adverse Event|0|||
42185439|NCT00090285|75994441|FG001|Extension 1|Adverse Event|0|||
42185440|NCT00090285|75994442|FG002|Extension 1|Adverse Event|2|||
42185441|NCT00090285|75994443|FG003|Extension 1|Adverse Event|0|||
42185442|NCT00090285|75994444|FG004|Extension 1|Adverse Event|0|||
42185443|NCT00090285|75994445|FG005|Extension 1|Adverse Event|0|||
42185444|NCT00090285|75994440|FG000|Extension 1|Lost to Follow-up|0|||
42185445|NCT00090285|75994441|FG001|Extension 1|Lost to Follow-up|0|||
42185446|NCT00090285|75994442|FG002|Extension 1|Lost to Follow-up|35|||
42185447|NCT00090285|75994443|FG003|Extension 1|Lost to Follow-up|0|||
42185448|NCT00090285|75994444|FG004|Extension 1|Lost to Follow-up|0|||
42185449|NCT00090285|75994445|FG005|Extension 1|Lost to Follow-up|0|||
42185450|NCT00090285|75994440|FG000|Extension 1|Withdrawal by Subject|0|||
42185451|NCT00090285|75994441|FG001|Extension 1|Withdrawal by Subject|0|||
42185452|NCT00090285|75994442|FG002|Extension 1|Withdrawal by Subject|13|||
42185453|NCT00090285|75994443|FG003|Extension 1|Withdrawal by Subject|1|||
42185454|NCT00090285|75994444|FG004|Extension 1|Withdrawal by Subject|0|||
42185455|NCT00090285|75994445|FG005|Extension 1|Withdrawal by Subject|0|||
42185456|NCT00090285|75994440|FG000|Extension 1|Other|0|||
42185457|NCT00090285|75994441|FG001|Extension 1|Other|0|||
42185458|NCT00090285|75994442|FG002|Extension 1|Other|4|||
42185459|NCT00090285|75994443|FG003|Extension 1|Other|0|||
42185460|NCT00090285|75994444|FG004|Extension 1|Other|0|||
42185461|NCT00090285|75994445|FG005|Extension 1|Other|0|||
42185462|NCT00090285|75994440|FG000|Extension 1|Moved|0|||
42185463|NCT00090285|75994441|FG001|Extension 1|Moved|0|||
42185464|NCT00090285|75994442|FG002|Extension 1|Moved|3|||
42185465|NCT00090285|75994443|FG003|Extension 1|Moved|0|||
42185466|NCT00090285|75994444|FG004|Extension 1|Moved|0|||
42185467|NCT00090285|75994445|FG005|Extension 1|Moved|0|||
42185468|NCT00090285|75994440|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
42185469|NCT00090285|75994441|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
42185470|NCT00090285|75994442|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
42185471|NCT00090285|75994443|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
42185472|NCT00090285|75994444|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
42185473|NCT00090285|75994445|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
42185474|NCT00090285|75994440|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
42185475|NCT00090285|75994441|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
42185476|NCT00090285|75994442|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
42185477|NCT00090285|75994443|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
42185478|NCT00090285|75994444|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
42185479|NCT00090285|75994445|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
42185480|NCT00090285|75994440|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
42185481|NCT00090285|75994441|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
42185482|NCT00090285|75994442|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
42185483|NCT00090285|75994443|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
42185484|NCT00090285|75994444|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
42185485|NCT00090285|75994445|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
42185486|NCT00090285|75994440|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
42185487|NCT00090285|75994441|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
42185488|NCT00090285|75994442|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
42018038|NCT01261325|75825740|FG000|Overall Study|Erroneously Randomized|1|||
42185489|NCT00090285|75994443|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
42185490|NCT00090285|75994444|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
42185491|NCT00090285|75994445|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
42185492|NCT00070941|75994463|FG000|Overall Study|Adverse Event|10|||
42018039|NCT01261325|75825741|FG001|Overall Study|Erroneously Randomized|0|||
42018040|NCT01261325|75825742|FG002|Overall Study|Erroneously Randomized|0|||
42018041|NCT01261325|75825740|FG000|Overall Study|Screen Failure|1|||
42018042|NCT01261325|75825741|FG001|Overall Study|Screen Failure|0|||
42185493|NCT00070941|75994464|FG001|Overall Study|Adverse Event|8|||
42185494|NCT00070941|75994465|FG002|Overall Study|Adverse Event|4|||
42185495|NCT00070707|75994475|FG000|Overall Study|Adverse Event|1|||
42018043|NCT01261325|75825742|FG002|Overall Study|Screen Failure|0|||
42018044|NCT01261325|75825740|FG000|Overall Study|Randomized in Error|0|||
42185496|NCT00070707|75994476|FG001|Overall Study|Adverse Event|2|||
42185497|NCT00070707|75994475|FG000|Overall Study|Lack of Efficacy|4|||
42185498|NCT00070707|75994476|FG001|Overall Study|Lack of Efficacy|1|||
42185499|NCT00070707|75994475|FG000|Overall Study|Protocol Violation|8|||
42185500|NCT00070707|75994476|FG001|Overall Study|Protocol Violation|4|||
42185501|NCT00070707|75994475|FG000|Overall Study|Unrelated to Study Medication|1|||
42185502|NCT00070707|75994476|FG001|Overall Study|Unrelated to Study Medication|0|||
42185503|NCT03036124|75994484|FG000|Overall Study|Lost to Follow-up|0|||
42092185|NCT00730028|75902484|FG000|Overall Study|Lost to Follow-up|13|||
42092186|NCT00730028|75902485|FG001|Overall Study|Lost to Follow-up|26|||
42092187|NCT00730028|75902486|FG002|Overall Study|Lost to Follow-up|22|||
42185504|NCT03036124|75994485|FG001|Overall Study|Lost to Follow-up|2|||
42185505|NCT03036124|75994484|FG000|Overall Study|Withdrawal by Subject|5|||
42185506|NCT03036124|75994485|FG001|Overall Study|Withdrawal by Subject|4|||
42185507|NCT00070317|75994491|FG000|Overall Study|Inevaluable (Never Treated)|1|||
42185508|NCT00070317|75994491|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
42185509|NCT00070317|75994491|FG000|Overall Study|Ineligible required test not done|1|||
42185510|NCT00070317|75994491|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
42185511|NCT00070317|75994491|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
42185512|NCT03649412|75994497|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
42185513|NCT03649412|75994498|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
42185514|NCT03649412|75994497|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
42185515|NCT03649412|75994498|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
42185516|NCT03649412|75994497|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
42185517|NCT03649412|75994498|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
42185518|NCT03649412|75994497|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
42185519|NCT03649412|75994498|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
42185520|NCT03649412|75994497|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
42185521|NCT03649412|75994498|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
42185522|NCT03649412|75994497|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
42185523|NCT03649412|75994498|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
42185524|NCT03587636|75994543|FG000|Overall Study|Lost to Follow-up|2|||
42185525|NCT03587636|75994544|FG001|Overall Study|Lost to Follow-up|5|||
42185526|NCT03586544|75994562|FG000|First Intervention|Adverse Event|0|||
42185527|NCT03586544|75994563|FG001|First Intervention|Adverse Event|1|||
42185528|NCT03586544|75994562|FG000|Second Intervention|Withdrawal by Subject|0|||
42185529|NCT03586544|75994563|FG001|Second Intervention|Withdrawal by Subject|1|||
42185530|NCT03585296|75994569|FG000|Overall Study|Adverse Event|1|||
42185531|NCT03585296|75994569|FG000|Overall Study|Lost to Follow-up|2|||
42185532|NCT03585296|75994569|FG000|Overall Study|Withdrawal by Subject|2|||
42092188|NCT00730028|75902487|FG003|Overall Study|Lost to Follow-up|26|||
42092189|NCT00730028|75902488|FG004|Overall Study|Lost to Follow-up|25|||
42092190|NCT00730028|75902484|FG000|Overall Study|Protocol Violation|6|||
42092191|NCT00730028|75902485|FG001|Overall Study|Protocol Violation|1|||
42092192|NCT00730028|75902486|FG002|Overall Study|Protocol Violation|1|||
42092193|NCT00730028|75902487|FG003|Overall Study|Protocol Violation|2|||
42092194|NCT00730028|75902488|FG004|Overall Study|Protocol Violation|0|||
42092195|NCT00730028|75902484|FG000|Overall Study|Withdrawal by Subject|9|||
42185533|NCT03589768|75994577|FG000|Overall Study|Death|1|||
42185534|NCT03589768|75994578|FG001|Overall Study|Death|0|||
42185535|NCT03589768|75994579|FG002|Overall Study|Death|8|||
42185536|NCT03589768|75994580|FG003|Overall Study|Death|3|||
42185537|NCT03589768|75994577|FG000|Overall Study|Withdrawal by Subject|2|||
42185538|NCT03589768|75994578|FG001|Overall Study|Withdrawal by Subject|0|||
42185539|NCT03589768|75994579|FG002|Overall Study|Withdrawal by Subject|0|||
42092196|NCT00730028|75902485|FG001|Overall Study|Withdrawal by Subject|5|||
42092197|NCT00730028|75902486|FG002|Overall Study|Withdrawal by Subject|4|||
42185540|NCT03589768|75994580|FG003|Overall Study|Withdrawal by Subject|0|||
42185541|NCT03589768|75994577|FG000|Overall Study|Protocol Violation|1|||
42185542|NCT03589768|75994578|FG001|Overall Study|Protocol Violation|0|||
42185543|NCT03589768|75994579|FG002|Overall Study|Protocol Violation|0|||
42185544|NCT03589768|75994580|FG003|Overall Study|Protocol Violation|0|||
42092198|NCT00730028|75902487|FG003|Overall Study|Withdrawal by Subject|5|||
42092199|NCT00730028|75902488|FG004|Overall Study|Withdrawal by Subject|9|||
42092200|NCT00730028|75902484|FG000|Overall Study|Physician Decision|3|||
42092201|NCT00730028|75902485|FG001|Overall Study|Physician Decision|3|||
42092202|NCT00730028|75902486|FG002|Overall Study|Physician Decision|2|||
42185545|NCT02892422|75994590|FG000|Overall Study|Enrolled not treated|4|||
42185546|NCT02892422|75994590|FG000|Overall Study|Adverse Event|38|||
42092203|NCT00730028|75902487|FG003|Overall Study|Physician Decision|3|||
42092204|NCT00730028|75902488|FG004|Overall Study|Physician Decision|2|||
42092205|NCT00730028|75902484|FG000|Overall Study|Treatment Failure|5|||
42092206|NCT00730028|75902485|FG001|Overall Study|Treatment Failure|5|||
42092207|NCT00730028|75902486|FG002|Overall Study|Treatment Failure|0|||
42092208|NCT00730028|75902487|FG003|Overall Study|Treatment Failure|0|||
42092209|NCT00730028|75902488|FG004|Overall Study|Treatment Failure|1|||
42092210|NCT00730028|75902484|FG000|Overall Study|Randomization Error|1|||
42092211|NCT00730028|75902485|FG001|Overall Study|Randomization Error|0|||
42185547|NCT02892422|75994590|FG000|Overall Study|Lack of Efficacy|32|||
42185548|NCT02892422|75994590|FG000|Overall Study|Non-compliance with study drug|11|||
42185549|NCT02892422|75994590|FG000|Overall Study|Protocol Violation|4|||
42185550|NCT02892422|75994590|FG000|Overall Study|Withdrawal by Subject|56|||
42185551|NCT02892422|75994590|FG000|Overall Study|Lost to Follow-up|5|||
42185552|NCT02892422|75994590|FG000|Overall Study|sponsor information 16159A results|21|||
42185553|NCT02892422|75994590|FG000|Overall Study|withdrawal of consent|13|||
42185554|NCT02892422|75994590|FG000|Overall Study|exclusion criteria met|3|||
42185555|NCT02892422|75994590|FG000|Overall Study|moving elsewhere|4|||
42185556|NCT02892422|75994590|FG000|Overall Study|non-compliance|10|||
42185557|NCT02892422|75994590|FG000|Overall Study|patient legally incapable|1|||
42185558|NCT02892422|75994590|FG000|Overall Study|patient decision|7|||
42185559|NCT02892422|75994590|FG000|Overall Study|Investigator decision|1|||
42185560|NCT03571646|75994596|FG000|Overall Study|Adverse Event|1|||
42185561|NCT03571646|75994597|FG001|Overall Study|Adverse Event|0|||
42185562|NCT03571646|75994596|FG000|Overall Study|Withdrawal by Subject|1|||
42185563|NCT03571646|75994597|FG001|Overall Study|Withdrawal by Subject|1|||
42185564|NCT03645434|75994603|FG000|Period 1|Adverse Event|0|||
42185565|NCT03645434|75994604|FG001|Period 1|Adverse Event|0|||
42185566|NCT03645434|75994605|FG002|Period 1|Adverse Event|0|||
42185567|NCT03645434|75994606|FG003|Period 1|Adverse Event|1|||
42185568|NCT03645434|75994607|FG004|Period 1|Adverse Event|0|||
42185569|NCT03645434|75994608|FG005|Period 1|Adverse Event|0|||
42185570|NCT03645434|75994603|FG000|Period 1|COPD exacerbation|0|||
42185571|NCT03645434|75994604|FG001|Period 1|COPD exacerbation|0|||
42185572|NCT03645434|75994605|FG002|Period 1|COPD exacerbation|0|||
42185573|NCT03645434|75994606|FG003|Period 1|COPD exacerbation|0|||
42185574|NCT03645434|75994607|FG004|Period 1|COPD exacerbation|1|||
42185575|NCT03645434|75994608|FG005|Period 1|COPD exacerbation|0|||
42185576|NCT00089505|75994620|FG000|Overall Study|Death|4|||
42185577|NCT00089505|75994621|FG001|Overall Study|Death|1|||
42185578|NCT00089505|75994622|FG002|Overall Study|Death|5|||
42185579|NCT00089505|75994623|FG003|Overall Study|Death|8|||
42185580|NCT00089505|75994620|FG000|Overall Study|Withdrawal by Subject|3|||
42185581|NCT00089505|75994621|FG001|Overall Study|Withdrawal by Subject|0|||
42185582|NCT00089505|75994622|FG002|Overall Study|Withdrawal by Subject|6|||
42185583|NCT00089505|75994623|FG003|Overall Study|Withdrawal by Subject|6|||
42185584|NCT00089505|75994620|FG000|Overall Study|Lost to Follow-up|1|||
42295299|NCT02504541|76129815|FG000|Overall Study|Termination by Sponsor|1|||
42092212|NCT00730028|75902486|FG002|Overall Study|Randomization Error|0|||
42185585|NCT00089505|75994621|FG001|Overall Study|Lost to Follow-up|1|||
42185586|NCT00089505|75994622|FG002|Overall Study|Lost to Follow-up|9|||
42185587|NCT00089505|75994623|FG003|Overall Study|Lost to Follow-up|7|||
42185588|NCT00089505|75994620|FG000|Overall Study|Physician Decision|1|||
42185589|NCT00089505|75994621|FG001|Overall Study|Physician Decision|0|||
42185590|NCT00089505|75994622|FG002|Overall Study|Physician Decision|0|||
42185591|NCT00089505|75994623|FG003|Overall Study|Physician Decision|0|||
42018045|NCT01261325|75825741|FG001|Overall Study|Randomized in Error|0|||
42018046|NCT01261325|75825742|FG002|Overall Study|Randomized in Error|1|||
42018047|NCT01261325|75825740|FG000|Overall Study|Protocol Violation|0|||
42018048|NCT01261325|75825741|FG001|Overall Study|Protocol Violation|3|||
42018049|NCT01261325|75825742|FG002|Overall Study|Protocol Violation|1|||
42018050|NCT01261325|75825740|FG000|Overall Study|Lost to Follow-up|0|||
42018051|NCT01261325|75825741|FG001|Overall Study|Lost to Follow-up|1|||
42018052|NCT01261325|75825742|FG002|Overall Study|Lost to Follow-up|3|||
42295300|NCT02504541|76129815|FG000|Overall Study|Other|2|||
42295301|NCT02504541|76129815|FG000|Overall Study|Multiple|5|||
42018053|NCT01261325|75825740|FG000|Overall Study|AE, serious fatal|0|||
42018054|NCT01261325|75825741|FG001|Overall Study|AE, serious fatal|0|||
42185592|NCT00089505|75994620|FG000|Overall Study|Protocol Violation|0|||
42185593|NCT00089505|75994621|FG001|Overall Study|Protocol Violation|0|||
42018055|NCT01261325|75825742|FG002|Overall Study|AE, serious fatal|2|||
42092213|NCT00730028|75902487|FG003|Overall Study|Randomization Error|0|||
42092214|NCT00730028|75902488|FG004|Overall Study|Randomization Error|2|||
42185594|NCT00089505|75994622|FG002|Overall Study|Protocol Violation|1|||
42092215|NCT00736502|75902500|FG000|Overall Study|Adverse Event|22|||
42092216|NCT00736502|75902500|FG000|Overall Study|Lack of Efficacy|16|||
42092217|NCT00736502|75902500|FG000|Overall Study|Lost to Follow-up|27|||
42092218|NCT00729560|75902504|FG000|Overall Study|Withdrawal by Subject|3|||
42092219|NCT00736190|75902508|FG000|Overall Study|Pregnancy|1|||
42092220|NCT00736190|75902508|FG000|Overall Study|Withdrawal by Subject|1|||
42092221|NCT00736190|75902508|FG000|Overall Study|Adverse Event|1|||
42092222|NCT00729326|75902514|FG000|Overall Study|Lost to Follow-up|2|||
42092223|NCT00729326|75902515|FG001|Overall Study|Lost to Follow-up|0|||
42092224|NCT00729326|75902514|FG000|Overall Study|Physician Decision|0|||
42092225|NCT00729326|75902515|FG001|Overall Study|Physician Decision|1|||
42092226|NCT00729326|75902514|FG000|Overall Study|Protocol Violation|3|||
42092227|NCT00729326|75902515|FG001|Overall Study|Protocol Violation|2|||
42092228|NCT00729326|75902514|FG000|Overall Study|Subject Decision|4|||
42092229|NCT00729326|75902515|FG001|Overall Study|Subject Decision|4|||
42185595|NCT00089505|75994623|FG003|Overall Study|Protocol Violation|0|||
42185596|NCT04009824|75994638|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
42185597|NCT04009824|75994639|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
42185598|NCT04009824|75994640|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
42185599|NCT04009824|75994641|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
42185600|NCT04009824|75994642|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
42185601|NCT03555890|75994658|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
42185602|NCT03555890|75994659|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
42185603|NCT03555890|75994660|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
42185604|NCT03555890|75994661|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
42185605|NCT03688074|75994673|FG000|Overall Study|Adverse Event|0|||
42185606|NCT03688074|75994674|FG001|Overall Study|Adverse Event|1|||
42185607|NCT03688074|75994673|FG000|Overall Study|Other|1|||
42185608|NCT03688074|75994674|FG001|Overall Study|Other|0|||
42185609|NCT03630120|75994684|FG000|Overall Study|Disease progression|0|||
42185610|NCT03630120|75994685|FG001|Overall Study|Disease progression|1|||
42185611|NCT03630120|75994686|FG002|Overall Study|Disease progression|1|||
42185612|NCT03630120|75994687|FG003|Overall Study|Disease progression|1|||
42185613|NCT03555266|75994699|FG000|Overall Study|Protocol Violation|6|||
42185614|NCT03555266|75994700|FG001|Overall Study|Protocol Violation|4|||
42185615|NCT03629886|75994708|FG000|Overall Study|Migrated / moved from the study area|0|||
42185616|NCT03629886|75994709|FG001|Overall Study|Migrated / moved from the study area|55|||
42185617|NCT03629886|75994708|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
42185618|NCT03629886|75994709|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
42185619|NCT03629886|75994708|FG000|Overall Study|Study vaccine not administrated|0|||
42185620|NCT03629886|75994709|FG001|Overall Study|Study vaccine not administrated|3|||
42185621|NCT03629886|75994708|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
42185622|NCT03629886|75994709|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
42185623|NCT03629886|75994708|FG000|Overall Study|Refused vaccination step of the study|0|||
42185624|NCT03629886|75994709|FG001|Overall Study|Refused vaccination step of the study|44|||
42185625|NCT03656874|75994718|FG000|Overall Study|Lost to Follow-up|3|||
42185626|NCT03656874|75994719|FG001|Overall Study|Lost to Follow-up|17|||
42185627|NCT03554486|75994727|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
42185628|NCT03554486|75994728|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
42185629|NCT03554486|75994729|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
42185630|NCT03554486|75994727|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
42185631|NCT03554486|75994728|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
42185632|NCT03554486|75994729|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
42185633|NCT03554486|75994727|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
42185634|NCT03554486|75994728|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
42185635|NCT03554486|75994729|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
42358934|NCT02864251|76204675|FG000|Treatment|Study Drug Toxicity|9|||
42185636|NCT03554018|75994738|FG000|Overall Study|Lost to Follow-up|3|||
42018056|NCT01260701|75825753|FG000|Overall Study|Adverse Event|9|||
42018057|NCT01260701|75825753|FG000|Overall Study|Withdrawal by Subject|2|||
42018058|NCT01260701|75825753|FG000|Overall Study|Progression|53|||
42018059|NCT01260701|75825753|FG000|Overall Study|Death|2|||
42018060|NCT01260701|75825753|FG000|Overall Study|Not protocol specified|3|||
42018061|NCT01260701|75825753|FG000|Overall Study|Under review|1|||
42018062|NCT01260701|75825753|FG000|Overall Study|Ineligible|4|||
42018063|NCT01260701|75825753|FG000|Overall Study|Did not begin protocol therapy|1|||
42018064|NCT01260467|75825757|FG000|Overall Study|Withdrawal by Subject|2|||
42092230|NCT00729326|75902514|FG000|Overall Study|Sponsor Decision|1|||
42092231|NCT00729326|75902515|FG001|Overall Study|Sponsor Decision|2|||
42092232|NCT00729248|75902521|FG000|Overall Study|Physician Decision|2|||
42185637|NCT03554018|75994739|FG001|Overall Study|Lost to Follow-up|7|||
42185638|NCT03571256|75994748|FG000|Overall Study|Adverse Event|3|||
42185639|NCT03571256|75994749|FG001|Overall Study|Adverse Event|0|||
42185640|NCT03571256|75994750|FG002|Overall Study|Adverse Event|1|||
42185641|NCT03571256|75994748|FG000|Overall Study|Withdrawal by Subject|3|||
42185642|NCT03571256|75994749|FG001|Overall Study|Withdrawal by Subject|1|||
42185643|NCT03571256|75994750|FG002|Overall Study|Withdrawal by Subject|1|||
42185644|NCT03571256|75994748|FG000|Overall Study|Other than specified|0|||
42185645|NCT03571256|75994749|FG001|Overall Study|Other than specified|1|||
42295302|NCT02448537|76129822|FG000|Overall Study|Withdrawal by Subject|1|||
42295303|NCT02448537|76129823|FG001|Overall Study|Withdrawal by Subject|1|||
42295304|NCT02448537|76129824|FG002|Overall Study|Withdrawal by Subject|1|||
42295305|NCT02504151|76129843|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
42295306|NCT02504151|76129844|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
42295307|NCT02504151|76129843|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
42295308|NCT02504151|76129844|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
42295309|NCT02504151|76129843|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
42295310|NCT02504151|76129844|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
42295311|NCT02504151|76129843|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
42295312|NCT02504151|76129844|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
42295313|NCT02448381|76129852|FG000|Overall Study|Adverse Event|2|||
42295314|NCT02448381|76129853|FG001|Overall Study|Adverse Event|0|||
42295315|NCT02448381|76129852|FG000|Overall Study|Lost to Follow-up|16|||
42295316|NCT02448381|76129853|FG001|Overall Study|Lost to Follow-up|9|||
42295317|NCT02448381|76129852|FG000|Overall Study|Physician Decision|1|||
42295318|NCT02448381|76129853|FG001|Overall Study|Physician Decision|1|||
42295319|NCT02448381|76129852|FG000|Overall Study|Pregnancy|1|||
42295320|NCT02448381|76129853|FG001|Overall Study|Pregnancy|0|||
42092233|NCT00696423|75902528|FG000|Overall Study|Lost to Follow-up|0|||
42092234|NCT00696423|75902529|FG001|Overall Study|Lost to Follow-up|5|||
42092235|NCT00736034|75902535|FG000|Overall Study|Adverse Event|2|||
42092236|NCT00576693|75902541|FG000|Overall Study|Lost to Follow-up|7|||
42295321|NCT02448381|76129852|FG000|Overall Study|Withdrawal by Subject|13|||
42295322|NCT02448381|76129853|FG001|Overall Study|Withdrawal by Subject|9|||
42295323|NCT02448381|76129852|FG000|Overall Study|Noncompliance with Study Procedures|2|||
42295324|NCT02448381|76129853|FG001|Overall Study|Noncompliance with Study Procedures|0|||
42295325|NCT02448225|76129865|FG000|Overall Study|Withdrawal by Subject|1|||
42295326|NCT02448225|76129865|FG000|Overall Study|Did not get FSPG scan|18|||
42295327|NCT02448225|76129865|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
42295328|NCT02503215|76129872|FG000|Overall Study|Unable to wear compression stockings|1|||
42092237|NCT00576693|75902542|FG001|Overall Study|Lost to Follow-up|11|||
42092238|NCT00576693|75902541|FG000|Overall Study|Withdrawal by Subject|3|||
42092239|NCT00576693|75902542|FG001|Overall Study|Withdrawal by Subject|13|||
42092240|NCT00698451|75902548|FG000|Overall Study|Adverse Event|22|||
42092241|NCT00698451|75902548|FG000|Overall Study|Physician Decision|2|||
42092242|NCT00698451|75902548|FG000|Overall Study|Protocol Violation|6|||
42092243|NCT00698451|75902548|FG000|Overall Study|Withdrawal by Subject|6|||
42092244|NCT00698451|75902548|FG000|Overall Study|Disease progression|3|||
42092245|NCT00697827|75902554|FG000|Overall Study|enrolled but not treated|2|||
42092246|NCT00697827|75902555|FG001|Overall Study|enrolled but not treated|1|||
42092247|NCT00728936|75902568|FG000|Overall Study|Withdrawal by Subject|0|||
42092248|NCT00728936|75902569|FG001|Overall Study|Withdrawal by Subject|0|||
42295329|NCT02503215|76129872|FG000|Overall Study|Unable to use positive airway pressure|2|||
42295330|NCT02447991|76129878|FG000|Overall Study|Withdrawn by subject - no data|0|||
42295331|NCT02447991|76129879|FG001|Overall Study|Withdrawn by subject - no data|2|||
42295332|NCT02447991|76129878|FG000|Overall Study|Withdrawn by Subject - with data|4|||
42295333|NCT02447991|76129879|FG001|Overall Study|Withdrawn by Subject - with data|4|||
42295334|NCT02447991|76129878|FG000|Overall Study|Lost to Follow-up - no data|3|||
42092249|NCT00728936|75902570|FG002|Overall Study|Withdrawal by Subject|0|||
42092250|NCT00728936|75902571|FG003|Overall Study|Withdrawal by Subject|0|||
42092251|NCT00728936|75902572|FG004|Overall Study|Withdrawal by Subject|0|||
42185646|NCT03571256|75994750|FG002|Overall Study|Other than specified|1|||
42185647|NCT03571256|75994748|FG000|Overall Study|Protocol Violation|0|||
42295335|NCT02447991|76129879|FG001|Overall Study|Lost to Follow-up - no data|6|||
42295336|NCT02447991|76129878|FG000|Overall Study|Lost to follow-up - with data|0|||
42092252|NCT00728936|75902573|FG005|Overall Study|Withdrawal by Subject|1|||
42092253|NCT00728936|75902574|FG006|Overall Study|Withdrawal by Subject|0|||
42092254|NCT00693693|75902593|FG000|Overall Study|Lost to Follow-up|1|||
42092255|NCT00693693|75902594|FG001|Overall Study|Lost to Follow-up|1|||
42185648|NCT03571256|75994749|FG001|Overall Study|Protocol Violation|1|||
42092256|NCT00693693|75902595|FG002|Overall Study|Lost to Follow-up|2|||
42092257|NCT00728468|75902603|FG000|Overall Study|Enrolled but not treated|1|||
42092258|NCT00728468|75902603|FG000|Overall Study|Death|1|||
42092259|NCT00728468|75902603|FG000|Overall Study|Protocol Violation|4|||
42092260|NCT00728468|75902603|FG000|Overall Study|Objective progression or relapse|9|||
42092261|NCT00728468|75902603|FG000|Overall Study|Study terminated by sponsor|1|||
42092262|NCT00727844|75902609|FG000|Initial Randomization|Physician Decision|2|||
42185649|NCT03571256|75994750|FG002|Overall Study|Protocol Violation|1|||
42185650|NCT03570554|75994764|FG000|Overall Study|Non-compliance with study drug|0|||
42185651|NCT03570554|75994765|FG001|Overall Study|Non-compliance with study drug|0|||
42185652|NCT03570554|75994766|FG002|Overall Study|Non-compliance with study drug|1|||
42185653|NCT03570554|75994767|FG003|Overall Study|Non-compliance with study drug|0|||
42185654|NCT03570554|75994764|FG000|Overall Study|Adverse Event|0|||
42185655|NCT03570554|75994765|FG001|Overall Study|Adverse Event|0|||
42185656|NCT03570554|75994766|FG002|Overall Study|Adverse Event|0|||
42295337|NCT02447991|76129879|FG001|Overall Study|Lost to follow-up - with data|3|||
42295338|NCT02447991|76129878|FG000|Overall Study|End of study - no treatment results|3|||
42295339|NCT02447991|76129879|FG001|Overall Study|End of study - no treatment results|6|||
42295340|NCT02447991|76129878|FG000|Overall Study|End of study - partial treatment results|0|||
42295341|NCT02447991|76129879|FG001|Overall Study|End of study - partial treatment results|9|||
42295342|NCT02586155|76129891|FG000|Overall Study|Adverse Event|2|||
42295343|NCT02586155|76129892|FG001|Overall Study|Adverse Event|3|||
42295344|NCT02586155|76129891|FG000|Overall Study|Withdrawal by Subject|31|||
42295345|NCT02586155|76129892|FG001|Overall Study|Withdrawal by Subject|24|||
42295346|NCT02586155|76129891|FG000|Overall Study|Lost to Follow-up|7|||
42295347|NCT02586155|76129892|FG001|Overall Study|Lost to Follow-up|13|||
42295348|NCT02586155|76129891|FG000|Overall Study|Death|61|||
42295349|NCT02586155|76129892|FG001|Overall Study|Death|72|||
42295350|NCT02586155|76129891|FG000|Overall Study|Other reasons|26|||
42295351|NCT02586155|76129892|FG001|Overall Study|Other reasons|15|||
42295352|NCT02446743|76129900|FG000|Overall Study|Withdrawal by Subject|1|||
42295353|NCT02446743|76129901|FG001|Overall Study|Withdrawal by Subject|1|||
42295354|NCT02446743|76129900|FG000|Overall Study|Lost to Follow-up|1|||
42295355|NCT02446743|76129901|FG001|Overall Study|Lost to Follow-up|0|||
42295356|NCT02446743|76129900|FG000|Overall Study|Adverse Event|1|||
42295357|NCT02446743|76129901|FG001|Overall Study|Adverse Event|1|||
42295358|NCT02446743|76129900|FG000|Overall Study|Other|2|||
42295359|NCT02446743|76129901|FG001|Overall Study|Other|3|||
42295360|NCT02586077|76129916|FG000|Overall Study|Withdrawal by Subject|1|||
42295361|NCT02586077|76129916|FG000|Overall Study|Physician Decision|4|||
42295362|NCT02586077|76129916|FG000|Overall Study|Lost to Follow-up|3|||
42295363|NCT02583425|76129921|FG000|Screening|Did not meet entry criteria|12|||
42295364|NCT02583425|76129921|FG000|Baseline|Did not meet continued criteria|5|||
42295365|NCT02583425|76129921|FG000|Treatment Period|Adverse Event|1|||
42295366|NCT02581163|76129926|FG000|Overall Study|Failure to return|15|||
42295367|NCT02581163|76129926|FG000|Overall Study|Insufficient virological response|3|||
42295368|NCT02581163|76129926|FG000|Overall Study|Withdrew consent|1|||
42295369|NCT02581163|76129926|FG000|Overall Study|Death|1|||
42295370|NCT02581163|76129926|FG000|Overall Study|Other, not specified|9|||
42295371|NCT02627677|76129936|FG000|Overall Study|Adverse event (not progressive disease)|1|||
42295372|NCT02627677|76129937|FG001|Overall Study|Adverse event (not progressive disease)|4|||
42295373|NCT02627677|76129938|FG002|Overall Study|Adverse event (not progressive disease)|1|||
42295374|NCT02627677|76129936|FG000|Overall Study|Progressive disease|1|||
42295375|NCT02627677|76129937|FG001|Overall Study|Progressive disease|3|||
42295376|NCT02627677|76129938|FG002|Overall Study|Progressive disease|0|||
42295377|NCT02627677|76129936|FG000|Overall Study|Lack of Efficacy|1|||
42295378|NCT02627677|76129937|FG001|Overall Study|Lack of Efficacy|2|||
42295379|NCT02627677|76129938|FG002|Overall Study|Lack of Efficacy|0|||
42295380|NCT02627677|76129936|FG000|Overall Study|Lost to Follow-up|0|||
42295381|NCT02627677|76129937|FG001|Overall Study|Lost to Follow-up|0|||
42295382|NCT02627677|76129938|FG002|Overall Study|Lost to Follow-up|1|||
42295383|NCT02627677|76129936|FG000|Overall Study|Pregnancy|0|||
42358935|NCT02864251|76204676|FG001|Treatment|Study Drug Toxicity|4|||
42092263|NCT00727844|75902610|FG001|Initial Randomization|Physician Decision|0|||
42092264|NCT00727844|75902611|FG002|Initial Randomization|Physician Decision|0|||
42092265|NCT00727844|75902612|FG003|Initial Randomization|Physician Decision|0|||
42092266|NCT00735878|75902620|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
42092267|NCT00735878|75902621|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
42092268|NCT00735878|75902622|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
42092269|NCT00695955|75902633|FG000|Cohort 1|Adverse Event|26|||
42092270|NCT00695955|75902633|FG000|Cohort 1|Protocol Violation|2|||
42092271|NCT00695955|75902633|FG000|Cohort 1|Lost to Follow-up|30|||
42092272|NCT00695955|75902633|FG000|Cohort 1|Withdrawal by Subject|25|||
42295384|NCT02627677|76129937|FG001|Overall Study|Pregnancy|1|||
42295385|NCT02627677|76129938|FG002|Overall Study|Pregnancy|0|||
42295386|NCT02627677|76129936|FG000|Overall Study|Study Terminated by Sponsor|5|||
42092273|NCT00695955|75902633|FG000|Cohort 1|Lack of Efficacy|3|||
42092274|NCT00695955|75902633|FG000|Cohort 1|Other|16|||
42092275|NCT00695955|75902633|FG000|Cohort 2|Adverse Event|24|||
42092276|NCT00695955|75902633|FG000|Cohort 2|Protocol Violation|5|||
42092277|NCT00695955|75902633|FG000|Cohort 2|Lost to Follow-up|38|||
42092278|NCT00695955|75902633|FG000|Cohort 2|Withdrawal by Subject|28|||
42092279|NCT00695955|75902633|FG000|Cohort 2|Lack of Efficacy|4|||
42185657|NCT03570554|75994767|FG003|Overall Study|Adverse Event|1|||
42185658|NCT04004208|75994779|FG000|Overall Study|Withdrawal by parent/guardian|1|||
42185659|NCT04004208|75994780|FG001|Overall Study|Withdrawal by parent/guardian|1|||
42185660|NCT04004208|75994779|FG000|Overall Study|Death|3|||
42185661|NCT04004208|75994780|FG001|Overall Study|Death|0|||
42185662|NCT04004208|75994779|FG000|Overall Study|COVID-19 pandemic|1|||
42185663|NCT04004208|75994780|FG001|Overall Study|COVID-19 pandemic|0|||
42185664|NCT04004208|75994779|FG000|Overall Study|Physician Decision|1|||
42092280|NCT00695955|75902633|FG000|Cohort 2|Other|5|||
42092281|NCT00693225|75902641|FG000|Overall Study|Lost to Follow-up|1|||
42092282|NCT00693225|75902642|FG001|Overall Study|Lost to Follow-up|2|||
42092283|NCT00693225|75902641|FG000|Overall Study|Adverse Event|1|||
42092284|NCT00693225|75902642|FG001|Overall Study|Adverse Event|3|||
42092285|NCT00735644|75902653|FG000|Overall Study|Did not receive study vaccine|0|||
42092286|NCT00735644|75902654|FG001|Overall Study|Did not receive study vaccine|1|||
42092287|NCT00735644|75902655|FG002|Overall Study|Did not receive study vaccine|0|||
42092288|NCT00735644|75902656|FG003|Overall Study|Did not receive study vaccine|0|||
42092289|NCT00735644|75902657|FG004|Overall Study|Did not receive study vaccine|0|||
42092290|NCT00735644|75902653|FG000|Overall Study|Withdrawal by Subject|0|||
42092291|NCT00735644|75902654|FG001|Overall Study|Withdrawal by Subject|1|||
42092292|NCT00735644|75902655|FG002|Overall Study|Withdrawal by Subject|1|||
42092293|NCT00735644|75902656|FG003|Overall Study|Withdrawal by Subject|1|||
42185665|NCT04004208|75994780|FG001|Overall Study|Physician Decision|0|||
42185666|NCT04004208|75994779|FG000|Overall Study|Adverse Event|1|||
42185667|NCT04004208|75994780|FG001|Overall Study|Adverse Event|1|||
42185668|NCT03643952|75994786|FG000|Overall Study|Lack of Efficacy|1|||
42185669|NCT03035032|75994798|FG000|Overall Study|Adverse Event|2|||
42185670|NCT03035032|75994798|FG000|Overall Study|Death|9|||
42185671|NCT03035032|75994798|FG000|Overall Study|Lost to Follow-up|1|||
42185672|NCT03035032|75994798|FG000|Overall Study|Progressive Disease|22|||
42185673|NCT03035032|75994798|FG000|Overall Study|Protocol Violation|2|||
42185674|NCT03035032|75994798|FG000|Overall Study|Withdrawal by Subject|2|||
42185675|NCT03035032|75994798|FG000|Overall Study|Physician Decision|5|||
42185676|NCT03629184|75994804|FG000|Overall Study|Withdrawal by Subject|2|||
42295387|NCT02627677|76129937|FG001|Overall Study|Study Terminated by Sponsor|10|||
42295388|NCT02627677|76129938|FG002|Overall Study|Study Terminated by Sponsor|6|||
42295389|NCT02627677|76129936|FG000|Overall Study|Physician Decision|0|||
42295390|NCT02627677|76129937|FG001|Overall Study|Physician Decision|0|||
42358936|NCT02864251|76204677|FG002|Treatment|Study Drug Toxicity|10|||
42295391|NCT02627677|76129938|FG002|Overall Study|Physician Decision|2|||
42358937|NCT02864251|76204675|FG000|Treatment|Death|0|||
42295392|NCT02627677|76129936|FG000|Overall Study|Withdrawal by Subject|2|||
42295393|NCT02627677|76129937|FG001|Overall Study|Withdrawal by Subject|1|||
42295394|NCT02627677|76129938|FG002|Overall Study|Withdrawal by Subject|1|||
42295395|NCT02627677|76129936|FG000|Overall Study|Reason not Specified|0|||
42295396|NCT02627677|76129937|FG001|Overall Study|Reason not Specified|0|||
42295397|NCT02627677|76129938|FG002|Overall Study|Reason not Specified|1|||
42295398|NCT02627677|76129936|FG000|Overall Study|Randomized but not Treated|1|||
42295399|NCT02627677|76129937|FG001|Overall Study|Randomized but not Treated|0|||
42295400|NCT02627677|76129938|FG002|Overall Study|Randomized but not Treated|0|||
42295401|NCT02501811|76129951|FG000|Overall Study|Death|1|||
42295402|NCT02501811|76129952|FG001|Overall Study|Death|3|||
42295403|NCT02501811|76129953|FG002|Overall Study|Death|2|||
42295404|NCT02501811|76129954|FG003|Overall Study|Death|3|||
42295405|NCT02501811|76129951|FG000|Overall Study|Withdrawal by Subject|3|||
42295406|NCT02501811|76129952|FG001|Overall Study|Withdrawal by Subject|3|||
42295407|NCT02501811|76129953|FG002|Overall Study|Withdrawal by Subject|2|||
42295408|NCT02501811|76129954|FG003|Overall Study|Withdrawal by Subject|3|||
42358938|NCT02864251|76204676|FG001|Treatment|Death|2|||
42092294|NCT00735644|75902657|FG004|Overall Study|Withdrawal by Subject|0|||
42358939|NCT02864251|76204677|FG002|Treatment|Death|3|||
42358940|NCT02864251|76204675|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
42092295|NCT03718299|75902676|FG000|Overall Study|Adverse Event|1|||
42092296|NCT03718299|75902676|FG000|Overall Study|Withdrawal by Subject|6|||
42092297|NCT03718299|75902676|FG000|Overall Study|Physician Decision|2|||
42092298|NCT03718299|75902676|FG000|Overall Study|Lost to Follow-up|1|||
42092299|NCT00724958|75902680|FG000|Overall Study|Adverse Event|28|||
42185677|NCT03629184|75994805|FG001|Overall Study|Withdrawal by Subject|1|||
42295409|NCT02501811|76129951|FG000|Overall Study|Lost to Follow-up|0|||
42295410|NCT02501811|76129952|FG001|Overall Study|Lost to Follow-up|0|||
42295411|NCT02501811|76129953|FG002|Overall Study|Lost to Follow-up|2|||
42295412|NCT02501811|76129954|FG003|Overall Study|Lost to Follow-up|1|||
42358941|NCT02864251|76204676|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
42092300|NCT00724958|75902680|FG000|Overall Study|Loss of Response|40|||
42358942|NCT02864251|76204677|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
42358943|NCT02864251|76204675|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
42358944|NCT02864251|76204676|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
42358945|NCT02864251|76204677|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
42092301|NCT00724958|75902680|FG000|Overall Study|No Response|18|||
42092302|NCT00724958|75902680|FG000|Overall Study|Remission|7|||
42092303|NCT00724958|75902680|FG000|Overall Study|Other Reason|76|||
42092304|NCT00724958|75902680|FG000|Overall Study|No documentation for end of therapy|13|||
42092305|NCT00695565|75902686|FG000|Overall Study|Lost to Follow-up|4|||
42092306|NCT00695565|75902687|FG001|Overall Study|Lost to Follow-up|4|||
42092307|NCT00695565|75902686|FG000|Overall Study|Adverse Event|3|||
42358946|NCT02864251|76204675|FG000|Treatment|Withdrawal by Participant|8|||
42358947|NCT02864251|76204676|FG001|Treatment|Withdrawal by Participant|5|||
42358948|NCT02864251|76204677|FG002|Treatment|Withdrawal by Participant|13|||
42358949|NCT02864251|76204675|FG000|Treatment|Maximum Clinical Benefit|1|||
42358950|NCT02864251|76204676|FG001|Treatment|Maximum Clinical Benefit|0|||
42358951|NCT02864251|76204677|FG002|Treatment|Maximum Clinical Benefit|1|||
42092308|NCT00695565|75902687|FG001|Overall Study|Adverse Event|1|||
42092309|NCT00695565|75902686|FG000|Overall Study|Protocol Violation|3|||
42358952|NCT02864251|76204675|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
42358953|NCT02864251|76204676|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
42358954|NCT02864251|76204677|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
42358955|NCT02864251|76204675|FG000|Treatment|Other Reasons|1|||
42358956|NCT02864251|76204676|FG001|Treatment|Other Reasons|1|||
42358957|NCT02864251|76204677|FG002|Treatment|Other Reasons|4|||
42358958|NCT02864251|76204675|FG000|Treatment|Administrative Reason by Sponsor|1|||
42358959|NCT02864251|76204676|FG001|Treatment|Administrative Reason by Sponsor|0|||
42358960|NCT02864251|76204677|FG002|Treatment|Administrative Reason by Sponsor|0|||
42358961|NCT02570113|76204711|FG000|Overall Study|Withdrawal by Subject|3|||
42358962|NCT02565914|76204715|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
42092310|NCT00695565|75902687|FG001|Overall Study|Protocol Violation|1|||
42092311|NCT00695565|75902686|FG000|Overall Study|Withdrawal by Subject|1|||
42358963|NCT02565914|76204715|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
42358964|NCT02565914|76204715|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
42092312|NCT00695565|75902687|FG001|Overall Study|Withdrawal by Subject|1|||
42092313|NCT00695565|75902686|FG000|Overall Study|Lack of Efficacy|1|||
42185678|NCT03629184|75994804|FG000|Overall Study|Physician Decision|1|||
42185679|NCT03629184|75994805|FG001|Overall Study|Physician Decision|0|||
42185680|NCT03549338|75994823|FG000|Overall Study|Progressive Disease|1|||
42185681|NCT03549338|75994824|FG001|Overall Study|Progressive Disease|0|||
42185682|NCT03549338|75994825|FG002|Overall Study|Progressive Disease|0|||
42185683|NCT03549338|75994823|FG000|Overall Study|Clinical Progression|0|||
42185684|NCT03549338|75994824|FG001|Overall Study|Clinical Progression|1|||
42185685|NCT03549338|75994825|FG002|Overall Study|Clinical Progression|0|||
42185686|NCT03629028|75994833|FG000|Overall Study|Lost to Follow-up|26|||
42185687|NCT03629028|75994834|FG001|Overall Study|Lost to Follow-up|23|||
42185688|NCT03629028|75994833|FG000|Overall Study|Pregnancy|4|||
42185689|NCT03629028|75994834|FG001|Overall Study|Pregnancy|2|||
42185690|NCT03629028|75994833|FG000|Overall Study|intolerance to examination|2|||
42185691|NCT03629028|75994834|FG001|Overall Study|intolerance to examination|0|||
42185692|NCT03549104|75994852|FG000|Overall Study|Physician Decision|2|||
42185693|NCT03549104|75994853|FG001|Overall Study|Physician Decision|0|||
42185694|NCT03549104|75994852|FG000|Overall Study|Withdrawal by Subject|5|||
42185695|NCT03549104|75994853|FG001|Overall Study|Withdrawal by Subject|2|||
42185696|NCT03549104|75994852|FG000|Overall Study|Covid shelter in place|1|||
42185697|NCT03549104|75994853|FG001|Overall Study|Covid shelter in place|2|||
42185698|NCT02892344|75994861|FG000|Overall Study|Protocol deviation|3|||
42185699|NCT02892344|75994862|FG001|Overall Study|Protocol deviation|4|||
42185700|NCT02892344|75994861|FG000|Overall Study|Adverse Event|1|||
42092314|NCT00695565|75902687|FG001|Overall Study|Lack of Efficacy|1|||
42092315|NCT00695565|75902686|FG000|Overall Study|Subject did not follow instructions|1|||
42092316|NCT00695565|75902687|FG001|Overall Study|Subject did not follow instructions|1|||
42092317|NCT00727532|75902693|FG000|Overall Study|Adverse Event|1|||
42092318|NCT00727532|75902693|FG000|Overall Study|Withdrawal by Subject|1|||
42185701|NCT02892344|75994862|FG001|Overall Study|Adverse Event|8|||
42185702|NCT02892344|75994861|FG000|Overall Study|Lost to Follow-up|0|||
42185703|NCT02892344|75994862|FG001|Overall Study|Lost to Follow-up|1|||
42185704|NCT02892344|75994861|FG000|Overall Study|Non-compliance with study treatment|0|||
42185705|NCT02892344|75994862|FG001|Overall Study|Non-compliance with study treatment|1|||
42185706|NCT02892344|75994861|FG000|Overall Study|Physician Decision|0|||
42185707|NCT02892344|75994862|FG001|Overall Study|Physician Decision|2|||
42185708|NCT02892344|75994861|FG000|Overall Study|Subject/guardian decision|0|||
42185709|NCT02892344|75994862|FG001|Overall Study|Subject/guardian decision|4|||
42185710|NCT02892344|75994861|FG000|Overall Study|Technical problems|0|||
42185711|NCT02892344|75994862|FG001|Overall Study|Technical problems|1|||
42092319|NCT00721214|75902697|FG000|Overall Study|Chose another center for transplant|1|||
42092320|NCT00721214|75902697|FG000|Overall Study|Death|3|||
42092321|NCT00720902|75902703|FG000|Overall Study|Withdrawal by Subject|1|||
42092322|NCT00720902|75902704|FG001|Overall Study|Withdrawal by Subject|0|||
42092323|NCT00720902|75902703|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
42092324|NCT00720902|75902704|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
42092325|NCT00695019|75902713|FG000|Overall Study|Withdrawal by Subject|8|||
42092326|NCT00695019|75902714|FG001|Overall Study|Withdrawal by Subject|6|||
42092327|NCT00695019|75902715|FG002|Overall Study|Withdrawal by Subject|4|||
42092328|NCT00695019|75902713|FG000|Overall Study|Protocol Violation|1|||
42092329|NCT00695019|75902714|FG001|Overall Study|Protocol Violation|3|||
42092330|NCT00695019|75902715|FG002|Overall Study|Protocol Violation|1|||
42092331|NCT00695019|75902713|FG000|Overall Study|Lack of Efficacy|0|||
42092332|NCT00695019|75902714|FG001|Overall Study|Lack of Efficacy|0|||
42092333|NCT00695019|75902715|FG002|Overall Study|Lack of Efficacy|1|||
42092334|NCT00695019|75902713|FG000|Overall Study|Various|4|||
42092335|NCT00695019|75902714|FG001|Overall Study|Various|5|||
42092336|NCT00695019|75902715|FG002|Overall Study|Various|4|||
42092337|NCT00694707|75902728|FG000|Overall Study|Did Not Receive Treatment|0|||
42092338|NCT00694707|75902729|FG001|Overall Study|Did Not Receive Treatment|0|||
42092339|NCT00694707|75902730|FG002|Overall Study|Did Not Receive Treatment|1|||
42092340|NCT00694707|75902731|FG003|Overall Study|Did Not Receive Treatment|1|||
42092341|NCT00694707|75902732|FG004|Overall Study|Did Not Receive Treatment|1|||
42092342|NCT00694707|75902728|FG000|Overall Study|Adverse Event|22|||
42092343|NCT00694707|75902729|FG001|Overall Study|Adverse Event|14|||
42092344|NCT00694707|75902730|FG002|Overall Study|Adverse Event|8|||
42092345|NCT00694707|75902731|FG003|Overall Study|Adverse Event|12|||
42092346|NCT00694707|75902732|FG004|Overall Study|Adverse Event|13|||
42092347|NCT00694707|75902728|FG000|Overall Study|Insufficient Therapeutic Response|33|||
42092348|NCT00694707|75902729|FG001|Overall Study|Insufficient Therapeutic Response|18|||
42092349|NCT00694707|75902730|FG002|Overall Study|Insufficient Therapeutic Response|17|||
42092350|NCT00694707|75902731|FG003|Overall Study|Insufficient Therapeutic Response|15|||
42092351|NCT00694707|75902732|FG004|Overall Study|Insufficient Therapeutic Response|10|||
42092352|NCT00694707|75902728|FG000|Overall Study|Protocol Violation|1|||
42092353|NCT00694707|75902729|FG001|Overall Study|Protocol Violation|2|||
42092354|NCT00694707|75902730|FG002|Overall Study|Protocol Violation|1|||
42092355|NCT00694707|75902731|FG003|Overall Study|Protocol Violation|3|||
42092356|NCT00694707|75902732|FG004|Overall Study|Protocol Violation|1|||
42092357|NCT00694707|75902728|FG000|Overall Study|Withdrawal of Consent|14|||
42185712|NCT03567980|75994868|FG000|Overall Study|Adverse Event|1|||
42185713|NCT02894840|75994876|FG000|Overall Study|Lost to Follow-up|1|||
42185714|NCT02894840|75994877|FG001|Overall Study|Lost to Follow-up|0|||
42185715|NCT02894840|75994878|FG002|Overall Study|Lost to Follow-up|3|||
42185716|NCT02894840|75994879|FG003|Overall Study|Lost to Follow-up|0|||
42185717|NCT03358030|75994898|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
42185718|NCT03358030|75994899|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
42185719|NCT03358030|75994900|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
42185720|NCT03358030|75994901|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
42185721|NCT03358030|75994898|FG000|Overall Study|Ineligibility|0|||
42185722|NCT03358030|75994899|FG001|Overall Study|Ineligibility|0|||
42185723|NCT03358030|75994900|FG002|Overall Study|Ineligibility|0|||
42185724|NCT03358030|75994901|FG003|Overall Study|Ineligibility|2|||
42185725|NCT03358030|75994898|FG000|Overall Study|Voluntary Withdrawal|1|||
42185726|NCT03358030|75994899|FG001|Overall Study|Voluntary Withdrawal|1|||
42185727|NCT03358030|75994900|FG002|Overall Study|Voluntary Withdrawal|3|||
42185728|NCT03358030|75994901|FG003|Overall Study|Voluntary Withdrawal|1|||
42185729|NCT03358030|75994898|FG000|Overall Study|Other|0|||
42185730|NCT03358030|75994899|FG001|Overall Study|Other|0|||
42185731|NCT03358030|75994900|FG002|Overall Study|Other|1|||
42185732|NCT03358030|75994901|FG003|Overall Study|Other|0|||
42185733|NCT03566810|75994915|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
42185734|NCT03566810|75994916|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
42185735|NCT03566810|75994917|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
42185736|NCT03566810|75994918|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
42185737|NCT03628716|75994941|FG000|Overall Study|Adverse Event|1|||
42185738|NCT03628716|75994942|FG001|Overall Study|Adverse Event|1|||
42092358|NCT00694707|75902729|FG001|Overall Study|Withdrawal of Consent|18|||
42092359|NCT00694707|75902730|FG002|Overall Study|Withdrawal of Consent|22|||
42092360|NCT00694707|75902731|FG003|Overall Study|Withdrawal of Consent|16|||
42092361|NCT00694707|75902732|FG004|Overall Study|Withdrawal of Consent|15|||
42185739|NCT03628716|75994941|FG000|Overall Study|Death|1|||
42185740|NCT03628716|75994942|FG001|Overall Study|Death|0|||
42185741|NCT03628716|75994941|FG000|Overall Study|Lack of Efficacy|15|||
42185742|NCT03628716|75994942|FG001|Overall Study|Lack of Efficacy|20|||
42185743|NCT03628716|75994941|FG000|Overall Study|Withdrawal by Subject|1|||
42092362|NCT00694707|75902728|FG000|Overall Study|Lost to Follow-up|0|||
42092363|NCT00694707|75902729|FG001|Overall Study|Lost to Follow-up|1|||
42092364|NCT00694707|75902730|FG002|Overall Study|Lost to Follow-up|2|||
42092365|NCT00694707|75902731|FG003|Overall Study|Lost to Follow-up|0|||
42092366|NCT00694707|75902732|FG004|Overall Study|Lost to Follow-up|0|||
42092367|NCT00694707|75902728|FG000|Overall Study|Jeopardizing Parole Status|1|||
42092368|NCT00694707|75902729|FG001|Overall Study|Jeopardizing Parole Status|0|||
42092369|NCT00694707|75902730|FG002|Overall Study|Jeopardizing Parole Status|0|||
42092370|NCT00694707|75902731|FG003|Overall Study|Jeopardizing Parole Status|0|||
42092371|NCT00694707|75902732|FG004|Overall Study|Jeopardizing Parole Status|0|||
42092372|NCT00694707|75902728|FG000|Overall Study|Death in the Family|1|||
42092373|NCT00694707|75902729|FG001|Overall Study|Death in the Family|0|||
42185744|NCT03628716|75994942|FG001|Overall Study|Withdrawal by Subject|2|||
42185745|NCT03628716|75994941|FG000|Overall Study|Study Terminated by Sponsor|1|||
42185746|NCT03628716|75994942|FG001|Overall Study|Study Terminated by Sponsor|0|||
42185747|NCT04002960|75994950|FG000|Overall Study|Withdrawn prior to Completion|2|||
42185748|NCT04002648|75994956|FG000|Overall Study|Lost to Follow-up|2|||
42185749|NCT04002648|75994957|FG001|Overall Study|Lost to Follow-up|0|||
42185750|NCT00088413|75994978|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
42185751|NCT00088413|75994979|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
42185752|NCT00088413|75994980|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
42185753|NCT00088413|75994981|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
42185754|NCT00088413|75994978|FG000|Overall Study|Adverse Events/Side Effects|0|||
42185755|NCT00088413|75994979|FG001|Overall Study|Adverse Events/Side Effects|1|||
42185756|NCT00088413|75994980|FG002|Overall Study|Adverse Events/Side Effects|1|||
42185757|NCT00088413|75994981|FG003|Overall Study|Adverse Events/Side Effects|0|||
42185758|NCT00088413|75994978|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
42185759|NCT00088413|75994979|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
42185760|NCT00088413|75994980|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
42185761|NCT00088413|75994981|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
42185762|NCT00088413|75994978|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
42185763|NCT00088413|75994979|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
42185764|NCT00088413|75994980|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
42185765|NCT00088413|75994981|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
42185766|NCT00088413|75994978|FG000|Overall Study|Death|0|||
42185767|NCT00088413|75994979|FG001|Overall Study|Death|1|||
42185768|NCT00088413|75994980|FG002|Overall Study|Death|0|||
42185769|NCT00088413|75994981|FG003|Overall Study|Death|0|||
42185770|NCT00088413|75994978|FG000|Overall Study|Progressive disease|9|||
42185771|NCT00088413|75994979|FG001|Overall Study|Progressive disease|11|||
42185772|NCT00088413|75994980|FG002|Overall Study|Progressive disease|8|||
42185773|NCT00088413|75994981|FG003|Overall Study|Progressive disease|14|||
42185774|NCT00088413|75994978|FG000|Overall Study|Other|0|||
42185775|NCT00088413|75994979|FG001|Overall Study|Other|1|||
42185776|NCT00088413|75994980|FG002|Overall Study|Other|0|||
42185777|NCT00088413|75994981|FG003|Overall Study|Other|0|||
42185778|NCT00088413|75994978|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
42185779|NCT00088413|75994979|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
42185780|NCT00088413|75994980|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
42185781|NCT00088413|75994981|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
42185782|NCT03995784|75994993|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
42185783|NCT00086385|75995008|FG000|Overall Study|Death|2|||
42185784|NCT00086385|75995009|FG001|Overall Study|Death|2|||
42185785|NCT00086385|75995010|FG002|Overall Study|Death|1|||
42185786|NCT00086385|75995011|FG003|Overall Study|Death|1|||
42185787|NCT03993288|75995023|FG000|Overall Study|Lost to Follow-up|2|||
42185788|NCT03993288|75995024|FG001|Overall Study|Lost to Follow-up|1|||
42185789|NCT03993288|75995023|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
42092374|NCT00694707|75902730|FG002|Overall Study|Death in the Family|0|||
42092375|NCT00694707|75902731|FG003|Overall Study|Death in the Family|0|||
42092376|NCT00694707|75902732|FG004|Overall Study|Death in the Family|0|||
42092377|NCT00694707|75902728|FG000|Overall Study|Arrest by Police|0|||
42092378|NCT00694707|75902729|FG001|Overall Study|Arrest by Police|1|||
42092379|NCT00694707|75902730|FG002|Overall Study|Arrest by Police|0|||
42092380|NCT00694707|75902731|FG003|Overall Study|Arrest by Police|0|||
42092381|NCT00694707|75902732|FG004|Overall Study|Arrest by Police|0|||
42092382|NCT00694707|75902728|FG000|Overall Study|Administrative Reasons|0|||
42092383|NCT00694707|75902729|FG001|Overall Study|Administrative Reasons|1|||
42092384|NCT00694707|75902730|FG002|Overall Study|Administrative Reasons|0|||
42092385|NCT00694707|75902731|FG003|Overall Study|Administrative Reasons|2|||
42092386|NCT00694707|75902732|FG004|Overall Study|Administrative Reasons|0|||
42185790|NCT03993288|75995024|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
42185791|NCT03993288|75995023|FG000|Overall Study|wrong randomization|0|||
42185792|NCT03993288|75995024|FG001|Overall Study|wrong randomization|1|||
42185793|NCT03993288|75995023|FG000|Overall Study|improper enrollment|0|||
42185794|NCT03993288|75995024|FG001|Overall Study|improper enrollment|1|||
42295413|NCT02585999|76129964|FG000|Overall Study|Lost to Follow-up|1|||
42092387|NCT00694707|75902728|FG000|Overall Study|Notification of Past Head Injury|0|||
42092388|NCT00694707|75902729|FG001|Overall Study|Notification of Past Head Injury|0|||
42092389|NCT00694707|75902730|FG002|Overall Study|Notification of Past Head Injury|0|||
42092390|NCT00694707|75902731|FG003|Overall Study|Notification of Past Head Injury|1|||
42092391|NCT00694707|75902732|FG004|Overall Study|Notification of Past Head Injury|0|||
42092392|NCT00692913|75902746|FG000|Overall Study|Adverse Event|8|||
42092393|NCT00692913|75902747|FG001|Overall Study|Adverse Event|4|||
42092394|NCT00692913|75902746|FG000|Overall Study|Lost to Follow-up|3|||
42185795|NCT03993288|75995023|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
42185796|NCT03993288|75995024|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
42185797|NCT03993288|75995023|FG000|Overall Study|developed SAE|2|||
42185798|NCT03993288|75995024|FG001|Overall Study|developed SAE|0|||
42185799|NCT03993288|75995023|FG000|Overall Study|consent withdrawal|1|||
42185800|NCT03993288|75995024|FG001|Overall Study|consent withdrawal|0|||
42185801|NCT03993288|75995023|FG000|Overall Study|did not follow the treatment schedule|1|||
42185802|NCT03993288|75995024|FG001|Overall Study|did not follow the treatment schedule|0|||
42185803|NCT03993288|75995023|FG000|Overall Study|did not follow the treatment regimen|1|||
42185804|NCT03993288|75995024|FG001|Overall Study|did not follow the treatment regimen|0|||
42185805|NCT03993288|75995023|FG000|Overall Study|Adverse Event|1|||
42185806|NCT03993288|75995024|FG001|Overall Study|Adverse Event|0|||
42185807|NCT03993288|75995023|FG000|Overall Study|Withdrawal by Subject|1|||
42185808|NCT03993288|75995024|FG001|Overall Study|Withdrawal by Subject|1|||
42185809|NCT03991494|75995030|FG000|Overall Study|Progressive Disease|4|||
42185810|NCT00086307|75995039|FG000|Overall Study|Lack of Efficacy|1|||
42185811|NCT00086307|75995040|FG001|Overall Study|Lack of Efficacy|1|||
42185812|NCT00086307|75995041|FG002|Overall Study|Lack of Efficacy|2|||
42185813|NCT00086307|75995039|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
42185814|NCT00086307|75995040|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
42185815|NCT00086307|75995041|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
42185816|NCT00086307|75995039|FG000|Overall Study|Nausea and headaches|0|||
42185817|NCT00086307|75995040|FG001|Overall Study|Nausea and headaches|0|||
42185818|NCT00086307|75995041|FG002|Overall Study|Nausea and headaches|1|||
42185819|NCT00086307|75995039|FG000|Overall Study|Constipation and sleepiness|0|||
42185820|NCT00086307|75995040|FG001|Overall Study|Constipation and sleepiness|0|||
42185821|NCT00086307|75995041|FG002|Overall Study|Constipation and sleepiness|1|||
42185822|NCT00086307|75995039|FG000|Overall Study|Suicidal ideation|0|||
42185823|NCT00086307|75995040|FG001|Overall Study|Suicidal ideation|0|||
42185824|NCT00086307|75995041|FG002|Overall Study|Suicidal ideation|1|||
42185825|NCT00086307|75995039|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
42185826|NCT00086307|75995040|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
42185827|NCT00086307|75995041|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
42185828|NCT00086307|75995039|FG000|Overall Study|Withdrawal by Subject|0|||
42185829|NCT00086307|75995040|FG001|Overall Study|Withdrawal by Subject|0|||
42185830|NCT00086307|75995041|FG002|Overall Study|Withdrawal by Subject|2|||
42185831|NCT03624972|75995052|FG000|Overall Study|Lost to Follow-up|2|||
42185832|NCT03624972|75995053|FG001|Overall Study|Lost to Follow-up|0|||
42185833|NCT03624972|75995054|FG002|Overall Study|Lost to Follow-up|0|||
42185834|NCT03624972|75995052|FG000|Overall Study|Withdrawal by Subject|0|||
42185835|NCT03624972|75995053|FG001|Overall Study|Withdrawal by Subject|2|||
42185836|NCT03624972|75995054|FG002|Overall Study|Withdrawal by Subject|0|||
42185837|NCT03988842|75995063|FG000|Overall Study|Death|1|||
42185838|NCT02668822|75995070|FG000|Overall Study|Protocol Violation|2|||
42185839|NCT02668822|75995071|FG001|Overall Study|Protocol Violation|0|||
42185840|NCT02668822|75995070|FG000|Overall Study|Study Terminated by Sponsor|7|||
42295414|NCT02585999|76129964|FG000|Overall Study|Protocol Violation|1|||
42018065|NCT01260311|75825763|FG000|Overall Study|Adverse Event|11|||
42018066|NCT01260311|75825763|FG000|Overall Study|Lack of Efficacy|4|||
42018067|NCT01260311|75825763|FG000|Overall Study|Lost to Follow-up|25|||
42018068|NCT01260311|75825763|FG000|Overall Study|Withdrawal by Subject|6|||
42018069|NCT01260311|75825763|FG000|Overall Study|Financial Constraints|77|||
42018070|NCT01260311|75825763|FG000|Overall Study|Gone to Province|2|||
42018071|NCT01260311|75825763|FG000|Overall Study|Medication Stopped|1|||
42018072|NCT01260311|75825763|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
42018073|NCT01259375|75825767|FG000|Overall Study|Adverse Event|1|||
42018074|NCT01259297|75825790|FG000|Double Blind Randomized Period|Death|1|||
42018075|NCT01259297|75825791|FG001|Double Blind Randomized Period|Death|1|||
42018076|NCT01259297|75825792|FG002|Double Blind Randomized Period|Death|1|||
42018077|NCT01259297|75825793|FG003|Double Blind Randomized Period|Death|2|||
42018078|NCT01259297|75825794|FG004|Double Blind Randomized Period|Death|1|||
42185841|NCT02668822|75995071|FG001|Overall Study|Study Terminated by Sponsor|9|||
42185842|NCT02524288|75995077|FG000|Overall Study|Adverse Event|115|||
42185843|NCT02524288|75995077|FG000|Overall Study|Lost to Follow-up|216|||
42185844|NCT02524288|75995077|FG000|Overall Study|Non-Compliance With Protocol|32|||
42185845|NCT02524288|75995077|FG000|Overall Study|Non-Compliance With Study Drug|14|||
42185846|NCT02524288|75995077|FG000|Overall Study|Pregnancy Wish|6|||
42185847|NCT02524288|75995077|FG000|Overall Study|Protocol Violation|6|||
42185848|NCT02524288|75995077|FG000|Overall Study|Screen Failure|2|||
42185849|NCT02524288|75995077|FG000|Overall Study|Site Discontinued Study Participation|1|||
42185850|NCT02524288|75995077|FG000|Overall Study|Study Terminated By Sponsor|1417|||
42185851|NCT02524288|75995077|FG000|Overall Study|Subject Moved|32|||
42185852|NCT02524288|75995077|FG000|Overall Study|Withdrawal by Subject|76|||
42185853|NCT02524288|75995077|FG000|Overall Study|Pregnancy|22|||
42185854|NCT02524288|75995077|FG000|Overall Study|Physician Decision|2|||
42295415|NCT02582255|76129971|FG000|Overall Study|Protocol Violation|0|||
42295416|NCT02582255|76129972|FG001|Overall Study|Protocol Violation|3|||
42295417|NCT02500719|76129981|FG000|Overall Study|Lost to Follow-up|2|||
42295418|NCT02500719|76129982|FG001|Overall Study|Lost to Follow-up|3|||
42295419|NCT02500719|76129981|FG000|Overall Study|Trauma history|1|||
42295420|NCT02500719|76129982|FG001|Overall Study|Trauma history|0|||
42092395|NCT00692913|75902747|FG001|Overall Study|Lost to Follow-up|5|||
42092396|NCT00692913|75902746|FG000|Overall Study|Physician Decision|2|||
42092397|NCT00692913|75902747|FG001|Overall Study|Physician Decision|0|||
42092398|NCT00692913|75902746|FG000|Overall Study|Protocol Violation|1|||
42295421|NCT02500719|76129981|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
42295422|NCT02500719|76129982|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
42295423|NCT02500719|76129981|FG000|Overall Study|Did not meet criteria for PTSD|0|||
42295424|NCT02500719|76129982|FG001|Overall Study|Did not meet criteria for PTSD|1|||
42295425|NCT02500719|76129981|FG000|Overall Study|Claustrophobia|0|||
42295426|NCT02500719|76129982|FG001|Overall Study|Claustrophobia|1|||
42295427|NCT02500719|76129981|FG000|Overall Study|History of head trauma|0|||
42295428|NCT02500719|76129982|FG001|Overall Study|History of head trauma|1|||
42092399|NCT00692913|75902747|FG001|Overall Study|Protocol Violation|1|||
42092400|NCT00692913|75902746|FG000|Overall Study|Withdrawal by Subject|15|||
42092401|NCT00692913|75902747|FG001|Overall Study|Withdrawal by Subject|20|||
42092402|NCT00694551|75902756|FG000|Overall Study|Disease Progression|1|||
42092403|NCT00694551|75902757|FG001|Overall Study|Disease Progression|0|||
42092404|NCT00694551|75902758|FG002|Overall Study|Disease Progression|1|||
42092405|NCT00689871|75902771|FG000|Overall Study|Lost to Follow-up|123|||
42092406|NCT00689871|75902772|FG001|Overall Study|Lost to Follow-up|13|||
42092407|NCT00689871|75902773|FG002|Overall Study|Lost to Follow-up|37|||
42092408|NCT00689871|75902774|FG003|Overall Study|Lost to Follow-up|1|||
42185855|NCT03624504|75995081|FG000|Overall Study|Unsuccessful Implant|1|||
42358965|NCT02565914|76204715|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
42092409|NCT00689871|75902771|FG000|Overall Study|Explanted of All Study Devices|36|||
42185856|NCT02954952|75995088|FG000|Overall Study|Withdrawal by Subject|1|||
42185857|NCT02954952|75995089|FG001|Overall Study|Withdrawal by Subject|0|||
42185858|NCT02954952|75995090|FG002|Overall Study|Withdrawal by Subject|0|||
42185859|NCT02954952|75995088|FG000|Overall Study|No data collected|0|||
42295429|NCT02500641|76129990|FG000|Overall Study|Adverse Event|0|||
42092410|NCT00689871|75902772|FG001|Overall Study|Explanted of All Study Devices|25|||
42092411|NCT00689871|75902773|FG002|Overall Study|Explanted of All Study Devices|29|||
42092412|NCT00689871|75902774|FG003|Overall Study|Explanted of All Study Devices|3|||
42092413|NCT00689871|75902771|FG000|Overall Study|Withdrawal by Subject|13|||
42092414|NCT00689871|75902772|FG001|Overall Study|Withdrawal by Subject|3|||
42092415|NCT00689871|75902773|FG002|Overall Study|Withdrawal by Subject|4|||
42092416|NCT00689871|75902774|FG003|Overall Study|Withdrawal by Subject|1|||
42092417|NCT00689871|75902771|FG000|Overall Study|Death|1|||
42092418|NCT00689871|75902772|FG001|Overall Study|Death|10|||
42092419|NCT00689871|75902773|FG002|Overall Study|Death|2|||
42092420|NCT00689871|75902774|FG003|Overall Study|Death|2|||
42092421|NCT00689871|75902771|FG000|Overall Study|Physician Decision|2|||
42092422|NCT00689871|75902772|FG001|Overall Study|Physician Decision|1|||
42092423|NCT00689871|75902773|FG002|Overall Study|Physician Decision|1|||
42092424|NCT00689871|75902774|FG003|Overall Study|Physician Decision|0|||
42092425|NCT00793793|75902796|FG000|Overall Study|Adverse Event|0|||
42092426|NCT00793793|75902797|FG001|Overall Study|Adverse Event|0|||
42092427|NCT00793793|75902798|FG002|Overall Study|Adverse Event|1|||
42092428|NCT00793793|75902799|FG003|Overall Study|Adverse Event|1|||
42092429|NCT00793793|75902800|FG004|Overall Study|Adverse Event|0|||
42092430|NCT00793793|75902801|FG005|Overall Study|Adverse Event|1|||
42092431|NCT00793793|75902802|FG006|Overall Study|Adverse Event|2|||
42092432|NCT00793793|75902803|FG007|Overall Study|Adverse Event|0|||
42092433|NCT00793793|75902804|FG008|Overall Study|Adverse Event|0|||
42092434|NCT00793793|75902805|FG009|Overall Study|Adverse Event|0|||
42092435|NCT00793793|75902806|FG010|Overall Study|Adverse Event|0|||
42092436|NCT00793793|75902807|FG011|Overall Study|Adverse Event|2|||
42092437|NCT00793793|75902796|FG000|Overall Study|Protocol Violation|0|||
42092438|NCT00793793|75902797|FG001|Overall Study|Protocol Violation|0|||
42092439|NCT00793793|75902798|FG002|Overall Study|Protocol Violation|0|||
42092440|NCT00793793|75902799|FG003|Overall Study|Protocol Violation|1|||
42092441|NCT00793793|75902800|FG004|Overall Study|Protocol Violation|0|||
42092442|NCT00793793|75902801|FG005|Overall Study|Protocol Violation|0|||
42092443|NCT00793793|75902802|FG006|Overall Study|Protocol Violation|0|||
42092444|NCT00793793|75902803|FG007|Overall Study|Protocol Violation|0|||
42092445|NCT00793793|75902804|FG008|Overall Study|Protocol Violation|0|||
42092446|NCT00793793|75902805|FG009|Overall Study|Protocol Violation|0|||
42092447|NCT00793793|75902806|FG010|Overall Study|Protocol Violation|0|||
42092448|NCT00793793|75902807|FG011|Overall Study|Protocol Violation|0|||
42092449|NCT00793793|75902796|FG000|Overall Study|Lost to Follow-up|0|||
42092450|NCT00793793|75902797|FG001|Overall Study|Lost to Follow-up|0|||
42092451|NCT00793793|75902798|FG002|Overall Study|Lost to Follow-up|1|||
42092452|NCT00793793|75902799|FG003|Overall Study|Lost to Follow-up|0|||
42092453|NCT00793793|75902800|FG004|Overall Study|Lost to Follow-up|0|||
42092454|NCT00793793|75902801|FG005|Overall Study|Lost to Follow-up|0|||
42092455|NCT00793793|75902802|FG006|Overall Study|Lost to Follow-up|0|||
42092456|NCT00793793|75902803|FG007|Overall Study|Lost to Follow-up|0|||
42092457|NCT00793793|75902804|FG008|Overall Study|Lost to Follow-up|1|||
42092458|NCT00793793|75902805|FG009|Overall Study|Lost to Follow-up|3|||
42092459|NCT00793793|75902806|FG010|Overall Study|Lost to Follow-up|1|||
42185860|NCT02954952|75995089|FG001|Overall Study|No data collected|1|||
42185861|NCT02954952|75995090|FG002|Overall Study|No data collected|0|||
42185862|NCT03547154|75995100|FG000|Overall Study|Disease Progression/Recurrence|6|||
42185863|NCT03547154|75995101|FG001|Overall Study|Disease Progression/Recurrence|14|||
42185864|NCT03547154|75995100|FG000|Overall Study|Adverse Event|26|||
42185865|NCT03547154|75995101|FG001|Overall Study|Adverse Event|31|||
42185866|NCT03547154|75995100|FG000|Overall Study|Protocol Violation|6|||
42185867|NCT03547154|75995101|FG001|Overall Study|Protocol Violation|1|||
42185868|NCT03547154|75995100|FG000|Overall Study|Physician Decision|4|||
42185869|NCT03547154|75995101|FG001|Overall Study|Physician Decision|3|||
42295430|NCT02500641|76129991|FG001|Overall Study|Adverse Event|2|||
42092460|NCT00793793|75902807|FG011|Overall Study|Lost to Follow-up|0|||
42092461|NCT00793793|75902796|FG000|Overall Study|Withdrawal by Subject|0|||
42092462|NCT00793793|75902797|FG001|Overall Study|Withdrawal by Subject|0|||
42092463|NCT00793793|75902798|FG002|Overall Study|Withdrawal by Subject|0|||
42092464|NCT00793793|75902799|FG003|Overall Study|Withdrawal by Subject|0|||
42092465|NCT00793793|75902800|FG004|Overall Study|Withdrawal by Subject|1|||
42092466|NCT00793793|75902801|FG005|Overall Study|Withdrawal by Subject|0|||
42092467|NCT00793793|75902802|FG006|Overall Study|Withdrawal by Subject|0|||
42185870|NCT03547154|75995100|FG000|Overall Study|Insufficient Therapeutic Response|13|||
42185871|NCT03547154|75995101|FG001|Overall Study|Insufficient Therapeutic Response|10|||
42185872|NCT03547154|75995100|FG000|Overall Study|Withdrawal by Subject|10|||
42185873|NCT03547154|75995101|FG001|Overall Study|Withdrawal by Subject|6|||
42092468|NCT00793793|75902803|FG007|Overall Study|Withdrawal by Subject|0|||
42092469|NCT00793793|75902804|FG008|Overall Study|Withdrawal by Subject|1|||
42092470|NCT00793793|75902805|FG009|Overall Study|Withdrawal by Subject|0|||
42092471|NCT00793793|75902806|FG010|Overall Study|Withdrawal by Subject|0|||
42185874|NCT03547154|75995100|FG000|Overall Study|Not Selected|0|||
42185875|NCT03547154|75995101|FG001|Overall Study|Not Selected|1|||
42185876|NCT03547154|75995100|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
42185877|NCT03547154|75995101|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
42185878|NCT02275546|75995107|FG000|Treatment Period 2|Withdrawal by Subject|2|||
42185879|NCT02275546|75995108|FG001|Treatment Period 2|Withdrawal by Subject|1|||
42185880|NCT02275546|75995107|FG000|Treatment Period 2|Protocol Violation|0|||
42185881|NCT02275546|75995108|FG001|Treatment Period 2|Protocol Violation|1|||
42092472|NCT00793793|75902807|FG011|Overall Study|Withdrawal by Subject|0|||
42092473|NCT00793793|75902796|FG000|Overall Study|reason not specified|0|||
42092474|NCT00793793|75902797|FG001|Overall Study|reason not specified|1|||
42185882|NCT03624192|75995114|FG000|Overall Study|Lost to Follow-up|1|||
42185883|NCT03624192|75995115|FG001|Overall Study|Lost to Follow-up|1|||
42185884|NCT03034954|75995125|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
42185885|NCT03034954|75995126|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
42185886|NCT03546842|75995132|FG000|Overall Study|Protocol Violation|1|||
42185887|NCT03546842|75995132|FG000|Overall Study|Withdrawal by Subject|2|||
42185888|NCT03640052|75995136|FG000|Overall Study|Lost to Follow-up|0|||
42185889|NCT03640052|75995137|FG001|Overall Study|Lost to Follow-up|1|||
42185890|NCT03640052|75995138|FG002|Overall Study|Lost to Follow-up|0|||
42185891|NCT03640052|75995139|FG003|Overall Study|Lost to Follow-up|0|||
42185892|NCT03640052|75995140|FG004|Overall Study|Lost to Follow-up|0|||
42185893|NCT00068601|75995154|FG000|Overall Study|Ineligible|11|||
42185894|NCT00068601|75995155|FG001|Overall Study|Ineligible|13|||
42185895|NCT00068601|75995154|FG000|Overall Study|Not evaluable: withdrew consent|5|||
42185896|NCT00068601|75995155|FG001|Overall Study|Not evaluable: withdrew consent|4|||
42185897|NCT00068601|75995154|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
42185898|NCT00068601|75995155|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
42295431|NCT02500641|76129990|FG000|Overall Study|Withdrawal by Subject|4|||
42295432|NCT02500641|76129991|FG001|Overall Study|Withdrawal by Subject|5|||
42295433|NCT02500641|76129990|FG000|Overall Study|Unable to follow study procedures|3|||
42295434|NCT02500641|76129991|FG001|Overall Study|Unable to follow study procedures|2|||
42295435|NCT02500641|76129990|FG000|Overall Study|Protocol Violation|1|||
42295436|NCT02500641|76129991|FG001|Overall Study|Protocol Violation|2|||
42295437|NCT02500641|76129990|FG000|Overall Study|Lost to Follow-up|1|||
42092475|NCT00793793|75902798|FG002|Overall Study|reason not specified|0|||
42295438|NCT02500641|76129991|FG001|Overall Study|Lost to Follow-up|0|||
42295439|NCT02500641|76129990|FG000|Overall Study|Sponsor decision|1|||
42295440|NCT02500641|76129991|FG001|Overall Study|Sponsor decision|0|||
42295441|NCT02500641|76129990|FG000|Overall Study|Non compliance to study drug|0|||
42295442|NCT02500641|76129991|FG001|Overall Study|Non compliance to study drug|1|||
42295443|NCT02499783|76129999|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
42295444|NCT02499783|76130000|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
42295445|NCT02499783|76130001|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
42295446|NCT02499783|76129999|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
42295447|NCT02499783|76130000|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
42295448|NCT02499783|76130001|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
42295449|NCT02499783|76129999|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
42295450|NCT02499783|76130000|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
42295451|NCT02499783|76130001|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
42295452|NCT02499783|76129999|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
42092476|NCT00793793|75902799|FG003|Overall Study|reason not specified|1|||
42092477|NCT00793793|75902800|FG004|Overall Study|reason not specified|1|||
42092478|NCT00793793|75902801|FG005|Overall Study|reason not specified|1|||
42092479|NCT00793793|75902802|FG006|Overall Study|reason not specified|2|||
42092480|NCT00793793|75902803|FG007|Overall Study|reason not specified|0|||
42092481|NCT00793793|75902804|FG008|Overall Study|reason not specified|7|||
42092482|NCT00793793|75902805|FG009|Overall Study|reason not specified|6|||
42092483|NCT00793793|75902806|FG010|Overall Study|reason not specified|2|||
42092484|NCT00793793|75902807|FG011|Overall Study|reason not specified|4|||
42295453|NCT02499783|76130000|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
42295454|NCT02499783|76130001|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
42295455|NCT02499783|76129999|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
42295456|NCT02499783|76130000|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
42092485|NCT00776789|75902855|FG000|Overall Study|Consent refusal|2|||
42092486|NCT00776789|75902856|FG001|Overall Study|Consent refusal|2|||
42092487|NCT00776789|75902855|FG000|Overall Study|Poor quality video|1|||
42185899|NCT00068601|75995154|FG000|Overall Study|Death|11|||
42185900|NCT00068601|75995155|FG001|Overall Study|Death|3|||
42185901|NCT00068601|75995154|FG000|Overall Study|Lost to Follow-up|3|||
42185902|NCT00068601|75995155|FG001|Overall Study|Lost to Follow-up|2|||
42185903|NCT00068601|75995154|FG000|Overall Study|Missing primary outcome data|30|||
42185904|NCT00068601|75995155|FG001|Overall Study|Missing primary outcome data|34|||
42295457|NCT02499783|76130001|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
42092488|NCT00776789|75902856|FG001|Overall Study|Poor quality video|1|||
42092489|NCT00776555|75902866|FG000|Overall Study|Study terminated|3|||
42092490|NCT00776555|75902867|FG001|Overall Study|Study terminated|0|||
42092491|NCT00720434|75902877|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
42092492|NCT00720434|75902878|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
42092493|NCT00720434|75902879|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
42092494|NCT00720434|75902880|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
42092495|NCT00720434|75902877|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
42092496|NCT00720434|75902878|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
42092497|NCT00720434|75902879|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
42092498|NCT00720434|75902880|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
42092499|NCT00720434|75902877|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
42092500|NCT00720434|75902878|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
42092501|NCT00720434|75902879|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
42092502|NCT00720434|75902880|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
42185905|NCT03638258|75995164|FG000|Overall Study|Adverse Event|1|||
42185906|NCT03638258|75995165|FG001|Overall Study|Adverse Event|0|||
42185907|NCT03638258|75995166|FG002|Overall Study|Adverse Event|2|||
42185908|NCT03638258|75995164|FG000|Overall Study|Lost to Follow-up|2|||
42185909|NCT03638258|75995165|FG001|Overall Study|Lost to Follow-up|4|||
42185910|NCT03638258|75995166|FG002|Overall Study|Lost to Follow-up|5|||
42185911|NCT03638258|75995164|FG000|Overall Study|Pregnancy|0|||
42185912|NCT03638258|75995165|FG001|Overall Study|Pregnancy|0|||
42185913|NCT03638258|75995166|FG002|Overall Study|Pregnancy|1|||
42185914|NCT03638258|75995164|FG000|Overall Study|Protocol Violation|0|||
42185915|NCT03638258|75995165|FG001|Overall Study|Protocol Violation|0|||
42185916|NCT03638258|75995166|FG002|Overall Study|Protocol Violation|1|||
42185917|NCT03638258|75995164|FG000|Overall Study|Withdrawal by Subject|4|||
42185918|NCT03638258|75995165|FG001|Overall Study|Withdrawal by Subject|5|||
42185919|NCT03638258|75995166|FG002|Overall Study|Withdrawal by Subject|12|||
42185920|NCT03638258|75995164|FG000|Overall Study|Lack of Efficacy|0|||
42185921|NCT03638258|75995165|FG001|Overall Study|Lack of Efficacy|0|||
42185922|NCT03638258|75995166|FG002|Overall Study|Lack of Efficacy|2|||
42092503|NCT00720434|75902877|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
42092504|NCT00720434|75902878|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
42185923|NCT01670656|75995180|FG000|Overall Study|Non-compliance with study drug|0|||
42185924|NCT01670656|75995181|FG001|Overall Study|Non-compliance with study drug|0|||
42185925|NCT01670656|75995182|FG002|Overall Study|Non-compliance with study drug|3|||
42185926|NCT01670656|75995183|FG003|Overall Study|Non-compliance with study drug|0|||
42185927|NCT01670656|75995184|FG004|Overall Study|Non-compliance with study drug|1|||
42185928|NCT01670656|75995180|FG000|Overall Study|Pregnancy|0|||
42185929|NCT01670656|75995181|FG001|Overall Study|Pregnancy|0|||
42185930|NCT01670656|75995182|FG002|Overall Study|Pregnancy|0|||
42185931|NCT01670656|75995183|FG003|Overall Study|Pregnancy|0|||
42185932|NCT01670656|75995184|FG004|Overall Study|Pregnancy|1|||
42185933|NCT01670656|75995180|FG000|Overall Study|Withdrawal by Subject|1|||
42185934|NCT01670656|75995181|FG001|Overall Study|Withdrawal by Subject|1|||
42185935|NCT01670656|75995182|FG002|Overall Study|Withdrawal by Subject|0|||
42185936|NCT01670656|75995183|FG003|Overall Study|Withdrawal by Subject|0|||
42185937|NCT01670656|75995184|FG004|Overall Study|Withdrawal by Subject|0|||
42185938|NCT01670656|75995180|FG000|Overall Study|Non-compliance with protocol|0|||
42295458|NCT02499783|76129999|FG000|DB Period: Weeks 0-8|Other|1|||
42295459|NCT02499783|76130000|FG001|DB Period: Weeks 0-8|Other|1|||
42295460|NCT02499783|76130001|FG002|DB Period: Weeks 0-8|Other|0|||
42295461|NCT02499783|76129999|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
42295462|NCT02499783|76130000|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
42295463|NCT02499783|76130001|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
42295464|NCT02499783|76129999|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
42295465|NCT02499783|76130000|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
42185939|NCT01670656|75995181|FG001|Overall Study|Non-compliance with protocol|3|||
42295466|NCT02499783|76130001|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
42358966|NCT02565914|76204715|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
42295467|NCT02499783|76129999|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
42295468|NCT02499783|76130000|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
42295469|NCT02499783|76130001|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
42092505|NCT00720434|75902879|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
42092506|NCT00720434|75902880|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
42092507|NCT00720434|75902877|FG000|Open-Label Period (Week 5-72)|Other|4|||
42092508|NCT00720434|75902878|FG001|Open-Label Period (Week 5-72)|Other|3|||
42092509|NCT00720434|75902879|FG002|Open-Label Period (Week 5-72)|Other|3|||
42092510|NCT00720434|75902880|FG003|Open-Label Period (Week 5-72)|Other|2|||
42092511|NCT00776009|75902896|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
42092512|NCT00776009|75902897|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
42092513|NCT00776009|75902898|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
42092514|NCT00776009|75902899|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
42092515|NCT00776009|75902900|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
42092516|NCT00776009|75902901|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
42185940|NCT01670656|75995182|FG002|Overall Study|Non-compliance with protocol|1|||
42185941|NCT01670656|75995183|FG003|Overall Study|Non-compliance with protocol|1|||
42185942|NCT01670656|75995184|FG004|Overall Study|Non-compliance with protocol|2|||
42185943|NCT01670656|75995180|FG000|Overall Study|Adverse Event|2|||
42092517|NCT00776009|75902896|FG000|Period 1: First Intervention|Protocol Violation|0|||
42092518|NCT00776009|75902897|FG001|Period 1: First Intervention|Protocol Violation|1|||
42092519|NCT00776009|75902898|FG002|Period 1: First Intervention|Protocol Violation|0|||
42185944|NCT01670656|75995181|FG001|Overall Study|Adverse Event|2|||
42185945|NCT01670656|75995182|FG002|Overall Study|Adverse Event|2|||
42092520|NCT00776009|75902899|FG003|Period 1: First Intervention|Protocol Violation|0|||
42092521|NCT00776009|75902900|FG004|Period 1: First Intervention|Protocol Violation|1|||
42092522|NCT00776009|75902901|FG005|Period 1: First Intervention|Protocol Violation|0|||
42092523|NCT00776009|75902896|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
42092524|NCT00776009|75902897|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
42092525|NCT00776009|75902898|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
42092526|NCT00776009|75902899|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
42092527|NCT00776009|75902900|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
42092528|NCT00776009|75902901|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
42092529|NCT00776009|75902896|FG000|Period 2: Second Intervention|Protocol Violation|1|||
42092530|NCT00776009|75902897|FG001|Period 2: Second Intervention|Protocol Violation|0|||
42185946|NCT01670656|75995183|FG003|Overall Study|Adverse Event|3|||
42185947|NCT01670656|75995184|FG004|Overall Study|Adverse Event|3|||
42185948|NCT01670656|75995180|FG000|Overall Study|Subject withdrew consent|0|||
42185949|NCT01670656|75995181|FG001|Overall Study|Subject withdrew consent|1|||
42185950|NCT01670656|75995182|FG002|Overall Study|Subject withdrew consent|2|||
42185951|NCT01670656|75995183|FG003|Overall Study|Subject withdrew consent|1|||
42185952|NCT01670656|75995184|FG004|Overall Study|Subject withdrew consent|1|||
42185953|NCT01670656|75995180|FG000|Overall Study|Lost to Follow-up|0|||
42185954|NCT01670656|75995181|FG001|Overall Study|Lost to Follow-up|0|||
42185955|NCT01670656|75995182|FG002|Overall Study|Lost to Follow-up|0|||
42185956|NCT01670656|75995183|FG003|Overall Study|Lost to Follow-up|0|||
42185957|NCT01670656|75995184|FG004|Overall Study|Lost to Follow-up|3|||
42185958|NCT01670656|75995180|FG000|Overall Study|Subject moved|0|||
42185959|NCT01670656|75995181|FG001|Overall Study|Subject moved|0|||
42185960|NCT01670656|75995182|FG002|Overall Study|Subject moved|0|||
42185961|NCT01670656|75995183|FG003|Overall Study|Subject moved|1|||
42185962|NCT01670656|75995184|FG004|Overall Study|Subject moved|0|||
42185963|NCT00068445|75995198|FG000|Randomization|Cancel|1|||
42185964|NCT00068445|75995199|FG001|Randomization|Cancel|3|||
42185965|NCT00068445|75995198|FG000|Randomization|Ineligible|1|||
42185966|NCT00068445|75995199|FG001|Randomization|Ineligible|1|||
42185967|NCT00068445|75995198|FG000|Treatment|Refused Further Treatment|13|||
42185968|NCT00068445|75995199|FG001|Treatment|Refused Further Treatment|10|||
42185969|NCT00068445|75995198|FG000|Treatment|Adverse Event|7|||
42185970|NCT00068445|75995199|FG001|Treatment|Adverse Event|1|||
42185971|NCT00068445|75995198|FG000|Treatment|Other (Specifics not available)|9|||
42185972|NCT00068445|75995199|FG001|Treatment|Other (Specifics not available)|5|||
42295470|NCT02499783|76129999|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
42295471|NCT02499783|76130000|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
42295472|NCT02499783|76130001|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
42295473|NCT02468193|76130011|FG000|Overall Study|Adverse Event|4|||
42295474|NCT02468193|76130011|FG000|Overall Study|Subject/ Guardian decision|2|||
42185973|NCT03653208|75995214|FG000|Overall Study|Withdrawal by Subject|0|||
42185974|NCT03653208|75995215|FG001|Overall Study|Withdrawal by Subject|0|||
42185975|NCT03653208|75995216|FG002|Overall Study|Withdrawal by Subject|0|||
42185976|NCT03653208|75995217|FG003|Overall Study|Withdrawal by Subject|0|||
42185977|NCT03653208|75995218|FG004|Overall Study|Withdrawal by Subject|1|||
42185978|NCT03653208|75995219|FG005|Overall Study|Withdrawal by Subject|0|||
42185979|NCT03653208|75995220|FG006|Overall Study|Withdrawal by Subject|0|||
42185980|NCT03653208|75995221|FG007|Overall Study|Withdrawal by Subject|1|||
42295475|NCT02466555|76130031|FG000|Overall Study|Lost to Follow-up|2|||
42295476|NCT02466399|76130038|FG000|Overall Study|Adverse Event|1|||
42185981|NCT03653208|75995222|FG008|Overall Study|Withdrawal by Subject|1|||
42185982|NCT03545984|75995244|FG000|Overall Study|CSF cases not present during rotation|11|||
42185983|NCT03545984|75995245|FG001|Overall Study|CSF cases not present during rotation|9|||
42185984|NCT03033784|75995253|FG000|Overall Study|Anxiety related to MRI scanner|0|||
42185985|NCT03033784|75995254|FG001|Overall Study|Anxiety related to MRI scanner|1|||
42185986|NCT03033784|75995255|FG002|Overall Study|Anxiety related to MRI scanner|0|||
42185987|NCT03033784|75995256|FG003|Overall Study|Anxiety related to MRI scanner|0|||
42185988|NCT03033784|75995257|FG004|Overall Study|Anxiety related to MRI scanner|0|||
42185989|NCT03033784|75995258|FG005|Overall Study|Anxiety related to MRI scanner|0|||
42092531|NCT00776009|75902898|FG002|Period 2: Second Intervention|Protocol Violation|1|||
42092532|NCT00776009|75902899|FG003|Period 2: Second Intervention|Protocol Violation|0|||
42092533|NCT00776009|75902900|FG004|Period 2: Second Intervention|Protocol Violation|0|||
42092534|NCT00776009|75902901|FG005|Period 2: Second Intervention|Protocol Violation|0|||
42092535|NCT00776009|75902896|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
42092536|NCT00776009|75902897|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
42092537|NCT00776009|75902898|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
42092538|NCT00776009|75902899|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
42092539|NCT00776009|75902900|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
42092540|NCT00776009|75902901|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
42092541|NCT00694161|75902909|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
42092542|NCT00694161|75902909|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
42092543|NCT00694161|75902909|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
42092544|NCT00720356|75902913|FG000|Registration to Study|Determined to have methylated MGMT|67|||
42092545|NCT00720356|75902913|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
42092546|NCT00720356|75902913|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
42092547|NCT00720356|75902913|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
42092548|NCT00720356|75902913|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
42185990|NCT03033784|75995259|FG006|Overall Study|Anxiety related to MRI scanner|0|||
42185991|NCT03033784|75995260|FG007|Overall Study|Anxiety related to MRI scanner|0|||
42185992|NCT03033784|75995261|FG008|Overall Study|Anxiety related to MRI scanner|0|||
42185993|NCT03033784|75995262|FG009|Overall Study|Anxiety related to MRI scanner|0|||
42185994|NCT03033784|75995263|FG010|Overall Study|Anxiety related to MRI scanner|0|||
42185995|NCT03033784|75995264|FG011|Overall Study|Anxiety related to MRI scanner|0|||
42185996|NCT03033784|75995265|FG012|Overall Study|Anxiety related to MRI scanner|0|||
42185997|NCT03033784|75995253|FG000|Overall Study|Withdrawal by Subject|0|||
42092549|NCT00720356|75902913|FG000|Follow up Until Death|Withdrawal by Subject|1|||
42092550|NCT00720356|75902913|FG000|Follow up Until Death|Alive at last data collection|4|||
42092551|NCT00720278|75902920|FG000|Overall Study|Adverse Event|5|||
42092552|NCT00720278|75902921|FG001|Overall Study|Adverse Event|3|||
42092553|NCT00720278|75902922|FG002|Overall Study|Adverse Event|4|||
42092554|NCT00720278|75902920|FG000|Overall Study|Withdrawal by Subject|0|||
42092555|NCT00720278|75902921|FG001|Overall Study|Withdrawal by Subject|1|||
42092556|NCT00720278|75902922|FG002|Overall Study|Withdrawal by Subject|0|||
42092557|NCT00720278|75902920|FG000|Overall Study|Lost to Follow-up|0|||
42092558|NCT00720278|75902921|FG001|Overall Study|Lost to Follow-up|0|||
42185998|NCT03033784|75995254|FG001|Overall Study|Withdrawal by Subject|0|||
42185999|NCT03033784|75995255|FG002|Overall Study|Withdrawal by Subject|0|||
42186000|NCT03033784|75995256|FG003|Overall Study|Withdrawal by Subject|0|||
42186001|NCT03033784|75995257|FG004|Overall Study|Withdrawal by Subject|0|||
42186002|NCT03033784|75995258|FG005|Overall Study|Withdrawal by Subject|0|||
42186003|NCT03033784|75995259|FG006|Overall Study|Withdrawal by Subject|0|||
42186004|NCT03033784|75995260|FG007|Overall Study|Withdrawal by Subject|0|||
42186005|NCT03033784|75995261|FG008|Overall Study|Withdrawal by Subject|0|||
42295477|NCT02466399|76130039|FG001|Overall Study|Adverse Event|0|||
42295478|NCT02466399|76130038|FG000|Overall Study|Early exit due to family emergency|1|||
42295479|NCT02466399|76130039|FG001|Overall Study|Early exit due to family emergency|0|||
42295480|NCT02465931|76130047|FG000|Overall Study|Lost to Follow-up|9|||
42295481|NCT02465931|76130048|FG001|Overall Study|Lost to Follow-up|11|||
42092559|NCT00720278|75902922|FG002|Overall Study|Lost to Follow-up|1|||
42186006|NCT03033784|75995262|FG009|Overall Study|Withdrawal by Subject|0|||
42186007|NCT03033784|75995263|FG010|Overall Study|Withdrawal by Subject|0|||
42186008|NCT03033784|75995264|FG011|Overall Study|Withdrawal by Subject|0|||
42186009|NCT03033784|75995265|FG012|Overall Study|Withdrawal by Subject|2|||
42186010|NCT00038649|75995276|FG000|Overall Study|Adverse Event|9|||
42186011|NCT03544268|75995282|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
42186012|NCT03544268|75995283|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
42186013|NCT03652818|75995294|FG000|Overall Study|Adverse Event|1|||
42186014|NCT03652818|75995295|FG001|Overall Study|Adverse Event|0|||
42186015|NCT03652818|75995296|FG002|Overall Study|Adverse Event|0|||
42186016|NCT03652818|75995297|FG003|Overall Study|Adverse Event|0|||
42186017|NCT03652818|75995298|FG004|Overall Study|Adverse Event|0|||
42186018|NCT03652818|75995294|FG000|Overall Study|Physician Decision|1|||
42186019|NCT03652818|75995295|FG001|Overall Study|Physician Decision|0|||
42186020|NCT03652818|75995296|FG002|Overall Study|Physician Decision|0|||
42186021|NCT03652818|75995297|FG003|Overall Study|Physician Decision|0|||
42186022|NCT03652818|75995298|FG004|Overall Study|Physician Decision|0|||
42186023|NCT03652818|75995294|FG000|Overall Study|Lost to Follow-up|0|||
42186024|NCT03652818|75995295|FG001|Overall Study|Lost to Follow-up|1|||
42186025|NCT03652818|75995296|FG002|Overall Study|Lost to Follow-up|2|||
42092560|NCT00720278|75902920|FG000|Overall Study|Non-compliance|1|||
42092561|NCT00720278|75902921|FG001|Overall Study|Non-compliance|0|||
42186026|NCT03652818|75995297|FG003|Overall Study|Lost to Follow-up|1|||
42358967|NCT02565914|76204715|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
42092562|NCT00720278|75902922|FG002|Overall Study|Non-compliance|0|||
42092563|NCT00720278|75902920|FG000|Overall Study|eligibility criteria violation|1|||
42092564|NCT00720278|75902921|FG001|Overall Study|eligibility criteria violation|0|||
42092565|NCT00720278|75902922|FG002|Overall Study|eligibility criteria violation|1|||
42092566|NCT00720122|75902930|FG000|Overall Study|Lost to Follow-up|1|||
42092567|NCT00720122|75902930|FG000|Overall Study|Physician Decision|1|||
42092568|NCT00720122|75902930|FG000|Overall Study|Withdrawal by Subject|7|||
42092569|NCT00717860|75902936|FG000|Overall Study|Clinical adverse experience|5|||
42092570|NCT00717860|75902937|FG001|Overall Study|Clinical adverse experience|9|||
42092571|NCT00717860|75902936|FG000|Overall Study|Laboratory adverse experience|2|||
42092572|NCT00717860|75902937|FG001|Overall Study|Laboratory adverse experience|2|||
42092573|NCT00717860|75902936|FG000|Overall Study|Lack of Efficacy|7|||
42092574|NCT00717860|75902937|FG001|Overall Study|Lack of Efficacy|13|||
42092575|NCT00717860|75902936|FG000|Overall Study|Discontinued for other reason|6|||
42092576|NCT00717860|75902937|FG001|Overall Study|Discontinued for other reason|1|||
42092577|NCT00717860|75902936|FG000|Overall Study|Withdrew consent|7|||
42092578|NCT00717860|75902937|FG001|Overall Study|Withdrew consent|3|||
42092579|NCT00717314|75902945|FG000|Overall Study|Adverse Event|3|||
42092580|NCT00717314|75902946|FG001|Overall Study|Adverse Event|2|||
42092581|NCT00717314|75902945|FG000|Overall Study|Protocol Violation|1|||
42092582|NCT00717314|75902946|FG001|Overall Study|Protocol Violation|0|||
42092583|NCT00717314|75902945|FG000|Overall Study|Lost to Follow-up|1|||
42092584|NCT00717314|75902946|FG001|Overall Study|Lost to Follow-up|5|||
42092585|NCT00717314|75902945|FG000|Overall Study|Withdrawal by Subject|1|||
42092586|NCT00717314|75902946|FG001|Overall Study|Withdrawal by Subject|3|||
42092587|NCT00689793|75902954|FG000|Overall Study|Lost to Follow-up|4|||
42092588|NCT00689793|75902955|FG001|Overall Study|Lost to Follow-up|5|||
42092589|NCT00723944|75902965|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
42092590|NCT00723944|75902966|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
42092591|NCT00723944|75902965|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
42092592|NCT00723944|75902966|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
42092593|NCT00723944|75902965|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
42092594|NCT00723944|75902966|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
42092595|NCT00689481|75902974|FG000|Overall Study|Adverse Event|7|||
42092596|NCT00689481|75902975|FG001|Overall Study|Adverse Event|1|||
42092597|NCT00689481|75902974|FG000|Overall Study|Lost to Follow-up|4|||
42092598|NCT00689481|75902975|FG001|Overall Study|Lost to Follow-up|3|||
42186027|NCT03652818|75995298|FG004|Overall Study|Lost to Follow-up|1|||
42186028|NCT03619902|75995310|FG000|Overall Study|Termination of Study by Investigator|1|||
42186029|NCT03619902|75995310|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
42358968|NCT02565914|76204715|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
42358969|NCT02565914|76204715|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
42186030|NCT00620464|75995316|FG000|Overall Study|Adverse Event|15|||
42358970|NCT02565914|76204715|FG000|Part A (Up to 96 Weeks)|Other|18|||
42092599|NCT00689481|75902974|FG000|Overall Study|Lack of Efficacy|4|||
42092600|NCT00689481|75902975|FG001|Overall Study|Lack of Efficacy|3|||
42092601|NCT00689481|75902974|FG000|Overall Study|Non-compliance with study treatment|1|||
42092602|NCT00689481|75902975|FG001|Overall Study|Non-compliance with study treatment|1|||
42092603|NCT00689481|75902974|FG000|Overall Study|Withdrawal by Subject|8|||
42092604|NCT00689481|75902975|FG001|Overall Study|Withdrawal by Subject|4|||
42092605|NCT00689481|75902974|FG000|Overall Study|Excluded medication started during study|0|||
42092606|NCT00689481|75902975|FG001|Overall Study|Excluded medication started during study|1|||
42092607|NCT00689481|75902974|FG000|Overall Study|Subject early term, left on vacation|0|||
42092608|NCT00689481|75902975|FG001|Overall Study|Subject early term, left on vacation|1|||
42092609|NCT00688701|75902984|FG000|Overall Study|Adverse Event|1|||
42092610|NCT00688701|75902985|FG001|Overall Study|Adverse Event|0|||
42092611|NCT00688701|75902986|FG002|Overall Study|Adverse Event|5|||
42092612|NCT00688701|75902987|FG003|Overall Study|Adverse Event|3|||
42092613|NCT00688701|75902984|FG000|Overall Study|Lack of Efficacy|0|||
42092614|NCT00688701|75902985|FG001|Overall Study|Lack of Efficacy|1|||
42092615|NCT00688701|75902986|FG002|Overall Study|Lack of Efficacy|0|||
42092616|NCT00688701|75902987|FG003|Overall Study|Lack of Efficacy|0|||
42092617|NCT00688701|75902984|FG000|Overall Study|Withdrawal by Subject|3|||
42092618|NCT00688701|75902985|FG001|Overall Study|Withdrawal by Subject|3|||
42092619|NCT00688701|75902986|FG002|Overall Study|Withdrawal by Subject|4|||
42092620|NCT00688701|75902987|FG003|Overall Study|Withdrawal by Subject|8|||
42092621|NCT00688701|75902984|FG000|Overall Study|Poor compliance to protocol|0|||
42092622|NCT00688701|75902985|FG001|Overall Study|Poor compliance to protocol|1|||
42092623|NCT00688701|75902986|FG002|Overall Study|Poor compliance to protocol|1|||
42092624|NCT00688701|75902987|FG003|Overall Study|Poor compliance to protocol|0|||
42186031|NCT00620464|75995317|FG001|Overall Study|Adverse Event|17|||
42186032|NCT00620464|75995316|FG000|Overall Study|Lost to Follow-up|1|||
42186033|NCT00620464|75995317|FG001|Overall Study|Lost to Follow-up|1|||
42186034|NCT00620464|75995316|FG000|Overall Study|Planning Pregnancy|1|||
42186035|NCT00620464|75995317|FG001|Overall Study|Planning Pregnancy|4|||
42186036|NCT00620464|75995316|FG000|Overall Study|Personal|2|||
42186037|NCT00620464|75995317|FG001|Overall Study|Personal|2|||
42186038|NCT00620464|75995316|FG000|Overall Study|Used prohibited medication|1|||
42186039|NCT00620464|75995317|FG001|Overall Study|Used prohibited medication|0|||
42186040|NCT03652662|75995325|FG000|Overall Study|Withdrawal by Subject|2|||
42186041|NCT03652662|75995326|FG001|Overall Study|Withdrawal by Subject|1|||
42186042|NCT03652662|75995325|FG000|Overall Study|Lost to Follow-up|1|||
42186043|NCT03652662|75995326|FG001|Overall Study|Lost to Follow-up|0|||
42186044|NCT03560258|75995335|FG000|Overall Study|Lost to Follow-up|3|||
42186045|NCT03560258|75995336|FG001|Overall Study|Lost to Follow-up|0|||
42186046|NCT03560258|75995337|FG002|Overall Study|Lost to Follow-up|0|||
42186047|NCT03560258|75995335|FG000|Overall Study|Protocol Violation|0|||
42186048|NCT03560258|75995336|FG001|Overall Study|Protocol Violation|1|||
42186049|NCT03560258|75995337|FG002|Overall Study|Protocol Violation|0|||
42186050|NCT03560258|75995335|FG000|Overall Study|Withdrawal by Subject|0|||
42092625|NCT00688623|75903007|FG000|Overall Study|Adverse Event|22|||
42092626|NCT00688623|75903007|FG000|Overall Study|abnormal lab value|1|||
42186051|NCT03560258|75995336|FG001|Overall Study|Withdrawal by Subject|0|||
42186052|NCT03560258|75995337|FG002|Overall Study|Withdrawal by Subject|1|||
42186053|NCT02768662|75995345|FG000|Overall Study|Adverse Event|1|||
42186054|NCT02768662|75995345|FG000|Overall Study|Lost to Follow-up|4|||
42186055|NCT02768662|75995345|FG000|Overall Study|Withdrawal by Subject|3|||
42186056|NCT02768662|75995345|FG000|Overall Study|Study terminated by Sponsor|78|||
42186057|NCT03539432|75995351|FG000|Overall Study|Lost to Follow-up|0|||
42186058|NCT03539432|75995352|FG001|Overall Study|Lost to Follow-up|1|||
42295482|NCT02465931|76130047|FG000|Overall Study|Protocol Violation|1|||
42295483|NCT02465931|76130048|FG001|Overall Study|Protocol Violation|0|||
42295484|NCT02465931|76130047|FG000|Overall Study|Withdrawal by Subject|1|||
42295485|NCT02465931|76130048|FG001|Overall Study|Withdrawal by Subject|0|||
42295486|NCT02465463|76130056|FG000|Overall Study|Lost to Follow-up|2|||
42295487|NCT02465463|76130057|FG001|Overall Study|Lost to Follow-up|1|||
42295488|NCT02465463|76130056|FG000|Overall Study|Death|1|||
42295489|NCT02465463|76130057|FG001|Overall Study|Death|0|||
42295490|NCT02465463|76130056|FG000|Overall Study|Protocol Violation|1|||
42295491|NCT02465463|76130057|FG001|Overall Study|Protocol Violation|0|||
42295492|NCT02464059|76130064|FG000|Overall Study|Lost to Follow-up|6|||
42295493|NCT02463357|76130073|FG000|Overall Study|Withdrawal by Subject|1|||
42295494|NCT02463357|76130074|FG001|Overall Study|Withdrawal by Subject|0|||
42186059|NCT03615924|75995360|FG000|Overall Study|Withdrawal by Subject|2|||
42186060|NCT03615924|75995361|FG001|Overall Study|Withdrawal by Subject|5|||
42295495|NCT02463357|76130075|FG002|Overall Study|Withdrawal by Subject|0|||
42092627|NCT00688623|75903007|FG000|Overall Study|Withdrawal by Subject|4|||
42295496|NCT02463357|76130076|FG003|Overall Study|Withdrawal by Subject|0|||
42092628|NCT00688623|75903007|FG000|Overall Study|Death|3|||
42186061|NCT03615924|75995360|FG000|Overall Study|Death|3|||
42186062|NCT03615924|75995361|FG001|Overall Study|Death|1|||
42186063|NCT03615924|75995360|FG000|Overall Study|Lost to Follow-up|1|||
42186064|NCT03615924|75995361|FG001|Overall Study|Lost to Follow-up|0|||
42186065|NCT03615924|75995360|FG000|Overall Study|Randomized in error|1|||
42092629|NCT00688623|75903007|FG000|Overall Study|disease progression|23|||
42092630|NCT00688623|75903007|FG000|Overall Study|Protocol Violation|2|||
42092631|NCT00717236|75903013|FG000|Double-Blind Period|Adverse Event|33|||
42186066|NCT03615924|75995361|FG001|Overall Study|Randomized in error|0|||
42295497|NCT02463357|76130077|FG004|Overall Study|Withdrawal by Subject|0|||
42295498|NCT02463357|76130073|FG000|Overall Study|Withdrawal by Subject|0|||
42186067|NCT03615924|75995360|FG000|Overall Study|Study termination by Sponsor|94|||
42186068|NCT03615924|75995361|FG001|Overall Study|Study termination by Sponsor|86|||
42186069|NCT03535844|75995369|FG000|Overall Study|Withdrawal by Subject|0|||
42186070|NCT03535844|75995370|FG001|Overall Study|Withdrawal by Subject|1|||
42186071|NCT03533114|75995378|FG000|Overall|Adverse Event|16|||
42295499|NCT02463357|76130074|FG001|Overall Study|Withdrawal by Subject|0|||
42295500|NCT02463357|76130075|FG002|Overall Study|Withdrawal by Subject|0|||
42295501|NCT02463357|76130076|FG003|Overall Study|Withdrawal by Subject|0|||
42295502|NCT02463357|76130077|FG004|Overall Study|Withdrawal by Subject|1|||
42295503|NCT02579759|76130092|FG000|Overall Study|Protocol Violation|2|||
42295504|NCT02579759|76130093|FG001|Overall Study|Protocol Violation|0|||
42295505|NCT02579759|76130094|FG002|Overall Study|Protocol Violation|0|||
42295506|NCT02579759|76130092|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
42295507|NCT02579759|76130093|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
42295508|NCT02579759|76130094|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
42295509|NCT02579759|76130092|FG000|Overall Study|BfArM hold|13|||
42295510|NCT02579759|76130093|FG001|Overall Study|BfArM hold|12|||
42295511|NCT02579759|76130094|FG002|Overall Study|BfArM hold|12|||
42295512|NCT02579759|76130092|FG000|Overall Study|Sponsor stopped Dose 2|0|||
42295513|NCT02579759|76130093|FG001|Overall Study|Sponsor stopped Dose 2|41|||
42295514|NCT02579759|76130094|FG002|Overall Study|Sponsor stopped Dose 2|0|||
42295515|NCT02579759|76130092|FG000|Overall Study|Non compliance|0|||
42092632|NCT00717236|75903014|FG001|Double-Blind Period|Adverse Event|6|||
42092633|NCT00717236|75903013|FG000|Double-Blind Period|Lack of Efficacy|6|||
42092634|NCT00717236|75903014|FG001|Double-Blind Period|Lack of Efficacy|6|||
42092635|NCT00717236|75903013|FG000|Double-Blind Period|Lost to Follow-up|3|||
42092636|NCT00717236|75903014|FG001|Double-Blind Period|Lost to Follow-up|5|||
42092637|NCT00717236|75903013|FG000|Double-Blind Period|Withdrawal by Subject|10|||
42092638|NCT00717236|75903014|FG001|Double-Blind Period|Withdrawal by Subject|2|||
42092639|NCT00717236|75903013|FG000|Double-Blind Period|Loss of efficacy|3|||
42092640|NCT00717236|75903014|FG001|Double-Blind Period|Loss of efficacy|0|||
42092641|NCT00717236|75903013|FG000|Double-Blind Period|Other: Death|1|||
42092642|NCT00717236|75903014|FG001|Double-Blind Period|Other: Death|0|||
42092643|NCT00717236|75903013|FG000|Double-Blind Period|Other: Pregnancy|1|||
42092644|NCT00717236|75903014|FG001|Double-Blind Period|Other: Pregnancy|0|||
42092645|NCT00717236|75903013|FG000|Double-Blind Period|Other: Protocol Violation|2|||
42092646|NCT00717236|75903014|FG001|Double-Blind Period|Other: Protocol Violation|0|||
42092647|NCT00717236|75903013|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
42092648|NCT00717236|75903014|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
42092649|NCT00717236|75903013|FG000|Double-Blind Period|Other: Site withdrew|2|||
42092650|NCT00717236|75903014|FG001|Double-Blind Period|Other: Site withdrew|0|||
42092651|NCT00717236|75903013|FG000|Double-Blind Period|Other: Screening failure|1|||
42092652|NCT00717236|75903014|FG001|Double-Blind Period|Other: Screening failure|0|||
42092653|NCT00717236|75903013|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
42092654|NCT00717236|75903014|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
42092655|NCT00717236|75903013|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
42092656|NCT00717236|75903014|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
42092657|NCT00717236|75903013|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
42092658|NCT00717236|75903014|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
42092659|NCT00717236|75903013|FG000|Double-Blind Period|Other: History of cancer|1|||
42092660|NCT00717236|75903014|FG001|Double-Blind Period|Other: History of cancer|0|||
42092661|NCT00717236|75903013|FG000|Double-Blind Period|Other: Sponsor request|1|||
42092662|NCT00717236|75903014|FG001|Double-Blind Period|Other: Sponsor request|0|||
42092663|NCT00717236|75903013|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
42092664|NCT00717236|75903014|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
42092665|NCT00717236|75903013|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
42092666|NCT00717236|75903014|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
42092667|NCT00717236|75903013|FG000|Double-Blind Period|Other: Subject moved|1|||
42092668|NCT00717236|75903014|FG001|Double-Blind Period|Other: Subject moved|1|||
42295516|NCT02579759|76130093|FG001|Overall Study|Non compliance|1|||
42295517|NCT02579759|76130094|FG002|Overall Study|Non compliance|0|||
42295518|NCT02579759|76130092|FG000|Overall Study|Pregnancy|0|||
42295519|NCT02579759|76130093|FG001|Overall Study|Pregnancy|1|||
42358971|NCT02565914|76204715|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
42092669|NCT00717236|75903013|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
42092670|NCT00717236|75903014|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
42186072|NCT03533114|75995379|FG001|Overall|Adverse Event|11|||
42186073|NCT03533114|75995378|FG000|Overall|Consent Withdrawal by Participant|7|||
42186074|NCT03533114|75995379|FG001|Overall|Consent Withdrawal by Participant|6|||
42295520|NCT02579759|76130094|FG002|Overall Study|Pregnancy|0|||
42295521|NCT02579759|76130092|FG000|Overall Study|Inclusion/exclusion criteria|0|||
42295522|NCT02579759|76130093|FG001|Overall Study|Inclusion/exclusion criteria|0|||
42295523|NCT02579759|76130094|FG002|Overall Study|Inclusion/exclusion criteria|1|||
42295524|NCT02579759|76130092|FG000|Overall Study|Adverse Event|4|||
42092671|NCT00717236|75903013|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
42092672|NCT00717236|75903014|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
42092673|NCT00717236|75903013|FG000|Double-Blind Period|Other: Transportation problems|0|||
42092674|NCT00717236|75903014|FG001|Double-Blind Period|Other: Transportation problems|1|||
42092675|NCT00717236|75903013|FG000|Double-Blind Period|Other: Investigator Decision|0|||
42092676|NCT00717236|75903014|FG001|Double-Blind Period|Other: Investigator Decision|1|||
42092677|NCT00717236|75903013|FG000|Open-Label Period|Adverse Event|29|||
42092678|NCT00717236|75903014|FG001|Open-Label Period|Adverse Event|4|||
42092679|NCT00717236|75903013|FG000|Open-Label Period|Lack of Efficacy|30|||
42092680|NCT00717236|75903014|FG001|Open-Label Period|Lack of Efficacy|8|||
42092681|NCT00717236|75903013|FG000|Open-Label Period|Lost to Follow-up|28|||
42092682|NCT00717236|75903014|FG001|Open-Label Period|Lost to Follow-up|4|||
42092683|NCT00717236|75903013|FG000|Open-Label Period|Withdrawal by Subject|20|||
42092684|NCT00717236|75903014|FG001|Open-Label Period|Withdrawal by Subject|2|||
42092685|NCT00717236|75903013|FG000|Open-Label Period|Loss of Efficacy|6|||
42092686|NCT00717236|75903014|FG001|Open-Label Period|Loss of Efficacy|1|||
42092687|NCT00717236|75903013|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
42092688|NCT00717236|75903014|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
42092689|NCT00717236|75903013|FG000|Open-Label Period|Other: Lack of Compliance|1|||
42092690|NCT00717236|75903014|FG001|Open-Label Period|Other: Lack of Compliance|1|||
42092691|NCT00717236|75903013|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
42092692|NCT00717236|75903014|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
42092693|NCT00717236|75903013|FG000|Open-Label Period|Other: Moved|1|||
42092694|NCT00717236|75903014|FG001|Open-Label Period|Other: Moved|0|||
42092695|NCT00717236|75903013|FG000|Open-Label Period|Other: Investigator Decision|1|||
42092696|NCT00717236|75903014|FG001|Open-Label Period|Other: Investigator Decision|0|||
42092697|NCT00717236|75903013|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
42092698|NCT00717236|75903014|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
42092699|NCT00717236|75903013|FG000|Open-Label Period|Other: Sponsor Request|3|||
42092700|NCT00717236|75903014|FG001|Open-Label Period|Other: Sponsor Request|0|||
42092701|NCT00717236|75903013|FG000|Open-Label Period|Other: Cataract Surgery|1|||
42092702|NCT00717236|75903014|FG001|Open-Label Period|Other: Cataract Surgery|0|||
42092703|NCT00717236|75903013|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
42092704|NCT00717236|75903014|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
42092705|NCT00717236|75903013|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
42186075|NCT03533114|75995378|FG000|Overall|Lack of Efficacy|5|||
42186076|NCT03533114|75995379|FG001|Overall|Lack of Efficacy|3|||
42186077|NCT03533114|75995378|FG000|Overall|Lost to Follow-up|1|||
42186078|NCT03533114|75995379|FG001|Overall|Lost to Follow-up|1|||
42186079|NCT03533114|75995378|FG000|Overall|Physician Decision|0|||
42186080|NCT03533114|75995379|FG001|Overall|Physician Decision|2|||
42186081|NCT03533114|75995378|FG000|Overall|Protocol deviation|1|||
42295525|NCT02579759|76130093|FG001|Overall Study|Adverse Event|3|||
42295526|NCT02579759|76130094|FG002|Overall Study|Adverse Event|1|||
42295527|NCT02579759|76130092|FG000|Overall Study|Withdrawal by Subject|3|||
42295528|NCT02579759|76130093|FG001|Overall Study|Withdrawal by Subject|3|||
42186082|NCT03533114|75995379|FG001|Overall|Protocol deviation|1|||
42295529|NCT02579759|76130094|FG002|Overall Study|Withdrawal by Subject|5|||
42295530|NCT02579759|76130092|FG000|Overall Study|Lost to Follow-up|2|||
42186083|NCT03533114|75995378|FG000|Overall|Failure to meet randomization criteria|1|||
42186084|NCT03533114|75995379|FG001|Overall|Failure to meet randomization criteria|2|||
42186085|NCT03533114|75995378|FG000|Overall|Non-Compliance with study drug|0|||
42186086|NCT03533114|75995379|FG001|Overall|Non-Compliance with study drug|1|||
42186087|NCT03533114|75995378|FG000|Overall|Other|0|||
42186088|NCT03533114|75995379|FG001|Overall|Other|1|||
42186089|NCT03533114|75995378|FG000|Open Label Titration and Optimization|Adverse Event|11|||
42186090|NCT03533114|75995379|FG001|Open Label Titration and Optimization|Adverse Event|8|||
42186091|NCT03533114|75995378|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
42186092|NCT03533114|75995379|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
42295531|NCT02579759|76130093|FG001|Overall Study|Lost to Follow-up|2|||
42295532|NCT02579759|76130094|FG002|Overall Study|Lost to Follow-up|2|||
42295533|NCT02445963|76130108|FG000|Overall Study|Lost to Follow-up|1|||
42092706|NCT00717236|75903014|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
42092707|NCT00717236|75903013|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
42092708|NCT00717236|75903014|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
42092709|NCT00719810|75903025|FG000|Overall Study|Adverse Event|0|||
42092710|NCT00719810|75903026|FG001|Overall Study|Adverse Event|2|||
42092711|NCT00719810|75903027|FG002|Overall Study|Adverse Event|3|||
42186093|NCT03533114|75995378|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
42186094|NCT03533114|75995379|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
42295534|NCT02445963|76130109|FG001|Overall Study|Lost to Follow-up|0|||
42295535|NCT02445963|76130110|FG002|Overall Study|Lost to Follow-up|0|||
42295536|NCT02445963|76130111|FG003|Overall Study|Lost to Follow-up|0|||
42295537|NCT02445963|76130108|FG000|Overall Study|Change in employment|1|||
42092712|NCT00719810|75903025|FG000|Overall Study|Lost to Follow-up|2|||
42092713|NCT00719810|75903026|FG001|Overall Study|Lost to Follow-up|0|||
42092714|NCT00719810|75903027|FG002|Overall Study|Lost to Follow-up|3|||
42092715|NCT00719810|75903025|FG000|Overall Study|Physician Decision|0|||
42092716|NCT00719810|75903026|FG001|Overall Study|Physician Decision|1|||
42092717|NCT00719810|75903027|FG002|Overall Study|Physician Decision|0|||
42092718|NCT00719810|75903025|FG000|Overall Study|Withdrawal by Subject|1|||
42092719|NCT00719810|75903026|FG001|Overall Study|Withdrawal by Subject|1|||
42092720|NCT00719810|75903027|FG002|Overall Study|Withdrawal by Subject|2|||
42092721|NCT00719732|75903035|FG000|Overall Study|Lost to Follow-up|20|||
42092722|NCT00719732|75903035|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
42092723|NCT00719732|75903035|FG000|Overall Study|Illness not associated with device|1|||
42092724|NCT00723710|75903039|FG000|Overall Study|Disease progression|48|||
42092725|NCT00723710|75903039|FG000|Overall Study|Adverse Event|88|||
42092726|NCT00723710|75903039|FG000|Overall Study|Withdrawal by Subject|36|||
42092727|NCT00723710|75903039|FG000|Overall Study|Physician Decision|2|||
42092728|NCT00688545|75903045|FG000|Overall Study|Lost to Follow-up|1|||
42092729|NCT00688545|75903046|FG001|Overall Study|Lost to Follow-up|4|||
42092730|NCT00688545|75903045|FG000|Overall Study|Insurance/cost of drug|0|||
42092731|NCT00688545|75903046|FG001|Overall Study|Insurance/cost of drug|1|||
42092732|NCT00688545|75903045|FG000|Overall Study|Withdrawal by Subject|2|||
42092733|NCT00688545|75903046|FG001|Overall Study|Withdrawal by Subject|3|||
42092734|NCT00688545|75903045|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
42092735|NCT00688545|75903046|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
42092736|NCT00688467|75903056|FG000|Treatment Period 1|Adverse Event|2|||
42092737|NCT00688467|75903057|FG001|Treatment Period 1|Adverse Event|1|||
42092738|NCT00688467|75903056|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
42092739|NCT00688467|75903057|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
42092740|NCT00688467|75903056|FG000|Treatment Period 2|Protocol Violation|0|||
42092741|NCT00688467|75903057|FG001|Treatment Period 2|Protocol Violation|1|||
42092742|NCT00688467|75903056|FG000|Treatment Period 2|Adverse Event|0|||
42092743|NCT00688467|75903057|FG001|Treatment Period 2|Adverse Event|1|||
42092744|NCT00688155|75903067|FG000|Overall Study|Withdrawal by Subject|2|||
42092745|NCT00688155|75903068|FG001|Overall Study|Withdrawal by Subject|2|||
42092746|NCT00688155|75903069|FG002|Overall Study|Withdrawal by Subject|1|||
42092747|NCT00688155|75903070|FG003|Overall Study|Withdrawal by Subject|1|||
42092748|NCT00690573|75903080|FG000|Overall Study|Lack of Efficacy|8|||
42092749|NCT00690573|75903080|FG000|Overall Study|Withdrawal by Subject|1|||
42092750|NCT00719264|75903086|FG000|Overall Study|Adverse Event|41|||
42092751|NCT00719264|75903087|FG001|Overall Study|Adverse Event|49|||
42092752|NCT00719264|75903086|FG000|Overall Study|Death|13|||
42092753|NCT00719264|75903087|FG001|Overall Study|Death|10|||
42092754|NCT00719264|75903086|FG000|Overall Study|Administrative Problems|6|||
42092755|NCT00719264|75903087|FG001|Overall Study|Administrative Problems|4|||
42092756|NCT00719264|75903086|FG000|Overall Study|Lost to Follow-up|1|||
42092757|NCT00719264|75903087|FG001|Overall Study|Lost to Follow-up|1|||
42092758|NCT00719264|75903086|FG000|Overall Study|Withdrawal by Subject|12|||
42092759|NCT00719264|75903087|FG001|Overall Study|Withdrawal by Subject|7|||
42092760|NCT00719264|75903086|FG000|Overall Study|Protocol Deviation|1|||
42092761|NCT00719264|75903087|FG001|Overall Study|Protocol Deviation|3|||
42295538|NCT02445963|76130109|FG001|Overall Study|Change in employment|0|||
42295539|NCT02445963|76130110|FG002|Overall Study|Change in employment|0|||
42295540|NCT02445963|76130111|FG003|Overall Study|Change in employment|0|||
42295541|NCT02445963|76130108|FG000|Overall Study|Symptoms post-vaccination|0|||
42295542|NCT02445963|76130109|FG001|Overall Study|Symptoms post-vaccination|0|||
42295543|NCT02445963|76130110|FG002|Overall Study|Symptoms post-vaccination|1|||
42295544|NCT02445963|76130111|FG003|Overall Study|Symptoms post-vaccination|0|||
42295545|NCT02499159|76130125|FG000|Randomization|Protocol Violation|1|||
42295546|NCT02499159|76130126|FG001|Randomization|Protocol Violation|1|||
42295547|NCT02499159|76130125|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
42092762|NCT00719264|75903086|FG000|Overall Study|New Cancer Therapy|4|||
42092763|NCT00719264|75903087|FG001|Overall Study|New Cancer Therapy|2|||
42092764|NCT00719264|75903086|FG000|Overall Study|Disease Progression|104|||
42092765|NCT00719264|75903087|FG001|Overall Study|Disease Progression|107|||
42092766|NCT00687609|75903093|FG000|Overall Study|Physician Decision|1|||
42092767|NCT00687609|75903093|FG000|Overall Study|Withdrawal by Subject|2|||
42092768|NCT00723554|75903097|FG000|Overall Study|Adverse Event|12|||
42092769|NCT00723554|75903097|FG000|Overall Study|Investigator's judgement|5|||
42092770|NCT00723554|75903097|FG000|Overall Study|Inhaled medication other than iloprost|4|||
42092771|NCT00723554|75903097|FG000|Overall Study|Withdrawal of consent|3|||
42092772|NCT00723554|75903097|FG000|Overall Study|Other|3|||
42092773|NCT00723554|75903097|FG000|Overall Study|Lost to Follow-up|1|||
42092774|NCT00723554|75903097|FG000|Overall Study|Non-compliance|1|||
42295548|NCT02499159|76130126|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
42295549|NCT02499159|76130125|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
42295550|NCT02499159|76130126|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
42186095|NCT03533114|75995378|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
42186096|NCT03533114|75995379|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
42186097|NCT03533114|75995378|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
42186098|NCT03533114|75995379|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
42186099|NCT03533114|75995378|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
42186100|NCT03533114|75995379|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
42186101|NCT03533114|75995378|FG000|Stable Dose|Adverse Event|0|||
42186102|NCT03533114|75995379|FG001|Stable Dose|Adverse Event|2|||
42186103|NCT03533114|75995378|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
42186104|NCT03533114|75995379|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
42186105|NCT03533114|75995378|FG000|Stable Dose|Lack of Efficacy|1|||
42186106|NCT03533114|75995379|FG001|Stable Dose|Lack of Efficacy|0|||
42186107|NCT03533114|75995378|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
42186108|NCT03533114|75995379|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
42186109|NCT03533114|75995378|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
42186110|NCT03533114|75995379|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
42092775|NCT00687219|75903103|FG000|Overall Study|Adverse Event|8|||
42092776|NCT00687219|75903103|FG000|Overall Study|Discontinuance criteria met|7|||
42092777|NCT00687219|75903103|FG000|Overall Study|HCV-RNA positive conversion|34|||
42092778|NCT00687219|75903103|FG000|Overall Study|Withdrawal by Subject|1|||
42092779|NCT00687219|75903103|FG000|Overall Study|Lack of Efficacy|1|||
42092780|NCT00723398|75903112|FG000|Overall Study|Withdrawal by Subject|2|||
42092781|NCT00723398|75903113|FG001|Overall Study|Withdrawal by Subject|6|||
42092782|NCT00723398|75903114|FG002|Overall Study|Withdrawal by Subject|4|||
42092783|NCT00723398|75903115|FG003|Overall Study|Withdrawal by Subject|4|||
42186111|NCT03533114|75995378|FG000|Open-Label Safety Extension|Adverse Event|3|||
42186112|NCT03533114|75995379|FG001|Open-Label Safety Extension|Adverse Event|0|||
42186113|NCT03533114|75995378|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
42186114|NCT03533114|75995379|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
42186115|NCT03533114|75995378|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
42186116|NCT03533114|75995379|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
42186117|NCT03533114|75995378|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
42186118|NCT03533114|75995379|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
42186119|NCT03533114|75995378|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
42186120|NCT03533114|75995379|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
42186121|NCT03033394|75995387|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
42186122|NCT03033394|75995387|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
42186123|NCT03033394|75995387|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
42186124|NCT03033394|75995387|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
42186125|NCT03033394|75995387|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
42186126|NCT03981822|75995404|FG000|Overall Study|Lost to Follow-up|0|||
42092784|NCT00723398|75903116|FG004|Overall Study|Withdrawal by Subject|4|||
42092785|NCT00723398|75903112|FG000|Overall Study|Protocol Violation|2|||
42092786|NCT00723398|75903113|FG001|Overall Study|Protocol Violation|1|||
42186127|NCT03981822|75995405|FG001|Overall Study|Lost to Follow-up|1|||
42186128|NCT03981822|75995406|FG002|Overall Study|Lost to Follow-up|1|||
42186129|NCT03981822|75995407|FG003|Overall Study|Lost to Follow-up|0|||
42186130|NCT03981822|75995408|FG004|Overall Study|Lost to Follow-up|6|||
42295551|NCT02499159|76130125|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
42295552|NCT02499159|76130126|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
42295553|NCT02499159|76130125|FG000|30-Day Follow-Up Phone Call|Other|1|||
42295554|NCT02499159|76130126|FG001|30-Day Follow-Up Phone Call|Other|0|||
42295555|NCT01664039|76130134|FG000|Overall Study|Adverse Event|3|||
42295556|NCT01664039|76130135|FG001|Overall Study|Adverse Event|4|||
42295557|NCT01664039|76130134|FG000|Overall Study|Lost to Follow-up|1|||
42295558|NCT01664039|76130135|FG001|Overall Study|Lost to Follow-up|1|||
42295559|NCT01664039|76130134|FG000|Overall Study|Withdrawal by Subject|1|||
42295560|NCT01664039|76130135|FG001|Overall Study|Withdrawal by Subject|3|||
42295561|NCT01664039|76130134|FG000|Overall Study|Noncompliance|1|||
42295562|NCT01664039|76130135|FG001|Overall Study|Noncompliance|1|||
42092787|NCT00723398|75903114|FG002|Overall Study|Protocol Violation|5|||
42092788|NCT00723398|75903115|FG003|Overall Study|Protocol Violation|0|||
42186131|NCT03981822|75995409|FG005|Overall Study|Lost to Follow-up|4|||
42186132|NCT03981822|75995410|FG006|Overall Study|Lost to Follow-up|4|||
42186133|NCT03981822|75995411|FG007|Overall Study|Lost to Follow-up|2|||
42186134|NCT03981822|75995404|FG000|Overall Study|Withdrawal by Subject|0|||
42186135|NCT03981822|75995405|FG001|Overall Study|Withdrawal by Subject|1|||
42186136|NCT03981822|75995406|FG002|Overall Study|Withdrawal by Subject|0|||
42295563|NCT02445573|76130143|FG000|Overall Study|Withdrawal by Subject|1|||
42295564|NCT02445573|76130144|FG001|Overall Study|Withdrawal by Subject|1|||
42092789|NCT00723398|75903116|FG004|Overall Study|Protocol Violation|0|||
42295565|NCT02445573|76130143|FG000|Overall Study|Lost to Follow-up|0|||
42092790|NCT00723398|75903112|FG000|Overall Study|Physician Decision|2|||
42092791|NCT00723398|75903113|FG001|Overall Study|Physician Decision|2|||
42186137|NCT03981822|75995407|FG003|Overall Study|Withdrawal by Subject|0|||
42186138|NCT03981822|75995408|FG004|Overall Study|Withdrawal by Subject|0|||
42186139|NCT03981822|75995409|FG005|Overall Study|Withdrawal by Subject|1|||
42186140|NCT03981822|75995410|FG006|Overall Study|Withdrawal by Subject|0|||
42186141|NCT03981822|75995411|FG007|Overall Study|Withdrawal by Subject|2|||
42186142|NCT03981822|75995404|FG000|Overall Study|COVID-19 Related|0|||
42186143|NCT03981822|75995405|FG001|Overall Study|COVID-19 Related|0|||
42186144|NCT03981822|75995406|FG002|Overall Study|COVID-19 Related|0|||
42186145|NCT03981822|75995407|FG003|Overall Study|COVID-19 Related|0|||
42186146|NCT03981822|75995408|FG004|Overall Study|COVID-19 Related|2|||
42186147|NCT03981822|75995409|FG005|Overall Study|COVID-19 Related|1|||
42186148|NCT03981822|75995410|FG006|Overall Study|COVID-19 Related|2|||
42186149|NCT03981822|75995411|FG007|Overall Study|COVID-19 Related|1|||
42186150|NCT03650556|75995423|FG000|Overall Study|Death|2|||
42186151|NCT03650556|75995423|FG000|Overall Study|Withdrawal by Subject|20|||
42186152|NCT03650556|75995423|FG000|Overall Study|Physician Decision|2|||
42186153|NCT03650556|75995423|FG000|Overall Study|Lost to Follow-up|8|||
42186154|NCT03650556|75995423|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
42092792|NCT00723398|75903114|FG002|Overall Study|Physician Decision|5|||
42092793|NCT00723398|75903115|FG003|Overall Study|Physician Decision|0|||
42092794|NCT00723398|75903116|FG004|Overall Study|Physician Decision|1|||
42092795|NCT00723398|75903112|FG000|Overall Study|Adverse Event|0|||
42092796|NCT00723398|75903113|FG001|Overall Study|Adverse Event|5|||
42092797|NCT00723398|75903114|FG002|Overall Study|Adverse Event|3|||
42092798|NCT00723398|75903115|FG003|Overall Study|Adverse Event|1|||
42092799|NCT00723398|75903116|FG004|Overall Study|Adverse Event|4|||
42186155|NCT03650556|75995423|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
42186156|NCT03531632|75995431|FG000|Overall Study|Adverse Event|0|||
42186157|NCT03531632|75995432|FG001|Overall Study|Adverse Event|0|||
42186158|NCT03531632|75995433|FG002|Overall Study|Adverse Event|1|||
42186159|NCT03531632|75995431|FG000|Overall Study|Death|4|||
42186160|NCT03531632|75995432|FG001|Overall Study|Death|0|||
42186161|NCT03531632|75995433|FG002|Overall Study|Death|14|||
42186162|NCT03531632|75995431|FG000|Overall Study|Study Terminated|1|||
42186163|NCT03531632|75995432|FG001|Overall Study|Study Terminated|3|||
42186164|NCT03531632|75995433|FG002|Overall Study|Study Terminated|11|||
42186165|NCT03979638|75995444|FG000|Period 1|Physician Decision|1|||
42186166|NCT03979638|75995445|FG001|Period 1|Physician Decision|1|||
42295566|NCT02445573|76130144|FG001|Overall Study|Lost to Follow-up|1|||
42295567|NCT02445339|76130152|FG000|Overall Study|Physician Decision|1|||
42295568|NCT02445339|76130153|FG001|Overall Study|Physician Decision|0|||
42295569|NCT02445339|76130152|FG000|Overall Study|Lost to Follow-up|11|||
42295570|NCT02445339|76130153|FG001|Overall Study|Lost to Follow-up|15|||
42092800|NCT00723398|75903112|FG000|Overall Study|Lost to Follow-up|0|||
42295571|NCT02579603|76130161|FG000|Overall Study|Not treated|1|||
42092801|NCT00723398|75903113|FG001|Overall Study|Lost to Follow-up|1|||
42092802|NCT00723398|75903114|FG002|Overall Study|Lost to Follow-up|0|||
42092803|NCT00723398|75903115|FG003|Overall Study|Lost to Follow-up|0|||
42092804|NCT00723398|75903116|FG004|Overall Study|Lost to Follow-up|0|||
42092805|NCT00716456|75903131|FG000|Overall Study|Adverse Event|0|||
42092806|NCT00716456|75903132|FG001|Overall Study|Adverse Event|2|||
42092807|NCT00716456|75903133|FG002|Overall Study|Adverse Event|0|||
42092808|NCT00684645|75903141|FG000|Overall Study|Death|2|||
42092809|NCT00684645|75903141|FG000|Overall Study|Progressive disease|67|||
42092810|NCT00684645|75903141|FG000|Overall Study|Adverse Event|27|||
42092811|NCT00684645|75903141|FG000|Overall Study|Lost to Follow-up|3|||
42092812|NCT00684645|75903141|FG000|Overall Study|Other|15|||
42092813|NCT00716144|75903149|FG000|Overall Study|Withdrawal by Subject|4|||
42092814|NCT00716144|75903150|FG001|Overall Study|Withdrawal by Subject|2|||
42186167|NCT03979638|75995444|FG000|Period 1|Withdrawal by Subject|4|||
42295572|NCT02579603|76130162|FG001|Overall Study|Not treated|0|||
42295573|NCT02579603|76130161|FG000|Overall Study|Adverse Event|2|||
42295574|NCT02579603|76130162|FG001|Overall Study|Adverse Event|2|||
42295575|NCT02579603|76130161|FG000|Overall Study|Other than stated|1|||
42295576|NCT02579603|76130162|FG001|Overall Study|Other than stated|0|||
42295577|NCT02625259|76130174|FG000|First Intervention (Day 1)|Other|0|||
42295578|NCT02625259|76130175|FG001|First Intervention (Day 1)|Other|0|||
42186168|NCT03979638|75995445|FG001|Period 1|Withdrawal by Subject|3|||
42186169|NCT03979638|75995444|FG000|Period 1|Study terminated by Sponsor|1|||
42186170|NCT03979638|75995445|FG001|Period 1|Study terminated by Sponsor|3|||
42295579|NCT02625259|76130176|FG002|First Intervention (Day 1)|Other|1|||
42295580|NCT02625259|76130177|FG003|First Intervention (Day 1)|Other|0|||
42092815|NCT00716144|75903151|FG002|Overall Study|Withdrawal by Subject|6|||
42092816|NCT00716144|75903152|FG003|Overall Study|Withdrawal by Subject|6|||
42092817|NCT00716144|75903149|FG000|Overall Study|Lost to Follow-up|2|||
42295581|NCT02625259|76130178|FG004|First Intervention (Day 1)|Other|0|||
42295582|NCT02625259|76130174|FG000|First Intervention (Day 1)|Adverse Event|2|||
42186171|NCT03979638|75995444|FG000|Period 1|Protocol Violation|1|||
42186172|NCT03979638|75995445|FG001|Period 1|Protocol Violation|0|||
42186173|NCT03979638|75995444|FG000|Period 2|Study terminated by Sponsor|1|||
42186174|NCT03979638|75995445|FG001|Period 2|Study terminated by Sponsor|1|||
42186175|NCT03655054|75995460|FG000|Overall Study|Lost to Follow-up|1|||
42186176|NCT03615144|75995466|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
42186177|NCT03615144|75995467|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
42295583|NCT02625259|76130175|FG001|First Intervention (Day 1)|Adverse Event|1|||
42295584|NCT02625259|76130176|FG002|First Intervention (Day 1)|Adverse Event|0|||
42295585|NCT02625259|76130177|FG003|First Intervention (Day 1)|Adverse Event|0|||
42295586|NCT02625259|76130178|FG004|First Intervention (Day 1)|Adverse Event|0|||
42295587|NCT02625259|76130174|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
42295588|NCT02625259|76130175|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
42295589|NCT02625259|76130176|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
42295590|NCT02625259|76130177|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
42358972|NCT02565914|76204715|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
42358973|NCT02565914|76204715|FG000|Part B (Up to 96 Weeks)|Other|1|||
42358974|NCT02565914|76204715|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
42358975|NCT02565914|76204715|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
42358976|NCT02565914|76204715|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
42358977|NCT02565914|76204715|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
42358978|NCT02565914|76204715|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
42358979|NCT02565914|76204715|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
42358980|NCT02565914|76204715|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
42358981|NCT02565914|76204715|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
42358982|NCT02565914|76204715|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
42358983|NCT02565914|76204715|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
42358984|NCT02565914|76204715|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
42358985|NCT02565914|76204715|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
42358986|NCT02248701|76204725|FG000|Overall Study|Withdrawal by Subject|2|||
42358987|NCT02248701|76204726|FG001|Overall Study|Withdrawal by Subject|1|||
42358988|NCT02248701|76204725|FG000|Overall Study|Physician Decision|0|||
42358989|NCT02248701|76204726|FG001|Overall Study|Physician Decision|1|||
42358990|NCT02248701|76204725|FG000|Overall Study|Adverse Event|1|||
42358991|NCT02248701|76204726|FG001|Overall Study|Adverse Event|0|||
42358992|NCT02248701|76204725|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
42358993|NCT02248701|76204726|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
42018079|NCT01259297|75825795|FG005|Double Blind Randomized Period|Death|5|||
42018080|NCT01259297|75825796|FG006|Double Blind Randomized Period|Death|2|||
42018081|NCT01259297|75825797|FG007|Double Blind Randomized Period|Death|1|||
42092818|NCT00716144|75903150|FG001|Overall Study|Lost to Follow-up|2|||
42092819|NCT00716144|75903151|FG002|Overall Study|Lost to Follow-up|1|||
42092820|NCT00716144|75903152|FG003|Overall Study|Lost to Follow-up|2|||
42092821|NCT00716144|75903149|FG000|Overall Study|Adverse Event|0|||
42092822|NCT00716144|75903150|FG001|Overall Study|Adverse Event|0|||
42092823|NCT00716144|75903151|FG002|Overall Study|Adverse Event|0|||
42092824|NCT00716144|75903152|FG003|Overall Study|Adverse Event|2|||
42018082|NCT01259297|75825790|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
42018083|NCT01259297|75825791|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
42018084|NCT01259297|75825792|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
42018085|NCT01259297|75825793|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
42018086|NCT01259297|75825794|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
42018087|NCT01259297|75825795|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
42018088|NCT01259297|75825796|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
42018089|NCT01259297|75825797|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
42018090|NCT01259297|75825790|FG000|Double Blind Randomized Period|Other reasons|0|||
42018091|NCT01259297|75825791|FG001|Double Blind Randomized Period|Other reasons|1|||
42092825|NCT00716144|75903149|FG000|Overall Study|Non-compliance|1|||
42092826|NCT00716144|75903150|FG001|Overall Study|Non-compliance|0|||
42092827|NCT00716144|75903151|FG002|Overall Study|Non-compliance|0|||
42092828|NCT00716144|75903152|FG003|Overall Study|Non-compliance|0|||
42092829|NCT00716144|75903149|FG000|Overall Study|Protocol Violation|2|||
42092830|NCT00716144|75903150|FG001|Overall Study|Protocol Violation|0|||
42092831|NCT00716144|75903151|FG002|Overall Study|Protocol Violation|1|||
42092832|NCT00716144|75903152|FG003|Overall Study|Protocol Violation|0|||
42092833|NCT00716144|75903149|FG000|Overall Study|Physician Decision|0|||
42092834|NCT00716144|75903150|FG001|Overall Study|Physician Decision|1|||
42092835|NCT00716144|75903151|FG002|Overall Study|Physician Decision|2|||
42092836|NCT00716144|75903152|FG003|Overall Study|Physician Decision|2|||
42092837|NCT00716144|75903149|FG000|Overall Study|Intercurrent illness|0|||
42092838|NCT00716144|75903150|FG001|Overall Study|Intercurrent illness|0|||
42186178|NCT03682302|75995477|FG000|Overall Study|Lost to Follow-up|1|||
42186179|NCT03682302|75995478|FG001|Overall Study|Lost to Follow-up|2|||
42186180|NCT03682302|75995479|FG002|Overall Study|Lost to Follow-up|0|||
42186181|NCT03682302|75995480|FG003|Overall Study|Lost to Follow-up|1|||
42186182|NCT03682302|75995477|FG000|Overall Study|Study drug was not administered|0|||
42092839|NCT00716144|75903151|FG002|Overall Study|Intercurrent illness|1|||
42092840|NCT00716144|75903152|FG003|Overall Study|Intercurrent illness|0|||
42092841|NCT00716144|75903149|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
42092842|NCT00716144|75903150|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
42092843|NCT00716144|75903151|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
42092844|NCT00716144|75903152|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
42092845|NCT00716144|75903149|FG000|Overall Study|Adverse event: left foot pain|0|||
42092846|NCT00716144|75903150|FG001|Overall Study|Adverse event: left foot pain|1|||
42092847|NCT00716144|75903151|FG002|Overall Study|Adverse event: left foot pain|0|||
42092848|NCT00716144|75903152|FG003|Overall Study|Adverse event: left foot pain|0|||
42092849|NCT00716144|75903149|FG000|Overall Study|Clinical Depression|0|||
42186183|NCT03682302|75995478|FG001|Overall Study|Study drug was not administered|0|||
42186184|NCT03682302|75995479|FG002|Overall Study|Study drug was not administered|1|||
42186185|NCT03682302|75995480|FG003|Overall Study|Study drug was not administered|1|||
42186186|NCT03522506|75995494|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42186187|NCT03522506|75995495|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42186188|NCT03522506|75995496|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42186189|NCT03522506|75995497|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
42186190|NCT03522506|75995494|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
42186191|NCT03522506|75995495|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
42186192|NCT03522506|75995496|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
42186193|NCT03522506|75995497|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
42186194|NCT02892734|75995528|FG000|Treatment on Study|Progressive Disease|2|||
42186195|NCT02892734|75995528|FG000|Follow up for 2 Years|Death|2|||
42186196|NCT02892734|75995528|FG000|Follow up for 2 Years|Study closed early|1|||
42186197|NCT00055497|75995536|FG000|Overall Study|Adverse Event|1|||
42186198|NCT00055497|75995537|FG001|Overall Study|Adverse Event|1|||
42186199|NCT00055497|75995538|FG002|Overall Study|Adverse Event|1|||
42186200|NCT00055497|75995539|FG003|Overall Study|Adverse Event|28|||
42186201|NCT00055497|75995536|FG000|Overall Study|Withdrawal by Subject|3|||
42186202|NCT00055497|75995537|FG001|Overall Study|Withdrawal by Subject|1|||
42186203|NCT00055497|75995538|FG002|Overall Study|Withdrawal by Subject|1|||
42186204|NCT00055497|75995539|FG003|Overall Study|Withdrawal by Subject|15|||
42186205|NCT00055497|75995536|FG000|Overall Study|Lost to Follow-up|0|||
42186206|NCT00055497|75995537|FG001|Overall Study|Lost to Follow-up|1|||
42186207|NCT00055497|75995538|FG002|Overall Study|Lost to Follow-up|0|||
42186208|NCT00055497|75995539|FG003|Overall Study|Lost to Follow-up|5|||
42186209|NCT00055497|75995536|FG000|Overall Study|Protocol Violation|0|||
42186210|NCT00055497|75995537|FG001|Overall Study|Protocol Violation|0|||
42186211|NCT00055497|75995538|FG002|Overall Study|Protocol Violation|0|||
42186212|NCT00055497|75995539|FG003|Overall Study|Protocol Violation|3|||
42186213|NCT00055497|75995536|FG000|Overall Study|Lack of Efficacy|1|||
42186214|NCT00055497|75995537|FG001|Overall Study|Lack of Efficacy|0|||
42186215|NCT00055497|75995538|FG002|Overall Study|Lack of Efficacy|0|||
42186216|NCT00055497|75995539|FG003|Overall Study|Lack of Efficacy|27|||
42186217|NCT00055497|75995536|FG000|Overall Study|Administrative Reasons|0|||
42295591|NCT02625259|76130178|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
42295592|NCT02577107|76130195|FG000|Overall Study|Protocol deviation|0|||
42295593|NCT02577107|76130196|FG001|Overall Study|Protocol deviation|1|||
42295594|NCT02444793|76130206|FG000|Overall Study|Lost to Follow-up|2|||
42295595|NCT02444793|76130207|FG001|Overall Study|Lost to Follow-up|2|||
42092850|NCT00716144|75903150|FG001|Overall Study|Clinical Depression|1|||
42092851|NCT00716144|75903151|FG002|Overall Study|Clinical Depression|0|||
42295596|NCT02444793|76130208|FG002|Overall Study|Lost to Follow-up|0|||
42295597|NCT02444793|76130209|FG003|Overall Study|Lost to Follow-up|0|||
42092852|NCT00716144|75903152|FG003|Overall Study|Clinical Depression|0|||
42092853|NCT00576381|75903162|FG000|Overall Study|Reoperation|3|||
42186218|NCT00055497|75995537|FG001|Overall Study|Administrative Reasons|0|||
42186219|NCT00055497|75995538|FG002|Overall Study|Administrative Reasons|0|||
42295598|NCT02444793|76130206|FG000|Overall Study|Death|0|||
42295599|NCT02444793|76130207|FG001|Overall Study|Death|3|||
42295600|NCT02444793|76130208|FG002|Overall Study|Death|0|||
42295601|NCT02444793|76130209|FG003|Overall Study|Death|0|||
42295602|NCT02444793|76130206|FG000|Overall Study|Other|0|||
42295603|NCT02444793|76130207|FG001|Overall Study|Other|0|||
42186220|NCT00055497|75995539|FG003|Overall Study|Administrative Reasons|1|||
42186221|NCT00055497|75995536|FG000|Overall Study|Other|0|||
42186222|NCT00055497|75995537|FG001|Overall Study|Other|0|||
42186223|NCT00055497|75995538|FG002|Overall Study|Other|0|||
42186224|NCT00055497|75995539|FG003|Overall Study|Other|11|||
42186225|NCT03520400|75995556|FG000|Overall Study|Physician Decision|15|||
42295604|NCT02444793|76130208|FG002|Overall Study|Other|2|||
42295605|NCT02444793|76130209|FG003|Overall Study|Other|0|||
42186226|NCT03520400|75995557|FG001|Overall Study|Physician Decision|7|||
42186227|NCT03615066|75995566|FG000|Main Study|Withdrew Consent|0|||
42186228|NCT03615066|75995567|FG001|Main Study|Withdrew Consent|1|||
42186229|NCT03615066|75995568|FG002|Main Study|Withdrew Consent|1|||
42186230|NCT03615066|75995566|FG000|Main Study|Lost to Follow-up|0|||
42186231|NCT03615066|75995567|FG001|Main Study|Lost to Follow-up|0|||
42186232|NCT03615066|75995568|FG002|Main Study|Lost to Follow-up|1|||
42186233|NCT03615066|75995566|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
42186234|NCT03615066|75995567|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
42186235|NCT03615066|75995568|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
42186236|NCT03615066|75995566|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
42186237|NCT03615066|75995567|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
42186238|NCT03615066|75995568|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
42186239|NCT03615066|75995566|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
42186240|NCT03615066|75995567|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
42186241|NCT03615066|75995568|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
42092854|NCT00576381|75903162|FG000|Overall Study|Adverse Event|4|||
42092855|NCT00684567|75903166|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
42092856|NCT00684567|75903166|FG000|Monotherapy Period|Adverse Event|2|||
42092857|NCT00684567|75903166|FG000|Monotherapy Period|Death|1|||
42092858|NCT00684567|75903166|FG000|Monotherapy Period|Progression of primary disease|11|||
42092859|NCT00684411|75903170|FG000|Overall Study|New Primary Cancer|1|||
42092860|NCT00684411|75903170|FG000|Overall Study|Disease Progression|10|||
42092861|NCT00684411|75903170|FG000|Overall Study|Adverse Event|1|||
42092862|NCT00686829|75903174|FG000|Overall Study|Adverse Event|5|||
42092863|NCT00686829|75903174|FG000|Overall Study|Lack of Efficacy|6|||
42092864|NCT00686829|75903174|FG000|Overall Study|Lost to Follow-up|4|||
42092865|NCT00686829|75903174|FG000|Overall Study|Withdrawal by Subject|14|||
42092866|NCT00686829|75903174|FG000|Overall Study|Protocol Violation|3|||
42092867|NCT00686829|75903174|FG000|Overall Study|Sponsor discontinued VCV|47|||
42092868|NCT00687297|75903180|FG000|Randomization|Withdrawal by Subject|2|||
42092869|NCT00687297|75903181|FG001|Randomization|Withdrawal by Subject|0|||
42092870|NCT00687297|75903180|FG000|Randomization|Withdrew before treatment, ineligible|1|||
42092871|NCT00687297|75903181|FG001|Randomization|Withdrew before treatment, ineligible|1|||
42092872|NCT00687297|75903180|FG000|Induction|Withdrawal by Subject|4|||
42092873|NCT00687297|75903181|FG001|Induction|Withdrawal by Subject|4|||
42092874|NCT00687297|75903180|FG000|Induction|Adverse Event|16|||
42092875|NCT00687297|75903181|FG001|Induction|Adverse Event|15|||
42092876|NCT00687297|75903180|FG000|Induction|Death|7|||
42092877|NCT00687297|75903181|FG001|Induction|Death|11|||
42092878|NCT00687297|75903180|FG000|Induction|Lack of Efficacy|17|||
42092879|NCT00687297|75903181|FG001|Induction|Lack of Efficacy|21|||
42092880|NCT00687297|75903180|FG000|Induction|Ineligible|0|||
42092881|NCT00687297|75903181|FG001|Induction|Ineligible|1|||
42186242|NCT03527966|75995582|FG000|Overall Study|Lost to Follow-up|3|||
42186243|NCT03527966|75995583|FG001|Overall Study|Lost to Follow-up|0|||
42186244|NCT03808545|75995591|FG000|Overall Study|Withdrawal by Subject|1|||
42186245|NCT03808545|75995592|FG001|Overall Study|Withdrawal by Subject|1|||
42186246|NCT03807843|75995601|FG000|Overall Study|Lost to Follow-up|1|||
42186247|NCT03807843|75995602|FG001|Overall Study|Lost to Follow-up|0|||
42186248|NCT03519932|75995608|FG000|First Intervention|Adverse Event|1|||
42186249|NCT03519932|75995609|FG001|First Intervention|Adverse Event|3|||
42186250|NCT03806127|75995622|FG000|Overall Study|Withdrawal by Subject|4|||
42186251|NCT03806127|75995623|FG001|Overall Study|Withdrawal by Subject|5|||
42186252|NCT03806127|75995622|FG000|Overall Study|Protocol Violation|3|||
42186253|NCT03806127|75995623|FG001|Overall Study|Protocol Violation|1|||
42092882|NCT00687297|75903180|FG000|Induction|Patient Noncompliance|1|||
42186254|NCT03806127|75995622|FG000|Overall Study|Adverse Event|3|||
42092883|NCT00687297|75903181|FG001|Induction|Patient Noncompliance|0|||
42092884|NCT00687297|75903180|FG000|Induction|Physician Decision|0|||
42092885|NCT00687297|75903181|FG001|Induction|Physician Decision|2|||
42092886|NCT00687297|75903180|FG000|Induction|Other|0|||
42092887|NCT00687297|75903181|FG001|Induction|Other|1|||
42092888|NCT00684177|75903191|FG000|Overall Study|Adverse Event|4|||
42092889|NCT00684177|75903192|FG001|Overall Study|Adverse Event|3|||
42092890|NCT00684177|75903191|FG000|Overall Study|Lack of Efficacy|10|||
42092891|NCT00684177|75903192|FG001|Overall Study|Lack of Efficacy|15|||
42092892|NCT00684177|75903191|FG000|Overall Study|Protocol Violation|1|||
42092893|NCT00684177|75903192|FG001|Overall Study|Protocol Violation|0|||
42092894|NCT00684177|75903191|FG000|Overall Study|Lost to Follow-up|2|||
42092895|NCT00684177|75903192|FG001|Overall Study|Lost to Follow-up|1|||
42092896|NCT00684177|75903191|FG000|Overall Study|Physician Decision|2|||
42092897|NCT00684177|75903192|FG001|Overall Study|Physician Decision|0|||
42092898|NCT00684177|75903191|FG000|Overall Study|Withdrawal by Subject|1|||
42186255|NCT03806127|75995623|FG001|Overall Study|Adverse Event|0|||
42186256|NCT03806127|75995622|FG000|Overall Study|Unable to Complete Procedures|0|||
42186257|NCT03806127|75995623|FG001|Overall Study|Unable to Complete Procedures|1|||
42186258|NCT03806127|75995622|FG000|Overall Study|Pregnancy|0|||
42092899|NCT00684177|75903192|FG001|Overall Study|Withdrawal by Subject|2|||
42186259|NCT03806127|75995623|FG001|Overall Study|Pregnancy|1|||
42186260|NCT03806127|75995622|FG000|Overall Study|Lost to Follow-up|5|||
42186261|NCT03806127|75995623|FG001|Overall Study|Lost to Follow-up|1|||
42186262|NCT03806127|75995622|FG000|Overall Study|Physician Decision|1|||
42186263|NCT03806127|75995623|FG001|Overall Study|Physician Decision|1|||
42186264|NCT03806127|75995622|FG000|Overall Study|Could Not Come Due to Covid|1|||
42186265|NCT03806127|75995623|FG001|Overall Study|Could Not Come Due to Covid|0|||
42186266|NCT03806127|75995622|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
42092900|NCT00684177|75903191|FG000|Overall Study|Other|1|||
42092901|NCT00684177|75903192|FG001|Overall Study|Other|2|||
42092902|NCT00684021|75903202|FG000|Overall Study|MRI Contraindicated|1|||
42092903|NCT00684021|75903203|FG001|Overall Study|MRI Contraindicated|1|||
42092904|NCT00684021|75903204|FG002|Overall Study|MRI Contraindicated|1|||
42092905|NCT00684021|75903205|FG003|Overall Study|MRI Contraindicated|0|||
42092906|NCT00684021|75903202|FG000|Overall Study|MRI not performed|0|||
42186267|NCT03806127|75995623|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
42186268|NCT03806127|75995622|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
42186269|NCT03806127|75995623|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
42186270|NCT03806127|75995622|FG000|Overall Study|Covid 19 Restrictions|2|||
42186271|NCT03806127|75995623|FG001|Overall Study|Covid 19 Restrictions|0|||
42186272|NCT03806127|75995622|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
42186273|NCT03806127|75995623|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
42186274|NCT03806127|75995622|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
42186275|NCT03806127|75995623|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
42186276|NCT03650400|75995631|FG000|Overall Study|Study terminated by sponsor|0|||
42186277|NCT03650400|75995632|FG001|Overall Study|Study terminated by sponsor|5|||
42186278|NCT00038103|75995640|FG000|Overall Study|Adverse Event|5|||
42186279|NCT00038103|75995641|FG001|Overall Study|Adverse Event|6|||
42186280|NCT00038103|75995640|FG000|Overall Study|Lack of Efficacy|48|||
42186281|NCT00038103|75995641|FG001|Overall Study|Lack of Efficacy|41|||
42186282|NCT00038103|75995640|FG000|Overall Study|Withdrawal by Subject|0|||
42186283|NCT00038103|75995641|FG001|Overall Study|Withdrawal by Subject|3|||
42186284|NCT00038103|75995640|FG000|Overall Study|Lost to Follow-up|0|||
42186285|NCT00038103|75995641|FG001|Overall Study|Lost to Follow-up|3|||
42186286|NCT00038103|75995640|FG000|Overall Study|Protocol Violation|0|||
42186287|NCT00038103|75995641|FG001|Overall Study|Protocol Violation|2|||
42186288|NCT00038103|75995640|FG000|Overall Study|Sponsor Decision|0|||
42186289|NCT00038103|75995641|FG001|Overall Study|Sponsor Decision|1|||
42295606|NCT02444793|76130206|FG000|Overall Study|Objective progression or relapse|9|||
42295607|NCT02444793|76130207|FG001|Overall Study|Objective progression or relapse|1|||
42295608|NCT02444793|76130208|FG002|Overall Study|Objective progression or relapse|2|||
42295609|NCT02444793|76130209|FG003|Overall Study|Objective progression or relapse|3|||
42295610|NCT02624713|76130222|FG000|Overall Study|Lost to Follow-up|14|||
42295611|NCT02624713|76130223|FG001|Overall Study|Lost to Follow-up|0|||
42295612|NCT02624791|76130230|FG000|Overall Study|Withdrawal by Subject|2|||
42295613|NCT02624791|76130231|FG001|Overall Study|Withdrawal by Subject|0|||
42295614|NCT02624791|76130232|FG002|Overall Study|Withdrawal by Subject|0|||
42295615|NCT02624791|76130233|FG003|Overall Study|Withdrawal by Subject|0|||
42295616|NCT02624791|76130234|FG004|Overall Study|Withdrawal by Subject|0|||
42295617|NCT02624791|76130235|FG005|Overall Study|Withdrawal by Subject|0|||
42295618|NCT02577029|76130247|FG000|Overall Study|Adverse Event|1|||
42295619|NCT02577029|76130248|FG001|Overall Study|Adverse Event|0|||
42018092|NCT01259297|75825792|FG002|Double Blind Randomized Period|Other reasons|0|||
42018093|NCT01259297|75825793|FG003|Double Blind Randomized Period|Other reasons|0|||
42018094|NCT01259297|75825794|FG004|Double Blind Randomized Period|Other reasons|1|||
42018095|NCT01259297|75825795|FG005|Double Blind Randomized Period|Other reasons|2|||
42018096|NCT01259297|75825796|FG006|Double Blind Randomized Period|Other reasons|3|||
42018097|NCT01259297|75825797|FG007|Double Blind Randomized Period|Other reasons|1|||
42018098|NCT01126437|75825817|FG000|Overall Study|Not treated|11|||
42018099|NCT01126437|75825818|FG001|Overall Study|Not treated|18|||
42018100|NCT01126437|75825819|FG002|Overall Study|Not treated|19|||
42018101|NCT01126437|75825817|FG000|Overall Study|Sites with data irregularities/fraud|6|||
42018102|NCT01126437|75825818|FG001|Overall Study|Sites with data irregularities/fraud|6|||
42018103|NCT01126437|75825819|FG002|Overall Study|Sites with data irregularities/fraud|7|||
42092907|NCT00684021|75903203|FG001|Overall Study|MRI not performed|1|||
42092908|NCT00684021|75903204|FG002|Overall Study|MRI not performed|1|||
42186290|NCT00038103|75995640|FG000|Overall Study|Randomized/never treated|2|||
42186291|NCT00038103|75995641|FG001|Overall Study|Randomized/never treated|0|||
42186292|NCT03680742|75995647|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
42186293|NCT03678870|75995653|FG000|Overall Study|prescribed non- protocol medications|10|||
42295620|NCT02577029|76130249|FG002|Overall Study|Adverse Event|2|||
42295621|NCT02577029|76130250|FG003|Overall Study|Adverse Event|0|||
42018104|NCT01126437|75825817|FG000|Overall Study|Adverse Event|602|||
42092909|NCT00684021|75903205|FG003|Overall Study|MRI not performed|2|||
42295622|NCT02577029|76130251|FG004|Overall Study|Adverse Event|1|||
42295623|NCT02577029|76130252|FG005|Overall Study|Adverse Event|0|||
42295624|NCT02577029|76130253|FG006|Overall Study|Adverse Event|0|||
42295625|NCT02577029|76130254|FG007|Overall Study|Adverse Event|0|||
42295626|NCT02577029|76130247|FG000|Overall Study|Withdrawal by Subject|0|||
42295627|NCT02577029|76130248|FG001|Overall Study|Withdrawal by Subject|0|||
42295628|NCT02577029|76130249|FG002|Overall Study|Withdrawal by Subject|0|||
42295629|NCT02577029|76130250|FG003|Overall Study|Withdrawal by Subject|0|||
42295630|NCT02577029|76130251|FG004|Overall Study|Withdrawal by Subject|0|||
42295631|NCT02577029|76130252|FG005|Overall Study|Withdrawal by Subject|1|||
42295632|NCT02577029|76130253|FG006|Overall Study|Withdrawal by Subject|0|||
42186294|NCT03678870|75995654|FG001|Overall Study|prescribed non- protocol medications|6|||
42186295|NCT03678870|75995653|FG000|Overall Study|Lost to Follow-up|3|||
42186296|NCT03678870|75995654|FG001|Overall Study|Lost to Follow-up|2|||
42186297|NCT03805971|75995660|FG000|Overall Study|Withdrawal by Subject|1|||
42186298|NCT03805971|75995660|FG000|Overall Study|Protocol Violation|2|||
42186299|NCT03032380|75995667|FG000|Overall Study|Adverse Event|0|||
42186300|NCT03032380|75995668|FG001|Overall Study|Adverse Event|1|||
42186301|NCT03032380|75995667|FG000|Overall Study|Lack of Efficacy|1|||
42295633|NCT02577029|76130254|FG007|Overall Study|Withdrawal by Subject|0|||
42295634|NCT02577029|76130247|FG000|Overall Study|Sponsor Termination of the Study|9|||
42092910|NCT00684021|75903202|FG000|Overall Study|Death|1|||
42092911|NCT00684021|75903203|FG001|Overall Study|Death|0|||
42092912|NCT00684021|75903204|FG002|Overall Study|Death|0|||
42092913|NCT00684021|75903205|FG003|Overall Study|Death|0|||
42092914|NCT00576303|75903215|FG000|Dose Titration Period|Early withdrawal|17|||
42092915|NCT00576303|75903215|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
42092916|NCT00576303|75903215|FG000|Long Term Safety Period|Early withdrawal|16|||
42092917|NCT00686517|75903222|FG000|Treatment|Serious Adverse Event|1|||
42092918|NCT00686517|75903223|FG001|Treatment|Serious Adverse Event|2|||
42092919|NCT00686517|75903224|FG002|Treatment|Serious Adverse Event|1|||
42092920|NCT00686517|75903222|FG000|Treatment|Adverse Event|2|||
42092921|NCT00686517|75903223|FG001|Treatment|Adverse Event|0|||
42092922|NCT00686517|75903224|FG002|Treatment|Adverse Event|0|||
42092923|NCT00686517|75903222|FG000|Treatment|Poor Protocol Compliance|1|||
42092924|NCT00686517|75903223|FG001|Treatment|Poor Protocol Compliance|0|||
42092925|NCT00686517|75903224|FG002|Treatment|Poor Protocol Compliance|0|||
42092926|NCT00686517|75903222|FG000|Treatment|Protocol Violation|2|||
42092927|NCT00686517|75903223|FG001|Treatment|Protocol Violation|1|||
42092928|NCT00686517|75903224|FG002|Treatment|Protocol Violation|0|||
42092929|NCT00686205|75903234|FG000|Overall Study|Protocol Violation|127|||
42092930|NCT00686205|75903235|FG001|Overall Study|Protocol Violation|0|||
42092931|NCT00686205|75903234|FG000|Overall Study|Withdrawal by Subject|2|||
42092932|NCT00686205|75903235|FG001|Overall Study|Withdrawal by Subject|0|||
42092933|NCT00686205|75903234|FG000|Overall Study|Specimen handling procedure altered|5878|||
42092934|NCT00686205|75903235|FG001|Overall Study|Specimen handling procedure altered|0|||
42092935|NCT00686205|75903234|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
42092936|NCT00686205|75903235|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
42186302|NCT03032380|75995668|FG001|Overall Study|Lack of Efficacy|0|||
42186303|NCT03032380|75995667|FG000|Overall Study|Withdrawal by Subject|2|||
42186304|NCT03032380|75995668|FG001|Overall Study|Withdrawal by Subject|3|||
42186305|NCT03032380|75995667|FG000|Overall Study|Recovery|0|||
42186306|NCT03032380|75995668|FG001|Overall Study|Recovery|1|||
42186307|NCT03032380|75995667|FG000|Overall Study|Death|39|||
42186308|NCT03032380|75995668|FG001|Overall Study|Death|34|||
42186309|NCT03032380|75995667|FG000|Overall Study|Other - Miscellaneous|0|||
42186310|NCT03032380|75995668|FG001|Overall Study|Other - Miscellaneous|1|||
42186311|NCT03519854|75995692|FG000|Overall Study|Technical Error|0|||
42186312|NCT03519854|75995693|FG001|Overall Study|Technical Error|0|||
42186313|NCT03519854|75995694|FG002|Overall Study|Technical Error|1|||
42295635|NCT02577029|76130248|FG001|Overall Study|Sponsor Termination of the Study|2|||
42295636|NCT02577029|76130249|FG002|Overall Study|Sponsor Termination of the Study|5|||
42295637|NCT02577029|76130250|FG003|Overall Study|Sponsor Termination of the Study|12|||
42092937|NCT00571701|75903243|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
42186314|NCT03519854|75995695|FG003|Overall Study|Technical Error|0|||
42295638|NCT02577029|76130251|FG004|Overall Study|Sponsor Termination of the Study|10|||
42092938|NCT00571701|75903244|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
42186315|NCT03519854|75995696|FG004|Overall Study|Technical Error|0|||
42295639|NCT02577029|76130252|FG005|Overall Study|Sponsor Termination of the Study|12|||
42092939|NCT00571701|75903243|FG000|First Intervention 12 Months|Death|1|||
42092940|NCT00571701|75903244|FG001|First Intervention 12 Months|Death|0|||
42092941|NCT00571701|75903243|FG000|Second Intervention 12 Months|Adverse Event|0|||
42092942|NCT00571701|75903244|FG001|Second Intervention 12 Months|Adverse Event|1|||
42186316|NCT03519854|75995697|FG005|Overall Study|Technical Error|0|||
42186317|NCT03519854|75995698|FG006|Overall Study|Technical Error|0|||
42295640|NCT02577029|76130253|FG006|Overall Study|Sponsor Termination of the Study|12|||
42092943|NCT00571701|75903243|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
42092944|NCT00571701|75903244|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
42092945|NCT00686127|75903270|FG000|Overall Study|Withdrawal by Subject|14|||
42092946|NCT00686127|75903271|FG001|Overall Study|Withdrawal by Subject|6|||
42092947|NCT00718718|75903284|FG000|Prior to Week 12|Adverse Event|0|||
42092948|NCT00718718|75903285|FG001|Prior to Week 12|Adverse Event|0|||
42186318|NCT03519854|75995699|FG007|Overall Study|Technical Error|0|||
42186319|NCT03519854|75995700|FG008|Overall Study|Technical Error|0|||
42186320|NCT03519854|75995701|FG009|Overall Study|Technical Error|0|||
42295641|NCT02577029|76130254|FG007|Overall Study|Sponsor Termination of the Study|12|||
42295642|NCT02577887|76130272|FG000|Overall Study|Death|93|||
42295643|NCT02577887|76130272|FG000|Overall Study|Protocol Violation|125|||
42092949|NCT00718718|75903286|FG002|Prior to Week 12|Adverse Event|0|||
42092950|NCT00718718|75903287|FG003|Prior to Week 12|Adverse Event|0|||
42092951|NCT00718718|75903288|FG004|Prior to Week 12|Adverse Event|0|||
42092952|NCT00718718|75903289|FG005|Prior to Week 12|Adverse Event|0|||
42092953|NCT00718718|75903290|FG006|Prior to Week 12|Adverse Event|0|||
42092954|NCT00718718|75903291|FG007|Prior to Week 12|Adverse Event|1|||
42092955|NCT00718718|75903292|FG008|Prior to Week 12|Adverse Event|1|||
42092956|NCT00718718|75903293|FG009|Prior to Week 12|Adverse Event|0|||
42092957|NCT00718718|75903284|FG000|Prior to Week 12|Withdrawal by Subject|0|||
42092958|NCT00718718|75903285|FG001|Prior to Week 12|Withdrawal by Subject|0|||
42092959|NCT00718718|75903286|FG002|Prior to Week 12|Withdrawal by Subject|0|||
42092960|NCT00718718|75903287|FG003|Prior to Week 12|Withdrawal by Subject|0|||
42092961|NCT00718718|75903288|FG004|Prior to Week 12|Withdrawal by Subject|3|||
42092962|NCT00718718|75903289|FG005|Prior to Week 12|Withdrawal by Subject|0|||
42092963|NCT00718718|75903290|FG006|Prior to Week 12|Withdrawal by Subject|1|||
42092964|NCT00718718|75903291|FG007|Prior to Week 12|Withdrawal by Subject|1|||
42092965|NCT00718718|75903292|FG008|Prior to Week 12|Withdrawal by Subject|1|||
42092966|NCT00718718|75903293|FG009|Prior to Week 12|Withdrawal by Subject|0|||
42092967|NCT00718718|75903284|FG000|Prior to Week 12|Other|1|||
42092968|NCT00718718|75903285|FG001|Prior to Week 12|Other|0|||
42092969|NCT00718718|75903286|FG002|Prior to Week 12|Other|1|||
42092970|NCT00718718|75903287|FG003|Prior to Week 12|Other|0|||
42092971|NCT00718718|75903288|FG004|Prior to Week 12|Other|0|||
42092972|NCT00718718|75903289|FG005|Prior to Week 12|Other|0|||
42092973|NCT00718718|75903290|FG006|Prior to Week 12|Other|0|||
42092974|NCT00718718|75903291|FG007|Prior to Week 12|Other|0|||
42092975|NCT00718718|75903292|FG008|Prior to Week 12|Other|0|||
42186321|NCT03519854|75995702|FG010|Overall Study|Technical Error|0|||
42186322|NCT03519854|75995703|FG011|Overall Study|Technical Error|0|||
42186323|NCT03519854|75995704|FG012|Overall Study|Technical Error|0|||
42186324|NCT03519854|75995705|FG013|Overall Study|Technical Error|0|||
42186325|NCT03519854|75995706|FG014|Overall Study|Technical Error|0|||
42186326|NCT03519854|75995707|FG015|Overall Study|Technical Error|0|||
42186327|NCT03519854|75995708|FG016|Overall Study|Technical Error|0|||
42186328|NCT03519854|75995709|FG017|Overall Study|Technical Error|0|||
42186329|NCT03479216|75995749|FG000|Overall Study|Withdrawal by Subject|3|||
42186330|NCT03479216|75995750|FG001|Overall Study|Withdrawal by Subject|2|||
42186331|NCT03479216|75995749|FG000|Overall Study|Physician Decision|2|||
42186332|NCT03479216|75995750|FG001|Overall Study|Physician Decision|3|||
42186333|NCT03518840|75995756|FG000|Overall Study|Lost to Follow-up|6|||
42186334|NCT03436082|75995765|FG000|Overall Study|Did not undergo procedure|1|||
42186335|NCT03436082|75995766|FG001|Overall Study|Did not undergo procedure|0|||
42186336|NCT03677934|75995774|FG000|Overall Study|Adverse Event|1|||
42186337|NCT03677934|75995775|FG001|Overall Study|Adverse Event|1|||
42186338|NCT03677934|75995774|FG000|Overall Study|Death|8|||
42295644|NCT02577887|76130272|FG000|Overall Study|Withdrawal by Subject|80|||
42295645|NCT03597347|76130279|FG000|Overall Study|Withdrawal by Subject|1|||
42295646|NCT03597347|76130280|FG001|Overall Study|Withdrawal by Subject|1|||
42295647|NCT03597347|76130281|FG002|Overall Study|Withdrawal by Subject|0|||
42295648|NCT03597347|76130279|FG000|Overall Study|Withdrawal due to Covid-19|3|||
42186339|NCT03677934|75995775|FG001|Overall Study|Death|4|||
42186340|NCT03677934|75995774|FG000|Overall Study|Lost to Follow-up|3|||
42186341|NCT03677934|75995775|FG001|Overall Study|Lost to Follow-up|0|||
42295649|NCT03597347|76130280|FG001|Overall Study|Withdrawal due to Covid-19|0|||
42186342|NCT03677934|75995774|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42186343|NCT03677934|75995775|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42186344|NCT03677934|75995774|FG000|Overall Study|Physician Decision|0|||
42186345|NCT03677934|75995775|FG001|Overall Study|Physician Decision|1|||
42186346|NCT03677934|75995774|FG000|Overall Study|Withdrawal by Subject|1|||
42092976|NCT00718718|75903293|FG009|Prior to Week 12|Other|0|||
42186347|NCT03677934|75995775|FG001|Overall Study|Withdrawal by Subject|7|||
42186348|NCT03435692|75995787|FG000|Overall Study|Lack of Efficacy|2|||
42186349|NCT03435692|75995788|FG001|Overall Study|Lack of Efficacy|2|||
42186350|NCT03435692|75995789|FG002|Overall Study|Lack of Efficacy|0|||
42295650|NCT03597347|76130281|FG002|Overall Study|Withdrawal due to Covid-19|0|||
42092977|NCT00718718|75903284|FG000|Week 12 to End of Study|Adverse Event|0|||
42092978|NCT00718718|75903285|FG001|Week 12 to End of Study|Adverse Event|0|||
42092979|NCT00718718|75903286|FG002|Week 12 to End of Study|Adverse Event|0|||
42092980|NCT00718718|75903287|FG003|Week 12 to End of Study|Adverse Event|0|||
42092981|NCT00718718|75903288|FG004|Week 12 to End of Study|Adverse Event|0|||
42092982|NCT00718718|75903289|FG005|Week 12 to End of Study|Adverse Event|0|||
42092983|NCT00718718|75903290|FG006|Week 12 to End of Study|Adverse Event|0|||
42092984|NCT00718718|75903291|FG007|Week 12 to End of Study|Adverse Event|1|||
42092985|NCT00718718|75903292|FG008|Week 12 to End of Study|Adverse Event|0|||
42092986|NCT00718718|75903293|FG009|Week 12 to End of Study|Adverse Event|0|||
42092987|NCT00718718|75903284|FG000|Week 12 to End of Study|Death|0|||
42092988|NCT00718718|75903285|FG001|Week 12 to End of Study|Death|0|||
42092989|NCT00718718|75903286|FG002|Week 12 to End of Study|Death|0|||
42092990|NCT00718718|75903287|FG003|Week 12 to End of Study|Death|0|||
42092991|NCT00718718|75903288|FG004|Week 12 to End of Study|Death|0|||
42092992|NCT00718718|75903289|FG005|Week 12 to End of Study|Death|1|||
42092993|NCT00718718|75903290|FG006|Week 12 to End of Study|Death|0|||
42092994|NCT00718718|75903291|FG007|Week 12 to End of Study|Death|0|||
42186351|NCT03475316|75995803|FG000|6 Month Intervention|Adverse Event|2|||
42186352|NCT03475316|75995804|FG001|6 Month Intervention|Adverse Event|1|||
42186353|NCT03475316|75995803|FG000|6 Month Intervention|Withdrawal by Subject|2|||
42186354|NCT03475316|75995804|FG001|6 Month Intervention|Withdrawal by Subject|0|||
42186355|NCT03475316|75995803|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
42186356|NCT03475316|75995804|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
42186357|NCT03475316|75995803|FG000|9 Months|Study stopped due to COVID pandemic|3|||
42186358|NCT03475316|75995804|FG001|9 Months|Study stopped due to COVID pandemic|4|||
42186359|NCT03673956|75995814|FG000|Overall Study|Lost to Follow-up|1|||
42186360|NCT03673956|75995815|FG001|Overall Study|Lost to Follow-up|0|||
42186361|NCT03673956|75995816|FG002|Overall Study|Lost to Follow-up|0|||
42186362|NCT03673956|75995817|FG003|Overall Study|Lost to Follow-up|0|||
42092995|NCT00718718|75903292|FG008|Week 12 to End of Study|Death|0|||
42092996|NCT00718718|75903293|FG009|Week 12 to End of Study|Death|0|||
42092997|NCT00718718|75903284|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
42092998|NCT00718718|75903285|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
42092999|NCT00718718|75903286|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
42093000|NCT00718718|75903287|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
42093001|NCT00718718|75903288|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
42093002|NCT00718718|75903289|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
42093003|NCT00718718|75903290|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
42093004|NCT00718718|75903291|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
42093005|NCT00718718|75903292|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
42093006|NCT00718718|75903293|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
42093007|NCT00718718|75903284|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
42093008|NCT00718718|75903285|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
42093009|NCT00718718|75903286|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
42093010|NCT00718718|75903287|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
42093011|NCT00718718|75903288|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
42093012|NCT00718718|75903289|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
42093013|NCT00718718|75903290|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
42093014|NCT00718718|75903291|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
42093015|NCT00718718|75903292|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
42093016|NCT00718718|75903293|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
42093017|NCT00718718|75903284|FG000|Week 12 to End of Study|Other|0|||
42093018|NCT00718718|75903285|FG001|Week 12 to End of Study|Other|1|||
42093019|NCT00718718|75903286|FG002|Week 12 to End of Study|Other|0|||
42093020|NCT00718718|75903287|FG003|Week 12 to End of Study|Other|1|||
42186363|NCT03673956|75995814|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
42186364|NCT03673956|75995815|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
42186365|NCT03673956|75995816|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
42186366|NCT03673956|75995817|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
42186367|NCT03673098|75995829|FG000|Overall Study|Lost to Follow-up|2|||
42186368|NCT03673098|75995830|FG001|Overall Study|Lost to Follow-up|3|||
42186369|NCT03673098|75995829|FG000|Overall Study|Withdrawal by Subject|6|||
42186370|NCT03673098|75995830|FG001|Overall Study|Withdrawal by Subject|1|||
42295651|NCT03597347|76130279|FG000|Overall Study|Sponsor decision to terminate study|3|||
42295652|NCT03597347|76130280|FG001|Overall Study|Sponsor decision to terminate study|2|||
42295653|NCT03597347|76130281|FG002|Overall Study|Sponsor decision to terminate study|4|||
42295654|NCT02576951|76130293|FG000|Overall Study|Lost to Follow-up|0|||
42295655|NCT02576951|76130294|FG001|Overall Study|Lost to Follow-up|0|||
42295656|NCT02576951|76130295|FG002|Overall Study|Lost to Follow-up|2|||
42093021|NCT00718718|75903288|FG004|Week 12 to End of Study|Other|0|||
42093022|NCT00718718|75903289|FG005|Week 12 to End of Study|Other|0|||
42093023|NCT00718718|75903290|FG006|Week 12 to End of Study|Other|1|||
42093024|NCT00718718|75903291|FG007|Week 12 to End of Study|Other|0|||
42093025|NCT00718718|75903292|FG008|Week 12 to End of Study|Other|0|||
42093026|NCT00718718|75903293|FG009|Week 12 to End of Study|Other|0|||
42295657|NCT02576951|76130296|FG003|Overall Study|Lost to Follow-up|2|||
42186371|NCT03673098|75995829|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
42186372|NCT03673098|75995830|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
42186373|NCT03435224|75995843|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
42186374|NCT03672396|75995847|FG000|Overall Study|Withdrawal by Subject|4|||
42186375|NCT03672396|75995847|FG000|Overall Study|Physician Decision|1|||
42186376|NCT03672396|75995847|FG000|Overall Study|Adverse Event|1|||
42093027|NCT00683787|75903322|FG000|Overall Study|Progression|3|||
42093028|NCT00683787|75903323|FG001|Overall Study|Progression|3|||
42093029|NCT00683787|75903324|FG002|Overall Study|Progression|0|||
42093030|NCT00683787|75903322|FG000|Overall Study|Adverse Event|0|||
42093031|NCT00683787|75903323|FG001|Overall Study|Adverse Event|0|||
42093032|NCT00683787|75903324|FG002|Overall Study|Adverse Event|2|||
42093033|NCT00723008|75903334|FG000|Enrollment|Lost to Follow-up|1|||
42093034|NCT00723008|75903335|FG001|Enrollment|Lost to Follow-up|0|||
42093035|NCT00723008|75903334|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
42093036|NCT00723008|75903335|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
42093037|NCT00723008|75903334|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
42093038|NCT00723008|75903335|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
42093039|NCT00723008|75903334|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
42093040|NCT00723008|75903335|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
42093041|NCT00723008|75903334|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
42093042|NCT00723008|75903335|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
42093043|NCT00723008|75903334|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
42093044|NCT00723008|75903335|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
42093045|NCT00718640|75903349|FG000|Overall Study|Adverse Event|4|||
42093046|NCT00718640|75903349|FG000|Overall Study|Death|1|||
42093047|NCT00718640|75903349|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
42093048|NCT00715910|75903357|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
42093049|NCT00715910|75903358|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
42093050|NCT00715910|75903359|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
42093051|NCT00715910|75903360|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
42093052|NCT00715910|75903361|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
42093053|NCT00715910|75903362|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
42093054|NCT00715910|75903357|FG000|Booster and ESFU Phase|Other|0|||
42093055|NCT00715910|75903358|FG001|Booster and ESFU Phase|Other|0|||
42093056|NCT00715910|75903359|FG002|Booster and ESFU Phase|Other|0|||
42093057|NCT00715910|75903360|FG003|Booster and ESFU Phase|Other|5|||
42093058|NCT00715910|75903361|FG004|Booster and ESFU Phase|Other|1|||
42093059|NCT00715910|75903362|FG005|Booster and ESFU Phase|Other|0|||
42093060|NCT00715676|75903381|FG000|Overall Study|Adverse Event|3|||
42093061|NCT00715676|75903382|FG001|Overall Study|Adverse Event|5|||
42093062|NCT00715676|75903383|FG002|Overall Study|Adverse Event|21|||
42093063|NCT00715676|75903381|FG000|Overall Study|Withdrawal by Subject|1|||
42093064|NCT00715676|75903382|FG001|Overall Study|Withdrawal by Subject|3|||
42093065|NCT00715676|75903383|FG002|Overall Study|Withdrawal by Subject|8|||
42093066|NCT00715676|75903381|FG000|Overall Study|Lost to Follow-up|1|||
42093067|NCT00715676|75903382|FG001|Overall Study|Lost to Follow-up|2|||
42186377|NCT03434834|75995851|FG000|Overall Study|unable to swallow OCT probe|16|||
42186378|NCT03605862|75995857|FG000|Overall Study|Withdrawal by Subject|12|||
42186379|NCT03605862|75995858|FG001|Overall Study|Withdrawal by Subject|9|||
42186380|NCT03605862|75995857|FG000|Overall Study|Adverse Event|2|||
42186381|NCT03605862|75995858|FG001|Overall Study|Adverse Event|1|||
42186382|NCT03605862|75995857|FG000|Overall Study|Physician Decision|3|||
42186383|NCT03605862|75995858|FG001|Overall Study|Physician Decision|1|||
42186384|NCT03605862|75995857|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
42093068|NCT00715676|75903383|FG002|Overall Study|Lost to Follow-up|1|||
42093069|NCT00715676|75903381|FG000|Overall Study|Terminated by Sponsor|1|||
42186385|NCT03605862|75995858|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
42186386|NCT03672006|75995867|FG000|Overall Study|exclusion criteria met|0|||
42186387|NCT03672006|75995868|FG001|Overall Study|exclusion criteria met|1|||
42186388|NCT03512288|75995878|FG000|Overall Study|Adverse Event|1|||
42186389|NCT03512288|75995879|FG001|Overall Study|Adverse Event|0|||
42295658|NCT02576951|76130293|FG000|Overall Study|Withdrawal by Subject|1|||
42295659|NCT02576951|76130294|FG001|Overall Study|Withdrawal by Subject|0|||
42093070|NCT00715676|75903382|FG001|Overall Study|Terminated by Sponsor|0|||
42093071|NCT00715676|75903383|FG002|Overall Study|Terminated by Sponsor|0|||
42093072|NCT00715676|75903381|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
42093073|NCT00715676|75903382|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
42186390|NCT03512288|75995878|FG000|Overall Study|Lost to Follow-up|12|||
42186391|NCT03512288|75995879|FG001|Overall Study|Lost to Follow-up|15|||
42093074|NCT00715676|75903383|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
42093075|NCT00715676|75903381|FG000|Overall Study|Use of Exclusionary Medication|0|||
42093076|NCT00715676|75903382|FG001|Overall Study|Use of Exclusionary Medication|0|||
42186392|NCT03512288|75995878|FG000|Overall Study|Physician Decision|0|||
42186393|NCT03512288|75995879|FG001|Overall Study|Physician Decision|2|||
42093077|NCT00715676|75903383|FG002|Overall Study|Use of Exclusionary Medication|1|||
42093078|NCT00715676|75903381|FG000|Overall Study|Elevated Blood Glucose|0|||
42093079|NCT00715676|75903382|FG001|Overall Study|Elevated Blood Glucose|1|||
42186394|NCT03512288|75995878|FG000|Overall Study|Protocol Violation|6|||
42186395|NCT03512288|75995879|FG001|Overall Study|Protocol Violation|4|||
42186396|NCT03512288|75995878|FG000|Overall Study|Medication error without associated adverse event|1|||
42186397|NCT03512288|75995879|FG001|Overall Study|Medication error without associated adverse event|0|||
42186398|NCT03512288|75995878|FG000|Overall Study|No longer met eligibility criteria|5|||
42186399|NCT03512288|75995879|FG001|Overall Study|No longer met eligibility criteria|2|||
42093080|NCT00715676|75903383|FG002|Overall Study|Elevated Blood Glucose|0|||
42093081|NCT00718328|75903393|FG000|Overall Study|Lost to Follow-up|1|||
42093082|NCT00718328|75903394|FG001|Overall Study|Lost to Follow-up|0|||
42093083|NCT00715520|75903403|FG000|Overall Study|Screen failure|8|||
42093084|NCT00715520|75903404|FG001|Overall Study|Screen failure|1|||
42186400|NCT03512288|75995878|FG000|Overall Study|Withdrawal by parent/guardian|14|||
42186401|NCT03512288|75995879|FG001|Overall Study|Withdrawal by parent/guardian|18|||
42186402|NCT03512288|75995878|FG000|Overall Study|Other|1|||
42186403|NCT03512288|75995879|FG001|Overall Study|Other|1|||
42186404|NCT03512288|75995878|FG000|Overall Study|Randomized but not treated|1|||
42186405|NCT03512288|75995879|FG001|Overall Study|Randomized but not treated|1|||
42186406|NCT03031678|75995885|FG000|Overall Study|Study closed prior to completion|1|||
42186407|NCT03669588|75995895|FG000|Overall Study|Adverse Event|1|||
42186408|NCT03669588|75995896|FG001|Overall Study|Adverse Event|0|||
42186409|NCT03669588|75995895|FG000|Overall Study|Physician Decision|0|||
42186410|NCT03669588|75995896|FG001|Overall Study|Physician Decision|1|||
42186411|NCT03669588|75995895|FG000|Overall Study|Protocol Violation|1|||
42186412|NCT03669588|75995896|FG001|Overall Study|Protocol Violation|0|||
42186413|NCT03669588|75995895|FG000|Overall Study|Sponsor Decision|1|||
42186414|NCT03669588|75995896|FG001|Overall Study|Sponsor Decision|1|||
42186415|NCT03669588|75995895|FG000|Overall Study|Withdrawal by Subject|1|||
42186416|NCT03669588|75995896|FG001|Overall Study|Withdrawal by Subject|4|||
42186417|NCT03669588|75995895|FG000|Overall Study|Rescue Therapy Needed|0|||
42186418|NCT03669588|75995896|FG001|Overall Study|Rescue Therapy Needed|1|||
42186419|NCT03598140|75995904|FG000|Overall Study|enrolled but didn't start|1|||
42186420|NCT03598140|75995905|FG001|Overall Study|enrolled but didn't start|0|||
42186421|NCT03644550|75995911|FG000|Overall Study|Withdrawal by Subject|3|||
42186422|NCT03644550|75995911|FG000|Overall Study|Progressive disease|15|||
42186423|NCT00054717|75995918|FG000|Overall Study|Randomized but not treated|2|||
42186424|NCT00054717|75995919|FG001|Overall Study|Randomized but not treated|8|||
42186425|NCT00054717|75995918|FG000|Overall Study|Adverse Event|70|||
42186426|NCT00054717|75995919|FG001|Overall Study|Adverse Event|22|||
42186427|NCT00054717|75995918|FG000|Overall Study|Protocol Violation|18|||
42186428|NCT00054717|75995919|FG001|Overall Study|Protocol Violation|19|||
42186429|NCT00054717|75995918|FG000|Overall Study|Lost to Follow-up|23|||
42186430|NCT00054717|75995919|FG001|Overall Study|Lost to Follow-up|13|||
42358994|NCT02204982|76204734|FG000|Overall Study|Patient ineligible-medical monitor|1|||
42358995|NCT02204982|76204735|FG001|Overall Study|Patient ineligible-medical monitor|0|||
42358996|NCT02204982|76204734|FG000|Overall Study|Withdrawal by Subject|1|||
42358997|NCT02204982|76204735|FG001|Overall Study|Withdrawal by Subject|0|||
42358998|NCT02204982|76204734|FG000|Overall Study|Adverse Event|1|||
42358999|NCT02204982|76204735|FG001|Overall Study|Adverse Event|0|||
42359000|NCT02204982|76204734|FG000|Overall Study|Adverse Event and Investigator decision|1|||
42359001|NCT02204982|76204735|FG001|Overall Study|Adverse Event and Investigator decision|0|||
42359002|NCT02204982|76204734|FG000|Overall Study|Physician Decision|0|||
42359003|NCT02204982|76204735|FG001|Overall Study|Physician Decision|2|||
42359004|NCT02204982|76204734|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
42359005|NCT02204982|76204735|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
42359006|NCT02204982|76204734|FG000|Overall Study|Termination of Study bySponsor|0|||
42359007|NCT02204982|76204735|FG001|Overall Study|Termination of Study bySponsor|1|||
42359008|NCT02101385|76204743|FG000|Study Treatment|Disease Progression|9|||
42359009|NCT02101385|76204744|FG001|Study Treatment|Disease Progression|3|||
42359010|NCT02101385|76204743|FG000|Study Treatment|Alternative therapy|0|||
42359011|NCT02101385|76204744|FG001|Study Treatment|Alternative therapy|1|||
42359012|NCT02101385|76204743|FG000|Study Treatment|No treatment, per protocol criteria|0|||
42359013|NCT02101385|76204744|FG001|Study Treatment|No treatment, per protocol criteria|4|||
42186431|NCT00054717|75995918|FG000|Overall Study|Withdrawal by Subject|32|||
42186432|NCT00054717|75995919|FG001|Overall Study|Withdrawal by Subject|20|||
42186433|NCT00054717|75995918|FG000|Overall Study|Other reason not defined above|117|||
42186434|NCT00054717|75995919|FG001|Overall Study|Other reason not defined above|217|||
42186435|NCT03430856|75995928|FG000|Overall Study|Adverse Event|0|||
42186436|NCT03430856|75995929|FG001|Overall Study|Adverse Event|1|||
42186437|NCT03430856|75995930|FG002|Overall Study|Adverse Event|0|||
42186438|NCT03430856|75995928|FG000|Overall Study|Rescue criteria|1|||
42186439|NCT03430856|75995929|FG001|Overall Study|Rescue criteria|1|||
42186440|NCT03430856|75995930|FG002|Overall Study|Rescue criteria|0|||
42359014|NCT02101385|76204743|FG000|Study Treatment|Patient Non compliance|0|||
42186441|NCT03430856|75995928|FG000|Overall Study|Voluntary withdrawal of consent|1|||
42186442|NCT03430856|75995929|FG001|Overall Study|Voluntary withdrawal of consent|1|||
42186443|NCT03430856|75995930|FG002|Overall Study|Voluntary withdrawal of consent|1|||
42186444|NCT03731364|75995946|FG000|Overall Study|Adverse Event|0|||
42186445|NCT03731364|75995947|FG001|Overall Study|Adverse Event|0|||
42186446|NCT03731364|75995948|FG002|Overall Study|Adverse Event|1|||
42186447|NCT03731364|75995949|FG003|Overall Study|Adverse Event|2|||
42186448|NCT03731364|75995950|FG004|Overall Study|Adverse Event|1|||
42186449|NCT03510182|75995962|FG000|Overall Study|Withdrawal by Subject|2|||
42186450|NCT00066807|75995968|FG000|Overall Study|Study was terminated early|14|||
42186451|NCT00066807|75995969|FG001|Overall Study|Study was terminated early|15|||
42186452|NCT03428750|75995977|FG000|Overall Study|Withdrawal by Subject|11|||
42186453|NCT03428750|75995978|FG001|Overall Study|Withdrawal by Subject|10|||
42186454|NCT03428750|75995977|FG000|Overall Study|Lost to Follow-up|3|||
42186455|NCT03428750|75995978|FG001|Overall Study|Lost to Follow-up|9|||
42186456|NCT03428750|75995977|FG000|Overall Study|Adverse Event|9|||
42186457|NCT03428750|75995978|FG001|Overall Study|Adverse Event|1|||
42186458|NCT03428750|75995977|FG000|Overall Study|Protocol Violation|1|||
42186459|NCT03428750|75995978|FG001|Overall Study|Protocol Violation|0|||
42186460|NCT03428750|75995977|FG000|Overall Study|Administrative|0|||
42186461|NCT03428750|75995978|FG001|Overall Study|Administrative|1|||
42186462|NCT03666858|75996007|FG000|Cohort 1|Adverse Event|1|||
42186463|NCT03666858|75996008|FG001|Cohort 1|Adverse Event|0|||
42186464|NCT03666858|75996007|FG000|Cohort 2|Adverse Event|0|||
42186465|NCT03666858|75996008|FG001|Cohort 2|Adverse Event|1|||
42186466|NCT00054639|75996014|FG000|Overall Study|Lack of Efficacy|1|||
42186467|NCT00054639|75996014|FG000|Overall Study|Physician Decision|1|||
42186468|NCT03428360|75996018|FG000|Overall Study|Informed consent withdrawn|5|||
42186469|NCT03428360|75996018|FG000|Overall Study|Withdrawal by Subject|4|||
42186470|NCT03428360|75996018|FG000|Overall Study|Lost to Follow-up|5|||
42186471|NCT03428360|75996018|FG000|Overall Study|Physician Decision|2|||
42186472|NCT03428360|75996018|FG000|Overall Study|Informed consent withdrawn|5|||
42186473|NCT03428360|75996018|FG000|Overall Study|Study terminated by sponsor|10|||
42186474|NCT03428360|75996018|FG000|Overall Study|Non-compliant with study|1|||
42186475|NCT03428360|75996018|FG000|Overall Study|Non-compliant with study drug|3|||
42186476|NCT03428360|75996018|FG000|Overall Study|Death|3|||
42186477|NCT03428360|75996018|FG000|Overall Study|Adverse Event|1|||
42186478|NCT03428360|75996018|FG000|Overall Study|Not on antiepileptic drug|1|||
42186479|NCT03427892|75996026|FG000|Overall Study|Lost to Follow-up|2|||
42186480|NCT03595332|75996032|FG000|Overall Study|Lost to Follow-up|16|||
42186481|NCT03595332|75996033|FG001|Overall Study|Lost to Follow-up|22|||
42186482|NCT03595332|75996032|FG000|Overall Study|Unable to retrieve ID from school|0|||
42186483|NCT03595332|75996033|FG001|Overall Study|Unable to retrieve ID from school|2|||
42186484|NCT03427268|75996042|FG000|Overall Study|Progressive disease|25|||
42186485|NCT03427268|75996042|FG000|Overall Study|Never treated|2|||
42186486|NCT03427268|75996042|FG000|Overall Study|Compassionate use|1|||
42186487|NCT03427268|75996042|FG000|Overall Study|Withdrawal by Subject|1|||
42186488|NCT03427268|75996042|FG000|Overall Study|Adverse Event|3|||
42186489|NCT03509948|75996046|FG000|Overall Study|Protocol Violation|0|||
42186490|NCT03509948|75996047|FG001|Overall Study|Protocol Violation|1|||
42186491|NCT03466658|75996053|FG000|Overall Study|Withdrawal by Subject|3|||
42186492|NCT03425396|75996064|FG000|Overall Study|Lost to Follow-up|2|||
42186493|NCT03425396|75996065|FG001|Overall Study|Lost to Follow-up|5|||
42186494|NCT03425396|75996066|FG002|Overall Study|Lost to Follow-up|2|||
42186495|NCT03425396|75996067|FG003|Overall Study|Lost to Follow-up|0|||
42186496|NCT03425396|75996068|FG004|Overall Study|Lost to Follow-up|0|||
42186497|NCT03425396|75996064|FG000|Overall Study|Withdrawal by Subject|0|||
42186498|NCT03425396|75996065|FG001|Overall Study|Withdrawal by Subject|1|||
42186499|NCT03425396|75996066|FG002|Overall Study|Withdrawal by Subject|0|||
42186500|NCT03425396|75996067|FG003|Overall Study|Withdrawal by Subject|1|||
42295660|NCT02576951|76130295|FG002|Overall Study|Withdrawal by Subject|0|||
42295661|NCT02576951|76130296|FG003|Overall Study|Withdrawal by Subject|2|||
42186501|NCT03425396|75996068|FG004|Overall Study|Withdrawal by Subject|0|||
42295662|NCT02576951|76130293|FG000|Overall Study|Protocol Violation|0|||
42295663|NCT02576951|76130294|FG001|Overall Study|Protocol Violation|0|||
42295664|NCT02576951|76130295|FG002|Overall Study|Protocol Violation|0|||
42295665|NCT02576951|76130296|FG003|Overall Study|Protocol Violation|1|||
42295666|NCT04929613|76130308|FG000|Overall Study|Withdrawal by Subject|12|||
42186502|NCT03425396|75996064|FG000|Overall Study|Other|0|||
42186503|NCT03425396|75996065|FG001|Overall Study|Other|1|||
42186504|NCT03425396|75996066|FG002|Overall Study|Other|1|||
42186505|NCT03425396|75996067|FG003|Overall Study|Other|0|||
42186506|NCT03425396|75996068|FG004|Overall Study|Other|1|||
42186507|NCT00032487|75996082|FG000|Overall Study|Withdrawal by Subject|67|||
42186508|NCT00032487|75996083|FG001|Overall Study|Withdrawal by Subject|43|||
42186509|NCT00032487|75996082|FG000|Overall Study|Adverse Event|3|||
42186510|NCT00032487|75996083|FG001|Overall Study|Adverse Event|7|||
42295667|NCT02621047|76130315|FG000|Overall Study|Adverse Event|0|||
42186511|NCT00032487|75996082|FG000|Overall Study|Lost to Follow-up|57|||
42186512|NCT00032487|75996083|FG001|Overall Study|Lost to Follow-up|58|||
42186513|NCT00032487|75996082|FG000|Overall Study|Had other reason|12|||
42186514|NCT00032487|75996083|FG001|Overall Study|Had other reason|12|||
42186515|NCT03641508|75996091|FG000|First Injection|Lost to Follow-up|2|||
42186516|NCT03641508|75996092|FG001|First Injection|Lost to Follow-up|0|||
42186517|NCT03465878|75996100|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
42186518|NCT03465878|75996101|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
42186519|NCT03465878|75996102|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
42186520|NCT03465878|75996103|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
42186521|NCT03465878|75996100|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
42186522|NCT03465878|75996101|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
42186523|NCT03465878|75996102|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
42186524|NCT03465878|75996103|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
42186525|NCT03465878|75996100|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
42186526|NCT03465878|75996101|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
42186527|NCT03465878|75996102|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
42186528|NCT03465878|75996103|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
42186529|NCT03637374|75996131|FG000|Overall Study|Death|2|||
42186530|NCT03637374|75996132|FG001|Overall Study|Death|0|||
42186531|NCT03421730|75996138|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
42186532|NCT03421730|75996139|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
42186533|NCT03421730|75996140|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
42186534|NCT03421730|75996141|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
42186535|NCT03421730|75996142|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
42186536|NCT03421730|75996143|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
42186537|NCT03421730|75996144|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
42186538|NCT03421730|75996145|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
42186539|NCT03421730|75996146|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
42186540|NCT03421730|75996147|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
42186541|NCT03421730|75996148|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
42186542|NCT03421730|75996149|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
42186543|NCT03421730|75996138|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
42186544|NCT03421730|75996139|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
42186545|NCT03421730|75996140|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
42186546|NCT03421730|75996141|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
42186547|NCT03421730|75996142|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
42186548|NCT03421730|75996143|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
42186549|NCT03421730|75996144|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
42186550|NCT03421730|75996145|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
42295668|NCT02621047|76130316|FG001|Overall Study|Adverse Event|0|||
42295669|NCT02621047|76130317|FG002|Overall Study|Adverse Event|1|||
42295670|NCT02443155|76130330|FG000|Overall Study|Adverse Event|3|||
42295671|NCT02443155|76130331|FG001|Overall Study|Adverse Event|4|||
42295672|NCT02443155|76130332|FG002|Overall Study|Adverse Event|1|||
42295673|NCT02443155|76130333|FG003|Overall Study|Adverse Event|2|||
42018105|NCT01126437|75825818|FG001|Overall Study|Adverse Event|606|||
42093085|NCT00715520|75903405|FG002|Overall Study|Screen failure|1|||
42186551|NCT03421730|75996146|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
42186552|NCT03421730|75996147|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
42186553|NCT03421730|75996148|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
42186554|NCT03421730|75996149|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
42186555|NCT00054327|75996169|FG000|Overall Study|Engraftment failure|1|||
42186556|NCT00054327|75996170|FG001|Overall Study|Engraftment failure|0|||
42295674|NCT02443155|76130330|FG000|Overall Study|Unclassified|0|||
42295675|NCT02443155|76130331|FG001|Overall Study|Unclassified|0|||
42186557|NCT00054327|75996171|FG002|Overall Study|Engraftment failure|0|||
42186558|NCT00054327|75996172|FG003|Overall Study|Engraftment failure|0|||
42186559|NCT00054327|75996173|FG004|Overall Study|Engraftment failure|0|||
42186560|NCT00054327|75996174|FG005|Overall Study|Engraftment failure|0|||
42186561|NCT03503162|75996188|FG000|Overall Study|did not meet eligibility|1|||
42186562|NCT03029650|75996192|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
42186563|NCT03029650|75996193|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
42186564|NCT03029650|75996192|FG000|Washout (1 Week)|Physician Decision|0|||
42186565|NCT03029650|75996193|FG001|Washout (1 Week)|Physician Decision|1|||
42186566|NCT03462680|75996205|FG000|Overall Study|Withdrawal by Subject|3|||
42186567|NCT03462680|75996206|FG001|Overall Study|Withdrawal by Subject|5|||
42186568|NCT03636906|75996215|FG000|Overall Study|Adverse Event|0|||
42186569|NCT03636906|75996216|FG001|Overall Study|Adverse Event|0|||
42186570|NCT03636906|75996217|FG002|Overall Study|Adverse Event|1|||
42186571|NCT03636906|75996215|FG000|Overall Study|Lost to Follow-up|1|||
42186572|NCT03636906|75996216|FG001|Overall Study|Lost to Follow-up|0|||
42186573|NCT03636906|75996217|FG002|Overall Study|Lost to Follow-up|0|||
42295676|NCT02443155|76130332|FG002|Overall Study|Unclassified|2|||
42295677|NCT02443155|76130333|FG003|Overall Study|Unclassified|1|||
42295678|NCT02443155|76130330|FG000|Overall Study|Withdrawal by Subject|4|||
42295679|NCT02443155|76130331|FG001|Overall Study|Withdrawal by Subject|7|||
42295680|NCT02443155|76130332|FG002|Overall Study|Withdrawal by Subject|3|||
42295681|NCT02443155|76130333|FG003|Overall Study|Withdrawal by Subject|9|||
42295682|NCT02443155|76130330|FG000|Overall Study|Pregnancy|3|||
42295683|NCT02443155|76130331|FG001|Overall Study|Pregnancy|1|||
42295684|NCT02443155|76130332|FG002|Overall Study|Pregnancy|1|||
42295685|NCT02443155|76130333|FG003|Overall Study|Pregnancy|2|||
42295686|NCT02443155|76130330|FG000|Overall Study|Lost to Follow-up|1|||
42295687|NCT02443155|76130331|FG001|Overall Study|Lost to Follow-up|2|||
42093086|NCT00715520|75903403|FG000|Overall Study|Withdrawal by Subject|2|||
42093087|NCT00715520|75903404|FG001|Overall Study|Withdrawal by Subject|0|||
42093088|NCT00715520|75903405|FG002|Overall Study|Withdrawal by Subject|1|||
42093089|NCT00790205|75903415|FG000|Overall Study|Lost to Follow-up|61|||
42093090|NCT00790205|75903416|FG001|Overall Study|Lost to Follow-up|71|||
42093091|NCT00790205|75903415|FG000|Overall Study|Withdrawal by Subject|299|||
42093092|NCT00790205|75903416|FG001|Overall Study|Withdrawal by Subject|363|||
42093093|NCT00715208|75903424|FG000|Overall Study|Withdrawal by Subject|1|||
42093094|NCT00715208|75903425|FG001|Overall Study|Withdrawal by Subject|1|||
42093095|NCT00715208|75903424|FG000|Overall Study|Adverse Event|0|||
42093096|NCT00715208|75903425|FG001|Overall Study|Adverse Event|6|||
42093097|NCT00715208|75903424|FG000|Overall Study|Lack of Efficacy|0|||
42295688|NCT02443155|76130332|FG002|Overall Study|Lost to Follow-up|0|||
42295689|NCT02443155|76130333|FG003|Overall Study|Lost to Follow-up|1|||
42295690|NCT02443155|76130330|FG000|Overall Study|Protocol Violation|1|||
42295691|NCT02443155|76130331|FG001|Overall Study|Protocol Violation|0|||
42295692|NCT02443155|76130332|FG002|Overall Study|Protocol Violation|1|||
42295693|NCT02443155|76130333|FG003|Overall Study|Protocol Violation|1|||
42295694|NCT02443155|76130330|FG000|Overall Study|Death|0|||
42018106|NCT01126437|75825819|FG002|Overall Study|Adverse Event|635|||
42018107|NCT01126437|75825817|FG000|Overall Study|Lack of Efficacy|65|||
42018108|NCT01126437|75825818|FG001|Overall Study|Lack of Efficacy|60|||
42018109|NCT01126437|75825819|FG002|Overall Study|Lack of Efficacy|59|||
42018110|NCT01126437|75825817|FG000|Overall Study|Protocol Violation|64|||
42018111|NCT01126437|75825818|FG001|Overall Study|Protocol Violation|66|||
42018112|NCT01126437|75825819|FG002|Overall Study|Protocol Violation|41|||
42018113|NCT01126437|75825817|FG000|Overall Study|Lost to Follow-up|52|||
42018114|NCT01126437|75825818|FG001|Overall Study|Lost to Follow-up|63|||
42018115|NCT01126437|75825819|FG002|Overall Study|Lost to Follow-up|55|||
42018116|NCT01126437|75825817|FG000|Overall Study|Withdrawal by Subject|331|||
42018117|NCT01126437|75825818|FG001|Overall Study|Withdrawal by Subject|335|||
42093098|NCT00715208|75903425|FG001|Overall Study|Lack of Efficacy|2|||
42093099|NCT00587795|75903433|FG000|Overall Study|Withdrawal by Subject|1|||
42093100|NCT00587795|75903434|FG001|Overall Study|Withdrawal by Subject|0|||
42295695|NCT02443155|76130331|FG001|Overall Study|Death|0|||
42093101|NCT00587639|75903440|FG000|Overall Study|Withdrawal by Subject|1|||
42186574|NCT03636906|75996215|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
42186575|NCT03636906|75996216|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
42186576|NCT03636906|75996217|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
42186577|NCT03636906|75996215|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
42186578|NCT03636906|75996216|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
42186579|NCT03636906|75996217|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
42186580|NCT03636906|75996215|FG000|Overall Study|Other|0|||
42186581|NCT03636906|75996216|FG001|Overall Study|Other|0|||
42186582|NCT03636906|75996217|FG002|Overall Study|Other|1|||
42186583|NCT03028870|75996235|FG000|Overall Study|Adverse Event|7|||
42186584|NCT03028870|75996236|FG001|Overall Study|Adverse Event|4|||
42186585|NCT03028870|75996237|FG002|Overall Study|Adverse Event|3|||
42186586|NCT03028870|75996238|FG003|Overall Study|Adverse Event|3|||
42186587|NCT03028870|75996235|FG000|Overall Study|Withdrawal by Subject|1|||
42186588|NCT03028870|75996236|FG001|Overall Study|Withdrawal by Subject|1|||
42186589|NCT03028870|75996237|FG002|Overall Study|Withdrawal by Subject|1|||
42186590|NCT03028870|75996238|FG003|Overall Study|Withdrawal by Subject|2|||
42186591|NCT03028870|75996235|FG000|Overall Study|Lost to Follow-up|1|||
42186592|NCT03028870|75996236|FG001|Overall Study|Lost to Follow-up|0|||
42186593|NCT03028870|75996237|FG002|Overall Study|Lost to Follow-up|0|||
42186594|NCT03028870|75996238|FG003|Overall Study|Lost to Follow-up|0|||
42186595|NCT03028870|75996235|FG000|Overall Study|Lack of Efficacy|3|||
42186596|NCT03028870|75996236|FG001|Overall Study|Lack of Efficacy|0|||
42186597|NCT03028870|75996237|FG002|Overall Study|Lack of Efficacy|0|||
42186598|NCT03028870|75996238|FG003|Overall Study|Lack of Efficacy|0|||
42186599|NCT03028870|75996235|FG000|Overall Study|Administrative|5|||
42186600|NCT03028870|75996236|FG001|Overall Study|Administrative|5|||
42186601|NCT03028870|75996237|FG002|Overall Study|Administrative|12|||
42186602|NCT03028870|75996238|FG003|Overall Study|Administrative|4|||
42186603|NCT03663582|75996248|FG000|Overall Study|Physician Decision|1|||
42186604|NCT03502616|75996254|FG000|Up to Week 16|Withdrawal by Subject|1|||
42186605|NCT03502616|75996255|FG001|Up to Week 16|Withdrawal by Subject|2|||
42186606|NCT03502616|75996254|FG000|Up to Week 16|Lost to Follow-up|0|||
42186607|NCT03502616|75996255|FG001|Up to Week 16|Lost to Follow-up|1|||
42186608|NCT03502616|75996254|FG000|Up to Week 16|Randomized, but not treated|1|||
42186609|NCT03502616|75996255|FG001|Up to Week 16|Randomized, but not treated|0|||
42186610|NCT03502616|75996254|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
42186611|NCT03502616|75996255|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
42186612|NCT03502616|75996254|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
42186613|NCT03502616|75996255|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
42186614|NCT03028012|75996276|FG000|Overall Study|Lost to Follow-up|2|||
42186615|NCT03028012|75996277|FG001|Overall Study|Lost to Follow-up|3|||
42186616|NCT03028012|75996278|FG002|Overall Study|Lost to Follow-up|3|||
42186617|NCT03635190|75996287|FG000|Overall Study|Lost to Follow-up|4|||
42186618|NCT03635190|75996287|FG000|Overall Study|Death|3|||
42186619|NCT03635190|75996287|FG000|Overall Study|Withdrawal by Subject|1|||
42186620|NCT03635190|75996287|FG000|Overall Study|Patient moved and did not return for follow up|1|||
42186621|NCT03634800|75996294|FG000|Overall Study|Adverse Event|1|||
42186622|NCT03634800|75996294|FG000|Overall Study|Disease Progression|4|||
42186623|NCT03634800|75996294|FG000|Overall Study|Withdrawal by Subject|1|||
42186624|NCT03027466|75996302|FG000|Overall Study|Opting out of the app|1869|||
42186625|NCT03027466|75996303|FG001|Overall Study|Opting out of the app|1819|||
42186626|NCT03027466|75996304|FG002|Overall Study|Opting out of the app|1743|||
42186627|NCT03027466|75996305|FG003|Overall Study|Opting out of the app|1821|||
42186628|NCT03662334|75996317|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
42186629|NCT03662334|75996318|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
42186630|NCT02955186|75996326|FG000|Overall Study|Withdrawal by Subject|6|||
42186631|NCT02955186|75996327|FG001|Overall Study|Withdrawal by Subject|2|||
42186632|NCT02955186|75996326|FG000|Overall Study|Protocol Violation|1|||
42186633|NCT02955186|75996327|FG001|Overall Study|Protocol Violation|0|||
42186634|NCT03502070|75996333|FG000|Overall Study|Withdrawal by Subject|1|||
42186635|NCT03502070|75996333|FG000|Overall Study|Screen Failure|1|||
42186636|NCT03586830|75996341|FG000|Overall Study|Site terminated by Sponsor|1|||
42186637|NCT03586830|75996342|FG001|Overall Study|Site terminated by Sponsor|4|||
42186638|NCT03586830|75996343|FG002|Overall Study|Site terminated by Sponsor|3|||
42186639|NCT03586830|75996344|FG003|Overall Study|Site terminated by Sponsor|3|||
42186640|NCT03586830|75996341|FG000|Overall Study|Lost to Follow-up|0|||
42186641|NCT03586830|75996342|FG001|Overall Study|Lost to Follow-up|2|||
42186642|NCT03586830|75996343|FG002|Overall Study|Lost to Follow-up|2|||
42186643|NCT03586830|75996344|FG003|Overall Study|Lost to Follow-up|1|||
42186644|NCT03586830|75996341|FG000|Overall Study|Withdrawal by Subject|1|||
42186645|NCT03586830|75996342|FG001|Overall Study|Withdrawal by Subject|0|||
42186646|NCT03586830|75996343|FG002|Overall Study|Withdrawal by Subject|3|||
42186647|NCT03586830|75996344|FG003|Overall Study|Withdrawal by Subject|1|||
42186648|NCT03026530|75996356|FG000|Overall Study|Lost to Follow-up|19|||
42186649|NCT03026530|75996357|FG001|Overall Study|Lost to Follow-up|24|||
42093102|NCT00774995|75903448|FG000|Overall Study|Protocol Violation|0|||
42093103|NCT00774995|75903449|FG001|Overall Study|Protocol Violation|0|||
42093104|NCT00774995|75903450|FG002|Overall Study|Protocol Violation|1|||
42093105|NCT00774995|75903451|FG003|Overall Study|Protocol Violation|0|||
42093106|NCT00713648|75903461|FG000|Overall Study|Adverse Event|1|||
42093107|NCT00713648|75903461|FG000|Overall Study|Unclassified|2|||
42093108|NCT00713648|75903461|FG000|Overall Study|According to Protocol|2|||
42093109|NCT00713648|75903461|FG000|Overall Study|Development of antibodies|3|||
42093110|NCT00768053|75903465|FG000|Overall Study|Adverse Event|10|||
42093111|NCT00768053|75903465|FG000|Overall Study|Lost to Follow-up|1|||
42093112|NCT00683475|75903471|FG000|Overall Study|Withdrawal by Subject|1|||
42186650|NCT03026530|75996356|FG000|Overall Study|Protocol Violation|2|||
42186651|NCT03026530|75996357|FG001|Overall Study|Protocol Violation|5|||
42186652|NCT03418376|75996367|FG000|Overall Study|Musculoskeletal injury|1|||
42186653|NCT03418376|75996368|FG001|Overall Study|Musculoskeletal injury|2|||
42186654|NCT03418376|75996369|FG002|Overall Study|Musculoskeletal injury|1|||
42186655|NCT03418376|75996370|FG003|Overall Study|Musculoskeletal injury|0|||
42186656|NCT03418376|75996367|FG000|Overall Study|Personal reasons|0|||
42186657|NCT03418376|75996368|FG001|Overall Study|Personal reasons|2|||
42186658|NCT03418376|75996369|FG002|Overall Study|Personal reasons|2|||
42186659|NCT03418376|75996370|FG003|Overall Study|Personal reasons|1|||
42186660|NCT03418376|75996367|FG000|Overall Study|Exacerbation|0|||
42186661|NCT03418376|75996368|FG001|Overall Study|Exacerbation|1|||
42186662|NCT03418376|75996369|FG002|Overall Study|Exacerbation|0|||
42186663|NCT03418376|75996370|FG003|Overall Study|Exacerbation|0|||
42186664|NCT03585504|75996382|FG000|Overall Study|Lost to Follow-up|26|||
42186665|NCT03585504|75996383|FG001|Overall Study|Lost to Follow-up|29|||
42186666|NCT03417830|75996391|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
42186667|NCT03417830|75996392|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
42186668|NCT03576768|75996403|FG000|Overall Study|Lost to Follow-up|3|||
42186669|NCT03576768|75996404|FG001|Overall Study|Lost to Follow-up|3|||
42186670|NCT03576768|75996405|FG002|Overall Study|Lost to Follow-up|0|||
42186671|NCT03576768|75996406|FG003|Overall Study|Lost to Follow-up|0|||
42186672|NCT03576066|75996418|FG000|Overall Study|Noncompliance with study drug|0|||
42186673|NCT03576066|75996419|FG001|Overall Study|Noncompliance with study drug|1|||
42186674|NCT03557034|75996431|FG000|Overall Study|Withdrawal by Subject|1|||
42186675|NCT03557034|75996432|FG001|Overall Study|Withdrawal by Subject|0|||
42186676|NCT03583554|75996438|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
42186677|NCT03583554|75996439|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
42186678|NCT03583554|75996440|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
42186679|NCT03948178|75996451|FG000|Overall Study|Protocol Violation|1|||
42186680|NCT03948178|75996451|FG000|Overall Study|Lost to Follow-up|2|||
42186681|NCT03948178|75996451|FG000|Overall Study|Withdrawal by Subject|2|||
42186682|NCT03948178|75996451|FG000|Overall Study|Reason not known|2|||
42186683|NCT03948178|75996451|FG000|Overall Study|Personal reason|14|||
42186684|NCT03948178|75996451|FG000|Overall Study|Disease progression|30|||
42186685|NCT03948178|75996451|FG000|Overall Study|Adverse Event|12|||
42186686|NCT03948178|75996451|FG000|Overall Study|Sponsor terminated study|164|||
42186687|NCT03520920|75996458|FG000|Overall Study|Death|13|||
42186688|NCT03520920|75996459|FG001|Overall Study|Death|1|||
42186689|NCT03520920|75996460|FG002|Overall Study|Death|0|||
42186690|NCT03520920|75996458|FG000|Overall Study|Withdrawal by Subject|2|||
42186691|NCT03520920|75996459|FG001|Overall Study|Withdrawal by Subject|1|||
42186692|NCT03520920|75996460|FG002|Overall Study|Withdrawal by Subject|0|||
42295696|NCT02443155|76130332|FG002|Overall Study|Death|1|||
42295697|NCT02443155|76130333|FG003|Overall Study|Death|0|||
42186693|NCT03520920|75996458|FG000|Overall Study|Study Terminated by the Sponsor|5|||
42186694|NCT03520920|75996459|FG001|Overall Study|Study Terminated by the Sponsor|14|||
42186695|NCT03520920|75996460|FG002|Overall Study|Study Terminated by the Sponsor|5|||
42186696|NCT02953340|75996476|FG000|Overall Study|Death|0|||
42186697|NCT02953340|75996477|FG001|Overall Study|Death|1|||
42186698|NCT02953340|75996476|FG000|Overall Study|Investigator Decision|3|||
42186699|NCT02953340|75996477|FG001|Overall Study|Investigator Decision|3|||
42295698|NCT02460159|76130346|FG000|Overall Study|Adverse Event|4|||
42295699|NCT02460159|76130347|FG001|Overall Study|Adverse Event|1|||
42295700|NCT02460159|76130346|FG000|Overall Study|Withdrawal by Subject|2|||
42186700|NCT02953340|75996476|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
42186701|NCT02953340|75996477|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
42295701|NCT02460159|76130347|FG001|Overall Study|Withdrawal by Subject|0|||
42093113|NCT00683475|75903472|FG001|Overall Study|Withdrawal by Subject|0|||
42186702|NCT02953340|75996476|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
42186703|NCT02953340|75996477|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
42186704|NCT02953340|75996476|FG000|Overall Study|Withdrawal by Subject|9|||
42186705|NCT02953340|75996477|FG001|Overall Study|Withdrawal by Subject|9|||
42186706|NCT02953340|75996476|FG000|Overall Study|Sponsor decision|0|||
42295702|NCT02498067|76130353|FG000|Overall Study|Lost to Follow-up|22|||
42186707|NCT02953340|75996477|FG001|Overall Study|Sponsor decision|2|||
42186708|NCT02953340|75996476|FG000|Overall Study|Lost to Follow-up|3|||
42186709|NCT02953340|75996477|FG001|Overall Study|Lost to Follow-up|2|||
42186710|NCT02953340|75996476|FG000|Overall Study|Reason not specified|2|||
42186711|NCT02953340|75996477|FG001|Overall Study|Reason not specified|2|||
42186712|NCT03554772|75996493|FG000|Overall Study|Lost to Follow-up|0|||
42186713|NCT03554772|75996494|FG001|Overall Study|Lost to Follow-up|0|||
42186714|NCT03554772|75996495|FG002|Overall Study|Lost to Follow-up|0|||
42186715|NCT03554772|75996496|FG003|Overall Study|Lost to Follow-up|2|||
42186716|NCT03573804|75996506|FG000|Overall Study|claustrophobia or MRI table problems|10|||
42186717|NCT03417440|75996524|FG000|Overall Study|Lost to Follow-up|0|||
42186718|NCT03417440|75996525|FG001|Overall Study|Lost to Follow-up|1|||
42186719|NCT03417440|75996526|FG002|Overall Study|Lost to Follow-up|0|||
42186720|NCT03417440|75996527|FG003|Overall Study|Lost to Follow-up|0|||
42186721|NCT03417440|75996528|FG004|Overall Study|Lost to Follow-up|1|||
42186722|NCT03417440|75996529|FG005|Overall Study|Lost to Follow-up|0|||
42186723|NCT03417440|75996530|FG006|Overall Study|Lost to Follow-up|0|||
42186724|NCT03417440|75996531|FG007|Overall Study|Lost to Follow-up|0|||
42295703|NCT02498067|76130353|FG000|Overall Study|Did not meet inclusion criteria|11|||
42295704|NCT02497755|76130361|FG000|Overall Study|Protocol Violation|1|||
42295705|NCT02497755|76130362|FG001|Overall Study|Protocol Violation|0|||
42295706|NCT02619175|76130371|FG000|Overall Study|Withdrawal by Subject|1|||
42295707|NCT02619175|76130372|FG001|Overall Study|Withdrawal by Subject|0|||
42295708|NCT02619175|76130371|FG000|Overall Study|foot pain|1|||
42186725|NCT03417440|75996524|FG000|Overall Study|Withdrawal by Subject|2|||
42186726|NCT03417440|75996525|FG001|Overall Study|Withdrawal by Subject|0|||
42186727|NCT03417440|75996526|FG002|Overall Study|Withdrawal by Subject|2|||
42186728|NCT03417440|75996527|FG003|Overall Study|Withdrawal by Subject|1|||
42186729|NCT03417440|75996528|FG004|Overall Study|Withdrawal by Subject|1|||
42186730|NCT03417440|75996529|FG005|Overall Study|Withdrawal by Subject|0|||
42186731|NCT03417440|75996530|FG006|Overall Study|Withdrawal by Subject|0|||
42186732|NCT03417440|75996531|FG007|Overall Study|Withdrawal by Subject|1|||
42186733|NCT03458702|75996554|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
42186734|NCT03458702|75996555|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
42186735|NCT03458702|75996554|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
42186736|NCT03458702|75996555|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
42186737|NCT03454412|75996561|FG000|Baseline Assesment|Physician Decision|12|||
42186738|NCT03452540|75996565|FG000|Overall Study|Adverse Event|1|||
42186739|NCT03452540|75996565|FG000|Overall Study|Withdrawal by Subject|1|||
42186740|NCT03452540|75996565|FG000|Overall Study|Other SAE and AE|2|||
42186741|NCT03573336|75996572|FG000|Overall Study|Study terminated|2|||
42186742|NCT03573336|75996573|FG001|Overall Study|Study terminated|4|||
42295709|NCT02619175|76130372|FG001|Overall Study|foot pain|0|||
42295710|NCT01360021|76130389|FG000|Overall Study|Eligibility criteria + other|2|||
42295711|NCT01360021|76130390|FG001|Overall Study|Eligibility criteria + other|1|||
42295712|NCT01360021|76130391|FG002|Overall Study|Eligibility criteria + other|1|||
42295713|NCT01360021|76130389|FG000|Overall Study|Protocol Violation|0|||
42295714|NCT01360021|76130390|FG001|Overall Study|Protocol Violation|0|||
42295715|NCT01360021|76130391|FG002|Overall Study|Protocol Violation|1|||
42295716|NCT01360021|76130389|FG000|Overall Study|Withdrawal by Subject|4|||
42295717|NCT01360021|76130390|FG001|Overall Study|Withdrawal by Subject|0|||
42295718|NCT01360021|76130391|FG002|Overall Study|Withdrawal by Subject|2|||
42295719|NCT01360021|76130389|FG000|Overall Study|Adverse Event|2|||
42295720|NCT01360021|76130390|FG001|Overall Study|Adverse Event|3|||
42093114|NCT00683475|75903471|FG000|Overall Study|Never Treated: Adverse Event|2|||
42093115|NCT00683475|75903472|FG001|Overall Study|Never Treated: Adverse Event|3|||
42093116|NCT00683475|75903471|FG000|Overall Study|Never Treated: Progressive Disease|1|||
42093117|NCT00683475|75903472|FG001|Overall Study|Never Treated: Progressive Disease|0|||
42093118|NCT00685035|75903479|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
42018118|NCT01126437|75825819|FG002|Overall Study|Withdrawal by Subject|319|||
42018119|NCT01126437|75825817|FG000|Overall Study|Other reason not specified|210|||
42093119|NCT00685035|75903480|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
42186743|NCT03573336|75996574|FG002|Overall Study|Study terminated|2|||
42186744|NCT03500198|75996584|FG000|Overall Study|Lost to Follow-up|0|||
42186745|NCT03500198|75996585|FG001|Overall Study|Lost to Follow-up|1|||
42186746|NCT03553758|75996593|FG000|Overall Study|Lost to Follow-up|1|||
42295721|NCT01360021|76130391|FG002|Overall Study|Adverse Event|3|||
42295722|NCT02497287|76130408|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
42295723|NCT02497287|76130408|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
42295724|NCT02497287|76130408|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
42018120|NCT01126437|75825818|FG001|Overall Study|Other reason not specified|176|||
42018121|NCT01126437|75825819|FG002|Overall Study|Other reason not specified|178|||
42018122|NCT01258595|75825829|FG000|Overall Study|Lost to Follow-up|1|||
42018123|NCT01258595|75825830|FG001|Overall Study|Lost to Follow-up|0|||
42018124|NCT01258595|75825829|FG000|Overall Study|Withdrawal by Subject|0|||
42186747|NCT03552198|75996603|FG000|Overall Study|Lost to Follow-up|42|||
42186748|NCT03552198|75996604|FG001|Overall Study|Lost to Follow-up|48|||
42186749|NCT03552198|75996605|FG002|Overall Study|Lost to Follow-up|15|||
42186750|NCT03552198|75996606|FG003|Overall Study|Lost to Follow-up|19|||
42186751|NCT03552198|75996603|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
42186752|NCT03552198|75996604|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
42186753|NCT03552198|75996605|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
42186754|NCT03552198|75996606|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
42186755|NCT03552198|75996603|FG000|Overall Study|Did not receive air alerts|1|||
42186756|NCT03552198|75996604|FG001|Overall Study|Did not receive air alerts|0|||
42186757|NCT03552198|75996605|FG002|Overall Study|Did not receive air alerts|0|||
42186758|NCT03552198|75996606|FG003|Overall Study|Did not receive air alerts|1|||
42186759|NCT02954354|75996619|FG000|Overall Study|Adverse Event|2|||
42186760|NCT02954354|75996620|FG001|Overall Study|Adverse Event|2|||
42186761|NCT02954354|75996621|FG002|Overall Study|Adverse Event|4|||
42186762|NCT02954354|75996619|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
42186763|NCT02954354|75996620|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
42186764|NCT02954354|75996621|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
42186765|NCT02954354|75996619|FG000|Overall Study|Lack of Efficacy|0|||
42186766|NCT02954354|75996620|FG001|Overall Study|Lack of Efficacy|2|||
42186767|NCT02954354|75996621|FG002|Overall Study|Lack of Efficacy|0|||
42186768|NCT02954354|75996619|FG000|Overall Study|Withdrawal by Subject|17|||
42186769|NCT02954354|75996620|FG001|Overall Study|Withdrawal by Subject|9|||
42186770|NCT02954354|75996621|FG002|Overall Study|Withdrawal by Subject|11|||
42018125|NCT01258595|75825830|FG001|Overall Study|Withdrawal by Subject|1|||
42018126|NCT01257737|75825838|FG000|Overall Study|Lost to Follow-up|1|||
42018127|NCT01257737|75825839|FG001|Overall Study|Lost to Follow-up|2|||
42018128|NCT01257737|75825838|FG000|Overall Study|Liver transplant|1|||
42018129|NCT01257737|75825839|FG001|Overall Study|Liver transplant|0|||
42018130|NCT01257737|75825838|FG000|Overall Study|Relocation out of the country|0|||
42018131|NCT01257737|75825839|FG001|Overall Study|Relocation out of the country|1|||
42018132|NCT01257737|75825838|FG000|Overall Study|Withdrew from study|0|||
42018133|NCT01257737|75825839|FG001|Overall Study|Withdrew from study|1|||
42018134|NCT01126359|75825846|FG000|First Intervention (20-minutes)|Physician Decision|0|||
42018135|NCT01126359|75825847|FG001|First Intervention (20-minutes)|Physician Decision|1|||
42018136|NCT01125813|75825857|FG000|Overall Study|Death|1|||
42018137|NCT01125813|75825857|FG000|Overall Study|Withdrawal by Subject|1|||
42018138|NCT01125813|75825857|FG000|Overall Study|Screen Failures|4|||
42018139|NCT00996892|75825861|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
42093120|NCT00773747|75903506|FG000|Overall Study|Lack of Efficacy|112|||
42093121|NCT00773747|75903507|FG001|Overall Study|Lack of Efficacy|144|||
42093122|NCT00773747|75903506|FG000|Overall Study|Physician Decision|26|||
42093123|NCT00773747|75903507|FG001|Overall Study|Physician Decision|18|||
42093124|NCT00773747|75903506|FG000|Overall Study|Lost to Follow-up|0|||
42093125|NCT00773747|75903507|FG001|Overall Study|Lost to Follow-up|1|||
42093126|NCT00773747|75903506|FG000|Overall Study|Protocol Violation|2|||
42093127|NCT00773747|75903507|FG001|Overall Study|Protocol Violation|2|||
42093128|NCT00773747|75903506|FG000|Overall Study|Withdrawal by Subject|89|||
42093129|NCT00773747|75903507|FG001|Overall Study|Withdrawal by Subject|61|||
42093130|NCT00773747|75903506|FG000|Overall Study|Adverse Event|61|||
42093131|NCT00773747|75903507|FG001|Overall Study|Adverse Event|62|||
42093132|NCT00773747|75903506|FG000|Overall Study|Death|5|||
42093133|NCT00773747|75903507|FG001|Overall Study|Death|8|||
42093134|NCT00773747|75903506|FG000|Overall Study|Not Treated|2|||
42093135|NCT00773747|75903507|FG001|Overall Study|Not Treated|0|||
42093136|NCT00784277|75903517|FG000|IR Treatment|Adverse Event|4|||
42093137|NCT00784277|75903518|FG001|IR Treatment|Adverse Event|8|||
42093138|NCT00784277|75903519|FG002|IR Treatment|Adverse Event|19|||
42093139|NCT00784277|75903520|FG003|IR Treatment|Adverse Event|35|||
42093140|NCT00784277|75903521|FG004|IR Treatment|Adverse Event|0|||
42093141|NCT00784277|75903522|FG005|IR Treatment|Adverse Event|0|||
42093142|NCT00784277|75903523|FG006|IR Treatment|Adverse Event|0|||
42093143|NCT00784277|75903517|FG000|IR Treatment|Lack of Efficacy|4|||
42093144|NCT00784277|75903518|FG001|IR Treatment|Lack of Efficacy|4|||
42093145|NCT00784277|75903519|FG002|IR Treatment|Lack of Efficacy|1|||
42093146|NCT00784277|75903520|FG003|IR Treatment|Lack of Efficacy|0|||
42093147|NCT00784277|75903521|FG004|IR Treatment|Lack of Efficacy|0|||
42093148|NCT00784277|75903522|FG005|IR Treatment|Lack of Efficacy|0|||
42093149|NCT00784277|75903523|FG006|IR Treatment|Lack of Efficacy|0|||
42093150|NCT00784277|75903517|FG000|IR Treatment|Lost to Follow-up|1|||
42093151|NCT00784277|75903518|FG001|IR Treatment|Lost to Follow-up|0|||
42093152|NCT00784277|75903519|FG002|IR Treatment|Lost to Follow-up|1|||
42093153|NCT00784277|75903520|FG003|IR Treatment|Lost to Follow-up|0|||
42093154|NCT00784277|75903521|FG004|IR Treatment|Lost to Follow-up|0|||
42093155|NCT00784277|75903522|FG005|IR Treatment|Lost to Follow-up|0|||
42093156|NCT00784277|75903523|FG006|IR Treatment|Lost to Follow-up|0|||
42186771|NCT02954354|75996619|FG000|Overall Study|Lost to Follow-up|12|||
42186772|NCT02954354|75996620|FG001|Overall Study|Lost to Follow-up|5|||
42186773|NCT02954354|75996621|FG002|Overall Study|Lost to Follow-up|0|||
42186774|NCT02954354|75996619|FG000|Overall Study|Miscellaneous|2|||
42186775|NCT02954354|75996620|FG001|Overall Study|Miscellaneous|2|||
42186776|NCT02954354|75996621|FG002|Overall Study|Miscellaneous|1|||
42186777|NCT03519516|75996633|FG000|Overall Study|Adverse Event|0|||
42186778|NCT03519516|75996634|FG001|Overall Study|Adverse Event|1|||
42186779|NCT03519204|75996642|FG000|Overall Study|Lost to Follow-up|3|||
42186780|NCT03519204|75996643|FG001|Overall Study|Lost to Follow-up|8|||
42186781|NCT03519204|75996642|FG000|Overall Study|Withdrawal by Subject|9|||
42186782|NCT03519204|75996643|FG001|Overall Study|Withdrawal by Subject|7|||
42186783|NCT03519204|75996642|FG000|Overall Study|Other Miscellaneous Reasons|1|||
42186784|NCT03519204|75996643|FG001|Overall Study|Other Miscellaneous Reasons|0|||
42186785|NCT03518658|75996655|FG000|Overall Study|Other|51|||
42186786|NCT03518658|75996656|FG001|Overall Study|Other|0|||
42186787|NCT03518112|75996664|FG000|Overall Study|Withdrawal by Subject|1|||
42093157|NCT00784277|75903517|FG000|IR Treatment|Withdrawal by Subject|5|||
42093158|NCT00784277|75903518|FG001|IR Treatment|Withdrawal by Subject|1|||
42093159|NCT00784277|75903519|FG002|IR Treatment|Withdrawal by Subject|4|||
42093160|NCT00784277|75903520|FG003|IR Treatment|Withdrawal by Subject|6|||
42093161|NCT00784277|75903521|FG004|IR Treatment|Withdrawal by Subject|0|||
42093162|NCT00784277|75903522|FG005|IR Treatment|Withdrawal by Subject|0|||
42093163|NCT00784277|75903523|FG006|IR Treatment|Withdrawal by Subject|0|||
42186788|NCT03517566|75996673|FG000|Overall Study|Adverse Event|5|||
42186789|NCT03517566|75996674|FG001|Overall Study|Adverse Event|2|||
42186790|NCT03517566|75996675|FG002|Overall Study|Adverse Event|2|||
42186791|NCT03517566|75996676|FG003|Overall Study|Adverse Event|8|||
42093164|NCT00784277|75903517|FG000|IR Treatment|Resolution Of Pain|0|||
42093165|NCT00784277|75903518|FG001|IR Treatment|Resolution Of Pain|1|||
42186792|NCT03517566|75996677|FG004|Overall Study|Adverse Event|7|||
42186793|NCT03517566|75996673|FG000|Overall Study|Lack of Efficacy|3|||
42186794|NCT03517566|75996674|FG001|Overall Study|Lack of Efficacy|2|||
42186795|NCT03517566|75996675|FG002|Overall Study|Lack of Efficacy|1|||
42186796|NCT03517566|75996676|FG003|Overall Study|Lack of Efficacy|1|||
42186797|NCT03517566|75996677|FG004|Overall Study|Lack of Efficacy|4|||
42186798|NCT03517566|75996673|FG000|Overall Study|Lost to Follow-up|3|||
42186799|NCT03517566|75996674|FG001|Overall Study|Lost to Follow-up|1|||
42186800|NCT03517566|75996675|FG002|Overall Study|Lost to Follow-up|1|||
42186801|NCT03517566|75996676|FG003|Overall Study|Lost to Follow-up|1|||
42186802|NCT03517566|75996677|FG004|Overall Study|Lost to Follow-up|0|||
42186803|NCT03517566|75996673|FG000|Overall Study|Physician Decision|1|||
42186804|NCT03517566|75996674|FG001|Overall Study|Physician Decision|1|||
42186805|NCT03517566|75996675|FG002|Overall Study|Physician Decision|0|||
42186806|NCT03517566|75996676|FG003|Overall Study|Physician Decision|1|||
42186807|NCT03517566|75996677|FG004|Overall Study|Physician Decision|0|||
42186808|NCT03517566|75996673|FG000|Overall Study|Pregnancy|0|||
42186809|NCT03517566|75996674|FG001|Overall Study|Pregnancy|1|||
42186810|NCT03517566|75996675|FG002|Overall Study|Pregnancy|0|||
42186811|NCT03517566|75996676|FG003|Overall Study|Pregnancy|0|||
42186812|NCT03517566|75996677|FG004|Overall Study|Pregnancy|0|||
42186813|NCT03517566|75996673|FG000|Overall Study|Protocol Deviation|0|||
42186814|NCT03517566|75996674|FG001|Overall Study|Protocol Deviation|1|||
42186815|NCT03517566|75996675|FG002|Overall Study|Protocol Deviation|0|||
42186816|NCT03517566|75996676|FG003|Overall Study|Protocol Deviation|1|||
42186817|NCT03517566|75996677|FG004|Overall Study|Protocol Deviation|1|||
42186818|NCT03517566|75996673|FG000|Overall Study|Study terminated by Sponsor|11|||
42295725|NCT02497287|76130408|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
42295726|NCT02497287|76130408|FG000|Induction Phase (4 Weeks)|Other|13|||
42295727|NCT02497287|76130408|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
42295728|NCT02497287|76130408|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
42093166|NCT00784277|75903519|FG002|IR Treatment|Resolution Of Pain|0|||
42093167|NCT00784277|75903520|FG003|IR Treatment|Resolution Of Pain|0|||
42093168|NCT00784277|75903521|FG004|IR Treatment|Resolution Of Pain|0|||
42093169|NCT00784277|75903522|FG005|IR Treatment|Resolution Of Pain|0|||
42093170|NCT00784277|75903523|FG006|IR Treatment|Resolution Of Pain|0|||
42093171|NCT00784277|75903517|FG000|IR Treatment|Other|2|||
42186819|NCT03517566|75996674|FG001|Overall Study|Study terminated by Sponsor|5|||
42295729|NCT02497287|76130408|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
42295730|NCT02497287|76130408|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
42093172|NCT00784277|75903518|FG001|IR Treatment|Other|3|||
42093173|NCT00784277|75903519|FG002|IR Treatment|Other|3|||
42093174|NCT00784277|75903520|FG003|IR Treatment|Other|2|||
42093175|NCT00784277|75903521|FG004|IR Treatment|Other|0|||
42186820|NCT03517566|75996675|FG002|Overall Study|Study terminated by Sponsor|6|||
42186821|NCT03517566|75996676|FG003|Overall Study|Study terminated by Sponsor|14|||
42186822|NCT03517566|75996677|FG004|Overall Study|Study terminated by Sponsor|12|||
42186823|NCT03517566|75996673|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
42186824|NCT03517566|75996674|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
42186825|NCT03517566|75996675|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
42186826|NCT03517566|75996676|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
42093176|NCT00784277|75903522|FG005|IR Treatment|Other|0|||
42093177|NCT00784277|75903523|FG006|IR Treatment|Other|0|||
42093178|NCT00784277|75903517|FG000|ER Treatment|Adverse Event|0|||
42093179|NCT00784277|75903518|FG001|ER Treatment|Adverse Event|0|||
42093180|NCT00784277|75903519|FG002|ER Treatment|Adverse Event|0|||
42093181|NCT00784277|75903520|FG003|ER Treatment|Adverse Event|0|||
42093182|NCT00784277|75903521|FG004|ER Treatment|Adverse Event|1|||
42093183|NCT00784277|75903522|FG005|ER Treatment|Adverse Event|7|||
42093184|NCT00784277|75903523|FG006|ER Treatment|Adverse Event|7|||
42093185|NCT00784277|75903517|FG000|ER Treatment|Lack of Efficacy|0|||
42093186|NCT00784277|75903518|FG001|ER Treatment|Lack of Efficacy|0|||
42093187|NCT00784277|75903519|FG002|ER Treatment|Lack of Efficacy|0|||
42093188|NCT00784277|75903520|FG003|ER Treatment|Lack of Efficacy|0|||
42093189|NCT00784277|75903521|FG004|ER Treatment|Lack of Efficacy|3|||
42093190|NCT00784277|75903522|FG005|ER Treatment|Lack of Efficacy|4|||
42093191|NCT00784277|75903523|FG006|ER Treatment|Lack of Efficacy|0|||
42093192|NCT00784277|75903517|FG000|ER Treatment|Lost to Follow-up|0|||
42093193|NCT00784277|75903518|FG001|ER Treatment|Lost to Follow-up|0|||
42093194|NCT00784277|75903519|FG002|ER Treatment|Lost to Follow-up|0|||
42093195|NCT00784277|75903520|FG003|ER Treatment|Lost to Follow-up|0|||
42093196|NCT00784277|75903521|FG004|ER Treatment|Lost to Follow-up|0|||
42093197|NCT00784277|75903522|FG005|ER Treatment|Lost to Follow-up|2|||
42093198|NCT00784277|75903523|FG006|ER Treatment|Lost to Follow-up|0|||
42093199|NCT00784277|75903517|FG000|ER Treatment|Withdrawal by Subject|0|||
42093200|NCT00784277|75903518|FG001|ER Treatment|Withdrawal by Subject|0|||
42093201|NCT00784277|75903519|FG002|ER Treatment|Withdrawal by Subject|0|||
42093202|NCT00784277|75903520|FG003|ER Treatment|Withdrawal by Subject|0|||
42093203|NCT00784277|75903521|FG004|ER Treatment|Withdrawal by Subject|2|||
42093204|NCT00784277|75903522|FG005|ER Treatment|Withdrawal by Subject|5|||
42093205|NCT00784277|75903523|FG006|ER Treatment|Withdrawal by Subject|3|||
42093206|NCT00784277|75903517|FG000|ER Treatment|Study Medication Non-Compliant|0|||
42093207|NCT00784277|75903518|FG001|ER Treatment|Study Medication Non-Compliant|0|||
42093208|NCT00784277|75903519|FG002|ER Treatment|Study Medication Non-Compliant|0|||
42093209|NCT00784277|75903520|FG003|ER Treatment|Study Medication Non-Compliant|0|||
42093210|NCT00784277|75903521|FG004|ER Treatment|Study Medication Non-Compliant|2|||
42093211|NCT00784277|75903522|FG005|ER Treatment|Study Medication Non-Compliant|3|||
42093212|NCT00784277|75903523|FG006|ER Treatment|Study Medication Non-Compliant|3|||
42093213|NCT00784277|75903517|FG000|ER Treatment|Other|0|||
42093214|NCT00784277|75903518|FG001|ER Treatment|Other|0|||
42093215|NCT00784277|75903519|FG002|ER Treatment|Other|0|||
42093216|NCT00784277|75903520|FG003|ER Treatment|Other|0|||
42093217|NCT00784277|75903521|FG004|ER Treatment|Other|1|||
42093218|NCT00784277|75903522|FG005|ER Treatment|Other|3|||
42093219|NCT00784277|75903523|FG006|ER Treatment|Other|2|||
42093220|NCT00682929|75903539|FG000|Overall Study|Adverse Event|4|||
42093221|NCT00682929|75903540|FG001|Overall Study|Adverse Event|1|||
42093222|NCT00682929|75903541|FG002|Overall Study|Adverse Event|1|||
42093223|NCT00682929|75903539|FG000|Overall Study|Withdrawal by Subject|1|||
42093224|NCT00682929|75903540|FG001|Overall Study|Withdrawal by Subject|2|||
42093225|NCT00682929|75903541|FG002|Overall Study|Withdrawal by Subject|1|||
42093226|NCT00682929|75903539|FG000|Overall Study|dosing compliance < 80%|0|||
42093227|NCT00682929|75903540|FG001|Overall Study|dosing compliance < 80%|2|||
42093228|NCT00682929|75903541|FG002|Overall Study|dosing compliance < 80%|0|||
42093229|NCT00682929|75903539|FG000|Overall Study|lag in DEA renewal|1|||
42093230|NCT00682929|75903540|FG001|Overall Study|lag in DEA renewal|0|||
42093231|NCT00682929|75903541|FG002|Overall Study|lag in DEA renewal|0|||
42093232|NCT00680745|75903553|FG000|Overall Study|Withdrawal by Subject|8|||
42093233|NCT00680745|75903554|FG001|Overall Study|Withdrawal by Subject|3|||
42093234|NCT00680745|75903555|FG002|Overall Study|Withdrawal by Subject|2|||
42093235|NCT00680745|75903556|FG003|Overall Study|Withdrawal by Subject|8|||
42093236|NCT00680745|75903553|FG000|Overall Study|Lost to Follow-up|0|||
42186827|NCT03517566|75996677|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
42186828|NCT03916744|75996693|FG000|Overall Study|Withdrawal by Subject|0|||
42018140|NCT00996892|75825862|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
42018141|NCT00996892|75825863|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
42018142|NCT00996892|75825864|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
42018143|NCT00996892|75825865|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
42018144|NCT00996892|75825866|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
42018145|NCT00996892|75825867|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
42018146|NCT00996892|75825868|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
42018147|NCT00996892|75825869|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
42018148|NCT00996892|75825870|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
42093237|NCT00680745|75903554|FG001|Overall Study|Lost to Follow-up|1|||
42093238|NCT00680745|75903555|FG002|Overall Study|Lost to Follow-up|1|||
42093239|NCT00680745|75903556|FG003|Overall Study|Lost to Follow-up|0|||
42093240|NCT00680745|75903553|FG000|Overall Study|Death|1|||
42093241|NCT00680745|75903554|FG001|Overall Study|Death|0|||
42093242|NCT00680745|75903555|FG002|Overall Study|Death|1|||
42186829|NCT03916744|75996694|FG001|Overall Study|Withdrawal by Subject|1|||
42093243|NCT00680745|75903556|FG003|Overall Study|Death|0|||
42093244|NCT00680745|75903553|FG000|Overall Study|Adverse Event|5|||
42093245|NCT00680745|75903554|FG001|Overall Study|Adverse Event|3|||
42093246|NCT00680745|75903555|FG002|Overall Study|Adverse Event|3|||
42093247|NCT00680745|75903556|FG003|Overall Study|Adverse Event|3|||
42093248|NCT00680745|75903553|FG000|Overall Study|Poor/Non-compliance|0|||
42093249|NCT00680745|75903554|FG001|Overall Study|Poor/Non-compliance|3|||
42093250|NCT00680745|75903555|FG002|Overall Study|Poor/Non-compliance|0|||
42093251|NCT00680745|75903556|FG003|Overall Study|Poor/Non-compliance|0|||
42093252|NCT00680745|75903553|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
42093253|NCT00680745|75903554|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
42093254|NCT00680745|75903555|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
42093255|NCT00680745|75903556|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
42093256|NCT00680745|75903553|FG000|Overall Study|False Treatment|0|||
42093257|NCT00680745|75903554|FG001|Overall Study|False Treatment|1|||
42093258|NCT00680745|75903555|FG002|Overall Study|False Treatment|3|||
42093259|NCT00680745|75903556|FG003|Overall Study|False Treatment|0|||
42093260|NCT00680121|75903569|FG000|Overall Study|Lost to Follow-up|27|||
42093261|NCT00680121|75903570|FG001|Overall Study|Lost to Follow-up|23|||
42093262|NCT00767819|75903579|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
42093263|NCT00767819|75903580|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
42093264|NCT00767819|75903581|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
42093265|NCT00767819|75903579|FG000|Overall Study|Withdrawal by Subject|1|||
42093266|NCT00767819|75903580|FG001|Overall Study|Withdrawal by Subject|1|||
42093267|NCT00767819|75903581|FG002|Overall Study|Withdrawal by Subject|0|||
42093268|NCT00767819|75903579|FG000|Overall Study|Administrative problems|0|||
42093269|NCT00767819|75903580|FG001|Overall Study|Administrative problems|1|||
42093270|NCT00767819|75903581|FG002|Overall Study|Administrative problems|0|||
42093271|NCT00767819|75903579|FG000|Overall Study|Death|2|||
42093272|NCT00767819|75903580|FG001|Overall Study|Death|3|||
42093273|NCT00767819|75903581|FG002|Overall Study|Death|0|||
42093274|NCT00767819|75903579|FG000|Overall Study|Adverse Event|2|||
42093275|NCT00767819|75903580|FG001|Overall Study|Adverse Event|0|||
42093276|NCT00767819|75903581|FG002|Overall Study|Adverse Event|0|||
42186830|NCT03916744|75996695|FG002|Overall Study|Withdrawal by Subject|2|||
42186831|NCT03639610|75996710|FG000|Overall Study|Adverse Event|7|||
42186832|NCT03639610|75996711|FG001|Overall Study|Adverse Event|1|||
42186833|NCT03639610|75996712|FG002|Overall Study|Adverse Event|0|||
42186834|NCT03639610|75996710|FG000|Overall Study|Physician Decision|3|||
42186835|NCT03639610|75996711|FG001|Overall Study|Physician Decision|1|||
42186836|NCT03639610|75996712|FG002|Overall Study|Physician Decision|0|||
42186837|NCT03639610|75996710|FG000|Overall Study|Disease progression|8|||
42186838|NCT03639610|75996711|FG001|Overall Study|Disease progression|5|||
42186839|NCT03639610|75996712|FG002|Overall Study|Disease progression|3|||
42186840|NCT03639610|75996710|FG000|Overall Study|Study terminated by sponsor|2|||
42186841|NCT03639610|75996711|FG001|Overall Study|Study terminated by sponsor|1|||
42186842|NCT03639610|75996712|FG002|Overall Study|Study terminated by sponsor|1|||
42186843|NCT03639610|75996710|FG000|Overall Study|Patient request to stop treatment|1|||
42186844|NCT03639610|75996711|FG001|Overall Study|Patient request to stop treatment|2|||
42186845|NCT03639610|75996712|FG002|Overall Study|Patient request to stop treatment|0|||
42093277|NCT00767819|75903579|FG000|Overall Study|Abnormal lab values|1|||
42093278|NCT00767819|75903580|FG001|Overall Study|Abnormal lab values|0|||
42093279|NCT00767819|75903581|FG002|Overall Study|Abnormal lab values|0|||
42186846|NCT02954406|75996730|FG000|Overall Study|Adverse Event|0|||
42186847|NCT02954406|75996731|FG001|Overall Study|Adverse Event|1|||
42186848|NCT02954406|75996732|FG002|Overall Study|Adverse Event|0|||
42186849|NCT02954406|75996733|FG003|Overall Study|Adverse Event|0|||
42186850|NCT02954406|75996734|FG004|Overall Study|Adverse Event|1|||
42186851|NCT02954406|75996735|FG005|Overall Study|Adverse Event|0|||
42186852|NCT02954406|75996736|FG006|Overall Study|Adverse Event|0|||
42186853|NCT02954406|75996737|FG007|Overall Study|Adverse Event|0|||
42186854|NCT02954406|75996738|FG008|Overall Study|Adverse Event|1|||
42186855|NCT02954406|75996739|FG009|Overall Study|Adverse Event|1|||
42186856|NCT02954406|75996740|FG010|Overall Study|Adverse Event|0|||
42093280|NCT00767819|75903579|FG000|Overall Study|Lost to Follow-up|1|||
42186857|NCT02954406|75996730|FG000|Overall Study|Progressive Disease|3|||
42186858|NCT02954406|75996731|FG001|Overall Study|Progressive Disease|4|||
42093281|NCT00767819|75903580|FG001|Overall Study|Lost to Follow-up|0|||
42093282|NCT00767819|75903581|FG002|Overall Study|Lost to Follow-up|0|||
42093283|NCT00584870|75903592|FG000|Overall Study|Adverse Event|4|||
42093284|NCT00584870|75903593|FG001|Overall Study|Adverse Event|3|||
42093285|NCT00584870|75903594|FG002|Overall Study|Adverse Event|2|||
42093286|NCT00584870|75903592|FG000|Overall Study|Lost to Follow-up|4|||
42093287|NCT00584870|75903593|FG001|Overall Study|Lost to Follow-up|1|||
42186859|NCT02954406|75996732|FG002|Overall Study|Progressive Disease|3|||
42186860|NCT02954406|75996733|FG003|Overall Study|Progressive Disease|4|||
42186861|NCT02954406|75996734|FG004|Overall Study|Progressive Disease|3|||
42186862|NCT02954406|75996735|FG005|Overall Study|Progressive Disease|3|||
42093288|NCT00584870|75903594|FG002|Overall Study|Lost to Follow-up|1|||
42093289|NCT00584870|75903592|FG000|Overall Study|Lack of Efficacy|7|||
42093290|NCT00584870|75903593|FG001|Overall Study|Lack of Efficacy|14|||
42093291|NCT00584870|75903594|FG002|Overall Study|Lack of Efficacy|8|||
42093292|NCT00584870|75903592|FG000|Overall Study|Withdrawal by Subject|10|||
42093293|NCT00584870|75903593|FG001|Overall Study|Withdrawal by Subject|5|||
42093294|NCT00584870|75903594|FG002|Overall Study|Withdrawal by Subject|3|||
42093295|NCT00584870|75903592|FG000|Overall Study|Protocol Violation|1|||
42093296|NCT00584870|75903593|FG001|Overall Study|Protocol Violation|1|||
42093297|NCT00584870|75903594|FG002|Overall Study|Protocol Violation|2|||
42093298|NCT00584870|75903592|FG000|Overall Study|Did not met entrance criteria|1|||
42093299|NCT00584870|75903593|FG001|Overall Study|Did not met entrance criteria|0|||
42093300|NCT00584870|75903594|FG002|Overall Study|Did not met entrance criteria|0|||
42093301|NCT00584870|75903592|FG000|Overall Study|Other|2|||
42093302|NCT00584870|75903593|FG001|Overall Study|Other|0|||
42093303|NCT00584870|75903594|FG002|Overall Study|Other|0|||
42093304|NCT00584870|75903592|FG000|Overall Study|Randomized but not treated|0|||
42093305|NCT00584870|75903593|FG001|Overall Study|Randomized but not treated|1|||
42093306|NCT00584870|75903594|FG002|Overall Study|Randomized but not treated|2|||
42093307|NCT00679341|75903604|FG000|Overall Study|Disease progression|42|||
42093308|NCT00679341|75903605|FG001|Overall Study|Disease progression|36|||
42093309|NCT00679341|75903604|FG000|Overall Study|Adverse Event|5|||
42186863|NCT02954406|75996736|FG006|Overall Study|Progressive Disease|2|||
42186864|NCT02954406|75996737|FG007|Overall Study|Progressive Disease|2|||
42186865|NCT02954406|75996738|FG008|Overall Study|Progressive Disease|1|||
42186866|NCT02954406|75996739|FG009|Overall Study|Progressive Disease|1|||
42186867|NCT02954406|75996740|FG010|Overall Study|Progressive Disease|0|||
42186868|NCT02954406|75996730|FG000|Overall Study|Symptomatic Deterioration|0|||
42186869|NCT02954406|75996731|FG001|Overall Study|Symptomatic Deterioration|1|||
42186870|NCT02954406|75996732|FG002|Overall Study|Symptomatic Deterioration|0|||
42186871|NCT02954406|75996733|FG003|Overall Study|Symptomatic Deterioration|0|||
42186872|NCT02954406|75996734|FG004|Overall Study|Symptomatic Deterioration|0|||
42186873|NCT02954406|75996735|FG005|Overall Study|Symptomatic Deterioration|0|||
42186874|NCT02954406|75996736|FG006|Overall Study|Symptomatic Deterioration|0|||
42186875|NCT02954406|75996737|FG007|Overall Study|Symptomatic Deterioration|0|||
42186876|NCT02954406|75996738|FG008|Overall Study|Symptomatic Deterioration|0|||
42186877|NCT02954406|75996739|FG009|Overall Study|Symptomatic Deterioration|0|||
42186878|NCT02954406|75996740|FG010|Overall Study|Symptomatic Deterioration|0|||
42186879|NCT02954406|75996730|FG000|Overall Study|Death|0|||
42186880|NCT02954406|75996731|FG001|Overall Study|Death|0|||
42186881|NCT02954406|75996732|FG002|Overall Study|Death|0|||
42186882|NCT02954406|75996733|FG003|Overall Study|Death|0|||
42186883|NCT02954406|75996734|FG004|Overall Study|Death|1|||
42186884|NCT02954406|75996735|FG005|Overall Study|Death|0|||
42186885|NCT02954406|75996736|FG006|Overall Study|Death|0|||
42186886|NCT02954406|75996737|FG007|Overall Study|Death|0|||
42359015|NCT02101385|76204744|FG001|Study Treatment|Patient Non compliance|2|||
42186887|NCT02954406|75996738|FG008|Overall Study|Death|1|||
42186888|NCT02954406|75996739|FG009|Overall Study|Death|1|||
42295731|NCT02497287|76130408|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
42295732|NCT02497287|76130408|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
42295733|NCT02497287|76130408|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
42295734|NCT02497287|76130408|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
42295735|NCT02497287|76130408|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
42295736|NCT02497287|76130408|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
42295737|NCT02497287|76130408|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
42295738|NCT02497287|76130408|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
42295739|NCT02497287|76130408|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
42295740|NCT02497287|76130408|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
42295741|NCT02497287|76130408|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
42359016|NCT02101385|76204743|FG000|Study Treatment|Withdrawal by Subject|5|||
42018149|NCT00996892|75825871|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
42018150|NCT00996892|75825872|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
42018151|NCT00996892|75825873|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
42018152|NCT00996892|75825874|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
42018153|NCT00996892|75825875|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
42018154|NCT00996892|75825876|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
42018155|NCT00996892|75825877|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
42018156|NCT00996892|75825878|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
42093310|NCT00679341|75903605|FG001|Overall Study|Adverse Event|6|||
42093311|NCT00679341|75903604|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
42186889|NCT02954406|75996740|FG010|Overall Study|Death|0|||
42186890|NCT02954406|75996730|FG000|Overall Study|Reason Not Specified|0|||
42186891|NCT02954406|75996731|FG001|Overall Study|Reason Not Specified|0|||
42186892|NCT02954406|75996732|FG002|Overall Study|Reason Not Specified|3|||
42186893|NCT02954406|75996733|FG003|Overall Study|Reason Not Specified|2|||
42186894|NCT02954406|75996734|FG004|Overall Study|Reason Not Specified|2|||
42186895|NCT02954406|75996735|FG005|Overall Study|Reason Not Specified|0|||
42186896|NCT02954406|75996736|FG006|Overall Study|Reason Not Specified|1|||
42186897|NCT02954406|75996737|FG007|Overall Study|Reason Not Specified|0|||
42186898|NCT02954406|75996738|FG008|Overall Study|Reason Not Specified|1|||
42186899|NCT02954406|75996739|FG009|Overall Study|Reason Not Specified|0|||
42186900|NCT02954406|75996740|FG010|Overall Study|Reason Not Specified|0|||
42186901|NCT03514914|75996770|FG000|Overall Study|Death|3|||
42186902|NCT03514914|75996771|FG001|Overall Study|Death|3|||
42186903|NCT03514914|75996770|FG000|Overall Study|Lost to Follow-up|117|||
42186904|NCT03514914|75996771|FG001|Overall Study|Lost to Follow-up|89|||
42186905|NCT03513588|75996780|FG000|Overall Study|Lost to Follow-up|0|||
42186906|NCT03513588|75996781|FG001|Overall Study|Lost to Follow-up|1|||
42186907|NCT03513588|75996782|FG002|Overall Study|Lost to Follow-up|1|||
42186908|NCT03513588|75996780|FG000|Overall Study|Study dosing paused by sponsor|1|||
42186909|NCT03513588|75996781|FG001|Overall Study|Study dosing paused by sponsor|1|||
42186910|NCT03513588|75996782|FG002|Overall Study|Study dosing paused by sponsor|0|||
42186911|NCT03513588|75996780|FG000|Overall Study|Death|0|||
42186912|NCT03513588|75996781|FG001|Overall Study|Death|0|||
42186913|NCT03513588|75996782|FG002|Overall Study|Death|1|||
42186914|NCT03512028|75996794|FG000|Overall Study|Withdrawal by Subject|2|||
42186915|NCT03512028|75996795|FG001|Overall Study|Withdrawal by Subject|0|||
42186916|NCT03512028|75996794|FG000|Overall Study|Protocol Violation|2|||
42186917|NCT03512028|75996795|FG001|Overall Study|Protocol Violation|0|||
42186918|NCT03511326|75996801|FG000|Overall Study|Withdrawal by Subject|1|||
42186919|NCT03508830|75996807|FG000|Overall Study|Withdrawal by Subject|3|||
42186920|NCT03508830|75996808|FG001|Overall Study|Withdrawal by Subject|4|||
42186921|NCT03508830|75996807|FG000|Overall Study|Physician Decision|2|||
42186922|NCT03508830|75996808|FG001|Overall Study|Physician Decision|2|||
42186923|NCT03508050|75996816|FG000|Overall Study|Pleural adhesions|1|||
42186924|NCT03508050|75996817|FG001|Overall Study|Pleural adhesions|0|||
42186925|NCT03508050|75996816|FG000|Overall Study|Mucus plug|1|||
42186926|NCT03508050|75996817|FG001|Overall Study|Mucus plug|0|||
42186927|NCT03508050|75996816|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
42186928|NCT03508050|75996817|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
42186929|NCT03508050|75996816|FG000|Overall Study|Sustained desaturation|0|||
42186930|NCT03508050|75996817|FG001|Overall Study|Sustained desaturation|1|||
42186931|NCT03569202|75996826|FG000|Part 3|Physician Decision|1|||
42186932|NCT03569202|75996827|FG001|Part 3|Physician Decision|0|||
42186933|NCT03569202|75996826|FG000|Part 3|Other|1|||
42186934|NCT03569202|75996827|FG001|Part 3|Other|1|||
42186935|NCT03568500|75996836|FG000|Overall Study|Lost to Follow-up|1|||
42186936|NCT03568500|75996837|FG001|Overall Study|Lost to Follow-up|1|||
42186937|NCT03568500|75996838|FG002|Overall Study|Lost to Follow-up|2|||
42186938|NCT03568500|75996836|FG000|Overall Study|Adverse Event|1|||
42186939|NCT03568500|75996837|FG001|Overall Study|Adverse Event|1|||
42186940|NCT03568500|75996838|FG002|Overall Study|Adverse Event|2|||
42186941|NCT03568500|75996836|FG000|Overall Study|Physician Decision|1|||
42186942|NCT03568500|75996837|FG001|Overall Study|Physician Decision|0|||
42186943|NCT03568500|75996838|FG002|Overall Study|Physician Decision|0|||
42186944|NCT03568500|75996836|FG000|Overall Study|Withdrawal by Subject|4|||
42186945|NCT03568500|75996837|FG001|Overall Study|Withdrawal by Subject|2|||
42186946|NCT03568500|75996838|FG002|Overall Study|Withdrawal by Subject|0|||
42186947|NCT03568500|75996836|FG000|Overall Study|Technical Problems|2|||
42186948|NCT03568500|75996837|FG001|Overall Study|Technical Problems|1|||
42186949|NCT03568500|75996838|FG002|Overall Study|Technical Problems|0|||
42186950|NCT03568500|75996836|FG000|Overall Study|Participant Noncompliance|1|||
42186951|NCT03568500|75996837|FG001|Overall Study|Participant Noncompliance|1|||
42186952|NCT03568500|75996838|FG002|Overall Study|Participant Noncompliance|0|||
42186953|NCT03504852|75996863|FG000|Overall Study|Withdrawal of informed consent|2|||
42186954|NCT03504852|75996864|FG001|Overall Study|Withdrawal of informed consent|1|||
42186955|NCT03504852|75996865|FG002|Overall Study|Withdrawal of informed consent|0|||
42186956|NCT03504852|75996863|FG000|Overall Study|Withdrawal by Subject|5|||
42186957|NCT03504852|75996864|FG001|Overall Study|Withdrawal by Subject|5|||
42359017|NCT02101385|76204744|FG001|Study Treatment|Withdrawal by Subject|2|||
42186958|NCT03504852|75996865|FG002|Overall Study|Withdrawal by Subject|1|||
42186959|NCT03504852|75996863|FG000|Overall Study|Lost to Follow-up|4|||
42359018|NCT02101385|76204743|FG000|Study Treatment|screen failure|1|||
42359019|NCT02101385|76204744|FG001|Study Treatment|screen failure|0|||
42359020|NCT02101385|76204743|FG000|Study Treatment|AE/Side Effects/Complications|8|||
42186960|NCT03504852|75996864|FG001|Overall Study|Lost to Follow-up|1|||
42186961|NCT03504852|75996865|FG002|Overall Study|Lost to Follow-up|0|||
42186962|NCT03504852|75996863|FG000|Overall Study|New therapy for study indication|1|||
42186963|NCT03504852|75996864|FG001|Overall Study|New therapy for study indication|0|||
42186964|NCT03504852|75996865|FG002|Overall Study|New therapy for study indication|0|||
42186965|NCT03504852|75996863|FG000|Overall Study|Lack of Efficacy|1|||
42186966|NCT03504852|75996864|FG001|Overall Study|Lack of Efficacy|2|||
42186967|NCT03504852|75996865|FG002|Overall Study|Lack of Efficacy|0|||
42186968|NCT03504852|75996863|FG000|Overall Study|Death|0|||
42186969|NCT03504852|75996864|FG001|Overall Study|Death|1|||
42186970|NCT03504852|75996865|FG002|Overall Study|Death|0|||
42186971|NCT03504852|75996863|FG000|Overall Study|Adverse Event|4|||
42093312|NCT00679341|75903605|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
42093313|NCT00679341|75903604|FG000|Overall Study|Death|1|||
42093314|NCT00679341|75903605|FG001|Overall Study|Death|1|||
42093315|NCT00679341|75903604|FG000|Overall Study|Other|1|||
42093316|NCT00679341|75903605|FG001|Overall Study|Other|0|||
42093317|NCT00679341|75903604|FG000|Overall Study|Physician Decision|1|||
42093318|NCT00679341|75903605|FG001|Overall Study|Physician Decision|0|||
42093319|NCT00679341|75903604|FG000|Overall Study|Not treated|0|||
42093320|NCT00679341|75903605|FG001|Overall Study|Not treated|2|||
42093321|NCT00679341|75903604|FG000|Overall Study|Physician/patient decision to withdraw|0|||
42093322|NCT00679341|75903605|FG001|Overall Study|Physician/patient decision to withdraw|6|||
42093323|NCT00679263|75903615|FG000|Visit 2/Dose 1|Adverse Event|1|||
42093324|NCT00679263|75903616|FG001|Visit 2/Dose 1|Adverse Event|0|||
42093325|NCT00679263|75903617|FG002|Visit 2/Dose 1|Adverse Event|0|||
42186972|NCT03504852|75996864|FG001|Overall Study|Adverse Event|8|||
42186973|NCT03504852|75996865|FG002|Overall Study|Adverse Event|2|||
42186974|NCT03025828|75996875|FG000|Overall Study|Lost to Follow-up|1|||
42186975|NCT03546816|75996881|FG000|Overall Study|Adverse Event|5|||
42186976|NCT03546816|75996882|FG001|Overall Study|Adverse Event|3|||
42186977|NCT03546816|75996881|FG000|Overall Study|Lack of Efficacy|2|||
42186978|NCT03546816|75996882|FG001|Overall Study|Lack of Efficacy|4|||
42186979|NCT03546816|75996881|FG000|Overall Study|Pregnancy|1|||
42186980|NCT03546816|75996882|FG001|Overall Study|Pregnancy|0|||
42186981|NCT03546816|75996881|FG000|Overall Study|Physician Decision|2|||
42186982|NCT03546816|75996882|FG001|Overall Study|Physician Decision|0|||
42186983|NCT03546816|75996881|FG000|Overall Study|Withdrawal by Subject|8|||
42186984|NCT03546816|75996882|FG001|Overall Study|Withdrawal by Subject|10|||
42186985|NCT03546816|75996881|FG000|Overall Study|Lost to Follow-up|3|||
42186986|NCT03546816|75996882|FG001|Overall Study|Lost to Follow-up|2|||
42186987|NCT03024970|75996890|FG000|First Intervention|Adverse Event|1|||
42186988|NCT03024970|75996891|FG001|First Intervention|Adverse Event|0|||
42186989|NCT03024970|75996890|FG000|Second Intervention|Lost to Follow-up|1|||
42186990|NCT03024970|75996891|FG001|Second Intervention|Lost to Follow-up|0|||
42186991|NCT03500094|75996897|FG000|Overall Study|Withdrawal by Subject|1|||
42186992|NCT03500094|75996897|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
42186993|NCT03500094|75996897|FG000|Overall Study|Lost to Follow-up|1|||
42186994|NCT03566550|75996905|FG000|Overall Study|Withdrawal by Subject|0|||
42186995|NCT03566550|75996906|FG001|Overall Study|Withdrawal by Subject|1|||
42295742|NCT02497287|76130408|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
42295743|NCT02497287|76130408|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
42295744|NCT02497287|76130408|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
42295745|NCT02497287|76130408|FG000|Follow-up Phase (4 Week)|Other|1|||
42295746|NCT02458287|76130418|FG000|Overall Study|Adverse Event|0|||
42295747|NCT02458287|76130419|FG001|Overall Study|Adverse Event|0|||
42295748|NCT02458287|76130420|FG002|Overall Study|Adverse Event|0|||
42295749|NCT02458287|76130421|FG003|Overall Study|Adverse Event|1|||
42295750|NCT02458287|76130418|FG000|Overall Study|Lost to Follow-up|0|||
42295751|NCT02458287|76130419|FG001|Overall Study|Lost to Follow-up|1|||
42295752|NCT02458287|76130420|FG002|Overall Study|Lost to Follow-up|1|||
42295753|NCT02458287|76130421|FG003|Overall Study|Lost to Follow-up|0|||
42186996|NCT03566238|75996915|FG000|Overall Study|Adverse Event|0|||
42186997|NCT03566238|75996916|FG001|Overall Study|Adverse Event|1|||
42186998|NCT03566238|75996917|FG002|Overall Study|Adverse Event|0|||
42295754|NCT02458287|76130418|FG000|Overall Study|Protocol Violation|0|||
42295755|NCT02458287|76130419|FG001|Overall Study|Protocol Violation|1|||
42295756|NCT02458287|76130420|FG002|Overall Study|Protocol Violation|0|||
42093326|NCT00679263|75903615|FG000|Visit 2/Dose 1|subject not compliance|1|||
42093327|NCT00679263|75903616|FG001|Visit 2/Dose 1|subject not compliance|1|||
42093328|NCT00679263|75903617|FG002|Visit 2/Dose 1|subject not compliance|0|||
42093329|NCT00680043|75903628|FG000|Overall Study|Withdrawal by Subject|1|||
42186999|NCT03566238|75996915|FG000|Overall Study|Lack of Efficacy|4|||
42187000|NCT03566238|75996916|FG001|Overall Study|Lack of Efficacy|2|||
42093330|NCT00680043|75903629|FG001|Overall Study|Withdrawal by Subject|0|||
42187001|NCT03566238|75996917|FG002|Overall Study|Lack of Efficacy|5|||
42093331|NCT00680043|75903630|FG002|Overall Study|Withdrawal by Subject|0|||
42187002|NCT03566238|75996915|FG000|Overall Study|Other|1|||
42187003|NCT03566238|75996916|FG001|Overall Study|Other|0|||
42187004|NCT03566238|75996917|FG002|Overall Study|Other|0|||
42187005|NCT02894502|75996928|FG000|Baseline|Withdrawal by Subject|24|||
42295757|NCT02458287|76130421|FG003|Overall Study|Protocol Violation|0|||
42093332|NCT00680043|75903628|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
42295758|NCT02458287|76130418|FG000|Overall Study|Withdrawal by Subject|0|||
42295759|NCT02458287|76130419|FG001|Overall Study|Withdrawal by Subject|2|||
42093333|NCT00680043|75903629|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
42187006|NCT02894502|75996929|FG001|Baseline|Withdrawal by Subject|31|||
42187007|NCT02894502|75996930|FG002|Baseline|Withdrawal by Subject|36|||
42187008|NCT02894502|75996928|FG000|Baseline|Death|3|||
42187009|NCT02894502|75996929|FG001|Baseline|Death|1|||
42187010|NCT02894502|75996930|FG002|Baseline|Death|9|||
42187011|NCT02894502|75996928|FG000|First Follow up|Withdrawal by Subject|32|||
42187012|NCT02894502|75996929|FG001|First Follow up|Withdrawal by Subject|29|||
42187013|NCT02894502|75996930|FG002|First Follow up|Withdrawal by Subject|37|||
42187014|NCT02894502|75996928|FG000|First Follow up|Death|2|||
42187015|NCT02894502|75996929|FG001|First Follow up|Death|2|||
42187016|NCT02894502|75996930|FG002|First Follow up|Death|3|||
42187017|NCT02894502|75996928|FG000|Second Follow up|Withdrawal by Subject|13|||
42187018|NCT02894502|75996929|FG001|Second Follow up|Withdrawal by Subject|15|||
42187019|NCT02894502|75996930|FG002|Second Follow up|Withdrawal by Subject|13|||
42187020|NCT02894502|75996928|FG000|Second Follow up|Death|2|||
42187021|NCT02894502|75996929|FG001|Second Follow up|Death|3|||
42187022|NCT02894502|75996930|FG002|Second Follow up|Death|1|||
42187023|NCT02894502|75996928|FG000|Third Follow up|Withdrawal by Subject|5|||
42187024|NCT02894502|75996929|FG001|Third Follow up|Withdrawal by Subject|6|||
42187025|NCT02894502|75996930|FG002|Third Follow up|Withdrawal by Subject|3|||
42187026|NCT02894502|75996928|FG000|Third Follow up|Death|1|||
42187027|NCT02894502|75996929|FG001|Third Follow up|Death|1|||
42187028|NCT02894502|75996930|FG002|Third Follow up|Death|0|||
42187029|NCT03449030|75996951|FG000|Overall Study|Withdrawal by Subject|0|||
42187030|NCT03449030|75996952|FG001|Overall Study|Withdrawal by Subject|0|||
42187031|NCT03449030|75996953|FG002|Overall Study|Withdrawal by Subject|0|||
42187032|NCT03449030|75996954|FG003|Overall Study|Withdrawal by Subject|1|||
42187033|NCT03449030|75996955|FG004|Overall Study|Withdrawal by Subject|1|||
42187034|NCT03449030|75996956|FG005|Overall Study|Withdrawal by Subject|1|||
42187035|NCT03449030|75996957|FG006|Overall Study|Withdrawal by Subject|1|||
42187036|NCT03449030|75996958|FG007|Overall Study|Withdrawal by Subject|2|||
42187037|NCT03449030|75996959|FG008|Overall Study|Withdrawal by Subject|0|||
42187038|NCT03449030|75996960|FG009|Overall Study|Withdrawal by Subject|0|||
42187039|NCT03449030|75996951|FG000|Overall Study|Symptomatic Deterioration|0|||
42187040|NCT03449030|75996952|FG001|Overall Study|Symptomatic Deterioration|1|||
42187041|NCT03449030|75996953|FG002|Overall Study|Symptomatic Deterioration|0|||
42187042|NCT03449030|75996954|FG003|Overall Study|Symptomatic Deterioration|0|||
42187043|NCT03449030|75996955|FG004|Overall Study|Symptomatic Deterioration|0|||
42187044|NCT03449030|75996956|FG005|Overall Study|Symptomatic Deterioration|1|||
42187045|NCT03449030|75996957|FG006|Overall Study|Symptomatic Deterioration|1|||
42187046|NCT03449030|75996958|FG007|Overall Study|Symptomatic Deterioration|0|||
42187047|NCT03449030|75996959|FG008|Overall Study|Symptomatic Deterioration|2|||
42187048|NCT03449030|75996960|FG009|Overall Study|Symptomatic Deterioration|0|||
42187049|NCT03449030|75996951|FG000|Overall Study|Progressive Disease|1|||
42187050|NCT03449030|75996952|FG001|Overall Study|Progressive Disease|0|||
42295760|NCT02458287|76130420|FG002|Overall Study|Withdrawal by Subject|2|||
42295761|NCT02458287|76130421|FG003|Overall Study|Withdrawal by Subject|1|||
42187051|NCT03449030|75996953|FG002|Overall Study|Progressive Disease|1|||
42187052|NCT03449030|75996954|FG003|Overall Study|Progressive Disease|4|||
42187053|NCT03449030|75996955|FG004|Overall Study|Progressive Disease|5|||
42187054|NCT03449030|75996956|FG005|Overall Study|Progressive Disease|3|||
42187055|NCT03449030|75996957|FG006|Overall Study|Progressive Disease|0|||
42187056|NCT03449030|75996958|FG007|Overall Study|Progressive Disease|1|||
42187057|NCT03449030|75996959|FG008|Overall Study|Progressive Disease|1|||
42187058|NCT03449030|75996960|FG009|Overall Study|Progressive Disease|1|||
42187059|NCT03449030|75996951|FG000|Overall Study|Adverse Event|0|||
42187060|NCT03449030|75996952|FG001|Overall Study|Adverse Event|0|||
42187061|NCT03449030|75996953|FG002|Overall Study|Adverse Event|0|||
42187062|NCT03449030|75996954|FG003|Overall Study|Adverse Event|0|||
42187063|NCT03449030|75996955|FG004|Overall Study|Adverse Event|0|||
42187064|NCT03449030|75996956|FG005|Overall Study|Adverse Event|2|||
42187065|NCT03449030|75996957|FG006|Overall Study|Adverse Event|0|||
42187066|NCT03449030|75996958|FG007|Overall Study|Adverse Event|0|||
42187067|NCT03449030|75996959|FG008|Overall Study|Adverse Event|0|||
42187068|NCT03449030|75996960|FG009|Overall Study|Adverse Event|0|||
42187069|NCT03449030|75996951|FG000|Overall Study|Death|0|||
42093334|NCT00680043|75903630|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
42093335|NCT00680043|75903628|FG000|Overall Study|Renal Transplant|1|||
42093336|NCT00680043|75903629|FG001|Overall Study|Renal Transplant|0|||
42187070|NCT03449030|75996952|FG001|Overall Study|Death|0|||
42187071|NCT03449030|75996953|FG002|Overall Study|Death|0|||
42187072|NCT03449030|75996954|FG003|Overall Study|Death|0|||
42359021|NCT02101385|76204744|FG001|Study Treatment|AE/Side Effects/Complications|0|||
42093337|NCT00680043|75903630|FG002|Overall Study|Renal Transplant|4|||
42093338|NCT00682539|75903641|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
42093339|NCT00682539|75903642|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
42093340|NCT00682539|75903643|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
42093341|NCT00682539|75903641|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
42093342|NCT00682539|75903642|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
42093343|NCT00682539|75903643|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
42093344|NCT00682461|75903653|FG000|Overall Study|Adverse Event|5|||
42093345|NCT00682461|75903654|FG001|Overall Study|Adverse Event|7|||
42093346|NCT00682461|75903653|FG000|Overall Study|Lost to Follow-up|8|||
42093347|NCT00682461|75903654|FG001|Overall Study|Lost to Follow-up|5|||
42093348|NCT00682461|75903653|FG000|Overall Study|Withdrawal by Subject|12|||
42093349|NCT00682461|75903654|FG001|Overall Study|Withdrawal by Subject|19|||
42093350|NCT00677235|75903663|FG000|Overall Study|Withdrawal by Subject|1|||
42093351|NCT00677235|75903664|FG001|Overall Study|Withdrawal by Subject|1|||
42093352|NCT00677235|75903663|FG000|Overall Study|Lost to Follow-up|2|||
42093353|NCT00677235|75903664|FG001|Overall Study|Lost to Follow-up|1|||
42093354|NCT00677235|75903663|FG000|Overall Study|Death|37|||
42093355|NCT00677235|75903664|FG001|Overall Study|Death|36|||
42093356|NCT00677235|75903663|FG000|Overall Study|Adverse Experience|1|||
42093357|NCT00677235|75903664|FG001|Overall Study|Adverse Experience|0|||
42093358|NCT00676689|75903670|FG000|Overall Study|Screen Failure|2|||
42093359|NCT00676689|75903670|FG000|Overall Study|Death|2|||
42093360|NCT00676689|75903670|FG000|Overall Study|Lost to Follow-up|4|||
42093361|NCT00676689|75903670|FG000|Overall Study|Physician Decision|1|||
42093362|NCT00676689|75903670|FG000|Overall Study|Withdrawal by Subject|3|||
42093363|NCT00676689|75903670|FG000|Overall Study|Continuing FU|49|||
42093364|NCT00678795|75903676|FG000|Overall Study|Adverse Event|7|||
42093365|NCT00678795|75903677|FG001|Overall Study|Adverse Event|3|||
42093366|NCT00678795|75903676|FG000|Overall Study|Withdrawal by Subject|3|||
42093367|NCT00678795|75903677|FG001|Overall Study|Withdrawal by Subject|0|||
42093368|NCT00678795|75903676|FG000|Overall Study|Protocol Violation|0|||
42093369|NCT00678795|75903677|FG001|Overall Study|Protocol Violation|1|||
42093370|NCT00678795|75903676|FG000|Overall Study|Lost to Follow-up|0|||
42093371|NCT00678795|75903677|FG001|Overall Study|Lost to Follow-up|1|||
42187073|NCT03449030|75996955|FG004|Overall Study|Death|1|||
42359022|NCT02101385|76204743|FG000|Study Treatment|Lost to Follow-up|1|||
42359023|NCT02101385|76204744|FG001|Study Treatment|Lost to Follow-up|0|||
42359024|NCT02101385|76204743|FG000|Study Treatment|Disease Progression before treatment|1|||
42359025|NCT02101385|76204744|FG001|Study Treatment|Disease Progression before treatment|0|||
42093372|NCT00678795|75903676|FG000|Overall Study|Lack of Efficacy|1|||
42093373|NCT00678795|75903677|FG001|Overall Study|Lack of Efficacy|1|||
42093374|NCT00678639|75903685|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
42093375|NCT00678639|75903686|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
42093376|NCT00678561|75903736|FG000|Overall Study|Adverse Event|0|||
42093377|NCT00678561|75903737|FG001|Overall Study|Adverse Event|1|||
42093378|NCT00678561|75903738|FG002|Overall Study|Adverse Event|1|||
42187074|NCT03449030|75996956|FG005|Overall Study|Death|0|||
42187075|NCT03449030|75996957|FG006|Overall Study|Death|0|||
42187076|NCT03449030|75996958|FG007|Overall Study|Death|0|||
42187077|NCT03449030|75996959|FG008|Overall Study|Death|0|||
42187078|NCT03449030|75996960|FG009|Overall Study|Death|0|||
42359026|NCT02101385|76204743|FG000|Study Treatment|Death|1|||
42187079|NCT03448406|75996985|FG000|Overall Study|Noncompliance of scheduled visits|1|||
42187080|NCT03448406|75996986|FG001|Overall Study|Noncompliance of scheduled visits|2|||
42187081|NCT03448406|75996985|FG000|Overall Study|Withdrawal by Subject|1|||
42187082|NCT03448406|75996986|FG001|Overall Study|Withdrawal by Subject|2|||
42187083|NCT03448406|75996985|FG000|Overall Study|Protocol Violation|1|||
42187084|NCT03448406|75996986|FG001|Overall Study|Protocol Violation|0|||
42187085|NCT03448406|75996985|FG000|Overall Study|Adverse Event|8|||
42187086|NCT03448406|75996986|FG001|Overall Study|Adverse Event|9|||
42187087|NCT03499028|75996994|FG000|Overall Study|Lost to Follow-up|12|||
42187088|NCT03499028|75996995|FG001|Overall Study|Lost to Follow-up|9|||
42187089|NCT03499028|75996994|FG000|Overall Study|Withdrawal by Subject|5|||
42187090|NCT03499028|75996995|FG001|Overall Study|Withdrawal by Subject|8|||
42187091|NCT03499028|75996994|FG000|Overall Study|Unplanned SNF discharge|5|||
42187092|NCT03499028|75996995|FG001|Overall Study|Unplanned SNF discharge|8|||
42187093|NCT03498560|75997003|FG000|Overall Study|Found Ineligible|2|||
42187094|NCT03498560|75997003|FG000|Overall Study|Withdrawal by Subject|14|||
42295762|NCT02458287|76130418|FG000|Overall Study|Relocated Out of State|0|||
42295763|NCT02458287|76130419|FG001|Overall Study|Relocated Out of State|0|||
42295764|NCT02458287|76130420|FG002|Overall Study|Relocated Out of State|0|||
42295765|NCT02458287|76130421|FG003|Overall Study|Relocated Out of State|1|||
42295766|NCT02441517|76130437|FG000|Overall Study|Lost to Follow-up|1|||
42295767|NCT02441517|76130437|FG000|Overall Study|Withdrawal by Subject|2|||
42295768|NCT02441517|76130437|FG000|Overall Study|Study Terminated by Sponsor|1|||
42295769|NCT02457819|76130441|FG000|Overall Study|reason not given|8|||
42295770|NCT02457819|76130441|FG000|Overall Study|Withdrawal by Subject|24|||
42295771|NCT02457819|76130441|FG000|Overall Study|Protocol Violation|1|||
42295772|NCT02457819|76130441|FG000|Overall Study|non compliance with study drug|4|||
42295773|NCT02457819|76130441|FG000|Overall Study|Lost to Follow-up|10|||
42295774|NCT02457819|76130441|FG000|Overall Study|Lack of Efficacy|19|||
42295775|NCT02457819|76130441|FG000|Overall Study|Adverse Event|33|||
42295776|NCT02496039|76130445|FG000|Overall Study|Adverse Event|3|||
42359027|NCT02101385|76204744|FG001|Study Treatment|Death|0|||
42359028|NCT02101385|76204743|FG000|Follow up|Lost to Follow-up|4|||
42359029|NCT02101385|76204744|FG001|Follow up|Lost to Follow-up|9|||
42359030|NCT02101385|76204743|FG000|Follow up|Refused to follow up|5|||
42359031|NCT02101385|76204744|FG001|Follow up|Refused to follow up|4|||
42093379|NCT00678561|75903739|FG003|Overall Study|Adverse Event|0|||
42093380|NCT00678561|75903740|FG004|Overall Study|Adverse Event|1|||
42093381|NCT00678561|75903741|FG005|Overall Study|Adverse Event|0|||
42093382|NCT00678561|75903742|FG006|Overall Study|Adverse Event|0|||
42093383|NCT00678561|75903743|FG007|Overall Study|Adverse Event|0|||
42093384|NCT00678561|75903736|FG000|Overall Study|Protocol Violation|0|||
42093385|NCT00678561|75903737|FG001|Overall Study|Protocol Violation|0|||
42093386|NCT00678561|75903738|FG002|Overall Study|Protocol Violation|0|||
42093387|NCT00678561|75903739|FG003|Overall Study|Protocol Violation|0|||
42093388|NCT00678561|75903740|FG004|Overall Study|Protocol Violation|1|||
42093389|NCT00678561|75903741|FG005|Overall Study|Protocol Violation|1|||
42093390|NCT00678561|75903742|FG006|Overall Study|Protocol Violation|0|||
42093391|NCT00678561|75903743|FG007|Overall Study|Protocol Violation|0|||
42093392|NCT00678561|75903736|FG000|Overall Study|Withdrawal by Subject|0|||
42093393|NCT00678561|75903737|FG001|Overall Study|Withdrawal by Subject|0|||
42093394|NCT00678561|75903738|FG002|Overall Study|Withdrawal by Subject|0|||
42093395|NCT00678561|75903739|FG003|Overall Study|Withdrawal by Subject|0|||
42359032|NCT02101385|76204743|FG000|Follow up|Death|21|||
42359033|NCT02101385|76204744|FG001|Follow up|Death|39|||
42359034|NCT02101385|76204743|FG000|Follow up|study completed|33|||
42359035|NCT02101385|76204744|FG001|Follow up|study completed|52|||
42359036|NCT02101385|76204743|FG000|Follow up|screen failure|2|||
42359037|NCT02101385|76204744|FG001|Follow up|screen failure|0|||
42359038|NCT02101385|76204743|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
42359039|NCT02101385|76204744|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
42359040|NCT02101385|76204743|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
42359041|NCT02101385|76204744|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
42359042|NCT02101385|76204743|FG000|Follow up|Withdrawal by Subject|2|||
42359043|NCT02101385|76204744|FG001|Follow up|Withdrawal by Subject|2|||
42093396|NCT00678561|75903740|FG004|Overall Study|Withdrawal by Subject|0|||
42093397|NCT00678561|75903741|FG005|Overall Study|Withdrawal by Subject|0|||
42093398|NCT00678561|75903742|FG006|Overall Study|Withdrawal by Subject|0|||
42093399|NCT00678561|75903743|FG007|Overall Study|Withdrawal by Subject|1|||
42187095|NCT03498560|75997003|FG000|Overall Study|Lost to Follow-up|4|||
42187096|NCT03498560|75997003|FG000|Overall Study|Death|1|||
42187097|NCT00064701|75997011|FG000|One Year Post-transplant|Did not receive study drug|7|||
42295777|NCT02496039|76130445|FG000|Overall Study|Protocol Violation|1|||
42295778|NCT02441283|76130449|FG000|Overall Study|Withdrew consent|15|||
42295779|NCT02441283|76130449|FG000|Overall Study|Lost to Follow-up|42|||
42295780|NCT02441283|76130449|FG000|Overall Study|Death|1|||
42187098|NCT00064701|75997012|FG001|One Year Post-transplant|Did not receive study drug|12|||
42187099|NCT00064701|75997013|FG002|One Year Post-transplant|Did not receive study drug|11|||
42187100|NCT00064701|75997011|FG000|One Year Post-transplant|Adverse Event|23|||
42093400|NCT00676143|75903770|FG000|Overall Study|Adverse Event|34|||
42093401|NCT00676143|75903771|FG001|Overall Study|Adverse Event|60|||
42187101|NCT00064701|75997012|FG001|One Year Post-transplant|Adverse Event|19|||
42187102|NCT00064701|75997013|FG002|One Year Post-transplant|Adverse Event|37|||
42187103|NCT00064701|75997011|FG000|One Year Post-transplant|Rejection|0|||
42187104|NCT00064701|75997012|FG001|One Year Post-transplant|Rejection|1|||
42187105|NCT00064701|75997013|FG002|One Year Post-transplant|Rejection|16|||
42187106|NCT00064701|75997011|FG000|One Year Post-transplant|Non-compliance|4|||
42187107|NCT00064701|75997012|FG001|One Year Post-transplant|Non-compliance|2|||
42187108|NCT00064701|75997013|FG002|One Year Post-transplant|Non-compliance|5|||
42187109|NCT00064701|75997011|FG000|One Year Post-transplant|Graft Failure|3|||
42187110|NCT00064701|75997012|FG001|One Year Post-transplant|Graft Failure|2|||
42187111|NCT00064701|75997013|FG002|One Year Post-transplant|Graft Failure|1|||
42187112|NCT00064701|75997011|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
42187113|NCT00064701|75997012|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
42187114|NCT00064701|75997013|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
42187115|NCT00064701|75997011|FG000|One Year Post-transplant|Lost to Follow-up|1|||
42187116|NCT00064701|75997012|FG001|One Year Post-transplant|Lost to Follow-up|0|||
42187117|NCT00064701|75997013|FG002|One Year Post-transplant|Lost to Follow-up|0|||
42187118|NCT00064701|75997011|FG000|One Year Post-transplant|Converted to rapamycin|1|||
42187119|NCT00064701|75997012|FG001|One Year Post-transplant|Converted to rapamycin|0|||
42187120|NCT00064701|75997013|FG002|One Year Post-transplant|Converted to rapamycin|0|||
42187121|NCT00064701|75997011|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
42187122|NCT00064701|75997012|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
42187123|NCT00064701|75997013|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
42187124|NCT00064701|75997011|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
42187125|NCT00064701|75997012|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
42187126|NCT00064701|75997013|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
42187127|NCT00064701|75997011|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
42187128|NCT00064701|75997012|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
42187129|NCT00064701|75997013|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
42187130|NCT00064701|75997011|FG000|One Year Post-transplant|Poor absorption|0|||
42295781|NCT02441283|76130449|FG000|Overall Study|Other, not specified|32|||
42295782|NCT02495883|76130455|FG000|Overall Study|Excessive head motion|1|||
42093402|NCT00676143|75903770|FG000|Overall Study|Death|4|||
42093403|NCT00676143|75903771|FG001|Overall Study|Death|4|||
42093404|NCT00676143|75903770|FG000|Overall Study|Lack of Efficacy|0|||
42093405|NCT00676143|75903771|FG001|Overall Study|Lack of Efficacy|6|||
42093406|NCT00676143|75903770|FG000|Overall Study|Lost to Follow-up|0|||
42093407|NCT00676143|75903771|FG001|Overall Study|Lost to Follow-up|13|||
42093408|NCT00676143|75903770|FG000|Overall Study|Physician Decision|5|||
42093409|NCT00676143|75903771|FG001|Overall Study|Physician Decision|8|||
42093410|NCT00676143|75903770|FG000|Overall Study|Protocol Violation|4|||
42093411|NCT00676143|75903771|FG001|Overall Study|Protocol Violation|8|||
42093412|NCT00676143|75903770|FG000|Overall Study|Withdrawal by Subject|24|||
42093413|NCT00676143|75903771|FG001|Overall Study|Withdrawal by Subject|42|||
42093414|NCT00676143|75903770|FG000|Overall Study|Discontinuation of study by sponsor|65|||
42093415|NCT00676143|75903771|FG001|Overall Study|Discontinuation of study by sponsor|88|||
42093416|NCT00676143|75903770|FG000|Overall Study|Failed to return|2|||
42093417|NCT00676143|75903771|FG001|Overall Study|Failed to return|1|||
42093418|NCT00676143|75903770|FG000|Overall Study|Loss of caregiver|5|||
42093419|NCT00676143|75903771|FG001|Overall Study|Loss of caregiver|3|||
42093420|NCT00676143|75903770|FG000|Overall Study|Other|11|||
42093421|NCT00676143|75903771|FG001|Overall Study|Other|20|||
42093422|NCT00676143|75903770|FG000|Overall Study|Participant participation unknown|1|||
42093423|NCT00676143|75903771|FG001|Overall Study|Participant participation unknown|4|||
42093424|NCT00676143|75903770|FG000|Overall Study|Vasogenic edema recurrence|1|||
42093425|NCT00676143|75903771|FG001|Overall Study|Vasogenic edema recurrence|3|||
42093426|NCT00675597|75903796|FG000|Overall Study|Withdrawal by Subject|3|||
42093427|NCT00675441|75903804|FG000|Overall Study|Withdrawal by Subject|2|||
42093428|NCT00675441|75903804|FG000|Overall Study|Death|1|||
42187131|NCT00064701|75997012|FG001|One Year Post-transplant|Poor absorption|1|||
42187132|NCT00064701|75997013|FG002|One Year Post-transplant|Poor absorption|0|||
42187133|NCT00064701|75997011|FG000|One Year Post-transplant|Pancreas transplant|0|||
42187134|NCT00064701|75997012|FG001|One Year Post-transplant|Pancreas transplant|0|||
42187135|NCT00064701|75997013|FG002|One Year Post-transplant|Pancreas transplant|1|||
42093429|NCT00674973|75903819|FG000|Overall Study|Insufficient Therapeutic Response|77|||
42093430|NCT00674973|75903820|FG001|Overall Study|Insufficient Therapeutic Response|72|||
42093431|NCT00674973|75903819|FG000|Overall Study|Refused Treatment|1|||
42093432|NCT00674973|75903820|FG001|Overall Study|Refused Treatment|5|||
42093433|NCT00674973|75903819|FG000|Overall Study|Failure to Return|1|||
42093434|NCT00674973|75903820|FG001|Overall Study|Failure to Return|0|||
42093435|NCT00674973|75903819|FG000|Overall Study|Adverse Event|2|||
42093436|NCT00674973|75903820|FG001|Overall Study|Adverse Event|9|||
42093437|NCT00674973|75903819|FG000|Overall Study|Death|19|||
42093438|NCT00674973|75903820|FG001|Overall Study|Death|15|||
42093439|NCT00674973|75903819|FG000|Overall Study|Protocol Violation|0|||
42093440|NCT00674973|75903820|FG001|Overall Study|Protocol Violation|1|||
42093441|NCT00673179|75903828|FG000|Overall Study|Toxicity/Complications|3|||
42093442|NCT00673179|75903829|FG001|Overall Study|Toxicity/Complications|0|||
42093443|NCT00584012|75903835|FG000|Overall Study|Withdrawal by Subject|1|||
42093444|NCT00674817|75903839|FG000|Period 1|Withdrawal by Subject|2|||
42093445|NCT00674817|75903839|FG000|Period 1|Protocol Violation|1|||
42187136|NCT00064701|75997011|FG000|Clinical Continuation Phase|Adverse Event|12|||
42187137|NCT00064701|75997012|FG001|Clinical Continuation Phase|Adverse Event|21|||
42187138|NCT00064701|75997013|FG002|Clinical Continuation Phase|Adverse Event|14|||
42187139|NCT00064701|75997011|FG000|Clinical Continuation Phase|Non-compliance|8|||
42187140|NCT00064701|75997012|FG001|Clinical Continuation Phase|Non-compliance|6|||
42187141|NCT00064701|75997013|FG002|Clinical Continuation Phase|Non-compliance|7|||
42187142|NCT00064701|75997011|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
42187143|NCT00064701|75997012|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
42187144|NCT00064701|75997013|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
42187145|NCT00064701|75997011|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
42187146|NCT00064701|75997012|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
42187147|NCT00064701|75997013|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
42187148|NCT00064701|75997011|FG000|Clinical Continuation Phase|Graft Failure|5|||
42187149|NCT00064701|75997012|FG001|Clinical Continuation Phase|Graft Failure|5|||
42187150|NCT00064701|75997013|FG002|Clinical Continuation Phase|Graft Failure|2|||
42187151|NCT00064701|75997011|FG000|Clinical Continuation Phase|Rejection|1|||
42187152|NCT00064701|75997012|FG001|Clinical Continuation Phase|Rejection|2|||
42187153|NCT00064701|75997013|FG002|Clinical Continuation Phase|Rejection|2|||
42093446|NCT00674817|75903839|FG000|Period 3|Adverse Event|1|||
42187154|NCT00064701|75997011|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
42187155|NCT00064701|75997012|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
42187156|NCT00064701|75997013|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
42187157|NCT00064701|75997011|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
42187158|NCT00064701|75997012|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
42187159|NCT00064701|75997013|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
42187160|NCT00064701|75997011|FG000|Clinical Continuation Phase|Physician Decision|1|||
42187161|NCT00064701|75997012|FG001|Clinical Continuation Phase|Physician Decision|3|||
42187162|NCT00064701|75997013|FG002|Clinical Continuation Phase|Physician Decision|0|||
42187163|NCT00064701|75997011|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
42187164|NCT00064701|75997012|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
42187165|NCT00064701|75997013|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
42187166|NCT00064701|75997011|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
42093447|NCT00674817|75903839|FG000|Period 3|Protocol Violation|1|||
42093448|NCT00674817|75903839|FG000|Period 4|Adverse Event|1|||
42093449|NCT00672633|75903855|FG000|Overall Study|Withdrawal by Subject|0|||
42093450|NCT00672633|75903856|FG001|Overall Study|Withdrawal by Subject|1|||
42093451|NCT00672555|75903862|FG000|Overall Study|Lost to Follow-up|4|||
42093452|NCT00672555|75903862|FG000|Overall Study|Did not want to answer questionnaire|2|||
42093453|NCT00672477|75903868|FG000|Overall Study|Adverse Event|10|||
42093454|NCT00672477|75903869|FG001|Overall Study|Adverse Event|7|||
42093455|NCT00672477|75903868|FG000|Overall Study|Death|7|||
42093456|NCT00672477|75903869|FG001|Overall Study|Death|11|||
42093457|NCT00672477|75903868|FG000|Overall Study|Physician Decision|2|||
42093458|NCT00672477|75903869|FG001|Overall Study|Physician Decision|0|||
42093459|NCT00672477|75903868|FG000|Overall Study|Protocol Violation|1|||
42093460|NCT00672477|75903869|FG001|Overall Study|Protocol Violation|1|||
42187167|NCT00064701|75997012|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
42187168|NCT00064701|75997013|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
42295783|NCT02495883|76130456|FG001|Overall Study|Excessive head motion|0|||
42295784|NCT02495025|76130463|FG000|Overall Study|Lost to Follow-up|21|||
42295785|NCT02495025|76130464|FG001|Overall Study|Lost to Follow-up|14|||
42295786|NCT02495025|76130463|FG000|Overall Study|Withdrawal by Subject|5|||
42093461|NCT00672477|75903868|FG000|Overall Study|Withdrawal by Subject|5|||
42093462|NCT00672477|75903869|FG001|Overall Study|Withdrawal by Subject|3|||
42093463|NCT00672477|75903868|FG000|Overall Study|Lack of Efficacy|1|||
42093464|NCT00672477|75903869|FG001|Overall Study|Lack of Efficacy|1|||
42093465|NCT00672477|75903868|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
42187169|NCT00064701|75997011|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
42187170|NCT00064701|75997012|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
42093466|NCT00672477|75903869|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
42093467|NCT00674661|75903877|FG000|Overall Study|Other|5|||
42093468|NCT00674661|75903878|FG001|Overall Study|Other|7|||
42093469|NCT00674661|75903877|FG000|Overall Study|Lost to Follow-up|6|||
42093470|NCT00674661|75903878|FG001|Overall Study|Lost to Follow-up|3|||
42093471|NCT00674661|75903877|FG000|Overall Study|Withdrawal by Subject|0|||
42093472|NCT00674661|75903878|FG001|Overall Study|Withdrawal by Subject|5|||
42093473|NCT00671931|75903889|FG000|Overall Study|Physician Decision|1|||
42093474|NCT00671931|75903890|FG001|Overall Study|Physician Decision|0|||
42093475|NCT00671931|75903891|FG002|Overall Study|Physician Decision|0|||
42093476|NCT00671931|75903892|FG003|Overall Study|Physician Decision|2|||
42093477|NCT00671931|75903893|FG004|Overall Study|Physician Decision|1|||
42093478|NCT00673881|75903909|FG000|Overall Study|Withdrawal by Subject|1|||
42093479|NCT00671853|75903915|FG000|Overall Study|Lack of Efficacy|3|||
42093480|NCT00671853|75903916|FG001|Overall Study|Lack of Efficacy|7|||
42093481|NCT00671853|75903915|FG000|Overall Study|Adverse Event|7|||
42093482|NCT00671853|75903916|FG001|Overall Study|Adverse Event|1|||
42093483|NCT00671853|75903915|FG000|Overall Study|Withdrawal by Subject|1|||
42093484|NCT00671853|75903916|FG001|Overall Study|Withdrawal by Subject|5|||
42187171|NCT00064701|75997013|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
42187172|NCT00064701|75997011|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
42187173|NCT00064701|75997012|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
42187174|NCT00064701|75997013|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
42187175|NCT00064701|75997011|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
42295787|NCT02495025|76130464|FG001|Overall Study|Withdrawal by Subject|0|||
42295788|NCT02439957|76130472|FG000|Overall Study|Study Terminated|3|||
42295789|NCT02439957|76130473|FG001|Overall Study|Study Terminated|3|||
42295790|NCT02494401|76130481|FG000|Overall Study|Lost to Follow-up|22|||
42093485|NCT00671853|75903915|FG000|Overall Study|Lost to Follow-up|8|||
42093486|NCT00671853|75903916|FG001|Overall Study|Lost to Follow-up|8|||
42093487|NCT00671853|75903915|FG000|Overall Study|Physician Decision|0|||
42093488|NCT00671853|75903916|FG001|Overall Study|Physician Decision|2|||
42093489|NCT00671853|75903915|FG000|Overall Study|Non-adherence with study procedures|1|||
42093490|NCT00671853|75903916|FG001|Overall Study|Non-adherence with study procedures|4|||
42093491|NCT00570921|75903924|FG000|Overall Study|Protocol Violation|1|||
42093492|NCT00570921|75903924|FG000|Overall Study|Physician Decision|1|||
42093493|NCT00670449|75903932|FG000|Overall Study|Adverse Event|6|||
42093494|NCT00670449|75903933|FG001|Overall Study|Adverse Event|2|||
42093495|NCT00670449|75903934|FG002|Overall Study|Adverse Event|8|||
42093496|NCT00670449|75903935|FG003|Overall Study|Adverse Event|5|||
42093497|NCT00670449|75903932|FG000|Overall Study|Protocol Deviation|1|||
42093498|NCT00670449|75903933|FG001|Overall Study|Protocol Deviation|2|||
42093499|NCT00670449|75903934|FG002|Overall Study|Protocol Deviation|0|||
42093500|NCT00670449|75903935|FG003|Overall Study|Protocol Deviation|1|||
42093501|NCT00670449|75903932|FG000|Overall Study|Administrative Problems|0|||
42093502|NCT00670449|75903933|FG001|Overall Study|Administrative Problems|2|||
42093503|NCT00670449|75903934|FG002|Overall Study|Administrative Problems|0|||
42093504|NCT00670449|75903935|FG003|Overall Study|Administrative Problems|1|||
42093505|NCT00670449|75903932|FG000|Overall Study|Subject Withdrew Consent|0|||
42093506|NCT00670449|75903933|FG001|Overall Study|Subject Withdrew Consent|2|||
42093507|NCT00670449|75903934|FG002|Overall Study|Subject Withdrew Consent|0|||
42093508|NCT00670449|75903935|FG003|Overall Study|Subject Withdrew Consent|1|||
42093509|NCT00670449|75903932|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
42093510|NCT00670449|75903933|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
42093511|NCT00670449|75903934|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
42093512|NCT00670449|75903935|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
42093513|NCT00670449|75903932|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
42093514|NCT00670449|75903933|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
42295791|NCT02494401|76130482|FG001|Overall Study|Lost to Follow-up|25|||
42295792|NCT02494401|76130481|FG000|Overall Study|Withdrawal by Subject|3|||
42093515|NCT00670449|75903934|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
42187176|NCT00064701|75997012|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
42093516|NCT00670449|75903935|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
42295793|NCT02494401|76130482|FG001|Overall Study|Withdrawal by Subject|2|||
42295794|NCT02457195|76130488|FG000|Overall Study|Adverse Event|3|||
42093517|NCT00668733|75903946|FG000|Overall Study|Lost to Follow-up|2|||
42093518|NCT00668733|75903947|FG001|Overall Study|Lost to Follow-up|3|||
42093519|NCT00668733|75903946|FG000|Overall Study|Withdrawal by Subject|0|||
42093520|NCT00668733|75903947|FG001|Overall Study|Withdrawal by Subject|4|||
42093521|NCT00673257|75903953|FG000|Overall Study|Withdrawal by Subject|4|||
42093522|NCT00673257|75903953|FG000|Overall Study|Unable to obtain specimen|1|||
42093523|NCT00667875|75903960|FG000|Overall Study|Adverse Event|0|||
42093524|NCT00667875|75903961|FG001|Overall Study|Adverse Event|2|||
42187177|NCT00064701|75997013|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
42187178|NCT00064701|75997011|FG000|Clinical Continuation Phase|Patient opted out|0|||
42187179|NCT00064701|75997012|FG001|Clinical Continuation Phase|Patient opted out|0|||
42187180|NCT00064701|75997013|FG002|Clinical Continuation Phase|Patient opted out|1|||
42187181|NCT00064077|75997025|FG000|Overall Study|Improper prior treatment|1|||
42295795|NCT02457195|76130488|FG000|Overall Study|Protocol Violation|2|||
42295796|NCT02457195|76130488|FG000|Overall Study|Withdrawal by Subject|4|||
42295797|NCT02456727|76130494|FG000|Overall Study|Lost to Follow-up|63|||
42295798|NCT02456727|76130495|FG001|Overall Study|Lost to Follow-up|65|||
42295799|NCT02456727|76130494|FG000|Overall Study|Death|2|||
42295800|NCT02456727|76130495|FG001|Overall Study|Death|1|||
42295801|NCT02456727|76130494|FG000|Overall Study|Withdrawal by Subject|1|||
42295802|NCT02456727|76130495|FG001|Overall Study|Withdrawal by Subject|10|||
42295803|NCT02456727|76130494|FG000|Overall Study|Never Initiated Treatment|43|||
42295804|NCT02456727|76130495|FG001|Overall Study|Never Initiated Treatment|30|||
42295805|NCT02456103|76130517|FG000|Overall Study|Study Closure|207|||
42093525|NCT00667875|75903962|FG002|Overall Study|Adverse Event|6|||
42093526|NCT00667875|75903960|FG000|Overall Study|Withdrawal by Subject|10|||
42093527|NCT00667875|75903961|FG001|Overall Study|Withdrawal by Subject|9|||
42093528|NCT00667875|75903962|FG002|Overall Study|Withdrawal by Subject|7|||
42093529|NCT03468998|75903982|FG000|Overall Study|Withdrawal by Subject|1|||
42093530|NCT03468998|75903983|FG001|Overall Study|Withdrawal by Subject|1|||
42093531|NCT03468998|75903984|FG002|Overall Study|Withdrawal by Subject|0|||
42093532|NCT03468998|75903985|FG003|Overall Study|Withdrawal by Subject|4|||
42093533|NCT03468998|75903986|FG004|Overall Study|Withdrawal by Subject|1|||
42093534|NCT03468998|75903987|FG005|Overall Study|Withdrawal by Subject|0|||
42187182|NCT00064077|75997026|FG001|Overall Study|Improper prior treatment|0|||
42187183|NCT00064077|75997027|FG002|Overall Study|Improper prior treatment|0|||
42187184|NCT00064077|75997028|FG003|Overall Study|Improper prior treatment|0|||
42187185|NCT00064077|75997025|FG000|Overall Study|Poor risk|2|||
42187186|NCT00064077|75997026|FG001|Overall Study|Poor risk|0|||
42187187|NCT00064077|75997027|FG002|Overall Study|Poor risk|1|||
42187188|NCT00064077|75997028|FG003|Overall Study|Poor risk|1|||
42187189|NCT00064077|75997025|FG000|Overall Study|Pathology|10|||
42187190|NCT00064077|75997026|FG001|Overall Study|Pathology|7|||
42187191|NCT00064077|75997027|FG002|Overall Study|Pathology|3|||
42187192|NCT00064077|75997028|FG003|Overall Study|Pathology|4|||
42187193|NCT00064077|75997025|FG000|Overall Study|No surgery|0|||
42187194|NCT00064077|75997026|FG001|Overall Study|No surgery|0|||
42187195|NCT00064077|75997027|FG002|Overall Study|No surgery|1|||
42187196|NCT00064077|75997028|FG003|Overall Study|No surgery|0|||
42187197|NCT00064077|75997025|FG000|Overall Study|No tumor|0|||
42187198|NCT00064077|75997026|FG001|Overall Study|No tumor|0|||
42187199|NCT00064077|75997027|FG002|Overall Study|No tumor|1|||
42187200|NCT00064077|75997028|FG003|Overall Study|No tumor|0|||
42187201|NCT00064077|75997025|FG000|Overall Study|Other reasons|2|||
42187202|NCT00064077|75997026|FG001|Overall Study|Other reasons|2|||
42187203|NCT00064077|75997027|FG002|Overall Study|Other reasons|1|||
42187204|NCT00064077|75997028|FG003|Overall Study|Other reasons|2|||
42187205|NCT00063999|75997040|FG000|Overall Study|Withdrawal by Subject|1|||
42187206|NCT00063999|75997041|FG001|Overall Study|Withdrawal by Subject|0|||
42187207|NCT00063999|75997040|FG000|Overall Study|Ineligible|44|||
42187208|NCT00063999|75997041|FG001|Overall Study|Ineligible|24|||
42187209|NCT03131440|75997086|FG000|Overall Study|Withdrawal by Subject|1|||
42187210|NCT03131440|75997087|FG001|Overall Study|Withdrawal by Subject|3|||
42187211|NCT03131440|75997088|FG002|Overall Study|Withdrawal by Subject|0|||
42187212|NCT03131440|75997089|FG003|Overall Study|Withdrawal by Subject|0|||
42187213|NCT03131440|75997090|FG004|Overall Study|Withdrawal by Subject|1|||
42187214|NCT03131440|75997091|FG005|Overall Study|Withdrawal by Subject|0|||
42187215|NCT03131440|75997092|FG006|Overall Study|Withdrawal by Subject|0|||
42187216|NCT03131440|75997093|FG007|Overall Study|Withdrawal by Subject|1|||
42187217|NCT03131440|75997094|FG008|Overall Study|Withdrawal by Subject|1|||
42187218|NCT03131440|75997095|FG009|Overall Study|Withdrawal by Subject|1|||
42295806|NCT02456103|76130517|FG000|Overall Study|Physician Decision|1|||
42295807|NCT02456103|76130517|FG000|Overall Study|Required prohibited medications|5|||
42295808|NCT02456103|76130517|FG000|Overall Study|Protocol Violation|1|||
42093535|NCT00667251|75904001|FG000|Overall Study|Adverse Event|13|||
42093536|NCT00667251|75904002|FG001|Overall Study|Adverse Event|4|||
42187219|NCT03131440|75997096|FG010|Overall Study|Withdrawal by Subject|0|||
42295809|NCT02456103|76130517|FG000|Overall Study|Adverse Event|5|||
42187220|NCT03131440|75997097|FG011|Overall Study|Withdrawal by Subject|1|||
42295810|NCT02456103|76130517|FG000|Overall Study|Abnormal Laboratory Value|2|||
42295811|NCT02456103|76130517|FG000|Overall Study|Lost to Follow-up|1|||
42187221|NCT03131440|75997098|FG012|Overall Study|Withdrawal by Subject|1|||
42187222|NCT03131440|75997099|FG013|Overall Study|Withdrawal by Subject|0|||
42187223|NCT03131440|75997100|FG014|Overall Study|Withdrawal by Subject|1|||
42187224|NCT03131440|75997101|FG015|Overall Study|Withdrawal by Subject|0|||
42187225|NCT03131440|75997102|FG016|Overall Study|Withdrawal by Subject|0|||
42187226|NCT03131440|75997103|FG017|Overall Study|Withdrawal by Subject|0|||
42187227|NCT03131440|75997104|FG018|Overall Study|Withdrawal by Subject|1|||
42187228|NCT03131440|75997105|FG019|Overall Study|Withdrawal by Subject|0|||
42187229|NCT03131440|75997106|FG020|Overall Study|Withdrawal by Subject|1|||
42187230|NCT03131440|75997107|FG021|Overall Study|Withdrawal by Subject|1|||
42187231|NCT03131440|75997108|FG022|Overall Study|Withdrawal by Subject|1|||
42187232|NCT03131440|75997109|FG023|Overall Study|Withdrawal by Subject|0|||
42187233|NCT03131440|75997110|FG024|Overall Study|Withdrawal by Subject|0|||
42187234|NCT03131440|75997111|FG025|Overall Study|Withdrawal by Subject|0|||
42187235|NCT03131440|75997112|FG026|Overall Study|Withdrawal by Subject|0|||
42093537|NCT00667251|75904001|FG000|Overall Study|Withdrawal by Subject|6|||
42093538|NCT00667251|75904002|FG001|Overall Study|Withdrawal by Subject|2|||
42093539|NCT00667251|75904001|FG000|Overall Study|Other/missing|46|||
42093540|NCT00667251|75904002|FG001|Overall Study|Other/missing|84|||
42093541|NCT00667251|75904001|FG000|Overall Study|Intercurrent Illness|4|||
42093542|NCT00667251|75904002|FG001|Overall Study|Intercurrent Illness|3|||
42093543|NCT00667251|75904001|FG000|Overall Study|Symptomatic progression|1|||
42093544|NCT00667251|75904002|FG001|Overall Study|Symptomatic progression|2|||
42093545|NCT00669903|75904020|FG000|Overall Study|Adverse Event|0|||
42295812|NCT02456103|76130517|FG000|Overall Study|Withdrawal by Subject|24|||
42295813|NCT01653327|76130521|FG000|Overall Study|Withdrawal by Subject|1|||
42295814|NCT02493855|76130530|FG000|Overall Study|Non-compliance|1|||
42295815|NCT02493855|76130531|FG001|Overall Study|Non-compliance|0|||
42295816|NCT02493855|76130532|FG002|Overall Study|Non-compliance|0|||
42295817|NCT02493855|76130530|FG000|Overall Study|Adverse Event|0|||
42295818|NCT02493855|76130531|FG001|Overall Study|Adverse Event|1|||
42295819|NCT02493855|76130532|FG002|Overall Study|Adverse Event|0|||
42295820|NCT02493855|76130530|FG000|Overall Study|Withdrawal by Subject|1|||
42295821|NCT02493855|76130531|FG001|Overall Study|Withdrawal by Subject|0|||
42295822|NCT02493855|76130532|FG002|Overall Study|Withdrawal by Subject|0|||
42295823|NCT02438787|76130543|FG000|Overall Study|Adverse Event|1|||
42295824|NCT02438787|76130544|FG001|Overall Study|Adverse Event|0|||
42295825|NCT02438787|76130545|FG002|Overall Study|Adverse Event|2|||
42295826|NCT02438787|76130543|FG000|Overall Study|Lack of Efficacy|1|||
42295827|NCT02438787|76130544|FG001|Overall Study|Lack of Efficacy|2|||
42295828|NCT02438787|76130545|FG002|Overall Study|Lack of Efficacy|0|||
42295829|NCT02438787|76130543|FG000|Overall Study|Lost to Follow-up|0|||
42295830|NCT02438787|76130544|FG001|Overall Study|Lost to Follow-up|1|||
42295831|NCT02438787|76130545|FG002|Overall Study|Lost to Follow-up|0|||
42295832|NCT02438787|76130543|FG000|Overall Study|Protocol Violation|0|||
42295833|NCT02438787|76130544|FG001|Overall Study|Protocol Violation|0|||
42295834|NCT02438787|76130545|FG002|Overall Study|Protocol Violation|1|||
42295835|NCT02438787|76130543|FG000|Overall Study|Withdrawal by Subject|15|||
42295836|NCT02438787|76130544|FG001|Overall Study|Withdrawal by Subject|7|||
42295837|NCT02438787|76130545|FG002|Overall Study|Withdrawal by Subject|10|||
42295838|NCT02438787|76130543|FG000|Overall Study|Study discontinued by sponsor|64|||
42295839|NCT02438787|76130544|FG001|Overall Study|Study discontinued by sponsor|72|||
42295840|NCT02438787|76130545|FG002|Overall Study|Study discontinued by sponsor|69|||
42295841|NCT02438787|76130543|FG000|Overall Study|Other|0|||
42295842|NCT02438787|76130544|FG001|Overall Study|Other|1|||
42295843|NCT02438787|76130545|FG002|Overall Study|Other|0|||
42295844|NCT02438787|76130543|FG000|Overall Study|Site terminated by sponsor|0|||
42295845|NCT02438787|76130544|FG001|Overall Study|Site terminated by sponsor|0|||
42295846|NCT02438787|76130545|FG002|Overall Study|Site terminated by sponsor|1|||
42295847|NCT02493777|76130560|FG000|Overall Study|Lost to Follow-up|0|||
42295848|NCT02493777|76130561|FG001|Overall Study|Lost to Follow-up|1|||
42295849|NCT02616601|76130570|FG000|Overall Study|Withdrawal by Subject|4|||
42295850|NCT02616601|76130571|FG001|Overall Study|Withdrawal by Subject|4|||
42295851|NCT02616601|76130572|FG002|Overall Study|Withdrawal by Subject|3|||
42295852|NCT02616601|76130570|FG000|Overall Study|Adverse Event|2|||
42295853|NCT02616601|76130571|FG001|Overall Study|Adverse Event|0|||
42359044|NCT02101385|76204743|FG000|Follow up|PI requested closure of site|0|||
42359045|NCT02101385|76204744|FG001|Follow up|PI requested closure of site|5|||
42359046|NCT02068443|76204759|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
42187236|NCT03131440|75997113|FG027|Overall Study|Withdrawal by Subject|0|||
42187237|NCT03131440|75997114|FG028|Overall Study|Withdrawal by Subject|0|||
42295854|NCT02616601|76130572|FG002|Overall Study|Adverse Event|2|||
42295855|NCT02616601|76130570|FG000|Overall Study|Death|1|||
42295856|NCT02616601|76130571|FG001|Overall Study|Death|0|||
42295857|NCT02616601|76130572|FG002|Overall Study|Death|0|||
42295858|NCT02616601|76130570|FG000|Overall Study|Lost to Follow-up|1|||
42295859|NCT02616601|76130571|FG001|Overall Study|Lost to Follow-up|0|||
42295860|NCT02616601|76130572|FG002|Overall Study|Lost to Follow-up|1|||
42295861|NCT02616601|76130570|FG000|Overall Study|Non-Compliance with Test Article|1|||
42295862|NCT02616601|76130571|FG001|Overall Study|Non-Compliance with Test Article|0|||
42295863|NCT02616601|76130572|FG002|Overall Study|Non-Compliance with Test Article|1|||
42295864|NCT02492997|76130582|FG000|Overall Study|Withdrawal by Subject|1|||
42093546|NCT00669903|75904021|FG001|Overall Study|Adverse Event|1|||
42093547|NCT00669903|75904022|FG002|Overall Study|Adverse Event|3|||
42093548|NCT00669903|75904023|FG003|Overall Study|Adverse Event|1|||
42093549|NCT00669903|75904020|FG000|Overall Study|Withdrawal by Subject|0|||
42093550|NCT00669903|75904021|FG001|Overall Study|Withdrawal by Subject|2|||
42093551|NCT00669903|75904022|FG002|Overall Study|Withdrawal by Subject|2|||
42093552|NCT00669903|75904023|FG003|Overall Study|Withdrawal by Subject|2|||
42093553|NCT00669903|75904020|FG000|Overall Study|Lost to Follow-up|1|||
42093554|NCT00669903|75904021|FG001|Overall Study|Lost to Follow-up|1|||
42093555|NCT00669903|75904022|FG002|Overall Study|Lost to Follow-up|0|||
42093556|NCT00669903|75904023|FG003|Overall Study|Lost to Follow-up|1|||
42093557|NCT00669903|75904020|FG000|Overall Study|Protocol Violation|0|||
42093558|NCT00669903|75904021|FG001|Overall Study|Protocol Violation|1|||
42187238|NCT03131440|75997115|FG029|Overall Study|Withdrawal by Subject|0|||
42187239|NCT03131440|75997116|FG030|Overall Study|Withdrawal by Subject|1|||
42187240|NCT03131440|75997117|FG031|Overall Study|Withdrawal by Subject|0|||
42187241|NCT03131440|75997086|FG000|Overall Study|Lost to Follow-up|0|||
42359047|NCT02068443|76204760|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
42359048|NCT02068443|76204761|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
42359049|NCT02068443|76204759|FG000|Overall Study|Voluntary Withdrawal|4|||
42359050|NCT02068443|76204760|FG001|Overall Study|Voluntary Withdrawal|0|||
42359051|NCT02068443|76204761|FG002|Overall Study|Voluntary Withdrawal|1|||
42359052|NCT02068443|76204759|FG000|Overall Study|Lack of Efficacy|2|||
42359053|NCT02068443|76204760|FG001|Overall Study|Lack of Efficacy|1|||
42359054|NCT02068443|76204761|FG002|Overall Study|Lack of Efficacy|0|||
42359055|NCT02068443|76204759|FG000|Overall Study|Other Reason Not Specified|1|||
42359056|NCT02068443|76204760|FG001|Overall Study|Other Reason Not Specified|0|||
42359057|NCT02068443|76204761|FG002|Overall Study|Other Reason Not Specified|0|||
42359058|NCT02065869|76204769|FG000|Overall Study|Death|7|||
42359059|NCT02065869|76204769|FG000|Overall Study|Disease relapse|16|||
42359060|NCT02065869|76204769|FG000|Overall Study|Lost to Follow-up|4|||
42295865|NCT02492997|76130583|FG001|Overall Study|Withdrawal by Subject|0|||
42295866|NCT02492997|76130582|FG000|Overall Study|Gained Weight|1|||
42295867|NCT02492997|76130583|FG001|Overall Study|Gained Weight|0|||
42295868|NCT02492997|76130582|FG000|Overall Study|Lost to Follow-up|0|||
42295869|NCT02492997|76130583|FG001|Overall Study|Lost to Follow-up|1|||
42295870|NCT02437305|76130591|FG000|Overall Study|Lost to Follow-up|18|||
42295871|NCT02437305|76130592|FG001|Overall Study|Lost to Follow-up|12|||
42295872|NCT02492841|76130601|FG000|Overall Study|Lost to Follow-up|34|||
42295873|NCT02492841|76130602|FG001|Overall Study|Lost to Follow-up|31|||
42295874|NCT02492841|76130603|FG002|Overall Study|Lost to Follow-up|35|||
42295875|NCT02436915|76130616|FG000|Overall Study|Withdrawal by Subject|0|||
42295876|NCT02436915|76130617|FG001|Overall Study|Withdrawal by Subject|1|||
42359061|NCT02065869|76204769|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
42359062|NCT02065869|76204769|FG000|Overall Study|Withdrawal by Subject|1|||
42359063|NCT02018861|76204784|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
42359064|NCT02018861|76204785|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
42359065|NCT02018861|76204786|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
42187242|NCT03131440|75997087|FG001|Overall Study|Lost to Follow-up|0|||
42187243|NCT03131440|75997088|FG002|Overall Study|Lost to Follow-up|0|||
42187244|NCT03131440|75997089|FG003|Overall Study|Lost to Follow-up|0|||
42187245|NCT03131440|75997090|FG004|Overall Study|Lost to Follow-up|0|||
42187246|NCT03131440|75997091|FG005|Overall Study|Lost to Follow-up|1|||
42187247|NCT03131440|75997092|FG006|Overall Study|Lost to Follow-up|0|||
42187248|NCT03131440|75997093|FG007|Overall Study|Lost to Follow-up|0|||
42187249|NCT03131440|75997094|FG008|Overall Study|Lost to Follow-up|0|||
42187250|NCT03131440|75997095|FG009|Overall Study|Lost to Follow-up|0|||
42187251|NCT03131440|75997096|FG010|Overall Study|Lost to Follow-up|0|||
42187252|NCT03131440|75997097|FG011|Overall Study|Lost to Follow-up|0|||
42187253|NCT03131440|75997098|FG012|Overall Study|Lost to Follow-up|0|||
42187254|NCT03131440|75997099|FG013|Overall Study|Lost to Follow-up|0|||
42295877|NCT02492763|76130629|FG000|Overall Study|Withdrawal by Subject|0|||
42295878|NCT02492763|76130630|FG001|Overall Study|Withdrawal by Subject|2|||
42295879|NCT02492763|76130631|FG002|Overall Study|Withdrawal by Subject|1|||
42359066|NCT02018861|76204787|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
42359067|NCT02018861|76204788|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
42359068|NCT02018861|76204789|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
42359069|NCT02018861|76204790|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
42295880|NCT02492763|76130632|FG003|Overall Study|Withdrawal by Subject|0|||
42359070|NCT02018861|76204791|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
42359071|NCT02018861|76204792|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
42093559|NCT00669903|75904022|FG002|Overall Study|Protocol Violation|0|||
42093560|NCT00669903|75904023|FG003|Overall Study|Protocol Violation|0|||
42187255|NCT03131440|75997100|FG014|Overall Study|Lost to Follow-up|0|||
42187256|NCT03131440|75997101|FG015|Overall Study|Lost to Follow-up|0|||
42187257|NCT03131440|75997102|FG016|Overall Study|Lost to Follow-up|0|||
42187258|NCT03131440|75997103|FG017|Overall Study|Lost to Follow-up|0|||
42187259|NCT03131440|75997104|FG018|Overall Study|Lost to Follow-up|0|||
42187260|NCT03131440|75997105|FG019|Overall Study|Lost to Follow-up|2|||
42359072|NCT02018861|76204793|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
42359073|NCT02018861|76204784|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
42359074|NCT02018861|76204785|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
42187261|NCT03131440|75997106|FG020|Overall Study|Lost to Follow-up|1|||
42187262|NCT03131440|75997107|FG021|Overall Study|Lost to Follow-up|0|||
42187263|NCT03131440|75997108|FG022|Overall Study|Lost to Follow-up|1|||
42187264|NCT03131440|75997109|FG023|Overall Study|Lost to Follow-up|0|||
42187265|NCT03131440|75997110|FG024|Overall Study|Lost to Follow-up|1|||
42187266|NCT03131440|75997111|FG025|Overall Study|Lost to Follow-up|0|||
42295881|NCT02492763|76130629|FG000|Overall Study|Adverse Event|3|||
42295882|NCT02492763|76130630|FG001|Overall Study|Adverse Event|1|||
42295883|NCT02492763|76130631|FG002|Overall Study|Adverse Event|1|||
42295884|NCT02492763|76130632|FG003|Overall Study|Adverse Event|2|||
42295885|NCT02492763|76130629|FG000|Overall Study|Death|0|||
42295886|NCT02492763|76130630|FG001|Overall Study|Death|0|||
42295887|NCT02492763|76130631|FG002|Overall Study|Death|1|||
42295888|NCT02492763|76130632|FG003|Overall Study|Death|0|||
42295889|NCT02492763|76130629|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
42295890|NCT02492763|76130630|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
42295891|NCT02492763|76130631|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
42295892|NCT02492763|76130632|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
42295893|NCT02492763|76130629|FG000|Overall Study|Lost to Follow-up|0|||
42295894|NCT02492763|76130630|FG001|Overall Study|Lost to Follow-up|0|||
42295895|NCT02492763|76130631|FG002|Overall Study|Lost to Follow-up|1|||
42295896|NCT02492763|76130632|FG003|Overall Study|Lost to Follow-up|0|||
42295897|NCT02492763|76130629|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42295898|NCT02492763|76130630|FG001|Overall Study|Non-Compliance With Study Drug|1|||
42359075|NCT02018861|76204786|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
42359076|NCT02018861|76204787|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
42359077|NCT02018861|76204788|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
42359078|NCT02018861|76204789|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
42359079|NCT02018861|76204790|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
42359080|NCT02018861|76204791|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
42359081|NCT02018861|76204792|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
42359082|NCT02018861|76204793|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
42359083|NCT02018861|76204784|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
42359084|NCT02018861|76204785|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
42093561|NCT03759392|75904035|FG000|Overall Study|Adverse Event|12|||
42093562|NCT03759392|75904036|FG001|Overall Study|Adverse Event|4|||
42093563|NCT03759392|75904035|FG000|Overall Study|Death|2|||
42093564|NCT03759392|75904036|FG001|Overall Study|Death|1|||
42093565|NCT03759392|75904035|FG000|Overall Study|Withdrawal by Subject|2|||
42093566|NCT03759392|75904036|FG001|Overall Study|Withdrawal by Subject|0|||
42093567|NCT03759392|75904035|FG000|Overall Study|Protocol Violation|2|||
42093568|NCT03759392|75904036|FG001|Overall Study|Protocol Violation|0|||
42093569|NCT03759392|75904035|FG000|Overall Study|Physician Decision|0|||
42093570|NCT03759392|75904036|FG001|Overall Study|Physician Decision|1|||
42093571|NCT03759392|75904035|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
42187267|NCT03131440|75997112|FG026|Overall Study|Lost to Follow-up|0|||
42187268|NCT03131440|75997113|FG027|Overall Study|Lost to Follow-up|2|||
42187269|NCT03131440|75997114|FG028|Overall Study|Lost to Follow-up|0|||
42187270|NCT03131440|75997115|FG029|Overall Study|Lost to Follow-up|2|||
42187271|NCT03131440|75997116|FG030|Overall Study|Lost to Follow-up|0|||
42187272|NCT03131440|75997117|FG031|Overall Study|Lost to Follow-up|0|||
42187273|NCT03131440|75997086|FG000|Overall Study|Death|0|||
42187274|NCT03131440|75997087|FG001|Overall Study|Death|0|||
42187275|NCT03131440|75997088|FG002|Overall Study|Death|0|||
42187276|NCT03131440|75997089|FG003|Overall Study|Death|0|||
42187277|NCT03131440|75997090|FG004|Overall Study|Death|0|||
42187278|NCT03131440|75997091|FG005|Overall Study|Death|0|||
42187279|NCT03131440|75997092|FG006|Overall Study|Death|0|||
42187280|NCT03131440|75997093|FG007|Overall Study|Death|0|||
42187281|NCT03131440|75997094|FG008|Overall Study|Death|0|||
42187282|NCT03131440|75997095|FG009|Overall Study|Death|0|||
42295899|NCT02492763|76130631|FG002|Overall Study|Non-Compliance With Study Drug|0|||
42295900|NCT02492763|76130632|FG003|Overall Study|Non-Compliance With Study Drug|0|||
42295901|NCT02492763|76130629|FG000|Overall Study|Screen Failure|0|||
42295902|NCT02492763|76130630|FG001|Overall Study|Screen Failure|0|||
42187283|NCT03131440|75997096|FG010|Overall Study|Death|0|||
42187284|NCT03131440|75997097|FG011|Overall Study|Death|0|||
42187285|NCT03131440|75997098|FG012|Overall Study|Death|0|||
42187286|NCT03131440|75997099|FG013|Overall Study|Death|0|||
42187287|NCT03131440|75997100|FG014|Overall Study|Death|0|||
42187288|NCT03131440|75997101|FG015|Overall Study|Death|0|||
42295903|NCT02492763|76130631|FG002|Overall Study|Screen Failure|0|||
42295904|NCT02492763|76130632|FG003|Overall Study|Screen Failure|1|||
42187289|NCT03131440|75997102|FG016|Overall Study|Death|0|||
42187290|NCT03131440|75997103|FG017|Overall Study|Death|0|||
42187291|NCT03131440|75997104|FG018|Overall Study|Death|0|||
42187292|NCT03131440|75997105|FG019|Overall Study|Death|0|||
42187293|NCT03131440|75997106|FG020|Overall Study|Death|0|||
42187294|NCT03131440|75997107|FG021|Overall Study|Death|0|||
42187295|NCT03131440|75997108|FG022|Overall Study|Death|0|||
42187296|NCT03131440|75997109|FG023|Overall Study|Death|0|||
42187297|NCT03131440|75997110|FG024|Overall Study|Death|0|||
42187298|NCT03131440|75997111|FG025|Overall Study|Death|1|||
42187299|NCT03131440|75997112|FG026|Overall Study|Death|0|||
42187300|NCT03131440|75997113|FG027|Overall Study|Death|0|||
42187301|NCT03131440|75997114|FG028|Overall Study|Death|0|||
42187302|NCT03131440|75997115|FG029|Overall Study|Death|0|||
42093572|NCT03759392|75904036|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
42093573|NCT03759392|75904035|FG000|Overall Study|No longer able to take medicines|1|||
42093574|NCT03759392|75904036|FG001|Overall Study|No longer able to take medicines|0|||
42093575|NCT03759392|75904035|FG000|Overall Study|Stopped taking study drug|1|||
42093576|NCT03759392|75904036|FG001|Overall Study|Stopped taking study drug|0|||
42093577|NCT00667719|75904042|FG000|Overall Study|Adverse Event|39|||
42187303|NCT03131440|75997116|FG030|Overall Study|Death|0|||
42187304|NCT03131440|75997117|FG031|Overall Study|Death|0|||
42187305|NCT02915302|75997162|FG000|Overall Study|Adverse Event|3|||
42187306|NCT02915302|75997163|FG001|Overall Study|Adverse Event|0|||
42187307|NCT02915302|75997162|FG000|Overall Study|Protocol Violation|20|||
42187308|NCT02915302|75997163|FG001|Overall Study|Protocol Violation|27|||
42187309|NCT02915302|75997162|FG000|Overall Study|Lost to Follow-up|19|||
42187310|NCT02915302|75997163|FG001|Overall Study|Lost to Follow-up|22|||
42187311|NCT02915302|75997162|FG000|Overall Study|Withdrawal by Subject|22|||
42187312|NCT02915302|75997163|FG001|Overall Study|Withdrawal by Subject|29|||
42187313|NCT02915302|75997162|FG000|Overall Study|Other|1|||
42187314|NCT02915302|75997163|FG001|Overall Study|Other|0|||
42187315|NCT03023878|75997169|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
42093578|NCT00667719|75904042|FG000|Overall Study|Abnormal Test Procedure|1|||
42187316|NCT03023878|75997169|FG000|Pre-Study Run-In Period|Death|1|||
42187317|NCT03023878|75997169|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
42187318|NCT03023878|75997169|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
42187319|NCT03023878|75997169|FG000|Treatment Period|Disease Progression|1|||
42187320|NCT03023878|75997169|FG000|Treatment Period|Withdrawal by Subject|1|||
42187321|NCT03023878|75997169|FG000|Treatment Period|Adverse Event|1|||
42187322|NCT03023878|75997169|FG000|Long Term Follow-Up Period|Death|2|||
42187323|NCT03022630|75997175|FG000|Overall Study|Death|9|||
42187324|NCT03022630|75997176|FG001|Overall Study|Death|7|||
42187325|NCT03022630|75997175|FG000|Overall Study|Withdrawal by Subject|0|||
42187326|NCT03022630|75997176|FG001|Overall Study|Withdrawal by Subject|5|||
42187327|NCT03023722|75997187|FG000|Overall Study|No follow-up assessment|4|||
42187328|NCT03022084|75997193|FG000|Overall Study|Lost to Follow-up|2|||
42187329|NCT03022084|75997194|FG001|Overall Study|Lost to Follow-up|3|||
42187330|NCT03021304|75997200|FG000|Overall Study|Lack of Efficacy|1|||
42187331|NCT03496298|75997211|FG000|Overall Study|Adverse Event|49|||
42187332|NCT03496298|75997212|FG001|Overall Study|Adverse Event|68|||
42187333|NCT03496298|75997213|FG002|Overall Study|Adverse Event|79|||
42187334|NCT03496298|75997211|FG000|Overall Study|Study terminated by Sponsor|1050|||
42359085|NCT02018861|76204786|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
42359086|NCT02018861|76204787|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
42093579|NCT00667719|75904042|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
42093580|NCT00667719|75904042|FG000|Overall Study|Protocol Violation|3|||
42093581|NCT00667719|75904042|FG000|Overall Study|Withdrawal by Subject|17|||
42093582|NCT00667719|75904042|FG000|Overall Study|Lost to Follow-up|8|||
42093583|NCT00669669|75904051|FG000|Overall Study|To late to start treatment|1|||
42093584|NCT00467779|75904070|FG000|Stage 1|Adverse Event|1|||
42093585|NCT00467779|75904071|FG001|Stage 1|Adverse Event|0|||
42093586|NCT00467779|75904072|FG002|Stage 1|Adverse Event|0|||
42093587|NCT00467779|75904073|FG003|Stage 1|Adverse Event|0|||
42187335|NCT03496298|75997212|FG001|Overall Study|Study terminated by Sponsor|1063|||
42187336|NCT03496298|75997213|FG002|Overall Study|Study terminated by Sponsor|1071|||
42187337|NCT03496298|75997211|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
42187338|NCT03496298|75997212|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
42187339|NCT03496298|75997213|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
42187340|NCT03496298|75997211|FG000|Overall Study|Withdrawal by Subject|176|||
42187341|NCT03496298|75997212|FG001|Overall Study|Withdrawal by Subject|154|||
42187342|NCT03496298|75997213|FG002|Overall Study|Withdrawal by Subject|151|||
42187343|NCT03496298|75997211|FG000|Overall Study|Other|29|||
42187344|NCT03496298|75997212|FG001|Overall Study|Other|20|||
42187345|NCT03496298|75997213|FG002|Overall Study|Other|23|||
42187346|NCT03496298|75997211|FG000|Overall Study|Randomized and not treated|1|||
42187347|NCT03496298|75997212|FG001|Overall Study|Randomized and not treated|1|||
42187348|NCT03496298|75997213|FG002|Overall Study|Randomized and not treated|1|||
42187349|NCT02914522|75997226|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
42187350|NCT02914522|75997227|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
42187351|NCT02914522|75997228|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
42187352|NCT02914522|75997229|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
42187353|NCT02914522|75997230|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
42187354|NCT02914522|75997231|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
42187355|NCT02914522|75997232|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
42187356|NCT02914522|75997233|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
42187357|NCT02914522|75997234|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
42187358|NCT02914522|75997235|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
42295905|NCT02492763|76130629|FG000|Overall Study|Study Terminated by Sponsor|13|||
42295906|NCT02492763|76130630|FG001|Overall Study|Study Terminated by Sponsor|10|||
42295907|NCT02492763|76130631|FG002|Overall Study|Study Terminated by Sponsor|6|||
42295908|NCT02492763|76130632|FG003|Overall Study|Study Terminated by Sponsor|10|||
42295909|NCT02491671|76130644|FG000|Overall Study|Adverse Event|6|||
42093588|NCT00467779|75904074|FG004|Stage 1|Adverse Event|0|||
42093589|NCT00467779|75904075|FG005|Stage 1|Adverse Event|1|||
42093590|NCT00467779|75904076|FG006|Stage 1|Adverse Event|2|||
42093591|NCT00467779|75904077|FG007|Stage 1|Adverse Event|1|||
42093592|NCT00467779|75904078|FG008|Stage 1|Adverse Event|0|||
42093593|NCT00467779|75904079|FG009|Stage 1|Adverse Event|0|||
42093594|NCT00467779|75904080|FG010|Stage 1|Adverse Event|0|||
42093595|NCT00467779|75904081|FG011|Stage 1|Adverse Event|0|||
42093596|NCT00467779|75904082|FG012|Stage 1|Adverse Event|0|||
42093597|NCT00467779|75904083|FG013|Stage 1|Adverse Event|0|||
42093598|NCT00467779|75904084|FG014|Stage 1|Adverse Event|0|||
42093599|NCT00467779|75904070|FG000|Stage 1|Disease Progression|2|||
42093600|NCT00467779|75904071|FG001|Stage 1|Disease Progression|2|||
42093601|NCT00467779|75904072|FG002|Stage 1|Disease Progression|2|||
42093602|NCT00467779|75904073|FG003|Stage 1|Disease Progression|3|||
42093603|NCT00467779|75904074|FG004|Stage 1|Disease Progression|2|||
42093604|NCT00467779|75904075|FG005|Stage 1|Disease Progression|2|||
42093605|NCT00467779|75904076|FG006|Stage 1|Disease Progression|4|||
42093606|NCT00467779|75904077|FG007|Stage 1|Disease Progression|5|||
42093607|NCT00467779|75904078|FG008|Stage 1|Disease Progression|0|||
42093608|NCT00467779|75904079|FG009|Stage 1|Disease Progression|0|||
42093609|NCT00467779|75904080|FG010|Stage 1|Disease Progression|0|||
42093610|NCT00467779|75904081|FG011|Stage 1|Disease Progression|0|||
42093611|NCT00467779|75904082|FG012|Stage 1|Disease Progression|0|||
42093612|NCT00467779|75904083|FG013|Stage 1|Disease Progression|0|||
42093613|NCT00467779|75904084|FG014|Stage 1|Disease Progression|0|||
42093614|NCT00467779|75904070|FG000|Stage 1|Unspecified Reason|1|||
42093615|NCT00467779|75904071|FG001|Stage 1|Unspecified Reason|0|||
42093616|NCT00467779|75904072|FG002|Stage 1|Unspecified Reason|1|||
42093617|NCT00467779|75904073|FG003|Stage 1|Unspecified Reason|0|||
42093618|NCT00467779|75904074|FG004|Stage 1|Unspecified Reason|1|||
42093619|NCT00467779|75904075|FG005|Stage 1|Unspecified Reason|2|||
42093620|NCT00467779|75904076|FG006|Stage 1|Unspecified Reason|0|||
42093621|NCT00467779|75904077|FG007|Stage 1|Unspecified Reason|0|||
42093622|NCT00467779|75904078|FG008|Stage 1|Unspecified Reason|0|||
42093623|NCT00467779|75904079|FG009|Stage 1|Unspecified Reason|0|||
42093624|NCT00467779|75904080|FG010|Stage 1|Unspecified Reason|0|||
42093625|NCT00467779|75904081|FG011|Stage 1|Unspecified Reason|0|||
42093626|NCT00467779|75904082|FG012|Stage 1|Unspecified Reason|0|||
42093627|NCT00467779|75904083|FG013|Stage 1|Unspecified Reason|0|||
42093628|NCT00467779|75904084|FG014|Stage 1|Unspecified Reason|0|||
42093629|NCT00467779|75904070|FG000|Stage 1|Physician Decision|0|||
42093630|NCT00467779|75904071|FG001|Stage 1|Physician Decision|1|||
42093631|NCT00467779|75904072|FG002|Stage 1|Physician Decision|0|||
42295910|NCT02491671|76130645|FG001|Overall Study|Adverse Event|8|||
42093632|NCT00467779|75904073|FG003|Stage 1|Physician Decision|0|||
42093633|NCT00467779|75904074|FG004|Stage 1|Physician Decision|0|||
42093634|NCT00467779|75904075|FG005|Stage 1|Physician Decision|0|||
42093635|NCT00467779|75904076|FG006|Stage 1|Physician Decision|0|||
42093636|NCT00467779|75904077|FG007|Stage 1|Physician Decision|0|||
42093637|NCT00467779|75904078|FG008|Stage 1|Physician Decision|0|||
42093638|NCT00467779|75904079|FG009|Stage 1|Physician Decision|0|||
42093639|NCT00467779|75904080|FG010|Stage 1|Physician Decision|0|||
42093640|NCT00467779|75904081|FG011|Stage 1|Physician Decision|0|||
42093641|NCT00467779|75904082|FG012|Stage 1|Physician Decision|0|||
42093642|NCT00467779|75904083|FG013|Stage 1|Physician Decision|0|||
42093643|NCT00467779|75904084|FG014|Stage 1|Physician Decision|0|||
42093644|NCT00467779|75904070|FG000|Stage 1|Withdrawal by Subject|0|||
42093645|NCT00467779|75904071|FG001|Stage 1|Withdrawal by Subject|0|||
42093646|NCT00467779|75904072|FG002|Stage 1|Withdrawal by Subject|0|||
42093647|NCT00467779|75904073|FG003|Stage 1|Withdrawal by Subject|0|||
42093648|NCT00467779|75904074|FG004|Stage 1|Withdrawal by Subject|0|||
42093649|NCT00467779|75904075|FG005|Stage 1|Withdrawal by Subject|0|||
42187359|NCT02914522|75997236|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
42187360|NCT02914522|75997226|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
42187361|NCT02914522|75997227|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
42187362|NCT02914522|75997228|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
42187363|NCT02914522|75997229|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
42187364|NCT02914522|75997230|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
42187365|NCT02914522|75997231|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
42187366|NCT02914522|75997232|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
42187367|NCT02914522|75997233|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
42187368|NCT02914522|75997234|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
42187369|NCT02914522|75997235|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
42187370|NCT02914522|75997236|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
42187371|NCT02914522|75997226|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
42187372|NCT02914522|75997227|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
42187373|NCT02914522|75997228|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
42187374|NCT02914522|75997229|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
42187375|NCT02914522|75997230|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
42187376|NCT02914522|75997231|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
42187377|NCT02914522|75997232|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
42187378|NCT02914522|75997233|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
42187379|NCT02914522|75997234|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
42187380|NCT02914522|75997235|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
42295911|NCT02491671|76130644|FG000|Overall Study|Death|0|||
42295912|NCT02491671|76130645|FG001|Overall Study|Death|2|||
42295913|NCT02491671|76130644|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
42295914|NCT02491671|76130645|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
42295915|NCT02453841|76130651|FG000|Overall Study|Protocol Violation|1|||
42295916|NCT02453841|76130651|FG000|Overall Study|Unable to obtain blood samples|2|||
42295917|NCT02453685|76130657|FG000|Overall Study|Adverse Event|0|||
42295918|NCT02453685|76130658|FG001|Overall Study|Adverse Event|1|||
42295919|NCT02453685|76130657|FG000|Overall Study|Protocol Violation|7|||
42295920|NCT02453685|76130658|FG001|Overall Study|Protocol Violation|4|||
42295921|NCT02453685|76130657|FG000|Overall Study|Lost to Follow-up|0|||
42295922|NCT02453685|76130658|FG001|Overall Study|Lost to Follow-up|1|||
42295923|NCT02453685|76130657|FG000|Overall Study|Withdrawal by Subject|8|||
42295924|NCT02453685|76130658|FG001|Overall Study|Withdrawal by Subject|4|||
42295925|NCT02453685|76130657|FG000|Overall Study|Unclassified|4|||
42295926|NCT02453685|76130658|FG001|Overall Study|Unclassified|2|||
42295927|NCT02436759|76130666|FG000|Overall Study|Adverse Event|3|||
42295928|NCT02436759|76130667|FG001|Overall Study|Adverse Event|0|||
42295929|NCT02436759|76130666|FG000|Overall Study|Protocol Violation|1|||
42295930|NCT02436759|76130667|FG001|Overall Study|Protocol Violation|0|||
42295931|NCT02436759|76130666|FG000|Overall Study|Withdrawal by Subject|0|||
42295932|NCT02436759|76130667|FG001|Overall Study|Withdrawal by Subject|1|||
42295933|NCT02436681|76130673|FG000|Overall Study|Lost to Follow-up|10|||
42295934|NCT02436681|76130673|FG000|Overall Study|Withdrawal by Subject|2|||
42295935|NCT02436681|76130673|FG000|Overall Study|Death|2|||
42295936|NCT02436135|76130679|FG000|Overall Study|Progressive Disease|3|||
42295937|NCT02436135|76130680|FG001|Overall Study|Progressive Disease|1|||
42295938|NCT02436135|76130679|FG000|Overall Study|Investigator Discretion|1|||
42295939|NCT02436135|76130680|FG001|Overall Study|Investigator Discretion|2|||
42093650|NCT00467779|75904076|FG006|Stage 1|Withdrawal by Subject|1|||
42093651|NCT00467779|75904077|FG007|Stage 1|Withdrawal by Subject|1|||
42187381|NCT02914522|75997236|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
42187382|NCT02914522|75997226|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
42295940|NCT02436135|76130679|FG000|Overall Study|Adverse Event|1|||
42295941|NCT02436135|76130680|FG001|Overall Study|Adverse Event|0|||
42295942|NCT02436135|76130679|FG000|Overall Study|Withdrawal by Participant|1|||
42295943|NCT02436135|76130680|FG001|Overall Study|Withdrawal by Participant|0|||
42093652|NCT00467779|75904078|FG008|Stage 1|Withdrawal by Subject|0|||
42093653|NCT00467779|75904079|FG009|Stage 1|Withdrawal by Subject|0|||
42187383|NCT02914522|75997227|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
42187384|NCT02914522|75997228|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
42187385|NCT02914522|75997229|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
42295944|NCT02436135|76130679|FG000|Overall Study|Study Terminated By Sponsor|0|||
42295945|NCT02436135|76130680|FG001|Overall Study|Study Terminated By Sponsor|1|||
42295946|NCT02489799|76130688|FG000|Overall Study|Lost to Follow-up|4|||
42187386|NCT02914522|75997230|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
42187387|NCT02914522|75997231|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
42187388|NCT02914522|75997232|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
42187389|NCT02914522|75997233|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
42187390|NCT02914522|75997234|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
42187391|NCT02914522|75997235|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
42187392|NCT02914522|75997236|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
42187393|NCT02914522|75997226|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
42187394|NCT02914522|75997227|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
42187395|NCT02914522|75997228|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
42187396|NCT02914522|75997229|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
42187397|NCT02914522|75997230|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
42187398|NCT02914522|75997231|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
42187399|NCT02914522|75997232|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
42187400|NCT02914522|75997233|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
42187401|NCT02914522|75997234|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
42187402|NCT02914522|75997235|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
42187403|NCT02914522|75997236|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
42187404|NCT02914522|75997226|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
42187405|NCT02914522|75997227|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
42187406|NCT02914522|75997228|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
42187407|NCT02914522|75997229|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
42187408|NCT02914522|75997230|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
42187409|NCT02914522|75997231|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
42187410|NCT02914522|75997232|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
42187411|NCT02914522|75997233|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
42187412|NCT02914522|75997234|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
42187413|NCT02914522|75997235|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
42187414|NCT02914522|75997236|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
42187415|NCT02914522|75997226|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
42187416|NCT02914522|75997227|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
42187417|NCT02914522|75997228|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
42187418|NCT02914522|75997229|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
42187419|NCT02914522|75997230|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
42187420|NCT02914522|75997231|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
42187421|NCT02914522|75997232|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
42187422|NCT02914522|75997233|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
42187423|NCT02914522|75997234|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
42187424|NCT02914522|75997235|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
42187425|NCT02914522|75997236|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
42187426|NCT02914522|75997226|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
42187427|NCT02914522|75997227|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
42187428|NCT02914522|75997228|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
42187429|NCT02914522|75997229|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
42187430|NCT02914522|75997230|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
42187431|NCT02914522|75997231|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
42187432|NCT02914522|75997232|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
42093654|NCT00467779|75904080|FG010|Stage 1|Withdrawal by Subject|0|||
42093655|NCT00467779|75904081|FG011|Stage 1|Withdrawal by Subject|0|||
42093656|NCT00467779|75904082|FG012|Stage 1|Withdrawal by Subject|0|||
42093657|NCT00467779|75904083|FG013|Stage 1|Withdrawal by Subject|0|||
42093658|NCT00467779|75904084|FG014|Stage 1|Withdrawal by Subject|0|||
42093659|NCT00467779|75904070|FG000|Stage 1A|Adverse Event|0|||
42093660|NCT00467779|75904071|FG001|Stage 1A|Adverse Event|0|||
42093661|NCT00467779|75904072|FG002|Stage 1A|Adverse Event|0|||
42093662|NCT00467779|75904073|FG003|Stage 1A|Adverse Event|0|||
42093663|NCT00467779|75904074|FG004|Stage 1A|Adverse Event|0|||
42093664|NCT00467779|75904075|FG005|Stage 1A|Adverse Event|0|||
42093665|NCT00467779|75904076|FG006|Stage 1A|Adverse Event|0|||
42093666|NCT00467779|75904077|FG007|Stage 1A|Adverse Event|0|||
42093667|NCT00467779|75904078|FG008|Stage 1A|Adverse Event|0|||
42093668|NCT00467779|75904079|FG009|Stage 1A|Adverse Event|0|||
42093669|NCT00467779|75904080|FG010|Stage 1A|Adverse Event|0|||
42187433|NCT02914522|75997233|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
42295947|NCT02489799|76130689|FG001|Overall Study|Lost to Follow-up|1|||
42295948|NCT02489799|76130688|FG000|Overall Study|Failure to Maintain Eligibility|4|||
42093670|NCT00467779|75904081|FG011|Stage 1A|Adverse Event|0|||
42093671|NCT00467779|75904082|FG012|Stage 1A|Adverse Event|1|||
42093672|NCT00467779|75904083|FG013|Stage 1A|Adverse Event|0|||
42187434|NCT02914522|75997234|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
42187435|NCT02914522|75997235|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
42187436|NCT02914522|75997236|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
42187437|NCT02914522|75997226|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
42187438|NCT02914522|75997227|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
42187439|NCT02914522|75997228|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
42187440|NCT02914522|75997229|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
42187441|NCT02914522|75997230|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
42187442|NCT02914522|75997231|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
42187443|NCT02914522|75997232|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
42187444|NCT02914522|75997233|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
42187445|NCT02914522|75997234|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
42187446|NCT02914522|75997235|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
42187447|NCT02914522|75997236|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
42187448|NCT02914522|75997226|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
42187449|NCT02914522|75997227|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
42187450|NCT02914522|75997228|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
42187451|NCT02914522|75997229|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
42187452|NCT02914522|75997230|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
42187453|NCT02914522|75997231|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
42187454|NCT02914522|75997232|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
42187455|NCT02914522|75997233|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
42187456|NCT02914522|75997234|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
42187457|NCT02914522|75997235|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
42187458|NCT02914522|75997236|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
42187459|NCT02914522|75997226|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
42359087|NCT02018861|76204788|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
42359088|NCT02018861|76204789|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
42359089|NCT02018861|76204790|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
42093673|NCT00467779|75904084|FG014|Stage 1A|Adverse Event|0|||
42093674|NCT00467779|75904070|FG000|Stage 1A|Death|0|||
42093675|NCT00467779|75904071|FG001|Stage 1A|Death|0|||
42093676|NCT00467779|75904072|FG002|Stage 1A|Death|0|||
42093677|NCT00467779|75904073|FG003|Stage 1A|Death|0|||
42093678|NCT00467779|75904074|FG004|Stage 1A|Death|0|||
42093679|NCT00467779|75904075|FG005|Stage 1A|Death|0|||
42093680|NCT00467779|75904076|FG006|Stage 1A|Death|0|||
42093681|NCT00467779|75904077|FG007|Stage 1A|Death|0|||
42093682|NCT00467779|75904078|FG008|Stage 1A|Death|0|||
42093683|NCT00467779|75904079|FG009|Stage 1A|Death|0|||
42093684|NCT00467779|75904080|FG010|Stage 1A|Death|0|||
42093685|NCT00467779|75904081|FG011|Stage 1A|Death|1|||
42093686|NCT00467779|75904082|FG012|Stage 1A|Death|1|||
42093687|NCT00467779|75904083|FG013|Stage 1A|Death|0|||
42093688|NCT00467779|75904084|FG014|Stage 1A|Death|0|||
42093689|NCT00467779|75904070|FG000|Stage 1A|Disease Progression|0|||
42093690|NCT00467779|75904071|FG001|Stage 1A|Disease Progression|0|||
42093691|NCT00467779|75904072|FG002|Stage 1A|Disease Progression|0|||
42093692|NCT00467779|75904073|FG003|Stage 1A|Disease Progression|0|||
42093693|NCT00467779|75904074|FG004|Stage 1A|Disease Progression|0|||
42093694|NCT00467779|75904075|FG005|Stage 1A|Disease Progression|0|||
42093695|NCT00467779|75904076|FG006|Stage 1A|Disease Progression|0|||
42093696|NCT00467779|75904077|FG007|Stage 1A|Disease Progression|0|||
42093697|NCT00467779|75904078|FG008|Stage 1A|Disease Progression|0|||
42359090|NCT02018861|76204791|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
42359091|NCT02018861|76204792|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
42359092|NCT02018861|76204793|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
42359093|NCT02018861|76204784|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
42359094|NCT02018861|76204785|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
42359095|NCT02018861|76204786|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
42359096|NCT02018861|76204787|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
42359097|NCT02018861|76204788|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
42093698|NCT00467779|75904079|FG009|Stage 1A|Disease Progression|2|||
42093699|NCT00467779|75904080|FG010|Stage 1A|Disease Progression|2|||
42093700|NCT00467779|75904081|FG011|Stage 1A|Disease Progression|5|||
42093701|NCT00467779|75904082|FG012|Stage 1A|Disease Progression|2|||
42093702|NCT00467779|75904083|FG013|Stage 1A|Disease Progression|0|||
42093703|NCT00467779|75904084|FG014|Stage 1A|Disease Progression|0|||
42093704|NCT00467779|75904070|FG000|Stage 1A|Physician Decision|0|||
42093705|NCT00467779|75904071|FG001|Stage 1A|Physician Decision|0|||
42093706|NCT00467779|75904072|FG002|Stage 1A|Physician Decision|0|||
42093707|NCT00467779|75904073|FG003|Stage 1A|Physician Decision|0|||
42093708|NCT00467779|75904074|FG004|Stage 1A|Physician Decision|0|||
42093709|NCT00467779|75904075|FG005|Stage 1A|Physician Decision|0|||
42093710|NCT00467779|75904076|FG006|Stage 1A|Physician Decision|0|||
42093711|NCT00467779|75904077|FG007|Stage 1A|Physician Decision|0|||
42093712|NCT00467779|75904078|FG008|Stage 1A|Physician Decision|0|||
42093713|NCT00467779|75904079|FG009|Stage 1A|Physician Decision|1|||
42093714|NCT00467779|75904080|FG010|Stage 1A|Physician Decision|0|||
42093715|NCT00467779|75904081|FG011|Stage 1A|Physician Decision|0|||
42187460|NCT02914522|75997227|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
42187461|NCT02914522|75997228|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
42187462|NCT02914522|75997229|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
42187463|NCT02914522|75997230|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
42187464|NCT02914522|75997231|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
42187465|NCT02914522|75997232|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
42187466|NCT02914522|75997233|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
42187467|NCT02914522|75997234|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
42187468|NCT02914522|75997235|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
42187469|NCT02914522|75997236|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
42187470|NCT02914522|75997226|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
42187471|NCT02914522|75997227|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
42187472|NCT02914522|75997228|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
42187473|NCT02914522|75997229|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
42187474|NCT02914522|75997230|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
42187475|NCT02914522|75997231|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
42187476|NCT02914522|75997232|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
42187477|NCT02914522|75997233|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
42187478|NCT02914522|75997234|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
42187479|NCT02914522|75997235|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
42187480|NCT02914522|75997236|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
42187481|NCT02914522|75997226|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
42187482|NCT02914522|75997227|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
42187483|NCT02914522|75997228|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
42187484|NCT02914522|75997229|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
42187485|NCT02914522|75997230|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
42187486|NCT02914522|75997231|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
42187487|NCT02914522|75997232|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
42187488|NCT02914522|75997233|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
42187489|NCT02914522|75997234|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
42187490|NCT02914522|75997235|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
42187491|NCT02914522|75997236|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
42187492|NCT02914522|75997226|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
42187493|NCT02914522|75997227|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
42187494|NCT02914522|75997228|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
42187495|NCT02914522|75997229|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
42187496|NCT02914522|75997230|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
42187497|NCT02914522|75997231|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
42187498|NCT02914522|75997232|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
42295949|NCT02489799|76130689|FG001|Overall Study|Failure to Maintain Eligibility|6|||
42295950|NCT02489799|76130688|FG000|Overall Study|Withdrawal by Subject|1|||
42295951|NCT02489799|76130689|FG001|Overall Study|Withdrawal by Subject|1|||
42093716|NCT00467779|75904082|FG012|Stage 1A|Physician Decision|0|||
42093717|NCT00467779|75904083|FG013|Stage 1A|Physician Decision|0|||
42295952|NCT02489799|76130688|FG000|Overall Study|Death|0|||
42295953|NCT02489799|76130689|FG001|Overall Study|Death|1|||
42295954|NCT02435277|76130699|FG000|Overall Study|Adverse Event|1|||
42295955|NCT02435277|76130700|FG001|Overall Study|Adverse Event|1|||
42295956|NCT02435277|76130701|FG002|Overall Study|Adverse Event|0|||
42295957|NCT02435277|76130702|FG003|Overall Study|Adverse Event|0|||
42295958|NCT02435277|76130699|FG000|Overall Study|Withdrawal by Subject|1|||
42295959|NCT02435277|76130700|FG001|Overall Study|Withdrawal by Subject|0|||
42295960|NCT02435277|76130701|FG002|Overall Study|Withdrawal by Subject|0|||
42295961|NCT02435277|76130702|FG003|Overall Study|Withdrawal by Subject|0|||
42295962|NCT02420223|76130714|FG000|Overall Study|Adverse Event|1|||
42093718|NCT00467779|75904084|FG014|Stage 1A|Physician Decision|0|||
42295963|NCT02420223|76130715|FG001|Overall Study|Adverse Event|0|||
42295964|NCT02420223|76130714|FG000|Overall Study|Physician Decision|0|||
42295965|NCT02420223|76130715|FG001|Overall Study|Physician Decision|2|||
42295966|NCT02433483|76130721|FG000|Overall Study|Unacceptable toxicity|1|||
42093719|NCT00467779|75904070|FG000|Stage 1A|Withdrawal by Subject|0|||
42093720|NCT00467779|75904071|FG001|Stage 1A|Withdrawal by Subject|0|||
42093721|NCT00467779|75904072|FG002|Stage 1A|Withdrawal by Subject|0|||
42359098|NCT02018861|76204789|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
42359099|NCT02018861|76204790|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
42359100|NCT02018861|76204791|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
42359101|NCT02018861|76204792|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
42359102|NCT02018861|76204793|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
42093722|NCT00467779|75904073|FG003|Stage 1A|Withdrawal by Subject|0|||
42093723|NCT00467779|75904074|FG004|Stage 1A|Withdrawal by Subject|0|||
42093724|NCT00467779|75904075|FG005|Stage 1A|Withdrawal by Subject|0|||
42093725|NCT00467779|75904076|FG006|Stage 1A|Withdrawal by Subject|0|||
42093726|NCT00467779|75904077|FG007|Stage 1A|Withdrawal by Subject|0|||
42093727|NCT00467779|75904078|FG008|Stage 1A|Withdrawal by Subject|0|||
42093728|NCT00467779|75904079|FG009|Stage 1A|Withdrawal by Subject|0|||
42093729|NCT00467779|75904080|FG010|Stage 1A|Withdrawal by Subject|1|||
42093730|NCT00467779|75904081|FG011|Stage 1A|Withdrawal by Subject|1|||
42093731|NCT00467779|75904082|FG012|Stage 1A|Withdrawal by Subject|1|||
42093732|NCT00467779|75904083|FG013|Stage 1A|Withdrawal by Subject|0|||
42093733|NCT00467779|75904084|FG014|Stage 1A|Withdrawal by Subject|0|||
42093734|NCT00467779|75904070|FG000|Stage 1A|Unspecified Reason|0|||
42093735|NCT00467779|75904071|FG001|Stage 1A|Unspecified Reason|0|||
42093736|NCT00467779|75904072|FG002|Stage 1A|Unspecified Reason|0|||
42093737|NCT00467779|75904073|FG003|Stage 1A|Unspecified Reason|0|||
42093738|NCT00467779|75904074|FG004|Stage 1A|Unspecified Reason|0|||
42093739|NCT00467779|75904075|FG005|Stage 1A|Unspecified Reason|0|||
42093740|NCT00467779|75904076|FG006|Stage 1A|Unspecified Reason|0|||
42093741|NCT00467779|75904077|FG007|Stage 1A|Unspecified Reason|0|||
42093742|NCT00467779|75904078|FG008|Stage 1A|Unspecified Reason|0|||
42093743|NCT00467779|75904079|FG009|Stage 1A|Unspecified Reason|0|||
42093744|NCT00467779|75904080|FG010|Stage 1A|Unspecified Reason|0|||
42093745|NCT00467779|75904081|FG011|Stage 1A|Unspecified Reason|1|||
42093746|NCT00467779|75904082|FG012|Stage 1A|Unspecified Reason|1|||
42093747|NCT00467779|75904083|FG013|Stage 1A|Unspecified Reason|0|||
42093748|NCT00467779|75904084|FG014|Stage 1A|Unspecified Reason|0|||
42093749|NCT00467779|75904070|FG000|Stage 2|Adverse Event|0|||
42093750|NCT00467779|75904071|FG001|Stage 2|Adverse Event|0|||
42093751|NCT00467779|75904072|FG002|Stage 2|Adverse Event|0|||
42093752|NCT00467779|75904073|FG003|Stage 2|Adverse Event|0|||
42093753|NCT00467779|75904074|FG004|Stage 2|Adverse Event|0|||
42295967|NCT02433483|76130721|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
42295968|NCT02419755|76130727|FG000|Overall Study|Death|1|||
42295969|NCT02419755|76130728|FG001|Overall Study|Death|3|||
42295970|NCT02419755|76130727|FG000|Overall Study|Relapse|0|||
42295971|NCT02419755|76130728|FG001|Overall Study|Relapse|1|||
42295972|NCT02419755|76130727|FG000|Overall Study|Ineligible|1|||
42295973|NCT02419755|76130728|FG001|Overall Study|Ineligible|0|||
42295974|NCT02419755|76130727|FG000|Overall Study|Withdrawal by Subject|1|||
42295975|NCT02419755|76130728|FG001|Overall Study|Withdrawal by Subject|0|||
42295976|NCT02488551|76130738|FG000|Overall Study|Lost to Follow-up|4|||
42295977|NCT02488551|76130739|FG001|Overall Study|Lost to Follow-up|7|||
42295978|NCT02488551|76130740|FG002|Overall Study|Lost to Follow-up|0|||
42295979|NCT02488551|76130741|FG003|Overall Study|Lost to Follow-up|0|||
42295980|NCT02488551|76130738|FG000|Overall Study|Military Deployment|1|||
42295981|NCT02488551|76130739|FG001|Overall Study|Military Deployment|1|||
42295982|NCT02488551|76130740|FG002|Overall Study|Military Deployment|0|||
42295983|NCT02488551|76130741|FG003|Overall Study|Military Deployment|0|||
42295984|NCT02488239|76130751|FG000|Overall Study|Death|3|||
42295985|NCT02488239|76130751|FG000|Overall Study|Withdrawal by Subject|3|||
42295986|NCT02488239|76130751|FG000|Overall Study|Physician Decision|2|||
42359103|NCT02018861|76204784|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
42093754|NCT00467779|75904075|FG005|Stage 2|Adverse Event|0|||
42093755|NCT00467779|75904076|FG006|Stage 2|Adverse Event|0|||
42093756|NCT00467779|75904077|FG007|Stage 2|Adverse Event|0|||
42093757|NCT00467779|75904078|FG008|Stage 2|Adverse Event|1|||
42093758|NCT00467779|75904079|FG009|Stage 2|Adverse Event|0|||
42093759|NCT00467779|75904080|FG010|Stage 2|Adverse Event|0|||
42093760|NCT00467779|75904081|FG011|Stage 2|Adverse Event|0|||
42295987|NCT02488239|76130751|FG000|Overall Study|Consent ineligible|1|||
42295988|NCT02488239|76130751|FG000|Overall Study|Did not undergo implant procedure|1|||
42295989|NCT02488005|76130756|FG000|Overall Study|Lost to Follow-up|2|||
42295990|NCT02487771|76130762|FG000|Overall Study|Lost to Follow-up|2|||
42295991|NCT02487771|76130763|FG001|Overall Study|Lost to Follow-up|3|||
42093761|NCT00467779|75904082|FG012|Stage 2|Adverse Event|0|||
42093762|NCT00467779|75904083|FG013|Stage 2|Adverse Event|0|||
42093763|NCT00467779|75904084|FG014|Stage 2|Adverse Event|0|||
42093764|NCT00467779|75904070|FG000|Stage 2|Death|0|||
42093765|NCT00467779|75904071|FG001|Stage 2|Death|0|||
42093766|NCT00467779|75904072|FG002|Stage 2|Death|0|||
42093767|NCT00467779|75904073|FG003|Stage 2|Death|0|||
42093768|NCT00467779|75904074|FG004|Stage 2|Death|0|||
42093769|NCT00467779|75904075|FG005|Stage 2|Death|0|||
42093770|NCT00467779|75904076|FG006|Stage 2|Death|0|||
42295992|NCT02487771|76130762|FG000|Overall Study|Moved out of area|5|||
42295993|NCT02487771|76130763|FG001|Overall Study|Moved out of area|6|||
42093771|NCT00467779|75904077|FG007|Stage 2|Death|0|||
42093772|NCT00467779|75904078|FG008|Stage 2|Death|1|||
42093773|NCT00467779|75904079|FG009|Stage 2|Death|0|||
42093774|NCT00467779|75904080|FG010|Stage 2|Death|0|||
42093775|NCT00467779|75904081|FG011|Stage 2|Death|0|||
42093776|NCT00467779|75904082|FG012|Stage 2|Death|0|||
42093777|NCT00467779|75904083|FG013|Stage 2|Death|0|||
42093778|NCT00467779|75904084|FG014|Stage 2|Death|0|||
42093779|NCT00467779|75904070|FG000|Stage 2|Disease Progression|0|||
42093780|NCT00467779|75904071|FG001|Stage 2|Disease Progression|0|||
42093781|NCT00467779|75904072|FG002|Stage 2|Disease Progression|0|||
42093782|NCT00467779|75904073|FG003|Stage 2|Disease Progression|0|||
42093783|NCT00467779|75904074|FG004|Stage 2|Disease Progression|0|||
42093784|NCT00467779|75904075|FG005|Stage 2|Disease Progression|0|||
42093785|NCT00467779|75904076|FG006|Stage 2|Disease Progression|0|||
42093786|NCT00467779|75904077|FG007|Stage 2|Disease Progression|0|||
42093787|NCT00467779|75904078|FG008|Stage 2|Disease Progression|16|||
42093788|NCT00467779|75904079|FG009|Stage 2|Disease Progression|0|||
42093789|NCT00467779|75904080|FG010|Stage 2|Disease Progression|0|||
42093790|NCT00467779|75904081|FG011|Stage 2|Disease Progression|0|||
42093791|NCT00467779|75904082|FG012|Stage 2|Disease Progression|0|||
42093792|NCT00467779|75904083|FG013|Stage 2|Disease Progression|0|||
42093793|NCT00467779|75904084|FG014|Stage 2|Disease Progression|0|||
42093794|NCT00467779|75904070|FG000|Stage 2|Unspecified Reason|0|||
42093795|NCT00467779|75904071|FG001|Stage 2|Unspecified Reason|0|||
42093796|NCT00467779|75904072|FG002|Stage 2|Unspecified Reason|0|||
42093797|NCT00467779|75904073|FG003|Stage 2|Unspecified Reason|0|||
42093798|NCT00467779|75904074|FG004|Stage 2|Unspecified Reason|0|||
42093799|NCT00467779|75904075|FG005|Stage 2|Unspecified Reason|0|||
42093800|NCT00467779|75904076|FG006|Stage 2|Unspecified Reason|0|||
42093801|NCT00467779|75904077|FG007|Stage 2|Unspecified Reason|0|||
42093802|NCT00467779|75904078|FG008|Stage 2|Unspecified Reason|3|||
42093803|NCT00467779|75904079|FG009|Stage 2|Unspecified Reason|0|||
42093804|NCT00467779|75904080|FG010|Stage 2|Unspecified Reason|0|||
42093805|NCT00467779|75904081|FG011|Stage 2|Unspecified Reason|0|||
42093806|NCT00467779|75904082|FG012|Stage 2|Unspecified Reason|0|||
42093807|NCT00467779|75904083|FG013|Stage 2|Unspecified Reason|0|||
42093808|NCT00467779|75904084|FG014|Stage 2|Unspecified Reason|0|||
42093809|NCT00467779|75904070|FG000|Stage 2A|Adverse Event|0|||
42093810|NCT00467779|75904071|FG001|Stage 2A|Adverse Event|0|||
42093811|NCT00467779|75904072|FG002|Stage 2A|Adverse Event|0|||
42093812|NCT00467779|75904073|FG003|Stage 2A|Adverse Event|0|||
42093813|NCT00467779|75904074|FG004|Stage 2A|Adverse Event|0|||
42093814|NCT00467779|75904075|FG005|Stage 2A|Adverse Event|0|||
42093815|NCT00467779|75904076|FG006|Stage 2A|Adverse Event|0|||
42093816|NCT00467779|75904077|FG007|Stage 2A|Adverse Event|0|||
42093817|NCT00467779|75904078|FG008|Stage 2A|Adverse Event|0|||
42093818|NCT00467779|75904079|FG009|Stage 2A|Adverse Event|0|||
42093819|NCT00467779|75904080|FG010|Stage 2A|Adverse Event|0|||
42093820|NCT00467779|75904081|FG011|Stage 2A|Adverse Event|0|||
42093821|NCT00467779|75904082|FG012|Stage 2A|Adverse Event|0|||
42093822|NCT00467779|75904083|FG013|Stage 2A|Adverse Event|2|||
42093823|NCT00467779|75904084|FG014|Stage 2A|Adverse Event|0|||
42093824|NCT00467779|75904070|FG000|Stage 2A|Death|0|||
42093825|NCT00467779|75904071|FG001|Stage 2A|Death|0|||
42093826|NCT00467779|75904072|FG002|Stage 2A|Death|0|||
42093827|NCT00467779|75904073|FG003|Stage 2A|Death|0|||
42093828|NCT00467779|75904074|FG004|Stage 2A|Death|0|||
42093829|NCT00467779|75904075|FG005|Stage 2A|Death|0|||
42093830|NCT00467779|75904076|FG006|Stage 2A|Death|0|||
42093831|NCT00467779|75904077|FG007|Stage 2A|Death|0|||
42295994|NCT02487771|76130762|FG000|Overall Study|Withdrawal by Subject|3|||
42295995|NCT02487771|76130763|FG001|Overall Study|Withdrawal by Subject|5|||
42295996|NCT01359943|76130772|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
42093832|NCT00467779|75904078|FG008|Stage 2A|Death|0|||
42093833|NCT00467779|75904079|FG009|Stage 2A|Death|0|||
42093834|NCT00467779|75904080|FG010|Stage 2A|Death|0|||
42093835|NCT00467779|75904081|FG011|Stage 2A|Death|0|||
42093836|NCT00467779|75904082|FG012|Stage 2A|Death|0|||
42093837|NCT00467779|75904083|FG013|Stage 2A|Death|1|||
42093838|NCT00467779|75904084|FG014|Stage 2A|Death|0|||
42093839|NCT00467779|75904070|FG000|Stage 2A|Disease Progression|0|||
42093840|NCT00467779|75904071|FG001|Stage 2A|Disease Progression|0|||
42093841|NCT00467779|75904072|FG002|Stage 2A|Disease Progression|0|||
42093842|NCT00467779|75904073|FG003|Stage 2A|Disease Progression|0|||
42093843|NCT00467779|75904074|FG004|Stage 2A|Disease Progression|0|||
42093844|NCT00467779|75904075|FG005|Stage 2A|Disease Progression|0|||
42093845|NCT00467779|75904076|FG006|Stage 2A|Disease Progression|0|||
42093846|NCT00467779|75904077|FG007|Stage 2A|Disease Progression|0|||
42093847|NCT00467779|75904078|FG008|Stage 2A|Disease Progression|0|||
42093848|NCT00467779|75904079|FG009|Stage 2A|Disease Progression|0|||
42093849|NCT00467779|75904080|FG010|Stage 2A|Disease Progression|0|||
42093850|NCT00467779|75904081|FG011|Stage 2A|Disease Progression|0|||
42093851|NCT00467779|75904082|FG012|Stage 2A|Disease Progression|0|||
42093852|NCT00467779|75904083|FG013|Stage 2A|Disease Progression|10|||
42093853|NCT00467779|75904084|FG014|Stage 2A|Disease Progression|0|||
42093854|NCT00467779|75904070|FG000|Stage 2A|Unspecified Reason|0|||
42093855|NCT00467779|75904071|FG001|Stage 2A|Unspecified Reason|0|||
42093856|NCT00467779|75904072|FG002|Stage 2A|Unspecified Reason|0|||
42093857|NCT00467779|75904073|FG003|Stage 2A|Unspecified Reason|0|||
42093858|NCT00467779|75904074|FG004|Stage 2A|Unspecified Reason|0|||
42093859|NCT00467779|75904075|FG005|Stage 2A|Unspecified Reason|0|||
42093860|NCT00467779|75904076|FG006|Stage 2A|Unspecified Reason|0|||
42093861|NCT00467779|75904077|FG007|Stage 2A|Unspecified Reason|0|||
42093862|NCT00467779|75904078|FG008|Stage 2A|Unspecified Reason|0|||
42093863|NCT00467779|75904079|FG009|Stage 2A|Unspecified Reason|0|||
42093864|NCT00467779|75904080|FG010|Stage 2A|Unspecified Reason|0|||
42093865|NCT00467779|75904081|FG011|Stage 2A|Unspecified Reason|0|||
42093866|NCT00467779|75904082|FG012|Stage 2A|Unspecified Reason|0|||
42093867|NCT00467779|75904083|FG013|Stage 2A|Unspecified Reason|7|||
42093868|NCT00467779|75904084|FG014|Stage 2A|Unspecified Reason|0|||
42093869|NCT00467779|75904070|FG000|Stage 2A|Withdrawal by Subject|0|||
42093870|NCT00467779|75904071|FG001|Stage 2A|Withdrawal by Subject|0|||
42093871|NCT00467779|75904072|FG002|Stage 2A|Withdrawal by Subject|0|||
42093872|NCT00467779|75904073|FG003|Stage 2A|Withdrawal by Subject|0|||
42093873|NCT00467779|75904074|FG004|Stage 2A|Withdrawal by Subject|0|||
42093874|NCT00467779|75904075|FG005|Stage 2A|Withdrawal by Subject|0|||
42093875|NCT00467779|75904076|FG006|Stage 2A|Withdrawal by Subject|0|||
42093876|NCT00467779|75904077|FG007|Stage 2A|Withdrawal by Subject|0|||
42093877|NCT00467779|75904078|FG008|Stage 2A|Withdrawal by Subject|0|||
42093878|NCT00467779|75904079|FG009|Stage 2A|Withdrawal by Subject|0|||
42093879|NCT00467779|75904080|FG010|Stage 2A|Withdrawal by Subject|0|||
42093880|NCT00467779|75904081|FG011|Stage 2A|Withdrawal by Subject|0|||
42093881|NCT00467779|75904082|FG012|Stage 2A|Withdrawal by Subject|0|||
42093882|NCT00467779|75904083|FG013|Stage 2A|Withdrawal by Subject|1|||
42093883|NCT00467779|75904084|FG014|Stage 2A|Withdrawal by Subject|0|||
42093884|NCT00467779|75904070|FG000|Stage 3|Adverse Event|0|||
42093885|NCT00467779|75904071|FG001|Stage 3|Adverse Event|0|||
42093886|NCT00467779|75904072|FG002|Stage 3|Adverse Event|0|||
42093887|NCT00467779|75904073|FG003|Stage 3|Adverse Event|0|||
42093888|NCT00467779|75904074|FG004|Stage 3|Adverse Event|0|||
42093889|NCT00467779|75904075|FG005|Stage 3|Adverse Event|0|||
42093890|NCT00467779|75904076|FG006|Stage 3|Adverse Event|0|||
42093891|NCT00467779|75904077|FG007|Stage 3|Adverse Event|0|||
42093892|NCT00467779|75904078|FG008|Stage 3|Adverse Event|0|||
42093893|NCT00467779|75904079|FG009|Stage 3|Adverse Event|0|||
42093894|NCT00467779|75904080|FG010|Stage 3|Adverse Event|0|||
42093895|NCT00467779|75904081|FG011|Stage 3|Adverse Event|0|||
42093896|NCT00467779|75904082|FG012|Stage 3|Adverse Event|0|||
42093897|NCT00467779|75904083|FG013|Stage 3|Adverse Event|0|||
42093898|NCT00467779|75904084|FG014|Stage 3|Adverse Event|2|||
42093899|NCT00467779|75904070|FG000|Stage 3|Death|0|||
42093900|NCT00467779|75904071|FG001|Stage 3|Death|0|||
42093901|NCT00467779|75904072|FG002|Stage 3|Death|0|||
42093902|NCT00467779|75904073|FG003|Stage 3|Death|0|||
42093903|NCT00467779|75904074|FG004|Stage 3|Death|0|||
42093904|NCT00467779|75904075|FG005|Stage 3|Death|0|||
42093905|NCT00467779|75904076|FG006|Stage 3|Death|0|||
42093906|NCT00467779|75904077|FG007|Stage 3|Death|0|||
42093907|NCT00467779|75904078|FG008|Stage 3|Death|0|||
42093908|NCT00467779|75904079|FG009|Stage 3|Death|0|||
42093909|NCT00467779|75904080|FG010|Stage 3|Death|0|||
42093910|NCT00467779|75904081|FG011|Stage 3|Death|0|||
42093911|NCT00467779|75904082|FG012|Stage 3|Death|0|||
42093912|NCT00467779|75904083|FG013|Stage 3|Death|0|||
42093913|NCT00467779|75904084|FG014|Stage 3|Death|1|||
42093914|NCT00467779|75904070|FG000|Stage 3|Disease Progression|0|||
42093915|NCT00467779|75904071|FG001|Stage 3|Disease Progression|0|||
42187499|NCT02914522|75997233|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
42187500|NCT02914522|75997234|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
42093916|NCT00467779|75904072|FG002|Stage 3|Disease Progression|0|||
42093917|NCT00467779|75904073|FG003|Stage 3|Disease Progression|0|||
42093918|NCT00467779|75904074|FG004|Stage 3|Disease Progression|0|||
42093919|NCT00467779|75904075|FG005|Stage 3|Disease Progression|0|||
42093920|NCT00467779|75904076|FG006|Stage 3|Disease Progression|0|||
42093921|NCT00467779|75904077|FG007|Stage 3|Disease Progression|0|||
42093922|NCT00467779|75904078|FG008|Stage 3|Disease Progression|0|||
42093923|NCT00467779|75904079|FG009|Stage 3|Disease Progression|0|||
42093924|NCT00467779|75904080|FG010|Stage 3|Disease Progression|0|||
42093925|NCT00467779|75904081|FG011|Stage 3|Disease Progression|0|||
42093926|NCT00467779|75904082|FG012|Stage 3|Disease Progression|0|||
42093927|NCT00467779|75904083|FG013|Stage 3|Disease Progression|0|||
42093928|NCT00467779|75904084|FG014|Stage 3|Disease Progression|9|||
42093929|NCT00467779|75904070|FG000|Stage 3|Unspecified Reason|0|||
42093930|NCT00467779|75904071|FG001|Stage 3|Unspecified Reason|0|||
42093931|NCT00467779|75904072|FG002|Stage 3|Unspecified Reason|0|||
42093932|NCT00467779|75904073|FG003|Stage 3|Unspecified Reason|0|||
42093933|NCT00467779|75904074|FG004|Stage 3|Unspecified Reason|0|||
42093934|NCT00467779|75904075|FG005|Stage 3|Unspecified Reason|0|||
42093935|NCT00467779|75904076|FG006|Stage 3|Unspecified Reason|0|||
42093936|NCT00467779|75904077|FG007|Stage 3|Unspecified Reason|0|||
42093937|NCT00467779|75904078|FG008|Stage 3|Unspecified Reason|0|||
42093938|NCT00467779|75904079|FG009|Stage 3|Unspecified Reason|0|||
42093939|NCT00467779|75904080|FG010|Stage 3|Unspecified Reason|0|||
42093940|NCT00467779|75904081|FG011|Stage 3|Unspecified Reason|0|||
42093941|NCT00467779|75904082|FG012|Stage 3|Unspecified Reason|0|||
42093942|NCT00467779|75904083|FG013|Stage 3|Unspecified Reason|0|||
42093943|NCT00467779|75904084|FG014|Stage 3|Unspecified Reason|5|||
42093944|NCT00570687|75904124|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093945|NCT00570687|75904125|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093946|NCT00570687|75904126|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093947|NCT00570687|75904127|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093948|NCT00570687|75904128|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
42093949|NCT00570687|75904129|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
42093950|NCT00570687|75904130|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
42093951|NCT00570687|75904131|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
42093952|NCT00570687|75904132|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
42093953|NCT00570687|75904133|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
42093954|NCT00570687|75904124|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093955|NCT00570687|75904125|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093956|NCT00570687|75904126|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093957|NCT00570687|75904127|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093958|NCT00570687|75904128|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093959|NCT00570687|75904129|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093960|NCT00570687|75904130|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093961|NCT00570687|75904131|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093962|NCT00570687|75904132|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
42093963|NCT00570687|75904133|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093964|NCT00570687|75904124|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093965|NCT00570687|75904125|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093966|NCT00570687|75904126|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093967|NCT00570687|75904127|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093968|NCT00570687|75904128|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093969|NCT00570687|75904129|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093970|NCT00570687|75904130|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
42093971|NCT00570687|75904131|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093972|NCT00570687|75904132|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093973|NCT00570687|75904133|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
42093974|NCT03836677|75904147|FG000|Period 1|Adverse Event|0|||
42093975|NCT03836677|75904148|FG001|Period 1|Adverse Event|1|||
42093976|NCT03836677|75904147|FG000|Period 2|Severe non-compliance to protocol|1|||
42093977|NCT03836677|75904148|FG001|Period 2|Severe non-compliance to protocol|0|||
42093978|NCT00434161|75904179|FG000|Overall Study|Adverse Event|5|||
42093979|NCT00434161|75904180|FG001|Overall Study|Adverse Event|1|||
42093980|NCT00434161|75904181|FG002|Overall Study|Adverse Event|4|||
42093981|NCT00434161|75904179|FG000|Overall Study|Lost to Follow-up|0|||
42093982|NCT00434161|75904180|FG001|Overall Study|Lost to Follow-up|1|||
42093983|NCT00434161|75904181|FG002|Overall Study|Lost to Follow-up|0|||
42093984|NCT00434161|75904179|FG000|Overall Study|Death|1|||
42093985|NCT00434161|75904180|FG001|Overall Study|Death|0|||
42093986|NCT00434161|75904181|FG002|Overall Study|Death|1|||
42093987|NCT00434161|75904179|FG000|Overall Study|Non-Compliance|1|||
42093988|NCT00434161|75904180|FG001|Overall Study|Non-Compliance|1|||
42093989|NCT00434161|75904181|FG002|Overall Study|Non-Compliance|0|||
42093990|NCT00434161|75904179|FG000|Overall Study|Withdrawal by Subject|2|||
42093991|NCT00434161|75904180|FG001|Overall Study|Withdrawal by Subject|0|||
42093992|NCT00434161|75904181|FG002|Overall Study|Withdrawal by Subject|3|||
42093993|NCT00434161|75904179|FG000|Overall Study|Logistical error study assessments|1|||
42093994|NCT00434161|75904180|FG001|Overall Study|Logistical error study assessments|0|||
42093995|NCT00434161|75904181|FG002|Overall Study|Logistical error study assessments|3|||
42093996|NCT00441103|75904198|FG000|Overall Study|Adverse Event|2|||
42093997|NCT00441103|75904199|FG001|Overall Study|Adverse Event|1|||
42093998|NCT00441103|75904198|FG000|Overall Study|Death|1|||
42295997|NCT01359943|76130773|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
42093999|NCT00441103|75904199|FG001|Overall Study|Death|0|||
42094000|NCT00441103|75904198|FG000|Overall Study|Disease Progression|2|||
42094001|NCT00441103|75904199|FG001|Overall Study|Disease Progression|0|||
42094002|NCT00441103|75904198|FG000|Overall Study|Lost to Follow-up|1|||
42094003|NCT00441103|75904199|FG001|Overall Study|Lost to Follow-up|0|||
42094004|NCT00441103|75904198|FG000|Overall Study|Protocol Violation|1|||
42094005|NCT00441103|75904199|FG001|Overall Study|Protocol Violation|0|||
42094006|NCT00441103|75904198|FG000|Overall Study|Participant unable to use Rebiject II|1|||
42094007|NCT00441103|75904199|FG001|Overall Study|Participant unable to use Rebiject II|0|||
42094008|NCT00441103|75904198|FG000|Overall Study|Participant refused MRI|1|||
42094009|NCT00441103|75904199|FG001|Overall Study|Participant refused MRI|0|||
42094010|NCT00441103|75904198|FG000|Overall Study|Inclusion criteria absent|1|||
42094011|NCT00441103|75904199|FG001|Overall Study|Inclusion criteria absent|0|||
42094012|NCT00441103|75904198|FG000|Overall Study|Non-compliant|0|||
42094013|NCT00441103|75904199|FG001|Overall Study|Non-compliant|1|||
42094014|NCT00441103|75904198|FG000|Overall Study|Participant decided to withdraw|1|||
42094015|NCT00441103|75904199|FG001|Overall Study|Participant decided to withdraw|0|||
42094016|NCT00441103|75904198|FG000|Overall Study|Participant's reason|0|||
42094017|NCT00441103|75904199|FG001|Overall Study|Participant's reason|1|||
42094018|NCT00441103|75904198|FG000|Overall Study|Participant decided to stop|0|||
42094019|NCT00441103|75904199|FG001|Overall Study|Participant decided to stop|1|||
42094020|NCT00433771|75904206|FG000|Overall Study|screen fail|14|||
42094021|NCT00433771|75904206|FG000|Overall Study|Treated and later found to be ineligible|2|||
42094022|NCT00433771|75904206|FG000|Overall Study|Death|2|||
42094023|NCT00433771|75904206|FG000|Overall Study|Failure to deploy stent|1|||
42094024|NCT00433537|75904210|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
42094025|NCT00433537|75904211|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
42094026|NCT00433537|75904212|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
42094027|NCT00433537|75904210|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
42094028|NCT00433537|75904211|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
42094029|NCT00433537|75904212|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
42094030|NCT00433537|75904210|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
42094031|NCT00433537|75904211|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
42094032|NCT00433537|75904212|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
42094033|NCT00433537|75904210|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
42094034|NCT00433537|75904211|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
42094035|NCT00433537|75904212|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
42094036|NCT00433537|75904210|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
42094037|NCT00433537|75904211|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
42094038|NCT00433537|75904212|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
42094039|NCT00433537|75904210|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
42094040|NCT00433537|75904211|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
42094041|NCT00433537|75904212|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
42094042|NCT00433537|75904210|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
42094043|NCT00433537|75904211|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
42094044|NCT00433537|75904212|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
42094045|NCT00433537|75904210|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
42094046|NCT00433537|75904211|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
42094047|NCT00433537|75904212|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
42094048|NCT00433537|75904210|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
42094049|NCT00433537|75904211|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
42094050|NCT00433537|75904212|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
42094051|NCT00570765|75904222|FG000|DB Phase|Withdrawal by Subject|1|||
42094052|NCT00570765|75904223|FG001|DB Phase|Withdrawal by Subject|0|||
42094053|NCT00570765|75904224|FG002|DB Phase|Withdrawal by Subject|0|||
42094054|NCT00570765|75904225|FG003|DB Phase|Withdrawal by Subject|0|||
42094055|NCT00570765|75904222|FG000|DB Phase|Protocol Violation|0|||
42094056|NCT00570765|75904223|FG001|DB Phase|Protocol Violation|1|||
42094057|NCT00570765|75904224|FG002|DB Phase|Protocol Violation|0|||
42094058|NCT00570765|75904225|FG003|DB Phase|Protocol Violation|0|||
42094059|NCT00570765|75904222|FG000|DB Phase|Adverse Event|3|||
42094060|NCT00570765|75904223|FG001|DB Phase|Adverse Event|6|||
42094061|NCT00570765|75904224|FG002|DB Phase|Adverse Event|0|||
42094062|NCT00570765|75904225|FG003|DB Phase|Adverse Event|0|||
42094063|NCT00570765|75904222|FG000|DB Phase|Did Not Receive Study Drug|0|||
42094064|NCT00570765|75904223|FG001|DB Phase|Did Not Receive Study Drug|0|||
42094065|NCT00570765|75904224|FG002|DB Phase|Did Not Receive Study Drug|1|||
42094066|NCT00570765|75904225|FG003|DB Phase|Did Not Receive Study Drug|0|||
42187501|NCT02914522|75997235|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
42187502|NCT02914522|75997236|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
42187503|NCT02914522|75997226|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
42187504|NCT02914522|75997227|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
42094067|NCT00570765|75904222|FG000|LTSE Phase|Withdrawal by Subject|0|||
42094068|NCT00570765|75904223|FG001|LTSE Phase|Withdrawal by Subject|0|||
42094069|NCT00570765|75904224|FG002|LTSE Phase|Withdrawal by Subject|0|||
42094070|NCT00570765|75904225|FG003|LTSE Phase|Withdrawal by Subject|1|||
42094071|NCT00570765|75904222|FG000|LTSE Phase|Adverse Event|0|||
42094072|NCT00570765|75904223|FG001|LTSE Phase|Adverse Event|0|||
42094073|NCT00570765|75904224|FG002|LTSE Phase|Adverse Event|0|||
42094074|NCT00570765|75904225|FG003|LTSE Phase|Adverse Event|7|||
42094075|NCT00570765|75904222|FG000|LTSE Phase|Physician Decision|0|||
42094076|NCT00570765|75904223|FG001|LTSE Phase|Physician Decision|0|||
42094077|NCT00570765|75904224|FG002|LTSE Phase|Physician Decision|0|||
42094078|NCT00570765|75904225|FG003|LTSE Phase|Physician Decision|4|||
42094079|NCT00667563|75904236|FG000|Overall Study|Protocol Violation|24|||
42094080|NCT00667095|75904242|FG000|Overall Study|Withdrawal by Subject|0|||
42094081|NCT00667095|75904243|FG001|Overall Study|Withdrawal by Subject|1|||
42094082|NCT00433381|75904251|FG000|Overall Study|Ineligible / no protocol treatment|3|||
42094083|NCT00433381|75904252|FG001|Overall Study|Ineligible / no protocol treatment|3|||
42295998|NCT01359943|76130774|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
42295999|NCT01359943|76130772|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
42296000|NCT01359943|76130773|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
42296001|NCT01359943|76130774|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
42296002|NCT01359943|76130772|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
42018157|NCT00996892|75825879|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
42018158|NCT00996892|75825880|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
42018159|NCT00996892|75825861|FG000|Dose-Escalation Stage 1|Death|1|||
42018160|NCT00996892|75825862|FG001|Dose-Escalation Stage 1|Death|0|||
42296003|NCT01359943|76130773|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
42094084|NCT00667017|75904266|FG000|Overall Study|Withdrawal by Subject|1|||
42094085|NCT00666705|75904270|FG000|Overall Study|Withdrawal by Subject|1|||
42094086|NCT00433147|75904283|FG000|Overall Study|Adverse Event|0|||
42094087|NCT00433147|75904284|FG001|Overall Study|Adverse Event|1|||
42094088|NCT00433147|75904285|FG002|Overall Study|Adverse Event|0|||
42094089|NCT00433147|75904286|FG003|Overall Study|Adverse Event|0|||
42094090|NCT00666237|75904298|FG000|Overall Study|Death|5|||
42094091|NCT00666237|75904299|FG001|Overall Study|Death|5|||
42094092|NCT00666237|75904298|FG000|Overall Study|Lost to Follow-up|29|||
42094093|NCT00666237|75904299|FG001|Overall Study|Lost to Follow-up|25|||
42094094|NCT00662025|75904305|FG000|Overall Study|Objective progression or relapse|51|||
42094095|NCT00662025|75904305|FG000|Overall Study|Adverse Event|7|||
42094096|NCT00662025|75904305|FG000|Overall Study|Withdrawal by Subject|1|||
42094097|NCT00662025|75904305|FG000|Overall Study|Results of other clinical study|2|||
42094098|NCT00662025|75904305|FG000|Overall Study|Target lesion cannot be evaluated|1|||
42187505|NCT02914522|75997228|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
42187506|NCT02914522|75997229|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
42187507|NCT02914522|75997230|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
42187508|NCT02914522|75997231|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
42187509|NCT02914522|75997232|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
42187510|NCT02914522|75997233|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
42187511|NCT02914522|75997234|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
42187512|NCT02914522|75997235|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
42187513|NCT02914522|75997236|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
42187514|NCT02914522|75997226|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
42187515|NCT02914522|75997227|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
42187516|NCT02914522|75997228|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
42187517|NCT02914522|75997229|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
42187518|NCT02914522|75997230|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
42187519|NCT02914522|75997231|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
42187520|NCT02914522|75997232|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
42187521|NCT02914522|75997233|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
42296004|NCT01359943|76130774|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
42296005|NCT01359943|76130772|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
42296006|NCT01359943|76130773|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
42296007|NCT01359943|76130774|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
42296008|NCT01359943|76130772|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
42018161|NCT00996892|75825863|FG002|Dose-Escalation Stage 1|Death|0|||
42018162|NCT00996892|75825864|FG003|Dose-Escalation Stage 1|Death|0|||
42018163|NCT00996892|75825865|FG004|Dose-Escalation Stage 1|Death|0|||
42018164|NCT00996892|75825866|FG005|Dose-Escalation Stage 1|Death|1|||
42018165|NCT00996892|75825867|FG006|Dose-Escalation Stage 1|Death|0|||
42018166|NCT00996892|75825868|FG007|Dose-Escalation Stage 1|Death|0|||
42018167|NCT00996892|75825869|FG008|Dose-Escalation Stage 1|Death|0|||
42018168|NCT00996892|75825870|FG009|Dose-Escalation Stage 1|Death|0|||
42018169|NCT00996892|75825871|FG010|Dose-Escalation Stage 1|Death|0|||
42094099|NCT00662025|75904305|FG000|Overall Study|Domestic circumstances|1|||
42094100|NCT00440947|75904309|FG000|36-Week Induction Phase|Adverse Event|16|||
42094101|NCT00440947|75904310|FG001|36-Week Induction Phase|Adverse Event|0|||
42094102|NCT00440947|75904311|FG002|36-Week Induction Phase|Adverse Event|0|||
42018170|NCT00996892|75825872|FG011|Dose-Escalation Stage 1|Death|0|||
42094103|NCT00440947|75904312|FG003|36-Week Induction Phase|Adverse Event|0|||
42094104|NCT00440947|75904313|FG004|36-Week Induction Phase|Adverse Event|0|||
42094105|NCT00440947|75904309|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
42187522|NCT02914522|75997234|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
42187523|NCT02914522|75997235|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
42187524|NCT02914522|75997236|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
42187525|NCT02924428|75997265|FG000|Overall Study|Adverse Event|1|||
42187526|NCT02924428|75997266|FG001|Overall Study|Adverse Event|0|||
42187527|NCT02924428|75997265|FG000|Overall Study|Physician Decision|1|||
42187528|NCT02924428|75997266|FG001|Overall Study|Physician Decision|0|||
42187529|NCT02924428|75997265|FG000|Overall Study|Lost to Follow-up|2|||
42187530|NCT02924428|75997266|FG001|Overall Study|Lost to Follow-up|4|||
42187531|NCT02924428|75997265|FG000|Overall Study|Pregnancy|0|||
42187532|NCT02924428|75997266|FG001|Overall Study|Pregnancy|1|||
42187533|NCT00062751|75997277|FG000|Overall Study|Disease progression|24|||
42187534|NCT00062751|75997278|FG001|Overall Study|Disease progression|17|||
42187535|NCT00062751|75997279|FG002|Overall Study|Disease progression|24|||
42187536|NCT00062751|75997280|FG003|Overall Study|Disease progression|2|||
42187537|NCT00062751|75997281|FG004|Overall Study|Disease progression|2|||
42187538|NCT00062751|75997277|FG000|Overall Study|Adverse Event|4|||
42094106|NCT00440947|75904310|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
42094107|NCT00440947|75904311|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
42094108|NCT00440947|75904312|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
42094109|NCT00440947|75904313|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
42094110|NCT00440947|75904309|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
42094111|NCT00440947|75904310|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
42094112|NCT00440947|75904311|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
42094113|NCT00440947|75904312|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
42094114|NCT00440947|75904313|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
42094115|NCT00440947|75904309|FG000|36-Week Induction Phase|Non-compliance|10|||
42094116|NCT00440947|75904310|FG001|36-Week Induction Phase|Non-compliance|0|||
42094117|NCT00440947|75904311|FG002|36-Week Induction Phase|Non-compliance|0|||
42094118|NCT00440947|75904312|FG003|36-Week Induction Phase|Non-compliance|0|||
42094119|NCT00440947|75904313|FG004|36-Week Induction Phase|Non-compliance|0|||
42094120|NCT00440947|75904309|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
42094121|NCT00440947|75904310|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
42094122|NCT00440947|75904311|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
42094123|NCT00440947|75904312|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
42094124|NCT00440947|75904313|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
42094125|NCT00440947|75904309|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
42094126|NCT00440947|75904310|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
42094127|NCT00440947|75904311|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
42094128|NCT00440947|75904312|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
42094129|NCT00440947|75904313|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
42094130|NCT00440947|75904309|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
42094131|NCT00440947|75904310|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
42094132|NCT00440947|75904311|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
42094133|NCT00440947|75904312|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
42094134|NCT00440947|75904313|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
42094135|NCT00440947|75904309|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
42094136|NCT00440947|75904310|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
42094137|NCT00440947|75904311|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
42094138|NCT00440947|75904312|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
42187539|NCT00062751|75997278|FG001|Overall Study|Adverse Event|7|||
42187540|NCT00062751|75997279|FG002|Overall Study|Adverse Event|2|||
42187541|NCT00062751|75997280|FG003|Overall Study|Adverse Event|2|||
42187542|NCT00062751|75997281|FG004|Overall Study|Adverse Event|2|||
42187543|NCT00062751|75997277|FG000|Overall Study|Other|2|||
42187544|NCT00062751|75997278|FG001|Overall Study|Other|3|||
42018171|NCT00996892|75825873|FG012|Dose-Escalation Stage 1|Death|0|||
42018172|NCT00996892|75825874|FG013|Dose-Escalation Stage 1|Death|0|||
42018173|NCT00996892|75825875|FG014|Dose-Escalation Stage 1|Death|0|||
42187545|NCT00062751|75997279|FG002|Overall Study|Other|1|||
42187546|NCT00062751|75997280|FG003|Overall Study|Other|0|||
42187547|NCT00062751|75997281|FG004|Overall Study|Other|1|||
42187548|NCT00062751|75997277|FG000|Overall Study|Withdrawal by Subject|1|||
42296009|NCT01359943|76130773|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
42296010|NCT01359943|76130774|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
42018174|NCT00996892|75825876|FG015|Dose-Escalation Stage 1|Death|0|||
42018175|NCT00996892|75825877|FG016|Dose-Escalation Stage 1|Death|0|||
42018176|NCT00996892|75825878|FG017|Dose-Escalation Stage 1|Death|0|||
42018177|NCT00996892|75825879|FG018|Dose-Escalation Stage 1|Death|0|||
42018178|NCT00996892|75825880|FG019|Dose-Escalation Stage 1|Death|0|||
42018179|NCT00996892|75825861|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
42018180|NCT00996892|75825862|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
42094139|NCT00440947|75904313|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
42094140|NCT00440947|75904309|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
42094141|NCT00440947|75904310|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
42094142|NCT00440947|75904311|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
42094143|NCT00440947|75904312|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
42094144|NCT00440947|75904313|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
42187549|NCT00062751|75997278|FG001|Overall Study|Withdrawal by Subject|2|||
42187550|NCT00062751|75997279|FG002|Overall Study|Withdrawal by Subject|2|||
42187551|NCT00062751|75997280|FG003|Overall Study|Withdrawal by Subject|1|||
42187552|NCT00062751|75997281|FG004|Overall Study|Withdrawal by Subject|0|||
42187553|NCT00062751|75997277|FG000|Overall Study|Symptomatic deterioration|1|||
42187554|NCT00062751|75997278|FG001|Overall Study|Symptomatic deterioration|1|||
42187555|NCT00062751|75997279|FG002|Overall Study|Symptomatic deterioration|0|||
42187556|NCT00062751|75997280|FG003|Overall Study|Symptomatic deterioration|0|||
42187557|NCT00062751|75997281|FG004|Overall Study|Symptomatic deterioration|1|||
42187558|NCT00062751|75997277|FG000|Overall Study|Death|1|||
42187559|NCT00062751|75997278|FG001|Overall Study|Death|0|||
42187560|NCT00062751|75997279|FG002|Overall Study|Death|1|||
42187561|NCT00062751|75997280|FG003|Overall Study|Death|0|||
42187562|NCT00062751|75997281|FG004|Overall Study|Death|0|||
42187563|NCT00062439|75997298|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
42187564|NCT00062439|75997298|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
42187565|NCT00062439|75997298|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
42187566|NCT00062439|75997298|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
42187567|NCT00062439|75997298|FG000|Post Chemoradiation Assessment|Death|1|||
42187568|NCT00062439|75997298|FG000|Post Chemoradiation Assessment|Disease progression|2|||
42187569|NCT00062439|75997298|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
42187570|NCT00062439|75997298|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
42187571|NCT00062439|75997298|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
42187572|NCT00062439|75997298|FG000|Surgery|Physician Decision|4|||
42187573|NCT00062439|75997298|FG000|Surgery|Death|1|||
42187574|NCT00062439|75997298|FG000|Surgery|Adverse Event|2|||
42187575|NCT00062439|75997298|FG000|Consolidation Chemotherapy|Adverse Event|2|||
42187576|NCT00051363|75997309|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
42187577|NCT00051363|75997310|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
42187578|NCT00051363|75997309|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
42187579|NCT00051363|75997310|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
42187580|NCT00051363|75997309|FG000|Overall Study|Death|2|||
42187581|NCT00051363|75997310|FG001|Overall Study|Death|2|||
42187582|NCT00051363|75997309|FG000|Overall Study|Excluded Pre-Randomization|2|||
42187583|NCT00051363|75997310|FG001|Overall Study|Excluded Pre-Randomization|5|||
42187584|NCT00031551|75997318|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
42094145|NCT00440947|75904309|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
42094146|NCT00440947|75904310|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
42094147|NCT00440947|75904311|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
42094148|NCT00440947|75904312|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
42094149|NCT00440947|75904313|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
42094150|NCT00440947|75904309|FG000|36-Week Induction Phase|Incarceration|3|||
42094151|NCT00440947|75904310|FG001|36-Week Induction Phase|Incarceration|0|||
42094152|NCT00440947|75904311|FG002|36-Week Induction Phase|Incarceration|0|||
42094153|NCT00440947|75904312|FG003|36-Week Induction Phase|Incarceration|0|||
42094154|NCT00440947|75904313|FG004|36-Week Induction Phase|Incarceration|0|||
42094155|NCT00440947|75904309|FG000|36-Week Induction Phase|Pregnancy|1|||
42094156|NCT00440947|75904310|FG001|36-Week Induction Phase|Pregnancy|0|||
42094157|NCT00440947|75904311|FG002|36-Week Induction Phase|Pregnancy|0|||
42094158|NCT00440947|75904312|FG003|36-Week Induction Phase|Pregnancy|0|||
42094159|NCT00440947|75904313|FG004|36-Week Induction Phase|Pregnancy|0|||
42094160|NCT00440947|75904309|FG000|48-Week Randomization Phase|Adverse Event|0|||
42094161|NCT00440947|75904310|FG001|48-Week Randomization Phase|Adverse Event|2|||
42094162|NCT00440947|75904311|FG002|48-Week Randomization Phase|Adverse Event|5|||
42187585|NCT00031551|75997319|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
42187586|NCT00049257|75997329|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
42187587|NCT00049257|75997329|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
42187588|NCT00049257|75997329|FG000|Carboplatin, Paclitaxel|Death|2|||
42094163|NCT00440947|75904312|FG003|48-Week Randomization Phase|Adverse Event|0|||
42187589|NCT00049257|75997329|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
42187590|NCT03020992|75997333|FG000|Overall Study|Adverse Event|5|||
42187591|NCT03020992|75997333|FG000|Overall Study|Withdrawal by Subject|1|||
42187592|NCT03020914|75997340|FG000|Overall Study|Surgery Cancelled|1|||
42187593|NCT03020914|75997341|FG001|Overall Study|Surgery Cancelled|0|||
42187594|NCT03018340|75997349|FG000|Overall Study|Adverse Event|1|||
42187595|NCT03018340|75997350|FG001|Overall Study|Adverse Event|2|||
42094164|NCT00440947|75904313|FG004|48-Week Randomization Phase|Adverse Event|0|||
42094165|NCT00440947|75904309|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
42094166|NCT00440947|75904310|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
42094167|NCT00440947|75904311|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
42094168|NCT00440947|75904312|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
42094169|NCT00440947|75904313|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
42094170|NCT00440947|75904309|FG000|48-Week Randomization Phase|Non-compliance|0|||
42094171|NCT00440947|75904310|FG001|48-Week Randomization Phase|Non-compliance|3|||
42094172|NCT00440947|75904311|FG002|48-Week Randomization Phase|Non-compliance|4|||
42094173|NCT00440947|75904312|FG003|48-Week Randomization Phase|Non-compliance|0|||
42094174|NCT00440947|75904313|FG004|48-Week Randomization Phase|Non-compliance|0|||
42094175|NCT00440947|75904309|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
42094176|NCT00440947|75904310|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
42094177|NCT00440947|75904311|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
42094178|NCT00440947|75904312|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
42094179|NCT00440947|75904313|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
42094180|NCT00440947|75904309|FG000|48-Week Randomization Phase|Protocol Violation|0|||
42094181|NCT00440947|75904310|FG001|48-Week Randomization Phase|Protocol Violation|0|||
42094182|NCT00440947|75904311|FG002|48-Week Randomization Phase|Protocol Violation|1|||
42094183|NCT00440947|75904312|FG003|48-Week Randomization Phase|Protocol Violation|0|||
42094184|NCT00440947|75904313|FG004|48-Week Randomization Phase|Protocol Violation|0|||
42094185|NCT00440947|75904309|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
42187596|NCT03018340|75997349|FG000|Overall Study|Withdrawal by Subject|0|||
42187597|NCT03018340|75997350|FG001|Overall Study|Withdrawal by Subject|8|||
42187598|NCT03018340|75997349|FG000|Overall Study|Lack of Efficacy|0|||
42187599|NCT03018340|75997350|FG001|Overall Study|Lack of Efficacy|1|||
42187600|NCT03018340|75997349|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
42187601|NCT03018340|75997350|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
42187602|NCT03018340|75997349|FG000|Overall Study|Lost to Follow-up|1|||
42187603|NCT03018340|75997350|FG001|Overall Study|Lost to Follow-up|7|||
42187604|NCT03018340|75997349|FG000|Overall Study|Protocol Violation|3|||
42187605|NCT03018340|75997350|FG001|Overall Study|Protocol Violation|7|||
42187606|NCT03018340|75997349|FG000|Overall Study|Not further specified|0|||
42187607|NCT03018340|75997350|FG001|Overall Study|Not further specified|1|||
42187608|NCT03016078|75997360|FG000|Overall Study|Protocol Violation|1|||
42187609|NCT03016078|75997360|FG000|Overall Study|Protocol Violation|1|||
42187610|NCT00048165|75997366|FG000|Completed 6 Months Study|Administration/Other|8|||
42187611|NCT00048165|75997367|FG001|Completed 6 Months Study|Administration/Other|8|||
42187612|NCT00048165|75997366|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
42187613|NCT00048165|75997367|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
42187614|NCT00048165|75997366|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
42187615|NCT00048165|75997367|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
42187616|NCT00048165|75997366|FG000|Completed 6 Months Study|Death|12|||
42187617|NCT00048165|75997367|FG001|Completed 6 Months Study|Death|6|||
42187618|NCT00048165|75997366|FG000|Completed 6 Months Study|Insufficient therapy|1|||
42187619|NCT00048165|75997367|FG001|Completed 6 Months Study|Insufficient therapy|4|||
42187620|NCT00048165|75997366|FG000|Completed 6 Months Study|Other violation|4|||
42187621|NCT00048165|75997367|FG001|Completed 6 Months Study|Other violation|6|||
42187622|NCT00048165|75997366|FG000|Completed 6 Months Study|Refused treatment|5|||
42187623|NCT00048165|75997367|FG001|Completed 6 Months Study|Refused treatment|5|||
42187624|NCT00048165|75997366|FG000|Completed 6 Months Study|Violation criteria|0|||
42187625|NCT00048165|75997367|FG001|Completed 6 Months Study|Violation criteria|2|||
42187626|NCT00048165|75997366|FG000|Completed 6 Months Study|Did not receive study drug|6|||
42296011|NCT01359943|76130772|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
42094186|NCT00440947|75904310|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
42094187|NCT00440947|75904311|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
42094188|NCT00440947|75904312|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
42094189|NCT00440947|75904313|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
42187627|NCT00048165|75997367|FG001|Completed 6 Months Study|Did not receive study drug|6|||
42187628|NCT00048165|75997366|FG000|Completed 12 Months Study|Administration/Other|0|||
42187629|NCT00048165|75997367|FG001|Completed 12 Months Study|Administration/Other|2|||
42187630|NCT00048165|75997366|FG000|Completed 12 Months Study|Death|2|||
42187631|NCT00048165|75997367|FG001|Completed 12 Months Study|Death|1|||
42187632|NCT00048165|75997366|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
42187633|NCT00048165|75997367|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
42187634|NCT00059787|75997375|FG000|Overall Study|Adverse Event|13|||
42187635|NCT00059787|75997375|FG000|Overall Study|disease progression|2|||
42187636|NCT00059787|75997375|FG000|Overall Study|ineligible|1|||
42187637|NCT00059787|75997375|FG000|Overall Study|Other|4|||
42187638|NCT00058539|75997380|FG000|Overall Study|Disease progression|24|||
42187639|NCT00058539|75997380|FG000|Overall Study|Adverse Event|3|||
42094190|NCT00440947|75904309|FG000|48-Week Randomization Phase|Pregnancy|0|||
42094191|NCT00440947|75904310|FG001|48-Week Randomization Phase|Pregnancy|0|||
42094192|NCT00440947|75904311|FG002|48-Week Randomization Phase|Pregnancy|1|||
42094193|NCT00440947|75904312|FG003|48-Week Randomization Phase|Pregnancy|0|||
42094194|NCT00440947|75904313|FG004|48-Week Randomization Phase|Pregnancy|0|||
42094195|NCT00440947|75904309|FG000|48-Week Randomization Phase|Incarceration|0|||
42094196|NCT00440947|75904310|FG001|48-Week Randomization Phase|Incarceration|3|||
42094197|NCT00440947|75904311|FG002|48-Week Randomization Phase|Incarceration|0|||
42094198|NCT00440947|75904312|FG003|48-Week Randomization Phase|Incarceration|0|||
42094199|NCT00440947|75904313|FG004|48-Week Randomization Phase|Incarceration|0|||
42094200|NCT00440947|75904309|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
42094201|NCT00440947|75904310|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
42094202|NCT00440947|75904311|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
42094203|NCT00440947|75904312|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
42094204|NCT00440947|75904313|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
42094205|NCT00440947|75904309|FG000|48-Week Randomization Phase|Physician Decision|0|||
42094206|NCT00440947|75904310|FG001|48-Week Randomization Phase|Physician Decision|2|||
42094207|NCT00440947|75904311|FG002|48-Week Randomization Phase|Physician Decision|0|||
42094208|NCT00440947|75904312|FG003|48-Week Randomization Phase|Physician Decision|0|||
42094209|NCT00440947|75904313|FG004|48-Week Randomization Phase|Physician Decision|0|||
42094210|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
42094211|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
42094212|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
42094213|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
42094214|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
42094215|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
42187640|NCT00058539|75997380|FG000|Overall Study|Withdrawal by Subject|5|||
42187641|NCT00058539|75997380|FG000|Overall Study|Physician Decision|9|||
42187642|NCT00058539|75997380|FG000|Overall Study|Death|1|||
42187643|NCT03015532|75997392|FG000|Overall Study|Adverse Event|0|||
42187644|NCT03015532|75997393|FG001|Overall Study|Adverse Event|0|||
42187645|NCT03015532|75997394|FG002|Overall Study|Adverse Event|0|||
42187646|NCT03015532|75997395|FG003|Overall Study|Adverse Event|0|||
42187647|NCT03015532|75997396|FG004|Overall Study|Adverse Event|0|||
42187648|NCT03015532|75997397|FG005|Overall Study|Adverse Event|2|||
42187649|NCT03015532|75997398|FG006|Overall Study|Adverse Event|1|||
42187650|NCT03015532|75997399|FG007|Overall Study|Adverse Event|0|||
42187651|NCT03015532|75997392|FG000|Overall Study|Withdrawal by Subject|0|||
42187652|NCT03015532|75997393|FG001|Overall Study|Withdrawal by Subject|0|||
42187653|NCT03015532|75997394|FG002|Overall Study|Withdrawal by Subject|0|||
42187654|NCT03015532|75997395|FG003|Overall Study|Withdrawal by Subject|0|||
42187655|NCT03015532|75997396|FG004|Overall Study|Withdrawal by Subject|0|||
42187656|NCT03015532|75997397|FG005|Overall Study|Withdrawal by Subject|0|||
42187657|NCT03015532|75997398|FG006|Overall Study|Withdrawal by Subject|1|||
42187658|NCT03015532|75997399|FG007|Overall Study|Withdrawal by Subject|0|||
42187659|NCT00047463|75997421|FG000|Overall Study|Withdrawal by Subject|0|||
42187660|NCT00047463|75997422|FG001|Overall Study|Withdrawal by Subject|3|||
42187661|NCT03015220|75997435|FG000|Overall Study|Withdrawal by Subject|3|||
42187662|NCT03015220|75997436|FG001|Overall Study|Withdrawal by Subject|2|||
42187663|NCT03015220|75997437|FG002|Overall Study|Withdrawal by Subject|2|||
42187664|NCT03015220|75997438|FG003|Overall Study|Withdrawal by Subject|2|||
42187665|NCT03015220|75997435|FG000|Overall Study|Lost to Follow-up|0|||
42187666|NCT03015220|75997436|FG001|Overall Study|Lost to Follow-up|0|||
42187667|NCT03015220|75997437|FG002|Overall Study|Lost to Follow-up|1|||
42187668|NCT03015220|75997438|FG003|Overall Study|Lost to Follow-up|0|||
42187669|NCT00022659|75997448|FG000|Overall Study|Ineligible: wrong primary|1|||
42187670|NCT00022659|75997448|FG000|Overall Study|Never treated|1|||
42187671|NCT03014674|75997459|FG000|Overall Study|Withdrawal by Subject|1|||
42187672|NCT03014674|75997460|FG001|Overall Study|Withdrawal by Subject|0|||
42094216|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
42187673|NCT03014674|75997461|FG002|Overall Study|Withdrawal by Subject|0|||
42187674|NCT03018106|75997471|FG000|Overall Study|Lost to Follow-up|0|||
42187675|NCT03018106|75997472|FG001|Overall Study|Lost to Follow-up|1|||
42187676|NCT03018028|75997481|FG000|Overall Study|Withdrawal by Subject|3|||
42187677|NCT03018028|75997482|FG001|Overall Study|Withdrawal by Subject|0|||
42094217|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
42094218|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
42094219|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
42094220|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
42187678|NCT03018028|75997483|FG002|Overall Study|Withdrawal by Subject|1|||
42187679|NCT03018028|75997484|FG003|Overall Study|Withdrawal by Subject|2|||
42187680|NCT03018028|75997485|FG004|Overall Study|Withdrawal by Subject|0|||
42187681|NCT03010462|75997499|FG000|Overall Study|Withdrawal by Subject|3|||
42187682|NCT03010462|75997500|FG001|Overall Study|Withdrawal by Subject|1|||
42187683|NCT00021255|75997509|FG000|Overall Study|Death|1|||
42187684|NCT00021255|75997510|FG001|Overall Study|Death|0|||
42187685|NCT00021255|75997511|FG002|Overall Study|Death|2|||
42187686|NCT00021255|75997509|FG000|Overall Study|Breast cancer relapse|5|||
42187687|NCT00021255|75997510|FG001|Overall Study|Breast cancer relapse|18|||
42187688|NCT00021255|75997511|FG002|Overall Study|Breast cancer relapse|11|||
42187689|NCT00021255|75997509|FG000|Overall Study|Second primary malignancy|0|||
42187690|NCT00021255|75997510|FG001|Overall Study|Second primary malignancy|4|||
42187691|NCT00021255|75997511|FG002|Overall Study|Second primary malignancy|1|||
42187692|NCT00021255|75997509|FG000|Overall Study|Withdrawal by Subject|41|||
42187693|NCT00021255|75997510|FG001|Overall Study|Withdrawal by Subject|64|||
42094221|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
42094222|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
42187694|NCT00021255|75997511|FG002|Overall Study|Withdrawal by Subject|26|||
42187695|NCT00021255|75997509|FG000|Overall Study|Lost to Follow-up|0|||
42187696|NCT00021255|75997510|FG001|Overall Study|Lost to Follow-up|2|||
42187697|NCT00021255|75997511|FG002|Overall Study|Lost to Follow-up|3|||
42187698|NCT00021255|75997509|FG000|Overall Study|Cardiac toxicity|0|||
42187699|NCT00021255|75997510|FG001|Overall Study|Cardiac toxicity|61|||
42187700|NCT00021255|75997511|FG002|Overall Study|Cardiac toxicity|32|||
42187701|NCT00021255|75997509|FG000|Overall Study|Herceptin toxicity|0|||
42187702|NCT00021255|75997510|FG001|Overall Study|Herceptin toxicity|22|||
42187703|NCT00021255|75997511|FG002|Overall Study|Herceptin toxicity|6|||
42187704|NCT00021255|75997509|FG000|Overall Study|Adverse Event|46|||
42187705|NCT00021255|75997510|FG001|Overall Study|Adverse Event|30|||
42187706|NCT00021255|75997511|FG002|Overall Study|Adverse Event|18|||
42187707|NCT00021255|75997509|FG000|Overall Study|Protocol Violation|0|||
42187708|NCT00021255|75997510|FG001|Overall Study|Protocol Violation|2|||
42187709|NCT00021255|75997511|FG002|Overall Study|Protocol Violation|0|||
42296012|NCT01359943|76130773|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
42296013|NCT01359943|76130774|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
42296014|NCT01359943|76130772|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
42296015|NCT01359943|76130773|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
42296016|NCT01359943|76130774|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
42296017|NCT01359943|76130772|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
42296018|NCT01359943|76130773|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
42296019|NCT01359943|76130774|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
42296020|NCT01359943|76130772|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
42296021|NCT01359943|76130773|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
42296022|NCT01359943|76130774|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
42296023|NCT01359943|76130772|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
42296024|NCT01359943|76130773|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
42296025|NCT01359943|76130774|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
42296026|NCT01359943|76130772|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
42296027|NCT01359943|76130773|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
42296028|NCT01359943|76130774|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
42296029|NCT01359943|76130772|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
42296030|NCT01359943|76130773|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
42296031|NCT01359943|76130774|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
42296032|NCT01359943|76130772|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
42296033|NCT01359943|76130773|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
42296034|NCT01359943|76130774|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
42296035|NCT01359943|76130772|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
42296036|NCT01359943|76130773|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
42296037|NCT01359943|76130774|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
42296038|NCT01359943|76130772|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
42094223|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
42094224|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
42094225|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
42094226|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
42094227|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
42296039|NCT01359943|76130773|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
42296040|NCT01359943|76130774|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
42296041|NCT02432703|76130786|FG000|Overall Study|Adverse Event|1|||
42296042|NCT02432703|76130787|FG001|Overall Study|Adverse Event|4|||
42296043|NCT02432703|76130786|FG000|Overall Study|Lack of Efficacy|1|||
42187710|NCT00021255|75997509|FG000|Overall Study|Other than specified above|0|||
42187711|NCT00021255|75997510|FG001|Overall Study|Other than specified above|38|||
42187712|NCT00021255|75997511|FG002|Overall Study|Other than specified above|19|||
42187713|NCT00021255|75997509|FG000|Overall Study|Missing|0|||
42187714|NCT00021255|75997510|FG001|Overall Study|Missing|27|||
42187715|NCT00021255|75997511|FG002|Overall Study|Missing|13|||
42187716|NCT00021255|75997509|FG000|Overall Study|Randomized but not treated|28|||
42187717|NCT00021255|75997510|FG001|Overall Study|Randomized but not treated|2|||
42187718|NCT00021255|75997511|FG002|Overall Study|Randomized but not treated|18|||
42187719|NCT03012334|75997529|FG000|Period 1|Withdrawal by Subject|0|||
42187720|NCT03012334|75997530|FG001|Period 1|Withdrawal by Subject|0|||
42187721|NCT03012334|75997531|FG002|Period 1|Withdrawal by Subject|0|||
42187722|NCT03012334|75997532|FG003|Period 1|Withdrawal by Subject|0|||
42094228|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
42094229|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
42094230|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
42094231|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
42094232|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
42094233|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
42094234|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
42094235|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
42094236|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
42094237|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
42094238|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
42094239|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
42187723|NCT03012334|75997533|FG004|Period 1|Withdrawal by Subject|0|||
42187724|NCT03012334|75997534|FG005|Period 1|Withdrawal by Subject|0|||
42187725|NCT03012334|75997535|FG006|Period 1|Withdrawal by Subject|0|||
42187726|NCT03012334|75997536|FG007|Period 1|Withdrawal by Subject|0|||
42187727|NCT03012334|75997537|FG008|Period 1|Withdrawal by Subject|0|||
42187728|NCT03012334|75997538|FG009|Period 1|Withdrawal by Subject|1|||
42187729|NCT03012334|75997529|FG000|Period 2|Withdrawal by Subject|0|||
42187730|NCT03012334|75997530|FG001|Period 2|Withdrawal by Subject|1|||
42187731|NCT03012334|75997531|FG002|Period 2|Withdrawal by Subject|0|||
42187732|NCT03012334|75997532|FG003|Period 2|Withdrawal by Subject|0|||
42187733|NCT03012334|75997533|FG004|Period 2|Withdrawal by Subject|0|||
42187734|NCT03012334|75997534|FG005|Period 2|Withdrawal by Subject|0|||
42187735|NCT03012334|75997535|FG006|Period 2|Withdrawal by Subject|0|||
42187736|NCT03012334|75997536|FG007|Period 2|Withdrawal by Subject|0|||
42187737|NCT03012334|75997537|FG008|Period 2|Withdrawal by Subject|0|||
42187738|NCT03012334|75997538|FG009|Period 2|Withdrawal by Subject|0|||
42187739|NCT03012334|75997529|FG000|Period 2|Protocol Violation|0|||
42187740|NCT03012334|75997530|FG001|Period 2|Protocol Violation|0|||
42094240|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
42094241|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
42187741|NCT03012334|75997531|FG002|Period 2|Protocol Violation|1|||
42187742|NCT03012334|75997532|FG003|Period 2|Protocol Violation|0|||
42187743|NCT03012334|75997533|FG004|Period 2|Protocol Violation|0|||
42187744|NCT03012334|75997534|FG005|Period 2|Protocol Violation|0|||
42187745|NCT03012334|75997535|FG006|Period 2|Protocol Violation|0|||
42187746|NCT03012334|75997536|FG007|Period 2|Protocol Violation|1|||
42187747|NCT03012334|75997537|FG008|Period 2|Protocol Violation|0|||
42187748|NCT03012334|75997538|FG009|Period 2|Protocol Violation|0|||
42187749|NCT03012334|75997529|FG000|Period 4|Non-Compliance|0|||
42187750|NCT03012334|75997530|FG001|Period 4|Non-Compliance|0|||
42187751|NCT03012334|75997531|FG002|Period 4|Non-Compliance|0|||
42187752|NCT03012334|75997532|FG003|Period 4|Non-Compliance|0|||
42187753|NCT03012334|75997533|FG004|Period 4|Non-Compliance|0|||
42187754|NCT03012334|75997534|FG005|Period 4|Non-Compliance|0|||
42296044|NCT02432703|76130787|FG001|Overall Study|Lack of Efficacy|0|||
42296045|NCT02432703|76130786|FG000|Overall Study|Lost to Follow-up|5|||
42094242|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
42094243|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
42094244|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
42094245|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
42094246|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
42094247|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
42094248|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
42094249|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
42187755|NCT03012334|75997535|FG006|Period 4|Non-Compliance|1|||
42187756|NCT03012334|75997536|FG007|Period 4|Non-Compliance|0|||
42094250|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
42187757|NCT03012334|75997537|FG008|Period 4|Non-Compliance|0|||
42187758|NCT03012334|75997538|FG009|Period 4|Non-Compliance|0|||
42187759|NCT03012334|75997529|FG000|Period 4|Adverse Event|0|||
42296046|NCT02432703|76130787|FG001|Overall Study|Lost to Follow-up|3|||
42187760|NCT03012334|75997530|FG001|Period 4|Adverse Event|0|||
42187761|NCT03012334|75997531|FG002|Period 4|Adverse Event|0|||
42187762|NCT03012334|75997532|FG003|Period 4|Adverse Event|0|||
42187763|NCT03012334|75997533|FG004|Period 4|Adverse Event|0|||
42187764|NCT03012334|75997534|FG005|Period 4|Adverse Event|0|||
42187765|NCT03012334|75997535|FG006|Period 4|Adverse Event|0|||
42187766|NCT03012334|75997536|FG007|Period 4|Adverse Event|0|||
42094251|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
42094252|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
42094253|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
42094254|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
42187767|NCT03012334|75997537|FG008|Period 4|Adverse Event|1|||
42187768|NCT03012334|75997538|FG009|Period 4|Adverse Event|0|||
42187769|NCT03565068|75997560|FG000|Overall Study|Protocol Violation|0|||
42187770|NCT03565068|75997561|FG001|Overall Study|Protocol Violation|0|||
42187771|NCT03565068|75997562|FG002|Overall Study|Protocol Violation|0|||
42187772|NCT03565068|75997563|FG003|Overall Study|Protocol Violation|0|||
42187773|NCT03565068|75997564|FG004|Overall Study|Protocol Violation|1|||
42187774|NCT03565068|75997565|FG005|Overall Study|Protocol Violation|0|||
42187775|NCT03565068|75997566|FG006|Overall Study|Protocol Violation|0|||
42187776|NCT03565068|75997567|FG007|Overall Study|Protocol Violation|1|||
42187777|NCT03565068|75997568|FG008|Overall Study|Protocol Violation|0|||
42187778|NCT03565068|75997560|FG000|Overall Study|Sponsor decision|0|||
42187779|NCT03565068|75997561|FG001|Overall Study|Sponsor decision|0|||
42187780|NCT03565068|75997562|FG002|Overall Study|Sponsor decision|0|||
42187781|NCT03565068|75997563|FG003|Overall Study|Sponsor decision|0|||
42187782|NCT03565068|75997564|FG004|Overall Study|Sponsor decision|1|||
42187783|NCT03565068|75997565|FG005|Overall Study|Sponsor decision|1|||
42094255|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
42094256|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
42094257|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
42094258|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
42187784|NCT03565068|75997566|FG006|Overall Study|Sponsor decision|0|||
42187785|NCT03565068|75997567|FG007|Overall Study|Sponsor decision|0|||
42187786|NCT03565068|75997568|FG008|Overall Study|Sponsor decision|0|||
42187787|NCT03565068|75997560|FG000|Overall Study|Withdrawal by Subject|0|||
42187788|NCT03565068|75997561|FG001|Overall Study|Withdrawal by Subject|0|||
42187789|NCT03565068|75997562|FG002|Overall Study|Withdrawal by Subject|1|||
42187790|NCT03565068|75997563|FG003|Overall Study|Withdrawal by Subject|0|||
42187791|NCT03565068|75997564|FG004|Overall Study|Withdrawal by Subject|2|||
42187792|NCT03565068|75997565|FG005|Overall Study|Withdrawal by Subject|0|||
42187793|NCT03565068|75997566|FG006|Overall Study|Withdrawal by Subject|1|||
42187794|NCT03565068|75997567|FG007|Overall Study|Withdrawal by Subject|5|||
42187795|NCT03565068|75997568|FG008|Overall Study|Withdrawal by Subject|1|||
42187796|NCT03565068|75997560|FG000|Overall Study|Physician Decision|0|||
42187797|NCT03565068|75997561|FG001|Overall Study|Physician Decision|0|||
42187798|NCT03565068|75997562|FG002|Overall Study|Physician Decision|0|||
42187799|NCT03565068|75997563|FG003|Overall Study|Physician Decision|0|||
42187800|NCT03565068|75997564|FG004|Overall Study|Physician Decision|0|||
42187801|NCT03565068|75997565|FG005|Overall Study|Physician Decision|0|||
42187802|NCT03565068|75997566|FG006|Overall Study|Physician Decision|0|||
42187803|NCT03565068|75997567|FG007|Overall Study|Physician Decision|1|||
42094259|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
42094260|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
42094261|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
42094262|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
42094263|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
42094264|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
42094265|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Other|0|||
42094266|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Other|0|||
42094267|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Other|0|||
42094268|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Other|1|||
42094269|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Other|0|||
42094270|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
42094271|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
42094272|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
42094273|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
42094274|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
42094275|NCT00440947|75904309|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
42094276|NCT00440947|75904310|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
42187804|NCT03565068|75997568|FG008|Overall Study|Physician Decision|0|||
42187805|NCT03565068|75997560|FG000|Overall Study|Lost to Follow-up|0|||
42187806|NCT03565068|75997561|FG001|Overall Study|Lost to Follow-up|0|||
42187807|NCT03565068|75997562|FG002|Overall Study|Lost to Follow-up|0|||
42187808|NCT03565068|75997563|FG003|Overall Study|Lost to Follow-up|0|||
42187809|NCT03565068|75997564|FG004|Overall Study|Lost to Follow-up|0|||
42187810|NCT03565068|75997565|FG005|Overall Study|Lost to Follow-up|0|||
42187811|NCT03565068|75997566|FG006|Overall Study|Lost to Follow-up|0|||
42187812|NCT03565068|75997567|FG007|Overall Study|Lost to Follow-up|1|||
42187813|NCT03565068|75997568|FG008|Overall Study|Lost to Follow-up|0|||
42187814|NCT00010803|75997627|FG000|Overall Study|Withdrawal by Subject|97|||
42187815|NCT00010803|75997628|FG001|Overall Study|Withdrawal by Subject|98|||
42094277|NCT00440947|75904311|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
42094278|NCT00440947|75904312|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
42094279|NCT00440947|75904313|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
42094280|NCT00664521|75904336|FG000|Overall Study|Adverse Event|4|||
42094281|NCT00664521|75904337|FG001|Overall Study|Adverse Event|1|||
42094282|NCT00664521|75904336|FG000|Overall Study|Lost to Follow-up|1|||
42094283|NCT00664521|75904337|FG001|Overall Study|Lost to Follow-up|0|||
42094284|NCT00664521|75904336|FG000|Overall Study|Other|1|||
42094285|NCT00664521|75904337|FG001|Overall Study|Other|0|||
42094286|NCT00664209|75904343|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
42094287|NCT00664209|75904343|FG000|Study Treatment Period|Physician Decision|4|||
42094288|NCT00664209|75904343|FG000|Study Treatment Period|Withdrawal by Subject|2|||
42094289|NCT00440557|75904351|FG000|Overall Study|Withdrawal by Subject|10|||
42094290|NCT00440557|75904352|FG001|Overall Study|Withdrawal by Subject|5|||
42094291|NCT00440557|75904353|FG002|Overall Study|Withdrawal by Subject|11|||
42094292|NCT00440557|75904351|FG000|Overall Study|Lost to Follow-up|1|||
42094293|NCT00440557|75904352|FG001|Overall Study|Lost to Follow-up|2|||
42187816|NCT02914834|75997636|FG000|Overall Study|Study halted due to COVID|1|||
42187817|NCT02914834|75997637|FG001|Overall Study|Study halted due to COVID|1|||
42187818|NCT02914834|75997636|FG000|Overall Study|1 subject withdrew|0|||
42187819|NCT02914834|75997637|FG001|Overall Study|1 subject withdrew|1|||
42187820|NCT03497130|75997645|FG000|Overall Study|Lost to Follow-up|1|||
42187821|NCT03497130|75997646|FG001|Overall Study|Lost to Follow-up|1|||
42094294|NCT00440557|75904353|FG002|Overall Study|Lost to Follow-up|6|||
42094295|NCT00440557|75904351|FG000|Overall Study|Adverse Event|3|||
42187822|NCT03006562|75997654|FG000|Overall Study|Lost to Follow-up|0|||
42187823|NCT03006562|75997655|FG001|Overall Study|Lost to Follow-up|1|||
42187824|NCT03007966|75997663|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
42187825|NCT03007966|75997664|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
42187826|NCT03007888|75997671|FG000|First Intervention (14 Days)|Adverse Event|1|||
42187827|NCT03007888|75997672|FG001|First Intervention (14 Days)|Adverse Event|0|||
42187828|NCT03541044|75997681|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
42187829|NCT03541044|75997682|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
42187830|NCT03541044|75997681|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
42187831|NCT03541044|75997682|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
42187832|NCT00009945|75997692|FG000|Overall Study|no follow up data|7|||
42187833|NCT00009945|75997693|FG001|Overall Study|no follow up data|5|||
42187834|NCT03540030|75997701|FG000|Overall Study|Withdrawal by Subject|2|||
42094296|NCT00440557|75904352|FG001|Overall Study|Adverse Event|3|||
42094297|NCT00440557|75904353|FG002|Overall Study|Adverse Event|5|||
42094298|NCT00440557|75904351|FG000|Overall Study|Death|2|||
42094299|NCT00440557|75904352|FG001|Overall Study|Death|6|||
42094300|NCT00440557|75904353|FG002|Overall Study|Death|3|||
42094301|NCT00440557|75904351|FG000|Overall Study|Began Dialysis|4|||
42094302|NCT00440557|75904352|FG001|Overall Study|Began Dialysis|1|||
42094303|NCT00440557|75904353|FG002|Overall Study|Began Dialysis|4|||
42094304|NCT00440557|75904351|FG000|Overall Study|Principal Investigator decision|0|||
42094305|NCT00440557|75904352|FG001|Overall Study|Principal Investigator decision|3|||
42187835|NCT03540030|75997702|FG001|Overall Study|Withdrawal by Subject|1|||
42187836|NCT03540030|75997701|FG000|Overall Study|screen fail|7|||
42094306|NCT00440557|75904353|FG002|Overall Study|Principal Investigator decision|1|||
42094307|NCT00440557|75904351|FG000|Overall Study|Patient moved|1|||
42094308|NCT00440557|75904352|FG001|Overall Study|Patient moved|2|||
42187837|NCT03540030|75997702|FG001|Overall Study|screen fail|1|||
42187838|NCT03540030|75997701|FG000|Overall Study|never had surgery after signing consent|9|||
42094309|NCT00440557|75904353|FG002|Overall Study|Patient moved|1|||
42094310|NCT00440557|75904351|FG000|Overall Study|Principal Investigator's office closed|3|||
42094311|NCT00440557|75904352|FG001|Overall Study|Principal Investigator's office closed|6|||
42187839|NCT03540030|75997702|FG001|Overall Study|never had surgery after signing consent|1|||
42187840|NCT03003676|75997710|FG000|Overall Study|Lack of Efficacy|5|||
42187841|NCT03003676|75997711|FG001|Overall Study|Lack of Efficacy|7|||
42187842|NCT03003676|75997710|FG000|Overall Study|Withdrawal by Subject|0|||
42187843|NCT03003676|75997711|FG001|Overall Study|Withdrawal by Subject|1|||
42187844|NCT03003676|75997710|FG000|Overall Study|Hepatitis B infection|1|||
42187845|NCT03003676|75997711|FG001|Overall Study|Hepatitis B infection|0|||
42094312|NCT00440557|75904353|FG002|Overall Study|Principal Investigator's office closed|4|||
42094313|NCT00440557|75904351|FG000|Overall Study|Patient transferred to nursing home|0|||
42187846|NCT00047385|75997721|FG000|Overall Study|Death before any screening|2|||
42187847|NCT00047385|75997722|FG001|Overall Study|Death before any screening|5|||
42187848|NCT00047385|75997721|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
42187849|NCT00047385|75997722|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
42187850|NCT00047385|75997721|FG000|Overall Study|Eligible for screening but had no screen|260|||
42187851|NCT00047385|75997722|FG001|Overall Study|Eligible for screening but had no screen|492|||
42094314|NCT00440557|75904352|FG001|Overall Study|Patient transferred to nursing home|1|||
42094315|NCT00440557|75904353|FG002|Overall Study|Patient transferred to nursing home|0|||
42094316|NCT00440557|75904351|FG000|Overall Study|Patient had surgery|1|||
42094317|NCT00440557|75904352|FG001|Overall Study|Patient had surgery|0|||
42094318|NCT00440557|75904353|FG002|Overall Study|Patient had surgery|0|||
42094319|NCT00582608|75904413|FG000|Overall Study|Not Treated|7|||
42094320|NCT00582608|75904413|FG000|Overall Study|Patient Ineligible|1|||
42094321|NCT00582608|75904413|FG000|Overall Study|Lack of accrual|4|||
42094322|NCT03014570|75904419|FG000|Overall Study|COVID-19 Restrictions|38|||
42094323|NCT03014570|75904420|FG001|Overall Study|COVID-19 Restrictions|24|||
42094324|NCT03014570|75904419|FG000|Overall Study|Death|70|||
42094325|NCT03014570|75904420|FG001|Overall Study|Death|79|||
42094326|NCT03014570|75904419|FG000|Overall Study|Transfer from facility|11|||
42094327|NCT03014570|75904420|FG001|Overall Study|Transfer from facility|14|||
42094328|NCT03014570|75904419|FG000|Overall Study|Hospitalized|5|||
42094329|NCT03014570|75904420|FG001|Overall Study|Hospitalized|3|||
42094330|NCT03014570|75904419|FG000|Overall Study|Transfer within facility|1|||
42094331|NCT03014570|75904420|FG001|Overall Study|Transfer within facility|0|||
42094332|NCT03014570|75904419|FG000|Overall Study|Site refusal|0|||
42094333|NCT03014570|75904420|FG001|Overall Study|Site refusal|11|||
42094334|NCT00427999|75904427|FG000|Overall Study|Adverse Event|6|||
42094335|NCT00427999|75904427|FG000|Overall Study|Abnormal laboratory values|1|||
42094336|NCT00427999|75904427|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
42094337|NCT00427999|75904427|FG000|Overall Study|Protocol Violation|2|||
42094338|NCT00427999|75904427|FG000|Overall Study|Withdrawal by Subject|9|||
42094339|NCT00427999|75904427|FG000|Overall Study|Death|1|||
42094340|NCT00661713|75904440|FG000|Overall Study|Death|1|||
42094341|NCT00661713|75904441|FG001|Overall Study|Death|0|||
42094342|NCT00661713|75904442|FG002|Overall Study|Death|0|||
42094343|NCT00661713|75904443|FG003|Overall Study|Death|0|||
42094344|NCT00661713|75904444|FG004|Overall Study|Death|1|||
42094345|NCT00661713|75904445|FG005|Overall Study|Death|0|||
42094346|NCT00661713|75904446|FG006|Overall Study|Death|0|||
42187852|NCT03002818|75997728|FG000|Overall Study|Decision of the investigator|1|||
42187853|NCT03002194|75997732|FG000|Overall Study|Lost to Follow-up|6|||
42187854|NCT03002194|75997732|FG000|Overall Study|Adverse Event|1|||
42187855|NCT03002194|75997732|FG000|Overall Study|Lack of Efficacy|1|||
42187856|NCT03002194|75997732|FG000|Overall Study|Withdrawal by Subject|2|||
42187857|NCT02912650|75997740|FG000|Overall Study|Withdrawal by Subject|1|||
42187858|NCT02912650|75997741|FG001|Overall Study|Withdrawal by Subject|0|||
42187859|NCT02912650|75997742|FG002|Overall Study|Withdrawal by Subject|1|||
42187860|NCT02912650|75997743|FG003|Overall Study|Withdrawal by Subject|5|||
42187861|NCT02912650|75997740|FG000|Overall Study|Adverse Event|0|||
42187862|NCT02912650|75997741|FG001|Overall Study|Adverse Event|0|||
42187863|NCT02912650|75997742|FG002|Overall Study|Adverse Event|1|||
42187864|NCT02912650|75997743|FG003|Overall Study|Adverse Event|0|||
42296047|NCT02432703|76130786|FG000|Overall Study|Withdrawal by Subject|9|||
42296048|NCT02432703|76130787|FG001|Overall Study|Withdrawal by Subject|6|||
42296049|NCT02432703|76130786|FG000|Overall Study|Other|6|||
42094347|NCT00661713|75904447|FG007|Overall Study|Death|0|||
42094348|NCT00661713|75904440|FG000|Overall Study|Unable to Classify|1|||
42094349|NCT00661713|75904441|FG001|Overall Study|Unable to Classify|0|||
42094350|NCT00661713|75904442|FG002|Overall Study|Unable to Classify|0|||
42094351|NCT00661713|75904443|FG003|Overall Study|Unable to Classify|0|||
42094352|NCT00661713|75904444|FG004|Overall Study|Unable to Classify|0|||
42187865|NCT03004924|75997756|FG000|Overall Study|Adverse Event|6|||
42187866|NCT03004924|75997757|FG001|Overall Study|Adverse Event|5|||
42187867|NCT03004924|75997758|FG002|Overall Study|Adverse Event|10|||
42296050|NCT02432703|76130787|FG001|Overall Study|Other|5|||
42094353|NCT00661713|75904445|FG005|Overall Study|Unable to Classify|0|||
42094354|NCT00661713|75904446|FG006|Overall Study|Unable to Classify|0|||
42094355|NCT00661713|75904447|FG007|Overall Study|Unable to Classify|0|||
42094356|NCT00661713|75904440|FG000|Overall Study|Protocol Violation|1|||
42094357|NCT00661713|75904441|FG001|Overall Study|Protocol Violation|6|||
42094358|NCT00661713|75904442|FG002|Overall Study|Protocol Violation|3|||
42094359|NCT00661713|75904443|FG003|Overall Study|Protocol Violation|3|||
42094360|NCT00661713|75904444|FG004|Overall Study|Protocol Violation|0|||
42094361|NCT00661713|75904445|FG005|Overall Study|Protocol Violation|2|||
42094362|NCT00661713|75904446|FG006|Overall Study|Protocol Violation|2|||
42187868|NCT03004924|75997756|FG000|Overall Study|Protocol Violation|4|||
42187869|NCT03004924|75997757|FG001|Overall Study|Protocol Violation|0|||
42187870|NCT03004924|75997758|FG002|Overall Study|Protocol Violation|1|||
42187871|NCT03004924|75997756|FG000|Overall Study|Withdrawal by Subject|5|||
42094363|NCT00661713|75904447|FG007|Overall Study|Protocol Violation|1|||
42094364|NCT00661713|75904440|FG000|Overall Study|Withdrawal by Subject|11|||
42094365|NCT00661713|75904441|FG001|Overall Study|Withdrawal by Subject|25|||
42187872|NCT03004924|75997757|FG001|Overall Study|Withdrawal by Subject|3|||
42187873|NCT03004924|75997758|FG002|Overall Study|Withdrawal by Subject|5|||
42187874|NCT03004924|75997756|FG000|Overall Study|Lost to Follow-up|6|||
42187875|NCT03004924|75997757|FG001|Overall Study|Lost to Follow-up|1|||
42187876|NCT03004924|75997758|FG002|Overall Study|Lost to Follow-up|4|||
42187877|NCT03004924|75997756|FG000|Overall Study|Lack of Efficacy|2|||
42187878|NCT03004924|75997757|FG001|Overall Study|Lack of Efficacy|4|||
42187879|NCT03004924|75997758|FG002|Overall Study|Lack of Efficacy|2|||
42187880|NCT03004924|75997756|FG000|Overall Study|Physician Decision|1|||
42187881|NCT03004924|75997757|FG001|Overall Study|Physician Decision|0|||
42187882|NCT03004924|75997758|FG002|Overall Study|Physician Decision|1|||
42187883|NCT03004924|75997756|FG000|Overall Study|Withdrawal by parent/guardian|1|||
42187884|NCT03004924|75997757|FG001|Overall Study|Withdrawal by parent/guardian|0|||
42187885|NCT03004924|75997758|FG002|Overall Study|Withdrawal by parent/guardian|2|||
42187886|NCT03004924|75997756|FG000|Overall Study|Screen Failure|1|||
42187887|NCT03004924|75997757|FG001|Overall Study|Screen Failure|0|||
42187888|NCT03004924|75997758|FG002|Overall Study|Screen Failure|0|||
42187889|NCT03004924|75997756|FG000|Overall Study|Pregnancy|0|||
42187890|NCT03004924|75997757|FG001|Overall Study|Pregnancy|1|||
42187891|NCT03004924|75997758|FG002|Overall Study|Pregnancy|0|||
42187892|NCT03004924|75997756|FG000|Overall Study|Terminated by Sponsor|0|||
42187893|NCT03004924|75997757|FG001|Overall Study|Terminated by Sponsor|0|||
42187894|NCT03004924|75997758|FG002|Overall Study|Terminated by Sponsor|1|||
42187895|NCT03004924|75997756|FG000|Overall Study|Missed Study Visit|0|||
42187896|NCT03004924|75997757|FG001|Overall Study|Missed Study Visit|0|||
42187897|NCT03004924|75997758|FG002|Overall Study|Missed Study Visit|2|||
42187898|NCT03004924|75997756|FG000|Overall Study|HSV1 Positive|1|||
42187899|NCT03004924|75997757|FG001|Overall Study|HSV1 Positive|0|||
42187900|NCT03004924|75997758|FG002|Overall Study|HSV1 Positive|0|||
42018181|NCT00996892|75825863|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
42018182|NCT00996892|75825864|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
42018183|NCT00996892|75825865|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
42187901|NCT03002038|75997769|FG000|Overall Study|Adverse Event|3|||
42187902|NCT03002038|75997770|FG001|Overall Study|Adverse Event|1|||
42187903|NCT03002038|75997769|FG000|Overall Study|Withdrawal by Subject|8|||
42187904|NCT03002038|75997770|FG001|Overall Study|Withdrawal by Subject|4|||
42187905|NCT03002038|75997769|FG000|Overall Study|Immigration to another region|0|||
42187906|NCT03002038|75997770|FG001|Overall Study|Immigration to another region|2|||
42187907|NCT02911948|75997778|FG000|Overall Study|Protocol Violation|0|||
42187908|NCT02911948|75997779|FG001|Overall Study|Protocol Violation|1|||
42187909|NCT02911948|75997778|FG000|Overall Study|Withdrawal by Subject|0|||
42187910|NCT02911948|75997779|FG001|Overall Study|Withdrawal by Subject|2|||
42187911|NCT02911948|75997778|FG000|Overall Study|Lack of Efficacy|0|||
42187912|NCT02911948|75997779|FG001|Overall Study|Lack of Efficacy|1|||
42187913|NCT02911948|75997778|FG000|Overall Study|Unclassified|0|||
42187914|NCT02911948|75997779|FG001|Overall Study|Unclassified|3|||
42187915|NCT02996968|75997787|FG000|Overall Study|Withdrawal by Subject|1|||
42187916|NCT02996968|75997788|FG001|Overall Study|Withdrawal by Subject|0|||
42094366|NCT00661713|75904442|FG002|Overall Study|Withdrawal by Subject|12|||
42094367|NCT00661713|75904443|FG003|Overall Study|Withdrawal by Subject|21|||
42187917|NCT00027027|75997799|FG000|Overall Study|Adverse Event|0|||
42018184|NCT00996892|75825866|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
42018185|NCT00996892|75825867|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
42018186|NCT00996892|75825868|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
42018187|NCT00996892|75825869|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
42018188|NCT00996892|75825870|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
42094368|NCT00661713|75904444|FG004|Overall Study|Withdrawal by Subject|12|||
42094369|NCT00661713|75904445|FG005|Overall Study|Withdrawal by Subject|26|||
42187918|NCT00027027|75997800|FG001|Overall Study|Adverse Event|0|||
42187919|NCT00027027|75997801|FG002|Overall Study|Adverse Event|1|||
42187920|NCT00027027|75997802|FG003|Overall Study|Adverse Event|0|||
42187921|NCT00027027|75997803|FG004|Overall Study|Adverse Event|1|||
42187922|NCT00027027|75997799|FG000|Overall Study|Admitted for Signs of PD|0|||
42187923|NCT00027027|75997800|FG001|Overall Study|Admitted for Signs of PD|0|||
42094370|NCT00661713|75904446|FG006|Overall Study|Withdrawal by Subject|45|||
42094371|NCT00661713|75904447|FG007|Overall Study|Withdrawal by Subject|9|||
42187924|NCT00027027|75997801|FG002|Overall Study|Admitted for Signs of PD|0|||
42187925|NCT00027027|75997802|FG003|Overall Study|Admitted for Signs of PD|0|||
42187926|NCT00027027|75997803|FG004|Overall Study|Admitted for Signs of PD|1|||
42187927|NCT00027027|75997799|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
42187928|NCT00027027|75997800|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
42187929|NCT00027027|75997801|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
42187930|NCT00027027|75997802|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
42187931|NCT00027027|75997803|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
42187932|NCT00027027|75997799|FG000|Overall Study|PD Requiring Surgery|0|||
42187933|NCT00027027|75997800|FG001|Overall Study|PD Requiring Surgery|0|||
42187934|NCT00027027|75997801|FG002|Overall Study|PD Requiring Surgery|1|||
42187935|NCT00027027|75997802|FG003|Overall Study|PD Requiring Surgery|0|||
42187936|NCT00027027|75997803|FG004|Overall Study|PD Requiring Surgery|0|||
42187937|NCT00027027|75997799|FG000|Overall Study|Physician Decision Due To PD|2|||
42187938|NCT00027027|75997800|FG001|Overall Study|Physician Decision Due To PD|3|||
42187939|NCT00027027|75997801|FG002|Overall Study|Physician Decision Due To PD|2|||
42187940|NCT00027027|75997802|FG003|Overall Study|Physician Decision Due To PD|3|||
42187941|NCT00027027|75997803|FG004|Overall Study|Physician Decision Due To PD|5|||
42187942|NCT00027027|75997799|FG000|Overall Study|Withdrawal by Subject|0|||
42187943|NCT00027027|75997800|FG001|Overall Study|Withdrawal by Subject|0|||
42187944|NCT00027027|75997801|FG002|Overall Study|Withdrawal by Subject|0|||
42187945|NCT00027027|75997802|FG003|Overall Study|Withdrawal by Subject|0|||
42187946|NCT00027027|75997803|FG004|Overall Study|Withdrawal by Subject|1|||
42187947|NCT00046839|75997821|FG000|Overall Study|Ineligible / No protocol treatment|0|||
42187948|NCT00046839|75997822|FG001|Overall Study|Ineligible / No protocol treatment|2|||
42187949|NCT00046839|75997821|FG000|Overall Study|Withdrawal of consent|1|||
42187950|NCT00046839|75997822|FG001|Overall Study|Withdrawal of consent|0|||
42187951|NCT00006903|75997831|FG000|Overall Study|Still receiving treatment|0|||
42187952|NCT00006903|75997832|FG001|Overall Study|Still receiving treatment|0|||
42187953|NCT00006903|75997833|FG002|Overall Study|Still receiving treatment|1|||
42187954|NCT00006903|75997831|FG000|Overall Study|Refused further treatment|0|||
42187955|NCT00006903|75997832|FG001|Overall Study|Refused further treatment|2|||
42187956|NCT00006903|75997833|FG002|Overall Study|Refused further treatment|1|||
42187957|NCT00006903|75997831|FG000|Overall Study|Adverse Event|0|||
42187958|NCT00006903|75997832|FG001|Overall Study|Adverse Event|0|||
42187959|NCT00006903|75997833|FG002|Overall Study|Adverse Event|1|||
42187960|NCT00006903|75997831|FG000|Overall Study|Death|0|||
42187961|NCT00006903|75997832|FG001|Overall Study|Death|1|||
42296051|NCT02486757|76130793|FG000|Overall Study|Lost to Follow-up|1|||
42296052|NCT02418819|76130801|FG000|Overall Study|Adverse Event|0|||
42094372|NCT00661713|75904440|FG000|Overall Study|Lost to Follow-up|2|||
42094373|NCT00661713|75904441|FG001|Overall Study|Lost to Follow-up|7|||
42094374|NCT00661713|75904442|FG002|Overall Study|Lost to Follow-up|2|||
42094375|NCT00661713|75904443|FG003|Overall Study|Lost to Follow-up|2|||
42094376|NCT00661713|75904444|FG004|Overall Study|Lost to Follow-up|5|||
42094377|NCT00661713|75904445|FG005|Overall Study|Lost to Follow-up|7|||
42094378|NCT00661713|75904446|FG006|Overall Study|Lost to Follow-up|14|||
42094379|NCT00661713|75904447|FG007|Overall Study|Lost to Follow-up|1|||
42094380|NCT00661713|75904440|FG000|Overall Study|Administrative Reason|0|||
42094381|NCT00661713|75904441|FG001|Overall Study|Administrative Reason|1|||
42094382|NCT00661713|75904442|FG002|Overall Study|Administrative Reason|0|||
42094383|NCT00661713|75904443|FG003|Overall Study|Administrative Reason|2|||
42094384|NCT00661713|75904444|FG004|Overall Study|Administrative Reason|2|||
42094385|NCT00661713|75904445|FG005|Overall Study|Administrative Reason|2|||
42094386|NCT00661713|75904446|FG006|Overall Study|Administrative Reason|1|||
42094387|NCT00661713|75904447|FG007|Overall Study|Administrative Reason|0|||
42094388|NCT00661713|75904440|FG000|Overall Study|Adverse Event|0|||
42094389|NCT00661713|75904441|FG001|Overall Study|Adverse Event|0|||
42094390|NCT00661713|75904442|FG002|Overall Study|Adverse Event|0|||
42094391|NCT00661713|75904443|FG003|Overall Study|Adverse Event|0|||
42187962|NCT00006903|75997833|FG002|Overall Study|Death|0|||
42187963|NCT00006903|75997831|FG000|Overall Study|Patient never treated|0|||
42187964|NCT00006903|75997832|FG001|Overall Study|Patient never treated|0|||
42187965|NCT00006903|75997833|FG002|Overall Study|Patient never treated|1|||
42187966|NCT00006903|75997831|FG000|Overall Study|Ineligible|10|||
42187967|NCT00006903|75997832|FG001|Overall Study|Ineligible|1|||
42187968|NCT00006903|75997833|FG002|Overall Study|Ineligible|2|||
42187969|NCT00026793|75997841|FG000|Overall Study|Death on study due to underlying disease|4|||
42187970|NCT00026793|75997841|FG000|Overall Study|Physician Decision|2|||
42094392|NCT00661713|75904444|FG004|Overall Study|Adverse Event|0|||
42094393|NCT00661713|75904445|FG005|Overall Study|Adverse Event|0|||
42094394|NCT00661713|75904446|FG006|Overall Study|Adverse Event|1|||
42094395|NCT00661713|75904447|FG007|Overall Study|Adverse Event|0|||
42094396|NCT00661713|75904440|FG000|Overall Study|Inappropriate Enrollment|0|||
42187971|NCT00026793|75997841|FG000|Overall Study|Off study|2|||
42187972|NCT03539484|75997852|FG000|Overall Study|Death|1|||
42187973|NCT03539484|75997853|FG001|Overall Study|Death|0|||
42187974|NCT03539484|75997854|FG002|Overall Study|Death|0|||
42187975|NCT03539484|75997855|FG003|Overall Study|Death|2|||
42187976|NCT03539484|75997856|FG004|Overall Study|Death|8|||
42187977|NCT03539484|75997857|FG005|Overall Study|Death|3|||
42187978|NCT03539484|75997858|FG006|Overall Study|Death|0|||
42187979|NCT03539484|75997852|FG000|Overall Study|Lost to Follow-up|0|||
42187980|NCT03539484|75997853|FG001|Overall Study|Lost to Follow-up|1|||
42187981|NCT03539484|75997854|FG002|Overall Study|Lost to Follow-up|0|||
42187982|NCT03539484|75997855|FG003|Overall Study|Lost to Follow-up|0|||
42187983|NCT03539484|75997856|FG004|Overall Study|Lost to Follow-up|1|||
42187984|NCT03539484|75997857|FG005|Overall Study|Lost to Follow-up|0|||
42187985|NCT03539484|75997858|FG006|Overall Study|Lost to Follow-up|0|||
42187986|NCT03539484|75997852|FG000|Overall Study|Withdrawal by Subject|0|||
42187987|NCT03539484|75997853|FG001|Overall Study|Withdrawal by Subject|0|||
42187988|NCT03539484|75997854|FG002|Overall Study|Withdrawal by Subject|0|||
42187989|NCT03539484|75997855|FG003|Overall Study|Withdrawal by Subject|0|||
42187990|NCT03539484|75997856|FG004|Overall Study|Withdrawal by Subject|2|||
42187991|NCT03539484|75997857|FG005|Overall Study|Withdrawal by Subject|0|||
42187992|NCT03539484|75997858|FG006|Overall Study|Withdrawal by Subject|1|||
42187993|NCT03539484|75997852|FG000|Overall Study|Study Terminated by Sponsor|0|||
42187994|NCT03539484|75997853|FG001|Overall Study|Study Terminated by Sponsor|0|||
42187995|NCT03539484|75997854|FG002|Overall Study|Study Terminated by Sponsor|1|||
42094397|NCT00661713|75904441|FG001|Overall Study|Inappropriate Enrollment|0|||
42094398|NCT00661713|75904442|FG002|Overall Study|Inappropriate Enrollment|0|||
42094399|NCT00661713|75904443|FG003|Overall Study|Inappropriate Enrollment|0|||
42094400|NCT00661713|75904444|FG004|Overall Study|Inappropriate Enrollment|0|||
42094401|NCT00661713|75904445|FG005|Overall Study|Inappropriate Enrollment|0|||
42094402|NCT00661713|75904446|FG006|Overall Study|Inappropriate Enrollment|1|||
42094403|NCT00661713|75904447|FG007|Overall Study|Inappropriate Enrollment|0|||
42187996|NCT03539484|75997855|FG003|Overall Study|Study Terminated by Sponsor|1|||
42296053|NCT02418819|76130802|FG001|Overall Study|Adverse Event|0|||
42296054|NCT02418819|76130803|FG002|Overall Study|Adverse Event|1|||
42296055|NCT02418819|76130804|FG003|Overall Study|Adverse Event|0|||
42296056|NCT02418819|76130801|FG000|Overall Study|Lost to Follow-up|1|||
42296057|NCT02418819|76130802|FG001|Overall Study|Lost to Follow-up|0|||
42296058|NCT02418819|76130803|FG002|Overall Study|Lost to Follow-up|0|||
42296059|NCT02418819|76130804|FG003|Overall Study|Lost to Follow-up|0|||
42296060|NCT02418819|76130801|FG000|Overall Study|No longer meets eligibility criteria|0|||
42296061|NCT02418819|76130802|FG001|Overall Study|No longer meets eligibility criteria|0|||
42296062|NCT02418819|76130803|FG002|Overall Study|No longer meets eligibility criteria|1|||
42296063|NCT02418819|76130804|FG003|Overall Study|No longer meets eligibility criteria|0|||
42296064|NCT02418819|76130801|FG000|Overall Study|No longer willing to participate|0|||
42296065|NCT02418819|76130802|FG001|Overall Study|No longer willing to participate|0|||
42296066|NCT02418819|76130803|FG002|Overall Study|No longer willing to participate|2|||
42296067|NCT02418819|76130804|FG003|Overall Study|No longer willing to participate|1|||
42296068|NCT02576639|76130819|FG000|Overall Study|Withdrawal by Subject|1|||
42296069|NCT02576639|76130820|FG001|Overall Study|Withdrawal by Subject|2|||
42296070|NCT02576639|76130821|FG002|Overall Study|Withdrawal by Subject|1|||
42296071|NCT02576639|76130822|FG003|Overall Study|Withdrawal by Subject|0|||
42296072|NCT02576639|76130823|FG004|Overall Study|Withdrawal by Subject|1|||
42296073|NCT02576639|76130819|FG000|Overall Study|Adverse Event|1|||
42296074|NCT02576639|76130820|FG001|Overall Study|Adverse Event|0|||
42296075|NCT02576639|76130821|FG002|Overall Study|Adverse Event|1|||
42296076|NCT02576639|76130822|FG003|Overall Study|Adverse Event|1|||
42296077|NCT02576639|76130823|FG004|Overall Study|Adverse Event|2|||
42296078|NCT02576639|76130819|FG000|Overall Study|Physician Decision|0|||
42296079|NCT02576639|76130820|FG001|Overall Study|Physician Decision|0|||
42296080|NCT02576639|76130821|FG002|Overall Study|Physician Decision|0|||
42296081|NCT02576639|76130822|FG003|Overall Study|Physician Decision|0|||
42094404|NCT03835975|75904472|FG000|Overall Study|Lost to Follow-up|1|||
42094405|NCT03835975|75904473|FG001|Overall Study|Lost to Follow-up|1|||
42094406|NCT03835975|75904474|FG002|Overall Study|Lost to Follow-up|0|||
42187997|NCT03539484|75997856|FG004|Overall Study|Study Terminated by Sponsor|2|||
42187998|NCT03539484|75997857|FG005|Overall Study|Study Terminated by Sponsor|2|||
42187999|NCT03539484|75997858|FG006|Overall Study|Study Terminated by Sponsor|1|||
42188000|NCT03561090|75997881|FG000|Overall Study|Adverse Event|11|||
42188001|NCT03561090|75997882|FG001|Overall Study|Adverse Event|7|||
42188002|NCT03561090|75997881|FG000|Overall Study|Non-Compliance With Study Drug|2|||
42188003|NCT03561090|75997882|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42188004|NCT03561090|75997881|FG000|Overall Study|Protocol Violation|2|||
42296082|NCT02576639|76130823|FG004|Overall Study|Physician Decision|1|||
42296083|NCT02418585|76130841|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
42296084|NCT02418585|76130842|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
42296085|NCT02418585|76130841|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
42188005|NCT03561090|75997882|FG001|Overall Study|Protocol Violation|2|||
42188006|NCT03561090|75997881|FG000|Overall Study|Withdrawal by Subject|7|||
42188007|NCT03561090|75997882|FG001|Overall Study|Withdrawal by Subject|7|||
42188008|NCT03561090|75997881|FG000|Overall Study|Lost to Follow-up|7|||
42188009|NCT03561090|75997882|FG001|Overall Study|Lost to Follow-up|2|||
42188010|NCT03561090|75997881|FG000|Overall Study|Study Terminated by Sponsor|10|||
42188011|NCT03561090|75997882|FG001|Overall Study|Study Terminated by Sponsor|15|||
42188012|NCT03561090|75997881|FG000|Overall Study|Randomized by Mistake|1|||
42188013|NCT03561090|75997882|FG001|Overall Study|Randomized by Mistake|1|||
42188014|NCT03561090|75997881|FG000|Overall Study|Other Not Specified|0|||
42188015|NCT03561090|75997882|FG001|Overall Study|Other Not Specified|2|||
42094407|NCT03835975|75904475|FG003|Overall Study|Lost to Follow-up|0|||
42094408|NCT03835975|75904476|FG004|Overall Study|Lost to Follow-up|0|||
42094409|NCT03835975|75904472|FG000|Overall Study|No longer met eligibility criteria|0|||
42094410|NCT03835975|75904473|FG001|Overall Study|No longer met eligibility criteria|1|||
42094411|NCT03835975|75904474|FG002|Overall Study|No longer met eligibility criteria|0|||
42094412|NCT03835975|75904475|FG003|Overall Study|No longer met eligibility criteria|0|||
42094413|NCT03835975|75904476|FG004|Overall Study|No longer met eligibility criteria|0|||
42094414|NCT03835975|75904472|FG000|Overall Study|Protocol Violation|1|||
42094415|NCT03835975|75904473|FG001|Overall Study|Protocol Violation|1|||
42094416|NCT03835975|75904474|FG002|Overall Study|Protocol Violation|2|||
42188016|NCT02996500|75997896|FG000|Overall Study|Adverse Event|1|||
42188017|NCT02996500|75997897|FG001|Overall Study|Adverse Event|1|||
42188018|NCT02996500|75997898|FG002|Overall Study|Adverse Event|4|||
42094417|NCT03835975|75904475|FG003|Overall Study|Protocol Violation|0|||
42188019|NCT02996500|75997899|FG003|Overall Study|Adverse Event|3|||
42188020|NCT02996500|75997900|FG004|Overall Study|Adverse Event|1|||
42188021|NCT02996500|75997901|FG005|Overall Study|Adverse Event|2|||
42188022|NCT02996500|75997896|FG000|Overall Study|Lack of Efficacy|0|||
42188023|NCT02996500|75997897|FG001|Overall Study|Lack of Efficacy|0|||
42188024|NCT02996500|75997898|FG002|Overall Study|Lack of Efficacy|0|||
42188025|NCT02996500|75997899|FG003|Overall Study|Lack of Efficacy|0|||
42188026|NCT02996500|75997900|FG004|Overall Study|Lack of Efficacy|2|||
42188027|NCT02996500|75997901|FG005|Overall Study|Lack of Efficacy|0|||
42188028|NCT02996500|75997896|FG000|Overall Study|Lost to Follow-up|1|||
42188029|NCT02996500|75997897|FG001|Overall Study|Lost to Follow-up|0|||
42188030|NCT02996500|75997898|FG002|Overall Study|Lost to Follow-up|0|||
42188031|NCT02996500|75997899|FG003|Overall Study|Lost to Follow-up|0|||
42188032|NCT02996500|75997900|FG004|Overall Study|Lost to Follow-up|0|||
42188033|NCT02996500|75997901|FG005|Overall Study|Lost to Follow-up|1|||
42188034|NCT02996500|75997896|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
42188035|NCT02996500|75997897|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
42188036|NCT02996500|75997898|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
42188037|NCT02996500|75997899|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
42188038|NCT02996500|75997900|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
42188039|NCT02996500|75997901|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
42094418|NCT03835975|75904476|FG004|Overall Study|Protocol Violation|0|||
42188040|NCT02996500|75997896|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42188041|NCT02996500|75997897|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42094419|NCT03835975|75904472|FG000|Overall Study|Withdrawal by Subject|1|||
42188042|NCT02996500|75997898|FG002|Overall Study|Non-Compliance With Study Drug|0|||
42188043|NCT02996500|75997899|FG003|Overall Study|Non-Compliance With Study Drug|0|||
42094420|NCT03835975|75904473|FG001|Overall Study|Withdrawal by Subject|0|||
42188044|NCT02996500|75997900|FG004|Overall Study|Non-Compliance With Study Drug|0|||
42188045|NCT02996500|75997901|FG005|Overall Study|Non-Compliance With Study Drug|1|||
42188046|NCT02996500|75997896|FG000|Overall Study|Progressive Disease|1|||
42188047|NCT02996500|75997897|FG001|Overall Study|Progressive Disease|0|||
42188048|NCT02996500|75997898|FG002|Overall Study|Progressive Disease|0|||
42188049|NCT02996500|75997899|FG003|Overall Study|Progressive Disease|0|||
42188050|NCT02996500|75997900|FG004|Overall Study|Progressive Disease|0|||
42188051|NCT02996500|75997901|FG005|Overall Study|Progressive Disease|0|||
42188052|NCT02996500|75997896|FG000|Overall Study|Other|2|||
42188053|NCT02996500|75997897|FG001|Overall Study|Other|0|||
42188054|NCT02996500|75997898|FG002|Overall Study|Other|2|||
42188055|NCT02996500|75997899|FG003|Overall Study|Other|0|||
42094421|NCT03835975|75904474|FG002|Overall Study|Withdrawal by Subject|1|||
42094422|NCT03835975|75904475|FG003|Overall Study|Withdrawal by Subject|1|||
42094423|NCT03835975|75904476|FG004|Overall Study|Withdrawal by Subject|0|||
42094424|NCT00427921|75904490|FG000|Overall Study|Adverse Event|26|||
42188056|NCT02996500|75997900|FG004|Overall Study|Other|0|||
42094425|NCT00427921|75904490|FG000|Overall Study|Withdrawal by Subject|4|||
42094426|NCT00427921|75904490|FG000|Overall Study|Lost to Follow-up|2|||
42188057|NCT02996500|75997901|FG005|Overall Study|Other|0|||
42188058|NCT02996500|75997896|FG000|Overall Study|Protocol Violation|0|||
42188059|NCT02996500|75997897|FG001|Overall Study|Protocol Violation|0|||
42188060|NCT02996500|75997898|FG002|Overall Study|Protocol Violation|0|||
42188061|NCT02996500|75997899|FG003|Overall Study|Protocol Violation|1|||
42188062|NCT02996500|75997900|FG004|Overall Study|Protocol Violation|0|||
42188063|NCT02996500|75997901|FG005|Overall Study|Protocol Violation|0|||
42188064|NCT02996500|75997896|FG000|Overall Study|Withdrawal by Subject|3|||
42188065|NCT02996500|75997897|FG001|Overall Study|Withdrawal by Subject|0|||
42188066|NCT02996500|75997898|FG002|Overall Study|Withdrawal by Subject|3|||
42188067|NCT02996500|75997899|FG003|Overall Study|Withdrawal by Subject|0|||
42188068|NCT02996500|75997900|FG004|Overall Study|Withdrawal by Subject|2|||
42188069|NCT02996500|75997901|FG005|Overall Study|Withdrawal by Subject|0|||
42188070|NCT00006489|75997923|FG000|Overall Study|Adverse Event|3|||
42188071|NCT00006489|75997924|FG001|Overall Study|Adverse Event|2|||
42188072|NCT00006489|75997925|FG002|Overall Study|Adverse Event|4|||
42188073|NCT00006489|75997926|FG003|Overall Study|Adverse Event|3|||
42188074|NCT00006489|75997923|FG000|Overall Study|Withdrawal by Subject|10|||
42188075|NCT00006489|75997924|FG001|Overall Study|Withdrawal by Subject|9|||
42188076|NCT00006489|75997925|FG002|Overall Study|Withdrawal by Subject|9|||
42188077|NCT00006489|75997926|FG003|Overall Study|Withdrawal by Subject|6|||
42188078|NCT00006489|75997923|FG000|Overall Study|Scheduling Conflict|0|||
42188079|NCT00006489|75997924|FG001|Overall Study|Scheduling Conflict|3|||
42188080|NCT00006489|75997925|FG002|Overall Study|Scheduling Conflict|2|||
42188081|NCT00006489|75997926|FG003|Overall Study|Scheduling Conflict|1|||
42188082|NCT00006489|75997923|FG000|Overall Study|Death|0|||
42188083|NCT00006489|75997924|FG001|Overall Study|Death|0|||
42188084|NCT00006489|75997925|FG002|Overall Study|Death|0|||
42188085|NCT00006489|75997926|FG003|Overall Study|Death|1|||
42188086|NCT03535974|75997939|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
42188087|NCT03535974|75997940|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
42188088|NCT03535974|75997941|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
42094427|NCT00427921|75904490|FG000|Overall Study|Other reason not specified|10|||
42094428|NCT00427921|75904490|FG000|Overall Study|Adverse Event + Hospitalization|1|||
42094429|NCT00427921|75904490|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
42094430|NCT00427921|75904490|FG000|Overall Study|Adverse Event + No Response|1|||
42094431|NCT00427921|75904490|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
42094432|NCT00427921|75904490|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
42094433|NCT00427921|75904490|FG000|Overall Study|Adverse Event + Lost Response|1|||
42188089|NCT03535974|75997939|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
42188090|NCT03535974|75997940|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
42188091|NCT03535974|75997941|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
42094434|NCT00427921|75904490|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
42188092|NCT00025233|75997949|FG000|Overall Study|Ineligible: wrong cell type|1|||
42188093|NCT00025233|75997949|FG000|Overall Study|Ineligible: wrong primary|1|||
42188094|NCT00025233|75997949|FG000|Overall Study|Ineligible: improper prior treatment|1|||
42094435|NCT00427921|75904490|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
42188095|NCT00025233|75997949|FG000|Overall Study|Never treated|1|||
42188096|NCT00025155|75997959|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
42188097|NCT00025155|75997959|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
42188098|NCT02998996|75997974|FG000|Overall Study|Lost to Follow-up|0|||
42188099|NCT02998996|75997975|FG001|Overall Study|Lost to Follow-up|0|||
42188100|NCT02998996|75997976|FG002|Overall Study|Lost to Follow-up|1|||
42094436|NCT00432991|75904496|FG000|Overall Study|Protocol Violation|7|||
42188101|NCT02998996|75997977|FG003|Overall Study|Lost to Follow-up|0|||
42188102|NCT02998996|75997978|FG004|Overall Study|Lost to Follow-up|0|||
42188103|NCT02998996|75997979|FG005|Overall Study|Lost to Follow-up|0|||
42094437|NCT00432991|75904497|FG001|Overall Study|Protocol Violation|12|||
42188104|NCT02998996|75997974|FG000|Overall Study|Pregnancy|0|||
42188105|NCT02998996|75997975|FG001|Overall Study|Pregnancy|1|||
42094438|NCT00432835|75904505|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
42094439|NCT00432835|75904506|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
42094440|NCT00580970|75904514|FG000|Pre-treatment|Non-compliance|1|||
42094441|NCT00580970|75904514|FG000|Treatment (Lovastatin)|Non-compliance|6|||
42094442|NCT00580970|75904514|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
42094443|NCT00580970|75904514|FG000|Treatment (Lovastatin)|Physician Decision|4|||
42094444|NCT00580970|75904514|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
42094445|NCT00580970|75904514|FG000|Treatment (Lovastatin)|Death|1|||
42094446|NCT00665925|75904522|FG000|Overall Study|Lack of Efficacy|10|||
42094447|NCT00665925|75904523|FG001|Overall Study|Lack of Efficacy|8|||
42094448|NCT00665925|75904524|FG002|Overall Study|Lack of Efficacy|9|||
42094449|NCT00665925|75904525|FG003|Overall Study|Lack of Efficacy|8|||
42094450|NCT00665925|75904522|FG000|Overall Study|Lost to Follow-up|1|||
42188106|NCT02998996|75997976|FG002|Overall Study|Pregnancy|0|||
42188107|NCT02998996|75997977|FG003|Overall Study|Pregnancy|0|||
42188108|NCT02998996|75997978|FG004|Overall Study|Pregnancy|0|||
42188109|NCT02998996|75997979|FG005|Overall Study|Pregnancy|0|||
42188110|NCT02998996|75997974|FG000|Overall Study|Family reasons|0|||
42188111|NCT02998996|75997975|FG001|Overall Study|Family reasons|0|||
42188112|NCT02998996|75997976|FG002|Overall Study|Family reasons|0|||
42188113|NCT02998996|75997977|FG003|Overall Study|Family reasons|0|||
42094451|NCT00665925|75904523|FG001|Overall Study|Lost to Follow-up|2|||
42094452|NCT00665925|75904524|FG002|Overall Study|Lost to Follow-up|2|||
42094453|NCT00665925|75904525|FG003|Overall Study|Lost to Follow-up|2|||
42094454|NCT00665925|75904522|FG000|Overall Study|Withdrawal by Subject|2|||
42094455|NCT00665925|75904523|FG001|Overall Study|Withdrawal by Subject|2|||
42094456|NCT00665925|75904524|FG002|Overall Study|Withdrawal by Subject|3|||
42094457|NCT00665925|75904525|FG003|Overall Study|Withdrawal by Subject|2|||
42094458|NCT00665925|75904522|FG000|Overall Study|Physician Decision|0|||
42094459|NCT00665925|75904523|FG001|Overall Study|Physician Decision|0|||
42094460|NCT00665925|75904524|FG002|Overall Study|Physician Decision|1|||
42094461|NCT00665925|75904525|FG003|Overall Study|Physician Decision|2|||
42094462|NCT00665925|75904522|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
42094463|NCT00665925|75904523|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
42094464|NCT00665925|75904524|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
42094465|NCT00665925|75904525|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
42094466|NCT00665925|75904522|FG000|Overall Study|Adverse Event|1|||
42188114|NCT02998996|75997978|FG004|Overall Study|Family reasons|1|||
42188115|NCT02998996|75997979|FG005|Overall Study|Family reasons|0|||
42094467|NCT00665925|75904523|FG001|Overall Study|Adverse Event|5|||
42188116|NCT02994940|75997995|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
42188117|NCT02994940|75997996|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
42188118|NCT02994940|75997995|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
42188119|NCT02994940|75997996|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
42188120|NCT02994940|75997995|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
42188121|NCT02994940|75997996|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
42188122|NCT02994394|75998004|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
42188123|NCT02994394|75998005|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
42188124|NCT02994394|75998006|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
42188125|NCT02994394|75998007|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
42188126|NCT02994394|75998008|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
42188127|NCT02994394|75998009|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
42188128|NCT02994394|75998004|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
42188129|NCT02994394|75998005|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
42188130|NCT02994394|75998006|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
42188131|NCT02994394|75998007|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
42188132|NCT02994394|75998008|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
42188133|NCT02994394|75998009|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
42188134|NCT02998840|75998027|FG000|Overall Study|Lost to Follow-up|1|||
42188135|NCT02998840|75998028|FG001|Overall Study|Lost to Follow-up|1|||
42188136|NCT02998840|75998029|FG002|Overall Study|Lost to Follow-up|2|||
42296086|NCT02418585|76130842|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
42296087|NCT02418585|76130841|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
42296088|NCT02418585|76130842|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
42188137|NCT02998840|75998030|FG003|Overall Study|Lost to Follow-up|3|||
42296089|NCT02418585|76130841|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
42188138|NCT02998840|75998027|FG000|Overall Study|Withdrawal by Subject|1|||
42094468|NCT00665925|75904524|FG002|Overall Study|Adverse Event|10|||
42094469|NCT00665925|75904525|FG003|Overall Study|Adverse Event|5|||
42094470|NCT00665925|75904522|FG000|Overall Study|Enrolled by mistake|0|||
42094471|NCT00665925|75904523|FG001|Overall Study|Enrolled by mistake|0|||
42094472|NCT00665925|75904524|FG002|Overall Study|Enrolled by mistake|0|||
42094473|NCT00665925|75904525|FG003|Overall Study|Enrolled by mistake|1|||
42188139|NCT02998840|75998028|FG001|Overall Study|Withdrawal by Subject|1|||
42188140|NCT02998840|75998029|FG002|Overall Study|Withdrawal by Subject|0|||
42188141|NCT02998840|75998030|FG003|Overall Study|Withdrawal by Subject|1|||
42188142|NCT02998840|75998027|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
42188143|NCT02998840|75998028|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
42188144|NCT02998840|75998029|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
42188145|NCT02998840|75998030|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
42188146|NCT00023673|75998041|FG000|Overall Study|Ineligible / no protocol treatment|0|||
42188147|NCT00023673|75998042|FG001|Overall Study|Ineligible / no protocol treatment|0|||
42188148|NCT00023673|75998043|FG002|Overall Study|Ineligible / no protocol treatment|0|||
42188149|NCT00023673|75998044|FG003|Overall Study|Ineligible / no protocol treatment|1|||
42188150|NCT00023673|75998041|FG000|Overall Study|Patient withdrew consent|0|||
42188151|NCT00023673|75998042|FG001|Overall Study|Patient withdrew consent|0|||
42188152|NCT00023673|75998043|FG002|Overall Study|Patient withdrew consent|0|||
42188153|NCT00023673|75998044|FG003|Overall Study|Patient withdrew consent|1|||
42188154|NCT01069900|75998056|FG000|Overall Study|Technical problems|0|||
42188155|NCT01069900|75998057|FG001|Overall Study|Technical problems|1|||
42188156|NCT01069900|75998056|FG000|Overall Study|Lost to Follow-up|7|||
42188157|NCT01069900|75998057|FG001|Overall Study|Lost to Follow-up|1|||
42188158|NCT01069900|75998056|FG000|Overall Study|Withdrawal by Subject|6|||
42188159|NCT01069900|75998057|FG001|Overall Study|Withdrawal by Subject|1|||
42188160|NCT01069900|75998056|FG000|Overall Study|Protocol Violation|4|||
42188161|NCT01069900|75998057|FG001|Overall Study|Protocol Violation|1|||
42188162|NCT01069900|75998056|FG000|Overall Study|Insufficient Therapeutic effect|1|||
42188163|NCT01069900|75998057|FG001|Overall Study|Insufficient Therapeutic effect|0|||
42188164|NCT01069120|75998065|FG000|Overall Study|Study prematurely terminated|27|||
42188165|NCT00006237|75998073|FG000|Overall Study|Adverse Event|39|||
42188166|NCT00006237|75998074|FG001|Overall Study|Adverse Event|29|||
42188167|NCT00006237|75998073|FG000|Overall Study|Death|1|||
42188168|NCT00006237|75998074|FG001|Overall Study|Death|0|||
42188169|NCT00006237|75998073|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
42188170|NCT00006237|75998074|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
42188171|NCT00006237|75998073|FG000|Overall Study|Progression/relapse|54|||
42188172|NCT00006237|75998074|FG001|Overall Study|Progression/relapse|2|||
42188173|NCT00006237|75998073|FG000|Overall Study|Not eligible|9|||
42188174|NCT00006237|75998074|FG001|Overall Study|Not eligible|20|||
42188175|NCT00006237|75998073|FG000|Overall Study|Withdrawal by Subject|0|||
42188176|NCT00006237|75998074|FG001|Overall Study|Withdrawal by Subject|1|||
42188177|NCT00006237|75998073|FG000|Overall Study|Not protocol specified|14|||
42188178|NCT00006237|75998074|FG001|Overall Study|Not protocol specified|5|||
42188179|NCT02993926|75998083|FG000|Enantone Treatment Phase|Adverse Event|1|||
42188180|NCT02993926|75998084|FG001|Enantone Treatment Phase|Adverse Event|0|||
42188181|NCT02993926|75998085|FG002|Enantone Treatment Phase|Adverse Event|0|||
42188182|NCT02993926|75998083|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
42188183|NCT02993926|75998084|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
42188184|NCT02993926|75998085|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
42188185|NCT02993926|75998083|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
42188186|NCT02993926|75998084|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
42094474|NCT00665925|75904522|FG000|Overall Study|Due to exclusion criteria|1|||
42094475|NCT00665925|75904523|FG001|Overall Study|Due to exclusion criteria|0|||
42094476|NCT00665925|75904524|FG002|Overall Study|Due to exclusion criteria|0|||
42094477|NCT00665925|75904525|FG003|Overall Study|Due to exclusion criteria|0|||
42094478|NCT00426751|75904538|FG000|Overall Study|Adverse Event|8|||
42094479|NCT00426751|75904539|FG001|Overall Study|Adverse Event|1|||
42094480|NCT00426751|75904538|FG000|Overall Study|Lost to Follow-up|7|||
42094481|NCT00426751|75904539|FG001|Overall Study|Lost to Follow-up|6|||
42094482|NCT00426751|75904538|FG000|Overall Study|Consent Withdrawn|0|||
42094483|NCT00426751|75904539|FG001|Overall Study|Consent Withdrawn|1|||
42094484|NCT00426751|75904538|FG000|Overall Study|Other Reasons|7|||
42094485|NCT00426751|75904539|FG001|Overall Study|Other Reasons|12|||
42188187|NCT02993926|75998085|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
42188188|NCT02993926|75998083|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
42188189|NCT02993926|75998084|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
42188190|NCT02993926|75998085|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
42188191|NCT02993224|75998095|FG000|Core Phase - Period 1|Adverse Event|4|||
42188192|NCT02993224|75998095|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
42188193|NCT02993224|75998095|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
42188194|NCT02993224|75998095|FG000|Core Phase- Period 2|Adverse Event|1|||
42188195|NCT02993224|75998095|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
42188196|NCT02993224|75998095|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
42188197|NCT02993224|75998095|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
42094486|NCT00440401|75904547|FG000|Overall Study|Adverse Event|2|||
42094487|NCT00440401|75904548|FG001|Overall Study|Adverse Event|1|||
42094488|NCT00440401|75904547|FG000|Overall Study|Other|2|||
42094489|NCT00440401|75904548|FG001|Overall Study|Other|5|||
42094490|NCT02598960|75904567|FG000|Treatment Period|Disease Progression|4|||
42094491|NCT02598960|75904568|FG001|Treatment Period|Disease Progression|4|||
42094492|NCT02598960|75904569|FG002|Treatment Period|Disease Progression|4|||
42094493|NCT02598960|75904570|FG003|Treatment Period|Disease Progression|6|||
42094494|NCT02598960|75904571|FG004|Treatment Period|Disease Progression|8|||
42094495|NCT02598960|75904572|FG005|Treatment Period|Disease Progression|2|||
42094496|NCT02598960|75904573|FG006|Treatment Period|Disease Progression|2|||
42094497|NCT02598960|75904574|FG007|Treatment Period|Disease Progression|3|||
42094498|NCT02598960|75904575|FG008|Treatment Period|Disease Progression|7|||
42094499|NCT02598960|75904576|FG009|Treatment Period|Disease Progression|9|||
42094500|NCT02598960|75904577|FG010|Treatment Period|Disease Progression|7|||
42094501|NCT02598960|75904578|FG011|Treatment Period|Disease Progression|143|||
42094502|NCT02598960|75904579|FG012|Treatment Period|Disease Progression|23|||
42094503|NCT02598960|75904567|FG000|Treatment Period|Study drug toxicity|0|||
42094504|NCT02598960|75904568|FG001|Treatment Period|Study drug toxicity|0|||
42094505|NCT02598960|75904569|FG002|Treatment Period|Study drug toxicity|0|||
42094506|NCT02598960|75904570|FG003|Treatment Period|Study drug toxicity|0|||
42188198|NCT02993224|75998095|FG000|Extension Phase|Adverse Event|3|||
42188199|NCT02993224|75998095|FG000|Extension Phase|Withdrawal by Subject|3|||
42188200|NCT02993224|75998095|FG000|Extension Phase|Lost to Follow-up|2|||
42188201|NCT02993224|75998095|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
42188202|NCT03495908|75998103|FG000|Overall Study|Withdrawal by Subject|3|||
42188203|NCT03495908|75998104|FG001|Overall Study|Withdrawal by Subject|1|||
42188204|NCT03495908|75998103|FG000|Overall Study|Lost to Follow-up|1|||
42188205|NCT03495908|75998104|FG001|Overall Study|Lost to Follow-up|4|||
42188206|NCT03495908|75998103|FG000|Overall Study|Adverse Event|0|||
42188207|NCT03495908|75998104|FG001|Overall Study|Adverse Event|2|||
42188208|NCT03495908|75998103|FG000|Overall Study|Death|1|||
42188209|NCT03495908|75998104|FG001|Overall Study|Death|0|||
42296090|NCT02418585|76130842|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
42296091|NCT02418585|76130841|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
42094507|NCT02598960|75904571|FG004|Treatment Period|Study drug toxicity|0|||
42094508|NCT02598960|75904572|FG005|Treatment Period|Study drug toxicity|0|||
42094509|NCT02598960|75904573|FG006|Treatment Period|Study drug toxicity|0|||
42094510|NCT02598960|75904574|FG007|Treatment Period|Study drug toxicity|0|||
42094511|NCT02598960|75904575|FG008|Treatment Period|Study drug toxicity|0|||
42094512|NCT02598960|75904576|FG009|Treatment Period|Study drug toxicity|1|||
42296092|NCT02418585|76130842|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
42094513|NCT02598960|75904577|FG010|Treatment Period|Study drug toxicity|0|||
42094514|NCT02598960|75904578|FG011|Treatment Period|Study drug toxicity|3|||
42094515|NCT02598960|75904579|FG012|Treatment Period|Study drug toxicity|0|||
42094516|NCT02598960|75904567|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
42094517|NCT02598960|75904568|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
42094518|NCT02598960|75904569|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
42094519|NCT02598960|75904570|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
42094520|NCT02598960|75904571|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
42094521|NCT02598960|75904572|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
42094522|NCT02598960|75904573|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
42094523|NCT02598960|75904574|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
42094524|NCT02598960|75904575|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
42094525|NCT02598960|75904576|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
42094526|NCT02598960|75904577|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
42094527|NCT02598960|75904578|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
42094528|NCT02598960|75904579|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
42094529|NCT02598960|75904567|FG000|Treatment Period|participant request to discontinue|0|||
42094530|NCT02598960|75904568|FG001|Treatment Period|participant request to discontinue|1|||
42094531|NCT02598960|75904569|FG002|Treatment Period|participant request to discontinue|0|||
42094532|NCT02598960|75904570|FG003|Treatment Period|participant request to discontinue|0|||
42094533|NCT02598960|75904571|FG004|Treatment Period|participant request to discontinue|1|||
42094534|NCT02598960|75904572|FG005|Treatment Period|participant request to discontinue|0|||
42094535|NCT02598960|75904573|FG006|Treatment Period|participant request to discontinue|0|||
42094536|NCT02598960|75904574|FG007|Treatment Period|participant request to discontinue|0|||
42188210|NCT03495908|75998103|FG000|Overall Study|Physician Decision|5|||
42296093|NCT02418585|76130841|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
42094537|NCT02598960|75904575|FG008|Treatment Period|participant request to discontinue|0|||
42094538|NCT02598960|75904576|FG009|Treatment Period|participant request to discontinue|0|||
42094539|NCT02598960|75904577|FG010|Treatment Period|participant request to discontinue|1|||
42094540|NCT02598960|75904578|FG011|Treatment Period|participant request to discontinue|4|||
42094541|NCT02598960|75904579|FG012|Treatment Period|participant request to discontinue|0|||
42188211|NCT03495908|75998104|FG001|Overall Study|Physician Decision|4|||
42094542|NCT02598960|75904567|FG000|Treatment Period|participant withdrew consent|0|||
42094543|NCT02598960|75904568|FG001|Treatment Period|participant withdrew consent|0|||
42094544|NCT02598960|75904569|FG002|Treatment Period|participant withdrew consent|0|||
42094545|NCT02598960|75904570|FG003|Treatment Period|participant withdrew consent|0|||
42094546|NCT02598960|75904571|FG004|Treatment Period|participant withdrew consent|0|||
42094547|NCT02598960|75904572|FG005|Treatment Period|participant withdrew consent|0|||
42094548|NCT02598960|75904573|FG006|Treatment Period|participant withdrew consent|0|||
42094549|NCT02598960|75904574|FG007|Treatment Period|participant withdrew consent|0|||
42094550|NCT02598960|75904575|FG008|Treatment Period|participant withdrew consent|0|||
42094551|NCT02598960|75904576|FG009|Treatment Period|participant withdrew consent|0|||
42094552|NCT02598960|75904577|FG010|Treatment Period|participant withdrew consent|0|||
42094553|NCT02598960|75904578|FG011|Treatment Period|participant withdrew consent|3|||
42094554|NCT02598960|75904579|FG012|Treatment Period|participant withdrew consent|0|||
42094555|NCT02598960|75904567|FG000|Treatment Period|No longer meets study criteria|0|||
42094556|NCT02598960|75904568|FG001|Treatment Period|No longer meets study criteria|0|||
42094557|NCT02598960|75904569|FG002|Treatment Period|No longer meets study criteria|0|||
42094558|NCT02598960|75904570|FG003|Treatment Period|No longer meets study criteria|0|||
42094559|NCT02598960|75904571|FG004|Treatment Period|No longer meets study criteria|0|||
42094560|NCT02598960|75904572|FG005|Treatment Period|No longer meets study criteria|0|||
42094561|NCT02598960|75904573|FG006|Treatment Period|No longer meets study criteria|0|||
42094562|NCT02598960|75904574|FG007|Treatment Period|No longer meets study criteria|0|||
42188212|NCT03495908|75998103|FG000|Overall Study|No documented reason|0|||
42188213|NCT03495908|75998104|FG001|Overall Study|No documented reason|2|||
42188214|NCT02992288|75998116|FG000|Overall Study|Adverse Event|8|||
42188215|NCT02992288|75998117|FG001|Overall Study|Adverse Event|2|||
42188216|NCT02992288|75998118|FG002|Overall Study|Adverse Event|2|||
42188217|NCT02992288|75998119|FG003|Overall Study|Adverse Event|2|||
42188218|NCT02992288|75998120|FG004|Overall Study|Adverse Event|2|||
42188219|NCT02992288|75998121|FG005|Overall Study|Adverse Event|7|||
42188220|NCT02992288|75998116|FG000|Overall Study|Non-compliance with study drug|0|||
42188221|NCT02992288|75998117|FG001|Overall Study|Non-compliance with study drug|1|||
42188222|NCT02992288|75998118|FG002|Overall Study|Non-compliance with study drug|1|||
42188223|NCT02992288|75998119|FG003|Overall Study|Non-compliance with study drug|0|||
42188224|NCT02992288|75998120|FG004|Overall Study|Non-compliance with study drug|1|||
42188225|NCT02992288|75998121|FG005|Overall Study|Non-compliance with study drug|0|||
42188226|NCT02992288|75998116|FG000|Overall Study|Physician Decision|3|||
42188227|NCT02992288|75998117|FG001|Overall Study|Physician Decision|0|||
42188228|NCT02992288|75998118|FG002|Overall Study|Physician Decision|1|||
42188229|NCT02992288|75998119|FG003|Overall Study|Physician Decision|0|||
42188230|NCT02992288|75998120|FG004|Overall Study|Physician Decision|0|||
42188231|NCT02992288|75998121|FG005|Overall Study|Physician Decision|1|||
42188232|NCT02992288|75998116|FG000|Overall Study|Death|2|||
42188233|NCT02992288|75998117|FG001|Overall Study|Death|0|||
42188234|NCT02992288|75998118|FG002|Overall Study|Death|2|||
42188235|NCT02992288|75998119|FG003|Overall Study|Death|1|||
42188236|NCT02992288|75998120|FG004|Overall Study|Death|2|||
42188237|NCT02992288|75998121|FG005|Overall Study|Death|0|||
42188238|NCT02992288|75998116|FG000|Overall Study|Lost to Follow-up|0|||
42188239|NCT02992288|75998117|FG001|Overall Study|Lost to Follow-up|0|||
42188240|NCT02992288|75998118|FG002|Overall Study|Lost to Follow-up|0|||
42188241|NCT02992288|75998119|FG003|Overall Study|Lost to Follow-up|1|||
42188242|NCT02992288|75998120|FG004|Overall Study|Lost to Follow-up|0|||
42188243|NCT02992288|75998121|FG005|Overall Study|Lost to Follow-up|0|||
42188244|NCT02992288|75998116|FG000|Overall Study|Protocol Violation|0|||
42188245|NCT02992288|75998117|FG001|Overall Study|Protocol Violation|0|||
42188246|NCT02992288|75998118|FG002|Overall Study|Protocol Violation|0|||
42188247|NCT02992288|75998119|FG003|Overall Study|Protocol Violation|0|||
42188248|NCT02992288|75998120|FG004|Overall Study|Protocol Violation|0|||
42188249|NCT02992288|75998121|FG005|Overall Study|Protocol Violation|1|||
42188250|NCT02992288|75998116|FG000|Overall Study|Withdrawal by Subject|4|||
42188251|NCT02992288|75998117|FG001|Overall Study|Withdrawal by Subject|2|||
42188252|NCT02992288|75998118|FG002|Overall Study|Withdrawal by Subject|1|||
42188253|NCT02992288|75998119|FG003|Overall Study|Withdrawal by Subject|5|||
42188254|NCT02992288|75998120|FG004|Overall Study|Withdrawal by Subject|3|||
42188255|NCT02992288|75998121|FG005|Overall Study|Withdrawal by Subject|4|||
42188256|NCT02992132|75998138|FG000|Overall Study|Adverse Event|4|||
42188257|NCT02992132|75998139|FG001|Overall Study|Adverse Event|1|||
42188258|NCT02992132|75998140|FG002|Overall Study|Adverse Event|3|||
42188259|NCT02992132|75998138|FG000|Overall Study|Lack of Efficacy|2|||
42188260|NCT02992132|75998139|FG001|Overall Study|Lack of Efficacy|0|||
42188261|NCT02992132|75998140|FG002|Overall Study|Lack of Efficacy|0|||
42188262|NCT02992132|75998138|FG000|Overall Study|Non-compliance with study drug|2|||
42188263|NCT02992132|75998139|FG001|Overall Study|Non-compliance with study drug|0|||
42188264|NCT02992132|75998140|FG002|Overall Study|Non-compliance with study drug|0|||
42188265|NCT02992132|75998138|FG000|Overall Study|Progressive disease|1|||
42188266|NCT02992132|75998139|FG001|Overall Study|Progressive disease|0|||
42188267|NCT02992132|75998140|FG002|Overall Study|Progressive disease|0|||
42188268|NCT02992132|75998138|FG000|Overall Study|Protocol Violation|2|||
42188269|NCT02992132|75998139|FG001|Overall Study|Protocol Violation|2|||
42188270|NCT02992132|75998140|FG002|Overall Study|Protocol Violation|0|||
42188271|NCT02992132|75998138|FG000|Overall Study|Caregiver withdrew consent|2|||
42188272|NCT02992132|75998139|FG001|Overall Study|Caregiver withdrew consent|3|||
42188273|NCT02992132|75998140|FG002|Overall Study|Caregiver withdrew consent|2|||
42188274|NCT02992132|75998138|FG000|Overall Study|Withdrawal by Subject|0|||
42188275|NCT02992132|75998139|FG001|Overall Study|Withdrawal by Subject|2|||
42188276|NCT02992132|75998140|FG002|Overall Study|Withdrawal by Subject|1|||
42188277|NCT02992132|75998138|FG000|Overall Study|Physician Decision|0|||
42188278|NCT02992132|75998139|FG001|Overall Study|Physician Decision|0|||
42188279|NCT02992132|75998140|FG002|Overall Study|Physician Decision|1|||
42188280|NCT03444584|75998150|FG000|Overall Study|Withdrawal by Subject|0|||
42188281|NCT03444584|75998151|FG001|Overall Study|Withdrawal by Subject|1|||
42188282|NCT03444584|75998150|FG000|Overall Study|Other|0|||
42188283|NCT03444584|75998151|FG001|Overall Study|Other|1|||
42188284|NCT02989168|75998160|FG000|Overall Study|Withdrawal by Subject|2|||
42188285|NCT02989168|75998161|FG001|Overall Study|Withdrawal by Subject|0|||
42188286|NCT02989168|75998160|FG000|Overall Study|Physician Decision|0|||
42188287|NCT02989168|75998161|FG001|Overall Study|Physician Decision|1|||
42188288|NCT02989168|75998160|FG000|Overall Study|Adverse Event|1|||
42188289|NCT02989168|75998161|FG001|Overall Study|Adverse Event|2|||
42188290|NCT02989168|75998160|FG000|Overall Study|Sponsor stopped study.|1|||
42188291|NCT02989168|75998161|FG001|Overall Study|Sponsor stopped study.|0|||
42188292|NCT02988622|75998169|FG000|Overall Study|Lost to Follow-up|17|||
42188293|NCT03412604|75998175|FG000|Overall Study|Withdrawal by Subject|1|||
42188294|NCT02991430|75998182|FG000|Treatment Period 1|Adverse Event|1|||
42188295|NCT02991430|75998183|FG001|Treatment Period 1|Adverse Event|0|||
42094563|NCT02598960|75904575|FG008|Treatment Period|No longer meets study criteria|0|||
42094564|NCT02598960|75904576|FG009|Treatment Period|No longer meets study criteria|0|||
42094565|NCT02598960|75904577|FG010|Treatment Period|No longer meets study criteria|0|||
42094566|NCT02598960|75904578|FG011|Treatment Period|No longer meets study criteria|1|||
42188296|NCT02991430|75998184|FG002|Treatment Period 1|Adverse Event|2|||
42188297|NCT02991430|75998182|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42188298|NCT02991430|75998183|FG001|Treatment Period 1|Withdrawal by Subject|4|||
42094567|NCT02598960|75904579|FG012|Treatment Period|No longer meets study criteria|0|||
42094568|NCT02598960|75904567|FG000|Treatment Period|Other Reasons|0|||
42094569|NCT02598960|75904568|FG001|Treatment Period|Other Reasons|0|||
42094570|NCT02598960|75904569|FG002|Treatment Period|Other Reasons|0|||
42094571|NCT02598960|75904570|FG003|Treatment Period|Other Reasons|0|||
42094572|NCT02598960|75904571|FG004|Treatment Period|Other Reasons|0|||
42094573|NCT02598960|75904572|FG005|Treatment Period|Other Reasons|0|||
42094574|NCT02598960|75904573|FG006|Treatment Period|Other Reasons|0|||
42094575|NCT02598960|75904574|FG007|Treatment Period|Other Reasons|0|||
42094576|NCT02598960|75904575|FG008|Treatment Period|Other Reasons|0|||
42094577|NCT02598960|75904576|FG009|Treatment Period|Other Reasons|0|||
42094578|NCT02598960|75904577|FG010|Treatment Period|Other Reasons|0|||
42094579|NCT02598960|75904578|FG011|Treatment Period|Other Reasons|0|||
42094580|NCT02598960|75904579|FG012|Treatment Period|Other Reasons|1|||
42094581|NCT02598960|75904567|FG000|Participants Entering Follow Up Period|Death|1|||
42094582|NCT02598960|75904568|FG001|Participants Entering Follow Up Period|Death|0|||
42094583|NCT02598960|75904569|FG002|Participants Entering Follow Up Period|Death|0|||
42094584|NCT02598960|75904570|FG003|Participants Entering Follow Up Period|Death|0|||
42094585|NCT02598960|75904571|FG004|Participants Entering Follow Up Period|Death|0|||
42094586|NCT02598960|75904572|FG005|Participants Entering Follow Up Period|Death|0|||
42094587|NCT02598960|75904573|FG006|Participants Entering Follow Up Period|Death|0|||
42094588|NCT02598960|75904574|FG007|Participants Entering Follow Up Period|Death|0|||
42094589|NCT02598960|75904575|FG008|Participants Entering Follow Up Period|Death|0|||
42094590|NCT02598960|75904576|FG009|Participants Entering Follow Up Period|Death|1|||
42188299|NCT02991430|75998184|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42188300|NCT02991430|75998182|FG000|Treatment Period 2|Study Termination|6|||
42188301|NCT02991430|75998183|FG001|Treatment Period 2|Study Termination|3|||
42094591|NCT02598960|75904577|FG010|Participants Entering Follow Up Period|Death|0|||
42094592|NCT02598960|75904578|FG011|Participants Entering Follow Up Period|Death|11|||
42188302|NCT02991430|75998184|FG002|Treatment Period 2|Study Termination|3|||
42188303|NCT02991430|75998182|FG000|Treatment Period 2|Lost to Follow-up|0|||
42094593|NCT02598960|75904579|FG012|Participants Entering Follow Up Period|Death|2|||
42188304|NCT02991430|75998183|FG001|Treatment Period 2|Lost to Follow-up|0|||
42188305|NCT02991430|75998184|FG002|Treatment Period 2|Lost to Follow-up|1|||
42188306|NCT02991430|75998182|FG000|Post-treatment Observation Period|Study Termination|3|||
42188307|NCT02991430|75998183|FG001|Post-treatment Observation Period|Study Termination|6|||
42094594|NCT02598960|75904567|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
42188308|NCT02991430|75998184|FG002|Post-treatment Observation Period|Study Termination|5|||
42188309|NCT03411902|75998194|FG000|Overall Study|Lost to Follow-up|3|||
42188310|NCT03411902|75998195|FG001|Overall Study|Lost to Follow-up|0|||
42188311|NCT03494816|75998201|FG000|Overall Study|Protocol Violation|2|||
42188312|NCT03494816|75998201|FG000|Overall Study|Physician Decision|2|||
42188313|NCT03494816|75998201|FG000|Overall Study|Did not start trial treatment|1|||
42188314|NCT03494816|75998201|FG000|Overall Study|Adverse Event|1|||
42188315|NCT03492554|75998211|FG000|Overall Study|Protocol Violation|0|||
42188316|NCT03492554|75998212|FG001|Overall Study|Protocol Violation|14|||
42188317|NCT04936334|75998257|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
42188318|NCT04822597|75998267|FG000|Overall Study|Withdrawal by Subject|0|||
42188319|NCT04822597|75998268|FG001|Overall Study|Withdrawal by Subject|1|||
42188320|NCT04822597|75998269|FG002|Overall Study|Withdrawal by Subject|1|||
42188321|NCT04822597|75998270|FG003|Overall Study|Withdrawal by Subject|0|||
42188322|NCT04822597|75998267|FG000|Overall Study|Physician Decision|0|||
42188323|NCT04822597|75998268|FG001|Overall Study|Physician Decision|0|||
42188324|NCT04822597|75998269|FG002|Overall Study|Physician Decision|1|||
42188325|NCT04822597|75998270|FG003|Overall Study|Physician Decision|1|||
42188326|NCT04822597|75998267|FG000|Overall Study|Subject withdrawn after enrollment|0|||
42188327|NCT04822597|75998268|FG001|Overall Study|Subject withdrawn after enrollment|1|||
42188328|NCT04822597|75998269|FG002|Overall Study|Subject withdrawn after enrollment|0|||
42188329|NCT04822597|75998270|FG003|Overall Study|Subject withdrawn after enrollment|1|||
42188330|NCT04822597|75998267|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
42188331|NCT04822597|75998268|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
42188332|NCT04822597|75998269|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
42188333|NCT04822597|75998270|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
42188334|NCT04639245|75998280|FG000|Overall Study|Death|1|||
42188335|NCT04599465|75998284|FG000|Overall Study|Physician Decision|1|||
42188336|NCT04599465|75998284|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
42188337|NCT04104646|75998331|FG000|Overall Study|Withdrawal by Subject|1|||
42188338|NCT04104646|75998332|FG001|Overall Study|Withdrawal by Subject|1|||
42188339|NCT04104646|75998331|FG000|Overall Study|Lost to Follow-up|1|||
42296094|NCT02418585|76130842|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
42296095|NCT02418585|76130841|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
42296096|NCT02418585|76130842|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
42296097|NCT02418585|76130841|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
42296098|NCT02418585|76130842|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
42296099|NCT02418585|76130841|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
42094595|NCT02598960|75904568|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
42094596|NCT02598960|75904569|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
42094597|NCT02598960|75904570|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
42094598|NCT02598960|75904571|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
42094599|NCT02598960|75904572|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
42094600|NCT02598960|75904573|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
42094601|NCT02598960|75904574|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
42094602|NCT02598960|75904575|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
42094603|NCT02598960|75904576|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
42094604|NCT02598960|75904577|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
42094605|NCT02598960|75904578|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
42094606|NCT02598960|75904579|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
42094607|NCT02598960|75904567|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
42094608|NCT02598960|75904568|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
42094609|NCT02598960|75904569|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
42094610|NCT02598960|75904570|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
42094611|NCT02598960|75904571|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
42094612|NCT02598960|75904572|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
42094613|NCT02598960|75904573|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
42094614|NCT02598960|75904574|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
42094615|NCT02598960|75904575|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
42094616|NCT02598960|75904576|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
42188340|NCT04104646|75998332|FG001|Overall Study|Lost to Follow-up|0|||
42188341|NCT04104646|75998331|FG000|Overall Study|Physician Decision|2|||
42188342|NCT04104646|75998332|FG001|Overall Study|Physician Decision|0|||
42188343|NCT03919669|75998343|FG000|Overall Study|Withdrawal by Subject|1|||
42188344|NCT03919669|75998344|FG001|Overall Study|Withdrawal by Subject|0|||
42188345|NCT03919669|75998345|FG002|Overall Study|Withdrawal by Subject|0|||
42188346|NCT03772665|75998356|FG000|Overall Study|Protocol Violation|1|||
42094617|NCT02598960|75904577|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
42094618|NCT02598960|75904578|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
42094619|NCT02598960|75904579|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
42094620|NCT02598960|75904567|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094621|NCT02598960|75904568|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094622|NCT02598960|75904569|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094623|NCT02598960|75904570|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094624|NCT02598960|75904571|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094625|NCT02598960|75904572|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094626|NCT02598960|75904573|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094627|NCT02598960|75904574|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094628|NCT02598960|75904575|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094629|NCT02598960|75904576|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094630|NCT02598960|75904577|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094631|NCT02598960|75904578|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
42094632|NCT02598960|75904579|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
42094633|NCT02598960|75904567|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
42094634|NCT02598960|75904568|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
42094635|NCT02598960|75904569|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
42094636|NCT02598960|75904570|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
42094637|NCT02598960|75904571|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
42094638|NCT02598960|75904572|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
42094639|NCT02598960|75904573|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
42094640|NCT02598960|75904574|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
42094641|NCT02598960|75904575|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
42094642|NCT02598960|75904576|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
42094643|NCT02598960|75904577|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
42094644|NCT02598960|75904578|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
42094645|NCT02598960|75904579|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
42094646|NCT00426361|75904610|FG000|Overall Study|Lost to Follow-up|3|||
42094647|NCT00426361|75904611|FG001|Overall Study|Lost to Follow-up|2|||
42094648|NCT00426361|75904612|FG002|Overall Study|Lost to Follow-up|5|||
42094649|NCT00426361|75904610|FG000|Overall Study|Withdrawal by Subject|1|||
42094650|NCT00426361|75904611|FG001|Overall Study|Withdrawal by Subject|3|||
42094651|NCT00426361|75904612|FG002|Overall Study|Withdrawal by Subject|0|||
42094652|NCT00665847|75904620|FG000|Overall Study|Adverse Event|8|||
42094653|NCT00665847|75904620|FG000|Overall Study|Withdrawal by Subject|2|||
42094654|NCT00665847|75904620|FG000|Overall Study|Subject non-compliant|8|||
42094655|NCT00665847|75904620|FG000|Overall Study|Subject reached a virologic endpoint|4|||
42094656|NCT00665847|75904620|FG000|Overall Study|Resistance to TMC125|1|||
42094657|NCT00665847|75904620|FG000|Overall Study|Subject ineligible to continue the trial|1|||
42094658|NCT00665847|75904620|FG000|Overall Study|Switch to Commercial Medication|1|||
42094659|NCT00426127|75904624|FG000|Overall Study|Adverse Event|1|||
42094660|NCT00426127|75904624|FG000|Overall Study|Removed due to disease progression|1|||
42188347|NCT03772665|75998357|FG001|Overall Study|Protocol Violation|0|||
42188348|NCT03594110|75998374|FG000|Overall Study|Participant concerned about study treatment|23|||
42188349|NCT03594110|75998375|FG001|Overall Study|Participant concerned about study treatment|28|||
42188350|NCT03594110|75998374|FG000|Overall Study|Doctor advice|38|||
42188351|NCT03594110|75998375|FG001|Overall Study|Doctor advice|40|||
42188352|NCT03594110|75998374|FG000|Overall Study|Participants' wish|89|||
42188353|NCT03594110|75998375|FG001|Overall Study|Participants' wish|68|||
42188354|NCT03594110|75998374|FG000|Overall Study|Adverse Event|119|||
42188355|NCT03594110|75998375|FG001|Overall Study|Adverse Event|116|||
42188356|NCT03594110|75998374|FG000|Overall Study|Study drug stopped, reason missing|337|||
42188357|NCT03594110|75998375|FG001|Overall Study|Study drug stopped, reason missing|295|||
42188358|NCT03594110|75998374|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
42094661|NCT00425503|75904628|FG000|Overall Study|Adverse Event|2|||
42188359|NCT03594110|75998375|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
42188360|NCT03594110|75998374|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
42296100|NCT02418585|76130842|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
42296101|NCT02418585|76130841|FG000|Follow-up Phase (24 Weeks)|Other|3|||
42296102|NCT02418585|76130842|FG001|Follow-up Phase (24 Weeks)|Other|2|||
42296103|NCT02417961|76130850|FG000|Overall Study|Adverse Event|1|||
42296104|NCT02417961|76130850|FG000|Overall Study|Lost to Follow-up|1|||
42296105|NCT02417961|76130850|FG000|Overall Study|Withdrawal by Subject|2|||
42296106|NCT01596127|76130854|FG000|Overall Study|Patient Ineligible|1|||
42296107|NCT01595581|76130860|FG000|Overall Study|Withdrawal by Subject|1|||
42094662|NCT00425503|75904628|FG000|Overall Study|Protocol Violation|1|||
42094663|NCT00425269|75904634|FG000|Overall Study|Pregnancy|5|||
42188361|NCT03594110|75998375|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
42188362|NCT03594110|75998374|FG000|Overall Study|Contraindicated drug started|32|||
42188363|NCT03594110|75998375|FG001|Overall Study|Contraindicated drug started|18|||
42188364|NCT03594110|75998374|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
42188365|NCT03594110|75998375|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
42188366|NCT03594110|75998374|FG000|Overall Study|Death|129|||
42188367|NCT03594110|75998375|FG001|Overall Study|Death|120|||
42359104|NCT02018861|76204785|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
42359105|NCT02018861|76204786|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
42359106|NCT02018861|76204787|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
42188368|NCT03024996|75998404|FG000|Overall Study|Death|57|||
42188369|NCT03024996|75998405|FG001|Overall Study|Death|55|||
42188370|NCT03024996|75998404|FG000|Overall Study|Disease relapse|1|||
42188371|NCT03024996|75998405|FG001|Overall Study|Disease relapse|0|||
42188372|NCT03024996|75998404|FG000|Overall Study|Lost to Follow-up|5|||
42188373|NCT03024996|75998405|FG001|Overall Study|Lost to Follow-up|10|||
42188374|NCT03024996|75998404|FG000|Overall Study|Other|3|||
42296108|NCT01595581|76130861|FG001|Overall Study|Withdrawal by Subject|0|||
42296109|NCT01610687|76130869|FG000|Overall Study|Lack of Efficacy|26|||
42296110|NCT01610687|76130869|FG000|Overall Study|Adverse Event|18|||
42296111|NCT01610687|76130869|FG000|Overall Study|Moved out of area|6|||
42296112|NCT01610687|76130869|FG000|Overall Study|Withdrawal by Subject|7|||
42296113|NCT01610687|76130869|FG000|Overall Study|Lost to Follow-up|4|||
42296114|NCT01610687|76130869|FG000|Overall Study|Symptom control without study medication|2|||
42296115|NCT01610687|76130869|FG000|Overall Study|Unable to make journey|1|||
42296116|NCT01610687|76130869|FG000|Overall Study|Death|1|||
42296117|NCT01610687|76130869|FG000|Overall Study|Cannabis affecting job|1|||
42296118|NCT01610687|76130869|FG000|Overall Study|Felt more alter without study medication|1|||
42296119|NCT02615509|76130873|FG000|Overall Study|Lost to Follow-up|134|||
42296120|NCT02615509|76130873|FG000|Overall Study|Death|4|||
42296121|NCT02615509|76130873|FG000|Overall Study|Withdrawal by Subject|8|||
42296122|NCT02575079|76130879|FG000|Overall Study|Death|3|||
42296123|NCT02575079|76130880|FG001|Overall Study|Death|0|||
42296124|NCT02575079|76130879|FG000|Overall Study|Withdrawal by Subject|3|||
42296125|NCT02575079|76130880|FG001|Overall Study|Withdrawal by Subject|0|||
42296126|NCT02614183|76130888|FG000|Double Blind Treatment Phase|Adverse Event|10|||
42296127|NCT02614183|76130889|FG001|Double Blind Treatment Phase|Adverse Event|9|||
42296128|NCT02614183|76130890|FG002|Double Blind Treatment Phase|Adverse Event|7|||
42296129|NCT02614183|76130888|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
42296130|NCT02614183|76130889|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
42296131|NCT02614183|76130890|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
42094664|NCT00425269|75904635|FG001|Overall Study|Pregnancy|7|||
42094665|NCT00425269|75904634|FG000|Overall Study|Lost to Follow-up|9|||
42094666|NCT00425269|75904635|FG001|Overall Study|Lost to Follow-up|9|||
42094667|NCT00425269|75904634|FG000|Overall Study|moved or medical reason|5|||
42094668|NCT00425269|75904635|FG001|Overall Study|moved or medical reason|4|||
42094669|NCT00430573|75904641|FG000|Overall Study|Withdrawal by Subject|5|||
42094670|NCT00430495|75904667|FG000|Overall Study|Adverse Event|2|||
42094671|NCT00430495|75904668|FG001|Overall Study|Adverse Event|3|||
42094672|NCT00430495|75904669|FG002|Overall Study|Adverse Event|2|||
42094673|NCT00430495|75904670|FG003|Overall Study|Adverse Event|0|||
42094674|NCT00430495|75904667|FG000|Overall Study|Death|0|||
42094675|NCT00430495|75904668|FG001|Overall Study|Death|0|||
42094676|NCT00430495|75904669|FG002|Overall Study|Death|1|||
42094677|NCT00430495|75904670|FG003|Overall Study|Death|0|||
42094678|NCT00430495|75904667|FG000|Overall Study|Lost to Follow-up|0|||
42296132|NCT02614183|76130888|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
42296133|NCT02614183|76130889|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
42094679|NCT00430495|75904668|FG001|Overall Study|Lost to Follow-up|1|||
42094680|NCT00430495|75904669|FG002|Overall Study|Lost to Follow-up|4|||
42094681|NCT00430495|75904670|FG003|Overall Study|Lost to Follow-up|0|||
42094682|NCT00430495|75904667|FG000|Overall Study|Protocol Violation|1|||
42094683|NCT00430495|75904668|FG001|Overall Study|Protocol Violation|0|||
42188375|NCT03024996|75998405|FG001|Overall Study|Other|3|||
42188376|NCT03024996|75998404|FG000|Overall Study|Physician Decision|0|||
42188377|NCT03024996|75998405|FG001|Overall Study|Physician Decision|1|||
42188378|NCT03024996|75998404|FG000|Overall Study|Study terminated by sponsor|303|||
42188379|NCT03024996|75998405|FG001|Overall Study|Study terminated by sponsor|283|||
42296134|NCT02614183|76130890|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
42296135|NCT02614183|76130888|FG000|Double Blind Treatment Phase|Physician Decision|7|||
42296136|NCT02614183|76130889|FG001|Double Blind Treatment Phase|Physician Decision|3|||
42296137|NCT02614183|76130890|FG002|Double Blind Treatment Phase|Physician Decision|2|||
42296138|NCT02614183|76130888|FG000|Double Blind Treatment Phase|Pregnancy|2|||
42188380|NCT03024996|75998404|FG000|Overall Study|Withdrawal by Subject|21|||
42188381|NCT03024996|75998405|FG001|Overall Study|Withdrawal by Subject|36|||
42188382|NCT02642965|75998429|FG000|Overall Study|Lack of Efficacy|4|||
42188383|NCT02642965|75998429|FG000|Overall Study|Physician Decision|9|||
42188384|NCT01038778|75998458|FG000|Overall Study|Withdrawal by Subject|0|||
42188385|NCT01038778|75998459|FG001|Overall Study|Withdrawal by Subject|2|||
42188386|NCT01038778|75998460|FG002|Overall Study|Withdrawal by Subject|3|||
42188387|NCT03443414|75998487|FG000|Overall Study|Adverse Event|6|||
42188388|NCT03443414|75998488|FG001|Overall Study|Adverse Event|0|||
42188389|NCT03443414|75998489|FG002|Overall Study|Adverse Event|4|||
42188390|NCT03443414|75998490|FG003|Overall Study|Adverse Event|2|||
42188391|NCT03443414|75998491|FG004|Overall Study|Adverse Event|3|||
42188392|NCT03443414|75998487|FG000|Overall Study|Withdrawal by Subject|3|||
42188393|NCT03443414|75998488|FG001|Overall Study|Withdrawal by Subject|2|||
42188394|NCT03443414|75998489|FG002|Overall Study|Withdrawal by Subject|2|||
42188395|NCT03443414|75998490|FG003|Overall Study|Withdrawal by Subject|2|||
42188396|NCT03443414|75998491|FG004|Overall Study|Withdrawal by Subject|1|||
42188397|NCT03443414|75998487|FG000|Overall Study|Death|0|||
42188398|NCT03443414|75998488|FG001|Overall Study|Death|1|||
42188399|NCT03443414|75998489|FG002|Overall Study|Death|0|||
42188400|NCT03443414|75998490|FG003|Overall Study|Death|1|||
42188401|NCT03443414|75998491|FG004|Overall Study|Death|0|||
42188402|NCT03443414|75998487|FG000|Overall Study|Reason not specified|2|||
42188403|NCT03443414|75998488|FG001|Overall Study|Reason not specified|0|||
42188404|NCT03443414|75998489|FG002|Overall Study|Reason not specified|0|||
42188405|NCT03443414|75998490|FG003|Overall Study|Reason not specified|0|||
42188406|NCT03443414|75998491|FG004|Overall Study|Reason not specified|1|||
42188407|NCT02991118|75998505|FG000|Overall Study|Death|3|||
42188408|NCT02991118|75998506|FG001|Overall Study|Death|8|||
42094684|NCT00430495|75904669|FG002|Overall Study|Protocol Violation|1|||
42094685|NCT00430495|75904670|FG003|Overall Study|Protocol Violation|0|||
42094686|NCT00430495|75904667|FG000|Overall Study|Disease Progression|1|||
42094687|NCT00430495|75904668|FG001|Overall Study|Disease Progression|1|||
42094688|NCT00430495|75904669|FG002|Overall Study|Disease Progression|0|||
42094689|NCT00430495|75904670|FG003|Overall Study|Disease Progression|0|||
42094690|NCT00430495|75904667|FG000|Overall Study|Other|8|||
42094691|NCT00430495|75904668|FG001|Overall Study|Other|2|||
42094692|NCT00430495|75904669|FG002|Overall Study|Other|5|||
42094693|NCT00430495|75904670|FG003|Overall Study|Other|4|||
42094694|NCT00430495|75904667|FG000|Overall Study|Randomized but not Treated|2|||
42094695|NCT00430495|75904668|FG001|Overall Study|Randomized but not Treated|0|||
42094696|NCT00430495|75904669|FG002|Overall Study|Randomized but not Treated|0|||
42094697|NCT00430495|75904670|FG003|Overall Study|Randomized but not Treated|0|||
42094698|NCT00425113|75904682|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
42188409|NCT02991118|75998505|FG000|Overall Study|Protocol Violation|0|||
42188410|NCT02991118|75998506|FG001|Overall Study|Protocol Violation|3|||
42188411|NCT02991118|75998505|FG000|Overall Study|Physician Decision|0|||
42188412|NCT02991118|75998506|FG001|Overall Study|Physician Decision|1|||
42188413|NCT02991118|75998505|FG000|Overall Study|Moved out of the country|0|||
42188414|NCT02991118|75998506|FG001|Overall Study|Moved out of the country|1|||
42188415|NCT02991118|75998505|FG000|Overall Study|Adverse Event|2|||
42188416|NCT02991118|75998506|FG001|Overall Study|Adverse Event|2|||
42188417|NCT02991118|75998505|FG000|Overall Study|Withdrawal by Subject|1|||
42188418|NCT02991118|75998506|FG001|Overall Study|Withdrawal by Subject|7|||
42188419|NCT02991118|75998505|FG000|Overall Study|Could not attend study visits|0|||
42188420|NCT02991118|75998506|FG001|Overall Study|Could not attend study visits|1|||
42296139|NCT02614183|76130889|FG001|Double Blind Treatment Phase|Pregnancy|1|||
42296140|NCT02614183|76130890|FG002|Double Blind Treatment Phase|Pregnancy|3|||
42188421|NCT02991118|75998505|FG000|Overall Study|Lost to Follow-up|1|||
42188422|NCT02991118|75998506|FG001|Overall Study|Lost to Follow-up|9|||
42188423|NCT03491150|75998514|FG000|Overall Study|Adverse Event|1|||
42296141|NCT02614183|76130888|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
42296142|NCT02614183|76130889|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
42296143|NCT02614183|76130890|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
42296144|NCT02614183|76130888|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
42296145|NCT02614183|76130889|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
42296146|NCT02614183|76130890|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
42296147|NCT02614183|76130888|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
42296148|NCT02614183|76130889|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
42296149|NCT02614183|76130890|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
42296150|NCT02614183|76130888|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
42296151|NCT02614183|76130889|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
42296152|NCT02614183|76130890|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
42094699|NCT00425113|75904683|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
42188424|NCT03491150|75998515|FG001|Overall Study|Adverse Event|0|||
42188425|NCT03491150|75998514|FG000|Overall Study|Study Terminated by Sponsor|74|||
42296153|NCT02614183|76130888|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
42094700|NCT00425113|75904682|FG000|Overall Study|diagnosis of abdominal TB|0|||
42094701|NCT00425113|75904683|FG001|Overall Study|diagnosis of abdominal TB|1|||
42094702|NCT00425113|75904682|FG000|Overall Study|missing study drug more than 14 days|0|||
42094703|NCT00425113|75904683|FG001|Overall Study|missing study drug more than 14 days|1|||
42094704|NCT00425113|75904682|FG000|Overall Study|Withdrawal by Subject|1|||
42094705|NCT00425113|75904683|FG001|Overall Study|Withdrawal by Subject|0|||
42094706|NCT00440011|75904692|FG000|Overall Study|Adverse Event|2|||
42094707|NCT00440011|75904693|FG001|Overall Study|Adverse Event|0|||
42094708|NCT00440011|75904692|FG000|Overall Study|Lost to Follow-up|0|||
42094709|NCT00440011|75904693|FG001|Overall Study|Lost to Follow-up|2|||
42094710|NCT00440011|75904692|FG000|Overall Study|Protocol Violation|1|||
42094711|NCT00440011|75904693|FG001|Overall Study|Protocol Violation|1|||
42188426|NCT03491150|75998515|FG001|Overall Study|Study Terminated by Sponsor|70|||
42188427|NCT03491150|75998514|FG000|Overall Study|Other|0|||
42188428|NCT03491150|75998515|FG001|Overall Study|Other|1|||
42188429|NCT03491150|75998514|FG000|Overall Study|Withdrawal by Subject|1|||
42188430|NCT03491150|75998515|FG001|Overall Study|Withdrawal by Subject|2|||
42188431|NCT02991040|75998521|FG000|Overall Study|Withdrawal by Subject|2|||
42188432|NCT02991040|75998521|FG000|Overall Study|Lost to Follow-up|2|||
42188433|NCT02910466|75998527|FG000|Overall Study|Adverse Event|1|||
42188434|NCT02910466|75998527|FG000|Overall Study|Withdrawal by Subject|3|||
42188435|NCT02910466|75998527|FG000|Overall Study|Lost to Follow-up|5|||
42188436|NCT02910466|75998527|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
42188437|NCT02910466|75998527|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
42188438|NCT03415178|75998533|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
42188439|NCT03415178|75998534|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
42188440|NCT03415178|75998533|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
42188441|NCT03415178|75998534|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
42188442|NCT01068730|75998544|FG000|Period 3|Personal reason|1|||
42188443|NCT01068730|75998545|FG001|Period 3|Personal reason|0|||
42188444|NCT01068730|75998546|FG002|Period 3|Personal reason|0|||
42188445|NCT01068730|75998547|FG003|Period 3|Personal reason|0|||
42188446|NCT01068730|75998544|FG000|Period 4|Family emergency|0|||
42188447|NCT01068730|75998545|FG001|Period 4|Family emergency|1|||
42188448|NCT01068730|75998546|FG002|Period 4|Family emergency|0|||
42188449|NCT01068730|75998547|FG003|Period 4|Family emergency|0|||
42188450|NCT01068652|75998566|FG000|Overall Study|Adverse Event|4|||
42188451|NCT01068652|75998567|FG001|Overall Study|Adverse Event|0|||
42188452|NCT01068652|75998566|FG000|Overall Study|Lack of Efficacy|0|||
42188453|NCT01068652|75998567|FG001|Overall Study|Lack of Efficacy|2|||
42188454|NCT01068652|75998566|FG000|Overall Study|Lost to Follow-up|2|||
42188455|NCT01068652|75998567|FG001|Overall Study|Lost to Follow-up|1|||
42188456|NCT01068652|75998566|FG000|Overall Study|Protocol Violation|3|||
42188457|NCT01068652|75998567|FG001|Overall Study|Protocol Violation|6|||
42188458|NCT01068652|75998566|FG000|Overall Study|Withdrawal criteria|1|||
42188459|NCT01068652|75998567|FG001|Overall Study|Withdrawal criteria|2|||
42188460|NCT01068652|75998566|FG000|Overall Study|Patient was not eligible|1|||
42188461|NCT01068652|75998567|FG001|Overall Study|Patient was not eligible|0|||
42094712|NCT00440011|75904692|FG000|Overall Study|Withdrawal by Subject|1|||
42094713|NCT00440011|75904693|FG001|Overall Study|Withdrawal by Subject|0|||
42094714|NCT00663117|75904730|FG000|Overall Study|Lack of Efficacy|1|||
42094715|NCT00663117|75904731|FG001|Overall Study|Lack of Efficacy|0|||
42094716|NCT00570141|75904752|FG000|Overall Study|Adverse Event|1|||
42094717|NCT00570141|75904752|FG000|Overall Study|Missed visits|1|||
42094718|NCT00570141|75904752|FG000|Overall Study|Lost to Follow-up|1|||
42094719|NCT00579254|75904756|FG000|Overall Study|Lost to Follow-up|39|||
42188462|NCT01068652|75998566|FG000|Overall Study|Unclassified|7|||
42188463|NCT01068652|75998567|FG001|Overall Study|Unclassified|4|||
42188464|NCT02921776|75998579|FG000|Overall Study|patient deterioration, fatigue|2|||
42188465|NCT02921776|75998580|FG001|Overall Study|patient deterioration, fatigue|6|||
42188466|NCT02921776|75998581|FG002|Overall Study|patient deterioration, fatigue|0|||
42188467|NCT02921776|75998582|FG003|Overall Study|patient deterioration, fatigue|0|||
42188468|NCT02921776|75998583|FG004|Overall Study|patient deterioration, fatigue|0|||
42188469|NCT02921776|75998584|FG005|Overall Study|patient deterioration, fatigue|0|||
42188470|NCT02921776|75998585|FG006|Overall Study|patient deterioration, fatigue|0|||
42188471|NCT02921776|75998586|FG007|Overall Study|patient deterioration, fatigue|0|||
42094720|NCT00579254|75904756|FG000|Overall Study|Discontinued when study terminated|73|||
42188472|NCT02921776|75998579|FG000|Overall Study|Withdrawal by Subject|0|||
42188473|NCT02921776|75998580|FG001|Overall Study|Withdrawal by Subject|2|||
42188474|NCT02921776|75998581|FG002|Overall Study|Withdrawal by Subject|0|||
42296154|NCT02614183|76130889|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
42094721|NCT00661089|75904762|FG000|Overall Study|1 subject withdrawal|0|||
42094722|NCT00661089|75904763|FG001|Overall Study|1 subject withdrawal|1|||
42094723|NCT00661089|75904762|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
42094724|NCT00661089|75904763|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
42296155|NCT02614183|76130890|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
42094725|NCT00582426|75904776|FG000|Overall Study|Lost to Follow-up|0|||
42094726|NCT00582426|75904777|FG001|Overall Study|Lost to Follow-up|2|||
42094727|NCT00582426|75904776|FG000|Overall Study|Adverse Event|4|||
42094728|NCT00582426|75904777|FG001|Overall Study|Adverse Event|2|||
42094729|NCT00582426|75904776|FG000|Overall Study|Protocol Violation|6|||
42094730|NCT00582426|75904777|FG001|Overall Study|Protocol Violation|2|||
42094731|NCT00582426|75904776|FG000|Overall Study|Death|4|||
42094732|NCT00582426|75904777|FG001|Overall Study|Death|3|||
42094733|NCT00582426|75904776|FG000|Overall Study|Withdrawal by Subject|3|||
42094734|NCT00582426|75904777|FG001|Overall Study|Withdrawal by Subject|2|||
42094735|NCT00582426|75904776|FG000|Overall Study|Disease Progression|2|||
42094736|NCT00582426|75904777|FG001|Overall Study|Disease Progression|2|||
42094737|NCT00582426|75904776|FG000|Overall Study|Use of illicit drugs|1|||
42188475|NCT02921776|75998582|FG003|Overall Study|Withdrawal by Subject|1|||
42188476|NCT02921776|75998583|FG004|Overall Study|Withdrawal by Subject|1|||
42188477|NCT02921776|75998584|FG005|Overall Study|Withdrawal by Subject|0|||
42094738|NCT00582426|75904777|FG001|Overall Study|Use of illicit drugs|0|||
42094739|NCT02387970|75904785|FG000|Overall Study|Did not complete 1-year follow up|1|||
42188478|NCT02921776|75998585|FG006|Overall Study|Withdrawal by Subject|8|||
42188479|NCT02921776|75998586|FG007|Overall Study|Withdrawal by Subject|1|||
42188480|NCT02921776|75998579|FG000|Overall Study|Death|0|||
42188481|NCT02921776|75998580|FG001|Overall Study|Death|0|||
42296156|NCT02614183|76130888|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
42296157|NCT02614183|76130889|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
42296158|NCT02614183|76130890|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
42359107|NCT02018861|76204788|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
42359108|NCT02018861|76204789|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
42296159|NCT02614183|76130888|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
42296160|NCT02614183|76130889|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
42296161|NCT02614183|76130890|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
42296162|NCT02612155|76130915|FG000|Overall Study|Death|1|||
42296163|NCT02612155|76130916|FG001|Overall Study|Death|1|||
42296164|NCT02612155|76130915|FG000|Overall Study|Lost to Follow-up|2|||
42296165|NCT02612155|76130916|FG001|Overall Study|Lost to Follow-up|2|||
42296166|NCT02614729|76130924|FG000|Overall Study|Withdrawal by Subject|1|||
42296167|NCT02614729|76130925|FG001|Overall Study|Withdrawal by Subject|0|||
42296168|NCT02613871|76130933|FG000|Overall Study|Death|2|||
42296169|NCT02613871|76130933|FG000|Overall Study|Withdrew Consent|1|||
42296170|NCT05021081|76130939|FG000|Phase 2|Subject enrolled in error|1|||
42094740|NCT02387970|75904786|FG001|Overall Study|Did not complete 1-year follow up|2|||
42094741|NCT00580034|75904792|FG000|Overall Study|Toxicity|10|||
42094742|NCT00580034|75904793|FG001|Overall Study|Toxicity|0|||
42188482|NCT02921776|75998581|FG002|Overall Study|Death|0|||
42296171|NCT05021081|76130940|FG001|Phase 2|Subject enrolled in error|1|||
42359109|NCT02018861|76204790|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
42094743|NCT00773513|75904799|FG000|Overall Study|Renal Transplant|254|||
42094744|NCT00773513|75904800|FG001|Overall Study|Renal Transplant|263|||
42094745|NCT00773513|75904799|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
42094746|NCT00773513|75904800|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
42296172|NCT05021081|76130941|FG002|Phase 2|Subject enrolled in error|0|||
42094747|NCT00773513|75904799|FG000|Overall Study|Withdrew Consent|68|||
42094748|NCT00773513|75904800|FG001|Overall Study|Withdrew Consent|69|||
42094749|NCT00773513|75904799|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
42094750|NCT00773513|75904800|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
42094751|NCT00773513|75904799|FG000|Overall Study|Failure to Return|22|||
42094752|NCT00773513|75904800|FG001|Overall Study|Failure to Return|8|||
42094753|NCT00773513|75904799|FG000|Overall Study|Insufficient Therapeutic Response|1|||
42094754|NCT00773513|75904800|FG001|Overall Study|Insufficient Therapeutic Response|18|||
42094755|NCT00773513|75904799|FG000|Overall Study|Reason Not Specified|159|||
42094756|NCT00773513|75904800|FG001|Overall Study|Reason Not Specified|126|||
42094757|NCT00773513|75904799|FG000|Overall Study|Death|531|||
42094758|NCT00773513|75904800|FG001|Overall Study|Death|545|||
42094759|NCT00767039|75904808|FG000|Overall Study|Death|5|||
42094760|NCT00767039|75904809|FG001|Overall Study|Death|2|||
42094761|NCT00662649|75904819|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
42094762|NCT00662649|75904820|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
42094763|NCT00662649|75904821|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
42094764|NCT00662649|75904822|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
42094765|NCT00662649|75904823|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
42094766|NCT00662649|75904819|FG000|Core Study (24 Months)|Adverse Event|22|||
42094767|NCT00662649|75904820|FG001|Core Study (24 Months)|Adverse Event|13|||
42094768|NCT00662649|75904821|FG002|Core Study (24 Months)|Adverse Event|18|||
42094769|NCT00662649|75904822|FG003|Core Study (24 Months)|Adverse Event|0|||
42094770|NCT00662649|75904823|FG004|Core Study (24 Months)|Adverse Event|0|||
42094771|NCT00662649|75904819|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
42094772|NCT00662649|75904820|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
42094773|NCT00662649|75904821|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
42094774|NCT00662649|75904822|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
42094775|NCT00662649|75904823|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
42094776|NCT00662649|75904819|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
42094777|NCT00662649|75904820|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
42094778|NCT00662649|75904821|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
42094779|NCT00662649|75904822|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
42094780|NCT00662649|75904823|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
42094781|NCT00662649|75904819|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
42094782|NCT00662649|75904820|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
42094783|NCT00662649|75904821|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
42094784|NCT00662649|75904822|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
42094785|NCT00662649|75904823|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
42094786|NCT00662649|75904819|FG000|Core Study (24 Months)|Protocol Violation|5|||
42094787|NCT00662649|75904820|FG001|Core Study (24 Months)|Protocol Violation|5|||
42094788|NCT00662649|75904821|FG002|Core Study (24 Months)|Protocol Violation|4|||
42094789|NCT00662649|75904822|FG003|Core Study (24 Months)|Protocol Violation|0|||
42094790|NCT00662649|75904823|FG004|Core Study (24 Months)|Protocol Violation|0|||
42094791|NCT00662649|75904819|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
42094792|NCT00662649|75904820|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
42094793|NCT00662649|75904821|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
42094794|NCT00662649|75904822|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
42094795|NCT00662649|75904823|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
42094796|NCT00662649|75904819|FG000|Core Study (24 Months)|Death|1|||
42094797|NCT00662649|75904820|FG001|Core Study (24 Months)|Death|0|||
42094798|NCT00662649|75904821|FG002|Core Study (24 Months)|Death|2|||
42094799|NCT00662649|75904822|FG003|Core Study (24 Months)|Death|0|||
42094800|NCT00662649|75904823|FG004|Core Study (24 Months)|Death|0|||
42094801|NCT00662649|75904819|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
42094802|NCT00662649|75904820|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
42094803|NCT00662649|75904821|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
42018189|NCT00996892|75825871|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
42018190|NCT00996892|75825872|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
42018191|NCT00996892|75825873|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
42018192|NCT00996892|75825874|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
42018193|NCT00996892|75825875|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
42018194|NCT00996892|75825876|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
42018195|NCT00996892|75825877|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
42018196|NCT00996892|75825878|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
42018197|NCT00996892|75825879|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
42018198|NCT00996892|75825880|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
42018199|NCT00996892|75825861|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018200|NCT00996892|75825862|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
42018201|NCT00996892|75825863|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018202|NCT00996892|75825864|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
42094804|NCT00662649|75904822|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
42094805|NCT00662649|75904823|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
42094806|NCT00662649|75904819|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
42094807|NCT00662649|75904820|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
42094808|NCT00662649|75904821|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
42094809|NCT00662649|75904822|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
42094810|NCT00662649|75904823|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
42094811|NCT00662649|75904819|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
42094812|NCT00662649|75904820|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
42094813|NCT00662649|75904821|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
42094814|NCT00662649|75904822|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
42094815|NCT00662649|75904823|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
42188483|NCT02921776|75998582|FG003|Overall Study|Death|2|||
42094816|NCT00662649|75904819|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
42094817|NCT00662649|75904820|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
42094818|NCT00662649|75904821|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
42094819|NCT00662649|75904822|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
42188484|NCT02921776|75998583|FG004|Overall Study|Death|0|||
42188485|NCT02921776|75998584|FG005|Overall Study|Death|0|||
42188486|NCT02921776|75998585|FG006|Overall Study|Death|0|||
42188487|NCT02921776|75998586|FG007|Overall Study|Death|0|||
42188488|NCT02921776|75998579|FG000|Overall Study|extubation or early discharge|0|||
42188489|NCT02921776|75998580|FG001|Overall Study|extubation or early discharge|0|||
42188490|NCT02921776|75998581|FG002|Overall Study|extubation or early discharge|0|||
42188491|NCT02921776|75998582|FG003|Overall Study|extubation or early discharge|5|||
42094820|NCT00662649|75904823|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
42094821|NCT00662649|75904819|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
42094822|NCT00662649|75904820|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
42094823|NCT00662649|75904821|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
42094824|NCT00662649|75904822|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
42094825|NCT00662649|75904823|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
42094826|NCT00662649|75904819|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
42094827|NCT00662649|75904820|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
42094828|NCT00662649|75904821|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
42094829|NCT00662649|75904822|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
42094830|NCT00662649|75904823|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
42094831|NCT00662649|75904819|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
42094832|NCT00662649|75904820|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
42094833|NCT00662649|75904821|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
42094834|NCT00662649|75904822|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
42094835|NCT00662649|75904823|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
42094836|NCT00662649|75904819|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
42188492|NCT02921776|75998583|FG004|Overall Study|extubation or early discharge|5|||
42188493|NCT02921776|75998584|FG005|Overall Study|extubation or early discharge|0|||
42188494|NCT02921776|75998585|FG006|Overall Study|extubation or early discharge|0|||
42188495|NCT02921776|75998586|FG007|Overall Study|extubation or early discharge|0|||
42188496|NCT02921776|75998579|FG000|Overall Study|Lost to Follow-up|0|||
42188497|NCT02921776|75998580|FG001|Overall Study|Lost to Follow-up|0|||
42188498|NCT02921776|75998581|FG002|Overall Study|Lost to Follow-up|0|||
42188499|NCT02921776|75998582|FG003|Overall Study|Lost to Follow-up|0|||
42094837|NCT00662649|75904820|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
42094838|NCT00662649|75904821|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
42094839|NCT00662649|75904822|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
42094840|NCT00662649|75904823|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
42094841|NCT00662649|75904819|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
42094842|NCT00662649|75904820|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
42094843|NCT00662649|75904821|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
42094844|NCT00662649|75904822|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
42094845|NCT00662649|75904823|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
42094846|NCT00766493|75904837|FG000|30 Days Post-Procedure|Discontinued|7|||
42094847|NCT00766493|75904837|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
42094848|NCT00766493|75904837|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
42188500|NCT02921776|75998583|FG004|Overall Study|Lost to Follow-up|0|||
42188501|NCT02921776|75998584|FG005|Overall Study|Lost to Follow-up|2|||
42188502|NCT02921776|75998585|FG006|Overall Study|Lost to Follow-up|3|||
42188503|NCT02921776|75998586|FG007|Overall Study|Lost to Follow-up|6|||
42188504|NCT02922634|75998610|FG000|Overall Study|Withdrawal by Subject|5|||
42094849|NCT03070392|75904843|FG000|Overall Study|Not Treated|7|||
42094850|NCT03070392|75904844|FG001|Overall Study|Not Treated|0|||
42094851|NCT03070392|75904845|FG002|Overall Study|Not Treated|3|||
42094852|NCT03070392|75904846|FG003|Overall Study|Not Treated|12|||
42094853|NCT03070392|75904843|FG000|Overall Study|Death|3|||
42094854|NCT03070392|75904844|FG001|Overall Study|Death|0|||
42094855|NCT03070392|75904845|FG002|Overall Study|Death|0|||
42094856|NCT03070392|75904846|FG003|Overall Study|Death|1|||
42094857|NCT03070392|75904843|FG000|Overall Study|Withdrawal by Subject|7|||
42094858|NCT03070392|75904844|FG001|Overall Study|Withdrawal by Subject|0|||
42094859|NCT03070392|75904845|FG002|Overall Study|Withdrawal by Subject|0|||
42094860|NCT03070392|75904846|FG003|Overall Study|Withdrawal by Subject|3|||
42094861|NCT03070392|75904843|FG000|Overall Study|Physician Decision|1|||
42094862|NCT03070392|75904844|FG001|Overall Study|Physician Decision|0|||
42094863|NCT03070392|75904845|FG002|Overall Study|Physician Decision|0|||
42094864|NCT03070392|75904846|FG003|Overall Study|Physician Decision|2|||
42094865|NCT03070392|75904843|FG000|Overall Study|Progressive Disease|154|||
42094866|NCT03070392|75904844|FG001|Overall Study|Progressive Disease|6|||
42094867|NCT03070392|75904845|FG002|Overall Study|Progressive Disease|2|||
42094868|NCT03070392|75904846|FG003|Overall Study|Progressive Disease|70|||
42094869|NCT03070392|75904843|FG000|Overall Study|Adverse Event|6|||
42094870|NCT03070392|75904844|FG001|Overall Study|Adverse Event|1|||
42094871|NCT03070392|75904845|FG002|Overall Study|Adverse Event|1|||
42094872|NCT03070392|75904846|FG003|Overall Study|Adverse Event|3|||
42094873|NCT03070392|75904843|FG000|Overall Study|Alternate anticancer treatment|1|||
42094874|NCT03070392|75904844|FG001|Overall Study|Alternate anticancer treatment|0|||
42094875|NCT03070392|75904845|FG002|Overall Study|Alternate anticancer treatment|0|||
42094876|NCT03070392|75904846|FG003|Overall Study|Alternate anticancer treatment|1|||
42094877|NCT03070392|75904843|FG000|Overall Study|Ongoing|73|||
42094878|NCT03070392|75904844|FG001|Overall Study|Ongoing|0|||
42094879|NCT03070392|75904845|FG002|Overall Study|Ongoing|0|||
42094880|NCT03070392|75904846|FG003|Overall Study|Ongoing|11|||
42094881|NCT00784043|75904854|FG000|Overall Study|Withdrawal by Subject|8|||
42188505|NCT02922634|75998610|FG000|Overall Study|Did not have their surgery|5|||
42188506|NCT00023595|75998626|FG000|5 Year Follow up|Lost to Follow-up|2|||
42188507|NCT00023595|75998627|FG001|5 Year Follow up|Lost to Follow-up|2|||
42188508|NCT00023595|75998628|FG002|5 Year Follow up|Lost to Follow-up|1|||
42094882|NCT00784043|75904855|FG001|Overall Study|Withdrawal by Subject|5|||
42188509|NCT00023595|75998629|FG003|5 Year Follow up|Lost to Follow-up|7|||
42188510|NCT00023595|75998630|FG004|5 Year Follow up|Lost to Follow-up|3|||
42188511|NCT00023595|75998626|FG000|10 Year Follow up|Lost to Follow-up|12|||
42188512|NCT00023595|75998627|FG001|10 Year Follow up|Lost to Follow-up|10|||
42188513|NCT00023595|75998628|FG002|10 Year Follow up|Lost to Follow-up|3|||
42188514|NCT00023595|75998629|FG003|10 Year Follow up|Lost to Follow-up|0|||
42188515|NCT00023595|75998630|FG004|10 Year Follow up|Lost to Follow-up|0|||
42188516|NCT02920528|75998656|FG000|Overall Study|Incomplete Data|1|||
42188517|NCT02920528|75998657|FG001|Overall Study|Incomplete Data|1|||
42188518|NCT02920528|75998658|FG002|Overall Study|Incomplete Data|1|||
42188519|NCT02920528|75998656|FG000|Overall Study|Adverse Event|0|||
42188520|NCT02920528|75998657|FG001|Overall Study|Adverse Event|0|||
42188521|NCT02920528|75998658|FG002|Overall Study|Adverse Event|3|||
42188522|NCT02920528|75998656|FG000|Overall Study|Did not meet inclusion criteria|2|||
42188523|NCT02920528|75998657|FG001|Overall Study|Did not meet inclusion criteria|0|||
42188524|NCT02920528|75998658|FG002|Overall Study|Did not meet inclusion criteria|1|||
42188525|NCT01068418|75998666|FG000|Overall Study|Physician Decision|12|||
42188526|NCT01068262|75998674|FG000|Overall Study|Adverse Event|2|||
42188527|NCT01068262|75998675|FG001|Overall Study|Adverse Event|0|||
42188528|NCT01068262|75998676|FG002|Overall Study|Adverse Event|1|||
42188529|NCT01068262|75998677|FG003|Overall Study|Adverse Event|0|||
42188530|NCT01068262|75998674|FG000|Overall Study|Protocol Violation|1|||
42188531|NCT01068262|75998675|FG001|Overall Study|Protocol Violation|0|||
42188532|NCT01068262|75998676|FG002|Overall Study|Protocol Violation|0|||
42188533|NCT01068262|75998677|FG003|Overall Study|Protocol Violation|0|||
42188534|NCT01068262|75998674|FG000|Overall Study|Withdrawal by Subject|0|||
42188535|NCT01068262|75998675|FG001|Overall Study|Withdrawal by Subject|1|||
42296173|NCT02612077|76130957|FG000|Overall Study|Adverse Event|3|||
42296174|NCT02612077|76130957|FG000|Overall Study|Withdrawal by Subject|9|||
42094883|NCT00784043|75904854|FG000|Overall Study|Protocol Terminated|23|||
42094884|NCT00784043|75904855|FG001|Overall Study|Protocol Terminated|1|||
42094885|NCT00773279|75904861|FG000|Period 1|Adverse Event|2|||
42094886|NCT00773279|75904862|FG001|Period 1|Adverse Event|1|||
42094887|NCT00773279|75904861|FG000|Period 1|Lack of Efficacy|0|||
42094888|NCT00773279|75904862|FG001|Period 1|Lack of Efficacy|2|||
42094889|NCT00773279|75904861|FG000|Period 1|Unclassified|5|||
42188536|NCT01068262|75998676|FG002|Overall Study|Withdrawal by Subject|0|||
42094890|NCT00773279|75904862|FG001|Period 1|Unclassified|1|||
42094891|NCT00773279|75904861|FG000|Period 2|Adverse Event|0|||
42094892|NCT00773279|75904862|FG001|Period 2|Adverse Event|1|||
42094893|NCT00773279|75904861|FG000|Period 2|Lack of Efficacy|1|||
42188537|NCT01068262|75998677|FG003|Overall Study|Withdrawal by Subject|0|||
42094894|NCT00773279|75904862|FG001|Period 2|Lack of Efficacy|0|||
42188538|NCT02920450|75998690|FG000|Overall Study|Death|1|||
42188539|NCT02920450|75998691|FG001|Overall Study|Death|0|||
42188540|NCT02920450|75998692|FG002|Overall Study|Death|0|||
42188541|NCT02920450|75998693|FG003|Overall Study|Death|0|||
42188542|NCT02920450|75998690|FG000|Overall Study|Withdrawal by Subject|1|||
42188543|NCT02920450|75998691|FG001|Overall Study|Withdrawal by Subject|0|||
42188544|NCT02920450|75998692|FG002|Overall Study|Withdrawal by Subject|0|||
42188545|NCT02920450|75998693|FG003|Overall Study|Withdrawal by Subject|0|||
42188546|NCT01066936|75998704|FG000|Overall Study|Death|2|||
42188547|NCT01066936|75998704|FG000|Overall Study|Device revised/removed|1|||
42188548|NCT01066936|75998704|FG000|Overall Study|Lost to Follow-up|3|||
42188549|NCT01066936|75998704|FG000|Overall Study|Withdrawal by Subject|4|||
42188550|NCT02919436|75998712|FG000|Overall Study|Did not undergo surgery|16|||
42188551|NCT02919436|75998713|FG001|Overall Study|Did not undergo surgery|20|||
42188552|NCT02919436|75998712|FG000|Overall Study|Enrolled before trial registration|44|||
42188553|NCT02919436|75998713|FG001|Overall Study|Enrolled before trial registration|33|||
42188554|NCT03804879|75998723|FG000|Overall Study|Adverse Event|3|||
42188555|NCT03804879|75998724|FG001|Overall Study|Adverse Event|0|||
42188556|NCT03804879|75998723|FG000|Overall Study|Study Terminated By Sponsor|10|||
42188557|NCT03804879|75998724|FG001|Overall Study|Study Terminated By Sponsor|12|||
42188558|NCT03804879|75998723|FG000|Overall Study|Withdrawal by Subject|3|||
42188559|NCT03804879|75998724|FG001|Overall Study|Withdrawal by Subject|1|||
42188560|NCT03803475|75998731|FG000|Overall Study|Physician Decision|1|||
42188561|NCT00005937|75998735|FG000|Overall Study|Lack of Efficacy|5|||
42094895|NCT00773279|75904861|FG000|Period 2|Protocol Violation|0|||
42094896|NCT00773279|75904862|FG001|Period 2|Protocol Violation|3|||
42094897|NCT00773279|75904861|FG000|Period 2|Unclassified|2|||
42094898|NCT00773279|75904862|FG001|Period 2|Unclassified|2|||
42094899|NCT00766415|75904871|FG000|Overall Study|Withdrawal by Subject|0|||
42094900|NCT00766415|75904872|FG001|Overall Study|Withdrawal by Subject|1|||
42094901|NCT00772967|75904878|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
42094902|NCT00772967|75904879|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
42094903|NCT00772967|75904880|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
42094904|NCT00772967|75904881|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
42188562|NCT03443024|75998743|FG000|Overall Study|Adverse Event|2|||
42188563|NCT03443024|75998744|FG001|Overall Study|Adverse Event|4|||
42188564|NCT03443024|75998745|FG002|Overall Study|Adverse Event|3|||
42188565|NCT03443024|75998746|FG003|Overall Study|Adverse Event|1|||
42188566|NCT03443024|75998743|FG000|Overall Study|Lost to Follow-up|9|||
42188567|NCT03443024|75998744|FG001|Overall Study|Lost to Follow-up|9|||
42188568|NCT03443024|75998745|FG002|Overall Study|Lost to Follow-up|7|||
42188569|NCT03443024|75998746|FG003|Overall Study|Lost to Follow-up|5|||
42188570|NCT03443024|75998743|FG000|Overall Study|Withdrawal by Subject|8|||
42188571|NCT03443024|75998744|FG001|Overall Study|Withdrawal by Subject|15|||
42188572|NCT03443024|75998745|FG002|Overall Study|Withdrawal by Subject|9|||
42188573|NCT03443024|75998746|FG003|Overall Study|Withdrawal by Subject|23|||
42188574|NCT03443024|75998743|FG000|Overall Study|Physician Decision|1|||
42188575|NCT03443024|75998744|FG001|Overall Study|Physician Decision|2|||
42188576|NCT03443024|75998745|FG002|Overall Study|Physician Decision|0|||
42188577|NCT03443024|75998746|FG003|Overall Study|Physician Decision|1|||
42188578|NCT03443024|75998743|FG000|Overall Study|Sponsor Decision|1|||
42188579|NCT03443024|75998744|FG001|Overall Study|Sponsor Decision|1|||
42188580|NCT03443024|75998745|FG002|Overall Study|Sponsor Decision|0|||
42188581|NCT03443024|75998746|FG003|Overall Study|Sponsor Decision|0|||
42188582|NCT03443024|75998743|FG000|Overall Study|Protocol Deviation|0|||
42188583|NCT03443024|75998744|FG001|Overall Study|Protocol Deviation|0|||
42188584|NCT03443024|75998745|FG002|Overall Study|Protocol Deviation|0|||
42188585|NCT03443024|75998746|FG003|Overall Study|Protocol Deviation|2|||
42188586|NCT02908516|75998758|FG000|Overall Study|Study Terminated|3|||
42188587|NCT02908516|75998759|FG001|Overall Study|Study Terminated|3|||
42188588|NCT02907892|75998767|FG000|Overall Study|Lost to Follow-up|27|||
42296175|NCT02612077|76130957|FG000|Overall Study|Protocol Violation|28|||
42094905|NCT00772967|75904882|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
42094906|NCT00772967|75904883|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
42188589|NCT02907892|75998768|FG001|Overall Study|Lost to Follow-up|40|||
42188590|NCT02906644|75998776|FG000|First 2 Weeks|Withdrawal by Subject|0|||
42188591|NCT02906644|75998777|FG001|First 2 Weeks|Withdrawal by Subject|2|||
42188592|NCT02906644|75998776|FG000|First 2 Weeks|Physician Decision|1|||
42188593|NCT02906644|75998777|FG001|First 2 Weeks|Physician Decision|1|||
42188594|NCT02906644|75998776|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
42188595|NCT02906644|75998777|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
42296176|NCT02612077|76130957|FG000|Overall Study|Lost to Follow-up|20|||
42094907|NCT00772967|75904878|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
42094908|NCT00772967|75904879|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
42188596|NCT02906644|75998776|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
42188597|NCT02906644|75998777|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
42188598|NCT03410108|75998784|FG000|Overall Study|Ongoing|41|||
42188599|NCT03410108|75998784|FG000|Overall Study|Adverse Event|4|||
42188600|NCT03410108|75998784|FG000|Overall Study|Progressive Disease|58|||
42188601|NCT03410108|75998784|FG000|Overall Study|Withdrawal by Subject|1|||
42188602|NCT02982772|75998793|FG000|Intervention|Lost to Follow-up|19|||
42188603|NCT02982772|75998794|FG001|Intervention|Lost to Follow-up|13|||
42188604|NCT02982772|75998793|FG000|1M Follow-Up|Lost to Follow-up|21|||
42188605|NCT02982772|75998794|FG001|1M Follow-Up|Lost to Follow-up|18|||
42094909|NCT00772967|75904880|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
42094910|NCT00772967|75904881|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
42094911|NCT00772967|75904882|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
42094912|NCT00772967|75904883|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
42094913|NCT00772967|75904878|FG000|Crossover Treatment 3|Adverse Event|0|||
42094914|NCT00772967|75904879|FG001|Crossover Treatment 3|Adverse Event|0|||
42094915|NCT00772967|75904880|FG002|Crossover Treatment 3|Adverse Event|0|||
42094916|NCT00772967|75904881|FG003|Crossover Treatment 3|Adverse Event|0|||
42094917|NCT00772967|75904882|FG004|Crossover Treatment 3|Adverse Event|1|||
42094918|NCT00772967|75904883|FG005|Crossover Treatment 3|Adverse Event|0|||
42094919|NCT00662259|75904906|FG000|Overall Study|Adverse Event|2|||
42094920|NCT00662259|75904907|FG001|Overall Study|Adverse Event|0|||
42094921|NCT00660699|75904913|FG000|Overall Study|Withdrawal by Subject|2|||
42094922|NCT00582114|75904919|FG000|Overall Study|Death|4|||
42094923|NCT00582114|75904920|FG001|Overall Study|Death|4|||
42094924|NCT00582114|75904919|FG000|Overall Study|Kidney Transplant|3|||
42094925|NCT00582114|75904920|FG001|Overall Study|Kidney Transplant|1|||
42094926|NCT00582114|75904919|FG000|Overall Study|Lost to Follow-up|7|||
42094927|NCT00582114|75904920|FG001|Overall Study|Lost to Follow-up|6|||
42094928|NCT00582114|75904919|FG000|Overall Study|Withdrawal by Subject|8|||
42094929|NCT00582114|75904920|FG001|Overall Study|Withdrawal by Subject|16|||
42094930|NCT00582114|75904919|FG000|Overall Study|Adverse Event|1|||
42094931|NCT00582114|75904920|FG001|Overall Study|Adverse Event|1|||
42094932|NCT00582114|75904919|FG000|Overall Study|Physician Decision|0|||
42094933|NCT00582114|75904920|FG001|Overall Study|Physician Decision|6|||
42188606|NCT02982772|75998793|FG000|3M Follow-Up|Lost to Follow-up|17|||
42188607|NCT02982772|75998794|FG001|3M Follow-Up|Lost to Follow-up|11|||
42188608|NCT02982772|75998793|FG000|6M Follow-Up|Lost to Follow-up|11|||
42296177|NCT02612077|76130957|FG000|Overall Study|Death|377|||
42296178|NCT02612077|76130957|FG000|Overall Study|Moved or Changed Medical Team|23|||
42296179|NCT02612077|76130957|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
42296180|NCT02612077|76130957|FG000|Overall Study|Disease Progression|3|||
42296181|NCT02612077|76130957|FG000|Overall Study|Unknown reason|2|||
42296182|NCT02613481|76130964|FG000|Overall Study|Lost to Follow-up|7|||
42296183|NCT02613481|76130964|FG000|Overall Study|Withdrawal by Subject|2|||
42296184|NCT02613403|76130972|FG000|Overall Study|Lost to Follow-up|0|||
42296185|NCT02613403|76130973|FG001|Overall Study|Lost to Follow-up|1|||
42296186|NCT02613403|76130974|FG002|Overall Study|Lost to Follow-up|0|||
42296187|NCT02613403|76130975|FG003|Overall Study|Lost to Follow-up|0|||
42296188|NCT02613403|76130976|FG004|Overall Study|Lost to Follow-up|0|||
42296189|NCT02613403|76130972|FG000|Overall Study|Withdrawal by Subject|2|||
42296190|NCT02613403|76130973|FG001|Overall Study|Withdrawal by Subject|0|||
42296191|NCT02613403|76130974|FG002|Overall Study|Withdrawal by Subject|0|||
42296192|NCT02613403|76130975|FG003|Overall Study|Withdrawal by Subject|0|||
42296193|NCT02613403|76130976|FG004|Overall Study|Withdrawal by Subject|0|||
42296194|NCT02572817|76130988|FG000|Overall Study|Death|6|||
42296195|NCT02572817|76130989|FG001|Overall Study|Death|3|||
42296196|NCT02572817|76130988|FG000|Overall Study|Lost to Follow-up|3|||
42296197|NCT02572817|76130989|FG001|Overall Study|Lost to Follow-up|3|||
42296198|NCT02566109|76130995|FG000|Overall Study|Withdrawal by Subject|1|||
42296199|NCT02566031|76131001|FG000|Overall Study|Patient/guardian decision|14|||
42296200|NCT02566031|76131002|FG001|Overall Study|Patient/guardian decision|7|||
42296201|NCT02566031|76131001|FG000|Overall Study|Protocol deviation|2|||
42296202|NCT02566031|76131002|FG001|Overall Study|Protocol deviation|3|||
42094934|NCT00582114|75904919|FG000|Overall Study|Stopped by data safety monitoring board|19|||
42094935|NCT00582114|75904920|FG001|Overall Study|Stopped by data safety monitoring board|20|||
42094936|NCT00582036|75904928|FG000|Overall Study|Withdrawal by Subject|0|||
42188609|NCT02982772|75998794|FG001|6M Follow-Up|Lost to Follow-up|9|||
42188610|NCT02982772|75998793|FG000|12M Follow-Up|Lost to Follow-up|11|||
42188611|NCT02982772|75998794|FG001|12M Follow-Up|Lost to Follow-up|5|||
42296203|NCT02566031|76131001|FG000|Overall Study|Adverse Event|3|||
42296204|NCT02566031|76131002|FG001|Overall Study|Adverse Event|1|||
42296205|NCT02566031|76131001|FG000|Overall Study|Lost to Follow-up|1|||
42296206|NCT02566031|76131002|FG001|Overall Study|Lost to Follow-up|1|||
42296207|NCT02569853|76131011|FG000|Overall Study|Adverse Event|2|||
42188612|NCT03488108|75998804|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
42296208|NCT02569853|76131012|FG001|Overall Study|Adverse Event|0|||
42296209|NCT02569853|76131011|FG000|Overall Study|Withdrawal by Subject|3|||
42296210|NCT02569853|76131012|FG001|Overall Study|Withdrawal by Subject|2|||
42094937|NCT00582036|75904929|FG001|Overall Study|Withdrawal by Subject|1|||
42094938|NCT00581360|75904935|FG000|Overall Study|Withdrawal by Subject|1|||
42094939|NCT00660387|75904941|FG000|Overall Study|Adverse Event|1|||
42094940|NCT00660387|75904942|FG001|Overall Study|Adverse Event|2|||
42094941|NCT00660387|75904941|FG000|Overall Study|Lack of Efficacy|0|||
42094942|NCT00660387|75904942|FG001|Overall Study|Lack of Efficacy|1|||
42094943|NCT00660387|75904941|FG000|Overall Study|Protocol Violation|1|||
42094944|NCT00660387|75904942|FG001|Overall Study|Protocol Violation|0|||
42094945|NCT00582738|75904950|FG000|Overall Study|Administrative Problems|7|||
42094946|NCT00582738|75904951|FG001|Overall Study|Administrative Problems|8|||
42094947|NCT00582738|75904950|FG000|Overall Study|Adverse Event|0|||
42094948|NCT00582738|75904951|FG001|Overall Study|Adverse Event|5|||
42094949|NCT00582738|75904950|FG000|Overall Study|Graft Lost|0|||
42188613|NCT03488108|75998805|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
42188614|NCT03488108|75998804|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
42188615|NCT03488108|75998805|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
42188616|NCT03440918|75998815|FG000|Overall Study|Protocol Violation|0|||
42188617|NCT03440918|75998816|FG001|Overall Study|Protocol Violation|16|||
42188618|NCT03486392|75998827|FG000|Overall Study|Lost to Follow-up|0|||
42188619|NCT03486392|75998828|FG001|Overall Study|Lost to Follow-up|0|||
42188620|NCT03486392|75998829|FG002|Overall Study|Lost to Follow-up|8|||
42188621|NCT03486392|75998830|FG003|Overall Study|Lost to Follow-up|5|||
42188622|NCT03486392|75998831|FG004|Overall Study|Lost to Follow-up|2|||
42188623|NCT03486392|75998827|FG000|Overall Study|Withdrawal by Subject|3|||
42188624|NCT03486392|75998828|FG001|Overall Study|Withdrawal by Subject|0|||
42188625|NCT03486392|75998829|FG002|Overall Study|Withdrawal by Subject|6|||
42188626|NCT03486392|75998830|FG003|Overall Study|Withdrawal by Subject|4|||
42188627|NCT03486392|75998831|FG004|Overall Study|Withdrawal by Subject|1|||
42188628|NCT03486392|75998827|FG000|Overall Study|Death|0|||
42188629|NCT03486392|75998828|FG001|Overall Study|Death|0|||
42188630|NCT03486392|75998829|FG002|Overall Study|Death|0|||
42188631|NCT03486392|75998830|FG003|Overall Study|Death|0|||
42188632|NCT03486392|75998831|FG004|Overall Study|Death|1|||
42188633|NCT02981602|75998848|FG000|Overall Study|Adverse Event|0|||
42188634|NCT02981602|75998849|FG001|Overall Study|Adverse Event|0|||
42188635|NCT02981602|75998850|FG002|Overall Study|Adverse Event|0|||
42188636|NCT02981602|75998851|FG003|Overall Study|Adverse Event|1|||
42188637|NCT02981602|75998852|FG004|Overall Study|Adverse Event|0|||
42188638|NCT02981524|75998865|FG000|Overall Study|Progressive Disease|14|||
42188639|NCT02981524|75998865|FG000|Overall Study|Death (unrelated)|1|||
42188640|NCT02981524|75998865|FG000|Overall Study|Treatment Related Toxicity|1|||
42188641|NCT02981524|75998865|FG000|Overall Study|Withdrawal by Subject|1|||
42094950|NCT00582738|75904951|FG001|Overall Study|Graft Lost|1|||
42094951|NCT00582738|75904950|FG000|Overall Study|Other|1|||
42094952|NCT00582738|75904951|FG001|Overall Study|Other|0|||
42094953|NCT00582738|75904950|FG000|Overall Study|Protocol Violation|1|||
42094954|NCT00582738|75904951|FG001|Overall Study|Protocol Violation|1|||
42094955|NCT00582738|75904950|FG000|Overall Study|Withdrawal by Subject|0|||
42094956|NCT00582738|75904951|FG001|Overall Study|Withdrawal by Subject|3|||
42094957|NCT00772889|75904966|FG000|Overall Study|Adverse Event|7|||
42094958|NCT00772889|75904967|FG001|Overall Study|Adverse Event|4|||
42094959|NCT00772889|75904968|FG002|Overall Study|Adverse Event|0|||
42094960|NCT00772889|75904966|FG000|Overall Study|Withdrawal by Subject|9|||
42094961|NCT00772889|75904967|FG001|Overall Study|Withdrawal by Subject|8|||
42094962|NCT00772889|75904968|FG002|Overall Study|Withdrawal by Subject|9|||
42094963|NCT00772889|75904966|FG000|Overall Study|Lost to Follow-up|6|||
42094964|NCT00772889|75904967|FG001|Overall Study|Lost to Follow-up|6|||
42188642|NCT03486314|75998869|FG000|Part A|Adverse Event|1|||
42188643|NCT03486314|75998870|FG001|Part A|Adverse Event|0|||
42188644|NCT03486314|75998871|FG002|Part A|Adverse Event|0|||
42188645|NCT03486314|75998869|FG000|Part A|Symptomatic Deterioration|2|||
42188646|NCT03486314|75998870|FG001|Part A|Symptomatic Deterioration|0|||
42188647|NCT03486314|75998871|FG002|Part A|Symptomatic Deterioration|0|||
42188648|NCT02905006|75998885|FG000|Overall Study|Adverse Event|1|||
42188649|NCT02905006|75998886|FG001|Overall Study|Adverse Event|1|||
42094965|NCT00772889|75904968|FG002|Overall Study|Lost to Follow-up|7|||
42094966|NCT01247324|75904978|FG000|Overall Study|Death|1|||
42094967|NCT01247324|75904979|FG001|Overall Study|Death|0|||
42094968|NCT01247324|75904978|FG000|Overall Study|Physician Decision|0|||
42094969|NCT01247324|75904979|FG001|Overall Study|Physician Decision|1|||
42188650|NCT02905006|75998887|FG002|Overall Study|Adverse Event|1|||
42188651|NCT02905006|75998888|FG003|Overall Study|Adverse Event|1|||
42188652|NCT02905006|75998889|FG004|Overall Study|Adverse Event|0|||
42094970|NCT01247324|75904978|FG000|Overall Study|Non-compliance with study drug|3|||
42094971|NCT01247324|75904979|FG001|Overall Study|Non-compliance with study drug|0|||
42094972|NCT01247324|75904978|FG000|Overall Study|Lack of Efficacy|12|||
42094973|NCT01247324|75904979|FG001|Overall Study|Lack of Efficacy|8|||
42094974|NCT01247324|75904978|FG000|Overall Study|Non-compliance|2|||
42188653|NCT02905006|75998890|FG005|Overall Study|Adverse Event|1|||
42188654|NCT02905006|75998885|FG000|Overall Study|Lack of Efficacy|1|||
42094975|NCT01247324|75904979|FG001|Overall Study|Non-compliance|0|||
42094976|NCT01247324|75904978|FG000|Overall Study|Pregnancy|2|||
42188655|NCT02905006|75998886|FG001|Overall Study|Lack of Efficacy|0|||
42188656|NCT02905006|75998887|FG002|Overall Study|Lack of Efficacy|0|||
42188657|NCT02905006|75998888|FG003|Overall Study|Lack of Efficacy|0|||
42188658|NCT02905006|75998889|FG004|Overall Study|Lack of Efficacy|0|||
42188659|NCT02905006|75998890|FG005|Overall Study|Lack of Efficacy|0|||
42188660|NCT02905006|75998885|FG000|Overall Study|Protocol Violation|2|||
42188661|NCT02905006|75998886|FG001|Overall Study|Protocol Violation|0|||
42188662|NCT02905006|75998887|FG002|Overall Study|Protocol Violation|0|||
42188663|NCT02905006|75998888|FG003|Overall Study|Protocol Violation|0|||
42188664|NCT02905006|75998889|FG004|Overall Study|Protocol Violation|0|||
42188665|NCT02905006|75998890|FG005|Overall Study|Protocol Violation|0|||
42188666|NCT02905006|75998885|FG000|Overall Study|Lost to Follow-up|0|||
42188667|NCT02905006|75998886|FG001|Overall Study|Lost to Follow-up|0|||
42188668|NCT02905006|75998887|FG002|Overall Study|Lost to Follow-up|0|||
42188669|NCT02905006|75998888|FG003|Overall Study|Lost to Follow-up|1|||
42094977|NCT01247324|75904979|FG001|Overall Study|Pregnancy|3|||
42094978|NCT01247324|75904978|FG000|Overall Study|Protocol Violation|1|||
42188670|NCT02905006|75998889|FG004|Overall Study|Lost to Follow-up|1|||
42188671|NCT02905006|75998890|FG005|Overall Study|Lost to Follow-up|0|||
42188672|NCT02905006|75998885|FG000|Overall Study|Withdrawal by Subject|0|||
42188673|NCT02905006|75998886|FG001|Overall Study|Withdrawal by Subject|0|||
42188674|NCT02905006|75998887|FG002|Overall Study|Withdrawal by Subject|1|||
42188675|NCT02905006|75998888|FG003|Overall Study|Withdrawal by Subject|1|||
42094979|NCT01247324|75904979|FG001|Overall Study|Protocol Violation|2|||
42094980|NCT01247324|75904978|FG000|Overall Study|Reason not specified|11|||
42094981|NCT01247324|75904979|FG001|Overall Study|Reason not specified|8|||
42094982|NCT01247324|75904978|FG000|Overall Study|Consent withdrawn by participant|13|||
42094983|NCT01247324|75904979|FG001|Overall Study|Consent withdrawn by participant|8|||
42094984|NCT01247324|75904978|FG000|Overall Study|Adverse Event|25|||
42094985|NCT01247324|75904979|FG001|Overall Study|Adverse Event|13|||
42188676|NCT02905006|75998889|FG004|Overall Study|Withdrawal by Subject|0|||
42188677|NCT02905006|75998890|FG005|Overall Study|Withdrawal by Subject|1|||
42094986|NCT01247324|75904978|FG000|Overall Study|Lost to Follow-up|1|||
42094987|NCT01247324|75904979|FG001|Overall Study|Lost to Follow-up|1|||
42094988|NCT00772577|75904988|FG000|Overall Study|Adverse Event|6|||
42094989|NCT00772577|75904989|FG001|Overall Study|Adverse Event|3|||
42094990|NCT00772577|75904988|FG000|Overall Study|Abnormal laboratory values|0|||
42094991|NCT00772577|75904989|FG001|Overall Study|Abnormal laboratory values|1|||
42094992|NCT00772577|75904988|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42094993|NCT00772577|75904989|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
42094994|NCT00772577|75904988|FG000|Overall Study|Patient withdrew consent|8|||
42094995|NCT00772577|75904989|FG001|Overall Study|Patient withdrew consent|5|||
42094996|NCT00772577|75904988|FG000|Overall Study|Lost to Follow-up|4|||
42188678|NCT02905006|75998885|FG000|Overall Study|Screening exclusion criteria met|1|||
42188679|NCT02905006|75998886|FG001|Overall Study|Screening exclusion criteria met|0|||
42188680|NCT02905006|75998887|FG002|Overall Study|Screening exclusion criteria met|0|||
42188681|NCT02905006|75998888|FG003|Overall Study|Screening exclusion criteria met|0|||
42188682|NCT02905006|75998889|FG004|Overall Study|Screening exclusion criteria met|0|||
42188683|NCT02905006|75998890|FG005|Overall Study|Screening exclusion criteria met|0|||
42188684|NCT02905006|75998885|FG000|Overall Study|Lab withdrawal criterion met|0|||
42188685|NCT02905006|75998886|FG001|Overall Study|Lab withdrawal criterion met|1|||
42188686|NCT02905006|75998887|FG002|Overall Study|Lab withdrawal criterion met|2|||
42188687|NCT02905006|75998888|FG003|Overall Study|Lab withdrawal criterion met|2|||
42188688|NCT02905006|75998889|FG004|Overall Study|Lab withdrawal criterion met|2|||
42188689|NCT02905006|75998890|FG005|Overall Study|Lab withdrawal criterion met|1|||
42188690|NCT02905006|75998885|FG000|Overall Study|Positive for Tuberculosis|0|||
42188691|NCT02905006|75998886|FG001|Overall Study|Positive for Tuberculosis|1|||
42188692|NCT02905006|75998887|FG002|Overall Study|Positive for Tuberculosis|0|||
42188693|NCT02905006|75998888|FG003|Overall Study|Positive for Tuberculosis|0|||
42188694|NCT02905006|75998889|FG004|Overall Study|Positive for Tuberculosis|0|||
42188695|NCT02905006|75998890|FG005|Overall Study|Positive for Tuberculosis|0|||
42188696|NCT02905006|75998885|FG000|Overall Study|Subject positive for Hep B|0|||
42188697|NCT02905006|75998886|FG001|Overall Study|Subject positive for Hep B|0|||
42188698|NCT02905006|75998887|FG002|Overall Study|Subject positive for Hep B|1|||
42188699|NCT02905006|75998888|FG003|Overall Study|Subject positive for Hep B|0|||
42188700|NCT02905006|75998889|FG004|Overall Study|Subject positive for Hep B|0|||
42188701|NCT02905006|75998890|FG005|Overall Study|Subject positive for Hep B|0|||
42188702|NCT02905006|75998885|FG000|Overall Study|Patient moved abroad|0|||
42359110|NCT02018861|76204791|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
42188703|NCT02905006|75998886|FG001|Overall Study|Patient moved abroad|0|||
42188704|NCT02905006|75998887|FG002|Overall Study|Patient moved abroad|0|||
42188705|NCT02905006|75998888|FG003|Overall Study|Patient moved abroad|1|||
42094997|NCT00772577|75904989|FG001|Overall Study|Lost to Follow-up|3|||
42094998|NCT00772577|75904988|FG000|Overall Study|Administrative problems|2|||
42094999|NCT00772577|75904989|FG001|Overall Study|Administrative problems|1|||
42095000|NCT00772577|75904988|FG000|Overall Study|Protocol Deviation|3|||
42188706|NCT02905006|75998889|FG004|Overall Study|Patient moved abroad|0|||
42188707|NCT02905006|75998890|FG005|Overall Study|Patient moved abroad|0|||
42188708|NCT02905006|75998885|FG000|Overall Study|Patient randomized by mistake|0|||
42188709|NCT02905006|75998886|FG001|Overall Study|Patient randomized by mistake|0|||
42188710|NCT02905006|75998887|FG002|Overall Study|Patient randomized by mistake|0|||
42188711|NCT02905006|75998888|FG003|Overall Study|Patient randomized by mistake|0|||
42188712|NCT02905006|75998889|FG004|Overall Study|Patient randomized by mistake|0|||
42188713|NCT02905006|75998890|FG005|Overall Study|Patient randomized by mistake|1|||
42188714|NCT01066780|75998928|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
42188715|NCT01066780|75998929|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
42188716|NCT02975206|75998936|FG000|Overall Study|Withdrawal by Subject|14|||
42188717|NCT02975206|75998937|FG001|Overall Study|Withdrawal by Subject|11|||
42188718|NCT02975206|75998938|FG002|Overall Study|Withdrawal by Subject|11|||
42188719|NCT02975206|75998936|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
42188720|NCT02975206|75998937|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
42188721|NCT02975206|75998938|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
42188722|NCT01066156|75998946|FG000|Overall Study|ineligible|2|||
42188723|NCT01066156|75998946|FG000|Overall Study|Lost to Follow-up|7|||
42188724|NCT01066156|75998946|FG000|Overall Study|Withdrawal by Subject|1|||
42188725|NCT02980042|75998952|FG000|Overall Study|Lost to Follow-up|5|||
42188726|NCT02980042|75998953|FG001|Overall Study|Lost to Follow-up|0|||
42188727|NCT02980042|75998952|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
42188728|NCT02980042|75998953|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
42188729|NCT01066000|75998971|FG000|Overall Study|Protocol Violation|4|||
42296211|NCT02569853|76131011|FG000|Overall Study|Lost to Follow-up|3|||
42296212|NCT02569853|76131012|FG001|Overall Study|Lost to Follow-up|3|||
42296213|NCT02569853|76131011|FG000|Overall Study|Protocol Violation|1|||
42296214|NCT02569853|76131012|FG001|Overall Study|Protocol Violation|1|||
42296215|NCT02569853|76131011|FG000|Overall Study|Did not experience migraine attack|10|||
42296216|NCT02569853|76131012|FG001|Overall Study|Did not experience migraine attack|7|||
42296217|NCT02569853|76131011|FG000|Overall Study|Physician Decision|1|||
42296218|NCT02569853|76131012|FG001|Overall Study|Physician Decision|1|||
42296219|NCT02570711|76131022|FG000|Overall Study|Death|1|||
42296220|NCT02570711|76131023|FG001|Overall Study|Death|0|||
42296221|NCT02570711|76131022|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
42296222|NCT02570711|76131023|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
42296223|NCT02570165|76131036|FG000|Overall Study|Adverse Event|1|||
42296224|NCT02570165|76131037|FG001|Overall Study|Adverse Event|0|||
42296225|NCT02570165|76131038|FG002|Overall Study|Adverse Event|2|||
42296226|NCT02570165|76131039|FG003|Overall Study|Adverse Event|0|||
42095001|NCT00772577|75904989|FG001|Overall Study|Protocol Deviation|2|||
42095002|NCT02345850|75904998|FG000|Overall Study|Not transplanted|10|||
42095003|NCT02345850|75904999|FG001|Overall Study|Not transplanted|5|||
42095004|NCT02345850|75905000|FG002|Overall Study|Not transplanted|4|||
42095005|NCT02345850|75904998|FG000|Overall Study|Lost to Follow-up|2|||
42095006|NCT02345850|75904999|FG001|Overall Study|Lost to Follow-up|3|||
42095007|NCT02345850|75905000|FG002|Overall Study|Lost to Follow-up|2|||
42095008|NCT02345850|75904998|FG000|Overall Study|Withdrawal by Subject|1|||
42095009|NCT02345850|75904999|FG001|Overall Study|Withdrawal by Subject|0|||
42095010|NCT02345850|75905000|FG002|Overall Study|Withdrawal by Subject|0|||
42095011|NCT00659607|75905008|FG000|Overall Study|No blood pressure recorded|147|||
42095012|NCT00659607|75905008|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
42095013|NCT00659607|75905008|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
42095014|NCT00659607|75905008|FG000|Overall Study|No recorded efficacy data|15|||
42095015|NCT00659607|75905008|FG000|Overall Study|Inconsistent BP measuring date|2|||
42095016|NCT02848092|75905016|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
42095017|NCT02848092|75905017|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
42095018|NCT02848092|75905016|FG000|1-month Post-training Follow-up|Adverse Event|2|||
42095019|NCT02848092|75905017|FG001|1-month Post-training Follow-up|Adverse Event|1|||
42095020|NCT02848092|75905016|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
42095021|NCT02848092|75905017|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
42095022|NCT02848092|75905016|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
42188730|NCT01066000|75998971|FG000|Overall Study|Death|3|||
42188731|NCT01066000|75998971|FG000|Overall Study|Withdrawal by Subject|1|||
42188732|NCT01066000|75998971|FG000|Overall Study|Adverse Event|1|||
42188733|NCT01065844|75998975|FG000|Overall Study|Adverse Event|5|||
42188734|NCT00004635|75998981|FG000|Period One|refused|2|||
42188735|NCT00004635|75998982|FG001|Period One|refused|1|||
42296227|NCT02570165|76131040|FG004|Overall Study|Adverse Event|0|||
42359111|NCT02018861|76204792|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
42095023|NCT02848092|75905017|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
42095024|NCT02848092|75905016|FG000|1-month Post-training Follow-up|fatigue|0|||
42095025|NCT02848092|75905017|FG001|1-month Post-training Follow-up|fatigue|1|||
42095026|NCT02848092|75905016|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
42296228|NCT02570165|76131041|FG005|Overall Study|Adverse Event|0|||
42188736|NCT00004635|75998981|FG000|Period One|Withdrawal by Subject|1|||
42188737|NCT00004635|75998982|FG001|Period One|Withdrawal by Subject|1|||
42188738|NCT00004635|75998981|FG000|Period One|Protocol Violation|1|||
42095027|NCT02848092|75905017|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
42095028|NCT02848092|75905016|FG000|6-month Post-training Follow-up|Adverse Event|1|||
42095029|NCT02848092|75905017|FG001|6-month Post-training Follow-up|Adverse Event|1|||
42095030|NCT02848092|75905016|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
42095031|NCT02848092|75905017|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
42095032|NCT02848092|75905016|FG000|6-month Post-training Follow-up|frustrated with task|1|||
42095033|NCT02848092|75905017|FG001|6-month Post-training Follow-up|frustrated with task|0|||
42095034|NCT02848092|75905016|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
42095035|NCT02848092|75905017|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
42095036|NCT02848092|75905016|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
42095037|NCT02848092|75905017|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
42095038|NCT00660309|75905025|FG000|Overall Study|Adverse Event|2|||
42095039|NCT00660309|75905026|FG001|Overall Study|Adverse Event|0|||
42095040|NCT00660309|75905025|FG000|Overall Study|Withdrawal by Subject|0|||
42095041|NCT00660309|75905026|FG001|Overall Study|Withdrawal by Subject|3|||
42095042|NCT00581100|75905035|FG000|Overall Study|Death|1|||
42095043|NCT00581100|75905036|FG001|Overall Study|Death|0|||
42095044|NCT00581100|75905035|FG000|Overall Study|Adverse Event|2|||
42095045|NCT00581100|75905036|FG001|Overall Study|Adverse Event|1|||
42095046|NCT00581100|75905035|FG000|Overall Study|Withdrawal by Subject|1|||
42188739|NCT00004635|75998982|FG001|Period One|Protocol Violation|0|||
42188740|NCT00004635|75998981|FG000|Period One|PSA did not go <5 ng/mL|1|||
42188741|NCT00004635|75998982|FG001|Period One|PSA did not go <5 ng/mL|0|||
42188742|NCT00004635|75998981|FG000|Period One|second malignancy|1|||
42188743|NCT00004635|75998982|FG001|Period One|second malignancy|0|||
42188744|NCT00004635|75998981|FG000|Period One|progressed|0|||
42188745|NCT00004635|75998982|FG001|Period One|progressed|2|||
42188746|NCT00004635|75998981|FG000|Period One|health problem|0|||
42188747|NCT00004635|75998982|FG001|Period One|health problem|1|||
42188748|NCT00004635|75998981|FG000|Period One|discrepancy in data entry|0|||
42188749|NCT00004635|75998982|FG001|Period One|discrepancy in data entry|1|||
42188750|NCT00004635|75998981|FG000|Period Two|progression|2|||
42296229|NCT02570165|76131042|FG006|Overall Study|Adverse Event|0|||
42296230|NCT02570165|76131036|FG000|Overall Study|Lack of Efficacy|0|||
42296231|NCT02570165|76131037|FG001|Overall Study|Lack of Efficacy|1|||
42296232|NCT02570165|76131038|FG002|Overall Study|Lack of Efficacy|0|||
42296233|NCT02570165|76131039|FG003|Overall Study|Lack of Efficacy|0|||
42296234|NCT02570165|76131040|FG004|Overall Study|Lack of Efficacy|4|||
42095047|NCT00581100|75905036|FG001|Overall Study|Withdrawal by Subject|4|||
42095048|NCT00581100|75905035|FG000|Overall Study|Other|3|||
42095049|NCT00581100|75905036|FG001|Overall Study|Other|0|||
42095050|NCT00579098|75905044|FG000|Overall Study|Lost to Follow-up|2|||
42095051|NCT00579098|75905045|FG001|Overall Study|Lost to Follow-up|0|||
42095052|NCT00579098|75905044|FG000|Overall Study|Adverse Event|2|||
42095053|NCT00579098|75905045|FG001|Overall Study|Adverse Event|3|||
42095054|NCT00579098|75905044|FG000|Overall Study|Withdrawal by Subject|2|||
42095055|NCT00579098|75905045|FG001|Overall Study|Withdrawal by Subject|3|||
42095056|NCT00579098|75905044|FG000|Overall Study|AF returned after ablation|3|||
42095057|NCT00579098|75905045|FG001|Overall Study|AF returned after ablation|2|||
42095058|NCT00772109|75905055|FG000|Overall Study|Serious adverse event|1|||
42095059|NCT00772109|75905056|FG001|Overall Study|Serious adverse event|0|||
42095060|NCT00772109|75905057|FG002|Overall Study|Serious adverse event|1|||
42095061|NCT00772109|75905058|FG003|Overall Study|Serious adverse event|0|||
42095062|NCT00772109|75905055|FG000|Overall Study|Protocol Violation|5|||
42095063|NCT00772109|75905056|FG001|Overall Study|Protocol Violation|8|||
42188751|NCT00004635|75998982|FG001|Period Two|progression|3|||
42188752|NCT00004635|75998981|FG000|Period Two|Adverse Event|1|||
42188753|NCT00004635|75998982|FG001|Period Two|Adverse Event|0|||
42188754|NCT00004635|75998981|FG000|Period Two|refused|0|||
42188755|NCT00004635|75998982|FG001|Period Two|refused|2|||
42188756|NCT00004635|75998981|FG000|Period Two|health problem|1|||
42188757|NCT00004635|75998982|FG001|Period Two|health problem|1|||
42188758|NCT00004635|75998981|FG000|Period Two|travel issues|0|||
42188759|NCT00004635|75998982|FG001|Period Two|travel issues|1|||
42188760|NCT00004635|75998981|FG000|Period Two|secondary malignancy|1|||
42188761|NCT00004635|75998982|FG001|Period Two|secondary malignancy|1|||
42188762|NCT00004635|75998981|FG000|Period Two|Lost to Follow-up|1|||
42188763|NCT00004635|75998982|FG001|Period Two|Lost to Follow-up|0|||
42188764|NCT00004635|75998981|FG000|Period Two|discrepancy in data entry|0|||
42188765|NCT00004635|75998982|FG001|Period Two|discrepancy in data entry|1|||
42188766|NCT00004563|75998993|FG000|Overall Study|Withdrawal by Subject|20|||
42095064|NCT00772109|75905057|FG002|Overall Study|Protocol Violation|7|||
42188767|NCT00004563|75998994|FG001|Overall Study|Withdrawal by Subject|16|||
42296235|NCT02570165|76131041|FG005|Overall Study|Lack of Efficacy|0|||
42296236|NCT02570165|76131042|FG006|Overall Study|Lack of Efficacy|0|||
42095065|NCT00772109|75905058|FG003|Overall Study|Protocol Violation|6|||
42095066|NCT00772109|75905055|FG000|Overall Study|Lost to Follow-up|7|||
42095067|NCT00772109|75905056|FG001|Overall Study|Lost to Follow-up|3|||
42095068|NCT00772109|75905057|FG002|Overall Study|Lost to Follow-up|5|||
42095069|NCT00772109|75905058|FG003|Overall Study|Lost to Follow-up|9|||
42095070|NCT00772109|75905055|FG000|Overall Study|Withdrawal by Subject|8|||
42095071|NCT00772109|75905056|FG001|Overall Study|Withdrawal by Subject|8|||
42095072|NCT00772109|75905057|FG002|Overall Study|Withdrawal by Subject|6|||
42095073|NCT00772109|75905058|FG003|Overall Study|Withdrawal by Subject|16|||
42095074|NCT00772031|75905070|FG000|Overall Study|Early termination of trial|12|||
42095075|NCT00772031|75905071|FG001|Overall Study|Early termination of trial|10|||
42095076|NCT00772031|75905070|FG000|Overall Study|Lost to Follow-up|20|||
42188768|NCT00004563|75998993|FG000|Overall Study|Lack of Efficacy|3|||
42188769|NCT00004563|75998994|FG001|Overall Study|Lack of Efficacy|5|||
42188770|NCT00004563|75998993|FG000|Overall Study|Death|2|||
42188771|NCT00004563|75998994|FG001|Overall Study|Death|3|||
42188772|NCT00003645|75999002|FG000|Overall Study|Death|4|||
42188773|NCT00003645|75999003|FG001|Overall Study|Death|1|||
42188774|NCT00003645|75999002|FG000|Overall Study|Lost to Follow-up|7|||
42188775|NCT00003645|75999003|FG001|Overall Study|Lost to Follow-up|8|||
42188776|NCT00003645|75999002|FG000|Overall Study|Withdrawal by Subject|1|||
42188777|NCT00003645|75999003|FG001|Overall Study|Withdrawal by Subject|3|||
42188778|NCT00003537|75999011|FG000|Overall Study|Not evalauable|1|||
42188779|NCT00003531|75999015|FG000|Overall Study|Not evaluable|10|||
42188780|NCT02918968|75999021|FG000|1st Line AAT|Progressive disease|9|||
42296237|NCT02570165|76131036|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
42296238|NCT02570165|76131037|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
42296239|NCT02570165|76131038|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
42296240|NCT02570165|76131039|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
42296241|NCT02570165|76131040|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
42296242|NCT02570165|76131041|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
42296243|NCT02570165|76131042|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
42296244|NCT02570165|76131036|FG000|Overall Study|Lost to Follow-up|0|||
42296245|NCT02570165|76131037|FG001|Overall Study|Lost to Follow-up|0|||
42296246|NCT02570165|76131038|FG002|Overall Study|Lost to Follow-up|1|||
42296247|NCT02570165|76131039|FG003|Overall Study|Lost to Follow-up|1|||
42296248|NCT02570165|76131040|FG004|Overall Study|Lost to Follow-up|0|||
42296249|NCT02570165|76131041|FG005|Overall Study|Lost to Follow-up|0|||
42296250|NCT02570165|76131042|FG006|Overall Study|Lost to Follow-up|0|||
42296251|NCT02570165|76131036|FG000|Overall Study|Physician Decision|0|||
42296252|NCT02570165|76131037|FG001|Overall Study|Physician Decision|1|||
42018203|NCT00996892|75825865|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
42018204|NCT00996892|75825866|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
42018205|NCT00996892|75825867|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
42018206|NCT00996892|75825868|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018207|NCT00996892|75825869|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018208|NCT00996892|75825870|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018209|NCT00996892|75825871|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018210|NCT00996892|75825872|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018211|NCT00996892|75825873|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018212|NCT00996892|75825874|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018213|NCT00996892|75825875|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018214|NCT00996892|75825876|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018215|NCT00996892|75825877|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018216|NCT00996892|75825878|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018217|NCT00996892|75825879|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018218|NCT00996892|75825880|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
42018219|NCT00996892|75825861|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
42018220|NCT00996892|75825862|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
42018221|NCT00996892|75825863|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
42018222|NCT00996892|75825864|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
42018223|NCT00996892|75825865|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
42095077|NCT00772031|75905071|FG001|Overall Study|Lost to Follow-up|33|||
42095078|NCT00580866|75905085|FG000|Overall Study|Lost to Follow-up|2|||
42095079|NCT00580866|75905086|FG001|Overall Study|Lost to Follow-up|2|||
42095080|NCT00771953|75905094|FG000|Overall Study|Adverse Event|5|||
42188781|NCT02918968|75999022|FG001|1st Line AAT|Progressive disease|4|||
42188782|NCT02918968|75999021|FG000|1st Line AAT|Adverse Event|12|||
42188783|NCT02918968|75999022|FG001|1st Line AAT|Adverse Event|3|||
42188784|NCT02918968|75999021|FG000|1st Line AAT|Physician Decision|4|||
42359112|NCT02018861|76204793|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
42018224|NCT00996892|75825866|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
42018225|NCT00996892|75825867|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
42095081|NCT00771953|75905095|FG001|Overall Study|Adverse Event|3|||
42188785|NCT02918968|75999022|FG001|1st Line AAT|Physician Decision|2|||
42188786|NCT02918968|75999021|FG000|1st Line AAT|Withdrawal by Subject|2|||
42095082|NCT00771953|75905094|FG000|Overall Study|Death|2|||
42095083|NCT00771953|75905095|FG001|Overall Study|Death|2|||
42095084|NCT00771953|75905094|FG000|Overall Study|Progression before active Tx|1|||
42095085|NCT00771953|75905095|FG001|Overall Study|Progression before active Tx|2|||
42296253|NCT02570165|76131038|FG002|Overall Study|Physician Decision|0|||
42296254|NCT02570165|76131039|FG003|Overall Study|Physician Decision|0|||
42296255|NCT02570165|76131040|FG004|Overall Study|Physician Decision|0|||
42296256|NCT02570165|76131041|FG005|Overall Study|Physician Decision|0|||
42296257|NCT02570165|76131042|FG006|Overall Study|Physician Decision|0|||
42296258|NCT02570165|76131036|FG000|Overall Study|Withdrawal by Subject|0|||
42296259|NCT02570165|76131037|FG001|Overall Study|Withdrawal by Subject|0|||
42296260|NCT02570165|76131038|FG002|Overall Study|Withdrawal by Subject|0|||
42296261|NCT02570165|76131039|FG003|Overall Study|Withdrawal by Subject|2|||
42296262|NCT02570165|76131040|FG004|Overall Study|Withdrawal by Subject|1|||
42296263|NCT02570165|76131041|FG005|Overall Study|Withdrawal by Subject|0|||
42296264|NCT02570165|76131042|FG006|Overall Study|Withdrawal by Subject|0|||
42296265|NCT02570165|76131036|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
42296266|NCT02570165|76131037|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
42296267|NCT02570165|76131038|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
42296268|NCT02570165|76131039|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
42296269|NCT02570165|76131040|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
42296270|NCT02570165|76131041|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
42296271|NCT02570165|76131042|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
42296272|NCT02570165|76131036|FG000|Overall Study|Withdrawal Request by GSK|0|||
42296273|NCT02570165|76131037|FG001|Overall Study|Withdrawal Request by GSK|0|||
42296274|NCT02570165|76131038|FG002|Overall Study|Withdrawal Request by GSK|2|||
42296275|NCT02570165|76131039|FG003|Overall Study|Withdrawal Request by GSK|0|||
42296276|NCT02570165|76131040|FG004|Overall Study|Withdrawal Request by GSK|0|||
42296277|NCT02570165|76131041|FG005|Overall Study|Withdrawal Request by GSK|0|||
42296278|NCT02570165|76131042|FG006|Overall Study|Withdrawal Request by GSK|0|||
42296279|NCT02564471|76131062|FG000|Overall Study|Adverse Event|1|||
42296280|NCT02564471|76131063|FG001|Overall Study|Adverse Event|0|||
42296281|NCT02564471|76131064|FG002|Overall Study|Adverse Event|0|||
42296282|NCT02564471|76131065|FG003|Overall Study|Adverse Event|0|||
42296283|NCT02564471|76131062|FG000|Overall Study|Withdrawal by Subject|2|||
42296284|NCT02564471|76131063|FG001|Overall Study|Withdrawal by Subject|1|||
42296285|NCT02564471|76131064|FG002|Overall Study|Withdrawal by Subject|3|||
42296286|NCT02564471|76131065|FG003|Overall Study|Withdrawal by Subject|0|||
42296287|NCT02564471|76131062|FG000|Overall Study|Lost to Follow-up|0|||
42296288|NCT02564471|76131063|FG001|Overall Study|Lost to Follow-up|2|||
42296289|NCT02564471|76131064|FG002|Overall Study|Lost to Follow-up|0|||
42095086|NCT00771953|75905094|FG000|Overall Study|Sponsor decision|1|||
42095087|NCT00771953|75905095|FG001|Overall Study|Sponsor decision|0|||
42095088|NCT00771953|75905094|FG000|Overall Study|Other complicating disease|1|||
42095089|NCT00771953|75905095|FG001|Overall Study|Other complicating disease|0|||
42095090|NCT00771953|75905094|FG000|Overall Study|Withdrawal by Subject|0|||
42095091|NCT00771953|75905095|FG001|Overall Study|Withdrawal by Subject|3|||
42095092|NCT00621244|75905107|FG000|Overall Study|Withdrawal by Subject|7|||
42095093|NCT00621244|75905108|FG001|Overall Study|Withdrawal by Subject|3|||
42188787|NCT02918968|75999022|FG001|1st Line AAT|Withdrawal by Subject|1|||
42188788|NCT02918968|75999021|FG000|1st Line AAT|Lost to Follow-up|0|||
42188789|NCT02918968|75999022|FG001|1st Line AAT|Lost to Follow-up|1|||
42188790|NCT02918968|75999021|FG000|1st Line AAT|Death|1|||
42188791|NCT02918968|75999022|FG001|1st Line AAT|Death|0|||
42188792|NCT02918968|75999021|FG000|1st Line AAT|Miscellaneous|1|||
42095094|NCT00621244|75905109|FG002|Overall Study|Withdrawal by Subject|3|||
42296290|NCT02564471|76131065|FG003|Overall Study|Lost to Follow-up|0|||
42095095|NCT00621244|75905110|FG003|Overall Study|Withdrawal by Subject|3|||
42095096|NCT00621244|75905107|FG000|Overall Study|Disease progression|44|||
42188793|NCT02918968|75999022|FG001|1st Line AAT|Miscellaneous|0|||
42188794|NCT02918968|75999021|FG000|2nd Line AAT|Progressive disease|21|||
42188795|NCT02918968|75999022|FG001|2nd Line AAT|Progressive disease|3|||
42296291|NCT02563067|76131078|FG000|Overall Study|Subject/guardian decision|14|||
42296292|NCT02563067|76131079|FG001|Overall Study|Subject/guardian decision|20|||
42095097|NCT00621244|75905108|FG001|Overall Study|Disease progression|20|||
42095098|NCT00621244|75905109|FG002|Overall Study|Disease progression|20|||
42095099|NCT00621244|75905110|FG003|Overall Study|Disease progression|15|||
42095100|NCT00621244|75905107|FG000|Overall Study|Death|3|||
42095101|NCT00621244|75905108|FG001|Overall Study|Death|3|||
42188796|NCT02918968|75999021|FG000|2nd Line AAT|Adverse Event|2|||
42296293|NCT02563067|76131080|FG002|Overall Study|Subject/guardian decision|16|||
42296294|NCT02563067|76131078|FG000|Overall Study|Physician Decision|0|||
42296295|NCT02563067|76131079|FG001|Overall Study|Physician Decision|1|||
42296296|NCT02563067|76131080|FG002|Overall Study|Physician Decision|3|||
42095102|NCT00621244|75905109|FG002|Overall Study|Death|1|||
42095103|NCT00621244|75905110|FG003|Overall Study|Death|1|||
42188797|NCT02918968|75999022|FG001|2nd Line AAT|Adverse Event|5|||
42188798|NCT02918968|75999021|FG000|2nd Line AAT|Physician Decision|0|||
42188799|NCT02918968|75999022|FG001|2nd Line AAT|Physician Decision|1|||
42188800|NCT02918968|75999021|FG000|2nd Line AAT|Withdrawal by Subject|2|||
42188801|NCT02918968|75999022|FG001|2nd Line AAT|Withdrawal by Subject|2|||
42188802|NCT02918968|75999021|FG000|2nd Line AAT|Death|0|||
42188803|NCT02918968|75999022|FG001|2nd Line AAT|Death|1|||
42188804|NCT01065766|75999030|FG000|Overall Study|Assessed before the contracted date|1|||
42188805|NCT01065766|75999030|FG000|Overall Study|Contraindication to administration|6|||
42188806|NCT01065766|75999030|FG000|Overall Study|Violated dosage/administration|25|||
42188807|NCT01063972|75999036|FG000|Overall Study|Death|12|||
42188808|NCT01063972|75999037|FG001|Overall Study|Death|11|||
42188809|NCT01063972|75999036|FG000|Overall Study|Incarcerated|2|||
42188810|NCT01063972|75999037|FG001|Overall Study|Incarcerated|1|||
42188811|NCT00003483|75999043|FG000|Overall Study|Not evaluable|1|||
42188812|NCT00003477|75999047|FG000|Overall Study|Not evalauable|4|||
42188813|NCT00003471|75999051|FG000|Overall Study|Not evaluable|4|||
42188814|NCT04185220|75999057|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
42188815|NCT04185220|75999058|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
42188816|NCT04185220|75999057|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
42188817|NCT04185220|75999058|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
42188818|NCT00002931|75999065|FG000|Overall Study|rapidly progressing disease during|2|||
42188819|NCT02918266|75999080|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
42188820|NCT02918266|75999081|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
42188821|NCT02918266|75999082|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
42188822|NCT02918266|75999083|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
42188823|NCT02918266|75999084|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
42188824|NCT02918266|75999085|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
42188825|NCT02918266|75999086|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
42188826|NCT02918266|75999087|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
42188827|NCT02918266|75999088|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
42188828|NCT02918266|75999089|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
42188829|NCT02918266|75999090|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
42188830|NCT00041067|75999110|FG000|Overall Study|Adverse Event|20|||
42095104|NCT00621244|75905107|FG000|Overall Study|Adverse Event|27|||
42095105|NCT00621244|75905108|FG001|Overall Study|Adverse Event|7|||
42095106|NCT00621244|75905109|FG002|Overall Study|Adverse Event|9|||
42095107|NCT00621244|75905110|FG003|Overall Study|Adverse Event|2|||
42188831|NCT00041067|75999110|FG000|Overall Study|Progression|19|||
42188832|NCT00041067|75999110|FG000|Overall Study|Patient refusal|12|||
42095108|NCT00621244|75905107|FG000|Overall Study|Administrative problems|5|||
42095109|NCT00621244|75905108|FG001|Overall Study|Administrative problems|1|||
42095110|NCT00621244|75905109|FG002|Overall Study|Administrative problems|0|||
42095111|NCT00621244|75905110|FG003|Overall Study|Administrative problems|2|||
42095112|NCT00659529|75905184|FG000|Overall Study|Withdrawal by Subject|4|||
42095113|NCT00659529|75905184|FG000|Overall Study|Protocol Violation|3|||
42095114|NCT00659529|75905184|FG000|Overall Study|Screen failure|9|||
42095115|NCT00578942|75905188|FG000|Overall Study|Lost to Follow-up|1|||
42095116|NCT00765245|75905194|FG000|Overall Study|disease progression|3|||
42188833|NCT00041067|75999110|FG000|Overall Study|Other reasons|23|||
42188834|NCT00041067|75999110|FG000|Overall Study|Ineligible|2|||
42095117|NCT00765245|75905195|FG001|Overall Study|disease progression|2|||
42095118|NCT00765245|75905194|FG000|Overall Study|Withdrawal by Subject|3|||
42095119|NCT00765245|75905195|FG001|Overall Study|Withdrawal by Subject|0|||
42188835|NCT01063036|75999115|FG000|Participants Treated With Study Drug|Adverse Event|1|||
42188836|NCT01063036|75999115|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
42188837|NCT01063036|75999115|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
42188838|NCT01063036|75999115|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
42188839|NCT01063036|75999115|FG000|Participants Treated With Study Drug|Pregnancy|1|||
42188840|NCT01063036|75999115|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
42188841|NCT01063036|75999115|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
42188842|NCT01063036|75999115|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
42188843|NCT00040365|75999119|FG000|Overall Study|Death|1|||
42095120|NCT00765245|75905194|FG000|Overall Study|Adverse Event|5|||
42095121|NCT00765245|75905195|FG001|Overall Study|Adverse Event|0|||
42188844|NCT00040365|75999119|FG000|Overall Study|Progressive disease|7|||
42188845|NCT00040365|75999119|FG000|Overall Study|Lost to Follow-up|3|||
42188846|NCT02974114|75999126|FG000|Overall Study|Other (Not specified)|0|||
42188847|NCT02974114|75999127|FG001|Overall Study|Other (Not specified)|1|||
42095122|NCT00765245|75905194|FG000|Overall Study|Physician Decision|1|||
42095123|NCT00765245|75905195|FG001|Overall Study|Physician Decision|0|||
42095124|NCT00765245|75905194|FG000|Overall Study|Death|1|||
42095125|NCT00765245|75905195|FG001|Overall Study|Death|0|||
42095126|NCT00782795|75905203|FG000|Overall Study|Withdrawal by Subject|1|||
42095127|NCT00782795|75905204|FG001|Overall Study|Withdrawal by Subject|2|||
42095128|NCT00656799|75905210|FG000|Overall Study|Death|2|||
42095129|NCT00764699|75905214|FG000|Overall Study|PI left and study terminated|3|||
42095130|NCT00782717|75905220|FG000|Overall Study|Adverse Event|2|||
42095131|NCT00782717|75905221|FG001|Overall Study|Adverse Event|5|||
42095132|NCT00782717|75905220|FG000|Overall Study|Patient decision unrelated to AE|6|||
42095133|NCT00782717|75905221|FG001|Overall Study|Patient decision unrelated to AE|3|||
42095134|NCT00782717|75905220|FG000|Overall Study|Noncompliance|2|||
42095135|NCT00782717|75905221|FG001|Overall Study|Noncompliance|1|||
42095136|NCT00782717|75905220|FG000|Overall Study|Treatment failure|3|||
42095137|NCT00782717|75905221|FG001|Overall Study|Treatment failure|14|||
42188848|NCT02974114|75999128|FG002|Overall Study|Other (Not specified)|2|||
42188849|NCT00001959|75999138|FG000|Overall Study|newly diagnosed colon cancer|1|||
42188850|NCT00001959|75999138|FG000|Overall Study|disabling sedation|1|||
42188851|NCT00001959|75999138|FG000|Overall Study|non-compliance|1|||
42188852|NCT00001941|75999142|FG000|Overall Study|not treated- rapidly progressing disease|0|||
42188853|NCT00001941|75999143|FG001|Overall Study|not treated- rapidly progressing disease|0|||
42188854|NCT00001941|75999144|FG002|Overall Study|not treated- rapidly progressing disease|0|||
42188855|NCT00001941|75999145|FG003|Overall Study|not treated- rapidly progressing disease|0|||
42188856|NCT00001941|75999146|FG004|Overall Study|not treated- rapidly progressing disease|1|||
42188857|NCT01061866|75999151|FG000|Overall Study|Adverse Event|2|||
42188858|NCT01061008|75999157|FG000|Overall Study|Badiocephalic fistula failed|3|||
42188859|NCT01061008|75999158|FG001|Overall Study|Badiocephalic fistula failed|2|||
42188860|NCT01061008|75999157|FG000|Overall Study|Death|1|||
42188861|NCT01061008|75999158|FG001|Overall Study|Death|0|||
42188862|NCT01061008|75999157|FG000|Overall Study|Withdrawal by Subject|1|||
42188863|NCT01061008|75999158|FG001|Overall Study|Withdrawal by Subject|3|||
42188864|NCT01061008|75999157|FG000|Overall Study|Unable to exercise following surgery|1|||
42188865|NCT01061008|75999158|FG001|Overall Study|Unable to exercise following surgery|0|||
42188866|NCT01061008|75999157|FG000|Overall Study|Adverse Event|0|||
42188867|NCT01061008|75999158|FG001|Overall Study|Adverse Event|1|||
42188868|NCT00039741|75999168|FG000|Overall Study|Death|0|||
42188869|NCT00039741|75999169|FG001|Overall Study|Death|1|||
42188870|NCT00039741|75999170|FG002|Overall Study|Death|0|||
42188871|NCT00039741|75999171|FG003|Overall Study|Death|0|||
42188872|NCT00039741|75999168|FG000|Overall Study|Lost to Follow-up|3|||
42188873|NCT00039741|75999169|FG001|Overall Study|Lost to Follow-up|1|||
42188874|NCT00039741|75999170|FG002|Overall Study|Lost to Follow-up|5|||
42188875|NCT00039741|75999171|FG003|Overall Study|Lost to Follow-up|2|||
42188876|NCT00039741|75999168|FG000|Overall Study|Confounding medical condition|1|||
42188877|NCT00039741|75999169|FG001|Overall Study|Confounding medical condition|0|||
42188878|NCT00039741|75999170|FG002|Overall Study|Confounding medical condition|0|||
42188879|NCT00039741|75999171|FG003|Overall Study|Confounding medical condition|0|||
42188880|NCT00039741|75999168|FG000|Overall Study|Not able to get to clinic|5|||
42188881|NCT00039741|75999169|FG001|Overall Study|Not able to get to clinic|2|||
42188882|NCT00039741|75999170|FG002|Overall Study|Not able to get to clinic|0|||
42188883|NCT00039741|75999171|FG003|Overall Study|Not able to get to clinic|3|||
42188884|NCT00039741|75999168|FG000|Overall Study|Moved|3|||
42188885|NCT00039741|75999169|FG001|Overall Study|Moved|2|||
42188886|NCT00039741|75999170|FG002|Overall Study|Moved|3|||
42188887|NCT00039741|75999171|FG003|Overall Study|Moved|6|||
42188888|NCT00039741|75999168|FG000|Overall Study|Non-compliance with protocol|1|||
42188889|NCT00039741|75999169|FG001|Overall Study|Non-compliance with protocol|0|||
42188890|NCT00039741|75999170|FG002|Overall Study|Non-compliance with protocol|1|||
42188891|NCT00039741|75999171|FG003|Overall Study|Non-compliance with protocol|0|||
42188892|NCT00039741|75999168|FG000|Overall Study|Withdrew consent|0|||
42296297|NCT02563067|76131078|FG000|Overall Study|Lost to Follow-up|1|||
42296298|NCT02563067|76131079|FG001|Overall Study|Lost to Follow-up|2|||
42296299|NCT02563067|76131080|FG002|Overall Study|Lost to Follow-up|0|||
42296300|NCT02563067|76131078|FG000|Overall Study|Technical problems|0|||
42095138|NCT00782717|75905220|FG000|Overall Study|Enrollment close prior to surgery|1|||
42188893|NCT00039741|75999169|FG001|Overall Study|Withdrew consent|5|||
42296301|NCT02563067|76131079|FG001|Overall Study|Technical problems|1|||
42296302|NCT02563067|76131080|FG002|Overall Study|Technical problems|0|||
42296303|NCT02563067|76131078|FG000|Overall Study|Lack of Efficacy|1|||
42296304|NCT02563067|76131079|FG001|Overall Study|Lack of Efficacy|0|||
42296305|NCT02563067|76131080|FG002|Overall Study|Lack of Efficacy|0|||
42296306|NCT02563067|76131078|FG000|Overall Study|Death|0|||
42296307|NCT02563067|76131079|FG001|Overall Study|Death|1|||
42296308|NCT02563067|76131080|FG002|Overall Study|Death|1|||
42296309|NCT02563067|76131078|FG000|Overall Study|Adverse Event|2|||
42296310|NCT02563067|76131079|FG001|Overall Study|Adverse Event|1|||
42296311|NCT02563067|76131080|FG002|Overall Study|Adverse Event|0|||
42296312|NCT02563067|76131078|FG000|Overall Study|Death post Treatment/safety period|1|||
42296313|NCT02563067|76131079|FG001|Overall Study|Death post Treatment/safety period|0|||
42296314|NCT02563067|76131080|FG002|Overall Study|Death post Treatment/safety period|0|||
42296315|NCT02568683|76131090|FG000|Overall Study|Death|0|||
42296316|NCT02568683|76131091|FG001|Overall Study|Death|2|||
42296317|NCT02568683|76131090|FG000|Overall Study|Withdrew Consent|1|||
42296318|NCT02568683|76131091|FG001|Overall Study|Withdrew Consent|0|||
42296319|NCT02568683|76131090|FG000|Overall Study|Study Terminated By Sponsor|5|||
42296320|NCT02568683|76131091|FG001|Overall Study|Study Terminated By Sponsor|2|||
42296321|NCT02563925|76131097|FG000|Overall Study|Withdrawal by Subject|2|||
42296322|NCT01663727|76131104|FG000|Overall Study|Death|161|||
42296323|NCT01663727|76131105|FG001|Overall Study|Death|155|||
42296324|NCT01663727|76131104|FG000|Overall Study|Lost to Follow-up|10|||
42296325|NCT01663727|76131105|FG001|Overall Study|Lost to Follow-up|8|||
42296326|NCT01663727|76131104|FG000|Overall Study|Withdrawal by Subject|18|||
42296327|NCT01663727|76131105|FG001|Overall Study|Withdrawal by Subject|25|||
42296328|NCT01663727|76131104|FG000|Overall Study|Study Terminated|51|||
42296329|NCT01663727|76131105|FG001|Overall Study|Study Terminated|50|||
42296330|NCT01663727|76131104|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
42296331|NCT01663727|76131105|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
42296332|NCT01663727|76131104|FG000|Overall Study|Withdrawal prior to dosing.|1|||
42296333|NCT01663727|76131105|FG001|Overall Study|Withdrawal prior to dosing.|0|||
42296334|NCT02614261|76131114|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
42296335|NCT02614261|76131115|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
42296336|NCT02614261|76131116|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
42296337|NCT02614261|76131117|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
42296338|NCT02614261|76131114|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
42296339|NCT02614261|76131115|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
42296340|NCT02614261|76131116|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
42296341|NCT02614261|76131117|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
42296342|NCT02614261|76131114|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
42296343|NCT02614261|76131115|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
42296344|NCT02614261|76131116|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
42296345|NCT02614261|76131117|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
42296346|NCT02614261|76131114|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
42296347|NCT02614261|76131115|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
42296348|NCT02614261|76131116|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
42296349|NCT02614261|76131117|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
42296350|NCT02614261|76131114|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
42095139|NCT00782717|75905221|FG001|Overall Study|Enrollment close prior to surgery|0|||
42095140|NCT00782717|75905220|FG000|Overall Study|Did not meet entrance criteria|1|||
42095141|NCT00782717|75905221|FG001|Overall Study|Did not meet entrance criteria|3|||
42095142|NCT00782717|75905220|FG000|Overall Study|Exited in error|0|||
42095143|NCT00782717|75905221|FG001|Overall Study|Exited in error|2|||
42095144|NCT00656175|75905229|FG000|Overall Study|Adverse Event|1|||
42095145|NCT00656175|75905230|FG001|Overall Study|Adverse Event|0|||
42095146|NCT00656175|75905229|FG000|Overall Study|Transportation issues|0|||
42095147|NCT00656175|75905230|FG001|Overall Study|Transportation issues|1|||
42095148|NCT00620776|75905238|FG000|Overall Study|Did not receive treatment|3|||
42095149|NCT00620776|75905239|FG001|Overall Study|Did not receive treatment|5|||
42095150|NCT00620776|75905238|FG000|Overall Study|Adverse Event|2|||
42296351|NCT02614261|76131115|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
42296352|NCT02614261|76131116|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
42296353|NCT02614261|76131117|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
42296354|NCT02614261|76131114|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
42296355|NCT02614261|76131115|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
42296356|NCT02614261|76131116|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
42296357|NCT02614261|76131117|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
42296358|NCT02614261|76131114|FG000|Double-Blind Treatment Phase|Screen failure|0|||
42296359|NCT02614261|76131115|FG001|Double-Blind Treatment Phase|Screen failure|1|||
42095151|NCT00620776|75905239|FG001|Overall Study|Adverse Event|3|||
42095152|NCT00620776|75905238|FG000|Overall Study|Lack of Efficacy|2|||
42296360|NCT02614261|76131116|FG002|Double-Blind Treatment Phase|Screen failure|2|||
42296361|NCT02614261|76131117|FG003|Double-Blind Treatment Phase|Screen failure|0|||
42296362|NCT02614261|76131114|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
42296363|NCT02614261|76131115|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
42296364|NCT02614261|76131116|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
42296365|NCT02614261|76131117|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
42296366|NCT02614261|76131114|FG000|Open-Label Extension Phase|Adverse Event|23|||
42296367|NCT02614261|76131115|FG001|Open-Label Extension Phase|Adverse Event|12|||
42296368|NCT02614261|76131116|FG002|Open-Label Extension Phase|Adverse Event|11|||
42296369|NCT02614261|76131117|FG003|Open-Label Extension Phase|Adverse Event|0|||
42296370|NCT02614261|76131114|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
42296371|NCT02614261|76131115|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
42296372|NCT02614261|76131116|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
42296373|NCT02614261|76131117|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
42359113|NCT02018861|76204784|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
42359114|NCT02018861|76204785|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
42359115|NCT02018861|76204786|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
42359116|NCT02018861|76204787|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
42359117|NCT02018861|76204788|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
42359118|NCT02018861|76204789|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
42359119|NCT02018861|76204790|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
42359120|NCT02018861|76204791|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
42359121|NCT02018861|76204792|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
42359122|NCT02018861|76204793|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
42359123|NCT02018861|76204784|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
42359124|NCT02018861|76204785|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
42359125|NCT02018861|76204786|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
42359126|NCT02018861|76204787|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
42359127|NCT02018861|76204788|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
42359128|NCT02018861|76204789|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
42359129|NCT02018861|76204790|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
42359130|NCT02018861|76204791|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
42359131|NCT02018861|76204792|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
42359132|NCT02018861|76204793|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
42359133|NCT02018861|76204784|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
42359134|NCT02018861|76204785|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
42359135|NCT02018861|76204786|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
42359136|NCT02018861|76204787|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
42359137|NCT02018861|76204788|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
42359138|NCT02018861|76204789|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
42359139|NCT02018861|76204790|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
42359140|NCT02018861|76204791|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
42359141|NCT02018861|76204792|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
42359142|NCT02018861|76204793|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
42359143|NCT02018861|76204784|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
42359144|NCT02018861|76204785|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
42359145|NCT02018861|76204786|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
42359146|NCT02018861|76204787|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
42359147|NCT02018861|76204788|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
42359148|NCT02018861|76204789|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
42359149|NCT02018861|76204790|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
42359150|NCT02018861|76204791|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
42095153|NCT00620776|75905239|FG001|Overall Study|Lack of Efficacy|1|||
42095154|NCT00620776|75905238|FG000|Overall Study|Lost to Follow-up|2|||
42095155|NCT00620776|75905239|FG001|Overall Study|Lost to Follow-up|5|||
42095156|NCT00620776|75905238|FG000|Overall Study|Withdrawal by Subject|3|||
42095157|NCT00620776|75905239|FG001|Overall Study|Withdrawal by Subject|2|||
42095158|NCT00656019|75905249|FG000|Overall Study|Not Eligible|10|||
42095159|NCT00656019|75905250|FG001|Overall Study|Not Eligible|0|||
42095160|NCT00656019|75905251|FG002|Overall Study|Not Eligible|0|||
42095161|NCT00656019|75905252|FG003|Overall Study|Not Eligible|0|||
42188894|NCT00039741|75999170|FG002|Overall Study|Withdrew consent|0|||
42188895|NCT00039741|75999171|FG003|Overall Study|Withdrew consent|1|||
42188896|NCT00039741|75999168|FG000|Overall Study|Missed final visit|2|||
42188897|NCT00039741|75999169|FG001|Overall Study|Missed final visit|1|||
42188898|NCT00039741|75999170|FG002|Overall Study|Missed final visit|2|||
42188899|NCT00039741|75999171|FG003|Overall Study|Missed final visit|2|||
42188900|NCT02973802|75999181|FG000|Overall Study|Lost to Follow-up|1|||
42188901|NCT02973802|75999181|FG000|Overall Study|Withdrawal by Subject|1|||
42188902|NCT02973100|75999190|FG000|Overall Study|Adverse Event|1|||
42188903|NCT02973100|75999191|FG001|Overall Study|Adverse Event|2|||
42188904|NCT02973100|75999192|FG002|Overall Study|Adverse Event|1|||
42188905|NCT02973100|75999193|FG003|Overall Study|Adverse Event|2|||
42188906|NCT02973100|75999190|FG000|Overall Study|Lost to Follow-up|3|||
42188907|NCT02973100|75999191|FG001|Overall Study|Lost to Follow-up|1|||
42188908|NCT02973100|75999192|FG002|Overall Study|Lost to Follow-up|1|||
42188909|NCT02973100|75999193|FG003|Overall Study|Lost to Follow-up|0|||
42188910|NCT02973100|75999190|FG000|Overall Study|Withdrawal by Subject|3|||
42188911|NCT02973100|75999191|FG001|Overall Study|Withdrawal by Subject|5|||
42188912|NCT02973100|75999192|FG002|Overall Study|Withdrawal by Subject|1|||
42188913|NCT02973100|75999193|FG003|Overall Study|Withdrawal by Subject|4|||
42188914|NCT02973100|75999190|FG000|Overall Study|Notification of change in address|0|||
42188915|NCT02973100|75999191|FG001|Overall Study|Notification of change in address|0|||
42188916|NCT02973100|75999192|FG002|Overall Study|Notification of change in address|0|||
42188917|NCT02973100|75999193|FG003|Overall Study|Notification of change in address|1|||
42188918|NCT02973100|75999190|FG000|Overall Study|Failed to attend Safety followup period|0|||
42188919|NCT02973100|75999191|FG001|Overall Study|Failed to attend Safety followup period|0|||
42188920|NCT02973100|75999192|FG002|Overall Study|Failed to attend Safety followup period|1|||
42188921|NCT02973100|75999193|FG003|Overall Study|Failed to attend Safety followup period|0|||
42188922|NCT01060540|75999208|FG000|Overall Study|Withdrawal by Subject|10|||
42188923|NCT01060540|75999209|FG001|Overall Study|Withdrawal by Subject|20|||
42296374|NCT02614261|76131114|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
42296375|NCT02614261|76131115|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
42296376|NCT02614261|76131116|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
42018226|NCT00996892|75825868|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
42188924|NCT01060540|75999208|FG000|Overall Study|Lost to Follow-up|52|||
42018227|NCT00996892|75825869|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
42188925|NCT01060540|75999209|FG001|Overall Study|Lost to Follow-up|43|||
42188926|NCT01060540|75999208|FG000|Overall Study|Death|2|||
42018228|NCT00996892|75825870|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
42188927|NCT01060540|75999209|FG001|Overall Study|Death|1|||
42188928|NCT01060540|75999208|FG000|Overall Study|Physician Decision|0|||
42188929|NCT01060540|75999209|FG001|Overall Study|Physician Decision|1|||
42188930|NCT02972632|75999234|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
42188931|NCT02972632|75999234|FG000|Overall Study|Lost to Follow-up|4|||
42188932|NCT02972632|75999234|FG000|Overall Study|Voluntary Withdrawal|10|||
42188933|NCT01060150|75999238|FG000|Overall Study|Adverse Event|6|||
42188934|NCT01060150|75999238|FG000|Overall Study|Lost to Follow-up|1|||
42188935|NCT01060150|75999238|FG000|Overall Study|Protocol Violation|6|||
42188936|NCT01060150|75999238|FG000|Overall Study|Withdrawal by Subject|8|||
42188937|NCT01060150|75999238|FG000|Overall Study|Enrolled, but not treated|2|||
42188938|NCT02972242|75999244|FG000|Overall Study|Withdrawal by Subject|1|||
42188939|NCT02972242|75999245|FG001|Overall Study|Withdrawal by Subject|0|||
42188940|NCT02970292|75999253|FG000|Overall Study|Physician Decision|1|||
42188941|NCT02970292|75999254|FG001|Overall Study|Physician Decision|1|||
42188942|NCT02970292|75999253|FG000|Overall Study|Withdrawal by Subject|11|||
42188943|NCT02970292|75999254|FG001|Overall Study|Withdrawal by Subject|5|||
42188944|NCT02970292|75999253|FG000|Overall Study|Noncompliance with study drug|2|||
42188945|NCT02970292|75999254|FG001|Overall Study|Noncompliance with study drug|2|||
42188946|NCT02970292|75999253|FG000|Overall Study|Adverse Event|5|||
42188947|NCT02970292|75999254|FG001|Overall Study|Adverse Event|0|||
42188948|NCT02970292|75999253|FG000|Overall Study|Lack of Efficacy|1|||
42188949|NCT02970292|75999254|FG001|Overall Study|Lack of Efficacy|0|||
42188950|NCT02970292|75999253|FG000|Overall Study|Lost to Follow-up|1|||
42188951|NCT02970292|75999254|FG001|Overall Study|Lost to Follow-up|0|||
42188952|NCT02970292|75999253|FG000|Overall Study|Protocol Violation|2|||
42188953|NCT02970292|75999254|FG001|Overall Study|Protocol Violation|0|||
42188954|NCT02970292|75999253|FG000|Overall Study|Other|1|||
42188955|NCT02970292|75999254|FG001|Overall Study|Other|0|||
42188956|NCT02971228|75999260|FG000|Overall Study|Withdrawal by Subject|1|||
42188957|NCT02971228|75999261|FG001|Overall Study|Withdrawal by Subject|1|||
42296377|NCT02614261|76131117|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
42296378|NCT02614261|76131114|FG000|Open-Label Extension Phase|Physician Decision|2|||
42296379|NCT02614261|76131115|FG001|Open-Label Extension Phase|Physician Decision|0|||
42296380|NCT02614261|76131116|FG002|Open-Label Extension Phase|Physician Decision|0|||
42296381|NCT02614261|76131117|FG003|Open-Label Extension Phase|Physician Decision|0|||
42296382|NCT02614261|76131114|FG000|Open-Label Extension Phase|Pregnancy|1|||
42296383|NCT02614261|76131115|FG001|Open-Label Extension Phase|Pregnancy|2|||
42296384|NCT02614261|76131116|FG002|Open-Label Extension Phase|Pregnancy|1|||
42296385|NCT02614261|76131117|FG003|Open-Label Extension Phase|Pregnancy|0|||
42296386|NCT02614261|76131114|FG000|Open-Label Extension Phase|Protocol Violation|3|||
42296387|NCT02614261|76131115|FG001|Open-Label Extension Phase|Protocol Violation|4|||
42296388|NCT02614261|76131116|FG002|Open-Label Extension Phase|Protocol Violation|1|||
42296389|NCT02614261|76131117|FG003|Open-Label Extension Phase|Protocol Violation|0|||
42296390|NCT02614261|76131114|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
42296391|NCT02614261|76131115|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
42296392|NCT02614261|76131116|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
42296393|NCT02614261|76131117|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
42296394|NCT02614261|76131114|FG000|Follow-up Phase|Adverse Event|2|||
42296395|NCT02614261|76131115|FG001|Follow-up Phase|Adverse Event|0|||
42296396|NCT02614261|76131116|FG002|Follow-up Phase|Adverse Event|1|||
42296397|NCT02614261|76131117|FG003|Follow-up Phase|Adverse Event|0|||
42296398|NCT02614261|76131114|FG000|Follow-up Phase|Lost to Follow-up|12|||
42296399|NCT02614261|76131115|FG001|Follow-up Phase|Lost to Follow-up|5|||
42296400|NCT02614261|76131116|FG002|Follow-up Phase|Lost to Follow-up|2|||
42296401|NCT02614261|76131117|FG003|Follow-up Phase|Lost to Follow-up|0|||
42296402|NCT02614261|76131114|FG000|Follow-up Phase|Physician Decision|5|||
42296403|NCT02614261|76131115|FG001|Follow-up Phase|Physician Decision|1|||
42296404|NCT02614261|76131116|FG002|Follow-up Phase|Physician Decision|0|||
42296405|NCT02614261|76131117|FG003|Follow-up Phase|Physician Decision|0|||
42296406|NCT02614261|76131114|FG000|Follow-up Phase|Pregnancy|0|||
42296407|NCT02614261|76131115|FG001|Follow-up Phase|Pregnancy|1|||
42296408|NCT02614261|76131116|FG002|Follow-up Phase|Pregnancy|0|||
42296409|NCT02614261|76131117|FG003|Follow-up Phase|Pregnancy|0|||
42296410|NCT02614261|76131114|FG000|Follow-up Phase|Protocol Violation|1|||
42296411|NCT02614261|76131115|FG001|Follow-up Phase|Protocol Violation|0|||
42296412|NCT02614261|76131116|FG002|Follow-up Phase|Protocol Violation|0|||
42296413|NCT02614261|76131117|FG003|Follow-up Phase|Protocol Violation|0|||
42296414|NCT02614261|76131114|FG000|Follow-up Phase|Withdrawal by Subject|12|||
42296415|NCT02614261|76131115|FG001|Follow-up Phase|Withdrawal by Subject|4|||
42296416|NCT02614261|76131116|FG002|Follow-up Phase|Withdrawal by Subject|11|||
42296417|NCT02614261|76131117|FG003|Follow-up Phase|Withdrawal by Subject|0|||
42188958|NCT02971228|75999262|FG002|Overall Study|Withdrawal by Subject|0|||
42188959|NCT02971228|75999263|FG003|Overall Study|Withdrawal by Subject|0|||
42188960|NCT02971228|75999264|FG004|Overall Study|Withdrawal by Subject|0|||
42188961|NCT02971228|75999260|FG000|Overall Study|Logistical challenges|0|||
42188962|NCT02971228|75999261|FG001|Overall Study|Logistical challenges|1|||
42188963|NCT02971228|75999262|FG002|Overall Study|Logistical challenges|0|||
42296418|NCT02614261|76131114|FG000|Israel Addendum|Withdrawal by Subject|0|||
42296419|NCT02614261|76131115|FG001|Israel Addendum|Withdrawal by Subject|0|||
42296420|NCT02614261|76131116|FG002|Israel Addendum|Withdrawal by Subject|0|||
42188964|NCT02971228|75999263|FG003|Overall Study|Logistical challenges|0|||
42188965|NCT02971228|75999264|FG004|Overall Study|Logistical challenges|0|||
42188966|NCT01060072|75999277|FG000|Overall Study|Adverse Event|1|||
42188967|NCT01060072|75999278|FG001|Overall Study|Adverse Event|1|||
42188968|NCT01060072|75999277|FG000|Overall Study|Physician Decision|0|||
42188969|NCT01060072|75999278|FG001|Overall Study|Physician Decision|2|||
42188970|NCT01060072|75999277|FG000|Overall Study|Protocol Violation|0|||
42188971|NCT01060072|75999278|FG001|Overall Study|Protocol Violation|1|||
42188972|NCT01060072|75999277|FG000|Overall Study|Acute cholecystitis|1|||
42188973|NCT01060072|75999278|FG001|Overall Study|Acute cholecystitis|0|||
42188974|NCT01060072|75999277|FG000|Overall Study|Excluded Medications|0|||
42188975|NCT01060072|75999278|FG001|Overall Study|Excluded Medications|1|||
42188976|NCT02969590|75999286|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
42188977|NCT02969590|75999287|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
42188978|NCT02969590|75999288|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
42188979|NCT03345849|75999300|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
42188980|NCT03345849|75999301|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
42188981|NCT03345849|75999302|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
42188982|NCT03345849|75999303|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
42188983|NCT03345849|75999300|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
42296421|NCT02614261|76131117|FG003|Israel Addendum|Withdrawal by Subject|4|||
42296422|NCT01594411|76131143|FG000|Overall Study|Lost to Follow-up|2|||
42296423|NCT01594333|76131152|FG000|Overall Study|Death|96|||
42296424|NCT01594333|76131153|FG001|Overall Study|Death|83|||
42296425|NCT01594333|76131152|FG000|Overall Study|Lost to Follow-up|5|||
42296426|NCT01594333|76131153|FG001|Overall Study|Lost to Follow-up|5|||
42296427|NCT01594333|76131152|FG000|Overall Study|Withdrawal by Subject|60|||
42296428|NCT01594333|76131153|FG001|Overall Study|Withdrawal by Subject|63|||
42296429|NCT02609659|76131159|FG000|Overall Study|Adverse Event|1|||
42296430|NCT02609659|76131159|FG000|Overall Study|Lost to Follow-up|6|||
42095162|NCT00656019|75905249|FG000|Overall Study|Withdrawal by Subject|2|||
42095163|NCT00656019|75905250|FG001|Overall Study|Withdrawal by Subject|0|||
42095164|NCT00656019|75905251|FG002|Overall Study|Withdrawal by Subject|0|||
42095165|NCT00656019|75905252|FG003|Overall Study|Withdrawal by Subject|0|||
42095166|NCT00656019|75905249|FG000|Overall Study|Lost to Follow-up|2|||
42095167|NCT00656019|75905250|FG001|Overall Study|Lost to Follow-up|1|||
42095168|NCT00656019|75905251|FG002|Overall Study|Lost to Follow-up|0|||
42095169|NCT00656019|75905252|FG003|Overall Study|Lost to Follow-up|0|||
42296431|NCT02609659|76131159|FG000|Overall Study|Other|1|||
42296432|NCT02612779|76131165|FG000|Overall Study|Administrative reason by sponsor|4|||
42296433|NCT02612779|76131166|FG001|Overall Study|Administrative reason by sponsor|1|||
42296434|NCT02612779|76131165|FG000|Overall Study|No longer meet study criteria|0|||
42296435|NCT02612779|76131166|FG001|Overall Study|No longer meet study criteria|1|||
42296436|NCT02612779|76131165|FG000|Overall Study|Disease progression|29|||
42296437|NCT02612779|76131166|FG001|Overall Study|Disease progression|2|||
42296438|NCT02612779|76131165|FG000|Overall Study|Study drug toxicity|10|||
42296439|NCT02612779|76131166|FG001|Overall Study|Study drug toxicity|1|||
42296440|NCT02612779|76131165|FG000|Overall Study|Death|1|||
42296441|NCT02612779|76131166|FG001|Overall Study|Death|0|||
42296442|NCT02612779|76131165|FG000|Overall Study|Adverse event unrelated to study drug|5|||
42296443|NCT02612779|76131166|FG001|Overall Study|Adverse event unrelated to study drug|0|||
42296444|NCT02612779|76131165|FG000|Overall Study|Participant withdrew consent|4|||
42296445|NCT02612779|76131166|FG001|Overall Study|Participant withdrew consent|0|||
42296446|NCT02612779|76131165|FG000|Overall Study|Lost to Follow-up|1|||
42296447|NCT02612779|76131166|FG001|Overall Study|Lost to Follow-up|0|||
42296448|NCT02612779|76131165|FG000|Overall Study|Maximum clinical benefit|10|||
42296449|NCT02612779|76131166|FG001|Overall Study|Maximum clinical benefit|1|||
42296450|NCT02612779|76131165|FG000|Overall Study|Other reasons|4|||
42296451|NCT02612779|76131166|FG001|Overall Study|Other reasons|0|||
42018229|NCT00996892|75825871|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
42018230|NCT00996892|75825872|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
42018231|NCT00996892|75825873|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
42018232|NCT00996892|75825874|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
42095170|NCT00782483|75905262|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
42095171|NCT00782171|75905268|FG000|Overall Study|Lost to Follow-up|2|||
42095172|NCT00782171|75905269|FG001|Overall Study|Lost to Follow-up|2|||
42095173|NCT00782171|75905268|FG000|Overall Study|Withdrawal by Subject|2|||
42095174|NCT00782171|75905269|FG001|Overall Study|Withdrawal by Subject|1|||
42095175|NCT00782171|75905268|FG000|Overall Study|complications|3|||
42095176|NCT00782171|75905269|FG001|Overall Study|complications|1|||
42095177|NCT00782171|75905268|FG000|Overall Study|others|7|||
42018233|NCT00996892|75825875|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
42018234|NCT00996892|75825876|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
42018235|NCT00996892|75825877|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
42018236|NCT00996892|75825878|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
42095178|NCT00782171|75905269|FG001|Overall Study|others|9|||
42095179|NCT00782171|75905268|FG000|Overall Study|not eligible|8|||
42095180|NCT00782171|75905269|FG001|Overall Study|not eligible|6|||
42188984|NCT03345849|75999301|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
42188985|NCT03345849|75999302|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
42188986|NCT03345849|75999303|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
42188987|NCT03345849|75999300|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
42188988|NCT03345849|75999301|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
42188989|NCT03345849|75999302|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
42188990|NCT03345849|75999303|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
42188991|NCT03345849|75999300|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
42188992|NCT03345849|75999301|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
42188993|NCT03345849|75999302|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
42095181|NCT00764465|75905281|FG000|Overall Study|Adverse Event|2|||
42095182|NCT00764465|75905282|FG001|Overall Study|Adverse Event|0|||
42188994|NCT03345849|75999303|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
42188995|NCT03345849|75999300|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
42296452|NCT02612623|76131177|FG000|Overall Study|Withdrawal by Subject|0|||
42296453|NCT02612623|76131178|FG001|Overall Study|Withdrawal by Subject|1|||
42296454|NCT02612623|76131179|FG002|Overall Study|Withdrawal by Subject|0|||
42296455|NCT02612623|76131180|FG003|Overall Study|Withdrawal by Subject|0|||
42296456|NCT02612623|76131177|FG000|Overall Study|Adverse Event|1|||
42296457|NCT02612623|76131178|FG001|Overall Study|Adverse Event|0|||
42296458|NCT02612623|76131179|FG002|Overall Study|Adverse Event|1|||
42296459|NCT02612623|76131180|FG003|Overall Study|Adverse Event|0|||
42296460|NCT02607865|76131194|FG000|Overall Study|Lost to Follow-up|9|||
42296461|NCT02607865|76131195|FG001|Overall Study|Lost to Follow-up|7|||
42296462|NCT02607865|76131196|FG002|Overall Study|Lost to Follow-up|7|||
42296463|NCT02607865|76131197|FG003|Overall Study|Lost to Follow-up|5|||
42296464|NCT02607865|76131194|FG000|Overall Study|Withdrawal by Subject|18|||
42296465|NCT02607865|76131195|FG001|Overall Study|Withdrawal by Subject|18|||
42296466|NCT02607865|76131196|FG002|Overall Study|Withdrawal by Subject|17|||
42296467|NCT02607865|76131197|FG003|Overall Study|Withdrawal by Subject|8|||
42296468|NCT02607865|76131194|FG000|Overall Study|Death|5|||
42296469|NCT02607865|76131195|FG001|Overall Study|Death|4|||
42296470|NCT02607865|76131196|FG002|Overall Study|Death|1|||
42296471|NCT02607865|76131197|FG003|Overall Study|Death|3|||
42296472|NCT02607865|76131194|FG000|Overall Study|Unclassified|1|||
42296473|NCT02607865|76131195|FG001|Overall Study|Unclassified|1|||
42296474|NCT02607865|76131196|FG002|Overall Study|Unclassified|2|||
42296475|NCT02607865|76131197|FG003|Overall Study|Unclassified|0|||
42296476|NCT01668667|76131211|FG000|Overall Study|Adverse Event|3|||
42296477|NCT01668667|76131212|FG001|Overall Study|Adverse Event|6|||
42296478|NCT01668667|76131213|FG002|Overall Study|Adverse Event|4|||
42296479|NCT01668667|76131214|FG003|Overall Study|Adverse Event|4|||
42018237|NCT00996892|75825879|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
42018238|NCT00996892|75825880|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
42018239|NCT00996892|75825861|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
42018240|NCT00996892|75825862|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
42018241|NCT00996892|75825863|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
42018242|NCT00996892|75825864|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
42018243|NCT00996892|75825865|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
42018244|NCT00996892|75825866|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
42018245|NCT00996892|75825867|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
42018246|NCT00996892|75825868|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
42095183|NCT00764465|75905283|FG002|Overall Study|Adverse Event|0|||
42095184|NCT00764465|75905284|FG003|Overall Study|Adverse Event|1|||
42095185|NCT00764465|75905285|FG004|Overall Study|Adverse Event|1|||
42095186|NCT00764465|75905286|FG005|Overall Study|Adverse Event|1|||
42095187|NCT00764465|75905281|FG000|Overall Study|Withdrawal by Subject|0|||
42095188|NCT00764465|75905282|FG001|Overall Study|Withdrawal by Subject|1|||
42095189|NCT00764465|75905283|FG002|Overall Study|Withdrawal by Subject|1|||
42095190|NCT00764465|75905284|FG003|Overall Study|Withdrawal by Subject|0|||
42095191|NCT00764465|75905285|FG004|Overall Study|Withdrawal by Subject|0|||
42095192|NCT00764465|75905286|FG005|Overall Study|Withdrawal by Subject|0|||
42296480|NCT01668667|76131211|FG000|Overall Study|Lack of Efficacy|3|||
42296481|NCT01668667|76131212|FG001|Overall Study|Lack of Efficacy|2|||
42296482|NCT01668667|76131213|FG002|Overall Study|Lack of Efficacy|2|||
42296483|NCT01668667|76131214|FG003|Overall Study|Lack of Efficacy|3|||
42296484|NCT01668667|76131211|FG000|Overall Study|Protocol Violation|6|||
42296485|NCT01668667|76131212|FG001|Overall Study|Protocol Violation|10|||
42296486|NCT01668667|76131213|FG002|Overall Study|Protocol Violation|12|||
42018247|NCT00996892|75825869|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
42018248|NCT00996892|75825870|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
42095193|NCT00655863|75905306|FG000|Overall Study|Lost to Follow-up|0|||
42095194|NCT00655863|75905307|FG001|Overall Study|Lost to Follow-up|0|||
42095195|NCT00655863|75905308|FG002|Overall Study|Lost to Follow-up|1|||
42095196|NCT00781937|75905318|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
42095197|NCT00781937|75905319|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
42095198|NCT00781937|75905318|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
42095199|NCT00781937|75905319|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
42095200|NCT00781937|75905318|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
42095201|NCT00781937|75905319|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
42095202|NCT00781937|75905318|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
42095203|NCT00781937|75905319|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
42095204|NCT00781937|75905318|FG000|Main Trial Period Through Week 56|Unclassified|10|||
42188996|NCT03345849|75999301|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
42188997|NCT03345849|75999302|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
42188998|NCT03345849|75999303|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
42188999|NCT03345849|75999300|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
42189000|NCT03345849|75999301|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
42189001|NCT03345849|75999302|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
42189002|NCT03345849|75999303|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
42189003|NCT03345849|75999300|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
42189004|NCT03345849|75999301|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
42189005|NCT03345849|75999302|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
42189006|NCT03345849|75999303|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
42189007|NCT03345849|75999300|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
42189008|NCT03345849|75999301|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
42189009|NCT03345849|75999302|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
42189010|NCT03345849|75999303|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
42189011|NCT03345849|75999300|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
42189012|NCT03345849|75999301|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
42189013|NCT03345849|75999302|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
42189014|NCT03345849|75999303|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
42189015|NCT03345849|75999300|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
42189016|NCT03345849|75999301|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
42189017|NCT03345849|75999302|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
42189018|NCT03345849|75999303|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
42189019|NCT03345849|75999300|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
42189020|NCT03345849|75999301|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
42189021|NCT03345849|75999302|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
42189022|NCT03345849|75999303|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
42189023|NCT03011307|75999313|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
42189024|NCT03011307|75999314|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
42189025|NCT03011307|75999313|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
42189026|NCT03011307|75999314|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
42189027|NCT03011307|75999313|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
42189028|NCT03011307|75999314|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
42189029|NCT03798717|75999326|FG000|Overall Study|Failed Screening|0|||
42189030|NCT03798717|75999327|FG001|Overall Study|Failed Screening|0|||
42189031|NCT03798717|75999328|FG002|Overall Study|Failed Screening|0|||
42095205|NCT00781937|75905319|FG001|Main Trial Period Through Week 56|Unclassified|15|||
42095206|NCT00781937|75905318|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
42095207|NCT00781937|75905319|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
42095208|NCT00781937|75905318|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
42095209|NCT00781937|75905319|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
42095210|NCT00659373|75905327|FG000|Overall Study|Withdrawal by Subject|3|||
42095211|NCT00659373|75905328|FG001|Overall Study|Withdrawal by Subject|5|||
42095212|NCT00659373|75905327|FG000|Overall Study|Assessment Missed|2|||
42095213|NCT00659373|75905328|FG001|Overall Study|Assessment Missed|2|||
42095214|NCT00439777|75905336|FG000|Treatment Period|Death|29|||
42095215|NCT00439777|75905337|FG001|Treatment Period|Death|21|||
42095216|NCT00439777|75905336|FG000|Treatment Period|Study terminated by sponsor|125|||
42095217|NCT00439777|75905337|FG001|Treatment Period|Study terminated by sponsor|132|||
42095218|NCT00439777|75905336|FG000|Treatment Period|Site closed by investigator|0|||
42095219|NCT00439777|75905337|FG001|Treatment Period|Site closed by investigator|1|||
42095220|NCT00439777|75905336|FG000|Treatment Period|Did not take study treatment|7|||
42095221|NCT00439777|75905337|FG001|Treatment Period|Did not take study treatment|8|||
42095222|NCT00439777|75905336|FG000|Treatment Period|Adverse Event|111|||
42095223|NCT00439777|75905337|FG001|Treatment Period|Adverse Event|92|||
42189032|NCT03798717|75999329|FG003|Overall Study|Failed Screening|0|||
42189033|NCT03798717|75999330|FG004|Overall Study|Failed Screening|0|||
42189034|NCT03798717|75999331|FG005|Overall Study|Failed Screening|1|||
42189035|NCT03798717|75999326|FG000|Overall Study|Physician Decision|1|||
42189036|NCT03798717|75999327|FG001|Overall Study|Physician Decision|0|||
42189037|NCT03798717|75999328|FG002|Overall Study|Physician Decision|1|||
42189038|NCT03798717|75999329|FG003|Overall Study|Physician Decision|0|||
42189039|NCT03798717|75999330|FG004|Overall Study|Physician Decision|0|||
42189040|NCT03798717|75999331|FG005|Overall Study|Physician Decision|0|||
42189041|NCT03798717|75999326|FG000|Overall Study|Withdrawal by Subject|0|||
42095224|NCT00439777|75905336|FG000|Treatment Period|Protocol Violation|23|||
42095225|NCT00439777|75905337|FG001|Treatment Period|Protocol Violation|30|||
42095226|NCT00439777|75905336|FG000|Treatment Period|Withdrawal by Subject|66|||
42095227|NCT00439777|75905337|FG001|Treatment Period|Withdrawal by Subject|118|||
42095228|NCT00439777|75905336|FG000|Treatment Period|Lack of Efficacy|1|||
42095229|NCT00439777|75905337|FG001|Treatment Period|Lack of Efficacy|4|||
42095230|NCT00439777|75905336|FG000|Treatment Period|Lost to Follow-up|8|||
42095231|NCT00439777|75905337|FG001|Treatment Period|Lost to Follow-up|10|||
42189042|NCT03798717|75999327|FG001|Overall Study|Withdrawal by Subject|0|||
42189043|NCT03798717|75999328|FG002|Overall Study|Withdrawal by Subject|0|||
42189044|NCT03798717|75999329|FG003|Overall Study|Withdrawal by Subject|1|||
42189045|NCT03798717|75999330|FG004|Overall Study|Withdrawal by Subject|0|||
42189046|NCT03798717|75999331|FG005|Overall Study|Withdrawal by Subject|0|||
42189047|NCT03798717|75999326|FG000|Overall Study|Lost to Follow-up|1|||
42189048|NCT03798717|75999327|FG001|Overall Study|Lost to Follow-up|0|||
42189049|NCT03798717|75999328|FG002|Overall Study|Lost to Follow-up|0|||
42189050|NCT03798717|75999329|FG003|Overall Study|Lost to Follow-up|1|||
42189051|NCT03798717|75999330|FG004|Overall Study|Lost to Follow-up|0|||
42189052|NCT03798717|75999331|FG005|Overall Study|Lost to Follow-up|0|||
42189053|NCT03798717|75999326|FG000|Overall Study|Adverse Event|0|||
42189054|NCT03798717|75999327|FG001|Overall Study|Adverse Event|1|||
42189055|NCT03798717|75999328|FG002|Overall Study|Adverse Event|0|||
42189056|NCT03798717|75999329|FG003|Overall Study|Adverse Event|0|||
42189057|NCT03798717|75999330|FG004|Overall Study|Adverse Event|0|||
42189058|NCT03798717|75999331|FG005|Overall Study|Adverse Event|0|||
42189059|NCT03798717|75999326|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
42189060|NCT03798717|75999327|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
42189061|NCT03798717|75999328|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
42189062|NCT03798717|75999329|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
42189063|NCT03798717|75999330|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
42189064|NCT03798717|75999331|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
42296487|NCT01668667|76131214|FG003|Overall Study|Protocol Violation|5|||
42095232|NCT00439777|75905336|FG000|Treatment Period|Protocol driven decision point|1|||
42095233|NCT00439777|75905337|FG001|Treatment Period|Protocol driven decision point|3|||
42095234|NCT00439777|75905336|FG000|Treatment Period|Physician Decision|7|||
42095235|NCT00439777|75905337|FG001|Treatment Period|Physician Decision|18|||
42095236|NCT00439777|75905336|FG000|Treatment Period|Clinical endpoint reached|26|||
42095237|NCT00439777|75905337|FG001|Treatment Period|Clinical endpoint reached|13|||
42095238|NCT00439777|75905336|FG000|Treatment Period|Technical problems|3|||
42095239|NCT00439777|75905337|FG001|Treatment Period|Technical problems|1|||
42095240|NCT00439777|75905336|FG000|Treatment Period|Participant convenience|12|||
42095241|NCT00439777|75905337|FG001|Treatment Period|Participant convenience|8|||
42095242|NCT00439777|75905336|FG000|Observational Period|Protocol Violation|0|||
42095243|NCT00439777|75905337|FG001|Observational Period|Protocol Violation|2|||
42095244|NCT00439777|75905336|FG000|Observational Period|Withdrawal by Subject|9|||
42095245|NCT00439777|75905337|FG001|Observational Period|Withdrawal by Subject|5|||
42095246|NCT00439777|75905336|FG000|Observational Period|Lost to Follow-up|1|||
42095247|NCT00439777|75905337|FG001|Observational Period|Lost to Follow-up|11|||
42095248|NCT00439777|75905336|FG000|Observational Period|Death|27|||
42095249|NCT00439777|75905337|FG001|Observational Period|Death|20|||
42189065|NCT03798483|75999340|FG000|Overall Study|Lost to Follow-up|2|||
42189066|NCT03792477|75999353|FG000|Overall Study|Adverse Event|0|||
42189067|NCT03792477|75999354|FG001|Overall Study|Adverse Event|0|||
42189068|NCT03792477|75999355|FG002|Overall Study|Adverse Event|0|||
42189069|NCT03792477|75999356|FG003|Overall Study|Adverse Event|1|||
42189070|NCT03792477|75999357|FG004|Overall Study|Adverse Event|0|||
42189071|NCT03792477|75999353|FG000|Overall Study|Lost to Follow-up|0|||
42189072|NCT03792477|75999354|FG001|Overall Study|Lost to Follow-up|0|||
42189073|NCT03792477|75999355|FG002|Overall Study|Lost to Follow-up|2|||
42189074|NCT03792477|75999356|FG003|Overall Study|Lost to Follow-up|0|||
42296488|NCT01668667|76131211|FG000|Overall Study|Lost to Follow-up|9|||
42189075|NCT03792477|75999357|FG004|Overall Study|Lost to Follow-up|0|||
42095250|NCT00439777|75905336|FG000|Observational Period|Study terminated by sponsor|3|||
42095251|NCT00439777|75905337|FG001|Observational Period|Study terminated by sponsor|1|||
42095252|NCT00439777|75905336|FG000|Observational Period|Protocol driven decision point|0|||
42189076|NCT03792477|75999353|FG000|Overall Study|Other|0|||
42296489|NCT01668667|76131212|FG001|Overall Study|Lost to Follow-up|4|||
42189077|NCT03792477|75999354|FG001|Overall Study|Other|0|||
42189078|NCT03792477|75999355|FG002|Overall Study|Other|0|||
42189079|NCT03792477|75999356|FG003|Overall Study|Other|0|||
42189080|NCT03792477|75999357|FG004|Overall Study|Other|1|||
42189081|NCT03790917|75999363|FG000|Overall Study|Death|1|||
42189082|NCT03788967|75999370|FG000|Overall Study|Lost to Follow-up|14|||
42189083|NCT03788967|75999371|FG001|Overall Study|Lost to Follow-up|10|||
42189084|NCT03788967|75999370|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
42189085|NCT03788967|75999371|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
42189086|NCT03788967|75999370|FG000|Overall Study|Participant Withdrawal of Consent|13|||
42189087|NCT03788967|75999371|FG001|Overall Study|Participant Withdrawal of Consent|5|||
42189088|NCT03788967|75999370|FG000|Overall Study|Adverse Event|1|||
42189089|NCT03788967|75999371|FG001|Overall Study|Adverse Event|1|||
42189090|NCT03788967|75999370|FG000|Overall Study|COVID-19|1|||
42296490|NCT01668667|76131213|FG002|Overall Study|Lost to Follow-up|7|||
42296491|NCT01668667|76131214|FG003|Overall Study|Lost to Follow-up|6|||
42296492|NCT01668667|76131211|FG000|Overall Study|Physician Decision|3|||
42296493|NCT01668667|76131212|FG001|Overall Study|Physician Decision|0|||
42018249|NCT00996892|75825871|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
42095253|NCT00439777|75905337|FG001|Observational Period|Protocol driven decision point|1|||
42095254|NCT00439777|75905336|FG000|Observational Period|Lack of Efficacy|1|||
42095255|NCT00439777|75905337|FG001|Observational Period|Lack of Efficacy|0|||
42095256|NCT00439777|75905336|FG000|Observational Period|Technical problems|0|||
42095257|NCT00439777|75905337|FG001|Observational Period|Technical problems|1|||
42189091|NCT03788967|75999371|FG001|Overall Study|COVID-19|2|||
42189092|NCT03782571|75999379|FG000|Period 1|Withdrawal by Subject|1|||
42189093|NCT03782571|75999380|FG001|Period 1|Withdrawal by Subject|0|||
42296494|NCT01668667|76131213|FG002|Overall Study|Physician Decision|1|||
42296495|NCT01668667|76131214|FG003|Overall Study|Physician Decision|0|||
42296496|NCT01668667|76131211|FG000|Overall Study|Withdrawal by Subject|7|||
42018250|NCT00996892|75825872|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
42018251|NCT00996892|75825873|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
42018252|NCT00996892|75825874|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
42018253|NCT00996892|75825875|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
42018254|NCT00996892|75825876|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
42018255|NCT00996892|75825877|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
42018256|NCT00996892|75825878|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
42018257|NCT00996892|75825879|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
42018258|NCT00996892|75825880|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
42018259|NCT00996892|75825861|FG000|Dose-Escalation Stage 1A|Death|0|||
42018260|NCT00996892|75825862|FG001|Dose-Escalation Stage 1A|Death|0|||
42018261|NCT00996892|75825863|FG002|Dose-Escalation Stage 1A|Death|0|||
42018262|NCT00996892|75825864|FG003|Dose-Escalation Stage 1A|Death|0|||
42018263|NCT00996892|75825865|FG004|Dose-Escalation Stage 1A|Death|0|||
42018264|NCT00996892|75825866|FG005|Dose-Escalation Stage 1A|Death|0|||
42018265|NCT00996892|75825867|FG006|Dose-Escalation Stage 1A|Death|0|||
42018266|NCT00996892|75825868|FG007|Dose-Escalation Stage 1A|Death|0|||
42018267|NCT00996892|75825869|FG008|Dose-Escalation Stage 1A|Death|0|||
42018268|NCT00996892|75825870|FG009|Dose-Escalation Stage 1A|Death|2|||
42018269|NCT00996892|75825871|FG010|Dose-Escalation Stage 1A|Death|0|||
42018270|NCT00996892|75825872|FG011|Dose-Escalation Stage 1A|Death|1|||
42018271|NCT00996892|75825873|FG012|Dose-Escalation Stage 1A|Death|1|||
42018272|NCT00996892|75825874|FG013|Dose-Escalation Stage 1A|Death|0|||
42018273|NCT00996892|75825875|FG014|Dose-Escalation Stage 1A|Death|0|||
42018274|NCT00996892|75825876|FG015|Dose-Escalation Stage 1A|Death|0|||
42018275|NCT00996892|75825877|FG016|Dose-Escalation Stage 1A|Death|0|||
42018276|NCT00996892|75825878|FG017|Dose-Escalation Stage 1A|Death|0|||
42018277|NCT00996892|75825879|FG018|Dose-Escalation Stage 1A|Death|0|||
42018278|NCT00996892|75825880|FG019|Dose-Escalation Stage 1A|Death|0|||
42018279|NCT00996892|75825861|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
42018280|NCT00996892|75825862|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
42018281|NCT00996892|75825863|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
42018282|NCT00996892|75825864|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
42018283|NCT00996892|75825865|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
42018284|NCT00996892|75825866|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
42018285|NCT00996892|75825867|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
42018286|NCT00996892|75825868|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
42018287|NCT00996892|75825869|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
42018288|NCT00996892|75825870|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
42018289|NCT00996892|75825871|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
42095258|NCT00620854|75905349|FG000|Washout 1|Withdrawal by Subject|0|||
42095259|NCT00620854|75905350|FG001|Washout 1|Withdrawal by Subject|0|||
42296497|NCT01668667|76131212|FG001|Overall Study|Withdrawal by Subject|4|||
42095260|NCT00620854|75905351|FG002|Washout 1|Withdrawal by Subject|1|||
42095261|NCT00620854|75905352|FG003|Washout 1|Withdrawal by Subject|1|||
42095262|NCT00620854|75905353|FG004|Washout 1|Withdrawal by Subject|0|||
42095263|NCT00620854|75905354|FG005|Washout 1|Withdrawal by Subject|0|||
42095264|NCT00430027|75905365|FG000|Overall Study|Study terminated|8|||
42095265|NCT00429793|75905369|FG000|Overall Study|Improper pre-protocol treatment|3|||
42095266|NCT00429793|75905369|FG000|Overall Study|Required test not done|1|||
42095267|NCT00429793|75905369|FG000|Overall Study|Never treated|1|||
42095268|NCT00429793|75905369|FG000|Overall Study|Non-measurable|1|||
42189094|NCT03782571|75999381|FG002|Period 1|Withdrawal by Subject|0|||
42189095|NCT03782571|75999382|FG003|Period 1|Withdrawal by Subject|0|||
42189096|NCT03782571|75999379|FG000|Period 3|Subject Unable to Attend V5|1|||
42189097|NCT03782571|75999380|FG001|Period 3|Subject Unable to Attend V5|0|||
42189098|NCT03782571|75999381|FG002|Period 3|Subject Unable to Attend V5|0|||
42189099|NCT03782571|75999382|FG003|Period 3|Subject Unable to Attend V5|0|||
42189100|NCT03782571|75999379|FG000|Period 3|Adverse Event|1|||
42189101|NCT03782571|75999380|FG001|Period 3|Adverse Event|0|||
42189102|NCT03782571|75999381|FG002|Period 3|Adverse Event|0|||
42189103|NCT03782571|75999382|FG003|Period 3|Adverse Event|0|||
42189104|NCT03783039|75999396|FG000|Overall Study|Death|2|||
42189105|NCT03783039|75999397|FG001|Overall Study|Death|1|||
42189106|NCT03776175|75999407|FG000|Treatment Period (42 Days)|Adverse Event|0|||
42189107|NCT03776175|75999408|FG001|Treatment Period (42 Days)|Adverse Event|1|||
42189108|NCT03776175|75999409|FG002|Treatment Period (42 Days)|Adverse Event|1|||
42189109|NCT03776175|75999410|FG003|Treatment Period (42 Days)|Adverse Event|0|||
42189110|NCT03776175|75999407|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
42189111|NCT03776175|75999408|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
42189112|NCT03776175|75999409|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
42189113|NCT03776175|75999410|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
42189114|NCT03776175|75999407|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
42189115|NCT03776175|75999408|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
42189116|NCT03776175|75999409|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
42189117|NCT03776175|75999410|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
42189118|NCT03776175|75999407|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
42189119|NCT03776175|75999408|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
42189120|NCT03776175|75999409|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
42189121|NCT03776175|75999410|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
42189122|NCT03776175|75999407|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
42095269|NCT00424645|75905380|FG000|Overall Study|Death|1|||
42095270|NCT00424645|75905381|FG001|Overall Study|Death|0|||
42095271|NCT00763451|75905391|FG000|Overall Study|Adverse Event|4|||
42189123|NCT03776175|75999408|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
42189124|NCT03776175|75999409|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
42189125|NCT03776175|75999410|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
42189126|NCT03776175|75999407|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
42189127|NCT03776175|75999408|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
42189128|NCT03776175|75999409|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
42189129|NCT03776175|75999410|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
42189130|NCT02903914|75999428|FG000|Overall Study|Adverse Event|0|||
42189131|NCT02903914|75999429|FG001|Overall Study|Adverse Event|0|||
42189132|NCT02903914|75999430|FG002|Overall Study|Adverse Event|1|||
42189133|NCT02903914|75999431|FG003|Overall Study|Adverse Event|0|||
42189134|NCT02903914|75999432|FG004|Overall Study|Adverse Event|0|||
42189135|NCT02903914|75999433|FG005|Overall Study|Adverse Event|1|||
42189136|NCT02903914|75999434|FG006|Overall Study|Adverse Event|2|||
42189137|NCT02903914|75999435|FG007|Overall Study|Adverse Event|1|||
42189138|NCT02903914|75999428|FG000|Overall Study|Withdrawal by Subject|3|||
42189139|NCT02903914|75999429|FG001|Overall Study|Withdrawal by Subject|1|||
42189140|NCT02903914|75999430|FG002|Overall Study|Withdrawal by Subject|28|||
42095272|NCT00763451|75905392|FG001|Overall Study|Adverse Event|6|||
42095273|NCT00763451|75905393|FG002|Overall Study|Adverse Event|19|||
42095274|NCT00763451|75905394|FG003|Overall Study|Adverse Event|14|||
42095275|NCT00763451|75905391|FG000|Overall Study|Lack of Efficacy|1|||
42095276|NCT00763451|75905392|FG001|Overall Study|Lack of Efficacy|4|||
42095277|NCT00763451|75905393|FG002|Overall Study|Lack of Efficacy|3|||
42095278|NCT00763451|75905394|FG003|Overall Study|Lack of Efficacy|2|||
42095279|NCT00763451|75905391|FG000|Overall Study|Withdrawal by Subject|1|||
42095280|NCT00763451|75905392|FG001|Overall Study|Withdrawal by Subject|6|||
42095281|NCT00763451|75905393|FG002|Overall Study|Withdrawal by Subject|9|||
42095282|NCT00763451|75905394|FG003|Overall Study|Withdrawal by Subject|7|||
42095283|NCT00763451|75905391|FG000|Overall Study|Protocol Violation|0|||
42095284|NCT00763451|75905392|FG001|Overall Study|Protocol Violation|0|||
42095285|NCT00763451|75905393|FG002|Overall Study|Protocol Violation|1|||
42095286|NCT00763451|75905394|FG003|Overall Study|Protocol Violation|0|||
42095287|NCT00763451|75905391|FG000|Overall Study|Poor Compliance to Protocol|1|||
42095288|NCT00763451|75905392|FG001|Overall Study|Poor Compliance to Protocol|1|||
42095289|NCT00763451|75905393|FG002|Overall Study|Poor Compliance to Protocol|2|||
42095290|NCT00763451|75905394|FG003|Overall Study|Poor Compliance to Protocol|2|||
42095291|NCT00763451|75905391|FG000|Overall Study|Familial and Personal Reasons|5|||
42095292|NCT00763451|75905392|FG001|Overall Study|Familial and Personal Reasons|3|||
42095293|NCT00763451|75905393|FG002|Overall Study|Familial and Personal Reasons|5|||
42095294|NCT00763451|75905394|FG003|Overall Study|Familial and Personal Reasons|4|||
42095295|NCT00763451|75905391|FG000|Overall Study|Randomized but not Treated|1|||
42095296|NCT00763451|75905392|FG001|Overall Study|Randomized but not Treated|1|||
42095297|NCT00763451|75905393|FG002|Overall Study|Randomized but not Treated|0|||
42095298|NCT00763451|75905394|FG003|Overall Study|Randomized but not Treated|0|||
42095299|NCT00763451|75905391|FG000|Overall Study|Study Site Reason|0|||
42095300|NCT00763451|75905392|FG001|Overall Study|Study Site Reason|1|||
42095301|NCT00763451|75905393|FG002|Overall Study|Study Site Reason|1|||
42095302|NCT00763451|75905394|FG003|Overall Study|Study Site Reason|1|||
42095303|NCT00762762|75905407|FG000|Overall Study|Did not return for appointments|6|||
42189141|NCT02903914|75999431|FG003|Overall Study|Withdrawal by Subject|0|||
42189142|NCT02903914|75999432|FG004|Overall Study|Withdrawal by Subject|1|||
42189143|NCT02903914|75999433|FG005|Overall Study|Withdrawal by Subject|1|||
42189144|NCT02903914|75999434|FG006|Overall Study|Withdrawal by Subject|12|||
42189145|NCT02903914|75999435|FG007|Overall Study|Withdrawal by Subject|0|||
42189146|NCT02903914|75999428|FG000|Overall Study|Progressive Disease|1|||
42189147|NCT02903914|75999429|FG001|Overall Study|Progressive Disease|0|||
42189148|NCT02903914|75999430|FG002|Overall Study|Progressive Disease|4|||
42189149|NCT02903914|75999431|FG003|Overall Study|Progressive Disease|0|||
42189150|NCT02903914|75999432|FG004|Overall Study|Progressive Disease|0|||
42095304|NCT00762762|75905408|FG001|Overall Study|Did not return for appointments|8|||
42189151|NCT02903914|75999433|FG005|Overall Study|Progressive Disease|0|||
42189152|NCT02903914|75999434|FG006|Overall Study|Progressive Disease|2|||
42189153|NCT02903914|75999435|FG007|Overall Study|Progressive Disease|4|||
42189154|NCT02903914|75999428|FG000|Overall Study|Death|0|||
42095305|NCT00424489|75905416|FG000|Overall Study|Death|3|||
42095306|NCT00578864|75905422|FG000|Overall Study|Death|1|||
42095307|NCT00578864|75905423|FG001|Overall Study|Death|0|||
42095308|NCT00770315|75905446|FG000|Overall Study|Adverse Event|11|||
42095309|NCT00770315|75905447|FG001|Overall Study|Adverse Event|17|||
42095310|NCT00770315|75905448|FG002|Overall Study|Adverse Event|16|||
42189155|NCT02903914|75999429|FG001|Overall Study|Death|0|||
42095311|NCT00770315|75905449|FG003|Overall Study|Adverse Event|6|||
42095312|NCT00770315|75905446|FG000|Overall Study|Lost to Follow-up|9|||
42095313|NCT00770315|75905447|FG001|Overall Study|Lost to Follow-up|5|||
42095314|NCT00770315|75905448|FG002|Overall Study|Lost to Follow-up|10|||
42095315|NCT00770315|75905449|FG003|Overall Study|Lost to Follow-up|3|||
42095316|NCT00770315|75905446|FG000|Overall Study|Withdrawal by Subject|13|||
42095317|NCT00770315|75905447|FG001|Overall Study|Withdrawal by Subject|17|||
42095318|NCT00770315|75905448|FG002|Overall Study|Withdrawal by Subject|24|||
42189156|NCT02903914|75999430|FG002|Overall Study|Death|9|||
42189157|NCT02903914|75999431|FG003|Overall Study|Death|0|||
42189158|NCT02903914|75999432|FG004|Overall Study|Death|1|||
42189159|NCT02903914|75999433|FG005|Overall Study|Death|3|||
42189160|NCT02903914|75999434|FG006|Overall Study|Death|24|||
42189161|NCT02903914|75999435|FG007|Overall Study|Death|0|||
42189162|NCT02903914|75999428|FG000|Overall Study|Lost to Follow-up|0|||
42189163|NCT02903914|75999429|FG001|Overall Study|Lost to Follow-up|1|||
42189164|NCT02903914|75999430|FG002|Overall Study|Lost to Follow-up|0|||
42189165|NCT02903914|75999431|FG003|Overall Study|Lost to Follow-up|0|||
42189166|NCT02903914|75999432|FG004|Overall Study|Lost to Follow-up|2|||
42189167|NCT02903914|75999433|FG005|Overall Study|Lost to Follow-up|0|||
42189168|NCT02903914|75999434|FG006|Overall Study|Lost to Follow-up|1|||
42095319|NCT00770315|75905449|FG003|Overall Study|Withdrawal by Subject|20|||
42095320|NCT00770315|75905446|FG000|Overall Study|Noncompliance with Protocol|7|||
42095321|NCT00770315|75905447|FG001|Overall Study|Noncompliance with Protocol|4|||
42095322|NCT00770315|75905448|FG002|Overall Study|Noncompliance with Protocol|7|||
42189169|NCT02903914|75999435|FG007|Overall Study|Lost to Follow-up|0|||
42189170|NCT02903914|75999428|FG000|Overall Study|Physician Decision|0|||
42189171|NCT02903914|75999429|FG001|Overall Study|Physician Decision|0|||
42189172|NCT02903914|75999430|FG002|Overall Study|Physician Decision|1|||
42189173|NCT02903914|75999431|FG003|Overall Study|Physician Decision|0|||
42189174|NCT02903914|75999432|FG004|Overall Study|Physician Decision|0|||
42189175|NCT02903914|75999433|FG005|Overall Study|Physician Decision|0|||
42189176|NCT02903914|75999434|FG006|Overall Study|Physician Decision|1|||
42189177|NCT02903914|75999435|FG007|Overall Study|Physician Decision|0|||
42189178|NCT02903914|75999428|FG000|Overall Study|Symptomatic Deterioration|0|||
42189179|NCT02903914|75999429|FG001|Overall Study|Symptomatic Deterioration|0|||
42189180|NCT02903914|75999430|FG002|Overall Study|Symptomatic Deterioration|1|||
42189181|NCT02903914|75999431|FG003|Overall Study|Symptomatic Deterioration|0|||
42095323|NCT00770315|75905449|FG003|Overall Study|Noncompliance with Protocol|9|||
42095324|NCT00587171|75905461|FG000|Overall Study|Lost to Follow-up|1|||
42095325|NCT00587171|75905462|FG001|Overall Study|Lost to Follow-up|1|||
42095326|NCT00763139|75905468|FG000|Overall Study|Adverse Event|4|||
42095327|NCT00763139|75905469|FG001|Overall Study|Adverse Event|2|||
42095328|NCT00763139|75905468|FG000|Overall Study|Withdrawal by Subject|0|||
42296498|NCT01668667|76131213|FG002|Overall Study|Withdrawal by Subject|5|||
42296499|NCT01668667|76131214|FG003|Overall Study|Withdrawal by Subject|5|||
42296500|NCT02608879|76131227|FG000|Overall Study|Lost to Follow-up|1|||
42095329|NCT00763139|75905469|FG001|Overall Study|Withdrawal by Subject|1|||
42095330|NCT00763139|75905468|FG000|Overall Study|med change not allowed by protocol|1|||
42095331|NCT00763139|75905469|FG001|Overall Study|med change not allowed by protocol|0|||
42095332|NCT01366092|75905480|FG000|Overall Study|Progressive cGVHD|2|||
42095333|NCT01366092|75905480|FG000|Overall Study|Physician Decision|1|||
42189182|NCT02903914|75999432|FG004|Overall Study|Symptomatic Deterioration|0|||
42189183|NCT02903914|75999433|FG005|Overall Study|Symptomatic Deterioration|0|||
42189184|NCT02903914|75999434|FG006|Overall Study|Symptomatic Deterioration|0|||
42189185|NCT02903914|75999435|FG007|Overall Study|Symptomatic Deterioration|0|||
42296501|NCT02608879|76131228|FG001|Overall Study|Lost to Follow-up|0|||
42296502|NCT02608879|76131229|FG002|Overall Study|Lost to Follow-up|0|||
42296503|NCT02608879|76131227|FG000|Overall Study|Did not meet continuation criteria|0|||
42296504|NCT02608879|76131228|FG001|Overall Study|Did not meet continuation criteria|0|||
42296505|NCT02608879|76131229|FG002|Overall Study|Did not meet continuation criteria|3|||
42189186|NCT02903914|75999428|FG000|Overall Study|New Cancer Therapy|2|||
42189187|NCT02903914|75999429|FG001|Overall Study|New Cancer Therapy|2|||
42189188|NCT02903914|75999430|FG002|Overall Study|New Cancer Therapy|21|||
42296506|NCT02608099|76131239|FG000|Overall Study|Ablation procedure not initiated|3|||
42189189|NCT02903914|75999431|FG003|Overall Study|New Cancer Therapy|4|||
42189190|NCT02903914|75999432|FG004|Overall Study|New Cancer Therapy|3|||
42189191|NCT02903914|75999433|FG005|Overall Study|New Cancer Therapy|6|||
42189192|NCT02903914|75999434|FG006|Overall Study|New Cancer Therapy|55|||
42189193|NCT02903914|75999435|FG007|Overall Study|New Cancer Therapy|0|||
42189194|NCT02903914|75999428|FG000|Overall Study|Reasoning not specified|2|||
42189195|NCT02903914|75999429|FG001|Overall Study|Reasoning not specified|3|||
42189196|NCT02903914|75999430|FG002|Overall Study|Reasoning not specified|20|||
42095334|NCT01366092|75905480|FG000|Overall Study|Withdrawal by Subject|1|||
42095335|NCT00781859|75905486|FG000|Overall Study|Adverse Event|2|||
42095336|NCT00781859|75905487|FG001|Overall Study|Adverse Event|2|||
42095337|NCT00781859|75905486|FG000|Overall Study|Withdrawal by Subject|8|||
42095338|NCT00781859|75905487|FG001|Overall Study|Withdrawal by Subject|4|||
42095339|NCT00781859|75905486|FG000|Overall Study|Lost to Follow-up|6|||
42095340|NCT00781859|75905487|FG001|Overall Study|Lost to Follow-up|3|||
42095341|NCT00781859|75905486|FG000|Overall Study|Death|3|||
42189197|NCT02903914|75999431|FG003|Overall Study|Reasoning not specified|3|||
42189198|NCT02903914|75999432|FG004|Overall Study|Reasoning not specified|3|||
42189199|NCT02903914|75999433|FG005|Overall Study|Reasoning not specified|3|||
42189200|NCT02903914|75999434|FG006|Overall Study|Reasoning not specified|20|||
42095342|NCT00781859|75905487|FG001|Overall Study|Death|0|||
42095343|NCT00580788|75905497|FG000|Overall Study|Adverse Event|0|||
42095344|NCT00580788|75905498|FG001|Overall Study|Adverse Event|0|||
42095345|NCT00580788|75905499|FG002|Overall Study|Adverse Event|0|||
42095346|NCT00580788|75905500|FG003|Overall Study|Adverse Event|1|||
42095347|NCT00417079|75905519|FG000|Overall Study|Disease progression|267|||
42095348|NCT00417079|75905520|FG001|Overall Study|Disease progression|180|||
42095349|NCT00417079|75905519|FG000|Overall Study|Adverse Event|32|||
42095350|NCT00417079|75905520|FG001|Overall Study|Adverse Event|67|||
42095351|NCT00417079|75905519|FG000|Overall Study|Non-compliance to protocol|0|||
42095352|NCT00417079|75905520|FG001|Overall Study|Non-compliance to protocol|1|||
42095353|NCT00417079|75905519|FG000|Overall Study|Lost to Follow-up|2|||
42095354|NCT00417079|75905520|FG001|Overall Study|Lost to Follow-up|0|||
42189201|NCT02903914|75999435|FG007|Overall Study|Reasoning not specified|0|||
42189202|NCT02969044|75999457|FG000|Overall Study|Withdrawal by Subject|2|||
42189203|NCT02969044|75999458|FG001|Overall Study|Withdrawal by Subject|6|||
42095355|NCT00417079|75905519|FG000|Overall Study|Withdrawal by Subject|17|||
42095356|NCT00417079|75905520|FG001|Overall Study|Withdrawal by Subject|8|||
42095357|NCT00417079|75905519|FG000|Overall Study|Not treated|6|||
42095358|NCT00417079|75905520|FG001|Overall Study|Not treated|7|||
42095359|NCT00417079|75905519|FG000|Overall Study|Screened failure|2|||
42095360|NCT00417079|75905520|FG001|Overall Study|Screened failure|1|||
42095361|NCT00417079|75905519|FG000|Overall Study|Investigator's decision|1|||
42095362|NCT00417079|75905520|FG001|Overall Study|Investigator's decision|4|||
42095363|NCT00417079|75905519|FG000|Overall Study|Non-confirmed Disease progression|1|||
42095364|NCT00417079|75905520|FG001|Overall Study|Non-confirmed Disease progression|1|||
42095365|NCT00417079|75905519|FG000|Overall Study|Clinical deterioration|1|||
42095366|NCT00417079|75905520|FG001|Overall Study|Clinical deterioration|0|||
42189204|NCT02969044|75999457|FG000|Overall Study|Adverse Event|3|||
42095367|NCT00417079|75905519|FG000|Overall Study|Screening error|2|||
42095368|NCT00417079|75905520|FG001|Overall Study|Screening error|1|||
42095369|NCT00417079|75905519|FG000|Overall Study|Withdrawal by subject's family|0|||
42095370|NCT00417079|75905520|FG001|Overall Study|Withdrawal by subject's family|1|||
42095371|NCT00417079|75905519|FG000|Overall Study|Patient unable to come to the clinic|0|||
42095372|NCT00417079|75905520|FG001|Overall Study|Patient unable to come to the clinic|1|||
42095373|NCT00417079|75905519|FG000|Overall Study|abnormal liver function tests|0|||
42095374|NCT00417079|75905520|FG001|Overall Study|abnormal liver function tests|1|||
42189205|NCT02969044|75999458|FG001|Overall Study|Adverse Event|0|||
42296507|NCT02608099|76131240|FG001|Overall Study|Ablation procedure not initiated|2|||
42296508|NCT01668589|76131250|FG000|Overall Study|Lost to Follow-up|29|||
42095375|NCT00429169|75905528|FG000|Overall Study|Lost to Follow-up|0|||
42095376|NCT00429169|75905529|FG001|Overall Study|Lost to Follow-up|1|||
42095377|NCT00429169|75905528|FG000|Overall Study|Ineligibility discovered after entry|2|||
42095378|NCT00429169|75905529|FG001|Overall Study|Ineligibility discovered after entry|1|||
42095379|NCT00416455|75905539|FG000|Overall Study|PET / CT not done|3|||
42095380|NCT00416455|75905540|FG001|Overall Study|PET / CT not done|5|||
42095381|NCT00416455|75905539|FG000|Overall Study|PET / CT poor quality|2|||
42095382|NCT00416455|75905540|FG001|Overall Study|PET / CT poor quality|1|||
42095383|NCT00416455|75905539|FG000|Overall Study|Inadequate pathology|11|||
42095384|NCT00416455|75905540|FG001|Overall Study|Inadequate pathology|2|||
42095385|NCT00415909|75905557|FG000|Overall Study|Withdrawal by Subject|2|||
42189206|NCT02967562|75999466|FG000|Overall Study|Consent not obtained|1|||
42189207|NCT02967562|75999467|FG001|Overall Study|Consent not obtained|0|||
42296509|NCT01668589|76131251|FG001|Overall Study|Lost to Follow-up|37|||
42296510|NCT01668589|76131252|FG002|Overall Study|Lost to Follow-up|15|||
42296511|NCT01668589|76131253|FG003|Overall Study|Lost to Follow-up|5|||
42095386|NCT00415909|75905557|FG000|Overall Study|Death|1|||
42189208|NCT02967562|75999466|FG000|Overall Study|High leak precluding analysis|1|||
42189209|NCT02967562|75999467|FG001|Overall Study|High leak precluding analysis|1|||
42095387|NCT00415597|75905561|FG000|Enrollment|Withdrawal by Subject|1|||
42095388|NCT00415597|75905561|FG000|Enrollment|Protocol Violation|1|||
42189210|NCT02968576|75999473|FG000|Overall Study|Pregnancy|0|||
42189211|NCT02968576|75999474|FG001|Overall Study|Pregnancy|1|||
42095389|NCT00415597|75905561|FG000|Treatment|Adverse Event|110|||
42095390|NCT00415597|75905561|FG000|Treatment|Lack of Efficacy|39|||
42095391|NCT00415597|75905561|FG000|Treatment|Protocol Violation|67|||
42095392|NCT00415597|75905561|FG000|Treatment|Physician Decision|3|||
42095393|NCT00415597|75905561|FG000|Treatment|Withdrawal by Subject|51|||
42095394|NCT00415597|75905561|FG000|Treatment|Lost to Follow-up|28|||
42189212|NCT02966002|75999478|FG000|Overall Study|Withdrawal by Subject|2|||
42189213|NCT02966002|75999478|FG000|Overall Study|Adverse Event|1|||
42189214|NCT02966002|75999478|FG000|Overall Study|Lost to Follow-up|1|||
42189215|NCT02965846|75999485|FG000|Overall Study|Lost to Follow-up|1|||
42189216|NCT02965846|75999486|FG001|Overall Study|Lost to Follow-up|0|||
42189217|NCT02965846|75999487|FG002|Overall Study|Lost to Follow-up|0|||
42189218|NCT02965846|75999485|FG000|Overall Study|Withdrawal by Subject|0|||
42189219|NCT02965846|75999486|FG001|Overall Study|Withdrawal by Subject|1|||
42095395|NCT00415597|75905561|FG000|Treatment|Drug Screen|2|||
42095396|NCT00415597|75905561|FG000|Treatment|Administrative|3|||
42095397|NCT00415597|75905561|FG000|Treatment|Sponsor Decision|1|||
42095398|NCT00415597|75905561|FG000|Treatment|Multiple Reasons|1|||
42095399|NCT00620542|75905567|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
42095400|NCT00620542|75905568|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
42095401|NCT00620542|75905569|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
42095402|NCT00620542|75905570|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
42095403|NCT00620542|75905567|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
42095404|NCT00620542|75905568|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
42095405|NCT00620542|75905569|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
42095406|NCT00620542|75905570|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
42189220|NCT02965846|75999487|FG002|Overall Study|Withdrawal by Subject|0|||
42189221|NCT02965846|75999485|FG000|Overall Study|Study Terminated By Sponsor|4|||
42189222|NCT02965846|75999486|FG001|Overall Study|Study Terminated By Sponsor|4|||
42189223|NCT02965846|75999487|FG002|Overall Study|Study Terminated By Sponsor|0|||
42189224|NCT02965846|75999485|FG000|Overall Study|Participants not randomized|0|||
42189225|NCT02965846|75999486|FG001|Overall Study|Participants not randomized|0|||
42189226|NCT02965846|75999487|FG002|Overall Study|Participants not randomized|33|||
42189227|NCT02900170|75999493|FG000|Overall Study|Lost to Follow-up|8|||
42189228|NCT02900092|75999497|FG000|Overall Study|Adverse Event|1|||
42189229|NCT02902120|75999505|FG000|Overall Study|Lack of Efficacy|1|||
42189230|NCT02965456|75999511|FG000|Overall Study|Lost to Follow-up|40|||
42189231|NCT02965456|75999512|FG001|Overall Study|Lost to Follow-up|18|||
42189232|NCT02965456|75999511|FG000|Overall Study|Subject Request|22|||
42189233|NCT02965456|75999512|FG001|Overall Study|Subject Request|13|||
42189234|NCT02965456|75999511|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
42189235|NCT02965456|75999512|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
42189236|NCT02965456|75999511|FG000|Overall Study|Adverse Event|3|||
42189237|NCT02965456|75999512|FG001|Overall Study|Adverse Event|0|||
42189238|NCT02965456|75999511|FG000|Overall Study|Noncompliance with Study Drug|1|||
42189239|NCT02965456|75999512|FG001|Overall Study|Noncompliance with Study Drug|1|||
42189240|NCT02965456|75999511|FG000|Overall Study|Worsening Condition|0|||
42189241|NCT02965456|75999512|FG001|Overall Study|Worsening Condition|2|||
42189242|NCT02965456|75999511|FG000|Overall Study|Lack of Efficacy|1|||
42189243|NCT02965456|75999512|FG001|Overall Study|Lack of Efficacy|0|||
42189244|NCT02965456|75999511|FG000|Overall Study|Physician Decision|0|||
42189245|NCT02965456|75999512|FG001|Overall Study|Physician Decision|1|||
42189246|NCT02965456|75999511|FG000|Overall Study|Pregnancy|1|||
42189247|NCT02965456|75999512|FG001|Overall Study|Pregnancy|0|||
42189248|NCT02965456|75999511|FG000|Overall Study|Protocol Violation|0|||
42189249|NCT02965456|75999512|FG001|Overall Study|Protocol Violation|1|||
42189250|NCT02965456|75999511|FG000|Overall Study|Participant ran out of study drug|0|||
42189251|NCT02965456|75999512|FG001|Overall Study|Participant ran out of study drug|1|||
42189252|NCT02965378|75999520|FG000|Overall Study|Progression|16|||
42189253|NCT02965378|75999521|FG001|Overall Study|Progression|4|||
42189254|NCT02965378|75999520|FG000|Overall Study|Adverse Event|5|||
42189255|NCT02965378|75999521|FG001|Overall Study|Adverse Event|2|||
42189256|NCT02965378|75999520|FG000|Overall Study|Death|2|||
42189257|NCT02965378|75999521|FG001|Overall Study|Death|0|||
42189258|NCT02965378|75999520|FG000|Overall Study|Refusal|2|||
42189259|NCT02965378|75999521|FG001|Overall Study|Refusal|1|||
42189260|NCT02965378|75999520|FG000|Overall Study|Not protocol specified|0|||
42296512|NCT01668589|76131250|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
42296513|NCT01668589|76131251|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
42095407|NCT00620542|75905567|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
42095408|NCT00620542|75905568|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
42095409|NCT00620542|75905569|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
42095410|NCT00620542|75905570|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
42095411|NCT00620542|75905567|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
42095412|NCT00620542|75905568|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
42095413|NCT00620542|75905569|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
42095414|NCT00620542|75905570|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
42095415|NCT00620542|75905567|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
42189261|NCT02965378|75999521|FG001|Overall Study|Not protocol specified|2|||
42296514|NCT01668589|76131252|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
42095416|NCT00620542|75905568|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
42189262|NCT03772041|75999529|FG000|Overall Study|Adverse Event|8|||
42189263|NCT03772041|75999530|FG001|Overall Study|Adverse Event|3|||
42189264|NCT03772041|75999529|FG000|Overall Study|Withdrawal by Subject|0|||
42189265|NCT03772041|75999530|FG001|Overall Study|Withdrawal by Subject|2|||
42189266|NCT03772041|75999529|FG000|Overall Study|Protocol Violation|4|||
42095417|NCT00620542|75905569|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
42095418|NCT00620542|75905570|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
42189267|NCT03772041|75999530|FG001|Overall Study|Protocol Violation|2|||
42095419|NCT00620542|75905567|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
42095420|NCT00620542|75905568|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
42095421|NCT00620542|75905569|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
42095422|NCT00620542|75905570|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
42095423|NCT00620542|75905567|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
42095424|NCT00620542|75905568|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
42095425|NCT00620542|75905569|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
42189268|NCT03772041|75999529|FG000|Overall Study|Physician Decision|2|||
42296515|NCT01668589|76131253|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
42095426|NCT00620542|75905570|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
42095427|NCT00620542|75905567|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
42095428|NCT00620542|75905568|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
42095429|NCT00620542|75905569|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
42095430|NCT00620542|75905570|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
42095431|NCT00620542|75905567|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
42095432|NCT00620542|75905568|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
42095433|NCT00620542|75905569|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
42095434|NCT00620542|75905570|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
42095435|NCT00620542|75905567|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
42095436|NCT00620542|75905568|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
42095437|NCT00620542|75905569|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
42095438|NCT00620542|75905570|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
42095439|NCT00620542|75905567|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
42189269|NCT03772041|75999530|FG001|Overall Study|Physician Decision|3|||
42296516|NCT01668589|76131250|FG000|Overall Study|Death|12|||
42296517|NCT01668589|76131251|FG001|Overall Study|Death|3|||
42296518|NCT01668589|76131252|FG002|Overall Study|Death|2|||
42296519|NCT01668589|76131253|FG003|Overall Study|Death|11|||
42296520|NCT01668589|76131250|FG000|Overall Study|Other|44|||
42296521|NCT01668589|76131251|FG001|Overall Study|Other|10|||
42296522|NCT01668589|76131252|FG002|Overall Study|Other|7|||
42296523|NCT01668589|76131253|FG003|Overall Study|Other|15|||
42296524|NCT02432235|76131275|FG000|Overall Study|Death|1|||
42296525|NCT02432235|76131276|FG001|Overall Study|Death|1|||
42296526|NCT02432235|76131277|FG002|Overall Study|Death|2|||
42296527|NCT02432235|76131278|FG003|Overall Study|Death|2|||
42296528|NCT02432235|76131279|FG004|Overall Study|Death|1|||
42296529|NCT02432235|76131280|FG005|Overall Study|Death|3|||
42296530|NCT02432235|76131281|FG006|Overall Study|Death|11|||
42296531|NCT02432235|76131282|FG007|Overall Study|Death|15|||
42296532|NCT02432235|76131283|FG008|Overall Study|Death|15|||
42296533|NCT02432235|76131284|FG009|Overall Study|Death|3|||
42296534|NCT02432235|76131285|FG010|Overall Study|Death|1|||
42296535|NCT02432235|76131286|FG011|Overall Study|Death|0|||
42296536|NCT02432235|76131275|FG000|Overall Study|Withdrawal by Subject|0|||
42296537|NCT02432235|76131276|FG001|Overall Study|Withdrawal by Subject|1|||
42296538|NCT02432235|76131277|FG002|Overall Study|Withdrawal by Subject|0|||
42296539|NCT02432235|76131278|FG003|Overall Study|Withdrawal by Subject|0|||
42296540|NCT02432235|76131279|FG004|Overall Study|Withdrawal by Subject|0|||
42296541|NCT02432235|76131280|FG005|Overall Study|Withdrawal by Subject|2|||
42296542|NCT02432235|76131281|FG006|Overall Study|Withdrawal by Subject|5|||
42296543|NCT02432235|76131282|FG007|Overall Study|Withdrawal by Subject|3|||
42296544|NCT02432235|76131283|FG008|Overall Study|Withdrawal by Subject|1|||
42296545|NCT02432235|76131284|FG009|Overall Study|Withdrawal by Subject|0|||
42296546|NCT02432235|76131285|FG010|Overall Study|Withdrawal by Subject|0|||
42095440|NCT00620542|75905568|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
42296547|NCT02432235|76131286|FG011|Overall Study|Withdrawal by Subject|0|||
42095441|NCT00620542|75905569|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
42189270|NCT02899156|75999538|FG000|Overall Study|Death|1|||
42296548|NCT02432235|76131275|FG000|Overall Study|Lost to Follow-up|0|||
42296549|NCT02432235|76131276|FG001|Overall Study|Lost to Follow-up|0|||
42296550|NCT02432235|76131277|FG002|Overall Study|Lost to Follow-up|0|||
42095442|NCT00620542|75905570|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
42095443|NCT00620542|75905567|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
42095444|NCT00620542|75905568|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
42296551|NCT02432235|76131278|FG003|Overall Study|Lost to Follow-up|0|||
42296552|NCT02432235|76131279|FG004|Overall Study|Lost to Follow-up|0|||
42296553|NCT02432235|76131280|FG005|Overall Study|Lost to Follow-up|1|||
42296554|NCT02432235|76131281|FG006|Overall Study|Lost to Follow-up|0|||
42296555|NCT02432235|76131282|FG007|Overall Study|Lost to Follow-up|0|||
42296556|NCT02432235|76131283|FG008|Overall Study|Lost to Follow-up|1|||
42189271|NCT02899156|75999539|FG001|Overall Study|Death|0|||
42095445|NCT00620542|75905569|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
42095446|NCT00620542|75905570|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
42095447|NCT00620542|75905567|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
42095448|NCT00620542|75905568|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
42189272|NCT02899156|75999538|FG000|Overall Study|Physician Decision|0|||
42189273|NCT02899156|75999539|FG001|Overall Study|Physician Decision|1|||
42189274|NCT03773133|75999545|FG000|Overall Study|Screen Failure|8|||
42189275|NCT02969356|75999550|FG000|Overall Study|Adverse Event|7|||
42189276|NCT02969356|75999550|FG000|Overall Study|Consent withdrawn|2|||
42189277|NCT02969356|75999550|FG000|Overall Study|Lost to Follow-up|3|||
42189278|NCT02969356|75999550|FG000|Overall Study|Did not need to be reinjected|6|||
42189279|NCT02969356|75999550|FG000|Overall Study|Personal reasons|5|||
42189280|NCT02898454|75999557|FG000|Overall Study|Adverse Event|4|||
42189281|NCT02898454|75999558|FG001|Overall Study|Adverse Event|1|||
42189282|NCT02898454|75999559|FG002|Overall Study|Adverse Event|2|||
42189283|NCT02898454|75999557|FG000|Overall Study|Protocol Violation|1|||
42359151|NCT02018861|76204792|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
42359152|NCT02018861|76204793|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
42359153|NCT02018861|76204784|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
42359154|NCT02018861|76204785|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
42359155|NCT02018861|76204786|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
42359156|NCT02018861|76204787|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
42359157|NCT02018861|76204788|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
42359158|NCT02018861|76204789|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
42359159|NCT02018861|76204790|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
42359160|NCT02018861|76204791|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
42359161|NCT02018861|76204792|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
42359162|NCT02018861|76204793|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
42359163|NCT02018861|76204784|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
42359164|NCT02018861|76204785|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
42359165|NCT02018861|76204786|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
42359166|NCT02018861|76204787|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
42359167|NCT02018861|76204788|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
42359168|NCT02018861|76204789|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
42359169|NCT02018861|76204790|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
42359170|NCT02018861|76204791|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
42359171|NCT02018861|76204792|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
42359172|NCT02018861|76204793|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
42359173|NCT02018861|76204784|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
42359174|NCT02018861|76204785|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
42359175|NCT02018861|76204786|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
42359176|NCT02018861|76204787|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
42359177|NCT02018861|76204788|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
42095449|NCT00620542|75905569|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
42095450|NCT00620542|75905570|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
42095451|NCT00620542|75905567|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
42095452|NCT00620542|75905568|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
42095453|NCT00620542|75905569|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
42095454|NCT00620542|75905570|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
42095455|NCT00620542|75905567|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
42095456|NCT00620542|75905568|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
42095457|NCT00620542|75905569|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
42095458|NCT00620542|75905570|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
42095459|NCT05096208|75905582|FG000|Overall Study|Lost to Follow-up|3|||
42095460|NCT05096208|75905583|FG001|Overall Study|Lost to Follow-up|5|||
42095461|NCT05096208|75905584|FG002|Overall Study|Lost to Follow-up|5|||
42189284|NCT02898454|75999558|FG001|Overall Study|Protocol Violation|0|||
42189285|NCT02898454|75999559|FG002|Overall Study|Protocol Violation|1|||
42189286|NCT02898454|75999557|FG000|Overall Study|Lack of Efficacy|4|||
42189287|NCT02898454|75999558|FG001|Overall Study|Lack of Efficacy|1|||
42189288|NCT02898454|75999559|FG002|Overall Study|Lack of Efficacy|0|||
42189289|NCT02898454|75999557|FG000|Overall Study|Withdrawal by Subject|6|||
42189290|NCT02898454|75999558|FG001|Overall Study|Withdrawal by Subject|3|||
42095462|NCT05096208|75905585|FG003|Overall Study|Lost to Follow-up|2|||
42095463|NCT05096208|75905582|FG000|Overall Study|Withdrawal by Subject|0|||
42189291|NCT02898454|75999559|FG002|Overall Study|Withdrawal by Subject|3|||
42189292|NCT02898454|75999557|FG000|Overall Study|Lost to Follow-up|1|||
42189293|NCT02898454|75999558|FG001|Overall Study|Lost to Follow-up|0|||
42095464|NCT05096208|75905583|FG001|Overall Study|Withdrawal by Subject|1|||
42095465|NCT05096208|75905584|FG002|Overall Study|Withdrawal by Subject|2|||
42095466|NCT05096208|75905585|FG003|Overall Study|Withdrawal by Subject|3|||
42095467|NCT05096208|75905582|FG000|Overall Study|No longer met eligibility criteria|1|||
42095468|NCT05096208|75905583|FG001|Overall Study|No longer met eligibility criteria|0|||
42095469|NCT05096208|75905584|FG002|Overall Study|No longer met eligibility criteria|0|||
42095470|NCT05096208|75905585|FG003|Overall Study|No longer met eligibility criteria|0|||
42095471|NCT05096208|75905582|FG000|Overall Study|Other|0|||
42095472|NCT05096208|75905583|FG001|Overall Study|Other|0|||
42095473|NCT05096208|75905584|FG002|Overall Study|Other|1|||
42095474|NCT05096208|75905585|FG003|Overall Study|Other|0|||
42189294|NCT02898454|75999559|FG002|Overall Study|Lost to Follow-up|0|||
42189295|NCT02898454|75999557|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
42189296|NCT02898454|75999558|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
42189297|NCT02898454|75999559|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
42189298|NCT03772587|75999577|FG000|Overall Study|COVID-19|0|||
42189299|NCT03772587|75999578|FG001|Overall Study|COVID-19|0|||
42189300|NCT03772587|75999579|FG002|Overall Study|COVID-19|1|||
42189301|NCT03772587|75999580|FG003|Overall Study|COVID-19|1|||
42189302|NCT03772587|75999581|FG004|Overall Study|COVID-19|0|||
42189303|NCT03772587|75999577|FG000|Overall Study|Withdrawal by Subject|1|||
42189304|NCT03772587|75999578|FG001|Overall Study|Withdrawal by Subject|0|||
42189305|NCT03772587|75999579|FG002|Overall Study|Withdrawal by Subject|0|||
42189306|NCT03772587|75999580|FG003|Overall Study|Withdrawal by Subject|0|||
42189307|NCT03772587|75999581|FG004|Overall Study|Withdrawal by Subject|0|||
42189308|NCT02963506|75999608|FG000|Double-Blind Period|Adverse Event|0|||
42189309|NCT02963506|75999609|FG001|Double-Blind Period|Adverse Event|0|||
42189310|NCT02963506|75999610|FG002|Double-Blind Period|Adverse Event|1|||
42189311|NCT02963506|75999611|FG003|Double-Blind Period|Adverse Event|0|||
42189312|NCT02963506|75999612|FG004|Double-Blind Period|Adverse Event|0|||
42189313|NCT02963506|75999613|FG005|Double-Blind Period|Adverse Event|0|||
42189314|NCT02963506|75999614|FG006|Double-Blind Period|Adverse Event|0|||
42189315|NCT02963506|75999615|FG007|Double-Blind Period|Adverse Event|0|||
42189316|NCT02963506|75999616|FG008|Double-Blind Period|Adverse Event|0|||
42189317|NCT02963506|75999617|FG009|Double-Blind Period|Adverse Event|0|||
42189318|NCT02963506|75999618|FG010|Double-Blind Period|Adverse Event|0|||
42189319|NCT02963506|75999619|FG011|Double-Blind Period|Adverse Event|0|||
42189320|NCT02963506|75999620|FG012|Double-Blind Period|Adverse Event|0|||
42189321|NCT02963506|75999608|FG000|Double-Blind Period|Death|0|||
42189322|NCT02963506|75999609|FG001|Double-Blind Period|Death|0|||
42189323|NCT02963506|75999610|FG002|Double-Blind Period|Death|0|||
42189324|NCT02963506|75999611|FG003|Double-Blind Period|Death|1|||
42189325|NCT02963506|75999612|FG004|Double-Blind Period|Death|0|||
42189326|NCT02963506|75999613|FG005|Double-Blind Period|Death|0|||
42189327|NCT02963506|75999614|FG006|Double-Blind Period|Death|0|||
42189328|NCT02963506|75999615|FG007|Double-Blind Period|Death|0|||
42189329|NCT02963506|75999616|FG008|Double-Blind Period|Death|0|||
42189330|NCT02963506|75999617|FG009|Double-Blind Period|Death|0|||
42189331|NCT02963506|75999618|FG010|Double-Blind Period|Death|0|||
42189332|NCT02963506|75999619|FG011|Double-Blind Period|Death|0|||
42189333|NCT02963506|75999620|FG012|Double-Blind Period|Death|0|||
42189334|NCT02963506|75999608|FG000|Double-Blind Period|Lost to Follow-up|0|||
42189335|NCT02963506|75999609|FG001|Double-Blind Period|Lost to Follow-up|1|||
42189336|NCT02963506|75999610|FG002|Double-Blind Period|Lost to Follow-up|0|||
42189337|NCT02963506|75999611|FG003|Double-Blind Period|Lost to Follow-up|0|||
42189338|NCT02963506|75999612|FG004|Double-Blind Period|Lost to Follow-up|0|||
42189339|NCT02963506|75999613|FG005|Double-Blind Period|Lost to Follow-up|0|||
42189340|NCT02963506|75999614|FG006|Double-Blind Period|Lost to Follow-up|0|||
42189341|NCT02963506|75999615|FG007|Double-Blind Period|Lost to Follow-up|0|||
42189342|NCT02963506|75999616|FG008|Double-Blind Period|Lost to Follow-up|0|||
42189343|NCT02963506|75999617|FG009|Double-Blind Period|Lost to Follow-up|0|||
42189344|NCT02963506|75999618|FG010|Double-Blind Period|Lost to Follow-up|0|||
42189345|NCT02963506|75999619|FG011|Double-Blind Period|Lost to Follow-up|0|||
42296557|NCT02432235|76131284|FG009|Overall Study|Lost to Follow-up|0|||
42296558|NCT02432235|76131285|FG010|Overall Study|Lost to Follow-up|0|||
42095475|NCT04555616|75905604|FG000|Overall Study|Death|1|||
42095476|NCT04555616|75905605|FG001|Overall Study|Death|0|||
42296559|NCT02432235|76131286|FG011|Overall Study|Lost to Follow-up|0|||
42095477|NCT04555616|75905606|FG002|Overall Study|Death|1|||
42095478|NCT04555616|75905604|FG000|Overall Study|Withdrawal by Subject|2|||
42189346|NCT02963506|75999620|FG012|Double-Blind Period|Lost to Follow-up|0|||
42095479|NCT04555616|75905605|FG001|Overall Study|Withdrawal by Subject|1|||
42095480|NCT04555616|75905606|FG002|Overall Study|Withdrawal by Subject|0|||
42189347|NCT02963506|75999608|FG000|Double-Blind Period|Withdrawal by Subject|0|||
42189348|NCT02963506|75999609|FG001|Double-Blind Period|Withdrawal by Subject|0|||
42189349|NCT02963506|75999610|FG002|Double-Blind Period|Withdrawal by Subject|1|||
42189350|NCT02963506|75999611|FG003|Double-Blind Period|Withdrawal by Subject|1|||
42189351|NCT02963506|75999612|FG004|Double-Blind Period|Withdrawal by Subject|0|||
42189352|NCT02963506|75999613|FG005|Double-Blind Period|Withdrawal by Subject|0|||
42189353|NCT02963506|75999614|FG006|Double-Blind Period|Withdrawal by Subject|0|||
42296560|NCT02432235|76131275|FG000|Overall Study|Miscellaneous|0|||
42189354|NCT02963506|75999615|FG007|Double-Blind Period|Withdrawal by Subject|0|||
42189355|NCT02963506|75999616|FG008|Double-Blind Period|Withdrawal by Subject|0|||
42189356|NCT02963506|75999617|FG009|Double-Blind Period|Withdrawal by Subject|0|||
42189357|NCT02963506|75999618|FG010|Double-Blind Period|Withdrawal by Subject|0|||
42189358|NCT02963506|75999619|FG011|Double-Blind Period|Withdrawal by Subject|0|||
42189359|NCT02963506|75999620|FG012|Double-Blind Period|Withdrawal by Subject|0|||
42189360|NCT02963506|75999608|FG000|Double-Blind Period|No compliance|0|||
42189361|NCT02963506|75999609|FG001|Double-Blind Period|No compliance|1|||
42189362|NCT02963506|75999610|FG002|Double-Blind Period|No compliance|0|||
42189363|NCT02963506|75999611|FG003|Double-Blind Period|No compliance|0|||
42189364|NCT02963506|75999612|FG004|Double-Blind Period|No compliance|0|||
42189365|NCT02963506|75999613|FG005|Double-Blind Period|No compliance|0|||
42189366|NCT02963506|75999614|FG006|Double-Blind Period|No compliance|0|||
42189367|NCT02963506|75999615|FG007|Double-Blind Period|No compliance|0|||
42189368|NCT02963506|75999616|FG008|Double-Blind Period|No compliance|0|||
42189369|NCT02963506|75999617|FG009|Double-Blind Period|No compliance|0|||
42189370|NCT02963506|75999618|FG010|Double-Blind Period|No compliance|0|||
42189371|NCT02963506|75999619|FG011|Double-Blind Period|No compliance|0|||
42189372|NCT02963506|75999620|FG012|Double-Blind Period|No compliance|0|||
42189373|NCT02963506|75999608|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189374|NCT02963506|75999609|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
42189375|NCT02963506|75999610|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189376|NCT02963506|75999611|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189377|NCT02963506|75999612|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189378|NCT02963506|75999613|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189379|NCT02963506|75999614|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189380|NCT02963506|75999615|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189381|NCT02963506|75999616|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189382|NCT02963506|75999617|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189383|NCT02963506|75999618|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189384|NCT02963506|75999619|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189385|NCT02963506|75999620|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
42189386|NCT02963506|75999608|FG000|Dose-Blind Period|Adverse Event|0|||
42189387|NCT02963506|75999609|FG001|Dose-Blind Period|Adverse Event|0|||
42189388|NCT02963506|75999610|FG002|Dose-Blind Period|Adverse Event|0|||
42189389|NCT02963506|75999611|FG003|Dose-Blind Period|Adverse Event|0|||
42189390|NCT02963506|75999612|FG004|Dose-Blind Period|Adverse Event|0|||
42189391|NCT02963506|75999613|FG005|Dose-Blind Period|Adverse Event|1|||
42189392|NCT02963506|75999614|FG006|Dose-Blind Period|Adverse Event|3|||
42189393|NCT02963506|75999615|FG007|Dose-Blind Period|Adverse Event|2|||
42189394|NCT02963506|75999616|FG008|Dose-Blind Period|Adverse Event|2|||
42189395|NCT02963506|75999617|FG009|Dose-Blind Period|Adverse Event|2|||
42189396|NCT02963506|75999618|FG010|Dose-Blind Period|Adverse Event|1|||
42189397|NCT02963506|75999619|FG011|Dose-Blind Period|Adverse Event|1|||
42189398|NCT02963506|75999620|FG012|Dose-Blind Period|Adverse Event|6|||
42189399|NCT02963506|75999608|FG000|Dose-Blind Period|Lack of Efficacy|0|||
42296561|NCT02432235|76131276|FG001|Overall Study|Miscellaneous|0|||
42296562|NCT02432235|76131277|FG002|Overall Study|Miscellaneous|0|||
42296563|NCT02432235|76131278|FG003|Overall Study|Miscellaneous|0|||
42095481|NCT04177758|75905630|FG000|Overall Study|Lost to Follow-up|19|||
42095482|NCT04177758|75905631|FG001|Overall Study|Lost to Follow-up|11|||
42095483|NCT04003103|75905640|FG000|Overall Study|Death|1|||
42095484|NCT04003103|75905641|FG001|Overall Study|Death|0|||
42095485|NCT04003103|75905642|FG002|Overall Study|Death|0|||
42095486|NCT04003103|75905640|FG000|Overall Study|Lost to Follow-up|4|||
42095487|NCT04003103|75905641|FG001|Overall Study|Lost to Follow-up|3|||
42095488|NCT04003103|75905642|FG002|Overall Study|Lost to Follow-up|2|||
42095489|NCT04003103|75905640|FG000|Overall Study|Withdrawal by Subject|10|||
42095490|NCT04003103|75905641|FG001|Overall Study|Withdrawal by Subject|1|||
42095491|NCT04003103|75905642|FG002|Overall Study|Withdrawal by Subject|1|||
42095492|NCT04003103|75905640|FG000|Overall Study|Status not recorded|0|||
42095493|NCT04003103|75905641|FG001|Overall Study|Status not recorded|2|||
42095494|NCT04003103|75905642|FG002|Overall Study|Status not recorded|0|||
42095495|NCT03921528|75905691|FG000|Overall Study|Withdrawal by Subject|0|||
42095496|NCT03921528|75905692|FG001|Overall Study|Withdrawal by Subject|1|||
42095497|NCT03921528|75905693|FG002|Overall Study|Withdrawal by Subject|0|||
42095498|NCT03921528|75905694|FG003|Overall Study|Withdrawal by Subject|0|||
42095499|NCT03921528|75905695|FG004|Overall Study|Withdrawal by Subject|0|||
42095500|NCT03832322|75905713|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
42095501|NCT03832322|75905714|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
42095502|NCT03642990|75905730|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
42095503|NCT03642990|75905730|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
42095504|NCT03639311|75905736|FG000|Overall Study|Ongoing at the time of analysis|88|||
42095505|NCT03639311|75905737|FG001|Overall Study|Ongoing at the time of analysis|0|||
42189400|NCT02963506|75999609|FG001|Dose-Blind Period|Lack of Efficacy|0|||
42189401|NCT02963506|75999610|FG002|Dose-Blind Period|Lack of Efficacy|0|||
42189402|NCT02963506|75999611|FG003|Dose-Blind Period|Lack of Efficacy|0|||
42189403|NCT02963506|75999612|FG004|Dose-Blind Period|Lack of Efficacy|0|||
42189404|NCT02963506|75999613|FG005|Dose-Blind Period|Lack of Efficacy|0|||
42189405|NCT02963506|75999614|FG006|Dose-Blind Period|Lack of Efficacy|0|||
42189406|NCT02963506|75999615|FG007|Dose-Blind Period|Lack of Efficacy|1|||
42189407|NCT02963506|75999616|FG008|Dose-Blind Period|Lack of Efficacy|0|||
42189408|NCT02963506|75999617|FG009|Dose-Blind Period|Lack of Efficacy|1|||
42189409|NCT02963506|75999618|FG010|Dose-Blind Period|Lack of Efficacy|0|||
42189410|NCT02963506|75999619|FG011|Dose-Blind Period|Lack of Efficacy|0|||
42189411|NCT02963506|75999620|FG012|Dose-Blind Period|Lack of Efficacy|0|||
42189412|NCT02963506|75999608|FG000|Dose-Blind Period|Lost to Follow-up|0|||
42189413|NCT02963506|75999609|FG001|Dose-Blind Period|Lost to Follow-up|0|||
42189414|NCT02963506|75999610|FG002|Dose-Blind Period|Lost to Follow-up|0|||
42296564|NCT02432235|76131279|FG004|Overall Study|Miscellaneous|1|||
42296565|NCT02432235|76131280|FG005|Overall Study|Miscellaneous|6|||
42296566|NCT02432235|76131281|FG006|Overall Study|Miscellaneous|2|||
42095506|NCT03639311|75905736|FG000|Overall Study|Lost to Follow-up|1|||
42296567|NCT02432235|76131282|FG007|Overall Study|Miscellaneous|2|||
42095507|NCT03639311|75905737|FG001|Overall Study|Lost to Follow-up|0|||
42095508|NCT03639311|75905736|FG000|Overall Study|Adverse Event|1|||
42095509|NCT03639311|75905737|FG001|Overall Study|Adverse Event|0|||
42095510|NCT03633825|75905748|FG000|Enrollment|Did not post on network|5066|||
42095511|NCT03633825|75905749|FG001|Enrollment|Did not post on network|5080|||
42095512|NCT03633825|75905748|FG000|Enrollment|Post not classified as crisis|13967|||
42095513|NCT03633825|75905749|FG001|Enrollment|Post not classified as crisis|13757|||
42095514|NCT03633825|75905748|FG000|Follow up|Lost to Follow-up|478|||
42095515|NCT03633825|75905749|FG001|Follow up|Lost to Follow-up|450|||
42095516|NCT05427539|75905755|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
42095517|NCT05427539|75905756|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
42095518|NCT05427539|75905755|FG000|Period 1|Withdrawal by Subject|1|||
42095519|NCT05427539|75905756|FG001|Period 1|Withdrawal by Subject|0|||
42095520|NCT05144945|75905764|FG000|Overall Study|Withdrawal by Subject|1|||
42095521|NCT05144945|75905765|FG001|Overall Study|Withdrawal by Subject|0|||
42095522|NCT04439318|75905781|FG000|Overall Study|Ineligible|1|||
42095523|NCT04439318|75905781|FG000|Overall Study|Never Started Treatment|3|||
42095524|NCT04439318|75905781|FG000|Overall Study|Adverse Event|10|||
42095525|NCT04439318|75905781|FG000|Overall Study|Death|2|||
42095526|NCT04439318|75905781|FG000|Overall Study|Disease Progression|25|||
42095527|NCT04439318|75905781|FG000|Overall Study|Other Complicating Disease|2|||
42095528|NCT04439318|75905781|FG000|Overall Study|Withdrawal by Subject|4|||
42095529|NCT04439318|75905781|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
42095530|NCT04439318|75905781|FG000|Overall Study|Non-Compliance|1|||
42095531|NCT04439318|75905781|FG000|Overall Study|Still on Treatment|1|||
42095532|NCT03768336|75905813|FG000|Overall Study|Lost to Follow-up|3|||
42095533|NCT03768336|75905814|FG001|Overall Study|Lost to Follow-up|2|||
42095534|NCT03768336|75905813|FG000|Overall Study|Became Ineligible|2|||
42095535|NCT03768336|75905814|FG001|Overall Study|Became Ineligible|0|||
42095536|NCT03768336|75905813|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
42095537|NCT03768336|75905814|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
42095538|NCT03768336|75905813|FG000|Overall Study|Missed final survey (post-treatment|0|||
42095539|NCT03768336|75905814|FG001|Overall Study|Missed final survey (post-treatment|1|||
42095540|NCT03742141|75905821|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
42095541|NCT02968849|75905827|FG000|Overall Study|Death|8|||
42095542|NCT02968849|75905828|FG001|Overall Study|Death|10|||
42095543|NCT02968849|75905827|FG000|Overall Study|Lost to Follow-up|31|||
42095544|NCT02968849|75905828|FG001|Overall Study|Lost to Follow-up|29|||
42095545|NCT02968849|75905827|FG000|Overall Study|Withdrawal by Subject|73|||
42095546|NCT02968849|75905828|FG001|Overall Study|Withdrawal by Subject|64|||
42095547|NCT02968849|75905827|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
42095548|NCT02968849|75905828|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
42095549|NCT02968849|75905827|FG000|Overall Study|Physician Decision|6|||
42095550|NCT02968849|75905828|FG001|Overall Study|Physician Decision|9|||
42095551|NCT02968849|75905827|FG000|Overall Study|Other|16|||
42095552|NCT02968849|75905828|FG001|Overall Study|Other|10|||
42095553|NCT02795104|75905840|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
42095554|NCT02795104|75905841|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
42095555|NCT02795104|75905842|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
42095556|NCT02795104|75905840|FG000|Overall Study|Withdrawal by Subject|0|||
42095557|NCT02795104|75905841|FG001|Overall Study|Withdrawal by Subject|2|||
42189415|NCT02963506|75999611|FG003|Dose-Blind Period|Lost to Follow-up|0|||
42296568|NCT02432235|76131283|FG008|Overall Study|Miscellaneous|4|||
42296569|NCT02432235|76131284|FG009|Overall Study|Miscellaneous|0|||
42296570|NCT02432235|76131285|FG010|Overall Study|Miscellaneous|0|||
42095558|NCT02795104|75905842|FG002|Overall Study|Withdrawal by Subject|0|||
42095559|NCT02795104|75905840|FG000|Overall Study|Lost to Follow-up|0|||
42095560|NCT02795104|75905841|FG001|Overall Study|Lost to Follow-up|0|||
42095561|NCT02795104|75905842|FG002|Overall Study|Lost to Follow-up|1|||
42095562|NCT02675244|75905855|FG000|Overall Study|Death|9|||
42095563|NCT02675244|75905856|FG001|Overall Study|Death|6|||
42095564|NCT02675244|75905855|FG000|Overall Study|Withdrawal by Subject|3|||
42095565|NCT02675244|75905856|FG001|Overall Study|Withdrawal by Subject|6|||
42095566|NCT02675244|75905855|FG000|Overall Study|Lost to Follow-up|1|||
42095567|NCT02675244|75905856|FG001|Overall Study|Lost to Follow-up|1|||
42189416|NCT02963506|75999612|FG004|Dose-Blind Period|Lost to Follow-up|0|||
42189417|NCT02963506|75999613|FG005|Dose-Blind Period|Lost to Follow-up|1|||
42189418|NCT02963506|75999614|FG006|Dose-Blind Period|Lost to Follow-up|0|||
42189419|NCT02963506|75999615|FG007|Dose-Blind Period|Lost to Follow-up|0|||
42189420|NCT02963506|75999616|FG008|Dose-Blind Period|Lost to Follow-up|1|||
42189421|NCT02963506|75999617|FG009|Dose-Blind Period|Lost to Follow-up|0|||
42189422|NCT02963506|75999618|FG010|Dose-Blind Period|Lost to Follow-up|0|||
42189423|NCT02963506|75999619|FG011|Dose-Blind Period|Lost to Follow-up|1|||
42189424|NCT02963506|75999620|FG012|Dose-Blind Period|Lost to Follow-up|0|||
42189425|NCT02963506|75999608|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
42189426|NCT02963506|75999609|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
42189427|NCT02963506|75999610|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
42189428|NCT02963506|75999611|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
42189429|NCT02963506|75999612|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
42189430|NCT02963506|75999613|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
42189431|NCT02963506|75999614|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
42189432|NCT02963506|75999615|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
42189433|NCT02963506|75999616|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
42189434|NCT02963506|75999617|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
42189435|NCT02963506|75999618|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
42189436|NCT02963506|75999619|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
42189437|NCT02963506|75999620|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
42189438|NCT02963506|75999608|FG000|Dose-Blind Period|Sponsor decision|0|||
42189439|NCT02963506|75999609|FG001|Dose-Blind Period|Sponsor decision|0|||
42189440|NCT02963506|75999610|FG002|Dose-Blind Period|Sponsor decision|0|||
42189441|NCT02963506|75999611|FG003|Dose-Blind Period|Sponsor decision|0|||
42189442|NCT02963506|75999612|FG004|Dose-Blind Period|Sponsor decision|0|||
42189443|NCT02963506|75999613|FG005|Dose-Blind Period|Sponsor decision|1|||
42189444|NCT02963506|75999614|FG006|Dose-Blind Period|Sponsor decision|0|||
42189445|NCT02963506|75999615|FG007|Dose-Blind Period|Sponsor decision|0|||
42189446|NCT02963506|75999616|FG008|Dose-Blind Period|Sponsor decision|0|||
42189447|NCT02963506|75999617|FG009|Dose-Blind Period|Sponsor decision|0|||
42189448|NCT02963506|75999618|FG010|Dose-Blind Period|Sponsor decision|0|||
42189449|NCT02963506|75999619|FG011|Dose-Blind Period|Sponsor decision|0|||
42189450|NCT02963506|75999620|FG012|Dose-Blind Period|Sponsor decision|0|||
42189451|NCT02963506|75999608|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189452|NCT02963506|75999609|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189453|NCT02963506|75999610|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189454|NCT02963506|75999611|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189455|NCT02963506|75999612|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189456|NCT02963506|75999613|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189457|NCT02963506|75999614|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189458|NCT02963506|75999615|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189459|NCT02963506|75999616|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189460|NCT02963506|75999617|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189461|NCT02963506|75999618|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189462|NCT02963506|75999619|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
42189463|NCT02963506|75999620|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
42189464|NCT01345162|75999639|FG000|Overall Study|Protocol Violation|2|||
42189465|NCT01345162|75999640|FG001|Overall Study|Protocol Violation|4|||
42189466|NCT01345318|75999646|FG000|Overall Study|Adverse Event|16|||
42189467|NCT01345318|75999646|FG000|Overall Study|Lack of Efficacy|17|||
42189468|NCT01345318|75999646|FG000|Overall Study|Lost to Follow-up|2|||
42095568|NCT02675244|75905855|FG000|Overall Study|Ongoing at 2 Years|190|||
42095569|NCT02675244|75905856|FG001|Overall Study|Ongoing at 2 Years|185|||
42095570|NCT01298323|75905926|FG000|Overall Study|Adverse Event|2|||
42189469|NCT01345318|75999646|FG000|Overall Study|Protocol Violation|1|||
42189470|NCT01345318|75999646|FG000|Overall Study|Withdrawal by Subject|41|||
42189471|NCT01345318|75999646|FG000|Overall Study|Other|3|||
42189472|NCT02961244|75999653|FG000|Overall Study|Protocol Violation|0|||
42189473|NCT02961244|75999654|FG001|Overall Study|Protocol Violation|1|||
42189474|NCT02961244|75999653|FG000|Overall Study|Withdrawal by Subject|1|||
42189475|NCT02961244|75999654|FG001|Overall Study|Withdrawal by Subject|2|||
42189476|NCT02961244|75999653|FG000|Overall Study|Surgery plan change after study approval|0|||
42189477|NCT02961244|75999654|FG001|Overall Study|Surgery plan change after study approval|2|||
42095571|NCT01298323|75905927|FG001|Overall Study|Adverse Event|4|||
42095572|NCT01298323|75905926|FG000|Overall Study|Death|11|||
42095573|NCT01298323|75905927|FG001|Overall Study|Death|16|||
42189478|NCT02961244|75999653|FG000|Overall Study|Lost to Follow-up|0|||
42189479|NCT02961244|75999654|FG001|Overall Study|Lost to Follow-up|2|||
42189480|NCT02961244|75999653|FG000|Overall Study|İnadequate data|0|||
42189481|NCT02961244|75999654|FG001|Overall Study|İnadequate data|2|||
42189482|NCT03771963|75999660|FG000|Overall Study|Lost to Follow-up|22|||
42189483|NCT03771963|75999660|FG000|Overall Study|Withdrawal of Consent|10|||
42189484|NCT02962648|75999664|FG000|Overall Study|Withdrawal by Subject|3|||
42189485|NCT02962648|75999664|FG000|Overall Study|Lost to Follow-up|3|||
42189486|NCT02962648|75999664|FG000|Overall Study|Physician Decision|1|||
42189487|NCT02962648|75999664|FG000|Overall Study|Subject had problems with transportation|2|||
42189488|NCT02962882|75999668|FG000|Overall Study|Adverse Event|2|||
42189489|NCT02962882|75999668|FG000|Overall Study|Withdrawal by Subject|2|||
42189490|NCT02962882|75999668|FG000|Overall Study|Transfer from ICU|32|||
42189491|NCT02961790|75999677|FG000|Overall Study|Canceled|4|||
42189492|NCT02961790|75999678|FG001|Overall Study|Canceled|5|||
42189493|NCT02961790|75999679|FG002|Overall Study|Canceled|1|||
42189494|NCT02961790|75999680|FG003|Overall Study|Canceled|4|||
42189495|NCT02961790|75999677|FG000|Overall Study|without baseline data|4|||
42189496|NCT02961790|75999678|FG001|Overall Study|without baseline data|0|||
42189497|NCT02961790|75999679|FG002|Overall Study|without baseline data|1|||
42095574|NCT01298323|75905926|FG000|Overall Study|Lost to Follow-up|1|||
42095575|NCT01298323|75905927|FG001|Overall Study|Lost to Follow-up|0|||
42095576|NCT01298323|75905926|FG000|Overall Study|Withdrawal by Subject|6|||
42095577|NCT01298323|75905927|FG001|Overall Study|Withdrawal by Subject|3|||
42095578|NCT01298323|75905926|FG000|Overall Study|Protocol Violation|1|||
42095579|NCT01298323|75905927|FG001|Overall Study|Protocol Violation|0|||
42095580|NCT01298323|75905926|FG000|Overall Study|Other|10|||
42189498|NCT02961790|75999680|FG003|Overall Study|without baseline data|0|||
42189499|NCT02961790|75999677|FG000|Overall Study|without post baseline data|7|||
42189500|NCT02961790|75999678|FG001|Overall Study|without post baseline data|6|||
42189501|NCT02961790|75999679|FG002|Overall Study|without post baseline data|4|||
42189502|NCT02961790|75999680|FG003|Overall Study|without post baseline data|1|||
42189503|NCT02960854|75999702|FG000|Overall Study|Not Disclosed|2|||
42189504|NCT02960854|75999703|FG001|Overall Study|Not Disclosed|2|||
42189505|NCT02960854|75999702|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
42189506|NCT02960854|75999703|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
42189507|NCT02960854|75999702|FG000|Overall Study|Subject Withdrew Consent|0|||
42189508|NCT02960854|75999703|FG001|Overall Study|Subject Withdrew Consent|1|||
42189509|NCT02960854|75999702|FG000|Overall Study|Death|4|||
42189510|NCT02960854|75999703|FG001|Overall Study|Death|6|||
42189511|NCT01344538|75999711|FG000|Overall Study|Adverse Event|1|||
42189512|NCT01344538|75999712|FG001|Overall Study|Adverse Event|1|||
42189513|NCT01344538|75999711|FG000|Overall Study|Lost to Follow-up|1|||
42189514|NCT01344538|75999712|FG001|Overall Study|Lost to Follow-up|0|||
42189515|NCT01344460|75999718|FG000|Overall Study|Withdrawal by Subject|1|||
42189516|NCT01344460|75999718|FG000|Overall Study|Lost to Follow-up|2|||
42189517|NCT03764631|75999728|FG000|Overall Study|Personal Reasons|3|||
42189518|NCT03764631|75999729|FG001|Overall Study|Personal Reasons|2|||
42095581|NCT01298323|75905927|FG001|Overall Study|Other|9|||
42189519|NCT03764631|75999728|FG000|Overall Study|Switching Therapy|3|||
42189520|NCT03764631|75999729|FG001|Overall Study|Switching Therapy|3|||
42189521|NCT03764631|75999728|FG000|Overall Study|Adverse Event|0|||
42189522|NCT03764631|75999729|FG001|Overall Study|Adverse Event|1|||
42189523|NCT03764631|75999728|FG000|Overall Study|Lost to Follow-up|33|||
42189524|NCT03764631|75999729|FG001|Overall Study|Lost to Follow-up|41|||
42189525|NCT03764631|75999728|FG000|Overall Study|No data as study site was closed|2|||
42189526|NCT03764631|75999729|FG001|Overall Study|No data as study site was closed|6|||
42296571|NCT02432235|76131286|FG011|Overall Study|Miscellaneous|1|||
42296572|NCT02431533|76131316|FG000|Overall Study|Withdrawal by Subject|1|||
42296573|NCT02431533|76131317|FG001|Overall Study|Withdrawal by Subject|3|||
42296574|NCT02431533|76131316|FG000|Overall Study|Developed Exclusionary criteria|1|||
42296575|NCT02431533|76131317|FG001|Overall Study|Developed Exclusionary criteria|0|||
42095582|NCT01298323|75905926|FG000|Overall Study|Ongoing|55|||
42095583|NCT01298323|75905927|FG001|Overall Study|Ongoing|55|||
42189527|NCT02956486|75999748|FG000|Core Phase|Adverse Event|51|||
42189528|NCT02956486|75999749|FG001|Core Phase|Adverse Event|88|||
42189529|NCT02956486|75999750|FG002|Core Phase|Adverse Event|0|||
42189530|NCT02956486|75999748|FG000|Core Phase|Lost to Follow-up|8|||
42189531|NCT02956486|75999749|FG001|Core Phase|Lost to Follow-up|6|||
42296576|NCT02416791|76131326|FG000|6 Months|Lost to Follow-up|0|||
42296577|NCT02416791|76131327|FG001|6 Months|Lost to Follow-up|0|||
42189532|NCT02956486|75999750|FG002|Core Phase|Lost to Follow-up|0|||
42189533|NCT02956486|75999748|FG000|Core Phase|Inadequate therapeutic effect|4|||
42189534|NCT02956486|75999749|FG001|Core Phase|Inadequate therapeutic effect|5|||
42189535|NCT02956486|75999750|FG002|Core Phase|Inadequate therapeutic effect|0|||
42095584|NCT01298323|75905926|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42095585|NCT01298323|75905927|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
42189536|NCT02956486|75999748|FG000|Core Phase|Withdrawal by Subject|101|||
42296578|NCT02416791|76131328|FG002|6 Months|Lost to Follow-up|1|||
42189537|NCT02956486|75999749|FG001|Core Phase|Withdrawal by Subject|104|||
42189538|NCT02956486|75999750|FG002|Core Phase|Withdrawal by Subject|0|||
42189539|NCT02956486|75999748|FG000|Core Phase|Study terminated by sponsor|888|||
42189540|NCT02956486|75999749|FG001|Core Phase|Study terminated by sponsor|848|||
42189541|NCT02956486|75999750|FG002|Core Phase|Study terminated by sponsor|0|||
42189542|NCT02956486|75999748|FG000|Core Phase|Other|27|||
42189543|NCT02956486|75999749|FG001|Core Phase|Other|18|||
42189544|NCT02956486|75999750|FG002|Core Phase|Other|0|||
42189545|NCT02956486|75999748|FG000|Core Phase|Not treated|0|||
42189546|NCT02956486|75999749|FG001|Core Phase|Not treated|3|||
42189547|NCT02956486|75999750|FG002|Core Phase|Not treated|0|||
42189548|NCT02956486|75999748|FG000|Extension Phase|Adverse Event|0|||
42189549|NCT02956486|75999749|FG001|Extension Phase|Adverse Event|0|||
42189550|NCT02956486|75999750|FG002|Extension Phase|Adverse Event|2|||
42189551|NCT02956486|75999748|FG000|Extension Phase|Study terminated by sponsor|0|||
42189552|NCT02956486|75999749|FG001|Extension Phase|Study terminated by sponsor|0|||
42095586|NCT01268579|75905933|FG000|Overall Study|Adverse Event|1|||
42095587|NCT01268579|75905933|FG000|Overall Study|Withdrawal by Subject|2|||
42095588|NCT01056523|75905937|FG000|Overall Study|Death|1|||
42095589|NCT01056523|75905938|FG001|Overall Study|Death|0|||
42095590|NCT01056523|75905939|FG002|Overall Study|Death|2|||
42095591|NCT01056523|75905940|FG003|Overall Study|Death|3|||
42189553|NCT02956486|75999750|FG002|Extension Phase|Study terminated by sponsor|16|||
42189554|NCT02956486|75999748|FG000|Extension Phase|Not Treated|0|||
42189555|NCT02956486|75999749|FG001|Extension Phase|Not Treated|0|||
42189556|NCT02956486|75999750|FG002|Extension Phase|Not Treated|1|||
42189557|NCT03445533|75999765|FG000|Overall Study|Progressive Disease|48|||
42189558|NCT03445533|75999766|FG001|Overall Study|Progressive Disease|81|||
42189559|NCT03445533|75999765|FG000|Overall Study|Adverse Event|60|||
42189560|NCT03445533|75999766|FG001|Overall Study|Adverse Event|64|||
42095592|NCT01056523|75905941|FG004|Overall Study|Death|0|||
42095593|NCT01056523|75905942|FG005|Overall Study|Death|0|||
42095594|NCT01056523|75905943|FG006|Overall Study|Death|1|||
42095595|NCT00554788|75905964|FG000|Overall Study|Adverse Event|0|||
42095596|NCT00554788|75905965|FG001|Overall Study|Adverse Event|1|||
42095597|NCT00554788|75905966|FG002|Overall Study|Adverse Event|2|||
42095598|NCT00554788|75905964|FG000|Overall Study|Lost to Follow-up|4|||
42095599|NCT00554788|75905965|FG001|Overall Study|Lost to Follow-up|3|||
42095600|NCT00554788|75905966|FG002|Overall Study|Lost to Follow-up|3|||
42095601|NCT00554788|75905964|FG000|Overall Study|Physician Decision|1|||
42095602|NCT00554788|75905965|FG001|Overall Study|Physician Decision|1|||
42095603|NCT00554788|75905966|FG002|Overall Study|Physician Decision|3|||
42189561|NCT03445533|75999765|FG000|Overall Study|Death|9|||
42189562|NCT03445533|75999766|FG001|Overall Study|Death|19|||
42189563|NCT03445533|75999765|FG000|Overall Study|Miscellaneous|0|||
42189564|NCT03445533|75999766|FG001|Overall Study|Miscellaneous|16|||
42095604|NCT00554788|75905964|FG000|Overall Study|Withdrawal by Subject|0|||
42095605|NCT00554788|75905965|FG001|Overall Study|Withdrawal by Subject|0|||
42095606|NCT00554788|75905966|FG002|Overall Study|Withdrawal by Subject|1|||
42095607|NCT00554788|75905964|FG000|Overall Study|Refusal of further protocol therapy|0|||
42095608|NCT00554788|75905965|FG001|Overall Study|Refusal of further protocol therapy|1|||
42095609|NCT00554788|75905966|FG002|Overall Study|Refusal of further protocol therapy|1|||
42095610|NCT00554788|75905964|FG000|Overall Study|Progressive disease|0|||
42095611|NCT00554788|75905965|FG001|Overall Study|Progressive disease|0|||
42095612|NCT00554788|75905966|FG002|Overall Study|Progressive disease|3|||
42095613|NCT00554788|75905964|FG000|Overall Study|Ineligible|2|||
42189565|NCT03445533|75999765|FG000|Overall Study|Withdrawal by Subject|3|||
42189566|NCT03445533|75999766|FG001|Overall Study|Withdrawal by Subject|4|||
42189567|NCT03445533|75999765|FG000|Overall Study|Physician Decision|1|||
42189568|NCT03445533|75999766|FG001|Overall Study|Physician Decision|3|||
42189569|NCT03445533|75999765|FG000|Overall Study|Sponsor Decision|0|||
42189570|NCT03445533|75999766|FG001|Overall Study|Sponsor Decision|1|||
42189571|NCT03445533|75999765|FG000|Overall Study|Lost to Follow-up|0|||
42189572|NCT03445533|75999766|FG001|Overall Study|Lost to Follow-up|1|||
42189573|NCT03445533|75999765|FG000|Overall Study|Never Received any Study Treatment|7|||
42189574|NCT03445533|75999766|FG001|Overall Study|Never Received any Study Treatment|4|||
42189575|NCT01337050|75999775|FG000|Overall Study|Death|0|||
42189576|NCT01337050|75999776|FG001|Overall Study|Death|0|||
42095614|NCT00554788|75905965|FG001|Overall Study|Ineligible|0|||
42095615|NCT00554788|75905966|FG002|Overall Study|Ineligible|1|||
42095616|NCT00410761|75905977|FG000|Overall Study|Adverse Event|29|||
42189577|NCT01337050|75999777|FG002|Overall Study|Death|4|||
42189578|NCT01337050|75999775|FG000|Overall Study|Other|4|||
42189579|NCT01337050|75999776|FG001|Overall Study|Other|6|||
42189580|NCT01337050|75999777|FG002|Overall Study|Other|8|||
42189581|NCT01337050|75999775|FG000|Overall Study|Participants refused further follow-up|0|||
42095617|NCT00410761|75905978|FG001|Overall Study|Adverse Event|3|||
42095618|NCT00410761|75905977|FG000|Overall Study|objective disease progression|71|||
42095619|NCT00410761|75905978|FG001|Overall Study|objective disease progression|55|||
42189582|NCT01337050|75999776|FG001|Overall Study|Participants refused further follow-up|7|||
42095620|NCT00410761|75905977|FG000|Overall Study|Withdrawal by Subject|8|||
42095621|NCT00410761|75905978|FG001|Overall Study|Withdrawal by Subject|4|||
42095622|NCT00410761|75905977|FG000|Overall Study|Other|12|||
42095623|NCT00410761|75905978|FG001|Overall Study|Other|9|||
42095624|NCT00410761|75905977|FG000|Overall Study|Never received randomised treatment|0|||
42095625|NCT00410761|75905978|FG001|Overall Study|Never received randomised treatment|1|||
42095626|NCT00374595|75905984|FG000|Overall Study|Death|23|||
42095627|NCT00374595|75905984|FG000|Overall Study|Withdrawal by Subject|39|||
42095628|NCT00374595|75905984|FG000|Overall Study|Lost to Follow-up|3|||
42095629|NCT00374595|75905984|FG000|Overall Study|too much time commitment|1|||
42189583|NCT01337050|75999777|FG002|Overall Study|Participants refused further follow-up|7|||
42189584|NCT01336972|75999789|FG000|Overall Study|Adverse Event|1|||
42189585|NCT01336972|75999790|FG001|Overall Study|Adverse Event|1|||
42189586|NCT01336972|75999791|FG002|Overall Study|Adverse Event|0|||
42189587|NCT03762681|75999808|FG000|Part 1|Withdrawal by Subject|0|||
42189588|NCT03762681|75999809|FG001|Part 1|Withdrawal by Subject|0|||
42189589|NCT03762681|75999810|FG002|Part 1|Withdrawal by Subject|0|||
42189590|NCT03762681|75999811|FG003|Part 1|Withdrawal by Subject|1|||
42189591|NCT03762681|75999812|FG004|Part 1|Withdrawal by Subject|0|||
42189592|NCT03762681|75999813|FG005|Part 1|Withdrawal by Subject|0|||
42189593|NCT03762681|75999814|FG006|Part 1|Withdrawal by Subject|0|||
42189594|NCT03762681|75999815|FG007|Part 1|Withdrawal by Subject|0|||
42189595|NCT03762681|75999808|FG000|Part 2a|Pandemic Travel Restrictions|0|||
42189596|NCT03762681|75999809|FG001|Part 2a|Pandemic Travel Restrictions|0|||
42189597|NCT03762681|75999810|FG002|Part 2a|Pandemic Travel Restrictions|0|||
42189598|NCT03762681|75999811|FG003|Part 2a|Pandemic Travel Restrictions|0|||
42189599|NCT03762681|75999812|FG004|Part 2a|Pandemic Travel Restrictions|0|||
42296579|NCT02414841|76131338|FG000|Overall Study|Withdrawal by Subject|7|||
42095630|NCT00374595|75905984|FG000|Overall Study|transfer care to other clinical site|1|||
42095631|NCT00374595|75905984|FG000|Overall Study|relocation|3|||
42095632|NCT03465540|75905994|FG000|Overall Study|Withdrawal by Subject|0|||
42095633|NCT03465540|75905995|FG001|Overall Study|Withdrawal by Subject|0|||
42095634|NCT03465540|75905996|FG002|Overall Study|Withdrawal by Subject|1|||
42095635|NCT03465540|75905997|FG003|Overall Study|Withdrawal by Subject|1|||
42095636|NCT03465540|75905998|FG004|Overall Study|Withdrawal by Subject|1|||
42095637|NCT03465540|75905999|FG005|Overall Study|Withdrawal by Subject|0|||
42095638|NCT03465540|75905994|FG000|Overall Study|Lost to Follow-up|0|||
42095639|NCT03465540|75905995|FG001|Overall Study|Lost to Follow-up|1|||
42095640|NCT03465540|75905996|FG002|Overall Study|Lost to Follow-up|0|||
42095641|NCT03465540|75905997|FG003|Overall Study|Lost to Follow-up|0|||
42095642|NCT03465540|75905998|FG004|Overall Study|Lost to Follow-up|1|||
42095643|NCT03465540|75905999|FG005|Overall Study|Lost to Follow-up|0|||
42095644|NCT03465540|75905994|FG000|Overall Study|Death|1|||
42095645|NCT03465540|75905995|FG001|Overall Study|Death|1|||
42095646|NCT03465540|75905996|FG002|Overall Study|Death|0|||
42095647|NCT03465540|75905997|FG003|Overall Study|Death|2|||
42095648|NCT03465540|75905998|FG004|Overall Study|Death|0|||
42095649|NCT03465540|75905999|FG005|Overall Study|Death|2|||
42095650|NCT03465540|75905994|FG000|Overall Study|Protocol specified criteria|0|||
42095651|NCT03465540|75905995|FG001|Overall Study|Protocol specified criteria|2|||
42095652|NCT03465540|75905996|FG002|Overall Study|Protocol specified criteria|2|||
42095653|NCT03465540|75905997|FG003|Overall Study|Protocol specified criteria|0|||
42095654|NCT03465540|75905998|FG004|Overall Study|Protocol specified criteria|2|||
42095655|NCT03465540|75905999|FG005|Overall Study|Protocol specified criteria|0|||
42095656|NCT03055832|75906047|FG000|Week 2|Withdrawal by Subject|1|||
42095657|NCT03055832|75906048|FG001|Week 2|Withdrawal by Subject|0|||
42095658|NCT02768870|75906089|FG000|Overall Study|Death|1|||
42095659|NCT02768870|75906089|FG000|Overall Study|Reoperation|6|||
42095660|NCT02768870|75906089|FG000|Overall Study|Lost to Follow-up|1|||
42189600|NCT03762681|75999813|FG005|Part 2a|Pandemic Travel Restrictions|0|||
42296580|NCT02414841|76131339|FG001|Overall Study|Withdrawal by Subject|5|||
42296581|NCT02414841|76131338|FG000|Overall Study|Lost to Follow-up|13|||
42296582|NCT02414841|76131339|FG001|Overall Study|Lost to Follow-up|6|||
42296583|NCT02414841|76131338|FG000|Overall Study|Death|17|||
42296584|NCT02414841|76131339|FG001|Overall Study|Death|14|||
42296585|NCT02414841|76131338|FG000|Overall Study|Received a Kidney Transplant|13|||
42095661|NCT02768870|75906089|FG000|Overall Study|Exit|4|||
42095662|NCT02750618|75906093|FG000|Overall Study|Withdrawal by Subject|1|||
42095663|NCT02537431|75906097|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
42095664|NCT02526160|75906103|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
42095665|NCT02526160|75906104|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
42095666|NCT02526160|75906103|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
42095667|NCT02526160|75906104|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
42189601|NCT03762681|75999814|FG006|Part 2a|Pandemic Travel Restrictions|0|||
42189602|NCT03762681|75999815|FG007|Part 2a|Pandemic Travel Restrictions|1|||
42296586|NCT02414841|76131339|FG001|Overall Study|Received a Kidney Transplant|4|||
42189603|NCT03764475|75999844|FG000|Overall Study|Adverse Event|11|||
42095668|NCT02526160|75906103|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
42095669|NCT02526160|75906104|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
42095670|NCT02526160|75906103|FG000|Open-Label Treatment Extension Period I|Death|0|||
42095671|NCT02526160|75906104|FG001|Open-Label Treatment Extension Period I|Death|1|||
42095672|NCT02526160|75906103|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
42095673|NCT02526160|75906104|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
42095674|NCT02526160|75906103|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
42095675|NCT02526160|75906104|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
42095676|NCT02526160|75906103|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
42095677|NCT02526160|75906104|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
42095678|NCT02526160|75906103|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
42095679|NCT02526160|75906104|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
42095680|NCT02157610|75906126|FG000|Overall Study|Death|4|||
42189604|NCT03764475|75999845|FG001|Overall Study|Adverse Event|2|||
42189605|NCT03764475|75999844|FG000|Overall Study|Lost to Follow-up|24|||
42189606|NCT03764475|75999845|FG001|Overall Study|Lost to Follow-up|10|||
42095681|NCT02157610|75906127|FG001|Overall Study|Death|4|||
42095682|NCT01511250|75906161|FG000|Overall Study|Withdrawal of Consent|1|||
42095683|NCT01511250|75906162|FG001|Overall Study|Withdrawal of Consent|0|||
42095684|NCT01511250|75906163|FG002|Overall Study|Withdrawal of Consent|0|||
42296587|NCT02414841|76131338|FG000|Overall Study|Randomized But Not Treated|6|||
42296588|NCT02414841|76131339|FG001|Overall Study|Randomized But Not Treated|4|||
42296589|NCT02413593|76131347|FG000|Overall Study|Lost to Follow-up|3|||
42296590|NCT02413593|76131347|FG000|Overall Study|Adverse Event|1|||
42296591|NCT01652703|76131357|FG000|Overall Study|Withdrawal by Subject|0|||
42296592|NCT01652703|76131358|FG001|Overall Study|Withdrawal by Subject|1|||
42296593|NCT01652703|76131359|FG002|Overall Study|Withdrawal by Subject|3|||
42296594|NCT01652703|76131360|FG003|Overall Study|Withdrawal by Subject|1|||
42296595|NCT01652703|76131361|FG004|Overall Study|Withdrawal by Subject|0|||
42296596|NCT01652703|76131362|FG005|Overall Study|Withdrawal by Subject|1|||
42296597|NCT01652703|76131357|FG000|Overall Study|Other|0|||
42296598|NCT01652703|76131358|FG001|Overall Study|Other|0|||
42296599|NCT01652703|76131359|FG002|Overall Study|Other|0|||
42296600|NCT01652703|76131360|FG003|Overall Study|Other|1|||
42296601|NCT01652703|76131361|FG004|Overall Study|Other|1|||
42296602|NCT01652703|76131362|FG005|Overall Study|Other|1|||
42296603|NCT01652469|76131378|FG000|Overall Study|Withdrawal by Subject|1|||
42296604|NCT01652469|76131379|FG001|Overall Study|Withdrawal by Subject|4|||
42296605|NCT01652469|76131378|FG000|Overall Study|Lost to Follow-up|0|||
42296606|NCT01652469|76131379|FG001|Overall Study|Lost to Follow-up|2|||
42296607|NCT02429427|76131387|FG000|Overall Study|Adverse Event|220|||
42296608|NCT02429427|76131388|FG001|Overall Study|Adverse Event|92|||
42296609|NCT02429427|76131387|FG000|Overall Study|Protocol Violation|10|||
42296610|NCT02429427|76131388|FG001|Overall Study|Protocol Violation|6|||
42296611|NCT02429427|76131387|FG000|Overall Study|Lost to Follow-up|15|||
42296612|NCT02429427|76131388|FG001|Overall Study|Lost to Follow-up|6|||
42296613|NCT02429427|76131387|FG000|Overall Study|Withdrawal by Subject|64|||
42296614|NCT02429427|76131388|FG001|Overall Study|Withdrawal by Subject|34|||
42296615|NCT02429427|76131387|FG000|Overall Study|Other|62|||
42296616|NCT02429427|76131388|FG001|Overall Study|Other|41|||
42296617|NCT02412735|76131397|FG000|Overall Study|Adverse Event|0|||
42296618|NCT02412735|76131398|FG001|Overall Study|Adverse Event|1|||
42296619|NCT02412735|76131399|FG002|Overall Study|Adverse Event|2|||
42296620|NCT02412735|76131397|FG000|Overall Study|Withdrawal by Subject|23|||
42296621|NCT02412735|76131398|FG001|Overall Study|Withdrawal by Subject|27|||
42296622|NCT02412735|76131399|FG002|Overall Study|Withdrawal by Subject|22|||
42296623|NCT02412735|76131397|FG000|Overall Study|Investigator Decision|3|||
42296624|NCT02412735|76131398|FG001|Overall Study|Investigator Decision|3|||
42296625|NCT02412735|76131399|FG002|Overall Study|Investigator Decision|2|||
42296626|NCT02412735|76131397|FG000|Overall Study|Lost to Follow-up|17|||
42296627|NCT02412735|76131398|FG001|Overall Study|Lost to Follow-up|11|||
42095685|NCT01511250|75906164|FG003|Overall Study|Withdrawal of Consent|0|||
42296628|NCT02412735|76131399|FG002|Overall Study|Lost to Follow-up|18|||
42296629|NCT02412735|76131397|FG000|Overall Study|Reason not Specified|3|||
42296630|NCT02412735|76131398|FG001|Overall Study|Reason not Specified|2|||
42296631|NCT02412735|76131399|FG002|Overall Study|Reason not Specified|2|||
42296632|NCT02412657|76131410|FG000|Overall Study|Lost to Follow-up|1|||
42296633|NCT02412657|76131411|FG001|Overall Study|Lost to Follow-up|0|||
42296634|NCT02412657|76131412|FG002|Overall Study|Lost to Follow-up|0|||
42296635|NCT02412657|76131410|FG000|Overall Study|Protocol Violation|0|||
42296636|NCT02412657|76131411|FG001|Overall Study|Protocol Violation|2|||
42296637|NCT02412657|76131412|FG002|Overall Study|Protocol Violation|3|||
42296638|NCT02428413|76131422|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
42359178|NCT02018861|76204789|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
42296639|NCT02428413|76131423|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
42296640|NCT02428413|76131422|FG000|Overall Study|Protocol Violation|1|||
42095686|NCT01511250|75906165|FG004|Overall Study|Withdrawal of Consent|0|||
42095687|NCT01511250|75906166|FG005|Overall Study|Withdrawal of Consent|0|||
42095688|NCT01511250|75906167|FG006|Overall Study|Withdrawal of Consent|0|||
42095689|NCT01511250|75906168|FG007|Overall Study|Withdrawal of Consent|1|||
42095690|NCT01511250|75906169|FG008|Overall Study|Withdrawal of Consent|1|||
42095691|NCT01511250|75906170|FG009|Overall Study|Withdrawal of Consent|0|||
42095692|NCT01511250|75906161|FG000|Overall Study|Sponsor/Investigator Decision|1|||
42095693|NCT01511250|75906162|FG001|Overall Study|Sponsor/Investigator Decision|0|||
42095694|NCT01511250|75906163|FG002|Overall Study|Sponsor/Investigator Decision|0|||
42095695|NCT01511250|75906164|FG003|Overall Study|Sponsor/Investigator Decision|0|||
42095696|NCT01511250|75906165|FG004|Overall Study|Sponsor/Investigator Decision|0|||
42095697|NCT01511250|75906166|FG005|Overall Study|Sponsor/Investigator Decision|0|||
42095698|NCT01511250|75906167|FG006|Overall Study|Sponsor/Investigator Decision|0|||
42095699|NCT01511250|75906168|FG007|Overall Study|Sponsor/Investigator Decision|0|||
42095700|NCT01511250|75906169|FG008|Overall Study|Sponsor/Investigator Decision|0|||
42095701|NCT01511250|75906170|FG009|Overall Study|Sponsor/Investigator Decision|0|||
42095702|NCT01511250|75906161|FG000|Overall Study|Lost to Follow-up|7|||
42095703|NCT01511250|75906162|FG001|Overall Study|Lost to Follow-up|3|||
42095704|NCT01511250|75906163|FG002|Overall Study|Lost to Follow-up|3|||
42095705|NCT01511250|75906164|FG003|Overall Study|Lost to Follow-up|3|||
42095706|NCT01511250|75906165|FG004|Overall Study|Lost to Follow-up|0|||
42095707|NCT01511250|75906166|FG005|Overall Study|Lost to Follow-up|0|||
42095708|NCT01511250|75906167|FG006|Overall Study|Lost to Follow-up|2|||
42189607|NCT03764475|75999844|FG000|Overall Study|Withdrawal by Subject|26|||
42189608|NCT03764475|75999845|FG001|Overall Study|Withdrawal by Subject|10|||
42189609|NCT03764475|75999844|FG000|Overall Study|Lack of Efficacy|3|||
42189610|NCT03764475|75999845|FG001|Overall Study|Lack of Efficacy|0|||
42189611|NCT03764475|75999844|FG000|Overall Study|COVID-19 Disruption|2|||
42189612|NCT03764475|75999845|FG001|Overall Study|COVID-19 Disruption|0|||
42189613|NCT02872012|75999860|FG000|Overall Study|Withdrawal by Subject|1|||
42189614|NCT02872012|75999861|FG001|Overall Study|Withdrawal by Subject|0|||
42189615|NCT02872012|75999862|FG002|Overall Study|Withdrawal by Subject|0|||
42189616|NCT02872012|75999863|FG003|Overall Study|Withdrawal by Subject|0|||
42189617|NCT02872012|75999864|FG004|Overall Study|Withdrawal by Subject|0|||
42189618|NCT02959138|75999881|FG000|Overall Study|Enrolled but Never Treated|0|||
42189619|NCT02959138|75999882|FG001|Overall Study|Enrolled but Never Treated|1|||
42189620|NCT02959138|75999883|FG002|Overall Study|Enrolled but Never Treated|0|||
42189621|NCT01344226|75999895|FG000|Overall Study|Protocol Violation|2|||
42189622|NCT01344226|75999895|FG000|Overall Study|Withdrawal by Subject|3|||
42189623|NCT01344226|75999895|FG000|Overall Study|Lack of Efficacy|3|||
42189624|NCT02869438|75999901|FG000|Overall Study|Lost to Follow-up|1|||
42095709|NCT01511250|75906168|FG007|Overall Study|Lost to Follow-up|3|||
42095710|NCT01511250|75906169|FG008|Overall Study|Lost to Follow-up|13|||
42095711|NCT01511250|75906170|FG009|Overall Study|Lost to Follow-up|5|||
42095712|NCT01511250|75906161|FG000|Overall Study|Protocol Violation|0|||
42189625|NCT02869438|75999902|FG001|Overall Study|Lost to Follow-up|0|||
42189626|NCT02869438|75999901|FG000|Overall Study|Adverse Event|1|||
42189627|NCT02869438|75999902|FG001|Overall Study|Adverse Event|0|||
42189628|NCT02869438|75999901|FG000|Overall Study|Withdrawal by Subject|1|||
42296641|NCT02428413|76131423|FG001|Overall Study|Protocol Violation|2|||
42296642|NCT02428413|76131422|FG000|Overall Study|Case Cancelled|2|||
42296643|NCT02428413|76131423|FG001|Overall Study|Case Cancelled|0|||
42296644|NCT02428413|76131422|FG000|Overall Study|Missed Cases|1|||
42296645|NCT02428413|76131423|FG001|Overall Study|Missed Cases|2|||
42296646|NCT02428413|76131422|FG000|Overall Study|Nurse Refusal|1|||
42296647|NCT02428413|76131423|FG001|Overall Study|Nurse Refusal|0|||
42296648|NCT02412111|76131431|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
42296649|NCT02412111|76131432|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
42296650|NCT02412111|76131433|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
42296651|NCT02412111|76131431|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
42296652|NCT02412111|76131432|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
42296653|NCT02412111|76131433|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
42296654|NCT02412111|76131431|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
42359179|NCT02018861|76204790|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
42095713|NCT01511250|75906162|FG001|Overall Study|Protocol Violation|2|||
42095714|NCT01511250|75906163|FG002|Overall Study|Protocol Violation|1|||
42095715|NCT01511250|75906164|FG003|Overall Study|Protocol Violation|0|||
42095716|NCT01511250|75906165|FG004|Overall Study|Protocol Violation|0|||
42189629|NCT02869438|75999902|FG001|Overall Study|Withdrawal by Subject|2|||
42189630|NCT02868892|75999908|FG000|Overall Study|Investigator left site and no follow-up|6|||
42189631|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Death|1|||
42189632|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Death|1|||
42189633|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Death|0|||
42095717|NCT01511250|75906166|FG005|Overall Study|Protocol Violation|0|||
42095718|NCT01511250|75906167|FG006|Overall Study|Protocol Violation|0|||
42095719|NCT01511250|75906168|FG007|Overall Study|Protocol Violation|0|||
42095720|NCT01511250|75906169|FG008|Overall Study|Protocol Violation|0|||
42095721|NCT01511250|75906170|FG009|Overall Study|Protocol Violation|0|||
42095722|NCT01424566|75906192|FG000|Single-blind Treatment|Adverse Event|71|||
42095723|NCT01424566|75906193|FG001|Single-blind Treatment|Adverse Event|0|||
42095724|NCT01424566|75906194|FG002|Single-blind Treatment|Adverse Event|0|||
42095725|NCT01424566|75906192|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
42095726|NCT01424566|75906193|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
42095727|NCT01424566|75906194|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
42095728|NCT01424566|75906192|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
42095729|NCT01424566|75906193|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
42095730|NCT01424566|75906194|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
42095731|NCT01424566|75906192|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
42095732|NCT01424566|75906193|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
42095733|NCT01424566|75906194|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
42095734|NCT01424566|75906192|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
42095735|NCT01424566|75906193|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
42095736|NCT01424566|75906194|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
42095737|NCT01424566|75906192|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
42095738|NCT01424566|75906193|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
42095739|NCT01424566|75906194|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
42095740|NCT01424566|75906192|FG000|Double-blind Treatment|Adverse Event|0|||
42095741|NCT01424566|75906193|FG001|Double-blind Treatment|Adverse Event|21|||
42095742|NCT01424566|75906194|FG002|Double-blind Treatment|Adverse Event|13|||
42095743|NCT01424566|75906192|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
42095744|NCT01424566|75906193|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
42095745|NCT01424566|75906194|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
42095746|NCT01424566|75906192|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
42095747|NCT01424566|75906193|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
42095748|NCT01424566|75906194|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
42095749|NCT01424566|75906192|FG000|Double-blind Treatment|Lack of Efficacy|0|||
42095750|NCT01424566|75906193|FG001|Double-blind Treatment|Lack of Efficacy|1|||
42095751|NCT01424566|75906194|FG002|Double-blind Treatment|Lack of Efficacy|1|||
42095752|NCT01361607|75906203|FG000|Overall Study|Adverse Event|38|||
42095753|NCT01361607|75906204|FG001|Overall Study|Adverse Event|29|||
42095754|NCT01361607|75906203|FG000|Overall Study|Withdrawal by Subject|19|||
42095755|NCT01361607|75906204|FG001|Overall Study|Withdrawal by Subject|8|||
42095756|NCT01361607|75906203|FG000|Overall Study|Withdrawal by Investigator|5|||
42095757|NCT01361607|75906204|FG001|Overall Study|Withdrawal by Investigator|3|||
42095758|NCT01361607|75906203|FG000|Overall Study|Lost to Follow-up|1|||
42095759|NCT01361607|75906204|FG001|Overall Study|Lost to Follow-up|0|||
42095760|NCT01361607|75906203|FG000|Overall Study|Met Withdrawal Criteria|1|||
42095761|NCT01361607|75906204|FG001|Overall Study|Met Withdrawal Criteria|1|||
42095762|NCT01337089|75906211|FG000|Overall Study|Adverse Event|237|||
42095763|NCT01337089|75906211|FG000|Overall Study|Withdrawal by Subject|129|||
42095764|NCT01337089|75906211|FG000|Overall Study|Withdrawal by Investigator|33|||
42095765|NCT01337089|75906211|FG000|Overall Study|Met Withdrawal Criteria|3|||
42095766|NCT01337089|75906211|FG000|Overall Study|Lost to Follow-up|2|||
42095767|NCT00114530|75906225|FG000|Overall Study|Death|3|||
42095768|NCT00114530|75906226|FG001|Overall Study|Death|11|||
42095769|NCT00114530|75906225|FG000|Overall Study|Lost to Follow-up|1|||
42095770|NCT00114530|75906226|FG001|Overall Study|Lost to Follow-up|1|||
42095771|NCT00114530|75906225|FG000|Overall Study|Physician Decision|1|||
42095772|NCT00114530|75906226|FG001|Overall Study|Physician Decision|1|||
42095773|NCT00114530|75906225|FG000|Overall Study|Withdrawal by Subject|2|||
42095774|NCT00114530|75906226|FG001|Overall Study|Withdrawal by Subject|6|||
42095775|NCT00114530|75906225|FG000|Overall Study|Breast Cancer|1|||
42095776|NCT00114530|75906226|FG001|Overall Study|Breast Cancer|0|||
42095777|NCT00114530|75906225|FG000|Overall Study|Subject decision after endpoint failure|0|||
42095778|NCT00114530|75906226|FG001|Overall Study|Subject decision after endpoint failure|1|||
42095779|NCT00114530|75906225|FG000|Overall Study|Ineligible|1|||
42095780|NCT00114530|75906226|FG001|Overall Study|Ineligible|0|||
42095781|NCT00618982|75906249|FG000|Overall Study|Adverse Event|23|||
42095782|NCT00618982|75906249|FG000|Overall Study|Withdrawal by Subject|1|||
42095783|NCT00618982|75906249|FG000|Overall Study|Protocol Violation|1|||
42095784|NCT00618982|75906249|FG000|Overall Study|ongoing, still treated with study med.|25|||
42095785|NCT00578786|75906259|FG000|Overall Study|Adverse Event|27|||
42095786|NCT00578786|75906260|FG001|Overall Study|Adverse Event|37|||
42095787|NCT00578786|75906261|FG002|Overall Study|Adverse Event|17|||
42095788|NCT00578786|75906259|FG000|Overall Study|Lack of Efficacy|2|||
42095789|NCT00578786|75906260|FG001|Overall Study|Lack of Efficacy|5|||
42095790|NCT00578786|75906261|FG002|Overall Study|Lack of Efficacy|2|||
42095791|NCT00578786|75906259|FG000|Overall Study|Early Escape from Prior Study|2|||
42095792|NCT00578786|75906260|FG001|Overall Study|Early Escape from Prior Study|1|||
42095793|NCT00578786|75906261|FG002|Overall Study|Early Escape from Prior Study|2|||
42189634|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Death|0|||
42189635|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Death|1|||
42189636|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Death|0|||
42189637|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Death|0|||
42189638|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Death|0|||
42189639|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Death|0|||
42189640|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Death|0|||
42189641|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
42189642|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
42189643|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
42189644|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
42189645|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
42189646|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
42189647|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
42189648|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
42189649|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
42189650|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
42189651|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
42189652|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
42189653|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
42189654|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
42189655|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
42189656|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
42189657|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
42189658|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
42189659|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
42189660|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
42189661|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
42189662|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
42189663|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
42189664|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
42189665|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
42189666|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
42189667|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
42189668|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
42189669|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
42189670|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
42189671|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
42189672|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
42189673|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
42189674|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
42189675|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
42189676|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
42189677|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
42189678|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
42189679|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
42189680|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
42189681|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
42189682|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
42189683|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
42189684|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
42189685|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
42359180|NCT02018861|76204791|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
42095794|NCT00578786|75906259|FG000|Overall Study|Withdrawal by Subject|7|||
42095795|NCT00578786|75906260|FG001|Overall Study|Withdrawal by Subject|8|||
42095796|NCT00578786|75906261|FG002|Overall Study|Withdrawal by Subject|5|||
42095797|NCT00578786|75906259|FG000|Overall Study|Protocol Violation|0|||
42095798|NCT00578786|75906260|FG001|Overall Study|Protocol Violation|3|||
42189686|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
42189687|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
42095799|NCT00578786|75906261|FG002|Overall Study|Protocol Violation|1|||
42095800|NCT00578786|75906259|FG000|Overall Study|Physician Decision|1|||
42095801|NCT00578786|75906260|FG001|Overall Study|Physician Decision|0|||
42095802|NCT00578786|75906261|FG002|Overall Study|Physician Decision|1|||
42095803|NCT00578786|75906259|FG000|Overall Study|Sponsor Decision|0|||
42189688|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
42189689|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
42095804|NCT00578786|75906260|FG001|Overall Study|Sponsor Decision|0|||
42095805|NCT00578786|75906261|FG002|Overall Study|Sponsor Decision|1|||
42095806|NCT00578786|75906259|FG000|Overall Study|Lost to Follow-up|0|||
42095807|NCT00578786|75906260|FG001|Overall Study|Lost to Follow-up|4|||
42095808|NCT00578786|75906261|FG002|Overall Study|Lost to Follow-up|0|||
42095809|NCT00578786|75906259|FG000|Overall Study|Pregnancy|0|||
42095810|NCT00578786|75906260|FG001|Overall Study|Pregnancy|1|||
42095811|NCT00578786|75906261|FG002|Overall Study|Pregnancy|0|||
42095812|NCT00578786|75906259|FG000|Overall Study|Not Otherwise Specified|0|||
42095813|NCT00578786|75906260|FG001|Overall Study|Not Otherwise Specified|4|||
42095814|NCT00578786|75906261|FG002|Overall Study|Not Otherwise Specified|1|||
42095815|NCT00578786|75906259|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
42095816|NCT00578786|75906260|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
42095817|NCT00578786|75906261|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
42189690|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
42189691|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
42189692|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
42189693|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
42189694|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
42189695|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
42189696|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
42189697|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
42189698|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
42189699|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
42189700|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
42189701|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
42189702|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
42189703|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
42189704|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189705|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
42189706|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189707|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189708|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189709|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189710|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189711|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
42189712|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
42189713|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
42189714|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
42189715|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
42189716|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
42189717|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
42189718|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
42189719|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
42189720|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
42189721|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
42189722|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
42189723|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189724|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
42189725|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
42189726|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189727|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189728|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189729|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42296655|NCT02412111|76131432|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
42095818|NCT00424255|75906281|FG000|Overall Study|Death|115|||
42095819|NCT00424255|75906282|FG001|Overall Study|Death|111|||
42095820|NCT00424255|75906281|FG000|Overall Study|Lost to Follow-up|26|||
42095821|NCT00424255|75906282|FG001|Overall Study|Lost to Follow-up|20|||
42095822|NCT00424255|75906281|FG000|Overall Study|Protocol Violation|0|||
42189730|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189731|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189732|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189733|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
42189734|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189735|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
42189736|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
42095823|NCT00424255|75906282|FG001|Overall Study|Protocol Violation|1|||
42095824|NCT00424255|75906281|FG000|Overall Study|Withdrawal by Subject|34|||
42095825|NCT00424255|75906282|FG001|Overall Study|Withdrawal by Subject|38|||
42095826|NCT00424255|75906281|FG000|Overall Study|Physician Decision|3|||
42095827|NCT00424255|75906282|FG001|Overall Study|Physician Decision|7|||
42095828|NCT00424255|75906281|FG000|Overall Study|Cognitive Disturbance|1|||
42095829|NCT00424255|75906282|FG001|Overall Study|Cognitive Disturbance|0|||
42189737|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189738|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
42095830|NCT00424255|75906281|FG000|Overall Study|Non-compliance by Participants|1|||
42095831|NCT00424255|75906282|FG001|Overall Study|Non-compliance by Participants|0|||
42189739|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189740|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189741|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
42189742|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
42189743|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
42189744|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
42189745|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
42189746|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
42189747|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
42189748|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
42189749|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
42189750|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
42189751|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189752|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189753|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189754|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
42189755|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
42189756|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189757|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189758|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189759|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42359181|NCT02018861|76204792|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
42095832|NCT00424255|75906281|FG000|Overall Study|Fatigue|1|||
42095833|NCT00424255|75906282|FG001|Overall Study|Fatigue|0|||
42095834|NCT00424255|75906281|FG000|Overall Study|Disease Progression|0|||
42095835|NCT00424255|75906282|FG001|Overall Study|Disease Progression|2|||
42095836|NCT00424255|75906281|FG000|Overall Study|Sponsor Terminated Study|161|||
42095837|NCT00424255|75906282|FG001|Overall Study|Sponsor Terminated Study|167|||
42095838|NCT00620074|75906288|FG000|Overall Study|Adverse Event|1|||
42095839|NCT00424177|75906292|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
42095840|NCT00424177|75906292|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
42095841|NCT00424177|75906292|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
42095842|NCT00424177|75906292|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
42095843|NCT00424177|75906292|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
42095844|NCT00424177|75906292|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
42095845|NCT00424177|75906292|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
42095846|NCT00424177|75906292|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
42095847|NCT00424177|75906292|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
42095848|NCT00424177|75906292|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
42095849|NCT00618826|75906304|FG000|Overall Study|Adverse Event|1|||
42095850|NCT00578448|75906309|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
42095851|NCT00578448|75906309|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
42095852|NCT00578448|75906309|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
42095853|NCT00578448|75906309|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
42095854|NCT00578318|75906317|FG000|Overall Study|Lost to Follow-up|2|||
42095855|NCT00578318|75906318|FG001|Overall Study|Lost to Follow-up|0|||
42095856|NCT00578318|75906317|FG000|Overall Study|Physician Decision|1|||
42095857|NCT00578318|75906318|FG001|Overall Study|Physician Decision|0|||
42095858|NCT00618748|75906327|FG000|Overall Study|Adverse Event|4|||
42095859|NCT00618748|75906328|FG001|Overall Study|Adverse Event|3|||
42095860|NCT00618748|75906329|FG002|Overall Study|Adverse Event|8|||
42095861|NCT00618748|75906327|FG000|Overall Study|Physician Decision|3|||
42095862|NCT00618748|75906328|FG001|Overall Study|Physician Decision|1|||
42095863|NCT00618748|75906329|FG002|Overall Study|Physician Decision|1|||
42095864|NCT00618748|75906327|FG000|Overall Study|Withdrawal by Subject|4|||
42095865|NCT00618748|75906328|FG001|Overall Study|Withdrawal by Subject|1|||
42095866|NCT00618748|75906329|FG002|Overall Study|Withdrawal by Subject|5|||
42095867|NCT00658359|75906340|FG000|Overall Study|Death|3|||
42095868|NCT00658359|75906341|FG001|Overall Study|Death|1|||
42095869|NCT00658359|75906342|FG002|Overall Study|Death|2|||
42095870|NCT00658359|75906340|FG000|Overall Study|Adverse Event|13|||
42095871|NCT00658359|75906341|FG001|Overall Study|Adverse Event|6|||
42095872|NCT00658359|75906342|FG002|Overall Study|Adverse Event|9|||
42095873|NCT00658359|75906340|FG000|Overall Study|Protocol Violation|1|||
42095874|NCT00658359|75906341|FG001|Overall Study|Protocol Violation|0|||
42095875|NCT00658359|75906342|FG002|Overall Study|Protocol Violation|0|||
42095876|NCT00658359|75906340|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
42095877|NCT00658359|75906341|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
42095878|NCT00658359|75906342|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
42095879|NCT00658359|75906340|FG000|Overall Study|Withdrawal by Subject|7|||
42095880|NCT00658359|75906341|FG001|Overall Study|Withdrawal by Subject|4|||
42095881|NCT00658359|75906342|FG002|Overall Study|Withdrawal by Subject|2|||
42095882|NCT00658359|75906340|FG000|Overall Study|Lost to Follow-up|2|||
42095883|NCT00658359|75906341|FG001|Overall Study|Lost to Follow-up|2|||
42095884|NCT00658359|75906342|FG002|Overall Study|Lost to Follow-up|4|||
42189760|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189761|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
42296656|NCT02412111|76131433|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
42296657|NCT02412111|76131431|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
42095885|NCT00658359|75906340|FG000|Overall Study|Lack of Efficacy|0|||
42296658|NCT02412111|76131432|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
42095886|NCT00658359|75906341|FG001|Overall Study|Lack of Efficacy|1|||
42095887|NCT00658359|75906342|FG002|Overall Study|Lack of Efficacy|0|||
42095888|NCT00619918|75906354|FG000|Overall Study|Withdrawal by Subject|4|||
42095889|NCT00619918|75906355|FG001|Overall Study|Withdrawal by Subject|3|||
42095890|NCT00619918|75906354|FG000|Overall Study|Physician Decision|8|||
42095891|NCT00619918|75906355|FG001|Overall Study|Physician Decision|8|||
42095892|NCT00619918|75906354|FG000|Overall Study|Transfer to outside facility|3|||
42095893|NCT00619918|75906355|FG001|Overall Study|Transfer to outside facility|3|||
42095894|NCT00619918|75906354|FG000|Overall Study|Left before receiving first dose|5|||
42095895|NCT00619918|75906355|FG001|Overall Study|Left before receiving first dose|8|||
42095896|NCT01005914|75906361|FG000|Overall Study|Adverse Event|4|||
42189762|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189763|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
42189764|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
42189765|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
42189766|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189767|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189768|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189769|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189770|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189771|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
42189772|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189773|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189774|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189775|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
42189776|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189777|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189778|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189779|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189780|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
42189781|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189782|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189783|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189784|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189785|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
42189786|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189787|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189788|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189789|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42296659|NCT02412111|76131433|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
42296660|NCT02412111|76131431|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
42296661|NCT02412111|76131432|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
42296662|NCT02412111|76131433|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
42296663|NCT02412111|76131431|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
42095897|NCT01005914|75906361|FG000|Overall Study|Death|4|||
42095898|NCT01005914|75906361|FG000|Overall Study|Lack of Efficacy|1|||
42095899|NCT01005914|75906361|FG000|Overall Study|Withdrawal by Subject|1|||
42095900|NCT00618514|75906372|FG000|Overall Study|Lost to Follow-up|11|||
42296664|NCT02412111|76131432|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
42296665|NCT02412111|76131433|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
42296666|NCT02412111|76131431|FG000|Active Comparator Period (8 Weeks)|Other|0|||
42296667|NCT02412111|76131432|FG001|Active Comparator Period (8 Weeks)|Other|0|||
42296668|NCT02412111|76131433|FG002|Active Comparator Period (8 Weeks)|Other|2|||
42296669|NCT02427477|76131445|FG000|Period 1|Adverse Event|1|||
42296670|NCT02427477|76131446|FG001|Period 1|Adverse Event|0|||
42296671|NCT02427399|76131457|FG000|Overall Study|Protocol Violation|14|||
42296672|NCT02427399|76131458|FG001|Overall Study|Protocol Violation|16|||
42296673|NCT02427399|76131459|FG002|Overall Study|Protocol Violation|12|||
42296674|NCT02427399|76131460|FG003|Overall Study|Protocol Violation|18|||
42296675|NCT02427399|76131461|FG004|Overall Study|Protocol Violation|15|||
42095901|NCT00618514|75906373|FG001|Overall Study|Lost to Follow-up|12|||
42095902|NCT00618514|75906374|FG002|Overall Study|Lost to Follow-up|4|||
42095903|NCT00655629|75906382|FG000|Overall Study|Adverse Event|4|||
42095904|NCT00655629|75906383|FG001|Overall Study|Adverse Event|1|||
42095905|NCT00655629|75906382|FG000|Overall Study|Lack of Efficacy|2|||
42095906|NCT00655629|75906383|FG001|Overall Study|Lack of Efficacy|12|||
42095907|NCT00655629|75906382|FG000|Overall Study|Lost to Follow-up|4|||
42095908|NCT00655629|75906383|FG001|Overall Study|Lost to Follow-up|3|||
42095909|NCT00655629|75906382|FG000|Overall Study|Protocol Violation|5|||
42095910|NCT00655629|75906383|FG001|Overall Study|Protocol Violation|3|||
42095911|NCT00655629|75906382|FG000|Overall Study|consent withdrawn|6|||
42095912|NCT00655629|75906383|FG001|Overall Study|consent withdrawn|4|||
42095913|NCT00578292|75906389|FG000|Overall Study|Death|1|||
42189790|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42095914|NCT00578292|75906389|FG000|Overall Study|Graft failure|2|||
42095915|NCT00570063|75906395|FG000|Overall Study|Adverse Event|4|||
42095916|NCT00570063|75906396|FG001|Overall Study|Adverse Event|1|||
42095917|NCT00570063|75906395|FG000|Overall Study|Lack of Efficacy|0|||
42095918|NCT00570063|75906396|FG001|Overall Study|Lack of Efficacy|1|||
42095919|NCT00570063|75906395|FG000|Overall Study|Withdrawal by Subject|4|||
42095920|NCT00570063|75906396|FG001|Overall Study|Withdrawal by Subject|3|||
42095921|NCT00570063|75906395|FG000|Overall Study|Sponsor's Decision|7|||
42095922|NCT00570063|75906396|FG001|Overall Study|Sponsor's Decision|3|||
42095923|NCT00577772|75906413|FG000|Overall Study|Lost to Follow-up|0|||
42189791|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
42189792|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
42189793|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
42189794|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
42189795|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
42189796|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
42189797|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
42189798|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
42189799|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
42189800|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
42189801|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
42189802|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
42189803|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
42189804|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
42189805|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
42189806|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
42189807|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
42189808|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
42189809|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
42359182|NCT02018861|76204793|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
42359183|NCT02018861|76204784|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
42359184|NCT02018861|76204785|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
42359185|NCT02018861|76204786|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
42095924|NCT00577772|75906414|FG001|Overall Study|Lost to Follow-up|1|||
42189810|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
42189811|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
42189812|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
42189813|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
42189814|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
42189815|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
42189816|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
42189817|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
42189818|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
42189819|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
42189820|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
42189821|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Other|5|||
42095925|NCT00578136|75906422|FG000|Overall Study|Not given intervention|1|||
42189822|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Other|1|||
42189823|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Other|0|||
42189824|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Other|3|||
42189825|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Other|0|||
42189826|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Other|0|||
42189827|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Other|0|||
42189828|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Other|0|||
42189829|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Other|0|||
42189830|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Other|0|||
42189831|NCT03352557|75999917|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
42095926|NCT00578136|75906423|FG001|Overall Study|Not given intervention|1|||
42189832|NCT03352557|75999918|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
42189833|NCT03352557|75999919|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
42189834|NCT03352557|75999920|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
42359186|NCT02018861|76204787|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
42359187|NCT02018861|76204788|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
42095927|NCT00655551|75906432|FG000|All Periods Combined|Adverse Event|0|||
42189835|NCT03352557|75999921|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
42189836|NCT03352557|75999922|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
42189837|NCT03352557|75999923|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
42189838|NCT03352557|75999924|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
42095928|NCT00655551|75906433|FG001|All Periods Combined|Adverse Event|3|||
42095929|NCT00655551|75906434|FG002|All Periods Combined|Adverse Event|4|||
42095930|NCT00655551|75906432|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
42189839|NCT03352557|75999925|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
42189840|NCT03352557|75999926|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
42189841|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|Death|0|||
42189842|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|Death|0|||
42189843|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|Death|0|||
42189844|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|Death|0|||
42095931|NCT00655551|75906433|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
42095932|NCT00655551|75906434|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
42095933|NCT00655551|75906432|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
42095934|NCT00655551|75906433|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
42095935|NCT00655551|75906434|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
42095936|NCT00655551|75906432|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
42095937|NCT00655551|75906433|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
42095938|NCT00655551|75906434|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
42095939|NCT00312728|75906442|FG000|Overall Study|Progressive disease|53|||
42095940|NCT00312728|75906442|FG000|Overall Study|Adverse Event|32|||
42189845|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|Death|0|||
42189846|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|Death|1|||
42189847|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|Death|0|||
42189848|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|Death|1|||
42189849|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|Death|1|||
42189850|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|Death|1|||
42189851|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
42189852|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
42189853|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
42189854|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
42189855|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
42189856|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
42189857|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
42095941|NCT00312728|75906442|FG000|Overall Study|Withdrawal by Subject|10|||
42095942|NCT00312728|75906442|FG000|Overall Study|Required non-protocol cancer treatment|2|||
42095943|NCT00312728|75906442|FG000|Overall Study|Protocol Violation|2|||
42095944|NCT00312728|75906442|FG000|Overall Study|Other|10|||
42095945|NCT00312728|75906442|FG000|Overall Study|Other|1|||
42095946|NCT00577824|75906449|FG000|Overall Study|Adverse Event|6|||
42095947|NCT00577824|75906450|FG001|Overall Study|Adverse Event|18|||
42095948|NCT00577824|75906451|FG002|Overall Study|Adverse Event|1|||
42095949|NCT00577824|75906449|FG000|Overall Study|Patient decision|0|||
42095950|NCT00577824|75906450|FG001|Overall Study|Patient decision|1|||
42095951|NCT00577824|75906451|FG002|Overall Study|Patient decision|1|||
42095952|NCT00577824|75906449|FG000|Overall Study|Protocol Violation|1|||
42095953|NCT00577824|75906450|FG001|Overall Study|Protocol Violation|1|||
42095954|NCT00577824|75906451|FG002|Overall Study|Protocol Violation|0|||
42189858|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
42189859|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
42189860|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
42189861|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
42189862|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
42189863|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
42189864|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
42095955|NCT00617344|75906462|FG000|Overall Study|Serious adverse event|1|||
42189865|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
42189866|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
42189867|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
42189868|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
42189869|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
42189870|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
42189871|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
42189872|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
42095956|NCT00617344|75906463|FG001|Overall Study|Serious adverse event|0|||
42095957|NCT00617344|75906464|FG002|Overall Study|Serious adverse event|0|||
42296676|NCT02426541|76131475|FG000|Overall Study|Protocol Violation|1|||
42296677|NCT02426541|76131476|FG001|Overall Study|Protocol Violation|0|||
42095958|NCT00617344|75906462|FG000|Overall Study|Other Adverse Event|1|||
42095959|NCT00617344|75906463|FG001|Overall Study|Other Adverse Event|1|||
42189873|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
42189874|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
42296678|NCT02484651|76131484|FG000|Overall Study|Patients' data files were corrupted.|1|||
42095960|NCT00617344|75906464|FG002|Overall Study|Other Adverse Event|0|||
42095961|NCT00617344|75906462|FG000|Overall Study|Protocol Violation|10|||
42095962|NCT00617344|75906463|FG001|Overall Study|Protocol Violation|8|||
42095963|NCT00617344|75906464|FG002|Overall Study|Protocol Violation|5|||
42189875|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
42189876|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
42189877|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
42189878|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
42189879|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
42189880|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
42189881|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189882|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189883|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189884|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189885|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189886|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
42189887|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
42189888|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
42189889|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
42189890|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
42189891|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189892|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189893|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189894|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189895|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189896|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
42189897|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189898|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
42189899|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
42189900|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
42189901|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
42189902|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
42189903|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
42189904|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
42189905|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
42189906|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
42359188|NCT02018861|76204789|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
42359189|NCT02018861|76204790|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
42359190|NCT02018861|76204791|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
42359191|NCT02018861|76204792|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
42359192|NCT02018861|76204793|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
42359193|NCT01827384|76204845|FG000|Overall Study|Switched to alternative treatment|0|||
42095964|NCT00617344|75906462|FG000|Overall Study|Lost to Follow-up|5|||
42095965|NCT00617344|75906463|FG001|Overall Study|Lost to Follow-up|4|||
42095966|NCT00617344|75906464|FG002|Overall Study|Lost to Follow-up|1|||
42095967|NCT00617344|75906462|FG000|Overall Study|Withdrawal by Subject|8|||
42095968|NCT00617344|75906463|FG001|Overall Study|Withdrawal by Subject|9|||
42095969|NCT00617344|75906464|FG002|Overall Study|Withdrawal by Subject|2|||
42095970|NCT00654381|75906497|FG000|1st Stage|Adverse Event|3|||
42359194|NCT01827384|76204846|FG001|Overall Study|Switched to alternative treatment|0|||
42359195|NCT01827384|76204847|FG002|Overall Study|Switched to alternative treatment|0|||
42359196|NCT01827384|76204848|FG003|Overall Study|Switched to alternative treatment|0|||
42359197|NCT01827384|76204849|FG004|Overall Study|Switched to alternative treatment|0|||
42359198|NCT01827384|76204850|FG005|Overall Study|Switched to alternative treatment|0|||
42359199|NCT01827384|76204851|FG006|Overall Study|Switched to alternative treatment|0|||
42359200|NCT01827384|76204852|FG007|Overall Study|Switched to alternative treatment|0|||
42359201|NCT01827384|76204853|FG008|Overall Study|Switched to alternative treatment|0|||
42359202|NCT01827384|76204854|FG009|Overall Study|Switched to alternative treatment|0|||
42359203|NCT01827384|76204855|FG010|Overall Study|Switched to alternative treatment|0|||
42095971|NCT00654381|75906498|FG001|1st Stage|Adverse Event|3|||
42095972|NCT00654381|75906499|FG002|1st Stage|Adverse Event|3|||
42095973|NCT00654381|75906500|FG003|1st Stage|Adverse Event|3|||
42095974|NCT00654381|75906501|FG004|1st Stage|Adverse Event|2|||
42095975|NCT00654381|75906502|FG005|1st Stage|Adverse Event|1|||
42095976|NCT00654381|75906497|FG000|1st Stage|Withdrawal by Subject|0|||
42095977|NCT00654381|75906498|FG001|1st Stage|Withdrawal by Subject|0|||
42359204|NCT01827384|76204856|FG011|Overall Study|Switched to alternative treatment|0|||
42359205|NCT01827384|76204857|FG012|Overall Study|Switched to alternative treatment|0|||
42095978|NCT00654381|75906499|FG002|1st Stage|Withdrawal by Subject|0|||
42095979|NCT00654381|75906500|FG003|1st Stage|Withdrawal by Subject|1|||
42095980|NCT00654381|75906501|FG004|1st Stage|Withdrawal by Subject|0|||
42095981|NCT00654381|75906502|FG005|1st Stage|Withdrawal by Subject|1|||
42095982|NCT00654381|75906497|FG000|1st Stage|Investigator's decision|0|||
42095983|NCT00654381|75906498|FG001|1st Stage|Investigator's decision|0|||
42095984|NCT00654381|75906499|FG002|1st Stage|Investigator's decision|0|||
42095985|NCT00654381|75906500|FG003|1st Stage|Investigator's decision|1|||
42095986|NCT00654381|75906501|FG004|1st Stage|Investigator's decision|0|||
42095987|NCT00654381|75906502|FG005|1st Stage|Investigator's decision|0|||
42359206|NCT01827384|76204858|FG013|Overall Study|Switched to alternative treatment|2|||
42359207|NCT01827384|76204845|FG000|Overall Study|Disease progression before treatment|0|||
42296679|NCT02484651|76131485|FG001|Overall Study|Patients' data files were corrupted.|1|||
42296680|NCT02484651|76131484|FG000|Overall Study|BIS monitoring failed.|1|||
42296681|NCT02484651|76131485|FG001|Overall Study|BIS monitoring failed.|1|||
42189907|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
42189908|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
42189909|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
42189910|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
42189911|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189912|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189913|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42296682|NCT02484651|76131484|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
42296683|NCT02484651|76131485|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
42296684|NCT02410551|76131492|FG000|Overall Study|Adverse Event|1|||
42296685|NCT02410551|76131492|FG000|Overall Study|Withdrawal by Subject|1|||
42296686|NCT02410551|76131492|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
42296687|NCT02424591|76131499|FG000|Overall Study|Protocol Violation|2|||
42296688|NCT02424591|76131500|FG001|Overall Study|Protocol Violation|3|||
42296689|NCT02408523|76131508|FG000|Overall Study|Adverse Event|4|||
42296690|NCT02408523|76131509|FG001|Overall Study|Adverse Event|10|||
42296691|NCT02408523|76131508|FG000|Overall Study|Lack of Efficacy|0|||
42296692|NCT02408523|76131509|FG001|Overall Study|Lack of Efficacy|1|||
42296693|NCT02408523|76131508|FG000|Overall Study|Protocol Violation|1|||
42296694|NCT02408523|76131509|FG001|Overall Study|Protocol Violation|2|||
42296695|NCT02408523|76131508|FG000|Overall Study|Lost to Follow-up|2|||
42296696|NCT02408523|76131509|FG001|Overall Study|Lost to Follow-up|3|||
42296697|NCT02408523|76131508|FG000|Overall Study|Withdrawal by Subject|3|||
42296698|NCT02408523|76131509|FG001|Overall Study|Withdrawal by Subject|1|||
42296699|NCT02408523|76131508|FG000|Overall Study|Sponsor request|1|||
42296700|NCT02408523|76131509|FG001|Overall Study|Sponsor request|0|||
42296701|NCT02408523|76131508|FG000|Overall Study|Did not satisfy extension conditions|0|||
42296702|NCT02408523|76131509|FG001|Overall Study|Did not satisfy extension conditions|1|||
42296703|NCT02603419|76131529|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
42296704|NCT02603419|76131530|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
42296705|NCT02603419|76131531|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
42296706|NCT02603419|76131532|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
42296707|NCT02603419|76131533|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
42296708|NCT02603419|76131534|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
42296709|NCT02603419|76131529|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
42296710|NCT02603419|76131530|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
42296711|NCT02603419|76131531|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
42296712|NCT02603419|76131532|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
42296713|NCT02603419|76131533|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
42359208|NCT01827384|76204846|FG001|Overall Study|Disease progression before treatment|0|||
42359209|NCT01827384|76204847|FG002|Overall Study|Disease progression before treatment|0|||
42359210|NCT01827384|76204848|FG003|Overall Study|Disease progression before treatment|0|||
42359211|NCT01827384|76204849|FG004|Overall Study|Disease progression before treatment|0|||
42095988|NCT00654381|75906497|FG000|2nd Stage|Adverse Event|2|||
42095989|NCT00654381|75906498|FG001|2nd Stage|Adverse Event|0|||
42095990|NCT00654381|75906499|FG002|2nd Stage|Adverse Event|2|||
42296714|NCT02603419|76131534|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
42296715|NCT02603419|76131529|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
42296716|NCT02603419|76131530|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
42095991|NCT00654381|75906500|FG003|2nd Stage|Adverse Event|3|||
42296717|NCT02603419|76131531|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
42095992|NCT00654381|75906501|FG004|2nd Stage|Adverse Event|7|||
42095993|NCT00654381|75906502|FG005|2nd Stage|Adverse Event|2|||
42095994|NCT00654381|75906497|FG000|2nd Stage|Withdrawal by Subject|0|||
42095995|NCT00654381|75906498|FG001|2nd Stage|Withdrawal by Subject|0|||
42189914|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189915|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189916|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189917|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189918|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
42189919|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
42189920|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
42189921|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189922|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189923|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189924|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189925|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189926|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189927|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189928|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
42095996|NCT00654381|75906499|FG002|2nd Stage|Withdrawal by Subject|0|||
42095997|NCT00654381|75906500|FG003|2nd Stage|Withdrawal by Subject|0|||
42095998|NCT00654381|75906501|FG004|2nd Stage|Withdrawal by Subject|1|||
42095999|NCT00654381|75906502|FG005|2nd Stage|Withdrawal by Subject|1|||
42096000|NCT00654381|75906497|FG000|2nd Stage|Investigator's decision|0|||
42096001|NCT00654381|75906498|FG001|2nd Stage|Investigator's decision|0|||
42096002|NCT00654381|75906499|FG002|2nd Stage|Investigator's decision|1|||
42096003|NCT00654381|75906500|FG003|2nd Stage|Investigator's decision|1|||
42096004|NCT00654381|75906501|FG004|2nd Stage|Investigator's decision|0|||
42096005|NCT00654381|75906502|FG005|2nd Stage|Investigator's decision|0|||
42096006|NCT00654381|75906497|FG000|Extension Stage|Adverse Event|1|||
42096007|NCT00654381|75906498|FG001|Extension Stage|Adverse Event|2|||
42189929|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189930|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
42189931|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
42189932|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
42189933|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
42189934|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
42189935|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
42189936|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
42189937|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
42189938|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
42189939|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
42189940|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
42189941|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189942|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189943|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189944|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189945|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42096008|NCT00654381|75906499|FG002|Extension Stage|Adverse Event|9|||
42096009|NCT00654381|75906500|FG003|Extension Stage|Adverse Event|7|||
42096010|NCT00654381|75906501|FG004|Extension Stage|Adverse Event|1|||
42096011|NCT00654381|75906502|FG005|Extension Stage|Adverse Event|1|||
42096012|NCT00654381|75906497|FG000|Extension Stage|Protocol Violation|0|||
42096013|NCT00654381|75906498|FG001|Extension Stage|Protocol Violation|0|||
42096014|NCT00654381|75906499|FG002|Extension Stage|Protocol Violation|0|||
42096015|NCT00654381|75906500|FG003|Extension Stage|Protocol Violation|1|||
42096016|NCT00654381|75906501|FG004|Extension Stage|Protocol Violation|0|||
42096017|NCT00654381|75906502|FG005|Extension Stage|Protocol Violation|0|||
42096018|NCT00654381|75906497|FG000|Extension Stage|Lack of Efficacy|0|||
42096019|NCT00654381|75906498|FG001|Extension Stage|Lack of Efficacy|0|||
42096020|NCT00654381|75906499|FG002|Extension Stage|Lack of Efficacy|1|||
42096021|NCT00654381|75906500|FG003|Extension Stage|Lack of Efficacy|0|||
42096022|NCT00654381|75906501|FG004|Extension Stage|Lack of Efficacy|0|||
42096023|NCT00654381|75906502|FG005|Extension Stage|Lack of Efficacy|0|||
42096024|NCT00654381|75906497|FG000|Extension Stage|Withdrawal by Subject|0|||
42096025|NCT00654381|75906498|FG001|Extension Stage|Withdrawal by Subject|0|||
42096026|NCT00654381|75906499|FG002|Extension Stage|Withdrawal by Subject|1|||
42296718|NCT02603419|76131532|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
42296719|NCT02603419|76131533|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
42296720|NCT02603419|76131534|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
42189946|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189947|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189948|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
42189949|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
42189950|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
42189951|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
42189952|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
42296721|NCT02603419|76131529|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
42296722|NCT02603419|76131530|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
42296723|NCT02603419|76131531|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
42296724|NCT02603419|76131532|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
42296725|NCT02603419|76131533|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
42296726|NCT02603419|76131534|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
42296727|NCT02603419|76131529|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
42296728|NCT02603419|76131530|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
42296729|NCT02603419|76131531|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
42296730|NCT02603419|76131532|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
42296731|NCT02603419|76131533|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
42296732|NCT02603419|76131534|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
42096027|NCT00654381|75906500|FG003|Extension Stage|Withdrawal by Subject|1|||
42096028|NCT00654381|75906501|FG004|Extension Stage|Withdrawal by Subject|1|||
42096029|NCT00654381|75906502|FG005|Extension Stage|Withdrawal by Subject|1|||
42096030|NCT00654381|75906497|FG000|Extension Stage|Closure of the trial site|0|||
42096031|NCT00654381|75906498|FG001|Extension Stage|Closure of the trial site|0|||
42096032|NCT00654381|75906499|FG002|Extension Stage|Closure of the trial site|0|||
42096033|NCT00654381|75906500|FG003|Extension Stage|Closure of the trial site|0|||
42096034|NCT00654381|75906501|FG004|Extension Stage|Closure of the trial site|1|||
42096035|NCT00654381|75906502|FG005|Extension Stage|Closure of the trial site|1|||
42096036|NCT00657267|75906532|FG000|Overall Study|Progressive disease|45|||
42096037|NCT00657267|75906532|FG000|Overall Study|Adverse Event|9|||
42096038|NCT00653991|75906540|FG000|3 Month Follow-up|Participant would not respond|150|||
42096039|NCT00653991|75906541|FG001|3 Month Follow-up|Participant would not respond|157|||
42096040|NCT00653991|75906540|FG000|6 Month Follow-up|Participant would not respond|133|||
42096041|NCT00653991|75906541|FG001|6 Month Follow-up|Participant would not respond|141|||
42096042|NCT00652899|75906549|FG000|Overall Study|Death|1|||
42096043|NCT00652899|75906549|FG000|Overall Study|Treating physician decision|1|||
42096044|NCT00617890|75906561|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
42096045|NCT00617890|75906562|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
42096046|NCT00617890|75906563|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
42096047|NCT00617890|75906564|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
42096048|NCT00617890|75906561|FG000|Overall Study|Lack of Efficacy|23|||
42096049|NCT00617890|75906562|FG001|Overall Study|Lack of Efficacy|26|||
42096050|NCT00617890|75906563|FG002|Overall Study|Lack of Efficacy|30|||
42096051|NCT00617890|75906564|FG003|Overall Study|Lack of Efficacy|97|||
42096052|NCT00617890|75906561|FG000|Overall Study|Lost to Follow-up|0|||
42096053|NCT00617890|75906562|FG001|Overall Study|Lost to Follow-up|0|||
42096054|NCT00617890|75906563|FG002|Overall Study|Lost to Follow-up|1|||
42096055|NCT00617890|75906564|FG003|Overall Study|Lost to Follow-up|2|||
42096056|NCT00617890|75906561|FG000|Overall Study|Withdrawal by Subject|4|||
42096057|NCT00617890|75906562|FG001|Overall Study|Withdrawal by Subject|1|||
42096058|NCT00617890|75906563|FG002|Overall Study|Withdrawal by Subject|0|||
42096059|NCT00617890|75906564|FG003|Overall Study|Withdrawal by Subject|2|||
42096060|NCT00617890|75906561|FG000|Overall Study|Protocol Violation|2|||
42096061|NCT00617890|75906562|FG001|Overall Study|Protocol Violation|1|||
42096062|NCT00617890|75906563|FG002|Overall Study|Protocol Violation|0|||
42096063|NCT00617890|75906564|FG003|Overall Study|Protocol Violation|0|||
42096064|NCT00617890|75906561|FG000|Overall Study|Adverse Event|1|||
42096065|NCT00617890|75906562|FG001|Overall Study|Adverse Event|0|||
42096066|NCT00617890|75906563|FG002|Overall Study|Adverse Event|3|||
42096067|NCT00617890|75906564|FG003|Overall Study|Adverse Event|8|||
42096068|NCT00617890|75906561|FG000|Overall Study|Not treated|1|||
42096069|NCT00617890|75906562|FG001|Overall Study|Not treated|0|||
42096070|NCT00617890|75906563|FG002|Overall Study|Not treated|1|||
42189953|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
42189954|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
42189955|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
42189956|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
42189957|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
42189958|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
42189959|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
42189960|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
42189961|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
42189962|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
42189963|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
42189964|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
42189965|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
42189966|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
42096071|NCT00617890|75906564|FG003|Overall Study|Not treated|1|||
42096072|NCT00712166|75906579|FG000|Overall Study|Noncompliance|0|||
42096073|NCT00712166|75906580|FG001|Overall Study|Noncompliance|1|||
42096074|NCT00652743|75906591|FG000|Months 12-18|Lost to Follow-up|1|||
42096075|NCT00652743|75906592|FG001|Months 12-18|Lost to Follow-up|2|||
42096076|NCT00652743|75906593|FG002|Months 12-18|Lost to Follow-up|7|||
42189967|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
42189968|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
42189969|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
42189970|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
42189971|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
42189972|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
42189973|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
42189974|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
42189975|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
42189976|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
42189977|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
42189978|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
42189979|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
42096077|NCT00652743|75906591|FG000|Months 24-30|Other|5|||
42096078|NCT00652743|75906592|FG001|Months 24-30|Other|1|||
42096079|NCT00652743|75906593|FG002|Months 24-30|Other|11|||
42096080|NCT00652743|75906591|FG000|Months 36-42|Serious Adverse Events|0|||
42096081|NCT00652743|75906592|FG001|Months 36-42|Serious Adverse Events|1|||
42096082|NCT00652743|75906593|FG002|Months 36-42|Serious Adverse Events|1|||
42096083|NCT00652743|75906591|FG000|Months 36-42|Withdrawal by Subject|1|||
42096084|NCT00652743|75906592|FG001|Months 36-42|Withdrawal by Subject|1|||
42096085|NCT00652743|75906593|FG002|Months 36-42|Withdrawal by Subject|0|||
42096086|NCT00652743|75906591|FG000|Months 36-42|Lost to Follow-up|0|||
42096087|NCT00652743|75906592|FG001|Months 36-42|Lost to Follow-up|1|||
42096088|NCT00652743|75906593|FG002|Months 36-42|Lost to Follow-up|0|||
42096089|NCT00652743|75906591|FG000|Months 36-42|Migrated/moved from study area|1|||
42096090|NCT00652743|75906592|FG001|Months 36-42|Migrated/moved from study area|0|||
42096091|NCT00652743|75906593|FG002|Months 36-42|Migrated/moved from study area|0|||
42096092|NCT00652743|75906591|FG000|Months 36-42|Other|4|||
42096093|NCT00652743|75906592|FG001|Months 36-42|Other|2|||
42096094|NCT00652743|75906593|FG002|Months 36-42|Other|8|||
42096095|NCT00712010|75906604|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
42189980|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
42018290|NCT00996892|75825872|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
42018291|NCT00996892|75825873|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
42018292|NCT00996892|75825874|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
42018293|NCT00996892|75825875|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
42018294|NCT00996892|75825876|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
42018295|NCT00996892|75825877|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
42018296|NCT00996892|75825878|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
42018297|NCT00996892|75825879|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
42018298|NCT00996892|75825880|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
42018299|NCT00996892|75825861|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018300|NCT00996892|75825862|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018301|NCT00996892|75825863|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018302|NCT00996892|75825864|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018303|NCT00996892|75825865|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018304|NCT00996892|75825866|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018305|NCT00996892|75825867|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018306|NCT00996892|75825868|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42096096|NCT00653523|75906620|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
42096097|NCT00653523|75906620|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
42096098|NCT00653523|75906620|FG000|Overall Study|Adverse Event|7|||
42096099|NCT00653523|75906620|FG000|Overall Study|Withdrawal by Subject|6|||
42096100|NCT00653523|75906620|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
42096101|NCT00653523|75906620|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
42096102|NCT02717442|75906626|FG000|Overall Study|Study Terminated by Sponsor|31|||
42096103|NCT02717442|75906627|FG001|Overall Study|Study Terminated by Sponsor|29|||
42096104|NCT02717442|75906626|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
42096105|NCT02717442|75906627|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
42096106|NCT02717442|75906626|FG000|Overall Study|Other - Not Specified|2|||
42096107|NCT02717442|75906627|FG001|Overall Study|Other - Not Specified|0|||
42096108|NCT05233085|75906652|FG000|Overall Study|Adverse Event|1|||
42096109|NCT05233085|75906653|FG001|Overall Study|Adverse Event|0|||
42096110|NCT05233085|75906654|FG002|Overall Study|Adverse Event|0|||
42096111|NCT05233085|75906655|FG003|Overall Study|Adverse Event|0|||
42096112|NCT04738734|75906673|FG000|Overall Study|Withdrawal by Subject|2|||
42096113|NCT04738734|75906674|FG001|Overall Study|Withdrawal by Subject|4|||
42096114|NCT04738734|75906673|FG000|Overall Study|Lost to Follow-up|5|||
42096115|NCT04738734|75906674|FG001|Overall Study|Lost to Follow-up|2|||
42096116|NCT04738734|75906673|FG000|Overall Study|Physician Decision|0|||
42096117|NCT04738734|75906674|FG001|Overall Study|Physician Decision|1|||
42096118|NCT04738734|75906673|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
42096119|NCT04738734|75906674|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
42096120|NCT04707196|75906682|FG000|Overall Study|Withdrawal by Subject|9|||
42096121|NCT04707196|75906683|FG001|Overall Study|Withdrawal by Subject|6|||
42096122|NCT04707196|75906682|FG000|Overall Study|Lost to Follow-up|1|||
42096123|NCT04707196|75906683|FG001|Overall Study|Lost to Follow-up|0|||
42096124|NCT04707196|75906682|FG000|Overall Study|Protocol Violation|4|||
42096125|NCT04707196|75906683|FG001|Overall Study|Protocol Violation|1|||
42096126|NCT04707196|75906682|FG000|Overall Study|Adverse Event|2|||
42096127|NCT04707196|75906683|FG001|Overall Study|Adverse Event|2|||
42096128|NCT04707196|75906682|FG000|Overall Study|Death|3|||
42096129|NCT04707196|75906683|FG001|Overall Study|Death|1|||
42096130|NCT04707196|75906682|FG000|Overall Study|Non-compliance with study drug|1|||
42096131|NCT04707196|75906683|FG001|Overall Study|Non-compliance with study drug|0|||
42096132|NCT04707196|75906682|FG000|Overall Study|Progressive disease|9|||
42096133|NCT04707196|75906683|FG001|Overall Study|Progressive disease|10|||
42096134|NCT04551963|75906701|FG000|Overall Study|Physician Decision|1|||
42096135|NCT04551963|75906702|FG001|Overall Study|Physician Decision|1|||
42096136|NCT04551963|75906701|FG000|Overall Study|Death|1|||
42096137|NCT04551963|75906702|FG001|Overall Study|Death|0|||
42096138|NCT04416555|75906712|FG000|Overall Study|Withdrawal by Subject|0|||
42096139|NCT04416555|75906713|FG001|Overall Study|Withdrawal by Subject|3|||
42096140|NCT04102007|75906719|FG000|Overall Study|Adverse Event|4|||
42096141|NCT04102007|75906719|FG000|Overall Study|Lost to Follow-up|3|||
42096142|NCT04102007|75906719|FG000|Overall Study|Withdrawal by Subject|12|||
42096143|NCT04102007|75906719|FG000|Overall Study|Eligibility Violation|5|||
42096144|NCT04102007|75906719|FG000|Overall Study|Lack of Efficacy|6|||
42096145|NCT04102007|75906719|FG000|Overall Study|Protocol Deviation|5|||
42096146|NCT04102007|75906719|FG000|Overall Study|Protocol Compliance|1|||
42096147|NCT04102007|75906719|FG000|Overall Study|Withdrew Treatment|2|||
42096148|NCT04102007|75906719|FG000|Overall Study|Pregnancy|1|||
42096149|NCT03898960|75906723|FG000|Overall Study|Death|10|||
42096150|NCT03734237|75906739|FG000|Overall Study|Lost to Follow-up|1|||
42096151|NCT03734237|75906740|FG001|Overall Study|Lost to Follow-up|3|||
42096152|NCT03734237|75906741|FG002|Overall Study|Lost to Follow-up|0|||
42096153|NCT03734237|75906739|FG000|Overall Study|Withdrawal by Subject|7|||
42096154|NCT03734237|75906740|FG001|Overall Study|Withdrawal by Subject|9|||
42096155|NCT03734237|75906741|FG002|Overall Study|Withdrawal by Subject|10|||
42096156|NCT03496623|75906801|FG000|Run-In Period (2 Weeks)|Death|1|||
42096157|NCT03496623|75906802|FG001|Run-In Period (2 Weeks)|Death|0|||
42096158|NCT03496623|75906803|FG002|Run-In Period (2 Weeks)|Death|0|||
42096159|NCT03496623|75906804|FG003|Run-In Period (2 Weeks)|Death|0|||
42189981|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
42189982|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
42189983|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
42189984|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
42189985|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
42189986|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
42096160|NCT03496623|75906805|FG004|Run-In Period (2 Weeks)|Death|0|||
42096161|NCT03496623|75906801|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
42096162|NCT03496623|75906802|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
42096163|NCT03496623|75906803|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
42096164|NCT03496623|75906804|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
42096165|NCT03496623|75906805|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
42096166|NCT03496623|75906801|FG000|Period 1 (12 Weeks)|Death|0|||
42096167|NCT03496623|75906802|FG001|Period 1 (12 Weeks)|Death|3|||
42096168|NCT03496623|75906803|FG002|Period 1 (12 Weeks)|Death|0|||
42096169|NCT03496623|75906804|FG003|Period 1 (12 Weeks)|Death|0|||
42189987|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
42189988|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
42189989|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
42189990|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
42189991|NCT03352557|75999917|FG000|LTE Period: Week 80 to Week 173|Other|0|||
42189992|NCT03352557|75999918|FG001|LTE Period: Week 80 to Week 173|Other|0|||
42189993|NCT03352557|75999919|FG002|LTE Period: Week 80 to Week 173|Other|0|||
42189994|NCT03352557|75999920|FG003|LTE Period: Week 80 to Week 173|Other|0|||
42189995|NCT03352557|75999921|FG004|LTE Period: Week 80 to Week 173|Other|0|||
42189996|NCT03352557|75999922|FG005|LTE Period: Week 80 to Week 173|Other|0|||
42189997|NCT03352557|75999923|FG006|LTE Period: Week 80 to Week 173|Other|0|||
42189998|NCT03352557|75999924|FG007|LTE Period: Week 80 to Week 173|Other|1|||
42189999|NCT03352557|75999925|FG008|LTE Period: Week 80 to Week 173|Other|0|||
42190000|NCT03352557|75999926|FG009|LTE Period: Week 80 to Week 173|Other|0|||
42190001|NCT02866942|75999951|FG000|Overall Study|Invalid consent|1|||
42190002|NCT01336894|76000005|FG000|Follow-up|Study terminated prematurely|2|||
42190003|NCT01336894|76000006|FG001|Follow-up|Study terminated prematurely|7|||
42190004|NCT02572167|76000015|FG000|Overall Study|Withdrawal by Subject|0|||
42190005|NCT02572167|76000016|FG001|Overall Study|Withdrawal by Subject|3|||
42190006|NCT02572167|76000017|FG002|Overall Study|Withdrawal by Subject|0|||
42190007|NCT02572167|76000015|FG000|Overall Study|Lost to Follow-up|2|||
42190008|NCT02572167|76000016|FG001|Overall Study|Lost to Follow-up|5|||
42190009|NCT02572167|76000017|FG002|Overall Study|Lost to Follow-up|3|||
42190010|NCT02572167|76000015|FG000|Overall Study|Death|0|||
42190011|NCT02572167|76000016|FG001|Overall Study|Death|8|||
42190012|NCT02572167|76000017|FG002|Overall Study|Death|3|||
42190013|NCT02572167|76000015|FG000|Overall Study|Did not meet inclusion criteria|0|||
42190014|NCT02572167|76000016|FG001|Overall Study|Did not meet inclusion criteria|0|||
42190015|NCT02572167|76000017|FG002|Overall Study|Did not meet inclusion criteria|1|||
42190016|NCT02572167|76000015|FG000|Overall Study|Study closure by Sponsor|4|||
42190017|NCT02572167|76000016|FG001|Overall Study|Study closure by Sponsor|40|||
42190018|NCT02572167|76000017|FG002|Overall Study|Study closure by Sponsor|24|||
42190019|NCT01336738|76000031|FG000|Overall Study|Adverse Event|0|||
42190020|NCT01336738|76000032|FG001|Overall Study|Adverse Event|3|||
42190021|NCT01336738|76000033|FG002|Overall Study|Adverse Event|2|||
42296733|NCT02603419|76131529|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
42096170|NCT03496623|75906805|FG004|Period 1 (12 Weeks)|Death|0|||
42096171|NCT03496623|75906801|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
42096172|NCT03496623|75906802|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
42096173|NCT03496623|75906803|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
42096174|NCT03496623|75906804|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
42096175|NCT03496623|75906805|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
42096176|NCT03496623|75906801|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
42190022|NCT01336738|76000034|FG003|Overall Study|Adverse Event|1|||
42190023|NCT01336738|76000035|FG004|Overall Study|Adverse Event|3|||
42190024|NCT01336738|76000031|FG000|Overall Study|Lost to Follow-up|2|||
42190025|NCT01336738|76000032|FG001|Overall Study|Lost to Follow-up|1|||
42190026|NCT01336738|76000033|FG002|Overall Study|Lost to Follow-up|2|||
42190027|NCT01336738|76000034|FG003|Overall Study|Lost to Follow-up|2|||
42190028|NCT01336738|76000035|FG004|Overall Study|Lost to Follow-up|2|||
42190029|NCT01336738|76000031|FG000|Overall Study|Did not meet entrance criteria|0|||
42296734|NCT02603419|76131530|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
42096177|NCT03496623|75906802|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
42096178|NCT03496623|75906803|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
42190030|NCT01336738|76000032|FG001|Overall Study|Did not meet entrance criteria|1|||
42190031|NCT01336738|76000033|FG002|Overall Study|Did not meet entrance criteria|0|||
42190032|NCT01336738|76000034|FG003|Overall Study|Did not meet entrance criteria|0|||
42190033|NCT01336738|76000035|FG004|Overall Study|Did not meet entrance criteria|0|||
42190034|NCT01336738|76000031|FG000|Overall Study|Protocol Violation|0|||
42190035|NCT01336738|76000032|FG001|Overall Study|Protocol Violation|1|||
42096179|NCT03496623|75906804|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
42096180|NCT03496623|75906805|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
42096181|NCT03496623|75906801|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
42096182|NCT03496623|75906802|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
42096183|NCT03496623|75906803|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
42096184|NCT03496623|75906804|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
42096185|NCT03496623|75906805|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
42096186|NCT03496623|75906801|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
42096187|NCT03496623|75906802|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
42096188|NCT03496623|75906803|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
42096189|NCT03496623|75906804|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
42096190|NCT03496623|75906805|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
42096191|NCT03496623|75906801|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
42096192|NCT03496623|75906802|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
42096193|NCT03496623|75906803|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
42096194|NCT03496623|75906804|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
42096195|NCT03496623|75906805|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
42096196|NCT03496623|75906801|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42096197|NCT03496623|75906802|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
42096198|NCT03496623|75906803|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
42096199|NCT03496623|75906804|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42096200|NCT03496623|75906805|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
42096201|NCT03224507|75906837|FG000|Overall Study|Death|3|||
42096202|NCT03224507|75906838|FG001|Overall Study|Death|0|||
42096203|NCT03224507|75906837|FG000|Overall Study|Lack of Efficacy|6|||
42096204|NCT03224507|75906838|FG001|Overall Study|Lack of Efficacy|0|||
42296735|NCT02603419|76131531|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
42296736|NCT02603419|76131532|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
42096205|NCT03224507|75906837|FG000|Overall Study|Withdrawal by Subject|6|||
42096206|NCT03224507|75906838|FG001|Overall Study|Withdrawal by Subject|0|||
42096207|NCT02720094|75906880|FG000|Overall Study|Scheduled exit visit/end of study|2|||
42096208|NCT02720094|75906881|FG001|Overall Study|Scheduled exit visit/end of study|1|||
42096209|NCT02720094|75906880|FG000|Overall Study|Death|4|||
42096210|NCT02720094|75906881|FG001|Overall Study|Death|7|||
42096211|NCT02720094|75906880|FG000|Overall Study|Withdrawal by Subject|55|||
42096212|NCT02720094|75906881|FG001|Overall Study|Withdrawal by Subject|56|||
42096213|NCT02720094|75906880|FG000|Overall Study|Lost to Follow-up|2|||
42096214|NCT02720094|75906881|FG001|Overall Study|Lost to Follow-up|7|||
42096215|NCT02720094|75906880|FG000|Overall Study|Physician Decision|1|||
42190036|NCT01336738|76000033|FG002|Overall Study|Protocol Violation|0|||
42190037|NCT01336738|76000034|FG003|Overall Study|Protocol Violation|0|||
42190038|NCT01336738|76000035|FG004|Overall Study|Protocol Violation|0|||
42190039|NCT01336738|76000031|FG000|Overall Study|Withdrawal by Subject|2|||
42190040|NCT01336738|76000032|FG001|Overall Study|Withdrawal by Subject|0|||
42190041|NCT01336738|76000033|FG002|Overall Study|Withdrawal by Subject|2|||
42190042|NCT01336738|76000034|FG003|Overall Study|Withdrawal by Subject|1|||
42190043|NCT01336738|76000035|FG004|Overall Study|Withdrawal by Subject|1|||
42190044|NCT01336738|76000031|FG000|Overall Study|Other|3|||
42190045|NCT01336738|76000032|FG001|Overall Study|Other|3|||
42190046|NCT01336738|76000033|FG002|Overall Study|Other|2|||
42190047|NCT01336738|76000034|FG003|Overall Study|Other|3|||
42190048|NCT01336738|76000035|FG004|Overall Study|Other|4|||
42190049|NCT02865538|76000052|FG000|Overall Study|Withdrawal by Subject|0|||
42190050|NCT02865538|76000053|FG001|Overall Study|Withdrawal by Subject|0|||
42190051|NCT02865538|76000054|FG002|Overall Study|Withdrawal by Subject|1|||
42190052|NCT02865538|76000055|FG003|Overall Study|Withdrawal by Subject|0|||
42190053|NCT02865538|76000056|FG004|Overall Study|Withdrawal by Subject|0|||
42190054|NCT02865538|76000052|FG000|Overall Study|Lost to Follow-up|1|||
42190055|NCT02865538|76000053|FG001|Overall Study|Lost to Follow-up|0|||
42296737|NCT02603419|76131533|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
42296738|NCT02603419|76131534|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
42190056|NCT02865538|76000054|FG002|Overall Study|Lost to Follow-up|0|||
42190057|NCT02865538|76000055|FG003|Overall Study|Lost to Follow-up|0|||
42296739|NCT02603419|76131529|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
42296740|NCT02603419|76131530|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
42296741|NCT02603419|76131531|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
42096216|NCT02720094|75906881|FG001|Overall Study|Physician Decision|3|||
42096217|NCT02720094|75906880|FG000|Overall Study|Inappropriate enrollment|1|||
42096218|NCT02720094|75906881|FG001|Overall Study|Inappropriate enrollment|3|||
42190058|NCT02865538|76000056|FG004|Overall Study|Lost to Follow-up|0|||
42190059|NCT02860546|76000068|FG000|Overall Study|Clinical Progression|6|||
42190060|NCT02860546|76000068|FG000|Overall Study|Radiological Progression|12|||
42190061|NCT01982955|76000077|FG000|Overall Study|Randomized but not treated|0|||
42190062|NCT01982955|76000078|FG001|Overall Study|Randomized but not treated|0|||
42190063|NCT01982955|76000079|FG002|Overall Study|Randomized but not treated|0|||
42190064|NCT01982955|76000080|FG003|Overall Study|Randomized but not treated|1|||
42190065|NCT01982955|76000081|FG004|Overall Study|Randomized but not treated|0|||
42190066|NCT00396279|76000094|FG000|Overall Study|Ongoing in study|26|||
42190067|NCT00396279|76000094|FG000|Overall Study|Disease progression|2|||
42190068|NCT00396279|76000094|FG000|Overall Study|Withdrawal by Subject|1|||
42190069|NCT00396279|76000094|FG000|Overall Study|Physician Decision|1|||
42190070|NCT01347866|76000115|FG000|Overall Study|Death|0|||
42190071|NCT01347866|76000116|FG001|Overall Study|Death|0|||
42190072|NCT01347866|76000117|FG002|Overall Study|Death|0|||
42190073|NCT01347866|76000118|FG003|Overall Study|Death|1|||
42190074|NCT01347866|76000119|FG004|Overall Study|Death|2|||
42190075|NCT01347866|76000120|FG005|Overall Study|Death|2|||
42190076|NCT01347866|76000121|FG006|Overall Study|Death|1|||
42190077|NCT01347866|76000122|FG007|Overall Study|Death|0|||
42190078|NCT01347866|76000123|FG008|Overall Study|Death|4|||
42190079|NCT01347866|76000124|FG009|Overall Study|Death|1|||
42190080|NCT01347866|76000125|FG010|Overall Study|Death|3|||
42190081|NCT01347866|76000126|FG011|Overall Study|Death|1|||
42190082|NCT01347866|76000127|FG012|Overall Study|Death|2|||
42190083|NCT01347866|76000128|FG013|Overall Study|Death|0|||
42190084|NCT01347866|76000129|FG014|Overall Study|Death|0|||
42190085|NCT01347866|76000130|FG015|Overall Study|Death|1|||
42190086|NCT01347866|76000131|FG016|Overall Study|Death|0|||
42190087|NCT01347866|76000115|FG000|Overall Study|Lost to Follow-up|0|||
42190088|NCT01347866|76000116|FG001|Overall Study|Lost to Follow-up|0|||
42190089|NCT01347866|76000117|FG002|Overall Study|Lost to Follow-up|0|||
42190090|NCT01347866|76000118|FG003|Overall Study|Lost to Follow-up|0|||
42190091|NCT01347866|76000119|FG004|Overall Study|Lost to Follow-up|0|||
42190092|NCT01347866|76000120|FG005|Overall Study|Lost to Follow-up|0|||
42190093|NCT01347866|76000121|FG006|Overall Study|Lost to Follow-up|0|||
42190094|NCT01347866|76000122|FG007|Overall Study|Lost to Follow-up|1|||
42190095|NCT01347866|76000123|FG008|Overall Study|Lost to Follow-up|1|||
42190096|NCT01347866|76000124|FG009|Overall Study|Lost to Follow-up|0|||
42190097|NCT01347866|76000125|FG010|Overall Study|Lost to Follow-up|0|||
42190098|NCT01347866|76000126|FG011|Overall Study|Lost to Follow-up|0|||
42190099|NCT01347866|76000127|FG012|Overall Study|Lost to Follow-up|0|||
42190100|NCT01347866|76000128|FG013|Overall Study|Lost to Follow-up|0|||
42190101|NCT01347866|76000129|FG014|Overall Study|Lost to Follow-up|0|||
42096219|NCT02720094|75906880|FG000|Overall Study|Ongoing|2210|||
42096220|NCT02720094|75906881|FG001|Overall Study|Ongoing|2203|||
42096221|NCT02720094|75906880|FG000|Overall Study|Relocation|1|||
42096222|NCT02720094|75906881|FG001|Overall Study|Relocation|1|||
42096223|NCT02646618|75906909|FG000|Overall Study|Lost to Follow-up|10|||
42096224|NCT02646618|75906910|FG001|Overall Study|Lost to Follow-up|14|||
42096225|NCT02362464|75906927|FG000|Overall Study|Switched to alternative therapy|1|||
42096226|NCT02362464|75906927|FG000|Overall Study|Refused further treatment|1|||
42096227|NCT02362464|75906927|FG000|Overall Study|Physician Decision|4|||
42096228|NCT02285114|75906934|FG000|Overall Study|Investigator's Discretion|0|||
42096229|NCT02285114|75906935|FG001|Overall Study|Investigator's Discretion|2|||
42096230|NCT02285114|75906936|FG002|Overall Study|Investigator's Discretion|0|||
42096231|NCT02285114|75906934|FG000|Overall Study|Withdrew Consent|0|||
42096232|NCT02285114|75906935|FG001|Overall Study|Withdrew Consent|0|||
42096233|NCT02285114|75906936|FG002|Overall Study|Withdrew Consent|1|||
42096234|NCT02285114|75906934|FG000|Overall Study|Enrolled but not treated|1|||
42096235|NCT02285114|75906935|FG001|Overall Study|Enrolled but not treated|0|||
42096236|NCT02285114|75906936|FG002|Overall Study|Enrolled but not treated|0|||
42096237|NCT02285114|75906934|FG000|Overall Study|Still on study|21|||
42096238|NCT02285114|75906935|FG001|Overall Study|Still on study|5|||
42190102|NCT01347866|76000130|FG015|Overall Study|Lost to Follow-up|0|||
42190103|NCT01347866|76000131|FG016|Overall Study|Lost to Follow-up|0|||
42190104|NCT01347866|76000115|FG000|Overall Study|Other|3|||
42190105|NCT01347866|76000116|FG001|Overall Study|Other|1|||
42096239|NCT02285114|75906936|FG002|Overall Study|Still on study|2|||
42190106|NCT01347866|76000117|FG002|Overall Study|Other|1|||
42190107|NCT01347866|76000118|FG003|Overall Study|Other|4|||
42190108|NCT01347866|76000119|FG004|Overall Study|Other|5|||
42190109|NCT01347866|76000120|FG005|Overall Study|Other|0|||
42096240|NCT01952366|75906950|FG000|Overall Study|Death|22|||
42096241|NCT01952366|75906950|FG000|Overall Study|Withdrawal by Subject|9|||
42190110|NCT01347866|76000121|FG006|Overall Study|Other|5|||
42190111|NCT01347866|76000122|FG007|Overall Study|Other|3|||
42190112|NCT01347866|76000123|FG008|Overall Study|Other|22|||
42190113|NCT01347866|76000124|FG009|Overall Study|Other|5|||
42190114|NCT01347866|76000125|FG010|Overall Study|Other|0|||
42190115|NCT01347866|76000126|FG011|Overall Study|Other|3|||
42190116|NCT01347866|76000127|FG012|Overall Study|Other|4|||
42190117|NCT01347866|76000128|FG013|Overall Study|Other|4|||
42190118|NCT01347866|76000129|FG014|Overall Study|Other|2|||
42190119|NCT01347866|76000130|FG015|Overall Study|Other|3|||
42096242|NCT01626079|75906960|FG000|Overall Study|Death|167|||
42096243|NCT01626079|75906961|FG001|Overall Study|Death|192|||
42096244|NCT01626079|75906962|FG002|Overall Study|Death|39|||
42096245|NCT01626079|75906960|FG000|Overall Study|Withdrawal by Subject|23|||
42096246|NCT01626079|75906961|FG001|Overall Study|Withdrawal by Subject|37|||
42096247|NCT01626079|75906962|FG002|Overall Study|Withdrawal by Subject|5|||
42096248|NCT01626079|75906960|FG000|Overall Study|Lost to Follow-up|7|||
42096249|NCT01626079|75906961|FG001|Overall Study|Lost to Follow-up|4|||
42096250|NCT01626079|75906962|FG002|Overall Study|Lost to Follow-up|2|||
42096251|NCT01626079|75906960|FG000|Overall Study|Missed Visits|1|||
42096252|NCT01626079|75906961|FG001|Overall Study|Missed Visits|4|||
42096253|NCT01626079|75906962|FG002|Overall Study|Missed Visits|6|||
42096254|NCT01349959|75906973|FG000|Overall Study|Adverse Event|7|||
42096255|NCT01331681|75906980|FG000|Overall Study|Adverse Event|10|||
42096256|NCT01331681|75906981|FG001|Overall Study|Adverse Event|13|||
42096257|NCT01331681|75906982|FG002|Overall Study|Adverse Event|10|||
42096258|NCT01331681|75906980|FG000|Overall Study|Death|6|||
42096259|NCT01331681|75906981|FG001|Overall Study|Death|6|||
42096260|NCT01331681|75906982|FG002|Overall Study|Death|2|||
42096261|NCT01331681|75906980|FG000|Overall Study|Lack of Efficacy|0|||
42190120|NCT01347866|76000131|FG016|Overall Study|Other|0|||
42190121|NCT01347866|76000115|FG000|Overall Study|Subject refused further follow-up|2|||
42190122|NCT01347866|76000116|FG001|Overall Study|Subject refused further follow-up|0|||
42190123|NCT01347866|76000117|FG002|Overall Study|Subject refused further follow-up|0|||
42190124|NCT01347866|76000118|FG003|Overall Study|Subject refused further follow-up|2|||
42190125|NCT01347866|76000119|FG004|Overall Study|Subject refused further follow-up|0|||
42190126|NCT01347866|76000120|FG005|Overall Study|Subject refused further follow-up|1|||
42190127|NCT01347866|76000121|FG006|Overall Study|Subject refused further follow-up|0|||
42190128|NCT01347866|76000122|FG007|Overall Study|Subject refused further follow-up|0|||
42190129|NCT01347866|76000123|FG008|Overall Study|Subject refused further follow-up|4|||
42190130|NCT01347866|76000124|FG009|Overall Study|Subject refused further follow-up|1|||
42190131|NCT01347866|76000125|FG010|Overall Study|Subject refused further follow-up|0|||
42190132|NCT01347866|76000126|FG011|Overall Study|Subject refused further follow-up|0|||
42190133|NCT01347866|76000127|FG012|Overall Study|Subject refused further follow-up|1|||
42190134|NCT01347866|76000128|FG013|Overall Study|Subject refused further follow-up|3|||
42190135|NCT01347866|76000129|FG014|Overall Study|Subject refused further follow-up|1|||
42190136|NCT01347866|76000130|FG015|Overall Study|Subject refused further follow-up|0|||
42190137|NCT01347866|76000131|FG016|Overall Study|Subject refused further follow-up|2|||
42190138|NCT01347710|76000202|FG000|Overall Study|Withdrawal by Subject|2|||
42190139|NCT01347710|76000202|FG000|Overall Study|Adverse Event|4|||
42190140|NCT01347710|76000202|FG000|Overall Study|Angio or SPECT not completed|18|||
42190141|NCT01347710|76000202|FG000|Overall Study|issue with vitals prior to dosing|1|||
42190142|NCT01347710|76000202|FG000|Overall Study|Lost to Follow-up|1|||
42190143|NCT01347710|76000202|FG000|Overall Study|Physician Decision|2|||
42190144|NCT01347710|76000202|FG000|Overall Study|Other|3|||
42190145|NCT03485222|76000212|FG000|Overall Study|Death|0|||
42190146|NCT03485222|76000213|FG001|Overall Study|Death|1|||
42096262|NCT01331681|75906981|FG001|Overall Study|Lack of Efficacy|1|||
42096263|NCT01331681|75906982|FG002|Overall Study|Lack of Efficacy|0|||
42096264|NCT01331681|75906980|FG000|Overall Study|Withdrawal by Subject|12|||
42096265|NCT01331681|75906981|FG001|Overall Study|Withdrawal by Subject|8|||
42190147|NCT03485222|76000212|FG000|Overall Study|Lost to Follow-up|2|||
42190148|NCT03485222|76000213|FG001|Overall Study|Lost to Follow-up|1|||
42190149|NCT01347554|76000221|FG000|Overall Study|Lack of Efficacy|7|||
42190150|NCT01347554|76000222|FG001|Overall Study|Lack of Efficacy|11|||
42190151|NCT03482882|76000228|FG000|Overall Study|Adverse Event|3|||
42190152|NCT03482882|76000228|FG000|Overall Study|Lost to Follow-up|1|||
42190153|NCT03482882|76000228|FG000|Overall Study|Protocol Violation|2|||
42096266|NCT01331681|75906982|FG002|Overall Study|Withdrawal by Subject|15|||
42096267|NCT01331681|75906980|FG000|Overall Study|Protocol Violation|1|||
42096268|NCT01331681|75906981|FG001|Overall Study|Protocol Violation|1|||
42190154|NCT03482882|76000228|FG000|Overall Study|Not further specified|1|||
42190155|NCT03480932|76000235|FG000|Overall Study|Death|1|||
42190156|NCT03480932|76000236|FG001|Overall Study|Death|1|||
42190157|NCT03480932|76000237|FG002|Overall Study|Death|0|||
42359212|NCT01827384|76204850|FG005|Overall Study|Disease progression before treatment|0|||
42096269|NCT01331681|75906982|FG002|Overall Study|Protocol Violation|0|||
42190158|NCT03480932|76000235|FG000|Overall Study|Lost to Follow-up|0|||
42190159|NCT03480932|76000236|FG001|Overall Study|Lost to Follow-up|2|||
42190160|NCT03480932|76000237|FG002|Overall Study|Lost to Follow-up|3|||
42190161|NCT03480932|76000235|FG000|Overall Study|Incarcerated|2|||
42190162|NCT03480932|76000236|FG001|Overall Study|Incarcerated|2|||
42096270|NCT01331681|75906980|FG000|Overall Study|Lost to Follow-up|2|||
42096271|NCT01331681|75906981|FG001|Overall Study|Lost to Follow-up|4|||
42096272|NCT01331681|75906982|FG002|Overall Study|Lost to Follow-up|1|||
42096273|NCT01331681|75906980|FG000|Overall Study|Physician Decision|2|||
42096274|NCT01331681|75906981|FG001|Overall Study|Physician Decision|0|||
42096275|NCT01331681|75906982|FG002|Overall Study|Physician Decision|4|||
42190163|NCT03480932|76000237|FG002|Overall Study|Incarcerated|2|||
42096276|NCT01331681|75906980|FG000|Overall Study|Therapeutic procedure required|1|||
42096277|NCT01331681|75906981|FG001|Overall Study|Therapeutic procedure required|0|||
42096278|NCT01331681|75906982|FG002|Overall Study|Therapeutic procedure required|0|||
42096279|NCT01331681|75906980|FG000|Overall Study|Sponsor decision|1|||
42096280|NCT01331681|75906981|FG001|Overall Study|Sponsor decision|1|||
42096281|NCT01331681|75906982|FG002|Overall Study|Sponsor decision|0|||
42096282|NCT01331681|75906980|FG000|Overall Study|Switching to other therapy|0|||
42096283|NCT01331681|75906981|FG001|Overall Study|Switching to other therapy|0|||
42096284|NCT01331681|75906982|FG002|Overall Study|Switching to other therapy|1|||
42096285|NCT01331681|75906980|FG000|Overall Study|Not Received Study Treatment|0|||
42096286|NCT01331681|75906981|FG001|Overall Study|Not Received Study Treatment|0|||
42096287|NCT01331681|75906982|FG002|Overall Study|Not Received Study Treatment|2|||
42096288|NCT01286272|75906992|FG000|Overall Study|Ineligible after beginning treatment|1|||
42096289|NCT01286272|75906993|FG001|Overall Study|Ineligible after beginning treatment|3|||
42096293|NCT01215136|75907005|FG000|Overall Study|Adverse Event|2|||
42096294|NCT01215136|75907006|FG001|Overall Study|Adverse Event|9|||
42096295|NCT01215136|75907005|FG000|Overall Study|Disease Progression|3|||
42096296|NCT01215136|75907006|FG001|Overall Study|Disease Progression|14|||
42096297|NCT01215136|75907005|FG000|Overall Study|Symptomatic Deterioration|1|||
42096298|NCT01215136|75907006|FG001|Overall Study|Symptomatic Deterioration|1|||
42096299|NCT01215136|75907005|FG000|Overall Study|Death|0|||
42096300|NCT01215136|75907006|FG001|Overall Study|Death|2|||
42096301|NCT01215136|75907005|FG000|Overall Study|Withdrawal by Subject|0|||
42096302|NCT01215136|75907006|FG001|Overall Study|Withdrawal by Subject|1|||
42096303|NCT01142388|75907031|FG000|Overall Study|Lack of Efficacy|21|||
42096304|NCT01142388|75907032|FG001|Overall Study|Lack of Efficacy|31|||
42096305|NCT01142388|75907031|FG000|Overall Study|Adverse Event|9|||
42096306|NCT01142388|75907032|FG001|Overall Study|Adverse Event|5|||
42096307|NCT01142388|75907031|FG000|Overall Study|Death|3|||
42096308|NCT01142388|75907032|FG001|Overall Study|Death|2|||
42096309|NCT01142388|75907031|FG000|Overall Study|Withdrawal by Subject|5|||
42096310|NCT01142388|75907032|FG001|Overall Study|Withdrawal by Subject|3|||
42096311|NCT01142388|75907031|FG000|Overall Study|Alternative therapy|1|||
42096312|NCT01142388|75907032|FG001|Overall Study|Alternative therapy|0|||
42096313|NCT01142388|75907031|FG000|Overall Study|Other complications|0|||
42096314|NCT01142388|75907032|FG001|Overall Study|Other complications|2|||
42096315|NCT01142388|75907031|FG000|Overall Study|Other|1|||
42096316|NCT01142388|75907032|FG001|Overall Study|Other|1|||
42096317|NCT01142388|75907031|FG000|Overall Study|Never started therapy|7|||
42190164|NCT03387020|76000248|FG000|Overall Study|Adverse Event|0|||
42190165|NCT03387020|76000249|FG001|Overall Study|Adverse Event|2|||
42190166|NCT03387020|76000250|FG002|Overall Study|Adverse Event|0|||
42190167|NCT03387020|76000248|FG000|Overall Study|Withdrawal by Subject|2|||
42190168|NCT03387020|76000249|FG001|Overall Study|Withdrawal by Subject|0|||
42190169|NCT03387020|76000250|FG002|Overall Study|Withdrawal by Subject|0|||
42190170|NCT03386474|76000270|FG000|Overall Study|Death|1|||
42190171|NCT03386474|76000271|FG001|Overall Study|Death|0|||
42190172|NCT03386474|76000270|FG000|Overall Study|Adverse Event|0|||
42190173|NCT03386474|76000271|FG001|Overall Study|Adverse Event|1|||
42190174|NCT03405818|76000282|FG000|Overall Study|Withdrawal by Subject|4|||
42190175|NCT03405818|76000282|FG000|Overall Study|Lost to Follow-up|4|||
42190176|NCT03403634|76000286|FG000|Overall Study|Disease progression|3|||
42190177|NCT03403634|76000286|FG000|Overall Study|Did not meet eligibility criteria|4|||
42190178|NCT03403400|76000293|FG000|Overall Study|Lost to Follow-up|1|||
42190179|NCT03403400|76000294|FG001|Overall Study|Lost to Follow-up|0|||
42190180|NCT03403400|76000295|FG002|Overall Study|Lost to Follow-up|1|||
42190181|NCT03403400|76000293|FG000|Overall Study|Hospitalization|1|||
42190182|NCT03403400|76000294|FG001|Overall Study|Hospitalization|0|||
42190183|NCT03403400|76000295|FG002|Overall Study|Hospitalization|0|||
42190184|NCT03403400|76000293|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
42190185|NCT03403400|76000294|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
42190186|NCT03403400|76000295|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
42190187|NCT02863354|76000320|FG000|Year 1|Lost to Follow-up|1|||
42296742|NCT02603419|76131532|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
42296743|NCT02603419|76131533|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
42296744|NCT02603419|76131534|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
42096318|NCT01142388|75907032|FG001|Overall Study|Never started therapy|3|||
42096319|NCT01134614|75907040|FG000|Overall Study|Still on treatment as of March 2013|21|||
42190188|NCT02863354|76000321|FG001|Year 1|Lost to Follow-up|1|||
42190189|NCT02863354|76000320|FG000|Year 1|Withdrawal by Subject|3|||
42190190|NCT02863354|76000321|FG001|Year 1|Withdrawal by Subject|0|||
42190191|NCT02863354|76000320|FG000|Year 1|Death|0|||
42190192|NCT02863354|76000321|FG001|Year 1|Death|1|||
42190193|NCT02863354|76000320|FG000|Year 2|Lost to Follow-up|2|||
42296745|NCT02603419|76131529|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
42296746|NCT02603419|76131530|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
42190194|NCT02863354|76000321|FG001|Year 2|Lost to Follow-up|2|||
42190195|NCT03480152|76000329|FG000|Phase I|Signed consent. Died before treatment.|1|||
42190196|NCT03480152|76000330|FG001|Phase I|Signed consent. Died before treatment.|0|||
42190197|NCT03480152|76000331|FG002|Phase I|Signed consent. Died before treatment.|0|||
42190198|NCT02859454|76000339|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
42190199|NCT02862730|76000346|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
42190200|NCT02862730|76000347|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
42190201|NCT02862730|76000348|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
42190202|NCT02862730|76000349|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
42190203|NCT02862730|76000350|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
42096320|NCT01134614|75907041|FG001|Overall Study|Still on treatment as of March 2013|13|||
42096321|NCT01134614|75907040|FG000|Overall Study|Progressive disease|60|||
42096322|NCT01134614|75907041|FG001|Overall Study|Progressive disease|54|||
42096323|NCT01134614|75907040|FG000|Overall Study|Adverse Event|26|||
42096324|NCT01134614|75907041|FG001|Overall Study|Adverse Event|39|||
42096325|NCT01134614|75907040|FG000|Overall Study|Death|5|||
42096326|NCT01134614|75907041|FG001|Overall Study|Death|8|||
42190204|NCT02862730|76000351|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
42190205|NCT02862730|76000352|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
42190206|NCT02862730|76000346|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
42190207|NCT02862730|76000347|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
42190208|NCT02862730|76000348|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
42190209|NCT02862730|76000349|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
42296747|NCT02603419|76131531|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
42296748|NCT02603419|76131532|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
42296749|NCT02603419|76131533|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
42296750|NCT02603419|76131534|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
42296751|NCT02603419|76131529|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
42296752|NCT02603419|76131530|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
42296753|NCT02603419|76131531|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
42296754|NCT02603419|76131532|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
42296755|NCT02603419|76131533|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
42296756|NCT02603419|76131534|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
42296757|NCT02603419|76131529|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
42296758|NCT02603419|76131530|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
42296759|NCT02603419|76131531|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
42296760|NCT02603419|76131532|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
42296761|NCT02603419|76131533|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
42296762|NCT02603419|76131534|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
42296763|NCT01668355|76131551|FG000|Overall Study|Death|3|||
42296764|NCT01668355|76131552|FG001|Overall Study|Death|1|||
42296765|NCT01668355|76131551|FG000|Overall Study|Withdrawal by Subject|6|||
42296766|NCT01668355|76131552|FG001|Overall Study|Withdrawal by Subject|1|||
42296767|NCT01667731|76131564|FG000|Overall Study|Enrolled but not treated|0|||
42296768|NCT01667731|76131565|FG001|Overall Study|Enrolled but not treated|0|||
42296769|NCT01667731|76131566|FG002|Overall Study|Enrolled but not treated|0|||
42296770|NCT01667731|76131567|FG003|Overall Study|Enrolled but not treated|0|||
42296771|NCT01667731|76131568|FG004|Overall Study|Enrolled but not treated|1|||
42296772|NCT01667731|76131564|FG000|Overall Study|Efficacy Failure|1|||
42296773|NCT01667731|76131565|FG001|Overall Study|Efficacy Failure|12|||
42296774|NCT01667731|76131566|FG002|Overall Study|Efficacy Failure|0|||
42296775|NCT01667731|76131567|FG003|Overall Study|Efficacy Failure|1|||
42296776|NCT01667731|76131568|FG004|Overall Study|Efficacy Failure|24|||
42296777|NCT01667731|76131564|FG000|Overall Study|Lost to Follow-up|2|||
42296778|NCT01667731|76131565|FG001|Overall Study|Lost to Follow-up|3|||
42296779|NCT01667731|76131566|FG002|Overall Study|Lost to Follow-up|1|||
42296780|NCT01667731|76131567|FG003|Overall Study|Lost to Follow-up|1|||
42296781|NCT01667731|76131568|FG004|Overall Study|Lost to Follow-up|2|||
42096327|NCT01134614|75907040|FG000|Overall Study|Withdrawal by Subject|3|||
42096328|NCT01134614|75907041|FG001|Overall Study|Withdrawal by Subject|2|||
42190210|NCT02862730|76000350|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
42190211|NCT02862730|76000351|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
42296782|NCT01667731|76131564|FG000|Overall Study|Subject Withdrew Consent|2|||
42296783|NCT01667731|76131565|FG001|Overall Study|Subject Withdrew Consent|0|||
42359213|NCT01827384|76204851|FG006|Overall Study|Disease progression before treatment|0|||
42190212|NCT02862730|76000352|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
42296784|NCT01667731|76131566|FG002|Overall Study|Subject Withdrew Consent|1|||
42096329|NCT01134614|75907040|FG000|Overall Study|Alternative therapy|2|||
42096330|NCT01134614|75907041|FG001|Overall Study|Alternative therapy|0|||
42190213|NCT02862730|76000346|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
42096331|NCT01134614|75907040|FG000|Overall Study|Complicating disease|2|||
42096332|NCT01134614|75907041|FG001|Overall Study|Complicating disease|1|||
42096333|NCT01134614|75907040|FG000|Overall Study|Physician's decision|0|||
42190214|NCT02862730|76000347|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
42190215|NCT02862730|76000348|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
42190216|NCT02862730|76000349|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
42190217|NCT02862730|76000350|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
42190218|NCT02862730|76000351|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
42190219|NCT02862730|76000352|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
42190220|NCT02862730|76000346|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
42190221|NCT02862730|76000347|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
42296785|NCT01667731|76131567|FG003|Overall Study|Subject Withdrew Consent|0|||
42296786|NCT01667731|76131568|FG004|Overall Study|Subject Withdrew Consent|1|||
42296787|NCT01667731|76131564|FG000|Overall Study|Death|0|||
42296788|NCT01667731|76131565|FG001|Overall Study|Death|1|||
42296789|NCT01667731|76131566|FG002|Overall Study|Death|0|||
42296790|NCT01667731|76131567|FG003|Overall Study|Death|0|||
42296791|NCT01667731|76131568|FG004|Overall Study|Death|0|||
42296792|NCT02605837|76131583|FG000|Overall Study|Adverse Event|3|||
42296793|NCT02605837|76131584|FG001|Overall Study|Adverse Event|1|||
42296794|NCT02605837|76131583|FG000|Overall Study|Non-Compliance with Study Drug|0|||
42296795|NCT02605837|76131584|FG001|Overall Study|Non-Compliance with Study Drug|1|||
42296796|NCT02605837|76131583|FG000|Overall Study|Withdrawal by Subject|8|||
42296797|NCT02605837|76131584|FG001|Overall Study|Withdrawal by Subject|8|||
42296798|NCT02605837|76131583|FG000|Overall Study|Physician Decision|0|||
42296799|NCT02605837|76131584|FG001|Overall Study|Physician Decision|1|||
42296800|NCT02423343|76131597|FG000|Overall Study|Withdrawal by Subject|0|||
42296801|NCT02423343|76131598|FG001|Overall Study|Withdrawal by Subject|1|||
42296802|NCT02423343|76131599|FG002|Overall Study|Withdrawal by Subject|0|||
42296803|NCT02423343|76131600|FG003|Overall Study|Withdrawal by Subject|0|||
42296804|NCT02423343|76131601|FG004|Overall Study|Withdrawal by Subject|0|||
42296805|NCT02423343|76131602|FG005|Overall Study|Withdrawal by Subject|0|||
42296806|NCT02423343|76131597|FG000|Overall Study|Progressive Disease|0|||
42296807|NCT02423343|76131598|FG001|Overall Study|Progressive Disease|0|||
42296808|NCT02423343|76131599|FG002|Overall Study|Progressive Disease|0|||
42296809|NCT02423343|76131600|FG003|Overall Study|Progressive Disease|0|||
42296810|NCT02423343|76131601|FG004|Overall Study|Progressive Disease|2|||
42296811|NCT02423343|76131602|FG005|Overall Study|Progressive Disease|0|||
42296812|NCT02423343|76131597|FG000|Overall Study|Adverse Event|0|||
42296813|NCT02423343|76131598|FG001|Overall Study|Adverse Event|0|||
42296814|NCT02423343|76131599|FG002|Overall Study|Adverse Event|0|||
42296815|NCT02423343|76131600|FG003|Overall Study|Adverse Event|0|||
42296816|NCT02423343|76131601|FG004|Overall Study|Adverse Event|2|||
42296817|NCT02423343|76131602|FG005|Overall Study|Adverse Event|0|||
42296818|NCT02423343|76131597|FG000|Overall Study|Death|0|||
42296819|NCT02423343|76131598|FG001|Overall Study|Death|0|||
42296820|NCT02423343|76131599|FG002|Overall Study|Death|0|||
42296821|NCT02423343|76131600|FG003|Overall Study|Death|0|||
42190222|NCT02862730|76000348|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
42190223|NCT02862730|76000349|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
42296822|NCT02423343|76131601|FG004|Overall Study|Death|1|||
42296823|NCT02423343|76131602|FG005|Overall Study|Death|0|||
42296824|NCT02605447|76131630|FG000|Overall Study|Death|66|||
42359214|NCT01827384|76204852|FG007|Overall Study|Disease progression before treatment|0|||
42359215|NCT01827384|76204853|FG008|Overall Study|Disease progression before treatment|0|||
42359216|NCT01827384|76204854|FG009|Overall Study|Disease progression before treatment|0|||
42096334|NCT01134614|75907041|FG001|Overall Study|Physician's decision|1|||
42096335|NCT01134614|75907040|FG000|Overall Study|Never started treatment|4|||
42096336|NCT01134614|75907041|FG001|Overall Study|Never started treatment|1|||
42096337|NCT01134614|75907040|FG000|Overall Study|Pt received tx not allowed on study|0|||
42096338|NCT01134614|75907041|FG001|Overall Study|Pt received tx not allowed on study|1|||
42190224|NCT02862730|76000350|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
42190225|NCT02862730|76000351|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
42190226|NCT02862730|76000352|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
42190227|NCT03353792|76000369|FG000|Overall Study|Lost to Follow-up|1|||
42296825|NCT02605447|76131630|FG000|Overall Study|Physician Decision|1|||
42296826|NCT02605447|76131630|FG000|Overall Study|Lost to Follow-up|24|||
42296827|NCT02605447|76131630|FG000|Overall Study|Withdrawal by Subject|10|||
42296828|NCT02605447|76131630|FG000|Overall Study|Not disclosed|1|||
42296829|NCT02485899|76131637|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
42096339|NCT01134614|75907040|FG000|Overall Study|Symptomatic deterioration|0|||
42296830|NCT02485899|76131638|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
42296831|NCT02485899|76131637|FG000|Overall Study|Withdrawal by Subject|1|||
42296832|NCT02485899|76131638|FG001|Overall Study|Withdrawal by Subject|0|||
42296833|NCT02485899|76131637|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
42296834|NCT02485899|76131638|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
42190228|NCT03353792|76000370|FG001|Overall Study|Lost to Follow-up|0|||
42190229|NCT03353792|76000369|FG000|Overall Study|Participant Unable to Manage Device|1|||
42190230|NCT03353792|76000370|FG001|Overall Study|Participant Unable to Manage Device|0|||
42190231|NCT02862574|76000379|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42190232|NCT02862574|76000380|FG001|Double-Blind Treatment Period|Adverse Event|1|||
42190233|NCT02862574|76000381|FG002|Double-Blind Treatment Period|Adverse Event|0|||
42190234|NCT02862574|76000379|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
42190235|NCT02862574|76000380|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
42190236|NCT02862574|76000381|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
42190237|NCT02862574|76000379|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
42190238|NCT02862574|76000380|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
42096340|NCT01134614|75907041|FG001|Overall Study|Symptomatic deterioration|1|||
42096341|NCT01134614|75907040|FG000|Overall Study|Patient in hospice care|0|||
42096342|NCT01134614|75907041|FG001|Overall Study|Patient in hospice care|1|||
42096343|NCT00616018|75907055|FG000|Overall Study|Protocol Violation|3|||
42096344|NCT00424021|75907064|FG000|NCT00046319 Study Period|Adverse Event|1|||
42096345|NCT00424021|75907065|FG001|NCT00046319 Study Period|Adverse Event|0|||
42096346|NCT00424021|75907066|FG002|NCT00046319 Study Period|Adverse Event|1|||
42096347|NCT00424021|75907067|FG003|NCT00046319 Study Period|Adverse Event|1|||
42096348|NCT00424021|75907064|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
42096349|NCT00424021|75907065|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
42096350|NCT00424021|75907066|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
42096351|NCT00424021|75907067|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
42096352|NCT00424021|75907064|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
42096353|NCT00424021|75907065|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
42190239|NCT02862574|76000381|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
42190240|NCT02862106|76000396|FG000|Overall Study|Adverse Event|4|||
42190241|NCT02862106|76000397|FG001|Overall Study|Adverse Event|0|||
42190242|NCT02862106|76000396|FG000|Overall Study|Protocol Violation|16|||
42190243|NCT02862106|76000397|FG001|Overall Study|Protocol Violation|1|||
42190244|NCT02862106|76000396|FG000|Overall Study|Lost to Follow-up|15|||
42190245|NCT02862106|76000397|FG001|Overall Study|Lost to Follow-up|5|||
42190246|NCT02862106|76000396|FG000|Overall Study|Withdrawal by Subject|2|||
42190247|NCT02862106|76000397|FG001|Overall Study|Withdrawal by Subject|0|||
42190248|NCT02862106|76000396|FG000|Overall Study|Subjects moved to other city|1|||
42190249|NCT02862106|76000397|FG001|Overall Study|Subjects moved to other city|0|||
42190250|NCT04157296|76000412|FG000|Overall Study|Withdrawal by Subject|0|||
42190251|NCT04157296|76000413|FG001|Overall Study|Withdrawal by Subject|1|||
42190252|NCT04157296|76000412|FG000|Overall Study|Did not obtain second fMRI.|0|||
42190253|NCT04157296|76000413|FG001|Overall Study|Did not obtain second fMRI.|1|||
42190254|NCT04157296|76000412|FG000|Overall Study|MRI failed/no second fMRI|0|||
42190255|NCT04157296|76000413|FG001|Overall Study|MRI failed/no second fMRI|1|||
42190256|NCT02859142|76000421|FG000|Overall Study|Adverse Event|1|||
42190257|NCT02859142|76000422|FG001|Overall Study|Adverse Event|2|||
42190258|NCT02859142|76000421|FG000|Overall Study|Lost to Follow-up|1|||
42190259|NCT02859142|76000422|FG001|Overall Study|Lost to Follow-up|4|||
42190260|NCT02859142|76000421|FG000|Overall Study|Withdrawal by Subject|2|||
42190261|NCT02859142|76000422|FG001|Overall Study|Withdrawal by Subject|0|||
42190262|NCT02859142|76000421|FG000|Overall Study|Scheduling difficulties|0|||
42190263|NCT02859142|76000422|FG001|Overall Study|Scheduling difficulties|3|||
42190264|NCT03351608|76000433|FG000|Overall Study|Lost to Follow-up|0|||
42096354|NCT00424021|75907066|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
42190265|NCT03351608|76000434|FG001|Overall Study|Lost to Follow-up|1|||
42018307|NCT00996892|75825869|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018308|NCT00996892|75825870|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
42018309|NCT00996892|75825871|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
42018310|NCT00996892|75825872|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
42018311|NCT00996892|75825873|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
42018312|NCT00996892|75825874|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018313|NCT00996892|75825875|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018314|NCT00996892|75825876|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018315|NCT00996892|75825877|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018316|NCT00996892|75825878|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018317|NCT00996892|75825879|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42018318|NCT00996892|75825880|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
42190266|NCT03351608|76000435|FG002|Overall Study|Lost to Follow-up|1|||
42190267|NCT03351608|76000436|FG003|Overall Study|Lost to Follow-up|1|||
42190268|NCT03351608|76000437|FG004|Overall Study|Lost to Follow-up|1|||
42190269|NCT03351608|76000433|FG000|Overall Study|Physician Decision|1|||
42359217|NCT01827384|76204855|FG010|Overall Study|Disease progression before treatment|0|||
42190270|NCT03351608|76000434|FG001|Overall Study|Physician Decision|0|||
42190271|NCT03351608|76000435|FG002|Overall Study|Physician Decision|0|||
42190272|NCT03351608|76000436|FG003|Overall Study|Physician Decision|2|||
42190273|NCT03351608|76000437|FG004|Overall Study|Physician Decision|1|||
42096355|NCT00424021|75907067|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
42096356|NCT00424021|75907064|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
42096357|NCT00424021|75907065|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
42190274|NCT03351608|76000433|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
42190275|NCT03351608|76000434|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
42190276|NCT03351608|76000435|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
42190277|NCT03351608|76000436|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
42190278|NCT03351608|76000437|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
42190279|NCT03351608|76000433|FG000|Overall Study|Withdrawal by parent/guardian|0|||
42190280|NCT03351608|76000434|FG001|Overall Study|Withdrawal by parent/guardian|0|||
42190281|NCT03351608|76000435|FG002|Overall Study|Withdrawal by parent/guardian|1|||
42190282|NCT03351608|76000436|FG003|Overall Study|Withdrawal by parent/guardian|1|||
42190283|NCT03351608|76000437|FG004|Overall Study|Withdrawal by parent/guardian|0|||
42190284|NCT03351608|76000433|FG000|Overall Study|Other|0|||
42190285|NCT03351608|76000434|FG001|Overall Study|Other|1|||
42190286|NCT03351608|76000435|FG002|Overall Study|Other|1|||
42190287|NCT03351608|76000436|FG003|Overall Study|Other|3|||
42190288|NCT03351608|76000437|FG004|Overall Study|Other|0|||
42190289|NCT02857816|76000460|FG000|Overall Study|Screen Failure|33|||
42190290|NCT02857816|76000460|FG000|Overall Study|Withdrawal by Subject|4|||
42190291|NCT02857816|76000460|FG000|Overall Study|Lost to Follow-up|1|||
42190292|NCT02858440|76000465|FG000|Overall Study|Lost to Follow-up|3|||
42190293|NCT02858440|76000465|FG000|Overall Study|Protocol Violation|2|||
42190294|NCT02858440|76000465|FG000|Overall Study|Consent withdrawal|3|||
42190295|NCT02858440|76000465|FG000|Overall Study|Migrated/moved from study area|4|||
42190296|NCT03382418|76000472|FG000|Overall Study|Withdrawal by Subject|1|||
42190297|NCT03382418|76000473|FG001|Overall Study|Withdrawal by Subject|0|||
42190298|NCT03382418|76000474|FG002|Overall Study|Withdrawal by Subject|0|||
42190299|NCT03382418|76000472|FG000|Overall Study|Lost to Follow-up|2|||
42096358|NCT00424021|75907066|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
42096359|NCT00424021|75907067|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
42096360|NCT00424021|75907064|FG000|AMB-220-E Study Period|Adverse Event|1|||
42096361|NCT00424021|75907065|FG001|AMB-220-E Study Period|Adverse Event|1|||
42096362|NCT00424021|75907066|FG002|AMB-220-E Study Period|Adverse Event|3|||
42096363|NCT00424021|75907067|FG003|AMB-220-E Study Period|Adverse Event|7|||
42096364|NCT00424021|75907064|FG000|AMB-220-E Study Period|Death|0|||
42096365|NCT00424021|75907065|FG001|AMB-220-E Study Period|Death|0|||
42096366|NCT00424021|75907066|FG002|AMB-220-E Study Period|Death|1|||
42096367|NCT00424021|75907067|FG003|AMB-220-E Study Period|Death|1|||
42096368|NCT00424021|75907064|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
42096369|NCT00424021|75907065|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
42096370|NCT00424021|75907066|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
42096371|NCT00424021|75907067|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
42096372|NCT00424021|75907064|FG000|AMB-220-E Study Period|Physician Decision|0|||
42096373|NCT00424021|75907065|FG001|AMB-220-E Study Period|Physician Decision|0|||
42190300|NCT03382418|76000473|FG001|Overall Study|Lost to Follow-up|3|||
42190301|NCT03382418|76000474|FG002|Overall Study|Lost to Follow-up|0|||
42190302|NCT02858362|76000486|FG000|Overall Study|Protocol Violation|0|||
42190303|NCT02858362|76000487|FG001|Overall Study|Protocol Violation|1|||
42190304|NCT02858362|76000488|FG002|Overall Study|Protocol Violation|0|||
42190305|NCT02858362|76000486|FG000|Overall Study|Withdrawal by Subject|1|||
42190306|NCT02858362|76000487|FG001|Overall Study|Withdrawal by Subject|0|||
42190307|NCT02858362|76000488|FG002|Overall Study|Withdrawal by Subject|0|||
42190308|NCT02858362|76000486|FG000|Overall Study|Early Study Termination|0|||
42096374|NCT00424021|75907066|FG002|AMB-220-E Study Period|Physician Decision|0|||
42096375|NCT00424021|75907067|FG003|AMB-220-E Study Period|Physician Decision|1|||
42096376|NCT00617734|75907086|FG000|Overall Study|Withdrew Consent|2|||
42096377|NCT00617734|75907087|FG001|Overall Study|Withdrew Consent|0|||
42096378|NCT00617734|75907086|FG000|Overall Study|Adverse Event|4|||
42096379|NCT00617734|75907087|FG001|Overall Study|Adverse Event|1|||
42096380|NCT00617734|75907086|FG000|Overall Study|Protocol Violation|1|||
42096381|NCT00617734|75907087|FG001|Overall Study|Protocol Violation|0|||
42096382|NCT00617734|75907086|FG000|Overall Study|Found Ineligible After Randomization|1|||
42359218|NCT01827384|76204856|FG011|Overall Study|Disease progression before treatment|0|||
42096383|NCT00617734|75907087|FG001|Overall Study|Found Ineligible After Randomization|4|||
42096384|NCT00617734|75907086|FG000|Overall Study|Lost to Follow-up|0|||
42190309|NCT02858362|76000487|FG001|Overall Study|Early Study Termination|0|||
42359219|NCT01827384|76204857|FG012|Overall Study|Disease progression before treatment|0|||
42096385|NCT00617734|75907087|FG001|Overall Study|Lost to Follow-up|1|||
42096386|NCT00577460|75907096|FG000|Overall Study|Adverse Event|11|||
42190310|NCT02858362|76000488|FG002|Overall Study|Early Study Termination|3|||
42190311|NCT02858362|76000486|FG000|Overall Study|Lost to Follow-up|1|||
42190312|NCT02858362|76000487|FG001|Overall Study|Lost to Follow-up|0|||
42190313|NCT02858362|76000488|FG002|Overall Study|Lost to Follow-up|0|||
42190314|NCT03350750|76000503|FG000|Overall Study|Death|1|||
42359220|NCT01827384|76204858|FG013|Overall Study|Disease progression before treatment|4|||
42190315|NCT03350750|76000504|FG001|Overall Study|Death|1|||
42190316|NCT03394508|76000514|FG000|Overall Study|Protocol Violation|0|||
42190317|NCT03394508|76000515|FG001|Overall Study|Protocol Violation|3|||
42190318|NCT03394508|76000514|FG000|Overall Study|Lost to Follow-up|1|||
42190319|NCT03394508|76000515|FG001|Overall Study|Lost to Follow-up|0|||
42190320|NCT02856880|76000525|FG000|Overall Study|Withdrawal of consent|1|||
42190321|NCT03393806|76000546|FG000|Overall Study|Physician Decision|1|||
42190322|NCT03393806|76000547|FG001|Overall Study|Physician Decision|0|||
42190323|NCT02856802|76000556|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
42190324|NCT02856802|76000557|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
42190325|NCT02856802|76000556|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
42190326|NCT02856802|76000557|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
42190327|NCT02856802|76000556|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
42190328|NCT02856802|76000557|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
42190329|NCT02856802|76000556|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
42190330|NCT02856802|76000557|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
42190331|NCT02856802|76000556|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
42190332|NCT02856802|76000557|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
42190333|NCT02856802|76000556|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
42190334|NCT02856802|76000557|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
42190335|NCT03380390|76000567|FG000|Overall Study|Adverse Event|3|||
42190336|NCT03350672|76000574|FG000|Overall Study|Withdrawal by Subject|7|||
42190337|NCT03350672|76000575|FG001|Overall Study|Withdrawal by Subject|0|||
42190338|NCT03350672|76000576|FG002|Overall Study|Withdrawal by Subject|0|||
42190339|NCT03392168|76000588|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
42190340|NCT03392168|76000589|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
42190341|NCT03392168|76000590|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
42190342|NCT03392168|76000591|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
42190343|NCT03392168|76000588|FG000|Period 2: Cohort 2|Other|0|||
42190344|NCT03392168|76000589|FG001|Period 2: Cohort 2|Other|1|||
42190345|NCT03392168|76000590|FG002|Period 2: Cohort 2|Other|0|||
42190346|NCT03392168|76000591|FG003|Period 2: Cohort 2|Other|0|||
42190347|NCT03391232|76000602|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
42190348|NCT03391232|76000603|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
42190349|NCT03391232|76000602|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
42190350|NCT03391232|76000603|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
42190351|NCT03379376|76000611|FG000|Overall Study|Lost to Follow-up|2|||
42190352|NCT03379376|76000611|FG000|Overall Study|Did not wish to complete follow up|1|||
42190353|NCT03379376|76000611|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
42190354|NCT03379376|76000611|FG000|Overall Study|Death|1|||
42190355|NCT03349034|76000617|FG000|Overall Study|catheters dislodged during transport|2|||
42190356|NCT03349034|76000618|FG001|Overall Study|catheters dislodged during transport|0|||
42190357|NCT03349034|76000617|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
42190358|NCT03349034|76000618|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
42190359|NCT03349034|76000617|FG000|Overall Study|soft tissue flap used|1|||
42190360|NCT03349034|76000618|FG001|Overall Study|soft tissue flap used|0|||
42190361|NCT03349034|76000617|FG000|Overall Study|Other|0|||
42190362|NCT03349034|76000618|FG001|Overall Study|Other|1|||
42190363|NCT00358215|76000628|FG000|Overall Study|Ineligibility determined|4|||
42190364|NCT00358215|76000629|FG001|Overall Study|Ineligibility determined|3|||
42190365|NCT00358215|76000628|FG000|Overall Study|Adverse Event|83|||
42190366|NCT00358215|76000629|FG001|Overall Study|Adverse Event|65|||
42190367|NCT00358215|76000628|FG000|Overall Study|Withdrawal by Subject|111|||
42190368|NCT00358215|76000629|FG001|Overall Study|Withdrawal by Subject|102|||
42190369|NCT00358215|76000628|FG000|Overall Study|Participant request|65|||
42190370|NCT00358215|76000629|FG001|Overall Study|Participant request|64|||
42190371|NCT00358215|76000628|FG000|Overall Study|Physician Decision|47|||
42190372|NCT00358215|76000629|FG001|Overall Study|Physician Decision|39|||
42296835|NCT02423109|76131644|FG000|Lens 1|Adverse Event|1|||
42296836|NCT02423109|76131645|FG001|Lens 1|Adverse Event|0|||
42296837|NCT02420691|76131653|FG000|Overall Study|Adverse Event|3|||
42296838|NCT02420691|76131653|FG000|Overall Study|Withdrawal by Subject|3|||
42296839|NCT02406651|76131657|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
42296840|NCT02406261|76131664|FG000|Period 1|Lost to Follow-up|2|||
42296841|NCT02406261|76131665|FG001|Period 1|Lost to Follow-up|0|||
42296842|NCT02406261|76131664|FG000|Period 1|Adverse Event|1|||
42190373|NCT00358215|76000628|FG000|Overall Study|Lost to Follow-up|16|||
42190374|NCT00358215|76000629|FG001|Overall Study|Lost to Follow-up|22|||
42190375|NCT00358215|76000628|FG000|Overall Study|Death|265|||
42190376|NCT00358215|76000629|FG001|Overall Study|Death|281|||
42190377|NCT00358215|76000628|FG000|Overall Study|Protocol Violation|64|||
42296843|NCT02406261|76131665|FG001|Period 1|Adverse Event|0|||
42296844|NCT02406261|76131664|FG000|Period 2|Physician Decision|0|||
42296845|NCT02406261|76131665|FG001|Period 2|Physician Decision|1|||
42096387|NCT00577460|75907097|FG001|Overall Study|Adverse Event|7|||
42190378|NCT00358215|76000629|FG001|Overall Study|Protocol Violation|59|||
42190379|NCT00358215|76000628|FG000|Overall Study|Pregnancy|1|||
42190380|NCT00358215|76000629|FG001|Overall Study|Pregnancy|0|||
42190381|NCT00358215|76000628|FG000|Overall Study|Other|21|||
42190382|NCT00358215|76000629|FG001|Overall Study|Other|14|||
42190383|NCT00358215|76000628|FG000|Overall Study|Did not receive investigational product|2|||
42190384|NCT00358215|76000629|FG001|Overall Study|Did not receive investigational product|3|||
42190385|NCT02855164|76000643|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
42190386|NCT02855164|76000644|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
42190387|NCT02855164|76000645|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
42190388|NCT02855164|76000646|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
42190389|NCT02855164|76000647|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
42190390|NCT02855164|76000648|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
42190391|NCT02855164|76000649|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
42190392|NCT02855164|76000650|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
42190393|NCT02855164|76000643|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
42190394|NCT02855164|76000644|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
42190395|NCT02855164|76000645|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
42190396|NCT02855164|76000646|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
42190397|NCT02855164|76000647|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
42190398|NCT02855164|76000648|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
42190399|NCT02855164|76000649|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
42190400|NCT02855164|76000650|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
42190401|NCT02855164|76000643|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
42190402|NCT02855164|76000644|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
42190403|NCT02855164|76000645|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
42190404|NCT02855164|76000646|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
42190405|NCT02855164|76000647|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
42190406|NCT02855164|76000648|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
42190407|NCT02855164|76000649|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
42190408|NCT02855164|76000650|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
42190409|NCT02855164|76000643|FG000|Part C (Randomized Set)|Adverse Event|0|||
42190410|NCT02855164|76000644|FG001|Part C (Randomized Set)|Adverse Event|0|||
42190411|NCT02855164|76000645|FG002|Part C (Randomized Set)|Adverse Event|0|||
42190412|NCT02855164|76000646|FG003|Part C (Randomized Set)|Adverse Event|0|||
42190413|NCT02855164|76000647|FG004|Part C (Randomized Set)|Adverse Event|0|||
42190414|NCT02855164|76000648|FG005|Part C (Randomized Set)|Adverse Event|5|||
42190415|NCT02855164|76000649|FG006|Part C (Randomized Set)|Adverse Event|9|||
42190416|NCT02855164|76000650|FG007|Part C (Randomized Set)|Adverse Event|2|||
42190417|NCT02855164|76000643|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
42096388|NCT00577460|75907098|FG002|Overall Study|Adverse Event|14|||
42096389|NCT00577460|75907096|FG000|Overall Study|Protocol Violation|0|||
42096390|NCT00577460|75907097|FG001|Overall Study|Protocol Violation|1|||
42096391|NCT00577460|75907098|FG002|Overall Study|Protocol Violation|1|||
42096392|NCT00577460|75907096|FG000|Overall Study|Lost to Follow-up|0|||
42096393|NCT00577460|75907097|FG001|Overall Study|Lost to Follow-up|3|||
42096394|NCT00577460|75907098|FG002|Overall Study|Lost to Follow-up|4|||
42096395|NCT00577460|75907096|FG000|Overall Study|Withdrawal by Subject|5|||
42096396|NCT00577460|75907097|FG001|Overall Study|Withdrawal by Subject|5|||
42096397|NCT00577460|75907098|FG002|Overall Study|Withdrawal by Subject|6|||
42096398|NCT00577460|75907096|FG000|Overall Study|Other|0|||
42096399|NCT00577460|75907097|FG001|Overall Study|Other|3|||
42096400|NCT00577460|75907098|FG002|Overall Study|Other|2|||
42096401|NCT00415519|75907115|FG000|Overall Study|Adverse Event|1|||
42096402|NCT00415519|75907116|FG001|Overall Study|Adverse Event|0|||
42096403|NCT00415519|75907115|FG000|Overall Study|Withdrawal by Subject|2|||
42096404|NCT00415519|75907116|FG001|Overall Study|Withdrawal by Subject|0|||
42096405|NCT00415519|75907115|FG000|Overall Study|Patient's convenience|1|||
42096406|NCT00415519|75907116|FG001|Overall Study|Patient's convenience|0|||
42096407|NCT00423943|75907124|FG000|Overall Study|Withdrawal by Subject|3|||
42096408|NCT00423943|75907125|FG001|Overall Study|Withdrawal by Subject|1|||
42190418|NCT02855164|76000644|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
42096409|NCT00428389|75907133|FG000|Core Phase|Adverse Event|6|||
42096410|NCT00428389|75907134|FG001|Core Phase|Adverse Event|4|||
42190419|NCT02855164|76000645|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
42190420|NCT02855164|76000646|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
42190421|NCT02855164|76000647|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
42190422|NCT02855164|76000648|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
42190423|NCT02855164|76000649|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
42190424|NCT02855164|76000650|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
42096411|NCT00428389|75907133|FG000|Core Phase|Lack of Efficacy|2|||
42296846|NCT02406261|76131664|FG000|Period 2|Protocol Violation|0|||
42296847|NCT02406261|76131665|FG001|Period 2|Protocol Violation|1|||
42296848|NCT02406261|76131664|FG000|Period 2|Withdrawal by Subject|0|||
42096412|NCT00428389|75907134|FG001|Core Phase|Lack of Efficacy|0|||
42190425|NCT02855164|76000643|FG000|Part C (Randomized Set)|Physician Decision|0|||
42190426|NCT02855164|76000644|FG001|Part C (Randomized Set)|Physician Decision|0|||
42190427|NCT02855164|76000645|FG002|Part C (Randomized Set)|Physician Decision|0|||
42190428|NCT02855164|76000646|FG003|Part C (Randomized Set)|Physician Decision|0|||
42190429|NCT02855164|76000647|FG004|Part C (Randomized Set)|Physician Decision|0|||
42190430|NCT02855164|76000648|FG005|Part C (Randomized Set)|Physician Decision|1|||
42190431|NCT02855164|76000649|FG006|Part C (Randomized Set)|Physician Decision|0|||
42190432|NCT02855164|76000650|FG007|Part C (Randomized Set)|Physician Decision|1|||
42190433|NCT02855164|76000643|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
42190434|NCT02855164|76000644|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
42190435|NCT02855164|76000645|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
42190436|NCT02855164|76000646|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
42190437|NCT02855164|76000647|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
42190438|NCT02855164|76000648|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
42190439|NCT02855164|76000649|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
42296849|NCT02406261|76131665|FG001|Period 2|Withdrawal by Subject|1|||
42296850|NCT02405091|76131675|FG000|Overall Study|Adverse Event|16|||
42296851|NCT02405091|76131676|FG001|Overall Study|Adverse Event|10|||
42296852|NCT02405091|76131677|FG002|Overall Study|Adverse Event|0|||
42296853|NCT02405091|76131675|FG000|Overall Study|Protocol Violation|1|||
42296854|NCT02405091|76131676|FG001|Overall Study|Protocol Violation|0|||
42296855|NCT02405091|76131677|FG002|Overall Study|Protocol Violation|0|||
42296856|NCT02405091|76131675|FG000|Overall Study|Noncompliance|1|||
42296857|NCT02405091|76131676|FG001|Overall Study|Noncompliance|6|||
42296858|NCT02405091|76131677|FG002|Overall Study|Noncompliance|2|||
42296859|NCT02405091|76131675|FG000|Overall Study|Withdrawal by Subject|4|||
42296860|NCT02405091|76131676|FG001|Overall Study|Withdrawal by Subject|8|||
42296861|NCT02405091|76131677|FG002|Overall Study|Withdrawal by Subject|0|||
42296862|NCT02405091|76131675|FG000|Overall Study|Death|0|||
42296863|NCT02405091|76131676|FG001|Overall Study|Death|1|||
42296864|NCT02405091|76131677|FG002|Overall Study|Death|0|||
42296865|NCT02405091|76131675|FG000|Overall Study|Lost to Follow-up|5|||
42296866|NCT02405091|76131676|FG001|Overall Study|Lost to Follow-up|6|||
42296867|NCT02405091|76131677|FG002|Overall Study|Lost to Follow-up|0|||
42296868|NCT02405091|76131675|FG000|Overall Study|Physician Decision|2|||
42296869|NCT02405091|76131676|FG001|Overall Study|Physician Decision|2|||
42296870|NCT02405091|76131677|FG002|Overall Study|Physician Decision|0|||
42296871|NCT02485353|76131688|FG000|Overall Study|Death|1|||
42296872|NCT02485353|76131688|FG000|Overall Study|Disease Progression|1|||
42296873|NCT02603107|76131694|FG000|Randomized Phase|Withdrew consent|8|||
42296874|NCT02603107|76131695|FG001|Randomized Phase|Withdrew consent|15|||
42296875|NCT02603107|76131694|FG000|Randomized Phase|Lost to Follow-up|1|||
42296876|NCT02603107|76131695|FG001|Randomized Phase|Lost to Follow-up|3|||
42296877|NCT02603107|76131694|FG000|Randomized Phase|Adverse Event|2|||
42296878|NCT02603107|76131695|FG001|Randomized Phase|Adverse Event|0|||
42296879|NCT02603107|76131694|FG000|Randomized Phase|Death|1|||
42296880|NCT02603107|76131695|FG001|Randomized Phase|Death|1|||
42296881|NCT02603107|76131694|FG000|Randomized Phase|Non-compliance with study drug|1|||
42296882|NCT02603107|76131695|FG001|Randomized Phase|Non-compliance with study drug|1|||
42296883|NCT02603107|76131694|FG000|Randomized Phase|Investigator's discretion|0|||
42296884|NCT02603107|76131695|FG001|Randomized Phase|Investigator's discretion|1|||
42296885|NCT02603107|76131694|FG000|Randomized Phase|Lack of Efficacy|1|||
42296886|NCT02603107|76131695|FG001|Randomized Phase|Lack of Efficacy|0|||
42296887|NCT02603107|76131694|FG000|Randomized Phase|Protocol Violation|1|||
42018319|NCT00996892|75825861|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
42018320|NCT00996892|75825862|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
42096413|NCT00428389|75907133|FG000|Core Phase|Abnormal test procedure result(s)|0|||
42096414|NCT00428389|75907134|FG001|Core Phase|Abnormal test procedure result(s)|1|||
42096415|NCT00428389|75907133|FG000|Core Phase|Withdrawal by Subject|3|||
42096416|NCT00428389|75907134|FG001|Core Phase|Withdrawal by Subject|4|||
42018321|NCT00996892|75825863|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
42018322|NCT00996892|75825864|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
42018323|NCT00996892|75825865|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
42018324|NCT00996892|75825866|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
42018325|NCT00996892|75825867|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
42018326|NCT00996892|75825868|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
42096417|NCT00428389|75907133|FG000|Core Phase|Protocol deviation|0|||
42096418|NCT00428389|75907134|FG001|Core Phase|Protocol deviation|2|||
42096419|NCT00428389|75907133|FG000|Extension Phase|Adverse Event|17|||
42096420|NCT00428389|75907134|FG001|Extension Phase|Adverse Event|11|||
42096421|NCT00428389|75907133|FG000|Extension Phase|Lack of Efficacy|4|||
42096422|NCT00428389|75907134|FG001|Extension Phase|Lack of Efficacy|3|||
42096423|NCT00428389|75907133|FG000|Extension Phase|Withdrawal by Subject|6|||
42096424|NCT00428389|75907134|FG001|Extension Phase|Withdrawal by Subject|6|||
42096425|NCT00428389|75907133|FG000|Extension Phase|Lost to Follow-up|0|||
42096426|NCT00428389|75907134|FG001|Extension Phase|Lost to Follow-up|3|||
42190440|NCT02855164|76000650|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
42190441|NCT01002742|76000690|FG000|Overall Study|Determined to be ineligible|0|||
42190442|NCT01002742|76000691|FG001|Overall Study|Determined to be ineligible|1|||
42190443|NCT02853760|76000697|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
42190444|NCT02853760|76000698|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
42190445|NCT02853760|76000699|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
42190446|NCT02853760|76000700|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
42190447|NCT02853760|76000701|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
42190448|NCT02853760|76000702|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
42190449|NCT02852434|76000712|FG000|Overall Study|Withdrawal by Subject|0|||
42190450|NCT02852434|76000713|FG001|Overall Study|Withdrawal by Subject|1|||
42190451|NCT02852434|76000712|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
42190452|NCT02852434|76000713|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
42190453|NCT02850016|76000721|FG000|Overall Study|Withdrawal by Subject|1|||
42296888|NCT02603107|76131695|FG001|Randomized Phase|Protocol Violation|0|||
42296889|NCT02603107|76131694|FG000|Optional Extension Phase|Lost to Follow-up|3|||
42296890|NCT02603107|76131695|FG001|Optional Extension Phase|Lost to Follow-up|3|||
42296891|NCT02603107|76131694|FG000|Optional Extension Phase|Withdrew consent|3|||
42296892|NCT02603107|76131695|FG001|Optional Extension Phase|Withdrew consent|2|||
42296893|NCT02603107|76131694|FG000|Optional Extension Phase|Investigator's discretion|2|||
42296894|NCT02603107|76131695|FG001|Optional Extension Phase|Investigator's discretion|2|||
42296895|NCT02603107|76131694|FG000|Optional Extension Phase|Pregnancy|0|||
42296896|NCT02603107|76131695|FG001|Optional Extension Phase|Pregnancy|3|||
42296897|NCT02603107|76131694|FG000|Optional Extension Phase|Adverse Event|0|||
42296898|NCT02603107|76131695|FG001|Optional Extension Phase|Adverse Event|2|||
42296899|NCT02603107|76131694|FG000|Optional Extension Phase|Not treated in extension phase|0|||
42296900|NCT02603107|76131695|FG001|Optional Extension Phase|Not treated in extension phase|1|||
42296901|NCT02603107|76131694|FG000|Optional Extension Phase|Protocol Violation|1|||
42296902|NCT02603107|76131695|FG001|Optional Extension Phase|Protocol Violation|0|||
42296903|NCT02484729|76131713|FG000|Overall Study|Failure of IntelliCap Error|0|||
42296904|NCT02484729|76131714|FG001|Overall Study|Failure of IntelliCap Error|0|||
42296905|NCT02484729|76131715|FG002|Overall Study|Failure of IntelliCap Error|0|||
42296906|NCT02484729|76131716|FG003|Overall Study|Failure of IntelliCap Error|0|||
42296907|NCT02484729|76131717|FG004|Overall Study|Failure of IntelliCap Error|0|||
42296908|NCT02484729|76131718|FG005|Overall Study|Failure of IntelliCap Error|0|||
42296909|NCT02484729|76131719|FG006|Overall Study|Failure of IntelliCap Error|0|||
42296910|NCT02484729|76131720|FG007|Overall Study|Failure of IntelliCap Error|0|||
42296911|NCT02484729|76131721|FG008|Overall Study|Failure of IntelliCap Error|0|||
42296912|NCT02484729|76131722|FG009|Overall Study|Failure of IntelliCap Error|1|||
42296913|NCT02601625|76131760|FG000|Overall Study|Lost to Follow-up|0|||
42296914|NCT02601625|76131761|FG001|Overall Study|Lost to Follow-up|0|||
42296915|NCT02601625|76131762|FG002|Overall Study|Lost to Follow-up|1|||
42296916|NCT02601625|76131763|FG003|Overall Study|Lost to Follow-up|1|||
42296917|NCT02601469|76131789|FG000|Overall Study|Enrolled in Error|1|||
42096427|NCT00428389|75907133|FG000|Extension Phase|Death|1|||
42096428|NCT00428389|75907134|FG001|Extension Phase|Death|0|||
42096429|NCT00428389|75907133|FG000|Extension Phase|Protocol Violation|3|||
42096430|NCT00428389|75907134|FG001|Extension Phase|Protocol Violation|2|||
42096431|NCT00428389|75907133|FG000|Extension Phase|Administrative problems|1|||
42096432|NCT00428389|75907134|FG001|Extension Phase|Administrative problems|1|||
42096433|NCT00616642|75907142|FG000|Overall Study|Withdrawal by Subject|0|||
42096434|NCT00616642|75907143|FG001|Overall Study|Withdrawal by Subject|1|||
42096435|NCT00406315|75907149|FG000|Overall Study|Death|1|||
42096436|NCT00406315|75907149|FG000|Overall Study|Adverse Event|39|||
42096437|NCT00406315|75907149|FG000|Overall Study|Laboratory Abnormality|4|||
42096438|NCT00406315|75907149|FG000|Overall Study|Lack of Efficacy|13|||
42096439|NCT00406315|75907149|FG000|Overall Study|Other|33|||
42096440|NCT00406315|75907149|FG000|Overall Study|Lost to Follow-up|21|||
42190454|NCT02850016|76000722|FG001|Overall Study|Withdrawal by Subject|2|||
42190455|NCT02849704|76000730|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
42190456|NCT02849704|76000731|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
42296918|NCT02601469|76131790|FG001|Overall Study|Enrolled in Error|0|||
42096441|NCT00406315|75907149|FG000|Overall Study|Withdrawal by Subject|30|||
42096442|NCT00711594|75907157|FG000|Overall Study|Progressive disease|2|||
42096443|NCT00711594|75907158|FG001|Overall Study|Progressive disease|2|||
42190457|NCT02849704|76000730|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
42190458|NCT02849704|76000731|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
42296919|NCT02604589|76131799|FG000|Overall Study|catheter dislodgement|0|||
42296920|NCT02604589|76131800|FG001|Overall Study|catheter dislodgement|0|||
42296921|NCT02604589|76131801|FG002|Overall Study|catheter dislodgement|1|||
42296922|NCT02601001|76131812|FG000|Dosing Period 2|Adverse Event|0|||
42096444|NCT00711594|75907159|FG002|Overall Study|Progressive disease|6|||
42096445|NCT00711594|75907160|FG003|Overall Study|Progressive disease|44|||
42096446|NCT00711594|75907157|FG000|Overall Study|Other Adverse Event|1|||
42190459|NCT02849704|76000730|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
42096447|NCT00711594|75907158|FG001|Overall Study|Other Adverse Event|0|||
42096448|NCT00711594|75907159|FG002|Overall Study|Other Adverse Event|0|||
42190460|NCT02849704|76000731|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
42096449|NCT00711594|75907160|FG003|Overall Study|Other Adverse Event|16|||
42096450|NCT00711594|75907157|FG000|Overall Study|Withdrawal by Subject|0|||
42096451|NCT00711594|75907158|FG001|Overall Study|Withdrawal by Subject|1|||
42096452|NCT00711594|75907159|FG002|Overall Study|Withdrawal by Subject|0|||
42096453|NCT00711594|75907160|FG003|Overall Study|Withdrawal by Subject|2|||
42096454|NCT00710762|75907174|FG000|Overall Study|Progressive disease|27|||
42096455|NCT00710762|75907175|FG001|Overall Study|Progressive disease|30|||
42190461|NCT03347396|76000752|FG000|Part A (26 Weeks)|Adverse Event|1|||
42190462|NCT03347396|76000753|FG001|Part A (26 Weeks)|Adverse Event|0|||
42190463|NCT03347396|76000752|FG000|Part A (26 Weeks)|Death|0|||
42190464|NCT03347396|76000753|FG001|Part A (26 Weeks)|Death|1|||
42190465|NCT03347396|76000752|FG000|Part B (149 Weeks)|Adverse Event|1|||
42190466|NCT03347396|76000753|FG001|Part B (149 Weeks)|Adverse Event|1|||
42190467|NCT03347396|76000752|FG000|Part B (149 Weeks)|Death|1|||
42190468|NCT03347396|76000753|FG001|Part B (149 Weeks)|Death|0|||
42190469|NCT03335150|76000764|FG000|Overall Study|Withdrawal by Subject|10|||
42190470|NCT03335150|76000765|FG001|Overall Study|Withdrawal by Subject|4|||
42190471|NCT03335150|76000764|FG000|Overall Study|Adverse Event|0|||
42190472|NCT03335150|76000765|FG001|Overall Study|Adverse Event|1|||
42190473|NCT03334448|76000771|FG000|Washout|Personal Reason|0|||
42190474|NCT03334448|76000772|FG001|Washout|Personal Reason|1|||
42190475|NCT03334448|76000773|FG002|Washout|Personal Reason|0|||
42190476|NCT03334448|76000774|FG003|Washout|Personal Reason|0|||
42190477|NCT03334448|76000771|FG000|Washout|Protocol Violation|0|||
42190478|NCT03334448|76000772|FG001|Washout|Protocol Violation|0|||
42190479|NCT03334448|76000773|FG002|Washout|Protocol Violation|0|||
42190480|NCT03334448|76000774|FG003|Washout|Protocol Violation|1|||
42190481|NCT02849080|76000782|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
42190482|NCT02849080|76000783|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
42190483|NCT02849080|76000784|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
42096456|NCT00710762|75907174|FG000|Overall Study|Adverse Event other disease worsening|2|||
42096457|NCT00710762|75907175|FG001|Overall Study|Adverse Event other disease worsening|1|||
42096458|NCT00710762|75907174|FG000|Overall Study|Other Adverse Event|7|||
42096459|NCT00710762|75907175|FG001|Overall Study|Other Adverse Event|7|||
42096460|NCT00710762|75907174|FG000|Overall Study|Lost to Follow-up|1|||
42096461|NCT00710762|75907175|FG001|Overall Study|Lost to Follow-up|0|||
42096462|NCT00710762|75907174|FG000|Overall Study|Reason other than listed above|2|||
42096463|NCT00710762|75907175|FG001|Overall Study|Reason other than listed above|2|||
42096464|NCT00573430|75907184|FG000|Overall Study|Incorrect enrollment of randomization|0|||
42096465|NCT00573430|75907185|FG001|Overall Study|Incorrect enrollment of randomization|4|||
42096466|NCT00573430|75907186|FG002|Overall Study|Incorrect enrollment of randomization|3|||
42096467|NCT00573430|75907184|FG000|Overall Study|Adverse Event|0|||
42096468|NCT00573430|75907185|FG001|Overall Study|Adverse Event|0|||
42096469|NCT00573430|75907186|FG002|Overall Study|Adverse Event|2|||
42096470|NCT00573430|75907184|FG000|Overall Study|Withdrawal by Subject|1|||
42096471|NCT00573430|75907185|FG001|Overall Study|Withdrawal by Subject|0|||
42096472|NCT00573430|75907186|FG002|Overall Study|Withdrawal by Subject|1|||
42096473|NCT00573430|75907184|FG000|Overall Study|Protocol Violation|0|||
42096474|NCT00573430|75907185|FG001|Overall Study|Protocol Violation|1|||
42096475|NCT00573430|75907186|FG002|Overall Study|Protocol Violation|1|||
42096476|NCT00573430|75907184|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42096477|NCT00573430|75907185|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
42096478|NCT00573430|75907186|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
42096479|NCT00711516|75907196|FG000|Overall Study|Adverse Event|1|||
42096480|NCT00711516|75907197|FG001|Overall Study|Adverse Event|1|||
42096481|NCT00711516|75907196|FG000|Overall Study|Withdrawal by Subject|0|||
42096482|NCT00711516|75907197|FG001|Overall Study|Withdrawal by Subject|1|||
42096483|NCT00711516|75907196|FG000|Overall Study|Protocol Violation|0|||
42190484|NCT02849080|76000785|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
42296923|NCT02601001|76131813|FG001|Dosing Period 2|Adverse Event|0|||
42096484|NCT00711516|75907197|FG001|Overall Study|Protocol Violation|1|||
42096485|NCT00615550|75907205|FG000|Overall Study|Lost to Follow-up|6|||
42096486|NCT00615550|75907206|FG001|Overall Study|Lost to Follow-up|1|||
42096487|NCT00577382|75907214|FG000|Overall Study|Adverse Event|0|||
42096488|NCT00577382|75907215|FG001|Overall Study|Adverse Event|6|||
42190485|NCT02849080|76000782|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
42190486|NCT02849080|76000783|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
42190487|NCT02849080|76000784|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
42296924|NCT02601001|76131814|FG002|Dosing Period 2|Adverse Event|0|||
42190488|NCT02849080|76000785|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
42190489|NCT02849080|76000782|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
42190490|NCT02849080|76000783|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
42296925|NCT02601001|76131815|FG003|Dosing Period 2|Adverse Event|0|||
42096489|NCT00577382|75907214|FG000|Overall Study|Withdrawal by Subject|0|||
42096490|NCT00577382|75907215|FG001|Overall Study|Withdrawal by Subject|1|||
42096491|NCT00577382|75907214|FG000|Overall Study|Progressive Disease|17|||
42096492|NCT00577382|75907215|FG001|Overall Study|Progressive Disease|19|||
42096493|NCT00577382|75907214|FG000|Overall Study|Intercurrent Illness|1|||
42096494|NCT00577382|75907215|FG001|Overall Study|Intercurrent Illness|2|||
42096495|NCT00577382|75907214|FG000|Overall Study|Death|1|||
42096496|NCT00577382|75907215|FG001|Overall Study|Death|1|||
42096497|NCT00577382|75907214|FG000|Overall Study|Lost to Follow-up|2|||
42096498|NCT00577382|75907215|FG001|Overall Study|Lost to Follow-up|2|||
42096499|NCT00614926|75907223|FG000|Overall Study|Burden of travel|1|||
42096500|NCT00614926|75907224|FG001|Overall Study|Burden of travel|0|||
42096501|NCT00614926|75907223|FG000|Overall Study|Adverse Event|3|||
42096502|NCT00614926|75907224|FG001|Overall Study|Adverse Event|0|||
42096503|NCT00423319|75907232|FG000|Overall Study|Death|2|||
42096504|NCT00423319|75907233|FG001|Overall Study|Death|0|||
42096505|NCT00423319|75907232|FG000|Overall Study|Adverse Event|93|||
42096506|NCT00423319|75907233|FG001|Overall Study|Adverse Event|112|||
42096507|NCT00423319|75907232|FG000|Overall Study|Withdrawal by Subject|86|||
42096508|NCT00423319|75907233|FG001|Overall Study|Withdrawal by Subject|99|||
42096509|NCT00423319|75907232|FG000|Overall Study|Lost to Follow-up|4|||
42096510|NCT00423319|75907233|FG001|Overall Study|Lost to Follow-up|3|||
42096511|NCT00423319|75907232|FG000|Overall Study|Poor compliance or noncompliance|1|||
42096512|NCT00423319|75907233|FG001|Overall Study|Poor compliance or noncompliance|1|||
42096513|NCT00423319|75907232|FG000|Overall Study|No longer meets study criteria|15|||
42096514|NCT00423319|75907233|FG001|Overall Study|No longer meets study criteria|15|||
42096515|NCT00423319|75907232|FG000|Overall Study|Other|23|||
42096516|NCT00423319|75907233|FG001|Overall Study|Other|22|||
42096517|NCT00710684|75907243|FG000|Overall Study|Adverse Event|11|||
42096518|NCT00710684|75907244|FG001|Overall Study|Adverse Event|19|||
42096519|NCT00710684|75907245|FG002|Overall Study|Adverse Event|16|||
42096520|NCT00710684|75907243|FG000|Overall Study|Lack of Efficacy|4|||
42096521|NCT00710684|75907244|FG001|Overall Study|Lack of Efficacy|3|||
42096522|NCT00710684|75907245|FG002|Overall Study|Lack of Efficacy|5|||
42096523|NCT00710684|75907243|FG000|Overall Study|Protocol Violation|5|||
42096524|NCT00710684|75907244|FG001|Overall Study|Protocol Violation|5|||
42096525|NCT00710684|75907245|FG002|Overall Study|Protocol Violation|5|||
42096526|NCT00710684|75907243|FG000|Overall Study|Lost to Follow-up|4|||
42096527|NCT00710684|75907244|FG001|Overall Study|Lost to Follow-up|6|||
42096528|NCT00710684|75907245|FG002|Overall Study|Lost to Follow-up|7|||
42096529|NCT00710684|75907243|FG000|Overall Study|Physician Decision|0|||
42096530|NCT00710684|75907244|FG001|Overall Study|Physician Decision|2|||
42096531|NCT00710684|75907245|FG002|Overall Study|Physician Decision|4|||
42096532|NCT00710684|75907243|FG000|Overall Study|Withdrawal by Subject|24|||
42096533|NCT00710684|75907244|FG001|Overall Study|Withdrawal by Subject|18|||
42096534|NCT00710684|75907245|FG002|Overall Study|Withdrawal by Subject|11|||
42190491|NCT02849080|76000784|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
42190492|NCT02849080|76000785|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
42190493|NCT02849080|76000782|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
42190494|NCT02849080|76000783|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
42190495|NCT02849080|76000784|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
42190496|NCT02849080|76000785|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
42190497|NCT02849080|76000782|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
42190498|NCT02849080|76000783|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
42190499|NCT02849080|76000784|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
42190500|NCT02849080|76000785|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
42190501|NCT02849080|76000782|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
42190502|NCT02849080|76000783|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
42190503|NCT02849080|76000784|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
42190504|NCT02849080|76000785|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
42190505|NCT03346070|76000802|FG000|Overall Study|Death|0|||
42190506|NCT03346070|76000803|FG001|Overall Study|Death|0|||
42190507|NCT03346070|76000804|FG002|Overall Study|Death|0|||
42190508|NCT03346070|76000805|FG003|Overall Study|Death|0|||
42190509|NCT03346070|76000806|FG004|Overall Study|Death|1|||
42190510|NCT03346070|76000802|FG000|Overall Study|Lost to Follow-up|0|||
42096535|NCT00710684|75907243|FG000|Overall Study|Missing|1|||
42096536|NCT00710684|75907244|FG001|Overall Study|Missing|0|||
42096537|NCT00710684|75907245|FG002|Overall Study|Missing|0|||
42096538|NCT00710684|75907243|FG000|Overall Study|Did not continue after week 24|25|||
42096539|NCT00710684|75907244|FG001|Overall Study|Did not continue after week 24|21|||
42190511|NCT03346070|76000803|FG001|Overall Study|Lost to Follow-up|1|||
42096540|NCT00710684|75907245|FG002|Overall Study|Did not continue after week 24|16|||
42096541|NCT00710606|75907261|FG000|Overall Study|Adverse Event|0|||
42096542|NCT00710606|75907262|FG001|Overall Study|Adverse Event|2|||
42096543|NCT00713544|75907276|FG000|Overall Study|Adverse Event|5|||
42190512|NCT03346070|76000804|FG002|Overall Study|Lost to Follow-up|2|||
42190513|NCT03346070|76000805|FG003|Overall Study|Lost to Follow-up|0|||
42190514|NCT03346070|76000806|FG004|Overall Study|Lost to Follow-up|0|||
42190515|NCT03346070|76000802|FG000|Overall Study|Physician Decision|0|||
42190516|NCT03346070|76000803|FG001|Overall Study|Physician Decision|0|||
42190517|NCT03346070|76000804|FG002|Overall Study|Physician Decision|0|||
42190518|NCT03346070|76000805|FG003|Overall Study|Physician Decision|1|||
42190519|NCT03346070|76000806|FG004|Overall Study|Physician Decision|1|||
42190520|NCT03346070|76000802|FG000|Overall Study|Withdrawal by Subject|1|||
42190521|NCT03346070|76000803|FG001|Overall Study|Withdrawal by Subject|0|||
42190522|NCT03346070|76000804|FG002|Overall Study|Withdrawal by Subject|0|||
42190523|NCT03346070|76000805|FG003|Overall Study|Withdrawal by Subject|1|||
42190524|NCT03346070|76000806|FG004|Overall Study|Withdrawal by Subject|0|||
42190525|NCT03346070|76000802|FG000|Overall Study|Study medication not received as planned|2|||
42190526|NCT03346070|76000803|FG001|Overall Study|Study medication not received as planned|3|||
42096544|NCT00713544|75907277|FG001|Overall Study|Adverse Event|3|||
42190527|NCT03346070|76000804|FG002|Overall Study|Study medication not received as planned|2|||
42190528|NCT03346070|76000805|FG003|Overall Study|Study medication not received as planned|3|||
42190529|NCT03346070|76000806|FG004|Overall Study|Study medication not received as planned|2|||
42190530|NCT03346070|76000802|FG000|Overall Study|Screen Failure|0|||
42190531|NCT03346070|76000803|FG001|Overall Study|Screen Failure|0|||
42190532|NCT03346070|76000804|FG002|Overall Study|Screen Failure|0|||
42190533|NCT03346070|76000805|FG003|Overall Study|Screen Failure|1|||
42190534|NCT03346070|76000806|FG004|Overall Study|Screen Failure|1|||
42190535|NCT02951780|76000829|FG000|Period 1|Adverse Event|0|||
42190536|NCT02951780|76000830|FG001|Period 1|Adverse Event|0|||
42296926|NCT02601001|76131816|FG004|Dosing Period 2|Adverse Event|0|||
42296927|NCT02601001|76131817|FG005|Dosing Period 2|Adverse Event|0|||
42296928|NCT02601001|76131818|FG006|Dosing Period 2|Adverse Event|1|||
42296929|NCT02604199|76131843|FG000|Overall Study|Pregnancy|0|||
42296930|NCT02604199|76131844|FG001|Overall Study|Pregnancy|0|||
42296931|NCT02604199|76131845|FG002|Overall Study|Pregnancy|0|||
42296932|NCT02604199|76131846|FG003|Overall Study|Pregnancy|1|||
42296933|NCT02604199|76131843|FG000|Overall Study|Study terminated by sponsor|0|||
42296934|NCT02604199|76131844|FG001|Overall Study|Study terminated by sponsor|2|||
42296935|NCT02604199|76131845|FG002|Overall Study|Study terminated by sponsor|0|||
42296936|NCT02604199|76131846|FG003|Overall Study|Study terminated by sponsor|2|||
42296937|NCT02604199|76131843|FG000|Overall Study|Withdrawal by Subject|0|||
42296938|NCT02604199|76131844|FG001|Overall Study|Withdrawal by Subject|1|||
42296939|NCT02604199|76131845|FG002|Overall Study|Withdrawal by Subject|0|||
42296940|NCT02604199|76131846|FG003|Overall Study|Withdrawal by Subject|0|||
42296941|NCT02600845|76131859|FG000|Overall Study|Reason Not Specified|3|||
42296942|NCT02600845|76131859|FG000|Overall Study|Non-compliance with Study Procedures|10|||
42296943|NCT02600845|76131859|FG000|Overall Study|Consent Withdrawal|5|||
42296944|NCT02599129|76131865|FG000|Overall Study|Lack of Efficacy|2|||
42296945|NCT02599129|76131866|FG001|Overall Study|Lack of Efficacy|2|||
42296946|NCT02599129|76131865|FG000|Overall Study|Lost to Follow-up|1|||
42296947|NCT02599129|76131866|FG001|Overall Study|Lost to Follow-up|0|||
42296948|NCT02599129|76131865|FG000|Overall Study|Withdrawal by Subject|2|||
42296949|NCT02599129|76131866|FG001|Overall Study|Withdrawal by Subject|1|||
42296950|NCT02596711|76131875|FG000|Overall Study|Lost to Follow-up|1|||
42296951|NCT02596711|76131876|FG001|Overall Study|Lost to Follow-up|2|||
42296952|NCT02596711|76131877|FG002|Overall Study|Lost to Follow-up|3|||
42296953|NCT02596009|76131885|FG000|Overall Study|Administrative problems|0|||
42296954|NCT02596009|76131886|FG001|Overall Study|Administrative problems|1|||
42096545|NCT00713544|75907278|FG002|Overall Study|Adverse Event|7|||
42096546|NCT00713544|75907279|FG003|Overall Study|Adverse Event|7|||
42096547|NCT00713544|75907280|FG004|Overall Study|Adverse Event|3|||
42096548|NCT00713544|75907281|FG005|Overall Study|Adverse Event|5|||
42096549|NCT00713544|75907276|FG000|Overall Study|Withdrawal by Subject|2|||
42096550|NCT00713544|75907277|FG001|Overall Study|Withdrawal by Subject|0|||
42096551|NCT00713544|75907278|FG002|Overall Study|Withdrawal by Subject|3|||
42096552|NCT00713544|75907279|FG003|Overall Study|Withdrawal by Subject|2|||
42096553|NCT00713544|75907280|FG004|Overall Study|Withdrawal by Subject|3|||
42296955|NCT02596009|76131887|FG002|Overall Study|Administrative problems|0|||
42096554|NCT00713544|75907281|FG005|Overall Study|Withdrawal by Subject|1|||
42096555|NCT00713544|75907276|FG000|Overall Study|Protocol Violation|0|||
42296956|NCT02596009|76131888|FG003|Overall Study|Administrative problems|0|||
42296957|NCT02596009|76131889|FG004|Overall Study|Administrative problems|0|||
42296958|NCT02596009|76131890|FG005|Overall Study|Administrative problems|0|||
42296959|NCT02590939|76131898|FG000|Overall Study|Withdrawal by Subject|3|||
42190537|NCT02951780|76000831|FG002|Period 1|Adverse Event|0|||
42190538|NCT02951780|76000832|FG003|Period 1|Adverse Event|1|||
42190539|NCT02951780|76000833|FG004|Period 1|Adverse Event|0|||
42190540|NCT02951780|76000834|FG005|Period 1|Adverse Event|0|||
42190541|NCT02951780|76000835|FG006|Period 1|Adverse Event|0|||
42190542|NCT02951780|76000836|FG007|Period 1|Adverse Event|0|||
42096556|NCT00713544|75907277|FG001|Overall Study|Protocol Violation|0|||
42190543|NCT02951780|76000837|FG008|Period 1|Adverse Event|0|||
42296960|NCT02590939|76131899|FG001|Overall Study|Withdrawal by Subject|1|||
42296961|NCT02590939|76131898|FG000|Overall Study|Failed the nociceptive test|2|||
42096557|NCT00713544|75907278|FG002|Overall Study|Protocol Violation|0|||
42096558|NCT00713544|75907279|FG003|Overall Study|Protocol Violation|0|||
42096559|NCT00713544|75907280|FG004|Overall Study|Protocol Violation|0|||
42096560|NCT00713544|75907281|FG005|Overall Study|Protocol Violation|1|||
42096561|NCT00713544|75907276|FG000|Overall Study|Physician Decision|0|||
42096562|NCT00713544|75907277|FG001|Overall Study|Physician Decision|0|||
42096563|NCT00713544|75907278|FG002|Overall Study|Physician Decision|0|||
42096564|NCT00713544|75907279|FG003|Overall Study|Physician Decision|0|||
42096565|NCT00713544|75907280|FG004|Overall Study|Physician Decision|0|||
42096566|NCT00713544|75907281|FG005|Overall Study|Physician Decision|2|||
42096567|NCT00713544|75907276|FG000|Overall Study|Lack of Efficacy|0|||
42096568|NCT00713544|75907277|FG001|Overall Study|Lack of Efficacy|1|||
42096569|NCT00713544|75907278|FG002|Overall Study|Lack of Efficacy|0|||
42096570|NCT00713544|75907279|FG003|Overall Study|Lack of Efficacy|1|||
42096571|NCT00713544|75907280|FG004|Overall Study|Lack of Efficacy|1|||
42096572|NCT00713544|75907281|FG005|Overall Study|Lack of Efficacy|0|||
42096573|NCT00713544|75907276|FG000|Overall Study|Lost to Follow-up|0|||
42096574|NCT00713544|75907277|FG001|Overall Study|Lost to Follow-up|0|||
42096575|NCT00713544|75907278|FG002|Overall Study|Lost to Follow-up|1|||
42096576|NCT00713544|75907279|FG003|Overall Study|Lost to Follow-up|0|||
42096577|NCT00713544|75907280|FG004|Overall Study|Lost to Follow-up|0|||
42096578|NCT00713544|75907281|FG005|Overall Study|Lost to Follow-up|0|||
42096579|NCT00713544|75907276|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
42096580|NCT00713544|75907277|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
42096581|NCT00713544|75907278|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
42096582|NCT00713544|75907279|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
42096583|NCT00713544|75907280|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
42096584|NCT00713544|75907281|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
42096585|NCT00713544|75907276|FG000|Overall Study|Incorrect enrollment|0|||
42096586|NCT00713544|75907277|FG001|Overall Study|Incorrect enrollment|1|||
42096587|NCT00713544|75907278|FG002|Overall Study|Incorrect enrollment|0|||
42190544|NCT02951780|76000829|FG000|Period 1|Scheduling Conflicts|0|||
42190545|NCT02951780|76000830|FG001|Period 1|Scheduling Conflicts|0|||
42190546|NCT02951780|76000831|FG002|Period 1|Scheduling Conflicts|0|||
42190547|NCT02951780|76000832|FG003|Period 1|Scheduling Conflicts|0|||
42190548|NCT02951780|76000833|FG004|Period 1|Scheduling Conflicts|0|||
42190549|NCT02951780|76000834|FG005|Period 1|Scheduling Conflicts|0|||
42190550|NCT02951780|76000835|FG006|Period 1|Scheduling Conflicts|0|||
42096588|NCT00713544|75907279|FG003|Overall Study|Incorrect enrollment|0|||
42096589|NCT00713544|75907280|FG004|Overall Study|Incorrect enrollment|0|||
42096590|NCT00713544|75907281|FG005|Overall Study|Incorrect enrollment|0|||
42096591|NCT00713544|75907276|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
42096592|NCT00713544|75907277|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
42096593|NCT00713544|75907278|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
42096594|NCT00713544|75907279|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
42190551|NCT02951780|76000836|FG007|Period 1|Scheduling Conflicts|1|||
42190552|NCT02951780|76000837|FG008|Period 1|Scheduling Conflicts|0|||
42190553|NCT02951780|76000829|FG000|Period 2|Scheduling Conflicts|0|||
42190554|NCT02951780|76000830|FG001|Period 2|Scheduling Conflicts|0|||
42190555|NCT02951780|76000831|FG002|Period 2|Scheduling Conflicts|0|||
42190556|NCT02951780|76000832|FG003|Period 2|Scheduling Conflicts|0|||
42190557|NCT02951780|76000833|FG004|Period 2|Scheduling Conflicts|0|||
42190558|NCT02951780|76000834|FG005|Period 2|Scheduling Conflicts|0|||
42190559|NCT02951780|76000835|FG006|Period 2|Scheduling Conflicts|0|||
42190560|NCT02951780|76000836|FG007|Period 2|Scheduling Conflicts|1|||
42190561|NCT02951780|76000837|FG008|Period 2|Scheduling Conflicts|0|||
42096595|NCT00713544|75907280|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
42190562|NCT03334214|76000859|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
42190563|NCT03334214|76000860|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
42296962|NCT02590939|76131899|FG001|Overall Study|Failed the nociceptive test|1|||
42096596|NCT00713544|75907281|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
42096597|NCT00415363|75907297|FG000|Overall Study|Withdrawal by Subject|4|||
42096598|NCT00415363|75907298|FG001|Overall Study|Withdrawal by Subject|4|||
42096599|NCT00415363|75907297|FG000|Overall Study|Adverse Event|4|||
42096600|NCT00415363|75907298|FG001|Overall Study|Adverse Event|4|||
42190564|NCT03334214|76000859|FG000|Overall Study|Withdrawal by Subject|0|||
42190565|NCT03334214|76000860|FG001|Overall Study|Withdrawal by Subject|1|||
42296963|NCT04351087|76131907|FG000|Overall Study|Lost to Follow-up|7|||
42296964|NCT04351087|76131908|FG001|Overall Study|Lost to Follow-up|3|||
42296965|NCT04351087|76131907|FG000|Overall Study|Withdrawal by Subject|3|||
42296966|NCT04351087|76131908|FG001|Overall Study|Withdrawal by Subject|4|||
42096601|NCT00415363|75907297|FG000|Overall Study|Lost to Follow-up|2|||
42096602|NCT00415363|75907298|FG001|Overall Study|Lost to Follow-up|1|||
42096603|NCT00415363|75907297|FG000|Overall Study|Physician Decision|3|||
42096604|NCT00415363|75907298|FG001|Overall Study|Physician Decision|1|||
42096605|NCT00415363|75907297|FG000|Overall Study|Death|16|||
42190566|NCT03334214|76000859|FG000|Overall Study|Other|1|||
42190567|NCT03334214|76000860|FG001|Overall Study|Other|0|||
42190568|NCT02250664|76000870|FG000|Overall Study|Lost to Follow-up|18|||
42190569|NCT02250664|76000871|FG001|Overall Study|Lost to Follow-up|28|||
42190570|NCT02250664|76000872|FG002|Overall Study|Lost to Follow-up|33|||
42190571|NCT02250664|76000870|FG000|Overall Study|Personal Reasons|7|||
42190572|NCT02250664|76000871|FG001|Overall Study|Personal Reasons|8|||
42296967|NCT04351087|76131907|FG000|Overall Study|Lack of Efficacy|3|||
42296968|NCT04351087|76131908|FG001|Overall Study|Lack of Efficacy|2|||
42296969|NCT02598193|76131914|FG000|Overall Study|Adverse Event|13|||
42296970|NCT02598193|76131914|FG000|Overall Study|Withdrawal by Subject|1|||
42296971|NCT02598193|76131914|FG000|Overall Study|Listed in active lung transplant list|1|||
42296972|NCT02598193|76131914|FG000|Overall Study|Does not want to take Nintedanib|1|||
42296973|NCT02595073|76131920|FG000|Overall Study|Progressive Disease|0|||
42296974|NCT02595073|76131921|FG001|Overall Study|Progressive Disease|1|||
42296975|NCT02595073|76131920|FG000|Overall Study|Protocol Violation|2|||
42296976|NCT02595073|76131921|FG001|Overall Study|Protocol Violation|0|||
42296977|NCT02593825|76131929|FG000|Intervention|Lost to Follow-up|10|||
42296978|NCT02593825|76131930|FG001|Intervention|Lost to Follow-up|12|||
42296979|NCT02388165|76131940|FG000|Overall Study|Study terminated by sponsor|5|||
42096606|NCT00415363|75907298|FG001|Overall Study|Death|12|||
42096607|NCT00415363|75907297|FG000|Overall Study|Progressive disease|26|||
42096608|NCT00415363|75907298|FG001|Overall Study|Progressive disease|32|||
42096609|NCT00415051|75907305|FG000|Overall Study|Protocol Violation|1|||
42096610|NCT00713258|75907311|FG000|Overall Study|Adverse Event|2|||
42096611|NCT00713258|75907312|FG001|Overall Study|Adverse Event|4|||
42296980|NCT02388165|76131941|FG001|Overall Study|Study terminated by sponsor|5|||
42296981|NCT02388165|76131940|FG000|Overall Study|Other|11|||
42296982|NCT02388165|76131941|FG001|Overall Study|Other|13|||
42296983|NCT02388165|76131940|FG000|Overall Study|No longer meet eligibility criteria|40|||
42296984|NCT02388165|76131941|FG001|Overall Study|No longer meet eligibility criteria|43|||
42296985|NCT02388165|76131940|FG000|Overall Study|Withdrawal of consent|31|||
42296986|NCT02388165|76131941|FG001|Overall Study|Withdrawal of consent|32|||
42296987|NCT02388165|76131940|FG000|Overall Study|Lost to Follow-up|19|||
42296988|NCT02388165|76131941|FG001|Overall Study|Lost to Follow-up|20|||
42296989|NCT02388165|76131940|FG000|Overall Study|Death|13|||
42296990|NCT02388165|76131941|FG001|Overall Study|Death|10|||
42296991|NCT02388165|76131940|FG000|Overall Study|Adverse Event|3|||
42296992|NCT02388165|76131941|FG001|Overall Study|Adverse Event|5|||
42296993|NCT02388165|76131940|FG000|Overall Study|Did not meet entrance criteria|5|||
42296994|NCT02388165|76131941|FG001|Overall Study|Did not meet entrance criteria|2|||
42296995|NCT02404545|76131949|FG000|Overall Study|Sponsor Termination|6|||
42296996|NCT02404545|76131950|FG001|Overall Study|Sponsor Termination|6|||
42296997|NCT02420379|76131959|FG000|Overall Study|Withdrawal by Subject|0|||
42296998|NCT02420379|76131960|FG001|Overall Study|Withdrawal by Subject|3|||
42296999|NCT02420379|76131959|FG000|Overall Study|Unable to complete due to schooling|0|||
42096612|NCT00713258|75907311|FG000|Overall Study|Non-Compliance|2|||
42190573|NCT02250664|76000872|FG002|Overall Study|Personal Reasons|14|||
42190574|NCT02250664|76000870|FG000|Overall Study|Adverse Event|6|||
42190575|NCT02250664|76000871|FG001|Overall Study|Adverse Event|3|||
42190576|NCT02250664|76000872|FG002|Overall Study|Adverse Event|8|||
42190577|NCT02250664|76000870|FG000|Overall Study|Incarcerated|2|||
42297000|NCT02420379|76131960|FG001|Overall Study|Unable to complete due to schooling|1|||
42297001|NCT02420379|76131959|FG000|Overall Study|Transitioned to commercial drug|1|||
42297002|NCT02420379|76131960|FG001|Overall Study|Transitioned to commercial drug|0|||
42297003|NCT02347761|76131969|FG000|All Collected|Death|1|||
42297004|NCT02347761|76131970|FG001|All Collected|Death|0|||
42297005|NCT02347761|76131971|FG002|All Collected|Death|0|||
42096613|NCT00713258|75907312|FG001|Overall Study|Non-Compliance|1|||
42190578|NCT02250664|76000871|FG001|Overall Study|Incarcerated|1|||
42190579|NCT02250664|76000872|FG002|Overall Study|Incarcerated|2|||
42297006|NCT02347761|76131969|FG000|All Collected|Lost to Follow-up|3|||
42297007|NCT02347761|76131970|FG001|All Collected|Lost to Follow-up|2|||
42297008|NCT02347761|76131971|FG002|All Collected|Lost to Follow-up|3|||
42297009|NCT02347761|76131969|FG000|All Collected|Withdrawal by Subject|11|||
42297010|NCT02347761|76131970|FG001|All Collected|Withdrawal by Subject|11|||
42297011|NCT02347761|76131971|FG002|All Collected|Withdrawal by Subject|22|||
42297012|NCT02347761|76131969|FG000|All Collected|invetigator disretion|2|||
42096614|NCT00713258|75907311|FG000|Overall Study|Other|1|||
42190580|NCT02250664|76000870|FG000|Overall Study|Withdrawal by Subject|0|||
42096615|NCT00713258|75907312|FG001|Overall Study|Other|1|||
42190581|NCT02250664|76000871|FG001|Overall Study|Withdrawal by Subject|1|||
42190582|NCT02250664|76000872|FG002|Overall Study|Withdrawal by Subject|2|||
42190583|NCT02250664|76000870|FG000|Overall Study|Death|0|||
42190584|NCT02250664|76000871|FG001|Overall Study|Death|1|||
42190585|NCT02250664|76000872|FG002|Overall Study|Death|1|||
42190586|NCT02250664|76000870|FG000|Overall Study|Physician Decision|1|||
42190587|NCT02250664|76000871|FG001|Overall Study|Physician Decision|3|||
42190588|NCT02250664|76000872|FG002|Overall Study|Physician Decision|1|||
42190589|NCT02250664|76000870|FG000|Overall Study|Protocol Violation|1|||
42190590|NCT02250664|76000871|FG001|Overall Study|Protocol Violation|0|||
42190591|NCT02250664|76000872|FG002|Overall Study|Protocol Violation|1|||
42096616|NCT00710034|75907320|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
42096617|NCT00710034|75907321|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
42190592|NCT02250664|76000870|FG000|Overall Study|Reason unknown|1|||
42190593|NCT02250664|76000871|FG001|Overall Study|Reason unknown|0|||
42190594|NCT02250664|76000872|FG002|Overall Study|Reason unknown|0|||
42190595|NCT02646982|76000882|FG000|Overall Study|Adverse Event|1|||
42190596|NCT02646982|76000883|FG001|Overall Study|Adverse Event|1|||
42190597|NCT02646982|76000882|FG000|Overall Study|Withdrawal by Subject|2|||
42096618|NCT00710034|75907320|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
42096619|NCT00710034|75907321|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
42096620|NCT00710034|75907320|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
42096621|NCT00710034|75907321|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
42096622|NCT00710034|75907320|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
42096623|NCT00710034|75907321|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
42096624|NCT00710034|75907320|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
42096625|NCT00710034|75907321|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
42096626|NCT00710034|75907320|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
42096627|NCT00710034|75907321|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
42096628|NCT00710034|75907320|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
42096629|NCT00710034|75907321|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
42096630|NCT00710034|75907320|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
42096631|NCT00710034|75907321|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
42096632|NCT00710034|75907320|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
42096633|NCT00710034|75907321|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
42096634|NCT00710034|75907320|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
42096635|NCT00710034|75907321|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
42096636|NCT00710034|75907320|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
42096637|NCT00710034|75907321|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
42096638|NCT00414973|75907331|FG000|Overall Study|Withdrawal by Subject|14|||
42096639|NCT00414973|75907332|FG001|Overall Study|Withdrawal by Subject|4|||
42096640|NCT00414973|75907333|FG002|Overall Study|Withdrawal by Subject|1|||
42096641|NCT00414973|75907334|FG003|Overall Study|Withdrawal by Subject|0|||
42190598|NCT02646982|76000883|FG001|Overall Study|Withdrawal by Subject|1|||
42190599|NCT02845336|76000891|FG000|Overall Study|Lost to Follow-up|3|||
42190600|NCT02845336|76000892|FG001|Overall Study|Lost to Follow-up|1|||
42190601|NCT02845336|76000891|FG000|Overall Study|Inability to get medication|2|||
42190602|NCT02845336|76000892|FG001|Overall Study|Inability to get medication|0|||
42190603|NCT02844946|76000900|FG000|Overall Study|Lost to Follow-up|7|||
42190604|NCT02844946|76000901|FG001|Overall Study|Lost to Follow-up|0|||
42190605|NCT02951156|76000910|FG000|Overall Study|Death|3|||
42190606|NCT02951156|76000911|FG001|Overall Study|Death|8|||
42190607|NCT02951156|76000912|FG002|Overall Study|Death|5|||
42190608|NCT02951156|76000910|FG000|Overall Study|Progressive disease|1|||
42190609|NCT02951156|76000911|FG001|Overall Study|Progressive disease|0|||
42190610|NCT02951156|76000912|FG002|Overall Study|Progressive disease|1|||
42190611|NCT02951156|76000910|FG000|Overall Study|Withdrawal by Subject|0|||
42190612|NCT02951156|76000911|FG001|Overall Study|Withdrawal by Subject|0|||
42190613|NCT02951156|76000912|FG002|Overall Study|Withdrawal by Subject|1|||
42190614|NCT02951156|76000910|FG000|Overall Study|Study terminated by sponsor|0|||
42190615|NCT02951156|76000911|FG001|Overall Study|Study terminated by sponsor|0|||
42190616|NCT02951156|76000912|FG002|Overall Study|Study terminated by sponsor|1|||
42096642|NCT00414973|75907331|FG000|Overall Study|Adverse Event|10|||
42096643|NCT00414973|75907332|FG001|Overall Study|Adverse Event|0|||
42096644|NCT00414973|75907333|FG002|Overall Study|Adverse Event|1|||
42096645|NCT00414973|75907334|FG003|Overall Study|Adverse Event|0|||
42096646|NCT00414973|75907331|FG000|Overall Study|Protocol Violation|3|||
42190617|NCT02951156|76000910|FG000|Overall Study|Other|5|||
42190618|NCT02951156|76000911|FG001|Overall Study|Other|1|||
42190619|NCT02951156|76000912|FG002|Overall Study|Other|2|||
42190620|NCT03345914|76000924|FG000|Overall Study|Transition to another study at week 16|80|||
42190621|NCT03345914|76000925|FG001|Overall Study|Transition to another study at week 16|86|||
42190622|NCT03345914|76000926|FG002|Overall Study|Transition to another study at week 16|78|||
42096647|NCT00414973|75907332|FG001|Overall Study|Protocol Violation|4|||
42190623|NCT03345914|76000924|FG000|Overall Study|Transition to OLE during follow-up|37|||
42359221|NCT01827384|76204845|FG000|Overall Study|Ineligible|0|||
42190624|NCT03345914|76000925|FG001|Overall Study|Transition to OLE during follow-up|33|||
42190625|NCT03345914|76000926|FG002|Overall Study|Transition to OLE during follow-up|39|||
42190626|NCT03345914|76000924|FG000|Overall Study|Physician Decision|0|||
42190627|NCT03345914|76000925|FG001|Overall Study|Physician Decision|1|||
42190628|NCT03345914|76000926|FG002|Overall Study|Physician Decision|1|||
42190629|NCT03345914|76000924|FG000|Overall Study|Withdrawal by Subject|5|||
42190630|NCT03345914|76000925|FG001|Overall Study|Withdrawal by Subject|1|||
42190631|NCT03345914|76000926|FG002|Overall Study|Withdrawal by Subject|2|||
42190632|NCT03345914|76000924|FG000|Overall Study|Other|1|||
42190633|NCT03345914|76000925|FG001|Overall Study|Other|1|||
42190634|NCT03345914|76000926|FG002|Overall Study|Other|1|||
42190635|NCT03345914|76000924|FG000|Overall Study|Ongoing|0|||
42190636|NCT03345914|76000925|FG001|Overall Study|Ongoing|0|||
42190637|NCT03345914|76000926|FG002|Overall Study|Ongoing|1|||
42190638|NCT03369704|76000936|FG000|Treatment Epoch|technical problems|1|||
42190639|NCT03369704|76000937|FG001|Treatment Epoch|technical problems|0|||
42190640|NCT03369704|76000936|FG000|Treatment Epoch|Protocol Violation|1|||
42190641|NCT03369704|76000937|FG001|Treatment Epoch|Protocol Violation|0|||
42190642|NCT03369704|76000936|FG000|Treatment Epoch|Lost to Follow-up|0|||
42190643|NCT03369704|76000937|FG001|Treatment Epoch|Lost to Follow-up|1|||
42096648|NCT00414973|75907333|FG002|Overall Study|Protocol Violation|0|||
42096649|NCT00414973|75907334|FG003|Overall Study|Protocol Violation|0|||
42096650|NCT00414973|75907331|FG000|Overall Study|Lost to Follow-up|0|||
42096651|NCT00414973|75907332|FG001|Overall Study|Lost to Follow-up|2|||
42096652|NCT00414973|75907333|FG002|Overall Study|Lost to Follow-up|0|||
42096653|NCT00414973|75907334|FG003|Overall Study|Lost to Follow-up|0|||
42096654|NCT00414973|75907331|FG000|Overall Study|Sponsor Decision|1|||
42096655|NCT00414973|75907332|FG001|Overall Study|Sponsor Decision|0|||
42096656|NCT00414973|75907333|FG002|Overall Study|Sponsor Decision|0|||
42096657|NCT00414973|75907334|FG003|Overall Study|Sponsor Decision|0|||
42096658|NCT00414973|75907331|FG000|Overall Study|Death|0|||
42096659|NCT00414973|75907332|FG001|Overall Study|Death|0|||
42096660|NCT00414973|75907333|FG002|Overall Study|Death|1|||
42190644|NCT03369704|76000936|FG000|Treatment Epoch|Lack of Efficacy|0|||
42190645|NCT03369704|76000937|FG001|Treatment Epoch|Lack of Efficacy|2|||
42190646|NCT03369704|76000936|FG000|Treatment Epoch|Adverse Event|2|||
42190647|NCT03369704|76000937|FG001|Treatment Epoch|Adverse Event|0|||
42190648|NCT03369704|76000936|FG000|Follow-up Epoch|Lost to Follow-up|1|||
42190649|NCT03369704|76000937|FG001|Follow-up Epoch|Lost to Follow-up|0|||
42190650|NCT03366428|76000943|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
42190651|NCT03366428|76000943|FG000|Overall Study|Adverse Event|12|||
42190652|NCT03366428|76000943|FG000|Overall Study|Clinical progression|2|||
42190653|NCT03366428|76000943|FG000|Overall Study|Withdrawal by Subject|4|||
42190654|NCT02839876|76000951|FG000|Overall Study|Protocol Violation|10|||
42190655|NCT02839876|76000952|FG001|Overall Study|Protocol Violation|11|||
42190656|NCT03366194|76000958|FG000|Overall Study|Lost to Follow-up|2|||
42190657|NCT02839798|76000963|FG000|Overall Study|Withdrawal by Subject|2|||
42190658|NCT03345836|76000970|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
42190659|NCT03345836|76000971|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
42190660|NCT03345836|76000972|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
42190661|NCT03345836|76000973|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
42190662|NCT03345836|76000974|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
42190663|NCT03345836|76000975|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
42190664|NCT03345836|76000970|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
42190665|NCT03345836|76000971|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
42190666|NCT03345836|76000972|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
42190667|NCT03345836|76000973|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
42190668|NCT03345836|76000974|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
42190669|NCT03345836|76000975|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
42190670|NCT03345836|76000970|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
42190671|NCT03345836|76000971|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
42096661|NCT00414973|75907334|FG003|Overall Study|Death|0|||
42096662|NCT00423085|75907347|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
42190672|NCT03345836|76000972|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
42190673|NCT03345836|76000973|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
42190674|NCT03345836|76000974|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
42190675|NCT03345836|76000975|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
42190676|NCT03345836|76000970|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
42190677|NCT03345836|76000971|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
42297013|NCT02347761|76131970|FG001|All Collected|invetigator disretion|0|||
42096663|NCT00423085|75907348|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
42096664|NCT00423085|75907349|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
42096665|NCT00423085|75907350|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
42096666|NCT00423085|75907347|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
42190678|NCT03345836|76000972|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
42190679|NCT03345836|76000973|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
42190680|NCT03345836|76000974|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
42096667|NCT00423085|75907348|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
42096668|NCT00423085|75907349|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
42096669|NCT00423085|75907350|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
42190681|NCT03345836|76000975|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
42190682|NCT03345836|76000970|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
42190683|NCT03345836|76000971|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
42190684|NCT03345836|76000972|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
42190685|NCT03345836|76000973|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
42190686|NCT03345836|76000974|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
42190687|NCT03345836|76000975|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
42190688|NCT03345836|76000970|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
42190689|NCT03345836|76000971|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
42190690|NCT03345836|76000972|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
42190691|NCT03345836|76000973|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
42190692|NCT03345836|76000974|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
42190693|NCT03345836|76000975|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
42190694|NCT03345836|76000970|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
42190695|NCT03345836|76000971|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
42190696|NCT03345836|76000972|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
42190697|NCT03345836|76000973|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
42190698|NCT03345836|76000974|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
42190699|NCT03345836|76000975|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
42190700|NCT03345836|76000970|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
42190701|NCT03345836|76000971|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
42190702|NCT03345836|76000972|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
42190703|NCT03345836|76000973|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
42190704|NCT03345836|76000974|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
42190705|NCT03345836|76000975|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
42190706|NCT03345836|76000970|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
42190707|NCT03345836|76000971|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
42190708|NCT03345836|76000972|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
42190709|NCT03345836|76000973|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
42297014|NCT02347761|76131971|FG002|All Collected|invetigator disretion|0|||
42297015|NCT02347761|76131969|FG000|All Collected|instillation site pain|0|||
42297016|NCT02347761|76131970|FG001|All Collected|instillation site pain|0|||
42297017|NCT02347761|76131971|FG002|All Collected|instillation site pain|1|||
42297018|NCT02347761|76131969|FG000|All Collected|exacerbation of COPD|0|||
42297019|NCT02347761|76131970|FG001|All Collected|exacerbation of COPD|0|||
42297020|NCT02347761|76131971|FG002|All Collected|exacerbation of COPD|1|||
42297021|NCT02347761|76131969|FG000|All Collected|moved/travel|0|||
42297022|NCT02347761|76131970|FG001|All Collected|moved/travel|1|||
42297023|NCT02347761|76131971|FG002|All Collected|moved/travel|0|||
42096670|NCT00423085|75907347|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
42096671|NCT00423085|75907348|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
42297024|NCT02347761|76131969|FG000|On Study Treatment|Lack of Efficacy|2|||
42297025|NCT02347761|76131970|FG001|On Study Treatment|Lack of Efficacy|3|||
42297026|NCT02347761|76131971|FG002|On Study Treatment|Lack of Efficacy|4|||
42297027|NCT02347761|76131969|FG000|On Study Treatment|non-compliance with study medication|0|||
42297028|NCT02347761|76131970|FG001|On Study Treatment|non-compliance with study medication|0|||
42297029|NCT02347761|76131971|FG002|On Study Treatment|non-compliance with study medication|2|||
42297030|NCT02347761|76131969|FG000|On Study Treatment|Withdrawal by Subject|7|||
42297031|NCT02347761|76131970|FG001|On Study Treatment|Withdrawal by Subject|3|||
42297032|NCT02347761|76131971|FG002|On Study Treatment|Withdrawal by Subject|5|||
42297033|NCT02347761|76131969|FG000|On Study Treatment|move/travel|2|||
42297034|NCT02347761|76131970|FG001|On Study Treatment|move/travel|6|||
42297035|NCT02347761|76131971|FG002|On Study Treatment|move/travel|5|||
42297036|NCT02347761|76131969|FG000|On Study Treatment|dissastisfaction with device|2|||
42297037|NCT02347761|76131970|FG001|On Study Treatment|dissastisfaction with device|1|||
42096672|NCT00423085|75907349|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
42190710|NCT03345836|76000974|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
42190711|NCT03345836|76000975|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
42297038|NCT02347761|76131971|FG002|On Study Treatment|dissastisfaction with device|4|||
42297039|NCT02347761|76131969|FG000|On Study Treatment|Lost to Follow-up|2|||
42297040|NCT02347761|76131970|FG001|On Study Treatment|Lost to Follow-up|1|||
42297041|NCT02347761|76131971|FG002|On Study Treatment|Lost to Follow-up|1|||
42190712|NCT03345836|76000970|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
42190713|NCT03345836|76000971|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
42190714|NCT03345836|76000972|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
42190715|NCT03345836|76000973|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
42190716|NCT03345836|76000974|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
42190717|NCT03345836|76000975|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
42190718|NCT03345836|76000970|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
42190719|NCT03345836|76000971|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
42190720|NCT03345836|76000972|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
42190721|NCT03345836|76000973|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
42190722|NCT03345836|76000974|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
42190723|NCT03345836|76000975|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
42190724|NCT02839330|76000995|FG000|Overall Study|Adverse Event|0|||
42190725|NCT02839330|76000996|FG001|Overall Study|Adverse Event|1|||
42297042|NCT02347761|76131969|FG000|On Study Treatment|investigator discretion|2|||
42297043|NCT02347761|76131970|FG001|On Study Treatment|investigator discretion|0|||
42297044|NCT02347761|76131971|FG002|On Study Treatment|investigator discretion|0|||
42297045|NCT02347761|76131969|FG000|On Study Treatment|durg not working|0|||
42297046|NCT02347761|76131970|FG001|On Study Treatment|durg not working|1|||
42297047|NCT02347761|76131971|FG002|On Study Treatment|durg not working|1|||
42297048|NCT02347761|76131969|FG000|On Study Treatment|Adverse Event|10|||
42297049|NCT02347761|76131970|FG001|On Study Treatment|Adverse Event|8|||
42297050|NCT02347761|76131971|FG002|On Study Treatment|Adverse Event|20|||
42297051|NCT02596945|76131979|FG000|Overall Study|No documentation of study drug dosing|3|||
42297052|NCT02596945|76131979|FG000|Overall Study|Other|32|||
42297053|NCT02596945|76131979|FG000|Overall Study|Change to hemodialysis|15|||
42297054|NCT02596945|76131979|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
42297055|NCT02596945|76131979|FG000|Overall Study|Withdrawal by Subject|1|||
42297056|NCT02596945|76131979|FG000|Overall Study|Missing|1|||
42297057|NCT02404389|76131997|FG000|Overall Study|Adverse Event|1|||
42297058|NCT02404389|76131998|FG001|Overall Study|Adverse Event|0|||
42297059|NCT02404389|76131999|FG002|Overall Study|Adverse Event|1|||
42297060|NCT02404389|76132000|FG003|Overall Study|Adverse Event|0|||
42297061|NCT02404389|76132001|FG004|Overall Study|Adverse Event|2|||
42297062|NCT02404389|76131997|FG000|Overall Study|Subject/guardian decision|1|||
42297063|NCT02404389|76131998|FG001|Overall Study|Subject/guardian decision|0|||
42297064|NCT02404389|76131999|FG002|Overall Study|Subject/guardian decision|0|||
42297065|NCT02404389|76132000|FG003|Overall Study|Subject/guardian decision|1|||
42297066|NCT02404389|76132001|FG004|Overall Study|Subject/guardian decision|1|||
42297067|NCT01667419|76132019|FG000|Overall Study|Reason Not Specified|1|||
42297068|NCT01667419|76132020|FG001|Overall Study|Reason Not Specified|0|||
42359222|NCT01827384|76204846|FG001|Overall Study|Ineligible|0|||
42359223|NCT01827384|76204847|FG002|Overall Study|Ineligible|0|||
42359224|NCT01827384|76204848|FG003|Overall Study|Ineligible|0|||
42359225|NCT01827384|76204849|FG004|Overall Study|Ineligible|0|||
42359226|NCT01827384|76204850|FG005|Overall Study|Ineligible|0|||
42359227|NCT01827384|76204851|FG006|Overall Study|Ineligible|0|||
42359228|NCT01827384|76204852|FG007|Overall Study|Ineligible|0|||
42359229|NCT01827384|76204853|FG008|Overall Study|Ineligible|0|||
42359230|NCT01827384|76204854|FG009|Overall Study|Ineligible|0|||
42359231|NCT01827384|76204855|FG010|Overall Study|Ineligible|0|||
42359232|NCT01827384|76204856|FG011|Overall Study|Ineligible|0|||
42359233|NCT01827384|76204857|FG012|Overall Study|Ineligible|0|||
42359234|NCT01827384|76204858|FG013|Overall Study|Ineligible|19|||
42096673|NCT00423085|75907350|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
42096674|NCT00423085|75907347|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
42096675|NCT00423085|75907348|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
42096676|NCT00423085|75907349|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
42096677|NCT00423085|75907350|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
42096678|NCT00423085|75907347|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
42096679|NCT00423085|75907348|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
42190726|NCT02839330|76000997|FG002|Overall Study|Adverse Event|2|||
42190727|NCT02839330|76000998|FG003|Overall Study|Adverse Event|2|||
42190728|NCT02839330|76000995|FG000|Overall Study|Death|4|||
42096680|NCT00423085|75907349|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
42190729|NCT02839330|76000996|FG001|Overall Study|Death|6|||
42190730|NCT02839330|76000997|FG002|Overall Study|Death|1|||
42297069|NCT01667419|76132021|FG002|Overall Study|Reason Not Specified|0|||
42297070|NCT01667419|76132022|FG003|Overall Study|Reason Not Specified|0|||
42297071|NCT01667419|76132019|FG000|Overall Study|Withdrawal by Subject|16|||
42359235|NCT01827384|76204845|FG000|Overall Study|Participant died before treatment|0|||
42359236|NCT01827384|76204846|FG001|Overall Study|Participant died before treatment|0|||
42359237|NCT01827384|76204847|FG002|Overall Study|Participant died before treatment|0|||
42190731|NCT02839330|76000998|FG003|Overall Study|Death|1|||
42190732|NCT02839330|76000995|FG000|Overall Study|Withdrawal by Subject|27|||
42297072|NCT01667419|76132020|FG001|Overall Study|Withdrawal by Subject|8|||
42297073|NCT01667419|76132021|FG002|Overall Study|Withdrawal by Subject|9|||
42297074|NCT01667419|76132022|FG003|Overall Study|Withdrawal by Subject|8|||
42297075|NCT01667419|76132019|FG000|Overall Study|Non-compliance|0|||
42297076|NCT01667419|76132020|FG001|Overall Study|Non-compliance|0|||
42297077|NCT01667419|76132021|FG002|Overall Study|Non-compliance|0|||
42297078|NCT01667419|76132022|FG003|Overall Study|Non-compliance|1|||
42297079|NCT01667419|76132019|FG000|Overall Study|Protocol Violation|1|||
42297080|NCT01667419|76132020|FG001|Overall Study|Protocol Violation|0|||
42297081|NCT01667419|76132021|FG002|Overall Study|Protocol Violation|0|||
42297082|NCT01667419|76132022|FG003|Overall Study|Protocol Violation|0|||
42297083|NCT01667419|76132019|FG000|Overall Study|Lost to Follow-up|7|||
42018327|NCT00996892|75825869|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
42018328|NCT00996892|75825870|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
42018329|NCT00996892|75825871|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
42018330|NCT00996892|75825872|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
42018331|NCT00996892|75825873|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
42018332|NCT00996892|75825874|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
42018333|NCT00996892|75825875|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
42018334|NCT00996892|75825876|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
42018335|NCT00996892|75825877|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
42018336|NCT00996892|75825878|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
42018337|NCT00996892|75825879|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
42018338|NCT00996892|75825880|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
42018339|NCT00996892|75825861|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
42096681|NCT00423085|75907350|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
42096682|NCT00423085|75907347|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
42096683|NCT00423085|75907348|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
42018340|NCT00996892|75825862|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
42018341|NCT00996892|75825863|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
42018342|NCT00996892|75825864|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
42018343|NCT00996892|75825865|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
42018344|NCT00996892|75825866|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
42018345|NCT00996892|75825867|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
42018346|NCT00996892|75825868|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
42018347|NCT00996892|75825869|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
42018348|NCT00996892|75825870|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
42018349|NCT00996892|75825871|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
42018350|NCT00996892|75825872|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
42018351|NCT00996892|75825873|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
42018352|NCT00996892|75825874|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
42018353|NCT00996892|75825875|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
42018354|NCT00996892|75825876|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
42018355|NCT00996892|75825877|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
42018356|NCT00996892|75825878|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
42018357|NCT00996892|75825879|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
42018358|NCT00996892|75825880|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
42018359|NCT00996892|75825861|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
42018360|NCT00996892|75825862|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
42018361|NCT00996892|75825863|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
42018362|NCT00996892|75825864|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
42018363|NCT00996892|75825865|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
42096684|NCT00423085|75907349|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
42096685|NCT00423085|75907350|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
42096686|NCT00423085|75907347|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
42096687|NCT00423085|75907348|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
42096688|NCT00423085|75907349|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
42096689|NCT00423085|75907350|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
42096690|NCT00423085|75907347|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
42096691|NCT00423085|75907348|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
42096692|NCT00423085|75907349|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
42096693|NCT00423085|75907350|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
42096694|NCT00423085|75907347|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
42096695|NCT00423085|75907348|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
42297084|NCT01667419|76132020|FG001|Overall Study|Lost to Follow-up|6|||
42297085|NCT01667419|76132021|FG002|Overall Study|Lost to Follow-up|2|||
42297086|NCT01667419|76132022|FG003|Overall Study|Lost to Follow-up|4|||
42018364|NCT00996892|75825866|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
42018365|NCT00996892|75825867|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
42096696|NCT00423085|75907349|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
42096697|NCT00423085|75907350|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
42190733|NCT02839330|76000996|FG001|Overall Study|Withdrawal by Subject|19|||
42190734|NCT02839330|76000997|FG002|Overall Study|Withdrawal by Subject|11|||
42190735|NCT02839330|76000998|FG003|Overall Study|Withdrawal by Subject|13|||
42096698|NCT00423085|75907347|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
42096699|NCT00423085|75907348|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
42096700|NCT00423085|75907349|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
42096701|NCT00423085|75907350|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
42096702|NCT00423085|75907347|FG000|52-Week Open-Label Extension Phase|Death|0|||
42096703|NCT00423085|75907348|FG001|52-Week Open-Label Extension Phase|Death|0|||
42096704|NCT00423085|75907349|FG002|52-Week Open-Label Extension Phase|Death|0|||
42096705|NCT00423085|75907350|FG003|52-Week Open-Label Extension Phase|Death|2|||
42096706|NCT00414661|75907364|FG000|Overall Study|Death|2|||
42096707|NCT00414661|75907365|FG001|Overall Study|Death|5|||
42096708|NCT00414661|75907366|FG002|Overall Study|Death|0|||
42096709|NCT00414661|75907367|FG003|Overall Study|Death|0|||
42096710|NCT00414661|75907364|FG000|Overall Study|Lost to Follow-up|1|||
42096711|NCT00414661|75907365|FG001|Overall Study|Lost to Follow-up|4|||
42096712|NCT00414661|75907366|FG002|Overall Study|Lost to Follow-up|0|||
42096713|NCT00414661|75907367|FG003|Overall Study|Lost to Follow-up|1|||
42096714|NCT00414661|75907364|FG000|Overall Study|Withdrawal by Subject|5|||
42096715|NCT00414661|75907365|FG001|Overall Study|Withdrawal by Subject|2|||
42096716|NCT00414661|75907366|FG002|Overall Study|Withdrawal by Subject|2|||
42096717|NCT00414661|75907367|FG003|Overall Study|Withdrawal by Subject|2|||
42096718|NCT00414661|75907364|FG000|Overall Study|Other|6|||
42096719|NCT00414661|75907365|FG001|Overall Study|Other|3|||
42096720|NCT00414661|75907366|FG002|Overall Study|Other|0|||
42096721|NCT00414661|75907367|FG003|Overall Study|Other|0|||
42190736|NCT02839330|76000995|FG000|Overall Study|Lost to Follow-up|22|||
42190737|NCT02839330|76000996|FG001|Overall Study|Lost to Follow-up|27|||
42190738|NCT02839330|76000997|FG002|Overall Study|Lost to Follow-up|29|||
42190739|NCT02839330|76000998|FG003|Overall Study|Lost to Follow-up|25|||
42096722|NCT00405067|75907380|FG000|Overall Study|Adverse Event|4|||
42096723|NCT00405067|75907381|FG001|Overall Study|Adverse Event|9|||
42096724|NCT00405067|75907382|FG002|Overall Study|Adverse Event|4|||
42096725|NCT00405067|75907380|FG000|Overall Study|Lost to Follow-up|0|||
42190740|NCT02839330|76000995|FG000|Overall Study|Administrative Reason|0|||
42190741|NCT02839330|76000996|FG001|Overall Study|Administrative Reason|0|||
42190742|NCT02839330|76000997|FG002|Overall Study|Administrative Reason|0|||
42190743|NCT02839330|76000998|FG003|Overall Study|Administrative Reason|1|||
42190744|NCT02839330|76000995|FG000|Overall Study|Protocol Violation|1|||
42190745|NCT02839330|76000996|FG001|Overall Study|Protocol Violation|2|||
42190746|NCT02839330|76000997|FG002|Overall Study|Protocol Violation|2|||
42190747|NCT02839330|76000998|FG003|Overall Study|Protocol Violation|3|||
42190748|NCT02839330|76000995|FG000|Overall Study|Other reason, not specified|4|||
42190749|NCT02839330|76000996|FG001|Overall Study|Other reason, not specified|3|||
42190750|NCT02839330|76000997|FG002|Overall Study|Other reason, not specified|3|||
42190751|NCT02839330|76000998|FG003|Overall Study|Other reason, not specified|6|||
42190752|NCT03363776|76001012|FG000|Overall Study|Progressive disease|2|||
42190753|NCT03363776|76001013|FG001|Overall Study|Progressive disease|3|||
42297087|NCT01667419|76132019|FG000|Overall Study|Death|18|||
42297088|NCT01667419|76132020|FG001|Overall Study|Death|33|||
42297089|NCT01667419|76132021|FG002|Overall Study|Death|25|||
42297090|NCT01667419|76132022|FG003|Overall Study|Death|26|||
42096726|NCT00405067|75907381|FG001|Overall Study|Lost to Follow-up|0|||
42297091|NCT02588833|76132039|FG000|Part 1|Withdrawal by Subject|1|||
42297092|NCT02588833|76132040|FG001|Part 1|Withdrawal by Subject|0|||
42297093|NCT02588833|76132039|FG000|Part 2A|Physician Decision|0|||
42297094|NCT02588833|76132040|FG001|Part 2A|Physician Decision|1|||
42297095|NCT02588833|76132039|FG000|Part 2A|Withdrawal by Subject|0|||
42297096|NCT02588833|76132040|FG001|Part 2A|Withdrawal by Subject|1|||
42096727|NCT00405067|75907382|FG002|Overall Study|Lost to Follow-up|1|||
42096728|NCT00708708|75907390|FG000|Overall Study|Another therapy instead of Enbrel|141|||
42096729|NCT00708708|75907390|FG000|Overall Study|Lost to Follow-up|52|||
42096730|NCT00708708|75907390|FG000|Overall Study|Withdrawal by Subject|51|||
42096731|NCT00708708|75907390|FG000|Overall Study|Intolerance|42|||
42096732|NCT00708708|75907390|FG000|Overall Study|Another therapy along with Enbrel|15|||
42096733|NCT00708708|75907390|FG000|Overall Study|Other unspecified|11|||
42190754|NCT03363776|76001014|FG002|Overall Study|Progressive disease|1|||
42190755|NCT03363776|76001012|FG000|Overall Study|Study drug toxicity|0|||
42190756|NCT03363776|76001013|FG001|Overall Study|Study drug toxicity|0|||
42190757|NCT03363776|76001014|FG002|Overall Study|Study drug toxicity|1|||
42190758|NCT03363776|76001012|FG000|Overall Study|Death|1|||
42190759|NCT03363776|76001013|FG001|Overall Study|Death|0|||
42297097|NCT02588833|76132039|FG000|Part 2B|Adverse Event|0|||
42190760|NCT03363776|76001014|FG002|Overall Study|Death|0|||
42297098|NCT02588833|76132040|FG001|Part 2B|Adverse Event|1|||
42297099|NCT02588833|76132039|FG000|Part 2C|Adverse Event|0|||
42096734|NCT00708708|75907390|FG000|Overall Study|Good effectiveness|9|||
42096735|NCT00708708|75907390|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
42096736|NCT00708708|75907390|FG000|Overall Study|Administrative reasons|7|||
42096737|NCT00708708|75907390|FG000|Overall Study|Lack of effectiveness|4|||
42096738|NCT00708708|75907390|FG000|Overall Study|Lack of compliance|3|||
42096739|NCT00708708|75907390|FG000|Overall Study|Pregnancy|3|||
42096740|NCT00708708|75907390|FG000|Overall Study|Adverse Event|3|||
42096741|NCT00708708|75907390|FG000|Overall Study|Missing values|392|||
42096742|NCT00404755|75907397|FG000|Phase I (Bupropion)|Adverse Event|3|||
42096743|NCT00404755|75907397|FG000|Phase I (Bupropion)|Other|1|||
42096744|NCT00404755|75907397|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
42096745|NCT00614614|75907407|FG000|Primary Vaccination Phase|Adverse Event|6|||
42096746|NCT00614614|75907408|FG001|Primary Vaccination Phase|Adverse Event|0|||
42096747|NCT00614614|75907409|FG002|Primary Vaccination Phase|Adverse Event|0|||
42096748|NCT00614614|75907410|FG003|Primary Vaccination Phase|Adverse Event|0|||
42096749|NCT00614614|75907411|FG004|Primary Vaccination Phase|Adverse Event|0|||
42096750|NCT00614614|75907407|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
42096751|NCT00614614|75907408|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
42096752|NCT00614614|75907409|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
42096753|NCT00614614|75907410|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
42096754|NCT00614614|75907411|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
42096755|NCT00614614|75907407|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
42096756|NCT00614614|75907408|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
42096757|NCT00614614|75907409|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
42096758|NCT00614614|75907410|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
42096759|NCT00614614|75907411|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
42096760|NCT00614614|75907407|FG000|Primary Vaccination Phase|Protocol Violation|9|||
42096761|NCT00614614|75907408|FG001|Primary Vaccination Phase|Protocol Violation|3|||
42096762|NCT00614614|75907409|FG002|Primary Vaccination Phase|Protocol Violation|0|||
42096763|NCT00614614|75907410|FG003|Primary Vaccination Phase|Protocol Violation|0|||
42096764|NCT00614614|75907411|FG004|Primary Vaccination Phase|Protocol Violation|0|||
42096765|NCT00614614|75907407|FG000|Primary Vaccination Phase|Other|4|||
42096766|NCT00614614|75907408|FG001|Primary Vaccination Phase|Other|0|||
42096767|NCT00614614|75907409|FG002|Primary Vaccination Phase|Other|0|||
42096768|NCT00614614|75907410|FG003|Primary Vaccination Phase|Other|0|||
42096769|NCT00614614|75907411|FG004|Primary Vaccination Phase|Other|0|||
42096770|NCT00614614|75907407|FG000|Booster Vaccination Phase|Adverse Event|0|||
42096771|NCT00614614|75907408|FG001|Booster Vaccination Phase|Adverse Event|0|||
42096772|NCT00614614|75907409|FG002|Booster Vaccination Phase|Adverse Event|1|||
42096773|NCT00614614|75907410|FG003|Booster Vaccination Phase|Adverse Event|1|||
42096774|NCT00614614|75907411|FG004|Booster Vaccination Phase|Adverse Event|0|||
42096775|NCT00614614|75907407|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
42096776|NCT00614614|75907408|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
42096777|NCT00614614|75907409|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
42096778|NCT00614614|75907410|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
42096779|NCT00614614|75907411|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
42096780|NCT00614614|75907407|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
42096781|NCT00614614|75907408|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
42096782|NCT00614614|75907409|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
42096783|NCT00614614|75907410|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
42096784|NCT00614614|75907411|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
42096785|NCT00614614|75907407|FG000|Booster Vaccination Phase|Protocol Violation|0|||
42096786|NCT00614614|75907408|FG001|Booster Vaccination Phase|Protocol Violation|0|||
42096787|NCT00614614|75907409|FG002|Booster Vaccination Phase|Protocol Violation|2|||
42096788|NCT00614614|75907410|FG003|Booster Vaccination Phase|Protocol Violation|3|||
42096789|NCT00614614|75907411|FG004|Booster Vaccination Phase|Protocol Violation|0|||
42096790|NCT00614614|75907407|FG000|Booster Vaccination Phase|Other|0|||
42096791|NCT00614614|75907408|FG001|Booster Vaccination Phase|Other|1|||
42297100|NCT02588833|76132040|FG001|Part 2C|Adverse Event|1|||
42297101|NCT02588833|76132039|FG000|Part 2C|Withdrawal by Subject|0|||
42096792|NCT00614614|75907409|FG002|Booster Vaccination Phase|Other|3|||
42096793|NCT00614614|75907410|FG003|Booster Vaccination Phase|Other|2|||
42096794|NCT00614614|75907411|FG004|Booster Vaccination Phase|Other|1|||
42096795|NCT00713310|75907428|FG000|Overall Study|Adverse Event|5|||
42096796|NCT00713310|75907429|FG001|Overall Study|Adverse Event|2|||
42096797|NCT00713310|75907428|FG000|Overall Study|Lack of Efficacy|0|||
42096798|NCT00713310|75907429|FG001|Overall Study|Lack of Efficacy|2|||
42096799|NCT00713310|75907428|FG000|Overall Study|Withdrawal by Subject|0|||
42096800|NCT00713310|75907429|FG001|Overall Study|Withdrawal by Subject|2|||
42096801|NCT00422461|75907439|FG000|Overall Study|Adverse Event|1|||
42096802|NCT00422461|75907440|FG001|Overall Study|Adverse Event|2|||
42096803|NCT00422461|75907441|FG002|Overall Study|Adverse Event|1|||
42096804|NCT00422461|75907442|FG003|Overall Study|Adverse Event|1|||
42096805|NCT00422461|75907439|FG000|Overall Study|Other|0|||
42096806|NCT00422461|75907440|FG001|Overall Study|Other|0|||
42096807|NCT00422461|75907441|FG002|Overall Study|Other|0|||
42096808|NCT00422461|75907442|FG003|Overall Study|Other|2|||
42096809|NCT00422461|75907439|FG000|Overall Study|Participants no longer willing to participate in study|1|||
42096810|NCT00422461|75907440|FG001|Overall Study|Participants no longer willing to participate in study|0|||
42096811|NCT00422461|75907441|FG002|Overall Study|Participants no longer willing to participate in study|0|||
42096812|NCT00422461|75907442|FG003|Overall Study|Participants no longer willing to participate in study|0|||
42096813|NCT00422461|75907439|FG000|Overall Study|Randomized but not treated|1|||
42096814|NCT00422461|75907440|FG001|Overall Study|Randomized but not treated|1|||
42096815|NCT00422461|75907441|FG002|Overall Study|Randomized but not treated|0|||
42096816|NCT00422461|75907442|FG003|Overall Study|Randomized but not treated|0|||
42096817|NCT00712920|75907455|FG000|Overall Study|Adverse Event|3|||
42096818|NCT00712920|75907456|FG001|Overall Study|Adverse Event|4|||
42096819|NCT00712920|75907457|FG002|Overall Study|Adverse Event|7|||
42096820|NCT00712920|75907455|FG000|Overall Study|Withdrawal by Subject|4|||
42096821|NCT00712920|75907456|FG001|Overall Study|Withdrawal by Subject|2|||
42096822|NCT00712920|75907457|FG002|Overall Study|Withdrawal by Subject|1|||
42096823|NCT00712920|75907455|FG000|Overall Study|Lost to Follow-up|1|||
42096824|NCT00712920|75907456|FG001|Overall Study|Lost to Follow-up|4|||
42096825|NCT00712920|75907457|FG002|Overall Study|Lost to Follow-up|0|||
42096826|NCT00712920|75907455|FG000|Overall Study|Lack of Efficacy|1|||
42096827|NCT00712920|75907456|FG001|Overall Study|Lack of Efficacy|0|||
42096828|NCT00712920|75907457|FG002|Overall Study|Lack of Efficacy|1|||
42096829|NCT00712920|75907455|FG000|Overall Study|Other|5|||
42190761|NCT03360344|76001025|FG000|Overall Study|Withdrawal by Subject|0|||
42190762|NCT03360344|76001026|FG001|Overall Study|Withdrawal by Subject|1|||
42190763|NCT03360344|76001027|FG002|Overall Study|Withdrawal by Subject|1|||
42190764|NCT02838628|76001037|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
42190765|NCT02838628|76001038|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
42190766|NCT02838628|76001037|FG000|Recurrence Follow-up Period|Adverse Event|1|||
42190767|NCT02838628|76001038|FG001|Recurrence Follow-up Period|Adverse Event|0|||
42190768|NCT02838628|76001037|FG000|Recurrence Follow-up Period|Non-compliance|0|||
42190769|NCT02838628|76001038|FG001|Recurrence Follow-up Period|Non-compliance|1|||
42190770|NCT02838628|76001037|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
42096830|NCT00712920|75907456|FG001|Overall Study|Other|7|||
42096831|NCT00712920|75907457|FG002|Overall Study|Other|3|||
42096832|NCT00712920|75907455|FG000|Overall Study|Non-compliance|3|||
42096833|NCT00712920|75907456|FG001|Overall Study|Non-compliance|0|||
42096834|NCT00712920|75907457|FG002|Overall Study|Non-compliance|0|||
42096835|NCT00612586|75907476|FG000|Overall Study|Adverse Event|6|||
42096836|NCT00612586|75907477|FG001|Overall Study|Adverse Event|2|||
42096837|NCT00612586|75907476|FG000|Overall Study|Death|1|||
42096838|NCT00612586|75907477|FG001|Overall Study|Death|0|||
42096839|NCT00612586|75907476|FG000|Overall Study|Entry Criteria Not Met|0|||
42190771|NCT02838628|76001038|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
42190772|NCT02838628|76001037|FG000|Recurrence Follow-up Period|Other un-specified|1|||
42190773|NCT02838628|76001038|FG001|Recurrence Follow-up Period|Other un-specified|1|||
42190774|NCT02835820|76001047|FG000|Overall Study|Baseline Screen Failure|0|||
42190775|NCT02835820|76001048|FG001|Overall Study|Baseline Screen Failure|3|||
42190776|NCT03359174|76001054|FG000|Overall Study|Adverse Event|1|||
42190777|NCT02832622|76001058|FG000|Overall Study|MPP not programmed|1259|||
42190778|NCT02832622|76001058|FG000|Overall Study|Withdrawal by Subject|123|||
42190779|NCT02832622|76001058|FG000|Overall Study|Death|119|||
42190780|NCT02832622|76001058|FG000|Overall Study|Unsuccessful CRT implant|93|||
42190781|NCT02832622|76001058|FG000|Overall Study|Lost to Follow-up|45|||
42190782|NCT02832622|76001058|FG000|Overall Study|Patient non-compliance|42|||
42190783|NCT02832622|76001058|FG000|Overall Study|Withdrawal by other reasons|25|||
42190784|NCT02832622|76001058|FG000|Overall Study|System explant|24|||
42190785|NCT02832622|76001058|FG000|Overall Study|Physician Decision|6|||
42190786|NCT00093015|76001065|FG000|Overall Study|Withdrawal by Subject|194|||
42190787|NCT00093015|76001066|FG001|Overall Study|Withdrawal by Subject|171|||
42190788|NCT00093015|76001065|FG000|Overall Study|Lost to Follow-up|96|||
42190789|NCT00093015|76001066|FG001|Overall Study|Lost to Follow-up|108|||
42190790|NCT00093015|76001065|FG000|Overall Study|Death|375|||
42190791|NCT00093015|76001066|FG001|Overall Study|Death|385|||
42096840|NCT00612586|75907477|FG001|Overall Study|Entry Criteria Not Met|2|||
42190792|NCT03358238|76001074|FG000|Overall Study|Withdrawal by Subject|0|||
42190793|NCT03358238|76001075|FG001|Overall Study|Withdrawal by Subject|1|||
42096841|NCT00612586|75907476|FG000|Overall Study|Withdrawal by Subject|7|||
42190794|NCT03342638|76001087|FG000|Overall Study|Withdrawal by Subject|1|||
42190795|NCT03342638|76001088|FG001|Overall Study|Withdrawal by Subject|0|||
42190796|NCT03342638|76001087|FG000|Overall Study|Physician Decision|0|||
42190797|NCT03342638|76001088|FG001|Overall Study|Physician Decision|1|||
42096842|NCT00612586|75907477|FG001|Overall Study|Withdrawal by Subject|9|||
42096843|NCT00612586|75907476|FG000|Overall Study|Physician Decision|1|||
42190798|NCT03342560|76001094|FG000|Overall Study|Lost to Follow-up|2|||
42190799|NCT03355742|76001111|FG000|Overall Study|Lost to Follow-up|4|||
42190800|NCT03355742|76001111|FG000|Overall Study|Withdrawal by Subject|29|||
42190801|NCT03355742|76001111|FG000|Overall Study|Physician Decision|6|||
42190802|NCT03355742|76001111|FG000|Overall Study|Death|55|||
42190803|NCT03355742|76001111|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
42190804|NCT03341312|76001115|FG000|Period 1|Withdrawal by Subject|0|||
42190805|NCT03341312|76001116|FG001|Period 1|Withdrawal by Subject|1|||
42190806|NCT03341312|76001117|FG002|Period 1|Withdrawal by Subject|0|||
42190807|NCT03341312|76001118|FG003|Period 1|Withdrawal by Subject|0|||
42190808|NCT02949908|76001130|FG000|Overall Study|Study termination|2|||
42190809|NCT01358734|76001137|FG000|Overall Study|Adverse Event|4|||
42190810|NCT01358734|76001138|FG001|Overall Study|Adverse Event|7|||
42190811|NCT01358734|76001139|FG002|Overall Study|Adverse Event|3|||
42190812|NCT01358734|76001137|FG000|Overall Study|Lack of Efficacy|0|||
42190813|NCT01358734|76001138|FG001|Overall Study|Lack of Efficacy|1|||
42190814|NCT01358734|76001139|FG002|Overall Study|Lack of Efficacy|3|||
42190815|NCT01358734|76001137|FG000|Overall Study|Withdrawal by Subject|1|||
42190816|NCT01358734|76001138|FG001|Overall Study|Withdrawal by Subject|6|||
42190817|NCT01358734|76001139|FG002|Overall Study|Withdrawal by Subject|3|||
42190818|NCT01358734|76001137|FG000|Overall Study|Death|3|||
42190819|NCT01358734|76001138|FG001|Overall Study|Death|7|||
42190820|NCT01358734|76001139|FG002|Overall Study|Death|2|||
42190821|NCT01358734|76001137|FG000|Overall Study|Progressive Disease|5|||
42190822|NCT01358734|76001138|FG001|Overall Study|Progressive Disease|13|||
42190823|NCT01358734|76001139|FG002|Overall Study|Progressive Disease|16|||
42190824|NCT01358734|76001137|FG000|Overall Study|Non-compliance with study drug|0|||
42190825|NCT01358734|76001138|FG001|Overall Study|Non-compliance with study drug|0|||
42190826|NCT01358734|76001139|FG002|Overall Study|Non-compliance with study drug|1|||
42190827|NCT01358734|76001137|FG000|Overall Study|Other|2|||
42190828|NCT01358734|76001138|FG001|Overall Study|Other|5|||
42190829|NCT01358734|76001139|FG002|Overall Study|Other|4|||
42190830|NCT01358734|76001137|FG000|Overall Study|Protocol Violation|0|||
42190831|NCT01358734|76001138|FG001|Overall Study|Protocol Violation|0|||
42190832|NCT01358734|76001139|FG002|Overall Study|Protocol Violation|2|||
42190833|NCT01341652|76001149|FG000|Overall Study|Incorrect Random Assignment|0|||
42190834|NCT01341652|76001150|FG001|Overall Study|Incorrect Random Assignment|1|||
42190835|NCT01341652|76001149|FG000|Overall Study|ineligible; presence metastatic disease|0|||
42190836|NCT01341652|76001150|FG001|Overall Study|ineligible; presence metastatic disease|1|||
42190837|NCT02828644|76001158|FG000|Overall Study|Lost to Follow-up|23|||
42190838|NCT02828644|76001159|FG001|Overall Study|Lost to Follow-up|22|||
42190839|NCT02949362|76001168|FG000|Retrospective Period|Inform consent not signed by participant|4|||
42190840|NCT02949362|76001169|FG001|Retrospective Period|Inform consent not signed by participant|1|||
42096844|NCT00612586|75907477|FG001|Overall Study|Physician Decision|2|||
42096845|NCT00612586|75907476|FG000|Overall Study|Sponsor Decision|1|||
42096846|NCT00612586|75907477|FG001|Overall Study|Sponsor Decision|1|||
42096847|NCT00612586|75907476|FG000|Overall Study|Progressive Disease|26|||
42096848|NCT00612586|75907477|FG001|Overall Study|Progressive Disease|24|||
42096849|NCT00612586|75907476|FG000|Overall Study|Randomized and Not Treated|1|||
42096850|NCT00612586|75907477|FG001|Overall Study|Randomized and Not Treated|1|||
42096851|NCT00614380|75907488|FG000|Overall Study|Adverse Event|14|||
42096852|NCT00614380|75907489|FG001|Overall Study|Adverse Event|4|||
42096853|NCT00614380|75907490|FG002|Overall Study|Adverse Event|0|||
42096854|NCT00614380|75907491|FG003|Overall Study|Adverse Event|0|||
42096855|NCT00614380|75907488|FG000|Overall Study|Lost to Follow-up|6|||
42096856|NCT00614380|75907489|FG001|Overall Study|Lost to Follow-up|1|||
42096857|NCT00614380|75907490|FG002|Overall Study|Lost to Follow-up|0|||
42096858|NCT00614380|75907491|FG003|Overall Study|Lost to Follow-up|0|||
42096859|NCT00614380|75907488|FG000|Overall Study|Non compliant with the protocol|12|||
42096860|NCT00614380|75907489|FG001|Overall Study|Non compliant with the protocol|2|||
42096861|NCT00614380|75907490|FG002|Overall Study|Non compliant with the protocol|1|||
42096862|NCT00614380|75907491|FG003|Overall Study|Non compliant with the protocol|2|||
42096863|NCT00614380|75907488|FG000|Overall Study|Consent withdrawn|3|||
42190841|NCT02949362|76001170|FG002|Retrospective Period|Inform consent not signed by participant|0|||
42190842|NCT02949362|76001171|FG003|Retrospective Period|Inform consent not signed by participant|0|||
42190843|NCT02949362|76001168|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
42190844|NCT02949362|76001169|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
42096864|NCT00614380|75907489|FG001|Overall Study|Consent withdrawn|1|||
42096865|NCT00614380|75907490|FG002|Overall Study|Consent withdrawn|0|||
42190845|NCT02949362|76001170|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
42096866|NCT00614380|75907491|FG003|Overall Study|Consent withdrawn|0|||
42096867|NCT00612508|75907508|FG000|Overall Study|Withdrawal by Subject|3|||
42096868|NCT00612508|75907509|FG001|Overall Study|Withdrawal by Subject|4|||
42096869|NCT00613834|75907519|FG000|Overall Study|Withdrawal by Subject|0|||
42096870|NCT00613834|75907520|FG001|Overall Study|Withdrawal by Subject|3|||
42096871|NCT00613366|75907534|FG000|Overall Study|Withdrawal by Subject|3|||
42190846|NCT02949362|76001171|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
42190847|NCT02949362|76001168|FG000|Prospective Period|Other|0|||
42190848|NCT02949362|76001169|FG001|Prospective Period|Other|0|||
42190849|NCT02949362|76001170|FG002|Prospective Period|Other|0|||
42190850|NCT02949362|76001171|FG003|Prospective Period|Other|4|||
42190851|NCT02947022|76001183|FG000|Overall Study|Study Stopped|1|||
42190852|NCT03338972|76001194|FG000|Overall Study|Death|1|||
42190853|NCT03338972|76001195|FG001|Overall Study|Death|1|||
42190854|NCT03338972|76001196|FG002|Overall Study|Death|0|||
42190855|NCT03338972|76001197|FG003|Overall Study|Death|0|||
42190856|NCT03338972|76001194|FG000|Overall Study|Withdrawal by Subject|1|||
42190857|NCT03338972|76001195|FG001|Overall Study|Withdrawal by Subject|0|||
42190858|NCT03338972|76001196|FG002|Overall Study|Withdrawal by Subject|0|||
42190859|NCT03338972|76001197|FG003|Overall Study|Withdrawal by Subject|0|||
42190860|NCT03338816|76001213|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
42190861|NCT03338816|76001214|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
42190862|NCT03338816|76001215|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
42190863|NCT03338816|76001216|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
42190864|NCT03338816|76001213|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
42190865|NCT03338816|76001214|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
42190866|NCT03338816|76001215|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
42190867|NCT03338816|76001216|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
42190868|NCT03338816|76001213|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
42190869|NCT03338816|76001214|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
42190870|NCT03338816|76001215|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
42190871|NCT03338816|76001216|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
42190872|NCT03338816|76001213|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
42190873|NCT03338816|76001214|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
42190874|NCT03338816|76001215|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
42190875|NCT03338816|76001216|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
42190876|NCT03338816|76001213|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
42190877|NCT03338816|76001214|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
42190878|NCT03338816|76001215|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
42190879|NCT03338816|76001216|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
42190880|NCT03338816|76001213|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
42190881|NCT03338816|76001214|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
42190882|NCT03338816|76001215|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
42190883|NCT03338816|76001216|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
42190884|NCT03338816|76001213|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
42190885|NCT03338816|76001214|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
42190886|NCT03338816|76001215|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
42190887|NCT03338816|76001216|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
42190888|NCT03337490|76001228|FG000|Overall Study|Withdrawal by Subject|1|||
42190889|NCT03337490|76001229|FG001|Overall Study|Withdrawal by Subject|0|||
42190890|NCT03337490|76001230|FG002|Overall Study|Withdrawal by Subject|0|||
42190891|NCT03337490|76001228|FG000|Overall Study|Lack of Efficacy|10|||
42190892|NCT03337490|76001229|FG001|Overall Study|Lack of Efficacy|12|||
42096872|NCT00613366|75907535|FG001|Overall Study|Withdrawal by Subject|2|||
42096873|NCT00612352|75907543|FG000|Overall Study|Adverse Event|1|||
42096874|NCT00612352|75907544|FG001|Overall Study|Adverse Event|0|||
42096875|NCT00612352|75907543|FG000|Overall Study|Withdrawal by Subject|3|||
42096876|NCT00612352|75907544|FG001|Overall Study|Withdrawal by Subject|5|||
42096877|NCT00612352|75907543|FG000|Overall Study|moved out of state|1|||
42096878|NCT00612352|75907544|FG001|Overall Study|moved out of state|0|||
42096879|NCT00612352|75907543|FG000|Overall Study|didn't return calls/show up on test date|4|||
42096880|NCT00612352|75907544|FG001|Overall Study|didn't return calls/show up on test date|1|||
42096881|NCT00704730|75907552|FG000|Overall Study|Adverse Event|35|||
42096882|NCT00704730|75907553|FG001|Overall Study|Adverse Event|9|||
42096883|NCT00704730|75907552|FG000|Overall Study|Death|11|||
42096884|NCT00704730|75907553|FG001|Overall Study|Death|5|||
42096885|NCT00704730|75907552|FG000|Overall Study|Physician Decision|2|||
42096886|NCT00704730|75907553|FG001|Overall Study|Physician Decision|0|||
42096887|NCT00704730|75907552|FG000|Overall Study|Did not receive drug|5|||
42096888|NCT00704730|75907553|FG001|Overall Study|Did not receive drug|2|||
42096889|NCT00704730|75907552|FG000|Overall Study|Disease progression per PI|58|||
42190893|NCT03337490|76001230|FG002|Overall Study|Lack of Efficacy|35|||
42190894|NCT03337490|76001228|FG000|Overall Study|Physician Decision|0|||
42190895|NCT03337490|76001229|FG001|Overall Study|Physician Decision|1|||
42190896|NCT03337490|76001230|FG002|Overall Study|Physician Decision|0|||
42096890|NCT00704730|75907553|FG001|Overall Study|Disease progression per PI|67|||
42096891|NCT00704730|75907552|FG000|Overall Study|data unavailable|1|||
42096892|NCT00704730|75907553|FG001|Overall Study|data unavailable|0|||
42096893|NCT00704730|75907552|FG000|Overall Study|Withdrawal by Subject|9|||
42096894|NCT00704730|75907553|FG001|Overall Study|Withdrawal by Subject|13|||
42190897|NCT03337490|76001228|FG000|Overall Study|Lost to Follow-up|0|||
42190898|NCT03337490|76001229|FG001|Overall Study|Lost to Follow-up|1|||
42190899|NCT03337490|76001230|FG002|Overall Study|Lost to Follow-up|0|||
42190900|NCT02944448|76001240|FG000|Overall Study|Adverse Event|37|||
42190901|NCT02944448|76001241|FG001|Overall Study|Adverse Event|6|||
42190902|NCT02944448|76001240|FG000|Overall Study|Lack of Efficacy|8|||
42190903|NCT02944448|76001241|FG001|Overall Study|Lack of Efficacy|5|||
42096895|NCT00651261|75907562|FG000|Overall Study|Adverse Event|32|||
42096896|NCT00651261|75907563|FG001|Overall Study|Adverse Event|22|||
42096897|NCT00651261|75907562|FG000|Overall Study|Death|18|||
42096898|NCT00651261|75907563|FG001|Overall Study|Death|18|||
42096899|NCT00651261|75907562|FG000|Overall Study|Withdrawal by Subject|22|||
42190904|NCT02944448|76001240|FG000|Overall Study|Lost to Follow-up|3|||
42096900|NCT00651261|75907563|FG001|Overall Study|Withdrawal by Subject|40|||
42096901|NCT00651261|75907562|FG000|Overall Study|Induction failure|24|||
42096902|NCT00651261|75907563|FG001|Overall Study|Induction failure|35|||
42096903|NCT00651261|75907562|FG000|Overall Study|Disease progression|58|||
42190905|NCT02944448|76001241|FG001|Overall Study|Lost to Follow-up|1|||
42190906|NCT02944448|76001240|FG000|Overall Study|Protocol Violation|25|||
42190907|NCT02944448|76001241|FG001|Overall Study|Protocol Violation|7|||
42190908|NCT02944448|76001240|FG000|Overall Study|Withdrawal by Subject|14|||
42190909|NCT02944448|76001241|FG001|Overall Study|Withdrawal by Subject|4|||
42190910|NCT02944448|76001240|FG000|Overall Study|Sponsor did not supply drug in time|0|||
42190911|NCT02944448|76001241|FG001|Overall Study|Sponsor did not supply drug in time|1|||
42190912|NCT02944448|76001240|FG000|Overall Study|Noncompliant with dosing|1|||
42190913|NCT02944448|76001241|FG001|Overall Study|Noncompliant with dosing|0|||
42096904|NCT00651261|75907563|FG001|Overall Study|Disease progression|58|||
42096905|NCT00651261|75907562|FG000|Overall Study|Alternative therapy|109|||
42096906|NCT00651261|75907563|FG001|Overall Study|Alternative therapy|107|||
42190914|NCT02944448|76001240|FG000|Overall Study|Abnormal laboratory values|1|||
42190915|NCT02944448|76001241|FG001|Overall Study|Abnormal laboratory values|0|||
42190916|NCT02943668|76001248|FG000|Overall Study|Disease Progression|1|||
42190917|NCT02891408|76001283|FG000|Overall Study|Lost to Follow-up|0|||
42190918|NCT02891408|76001284|FG001|Overall Study|Lost to Follow-up|0|||
42190919|NCT02891408|76001285|FG002|Overall Study|Lost to Follow-up|1|||
42190920|NCT02891408|76001286|FG003|Overall Study|Lost to Follow-up|0|||
42190921|NCT02891408|76001287|FG004|Overall Study|Lost to Follow-up|0|||
42190922|NCT02891408|76001288|FG005|Overall Study|Lost to Follow-up|0|||
42190923|NCT02891408|76001289|FG006|Overall Study|Lost to Follow-up|0|||
42190924|NCT03283670|76001315|FG000|Placebo Gas|Withdrawal by Subject|2|||
42190925|NCT03283670|76001315|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
42190926|NCT03283670|76001315|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
42190927|NCT01358578|76001336|FG000|Induction Period|Adverse Event|2|||
42190928|NCT01358578|76001337|FG001|Induction Period|Adverse Event|4|||
42190929|NCT01358578|76001338|FG002|Induction Period|Adverse Event|2|||
42190930|NCT01358578|76001339|FG003|Induction Period|Adverse Event|6|||
42190931|NCT01358578|76001340|FG004|Induction Period|Adverse Event|0|||
42190932|NCT01358578|76001341|FG005|Induction Period|Adverse Event|0|||
42190933|NCT01358578|76001336|FG000|Induction Period|Lack of Efficacy|0|||
42190934|NCT01358578|76001337|FG001|Induction Period|Lack of Efficacy|0|||
42190935|NCT01358578|76001338|FG002|Induction Period|Lack of Efficacy|9|||
42190936|NCT01358578|76001339|FG003|Induction Period|Lack of Efficacy|1|||
42190937|NCT01358578|76001340|FG004|Induction Period|Lack of Efficacy|0|||
42190938|NCT01358578|76001341|FG005|Induction Period|Lack of Efficacy|0|||
42190939|NCT01358578|76001336|FG000|Induction Period|Lost to Follow-up|0|||
42297102|NCT02588833|76132040|FG001|Part 2C|Withdrawal by Subject|1|||
42297103|NCT02588833|76132039|FG000|Part 3 (Safety Follow-up)|Other|0|||
42297104|NCT02588833|76132040|FG001|Part 3 (Safety Follow-up)|Other|2|||
42297105|NCT01667107|76132049|FG000|Overall Study|Adverse Event|4|||
42297106|NCT01667107|76132050|FG001|Overall Study|Adverse Event|3|||
42297107|NCT01667107|76132049|FG000|Overall Study|Tolerability issues|0|||
42096907|NCT00651261|75907562|FG000|Overall Study|Other disease or participant decisions|23|||
42096908|NCT00651261|75907563|FG001|Overall Study|Other disease or participant decisions|23|||
42096909|NCT00651261|75907562|FG000|Overall Study|Never treated|5|||
42096910|NCT00651261|75907563|FG001|Overall Study|Never treated|3|||
42190940|NCT01358578|76001337|FG001|Induction Period|Lost to Follow-up|0|||
42190941|NCT01358578|76001338|FG002|Induction Period|Lost to Follow-up|1|||
42190942|NCT01358578|76001339|FG003|Induction Period|Lost to Follow-up|4|||
42190943|NCT01358578|76001340|FG004|Induction Period|Lost to Follow-up|0|||
42190944|NCT01358578|76001341|FG005|Induction Period|Lost to Follow-up|0|||
42297108|NCT01667107|76132050|FG001|Overall Study|Tolerability issues|2|||
42297109|NCT01667107|76132049|FG000|Overall Study|Protocol Violation|0|||
42190945|NCT01358578|76001336|FG000|Induction Period|Physician Decision|2|||
42190946|NCT01358578|76001337|FG001|Induction Period|Physician Decision|1|||
42190947|NCT01358578|76001338|FG002|Induction Period|Physician Decision|2|||
42190948|NCT01358578|76001339|FG003|Induction Period|Physician Decision|0|||
42190949|NCT01358578|76001340|FG004|Induction Period|Physician Decision|0|||
42190950|NCT01358578|76001341|FG005|Induction Period|Physician Decision|0|||
42297110|NCT01667107|76132050|FG001|Overall Study|Protocol Violation|1|||
42190951|NCT01358578|76001336|FG000|Induction Period|Protocol Deviation|3|||
42190952|NCT01358578|76001337|FG001|Induction Period|Protocol Deviation|5|||
42190953|NCT01358578|76001338|FG002|Induction Period|Protocol Deviation|0|||
42190954|NCT01358578|76001339|FG003|Induction Period|Protocol Deviation|3|||
42190955|NCT01358578|76001340|FG004|Induction Period|Protocol Deviation|0|||
42190956|NCT01358578|76001341|FG005|Induction Period|Protocol Deviation|0|||
42190957|NCT01358578|76001336|FG000|Induction Period|technical problems|0|||
42190958|NCT01358578|76001337|FG001|Induction Period|technical problems|0|||
42190959|NCT01358578|76001338|FG002|Induction Period|technical problems|1|||
42190960|NCT01358578|76001339|FG003|Induction Period|technical problems|1|||
42190961|NCT01358578|76001340|FG004|Induction Period|technical problems|0|||
42190962|NCT01358578|76001341|FG005|Induction Period|technical problems|0|||
42190963|NCT01358578|76001336|FG000|Induction Period|Withdrawal by Subject|5|||
42190964|NCT01358578|76001337|FG001|Induction Period|Withdrawal by Subject|5|||
42190965|NCT01358578|76001338|FG002|Induction Period|Withdrawal by Subject|10|||
42190966|NCT01358578|76001339|FG003|Induction Period|Withdrawal by Subject|6|||
42190967|NCT01358578|76001340|FG004|Induction Period|Withdrawal by Subject|0|||
42190968|NCT01358578|76001341|FG005|Induction Period|Withdrawal by Subject|0|||
42190969|NCT01358578|76001336|FG000|Maintenance Period|Adverse Event|2|||
42190970|NCT01358578|76001337|FG001|Maintenance Period|Adverse Event|7|||
42190971|NCT01358578|76001338|FG002|Maintenance Period|Adverse Event|0|||
42190972|NCT01358578|76001339|FG003|Maintenance Period|Adverse Event|6|||
42190973|NCT01358578|76001340|FG004|Maintenance Period|Adverse Event|4|||
42190974|NCT01358578|76001341|FG005|Maintenance Period|Adverse Event|3|||
42190975|NCT01358578|76001336|FG000|Maintenance Period|Lack of Efficacy|10|||
42190976|NCT01358578|76001337|FG001|Maintenance Period|Lack of Efficacy|2|||
42190977|NCT01358578|76001338|FG002|Maintenance Period|Lack of Efficacy|0|||
42190978|NCT01358578|76001339|FG003|Maintenance Period|Lack of Efficacy|11|||
42190979|NCT01358578|76001340|FG004|Maintenance Period|Lack of Efficacy|3|||
42190980|NCT01358578|76001341|FG005|Maintenance Period|Lack of Efficacy|0|||
42190981|NCT01358578|76001336|FG000|Maintenance Period|Lost to Follow-up|4|||
42190982|NCT01358578|76001337|FG001|Maintenance Period|Lost to Follow-up|0|||
42190983|NCT01358578|76001338|FG002|Maintenance Period|Lost to Follow-up|0|||
42190984|NCT01358578|76001339|FG003|Maintenance Period|Lost to Follow-up|5|||
42190985|NCT01358578|76001340|FG004|Maintenance Period|Lost to Follow-up|1|||
42190986|NCT01358578|76001341|FG005|Maintenance Period|Lost to Follow-up|1|||
42190987|NCT01358578|76001336|FG000|Maintenance Period|Non-compliance with study treatment|3|||
42190988|NCT01358578|76001337|FG001|Maintenance Period|Non-compliance with study treatment|1|||
42190989|NCT01358578|76001338|FG002|Maintenance Period|Non-compliance with study treatment|0|||
42190990|NCT01358578|76001339|FG003|Maintenance Period|Non-compliance with study treatment|2|||
42190991|NCT01358578|76001340|FG004|Maintenance Period|Non-compliance with study treatment|1|||
42190992|NCT01358578|76001341|FG005|Maintenance Period|Non-compliance with study treatment|2|||
42190993|NCT01358578|76001336|FG000|Maintenance Period|Physician Decision|0|||
42190994|NCT01358578|76001337|FG001|Maintenance Period|Physician Decision|1|||
42190995|NCT01358578|76001338|FG002|Maintenance Period|Physician Decision|0|||
42190996|NCT01358578|76001339|FG003|Maintenance Period|Physician Decision|1|||
42096911|NCT00651183|75907571|FG000|Overall Study|Lack of Efficacy|1|||
42096912|NCT00651183|75907572|FG001|Overall Study|Lack of Efficacy|0|||
42096913|NCT00651183|75907571|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
42096914|NCT00651183|75907572|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
42096915|NCT00651183|75907571|FG000|Overall Study|Tolerability insufficient|5|||
42096916|NCT00651183|75907572|FG001|Overall Study|Tolerability insufficient|2|||
42096917|NCT00651183|75907571|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
42096918|NCT00651183|75907572|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
42096919|NCT00651183|75907571|FG000|Overall Study|Withdrawal by Subject|6|||
42096920|NCT00651183|75907572|FG001|Overall Study|Withdrawal by Subject|3|||
42096921|NCT00651183|75907571|FG000|Overall Study|Lost to Follow-up|3|||
42096922|NCT00651183|75907572|FG001|Overall Study|Lost to Follow-up|1|||
42096923|NCT00651183|75907571|FG000|Overall Study|Other reasons|4|||
42096924|NCT00651183|75907572|FG001|Overall Study|Other reasons|2|||
42096925|NCT00651183|75907571|FG000|Overall Study|missing|1|||
42096926|NCT00651183|75907572|FG001|Overall Study|missing|0|||
42096927|NCT00699972|75907581|FG000|Overall Study|Adverse Event|7|||
42096928|NCT00699972|75907582|FG001|Overall Study|Adverse Event|9|||
42096929|NCT00699972|75907583|FG002|Overall Study|Adverse Event|24|||
42096930|NCT00699972|75907581|FG000|Overall Study|Lost to Follow-up|0|||
42190997|NCT01358578|76001340|FG004|Maintenance Period|Physician Decision|0|||
42190998|NCT01358578|76001341|FG005|Maintenance Period|Physician Decision|0|||
42190999|NCT01358578|76001336|FG000|Maintenance Period|Pregnancy|1|||
42096931|NCT00699972|75907582|FG001|Overall Study|Lost to Follow-up|2|||
42096932|NCT00699972|75907583|FG002|Overall Study|Lost to Follow-up|0|||
42191000|NCT01358578|76001337|FG001|Maintenance Period|Pregnancy|0|||
42096933|NCT00699972|75907581|FG000|Overall Study|Withdrawal by Subject|3|||
42191001|NCT01358578|76001338|FG002|Maintenance Period|Pregnancy|0|||
42191002|NCT01358578|76001339|FG003|Maintenance Period|Pregnancy|0|||
42191003|NCT01358578|76001340|FG004|Maintenance Period|Pregnancy|0|||
42191004|NCT01358578|76001341|FG005|Maintenance Period|Pregnancy|0|||
42191005|NCT01358578|76001336|FG000|Maintenance Period|Protocol deviation|7|||
42191006|NCT01358578|76001337|FG001|Maintenance Period|Protocol deviation|4|||
42191007|NCT01358578|76001338|FG002|Maintenance Period|Protocol deviation|0|||
42191008|NCT01358578|76001339|FG003|Maintenance Period|Protocol deviation|2|||
42297111|NCT01667107|76132049|FG000|Overall Study|Lack of Efficacy|0|||
42297112|NCT01667107|76132050|FG001|Overall Study|Lack of Efficacy|1|||
42297113|NCT02590003|76132074|FG000|Overall Study|Death|1|||
42297114|NCT02590003|76132075|FG001|Overall Study|Death|2|||
42297115|NCT02404311|76132104|FG000|Part A: Month 0-18|Death|2|||
42297116|NCT02404311|76132105|FG001|Part A: Month 0-18|Death|0|||
42297117|NCT02404311|76132106|FG002|Part A: Month 0-18|Death|0|||
42297118|NCT02404311|76132107|FG003|Part A: Month 0-18|Death|0|||
42297119|NCT02404311|76132108|FG004|Part A: Month 0-18|Death|0|||
42297120|NCT02404311|76132104|FG000|Part A: Month 0-18|Physician Decision|1|||
42297121|NCT02404311|76132105|FG001|Part A: Month 0-18|Physician Decision|0|||
42297122|NCT02404311|76132106|FG002|Part A: Month 0-18|Physician Decision|0|||
42297123|NCT02404311|76132107|FG003|Part A: Month 0-18|Physician Decision|0|||
42297124|NCT02404311|76132108|FG004|Part A: Month 0-18|Physician Decision|0|||
42096934|NCT00699972|75907582|FG001|Overall Study|Withdrawal by Subject|7|||
42096935|NCT00699972|75907583|FG002|Overall Study|Withdrawal by Subject|4|||
42096936|NCT00699972|75907581|FG000|Overall Study|Lack of Efficacy|2|||
42297125|NCT02404311|76132104|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
42297126|NCT02404311|76132105|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
42297127|NCT02404311|76132106|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
42297128|NCT02404311|76132107|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
42297129|NCT02404311|76132108|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
42297130|NCT02404311|76132104|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
42297131|NCT02404311|76132105|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
42297132|NCT02404311|76132106|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
42297133|NCT02404311|76132107|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
42297134|NCT02404311|76132108|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
42297135|NCT02404311|76132104|FG000|Part A: Month 0-18|HIV Infection|6|||
42297136|NCT02404311|76132105|FG001|Part A: Month 0-18|HIV Infection|2|||
42297137|NCT02404311|76132106|FG002|Part A: Month 0-18|HIV Infection|0|||
42297138|NCT02404311|76132107|FG003|Part A: Month 0-18|HIV Infection|0|||
42297139|NCT02404311|76132108|FG004|Part A: Month 0-18|HIV Infection|0|||
42297140|NCT02404311|76132104|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
42297141|NCT02404311|76132105|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
42297142|NCT02404311|76132106|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
42297143|NCT02404311|76132107|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
42359238|NCT01827384|76204848|FG003|Overall Study|Participant died before treatment|0|||
42096937|NCT00699972|75907582|FG001|Overall Study|Lack of Efficacy|0|||
42096938|NCT00699972|75907583|FG002|Overall Study|Lack of Efficacy|2|||
42096939|NCT00699972|75907581|FG000|Overall Study|Administrative/Other|3|||
42096940|NCT00699972|75907582|FG001|Overall Study|Administrative/Other|1|||
42096941|NCT00699972|75907583|FG002|Overall Study|Administrative/Other|4|||
42096942|NCT00699972|75907581|FG000|Overall Study|Randomized, Not Treated|1|||
42096943|NCT00699972|75907582|FG001|Overall Study|Randomized, Not Treated|0|||
42096944|NCT00699972|75907583|FG002|Overall Study|Randomized, Not Treated|1|||
42096945|NCT00642759|75907591|FG000|Overall Study|Protocol Violation|1|||
42096946|NCT00611026|75907599|FG000|Randomized to Double-blind Treatment|Not treated|2|||
42096947|NCT00611026|75907600|FG001|Randomized to Double-blind Treatment|Not treated|1|||
42096948|NCT00611026|75907601|FG002|Randomized to Double-blind Treatment|Not treated|3|||
42096949|NCT00611026|75907599|FG000|Double-blind Treatment Period|Death|1|||
42096950|NCT00611026|75907600|FG001|Double-blind Treatment Period|Death|0|||
42096951|NCT00611026|75907601|FG002|Double-blind Treatment Period|Death|0|||
42096952|NCT00611026|75907599|FG000|Double-blind Treatment Period|Adverse Event|9|||
42096953|NCT00611026|75907600|FG001|Double-blind Treatment Period|Adverse Event|28|||
42096954|NCT00611026|75907601|FG002|Double-blind Treatment Period|Adverse Event|46|||
42191009|NCT01358578|76001340|FG004|Maintenance Period|Protocol deviation|2|||
42191010|NCT01358578|76001341|FG005|Maintenance Period|Protocol deviation|2|||
42191011|NCT01358578|76001336|FG000|Maintenance Period|Withdrawal by Subject|12|||
42359239|NCT01827384|76204849|FG004|Overall Study|Participant died before treatment|0|||
42096955|NCT00611026|75907599|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
42096956|NCT00611026|75907600|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
42096957|NCT00611026|75907601|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
42191012|NCT01358578|76001337|FG001|Maintenance Period|Withdrawal by Subject|7|||
42191013|NCT01358578|76001338|FG002|Maintenance Period|Withdrawal by Subject|2|||
42297144|NCT02404311|76132108|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
42297145|NCT01650519|76132122|FG000|Overall Study|Withdrawal by Subject|1|||
42297146|NCT01650519|76132123|FG001|Overall Study|Withdrawal by Subject|0|||
42297147|NCT01650285|76132129|FG000|Overall Study|Adverse Event|1|||
42297148|NCT02347527|76132137|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
42297149|NCT02347527|76132138|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
42191014|NCT01358578|76001339|FG003|Maintenance Period|Withdrawal by Subject|15|||
42191015|NCT01358578|76001340|FG004|Maintenance Period|Withdrawal by Subject|6|||
42191016|NCT01358578|76001341|FG005|Maintenance Period|Withdrawal by Subject|3|||
42191017|NCT01358578|76001336|FG000|Follow-up Period|Adverse Event|1|||
42191018|NCT01358578|76001337|FG001|Follow-up Period|Adverse Event|1|||
42191019|NCT01358578|76001338|FG002|Follow-up Period|Adverse Event|0|||
42191020|NCT01358578|76001339|FG003|Follow-up Period|Adverse Event|0|||
42191021|NCT01358578|76001340|FG004|Follow-up Period|Adverse Event|0|||
42191022|NCT01358578|76001341|FG005|Follow-up Period|Adverse Event|0|||
42191023|NCT01358578|76001336|FG000|Follow-up Period|Lack of Efficacy|3|||
42191024|NCT01358578|76001337|FG001|Follow-up Period|Lack of Efficacy|0|||
42191025|NCT01358578|76001338|FG002|Follow-up Period|Lack of Efficacy|4|||
42191026|NCT01358578|76001339|FG003|Follow-up Period|Lack of Efficacy|1|||
42191027|NCT01358578|76001340|FG004|Follow-up Period|Lack of Efficacy|0|||
42191028|NCT01358578|76001341|FG005|Follow-up Period|Lack of Efficacy|0|||
42191029|NCT01358578|76001336|FG000|Follow-up Period|Lost to Follow-up|0|||
42191030|NCT01358578|76001337|FG001|Follow-up Period|Lost to Follow-up|1|||
42191031|NCT01358578|76001338|FG002|Follow-up Period|Lost to Follow-up|0|||
42191032|NCT01358578|76001339|FG003|Follow-up Period|Lost to Follow-up|4|||
42191033|NCT01358578|76001340|FG004|Follow-up Period|Lost to Follow-up|0|||
42191034|NCT01358578|76001341|FG005|Follow-up Period|Lost to Follow-up|0|||
42191035|NCT01358578|76001336|FG000|Follow-up Period|non- compliance with study treatment|1|||
42191036|NCT01358578|76001337|FG001|Follow-up Period|non- compliance with study treatment|0|||
42191037|NCT01358578|76001338|FG002|Follow-up Period|non- compliance with study treatment|0|||
42191038|NCT01358578|76001339|FG003|Follow-up Period|non- compliance with study treatment|0|||
42191039|NCT01358578|76001340|FG004|Follow-up Period|non- compliance with study treatment|0|||
42191040|NCT01358578|76001341|FG005|Follow-up Period|non- compliance with study treatment|0|||
42191041|NCT01358578|76001336|FG000|Follow-up Period|Pregnancy|1|||
42191042|NCT01358578|76001337|FG001|Follow-up Period|Pregnancy|0|||
42191043|NCT01358578|76001338|FG002|Follow-up Period|Pregnancy|0|||
42191044|NCT01358578|76001339|FG003|Follow-up Period|Pregnancy|0|||
42191045|NCT01358578|76001340|FG004|Follow-up Period|Pregnancy|0|||
42191046|NCT01358578|76001341|FG005|Follow-up Period|Pregnancy|0|||
42191047|NCT01358578|76001336|FG000|Follow-up Period|Withdrawal by Subject|3|||
42191048|NCT01358578|76001337|FG001|Follow-up Period|Withdrawal by Subject|3|||
42191049|NCT01358578|76001338|FG002|Follow-up Period|Withdrawal by Subject|1|||
42191050|NCT01358578|76001339|FG003|Follow-up Period|Withdrawal by Subject|12|||
42096958|NCT00611026|75907599|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
42096959|NCT00611026|75907600|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
42096960|NCT00611026|75907601|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
42096961|NCT00611026|75907599|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
42096962|NCT00611026|75907600|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
42096963|NCT00611026|75907601|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
42096964|NCT00611026|75907599|FG000|Double-blind Treatment Period|Other|13|||
42096965|NCT00611026|75907600|FG001|Double-blind Treatment Period|Other|20|||
42096966|NCT00611026|75907601|FG002|Double-blind Treatment Period|Other|18|||
42096967|NCT00646113|75907611|FG000|Overall Study|Lost to Follow-up|5|||
42096968|NCT00646113|75907611|FG000|Overall Study|Adverse Event|3|||
42096969|NCT00422383|75907620|FG000|Overall Study|Adverse Event|5|||
42096970|NCT00422383|75907621|FG001|Overall Study|Adverse Event|3|||
42096971|NCT00422383|75907622|FG002|Overall Study|Adverse Event|1|||
42096972|NCT00422383|75907623|FG003|Overall Study|Adverse Event|1|||
42191051|NCT01358578|76001340|FG004|Follow-up Period|Withdrawal by Subject|0|||
42191052|NCT01358578|76001341|FG005|Follow-up Period|Withdrawal by Subject|0|||
42191053|NCT01358578|76001336|FG000|Follow-up Period|Physician Decision|1|||
42191054|NCT01358578|76001337|FG001|Follow-up Period|Physician Decision|1|||
42191055|NCT01358578|76001338|FG002|Follow-up Period|Physician Decision|0|||
42191056|NCT01358578|76001339|FG003|Follow-up Period|Physician Decision|2|||
42191057|NCT01358578|76001340|FG004|Follow-up Period|Physician Decision|0|||
42191058|NCT01358578|76001341|FG005|Follow-up Period|Physician Decision|0|||
42191059|NCT02833948|76001371|FG000|Overall Study|Death|2|||
42191060|NCT02833948|76001372|FG001|Overall Study|Death|3|||
42191061|NCT02833948|76001371|FG000|Overall Study|were not scanned|8|||
42191062|NCT02833948|76001372|FG001|Overall Study|were not scanned|13|||
42191063|NCT02833948|76001371|FG000|Overall Study|scans could not be evaluated|5|||
42191064|NCT02833948|76001372|FG001|Overall Study|scans could not be evaluated|2|||
42191065|NCT02828020|76001385|FG000|Treatment Period|Adverse Event|3|||
42191066|NCT02828020|76001386|FG001|Treatment Period|Adverse Event|1|||
42191067|NCT02828020|76001387|FG002|Treatment Period|Adverse Event|1|||
42191068|NCT02828020|76001385|FG000|Treatment Period|Withdrawal of Consent|10|||
42096973|NCT00422383|75907624|FG004|Overall Study|Adverse Event|0|||
42191069|NCT02828020|76001386|FG001|Treatment Period|Withdrawal of Consent|14|||
42191070|NCT02828020|76001387|FG002|Treatment Period|Withdrawal of Consent|9|||
42297150|NCT02347527|76132139|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
42096974|NCT00422383|75907620|FG000|Overall Study|Lack of Efficacy|4|||
42096975|NCT00422383|75907621|FG001|Overall Study|Lack of Efficacy|4|||
42191071|NCT02828020|76001385|FG000|Treatment Period|Lost to Follow-up|21|||
42191072|NCT02828020|76001386|FG001|Treatment Period|Lost to Follow-up|24|||
42191073|NCT02828020|76001387|FG002|Treatment Period|Lost to Follow-up|18|||
42191074|NCT02828020|76001385|FG000|Treatment Period|Lack of Qualifying Event|44|||
42191075|NCT02828020|76001386|FG001|Treatment Period|Lack of Qualifying Event|53|||
42191076|NCT02828020|76001387|FG002|Treatment Period|Lack of Qualifying Event|43|||
42191077|NCT02828020|76001385|FG000|Treatment Period|Pregnancy|0|||
42191078|NCT02828020|76001386|FG001|Treatment Period|Pregnancy|2|||
42191079|NCT02828020|76001387|FG002|Treatment Period|Pregnancy|0|||
42191080|NCT02828020|76001385|FG000|Treatment Period|Protocol Violation|2|||
42191081|NCT02828020|76001386|FG001|Treatment Period|Protocol Violation|4|||
42191082|NCT02828020|76001387|FG002|Treatment Period|Protocol Violation|7|||
42191083|NCT02828020|76001385|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
42191084|NCT02828020|76001386|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
42191085|NCT02828020|76001387|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
42191086|NCT02828020|76001385|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
42191087|NCT02828020|76001386|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
42191088|NCT02828020|76001387|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
42191089|NCT02828020|76001385|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
42191090|NCT02828020|76001386|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
42191091|NCT02828020|76001387|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
42191092|NCT02828020|76001385|FG000|Safety Follow-up Period|Protocol Violation|0|||
42191093|NCT02828020|76001386|FG001|Safety Follow-up Period|Protocol Violation|2|||
42191094|NCT02828020|76001387|FG002|Safety Follow-up Period|Protocol Violation|1|||
42191095|NCT02828020|76001385|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
42191096|NCT02828020|76001386|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
42191097|NCT02828020|76001387|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
42191098|NCT02827708|76001406|FG000|Overall Study|Lost to Follow-up|3|||
42191099|NCT02827708|76001407|FG001|Overall Study|Lost to Follow-up|1|||
42191100|NCT02827708|76001406|FG000|Overall Study|Withdrawal by Subject|1|||
42191101|NCT02827708|76001407|FG001|Overall Study|Withdrawal by Subject|2|||
42191102|NCT02827708|76001406|FG000|Overall Study|Death|1|||
42191103|NCT02827708|76001407|FG001|Overall Study|Death|2|||
42191104|NCT03760185|76001413|FG000|Overall Study|Lost to Follow-up|1|||
42096976|NCT00422383|75907622|FG002|Overall Study|Lack of Efficacy|2|||
42096977|NCT00422383|75907623|FG003|Overall Study|Lack of Efficacy|1|||
42096978|NCT00422383|75907624|FG004|Overall Study|Lack of Efficacy|1|||
42096979|NCT00422383|75907620|FG000|Overall Study|Lost to Follow-up|0|||
42096980|NCT00422383|75907621|FG001|Overall Study|Lost to Follow-up|1|||
42096981|NCT00422383|75907622|FG002|Overall Study|Lost to Follow-up|0|||
42096982|NCT00422383|75907623|FG003|Overall Study|Lost to Follow-up|0|||
42096983|NCT00422383|75907624|FG004|Overall Study|Lost to Follow-up|1|||
42096984|NCT00422383|75907620|FG000|Overall Study|Protocol Violation|1|||
42096985|NCT00422383|75907621|FG001|Overall Study|Protocol Violation|1|||
42096986|NCT00422383|75907622|FG002|Overall Study|Protocol Violation|1|||
42191105|NCT03760185|76001414|FG001|Overall Study|Lost to Follow-up|1|||
42191106|NCT02891174|76001424|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
42191107|NCT02891174|76001425|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
42191108|NCT02891174|76001424|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
42191109|NCT02891174|76001425|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
42191110|NCT02891174|76001424|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
42297151|NCT02347527|76132140|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
42297152|NCT02347527|76132137|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
42297153|NCT02347527|76132138|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
42096987|NCT00422383|75907623|FG003|Overall Study|Protocol Violation|0|||
42096988|NCT00422383|75907624|FG004|Overall Study|Protocol Violation|0|||
42096989|NCT00422383|75907620|FG000|Overall Study|Withdrawal by Subject|5|||
42096990|NCT00422383|75907621|FG001|Overall Study|Withdrawal by Subject|5|||
42096991|NCT00422383|75907622|FG002|Overall Study|Withdrawal by Subject|0|||
42096992|NCT00422383|75907623|FG003|Overall Study|Withdrawal by Subject|0|||
42096993|NCT00422383|75907624|FG004|Overall Study|Withdrawal by Subject|1|||
42096994|NCT00612040|75907645|FG000|Overall Study|Adverse Event|0|||
42096995|NCT00612040|75907646|FG001|Overall Study|Adverse Event|2|||
42096996|NCT00612040|75907647|FG002|Overall Study|Adverse Event|1|||
42297154|NCT02347527|76132139|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
42096997|NCT00612040|75907645|FG000|Overall Study|Protocol Violation|1|||
42096998|NCT00612040|75907646|FG001|Overall Study|Protocol Violation|2|||
42096999|NCT00612040|75907647|FG002|Overall Study|Protocol Violation|1|||
42097000|NCT00612040|75907645|FG000|Overall Study|Lack of Efficacy|2|||
42097001|NCT00612040|75907646|FG001|Overall Study|Lack of Efficacy|1|||
42097002|NCT00612040|75907647|FG002|Overall Study|Lack of Efficacy|0|||
42097003|NCT00612040|75907645|FG000|Overall Study|Unclassified|2|||
42191111|NCT02891174|76001425|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
42191112|NCT02891174|76001424|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
42097004|NCT00612040|75907646|FG001|Overall Study|Unclassified|2|||
42097005|NCT00612040|75907647|FG002|Overall Study|Unclassified|5|||
42097006|NCT00422227|75907657|FG000|Overall Study|Adverse Event|3|||
42097007|NCT00422227|75907658|FG001|Overall Study|Adverse Event|8|||
42097008|NCT00422227|75907657|FG000|Overall Study|Lost to Follow-up|1|||
42097009|NCT00422227|75907658|FG001|Overall Study|Lost to Follow-up|3|||
42097010|NCT00422227|75907657|FG000|Overall Study|Withdrawal by Subject|0|||
42097011|NCT00422227|75907658|FG001|Overall Study|Withdrawal by Subject|4|||
42097012|NCT00421993|75907668|FG000|Overall Study|Withdrawal by Subject|22|||
42097013|NCT00421993|75907669|FG001|Overall Study|Withdrawal by Subject|23|||
42097014|NCT00421993|75907670|FG002|Overall Study|Withdrawal by Subject|23|||
42097015|NCT00421993|75907671|FG003|Overall Study|Withdrawal by Subject|24|||
42097016|NCT00421993|75907668|FG000|Overall Study|Lost to Follow-up|18|||
42097017|NCT00421993|75907669|FG001|Overall Study|Lost to Follow-up|19|||
42097018|NCT00421993|75907670|FG002|Overall Study|Lost to Follow-up|22|||
42097019|NCT00421993|75907671|FG003|Overall Study|Lost to Follow-up|20|||
42097020|NCT00421993|75907668|FG000|Overall Study|Adverse Event|11|||
42097021|NCT00421993|75907669|FG001|Overall Study|Adverse Event|1|||
42191113|NCT02891174|76001425|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
42191114|NCT02891174|76001424|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
42191115|NCT02891174|76001425|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
42191116|NCT02891174|76001424|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
42191117|NCT02891174|76001425|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
42191118|NCT02891174|76001424|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
42191119|NCT02891174|76001425|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
42191120|NCT01751984|76001446|FG000|Overall Study|Adverse Event|5|||
42097022|NCT00421993|75907670|FG002|Overall Study|Adverse Event|6|||
42191121|NCT01751984|76001447|FG001|Overall Study|Adverse Event|3|||
42191122|NCT01751984|76001446|FG000|Overall Study|Withdrawal by Subject|0|||
42191123|NCT01751984|76001447|FG001|Overall Study|Withdrawal by Subject|1|||
42191124|NCT01751984|76001446|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
42191125|NCT01751984|76001447|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
42191126|NCT03330236|76001455|FG000|Overall Study|Death|2|||
42191127|NCT03330236|76001456|FG001|Overall Study|Death|1|||
42191128|NCT03330236|76001455|FG000|Overall Study|Withdrawal by Subject|2|||
42191129|NCT03330236|76001456|FG001|Overall Study|Withdrawal by Subject|4|||
42191130|NCT03330236|76001455|FG000|Overall Study|Lost to Follow-up|0|||
42191131|NCT03330236|76001456|FG001|Overall Study|Lost to Follow-up|2|||
42191132|NCT03330236|76001455|FG000|Overall Study|Physician Decision|2|||
42097023|NCT00421993|75907671|FG003|Overall Study|Adverse Event|4|||
42097024|NCT00421993|75907668|FG000|Overall Study|Protocol Violation|2|||
42097025|NCT00421993|75907669|FG001|Overall Study|Protocol Violation|2|||
42097026|NCT00421993|75907670|FG002|Overall Study|Protocol Violation|0|||
42097027|NCT00421993|75907671|FG003|Overall Study|Protocol Violation|1|||
42097028|NCT00421993|75907668|FG000|Overall Study|Lack of Efficacy|0|||
42097029|NCT00421993|75907669|FG001|Overall Study|Lack of Efficacy|3|||
42191133|NCT03330236|76001456|FG001|Overall Study|Physician Decision|0|||
42191134|NCT03330236|76001455|FG000|Overall Study|Protocol Violation|4|||
42191135|NCT03330236|76001456|FG001|Overall Study|Protocol Violation|3|||
42191136|NCT03330236|76001455|FG000|Overall Study|SedLine malfunction/blinding|19|||
42191137|NCT03330236|76001456|FG001|Overall Study|SedLine malfunction/blinding|14|||
42191138|NCT03330236|76001455|FG000|Overall Study|Volatile anesthetics used|11|||
42191139|NCT03330236|76001456|FG001|Overall Study|Volatile anesthetics used|8|||
42191140|NCT03330236|76001455|FG000|Overall Study|Surgery aborted/converted to open|60|||
42191141|NCT03330236|76001456|FG001|Overall Study|Surgery aborted/converted to open|52|||
42191142|NCT03330002|76001462|FG000|Overall Study|Lost to Follow-up|15|||
42191143|NCT03330002|76001462|FG000|Overall Study|Death|7|||
42191144|NCT02948582|76001466|FG000|Washout Period 1|Adverse Event|0|||
42191145|NCT02948582|76001467|FG001|Washout Period 1|Adverse Event|2|||
42191146|NCT02948582|76001468|FG002|Washout Period 1|Adverse Event|0|||
42191147|NCT02948582|76001469|FG003|Washout Period 1|Adverse Event|0|||
42097030|NCT00421993|75907670|FG002|Overall Study|Lack of Efficacy|0|||
42097031|NCT00421993|75907671|FG003|Overall Study|Lack of Efficacy|5|||
42097032|NCT00421993|75907668|FG000|Overall Study|Pregnancy|0|||
42097033|NCT00421993|75907669|FG001|Overall Study|Pregnancy|1|||
42097034|NCT00421993|75907670|FG002|Overall Study|Pregnancy|1|||
42097035|NCT00421993|75907671|FG003|Overall Study|Pregnancy|2|||
42097036|NCT00421993|75907668|FG000|Overall Study|Subject transportation issues|0|||
42097037|NCT00421993|75907669|FG001|Overall Study|Subject transportation issues|0|||
42097038|NCT00421993|75907670|FG002|Overall Study|Subject transportation issues|0|||
42191148|NCT02948582|76001470|FG004|Washout Period 1|Adverse Event|0|||
42097039|NCT00421993|75907671|FG003|Overall Study|Subject transportation issues|1|||
42191149|NCT02948582|76001471|FG005|Washout Period 1|Adverse Event|0|||
42191150|NCT02948582|76001466|FG000|Washout Period 1|Protocol Violation|0|||
42191151|NCT02948582|76001467|FG001|Washout Period 1|Protocol Violation|0|||
42191152|NCT02948582|76001468|FG002|Washout Period 1|Protocol Violation|0|||
42191153|NCT02948582|76001469|FG003|Washout Period 1|Protocol Violation|0|||
42191154|NCT02948582|76001470|FG004|Washout Period 1|Protocol Violation|0|||
42191155|NCT02948582|76001471|FG005|Washout Period 1|Protocol Violation|1|||
42191156|NCT02948582|76001466|FG000|Washout Period 2|Adverse Event|0|||
42191157|NCT02948582|76001467|FG001|Washout Period 2|Adverse Event|1|||
42191158|NCT02948582|76001468|FG002|Washout Period 2|Adverse Event|0|||
42191159|NCT02948582|76001469|FG003|Washout Period 2|Adverse Event|0|||
42191160|NCT02948582|76001470|FG004|Washout Period 2|Adverse Event|0|||
42191161|NCT02948582|76001471|FG005|Washout Period 2|Adverse Event|0|||
42191162|NCT02948582|76001466|FG000|Washout Period 2|personal reasons|0|||
42191163|NCT02948582|76001467|FG001|Washout Period 2|personal reasons|0|||
42191164|NCT02948582|76001468|FG002|Washout Period 2|personal reasons|0|||
42191165|NCT02948582|76001469|FG003|Washout Period 2|personal reasons|1|||
42191166|NCT02948582|76001470|FG004|Washout Period 2|personal reasons|0|||
42191167|NCT02948582|76001471|FG005|Washout Period 2|personal reasons|0|||
42191168|NCT02948582|76001466|FG000|Washout Period 4|Adverse Event|1|||
42191169|NCT02948582|76001467|FG001|Washout Period 4|Adverse Event|0|||
42191170|NCT02948582|76001468|FG002|Washout Period 4|Adverse Event|1|||
42191171|NCT02948582|76001469|FG003|Washout Period 4|Adverse Event|0|||
42191172|NCT02948582|76001470|FG004|Washout Period 4|Adverse Event|0|||
42191173|NCT02948582|76001471|FG005|Washout Period 4|Adverse Event|0|||
42191174|NCT03756285|76001487|FG000|Overall Study|Lost to Follow-up|0|||
42297155|NCT02347527|76132140|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
42297156|NCT02347527|76132137|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
42297157|NCT02347527|76132138|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
42297158|NCT02347527|76132139|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
42297159|NCT02347527|76132140|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
42297160|NCT02347527|76132137|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
42297161|NCT02347527|76132138|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
42297162|NCT02347527|76132139|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
42297163|NCT02347527|76132140|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
42297164|NCT02347527|76132137|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
42297165|NCT02347527|76132138|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
42297166|NCT02347527|76132139|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
42297167|NCT02347527|76132140|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
42297168|NCT02386839|76132154|FG000|Overall Study|Death|1|||
42297169|NCT02386839|76132155|FG001|Overall Study|Death|0|||
42297170|NCT02386839|76132154|FG000|Overall Study|Withdrawal by Subject|9|||
42297171|NCT02386839|76132155|FG001|Overall Study|Withdrawal by Subject|10|||
42297172|NCT02386839|76132154|FG000|Overall Study|Lost to Follow-up|4|||
42297173|NCT02386839|76132155|FG001|Overall Study|Lost to Follow-up|4|||
42297174|NCT02386839|76132154|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
42297175|NCT02386839|76132155|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
42297176|NCT02386839|76132154|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
42297177|NCT02386839|76132155|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
42297178|NCT02386839|76132154|FG000|Overall Study|Other (unspecified)|1|||
42297179|NCT02386839|76132155|FG001|Overall Study|Other (unspecified)|0|||
42297180|NCT01649271|76132167|FG000|Overall Study|Progressive disease|4|||
42297181|NCT01649271|76132168|FG001|Overall Study|Progressive disease|5|||
42297182|NCT01649271|76132167|FG000|Overall Study|Other Adverse Event|0|||
42297183|NCT01649271|76132168|FG001|Overall Study|Other Adverse Event|2|||
42297184|NCT01649271|76132167|FG000|Overall Study|Withdrawal by Subject|1|||
42097040|NCT00413959|75907681|FG000|Overall Study|Pt had only one cycle.|1|||
42097041|NCT00645567|75907685|FG000|Overall Study|Adverse Event|1|||
42097042|NCT00611884|75907697|FG000|Overall Study|Adverse Event|1|||
42097043|NCT00611884|75907698|FG001|Overall Study|Adverse Event|0|||
42097044|NCT00611884|75907699|FG002|Overall Study|Adverse Event|0|||
42097045|NCT00611884|75907700|FG003|Overall Study|Adverse Event|1|||
42097046|NCT00611884|75907697|FG000|Overall Study|Non-Compliance|1|||
42097047|NCT00611884|75907698|FG001|Overall Study|Non-Compliance|4|||
42191175|NCT03756285|76001488|FG001|Overall Study|Lost to Follow-up|1|||
42191176|NCT03756285|76001487|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
42097048|NCT00611884|75907699|FG002|Overall Study|Non-Compliance|2|||
42097049|NCT00611884|75907700|FG003|Overall Study|Non-Compliance|2|||
42097050|NCT00611884|75907697|FG000|Overall Study|Lack of Efficacy|0|||
42191177|NCT03756285|76001488|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
42191178|NCT03756285|76001487|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
42191179|NCT03756285|76001488|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
42297185|NCT01649271|76132168|FG001|Overall Study|Withdrawal by Subject|0|||
42191180|NCT02825992|76001495|FG000|Overall Study|Withdrawal by Subject|4|||
42191181|NCT02825992|76001495|FG000|Overall Study|Lost to Follow-up|2|||
42191182|NCT02825992|76001495|FG000|Overall Study|Procedure terminated|2|||
42191183|NCT01339000|76001507|FG000|Overall Study|study closed due to lack of drug supply|1|||
42191184|NCT01339000|76001508|FG001|Overall Study|study closed due to lack of drug supply|0|||
42191185|NCT03755661|76001519|FG000|Overall Study|Lost to Follow-up|1|||
42191186|NCT03755661|76001520|FG001|Overall Study|Lost to Follow-up|0|||
42191187|NCT03752151|76001526|FG000|Overall Study|Withdrawal by Subject|1|||
42097051|NCT00611884|75907698|FG001|Overall Study|Lack of Efficacy|1|||
42097052|NCT00611884|75907699|FG002|Overall Study|Lack of Efficacy|0|||
42097053|NCT00611884|75907700|FG003|Overall Study|Lack of Efficacy|0|||
42097054|NCT00611884|75907697|FG000|Overall Study|Unclassified|7|||
42097055|NCT00611884|75907698|FG001|Overall Study|Unclassified|4|||
42097056|NCT00611884|75907699|FG002|Overall Study|Unclassified|2|||
42097057|NCT00611884|75907700|FG003|Overall Study|Unclassified|3|||
42097058|NCT00420745|75907712|FG000|Overall Study|Adverse Event|2|||
42097059|NCT00420745|75907713|FG001|Overall Study|Adverse Event|2|||
42097060|NCT00420745|75907712|FG000|Overall Study|Lost to Follow-up|10|||
42097061|NCT00420745|75907713|FG001|Overall Study|Lost to Follow-up|2|||
42097062|NCT00420745|75907712|FG000|Overall Study|Protocol Violation|1|||
42097063|NCT00420745|75907713|FG001|Overall Study|Protocol Violation|0|||
42097064|NCT00420745|75907712|FG000|Overall Study|Physician Decision|1|||
42097065|NCT00420745|75907713|FG001|Overall Study|Physician Decision|1|||
42097066|NCT00420745|75907712|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
42097067|NCT00420745|75907713|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
42097068|NCT00420745|75907712|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
42097069|NCT00420745|75907713|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
42097070|NCT00611806|75907721|FG000|Overall Study|Withdrawal by Subject|8|||
42097071|NCT00611806|75907722|FG001|Overall Study|Withdrawal by Subject|2|||
42097072|NCT00611806|75907721|FG000|Overall Study|Adverse Event|2|||
42097073|NCT00611806|75907722|FG001|Overall Study|Adverse Event|1|||
42097074|NCT00611806|75907721|FG000|Overall Study|Lost to Follow-up|6|||
42097075|NCT00611806|75907722|FG001|Overall Study|Lost to Follow-up|0|||
42097076|NCT00413413|75907731|FG000|Single-Blind|Adverse Event|0|||
42097077|NCT00413413|75907732|FG001|Single-Blind|Adverse Event|9|||
42097078|NCT00413413|75907733|FG002|Single-Blind|Adverse Event|0|||
42097079|NCT00413413|75907731|FG000|Single-Blind|Lack of Efficacy|0|||
42097080|NCT00413413|75907732|FG001|Single-Blind|Lack of Efficacy|5|||
42097081|NCT00413413|75907733|FG002|Single-Blind|Lack of Efficacy|0|||
42097082|NCT00413413|75907731|FG000|Single-Blind|Subject no longer requires study drug|0|||
42097083|NCT00413413|75907732|FG001|Single-Blind|Subject no longer requires study drug|151|||
42097084|NCT00413413|75907733|FG002|Single-Blind|Subject no longer requires study drug|0|||
42097085|NCT00413413|75907731|FG000|Single-Blind|Protocol Violation|0|||
42097086|NCT00413413|75907732|FG001|Single-Blind|Protocol Violation|16|||
42097087|NCT00413413|75907733|FG002|Single-Blind|Protocol Violation|0|||
42097088|NCT00413413|75907731|FG000|Single-Blind|Withdrawal by Subject|0|||
42097089|NCT00413413|75907732|FG001|Single-Blind|Withdrawal by Subject|27|||
42097090|NCT00413413|75907733|FG002|Single-Blind|Withdrawal by Subject|0|||
42097091|NCT00413413|75907731|FG000|Single-Blind|Lost to Follow-up|0|||
42097092|NCT00413413|75907732|FG001|Single-Blind|Lost to Follow-up|8|||
42097093|NCT00413413|75907733|FG002|Single-Blind|Lost to Follow-up|0|||
42097094|NCT00413413|75907731|FG000|Double-Blind|Adverse Event|6|||
42191188|NCT03752151|76001526|FG000|Overall Study|Protocol Violation|1|||
42191189|NCT01336634|76001534|FG000|Overall Study|Study closed/terminated|5|||
42191190|NCT01336634|76001535|FG001|Overall Study|Study closed/terminated|6|||
42191191|NCT01336634|76001536|FG002|Overall Study|Study closed/terminated|6|||
42191192|NCT01336634|76001534|FG000|Overall Study|Lost to Follow-up|2|||
42191193|NCT01336634|76001535|FG001|Overall Study|Lost to Follow-up|1|||
42191194|NCT01336634|76001536|FG002|Overall Study|Lost to Follow-up|1|||
42191195|NCT01336634|76001534|FG000|Overall Study|Physician Decision|1|||
42191196|NCT01336634|76001535|FG001|Overall Study|Physician Decision|1|||
42191197|NCT01336634|76001536|FG002|Overall Study|Physician Decision|0|||
42191198|NCT01336634|76001534|FG000|Overall Study|Withdrawal by Subject|6|||
42097095|NCT00413413|75907732|FG001|Double-Blind|Adverse Event|0|||
42097096|NCT00413413|75907733|FG002|Double-Blind|Adverse Event|5|||
42097097|NCT00413413|75907731|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
42097098|NCT00413413|75907732|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
42191199|NCT01336634|76001535|FG001|Overall Study|Withdrawal by Subject|0|||
42191200|NCT01336634|76001536|FG002|Overall Study|Withdrawal by Subject|2|||
42097099|NCT00413413|75907733|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
42097100|NCT00413413|75907731|FG000|Double-Blind|Protocol deviation|1|||
42097101|NCT00413413|75907732|FG001|Double-Blind|Protocol deviation|2|||
42097102|NCT00413413|75907733|FG002|Double-Blind|Protocol deviation|1|||
42097103|NCT00413413|75907731|FG000|Double-Blind|Subject withdrew consent|4|||
42097104|NCT00413413|75907732|FG001|Double-Blind|Subject withdrew consent|6|||
42097105|NCT00413413|75907733|FG002|Double-Blind|Subject withdrew consent|9|||
42097106|NCT00413413|75907731|FG000|Double-Blind|Lost to Follow-up|3|||
42097107|NCT00413413|75907732|FG001|Double-Blind|Lost to Follow-up|4|||
42097108|NCT00413413|75907733|FG002|Double-Blind|Lost to Follow-up|2|||
42097109|NCT00610714|75907743|FG000|Overall Study|Adverse Event|3|||
42097110|NCT00610714|75907744|FG001|Overall Study|Adverse Event|1|||
42097111|NCT00610714|75907743|FG000|Overall Study|Death|12|||
42097112|NCT00610714|75907744|FG001|Overall Study|Death|18|||
42097113|NCT00610714|75907743|FG000|Overall Study|Withdrawal by Subject|9|||
42097114|NCT00610714|75907744|FG001|Overall Study|Withdrawal by Subject|3|||
42097115|NCT00610714|75907743|FG000|Overall Study|Study completion at 120 PFS events|2|||
42191201|NCT02947100|76001551|FG000|Overall Study|study terminated early|3|||
42191202|NCT02947100|76001551|FG000|Overall Study|did not meet inclusion criteria|1|||
42191203|NCT03329846|76001557|FG000|Overall Study|Disease progression|4|||
42191204|NCT03329846|76001558|FG001|Overall Study|Disease progression|6|||
42191205|NCT03329846|76001557|FG000|Overall Study|Study drug toxicity|1|||
42191206|NCT03329846|76001558|FG001|Overall Study|Study drug toxicity|0|||
42191207|NCT03329846|76001557|FG000|Overall Study|Participant request to discontinue treatment|0|||
42297186|NCT01649271|76132167|FG000|Overall Study|Other than stated above|1|||
42297187|NCT01649271|76132168|FG001|Overall Study|Other than stated above|0|||
42297188|NCT02385669|76132175|FG000|Overall Study|Adverse Event|2|||
42297189|NCT02402907|76132181|FG000|Overall Study|Delivered vaginally|9|||
42297190|NCT02402907|76132182|FG001|Overall Study|Delivered vaginally|3|||
42297191|NCT02402907|76132181|FG000|Overall Study|Delivered outside of Sinai|1|||
42297192|NCT02402907|76132182|FG001|Overall Study|Delivered outside of Sinai|1|||
42297193|NCT02402907|76132181|FG000|Overall Study|Lost to follow up after C-Section|10|||
42297194|NCT02402907|76132182|FG001|Overall Study|Lost to follow up after C-Section|23|||
42297195|NCT02345889|76132192|FG000|Overall Study|Inadequate Bowel Prep|17|||
42297196|NCT02345889|76132193|FG001|Overall Study|Inadequate Bowel Prep|16|||
42297197|NCT02345889|76132194|FG002|Overall Study|Inadequate Bowel Prep|18|||
42297198|NCT02345889|76132195|FG003|Overall Study|Inadequate Bowel Prep|14|||
42297199|NCT02345889|76132192|FG000|Overall Study|Polyposis identified during procedure|1|||
42297200|NCT02345889|76132193|FG001|Overall Study|Polyposis identified during procedure|1|||
42297201|NCT02345889|76132194|FG002|Overall Study|Polyposis identified during procedure|0|||
42297202|NCT02345889|76132195|FG003|Overall Study|Polyposis identified during procedure|1|||
42297203|NCT02345889|76132192|FG000|Overall Study|Recognized ineligible post-randomization|1|||
42297204|NCT02345889|76132193|FG001|Overall Study|Recognized ineligible post-randomization|0|||
42297205|NCT02345889|76132194|FG002|Overall Study|Recognized ineligible post-randomization|2|||
42297206|NCT02345889|76132195|FG003|Overall Study|Recognized ineligible post-randomization|1|||
42297207|NCT02345889|76132192|FG000|Overall Study|Ulcerative Colitis identified|1|||
42297208|NCT02345889|76132193|FG001|Overall Study|Ulcerative Colitis identified|0|||
42297209|NCT02345889|76132194|FG002|Overall Study|Ulcerative Colitis identified|0|||
42297210|NCT02345889|76132195|FG003|Overall Study|Ulcerative Colitis identified|0|||
42297211|NCT02345889|76132192|FG000|Overall Study|Cecum not intubated|1|||
42297212|NCT02345889|76132193|FG001|Overall Study|Cecum not intubated|0|||
42297213|NCT02345889|76132194|FG002|Overall Study|Cecum not intubated|0|||
42297214|NCT02345889|76132195|FG003|Overall Study|Cecum not intubated|0|||
42297215|NCT02345811|76132205|FG000|First Intervention|Withdrawal by Subject|1|||
42297216|NCT02345811|76132206|FG001|First Intervention|Withdrawal by Subject|1|||
42097116|NCT00610714|75907744|FG001|Overall Study|Study completion at 120 PFS events|2|||
42097117|NCT00403585|75907750|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
42097118|NCT00403585|75907750|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
42097119|NCT00403585|75907750|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
42097120|NCT00645411|75907758|FG000|Overall Study|Adverse Event|0|||
42097121|NCT00645411|75907759|FG001|Overall Study|Adverse Event|0|||
42097122|NCT00645411|75907760|FG002|Overall Study|Adverse Event|0|||
42097123|NCT00645411|75907761|FG003|Overall Study|Adverse Event|2|||
42097124|NCT00645411|75907758|FG000|Overall Study|Withdrawal by Subject|2|||
42097125|NCT00645411|75907759|FG001|Overall Study|Withdrawal by Subject|1|||
42097126|NCT00645411|75907760|FG002|Overall Study|Withdrawal by Subject|19|||
42097127|NCT00645411|75907761|FG003|Overall Study|Withdrawal by Subject|21|||
42191208|NCT03329846|76001558|FG001|Overall Study|Participant request to discontinue treatment|1|||
42191209|NCT03329846|76001557|FG000|Overall Study|Participant withdrew consent|1|||
42191210|NCT03329846|76001558|FG001|Overall Study|Participant withdrew consent|0|||
42297217|NCT02344173|76132214|FG000|Procedure|Ablation Procedure Not Performed|7|||
42297218|NCT02344173|76132214|FG000|12-month Visit|Death|8|||
42097128|NCT00645411|75907758|FG000|Overall Study|Lost to Follow-up|10|||
42097129|NCT00645411|75907759|FG001|Overall Study|Lost to Follow-up|5|||
42097130|NCT00645411|75907760|FG002|Overall Study|Lost to Follow-up|124|||
42191211|NCT03329846|76001557|FG000|Overall Study|Other reasons|2|||
42097131|NCT00645411|75907761|FG003|Overall Study|Lost to Follow-up|75|||
42191212|NCT03329846|76001558|FG001|Overall Study|Other reasons|2|||
42297219|NCT02344173|76132214|FG000|12-month Visit|Withdrawal by Subject|30|||
42297220|NCT02344173|76132214|FG000|12-month Visit|Lost to Follow-up|58|||
42297221|NCT02586493|76132220|FG000|Overall Study|Adverse Event|4|||
42297222|NCT02586493|76132220|FG000|Overall Study|Protocol Violation|6|||
42297223|NCT02586493|76132220|FG000|Overall Study|Lost to Follow-up|1|||
42097132|NCT00645411|75907758|FG000|Overall Study|Protocol Violation|1|||
42097133|NCT00645411|75907759|FG001|Overall Study|Protocol Violation|0|||
42097134|NCT00645411|75907760|FG002|Overall Study|Protocol Violation|1|||
42097135|NCT00645411|75907761|FG003|Overall Study|Protocol Violation|0|||
42097136|NCT00645411|75907758|FG000|Overall Study|Inappropriate enrollment|0|||
42097137|NCT00645411|75907759|FG001|Overall Study|Inappropriate enrollment|0|||
42097138|NCT00645411|75907760|FG002|Overall Study|Inappropriate enrollment|4|||
42097139|NCT00645411|75907761|FG003|Overall Study|Inappropriate enrollment|1|||
42097140|NCT00645411|75907758|FG000|Overall Study|Unable to classify|0|||
42097141|NCT00645411|75907759|FG001|Overall Study|Unable to classify|0|||
42097142|NCT00645411|75907760|FG002|Overall Study|Unable to classify|3|||
42097143|NCT00645411|75907761|FG003|Overall Study|Unable to classify|4|||
42097144|NCT00403273|75907780|FG000|Overall Study|Lost to Follow-up|3|||
42097145|NCT00403273|75907781|FG001|Overall Study|Lost to Follow-up|2|||
42097146|NCT00403273|75907780|FG000|Overall Study|Physician Decision|0|||
42097147|NCT00403273|75907781|FG001|Overall Study|Physician Decision|1|||
42097148|NCT00403273|75907780|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
42191213|NCT03325010|76001566|FG000|Overall Study|Adverse Event|3|||
42191214|NCT03325010|76001567|FG001|Overall Study|Adverse Event|8|||
42191215|NCT03325010|76001566|FG000|Overall Study|Protocol Violation|1|||
42191216|NCT03325010|76001567|FG001|Overall Study|Protocol Violation|8|||
42191217|NCT03325010|76001566|FG000|Overall Study|Withdrawal by Subject|1|||
42191218|NCT03325010|76001567|FG001|Overall Study|Withdrawal by Subject|3|||
42097149|NCT00403273|75907781|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
42097150|NCT00402727|75907804|FG000|Overall Study|Adverse Event|10|||
42097151|NCT00402727|75907805|FG001|Overall Study|Adverse Event|6|||
42097152|NCT00402727|75907804|FG000|Overall Study|Death|1|||
42097153|NCT00402727|75907805|FG001|Overall Study|Death|0|||
42097154|NCT00402727|75907804|FG000|Overall Study|Lack of Efficacy|1|||
42097155|NCT00402727|75907805|FG001|Overall Study|Lack of Efficacy|3|||
42097156|NCT00402727|75907804|FG000|Overall Study|Lost to Follow-up|24|||
42097157|NCT00402727|75907805|FG001|Overall Study|Lost to Follow-up|11|||
42097158|NCT00402727|75907804|FG000|Overall Study|Physician Decision|1|||
42097159|NCT00402727|75907805|FG001|Overall Study|Physician Decision|1|||
42097160|NCT00402727|75907804|FG000|Overall Study|Protocol Violation|0|||
42097161|NCT00402727|75907805|FG001|Overall Study|Protocol Violation|4|||
42191219|NCT03325010|76001566|FG000|Overall Study|Lost to Follow-up|1|||
42191220|NCT03325010|76001567|FG001|Overall Study|Lost to Follow-up|0|||
42191221|NCT03325010|76001566|FG000|Overall Study|Physician Decision|1|||
42191222|NCT03325010|76001567|FG001|Overall Study|Physician Decision|1|||
42191223|NCT03325010|76001566|FG000|Overall Study|Lack of Efficacy|2|||
42191224|NCT03325010|76001567|FG001|Overall Study|Lack of Efficacy|0|||
42191225|NCT02824432|76001575|FG000|Overall Study|Major Protocol Deviation|1|||
42191226|NCT02824432|76001576|FG001|Overall Study|Major Protocol Deviation|0|||
42191227|NCT02823964|76001582|FG000|Overall Study|Adverse Event|2|||
42297224|NCT02586493|76132220|FG000|Overall Study|Withdrawal by Subject|1|||
42297225|NCT02400333|76132228|FG000|Overall Study|Withdrawal by Subject|0|||
42297226|NCT02400333|76132229|FG001|Overall Study|Withdrawal by Subject|1|||
42191228|NCT02823964|76001582|FG000|Overall Study|Physician Decision|1|||
42191229|NCT02823964|76001582|FG000|Overall Study|Lack of Efficacy|1|||
42191230|NCT02823964|76001582|FG000|Overall Study|Withdrawal by Subject|1|||
42191231|NCT01338610|76001589|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
42191232|NCT01338610|76001590|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
42191233|NCT01338610|76001591|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
42191234|NCT01338610|76001589|FG000|Overall Study|Protocol Violation|1|||
42191235|NCT01338610|76001590|FG001|Overall Study|Protocol Violation|0|||
42297227|NCT02400333|76132230|FG002|Overall Study|Withdrawal by Subject|0|||
42297228|NCT02400333|76132231|FG003|Overall Study|Withdrawal by Subject|1|||
42297229|NCT02400333|76132228|FG000|Overall Study|Protocol Violation|1|||
42297230|NCT02400333|76132229|FG001|Overall Study|Protocol Violation|0|||
42297231|NCT02400333|76132230|FG002|Overall Study|Protocol Violation|2|||
42097162|NCT00402727|75907804|FG000|Overall Study|Withdrawal by Subject|3|||
42297232|NCT02400333|76132231|FG003|Overall Study|Protocol Violation|1|||
42097163|NCT00402727|75907805|FG001|Overall Study|Withdrawal by Subject|7|||
42097164|NCT00402727|75907804|FG000|Overall Study|supply problems|2|||
42097165|NCT00402727|75907805|FG001|Overall Study|supply problems|1|||
42097166|NCT00402727|75907804|FG000|Overall Study|non-compliance|0|||
42191236|NCT01338610|76001591|FG002|Overall Study|Protocol Violation|1|||
42191237|NCT01338610|76001589|FG000|Overall Study|Adverse Event|3|||
42191238|NCT01338610|76001590|FG001|Overall Study|Adverse Event|0|||
42191239|NCT01338610|76001591|FG002|Overall Study|Adverse Event|0|||
42297233|NCT02399475|76132244|FG000|Overall Study|Physician Decision|1|||
42097167|NCT00402727|75907805|FG001|Overall Study|non-compliance|1|||
42097168|NCT00402649|75907811|FG000|Overall Study|Lost to Follow-up|1|||
42097169|NCT00402649|75907811|FG000|Overall Study|Withdrawal by Subject|1|||
42097170|NCT00402337|75907820|FG000|Overall Study|Adverse Event|0|||
42097171|NCT00402337|75907821|FG001|Overall Study|Adverse Event|2|||
42297234|NCT02399475|76132245|FG001|Overall Study|Physician Decision|0|||
42097172|NCT00402337|75907822|FG002|Overall Study|Adverse Event|2|||
42097173|NCT00402337|75907823|FG003|Overall Study|Adverse Event|3|||
42097174|NCT00402337|75907824|FG004|Overall Study|Adverse Event|2|||
42097175|NCT00402337|75907820|FG000|Overall Study|Noncompliance|0|||
42097176|NCT00402337|75907821|FG001|Overall Study|Noncompliance|0|||
42097177|NCT00402337|75907822|FG002|Overall Study|Noncompliance|0|||
42191240|NCT01355302|76001598|FG000|Phase 1b|Death|4|||
42297235|NCT02399163|76132251|FG000|Overall Study|Adverse Event|2|||
42297236|NCT02399163|76132251|FG000|Overall Study|Protocol Deviation|2|||
42297237|NCT02399163|76132251|FG000|Overall Study|Withdrawal by Participant|5|||
42297238|NCT02398227|76132265|FG000|Overall Study|Lost to Follow-up|21|||
42297239|NCT02398227|76132266|FG001|Overall Study|Lost to Follow-up|12|||
42297240|NCT02398227|76132265|FG000|Overall Study|Withdrawal by Subject|5|||
42297241|NCT02398227|76132266|FG001|Overall Study|Withdrawal by Subject|6|||
42297242|NCT02398227|76132265|FG000|Overall Study|Removed from treatment and dropped out|1|||
42297243|NCT02398227|76132266|FG001|Overall Study|Removed from treatment and dropped out|0|||
42297244|NCT02397915|76132272|FG000|Period 1|Protocol Violation|0|||
42297245|NCT02397915|76132273|FG001|Period 1|Protocol Violation|1|||
42297246|NCT02397915|76132274|FG002|Period 1|Protocol Violation|0|||
42297247|NCT02397915|76132275|FG003|Period 1|Protocol Violation|0|||
42297248|NCT02397915|76132272|FG000|Period 1|Physician Decision|1|||
42297249|NCT02397915|76132273|FG001|Period 1|Physician Decision|0|||
42297250|NCT02397915|76132274|FG002|Period 1|Physician Decision|0|||
42191241|NCT01355302|76001599|FG001|Phase 1b|Death|0|||
42191242|NCT01355302|76001600|FG002|Phase 1b|Death|0|||
42191243|NCT01355302|76001598|FG000|Phase 1b|Study terminated by sponsor|2|||
42191244|NCT01355302|76001599|FG001|Phase 1b|Study terminated by sponsor|0|||
42191245|NCT01355302|76001600|FG002|Phase 1b|Study terminated by sponsor|0|||
42191246|NCT01355068|76001608|FG000|First Intervention Period|Adverse Event|0|||
42191247|NCT01355068|76001609|FG001|First Intervention Period|Adverse Event|1|||
42191248|NCT01355068|76001608|FG000|First Intervention Period|Withdrawal by Subject|0|||
42191249|NCT01355068|76001609|FG001|First Intervention Period|Withdrawal by Subject|1|||
42191250|NCT03756129|76001621|FG000|Overall Study|Adverse Event|1|||
42191251|NCT03756129|76001622|FG001|Overall Study|Adverse Event|1|||
42191252|NCT03756129|76001623|FG002|Overall Study|Adverse Event|0|||
42191253|NCT03756129|76001624|FG003|Overall Study|Adverse Event|2|||
42191254|NCT03756129|76001625|FG004|Overall Study|Adverse Event|0|||
42191255|NCT03756129|76001626|FG005|Overall Study|Adverse Event|0|||
42191256|NCT03756129|76001621|FG000|Overall Study|Withdrawal by Subject|2|||
42191257|NCT03756129|76001622|FG001|Overall Study|Withdrawal by Subject|1|||
42191258|NCT03756129|76001623|FG002|Overall Study|Withdrawal by Subject|3|||
42191259|NCT03756129|76001624|FG003|Overall Study|Withdrawal by Subject|1|||
42191260|NCT03756129|76001625|FG004|Overall Study|Withdrawal by Subject|1|||
42191261|NCT03756129|76001626|FG005|Overall Study|Withdrawal by Subject|3|||
42191262|NCT03756129|76001621|FG000|Overall Study|Lost to Follow-up|0|||
42191263|NCT03756129|76001622|FG001|Overall Study|Lost to Follow-up|0|||
42191264|NCT03756129|76001623|FG002|Overall Study|Lost to Follow-up|0|||
42191265|NCT03756129|76001624|FG003|Overall Study|Lost to Follow-up|0|||
42191266|NCT03756129|76001625|FG004|Overall Study|Lost to Follow-up|0|||
42191267|NCT03756129|76001626|FG005|Overall Study|Lost to Follow-up|1|||
42191268|NCT03756129|76001621|FG000|Overall Study|Physician Decision|0|||
42191269|NCT03756129|76001622|FG001|Overall Study|Physician Decision|0|||
42191270|NCT03756129|76001623|FG002|Overall Study|Physician Decision|0|||
42297251|NCT02397915|76132275|FG003|Period 1|Physician Decision|0|||
42297252|NCT02397837|76132285|FG000|Overall Study|Withdrawal by Subject|6|||
42297253|NCT02397837|76132286|FG001|Overall Study|Withdrawal by Subject|5|||
42297254|NCT02397837|76132285|FG000|Overall Study|Physician Decision|1|||
42297255|NCT02397837|76132286|FG001|Overall Study|Physician Decision|1|||
42297256|NCT02586415|76132294|FG000|Overall Study|Death|13|||
42297257|NCT02586415|76132295|FG001|Overall Study|Death|23|||
42097178|NCT00402337|75907823|FG003|Overall Study|Noncompliance|0|||
42097179|NCT00402337|75907824|FG004|Overall Study|Noncompliance|2|||
42097180|NCT00402337|75907820|FG000|Overall Study|Withdrawal by Subject|5|||
42097181|NCT00402337|75907821|FG001|Overall Study|Withdrawal by Subject|3|||
42097182|NCT00402337|75907822|FG002|Overall Study|Withdrawal by Subject|1|||
42097183|NCT00402337|75907823|FG003|Overall Study|Withdrawal by Subject|6|||
42097184|NCT00402337|75907824|FG004|Overall Study|Withdrawal by Subject|4|||
42097185|NCT00402337|75907820|FG000|Overall Study|Lost to Follow-up|0|||
42191271|NCT03756129|76001624|FG003|Overall Study|Physician Decision|0|||
42191272|NCT03756129|76001625|FG004|Overall Study|Physician Decision|0|||
42191273|NCT03756129|76001626|FG005|Overall Study|Physician Decision|1|||
42191274|NCT02822794|76001652|FG000|Overall Study|Withdrew Consent|1|||
42191275|NCT02822794|76001653|FG001|Overall Study|Withdrew Consent|0|||
42191276|NCT01338298|76001668|FG000|Overall Study|Withdrawal by Subject|1|||
42097186|NCT00402337|75907821|FG001|Overall Study|Lost to Follow-up|0|||
42097187|NCT00402337|75907822|FG002|Overall Study|Lost to Follow-up|1|||
42097188|NCT00402337|75907823|FG003|Overall Study|Lost to Follow-up|2|||
42297258|NCT02586415|76132294|FG000|Overall Study|Lost to Follow-up|1|||
42297259|NCT02586415|76132295|FG001|Overall Study|Lost to Follow-up|2|||
42097189|NCT00402337|75907824|FG004|Overall Study|Lost to Follow-up|0|||
42097190|NCT00402337|75907820|FG000|Overall Study|Physician Decision|0|||
42097191|NCT00402337|75907821|FG001|Overall Study|Physician Decision|0|||
42097192|NCT00402337|75907822|FG002|Overall Study|Physician Decision|0|||
42097193|NCT00402337|75907823|FG003|Overall Study|Physician Decision|1|||
42097194|NCT00402337|75907824|FG004|Overall Study|Physician Decision|0|||
42097195|NCT00402337|75907820|FG000|Overall Study|Other Reason|0|||
42191277|NCT01338298|76001669|FG001|Overall Study|Withdrawal by Subject|1|||
42191278|NCT01338298|76001668|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
42191279|NCT01338298|76001669|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
42191280|NCT01338298|76001668|FG000|Overall Study|Administrative error|0|||
42191281|NCT01338298|76001669|FG001|Overall Study|Administrative error|1|||
42191282|NCT01338298|76001668|FG000|Overall Study|Positive symptom worsening|1|||
42191283|NCT01338298|76001669|FG001|Overall Study|Positive symptom worsening|0|||
42191284|NCT01338298|76001668|FG000|Overall Study|Depressive symptoms and nausea|1|||
42191285|NCT01338298|76001669|FG001|Overall Study|Depressive symptoms and nausea|0|||
42191286|NCT01338298|76001668|FG000|Overall Study|Non-adherence|1|||
42191287|NCT01338298|76001669|FG001|Overall Study|Non-adherence|0|||
42191288|NCT01354132|76001677|FG000|Randomization|Physician Decision|1|||
42191289|NCT01354132|76001678|FG001|Randomization|Physician Decision|0|||
42191290|NCT01354132|76001677|FG000|Randomization|Withdrawal by Subject|0|||
42191291|NCT01354132|76001678|FG001|Randomization|Withdrawal by Subject|1|||
42191292|NCT01354132|76001677|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
42191293|NCT01354132|76001678|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
42191294|NCT01354132|76001677|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
42191295|NCT01354132|76001678|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
42191296|NCT01354132|76001677|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
42191297|NCT01354132|76001678|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
42191298|NCT01353898|76001693|FG000|Overall Study|Study site terminated|0|||
42191299|NCT01353898|76001694|FG001|Overall Study|Study site terminated|0|||
42191300|NCT01353898|76001695|FG002|Overall Study|Study site terminated|0|||
42191301|NCT01353898|76001696|FG003|Overall Study|Study site terminated|0|||
42191302|NCT01353898|76001697|FG004|Overall Study|Study site terminated|0|||
42191303|NCT01353898|76001698|FG005|Overall Study|Study site terminated|1|||
42191304|NCT01372150|76001715|FG000|Overall Study|Lack of Efficacy|3|||
42191305|NCT01372150|76001716|FG001|Overall Study|Lack of Efficacy|0|||
42191306|NCT01372150|76001717|FG002|Overall Study|Lack of Efficacy|1|||
42191307|NCT01372150|76001715|FG000|Overall Study|Lost to Follow-up|4|||
42191308|NCT01372150|76001716|FG001|Overall Study|Lost to Follow-up|5|||
42191309|NCT01372150|76001717|FG002|Overall Study|Lost to Follow-up|6|||
42191310|NCT01372150|76001715|FG000|Overall Study|Protocol Violation|1|||
42191311|NCT01372150|76001716|FG001|Overall Study|Protocol Violation|0|||
42191312|NCT01372150|76001717|FG002|Overall Study|Protocol Violation|3|||
42191313|NCT01372150|76001715|FG000|Overall Study|Withdrawal by Subject|2|||
42191314|NCT01372150|76001716|FG001|Overall Study|Withdrawal by Subject|7|||
42191315|NCT01372150|76001717|FG002|Overall Study|Withdrawal by Subject|2|||
42191316|NCT01372150|76001715|FG000|Overall Study|Other|1|||
42191317|NCT01372150|76001716|FG001|Overall Study|Other|0|||
42191318|NCT01372150|76001717|FG002|Overall Study|Other|2|||
42191319|NCT01372150|76001715|FG000|Overall Study|Adverse Event|2|||
42191320|NCT01372150|76001716|FG001|Overall Study|Adverse Event|1|||
42191321|NCT01372150|76001717|FG002|Overall Study|Adverse Event|2|||
42191322|NCT01372150|76001715|FG000|Overall Study|Randomized but not treated|0|||
42191323|NCT01372150|76001716|FG001|Overall Study|Randomized but not treated|1|||
42191324|NCT01372150|76001717|FG002|Overall Study|Randomized but not treated|0|||
42191325|NCT03329690|76001730|FG000|Overall Study|Progressive disease per RECIST|85|||
42297260|NCT02383017|76132304|FG000|Overall Study|Injury Sustained Outside Study|1|||
42297261|NCT02383017|76132305|FG001|Overall Study|Injury Sustained Outside Study|0|||
42297262|NCT02383017|76132304|FG000|Overall Study|Compliance|3|||
42297263|NCT02383017|76132305|FG001|Overall Study|Compliance|2|||
42297264|NCT02383017|76132304|FG000|Overall Study|Found to be Hypogonadal|1|||
42297265|NCT02383017|76132305|FG001|Overall Study|Found to be Hypogonadal|0|||
42097196|NCT00402337|75907821|FG001|Overall Study|Other Reason|1|||
42097197|NCT00402337|75907822|FG002|Overall Study|Other Reason|0|||
42097198|NCT00402337|75907823|FG003|Overall Study|Other Reason|0|||
42097199|NCT00402337|75907824|FG004|Overall Study|Other Reason|0|||
42191326|NCT03329690|76001731|FG001|Overall Study|Progressive disease per RECIST|44|||
42191327|NCT03329690|76001732|FG002|Overall Study|Progressive disease per RECIST|6|||
42191328|NCT03329690|76001733|FG003|Overall Study|Progressive disease per RECIST|16|||
42191329|NCT03329690|76001734|FG004|Overall Study|Progressive disease per RECIST|20|||
42191330|NCT03329690|76001730|FG000|Overall Study|Clinical progression|7|||
42191331|NCT03329690|76001731|FG001|Overall Study|Clinical progression|4|||
42191332|NCT03329690|76001732|FG002|Overall Study|Clinical progression|1|||
42191333|NCT03329690|76001733|FG003|Overall Study|Clinical progression|1|||
42097200|NCT00650091|75907838|FG000|Amended Study Design|Withdrawal by Subject|12|||
42097201|NCT00650091|75907839|FG001|Amended Study Design|Withdrawal by Subject|11|||
42097202|NCT00650091|75907840|FG002|Amended Study Design|Withdrawal by Subject|0|||
42097203|NCT00650091|75907838|FG000|Amended Study Design|Physician Decision|5|||
42097204|NCT00650091|75907839|FG001|Amended Study Design|Physician Decision|0|||
42097205|NCT00650091|75907840|FG002|Amended Study Design|Physician Decision|0|||
42097206|NCT00650091|75907838|FG000|Amended Study Design|Adverse Event|1|||
42097207|NCT00650091|75907839|FG001|Amended Study Design|Adverse Event|4|||
42097208|NCT00650091|75907840|FG002|Amended Study Design|Adverse Event|0|||
42097209|NCT00650091|75907838|FG000|Amended Study Design|Lung transplantation|4|||
42097210|NCT00650091|75907839|FG001|Amended Study Design|Lung transplantation|2|||
42097211|NCT00650091|75907840|FG002|Amended Study Design|Lung transplantation|0|||
42097212|NCT00650091|75907838|FG000|Amended Study Design|Other|1|||
42097213|NCT00650091|75907839|FG001|Amended Study Design|Other|3|||
42097214|NCT00650091|75907840|FG002|Amended Study Design|Other|0|||
42097215|NCT00642369|75907850|FG000|Overall Study|Adverse Event|2|||
42191334|NCT03329690|76001734|FG004|Overall Study|Clinical progression|1|||
42191335|NCT03329690|76001730|FG000|Overall Study|Adverse Event|22|||
42191336|NCT03329690|76001731|FG001|Overall Study|Adverse Event|4|||
42191337|NCT03329690|76001732|FG002|Overall Study|Adverse Event|0|||
42191338|NCT03329690|76001733|FG003|Overall Study|Adverse Event|1|||
42191339|NCT03329690|76001734|FG004|Overall Study|Adverse Event|2|||
42191340|NCT03329690|76001730|FG000|Overall Study|Death|2|||
42191341|NCT03329690|76001731|FG001|Overall Study|Death|0|||
42191342|NCT03329690|76001732|FG002|Overall Study|Death|0|||
42191343|NCT03329690|76001733|FG003|Overall Study|Death|1|||
42191344|NCT03329690|76001734|FG004|Overall Study|Death|0|||
42191345|NCT03329690|76001730|FG000|Overall Study|Withdrawal by Subject|2|||
42191346|NCT03329690|76001731|FG001|Overall Study|Withdrawal by Subject|3|||
42191347|NCT03329690|76001732|FG002|Overall Study|Withdrawal by Subject|0|||
42191348|NCT03329690|76001733|FG003|Overall Study|Withdrawal by Subject|1|||
42191349|NCT03329690|76001734|FG004|Overall Study|Withdrawal by Subject|0|||
42191350|NCT03329690|76001730|FG000|Overall Study|Physician Decision|1|||
42191351|NCT03329690|76001731|FG001|Overall Study|Physician Decision|0|||
42191352|NCT03329690|76001732|FG002|Overall Study|Physician Decision|0|||
42191353|NCT03329690|76001733|FG003|Overall Study|Physician Decision|0|||
42191354|NCT03329690|76001734|FG004|Overall Study|Physician Decision|1|||
42191355|NCT03329690|76001730|FG000|Overall Study|Miscellaneous|6|||
42191356|NCT03329690|76001731|FG001|Overall Study|Miscellaneous|0|||
42191357|NCT03329690|76001732|FG002|Overall Study|Miscellaneous|0|||
42191358|NCT03329690|76001733|FG003|Overall Study|Miscellaneous|0|||
42191359|NCT03329690|76001734|FG004|Overall Study|Miscellaneous|0|||
42191360|NCT03329690|76001730|FG000|Overall Study|Did not receive treatment|1|||
42191361|NCT03329690|76001731|FG001|Overall Study|Did not receive treatment|0|||
42191362|NCT03329690|76001732|FG002|Overall Study|Did not receive treatment|0|||
42191363|NCT03329690|76001733|FG003|Overall Study|Did not receive treatment|1|||
42191364|NCT03329690|76001734|FG004|Overall Study|Did not receive treatment|0|||
42191365|NCT03328832|76001754|FG000|Overall Study|Lost to Follow-up|0|||
42191366|NCT03328832|76001755|FG001|Overall Study|Lost to Follow-up|1|||
42191367|NCT02820844|76001763|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
42191368|NCT02820844|76001764|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
42191369|NCT02820844|76001765|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
42191370|NCT02820844|76001766|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
42191371|NCT02820844|76001767|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
42191372|NCT02820844|76001768|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
42191373|NCT02820844|76001763|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
42191374|NCT02820844|76001764|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
42191375|NCT02820844|76001765|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
42191376|NCT02820844|76001766|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
42191377|NCT02820844|76001767|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
42191378|NCT02820844|76001768|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
42191379|NCT02820844|76001763|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
42191380|NCT02820844|76001764|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
42297266|NCT02382939|76132313|FG000|Overall Study|Adverse Event|1|||
42097216|NCT00642369|75907851|FG001|Overall Study|Adverse Event|3|||
42191381|NCT02820844|76001765|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
42191382|NCT02820844|76001766|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
42191383|NCT02820844|76001767|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
42191384|NCT02820844|76001768|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
42191385|NCT02820844|76001763|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
42191386|NCT02820844|76001764|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
42191387|NCT02820844|76001765|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
42191388|NCT02820844|76001766|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
42191389|NCT02820844|76001767|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
42097217|NCT00642369|75907850|FG000|Overall Study|Withdrawal by Subject|1|||
42097218|NCT00642369|75907851|FG001|Overall Study|Withdrawal by Subject|0|||
42191390|NCT02820844|76001768|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
42191391|NCT02820844|76001763|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
42097219|NCT00642369|75907850|FG000|Overall Study|misdiagnosis|0|||
42097220|NCT00642369|75907851|FG001|Overall Study|misdiagnosis|1|||
42097221|NCT00642369|75907850|FG000|Overall Study|Lack of Efficacy|2|||
42097222|NCT00642369|75907851|FG001|Overall Study|Lack of Efficacy|2|||
42097223|NCT00645099|75907876|FG000|Overall Study|Lack of Efficacy|15|||
42097224|NCT00645099|75907877|FG001|Overall Study|Lack of Efficacy|6|||
42097225|NCT00645099|75907876|FG000|Overall Study|Withdrawal by Subject|30|||
42097226|NCT00645099|75907877|FG001|Overall Study|Withdrawal by Subject|22|||
42097227|NCT00645099|75907876|FG000|Overall Study|Lost to Follow-up|6|||
42191392|NCT02820844|76001764|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
42191393|NCT02820844|76001765|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
42191394|NCT02820844|76001766|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
42191395|NCT02820844|76001767|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
42191396|NCT02820844|76001768|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
42191397|NCT02820844|76001763|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
42191398|NCT02820844|76001764|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
42191399|NCT02820844|76001765|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
42191400|NCT02820844|76001766|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
42191401|NCT02820844|76001767|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
42191402|NCT02820844|76001768|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
42191403|NCT02820844|76001763|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
42191404|NCT02820844|76001764|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
42191405|NCT02820844|76001765|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
42191406|NCT02820844|76001766|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
42191407|NCT02820844|76001767|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
42191408|NCT02820844|76001768|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
42191409|NCT02820844|76001763|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
42191410|NCT02820844|76001764|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
42191411|NCT02820844|76001765|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
42191412|NCT02820844|76001766|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
42191413|NCT02820844|76001767|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
42191414|NCT02820844|76001768|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
42191415|NCT02820844|76001763|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
42191416|NCT02820844|76001764|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
42191417|NCT02820844|76001765|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
42191418|NCT02820844|76001766|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
42097228|NCT00645099|75907877|FG001|Overall Study|Lost to Follow-up|4|||
42097229|NCT00645099|75907876|FG000|Overall Study|Adverse Event|11|||
42097230|NCT00645099|75907877|FG001|Overall Study|Adverse Event|5|||
42097231|NCT00645099|75907876|FG000|Overall Study|Other|9|||
42097232|NCT00645099|75907877|FG001|Overall Study|Other|5|||
42097233|NCT00420511|75907885|FG000|Overall Study|Adverse Event|1|||
42097234|NCT00420511|75907886|FG001|Overall Study|Adverse Event|1|||
42097235|NCT00420511|75907885|FG000|Overall Study|Lost to Follow-up|1|||
42097236|NCT00420511|75907886|FG001|Overall Study|Lost to Follow-up|0|||
42097237|NCT00420199|75907896|FG000|Overall Study|Participant no longer met study criteria|1|||
42097238|NCT00420199|75907897|FG001|Overall Study|Participant no longer met study criteria|0|||
42097239|NCT00649389|75907912|FG000|Overall Study|Adverse Event|22|||
42097240|NCT00649389|75907913|FG001|Overall Study|Adverse Event|46|||
42097241|NCT00649389|75907914|FG002|Overall Study|Adverse Event|38|||
42097242|NCT00649389|75907915|FG003|Overall Study|Adverse Event|48|||
42097243|NCT00649389|75907912|FG000|Overall Study|Lost to Follow-up|15|||
42097244|NCT00649389|75907913|FG001|Overall Study|Lost to Follow-up|17|||
42097245|NCT00649389|75907914|FG002|Overall Study|Lost to Follow-up|21|||
42097246|NCT00649389|75907915|FG003|Overall Study|Lost to Follow-up|26|||
42097247|NCT00649389|75907912|FG000|Overall Study|Protocol Violation|11|||
42097248|NCT00649389|75907913|FG001|Overall Study|Protocol Violation|13|||
42097249|NCT00649389|75907914|FG002|Overall Study|Protocol Violation|9|||
42191419|NCT02820844|76001767|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
42191420|NCT02820844|76001768|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
42097250|NCT00649389|75907915|FG003|Overall Study|Protocol Violation|8|||
42097251|NCT00649389|75907912|FG000|Overall Study|Withdrawal by Subject|20|||
42097252|NCT00649389|75907913|FG001|Overall Study|Withdrawal by Subject|21|||
42097253|NCT00649389|75907914|FG002|Overall Study|Withdrawal by Subject|19|||
42097254|NCT00649389|75907915|FG003|Overall Study|Withdrawal by Subject|23|||
42097255|NCT00649389|75907912|FG000|Overall Study|Other|3|||
42097256|NCT00649389|75907913|FG001|Overall Study|Other|9|||
42097257|NCT00649389|75907914|FG002|Overall Study|Other|1|||
42097258|NCT00649389|75907915|FG003|Overall Study|Other|6|||
42191421|NCT02820844|76001763|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
42191422|NCT02820844|76001764|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
42191423|NCT02820844|76001765|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
42191424|NCT02820844|76001766|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
42297267|NCT02382939|76132314|FG001|Overall Study|Adverse Event|1|||
42297268|NCT02382939|76132313|FG000|Overall Study|Withdrawal by Subject|2|||
42297269|NCT02382939|76132314|FG001|Overall Study|Withdrawal by Subject|2|||
42297270|NCT02587819|76132321|FG000|Overall Study|Adverse Event|1|||
42097259|NCT00402103|75907927|FG000|Overall Study|Adverse Event|60|||
42097260|NCT00402103|75907928|FG001|Overall Study|Adverse Event|7|||
42097261|NCT00402103|75907927|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42097262|NCT00402103|75907928|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42297271|NCT02587819|76132321|FG000|Overall Study|Lost to Follow-up|1|||
42297272|NCT01666951|76132328|FG000|Overall Study|Not dosed|1|||
42297273|NCT01666951|76132329|FG001|Overall Study|Not dosed|1|||
42297274|NCT02586805|76132339|FG000|Overall Study|Withdrawal by Subject|3|||
42297275|NCT02586805|76132340|FG001|Overall Study|Withdrawal by Subject|1|||
42297276|NCT02586805|76132341|FG002|Overall Study|Withdrawal by Subject|1|||
42297277|NCT02586805|76132342|FG003|Overall Study|Withdrawal by Subject|2|||
42297278|NCT02586805|76132339|FG000|Overall Study|Adverse Event|2|||
42297279|NCT02586805|76132340|FG001|Overall Study|Adverse Event|0|||
42297280|NCT02586805|76132341|FG002|Overall Study|Adverse Event|1|||
42297281|NCT02586805|76132342|FG003|Overall Study|Adverse Event|0|||
42297282|NCT02586805|76132339|FG000|Overall Study|Lost to Follow-up|0|||
42297283|NCT02586805|76132340|FG001|Overall Study|Lost to Follow-up|0|||
42297284|NCT02586805|76132341|FG002|Overall Study|Lost to Follow-up|1|||
42297285|NCT02586805|76132342|FG003|Overall Study|Lost to Follow-up|0|||
42297286|NCT02586805|76132339|FG000|Overall Study|Physician Decision|1|||
42297287|NCT02586805|76132340|FG001|Overall Study|Physician Decision|0|||
42297288|NCT02586805|76132341|FG002|Overall Study|Physician Decision|0|||
42297289|NCT02586805|76132342|FG003|Overall Study|Physician Decision|0|||
42297290|NCT02580877|76132354|FG000|Overall Study|Withdrawal by Subject|1|||
42297291|NCT02580877|76132355|FG001|Overall Study|Withdrawal by Subject|3|||
42297292|NCT02580877|76132354|FG000|Overall Study|Adverse Event|0|||
42297293|NCT02580877|76132355|FG001|Overall Study|Adverse Event|1|||
42297294|NCT02582983|76132371|FG000|Overall Study|Death|3|||
42297295|NCT02582983|76132371|FG000|Overall Study|Withdrawal by Subject|2|||
42297296|NCT02582983|76132371|FG000|Overall Study|Adverse Event|1|||
42297297|NCT02582749|76132377|FG000|Overall Study|Study terminated by funder|5|||
42297298|NCT02582749|76132378|FG001|Overall Study|Study terminated by funder|10|||
42297299|NCT02582749|76132377|FG000|Overall Study|Withdrawal by Subject|0|||
42297300|NCT02582749|76132378|FG001|Overall Study|Withdrawal by Subject|1|||
42297301|NCT02582671|76132384|FG000|Overall Study|Failure to return|1|||
42297302|NCT02582671|76132384|FG000|Overall Study|Other, not specified|1|||
42297303|NCT02585713|76132391|FG000|Overall Study|Withdrew prior to treatment|2|||
42297304|NCT02585713|76132392|FG001|Overall Study|Withdrew prior to treatment|7|||
42297305|NCT02585713|76132391|FG000|Overall Study|Other|3|||
42297306|NCT02585713|76132392|FG001|Overall Study|Other|1|||
42297307|NCT02579863|76132400|FG000|Overall Study|Final Disposition Unknown|2|||
42297308|NCT02579863|76132401|FG001|Overall Study|Final Disposition Unknown|1|||
42297309|NCT02579863|76132400|FG000|Overall Study|Adverse Event|18|||
42297310|NCT02579863|76132401|FG001|Overall Study|Adverse Event|11|||
42297311|NCT02579863|76132400|FG000|Overall Study|Death|31|||
42297312|NCT02579863|76132401|FG001|Overall Study|Death|29|||
42097263|NCT00402103|75907927|FG000|Overall Study|Condition no longer requires study drug|2|||
42097264|NCT00402103|75907928|FG001|Overall Study|Condition no longer requires study drug|0|||
42097265|NCT00402103|75907927|FG000|Overall Study|Protocol Deviation|8|||
42097266|NCT00402103|75907928|FG001|Overall Study|Protocol Deviation|0|||
42097267|NCT00402103|75907927|FG000|Overall Study|Patient withdrew consent|12|||
42097268|NCT00402103|75907928|FG001|Overall Study|Patient withdrew consent|1|||
42097269|NCT00402103|75907927|FG000|Overall Study|Lost to Follow-up|6|||
42097270|NCT00402103|75907928|FG001|Overall Study|Lost to Follow-up|3|||
42191425|NCT02820844|76001767|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
42191426|NCT02820844|76001768|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
42297313|NCT02579863|76132400|FG000|Overall Study|Lost to Follow-up|2|||
42297314|NCT02579863|76132401|FG001|Overall Study|Lost to Follow-up|1|||
42297315|NCT02579863|76132400|FG000|Overall Study|Physician Decision|1|||
42297316|NCT02579863|76132401|FG001|Overall Study|Physician Decision|2|||
42297317|NCT02579863|76132400|FG000|Overall Study|Screen Failure|0|||
42297318|NCT02579863|76132401|FG001|Overall Study|Screen Failure|2|||
42297319|NCT02579863|76132400|FG000|Overall Study|Study Terminated at Selected Sites|82|||
42297320|NCT02579863|76132401|FG001|Overall Study|Study Terminated at Selected Sites|88|||
42097271|NCT00402103|75907927|FG000|Overall Study|Administrative problems|2|||
42097272|NCT00402103|75907928|FG001|Overall Study|Administrative problems|0|||
42297321|NCT02579863|76132400|FG000|Overall Study|Withdrawal by Subject|20|||
42297322|NCT02579863|76132401|FG001|Overall Study|Withdrawal by Subject|20|||
42297323|NCT02582515|76132409|FG000|Overall Study|Withdrawal by Subject|0|||
42191427|NCT02942576|76001787|FG000|Overall Study|Adverse Event|28|||
42191428|NCT02942576|76001788|FG001|Overall Study|Adverse Event|6|||
42191429|NCT02942576|76001787|FG000|Overall Study|Withdrawal by Subject|7|||
42191430|NCT02942576|76001788|FG001|Overall Study|Withdrawal by Subject|5|||
42191431|NCT02942576|76001787|FG000|Overall Study|Physician Decision|1|||
42191432|NCT02942576|76001788|FG001|Overall Study|Physician Decision|4|||
42191433|NCT02942576|76001787|FG000|Overall Study|Other|10|||
42191434|NCT02942576|76001788|FG001|Overall Study|Other|8|||
42191435|NCT02820298|76001796|FG000|Overall Study|Withdrawal by Subject|0|||
42191436|NCT02820298|76001797|FG001|Overall Study|Withdrawal by Subject|1|||
42191437|NCT02820298|76001796|FG000|Overall Study|Physician Decision|1|||
42191438|NCT02820298|76001797|FG001|Overall Study|Physician Decision|0|||
42191439|NCT02820298|76001796|FG000|Overall Study|Protocol Violation|0|||
42191440|NCT02820298|76001797|FG001|Overall Study|Protocol Violation|1|||
42191441|NCT02819440|76001811|FG000|Overall Study|Adverse Event|3|||
42191442|NCT02819440|76001812|FG001|Overall Study|Adverse Event|1|||
42191443|NCT02819440|76001811|FG000|Overall Study|Lost to Follow-up|1|||
42191444|NCT02819440|76001812|FG001|Overall Study|Lost to Follow-up|3|||
42191445|NCT02819440|76001811|FG000|Overall Study|Withdrawal by Subject|9|||
42191446|NCT02819440|76001812|FG001|Overall Study|Withdrawal by Subject|8|||
42191447|NCT03814720|76001823|FG000|Overall Study|Lost to Follow-up|0|||
42191448|NCT03814720|76001824|FG001|Overall Study|Lost to Follow-up|1|||
42191449|NCT03814720|76001825|FG002|Overall Study|Lost to Follow-up|0|||
42191450|NCT03814720|76001826|FG003|Overall Study|Lost to Follow-up|0|||
42191451|NCT03814720|76001827|FG004|Overall Study|Lost to Follow-up|0|||
42191452|NCT02818036|76001843|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
42191453|NCT02818036|76001844|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
42191454|NCT02818036|76001843|FG000|Overall Study|Withdrawal by Subject|1|||
42191455|NCT02818036|76001844|FG001|Overall Study|Withdrawal by Subject|0|||
42191456|NCT01287741|76001852|FG000|Overall Study|Withdrawal by Subject|35|||
42191457|NCT01287741|76001853|FG001|Overall Study|Withdrawal by Subject|38|||
42191458|NCT01287741|76001852|FG000|Overall Study|Protocol Violation|2|||
42191459|NCT01287741|76001853|FG001|Overall Study|Protocol Violation|0|||
42191460|NCT01287741|76001852|FG000|Overall Study|Physician Decision|15|||
42191461|NCT01287741|76001853|FG001|Overall Study|Physician Decision|23|||
42191462|NCT01287741|76001852|FG000|Overall Study|Non-compliance|8|||
42191463|NCT01287741|76001853|FG001|Overall Study|Non-compliance|6|||
42191464|NCT01287741|76001852|FG000|Overall Study|Lost to Follow-up|10|||
42097273|NCT00641667|75907938|FG000|Overall Study|Withdrawal by Subject|1|||
42097274|NCT00641667|75907938|FG000|Overall Study|Adverse Event|1|||
42097275|NCT00641667|75907938|FG000|Overall Study|Physician Decision|1|||
42191465|NCT01287741|76001853|FG001|Overall Study|Lost to Follow-up|8|||
42191466|NCT01287741|76001852|FG000|Overall Study|Death|32|||
42297324|NCT02582515|76132410|FG001|Overall Study|Withdrawal by Subject|1|||
42297325|NCT02579629|76132419|FG000|Overall Study|Withdrawal by Subject|0|||
42297326|NCT02579629|76132420|FG001|Overall Study|Withdrawal by Subject|1|||
42297327|NCT02579629|76132421|FG002|Overall Study|Withdrawal by Subject|0|||
42297328|NCT02579629|76132419|FG000|Overall Study|Screen Failure|2|||
42297329|NCT02579629|76132420|FG001|Overall Study|Screen Failure|0|||
42297330|NCT02579629|76132421|FG002|Overall Study|Screen Failure|2|||
42297331|NCT02343939|76132438|FG000|Overall Study|Death|0|||
42297332|NCT02343939|76132439|FG001|Overall Study|Death|15|||
42297333|NCT02343939|76132440|FG002|Overall Study|Death|4|||
42297334|NCT02343939|76132441|FG003|Overall Study|Death|2|||
42297335|NCT02343939|76132442|FG004|Overall Study|Death|5|||
42297336|NCT02343939|76132443|FG005|Overall Study|Death|11|||
42297337|NCT02343939|76132444|FG006|Overall Study|Death|8|||
42297338|NCT02343939|76132445|FG007|Overall Study|Death|22|||
42359240|NCT01827384|76204850|FG005|Overall Study|Participant died before treatment|0|||
42359241|NCT01827384|76204851|FG006|Overall Study|Participant died before treatment|0|||
42097276|NCT00641667|75907938|FG000|Overall Study|Worsening of underlying disease|3|||
42097277|NCT00704184|75907947|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
42097278|NCT00704184|75907948|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
42097279|NCT00704184|75907949|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
42097280|NCT00704184|75907950|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
42359242|NCT01827384|76204852|FG007|Overall Study|Participant died before treatment|0|||
42097281|NCT00704184|75907951|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
42191467|NCT01287741|76001853|FG001|Overall Study|Death|44|||
42191468|NCT01287741|76001852|FG000|Overall Study|Adverse Event|4|||
42191469|NCT01287741|76001853|FG001|Overall Study|Adverse Event|6|||
42191470|NCT01287741|76001852|FG000|Overall Study|Study terminated by Sponsor|307|||
42191471|NCT01287741|76001853|FG001|Overall Study|Study terminated by Sponsor|315|||
42191472|NCT01287741|76001852|FG000|Overall Study|Progressive disease|190|||
42191473|NCT01287741|76001853|FG001|Overall Study|Progressive disease|166|||
42297339|NCT02343939|76132446|FG008|Overall Study|Death|1|||
42297340|NCT02343939|76132438|FG000|Overall Study|Study terminated by sponsor|0|||
42297341|NCT02343939|76132439|FG001|Overall Study|Study terminated by sponsor|27|||
42297342|NCT02343939|76132440|FG002|Overall Study|Study terminated by sponsor|0|||
42359243|NCT01827384|76204853|FG008|Overall Study|Participant died before treatment|0|||
42097282|NCT00704184|75907947|FG000|Open-Label Treatment|Adverse Event|0|||
42097283|NCT00704184|75907948|FG001|Open-Label Treatment|Adverse Event|0|||
42097284|NCT00704184|75907949|FG002|Open-Label Treatment|Adverse Event|2|||
42097285|NCT00704184|75907950|FG003|Open-Label Treatment|Adverse Event|0|||
42097286|NCT00704184|75907951|FG004|Open-Label Treatment|Adverse Event|1|||
42097287|NCT00704184|75907947|FG000|Open-Label Treatment|Lack of Efficacy|0|||
42097288|NCT00704184|75907948|FG001|Open-Label Treatment|Lack of Efficacy|2|||
42097289|NCT00704184|75907949|FG002|Open-Label Treatment|Lack of Efficacy|2|||
42097290|NCT00704184|75907950|FG003|Open-Label Treatment|Lack of Efficacy|2|||
42097291|NCT00704184|75907951|FG004|Open-Label Treatment|Lack of Efficacy|1|||
42097292|NCT00704184|75907947|FG000|Open-Label Treatment|Physician Decision|0|||
42097293|NCT00704184|75907948|FG001|Open-Label Treatment|Physician Decision|0|||
42097294|NCT00704184|75907949|FG002|Open-Label Treatment|Physician Decision|0|||
42097295|NCT00704184|75907950|FG003|Open-Label Treatment|Physician Decision|0|||
42097296|NCT00704184|75907951|FG004|Open-Label Treatment|Physician Decision|1|||
42097297|NCT00704184|75907947|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
42097298|NCT00704184|75907948|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
42097299|NCT00704184|75907949|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
42097300|NCT00704184|75907950|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
42097301|NCT00704184|75907951|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
42097302|NCT00641043|75907965|FG000|Overall Study|Adverse Event|6|||
42097303|NCT00641043|75907966|FG001|Overall Study|Adverse Event|4|||
42097304|NCT00641043|75907965|FG000|Overall Study|Protocol Violation|2|||
42097305|NCT00641043|75907966|FG001|Overall Study|Protocol Violation|3|||
42097306|NCT00641043|75907965|FG000|Overall Study|Lost to Follow-up|3|||
42097307|NCT00641043|75907966|FG001|Overall Study|Lost to Follow-up|2|||
42097308|NCT00641043|75907965|FG000|Overall Study|Withdrawal by Subject|4|||
42097309|NCT00641043|75907966|FG001|Overall Study|Withdrawal by Subject|4|||
42097310|NCT00641043|75907965|FG000|Overall Study|Other incl. lack of efficacy|4|||
42097311|NCT00641043|75907966|FG001|Overall Study|Other incl. lack of efficacy|2|||
42097312|NCT00402025|75907975|FG000|Overall Study|Adverse Event|0|||
42097313|NCT00402025|75907976|FG001|Overall Study|Adverse Event|0|||
42097314|NCT00402025|75907977|FG002|Overall Study|Adverse Event|2|||
42097315|NCT00402025|75907975|FG000|Overall Study|Death|0|||
42097316|NCT00402025|75907976|FG001|Overall Study|Death|1|||
42097317|NCT00402025|75907977|FG002|Overall Study|Death|5|||
42097318|NCT00402025|75907975|FG000|Overall Study|Disease Progression|1|||
42097319|NCT00402025|75907976|FG001|Overall Study|Disease Progression|1|||
42097320|NCT00402025|75907977|FG002|Overall Study|Disease Progression|2|||
42097321|NCT00402025|75907975|FG000|Overall Study|Physician Decision|1|||
42097322|NCT00402025|75907976|FG001|Overall Study|Physician Decision|1|||
42097323|NCT00402025|75907977|FG002|Overall Study|Physician Decision|0|||
42097324|NCT00402025|75907975|FG000|Overall Study|Participant Decision|0|||
42097325|NCT00402025|75907976|FG001|Overall Study|Participant Decision|0|||
42097326|NCT00402025|75907977|FG002|Overall Study|Participant Decision|1|||
42097327|NCT00609622|75907987|FG000|Overall Study|Adverse Event|14|||
42097328|NCT00609622|75907988|FG001|Overall Study|Adverse Event|10|||
42097329|NCT00609622|75907987|FG000|Overall Study|Withdrawal by Subject|4|||
42097330|NCT00609622|75907988|FG001|Overall Study|Withdrawal by Subject|20|||
42097331|NCT00609622|75907987|FG000|Overall Study|Death|1|||
42097332|NCT00609622|75907988|FG001|Overall Study|Death|4|||
42097333|NCT00609622|75907987|FG000|Overall Study|Protocol Violation|1|||
42097334|NCT00609622|75907988|FG001|Overall Study|Protocol Violation|1|||
42097335|NCT00609622|75907987|FG000|Overall Study|Objective progression or relapse|47|||
42097336|NCT00609622|75907988|FG001|Overall Study|Objective progression or relapse|41|||
42097337|NCT00609622|75907987|FG000|Overall Study|Study terminated by sponsor|16|||
42097338|NCT00609622|75907988|FG001|Overall Study|Study terminated by sponsor|3|||
42097339|NCT00609622|75907987|FG000|Overall Study|Other|7|||
42097340|NCT00609622|75907988|FG001|Overall Study|Other|14|||
42097341|NCT00609622|75907987|FG000|Overall Study|Global deterioration of health status|6|||
42097342|NCT00609622|75907988|FG001|Overall Study|Global deterioration of health status|2|||
42097343|NCT00699660|75907996|FG000|Overall Study|Lost to Follow-up|4|||
42097344|NCT00699660|75907997|FG001|Overall Study|Lost to Follow-up|2|||
42097345|NCT00699660|75907996|FG000|Overall Study|missing reports and recording failures|10|||
42097346|NCT00699660|75907997|FG001|Overall Study|missing reports and recording failures|6|||
42097347|NCT00627705|75908005|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
42097348|NCT00627705|75908006|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
42097349|NCT00627705|75908005|FG000|Overall Study|Adverse Event|1|||
42097350|NCT00627705|75908006|FG001|Overall Study|Adverse Event|0|||
42097351|NCT00627705|75908005|FG000|Overall Study|Withdrawal by Subject|0|||
42097352|NCT00627705|75908006|FG001|Overall Study|Withdrawal by Subject|2|||
42097353|NCT00627705|75908005|FG000|Overall Study|Lost to Follow-up|0|||
42097354|NCT00627705|75908006|FG001|Overall Study|Lost to Follow-up|1|||
42097355|NCT00610168|75908014|FG000|Overall Study|Withdrawal by Subject|2|||
42097356|NCT00610168|75908015|FG001|Overall Study|Withdrawal by Subject|0|||
42097357|NCT00644787|75908021|FG000|Period 1: Titration Phase|Adverse Event|11|||
42097358|NCT00644787|75908022|FG001|Period 1: Titration Phase|Adverse Event|0|||
42097359|NCT00644787|75908023|FG002|Period 1: Titration Phase|Adverse Event|0|||
42097360|NCT00644787|75908021|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
42097361|NCT00644787|75908022|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
42097362|NCT00644787|75908023|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
42097363|NCT00644787|75908021|FG000|Period 1: Titration Phase|Physician Decision|1|||
42097364|NCT00644787|75908022|FG001|Period 1: Titration Phase|Physician Decision|0|||
42097365|NCT00644787|75908023|FG002|Period 1: Titration Phase|Physician Decision|0|||
42097366|NCT00644787|75908021|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
42097367|NCT00644787|75908022|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
42097368|NCT00644787|75908023|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
42097369|NCT00644787|75908021|FG000|Period 1: Titration Phase|Worsening of complications|1|||
42097370|NCT00644787|75908022|FG001|Period 1: Titration Phase|Worsening of complications|0|||
42097371|NCT00644787|75908023|FG002|Period 1: Titration Phase|Worsening of complications|0|||
42097372|NCT00644787|75908021|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
42191474|NCT01287741|76001852|FG000|Overall Study|Reason not specified|23|||
42191475|NCT01287741|76001853|FG001|Overall Study|Reason not specified|9|||
42191476|NCT05372315|76001866|FG000|Overall Study|Withdrawal by Subject|1|||
42191477|NCT05372315|76001867|FG001|Overall Study|Withdrawal by Subject|0|||
42191478|NCT04913675|76001887|FG000|Main Study (Up to Week 36)|Death|0|||
42191479|NCT04913675|76001888|FG001|Main Study (Up to Week 36)|Death|2|||
42191480|NCT04913675|76001889|FG002|Main Study (Up to Week 36)|Death|2|||
42191481|NCT04913675|76001890|FG003|Main Study (Up to Week 36)|Death|0|||
42191482|NCT04913675|76001887|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
42191483|NCT04913675|76001888|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
42191484|NCT04913675|76001889|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
42191485|NCT04913675|76001890|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
42097373|NCT00644787|75908022|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
42097374|NCT00644787|75908023|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
42097375|NCT00644787|75908021|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
42097376|NCT00644787|75908022|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
42191486|NCT04913675|76001887|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
42191487|NCT04913675|76001888|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
42191488|NCT04913675|76001889|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
42191489|NCT04913675|76001890|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
42191490|NCT04913675|76001887|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
42191491|NCT04913675|76001888|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
42191492|NCT04913675|76001889|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
42191493|NCT04913675|76001890|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
42191494|NCT04913675|76001887|FG000|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
42191495|NCT04913675|76001888|FG001|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
42191496|NCT04913675|76001889|FG002|Safety Sub-study (Up to Day 29)|Ongoing in this study|0|||
42191497|NCT04913675|76001890|FG003|Safety Sub-study (Up to Day 29)|Ongoing in this study|80|||
42191498|NCT04913675|76001887|FG000|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
42191499|NCT04913675|76001888|FG001|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
42191500|NCT04913675|76001889|FG002|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|0|||
42097377|NCT00644787|75908023|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
42097378|NCT00644787|75908021|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
42097379|NCT00644787|75908022|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
42097380|NCT00644787|75908023|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
42097381|NCT00644787|75908021|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
42191501|NCT04913675|76001890|FG003|Safety Sub-study (Up to Day 29)|Withdrawal by Subject|1|||
42191502|NCT04760314|76001907|FG000|Induction Period|Withdrawal by Subject|0|||
42191503|NCT04760314|76001908|FG001|Induction Period|Withdrawal by Subject|1|||
42191504|NCT04760314|76001909|FG002|Induction Period|Withdrawal by Subject|1|||
42191505|NCT04760314|76001910|FG003|Induction Period|Withdrawal by Subject|0|||
42191506|NCT04760314|76001911|FG004|Induction Period|Withdrawal by Subject|0|||
42191507|NCT04760314|76001912|FG005|Induction Period|Withdrawal by Subject|0|||
42191508|NCT04760314|76001913|FG006|Induction Period|Withdrawal by Subject|0|||
42191509|NCT04760314|76001914|FG007|Induction Period|Withdrawal by Subject|0|||
42191510|NCT04760314|76001915|FG008|Induction Period|Withdrawal by Subject|0|||
42297343|NCT02343939|76132441|FG003|Overall Study|Study terminated by sponsor|1|||
42191511|NCT04760314|76001916|FG009|Induction Period|Withdrawal by Subject|0|||
42191512|NCT04760314|76001917|FG010|Induction Period|Withdrawal by Subject|0|||
42191513|NCT04760314|76001907|FG000|Induction Period|Adverse Event|0|||
42191514|NCT04760314|76001908|FG001|Induction Period|Adverse Event|0|||
42191515|NCT04760314|76001909|FG002|Induction Period|Adverse Event|2|||
42191516|NCT04760314|76001910|FG003|Induction Period|Adverse Event|0|||
42191517|NCT04760314|76001911|FG004|Induction Period|Adverse Event|0|||
42191518|NCT04760314|76001912|FG005|Induction Period|Adverse Event|0|||
42191519|NCT04760314|76001913|FG006|Induction Period|Adverse Event|0|||
42191520|NCT04760314|76001914|FG007|Induction Period|Adverse Event|0|||
42191521|NCT04760314|76001915|FG008|Induction Period|Adverse Event|0|||
42191522|NCT04760314|76001916|FG009|Induction Period|Adverse Event|0|||
42191523|NCT04760314|76001917|FG010|Induction Period|Adverse Event|0|||
42191524|NCT04760314|76001907|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
42191525|NCT04760314|76001908|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
42191526|NCT04760314|76001909|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
42191527|NCT04760314|76001910|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
42191528|NCT04760314|76001911|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
42191529|NCT04760314|76001912|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
42191530|NCT04760314|76001913|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
42191531|NCT04760314|76001914|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
42191532|NCT04760314|76001915|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
42191533|NCT04760314|76001916|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
42191534|NCT04760314|76001917|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
42191535|NCT04760314|76001907|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
42191536|NCT04760314|76001908|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
42191537|NCT04760314|76001909|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
42191538|NCT04760314|76001910|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
42191539|NCT04760314|76001911|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
42191540|NCT04760314|76001912|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
42191541|NCT04760314|76001913|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
42191542|NCT04760314|76001914|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
42191543|NCT04760314|76001915|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
42191544|NCT04760314|76001916|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
42191545|NCT04760314|76001917|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
42191546|NCT04760314|76001907|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
42191547|NCT04760314|76001908|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
42191548|NCT04760314|76001909|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
42191549|NCT04760314|76001910|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
42191550|NCT04760314|76001911|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
42191551|NCT04760314|76001912|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
42297344|NCT02343939|76132442|FG004|Overall Study|Study terminated by sponsor|1|||
42097382|NCT00644787|75908022|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
42097383|NCT00644787|75908023|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
42097384|NCT00644787|75908021|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
42097385|NCT00644787|75908022|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
42097386|NCT00644787|75908023|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
42097387|NCT00644787|75908021|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
42097388|NCT00644787|75908022|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
42097389|NCT00644787|75908023|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
42097390|NCT00644787|75908021|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
42097391|NCT00644787|75908022|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
42097392|NCT00644787|75908023|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
42097393|NCT00699582|75908034|FG000|Overall Study|Adverse Event|4|||
42097394|NCT00699582|75908035|FG001|Overall Study|Adverse Event|11|||
42097395|NCT00699582|75908036|FG002|Overall Study|Adverse Event|23|||
42097396|NCT00699582|75908034|FG000|Overall Study|Withdrawal by Subject|6|||
42097397|NCT00699582|75908035|FG001|Overall Study|Withdrawal by Subject|7|||
42097398|NCT00699582|75908036|FG002|Overall Study|Withdrawal by Subject|4|||
42097399|NCT00699582|75908034|FG000|Overall Study|Lack of Efficacy|1|||
42097400|NCT00699582|75908035|FG001|Overall Study|Lack of Efficacy|0|||
42097401|NCT00699582|75908036|FG002|Overall Study|Lack of Efficacy|1|||
42097402|NCT00699582|75908034|FG000|Overall Study|Progressive Disease|1|||
42097403|NCT00699582|75908035|FG001|Overall Study|Progressive Disease|0|||
42097404|NCT00699582|75908036|FG002|Overall Study|Progressive Disease|0|||
42097405|NCT00699582|75908034|FG000|Overall Study|Administrative/Other|4|||
42191552|NCT04760314|76001913|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
42297345|NCT02343939|76132443|FG005|Overall Study|Study terminated by sponsor|5|||
42297346|NCT02343939|76132444|FG006|Overall Study|Study terminated by sponsor|3|||
42097406|NCT00699582|75908035|FG001|Overall Study|Administrative/Other|3|||
42191553|NCT04760314|76001914|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
42191554|NCT04760314|76001915|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
42191555|NCT04760314|76001916|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
42097407|NCT00699582|75908036|FG002|Overall Study|Administrative/Other|0|||
42297347|NCT02343939|76132445|FG007|Overall Study|Study terminated by sponsor|4|||
42191556|NCT04760314|76001917|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
42191557|NCT04760314|76001907|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
42191558|NCT04760314|76001908|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
42191559|NCT04760314|76001909|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
42191560|NCT04760314|76001910|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
42191561|NCT04760314|76001911|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
42191562|NCT04760314|76001912|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
42191563|NCT04760314|76001913|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
42191564|NCT04760314|76001914|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
42191565|NCT04760314|76001915|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
42191566|NCT04760314|76001916|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
42191567|NCT04760314|76001917|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
42191568|NCT04760314|76001907|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42191569|NCT04760314|76001908|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42191570|NCT04760314|76001909|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42191571|NCT04760314|76001910|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42097408|NCT00699582|75908034|FG000|Overall Study|Randomized, Not Treated|2|||
42097409|NCT00699582|75908035|FG001|Overall Study|Randomized, Not Treated|1|||
42097410|NCT00699582|75908036|FG002|Overall Study|Randomized, Not Treated|0|||
42097411|NCT00640341|75908047|FG000|Overall Study|Adverse Event|0|||
42097412|NCT00640341|75908048|FG001|Overall Study|Adverse Event|0|||
42097413|NCT00640341|75908049|FG002|Overall Study|Adverse Event|1|||
42097414|NCT00640341|75908047|FG000|Overall Study|Positive Slit Lamp Findings|0|||
42097415|NCT00640341|75908048|FG001|Overall Study|Positive Slit Lamp Findings|0|||
42191572|NCT04760314|76001911|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42191573|NCT04760314|76001912|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42097416|NCT00640341|75908049|FG002|Overall Study|Positive Slit Lamp Findings|1|||
42097417|NCT00640341|75908047|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
42191574|NCT04760314|76001913|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42191575|NCT04760314|76001914|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
42191576|NCT04760314|76001915|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42191577|NCT04760314|76001916|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
42097418|NCT00640341|75908048|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
42097419|NCT00640341|75908049|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
42097420|NCT00640341|75908047|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
42097421|NCT00640341|75908048|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
42097422|NCT00640341|75908049|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
42097423|NCT00640341|75908047|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
42191578|NCT04760314|76001917|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
42191579|NCT04760314|76001907|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42191580|NCT04760314|76001908|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42191581|NCT04760314|76001909|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42191582|NCT04760314|76001910|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42191583|NCT04760314|76001911|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42191584|NCT04760314|76001912|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42191585|NCT04760314|76001913|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42191586|NCT04760314|76001914|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
42191587|NCT04760314|76001915|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
42191588|NCT04760314|76001916|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
42191589|NCT04760314|76001917|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42191590|NCT04760314|76001907|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42191591|NCT04760314|76001908|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42191592|NCT04760314|76001909|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42191593|NCT04760314|76001910|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42191594|NCT04760314|76001911|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42097424|NCT00640341|75908048|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
42097425|NCT00640341|75908049|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
42097426|NCT00640341|75908047|FG000|Overall Study|Lost to Follow-up|2|||
42191595|NCT04760314|76001912|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42191596|NCT04760314|76001913|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42097427|NCT00640341|75908048|FG001|Overall Study|Lost to Follow-up|0|||
42097428|NCT00640341|75908049|FG002|Overall Study|Lost to Follow-up|0|||
42097429|NCT00640341|75908047|FG000|Overall Study|Withdrawal by Subject|4|||
42097430|NCT00640341|75908048|FG001|Overall Study|Withdrawal by Subject|0|||
42097431|NCT00640341|75908049|FG002|Overall Study|Withdrawal by Subject|1|||
42097432|NCT00640341|75908047|FG000|Overall Study|Unacceptable Lens Movement|1|||
42097433|NCT00640341|75908048|FG001|Overall Study|Unacceptable Lens Movement|0|||
42097434|NCT00640341|75908049|FG002|Overall Study|Unacceptable Lens Movement|0|||
42097435|NCT00640341|75908047|FG000|Overall Study|Poor fit/Uncomfortable|4|||
42097436|NCT00640341|75908048|FG001|Overall Study|Poor fit/Uncomfortable|0|||
42097437|NCT00640341|75908049|FG002|Overall Study|Poor fit/Uncomfortable|0|||
42097438|NCT00640341|75908047|FG000|Overall Study|Ineligable at Baseline|5|||
42097439|NCT00640341|75908048|FG001|Overall Study|Ineligable at Baseline|3|||
42097440|NCT00640341|75908049|FG002|Overall Study|Ineligable at Baseline|2|||
42097441|NCT00640341|75908047|FG000|Overall Study|Adverse event and positive slit lamp|1|||
42097442|NCT00640341|75908048|FG001|Overall Study|Adverse event and positive slit lamp|0|||
42097443|NCT00640341|75908049|FG002|Overall Study|Adverse event and positive slit lamp|0|||
42191597|NCT04760314|76001914|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
42191598|NCT04760314|76001915|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42191599|NCT04760314|76001916|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42191600|NCT04760314|76001917|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42191601|NCT04760314|76001907|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
42191602|NCT04760314|76001908|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
42191603|NCT04760314|76001909|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
42191604|NCT04760314|76001910|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
42191605|NCT04760314|76001911|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
42191606|NCT04760314|76001912|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
42191607|NCT04760314|76001913|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
42191608|NCT04760314|76001914|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
42191609|NCT04760314|76001915|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
42191610|NCT04760314|76001916|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
42191611|NCT04760314|76001917|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
42191612|NCT04493684|76001960|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
42191613|NCT04493684|76001961|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191614|NCT04493684|76001962|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
42191615|NCT04493684|76001963|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191616|NCT04493684|76001964|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191617|NCT04493684|76001965|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
42191618|NCT04493684|76001966|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191619|NCT04493684|76001967|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191620|NCT04493684|76001968|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191621|NCT04493684|76001969|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191622|NCT04493684|76001970|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191623|NCT04493684|76001971|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191624|NCT04493684|76001972|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191625|NCT04493684|76001973|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191626|NCT04493684|76001974|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191627|NCT04493684|76001975|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191628|NCT04493684|76001976|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
42191629|NCT04493684|76001960|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
42191630|NCT04493684|76001961|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191631|NCT04493684|76001962|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191632|NCT04493684|76001963|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42097444|NCT00699348|75908057|FG000|Overall Study|Death|6|||
42097445|NCT00699348|75908057|FG000|Overall Study|Adverse Event|15|||
42097446|NCT00699348|75908057|FG000|Overall Study|Withdrawal by Subject|11|||
42191633|NCT04493684|76001964|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191634|NCT04493684|76001965|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191635|NCT04493684|76001966|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191636|NCT04493684|76001967|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191637|NCT04493684|76001968|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191638|NCT04493684|76001969|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191639|NCT04493684|76001970|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191640|NCT04493684|76001971|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42097447|NCT00699348|75908057|FG000|Overall Study|Protocol Violation|10|||
42097448|NCT00699348|75908057|FG000|Overall Study|Lack of Efficacy|8|||
42097449|NCT00699348|75908057|FG000|Overall Study|Failure to return|1|||
42191641|NCT04493684|76001972|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191642|NCT04493684|76001973|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191643|NCT04493684|76001974|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191644|NCT04493684|76001975|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191645|NCT04493684|76001976|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
42191646|NCT04493684|76001960|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191647|NCT04493684|76001961|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191648|NCT04493684|76001962|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191649|NCT04493684|76001963|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191650|NCT04493684|76001964|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42097450|NCT00699348|75908057|FG000|Overall Study|Blood transfusion|24|||
42097451|NCT00699348|75908057|FG000|Overall Study|Renal transplantation|10|||
42191651|NCT04493684|76001965|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191652|NCT04493684|76001966|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
42191653|NCT04493684|76001967|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191654|NCT04493684|76001968|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191655|NCT04493684|76001969|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191656|NCT04493684|76001970|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191657|NCT04493684|76001971|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191658|NCT04493684|76001972|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191659|NCT04493684|76001973|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191660|NCT04493684|76001974|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191661|NCT04493684|76001975|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42097452|NCT00699348|75908057|FG000|Overall Study|Other|5|||
42097453|NCT00643851|75908064|FG000|Overall Study|Death|0|||
42097454|NCT00643851|75908065|FG001|Overall Study|Death|1|||
42097455|NCT00643851|75908066|FG002|Overall Study|Death|0|||
42097456|NCT00643851|75908064|FG000|Overall Study|Lack of Efficacy|0|||
42097457|NCT00643851|75908065|FG001|Overall Study|Lack of Efficacy|1|||
42097458|NCT00643851|75908066|FG002|Overall Study|Lack of Efficacy|0|||
42097459|NCT00643851|75908064|FG000|Overall Study|Adverse Event|2|||
42097460|NCT00643851|75908065|FG001|Overall Study|Adverse Event|6|||
42097461|NCT00643851|75908066|FG002|Overall Study|Adverse Event|6|||
42097462|NCT00643851|75908064|FG000|Overall Study|Lost to Follow-up|4|||
42097463|NCT00643851|75908065|FG001|Overall Study|Lost to Follow-up|6|||
42097464|NCT00643851|75908066|FG002|Overall Study|Lost to Follow-up|9|||
42097465|NCT00643851|75908064|FG000|Overall Study|Withdrawal by Subject|8|||
42097466|NCT00643851|75908065|FG001|Overall Study|Withdrawal by Subject|15|||
42097467|NCT00643851|75908066|FG002|Overall Study|Withdrawal by Subject|9|||
42097468|NCT00643851|75908064|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
42097469|NCT00643851|75908065|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
42097470|NCT00643851|75908066|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
42097471|NCT03667690|75908076|FG000|Overall Study|Adverse Event|0|||
42097472|NCT03667690|75908077|FG001|Overall Study|Adverse Event|3|||
42097473|NCT03667690|75908076|FG000|Overall Study|Death|22|||
42097474|NCT03667690|75908077|FG001|Overall Study|Death|21|||
42097475|NCT03667690|75908076|FG000|Overall Study|Lost to Follow-up|4|||
42097476|NCT03667690|75908077|FG001|Overall Study|Lost to Follow-up|5|||
42097477|NCT03667690|75908076|FG000|Overall Study|Withdrawal by Subject|7|||
42097478|NCT03667690|75908077|FG001|Overall Study|Withdrawal by Subject|8|||
42097479|NCT03667690|75908076|FG000|Overall Study|Subject could not return for additional investigational product|1|||
42097480|NCT03667690|75908077|FG001|Overall Study|Subject could not return for additional investigational product|0|||
42097481|NCT03667690|75908076|FG000|Overall Study|Subject discharged to hospice care|2|||
42097482|NCT03667690|75908077|FG001|Overall Study|Subject discharged to hospice care|0|||
42097483|NCT03667690|75908076|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
42097484|NCT03667690|75908077|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
42097485|NCT03667690|75908076|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
42097486|NCT03667690|75908077|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
42191662|NCT04493684|76001976|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
42191663|NCT04493684|76001960|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
42191664|NCT04493684|76001961|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191665|NCT04493684|76001962|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191666|NCT04493684|76001963|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42097487|NCT03667690|75908076|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
42097488|NCT03667690|75908077|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
42097489|NCT03667690|75908076|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
42097490|NCT03667690|75908077|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
42191667|NCT04493684|76001964|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191668|NCT04493684|76001965|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191669|NCT04493684|76001966|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191670|NCT04493684|76001967|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191671|NCT04493684|76001968|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191672|NCT04493684|76001969|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191673|NCT04493684|76001970|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191674|NCT04493684|76001971|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191675|NCT04493684|76001972|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191676|NCT04493684|76001973|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191677|NCT04493684|76001974|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191678|NCT04493684|76001975|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191679|NCT04493684|76001976|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
42191680|NCT04493684|76001960|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191681|NCT04493684|76001961|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191682|NCT04493684|76001962|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42097491|NCT03667690|75908076|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
42097492|NCT03667690|75908077|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
42097493|NCT00627393|75908085|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
42097494|NCT00627393|75908086|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
42191683|NCT04493684|76001963|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191684|NCT04493684|76001964|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191685|NCT04493684|76001965|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
42191686|NCT04493684|76001966|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191687|NCT04493684|76001967|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191688|NCT04493684|76001968|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191689|NCT04493684|76001969|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191690|NCT04493684|76001970|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191691|NCT04493684|76001971|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191692|NCT04493684|76001972|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191693|NCT04493684|76001973|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42097495|NCT00627393|75908085|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
42097496|NCT00627393|75908086|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
42097497|NCT00627393|75908085|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
42097498|NCT00627393|75908086|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
42097499|NCT00627393|75908085|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
42097500|NCT00627393|75908086|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
42097501|NCT00696774|75908097|FG000|Period II|Adverse Event|0|||
42097502|NCT00696774|75908098|FG001|Period II|Adverse Event|0|||
42097503|NCT00696774|75908099|FG002|Period II|Adverse Event|15|||
42191694|NCT04493684|76001974|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191695|NCT04493684|76001975|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191696|NCT04493684|76001976|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
42191697|NCT04493684|76001960|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42097504|NCT00696774|75908097|FG000|Period II|Lost to Follow-up|0|||
42097505|NCT00696774|75908098|FG001|Period II|Lost to Follow-up|0|||
42097506|NCT00696774|75908099|FG002|Period II|Lost to Follow-up|4|||
42097507|NCT00696774|75908097|FG000|Period II|Protocol Violation|0|||
42097508|NCT00696774|75908098|FG001|Period II|Protocol Violation|0|||
42097509|NCT00696774|75908099|FG002|Period II|Protocol Violation|11|||
42097510|NCT00696774|75908097|FG000|Period II|Withdrawal by Subject|0|||
42191698|NCT04493684|76001961|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191699|NCT04493684|76001962|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191700|NCT04493684|76001963|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191701|NCT04493684|76001964|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191702|NCT04493684|76001965|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191703|NCT04493684|76001966|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191704|NCT04493684|76001967|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191705|NCT04493684|76001968|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191706|NCT04493684|76001969|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191707|NCT04493684|76001970|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191708|NCT04493684|76001971|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
42191709|NCT04493684|76001972|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191710|NCT04493684|76001973|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191711|NCT04493684|76001974|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42297348|NCT02343939|76132446|FG008|Overall Study|Study terminated by sponsor|0|||
42297349|NCT02343939|76132438|FG000|Overall Study|Withdrew consent|3|||
42297350|NCT02343939|76132439|FG001|Overall Study|Withdrew consent|6|||
42297351|NCT02343939|76132440|FG002|Overall Study|Withdrew consent|1|||
42297352|NCT02343939|76132441|FG003|Overall Study|Withdrew consent|2|||
42297353|NCT02343939|76132442|FG004|Overall Study|Withdrew consent|2|||
42297354|NCT02343939|76132443|FG005|Overall Study|Withdrew consent|0|||
42297355|NCT02343939|76132444|FG006|Overall Study|Withdrew consent|0|||
42297356|NCT02343939|76132445|FG007|Overall Study|Withdrew consent|8|||
42297357|NCT02343939|76132446|FG008|Overall Study|Withdrew consent|6|||
42297358|NCT02343939|76132438|FG000|Overall Study|Treatment failure|0|||
42297359|NCT02343939|76132439|FG001|Overall Study|Treatment failure|0|||
42297360|NCT02343939|76132440|FG002|Overall Study|Treatment failure|0|||
42297361|NCT02343939|76132441|FG003|Overall Study|Treatment failure|0|||
42297362|NCT02343939|76132442|FG004|Overall Study|Treatment failure|0|||
42297363|NCT02343939|76132443|FG005|Overall Study|Treatment failure|0|||
42297364|NCT02343939|76132444|FG006|Overall Study|Treatment failure|2|||
42297365|NCT02343939|76132445|FG007|Overall Study|Treatment failure|1|||
42297366|NCT02343939|76132446|FG008|Overall Study|Treatment failure|0|||
42297367|NCT02343939|76132438|FG000|Overall Study|Investigator's discretion|0|||
42297368|NCT02343939|76132439|FG001|Overall Study|Investigator's discretion|0|||
42297369|NCT02343939|76132440|FG002|Overall Study|Investigator's discretion|0|||
42297370|NCT02343939|76132441|FG003|Overall Study|Investigator's discretion|1|||
42297371|NCT02343939|76132442|FG004|Overall Study|Investigator's discretion|0|||
42297372|NCT02343939|76132443|FG005|Overall Study|Investigator's discretion|0|||
42297373|NCT02343939|76132444|FG006|Overall Study|Investigator's discretion|1|||
42297374|NCT02343939|76132445|FG007|Overall Study|Investigator's discretion|0|||
42297375|NCT02343939|76132446|FG008|Overall Study|Investigator's discretion|0|||
42297376|NCT02343939|76132438|FG000|Overall Study|Adverse Event|0|||
42018366|NCT00996892|75825868|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
42018367|NCT00996892|75825869|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
42018368|NCT00996892|75825870|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
42018369|NCT00996892|75825871|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
42018370|NCT00996892|75825872|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
42018371|NCT00996892|75825873|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
42018372|NCT00996892|75825874|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
42018373|NCT00996892|75825875|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
42018374|NCT00996892|75825876|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
42018375|NCT00996892|75825877|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
42018376|NCT00996892|75825878|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
42018377|NCT00996892|75825879|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
42018378|NCT00996892|75825880|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
42097511|NCT00696774|75908098|FG001|Period II|Withdrawal by Subject|0|||
42097512|NCT00696774|75908099|FG002|Period II|Withdrawal by Subject|4|||
42097513|NCT00696774|75908097|FG000|Period II|Sponsor Decision|0|||
42297377|NCT02343939|76132439|FG001|Overall Study|Adverse Event|0|||
42297378|NCT02343939|76132440|FG002|Overall Study|Adverse Event|0|||
42297379|NCT02343939|76132441|FG003|Overall Study|Adverse Event|0|||
42297380|NCT02343939|76132442|FG004|Overall Study|Adverse Event|0|||
42297381|NCT02343939|76132443|FG005|Overall Study|Adverse Event|1|||
42297382|NCT02343939|76132444|FG006|Overall Study|Adverse Event|0|||
42297383|NCT02343939|76132445|FG007|Overall Study|Adverse Event|0|||
42191712|NCT04493684|76001975|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191713|NCT04493684|76001976|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
42191714|NCT04493684|76001960|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191715|NCT04493684|76001961|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191716|NCT04493684|76001962|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191717|NCT04493684|76001963|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191718|NCT04493684|76001964|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191719|NCT04493684|76001965|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191720|NCT04493684|76001966|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191721|NCT04493684|76001967|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191722|NCT04493684|76001968|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42297384|NCT02343939|76132446|FG008|Overall Study|Adverse Event|0|||
42297385|NCT02343939|76132438|FG000|Overall Study|Never Treated With ENTO|0|||
42297386|NCT02343939|76132439|FG001|Overall Study|Never Treated With ENTO|0|||
42297387|NCT02343939|76132440|FG002|Overall Study|Never Treated With ENTO|0|||
42097514|NCT00696774|75908098|FG001|Period II|Sponsor Decision|0|||
42097515|NCT00696774|75908099|FG002|Period II|Sponsor Decision|0|||
42097516|NCT00696774|75908097|FG000|Period II|Lack of Efficacy|0|||
42097517|NCT00696774|75908098|FG001|Period II|Lack of Efficacy|0|||
42097518|NCT00696774|75908099|FG002|Period II|Lack of Efficacy|2|||
42097519|NCT00696774|75908097|FG000|Period III|Adverse Event|1|||
42297388|NCT02343939|76132441|FG003|Overall Study|Never Treated With ENTO|0|||
42297389|NCT02343939|76132442|FG004|Overall Study|Never Treated With ENTO|0|||
42297390|NCT02343939|76132443|FG005|Overall Study|Never Treated With ENTO|0|||
42297391|NCT02343939|76132444|FG006|Overall Study|Never Treated With ENTO|1|||
42297392|NCT02343939|76132445|FG007|Overall Study|Never Treated With ENTO|2|||
42297393|NCT02343939|76132446|FG008|Overall Study|Never Treated With ENTO|0|||
42297394|NCT02397447|76132482|FG000|Overall Study|Lost to Follow-up|2|||
42097520|NCT00696774|75908098|FG001|Period III|Adverse Event|1|||
42097521|NCT00696774|75908099|FG002|Period III|Adverse Event|0|||
42097522|NCT00696774|75908097|FG000|Period III|Lost to Follow-up|2|||
42097523|NCT00696774|75908098|FG001|Period III|Lost to Follow-up|1|||
42097524|NCT00696774|75908099|FG002|Period III|Lost to Follow-up|0|||
42097525|NCT00696774|75908097|FG000|Period III|Protocol Violation|1|||
42097526|NCT00696774|75908098|FG001|Period III|Protocol Violation|1|||
42097527|NCT00696774|75908099|FG002|Period III|Protocol Violation|0|||
42097528|NCT00696774|75908097|FG000|Period III|Withdrawal by Subject|1|||
42097529|NCT00696774|75908098|FG001|Period III|Withdrawal by Subject|2|||
42097530|NCT00696774|75908099|FG002|Period III|Withdrawal by Subject|0|||
42097531|NCT00696774|75908097|FG000|Period III|Sponsor Decision|2|||
42097532|NCT00696774|75908098|FG001|Period III|Sponsor Decision|0|||
42097533|NCT00696774|75908099|FG002|Period III|Sponsor Decision|0|||
42297395|NCT02397447|76132483|FG001|Overall Study|Lost to Follow-up|2|||
42297396|NCT02397057|76132491|FG000|Overall Study|Withdrawal by Subject|6|||
42097534|NCT00696774|75908097|FG000|Period III|Lack of Efficacy|0|||
42097535|NCT00696774|75908098|FG001|Period III|Lack of Efficacy|2|||
42097536|NCT00696774|75908099|FG002|Period III|Lack of Efficacy|0|||
42097537|NCT00608842|75908111|FG000|Overall Study|Participant's Request|0|||
42097538|NCT00608842|75908112|FG001|Overall Study|Participant's Request|1|||
42097539|NCT00608842|75908113|FG002|Overall Study|Participant's Request|2|||
42097540|NCT00608842|75908114|FG003|Overall Study|Participant's Request|1|||
42097541|NCT00608842|75908111|FG000|Overall Study|Lost to Follow-up|1|||
42097542|NCT00608842|75908112|FG001|Overall Study|Lost to Follow-up|0|||
42097543|NCT00608842|75908113|FG002|Overall Study|Lost to Follow-up|0|||
42097544|NCT00608842|75908114|FG003|Overall Study|Lost to Follow-up|0|||
42097545|NCT00626925|75908126|FG000|Overall Study|Lost to Follow-up|1|||
42097546|NCT00626925|75908127|FG001|Overall Study|Lost to Follow-up|2|||
42097547|NCT00626925|75908126|FG000|Overall Study|relapse|1|||
42097548|NCT00626925|75908127|FG001|Overall Study|relapse|0|||
42097549|NCT00626925|75908126|FG000|Overall Study|Adverse effect|6|||
42191723|NCT04493684|76001969|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191724|NCT04493684|76001970|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191725|NCT04493684|76001971|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191726|NCT04493684|76001972|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191727|NCT04493684|76001973|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191728|NCT04493684|76001974|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191729|NCT04493684|76001975|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
42191730|NCT04493684|76001976|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
42191731|NCT04493684|76001960|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191732|NCT04493684|76001961|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42097550|NCT00626925|75908127|FG001|Overall Study|Adverse effect|2|||
42097551|NCT00626925|75908126|FG000|Overall Study|Lack of Efficacy|1|||
42191733|NCT04493684|76001962|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191734|NCT04493684|76001963|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191735|NCT04493684|76001964|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191736|NCT04493684|76001965|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191737|NCT04493684|76001966|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191738|NCT04493684|76001967|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191739|NCT04493684|76001968|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191740|NCT04493684|76001969|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191741|NCT04493684|76001970|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191742|NCT04493684|76001971|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191743|NCT04493684|76001972|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191744|NCT04493684|76001973|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191745|NCT04493684|76001974|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191746|NCT04493684|76001975|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
42191747|NCT04493684|76001976|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
42191748|NCT04289298|76002041|FG000|Overall Study|Lost to Follow-up|5|||
42191749|NCT04289298|76002042|FG001|Overall Study|Lost to Follow-up|0|||
42191750|NCT04289298|76002041|FG000|Overall Study|Withdrawal by Subject|2|||
42191751|NCT04289298|76002042|FG001|Overall Study|Withdrawal by Subject|0|||
42191752|NCT04116710|76002053|FG000|Overall Study|Death|4|||
42191753|NCT04116710|76002054|FG001|Overall Study|Death|6|||
42191754|NCT04116710|76002055|FG002|Overall Study|Death|3|||
42191755|NCT04116710|76002056|FG003|Overall Study|Death|1|||
42191756|NCT04116710|76002053|FG000|Overall Study|Withdrawal by Subject|0|||
42191757|NCT04116710|76002054|FG001|Overall Study|Withdrawal by Subject|0|||
42297397|NCT02397057|76132492|FG001|Overall Study|Withdrawal by Subject|7|||
42297398|NCT02397057|76132491|FG000|Overall Study|Lost to Follow-up|4|||
42297399|NCT02397057|76132492|FG001|Overall Study|Lost to Follow-up|3|||
42297400|NCT02397057|76132491|FG000|Overall Study|Death|1|||
42297401|NCT02397057|76132492|FG001|Overall Study|Death|0|||
42297402|NCT02397057|76132491|FG000|Overall Study|Adverse Event|0|||
42297403|NCT02397057|76132492|FG001|Overall Study|Adverse Event|1|||
42297404|NCT02397057|76132491|FG000|Overall Study|Physician Decision|0|||
42297405|NCT02397057|76132492|FG001|Overall Study|Physician Decision|1|||
42297406|NCT02397057|76132491|FG000|Overall Study|Subject did not receive study drug|0|||
42297407|NCT02397057|76132492|FG001|Overall Study|Subject did not receive study drug|1|||
42297408|NCT02343549|76132498|FG000|Overall Study|Death|11|||
42018379|NCT00996892|75825861|FG000|Expansion Stage 2|Adverse Event|0|||
42018380|NCT00996892|75825862|FG001|Expansion Stage 2|Adverse Event|0|||
42018381|NCT00996892|75825863|FG002|Expansion Stage 2|Adverse Event|0|||
42018382|NCT00996892|75825864|FG003|Expansion Stage 2|Adverse Event|0|||
42018383|NCT00996892|75825865|FG004|Expansion Stage 2|Adverse Event|0|||
42018384|NCT00996892|75825866|FG005|Expansion Stage 2|Adverse Event|0|||
42018385|NCT00996892|75825867|FG006|Expansion Stage 2|Adverse Event|0|||
42018386|NCT00996892|75825868|FG007|Expansion Stage 2|Adverse Event|0|||
42018387|NCT00996892|75825869|FG008|Expansion Stage 2|Adverse Event|0|||
42018388|NCT00996892|75825870|FG009|Expansion Stage 2|Adverse Event|0|||
42018389|NCT00996892|75825871|FG010|Expansion Stage 2|Adverse Event|0|||
42018390|NCT00996892|75825872|FG011|Expansion Stage 2|Adverse Event|0|||
42018391|NCT00996892|75825873|FG012|Expansion Stage 2|Adverse Event|0|||
42018392|NCT00996892|75825874|FG013|Expansion Stage 2|Adverse Event|0|||
42097552|NCT00626925|75908127|FG001|Overall Study|Lack of Efficacy|4|||
42191758|NCT04116710|76002055|FG002|Overall Study|Withdrawal by Subject|0|||
42191759|NCT04116710|76002056|FG003|Overall Study|Withdrawal by Subject|1|||
42191760|NCT02946515|76002095|FG000|Overall Study|Lost to Follow-up|2|||
42191761|NCT02946515|76002096|FG001|Overall Study|Lost to Follow-up|1|||
42191762|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
42191763|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
42191764|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
42191765|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
42191766|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
42191767|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
42191768|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
42191769|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
42191770|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
42191771|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
42191772|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
42191773|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
42191774|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
42191775|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
42191776|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
42191777|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
42191778|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
42191779|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
42191780|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
42191781|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
42191782|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
42191783|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
42191784|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
42297409|NCT02343549|76132498|FG000|Overall Study|Withdrawal by Subject|2|||
42297410|NCT02343159|76132505|FG000|Overall Study|Early Study Termination|16|||
42297411|NCT02343159|76132506|FG001|Overall Study|Early Study Termination|19|||
42297412|NCT02343159|76132507|FG002|Overall Study|Early Study Termination|23|||
42297413|NCT02343159|76132505|FG000|Overall Study|Physician Decision|2|||
42297414|NCT02343159|76132506|FG001|Overall Study|Physician Decision|0|||
42297415|NCT02343159|76132507|FG002|Overall Study|Physician Decision|1|||
42297416|NCT02343159|76132505|FG000|Overall Study|Withdrawal by Subject|3|||
42297417|NCT02343159|76132506|FG001|Overall Study|Withdrawal by Subject|0|||
42297418|NCT02343159|76132507|FG002|Overall Study|Withdrawal by Subject|2|||
42297419|NCT02343159|76132505|FG000|Overall Study|Lost to Follow-up|0|||
42297420|NCT02343159|76132506|FG001|Overall Study|Lost to Follow-up|2|||
42297421|NCT02343159|76132507|FG002|Overall Study|Lost to Follow-up|2|||
42297422|NCT02343159|76132505|FG000|Overall Study|Adverse Event|4|||
42297423|NCT02343159|76132506|FG001|Overall Study|Adverse Event|4|||
42297424|NCT02343159|76132507|FG002|Overall Study|Adverse Event|2|||
42297425|NCT02343159|76132505|FG000|Overall Study|Sponsor Decision|0|||
42297426|NCT02343159|76132506|FG001|Overall Study|Sponsor Decision|1|||
42297427|NCT02343159|76132507|FG002|Overall Study|Sponsor Decision|0|||
42297428|NCT02343159|76132505|FG000|Overall Study|Enrollment Error|1|||
42297429|NCT02343159|76132506|FG001|Overall Study|Enrollment Error|0|||
42297430|NCT02343159|76132507|FG002|Overall Study|Enrollment Error|0|||
42297431|NCT02395653|76132516|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
42297432|NCT02395653|76132516|FG000|Overall Study|Consent Withdrawn at Screening|1|||
42297433|NCT02395653|76132516|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
42297434|NCT02395653|76132516|FG000|Overall Study|Investigator Decision at Screening|1|||
42297435|NCT02395653|76132516|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
42297436|NCT02395653|76132516|FG000|Overall Study|Withdrawal by Subject|1|||
42297437|NCT02395653|76132516|FG000|Overall Study|Lost to Follow-up|1|||
42297438|NCT01664923|76132522|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
42297439|NCT01664923|76132523|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
42297440|NCT01664923|76132522|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
42297441|NCT01664923|76132523|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
42297442|NCT01664923|76132522|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
42297443|NCT01664923|76132523|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
42297444|NCT01664923|76132522|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
42191785|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
42191786|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
42191787|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
42297445|NCT01664923|76132523|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
42297446|NCT01664923|76132522|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
42297447|NCT01664923|76132523|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
42297448|NCT01664923|76132522|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
42297449|NCT01664923|76132523|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
42191788|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
42191789|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
42191790|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
42191791|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
42191792|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
42191793|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
42191794|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
42191795|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
42191796|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
42191797|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
42191798|NCT02586623|76002109|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
42297450|NCT01664923|76132522|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
42297451|NCT01664923|76132523|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
42297452|NCT01664923|76132522|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
42297453|NCT01664923|76132523|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
42297454|NCT01664923|76132522|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
42297455|NCT01664923|76132523|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
42297456|NCT01664923|76132522|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
42297457|NCT01664923|76132523|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
42297458|NCT01664923|76132522|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
42297459|NCT01664923|76132523|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
42297460|NCT01664923|76132522|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
42297461|NCT01664923|76132523|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
42297462|NCT01664923|76132522|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
42297463|NCT01664923|76132523|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
42297464|NCT01664923|76132522|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
42297465|NCT01664923|76132523|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
42297466|NCT01664533|76132533|FG000|Overall Study|Death|42|||
42297467|NCT01664533|76132533|FG000|Overall Study|Lost to Follow-up|3|||
42297468|NCT01664533|76132533|FG000|Overall Study|Study termination|9|||
42297469|NCT01664533|76132533|FG000|Overall Study|Protocol Violation|3|||
42297470|NCT02584855|76132538|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
42297471|NCT02584855|76132539|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
42297472|NCT02584855|76132540|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
42297473|NCT02584855|76132541|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
42297474|NCT02584855|76132542|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
42297475|NCT02584855|76132543|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
42297476|NCT02584855|76132538|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
42297477|NCT02584855|76132539|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
42297478|NCT02584855|76132540|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
42297479|NCT02584855|76132541|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
42297480|NCT02584855|76132542|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
42297481|NCT02584855|76132543|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
42297482|NCT02584855|76132538|FG000|Open-Label Treatment Period|Adverse Event|14|||
42297483|NCT02584855|76132539|FG001|Open-Label Treatment Period|Adverse Event|0|||
42297484|NCT02584855|76132540|FG002|Open-Label Treatment Period|Adverse Event|0|||
42297485|NCT02584855|76132541|FG003|Open-Label Treatment Period|Adverse Event|0|||
42297486|NCT02584855|76132542|FG004|Open-Label Treatment Period|Adverse Event|0|||
42297487|NCT02584855|76132543|FG005|Open-Label Treatment Period|Adverse Event|0|||
42297488|NCT02584855|76132538|FG000|Open-Label Treatment Period|Death|2|||
42297489|NCT02584855|76132539|FG001|Open-Label Treatment Period|Death|0|||
42297490|NCT02584855|76132540|FG002|Open-Label Treatment Period|Death|0|||
42191799|NCT02586623|76002110|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
42191800|NCT02586623|76002111|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
42191801|NCT02586623|76002109|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
42191802|NCT02586623|76002110|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
42191803|NCT02586623|76002111|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
42191804|NCT02586623|76002109|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
42191805|NCT02586623|76002110|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
42297491|NCT02584855|76132541|FG003|Open-Label Treatment Period|Death|0|||
42297492|NCT02584855|76132542|FG004|Open-Label Treatment Period|Death|0|||
42191806|NCT02586623|76002111|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
42297493|NCT02584855|76132543|FG005|Open-Label Treatment Period|Death|0|||
42297494|NCT02584855|76132538|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
42297495|NCT02584855|76132539|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
42297496|NCT02584855|76132540|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
42297497|NCT02584855|76132541|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
42297498|NCT02584855|76132542|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
42191807|NCT02586623|76002109|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
42191808|NCT02586623|76002110|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
42191809|NCT02586623|76002111|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
42191810|NCT02586623|76002109|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
42191811|NCT02586623|76002110|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
42191812|NCT02586623|76002111|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
42191813|NCT02586623|76002109|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
42191814|NCT02586623|76002110|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
42191815|NCT02586623|76002111|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
42191816|NCT02586623|76002109|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
42191817|NCT02586623|76002110|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
42191818|NCT02586623|76002111|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
42191819|NCT02586623|76002109|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
42191820|NCT02586623|76002110|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
42191821|NCT02586623|76002111|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
42191822|NCT02586623|76002109|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
42191823|NCT02586623|76002110|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
42191824|NCT02586623|76002111|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
42191825|NCT01819831|76002118|FG000|Overall Study|Withdrawal by Subject|1|||
42191826|NCT00078949|76002135|FG000|Overall Study|No treated|4|||
42191827|NCT00078949|76002136|FG001|Overall Study|No treated|5|||
42191828|NCT00078949|76002137|FG002|Overall Study|No treated|3|||
42191829|NCT00078949|76002138|FG003|Overall Study|No treated|3|||
42191830|NCT03739203|76002153|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
42191831|NCT03739203|76002154|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
42191832|NCT03739203|76002155|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
42191833|NCT03739203|76002153|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
42191834|NCT03739203|76002154|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
42191835|NCT03739203|76002155|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
42191836|NCT03739203|76002153|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
42191837|NCT03739203|76002154|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
42191838|NCT03739203|76002155|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
42191839|NCT03739203|76002153|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
42191840|NCT03739203|76002154|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
42191841|NCT03739203|76002155|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
42191842|NCT03739203|76002153|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
42191843|NCT03739203|76002154|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
42191844|NCT03739203|76002155|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
42191845|NCT03739203|76002153|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
42191846|NCT03739203|76002154|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
42191847|NCT03739203|76002155|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
42191848|NCT03739203|76002153|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
42191849|NCT03739203|76002154|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
42191850|NCT03739203|76002155|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
42191851|NCT03739203|76002153|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
42191852|NCT03739203|76002154|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
42191853|NCT03739203|76002155|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
42191854|NCT03739203|76002153|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
42097553|NCT00626925|75908126|FG000|Overall Study|Time constraints|3|||
42097554|NCT00626925|75908127|FG001|Overall Study|Time constraints|1|||
42097555|NCT00698646|75908150|FG000|Overall Study|Adverse Event|8|||
42097556|NCT00698646|75908151|FG001|Overall Study|Adverse Event|7|||
42097557|NCT00698646|75908152|FG002|Overall Study|Adverse Event|8|||
42097558|NCT00698646|75908150|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
42097559|NCT00698646|75908151|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
42097560|NCT00698646|75908152|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
42191855|NCT03739203|76002154|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
42191856|NCT03739203|76002155|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
42191857|NCT03739203|76002153|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
42191858|NCT03739203|76002154|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
42191859|NCT03739203|76002155|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
42191860|NCT03739203|76002153|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
42191861|NCT03739203|76002154|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
42191862|NCT03739203|76002155|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
42191863|NCT02942264|76002172|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
42191864|NCT02942264|76002173|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
42191865|NCT02942264|76002174|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
42097561|NCT00698646|75908150|FG000|Overall Study|Protocol Deviation|6|||
42097562|NCT00698646|75908151|FG001|Overall Study|Protocol Deviation|2|||
42097563|NCT00698646|75908152|FG002|Overall Study|Protocol Deviation|3|||
42097564|NCT00698646|75908150|FG000|Overall Study|Withdrawal by Subject|10|||
42097565|NCT00698646|75908151|FG001|Overall Study|Withdrawal by Subject|11|||
42097566|NCT00698646|75908152|FG002|Overall Study|Withdrawal by Subject|8|||
42097567|NCT00698646|75908150|FG000|Overall Study|Lost to Follow-up|0|||
42097568|NCT00698646|75908151|FG001|Overall Study|Lost to Follow-up|0|||
42097569|NCT00698646|75908152|FG002|Overall Study|Lost to Follow-up|2|||
42097570|NCT00698646|75908150|FG000|Overall Study|Administrative problems|1|||
42097571|NCT00698646|75908151|FG001|Overall Study|Administrative problems|0|||
42097572|NCT00698646|75908152|FG002|Overall Study|Administrative problems|1|||
42097573|NCT00609466|75908163|FG000|Overall Study|Withdrawal by Subject|0|||
42097574|NCT00609466|75908164|FG001|Overall Study|Withdrawal by Subject|1|||
42097575|NCT00609466|75908165|FG002|Overall Study|Withdrawal by Subject|1|||
42191866|NCT02942264|76002175|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
42191867|NCT02942264|76002176|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
42191868|NCT02942264|76002177|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
42191869|NCT02942264|76002178|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
42191870|NCT02942264|76002179|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
42191871|NCT02942264|76002180|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
42191872|NCT02942264|76002172|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
42191873|NCT02942264|76002173|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
42191874|NCT02942264|76002174|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
42191875|NCT02942264|76002175|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
42191876|NCT02942264|76002176|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
42191877|NCT02942264|76002177|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
42191878|NCT02942264|76002178|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
42191879|NCT02942264|76002179|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
42191880|NCT02942264|76002180|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
42191881|NCT03322514|76002207|FG000|Overall Study|Withdrawal by Subject|1|||
42191882|NCT03322514|76002208|FG001|Overall Study|Withdrawal by Subject|1|||
42191883|NCT03325712|76002222|FG000|Overall Study|Protocol Violation|0|||
42191884|NCT03325712|76002223|FG001|Overall Study|Protocol Violation|0|||
42191885|NCT03325712|76002224|FG002|Overall Study|Protocol Violation|0|||
42191886|NCT03325712|76002225|FG003|Overall Study|Protocol Violation|0|||
42191887|NCT03325712|76002226|FG004|Overall Study|Protocol Violation|1|||
42191888|NCT03325712|76002227|FG005|Overall Study|Protocol Violation|0|||
42191889|NCT03325712|76002228|FG006|Overall Study|Protocol Violation|0|||
42191890|NCT03325712|76002229|FG007|Overall Study|Protocol Violation|0|||
42191891|NCT03325712|76002222|FG000|Overall Study|Adverse Event|0|||
42191892|NCT03325712|76002223|FG001|Overall Study|Adverse Event|0|||
42191893|NCT03325712|76002224|FG002|Overall Study|Adverse Event|0|||
42191894|NCT03325712|76002225|FG003|Overall Study|Adverse Event|0|||
42191895|NCT03325712|76002226|FG004|Overall Study|Adverse Event|1|||
42191896|NCT03325712|76002227|FG005|Overall Study|Adverse Event|0|||
42191897|NCT03325712|76002228|FG006|Overall Study|Adverse Event|0|||
42191898|NCT03325712|76002229|FG007|Overall Study|Adverse Event|0|||
42097576|NCT00609466|75908163|FG000|Overall Study|Adverse Event|2|||
42097577|NCT00609466|75908164|FG001|Overall Study|Adverse Event|3|||
42191899|NCT03734679|76002257|FG000|Overall Study|Missed Visit|1|||
42191900|NCT03325556|76002261|FG000|Open-label Period|Lack of Response in OL period|70|||
42191901|NCT03325556|76002262|FG001|Open-label Period|Lack of Response in OL period|0|||
42191902|NCT03325556|76002263|FG002|Open-label Period|Lack of Response in OL period|0|||
42191903|NCT03325556|76002261|FG000|Open-label Period|Adverse Event|27|||
42191904|NCT03325556|76002262|FG001|Open-label Period|Adverse Event|0|||
42191905|NCT03325556|76002263|FG002|Open-label Period|Adverse Event|0|||
42097578|NCT00609466|75908165|FG002|Overall Study|Adverse Event|1|||
42097579|NCT00609466|75908163|FG000|Overall Study|Lack of Efficacy|0|||
42097580|NCT00609466|75908164|FG001|Overall Study|Lack of Efficacy|2|||
42097581|NCT00609466|75908165|FG002|Overall Study|Lack of Efficacy|2|||
42097582|NCT00608530|75908177|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
42191906|NCT03325556|76002261|FG000|Open-label Period|Death|1|||
42191907|NCT03325556|76002262|FG001|Open-label Period|Death|0|||
42191908|NCT03325556|76002263|FG002|Open-label Period|Death|0|||
42191909|NCT03325556|76002261|FG000|Open-label Period|Lost to Follow-up|1|||
42191910|NCT03325556|76002262|FG001|Open-label Period|Lost to Follow-up|0|||
42191911|NCT03325556|76002263|FG002|Open-label Period|Lost to Follow-up|0|||
42191912|NCT03325556|76002261|FG000|Open-label Period|Non-compliance with study drug|5|||
42097583|NCT00608530|75908178|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
42097584|NCT00608530|75908179|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
42097585|NCT00608530|75908180|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
42191913|NCT03325556|76002262|FG001|Open-label Period|Non-compliance with study drug|0|||
42191914|NCT03325556|76002263|FG002|Open-label Period|Non-compliance with study drug|0|||
42191915|NCT03325556|76002261|FG000|Open-label Period|Use of prohibited medication|1|||
42191916|NCT03325556|76002262|FG001|Open-label Period|Use of prohibited medication|0|||
42191917|NCT03325556|76002263|FG002|Open-label Period|Use of prohibited medication|0|||
42191918|NCT03325556|76002261|FG000|Open-label Period|Protocol Violation|4|||
42191919|NCT03325556|76002262|FG001|Open-label Period|Protocol Violation|0|||
42191920|NCT03325556|76002263|FG002|Open-label Period|Protocol Violation|0|||
42191921|NCT03325556|76002261|FG000|Open-label Period|Withdrawal by Subject|17|||
42191922|NCT03325556|76002262|FG001|Open-label Period|Withdrawal by Subject|0|||
42191923|NCT03325556|76002263|FG002|Open-label Period|Withdrawal by Subject|0|||
42191924|NCT03325556|76002261|FG000|Open-label Period|Not otherwise specified|8|||
42191925|NCT03325556|76002262|FG001|Open-label Period|Not otherwise specified|0|||
42191926|NCT03325556|76002263|FG002|Open-label Period|Not otherwise specified|0|||
42191927|NCT03325556|76002261|FG000|Open-label Period|Administrative discont. at study termination|41|||
42191928|NCT03325556|76002262|FG001|Open-label Period|Administrative discont. at study termination|0|||
42191929|NCT03325556|76002263|FG002|Open-label Period|Administrative discont. at study termination|0|||
42191930|NCT03325556|76002261|FG000|Double-blind Period|Relapse|0|||
42191931|NCT03325556|76002262|FG001|Double-blind Period|Relapse|15|||
42097586|NCT00608530|75908177|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
42097587|NCT00608530|75908178|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
42097588|NCT00608530|75908179|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
42097589|NCT00608530|75908180|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
42097590|NCT00608530|75908177|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
42097591|NCT00608530|75908178|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
42097592|NCT00608530|75908179|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
42097593|NCT00608530|75908180|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
42097594|NCT00608530|75908177|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
42097595|NCT00608530|75908178|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
42097596|NCT00608530|75908179|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
42097597|NCT00608530|75908180|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
42191932|NCT03325556|76002263|FG002|Double-blind Period|Relapse|34|||
42191933|NCT03325556|76002261|FG000|Double-blind Period|Adverse Event|0|||
42191934|NCT03325556|76002262|FG001|Double-blind Period|Adverse Event|3|||
42191935|NCT03325556|76002263|FG002|Double-blind Period|Adverse Event|1|||
42191936|NCT03325556|76002261|FG000|Double-blind Period|Noncompliance with study drug|0|||
42191937|NCT03325556|76002262|FG001|Double-blind Period|Noncompliance with study drug|0|||
42191938|NCT03325556|76002263|FG002|Double-blind Period|Noncompliance with study drug|1|||
42191939|NCT03325556|76002261|FG000|Double-blind Period|Use of prohibited medication|0|||
42191940|NCT03325556|76002262|FG001|Double-blind Period|Use of prohibited medication|1|||
42191941|NCT03325556|76002263|FG002|Double-blind Period|Use of prohibited medication|0|||
42191942|NCT03325556|76002261|FG000|Double-blind Period|Physician Decision|0|||
42191943|NCT03325556|76002262|FG001|Double-blind Period|Physician Decision|0|||
42191944|NCT03325556|76002263|FG002|Double-blind Period|Physician Decision|1|||
42191945|NCT03325556|76002261|FG000|Double-blind Period|Withdrawal by Subject|0|||
42191946|NCT03325556|76002262|FG001|Double-blind Period|Withdrawal by Subject|6|||
42191947|NCT03325556|76002263|FG002|Double-blind Period|Withdrawal by Subject|4|||
42191948|NCT03325556|76002261|FG000|Double-blind Period|Not otherwise specified|0|||
42191949|NCT03325556|76002262|FG001|Double-blind Period|Not otherwise specified|1|||
42097598|NCT00608530|75908177|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
42097599|NCT00608530|75908178|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
42097600|NCT00608530|75908179|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
42097601|NCT00608530|75908180|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
42097602|NCT00608530|75908177|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
42097603|NCT00608530|75908178|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
42097604|NCT00608530|75908179|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
42097605|NCT00608530|75908180|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
42097606|NCT00642993|75908197|FG000|Overall Study|Adverse Event|85|||
42191950|NCT03325556|76002263|FG002|Double-blind Period|Not otherwise specified|5|||
42191951|NCT03325556|76002261|FG000|Double-blind Period|Administrative discont. at study termination|0|||
42191952|NCT03325556|76002262|FG001|Double-blind Period|Administrative discont. at study termination|35|||
42191953|NCT03325556|76002263|FG002|Double-blind Period|Administrative discont. at study termination|31|||
42191954|NCT03320564|76002270|FG000|Overall Study|Protocol Violation|1|||
42191955|NCT03325166|76002274|FG000|Overall Study|Adverse Event|1|||
42191956|NCT02888756|76002281|FG000|Analytical Treatment Interruption|Physician Decision|10|||
42191957|NCT02888756|76002282|FG001|Analytical Treatment Interruption|Physician Decision|6|||
42097607|NCT00642993|75908198|FG001|Overall Study|Adverse Event|4|||
42191958|NCT02888756|76002283|FG002|Analytical Treatment Interruption|Physician Decision|5|||
42191959|NCT03305666|76002293|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
42191960|NCT03305666|76002294|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
42191961|NCT03304184|76002302|FG000|Overall Study|Withdrawal by Subject|1|||
42191962|NCT03304184|76002303|FG001|Overall Study|Withdrawal by Subject|2|||
42097608|NCT00642993|75908197|FG000|Overall Study|Lost to Follow-up|8|||
42191963|NCT03736785|76002313|FG000|Overall Study|Adverse Event|1|||
42191964|NCT03736785|76002314|FG001|Overall Study|Adverse Event|1|||
42191965|NCT03736785|76002315|FG002|Overall Study|Adverse Event|1|||
42191966|NCT03736785|76002313|FG000|Overall Study|Death|1|||
42191967|NCT03736785|76002314|FG001|Overall Study|Death|0|||
42191968|NCT03736785|76002315|FG002|Overall Study|Death|1|||
42191969|NCT03736785|76002313|FG000|Overall Study|Lost to Follow-up|0|||
42191970|NCT03736785|76002314|FG001|Overall Study|Lost to Follow-up|2|||
42191971|NCT03736785|76002315|FG002|Overall Study|Lost to Follow-up|3|||
42191972|NCT03736785|76002313|FG000|Overall Study|Non compliance with study drug|1|||
42191973|NCT03736785|76002314|FG001|Overall Study|Non compliance with study drug|1|||
42191974|NCT03736785|76002315|FG002|Overall Study|Non compliance with study drug|0|||
42191975|NCT03736785|76002313|FG000|Overall Study|Physician Decision|0|||
42191976|NCT03736785|76002314|FG001|Overall Study|Physician Decision|1|||
42191977|NCT03736785|76002315|FG002|Overall Study|Physician Decision|1|||
42191978|NCT03736785|76002313|FG000|Overall Study|Protocol Violation|1|||
42191979|NCT03736785|76002314|FG001|Overall Study|Protocol Violation|4|||
42191980|NCT03736785|76002315|FG002|Overall Study|Protocol Violation|3|||
42191981|NCT03736785|76002313|FG000|Overall Study|Sponsor Decision|1|||
42191982|NCT03736785|76002314|FG001|Overall Study|Sponsor Decision|0|||
42191983|NCT03736785|76002315|FG002|Overall Study|Sponsor Decision|0|||
42191984|NCT03736785|76002313|FG000|Overall Study|Unknown/Missing data|3|||
42191985|NCT03736785|76002314|FG001|Overall Study|Unknown/Missing data|2|||
42191986|NCT03736785|76002315|FG002|Overall Study|Unknown/Missing data|1|||
42191987|NCT03736785|76002313|FG000|Overall Study|Withdrawal by Subject|9|||
42191988|NCT03736785|76002314|FG001|Overall Study|Withdrawal by Subject|6|||
42191989|NCT03736785|76002315|FG002|Overall Study|Withdrawal by Subject|4|||
42191990|NCT03734991|76002326|FG000|Overall Study|Adverse Event|4|||
42191991|NCT03734991|76002327|FG001|Overall Study|Adverse Event|0|||
42191992|NCT03734991|76002326|FG000|Overall Study|Lost to Follow-up|4|||
42191993|NCT03734991|76002327|FG001|Overall Study|Lost to Follow-up|0|||
42191994|NCT03734991|76002326|FG000|Overall Study|Physician Decision|0|||
42191995|NCT03734991|76002327|FG001|Overall Study|Physician Decision|1|||
42191996|NCT03734991|76002326|FG000|Overall Study|Pregnancy|1|||
42191997|NCT03734991|76002327|FG001|Overall Study|Pregnancy|0|||
42191998|NCT03734991|76002326|FG000|Overall Study|Withdrawal by Subject|6|||
42191999|NCT03734991|76002327|FG001|Overall Study|Withdrawal by Subject|3|||
42192000|NCT03734991|76002326|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
42192001|NCT03734991|76002327|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
42192002|NCT03734991|76002326|FG000|Overall Study|Other|2|||
42192003|NCT03734991|76002327|FG001|Overall Study|Other|2|||
42192004|NCT03303092|76002336|FG000|Overall Study|Adverse Event|1|||
42192005|NCT03303092|76002337|FG001|Overall Study|Adverse Event|0|||
42192006|NCT03303092|76002338|FG002|Overall Study|Adverse Event|1|||
42192007|NCT03303092|76002336|FG000|Overall Study|Protocol Violation|1|||
42192008|NCT03303092|76002337|FG001|Overall Study|Protocol Violation|5|||
42097609|NCT00642993|75908198|FG001|Overall Study|Lost to Follow-up|4|||
42097610|NCT00642993|75908197|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
42097611|NCT00642993|75908198|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
42097612|NCT00642993|75908197|FG000|Overall Study|Protocol Violation|1|||
42097613|NCT00642993|75908198|FG001|Overall Study|Protocol Violation|4|||
42097614|NCT00642993|75908197|FG000|Overall Study|Did not meet protocol eligibility|0|||
42097615|NCT00642993|75908198|FG001|Overall Study|Did not meet protocol eligibility|1|||
42097616|NCT00642993|75908197|FG000|Overall Study|Administrative|1|||
42097617|NCT00642993|75908198|FG001|Overall Study|Administrative|0|||
42097618|NCT00696696|75908204|FG000|Overall Study|Adverse Event|5|||
42097619|NCT00696696|75908204|FG000|Overall Study|Withdrawal by Subject|8|||
42097620|NCT00696696|75908204|FG000|Overall Study|Physician Decision|2|||
42192009|NCT03303092|76002338|FG002|Overall Study|Protocol Violation|1|||
42192010|NCT03303092|76002336|FG000|Overall Study|Withdrawal by Subject|1|||
42192011|NCT03303092|76002337|FG001|Overall Study|Withdrawal by Subject|1|||
42192012|NCT03303092|76002338|FG002|Overall Study|Withdrawal by Subject|3|||
42192013|NCT03302936|76002348|FG000|Overall Study|Protocol Violation|3|||
42297499|NCT02584855|76132543|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
42297500|NCT02584855|76132538|FG000|Open-Label Treatment Period|Protocol Violation|1|||
42297501|NCT02584855|76132539|FG001|Open-Label Treatment Period|Protocol Violation|0|||
42192014|NCT03302936|76002349|FG001|Overall Study|Protocol Violation|4|||
42192015|NCT03733899|76002359|FG000|Period 1|Protocol Violation|0|||
42192016|NCT03733899|76002360|FG001|Period 1|Protocol Violation|0|||
42192017|NCT03733899|76002361|FG002|Period 1|Protocol Violation|0|||
42192018|NCT03733899|76002362|FG003|Period 1|Protocol Violation|0|||
42192019|NCT03733899|76002363|FG004|Period 1|Protocol Violation|0|||
42192020|NCT03733899|76002364|FG005|Period 1|Protocol Violation|1|||
42192021|NCT03733899|76002359|FG000|Period 2|Unscuccessful Treatment|0|||
42097621|NCT00696696|75908204|FG000|Overall Study|Death|3|||
42097622|NCT00699192|75908211|FG000|Overall Study|Missing|1|||
42192022|NCT03733899|76002360|FG001|Period 2|Unscuccessful Treatment|1|||
42192023|NCT03733899|76002361|FG002|Period 2|Unscuccessful Treatment|0|||
42097623|NCT00699192|75908212|FG001|Overall Study|Missing|1|||
42097624|NCT00699192|75908213|FG002|Overall Study|Missing|1|||
42097625|NCT00699192|75908211|FG000|Overall Study|Adverse Event|9|||
42097626|NCT00699192|75908212|FG001|Overall Study|Adverse Event|4|||
42097627|NCT00699192|75908213|FG002|Overall Study|Adverse Event|3|||
42097628|NCT00699192|75908211|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42097629|NCT00699192|75908212|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42097630|NCT00699192|75908213|FG002|Overall Study|Abnormal test procedure result(s)|1|||
42192024|NCT03733899|76002362|FG003|Period 2|Unscuccessful Treatment|0|||
42192025|NCT03733899|76002363|FG004|Period 2|Unscuccessful Treatment|0|||
42192026|NCT03733899|76002364|FG005|Period 2|Unscuccessful Treatment|0|||
42192027|NCT03733899|76002359|FG000|Period 3|Withdrawal by Subject|1|||
42192028|NCT03733899|76002360|FG001|Period 3|Withdrawal by Subject|0|||
42192029|NCT03733899|76002361|FG002|Period 3|Withdrawal by Subject|0|||
42192030|NCT03733899|76002362|FG003|Period 3|Withdrawal by Subject|0|||
42192031|NCT03733899|76002363|FG004|Period 3|Withdrawal by Subject|0|||
42192032|NCT03733899|76002364|FG005|Period 3|Withdrawal by Subject|0|||
42192033|NCT03727347|76002377|FG000|Overall Study|Withdrawal by Subject|2|||
42192034|NCT03727347|76002377|FG000|Overall Study|Lost to Follow-up|1|||
42192035|NCT03915626|76002390|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
42192036|NCT03301844|76002402|FG000|Overall Study|suspected colon cancer|1|||
42192037|NCT03301844|76002403|FG001|Overall Study|suspected colon cancer|1|||
42192038|NCT03313310|76002411|FG000|Phase 2|Lost to Follow-up|4|||
42192039|NCT03313310|76002412|FG001|Phase 2|Lost to Follow-up|0|||
42192040|NCT03313310|76002411|FG000|Phase 3|Lost to Follow-up|0|||
42192041|NCT03313310|76002412|FG001|Phase 3|Lost to Follow-up|1|||
42192042|NCT03313076|76002422|FG000|Overall Study|Withdrawal by Subject|2|||
42192043|NCT03313076|76002423|FG001|Overall Study|Withdrawal by Subject|0|||
42192044|NCT03313076|76002424|FG002|Overall Study|Withdrawal by Subject|0|||
42192045|NCT03313076|76002425|FG003|Overall Study|Withdrawal by Subject|0|||
42192046|NCT03313076|76002422|FG000|Overall Study|Lost to Follow-up|0|||
42192047|NCT03313076|76002423|FG001|Overall Study|Lost to Follow-up|2|||
42359244|NCT01827384|76204854|FG009|Overall Study|Participant died before treatment|0|||
42359245|NCT01827384|76204855|FG010|Overall Study|Participant died before treatment|0|||
42359246|NCT01827384|76204856|FG011|Overall Study|Participant died before treatment|0|||
42359247|NCT01827384|76204857|FG012|Overall Study|Participant died before treatment|0|||
42097631|NCT00699192|75908211|FG000|Overall Study|Lack of Efficacy|0|||
42097632|NCT00699192|75908212|FG001|Overall Study|Lack of Efficacy|0|||
42192048|NCT03313076|76002424|FG002|Overall Study|Lost to Follow-up|2|||
42192049|NCT03313076|76002425|FG003|Overall Study|Lost to Follow-up|2|||
42192050|NCT02940626|76002443|FG000|Overall Study|Death|40|||
42192051|NCT02940626|76002444|FG001|Overall Study|Death|32|||
42192052|NCT02940626|76002443|FG000|Overall Study|Lost to Follow-up|5|||
42192053|NCT02940626|76002444|FG001|Overall Study|Lost to Follow-up|2|||
42097633|NCT00699192|75908213|FG002|Overall Study|Lack of Efficacy|1|||
42097634|NCT00699192|75908211|FG000|Overall Study|Withdrawal by Subject|3|||
42097635|NCT00699192|75908212|FG001|Overall Study|Withdrawal by Subject|2|||
42097636|NCT00699192|75908213|FG002|Overall Study|Withdrawal by Subject|4|||
42097637|NCT00699192|75908211|FG000|Overall Study|Administrative problems|1|||
42097638|NCT00699192|75908212|FG001|Overall Study|Administrative problems|3|||
42097639|NCT00699192|75908213|FG002|Overall Study|Administrative problems|1|||
42097640|NCT00699192|75908211|FG000|Overall Study|Protocol Violation|2|||
42097641|NCT00699192|75908212|FG001|Overall Study|Protocol Violation|2|||
42097642|NCT00699192|75908213|FG002|Overall Study|Protocol Violation|0|||
42097643|NCT00401245|75908225|FG000|Double Blind Titration Phase|Adverse Event|3|||
42097644|NCT00401245|75908226|FG001|Double Blind Titration Phase|Adverse Event|2|||
42097645|NCT00401245|75908227|FG002|Double Blind Titration Phase|Adverse Event|5|||
42192054|NCT02940626|76002443|FG000|Overall Study|Withdrawal by Subject|1|||
42192055|NCT02940626|76002444|FG001|Overall Study|Withdrawal by Subject|0|||
42192056|NCT02940626|76002443|FG000|Overall Study|Transfer to Hospice Care|1|||
42192057|NCT02940626|76002444|FG001|Overall Study|Transfer to Hospice Care|0|||
42192058|NCT02940626|76002443|FG000|Overall Study|Prohibited Concomitant Medication|0|||
42192059|NCT02940626|76002444|FG001|Overall Study|Prohibited Concomitant Medication|1|||
42192060|NCT03300050|76002457|FG000|Overall Study|Lost to Follow-up|2|||
42192061|NCT03300050|76002458|FG001|Overall Study|Lost to Follow-up|1|||
42192062|NCT03300050|76002459|FG002|Overall Study|Lost to Follow-up|0|||
42192063|NCT03300050|76002460|FG003|Overall Study|Lost to Follow-up|0|||
42192064|NCT03300050|76002461|FG004|Overall Study|Lost to Follow-up|1|||
42192065|NCT03300050|76002457|FG000|Overall Study|Withdrawal by Subject|1|||
42192066|NCT03300050|76002458|FG001|Overall Study|Withdrawal by Subject|1|||
42192067|NCT03300050|76002459|FG002|Overall Study|Withdrawal by Subject|1|||
42097646|NCT00401245|75908228|FG003|Double Blind Titration Phase|Adverse Event|12|||
42097647|NCT00401245|75908229|FG004|Double Blind Titration Phase|Adverse Event|0|||
42097648|NCT00401245|75908230|FG005|Double Blind Titration Phase|Adverse Event|0|||
42192068|NCT03300050|76002460|FG003|Overall Study|Withdrawal by Subject|0|||
42192069|NCT03300050|76002461|FG004|Overall Study|Withdrawal by Subject|0|||
42359248|NCT01827384|76204858|FG013|Overall Study|Participant died before treatment|5|||
42192070|NCT03300050|76002457|FG000|Overall Study|Death|0|||
42192071|NCT03300050|76002458|FG001|Overall Study|Death|0|||
42192072|NCT03300050|76002459|FG002|Overall Study|Death|1|||
42192073|NCT03300050|76002460|FG003|Overall Study|Death|0|||
42192074|NCT03300050|76002461|FG004|Overall Study|Death|0|||
42192075|NCT03300050|76002457|FG000|Overall Study|Not Eligible at Randomization|0|||
42192076|NCT03300050|76002458|FG001|Overall Study|Not Eligible at Randomization|0|||
42192077|NCT03300050|76002459|FG002|Overall Study|Not Eligible at Randomization|1|||
42192078|NCT03300050|76002460|FG003|Overall Study|Not Eligible at Randomization|1|||
42192079|NCT03300050|76002461|FG004|Overall Study|Not Eligible at Randomization|0|||
42192080|NCT03725085|76002473|FG000|Overall Study|Lost to Follow-up|2|||
42192081|NCT02940392|76002478|FG000|Overall Study|Lost to Follow-up|3|||
42192082|NCT02940392|76002478|FG000|Overall Study|Retreatment|3|||
42192083|NCT02940392|76002478|FG000|Overall Study|Death|2|||
42192084|NCT03298412|76002491|FG000|Run-in Period|Other, Not Specified|1|||
42192085|NCT03298412|76002491|FG000|Run-in Period|Disease Progression|1|||
42192086|NCT03298412|76002491|FG000|Run-in Period|Ineligibility Determined|1|||
42192087|NCT03298412|76002491|FG000|Run-in Period|Decision by Sponsor|6|||
42192088|NCT03297398|76002498|FG000|Overall Study|Sponsor's decision|6|||
42192089|NCT03297398|76002499|FG001|Overall Study|Sponsor's decision|9|||
42192090|NCT03297398|76002500|FG002|Overall Study|Sponsor's decision|7|||
42192091|NCT03297398|76002498|FG000|Overall Study|Adverse Event|1|||
42192092|NCT03297398|76002499|FG001|Overall Study|Adverse Event|4|||
42192093|NCT03297398|76002500|FG002|Overall Study|Adverse Event|4|||
42192094|NCT03297398|76002498|FG000|Overall Study|Withdrawal by Subject|1|||
42192095|NCT03297398|76002499|FG001|Overall Study|Withdrawal by Subject|2|||
42192096|NCT03297398|76002500|FG002|Overall Study|Withdrawal by Subject|2|||
42192097|NCT03297398|76002498|FG000|Overall Study|Protocol Violation|0|||
42192098|NCT03297398|76002499|FG001|Overall Study|Protocol Violation|2|||
42192099|NCT03297398|76002500|FG002|Overall Study|Protocol Violation|0|||
42192100|NCT03297398|76002498|FG000|Overall Study|Physician Decision|0|||
42192101|NCT03297398|76002499|FG001|Overall Study|Physician Decision|0|||
42097649|NCT00401245|75908231|FG006|Double Blind Titration Phase|Adverse Event|0|||
42097650|NCT00401245|75908232|FG007|Double Blind Titration Phase|Adverse Event|0|||
42097651|NCT00401245|75908225|FG000|Double Blind Titration Phase|Other|0|||
42192102|NCT03297398|76002500|FG002|Overall Study|Physician Decision|1|||
42192103|NCT03297398|76002498|FG000|Overall Study|Lost to Follow-up|0|||
42192104|NCT03297398|76002499|FG001|Overall Study|Lost to Follow-up|0|||
42192105|NCT03297398|76002500|FG002|Overall Study|Lost to Follow-up|1|||
42192106|NCT03293654|76002511|FG000|Overall Study|Lost to Follow-up|0|||
42192107|NCT03293654|76002512|FG001|Overall Study|Lost to Follow-up|1|||
42192108|NCT03293654|76002513|FG002|Overall Study|Lost to Follow-up|0|||
42192109|NCT03312218|76002523|FG000|Overall Study|Never signed in to access the app|54|||
42192110|NCT03312218|76002524|FG001|Overall Study|Never signed in to access the app|58|||
42192111|NCT03930615|76002532|FG000|Overall Study|Death|9|||
42192112|NCT03930615|76002533|FG001|Overall Study|Death|3|||
42192113|NCT03930615|76002532|FG000|Overall Study|Lost to Follow-up|1|||
42192114|NCT03930615|76002533|FG001|Overall Study|Lost to Follow-up|2|||
42192115|NCT03930615|76002532|FG000|Overall Study|Physician Decision|3|||
42192116|NCT03930615|76002533|FG001|Overall Study|Physician Decision|4|||
42192117|NCT03930615|76002532|FG000|Overall Study|Withdrawal by Subject|13|||
42192118|NCT03930615|76002533|FG001|Overall Study|Withdrawal by Subject|2|||
42297502|NCT02584855|76132540|FG002|Open-Label Treatment Period|Protocol Violation|0|||
42297503|NCT02584855|76132541|FG003|Open-Label Treatment Period|Protocol Violation|0|||
42297504|NCT02584855|76132542|FG004|Open-Label Treatment Period|Protocol Violation|0|||
42297505|NCT02584855|76132543|FG005|Open-Label Treatment Period|Protocol Violation|0|||
42297506|NCT02584855|76132538|FG000|Open-Label Treatment Period|No PI Available|2|||
42097652|NCT00401245|75908226|FG001|Double Blind Titration Phase|Other|0|||
42097653|NCT00401245|75908227|FG002|Double Blind Titration Phase|Other|1|||
42097654|NCT00401245|75908228|FG003|Double Blind Titration Phase|Other|0|||
42097655|NCT00401245|75908229|FG004|Double Blind Titration Phase|Other|0|||
42097656|NCT00401245|75908230|FG005|Double Blind Titration Phase|Other|0|||
42192119|NCT03930615|76002532|FG000|Overall Study|Not treated|1|||
42192120|NCT03930615|76002533|FG001|Overall Study|Not treated|1|||
42192121|NCT03292640|76002541|FG000|Overall Study|Withdrawal by Subject|17|||
42192122|NCT03292640|76002542|FG001|Overall Study|Withdrawal by Subject|16|||
42192123|NCT03292640|76002541|FG000|Overall Study|Adverse Event|20|||
42192124|NCT03292640|76002542|FG001|Overall Study|Adverse Event|2|||
42192125|NCT03292640|76002541|FG000|Overall Study|Lost to Follow-up|24|||
42097657|NCT00401245|75908231|FG006|Double Blind Titration Phase|Other|0|||
42097658|NCT00401245|75908232|FG007|Double Blind Titration Phase|Other|0|||
42192126|NCT03292640|76002542|FG001|Overall Study|Lost to Follow-up|24|||
42192127|NCT03292406|76002555|FG000|Overall Study|Progressive Disease|6|||
42192128|NCT03292406|76002556|FG001|Overall Study|Progressive Disease|3|||
42192129|NCT03292406|76002557|FG002|Overall Study|Progressive Disease|4|||
42192130|NCT03292406|76002555|FG000|Overall Study|Adverse Event|7|||
42192131|NCT03292406|76002556|FG001|Overall Study|Adverse Event|1|||
42192132|NCT03292406|76002557|FG002|Overall Study|Adverse Event|4|||
42097659|NCT00401245|75908225|FG000|Double Blind Titration Phase|Protocol Violation|0|||
42097660|NCT00401245|75908226|FG001|Double Blind Titration Phase|Protocol Violation|0|||
42097661|NCT00401245|75908227|FG002|Double Blind Titration Phase|Protocol Violation|0|||
42097662|NCT00401245|75908228|FG003|Double Blind Titration Phase|Protocol Violation|1|||
42097663|NCT00401245|75908229|FG004|Double Blind Titration Phase|Protocol Violation|0|||
42097664|NCT00401245|75908230|FG005|Double Blind Titration Phase|Protocol Violation|0|||
42097665|NCT00401245|75908231|FG006|Double Blind Titration Phase|Protocol Violation|0|||
42192133|NCT03292406|76002555|FG000|Overall Study|Withdrawal by Subject|0|||
42297507|NCT02584855|76132539|FG001|Open-Label Treatment Period|No PI Available|0|||
42297508|NCT02584855|76132540|FG002|Open-Label Treatment Period|No PI Available|0|||
42297509|NCT02584855|76132541|FG003|Open-Label Treatment Period|No PI Available|0|||
42297510|NCT02584855|76132542|FG004|Open-Label Treatment Period|No PI Available|0|||
42297511|NCT02584855|76132543|FG005|Open-Label Treatment Period|No PI Available|0|||
42297512|NCT02584855|76132538|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
42297513|NCT02584855|76132539|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
42297514|NCT02584855|76132540|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
42297515|NCT02584855|76132541|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
42297516|NCT02584855|76132542|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
42297517|NCT02584855|76132543|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
42297518|NCT02584855|76132538|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
42297519|NCT02584855|76132539|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
42297520|NCT02584855|76132540|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
42297521|NCT02584855|76132541|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
42297522|NCT02584855|76132542|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
42297523|NCT02584855|76132543|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
42297524|NCT02584855|76132538|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
42297525|NCT02584855|76132539|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
42297526|NCT02584855|76132540|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
42297527|NCT02584855|76132541|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
42297528|NCT02584855|76132542|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
42297529|NCT02584855|76132543|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
42297530|NCT02584855|76132538|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
42297531|NCT02584855|76132539|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
42297532|NCT02584855|76132540|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
42297533|NCT02584855|76132541|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
42097666|NCT00401245|75908232|FG007|Double Blind Titration Phase|Protocol Violation|0|||
42097667|NCT00401245|75908225|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
42297534|NCT02584855|76132542|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
42297535|NCT02584855|76132543|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
42297536|NCT02584855|76132538|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
42297537|NCT02584855|76132539|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
42297538|NCT02584855|76132540|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
42297539|NCT02584855|76132541|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
42297540|NCT02584855|76132542|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
42297541|NCT02584855|76132543|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
42297542|NCT02584855|76132538|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
42297543|NCT02584855|76132539|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
42297544|NCT02584855|76132540|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
42297545|NCT02584855|76132541|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
42297546|NCT02584855|76132542|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
42297547|NCT02584855|76132543|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
42297548|NCT02584855|76132538|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
42297549|NCT02584855|76132539|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
42297550|NCT02584855|76132540|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
42297551|NCT02584855|76132541|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
42297552|NCT02584855|76132542|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
42097668|NCT00401245|75908226|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
42297553|NCT02584855|76132543|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
42297554|NCT02581345|76132558|FG000|Part 1: up to Week 16|Adverse Event|3|||
42297555|NCT02581345|76132559|FG001|Part 1: up to Week 16|Adverse Event|8|||
42297556|NCT02581345|76132560|FG002|Part 1: up to Week 16|Adverse Event|0|||
42097669|NCT00401245|75908227|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
42297557|NCT02581345|76132561|FG003|Part 1: up to Week 16|Adverse Event|0|||
42297558|NCT02581345|76132558|FG000|Part 1: up to Week 16|Physician Decision|2|||
42097670|NCT00401245|75908228|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
42097671|NCT00401245|75908229|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
42297559|NCT02581345|76132559|FG001|Part 1: up to Week 16|Physician Decision|4|||
42297560|NCT02581345|76132560|FG002|Part 1: up to Week 16|Physician Decision|0|||
42097672|NCT00401245|75908230|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
42097673|NCT00401245|75908231|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
42297561|NCT02581345|76132561|FG003|Part 1: up to Week 16|Physician Decision|0|||
42297562|NCT02581345|76132558|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
42359249|NCT01827384|76204845|FG000|Overall Study|Insufficient tumor cells|0|||
42359250|NCT01827384|76204846|FG001|Overall Study|Insufficient tumor cells|0|||
42359251|NCT01827384|76204847|FG002|Overall Study|Insufficient tumor cells|0|||
42359252|NCT01827384|76204848|FG003|Overall Study|Insufficient tumor cells|0|||
42359253|NCT01827384|76204849|FG004|Overall Study|Insufficient tumor cells|0|||
42359254|NCT01827384|76204850|FG005|Overall Study|Insufficient tumor cells|0|||
42359255|NCT01827384|76204851|FG006|Overall Study|Insufficient tumor cells|0|||
42359256|NCT01827384|76204852|FG007|Overall Study|Insufficient tumor cells|0|||
42359257|NCT01827384|76204853|FG008|Overall Study|Insufficient tumor cells|0|||
42359258|NCT01827384|76204854|FG009|Overall Study|Insufficient tumor cells|0|||
42359259|NCT01827384|76204855|FG010|Overall Study|Insufficient tumor cells|0|||
42359260|NCT01827384|76204856|FG011|Overall Study|Insufficient tumor cells|0|||
42359261|NCT01827384|76204857|FG012|Overall Study|Insufficient tumor cells|0|||
42359262|NCT01827384|76204858|FG013|Overall Study|Insufficient tumor cells|13|||
42359263|NCT01827384|76204845|FG000|Overall Study|No actionable mutation|0|||
42359264|NCT01827384|76204846|FG001|Overall Study|No actionable mutation|0|||
42359265|NCT01827384|76204847|FG002|Overall Study|No actionable mutation|0|||
42359266|NCT01827384|76204848|FG003|Overall Study|No actionable mutation|0|||
42359267|NCT01827384|76204849|FG004|Overall Study|No actionable mutation|0|||
42359268|NCT01827384|76204850|FG005|Overall Study|No actionable mutation|0|||
42359269|NCT01827384|76204851|FG006|Overall Study|No actionable mutation|0|||
42359270|NCT01827384|76204852|FG007|Overall Study|No actionable mutation|0|||
42359271|NCT01827384|76204853|FG008|Overall Study|No actionable mutation|0|||
42359272|NCT01827384|76204854|FG009|Overall Study|No actionable mutation|0|||
42018393|NCT00996892|75825875|FG014|Expansion Stage 2|Adverse Event|0|||
42018394|NCT00996892|75825876|FG015|Expansion Stage 2|Adverse Event|0|||
42097674|NCT00401245|75908232|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
42097675|NCT00401245|75908225|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
42097676|NCT00401245|75908226|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
42097677|NCT00401245|75908227|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
42297563|NCT02581345|76132559|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
42297564|NCT02581345|76132560|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
42297565|NCT02581345|76132561|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
42297566|NCT02581345|76132558|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
42097678|NCT00401245|75908228|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
42097679|NCT00401245|75908229|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
42097680|NCT00401245|75908230|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
42097681|NCT00401245|75908231|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
42097682|NCT00401245|75908232|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
42192134|NCT03292406|76002556|FG001|Overall Study|Withdrawal by Subject|7|||
42192135|NCT03292406|76002557|FG002|Overall Study|Withdrawal by Subject|2|||
42192136|NCT03292406|76002555|FG000|Overall Study|Protocol Violation|0|||
42192137|NCT03292406|76002556|FG001|Overall Study|Protocol Violation|1|||
42192138|NCT03292406|76002557|FG002|Overall Study|Protocol Violation|1|||
42192139|NCT03292406|76002555|FG000|Overall Study|Other|0|||
42192140|NCT03292406|76002556|FG001|Overall Study|Other|1|||
42192141|NCT03292406|76002557|FG002|Overall Study|Other|2|||
42297567|NCT02581345|76132559|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
42297568|NCT02581345|76132560|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
42297569|NCT02581345|76132561|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
42297570|NCT02581345|76132558|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
42297571|NCT02581345|76132559|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
42297572|NCT02581345|76132560|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
42297573|NCT02581345|76132561|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
42297574|NCT02581345|76132558|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
42018395|NCT00996892|75825877|FG016|Expansion Stage 2|Adverse Event|0|||
42018396|NCT00996892|75825878|FG017|Expansion Stage 2|Adverse Event|0|||
42018397|NCT00996892|75825879|FG018|Expansion Stage 2|Adverse Event|3|||
42018398|NCT00996892|75825880|FG019|Expansion Stage 2|Adverse Event|0|||
42018399|NCT00996892|75825861|FG000|Expansion Stage 2|Death|0|||
42018400|NCT00996892|75825862|FG001|Expansion Stage 2|Death|0|||
42018401|NCT00996892|75825863|FG002|Expansion Stage 2|Death|0|||
42018402|NCT00996892|75825864|FG003|Expansion Stage 2|Death|0|||
42192142|NCT03292016|76002594|FG000|Second Washout|Adverse Event|0|||
42297575|NCT02581345|76132559|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
42359273|NCT01827384|76204855|FG010|Overall Study|No actionable mutation|0|||
42359274|NCT01827384|76204856|FG011|Overall Study|No actionable mutation|0|||
42359275|NCT01827384|76204857|FG012|Overall Study|No actionable mutation|0|||
42359276|NCT01827384|76204858|FG013|Overall Study|No actionable mutation|73|||
42097683|NCT00401245|75908225|FG000|Open Label Phase|Adverse Event|5|||
42192143|NCT03292016|76002595|FG001|Second Washout|Adverse Event|1|||
42192144|NCT03292016|76002596|FG002|Second Washout|Adverse Event|0|||
42192145|NCT03292016|76002597|FG003|Second Washout|Adverse Event|0|||
42192146|NCT03292016|76002598|FG004|Second Washout|Adverse Event|0|||
42097684|NCT00401245|75908226|FG001|Open Label Phase|Adverse Event|14|||
42097685|NCT00401245|75908227|FG002|Open Label Phase|Adverse Event|6|||
42097686|NCT00401245|75908228|FG003|Open Label Phase|Adverse Event|7|||
42192147|NCT03292016|76002599|FG005|Second Washout|Adverse Event|0|||
42192148|NCT03290300|76002607|FG000|Overall Study|Lost to Follow-up|3|||
42192149|NCT03289676|76002620|FG000|Overall Study|Withdrawal by Subject|2|||
42192150|NCT03289676|76002621|FG001|Overall Study|Withdrawal by Subject|0|||
42192151|NCT03289676|76002620|FG000|Overall Study|Protocol Violation|2|||
42192152|NCT03289676|76002621|FG001|Overall Study|Protocol Violation|0|||
42192153|NCT03289676|76002620|FG000|Overall Study|Lost to Follow-up|0|||
42192154|NCT03289676|76002621|FG001|Overall Study|Lost to Follow-up|1|||
42192155|NCT03287804|76002637|FG000|Overall Study|Death|1|||
42192156|NCT03287804|76002637|FG000|Overall Study|Physician Decision|2|||
42192157|NCT03287804|76002637|FG000|Overall Study|Progressive disease|8|||
42192158|NCT03286400|76002642|FG000|Overall Study|Death|10|||
42192159|NCT03286400|76002642|FG000|Overall Study|Lost to Follow-up|10|||
42192160|NCT03286400|76002642|FG000|Overall Study|Physician Decision|1|||
42192161|NCT03286400|76002642|FG000|Overall Study|Scheduling difficulty|4|||
42192162|NCT03310970|76002646|FG000|Overall Study|Withdrawal by Subject|0|||
42192163|NCT03310970|76002647|FG001|Overall Study|Withdrawal by Subject|1|||
42192164|NCT03285308|76002656|FG000|Overall Study|Adverse Event|3|||
42192165|NCT03285308|76002657|FG001|Overall Study|Adverse Event|7|||
42192166|NCT03285308|76002656|FG000|Overall Study|Withdrawal by Subject|8|||
42192167|NCT03285308|76002657|FG001|Overall Study|Withdrawal by Subject|9|||
42192168|NCT03285308|76002656|FG000|Overall Study|Lost to Follow-up|3|||
42192169|NCT03285308|76002657|FG001|Overall Study|Lost to Follow-up|1|||
42192170|NCT03285308|76002656|FG000|Overall Study|Protocol Deviation|6|||
42192171|NCT03285308|76002657|FG001|Overall Study|Protocol Deviation|5|||
42192172|NCT03285308|76002656|FG000|Overall Study|Reason not Specified|0|||
42192173|NCT03285308|76002657|FG001|Overall Study|Reason not Specified|1|||
42192174|NCT03723915|76002673|FG000|Screening|Failed to meet screening requirements.|2|||
42192175|NCT03723915|76002673|FG000|On Treatment|Failed to meet treatment requirements|2|||
42192176|NCT03281876|76002679|FG000|Overall Study|Adverse Event|4|||
42192177|NCT03281876|76002680|FG001|Overall Study|Adverse Event|15|||
42192178|NCT03281876|76002679|FG000|Overall Study|Lost to Follow-up|1|||
42097687|NCT00401245|75908229|FG004|Open Label Phase|Adverse Event|0|||
42097688|NCT00401245|75908230|FG005|Open Label Phase|Adverse Event|0|||
42097689|NCT00401245|75908231|FG006|Open Label Phase|Adverse Event|0|||
42097690|NCT00401245|75908232|FG007|Open Label Phase|Adverse Event|0|||
42097691|NCT00401245|75908225|FG000|Open Label Phase|Lost to Follow-up|5|||
42097692|NCT00401245|75908226|FG001|Open Label Phase|Lost to Follow-up|7|||
42097693|NCT00401245|75908227|FG002|Open Label Phase|Lost to Follow-up|5|||
42097694|NCT00401245|75908228|FG003|Open Label Phase|Lost to Follow-up|4|||
42097695|NCT00401245|75908229|FG004|Open Label Phase|Lost to Follow-up|0|||
42097696|NCT00401245|75908230|FG005|Open Label Phase|Lost to Follow-up|0|||
42097697|NCT00401245|75908231|FG006|Open Label Phase|Lost to Follow-up|0|||
42097698|NCT00401245|75908232|FG007|Open Label Phase|Lost to Follow-up|0|||
42097699|NCT00401245|75908225|FG000|Open Label Phase|Other|4|||
42097700|NCT00401245|75908226|FG001|Open Label Phase|Other|8|||
42097701|NCT00401245|75908227|FG002|Open Label Phase|Other|7|||
42097702|NCT00401245|75908228|FG003|Open Label Phase|Other|8|||
42097703|NCT00401245|75908229|FG004|Open Label Phase|Other|0|||
42097704|NCT00401245|75908230|FG005|Open Label Phase|Other|0|||
42097705|NCT00401245|75908231|FG006|Open Label Phase|Other|0|||
42097706|NCT00401245|75908232|FG007|Open Label Phase|Other|0|||
42097707|NCT00401245|75908225|FG000|Open Label Phase|Protocol Violation|0|||
42097708|NCT00401245|75908226|FG001|Open Label Phase|Protocol Violation|1|||
42297576|NCT02581345|76132560|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
42192179|NCT03281876|76002680|FG001|Overall Study|Lost to Follow-up|4|||
42297577|NCT02581345|76132561|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
42097709|NCT00401245|75908227|FG002|Open Label Phase|Protocol Violation|0|||
42192180|NCT03281876|76002679|FG000|Overall Study|Withdrawal by Subject|11|||
42192181|NCT03281876|76002680|FG001|Overall Study|Withdrawal by Subject|15|||
42192182|NCT03281876|76002679|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
42192183|NCT03281876|76002680|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42192184|NCT03281876|76002679|FG000|Overall Study|OTHER|5|||
42192185|NCT03281876|76002680|FG001|Overall Study|OTHER|5|||
42192186|NCT03310580|76002689|FG000|Overall Study|Adverse Event|0|||
42097710|NCT00401245|75908228|FG003|Open Label Phase|Protocol Violation|1|||
42097711|NCT00401245|75908229|FG004|Open Label Phase|Protocol Violation|0|||
42097712|NCT00401245|75908230|FG005|Open Label Phase|Protocol Violation|0|||
42097713|NCT00401245|75908231|FG006|Open Label Phase|Protocol Violation|0|||
42297578|NCT02581345|76132558|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
42297579|NCT02581345|76132559|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
42192187|NCT03310580|76002690|FG001|Overall Study|Adverse Event|1|||
42192188|NCT03310580|76002691|FG002|Overall Study|Adverse Event|0|||
42192189|NCT03415022|76002714|FG000|Overall Study|Withdrawal by Subject|1|||
42192190|NCT03415022|76002715|FG001|Overall Study|Withdrawal by Subject|2|||
42192191|NCT03415022|76002714|FG000|Overall Study|COVID-19 Suspension|2|||
42192192|NCT03415022|76002715|FG001|Overall Study|COVID-19 Suspension|3|||
42192193|NCT03415022|76002714|FG000|Overall Study|Lost to Follow-up|2|||
42192194|NCT03415022|76002715|FG001|Overall Study|Lost to Follow-up|0|||
42192195|NCT02816398|76002721|FG000|Overall Study|Death|5|||
42192196|NCT02816398|76002721|FG000|Overall Study|Lack of Efficacy|8|||
42192197|NCT02816398|76002721|FG000|Overall Study|Lost to Follow-up|1|||
42192198|NCT02812186|76002727|FG000|Period 1|Post randomization screen failure|5|||
42192199|NCT02812186|76002728|FG001|Period 1|Post randomization screen failure|9|||
42192200|NCT02812186|76002727|FG000|Period 1|nonevaluable data sets|6|||
42192201|NCT02812186|76002728|FG001|Period 1|nonevaluable data sets|6|||
42192202|NCT02811640|76002737|FG000|Overall Study|Technology malfunction|2|||
42192203|NCT03310268|76002744|FG000|Overall Study|(Not specified)|1|||
42192204|NCT03310268|76002745|FG001|Overall Study|(Not specified)|5|||
42192205|NCT03310268|76002746|FG002|Overall Study|(Not specified)|0|||
42192206|NCT02810392|76002756|FG000|Overall Study|Subject too ill to continue|1|||
42192207|NCT02810392|76002757|FG001|Overall Study|Subject too ill to continue|0|||
42192208|NCT02810392|76002756|FG000|Overall Study|COVID 19 research restrictions|0|||
42192209|NCT02810392|76002757|FG001|Overall Study|COVID 19 research restrictions|1|||
42192210|NCT02815540|76002763|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
42192211|NCT03280550|76002769|FG000|Overall Study|Withdrawal by Subject|2|||
42192212|NCT03280550|76002770|FG001|Overall Study|Withdrawal by Subject|2|||
42192213|NCT03280550|76002769|FG000|Overall Study|Physician Decision|0|||
42192214|NCT03280550|76002770|FG001|Overall Study|Physician Decision|1|||
42192215|NCT03276026|76002778|FG000|Overall Study|Protocol Violation|1|||
42192216|NCT03276026|76002779|FG001|Overall Study|Protocol Violation|0|||
42192217|NCT01589523|76002785|FG000|Overall Study|Withdrawal by Subject|1|||
42192218|NCT03277352|76002791|FG000|Overall Study|Study Terminated By Sponsor|2|||
42192219|NCT03277352|76002791|FG000|Overall Study|Withdrawal by Subject|4|||
42192220|NCT03277352|76002791|FG000|Overall Study|Death|4|||
42192221|NCT03276728|76002804|FG000|Overall Study|Lost to Follow-up|0|||
42192222|NCT03276728|76002805|FG001|Overall Study|Lost to Follow-up|0|||
42192223|NCT03276728|76002806|FG002|Overall Study|Lost to Follow-up|2|||
42192224|NCT03276728|76002807|FG003|Overall Study|Lost to Follow-up|2|||
42192225|NCT03276728|76002808|FG004|Overall Study|Lost to Follow-up|0|||
42192226|NCT03276728|76002809|FG005|Overall Study|Lost to Follow-up|0|||
42192227|NCT03276728|76002810|FG006|Overall Study|Lost to Follow-up|0|||
42192228|NCT03276728|76002811|FG007|Overall Study|Lost to Follow-up|0|||
42192229|NCT03276728|76002804|FG000|Overall Study|Withdrawal by Subject|0|||
42192230|NCT03276728|76002805|FG001|Overall Study|Withdrawal by Subject|0|||
42192231|NCT03276728|76002806|FG002|Overall Study|Withdrawal by Subject|0|||
42192232|NCT03276728|76002807|FG003|Overall Study|Withdrawal by Subject|3|||
42192233|NCT03276728|76002808|FG004|Overall Study|Withdrawal by Subject|0|||
42192234|NCT03276728|76002809|FG005|Overall Study|Withdrawal by Subject|0|||
42192235|NCT03276728|76002810|FG006|Overall Study|Withdrawal by Subject|0|||
42192236|NCT03276728|76002811|FG007|Overall Study|Withdrawal by Subject|0|||
42192237|NCT03276728|76002804|FG000|Overall Study|Decision by sponsor|0|||
42192238|NCT03276728|76002805|FG001|Overall Study|Decision by sponsor|0|||
42192239|NCT03276728|76002806|FG002|Overall Study|Decision by sponsor|0|||
42192240|NCT03276728|76002807|FG003|Overall Study|Decision by sponsor|0|||
42192241|NCT03276728|76002808|FG004|Overall Study|Decision by sponsor|1|||
42192242|NCT03276728|76002809|FG005|Overall Study|Decision by sponsor|0|||
42192243|NCT03276728|76002810|FG006|Overall Study|Decision by sponsor|2|||
42192244|NCT03276728|76002811|FG007|Overall Study|Decision by sponsor|1|||
42192245|NCT03275246|76002831|FG000|Overall Study|Protocol Violation|5|||
42359277|NCT01827384|76204845|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
42359278|NCT01827384|76204846|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
42359279|NCT01827384|76204847|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
42192246|NCT03275246|76002831|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
42192247|NCT02940860|76002837|FG000|Overall Study|Non-serious AE|1|||
42192248|NCT02940860|76002838|FG001|Overall Study|Non-serious AE|2|||
42192249|NCT02940860|76002837|FG000|Overall Study|Serious AE|7|||
42192250|NCT02940860|76002838|FG001|Overall Study|Serious AE|3|||
42192251|NCT02940860|76002837|FG000|Overall Study|Withdrawal by Subject|19|||
42192252|NCT02940860|76002838|FG001|Overall Study|Withdrawal by Subject|9|||
42192253|NCT02940860|76002837|FG000|Overall Study|Lost to Follow-up|13|||
42192254|NCT02940860|76002838|FG001|Overall Study|Lost to Follow-up|7|||
42192255|NCT02940860|76002837|FG000|Overall Study|Physician Decision|5|||
42192256|NCT02940860|76002838|FG001|Overall Study|Physician Decision|3|||
42192257|NCT02940860|76002837|FG000|Overall Study|Sponsor Decision|0|||
42192258|NCT02940860|76002838|FG001|Overall Study|Sponsor Decision|1|||
42192259|NCT02940860|76002837|FG000|Overall Study|Protocol Violation|0|||
42192260|NCT02940860|76002838|FG001|Overall Study|Protocol Violation|2|||
42192261|NCT02940860|76002837|FG000|Overall Study|Death|3|||
42192262|NCT02940860|76002838|FG001|Overall Study|Death|2|||
42192263|NCT02940860|76002837|FG000|Overall Study|Moved, poor venous access, transport|6|||
42192264|NCT02940860|76002838|FG001|Overall Study|Moved, poor venous access, transport|4|||
42192265|NCT02940860|76002837|FG000|Overall Study|Not treated|2|||
42192266|NCT02940860|76002838|FG001|Overall Study|Not treated|2|||
42192267|NCT03309020|76002848|FG000|Overall Study|Death|1|||
42192268|NCT03309020|76002849|FG001|Overall Study|Death|0|||
42192269|NCT03309020|76002848|FG000|Overall Study|Did not undergo surgery|2|||
42192270|NCT03309020|76002849|FG001|Overall Study|Did not undergo surgery|1|||
42192271|NCT02806960|76002857|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
42192272|NCT02806960|76002858|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
42192273|NCT02806960|76002859|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
42192274|NCT02806960|76002860|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
42192275|NCT03718143|76002870|FG000|Overall Study|Death|1|||
42192276|NCT03718143|76002871|FG001|Overall Study|Death|0|||
42192277|NCT03718143|76002872|FG002|Overall Study|Death|0|||
42192278|NCT03718143|76002870|FG000|Overall Study|Progression of Disease|1|||
42192279|NCT03718143|76002871|FG001|Overall Study|Progression of Disease|0|||
42192280|NCT03718143|76002872|FG002|Overall Study|Progression of Disease|0|||
42192281|NCT03718143|76002870|FG000|Overall Study|Withdrawal of Informed Consent|1|||
42192282|NCT03718143|76002871|FG001|Overall Study|Withdrawal of Informed Consent|2|||
42192283|NCT03718143|76002872|FG002|Overall Study|Withdrawal of Informed Consent|1|||
42192284|NCT03274466|76002882|FG000|Overall Study|Withdrawal by Subject|7|||
42192285|NCT03274466|76002883|FG001|Overall Study|Withdrawal by Subject|3|||
42192286|NCT03274466|76002882|FG000|Overall Study|Protocol Specified Withdrawal|5|||
42192287|NCT03274466|76002883|FG001|Overall Study|Protocol Specified Withdrawal|11|||
42192288|NCT03274466|76002882|FG000|Overall Study|Lost to Follow-up|5|||
42192289|NCT03274466|76002883|FG001|Overall Study|Lost to Follow-up|7|||
42192290|NCT03274466|76002882|FG000|Overall Study|Subject Non-compliance|0|||
42192291|NCT03274466|76002883|FG001|Overall Study|Subject Non-compliance|1|||
42192292|NCT03274466|76002882|FG000|Overall Study|Adverse Event|3|||
42192293|NCT03274466|76002883|FG001|Overall Study|Adverse Event|3|||
42192294|NCT03274466|76002882|FG000|Overall Study|Physician Decision|0|||
42192295|NCT03274466|76002883|FG001|Overall Study|Physician Decision|1|||
42192296|NCT03274466|76002882|FG000|Overall Study|Protocol Violation|3|||
42192297|NCT03274466|76002883|FG001|Overall Study|Protocol Violation|3|||
42192298|NCT02806726|76002889|FG000|Overall Study|Lost to Follow-up|1|||
42192299|NCT02806414|76002894|FG000|Overall Study|Lost to Follow-up|2|||
42192300|NCT02806024|76002900|FG000|Overall Study|Night Delivery|1|||
42192301|NCT02806024|76002901|FG001|Overall Study|Night Delivery|1|||
42192302|NCT02806024|76002900|FG000|Overall Study|DVT during antepartum admission|0|||
42097714|NCT00401245|75908232|FG007|Open Label Phase|Protocol Violation|0|||
42097715|NCT00401245|75908225|FG000|Open Label Phase|Withdrawal by Subject|3|||
42097716|NCT00401245|75908226|FG001|Open Label Phase|Withdrawal by Subject|3|||
42097717|NCT00401245|75908227|FG002|Open Label Phase|Withdrawal by Subject|2|||
42192303|NCT02806024|76002901|FG001|Overall Study|DVT during antepartum admission|1|||
42192304|NCT02805790|76002909|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
42192305|NCT02805790|76002910|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
42192306|NCT02802592|76002916|FG000|Overall Study|Study terminated due to loss of funding|4|||
42192307|NCT02803138|76002921|FG000|Overall Study|Failure to return|38|||
42192308|NCT02803138|76002921|FG000|Overall Study|Insufficient virological response|2|||
42192309|NCT02803138|76002921|FG000|Overall Study|Withdrawn consent|1|||
42297580|NCT02581345|76132560|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
42297581|NCT02581345|76132561|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
42097718|NCT00401245|75908228|FG003|Open Label Phase|Withdrawal by Subject|1|||
42097719|NCT00401245|75908229|FG004|Open Label Phase|Withdrawal by Subject|0|||
42097720|NCT00401245|75908230|FG005|Open Label Phase|Withdrawal by Subject|0|||
42097721|NCT00401245|75908231|FG006|Open Label Phase|Withdrawal by Subject|0|||
42097722|NCT00401245|75908232|FG007|Open Label Phase|Withdrawal by Subject|0|||
42192310|NCT02803138|76002921|FG000|Overall Study|Death|1|||
42297582|NCT02581345|76132558|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
42297583|NCT02581345|76132559|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
42297584|NCT02581345|76132560|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
42192311|NCT02803138|76002921|FG000|Overall Study|Other, not specified|28|||
42192312|NCT02801578|76002927|FG000|Overall Study|Adverse Event|2|||
42192313|NCT02799472|76002933|FG000|Overall Study|Withdrawal by Subject|2|||
42192314|NCT02799472|76002934|FG001|Overall Study|Withdrawal by Subject|4|||
42192315|NCT02799472|76002933|FG000|Overall Study|Lack of Efficacy|2|||
42192316|NCT02799472|76002934|FG001|Overall Study|Lack of Efficacy|0|||
42097723|NCT00401245|75908225|FG000|Open Label Phase|Lack of Efficacy|4|||
42192317|NCT02799472|76002933|FG000|Overall Study|Lost to Follow-up|0|||
42192318|NCT02799472|76002934|FG001|Overall Study|Lost to Follow-up|1|||
42192319|NCT03245450|76002947|FG000|Overall Study|Radiological disease progression|3|||
42297585|NCT02581345|76132561|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
42192320|NCT03245450|76002948|FG001|Overall Study|Radiological disease progression|3|||
42192321|NCT03245450|76002949|FG002|Overall Study|Radiological disease progression|2|||
42192322|NCT03245450|76002950|FG003|Overall Study|Radiological disease progression|2|||
42192323|NCT03245450|76002951|FG004|Overall Study|Radiological disease progression|7|||
42297586|NCT02581345|76132558|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
42297587|NCT02581345|76132559|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
42297588|NCT02581345|76132560|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
42297589|NCT02581345|76132561|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
42297590|NCT02581345|76132558|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
42297591|NCT02581345|76132559|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
42297592|NCT02581345|76132560|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
42297593|NCT02581345|76132561|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
42297594|NCT02581345|76132558|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
42297595|NCT02581345|76132559|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
42297596|NCT02581345|76132560|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
42297597|NCT02581345|76132561|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
42297598|NCT02581345|76132558|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
42297599|NCT02581345|76132559|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
42297600|NCT02581345|76132560|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
42297601|NCT02581345|76132561|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
42297602|NCT02581189|76132579|FG000|Overall Study|Failure to return|36|||
42297603|NCT02581189|76132579|FG000|Overall Study|Withdrew consent|5|||
42297604|NCT02581189|76132579|FG000|Overall Study|Death|3|||
42297605|NCT02581189|76132579|FG000|Overall Study|Insufficient virological response|2|||
42297606|NCT02581189|76132579|FG000|Overall Study|Other, not specified|7|||
42297607|NCT02576977|76132588|FG000|Overall Study|Adverse Event|13|||
42297608|NCT02576977|76132589|FG001|Overall Study|Adverse Event|2|||
42297609|NCT02576977|76132588|FG000|Overall Study|Death|73|||
42297610|NCT02576977|76132589|FG001|Overall Study|Death|60|||
42297611|NCT02576977|76132588|FG000|Overall Study|Screen failure|1|||
42297612|NCT02576977|76132589|FG001|Overall Study|Screen failure|0|||
42297613|NCT02576977|76132588|FG000|Overall Study|Study Terminated at Selected Sites|27|||
42297614|NCT02576977|76132589|FG001|Overall Study|Study Terminated at Selected Sites|50|||
42297615|NCT02576977|76132588|FG000|Overall Study|Withdrawal by Subject|11|||
42297616|NCT02576977|76132589|FG001|Overall Study|Withdrawal by Subject|11|||
42297617|NCT02576977|76132588|FG000|Overall Study|Final Disposition Unknown|0|||
42297618|NCT02576977|76132589|FG001|Overall Study|Final Disposition Unknown|1|||
42297619|NCT02576977|76132588|FG000|Overall Study|Lost to Follow-up|1|||
42097724|NCT00401245|75908226|FG001|Open Label Phase|Lack of Efficacy|2|||
42097725|NCT00401245|75908227|FG002|Open Label Phase|Lack of Efficacy|3|||
42097726|NCT00401245|75908228|FG003|Open Label Phase|Lack of Efficacy|0|||
42097727|NCT00401245|75908229|FG004|Open Label Phase|Lack of Efficacy|0|||
42097728|NCT00401245|75908230|FG005|Open Label Phase|Lack of Efficacy|0|||
42097729|NCT00401245|75908231|FG006|Open Label Phase|Lack of Efficacy|0|||
42097730|NCT00401245|75908232|FG007|Open Label Phase|Lack of Efficacy|0|||
42097731|NCT00401245|75908225|FG000|Double Blind Tapering Phase|Adverse Event|0|||
42097732|NCT00401245|75908226|FG001|Double Blind Tapering Phase|Adverse Event|0|||
42097733|NCT00401245|75908227|FG002|Double Blind Tapering Phase|Adverse Event|0|||
42097734|NCT00401245|75908228|FG003|Double Blind Tapering Phase|Adverse Event|0|||
42097735|NCT00401245|75908229|FG004|Double Blind Tapering Phase|Adverse Event|1|||
42097736|NCT00401245|75908230|FG005|Double Blind Tapering Phase|Adverse Event|1|||
42097737|NCT00401245|75908231|FG006|Double Blind Tapering Phase|Adverse Event|2|||
42097738|NCT00401245|75908232|FG007|Double Blind Tapering Phase|Adverse Event|4|||
42097739|NCT00401245|75908225|FG000|Double Blind Tapering Phase|Investigator request|0|||
42359280|NCT01827384|76204848|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
42359281|NCT01827384|76204849|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
42359282|NCT01827384|76204850|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
42097740|NCT00401245|75908226|FG001|Double Blind Tapering Phase|Investigator request|0|||
42097741|NCT00401245|75908227|FG002|Double Blind Tapering Phase|Investigator request|0|||
42097742|NCT00401245|75908228|FG003|Double Blind Tapering Phase|Investigator request|0|||
42097743|NCT00401245|75908229|FG004|Double Blind Tapering Phase|Investigator request|0|||
42192324|NCT03245450|76002952|FG005|Overall Study|Radiological disease progression|6|||
42297620|NCT02576977|76132589|FG001|Overall Study|Lost to Follow-up|0|||
42297621|NCT02576977|76132588|FG000|Overall Study|Progressive Disease|0|||
42297622|NCT02576977|76132589|FG001|Overall Study|Progressive Disease|1|||
42297623|NCT05150964|76132595|FG000|Overall Study|Lost to Follow-up|2|||
42297624|NCT04952402|76132603|FG000|Overall Study|Lost to Follow-up|1|||
42297625|NCT04952402|76132604|FG001|Overall Study|Lost to Follow-up|3|||
42297626|NCT04952402|76132603|FG000|Overall Study|Lack Of Venous Access|0|||
42297627|NCT04952402|76132604|FG001|Overall Study|Lack Of Venous Access|1|||
42192325|NCT03245450|76002953|FG006|Overall Study|Radiological disease progression|6|||
42192326|NCT03245450|76002947|FG000|Overall Study|Clinical disease progression|0|||
42192327|NCT03245450|76002948|FG001|Overall Study|Clinical disease progression|0|||
42192328|NCT03245450|76002949|FG002|Overall Study|Clinical disease progression|1|||
42192329|NCT03245450|76002950|FG003|Overall Study|Clinical disease progression|0|||
42192330|NCT03245450|76002951|FG004|Overall Study|Clinical disease progression|0|||
42192331|NCT03245450|76002952|FG005|Overall Study|Clinical disease progression|2|||
42192332|NCT03245450|76002953|FG006|Overall Study|Clinical disease progression|0|||
42192333|NCT03245450|76002947|FG000|Overall Study|Other|0|||
42192334|NCT03245450|76002948|FG001|Overall Study|Other|0|||
42192335|NCT03245450|76002949|FG002|Overall Study|Other|0|||
42192336|NCT03245450|76002950|FG003|Overall Study|Other|1|||
42192337|NCT03245450|76002951|FG004|Overall Study|Other|1|||
42192338|NCT03245450|76002952|FG005|Overall Study|Other|1|||
42192339|NCT03245450|76002953|FG006|Overall Study|Other|1|||
42192340|NCT03245450|76002947|FG000|Overall Study|Withdrawal by Subject|0|||
42097744|NCT00401245|75908230|FG005|Double Blind Tapering Phase|Investigator request|0|||
42097745|NCT00401245|75908231|FG006|Double Blind Tapering Phase|Investigator request|0|||
42097746|NCT00401245|75908232|FG007|Double Blind Tapering Phase|Investigator request|1|||
42097747|NCT00401245|75908225|FG000|Double Blind Tapering Phase|Other|0|||
42097748|NCT00401245|75908226|FG001|Double Blind Tapering Phase|Other|0|||
42192341|NCT03245450|76002948|FG001|Overall Study|Withdrawal by Subject|1|||
42192342|NCT03245450|76002949|FG002|Overall Study|Withdrawal by Subject|0|||
42192343|NCT03245450|76002950|FG003|Overall Study|Withdrawal by Subject|0|||
42097749|NCT00401245|75908227|FG002|Double Blind Tapering Phase|Other|0|||
42097750|NCT00401245|75908228|FG003|Double Blind Tapering Phase|Other|0|||
42097751|NCT00401245|75908229|FG004|Double Blind Tapering Phase|Other|1|||
42097752|NCT00401245|75908230|FG005|Double Blind Tapering Phase|Other|0|||
42097753|NCT00401245|75908231|FG006|Double Blind Tapering Phase|Other|2|||
42097754|NCT00401245|75908232|FG007|Double Blind Tapering Phase|Other|2|||
42097755|NCT00401245|75908225|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
42097756|NCT00401245|75908226|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
42097757|NCT00401245|75908227|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
42097758|NCT00401245|75908228|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
42097759|NCT00401245|75908229|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
42097760|NCT00401245|75908230|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
42097761|NCT00401245|75908231|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
42097762|NCT00401245|75908232|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
42097763|NCT00401245|75908225|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
42192344|NCT03245450|76002951|FG004|Overall Study|Withdrawal by Subject|0|||
42192345|NCT03245450|76002952|FG005|Overall Study|Withdrawal by Subject|0|||
42192346|NCT03245450|76002953|FG006|Overall Study|Withdrawal by Subject|0|||
42192347|NCT03245450|76002947|FG000|Overall Study|Adverse Event|0|||
42192348|NCT03245450|76002948|FG001|Overall Study|Adverse Event|0|||
42192349|NCT03245450|76002949|FG002|Overall Study|Adverse Event|0|||
42097764|NCT00401245|75908226|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
42097765|NCT00401245|75908227|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
42192350|NCT03245450|76002950|FG003|Overall Study|Adverse Event|0|||
42192351|NCT03245450|76002951|FG004|Overall Study|Adverse Event|1|||
42192352|NCT03245450|76002952|FG005|Overall Study|Adverse Event|0|||
42192353|NCT03245450|76002953|FG006|Overall Study|Adverse Event|2|||
42192354|NCT03712917|76002978|FG000|Overall Study|Pregnancy|0|||
42192355|NCT03712917|76002979|FG001|Overall Study|Pregnancy|0|||
42192356|NCT03712917|76002980|FG002|Overall Study|Pregnancy|1|||
42192357|NCT03712917|76002978|FG000|Overall Study|Adverse Event|0|||
42192358|NCT03712917|76002979|FG001|Overall Study|Adverse Event|4|||
42192359|NCT03712917|76002980|FG002|Overall Study|Adverse Event|3|||
42192360|NCT03712917|76002978|FG000|Overall Study|Lost to Follow-up|9|||
42097766|NCT00401245|75908228|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
42192361|NCT03712917|76002979|FG001|Overall Study|Lost to Follow-up|4|||
42097767|NCT00401245|75908229|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
42097768|NCT00401245|75908230|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
42192362|NCT03712917|76002980|FG002|Overall Study|Lost to Follow-up|5|||
42192363|NCT02748694|76003003|FG000|Overall Study|Voluntary Withdrawal|0|||
42192364|NCT02748694|76003004|FG001|Overall Study|Voluntary Withdrawal|0|||
42192365|NCT02748694|76003005|FG002|Overall Study|Voluntary Withdrawal|0|||
42192366|NCT02748694|76003006|FG003|Overall Study|Voluntary Withdrawal|0|||
42192367|NCT02748694|76003007|FG004|Overall Study|Voluntary Withdrawal|0|||
42192368|NCT02748694|76003008|FG005|Overall Study|Voluntary Withdrawal|0|||
42192369|NCT02748694|76003009|FG006|Overall Study|Voluntary Withdrawal|0|||
42192370|NCT02748694|76003010|FG007|Overall Study|Voluntary Withdrawal|0|||
42192371|NCT02748694|76003011|FG008|Overall Study|Voluntary Withdrawal|0|||
42192372|NCT02748694|76003012|FG009|Overall Study|Voluntary Withdrawal|0|||
42192373|NCT02748694|76003013|FG010|Overall Study|Voluntary Withdrawal|0|||
42097769|NCT00401245|75908231|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
42097770|NCT00401245|75908232|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
42097771|NCT00696384|75908252|FG000|Open Label Phase|Adverse Event|27|||
42297628|NCT04378010|76132643|FG000|Overall Study|Adverse Event|8|||
42297629|NCT04378010|76132644|FG001|Overall Study|Adverse Event|14|||
42297630|NCT04378010|76132645|FG002|Overall Study|Adverse Event|4|||
42297631|NCT04378010|76132643|FG000|Overall Study|Withdrawal by Subject|0|||
42297632|NCT04378010|76132644|FG001|Overall Study|Withdrawal by Subject|2|||
42297633|NCT04378010|76132645|FG002|Overall Study|Withdrawal by Subject|1|||
42297634|NCT04378010|76132643|FG000|Overall Study|Protocol Violation|2|||
42297635|NCT04378010|76132644|FG001|Overall Study|Protocol Violation|1|||
42297636|NCT04378010|76132645|FG002|Overall Study|Protocol Violation|4|||
42297637|NCT04378010|76132643|FG000|Overall Study|Study terminated by Sponsor|22|||
42297638|NCT04378010|76132644|FG001|Overall Study|Study terminated by Sponsor|16|||
42297639|NCT04378010|76132645|FG002|Overall Study|Study terminated by Sponsor|22|||
42297640|NCT04378010|76132643|FG000|Overall Study|Subject inability to complete study visit|0|||
42297641|NCT04378010|76132644|FG001|Overall Study|Subject inability to complete study visit|0|||
42297642|NCT04378010|76132645|FG002|Overall Study|Subject inability to complete study visit|1|||
42297643|NCT04378010|76132643|FG000|Overall Study|Subject never dosed|0|||
42297644|NCT04378010|76132644|FG001|Overall Study|Subject never dosed|1|||
42297645|NCT04378010|76132645|FG002|Overall Study|Subject never dosed|0|||
42297646|NCT04349072|76132656|FG000|Randomization Period|Found ineligible post enrollment|0|||
42097772|NCT00696384|75908253|FG001|Open Label Phase|Adverse Event|0|||
42097773|NCT00696384|75908254|FG002|Open Label Phase|Adverse Event|0|||
42097774|NCT00696384|75908252|FG000|Open Label Phase|Protocol Violation|18|||
42097775|NCT00696384|75908253|FG001|Open Label Phase|Protocol Violation|0|||
42097776|NCT00696384|75908254|FG002|Open Label Phase|Protocol Violation|0|||
42097777|NCT00696384|75908252|FG000|Open Label Phase|Lost to Follow-up|24|||
42097778|NCT00696384|75908253|FG001|Open Label Phase|Lost to Follow-up|0|||
42097779|NCT00696384|75908254|FG002|Open Label Phase|Lost to Follow-up|0|||
42097780|NCT00696384|75908252|FG000|Open Label Phase|Withdrawal by Subject|37|||
42097781|NCT00696384|75908253|FG001|Open Label Phase|Withdrawal by Subject|0|||
42097782|NCT00696384|75908254|FG002|Open Label Phase|Withdrawal by Subject|0|||
42192374|NCT02748694|76003014|FG011|Overall Study|Voluntary Withdrawal|0|||
42192375|NCT02748694|76003015|FG012|Overall Study|Voluntary Withdrawal|0|||
42192376|NCT02748694|76003016|FG013|Overall Study|Voluntary Withdrawal|0|||
42192377|NCT02748694|76003017|FG014|Overall Study|Voluntary Withdrawal|2|||
42192378|NCT02800642|76003073|FG000|Overall Study|Death|3|||
42192379|NCT02800642|76003073|FG000|Overall Study|Other|10|||
42192380|NCT02800642|76003073|FG000|Overall Study|Physician Decision|2|||
42192381|NCT02800642|76003073|FG000|Overall Study|Adverse Event|6|||
42192382|NCT02800642|76003073|FG000|Overall Study|Withdrawal by Subject|3|||
42192383|NCT02800642|76003073|FG000|Overall Study|Lost to Follow-up|1|||
42192384|NCT02799784|76003077|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
42297647|NCT04349072|76132657|FG001|Randomization Period|Found ineligible post enrollment|1|||
42297648|NCT04349072|76132656|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
42297649|NCT04349072|76132657|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
42297650|NCT04349072|76132656|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
42297651|NCT04349072|76132657|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
42297652|NCT04349072|76132656|FG000|Treatment Period|Physician Decision|0|||
42297653|NCT04349072|76132657|FG001|Treatment Period|Physician Decision|1|||
42297654|NCT04349072|76132656|FG000|Treatment Period|Protocol Violation|0|||
42297655|NCT04349072|76132657|FG001|Treatment Period|Protocol Violation|1|||
42297656|NCT04349072|76132656|FG000|Treatment Period|Withdrawal by Subject|1|||
42297657|NCT04349072|76132657|FG001|Treatment Period|Withdrawal by Subject|1|||
42297658|NCT04240886|76132663|FG000|Treatment Phase|Death|4|||
42297659|NCT04240886|76132663|FG000|Treatment Phase|Discontinuation by Subject|1|||
42297660|NCT04240886|76132663|FG000|Treatment Phase|Adverse Event|5|||
42297661|NCT04240886|76132663|FG000|Follow-up Phase|Withdrawal by Subject|1|||
42297662|NCT04240886|76132663|FG000|Follow-up Phase|Discontinuation by Subject|1|||
42297663|NCT04240886|76132663|FG000|Follow-up Phase|Death|2|||
42297664|NCT04074161|76132679|FG000|Overall Study|Withdrawal by Subject|2|||
42297665|NCT04074161|76132680|FG001|Overall Study|Withdrawal by Subject|4|||
42297666|NCT04074161|76132681|FG002|Overall Study|Withdrawal by Subject|1|||
42297667|NCT04074161|76132679|FG000|Overall Study|Lost to Follow-up|4|||
42297668|NCT04074161|76132680|FG001|Overall Study|Lost to Follow-up|5|||
42297669|NCT04074161|76132681|FG002|Overall Study|Lost to Follow-up|3|||
42297670|NCT03966157|76132691|FG000|Overall Study|Physician Decision|1|||
42297671|NCT03966157|76132692|FG001|Overall Study|Physician Decision|0|||
42097783|NCT00696384|75908252|FG000|Open Label Phase|Other|6|||
42097784|NCT00696384|75908253|FG001|Open Label Phase|Other|0|||
42097785|NCT00696384|75908254|FG002|Open Label Phase|Other|0|||
42097786|NCT00696384|75908252|FG000|Open Label Phase|Lack of Efficacy|3|||
42192385|NCT02799784|76003078|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
42297672|NCT03733210|76132700|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
42097787|NCT00696384|75908253|FG001|Open Label Phase|Lack of Efficacy|0|||
42097788|NCT00696384|75908254|FG002|Open Label Phase|Lack of Efficacy|0|||
42097789|NCT00696384|75908252|FG000|Open Label Phase|Physician Decision|4|||
42097790|NCT00696384|75908253|FG001|Open Label Phase|Physician Decision|0|||
42097791|NCT00696384|75908254|FG002|Open Label Phase|Physician Decision|0|||
42097792|NCT00696384|75908252|FG000|Double Blind Phase|Adverse Event|0|||
42097793|NCT00696384|75908253|FG001|Double Blind Phase|Adverse Event|2|||
42097794|NCT00696384|75908254|FG002|Double Blind Phase|Adverse Event|2|||
42097795|NCT00696384|75908252|FG000|Double Blind Phase|Lost to Follow-up|0|||
42097796|NCT00696384|75908253|FG001|Double Blind Phase|Lost to Follow-up|2|||
42097797|NCT00696384|75908254|FG002|Double Blind Phase|Lost to Follow-up|1|||
42097798|NCT00696384|75908252|FG000|Double Blind Phase|Withdrawal by Subject|0|||
42097799|NCT00696384|75908253|FG001|Double Blind Phase|Withdrawal by Subject|4|||
42097800|NCT00696384|75908254|FG002|Double Blind Phase|Withdrawal by Subject|3|||
42097801|NCT00696384|75908252|FG000|Double Blind Phase|Lack of Efficacy|0|||
42192386|NCT02799784|76003077|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
42192387|NCT02799784|76003078|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
42192388|NCT02799784|76003077|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
42192389|NCT02799784|76003078|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
42192390|NCT02799784|76003077|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
42192391|NCT02799784|76003078|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
42192392|NCT02799784|76003077|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
42192393|NCT02799784|76003078|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
42192394|NCT02799784|76003077|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
42192395|NCT02799784|76003078|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
42192396|NCT02054806|76003084|FG000|Overall Study|Sponsor Decision|31|||
42192397|NCT02054806|76003084|FG000|Overall Study|Withdrawal by Subject|43|||
42192398|NCT02054806|76003084|FG000|Overall Study|Protocol Violation|2|||
42192399|NCT02054806|76003084|FG000|Overall Study|Lost to Follow-up|10|||
42192400|NCT02054806|76003084|FG000|Overall Study|Death|391|||
42192401|NCT01333072|76003117|FG000|Overall Study|Lost to Follow-up|3|||
42192402|NCT01333072|76003118|FG001|Overall Study|Lost to Follow-up|0|||
42192403|NCT01333072|76003117|FG000|Overall Study|Adverse Event|2|||
42192404|NCT01333072|76003118|FG001|Overall Study|Adverse Event|4|||
42097802|NCT00696384|75908253|FG001|Double Blind Phase|Lack of Efficacy|1|||
42097803|NCT00696384|75908254|FG002|Double Blind Phase|Lack of Efficacy|0|||
42097804|NCT00696384|75908252|FG000|Double Blind Phase|Physician Decision|0|||
42097805|NCT00696384|75908253|FG001|Double Blind Phase|Physician Decision|2|||
42097806|NCT00696384|75908254|FG002|Double Blind Phase|Physician Decision|0|||
42192405|NCT01333072|76003117|FG000|Overall Study|Physician Decision|1|||
42192406|NCT01333072|76003118|FG001|Overall Study|Physician Decision|0|||
42192407|NCT01315353|76003127|FG000|Overall Study|Death|2|||
42192408|NCT01315353|76003128|FG001|Overall Study|Death|1|||
42192409|NCT01315353|76003129|FG002|Overall Study|Death|0|||
42192410|NCT01315353|76003127|FG000|Overall Study|Withdrawal by Subject|2|||
42192411|NCT01315353|76003128|FG001|Overall Study|Withdrawal by Subject|6|||
42192412|NCT01315353|76003129|FG002|Overall Study|Withdrawal by Subject|1|||
42192413|NCT01315353|76003127|FG000|Overall Study|Lost to Follow-up|13|||
42192414|NCT01315353|76003128|FG001|Overall Study|Lost to Follow-up|6|||
42192415|NCT01315353|76003129|FG002|Overall Study|Lost to Follow-up|6|||
42192416|NCT01315353|76003127|FG000|Overall Study|Unwilling to adhere to requirements|5|||
42192417|NCT01315353|76003128|FG001|Overall Study|Unwilling to adhere to requirements|5|||
42192418|NCT01315353|76003129|FG002|Overall Study|Unwilling to adhere to requirements|4|||
42192419|NCT01315353|76003127|FG000|Overall Study|Site closing|7|||
42192420|NCT01315353|76003128|FG001|Overall Study|Site closing|4|||
42192421|NCT01315353|76003129|FG002|Overall Study|Site closing|0|||
42192422|NCT01315353|76003127|FG000|Overall Study|Taken off study by site in error|0|||
42192423|NCT01315353|76003128|FG001|Overall Study|Taken off study by site in error|1|||
42192424|NCT01315353|76003129|FG002|Overall Study|Taken off study by site in error|0|||
42192425|NCT01315353|76003127|FG000|Overall Study|Inadvertent randomization/assignment|0|||
42192426|NCT01315353|76003128|FG001|Overall Study|Inadvertent randomization/assignment|0|||
42192427|NCT01315353|76003129|FG002|Overall Study|Inadvertent randomization/assignment|2|||
42192428|NCT03517540|76003141|FG000|Overall Study|Protocol Violation|2|||
42192429|NCT03517540|76003142|FG001|Overall Study|Protocol Violation|0|||
42359283|NCT01827384|76204851|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
42359284|NCT01827384|76204852|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
42359285|NCT01827384|76204853|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
42097807|NCT00636675|75908265|FG000|Overall Study|Lost to Follow-up|121|||
42192430|NCT03517540|76003143|FG002|Overall Study|Protocol Violation|0|||
42097808|NCT00636675|75908266|FG001|Overall Study|Lost to Follow-up|31|||
42097809|NCT00636675|75908265|FG000|Overall Study|Withdrawal by Subject|19|||
42097810|NCT00636675|75908266|FG001|Overall Study|Withdrawal by Subject|10|||
42192431|NCT03517540|76003144|FG003|Overall Study|Protocol Violation|1|||
42192432|NCT03517540|76003141|FG000|Overall Study|Adverse Event|9|||
42192433|NCT03517540|76003142|FG001|Overall Study|Adverse Event|3|||
42192434|NCT03517540|76003143|FG002|Overall Study|Adverse Event|8|||
42192435|NCT03517540|76003144|FG003|Overall Study|Adverse Event|1|||
42192436|NCT03517540|76003141|FG000|Overall Study|Withdrawal by Subject|3|||
42192437|NCT03517540|76003142|FG001|Overall Study|Withdrawal by Subject|4|||
42192438|NCT03517540|76003143|FG002|Overall Study|Withdrawal by Subject|1|||
42192439|NCT03517540|76003144|FG003|Overall Study|Withdrawal by Subject|3|||
42192440|NCT02799082|76003156|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
42192441|NCT02799082|76003157|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
42192442|NCT02799082|76003156|FG000|Overall Study|Protocol Violation|0|||
42192443|NCT02799082|76003157|FG001|Overall Study|Protocol Violation|1|||
42192444|NCT03710889|76003163|FG000|Overall Study|Adverse Event|2|||
42192445|NCT03710889|76003163|FG000|Overall Study|Protocol Deviation|1|||
42192446|NCT02797678|76003167|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
42192447|NCT02797678|76003168|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
42192448|NCT02797678|76003169|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
42192449|NCT02797678|76003170|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
42192450|NCT02797678|76003167|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
42192451|NCT02797678|76003168|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
42192452|NCT02797678|76003169|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
42192453|NCT02797678|76003170|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
42297673|NCT03733210|76132701|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
42297674|NCT03627468|76132709|FG000|Overall Study|Adverse Event|5|||
42297675|NCT03627468|76132710|FG001|Overall Study|Adverse Event|33|||
42297676|NCT03627468|76132709|FG000|Overall Study|Withdrawal by Subject|13|||
42297677|NCT03627468|76132710|FG001|Overall Study|Withdrawal by Subject|23|||
42297678|NCT03627468|76132709|FG000|Overall Study|Physician Decision|1|||
42297679|NCT03627468|76132710|FG001|Overall Study|Physician Decision|0|||
42297680|NCT03627468|76132709|FG000|Overall Study|Protocol Violation|0|||
42297681|NCT03627468|76132710|FG001|Overall Study|Protocol Violation|2|||
42297682|NCT03627468|76132709|FG000|Overall Study|Lost to Follow-up|10|||
42297683|NCT03627468|76132710|FG001|Overall Study|Lost to Follow-up|16|||
42297684|NCT03627468|76132709|FG000|Overall Study|Death|1|||
42297685|NCT03627468|76132710|FG001|Overall Study|Death|0|||
42297686|NCT03627468|76132709|FG000|Overall Study|Pregnancy|1|||
42297687|NCT03627468|76132710|FG001|Overall Study|Pregnancy|1|||
42297688|NCT03627468|76132709|FG000|Overall Study|Lack of Efficacy|0|||
42297689|NCT03627468|76132710|FG001|Overall Study|Lack of Efficacy|2|||
42297690|NCT03627468|76132709|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
42297691|NCT03627468|76132710|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
42297692|NCT03595176|76132718|FG000|Overall Study|Death|0|||
42297693|NCT03595176|76132719|FG001|Overall Study|Death|2|||
42297694|NCT03595176|76132718|FG000|Overall Study|Lost to Follow-up|0|||
42297695|NCT03595176|76132719|FG001|Overall Study|Lost to Follow-up|1|||
42297696|NCT03052816|76132728|FG000|Overall Study|Withdrawal by Subject|1|||
42297697|NCT03052816|76132729|FG001|Overall Study|Withdrawal by Subject|0|||
42297698|NCT03052816|76132728|FG000|Overall Study|Desired opioids|2|||
42359286|NCT01827384|76204854|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
42359287|NCT01827384|76204855|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
42359288|NCT01827384|76204856|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
42359289|NCT01827384|76204857|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
42359290|NCT01827384|76204858|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
42359291|NCT01585194|76204893|FG000|Overall Study|Withdrawal by Subject|1|||
42359292|NCT01585194|76204893|FG000|Overall Study|Physician Decision|2|||
42097811|NCT00699998|75908276|FG000|Overall Study|Withdrawal by Subject|194|||
42097812|NCT00699998|75908277|FG001|Overall Study|Withdrawal by Subject|83|||
42097813|NCT00699998|75908278|FG002|Overall Study|Withdrawal by Subject|202|||
42097814|NCT00699998|75908279|FG003|Overall Study|Withdrawal by Subject|80|||
42097815|NCT00699998|75908276|FG000|Overall Study|Physician Decision|3|||
42097816|NCT00699998|75908277|FG001|Overall Study|Physician Decision|2|||
42097817|NCT00699998|75908278|FG002|Overall Study|Physician Decision|1|||
42097818|NCT00699998|75908279|FG003|Overall Study|Physician Decision|1|||
42097819|NCT00699998|75908276|FG000|Overall Study|Lost to Follow-up|2|||
42097820|NCT00699998|75908277|FG001|Overall Study|Lost to Follow-up|1|||
42097821|NCT00699998|75908278|FG002|Overall Study|Lost to Follow-up|3|||
42097822|NCT00699998|75908279|FG003|Overall Study|Lost to Follow-up|1|||
42297699|NCT03052816|76132729|FG001|Overall Study|Desired opioids|0|||
42297700|NCT02682238|76132748|FG000|Overall Study|Lost to Follow-up|0|||
42097823|NCT00696072|75908296|FG000|Overall Study|continuing active treatment|10|||
42297701|NCT02682238|76132749|FG001|Overall Study|Lost to Follow-up|2|||
42297702|NCT02682238|76132748|FG000|Overall Study|Withdrawal by Subject|1|||
42297703|NCT02682238|76132749|FG001|Overall Study|Withdrawal by Subject|0|||
42297704|NCT02682238|76132748|FG000|Overall Study|Adverse Event|1|||
42097824|NCT00696072|75908297|FG001|Overall Study|continuing active treatment|13|||
42192454|NCT02797678|76003167|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
42192455|NCT02797678|76003168|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
42192456|NCT02797678|76003169|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
42192457|NCT02797678|76003170|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
42192458|NCT03308786|76003183|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
42192459|NCT03274076|76003190|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
42192460|NCT03274076|76003191|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
42192461|NCT03274076|76003192|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
42192462|NCT03274076|76003193|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
42192463|NCT03274076|76003190|FG000|24 Weeks Open Label|Adverse Event|0|||
42192464|NCT03274076|76003191|FG001|24 Weeks Open Label|Adverse Event|0|||
42192465|NCT03274076|76003192|FG002|24 Weeks Open Label|Adverse Event|2|||
42192466|NCT03274076|76003193|FG003|24 Weeks Open Label|Adverse Event|0|||
42192467|NCT03274076|76003190|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
42192468|NCT03274076|76003191|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
42192469|NCT03274076|76003192|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
42192470|NCT03274076|76003193|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
42192471|NCT02797522|76003223|FG000|Overall Study|Study Terminated by Sponsor|0|||
42192472|NCT02797522|76003224|FG001|Overall Study|Study Terminated by Sponsor|0|||
42192473|NCT02797522|76003225|FG002|Overall Study|Study Terminated by Sponsor|0|||
42192474|NCT02797522|76003226|FG003|Overall Study|Study Terminated by Sponsor|0|||
42192475|NCT02797522|76003227|FG004|Overall Study|Study Terminated by Sponsor|0|||
42192476|NCT02797522|76003228|FG005|Overall Study|Study Terminated by Sponsor|0|||
42192477|NCT02797522|76003229|FG006|Overall Study|Study Terminated by Sponsor|0|||
42192478|NCT02797522|76003230|FG007|Overall Study|Study Terminated by Sponsor|4|||
42192479|NCT02797522|76003231|FG008|Overall Study|Study Terminated by Sponsor|2|||
42192480|NCT02797522|76003232|FG009|Overall Study|Study Terminated by Sponsor|4|||
42192481|NCT02797522|76003233|FG010|Overall Study|Study Terminated by Sponsor|1|||
42192482|NCT02659514|76003272|FG000|Overall Study|Adverse Event|3|||
42192483|NCT02659514|76003273|FG001|Overall Study|Adverse Event|12|||
42297705|NCT02682238|76132749|FG001|Overall Study|Adverse Event|0|||
42097825|NCT00696072|75908296|FG000|Overall Study|Adverse Event|10|||
42097826|NCT00696072|75908297|FG001|Overall Study|Adverse Event|6|||
42097827|NCT00696072|75908296|FG000|Overall Study|Patient Request|3|||
42097828|NCT00696072|75908297|FG001|Overall Study|Patient Request|7|||
42097829|NCT00696072|75908296|FG000|Overall Study|Investigator Request|1|||
42097830|NCT00696072|75908297|FG001|Overall Study|Investigator Request|4|||
42097831|NCT00696072|75908296|FG000|Overall Study|Sponsor Request|0|||
42097832|NCT00696072|75908297|FG001|Overall Study|Sponsor Request|1|||
42097833|NCT00696072|75908296|FG000|Overall Study|Disease Progression|32|||
42097834|NCT00696072|75908297|FG001|Overall Study|Disease Progression|30|||
42097835|NCT00696072|75908296|FG000|Overall Study|Non-specified|1|||
42097836|NCT00696072|75908297|FG001|Overall Study|Non-specified|2|||
42097837|NCT00634647|75908304|FG000|Overall Study|death on study|3|||
42097838|NCT00634647|75908304|FG000|Overall Study|refused further treatment|3|||
42097839|NCT00634647|75908304|FG000|Overall Study|declined to participate before treatment|1|||
42097840|NCT00576732|75908311|FG000|DOUBLE BLIND|Adverse Event|0|||
42097841|NCT00576732|75908312|FG001|DOUBLE BLIND|Adverse Event|0|||
42097842|NCT00576732|75908313|FG002|DOUBLE BLIND|Adverse Event|1|||
42097843|NCT00576732|75908314|FG003|DOUBLE BLIND|Adverse Event|0|||
42097844|NCT00576732|75908315|FG004|DOUBLE BLIND|Adverse Event|0|||
42097845|NCT00576732|75908316|FG005|DOUBLE BLIND|Adverse Event|0|||
42097846|NCT00576732|75908311|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
42097847|NCT00576732|75908312|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
42097848|NCT00576732|75908313|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
42097849|NCT00576732|75908314|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
42097850|NCT00576732|75908315|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
42097851|NCT00576732|75908316|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
42097852|NCT00576732|75908311|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
42097853|NCT00576732|75908312|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
42097854|NCT00576732|75908313|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
42192484|NCT02659514|76003272|FG000|Overall Study|Disease Progression|23|||
42192485|NCT02659514|76003273|FG001|Overall Study|Disease Progression|13|||
42192486|NCT02659514|76003272|FG000|Overall Study|Withdrawal by Subject|0|||
42097855|NCT00576732|75908314|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
42192487|NCT02659514|76003273|FG001|Overall Study|Withdrawal by Subject|4|||
42192488|NCT02659514|76003272|FG000|Overall Study|Lost to Follow-up|0|||
42097856|NCT00576732|75908315|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
42097857|NCT00576732|75908316|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
42097858|NCT00576732|75908311|FG000|DOUBLE BLIND|OTHER|0|||
42097859|NCT00576732|75908312|FG001|DOUBLE BLIND|OTHER|2|||
42097860|NCT00576732|75908313|FG002|DOUBLE BLIND|OTHER|1|||
42097861|NCT00576732|75908314|FG003|DOUBLE BLIND|OTHER|0|||
42097862|NCT00576732|75908315|FG004|DOUBLE BLIND|OTHER|0|||
42192489|NCT02659514|76003273|FG001|Overall Study|Lost to Follow-up|1|||
42192490|NCT02659514|76003272|FG000|Overall Study|Death|6|||
42097863|NCT00576732|75908316|FG005|DOUBLE BLIND|OTHER|0|||
42097864|NCT00576732|75908311|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
42097865|NCT00576732|75908312|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
42097866|NCT00576732|75908313|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
42097867|NCT00576732|75908314|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
42097868|NCT00576732|75908315|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
42097869|NCT00576732|75908316|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
42097870|NCT00576732|75908311|FG000|DOUBLE BLIND|Protocol Violation|1|||
42097871|NCT00576732|75908312|FG001|DOUBLE BLIND|Protocol Violation|0|||
42192491|NCT02659514|76003273|FG001|Overall Study|Death|1|||
42192492|NCT02659514|76003272|FG000|Overall Study|Reason Unspecified|0|||
42192493|NCT02659514|76003273|FG001|Overall Study|Reason Unspecified|3|||
42192494|NCT04570670|76003281|FG000|Overall Study|Withdrawal by Subject|1|||
42192495|NCT04570670|76003282|FG001|Overall Study|Withdrawal by Subject|0|||
42192496|NCT02797132|76003288|FG000|Part A (15 Days)|Adverse Event|1|||
42192497|NCT02797132|76003288|FG000|Part B (24 Weeks)|Adverse Event|3|||
42192498|NCT03270644|76003301|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
42192499|NCT03270644|76003301|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
42192500|NCT03269552|76003312|FG000|Overall Study|Adverse Event|2|||
42192501|NCT02796664|76003319|FG000|Overall Study|Withdrawal by Subject|0|||
42192502|NCT02796664|76003320|FG001|Overall Study|Withdrawal by Subject|3|||
42192503|NCT02796664|76003319|FG000|Overall Study|Noncompliance|1|||
42192504|NCT02796664|76003320|FG001|Overall Study|Noncompliance|1|||
42192505|NCT02796664|76003319|FG000|Overall Study|Death|0|||
42192506|NCT02796664|76003320|FG001|Overall Study|Death|1|||
42192507|NCT04233879|76003330|FG000|Overall Study|Death|2|||
42192508|NCT04233879|76003331|FG001|Overall Study|Death|0|||
42192509|NCT04233879|76003330|FG000|Overall Study|Lost to Follow-up|3|||
42192510|NCT04233879|76003331|FG001|Overall Study|Lost to Follow-up|8|||
42192511|NCT04233879|76003330|FG000|Overall Study|Physician Decision|4|||
42192512|NCT04233879|76003331|FG001|Overall Study|Physician Decision|4|||
42192513|NCT04233879|76003330|FG000|Overall Study|Withdrawal by Subject|7|||
42192514|NCT04233879|76003331|FG001|Overall Study|Withdrawal by Subject|10|||
42192515|NCT04233879|76003330|FG000|Overall Study|Other|281|||
42192516|NCT04233879|76003331|FG001|Overall Study|Other|279|||
42192517|NCT01370356|76003339|FG000|Overall Study|Death|1|||
42192518|NCT01370356|76003340|FG001|Overall Study|Death|0|||
42192519|NCT01370356|76003339|FG000|Overall Study|Lack of Efficacy|6|||
42192520|NCT01370356|76003340|FG001|Overall Study|Lack of Efficacy|28|||
42192521|NCT01370356|76003339|FG000|Overall Study|Lost to Follow-up|76|||
42192522|NCT01370356|76003340|FG001|Overall Study|Lost to Follow-up|81|||
42192523|NCT01370356|76003339|FG000|Overall Study|Withdrawal by Subject|54|||
42192524|NCT01370356|76003340|FG001|Overall Study|Withdrawal by Subject|59|||
42192525|NCT01370356|76003339|FG000|Overall Study|Reason not specified|39|||
42192526|NCT01370356|76003340|FG001|Overall Study|Reason not specified|43|||
42192527|NCT01370356|76003339|FG000|Overall Study|Protocol Violation|3|||
42192528|NCT01370356|76003340|FG001|Overall Study|Protocol Violation|3|||
42192529|NCT01370356|76003339|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
42192530|NCT01370356|76003340|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
42192531|NCT01370356|76003339|FG000|Overall Study|AE Not Related to Study Drug|1|||
42192532|NCT01370356|76003340|FG001|Overall Study|AE Not Related to Study Drug|4|||
42192533|NCT02794870|76003348|FG000|Overall Study|Withdrawal by Subject|2|||
42192534|NCT02794870|76003349|FG001|Overall Study|Withdrawal by Subject|0|||
42192535|NCT01370590|76003357|FG000|Period 1|Adverse Event|8|||
42192536|NCT01370590|76003358|FG001|Period 1|Adverse Event|4|||
42192537|NCT01370590|76003357|FG000|Period 1|Lost to Follow-up|2|||
42192538|NCT01370590|76003358|FG001|Period 1|Lost to Follow-up|2|||
42192539|NCT01370590|76003357|FG000|Period 1|Protocol Violation|2|||
42297706|NCT02682238|76132748|FG000|Overall Study|Non-compliance with Study Drug|1|||
42297707|NCT02682238|76132749|FG001|Overall Study|Non-compliance with Study Drug|0|||
42018403|NCT00996892|75825865|FG004|Expansion Stage 2|Death|0|||
42097872|NCT00576732|75908313|FG002|DOUBLE BLIND|Protocol Violation|0|||
42192540|NCT01370590|76003358|FG001|Period 1|Protocol Violation|2|||
42192541|NCT01370590|76003357|FG000|Period 1|Withdrawal by Subject|4|||
42097873|NCT00576732|75908314|FG003|DOUBLE BLIND|Protocol Violation|0|||
42097874|NCT00576732|75908315|FG004|DOUBLE BLIND|Protocol Violation|0|||
42097875|NCT00576732|75908316|FG005|DOUBLE BLIND|Protocol Violation|0|||
42097876|NCT00576732|75908311|FG000|OPEN LABEL|Adverse Event|0|||
42192542|NCT01370590|76003358|FG001|Period 1|Withdrawal by Subject|2|||
42192543|NCT01370590|76003357|FG000|Period 1|Could not access randomization system|0|||
42192544|NCT01370590|76003358|FG001|Period 1|Could not access randomization system|1|||
42192545|NCT01370590|76003357|FG000|Crossover Washout Period|Adverse Event|1|||
42192546|NCT01370590|76003358|FG001|Crossover Washout Period|Adverse Event|4|||
42192547|NCT01370590|76003357|FG000|Crossover Washout Period|Lost to Follow-up|2|||
42192548|NCT01370590|76003358|FG001|Crossover Washout Period|Lost to Follow-up|0|||
42192549|NCT01370590|76003357|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
42192550|NCT01370590|76003358|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
42192551|NCT01370590|76003357|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
42192552|NCT01370590|76003358|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
42192553|NCT01370590|76003357|FG000|Period 2|Adverse Event|0|||
42192554|NCT01370590|76003358|FG001|Period 2|Adverse Event|1|||
42192555|NCT01370590|76003357|FG000|Period 2|Withdrawal by Subject|1|||
42192556|NCT01370590|76003358|FG001|Period 2|Withdrawal by Subject|1|||
42192557|NCT05200455|76003369|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
42192558|NCT04646109|76003376|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
42192559|NCT04646109|76003377|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
42192560|NCT04502979|76003386|FG000|Overall Study|Lost to Follow-up|1|||
42192561|NCT04502979|76003387|FG001|Overall Study|Lost to Follow-up|3|||
42192562|NCT04502979|76003386|FG000|Overall Study|Withdrawal by Subject|2|||
42192563|NCT04502979|76003387|FG001|Overall Study|Withdrawal by Subject|1|||
42192564|NCT04590027|76003395|FG000|Overall Study|Lost to Follow-up|17|||
42192565|NCT04590027|76003396|FG001|Overall Study|Lost to Follow-up|14|||
42192566|NCT04590027|76003395|FG000|Overall Study|Protocol Violation|0|||
42192567|NCT04590027|76003396|FG001|Overall Study|Protocol Violation|3|||
42192568|NCT04587453|76003408|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
42192569|NCT04587453|76003409|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
42297708|NCT02682238|76132748|FG000|Overall Study|Non-compliance with Protocol|0|||
42297709|NCT02682238|76132749|FG001|Overall Study|Non-compliance with Protocol|2|||
42297710|NCT02657356|76132773|FG000|Overall Study|Death|1|||
42297711|NCT02657356|76132774|FG001|Overall Study|Death|0|||
42297712|NCT02657356|76132773|FG000|Overall Study|Withdrawal by Subject|5|||
42297713|NCT02657356|76132774|FG001|Overall Study|Withdrawal by Subject|6|||
42297714|NCT02657356|76132773|FG000|Overall Study|Terminated by Sponsor|8|||
42297715|NCT02657356|76132774|FG001|Overall Study|Terminated by Sponsor|5|||
42297716|NCT02657356|76132773|FG000|Overall Study|Rolled over to EAP study|6|||
42297717|NCT02657356|76132774|FG001|Overall Study|Rolled over to EAP study|4|||
42297718|NCT01719562|76132800|FG000|Overall Study|Lost to Follow-up|1|||
42097877|NCT00576732|75908312|FG001|OPEN LABEL|Adverse Event|0|||
42097878|NCT00576732|75908313|FG002|OPEN LABEL|Adverse Event|0|||
42097879|NCT00576732|75908314|FG003|OPEN LABEL|Adverse Event|4|||
42097880|NCT00576732|75908315|FG004|OPEN LABEL|Adverse Event|0|||
42097881|NCT00576732|75908316|FG005|OPEN LABEL|Adverse Event|1|||
42097882|NCT00576732|75908311|FG000|OPEN LABEL|Lost to Follow-up|0|||
42297719|NCT01719562|76132801|FG001|Overall Study|Lost to Follow-up|0|||
42297720|NCT01719562|76132800|FG000|Overall Study|Death|1|||
42297721|NCT01719562|76132801|FG001|Overall Study|Death|0|||
42297722|NCT01719562|76132800|FG000|Overall Study|New cancer diagnosis|1|||
42297723|NCT01719562|76132801|FG001|Overall Study|New cancer diagnosis|0|||
42297724|NCT01700439|76132807|FG000|Overall Study|Lost to Follow-up|47|||
42297725|NCT01700439|76132807|FG000|Overall Study|Withdrawal by Subject|183|||
42097883|NCT00576732|75908312|FG001|OPEN LABEL|Lost to Follow-up|0|||
42097884|NCT00576732|75908313|FG002|OPEN LABEL|Lost to Follow-up|0|||
42097885|NCT00576732|75908314|FG003|OPEN LABEL|Lost to Follow-up|2|||
42097886|NCT00576732|75908315|FG004|OPEN LABEL|Lost to Follow-up|1|||
42097887|NCT00576732|75908316|FG005|OPEN LABEL|Lost to Follow-up|1|||
42097888|NCT00576732|75908311|FG000|OPEN LABEL|Withdrawal by Subject|0|||
42097889|NCT00576732|75908312|FG001|OPEN LABEL|Withdrawal by Subject|0|||
42097890|NCT00576732|75908313|FG002|OPEN LABEL|Withdrawal by Subject|0|||
42097891|NCT00576732|75908314|FG003|OPEN LABEL|Withdrawal by Subject|1|||
42097892|NCT00576732|75908315|FG004|OPEN LABEL|Withdrawal by Subject|0|||
42097893|NCT00576732|75908316|FG005|OPEN LABEL|Withdrawal by Subject|1|||
42097894|NCT00576732|75908311|FG000|OPEN LABEL|OTHER|0|||
42097895|NCT00576732|75908312|FG001|OPEN LABEL|OTHER|0|||
42097896|NCT00576732|75908313|FG002|OPEN LABEL|OTHER|0|||
42097897|NCT00576732|75908314|FG003|OPEN LABEL|OTHER|0|||
42192570|NCT02793232|76003426|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
42192571|NCT02793232|76003427|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
42297726|NCT01700439|76132807|FG000|Overall Study|Death|186|||
42297727|NCT01433289|76132829|FG000|Overall Study|Pregnancy|0|||
42297728|NCT01433289|76132830|FG001|Overall Study|Pregnancy|1|||
42018404|NCT00996892|75825866|FG005|Expansion Stage 2|Death|0|||
42297729|NCT01433289|76132831|FG002|Overall Study|Pregnancy|0|||
42297730|NCT01433289|76132832|FG003|Overall Study|Pregnancy|0|||
42297731|NCT02576587|76132876|FG000|Baseline|Equipment failure|0|||
42297732|NCT02576587|76132877|FG001|Baseline|Equipment failure|1|||
42018405|NCT00996892|75825867|FG006|Expansion Stage 2|Death|0|||
42018406|NCT00996892|75825868|FG007|Expansion Stage 2|Death|0|||
42018407|NCT00996892|75825869|FG008|Expansion Stage 2|Death|0|||
42018408|NCT00996892|75825870|FG009|Expansion Stage 2|Death|0|||
42018409|NCT00996892|75825871|FG010|Expansion Stage 2|Death|0|||
42018410|NCT00996892|75825872|FG011|Expansion Stage 2|Death|0|||
42018411|NCT00996892|75825873|FG012|Expansion Stage 2|Death|0|||
42018412|NCT00996892|75825874|FG013|Expansion Stage 2|Death|0|||
42018413|NCT00996892|75825875|FG014|Expansion Stage 2|Death|0|||
42018414|NCT00996892|75825876|FG015|Expansion Stage 2|Death|0|||
42018415|NCT00996892|75825877|FG016|Expansion Stage 2|Death|0|||
42018416|NCT00996892|75825878|FG017|Expansion Stage 2|Death|0|||
42192572|NCT02793232|76003428|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
42192573|NCT02793232|76003429|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
42192574|NCT02793232|76003430|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
42192575|NCT02793232|76003431|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
42097898|NCT00576732|75908315|FG004|OPEN LABEL|OTHER|0|||
42097899|NCT00576732|75908316|FG005|OPEN LABEL|OTHER|2|||
42097900|NCT00576732|75908311|FG000|OPEN LABEL|Lack of Efficacy|0|||
42097901|NCT00576732|75908312|FG001|OPEN LABEL|Lack of Efficacy|0|||
42097902|NCT00576732|75908313|FG002|OPEN LABEL|Lack of Efficacy|0|||
42097903|NCT00576732|75908314|FG003|OPEN LABEL|Lack of Efficacy|2|||
42097904|NCT00576732|75908315|FG004|OPEN LABEL|Lack of Efficacy|2|||
42097905|NCT00576732|75908316|FG005|OPEN LABEL|Lack of Efficacy|3|||
42097906|NCT00576732|75908311|FG000|OPEN LABEL|Protocol Violation|0|||
42192576|NCT02793232|76003432|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
42192577|NCT02793232|76003433|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
42192578|NCT02793232|76003434|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
42192579|NCT04584645|76003470|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
42192580|NCT04584645|76003471|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
42192581|NCT03695367|76003497|FG000|Overall Study|Missed the Day 28 visit.|1|||
42192582|NCT03695367|76003498|FG001|Overall Study|Missed the Day 28 visit.|0|||
42192583|NCT03695367|76003497|FG000|Overall Study|Lost to Follow-up|0|||
42192584|NCT03695367|76003498|FG001|Overall Study|Lost to Follow-up|1|||
42192585|NCT03695367|76003497|FG000|Overall Study|Withdrawal by Subject|0|||
42192586|NCT03695367|76003498|FG001|Overall Study|Withdrawal by Subject|1|||
42192587|NCT03695367|76003497|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
42192588|NCT03695367|76003498|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
42192589|NCT02794480|76003506|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
42192590|NCT02794480|76003507|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
42192591|NCT02794480|76003508|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
42192592|NCT02794480|76003509|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
42192593|NCT02794480|76003506|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
42192594|NCT02794480|76003507|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
42192595|NCT02794480|76003508|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
42192596|NCT02794480|76003509|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
42192597|NCT02794480|76003506|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42192598|NCT02794480|76003507|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42192599|NCT02794480|76003508|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
42192600|NCT02794480|76003509|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
42192601|NCT02794480|76003506|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42192602|NCT02794480|76003507|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
42192603|NCT02794480|76003508|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
42192604|NCT02794480|76003509|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
42192605|NCT02794480|76003506|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
42192606|NCT02794480|76003507|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42192607|NCT02794480|76003508|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
42192608|NCT02794480|76003509|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
42192609|NCT04558125|76003517|FG000|Overall Study|Death|1|||
42192610|NCT02793622|76003523|FG000|Overall Study|Lost to Follow-up|31|||
42192611|NCT02793622|76003524|FG001|Overall Study|Lost to Follow-up|19|||
42192612|NCT02793622|76003523|FG000|Overall Study|Withdrawal by Subject|21|||
42192613|NCT02793622|76003524|FG001|Overall Study|Withdrawal by Subject|17|||
42192614|NCT02793622|76003523|FG000|Overall Study|Adverse Event|0|||
42097907|NCT00576732|75908312|FG001|OPEN LABEL|Protocol Violation|0|||
42097908|NCT00576732|75908313|FG002|OPEN LABEL|Protocol Violation|0|||
42097909|NCT00576732|75908314|FG003|OPEN LABEL|Protocol Violation|2|||
42097910|NCT00576732|75908315|FG004|OPEN LABEL|Protocol Violation|1|||
42097911|NCT00576732|75908316|FG005|OPEN LABEL|Protocol Violation|0|||
42097912|NCT00697788|75908328|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
42192615|NCT02793622|76003524|FG001|Overall Study|Adverse Event|1|||
42192616|NCT02793622|76003523|FG000|Overall Study|Protocol Violation|1|||
42192617|NCT02793622|76003524|FG001|Overall Study|Protocol Violation|5|||
42192618|NCT04493931|76003537|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
42097913|NCT00697788|75908329|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
42097914|NCT00697788|75908330|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
42097915|NCT00697788|75908331|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
42097916|NCT00697788|75908332|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
42192619|NCT04493931|76003538|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
42192620|NCT04493931|76003539|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
42192621|NCT04493931|76003540|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
42192622|NCT04493931|76003541|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
42192623|NCT04493931|76003542|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
42192624|NCT04493931|76003543|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
42097917|NCT00697788|75908333|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
42097918|NCT00697788|75908334|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
42097919|NCT00697788|75908335|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
42097920|NCT00697788|75908328|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
42097921|NCT00697788|75908329|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
42097922|NCT00697788|75908330|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
42097923|NCT00697788|75908331|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
42097924|NCT00697788|75908332|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
42097925|NCT00697788|75908333|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
42192625|NCT04493931|76003537|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
42192626|NCT04493931|76003538|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
42192627|NCT04493931|76003539|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
42192628|NCT04493931|76003540|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
42192629|NCT04493931|76003541|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
42192630|NCT04493931|76003542|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
42192631|NCT04493931|76003543|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
42192632|NCT04493931|76003537|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
42192633|NCT04493931|76003538|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
42192634|NCT04493931|76003539|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
42192635|NCT04493931|76003540|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
42192636|NCT04493931|76003541|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
42192637|NCT04493931|76003542|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
42192638|NCT04493931|76003543|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
42192639|NCT04493931|76003537|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
42192640|NCT04493931|76003538|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
42192641|NCT04493931|76003539|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
42192642|NCT04493931|76003540|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
42192643|NCT04493931|76003541|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
42192644|NCT04493931|76003542|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
42192645|NCT04493931|76003543|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
42192646|NCT03437278|76003576|FG000|Overall Study|Adverse Event|0|||
42192647|NCT03437278|76003577|FG001|Overall Study|Adverse Event|0|||
42192648|NCT03437278|76003578|FG002|Overall Study|Adverse Event|1|||
42192649|NCT03437278|76003576|FG000|Overall Study|Progressive disease|1|||
42192650|NCT03437278|76003577|FG001|Overall Study|Progressive disease|0|||
42192651|NCT03437278|76003578|FG002|Overall Study|Progressive disease|0|||
42192652|NCT03437278|76003576|FG000|Overall Study|Physician Decision|1|||
42192653|NCT03437278|76003577|FG001|Overall Study|Physician Decision|0|||
42192654|NCT03437278|76003578|FG002|Overall Study|Physician Decision|1|||
42192655|NCT04553913|76003588|FG000|Overall Study|patient's block resolved prior to PACU|1|||
42192656|NCT04553913|76003588|FG000|Overall Study|did not use the device properly|5|||
42097926|NCT00697788|75908334|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
42097927|NCT00697788|75908335|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
42097928|NCT00400153|75908365|FG000|Overall Study|AE due to study disease worsening|14|||
42097929|NCT00400153|75908366|FG001|Overall Study|AE due to study disease worsening|19|||
42097930|NCT00400153|75908367|FG002|Overall Study|AE due to study disease worsening|20|||
42192657|NCT04490499|76003593|FG000|Overall Study|Withdrawal by Subject|2|||
42192658|NCT01332994|76003597|FG000|Overall Study|Adverse Event|34|||
42192659|NCT01332994|76003597|FG000|Overall Study|Death|1|||
42192660|NCT01332994|76003597|FG000|Overall Study|Lack of Efficacy|1|||
42192661|NCT01332994|76003597|FG000|Overall Study|Lost to Follow-up|4|||
42192662|NCT01332994|76003597|FG000|Overall Study|Protocol Violation|6|||
42192663|NCT01332994|76003597|FG000|Overall Study|Withdrawal by Subject|15|||
42192664|NCT01332994|76003597|FG000|Overall Study|Administrative Problem|2|||
42192665|NCT01332994|76003597|FG000|Overall Study|Other|8|||
42192666|NCT03698331|76003603|FG000|Overall Study|Adverse Event|2|||
42192667|NCT03698331|76003604|FG001|Overall Study|Adverse Event|3|||
42097931|NCT00400153|75908365|FG000|Overall Study|AE due to other disease worsening|2|||
42192668|NCT03698331|76003603|FG000|Overall Study|Withdrawal by Subject|1|||
42192669|NCT03698331|76003604|FG001|Overall Study|Withdrawal by Subject|1|||
42192670|NCT03698331|76003603|FG000|Overall Study|Lost to Follow-up|0|||
42097932|NCT00400153|75908366|FG001|Overall Study|AE due to other disease worsening|1|||
42192671|NCT03698331|76003604|FG001|Overall Study|Lost to Follow-up|2|||
42192672|NCT03698331|76003603|FG000|Overall Study|Non-compliance with study drug|1|||
42192673|NCT03698331|76003604|FG001|Overall Study|Non-compliance with study drug|0|||
42192674|NCT04889625|76003610|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
42192675|NCT04889625|76003611|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
42192676|NCT04889625|76003610|FG000|Period 1|Subject out of window|0|||
42192677|NCT04889625|76003611|FG001|Period 1|Subject out of window|1|||
42192678|NCT04889625|76003610|FG000|Period 1|Wrong add power dispensed|0|||
42192679|NCT04889625|76003611|FG001|Period 1|Wrong add power dispensed|1|||
42192680|NCT04889625|76003610|FG000|Period 1|Discontinued due to fitting guide error|1|||
42192681|NCT04889625|76003611|FG001|Period 1|Discontinued due to fitting guide error|1|||
42192682|NCT04889625|76003610|FG000|Period 2|Test article no longer available|1|||
42192683|NCT04889625|76003611|FG001|Period 2|Test article no longer available|0|||
42192684|NCT04889625|76003610|FG000|Period 2|Incorrect lens dispensed|1|||
42192685|NCT04889625|76003611|FG001|Period 2|Incorrect lens dispensed|0|||
42192686|NCT04889625|76003610|FG000|Period 2|Wrong add power dispensed|0|||
42192687|NCT04889625|76003611|FG001|Period 2|Wrong add power dispensed|1|||
42192688|NCT04883541|76003619|FG000|Overall Study|Not attending regular yoga class|16|||
42192689|NCT04883541|76003620|FG001|Overall Study|Not attending regular yoga class|0|||
42192690|NCT04883541|76003619|FG000|Overall Study|Not attending the pregnancy school|0|||
42192691|NCT04883541|76003620|FG001|Overall Study|Not attending the pregnancy school|9|||
42192692|NCT04882995|76003628|FG000|Overall Study|Withdrawal by Subject|1|||
42192693|NCT04882995|76003629|FG001|Overall Study|Withdrawal by Subject|2|||
42192694|NCT04882995|76003628|FG000|Overall Study|Protocol Violation|4|||
42192695|NCT04882995|76003629|FG001|Overall Study|Protocol Violation|4|||
42192696|NCT04882995|76003628|FG000|Overall Study|Surgery postponed due to COVID|1|||
42192697|NCT04882995|76003629|FG001|Overall Study|Surgery postponed due to COVID|1|||
42192698|NCT04483011|76003637|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
42192699|NCT04483011|76003638|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
42192700|NCT04545567|76003648|FG000|Overall Study|tested positive for SARS-co-V2|1|||
42192701|NCT04545567|76003649|FG001|Overall Study|tested positive for SARS-co-V2|1|||
42097933|NCT00400153|75908367|FG002|Overall Study|AE due to other disease worsening|0|||
42097934|NCT00400153|75908365|FG000|Overall Study|AE due to other condition|3|||
42097935|NCT00400153|75908366|FG001|Overall Study|AE due to other condition|14|||
42097936|NCT00400153|75908367|FG002|Overall Study|AE due to other condition|15|||
42192702|NCT04545567|76003648|FG000|Overall Study|Withdrawal by Subject|0|||
42097937|NCT00400153|75908365|FG000|Overall Study|Protocol Violation|7|||
42097938|NCT00400153|75908366|FG001|Overall Study|Protocol Violation|4|||
42097939|NCT00400153|75908367|FG002|Overall Study|Protocol Violation|9|||
42097940|NCT00400153|75908365|FG000|Overall Study|Lost to Follow-up|2|||
42192703|NCT04545567|76003649|FG001|Overall Study|Withdrawal by Subject|1|||
42192704|NCT04534491|76003655|FG000|Overall Study|Not completed end-of-study interview|24|||
42192705|NCT04534491|76003655|FG000|Overall Study|Non-users|70|||
42192706|NCT04534491|76003655|FG000|Overall Study|Non-verifiable users|58|||
42192707|NCT03694821|76003662|FG000|Overall Study|Study terminated|4|||
42192708|NCT03694821|76003663|FG001|Overall Study|Study terminated|8|||
42192709|NCT03694821|76003664|FG002|Overall Study|Study terminated|4|||
42192710|NCT04531527|76003672|FG000|Overall Study|Found to be Ineligible|3|||
42192711|NCT04474197|76003680|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
42192712|NCT04474197|76003681|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
42192713|NCT04474197|76003682|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
42192714|NCT04474197|76003683|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
42192715|NCT02079766|76003700|FG000|Overall Study|Physician Decision|1|||
42192716|NCT02079766|76003701|FG001|Overall Study|Physician Decision|0|||
42192717|NCT02079766|76003700|FG000|Overall Study|Withdrawal by Subject|1|||
42297733|NCT02576587|76132876|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
42297734|NCT02576587|76132877|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
42297735|NCT02576587|76132876|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
42297736|NCT02576587|76132877|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
42297737|NCT02576587|76132876|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
42297738|NCT02576587|76132877|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
42192718|NCT02079766|76003701|FG001|Overall Study|Withdrawal by Subject|0|||
42097941|NCT00400153|75908366|FG001|Overall Study|Lost to Follow-up|1|||
42097942|NCT00400153|75908367|FG002|Overall Study|Lost to Follow-up|4|||
42192719|NCT04841577|76003709|FG000|Overall Study|Adverse Event|5|||
42192720|NCT04841577|76003710|FG001|Overall Study|Adverse Event|10|||
42192721|NCT04841577|76003709|FG000|Overall Study|Lost to Follow-up|8|||
42192722|NCT04841577|76003710|FG001|Overall Study|Lost to Follow-up|7|||
42192723|NCT04841577|76003709|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
42192724|NCT04841577|76003710|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
42192725|NCT04841577|76003709|FG000|Overall Study|Other|0|||
42297739|NCT05340751|76132942|FG000|Overall Study|Physician Decision|3|||
42297740|NCT02575807|76132951|FG000|Overall Study|Death|8|||
42192726|NCT04841577|76003710|FG001|Overall Study|Other|1|||
42192727|NCT04529109|76003716|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
42192728|NCT04529109|76003717|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
42192729|NCT04528641|76003729|FG000|Overall Study|Withdrawal by Subject|0|||
42192730|NCT04528641|76003730|FG001|Overall Study|Withdrawal by Subject|0|||
42192731|NCT04528641|76003731|FG002|Overall Study|Withdrawal by Subject|0|||
42192732|NCT04528641|76003732|FG003|Overall Study|Withdrawal by Subject|1|||
42192733|NCT04528641|76003733|FG004|Overall Study|Withdrawal by Subject|0|||
42192734|NCT04528641|76003734|FG005|Overall Study|Withdrawal by Subject|1|||
42192735|NCT04527471|76003753|FG000|Overall Study|Adverse Event|1|||
42192736|NCT04527471|76003754|FG001|Overall Study|Adverse Event|0|||
42192737|NCT04527471|76003753|FG000|Overall Study|Lost to Follow-up|1|||
42192738|NCT04527471|76003754|FG001|Overall Study|Lost to Follow-up|0|||
42192739|NCT04471935|76003760|FG000|Overall Study|Withdrawal by Subject|1|||
42192740|NCT04471935|76003760|FG000|Overall Study|Deemed ineligible to participate|1|||
42192741|NCT04468347|76003768|FG000|Overall Study|Withdrawal by Subject|0|||
42192742|NCT04468347|76003769|FG001|Overall Study|Withdrawal by Subject|1|||
42192743|NCT04468347|76003770|FG002|Overall Study|Withdrawal by Subject|3|||
42192744|NCT04468347|76003771|FG003|Overall Study|Withdrawal by Subject|3|||
42192745|NCT04468347|76003768|FG000|Overall Study|Lost to Follow-up|0|||
42192746|NCT04468347|76003769|FG001|Overall Study|Lost to Follow-up|0|||
42192747|NCT04468347|76003770|FG002|Overall Study|Lost to Follow-up|1|||
42192748|NCT04468347|76003771|FG003|Overall Study|Lost to Follow-up|1|||
42192749|NCT04468347|76003768|FG000|Overall Study|Physician Decision|1|||
42192750|NCT04468347|76003769|FG001|Overall Study|Physician Decision|0|||
42192751|NCT04468347|76003770|FG002|Overall Study|Physician Decision|2|||
42192752|NCT04468347|76003771|FG003|Overall Study|Physician Decision|0|||
42192753|NCT04468347|76003768|FG000|Overall Study|Protocol Violation|1|||
42192754|NCT04468347|76003769|FG001|Overall Study|Protocol Violation|0|||
42192755|NCT04468347|76003770|FG002|Overall Study|Protocol Violation|0|||
42192756|NCT04468347|76003771|FG003|Overall Study|Protocol Violation|0|||
42192757|NCT04822701|76003787|FG000|Overall Study|Not treated|2|||
42192758|NCT04822701|76003788|FG001|Overall Study|Not treated|0|||
42192759|NCT04822701|76003787|FG000|Overall Study|Lost to Follow-up|1|||
42192760|NCT04822701|76003788|FG001|Overall Study|Lost to Follow-up|0|||
42192761|NCT04822701|76003787|FG000|Overall Study|Withdrawal by Subject|1|||
42192762|NCT04822701|76003788|FG001|Overall Study|Withdrawal by Subject|0|||
42192763|NCT04461795|76003794|FG000|Overall Study|Lost to Follow-up|2|||
42192764|NCT04461795|76003794|FG000|Overall Study|Withdrawal by Subject|2|||
42192765|NCT04461795|76003794|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
42192766|NCT04461015|76003801|FG000|Overall Study|IV access lost during the study|0|||
42192767|NCT04461015|76003802|FG001|Overall Study|IV access lost during the study|1|||
42192768|NCT04461015|76003801|FG000|Overall Study|Withdrawal by Subject|0|||
42192769|NCT04461015|76003802|FG001|Overall Study|Withdrawal by Subject|1|||
42097943|NCT00400153|75908365|FG000|Overall Study|Withdrawal by Subject|12|||
42097944|NCT00400153|75908366|FG001|Overall Study|Withdrawal by Subject|11|||
42097945|NCT00400153|75908367|FG002|Overall Study|Withdrawal by Subject|10|||
42097946|NCT00400153|75908365|FG000|Overall Study|Other reasons - not mentioned above|8|||
42097947|NCT00400153|75908366|FG001|Overall Study|Other reasons - not mentioned above|5|||
42097948|NCT00400153|75908367|FG002|Overall Study|Other reasons - not mentioned above|3|||
42097949|NCT00631917|75908382|FG000|Overall Study|Adverse Event|34|||
42097950|NCT00631917|75908383|FG001|Overall Study|Adverse Event|45|||
42097951|NCT00631917|75908382|FG000|Overall Study|Abnormal laboratory value(s)|2|||
42097952|NCT00631917|75908383|FG001|Overall Study|Abnormal laboratory value(s)|1|||
42097953|NCT00631917|75908382|FG000|Overall Study|Abnormal test procedure result(s)|3|||
42097954|NCT00631917|75908383|FG001|Overall Study|Abnormal test procedure result(s)|2|||
42097955|NCT00631917|75908382|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
42097956|NCT00631917|75908383|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
42097957|NCT00631917|75908382|FG000|Overall Study|No longer required study drug|0|||
42097958|NCT00631917|75908383|FG001|Overall Study|No longer required study drug|1|||
42097959|NCT00631917|75908382|FG000|Overall Study|Protocol deviation|6|||
42192770|NCT04810221|76003808|FG000|Overall Study|Physician Decision|3|||
42192771|NCT03694353|76003812|FG000|Overall Study|Withdrawal by Subject|1|||
42192772|NCT03694353|76003812|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
42192773|NCT04521777|76003816|FG000|Overall Study|Death|2|||
42192774|NCT04521777|76003816|FG000|Overall Study|Withdrawal by Subject|2|||
42192775|NCT03700671|76003822|FG000|Overall Study|Lack of Efficacy|1|||
42192776|NCT03700671|76003823|FG001|Overall Study|Lack of Efficacy|2|||
42192777|NCT04764669|76003835|FG000|Overall Study|Adverse Event|1|||
42192778|NCT04764669|76003836|FG001|Overall Study|Adverse Event|0|||
42192779|NCT04764669|76003837|FG002|Overall Study|Adverse Event|1|||
42192780|NCT04764669|76003838|FG003|Overall Study|Adverse Event|0|||
42359293|NCT01585194|76204893|FG000|Overall Study|Lack of insurance|1|||
42097960|NCT00631917|75908383|FG001|Overall Study|Protocol deviation|5|||
42097961|NCT00631917|75908382|FG000|Overall Study|Subject withdrew consent|25|||
42192781|NCT04764669|76003835|FG000|Overall Study|Subject Choice|0|||
42192782|NCT04764669|76003836|FG001|Overall Study|Subject Choice|0|||
42192783|NCT04764669|76003837|FG002|Overall Study|Subject Choice|1|||
42192784|NCT04764669|76003838|FG003|Overall Study|Subject Choice|0|||
42192785|NCT04764669|76003835|FG000|Overall Study|Withdrawal by Subject|2|||
42192786|NCT04764669|76003836|FG001|Overall Study|Withdrawal by Subject|0|||
42192787|NCT04764669|76003837|FG002|Overall Study|Withdrawal by Subject|0|||
42097962|NCT00631917|75908383|FG001|Overall Study|Subject withdrew consent|33|||
42097963|NCT00631917|75908382|FG000|Overall Study|Lost to Follow-up|7|||
42097964|NCT00631917|75908383|FG001|Overall Study|Lost to Follow-up|7|||
42097965|NCT00631917|75908382|FG000|Overall Study|Administrative problems|2|||
42097966|NCT00631917|75908383|FG001|Overall Study|Administrative problems|0|||
42097967|NCT00631917|75908382|FG000|Overall Study|Death|1|||
42097968|NCT00631917|75908383|FG001|Overall Study|Death|0|||
42297741|NCT02575807|76132952|FG001|Overall Study|Death|3|||
42097969|NCT00419341|75908400|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
42097970|NCT00419341|75908400|FG000|Wash in/Wash Out Period|Adverse Event|2|||
42097971|NCT00419341|75908400|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
42097972|NCT00419341|75908400|FG000|Efficacy Period|Withdrawal by Subject|6|||
42097973|NCT00419341|75908400|FG000|Efficacy Period|Protocol Violation|1|||
42097974|NCT00419341|75908400|FG000|Efficacy Period|Lost to Follow-up|1|||
42097975|NCT00419341|75908400|FG000|Efficacy Period|Non-compliance|1|||
42097976|NCT00419341|75908400|FG000|Efficacy Period|Termination of study site|1|||
42097977|NCT00694122|75908406|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
42097978|NCT00694122|75908407|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
42097979|NCT00694122|75908406|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
42097980|NCT00694122|75908407|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
42192788|NCT04764669|76003838|FG003|Overall Study|Withdrawal by Subject|0|||
42192789|NCT04439253|76003848|FG000|Overall Study|Adverse Event|1|||
42192790|NCT04439253|76003848|FG000|Overall Study|Disease progression|2|||
42192791|NCT04439253|76003848|FG000|Overall Study|Complicating disease|1|||
42192792|NCT04438785|76003854|FG000|Overall Study|change of weight, give up intervention|2|||
42192793|NCT04438785|76003855|FG001|Overall Study|change of weight, give up intervention|10|||
42192794|NCT04741503|76003863|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
42192795|NCT04741503|76003864|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
42097981|NCT00694122|75908406|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
42097982|NCT00694122|75908407|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
42097983|NCT03922620|75908420|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
42097984|NCT03922620|75908421|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
42097985|NCT00419263|75908430|FG000|Overall Study|Lost to Follow-up|2|||
42097986|NCT00419263|75908431|FG001|Overall Study|Lost to Follow-up|1|||
42097987|NCT00419263|75908432|FG002|Overall Study|Lost to Follow-up|1|||
42097988|NCT00419263|75908430|FG000|Overall Study|Randomized in Error, Not Treated|1|||
42097989|NCT00419263|75908431|FG001|Overall Study|Randomized in Error, Not Treated|1|||
42097990|NCT00419263|75908432|FG002|Overall Study|Randomized in Error, Not Treated|0|||
42097991|NCT00419263|75908430|FG000|Overall Study|Adverse Event|0|||
42097992|NCT00419263|75908431|FG001|Overall Study|Adverse Event|0|||
42097993|NCT00419263|75908432|FG002|Overall Study|Adverse Event|1|||
42097994|NCT00419263|75908430|FG000|Overall Study|Withdrawal by Subject|0|||
42097995|NCT00419263|75908431|FG001|Overall Study|Withdrawal by Subject|0|||
42097996|NCT00419263|75908432|FG002|Overall Study|Withdrawal by Subject|1|||
42097997|NCT00399763|75908443|FG000|Overall Study|Lost to Follow-up|2|||
42097998|NCT00399763|75908444|FG001|Overall Study|Lost to Follow-up|3|||
42097999|NCT00699842|75908453|FG000|Overall Study|Death|0|||
42098000|NCT00699842|75908454|FG001|Overall Study|Death|1|||
42098001|NCT00699842|75908455|FG002|Overall Study|Death|0|||
42098002|NCT00399529|75908463|FG000|Overall Study|Off Study Prior to Treatment|2|||
42098003|NCT00712712|75908468|FG000|Overall Study|Protocol Violation|11|||
42098004|NCT00712712|75908468|FG000|Overall Study|Radiofrequency not done|3|||
42098005|NCT00712712|75908468|FG000|Overall Study|Death|8|||
42098006|NCT00712712|75908468|FG000|Overall Study|Withdrawal by Subject|1|||
42098007|NCT00411151|75908472|FG000|Overall Study|Death|38|||
42192796|NCT04741503|76003865|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
42192797|NCT04741503|76003863|FG000|Initial Enrollment|Overquotas removed|0|||
42297742|NCT02575807|76132953|FG002|Overall Study|Death|7|||
42297743|NCT02575807|76132954|FG003|Overall Study|Death|0|||
42098008|NCT00411151|75908472|FG000|Overall Study|Withdrawal by Subject|2|||
42098009|NCT00411151|75908472|FG000|Overall Study|Lost to Follow-up|2|||
42098010|NCT00411151|75908472|FG000|Overall Study|Protocol Violation|1|||
42098011|NCT00411151|75908472|FG000|Overall Study|Trial prematurely closed|4|||
42098012|NCT00607048|75908478|FG000|Overall Study|Adverse Event|0|||
42098013|NCT00607048|75908479|FG001|Overall Study|Adverse Event|1|||
42098014|NCT00607048|75908480|FG002|Overall Study|Adverse Event|0|||
42098015|NCT00607048|75908481|FG003|Overall Study|Adverse Event|0|||
42297744|NCT02575807|76132955|FG004|Overall Study|Death|1|||
42098016|NCT00607048|75908482|FG004|Overall Study|Adverse Event|4|||
42098017|NCT00607048|75908483|FG005|Overall Study|Adverse Event|0|||
42192798|NCT04741503|76003864|FG001|Initial Enrollment|Overquotas removed|0|||
42192799|NCT04741503|76003865|FG002|Initial Enrollment|Overquotas removed|186|||
42192800|NCT04741503|76003863|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
42192801|NCT04741503|76003864|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
42192802|NCT04741503|76003865|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
42192803|NCT04734873|76003874|FG000|Overall Study|Lost to Follow-up|1|||
42192804|NCT04734873|76003875|FG001|Overall Study|Lost to Follow-up|3|||
42192805|NCT04734873|76003876|FG002|Overall Study|Lost to Follow-up|2|||
42192806|NCT04734873|76003874|FG000|Overall Study|Randomized but not dosed|1|||
42192807|NCT04734873|76003875|FG001|Overall Study|Randomized but not dosed|0|||
42192808|NCT04734873|76003876|FG002|Overall Study|Randomized but not dosed|1|||
42192809|NCT04435665|76003888|FG000|Overall Study|Lost to Follow-up|0|||
42192810|NCT04435665|76003889|FG001|Overall Study|Lost to Follow-up|0|||
42192811|NCT04435665|76003890|FG002|Overall Study|Lost to Follow-up|0|||
42192812|NCT04435665|76003891|FG003|Overall Study|Lost to Follow-up|1|||
42192813|NCT04428411|76003901|FG000|Overall Study|Lost to Follow-up|114|||
42192814|NCT04422561|76003910|FG000|Overall Study|Lost to Follow-up|25|||
42192815|NCT04422561|76003911|FG001|Overall Study|Lost to Follow-up|11|||
42192816|NCT01369498|76003921|FG000|Overall Study|Lack of Efficacy|9|||
42192817|NCT01369498|76003922|FG001|Overall Study|Lack of Efficacy|9|||
42192818|NCT01369498|76003923|FG002|Overall Study|Lack of Efficacy|1|||
42192819|NCT01369498|76003924|FG003|Overall Study|Lack of Efficacy|3|||
42192820|NCT01369498|76003921|FG000|Overall Study|Adverse Event|1|||
42192821|NCT01369498|76003922|FG001|Overall Study|Adverse Event|2|||
42192822|NCT01369498|76003923|FG002|Overall Study|Adverse Event|0|||
42192823|NCT01369498|76003924|FG003|Overall Study|Adverse Event|1|||
42192824|NCT01369498|76003921|FG000|Overall Study|Withdrawal of Consent|0|||
42192825|NCT01369498|76003922|FG001|Overall Study|Withdrawal of Consent|1|||
42192826|NCT01369498|76003923|FG002|Overall Study|Withdrawal of Consent|1|||
42192827|NCT01369498|76003924|FG003|Overall Study|Withdrawal of Consent|1|||
42192828|NCT01369498|76003921|FG000|Overall Study|Death|0|||
42192829|NCT01369498|76003922|FG001|Overall Study|Death|0|||
42192830|NCT01369498|76003923|FG002|Overall Study|Death|1|||
42192831|NCT01369498|76003924|FG003|Overall Study|Death|0|||
42192832|NCT01369498|76003921|FG000|Overall Study|Investigator's Discretion|1|||
42098018|NCT00607048|75908478|FG000|Overall Study|Global deterioration of health|1|||
42098019|NCT00607048|75908479|FG001|Overall Study|Global deterioration of health|0|||
42098020|NCT00607048|75908480|FG002|Overall Study|Global deterioration of health|0|||
42098021|NCT00607048|75908481|FG003|Overall Study|Global deterioration of health|0|||
42098022|NCT00607048|75908482|FG004|Overall Study|Global deterioration of health|0|||
42098023|NCT00607048|75908483|FG005|Overall Study|Global deterioration of health|0|||
42098024|NCT00607048|75908478|FG000|Overall Study|Objective disease progression - relapse|1|||
42192833|NCT01369498|76003922|FG001|Overall Study|Investigator's Discretion|0|||
42192834|NCT01369498|76003923|FG002|Overall Study|Investigator's Discretion|1|||
42192835|NCT01369498|76003924|FG003|Overall Study|Investigator's Discretion|3|||
42192836|NCT01369498|76003921|FG000|Overall Study|Unknown Reason|1|||
42192837|NCT01369498|76003922|FG001|Overall Study|Unknown Reason|0|||
42192838|NCT01369498|76003923|FG002|Overall Study|Unknown Reason|11|||
42192839|NCT01369498|76003924|FG003|Overall Study|Unknown Reason|6|||
42192840|NCT01369498|76003921|FG000|Overall Study|Disease Progression|0|||
42192841|NCT01369498|76003922|FG001|Overall Study|Disease Progression|0|||
42192842|NCT01369498|76003923|FG002|Overall Study|Disease Progression|0|||
42192843|NCT01369498|76003924|FG003|Overall Study|Disease Progression|1|||
42192844|NCT04709835|76003938|FG000|Overall Study|Withdrawal by Subject|0|||
42192845|NCT04709835|76003939|FG001|Overall Study|Withdrawal by Subject|1|||
42192846|NCT04709835|76003940|FG002|Overall Study|Withdrawal by Subject|0|||
42192847|NCT04407507|76003954|FG000|Overall Study|Withdrawal by Subject|0|||
42192848|NCT04407507|76003955|FG001|Overall Study|Withdrawal by Subject|1|||
42192849|NCT04698993|76003963|FG000|Overall Study|PCR results not accessible|2|||
42192850|NCT04698993|76003964|FG001|Overall Study|PCR results not accessible|7|||
42192851|NCT04698993|76003963|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
42192852|NCT04698993|76003964|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
42192853|NCT04359771|76003972|FG000|Overall Study|Lack of Efficacy|2|||
42192854|NCT04359771|76003973|FG001|Overall Study|Lack of Efficacy|2|||
42192855|NCT04356573|76003981|FG000|Overall Study|Didn't Qualify|1|||
42192856|NCT04356573|76003982|FG001|Overall Study|Didn't Qualify|0|||
42192857|NCT04352127|76003998|FG000|Overall Study|Unable to obtain readings|4|||
42192858|NCT04352127|76003999|FG001|Overall Study|Unable to obtain readings|1|||
42192859|NCT04351269|76004008|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
42192860|NCT04351269|76004009|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
42192861|NCT04351269|76004010|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
42098025|NCT00607048|75908479|FG001|Overall Study|Objective disease progression - relapse|2|||
42192862|NCT04351269|76004008|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
42192863|NCT04351269|76004009|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
42192864|NCT04351269|76004010|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
42098026|NCT00607048|75908480|FG002|Overall Study|Objective disease progression - relapse|4|||
42098027|NCT00607048|75908481|FG003|Overall Study|Objective disease progression - relapse|2|||
42098028|NCT00607048|75908482|FG004|Overall Study|Objective disease progression - relapse|2|||
42098029|NCT00607048|75908483|FG005|Overall Study|Objective disease progression - relapse|2|||
42098030|NCT00607048|75908478|FG000|Overall Study|Withdrawal by Subject|0|||
42098031|NCT00607048|75908479|FG001|Overall Study|Withdrawal by Subject|0|||
42098032|NCT00607048|75908480|FG002|Overall Study|Withdrawal by Subject|0|||
42098033|NCT00607048|75908481|FG003|Overall Study|Withdrawal by Subject|1|||
42192865|NCT04351269|76004008|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
42192866|NCT04351269|76004009|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
42192867|NCT04351269|76004010|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
42192868|NCT04351269|76004008|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
42192869|NCT04351269|76004009|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
42192870|NCT04351269|76004010|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
42192871|NCT04351269|76004008|FG000|Overall Study|Lost to Follow-up|1|||
42192872|NCT04351269|76004009|FG001|Overall Study|Lost to Follow-up|3|||
42192873|NCT04351269|76004010|FG002|Overall Study|Lost to Follow-up|0|||
42192874|NCT04348851|76004025|FG000|Post-Test 1|Withdrawal by Subject|0|||
42192875|NCT04348851|76004026|FG001|Post-Test 1|Withdrawal by Subject|1|||
42192876|NCT04348851|76004027|FG002|Post-Test 1|Withdrawal by Subject|0|||
42192877|NCT04348851|76004028|FG003|Post-Test 1|Withdrawal by Subject|0|||
42192878|NCT04348851|76004025|FG000|Post-Test 1|Lost to Follow-up|0|||
42192879|NCT04348851|76004026|FG001|Post-Test 1|Lost to Follow-up|1|||
42192880|NCT04348851|76004027|FG002|Post-Test 1|Lost to Follow-up|0|||
42192881|NCT04348851|76004028|FG003|Post-Test 1|Lost to Follow-up|0|||
42192882|NCT04348851|76004025|FG000|Post-Test 2|Stroke survivor death|0|||
42192883|NCT04348851|76004026|FG001|Post-Test 2|Stroke survivor death|1|||
42192884|NCT04348851|76004027|FG002|Post-Test 2|Stroke survivor death|0|||
42192885|NCT04348851|76004028|FG003|Post-Test 2|Stroke survivor death|1|||
42192886|NCT04346199|76004040|FG000|Overall Study|Death|8|||
42192887|NCT04346199|76004041|FG001|Overall Study|Death|9|||
42192888|NCT04346199|76004040|FG000|Overall Study|Lost to Follow-up|0|||
42192889|NCT04346199|76004041|FG001|Overall Study|Lost to Follow-up|1|||
42192890|NCT04346199|76004040|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
42192891|NCT04346199|76004041|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
42192892|NCT04346199|76004040|FG000|Overall Study|Withdrawal by Subject|5|||
42192893|NCT04346199|76004041|FG001|Overall Study|Withdrawal by Subject|1|||
42192894|NCT04345653|76004047|FG000|Overall Study|Withdrawal by Subject|2|||
42192895|NCT04342689|76004054|FG000|Overall Study|Withdrawal by Subject|32|||
42192896|NCT04342689|76004055|FG001|Overall Study|Withdrawal by Subject|33|||
42192897|NCT04342689|76004054|FG000|Overall Study|Lost to Follow-up|10|||
42192898|NCT04342689|76004055|FG001|Overall Study|Lost to Follow-up|12|||
42192899|NCT04169061|76004063|FG000|Overall Study|Adverse Event|2|||
42192900|NCT04169061|76004063|FG000|Overall Study|Death|1|||
42192901|NCT04169061|76004063|FG000|Overall Study|Withdrawal by Subject|1|||
42192902|NCT04169061|76004063|FG000|Overall Study|Protocol Violation|1|||
42098034|NCT00607048|75908482|FG004|Overall Study|Withdrawal by Subject|0|||
42098035|NCT00607048|75908483|FG005|Overall Study|Withdrawal by Subject|2|||
42098036|NCT00607048|75908478|FG000|Overall Study|Other|1|||
42098037|NCT00607048|75908479|FG001|Overall Study|Other|1|||
42098038|NCT00607048|75908480|FG002|Overall Study|Other|0|||
42098039|NCT00607048|75908481|FG003|Overall Study|Other|0|||
42098040|NCT00607048|75908482|FG004|Overall Study|Other|0|||
42098041|NCT00607048|75908483|FG005|Overall Study|Other|1|||
42098042|NCT00699608|75908499|FG000|First Intervention|Withdrawal by Subject|0|||
42098043|NCT00699608|75908500|FG001|First Intervention|Withdrawal by Subject|0|||
42098044|NCT00699608|75908501|FG002|First Intervention|Withdrawal by Subject|1|||
42098045|NCT00699608|75908502|FG003|First Intervention|Withdrawal by Subject|0|||
42098046|NCT00699608|75908503|FG004|First Intervention|Withdrawal by Subject|0|||
42098047|NCT00699608|75908504|FG005|First Intervention|Withdrawal by Subject|0|||
42098048|NCT00699608|75908499|FG000|First Intervention|Protocol Violation|0|||
42098049|NCT00699608|75908500|FG001|First Intervention|Protocol Violation|0|||
42192903|NCT02792218|76004069|FG000|Overall Study|Patient/guardian decision|15|||
42192904|NCT02792218|76004070|FG001|Overall Study|Patient/guardian decision|42|||
42192905|NCT02792218|76004069|FG000|Overall Study|Adverse Event|15|||
42098050|NCT00699608|75908501|FG002|First Intervention|Protocol Violation|0|||
42098051|NCT00699608|75908502|FG003|First Intervention|Protocol Violation|0|||
42098052|NCT00699608|75908503|FG004|First Intervention|Protocol Violation|1|||
42098053|NCT00699608|75908504|FG005|First Intervention|Protocol Violation|0|||
42098054|NCT00699608|75908499|FG000|Second Intervention|Adverse Event|0|||
42098055|NCT00699608|75908500|FG001|Second Intervention|Adverse Event|0|||
42098056|NCT00699608|75908501|FG002|Second Intervention|Adverse Event|1|||
42098057|NCT00699608|75908502|FG003|Second Intervention|Adverse Event|0|||
42098058|NCT00699608|75908503|FG004|Second Intervention|Adverse Event|0|||
42098059|NCT00699608|75908504|FG005|Second Intervention|Adverse Event|0|||
42098060|NCT00699608|75908499|FG000|Second Intervention|Withdrawal by Subject|0|||
42098061|NCT00699608|75908500|FG001|Second Intervention|Withdrawal by Subject|0|||
42098062|NCT00699608|75908501|FG002|Second Intervention|Withdrawal by Subject|0|||
42098063|NCT00699608|75908502|FG003|Second Intervention|Withdrawal by Subject|1|||
42098064|NCT00699608|75908503|FG004|Second Intervention|Withdrawal by Subject|0|||
42192906|NCT02792218|76004070|FG001|Overall Study|Adverse Event|14|||
42192907|NCT02792218|76004069|FG000|Overall Study|Lost to Follow-up|10|||
42192908|NCT02792218|76004070|FG001|Overall Study|Lost to Follow-up|5|||
42192909|NCT02792218|76004069|FG000|Overall Study|Lack of Efficacy|1|||
42192910|NCT02792218|76004070|FG001|Overall Study|Lack of Efficacy|12|||
42192911|NCT02792218|76004069|FG000|Overall Study|Physician Decision|4|||
42192912|NCT02792218|76004070|FG001|Overall Study|Physician Decision|4|||
42192913|NCT02792218|76004069|FG000|Overall Study|Protocol deviation|3|||
42192914|NCT02792218|76004070|FG001|Overall Study|Protocol deviation|2|||
42192915|NCT02792218|76004069|FG000|Overall Study|New therapy for study indication|0|||
42192916|NCT02792218|76004070|FG001|Overall Study|New therapy for study indication|1|||
42192917|NCT02792218|76004069|FG000|Overall Study|Non-compliance with study treatment|0|||
42192918|NCT02792218|76004070|FG001|Overall Study|Non-compliance with study treatment|1|||
42192919|NCT02792218|76004069|FG000|Overall Study|Pregnancy|1|||
42192920|NCT02792218|76004070|FG001|Overall Study|Pregnancy|0|||
42192921|NCT00153101|76004081|FG000|Overall Study|Lost to Follow-up|14|||
42098065|NCT00699608|75908504|FG005|Second Intervention|Withdrawal by Subject|0|||
42098066|NCT03823404|75908515|FG000|Overall Study|Lost to Follow-up|1|||
42098067|NCT03823404|75908516|FG001|Overall Study|Lost to Follow-up|2|||
42098068|NCT03823404|75908517|FG002|Overall Study|Lost to Follow-up|3|||
42098069|NCT03823404|75908515|FG000|Overall Study|Protocol Violation|2|||
42098070|NCT03823404|75908516|FG001|Overall Study|Protocol Violation|0|||
42192922|NCT00153101|76004082|FG001|Overall Study|Lost to Follow-up|14|||
42192923|NCT00153101|76004083|FG002|Overall Study|Lost to Follow-up|12|||
42192924|NCT00153101|76004084|FG003|Overall Study|Lost to Follow-up|5|||
42192925|NCT00153101|76004085|FG004|Overall Study|Lost to Follow-up|5|||
42192926|NCT00153101|76004081|FG000|Overall Study|Withdrawal by Subject|3|||
42192927|NCT00153101|76004082|FG001|Overall Study|Withdrawal by Subject|4|||
42192928|NCT00153101|76004083|FG002|Overall Study|Withdrawal by Subject|3|||
42192929|NCT00153101|76004084|FG003|Overall Study|Withdrawal by Subject|3|||
42192930|NCT00153101|76004085|FG004|Overall Study|Withdrawal by Subject|5|||
42192931|NCT04401579|76004101|FG000|Overall Study|Death|23|||
42192932|NCT04401579|76004102|FG001|Overall Study|Death|36|||
42192933|NCT04401579|76004101|FG000|Overall Study|Lost to Follow-up|40|||
42192934|NCT04401579|76004102|FG001|Overall Study|Lost to Follow-up|41|||
42192935|NCT04401579|76004101|FG000|Overall Study|Withdrawal by Subject|8|||
42192936|NCT04401579|76004102|FG001|Overall Study|Withdrawal by Subject|16|||
42297745|NCT02575807|76132951|FG000|Overall Study|Study terminated by Sponsor|0|||
42297746|NCT02575807|76132952|FG001|Overall Study|Study terminated by Sponsor|1|||
42098071|NCT03823404|75908517|FG002|Overall Study|Protocol Violation|2|||
42098072|NCT03823404|75908515|FG000|Overall Study|Adverse Event|35|||
42098073|NCT03823404|75908516|FG001|Overall Study|Adverse Event|38|||
42098074|NCT03823404|75908517|FG002|Overall Study|Adverse Event|8|||
42098075|NCT03823404|75908515|FG000|Overall Study|Withdrawal by Subject|38|||
42098076|NCT03823404|75908516|FG001|Overall Study|Withdrawal by Subject|40|||
42098077|NCT03823404|75908517|FG002|Overall Study|Withdrawal by Subject|35|||
42098078|NCT03823404|75908515|FG000|Overall Study|Death|4|||
42098079|NCT03823404|75908516|FG001|Overall Study|Death|0|||
42098080|NCT03823404|75908517|FG002|Overall Study|Death|0|||
42192937|NCT04401579|76004101|FG000|Overall Study|Physician Decision|1|||
42192938|NCT04401579|76004102|FG001|Overall Study|Physician Decision|2|||
42192939|NCT04401579|76004101|FG000|Overall Study|Became ineligible after enrollment|1|||
42192940|NCT04401579|76004102|FG001|Overall Study|Became ineligible after enrollment|1|||
42192941|NCT04401579|76004101|FG000|Overall Study|Enrolled but treatment not administered|7|||
42297747|NCT02575807|76132953|FG002|Overall Study|Study terminated by Sponsor|7|||
42297748|NCT02575807|76132954|FG003|Overall Study|Study terminated by Sponsor|0|||
42192942|NCT04401579|76004102|FG001|Overall Study|Enrolled but treatment not administered|9|||
42192943|NCT04401579|76004101|FG000|Overall Study|Adverse Event|2|||
42297749|NCT02575807|76132955|FG004|Overall Study|Study terminated by Sponsor|1|||
42098081|NCT03823404|75908515|FG000|Overall Study|Other: Various reasons provided|5|||
42098082|NCT03823404|75908516|FG001|Overall Study|Other: Various reasons provided|5|||
42098083|NCT03823404|75908517|FG002|Overall Study|Other: Various reasons provided|6|||
42098084|NCT00706706|75908525|FG000|Overall Study|Death|53|||
42192944|NCT04401579|76004102|FG001|Overall Study|Adverse Event|1|||
42192945|NCT04401579|76004101|FG000|Overall Study|Scheduling error|1|||
42098085|NCT00706706|75908525|FG000|Overall Study|Lost to Follow-up|7|||
42192946|NCT04401579|76004102|FG001|Overall Study|Scheduling error|2|||
42297750|NCT02575807|76132951|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
42098086|NCT00706706|75908525|FG000|Overall Study|Study endpoint had reached|45|||
42098087|NCT00410605|75908529|FG000|Overall Study|Adverse Event|12|||
42098088|NCT00410605|75908529|FG000|Overall Study|Physician Decision|3|||
42098089|NCT00410605|75908529|FG000|Overall Study|Withdrawal by Subject|5|||
42098090|NCT00410605|75908529|FG000|Overall Study|Started Non-Protocol Therapy|3|||
42098091|NCT00410605|75908529|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
42098092|NCT00410605|75908529|FG000|Overall Study|Transferred to another Institution|1|||
42098093|NCT00418717|75908533|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
42098094|NCT00418717|75908533|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
42359294|NCT01377389|76204897|FG000|Overall Study|Withdrawal by Subject|1|||
42359295|NCT01377389|76204897|FG000|Overall Study|Screen failure|2|||
42098095|NCT00572572|75908539|FG000|Overall Study|Withdrawal by Subject|3|||
42098096|NCT00572572|75908540|FG001|Overall Study|Withdrawal by Subject|6|||
42098097|NCT00418561|75908549|FG000|Overall Study|Participant's (guardian's) decision|0|||
42098098|NCT00418561|75908550|FG001|Overall Study|Participant's (guardian's) decision|1|||
42098099|NCT00418561|75908551|FG002|Overall Study|Participant's (guardian's) decision|0|||
42098100|NCT00398047|75908559|FG000|Overall Study|all patient progressed before completion|3|||
42098101|NCT00631371|75908566|FG000|Overall Study|Lost to Follow-up|24|||
42098102|NCT00631371|75908567|FG001|Overall Study|Lost to Follow-up|19|||
42098103|NCT00631371|75908566|FG000|Overall Study|Other reason|5|||
42098104|NCT00631371|75908567|FG001|Overall Study|Other reason|12|||
42098105|NCT00631371|75908566|FG000|Overall Study|subject request|38|||
42098106|NCT00631371|75908567|FG001|Overall Study|subject request|45|||
42098107|NCT00631371|75908566|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
42098108|NCT00631371|75908567|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
42098109|NCT00631371|75908566|FG000|Overall Study|Death|263|||
42098110|NCT00631371|75908567|FG001|Overall Study|Death|239|||
42098111|NCT00409747|75908573|FG000|Overall Study|Withdrawal by Subject|1|||
42098112|NCT00630747|75908577|FG000|Overall Study|Death|1|||
42098113|NCT00630747|75908577|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
42098114|NCT00630747|75908577|FG000|Overall Study|Returned to country of origin|1|||
42098115|NCT00397891|75908586|FG000|Overall Study|Withdrawal by Subject|1|||
42098116|NCT00397891|75908587|FG001|Overall Study|Withdrawal by Subject|0|||
42098117|NCT00397891|75908588|FG002|Overall Study|Withdrawal by Subject|0|||
42098118|NCT00397891|75908589|FG003|Overall Study|Withdrawal by Subject|0|||
42098119|NCT00397891|75908590|FG004|Overall Study|Withdrawal by Subject|1|||
42098120|NCT00397189|75908604|FG000|3 Weeks Period|Lost to Follow-up|5|||
42098121|NCT00397189|75908605|FG001|3 Weeks Period|Lost to Follow-up|4|||
42098122|NCT00397189|75908604|FG000|3 Weeks Period|Adverse Event|3|||
42098123|NCT00397189|75908605|FG001|3 Weeks Period|Adverse Event|2|||
42098124|NCT00397189|75908604|FG000|3 Weeks Period|Withdrawal by Subject|13|||
42098125|NCT00397189|75908605|FG001|3 Weeks Period|Withdrawal by Subject|9|||
42098126|NCT00397189|75908604|FG000|3 Weeks Period|Physician Decision|0|||
42098127|NCT00397189|75908605|FG001|3 Weeks Period|Physician Decision|2|||
42098128|NCT00397189|75908604|FG000|3 Weeks Period|Protocol Violation|0|||
42098129|NCT00397189|75908605|FG001|3 Weeks Period|Protocol Violation|3|||
42098130|NCT00397189|75908604|FG000|3 Weeks Period|Other|0|||
42098131|NCT00397189|75908605|FG001|3 Weeks Period|Other|2|||
42098132|NCT00606034|75908613|FG000|Overall Study|incarceration|1|||
42098133|NCT00397033|75908622|FG000|Overall Study|Adverse Event|7|||
42098134|NCT00397033|75908623|FG001|Overall Study|Adverse Event|10|||
42098135|NCT00397033|75908624|FG002|Overall Study|Adverse Event|4|||
42098136|NCT00397033|75908622|FG000|Overall Study|Lack of Efficacy|22|||
42098137|NCT00397033|75908623|FG001|Overall Study|Lack of Efficacy|12|||
42098138|NCT00397033|75908624|FG002|Overall Study|Lack of Efficacy|9|||
42098139|NCT00397033|75908622|FG000|Overall Study|Lost to Follow-up|3|||
42098140|NCT00397033|75908623|FG001|Overall Study|Lost to Follow-up|3|||
42098141|NCT00397033|75908624|FG002|Overall Study|Lost to Follow-up|3|||
42098142|NCT00397033|75908622|FG000|Overall Study|Withdrawal by Subject|12|||
42098143|NCT00397033|75908623|FG001|Overall Study|Withdrawal by Subject|7|||
42098144|NCT00397033|75908624|FG002|Overall Study|Withdrawal by Subject|5|||
42098145|NCT00397033|75908622|FG000|Overall Study|Other|0|||
42098146|NCT00397033|75908623|FG001|Overall Study|Other|5|||
42098147|NCT00397033|75908624|FG002|Overall Study|Other|2|||
42098148|NCT00572728|75908632|FG000|Overall Study|Withdrawal by Subject|10|||
42098149|NCT00572728|75908632|FG000|Overall Study|Ineligible|3|||
42098150|NCT00572728|75908632|FG000|Overall Study|Enrolled under Amendment 4|5|||
42098151|NCT00572728|75908632|FG000|Overall Study|Offstudy due to complicating disease|1|||
42098152|NCT00572728|75908632|FG000|Overall Study|FLT1 not completed|4|||
42098153|NCT00572728|75908632|FG000|Overall Study|First Chemotherapy not initiated|2|||
42098154|NCT00572728|75908632|FG000|Overall Study|FLT2 not completed|5|||
42098155|NCT00572728|75908632|FG000|Overall Study|Second chemotherapy not initiated|1|||
42098156|NCT00572728|75908632|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
42098157|NCT00572728|75908632|FG000|Overall Study|Pathology missing|1|||
42098158|NCT00699374|75908640|FG000|Overall Study|Death|93|||
42098159|NCT00699374|75908641|FG001|Overall Study|Death|83|||
42098160|NCT00699374|75908640|FG000|Overall Study|Adverse Event|70|||
42098161|NCT00699374|75908641|FG001|Overall Study|Adverse Event|67|||
42192947|NCT04401579|76004101|FG000|Overall Study|Transferred to another hospital|1|||
42192948|NCT04401579|76004102|FG001|Overall Study|Transferred to another hospital|2|||
42192949|NCT04161807|76004108|FG000|Overall Study|Withdrawal by Subject|2|||
42192950|NCT04161807|76004108|FG000|Overall Study|Performed only 1 treatment|2|||
42192951|NCT04401423|76004114|FG000|Overall Study|Withdrawal by Subject|3|||
42192952|NCT04401423|76004115|FG001|Overall Study|Withdrawal by Subject|1|||
42192953|NCT04401423|76004114|FG000|Overall Study|Physician Decision|2|||
42192954|NCT04401423|76004115|FG001|Overall Study|Physician Decision|1|||
42192955|NCT04399161|76004126|FG000|Overall Study|Withdrawal by Subject|1|||
42192956|NCT04399161|76004127|FG001|Overall Study|Withdrawal by Subject|0|||
42192957|NCT04399161|76004128|FG002|Overall Study|Withdrawal by Subject|2|||
42192958|NCT04399161|76004126|FG000|Overall Study|Protocol Violation|1|||
42192959|NCT04399161|76004127|FG001|Overall Study|Protocol Violation|2|||
42192960|NCT04399161|76004128|FG002|Overall Study|Protocol Violation|0|||
42192961|NCT02076178|76004138|FG000|Oral Phase|Adverse Event|0|||
42098162|NCT00699374|75908640|FG000|Overall Study|Global deterioration of health status|7|||
42098163|NCT00699374|75908641|FG001|Overall Study|Global deterioration of health status|8|||
42098164|NCT00699374|75908640|FG000|Overall Study|Lost to Follow-up|3|||
42192962|NCT02076178|76004139|FG001|Oral Phase|Adverse Event|7|||
42192963|NCT02076178|76004138|FG000|Oral Phase|Withdrawal by Subject|0|||
42192964|NCT02076178|76004139|FG001|Oral Phase|Withdrawal by Subject|4|||
42192965|NCT02076178|76004138|FG000|Oral Phase|Physician Decision|0|||
42192966|NCT02076178|76004139|FG001|Oral Phase|Physician Decision|1|||
42192967|NCT02076178|76004138|FG000|Injection Phase|Protocol defined stopping criteria|1|||
42192968|NCT02076178|76004139|FG001|Injection Phase|Protocol defined stopping criteria|0|||
42192969|NCT02076178|76004138|FG000|Injection Phase|Withdrawal by Subject|0|||
42192970|NCT02076178|76004139|FG001|Injection Phase|Withdrawal by Subject|3|||
42192971|NCT02076178|76004138|FG000|Injection Phase|Physician Decision|0|||
42192972|NCT02076178|76004139|FG001|Injection Phase|Physician Decision|3|||
42297751|NCT02575807|76132952|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
42297752|NCT02575807|76132953|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
42297753|NCT02575807|76132954|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
42098165|NCT00699374|75908641|FG001|Overall Study|Lost to Follow-up|5|||
42098166|NCT00699374|75908640|FG000|Overall Study|Withdrawal by Subject|34|||
42098167|NCT00699374|75908641|FG001|Overall Study|Withdrawal by Subject|44|||
42098168|NCT00699374|75908640|FG000|Overall Study|Objective progression or relapse|281|||
42098169|NCT00699374|75908641|FG001|Overall Study|Objective progression or relapse|277|||
42098170|NCT00699374|75908640|FG000|Overall Study|Other|18|||
42098171|NCT00699374|75908641|FG001|Overall Study|Other|15|||
42098172|NCT00699374|75908640|FG000|Overall Study|Protocol Violation|2|||
42098173|NCT00699374|75908641|FG001|Overall Study|Protocol Violation|6|||
42098174|NCT00699374|75908640|FG000|Overall Study|Study terminated by sponsor|13|||
42098175|NCT00699374|75908641|FG001|Overall Study|Study terminated by sponsor|28|||
42098176|NCT00699374|75908640|FG000|Overall Study|Randomized but not treated|4|||
42098177|NCT00699374|75908641|FG001|Overall Study|Randomized but not treated|2|||
42098178|NCT00699374|75908640|FG000|Overall Study|Died 28 days after last dose|5|||
42098179|NCT00699374|75908641|FG001|Overall Study|Died 28 days after last dose|9|||
42098180|NCT00606892|75908647|FG000|First Intervention|Protocol Violation|1|||
42098181|NCT00606892|75908648|FG001|First Intervention|Protocol Violation|4|||
42098182|NCT00625443|75908683|FG000|Overall Study|Adverse Event|1|||
42098183|NCT00625443|75908684|FG001|Overall Study|Adverse Event|4|||
42098184|NCT00625443|75908685|FG002|Overall Study|Adverse Event|0|||
42098185|NCT00625443|75908683|FG000|Overall Study|Non-compliance with protocol|0|||
42098186|NCT00625443|75908684|FG001|Overall Study|Non-compliance with protocol|1|||
42098187|NCT00625443|75908685|FG002|Overall Study|Non-compliance with protocol|0|||
42098188|NCT00625443|75908683|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
42098189|NCT00625443|75908684|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
42098190|NCT00625443|75908685|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
42098191|NCT00625443|75908683|FG000|Overall Study|Withdrawal by Subject|0|||
42098192|NCT00625443|75908684|FG001|Overall Study|Withdrawal by Subject|1|||
42098193|NCT00625443|75908685|FG002|Overall Study|Withdrawal by Subject|2|||
42098194|NCT00625443|75908683|FG000|Overall Study|Physician Decision|0|||
42098195|NCT00625443|75908684|FG001|Overall Study|Physician Decision|4|||
42098196|NCT00625443|75908685|FG002|Overall Study|Physician Decision|2|||
42098197|NCT00625443|75908683|FG000|Overall Study|Other|0|||
42098198|NCT00625443|75908684|FG001|Overall Study|Other|1|||
42098199|NCT00625443|75908685|FG002|Overall Study|Other|1|||
42098200|NCT00625365|75908696|FG000|Overall Study|Withdrawal by Subject|1|||
42098201|NCT00625365|75908696|FG000|Overall Study|No IV access|5|||
42098202|NCT00625365|75908696|FG000|Overall Study|VSD|1|||
42098203|NCT00606580|75908703|FG000|Overall Study|Lost to Follow-up|1|||
42098204|NCT00606580|75908704|FG001|Overall Study|Lost to Follow-up|1|||
42098205|NCT00606580|75908705|FG002|Overall Study|Lost to Follow-up|4|||
42192973|NCT02076178|76004138|FG000|Injection Phase|Lost to Follow-up|0|||
42192974|NCT02076178|76004139|FG001|Injection Phase|Lost to Follow-up|1|||
42297754|NCT02575807|76132955|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
42192975|NCT00149825|76004149|FG000|Overall Study|Intolerance to medication side effects|1|||
42192976|NCT00149825|76004150|FG001|Overall Study|Intolerance to medication side effects|2|||
42192977|NCT00149825|76004149|FG000|Overall Study|Time commitments|2|||
42192978|NCT00149825|76004150|FG001|Overall Study|Time commitments|1|||
42098206|NCT00606580|75908703|FG000|Overall Study|Clinical failures|1|||
42098207|NCT00606580|75908704|FG001|Overall Study|Clinical failures|0|||
42098208|NCT00606580|75908705|FG002|Overall Study|Clinical failures|12|||
42098209|NCT00606580|75908703|FG000|Overall Study|Withdrawal by investigator|0|||
42098210|NCT00606580|75908704|FG001|Overall Study|Withdrawal by investigator|1|||
42098211|NCT00606580|75908705|FG002|Overall Study|Withdrawal by investigator|6|||
42098212|NCT00606580|75908703|FG000|Overall Study|Withdrawal by Subject|0|||
42098213|NCT00606580|75908704|FG001|Overall Study|Withdrawal by Subject|1|||
42098214|NCT00606580|75908705|FG002|Overall Study|Withdrawal by Subject|0|||
42098215|NCT00629265|75908715|FG000|Overall Study|Lost to Follow-up|4|||
42098216|NCT00629265|75908716|FG001|Overall Study|Lost to Follow-up|5|||
42098217|NCT00629265|75908715|FG000|Overall Study|Withdrawal by Subject|11|||
42098218|NCT00629265|75908716|FG001|Overall Study|Withdrawal by Subject|8|||
42098219|NCT00629265|75908715|FG000|Overall Study|Death|1|||
42098220|NCT00629265|75908716|FG001|Overall Study|Death|0|||
42098221|NCT00629265|75908715|FG000|Overall Study|Adverse Event|2|||
42098222|NCT00629265|75908716|FG001|Overall Study|Adverse Event|0|||
42098223|NCT00629265|75908715|FG000|Overall Study|HNC Recurrence|4|||
42098224|NCT00629265|75908716|FG001|Overall Study|HNC Recurrence|0|||
42098225|NCT00629265|75908715|FG000|Overall Study|Other CA Requiring Treatment|1|||
42098226|NCT00629265|75908716|FG001|Overall Study|Other CA Requiring Treatment|3|||
42098227|NCT00629265|75908715|FG000|Overall Study|Needed Esophageal Dilation|4|||
42098228|NCT00629265|75908716|FG001|Overall Study|Needed Esophageal Dilation|1|||
42098229|NCT00629265|75908715|FG000|Overall Study|Unrelated Medical Complications|3|||
42098230|NCT00629265|75908716|FG001|Overall Study|Unrelated Medical Complications|1|||
42098231|NCT00629265|75908715|FG000|Overall Study|Unknown Reason|2|||
42098232|NCT00629265|75908716|FG001|Overall Study|Unknown Reason|2|||
42098233|NCT00606502|75908724|FG000|Randomization|Randomized but not treated|3|||
42098234|NCT00606502|75908725|FG001|Randomization|Randomized but not treated|0|||
42098235|NCT00606502|75908724|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
42098236|NCT00606502|75908725|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
42098237|NCT00605722|75908731|FG000|Overall Study|Adverse Event|6|||
42098238|NCT00605722|75908731|FG000|Overall Study|Insufficient therapeutic response|44|||
42098239|NCT00605722|75908731|FG000|Overall Study|Failure to return|1|||
42098240|NCT00605566|75908735|FG000|Overall Study|Adverse Event|1|||
42098241|NCT00605566|75908735|FG000|Overall Study|Clinical deterioration|1|||
42098242|NCT00605566|75908735|FG000|Overall Study|Poor compliance in run-in period|1|||
42098243|NCT00396877|75908741|FG000|Overall Study|Lost to Follow-up|2|||
42098244|NCT00396877|75908742|FG001|Overall Study|Lost to Follow-up|1|||
42098245|NCT00396877|75908741|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
42098246|NCT00396877|75908742|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
42098247|NCT00628251|75908751|FG000|Randomised Part|Withdrawal by Subject|0|||
42098248|NCT00628251|75908752|FG001|Randomised Part|Withdrawal by Subject|0|||
42098249|NCT00628251|75908753|FG002|Randomised Part|Withdrawal by Subject|1|||
42098250|NCT00628251|75908751|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
42098251|NCT00628251|75908752|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
42098252|NCT00628251|75908753|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
42098253|NCT00628251|75908751|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
42098254|NCT00628251|75908752|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
42098255|NCT00628251|75908753|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
42098256|NCT00628251|75908751|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
42098257|NCT00628251|75908752|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
42098258|NCT00628251|75908753|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
42098259|NCT00628251|75908751|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
42098260|NCT00628251|75908752|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
42098261|NCT00628251|75908753|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
42098262|NCT00628251|75908751|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
42098263|NCT00628251|75908752|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
42098264|NCT00628251|75908753|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
42098265|NCT00625131|75908765|FG000|Overall Study|Lost to Follow-up|3|||
42192979|NCT00149825|76004149|FG000|Overall Study|Not liking insomnia therapy|1|||
42098266|NCT00625131|75908766|FG001|Overall Study|Lost to Follow-up|2|||
42098267|NCT00625131|75908767|FG002|Overall Study|Lost to Follow-up|0|||
42098268|NCT00625131|75908765|FG000|Overall Study|Withdrawal by Subject|1|||
42098269|NCT00625131|75908766|FG001|Overall Study|Withdrawal by Subject|0|||
42098270|NCT00625131|75908767|FG002|Overall Study|Withdrawal by Subject|5|||
42098271|NCT00408499|75908773|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
42098272|NCT00408499|75908774|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
42098273|NCT00408499|75908775|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
42098274|NCT00408499|75908776|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
42098275|NCT00408499|75908777|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
42098276|NCT00408499|75908773|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
42098277|NCT00408499|75908774|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
42098278|NCT00408499|75908775|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
42098279|NCT00408499|75908776|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
42098280|NCT00408499|75908777|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
42098281|NCT00408499|75908773|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
42098282|NCT00408499|75908774|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
42098283|NCT00408499|75908775|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
42098284|NCT00408499|75908776|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
42098285|NCT00408499|75908777|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
42098286|NCT00408499|75908773|FG000|Phase II- MTD Expansion|Adverse Event|0|||
42098287|NCT00408499|75908774|FG001|Phase II- MTD Expansion|Adverse Event|0|||
42098288|NCT00408499|75908775|FG002|Phase II- MTD Expansion|Adverse Event|0|||
42098289|NCT00408499|75908776|FG003|Phase II- MTD Expansion|Adverse Event|0|||
42098290|NCT00408499|75908777|FG004|Phase II- MTD Expansion|Adverse Event|9|||
42098291|NCT00408499|75908773|FG000|Phase II- MTD Expansion|Death|0|||
42098292|NCT00408499|75908774|FG001|Phase II- MTD Expansion|Death|0|||
42098293|NCT00408499|75908775|FG002|Phase II- MTD Expansion|Death|0|||
42098294|NCT00408499|75908776|FG003|Phase II- MTD Expansion|Death|0|||
42098295|NCT00408499|75908777|FG004|Phase II- MTD Expansion|Death|2|||
42098296|NCT00408499|75908773|FG000|Phase II- MTD Expansion|Physician Decision|0|||
42098297|NCT00408499|75908774|FG001|Phase II- MTD Expansion|Physician Decision|0|||
42098298|NCT00408499|75908775|FG002|Phase II- MTD Expansion|Physician Decision|0|||
42098299|NCT00408499|75908776|FG003|Phase II- MTD Expansion|Physician Decision|0|||
42098300|NCT00408499|75908777|FG004|Phase II- MTD Expansion|Physician Decision|1|||
42098301|NCT00408499|75908773|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
42098302|NCT00408499|75908774|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
42098303|NCT00408499|75908775|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
42098304|NCT00408499|75908776|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
42098305|NCT00408499|75908777|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
42098306|NCT00408499|75908773|FG000|Phase II- MTD Expansion|treatment delay|0|||
42098307|NCT00408499|75908774|FG001|Phase II- MTD Expansion|treatment delay|0|||
42098308|NCT00408499|75908775|FG002|Phase II- MTD Expansion|treatment delay|0|||
42192980|NCT00149825|76004150|FG001|Overall Study|Not liking insomnia therapy|0|||
42192981|NCT00149825|76004149|FG000|Overall Study|Other|1|||
42192982|NCT00149825|76004150|FG001|Overall Study|Other|0|||
42192983|NCT04397757|76004158|FG000|Overall Study|Death|3|||
42192984|NCT04397757|76004159|FG001|Overall Study|Death|11|||
42192985|NCT04397757|76004158|FG000|Overall Study|Withdrawal by Subject|2|||
42192986|NCT04397757|76004159|FG001|Overall Study|Withdrawal by Subject|0|||
42192987|NCT04397757|76004158|FG000|Overall Study|Lost to Follow-up|4|||
42297755|NCT02575807|76132951|FG000|Overall Study|Terminated due to physician decision|0|||
42297756|NCT02575807|76132952|FG001|Overall Study|Terminated due to physician decision|0|||
42297757|NCT02575807|76132953|FG002|Overall Study|Terminated due to physician decision|1|||
42297758|NCT02575807|76132954|FG003|Overall Study|Terminated due to physician decision|0|||
42098309|NCT00408499|75908776|FG003|Phase II- MTD Expansion|treatment delay|0|||
42098310|NCT00408499|75908777|FG004|Phase II- MTD Expansion|treatment delay|3|||
42192988|NCT04397757|76004159|FG001|Overall Study|Lost to Follow-up|3|||
42098311|NCT00621777|75908797|FG000|Open Phase|Adverse Event|20|||
42098312|NCT00621777|75908798|FG001|Open Phase|Adverse Event|0|||
42098313|NCT00621777|75908797|FG000|Open Phase|Did not abstain during open phase|56|||
42098314|NCT00621777|75908798|FG001|Open Phase|Did not abstain during open phase|0|||
42098315|NCT00621777|75908797|FG000|Open Phase|Withdrawal by Subject|17|||
42098316|NCT00621777|75908798|FG001|Open Phase|Withdrawal by Subject|0|||
42098317|NCT00621777|75908797|FG000|Open Phase|administrative|13|||
42098318|NCT00621777|75908798|FG001|Open Phase|administrative|0|||
42098319|NCT00621777|75908797|FG000|Open Phase|Lost to Follow-up|10|||
42098320|NCT00621777|75908798|FG001|Open Phase|Lost to Follow-up|0|||
42098321|NCT00621777|75908797|FG000|Randomized Phase|Adverse Event|3|||
42098322|NCT00621777|75908798|FG001|Randomized Phase|Adverse Event|3|||
42098323|NCT00621777|75908797|FG000|Randomized Phase|Lost to Follow-up|3|||
42098324|NCT00621777|75908798|FG001|Randomized Phase|Lost to Follow-up|3|||
42098325|NCT00621777|75908797|FG000|Randomized Phase|Withdrawal by Subject|1|||
42098326|NCT00621777|75908798|FG001|Randomized Phase|Withdrawal by Subject|9|||
42098327|NCT00621777|75908797|FG000|Randomized Phase|administrative|0|||
42098328|NCT00621777|75908798|FG001|Randomized Phase|administrative|3|||
42098329|NCT00621777|75908797|FG000|Randomized Phase|Death|0|||
42098330|NCT00621777|75908798|FG001|Randomized Phase|Death|1|||
42098331|NCT00408421|75908808|FG000|Treatment Initial Randomization|Adverse Event|5|||
42098332|NCT00408421|75908809|FG001|Treatment Initial Randomization|Adverse Event|9|||
42098333|NCT00408421|75908810|FG002|Treatment Initial Randomization|Adverse Event|0|||
42098334|NCT00408421|75908808|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
42098335|NCT00408421|75908809|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
42098336|NCT00408421|75908810|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
42098337|NCT00408421|75908808|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
42098338|NCT00408421|75908809|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
42098339|NCT00408421|75908810|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
42098340|NCT00408421|75908808|FG000|Treatment Initial Randomization|Physician Decision|1|||
42098341|NCT00408421|75908809|FG001|Treatment Initial Randomization|Physician Decision|0|||
42098342|NCT00408421|75908810|FG002|Treatment Initial Randomization|Physician Decision|0|||
42098343|NCT00408421|75908808|FG000|Treatment Initial Randomization|Protocol Violation|0|||
42098344|NCT00408421|75908809|FG001|Treatment Initial Randomization|Protocol Violation|1|||
42098345|NCT00408421|75908810|FG002|Treatment Initial Randomization|Protocol Violation|0|||
42098346|NCT00408421|75908808|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
42098347|NCT00408421|75908809|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
42098348|NCT00408421|75908810|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
42098349|NCT00408421|75908808|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
42098350|NCT00408421|75908809|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
42098351|NCT00408421|75908810|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
42098352|NCT00408421|75908808|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
42098353|NCT00408421|75908809|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
42098354|NCT00408421|75908810|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
42098355|NCT00408421|75908808|FG000|Treatment Re-Randomization|Adverse Event|2|||
42098356|NCT00408421|75908809|FG001|Treatment Re-Randomization|Adverse Event|2|||
42098357|NCT00408421|75908810|FG002|Treatment Re-Randomization|Adverse Event|4|||
42098358|NCT00408421|75908808|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
42098359|NCT00408421|75908809|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
42098360|NCT00408421|75908810|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
42098361|NCT00408421|75908808|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
42098362|NCT00408421|75908809|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
42098363|NCT00408421|75908810|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
42098364|NCT00408421|75908808|FG000|Treatment Re-Randomization|Physician Decision|1|||
42192989|NCT02792062|76004176|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
42192990|NCT02792062|76004177|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
42192991|NCT02792062|76004178|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
42192992|NCT02792062|76004179|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
42192993|NCT02792062|76004180|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
42192994|NCT02792062|76004181|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
42192995|NCT00196937|76004192|FG000|Overall Study|Serious Adverse Event|1|||
42192996|NCT00196937|76004193|FG001|Overall Study|Serious Adverse Event|0|||
42192997|NCT00196937|76004194|FG002|Overall Study|Serious Adverse Event|0|||
42192998|NCT00196937|76004192|FG000|Overall Study|Non-serious adverse event|1|||
42192999|NCT00196937|76004193|FG001|Overall Study|Non-serious adverse event|1|||
42193000|NCT00196937|76004194|FG002|Overall Study|Non-serious adverse event|1|||
42193001|NCT00196937|76004192|FG000|Overall Study|Withdrawal by Subject|0|||
42193002|NCT00196937|76004193|FG001|Overall Study|Withdrawal by Subject|0|||
42193003|NCT00196937|76004194|FG002|Overall Study|Withdrawal by Subject|2|||
42193004|NCT00196937|76004192|FG000|Overall Study|Lost to Follow-up|4|||
42193005|NCT00196937|76004193|FG001|Overall Study|Lost to Follow-up|3|||
42193006|NCT00196937|76004194|FG002|Overall Study|Lost to Follow-up|3|||
42193007|NCT00196937|76004192|FG000|Overall Study|Other|3|||
42193008|NCT00196937|76004193|FG001|Overall Study|Other|1|||
42193009|NCT00196937|76004194|FG002|Overall Study|Other|1|||
42098365|NCT00408421|75908809|FG001|Treatment Re-Randomization|Physician Decision|3|||
42098366|NCT00408421|75908810|FG002|Treatment Re-Randomization|Physician Decision|0|||
42098367|NCT00408421|75908808|FG000|Treatment Re-Randomization|Protocol Violation|1|||
42098368|NCT00408421|75908809|FG001|Treatment Re-Randomization|Protocol Violation|1|||
42098369|NCT00408421|75908810|FG002|Treatment Re-Randomization|Protocol Violation|0|||
42098370|NCT00408421|75908808|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
42193010|NCT04397445|76004203|FG000|Overall Study|Withdrawal by Subject|1|||
42193011|NCT04397445|76004204|FG001|Overall Study|Withdrawal by Subject|0|||
42098371|NCT00408421|75908809|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
42098372|NCT00408421|75908810|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
42193012|NCT04397445|76004205|FG002|Overall Study|Withdrawal by Subject|0|||
42193013|NCT04397445|76004206|FG003|Overall Study|Withdrawal by Subject|0|||
42193014|NCT00191945|76004223|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
42193015|NCT00191945|76004224|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
42193016|NCT00191945|76004223|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
42193017|NCT00191945|76004224|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
42193018|NCT00191945|76004223|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
42193019|NCT00191945|76004224|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
42193020|NCT00191945|76004223|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
42193021|NCT00191945|76004224|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
42193022|NCT01369342|76004234|FG000|Overall Study|Withdrawal by Subject|7|||
42193023|NCT01369342|76004235|FG001|Overall Study|Withdrawal by Subject|7|||
42193024|NCT01369342|76004236|FG002|Overall Study|Withdrawal by Subject|2|||
42193025|NCT01369342|76004234|FG000|Overall Study|Lost to Follow-up|5|||
42193026|NCT01369342|76004235|FG001|Overall Study|Lost to Follow-up|2|||
42193027|NCT01369342|76004236|FG002|Overall Study|Lost to Follow-up|1|||
42193028|NCT01369342|76004234|FG000|Overall Study|Not Treated|1|||
42193029|NCT01369342|76004235|FG001|Overall Study|Not Treated|0|||
42193030|NCT01369342|76004236|FG002|Overall Study|Not Treated|0|||
42193031|NCT00191477|76004246|FG000|Overall Study|Tumor Recurrence|49|||
42193032|NCT00191477|76004247|FG001|Overall Study|Tumor Recurrence|48|||
42193033|NCT00191477|76004246|FG000|Overall Study|Death, Study Disease|1|||
42193034|NCT00191477|76004247|FG001|Overall Study|Death, Study Disease|1|||
42193035|NCT00191477|76004246|FG000|Overall Study|Death, Other Cause|3|||
42193036|NCT00191477|76004247|FG001|Overall Study|Death, Other Cause|6|||
42193037|NCT00191477|76004246|FG000|Overall Study|Lost to Follow-up|23|||
42193038|NCT00191477|76004247|FG001|Overall Study|Lost to Follow-up|21|||
42193039|NCT00191477|76004246|FG000|Overall Study|Protocol Violation|1|||
42193040|NCT00191477|76004247|FG001|Overall Study|Protocol Violation|1|||
42193041|NCT00191477|76004246|FG000|Overall Study|Treatment Change|2|||
42193042|NCT00191477|76004247|FG001|Overall Study|Treatment Change|0|||
42193043|NCT00191477|76004246|FG000|Overall Study|Withdrawal by Subject|2|||
42193044|NCT00191477|76004247|FG001|Overall Study|Withdrawal by Subject|0|||
42193045|NCT00191477|76004246|FG000|Overall Study|Other|2|||
42193046|NCT00191477|76004247|FG001|Overall Study|Other|0|||
42193047|NCT00191477|76004246|FG000|Overall Study|Not Eligible|41|||
42193048|NCT00191477|76004247|FG001|Overall Study|Not Eligible|38|||
42193049|NCT00191477|76004246|FG000|Overall Study|Pathological Specimen Lost|1|||
42193050|NCT00191477|76004247|FG001|Overall Study|Pathological Specimen Lost|0|||
42193051|NCT00191477|76004246|FG000|Overall Study|Discontinued Prior to Instillation|13|||
42193052|NCT00191477|76004247|FG001|Overall Study|Discontinued Prior to Instillation|14|||
42193053|NCT04320615|76004255|FG000|Overall Study|Withdrawal by Subject|4|||
42193054|NCT04320615|76004256|FG001|Overall Study|Withdrawal by Subject|10|||
42193055|NCT04320615|76004255|FG000|Overall Study|Physician Decision|2|||
42193056|NCT04320615|76004256|FG001|Overall Study|Physician Decision|0|||
42193057|NCT04320615|76004255|FG000|Overall Study|Other|2|||
42193058|NCT04320615|76004256|FG001|Overall Study|Other|0|||
42193059|NCT04320615|76004255|FG000|Overall Study|Lost to Follow-up|5|||
42193060|NCT04320615|76004256|FG001|Overall Study|Lost to Follow-up|23|||
42193061|NCT04320615|76004255|FG000|Overall Study|Death|35|||
42193062|NCT04320615|76004256|FG001|Overall Study|Death|71|||
42193063|NCT00149747|76004268|FG000|Overall Study|Death|1|||
42193064|NCT00149747|76004269|FG001|Overall Study|Death|0|||
42193065|NCT00149747|76004268|FG000|Overall Study|Withdrawal by Subject|3|||
42193066|NCT00149747|76004269|FG001|Overall Study|Withdrawal by Subject|3|||
42193067|NCT00187889|76004277|FG000|Overall Study|Withdrawal by Subject|6|||
42193068|NCT00187889|76004278|FG001|Overall Study|Withdrawal by Subject|4|||
42193069|NCT00148343|76004287|FG000|Overall Study|Withdrawal by Subject|12|||
42193070|NCT00148343|76004288|FG001|Overall Study|Withdrawal by Subject|7|||
42193071|NCT00148343|76004287|FG000|Overall Study|Physician Decision|3|||
42193072|NCT00148343|76004288|FG001|Overall Study|Physician Decision|4|||
42193073|NCT04150341|76004294|FG000|Overall Study|Physician Decision|0|||
42193074|NCT04150341|76004295|FG001|Overall Study|Physician Decision|0|||
42193075|NCT04150341|76004296|FG002|Overall Study|Physician Decision|1|||
42193076|NCT04150341|76004297|FG003|Overall Study|Physician Decision|0|||
42193077|NCT04150341|76004298|FG004|Overall Study|Physician Decision|0|||
42193078|NCT04150341|76004299|FG005|Overall Study|Physician Decision|0|||
42193079|NCT04150341|76004294|FG000|Overall Study|Adverse Event|0|||
42193080|NCT04150341|76004295|FG001|Overall Study|Adverse Event|0|||
42193081|NCT04150341|76004296|FG002|Overall Study|Adverse Event|0|||
42193082|NCT04150341|76004297|FG003|Overall Study|Adverse Event|0|||
42359296|NCT01287611|76204903|FG000|Overall Study|Lost to Follow-up|29|||
42193083|NCT04150341|76004298|FG004|Overall Study|Adverse Event|1|||
42193084|NCT04150341|76004299|FG005|Overall Study|Adverse Event|0|||
42193085|NCT00148109|76004311|FG000|Overall Study|Lack of Efficacy|10|||
42193086|NCT00148109|76004312|FG001|Overall Study|Lack of Efficacy|18|||
42193087|NCT00148109|76004311|FG000|Overall Study|Adverse Event|0|||
42193088|NCT00148109|76004312|FG001|Overall Study|Adverse Event|2|||
42193089|NCT00148109|76004311|FG000|Overall Study|Withdrawal by Subject|2|||
42193090|NCT00148109|76004312|FG001|Overall Study|Withdrawal by Subject|0|||
42193091|NCT00186485|76004318|FG000|Overall Study|Lost to Follow-up|3|||
42193092|NCT00147251|76004324|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
42193093|NCT00147251|76004325|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
42193094|NCT04390191|76004335|FG000|Overall Study|Withdrawal by Subject|1|||
42193095|NCT04390191|76004336|FG001|Overall Study|Withdrawal by Subject|0|||
42193096|NCT04405076|76004348|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
42193097|NCT04405076|76004349|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
42193098|NCT04405076|76004350|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
42193099|NCT04405076|76004351|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
42193100|NCT04405076|76004352|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
42193101|NCT04405076|76004353|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
42193102|NCT04405076|76004354|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
42193103|NCT04405076|76004355|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
42193104|NCT04405076|76004356|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
42193105|NCT04405076|76004348|FG000|Part A (Blinded Phase)|Physician Decision|1|||
42193106|NCT04405076|76004349|FG001|Part A (Blinded Phase)|Physician Decision|2|||
42193107|NCT04405076|76004350|FG002|Part A (Blinded Phase)|Physician Decision|0|||
42193108|NCT04405076|76004351|FG003|Part A (Blinded Phase)|Physician Decision|0|||
42193109|NCT04405076|76004352|FG004|Part A (Blinded Phase)|Physician Decision|0|||
42098373|NCT00604786|75908820|FG000|Overall Study|Lost to Follow-up|2|||
42098374|NCT00604786|75908821|FG001|Overall Study|Lost to Follow-up|0|||
42098375|NCT00604708|75908829|FG000|Overall Study|Withdrawal by Subject|9|||
42098376|NCT00604708|75908830|FG001|Overall Study|Withdrawal by Subject|10|||
42098377|NCT00604708|75908829|FG000|Overall Study|Protocol Violation|2|||
42098378|NCT00604708|75908830|FG001|Overall Study|Protocol Violation|8|||
42098379|NCT00604708|75908829|FG000|Overall Study|Lost to Follow-up|5|||
42098380|NCT00604708|75908830|FG001|Overall Study|Lost to Follow-up|5|||
42098381|NCT00604708|75908829|FG000|Overall Study|administrative reasons|9|||
42098382|NCT00604708|75908830|FG001|Overall Study|administrative reasons|11|||
42098383|NCT00604708|75908829|FG000|Overall Study|Adverse Event|6|||
42098384|NCT00604708|75908830|FG001|Overall Study|Adverse Event|6|||
42098385|NCT00407797|75908836|FG000|Overall Study|Lost to Follow-up|2|||
42098386|NCT00407797|75908836|FG000|Overall Study|Adverse Event|6|||
42098387|NCT00407797|75908836|FG000|Overall Study|Other|7|||
42098388|NCT00407797|75908836|FG000|Overall Study|Withdrawal by Subject|3|||
42098389|NCT00568126|75908842|FG000|Overall Study|Adverse Event|3|||
42098390|NCT00568126|75908843|FG001|Overall Study|Adverse Event|0|||
42098391|NCT00568126|75908842|FG000|Overall Study|Withdrawal by Subject|2|||
42098392|NCT00568126|75908843|FG001|Overall Study|Withdrawal by Subject|3|||
42098393|NCT00568126|75908842|FG000|Overall Study|Lost to Follow-up|4|||
42098394|NCT00568126|75908843|FG001|Overall Study|Lost to Follow-up|3|||
42098395|NCT00568126|75908842|FG000|Overall Study|Lack of Efficacy|0|||
42098396|NCT00568126|75908843|FG001|Overall Study|Lack of Efficacy|1|||
42098397|NCT00568126|75908842|FG000|Overall Study|Physician Decision|2|||
42098398|NCT00568126|75908843|FG001|Overall Study|Physician Decision|2|||
42098399|NCT00407563|75908849|FG000|Overall Study|Patient continues on treatment|1|||
42193110|NCT04405076|76004353|FG005|Part A (Blinded Phase)|Physician Decision|0|||
42193111|NCT04405076|76004354|FG006|Part A (Blinded Phase)|Physician Decision|0|||
42193112|NCT04405076|76004355|FG007|Part A (Blinded Phase)|Physician Decision|0|||
42193113|NCT04405076|76004356|FG008|Part A (Blinded Phase)|Physician Decision|0|||
42098400|NCT00567892|75908855|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
42098401|NCT00567892|75908856|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
42098402|NCT00567892|75908857|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
42098403|NCT00567892|75908858|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
42098404|NCT00567892|75908855|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
42098405|NCT00567892|75908856|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
42098406|NCT00567892|75908857|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
42098407|NCT00567892|75908858|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
42098408|NCT00623103|75908872|FG000|Overall Study|Adverse Event|70|||
42098409|NCT00623103|75908873|FG001|Overall Study|Adverse Event|60|||
42098410|NCT00623103|75908872|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
42098411|NCT00623103|75908873|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
42098412|NCT00623103|75908872|FG000|Overall Study|Withdrawal by Subject|18|||
42098413|NCT00623103|75908873|FG001|Overall Study|Withdrawal by Subject|24|||
42098414|NCT00623103|75908872|FG000|Overall Study|Lost to Follow-up|4|||
42098415|NCT00623103|75908873|FG001|Overall Study|Lost to Follow-up|1|||
42098416|NCT00623103|75908872|FG000|Overall Study|Administrative problems|2|||
42098417|NCT00623103|75908873|FG001|Overall Study|Administrative problems|4|||
42098418|NCT00623103|75908872|FG000|Overall Study|Death|11|||
42098419|NCT00623103|75908873|FG001|Overall Study|Death|11|||
42193114|NCT04405076|76004348|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
42098420|NCT00623103|75908872|FG000|Overall Study|Protocol deviation|2|||
42098421|NCT00623103|75908873|FG001|Overall Study|Protocol deviation|1|||
42098422|NCT00396565|75908882|FG000|Overall Study|Physician Decision|3|||
42098423|NCT00396565|75908883|FG001|Overall Study|Physician Decision|1|||
42098424|NCT00396565|75908884|FG002|Overall Study|Physician Decision|2|||
42193115|NCT04405076|76004349|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
42193116|NCT04405076|76004350|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
42193117|NCT04405076|76004351|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
42193118|NCT04405076|76004352|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
42193119|NCT04405076|76004353|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
42193120|NCT04405076|76004354|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
42193121|NCT04405076|76004355|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
42193122|NCT04405076|76004356|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
42193123|NCT04405076|76004348|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
42193124|NCT04405076|76004349|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
42193125|NCT04405076|76004350|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
42193126|NCT04405076|76004351|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
42193127|NCT04405076|76004352|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
42193128|NCT04405076|76004353|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
42193129|NCT04405076|76004354|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
42193130|NCT04405076|76004355|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
42193131|NCT04405076|76004356|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
42193132|NCT04405076|76004348|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
42193133|NCT04405076|76004349|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
42193134|NCT04405076|76004350|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
42193135|NCT04405076|76004351|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
42193136|NCT04405076|76004352|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
42193137|NCT04405076|76004353|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
42193138|NCT04405076|76004354|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
42193139|NCT04405076|76004355|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
42098425|NCT00396565|75908882|FG000|Overall Study|Adverse Event|5|||
42098426|NCT00396565|75908883|FG001|Overall Study|Adverse Event|13|||
42098427|NCT00396565|75908884|FG002|Overall Study|Adverse Event|3|||
42098428|NCT00396565|75908882|FG000|Overall Study|Withdrawal by Subject|8|||
42098429|NCT00396565|75908883|FG001|Overall Study|Withdrawal by Subject|13|||
42098430|NCT00396565|75908884|FG002|Overall Study|Withdrawal by Subject|1|||
42193140|NCT04405076|76004356|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
42193141|NCT04405076|76004348|FG000|Part A (Blinded Phase)|Other than Specified|0|||
42193142|NCT04405076|76004349|FG001|Part A (Blinded Phase)|Other than Specified|0|||
42193143|NCT04405076|76004350|FG002|Part A (Blinded Phase)|Other than Specified|3|||
42193144|NCT04405076|76004351|FG003|Part A (Blinded Phase)|Other than Specified|0|||
42193145|NCT04405076|76004352|FG004|Part A (Blinded Phase)|Other than Specified|0|||
42193146|NCT04405076|76004353|FG005|Part A (Blinded Phase)|Other than Specified|0|||
42193147|NCT04405076|76004354|FG006|Part A (Blinded Phase)|Other than Specified|0|||
42098431|NCT00396565|75908882|FG000|Overall Study|Lack of Efficacy|32|||
42193148|NCT04405076|76004355|FG007|Part A (Blinded Phase)|Other than Specified|0|||
42193149|NCT04405076|76004356|FG008|Part A (Blinded Phase)|Other than Specified|0|||
42193150|NCT04405076|76004348|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
42193151|NCT04405076|76004349|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
42193152|NCT04405076|76004350|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
42193153|NCT04405076|76004351|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
42193154|NCT04405076|76004352|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
42098432|NCT00396565|75908883|FG001|Overall Study|Lack of Efficacy|64|||
42098433|NCT00396565|75908884|FG002|Overall Study|Lack of Efficacy|11|||
42098434|NCT00394771|75908896|FG000|Overall Study|Did not meet protocol requirements|1|||
42297759|NCT02575807|76132955|FG004|Overall Study|Terminated due to physician decision|0|||
42297760|NCT02575807|76132951|FG000|Overall Study|Subject ineligible - medical implant|0|||
42193155|NCT04405076|76004353|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
42193156|NCT04405076|76004354|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
42193157|NCT04405076|76004355|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
42193158|NCT04405076|76004356|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
42193159|NCT04405076|76004348|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
42193160|NCT04405076|76004349|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
42193161|NCT04405076|76004350|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
42193162|NCT04405076|76004351|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
42193163|NCT04405076|76004352|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
42193164|NCT04405076|76004353|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
42193165|NCT04405076|76004354|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
42193166|NCT04405076|76004355|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
42359297|NCT01287611|76204904|FG001|Overall Study|Lost to Follow-up|16|||
42098435|NCT00394771|75908897|FG001|Overall Study|Did not meet protocol requirements|0|||
42098436|NCT00394771|75908898|FG002|Overall Study|Did not meet protocol requirements|2|||
42098437|NCT00394771|75908899|FG003|Overall Study|Did not meet protocol requirements|0|||
42098438|NCT00394771|75908896|FG000|Overall Study|Protocol Violation|2|||
42098439|NCT00394771|75908897|FG001|Overall Study|Protocol Violation|4|||
42098440|NCT00394771|75908898|FG002|Overall Study|Protocol Violation|9|||
42098441|NCT00394771|75908899|FG003|Overall Study|Protocol Violation|7|||
42098442|NCT00394771|75908896|FG000|Overall Study|Withdrawal by Subject|10|||
42098443|NCT00394771|75908897|FG001|Overall Study|Withdrawal by Subject|6|||
42098444|NCT00394771|75908898|FG002|Overall Study|Withdrawal by Subject|8|||
42098445|NCT00394771|75908899|FG003|Overall Study|Withdrawal by Subject|12|||
42098446|NCT00394771|75908896|FG000|Overall Study|Adverse Event|10|||
42098447|NCT00394771|75908897|FG001|Overall Study|Adverse Event|5|||
42098448|NCT00394771|75908898|FG002|Overall Study|Adverse Event|12|||
42098449|NCT00394771|75908899|FG003|Overall Study|Adverse Event|8|||
42098450|NCT00394771|75908896|FG000|Overall Study|Participant pregnant|0|||
42098451|NCT00394771|75908897|FG001|Overall Study|Participant pregnant|1|||
42098452|NCT00394771|75908898|FG002|Overall Study|Participant pregnant|2|||
42098453|NCT00394771|75908899|FG003|Overall Study|Participant pregnant|2|||
42098454|NCT00394771|75908896|FG000|Overall Study|Lost to Follow-up|15|||
42098455|NCT00394771|75908897|FG001|Overall Study|Lost to Follow-up|15|||
42098456|NCT00394771|75908898|FG002|Overall Study|Lost to Follow-up|13|||
42098457|NCT00394771|75908899|FG003|Overall Study|Lost to Follow-up|10|||
42098458|NCT00394771|75908896|FG000|Overall Study|Other|3|||
42098459|NCT00394771|75908897|FG001|Overall Study|Other|3|||
42098460|NCT00394771|75908898|FG002|Overall Study|Other|1|||
42098461|NCT00394771|75908899|FG003|Overall Study|Other|0|||
42098462|NCT00396409|75908911|FG000|Period 1 - 2007|Adverse Event|0|||
42098463|NCT00396409|75908912|FG001|Period 1 - 2007|Adverse Event|1|||
42098464|NCT00396409|75908911|FG000|Period 1 - 2007|Lack of Efficacy|0|||
42098465|NCT00396409|75908912|FG001|Period 1 - 2007|Lack of Efficacy|1|||
42098466|NCT00396409|75908911|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
42098467|NCT00396409|75908912|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
42098468|NCT00396409|75908911|FG000|Period 1 - 2007|Lost to Follow-up|2|||
42098469|NCT00396409|75908912|FG001|Period 1 - 2007|Lost to Follow-up|3|||
42098470|NCT00396409|75908911|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
42098471|NCT00396409|75908912|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
42098472|NCT00396409|75908911|FG000|Period 2 - 2008|Protocol Violation|1|||
42098473|NCT00396409|75908912|FG001|Period 2 - 2008|Protocol Violation|0|||
42098474|NCT00396409|75908911|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
42098475|NCT00396409|75908912|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
42098476|NCT00396409|75908911|FG000|Period 2 - 2008|Lost to Follow-up|3|||
42098477|NCT00396409|75908912|FG001|Period 2 - 2008|Lost to Follow-up|1|||
42098478|NCT02924376|75908924|FG000|Overall Study|Progressive Disease|4|||
42098479|NCT02924376|75908925|FG001|Overall Study|Progressive Disease|0|||
42098480|NCT02924376|75908926|FG002|Overall Study|Progressive Disease|1|||
42098481|NCT02924376|75908927|FG003|Overall Study|Progressive Disease|0|||
42098482|NCT02924376|75908924|FG000|Overall Study|Death|73|||
42098483|NCT02924376|75908925|FG001|Overall Study|Death|18|||
42098484|NCT02924376|75908926|FG002|Overall Study|Death|15|||
42098485|NCT02924376|75908927|FG003|Overall Study|Death|2|||
42098486|NCT02924376|75908924|FG000|Overall Study|Lost to Follow-up|3|||
42098487|NCT02924376|75908925|FG001|Overall Study|Lost to Follow-up|0|||
42098488|NCT02924376|75908926|FG002|Overall Study|Lost to Follow-up|0|||
42098489|NCT02924376|75908927|FG003|Overall Study|Lost to Follow-up|0|||
42098490|NCT02924376|75908924|FG000|Overall Study|Study Terminated by Sponsor|19|||
42098491|NCT02924376|75908925|FG001|Overall Study|Study Terminated by Sponsor|0|||
42193167|NCT04405076|76004356|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
42193168|NCT04405076|76004348|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
42193169|NCT04405076|76004349|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
42193170|NCT04405076|76004350|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
42193171|NCT04405076|76004351|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
42193172|NCT04405076|76004352|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
42193173|NCT04405076|76004353|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
42193174|NCT04405076|76004354|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
42193175|NCT04405076|76004355|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
42193176|NCT04405076|76004356|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
42193177|NCT04405076|76004348|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
42098492|NCT02924376|75908926|FG002|Overall Study|Study Terminated by Sponsor|0|||
42098493|NCT02924376|75908927|FG003|Overall Study|Study Terminated by Sponsor|0|||
42098494|NCT02924376|75908924|FG000|Overall Study|Physician Decision|1|||
42098495|NCT02924376|75908925|FG001|Overall Study|Physician Decision|0|||
42098496|NCT02924376|75908926|FG002|Overall Study|Physician Decision|0|||
42193178|NCT04405076|76004349|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
42193179|NCT04405076|76004350|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
42098497|NCT02924376|75908927|FG003|Overall Study|Physician Decision|0|||
42098498|NCT02924376|75908924|FG000|Overall Study|Withdrawal by Subject|7|||
42193180|NCT04405076|76004351|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
42193181|NCT04405076|76004352|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
42193182|NCT04405076|76004353|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
42193183|NCT04405076|76004354|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
42193184|NCT04405076|76004355|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
42193185|NCT04405076|76004356|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
42193186|NCT04405076|76004348|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
42193187|NCT04405076|76004349|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
42193188|NCT04405076|76004350|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
42193189|NCT04405076|76004351|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
42193190|NCT04405076|76004352|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
42193191|NCT04405076|76004353|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
42193192|NCT04405076|76004354|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
42193193|NCT04405076|76004355|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
42193194|NCT04405076|76004356|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
42098499|NCT02924376|75908925|FG001|Overall Study|Withdrawal by Subject|2|||
42193195|NCT04311177|76004384|FG000|Overall Study|Adverse Event|3|||
42193196|NCT04311177|76004385|FG001|Overall Study|Adverse Event|1|||
42193197|NCT04311177|76004384|FG000|Overall Study|Physician Decision|4|||
42193198|NCT04311177|76004385|FG001|Overall Study|Physician Decision|3|||
42359298|NCT01287611|76204903|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
42098500|NCT02924376|75908926|FG002|Overall Study|Withdrawal by Subject|1|||
42098501|NCT02924376|75908927|FG003|Overall Study|Withdrawal by Subject|0|||
42098502|NCT02924376|75908924|FG000|Overall Study|Rolled Over to Another Study|1|||
42098503|NCT02924376|75908925|FG001|Overall Study|Rolled Over to Another Study|0|||
42098504|NCT02924376|75908926|FG002|Overall Study|Rolled Over to Another Study|0|||
42098505|NCT02924376|75908927|FG003|Overall Study|Rolled Over to Another Study|0|||
42098506|NCT00693420|75908942|FG000|Overall Study|Adverse Event|4|||
42098507|NCT00693420|75908943|FG001|Overall Study|Adverse Event|4|||
42098508|NCT00693420|75908942|FG000|Overall Study|Lost to Follow-up|0|||
42098509|NCT00693420|75908943|FG001|Overall Study|Lost to Follow-up|3|||
42098510|NCT00693420|75908942|FG000|Overall Study|Withdrawal by Subject|1|||
42098511|NCT00693420|75908943|FG001|Overall Study|Withdrawal by Subject|0|||
42098512|NCT00693420|75908942|FG000|Overall Study|Protocol Violation|0|||
42098513|NCT00693420|75908943|FG001|Overall Study|Protocol Violation|2|||
42098514|NCT00693420|75908942|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
42098515|NCT00693420|75908943|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
42098516|NCT00693420|75908942|FG000|Overall Study|Personal Reasons|1|||
42098517|NCT00693420|75908943|FG001|Overall Study|Personal Reasons|4|||
42098518|NCT00695136|75908949|FG000|Overall Study|Withdrawal by Subject|1|||
42098519|NCT00695136|75908949|FG000|Overall Study|unrelated adverse event|1|||
42098520|NCT00605176|75908965|FG000|Overall Study|Adverse Event|2|||
42098521|NCT00605176|75908966|FG001|Overall Study|Adverse Event|1|||
42098522|NCT00605176|75908967|FG002|Overall Study|Adverse Event|3|||
42193199|NCT04311177|76004384|FG000|Overall Study|Withdrawal by Subject|1|||
42359299|NCT01287611|76204904|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
42098523|NCT00605176|75908965|FG000|Overall Study|Withdrawal by Subject|4|||
42098524|NCT00605176|75908966|FG001|Overall Study|Withdrawal by Subject|2|||
42098525|NCT00605176|75908967|FG002|Overall Study|Withdrawal by Subject|4|||
42193200|NCT04311177|76004385|FG001|Overall Study|Withdrawal by Subject|0|||
42193201|NCT03267212|76004391|FG000|First Intervention|Lost to Follow-up|0|||
42098526|NCT00605176|75908965|FG000|Overall Study|Lost to Follow-up|2|||
42098527|NCT00605176|75908966|FG001|Overall Study|Lost to Follow-up|2|||
42193202|NCT03267212|76004392|FG001|First Intervention|Lost to Follow-up|2|||
42193203|NCT03267212|76004391|FG000|First Intervention|Withdrawal by Subject|1|||
42193204|NCT03267212|76004392|FG001|First Intervention|Withdrawal by Subject|1|||
42193205|NCT03267212|76004391|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
42193206|NCT03267212|76004392|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
42193207|NCT04292535|76004412|FG000|Overall Study|Withdrawal by Subject|0|||
42193208|NCT04292535|76004413|FG001|Overall Study|Withdrawal by Subject|0|||
42193209|NCT04292535|76004414|FG002|Overall Study|Withdrawal by Subject|0|||
42193210|NCT04292535|76004415|FG003|Overall Study|Withdrawal by Subject|0|||
42193211|NCT04292535|76004416|FG004|Overall Study|Withdrawal by Subject|0|||
42193212|NCT04292535|76004417|FG005|Overall Study|Withdrawal by Subject|0|||
42193213|NCT04292535|76004418|FG006|Overall Study|Withdrawal by Subject|0|||
42193214|NCT04292535|76004419|FG007|Overall Study|Withdrawal by Subject|1|||
42098528|NCT00605176|75908967|FG002|Overall Study|Lost to Follow-up|1|||
42098529|NCT00605176|75908965|FG000|Overall Study|Non-complicance with study procedures|1|||
42098530|NCT00605176|75908966|FG001|Overall Study|Non-complicance with study procedures|0|||
42098531|NCT00605176|75908967|FG002|Overall Study|Non-complicance with study procedures|0|||
42098532|NCT00605176|75908965|FG000|Overall Study|Use of concomitant therapy|1|||
42098533|NCT00605176|75908966|FG001|Overall Study|Use of concomitant therapy|0|||
42193215|NCT04292535|76004420|FG008|Overall Study|Withdrawal by Subject|0|||
42193216|NCT04292535|76004421|FG009|Overall Study|Withdrawal by Subject|0|||
42193217|NCT04292535|76004422|FG010|Overall Study|Withdrawal by Subject|0|||
42193218|NCT04292535|76004423|FG011|Overall Study|Withdrawal by Subject|0|||
42193219|NCT04292535|76004424|FG012|Overall Study|Withdrawal by Subject|0|||
42193220|NCT04292535|76004425|FG013|Overall Study|Withdrawal by Subject|0|||
42193221|NCT04292535|76004412|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
42193222|NCT04292535|76004413|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
42193223|NCT04292535|76004414|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
42193224|NCT04292535|76004415|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
42193225|NCT04292535|76004416|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
42193226|NCT04292535|76004417|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
42193227|NCT04292535|76004418|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
42193228|NCT04292535|76004419|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
42098534|NCT00605176|75908967|FG002|Overall Study|Use of concomitant therapy|1|||
42098535|NCT00605176|75908965|FG000|Overall Study|Other (not due to AE)|1|||
42193229|NCT04292535|76004420|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
42193230|NCT04292535|76004421|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
42193231|NCT04292535|76004422|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
42193232|NCT04292535|76004423|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
42193233|NCT04292535|76004424|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
42193234|NCT04292535|76004425|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
42193235|NCT04292535|76004412|FG000|Overall Study|Report of Dizziness|0|||
42098536|NCT00605176|75908966|FG001|Overall Study|Other (not due to AE)|1|||
42098537|NCT00605176|75908967|FG002|Overall Study|Other (not due to AE)|0|||
42193236|NCT04292535|76004413|FG001|Overall Study|Report of Dizziness|0|||
42193237|NCT04292535|76004414|FG002|Overall Study|Report of Dizziness|0|||
42193238|NCT04292535|76004415|FG003|Overall Study|Report of Dizziness|0|||
42193239|NCT04292535|76004416|FG004|Overall Study|Report of Dizziness|0|||
42193240|NCT04292535|76004417|FG005|Overall Study|Report of Dizziness|0|||
42193241|NCT04292535|76004418|FG006|Overall Study|Report of Dizziness|0|||
42193242|NCT04292535|76004419|FG007|Overall Study|Report of Dizziness|0|||
42193243|NCT04292535|76004420|FG008|Overall Study|Report of Dizziness|0|||
42193244|NCT04292535|76004421|FG009|Overall Study|Report of Dizziness|0|||
42193245|NCT04292535|76004422|FG010|Overall Study|Report of Dizziness|0|||
42193246|NCT04292535|76004423|FG011|Overall Study|Report of Dizziness|0|||
42193247|NCT04292535|76004424|FG012|Overall Study|Report of Dizziness|0|||
42193248|NCT04292535|76004425|FG013|Overall Study|Report of Dizziness|1|||
42193249|NCT04292535|76004412|FG000|Overall Study|Equipment Failure|0|||
42098538|NCT00694356|75908978|FG000|Overall Study|Adverse Event|1|||
42098539|NCT00694356|75908979|FG001|Overall Study|Adverse Event|0|||
42098540|NCT00694356|75908980|FG002|Overall Study|Adverse Event|0|||
42193250|NCT04292535|76004413|FG001|Overall Study|Equipment Failure|0|||
42193251|NCT04292535|76004414|FG002|Overall Study|Equipment Failure|0|||
42193252|NCT04292535|76004415|FG003|Overall Study|Equipment Failure|0|||
42193253|NCT04292535|76004416|FG004|Overall Study|Equipment Failure|0|||
42193254|NCT04292535|76004417|FG005|Overall Study|Equipment Failure|0|||
42193255|NCT04292535|76004418|FG006|Overall Study|Equipment Failure|0|||
42193256|NCT04292535|76004419|FG007|Overall Study|Equipment Failure|0|||
42193257|NCT04292535|76004420|FG008|Overall Study|Equipment Failure|0|||
42193258|NCT04292535|76004421|FG009|Overall Study|Equipment Failure|0|||
42193259|NCT04292535|76004422|FG010|Overall Study|Equipment Failure|0|||
42193260|NCT04292535|76004423|FG011|Overall Study|Equipment Failure|1|||
42193261|NCT04292535|76004424|FG012|Overall Study|Equipment Failure|0|||
42193262|NCT04292535|76004425|FG013|Overall Study|Equipment Failure|0|||
42193263|NCT04385199|76004457|FG000|Overall Study|Withdrawal by Subject|1|||
42193264|NCT04385199|76004458|FG001|Overall Study|Withdrawal by Subject|0|||
42193265|NCT04284813|76004464|FG000|Overall Study|Withdrawal by Subject|1|||
42193266|NCT03263780|76004468|FG000|Overall Study|Withdrawal by Subject|3|||
42193267|NCT03263780|76004468|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
42193268|NCT02791438|76004474|FG000|Treatment Period|Adverse Event|1|||
42193269|NCT02791438|76004475|FG001|Treatment Period|Adverse Event|0|||
42193270|NCT02791438|76004474|FG000|Treatment Period|Withdrawal by Subject|0|||
42193271|NCT02791438|76004475|FG001|Treatment Period|Withdrawal by Subject|1|||
42193272|NCT02791438|76004474|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
42193273|NCT02791438|76004475|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
42193274|NCT03712124|76004483|FG000|Overall Study|Protocol Violation|1|||
42193275|NCT03712124|76004484|FG001|Overall Study|Protocol Violation|0|||
42193276|NCT02791516|76004498|FG000|Overall Study|Withdrawal by Subject|1|||
42193277|NCT02791516|76004499|FG001|Overall Study|Withdrawal by Subject|1|||
42193278|NCT03263702|76004507|FG000|Overall Study|Lost to Follow-up|2|||
42193279|NCT03263702|76004508|FG001|Overall Study|Lost to Follow-up|2|||
42193280|NCT03263702|76004507|FG000|Overall Study|Withdrawal by Subject|1|||
42193281|NCT03263702|76004508|FG001|Overall Study|Withdrawal by Subject|2|||
42193282|NCT04130919|76004517|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
42193283|NCT04130919|76004518|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
42193284|NCT04130919|76004519|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
42193285|NCT04130919|76004520|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
42193286|NCT04130919|76004521|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
42193287|NCT04130919|76004522|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
42193288|NCT04130919|76004517|FG000|Blinded Treatment Phase|Adverse Event|0|||
42193289|NCT04130919|76004518|FG001|Blinded Treatment Phase|Adverse Event|0|||
42193290|NCT04130919|76004519|FG002|Blinded Treatment Phase|Adverse Event|1|||
42193291|NCT04130919|76004520|FG003|Blinded Treatment Phase|Adverse Event|0|||
42193292|NCT04130919|76004521|FG004|Blinded Treatment Phase|Adverse Event|0|||
42193293|NCT04130919|76004522|FG005|Blinded Treatment Phase|Adverse Event|0|||
42193294|NCT04130919|76004517|FG000|Blinded Treatment Phase|Disease worsening|0|||
42193295|NCT04130919|76004518|FG001|Blinded Treatment Phase|Disease worsening|0|||
42193296|NCT04130919|76004519|FG002|Blinded Treatment Phase|Disease worsening|1|||
42193297|NCT04130919|76004520|FG003|Blinded Treatment Phase|Disease worsening|0|||
42193298|NCT04130919|76004521|FG004|Blinded Treatment Phase|Disease worsening|0|||
42193299|NCT04130919|76004522|FG005|Blinded Treatment Phase|Disease worsening|0|||
42193300|NCT04130919|76004517|FG000|Blinded Treatment Phase|Investigator's decision|0|||
42193301|NCT04130919|76004518|FG001|Blinded Treatment Phase|Investigator's decision|1|||
42297761|NCT02575807|76132952|FG001|Overall Study|Subject ineligible - medical implant|0|||
42297762|NCT02575807|76132953|FG002|Overall Study|Subject ineligible - medical implant|0|||
42297763|NCT02575807|76132954|FG003|Overall Study|Subject ineligible - medical implant|1|||
42297764|NCT02575807|76132955|FG004|Overall Study|Subject ineligible - medical implant|0|||
42297765|NCT02575807|76132951|FG000|Overall Study|Withdrawal by Subject|0|||
42297766|NCT02575807|76132952|FG001|Overall Study|Withdrawal by Subject|0|||
42297767|NCT02575807|76132953|FG002|Overall Study|Withdrawal by Subject|1|||
42297768|NCT02575807|76132954|FG003|Overall Study|Withdrawal by Subject|1|||
42297769|NCT02575807|76132955|FG004|Overall Study|Withdrawal by Subject|2|||
42359300|NCT01194271|76204912|FG000|Overall Study|Withdrawal by Subject|1|||
42193302|NCT04130919|76004519|FG002|Blinded Treatment Phase|Investigator's decision|0|||
42193303|NCT04130919|76004520|FG003|Blinded Treatment Phase|Investigator's decision|0|||
42193304|NCT04130919|76004521|FG004|Blinded Treatment Phase|Investigator's decision|0|||
42193305|NCT04130919|76004522|FG005|Blinded Treatment Phase|Investigator's decision|0|||
42193306|NCT04130919|76004517|FG000|Blinded Treatment Phase|Withdrew consent|1|||
42193307|NCT04130919|76004518|FG001|Blinded Treatment Phase|Withdrew consent|0|||
42193308|NCT04130919|76004519|FG002|Blinded Treatment Phase|Withdrew consent|0|||
42193309|NCT04130919|76004520|FG003|Blinded Treatment Phase|Withdrew consent|0|||
42193310|NCT04130919|76004521|FG004|Blinded Treatment Phase|Withdrew consent|0|||
42193311|NCT04130919|76004522|FG005|Blinded Treatment Phase|Withdrew consent|0|||
42193312|NCT04130919|76004517|FG000|Open-label Treatment Phase|Withdrew consent|0|||
42193313|NCT04130919|76004518|FG001|Open-label Treatment Phase|Withdrew consent|0|||
42193314|NCT04130919|76004519|FG002|Open-label Treatment Phase|Withdrew consent|0|||
42193315|NCT04130919|76004520|FG003|Open-label Treatment Phase|Withdrew consent|1|||
42193316|NCT04130919|76004521|FG004|Open-label Treatment Phase|Withdrew consent|1|||
42193317|NCT04130919|76004522|FG005|Open-label Treatment Phase|Withdrew consent|1|||
42359301|NCT01194271|76204912|FG000|Overall Study|Ineligible, Screen Failure|1|||
42193318|NCT04130919|76004517|FG000|Open-label Treatment Phase|Disease worsening|0|||
42193319|NCT04130919|76004518|FG001|Open-label Treatment Phase|Disease worsening|0|||
42193320|NCT04130919|76004519|FG002|Open-label Treatment Phase|Disease worsening|0|||
42193321|NCT04130919|76004520|FG003|Open-label Treatment Phase|Disease worsening|1|||
42193322|NCT04130919|76004521|FG004|Open-label Treatment Phase|Disease worsening|0|||
42193323|NCT04130919|76004522|FG005|Open-label Treatment Phase|Disease worsening|1|||
42193324|NCT04130919|76004517|FG000|Open-label Treatment Phase|Investigator's decision|0|||
42193325|NCT04130919|76004518|FG001|Open-label Treatment Phase|Investigator's decision|0|||
42193326|NCT04130919|76004519|FG002|Open-label Treatment Phase|Investigator's decision|0|||
42193327|NCT04130919|76004520|FG003|Open-label Treatment Phase|Investigator's decision|1|||
42193328|NCT04130919|76004521|FG004|Open-label Treatment Phase|Investigator's decision|0|||
42193329|NCT04130919|76004522|FG005|Open-label Treatment Phase|Investigator's decision|0|||
42193330|NCT04130919|76004517|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
42193331|NCT04130919|76004518|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
42193332|NCT04130919|76004519|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
42193333|NCT04130919|76004520|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
42193334|NCT04130919|76004521|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
42193335|NCT04130919|76004522|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
42193336|NCT04130919|76004517|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
42193337|NCT04130919|76004518|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
42193338|NCT04130919|76004519|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
42193339|NCT04130919|76004520|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
42193340|NCT04130919|76004521|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
42193341|NCT04130919|76004522|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
42193342|NCT04128267|76004536|FG000|Overall Study|Withdrawal by Subject|6|||
42098541|NCT00694356|75908978|FG000|Overall Study|Progressive Disease|2|||
42098542|NCT00694356|75908979|FG001|Overall Study|Progressive Disease|6|||
42098543|NCT00694356|75908980|FG002|Overall Study|Progressive Disease|6|||
42098544|NCT00692406|75908988|FG000|Overall Study|PI dropped, bad data|57|||
42098545|NCT00567502|75909005|FG000|Overall Study|Lost to Follow-up|91|||
42098546|NCT00567502|75909006|FG001|Overall Study|Lost to Follow-up|14|||
42193343|NCT04128267|76004536|FG000|Overall Study|Death|2|||
42193344|NCT04128267|76004536|FG000|Overall Study|Disease progression|1|||
42193345|NCT04128267|76004536|FG000|Overall Study|Participant had other medical issues|4|||
42193346|NCT04128267|76004536|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
42193347|NCT03691779|76004540|FG000|Part B (24 Weeks)|Adverse Event|0|||
42193348|NCT03691779|76004541|FG001|Part B (24 Weeks)|Adverse Event|1|||
42193349|NCT03691779|76004540|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
42193350|NCT03691779|76004541|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
42193351|NCT04258995|76004550|FG000|Overall Study|Lost to Follow-up|1|||
42193352|NCT04258995|76004551|FG001|Overall Study|Lost to Follow-up|1|||
42193353|NCT04247061|76004557|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
42193354|NCT04247061|76004557|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
42193355|NCT04247061|76004557|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
42193356|NCT04241133|76004563|FG000|Overall Study|COVID19 Precautions|14|||
42098547|NCT00567502|75909007|FG002|Overall Study|Lost to Follow-up|351|||
42098548|NCT00567502|75909008|FG003|Overall Study|Lost to Follow-up|2|||
42098549|NCT00567502|75909005|FG000|Overall Study|Death|65|||
42098550|NCT00567502|75909006|FG001|Overall Study|Death|16|||
42098551|NCT00567502|75909007|FG002|Overall Study|Death|360|||
42098552|NCT00567502|75909008|FG003|Overall Study|Death|5|||
42098553|NCT00567502|75909005|FG000|Overall Study|Other|64|||
42098554|NCT00567502|75909006|FG001|Overall Study|Other|2|||
42098555|NCT00567502|75909007|FG002|Overall Study|Other|134|||
42098556|NCT00567502|75909008|FG003|Overall Study|Other|6|||
42098557|NCT00567502|75909005|FG000|Overall Study|Participant request|12|||
42098558|NCT00567502|75909006|FG001|Overall Study|Participant request|1|||
42098559|NCT00567502|75909007|FG002|Overall Study|Participant request|33|||
42193357|NCT04241133|76004564|FG001|Overall Study|COVID19 Precautions|34|||
42193358|NCT04123665|76004572|FG000|Overall Study|Withdrawal by Subject|7|||
42193359|NCT04123665|76004573|FG001|Overall Study|Withdrawal by Subject|0|||
42098560|NCT00567502|75909008|FG003|Overall Study|Participant request|1|||
42098561|NCT00567502|75909005|FG000|Overall Study|Sponsor request|9|||
42098562|NCT00567502|75909006|FG001|Overall Study|Sponsor request|0|||
42098563|NCT00567502|75909007|FG002|Overall Study|Sponsor request|30|||
42098564|NCT00567502|75909008|FG003|Overall Study|Sponsor request|1|||
42098565|NCT00567502|75909005|FG000|Overall Study|Never Initiated Treatment|0|||
42098566|NCT00567502|75909006|FG001|Overall Study|Never Initiated Treatment|0|||
42098567|NCT00567502|75909007|FG002|Overall Study|Never Initiated Treatment|0|||
42098568|NCT00567502|75909008|FG003|Overall Study|Never Initiated Treatment|72|||
42098569|NCT00396331|75909033|FG000|Overall Study|Failed to mobilize - no transplant|8|||
42098570|NCT00396331|75909033|FG000|Overall Study|Did not go on to transplant|5|||
42098571|NCT00396331|75909033|FG000|Overall Study|Lost to Follow-up|3|||
42098572|NCT00396331|75909033|FG000|Overall Study|Death|16|||
42098573|NCT00396253|75909045|FG000|Overall Study|Protocol Violation|1|||
42098574|NCT00396253|75909045|FG000|Overall Study|Withdrawal by Subject|7|||
42098575|NCT00396253|75909045|FG000|Overall Study|Death|3|||
42098576|NCT00396253|75909045|FG000|Overall Study|Physician Decision|1|||
42193360|NCT04123665|76004572|FG000|Overall Study|Lost to Follow-up|1|||
42193361|NCT04123665|76004573|FG001|Overall Study|Lost to Follow-up|0|||
42098577|NCT00396253|75909045|FG000|Overall Study|Change in eligibility status|1|||
42098578|NCT00604162|75909049|FG000|Overall Study|Physician Decision|3|||
42098579|NCT00604162|75909049|FG000|Overall Study|Withdrawal by Subject|1|||
42098580|NCT00396097|75909058|FG000|Overall Study|Withdrawal by Subject|17|||
42098581|NCT00396097|75909059|FG001|Overall Study|Withdrawal by Subject|17|||
42098582|NCT00396097|75909058|FG000|Overall Study|Lost to Follow-up|4|||
42098583|NCT00396097|75909059|FG001|Overall Study|Lost to Follow-up|9|||
42098584|NCT00396097|75909058|FG000|Overall Study|Other|3|||
42098585|NCT00396097|75909059|FG001|Overall Study|Other|5|||
42098586|NCT00396097|75909058|FG000|Overall Study|Protocol Violation|0|||
42098587|NCT00396097|75909059|FG001|Overall Study|Protocol Violation|6|||
42098588|NCT00396097|75909058|FG000|Overall Study|Adverse Event|1|||
42098589|NCT00396097|75909059|FG001|Overall Study|Adverse Event|5|||
42098590|NCT00396097|75909058|FG000|Overall Study|Insufficient Clinical Response|1|||
42098591|NCT00396097|75909059|FG001|Overall Study|Insufficient Clinical Response|4|||
42098592|NCT00375505|75909071|FG000|Overall Study|Adverse Event|1|||
42098593|NCT00375505|75909072|FG001|Overall Study|Adverse Event|2|||
42098594|NCT00375427|75909080|FG000|Overall Study|Adverse Event|21|||
42098595|NCT00375427|75909081|FG001|Overall Study|Adverse Event|27|||
42098596|NCT00375427|75909080|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42098597|NCT00375427|75909081|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42098598|NCT00375427|75909080|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42098599|NCT00375427|75909081|FG001|Overall Study|Abnormal laboratory value(s)|2|||
42098600|NCT00375427|75909080|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
42098601|NCT00375427|75909081|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
42098602|NCT00375427|75909080|FG000|Overall Study|Patient no longer requires study drug|3|||
42098603|NCT00375427|75909081|FG001|Overall Study|Patient no longer requires study drug|7|||
42098604|NCT00375427|75909080|FG000|Overall Study|Protocol Violation|10|||
42098605|NCT00375427|75909081|FG001|Overall Study|Protocol Violation|8|||
42098606|NCT00375427|75909080|FG000|Overall Study|Withdrawal by Subject|9|||
42193362|NCT04232943|76004582|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
42193363|NCT04232943|76004583|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
42193364|NCT04232943|76004584|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
42193365|NCT04232943|76004582|FG000|Overall Study|Withdrawal by Subject|1|||
42193366|NCT04232943|76004583|FG001|Overall Study|Withdrawal by Subject|1|||
42193367|NCT04232943|76004584|FG002|Overall Study|Withdrawal by Subject|0|||
42193368|NCT03694275|76004595|FG000|Overall Study|Adverse Event|0|||
42193369|NCT03694275|76004596|FG001|Overall Study|Adverse Event|1|||
42193370|NCT03694275|76004595|FG000|Overall Study|Reason not Specified|0|||
42193371|NCT03694275|76004596|FG001|Overall Study|Reason not Specified|1|||
42193372|NCT04230213|76004603|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
42193373|NCT04230213|76004604|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
42193374|NCT04230213|76004605|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
42193375|NCT04230213|76004603|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
42193376|NCT04230213|76004604|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
42193377|NCT04230213|76004605|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
42193378|NCT04230213|76004603|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
42193379|NCT04230213|76004604|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
42193380|NCT04230213|76004605|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
42193381|NCT04230213|76004603|FG000|TP2: Week 10 to Week 16|Other|0|||
42098607|NCT00375427|75909081|FG001|Overall Study|Withdrawal by Subject|13|||
42098608|NCT00375427|75909080|FG000|Overall Study|Lost to Follow-up|1|||
42098609|NCT00375427|75909081|FG001|Overall Study|Lost to Follow-up|1|||
42098610|NCT00375427|75909080|FG000|Overall Study|Administrative reasons|0|||
42098611|NCT00375427|75909081|FG001|Overall Study|Administrative reasons|1|||
42098612|NCT00375427|75909080|FG000|Overall Study|Death|11|||
42098613|NCT00375427|75909081|FG001|Overall Study|Death|10|||
42098614|NCT00393913|75909087|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
42098615|NCT00393913|75909087|FG000|Initial Assessment|Withdrawal by Subject|16|||
42098616|NCT00393913|75909087|FG000|CPAP|Withdrawal by Subject|3|||
42098617|NCT00393913|75909087|FG000|CPAP|Physician Decision|1|||
42098618|NCT00393913|75909087|FG000|CPAP|TEchnical problem with CPAP|3|||
42098619|NCT00567268|75909092|FG000|Overall Study|Protocol Violation|7|||
42193382|NCT04230213|76004604|FG001|TP2: Week 10 to Week 16|Other|2|||
42193383|NCT04230213|76004605|FG002|TP2: Week 10 to Week 16|Other|1|||
42193384|NCT04230213|76004603|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
42193385|NCT04230213|76004604|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
42193386|NCT04230213|76004605|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
42193387|NCT04230213|76004603|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
42193388|NCT04230213|76004604|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
42193389|NCT04230213|76004605|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
42193390|NCT04230213|76004603|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
42193391|NCT04230213|76004604|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
42098620|NCT00567268|75909092|FG000|Overall Study|Lost to Follow-up|36|||
42098621|NCT00567268|75909092|FG000|Overall Study|No Visit After First Day of Treatment|2|||
42098622|NCT00567268|75909092|FG000|Overall Study|No Drug Administration|4|||
42098623|NCT00567268|75909092|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
42098624|NCT03976648|75909133|FG000|Overall Study|Adverse Event|0|||
42098625|NCT03976648|75909134|FG001|Overall Study|Adverse Event|2|||
42098626|NCT03976648|75909133|FG000|Overall Study|Study terminated by sponsor|21|||
42098627|NCT03976648|75909134|FG001|Overall Study|Study terminated by sponsor|8|||
42098628|NCT00566254|75909142|FG000|Overall Study|Adverse Event|3|||
42098629|NCT00566254|75909143|FG001|Overall Study|Adverse Event|1|||
42098630|NCT00566254|75909142|FG000|Overall Study|Protocol Violation|1|||
42098631|NCT00566254|75909143|FG001|Overall Study|Protocol Violation|3|||
42098632|NCT00566254|75909142|FG000|Overall Study|Withdrawal by Subject|1|||
42098633|NCT00566254|75909143|FG001|Overall Study|Withdrawal by Subject|2|||
42098634|NCT00566254|75909142|FG000|Overall Study|Lack of Efficacy|5|||
42098635|NCT00566254|75909143|FG001|Overall Study|Lack of Efficacy|6|||
42098636|NCT00566254|75909142|FG000|Overall Study|Other|0|||
42098637|NCT00566254|75909143|FG001|Overall Study|Other|2|||
42098638|NCT00393523|75909154|FG000|Overall Study|Lost to Follow-up|0|||
42098639|NCT00393523|75909155|FG001|Overall Study|Lost to Follow-up|0|||
42098640|NCT00393523|75909156|FG002|Overall Study|Lost to Follow-up|0|||
42098641|NCT00393523|75909157|FG003|Overall Study|Lost to Follow-up|2|||
42098642|NCT00393523|75909158|FG004|Overall Study|Lost to Follow-up|1|||
42098643|NCT00393523|75909154|FG000|Overall Study|Protocol Violation|6|||
42098644|NCT00393523|75909155|FG001|Overall Study|Protocol Violation|2|||
42098645|NCT00393523|75909156|FG002|Overall Study|Protocol Violation|0|||
42098646|NCT00393523|75909157|FG003|Overall Study|Protocol Violation|1|||
42098647|NCT00393523|75909158|FG004|Overall Study|Protocol Violation|0|||
42098648|NCT00393523|75909154|FG000|Overall Study|Withdrawal by Subject|6|||
42098649|NCT00393523|75909155|FG001|Overall Study|Withdrawal by Subject|7|||
42098650|NCT00393523|75909156|FG002|Overall Study|Withdrawal by Subject|2|||
42098651|NCT00393523|75909157|FG003|Overall Study|Withdrawal by Subject|3|||
42098652|NCT00393523|75909158|FG004|Overall Study|Withdrawal by Subject|0|||
42098653|NCT00393523|75909154|FG000|Overall Study|Difficulties in specimen collection|0|||
42098654|NCT00393523|75909155|FG001|Overall Study|Difficulties in specimen collection|0|||
42098655|NCT00393523|75909156|FG002|Overall Study|Difficulties in specimen collection|1|||
42098656|NCT00393523|75909157|FG003|Overall Study|Difficulties in specimen collection|0|||
42098657|NCT00393523|75909158|FG004|Overall Study|Difficulties in specimen collection|0|||
42098658|NCT00393523|75909154|FG000|Overall Study|Vaccine supply issue|0|||
42098659|NCT00393523|75909155|FG001|Overall Study|Vaccine supply issue|0|||
42098660|NCT00393523|75909156|FG002|Overall Study|Vaccine supply issue|1|||
42098661|NCT00393523|75909157|FG003|Overall Study|Vaccine supply issue|0|||
42098662|NCT00393523|75909158|FG004|Overall Study|Vaccine supply issue|0|||
42098663|NCT00393367|75909171|FG000|Overall Study|Protocol Violation|2|||
42098664|NCT00393367|75909172|FG001|Overall Study|Protocol Violation|5|||
42098665|NCT00393367|75909171|FG000|Overall Study|Withdrawal by Subject|0|||
42098666|NCT00393367|75909172|FG001|Overall Study|Withdrawal by Subject|2|||
42098667|NCT00395863|75909182|FG000|Overall Study|Patients did not complete both exams|2|||
42098668|NCT00395863|75909183|FG001|Overall Study|Patients did not complete both exams|3|||
42098669|NCT00395629|75909195|FG000|Core Study|Adverse Event|0|||
42098670|NCT00395629|75909196|FG001|Core Study|Adverse Event|3|||
42098671|NCT00395629|75909197|FG002|Core Study|Adverse Event|4|||
42098672|NCT00395629|75909195|FG000|Core Study|Abnormal laboratory value(s)|0|||
42098673|NCT00395629|75909196|FG001|Core Study|Abnormal laboratory value(s)|0|||
42098674|NCT00395629|75909197|FG002|Core Study|Abnormal laboratory value(s)|1|||
42098675|NCT00395629|75909195|FG000|Core Study|Protocol Violation|1|||
42098676|NCT00395629|75909196|FG001|Core Study|Protocol Violation|0|||
42098677|NCT00395629|75909197|FG002|Core Study|Protocol Violation|0|||
42098678|NCT00395629|75909195|FG000|Core Study|Withdrawal by Subject|0|||
42098679|NCT00395629|75909196|FG001|Core Study|Withdrawal by Subject|1|||
42098680|NCT00395629|75909197|FG002|Core Study|Withdrawal by Subject|1|||
42098681|NCT00395629|75909195|FG000|Core Study|Lost to Follow-up|0|||
42098682|NCT00395629|75909196|FG001|Core Study|Lost to Follow-up|0|||
42098683|NCT00395629|75909197|FG002|Core Study|Lost to Follow-up|1|||
42193392|NCT04230213|76004605|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
42193393|NCT04230213|76004603|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
42098684|NCT00395629|75909195|FG000|Extension Study|Adverse Event|0|||
42098685|NCT00395629|75909196|FG001|Extension Study|Adverse Event|0|||
42098686|NCT00395629|75909197|FG002|Extension Study|Adverse Event|2|||
42098687|NCT00395629|75909195|FG000|Extension Study|Administrative problems|0|||
42193394|NCT04230213|76004604|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
42098688|NCT00395629|75909196|FG001|Extension Study|Administrative problems|0|||
42193395|NCT04230213|76004605|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
42193396|NCT04230213|76004603|FG000|TP3: Week 16 to Week 22|Other|0|||
42193397|NCT04230213|76004604|FG001|TP3: Week 16 to Week 22|Other|1|||
42193398|NCT04230213|76004605|FG002|TP3: Week 16 to Week 22|Other|3|||
42297770|NCT02575339|76132981|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
42297771|NCT02575339|76132982|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
42297772|NCT02575339|76132983|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
42297773|NCT02575339|76132981|FG000|Study Treatment|Disease Progression|5|||
42297774|NCT02575339|76132982|FG001|Study Treatment|Disease Progression|2|||
42297775|NCT02575339|76132983|FG002|Study Treatment|Disease Progression|0|||
42297776|NCT02575339|76132981|FG000|Study Treatment|Adverse Event|1|||
42297777|NCT02575339|76132982|FG001|Study Treatment|Adverse Event|2|||
42297778|NCT02575339|76132983|FG002|Study Treatment|Adverse Event|0|||
42297779|NCT02575339|76132981|FG000|Follow up|Death|6|||
42297780|NCT02575339|76132982|FG001|Follow up|Death|2|||
42297781|NCT02575339|76132983|FG002|Follow up|Death|0|||
42297782|NCT02575339|76132981|FG000|Follow up|Study Terminated|0|||
42297783|NCT02575339|76132982|FG001|Follow up|Study Terminated|2|||
42297784|NCT02575339|76132983|FG002|Follow up|Study Terminated|0|||
42297785|NCT02575339|76132981|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
42297786|NCT02575339|76132982|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
42297787|NCT02575339|76132983|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
42297788|NCT01712659|76132996|FG000|Dose Escalation|Physician Decision|0|||
42297789|NCT01712659|76132997|FG001|Dose Escalation|Physician Decision|1|||
42297790|NCT01712659|76132998|FG002|Dose Escalation|Physician Decision|0|||
42297791|NCT01712659|76132999|FG003|Dose Escalation|Physician Decision|0|||
42297792|NCT01712659|76133000|FG004|Dose Escalation|Physician Decision|0|||
42297793|NCT01712659|76132996|FG000|Dose Escalation|Unable to take study drug|0|||
42297794|NCT01712659|76132997|FG001|Dose Escalation|Unable to take study drug|1|||
42297795|NCT01712659|76132998|FG002|Dose Escalation|Unable to take study drug|0|||
42297796|NCT01712659|76132999|FG003|Dose Escalation|Unable to take study drug|0|||
42297797|NCT01712659|76133000|FG004|Dose Escalation|Unable to take study drug|0|||
42297798|NCT01712659|76132996|FG000|Dose Expansion|Early disease progression|1|||
42297799|NCT01712659|76132997|FG001|Dose Expansion|Early disease progression|0|||
42297800|NCT01712659|76132998|FG002|Dose Expansion|Early disease progression|0|||
42297801|NCT01712659|76132999|FG003|Dose Expansion|Early disease progression|0|||
42297802|NCT01712659|76133000|FG004|Dose Expansion|Early disease progression|0|||
42297803|NCT01712659|76132996|FG000|Dose Expansion|Physician Decision|1|||
42297804|NCT01712659|76132997|FG001|Dose Expansion|Physician Decision|0|||
42297805|NCT01712659|76132998|FG002|Dose Expansion|Physician Decision|0|||
42297806|NCT01712659|76132999|FG003|Dose Expansion|Physician Decision|0|||
42297807|NCT01712659|76133000|FG004|Dose Expansion|Physician Decision|0|||
42098689|NCT00395629|75909197|FG002|Extension Study|Administrative problems|1|||
42098690|NCT00392665|75909210|FG000|Overall Study|Death|16|||
42098691|NCT00392665|75909211|FG001|Overall Study|Death|14|||
42098692|NCT00392665|75909210|FG000|Overall Study|Lost to Follow-up|1|||
42098693|NCT00392665|75909211|FG001|Overall Study|Lost to Follow-up|1|||
42098694|NCT00622869|75909220|FG000|Overall Study|Subject Withdrew Consent|13|||
42098695|NCT00622869|75909221|FG001|Overall Study|Subject Withdrew Consent|17|||
42098696|NCT00622869|75909222|FG002|Overall Study|Subject Withdrew Consent|11|||
42098697|NCT00622869|75909220|FG000|Overall Study|Administrative Problems|11|||
42098698|NCT00622869|75909221|FG001|Overall Study|Administrative Problems|17|||
42098699|NCT00622869|75909222|FG002|Overall Study|Administrative Problems|13|||
42098700|NCT00622869|75909220|FG000|Overall Study|Death|12|||
42098701|NCT00622869|75909221|FG001|Overall Study|Death|15|||
42098702|NCT00622869|75909222|FG002|Overall Study|Death|10|||
42098703|NCT00622869|75909220|FG000|Overall Study|Lost to Follow-up|2|||
42098704|NCT00622869|75909221|FG001|Overall Study|Lost to Follow-up|4|||
42297808|NCT01610713|76133026|FG000|Overall Study|Adverse Event|3|||
42297809|NCT01610713|76133027|FG001|Overall Study|Adverse Event|0|||
42297810|NCT01610713|76133026|FG000|Overall Study|Lack of Efficacy|1|||
42098705|NCT00622869|75909222|FG002|Overall Study|Lost to Follow-up|2|||
42098706|NCT00622869|75909220|FG000|Overall Study|Graft Loss|5|||
42098707|NCT00622869|75909221|FG001|Overall Study|Graft Loss|3|||
42193399|NCT04230213|76004603|FG000|TP4: Week 22 to Week 32|Other|0|||
42193400|NCT04230213|76004604|FG001|TP4: Week 22 to Week 32|Other|5|||
42193401|NCT04230213|76004605|FG002|TP4: Week 22 to Week 32|Other|5|||
42193402|NCT04230213|76004603|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
42193403|NCT04230213|76004604|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
42193404|NCT04230213|76004605|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
42193405|NCT04230213|76004603|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
42193406|NCT04230213|76004604|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
42193407|NCT04230213|76004605|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
42098708|NCT00622869|75909222|FG002|Overall Study|Graft Loss|2|||
42193408|NCT04230213|76004603|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
42193409|NCT04230213|76004604|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
42098709|NCT00622869|75909220|FG000|Overall Study|Missing|0|||
42098710|NCT00622869|75909221|FG001|Overall Study|Missing|1|||
42193410|NCT04230213|76004605|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
42193411|NCT04230213|76004603|FG000|Follow up: Week 32 to Week 36|Other|0|||
42193412|NCT04230213|76004604|FG001|Follow up: Week 32 to Week 36|Other|1|||
42193413|NCT04230213|76004605|FG002|Follow up: Week 32 to Week 36|Other|1|||
42193414|NCT04222725|76004617|FG000|Overall Study|Adverse Event|0|||
42193415|NCT04222725|76004618|FG001|Overall Study|Adverse Event|1|||
42193416|NCT04222725|76004619|FG002|Overall Study|Adverse Event|0|||
42193417|NCT04222725|76004620|FG003|Overall Study|Adverse Event|0|||
42193418|NCT04213989|76004632|FG000|Overall Study|Withdrawal by Subject|3|||
42193419|NCT04213989|76004633|FG001|Overall Study|Withdrawal by Subject|2|||
42193420|NCT04213989|76004632|FG000|Overall Study|Physician Decision|1|||
42193421|NCT04213989|76004633|FG001|Overall Study|Physician Decision|0|||
42193422|NCT04213989|76004632|FG000|Overall Study|Lost to Follow-up|0|||
42193423|NCT04213989|76004633|FG001|Overall Study|Lost to Follow-up|4|||
42193424|NCT03242252|76004642|FG000|Overall Study|At the Participant's own Request|18|||
42193425|NCT03242252|76004643|FG001|Overall Study|At the Participant's own Request|10|||
42193426|NCT03242252|76004644|FG002|Overall Study|At the Participant's own Request|15|||
42193427|NCT03242252|76004642|FG000|Overall Study|Adverse Event|8|||
42098711|NCT00622869|75909222|FG002|Overall Study|Missing|1|||
42098712|NCT00395083|75909232|FG000|Overall Study|Withdrawal by Subject|6|||
42098713|NCT00395083|75909233|FG001|Overall Study|Withdrawal by Subject|5|||
42098714|NCT00395083|75909232|FG000|Overall Study|Developed another disease|4|||
42193428|NCT03242252|76004643|FG001|Overall Study|Adverse Event|6|||
42297811|NCT01610713|76133027|FG001|Overall Study|Lack of Efficacy|0|||
42297812|NCT01610713|76133026|FG000|Overall Study|low mood and poor motivation|1|||
42297813|NCT01610713|76133027|FG001|Overall Study|low mood and poor motivation|0|||
42297814|NCT01610713|76133026|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
42297815|NCT01610713|76133027|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
42297816|NCT01610713|76133026|FG000|Overall Study|Lost to Follow-up|0|||
42297817|NCT01610713|76133027|FG001|Overall Study|Lost to Follow-up|1|||
42297818|NCT01606189|76133033|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
42297819|NCT01606189|76133034|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
42297820|NCT01606189|76133035|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
42297821|NCT01606189|76133036|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
42297822|NCT01606189|76133037|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
42297823|NCT01606189|76133038|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
42297824|NCT01606189|76133033|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
42297825|NCT01606189|76133034|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
42297826|NCT01606189|76133035|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
42098715|NCT00395083|75909233|FG001|Overall Study|Developed another disease|3|||
42098716|NCT00366457|75909239|FG000|Overall Study|never began study therapy|2|||
42098717|NCT00624819|75909247|FG000|Follow-up Period: Year 4|Parents decision|0|||
42098718|NCT00624819|75909248|FG001|Follow-up Period: Year 4|Parents decision|0|||
42098719|NCT00624819|75909249|FG002|Follow-up Period: Year 4|Parents decision|1|||
42297827|NCT01606189|76133036|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
42297828|NCT01606189|76133037|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
42297829|NCT01606189|76133038|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
42297830|NCT01663987|76133048|FG000|Overall Study|Adverse Event|7|||
42098720|NCT00624819|75909250|FG003|Follow-up Period: Year 4|Parents decision|0|||
42098721|NCT00624819|75909247|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
42297831|NCT01663987|76133049|FG001|Overall Study|Adverse Event|2|||
42297832|NCT01663987|76133048|FG000|Overall Study|Lost to Follow-up|1|||
42297833|NCT01663987|76133049|FG001|Overall Study|Lost to Follow-up|1|||
42297834|NCT01663987|76133048|FG000|Overall Study|Withdrawal by Subject|2|||
42297835|NCT01663987|76133049|FG001|Overall Study|Withdrawal by Subject|3|||
42098722|NCT00624819|75909248|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
42193429|NCT03242252|76004644|FG002|Overall Study|Adverse Event|9|||
42193430|NCT03242252|76004642|FG000|Overall Study|Poor Compliance to Protocol|0|||
42193431|NCT03242252|76004643|FG001|Overall Study|Poor Compliance to Protocol|2|||
42193432|NCT03242252|76004644|FG002|Overall Study|Poor Compliance to Protocol|3|||
42193433|NCT03242252|76004642|FG000|Overall Study|Study Terminated by Sponsor|1|||
42193434|NCT03242252|76004643|FG001|Overall Study|Study Terminated by Sponsor|0|||
42193435|NCT03242252|76004644|FG002|Overall Study|Study Terminated by Sponsor|0|||
42193436|NCT03242252|76004642|FG000|Overall Study|Reason not Specified|4|||
42193437|NCT03242252|76004643|FG001|Overall Study|Reason not Specified|4|||
42193438|NCT03242252|76004644|FG002|Overall Study|Reason not Specified|1|||
42193439|NCT03242252|76004642|FG000|Overall Study|Lost to Follow-up|5|||
42193440|NCT03242252|76004643|FG001|Overall Study|Lost to Follow-up|1|||
42193441|NCT03242252|76004644|FG002|Overall Study|Lost to Follow-up|4|||
42193442|NCT04109391|76004661|FG000|Overall Study|Adverse Event|2|||
42193443|NCT04109391|76004662|FG001|Overall Study|Adverse Event|2|||
42098723|NCT00624819|75909249|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
42098724|NCT00624819|75909250|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
42098725|NCT03832387|75909262|FG000|Overall Study|Protocol Violation|2|||
42098726|NCT03832387|75909263|FG001|Overall Study|Protocol Violation|6|||
42098727|NCT03832387|75909262|FG000|Overall Study|EXCLUSION CRITERIA|3|||
42098728|NCT03832387|75909263|FG001|Overall Study|EXCLUSION CRITERIA|1|||
42098729|NCT00366301|75909273|FG000|Overall Study|Lost to Follow-up|4|||
42098730|NCT00366301|75909274|FG001|Overall Study|Lost to Follow-up|4|||
42098731|NCT00366301|75909275|FG002|Overall Study|Lost to Follow-up|3|||
42098732|NCT00366301|75909276|FG003|Overall Study|Lost to Follow-up|7|||
42098733|NCT00366301|75909273|FG000|Overall Study|Withdrawal by Subject|4|||
42098734|NCT00366301|75909274|FG001|Overall Study|Withdrawal by Subject|2|||
42098735|NCT00366301|75909275|FG002|Overall Study|Withdrawal by Subject|1|||
42098736|NCT00366301|75909276|FG003|Overall Study|Withdrawal by Subject|1|||
42098737|NCT00365989|75909286|FG000|Overall Study|Withdrawal by Subject|1|||
42098738|NCT00365989|75909286|FG000|Overall Study|Non-compliance|1|||
42098739|NCT00622713|75909291|FG000|Overall Study|Adverse Event|35|||
42098740|NCT00622713|75909291|FG000|Overall Study|Administrative problems|4|||
42098741|NCT00622713|75909291|FG000|Overall Study|Withdrawal by Subject|11|||
42098742|NCT00622713|75909291|FG000|Overall Study|Lost to Follow-up|5|||
42098743|NCT00622713|75909291|FG000|Overall Study|Death|2|||
42098744|NCT00622713|75909291|FG000|Overall Study|Subject no longer required study drug|1|||
42098745|NCT00622713|75909291|FG000|Overall Study|Did not meet eligibility criteria|1|||
42098746|NCT00392197|75909297|FG000|Overall Study|Adverse Event|4|||
42098747|NCT00392197|75909298|FG001|Overall Study|Adverse Event|12|||
42098748|NCT00392197|75909297|FG000|Overall Study|Lack of Efficacy|3|||
42098749|NCT00392197|75909298|FG001|Overall Study|Lack of Efficacy|4|||
42098750|NCT00392197|75909297|FG000|Overall Study|Lost to Follow-up|0|||
42098751|NCT00392197|75909298|FG001|Overall Study|Lost to Follow-up|1|||
42098752|NCT00392197|75909297|FG000|Overall Study|Physician Decision|3|||
42098753|NCT00392197|75909298|FG001|Overall Study|Physician Decision|2|||
42098754|NCT00392197|75909297|FG000|Overall Study|Protocol Violation|7|||
42193444|NCT04109391|76004663|FG002|Overall Study|Adverse Event|0|||
42193445|NCT04109391|76004661|FG000|Overall Study|Withdrawal by Subject|2|||
42193446|NCT04109391|76004662|FG001|Overall Study|Withdrawal by Subject|0|||
42193447|NCT04109391|76004663|FG002|Overall Study|Withdrawal by Subject|0|||
42193448|NCT04109391|76004661|FG000|Overall Study|Pregnancy|1|||
42193449|NCT04109391|76004662|FG001|Overall Study|Pregnancy|0|||
42193450|NCT04109391|76004663|FG002|Overall Study|Pregnancy|0|||
42193451|NCT04109391|76004661|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
42193452|NCT04109391|76004662|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
42193453|NCT04109391|76004663|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
42098755|NCT00392197|75909298|FG001|Overall Study|Protocol Violation|5|||
42098756|NCT00392197|75909297|FG000|Overall Study|Withdrawal by Subject|4|||
42098757|NCT00392197|75909298|FG001|Overall Study|Withdrawal by Subject|6|||
42098758|NCT00391807|75909304|FG000|Overall Study|Did not receive study medication|23|||
42098759|NCT00391807|75909304|FG000|Overall Study|Adverse Event|177|||
42098760|NCT00391807|75909304|FG000|Overall Study|Pregnancy|25|||
42098761|NCT00391807|75909304|FG000|Overall Study|Lost to Follow-up|227|||
42193454|NCT04109391|76004661|FG000|Overall Study|Lost to Follow-up|0|||
42193455|NCT04109391|76004662|FG001|Overall Study|Lost to Follow-up|0|||
42193456|NCT04109391|76004663|FG002|Overall Study|Lost to Follow-up|1|||
42193457|NCT04109391|76004661|FG000|Overall Study|Lack of Efficacy|2|||
42193458|NCT04109391|76004662|FG001|Overall Study|Lack of Efficacy|2|||
42193459|NCT04109391|76004663|FG002|Overall Study|Lack of Efficacy|3|||
42193460|NCT04106817|76004674|FG000|Overall Study|Lost to Follow-up|1|||
42193461|NCT04106817|76004675|FG001|Overall Study|Lost to Follow-up|0|||
42098762|NCT00391807|75909304|FG000|Overall Study|Withdrawal by Subject|147|||
42098763|NCT00391807|75909304|FG000|Overall Study|Protocol Violation|20|||
42098764|NCT00391807|75909304|FG000|Overall Study|Various|96|||
42098765|NCT00624585|75909308|FG000|Overall Study|Death|3|||
42098766|NCT00624585|75909308|FG000|Overall Study|Disease Progression|6|||
42098767|NCT00624585|75909308|FG000|Overall Study|Adverse Event|3|||
42193462|NCT04106817|76004676|FG002|Overall Study|Lost to Follow-up|0|||
42098768|NCT00622635|75909312|FG000|Treatment Period 1|Adverse Event|0|||
42193463|NCT04097925|76004684|FG000|Overall Study|Withdrawal by Subject|1|||
42193464|NCT04195893|76004688|FG000|Second Intervention|Withdrawal by Subject|1|||
42193465|NCT04195893|76004689|FG001|Second Intervention|Withdrawal by Subject|0|||
42193466|NCT04195581|76004695|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
42193467|NCT04195581|76004695|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
42193468|NCT04195581|76004695|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
42193469|NCT04195581|76004695|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
42193470|NCT04195581|76004695|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
42193471|NCT04195581|76004695|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
42193472|NCT04096365|76004713|FG000|Overall Study|Adverse Event|1|||
42193473|NCT04094883|76004717|FG000|Overall Study|Withdrawal by Subject|1|||
42193474|NCT01368562|76004721|FG000|Overall Study|Adverse Event|1|||
42098769|NCT00622635|75909313|FG001|Treatment Period 1|Adverse Event|0|||
42098770|NCT00622635|75909314|FG002|Treatment Period 1|Adverse Event|1|||
42098771|NCT00622635|75909315|FG003|Treatment Period 1|Adverse Event|0|||
42098772|NCT00622635|75909316|FG004|Treatment Period 1|Adverse Event|0|||
42098773|NCT00622635|75909317|FG005|Treatment Period 1|Adverse Event|0|||
42098774|NCT00622635|75909312|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42098775|NCT00622635|75909313|FG001|Treatment Period 1|Withdrawal by Subject|1|||
42098776|NCT00622635|75909314|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42098777|NCT00622635|75909315|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42098778|NCT00622635|75909316|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42098779|NCT00622635|75909317|FG005|Treatment Period 1|Withdrawal by Subject|0|||
42098780|NCT00622635|75909312|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
42098781|NCT00622635|75909313|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
42098782|NCT00622635|75909314|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
42098783|NCT00622635|75909315|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
42098784|NCT00622635|75909316|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
42098785|NCT00622635|75909317|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
42098786|NCT00622635|75909312|FG000|Treatment Period 2|Adverse Event|1|||
42098787|NCT00622635|75909313|FG001|Treatment Period 2|Adverse Event|0|||
42098788|NCT00622635|75909314|FG002|Treatment Period 2|Adverse Event|0|||
42098789|NCT00622635|75909315|FG003|Treatment Period 2|Adverse Event|0|||
42098790|NCT00622635|75909316|FG004|Treatment Period 2|Adverse Event|0|||
42098791|NCT00622635|75909317|FG005|Treatment Period 2|Adverse Event|0|||
42098792|NCT00622635|75909312|FG000|Treatment Period 3|Adverse Event|0|||
42098793|NCT00622635|75909313|FG001|Treatment Period 3|Adverse Event|0|||
42098794|NCT00622635|75909314|FG002|Treatment Period 3|Adverse Event|0|||
42098795|NCT00622635|75909315|FG003|Treatment Period 3|Adverse Event|2|||
42098796|NCT00622635|75909316|FG004|Treatment Period 3|Adverse Event|0|||
42098797|NCT00622635|75909317|FG005|Treatment Period 3|Adverse Event|0|||
42098798|NCT00622635|75909312|FG000|Treatment Period 3|Withdrawal by Subject|0|||
42098799|NCT00622635|75909313|FG001|Treatment Period 3|Withdrawal by Subject|0|||
42098800|NCT00622635|75909314|FG002|Treatment Period 3|Withdrawal by Subject|0|||
42098801|NCT00622635|75909315|FG003|Treatment Period 3|Withdrawal by Subject|1|||
42098802|NCT00622635|75909316|FG004|Treatment Period 3|Withdrawal by Subject|0|||
42098803|NCT00622635|75909317|FG005|Treatment Period 3|Withdrawal by Subject|0|||
42098804|NCT00391027|75909327|FG000|Overall Study|Adverse Event|8|||
42098805|NCT00391027|75909328|FG001|Overall Study|Adverse Event|8|||
42098806|NCT00391027|75909327|FG000|Overall Study|Lack of Efficacy|3|||
42098807|NCT00391027|75909328|FG001|Overall Study|Lack of Efficacy|0|||
42098808|NCT00391027|75909327|FG000|Overall Study|Withdrawal by Subject|10|||
42098809|NCT00391027|75909328|FG001|Overall Study|Withdrawal by Subject|1|||
42098810|NCT00391027|75909327|FG000|Overall Study|Other|4|||
42098811|NCT00391027|75909328|FG001|Overall Study|Other|3|||
42098812|NCT00622401|75909337|FG000|Overall Study|Disease progression prior to treatment|3|||
42098813|NCT00622401|75909338|FG001|Overall Study|Disease progression prior to treatment|2|||
42098814|NCT00622401|75909339|FG002|Overall Study|Disease progression prior to treatment|0|||
42098815|NCT00621621|75909349|FG000|Overall Study|Subjects were exited at EP study|30|||
42193475|NCT01368562|76004721|FG000|Overall Study|Disease progression|1|||
42193476|NCT01368562|76004721|FG000|Overall Study|Lost to Follow-up|1|||
42193477|NCT01368562|76004721|FG000|Overall Study|Death|6|||
42098816|NCT00621621|75909350|FG001|Overall Study|Subjects were exited at EP study|0|||
42098817|NCT00621543|75909358|FG000|Overall Study|Lost to Follow-up|23|||
42098818|NCT00623805|75909364|FG000|Overall Study|Adverse Event|9|||
42098819|NCT00623805|75909365|FG001|Overall Study|Adverse Event|6|||
42098820|NCT00623805|75909364|FG000|Overall Study|Death|2|||
42193478|NCT01368562|76004721|FG000|Overall Study|Unresponsive to treatment|5|||
42193479|NCT01368562|76004721|FG000|Overall Study|Other|3|||
42193480|NCT01368562|76004721|FG000|Overall Study|Other than specified|2|||
42098821|NCT00623805|75909365|FG001|Overall Study|Death|0|||
42098822|NCT00623805|75909364|FG000|Overall Study|Lack of Efficacy|3|||
42098823|NCT00623805|75909365|FG001|Overall Study|Lack of Efficacy|7|||
42098824|NCT00623805|75909364|FG000|Overall Study|Lost to Follow-up|2|||
42098825|NCT00623805|75909365|FG001|Overall Study|Lost to Follow-up|2|||
42098826|NCT00623805|75909364|FG000|Overall Study|Protocol Violation|1|||
42098827|NCT00623805|75909365|FG001|Overall Study|Protocol Violation|1|||
42193481|NCT03242018|76004728|FG000|Overall Study|Adverse Event|7|||
42193482|NCT03242018|76004729|FG001|Overall Study|Adverse Event|7|||
42193483|NCT03242018|76004730|FG002|Overall Study|Adverse Event|6|||
42193484|NCT03242018|76004728|FG000|Overall Study|Lost to Follow-up|2|||
42193485|NCT03242018|76004729|FG001|Overall Study|Lost to Follow-up|2|||
42193486|NCT03242018|76004730|FG002|Overall Study|Lost to Follow-up|2|||
42193487|NCT03242018|76004728|FG000|Overall Study|At the Participant's Own Request|5|||
42193488|NCT03242018|76004729|FG001|Overall Study|At the Participant's Own Request|1|||
42193489|NCT03242018|76004730|FG002|Overall Study|At the Participant's Own Request|4|||
42193490|NCT03242018|76004728|FG000|Overall Study|Reason Not Specified|3|||
42098828|NCT00623805|75909364|FG000|Overall Study|Reason not Specified|3|||
42098829|NCT00623805|75909365|FG001|Overall Study|Reason not Specified|6|||
42098830|NCT00621309|75909371|FG000|Overall Study|Withdrawal by Subject|2|||
42098831|NCT00621309|75909372|FG001|Overall Study|Withdrawal by Subject|0|||
42098832|NCT00621309|75909373|FG002|Overall Study|Withdrawal by Subject|1|||
42098833|NCT00621309|75909374|FG003|Overall Study|Withdrawal by Subject|1|||
42098834|NCT00621309|75909375|FG004|Overall Study|Withdrawal by Subject|1|||
42098835|NCT00621309|75909376|FG005|Overall Study|Withdrawal by Subject|1|||
42098836|NCT00567190|75909384|FG000|Overall Study|Death|235|||
42098837|NCT00567190|75909385|FG001|Overall Study|Death|280|||
42098838|NCT00567190|75909384|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
42098839|NCT00567190|75909385|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
42098840|NCT00691938|75909403|FG000|Overall Study|QTc prolongation|1|||
42098841|NCT00691938|75909404|FG001|Overall Study|QTc prolongation|0|||
42098842|NCT00691938|75909405|FG002|Overall Study|QTc prolongation|0|||
42098843|NCT00691938|75909406|FG003|Overall Study|QTc prolongation|0|||
42098844|NCT00691938|75909407|FG004|Overall Study|QTc prolongation|0|||
42098845|NCT00691938|75909408|FG005|Overall Study|QTc prolongation|0|||
42098846|NCT00691938|75909409|FG006|Overall Study|QTc prolongation|0|||
42098847|NCT00365365|75909423|FG000|Overall Study|Randomized but not treated|0|||
42098848|NCT00365365|75909424|FG001|Overall Study|Randomized but not treated|2|||
42098849|NCT00365365|75909425|FG002|Overall Study|Randomized but not treated|0|||
42098850|NCT00365365|75909423|FG000|Overall Study|Poor compliance to protocol|0|||
42098851|NCT00365365|75909424|FG001|Overall Study|Poor compliance to protocol|1|||
42098852|NCT00365365|75909425|FG002|Overall Study|Poor compliance to protocol|0|||
42098853|NCT00365365|75909423|FG000|Overall Study|Lost to Follow-up|3|||
42098854|NCT00365365|75909424|FG001|Overall Study|Lost to Follow-up|3|||
42098855|NCT00365365|75909425|FG002|Overall Study|Lost to Follow-up|3|||
42098856|NCT00365365|75909423|FG000|Overall Study|Death|1|||
42098857|NCT00365365|75909424|FG001|Overall Study|Death|3|||
42098858|NCT00365365|75909425|FG002|Overall Study|Death|0|||
42098859|NCT00365365|75909423|FG000|Overall Study|Subject's request|11|||
42098860|NCT00365365|75909424|FG001|Overall Study|Subject's request|13|||
42098861|NCT00365365|75909425|FG002|Overall Study|Subject's request|1|||
42098862|NCT00365365|75909423|FG000|Overall Study|Disease progression/relapse|9|||
42098863|NCT00365365|75909424|FG001|Overall Study|Disease progression/relapse|6|||
42098864|NCT00365365|75909425|FG002|Overall Study|Disease progression/relapse|7|||
42098865|NCT00365365|75909423|FG000|Overall Study|Adverse Event|6|||
42098866|NCT00365365|75909424|FG001|Overall Study|Adverse Event|6|||
42098867|NCT00365365|75909425|FG002|Overall Study|Adverse Event|3|||
42098868|NCT00365365|75909423|FG000|Overall Study|Moved|2|||
42098869|NCT00365365|75909424|FG001|Overall Study|Moved|0|||
42098870|NCT00365365|75909425|FG002|Overall Study|Moved|0|||
42098871|NCT00365365|75909423|FG000|Overall Study|New cancer|1|||
42098872|NCT00365365|75909424|FG001|Overall Study|New cancer|0|||
42098873|NCT00365365|75909425|FG002|Overall Study|New cancer|0|||
42098874|NCT00365365|75909423|FG000|Overall Study|Withdrew consent|1|||
42098875|NCT00365365|75909424|FG001|Overall Study|Withdrew consent|1|||
42098876|NCT00365365|75909425|FG002|Overall Study|Withdrew consent|0|||
42098877|NCT00365365|75909423|FG000|Overall Study|Second malignancy|0|||
42098878|NCT00365365|75909424|FG001|Overall Study|Second malignancy|1|||
42098879|NCT00365365|75909425|FG002|Overall Study|Second malignancy|0|||
42098880|NCT00365365|75909423|FG000|Overall Study|Patient/physician decision|0|||
42098881|NCT00365365|75909424|FG001|Overall Study|Patient/physician decision|0|||
42098882|NCT00365365|75909425|FG002|Overall Study|Patient/physician decision|1|||
42098883|NCT00623727|75909435|FG000|Double Blind (DB)|Adverse Event|1|||
42098884|NCT00623727|75909436|FG001|Double Blind (DB)|Adverse Event|3|||
42098885|NCT00623727|75909435|FG000|Double Blind (DB)|Physician Decision|0|||
42098886|NCT00623727|75909436|FG001|Double Blind (DB)|Physician Decision|1|||
42098887|NCT00623727|75909435|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
42098888|NCT00623727|75909436|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
42098889|NCT00623727|75909435|FG000|Double Blind (DB)|Lack of Efficacy|2|||
42098890|NCT00623727|75909436|FG001|Double Blind (DB)|Lack of Efficacy|2|||
42193491|NCT03242018|76004729|FG001|Overall Study|Reason Not Specified|4|||
42193492|NCT03242018|76004730|FG002|Overall Study|Reason Not Specified|1|||
42193493|NCT03242018|76004728|FG000|Overall Study|Study Terminated by Sponsor|1|||
42193494|NCT03242018|76004729|FG001|Overall Study|Study Terminated by Sponsor|0|||
42193495|NCT03242018|76004730|FG002|Overall Study|Study Terminated by Sponsor|1|||
42297836|NCT01663987|76133048|FG000|Overall Study|Other reason not defined above|3|||
42297837|NCT01663987|76133049|FG001|Overall Study|Other reason not defined above|0|||
42297838|NCT02380677|76133067|FG000|Overall Study|Adverse Event|0|||
42297839|NCT02380677|76133068|FG001|Overall Study|Adverse Event|0|||
42297840|NCT02380677|76133069|FG002|Overall Study|Adverse Event|0|||
42297841|NCT02380677|76133070|FG003|Overall Study|Adverse Event|1|||
42297842|NCT02380677|76133071|FG004|Overall Study|Adverse Event|1|||
42297843|NCT02380677|76133072|FG005|Overall Study|Adverse Event|4|||
42098891|NCT00623727|75909435|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
42098892|NCT00623727|75909436|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
42098893|NCT00623727|75909435|FG000|Double Blind (DB)|Lost to Follow-up|1|||
42098894|NCT00623727|75909436|FG001|Double Blind (DB)|Lost to Follow-up|1|||
42098895|NCT00623727|75909435|FG000|Double Blind (DB)|Protocol Violation|2|||
42098896|NCT00623727|75909436|FG001|Double Blind (DB)|Protocol Violation|2|||
42098897|NCT00623727|75909435|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
42098898|NCT00623727|75909436|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
42098899|NCT00623727|75909435|FG000|Open Label Follow-up|Study termination|0|||
42098900|NCT00623727|75909436|FG001|Open Label Follow-up|Study termination|6|||
42098901|NCT00623727|75909435|FG000|Open Label Follow-up|Participant convenience|0|||
42098902|NCT00623727|75909436|FG001|Open Label Follow-up|Participant convenience|1|||
42098903|NCT00372775|75909444|FG000|Overall Study|Adverse Event|8|||
42098904|NCT00372775|75909444|FG000|Overall Study|Death|15|||
42098905|NCT00372775|75909444|FG000|Overall Study|Objective progression or relapse|30|||
42098906|NCT00372775|75909444|FG000|Overall Study|Global deterioration of health status|6|||
42098907|NCT00372775|75909444|FG000|Overall Study|Withdrawal by Subject|1|||
42098908|NCT00372775|75909444|FG000|Overall Study|Other|1|||
42098909|NCT00372775|75909444|FG000|Overall Study|Not Treated|2|||
42098910|NCT00372697|75909450|FG000|Overall Study|Protocol Violation|1|||
42098911|NCT00372697|75909451|FG001|Overall Study|Protocol Violation|1|||
42098912|NCT00690378|75909463|FG000|Overall Study|Adverse Event|1|||
42098913|NCT00690378|75909464|FG001|Overall Study|Adverse Event|0|||
42098914|NCT00690378|75909463|FG000|Overall Study|Withdrawal by Subject|2|||
42098915|NCT00690378|75909464|FG001|Overall Study|Withdrawal by Subject|0|||
42098916|NCT00690378|75909463|FG000|Overall Study|Protocol Violation|1|||
42098917|NCT00690378|75909464|FG001|Overall Study|Protocol Violation|0|||
42098918|NCT00690378|75909463|FG000|Overall Study|Lost to Follow-up|2|||
42098919|NCT00690378|75909464|FG001|Overall Study|Lost to Follow-up|3|||
42098920|NCT00690378|75909463|FG000|Overall Study|Did not meet inc/exc criteria|13|||
42098921|NCT00690378|75909464|FG001|Overall Study|Did not meet inc/exc criteria|11|||
42098922|NCT00690378|75909463|FG000|Overall Study|Social problem|1|||
42098923|NCT00690378|75909464|FG001|Overall Study|Social problem|0|||
42098924|NCT00574275|75909472|FG000|Overall Study|Randomized but not treated|2|||
42098925|NCT00574275|75909473|FG001|Overall Study|Randomized but not treated|3|||
42098926|NCT00574275|75909472|FG000|Overall Study|Adverse Event|32|||
42098927|NCT00574275|75909473|FG001|Overall Study|Adverse Event|76|||
42098928|NCT00574275|75909472|FG000|Overall Study|Disease progression|160|||
42098929|NCT00574275|75909473|FG001|Overall Study|Disease progression|146|||
42098930|NCT00574275|75909472|FG000|Overall Study|Lost to Follow-up|2|||
42098931|NCT00574275|75909473|FG001|Overall Study|Lost to Follow-up|1|||
42098932|NCT00574275|75909472|FG000|Overall Study|Study stopped based on DMC decision|62|||
42098933|NCT00574275|75909473|FG001|Overall Study|Study stopped based on DMC decision|23|||
42098934|NCT00574275|75909472|FG000|Overall Study|Withdrawal by Subject|15|||
42098935|NCT00574275|75909473|FG001|Overall Study|Withdrawal by Subject|17|||
42098936|NCT00574275|75909472|FG000|Overall Study|Error calculating tumor measurement|1|||
42098937|NCT00574275|75909473|FG001|Overall Study|Error calculating tumor measurement|0|||
42098938|NCT00574275|75909472|FG000|Overall Study|Physician Decision|1|||
42098939|NCT00574275|75909473|FG001|Overall Study|Physician Decision|1|||
42098940|NCT00574275|75909472|FG000|Overall Study|Protocol Violation|0|||
42098941|NCT00574275|75909473|FG001|Overall Study|Protocol Violation|1|||
42098942|NCT00574275|75909472|FG000|Overall Study|Patient and Investigator decision|0|||
42193496|NCT02789176|76004743|FG000|Overall Study|Death|0|||
42193497|NCT02789176|76004744|FG001|Overall Study|Death|0|||
42098943|NCT00574275|75909473|FG001|Overall Study|Patient and Investigator decision|1|||
42098944|NCT00574275|75909472|FG000|Overall Study|Insurance change|0|||
42098945|NCT00574275|75909473|FG001|Overall Study|Insurance change|1|||
42098946|NCT00574275|75909472|FG000|Overall Study|Operation for curative intent|0|||
42098947|NCT00574275|75909473|FG001|Overall Study|Operation for curative intent|1|||
42098948|NCT00567112|75909479|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
42098949|NCT00567112|75909480|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
42098950|NCT00567112|75909481|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
42193498|NCT02789176|76004745|FG002|Overall Study|Death|3|||
42297844|NCT02380677|76133073|FG006|Overall Study|Adverse Event|2|||
42193499|NCT02789176|76004746|FG003|Overall Study|Death|0|||
42193500|NCT02789176|76004743|FG000|Overall Study|Withdrawal by Subject|0|||
42193501|NCT02789176|76004744|FG001|Overall Study|Withdrawal by Subject|0|||
42193502|NCT02789176|76004745|FG002|Overall Study|Withdrawal by Subject|1|||
42193503|NCT02789176|76004746|FG003|Overall Study|Withdrawal by Subject|0|||
42193504|NCT02789176|76004743|FG000|Overall Study|Lost to Follow-up|8|||
42193505|NCT02789176|76004744|FG001|Overall Study|Lost to Follow-up|2|||
42193506|NCT02789176|76004745|FG002|Overall Study|Lost to Follow-up|6|||
42297845|NCT02380677|76133074|FG007|Overall Study|Adverse Event|2|||
42297846|NCT02380677|76133075|FG008|Overall Study|Adverse Event|2|||
42297847|NCT02380677|76133076|FG009|Overall Study|Adverse Event|1|||
42297848|NCT02380677|76133077|FG010|Overall Study|Adverse Event|2|||
42297849|NCT02380677|76133078|FG011|Overall Study|Adverse Event|1|||
42297850|NCT02380677|76133067|FG000|Overall Study|Physician Decision|1|||
42297851|NCT02380677|76133068|FG001|Overall Study|Physician Decision|0|||
42297852|NCT02380677|76133069|FG002|Overall Study|Physician Decision|1|||
42297853|NCT02380677|76133070|FG003|Overall Study|Physician Decision|1|||
42297854|NCT02380677|76133071|FG004|Overall Study|Physician Decision|0|||
42297855|NCT02380677|76133072|FG005|Overall Study|Physician Decision|0|||
42297856|NCT02380677|76133073|FG006|Overall Study|Physician Decision|0|||
42297857|NCT02380677|76133074|FG007|Overall Study|Physician Decision|0|||
42297858|NCT02380677|76133075|FG008|Overall Study|Physician Decision|0|||
42297859|NCT02380677|76133076|FG009|Overall Study|Physician Decision|0|||
42297860|NCT02380677|76133077|FG010|Overall Study|Physician Decision|0|||
42297861|NCT02380677|76133078|FG011|Overall Study|Physician Decision|0|||
42297862|NCT02380677|76133067|FG000|Overall Study|Lack of Efficacy|0|||
42297863|NCT02380677|76133068|FG001|Overall Study|Lack of Efficacy|1|||
42297864|NCT02380677|76133069|FG002|Overall Study|Lack of Efficacy|2|||
42297865|NCT02380677|76133070|FG003|Overall Study|Lack of Efficacy|0|||
42297866|NCT02380677|76133071|FG004|Overall Study|Lack of Efficacy|4|||
42297867|NCT02380677|76133072|FG005|Overall Study|Lack of Efficacy|1|||
42297868|NCT02380677|76133073|FG006|Overall Study|Lack of Efficacy|1|||
42297869|NCT02380677|76133074|FG007|Overall Study|Lack of Efficacy|2|||
42297870|NCT02380677|76133075|FG008|Overall Study|Lack of Efficacy|2|||
42297871|NCT02380677|76133076|FG009|Overall Study|Lack of Efficacy|0|||
42297872|NCT02380677|76133077|FG010|Overall Study|Lack of Efficacy|2|||
42297873|NCT02380677|76133078|FG011|Overall Study|Lack of Efficacy|1|||
42297874|NCT02380677|76133067|FG000|Overall Study|Withdrawal by Subject|0|||
42297875|NCT02380677|76133068|FG001|Overall Study|Withdrawal by Subject|0|||
42297876|NCT02380677|76133069|FG002|Overall Study|Withdrawal by Subject|0|||
42297877|NCT02380677|76133070|FG003|Overall Study|Withdrawal by Subject|0|||
42297878|NCT02380677|76133071|FG004|Overall Study|Withdrawal by Subject|0|||
42297879|NCT02380677|76133072|FG005|Overall Study|Withdrawal by Subject|0|||
42297880|NCT02380677|76133073|FG006|Overall Study|Withdrawal by Subject|0|||
42297881|NCT02380677|76133074|FG007|Overall Study|Withdrawal by Subject|0|||
42297882|NCT02380677|76133075|FG008|Overall Study|Withdrawal by Subject|0|||
42297883|NCT02380677|76133076|FG009|Overall Study|Withdrawal by Subject|1|||
42297884|NCT02380677|76133077|FG010|Overall Study|Withdrawal by Subject|0|||
42297885|NCT02380677|76133078|FG011|Overall Study|Withdrawal by Subject|3|||
42297886|NCT02380677|76133067|FG000|Overall Study|Other|0|||
42297887|NCT02380677|76133068|FG001|Overall Study|Other|0|||
42359302|NCT01194271|76204912|FG000|Overall Study|Death|1|||
42359303|NCT01119508|76204927|FG000|Overall Study|Adverse Event|56|||
42359304|NCT01119508|76204927|FG000|Overall Study|Withdrawal by Subject|2|||
42359305|NCT01119508|76204927|FG000|Overall Study|Died before tumor response evaluation|1|||
42359306|NCT00754338|76204939|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
42359307|NCT00754338|76204940|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
42359308|NCT00754338|76204941|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
42359309|NCT00754338|76204942|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
42297888|NCT02380677|76133069|FG002|Overall Study|Other|0|||
42297889|NCT02380677|76133070|FG003|Overall Study|Other|1|||
42297890|NCT02380677|76133071|FG004|Overall Study|Other|1|||
42297891|NCT02380677|76133072|FG005|Overall Study|Other|1|||
42297892|NCT02380677|76133073|FG006|Overall Study|Other|0|||
42297893|NCT02380677|76133074|FG007|Overall Study|Other|0|||
42297894|NCT02380677|76133075|FG008|Overall Study|Other|0|||
42297895|NCT02380677|76133076|FG009|Overall Study|Other|0|||
42359310|NCT00754338|76204939|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
42359311|NCT00754338|76204940|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
42193507|NCT02789176|76004746|FG003|Overall Study|Lost to Follow-up|1|||
42297896|NCT02380677|76133077|FG010|Overall Study|Other|0|||
42297897|NCT02380677|76133078|FG011|Overall Study|Other|0|||
42193508|NCT03259490|76004758|FG000|Period 1|Withdrawal by Subject|0|||
42297898|NCT02380287|76133114|FG000|Overall Study|Adverse Event|0|||
42297899|NCT02380287|76133115|FG001|Overall Study|Adverse Event|0|||
42297900|NCT02380287|76133116|FG002|Overall Study|Adverse Event|1|||
42297901|NCT02380287|76133117|FG003|Overall Study|Adverse Event|0|||
42297902|NCT02380287|76133118|FG004|Overall Study|Adverse Event|0|||
42297903|NCT02380287|76133119|FG005|Overall Study|Adverse Event|0|||
42193509|NCT03259490|76004759|FG001|Period 1|Withdrawal by Subject|1|||
42193510|NCT03259490|76004758|FG000|Period 2|Protocol Violation|1|||
42193511|NCT03259490|76004759|FG001|Period 2|Protocol Violation|0|||
42297904|NCT02380287|76133120|FG006|Overall Study|Adverse Event|0|||
42297905|NCT02380287|76133121|FG007|Overall Study|Adverse Event|0|||
42297906|NCT02343003|76133148|FG000|Overall Study|Withdrawal by Subject|9|||
42297907|NCT02343003|76133149|FG001|Overall Study|Withdrawal by Subject|4|||
42297908|NCT02343003|76133148|FG000|Overall Study|Lost to Follow-up|5|||
42297909|NCT02343003|76133149|FG001|Overall Study|Lost to Follow-up|1|||
42297910|NCT02343003|76133148|FG000|Overall Study|Protocol Violation|1|||
42297911|NCT02343003|76133149|FG001|Overall Study|Protocol Violation|0|||
42297912|NCT02343003|76133148|FG000|Overall Study|Death|0|||
42297913|NCT02343003|76133149|FG001|Overall Study|Death|1|||
42297914|NCT02343003|76133148|FG000|Overall Study|exclusion criteria met|1|||
42297915|NCT02343003|76133149|FG001|Overall Study|exclusion criteria met|1|||
42297916|NCT02343003|76133148|FG000|Overall Study|terminated by sponsor|2|||
42297917|NCT02343003|76133149|FG001|Overall Study|terminated by sponsor|0|||
42297918|NCT02394561|76133157|FG000|CORE Phase|Adverse Event|7|||
42297919|NCT02394561|76133158|FG001|CORE Phase|Adverse Event|9|||
42297920|NCT02394561|76133157|FG000|CORE Phase|Death|0|||
42297921|NCT02394561|76133158|FG001|CORE Phase|Death|1|||
42297922|NCT02394561|76133157|FG000|CORE Phase|Pregnancy|1|||
42297923|NCT02394561|76133158|FG001|CORE Phase|Pregnancy|0|||
42297924|NCT02394561|76133157|FG000|CORE Phase|Lost to Follow-up|1|||
42297925|NCT02394561|76133158|FG001|CORE Phase|Lost to Follow-up|0|||
42297926|NCT02394561|76133157|FG000|CORE Phase|Physician Decision|1|||
42297927|NCT02394561|76133158|FG001|CORE Phase|Physician Decision|1|||
42297928|NCT02394561|76133157|FG000|CORE Phase|Withdrawal by Subject|2|||
42297929|NCT02394561|76133158|FG001|CORE Phase|Withdrawal by Subject|2|||
42297930|NCT02394561|76133157|FG000|CORE Phase|Lack of Efficacy|1|||
42297931|NCT02394561|76133158|FG001|CORE Phase|Lack of Efficacy|6|||
42297932|NCT02394561|76133157|FG000|Extension Phase|Adverse Event|6|||
42297933|NCT02394561|76133158|FG001|Extension Phase|Adverse Event|1|||
42297934|NCT02394561|76133157|FG000|Extension Phase|Death|0|||
42297935|NCT02394561|76133158|FG001|Extension Phase|Death|1|||
42297936|NCT02394561|76133157|FG000|Extension Phase|Protocol Violation|1|||
42297937|NCT02394561|76133158|FG001|Extension Phase|Protocol Violation|0|||
42297938|NCT02394561|76133157|FG000|Extension Phase|Lost to Follow-up|1|||
42297939|NCT02394561|76133158|FG001|Extension Phase|Lost to Follow-up|0|||
42297940|NCT02394561|76133157|FG000|Extension Phase|Physician Decision|0|||
42297941|NCT02394561|76133158|FG001|Extension Phase|Physician Decision|2|||
42297942|NCT02394561|76133157|FG000|Extension Phase|Withdrawal by Subject|0|||
42297943|NCT02394561|76133158|FG001|Extension Phase|Withdrawal by Subject|5|||
42297944|NCT02394561|76133157|FG000|Extension Phase|Lack of Efficacy|3|||
42297945|NCT02394561|76133158|FG001|Extension Phase|Lack of Efficacy|3|||
42297946|NCT02342223|76133167|FG000|Overall Study|Lost to Follow-up|1|||
42297947|NCT02393547|76133171|FG000|Overall Study|Adverse Event|2|||
42297948|NCT02393547|76133171|FG000|Overall Study|Withdrawal by Subject|3|||
42297949|NCT02393547|76133171|FG000|Overall Study|Lost to Follow-up|1|||
42297950|NCT02574637|76133180|FG000|Double-blind Period|Adverse Event|1|||
42297951|NCT02574637|76133181|FG001|Double-blind Period|Adverse Event|0|||
42297952|NCT02574637|76133182|FG002|Double-blind Period|Adverse Event|0|||
42297953|NCT02574637|76133183|FG003|Double-blind Period|Adverse Event|0|||
42098951|NCT00567112|75909479|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
42098952|NCT00567112|75909480|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
42098953|NCT00567112|75909481|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
42098954|NCT00567112|75909479|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
42098955|NCT00567112|75909480|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
42098956|NCT00567112|75909481|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
42098957|NCT01618656|75909501|FG000|Overall Study|Withdrawal by Subject|7|||
42098958|NCT01618656|75909502|FG001|Overall Study|Withdrawal by Subject|3|||
42098959|NCT01618656|75909501|FG000|Overall Study|Physician Decision|1|||
42098960|NCT01618656|75909502|FG001|Overall Study|Physician Decision|1|||
42098961|NCT03978832|75909508|FG000|Overall Study|Adverse Event|1|||
42098962|NCT03978832|75909508|FG000|Overall Study|Lost to Follow-up|1|||
42098963|NCT03978832|75909508|FG000|Overall Study|Withdrawal by Subject|6|||
42098964|NCT03978832|75909508|FG000|Overall Study|Physician Decision|2|||
42098965|NCT03978832|75909508|FG000|Overall Study|did not pass screening criteria|44|||
42098966|NCT00566722|75909515|FG000|Overall Study|Adverse Event|0|||
42098967|NCT00566722|75909516|FG001|Overall Study|Adverse Event|1|||
42098968|NCT00566722|75909517|FG002|Overall Study|Adverse Event|0|||
42098969|NCT00566722|75909515|FG000|Overall Study|Withdrawal by Subject|0|||
42098970|NCT00566722|75909516|FG001|Overall Study|Withdrawal by Subject|0|||
42193512|NCT03259334|76004768|FG000|Overall Study|Adverse Event|3|||
42297954|NCT02574637|76133184|FG004|Double-blind Period|Adverse Event|0|||
42297955|NCT02574637|76133185|FG005|Double-blind Period|Adverse Event|0|||
42297956|NCT02574637|76133186|FG006|Double-blind Period|Adverse Event|0|||
42098971|NCT00566722|75909517|FG002|Overall Study|Withdrawal by Subject|1|||
42297957|NCT02574637|76133187|FG007|Double-blind Period|Adverse Event|0|||
42297958|NCT02574637|76133188|FG008|Double-blind Period|Adverse Event|0|||
42193513|NCT03259334|76004769|FG001|Overall Study|Adverse Event|8|||
42193514|NCT03259334|76004770|FG002|Overall Study|Adverse Event|5|||
42193515|NCT03259334|76004768|FG000|Overall Study|Withdrawal by Subject|4|||
42193516|NCT03259334|76004769|FG001|Overall Study|Withdrawal by Subject|2|||
42193517|NCT03259334|76004770|FG002|Overall Study|Withdrawal by Subject|4|||
42193518|NCT03259334|76004768|FG000|Overall Study|Physician Decision|1|||
42193519|NCT03259334|76004769|FG001|Overall Study|Physician Decision|0|||
42193520|NCT03259334|76004770|FG002|Overall Study|Physician Decision|0|||
42297959|NCT02574637|76133189|FG009|Double-blind Period|Adverse Event|0|||
42297960|NCT02574637|76133180|FG000|Double-blind Period|Lack of Efficacy|0|||
42297961|NCT02574637|76133181|FG001|Double-blind Period|Lack of Efficacy|0|||
42297962|NCT02574637|76133182|FG002|Double-blind Period|Lack of Efficacy|2|||
42098972|NCT00566722|75909515|FG000|Overall Study|Lost to Follow-up|1|||
42098973|NCT00566722|75909516|FG001|Overall Study|Lost to Follow-up|1|||
42098974|NCT00566722|75909517|FG002|Overall Study|Lost to Follow-up|1|||
42098975|NCT00566722|75909515|FG000|Overall Study|Lack of Efficacy|1|||
42098976|NCT00566722|75909516|FG001|Overall Study|Lack of Efficacy|2|||
42098977|NCT00566722|75909517|FG002|Overall Study|Lack of Efficacy|4|||
42098978|NCT00566722|75909515|FG000|Overall Study|Did not meet exclusion criteria|0|||
42098979|NCT00566722|75909516|FG001|Overall Study|Did not meet exclusion criteria|0|||
42098980|NCT00566722|75909517|FG002|Overall Study|Did not meet exclusion criteria|2|||
42098981|NCT00566722|75909515|FG000|Overall Study|Serious adverse event|0|||
42098982|NCT00566722|75909516|FG001|Overall Study|Serious adverse event|1|||
42098983|NCT00566722|75909517|FG002|Overall Study|Serious adverse event|0|||
42098984|NCT00566722|75909515|FG000|Overall Study|Noncompliant with drug administration|0|||
42098985|NCT00566722|75909516|FG001|Overall Study|Noncompliant with drug administration|0|||
42098986|NCT00566722|75909517|FG002|Overall Study|Noncompliant with drug administration|1|||
42098987|NCT00691704|75909528|FG000|Induction Therapy|Disease Progression|1|||
42098988|NCT00691704|75909528|FG000|Induction Therapy|Active Hepatitis|1|||
42098989|NCT00691704|75909528|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
42098990|NCT00691704|75909528|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
42098991|NCT00691704|75909528|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
42098992|NCT00566020|75909532|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
42098993|NCT00566020|75909533|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
42098994|NCT00566020|75909532|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
42098995|NCT00566020|75909533|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
42098996|NCT00566020|75909532|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
42098997|NCT00566020|75909533|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
42098998|NCT00566020|75909532|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
42098999|NCT00566020|75909533|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
42099000|NCT00566020|75909532|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
42099001|NCT00566020|75909533|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
42099002|NCT00566020|75909532|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
42099003|NCT00566020|75909533|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
42099004|NCT00564070|75909540|FG000|Overall Study|Lost to Follow-up|9|||
42099005|NCT00564070|75909541|FG001|Overall Study|Lost to Follow-up|7|||
42099006|NCT00564070|75909540|FG000|Overall Study|Worsening depression, referred to care|3|||
42099007|NCT00564070|75909541|FG001|Overall Study|Worsening depression, referred to care|0|||
42099008|NCT00690612|75909547|FG000|Overall Study|Adverse Event|1|||
42099009|NCT00690612|75909547|FG000|Overall Study|Withdrawal by Subject|2|||
42099010|NCT00621153|75909553|FG000|Overall Study|Safety Reason|8|||
42099011|NCT00621153|75909554|FG001|Overall Study|Safety Reason|7|||
42099012|NCT00621153|75909553|FG000|Overall Study|Adverse Event|3|||
42099013|NCT00621153|75909554|FG001|Overall Study|Adverse Event|2|||
42099014|NCT00621153|75909553|FG000|Overall Study|Lost to Follow-up|5|||
42099015|NCT00621153|75909554|FG001|Overall Study|Lost to Follow-up|1|||
42099016|NCT00621153|75909553|FG000|Overall Study|Withdrawal by Subject|4|||
42099017|NCT00621153|75909554|FG001|Overall Study|Withdrawal by Subject|5|||
42099018|NCT00574119|75909560|FG000|Overall Study|Adverse Event|1|||
42099019|NCT00574119|75909560|FG000|Overall Study|Protocol Violation|1|||
42099020|NCT00574119|75909560|FG000|Overall Study|Withdrawal by Subject|1|||
42099021|NCT00574119|75909560|FG000|Overall Study|Physician Decision|1|||
42099022|NCT00705614|75909566|FG000|Initial Intervention|Adverse Event|40|||
42193521|NCT03259334|76004768|FG000|Overall Study|Lost to Follow-up|0|||
42193522|NCT03259334|76004769|FG001|Overall Study|Lost to Follow-up|2|||
42193523|NCT03259334|76004770|FG002|Overall Study|Lost to Follow-up|1|||
42193524|NCT03259334|76004768|FG000|Overall Study|Protocol Deviation|0|||
42297963|NCT02574637|76133183|FG003|Double-blind Period|Lack of Efficacy|0|||
42297964|NCT02574637|76133184|FG004|Double-blind Period|Lack of Efficacy|0|||
42099023|NCT00705614|75909567|FG001|Initial Intervention|Adverse Event|21|||
42099024|NCT00705614|75909566|FG000|Initial Intervention|Lost to Follow-up|310|||
42099025|NCT00705614|75909567|FG001|Initial Intervention|Lost to Follow-up|191|||
42099026|NCT00705614|75909566|FG000|Initial Intervention|Withdrawal by Subject|114|||
42193525|NCT03259334|76004769|FG001|Overall Study|Protocol Deviation|3|||
42193526|NCT03259334|76004770|FG002|Overall Study|Protocol Deviation|2|||
42193527|NCT03259334|76004768|FG000|Overall Study|Lack of Efficacy|2|||
42193528|NCT03259334|76004769|FG001|Overall Study|Lack of Efficacy|0|||
42193529|NCT03259334|76004770|FG002|Overall Study|Lack of Efficacy|1|||
42193530|NCT03259334|76004768|FG000|Overall Study|Randomized but never treated|0|||
42193531|NCT03259334|76004769|FG001|Overall Study|Randomized but never treated|2|||
42193532|NCT03259334|76004770|FG002|Overall Study|Randomized but never treated|0|||
42193533|NCT01331824|76004778|FG000|Overall Study|Adverse Event|2|||
42193534|NCT01331824|76004778|FG000|Overall Study|Death|1|||
42193535|NCT01331824|76004778|FG000|Overall Study|Disease Progression|9|||
42193536|NCT01331824|76004778|FG000|Overall Study|Withdrawal by Subject|1|||
42193537|NCT03258710|76004782|FG000|Overall Study|Adverse Event|1|||
42193538|NCT03258710|76004782|FG000|Overall Study|Protocol-defined stopping criteria|1|||
42193539|NCT03258710|76004782|FG000|Overall Study|Physician Decision|1|||
42193540|NCT03240692|76004786|FG000|Overall Study|Physician Decision|1|||
42193541|NCT03240692|76004786|FG000|Overall Study|Withdrawal by Subject|1|||
42193542|NCT03233048|76004790|FG000|Overall Study|Withdrawal by Subject|1|||
42193543|NCT02937740|76004796|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
42193544|NCT02937740|76004797|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
42193545|NCT02937740|76004796|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
42193546|NCT02937740|76004797|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
42193547|NCT02937740|76004796|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
42193548|NCT02937740|76004797|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
42193549|NCT02937740|76004796|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
42193550|NCT02937740|76004797|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
42193551|NCT02937740|76004796|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
42193552|NCT02937740|76004797|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
42193553|NCT02937740|76004796|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
42193554|NCT02937740|76004797|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
42193555|NCT04173741|76004820|FG000|Overall Study|IVC measurement cannot be done|1|||
42193556|NCT04173741|76004821|FG001|Overall Study|IVC measurement cannot be done|1|||
42193557|NCT03231800|76004829|FG000|Overall Study|Lost to Follow-up|0|||
42193558|NCT03231800|76004830|FG001|Overall Study|Lost to Follow-up|2|||
42193559|NCT03231800|76004829|FG000|Overall Study|Protocol Violation|1|||
42193560|NCT03231800|76004830|FG001|Overall Study|Protocol Violation|1|||
42193561|NCT03231800|76004829|FG000|Overall Study|reason not provided|2|||
42193562|NCT03231800|76004830|FG001|Overall Study|reason not provided|0|||
42297965|NCT02574637|76133185|FG005|Double-blind Period|Lack of Efficacy|0|||
42297966|NCT02574637|76133186|FG006|Double-blind Period|Lack of Efficacy|0|||
42297967|NCT02574637|76133187|FG007|Double-blind Period|Lack of Efficacy|0|||
42297968|NCT02574637|76133188|FG008|Double-blind Period|Lack of Efficacy|0|||
42297969|NCT02574637|76133189|FG009|Double-blind Period|Lack of Efficacy|0|||
42297970|NCT02574637|76133180|FG000|Double-blind Period|Protocol Deviation|1|||
42297971|NCT02574637|76133181|FG001|Double-blind Period|Protocol Deviation|0|||
42297972|NCT02574637|76133182|FG002|Double-blind Period|Protocol Deviation|0|||
42297973|NCT02574637|76133183|FG003|Double-blind Period|Protocol Deviation|0|||
42297974|NCT02574637|76133184|FG004|Double-blind Period|Protocol Deviation|0|||
42297975|NCT02574637|76133185|FG005|Double-blind Period|Protocol Deviation|0|||
42297976|NCT02574637|76133186|FG006|Double-blind Period|Protocol Deviation|0|||
42297977|NCT02574637|76133187|FG007|Double-blind Period|Protocol Deviation|0|||
42297978|NCT02574637|76133188|FG008|Double-blind Period|Protocol Deviation|0|||
42297979|NCT02574637|76133189|FG009|Double-blind Period|Protocol Deviation|0|||
42297980|NCT02574637|76133180|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
42359312|NCT00754338|76204941|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
42359313|NCT00754338|76204942|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
42193563|NCT04085601|76004838|FG000|Overall Study|Lost to Follow-up|1|||
42193564|NCT04085601|76004839|FG001|Overall Study|Lost to Follow-up|0|||
42297981|NCT02574637|76133181|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
42297982|NCT02574637|76133182|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
42297983|NCT02574637|76133183|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
42297984|NCT02574637|76133184|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
42297985|NCT02574637|76133185|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
42193565|NCT04085601|76004838|FG000|Overall Study|Death|1|||
42193566|NCT04085601|76004839|FG001|Overall Study|Death|1|||
42193567|NCT03230864|76004848|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
42193568|NCT03230864|76004849|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
42193569|NCT03230864|76004850|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
42193570|NCT03230864|76004851|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
42193571|NCT03230864|76004848|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
42297986|NCT02574637|76133186|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
42193572|NCT03230864|76004849|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
42297987|NCT02574637|76133187|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
42193573|NCT03230864|76004850|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
42193574|NCT03230864|76004851|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
42193575|NCT03230864|76004848|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
42193576|NCT03230864|76004849|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
42193577|NCT03230864|76004850|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
42193578|NCT03230864|76004851|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
42193579|NCT03230864|76004848|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
42193580|NCT03230864|76004849|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
42193581|NCT03230864|76004850|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
42193582|NCT03230864|76004851|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
42193583|NCT03230864|76004848|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
42193584|NCT03230864|76004849|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
42193585|NCT03230864|76004850|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
42193586|NCT03230864|76004851|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
42193587|NCT03230864|76004848|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
42193588|NCT03230864|76004849|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
42193589|NCT03230864|76004850|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
42193590|NCT03230864|76004851|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
42193591|NCT03230864|76004848|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
42193592|NCT03230864|76004849|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
42193593|NCT03230864|76004850|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
42193594|NCT03230864|76004851|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
42193595|NCT03230864|76004848|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
42193596|NCT03230864|76004849|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
42193597|NCT03230864|76004850|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
42193598|NCT03230864|76004851|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
42193599|NCT03230864|76004848|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
42297988|NCT02574637|76133188|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
42297989|NCT02574637|76133189|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
42297990|NCT02574637|76133180|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
42297991|NCT02574637|76133181|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
42297992|NCT02574637|76133182|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
42297993|NCT02574637|76133183|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
42297994|NCT02574637|76133184|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
42297995|NCT02574637|76133185|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
42297996|NCT02574637|76133186|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
42297997|NCT02574637|76133187|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
42297998|NCT02574637|76133188|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
42297999|NCT02574637|76133189|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
42298000|NCT02574637|76133180|FG000|Double-blind Period|Reason Not Specified|0|||
42298001|NCT02574637|76133181|FG001|Double-blind Period|Reason Not Specified|0|||
42298002|NCT02574637|76133182|FG002|Double-blind Period|Reason Not Specified|0|||
42298003|NCT02574637|76133183|FG003|Double-blind Period|Reason Not Specified|1|||
42298004|NCT02574637|76133184|FG004|Double-blind Period|Reason Not Specified|0|||
42359314|NCT00574496|76204968|FG000|Overall Study|Withdrawal by Subject|1|||
42359315|NCT00499083|76204972|FG000|Overall Study|Not evaluable|3|||
42359316|NCT00418886|76204978|FG000|Overall Study|discontinue treatment survival follow up|90|||
42298005|NCT02574637|76133185|FG005|Double-blind Period|Reason Not Specified|0|||
42298006|NCT02574637|76133186|FG006|Double-blind Period|Reason Not Specified|0|||
42193600|NCT03230864|76004849|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
42193601|NCT03230864|76004850|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
42193602|NCT03230864|76004851|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
42193603|NCT03230864|76004848|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
42193604|NCT03230864|76004849|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
42193605|NCT03230864|76004850|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
42193606|NCT03230864|76004851|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
42193607|NCT04085367|76004863|FG000|Overall Study|Adverse Event|1|||
42193608|NCT04085367|76004864|FG001|Overall Study|Adverse Event|1|||
42193609|NCT04085367|76004863|FG000|Overall Study|Withdrawal by Subject|13|||
42193610|NCT04085367|76004864|FG001|Overall Study|Withdrawal by Subject|4|||
42193611|NCT04085367|76004863|FG000|Overall Study|Lost to Follow-up|3|||
42193612|NCT04085367|76004864|FG001|Overall Study|Lost to Follow-up|1|||
42193613|NCT04085367|76004863|FG000|Overall Study|Other unspecified|2|||
42193614|NCT04085367|76004864|FG001|Overall Study|Other unspecified|1|||
42193615|NCT04085367|76004863|FG000|Overall Study|Status Unknown|1|||
42193616|NCT04085367|76004864|FG001|Overall Study|Status Unknown|1|||
42193617|NCT03228836|76004870|FG000|Overall Study|Adverse Event|3|||
42193618|NCT03228836|76004870|FG000|Overall Study|Withdrawal by Subject|1|||
42193619|NCT03228836|76004870|FG000|Overall Study|Death|1|||
42193620|NCT03228836|76004870|FG000|Overall Study|Physician Decision|1|||
42193621|NCT03228836|76004870|FG000|Overall Study|Disease Progression|7|||
42193622|NCT03228836|76004870|FG000|Overall Study|Other|4|||
42193623|NCT02937350|76004877|FG000|Overall Study|Withdrawal by Subject|0|||
42193624|NCT02937350|76004878|FG001|Overall Study|Withdrawal by Subject|1|||
42193625|NCT02937350|76004879|FG002|Overall Study|Withdrawal by Subject|0|||
42193626|NCT04085289|76004888|FG000|Overall Study|Withdrawal by Subject|0|||
42193627|NCT04085289|76004889|FG001|Overall Study|Withdrawal by Subject|0|||
42193628|NCT04085289|76004890|FG002|Overall Study|Withdrawal by Subject|1|||
42193629|NCT04080297|76004899|FG000|Overall Study|Adverse Event|1|||
42099027|NCT00705614|75909567|FG001|Initial Intervention|Withdrawal by Subject|71|||
42099028|NCT00705614|75909566|FG000|Initial Intervention|Administrative Reason|51|||
42099029|NCT00705614|75909567|FG001|Initial Intervention|Administrative Reason|38|||
42099030|NCT00705614|75909566|FG000|Initial Intervention|Status completion unknown|3|||
42099031|NCT00705614|75909567|FG001|Initial Intervention|Status completion unknown|0|||
42099032|NCT00705614|75909566|FG000|Switch to Remicade|Adverse Event|0|||
42193630|NCT04080297|76004900|FG001|Overall Study|Adverse Event|3|||
42193631|NCT04080297|76004899|FG000|Overall Study|concurrent illness|1|||
42193632|NCT04080297|76004900|FG001|Overall Study|concurrent illness|0|||
42193633|NCT04013529|76004908|FG000|Overall Study|Withdrawal by Subject|1|||
42193634|NCT04013529|76004909|FG001|Overall Study|Withdrawal by Subject|1|||
42193635|NCT04011735|76004918|FG000|Overall Study|Withdrawal by Subject|1|||
42193636|NCT04011735|76004919|FG001|Overall Study|Withdrawal by Subject|0|||
42193637|NCT04011735|76004920|FG002|Overall Study|Withdrawal by Subject|1|||
42193638|NCT04011735|76004918|FG000|Overall Study|Met exclusion criteria after study entry|0|||
42193639|NCT04011735|76004919|FG001|Overall Study|Met exclusion criteria after study entry|1|||
42193640|NCT04011735|76004920|FG002|Overall Study|Met exclusion criteria after study entry|0|||
42193641|NCT04009629|76004932|FG000|Overall Study|Withdrawal by Subject|2|||
42193642|NCT04009629|76004933|FG001|Overall Study|Withdrawal by Subject|0|||
42193643|NCT03694197|76004942|FG000|Overall Study|Adverse Event|9|||
42193644|NCT03694197|76004942|FG000|Overall Study|Protocol became inconvenient to participate|1|||
42193645|NCT03694197|76004942|FG000|Overall Study|Physician Decision|4|||
42193646|NCT03694197|76004942|FG000|Overall Study|Study terminated by sponsor|1350|||
42193647|NCT03694197|76004942|FG000|Overall Study|Participant moved|5|||
42193648|NCT03694197|76004942|FG000|Overall Study|Participant withdrew consent|10|||
42193649|NCT03694197|76004942|FG000|Overall Study|Related to IMP administration|1|||
42193650|NCT03694197|76004942|FG000|Overall Study|Not disclosed|5|||
42193651|NCT04365699|76004949|FG000|Overall Study|Death|2|||
42193652|NCT04365699|76004950|FG001|Overall Study|Death|5|||
42193653|NCT04365699|76004951|FG002|Overall Study|Death|15|||
42193654|NCT04005885|76004959|FG000|First Intervention|Withdrawal by Subject|1|||
42193655|NCT04005885|76004960|FG001|First Intervention|Withdrawal by Subject|1|||
42193656|NCT04005885|76004959|FG000|Second Intervention|Withdrawal by Subject|0|||
42193657|NCT04005885|76004960|FG001|Second Intervention|Withdrawal by Subject|2|||
42193658|NCT04003623|76004973|FG000|Overall Study|Withdrawal by Subject|1|||
42193659|NCT04003623|76004974|FG001|Overall Study|Withdrawal by Subject|0|||
42193660|NCT04480424|76004982|FG000|Overall Study|Withdrawal by Subject|0|||
42193661|NCT04480424|76004983|FG001|Overall Study|Withdrawal by Subject|2|||
42193662|NCT04480424|76004982|FG000|Overall Study|Lost to Follow-up|3|||
42193663|NCT04480424|76004983|FG001|Overall Study|Lost to Follow-up|3|||
42193664|NCT04480424|76004982|FG000|Overall Study|Death|14|||
42193665|NCT04480424|76004983|FG001|Overall Study|Death|16|||
42193666|NCT04480424|76004982|FG000|Overall Study|Reason not Specified|5|||
42193667|NCT04480424|76004983|FG001|Overall Study|Reason not Specified|5|||
42193668|NCT03256526|76004992|FG000|Overall Study|Adverse Event|1|||
42193669|NCT03256526|76004993|FG001|Overall Study|Adverse Event|0|||
42193670|NCT03256526|76004994|FG002|Overall Study|Adverse Event|1|||
42193671|NCT03256526|76004992|FG000|Overall Study|Lost to Follow-up|1|||
42193672|NCT03256526|76004993|FG001|Overall Study|Lost to Follow-up|0|||
42193673|NCT03256526|76004994|FG002|Overall Study|Lost to Follow-up|2|||
42193674|NCT03255980|76005006|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
42193675|NCT03255980|76005007|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
42193676|NCT03255980|76005008|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
42193677|NCT03255980|76005009|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
42193678|NCT03255980|76005006|FG000|Overall Study|Adverse Event|1|||
42193679|NCT03255980|76005007|FG001|Overall Study|Adverse Event|1|||
42193680|NCT03255980|76005008|FG002|Overall Study|Adverse Event|0|||
42193681|NCT03255980|76005009|FG003|Overall Study|Adverse Event|1|||
42193682|NCT03255980|76005006|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
42193683|NCT03255980|76005007|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
42193684|NCT03255980|76005008|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
42193685|NCT03255980|76005009|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
42193686|NCT03255980|76005006|FG000|Overall Study|Lost to Follow-up|1|||
42193687|NCT03255980|76005007|FG001|Overall Study|Lost to Follow-up|1|||
42193688|NCT03255980|76005008|FG002|Overall Study|Lost to Follow-up|0|||
42193689|NCT03255980|76005009|FG003|Overall Study|Lost to Follow-up|3|||
42193690|NCT03255980|76005006|FG000|Overall Study|Withdrawal by Subject|0|||
42193691|NCT03255980|76005007|FG001|Overall Study|Withdrawal by Subject|1|||
42193692|NCT03255980|76005008|FG002|Overall Study|Withdrawal by Subject|0|||
42193693|NCT03255980|76005009|FG003|Overall Study|Withdrawal by Subject|3|||
42193694|NCT03228212|76005019|FG000|Period 1|Adverse Event|1|||
42193695|NCT03228212|76005020|FG001|Period 1|Adverse Event|0|||
42193696|NCT03228212|76005019|FG000|Period 1|no longer meets eligibility criteria|0|||
42193697|NCT03228212|76005020|FG001|Period 1|no longer meets eligibility criteria|1|||
42193698|NCT03228212|76005019|FG000|Period 2|Lost to Follow-up|1|||
42193699|NCT03228212|76005020|FG001|Period 2|Lost to Follow-up|0|||
42099033|NCT00705614|75909567|FG001|Switch to Remicade|Adverse Event|5|||
42099034|NCT00705614|75909566|FG000|Switch to Remicade|Lost to Follow-up|0|||
42099035|NCT00705614|75909567|FG001|Switch to Remicade|Lost to Follow-up|23|||
42099036|NCT00705614|75909566|FG000|Switch to Remicade|Withdrawal by Subject|0|||
42099037|NCT00705614|75909567|FG001|Switch to Remicade|Withdrawal by Subject|12|||
42099038|NCT00705614|75909566|FG000|Switch to Remicade|Administrative Reason|0|||
42193700|NCT04000815|76005029|FG000|Overall Study|Lost to Follow-up|9|||
42193701|NCT04000815|76005030|FG001|Overall Study|Lost to Follow-up|2|||
42193702|NCT04000815|76005031|FG002|Overall Study|Lost to Follow-up|3|||
42193703|NCT04000815|76005029|FG000|Overall Study|Withdrawal by Subject|4|||
42193704|NCT04000815|76005030|FG001|Overall Study|Withdrawal by Subject|3|||
42193705|NCT04000815|76005031|FG002|Overall Study|Withdrawal by Subject|2|||
42193706|NCT04000815|76005029|FG000|Overall Study|Right ovarian cyst occured|1|||
42193707|NCT04000815|76005030|FG001|Overall Study|Right ovarian cyst occured|0|||
42193708|NCT04000815|76005031|FG002|Overall Study|Right ovarian cyst occured|0|||
42193709|NCT04000815|76005029|FG000|Overall Study|Hypertension occured on follow up|0|||
42193710|NCT04000815|76005030|FG001|Overall Study|Hypertension occured on follow up|0|||
42193711|NCT04000815|76005031|FG002|Overall Study|Hypertension occured on follow up|2|||
42193712|NCT04000581|76005041|FG000|Overall Study|Withdrawal by Subject|0|||
42099039|NCT00705614|75909567|FG001|Switch to Remicade|Administrative Reason|9|||
42099040|NCT00620763|75909575|FG000|Period: First Intervention|Withdrawal by Subject|0|||
42099041|NCT00620763|75909576|FG001|Period: First Intervention|Withdrawal by Subject|2|||
42099042|NCT00620763|75909575|FG000|Period: First Intervention|Protocol Violation|0|||
42099043|NCT00620763|75909576|FG001|Period: First Intervention|Protocol Violation|3|||
42099044|NCT00620763|75909575|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
42099045|NCT00620763|75909576|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
42099046|NCT00562978|75909584|FG000|Overall Study|Patient had imaging dose only|1|||
42099047|NCT00562978|75909585|FG001|Overall Study|Patient had imaging dose only|11|||
42099048|NCT00620373|75909591|FG000|Overall Study|Unverified cancer status|33|||
42099049|NCT00372619|75909605|FG000|Overall Study|Ineligible|0|||
42099050|NCT00372619|75909606|FG001|Overall Study|Ineligible|0|||
42099051|NCT00372619|75909607|FG002|Overall Study|Ineligible|0|||
42099052|NCT00372619|75909608|FG003|Overall Study|Ineligible|0|||
42099053|NCT00372619|75909609|FG004|Overall Study|Ineligible|0|||
42099054|NCT00372619|75909610|FG005|Overall Study|Ineligible|2|||
42099055|NCT00372619|75909611|FG006|Overall Study|Ineligible|0|||
42099056|NCT00372619|75909605|FG000|Overall Study|Inevaluable|0|||
42099057|NCT00372619|75909606|FG001|Overall Study|Inevaluable|0|||
42193713|NCT04000581|76005042|FG001|Overall Study|Withdrawal by Subject|1|||
42193714|NCT03848403|76005048|FG000|Period 2 (Day 8)|Adverse Event|1|||
42193715|NCT03848403|76005049|FG001|Period 2 (Day 8)|Adverse Event|2|||
42193716|NCT03848403|76005050|FG002|Period 2 (Day 8)|Adverse Event|2|||
42193717|NCT03848403|76005048|FG000|Period 2 (Day 8)|Physician Decision|0|||
42193718|NCT03848403|76005049|FG001|Period 2 (Day 8)|Physician Decision|1|||
42099058|NCT00372619|75909607|FG002|Overall Study|Inevaluable|0|||
42193719|NCT03848403|76005050|FG002|Period 2 (Day 8)|Physician Decision|0|||
42193720|NCT03848403|76005048|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
42193721|NCT03848403|76005049|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
42193722|NCT03848403|76005050|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
42193723|NCT04054011|76005058|FG000|Overall Study|COVID|3|||
42193724|NCT04053465|76005066|FG000|Overall Study|Withdrawal by Subject|4|||
42193725|NCT04053465|76005067|FG001|Overall Study|Withdrawal by Subject|4|||
42193726|NCT00143507|76005075|FG000|Overall Study|Death|572|||
42193727|NCT00143507|76005076|FG001|Overall Study|Death|547|||
42193728|NCT00143507|76005075|FG000|Overall Study|Withdrawal by Subject|114|||
42193729|NCT00143507|76005076|FG001|Overall Study|Withdrawal by Subject|102|||
42193730|NCT00143507|76005075|FG000|Overall Study|Lost to Follow-up|1|||
42193731|NCT00143507|76005076|FG001|Overall Study|Lost to Follow-up|0|||
42193732|NCT00143507|76005075|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
42193733|NCT00143507|76005076|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
42193734|NCT03988803|76005082|FG000|Period 2|Prematurely discontinued from medication|2|||
42193735|NCT03988803|76005082|FG000|Period 2|Adverse Event|1|||
42193736|NCT00181883|76005090|FG000|Overall Study|Lack of Efficacy|2|||
42193737|NCT00181883|76005090|FG000|Overall Study|Treatment Limiting AEs|3|||
42193738|NCT00181883|76005090|FG000|Overall Study|Withdrawal by Subject|4|||
42193739|NCT00181883|76005090|FG000|Overall Study|Lost to Follow-up|1|||
42193740|NCT00180713|76005096|FG000|Overall Study|Withdrawal by Subject|2|||
42193741|NCT00180713|76005097|FG001|Overall Study|Withdrawal by Subject|0|||
42193742|NCT00180713|76005096|FG000|Overall Study|Adverse Event|3|||
42193743|NCT00180713|76005097|FG001|Overall Study|Adverse Event|3|||
42193744|NCT03988023|76005105|FG000|Overall Study|Non-compliance|3|||
42193745|NCT03988023|76005106|FG001|Overall Study|Non-compliance|0|||
42099059|NCT00372619|75909608|FG003|Overall Study|Inevaluable|0|||
42099060|NCT00372619|75909609|FG004|Overall Study|Inevaluable|0|||
42099061|NCT00372619|75909610|FG005|Overall Study|Inevaluable|1|||
42099062|NCT00372619|75909611|FG006|Overall Study|Inevaluable|0|||
42099063|NCT00562588|75909629|FG000|Overall Study|Adverse Event|40|||
42099064|NCT00562588|75909630|FG001|Overall Study|Adverse Event|58|||
42099065|NCT00562588|75909629|FG000|Overall Study|Protocol Violation|30|||
42099066|NCT00562588|75909630|FG001|Overall Study|Protocol Violation|26|||
42099067|NCT00562588|75909629|FG000|Overall Study|Lost to Follow-up|12|||
42099068|NCT00562588|75909630|FG001|Overall Study|Lost to Follow-up|4|||
42099069|NCT00562588|75909629|FG000|Overall Study|Withdrawal by Subject|10|||
42099070|NCT00562588|75909630|FG001|Overall Study|Withdrawal by Subject|9|||
42099071|NCT00562588|75909629|FG000|Overall Study|Other|0|||
42099072|NCT00562588|75909630|FG001|Overall Study|Other|2|||
42099073|NCT00622167|75909636|FG000|Overall Study|Did not meet angiographic criteria|20|||
42099074|NCT00562354|75909642|FG000|Overall Study|Physician Decision|0|||
42099075|NCT00562354|75909643|FG001|Overall Study|Physician Decision|1|||
42099076|NCT00562354|75909642|FG000|Overall Study|Lost to Follow-up|0|||
42099077|NCT00562354|75909643|FG001|Overall Study|Lost to Follow-up|1|||
42099078|NCT00372385|75909655|FG000|Overall Study|Adverse Event|6|||
42099079|NCT00372385|75909656|FG001|Overall Study|Adverse Event|11|||
42099080|NCT00372385|75909657|FG002|Overall Study|Adverse Event|9|||
42099081|NCT00372385|75909658|FG003|Overall Study|Adverse Event|7|||
42099082|NCT00372385|75909655|FG000|Overall Study|Noncompliance|0|||
42099083|NCT00372385|75909656|FG001|Overall Study|Noncompliance|1|||
42099084|NCT00372385|75909657|FG002|Overall Study|Noncompliance|1|||
42099085|NCT00372385|75909658|FG003|Overall Study|Noncompliance|1|||
42099086|NCT00372385|75909655|FG000|Overall Study|Physician Decision|1|||
42099087|NCT00372385|75909656|FG001|Overall Study|Physician Decision|0|||
42099088|NCT00372385|75909657|FG002|Overall Study|Physician Decision|0|||
42099089|NCT00372385|75909658|FG003|Overall Study|Physician Decision|0|||
42099090|NCT00372385|75909655|FG000|Overall Study|Lost to Follow-up|2|||
42099091|NCT00372385|75909656|FG001|Overall Study|Lost to Follow-up|0|||
42099092|NCT00372385|75909657|FG002|Overall Study|Lost to Follow-up|0|||
42099093|NCT00372385|75909658|FG003|Overall Study|Lost to Follow-up|0|||
42099094|NCT00372385|75909655|FG000|Overall Study|Withdrawal by Subject|2|||
42099095|NCT00372385|75909656|FG001|Overall Study|Withdrawal by Subject|1|||
42099096|NCT00372385|75909657|FG002|Overall Study|Withdrawal by Subject|0|||
42099097|NCT00372385|75909658|FG003|Overall Study|Withdrawal by Subject|0|||
42099098|NCT00372385|75909655|FG000|Overall Study|Refusal of Treatment|3|||
42099099|NCT00372385|75909656|FG001|Overall Study|Refusal of Treatment|6|||
42099100|NCT00372385|75909657|FG002|Overall Study|Refusal of Treatment|0|||
42099101|NCT00372385|75909658|FG003|Overall Study|Refusal of Treatment|0|||
42099102|NCT00372385|75909655|FG000|Overall Study|No Response|1|||
42099103|NCT00372385|75909656|FG001|Overall Study|No Response|1|||
42099104|NCT00372385|75909657|FG002|Overall Study|No Response|0|||
42193746|NCT03988023|76005105|FG000|Overall Study|Withdrawal by Subject|39|||
42099105|NCT00372385|75909658|FG003|Overall Study|No Response|0|||
42193747|NCT03988023|76005106|FG001|Overall Study|Withdrawal by Subject|37|||
42099106|NCT00372385|75909655|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
42099107|NCT00372385|75909656|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
42099108|NCT00372385|75909657|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
42099109|NCT00372385|75909658|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
42099110|NCT00372385|75909655|FG000|Overall Study|Virologic Stopping Rule|17|||
42193748|NCT03988023|76005105|FG000|Overall Study|Adverse Event|0|||
42193749|NCT03988023|76005106|FG001|Overall Study|Adverse Event|2|||
42193750|NCT03988023|76005105|FG000|Overall Study|Physician Decision|0|||
42193751|NCT03988023|76005106|FG001|Overall Study|Physician Decision|1|||
42193752|NCT03988023|76005105|FG000|Overall Study|Lost to Follow-up|5|||
42193753|NCT03988023|76005106|FG001|Overall Study|Lost to Follow-up|8|||
42193754|NCT03988023|76005105|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
42193755|NCT03988023|76005106|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
42193756|NCT03988023|76005105|FG000|Overall Study|Lack of Efficacy|3|||
42193757|NCT03988023|76005106|FG001|Overall Study|Lack of Efficacy|1|||
42193758|NCT03988023|76005105|FG000|Overall Study|COVID-19 pandemic|225|||
42193759|NCT03988023|76005106|FG001|Overall Study|COVID-19 pandemic|227|||
42193760|NCT04052139|76005115|FG000|Overall Study|Lost to Follow-up|2|||
42193761|NCT04052139|76005116|FG001|Overall Study|Lost to Follow-up|0|||
42193762|NCT04052139|76005117|FG002|Overall Study|Lost to Follow-up|0|||
42193763|NCT04052139|76005115|FG000|Overall Study|Withdrawal by Subject|1|||
42193764|NCT04052139|76005116|FG001|Overall Study|Withdrawal by Subject|0|||
42193765|NCT04052139|76005117|FG002|Overall Study|Withdrawal by Subject|0|||
42193766|NCT03984825|76005125|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
42193767|NCT03984825|76005125|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
42193768|NCT03984825|76005125|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
42193769|NCT03981861|76005134|FG000|Overall Study|Withdrawal by Subject|3|||
42193770|NCT01332266|76005143|FG000|Phase 1b|Death|3|||
42193771|NCT01332266|76005144|FG001|Phase 1b|Death|3|||
42193772|NCT01332266|76005145|FG002|Phase 1b|Death|2|||
42193773|NCT01332266|76005146|FG003|Phase 1b|Death|0|||
42193774|NCT01332266|76005147|FG004|Phase 1b|Death|0|||
42193775|NCT01332266|76005143|FG000|Phase 1b|Lost to Follow-up|0|||
42193776|NCT01332266|76005144|FG001|Phase 1b|Lost to Follow-up|1|||
42193777|NCT01332266|76005145|FG002|Phase 1b|Lost to Follow-up|0|||
42193778|NCT01332266|76005146|FG003|Phase 1b|Lost to Follow-up|0|||
42193779|NCT01332266|76005147|FG004|Phase 1b|Lost to Follow-up|0|||
42193780|NCT01332266|76005143|FG000|Phase 1b|Withdrawal by Subject|1|||
42193781|NCT01332266|76005144|FG001|Phase 1b|Withdrawal by Subject|1|||
42193782|NCT01332266|76005145|FG002|Phase 1b|Withdrawal by Subject|1|||
42193783|NCT01332266|76005146|FG003|Phase 1b|Withdrawal by Subject|0|||
42193784|NCT01332266|76005147|FG004|Phase 1b|Withdrawal by Subject|0|||
42193785|NCT01332266|76005143|FG000|Phase 2|Death|0|||
42193786|NCT01332266|76005144|FG001|Phase 2|Death|0|||
42099111|NCT00372385|75909656|FG001|Overall Study|Virologic Stopping Rule|0|||
42099112|NCT00372385|75909657|FG002|Overall Study|Virologic Stopping Rule|0|||
42099113|NCT00372385|75909658|FG003|Overall Study|Virologic Stopping Rule|0|||
42099114|NCT03830281|75909671|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
42099115|NCT03830281|75909672|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
42099116|NCT03830281|75909671|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
42099117|NCT03830281|75909672|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
42099118|NCT03830281|75909671|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
42099119|NCT03830281|75909672|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
42099120|NCT03830281|75909671|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
42099121|NCT03830281|75909672|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
42099122|NCT03830281|75909671|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
42099123|NCT03830281|75909672|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
42099124|NCT03830281|75909671|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
42099125|NCT03830281|75909672|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
42099126|NCT03830281|75909671|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
42099127|NCT03830281|75909672|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
42193787|NCT01332266|76005145|FG002|Phase 2|Death|0|||
42193788|NCT01332266|76005146|FG003|Phase 2|Death|33|||
42193789|NCT01332266|76005147|FG004|Phase 2|Death|36|||
42193790|NCT01332266|76005143|FG000|Phase 2|Lost to Follow-up|0|||
42193791|NCT01332266|76005144|FG001|Phase 2|Lost to Follow-up|0|||
42193792|NCT01332266|76005145|FG002|Phase 2|Lost to Follow-up|0|||
42193793|NCT01332266|76005146|FG003|Phase 2|Lost to Follow-up|2|||
42193794|NCT01332266|76005147|FG004|Phase 2|Lost to Follow-up|0|||
42193795|NCT01332266|76005143|FG000|Phase 2|Physician Decision|0|||
42193796|NCT01332266|76005144|FG001|Phase 2|Physician Decision|0|||
42193797|NCT01332266|76005145|FG002|Phase 2|Physician Decision|0|||
42193798|NCT01332266|76005146|FG003|Phase 2|Physician Decision|3|||
42193799|NCT01332266|76005147|FG004|Phase 2|Physician Decision|1|||
42193800|NCT01332266|76005143|FG000|Phase 2|Symptomatic deterioration|0|||
42193801|NCT01332266|76005144|FG001|Phase 2|Symptomatic deterioration|0|||
42193802|NCT01332266|76005145|FG002|Phase 2|Symptomatic deterioration|0|||
42193803|NCT01332266|76005146|FG003|Phase 2|Symptomatic deterioration|0|||
42193804|NCT01332266|76005147|FG004|Phase 2|Symptomatic deterioration|1|||
42193805|NCT01332266|76005143|FG000|Phase 2|Progression Disease|0|||
42099128|NCT03830281|75909671|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
42099129|NCT03830281|75909672|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
42193806|NCT01332266|76005144|FG001|Phase 2|Progression Disease|0|||
42193807|NCT01332266|76005145|FG002|Phase 2|Progression Disease|0|||
42193808|NCT01332266|76005146|FG003|Phase 2|Progression Disease|2|||
42193809|NCT01332266|76005147|FG004|Phase 2|Progression Disease|1|||
42193810|NCT01332266|76005143|FG000|Phase 2|Withdrawal by Subject|0|||
42193811|NCT01332266|76005144|FG001|Phase 2|Withdrawal by Subject|0|||
42193812|NCT01332266|76005145|FG002|Phase 2|Withdrawal by Subject|0|||
42193813|NCT01332266|76005146|FG003|Phase 2|Withdrawal by Subject|2|||
42193814|NCT01332266|76005147|FG004|Phase 2|Withdrawal by Subject|2|||
42193815|NCT03255824|76005162|FG000|Overall Study|Under-sedation|2|||
42193816|NCT03255824|76005163|FG001|Overall Study|Under-sedation|1|||
42193817|NCT03238352|76005172|FG000|Overall Study|Lost to Follow-up|0|||
42193818|NCT03238352|76005173|FG001|Overall Study|Lost to Follow-up|2|||
42193819|NCT03238352|76005174|FG002|Overall Study|Lost to Follow-up|1|||
42193820|NCT03238352|76005172|FG000|Overall Study|Withdrawal by Subject|0|||
42193821|NCT03238352|76005173|FG001|Overall Study|Withdrawal by Subject|1|||
42298007|NCT02574637|76133187|FG007|Double-blind Period|Reason Not Specified|0|||
42298008|NCT02574637|76133188|FG008|Double-blind Period|Reason Not Specified|0|||
42298009|NCT02574637|76133189|FG009|Double-blind Period|Reason Not Specified|0|||
42298010|NCT02574637|76133180|FG000|Open-label (OL) Period|Adverse Event|0|||
42298011|NCT02574637|76133181|FG001|Open-label (OL) Period|Adverse Event|0|||
42298012|NCT02574637|76133182|FG002|Open-label (OL) Period|Adverse Event|0|||
42298013|NCT02574637|76133183|FG003|Open-label (OL) Period|Adverse Event|0|||
42298014|NCT02574637|76133184|FG004|Open-label (OL) Period|Adverse Event|0|||
42099130|NCT03830281|75909671|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
42099131|NCT03830281|75909672|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
42099132|NCT00563368|75909686|FG000|Overall Study|Lost to Follow-up|14|||
42099133|NCT00563368|75909687|FG001|Overall Study|Lost to Follow-up|14|||
42099134|NCT00563368|75909688|FG002|Overall Study|Lost to Follow-up|12|||
42099135|NCT00563368|75909689|FG003|Overall Study|Lost to Follow-up|6|||
42099136|NCT00563368|75909690|FG004|Overall Study|Lost to Follow-up|9|||
42099137|NCT00563368|75909691|FG005|Overall Study|Lost to Follow-up|8|||
42099138|NCT00563368|75909692|FG006|Overall Study|Lost to Follow-up|9|||
42099139|NCT00563368|75909686|FG000|Overall Study|Adverse Event|3|||
42099140|NCT00563368|75909687|FG001|Overall Study|Adverse Event|4|||
42099141|NCT00563368|75909688|FG002|Overall Study|Adverse Event|5|||
42099142|NCT00563368|75909689|FG003|Overall Study|Adverse Event|9|||
42099143|NCT00563368|75909690|FG004|Overall Study|Adverse Event|6|||
42099144|NCT00563368|75909691|FG005|Overall Study|Adverse Event|10|||
42099145|NCT00563368|75909692|FG006|Overall Study|Adverse Event|17|||
42099146|NCT00563368|75909686|FG000|Overall Study|Withdrawal by Subject|11|||
42099147|NCT00563368|75909687|FG001|Overall Study|Withdrawal by Subject|6|||
42099148|NCT00563368|75909688|FG002|Overall Study|Withdrawal by Subject|5|||
42099149|NCT00563368|75909689|FG003|Overall Study|Withdrawal by Subject|7|||
42099150|NCT00563368|75909690|FG004|Overall Study|Withdrawal by Subject|8|||
42099151|NCT00563368|75909691|FG005|Overall Study|Withdrawal by Subject|5|||
42099152|NCT00563368|75909692|FG006|Overall Study|Withdrawal by Subject|4|||
42099153|NCT00563368|75909686|FG000|Overall Study|protocol non-compliance|1|||
42099154|NCT00563368|75909687|FG001|Overall Study|protocol non-compliance|1|||
42099155|NCT00563368|75909688|FG002|Overall Study|protocol non-compliance|2|||
42099156|NCT00563368|75909689|FG003|Overall Study|protocol non-compliance|1|||
42193822|NCT03238352|76005174|FG002|Overall Study|Withdrawal by Subject|0|||
42193823|NCT00180479|76005188|FG000|Overall Study|Death|4|||
42193824|NCT00180479|76005189|FG001|Overall Study|Death|2|||
42193825|NCT00180479|76005188|FG000|Overall Study|Lost to Follow-up|9|||
42099157|NCT00563368|75909690|FG004|Overall Study|protocol non-compliance|0|||
42099158|NCT00563368|75909691|FG005|Overall Study|protocol non-compliance|1|||
42099159|NCT00563368|75909692|FG006|Overall Study|protocol non-compliance|3|||
42099160|NCT00563368|75909686|FG000|Overall Study|Pregnancy|1|||
42099161|NCT00563368|75909687|FG001|Overall Study|Pregnancy|0|||
42099162|NCT00563368|75909688|FG002|Overall Study|Pregnancy|1|||
42099163|NCT00563368|75909689|FG003|Overall Study|Pregnancy|2|||
42099164|NCT00563368|75909690|FG004|Overall Study|Pregnancy|1|||
42099165|NCT00563368|75909691|FG005|Overall Study|Pregnancy|2|||
42193826|NCT00180479|76005189|FG001|Overall Study|Lost to Follow-up|7|||
42193827|NCT00180479|76005188|FG000|Overall Study|Withdrawal by Subject|3|||
42298015|NCT02574637|76133185|FG005|Open-label (OL) Period|Adverse Event|0|||
42298016|NCT02574637|76133186|FG006|Open-label (OL) Period|Adverse Event|0|||
42298017|NCT02574637|76133187|FG007|Open-label (OL) Period|Adverse Event|0|||
42298018|NCT02574637|76133188|FG008|Open-label (OL) Period|Adverse Event|1|||
42298019|NCT02574637|76133189|FG009|Open-label (OL) Period|Adverse Event|0|||
42099166|NCT00563368|75909692|FG006|Overall Study|Pregnancy|0|||
42099167|NCT00563368|75909686|FG000|Overall Study|requirement for restricted medication|0|||
42099168|NCT00563368|75909687|FG001|Overall Study|requirement for restricted medication|0|||
42099169|NCT00563368|75909688|FG002|Overall Study|requirement for restricted medication|2|||
42099170|NCT00563368|75909689|FG003|Overall Study|requirement for restricted medication|0|||
42099171|NCT00563368|75909690|FG004|Overall Study|requirement for restricted medication|0|||
42099172|NCT00563368|75909691|FG005|Overall Study|requirement for restricted medication|0|||
42193828|NCT00180479|76005189|FG001|Overall Study|Withdrawal by Subject|3|||
42193829|NCT00180479|76005188|FG000|Overall Study|Informed consent not signed|0|||
42193830|NCT00180479|76005189|FG001|Overall Study|Informed consent not signed|1|||
42193831|NCT03224234|76005199|FG000|Main Study|Lost to Follow-up|5|||
42099173|NCT00563368|75909692|FG006|Overall Study|requirement for restricted medication|0|||
42099174|NCT00563368|75909686|FG000|Overall Study|Other|5|||
42099175|NCT00563368|75909687|FG001|Overall Study|Other|5|||
42099176|NCT00563368|75909688|FG002|Overall Study|Other|3|||
42099177|NCT00563368|75909689|FG003|Overall Study|Other|4|||
42099178|NCT00563368|75909690|FG004|Overall Study|Other|4|||
42099179|NCT00563368|75909691|FG005|Overall Study|Other|4|||
42099180|NCT00563368|75909692|FG006|Overall Study|Other|0|||
42099181|NCT00390013|75909711|FG000|Phase 1|tired|0|||
42099182|NCT00390013|75909712|FG001|Phase 1|tired|0|||
42099183|NCT00390013|75909713|FG002|Phase 1|tired|0|||
42099184|NCT00390013|75909714|FG003|Phase 1|tired|1|||
42099185|NCT00390013|75909711|FG000|Phase 2 First Treatment|tired|1|||
42099186|NCT00390013|75909712|FG001|Phase 2 First Treatment|tired|0|||
42099187|NCT00390013|75909713|FG002|Phase 2 First Treatment|tired|0|||
42099188|NCT00390013|75909714|FG003|Phase 2 First Treatment|tired|0|||
42099189|NCT00390013|75909711|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
42099190|NCT00390013|75909712|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
42099191|NCT00390013|75909713|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
42099192|NCT00390013|75909714|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
42099193|NCT00561652|75909722|FG000|Overall Study|Withdrawal by Subject|0|||
42099194|NCT00561652|75909723|FG001|Overall Study|Withdrawal by Subject|1|||
42099195|NCT00697346|75909732|FG000|Overall Study|Adverse Event|4|||
42099196|NCT00697346|75909733|FG001|Overall Study|Adverse Event|5|||
42099197|NCT00697346|75909734|FG002|Overall Study|Adverse Event|0|||
42099198|NCT00697346|75909732|FG000|Overall Study|Progressive Disease|19|||
42099199|NCT00697346|75909733|FG001|Overall Study|Progressive Disease|18|||
42099200|NCT00697346|75909734|FG002|Overall Study|Progressive Disease|0|||
42099201|NCT00697346|75909732|FG000|Overall Study|Symptomatic Deterioration|0|||
42099202|NCT00697346|75909733|FG001|Overall Study|Symptomatic Deterioration|1|||
42099203|NCT00697346|75909734|FG002|Overall Study|Symptomatic Deterioration|0|||
42099204|NCT00697346|75909732|FG000|Overall Study|Withdrawal by Subject|2|||
42193832|NCT03224234|76005200|FG001|Main Study|Lost to Follow-up|5|||
42193833|NCT02955069|76005214|FG000|Overall Study|Adverse Event|7|||
42193834|NCT02955069|76005215|FG001|Overall Study|Adverse Event|2|||
42193835|NCT02955069|76005214|FG000|Overall Study|Death|7|||
42193836|NCT02955069|76005215|FG001|Overall Study|Death|3|||
42193837|NCT02955069|76005214|FG000|Overall Study|Physician Decision|10|||
42193838|NCT02955069|76005215|FG001|Overall Study|Physician Decision|2|||
42193839|NCT02955069|76005214|FG000|Overall Study|Progressive disease|64|||
42193840|NCT02955069|76005215|FG001|Overall Study|Progressive disease|13|||
42193841|NCT02955069|76005214|FG000|Overall Study|Study terminated by sponsor|4|||
42193842|NCT02955069|76005215|FG001|Overall Study|Study terminated by sponsor|0|||
42193843|NCT02955069|76005214|FG000|Overall Study|Subject/Guardian decision|3|||
42193844|NCT02955069|76005215|FG001|Overall Study|Subject/Guardian decision|1|||
42193845|NCT03254108|76005228|FG000|Overall Study|Adverse Event|0|||
42193846|NCT03254108|76005229|FG001|Overall Study|Adverse Event|2|||
42193847|NCT03254108|76005230|FG002|Overall Study|Adverse Event|0|||
42193848|NCT03254108|76005231|FG003|Overall Study|Adverse Event|1|||
42193849|NCT03254108|76005232|FG004|Overall Study|Adverse Event|1|||
42193850|NCT03254108|76005228|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
42193851|NCT03254108|76005229|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
42193852|NCT03254108|76005230|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
42193853|NCT03254108|76005231|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
42193854|NCT03254108|76005232|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
42193855|NCT03773978|76005256|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
42193856|NCT03773978|76005257|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
42193857|NCT03773978|76005256|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
42193858|NCT03773978|76005257|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
42193859|NCT03773978|76005256|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
42193860|NCT03773978|76005257|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
42193861|NCT03773978|76005256|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
42193862|NCT03773978|76005257|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
42193863|NCT03773978|76005256|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
42193864|NCT03773978|76005257|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
42099205|NCT00697346|75909733|FG001|Overall Study|Withdrawal by Subject|2|||
42099206|NCT00697346|75909734|FG002|Overall Study|Withdrawal by Subject|0|||
42099207|NCT00697346|75909732|FG000|Overall Study|Reason not Specified|3|||
42099208|NCT00697346|75909733|FG001|Overall Study|Reason not Specified|0|||
42099209|NCT00697346|75909734|FG002|Overall Study|Reason not Specified|1|||
42099210|NCT00562120|75909761|FG000|First Intervention Period|Adverse Event|1|||
42099211|NCT00562120|75909762|FG001|First Intervention Period|Adverse Event|0|||
42193865|NCT03773978|76005256|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
42193866|NCT03773978|76005257|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
42193867|NCT03773978|76005256|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
42193868|NCT03773978|76005257|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
42193869|NCT03773978|76005256|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
42193870|NCT03773978|76005257|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
42193871|NCT03773978|76005256|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
42193872|NCT03773978|76005257|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
42193873|NCT03773978|76005256|FG000|DBW Period|Adverse Event|2|||
42193874|NCT03773978|76005257|FG001|DBW Period|Adverse Event|2|||
42193875|NCT03773978|76005256|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
42193876|NCT03773978|76005257|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
42193877|NCT03773978|76005256|FG000|DBW Period|Withdrawal by Subject|2|||
42193878|NCT03773978|76005257|FG001|DBW Period|Withdrawal by Subject|1|||
42193879|NCT03773978|76005256|FG000|DBW Period|Due to epidemic or pandemic|5|||
42193880|NCT03773978|76005257|FG001|DBW Period|Due to epidemic or pandemic|6|||
42193881|NCT03773978|76005256|FG000|DBW Period|Study team decision|1|||
42193882|NCT03773978|76005257|FG001|DBW Period|Study team decision|0|||
42193883|NCT03682107|76005273|FG000|Overall Study|Withdrawal by Subject|0|||
42193884|NCT03682107|76005274|FG001|Overall Study|Withdrawal by Subject|1|||
42193885|NCT03682107|76005275|FG002|Overall Study|Withdrawal by Subject|0|||
42193886|NCT03682107|76005276|FG003|Overall Study|Withdrawal by Subject|0|||
42193887|NCT03682107|76005277|FG004|Overall Study|Withdrawal by Subject|0|||
42193888|NCT03673046|76005291|FG000|Overall Study|Adverse Event|1|||
42193889|NCT03673046|76005292|FG001|Overall Study|Adverse Event|1|||
42193890|NCT03673046|76005291|FG000|Overall Study|Withdrawal by Subject|8|||
42193891|NCT03673046|76005292|FG001|Overall Study|Withdrawal by Subject|2|||
42193892|NCT02956005|76005298|FG000|Overall Study|Not eligible|1|||
42193893|NCT02956005|76005298|FG000|Overall Study|Withdrawal by Subject|3|||
42193894|NCT02956005|76005298|FG000|Overall Study|Physician Decision|12|||
42193895|NCT03253094|76005308|FG000|Overall Study|Adverse Event|2|||
42193896|NCT03253094|76005309|FG001|Overall Study|Adverse Event|0|||
42193897|NCT03253094|76005310|FG002|Overall Study|Adverse Event|0|||
42193898|NCT03253094|76005311|FG003|Overall Study|Adverse Event|0|||
42193899|NCT03253094|76005312|FG004|Overall Study|Adverse Event|0|||
42193900|NCT03253094|76005313|FG005|Overall Study|Adverse Event|0|||
42193901|NCT03253094|76005308|FG000|Overall Study|Lack of Efficacy|0|||
42193902|NCT03253094|76005309|FG001|Overall Study|Lack of Efficacy|0|||
42099212|NCT00562120|75909763|FG002|First Intervention Period|Adverse Event|0|||
42099213|NCT00562120|75909764|FG003|First Intervention Period|Adverse Event|0|||
42099214|NCT00562120|75909761|FG000|First Intervention Period|Randomized but not Treated|1|||
42099215|NCT00562120|75909762|FG001|First Intervention Period|Randomized but not Treated|0|||
42099216|NCT00562120|75909763|FG002|First Intervention Period|Randomized but not Treated|0|||
42099217|NCT00562120|75909764|FG003|First Intervention Period|Randomized but not Treated|0|||
42099218|NCT00561730|75909774|FG000|Overall Study|Adverse Event|2|||
42099219|NCT00561730|75909774|FG000|Overall Study|Handling of the drug|1|||
42099220|NCT00561730|75909774|FG000|Overall Study|Lost to Follow-up|5|||
42099221|NCT00561730|75909774|FG000|Overall Study|Not specified reasons|1|||
42099222|NCT00697112|75909780|FG000|Overall Study|Adverse Event|8|||
42099223|NCT00697112|75909780|FG000|Overall Study|Lost to Follow-up|1|||
42099224|NCT00697112|75909780|FG000|Overall Study|Did not meet inclusion criteria|1|||
42099225|NCT00621855|75909789|FG000|Overall Study|Adverse Event|32|||
42099226|NCT00621855|75909790|FG001|Overall Study|Adverse Event|31|||
42099227|NCT00621855|75909791|FG002|Overall Study|Adverse Event|48|||
42099228|NCT00621855|75909792|FG003|Overall Study|Adverse Event|34|||
42099229|NCT00621855|75909793|FG004|Overall Study|Adverse Event|31|||
42193903|NCT03253094|76005310|FG002|Overall Study|Lack of Efficacy|2|||
42193904|NCT03253094|76005311|FG003|Overall Study|Lack of Efficacy|1|||
42193905|NCT03253094|76005312|FG004|Overall Study|Lack of Efficacy|2|||
42193906|NCT03253094|76005313|FG005|Overall Study|Lack of Efficacy|1|||
42193907|NCT03253094|76005308|FG000|Overall Study|Lost to Follow-up|0|||
42193908|NCT03253094|76005309|FG001|Overall Study|Lost to Follow-up|0|||
42193909|NCT03253094|76005310|FG002|Overall Study|Lost to Follow-up|1|||
42018417|NCT00996892|75825879|FG018|Expansion Stage 2|Death|2|||
42018418|NCT00996892|75825880|FG019|Expansion Stage 2|Death|0|||
42018419|NCT00996892|75825861|FG000|Expansion Stage 2|Physician Decision|0|||
42018420|NCT00996892|75825862|FG001|Expansion Stage 2|Physician Decision|0|||
42018421|NCT00996892|75825863|FG002|Expansion Stage 2|Physician Decision|0|||
42018422|NCT00996892|75825864|FG003|Expansion Stage 2|Physician Decision|0|||
42018423|NCT00996892|75825865|FG004|Expansion Stage 2|Physician Decision|0|||
42099230|NCT00621855|75909789|FG000|Overall Study|Lost to Follow-up|0|||
42099231|NCT00621855|75909790|FG001|Overall Study|Lost to Follow-up|1|||
42193910|NCT03253094|76005311|FG003|Overall Study|Lost to Follow-up|1|||
42193911|NCT03253094|76005312|FG004|Overall Study|Lost to Follow-up|0|||
42018424|NCT00996892|75825866|FG005|Expansion Stage 2|Physician Decision|0|||
42018425|NCT00996892|75825867|FG006|Expansion Stage 2|Physician Decision|0|||
42193912|NCT03253094|76005313|FG005|Overall Study|Lost to Follow-up|1|||
42099232|NCT00621855|75909791|FG002|Overall Study|Lost to Follow-up|3|||
42099233|NCT00621855|75909792|FG003|Overall Study|Lost to Follow-up|4|||
42099234|NCT00621855|75909793|FG004|Overall Study|Lost to Follow-up|1|||
42099235|NCT00621855|75909789|FG000|Overall Study|Protocol Violation|16|||
42099236|NCT00621855|75909790|FG001|Overall Study|Protocol Violation|8|||
42099237|NCT00621855|75909791|FG002|Overall Study|Protocol Violation|6|||
42099238|NCT00621855|75909792|FG003|Overall Study|Protocol Violation|7|||
42193913|NCT03253094|76005308|FG000|Overall Study|Physician Decision|1|||
42193914|NCT03253094|76005309|FG001|Overall Study|Physician Decision|0|||
42193915|NCT03253094|76005310|FG002|Overall Study|Physician Decision|0|||
42193916|NCT03253094|76005311|FG003|Overall Study|Physician Decision|1|||
42193917|NCT03253094|76005312|FG004|Overall Study|Physician Decision|0|||
42193918|NCT03253094|76005313|FG005|Overall Study|Physician Decision|2|||
42193919|NCT03253094|76005308|FG000|Overall Study|Withdrawal by Subject|1|||
42193920|NCT03253094|76005309|FG001|Overall Study|Withdrawal by Subject|2|||
42193921|NCT03253094|76005310|FG002|Overall Study|Withdrawal by Subject|1|||
42193922|NCT03253094|76005311|FG003|Overall Study|Withdrawal by Subject|0|||
42193923|NCT03253094|76005312|FG004|Overall Study|Withdrawal by Subject|3|||
42193924|NCT03253094|76005313|FG005|Overall Study|Withdrawal by Subject|0|||
42193925|NCT03253094|76005308|FG000|Overall Study|Other|0|||
42193926|NCT03253094|76005309|FG001|Overall Study|Other|1|||
42193927|NCT03253094|76005310|FG002|Overall Study|Other|2|||
42193928|NCT03253094|76005311|FG003|Overall Study|Other|1|||
42193929|NCT03253094|76005312|FG004|Overall Study|Other|0|||
42193930|NCT03253094|76005313|FG005|Overall Study|Other|0|||
42193931|NCT03654885|76005329|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
42193932|NCT03654885|76005330|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
42193933|NCT03654885|76005329|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
42193934|NCT03654885|76005330|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
42193935|NCT03654885|76005329|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
42193936|NCT03654885|76005330|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
42193937|NCT03654885|76005329|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
42193938|NCT03654885|76005330|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
42193939|NCT03654885|76005329|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
42193940|NCT03654885|76005330|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
42193941|NCT03654885|76005329|FG000|Overall Study|Adverse Event in Study Eye|3|||
42193942|NCT03654885|76005330|FG001|Overall Study|Adverse Event in Study Eye|0|||
42193943|NCT03654885|76005329|FG000|Overall Study|Consent Withdrawn|1|||
42193944|NCT03654885|76005330|FG001|Overall Study|Consent Withdrawn|0|||
42193945|NCT03654885|76005329|FG000|Overall Study|Death|3|||
42193946|NCT03654885|76005330|FG001|Overall Study|Death|1|||
42193947|NCT03654885|76005329|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
42193948|NCT03654885|76005330|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
42193949|NCT03654885|76005329|FG000|Overall Study|Lost to Follow-up|3|||
42193950|NCT03654885|76005330|FG001|Overall Study|Lost to Follow-up|3|||
42193951|NCT03236246|76005338|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
42193952|NCT03236246|76005339|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
42099239|NCT00621855|75909793|FG004|Overall Study|Protocol Violation|8|||
42099240|NCT00621855|75909789|FG000|Overall Study|Withdrawal by Subject|16|||
42099241|NCT00621855|75909790|FG001|Overall Study|Withdrawal by Subject|11|||
42099242|NCT00621855|75909791|FG002|Overall Study|Withdrawal by Subject|13|||
42099243|NCT00621855|75909792|FG003|Overall Study|Withdrawal by Subject|13|||
42099244|NCT00621855|75909793|FG004|Overall Study|Withdrawal by Subject|9|||
42099245|NCT00621855|75909789|FG000|Overall Study|Other|9|||
42099246|NCT00621855|75909790|FG001|Overall Study|Other|7|||
42099247|NCT00621855|75909791|FG002|Overall Study|Other|6|||
42099248|NCT00621855|75909792|FG003|Overall Study|Other|5|||
42099249|NCT00621855|75909793|FG004|Overall Study|Other|4|||
42099250|NCT00621855|75909789|FG000|Overall Study|Patients did not receive study drug|3|||
42099251|NCT00621855|75909790|FG001|Overall Study|Patients did not receive study drug|3|||
42099252|NCT00621855|75909791|FG002|Overall Study|Patients did not receive study drug|5|||
42099253|NCT00621855|75909792|FG003|Overall Study|Patients did not receive study drug|4|||
42099254|NCT00621855|75909793|FG004|Overall Study|Patients did not receive study drug|2|||
42099255|NCT00561574|75909807|FG000|Overall Study|Adverse Event|21|||
42099256|NCT00561574|75909808|FG001|Overall Study|Adverse Event|24|||
42099257|NCT00561574|75909807|FG000|Overall Study|Lack of Efficacy|11|||
42099258|NCT00561574|75909808|FG001|Overall Study|Lack of Efficacy|21|||
42099259|NCT00561574|75909807|FG000|Overall Study|Withdrawal by Subject|4|||
42099260|NCT00561574|75909808|FG001|Overall Study|Withdrawal by Subject|4|||
42099261|NCT00561574|75909807|FG000|Overall Study|Reason Unrelated to Trial|6|||
42099262|NCT00561574|75909808|FG001|Overall Study|Reason Unrelated to Trial|2|||
42099263|NCT00561574|75909807|FG000|Overall Study|Lost to Follow-up|1|||
42193953|NCT03236246|76005338|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
42193954|NCT03236246|76005339|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
42193955|NCT03236246|76005338|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
42193956|NCT03236246|76005339|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
42193957|NCT03236246|76005338|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
42193958|NCT03236246|76005339|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
42193959|NCT03236246|76005338|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
42193960|NCT03236246|76005339|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
42193961|NCT03236246|76005338|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
42193962|NCT03236246|76005339|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
42193963|NCT03236246|76005338|FG000|24-Week Dose Titration Period|Death|3|||
42193964|NCT03236246|76005339|FG001|24-Week Dose Titration Period|Death|1|||
42193965|NCT03236246|76005338|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
42193966|NCT03236246|76005339|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
42193967|NCT03236246|76005338|FG000|24-Week Dose Titration Period|Adverse Event|7|||
42193968|NCT03236246|76005339|FG001|24-Week Dose Titration Period|Adverse Event|8|||
42193969|NCT03236246|76005338|FG000|24-Week Dose Titration Period|Captured as Other|1|||
42193970|NCT03236246|76005339|FG001|24-Week Dose Titration Period|Captured as Other|2|||
42193971|NCT03236246|76005338|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
42193972|NCT03236246|76005339|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
42193973|NCT03236246|76005338|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
42193974|NCT03236246|76005339|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
42099264|NCT00561574|75909808|FG001|Overall Study|Lost to Follow-up|0|||
42099265|NCT00561574|75909807|FG000|Overall Study|Other|5|||
42099266|NCT00561574|75909808|FG001|Overall Study|Other|7|||
42099267|NCT00619827|75909816|FG000|Overall Study|Adverse Event|1|||
42099268|NCT00619827|75909817|FG001|Overall Study|Adverse Event|2|||
42099269|NCT00619827|75909816|FG000|Overall Study|Withdrawal by Subject|2|||
42099270|NCT00619827|75909817|FG001|Overall Study|Withdrawal by Subject|2|||
42099271|NCT00687804|75909826|FG000|Core Study|Adverse Event|5|||
42099272|NCT00687804|75909827|FG001|Core Study|Adverse Event|3|||
42099273|NCT00687804|75909828|FG002|Core Study|Adverse Event|3|||
42099274|NCT00687804|75909826|FG000|Core Study|Abnormal laboratory value(s)|1|||
42099275|NCT00687804|75909827|FG001|Core Study|Abnormal laboratory value(s)|0|||
42099276|NCT00687804|75909828|FG002|Core Study|Abnormal laboratory value(s)|0|||
42099277|NCT00687804|75909826|FG000|Core Study|Lack of Efficacy|1|||
42193975|NCT03236246|76005338|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
42193976|NCT03236246|76005339|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
42193977|NCT03236246|76005338|FG000|24-Week Dose Maintenance Period|Death|0|||
42193978|NCT03236246|76005339|FG001|24-Week Dose Maintenance Period|Death|1|||
42193979|NCT03236246|76005338|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
42193980|NCT03236246|76005339|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
42193981|NCT02937584|76005345|FG000|Period 1|Adverse Event|1|||
42193982|NCT02937584|76005346|FG001|Period 1|Adverse Event|2|||
42193983|NCT02937584|76005345|FG000|Washout|Adverse Event|0|||
42193984|NCT02937584|76005346|FG001|Washout|Adverse Event|1|||
42193985|NCT00179621|76005355|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
42193986|NCT00179621|76005356|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
42193987|NCT00179621|76005357|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
42193988|NCT00179621|76005358|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
42193989|NCT00179621|76005355|FG000|Double-Blind Period|Adverse Event|2|||
42193990|NCT00179621|76005356|FG001|Double-Blind Period|Adverse Event|7|||
42193991|NCT00179621|76005357|FG002|Double-Blind Period|Adverse Event|4|||
42193992|NCT00179621|76005358|FG003|Double-Blind Period|Adverse Event|0|||
42193993|NCT00179621|76005355|FG000|Double-Blind Period|Withdrawal by Subject|2|||
42193994|NCT00179621|76005356|FG001|Double-Blind Period|Withdrawal by Subject|1|||
42193995|NCT00179621|76005357|FG002|Double-Blind Period|Withdrawal by Subject|3|||
42193996|NCT00179621|76005358|FG003|Double-Blind Period|Withdrawal by Subject|0|||
42193997|NCT00179621|76005355|FG000|Double-Blind Period|Death|0|||
42193998|NCT00179621|76005356|FG001|Double-Blind Period|Death|1|||
42099278|NCT00687804|75909827|FG001|Core Study|Lack of Efficacy|1|||
42099279|NCT00687804|75909828|FG002|Core Study|Lack of Efficacy|1|||
42099280|NCT00687804|75909826|FG000|Core Study|Withdrawal by Subject|4|||
42099281|NCT00687804|75909827|FG001|Core Study|Withdrawal by Subject|7|||
42193999|NCT00179621|76005357|FG002|Double-Blind Period|Death|2|||
42194000|NCT00179621|76005358|FG003|Double-Blind Period|Death|0|||
42194001|NCT00179621|76005355|FG000|Double-Blind Period|Protocol Violation|1|||
42099282|NCT00687804|75909828|FG002|Core Study|Withdrawal by Subject|7|||
42099283|NCT00687804|75909826|FG000|Core Study|Lost to Follow-up|0|||
42194002|NCT00179621|76005356|FG001|Double-Blind Period|Protocol Violation|0|||
42359317|NCT00418886|76204979|FG001|Overall Study|discontinue treatment survival follow up|91|||
42194003|NCT00179621|76005357|FG002|Double-Blind Period|Protocol Violation|0|||
42194004|NCT00179621|76005358|FG003|Double-Blind Period|Protocol Violation|0|||
42099284|NCT00687804|75909827|FG001|Core Study|Lost to Follow-up|1|||
42099285|NCT00687804|75909828|FG002|Core Study|Lost to Follow-up|0|||
42194005|NCT00179621|76005355|FG000|Double-Blind Period|Other|0|||
42194006|NCT00179621|76005356|FG001|Double-Blind Period|Other|2|||
42194007|NCT00179621|76005357|FG002|Double-Blind Period|Other|2|||
42194008|NCT00179621|76005358|FG003|Double-Blind Period|Other|0|||
42194009|NCT00179621|76005355|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
42194010|NCT00179621|76005356|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
42194011|NCT00179621|76005357|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
42194012|NCT00179621|76005358|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
42194013|NCT00179621|76005355|FG000|Open-Label Period|Adverse Event|0|||
42194014|NCT00179621|76005356|FG001|Open-Label Period|Adverse Event|6|||
42194015|NCT00179621|76005357|FG002|Open-Label Period|Adverse Event|5|||
42194016|NCT00179621|76005358|FG003|Open-Label Period|Adverse Event|6|||
42194017|NCT00179621|76005355|FG000|Open-Label Period|Withdrawal by Subject|0|||
42194018|NCT00179621|76005356|FG001|Open-Label Period|Withdrawal by Subject|2|||
42194019|NCT00179621|76005357|FG002|Open-Label Period|Withdrawal by Subject|2|||
42194020|NCT00179621|76005358|FG003|Open-Label Period|Withdrawal by Subject|2|||
42194021|NCT00179621|76005355|FG000|Open-Label Period|Death|0|||
42194022|NCT00179621|76005356|FG001|Open-Label Period|Death|0|||
42194023|NCT00179621|76005357|FG002|Open-Label Period|Death|1|||
42194024|NCT00179621|76005358|FG003|Open-Label Period|Death|2|||
42194025|NCT00179621|76005355|FG000|Open-Label Period|Other|0|||
42194026|NCT00179621|76005356|FG001|Open-Label Period|Other|1|||
42194027|NCT00179621|76005357|FG002|Open-Label Period|Other|1|||
42194028|NCT00179621|76005358|FG003|Open-Label Period|Other|2|||
42194029|NCT00179309|76005369|FG000|Treatment|Toxicity|2|||
42194030|NCT00179309|76005370|FG001|Treatment|Toxicity|3|||
42194031|NCT00179309|76005369|FG000|Treatment|Withdrawal by Subject|1|||
42194032|NCT00179309|76005370|FG001|Treatment|Withdrawal by Subject|2|||
42194033|NCT00179309|76005369|FG000|Treatment|Allergy|1|||
42194034|NCT00179309|76005370|FG001|Treatment|Allergy|0|||
42194035|NCT00178685|76005391|FG000|Overall Study|Death|3|||
42194036|NCT00178685|76005392|FG001|Overall Study|Death|3|||
42194037|NCT00178685|76005393|FG002|Overall Study|Death|6|||
42194038|NCT00178685|76005391|FG000|Overall Study|Lost to Follow-up|100|||
42194039|NCT00178685|76005392|FG001|Overall Study|Lost to Follow-up|187|||
42194040|NCT00178685|76005393|FG002|Overall Study|Lost to Follow-up|183|||
42194041|NCT00178685|76005391|FG000|Overall Study|Withdrawal by Subject|8|||
42194042|NCT00178685|76005392|FG001|Overall Study|Withdrawal by Subject|14|||
42194043|NCT00178685|76005393|FG002|Overall Study|Withdrawal by Subject|7|||
42194044|NCT02933528|76005401|FG000|Overall Study|Lost to Follow-up|2|||
42194045|NCT00177671|76005407|FG000|Overall Study|Withdrawal by Subject|5|||
42194046|NCT00177671|76005408|FG001|Overall Study|Withdrawal by Subject|6|||
42194047|NCT00177671|76005407|FG000|Overall Study|medical complications|2|||
42194048|NCT00177671|76005408|FG001|Overall Study|medical complications|0|||
42194049|NCT00177671|76005407|FG000|Overall Study|Adverse Event|6|||
42194050|NCT00177671|76005408|FG001|Overall Study|Adverse Event|0|||
42194051|NCT00177671|76005407|FG000|Overall Study|Physician Decision|12|||
42194052|NCT00177671|76005408|FG001|Overall Study|Physician Decision|8|||
42194053|NCT02933060|76005416|FG000|Overall Study|Withdrawal by Subject|0|||
42194054|NCT02933060|76005417|FG001|Overall Study|Withdrawal by Subject|1|||
42194055|NCT03235154|76005423|FG000|Overall Study|Withdrawal by Subject|1|||
42194056|NCT03235154|76005423|FG000|Overall Study|Adverse Event|1|||
42194057|NCT03235154|76005423|FG000|Overall Study|Lost to Follow-up|2|||
42194058|NCT03234608|76005431|FG000|Overall Study|Lost to Follow-up|23|||
42194059|NCT03234608|76005432|FG001|Overall Study|Lost to Follow-up|21|||
42099286|NCT00687804|75909826|FG000|Core Study|Death|2|||
42099287|NCT00687804|75909827|FG001|Core Study|Death|2|||
42099288|NCT00687804|75909828|FG002|Core Study|Death|2|||
42099289|NCT00687804|75909826|FG000|Core Study|Protocol Violation|1|||
42099290|NCT00687804|75909827|FG001|Core Study|Protocol Violation|1|||
42099291|NCT00687804|75909828|FG002|Core Study|Protocol Violation|0|||
42099292|NCT00687804|75909826|FG000|Open-Label Extension Study|Adverse Event|2|||
42099293|NCT00687804|75909827|FG001|Open-Label Extension Study|Adverse Event|2|||
42099294|NCT00687804|75909828|FG002|Open-Label Extension Study|Adverse Event|2|||
42194060|NCT03248882|76005443|FG000|Overall Study|Adverse Event|3|||
42194061|NCT03248882|76005444|FG001|Overall Study|Adverse Event|3|||
42099295|NCT00687804|75909826|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
42194062|NCT03248882|76005445|FG002|Overall Study|Adverse Event|2|||
42194063|NCT03248882|76005446|FG003|Overall Study|Adverse Event|6|||
42194064|NCT03248882|76005447|FG004|Overall Study|Adverse Event|9|||
42359318|NCT00418886|76204978|FG000|Overall Study|Death|122|||
42099296|NCT00687804|75909827|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
42099297|NCT00687804|75909828|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
42194065|NCT03248882|76005443|FG000|Overall Study|Lost to Follow-up|0|||
42194066|NCT03248882|76005444|FG001|Overall Study|Lost to Follow-up|0|||
42194067|NCT03248882|76005445|FG002|Overall Study|Lost to Follow-up|0|||
42194068|NCT03248882|76005446|FG003|Overall Study|Lost to Follow-up|0|||
42194069|NCT03248882|76005447|FG004|Overall Study|Lost to Follow-up|1|||
42194070|NCT03248882|76005443|FG000|Overall Study|Protocol Violation|2|||
42194071|NCT03248882|76005444|FG001|Overall Study|Protocol Violation|0|||
42194072|NCT03248882|76005445|FG002|Overall Study|Protocol Violation|2|||
42194073|NCT03248882|76005446|FG003|Overall Study|Protocol Violation|0|||
42194074|NCT03248882|76005447|FG004|Overall Study|Protocol Violation|1|||
42194075|NCT03248882|76005443|FG000|Overall Study|Withdrawal by Subject|2|||
42194076|NCT03248882|76005444|FG001|Overall Study|Withdrawal by Subject|2|||
42194077|NCT03248882|76005445|FG002|Overall Study|Withdrawal by Subject|3|||
42194078|NCT03248882|76005446|FG003|Overall Study|Withdrawal by Subject|4|||
42194079|NCT03248882|76005447|FG004|Overall Study|Withdrawal by Subject|2|||
42194080|NCT03233438|76005461|FG000|Overall Study|Lost to Follow-up|4|||
42194081|NCT03233438|76005462|FG001|Overall Study|Lost to Follow-up|9|||
42194082|NCT03233438|76005461|FG000|Overall Study|Withdrawal by Subject|2|||
42194083|NCT03233438|76005462|FG001|Overall Study|Withdrawal by Subject|1|||
42194084|NCT03233438|76005461|FG000|Overall Study|No recording of dalbavancin|0|||
42194085|NCT03233438|76005462|FG001|Overall Study|No recording of dalbavancin|1|||
42194086|NCT01368406|76005470|FG000|Overall Study|Lost to Follow-up|8|||
42194087|NCT01368406|76005471|FG001|Overall Study|Lost to Follow-up|4|||
42194088|NCT01368406|76005470|FG000|Overall Study|Withdrawal by Subject|8|||
42194089|NCT01368406|76005471|FG001|Overall Study|Withdrawal by Subject|4|||
42194090|NCT01368406|76005470|FG000|Overall Study|relapse of the disease|3|||
42099298|NCT00687804|75909826|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
42099299|NCT00687804|75909827|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
42099300|NCT00687804|75909828|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
42194091|NCT01368406|76005471|FG001|Overall Study|relapse of the disease|2|||
42194092|NCT01368406|76005470|FG000|Overall Study|started working|2|||
42194093|NCT01368406|76005471|FG001|Overall Study|started working|3|||
42194094|NCT00175877|76005477|FG000|Overall Study|Adverse Event|136|||
42194095|NCT00175877|76005477|FG000|Overall Study|Withdrawal by Subject|141|||
42194096|NCT00175877|76005477|FG000|Overall Study|Lost to Follow-up|9|||
42194097|NCT00175877|76005477|FG000|Overall Study|Lack of Efficacy|26|||
42194098|NCT00175877|76005477|FG000|Overall Study|Protocol Violation|15|||
42194099|NCT00175877|76005477|FG000|Overall Study|Other Reason|20|||
42194100|NCT00175877|76005477|FG000|Overall Study|AE & Other|1|||
42194101|NCT00175877|76005477|FG000|Overall Study|Withdrawal by subject & Other|1|||
42194102|NCT03247556|76005484|FG000|Overall Study|Adverse Event|1|||
42194103|NCT03247556|76005485|FG001|Overall Study|Adverse Event|4|||
42194104|NCT03247556|76005486|FG002|Overall Study|Adverse Event|5|||
42099301|NCT00687804|75909826|FG000|Open-Label Extension Study|Administrative problems|1|||
42099302|NCT00687804|75909827|FG001|Open-Label Extension Study|Administrative problems|1|||
42099303|NCT00687804|75909828|FG002|Open-Label Extension Study|Administrative problems|0|||
42194105|NCT03247556|76005484|FG000|Overall Study|Lost to Follow-up|5|||
42099304|NCT00687804|75909826|FG000|Open-Label Extension Study|Death|2|||
42099305|NCT00687804|75909827|FG001|Open-Label Extension Study|Death|3|||
42099306|NCT00687804|75909828|FG002|Open-Label Extension Study|Death|3|||
42099307|NCT00689052|75909855|FG000|Overall Study|Adverse Event|4|||
42099308|NCT00689052|75909856|FG001|Overall Study|Adverse Event|6|||
42099309|NCT00689052|75909855|FG000|Overall Study|Protocol Violation|1|||
42099310|NCT00689052|75909856|FG001|Overall Study|Protocol Violation|0|||
42099311|NCT00689052|75909855|FG000|Overall Study|Lost to Follow-up|2|||
42099312|NCT00689052|75909856|FG001|Overall Study|Lost to Follow-up|0|||
42099313|NCT00689052|75909855|FG000|Overall Study|Withdrawal by Subject|2|||
42099314|NCT00689052|75909856|FG001|Overall Study|Withdrawal by Subject|0|||
42099315|NCT00689052|75909855|FG000|Overall Study|Early termination of the trial|22|||
42099316|NCT00689052|75909856|FG001|Overall Study|Early termination of the trial|24|||
42099317|NCT00560950|75909866|FG000|Overall Study|Lost to Follow-up|1|||
42099318|NCT00560950|75909867|FG001|Overall Study|Lost to Follow-up|0|||
42099319|NCT00576758|75909877|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
42099320|NCT00576758|75909878|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
42099321|NCT00576758|75909877|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
42099322|NCT00576758|75909878|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
42099323|NCT00576758|75909877|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
42099324|NCT00576758|75909878|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
42099325|NCT00576758|75909877|FG000|Induction Treatment Period|Death|1|||
42099326|NCT00576758|75909878|FG001|Induction Treatment Period|Death|0|||
42099327|NCT00576758|75909877|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
42099328|NCT00576758|75909878|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
42099329|NCT00576758|75909877|FG000|Induction Treatment Period|Withdrew consent|1|||
42099330|NCT00576758|75909878|FG001|Induction Treatment Period|Withdrew consent|0|||
42099331|NCT00576758|75909877|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
42099332|NCT00576758|75909878|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
42099333|NCT00576758|75909877|FG000|Extension Treatment Period|Death|1|||
42194106|NCT03247556|76005485|FG001|Overall Study|Lost to Follow-up|5|||
42194107|NCT03247556|76005486|FG002|Overall Study|Lost to Follow-up|4|||
42194108|NCT03247556|76005484|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
42194109|NCT03247556|76005485|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
42099334|NCT00576758|75909878|FG001|Extension Treatment Period|Death|1|||
42194110|NCT03247556|76005486|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
42194111|NCT03247556|76005484|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
42194112|NCT03247556|76005485|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
42194113|NCT03247556|76005486|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
42194114|NCT03247556|76005484|FG000|Overall Study|Protocol Violation|2|||
42194115|NCT03247556|76005485|FG001|Overall Study|Protocol Violation|0|||
42194116|NCT03247556|76005486|FG002|Overall Study|Protocol Violation|1|||
42194117|NCT03247556|76005484|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
42194118|NCT03247556|76005485|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
42194119|NCT03247556|76005486|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
42194120|NCT03216746|76005498|FG000|Overall Study|Lost to Follow-up|6|||
42194121|NCT03216746|76005499|FG001|Overall Study|Lost to Follow-up|8|||
42099335|NCT00576758|75909877|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
42099336|NCT00576758|75909878|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
42099337|NCT00576758|75909877|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
42099338|NCT00576758|75909878|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
42099339|NCT00576758|75909877|FG000|Extension Treatment Period|Administrative/Other|3|||
42099340|NCT00576758|75909878|FG001|Extension Treatment Period|Administrative/Other|1|||
42099341|NCT00576758|75909877|FG000|Follow-up Period|Administrative/Other|6|||
42099342|NCT00576758|75909878|FG001|Follow-up Period|Administrative/Other|8|||
42099343|NCT00576758|75909877|FG000|Follow-up Period|Death|3|||
42194122|NCT03216746|76005500|FG002|Overall Study|Lost to Follow-up|5|||
42194123|NCT03216746|76005501|FG003|Overall Study|Lost to Follow-up|6|||
42194124|NCT02787304|76005515|FG000|Overall Study|Adverse Event|9|||
42194125|NCT02787304|76005516|FG001|Overall Study|Adverse Event|3|||
42194126|NCT02787304|76005517|FG002|Overall Study|Adverse Event|8|||
42194127|NCT02787304|76005518|FG003|Overall Study|Adverse Event|1|||
42194128|NCT02787304|76005515|FG000|Overall Study|Withdrawal by Subject|1|||
42194129|NCT02787304|76005516|FG001|Overall Study|Withdrawal by Subject|4|||
42194130|NCT02787304|76005517|FG002|Overall Study|Withdrawal by Subject|0|||
42194131|NCT02787304|76005518|FG003|Overall Study|Withdrawal by Subject|0|||
42194132|NCT02787304|76005515|FG000|Overall Study|Lost to Follow-up|1|||
42194133|NCT02787304|76005516|FG001|Overall Study|Lost to Follow-up|0|||
42194134|NCT02787304|76005517|FG002|Overall Study|Lost to Follow-up|0|||
42194135|NCT02787304|76005518|FG003|Overall Study|Lost to Follow-up|1|||
42194136|NCT02787304|76005515|FG000|Overall Study|Noncompliance with study drug|0|||
42194137|NCT02787304|76005516|FG001|Overall Study|Noncompliance with study drug|0|||
42194138|NCT02787304|76005517|FG002|Overall Study|Noncompliance with study drug|1|||
42194139|NCT02787304|76005518|FG003|Overall Study|Noncompliance with study drug|0|||
42194140|NCT02787304|76005515|FG000|Overall Study|Physician Decision|0|||
42194141|NCT02787304|76005516|FG001|Overall Study|Physician Decision|0|||
42194142|NCT02787304|76005517|FG002|Overall Study|Physician Decision|1|||
42194143|NCT02787304|76005518|FG003|Overall Study|Physician Decision|0|||
42194144|NCT02787304|76005515|FG000|Overall Study|Study terminated by sponsor|25|||
42194145|NCT02787304|76005516|FG001|Overall Study|Study terminated by sponsor|31|||
42194146|NCT02787304|76005517|FG002|Overall Study|Study terminated by sponsor|31|||
42194147|NCT02787304|76005518|FG003|Overall Study|Study terminated by sponsor|32|||
42099344|NCT00576758|75909878|FG001|Follow-up Period|Death|3|||
42099345|NCT00576758|75909877|FG000|Follow-up Period|Insufficient therapeutic response|16|||
42099346|NCT00576758|75909878|FG001|Follow-up Period|Insufficient therapeutic response|5|||
42099347|NCT00576758|75909877|FG000|Follow-up Period|Withdrew consent|2|||
42194148|NCT02932904|76005532|FG000|Overall Study|Reason not Specified|1|||
42194149|NCT02932904|76005533|FG001|Overall Study|Reason not Specified|0|||
42298020|NCT02574637|76133180|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
42298021|NCT02574637|76133181|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
42298022|NCT02574637|76133182|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
42298023|NCT02574637|76133183|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
42298024|NCT02574637|76133184|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
42298025|NCT02574637|76133185|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
42298026|NCT02574637|76133186|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
42359319|NCT00418886|76204979|FG001|Overall Study|Death|147|||
42359320|NCT00418886|76204978|FG000|Overall Study|Withdrawal by Subject|9|||
42194150|NCT02932904|76005534|FG002|Overall Study|Reason not Specified|2|||
42194151|NCT02932904|76005535|FG003|Overall Study|Reason not Specified|2|||
42194152|NCT02932904|76005532|FG000|Overall Study|Noncompliance with Study Drug|2|||
42194153|NCT02932904|76005533|FG001|Overall Study|Noncompliance with Study Drug|3|||
42194154|NCT02932904|76005534|FG002|Overall Study|Noncompliance with Study Drug|3|||
42194155|NCT02932904|76005535|FG003|Overall Study|Noncompliance with Study Drug|4|||
42194156|NCT02932904|76005532|FG000|Overall Study|Pregnancy|0|||
42194157|NCT02932904|76005533|FG001|Overall Study|Pregnancy|1|||
42194158|NCT02932904|76005534|FG002|Overall Study|Pregnancy|1|||
42194159|NCT02932904|76005535|FG003|Overall Study|Pregnancy|0|||
42194160|NCT02932904|76005532|FG000|Overall Study|Study Termination|0|||
42099348|NCT00576758|75909878|FG001|Follow-up Period|Withdrew consent|1|||
42099349|NCT00560794|75909885|FG000|Overall Study|Adverse Event|2|||
42099350|NCT00560794|75909885|FG000|Overall Study|Patient was not Compliant|1|||
42099351|NCT00560794|75909885|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
42099352|NCT00560794|75909885|FG000|Overall Study|Hematological Relapse|1|||
42099353|NCT00560794|75909885|FG000|Overall Study|Received Bone Marrow Transplant|6|||
42099354|NCT00619359|75909893|FG000|Overall Study|Adverse Event|32|||
42099355|NCT00619359|75909894|FG001|Overall Study|Adverse Event|36|||
42099356|NCT00619359|75909893|FG000|Overall Study|Lost to Follow-up|12|||
42099357|NCT00619359|75909894|FG001|Overall Study|Lost to Follow-up|16|||
42099358|NCT00619359|75909893|FG000|Overall Study|Physician Decision|0|||
42099359|NCT00619359|75909894|FG001|Overall Study|Physician Decision|7|||
42194161|NCT02932904|76005533|FG001|Overall Study|Study Termination|1|||
42194162|NCT02932904|76005534|FG002|Overall Study|Study Termination|0|||
42099360|NCT00619359|75909893|FG000|Overall Study|Protocol Violation|1|||
42194163|NCT02932904|76005535|FG003|Overall Study|Study Termination|0|||
42194164|NCT02932904|76005532|FG000|Overall Study|Voluntary Withdrawal|2|||
42194165|NCT02932904|76005533|FG001|Overall Study|Voluntary Withdrawal|1|||
42194166|NCT02932904|76005534|FG002|Overall Study|Voluntary Withdrawal|4|||
42194167|NCT02932904|76005535|FG003|Overall Study|Voluntary Withdrawal|2|||
42194168|NCT02932904|76005532|FG000|Overall Study|Lost to Follow-up|5|||
42194169|NCT02932904|76005533|FG001|Overall Study|Lost to Follow-up|3|||
42194170|NCT02932904|76005534|FG002|Overall Study|Lost to Follow-up|6|||
42194171|NCT02932904|76005535|FG003|Overall Study|Lost to Follow-up|0|||
42194172|NCT02932904|76005532|FG000|Overall Study|Significant Protocol Deviation|2|||
42194173|NCT02932904|76005533|FG001|Overall Study|Significant Protocol Deviation|3|||
42194174|NCT02932904|76005534|FG002|Overall Study|Significant Protocol Deviation|6|||
42194175|NCT02932904|76005535|FG003|Overall Study|Significant Protocol Deviation|1|||
42194176|NCT02932904|76005532|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
42194177|NCT02932904|76005533|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
42194178|NCT02932904|76005534|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
42298027|NCT02574637|76133187|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
42298028|NCT02574637|76133188|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
42298029|NCT02574637|76133189|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
42298030|NCT02574637|76133180|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
42298031|NCT02574637|76133181|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
42298032|NCT02574637|76133182|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
42298033|NCT02574637|76133183|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
42298034|NCT02574637|76133184|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
42298035|NCT02574637|76133185|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
42298036|NCT02574637|76133186|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
42298037|NCT02574637|76133187|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
42298038|NCT02574637|76133188|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
42298039|NCT02574637|76133189|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
42298040|NCT02392611|76133219|FG000|Overall Study|Adverse Event|0|||
42298041|NCT02392611|76133220|FG001|Overall Study|Adverse Event|0|||
42298042|NCT02392611|76133221|FG002|Overall Study|Adverse Event|0|||
42298043|NCT02392611|76133222|FG003|Overall Study|Adverse Event|1|||
42298044|NCT02392611|76133223|FG004|Overall Study|Adverse Event|0|||
42298045|NCT02392611|76133224|FG005|Overall Study|Adverse Event|0|||
42298046|NCT02392611|76133225|FG006|Overall Study|Adverse Event|0|||
42298047|NCT02392611|76133226|FG007|Overall Study|Adverse Event|0|||
42298048|NCT02392611|76133227|FG008|Overall Study|Adverse Event|0|||
42298049|NCT02392611|76133219|FG000|Overall Study|Progressive disease|0|||
42298050|NCT02392611|76133220|FG001|Overall Study|Progressive disease|0|||
42298051|NCT02392611|76133221|FG002|Overall Study|Progressive disease|0|||
42298052|NCT02392611|76133222|FG003|Overall Study|Progressive disease|2|||
42298053|NCT02392611|76133223|FG004|Overall Study|Progressive disease|1|||
42298054|NCT02392611|76133224|FG005|Overall Study|Progressive disease|0|||
42298055|NCT02392611|76133225|FG006|Overall Study|Progressive disease|0|||
42298056|NCT02392611|76133226|FG007|Overall Study|Progressive disease|0|||
42298057|NCT02392611|76133227|FG008|Overall Study|Progressive disease|0|||
42194179|NCT02932904|76005535|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
42194180|NCT02932904|76005532|FG000|Overall Study|Randomized But Not Treated|1|||
42194181|NCT02932904|76005533|FG001|Overall Study|Randomized But Not Treated|1|||
42298058|NCT02392611|76133219|FG000|Overall Study|Death|1|||
42298059|NCT02392611|76133220|FG001|Overall Study|Death|0|||
42298060|NCT02392611|76133221|FG002|Overall Study|Death|0|||
42298061|NCT02392611|76133222|FG003|Overall Study|Death|0|||
42298062|NCT02392611|76133223|FG004|Overall Study|Death|0|||
42194182|NCT02932904|76005534|FG002|Overall Study|Randomized But Not Treated|0|||
42194183|NCT02932904|76005535|FG003|Overall Study|Randomized But Not Treated|2|||
42194184|NCT00688376|76005550|FG000|Double-Blind Phase|Adverse Event|4|||
42298063|NCT02392611|76133224|FG005|Overall Study|Death|1|||
42298064|NCT02392611|76133225|FG006|Overall Study|Death|0|||
42099361|NCT00619359|75909894|FG001|Overall Study|Protocol Violation|1|||
42194185|NCT00688376|76005551|FG001|Double-Blind Phase|Adverse Event|4|||
42298065|NCT02392611|76133226|FG007|Overall Study|Death|0|||
42298066|NCT02392611|76133227|FG008|Overall Study|Death|0|||
42099362|NCT00619359|75909893|FG000|Overall Study|Withdrawal by Subject|19|||
42099363|NCT00619359|75909894|FG001|Overall Study|Withdrawal by Subject|20|||
42099364|NCT00619359|75909893|FG000|Overall Study|Progressive Disease|3|||
42099365|NCT00619359|75909894|FG001|Overall Study|Progressive Disease|1|||
42194186|NCT00688376|76005550|FG000|Double-Blind Phase|Protocol Violation|1|||
42194187|NCT00688376|76005551|FG001|Double-Blind Phase|Protocol Violation|2|||
42194188|NCT00688376|76005550|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
42194189|NCT00688376|76005551|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
42194190|NCT00688376|76005550|FG000|Double-Blind Phase|Not treated|0|||
42194191|NCT00688376|76005551|FG001|Double-Blind Phase|Not treated|1|||
42194192|NCT00688376|76005550|FG000|Blinded Extension Phase|Adverse Event|3|||
42194193|NCT00688376|76005551|FG001|Blinded Extension Phase|Adverse Event|4|||
42194194|NCT00688376|76005550|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
42194195|NCT00688376|76005551|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
42194196|NCT00688376|76005550|FG000|Blinded Extension Phase|Physician Decision|1|||
42194197|NCT00688376|76005551|FG001|Blinded Extension Phase|Physician Decision|0|||
42194198|NCT00688376|76005550|FG000|Blinded Extension Phase|Other|1|||
42194199|NCT00688376|76005551|FG001|Blinded Extension Phase|Other|0|||
42194200|NCT03214952|76005559|FG000|Overall Study|Protocol Deviation|45|||
42194201|NCT03214952|76005559|FG000|Overall Study|Case Report Forms Uncollected|13|||
42194202|NCT01367704|76005565|FG000|Overall Study|Lost to Follow-up|47|||
42194203|NCT01367704|76005566|FG001|Overall Study|Lost to Follow-up|161|||
42194204|NCT03214094|76005572|FG000|Overall Study|Case Report Forms Uncollected|14|||
42194205|NCT03214094|76005572|FG000|Overall Study|Protocol Deviation|46|||
42194206|NCT05299359|76005583|FG000|Overall Study|Ongoing in Study|149|||
42194207|NCT05299359|76005583|FG000|Overall Study|Other|1|||
42194208|NCT05069155|76005600|FG000|Overall Study|Withdrawal by Subject|1|||
42194209|NCT05069155|76005601|FG001|Overall Study|Withdrawal by Subject|3|||
42194210|NCT04875533|76005609|FG000|Overall Study|Adverse Event|6|||
42194211|NCT04875533|76005610|FG001|Overall Study|Adverse Event|4|||
42194212|NCT04875533|76005609|FG000|Overall Study|Protocol Violation|4|||
42194213|NCT04875533|76005610|FG001|Overall Study|Protocol Violation|0|||
42194214|NCT04875533|76005609|FG000|Overall Study|Withdrawal by Subject|8|||
42194215|NCT04875533|76005610|FG001|Overall Study|Withdrawal by Subject|5|||
42194216|NCT04875533|76005609|FG000|Overall Study|No longer meets eligibility criteria|1|||
42194217|NCT04875533|76005610|FG001|Overall Study|No longer meets eligibility criteria|0|||
42194218|NCT04875533|76005609|FG000|Overall Study|Other|0|||
42194219|NCT04875533|76005610|FG001|Overall Study|Other|2|||
42194220|NCT04854551|76005620|FG000|Overall Study|Withdrawal by Subject|1|||
42194221|NCT04854551|76005621|FG001|Overall Study|Withdrawal by Subject|1|||
42194222|NCT04672941|76005628|FG000|Overall Study|Investigator decision|1|||
42194223|NCT04672941|76005628|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
42194224|NCT04672941|76005628|FG000|Overall Study|COVID-19 related but no adverse event|1|||
42194225|NCT04672941|76005628|FG000|Overall Study|Adverse Event|2|||
42298067|NCT02392611|76133219|FG000|Overall Study|Withdrawal by Subject|0|||
42298068|NCT02392611|76133220|FG001|Overall Study|Withdrawal by Subject|0|||
42298069|NCT02392611|76133221|FG002|Overall Study|Withdrawal by Subject|0|||
42298070|NCT02392611|76133222|FG003|Overall Study|Withdrawal by Subject|1|||
42298071|NCT02392611|76133223|FG004|Overall Study|Withdrawal by Subject|0|||
42298072|NCT02392611|76133224|FG005|Overall Study|Withdrawal by Subject|0|||
42298073|NCT02392611|76133225|FG006|Overall Study|Withdrawal by Subject|0|||
42298074|NCT02392611|76133226|FG007|Overall Study|Withdrawal by Subject|0|||
42298075|NCT02392611|76133227|FG008|Overall Study|Withdrawal by Subject|0|||
42298076|NCT02392611|76133219|FG000|Overall Study|Lost to Follow-up|0|||
42298077|NCT02392611|76133220|FG001|Overall Study|Lost to Follow-up|0|||
42298078|NCT02392611|76133221|FG002|Overall Study|Lost to Follow-up|0|||
42298079|NCT02392611|76133222|FG003|Overall Study|Lost to Follow-up|0|||
42298080|NCT02392611|76133223|FG004|Overall Study|Lost to Follow-up|0|||
42359321|NCT00418886|76204979|FG001|Overall Study|Withdrawal by Subject|10|||
42099366|NCT00372229|75909902|FG000|Study Phase|Graft loss|0|||
42099367|NCT00372229|75909903|FG001|Study Phase|Graft loss|3|||
42099368|NCT00372229|75909902|FG000|Study Phase|Protocol Violation|3|||
42298081|NCT02392611|76133224|FG005|Overall Study|Lost to Follow-up|0|||
42298082|NCT02392611|76133225|FG006|Overall Study|Lost to Follow-up|1|||
42298083|NCT02392611|76133226|FG007|Overall Study|Lost to Follow-up|0|||
42099369|NCT00372229|75909903|FG001|Study Phase|Protocol Violation|4|||
42099370|NCT00372229|75909902|FG000|Study Phase|Consent withdrawn|16|||
42194226|NCT04672941|76005628|FG000|Overall Study|Lost to Follow-up|2|||
42194227|NCT04599972|76005653|FG000|Overall Study|Withdrawal by Subject|6|||
42194228|NCT04599972|76005654|FG001|Overall Study|Withdrawal by Subject|1|||
42099371|NCT00372229|75909903|FG001|Study Phase|Consent withdrawn|14|||
42194229|NCT04599972|76005653|FG000|Overall Study|Adverse Event|1|||
42194230|NCT04599972|76005654|FG001|Overall Study|Adverse Event|1|||
42298084|NCT02392611|76133227|FG008|Overall Study|Lost to Follow-up|0|||
42298085|NCT02392611|76133219|FG000|Overall Study|Enrolled, not treated|0|||
42099372|NCT00372229|75909902|FG000|Study Phase|Refused treatment/did not cooperate|3|||
42298086|NCT02392611|76133220|FG001|Overall Study|Enrolled, not treated|0|||
42099373|NCT00372229|75909903|FG001|Study Phase|Refused treatment/did not cooperate|1|||
42099374|NCT00372229|75909902|FG000|Study Phase|Death|3|||
42099375|NCT00372229|75909903|FG001|Study Phase|Death|2|||
42099376|NCT00372229|75909902|FG000|Study Phase|Reason not specified|3|||
42099377|NCT00372229|75909903|FG001|Study Phase|Reason not specified|2|||
42099378|NCT00372229|75909902|FG000|Study Phase|Lost to Follow-up|3|||
42099379|NCT00372229|75909903|FG001|Study Phase|Lost to Follow-up|3|||
42099380|NCT00372229|75909902|FG000|Follow-Up Phase|Graft loss|8|||
42194231|NCT04599972|76005653|FG000|Overall Study|Lost to Follow-up|1|||
42194232|NCT04599972|76005654|FG001|Overall Study|Lost to Follow-up|6|||
42194233|NCT04599972|76005653|FG000|Overall Study|Protocol Violation|1|||
42194234|NCT04599972|76005654|FG001|Overall Study|Protocol Violation|0|||
42194235|NCT04599972|76005653|FG000|Overall Study|Other reason|1|||
42194236|NCT04599972|76005654|FG001|Overall Study|Other reason|0|||
42099381|NCT00372229|75909903|FG001|Follow-Up Phase|Graft loss|7|||
42099382|NCT00372229|75909902|FG000|Follow-Up Phase|Consent withdrawn|13|||
42099383|NCT00372229|75909903|FG001|Follow-Up Phase|Consent withdrawn|19|||
42099384|NCT00372229|75909902|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
42099385|NCT00372229|75909903|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
42099386|NCT00372229|75909902|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
42099387|NCT00372229|75909903|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
42099388|NCT00372229|75909902|FG000|Follow-Up Phase|Death|9|||
42099389|NCT00372229|75909903|FG001|Follow-Up Phase|Death|12|||
42099390|NCT00372229|75909902|FG000|Follow-Up Phase|Administrative|1|||
42099391|NCT00372229|75909903|FG001|Follow-Up Phase|Administrative|0|||
42099392|NCT00372229|75909902|FG000|Follow-Up Phase|Reason not specified|2|||
42194237|NCT04599933|76005662|FG000|Overall Study|Adverse Event|4|||
42298087|NCT02392611|76133221|FG002|Overall Study|Enrolled, not treated|0|||
42298088|NCT02392611|76133222|FG003|Overall Study|Enrolled, not treated|2|||
42298089|NCT02392611|76133223|FG004|Overall Study|Enrolled, not treated|0|||
42298090|NCT02392611|76133224|FG005|Overall Study|Enrolled, not treated|0|||
42298091|NCT02392611|76133225|FG006|Overall Study|Enrolled, not treated|0|||
42298092|NCT02392611|76133226|FG007|Overall Study|Enrolled, not treated|0|||
42298093|NCT02392611|76133227|FG008|Overall Study|Enrolled, not treated|0|||
42298094|NCT02378961|76133251|FG000|Overall Study|Lack of Efficacy|4|||
42298095|NCT02378961|76133252|FG001|Overall Study|Lack of Efficacy|2|||
42298096|NCT02378961|76133253|FG002|Overall Study|Lack of Efficacy|0|||
42298097|NCT02378961|76133254|FG003|Overall Study|Lack of Efficacy|1|||
42298098|NCT02378961|76133251|FG000|Overall Study|Death|0|||
42298099|NCT02378961|76133252|FG001|Overall Study|Death|0|||
42298100|NCT02378961|76133253|FG002|Overall Study|Death|1|||
42298101|NCT02378961|76133254|FG003|Overall Study|Death|0|||
42298102|NCT02378883|76133264|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
42298103|NCT02378883|76133264|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
42298104|NCT02378883|76133264|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
42298105|NCT02378883|76133264|FG000|30 Day Follow-Up|Physician Decision|2|||
42298106|NCT02378883|76133264|FG000|30 Day Follow-Up|Missed Visit|2|||
42298107|NCT02378883|76133264|FG000|30 Day Follow-Up|Death|1|||
42298108|NCT02378883|76133264|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
42298109|NCT02378883|76133264|FG000|12 Months Follow-Up|Death|2|||
42298110|NCT02340975|76133275|FG000|Overall Study|Death|6|||
42298111|NCT02340975|76133276|FG001|Overall Study|Death|23|||
42298112|NCT02340975|76133277|FG002|Overall Study|Death|21|||
42298113|NCT02340975|76133278|FG003|Overall Study|Death|7|||
42298114|NCT02340975|76133279|FG004|Overall Study|Death|21|||
42298115|NCT02340975|76133280|FG005|Overall Study|Death|13|||
42298116|NCT02340975|76133275|FG000|Overall Study|Lost to Follow-up|0|||
42298117|NCT02340975|76133276|FG001|Overall Study|Lost to Follow-up|0|||
42359322|NCT00418886|76204978|FG000|Overall Study|Lost to Follow-up|4|||
42359323|NCT00418886|76204979|FG001|Overall Study|Lost to Follow-up|6|||
42194238|NCT04599933|76005663|FG001|Overall Study|Adverse Event|1|||
42298118|NCT02340975|76133277|FG002|Overall Study|Lost to Follow-up|0|||
42298119|NCT02340975|76133278|FG003|Overall Study|Lost to Follow-up|0|||
42298120|NCT02340975|76133279|FG004|Overall Study|Lost to Follow-up|2|||
42298121|NCT02340975|76133280|FG005|Overall Study|Lost to Follow-up|0|||
42298122|NCT02340975|76133275|FG000|Overall Study|Withdrawal by Subject|0|||
42298123|NCT02340975|76133276|FG001|Overall Study|Withdrawal by Subject|0|||
42298124|NCT02340975|76133277|FG002|Overall Study|Withdrawal by Subject|3|||
42298125|NCT02340975|76133278|FG003|Overall Study|Withdrawal by Subject|3|||
42298126|NCT02340975|76133279|FG004|Overall Study|Withdrawal by Subject|2|||
42099393|NCT00372229|75909903|FG001|Follow-Up Phase|Reason not specified|3|||
42099394|NCT00372229|75909902|FG000|Follow-Up Phase|Lost to Follow-up|12|||
42099395|NCT00372229|75909903|FG001|Follow-Up Phase|Lost to Follow-up|10|||
42194239|NCT04599933|76005662|FG000|Overall Study|Withdrawal by Subject|4|||
42099396|NCT00698828|75909916|FG000|Overall Study|Adverse Event|3|||
42099397|NCT00698828|75909917|FG001|Overall Study|Adverse Event|4|||
42298127|NCT02340975|76133280|FG005|Overall Study|Withdrawal by Subject|0|||
42298128|NCT02340975|76133275|FG000|Overall Study|Other|0|||
42298129|NCT02340975|76133276|FG001|Overall Study|Other|4|||
42298130|NCT02340975|76133277|FG002|Overall Study|Other|0|||
42194240|NCT04599933|76005663|FG001|Overall Study|Withdrawal by Subject|2|||
42194241|NCT04599933|76005662|FG000|Overall Study|Lost to Follow-up|0|||
42194242|NCT04599933|76005663|FG001|Overall Study|Lost to Follow-up|1|||
42194243|NCT04599933|76005662|FG000|Overall Study|Physician Decision|0|||
42194244|NCT04599933|76005663|FG001|Overall Study|Physician Decision|1|||
42194245|NCT04599933|76005662|FG000|Overall Study|Screen Failure|1|||
42194246|NCT04599933|76005663|FG001|Overall Study|Screen Failure|2|||
42194247|NCT04558918|76005671|FG000|Randomized Treatment Period|Pregnancy|1|||
42194248|NCT04558918|76005672|FG001|Randomized Treatment Period|Pregnancy|0|||
42194249|NCT04558918|76005671|FG000|Extension Treatment Period|Pregnancy|1|||
42194250|NCT04558918|76005672|FG001|Extension Treatment Period|Pregnancy|0|||
42194251|NCT04558918|76005671|FG000|Extension Treatment Period|Participants still ongoing at the time of the data cut-off date 2022-09-26|28|||
42194252|NCT04558918|76005672|FG001|Extension Treatment Period|Participants still ongoing at the time of the data cut-off date 2022-09-26|14|||
42194253|NCT04498910|76005682|FG000|Overall Study|Lost to Follow-up|0|||
42194254|NCT04498910|76005683|FG001|Overall Study|Lost to Follow-up|1|||
42194255|NCT04498910|76005682|FG000|Overall Study|Withdrawal by Subject|2|||
42194256|NCT04498910|76005683|FG001|Overall Study|Withdrawal by Subject|1|||
42194257|NCT04498910|76005682|FG000|Overall Study|Adverse Event|1|||
42194258|NCT04498910|76005683|FG001|Overall Study|Adverse Event|0|||
42194259|NCT04439344|76005690|FG000|Overall Study|Never started threapy|3|||
42194260|NCT04439344|76005690|FG000|Overall Study|Ineligible|3|||
42194261|NCT04439344|76005690|FG000|Overall Study|Adverse Event|13|||
42194262|NCT04439344|76005690|FG000|Overall Study|Death|2|||
42194263|NCT04439344|76005690|FG000|Overall Study|Disease progression|29|||
42194264|NCT04439344|76005690|FG000|Overall Study|Withdrawal by Subject|2|||
42194265|NCT04439344|76005690|FG000|Overall Study|Alternative therapy|1|||
42194266|NCT04439110|76005694|FG000|Overall Study|Ineligible|2|||
42194267|NCT04439110|76005694|FG000|Overall Study|Adverse Event|4|||
42194268|NCT04439110|76005694|FG000|Overall Study|Death|2|||
42194269|NCT04439110|76005694|FG000|Overall Study|Disease proression|25|||
42194270|NCT04439110|76005694|FG000|Overall Study|Withdrawal by Subject|1|||
42194271|NCT04439110|76005694|FG000|Overall Study|Alternative therapy|1|||
42194272|NCT04439110|76005694|FG000|Overall Study|Other complicating disease|1|||
42194273|NCT04439110|76005694|FG000|Overall Study|Personal reasons|1|||
42194274|NCT04439110|76005694|FG000|Overall Study|Still on treatment|1|||
42194275|NCT04392167|76005698|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
42194276|NCT03813147|76005741|FG000|Overall Study|Lack of Efficacy|4|||
42194277|NCT03813147|76005742|FG001|Overall Study|Lack of Efficacy|4|||
42298131|NCT02340975|76133278|FG003|Overall Study|Other|2|||
42018426|NCT00996892|75825868|FG007|Expansion Stage 2|Physician Decision|0|||
42018427|NCT00996892|75825869|FG008|Expansion Stage 2|Physician Decision|0|||
42018428|NCT00996892|75825870|FG009|Expansion Stage 2|Physician Decision|0|||
42099398|NCT00698828|75909918|FG002|Overall Study|Adverse Event|4|||
42099399|NCT00698828|75909916|FG000|Overall Study|Death|0|||
42099400|NCT00698828|75909917|FG001|Overall Study|Death|0|||
42099401|NCT00698828|75909918|FG002|Overall Study|Death|1|||
42099402|NCT00698828|75909916|FG000|Overall Study|Exacerbation of COPD|1|||
42099403|NCT00698828|75909917|FG001|Overall Study|Exacerbation of COPD|3|||
42099404|NCT00698828|75909918|FG002|Overall Study|Exacerbation of COPD|0|||
42099405|NCT00698828|75909916|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
42194278|NCT03813147|76005741|FG000|Overall Study|Physician Decision|2|||
42194279|NCT03813147|76005742|FG001|Overall Study|Physician Decision|1|||
42194280|NCT03738228|76005783|FG000|Overall Study|Never received study treatment|2|||
42194281|NCT03738228|76005784|FG001|Overall Study|Never received study treatment|2|||
42194282|NCT03689894|76005790|FG000|Overall Study|Adverse Event|1|||
42194283|NCT03640754|76005797|FG000|Overall Study|Withdrawal by Subject|1|||
42298132|NCT02340975|76133279|FG004|Overall Study|Other|0|||
42298133|NCT02340975|76133280|FG005|Overall Study|Other|6|||
42018429|NCT00996892|75825871|FG010|Expansion Stage 2|Physician Decision|0|||
42018430|NCT00996892|75825872|FG011|Expansion Stage 2|Physician Decision|0|||
42018431|NCT00996892|75825873|FG012|Expansion Stage 2|Physician Decision|0|||
42018432|NCT00996892|75825874|FG013|Expansion Stage 2|Physician Decision|0|||
42018433|NCT00996892|75825875|FG014|Expansion Stage 2|Physician Decision|0|||
42018434|NCT00996892|75825876|FG015|Expansion Stage 2|Physician Decision|0|||
42018435|NCT00996892|75825877|FG016|Expansion Stage 2|Physician Decision|0|||
42018436|NCT00996892|75825878|FG017|Expansion Stage 2|Physician Decision|0|||
42018437|NCT00996892|75825879|FG018|Expansion Stage 2|Physician Decision|1|||
42018438|NCT00996892|75825880|FG019|Expansion Stage 2|Physician Decision|0|||
42018439|NCT00996892|75825861|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
42099406|NCT00698828|75909917|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
42099407|NCT00698828|75909918|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
42099408|NCT00698828|75909916|FG000|Overall Study|Investigator/Sponsor decision|1|||
42194284|NCT03640754|76005798|FG001|Overall Study|Withdrawal by Subject|0|||
42194285|NCT03640754|76005797|FG000|Overall Study|Lost to Follow-up|0|||
42194286|NCT03640754|76005798|FG001|Overall Study|Lost to Follow-up|1|||
42194287|NCT03345784|76005819|FG000|Overall Study|Withdrawal by Subject|2|||
42194288|NCT03345784|76005820|FG001|Overall Study|Withdrawal by Subject|1|||
42194289|NCT03255018|76005828|FG000|Overall Study|Death on study|0|||
42298134|NCT02392377|76133297|FG000|Overall Study|Withdrawal by Subject|0|||
42298135|NCT02392377|76133298|FG001|Overall Study|Withdrawal by Subject|1|||
42298136|NCT02340819|76133306|FG000|Overall Study|Adverse Event|1|||
42298137|NCT02340819|76133306|FG000|Overall Study|Withdrawal by Subject|2|||
42298138|NCT02340819|76133306|FG000|Overall Study|Discontinued with other reason|1|||
42298139|NCT02340663|76133312|FG000|Overall Study|Lost to Follow-up|1|||
42298140|NCT02340663|76133313|FG001|Overall Study|Lost to Follow-up|0|||
42298141|NCT02340663|76133312|FG000|Overall Study|Protocol Violation|1|||
42298142|NCT02340663|76133313|FG001|Overall Study|Protocol Violation|0|||
42298143|NCT02340663|76133312|FG000|Overall Study|Withdrawal by Subject|3|||
42298144|NCT02340663|76133313|FG001|Overall Study|Withdrawal by Subject|1|||
42298145|NCT02573467|76133323|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
42298146|NCT02573467|76133324|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
42298147|NCT02573467|76133325|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
42298148|NCT02573467|76133326|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
42298149|NCT02573467|76133323|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
42298150|NCT02573467|76133324|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
42298151|NCT02573467|76133325|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
42298152|NCT02573467|76133326|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
42298153|NCT02573467|76133323|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
42298154|NCT02573467|76133324|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
42298155|NCT02573467|76133325|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
42298156|NCT02573467|76133326|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
42298157|NCT02573467|76133323|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
42298158|NCT02573467|76133324|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
42298159|NCT02573467|76133325|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
42099409|NCT00698828|75909917|FG001|Overall Study|Investigator/Sponsor decision|0|||
42099410|NCT00698828|75909918|FG002|Overall Study|Investigator/Sponsor decision|2|||
42099411|NCT00698828|75909916|FG000|Overall Study|Lost to Follow-up|1|||
42099412|NCT00698828|75909917|FG001|Overall Study|Lost to Follow-up|1|||
42099413|NCT00698828|75909918|FG002|Overall Study|Lost to Follow-up|0|||
42099414|NCT00698828|75909916|FG000|Overall Study|Withdrew consent|0|||
42099415|NCT00698828|75909917|FG001|Overall Study|Withdrew consent|7|||
42099416|NCT00698828|75909918|FG002|Overall Study|Withdrew consent|4|||
42099417|NCT00698828|75909916|FG000|Overall Study|Withdrew consent (not treated)|2|||
42099418|NCT00698828|75909917|FG001|Overall Study|Withdrew consent (not treated)|0|||
42298160|NCT02573467|76133326|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
42298161|NCT02573467|76133323|FG000|Post-treatment Follow up Epoch|Death|1|||
42298162|NCT02573467|76133324|FG001|Post-treatment Follow up Epoch|Death|1|||
42298163|NCT02573467|76133325|FG002|Post-treatment Follow up Epoch|Death|0|||
42298164|NCT02573467|76133326|FG003|Post-treatment Follow up Epoch|Death|1|||
42298165|NCT02573467|76133323|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
42298166|NCT02573467|76133324|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
42298167|NCT02573467|76133325|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
42298168|NCT02573467|76133326|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
42298169|NCT02573467|76133323|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
42298170|NCT02573467|76133324|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
42099419|NCT00698828|75909918|FG002|Overall Study|Withdrew consent (not treated)|0|||
42099420|NCT00619515|75909926|FG000|Overall Study|Study Termination by IRB|73|||
42099421|NCT03167606|75909932|FG000|Overall Study|Lost to Follow-up|73|||
42099422|NCT03167606|75909933|FG001|Overall Study|Lost to Follow-up|64|||
42099423|NCT03167606|75909932|FG000|Overall Study|Withdrawal by Subject|6|||
42099424|NCT03167606|75909933|FG001|Overall Study|Withdrawal by Subject|5|||
42099425|NCT03167606|75909932|FG000|Overall Study|Withdrawal by Investigator|0|||
42194290|NCT03255018|76005829|FG001|Overall Study|Death on study|5|||
42194291|NCT03255018|76005828|FG000|Overall Study|Withdrawal by Subject|0|||
42194292|NCT03255018|76005829|FG001|Overall Study|Withdrawal by Subject|2|||
42194293|NCT03204188|76005835|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
42298171|NCT02573467|76133325|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
42298172|NCT02573467|76133326|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
42298173|NCT02337387|76133341|FG000|Overall Study|Adverse Event|0|||
42298174|NCT02337387|76133342|FG001|Overall Study|Adverse Event|1|||
42298175|NCT02337387|76133343|FG002|Overall Study|Adverse Event|0|||
42298176|NCT02337387|76133344|FG003|Overall Study|Adverse Event|0|||
42298177|NCT02337387|76133341|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
42298178|NCT02337387|76133342|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
42099426|NCT03167606|75909933|FG001|Overall Study|Withdrawal by Investigator|2|||
42099427|NCT00688740|75909941|FG000|Overall Study|Adverse Event|45|||
42099428|NCT00688740|75909942|FG001|Overall Study|Adverse Event|8|||
42099429|NCT00688740|75909941|FG000|Overall Study|Death|2|||
42194294|NCT03204188|76005835|FG000|Immunotherapy Phase (1 Year)|Death|1|||
42194295|NCT03204188|76005835|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
42194296|NCT03204188|76005835|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
42194297|NCT03000530|76005857|FG000|Overall Study|Adverse Event|0|||
42194298|NCT03000530|76005858|FG001|Overall Study|Adverse Event|0|||
42194299|NCT03000530|76005859|FG002|Overall Study|Adverse Event|2|||
42194300|NCT03000530|76005857|FG000|Overall Study|Lost to Follow-up|0|||
42194301|NCT03000530|76005858|FG001|Overall Study|Lost to Follow-up|3|||
42194302|NCT03000530|76005859|FG002|Overall Study|Lost to Follow-up|1|||
42194303|NCT03000530|76005857|FG000|Overall Study|Withdrawal by Subject|0|||
42194304|NCT03000530|76005858|FG001|Overall Study|Withdrawal by Subject|2|||
42194305|NCT03000530|76005859|FG002|Overall Study|Withdrawal by Subject|1|||
42194306|NCT02978781|76005873|FG000|Part A|Adverse Event|1|||
42194307|NCT02978781|76005874|FG001|Part A|Adverse Event|1|||
42194308|NCT02978781|76005875|FG002|Part A|Adverse Event|0|||
42194309|NCT02978781|76005876|FG003|Part A|Adverse Event|0|||
42194310|NCT02978781|76005877|FG004|Part A|Adverse Event|0|||
42194311|NCT02978781|76005873|FG000|Part A|Withdrawal by Subject|0|||
42194312|NCT02978781|76005874|FG001|Part A|Withdrawal by Subject|1|||
42194313|NCT02978781|76005875|FG002|Part A|Withdrawal by Subject|0|||
42194314|NCT02978781|76005876|FG003|Part A|Withdrawal by Subject|0|||
42194315|NCT02978781|76005877|FG004|Part A|Withdrawal by Subject|0|||
42194316|NCT02978781|76005873|FG000|Part B|Withdrawal by Subject|0|||
42194317|NCT02978781|76005874|FG001|Part B|Withdrawal by Subject|0|||
42194318|NCT02978781|76005875|FG002|Part B|Withdrawal by Subject|0|||
42194319|NCT02978781|76005876|FG003|Part B|Withdrawal by Subject|1|||
42194320|NCT02978781|76005877|FG004|Part B|Withdrawal by Subject|0|||
42194321|NCT02978781|76005873|FG000|Part C|Adverse Event|0|||
42194322|NCT02978781|76005874|FG001|Part C|Adverse Event|0|||
42194323|NCT02978781|76005875|FG002|Part C|Adverse Event|0|||
42194324|NCT02978781|76005876|FG003|Part C|Adverse Event|0|||
42194325|NCT02978781|76005877|FG004|Part C|Adverse Event|2|||
42194326|NCT02978781|76005873|FG000|Part C|Withdrawal by Subject|0|||
42194327|NCT02978781|76005874|FG001|Part C|Withdrawal by Subject|0|||
42194328|NCT02978781|76005875|FG002|Part C|Withdrawal by Subject|0|||
42194329|NCT02978781|76005876|FG003|Part C|Withdrawal by Subject|0|||
42194330|NCT02978781|76005877|FG004|Part C|Withdrawal by Subject|1|||
42194331|NCT02978781|76005873|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
42194332|NCT02978781|76005874|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
42194333|NCT02978781|76005875|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
42194334|NCT02978781|76005876|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
42194335|NCT02978781|76005877|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
42194336|NCT02549092|76005920|FG000|Treatment Period|Adverse Event|2|||
42194337|NCT02549092|76005921|FG001|Treatment Period|Adverse Event|2|||
42194338|NCT02549092|76005920|FG000|Treatment Period|Withdrawal by Subject|1|||
42194339|NCT02549092|76005921|FG001|Treatment Period|Withdrawal by Subject|3|||
42194340|NCT02549092|76005920|FG000|Treatment Period|Lack of Efficacy|0|||
42194341|NCT02549092|76005921|FG001|Treatment Period|Lack of Efficacy|2|||
42194342|NCT02549092|76005920|FG000|Extension/Transition Period|Adverse Event|1|||
42194343|NCT02549092|76005921|FG001|Extension/Transition Period|Adverse Event|1|||
42194344|NCT02549092|76005920|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
42194345|NCT02549092|76005921|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
42194346|NCT02549092|76005920|FG000|Extension/Transition Period|Other, Not Specified|4|||
42194347|NCT02549092|76005921|FG001|Extension/Transition Period|Other, Not Specified|2|||
42099430|NCT00688740|75909942|FG001|Overall Study|Death|2|||
42099431|NCT00688740|75909941|FG000|Overall Study|Lost to Follow-up|0|||
42099432|NCT00688740|75909942|FG001|Overall Study|Lost to Follow-up|1|||
42099433|NCT00688740|75909941|FG000|Overall Study|Consent Withdrawn|17|||
42099434|NCT00688740|75909942|FG001|Overall Study|Consent Withdrawn|17|||
42099435|NCT00688740|75909941|FG000|Overall Study|Breast Cancer Relapse|1|||
42099436|NCT00688740|75909942|FG001|Overall Study|Breast Cancer Relapse|4|||
42194348|NCT02543281|76005933|FG000|Overall Study|Lost to Follow-up|0|||
42194349|NCT02543281|76005934|FG001|Overall Study|Lost to Follow-up|0|||
42194350|NCT02543281|76005935|FG002|Overall Study|Lost to Follow-up|1|||
42194351|NCT02429791|76005945|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
42194352|NCT02429791|76005946|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
42194353|NCT02429791|76005945|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
42194354|NCT02429791|76005946|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
42194355|NCT02429791|76005945|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
42099437|NCT00688740|75909941|FG000|Overall Study|Violation of Inclusion Criteria|1|||
42194356|NCT02429791|76005946|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
42194357|NCT02429791|76005945|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
42194358|NCT02429791|76005946|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
42194359|NCT02429791|76005945|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
42099438|NCT00688740|75909942|FG001|Overall Study|Violation of Inclusion Criteria|3|||
42099439|NCT00552760|75909950|FG000|Overall Study|Adverse Event|3|||
42194360|NCT02429791|76005946|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
42099440|NCT00552760|75909951|FG001|Overall Study|Adverse Event|5|||
42099441|NCT00552760|75909950|FG000|Overall Study|Relapsed- Depressed Event|10|||
42194361|NCT02429791|76005945|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
42194362|NCT02429791|76005946|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
42194363|NCT02429791|76005945|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
42194364|NCT02429791|76005946|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
42194365|NCT02429791|76005945|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
42194366|NCT02429791|76005946|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
42194367|NCT02429791|76005945|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
42194368|NCT02429791|76005946|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
42194369|NCT02429791|76005945|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
42194370|NCT02429791|76005946|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
42194371|NCT02429791|76005945|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
42194372|NCT02429791|76005946|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
42194373|NCT02429791|76005945|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
42194374|NCT02429791|76005946|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
42194375|NCT02422797|76005971|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
42194376|NCT02422797|76005972|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
42194377|NCT02422797|76005971|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
42194378|NCT02422797|76005972|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
42194379|NCT02422797|76005971|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
42194380|NCT02422797|76005972|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
42194381|NCT02422797|76005971|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
42194382|NCT02422797|76005972|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
42194383|NCT02422797|76005971|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
42194384|NCT02422797|76005972|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
42194385|NCT02422797|76005971|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
42194386|NCT02422797|76005972|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
42194387|NCT02422797|76005971|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
42194388|NCT02422797|76005972|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
42194389|NCT02422797|76005971|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
42194390|NCT02422797|76005972|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
42194391|NCT02422797|76005971|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
42194392|NCT02422797|76005972|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
42194393|NCT02422797|76005971|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
42194394|NCT02422797|76005972|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
42194395|NCT02422797|76005971|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
42194396|NCT02422797|76005972|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
42194397|NCT02422797|76005971|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
42099442|NCT00552760|75909951|FG001|Overall Study|Relapsed- Depressed Event|16|||
42099443|NCT00552760|75909950|FG000|Overall Study|Relapse- Manic Event|3|||
42099444|NCT00552760|75909951|FG001|Overall Study|Relapse- Manic Event|3|||
42099445|NCT00552760|75909950|FG000|Overall Study|Relapsed- Mixed Event|3|||
42099446|NCT00552760|75909951|FG001|Overall Study|Relapsed- Mixed Event|5|||
42099447|NCT00552760|75909950|FG000|Overall Study|Protocol Violation|0|||
42099448|NCT00552760|75909951|FG001|Overall Study|Protocol Violation|1|||
42099449|NCT00552760|75909950|FG000|Overall Study|Lost to Follow-up|1|||
42099450|NCT00552760|75909951|FG001|Overall Study|Lost to Follow-up|1|||
42099451|NCT00552760|75909950|FG000|Overall Study|Non-compliance|1|||
42099452|NCT00552760|75909951|FG001|Overall Study|Non-compliance|1|||
42099453|NCT00552760|75909950|FG000|Overall Study|Medical Condition|1|||
42099454|NCT00552760|75909951|FG001|Overall Study|Medical Condition|1|||
42099455|NCT00552760|75909950|FG000|Overall Study|Withdrawal by Subject|3|||
42099456|NCT00552760|75909951|FG001|Overall Study|Withdrawal by Subject|0|||
42099457|NCT00552760|75909950|FG000|Overall Study|Medication Change|1|||
42099458|NCT00552760|75909951|FG001|Overall Study|Medication Change|0|||
42099459|NCT00686790|75909957|FG000|Overall Study|Adverse Event|2|||
42099460|NCT00686790|75909957|FG000|Overall Study|Withdrawal by Subject|1|||
42099461|NCT00686790|75909957|FG000|Overall Study|Death|1|||
42099462|NCT00686790|75909957|FG000|Overall Study|Lost to Follow-up|12|||
42099463|NCT00686712|75909964|FG000|Overall Study|Protocol Violation|8|||
42194398|NCT02422797|76005972|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
42194399|NCT02422797|76005971|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
42194400|NCT02422797|76005972|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
42099464|NCT00686712|75909965|FG001|Overall Study|Protocol Violation|8|||
42099465|NCT00686712|75909966|FG002|Overall Study|Protocol Violation|10|||
42099466|NCT00686712|75909964|FG000|Overall Study|Lost to Follow-up|1|||
42099467|NCT00686712|75909965|FG001|Overall Study|Lost to Follow-up|2|||
42099468|NCT00686712|75909966|FG002|Overall Study|Lost to Follow-up|3|||
42298179|NCT02337387|76133343|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
42298180|NCT02337387|76133344|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
42298181|NCT02574247|76133357|FG000|Overall Study|Withdrawal by Subject|1|||
42298182|NCT02574247|76133358|FG001|Overall Study|Withdrawal by Subject|0|||
42298183|NCT02574247|76133359|FG002|Overall Study|Withdrawal by Subject|0|||
42298184|NCT02574247|76133357|FG000|Overall Study|Did not meet inclusion criteria|4|||
42298185|NCT02574247|76133358|FG001|Overall Study|Did not meet inclusion criteria|3|||
42298186|NCT02574247|76133359|FG002|Overall Study|Did not meet inclusion criteria|5|||
42298187|NCT02391363|76133371|FG000|Overall Study|Lost to Follow-up|5|||
42298188|NCT02391363|76133372|FG001|Overall Study|Lost to Follow-up|5|||
42298189|NCT02391363|76133371|FG000|Overall Study|Withdrawal by Subject|6|||
42194401|NCT02422797|76005971|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
42194402|NCT02422797|76005972|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
42298190|NCT02391363|76133372|FG001|Overall Study|Withdrawal by Subject|3|||
42298191|NCT02569957|76133380|FG000|Overall Study|Withdrawal by Subject|0|||
42298192|NCT02569957|76133381|FG001|Overall Study|Withdrawal by Subject|1|||
42194403|NCT02181738|76005992|FG000|Overall Study|Participant Withdrew Consent|2|||
42194404|NCT02181738|76005993|FG001|Overall Study|Participant Withdrew Consent|1|||
42298193|NCT01649427|76133389|FG000|Overall Study|Adverse Event|1|||
42298194|NCT01649427|76133390|FG001|Overall Study|Adverse Event|1|||
42298195|NCT01649427|76133389|FG000|Overall Study|Withdrawal by Subject|8|||
42298196|NCT01649427|76133390|FG001|Overall Study|Withdrawal by Subject|7|||
42298197|NCT01649427|76133389|FG000|Overall Study|Lost to Follow-up|0|||
42298198|NCT01649427|76133390|FG001|Overall Study|Lost to Follow-up|1|||
42298199|NCT01649427|76133389|FG000|Overall Study|Graft loss|0|||
42298200|NCT01649427|76133390|FG001|Overall Study|Graft loss|1|||
42298201|NCT01649427|76133389|FG000|Overall Study|Surgical problems during nephrectomy|2|||
42298202|NCT01649427|76133390|FG001|Overall Study|Surgical problems during nephrectomy|2|||
42298203|NCT02375373|76133396|FG000|Overall Study|Withdrawal by Subject|11|||
42298204|NCT02336607|76133404|FG000|Overall Study|Physician Decision|1|||
42298205|NCT02336607|76133405|FG001|Overall Study|Physician Decision|4|||
42298206|NCT02336607|76133406|FG002|Overall Study|Physician Decision|3|||
42298207|NCT02336607|76133407|FG003|Overall Study|Physician Decision|15|||
42298208|NCT02336607|76133404|FG000|Overall Study|Lack of Efficacy|1|||
42298209|NCT02336607|76133405|FG001|Overall Study|Lack of Efficacy|0|||
42298210|NCT02336607|76133406|FG002|Overall Study|Lack of Efficacy|0|||
42298211|NCT02336607|76133407|FG003|Overall Study|Lack of Efficacy|2|||
42298212|NCT02336607|76133404|FG000|Overall Study|Lost to Follow-up|2|||
42298213|NCT02336607|76133405|FG001|Overall Study|Lost to Follow-up|1|||
42298214|NCT02336607|76133406|FG002|Overall Study|Lost to Follow-up|0|||
42298215|NCT02336607|76133407|FG003|Overall Study|Lost to Follow-up|21|||
42298216|NCT02336607|76133404|FG000|Overall Study|Protocol Violation|0|||
42359324|NCT00418886|76204978|FG000|Overall Study|withdrawn due to other reason|1|||
42099469|NCT00686712|75909964|FG000|Overall Study|Adverse Event|1|||
42099470|NCT00686712|75909965|FG001|Overall Study|Adverse Event|1|||
42099471|NCT00686712|75909966|FG002|Overall Study|Adverse Event|0|||
42099472|NCT00686634|75909977|FG000|Overall Study|Protocol Violation|6|||
42099473|NCT00560404|75909984|FG000|Overall Study|Adverse Event|2|||
42099474|NCT00560404|75909985|FG001|Overall Study|Adverse Event|3|||
42099475|NCT00560404|75909984|FG000|Overall Study|Death|3|||
42099476|NCT00560404|75909985|FG001|Overall Study|Death|3|||
42099477|NCT00560404|75909984|FG000|Overall Study|Protocol Violation|12|||
42099478|NCT00560404|75909985|FG001|Overall Study|Protocol Violation|7|||
42194405|NCT02181738|76005994|FG002|Overall Study|Participant Withdrew Consent|1|||
42194406|NCT02181738|76005995|FG003|Overall Study|Participant Withdrew Consent|1|||
42194407|NCT02181738|76005992|FG000|Overall Study|Lost to Follow-up|1|||
42194408|NCT02181738|76005993|FG001|Overall Study|Lost to Follow-up|2|||
42194409|NCT02181738|76005994|FG002|Overall Study|Lost to Follow-up|1|||
42194410|NCT02181738|76005995|FG003|Overall Study|Lost to Follow-up|1|||
42194411|NCT02181738|76005992|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
42298217|NCT02336607|76133405|FG001|Overall Study|Protocol Violation|1|||
42298218|NCT02336607|76133406|FG002|Overall Study|Protocol Violation|1|||
42298219|NCT02336607|76133407|FG003|Overall Study|Protocol Violation|3|||
42298220|NCT02336607|76133404|FG000|Overall Study|Adverse Event|0|||
42298221|NCT02336607|76133405|FG001|Overall Study|Adverse Event|2|||
42298222|NCT02336607|76133406|FG002|Overall Study|Adverse Event|2|||
42298223|NCT02336607|76133407|FG003|Overall Study|Adverse Event|26|||
42298224|NCT02336607|76133404|FG000|Overall Study|Withdrawal by Subject|0|||
42298225|NCT02336607|76133405|FG001|Overall Study|Withdrawal by Subject|2|||
42298226|NCT02336607|76133406|FG002|Overall Study|Withdrawal by Subject|0|||
42099479|NCT00560404|75909984|FG000|Overall Study|Administrative Reasons|1|||
42099480|NCT00560404|75909985|FG001|Overall Study|Administrative Reasons|1|||
42298227|NCT02336607|76133407|FG003|Overall Study|Withdrawal by Subject|20|||
42298228|NCT02374671|76133420|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
42099481|NCT00560404|75909984|FG000|Overall Study|Withdrew Consent|4|||
42099482|NCT00560404|75909985|FG001|Overall Study|Withdrew Consent|0|||
42099483|NCT00560404|75909984|FG000|Overall Study|Failure to return|1|||
42298229|NCT02374671|76133421|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
42298230|NCT02374671|76133422|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
42298231|NCT02374671|76133420|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
42298232|NCT02374671|76133421|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
42298233|NCT02374671|76133422|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
42298234|NCT02374671|76133420|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
42298235|NCT02374671|76133421|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
42298236|NCT02374671|76133422|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
42298237|NCT02374671|76133420|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
42298238|NCT02374671|76133421|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
42298239|NCT02374671|76133422|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
42298240|NCT02374671|76133420|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
42298241|NCT02374671|76133421|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
42298242|NCT02374671|76133422|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
42298243|NCT02569801|76133430|FG000|Overall Study|Withdrawal by Subject|9|||
42298244|NCT02569801|76133431|FG001|Overall Study|Withdrawal by Subject|9|||
42298245|NCT02569801|76133430|FG000|Overall Study|Sponsor Decision|13|||
42298246|NCT02569801|76133431|FG001|Overall Study|Sponsor Decision|14|||
42298247|NCT02569801|76133430|FG000|Overall Study|Progressive Disease|2|||
42298248|NCT02569801|76133431|FG001|Overall Study|Progressive Disease|7|||
42298249|NCT02569801|76133430|FG000|Overall Study|Lost to Follow-up|0|||
42298250|NCT02569801|76133431|FG001|Overall Study|Lost to Follow-up|1|||
42298251|NCT02569801|76133430|FG000|Overall Study|Death|12|||
42298252|NCT02569801|76133431|FG001|Overall Study|Death|4|||
42298253|NCT02573311|76133439|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
42298254|NCT02573311|76133440|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
42298255|NCT02573311|76133439|FG000|Disposition for Part 2|Physician Decision|25|||
42298256|NCT02573311|76133440|FG001|Disposition for Part 2|Physician Decision|7|||
42298257|NCT02573311|76133439|FG000|Disposition for Part 2|Adverse Event|36|||
42298258|NCT02573311|76133440|FG001|Disposition for Part 2|Adverse Event|5|||
42298259|NCT02573311|76133439|FG000|Disposition for Part 2|Lost to Follow-up|76|||
42298260|NCT02573311|76133440|FG001|Disposition for Part 2|Lost to Follow-up|7|||
42298261|NCT02573311|76133439|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
42298262|NCT02573311|76133440|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
42298263|NCT02573311|76133439|FG000|Disposition for Part 2|Investigator decision|0|||
42298264|NCT02573311|76133440|FG001|Disposition for Part 2|Investigator decision|1|||
42298265|NCT02573311|76133439|FG000|Disposition for Part 2|Other than specified above|13|||
42298266|NCT02573311|76133440|FG001|Disposition for Part 2|Other than specified above|3|||
42298267|NCT02571049|76133446|FG000|Screening|Did not meet entry criteria|2|||
42298268|NCT02571049|76133447|FG001|Screening|Did not meet entry criteria|2|||
42298269|NCT02571049|76133446|FG000|Randomization|No migraine attack|0|||
42298270|NCT02571049|76133447|FG001|Randomization|No migraine attack|1|||
42298271|NCT02571049|76133446|FG000|Randomization|Adverse Event|0|||
42298272|NCT02571049|76133447|FG001|Randomization|Adverse Event|1|||
42298273|NCT02573155|76133455|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
42298274|NCT02573155|76133456|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
42298275|NCT02573155|76133455|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
42298276|NCT02573155|76133456|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
42298277|NCT02573155|76133455|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
42298278|NCT02573155|76133456|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
42298279|NCT02573155|76133455|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
42298280|NCT02573155|76133456|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
42298281|NCT02573155|76133455|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
42298282|NCT02573155|76133456|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
42298283|NCT02573155|76133455|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
42298284|NCT02573155|76133456|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
42298285|NCT02573155|76133455|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
42298286|NCT02573155|76133456|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
42298287|NCT02573155|76133455|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
42298288|NCT02573155|76133456|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
42298289|NCT02568475|76133484|FG000|Overall Study|Lost to Follow-up|40|||
42298290|NCT02568475|76133485|FG001|Overall Study|Lost to Follow-up|39|||
42298291|NCT02568475|76133484|FG000|Overall Study|Withdrawal by Subject|2|||
42298292|NCT02568475|76133485|FG001|Overall Study|Withdrawal by Subject|0|||
42298293|NCT02568475|76133484|FG000|Overall Study|Discharged home|4|||
42298294|NCT02568475|76133485|FG001|Overall Study|Discharged home|4|||
42298295|NCT02568475|76133484|FG000|Overall Study|Short-term: Discharge location unknown|4|||
42298296|NCT02568475|76133485|FG001|Overall Study|Short-term: Discharge location unknown|0|||
42298297|NCT02568475|76133484|FG000|Overall Study|Transferred to another facility|1|||
42298298|NCT02568475|76133485|FG001|Overall Study|Transferred to another facility|0|||
42298299|NCT02568397|76133491|FG000|Period 2|Withdrawal by Subject|0|||
42298300|NCT02568397|76133492|FG001|Period 2|Withdrawal by Subject|1|||
42298301|NCT02568397|76133491|FG000|Period 2|Physician Decision|0|||
42298302|NCT02568397|76133492|FG001|Period 2|Physician Decision|1|||
42298303|NCT02566525|76133509|FG000|Overall Study|Protocol Violation|3|||
42099484|NCT00560404|75909985|FG001|Overall Study|Failure to return|2|||
42099485|NCT00560404|75909984|FG000|Overall Study|Other withdrawal reason|13|||
42099486|NCT00560404|75909985|FG001|Overall Study|Other withdrawal reason|5|||
42099487|NCT03967444|75909993|FG000|Overall Study|Lost to Follow-up|1|||
42099488|NCT03967444|75909994|FG001|Overall Study|Lost to Follow-up|2|||
42194412|NCT02181738|76005993|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
42194413|NCT02181738|76005994|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
42194414|NCT02181738|76005995|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
42194415|NCT02181738|76005992|FG000|Overall Study|Poor/Non-Compliance|1|||
42194416|NCT02181738|76005993|FG001|Overall Study|Poor/Non-Compliance|0|||
42194417|NCT02181738|76005994|FG002|Overall Study|Poor/Non-Compliance|2|||
42194418|NCT02181738|76005995|FG003|Overall Study|Poor/Non-Compliance|1|||
42194419|NCT02181738|76005992|FG000|Overall Study|Disease Progression|28|||
42194420|NCT02181738|76005993|FG001|Overall Study|Disease Progression|35|||
42194421|NCT02181738|76005994|FG002|Overall Study|Disease Progression|40|||
42099489|NCT00619983|75910004|FG000|Test Drug Alone|Withdrawal by Subject|1|||
42099490|NCT00619983|75910005|FG001|Test Drug Alone|Withdrawal by Subject|0|||
42194422|NCT02181738|76005995|FG003|Overall Study|Disease Progression|0|||
42194423|NCT02181738|76005992|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
42194424|NCT02181738|76005993|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
42194425|NCT02181738|76005994|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
42194426|NCT02181738|76005995|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
42194427|NCT02181738|76005992|FG000|Overall Study|Study Drug Toxicity|6|||
42194428|NCT02181738|76005993|FG001|Overall Study|Study Drug Toxicity|11|||
42194429|NCT02181738|76005994|FG002|Overall Study|Study Drug Toxicity|8|||
42194430|NCT02181738|76005995|FG003|Overall Study|Study Drug Toxicity|1|||
42194431|NCT02181738|76005992|FG000|Overall Study|Other Reasons|14|||
42194432|NCT02181738|76005993|FG001|Overall Study|Other Reasons|16|||
42194433|NCT02181738|76005994|FG002|Overall Study|Other Reasons|28|||
42194434|NCT02181738|76005995|FG003|Overall Study|Other Reasons|0|||
42194435|NCT02181738|76005992|FG000|Overall Study|Maximum Clinical Benefit|3|||
42194436|NCT02181738|76005993|FG001|Overall Study|Maximum Clinical Benefit|0|||
42194437|NCT02181738|76005994|FG002|Overall Study|Maximum Clinical Benefit|1|||
42194438|NCT02181738|76005995|FG003|Overall Study|Maximum Clinical Benefit|0|||
42194439|NCT02181738|76005992|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
42194440|NCT02181738|76005993|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
42194441|NCT02181738|76005994|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
42194442|NCT02181738|76005995|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
42194443|NCT02142803|76006014|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
42194444|NCT02142803|76006015|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
42194445|NCT02142803|76006016|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
42194446|NCT02142803|76006017|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
42194447|NCT01844986|76006034|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
42194448|NCT01844986|76006035|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
42194449|NCT01844986|76006034|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
42194450|NCT01844986|76006035|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
42194451|NCT01844986|76006034|FG000|Overall Study (Global Cohort)|Death|55|||
42194452|NCT01844986|76006035|FG001|Overall Study (Global Cohort)|Death|26|||
42194453|NCT01844986|76006034|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
42194454|NCT01844986|76006035|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
42298304|NCT02566525|76133510|FG001|Overall Study|Protocol Violation|5|||
42099491|NCT00619983|75910006|FG002|Test Drug Alone|Withdrawal by Subject|0|||
42099492|NCT00619983|75910007|FG003|Test Drug Alone|Withdrawal by Subject|1|||
42099493|NCT00619983|75910004|FG000|Test Drug Alone|Failure of daily diary device|1|||
42194455|NCT01844986|76006034|FG000|Overall Study (China Cohort)|Death|10|||
42194456|NCT01844986|76006035|FG001|Overall Study (China Cohort)|Death|6|||
42298305|NCT02567227|76133520|FG000|9 Weeks|Adverse Event|5|||
42298306|NCT02567227|76133521|FG001|9 Weeks|Adverse Event|5|||
42099494|NCT00619983|75910005|FG001|Test Drug Alone|Failure of daily diary device|1|||
42194463|NCT01367236|76006105|FG000|Overall Study|Withdrawal by Subject|3|||
42298307|NCT02567227|76133520|FG000|9 Weeks|Withdrawal by Subject|18|||
42298308|NCT02567227|76133521|FG001|9 Weeks|Withdrawal by Subject|8|||
42099495|NCT00619983|75910006|FG002|Test Drug Alone|Failure of daily diary device|2|||
42099496|NCT00619983|75910007|FG003|Test Drug Alone|Failure of daily diary device|2|||
42099497|NCT00576420|75910020|FG000|Overall Study|Death|0|||
42099498|NCT00576420|75910021|FG001|Overall Study|Death|0|||
42099499|NCT00576420|75910022|FG002|Overall Study|Death|1|||
42298309|NCT02567227|76133520|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
42298310|NCT02567227|76133521|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
42298311|NCT02567227|76133520|FG000|6 Month|Death|2|||
42298312|NCT02567227|76133521|FG001|6 Month|Death|0|||
42298313|NCT02567227|76133520|FG000|6 Month|Lost to Follow-up|43|||
42298314|NCT02567227|76133521|FG001|6 Month|Lost to Follow-up|40|||
42298315|NCT02567227|76133520|FG000|12 Months|Lost to Follow-up|31|||
42298316|NCT02567227|76133521|FG001|12 Months|Lost to Follow-up|32|||
42298317|NCT02567227|76133520|FG000|12 Months|Death|0|||
42298318|NCT02567227|76133521|FG001|12 Months|Death|2|||
42298319|NCT02336451|76133532|FG000|Overall Study|Adverse Event|1|||
42298320|NCT02336451|76133533|FG001|Overall Study|Adverse Event|2|||
42298321|NCT02336451|76133534|FG002|Overall Study|Adverse Event|0|||
42298322|NCT02336451|76133535|FG003|Overall Study|Adverse Event|6|||
42298323|NCT02336451|76133536|FG004|Overall Study|Adverse Event|4|||
42298324|NCT02336451|76133532|FG000|Overall Study|Death|6|||
42298325|NCT02336451|76133533|FG001|Overall Study|Death|2|||
42298326|NCT02336451|76133534|FG002|Overall Study|Death|3|||
42298327|NCT02336451|76133535|FG003|Overall Study|Death|6|||
42298328|NCT02336451|76133536|FG004|Overall Study|Death|6|||
42298329|NCT02336451|76133532|FG000|Overall Study|Physician Decision|9|||
42298330|NCT02336451|76133533|FG001|Overall Study|Physician Decision|6|||
42298331|NCT02336451|76133534|FG002|Overall Study|Physician Decision|7|||
42298332|NCT02336451|76133535|FG003|Overall Study|Physician Decision|16|||
42298333|NCT02336451|76133536|FG004|Overall Study|Physician Decision|3|||
42298334|NCT02336451|76133532|FG000|Overall Study|Progressive disease|23|||
42298335|NCT02336451|76133533|FG001|Overall Study|Progressive disease|26|||
42298336|NCT02336451|76133534|FG002|Overall Study|Progressive disease|2|||
42298337|NCT02336451|76133535|FG003|Overall Study|Progressive disease|14|||
42298338|NCT02336451|76133536|FG004|Overall Study|Progressive disease|4|||
42298339|NCT02336451|76133532|FG000|Overall Study|Protocol Violation|1|||
42298340|NCT02336451|76133533|FG001|Overall Study|Protocol Violation|0|||
42298341|NCT02336451|76133534|FG002|Overall Study|Protocol Violation|0|||
42298342|NCT02336451|76133535|FG003|Overall Study|Protocol Violation|0|||
42298343|NCT02336451|76133536|FG004|Overall Study|Protocol Violation|0|||
42298344|NCT02336451|76133532|FG000|Overall Study|Patient/guardian decision|2|||
42298345|NCT02336451|76133533|FG001|Overall Study|Patient/guardian decision|4|||
42298346|NCT02336451|76133534|FG002|Overall Study|Patient/guardian decision|0|||
42298347|NCT02336451|76133535|FG003|Overall Study|Patient/guardian decision|2|||
42298348|NCT02336451|76133536|FG004|Overall Study|Patient/guardian decision|1|||
42298349|NCT02374593|76133552|FG000|Overall Study|non-compliant|2|||
42298350|NCT02374593|76133553|FG001|Overall Study|non-compliant|0|||
42298351|NCT01648101|76133566|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
42298352|NCT01648101|76133567|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
42298353|NCT01648101|76133568|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
42298354|NCT01648101|76133566|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
42298355|NCT01648101|76133567|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
42298356|NCT01648101|76133568|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
42298357|NCT01648101|76133566|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
42298358|NCT01648101|76133567|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
42298359|NCT01648101|76133568|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
42298360|NCT01648101|76133566|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
42298361|NCT01648101|76133567|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
42298362|NCT01648101|76133568|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
42099500|NCT00364351|75910073|FG000|Overall Study|Adverse Event|90|||
42099501|NCT00364351|75910074|FG001|Overall Study|Adverse Event|44|||
42194464|NCT01367236|76006106|FG001|Overall Study|Withdrawal by Subject|1|||
42194465|NCT03681951|76006120|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
42298363|NCT01648101|76133566|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
42298364|NCT01648101|76133567|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
42298365|NCT01648101|76133568|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
42298366|NCT01648101|76133566|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
42298367|NCT01648101|76133567|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
42298368|NCT01648101|76133568|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
42298369|NCT01648101|76133566|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
42298370|NCT01648101|76133567|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
42298371|NCT01648101|76133568|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
42298372|NCT01648101|76133566|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
42298373|NCT01648101|76133567|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
42298374|NCT01648101|76133568|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
42298375|NCT01648101|76133566|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
42298376|NCT01648101|76133567|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
42298377|NCT01648101|76133568|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
42298378|NCT01648101|76133566|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
42359325|NCT00418886|76204979|FG001|Overall Study|withdrawn due to other reason|0|||
42298379|NCT01648101|76133567|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
42298380|NCT01648101|76133568|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
42298381|NCT01648101|76133566|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
42298382|NCT01648101|76133567|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
42298383|NCT01648101|76133568|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
42298384|NCT02336373|76133580|FG000|Overall Study|Protocol closed early|4|||
42298385|NCT02336373|76133580|FG000|Overall Study|Physician Decision|14|||
42298386|NCT02372799|76133589|FG000|Treatment Period|Adverse Event|3|||
42298387|NCT02372799|76133590|FG001|Treatment Period|Adverse Event|10|||
42298388|NCT02372799|76133591|FG002|Treatment Period|Adverse Event|6|||
42298389|NCT02372799|76133589|FG000|Treatment Period|Insufficient therapeutic response|2|||
42298390|NCT02372799|76133590|FG001|Treatment Period|Insufficient therapeutic response|2|||
42298391|NCT02372799|76133591|FG002|Treatment Period|Insufficient therapeutic response|0|||
42298392|NCT02372799|76133589|FG000|Treatment Period|Withdrawal by Subject|10|||
42298393|NCT02372799|76133590|FG001|Treatment Period|Withdrawal by Subject|10|||
42298394|NCT02372799|76133591|FG002|Treatment Period|Withdrawal by Subject|2|||
42298395|NCT02372799|76133589|FG000|Treatment Period|Lost to Follow-up|11|||
42298396|NCT02372799|76133590|FG001|Treatment Period|Lost to Follow-up|5|||
42298397|NCT02372799|76133591|FG002|Treatment Period|Lost to Follow-up|3|||
42298398|NCT02372799|76133589|FG000|Treatment Period|Protocol Violation|3|||
42298399|NCT02372799|76133590|FG001|Treatment Period|Protocol Violation|0|||
42298400|NCT02372799|76133591|FG002|Treatment Period|Protocol Violation|0|||
42359326|NCT00418886|76204978|FG000|Overall Study|randomised but no treatment received|0|||
42359327|NCT00418886|76204979|FG001|Overall Study|randomised but no treatment received|1|||
42298401|NCT02372799|76133589|FG000|Treatment Period|Non-compliance with study drug|4|||
42298402|NCT02372799|76133590|FG001|Treatment Period|Non-compliance with study drug|4|||
42298403|NCT02372799|76133591|FG002|Treatment Period|Non-compliance with study drug|4|||
42298404|NCT02372799|76133589|FG000|Treatment Period|Miscellaneous Reasons|1|||
42298405|NCT02372799|76133590|FG001|Treatment Period|Miscellaneous Reasons|1|||
42298406|NCT02372799|76133591|FG002|Treatment Period|Miscellaneous Reasons|0|||
42298407|NCT02372799|76133589|FG000|Down-taper Period|Lost to Follow-up|1|||
42298408|NCT02372799|76133590|FG001|Down-taper Period|Lost to Follow-up|2|||
42298409|NCT02372799|76133591|FG002|Down-taper Period|Lost to Follow-up|2|||
42298410|NCT02566993|76133601|FG000|Overall Study|Randomized but not treated|5|||
42298411|NCT02566993|76133602|FG001|Overall Study|Randomized but not treated|16|||
42298412|NCT02566993|76133601|FG000|Overall Study|Progressive disease|213|||
42298413|NCT02566993|76133602|FG001|Overall Study|Progressive disease|152|||
42298414|NCT02566993|76133601|FG000|Overall Study|Withdrawal by Subject|12|||
42298415|NCT02566993|76133602|FG001|Overall Study|Withdrawal by Subject|28|||
42298416|NCT02566993|76133601|FG000|Overall Study|Death|17|||
42298417|NCT02566993|76133602|FG001|Overall Study|Death|23|||
42298418|NCT02566993|76133601|FG000|Overall Study|Physician Decision|10|||
42298419|NCT02566993|76133602|FG001|Overall Study|Physician Decision|17|||
42298420|NCT02566993|76133601|FG000|Overall Study|Study drug-related adverse event|20|||
42298421|NCT02566993|76133602|FG001|Overall Study|Study drug-related adverse event|41|||
42298422|NCT02566993|76133601|FG000|Overall Study|Non study drug-related adverse event|9|||
42298423|NCT02566993|76133602|FG001|Overall Study|Non study drug-related adverse event|9|||
42298424|NCT02566993|76133601|FG000|Overall Study|Symptomatic deterioration|9|||
42298425|NCT02566993|76133602|FG001|Overall Study|Symptomatic deterioration|16|||
42298426|NCT02566993|76133601|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
42298427|NCT02566993|76133602|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
42298428|NCT02566993|76133601|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
42298429|NCT02566993|76133602|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
42298430|NCT02566993|76133601|FG000|Overall Study|Screening failure|2|||
42298431|NCT02566993|76133602|FG001|Overall Study|Screening failure|0|||
42298432|NCT02566993|76133601|FG000|Overall Study|Lost to Follow-up|0|||
42298433|NCT02566993|76133602|FG001|Overall Study|Lost to Follow-up|1|||
42298434|NCT02566993|76133601|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
42298435|NCT02566993|76133602|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
42099502|NCT00364351|75910073|FG000|Overall Study|Condition under investigation worsened|469|||
42298436|NCT02311881|76133613|FG000|Overall Study|Did not meet the study criteria|2|||
42298437|NCT02311881|76133614|FG001|Overall Study|Did not meet the study criteria|2|||
42298438|NCT02311881|76133615|FG002|Overall Study|Did not meet the study criteria|0|||
42298439|NCT02311881|76133613|FG000|Overall Study|Adverse Event|7|||
42298440|NCT02311881|76133614|FG001|Overall Study|Adverse Event|15|||
42298441|NCT02311881|76133615|FG002|Overall Study|Adverse Event|8|||
42298442|NCT02311881|76133613|FG000|Overall Study|Lost to Follow-up|3|||
42298443|NCT02311881|76133614|FG001|Overall Study|Lost to Follow-up|3|||
42298444|NCT02311881|76133615|FG002|Overall Study|Lost to Follow-up|2|||
42298445|NCT02311881|76133613|FG000|Overall Study|Protocol Violation|1|||
42298446|NCT02311881|76133614|FG001|Overall Study|Protocol Violation|2|||
42298447|NCT02311881|76133615|FG002|Overall Study|Protocol Violation|3|||
42298448|NCT02311881|76133613|FG000|Overall Study|Withdrawal of consent|14|||
42298449|NCT02311881|76133614|FG001|Overall Study|Withdrawal of consent|16|||
42298450|NCT02311881|76133615|FG002|Overall Study|Withdrawal of consent|17|||
42298451|NCT02311881|76133613|FG000|Overall Study|Other|0|||
42298452|NCT02311881|76133614|FG001|Overall Study|Other|0|||
42298453|NCT02311881|76133615|FG002|Overall Study|Other|1|||
42298454|NCT02311881|76133613|FG000|Overall Study|Lack of Efficacy|1|||
42298455|NCT02311881|76133614|FG001|Overall Study|Lack of Efficacy|2|||
42298456|NCT02311881|76133615|FG002|Overall Study|Lack of Efficacy|0|||
42298457|NCT02311881|76133613|FG000|Overall Study|Subject has border line pregnancy test|1|||
42298458|NCT02311881|76133614|FG001|Overall Study|Subject has border line pregnancy test|0|||
42298459|NCT02311881|76133615|FG002|Overall Study|Subject has border line pregnancy test|0|||
42298460|NCT02311881|76133613|FG000|Overall Study|Withdrawal by Subject|3|||
42298461|NCT02311881|76133614|FG001|Overall Study|Withdrawal by Subject|1|||
42298462|NCT02311881|76133615|FG002|Overall Study|Withdrawal by Subject|4|||
42298463|NCT02311881|76133613|FG000|Overall Study|Sponsor Decision|1|||
42298464|NCT02311881|76133614|FG001|Overall Study|Sponsor Decision|1|||
42298465|NCT02311881|76133615|FG002|Overall Study|Sponsor Decision|1|||
42298466|NCT02311881|76133613|FG000|Overall Study|Protocol Deviation|1|||
42298467|NCT02311881|76133614|FG001|Overall Study|Protocol Deviation|0|||
42298468|NCT02311881|76133615|FG002|Overall Study|Protocol Deviation|0|||
42298469|NCT02311881|76133613|FG000|Overall Study|Non-Compliance|1|||
42298470|NCT02311881|76133614|FG001|Overall Study|Non-Compliance|0|||
42298471|NCT02311881|76133615|FG002|Overall Study|Non-Compliance|2|||
42298472|NCT02311881|76133613|FG000|Overall Study|Physician Decision|0|||
42298473|NCT02311881|76133614|FG001|Overall Study|Physician Decision|0|||
42298474|NCT02311881|76133615|FG002|Overall Study|Physician Decision|1|||
42298475|NCT02311881|76133613|FG000|Overall Study|Medical Monitor Discretion|0|||
42298476|NCT02311881|76133614|FG001|Overall Study|Medical Monitor Discretion|0|||
42298477|NCT02311881|76133615|FG002|Overall Study|Medical Monitor Discretion|1|||
42298478|NCT02311881|76133613|FG000|Overall Study|Participant taking another medication|0|||
42298479|NCT02311881|76133614|FG001|Overall Study|Participant taking another medication|0|||
42298480|NCT02311881|76133615|FG002|Overall Study|Participant taking another medication|1|||
42298481|NCT02311881|76133613|FG000|Overall Study|Serious Adverse Event|0|||
42298482|NCT02311881|76133614|FG001|Overall Study|Serious Adverse Event|1|||
42298483|NCT02311881|76133615|FG002|Overall Study|Serious Adverse Event|0|||
42298484|NCT02565511|76133630|FG000|Overall Study|Study terminated by Sponsor|35|||
42298485|NCT02565511|76133631|FG001|Overall Study|Study terminated by Sponsor|22|||
42194466|NCT03681951|76006121|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
42194467|NCT03681951|76006122|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
42194468|NCT03681951|76006123|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
42194469|NCT03681951|76006124|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
42194470|NCT03681951|76006125|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
42194471|NCT03681951|76006126|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
42194472|NCT03681951|76006127|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
42194473|NCT03681951|76006120|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
42194474|NCT03681951|76006121|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
42194475|NCT03681951|76006122|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
42194476|NCT03681951|76006123|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
42194477|NCT03681951|76006124|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
42194478|NCT03681951|76006125|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
42194479|NCT03681951|76006126|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
42194480|NCT03681951|76006127|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
42194481|NCT03681951|76006120|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
42194482|NCT03681951|76006121|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
42194483|NCT03681951|76006122|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
42194484|NCT03681951|76006123|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
42194485|NCT03681951|76006124|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
42194486|NCT03681951|76006125|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
42298486|NCT02565511|76133632|FG002|Overall Study|Study terminated by Sponsor|235|||
42298487|NCT02565511|76133633|FG003|Overall Study|Study terminated by Sponsor|156|||
42359328|NCT01819129|76204991|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
42359329|NCT01819129|76204992|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
42359330|NCT01819129|76204991|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
42298488|NCT02565511|76133630|FG000|Overall Study|Withdrawal by Subject|3|||
42298489|NCT02565511|76133631|FG001|Overall Study|Withdrawal by Subject|0|||
42298490|NCT02565511|76133632|FG002|Overall Study|Withdrawal by Subject|12|||
42298491|NCT02565511|76133633|FG003|Overall Study|Withdrawal by Subject|5|||
42359331|NCT01819129|76204992|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
42194487|NCT03681951|76006126|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
42194488|NCT03681951|76006127|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
42194489|NCT03681405|76006152|FG000|Overall Study|Found to be ineligible after randomized|1|||
42194490|NCT03681405|76006153|FG001|Overall Study|Found to be ineligible after randomized|0|||
42194491|NCT00174785|76006163|FG000|Overall Study|Adverse Event|293|||
42194492|NCT00174785|76006164|FG001|Overall Study|Adverse Event|191|||
42194493|NCT00174785|76006163|FG000|Overall Study|Protocol Violation|14|||
42194494|NCT00174785|76006164|FG001|Overall Study|Protocol Violation|14|||
42194495|NCT00174785|76006163|FG000|Overall Study|Withdrawal by Subject|173|||
42194496|NCT00174785|76006164|FG001|Overall Study|Withdrawal by Subject|175|||
42194497|NCT00174785|76006163|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
42194498|NCT00174785|76006164|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
42194499|NCT00174785|76006163|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
42194500|NCT00174785|76006164|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
42194501|NCT00174785|76006163|FG000|Overall Study|Other prohibited medication|5|||
42194502|NCT00174785|76006164|FG001|Overall Study|Other prohibited medication|3|||
42194503|NCT00174785|76006163|FG000|Overall Study|Family request|6|||
42194504|NCT00174785|76006164|FG001|Overall Study|Family request|8|||
42194505|NCT00174785|76006163|FG000|Overall Study|Not pre-specified/Not coded|56|||
42194506|NCT00174785|76006164|FG001|Overall Study|Not pre-specified/Not coded|70|||
42194507|NCT03681093|76006173|FG000|Overall Study|Subject decision|0|||
42194508|NCT03681093|76006174|FG001|Overall Study|Subject decision|2|||
42194509|NCT03681093|76006175|FG002|Overall Study|Subject decision|1|||
42194510|NCT00166517|76006185|FG000|Overall Study|Lost to Follow-up|1|||
42194511|NCT00166517|76006186|FG001|Overall Study|Lost to Follow-up|0|||
42194512|NCT00166517|76006185|FG000|Overall Study|Protocol Violation|4|||
42194513|NCT00166517|76006186|FG001|Overall Study|Protocol Violation|1|||
42194514|NCT00166517|76006185|FG000|Overall Study|Withdrawal by Subject|0|||
42194515|NCT00166517|76006186|FG001|Overall Study|Withdrawal by Subject|1|||
42194516|NCT00166439|76006192|FG000|Overall Study|Ineligible|5|||
42194517|NCT00138671|76006198|FG000|Overall Study|Death|0|||
42194518|NCT00138671|76006199|FG001|Overall Study|Death|3|||
42194519|NCT00138671|76006198|FG000|Overall Study|Adverse Event|6|||
42194520|NCT00138671|76006199|FG001|Overall Study|Adverse Event|3|||
42194521|NCT00138671|76006198|FG000|Overall Study|Lost to Follow-up|1|||
42194522|NCT00138671|76006199|FG001|Overall Study|Lost to Follow-up|2|||
42194523|NCT00138671|76006198|FG000|Overall Study|Withdrawal by Subject|3|||
42194524|NCT00138671|76006199|FG001|Overall Study|Withdrawal by Subject|5|||
42194525|NCT00138671|76006198|FG000|Overall Study|Other|3|||
42194526|NCT00138671|76006199|FG001|Overall Study|Other|3|||
42194527|NCT01367158|76006218|FG000|Overall Study|Withdrew consent|0|||
42194528|NCT01367158|76006219|FG001|Overall Study|Withdrew consent|2|||
42194529|NCT01367158|76006220|FG002|Overall Study|Withdrew consent|1|||
42194530|NCT01367158|76006221|FG003|Overall Study|Withdrew consent|0|||
42194531|NCT01367158|76006222|FG004|Overall Study|Withdrew consent|2|||
42194532|NCT01367158|76006223|FG005|Overall Study|Withdrew consent|0|||
42194533|NCT01367158|76006224|FG006|Overall Study|Withdrew consent|0|||
42194534|NCT01367158|76006225|FG007|Overall Study|Withdrew consent|1|||
42194535|NCT01367158|76006226|FG008|Overall Study|Withdrew consent|0|||
42359332|NCT01819129|76204991|FG000|Overall Study|Other, Subject moved out of the country|0|||
42359333|NCT01819129|76204992|FG001|Overall Study|Other, Subject moved out of the country|1|||
42359334|NCT01819129|76204991|FG000|Overall Study|Withdrawal by Subject|15|||
42359335|NCT01819129|76204992|FG001|Overall Study|Withdrawal by Subject|15|||
42359336|NCT01819129|76204991|FG000|Overall Study|Lost to Follow-up|5|||
42359337|NCT01819129|76204992|FG001|Overall Study|Lost to Follow-up|2|||
42359338|NCT01819129|76204991|FG000|Overall Study|Lack of Efficacy|0|||
42359339|NCT01819129|76204992|FG001|Overall Study|Lack of Efficacy|1|||
42359340|NCT01819129|76204991|FG000|Overall Study|Adverse Event|1|||
42359341|NCT01819129|76204992|FG001|Overall Study|Adverse Event|4|||
42359342|NCT01819129|76204991|FG000|Overall Study|Death|1|||
42359343|NCT01819129|76204992|FG001|Overall Study|Death|1|||
42194536|NCT01367158|76006227|FG009|Overall Study|Withdrew consent|0|||
42194537|NCT01367158|76006228|FG010|Overall Study|Withdrew consent|0|||
42194538|NCT01367158|76006218|FG000|Overall Study|Lost to Follow-up|0|||
42194539|NCT01367158|76006219|FG001|Overall Study|Lost to Follow-up|0|||
42194540|NCT01367158|76006220|FG002|Overall Study|Lost to Follow-up|0|||
42194541|NCT01367158|76006221|FG003|Overall Study|Lost to Follow-up|1|||
42194542|NCT01367158|76006222|FG004|Overall Study|Lost to Follow-up|0|||
42194543|NCT01367158|76006223|FG005|Overall Study|Lost to Follow-up|2|||
42194544|NCT01367158|76006224|FG006|Overall Study|Lost to Follow-up|0|||
42194545|NCT01367158|76006225|FG007|Overall Study|Lost to Follow-up|1|||
42194546|NCT01367158|76006226|FG008|Overall Study|Lost to Follow-up|0|||
42194547|NCT01367158|76006227|FG009|Overall Study|Lost to Follow-up|0|||
42359344|NCT01819129|76204991|FG000|Overall Study|Withdrawal Criteria|20|||
42194548|NCT01367158|76006228|FG010|Overall Study|Lost to Follow-up|1|||
42194549|NCT01367158|76006218|FG000|Overall Study|Protocol Violation|0|||
42194550|NCT01367158|76006219|FG001|Overall Study|Protocol Violation|1|||
42359345|NCT01819129|76204992|FG001|Overall Study|Withdrawal Criteria|15|||
42194551|NCT01367158|76006220|FG002|Overall Study|Protocol Violation|0|||
42194552|NCT01367158|76006221|FG003|Overall Study|Protocol Violation|0|||
42194553|NCT01367158|76006222|FG004|Overall Study|Protocol Violation|0|||
42194554|NCT01367158|76006223|FG005|Overall Study|Protocol Violation|0|||
42194555|NCT01367158|76006224|FG006|Overall Study|Protocol Violation|0|||
42194556|NCT01367158|76006225|FG007|Overall Study|Protocol Violation|0|||
42194557|NCT01367158|76006226|FG008|Overall Study|Protocol Violation|0|||
42194558|NCT01367158|76006227|FG009|Overall Study|Protocol Violation|0|||
42194559|NCT01367158|76006228|FG010|Overall Study|Protocol Violation|0|||
42194560|NCT00130637|76006263|FG000|Overall Study|Adverse Event|2|||
42194561|NCT00130637|76006263|FG000|Overall Study|Withdrawal by Subject|1|||
42194562|NCT03679767|76006271|FG000|Overall Study|Death|16|||
42194563|NCT03679767|76006272|FG001|Overall Study|Death|11|||
42194564|NCT03679767|76006273|FG002|Overall Study|Death|17|||
42194565|NCT03679767|76006274|FG003|Overall Study|Death|10|||
42194566|NCT03679767|76006271|FG000|Overall Study|Lost to Follow-up|1|||
42194567|NCT03679767|76006272|FG001|Overall Study|Lost to Follow-up|1|||
42194568|NCT03679767|76006273|FG002|Overall Study|Lost to Follow-up|1|||
42194569|NCT03679767|76006274|FG003|Overall Study|Lost to Follow-up|1|||
42194570|NCT03679767|76006271|FG000|Overall Study|Withdrawal by Subject|0|||
42194571|NCT03679767|76006272|FG001|Overall Study|Withdrawal by Subject|0|||
42194572|NCT03679767|76006273|FG002|Overall Study|Withdrawal by Subject|0|||
42194573|NCT03679767|76006274|FG003|Overall Study|Withdrawal by Subject|1|||
42194574|NCT03679767|76006271|FG000|Overall Study|Follow-up Completed|18|||
42194575|NCT03679767|76006272|FG001|Overall Study|Follow-up Completed|11|||
42194576|NCT03679767|76006273|FG002|Overall Study|Follow-up Completed|11|||
42194577|NCT03679767|76006274|FG003|Overall Study|Follow-up Completed|20|||
42194578|NCT03679767|76006271|FG000|Overall Study|Entered Hospice Care|0|||
42194579|NCT03679767|76006272|FG001|Overall Study|Entered Hospice Care|0|||
42194580|NCT03679767|76006273|FG002|Overall Study|Entered Hospice Care|0|||
42194581|NCT03679767|76006274|FG003|Overall Study|Entered Hospice Care|1|||
42194582|NCT03679767|76006271|FG000|Overall Study|Progressive Disease|0|||
42194583|NCT03679767|76006272|FG001|Overall Study|Progressive Disease|0|||
42194584|NCT03679767|76006273|FG002|Overall Study|Progressive Disease|0|||
42194585|NCT03679767|76006274|FG003|Overall Study|Progressive Disease|1|||
42194586|NCT00130247|76006288|FG000|Overall Study|Pregnancy|1|||
42359346|NCT04022889|76205000|FG000|Stage 1: Period 1|Adverse Event|1|||
42359347|NCT04022889|76205001|FG001|Stage 1: Period 1|Adverse Event|0|||
42359348|NCT04022889|76205002|FG002|Stage 1: Period 1|Adverse Event|0|||
42359349|NCT04022889|76205000|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
42359350|NCT04022889|76205001|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
42359351|NCT04022889|76205002|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
42359352|NCT04022889|76205000|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
42359353|NCT04022889|76205001|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
42359354|NCT04022889|76205002|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
42359355|NCT04022889|76205000|FG000|Stage 2|Screen Failure|0|||
42194587|NCT00130247|76006289|FG001|Overall Study|Pregnancy|0|||
42194588|NCT00130247|76006288|FG000|Overall Study|Post-randomization exclusion|1|||
42194589|NCT00130247|76006289|FG001|Overall Study|Post-randomization exclusion|2|||
42194590|NCT00130247|76006288|FG000|Overall Study|Not compliant with DOT|0|||
42194591|NCT00130247|76006289|FG001|Overall Study|Not compliant with DOT|2|||
42298492|NCT02565511|76133630|FG000|Overall Study|Adverse Event|0|||
42298493|NCT02565511|76133631|FG001|Overall Study|Adverse Event|0|||
42298494|NCT02565511|76133632|FG002|Overall Study|Adverse Event|1|||
42298495|NCT02565511|76133633|FG003|Overall Study|Adverse Event|1|||
42298496|NCT02565511|76133630|FG000|Overall Study|Lost to Follow-up|4|||
42298497|NCT02565511|76133631|FG001|Overall Study|Lost to Follow-up|1|||
42298498|NCT02565511|76133632|FG002|Overall Study|Lost to Follow-up|0|||
42298499|NCT02565511|76133633|FG003|Overall Study|Lost to Follow-up|1|||
42298500|NCT02565511|76133630|FG000|Overall Study|Physician Decision|0|||
42298501|NCT02565511|76133631|FG001|Overall Study|Physician Decision|0|||
42298502|NCT02565511|76133632|FG002|Overall Study|Physician Decision|0|||
42298503|NCT02565511|76133633|FG003|Overall Study|Physician Decision|1|||
42298504|NCT02565511|76133630|FG000|Overall Study|Protocol deviation|0|||
42298505|NCT02565511|76133631|FG001|Overall Study|Protocol deviation|0|||
42298506|NCT02565511|76133632|FG002|Overall Study|Protocol deviation|3|||
42359356|NCT04022889|76205001|FG001|Stage 2|Screen Failure|0|||
42359357|NCT04022889|76205002|FG002|Stage 2|Screen Failure|3|||
42359358|NCT04022889|76205000|FG000|Stage 2|Ineligible for apheresis donation|0|||
42194592|NCT03678285|76006295|FG000|Overall Study|Adverse Event|2|||
42194593|NCT03678285|76006295|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
42194594|NCT03678285|76006295|FG000|Overall Study|Dehydrated prior to start of workout|1|||
42194595|NCT04032171|76006301|FG000|Overall Study|Study Termination|1|||
42194596|NCT04032171|76006302|FG001|Overall Study|Study Termination|0|||
42194597|NCT00137423|76006310|FG000|Overall Study|Adverse Event|7|||
42194598|NCT00137423|76006311|FG001|Overall Study|Adverse Event|9|||
42194599|NCT00137423|76006310|FG000|Overall Study|consent withdrawn|1|||
42194600|NCT00137423|76006311|FG001|Overall Study|consent withdrawn|1|||
42359359|NCT04022889|76205001|FG001|Stage 2|Ineligible for apheresis donation|0|||
42359360|NCT04022889|76205002|FG002|Stage 2|Ineligible for apheresis donation|2|||
42359361|NCT04022889|76205000|FG000|Stage 2|Adverse Event|0|||
42359362|NCT04022889|76205001|FG001|Stage 2|Adverse Event|0|||
42359363|NCT04022889|76205002|FG002|Stage 2|Adverse Event|2|||
42359364|NCT04022889|76205000|FG000|Stage 2|Protocol Violation|0|||
42359365|NCT04022889|76205001|FG001|Stage 2|Protocol Violation|0|||
42359366|NCT04022889|76205002|FG002|Stage 2|Protocol Violation|1|||
42359367|NCT04022889|76205000|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
42359368|NCT04022889|76205001|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
42359369|NCT04022889|76205002|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
42359370|NCT01849783|76205020|FG000|Overall Study|Adverse Event|5|||
42359371|NCT01849783|76205020|FG000|Overall Study|Death|2|||
42359372|NCT01849783|76205020|FG000|Overall Study|Physician Decision|1|||
42359373|NCT01849783|76205020|FG000|Overall Study|Withdrawal by Subject|1|||
42359374|NCT01849783|76205020|FG000|Overall Study|Unable to comply|2|||
42359375|NCT01849783|76205020|FG000|Overall Study|Disease progression|11|||
42359376|NCT01611883|76205032|FG000|Overall Study|Adverse Event|1|||
42359377|NCT01611883|76205033|FG001|Overall Study|Adverse Event|1|||
42359378|NCT01848457|76205043|FG000|Overall Study|Death|1|||
42359379|NCT01848457|76205044|FG001|Overall Study|Death|0|||
42359380|NCT01848457|76205045|FG002|Overall Study|Death|0|||
42359381|NCT01848457|76205046|FG003|Overall Study|Death|0|||
42359382|NCT01817725|76205064|FG000|Overall Study|Withdrawal by Subject|1|||
42359383|NCT01870999|76205071|FG000|Overall Study|Adverse Event|0|||
42359384|NCT01870999|76205072|FG001|Overall Study|Adverse Event|4|||
42359385|NCT01870999|76205073|FG002|Overall Study|Adverse Event|1|||
42359386|NCT01870999|76205071|FG000|Overall Study|Subject met withdrawal criteria|3|||
42359387|NCT01870999|76205072|FG001|Overall Study|Subject met withdrawal criteria|2|||
42359388|NCT01870999|76205073|FG002|Overall Study|Subject met withdrawal criteria|0|||
42359389|NCT01870999|76205071|FG000|Overall Study|Subject withdrawn by Investigator|1|||
42359390|NCT01870999|76205072|FG001|Overall Study|Subject withdrawn by Investigator|0|||
42099503|NCT00364351|75910074|FG001|Overall Study|Condition under investigation worsened|497|||
42194601|NCT00137423|76006310|FG000|Overall Study|Lack of Efficacy|31|||
42194602|NCT00137423|76006311|FG001|Overall Study|Lack of Efficacy|33|||
42194603|NCT00137423|76006310|FG000|Overall Study|Death|0|||
42194604|NCT00137423|76006311|FG001|Overall Study|Death|1|||
42194605|NCT02786836|76006321|FG000|Overall Study|Death|1|||
42194606|NCT02786836|76006321|FG000|Overall Study|Lack of Efficacy|2|||
42194607|NCT02786836|76006321|FG000|Overall Study|Protocol Violation|3|||
42194608|NCT02786836|76006321|FG000|Overall Study|Withdrawal by Subject|3|||
42194609|NCT02786836|76006321|FG000|Overall Study|Liver Transplantation|2|||
42194610|NCT02786836|76006321|FG000|Overall Study|Device or Pharmacy Issues|3|||
42194611|NCT00137267|76006328|FG000|Overall Study|Lost to Follow-up|15|||
42194612|NCT00137267|76006329|FG001|Overall Study|Lost to Follow-up|21|||
42194613|NCT00137111|76006339|FG000|Total Therapy|Death|35|||
42194614|NCT00137111|76006340|FG001|Total Therapy|Death|0|||
42194615|NCT00137111|76006341|FG002|Total Therapy|Death|0|||
42194616|NCT00137111|76006342|FG003|Total Therapy|Death|0|||
42194617|NCT00137111|76006339|FG000|Total Therapy|Non Compliance|5|||
42194618|NCT00137111|76006340|FG001|Total Therapy|Non Compliance|0|||
42194619|NCT00137111|76006341|FG002|Total Therapy|Non Compliance|0|||
42194620|NCT00137111|76006342|FG003|Total Therapy|Non Compliance|0|||
42194621|NCT00136955|76006349|FG000|Overall Study|Adverse Event|8|||
42359391|NCT01870999|76205073|FG002|Overall Study|Subject withdrawn by Investigator|0|||
42359392|NCT01870999|76205071|FG000|Overall Study|Withdrawal by Subject|0|||
42099504|NCT00364351|75910073|FG000|Overall Study|Prohibited concomitant medication|0|||
42099505|NCT00364351|75910074|FG001|Overall Study|Prohibited concomitant medication|2|||
42099506|NCT00364351|75910073|FG000|Overall Study|Lost to Follow-up|1|||
42099507|NCT00364351|75910074|FG001|Overall Study|Lost to Follow-up|1|||
42099508|NCT00364351|75910073|FG000|Overall Study|Withdrawal by Subject|30|||
42359393|NCT01870999|76205072|FG001|Overall Study|Withdrawal by Subject|2|||
42359394|NCT01870999|76205073|FG002|Overall Study|Withdrawal by Subject|5|||
42359395|NCT01870999|76205071|FG000|Overall Study|Protocol Violation|0|||
42359396|NCT01870999|76205072|FG001|Overall Study|Protocol Violation|0|||
42359397|NCT01870999|76205073|FG002|Overall Study|Protocol Violation|1|||
42099509|NCT00364351|75910074|FG001|Overall Study|Withdrawal by Subject|29|||
42099510|NCT00364351|75910073|FG000|Overall Study|Incorrect enrollment|1|||
42359398|NCT01870921|76205081|FG000|Overall Study|Subject decision|80|||
42099511|NCT00364351|75910074|FG001|Overall Study|Incorrect enrollment|1|||
42359399|NCT01870921|76205081|FG000|Overall Study|Severe non-compliance to protocol|7|||
42359400|NCT01870921|76205081|FG000|Overall Study|Subject Lost to Follow up|2|||
42099512|NCT00364351|75910073|FG000|Overall Study|Sponsor decision|1|||
42099513|NCT00364351|75910074|FG001|Overall Study|Sponsor decision|0|||
42194622|NCT00136955|76006349|FG000|Overall Study|Lost to Follow-up|1|||
42194623|NCT00136955|76006349|FG000|Overall Study|Withdrawal by Subject|2|||
42194624|NCT00136955|76006349|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
42359401|NCT01870921|76205081|FG000|Overall Study|Other|1|||
42359402|NCT01848145|76205094|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
42359403|NCT01848145|76205094|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
42359404|NCT01848145|76205094|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
42359405|NCT01848145|76205094|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
42359406|NCT01848145|76205094|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
42359407|NCT01848145|76205094|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
42359408|NCT01848145|76205094|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
42359409|NCT01847755|76205098|FG000|Overall Study|Adverse Event|2|||
42359410|NCT01847755|76205098|FG000|Overall Study|Withdrawal by Subject|2|||
42359411|NCT01847755|76205098|FG000|Overall Study|Physician Decision|1|||
42359412|NCT01847443|76205129|FG000|Study Period 1|Withdrawal by Subject|0|||
42359413|NCT01847443|76205130|FG001|Study Period 1|Withdrawal by Subject|1|||
42359414|NCT01847443|76205131|FG002|Study Period 1|Withdrawal by Subject|0|||
42359415|NCT01847443|76205132|FG003|Study Period 1|Withdrawal by Subject|0|||
42359416|NCT01847443|76205129|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
42359417|NCT01847443|76205130|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
42359418|NCT01847443|76205131|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
42359419|NCT01847443|76205132|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
42359420|NCT01847443|76205129|FG000|Washout Period Before Study Period 2|Other reason|1|||
42359421|NCT01847443|76205130|FG001|Washout Period Before Study Period 2|Other reason|0|||
42359422|NCT01847443|76205131|FG002|Washout Period Before Study Period 2|Other reason|0|||
42359423|NCT01847443|76205132|FG003|Washout Period Before Study Period 2|Other reason|0|||
42359424|NCT01847443|76205129|FG000|Washout Period Before Study Period 3|Other reason|1|||
42359425|NCT01847443|76205130|FG001|Washout Period Before Study Period 3|Other reason|0|||
42359426|NCT01847443|76205131|FG002|Washout Period Before Study Period 3|Other reason|0|||
42359427|NCT01847443|76205132|FG003|Washout Period Before Study Period 3|Other reason|0|||
42359428|NCT01847443|76205129|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
42359429|NCT01847443|76205130|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
42359430|NCT01847443|76205131|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
42359431|NCT01847443|76205132|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
42359432|NCT01847443|76205129|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
42359433|NCT01847443|76205130|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
42359434|NCT01847443|76205131|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
42359435|NCT01847443|76205132|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
42359436|NCT01847209|76205151|FG000|Overall Study|Withdrawal by Subject|1|||
42359437|NCT01847209|76205151|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
42359438|NCT01846741|76205155|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
42359439|NCT01870843|76205194|FG000|Overall Study|Adverse Event|10|||
42359440|NCT01870843|76205194|FG000|Overall Study|Lost to Follow-up|24|||
42359441|NCT01870843|76205194|FG000|Overall Study|Death|1|||
42194625|NCT00135707|76006355|FG000|Overall Study|Lost to Follow-up|94|||
42194626|NCT00135707|76006356|FG001|Overall Study|Lost to Follow-up|89|||
42194627|NCT00135707|76006355|FG000|Overall Study|Withdrawal by Subject|0|||
42194628|NCT00135707|76006356|FG001|Overall Study|Withdrawal by Subject|1|||
42194629|NCT00135707|76006355|FG000|Overall Study|Institutional review board request|1|||
42194630|NCT00135707|76006356|FG001|Overall Study|Institutional review board request|0|||
42194631|NCT00129623|76006368|FG000|Overall Study|Adverse Event|3|||
42194632|NCT00129623|76006369|FG001|Overall Study|Adverse Event|7|||
42194633|NCT00129623|76006368|FG000|Overall Study|Refused Treatment|5|||
42359442|NCT01870843|76205194|FG000|Overall Study|Withdrawal by Subject|18|||
42359443|NCT01816477|76205200|FG000|Overall Study|Withdrawal by Subject|13|||
42359444|NCT01816477|76205201|FG001|Overall Study|Withdrawal by Subject|1|||
42359445|NCT01816477|76205200|FG000|Overall Study|Unable to tolerate catheter placement|3|||
42359446|NCT01816477|76205201|FG001|Overall Study|Unable to tolerate catheter placement|0|||
42359447|NCT01846507|76205207|FG000|Overall Study|Lost to Follow-up|4|||
42359448|NCT01846507|76205207|FG000|Overall Study|Protocol Violation|1|||
42359449|NCT01846507|76205207|FG000|Overall Study|Missing data|2|||
42359450|NCT01846039|76205213|FG000|Overall Study|Protocol Violation|1|||
42359451|NCT01846039|76205213|FG000|Overall Study|Subject Withdrew Consent|1|||
42359452|NCT01610167|76205220|FG000|Overall Study|Scheduling conflict.|0|||
42359453|NCT01610167|76205221|FG001|Overall Study|Scheduling conflict.|0|||
42359454|NCT01610167|76205222|FG002|Overall Study|Scheduling conflict.|2|||
42359455|NCT01816243|76205230|FG000|Overall Study|Adverse Event|6|||
42359456|NCT01816243|76205230|FG000|Overall Study|Lost to Follow-up|1|||
42194634|NCT00129623|76006369|FG001|Overall Study|Refused Treatment|3|||
42359457|NCT01816243|76205230|FG000|Overall Study|Lack of Efficacy|1|||
42359458|NCT01816243|76205230|FG000|Overall Study|Not eligible for the study|1|||
42359459|NCT01816243|76205230|FG000|Overall Study|Amputation|3|||
42359460|NCT01845805|76205236|FG000|Overall Study|Withdrawal by Subject|1|||
42359461|NCT01845805|76205237|FG001|Overall Study|Withdrawal by Subject|2|||
42359462|NCT01845805|76205236|FG000|Overall Study|Disease Progression|13|||
42194635|NCT00129623|76006368|FG000|Overall Study|Failure to Return|1|||
42194636|NCT00129623|76006369|FG001|Overall Study|Failure to Return|1|||
42359463|NCT01845805|76205237|FG001|Overall Study|Disease Progression|14|||
42359464|NCT01845805|76205236|FG000|Overall Study|Drug-related Toxicity|4|||
42359465|NCT01845805|76205237|FG001|Overall Study|Drug-related Toxicity|0|||
42359466|NCT01845025|76205245|FG000|Overall Study|Adverse Event|6|||
42359467|NCT01845025|76205246|FG001|Overall Study|Adverse Event|3|||
42359468|NCT01845025|76205245|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
42359469|NCT01845025|76205246|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42359470|NCT01845025|76205245|FG000|Overall Study|Withdrawal by Subject|48|||
42359471|NCT01845025|76205246|FG001|Overall Study|Withdrawal by Subject|44|||
42359472|NCT01845025|76205245|FG000|Overall Study|Lost to Follow-up|13|||
42359473|NCT01845025|76205246|FG001|Overall Study|Lost to Follow-up|13|||
42359474|NCT01845025|76205245|FG000|Overall Study|Administrative problems|8|||
42359475|NCT01845025|76205246|FG001|Overall Study|Administrative problems|8|||
42359476|NCT01845025|76205245|FG000|Overall Study|Death|2|||
42099514|NCT00364351|75910073|FG000|Overall Study|Poor treatment compliance|0|||
42099515|NCT00364351|75910074|FG001|Overall Study|Poor treatment compliance|3|||
42099516|NCT00364351|75910073|FG000|Overall Study|Investigator error|0|||
42099517|NCT00364351|75910074|FG001|Overall Study|Investigator error|2|||
42099518|NCT00364351|75910073|FG000|Overall Study|Patient could not travel to site|0|||
42099519|NCT00364351|75910074|FG001|Overall Study|Patient could not travel to site|1|||
42099520|NCT00364351|75910073|FG000|Overall Study|Randomised treatment not started|0|||
42099521|NCT00364351|75910074|FG001|Overall Study|Randomised treatment not started|3|||
42099522|NCT00388297|75910084|FG000|Overall Study|Lost to Follow-up|16|||
42194637|NCT00129623|76006368|FG000|Overall Study|Relocated job out of state|1|||
42194638|NCT00129623|76006369|FG001|Overall Study|Relocated job out of state|0|||
42194639|NCT00129623|76006368|FG000|Overall Study|Uncertainty to return|0|||
42194640|NCT00129623|76006369|FG001|Overall Study|Uncertainty to return|1|||
42194641|NCT00129545|76006380|FG000|Overall Study|Death|5|||
42194642|NCT00129545|76006381|FG001|Overall Study|Death|60|||
42194643|NCT00129545|76006382|FG002|Overall Study|Death|44|||
42194644|NCT00129545|76006380|FG000|Overall Study|Withdrawal by Subject|3|||
42194645|NCT00129545|76006381|FG001|Overall Study|Withdrawal by Subject|18|||
42194646|NCT00129545|76006382|FG002|Overall Study|Withdrawal by Subject|44|||
42194647|NCT00129545|76006380|FG000|Overall Study|Lost to Follow-up|2|||
42194648|NCT00129545|76006381|FG001|Overall Study|Lost to Follow-up|22|||
42194649|NCT00129545|76006382|FG002|Overall Study|Lost to Follow-up|13|||
42194650|NCT00129545|76006380|FG000|Overall Study|Physician Decision|0|||
42194651|NCT00129545|76006381|FG001|Overall Study|Physician Decision|3|||
42194652|NCT00129545|76006382|FG002|Overall Study|Physician Decision|10|||
42194653|NCT00129545|76006380|FG000|Overall Study|Device not implanted|16|||
42194654|NCT00129545|76006381|FG001|Overall Study|Device not implanted|61|||
42194655|NCT00129545|76006382|FG002|Overall Study|Device not implanted|0|||
42194656|NCT00129467|76006392|FG000|Received Intervention|Death|1|||
42194657|NCT00129467|76006393|FG001|Received Intervention|Death|1|||
42194658|NCT00129467|76006392|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
42194659|NCT00129467|76006393|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
42194660|NCT00129467|76006392|FG000|Received Intervention|Delirium|2|||
42194661|NCT00129467|76006393|FG001|Received Intervention|Delirium|0|||
42194662|NCT00129467|76006392|FG000|Received Intervention|Withdrawal by Subject|1|||
42194663|NCT00129467|76006393|FG001|Received Intervention|Withdrawal by Subject|0|||
42194664|NCT00129467|76006392|FG000|Received Intervention|Nausea|1|||
42194665|NCT00129467|76006393|FG001|Received Intervention|Nausea|0|||
42194666|NCT00129467|76006392|FG000|Received Intervention|Intolerance to citalopram|0|||
42194667|NCT00129467|76006393|FG001|Received Intervention|Intolerance to citalopram|1|||
42194668|NCT00129467|76006392|FG000|Received Intervention|Dizzyness, fatigue|0|||
42359477|NCT01845025|76205246|FG001|Overall Study|Death|0|||
42359478|NCT01845025|76205245|FG000|Overall Study|Protocol deviation|3|||
42359479|NCT01845025|76205246|FG001|Overall Study|Protocol deviation|6|||
42359480|NCT01845025|76205245|FG000|Overall Study|Missing|1|||
42359481|NCT01845025|76205246|FG001|Overall Study|Missing|1|||
42359482|NCT01870297|76205287|FG000|Overall Study|Adverse Event|0|||
42359483|NCT01870297|76205288|FG001|Overall Study|Adverse Event|0|||
42359484|NCT01870297|76205289|FG002|Overall Study|Adverse Event|0|||
42359485|NCT01870297|76205290|FG003|Overall Study|Adverse Event|0|||
42359486|NCT01870297|76205291|FG004|Overall Study|Adverse Event|2|||
42359487|NCT01870297|76205292|FG005|Overall Study|Adverse Event|0|||
42359488|NCT01870297|76205293|FG006|Overall Study|Adverse Event|0|||
42359489|NCT01870297|76205287|FG000|Overall Study|Lost to Follow-up|0|||
42359490|NCT01870297|76205288|FG001|Overall Study|Lost to Follow-up|1|||
42359491|NCT01870297|76205289|FG002|Overall Study|Lost to Follow-up|1|||
42194669|NCT00129467|76006393|FG001|Received Intervention|Dizzyness, fatigue|1|||
42194670|NCT00129467|76006392|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
42194671|NCT00129467|76006393|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
42099523|NCT00388297|75910085|FG001|Overall Study|Lost to Follow-up|12|||
42099524|NCT00388297|75910086|FG002|Overall Study|Lost to Follow-up|11|||
42194672|NCT00129467|76006392|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
42359492|NCT01870297|76205290|FG003|Overall Study|Lost to Follow-up|0|||
42359493|NCT01870297|76205291|FG004|Overall Study|Lost to Follow-up|0|||
42359494|NCT01870297|76205292|FG005|Overall Study|Lost to Follow-up|0|||
42359495|NCT01870297|76205293|FG006|Overall Study|Lost to Follow-up|0|||
42359496|NCT01870297|76205287|FG000|Overall Study|Withdrawal by Subject|0|||
42359497|NCT01870297|76205288|FG001|Overall Study|Withdrawal by Subject|0|||
42359498|NCT01870297|76205289|FG002|Overall Study|Withdrawal by Subject|0|||
42359499|NCT01870297|76205290|FG003|Overall Study|Withdrawal by Subject|0|||
42359500|NCT01870297|76205291|FG004|Overall Study|Withdrawal by Subject|1|||
42359501|NCT01870297|76205292|FG005|Overall Study|Withdrawal by Subject|1|||
42359502|NCT01870297|76205293|FG006|Overall Study|Withdrawal by Subject|1|||
42359503|NCT01870297|76205287|FG000|Overall Study|Sponsor Decision|0|||
42359504|NCT01870297|76205288|FG001|Overall Study|Sponsor Decision|6|||
42359505|NCT01870297|76205289|FG002|Overall Study|Sponsor Decision|0|||
42359506|NCT01870297|76205290|FG003|Overall Study|Sponsor Decision|0|||
42359507|NCT01870297|76205291|FG004|Overall Study|Sponsor Decision|0|||
42359508|NCT01870297|76205292|FG005|Overall Study|Sponsor Decision|0|||
42359509|NCT01870297|76205293|FG006|Overall Study|Sponsor Decision|1|||
42359510|NCT01814761|76205320|FG000|Overall Study|Other Reasons|1|||
42359511|NCT01814761|76205321|FG001|Overall Study|Other Reasons|10|||
42359512|NCT01814761|76205320|FG000|Overall Study|Ocular Adverse Event|6|||
42359513|NCT01814761|76205321|FG001|Overall Study|Ocular Adverse Event|15|||
42194673|NCT00129467|76006393|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
42194674|NCT00129311|76006401|FG000|Overall Study|Withdrawal by Subject|12|||
42359514|NCT01814761|76205320|FG000|Overall Study|Lost to Follow-up|1|||
42194675|NCT00129311|76006402|FG001|Overall Study|Withdrawal by Subject|19|||
42359515|NCT01814761|76205321|FG001|Overall Study|Lost to Follow-up|5|||
42359516|NCT01843933|76205329|FG000|Overall Study|Data lost|6|||
42359517|NCT01843933|76205330|FG001|Overall Study|Data lost|4|||
42359518|NCT01814371|76205338|FG000|Overall Study|Lost to Follow-up|30|||
42359519|NCT01814371|76205339|FG001|Overall Study|Lost to Follow-up|27|||
42359520|NCT01814137|76205413|FG000|Overall Study|Adverse Event|0|||
42359521|NCT01814137|76205414|FG001|Overall Study|Adverse Event|1|||
42359522|NCT01814137|76205413|FG000|Overall Study|Withdrawal by Subject|2|||
42359523|NCT01814137|76205414|FG001|Overall Study|Withdrawal by Subject|2|||
42359524|NCT01814137|76205413|FG000|Overall Study|Physician Decision|1|||
42359525|NCT01814137|76205414|FG001|Overall Study|Physician Decision|1|||
42359526|NCT01814137|76205413|FG000|Overall Study|Unclassified|2|||
42359527|NCT01814137|76205414|FG001|Overall Study|Unclassified|1|||
42359528|NCT01813435|76205431|FG000|Overall Study|did not finish experimental regimen|1902|||
42359529|NCT01813435|76205432|FG001|Overall Study|did not finish experimental regimen|770|||
42359530|NCT01813435|76205431|FG000|Overall Study|Lost to Follow-up|268|||
42359531|NCT01813435|76205432|FG001|Overall Study|Lost to Follow-up|237|||
42359532|NCT01813357|76205440|FG000|Overall Study|Lost to Follow-up|5|||
42359533|NCT01813357|76205441|FG001|Overall Study|Lost to Follow-up|6|||
42359534|NCT01812655|76205450|FG000|Overall Study|Protocol Violation|1|||
42359535|NCT01812655|76205451|FG001|Overall Study|Protocol Violation|1|||
42359536|NCT01812655|76205452|FG002|Overall Study|Protocol Violation|0|||
42359537|NCT01812109|76205473|FG000|Overall Study|research personnel delay|16|||
42359538|NCT01812109|76205473|FG000|Overall Study|NIRS Unattainable|17|||
42359539|NCT01811953|76205483|FG000|Overall Study|Adverse Event|0|||
42194676|NCT00133991|76006408|FG000|Overall Study|Death|4|||
42194677|NCT02784106|76006414|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
42194678|NCT02784106|76006415|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
42194679|NCT02784106|76006416|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
42194680|NCT02784106|76006417|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
42194681|NCT02784106|76006414|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
42194682|NCT02784106|76006415|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
42194683|NCT02784106|76006416|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
42194684|NCT02784106|76006417|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
42194685|NCT02784106|76006414|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
42194686|NCT02784106|76006415|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
42194687|NCT02784106|76006416|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
42194688|NCT02784106|76006417|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
42194689|NCT02784106|76006414|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
42194690|NCT02784106|76006415|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
42359540|NCT01811953|76205484|FG001|Overall Study|Adverse Event|0|||
42359541|NCT01811953|76205485|FG002|Overall Study|Adverse Event|0|||
42359542|NCT01811953|76205486|FG003|Overall Study|Adverse Event|1|||
42359543|NCT01811953|76205487|FG004|Overall Study|Adverse Event|0|||
42359544|NCT01811953|76205488|FG005|Overall Study|Adverse Event|1|||
42359545|NCT01811953|76205483|FG000|Overall Study|Protocol Violation|0|||
42359546|NCT01811953|76205484|FG001|Overall Study|Protocol Violation|0|||
42359547|NCT01811953|76205485|FG002|Overall Study|Protocol Violation|0|||
42359548|NCT01811953|76205486|FG003|Overall Study|Protocol Violation|0|||
42359549|NCT01811953|76205487|FG004|Overall Study|Protocol Violation|1|||
42359550|NCT01811953|76205488|FG005|Overall Study|Protocol Violation|0|||
42359551|NCT01811563|76205504|FG000|Overall Study|Lost to Follow-up|5|||
42194691|NCT02784106|76006416|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
42194692|NCT02784106|76006417|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
42194693|NCT02784106|76006414|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
42194694|NCT02784106|76006415|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
42194695|NCT02784106|76006416|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
42194696|NCT02784106|76006417|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
42194697|NCT02784106|76006414|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
42194698|NCT02784106|76006415|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
42194699|NCT02784106|76006416|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
42194700|NCT02784106|76006417|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
42359552|NCT01811563|76205505|FG001|Overall Study|Lost to Follow-up|2|||
42359553|NCT01811563|76205504|FG000|Overall Study|Incorrect Randomization procedure|0|||
42359554|NCT01811563|76205505|FG001|Overall Study|Incorrect Randomization procedure|1|||
42359555|NCT01811485|76205514|FG000|Overall Study|Adverse Event|1|||
42359556|NCT01811485|76205515|FG001|Overall Study|Adverse Event|3|||
42359557|NCT01811485|76205516|FG002|Overall Study|Adverse Event|2|||
42359558|NCT01811485|76205514|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42359559|NCT01811485|76205515|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42359560|NCT01811485|76205516|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
42359561|NCT01811485|76205514|FG000|Overall Study|Administrative problems|1|||
42359562|NCT01811485|76205515|FG001|Overall Study|Administrative problems|0|||
42359563|NCT01811485|76205516|FG002|Overall Study|Administrative problems|0|||
42359564|NCT01811485|76205514|FG000|Overall Study|Protocol Deviation|0|||
42359565|NCT01811485|76205515|FG001|Overall Study|Protocol Deviation|1|||
42359566|NCT01811485|76205516|FG002|Overall Study|Protocol Deviation|0|||
42359567|NCT01810939|76205527|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
42359568|NCT01810939|76205528|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
42359569|NCT01810939|76205529|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
42359570|NCT01810939|76205527|FG000|Part A Treatment Period|Protocol Violation|2|||
42359571|NCT01810939|76205528|FG001|Part A Treatment Period|Protocol Violation|0|||
42099525|NCT00388297|75910087|FG003|Overall Study|Lost to Follow-up|8|||
42099526|NCT00686166|75910097|FG000|Overall Study|Adverse Event|7|||
42099527|NCT00686166|75910097|FG000|Overall Study|Withdrawal by Subject|1|||
42099528|NCT00686166|75910097|FG000|Overall Study|Progression/Relapse|1|||
42099529|NCT00686166|75910097|FG000|Overall Study|Death|1|||
42099530|NCT00686166|75910097|FG000|Overall Study|Not Protocol Specified|1|||
42099531|NCT00686166|75910097|FG000|Overall Study|Ineligible|5|||
42099532|NCT00686166|75910097|FG000|Overall Study|Did not begin protocol therapy|4|||
42099533|NCT00363649|75910108|FG000|Overall Study|Withdrawal by Subject|1|||
42194701|NCT02785900|76006428|FG000|Overall Study|Study Termination by Sponsor|64|||
42194702|NCT02785900|76006429|FG001|Overall Study|Study Termination by Sponsor|81|||
42194703|NCT02785900|76006428|FG000|Overall Study|Death|46|||
42194704|NCT02785900|76006429|FG001|Overall Study|Death|32|||
42194705|NCT02785900|76006428|FG000|Overall Study|Withdrawal by Subject|4|||
42194706|NCT02785900|76006429|FG001|Overall Study|Withdrawal by Subject|8|||
42359572|NCT01810939|76205529|FG002|Part A Treatment Period|Protocol Violation|0|||
42099534|NCT00363649|75910109|FG001|Overall Study|Withdrawal by Subject|1|||
42099535|NCT00363649|75910108|FG000|Overall Study|Adverse Event|6|||
42099536|NCT00363649|75910109|FG001|Overall Study|Adverse Event|0|||
42099537|NCT00684060|75910117|FG000|Overall Study|Lost to Follow-up|1|||
42099538|NCT00684060|75910118|FG001|Overall Study|Lost to Follow-up|0|||
42099539|NCT00684060|75910117|FG000|Overall Study|New stenosis identified|1|||
42099540|NCT00684060|75910118|FG001|Overall Study|New stenosis identified|0|||
42099541|NCT00684060|75910117|FG000|Overall Study|Unable to collect MRI|1|||
42099542|NCT00684060|75910118|FG001|Overall Study|Unable to collect MRI|2|||
42099543|NCT00684060|75910117|FG000|Overall Study|Death|0|||
42099544|NCT00684060|75910118|FG001|Overall Study|Death|1|||
42099545|NCT03131648|75910126|FG000|Initial Treatment Period|Not dosed|2|||
42099546|NCT03131648|75910127|FG001|Initial Treatment Period|Not dosed|2|||
42099547|NCT03131648|75910128|FG002|Initial Treatment Period|Not dosed|0|||
42099548|NCT03131648|75910129|FG003|Initial Treatment Period|Not dosed|0|||
42099549|NCT03131648|75910130|FG004|Initial Treatment Period|Not dosed|0|||
42359573|NCT01810939|76205527|FG000|Part A Treatment Period|Adverse Event|10|||
42099550|NCT03131648|75910131|FG005|Initial Treatment Period|Not dosed|0|||
42099551|NCT03131648|75910132|FG006|Initial Treatment Period|Not dosed|0|||
42099552|NCT03131648|75910133|FG007|Initial Treatment Period|Not dosed|0|||
42099553|NCT03131648|75910126|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
42194707|NCT02785900|76006428|FG000|Overall Study|Physician Decision|3|||
42194708|NCT02785900|76006429|FG001|Overall Study|Physician Decision|2|||
42194709|NCT00127205|76006438|FG000|Overall Study|Adverse Event|228|||
42359574|NCT01810939|76205528|FG001|Part A Treatment Period|Adverse Event|0|||
42099554|NCT03131648|75910127|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
42099555|NCT03131648|75910128|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
42359575|NCT01810939|76205529|FG002|Part A Treatment Period|Adverse Event|0|||
42359576|NCT01810939|76205527|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
42359577|NCT01810939|76205528|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
42359578|NCT01810939|76205529|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
42359579|NCT01810939|76205527|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
42359580|NCT01810939|76205528|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
42359581|NCT01810939|76205529|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
42359582|NCT01810939|76205527|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
42359583|NCT01810939|76205528|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
42359584|NCT01810939|76205529|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
42359585|NCT01810939|76205527|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
42359586|NCT01810939|76205528|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
42359587|NCT01810939|76205529|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
42359588|NCT01810939|76205527|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
42359589|NCT01810939|76205528|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
42359590|NCT01810939|76205529|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
42359591|NCT01810939|76205527|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
42359592|NCT01810939|76205528|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
42359593|NCT01810939|76205529|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
42359594|NCT01810939|76205527|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
42359595|NCT01810939|76205528|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
42359596|NCT01810939|76205529|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
42359597|NCT01810939|76205527|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
42359598|NCT01810939|76205528|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
42359599|NCT01810939|76205529|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
42359600|NCT01810939|76205527|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
42359601|NCT01810939|76205528|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
42359602|NCT01810939|76205529|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
42359603|NCT01810939|76205527|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
42359604|NCT01810939|76205528|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
42359605|NCT01810939|76205529|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
42359606|NCT01810939|76205527|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
42359607|NCT01810939|76205528|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
42359608|NCT01810939|76205529|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
42359609|NCT01810939|76205527|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
42359610|NCT01810939|76205528|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
42359611|NCT01810939|76205529|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
42359612|NCT01810939|76205527|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
42359613|NCT01810939|76205528|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
42359614|NCT01810939|76205529|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
42359615|NCT01810939|76205527|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
42359616|NCT01810939|76205528|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
42359617|NCT01810939|76205529|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
42359618|NCT01810783|76205548|FG000|Overall Study|Adverse Event|32|||
42359619|NCT01810783|76205548|FG000|Overall Study|Withdrawal by Subject|22|||
42359620|NCT01810783|76205548|FG000|Overall Study|Lack of Efficacy|12|||
42359621|NCT01810783|76205548|FG000|Overall Study|Lost to Follow-up|10|||
42359622|NCT01810783|76205548|FG000|Overall Study|Protocol Violation|5|||
42359623|NCT01810783|76205548|FG000|Overall Study|Non-compliance with IMP|4|||
42359624|NCT01810783|76205548|FG000|Overall Study|Adminstrative or other reason(s)|23|||
42359625|NCT01810783|76205548|FG000|Overall Study|Enrolled, not treated|1|||
42359626|NCT01808209|76205569|FG000|Overall Study|Lost to Follow-up|0|||
42359627|NCT01808209|76205570|FG001|Overall Study|Lost to Follow-up|1|||
42359628|NCT01807117|76205580|FG000|Overall Study|Physician Decision|2|||
42359629|NCT01807117|76205580|FG000|Overall Study|Disease diagnosis not a study disease|1|||
42359630|NCT01806961|76205586|FG000|Overall Study|sponsor decision|16|||
42359631|NCT01613131|76205592|FG000|Overall Study|Withdrawal by Subject|3|||
42359632|NCT01613131|76205593|FG001|Overall Study|Withdrawal by Subject|5|||
42359633|NCT01868893|76205599|FG000|Overall Study|Adverse Event|2|||
42359634|NCT01868893|76205599|FG000|Overall Study|Commercial availability of study drug|17|||
42359635|NCT01868893|76205599|FG000|Overall Study|Neutropenia|1|||
42359636|NCT01868503|76205605|FG000|Overall Study|Withdrawal by Subject|1|||
42359637|NCT01868503|76205605|FG000|Overall Study|Protocol Violation|1|||
42359638|NCT01868035|76205615|FG000|Overall Study|Lost to Follow-up|3|||
42359639|NCT01868035|76205615|FG000|Overall Study|Withdrawal by Subject|1|||
42359640|NCT01868035|76205615|FG000|Overall Study|Progressive Disease|2|||
42359641|NCT01868035|76205615|FG000|Overall Study|Non-compliance|1|||
42359642|NCT01609933|76205619|FG000|Overall Study|Adverse Event|1|||
42359643|NCT01609933|76205619|FG000|Overall Study|Withdrawal by Subject|3|||
42359644|NCT01843777|76205627|FG000|Overall Study|Withdrawal by Subject|1|||
42359645|NCT01843777|76205628|FG001|Overall Study|Withdrawal by Subject|0|||
42359646|NCT01842607|76205634|FG000|Overall Study|Adverse Event|11|||
42359647|NCT01842607|76205634|FG000|Overall Study|Lack of Efficacy|19|||
42359648|NCT01842607|76205634|FG000|Overall Study|Protocol Violation|8|||
42359649|NCT01842607|76205634|FG000|Overall Study|Protocol defined stopping criteria|2|||
42359650|NCT01842607|76205634|FG000|Overall Study|Lost to Follow-up|3|||
42359651|NCT01842607|76205634|FG000|Overall Study|Physician Decision|9|||
42359652|NCT01842607|76205634|FG000|Overall Study|Withdrawal by Subject|14|||
42359653|NCT01803607|76205640|FG000|Overall Study|Adverse Event|5|||
42359654|NCT01803607|76205641|FG001|Overall Study|Adverse Event|3|||
42359655|NCT01803607|76205640|FG000|Overall Study|Lack of Efficacy|0|||
42359656|NCT01803607|76205641|FG001|Overall Study|Lack of Efficacy|1|||
42359657|NCT01803607|76205640|FG000|Overall Study|Protocol Violation|3|||
42359658|NCT01803607|76205641|FG001|Overall Study|Protocol Violation|2|||
42359659|NCT01803607|76205640|FG000|Overall Study|Study terminated by sponsor|54|||
42359660|NCT01803607|76205641|FG001|Overall Study|Study terminated by sponsor|56|||
42359661|NCT01803607|76205640|FG000|Overall Study|Withdrawal by Subject|6|||
42359662|NCT01803607|76205641|FG001|Overall Study|Withdrawal by Subject|5|||
42359663|NCT01867021|76205649|FG000|Overall Study|Adverse Event|0|||
42359664|NCT01867021|76205650|FG001|Overall Study|Adverse Event|1|||
42359665|NCT01867021|76205649|FG000|Overall Study|Not Eligible|0|||
42359666|NCT01867021|76205650|FG001|Overall Study|Not Eligible|1|||
42359667|NCT01867021|76205649|FG000|Overall Study|Death|1|||
42359668|NCT01867021|76205650|FG001|Overall Study|Death|0|||
42359669|NCT01867021|76205649|FG000|Overall Study|Lost to Follow-up|0|||
42359670|NCT01867021|76205650|FG001|Overall Study|Lost to Follow-up|2|||
42359671|NCT01867021|76205649|FG000|Overall Study|Withdrawal by Subject|1|||
42359672|NCT01867021|76205650|FG001|Overall Study|Withdrawal by Subject|6|||
42359673|NCT01866709|76205663|FG000|Overall Study|Adverse Event|1|||
42359674|NCT01866709|76205664|FG001|Overall Study|Adverse Event|0|||
42359675|NCT01841593|76205672|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
42359676|NCT01841593|76205673|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
42359677|NCT01841593|76205672|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
42359678|NCT01841593|76205673|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
42359679|NCT01866319|76205926|FG000|Overall Study|Adverse Event|12|||
42359680|NCT01866319|76205927|FG001|Overall Study|Adverse Event|5|||
42359681|NCT01866319|76205928|FG002|Overall Study|Adverse Event|9|||
42359682|NCT01866319|76205926|FG000|Overall Study|Clinical progression|3|||
42359683|NCT01866319|76205927|FG001|Overall Study|Clinical progression|2|||
42359684|NCT01866319|76205928|FG002|Overall Study|Clinical progression|2|||
42359685|NCT01866319|76205926|FG000|Overall Study|Death|153|||
42359686|NCT01866319|76205927|FG001|Overall Study|Death|154|||
42359687|NCT01866319|76205928|FG002|Overall Study|Death|147|||
42359688|NCT01866319|76205926|FG000|Overall Study|Lost to Follow-up|6|||
42359689|NCT01866319|76205927|FG001|Overall Study|Lost to Follow-up|3|||
42359690|NCT01866319|76205928|FG002|Overall Study|Lost to Follow-up|8|||
42359691|NCT01866319|76205926|FG000|Overall Study|Physician Decision|1|||
42359692|NCT01866319|76205927|FG001|Overall Study|Physician Decision|0|||
42359693|NCT01866319|76205928|FG002|Overall Study|Physician Decision|1|||
42359694|NCT01866319|76205926|FG000|Overall Study|Protocol Violation|0|||
42359695|NCT01866319|76205927|FG001|Overall Study|Protocol Violation|0|||
42359696|NCT01866319|76205928|FG002|Overall Study|Protocol Violation|1|||
42359697|NCT01866319|76205926|FG000|Overall Study|Withdrawal by Subject|32|||
42359698|NCT01866319|76205927|FG001|Overall Study|Withdrawal by Subject|14|||
42359699|NCT01866319|76205928|FG002|Overall Study|Withdrawal by Subject|12|||
42359700|NCT01802515|76205955|FG000|Overall Study|Withdrawal by Subject|3|||
42359701|NCT01802515|76205956|FG001|Overall Study|Withdrawal by Subject|0|||
42359702|NCT01802515|76205957|FG002|Overall Study|Withdrawal by Subject|0|||
42359703|NCT01802437|76205967|FG000|Overall Study|Lost to Follow-up|1|||
42359704|NCT01802437|76205968|FG001|Overall Study|Lost to Follow-up|0|||
42359705|NCT01802437|76205967|FG000|Overall Study|Withdrawal by Subject|3|||
42359706|NCT01802437|76205968|FG001|Overall Study|Withdrawal by Subject|4|||
42099556|NCT03131648|75910129|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
42359707|NCT01801735|76206075|FG000|Overall Study|Adverse Event|79|||
42359708|NCT01801735|76206075|FG000|Overall Study|Lack of Efficacy|28|||
42359709|NCT01801735|76206075|FG000|Overall Study|Withdrawal by Subject|27|||
42359710|NCT01801735|76206075|FG000|Overall Study|Protocol Violation|25|||
42099557|NCT03131648|75910130|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
42359711|NCT01801735|76206075|FG000|Overall Study|Lost to Follow-up|15|||
42099558|NCT03131648|75910131|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
42194710|NCT00127205|76006439|FG001|Overall Study|Adverse Event|387|||
42359712|NCT01801735|76206075|FG000|Overall Study|Non-compliance with Trial Drug|13|||
42359713|NCT01801735|76206075|FG000|Overall Study|Physician Decision|3|||
42359714|NCT01801735|76206075|FG000|Overall Study|Death|1|||
42359715|NCT01801735|76206075|FG000|Overall Study|Other, including site closure|19|||
42359716|NCT01840579|76206833|FG000|Overall Study|Status not recorded|0|||
42359717|NCT01840579|76206834|FG001|Overall Study|Status not recorded|0|||
42099559|NCT03131648|75910132|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
42099560|NCT03131648|75910133|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
42099561|NCT03131648|75910126|FG000|Open-label Treatment|Discontinued IMP|0|||
42194711|NCT00127205|76006440|FG002|Overall Study|Adverse Event|273|||
42194712|NCT00127205|76006438|FG000|Overall Study|Death|8|||
42194713|NCT00127205|76006439|FG001|Overall Study|Death|6|||
42194714|NCT00127205|76006440|FG002|Overall Study|Death|5|||
42194715|NCT00127205|76006438|FG000|Overall Study|Withdrawal by Subject|318|||
42194716|NCT00127205|76006439|FG001|Overall Study|Withdrawal by Subject|310|||
42194717|NCT00127205|76006440|FG002|Overall Study|Withdrawal by Subject|172|||
42194718|NCT00127205|76006438|FG000|Overall Study|Other-non protocol specified|142|||
42194719|NCT00127205|76006439|FG001|Overall Study|Other-non protocol specified|129|||
42194720|NCT00127205|76006440|FG002|Overall Study|Other-non protocol specified|77|||
42194721|NCT00127205|76006438|FG000|Overall Study|Data not reported|6|||
42194722|NCT00127205|76006439|FG001|Overall Study|Data not reported|10|||
42194723|NCT00127205|76006440|FG002|Overall Study|Data not reported|1|||
42194724|NCT00127205|76006438|FG000|Overall Study|Progression|127|||
42194725|NCT00127205|76006439|FG001|Overall Study|Progression|131|||
42194726|NCT00127205|76006440|FG002|Overall Study|Progression|84|||
42194727|NCT02785588|76006450|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
42194728|NCT02785588|76006450|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
42194729|NCT03670641|76006454|FG000|Overall Study|Lost to Follow-up|3|||
42194730|NCT04029519|76006461|FG000|Overall Study|Protocol Violation|1|||
42194731|NCT04029519|76006461|FG000|Overall Study|Withdrawal by Subject|3|||
42194732|NCT04029519|76006461|FG000|Overall Study|Lost to Follow-up|1|||
42194733|NCT03669861|76006465|FG000|Overall Study|Disease Flare|5|||
42194734|NCT03669861|76006465|FG000|Overall Study|Lack of Efficacy|2|||
42194735|NCT00127127|76006473|FG000|Overall Study|Adverse Event|0|||
42194736|NCT00127127|76006474|FG001|Overall Study|Adverse Event|2|||
42194737|NCT00127127|76006475|FG002|Overall Study|Adverse Event|0|||
42194738|NCT00127127|76006476|FG003|Overall Study|Adverse Event|1|||
42194739|NCT00127127|76006473|FG000|Overall Study|Lack of Efficacy|1|||
42194740|NCT00127127|76006474|FG001|Overall Study|Lack of Efficacy|3|||
42194741|NCT00127127|76006475|FG002|Overall Study|Lack of Efficacy|0|||
42194742|NCT00127127|76006476|FG003|Overall Study|Lack of Efficacy|2|||
42194743|NCT03669549|76006513|FG000|Overall Study|Adverse Event|4|||
42194744|NCT03669549|76006513|FG000|Overall Study|Withdrawal by Subject|1|||
42194745|NCT03669549|76006513|FG000|Overall Study|Study terminated by the Sponsor|1|||
42194746|NCT00126659|76006524|FG000|Overall Study|Adverse Event|0|||
42194747|NCT00126659|76006525|FG001|Overall Study|Adverse Event|0|||
42194748|NCT00126659|76006526|FG002|Overall Study|Adverse Event|2|||
42194749|NCT03669081|76006534|FG000|Overall Study|Data could not be validated|1|||
42194750|NCT03669081|76006535|FG001|Overall Study|Data could not be validated|1|||
42359718|NCT01840579|76206835|FG002|Overall Study|Status not recorded|2|||
42099562|NCT03131648|75910127|FG001|Open-label Treatment|Discontinued IMP|0|||
42194751|NCT03667053|76006544|FG000|Overall Study|Withdrawal by Subject|1|||
42194752|NCT03667053|76006545|FG001|Overall Study|Withdrawal by Subject|0|||
42194753|NCT03667053|76006546|FG002|Overall Study|Withdrawal by Subject|0|||
42194754|NCT03631407|76006563|FG000|Overall Study|Withdrawal by Subject|3|||
42194755|NCT03631407|76006564|FG001|Overall Study|Withdrawal by Subject|2|||
42194756|NCT03631407|76006563|FG000|Overall Study|Sponsor Decision|0|||
42194757|NCT03631407|76006564|FG001|Overall Study|Sponsor Decision|2|||
42194758|NCT03631407|76006563|FG000|Overall Study|Death|16|||
42194759|NCT03631407|76006564|FG001|Overall Study|Death|16|||
42099563|NCT03131648|75910128|FG002|Open-label Treatment|Discontinued IMP|0|||
42099564|NCT03131648|75910129|FG003|Open-label Treatment|Discontinued IMP|0|||
42099565|NCT03131648|75910130|FG004|Open-label Treatment|Discontinued IMP|0|||
42099566|NCT03131648|75910131|FG005|Open-label Treatment|Discontinued IMP|0|||
42194760|NCT03631407|76006563|FG000|Overall Study|Randomized by mistake without study treatment|1|||
42194761|NCT03631407|76006564|FG001|Overall Study|Randomized by mistake without study treatment|0|||
42194762|NCT03630393|76006581|FG000|Overall Study|Death|1|||
42194763|NCT03630393|76006582|FG001|Overall Study|Death|0|||
42194764|NCT03628599|76006599|FG000|Overall Study|Adverse Event|0|||
42194765|NCT03628599|76006600|FG001|Overall Study|Adverse Event|1|||
42194766|NCT03627195|76006626|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
42194767|NCT03627195|76006627|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
42099567|NCT03131648|75910132|FG006|Open-label Treatment|Discontinued IMP|112|||
42099568|NCT03131648|75910133|FG007|Open-label Treatment|Discontinued IMP|0|||
42194768|NCT03627195|76006628|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
42194769|NCT03627195|76006629|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
42194770|NCT03627195|76006630|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
42194771|NCT03627195|76006631|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
42194772|NCT00126581|76006647|FG000|Overall Study|Adverse Event|3|||
42194773|NCT00126581|76006648|FG001|Overall Study|Adverse Event|7|||
42194774|NCT00126581|76006647|FG000|Overall Study|Death|3|||
42194775|NCT00126581|76006648|FG001|Overall Study|Death|2|||
42099569|NCT03131648|75910126|FG000|Open-label Treatment|Completed Week 50|0|||
42359719|NCT01840579|76206836|FG003|Overall Study|Status not recorded|3|||
42359720|NCT01840579|76206837|FG004|Overall Study|Status not recorded|4|||
42359721|NCT01840579|76206838|FG005|Overall Study|Status not recorded|3|||
42359722|NCT01840579|76206839|FG006|Overall Study|Status not recorded|0|||
42359723|NCT01840579|76206840|FG007|Overall Study|Status not recorded|3|||
42359724|NCT01840579|76206841|FG008|Overall Study|Status not recorded|3|||
42359725|NCT01840579|76206842|FG009|Overall Study|Status not recorded|3|||
42359726|NCT01840579|76206833|FG000|Overall Study|Progressive disease|3|||
42359727|NCT01840579|76206834|FG001|Overall Study|Progressive disease|5|||
42359728|NCT01840579|76206835|FG002|Overall Study|Progressive disease|0|||
42194776|NCT00126581|76006647|FG000|Overall Study|Withdrawal by Subject|1|||
42194777|NCT00126581|76006648|FG001|Overall Study|Withdrawal by Subject|4|||
42194778|NCT00126581|76006647|FG000|Overall Study|Alternative therapy|3|||
42194779|NCT00126581|76006648|FG001|Overall Study|Alternative therapy|3|||
42194780|NCT00126581|76006647|FG000|Overall Study|Other illness/MD discretion|3|||
42194781|NCT00126581|76006648|FG001|Overall Study|Other illness/MD discretion|4|||
42194782|NCT03704584|76006658|FG000|Overall Study|Withdrawal by Subject|1|||
42194783|NCT03704584|76006659|FG001|Overall Study|Withdrawal by Subject|0|||
42194784|NCT03662997|76006669|FG000|Overall Study|Adverse Event|0|||
42194785|NCT03662997|76006670|FG001|Overall Study|Adverse Event|2|||
42194786|NCT03662997|76006671|FG002|Overall Study|Adverse Event|0|||
42194787|NCT03662997|76006672|FG003|Overall Study|Adverse Event|0|||
42194788|NCT03648879|76006684|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
42194789|NCT03647709|76006688|FG000|Overall Study|Lost to Follow-up|5|||
42194790|NCT03647709|76006688|FG000|Overall Study|Physician Decision|6|||
42194791|NCT03647709|76006688|FG000|Overall Study|Withdrawal by Subject|3|||
42194792|NCT03661983|76006694|FG000|Open Label Stabilization Phase|Adverse Event|5|||
42194793|NCT03661983|76006695|FG001|Open Label Stabilization Phase|Adverse Event|0|||
42194794|NCT03661983|76006696|FG002|Open Label Stabilization Phase|Adverse Event|0|||
42194795|NCT03661983|76006697|FG003|Open Label Stabilization Phase|Adverse Event|0|||
42194796|NCT03661983|76006694|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
42194797|NCT03661983|76006695|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
42194798|NCT03661983|76006696|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
42194799|NCT03661983|76006697|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
42194800|NCT03661983|76006694|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
42194801|NCT03661983|76006695|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
42194802|NCT03661983|76006696|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
42194803|NCT03661983|76006697|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
42194804|NCT03661983|76006694|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
42194805|NCT03661983|76006695|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
42194806|NCT03661983|76006696|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
42194807|NCT03661983|76006697|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
42194808|NCT03661983|76006694|FG000|Double-blind Randomized Phase|Adverse Event|0|||
42194809|NCT03661983|76006695|FG001|Double-blind Randomized Phase|Adverse Event|1|||
42194810|NCT03661983|76006696|FG002|Double-blind Randomized Phase|Adverse Event|0|||
42194811|NCT03661983|76006697|FG003|Double-blind Randomized Phase|Adverse Event|0|||
42194812|NCT03661983|76006694|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
42194813|NCT03661983|76006695|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
42194814|NCT03661983|76006696|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
42194815|NCT03661983|76006697|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
42194816|NCT03661983|76006694|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
42194817|NCT03661983|76006695|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
42194818|NCT03661983|76006696|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
42194819|NCT03661983|76006697|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
42359729|NCT01840579|76206836|FG003|Overall Study|Progressive disease|0|||
42359730|NCT01840579|76206837|FG004|Overall Study|Progressive disease|0|||
42099570|NCT03131648|75910127|FG001|Open-label Treatment|Completed Week 50|0|||
42099571|NCT03131648|75910128|FG002|Open-label Treatment|Completed Week 50|0|||
42099572|NCT03131648|75910129|FG003|Open-label Treatment|Completed Week 50|0|||
42099573|NCT03131648|75910130|FG004|Open-label Treatment|Completed Week 50|0|||
42099574|NCT03131648|75910131|FG005|Open-label Treatment|Completed Week 50|0|||
42099575|NCT03131648|75910132|FG006|Open-label Treatment|Completed Week 50|6|||
42099576|NCT03131648|75910133|FG007|Open-label Treatment|Completed Week 50|0|||
42099577|NCT03131648|75910126|FG000|Maintenance Treatment Period|Not dosed|0|||
42194820|NCT03661983|76006694|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
42359731|NCT01840579|76206838|FG005|Overall Study|Progressive disease|0|||
42359732|NCT01840579|76206839|FG006|Overall Study|Progressive disease|0|||
42359733|NCT01840579|76206840|FG007|Overall Study|Progressive disease|0|||
42359734|NCT01840579|76206841|FG008|Overall Study|Progressive disease|0|||
42359735|NCT01840579|76206842|FG009|Overall Study|Progressive disease|0|||
42359736|NCT01840579|76206833|FG000|Overall Study|Ongoing in study|0|||
42099578|NCT03131648|75910127|FG001|Maintenance Treatment Period|Not dosed|0|||
42194821|NCT03661983|76006695|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
42194822|NCT03661983|76006696|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
42194823|NCT03661983|76006697|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
42194824|NCT02783170|76006708|FG000|Overall Study|Randomized but not Vaccinated|1|||
42194825|NCT02783170|76006709|FG001|Overall Study|Randomized but not Vaccinated|0|||
42194826|NCT03646305|76006720|FG000|Overall Study|Lost to Follow-up|4|||
42194827|NCT03646305|76006721|FG001|Overall Study|Lost to Follow-up|2|||
42194828|NCT03646305|76006722|FG002|Overall Study|Lost to Follow-up|2|||
42194829|NCT03646305|76006723|FG003|Overall Study|Lost to Follow-up|1|||
42194830|NCT03646305|76006720|FG000|Overall Study|Withdrawal by Subject|1|||
42194831|NCT03646305|76006721|FG001|Overall Study|Withdrawal by Subject|0|||
42194832|NCT03646305|76006722|FG002|Overall Study|Withdrawal by Subject|0|||
42194833|NCT03646305|76006723|FG003|Overall Study|Withdrawal by Subject|1|||
42194834|NCT02782780|76006739|FG000|Overall Study|dropped out after randomization.|7|||
42194835|NCT02782780|76006740|FG001|Overall Study|dropped out after randomization.|5|||
42194836|NCT02782780|76006739|FG000|Overall Study|Protocol Violation|0|||
42194837|NCT02782780|76006740|FG001|Overall Study|Protocol Violation|2|||
42194838|NCT00126503|76006752|FG000|Overall Study|disease progression|23|||
42194839|NCT00126503|76006753|FG001|Overall Study|disease progression|14|||
42194840|NCT00126503|76006752|FG000|Overall Study|Withdrawal by Subject|0|||
42194841|NCT00126503|76006753|FG001|Overall Study|Withdrawal by Subject|1|||
42194842|NCT00126503|76006752|FG000|Overall Study|alternative therapy|1|||
42194843|NCT00126503|76006753|FG001|Overall Study|alternative therapy|1|||
42194844|NCT00126503|76006752|FG000|Overall Study|other complicating disease|4|||
42194845|NCT00126503|76006753|FG001|Overall Study|other complicating disease|1|||
42194846|NCT00126503|76006752|FG000|Overall Study|Death|3|||
42194847|NCT00126503|76006753|FG001|Overall Study|Death|0|||
42194848|NCT00126503|76006752|FG000|Overall Study|Adverse Event|13|||
42194849|NCT00126503|76006753|FG001|Overall Study|Adverse Event|3|||
42194850|NCT00126503|76006752|FG000|Overall Study|non-compliant|1|||
42194851|NCT00126503|76006753|FG001|Overall Study|non-compliant|0|||
42194852|NCT00126503|76006752|FG000|Overall Study|Physician Decision|2|||
42194853|NCT00126503|76006753|FG001|Overall Study|Physician Decision|1|||
42194854|NCT00126425|76006765|FG000|Overall Study|Withdrawal by Subject|17|||
42194855|NCT00126425|76006766|FG001|Overall Study|Withdrawal by Subject|1|||
42194856|NCT00126425|76006765|FG000|Overall Study|Lost to Follow-up|8|||
42194857|NCT00126425|76006766|FG001|Overall Study|Lost to Follow-up|4|||
42194858|NCT00126425|76006765|FG000|Overall Study|Protocol Violation|9|||
42194859|NCT00126425|76006766|FG001|Overall Study|Protocol Violation|6|||
42194860|NCT00126425|76006765|FG000|Overall Study|Adverse Event|1|||
42194861|NCT00126425|76006766|FG001|Overall Study|Adverse Event|0|||
42194862|NCT00126425|76006765|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
42194863|NCT00126425|76006766|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
42194864|NCT00126425|76006765|FG000|Overall Study|Other|5|||
42194865|NCT00126425|76006766|FG001|Overall Study|Other|0|||
42194866|NCT00126191|76006774|FG000|Overall Study|Physician Decision|0|||
42194867|NCT00126191|76006775|FG001|Overall Study|Physician Decision|1|||
42194868|NCT00126191|76006774|FG000|Overall Study|Death|0|||
42194869|NCT00126191|76006775|FG001|Overall Study|Death|1|||
42194870|NCT00124943|76006785|FG000|Phase II|Adverse Event|0|||
42194871|NCT00124943|76006786|FG001|Phase II|Adverse Event|2|||
42194872|NCT00124943|76006787|FG002|Phase II|Adverse Event|0|||
42194873|NCT00124943|76006788|FG003|Phase II|Adverse Event|1|||
42194874|NCT00124943|76006785|FG000|Phase II|Protocol Violation|0|||
42194875|NCT00124943|76006786|FG001|Phase II|Protocol Violation|0|||
42194876|NCT00124943|76006787|FG002|Phase II|Protocol Violation|0|||
42194877|NCT00124943|76006788|FG003|Phase II|Protocol Violation|1|||
42359737|NCT01840579|76206834|FG001|Overall Study|Ongoing in study|1|||
42099579|NCT03131648|75910128|FG002|Maintenance Treatment Period|Not dosed|3|||
42099580|NCT03131648|75910129|FG003|Maintenance Treatment Period|Not dosed|2|||
42099581|NCT03131648|75910130|FG004|Maintenance Treatment Period|Not dosed|1|||
42099582|NCT03131648|75910131|FG005|Maintenance Treatment Period|Not dosed|0|||
42099583|NCT03131648|75910132|FG006|Maintenance Treatment Period|Not dosed|0|||
42099584|NCT03131648|75910133|FG007|Maintenance Treatment Period|Not dosed|0|||
42099585|NCT03131648|75910126|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
42099586|NCT03131648|75910127|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
42359738|NCT01840579|76206835|FG002|Overall Study|Ongoing in study|0|||
42099587|NCT03131648|75910128|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
42194878|NCT00124943|76006785|FG000|Phase II|Lost to Follow-up|0|||
42194879|NCT00124943|76006786|FG001|Phase II|Lost to Follow-up|0|||
42194880|NCT00124943|76006787|FG002|Phase II|Lost to Follow-up|0|||
42194881|NCT00124943|76006788|FG003|Phase II|Lost to Follow-up|1|||
42194882|NCT00124943|76006785|FG000|Phase II|Withdrawal by Subject|0|||
42194883|NCT00124943|76006786|FG001|Phase II|Withdrawal by Subject|0|||
42194884|NCT00124943|76006787|FG002|Phase II|Withdrawal by Subject|0|||
42359739|NCT01840579|76206836|FG003|Overall Study|Ongoing in study|0|||
42099588|NCT03131648|75910129|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
42194885|NCT00124943|76006788|FG003|Phase II|Withdrawal by Subject|2|||
42194886|NCT00124709|76006800|FG000|Overall Study|Randomized but did not take medication|3|||
42194887|NCT00124709|76006801|FG001|Overall Study|Randomized but did not take medication|1|||
42194888|NCT00124709|76006800|FG000|Overall Study|Adverse Event|3|||
42194889|NCT00124709|76006801|FG001|Overall Study|Adverse Event|0|||
42194890|NCT00124709|76006800|FG000|Overall Study|Lack of Efficacy|5|||
42194891|NCT00124709|76006801|FG001|Overall Study|Lack of Efficacy|10|||
42194892|NCT00124709|76006800|FG000|Overall Study|Protocol Violation|3|||
42194893|NCT00124709|76006801|FG001|Overall Study|Protocol Violation|5|||
42194894|NCT00124709|76006800|FG000|Overall Study|Withdrawal by Subject|127|||
42194895|NCT00124709|76006801|FG001|Overall Study|Withdrawal by Subject|136|||
42194896|NCT00124709|76006800|FG000|Overall Study|Lost to Follow-up|114|||
42194897|NCT00124709|76006801|FG001|Overall Study|Lost to Follow-up|120|||
42298507|NCT02565511|76133633|FG003|Overall Study|Protocol deviation|0|||
42298508|NCT02561455|76133647|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
42298509|NCT02561455|76133648|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
42298510|NCT02561455|76133649|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
42298511|NCT02561455|76133650|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
42298512|NCT02561455|76133647|FG000|Overall Study|Withdrawal by Subject|1|||
42298513|NCT02561455|76133648|FG001|Overall Study|Withdrawal by Subject|0|||
42298514|NCT02561455|76133649|FG002|Overall Study|Withdrawal by Subject|1|||
42298515|NCT02561455|76133650|FG003|Overall Study|Withdrawal by Subject|0|||
42298516|NCT02561455|76133647|FG000|Overall Study|Disease Progression|0|||
42298517|NCT02561455|76133648|FG001|Overall Study|Disease Progression|1|||
42298518|NCT02561455|76133649|FG002|Overall Study|Disease Progression|0|||
42298519|NCT02561455|76133650|FG003|Overall Study|Disease Progression|0|||
42298520|NCT02561299|76133662|FG000|Overall Study|Death|2|||
42298521|NCT02561299|76133663|FG001|Overall Study|Death|4|||
42298522|NCT02561299|76133662|FG000|Overall Study|Lost to Follow-up|1|||
42298523|NCT02561299|76133663|FG001|Overall Study|Lost to Follow-up|0|||
42298524|NCT02561299|76133662|FG000|Overall Study|Withdrawal by Subject|2|||
42298525|NCT02561299|76133663|FG001|Overall Study|Withdrawal by Subject|2|||
42298526|NCT02566759|76133686|FG000|All Parts|Withdrawal by Subject|0|||
42298527|NCT02566759|76133687|FG001|All Parts|Withdrawal by Subject|1|||
42298528|NCT02566759|76133688|FG002|All Parts|Withdrawal by Subject|0|||
42298529|NCT02566759|76133689|FG003|All Parts|Withdrawal by Subject|0|||
42298530|NCT02566759|76133690|FG004|All Parts|Withdrawal by Subject|0|||
42298531|NCT02566759|76133691|FG005|All Parts|Withdrawal by Subject|0|||
42298532|NCT02566759|76133692|FG006|All Parts|Withdrawal by Subject|0|||
42298533|NCT02566759|76133693|FG007|All Parts|Withdrawal by Subject|0|||
42298534|NCT02566759|76133694|FG008|All Parts|Withdrawal by Subject|0|||
42298535|NCT02566759|76133695|FG009|All Parts|Withdrawal by Subject|0|||
42298536|NCT02566759|76133696|FG010|All Parts|Withdrawal by Subject|0|||
42298537|NCT02566759|76133697|FG011|All Parts|Withdrawal by Subject|0|||
42298538|NCT02566759|76133698|FG012|All Parts|Withdrawal by Subject|0|||
42298539|NCT02566759|76133699|FG013|All Parts|Withdrawal by Subject|0|||
42298540|NCT02566759|76133700|FG014|All Parts|Withdrawal by Subject|0|||
42298541|NCT02566759|76133701|FG015|All Parts|Withdrawal by Subject|0|||
42298542|NCT02566759|76133702|FG016|All Parts|Withdrawal by Subject|0|||
42298543|NCT02566759|76133686|FG000|All Parts|Adverse Event|0|||
42298544|NCT02566759|76133687|FG001|All Parts|Adverse Event|0|||
42298545|NCT02566759|76133688|FG002|All Parts|Adverse Event|0|||
42298546|NCT02566759|76133689|FG003|All Parts|Adverse Event|0|||
42298547|NCT02566759|76133690|FG004|All Parts|Adverse Event|0|||
42298548|NCT02566759|76133691|FG005|All Parts|Adverse Event|0|||
42298549|NCT02566759|76133692|FG006|All Parts|Adverse Event|0|||
42298550|NCT02566759|76133693|FG007|All Parts|Adverse Event|0|||
42298551|NCT02566759|76133694|FG008|All Parts|Adverse Event|0|||
42298552|NCT02566759|76133695|FG009|All Parts|Adverse Event|0|||
42298553|NCT02566759|76133696|FG010|All Parts|Adverse Event|0|||
42298554|NCT02566759|76133697|FG011|All Parts|Adverse Event|0|||
42298555|NCT02566759|76133698|FG012|All Parts|Adverse Event|1|||
42298556|NCT02566759|76133699|FG013|All Parts|Adverse Event|3|||
42359740|NCT01840579|76206837|FG004|Overall Study|Ongoing in study|0|||
42359741|NCT01840579|76206838|FG005|Overall Study|Ongoing in study|0|||
42298557|NCT02566759|76133700|FG014|All Parts|Adverse Event|0|||
42298558|NCT02566759|76133701|FG015|All Parts|Adverse Event|0|||
42298559|NCT02566759|76133702|FG016|All Parts|Adverse Event|0|||
42359742|NCT01840579|76206839|FG006|Overall Study|Ongoing in study|0|||
42298560|NCT02566759|76133686|FG000|All Parts|Other|0|||
42298561|NCT02566759|76133687|FG001|All Parts|Other|0|||
42298562|NCT02566759|76133688|FG002|All Parts|Other|0|||
42298563|NCT02566759|76133689|FG003|All Parts|Other|0|||
42298564|NCT02566759|76133690|FG004|All Parts|Other|0|||
42298565|NCT02566759|76133691|FG005|All Parts|Other|0|||
42298566|NCT02566759|76133692|FG006|All Parts|Other|0|||
42298567|NCT02566759|76133693|FG007|All Parts|Other|0|||
42298568|NCT02566759|76133694|FG008|All Parts|Other|0|||
42298569|NCT02566759|76133695|FG009|All Parts|Other|0|||
42298570|NCT02566759|76133696|FG010|All Parts|Other|0|||
42298571|NCT02566759|76133697|FG011|All Parts|Other|0|||
42298572|NCT02566759|76133698|FG012|All Parts|Other|0|||
42359743|NCT01840579|76206840|FG007|Overall Study|Ongoing in study|0|||
42194898|NCT00108862|76006809|FG000|Overall Study|Death|31|||
42194899|NCT00108862|76006810|FG001|Overall Study|Death|37|||
42194900|NCT00108862|76006809|FG000|Overall Study|Withdrawal by Subject|10|||
42194901|NCT00108862|76006810|FG001|Overall Study|Withdrawal by Subject|6|||
42194902|NCT00108862|76006809|FG000|Overall Study|Lost to Follow-up|27|||
42194903|NCT00108862|76006810|FG001|Overall Study|Lost to Follow-up|19|||
42194904|NCT00564850|76006816|FG000|Overall Study|Protocol Violation|2|||
42194905|NCT00108628|76006822|FG000|Overall Study|Withdrawal by Subject|17|||
42194906|NCT00108628|76006823|FG001|Overall Study|Withdrawal by Subject|9|||
42194907|NCT00108628|76006822|FG000|Overall Study|Lack of Efficacy|2|||
42194908|NCT00108628|76006823|FG001|Overall Study|Lack of Efficacy|1|||
42194909|NCT00108628|76006822|FG000|Overall Study|Death|1|||
42194910|NCT00108628|76006823|FG001|Overall Study|Death|0|||
42194911|NCT02715856|76006831|FG000|Overall Study|Software Issues|12|||
42194912|NCT02715856|76006832|FG001|Overall Study|Software Issues|7|||
42194913|NCT02715856|76006831|FG000|Overall Study|Death|6|||
42194914|NCT02715856|76006832|FG001|Overall Study|Death|5|||
42194915|NCT02715856|76006831|FG000|Overall Study|Non- Compliant|0|||
42194916|NCT02715856|76006832|FG001|Overall Study|Non- Compliant|40|||
42194917|NCT00108160|76006840|FG000|Overall Study|Lost to Follow-up|25|||
42194918|NCT00108160|76006841|FG001|Overall Study|Lost to Follow-up|12|||
42194919|NCT00108160|76006840|FG000|Overall Study|Death|1|||
42194920|NCT00108160|76006841|FG001|Overall Study|Death|2|||
42194921|NCT00108160|76006840|FG000|Overall Study|Withdrawal by Subject|4|||
42194922|NCT00108160|76006841|FG001|Overall Study|Withdrawal by Subject|2|||
42194923|NCT00108160|76006840|FG000|Overall Study|Protocol Violation|9|||
42194924|NCT00108160|76006841|FG001|Overall Study|Protocol Violation|5|||
42194925|NCT01366846|76006853|FG000|Overall Study|Withdrawal by Subject|2|||
42194926|NCT01366846|76006854|FG001|Overall Study|Withdrawal by Subject|0|||
42194927|NCT01366846|76006855|FG002|Overall Study|Withdrawal by Subject|0|||
42194928|NCT01366846|76006856|FG003|Overall Study|Withdrawal by Subject|0|||
42194929|NCT01366846|76006853|FG000|Overall Study|Communication Difficulties|1|||
42194930|NCT01366846|76006854|FG001|Overall Study|Communication Difficulties|4|||
42194931|NCT01366846|76006855|FG002|Overall Study|Communication Difficulties|0|||
42194932|NCT01366846|76006856|FG003|Overall Study|Communication Difficulties|1|||
42194933|NCT01366846|76006853|FG000|Overall Study|Scheduling Conflicts|0|||
42194934|NCT01366846|76006854|FG001|Overall Study|Scheduling Conflicts|0|||
42194935|NCT01366846|76006855|FG002|Overall Study|Scheduling Conflicts|1|||
42194936|NCT01366846|76006856|FG003|Overall Study|Scheduling Conflicts|0|||
42194937|NCT00108082|76006872|FG000|Overall Study|Adverse Event|14|||
42194938|NCT00108082|76006873|FG001|Overall Study|Adverse Event|12|||
42194939|NCT00108082|76006874|FG002|Overall Study|Adverse Event|17|||
42194940|NCT00108082|76006872|FG000|Overall Study|Lost to Follow-up|6|||
42194941|NCT00108082|76006873|FG001|Overall Study|Lost to Follow-up|3|||
42194942|NCT00108082|76006874|FG002|Overall Study|Lost to Follow-up|7|||
42194943|NCT00108082|76006872|FG000|Overall Study|Consent Withdrawn|3|||
42194944|NCT00108082|76006873|FG001|Overall Study|Consent Withdrawn|3|||
42194945|NCT00108082|76006874|FG002|Overall Study|Consent Withdrawn|5|||
42194946|NCT00108082|76006872|FG000|Overall Study|Protocol Violation|1|||
42194947|NCT00108082|76006873|FG001|Overall Study|Protocol Violation|2|||
42194948|NCT00108082|76006874|FG002|Overall Study|Protocol Violation|0|||
42194949|NCT00108082|76006872|FG000|Overall Study|Lack of Efficacy|3|||
42194950|NCT00108082|76006873|FG001|Overall Study|Lack of Efficacy|1|||
42194951|NCT00108082|76006874|FG002|Overall Study|Lack of Efficacy|2|||
42194952|NCT00108082|76006872|FG000|Overall Study|Amendment 4: > Month 12|5|||
42194953|NCT00108082|76006873|FG001|Overall Study|Amendment 4: > Month 12|7|||
42194954|NCT00108082|76006874|FG002|Overall Study|Amendment 4: > Month 12|5|||
42194955|NCT00108082|76006872|FG000|Overall Study|Woman of Child-bearing Potential|2|||
42194956|NCT00108082|76006873|FG001|Overall Study|Woman of Child-bearing Potential|0|||
42194957|NCT00108082|76006874|FG002|Overall Study|Woman of Child-bearing Potential|2|||
42194958|NCT00108082|76006872|FG000|Overall Study|Incorrectly Randomized|0|||
42194959|NCT00108082|76006873|FG001|Overall Study|Incorrectly Randomized|0|||
42194960|NCT00108082|76006874|FG002|Overall Study|Incorrectly Randomized|2|||
42194961|NCT00108082|76006872|FG000|Overall Study|Non-compliance|1|||
42194962|NCT00108082|76006873|FG001|Overall Study|Non-compliance|0|||
42194963|NCT00108082|76006874|FG002|Overall Study|Non-compliance|2|||
42194964|NCT00108082|76006872|FG000|Overall Study|Stopped Study Medication|0|||
42194965|NCT00108082|76006873|FG001|Overall Study|Stopped Study Medication|0|||
42194966|NCT00108082|76006874|FG002|Overall Study|Stopped Study Medication|1|||
42194967|NCT00108082|76006872|FG000|Overall Study|Site Closed Study|0|||
42194968|NCT00108082|76006873|FG001|Overall Study|Site Closed Study|2|||
42194969|NCT00108082|76006874|FG002|Overall Study|Site Closed Study|0|||
42194970|NCT00108082|76006872|FG000|Overall Study|Protocol Amendment|0|||
42194971|NCT00108082|76006873|FG001|Overall Study|Protocol Amendment|1|||
42194972|NCT00108082|76006874|FG002|Overall Study|Protocol Amendment|0|||
42194973|NCT00108082|76006872|FG000|Overall Study|Study Medication Not Tapered|0|||
42194974|NCT00108082|76006873|FG001|Overall Study|Study Medication Not Tapered|1|||
42194975|NCT00108082|76006874|FG002|Overall Study|Study Medication Not Tapered|0|||
42194976|NCT00108082|76006872|FG000|Overall Study|Subject Left Site Location|1|||
42194977|NCT00108082|76006873|FG001|Overall Study|Subject Left Site Location|0|||
42194978|NCT00108082|76006874|FG002|Overall Study|Subject Left Site Location|0|||
42194979|NCT00108082|76006872|FG000|Overall Study|Investigator Not at Site|1|||
42194980|NCT00108082|76006873|FG001|Overall Study|Investigator Not at Site|0|||
42194981|NCT00108082|76006874|FG002|Overall Study|Investigator Not at Site|0|||
42194982|NCT00108082|76006872|FG000|Overall Study|Blood Pressure Not Controlled|1|||
42194983|NCT00108082|76006873|FG001|Overall Study|Blood Pressure Not Controlled|0|||
42194984|NCT00108082|76006874|FG002|Overall Study|Blood Pressure Not Controlled|0|||
42194985|NCT00104728|76006886|FG000|Overall Study|screen failures|19|||
42194986|NCT02781844|76006894|FG000|Treatment Period 1|Adverse Event|0|||
42194987|NCT02781844|76006895|FG001|Treatment Period 1|Adverse Event|0|||
42194988|NCT02781844|76006896|FG002|Treatment Period 1|Adverse Event|0|||
42194989|NCT02781844|76006897|FG003|Treatment Period 1|Adverse Event|0|||
42194990|NCT02781844|76006898|FG004|Treatment Period 1|Adverse Event|0|||
42194991|NCT02781844|76006899|FG005|Treatment Period 1|Adverse Event|1|||
42194992|NCT02781844|76006900|FG006|Treatment Period 1|Adverse Event|0|||
42194993|NCT02781844|76006901|FG007|Treatment Period 1|Adverse Event|0|||
42194994|NCT02775916|76006919|FG000|Overall Study|Adverse Event|1|||
42194995|NCT02775916|76006920|FG001|Overall Study|Adverse Event|0|||
42194996|NCT02775916|76006919|FG000|Overall Study|Subject/Guardian Decision|2|||
42194997|NCT02775916|76006920|FG001|Overall Study|Subject/Guardian Decision|0|||
42194998|NCT00122681|76006928|FG000|Overall Study|Adverse Event|20|||
42194999|NCT00122681|76006929|FG001|Overall Study|Adverse Event|16|||
42195000|NCT00122681|76006928|FG000|Overall Study|Lost to Follow-up|1080|||
42195001|NCT00122681|76006929|FG001|Overall Study|Lost to Follow-up|1097|||
42298573|NCT02566759|76133699|FG013|All Parts|Other|2|||
42099589|NCT03131648|75910130|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
42099590|NCT03131648|75910131|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
42099591|NCT03131648|75910132|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
42099592|NCT03131648|75910133|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
42099593|NCT03131648|75910126|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
42099594|NCT03131648|75910127|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
42099595|NCT03131648|75910128|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
42099596|NCT03131648|75910129|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
42099597|NCT03131648|75910130|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
42099598|NCT03131648|75910131|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
42099599|NCT03131648|75910132|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
42099600|NCT03131648|75910133|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
42099601|NCT03131648|75910126|FG000|Maintenance Treatment Period|Completed Week 50|0|||
42099602|NCT03131648|75910127|FG001|Maintenance Treatment Period|Completed Week 50|0|||
42099603|NCT03131648|75910128|FG002|Maintenance Treatment Period|Completed Week 50|0|||
42099604|NCT03131648|75910129|FG003|Maintenance Treatment Period|Completed Week 50|0|||
42099605|NCT03131648|75910130|FG004|Maintenance Treatment Period|Completed Week 50|1|||
42099606|NCT03131648|75910131|FG005|Maintenance Treatment Period|Completed Week 50|0|||
42099607|NCT03131648|75910132|FG006|Maintenance Treatment Period|Completed Week 50|0|||
42099608|NCT03131648|75910133|FG007|Maintenance Treatment Period|Completed Week 50|0|||
42099609|NCT03131648|75910126|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
42099610|NCT03131648|75910127|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
42099611|NCT03131648|75910128|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
42099612|NCT03131648|75910129|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
42099613|NCT03131648|75910130|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
42099614|NCT03131648|75910131|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
42099615|NCT03131648|75910132|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
42099616|NCT03131648|75910133|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
42099617|NCT00618813|75910150|FG000|Overall Study|Lack of Efficacy|1|||
42099618|NCT00618813|75910150|FG000|Overall Study|Physician Decision|2|||
42099619|NCT00618813|75910150|FG000|Overall Study|Withdrawal by Subject|1|||
42099620|NCT00685698|75910154|FG000|Overall Study|Withdrawal by Subject|1|||
42195002|NCT00122681|76006928|FG000|Overall Study|Protocol Violation|7|||
42195003|NCT00122681|76006929|FG001|Overall Study|Protocol Violation|10|||
42195004|NCT00122681|76006928|FG000|Overall Study|Withdrawal by Subject|257|||
42195005|NCT00122681|76006929|FG001|Overall Study|Withdrawal by Subject|251|||
42298574|NCT02566759|76133700|FG014|All Parts|Other|0|||
42298575|NCT02566759|76133701|FG015|All Parts|Other|0|||
42298576|NCT02566759|76133702|FG016|All Parts|Other|0|||
42298577|NCT02566759|76133686|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298578|NCT02566759|76133687|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298579|NCT02566759|76133688|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42195006|NCT00122681|76006928|FG000|Overall Study|Personal reasons|150|||
42195007|NCT00122681|76006929|FG001|Overall Study|Personal reasons|147|||
42298580|NCT02566759|76133689|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42359744|NCT01840579|76206841|FG008|Overall Study|Ongoing in study|0|||
42359745|NCT01840579|76206842|FG009|Overall Study|Ongoing in study|0|||
42359746|NCT01840579|76206833|FG000|Overall Study|Death|0|||
42359747|NCT01840579|76206834|FG001|Overall Study|Death|0|||
42359748|NCT01840579|76206835|FG002|Overall Study|Death|0|||
42359749|NCT01840579|76206836|FG003|Overall Study|Death|0|||
42359750|NCT01840579|76206837|FG004|Overall Study|Death|0|||
42359751|NCT01840579|76206838|FG005|Overall Study|Death|1|||
42359752|NCT01840579|76206839|FG006|Overall Study|Death|0|||
42359753|NCT01840579|76206840|FG007|Overall Study|Death|0|||
42359754|NCT01840579|76206841|FG008|Overall Study|Death|0|||
42359755|NCT01840579|76206842|FG009|Overall Study|Death|0|||
42359756|NCT01840579|76206833|FG000|Overall Study|Adverse Event|0|||
42359757|NCT01840579|76206834|FG001|Overall Study|Adverse Event|1|||
42359758|NCT01840579|76206835|FG002|Overall Study|Adverse Event|0|||
42359759|NCT01840579|76206836|FG003|Overall Study|Adverse Event|0|||
42359760|NCT01840579|76206837|FG004|Overall Study|Adverse Event|0|||
42359761|NCT01840579|76206838|FG005|Overall Study|Adverse Event|0|||
42359762|NCT01840579|76206839|FG006|Overall Study|Adverse Event|0|||
42359763|NCT01840579|76206840|FG007|Overall Study|Adverse Event|0|||
42359764|NCT01840579|76206841|FG008|Overall Study|Adverse Event|0|||
42359765|NCT01840579|76206842|FG009|Overall Study|Adverse Event|0|||
42359766|NCT01840579|76206833|FG000|Overall Study|Follow-up ended by Sponsor|0|||
42359767|NCT01840579|76206834|FG001|Overall Study|Follow-up ended by Sponsor|0|||
42359768|NCT01840579|76206835|FG002|Overall Study|Follow-up ended by Sponsor|0|||
42359769|NCT01840579|76206836|FG003|Overall Study|Follow-up ended by Sponsor|0|||
42359770|NCT01840579|76206837|FG004|Overall Study|Follow-up ended by Sponsor|0|||
42359771|NCT01840579|76206838|FG005|Overall Study|Follow-up ended by Sponsor|0|||
42359772|NCT01840579|76206839|FG006|Overall Study|Follow-up ended by Sponsor|2|||
42359773|NCT01840579|76206840|FG007|Overall Study|Follow-up ended by Sponsor|0|||
42359774|NCT01840579|76206841|FG008|Overall Study|Follow-up ended by Sponsor|0|||
42359775|NCT01840579|76206842|FG009|Overall Study|Follow-up ended by Sponsor|0|||
42359776|NCT01801111|76206921|FG000|Overall Study|Adverse Event|12|||
42359777|NCT01801111|76206921|FG000|Overall Study|Death|8|||
42359778|NCT01801111|76206921|FG000|Overall Study|Physician Decision|5|||
42359779|NCT01801111|76206921|FG000|Overall Study|Other|1|||
42359780|NCT01801111|76206921|FG000|Overall Study|Withdrawal by Subject|4|||
42359781|NCT01801111|76206921|FG000|Overall Study|Study Terminated by Sponsor|27|||
42359782|NCT01801111|76206921|FG000|Overall Study|Progressive Disease|81|||
42359783|NCT01773967|76206953|FG000|Overall Study|Lost to Follow-up|15|||
42359784|NCT01773967|76206954|FG001|Overall Study|Lost to Follow-up|13|||
42359785|NCT01773889|76206964|FG000|Overall Study|lack of funding|2|||
42359786|NCT01839487|76207142|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
42359787|NCT01839487|76207143|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
42359788|NCT01839487|76207144|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
42359789|NCT01839487|76207145|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
42359790|NCT01839487|76207146|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
42359791|NCT01839487|76207147|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
42359792|NCT01839487|76207142|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
42359793|NCT01839487|76207143|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
42359794|NCT01839487|76207144|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
42359795|NCT01839487|76207145|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
42359796|NCT01839487|76207146|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
42359797|NCT01839487|76207147|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
42359798|NCT01839487|76207142|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
42359799|NCT01839487|76207143|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
42359800|NCT01839487|76207144|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
42359801|NCT01839487|76207145|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
42359802|NCT01839487|76207146|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
42359803|NCT01839487|76207147|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
42359804|NCT01839487|76207142|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
42359805|NCT01839487|76207143|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
42359806|NCT01839487|76207144|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
42359807|NCT01839487|76207145|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
42359808|NCT01839487|76207146|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
42359809|NCT01839487|76207147|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
42359810|NCT01839487|76207142|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
42359811|NCT01839487|76207143|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
42359812|NCT01839487|76207144|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
42359813|NCT01839487|76207145|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
42359814|NCT01839487|76207146|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
42359815|NCT01839487|76207147|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
42359816|NCT01839487|76207142|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
42359817|NCT01839487|76207143|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
42359818|NCT01839487|76207144|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
42359819|NCT01839487|76207145|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
42359820|NCT01839487|76207146|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
42359821|NCT01839487|76207147|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
42359822|NCT01839487|76207142|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
42359823|NCT01839487|76207143|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
42359824|NCT01839487|76207144|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
42359825|NCT01839487|76207145|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
42359826|NCT01839487|76207146|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
42359827|NCT01839487|76207147|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
42359828|NCT01839487|76207142|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
42359829|NCT01839487|76207143|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
42359830|NCT01839487|76207144|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
42359831|NCT01839487|76207145|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
42359832|NCT01839487|76207146|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
42359833|NCT01839487|76207147|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
42359834|NCT01839487|76207142|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
42359835|NCT01839487|76207143|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
42359836|NCT01839487|76207144|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
42195008|NCT02774278|76006943|FG000|Overall Study|Lack of Efficacy|199|||
42195009|NCT02774278|76006943|FG000|Overall Study|Death|29|||
42195010|NCT02774278|76006943|FG000|Overall Study|Adverse event/intercurrent illness|16|||
42195011|NCT02774278|76006943|FG000|Overall Study|Refused treatment/did not cooperate|9|||
42195012|NCT02774278|76006943|FG000|Overall Study|Administrative reasons|6|||
42195013|NCT02774278|76006943|FG000|Overall Study|Withdrawal by Subject|3|||
42195014|NCT02774278|76006943|FG000|Overall Study|Protocol Violation|2|||
42195015|NCT00122135|76006949|FG000|Overall Study|Withdrawal by Subject|3|||
42195016|NCT00122135|76006950|FG001|Overall Study|Withdrawal by Subject|0|||
42195017|NCT03645057|76006960|FG000|Randomization to Baseline|Lost to Follow-up|1|||
42195018|NCT03645057|76006961|FG001|Randomization to Baseline|Lost to Follow-up|0|||
42195019|NCT03645057|76006962|FG002|Randomization to Baseline|Lost to Follow-up|1|||
42195020|NCT03645057|76006963|FG003|Randomization to Baseline|Lost to Follow-up|0|||
42099621|NCT00685698|75910154|FG000|Overall Study|Protocol Violation|6|||
42099622|NCT00685698|75910154|FG000|Overall Study|Adverse Event|3|||
42099623|NCT00685698|75910154|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
42195021|NCT03645057|76006960|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
42195022|NCT03645057|76006961|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
42195023|NCT03645057|76006962|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
42195024|NCT03645057|76006963|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
42195025|NCT03645057|76006960|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
42195026|NCT03645057|76006961|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
42195027|NCT03645057|76006962|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
42099624|NCT00685698|75910154|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
42099625|NCT00685698|75910154|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
42099626|NCT00549328|75910170|FG000|Overall Study|Adverse Event|2|||
42099627|NCT00549328|75910170|FG000|Overall Study|Disease Progression|10|||
42099628|NCT00549328|75910170|FG000|Overall Study|Death|1|||
42099629|NCT00549328|75910170|FG000|Overall Study|Use of Prohibited Medication|1|||
42099630|NCT00696410|75910176|FG000|Overall Study|Lost to Follow-up|2|||
42099631|NCT00696410|75910177|FG001|Overall Study|Lost to Follow-up|0|||
42099632|NCT00696410|75910176|FG000|Overall Study|Withdrawal by Subject|8|||
42099633|NCT00696410|75910177|FG001|Overall Study|Withdrawal by Subject|0|||
42099634|NCT00696410|75910176|FG000|Overall Study|Physician Decision|3|||
42099635|NCT00696410|75910177|FG001|Overall Study|Physician Decision|0|||
42195028|NCT03645057|76006963|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
42298581|NCT02566759|76133690|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298582|NCT02566759|76133691|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298583|NCT02566759|76133692|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298584|NCT02566759|76133693|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298585|NCT02566759|76133694|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298586|NCT02566759|76133695|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298587|NCT02566759|76133696|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298588|NCT02566759|76133697|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298589|NCT02566759|76133698|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42359837|NCT01839487|76207145|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
42099636|NCT00683904|75910190|FG000|Dose Level 1|Disease progression|2|||
42099637|NCT00683904|75910191|FG001|Dose Level 1|Disease progression|0|||
42359838|NCT01839487|76207146|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
42359839|NCT01839487|76207147|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
42359840|NCT01799941|76207174|FG000|Overall Study|Adverse Event|34|||
42359841|NCT01799941|76207174|FG000|Overall Study|Withdrawal by Subject|21|||
42359842|NCT01799941|76207174|FG000|Overall Study|Death|2|||
42359843|NCT01799941|76207174|FG000|Overall Study|Investigator Decision|4|||
42359844|NCT01799941|76207174|FG000|Overall Study|Lack of Efficacy|3|||
42359845|NCT01799941|76207174|FG000|Overall Study|Lost to Follow-up|17|||
42359846|NCT01799941|76207174|FG000|Overall Study|Other|15|||
42359847|NCT01799239|76207202|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
42359848|NCT01799239|76207203|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
42359849|NCT01799239|76207202|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
42359850|NCT01799239|76207203|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
42359851|NCT01799239|76207202|FG000|Period 1 (7 Days)|Protocol Violation|0|||
42359852|NCT01799239|76207203|FG001|Period 1 (7 Days)|Protocol Violation|1|||
42359853|NCT01799239|76207202|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
42359854|NCT01799239|76207203|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
42359855|NCT01799239|76207202|FG000|Period 2 (7 Days)|Protocol Violation|1|||
42195029|NCT03645057|76006960|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
42195030|NCT03645057|76006961|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
42195031|NCT03645057|76006962|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
42195032|NCT03645057|76006963|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
42195033|NCT00132041|76006969|FG000|Baseline|Ineligible|6|||
42195034|NCT00132041|76006969|FG000|3 Months Post Ablation|Transplant|1|||
42195035|NCT00132041|76006969|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
42195036|NCT00132041|76006969|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
42195037|NCT00132041|76006969|FG000|6 Months Post Ablation|Death|2|||
42195038|NCT00132041|76006969|FG000|6 Months Post Ablation|Transplant|6|||
42195039|NCT00132041|76006969|FG000|9 Months Post Ablation|Death|1|||
42195040|NCT00132041|76006969|FG000|9 Months Post Ablation|Transplant|1|||
42195041|NCT00132041|76006969|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
42195042|NCT00132041|76006969|FG000|12 Months Post Ablation|Death|1|||
42195043|NCT00132041|76006969|FG000|12 Months Post Ablation|Transplant|1|||
42195044|NCT00132041|76006969|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
42195045|NCT00132041|76006969|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
42195046|NCT00132041|76006969|FG000|15 Months Post Ablation|Death|1|||
42195047|NCT00132041|76006969|FG000|15 Months Post Ablation|Transplant|5|||
42195048|NCT00132041|76006969|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
42195049|NCT00132041|76006969|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
42195050|NCT00132041|76006969|FG000|18 Months Post Ablation|Transplant|1|||
42195051|NCT00132041|76006969|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
42195052|NCT00132041|76006969|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
42195053|NCT03643575|76006979|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
42195054|NCT03643575|76006980|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
42195055|NCT03643575|76006981|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
42195056|NCT03643575|76006982|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
42195057|NCT03643575|76006983|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
42195058|NCT03643575|76006984|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
42195059|NCT03643575|76006979|FG000|Washout: 7 Days|Adverse Event|1|||
42195060|NCT03643575|76006980|FG001|Washout: 7 Days|Adverse Event|0|||
42195061|NCT03643575|76006981|FG002|Washout: 7 Days|Adverse Event|0|||
42195062|NCT03643575|76006982|FG003|Washout: 7 Days|Adverse Event|0|||
42195063|NCT03643575|76006983|FG004|Washout: 7 Days|Adverse Event|0|||
42359856|NCT01799239|76207203|FG001|Period 2 (7 Days)|Protocol Violation|0|||
42099638|NCT00683904|75910190|FG000|Dose Level 1|Adverse Event|1|||
42099639|NCT00683904|75910191|FG001|Dose Level 1|Adverse Event|0|||
42099640|NCT00683904|75910190|FG000|Dose Level 2|Adverse Event|0|||
42099641|NCT00683904|75910191|FG001|Dose Level 2|Adverse Event|2|||
42099642|NCT00363415|75910205|FG000|Overall Study|Progressive Disease|196|||
42099643|NCT00363415|75910206|FG001|Overall Study|Progressive Disease|107|||
42099644|NCT00363415|75910205|FG000|Overall Study|Sponsor Decision|67|||
42099645|NCT00363415|75910206|FG001|Overall Study|Sponsor Decision|31|||
42195064|NCT03643575|76006984|FG005|Washout: 7 Days|Adverse Event|0|||
42195065|NCT03643575|76006979|FG000|Washout: 7 Days|Non compliance check in|0|||
42195066|NCT03643575|76006980|FG001|Washout: 7 Days|Non compliance check in|1|||
42195067|NCT03643575|76006981|FG002|Washout: 7 Days|Non compliance check in|0|||
42195068|NCT03643575|76006982|FG003|Washout: 7 Days|Non compliance check in|0|||
42195069|NCT03643575|76006983|FG004|Washout: 7 Days|Non compliance check in|0|||
42195070|NCT03643575|76006984|FG005|Washout: 7 Days|Non compliance check in|0|||
42195071|NCT02768194|76006992|FG000|Period 1|Adverse Event|0|||
42195072|NCT02768194|76006993|FG001|Period 1|Adverse Event|0|||
42359857|NCT02999854|76207219|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
42359858|NCT02999854|76207220|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
42359859|NCT02999854|76207219|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
42099646|NCT00363415|75910205|FG000|Overall Study|Death|32|||
42359860|NCT02999854|76207220|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
42298590|NCT02566759|76133699|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42359861|NCT02999854|76207219|FG000|Active Study Phase (up to 18 Months)|Death|7|||
42359862|NCT02999854|76207220|FG001|Active Study Phase (up to 18 Months)|Death|5|||
42359863|NCT02999854|76207219|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
42359864|NCT02999854|76207220|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
42359865|NCT02999854|76207219|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
42359866|NCT02999854|76207220|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
42359867|NCT02999854|76207219|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
42359868|NCT02999854|76207220|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
42359869|NCT02999854|76207219|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
42359870|NCT02999854|76207220|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
42359871|NCT02999854|76207219|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
42359872|NCT02999854|76207220|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
42359873|NCT04146363|76207348|FG000|Induction Period|Adverse Event|1|||
42359874|NCT04146363|76207349|FG001|Induction Period|Adverse Event|2|||
42359875|NCT04146363|76207350|FG002|Induction Period|Adverse Event|0|||
42359876|NCT04146363|76207351|FG003|Induction Period|Adverse Event|0|||
42359877|NCT04146363|76207352|FG004|Induction Period|Adverse Event|0|||
42359878|NCT04146363|76207353|FG005|Induction Period|Adverse Event|0|||
42359879|NCT04146363|76207354|FG006|Induction Period|Adverse Event|0|||
42359880|NCT04146363|76207355|FG007|Induction Period|Adverse Event|0|||
42099647|NCT00363415|75910206|FG001|Overall Study|Death|29|||
42359881|NCT04146363|76207356|FG008|Induction Period|Adverse Event|0|||
42359882|NCT04146363|76207357|FG009|Induction Period|Adverse Event|0|||
42359883|NCT04146363|76207358|FG010|Induction Period|Adverse Event|0|||
42359884|NCT04146363|76207348|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
42359885|NCT04146363|76207349|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
42359886|NCT04146363|76207350|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
42359887|NCT04146363|76207351|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
42359888|NCT04146363|76207352|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
42359889|NCT04146363|76207353|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
42359890|NCT04146363|76207354|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
42359891|NCT04146363|76207355|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
42359892|NCT04146363|76207356|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
42359893|NCT04146363|76207357|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
42359894|NCT04146363|76207358|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
42359895|NCT04146363|76207348|FG000|Induction Period|Lack of Efficacy|7|||
42359896|NCT04146363|76207349|FG001|Induction Period|Lack of Efficacy|2|||
42359897|NCT04146363|76207350|FG002|Induction Period|Lack of Efficacy|0|||
42359898|NCT04146363|76207351|FG003|Induction Period|Lack of Efficacy|0|||
42359899|NCT04146363|76207352|FG004|Induction Period|Lack of Efficacy|0|||
42359900|NCT04146363|76207353|FG005|Induction Period|Lack of Efficacy|0|||
42359901|NCT04146363|76207354|FG006|Induction Period|Lack of Efficacy|0|||
42099648|NCT00363415|75910205|FG000|Overall Study|Adverse Event|24|||
42099649|NCT00363415|75910206|FG001|Overall Study|Adverse Event|15|||
42099650|NCT00363415|75910205|FG000|Overall Study|Physician Decision|18|||
42099651|NCT00363415|75910206|FG001|Overall Study|Physician Decision|35|||
42099652|NCT00363415|75910205|FG000|Overall Study|Entry Criteria Not Met|11|||
42099653|NCT00363415|75910206|FG001|Overall Study|Entry Criteria Not Met|10|||
42099654|NCT00363415|75910205|FG000|Overall Study|Withdrawal by Subject|9|||
42099655|NCT00363415|75910206|FG001|Overall Study|Withdrawal by Subject|15|||
42099656|NCT00363415|75910205|FG000|Overall Study|Lost to Follow-up|3|||
42099657|NCT00363415|75910206|FG001|Overall Study|Lost to Follow-up|3|||
42099658|NCT00363415|75910205|FG000|Overall Study|Protocol Violation|1|||
42099659|NCT00363415|75910206|FG001|Overall Study|Protocol Violation|4|||
42099660|NCT00696020|75910216|FG000|Overall Study|Adverse Event|3|||
42195073|NCT02768194|76006994|FG002|Period 1|Adverse Event|0|||
42298591|NCT02566759|76133700|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298592|NCT02566759|76133701|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
42298593|NCT02566759|76133702|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
42298594|NCT02335983|76133767|FG000|Overall Study|Sponsor Decision|0|||
42359902|NCT04146363|76207355|FG007|Induction Period|Lack of Efficacy|0|||
42359903|NCT04146363|76207356|FG008|Induction Period|Lack of Efficacy|0|||
42359904|NCT04146363|76207357|FG009|Induction Period|Lack of Efficacy|0|||
42195074|NCT02768194|76006995|FG003|Period 1|Adverse Event|1|||
42359905|NCT04146363|76207358|FG010|Induction Period|Lack of Efficacy|0|||
42359906|NCT04146363|76207348|FG000|Induction Period|Lost to Follow-up|1|||
42099661|NCT00696020|75910217|FG001|Overall Study|Adverse Event|1|||
42298595|NCT02335983|76133768|FG001|Overall Study|Sponsor Decision|0|||
42298596|NCT02335983|76133769|FG002|Overall Study|Sponsor Decision|1|||
42298597|NCT02335983|76133770|FG003|Overall Study|Sponsor Decision|1|||
42359907|NCT04146363|76207349|FG001|Induction Period|Lost to Follow-up|4|||
42359908|NCT04146363|76207350|FG002|Induction Period|Lost to Follow-up|0|||
42359909|NCT04146363|76207351|FG003|Induction Period|Lost to Follow-up|0|||
42359910|NCT04146363|76207352|FG004|Induction Period|Lost to Follow-up|0|||
42195075|NCT02768194|76006996|FG004|Period 1|Adverse Event|0|||
42195076|NCT02768194|76006997|FG005|Period 1|Adverse Event|0|||
42195077|NCT02768194|76006992|FG000|Period 2|Other (Reason not specified)|1|||
42359911|NCT04146363|76207353|FG005|Induction Period|Lost to Follow-up|0|||
42359912|NCT04146363|76207354|FG006|Induction Period|Lost to Follow-up|0|||
42359913|NCT04146363|76207355|FG007|Induction Period|Lost to Follow-up|0|||
42359914|NCT04146363|76207356|FG008|Induction Period|Lost to Follow-up|0|||
42359915|NCT04146363|76207357|FG009|Induction Period|Lost to Follow-up|0|||
42359916|NCT04146363|76207358|FG010|Induction Period|Lost to Follow-up|0|||
42359917|NCT04146363|76207348|FG000|Induction Period|Positive quantiferon test|0|||
42359918|NCT04146363|76207349|FG001|Induction Period|Positive quantiferon test|1|||
42359919|NCT04146363|76207350|FG002|Induction Period|Positive quantiferon test|0|||
42359920|NCT04146363|76207351|FG003|Induction Period|Positive quantiferon test|0|||
42359921|NCT04146363|76207352|FG004|Induction Period|Positive quantiferon test|0|||
42359922|NCT04146363|76207353|FG005|Induction Period|Positive quantiferon test|0|||
42359923|NCT04146363|76207354|FG006|Induction Period|Positive quantiferon test|0|||
42359924|NCT04146363|76207355|FG007|Induction Period|Positive quantiferon test|0|||
42359925|NCT04146363|76207356|FG008|Induction Period|Positive quantiferon test|0|||
42359926|NCT04146363|76207357|FG009|Induction Period|Positive quantiferon test|0|||
42359927|NCT04146363|76207358|FG010|Induction Period|Positive quantiferon test|0|||
42359928|NCT04146363|76207348|FG000|Induction Period|Protocol Deviation|5|||
42359929|NCT04146363|76207349|FG001|Induction Period|Protocol Deviation|6|||
42359930|NCT04146363|76207350|FG002|Induction Period|Protocol Deviation|0|||
42195078|NCT02768194|76006993|FG001|Period 2|Other (Reason not specified)|0|||
42195079|NCT02768194|76006994|FG002|Period 2|Other (Reason not specified)|0|||
42195080|NCT02768194|76006995|FG003|Period 2|Other (Reason not specified)|0|||
42195081|NCT02768194|76006996|FG004|Period 2|Other (Reason not specified)|0|||
42195082|NCT02768194|76006997|FG005|Period 2|Other (Reason not specified)|0|||
42195083|NCT02768194|76006992|FG000|Period 3|Other (Reason not specified)|0|||
42195084|NCT02768194|76006993|FG001|Period 3|Other (Reason not specified)|1|||
42195085|NCT02768194|76006994|FG002|Period 3|Other (Reason not specified)|0|||
42195086|NCT02768194|76006995|FG003|Period 3|Other (Reason not specified)|0|||
42195087|NCT02768194|76006996|FG004|Period 3|Other (Reason not specified)|0|||
42195088|NCT02768194|76006997|FG005|Period 3|Other (Reason not specified)|0|||
42195089|NCT00130793|76007007|FG000|Overall Study|Lost to Follow-up|1|||
42099662|NCT00696020|75910218|FG002|Overall Study|Adverse Event|2|||
42099663|NCT00696020|75910219|FG003|Overall Study|Adverse Event|1|||
42195090|NCT00130793|76007008|FG001|Overall Study|Lost to Follow-up|4|||
42195091|NCT00130793|76007007|FG000|Overall Study|Withdrew consent|2|||
42195092|NCT00130793|76007008|FG001|Overall Study|Withdrew consent|0|||
42195093|NCT03818399|76007015|FG000|Overall Study|Lost to Follow-up|11|||
42195094|NCT03818399|76007015|FG000|Overall Study|Withdrawal by Subject|1|||
42195095|NCT03818399|76007015|FG000|Overall Study|Protocol Violation|2|||
42195096|NCT03642873|76007019|FG000|Third Intervention (1 Day)|Screen failure|0|||
42195097|NCT03642873|76007020|FG001|Third Intervention (1 Day)|Screen failure|0|||
42195098|NCT03642873|76007021|FG002|Third Intervention (1 Day)|Screen failure|0|||
42195099|NCT03642873|76007022|FG003|Third Intervention (1 Day)|Screen failure|0|||
42195100|NCT03642873|76007023|FG004|Third Intervention (1 Day)|Screen failure|1|||
42195101|NCT03642873|76007024|FG005|Third Intervention (1 Day)|Screen failure|0|||
42195102|NCT03818321|76007038|FG000|Overall Study|Withdrawal by Subject|1|||
42195103|NCT03818321|76007039|FG001|Overall Study|Withdrawal by Subject|2|||
42195104|NCT03616977|76007045|FG000|Period 1|Physician Decision|0|||
42195105|NCT03616977|76007046|FG001|Period 1|Physician Decision|1|||
42195106|NCT03616977|76007045|FG000|Period 3|Adverse Event|1|||
42195107|NCT03616977|76007046|FG001|Period 3|Adverse Event|1|||
42359931|NCT04146363|76207351|FG003|Induction Period|Protocol Deviation|0|||
42359932|NCT04146363|76207352|FG004|Induction Period|Protocol Deviation|0|||
42099664|NCT00696020|75910216|FG000|Overall Study|Lack of Efficacy|1|||
42099665|NCT00696020|75910217|FG001|Overall Study|Lack of Efficacy|0|||
42099666|NCT00696020|75910218|FG002|Overall Study|Lack of Efficacy|0|||
42099667|NCT00696020|75910219|FG003|Overall Study|Lack of Efficacy|0|||
42099668|NCT00696020|75910216|FG000|Overall Study|Protocol Violation|0|||
42099669|NCT00696020|75910217|FG001|Overall Study|Protocol Violation|0|||
42195108|NCT02767570|76007055|FG000|Overall Study|Lost to Follow-up|3|||
42195109|NCT02767570|76007056|FG001|Overall Study|Lost to Follow-up|0|||
42359933|NCT04146363|76207353|FG005|Induction Period|Protocol Deviation|0|||
42359934|NCT04146363|76207354|FG006|Induction Period|Protocol Deviation|0|||
42359935|NCT04146363|76207355|FG007|Induction Period|Protocol Deviation|0|||
42195110|NCT02767570|76007055|FG000|Overall Study|COVID shutdown|2|||
42195111|NCT02767570|76007056|FG001|Overall Study|COVID shutdown|5|||
42359936|NCT04146363|76207356|FG008|Induction Period|Protocol Deviation|0|||
42195112|NCT02767570|76007055|FG000|Overall Study|Increased pain|2|||
42195113|NCT02767570|76007056|FG001|Overall Study|Increased pain|0|||
42359937|NCT04146363|76207357|FG009|Induction Period|Protocol Deviation|0|||
42359938|NCT04146363|76207358|FG010|Induction Period|Protocol Deviation|0|||
42195114|NCT02767570|76007055|FG000|Overall Study|Withdrawal by Subject|1|||
42359939|NCT04146363|76207348|FG000|Induction Period|Withdrawal by Subject|6|||
42359940|NCT04146363|76207349|FG001|Induction Period|Withdrawal by Subject|3|||
42359941|NCT04146363|76207350|FG002|Induction Period|Withdrawal by Subject|0|||
42359942|NCT04146363|76207351|FG003|Induction Period|Withdrawal by Subject|0|||
42359943|NCT04146363|76207352|FG004|Induction Period|Withdrawal by Subject|0|||
42359944|NCT04146363|76207353|FG005|Induction Period|Withdrawal by Subject|0|||
42359945|NCT04146363|76207354|FG006|Induction Period|Withdrawal by Subject|0|||
42359946|NCT04146363|76207355|FG007|Induction Period|Withdrawal by Subject|0|||
42359947|NCT04146363|76207356|FG008|Induction Period|Withdrawal by Subject|0|||
42359948|NCT04146363|76207357|FG009|Induction Period|Withdrawal by Subject|0|||
42359949|NCT04146363|76207358|FG010|Induction Period|Withdrawal by Subject|0|||
42359950|NCT04146363|76207348|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
42359951|NCT04146363|76207349|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
42359952|NCT04146363|76207350|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
42359953|NCT04146363|76207351|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
42359954|NCT04146363|76207352|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
42359955|NCT04146363|76207353|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
42359956|NCT04146363|76207354|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
42359957|NCT04146363|76207355|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
42359958|NCT04146363|76207356|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
42359959|NCT04146363|76207357|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
42359960|NCT04146363|76207358|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
42359961|NCT04146363|76207348|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42359962|NCT04146363|76207349|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42359963|NCT04146363|76207350|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42359964|NCT04146363|76207351|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42359965|NCT04146363|76207352|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42359966|NCT04146363|76207353|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42359967|NCT04146363|76207354|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42359968|NCT04146363|76207355|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
42359969|NCT04146363|76207356|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42359970|NCT04146363|76207357|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42359971|NCT04146363|76207358|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42359972|NCT04146363|76207348|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42359973|NCT04146363|76207349|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42359974|NCT04146363|76207350|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42359975|NCT04146363|76207351|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42359976|NCT04146363|76207352|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42359977|NCT04146363|76207353|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42359978|NCT04146363|76207354|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
42359979|NCT04146363|76207355|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
42359980|NCT04146363|76207356|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42359981|NCT04146363|76207357|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42359982|NCT04146363|76207358|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42359983|NCT04146363|76207348|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
42359984|NCT04146363|76207349|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
42359985|NCT04146363|76207350|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
42359986|NCT04146363|76207351|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
42359987|NCT04146363|76207352|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
42359988|NCT04146363|76207353|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
42359989|NCT04146363|76207354|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
42359990|NCT04146363|76207355|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
42359991|NCT04146363|76207356|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
42099670|NCT00696020|75910218|FG002|Overall Study|Protocol Violation|0|||
42099671|NCT00696020|75910219|FG003|Overall Study|Protocol Violation|1|||
42099672|NCT00696020|75910216|FG000|Overall Study|Withdrawal by Subject|0|||
42359992|NCT04146363|76207357|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
42359993|NCT04146363|76207358|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
42359994|NCT04146363|76207348|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42359995|NCT04146363|76207349|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42359996|NCT04146363|76207350|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42359997|NCT04146363|76207351|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42359998|NCT04146363|76207352|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
42359999|NCT04146363|76207353|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
42360000|NCT04146363|76207354|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
42360001|NCT04146363|76207355|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
42360002|NCT04146363|76207356|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42360003|NCT04146363|76207357|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42099673|NCT00696020|75910217|FG001|Overall Study|Withdrawal by Subject|1|||
42099674|NCT00696020|75910218|FG002|Overall Study|Withdrawal by Subject|0|||
42099675|NCT00696020|75910219|FG003|Overall Study|Withdrawal by Subject|1|||
42099676|NCT00696020|75910216|FG000|Overall Study|Other not stated above|0|||
42195115|NCT02767570|76007056|FG001|Overall Study|Withdrawal by Subject|3|||
42195116|NCT02767570|76007055|FG000|Overall Study|Unrelated medical issue|1|||
42099677|NCT00696020|75910217|FG001|Overall Study|Other not stated above|0|||
42099678|NCT00696020|75910218|FG002|Overall Study|Other not stated above|1|||
42099679|NCT00696020|75910219|FG003|Overall Study|Other not stated above|1|||
42099680|NCT00576576|75910231|FG000|Overall Study|Lost to Follow-up|6|||
42099681|NCT00576576|75910231|FG000|Overall Study|Protocol Violation|1|||
42099682|NCT00695864|75910250|FG000|Placebo|Withdrawal by Subject|1|||
42099683|NCT00695864|75910250|FG000|Placebo|Physician Decision|4|||
42099684|NCT00684996|75910256|FG000|Overall Study|Adverse Event|1|||
42099685|NCT00684996|75910256|FG000|Overall Study|Refusal unrelated to adverse event|1|||
42099686|NCT00684996|75910256|FG000|Overall Study|Progression/relapse|2|||
42099687|NCT00684996|75910256|FG000|Overall Study|Other reasons not protocol specified|1|||
42099688|NCT00684762|75910263|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
42099689|NCT00684762|75910264|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
42099690|NCT00695786|75910274|FG000|Overall Study|Adverse Event|0|||
42099691|NCT00695786|75910275|FG001|Overall Study|Adverse Event|3|||
42099692|NCT00695786|75910276|FG002|Overall Study|Adverse Event|4|||
42099693|NCT00695786|75910277|FG003|Overall Study|Adverse Event|2|||
42099694|NCT00695786|75910274|FG000|Overall Study|Lost to Follow-up|0|||
42099695|NCT00695786|75910275|FG001|Overall Study|Lost to Follow-up|5|||
42099696|NCT00695786|75910276|FG002|Overall Study|Lost to Follow-up|1|||
42099697|NCT00695786|75910277|FG003|Overall Study|Lost to Follow-up|1|||
42099698|NCT00695786|75910274|FG000|Overall Study|Withdrawal by Subject|0|||
42099699|NCT00695786|75910275|FG001|Overall Study|Withdrawal by Subject|4|||
42099700|NCT00695786|75910276|FG002|Overall Study|Withdrawal by Subject|3|||
42099701|NCT00695786|75910277|FG003|Overall Study|Withdrawal by Subject|1|||
42099702|NCT00695786|75910274|FG000|Overall Study|Deemed Ineligible|1|||
42099703|NCT00695786|75910275|FG001|Overall Study|Deemed Ineligible|0|||
42099704|NCT00695786|75910276|FG002|Overall Study|Deemed Ineligible|0|||
42099705|NCT00695786|75910277|FG003|Overall Study|Deemed Ineligible|0|||
42099706|NCT00695786|75910274|FG000|Overall Study|Lack of Efficacy|0|||
42099707|NCT00695786|75910275|FG001|Overall Study|Lack of Efficacy|0|||
42099708|NCT00695786|75910276|FG002|Overall Study|Lack of Efficacy|0|||
42195117|NCT02767570|76007056|FG001|Overall Study|Unrelated medical issue|1|||
42195118|NCT02767570|76007055|FG000|Overall Study|Received intra-articular injection|0|||
42195119|NCT02767570|76007056|FG001|Overall Study|Received intra-articular injection|1|||
42195120|NCT03816761|76007065|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
42195121|NCT03816761|76007066|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
42195122|NCT03816761|76007067|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
42195123|NCT03816761|76007068|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
42360004|NCT04146363|76207358|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42360005|NCT04146363|76207348|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42360006|NCT04146363|76207349|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42099709|NCT00695786|75910277|FG003|Overall Study|Lack of Efficacy|4|||
42099710|NCT00387127|75910289|FG000|Overall Study|Lost to Follow-up|0|||
42099711|NCT00387127|75910290|FG001|Overall Study|Lost to Follow-up|4|||
42360007|NCT04146363|76207350|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
42099712|NCT00387127|75910289|FG000|Overall Study|Death|16|||
42099713|NCT00387127|75910290|FG001|Overall Study|Death|16|||
42099714|NCT00387127|75910289|FG000|Overall Study|Physician Decision|0|||
42099715|NCT00387127|75910290|FG001|Overall Study|Physician Decision|1|||
42360008|NCT04146363|76207351|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42360009|NCT04146363|76207352|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42360010|NCT04146363|76207353|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
42360011|NCT04146363|76207354|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
42360012|NCT04146363|76207355|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
42360013|NCT04146363|76207356|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42360014|NCT04146363|76207357|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42360015|NCT04146363|76207358|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42360016|NCT04146363|76207348|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
42360017|NCT04146363|76207349|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
42360018|NCT04146363|76207350|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
42360019|NCT04146363|76207351|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
42360020|NCT04146363|76207352|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
42360021|NCT04146363|76207353|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
42360022|NCT04146363|76207354|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
42360023|NCT04146363|76207355|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
42360024|NCT04146363|76207356|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
42360025|NCT04146363|76207357|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
42195124|NCT03816761|76007069|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
42195125|NCT03816761|76007070|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
42195126|NCT03816761|76007065|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
42195127|NCT03816761|76007066|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
42195128|NCT03816761|76007067|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
42195129|NCT03816761|76007068|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
42195130|NCT03816761|76007069|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
42195131|NCT03816761|76007070|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
42360026|NCT04146363|76207358|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
42360027|NCT04146363|76207348|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42360028|NCT04146363|76207349|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42360029|NCT04146363|76207350|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42360030|NCT04146363|76207351|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42360031|NCT04146363|76207352|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42360032|NCT04146363|76207353|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42360033|NCT04146363|76207354|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42360034|NCT04146363|76207355|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42360035|NCT04146363|76207356|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
42360036|NCT04146363|76207357|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
42360037|NCT04146363|76207358|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
42360038|NCT04146363|76207348|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42360039|NCT04146363|76207349|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42360040|NCT04146363|76207350|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42360041|NCT04146363|76207351|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42360042|NCT04146363|76207352|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42360043|NCT04146363|76207353|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42360044|NCT04146363|76207354|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42360045|NCT04146363|76207355|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42360046|NCT04146363|76207356|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
42360047|NCT04146363|76207357|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
42360048|NCT04146363|76207358|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42360049|NCT04146363|76207348|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
42360050|NCT04146363|76207349|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
42360051|NCT04146363|76207350|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
42360052|NCT04146363|76207351|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
42360053|NCT04146363|76207352|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
42360054|NCT04146363|76207353|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
42360055|NCT04146363|76207354|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
42360056|NCT04146363|76207355|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
42099716|NCT00387127|75910289|FG000|Overall Study|Withdrawal by Subject|3|||
42099717|NCT00387127|75910290|FG001|Overall Study|Withdrawal by Subject|2|||
42099718|NCT00387127|75910289|FG000|Overall Study|Required by Protocol Amendment #4|12|||
42099719|NCT00387127|75910290|FG001|Overall Study|Required by Protocol Amendment #4|10|||
42099720|NCT00387127|75910289|FG000|Overall Study|Serious Adverse Event|1|||
42099721|NCT00387127|75910290|FG001|Overall Study|Serious Adverse Event|1|||
42099722|NCT00387127|75910289|FG000|Overall Study|Sponsor Unblinded|1|||
42360057|NCT04146363|76207356|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
42099723|NCT00387127|75910290|FG001|Overall Study|Sponsor Unblinded|0|||
42099724|NCT00683592|75910300|FG000|Overall Study|Adverse Event|12|||
42195132|NCT02770612|76007092|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
42360058|NCT04146363|76207357|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
42360059|NCT04146363|76207358|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
42360060|NCT04146363|76207348|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42360061|NCT04146363|76207349|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42360062|NCT04146363|76207350|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42360063|NCT04146363|76207351|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42360064|NCT04146363|76207352|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42360065|NCT04146363|76207353|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42360066|NCT04146363|76207354|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42360067|NCT04146363|76207355|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42360068|NCT04146363|76207356|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
42360069|NCT04146363|76207357|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
42360070|NCT04146363|76207358|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
42360071|NCT04146363|76207348|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
42360072|NCT04146363|76207349|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
42360073|NCT04146363|76207350|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
42360074|NCT04146363|76207351|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
42360075|NCT04146363|76207352|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
42360076|NCT04146363|76207353|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
42360077|NCT04146363|76207354|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
42360078|NCT04146363|76207355|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
42360079|NCT04146363|76207356|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
42360080|NCT04146363|76207357|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
42360081|NCT04146363|76207358|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
42360082|NCT04146363|76207348|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
42360083|NCT04146363|76207349|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
42360084|NCT04146363|76207350|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
42360085|NCT04146363|76207351|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
42360086|NCT04146363|76207352|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
42360087|NCT04146363|76207353|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
42360088|NCT04146363|76207354|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
42360089|NCT04146363|76207355|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
42360090|NCT04146363|76207356|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
42360091|NCT04146363|76207357|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
42360092|NCT04146363|76207358|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
42360093|NCT01838941|76207383|FG000|Overall Study|Adverse Event|1|||
42360094|NCT01838941|76207383|FG000|Overall Study|Withdrawal by Subject|1|||
42360095|NCT01773109|76207388|FG000|Overall Study|Symptomatic Progression|2|||
42360096|NCT01773109|76207388|FG000|Overall Study|Death|1|||
42195133|NCT03575871|76007099|FG000|Overall Study|Adverse Event|5|||
42195134|NCT03575871|76007100|FG001|Overall Study|Adverse Event|5|||
42195135|NCT03575871|76007101|FG002|Overall Study|Adverse Event|8|||
42195136|NCT03575871|76007099|FG000|Overall Study|Death|1|||
42195137|NCT03575871|76007100|FG001|Overall Study|Death|0|||
42360097|NCT01772719|76207392|FG000|Overall Study|Withdrawal by Subject|3|||
42099725|NCT00683592|75910301|FG001|Overall Study|Adverse Event|4|||
42099726|NCT00683592|75910300|FG000|Overall Study|Withdrawal by Subject|11|||
42099727|NCT00683592|75910301|FG001|Overall Study|Withdrawal by Subject|11|||
42099728|NCT00683592|75910300|FG000|Overall Study|Lost to Follow-up|17|||
42099729|NCT00683592|75910301|FG001|Overall Study|Lost to Follow-up|17|||
42099730|NCT00683592|75910300|FG000|Overall Study|Lack of Efficacy|3|||
42099731|NCT00683592|75910301|FG001|Overall Study|Lack of Efficacy|7|||
42360098|NCT01772719|76207392|FG000|Overall Study|Adverse Event|2|||
42360099|NCT01772719|76207392|FG000|Overall Study|Protocol Violation|1|||
42360100|NCT01772719|76207392|FG000|Overall Study|Lost to Follow-up|1|||
42360101|NCT01798927|76207399|FG000|Overall Study|Withdrawal by Subject|1|||
42360102|NCT01276288|76207468|FG000|Overall Study|Adverse Event|1|||
42360103|NCT01276288|76207469|FG001|Overall Study|Adverse Event|1|||
42099732|NCT00683592|75910300|FG000|Overall Study|Physician Decision|0|||
42099733|NCT00683592|75910301|FG001|Overall Study|Physician Decision|1|||
42099734|NCT00683592|75910300|FG000|Overall Study|Non-compliance|3|||
42099735|NCT00683592|75910301|FG001|Overall Study|Non-compliance|5|||
42360104|NCT01276288|76207470|FG002|Overall Study|Adverse Event|0|||
42360105|NCT01276288|76207471|FG003|Overall Study|Adverse Event|0|||
42360106|NCT01276288|76207468|FG000|Overall Study|not treated|1|||
42360107|NCT01276288|76207469|FG001|Overall Study|not treated|0|||
42360108|NCT01276288|76207470|FG002|Overall Study|not treated|0|||
42099736|NCT00683592|75910300|FG000|Overall Study|Other|1|||
42099737|NCT00683592|75910301|FG001|Overall Study|Other|1|||
42099738|NCT00695396|75910310|FG000|Overall Study|Study Closed Prematurely|5|||
42195138|NCT03575871|76007101|FG002|Overall Study|Death|0|||
42195139|NCT03575871|76007099|FG000|Overall Study|Lack of Efficacy|5|||
42099739|NCT00695396|75910311|FG001|Overall Study|Study Closed Prematurely|6|||
42195140|NCT03575871|76007100|FG001|Overall Study|Lack of Efficacy|4|||
42195141|NCT03575871|76007101|FG002|Overall Study|Lack of Efficacy|7|||
42195142|NCT03575871|76007099|FG000|Overall Study|Lost to Follow-up|1|||
42195143|NCT03575871|76007100|FG001|Overall Study|Lost to Follow-up|1|||
42195144|NCT03575871|76007101|FG002|Overall Study|Lost to Follow-up|1|||
42195145|NCT03575871|76007099|FG000|Overall Study|Protocol Deviation|1|||
42195146|NCT03575871|76007100|FG001|Overall Study|Protocol Deviation|1|||
42195147|NCT03575871|76007101|FG002|Overall Study|Protocol Deviation|1|||
42195148|NCT03575871|76007099|FG000|Overall Study|Withdrawal by Subject|6|||
42195149|NCT03575871|76007100|FG001|Overall Study|Withdrawal by Subject|1|||
42195150|NCT03575871|76007101|FG002|Overall Study|Withdrawal by Subject|9|||
42195151|NCT03575871|76007099|FG000|Overall Study|Other than specified|2|||
42195152|NCT03575871|76007100|FG001|Overall Study|Other than specified|2|||
42360109|NCT01276288|76207471|FG003|Overall Study|not treated|0|||
42360110|NCT02702271|76207495|FG000|Overall Study|Death|36|||
42360111|NCT02702271|76207496|FG001|Overall Study|Death|7|||
42360112|NCT02702271|76207495|FG000|Overall Study|Lost to Follow-up|12|||
42360113|NCT02702271|76207496|FG001|Overall Study|Lost to Follow-up|0|||
42360114|NCT02702271|76207495|FG000|Overall Study|Withdrawal by Subject|8|||
42360115|NCT02702271|76207496|FG001|Overall Study|Withdrawal by Subject|1|||
42360116|NCT02702271|76207495|FG000|Overall Study|Physician Decision|2|||
42360117|NCT02702271|76207496|FG001|Overall Study|Physician Decision|0|||
42360118|NCT02702271|76207495|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
42360119|NCT02702271|76207496|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
42360120|NCT01276054|76207581|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
42360121|NCT01276054|76207582|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
42360122|NCT01798849|76207591|FG000|Overall Study|Physician Decision|0|||
42360123|NCT01798849|76207592|FG001|Overall Study|Physician Decision|0|||
42360124|NCT01798849|76207593|FG002|Overall Study|Physician Decision|1|||
42360125|NCT01797835|76207673|FG000|Overall Study|Lost to Follow-up|31|||
42360126|NCT01797835|76207674|FG001|Overall Study|Lost to Follow-up|27|||
42360127|NCT01275430|76207680|FG000|Overall Study|Adverse Event|1|||
42360128|NCT01275430|76207680|FG000|Overall Study|No Contrast Injection|6|||
42360129|NCT01275430|76207680|FG000|Overall Study|Device Malfunction|1|||
42360130|NCT01275430|76207680|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
42360131|NCT01838551|76207685|FG000|Overall Study|Adverse Event|16|||
42360132|NCT01838551|76207685|FG000|Overall Study|Death|1|||
42360133|NCT01838551|76207685|FG000|Overall Study|Lack of Efficacy|10|||
42360134|NCT01838551|76207685|FG000|Overall Study|Physician Decision|4|||
42360135|NCT01838551|76207685|FG000|Overall Study|Withdrawal by Subject|10|||
42360136|NCT01838551|76207685|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
42360137|NCT01797445|76207691|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
42360138|NCT01797445|76207692|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
42360139|NCT01797445|76207691|FG000|Double-Blind Phase|Adverse Event|3|||
42360140|NCT01797445|76207692|FG001|Double-Blind Phase|Adverse Event|0|||
42360141|NCT01797445|76207691|FG000|Double-Blind Phase|Death|5|||
42360142|NCT01797445|76207692|FG001|Double-Blind Phase|Death|4|||
42360143|NCT01797445|76207691|FG000|Double-Blind Phase|Pregnancy|0|||
42360144|NCT01797445|76207692|FG001|Double-Blind Phase|Pregnancy|1|||
42360145|NCT01797445|76207691|FG000|Double-Blind Phase|Lack of Efficacy|1|||
42360146|NCT01797445|76207692|FG001|Double-Blind Phase|Lack of Efficacy|2|||
42360147|NCT01797445|76207691|FG000|Double-Blind Phase|Investigator's Discretion|15|||
42099740|NCT00695396|75910312|FG002|Overall Study|Study Closed Prematurely|8|||
42099741|NCT00695396|75910310|FG000|Overall Study|Withdrawal by Subject|2|||
42099742|NCT00695396|75910311|FG001|Overall Study|Withdrawal by Subject|2|||
42099743|NCT00695396|75910312|FG002|Overall Study|Withdrawal by Subject|0|||
42099744|NCT02656706|75910320|FG000|Overall Study|Insurance Denial|1|||
42099745|NCT00575328|75910326|FG000|Overall Study|Adverse Event|1|||
42099746|NCT00575328|75910327|FG001|Overall Study|Adverse Event|1|||
42099747|NCT00575328|75910326|FG000|Overall Study|Lost to Follow-up|2|||
42099748|NCT00575328|75910327|FG001|Overall Study|Lost to Follow-up|1|||
42099749|NCT00575094|75910333|FG000|Overall Study|Adverse Event|2|||
42099750|NCT00575094|75910333|FG000|Overall Study|Withdrawal by Subject|1|||
42099751|NCT00553696|75910341|FG000|Overall Study|Adverse Event|2|||
42099752|NCT00553696|75910342|FG001|Overall Study|Adverse Event|4|||
42099753|NCT00553696|75910343|FG002|Overall Study|Adverse Event|0|||
42099754|NCT00553696|75910344|FG003|Overall Study|Adverse Event|1|||
42099755|NCT00553696|75910341|FG000|Overall Study|Global deterioration of health status|0|||
42195153|NCT03575871|76007101|FG002|Overall Study|Other than specified|0|||
42195154|NCT03642717|76007109|FG000|Overall Study|Lost to Follow-up|2|||
42195155|NCT03642717|76007109|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
42195156|NCT03642717|76007109|FG000|Overall Study|Taken study drug prior to contract date|3|||
42195157|NCT02766478|76007116|FG000|Overall Study|Withdrawal by Subject|1|||
42360148|NCT01797445|76207692|FG001|Double-Blind Phase|Investigator's Discretion|17|||
42360149|NCT01797445|76207691|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
42360150|NCT01797445|76207692|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
42360151|NCT01797445|76207691|FG000|Double-Blind Phase|Protocol Violation|0|||
42360152|NCT01797445|76207692|FG001|Double-Blind Phase|Protocol Violation|1|||
42099756|NCT00553696|75910342|FG001|Overall Study|Global deterioration of health status|2|||
42099757|NCT00553696|75910343|FG002|Overall Study|Global deterioration of health status|0|||
42099758|NCT00553696|75910344|FG003|Overall Study|Global deterioration of health status|0|||
42099759|NCT00553696|75910341|FG000|Overall Study|Objective progression or relapse|2|||
42099760|NCT00553696|75910342|FG001|Overall Study|Objective progression or relapse|9|||
42099761|NCT00553696|75910343|FG002|Overall Study|Objective progression or relapse|6|||
42099762|NCT00553696|75910344|FG003|Overall Study|Objective progression or relapse|0|||
42099763|NCT00553696|75910341|FG000|Overall Study|Withdrawal by Subject|0|||
42099764|NCT00553696|75910342|FG001|Overall Study|Withdrawal by Subject|1|||
42099765|NCT00553696|75910343|FG002|Overall Study|Withdrawal by Subject|0|||
42099766|NCT00553696|75910344|FG003|Overall Study|Withdrawal by Subject|0|||
42195158|NCT02766478|76007117|FG001|Overall Study|Withdrawal by Subject|1|||
42195159|NCT02766400|76007125|FG000|Overall Study|Death|1|||
42195160|NCT02766400|76007126|FG001|Overall Study|Death|2|||
42195161|NCT02766400|76007125|FG000|Overall Study|Withdrawal by Subject|1|||
42195162|NCT02766400|76007126|FG001|Overall Study|Withdrawal by Subject|0|||
42195163|NCT00104650|76007135|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
42195164|NCT00104650|76007136|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
42195165|NCT00104650|76007137|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
42195166|NCT00104650|76007135|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
42195167|NCT00104650|76007136|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
42195168|NCT00104650|76007137|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
42195169|NCT00104650|76007135|FG000|Treatment Period (25 Weeks)|Death|7|||
42195170|NCT00104650|76007136|FG001|Treatment Period (25 Weeks)|Death|5|||
42195171|NCT00104650|76007137|FG002|Treatment Period (25 Weeks)|Death|6|||
42195172|NCT00104650|76007135|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
42195173|NCT00104650|76007136|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
42195174|NCT00104650|76007137|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
42195175|NCT00104650|76007135|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
42195176|NCT00104650|76007136|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
42195177|NCT00104650|76007137|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
42195178|NCT00104650|76007135|FG000|Treatment Period (25 Weeks)|Other|1|||
42195179|NCT00104650|76007136|FG001|Treatment Period (25 Weeks)|Other|0|||
42195180|NCT00104650|76007137|FG002|Treatment Period (25 Weeks)|Other|0|||
42195181|NCT00104650|76007135|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
42195182|NCT00104650|76007136|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
42195183|NCT00104650|76007137|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
42195184|NCT00104650|76007135|FG000|Follow-up Period|Physician Decision|1|||
42195185|NCT00104650|76007136|FG001|Follow-up Period|Physician Decision|1|||
42195186|NCT00104650|76007137|FG002|Follow-up Period|Physician Decision|0|||
42195187|NCT00104650|76007135|FG000|Follow-up Period|Adverse Event|1|||
42298598|NCT02335983|76133771|FG004|Overall Study|Sponsor Decision|0|||
42099767|NCT00553540|75910359|FG000|Overall Study|discharged after first visit|2|||
42195188|NCT00104650|76007136|FG001|Follow-up Period|Adverse Event|0|||
42195189|NCT00104650|76007137|FG002|Follow-up Period|Adverse Event|1|||
42195190|NCT00104650|76007135|FG000|Follow-up Period|Withdrawal by Subject|0|||
42195191|NCT00104650|76007136|FG001|Follow-up Period|Withdrawal by Subject|3|||
42298599|NCT02335983|76133772|FG005|Overall Study|Sponsor Decision|1|||
42099768|NCT00553540|75910360|FG001|Overall Study|discharged after first visit|5|||
42099769|NCT00617409|75910369|FG000|Overall Study|Withdrawal by Subject|4|||
42099770|NCT00617409|75910370|FG001|Overall Study|Withdrawal by Subject|1|||
42099771|NCT00617409|75910371|FG002|Overall Study|Withdrawal by Subject|2|||
42099772|NCT00617409|75910369|FG000|Overall Study|Adverse Event|0|||
42099773|NCT00617409|75910370|FG001|Overall Study|Adverse Event|2|||
42099774|NCT00617409|75910371|FG002|Overall Study|Adverse Event|3|||
42099775|NCT00617409|75910369|FG000|Overall Study|Disease Progression|8|||
42099776|NCT00617409|75910370|FG001|Overall Study|Disease Progression|8|||
42099777|NCT00617409|75910371|FG002|Overall Study|Disease Progression|18|||
42099778|NCT00617409|75910369|FG000|Overall Study|Death|3|||
42099779|NCT00617409|75910370|FG001|Overall Study|Death|5|||
42099780|NCT00617409|75910371|FG002|Overall Study|Death|4|||
42099781|NCT00617409|75910369|FG000|Overall Study|Alternative Therapy|1|||
42099782|NCT00617409|75910370|FG001|Overall Study|Alternative Therapy|2|||
42099783|NCT00617409|75910371|FG002|Overall Study|Alternative Therapy|0|||
42099784|NCT00695318|75910382|FG000|Overall Study|Lost to Follow-up|1|||
42099785|NCT00695318|75910383|FG001|Overall Study|Lost to Follow-up|0|||
42099786|NCT00695318|75910382|FG000|Overall Study|Withdrawal by Subject|2|||
42099787|NCT00695318|75910383|FG001|Overall Study|Withdrawal by Subject|0|||
42099788|NCT00695318|75910382|FG000|Overall Study|Death|1|||
42099789|NCT00695318|75910383|FG001|Overall Study|Death|1|||
42099790|NCT00695318|75910382|FG000|Overall Study|Study Terminated|1|||
42360153|NCT01797445|76207691|FG000|Double-Blind Phase|Withdrew Consent|20|||
42360154|NCT01797445|76207692|FG001|Double-Blind Phase|Withdrew Consent|35|||
42360155|NCT01797445|76207691|FG000|Double-Blind Phase|Lost to Follow-up|34|||
42360156|NCT01797445|76207692|FG001|Double-Blind Phase|Lost to Follow-up|26|||
42360157|NCT01797445|76207691|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
42360158|NCT01797445|76207692|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
42360159|NCT01611259|76207700|FG000|Overall Study|Physician Decision|1|||
42360160|NCT01611259|76207700|FG000|Overall Study|Lack of Efficacy|2|||
42360161|NCT01611259|76207700|FG000|Overall Study|Adverse Event|4|||
42360162|NCT01611259|76207700|FG000|Overall Study|Withdrawal by Subject|7|||
42360163|NCT01795495|76207707|FG000|Overall Study|Protocol Violation|1|||
42360164|NCT01795495|76207708|FG001|Overall Study|Protocol Violation|0|||
42360165|NCT01795495|76207709|FG002|Overall Study|Protocol Violation|1|||
42360166|NCT01795495|76207707|FG000|Overall Study|Physician Decision|0|||
42360167|NCT01795495|76207708|FG001|Overall Study|Physician Decision|0|||
42360168|NCT01795495|76207709|FG002|Overall Study|Physician Decision|1|||
42360169|NCT01794949|76207719|FG000|Overall Study|Lost to Follow-up|1|||
42360170|NCT01794949|76207720|FG001|Overall Study|Lost to Follow-up|0|||
42360171|NCT01770379|76207729|FG000|Overall Study|Technical issues|1|||
42195192|NCT00104650|76007137|FG002|Follow-up Period|Withdrawal by Subject|3|||
42195193|NCT00104650|76007135|FG000|Follow-up Period|Death|6|||
42195194|NCT00104650|76007136|FG001|Follow-up Period|Death|6|||
42195195|NCT00104650|76007137|FG002|Follow-up Period|Death|4|||
42195196|NCT00104650|76007135|FG000|Follow-up Period|Disease progression|3|||
42195197|NCT00104650|76007136|FG001|Follow-up Period|Disease progression|1|||
42195198|NCT00104650|76007137|FG002|Follow-up Period|Disease progression|0|||
42195199|NCT00104650|76007135|FG000|Follow-up Period|Lost to Follow-up|0|||
42195200|NCT00104650|76007136|FG001|Follow-up Period|Lost to Follow-up|1|||
42195201|NCT00104650|76007137|FG002|Follow-up Period|Lost to Follow-up|2|||
42195202|NCT00104650|76007135|FG000|Follow-up Period|Other|0|||
42195203|NCT00104650|76007136|FG001|Follow-up Period|Other|1|||
42195204|NCT00104650|76007137|FG002|Follow-up Period|Other|0|||
42360172|NCT01770379|76207730|FG001|Overall Study|Technical issues|0|||
42360173|NCT01770379|76207731|FG002|Overall Study|Technical issues|0|||
42360174|NCT01770379|76207729|FG000|Overall Study|Withdrawal by Subject|7|||
42360175|NCT01770379|76207730|FG001|Overall Study|Withdrawal by Subject|10|||
42360176|NCT01770379|76207731|FG002|Overall Study|Withdrawal by Subject|7|||
42099791|NCT00695318|75910383|FG001|Overall Study|Study Terminated|0|||
42099792|NCT00386425|75910397|FG000|Overall Study|Physician Decision|3|||
42099793|NCT00386425|75910398|FG001|Overall Study|Physician Decision|0|||
42099794|NCT00386425|75910399|FG002|Overall Study|Physician Decision|0|||
42099795|NCT00386425|75910397|FG000|Overall Study|Withdrawal by Subject|0|||
42099796|NCT00386425|75910398|FG001|Overall Study|Withdrawal by Subject|1|||
42099797|NCT00386425|75910399|FG002|Overall Study|Withdrawal by Subject|0|||
42099798|NCT00694304|75910411|FG000|Overall Study|Adverse Event|42|||
42099799|NCT00694304|75910411|FG000|Overall Study|Lack of Efficacy|35|||
42099800|NCT00694304|75910411|FG000|Overall Study|Non-compliance With Study Product|16|||
42099801|NCT00694304|75910411|FG000|Overall Study|Protocol Violation|6|||
42195205|NCT03732807|76007152|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
42195206|NCT03732807|76007153|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
42099802|NCT00694304|75910411|FG000|Overall Study|Withdrawal of Consent|61|||
42195207|NCT03732807|76007154|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
42360177|NCT01770379|76207729|FG000|Overall Study|study terminated by sponsor|22|||
42360178|NCT01770379|76207730|FG001|Overall Study|study terminated by sponsor|23|||
42360179|NCT01770379|76207731|FG002|Overall Study|study terminated by sponsor|22|||
42360180|NCT01770379|76207729|FG000|Overall Study|Protocol Violation|0|||
42195208|NCT03732807|76007155|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
42195209|NCT03732807|76007156|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
42195210|NCT03732807|76007157|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
42195211|NCT03732807|76007158|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
42195212|NCT03732807|76007152|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
42195213|NCT03732807|76007153|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
42195214|NCT03732807|76007154|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
42195215|NCT03732807|76007155|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
42195216|NCT03732807|76007156|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
42195217|NCT03732807|76007157|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
42195218|NCT03732807|76007158|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
42195219|NCT03732807|76007152|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
42195220|NCT03732807|76007153|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
42360181|NCT01770379|76207730|FG001|Overall Study|Protocol Violation|1|||
42360182|NCT01770379|76207731|FG002|Overall Study|Protocol Violation|1|||
42360183|NCT01770379|76207729|FG000|Overall Study|Physician Decision|0|||
42360184|NCT01770379|76207730|FG001|Overall Study|Physician Decision|1|||
42360185|NCT01770379|76207731|FG002|Overall Study|Physician Decision|2|||
42360186|NCT01770379|76207729|FG000|Overall Study|Lost to Follow-up|0|||
42360187|NCT01770379|76207730|FG001|Overall Study|Lost to Follow-up|0|||
42195221|NCT03732807|76007154|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
42195222|NCT03732807|76007155|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
42195223|NCT03732807|76007156|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
42195224|NCT03732807|76007157|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
42195225|NCT03732807|76007158|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
42195226|NCT03732807|76007152|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
42195227|NCT03732807|76007153|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
42195228|NCT03732807|76007154|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
42360188|NCT01770379|76207731|FG002|Overall Study|Lost to Follow-up|2|||
42360189|NCT01770379|76207729|FG000|Overall Study|Lack of Efficacy|8|||
42360190|NCT01770379|76207730|FG001|Overall Study|Lack of Efficacy|6|||
42360191|NCT01770379|76207731|FG002|Overall Study|Lack of Efficacy|6|||
42360192|NCT01770379|76207729|FG000|Overall Study|Adverse Event|1|||
42360193|NCT01770379|76207730|FG001|Overall Study|Adverse Event|3|||
42360194|NCT01770379|76207731|FG002|Overall Study|Adverse Event|2|||
42360195|NCT01986881|76207744|FG000|Overall Study|Death|228|||
42360196|NCT01986881|76207745|FG001|Overall Study|Death|233|||
42099803|NCT00694304|75910411|FG000|Overall Study|Lost to Follow-up|15|||
42099804|NCT00694304|75910411|FG000|Overall Study|Administrative or Other Reasons|32|||
42099805|NCT00371839|75910418|FG000|Overall Study|Death|4|||
42099806|NCT00371839|75910419|FG001|Overall Study|Death|0|||
42099807|NCT00371839|75910420|FG002|Overall Study|Death|0|||
42099808|NCT00371839|75910418|FG000|Overall Study|Withdrawal by Subject|7|||
42099809|NCT00371839|75910419|FG001|Overall Study|Withdrawal by Subject|4|||
42099810|NCT00371839|75910420|FG002|Overall Study|Withdrawal by Subject|0|||
42099811|NCT00371839|75910418|FG000|Overall Study|Lost to Follow-up|6|||
42099812|NCT00371839|75910419|FG001|Overall Study|Lost to Follow-up|3|||
42099813|NCT00371839|75910420|FG002|Overall Study|Lost to Follow-up|2|||
42099814|NCT00682890|75910428|FG000|Overall Study|Lost to Follow-up|1|||
42099815|NCT00682890|75910429|FG001|Overall Study|Lost to Follow-up|1|||
42099816|NCT00682890|75910428|FG000|Overall Study|subject moved away|0|||
42099817|NCT00682890|75910429|FG001|Overall Study|subject moved away|1|||
42099818|NCT00682890|75910428|FG000|Overall Study|heavy menstrual bleeding|1|||
42099819|NCT00682890|75910429|FG001|Overall Study|heavy menstrual bleeding|0|||
42195229|NCT03732807|76007155|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
42195230|NCT03732807|76007156|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
42195231|NCT03732807|76007157|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
42298600|NCT02335983|76133767|FG000|Overall Study|Withdrawal by Subject|3|||
42298601|NCT02335983|76133768|FG001|Overall Study|Withdrawal by Subject|2|||
42298602|NCT02335983|76133769|FG002|Overall Study|Withdrawal by Subject|2|||
42298603|NCT02335983|76133770|FG003|Overall Study|Withdrawal by Subject|1|||
42360197|NCT01986881|76207746|FG002|Overall Study|Death|247|||
42360198|NCT01986881|76207744|FG000|Overall Study|Lost to Follow-up|51|||
42099820|NCT00385723|75910438|FG000|Overall Study|Lost to Follow-up|1|||
42195232|NCT03732807|76007158|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
42195233|NCT03732807|76007152|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
42298604|NCT02335983|76133771|FG004|Overall Study|Withdrawal by Subject|3|||
42298605|NCT02335983|76133772|FG005|Overall Study|Withdrawal by Subject|9|||
42298606|NCT02335983|76133767|FG000|Overall Study|Death|0|||
42298607|NCT02335983|76133768|FG001|Overall Study|Death|0|||
42298608|NCT02335983|76133769|FG002|Overall Study|Death|2|||
42360199|NCT01986881|76207745|FG001|Overall Study|Lost to Follow-up|44|||
42360200|NCT01986881|76207746|FG002|Overall Study|Lost to Follow-up|55|||
42360201|NCT01986881|76207744|FG000|Overall Study|Physician Decision|7|||
42360202|NCT01986881|76207745|FG001|Overall Study|Physician Decision|4|||
42360203|NCT01986881|76207746|FG002|Overall Study|Physician Decision|6|||
42360204|NCT01986881|76207744|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
42360205|NCT01986881|76207745|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
42360206|NCT01986881|76207746|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
42360207|NCT01986881|76207744|FG000|Overall Study|Withdrawal by Subject|41|||
42360208|NCT01986881|76207745|FG001|Overall Study|Withdrawal by Subject|60|||
42360209|NCT01986881|76207746|FG002|Overall Study|Withdrawal by Subject|45|||
42360210|NCT01986881|76207744|FG000|Overall Study|Subject Moved|0|||
42360211|NCT01986881|76207745|FG001|Overall Study|Subject Moved|1|||
42360212|NCT01986881|76207746|FG002|Overall Study|Subject Moved|0|||
42360213|NCT01986881|76207744|FG000|Overall Study|Other|1|||
42360214|NCT01986881|76207745|FG001|Overall Study|Other|2|||
42360215|NCT01986881|76207746|FG002|Overall Study|Other|2|||
42360216|NCT01609543|76207777|FG000|Overall Study|Disease Progression|28|||
42360217|NCT01609543|76207777|FG000|Overall Study|Adverse Event|5|||
42360218|NCT01609543|76207777|FG000|Overall Study|Withdrawal by Subject|1|||
42360219|NCT01609543|76207777|FG000|Overall Study|Protocol Violation|1|||
42360220|NCT01609543|76207777|FG000|Overall Study|Death|7|||
42360221|NCT02003183|76207784|FG000|Overall Study|Lost to Follow-up|0|||
42360222|NCT02003183|76207785|FG001|Overall Study|Lost to Follow-up|2|||
42360223|NCT01986647|76207795|FG000|Overall Study|Lost to Follow-up|4|||
42360224|NCT01986647|76207796|FG001|Overall Study|Lost to Follow-up|1|||
42360225|NCT01986647|76207797|FG002|Overall Study|Lost to Follow-up|4|||
42360226|NCT01986647|76207798|FG003|Overall Study|Lost to Follow-up|4|||
42360227|NCT01986647|76207795|FG000|Overall Study|Withdrawal by Subject|1|||
42360228|NCT01986647|76207796|FG001|Overall Study|Withdrawal by Subject|3|||
42360229|NCT01986647|76207797|FG002|Overall Study|Withdrawal by Subject|2|||
42360230|NCT01986647|76207798|FG003|Overall Study|Withdrawal by Subject|3|||
42360231|NCT01986647|76207795|FG000|Overall Study|Health|5|||
42360232|NCT01986647|76207796|FG001|Overall Study|Health|3|||
42360233|NCT01986647|76207797|FG002|Overall Study|Health|6|||
42360234|NCT01986647|76207798|FG003|Overall Study|Health|4|||
42360235|NCT02002091|76207814|FG000|Screening|Lost to Follow-up|10|||
42360236|NCT02002091|76207815|FG001|Screening|Lost to Follow-up|12|||
42360237|NCT02002091|76207814|FG000|Screening|Death|3|||
42360238|NCT02002091|76207815|FG001|Screening|Death|2|||
42360239|NCT01985321|76207852|FG000|Overall Study|Protocol Violation|4|||
42360240|NCT01985321|76207853|FG001|Overall Study|Protocol Violation|3|||
42360241|NCT01985321|76207852|FG000|Overall Study|Withdrawal by Subject|1|||
42360242|NCT01985321|76207853|FG001|Overall Study|Withdrawal by Subject|0|||
42360243|NCT01985321|76207852|FG000|Overall Study|Lost to Follow-up|5|||
42360244|NCT01985321|76207853|FG001|Overall Study|Lost to Follow-up|2|||
42360245|NCT01985321|76207852|FG000|Overall Study|Subject treated wrong type of sore|1|||
42360246|NCT01985321|76207853|FG001|Overall Study|Subject treated wrong type of sore|0|||
42360247|NCT02000921|76207862|FG000|Overall Study|Withdrawal by Subject|3|||
42360248|NCT02000921|76207863|FG001|Overall Study|Withdrawal by Subject|10|||
42360249|NCT02000921|76207864|FG002|Overall Study|Withdrawal by Subject|5|||
42195234|NCT03732807|76007153|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
42195235|NCT03732807|76007154|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
42195236|NCT03732807|76007155|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
42195237|NCT03732807|76007156|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
42195238|NCT03732807|76007157|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
42195239|NCT03732807|76007158|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
42195240|NCT03732807|76007152|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
42195241|NCT03732807|76007153|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
42195242|NCT03732807|76007154|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
42195243|NCT03732807|76007155|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
42195244|NCT03732807|76007156|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
42360250|NCT02000921|76207862|FG000|Overall Study|Lost to Follow-up|2|||
42360251|NCT02000921|76207863|FG001|Overall Study|Lost to Follow-up|4|||
42195245|NCT03732807|76007157|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
42195246|NCT03732807|76007158|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
42360252|NCT02000921|76207864|FG002|Overall Study|Lost to Follow-up|5|||
42360253|NCT02000921|76207862|FG000|Overall Study|Physician Decision|0|||
42195247|NCT03732807|76007152|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
42195248|NCT03732807|76007153|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
42195249|NCT03732807|76007154|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
42360254|NCT02000921|76207863|FG001|Overall Study|Physician Decision|2|||
42360255|NCT02000921|76207864|FG002|Overall Study|Physician Decision|0|||
42360256|NCT01836523|76207910|FG000|Overall Study|Adverse Event|15|||
42360257|NCT01836523|76207911|FG001|Overall Study|Adverse Event|41|||
42360258|NCT01836523|76207912|FG002|Overall Study|Adverse Event|49|||
42360259|NCT01836523|76207913|FG003|Overall Study|Adverse Event|14|||
42360260|NCT01836523|76207910|FG000|Overall Study|Protocol Violation|6|||
42360261|NCT01836523|76207911|FG001|Overall Study|Protocol Violation|3|||
42360262|NCT01836523|76207912|FG002|Overall Study|Protocol Violation|2|||
42360263|NCT01836523|76207913|FG003|Overall Study|Protocol Violation|4|||
42360264|NCT01836523|76207910|FG000|Overall Study|Met Withdrawal Criteria|13|||
42360265|NCT01836523|76207911|FG001|Overall Study|Met Withdrawal Criteria|13|||
42360266|NCT01836523|76207912|FG002|Overall Study|Met Withdrawal Criteria|21|||
42360267|NCT01836523|76207913|FG003|Overall Study|Met Withdrawal Criteria|27|||
42360268|NCT01836523|76207910|FG000|Overall Study|Unclassified|17|||
42360269|NCT01836523|76207911|FG001|Overall Study|Unclassified|28|||
42360270|NCT01836523|76207912|FG002|Overall Study|Unclassified|19|||
42360271|NCT01836523|76207913|FG003|Overall Study|Unclassified|29|||
42360272|NCT01275196|76207925|FG000|Overall Study|Adverse Event|3|||
42360273|NCT01275196|76207926|FG001|Overall Study|Adverse Event|5|||
42360274|NCT01275196|76207925|FG000|Overall Study|Withdrawal by Subject|4|||
42360275|NCT01275196|76207926|FG001|Overall Study|Withdrawal by Subject|5|||
42360276|NCT01275196|76207925|FG000|Overall Study|Lost to Follow-up|1|||
42360277|NCT01275196|76207926|FG001|Overall Study|Lost to Follow-up|0|||
42360278|NCT01275196|76207925|FG000|Overall Study|Disease Progression|6|||
42360279|NCT01275196|76207926|FG001|Overall Study|Disease Progression|5|||
42360280|NCT01275196|76207925|FG000|Overall Study|Protocol Violation|1|||
42360281|NCT01275196|76207926|FG001|Overall Study|Protocol Violation|0|||
42360282|NCT01275196|76207925|FG000|Overall Study|Suboptimal response/treatment failure|5|||
42360283|NCT01275196|76207926|FG001|Overall Study|Suboptimal response/treatment failure|6|||
42360284|NCT01984697|76207939|FG000|Overall Study|Adverse Event|0|||
42360285|NCT01984697|76207940|FG001|Overall Study|Adverse Event|0|||
42360286|NCT01984697|76207941|FG002|Overall Study|Adverse Event|2|||
42360287|NCT01984697|76207942|FG003|Overall Study|Adverse Event|0|||
42360288|NCT01984697|76207943|FG004|Overall Study|Adverse Event|0|||
42360289|NCT01984697|76207939|FG000|Overall Study|Lost to Follow-up|14|||
42360290|NCT01984697|76207940|FG001|Overall Study|Lost to Follow-up|5|||
42360291|NCT01984697|76207941|FG002|Overall Study|Lost to Follow-up|10|||
42360292|NCT01984697|76207942|FG003|Overall Study|Lost to Follow-up|6|||
42360293|NCT01984697|76207943|FG004|Overall Study|Lost to Follow-up|21|||
42360294|NCT01984697|76207939|FG000|Overall Study|Physician Decision|3|||
42360295|NCT01984697|76207940|FG001|Overall Study|Physician Decision|0|||
42360296|NCT01984697|76207941|FG002|Overall Study|Physician Decision|0|||
42360297|NCT01984697|76207942|FG003|Overall Study|Physician Decision|1|||
42360298|NCT01984697|76207943|FG004|Overall Study|Physician Decision|0|||
42360299|NCT01984697|76207939|FG000|Overall Study|Protocol Violation|8|||
42360300|NCT01984697|76207940|FG001|Overall Study|Protocol Violation|5|||
42360301|NCT01984697|76207941|FG002|Overall Study|Protocol Violation|3|||
42360302|NCT01984697|76207942|FG003|Overall Study|Protocol Violation|2|||
42360303|NCT01984697|76207943|FG004|Overall Study|Protocol Violation|0|||
42360304|NCT01984697|76207939|FG000|Overall Study|Withdrawal by Subject|15|||
42360305|NCT01984697|76207940|FG001|Overall Study|Withdrawal by Subject|21|||
42360306|NCT01984697|76207941|FG002|Overall Study|Withdrawal by Subject|13|||
42360307|NCT01984697|76207942|FG003|Overall Study|Withdrawal by Subject|11|||
42099821|NCT00385723|75910439|FG001|Overall Study|Lost to Follow-up|1|||
42360308|NCT01984697|76207943|FG004|Overall Study|Withdrawal by Subject|13|||
42360309|NCT01984697|76207939|FG000|Overall Study|Missed last follow-up visit|1|||
42360310|NCT01984697|76207940|FG001|Overall Study|Missed last follow-up visit|0|||
42099822|NCT00385723|75910440|FG002|Overall Study|Lost to Follow-up|0|||
42099823|NCT00385723|75910438|FG000|Overall Study|Withdrawal by Subject|1|||
42099824|NCT00385723|75910439|FG001|Overall Study|Withdrawal by Subject|0|||
42099825|NCT00385723|75910440|FG002|Overall Study|Withdrawal by Subject|2|||
42099826|NCT00698516|75910448|FG000|Overall Study|Study Termination|2|||
42099827|NCT00698516|75910448|FG000|Overall Study|Withdrawal by Subject|3|||
42099828|NCT00679302|75910458|FG000|Overall Study|Lost to Follow-up|8|||
42099829|NCT00679302|75910459|FG001|Overall Study|Lost to Follow-up|4|||
42099830|NCT00690482|75910488|FG000|Overall Study|Adverse Event|2|||
42099831|NCT00690482|75910489|FG001|Overall Study|Adverse Event|1|||
42298609|NCT02335983|76133770|FG003|Overall Study|Death|0|||
42298610|NCT02335983|76133771|FG004|Overall Study|Death|0|||
42298611|NCT02335983|76133772|FG005|Overall Study|Death|0|||
42298612|NCT02335983|76133767|FG000|Overall Study|Lost to Follow-up|0|||
42298613|NCT02335983|76133768|FG001|Overall Study|Lost to Follow-up|0|||
42298614|NCT02335983|76133769|FG002|Overall Study|Lost to Follow-up|0|||
42298615|NCT02335983|76133770|FG003|Overall Study|Lost to Follow-up|0|||
42298616|NCT02335983|76133771|FG004|Overall Study|Lost to Follow-up|0|||
42298617|NCT02335983|76133772|FG005|Overall Study|Lost to Follow-up|1|||
42298618|NCT02335983|76133767|FG000|Overall Study|Protocol Specified Criteria|5|||
42298619|NCT02335983|76133768|FG001|Overall Study|Protocol Specified Criteria|7|||
42298620|NCT02335983|76133769|FG002|Overall Study|Protocol Specified Criteria|27|||
42298621|NCT02335983|76133770|FG003|Overall Study|Protocol Specified Criteria|7|||
42298622|NCT02335983|76133771|FG004|Overall Study|Protocol Specified Criteria|5|||
42298623|NCT02335983|76133772|FG005|Overall Study|Protocol Specified Criteria|21|||
42298624|NCT04640311|76133808|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
42298625|NCT04640311|76133809|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298626|NCT04640311|76133810|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298627|NCT04640311|76133811|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298628|NCT04640311|76133812|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298629|NCT04640311|76133813|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298630|NCT04640311|76133814|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298631|NCT04640311|76133815|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298632|NCT04640311|76133816|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298633|NCT04640311|76133817|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298634|NCT04640311|76133818|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298635|NCT04640311|76133819|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298636|NCT04640311|76133820|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298637|NCT04640311|76133808|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42298638|NCT04640311|76133809|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
42298639|NCT04640311|76133810|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42298640|NCT04640311|76133811|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42298641|NCT04640311|76133812|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42298642|NCT04640311|76133813|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42298643|NCT04640311|76133814|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42298644|NCT04640311|76133815|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42298645|NCT04640311|76133816|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42298646|NCT04640311|76133817|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42298647|NCT04640311|76133818|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42298648|NCT04640311|76133819|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42360311|NCT01984697|76207941|FG002|Overall Study|Missed last follow-up visit|0|||
42099832|NCT00690482|75910488|FG000|Overall Study|Incorrect enrolment|0|||
42099833|NCT00690482|75910489|FG001|Overall Study|Incorrect enrolment|1|||
42195250|NCT03732807|76007155|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
42195251|NCT03732807|76007156|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
42195252|NCT03732807|76007157|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
42195253|NCT03732807|76007158|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
42195254|NCT03732807|76007152|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
42195255|NCT03732807|76007153|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
42195256|NCT03732807|76007154|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
42195257|NCT03732807|76007155|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
42195258|NCT03732807|76007156|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
42195259|NCT03732807|76007157|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
42195260|NCT03732807|76007158|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
42195261|NCT03732807|76007152|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
42195262|NCT03732807|76007153|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
42195263|NCT03732807|76007154|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
42195264|NCT03732807|76007155|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
42195265|NCT03732807|76007156|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
42195266|NCT03732807|76007157|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
42195267|NCT03732807|76007158|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
42195268|NCT03732807|76007152|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
42195269|NCT03732807|76007153|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
42195270|NCT03732807|76007154|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
42195271|NCT03732807|76007155|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
42195272|NCT03732807|76007156|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
42099834|NCT00690482|75910488|FG000|Overall Study|Study-specific discontinuation criteria|1|||
42099835|NCT00690482|75910489|FG001|Overall Study|Study-specific discontinuation criteria|0|||
42099836|NCT00690482|75910488|FG000|Overall Study|Intake of prohibited medicine|1|||
42099837|NCT00690482|75910489|FG001|Overall Study|Intake of prohibited medicine|0|||
42099838|NCT00690482|75910488|FG000|Overall Study|withdrew consent at rand.day|0|||
42099839|NCT00690482|75910489|FG001|Overall Study|withdrew consent at rand.day|1|||
42195273|NCT03732807|76007157|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
42195274|NCT03732807|76007158|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
42195275|NCT03732807|76007152|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
42195276|NCT03732807|76007153|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
42195277|NCT03732807|76007154|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
42195278|NCT03732807|76007155|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
42195279|NCT03732807|76007156|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
42195280|NCT03732807|76007157|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
42195281|NCT03732807|76007158|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
42195282|NCT03732807|76007152|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
42195283|NCT03732807|76007153|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
42195284|NCT03732807|76007154|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
42195285|NCT03732807|76007155|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
42195286|NCT03732807|76007156|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
42195287|NCT03732807|76007157|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
42195288|NCT03732807|76007158|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
42195289|NCT03732807|76007152|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
42099840|NCT00385255|75910497|FG000|Overall Study|Serious Adverse Event|1|||
42195290|NCT03732807|76007153|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
42298649|NCT04640311|76133820|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
42298650|NCT04640311|76133808|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298651|NCT04640311|76133809|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
42298652|NCT04640311|76133810|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298653|NCT04640311|76133811|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298654|NCT04640311|76133812|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298655|NCT04640311|76133813|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298656|NCT04640311|76133814|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298657|NCT04640311|76133815|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298658|NCT04640311|76133816|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298659|NCT04640311|76133817|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298660|NCT04640311|76133818|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42360312|NCT01984697|76207942|FG003|Overall Study|Missed last follow-up visit|0|||
42360313|NCT01984697|76207943|FG004|Overall Study|Missed last follow-up visit|0|||
42360314|NCT01984697|76207939|FG000|Overall Study|Death|0|||
42360315|NCT01984697|76207940|FG001|Overall Study|Death|0|||
42360316|NCT01984697|76207941|FG002|Overall Study|Death|0|||
42360317|NCT01984697|76207942|FG003|Overall Study|Death|1|||
42360318|NCT01984697|76207943|FG004|Overall Study|Death|0|||
42360319|NCT01984697|76207939|FG000|Overall Study|Pregnancy|2|||
42360320|NCT01984697|76207940|FG001|Overall Study|Pregnancy|0|||
42360321|NCT01984697|76207941|FG002|Overall Study|Pregnancy|1|||
42360322|NCT01984697|76207942|FG003|Overall Study|Pregnancy|0|||
42360323|NCT01984697|76207943|FG004|Overall Study|Pregnancy|1|||
42360324|NCT02000531|76207957|FG000|Overall Study|Lost to Follow-up|1|||
42360325|NCT02000531|76207958|FG001|Overall Study|Lost to Follow-up|0|||
42360326|NCT02000531|76207957|FG000|Overall Study|Discontinued due to data cut-off|3|||
42360327|NCT02000531|76207958|FG001|Overall Study|Discontinued due to data cut-off|8|||
42360328|NCT01609231|76207966|FG000|Overall Study|Adverse Event|1|||
42360329|NCT01609231|76207967|FG001|Overall Study|Adverse Event|3|||
42360330|NCT01609231|76207966|FG000|Overall Study|Physician Decision|1|||
42360331|NCT01609231|76207967|FG001|Overall Study|Physician Decision|0|||
42360332|NCT01609231|76207966|FG000|Overall Study|Withdrawal by Subject|1|||
42360333|NCT01609231|76207967|FG001|Overall Study|Withdrawal by Subject|0|||
42360334|NCT01793935|76207975|FG000|Overall Study|Pregnancy|1|||
42360335|NCT01793935|76207976|FG001|Overall Study|Pregnancy|0|||
42360336|NCT01793935|76207975|FG000|Overall Study|Protocol Violation|2|||
42360337|NCT01793935|76207976|FG001|Overall Study|Protocol Violation|1|||
42360338|NCT01793935|76207975|FG000|Overall Study|Adverse Event|2|||
42360339|NCT01793935|76207976|FG001|Overall Study|Adverse Event|0|||
42360340|NCT01793935|76207975|FG000|Overall Study|Patient did not take study medication|1|||
42360341|NCT01793935|76207976|FG001|Overall Study|Patient did not take study medication|1|||
42360342|NCT01793935|76207975|FG000|Overall Study|Lost to Follow-up|0|||
42360343|NCT01793935|76207976|FG001|Overall Study|Lost to Follow-up|1|||
42360344|NCT02092025|76207982|FG000|Overall Study|Case Report Forms Uncollected|44|||
42360345|NCT02092025|76207982|FG000|Overall Study|Protocol Deviation|24|||
42360346|NCT01769443|76207988|FG000|Overall Study|Study closure|1|||
42360347|NCT01769443|76207989|FG001|Overall Study|Study closure|0|||
42360348|NCT01768117|76207996|FG000|Overall Study|Lost to Follow-up|1|||
42360349|NCT01768117|76207996|FG000|Overall Study|Withdrawal by Subject|2|||
42360350|NCT01768117|76207996|FG000|Overall Study|Protocol Violation|3|||
42360351|NCT01767493|76208000|FG000|Overall Study|screen failures|3|||
42360352|NCT01274182|76208007|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
42360353|NCT01274182|76208008|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
42360354|NCT01274182|76208009|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
42360355|NCT01274182|76208007|FG000|Overall Study|Adverse Event|4|||
42360356|NCT01274182|76208008|FG001|Overall Study|Adverse Event|5|||
42360357|NCT01274182|76208009|FG002|Overall Study|Adverse Event|3|||
42360358|NCT01274182|76208007|FG000|Overall Study|Withdrawal by Subject|5|||
42360359|NCT01274182|76208008|FG001|Overall Study|Withdrawal by Subject|5|||
42360360|NCT01274182|76208009|FG002|Overall Study|Withdrawal by Subject|3|||
42360361|NCT01274182|76208007|FG000|Overall Study|Lost to Follow-up|2|||
42360362|NCT01274182|76208008|FG001|Overall Study|Lost to Follow-up|3|||
42360363|NCT01274182|76208009|FG002|Overall Study|Lost to Follow-up|1|||
42360364|NCT01274182|76208007|FG000|Overall Study|Protocol Violation|3|||
42360365|NCT01274182|76208008|FG001|Overall Study|Protocol Violation|2|||
42360366|NCT01274182|76208009|FG002|Overall Study|Protocol Violation|0|||
42360367|NCT01274182|76208007|FG000|Overall Study|Death|1|||
42360368|NCT01274182|76208008|FG001|Overall Study|Death|0|||
42360369|NCT01274182|76208009|FG002|Overall Study|Death|1|||
42360370|NCT01984229|76208023|FG000|Safety Follow-up Period|Adverse Event|1|||
42360371|NCT01984229|76208024|FG001|Safety Follow-up Period|Adverse Event|1|||
42360372|NCT01984229|76208023|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
42360373|NCT01984229|76208024|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
42360374|NCT01835899|76208039|FG000|Overall Study|Adverse Event|0|||
42360375|NCT01835899|76208040|FG001|Overall Study|Adverse Event|0|||
42360376|NCT01835899|76208041|FG002|Overall Study|Adverse Event|1|||
42360377|NCT01835899|76208039|FG000|Overall Study|Other than stated above|0|||
42360378|NCT01835899|76208040|FG001|Overall Study|Other than stated above|1|||
42360379|NCT01835899|76208041|FG002|Overall Study|Other than stated above|0|||
42360380|NCT01766401|76208053|FG000|Overall Study|Adverse Event|7|||
42360381|NCT01766401|76208054|FG001|Overall Study|Adverse Event|22|||
42360382|NCT01766401|76208053|FG000|Overall Study|Lack of Efficacy|1|||
42360383|NCT01766401|76208054|FG001|Overall Study|Lack of Efficacy|2|||
42360384|NCT01766401|76208053|FG000|Overall Study|Protocol Violation|3|||
42360385|NCT01766401|76208054|FG001|Overall Study|Protocol Violation|8|||
42360386|NCT01766401|76208053|FG000|Overall Study|Withdrawal by Subject|15|||
42360387|NCT01766401|76208054|FG001|Overall Study|Withdrawal by Subject|12|||
42360388|NCT01766401|76208053|FG000|Overall Study|Lost to Follow-up|10|||
42360389|NCT01766401|76208054|FG001|Overall Study|Lost to Follow-up|11|||
42360390|NCT01766401|76208053|FG000|Overall Study|Pregnancy|1|||
42360391|NCT01766401|76208054|FG001|Overall Study|Pregnancy|1|||
42360392|NCT01272934|76208062|FG000|Overall Study|Adverse Event|0|||
42360393|NCT01272934|76208063|FG001|Overall Study|Adverse Event|1|||
42360394|NCT01272934|76208062|FG000|Overall Study|Abnormal Laboratory Value|0|||
42360395|NCT01272934|76208063|FG001|Overall Study|Abnormal Laboratory Value|1|||
42360396|NCT01983683|76208081|FG000|Overall Study|Withdrawal by Subject|14|||
42360397|NCT01983683|76208082|FG001|Overall Study|Withdrawal by Subject|18|||
42360398|NCT01983683|76208081|FG000|Overall Study|Death|11|||
42360399|NCT01983683|76208082|FG001|Overall Study|Death|15|||
42360400|NCT01983683|76208081|FG000|Overall Study|Physician Decision|8|||
42360401|NCT01983683|76208082|FG001|Overall Study|Physician Decision|9|||
42360402|NCT01983683|76208081|FG000|Overall Study|Lost to Follow-up|4|||
42360403|NCT01983683|76208082|FG001|Overall Study|Lost to Follow-up|8|||
42360404|NCT01983683|76208081|FG000|Overall Study|Sponsor Decision|1|||
42360405|NCT01983683|76208082|FG001|Overall Study|Sponsor Decision|1|||
42360406|NCT01998893|76208088|FG000|Overall Study|Adverse Event|2|||
42360407|NCT01998893|76208088|FG000|Overall Study|Death|1|||
42360408|NCT01998893|76208088|FG000|Overall Study|Lost to Follow-up|8|||
42360409|NCT01998893|76208088|FG000|Overall Study|Physician Decision|2|||
42360410|NCT01998893|76208088|FG000|Overall Study|Protocol Violation|2|||
42360411|NCT01998893|76208088|FG000|Overall Study|Withdrawal by Subject|1|||
42360412|NCT01998893|76208088|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
42360413|NCT01791985|76208092|FG000|Overall Study|Adverse Event|7|||
42360414|NCT01791985|76208092|FG000|Overall Study|Withdrawal by Subject|1|||
42360415|NCT01998737|76208099|FG000|Overall Study|Corrupted database|23|||
42360416|NCT01998737|76208100|FG001|Overall Study|Corrupted database|0|||
42360417|NCT01791517|76208109|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
42360418|NCT01791517|76208110|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
42360419|NCT01791517|76208111|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
42360420|NCT01791517|76208112|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
42360421|NCT01791517|76208113|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
42360422|NCT01791517|76208114|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
42360423|NCT01791517|76208115|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
42360424|NCT01791517|76208116|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
42360425|NCT01791517|76208117|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
42360426|NCT01791517|76208118|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
42360427|NCT01791517|76208119|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
42360428|NCT01791517|76208120|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
42360429|NCT01791517|76208109|FG000|Phase I: Period 1|Adverse Event|0|||
42360430|NCT01791517|76208110|FG001|Phase I: Period 1|Adverse Event|0|||
42360431|NCT01791517|76208111|FG002|Phase I: Period 1|Adverse Event|1|||
42360432|NCT01791517|76208112|FG003|Phase I: Period 1|Adverse Event|1|||
42360433|NCT01791517|76208113|FG004|Phase I: Period 1|Adverse Event|0|||
42360434|NCT01791517|76208114|FG005|Phase I: Period 1|Adverse Event|0|||
42360435|NCT01791517|76208115|FG006|Phase I: Period 1|Adverse Event|0|||
42360436|NCT01791517|76208116|FG007|Phase I: Period 1|Adverse Event|0|||
42360437|NCT01791517|76208117|FG008|Phase I: Period 1|Adverse Event|0|||
42360438|NCT01791517|76208118|FG009|Phase I: Period 1|Adverse Event|0|||
42360439|NCT01791517|76208119|FG010|Phase I: Period 1|Adverse Event|0|||
42360440|NCT01791517|76208120|FG011|Phase I: Period 1|Adverse Event|0|||
42360441|NCT01791517|76208109|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
42360442|NCT01791517|76208110|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
42360443|NCT01791517|76208111|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
42360444|NCT01791517|76208112|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
42360445|NCT01791517|76208113|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
42360446|NCT01791517|76208114|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
42360447|NCT01791517|76208115|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
42195291|NCT03732807|76007154|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
42195292|NCT03732807|76007155|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
42195293|NCT03732807|76007156|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
42195294|NCT03732807|76007157|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
42195295|NCT03732807|76007158|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
42195296|NCT03732807|76007152|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
42195297|NCT03732807|76007153|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
42360448|NCT01791517|76208116|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
42360449|NCT01791517|76208117|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
42360450|NCT01791517|76208118|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
42360451|NCT01791517|76208119|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
42360452|NCT01791517|76208120|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
42360453|NCT01791517|76208109|FG000|Phase I: Period 1|Protocol Violation|0|||
42360454|NCT01791517|76208110|FG001|Phase I: Period 1|Protocol Violation|1|||
42360455|NCT01791517|76208111|FG002|Phase I: Period 1|Protocol Violation|0|||
42360456|NCT01791517|76208112|FG003|Phase I: Period 1|Protocol Violation|0|||
42360457|NCT01791517|76208113|FG004|Phase I: Period 1|Protocol Violation|0|||
42360458|NCT01791517|76208114|FG005|Phase I: Period 1|Protocol Violation|0|||
42360459|NCT01791517|76208115|FG006|Phase I: Period 1|Protocol Violation|0|||
42360460|NCT01791517|76208116|FG007|Phase I: Period 1|Protocol Violation|0|||
42360461|NCT01791517|76208117|FG008|Phase I: Period 1|Protocol Violation|0|||
42360462|NCT01791517|76208118|FG009|Phase I: Period 1|Protocol Violation|0|||
42360463|NCT01791517|76208119|FG010|Phase I: Period 1|Protocol Violation|0|||
42360464|NCT01791517|76208120|FG011|Phase I: Period 1|Protocol Violation|0|||
42360465|NCT01791517|76208109|FG000|Phase I: Period 1|Lost to Follow-up|0|||
42360466|NCT01791517|76208110|FG001|Phase I: Period 1|Lost to Follow-up|0|||
42360467|NCT01791517|76208111|FG002|Phase I: Period 1|Lost to Follow-up|0|||
42360468|NCT01791517|76208112|FG003|Phase I: Period 1|Lost to Follow-up|1|||
42360469|NCT01791517|76208113|FG004|Phase I: Period 1|Lost to Follow-up|0|||
42360470|NCT01791517|76208114|FG005|Phase I: Period 1|Lost to Follow-up|0|||
42360471|NCT01791517|76208115|FG006|Phase I: Period 1|Lost to Follow-up|1|||
42360472|NCT01791517|76208116|FG007|Phase I: Period 1|Lost to Follow-up|0|||
42360473|NCT01791517|76208117|FG008|Phase I: Period 1|Lost to Follow-up|1|||
42360474|NCT01791517|76208118|FG009|Phase I: Period 1|Lost to Follow-up|1|||
42360475|NCT01791517|76208119|FG010|Phase I: Period 1|Lost to Follow-up|0|||
42360476|NCT01791517|76208120|FG011|Phase I: Period 1|Lost to Follow-up|0|||
42360477|NCT01791517|76208109|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
42360478|NCT01791517|76208110|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
42360479|NCT01791517|76208111|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
42360480|NCT01791517|76208112|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
42360481|NCT01791517|76208113|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
42360482|NCT01791517|76208114|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
42360483|NCT01791517|76208115|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
42360484|NCT01791517|76208116|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
42360485|NCT01791517|76208117|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
42360486|NCT01791517|76208118|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
42360487|NCT01791517|76208119|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
42360488|NCT01791517|76208120|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
42360489|NCT01791517|76208109|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
42360490|NCT01791517|76208110|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
42360491|NCT01791517|76208111|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
42360492|NCT01791517|76208112|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
42360493|NCT01791517|76208113|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
42360494|NCT01791517|76208114|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
42360495|NCT01791517|76208115|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
42360496|NCT01791517|76208116|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
42360497|NCT01791517|76208117|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
42360498|NCT01791517|76208118|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
42360499|NCT01791517|76208119|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
42360500|NCT01791517|76208120|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
42360501|NCT01791517|76208109|FG000|Phase I: Period 2|Protocol Violation|0|||
42360502|NCT01791517|76208110|FG001|Phase I: Period 2|Protocol Violation|0|||
42099841|NCT00385255|75910498|FG001|Overall Study|Serious Adverse Event|2|||
42099842|NCT00385255|75910497|FG000|Overall Study|Protocol Violation|0|||
42099843|NCT00385255|75910498|FG001|Overall Study|Protocol Violation|4|||
42099844|NCT00385255|75910497|FG000|Overall Study|Withdrawal by Subject|0|||
42099845|NCT00385255|75910498|FG001|Overall Study|Withdrawal by Subject|8|||
42099846|NCT00385255|75910497|FG000|Overall Study|Migrated/moved from study area|0|||
42099847|NCT00385255|75910498|FG001|Overall Study|Migrated/moved from study area|1|||
42099848|NCT00385255|75910497|FG000|Overall Study|Lost to Follow-up|20|||
42360503|NCT01791517|76208111|FG002|Phase I: Period 2|Protocol Violation|0|||
42360504|NCT01791517|76208112|FG003|Phase I: Period 2|Protocol Violation|1|||
42360505|NCT01791517|76208113|FG004|Phase I: Period 2|Protocol Violation|0|||
42360506|NCT01791517|76208114|FG005|Phase I: Period 2|Protocol Violation|0|||
42360507|NCT01791517|76208115|FG006|Phase I: Period 2|Protocol Violation|0|||
42360508|NCT01791517|76208116|FG007|Phase I: Period 2|Protocol Violation|0|||
42360509|NCT01791517|76208117|FG008|Phase I: Period 2|Protocol Violation|0|||
42360510|NCT01791517|76208118|FG009|Phase I: Period 2|Protocol Violation|0|||
42360511|NCT01791517|76208119|FG010|Phase I: Period 2|Protocol Violation|0|||
42360512|NCT01791517|76208120|FG011|Phase I: Period 2|Protocol Violation|0|||
42360513|NCT01791517|76208109|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
42360514|NCT01791517|76208110|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
42360515|NCT01791517|76208111|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
42360516|NCT01791517|76208112|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
42360517|NCT01791517|76208113|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
42099849|NCT00385255|75910498|FG001|Overall Study|Lost to Follow-up|58|||
42360518|NCT01791517|76208114|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
42360519|NCT01791517|76208115|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
42360520|NCT01791517|76208116|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
42099850|NCT00698204|75910510|FG000|Overall Study|Withdrawal by Subject|1|||
42360521|NCT01791517|76208117|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
42360522|NCT01791517|76208118|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
42360523|NCT01791517|76208119|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
42360524|NCT01791517|76208120|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
42360525|NCT01791517|76208109|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
42360526|NCT01791517|76208110|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
42360527|NCT01791517|76208111|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
42360528|NCT01791517|76208112|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
42360529|NCT01791517|76208113|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
42360530|NCT01791517|76208114|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
42360531|NCT01791517|76208115|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
42360532|NCT01791517|76208116|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
42360533|NCT01791517|76208117|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
42360534|NCT01791517|76208118|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
42360535|NCT01791517|76208119|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
42360536|NCT01791517|76208120|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
42360537|NCT01791517|76208109|FG000|Phase I: Period 2|Lens Discomfort|0|||
42360538|NCT01791517|76208110|FG001|Phase I: Period 2|Lens Discomfort|0|||
42360539|NCT01791517|76208111|FG002|Phase I: Period 2|Lens Discomfort|0|||
42360540|NCT01791517|76208112|FG003|Phase I: Period 2|Lens Discomfort|0|||
42360541|NCT01791517|76208113|FG004|Phase I: Period 2|Lens Discomfort|0|||
42360542|NCT01791517|76208114|FG005|Phase I: Period 2|Lens Discomfort|1|||
42360543|NCT01791517|76208115|FG006|Phase I: Period 2|Lens Discomfort|0|||
42360544|NCT01791517|76208116|FG007|Phase I: Period 2|Lens Discomfort|0|||
42360545|NCT01791517|76208117|FG008|Phase I: Period 2|Lens Discomfort|0|||
42360546|NCT01791517|76208118|FG009|Phase I: Period 2|Lens Discomfort|0|||
42360547|NCT01791517|76208119|FG010|Phase I: Period 2|Lens Discomfort|0|||
42360548|NCT01791517|76208120|FG011|Phase I: Period 2|Lens Discomfort|0|||
42360549|NCT01791517|76208109|FG000|Phase I: Period 2|Lost to Follow-up|0|||
42360550|NCT01791517|76208110|FG001|Phase I: Period 2|Lost to Follow-up|3|||
42360551|NCT01791517|76208111|FG002|Phase I: Period 2|Lost to Follow-up|2|||
42360552|NCT01791517|76208112|FG003|Phase I: Period 2|Lost to Follow-up|0|||
42360553|NCT01791517|76208113|FG004|Phase I: Period 2|Lost to Follow-up|0|||
42360554|NCT01791517|76208114|FG005|Phase I: Period 2|Lost to Follow-up|0|||
42360555|NCT01791517|76208115|FG006|Phase I: Period 2|Lost to Follow-up|0|||
42360556|NCT01791517|76208116|FG007|Phase I: Period 2|Lost to Follow-up|0|||
42360557|NCT01791517|76208117|FG008|Phase I: Period 2|Lost to Follow-up|0|||
42360558|NCT01791517|76208118|FG009|Phase I: Period 2|Lost to Follow-up|0|||
42360559|NCT01791517|76208119|FG010|Phase I: Period 2|Lost to Follow-up|0|||
42360560|NCT01791517|76208120|FG011|Phase I: Period 2|Lost to Follow-up|0|||
42360561|NCT01791517|76208109|FG000|Phase I: Period 3|Lens Discomfort|0|||
42360562|NCT01791517|76208110|FG001|Phase I: Period 3|Lens Discomfort|0|||
42360563|NCT01791517|76208111|FG002|Phase I: Period 3|Lens Discomfort|0|||
42360564|NCT01791517|76208112|FG003|Phase I: Period 3|Lens Discomfort|0|||
42360565|NCT01791517|76208113|FG004|Phase I: Period 3|Lens Discomfort|0|||
42360566|NCT01791517|76208114|FG005|Phase I: Period 3|Lens Discomfort|0|||
42360567|NCT01791517|76208115|FG006|Phase I: Period 3|Lens Discomfort|0|||
42360568|NCT01791517|76208116|FG007|Phase I: Period 3|Lens Discomfort|0|||
42360569|NCT01791517|76208117|FG008|Phase I: Period 3|Lens Discomfort|0|||
42360570|NCT01791517|76208118|FG009|Phase I: Period 3|Lens Discomfort|0|||
42360571|NCT01791517|76208119|FG010|Phase I: Period 3|Lens Discomfort|0|||
42360572|NCT01791517|76208120|FG011|Phase I: Period 3|Lens Discomfort|1|||
42360573|NCT01791517|76208109|FG000|Phase I: Period 3|Lost to Follow-up|0|||
42360574|NCT01791517|76208110|FG001|Phase I: Period 3|Lost to Follow-up|1|||
42360575|NCT01791517|76208111|FG002|Phase I: Period 3|Lost to Follow-up|0|||
42360576|NCT01791517|76208112|FG003|Phase I: Period 3|Lost to Follow-up|0|||
42360577|NCT01791517|76208113|FG004|Phase I: Period 3|Lost to Follow-up|1|||
42360578|NCT01791517|76208114|FG005|Phase I: Period 3|Lost to Follow-up|0|||
42360579|NCT01791517|76208115|FG006|Phase I: Period 3|Lost to Follow-up|0|||
42360580|NCT01791517|76208116|FG007|Phase I: Period 3|Lost to Follow-up|0|||
42360581|NCT01791517|76208117|FG008|Phase I: Period 3|Lost to Follow-up|0|||
42360582|NCT01791517|76208118|FG009|Phase I: Period 3|Lost to Follow-up|0|||
42360583|NCT01791517|76208119|FG010|Phase I: Period 3|Lost to Follow-up|0|||
42360584|NCT01791517|76208120|FG011|Phase I: Period 3|Lost to Follow-up|0|||
42360585|NCT01791517|76208109|FG000|Phase I: Period 3|Adverse Event|0|||
42360586|NCT01791517|76208110|FG001|Phase I: Period 3|Adverse Event|0|||
42360587|NCT01791517|76208111|FG002|Phase I: Period 3|Adverse Event|0|||
42360588|NCT01791517|76208112|FG003|Phase I: Period 3|Adverse Event|1|||
42360589|NCT01791517|76208113|FG004|Phase I: Period 3|Adverse Event|0|||
42360590|NCT01791517|76208114|FG005|Phase I: Period 3|Adverse Event|0|||
42360591|NCT01791517|76208115|FG006|Phase I: Period 3|Adverse Event|0|||
42360592|NCT01791517|76208116|FG007|Phase I: Period 3|Adverse Event|0|||
42360593|NCT01791517|76208117|FG008|Phase I: Period 3|Adverse Event|0|||
42360594|NCT01791517|76208118|FG009|Phase I: Period 3|Adverse Event|0|||
42360595|NCT01791517|76208119|FG010|Phase I: Period 3|Adverse Event|0|||
42360596|NCT01791517|76208120|FG011|Phase I: Period 3|Adverse Event|0|||
42360597|NCT01791517|76208109|FG000|Phase II|Lost to Follow-up|1|||
42360598|NCT01791517|76208110|FG001|Phase II|Lost to Follow-up|0|||
42360599|NCT01791517|76208111|FG002|Phase II|Lost to Follow-up|1|||
42360600|NCT01791517|76208112|FG003|Phase II|Lost to Follow-up|0|||
42360601|NCT01791517|76208113|FG004|Phase II|Lost to Follow-up|1|||
42360602|NCT01791517|76208114|FG005|Phase II|Lost to Follow-up|2|||
42360603|NCT01791517|76208115|FG006|Phase II|Lost to Follow-up|0|||
42360604|NCT01791517|76208116|FG007|Phase II|Lost to Follow-up|1|||
42360605|NCT01791517|76208117|FG008|Phase II|Lost to Follow-up|1|||
42360606|NCT01791517|76208118|FG009|Phase II|Lost to Follow-up|1|||
42360607|NCT01791517|76208119|FG010|Phase II|Lost to Follow-up|0|||
42360608|NCT01791517|76208120|FG011|Phase II|Lost to Follow-up|0|||
42360609|NCT01791517|76208109|FG000|Phase II|Withdrawal by Subject|1|||
42360610|NCT01791517|76208110|FG001|Phase II|Withdrawal by Subject|0|||
42360611|NCT01791517|76208111|FG002|Phase II|Withdrawal by Subject|0|||
42360612|NCT01791517|76208112|FG003|Phase II|Withdrawal by Subject|0|||
42360613|NCT01791517|76208113|FG004|Phase II|Withdrawal by Subject|0|||
42360614|NCT01791517|76208114|FG005|Phase II|Withdrawal by Subject|2|||
42360615|NCT01791517|76208115|FG006|Phase II|Withdrawal by Subject|0|||
42360616|NCT01791517|76208116|FG007|Phase II|Withdrawal by Subject|1|||
42360617|NCT01791517|76208117|FG008|Phase II|Withdrawal by Subject|0|||
42360618|NCT01791517|76208118|FG009|Phase II|Withdrawal by Subject|0|||
42360619|NCT01791517|76208119|FG010|Phase II|Withdrawal by Subject|1|||
42360620|NCT01791517|76208120|FG011|Phase II|Withdrawal by Subject|0|||
42360621|NCT01791517|76208109|FG000|Phase II|Lack of Efficacy|0|||
42360622|NCT01791517|76208110|FG001|Phase II|Lack of Efficacy|0|||
42360623|NCT01791517|76208111|FG002|Phase II|Lack of Efficacy|0|||
42360624|NCT01791517|76208112|FG003|Phase II|Lack of Efficacy|0|||
42360625|NCT01791517|76208113|FG004|Phase II|Lack of Efficacy|1|||
42360626|NCT01791517|76208114|FG005|Phase II|Lack of Efficacy|0|||
42360627|NCT01791517|76208115|FG006|Phase II|Lack of Efficacy|0|||
42360628|NCT01791517|76208116|FG007|Phase II|Lack of Efficacy|0|||
42360629|NCT01791517|76208117|FG008|Phase II|Lack of Efficacy|0|||
42360630|NCT01791517|76208118|FG009|Phase II|Lack of Efficacy|0|||
42360631|NCT01791517|76208119|FG010|Phase II|Lack of Efficacy|0|||
42360632|NCT01791517|76208120|FG011|Phase II|Lack of Efficacy|0|||
42360633|NCT01791517|76208109|FG000|Phase II|Adverse Event|0|||
42360634|NCT01791517|76208110|FG001|Phase II|Adverse Event|0|||
42360635|NCT01791517|76208111|FG002|Phase II|Adverse Event|0|||
42360636|NCT01791517|76208112|FG003|Phase II|Adverse Event|0|||
42360637|NCT01791517|76208113|FG004|Phase II|Adverse Event|0|||
42360638|NCT01791517|76208114|FG005|Phase II|Adverse Event|0|||
42360639|NCT01791517|76208115|FG006|Phase II|Adverse Event|2|||
42360640|NCT01791517|76208116|FG007|Phase II|Adverse Event|1|||
42360641|NCT01791517|76208117|FG008|Phase II|Adverse Event|0|||
42360642|NCT01791517|76208118|FG009|Phase II|Adverse Event|1|||
42360643|NCT01791517|76208119|FG010|Phase II|Adverse Event|0|||
42360644|NCT01791517|76208120|FG011|Phase II|Adverse Event|0|||
42360645|NCT01791517|76208109|FG000|Phase II|Lens Handling Difficulties|0|||
42360646|NCT01791517|76208110|FG001|Phase II|Lens Handling Difficulties|0|||
42360647|NCT01791517|76208111|FG002|Phase II|Lens Handling Difficulties|0|||
42360648|NCT01791517|76208112|FG003|Phase II|Lens Handling Difficulties|0|||
42360649|NCT01791517|76208113|FG004|Phase II|Lens Handling Difficulties|0|||
42360650|NCT01791517|76208114|FG005|Phase II|Lens Handling Difficulties|0|||
42360651|NCT01791517|76208115|FG006|Phase II|Lens Handling Difficulties|0|||
42360652|NCT01791517|76208116|FG007|Phase II|Lens Handling Difficulties|0|||
42360653|NCT01791517|76208117|FG008|Phase II|Lens Handling Difficulties|1|||
42360654|NCT01791517|76208118|FG009|Phase II|Lens Handling Difficulties|0|||
42360655|NCT01791517|76208119|FG010|Phase II|Lens Handling Difficulties|0|||
42360656|NCT01791517|76208120|FG011|Phase II|Lens Handling Difficulties|0|||
42360657|NCT01791517|76208109|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
42360658|NCT01791517|76208110|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
42360659|NCT01791517|76208111|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
42360660|NCT01791517|76208112|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
42360661|NCT01791517|76208113|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
42360662|NCT01791517|76208114|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
42360663|NCT01791517|76208115|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
42360664|NCT01791517|76208116|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
42360665|NCT01791517|76208117|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
42360666|NCT01791517|76208118|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
42360667|NCT01791517|76208119|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
42360668|NCT01791517|76208120|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
42360669|NCT01791517|76208109|FG000|Phase II|Pre-Existing Ocular Issue|0|||
42360670|NCT01791517|76208110|FG001|Phase II|Pre-Existing Ocular Issue|0|||
42360671|NCT01791517|76208111|FG002|Phase II|Pre-Existing Ocular Issue|0|||
42360672|NCT01791517|76208112|FG003|Phase II|Pre-Existing Ocular Issue|0|||
42360673|NCT01791517|76208113|FG004|Phase II|Pre-Existing Ocular Issue|0|||
42360674|NCT01791517|76208114|FG005|Phase II|Pre-Existing Ocular Issue|0|||
42360675|NCT01791517|76208115|FG006|Phase II|Pre-Existing Ocular Issue|0|||
42360676|NCT01791517|76208116|FG007|Phase II|Pre-Existing Ocular Issue|0|||
42360677|NCT01791517|76208117|FG008|Phase II|Pre-Existing Ocular Issue|0|||
42360678|NCT01791517|76208118|FG009|Phase II|Pre-Existing Ocular Issue|0|||
42360679|NCT01791517|76208119|FG010|Phase II|Pre-Existing Ocular Issue|0|||
42360680|NCT01791517|76208120|FG011|Phase II|Pre-Existing Ocular Issue|1|||
42360681|NCT01998581|76208140|FG000|Overall Study|Refused repeat treatment|20|||
42360682|NCT01998581|76208141|FG001|Overall Study|Refused repeat treatment|4|||
42360683|NCT01998581|76208140|FG000|Overall Study|Protocol Violation|1|||
42360684|NCT01998581|76208141|FG001|Overall Study|Protocol Violation|0|||
42360685|NCT01998581|76208140|FG000|Overall Study|Withdrawal by Subject|8|||
42360686|NCT01998581|76208141|FG001|Overall Study|Withdrawal by Subject|1|||
42360687|NCT01998581|76208140|FG000|Overall Study|Lost to Follow-up|12|||
42360688|NCT01998581|76208141|FG001|Overall Study|Lost to Follow-up|4|||
42360689|NCT01998581|76208140|FG000|Overall Study|Adverse Event|1|||
42360690|NCT01998581|76208141|FG001|Overall Study|Adverse Event|1|||
42360691|NCT01998581|76208140|FG000|Overall Study|Other reasons|3|||
42360692|NCT01998581|76208141|FG001|Overall Study|Other reasons|2|||
42360693|NCT01998581|76208140|FG000|Overall Study|Randomized but withdrew before treatment|1|||
42360694|NCT01998581|76208141|FG001|Overall Study|Randomized but withdrew before treatment|0|||
42360695|NCT01983293|76208150|FG000|Overall Study|Withdrawal by Subject|29|||
42360696|NCT01983293|76208151|FG001|Overall Study|Withdrawal by Subject|15|||
42360697|NCT01983293|76208150|FG000|Overall Study|Missing 12-month visit|3|||
42360698|NCT01983293|76208151|FG001|Overall Study|Missing 12-month visit|3|||
42360699|NCT01983293|76208150|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
42360700|NCT01983293|76208151|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
42360701|NCT01791205|76208159|FG000|Phase II|Lack of Efficacy|6|||
42360702|NCT01791205|76208160|FG001|Phase II|Lack of Efficacy|0|||
42360703|NCT01791205|76208159|FG000|Phase II|Adverse Event|2|||
42360704|NCT01791205|76208160|FG001|Phase II|Adverse Event|0|||
42360705|NCT01791205|76208159|FG000|Phase II|Safety|1|||
42360706|NCT01791205|76208160|FG001|Phase II|Safety|0|||
42360707|NCT01791205|76208159|FG000|Phase II|Lost to Follow-up|1|||
42360708|NCT01791205|76208160|FG001|Phase II|Lost to Follow-up|0|||
42360709|NCT01791205|76208159|FG000|Phase II|Remission of disease|1|||
42360710|NCT01791205|76208160|FG001|Phase II|Remission of disease|0|||
42360711|NCT01791205|76208159|FG000|Phase II|Physician's decision|1|||
42360712|NCT01791205|76208160|FG001|Phase II|Physician's decision|0|||
42360713|NCT01272232|76208169|FG000|Weeks 0-56|Adverse Event|39|||
42360714|NCT01272232|76208170|FG001|Weeks 0-56|Adverse Event|18|||
42360715|NCT01272232|76208171|FG002|Weeks 0-56|Adverse Event|7|||
42360716|NCT01272232|76208169|FG000|Weeks 0-56|Lack of Efficacy|0|||
42360717|NCT01272232|76208170|FG001|Weeks 0-56|Lack of Efficacy|0|||
42360718|NCT01272232|76208171|FG002|Weeks 0-56|Lack of Efficacy|3|||
42360719|NCT01272232|76208169|FG000|Weeks 0-56|Protocol Violation|12|||
42360720|NCT01272232|76208170|FG001|Weeks 0-56|Protocol Violation|8|||
42360721|NCT01272232|76208171|FG002|Weeks 0-56|Protocol Violation|13|||
42360722|NCT01272232|76208169|FG000|Weeks 0-56|Withdrawal criteria|32|||
42360723|NCT01272232|76208170|FG001|Weeks 0-56|Withdrawal criteria|14|||
42360724|NCT01272232|76208171|FG002|Weeks 0-56|Withdrawal criteria|37|||
42360725|NCT01272232|76208169|FG000|Weeks 0-56|Unclassified|16|||
42360726|NCT01272232|76208170|FG001|Weeks 0-56|Unclassified|7|||
42360727|NCT01272232|76208171|FG002|Weeks 0-56|Unclassified|12|||
42360728|NCT01272232|76208169|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
42360729|NCT01272232|76208170|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
42360730|NCT01272232|76208171|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
42360731|NCT01272232|76208169|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
42360732|NCT01272232|76208170|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
42360733|NCT01272232|76208171|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
42360734|NCT01272232|76208169|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
42360735|NCT01272232|76208170|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
42360736|NCT01272232|76208171|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
42360737|NCT01272232|76208169|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
42360738|NCT01272232|76208170|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
42360739|NCT01272232|76208171|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
42360740|NCT01272232|76208169|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
42360741|NCT01272232|76208170|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
42360742|NCT01272232|76208171|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
42360743|NCT01791127|76208179|FG000|Overall Study|Death|356|||
42360744|NCT01791127|76208179|FG000|Overall Study|Patient has withdrawn from study|293|||
42360745|NCT01791127|76208179|FG000|Overall Study|Lost to Follow-up|42|||
42360746|NCT01791127|76208179|FG000|Overall Study|All Siello leads are explanted|31|||
42360747|NCT01791127|76208179|FG000|Overall Study|Completion of 30 day safety registry|1|||
42195298|NCT03732807|76007154|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
42195299|NCT03732807|76007155|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
42195300|NCT03732807|76007156|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
42195301|NCT03732807|76007157|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
42195302|NCT03732807|76007158|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
42195303|NCT00104416|76007177|FG000|Double-Blind Phase|Adverse Event|2|||
42195304|NCT00104416|76007178|FG001|Double-Blind Phase|Adverse Event|1|||
42195305|NCT00104416|76007179|FG002|Double-Blind Phase|Adverse Event|0|||
42195306|NCT00104416|76007180|FG003|Double-Blind Phase|Adverse Event|0|||
42195307|NCT00104416|76007181|FG004|Double-Blind Phase|Adverse Event|0|||
42195308|NCT00104416|76007177|FG000|Double-Blind Phase|Lost to Follow-up|0|||
42195309|NCT00104416|76007178|FG001|Double-Blind Phase|Lost to Follow-up|1|||
42195310|NCT00104416|76007179|FG002|Double-Blind Phase|Lost to Follow-up|0|||
42195311|NCT00104416|76007180|FG003|Double-Blind Phase|Lost to Follow-up|0|||
42195312|NCT00104416|76007181|FG004|Double-Blind Phase|Lost to Follow-up|0|||
42195313|NCT00104416|76007177|FG000|Double-Blind Phase|Protocol Violation|0|||
42195314|NCT00104416|76007178|FG001|Double-Blind Phase|Protocol Violation|1|||
42195315|NCT00104416|76007179|FG002|Double-Blind Phase|Protocol Violation|0|||
42195316|NCT00104416|76007180|FG003|Double-Blind Phase|Protocol Violation|0|||
42195317|NCT00104416|76007181|FG004|Double-Blind Phase|Protocol Violation|0|||
42195318|NCT00104416|76007177|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
42195319|NCT00104416|76007178|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
42195320|NCT00104416|76007179|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
42195321|NCT00104416|76007180|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
42195322|NCT00104416|76007181|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
42195323|NCT00104416|76007177|FG000|Double-Blind Phase|Pregnancy|1|||
42195324|NCT00104416|76007178|FG001|Double-Blind Phase|Pregnancy|0|||
42195325|NCT00104416|76007179|FG002|Double-Blind Phase|Pregnancy|0|||
42195326|NCT00104416|76007180|FG003|Double-Blind Phase|Pregnancy|0|||
42195327|NCT00104416|76007181|FG004|Double-Blind Phase|Pregnancy|0|||
42195328|NCT00104416|76007177|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
42195329|NCT00104416|76007178|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
42195330|NCT00104416|76007179|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
42195331|NCT00104416|76007180|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
42195332|NCT00104416|76007181|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
42195333|NCT00104416|76007177|FG000|Continuation Phase|Adverse Event|0|||
42195334|NCT00104416|76007178|FG001|Continuation Phase|Adverse Event|0|||
42195335|NCT00104416|76007179|FG002|Continuation Phase|Adverse Event|2|||
42195336|NCT00104416|76007180|FG003|Continuation Phase|Adverse Event|0|||
42195337|NCT00104416|76007181|FG004|Continuation Phase|Adverse Event|2|||
42195338|NCT00104416|76007177|FG000|Continuation Phase|Lost to Follow-up|0|||
42195339|NCT00104416|76007178|FG001|Continuation Phase|Lost to Follow-up|0|||
42195340|NCT00104416|76007179|FG002|Continuation Phase|Lost to Follow-up|1|||
42195341|NCT00104416|76007180|FG003|Continuation Phase|Lost to Follow-up|0|||
42195342|NCT00104416|76007181|FG004|Continuation Phase|Lost to Follow-up|1|||
42195343|NCT00104416|76007177|FG000|Continuation Phase|Withdrawal by Subject|0|||
42195344|NCT00104416|76007178|FG001|Continuation Phase|Withdrawal by Subject|0|||
42195345|NCT00104416|76007179|FG002|Continuation Phase|Withdrawal by Subject|2|||
42195346|NCT00104416|76007180|FG003|Continuation Phase|Withdrawal by Subject|1|||
42195347|NCT00104416|76007181|FG004|Continuation Phase|Withdrawal by Subject|1|||
42195348|NCT00104416|76007177|FG000|Continuation Phase|Pregnancy|0|||
42195349|NCT00104416|76007178|FG001|Continuation Phase|Pregnancy|0|||
42195350|NCT00104416|76007179|FG002|Continuation Phase|Pregnancy|1|||
42195351|NCT00104416|76007180|FG003|Continuation Phase|Pregnancy|1|||
42195352|NCT00104416|76007181|FG004|Continuation Phase|Pregnancy|0|||
42195353|NCT00104416|76007177|FG000|Continuation Phase|Non-compliance|0|||
42195354|NCT00104416|76007178|FG001|Continuation Phase|Non-compliance|0|||
42195355|NCT00104416|76007179|FG002|Continuation Phase|Non-compliance|0|||
42195356|NCT00104416|76007180|FG003|Continuation Phase|Non-compliance|0|||
42195357|NCT00104416|76007181|FG004|Continuation Phase|Non-compliance|1|||
42195358|NCT03639987|76007195|FG000|Overall Study|Study terminated by sponsor|26|||
42195359|NCT03639987|76007196|FG001|Overall Study|Study terminated by sponsor|25|||
42360748|NCT01791127|76208179|FG000|Overall Study|Study terminated for EP Passion|749|||
42195360|NCT03639987|76007195|FG000|Overall Study|Lost to Follow-up|0|||
42195361|NCT03639987|76007196|FG001|Overall Study|Lost to Follow-up|1|||
42195362|NCT02766088|76007202|FG000|Overall Study|Sponsor study termination|498|||
42195363|NCT02766088|76007202|FG000|Overall Study|Migrated/moved from the study area|1|||
42195364|NCT02766088|76007202|FG000|Overall Study|Lost to Follow-up|5|||
42195365|NCT02766088|76007202|FG000|Overall Study|Other|1|||
42195366|NCT02766088|76007202|FG000|Overall Study|Death|1|||
42195367|NCT03639675|76007206|FG000|Overall Study|Withdrawal by Subject|1|||
42360749|NCT01997333|76208210|FG000|Randomization and Treatment|Disease Progression|70|||
42195368|NCT03635775|76007214|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
42195369|NCT03635775|76007215|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
42360750|NCT01997333|76208211|FG001|Randomization and Treatment|Disease Progression|159|||
42360751|NCT01997333|76208210|FG000|Randomization and Treatment|Adverse Event|10|||
42360752|NCT01997333|76208211|FG001|Randomization and Treatment|Adverse Event|32|||
42360753|NCT01997333|76208210|FG000|Randomization and Treatment|Physician Decision|0|||
42360754|NCT01997333|76208211|FG001|Randomization and Treatment|Physician Decision|4|||
42360755|NCT01997333|76208210|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
42360756|NCT01997333|76208211|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
42360757|NCT01997333|76208210|FG000|Randomization and Treatment|Did not receive treatment|17|||
42360758|NCT01997333|76208211|FG001|Randomization and Treatment|Did not receive treatment|5|||
42360759|NCT01997333|76208210|FG000|Survival Follow up|Withdrawal by Subject|15|||
42360760|NCT01997333|76208211|FG001|Survival Follow up|Withdrawal by Subject|6|||
42360761|NCT01997333|76208210|FG000|Survival Follow up|Lost to Follow-up|0|||
42360762|NCT01997333|76208211|FG001|Survival Follow up|Lost to Follow-up|6|||
42360763|NCT01997333|76208210|FG000|Survival Follow up|Various|1|||
42360764|NCT01997333|76208211|FG001|Survival Follow up|Various|2|||
42360765|NCT01982435|76208275|FG000|Overall Study|Adverse Event|1|||
42360766|NCT01982435|76208276|FG001|Overall Study|Adverse Event|0|||
42360767|NCT01620983|76208316|FG000|Overall Study|Lost to Follow-up|8|||
42360768|NCT01620983|76208317|FG001|Overall Study|Lost to Follow-up|4|||
42360769|NCT01620983|76208318|FG002|Overall Study|Lost to Follow-up|9|||
42360770|NCT01620983|76208316|FG000|Overall Study|Withdrawal by Subject|6|||
42360771|NCT01620983|76208317|FG001|Overall Study|Withdrawal by Subject|8|||
42360772|NCT01620983|76208318|FG002|Overall Study|Withdrawal by Subject|1|||
42360773|NCT01620983|76208316|FG000|Overall Study|Death|2|||
42360774|NCT01620983|76208317|FG001|Overall Study|Death|0|||
42360775|NCT01620983|76208318|FG002|Overall Study|Death|0|||
42360776|NCT01620983|76208316|FG000|Overall Study|Physician Decision|3|||
42360777|NCT01620983|76208317|FG001|Overall Study|Physician Decision|10|||
42360778|NCT01620983|76208318|FG002|Overall Study|Physician Decision|5|||
42360779|NCT01996709|76208328|FG000|Overall Study|Withdrawal by Subject|1|||
42360780|NCT01996709|76208329|FG001|Overall Study|Withdrawal by Subject|0|||
42360781|NCT01996709|76208328|FG000|Overall Study|Lost to Follow-up|3|||
42360782|NCT01996709|76208329|FG001|Overall Study|Lost to Follow-up|0|||
42360783|NCT01996709|76208328|FG000|Overall Study|Subject Non-Compliant|1|||
42360784|NCT01996709|76208329|FG001|Overall Study|Subject Non-Compliant|0|||
42360785|NCT01996709|76208328|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
42360786|NCT01996709|76208329|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
42360787|NCT01996319|76208354|FG000|Overall Study|Protocol Violation|1|||
42360788|NCT01996319|76208355|FG001|Overall Study|Protocol Violation|0|||
42360789|NCT01996319|76208354|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
42360790|NCT01996319|76208355|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
42360791|NCT01996319|76208354|FG000|Overall Study|Adverse Event|2|||
42360792|NCT01996319|76208355|FG001|Overall Study|Adverse Event|2|||
42360793|NCT01279486|76208361|FG000|Overall Study|Lost to Follow-up|1|||
42360794|NCT01279954|76208367|FG000|Overall Study|Lack of Efficacy|3|||
42360795|NCT01279954|76208368|FG001|Overall Study|Lack of Efficacy|4|||
42360796|NCT01278862|76208379|FG000|Overall Study|Lost to Follow-up|1|||
42360797|NCT01278862|76208380|FG001|Overall Study|Lost to Follow-up|1|||
42360798|NCT01278394|76208395|FG000|Overall Study|Lost to Follow-up|1|||
42360799|NCT01981187|76208399|FG000|Overall Study|Participant/guardian decision|2|||
42360800|NCT01981187|76208399|FG000|Overall Study|Physician Decision|1|||
42360801|NCT01981187|76208399|FG000|Overall Study|Disease progression|2|||
42360802|NCT01981187|76208399|FG000|Overall Study|Adverse Event|7|||
42360803|NCT01278160|76208405|FG000|Overall Study|Adverse Event|1|||
42360804|NCT01278160|76208406|FG001|Overall Study|Adverse Event|1|||
42360805|NCT01278160|76208405|FG000|Overall Study|Lost to Follow-up|0|||
42360806|NCT01278160|76208406|FG001|Overall Study|Lost to Follow-up|1|||
42360807|NCT01278160|76208405|FG000|Overall Study|Withdrawal by Subject|3|||
42360808|NCT01278160|76208406|FG001|Overall Study|Withdrawal by Subject|2|||
42360809|NCT01278160|76208405|FG000|Overall Study|Unclassified|1|||
42360810|NCT01278160|76208406|FG001|Overall Study|Unclassified|2|||
42360811|NCT01996241|76208414|FG000|Overall Study|Lost to Follow-up|252|||
42360812|NCT01996241|76208415|FG001|Overall Study|Lost to Follow-up|235|||
42360813|NCT02091869|76208425|FG000|Overall Study|Withdrawal by Subject|0|||
42360814|NCT02091869|76208426|FG001|Overall Study|Withdrawal by Subject|3|||
42360815|NCT01981109|76208441|FG000|Overall Study|Death|36|||
42360816|NCT01981109|76208441|FG000|Overall Study|Withdrawal by Subject|40|||
42360817|NCT01981109|76208441|FG000|Overall Study|Lost to Follow-up|9|||
42360818|NCT01981109|76208441|FG000|Overall Study|No Discontinuation Documentation|37|||
42360819|NCT01981109|76208441|FG000|Overall Study|Study Termination|100|||
42360820|NCT01981109|76208441|FG000|Overall Study|No data available|2|||
42360821|NCT00248794|76208449|FG000|Overall Study|Lost to Follow-up|6|||
42360822|NCT00248794|76208450|FG001|Overall Study|Lost to Follow-up|8|||
42360823|NCT00248794|76208451|FG002|Overall Study|Lost to Follow-up|3|||
42360824|NCT01995539|76208465|FG000|Overall Study|Screening Failure|1|||
42360825|NCT01995539|76208465|FG000|Overall Study|Withdrawal by Investigator|15|||
42360826|NCT01995539|76208465|FG000|Overall Study|Withdrawal by Subject|11|||
42360827|NCT01995539|76208465|FG000|Overall Study|Lost to Follow-up|5|||
42360828|NCT01995539|76208465|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
42360829|NCT01835587|76208473|FG000|Overall Study|Disease Recurrence or Relapse|0|||
42360830|NCT01835587|76208474|FG001|Overall Study|Disease Recurrence or Relapse|3|||
42360831|NCT01835587|76208475|FG002|Overall Study|Disease Recurrence or Relapse|0|||
42360832|NCT01835587|76208476|FG003|Overall Study|Disease Recurrence or Relapse|3|||
42360833|NCT01835587|76208473|FG000|Overall Study|Withdrawal by Subject|2|||
42360834|NCT01835587|76208474|FG001|Overall Study|Withdrawal by Subject|0|||
42360835|NCT01835587|76208475|FG002|Overall Study|Withdrawal by Subject|0|||
42360836|NCT01835587|76208476|FG003|Overall Study|Withdrawal by Subject|3|||
42360837|NCT01835587|76208473|FG000|Overall Study|Adverse Event|0|||
42360838|NCT01835587|76208474|FG001|Overall Study|Adverse Event|0|||
42360839|NCT01835587|76208475|FG002|Overall Study|Adverse Event|2|||
42360840|NCT01835587|76208476|FG003|Overall Study|Adverse Event|2|||
42360841|NCT01835587|76208473|FG000|Overall Study|Death|0|||
42360842|NCT01835587|76208474|FG001|Overall Study|Death|0|||
42360843|NCT01835587|76208475|FG002|Overall Study|Death|0|||
42360844|NCT01835587|76208476|FG003|Overall Study|Death|1|||
42360845|NCT01835587|76208473|FG000|Overall Study|Miscellaneous|0|||
42360846|NCT01835587|76208474|FG001|Overall Study|Miscellaneous|1|||
42360847|NCT01835587|76208475|FG002|Overall Study|Miscellaneous|0|||
42360848|NCT01835587|76208476|FG003|Overall Study|Miscellaneous|0|||
42360849|NCT01736917|76208493|FG000|Overall Study|Adverse Event|1|||
42360850|NCT01736917|76208493|FG000|Overall Study|Protocol Violation|10|||
42360851|NCT01277302|76208502|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
42360852|NCT01277302|76208503|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
42360853|NCT01277302|76208504|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
42360854|NCT01277302|76208502|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
42360855|NCT01277302|76208503|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
42360856|NCT01277302|76208504|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
42360857|NCT01277302|76208502|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
42360858|NCT01277302|76208503|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
42360859|NCT01277302|76208504|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
42360860|NCT01277302|76208502|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
42360861|NCT01277302|76208503|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
42360862|NCT01277302|76208504|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
42360863|NCT01277302|76208502|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
42360864|NCT01277302|76208503|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
42360865|NCT01277302|76208504|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
42360866|NCT01277302|76208502|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
42360867|NCT01277302|76208503|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
42360868|NCT01277302|76208504|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
42360869|NCT01277302|76208502|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
42360870|NCT01277302|76208503|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
42360871|NCT01277302|76208504|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
42360872|NCT01277302|76208502|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
42360873|NCT01277302|76208503|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
42360874|NCT01277302|76208504|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
42360875|NCT01277302|76208502|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
42360876|NCT01277302|76208503|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
42360877|NCT01277302|76208504|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
42099851|NCT00698204|75910511|FG001|Overall Study|Withdrawal by Subject|0|||
42099852|NCT00549718|75910523|FG000|Overall Study|Insufficient clinical response|20|||
42099853|NCT00549718|75910524|FG001|Overall Study|Insufficient clinical response|7|||
42360878|NCT01980875|76208515|FG000|Overall Study|Withdrew Consent|1|||
42360879|NCT01980875|76208516|FG001|Overall Study|Withdrew Consent|1|||
42360880|NCT01980875|76208517|FG002|Overall Study|Withdrew Consent|1|||
42360881|NCT01980875|76208515|FG000|Overall Study|Study Terminated by Sponsor|7|||
42360882|NCT01980875|76208516|FG001|Overall Study|Study Terminated by Sponsor|24|||
42360883|NCT01980875|76208517|FG002|Overall Study|Study Terminated by Sponsor|22|||
42360884|NCT01980875|76208515|FG000|Overall Study|Lost to Follow-up|0|||
42360885|NCT01980875|76208516|FG001|Overall Study|Lost to Follow-up|0|||
42360886|NCT01980875|76208517|FG002|Overall Study|Lost to Follow-up|1|||
42360887|NCT01995461|76208525|FG000|Overall Study|Death|1|||
42360888|NCT01995461|76208525|FG000|Overall Study|Lost to Follow-up|2|||
42360889|NCT01995461|76208525|FG000|Overall Study|Withdrawal by Subject|2|||
42099854|NCT00549718|75910525|FG002|Overall Study|Insufficient clinical response|18|||
42360890|NCT01980095|76208531|FG000|Overall Study|Lost to Follow-up|6|||
42360891|NCT01980095|76208532|FG001|Overall Study|Lost to Follow-up|7|||
42360892|NCT01980095|76208531|FG000|Overall Study|Withdrawal by Subject|2|||
42360893|NCT01980095|76208532|FG001|Overall Study|Withdrawal by Subject|3|||
42360894|NCT01980095|76208531|FG000|Overall Study|Poor compliance|5|||
42360895|NCT01980095|76208532|FG001|Overall Study|Poor compliance|0|||
42360896|NCT01980095|76208531|FG000|Overall Study|Safety issue|0|||
42360897|NCT01980095|76208532|FG001|Overall Study|Safety issue|1|||
42360898|NCT01980095|76208531|FG000|Overall Study|Study drug discontinued|1|||
42360899|NCT01980095|76208532|FG001|Overall Study|Study drug discontinued|0|||
42360900|NCT01980095|76208531|FG000|Overall Study|Randomized by mistake|1|||
42360901|NCT01980095|76208532|FG001|Overall Study|Randomized by mistake|0|||
42360902|NCT01980017|76208542|FG000|Overall Study|Lost to Follow-up|30|||
42360903|NCT01980017|76208543|FG001|Overall Study|Lost to Follow-up|21|||
42360904|NCT01980017|76208542|FG000|Overall Study|Death|0|||
42360905|NCT01980017|76208543|FG001|Overall Study|Death|1|||
42360906|NCT01978145|76208552|FG000|Treatment Period 1|Adverse Event|1|||
42360907|NCT01978145|76208553|FG001|Treatment Period 1|Adverse Event|9|||
42360908|NCT01978145|76208552|FG000|Treatment Period 1|Physician Decision|1|||
42360909|NCT01978145|76208553|FG001|Treatment Period 1|Physician Decision|0|||
42360910|NCT01978145|76208552|FG000|Treatment Period 1|Withdrawal by Subject|5|||
42360911|NCT01978145|76208553|FG001|Treatment Period 1|Withdrawal by Subject|4|||
42360912|NCT01978145|76208552|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
42360913|NCT01978145|76208553|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
42360914|NCT01978145|76208552|FG000|Washout Period 1|Adverse Event|0|||
42360915|NCT01978145|76208553|FG001|Washout Period 1|Adverse Event|1|||
42360916|NCT01978145|76208552|FG000|Washout Period 1|Withdrawal by Subject|1|||
42360917|NCT01978145|76208553|FG001|Washout Period 1|Withdrawal by Subject|1|||
42360918|NCT01978145|76208552|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
42360919|NCT01978145|76208553|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
42360920|NCT01978145|76208552|FG000|Treatment Period 2|Adverse Event|3|||
42360921|NCT01978145|76208553|FG001|Treatment Period 2|Adverse Event|3|||
42360922|NCT01978145|76208552|FG000|Treatment Period 2|Protocol Violation|0|||
42360923|NCT01978145|76208553|FG001|Treatment Period 2|Protocol Violation|1|||
42099855|NCT00549718|75910526|FG003|Overall Study|Insufficient clinical response|32|||
42360924|NCT01978145|76208552|FG000|Treatment Period 2|Lost to Follow-up|1|||
42360925|NCT01978145|76208553|FG001|Treatment Period 2|Lost to Follow-up|1|||
42360926|NCT01978145|76208552|FG000|Treatment Period 2|Withdrawal by Subject|7|||
42360927|NCT01978145|76208553|FG001|Treatment Period 2|Withdrawal by Subject|4|||
42360928|NCT01978145|76208552|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
42360929|NCT01978145|76208553|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
42360930|NCT01967537|76208559|FG000|Overall Study|Withdrawal by Subject|52|||
42360931|NCT01967537|76208559|FG000|Overall Study|Refuse treatment|2|||
42360932|NCT01967537|76208559|FG000|Overall Study|Lost to Follow-up|6|||
42360933|NCT01967225|76208567|FG000|Overall Study|Adverse Event|3|||
42360934|NCT01967225|76208568|FG001|Overall Study|Adverse Event|1|||
42360935|NCT01967225|76208567|FG000|Overall Study|Withdrawal by Subject|2|||
42360936|NCT01967225|76208568|FG001|Overall Study|Withdrawal by Subject|1|||
42360937|NCT01967225|76208567|FG000|Overall Study|Lack of Efficacy|1|||
42360938|NCT01967225|76208568|FG001|Overall Study|Lack of Efficacy|1|||
42099856|NCT00549718|75910523|FG000|Overall Study|Adverse Event|6|||
42099857|NCT00549718|75910524|FG001|Overall Study|Adverse Event|8|||
42099858|NCT00549718|75910525|FG002|Overall Study|Adverse Event|7|||
42099859|NCT00549718|75910526|FG003|Overall Study|Adverse Event|3|||
42099860|NCT00549718|75910523|FG000|Overall Study|Lost to Follow-up|4|||
42099861|NCT00549718|75910524|FG001|Overall Study|Lost to Follow-up|2|||
42360939|NCT01967225|76208567|FG000|Overall Study|Switching to other therapy|2|||
42360940|NCT01967225|76208568|FG001|Overall Study|Switching to other therapy|0|||
42360941|NCT01967225|76208567|FG000|Overall Study|Protocol driven decision point|1|||
42360942|NCT01967225|76208568|FG001|Overall Study|Protocol driven decision point|0|||
42360943|NCT01967225|76208567|FG000|Overall Study|Logistical difficulties|1|||
42360944|NCT01967225|76208568|FG001|Overall Study|Logistical difficulties|0|||
42360945|NCT01967225|76208567|FG000|Overall Study|Protocol Violation|2|||
42360946|NCT01967225|76208568|FG001|Overall Study|Protocol Violation|0|||
42360947|NCT01967147|76208578|FG000|Overall Study|Adverse Event|5|||
42360948|NCT01967147|76208579|FG001|Overall Study|Adverse Event|2|||
42360949|NCT01967147|76208578|FG000|Overall Study|Lack of Efficacy|1|||
42360950|NCT01967147|76208579|FG001|Overall Study|Lack of Efficacy|4|||
42360951|NCT01967147|76208578|FG000|Overall Study|Lost to Follow-up|1|||
42360952|NCT01967147|76208579|FG001|Overall Study|Lost to Follow-up|2|||
42360953|NCT01967147|76208578|FG000|Overall Study|Withdrawal by Subject|2|||
42360954|NCT01967147|76208579|FG001|Overall Study|Withdrawal by Subject|4|||
42360955|NCT01967147|76208578|FG000|Overall Study|Non-compliance with Study Drug|0|||
42360956|NCT01967147|76208579|FG001|Overall Study|Non-compliance with Study Drug|3|||
42360957|NCT01967147|76208578|FG000|Overall Study|Other|4|||
42360958|NCT01967147|76208579|FG001|Overall Study|Other|5|||
42360959|NCT01967069|76208588|FG000|Overall Study|Adverse Event|2|||
42195370|NCT03635775|76007216|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
42195371|NCT03635775|76007217|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
42195372|NCT03610581|76007229|FG000|Overall Study|Study terminated by sponsor|2|||
42099862|NCT00549718|75910525|FG002|Overall Study|Lost to Follow-up|0|||
42099863|NCT00549718|75910526|FG003|Overall Study|Lost to Follow-up|6|||
42099864|NCT00549718|75910523|FG000|Overall Study|Withdrawal by Subject|9|||
42099865|NCT00549718|75910524|FG001|Overall Study|Withdrawal by Subject|18|||
42099866|NCT00549718|75910525|FG002|Overall Study|Withdrawal by Subject|12|||
42099867|NCT00549718|75910526|FG003|Overall Study|Withdrawal by Subject|13|||
42099868|NCT00549718|75910523|FG000|Overall Study|Administrative|2|||
42099869|NCT00549718|75910524|FG001|Overall Study|Administrative|2|||
42099870|NCT00549718|75910525|FG002|Overall Study|Administrative|2|||
42099871|NCT00549718|75910526|FG003|Overall Study|Administrative|1|||
42099872|NCT00371761|75910538|FG000|Overall Study|Adverse Event|1|||
42099873|NCT00371761|75910539|FG001|Overall Study|Adverse Event|1|||
42099874|NCT00371761|75910538|FG000|Overall Study|Withdrawal by Subject|1|||
42099875|NCT00371761|75910539|FG001|Overall Study|Withdrawal by Subject|3|||
42099876|NCT00371761|75910538|FG000|Overall Study|Investigator Judgment|2|||
42099877|NCT00371761|75910539|FG001|Overall Study|Investigator Judgment|3|||
42099878|NCT00371761|75910538|FG000|Overall Study|Study termination|4|||
42099879|NCT00371761|75910539|FG001|Overall Study|Study termination|3|||
42099880|NCT00549640|75910547|FG000|Overall Study|Withdrawal by Subject|6|||
42099881|NCT00549640|75910548|FG001|Overall Study|Withdrawal by Subject|12|||
42099882|NCT00549640|75910547|FG000|Overall Study|Adverse Event|5|||
42099883|NCT00549640|75910548|FG001|Overall Study|Adverse Event|0|||
42099884|NCT00549640|75910547|FG000|Overall Study|Lost to Follow-up|7|||
42099885|NCT00549640|75910548|FG001|Overall Study|Lost to Follow-up|4|||
42195373|NCT03610581|76007230|FG001|Overall Study|Study terminated by sponsor|0|||
42195374|NCT03610581|76007229|FG000|Overall Study|Other|0|||
42195375|NCT03610581|76007230|FG001|Overall Study|Other|1|||
42195376|NCT03610581|76007229|FG000|Overall Study|Withdrawal by Subject|1|||
42099886|NCT00549562|75910570|FG000|Overall Study|Adverse Event|1|||
42099887|NCT00549562|75910570|FG000|Overall Study|Lack of Efficacy|1|||
42099888|NCT00681564|75910576|FG000|Overall Study|Lost to Follow-up|6|||
42099889|NCT00681564|75910577|FG001|Overall Study|Lost to Follow-up|6|||
42099890|NCT00681564|75910576|FG000|Overall Study|Withdrawal by Subject|0|||
42099891|NCT00681564|75910577|FG001|Overall Study|Withdrawal by Subject|1|||
42099892|NCT00681564|75910576|FG000|Overall Study|Death|0|||
42099893|NCT00681564|75910577|FG001|Overall Study|Death|1|||
42099894|NCT00677352|75910585|FG000|Treatment Phase|Adverse Event|14|||
42099895|NCT00677352|75910586|FG001|Treatment Phase|Adverse Event|22|||
42099896|NCT00677352|75910585|FG000|Treatment Phase|Lack of Efficacy|2|||
42099897|NCT00677352|75910586|FG001|Treatment Phase|Lack of Efficacy|3|||
42099898|NCT00677352|75910585|FG000|Treatment Phase|Lost to Follow-up|0|||
42099899|NCT00677352|75910586|FG001|Treatment Phase|Lost to Follow-up|1|||
42099900|NCT00677352|75910585|FG000|Treatment Phase|Withdrawal by Subject|7|||
42195377|NCT03610581|76007230|FG001|Overall Study|Withdrawal by Subject|0|||
42195378|NCT03610269|76007236|FG000|Overall Study|Physician Decision|10|||
42360960|NCT01967069|76208589|FG001|Overall Study|Adverse Event|2|||
42360961|NCT01967069|76208588|FG000|Overall Study|Lost to Follow-up|5|||
42360962|NCT01967069|76208589|FG001|Overall Study|Lost to Follow-up|2|||
42360963|NCT01967069|76208588|FG000|Overall Study|Withdrawal by Subject|1|||
42360964|NCT01967069|76208589|FG001|Overall Study|Withdrawal by Subject|3|||
42360965|NCT01967069|76208588|FG000|Overall Study|Lack of Efficacy|0|||
42360966|NCT01967069|76208589|FG001|Overall Study|Lack of Efficacy|1|||
42360967|NCT01790503|76208606|FG000|Overall Study|Adverse Event|1|||
42360968|NCT01790503|76208607|FG001|Overall Study|Adverse Event|0|||
42360969|NCT01790503|76208608|FG002|Overall Study|Adverse Event|0|||
42360970|NCT01790503|76208609|FG003|Overall Study|Adverse Event|0|||
42360971|NCT01790503|76208610|FG004|Overall Study|Adverse Event|0|||
42360972|NCT01790503|76208611|FG005|Overall Study|Adverse Event|2|||
42360973|NCT01790503|76208612|FG006|Overall Study|Adverse Event|0|||
42360974|NCT01790503|76208613|FG007|Overall Study|Adverse Event|0|||
42360975|NCT01790503|76208614|FG008|Overall Study|Adverse Event|2|||
42360976|NCT01790503|76208615|FG009|Overall Study|Adverse Event|4|||
42099901|NCT00677352|75910586|FG001|Treatment Phase|Withdrawal by Subject|7|||
42099902|NCT00677352|75910585|FG000|Treatment Phase|Physician Decision|1|||
42099903|NCT00677352|75910586|FG001|Treatment Phase|Physician Decision|0|||
42099904|NCT00677352|75910585|FG000|Treatment Phase|Pregnancy|0|||
42099905|NCT00677352|75910586|FG001|Treatment Phase|Pregnancy|1|||
42099906|NCT00677352|75910585|FG000|Treatment Phase|Protocol Violation|1|||
42099907|NCT00677352|75910586|FG001|Treatment Phase|Protocol Violation|1|||
42360977|NCT01790503|76208616|FG010|Overall Study|Adverse Event|7|||
42360978|NCT01790503|76208606|FG000|Overall Study|Withdrawal by Subject|0|||
42360979|NCT01790503|76208607|FG001|Overall Study|Withdrawal by Subject|0|||
42360980|NCT01790503|76208608|FG002|Overall Study|Withdrawal by Subject|1|||
42360981|NCT01790503|76208609|FG003|Overall Study|Withdrawal by Subject|1|||
42360982|NCT01790503|76208610|FG004|Overall Study|Withdrawal by Subject|1|||
42360983|NCT01790503|76208611|FG005|Overall Study|Withdrawal by Subject|2|||
42360984|NCT01790503|76208612|FG006|Overall Study|Withdrawal by Subject|1|||
42360985|NCT01790503|76208613|FG007|Overall Study|Withdrawal by Subject|0|||
42360986|NCT01790503|76208614|FG008|Overall Study|Withdrawal by Subject|0|||
42360987|NCT01790503|76208615|FG009|Overall Study|Withdrawal by Subject|0|||
42360988|NCT01790503|76208616|FG010|Overall Study|Withdrawal by Subject|1|||
42360989|NCT01790503|76208606|FG000|Overall Study|Disease progression|2|||
42360990|NCT01790503|76208607|FG001|Overall Study|Disease progression|1|||
42360991|NCT01790503|76208608|FG002|Overall Study|Disease progression|0|||
42360992|NCT01790503|76208609|FG003|Overall Study|Disease progression|1|||
42360993|NCT01790503|76208610|FG004|Overall Study|Disease progression|2|||
42360994|NCT01790503|76208611|FG005|Overall Study|Disease progression|1|||
42360995|NCT01790503|76208612|FG006|Overall Study|Disease progression|0|||
42360996|NCT01790503|76208613|FG007|Overall Study|Disease progression|1|||
42360997|NCT01790503|76208614|FG008|Overall Study|Disease progression|0|||
42360998|NCT01790503|76208615|FG009|Overall Study|Disease progression|17|||
42360999|NCT01790503|76208616|FG010|Overall Study|Disease progression|7|||
42361000|NCT01790503|76208606|FG000|Overall Study|Protocol Violation|0|||
42361001|NCT01790503|76208607|FG001|Overall Study|Protocol Violation|0|||
42361002|NCT01790503|76208608|FG002|Overall Study|Protocol Violation|0|||
42361003|NCT01790503|76208609|FG003|Overall Study|Protocol Violation|0|||
42361004|NCT01790503|76208610|FG004|Overall Study|Protocol Violation|0|||
42361005|NCT01790503|76208611|FG005|Overall Study|Protocol Violation|0|||
42361006|NCT01790503|76208612|FG006|Overall Study|Protocol Violation|0|||
42361007|NCT01790503|76208613|FG007|Overall Study|Protocol Violation|0|||
42361008|NCT01790503|76208614|FG008|Overall Study|Protocol Violation|0|||
42361009|NCT01790503|76208615|FG009|Overall Study|Protocol Violation|1|||
42361010|NCT01790503|76208616|FG010|Overall Study|Protocol Violation|0|||
42361011|NCT01790503|76208606|FG000|Overall Study|Physician Decision|0|||
42361012|NCT01790503|76208607|FG001|Overall Study|Physician Decision|0|||
42361013|NCT01790503|76208608|FG002|Overall Study|Physician Decision|0|||
42361014|NCT01790503|76208609|FG003|Overall Study|Physician Decision|0|||
42361015|NCT01790503|76208610|FG004|Overall Study|Physician Decision|0|||
42361016|NCT01790503|76208611|FG005|Overall Study|Physician Decision|0|||
42361017|NCT01790503|76208612|FG006|Overall Study|Physician Decision|0|||
42195379|NCT03610269|76007236|FG000|Overall Study|Protocol Violation|1|||
42195380|NCT03610269|76007236|FG000|Overall Study|Unable to draw blood|1|||
42195381|NCT03610269|76007236|FG000|Overall Study|Screen fail|4|||
42195382|NCT00121667|76007244|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
42195383|NCT00121667|76007245|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
42195384|NCT00121667|76007246|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
42195385|NCT00121667|76007247|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
42195386|NCT00121667|76007244|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
42361018|NCT01790503|76208613|FG007|Overall Study|Physician Decision|0|||
42361019|NCT01790503|76208614|FG008|Overall Study|Physician Decision|0|||
42361020|NCT01790503|76208615|FG009|Overall Study|Physician Decision|1|||
42361021|NCT01790503|76208616|FG010|Overall Study|Physician Decision|1|||
42361022|NCT01790503|76208606|FG000|Overall Study|Death|0|||
42361023|NCT01790503|76208607|FG001|Overall Study|Death|0|||
42361024|NCT01790503|76208608|FG002|Overall Study|Death|0|||
42361025|NCT01790503|76208609|FG003|Overall Study|Death|0|||
42361026|NCT01790503|76208610|FG004|Overall Study|Death|0|||
42361027|NCT01790503|76208611|FG005|Overall Study|Death|0|||
42361028|NCT01790503|76208612|FG006|Overall Study|Death|0|||
42361029|NCT01790503|76208613|FG007|Overall Study|Death|0|||
42361030|NCT01790503|76208614|FG008|Overall Study|Death|0|||
42195387|NCT00121667|76007245|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
42195388|NCT00121667|76007246|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
42195389|NCT00121667|76007247|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
42195390|NCT00121667|76007244|FG000|Short Term (ST) Period|Adverse Event|5|||
42361031|NCT01790503|76208615|FG009|Overall Study|Death|1|||
42361032|NCT01790503|76208616|FG010|Overall Study|Death|0|||
42361033|NCT01790503|76208606|FG000|Overall Study|Non Compliance|0|||
42361034|NCT01790503|76208607|FG001|Overall Study|Non Compliance|0|||
42361035|NCT01790503|76208608|FG002|Overall Study|Non Compliance|0|||
42361036|NCT01790503|76208609|FG003|Overall Study|Non Compliance|0|||
42361037|NCT01790503|76208610|FG004|Overall Study|Non Compliance|1|||
42361038|NCT01790503|76208611|FG005|Overall Study|Non Compliance|0|||
42361039|NCT01790503|76208612|FG006|Overall Study|Non Compliance|0|||
42361040|NCT01790503|76208613|FG007|Overall Study|Non Compliance|0|||
42361041|NCT01790503|76208614|FG008|Overall Study|Non Compliance|0|||
42361042|NCT01790503|76208615|FG009|Overall Study|Non Compliance|0|||
42361043|NCT01790503|76208616|FG010|Overall Study|Non Compliance|0|||
42361044|NCT01790503|76208606|FG000|Overall Study|Other|0|||
42361045|NCT01790503|76208607|FG001|Overall Study|Other|0|||
42361046|NCT01790503|76208608|FG002|Overall Study|Other|0|||
42361047|NCT01790503|76208609|FG003|Overall Study|Other|0|||
42361048|NCT01790503|76208610|FG004|Overall Study|Other|1|||
42361049|NCT01790503|76208611|FG005|Overall Study|Other|0|||
42361050|NCT01790503|76208612|FG006|Overall Study|Other|0|||
42361051|NCT01790503|76208613|FG007|Overall Study|Other|0|||
42361052|NCT01790503|76208614|FG008|Overall Study|Other|1|||
42361053|NCT01790503|76208615|FG009|Overall Study|Other|2|||
42361054|NCT01790503|76208616|FG010|Overall Study|Other|0|||
42361055|NCT01790113|76208655|FG000|Overall Study|Adverse Event|2|||
42361056|NCT01790113|76208656|FG001|Overall Study|Adverse Event|7|||
42361057|NCT01790113|76208655|FG000|Overall Study|Study ended due to FDA clearance|1|||
42361058|NCT01790113|76208656|FG001|Overall Study|Study ended due to FDA clearance|68|||
42361059|NCT01789567|76208662|FG000|Overall Study|Death|6|||
42361060|NCT01765543|76208666|FG000|Overall Study|Death|1|||
42361061|NCT01765543|76208666|FG000|Overall Study|Withdrawal by Subject|2|||
42361062|NCT01765153|76208676|FG000|Training Phase 1|Format of intervention differed|1|||
42361063|NCT01765153|76208677|FG001|Training Phase 1|Format of intervention differed|0|||
42361064|NCT01765153|76208676|FG000|Training Phase 1|Poor participation in intervention|0|||
42361065|NCT01765153|76208677|FG001|Training Phase 1|Poor participation in intervention|1|||
42361066|NCT01765153|76208676|FG000|Rest Phase 1|Withdrawal by Subject|0|||
42361067|NCT01765153|76208677|FG001|Rest Phase 1|Withdrawal by Subject|1|||
42361068|NCT01765153|76208676|FG000|Training Phase 2|Withdrawal by Subject|0|||
42361069|NCT01765153|76208677|FG001|Training Phase 2|Withdrawal by Subject|1|||
42361070|NCT01765153|76208676|FG000|Rest Phase 2|Lost to Follow-up|2|||
42361071|NCT01765153|76208677|FG001|Rest Phase 2|Lost to Follow-up|1|||
42361072|NCT00248170|76208689|FG000|Overall Study|Withdrawal by Subject|71|||
42361073|NCT00248170|76208690|FG001|Overall Study|Withdrawal by Subject|79|||
42361074|NCT00248170|76208689|FG000|Overall Study|Protocol Violation|35|||
42361075|NCT00248170|76208690|FG001|Overall Study|Protocol Violation|30|||
42361076|NCT00248170|76208689|FG000|Overall Study|Lost to Follow-up|28|||
42361077|NCT00248170|76208690|FG001|Overall Study|Lost to Follow-up|35|||
42361078|NCT00248170|76208689|FG000|Overall Study|Disease progression|196|||
42361079|NCT00248170|76208690|FG001|Overall Study|Disease progression|216|||
42361080|NCT00248170|76208689|FG000|Overall Study|Death|28|||
42361081|NCT00248170|76208690|FG001|Overall Study|Death|47|||
42361082|NCT00248170|76208689|FG000|Overall Study|Adverse Event|311|||
42195391|NCT00121667|76007245|FG001|Short Term (ST) Period|Adverse Event|6|||
42195392|NCT00121667|76007246|FG002|Short Term (ST) Period|Adverse Event|5|||
42195393|NCT00121667|76007247|FG003|Short Term (ST) Period|Adverse Event|3|||
42195394|NCT00121667|76007244|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
42361083|NCT00248170|76208690|FG001|Overall Study|Adverse Event|296|||
42361084|NCT00248170|76208689|FG000|Overall Study|Administrative problems|22|||
42361085|NCT00248170|76208690|FG001|Overall Study|Administrative problems|25|||
42361086|NCT00248170|76208689|FG000|Overall Study|Abnormal test procedure(s) result|49|||
42361087|NCT00248170|76208690|FG001|Overall Study|Abnormal test procedure(s) result|61|||
42361088|NCT00248170|76208689|FG000|Overall Study|Abnormal laboratory values|4|||
42361089|NCT00248170|76208690|FG001|Overall Study|Abnormal laboratory values|0|||
42361090|NCT00248170|76208689|FG000|Overall Study|Protocol deviation|17|||
42099908|NCT00677352|75910585|FG000|Treatment Phase|Transference or work related matter|0|||
42099909|NCT00677352|75910586|FG001|Treatment Phase|Transference or work related matter|5|||
42099910|NCT00677352|75910585|FG000|Treatment Phase|Not treated|0|||
42099911|NCT00677352|75910586|FG001|Treatment Phase|Not treated|2|||
42099912|NCT00677352|75910585|FG000|Tapering Phase|Adverse Event|1|||
42099913|NCT00677352|75910586|FG001|Tapering Phase|Adverse Event|5|||
42099914|NCT00677352|75910585|FG000|Tapering Phase|Withdrawal by Subject|5|||
42099915|NCT00677352|75910586|FG001|Tapering Phase|Withdrawal by Subject|3|||
42099916|NCT00677352|75910585|FG000|Tapering Phase|Pregnancy|0|||
42099917|NCT00677352|75910586|FG001|Tapering Phase|Pregnancy|1|||
42099918|NCT00677352|75910585|FG000|Tapering Phase|Job transfer|0|||
42099919|NCT00677352|75910586|FG001|Tapering Phase|Job transfer|1|||
42099920|NCT00371683|75910599|FG000|DB Treatment Period-Randomized Patients|Death|1|||
42099921|NCT00371683|75910600|FG001|DB Treatment Period-Randomized Patients|Death|1|||
42195395|NCT00121667|76007245|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
42361091|NCT00248170|76208690|FG001|Overall Study|Protocol deviation|19|||
42361092|NCT01764997|76208701|FG000|Run-in Period|Adverse Event|15|||
42361093|NCT01764997|76208702|FG001|Run-in Period|Adverse Event|0|||
42361094|NCT01764997|76208703|FG002|Run-in Period|Adverse Event|0|||
42361095|NCT01764997|76208704|FG003|Run-in Period|Adverse Event|0|||
42361096|NCT01764997|76208705|FG004|Run-in Period|Adverse Event|0|||
42361097|NCT01764997|76208701|FG000|Run-in Period|Lack of Efficacy|5|||
42361098|NCT01764997|76208702|FG001|Run-in Period|Lack of Efficacy|0|||
42361099|NCT01764997|76208703|FG002|Run-in Period|Lack of Efficacy|0|||
42361100|NCT01764997|76208704|FG003|Run-in Period|Lack of Efficacy|0|||
42361101|NCT01764997|76208705|FG004|Run-in Period|Lack of Efficacy|0|||
42361102|NCT01764997|76208701|FG000|Run-in Period|Poor compliance to protocol|1|||
42361103|NCT01764997|76208702|FG001|Run-in Period|Poor compliance to protocol|0|||
42361104|NCT01764997|76208703|FG002|Run-in Period|Poor compliance to protocol|0|||
42195396|NCT00121667|76007246|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
42195397|NCT00121667|76007247|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
42361105|NCT01764997|76208704|FG003|Run-in Period|Poor compliance to protocol|0|||
42361106|NCT01764997|76208705|FG004|Run-in Period|Poor compliance to protocol|0|||
42361107|NCT01764997|76208701|FG000|Run-in Period|Other than specified above|17|||
42361108|NCT01764997|76208702|FG001|Run-in Period|Other than specified above|0|||
42361109|NCT01764997|76208703|FG002|Run-in Period|Other than specified above|0|||
42361110|NCT01764997|76208704|FG003|Run-in Period|Other than specified above|0|||
42361111|NCT01764997|76208705|FG004|Run-in Period|Other than specified above|0|||
42361112|NCT01764997|76208701|FG000|Study Drug Treatment Period|Adverse Event|0|||
42195398|NCT00121667|76007244|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
42195399|NCT00121667|76007245|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
42195400|NCT00121667|76007246|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
42195401|NCT00121667|76007247|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
42361113|NCT01764997|76208702|FG001|Study Drug Treatment Period|Adverse Event|1|||
42361114|NCT01764997|76208703|FG002|Study Drug Treatment Period|Adverse Event|0|||
42361115|NCT01764997|76208704|FG003|Study Drug Treatment Period|Adverse Event|0|||
42361116|NCT01764997|76208705|FG004|Study Drug Treatment Period|Adverse Event|24|||
42361117|NCT01764997|76208701|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
42361118|NCT01764997|76208702|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
42361119|NCT01764997|76208703|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
42361120|NCT01764997|76208704|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
42361121|NCT01764997|76208705|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
42361122|NCT01764997|76208701|FG000|Study Drug Treatment Period|Other than specified above|0|||
42361123|NCT01764997|76208702|FG001|Study Drug Treatment Period|Other than specified above|0|||
42361124|NCT01764997|76208703|FG002|Study Drug Treatment Period|Other than specified above|0|||
42361125|NCT01764997|76208704|FG003|Study Drug Treatment Period|Other than specified above|0|||
42361126|NCT01764997|76208705|FG004|Study Drug Treatment Period|Other than specified above|10|||
42361127|NCT01276756|76208717|FG000|Overall Study|Lost to Follow-up|2|||
42361128|NCT01276756|76208718|FG001|Overall Study|Lost to Follow-up|0|||
42361129|NCT01276756|76208717|FG000|Overall Study|Adverse Event|3|||
42195402|NCT00121667|76007244|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
42195403|NCT00121667|76007245|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
42195404|NCT00121667|76007246|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
42195405|NCT00121667|76007247|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
42195406|NCT00121667|76007244|FG000|Short Term (ST) Period|Other Reason|3|||
42195407|NCT00121667|76007245|FG001|Short Term (ST) Period|Other Reason|0|||
42195408|NCT00121667|76007246|FG002|Short Term (ST) Period|Other Reason|0|||
42195409|NCT00121667|76007247|FG003|Short Term (ST) Period|Other Reason|0|||
42195410|NCT00121667|76007244|FG000|Short Term (ST) Period|Death|0|||
42195411|NCT00121667|76007245|FG001|Short Term (ST) Period|Death|0|||
42195412|NCT00121667|76007246|FG002|Short Term (ST) Period|Death|0|||
42195413|NCT00121667|76007247|FG003|Short Term (ST) Period|Death|1|||
42195414|NCT00121667|76007244|FG000|Short Term (ST) Period|Pregnancy|0|||
42195415|NCT00121667|76007245|FG001|Short Term (ST) Period|Pregnancy|0|||
42195416|NCT00121667|76007246|FG002|Short Term (ST) Period|Pregnancy|0|||
42195417|NCT00121667|76007247|FG003|Short Term (ST) Period|Pregnancy|1|||
42195418|NCT00121667|76007244|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
42195419|NCT00121667|76007245|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
42195420|NCT00121667|76007246|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
42195421|NCT00121667|76007247|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
42361130|NCT01276756|76208718|FG001|Overall Study|Adverse Event|2|||
42361131|NCT00246376|76208729|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
42361132|NCT00246376|76208730|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
42361133|NCT00246376|76208731|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
42361134|NCT00246376|76208732|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
42195422|NCT00121667|76007244|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
42195423|NCT00121667|76007245|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
42195424|NCT00121667|76007246|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
42361135|NCT00246376|76208733|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
42361136|NCT00246376|76208729|FG000|Overall Study|Adverse Event|2|||
42361137|NCT00246376|76208730|FG001|Overall Study|Adverse Event|3|||
42195425|NCT00121667|76007247|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
42195426|NCT00121667|76007244|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
42361138|NCT00246376|76208731|FG002|Overall Study|Adverse Event|1|||
42361139|NCT00246376|76208732|FG003|Overall Study|Adverse Event|3|||
42361140|NCT00246376|76208733|FG004|Overall Study|Adverse Event|1|||
42361141|NCT00246376|76208729|FG000|Overall Study|Lost to Follow-up|2|||
42361142|NCT00246376|76208730|FG001|Overall Study|Lost to Follow-up|11|||
42361143|NCT00246376|76208731|FG002|Overall Study|Lost to Follow-up|11|||
42195427|NCT00121667|76007245|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
42195428|NCT00121667|76007246|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
42361144|NCT00246376|76208732|FG003|Overall Study|Lost to Follow-up|16|||
42361145|NCT00246376|76208733|FG004|Overall Study|Lost to Follow-up|13|||
42195429|NCT00121667|76007247|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
42195430|NCT00121667|76007244|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
42195431|NCT00121667|76007245|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
42195432|NCT00121667|76007246|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
42195433|NCT00121667|76007247|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
42195434|NCT00121667|76007244|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
42195435|NCT00121667|76007245|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
42195436|NCT00121667|76007246|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
42195437|NCT00121667|76007247|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
42195438|NCT00121667|76007244|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
42195439|NCT00121667|76007245|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
42195440|NCT00121667|76007246|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
42361146|NCT01764841|76208791|FG000|Overall Study|Logistical Difficulties|0|||
42361147|NCT01764841|76208792|FG001|Overall Study|Logistical Difficulties|1|||
42361148|NCT01764841|76208793|FG002|Overall Study|Logistical Difficulties|0|||
42361149|NCT01764841|76208794|FG003|Overall Study|Logistical Difficulties|0|||
42361150|NCT01764841|76208791|FG000|Overall Study|Death|3|||
42361151|NCT01764841|76208792|FG001|Overall Study|Death|0|||
42361152|NCT01764841|76208793|FG002|Overall Study|Death|1|||
42361153|NCT01764841|76208794|FG003|Overall Study|Death|4|||
42361154|NCT01764841|76208791|FG000|Overall Study|No Follow Up|1|||
42361155|NCT01764841|76208792|FG001|Overall Study|No Follow Up|0|||
42361156|NCT01764841|76208793|FG002|Overall Study|No Follow Up|1|||
42361157|NCT01764841|76208794|FG003|Overall Study|No Follow Up|0|||
42361158|NCT01764841|76208791|FG000|Overall Study|Protocol Violation|0|||
42361159|NCT01764841|76208792|FG001|Overall Study|Protocol Violation|1|||
42361160|NCT01764841|76208793|FG002|Overall Study|Protocol Violation|0|||
42361161|NCT01764841|76208794|FG003|Overall Study|Protocol Violation|0|||
42361162|NCT01764841|76208791|FG000|Overall Study|Withdrawal by Subject|16|||
42361163|NCT01764841|76208792|FG001|Overall Study|Withdrawal by Subject|24|||
42361164|NCT01764841|76208793|FG002|Overall Study|Withdrawal by Subject|11|||
42361165|NCT01764841|76208794|FG003|Overall Study|Withdrawal by Subject|15|||
42361166|NCT01764841|76208791|FG000|Overall Study|Lost to Follow-up|3|||
42361167|NCT01764841|76208792|FG001|Overall Study|Lost to Follow-up|0|||
42361168|NCT01764841|76208793|FG002|Overall Study|Lost to Follow-up|1|||
42361169|NCT01764841|76208794|FG003|Overall Study|Lost to Follow-up|0|||
42361170|NCT00245050|76208806|FG000|Overall Study|Adverse Event|3|||
42361171|NCT00245050|76208807|FG001|Overall Study|Adverse Event|2|||
42361172|NCT00243412|76208845|FG000|Overall Study|Death|0|||
42361173|NCT00243412|76208846|FG001|Overall Study|Death|1|||
42361174|NCT00243412|76208845|FG000|Overall Study|Adverse Event|4|||
42361175|NCT00243412|76208846|FG001|Overall Study|Adverse Event|2|||
42361176|NCT00243412|76208845|FG000|Overall Study|Lost to Follow-up|0|||
42361177|NCT00243412|76208846|FG001|Overall Study|Lost to Follow-up|1|||
42361178|NCT00243412|76208845|FG000|Overall Study|Physician Decision|1|||
42361179|NCT00243412|76208846|FG001|Overall Study|Physician Decision|1|||
42099922|NCT00371683|75910599|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
42099923|NCT00371683|75910600|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
42099924|NCT00371683|75910599|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
42099925|NCT00371683|75910600|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
42099926|NCT00371683|75910599|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
42099927|NCT00371683|75910600|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
42099928|NCT00371683|75910599|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
42195441|NCT00121667|76007247|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
42195442|NCT00121667|76007244|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
42195443|NCT00121667|76007245|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
42361180|NCT00243412|76208845|FG000|Overall Study|Withdrawal by Subject|4|||
42361181|NCT00243412|76208846|FG001|Overall Study|Withdrawal by Subject|5|||
42361182|NCT00243412|76208845|FG000|Overall Study|Other|1|||
42361183|NCT00243412|76208846|FG001|Overall Study|Other|1|||
42361184|NCT03805750|76208861|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
42361185|NCT03805750|76208862|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
42361186|NCT03804268|76208870|FG000|Overall Study|Adverse Event|2|||
42361187|NCT03804268|76208871|FG001|Overall Study|Adverse Event|2|||
42361188|NCT03804268|76208870|FG000|Overall Study|Withdrawal by Subject|2|||
42361189|NCT03804268|76208871|FG001|Overall Study|Withdrawal by Subject|0|||
42361190|NCT03804268|76208870|FG000|Overall Study|Lost to Follow-up|1|||
42361191|NCT03804268|76208871|FG001|Overall Study|Lost to Follow-up|0|||
42361192|NCT03804268|76208870|FG000|Overall Study|Physician Decision|2|||
42361193|NCT03804268|76208871|FG001|Overall Study|Physician Decision|0|||
42361194|NCT00243022|76208896|FG000|Overall Study|Withdrawal by Subject|1|||
42361195|NCT00243022|76208897|FG001|Overall Study|Withdrawal by Subject|0|||
42361196|NCT00243022|76208896|FG000|Overall Study|Death|1|||
42361197|NCT00243022|76208897|FG001|Overall Study|Death|0|||
42361198|NCT00243022|76208896|FG000|Overall Study|Difficult Travel Distance|0|||
42361199|NCT00243022|76208897|FG001|Overall Study|Difficult Travel Distance|1|||
42361200|NCT01736683|76208982|FG000|Overall Study|Disease Relapse|0|||
42361201|NCT01736683|76208983|FG001|Overall Study|Disease Relapse|0|||
42361202|NCT01736683|76208984|FG002|Overall Study|Disease Relapse|2|||
42361203|NCT01736683|76208985|FG003|Overall Study|Disease Relapse|1|||
42361204|NCT01736683|76208986|FG004|Overall Study|Disease Relapse|0|||
42361205|NCT01736683|76208982|FG000|Overall Study|Adverse Event|0|||
42361206|NCT01736683|76208983|FG001|Overall Study|Adverse Event|2|||
42361207|NCT01736683|76208984|FG002|Overall Study|Adverse Event|2|||
42361208|NCT01736683|76208985|FG003|Overall Study|Adverse Event|3|||
42361209|NCT01736683|76208986|FG004|Overall Study|Adverse Event|2|||
42361210|NCT01736683|76208982|FG000|Overall Study|Withdrawal by Subject|0|||
42361211|NCT01736683|76208983|FG001|Overall Study|Withdrawal by Subject|0|||
42099929|NCT00371683|75910600|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
42099930|NCT00371683|75910599|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
42099931|NCT00371683|75910600|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
42099932|NCT00371683|75910599|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
42099933|NCT00371683|75910600|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
42099934|NCT00371683|75910599|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
42361212|NCT01736683|76208984|FG002|Overall Study|Withdrawal by Subject|3|||
42361213|NCT01736683|76208985|FG003|Overall Study|Withdrawal by Subject|1|||
42361214|NCT01736683|76208986|FG004|Overall Study|Withdrawal by Subject|1|||
42361215|NCT01736683|76208982|FG000|Overall Study|Lack of Therapeutic Effect|7|||
42361216|NCT01736683|76208983|FG001|Overall Study|Lack of Therapeutic Effect|4|||
42361217|NCT01736683|76208984|FG002|Overall Study|Lack of Therapeutic Effect|13|||
42361218|NCT01736683|76208985|FG003|Overall Study|Lack of Therapeutic Effect|20|||
42361219|NCT01736683|76208986|FG004|Overall Study|Lack of Therapeutic Effect|1|||
42361220|NCT01736683|76208982|FG000|Overall Study|Progressive Disease|0|||
42361221|NCT01736683|76208983|FG001|Overall Study|Progressive Disease|0|||
42361222|NCT01736683|76208984|FG002|Overall Study|Progressive Disease|0|||
42361223|NCT01736683|76208985|FG003|Overall Study|Progressive Disease|1|||
42361224|NCT01736683|76208986|FG004|Overall Study|Progressive Disease|0|||
42361225|NCT01736683|76208982|FG000|Overall Study|Other|0|||
42361226|NCT01736683|76208983|FG001|Overall Study|Other|0|||
42361227|NCT01736683|76208984|FG002|Overall Study|Other|1|||
42361228|NCT01736683|76208985|FG003|Overall Study|Other|9|||
42361229|NCT01736683|76208986|FG004|Overall Study|Other|1|||
42361230|NCT01788943|76209002|FG000|Overall Study|Withdrawal by Subject|1|||
42361231|NCT01788943|76209003|FG001|Overall Study|Withdrawal by Subject|0|||
42361232|NCT01788163|76209030|FG000|Overall Study|Other|53|||
42361233|NCT01788163|76209031|FG001|Overall Study|Other|0|||
42361234|NCT01788163|76209032|FG002|Overall Study|Other|0|||
42361235|NCT01788163|76209033|FG003|Overall Study|Other|0|||
42361236|NCT01788163|76209034|FG004|Overall Study|Other|0|||
42361237|NCT01788163|76209035|FG005|Overall Study|Other|7|||
42361238|NCT01788163|76209036|FG006|Overall Study|Other|1|||
42361239|NCT01788163|76209037|FG007|Overall Study|Other|48|||
42361240|NCT01788163|76209038|FG008|Overall Study|Other|15|||
42361241|NCT01788163|76209030|FG000|Overall Study|Withdrawal by Subject|2|||
42361242|NCT01788163|76209031|FG001|Overall Study|Withdrawal by Subject|0|||
42361243|NCT01788163|76209032|FG002|Overall Study|Withdrawal by Subject|0|||
42361244|NCT01788163|76209033|FG003|Overall Study|Withdrawal by Subject|0|||
42361245|NCT01788163|76209034|FG004|Overall Study|Withdrawal by Subject|0|||
42361246|NCT01788163|76209035|FG005|Overall Study|Withdrawal by Subject|0|||
42361247|NCT01788163|76209036|FG006|Overall Study|Withdrawal by Subject|0|||
42361248|NCT01788163|76209037|FG007|Overall Study|Withdrawal by Subject|0|||
42361249|NCT01788163|76209038|FG008|Overall Study|Withdrawal by Subject|1|||
42361250|NCT01787461|76209174|FG000|Overall Study|Adverse Event|4|||
42361251|NCT01787461|76209175|FG001|Overall Study|Adverse Event|3|||
42361252|NCT01787461|76209174|FG000|Overall Study|Lost to Follow-up|3|||
42361253|NCT01787461|76209175|FG001|Overall Study|Lost to Follow-up|2|||
42361254|NCT01787461|76209174|FG000|Overall Study|No longer met eligibility criteria|1|||
42361255|NCT01787461|76209175|FG001|Overall Study|No longer met eligibility criteria|0|||
42361256|NCT01787461|76209174|FG000|Overall Study|Withdrawal by Subject|3|||
42361257|NCT01787461|76209175|FG001|Overall Study|Withdrawal by Subject|4|||
42361258|NCT01787461|76209174|FG000|Overall Study|Protocol Violation|3|||
42361259|NCT01787461|76209175|FG001|Overall Study|Protocol Violation|0|||
42361260|NCT01786993|76209200|FG000|Overall Study|Death|6|||
42361261|NCT01786993|76209201|FG001|Overall Study|Death|7|||
42361262|NCT01786993|76209200|FG000|Overall Study|Withdrawal by Subject|3|||
42361263|NCT01786993|76209201|FG001|Overall Study|Withdrawal by Subject|2|||
42361264|NCT01786993|76209200|FG000|Overall Study|Lost to Follow-up|0|||
42361265|NCT01786993|76209201|FG001|Overall Study|Lost to Follow-up|1|||
42361266|NCT01786993|76209200|FG000|Overall Study|Subject Non-Compliance|1|||
42361267|NCT01786993|76209201|FG001|Overall Study|Subject Non-Compliance|0|||
42361268|NCT01786993|76209200|FG000|Overall Study|System Explant|1|||
42361269|NCT01786993|76209201|FG001|Overall Study|System Explant|0|||
42361270|NCT01786993|76209200|FG000|Overall Study|Hospice Admission|1|||
42361271|NCT01786993|76209201|FG001|Overall Study|Hospice Admission|0|||
42361272|NCT01966445|76209226|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
42361273|NCT01966445|76209227|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
42361274|NCT01966445|76209228|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
42361275|NCT01966445|76209229|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
42361276|NCT01966445|76209230|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
42361277|NCT01966445|76209231|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
42361278|NCT01966445|76209232|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
42361279|NCT01966445|76209226|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
42361280|NCT01966445|76209227|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
42361281|NCT01966445|76209228|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
42361282|NCT01966445|76209229|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
42361283|NCT01966445|76209230|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
42361284|NCT01966445|76209231|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
42361285|NCT01966445|76209232|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
42361286|NCT01966445|76209226|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
42361287|NCT01966445|76209227|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
42361288|NCT01966445|76209228|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
42361289|NCT01966445|76209229|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
42361290|NCT01966445|76209230|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
42361291|NCT01966445|76209231|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
42361292|NCT01966445|76209232|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
42361293|NCT01966445|76209226|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
42361294|NCT01966445|76209227|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
42361295|NCT01966445|76209228|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
42361296|NCT01966445|76209229|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
42361297|NCT01966445|76209230|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
42361298|NCT01966445|76209231|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
42361299|NCT01966445|76209232|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
42361300|NCT01966445|76209226|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
42361301|NCT01966445|76209227|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
42361302|NCT01966445|76209228|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
42361303|NCT01966445|76209229|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
42361304|NCT01966445|76209230|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
42361305|NCT01966445|76209231|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
42361306|NCT01966445|76209232|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
42361307|NCT01763905|76209252|FG000|Overall Study|Withdrawal by Subject|1|||
42361308|NCT01763905|76209253|FG001|Overall Study|Withdrawal by Subject|1|||
42361309|NCT01763905|76209254|FG002|Overall Study|Withdrawal by Subject|0|||
42361310|NCT01763905|76209255|FG003|Overall Study|Withdrawal by Subject|1|||
42361311|NCT01763905|76209252|FG000|Overall Study|Decision by sponsor|5|||
42361312|NCT01763905|76209253|FG001|Overall Study|Decision by sponsor|0|||
42361313|NCT01763905|76209254|FG002|Overall Study|Decision by sponsor|8|||
42361314|NCT01763905|76209255|FG003|Overall Study|Decision by sponsor|0|||
42361315|NCT01763905|76209252|FG000|Overall Study|Lost to Follow-up|0|||
42361316|NCT01763905|76209253|FG001|Overall Study|Lost to Follow-up|0|||
42361317|NCT01763905|76209254|FG002|Overall Study|Lost to Follow-up|1|||
42361318|NCT01763905|76209255|FG003|Overall Study|Lost to Follow-up|0|||
42361319|NCT02091167|76209267|FG000|Overall Study|Lost to Follow-up|0|||
42361320|NCT02091167|76209268|FG001|Overall Study|Lost to Follow-up|2|||
42099935|NCT00371683|75910600|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
42361321|NCT02091089|76209274|FG000|Overall Study|Lost to Follow-up|2|||
42099936|NCT00371683|75910599|FG000|Follow-Up Period - Randomized Patients|Death|0|||
42099937|NCT00371683|75910600|FG001|Follow-Up Period - Randomized Patients|Death|2|||
42099938|NCT00371683|75910599|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
42099939|NCT00371683|75910600|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
42099940|NCT00371683|75910599|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
42099941|NCT00371683|75910600|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
42099942|NCT03951766|75910616|FG000|Treatment Phase|Lost to Follow-up|1|||
42099943|NCT03951766|75910616|FG000|Follow-up Phase|Lost to Follow-up|10|||
42099944|NCT00371137|75910625|FG000|Overall Study|Adverse Event|20|||
42195444|NCT00121667|76007246|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
42195445|NCT00121667|76007247|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
42195446|NCT00121667|76007244|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
42195447|NCT00121667|76007245|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
42195448|NCT00121667|76007246|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
42195449|NCT00121667|76007247|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
42195450|NCT00121667|76007244|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
42195451|NCT00121667|76007245|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
42099945|NCT00371137|75910626|FG001|Overall Study|Adverse Event|35|||
42099946|NCT00371137|75910627|FG002|Overall Study|Adverse Event|42|||
42099947|NCT00371137|75910625|FG000|Overall Study|Withdrawal by Subject|11|||
42099948|NCT00371137|75910626|FG001|Overall Study|Withdrawal by Subject|10|||
42099949|NCT00371137|75910627|FG002|Overall Study|Withdrawal by Subject|15|||
42099950|NCT00371137|75910625|FG000|Overall Study|Lost to Follow-up|6|||
42099951|NCT00371137|75910626|FG001|Overall Study|Lost to Follow-up|3|||
42099952|NCT00371137|75910627|FG002|Overall Study|Lost to Follow-up|5|||
42099953|NCT00371137|75910625|FG000|Overall Study|Lack of Efficacy|30|||
42099954|NCT00371137|75910626|FG001|Overall Study|Lack of Efficacy|12|||
42099955|NCT00371137|75910627|FG002|Overall Study|Lack of Efficacy|13|||
42099956|NCT00371137|75910625|FG000|Overall Study|Sponsor Decision|2|||
42099957|NCT00371137|75910626|FG001|Overall Study|Sponsor Decision|1|||
42099958|NCT00371137|75910627|FG002|Overall Study|Sponsor Decision|2|||
42099959|NCT00371137|75910625|FG000|Overall Study|Physician Decision|1|||
42099960|NCT00371137|75910626|FG001|Overall Study|Physician Decision|1|||
42099961|NCT00371137|75910627|FG002|Overall Study|Physician Decision|1|||
42099962|NCT00371137|75910625|FG000|Overall Study|Protocol Violation|2|||
42099963|NCT00371137|75910626|FG001|Overall Study|Protocol Violation|1|||
42099964|NCT00371137|75910627|FG002|Overall Study|Protocol Violation|1|||
42099965|NCT03753789|75910635|FG000|Overall Study|Withdrawal by Subject|2|||
42099966|NCT00616239|75910639|FG000|Overall Study|Withdrawal by Subject|2|||
42099967|NCT00547534|75910643|FG000|Overall Study|Adverse Event|7|||
42099968|NCT00547534|75910643|FG000|Overall Study|Disease Progression|4|||
42099969|NCT00384397|75910651|FG000|Overall Study|Adverse Event|0|||
42099970|NCT00384397|75910652|FG001|Overall Study|Adverse Event|1|||
42099971|NCT00384397|75910653|FG002|Overall Study|Adverse Event|2|||
42099972|NCT00384397|75910651|FG000|Overall Study|Protocol Violation|7|||
42099973|NCT00384397|75910652|FG001|Overall Study|Protocol Violation|15|||
42099974|NCT00384397|75910653|FG002|Overall Study|Protocol Violation|13|||
42099975|NCT00384397|75910651|FG000|Overall Study|Lost to Follow-up|11|||
42099976|NCT00384397|75910652|FG001|Overall Study|Lost to Follow-up|13|||
42099977|NCT00384397|75910653|FG002|Overall Study|Lost to Follow-up|3|||
42099978|NCT00384397|75910651|FG000|Overall Study|Withdrawal by Subject|14|||
42099979|NCT00384397|75910652|FG001|Overall Study|Withdrawal by Subject|17|||
42195452|NCT00121667|76007246|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
42195453|NCT00121667|76007247|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
42195454|NCT02954601|76007261|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
42195455|NCT02954601|76007262|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
42195456|NCT02954601|76007263|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
42195457|NCT02954601|76007264|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
42361322|NCT01763203|76209289|FG000|Overall Study|Death|4|||
42361323|NCT01763203|76209290|FG001|Overall Study|Death|7|||
42361324|NCT01763203|76209289|FG000|Overall Study|Lost to Follow-up|12|||
42361325|NCT01763203|76209290|FG001|Overall Study|Lost to Follow-up|12|||
42361326|NCT01763203|76209289|FG000|Overall Study|Withdrawal by Subject|8|||
42361327|NCT01763203|76209290|FG001|Overall Study|Withdrawal by Subject|12|||
42361328|NCT01763203|76209289|FG000|Overall Study|Moved out of study region|7|||
42361329|NCT01763203|76209290|FG001|Overall Study|Moved out of study region|10|||
42361330|NCT01763203|76209289|FG000|Overall Study|Physician Decision|2|||
42361331|NCT01763203|76209290|FG001|Overall Study|Physician Decision|1|||
42361332|NCT01763047|76209307|FG000|Period 1|Test Article Not Available|4|||
42361333|NCT01763047|76209308|FG001|Period 1|Test Article Not Available|1|||
42099980|NCT00384397|75910653|FG002|Overall Study|Withdrawal by Subject|15|||
42099981|NCT00384085|75910664|FG000|Overall Study|Adverse Event|5|||
42099982|NCT00384085|75910665|FG001|Overall Study|Adverse Event|5|||
42099983|NCT00384085|75910666|FG002|Overall Study|Adverse Event|4|||
42099984|NCT00384085|75910664|FG000|Overall Study|Lack of Efficacy|0|||
42099985|NCT00384085|75910665|FG001|Overall Study|Lack of Efficacy|3|||
42099986|NCT00384085|75910666|FG002|Overall Study|Lack of Efficacy|2|||
42099987|NCT00384085|75910664|FG000|Overall Study|No longer Requires Study Treatment|1|||
42361334|NCT01763047|76209307|FG000|Period 1|Protocol Violation|4|||
42361335|NCT01763047|76209308|FG001|Period 1|Protocol Violation|4|||
42361336|NCT01763047|76209307|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
42361337|NCT01763047|76209308|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
42361338|NCT01763047|76209307|FG000|Period 1|Adverse Event|0|||
42361339|NCT01763047|76209308|FG001|Period 1|Adverse Event|1|||
42361340|NCT01763047|76209307|FG000|Period 1|Unsatisfactory Visual Response|0|||
42361341|NCT01763047|76209308|FG001|Period 1|Unsatisfactory Visual Response|3|||
42361342|NCT01763047|76209307|FG000|Period 1|Lens Power Not Available|0|||
42361343|NCT01763047|76209308|FG001|Period 1|Lens Power Not Available|1|||
42361344|NCT01763047|76209307|FG000|Period 1|Study Site office Closed|0|||
42361345|NCT01763047|76209308|FG001|Period 1|Study Site office Closed|1|||
42361346|NCT01763047|76209307|FG000|Period 2|Lens Discomfort|1|||
42361347|NCT01763047|76209308|FG001|Period 2|Lens Discomfort|0|||
42361348|NCT01763047|76209307|FG000|Period 2|No longer meets Eligibility Criteria|1|||
42361349|NCT01763047|76209308|FG001|Period 2|No longer meets Eligibility Criteria|0|||
42361350|NCT01763047|76209307|FG000|Period 2|Study Site office Closed|1|||
42361351|NCT01763047|76209308|FG001|Period 2|Study Site office Closed|1|||
42361352|NCT01763047|76209307|FG000|Period 2|Unsatisfactory Visual Response|1|||
42361353|NCT01763047|76209308|FG001|Period 2|Unsatisfactory Visual Response|1|||
42361354|NCT01763047|76209307|FG000|Period 2|Protocol Violation|0|||
42361355|NCT01763047|76209308|FG001|Period 2|Protocol Violation|2|||
42361356|NCT01763047|76209307|FG000|Period 2|Unsatisfactory lens Fitting|0|||
42361357|NCT01763047|76209308|FG001|Period 2|Unsatisfactory lens Fitting|1|||
42361358|NCT01977677|76209320|FG000|Overall Study|Unrelated Adverse Event|0|||
42361359|NCT01977677|76209321|FG001|Overall Study|Unrelated Adverse Event|0|||
42361360|NCT01977677|76209322|FG002|Overall Study|Unrelated Adverse Event|1|||
42361361|NCT01762345|76209330|FG000|Overall Study|Adverse Event|5|||
42361362|NCT01762345|76209330|FG000|Overall Study|Protocol Violation|2|||
42361363|NCT02090855|76209335|FG000|Overall Study|no evaluable Standard of Truth results|2|||
42361364|NCT01761565|76209342|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
42361365|NCT01619579|76209352|FG000|Overall Study|Withdrawal by Subject|0|||
42361366|NCT01619579|76209353|FG001|Overall Study|Withdrawal by Subject|3|||
42361367|NCT01736215|76209359|FG000|Overall Study|Early termination of erythropoietin use|1|||
42361368|NCT01736215|76209359|FG000|Overall Study|Adverse Event|4|||
42361369|NCT01736215|76209359|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
42361370|NCT01736215|76209359|FG000|Overall Study|Insufficient data to perform analysis|8|||
42361371|NCT01786603|76209365|FG000|Overall Study|Death|5|||
42361372|NCT01786603|76209366|FG001|Overall Study|Death|1|||
42361373|NCT01786603|76209365|FG000|Overall Study|Adverse Event|6|||
42361374|NCT01786603|76209366|FG001|Overall Study|Adverse Event|2|||
42361375|NCT01786603|76209365|FG000|Overall Study|Physician decision to withdraw|6|||
42361376|NCT01786603|76209366|FG001|Overall Study|Physician decision to withdraw|7|||
42361377|NCT01786603|76209365|FG000|Overall Study|Lost to Follow-up|1|||
42361378|NCT01786603|76209366|FG001|Overall Study|Lost to Follow-up|2|||
42361379|NCT01619423|76209389|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
42361380|NCT01619423|76209390|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
42361381|NCT01619423|76209391|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
42361382|NCT01619423|76209392|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
42361383|NCT01735279|76209405|FG000|Overall Study|Lost to Follow-up|11|||
42099988|NCT00384085|75910665|FG001|Overall Study|No longer Requires Study Treatment|0|||
42099989|NCT00384085|75910666|FG002|Overall Study|No longer Requires Study Treatment|1|||
42099990|NCT00384085|75910664|FG000|Overall Study|Protocol Violation|2|||
42099991|NCT00384085|75910665|FG001|Overall Study|Protocol Violation|2|||
42099992|NCT00384085|75910666|FG002|Overall Study|Protocol Violation|2|||
42099993|NCT00384085|75910664|FG000|Overall Study|Lost to Follow-up|9|||
42099994|NCT00384085|75910665|FG001|Overall Study|Lost to Follow-up|9|||
42099995|NCT00384085|75910666|FG002|Overall Study|Lost to Follow-up|10|||
42361384|NCT01735279|76209406|FG001|Overall Study|Lost to Follow-up|8|||
42361385|NCT01759381|76209414|FG000|Overall Study|Death|1|||
42361386|NCT01759381|76209415|FG001|Overall Study|Death|0|||
42361387|NCT01758523|76209434|FG000|Overall Study|Adverse Event|2|||
42361388|NCT01758523|76209435|FG001|Overall Study|Adverse Event|1|||
42361389|NCT01758523|76209434|FG000|Overall Study|Lack of Efficacy|4|||
42361390|NCT01758523|76209435|FG001|Overall Study|Lack of Efficacy|2|||
42361391|NCT01758523|76209434|FG000|Overall Study|Lost to Follow-up|3|||
42361392|NCT01758523|76209435|FG001|Overall Study|Lost to Follow-up|4|||
42361393|NCT01758523|76209434|FG000|Overall Study|Withdrawal by Subject|12|||
42361394|NCT01758523|76209435|FG001|Overall Study|Withdrawal by Subject|7|||
42361395|NCT01758289|76209458|FG000|Overall Study|Premature Study Termination|44|||
42361396|NCT01758289|76209458|FG000|Overall Study|Adverse Event|9|||
42361397|NCT01757821|76209482|FG000|Overall Study|Adverse Event|1|||
42361398|NCT01735201|76209511|FG000|Overall Study|Adverse Event|1|||
42361399|NCT01735201|76209512|FG001|Overall Study|Adverse Event|1|||
42361400|NCT01735201|76209513|FG002|Overall Study|Adverse Event|0|||
42361401|NCT01735201|76209514|FG003|Overall Study|Adverse Event|1|||
42361402|NCT01735201|76209515|FG004|Overall Study|Adverse Event|1|||
42361403|NCT01735201|76209516|FG005|Overall Study|Adverse Event|3|||
42361404|NCT01735201|76209517|FG006|Overall Study|Adverse Event|2|||
42361405|NCT01735201|76209518|FG007|Overall Study|Adverse Event|1|||
42361406|NCT01735201|76209511|FG000|Overall Study|Personal Reasons|1|||
42361407|NCT01735201|76209512|FG001|Overall Study|Personal Reasons|0|||
42361408|NCT01735201|76209513|FG002|Overall Study|Personal Reasons|0|||
42361409|NCT01735201|76209514|FG003|Overall Study|Personal Reasons|0|||
42361410|NCT01735201|76209515|FG004|Overall Study|Personal Reasons|0|||
42361411|NCT01735201|76209516|FG005|Overall Study|Personal Reasons|0|||
42361412|NCT01735201|76209517|FG006|Overall Study|Personal Reasons|0|||
42361413|NCT01735201|76209518|FG007|Overall Study|Personal Reasons|0|||
42361414|NCT01735201|76209511|FG000|Overall Study|Protocol Violation|1|||
42361415|NCT01735201|76209512|FG001|Overall Study|Protocol Violation|0|||
42361416|NCT01735201|76209513|FG002|Overall Study|Protocol Violation|0|||
42361417|NCT01735201|76209514|FG003|Overall Study|Protocol Violation|0|||
42361418|NCT01735201|76209515|FG004|Overall Study|Protocol Violation|0|||
42361419|NCT01735201|76209516|FG005|Overall Study|Protocol Violation|0|||
42361420|NCT01735201|76209517|FG006|Overall Study|Protocol Violation|0|||
42361421|NCT01735201|76209518|FG007|Overall Study|Protocol Violation|0|||
42361422|NCT01735201|76209511|FG000|Overall Study|Other Miscellaneous Reasons|0|||
42361423|NCT01735201|76209512|FG001|Overall Study|Other Miscellaneous Reasons|0|||
42361424|NCT01735201|76209513|FG002|Overall Study|Other Miscellaneous Reasons|0|||
42361425|NCT01735201|76209514|FG003|Overall Study|Other Miscellaneous Reasons|1|||
42361426|NCT01735201|76209515|FG004|Overall Study|Other Miscellaneous Reasons|0|||
42361427|NCT01735201|76209516|FG005|Overall Study|Other Miscellaneous Reasons|2|||
42361428|NCT01735201|76209517|FG006|Overall Study|Other Miscellaneous Reasons|1|||
42361429|NCT01735201|76209518|FG007|Overall Study|Other Miscellaneous Reasons|1|||
42361430|NCT01734811|76209538|FG000|Overall Study|Lost to Follow-up|2|||
42361431|NCT01734811|76209539|FG001|Overall Study|Lost to Follow-up|3|||
42361432|NCT01734811|76209538|FG000|Overall Study|Withdrawal by Subject|2|||
42361433|NCT01734811|76209539|FG001|Overall Study|Withdrawal by Subject|0|||
42361434|NCT01757275|76209547|FG000|Overall Study|Lost to Follow-up|1|||
42361435|NCT01757275|76209548|FG001|Overall Study|Lost to Follow-up|2|||
42361436|NCT01757275|76209547|FG000|Overall Study|Adverse Event|3|||
42361437|NCT01757275|76209548|FG001|Overall Study|Adverse Event|3|||
42361438|NCT01757275|76209547|FG000|Overall Study|Withdrawal by Subject|2|||
42361439|NCT01757275|76209548|FG001|Overall Study|Withdrawal by Subject|4|||
42361440|NCT01757275|76209547|FG000|Overall Study|Not treated|3|||
42361441|NCT01757275|76209548|FG001|Overall Study|Not treated|4|||
42361442|NCT01757197|76209563|FG000|Overall Study|Death|2|||
42361443|NCT01784965|76209587|FG000|Overall Study|Withdrawal by Subject|6|||
42361444|NCT01784965|76209588|FG001|Overall Study|Withdrawal by Subject|3|||
42361445|NCT01784965|76209587|FG000|Overall Study|Adverse Event|0|||
42361446|NCT01784965|76209588|FG001|Overall Study|Adverse Event|8|||
42361447|NCT01784419|76209596|FG000|Overall Study|Adverse Event|3|||
42361448|NCT01784029|76209603|FG000|Overall Study|Lost to Follow-up|19|||
42361449|NCT01784029|76209604|FG001|Overall Study|Lost to Follow-up|20|||
42361450|NCT01784029|76209605|FG002|Overall Study|Lost to Follow-up|22|||
42361451|NCT01733329|76209627|FG000|Overall Study|Protocol Violation|1|||
42361452|NCT01733329|76209628|FG001|Overall Study|Protocol Violation|1|||
42361453|NCT01733329|76209627|FG000|Overall Study|Uterine artery injury|1|||
42361454|NCT01733329|76209628|FG001|Overall Study|Uterine artery injury|0|||
42361455|NCT01783483|76209636|FG000|Overall Study|Death|3|||
42361456|NCT01783483|76209637|FG001|Overall Study|Death|3|||
42361457|NCT01783483|76209636|FG000|Overall Study|Lost to Follow-up|14|||
42361458|NCT01783483|76209637|FG001|Overall Study|Lost to Follow-up|10|||
42361459|NCT01783483|76209636|FG000|Overall Study|Withdrawal by Subject|2|||
42361460|NCT01783483|76209637|FG001|Overall Study|Withdrawal by Subject|1|||
42361461|NCT01783483|76209636|FG000|Overall Study|Physician Decision|1|||
42361462|NCT01783483|76209637|FG001|Overall Study|Physician Decision|1|||
42361463|NCT01607593|76209656|FG000|Overall Study|Adverse Event|15|||
42361464|NCT01607593|76209656|FG000|Overall Study|Lack of Efficacy|16|||
42361465|NCT01607593|76209656|FG000|Overall Study|Lost to Follow-up|25|||
42361466|NCT01607593|76209656|FG000|Overall Study|Continuation|33|||
42361467|NCT01607593|76209656|FG000|Overall Study|Other|4|||
42361468|NCT01755637|76209669|FG000|Period 1|Adverse Event|0|||
42361469|NCT01755637|76209670|FG001|Period 1|Adverse Event|1|||
42361470|NCT01732549|76209688|FG000|Overall Study|Adverse Event|13|||
42361471|NCT01732549|76209689|FG001|Overall Study|Adverse Event|3|||
42361472|NCT01732549|76209688|FG000|Overall Study|Consent withdrawn|13|||
42361473|NCT01732549|76209689|FG001|Overall Study|Consent withdrawn|6|||
42361474|NCT01732549|76209688|FG000|Overall Study|Disease progression|37|||
42361475|NCT01732549|76209689|FG001|Overall Study|Disease progression|50|||
42361476|NCT01732549|76209688|FG000|Overall Study|Other|8|||
42361477|NCT01732549|76209689|FG001|Overall Study|Other|14|||
42361478|NCT01755091|76209708|FG000|Overall Study|Withdrawal by Subject|6|||
42361479|NCT01755091|76209709|FG001|Overall Study|Withdrawal by Subject|1|||
42361480|NCT01755091|76209710|FG002|Overall Study|Withdrawal by Subject|3|||
42361481|NCT01755091|76209708|FG000|Overall Study|Adverse Event|1|||
42361482|NCT01755091|76209709|FG001|Overall Study|Adverse Event|1|||
42361483|NCT01755091|76209710|FG002|Overall Study|Adverse Event|1|||
42361484|NCT01755091|76209708|FG000|Overall Study|Lost to Follow-up|1|||
42361485|NCT01755091|76209709|FG001|Overall Study|Lost to Follow-up|0|||
42361486|NCT01755091|76209710|FG002|Overall Study|Lost to Follow-up|1|||
42361487|NCT01755091|76209708|FG000|Overall Study|Physician Decision|1|||
42361488|NCT01755091|76209709|FG001|Overall Study|Physician Decision|1|||
42361489|NCT01755091|76209710|FG002|Overall Study|Physician Decision|2|||
42361490|NCT01754467|76209743|FG000|Overall Study|Lost to Follow-up|1|||
42361491|NCT01753999|76209747|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
42361492|NCT01753999|76209748|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
42361493|NCT01753999|76209747|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
42361494|NCT01753999|76209748|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
42361495|NCT01753999|76209747|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
42361496|NCT01753999|76209748|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
42361497|NCT01753999|76209747|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
42361498|NCT01753999|76209748|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
42361499|NCT01753999|76209747|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
42361500|NCT01753999|76209748|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
42361501|NCT01753999|76209747|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
42361502|NCT01753999|76209748|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
42361503|NCT01783015|76209768|FG000|Blinded Treatment|Adverse Event|0|||
42361504|NCT01783015|76209769|FG001|Blinded Treatment|Adverse Event|1|||
42361505|NCT01783015|76209770|FG002|Blinded Treatment|Adverse Event|0|||
42361506|NCT01783015|76209768|FG000|Blinded Treatment|Protocol Violation|0|||
42361507|NCT01783015|76209769|FG001|Blinded Treatment|Protocol Violation|1|||
42361508|NCT01783015|76209770|FG002|Blinded Treatment|Protocol Violation|0|||
42361509|NCT01783015|76209768|FG000|Blinded Treatment|Withdrawal by Subject|0|||
42361510|NCT01783015|76209769|FG001|Blinded Treatment|Withdrawal by Subject|1|||
42361511|NCT01783015|76209770|FG002|Blinded Treatment|Withdrawal by Subject|0|||
42361512|NCT01783015|76209768|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
42361513|NCT01783015|76209769|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
42361514|NCT01783015|76209770|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
42361515|NCT01783015|76209768|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
42361516|NCT01783015|76209769|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
42361517|NCT01783015|76209770|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
42361518|NCT01782859|76209780|FG000|Overall Study|Protocol Violation|6|||
42361519|NCT01782859|76209781|FG001|Overall Study|Protocol Violation|6|||
42361520|NCT01782859|76209780|FG000|Overall Study|Withdrawal by Subject|0|||
42361521|NCT01782859|76209781|FG001|Overall Study|Withdrawal by Subject|1|||
42361522|NCT01782469|76209788|FG000|Overall Study|Lost to Follow-up|1|||
42361523|NCT01782313|76209792|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
42361524|NCT01782313|76209792|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
42361525|NCT01782313|76209792|FG000|Treated Cycle 3|Progressive Disease|21|||
42361526|NCT01782313|76209792|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
42361527|NCT01782313|76209792|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
42361528|NCT01782313|76209792|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
42361529|NCT01782313|76209792|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
42361530|NCT01782313|76209792|FG000|Survival Follow up|Lost to Follow-up|1|||
42361531|NCT01781611|76209815|FG000|Overall Study|Adverse Event|4|||
42361532|NCT01781611|76209816|FG001|Overall Study|Adverse Event|0|||
42099996|NCT00384085|75910664|FG000|Overall Study|Progressive Disease|0|||
42099997|NCT00384085|75910665|FG001|Overall Study|Progressive Disease|1|||
42099998|NCT00384085|75910666|FG002|Overall Study|Progressive Disease|0|||
42099999|NCT00384085|75910664|FG000|Overall Study|Withdrawal by Subject|14|||
42100000|NCT00384085|75910665|FG001|Overall Study|Withdrawal by Subject|19|||
42361533|NCT01781299|76209833|FG000|Overall Study|Withdrawal by Subject|0|||
42100001|NCT00384085|75910666|FG002|Overall Study|Withdrawal by Subject|29|||
42100002|NCT00384085|75910664|FG000|Overall Study|Patient non-compliant|4|||
42100003|NCT00384085|75910665|FG001|Overall Study|Patient non-compliant|4|||
42100004|NCT00384085|75910666|FG002|Overall Study|Patient non-compliant|5|||
42361534|NCT01781299|76209834|FG001|Overall Study|Withdrawal by Subject|1|||
42361535|NCT01732471|76209840|FG000|Overall Study|Withdrawal by Subject|1|||
42361536|NCT01780987|76209859|FG000|Overall Study|Adverse Event|0|||
42361537|NCT01780987|76209860|FG001|Overall Study|Adverse Event|4|||
42361538|NCT01780987|76209859|FG000|Overall Study|Withdrawal by Subject|2|||
42100005|NCT00384085|75910664|FG000|Overall Study|Physician Decision|1|||
42361539|NCT01780987|76209860|FG001|Overall Study|Withdrawal by Subject|0|||
42361540|NCT01780987|76209859|FG000|Overall Study|Request of Changing Hospital|0|||
42361541|NCT01780987|76209860|FG001|Overall Study|Request of Changing Hospital|1|||
42361542|NCT01780987|76209859|FG000|Overall Study|Changing Residence|1|||
42361543|NCT01780987|76209860|FG001|Overall Study|Changing Residence|0|||
42100006|NCT00384085|75910665|FG001|Overall Study|Physician Decision|0|||
42361544|NCT01780987|76209859|FG000|Overall Study|Not Receiving any Study Medication|0|||
42361545|NCT01780987|76209860|FG001|Overall Study|Not Receiving any Study Medication|1|||
42361546|NCT01730053|76209949|FG000|Overall Study|Participant moved|0|||
42361547|NCT01730053|76209950|FG001|Overall Study|Participant moved|0|||
42361548|NCT01730053|76209951|FG002|Overall Study|Participant moved|1|||
42361549|NCT01730053|76209952|FG003|Overall Study|Participant moved|0|||
42361550|NCT01730053|76209953|FG004|Overall Study|Participant moved|0|||
42361551|NCT01730053|76209954|FG005|Overall Study|Participant moved|0|||
42361552|NCT01730053|76209949|FG000|Overall Study|Physician Decision|0|||
42361553|NCT01730053|76209950|FG001|Overall Study|Physician Decision|0|||
42361554|NCT01730053|76209951|FG002|Overall Study|Physician Decision|0|||
42195458|NCT03633903|76007276|FG000|Overall Study|Withdrawal by Subject|1|||
42195459|NCT03633903|76007277|FG001|Overall Study|Withdrawal by Subject|2|||
42195460|NCT03633903|76007276|FG000|Overall Study|Lost to Follow-up|5|||
42195461|NCT03633903|76007277|FG001|Overall Study|Lost to Follow-up|5|||
42195462|NCT03607695|76007283|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
42195463|NCT03607695|76007283|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
42195464|NCT03557775|76007290|FG000|Overall Study|Withdrawal by Subject|1|||
42195465|NCT03557775|76007291|FG001|Overall Study|Withdrawal by Subject|2|||
42195466|NCT03557775|76007292|FG002|Overall Study|Withdrawal by Subject|4|||
42195467|NCT03557775|76007290|FG000|Overall Study|Physician Decision|0|||
42195468|NCT03557775|76007291|FG001|Overall Study|Physician Decision|1|||
42195469|NCT03557775|76007292|FG002|Overall Study|Physician Decision|0|||
42195470|NCT00121199|76007300|FG000|Overall Study|Adverse Event|11|||
42195471|NCT00121199|76007300|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
42195472|NCT00121199|76007300|FG000|Overall Study|Progression/Relapse|1|||
42195473|NCT00121199|76007300|FG000|Overall Study|Death|3|||
42195474|NCT00121199|76007300|FG000|Overall Study|Other - Not Protocol Specified|3|||
42195475|NCT00121199|76007300|FG000|Overall Study|Ineligible|9|||
42195476|NCT00119405|76007304|FG000|Overall Study|Withdrawal by Subject|1|||
42195477|NCT00119015|76007310|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
42195478|NCT00119015|76007311|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
42195479|NCT00119015|76007312|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
42195480|NCT01981850|76007325|FG000|Main Phase Stage 1|Death|2|||
42195481|NCT01981850|76007326|FG001|Main Phase Stage 1|Death|0|||
42195482|NCT01981850|76007327|FG002|Main Phase Stage 1|Death|0|||
42195483|NCT01981850|76007328|FG003|Main Phase Stage 1|Death|0|||
42195484|NCT01981850|76007329|FG004|Main Phase Stage 1|Death|0|||
42195485|NCT01981850|76007330|FG005|Main Phase Stage 1|Death|0|||
42195486|NCT01981850|76007331|FG006|Main Phase Stage 1|Death|0|||
42195487|NCT01981850|76007332|FG007|Main Phase Stage 1|Death|0|||
42195488|NCT01981850|76007333|FG008|Main Phase Stage 1|Death|0|||
42195489|NCT01981850|76007334|FG009|Main Phase Stage 1|Death|0|||
42195490|NCT01981850|76007325|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
42195491|NCT01981850|76007326|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
42195492|NCT01981850|76007327|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
42195493|NCT01981850|76007328|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
42195494|NCT01981850|76007329|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
42195495|NCT01981850|76007330|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
42195496|NCT01981850|76007331|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
42195497|NCT01981850|76007332|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
42195498|NCT01981850|76007333|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
42195499|NCT01981850|76007334|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
42195500|NCT01981850|76007325|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
42195501|NCT01981850|76007326|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
42195502|NCT01981850|76007327|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
42195503|NCT01981850|76007328|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
42195504|NCT01981850|76007329|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
42195505|NCT01981850|76007330|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
42195506|NCT01981850|76007331|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
42195507|NCT01981850|76007332|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
42195508|NCT01981850|76007333|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
42195509|NCT01981850|76007334|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
42100007|NCT00384085|75910666|FG002|Overall Study|Physician Decision|0|||
42195510|NCT01981850|76007325|FG000|Main Phase Stage 1|Various reasons|0|||
42195511|NCT01981850|76007326|FG001|Main Phase Stage 1|Various reasons|0|||
42195512|NCT01981850|76007327|FG002|Main Phase Stage 1|Various reasons|2|||
42195513|NCT01981850|76007328|FG003|Main Phase Stage 1|Various reasons|0|||
42195514|NCT01981850|76007329|FG004|Main Phase Stage 1|Various reasons|0|||
42361555|NCT01730053|76209952|FG003|Overall Study|Physician Decision|1|||
42195515|NCT01981850|76007330|FG005|Main Phase Stage 1|Various reasons|0|||
42195516|NCT01981850|76007331|FG006|Main Phase Stage 1|Various reasons|0|||
42195517|NCT01981850|76007332|FG007|Main Phase Stage 1|Various reasons|0|||
42195518|NCT01981850|76007333|FG008|Main Phase Stage 1|Various reasons|0|||
42361556|NCT01730053|76209953|FG004|Overall Study|Physician Decision|0|||
42361557|NCT01730053|76209954|FG005|Overall Study|Physician Decision|0|||
42195519|NCT01981850|76007334|FG009|Main Phase Stage 1|Various reasons|0|||
42195520|NCT01981850|76007325|FG000|Main Phase Stage 2|Adverse Event|0|||
42195521|NCT01981850|76007326|FG001|Main Phase Stage 2|Adverse Event|0|||
42195522|NCT01981850|76007327|FG002|Main Phase Stage 2|Adverse Event|0|||
42195523|NCT01981850|76007328|FG003|Main Phase Stage 2|Adverse Event|0|||
42195524|NCT01981850|76007329|FG004|Main Phase Stage 2|Adverse Event|6|||
42195525|NCT01981850|76007330|FG005|Main Phase Stage 2|Adverse Event|5|||
42195526|NCT01981850|76007331|FG006|Main Phase Stage 2|Adverse Event|7|||
42195527|NCT01981850|76007332|FG007|Main Phase Stage 2|Adverse Event|0|||
42195528|NCT01981850|76007333|FG008|Main Phase Stage 2|Adverse Event|0|||
42361558|NCT01730053|76209949|FG000|Overall Study|Adverse Event|2|||
42361559|NCT01730053|76209950|FG001|Overall Study|Adverse Event|6|||
42361560|NCT01730053|76209951|FG002|Overall Study|Adverse Event|3|||
42361561|NCT01730053|76209952|FG003|Overall Study|Adverse Event|3|||
42361562|NCT01730053|76209953|FG004|Overall Study|Adverse Event|2|||
42361563|NCT01730053|76209954|FG005|Overall Study|Adverse Event|2|||
42361564|NCT01730053|76209949|FG000|Overall Study|Poor compliance to protocol|1|||
42361565|NCT01730053|76209950|FG001|Overall Study|Poor compliance to protocol|2|||
42361566|NCT01730053|76209951|FG002|Overall Study|Poor compliance to protocol|2|||
42361567|NCT01730053|76209952|FG003|Overall Study|Poor compliance to protocol|0|||
42361568|NCT01730053|76209953|FG004|Overall Study|Poor compliance to protocol|0|||
42361569|NCT01730053|76209954|FG005|Overall Study|Poor compliance to protocol|2|||
42361570|NCT01730053|76209949|FG000|Overall Study|Other than specified|2|||
42361571|NCT01730053|76209950|FG001|Overall Study|Other than specified|6|||
42361572|NCT01730053|76209951|FG002|Overall Study|Other than specified|5|||
42361573|NCT01730053|76209952|FG003|Overall Study|Other than specified|4|||
42361574|NCT01730053|76209953|FG004|Overall Study|Other than specified|7|||
42361575|NCT01730053|76209954|FG005|Overall Study|Other than specified|9|||
42361576|NCT01752985|76209989|FG000|Treatment Period|Subject request to discontinue treatment|1|||
42361577|NCT01752985|76209990|FG001|Treatment Period|Subject request to discontinue treatment|0|||
42361578|NCT01752985|76209991|FG002|Treatment Period|Subject request to discontinue treatment|1|||
42361579|NCT01752985|76209989|FG000|Treatment Period|Subject no longer meets study criteria|0|||
42361580|NCT01752985|76209990|FG001|Treatment Period|Subject no longer meets study criteria|1|||
42361581|NCT01752985|76209991|FG002|Treatment Period|Subject no longer meets study criteria|1|||
42361582|NCT01752985|76209989|FG000|Treatment Period|Adverse Event|2|||
42361583|NCT01752985|76209990|FG001|Treatment Period|Adverse Event|1|||
42361584|NCT01752985|76209991|FG002|Treatment Period|Adverse Event|2|||
42361585|NCT01752985|76209989|FG000|Treatment Period|Withdrawal by Subject|1|||
42361586|NCT01752985|76209990|FG001|Treatment Period|Withdrawal by Subject|1|||
42361587|NCT01752985|76209991|FG002|Treatment Period|Withdrawal by Subject|0|||
42361588|NCT01752985|76209989|FG000|Treatment Period|Lost to Follow-up|0|||
42361589|NCT01752985|76209990|FG001|Treatment Period|Lost to Follow-up|0|||
42361590|NCT01752985|76209991|FG002|Treatment Period|Lost to Follow-up|1|||
42361591|NCT01751113|76209999|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
42195529|NCT01981850|76007334|FG009|Main Phase Stage 2|Adverse Event|0|||
42195530|NCT01981850|76007325|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
42195531|NCT01981850|76007326|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
42195532|NCT01981850|76007327|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
42195533|NCT01981850|76007328|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
42195534|NCT01981850|76007329|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
42195535|NCT01981850|76007330|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
42195536|NCT01981850|76007331|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
42195537|NCT01981850|76007332|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
42195538|NCT01981850|76007333|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
42195539|NCT01981850|76007334|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
42195540|NCT01981850|76007325|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
42195541|NCT01981850|76007326|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
42195542|NCT01981850|76007327|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
42195543|NCT01981850|76007328|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
42195544|NCT01981850|76007329|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
42361592|NCT01751113|76210000|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
42361593|NCT01751113|76210001|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
42195545|NCT01981850|76007330|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
42361594|NCT01751113|76210002|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
42361595|NCT01751113|76210003|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
42100008|NCT00384085|75910664|FG000|Overall Study|Loss of site personnel|1|||
42195546|NCT01981850|76007331|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
42195547|NCT01981850|76007332|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
42195548|NCT01981850|76007333|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
42361596|NCT01751113|76210004|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
42361597|NCT01751113|76209999|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
42361598|NCT01751113|76210000|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
42361599|NCT01751113|76210001|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
42361600|NCT01751113|76210002|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
42195549|NCT01981850|76007334|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
42195550|NCT01981850|76007325|FG000|Main Phase Stage 2|Various reasons|0|||
42195551|NCT01981850|76007326|FG001|Main Phase Stage 2|Various reasons|0|||
42195552|NCT01981850|76007327|FG002|Main Phase Stage 2|Various reasons|0|||
42195553|NCT01981850|76007328|FG003|Main Phase Stage 2|Various reasons|0|||
42195554|NCT01981850|76007329|FG004|Main Phase Stage 2|Various reasons|2|||
42195555|NCT01981850|76007330|FG005|Main Phase Stage 2|Various reasons|0|||
42195556|NCT01981850|76007331|FG006|Main Phase Stage 2|Various reasons|1|||
42195557|NCT01981850|76007332|FG007|Main Phase Stage 2|Various reasons|0|||
42195558|NCT01981850|76007333|FG008|Main Phase Stage 2|Various reasons|0|||
42195559|NCT01981850|76007334|FG009|Main Phase Stage 2|Various reasons|0|||
42195560|NCT01981850|76007325|FG000|Main Phase Stage 2|Progressive Disease|0|||
42195561|NCT01981850|76007326|FG001|Main Phase Stage 2|Progressive Disease|0|||
42195562|NCT01981850|76007327|FG002|Main Phase Stage 2|Progressive Disease|0|||
42195563|NCT01981850|76007328|FG003|Main Phase Stage 2|Progressive Disease|0|||
42195564|NCT01981850|76007329|FG004|Main Phase Stage 2|Progressive Disease|0|||
42195565|NCT01981850|76007330|FG005|Main Phase Stage 2|Progressive Disease|6|||
42195566|NCT01981850|76007331|FG006|Main Phase Stage 2|Progressive Disease|6|||
42195567|NCT01981850|76007332|FG007|Main Phase Stage 2|Progressive Disease|0|||
42195568|NCT01981850|76007333|FG008|Main Phase Stage 2|Progressive Disease|0|||
42195569|NCT01981850|76007334|FG009|Main Phase Stage 2|Progressive Disease|0|||
42195570|NCT01981850|76007325|FG000|Open Label Extension (OLE)|Adverse Event|0|||
42195571|NCT01981850|76007326|FG001|Open Label Extension (OLE)|Adverse Event|0|||
42195572|NCT01981850|76007327|FG002|Open Label Extension (OLE)|Adverse Event|0|||
42195573|NCT01981850|76007328|FG003|Open Label Extension (OLE)|Adverse Event|0|||
42195574|NCT01981850|76007329|FG004|Open Label Extension (OLE)|Adverse Event|0|||
42195575|NCT01981850|76007330|FG005|Open Label Extension (OLE)|Adverse Event|0|||
42195576|NCT01981850|76007331|FG006|Open Label Extension (OLE)|Adverse Event|0|||
42195577|NCT01981850|76007332|FG007|Open Label Extension (OLE)|Adverse Event|2|||
42195578|NCT01981850|76007333|FG008|Open Label Extension (OLE)|Adverse Event|1|||
42195579|NCT01981850|76007334|FG009|Open Label Extension (OLE)|Adverse Event|8|||
42195580|NCT01981850|76007325|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
42195581|NCT01981850|76007326|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
42195582|NCT01981850|76007327|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
42195583|NCT01981850|76007328|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
42195584|NCT01981850|76007329|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
42195585|NCT01981850|76007330|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
42195586|NCT01981850|76007331|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
42195587|NCT01981850|76007332|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
42195588|NCT01981850|76007333|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
42195589|NCT01981850|76007334|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
42195590|NCT01981850|76007325|FG000|Open Label Extension (OLE)|Various reasons|0|||
42195591|NCT01981850|76007326|FG001|Open Label Extension (OLE)|Various reasons|0|||
42195592|NCT01981850|76007327|FG002|Open Label Extension (OLE)|Various reasons|0|||
42195593|NCT01981850|76007328|FG003|Open Label Extension (OLE)|Various reasons|0|||
42195594|NCT01981850|76007329|FG004|Open Label Extension (OLE)|Various reasons|0|||
42195595|NCT01981850|76007330|FG005|Open Label Extension (OLE)|Various reasons|0|||
42195596|NCT01981850|76007331|FG006|Open Label Extension (OLE)|Various reasons|0|||
42195597|NCT01981850|76007332|FG007|Open Label Extension (OLE)|Various reasons|3|||
42195598|NCT01981850|76007333|FG008|Open Label Extension (OLE)|Various reasons|1|||
42195599|NCT01981850|76007334|FG009|Open Label Extension (OLE)|Various reasons|3|||
42195600|NCT01981850|76007325|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
42195601|NCT01981850|76007326|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
42195602|NCT01981850|76007327|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
42195603|NCT01981850|76007328|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
42195604|NCT01981850|76007329|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
42195605|NCT01981850|76007330|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
42195606|NCT01981850|76007331|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
42195607|NCT01981850|76007332|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
42195608|NCT01981850|76007333|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
42195609|NCT01981850|76007334|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
42195610|NCT01981850|76007325|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
42195611|NCT01981850|76007326|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
42195612|NCT01981850|76007327|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
42195613|NCT01981850|76007328|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
42195614|NCT01981850|76007329|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
42195615|NCT01981850|76007330|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
42195616|NCT01981850|76007331|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
42195617|NCT01981850|76007332|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
42195618|NCT01981850|76007333|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
42195619|NCT01981850|76007334|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
42195620|NCT01981850|76007325|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
42195621|NCT01981850|76007326|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
42195622|NCT01981850|76007327|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
42195623|NCT01981850|76007328|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
42195624|NCT01981850|76007329|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
42195625|NCT01981850|76007330|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
42195626|NCT01981850|76007331|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
42195627|NCT01981850|76007332|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
42361601|NCT01751113|76210003|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
42361602|NCT01751113|76210004|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
42361603|NCT01750879|76210015|FG000|Overall Study|Adverse Event|8|||
42361604|NCT01750879|76210016|FG001|Overall Study|Adverse Event|0|||
42361605|NCT01750879|76210015|FG000|Overall Study|Lack of Efficacy|1|||
42361606|NCT01750879|76210016|FG001|Overall Study|Lack of Efficacy|0|||
42361607|NCT01750879|76210015|FG000|Overall Study|Withdrawal by Subject|1|||
42361608|NCT01750879|76210016|FG001|Overall Study|Withdrawal by Subject|0|||
42195628|NCT01981850|76007333|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
42195629|NCT01981850|76007334|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
42195630|NCT03557307|76007366|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
42361609|NCT01750879|76210015|FG000|Overall Study|Did not complete per protocol|0|||
42361610|NCT01750879|76210016|FG001|Overall Study|Did not complete per protocol|3|||
42361611|NCT01719380|76210042|FG000|Overall Study|Adverse Event|0|||
42195631|NCT03557307|76007366|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
42195632|NCT03557307|76007366|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
42195633|NCT03557307|76007366|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
42195634|NCT03557307|76007366|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
42361612|NCT01719380|76210043|FG001|Overall Study|Adverse Event|0|||
42361613|NCT01719380|76210044|FG002|Overall Study|Adverse Event|1|||
42361614|NCT01719380|76210045|FG003|Overall Study|Adverse Event|2|||
42361615|NCT01719380|76210046|FG004|Overall Study|Adverse Event|0|||
42361616|NCT01719380|76210047|FG005|Overall Study|Adverse Event|1|||
42361617|NCT01719380|76210048|FG006|Overall Study|Adverse Event|0|||
42361618|NCT01719380|76210049|FG007|Overall Study|Adverse Event|1|||
42361619|NCT01719380|76210050|FG008|Overall Study|Adverse Event|4|||
42361620|NCT01719380|76210051|FG009|Overall Study|Adverse Event|3|||
42361621|NCT01719380|76210042|FG000|Overall Study|Death|0|||
42361622|NCT01719380|76210043|FG001|Overall Study|Death|1|||
42361623|NCT01719380|76210044|FG002|Overall Study|Death|0|||
42361624|NCT01719380|76210045|FG003|Overall Study|Death|0|||
42361625|NCT01719380|76210046|FG004|Overall Study|Death|0|||
42361626|NCT01719380|76210047|FG005|Overall Study|Death|0|||
42361627|NCT01719380|76210048|FG006|Overall Study|Death|0|||
42361628|NCT01719380|76210049|FG007|Overall Study|Death|0|||
42361629|NCT01719380|76210050|FG008|Overall Study|Death|3|||
42361630|NCT01719380|76210051|FG009|Overall Study|Death|3|||
42361631|NCT01719380|76210042|FG000|Overall Study|Participant/Guardian Decision|0|||
42361632|NCT01719380|76210043|FG001|Overall Study|Participant/Guardian Decision|0|||
42361633|NCT01719380|76210044|FG002|Overall Study|Participant/Guardian Decision|1|||
42361634|NCT01719380|76210045|FG003|Overall Study|Participant/Guardian Decision|0|||
42361635|NCT01719380|76210046|FG004|Overall Study|Participant/Guardian Decision|0|||
42361636|NCT01719380|76210047|FG005|Overall Study|Participant/Guardian Decision|0|||
42361637|NCT01719380|76210048|FG006|Overall Study|Participant/Guardian Decision|0|||
42361638|NCT01719380|76210049|FG007|Overall Study|Participant/Guardian Decision|0|||
42361639|NCT01719380|76210050|FG008|Overall Study|Participant/Guardian Decision|2|||
42361640|NCT01719380|76210051|FG009|Overall Study|Participant/Guardian Decision|2|||
42361641|NCT01719380|76210042|FG000|Overall Study|Physician Decision|0|||
42195635|NCT03557307|76007366|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
42195636|NCT03557307|76007366|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
42195637|NCT03557307|76007366|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
42195638|NCT03557307|76007366|FG000|Period 2: Maintenance Phase|Death|3|||
42195639|NCT03557307|76007366|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
42361642|NCT01719380|76210043|FG001|Overall Study|Physician Decision|0|||
42361643|NCT01719380|76210044|FG002|Overall Study|Physician Decision|2|||
42361644|NCT01719380|76210045|FG003|Overall Study|Physician Decision|0|||
42361645|NCT01719380|76210046|FG004|Overall Study|Physician Decision|0|||
42361646|NCT01719380|76210047|FG005|Overall Study|Physician Decision|0|||
42361647|NCT01719380|76210048|FG006|Overall Study|Physician Decision|0|||
42361648|NCT01719380|76210049|FG007|Overall Study|Physician Decision|0|||
42361649|NCT01719380|76210050|FG008|Overall Study|Physician Decision|1|||
42361650|NCT01719380|76210051|FG009|Overall Study|Physician Decision|1|||
42361651|NCT01719380|76210042|FG000|Overall Study|Lack of Efficacy|2|||
42361652|NCT01719380|76210043|FG001|Overall Study|Lack of Efficacy|6|||
42361653|NCT01719380|76210044|FG002|Overall Study|Lack of Efficacy|5|||
42361654|NCT01719380|76210045|FG003|Overall Study|Lack of Efficacy|6|||
42361655|NCT01719380|76210046|FG004|Overall Study|Lack of Efficacy|3|||
42361656|NCT01719380|76210047|FG005|Overall Study|Lack of Efficacy|7|||
42361657|NCT01719380|76210048|FG006|Overall Study|Lack of Efficacy|10|||
42361658|NCT01719380|76210049|FG007|Overall Study|Lack of Efficacy|6|||
42361659|NCT01719380|76210050|FG008|Overall Study|Lack of Efficacy|39|||
42361660|NCT01719380|76210051|FG009|Overall Study|Lack of Efficacy|42|||
42361661|NCT01719380|76210042|FG000|Overall Study|Progressive Disease|0|||
42361662|NCT01719380|76210043|FG001|Overall Study|Progressive Disease|0|||
42361663|NCT01719380|76210044|FG002|Overall Study|Progressive Disease|0|||
42361664|NCT01719380|76210045|FG003|Overall Study|Progressive Disease|0|||
42361665|NCT01719380|76210046|FG004|Overall Study|Progressive Disease|0|||
42361666|NCT01719380|76210047|FG005|Overall Study|Progressive Disease|0|||
42361667|NCT01719380|76210048|FG006|Overall Study|Progressive Disease|0|||
42361668|NCT01719380|76210049|FG007|Overall Study|Progressive Disease|0|||
42361669|NCT01719380|76210050|FG008|Overall Study|Progressive Disease|1|||
42361670|NCT01719380|76210051|FG009|Overall Study|Progressive Disease|0|||
42361671|NCT01743560|76210101|FG000|Overall Study|Disease progression|26|||
42361672|NCT01743560|76210101|FG000|Overall Study|Adverse Event|8|||
42361673|NCT01743560|76210101|FG000|Overall Study|Death|3|||
42361674|NCT01743560|76210101|FG000|Overall Study|Withdrawal by Subject|2|||
42361675|NCT01743560|76210101|FG000|Overall Study|Protocol Violation|1|||
42195640|NCT03557307|76007366|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
42195641|NCT03557307|76007366|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
42195642|NCT03557307|76007366|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
42195643|NCT03557307|76007366|FG000|Period 2: Maintenance Phase|other|3|||
42195644|NCT00118703|76007378|FG000|Overall Study|Protocol Violation|1|||
42195645|NCT00118703|76007379|FG001|Overall Study|Protocol Violation|0|||
42361676|NCT01743560|76210101|FG000|Overall Study|>1 dose of study drug|3|||
42361677|NCT01743092|76210131|FG000|Overall Study|Lost to Follow-up|14|||
42361678|NCT01743092|76210132|FG001|Overall Study|Lost to Follow-up|15|||
42361679|NCT01780831|76210165|FG000|Overall Study|Withdrawal by Subject|0|||
42361680|NCT01780831|76210166|FG001|Overall Study|Withdrawal by Subject|0|||
42361681|NCT01780831|76210167|FG002|Overall Study|Withdrawal by Subject|4|||
42361682|NCT01780831|76210168|FG003|Overall Study|Withdrawal by Subject|0|||
42195646|NCT00118703|76007378|FG000|Overall Study|Adverse Event|1|||
42195647|NCT00118703|76007379|FG001|Overall Study|Adverse Event|1|||
42195648|NCT00118703|76007378|FG000|Overall Study|Participant took two different treatment|0|||
42195649|NCT00118703|76007379|FG001|Overall Study|Participant took two different treatment|1|||
42195650|NCT00118703|76007378|FG000|Overall Study|Withdrawal by Subject|2|||
42195651|NCT00118703|76007379|FG001|Overall Study|Withdrawal by Subject|5|||
42195652|NCT00118703|76007378|FG000|Overall Study|Lost to Follow-up|1|||
42195653|NCT00118703|76007379|FG001|Overall Study|Lost to Follow-up|2|||
42195654|NCT00104104|76007387|FG000|Overall Study|Adverse Event|8|||
42195655|NCT00104104|76007388|FG001|Overall Study|Adverse Event|8|||
42195656|NCT00104104|76007387|FG000|Overall Study|Abnormal laboratory value(s)|20|||
42195657|NCT00104104|76007388|FG001|Overall Study|Abnormal laboratory value(s)|14|||
42195658|NCT00104104|76007387|FG000|Overall Study|Lack of Efficacy|0|||
42195659|NCT00104104|76007388|FG001|Overall Study|Lack of Efficacy|3|||
42195660|NCT00104104|76007387|FG000|Overall Study|Condition no longer requires study drug|7|||
42195661|NCT00104104|76007388|FG001|Overall Study|Condition no longer requires study drug|4|||
42195662|NCT00104104|76007387|FG000|Overall Study|Protocol Violation|5|||
42195663|NCT00104104|76007388|FG001|Overall Study|Protocol Violation|2|||
42195664|NCT00104104|76007387|FG000|Overall Study|Withdrawal by Subject|11|||
42361683|NCT01780831|76210165|FG000|Overall Study|Lost to Follow-up|0|||
42361684|NCT01780831|76210166|FG001|Overall Study|Lost to Follow-up|0|||
42361685|NCT01780831|76210167|FG002|Overall Study|Lost to Follow-up|0|||
42361686|NCT01780831|76210168|FG003|Overall Study|Lost to Follow-up|1|||
42361687|NCT01778023|76210227|FG000|Overall Study|Withdrawal by Subject|0|||
42361688|NCT01778023|76210228|FG001|Overall Study|Withdrawal by Subject|3|||
42195665|NCT00104104|76007388|FG001|Overall Study|Withdrawal by Subject|15|||
42361689|NCT01753297|76210236|FG000|Overall Study|Lost to Follow-up|7|||
42195666|NCT00104104|76007387|FG000|Overall Study|Lost to Follow-up|3|||
42195667|NCT00104104|76007388|FG001|Overall Study|Lost to Follow-up|7|||
42195668|NCT00104104|76007387|FG000|Overall Study|Administrative problems|12|||
42195669|NCT00104104|76007388|FG001|Overall Study|Administrative problems|13|||
42195670|NCT00104104|76007387|FG000|Overall Study|Death|9|||
42361690|NCT01753297|76210237|FG001|Overall Study|Lost to Follow-up|2|||
42361691|NCT01753297|76210236|FG000|Overall Study|Withdrawal by Subject|26|||
42361692|NCT01753297|76210237|FG001|Overall Study|Withdrawal by Subject|23|||
42361693|NCT01753297|76210236|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
42361694|NCT01753297|76210237|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
42361695|NCT01753297|76210236|FG000|Overall Study|Death|0|||
42361696|NCT01753297|76210237|FG001|Overall Study|Death|2|||
42361697|NCT01753297|76210236|FG000|Overall Study|Did not attend end of study visit|7|||
42195671|NCT00104104|76007388|FG001|Overall Study|Death|6|||
42195672|NCT03557151|76007396|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
42195673|NCT03557151|76007397|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
42361698|NCT01753297|76210237|FG001|Overall Study|Did not attend end of study visit|8|||
42361699|NCT01777321|76210247|FG000|Overall Study|Withdrawal by Subject|0|||
42361700|NCT01777321|76210248|FG001|Overall Study|Withdrawal by Subject|1|||
42361701|NCT01729819|76210256|FG000|Overall Study|Adverse Event|2|||
42361702|NCT01729819|76210257|FG001|Overall Study|Adverse Event|4|||
42361703|NCT01729819|76210256|FG000|Overall Study|Lack of Efficacy|1|||
42361704|NCT01729819|76210257|FG001|Overall Study|Lack of Efficacy|0|||
42361705|NCT01729819|76210256|FG000|Overall Study|Lost to Follow-up|2|||
42361706|NCT01729819|76210257|FG001|Overall Study|Lost to Follow-up|0|||
42361707|NCT01729819|76210256|FG000|Overall Study|Other reason|1|||
42361708|NCT01729819|76210257|FG001|Overall Study|Other reason|0|||
42361709|NCT01729819|76210256|FG000|Overall Study|Protocol Violation|0|||
42361710|NCT01729819|76210257|FG001|Overall Study|Protocol Violation|1|||
42361711|NCT01729819|76210256|FG000|Overall Study|Withdrawal by Subject|0|||
42361712|NCT01729819|76210257|FG001|Overall Study|Withdrawal by Subject|2|||
42361713|NCT01776541|76210268|FG000|Overall Study|Administrative Reason|6|||
42361714|NCT01776541|76210269|FG001|Overall Study|Administrative Reason|2|||
42361715|NCT01776541|76210268|FG000|Overall Study|Death|4|||
42361716|NCT01776541|76210269|FG001|Overall Study|Death|0|||
42361717|NCT01776541|76210268|FG000|Overall Study|Lost to Follow-up|27|||
42361718|NCT01776541|76210269|FG001|Overall Study|Lost to Follow-up|48|||
42361719|NCT01776541|76210268|FG000|Overall Study|Unclassified|5|||
42361720|NCT01776541|76210269|FG001|Overall Study|Unclassified|4|||
42361721|NCT01776541|76210268|FG000|Overall Study|Protocol Violation|2|||
42361722|NCT01776541|76210269|FG001|Overall Study|Protocol Violation|1|||
42361723|NCT01776541|76210268|FG000|Overall Study|Withdrawal by Subject|12|||
42361724|NCT01776541|76210269|FG001|Overall Study|Withdrawal by Subject|20|||
42361725|NCT01742078|76210298|FG000|Overall Study|Withdrawal by Subject|0|||
42361726|NCT01742078|76210299|FG001|Overall Study|Withdrawal by Subject|0|||
42361727|NCT01742078|76210300|FG002|Overall Study|Withdrawal by Subject|0|||
42361728|NCT01742078|76210301|FG003|Overall Study|Withdrawal by Subject|1|||
42361729|NCT01742078|76210302|FG004|Overall Study|Withdrawal by Subject|0|||
42361730|NCT01742078|76210303|FG005|Overall Study|Withdrawal by Subject|0|||
42361731|NCT01742078|76210304|FG006|Overall Study|Withdrawal by Subject|0|||
42361732|NCT01742078|76210305|FG007|Overall Study|Withdrawal by Subject|0|||
42361733|NCT01742078|76210306|FG008|Overall Study|Withdrawal by Subject|0|||
42361734|NCT01741688|76210328|FG000|Overall Study|Lack of insurance coverage|2|||
42361735|NCT01741688|76210328|FG000|Overall Study|Withdrawal by Subject|1|||
42361736|NCT01709084|76210335|FG000|Overall Study|Lost to Follow-up|4|||
42361737|NCT01709084|76210336|FG001|Overall Study|Lost to Follow-up|7|||
42361738|NCT01709084|76210335|FG000|Overall Study|Withdrawal by Subject|2|||
42361739|NCT01709084|76210336|FG001|Overall Study|Withdrawal by Subject|2|||
42361740|NCT01709084|76210335|FG000|Overall Study|Adverse Event|5|||
42361741|NCT01709084|76210336|FG001|Overall Study|Adverse Event|0|||
42361742|NCT01709084|76210335|FG000|Overall Study|Other|5|||
42361743|NCT01709084|76210336|FG001|Overall Study|Other|3|||
42100009|NCT00384085|75910665|FG001|Overall Study|Loss of site personnel|0|||
42100010|NCT00384085|75910666|FG002|Overall Study|Loss of site personnel|1|||
42100011|NCT00384085|75910664|FG000|Overall Study|Sponsor decision|1|||
42100012|NCT00384085|75910665|FG001|Overall Study|Sponsor decision|2|||
42100013|NCT00384085|75910666|FG002|Overall Study|Sponsor decision|1|||
42100014|NCT00384085|75910664|FG000|Overall Study|Patient moved|1|||
42100015|NCT00384085|75910665|FG001|Overall Study|Patient moved|0|||
42195674|NCT03557151|76007396|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
42195675|NCT03557151|76007397|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
42195676|NCT03557151|76007396|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
42361744|NCT01709084|76210335|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
42361745|NCT01709084|76210336|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
42361746|NCT01709084|76210335|FG000|Overall Study|Not Treated|0|||
42361747|NCT01709084|76210336|FG001|Overall Study|Not Treated|2|||
42361748|NCT01729039|76210344|FG000|Overall Study|disqualified|2|||
42361749|NCT01729039|76210345|FG001|Overall Study|disqualified|5|||
42361750|NCT01729039|76210344|FG000|Overall Study|Withdrawal by Subject|8|||
42361751|NCT01729039|76210345|FG001|Overall Study|Withdrawal by Subject|7|||
42361752|NCT01775995|76210356|FG000|Overall Study|Lost to Follow-up|1|||
42361753|NCT01775995|76210357|FG001|Overall Study|Lost to Follow-up|1|||
42361754|NCT01741532|76210365|FG000|Overall Study|Adverse Event|4|||
42361755|NCT01741532|76210366|FG001|Overall Study|Adverse Event|0|||
42361756|NCT01741532|76210365|FG000|Overall Study|Withdrawal by Subject|1|||
42361757|NCT01741532|76210366|FG001|Overall Study|Withdrawal by Subject|1|||
42100016|NCT00384085|75910666|FG002|Overall Study|Patient moved|1|||
42361758|NCT01741532|76210365|FG000|Overall Study|Protocol Violation|0|||
42361759|NCT01741532|76210366|FG001|Overall Study|Protocol Violation|1|||
42361760|NCT01741532|76210365|FG000|Overall Study|Worsening of the disease|3|||
42361761|NCT01741532|76210366|FG001|Overall Study|Worsening of the disease|1|||
42361762|NCT01741532|76210365|FG000|Overall Study|Sponsor decision|1|||
42361763|NCT01741532|76210366|FG001|Overall Study|Sponsor decision|0|||
42361764|NCT01741532|76210365|FG000|Overall Study|Medical event|1|||
42361765|NCT01741532|76210366|FG001|Overall Study|Medical event|0|||
42361766|NCT01719224|76210376|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
42361767|NCT01719224|76210377|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
42361768|NCT01717976|76210388|FG000|Overall Study|Protocol Violation|0|||
42361769|NCT01717976|76210389|FG001|Overall Study|Protocol Violation|1|||
42361770|NCT01740440|76210395|FG000|Overall Study|Lost to Follow-up|3|||
42361771|NCT01740128|76210402|FG000|Overall Study|Pregnancy|0|||
42361772|NCT01740128|76210403|FG001|Overall Study|Pregnancy|1|||
42361773|NCT01740128|76210402|FG000|Overall Study|Protocol Violation|1|||
42361774|NCT01740128|76210403|FG001|Overall Study|Protocol Violation|2|||
42361775|NCT01740128|76210402|FG000|Overall Study|Lost to Follow-up|2|||
42361776|NCT01740128|76210403|FG001|Overall Study|Lost to Follow-up|2|||
42361777|NCT01740128|76210402|FG000|Overall Study|Withdrawal by Subject|1|||
42361778|NCT01740128|76210403|FG001|Overall Study|Withdrawal by Subject|0|||
42361779|NCT01740128|76210402|FG000|Overall Study|Insufficient protocol compliance|2|||
42361780|NCT01740128|76210403|FG001|Overall Study|Insufficient protocol compliance|2|||
42361781|NCT01976741|76210419|FG000|Overall Study|Withdrawal by Subject|1|||
42361782|NCT01976741|76210420|FG001|Overall Study|Withdrawal by Subject|0|||
42361783|NCT01976741|76210421|FG002|Overall Study|Withdrawal by Subject|1|||
42361784|NCT01976741|76210422|FG003|Overall Study|Withdrawal by Subject|1|||
42361785|NCT01976741|76210423|FG004|Overall Study|Withdrawal by Subject|0|||
42361786|NCT01976741|76210424|FG005|Overall Study|Withdrawal by Subject|0|||
42361787|NCT01976741|76210425|FG006|Overall Study|Withdrawal by Subject|1|||
42361788|NCT01976741|76210426|FG007|Overall Study|Withdrawal by Subject|4|||
42361789|NCT01976741|76210427|FG008|Overall Study|Withdrawal by Subject|0|||
42361790|NCT01976741|76210428|FG009|Overall Study|Withdrawal by Subject|0|||
42361791|NCT01976741|76210419|FG000|Overall Study|Adverse Event|0|||
42361792|NCT01976741|76210420|FG001|Overall Study|Adverse Event|0|||
42361793|NCT01976741|76210421|FG002|Overall Study|Adverse Event|2|||
42361794|NCT01976741|76210422|FG003|Overall Study|Adverse Event|0|||
42361795|NCT01976741|76210423|FG004|Overall Study|Adverse Event|0|||
42361796|NCT01976741|76210424|FG005|Overall Study|Adverse Event|0|||
42361797|NCT01976741|76210425|FG006|Overall Study|Adverse Event|3|||
42361798|NCT01976741|76210426|FG007|Overall Study|Adverse Event|8|||
42361799|NCT01976741|76210427|FG008|Overall Study|Adverse Event|1|||
42361800|NCT01976741|76210428|FG009|Overall Study|Adverse Event|4|||
42361801|NCT01727713|76210462|FG000|Overall Study|Lost to Follow-up|5|||
42361802|NCT01727713|76210462|FG000|Overall Study|Adverse Event|10|||
42361803|NCT01727713|76210462|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
42361804|NCT01727713|76210462|FG000|Overall Study|Withdrawal by Subject|13|||
42361805|NCT01727713|76210462|FG000|Overall Study|Protocol Deviation|2|||
42361806|NCT01965431|76210466|FG000|Overall Study|Adverse Event|0|||
42361807|NCT01965431|76210467|FG001|Overall Study|Adverse Event|1|||
42361808|NCT01965431|76210468|FG002|Overall Study|Adverse Event|0|||
42361809|NCT01965431|76210469|FG003|Overall Study|Adverse Event|0|||
42361810|NCT01965431|76210470|FG004|Overall Study|Adverse Event|0|||
42361811|NCT01965431|76210471|FG005|Overall Study|Adverse Event|0|||
42361812|NCT01965431|76210466|FG000|Overall Study|Other than stated above|6|||
42361813|NCT01965431|76210467|FG001|Overall Study|Other than stated above|5|||
42361814|NCT01965431|76210468|FG002|Overall Study|Other than stated above|6|||
42361815|NCT01965431|76210469|FG003|Overall Study|Other than stated above|6|||
42361816|NCT01965431|76210470|FG004|Overall Study|Other than stated above|6|||
42361817|NCT01965431|76210471|FG005|Overall Study|Other than stated above|6|||
42361818|NCT01976663|76210481|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
42361819|NCT01976663|76210481|FG000|Overall Study|Personal Reasons|6|||
42361820|NCT01976663|76210481|FG000|Overall Study|Withdrawal by Subject|4|||
42361821|NCT01976663|76210481|FG000|Overall Study|Screen Failure|3|||
42361822|NCT01976663|76210481|FG000|Overall Study|Adverse Event|2|||
42361823|NCT01976663|76210481|FG000|Overall Study|Lost to Follow-up|3|||
42361824|NCT01775137|76210489|FG000|Overall Study|Death|1|||
42361825|NCT01775137|76210489|FG000|Overall Study|Protocol deviation|2|||
42361826|NCT01775137|76210489|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
42361827|NCT01775137|76210489|FG000|Overall Study|Adverse Event|1|||
42361828|NCT01775137|76210489|FG000|Overall Study|Withdrawal by participants|5|||
42361829|NCT01976507|76210496|FG000|Overall Study|Adverse Event|6|||
42361830|NCT01976507|76210496|FG000|Overall Study|ablation not done, drug not given|1|||
42361831|NCT01964963|76210500|FG000|Overall Study|Case Report Forms Uncollected|888|||
42361832|NCT01964963|76210500|FG000|Overall Study|Protocol Deviation|50|||
42361833|NCT01964963|76210500|FG000|Overall Study|Data Reliability was not Assured|5|||
42361834|NCT01964105|76210507|FG000|Overall Study|Lost to Follow-up|2|||
42361835|NCT01964105|76210508|FG001|Overall Study|Lost to Follow-up|13|||
42361836|NCT01964105|76210509|FG002|Overall Study|Lost to Follow-up|0|||
42361837|NCT01974323|76210519|FG000|Overall Study|Other Reasons|25|||
42361838|NCT01974323|76210520|FG001|Overall Study|Other Reasons|28|||
42361839|NCT01974323|76210519|FG000|Overall Study|Protocol Violation|2|||
42361840|NCT01974323|76210520|FG001|Overall Study|Protocol Violation|2|||
42361841|NCT01974323|76210519|FG000|Overall Study|Personal Reasons|15|||
42361842|NCT01974323|76210520|FG001|Overall Study|Personal Reasons|19|||
42361843|NCT01974323|76210519|FG000|Overall Study|Lost to Follow-up|45|||
42361844|NCT01974323|76210520|FG001|Overall Study|Lost to Follow-up|40|||
42195677|NCT03557151|76007397|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
42195678|NCT00115739|76007405|FG000|Overall Study|Lost to Follow-up|3|||
42195679|NCT01347086|76007421|FG000|Overall Study|failed screening visit|0|||
42195680|NCT01347086|76007422|FG001|Overall Study|failed screening visit|0|||
42195681|NCT01347086|76007423|FG002|Overall Study|failed screening visit|1|||
42195682|NCT01347086|76007424|FG003|Overall Study|failed screening visit|0|||
42195683|NCT01347086|76007425|FG004|Overall Study|failed screening visit|0|||
42195684|NCT01347086|76007426|FG005|Overall Study|failed screening visit|0|||
42195685|NCT01347086|76007427|FG006|Overall Study|failed screening visit|1|||
42195686|NCT01347086|76007428|FG007|Overall Study|failed screening visit|1|||
42195687|NCT01347086|76007429|FG008|Overall Study|failed screening visit|0|||
42195688|NCT01347086|76007430|FG009|Overall Study|failed screening visit|1|||
42195689|NCT03605745|76007462|FG000|Overall Study|Study was terminated for business reasons|47|||
42195690|NCT03246152|76007466|FG000|Overall Study|Lost to Follow-up|2|||
42195691|NCT03246152|76007466|FG000|Overall Study|Protocol Violation|1|||
42195692|NCT03571581|76007470|FG000|Overall Study|Death|2|||
42361845|NCT01974323|76210519|FG000|Overall Study|Pregnancy|2|||
42361846|NCT01974323|76210520|FG001|Overall Study|Pregnancy|1|||
42361847|NCT01974323|76210519|FG000|Overall Study|Lack of Efficacy|1|||
42361848|NCT01974323|76210520|FG001|Overall Study|Lack of Efficacy|1|||
42361849|NCT01974323|76210519|FG000|Overall Study|Adverse Event|2|||
42361850|NCT01974323|76210520|FG001|Overall Study|Adverse Event|2|||
42361851|NCT01963403|76210528|FG000|Overall Study|Lost to Follow-up|2|||
42361852|NCT01963403|76210529|FG001|Overall Study|Lost to Follow-up|3|||
42361853|NCT01963403|76210528|FG000|Overall Study|Implant removal|0|||
42361854|NCT01963403|76210529|FG001|Overall Study|Implant removal|1|||
42361855|NCT01973387|76210539|FG000|Overall Study|Adverse Event|14|||
42361856|NCT01973387|76210540|FG001|Overall Study|Adverse Event|4|||
42361857|NCT01973387|76210539|FG000|Overall Study|Withdrawal by Subject|7|||
42361858|NCT01973387|76210540|FG001|Overall Study|Withdrawal by Subject|4|||
42361859|NCT01973387|76210539|FG000|Overall Study|Study terminated by sponsor|63|||
42361860|NCT01973387|76210540|FG001|Overall Study|Study terminated by sponsor|0|||
42361861|NCT01973387|76210539|FG000|Overall Study|Progressive disease or relapse|16|||
42361862|NCT01973387|76210540|FG001|Overall Study|Progressive disease or relapse|5|||
42361863|NCT01973387|76210539|FG000|Overall Study|Death|4|||
42361864|NCT01973387|76210540|FG001|Overall Study|Death|3|||
42361865|NCT01973387|76210539|FG000|Overall Study|Randomized, not treated|2|||
42100017|NCT00384085|75910664|FG000|Overall Study|Patient required surgery|0|||
42100018|NCT00384085|75910665|FG001|Overall Study|Patient required surgery|1|||
42100019|NCT00384085|75910666|FG002|Overall Study|Patient required surgery|0|||
42100020|NCT00361231|75910676|FG000|Overall Study|Physician Decision|3|||
42100021|NCT00361231|75910676|FG000|Overall Study|Symptomatic deterioration|5|||
42100022|NCT00361231|75910676|FG000|Overall Study|Radiographic disease progression|16|||
42100023|NCT00361231|75910676|FG000|Overall Study|Withdrawal by Subject|4|||
42100024|NCT00361231|75910676|FG000|Overall Study|Adverse Event|6|||
42100025|NCT00676650|75910682|FG000|Overall Study|Death|45|||
42100026|NCT00676650|75910683|FG001|Overall Study|Death|14|||
42100027|NCT00676650|75910682|FG000|Overall Study|Adverse Event|159|||
42100028|NCT00676650|75910683|FG001|Overall Study|Adverse Event|21|||
42100029|NCT00676650|75910682|FG000|Overall Study|Global deterioration of health status|66|||
42100030|NCT00676650|75910683|FG001|Overall Study|Global deterioration of health status|31|||
42100031|NCT00676650|75910682|FG000|Overall Study|Lost to Follow-up|0|||
42100032|NCT00676650|75910683|FG001|Overall Study|Lost to Follow-up|1|||
42195693|NCT03571581|76007470|FG000|Overall Study|Withdrawal by Subject|2|||
42195694|NCT00115349|76007479|FG000|Overall Study|Study closed due to low enrollment.|11|||
42195695|NCT00115349|76007480|FG001|Overall Study|Study closed due to low enrollment.|9|||
42195696|NCT00115037|76007488|FG000|Phase1|Lost to Follow-up|16|||
42361866|NCT01973387|76210540|FG001|Overall Study|Randomized, not treated|2|||
42361867|NCT01973231|76210548|FG000|Overall Study|Protocol Violation|1|||
42361868|NCT01973231|76210549|FG001|Overall Study|Protocol Violation|1|||
42361869|NCT01973231|76210548|FG000|Overall Study|Lost to Follow-up|1|||
42361870|NCT01973231|76210549|FG001|Overall Study|Lost to Follow-up|1|||
42361871|NCT01973231|76210548|FG000|Overall Study|unclassified|2|||
42361872|NCT01973231|76210549|FG001|Overall Study|unclassified|1|||
42361873|NCT01973231|76210548|FG000|Overall Study|Withdrawal by Subject|7|||
42361874|NCT01973231|76210549|FG001|Overall Study|Withdrawal by Subject|9|||
42361875|NCT01961687|76210555|FG000|Overall Study|Lost to Follow-up|19|||
42100033|NCT00676650|75910682|FG000|Overall Study|Objective progression or relapse|189|||
42100034|NCT00676650|75910683|FG001|Overall Study|Objective progression or relapse|140|||
42100035|NCT00676650|75910682|FG000|Overall Study|Other|14|||
42361876|NCT01961687|76210555|FG000|Overall Study|Re-operation|17|||
42361877|NCT01961687|76210555|FG000|Overall Study|Death|7|||
42361878|NCT01961687|76210555|FG000|Overall Study|Withdrawal by Subject|6|||
42361879|NCT01961687|76210555|FG000|Overall Study|Adverse Event|6|||
42361880|NCT01961687|76210555|FG000|Overall Study|Moved to area without study site|2|||
42361881|NCT01961687|76210555|FG000|Overall Study|Sponsor decision|2|||
42361882|NCT01961687|76210555|FG000|Overall Study|Physician Decision|1|||
42361883|NCT01961687|76210555|FG000|Overall Study|Unable to meet follow-up requirements|1|||
42361884|NCT01961609|76210617|FG000|Initiation|Missing|3|||
42361885|NCT01961609|76210618|FG001|Initiation|Missing|2|||
42361886|NCT01961609|76210619|FG002|Initiation|Missing|0|||
42361887|NCT01961609|76210620|FG003|Initiation|Missing|0|||
42361888|NCT01961609|76210617|FG000|Initiation|Protocol deviation|1|||
42361889|NCT01961609|76210618|FG001|Initiation|Protocol deviation|0|||
42361890|NCT01961609|76210619|FG002|Initiation|Protocol deviation|0|||
42361891|NCT01961609|76210620|FG003|Initiation|Protocol deviation|0|||
42361892|NCT01961609|76210617|FG000|Initiation|Death|0|||
42361893|NCT01961609|76210618|FG001|Initiation|Death|1|||
42361894|NCT01961609|76210619|FG002|Initiation|Death|0|||
42361895|NCT01961609|76210620|FG003|Initiation|Death|0|||
42361896|NCT01961609|76210617|FG000|Initiation|Administrative problems|1|||
42361897|NCT01961609|76210618|FG001|Initiation|Administrative problems|0|||
42361898|NCT01961609|76210619|FG002|Initiation|Administrative problems|0|||
42361899|NCT01961609|76210620|FG003|Initiation|Administrative problems|0|||
42361900|NCT01961609|76210617|FG000|Initiation|Withdrawal by Subject|1|||
42361901|NCT01961609|76210618|FG001|Initiation|Withdrawal by Subject|2|||
42361902|NCT01961609|76210619|FG002|Initiation|Withdrawal by Subject|0|||
42361903|NCT01961609|76210620|FG003|Initiation|Withdrawal by Subject|0|||
42361904|NCT01961609|76210617|FG000|Initiation|Lack of Efficacy|2|||
42361905|NCT01961609|76210618|FG001|Initiation|Lack of Efficacy|1|||
42361906|NCT01961609|76210619|FG002|Initiation|Lack of Efficacy|0|||
42361907|NCT01961609|76210620|FG003|Initiation|Lack of Efficacy|0|||
42361908|NCT01961609|76210617|FG000|Initiation|Abnormal lab values|0|||
42361909|NCT01961609|76210618|FG001|Initiation|Abnormal lab values|1|||
42361910|NCT01961609|76210619|FG002|Initiation|Abnormal lab values|0|||
42361911|NCT01961609|76210620|FG003|Initiation|Abnormal lab values|0|||
42361912|NCT01961609|76210617|FG000|Initiation|Adverse Event|3|||
42361913|NCT01961609|76210618|FG001|Initiation|Adverse Event|5|||
42361914|NCT01961609|76210619|FG002|Initiation|Adverse Event|0|||
42361915|NCT01961609|76210620|FG003|Initiation|Adverse Event|0|||
42361916|NCT01961609|76210617|FG000|Initiation|Randomized but not treated|1|||
42361917|NCT01961609|76210618|FG001|Initiation|Randomized but not treated|1|||
42361918|NCT01961609|76210619|FG002|Initiation|Randomized but not treated|0|||
42361919|NCT01961609|76210620|FG003|Initiation|Randomized but not treated|0|||
42361920|NCT01961609|76210617|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
42361921|NCT01961609|76210618|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
42361922|NCT01961609|76210619|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
42361923|NCT01961609|76210620|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
42361924|NCT01961609|76210617|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
42361925|NCT01961609|76210618|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
42361926|NCT01961609|76210619|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
42361927|NCT01961609|76210620|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
42361928|NCT01961609|76210617|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
42361929|NCT01961609|76210618|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
42361930|NCT01961609|76210619|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
42361931|NCT01961609|76210620|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
42361932|NCT01961609|76210617|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
42361933|NCT01961609|76210618|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
42361934|NCT01961609|76210619|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
42361935|NCT01961609|76210620|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
42100036|NCT00676650|75910683|FG001|Overall Study|Other|10|||
42100037|NCT00676650|75910682|FG000|Overall Study|Protocol Violation|3|||
42100038|NCT00676650|75910683|FG001|Overall Study|Protocol Violation|1|||
42100039|NCT00676650|75910682|FG000|Overall Study|Study terminated by sponsor|57|||
42195697|NCT00115037|76007489|FG001|Phase1|Lost to Follow-up|23|||
42361936|NCT01961609|76210617|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
42361937|NCT01961609|76210618|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
42361938|NCT01961609|76210619|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
42361939|NCT01961609|76210620|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
42361940|NCT01961609|76210617|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
42361941|NCT01961609|76210618|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
42361942|NCT01961609|76210619|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
42361943|NCT01961609|76210620|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
42100040|NCT00676650|75910683|FG001|Overall Study|Study terminated by sponsor|43|||
42100041|NCT00676650|75910682|FG000|Overall Study|Withdrawal by Subject|48|||
42361944|NCT01961609|76210617|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
42361945|NCT01961609|76210618|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
42361946|NCT01961609|76210619|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
42361947|NCT01961609|76210620|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
42361948|NCT01961609|76210617|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
42361949|NCT01961609|76210618|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
42361950|NCT01961609|76210619|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
42361951|NCT01961609|76210620|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
42361952|NCT01961609|76210617|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
42361953|NCT01961609|76210618|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
42361954|NCT01961609|76210619|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
42361955|NCT01961609|76210620|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
42361956|NCT01961609|76210617|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
42361957|NCT01961609|76210618|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
42361958|NCT01961609|76210619|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
42361959|NCT01961609|76210620|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
42361960|NCT01961609|76210617|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
42361961|NCT01961609|76210618|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
42361962|NCT01961609|76210619|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
42361963|NCT01961609|76210620|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
42361964|NCT01961609|76210617|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
42361965|NCT01961609|76210618|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
42361966|NCT01961609|76210619|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
42361967|NCT01961609|76210620|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
42361968|NCT01774981|76210729|FG000|Overall Study|Adverse Event|0|||
42361969|NCT01774981|76210730|FG001|Overall Study|Adverse Event|0|||
42361970|NCT01774981|76210731|FG002|Overall Study|Adverse Event|0|||
42361971|NCT01774981|76210732|FG003|Overall Study|Adverse Event|0|||
42361972|NCT01774981|76210733|FG004|Overall Study|Adverse Event|0|||
42361973|NCT01774981|76210734|FG005|Overall Study|Adverse Event|1|||
42361974|NCT01774981|76210735|FG006|Overall Study|Adverse Event|0|||
42361975|NCT01774981|76210736|FG007|Overall Study|Adverse Event|0|||
42361976|NCT01774981|76210729|FG000|Overall Study|Withdrawal by Subject|0|||
42361977|NCT01774981|76210730|FG001|Overall Study|Withdrawal by Subject|0|||
42361978|NCT01774981|76210731|FG002|Overall Study|Withdrawal by Subject|0|||
42361979|NCT01774981|76210732|FG003|Overall Study|Withdrawal by Subject|0|||
42361980|NCT01774981|76210733|FG004|Overall Study|Withdrawal by Subject|0|||
42361981|NCT01774981|76210734|FG005|Overall Study|Withdrawal by Subject|0|||
42361982|NCT01774981|76210735|FG006|Overall Study|Withdrawal by Subject|0|||
42361983|NCT01774981|76210736|FG007|Overall Study|Withdrawal by Subject|1|||
42361984|NCT01774981|76210729|FG000|Overall Study|Death|0|||
42361985|NCT01774981|76210730|FG001|Overall Study|Death|0|||
42361986|NCT01774981|76210731|FG002|Overall Study|Death|0|||
42361987|NCT01774981|76210732|FG003|Overall Study|Death|0|||
42100042|NCT00676650|75910683|FG001|Overall Study|Withdrawal by Subject|24|||
42100043|NCT00676650|75910682|FG000|Overall Study|Randomized but not treated|3|||
42100044|NCT00676650|75910683|FG001|Overall Study|Randomized but not treated|4|||
42100045|NCT00573183|75910691|FG000|Overall Study|Lost to Follow-up|52|||
42100046|NCT00573183|75910692|FG001|Overall Study|Lost to Follow-up|50|||
42100047|NCT00573183|75910691|FG000|Overall Study|Withdrawal by Subject|8|||
42100048|NCT00573183|75910692|FG001|Overall Study|Withdrawal by Subject|2|||
42100049|NCT00573183|75910691|FG000|Overall Study|Death|0|||
42195698|NCT00115037|76007490|FG002|Phase1|Lost to Follow-up|0|||
42195699|NCT00115037|76007491|FG003|Phase1|Lost to Follow-up|0|||
42195700|NCT00115037|76007492|FG004|Phase1|Lost to Follow-up|0|||
42195701|NCT00115037|76007493|FG005|Phase1|Lost to Follow-up|0|||
42195702|NCT00115037|76007488|FG000|Phase1|Withdrawal by Subject|9|||
42195703|NCT00115037|76007489|FG001|Phase1|Withdrawal by Subject|4|||
42195704|NCT00115037|76007490|FG002|Phase1|Withdrawal by Subject|0|||
42195705|NCT00115037|76007491|FG003|Phase1|Withdrawal by Subject|0|||
42195706|NCT00115037|76007492|FG004|Phase1|Withdrawal by Subject|0|||
42195707|NCT00115037|76007493|FG005|Phase1|Withdrawal by Subject|0|||
42361988|NCT01774981|76210733|FG004|Overall Study|Death|1|||
42361989|NCT01774981|76210734|FG005|Overall Study|Death|0|||
42361990|NCT01774981|76210735|FG006|Overall Study|Death|0|||
42361991|NCT01774981|76210736|FG007|Overall Study|Death|0|||
42361992|NCT01972841|76210765|FG000|Overall Study|Randomized but Never Received Treatment|2|||
42361993|NCT01972841|76210766|FG001|Overall Study|Randomized but Never Received Treatment|5|||
42361994|NCT01972841|76210767|FG002|Overall Study|Randomized but Never Received Treatment|4|||
42361995|NCT01972841|76210768|FG003|Overall Study|Randomized but Never Received Treatment|2|||
42100050|NCT00573183|75910692|FG001|Overall Study|Death|1|||
42100051|NCT00573183|75910691|FG000|Overall Study|Adverse Event|2|||
42100052|NCT00573183|75910692|FG001|Overall Study|Adverse Event|0|||
42195708|NCT00115037|76007488|FG000|Phase2|Death|0|||
42195709|NCT00115037|76007489|FG001|Phase2|Death|0|||
42361996|NCT01972841|76210769|FG004|Overall Study|Randomized but Never Received Treatment|6|||
42361997|NCT01972841|76210770|FG005|Overall Study|Randomized but Never Received Treatment|13|||
42361998|NCT01972841|76210765|FG000|Overall Study|Adverse Event|13|||
42361999|NCT01972841|76210766|FG001|Overall Study|Adverse Event|8|||
42362000|NCT01972841|76210767|FG002|Overall Study|Adverse Event|12|||
42362001|NCT01972841|76210768|FG003|Overall Study|Adverse Event|9|||
42362002|NCT01972841|76210769|FG004|Overall Study|Adverse Event|21|||
42362003|NCT01972841|76210770|FG005|Overall Study|Adverse Event|26|||
42362004|NCT01972841|76210765|FG000|Overall Study|Lack of Efficacy|1|||
42362005|NCT01972841|76210766|FG001|Overall Study|Lack of Efficacy|0|||
42362006|NCT01972841|76210767|FG002|Overall Study|Lack of Efficacy|0|||
42362007|NCT01972841|76210768|FG003|Overall Study|Lack of Efficacy|2|||
42362008|NCT01972841|76210769|FG004|Overall Study|Lack of Efficacy|4|||
42362009|NCT01972841|76210770|FG005|Overall Study|Lack of Efficacy|1|||
42362010|NCT01972841|76210765|FG000|Overall Study|Lost to Follow-up|4|||
42362011|NCT01972841|76210766|FG001|Overall Study|Lost to Follow-up|2|||
42362012|NCT01972841|76210767|FG002|Overall Study|Lost to Follow-up|4|||
42362013|NCT01972841|76210768|FG003|Overall Study|Lost to Follow-up|2|||
42362014|NCT01972841|76210769|FG004|Overall Study|Lost to Follow-up|9|||
42362015|NCT01972841|76210770|FG005|Overall Study|Lost to Follow-up|3|||
42362016|NCT01972841|76210765|FG000|Overall Study|Protocol Violation|2|||
42362017|NCT01972841|76210766|FG001|Overall Study|Protocol Violation|2|||
42362018|NCT01972841|76210767|FG002|Overall Study|Protocol Violation|3|||
42362019|NCT01972841|76210768|FG003|Overall Study|Protocol Violation|5|||
42100053|NCT00573183|75910691|FG000|Overall Study|Incarceration|5|||
42100054|NCT00573183|75910692|FG001|Overall Study|Incarceration|8|||
42100055|NCT00573183|75910691|FG000|Overall Study|Other|5|||
42100056|NCT00573183|75910692|FG001|Overall Study|Other|2|||
42100057|NCT00615459|75910700|FG000|Period I|Adverse Event|2|||
42100058|NCT00615459|75910701|FG001|Period I|Adverse Event|0|||
42100059|NCT00615459|75910702|FG002|Period I|Adverse Event|1|||
42100060|NCT00615459|75910703|FG003|Period I|Adverse Event|0|||
42100061|NCT00615459|75910700|FG000|Period I|Subject withdrew consent|1|||
42100062|NCT00615459|75910701|FG001|Period I|Subject withdrew consent|0|||
42100063|NCT00615459|75910702|FG002|Period I|Subject withdrew consent|0|||
42100064|NCT00615459|75910703|FG003|Period I|Subject withdrew consent|1|||
42195710|NCT00115037|76007490|FG002|Phase2|Death|1|||
42195711|NCT00115037|76007491|FG003|Phase2|Death|0|||
42195712|NCT00115037|76007492|FG004|Phase2|Death|0|||
42195713|NCT00115037|76007493|FG005|Phase2|Death|1|||
42195714|NCT00115037|76007488|FG000|Phase2|Withdrawal by Subject|0|||
42195715|NCT00115037|76007489|FG001|Phase2|Withdrawal by Subject|0|||
42195716|NCT00115037|76007490|FG002|Phase2|Withdrawal by Subject|2|||
42195717|NCT00115037|76007491|FG003|Phase2|Withdrawal by Subject|1|||
42195718|NCT00115037|76007492|FG004|Phase2|Withdrawal by Subject|2|||
42100065|NCT00615459|75910700|FG000|Period I|Abnormal test procedure results|1|||
42100066|NCT00615459|75910701|FG001|Period I|Abnormal test procedure results|1|||
42100067|NCT00615459|75910702|FG002|Period I|Abnormal test procedure results|1|||
42100068|NCT00615459|75910703|FG003|Period I|Abnormal test procedure results|0|||
42100069|NCT00615459|75910700|FG000|Period II|Adverse Event|1|||
42100070|NCT00615459|75910701|FG001|Period II|Adverse Event|0|||
42100071|NCT00615459|75910702|FG002|Period II|Adverse Event|0|||
42100072|NCT00615459|75910703|FG003|Period II|Adverse Event|0|||
42100073|NCT00615459|75910700|FG000|Period II|Lost to Follow-up|0|||
42195719|NCT00115037|76007493|FG005|Phase2|Withdrawal by Subject|1|||
42195720|NCT00115037|76007488|FG000|Phase2|Lost to Follow-up|0|||
42195721|NCT00115037|76007489|FG001|Phase2|Lost to Follow-up|0|||
42195722|NCT00115037|76007490|FG002|Phase2|Lost to Follow-up|12|||
42195723|NCT00115037|76007491|FG003|Phase2|Lost to Follow-up|14|||
42195724|NCT00115037|76007492|FG004|Phase2|Lost to Follow-up|4|||
42195725|NCT00115037|76007493|FG005|Phase2|Lost to Follow-up|10|||
42195726|NCT03214640|76007511|FG000|Overall Study|Protocol Violation|1|||
42195727|NCT03214640|76007512|FG001|Overall Study|Protocol Violation|2|||
42362020|NCT01972841|76210769|FG004|Overall Study|Protocol Violation|9|||
42362021|NCT01972841|76210770|FG005|Overall Study|Protocol Violation|4|||
42362022|NCT01972841|76210765|FG000|Overall Study|Withdrawal by participants|21|||
42362023|NCT01972841|76210766|FG001|Overall Study|Withdrawal by participants|27|||
42362024|NCT01972841|76210767|FG002|Overall Study|Withdrawal by participants|23|||
42362025|NCT01972841|76210768|FG003|Overall Study|Withdrawal by participants|16|||
42362026|NCT01972841|76210769|FG004|Overall Study|Withdrawal by participants|33|||
42362027|NCT01972841|76210770|FG005|Overall Study|Withdrawal by participants|34|||
42362028|NCT01972841|76210765|FG000|Overall Study|Miscellaneous|0|||
42100074|NCT00615459|75910701|FG001|Period II|Lost to Follow-up|0|||
42100075|NCT00615459|75910702|FG002|Period II|Lost to Follow-up|0|||
42195728|NCT03214640|76007513|FG002|Overall Study|Protocol Violation|1|||
42362029|NCT01972841|76210766|FG001|Overall Study|Miscellaneous|0|||
42362030|NCT01972841|76210767|FG002|Overall Study|Miscellaneous|4|||
42100076|NCT00615459|75910703|FG003|Period II|Lost to Follow-up|1|||
42100077|NCT00615459|75910700|FG000|Period III|Adverse Event|0|||
42195729|NCT03214640|76007514|FG003|Overall Study|Protocol Violation|4|||
42195730|NCT03214406|76007526|FG000|Overall Study|did not meet enrollment criteria|9|||
42195731|NCT03214406|76007527|FG001|Overall Study|did not meet enrollment criteria|13|||
42362031|NCT01972841|76210768|FG003|Overall Study|Miscellaneous|1|||
42362032|NCT01972841|76210769|FG004|Overall Study|Miscellaneous|0|||
42362033|NCT01972841|76210770|FG005|Overall Study|Miscellaneous|4|||
42362034|NCT01972841|76210765|FG000|Overall Study|Did not have end of treatment page|0|||
42362035|NCT01972841|76210766|FG001|Overall Study|Did not have end of treatment page|0|||
42362036|NCT01972841|76210767|FG002|Overall Study|Did not have end of treatment page|0|||
42362037|NCT01972841|76210768|FG003|Overall Study|Did not have end of treatment page|0|||
42362038|NCT01972841|76210769|FG004|Overall Study|Did not have end of treatment page|1|||
42362039|NCT01972841|76210770|FG005|Overall Study|Did not have end of treatment page|0|||
42362040|NCT01774903|76210784|FG000|Overall Study|Adverse Event|7|||
42362041|NCT01774903|76210784|FG000|Overall Study|Withdrawal by Subject|2|||
42362042|NCT01774903|76210784|FG000|Overall Study|Lack of Efficacy|1|||
42362043|NCT01774903|76210784|FG000|Overall Study|Ineligible to continue the trial|1|||
42362044|NCT01774591|76210791|FG000|Overall Study|Physician Decision|1|||
42362045|NCT01774591|76210792|FG001|Overall Study|Physician Decision|1|||
42362046|NCT01774591|76210791|FG000|Overall Study|Withdrawal by Subject|0|||
42362047|NCT01774591|76210792|FG001|Overall Study|Withdrawal by Subject|1|||
42362048|NCT01774591|76210791|FG000|Overall Study|Adverse Event|0|||
42362049|NCT01774591|76210792|FG001|Overall Study|Adverse Event|2|||
42362050|NCT01708915|76210802|FG000|Overall Study|Adverse Event|1|||
42362051|NCT01708915|76210803|FG001|Overall Study|Adverse Event|0|||
42362052|NCT01708915|76210804|FG002|Overall Study|Adverse Event|9|||
42362053|NCT01708915|76210805|FG003|Overall Study|Adverse Event|13|||
42362054|NCT01708915|76210802|FG000|Overall Study|Lack of Efficacy|84|||
42362055|NCT01708915|76210803|FG001|Overall Study|Lack of Efficacy|60|||
42362056|NCT01708915|76210804|FG002|Overall Study|Lack of Efficacy|35|||
42362057|NCT01708915|76210805|FG003|Overall Study|Lack of Efficacy|15|||
42362058|NCT01708915|76210802|FG000|Overall Study|Protocol Violation|0|||
42362059|NCT01708915|76210803|FG001|Overall Study|Protocol Violation|0|||
42362060|NCT01708915|76210804|FG002|Overall Study|Protocol Violation|0|||
42362061|NCT01708915|76210805|FG003|Overall Study|Protocol Violation|1|||
42362062|NCT01708915|76210802|FG000|Overall Study|Withdrawal by Subject|0|||
42362063|NCT01708915|76210803|FG001|Overall Study|Withdrawal by Subject|1|||
42362064|NCT01708915|76210804|FG002|Overall Study|Withdrawal by Subject|2|||
42362065|NCT01708915|76210805|FG003|Overall Study|Withdrawal by Subject|2|||
42362066|NCT01708915|76210802|FG000|Overall Study|Other reasons than stated above|1|||
42362067|NCT01708915|76210803|FG001|Overall Study|Other reasons than stated above|1|||
42362068|NCT01708915|76210804|FG002|Overall Study|Other reasons than stated above|0|||
42362069|NCT01708915|76210805|FG003|Overall Study|Other reasons than stated above|2|||
42362070|NCT01708291|76210817|FG000|Overall Study|fighting|2|||
42362071|NCT01708291|76210818|FG001|Overall Study|fighting|1|||
42362072|NCT01708057|76210824|FG000|Overall Study|Withdrawal due to study termination.|1|||
42362073|NCT01708057|76210825|FG001|Overall Study|Withdrawal due to study termination.|1|||
42362074|NCT01708057|76210826|FG002|Overall Study|Withdrawal due to study termination.|1|||
42362075|NCT01748071|76210843|FG000|Overall Study|Adverse Event|2|||
42362076|NCT01748071|76210844|FG001|Overall Study|Adverse Event|2|||
42100078|NCT00615459|75910701|FG001|Period III|Adverse Event|1|||
42100079|NCT00615459|75910702|FG002|Period III|Adverse Event|0|||
42362077|NCT01748071|76210845|FG002|Overall Study|Adverse Event|0|||
42100080|NCT00615459|75910703|FG003|Period III|Adverse Event|0|||
42100081|NCT00615459|75910700|FG000|Period III|Administrative problems|0|||
42100082|NCT00615459|75910701|FG001|Period III|Administrative problems|1|||
42100083|NCT00615459|75910702|FG002|Period III|Administrative problems|1|||
42100084|NCT00615459|75910703|FG003|Period III|Administrative problems|0|||
42362078|NCT01972529|76210857|FG000|Overall Study|Adverse Event|0|||
42362079|NCT01972529|76210858|FG001|Overall Study|Adverse Event|1|||
42362080|NCT01972529|76210859|FG002|Overall Study|Adverse Event|0|||
42100085|NCT00615459|75910700|FG000|Period III|Unsatisfactory therapeutic effect|0|||
42100086|NCT00615459|75910701|FG001|Period III|Unsatisfactory therapeutic effect|1|||
42362081|NCT01972529|76210860|FG003|Overall Study|Adverse Event|0|||
42362082|NCT01972529|76210857|FG000|Overall Study|Lost to Follow-up|1|||
42362083|NCT01972529|76210858|FG001|Overall Study|Lost to Follow-up|0|||
42362084|NCT01972529|76210859|FG002|Overall Study|Lost to Follow-up|0|||
42362085|NCT01972529|76210860|FG003|Overall Study|Lost to Follow-up|0|||
42362086|NCT01972529|76210857|FG000|Overall Study|Participant Choice|0|||
42100087|NCT00615459|75910702|FG002|Period III|Unsatisfactory therapeutic effect|0|||
42100088|NCT00615459|75910703|FG003|Period III|Unsatisfactory therapeutic effect|0|||
42100089|NCT00383149|75910717|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
42362087|NCT01972529|76210858|FG001|Overall Study|Participant Choice|1|||
42362088|NCT01972529|76210859|FG002|Overall Study|Participant Choice|0|||
42362089|NCT01972529|76210860|FG003|Overall Study|Participant Choice|0|||
42362090|NCT01972529|76210857|FG000|Overall Study|Withdrawl of Consent|1|||
42362091|NCT01972529|76210858|FG001|Overall Study|Withdrawl of Consent|2|||
42362092|NCT01972529|76210859|FG002|Overall Study|Withdrawl of Consent|0|||
42362093|NCT01972529|76210860|FG003|Overall Study|Withdrawl of Consent|1|||
42362094|NCT01972529|76210857|FG000|Overall Study|Other|0|||
42362095|NCT01972529|76210858|FG001|Overall Study|Other|0|||
42362096|NCT01972529|76210859|FG002|Overall Study|Other|0|||
42362097|NCT01972529|76210860|FG003|Overall Study|Other|2|||
42362098|NCT01972529|76210857|FG000|Overall Study|Not treated|0|||
42362099|NCT01972529|76210858|FG001|Overall Study|Not treated|1|||
42362100|NCT01972529|76210859|FG002|Overall Study|Not treated|2|||
42362101|NCT01972529|76210860|FG003|Overall Study|Not treated|1|||
42362102|NCT01747915|76210874|FG000|Overall Study|Other|1|||
42362103|NCT01747915|76210875|FG001|Overall Study|Other|1|||
42362104|NCT01747915|76210876|FG002|Overall Study|Other|1|||
42362105|NCT01747915|76210874|FG000|Overall Study|Adverse Event|8|||
42362106|NCT01747915|76210875|FG001|Overall Study|Adverse Event|5|||
42362107|NCT01747915|76210876|FG002|Overall Study|Adverse Event|2|||
42362108|NCT01747915|76210874|FG000|Overall Study|Death|0|||
42362109|NCT01747915|76210875|FG001|Overall Study|Death|0|||
42362110|NCT01747915|76210876|FG002|Overall Study|Death|1|||
42362111|NCT01747915|76210874|FG000|Overall Study|Lack of Efficacy|0|||
42362112|NCT01747915|76210875|FG001|Overall Study|Lack of Efficacy|1|||
42362113|NCT01747915|76210876|FG002|Overall Study|Lack of Efficacy|0|||
42362114|NCT01747915|76210874|FG000|Overall Study|Lost to Follow-up|1|||
42362115|NCT01747915|76210875|FG001|Overall Study|Lost to Follow-up|0|||
42362116|NCT01747915|76210876|FG002|Overall Study|Lost to Follow-up|0|||
42362117|NCT01747915|76210874|FG000|Overall Study|Withdrawal by Subject|4|||
42362118|NCT01747915|76210875|FG001|Overall Study|Withdrawal by Subject|4|||
42362119|NCT01747915|76210876|FG002|Overall Study|Withdrawal by Subject|1|||
42362120|NCT01747915|76210874|FG000|Overall Study|Protocol Violation|1|||
42362121|NCT01747915|76210875|FG001|Overall Study|Protocol Violation|0|||
42362122|NCT01747915|76210876|FG002|Overall Study|Protocol Violation|0|||
42362123|NCT01747915|76210874|FG000|Overall Study|Pregnancy|0|||
42362124|NCT01747915|76210875|FG001|Overall Study|Pregnancy|0|||
42362125|NCT01747915|76210876|FG002|Overall Study|Pregnancy|1|||
42362126|NCT01961297|76210886|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
42362127|NCT01961297|76210887|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
42362128|NCT01960907|76210895|FG000|Overall Study|Death|4|||
42362129|NCT01960907|76210896|FG001|Overall Study|Death|3|||
42362130|NCT01960907|76210895|FG000|Overall Study|Withdrawal by Subject|32|||
42362131|NCT01960907|76210896|FG001|Overall Study|Withdrawal by Subject|42|||
42362132|NCT01747837|76210907|FG000|Overall Study|Lost to Follow-up|5|||
42362133|NCT01747837|76210908|FG001|Overall Study|Lost to Follow-up|2|||
42362134|NCT01747837|76210907|FG000|Overall Study|Death|4|||
42362135|NCT01747837|76210908|FG001|Overall Study|Death|4|||
42362136|NCT01971203|76210916|FG000|Overall Study|Protocol Violation|3|||
42362137|NCT01971203|76210917|FG001|Overall Study|Protocol Violation|2|||
42362138|NCT01971203|76210916|FG000|Overall Study|Withdrawal by Subject|5|||
42362139|NCT01971203|76210917|FG001|Overall Study|Withdrawal by Subject|6|||
42362140|NCT01971203|76210916|FG000|Overall Study|Adverse Event|1|||
42362141|NCT01971203|76210917|FG001|Overall Study|Adverse Event|0|||
42362142|NCT01605877|76210923|FG000|Overall Study|Withdrawal by Subject|1|||
42362143|NCT01970501|76210947|FG000|Overall Study|Discontinuation of study by sponsor|16|||
42362144|NCT01970501|76210948|FG001|Overall Study|Discontinuation of study by sponsor|14|||
42362145|NCT01970501|76210947|FG000|Overall Study|Withdrawal by Subject|6|||
42362146|NCT01970501|76210948|FG001|Overall Study|Withdrawal by Subject|7|||
42362147|NCT01970501|76210947|FG000|Overall Study|Adverse Event|2|||
42362148|NCT01970501|76210948|FG001|Overall Study|Adverse Event|4|||
42362149|NCT01970501|76210947|FG000|Overall Study|Death|1|||
42362150|NCT01970501|76210948|FG001|Overall Study|Death|3|||
42362151|NCT01970501|76210947|FG000|Overall Study|Physician Decision|2|||
42362152|NCT01970501|76210948|FG001|Overall Study|Physician Decision|0|||
42362153|NCT01969799|76210956|FG000|Overall Study|Adverse Event|0|||
42362154|NCT01969799|76210957|FG001|Overall Study|Adverse Event|1|||
42362155|NCT01969799|76210956|FG000|Overall Study|Death|16|||
42362156|NCT01969799|76210957|FG001|Overall Study|Death|11|||
42362157|NCT01969799|76210956|FG000|Overall Study|Lost to Follow-up|0|||
42362158|NCT01969799|76210957|FG001|Overall Study|Lost to Follow-up|2|||
42362159|NCT01969799|76210956|FG000|Overall Study|Physician Decision|1|||
42362160|NCT01969799|76210957|FG001|Overall Study|Physician Decision|0|||
42362161|NCT01969721|76210963|FG000|Overall Study|Adverse Event|3|||
42362162|NCT01969721|76210964|FG001|Overall Study|Adverse Event|8|||
42362163|NCT01969721|76210965|FG002|Overall Study|Adverse Event|3|||
42362164|NCT01969721|76210966|FG003|Overall Study|Adverse Event|2|||
42362165|NCT01969721|76210963|FG000|Overall Study|Lack of Efficacy|0|||
42362166|NCT01969721|76210964|FG001|Overall Study|Lack of Efficacy|0|||
42362167|NCT01969721|76210965|FG002|Overall Study|Lack of Efficacy|1|||
42362168|NCT01969721|76210966|FG003|Overall Study|Lack of Efficacy|0|||
42362169|NCT01969721|76210963|FG000|Overall Study|Non compliant with protocol|1|||
42362170|NCT01969721|76210964|FG001|Overall Study|Non compliant with protocol|1|||
42362171|NCT01969721|76210965|FG002|Overall Study|Non compliant with protocol|0|||
42362172|NCT01969721|76210966|FG003|Overall Study|Non compliant with protocol|2|||
42362173|NCT01969721|76210963|FG000|Overall Study|Other not defined above|0|||
42362174|NCT01969721|76210964|FG001|Overall Study|Other not defined above|2|||
42362175|NCT01969721|76210965|FG002|Overall Study|Other not defined above|0|||
42362176|NCT01969721|76210966|FG003|Overall Study|Other not defined above|0|||
42362177|NCT01969721|76210963|FG000|Overall Study|Discontinued during washout periods.|0|||
42362178|NCT01969721|76210964|FG001|Overall Study|Discontinued during washout periods.|1|||
42362179|NCT01969721|76210965|FG002|Overall Study|Discontinued during washout periods.|1|||
42362180|NCT01969721|76210966|FG003|Overall Study|Discontinued during washout periods.|2|||
42362181|NCT01969565|76210976|FG000|Overall Study|Withdrawal by Subject|1|||
42362182|NCT01968707|76210989|FG000|Overall Study|Did not meet treatment day baseline|49|||
42362183|NCT01968707|76210990|FG001|Overall Study|Did not meet treatment day baseline|12|||
42362184|NCT01968707|76210991|FG002|Overall Study|Did not meet treatment day baseline|41|||
42362185|NCT01968707|76210992|FG003|Overall Study|Did not meet treatment day baseline|44|||
42362186|NCT01968707|76210993|FG004|Overall Study|Did not meet treatment day baseline|36|||
42362187|NCT01968707|76210994|FG005|Overall Study|Did not meet treatment day baseline|11|||
42362188|NCT01968707|76210995|FG006|Overall Study|Did not meet treatment day baseline|34|||
42362189|NCT01968707|76210996|FG007|Overall Study|Did not meet treatment day baseline|35|||
42362190|NCT01959581|76211029|FG000|Overall Study|Lost to Follow-up|5|||
42100090|NCT00383149|75910717|FG000|Overall Study|Death|2|||
42362191|NCT01746901|76211033|FG000|Naloxone Challenge Phase|Adverse Event|2|||
42362192|NCT01746901|76211034|FG001|Naloxone Challenge Phase|Adverse Event|0|||
42362193|NCT01746901|76211035|FG002|Naloxone Challenge Phase|Adverse Event|0|||
42362194|NCT01746901|76211036|FG003|Naloxone Challenge Phase|Adverse Event|0|||
42362195|NCT01746901|76211037|FG004|Naloxone Challenge Phase|Adverse Event|0|||
42362196|NCT01746901|76211038|FG005|Naloxone Challenge Phase|Adverse Event|0|||
42362197|NCT01746901|76211039|FG006|Naloxone Challenge Phase|Adverse Event|0|||
42362198|NCT01746901|76211040|FG007|Naloxone Challenge Phase|Adverse Event|0|||
42362199|NCT01746901|76211041|FG008|Naloxone Challenge Phase|Adverse Event|0|||
42362200|NCT01746901|76211033|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
42362201|NCT01746901|76211034|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
42362202|NCT01746901|76211035|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
42362203|NCT01746901|76211036|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
42362204|NCT01746901|76211037|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
42362205|NCT01746901|76211038|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
42362206|NCT01746901|76211039|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
42362207|NCT01746901|76211040|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
42362208|NCT01746901|76211041|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
42362209|NCT01746901|76211033|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42362210|NCT01746901|76211034|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
42362211|NCT01746901|76211035|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42362212|NCT01746901|76211036|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42362213|NCT01746901|76211037|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42362214|NCT01746901|76211038|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42362215|NCT01746901|76211039|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42362216|NCT01746901|76211040|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42362217|NCT01746901|76211041|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42362218|NCT01746901|76211033|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
42362219|NCT01746901|76211034|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
42362220|NCT01746901|76211035|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
42362221|NCT01746901|76211036|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
42362222|NCT01746901|76211037|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
42362223|NCT01746901|76211038|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
42100091|NCT00383149|75910717|FG000|Overall Study|Disease Progression|38|||
42100092|NCT00383149|75910717|FG000|Overall Study|Lost to Follow-up|1|||
42100093|NCT00383149|75910717|FG000|Overall Study|Other|1|||
42362224|NCT01746901|76211039|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
42362225|NCT01746901|76211040|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
42100094|NCT00383149|75910717|FG000|Overall Study|Study Drug Toxicity|4|||
42100095|NCT00383149|75910717|FG000|Overall Study|Request to Discontinue Treatment|4|||
42100096|NCT00383149|75910717|FG000|Overall Study|Participant Withdrew Consent|1|||
42100097|NCT00382993|75910723|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
42100098|NCT00382993|75910724|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
42100099|NCT00382993|75910723|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
42100100|NCT00382993|75910724|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
42100101|NCT00382993|75910723|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
42100102|NCT00382993|75910724|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
42100103|NCT00382993|75910723|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
42100104|NCT00382993|75910724|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
42100105|NCT00382993|75910723|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
42100106|NCT00382993|75910724|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
42100107|NCT00382993|75910723|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
42100108|NCT00382993|75910724|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
42362226|NCT01746901|76211041|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
42362227|NCT01746901|76211033|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
42362228|NCT01746901|76211034|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
42362229|NCT01746901|76211035|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
42195732|NCT03214406|76007526|FG000|Overall Study|Withdrawal by Subject|1|||
42362230|NCT01746901|76211036|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
42362231|NCT01746901|76211037|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
42195733|NCT03214406|76007527|FG001|Overall Study|Withdrawal by Subject|0|||
42195734|NCT03214406|76007526|FG000|Overall Study|Lost to Follow-up|0|||
42195735|NCT03214406|76007527|FG001|Overall Study|Lost to Follow-up|2|||
42195736|NCT03213938|76007535|FG000|Overall Study|Lost to Follow-up|4|||
42195737|NCT03213938|76007536|FG001|Overall Study|Lost to Follow-up|3|||
42195738|NCT03213938|76007535|FG000|Overall Study|Lack of Efficacy|1|||
42195739|NCT03213938|76007536|FG001|Overall Study|Lack of Efficacy|0|||
42195740|NCT03213938|76007535|FG000|Overall Study|Decline to participate|5|||
42362232|NCT01746901|76211038|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
42362233|NCT01746901|76211039|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
42195741|NCT03213938|76007536|FG001|Overall Study|Decline to participate|4|||
42195742|NCT03213938|76007535|FG000|Overall Study|Without reason|4|||
42195743|NCT03213938|76007536|FG001|Overall Study|Without reason|5|||
42195744|NCT03604497|76007542|FG000|Overall Study|Protocol Violation|52|||
42195745|NCT03213626|76007550|FG000|Overall Study|Adverse Event|1|||
42195746|NCT03213626|76007550|FG000|Overall Study|Progressive Disease|6|||
42195747|NCT03604341|76007556|FG000|Overall Study|Withdrawal by Subject|1|||
42362234|NCT01746901|76211040|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
42362235|NCT01746901|76211041|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
42362236|NCT01746901|76211033|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42362237|NCT01746901|76211034|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
42362238|NCT01746901|76211035|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
42362239|NCT01746901|76211036|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42362240|NCT01746901|76211037|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42362241|NCT01746901|76211038|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42362242|NCT01746901|76211039|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42362243|NCT01746901|76211040|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42362244|NCT01746901|76211041|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42362245|NCT01746901|76211033|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
42362246|NCT01746901|76211034|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
42362247|NCT01746901|76211035|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
42362248|NCT01746901|76211036|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
42362249|NCT01746901|76211037|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
42362250|NCT01746901|76211038|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
42362251|NCT01746901|76211039|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
42362252|NCT01746901|76211040|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
42362253|NCT01746901|76211041|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
42362254|NCT01746901|76211033|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
42362255|NCT01746901|76211034|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
42362256|NCT01746901|76211035|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
42362257|NCT01746901|76211036|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
42362258|NCT01746901|76211037|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
42362259|NCT01746901|76211038|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
42362260|NCT01746901|76211039|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
42100109|NCT00382993|75910723|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
42100110|NCT00382993|75910724|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
42100111|NCT00382993|75910723|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
42100112|NCT00382993|75910724|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
42100113|NCT00382993|75910723|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
42100114|NCT00382993|75910724|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
42100115|NCT00382993|75910723|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
42100116|NCT00382993|75910724|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
42100117|NCT00369967|75910732|FG000|Overall Study|Lost to Follow-up|23|||
42195748|NCT03604341|76007557|FG001|Overall Study|Withdrawal by Subject|1|||
42195749|NCT03604341|76007556|FG000|Overall Study|Adverse Event|1|||
42195750|NCT03604341|76007557|FG001|Overall Study|Adverse Event|0|||
42195751|NCT03604341|76007556|FG000|Overall Study|Protocol Violation|0|||
42195752|NCT03604341|76007557|FG001|Overall Study|Protocol Violation|1|||
42195753|NCT03603639|76007563|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
42195754|NCT03603639|76007564|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
42195755|NCT03603639|76007565|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
42195756|NCT03603639|76007566|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
42362261|NCT01746901|76211040|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
42362262|NCT01746901|76211041|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
42362263|NCT01746901|76211033|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
42362264|NCT01746901|76211034|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
42195757|NCT03603639|76007567|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
42195758|NCT03603639|76007568|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
42195759|NCT03603639|76007563|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
42195760|NCT03603639|76007564|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
42195761|NCT03603639|76007565|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
42195762|NCT03603639|76007566|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
42195763|NCT03603639|76007567|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
42195764|NCT03603639|76007568|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
42195765|NCT00114959|76007578|FG000|Overall Study|Lack of Efficacy|6|||
42195766|NCT00114959|76007578|FG000|Overall Study|Physician Decision|1|||
42195767|NCT00114959|76007578|FG000|Overall Study|Death|1|||
42195768|NCT02778100|76007584|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
42195769|NCT02778100|76007585|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
42195770|NCT00118157|76007593|FG000|Overall Study|Adverse Event|2|||
42195771|NCT00118157|76007593|FG000|Overall Study|Death|8|||
42195772|NCT00118157|76007593|FG000|Overall Study|Withdrawal by Subject|2|||
42195773|NCT02762500|76007600|FG000|Overall Study|Lack of Efficacy|1|||
42195774|NCT02762500|76007601|FG001|Overall Study|Lack of Efficacy|0|||
42195775|NCT02762500|76007600|FG000|Overall Study|Withdrawal by Subject|1|||
42362265|NCT01746901|76211035|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
42362266|NCT01746901|76211036|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
42100118|NCT00369967|75910733|FG001|Overall Study|Lost to Follow-up|12|||
42100119|NCT00616629|75910748|FG000|Overall Study|Protocol Violation|1|||
42100120|NCT00616629|75910749|FG001|Overall Study|Protocol Violation|2|||
42100121|NCT00616629|75910750|FG002|Overall Study|Protocol Violation|1|||
42100122|NCT00616629|75910751|FG003|Overall Study|Protocol Violation|0|||
42100123|NCT00616629|75910752|FG004|Overall Study|Protocol Violation|0|||
42100124|NCT00616629|75910748|FG000|Overall Study|AV-block|1|||
42100125|NCT00616629|75910749|FG001|Overall Study|AV-block|0|||
42100126|NCT00616629|75910750|FG002|Overall Study|AV-block|0|||
42100127|NCT00616629|75910751|FG003|Overall Study|AV-block|0|||
42100128|NCT00616629|75910752|FG004|Overall Study|AV-block|0|||
42100129|NCT00369655|75910764|FG000|Overall Study|Refusal of further treatment|2|||
42100130|NCT00615069|75910768|FG000|Overall Study|Death|10|||
42100131|NCT00615069|75910768|FG000|Overall Study|Physician Decision|2|||
42100132|NCT00615069|75910768|FG000|Overall Study|Withdrawal by Subject|4|||
42100133|NCT00676338|75910776|FG000|Overall Study|Adverse Event|6|||
42100134|NCT00676338|75910777|FG001|Overall Study|Adverse Event|6|||
42100135|NCT00676338|75910778|FG002|Overall Study|Adverse Event|5|||
42100136|NCT00676338|75910779|FG003|Overall Study|Adverse Event|1|||
42100137|NCT00676338|75910776|FG000|Overall Study|Lost to Follow-up|4|||
42100138|NCT00676338|75910777|FG001|Overall Study|Lost to Follow-up|1|||
42100139|NCT00676338|75910778|FG002|Overall Study|Lost to Follow-up|3|||
42100140|NCT00676338|75910779|FG003|Overall Study|Lost to Follow-up|4|||
42100141|NCT00676338|75910776|FG000|Overall Study|Physician Decision|3|||
42100142|NCT00676338|75910777|FG001|Overall Study|Physician Decision|3|||
42100143|NCT00676338|75910778|FG002|Overall Study|Physician Decision|2|||
42100144|NCT00676338|75910779|FG003|Overall Study|Physician Decision|3|||
42100145|NCT00676338|75910776|FG000|Overall Study|Protocol Violation|5|||
42100146|NCT00676338|75910777|FG001|Overall Study|Protocol Violation|9|||
42100147|NCT00676338|75910778|FG002|Overall Study|Protocol Violation|2|||
42100148|NCT00676338|75910779|FG003|Overall Study|Protocol Violation|5|||
42100149|NCT00676338|75910776|FG000|Overall Study|Withdrawal by Subject|17|||
42100150|NCT00676338|75910777|FG001|Overall Study|Withdrawal by Subject|9|||
42362267|NCT01746901|76211037|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
42362268|NCT01746901|76211038|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
42362269|NCT01746901|76211039|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
42362270|NCT01746901|76211040|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
42362271|NCT01746901|76211041|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
42362272|NCT01746901|76211033|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
42362273|NCT01746901|76211034|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
42362274|NCT01746901|76211035|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
42362275|NCT01746901|76211036|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
42195776|NCT02762500|76007601|FG001|Overall Study|Withdrawal by Subject|1|||
42195777|NCT02762500|76007600|FG000|Overall Study|Adverse Event|0|||
42195778|NCT02762500|76007601|FG001|Overall Study|Adverse Event|2|||
42100151|NCT00676338|75910778|FG002|Overall Study|Withdrawal by Subject|12|||
42100152|NCT00676338|75910779|FG003|Overall Study|Withdrawal by Subject|6|||
42100153|NCT00676338|75910776|FG000|Overall Study|Entry Criteria Not Met|0|||
42362276|NCT01746901|76211037|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
42195779|NCT03552549|76007609|FG000|Overall Study|Disease progression|25|||
42195780|NCT03552549|76007610|FG001|Overall Study|Disease progression|17|||
42362277|NCT01746901|76211038|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
42362278|NCT01746901|76211039|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
42362279|NCT01746901|76211040|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
42362280|NCT01746901|76211041|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
42362281|NCT01746901|76211033|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
42362282|NCT01746901|76211034|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
42362283|NCT01746901|76211035|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
42362284|NCT01746901|76211036|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
42362285|NCT01746901|76211037|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
42362286|NCT01746901|76211038|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
42362287|NCT01746901|76211039|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
42362288|NCT01746901|76211040|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
42362289|NCT01746901|76211041|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
42362290|NCT01746901|76211033|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
42362291|NCT01746901|76211034|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
42362292|NCT01746901|76211035|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
42362293|NCT01746901|76211036|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
42362294|NCT01746901|76211037|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
42018440|NCT00996892|75825862|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
42018441|NCT00996892|75825863|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
42018442|NCT00996892|75825864|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
42018443|NCT00996892|75825865|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
42362295|NCT01746901|76211038|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
42362296|NCT01746901|76211039|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
42362297|NCT01746901|76211040|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
42362298|NCT01746901|76211041|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
42362299|NCT01968551|76211080|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
42362300|NCT01968551|76211081|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
42362301|NCT01968551|76211082|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
42195781|NCT03552549|76007609|FG000|Overall Study|Adverse event in first 12 months|12|||
42195782|NCT03552549|76007610|FG001|Overall Study|Adverse event in first 12 months|8|||
42195783|NCT03552549|76007609|FG000|Overall Study|Withdrawal by Subject|7|||
42195784|NCT03552549|76007610|FG001|Overall Study|Withdrawal by Subject|7|||
42195785|NCT03552549|76007609|FG000|Overall Study|Unknown (no reason provided)|4|||
42195786|NCT03552549|76007610|FG001|Overall Study|Unknown (no reason provided)|2|||
42195787|NCT03552549|76007609|FG000|Overall Study|Not in participant's best interest|2|||
42195788|NCT03552549|76007610|FG001|Overall Study|Not in participant's best interest|1|||
42195789|NCT03552549|76007609|FG000|Overall Study|Did not complete study treatment|2|||
42195790|NCT03552549|76007610|FG001|Overall Study|Did not complete study treatment|3|||
42195791|NCT03552549|76007609|FG000|Overall Study|Did not meet eligibility criteria|1|||
42195792|NCT03552549|76007610|FG001|Overall Study|Did not meet eligibility criteria|0|||
42195793|NCT03552549|76007609|FG000|Overall Study|Administrative|0|||
42195794|NCT03552549|76007610|FG001|Overall Study|Administrative|14|||
42195795|NCT00117845|76007616|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
42195796|NCT02761642|76007620|FG000|Overall Study|Did not Receive Study Treatment|3|||
42195797|NCT02761642|76007620|FG000|Overall Study|Adverse Event|13|||
42195798|NCT02761642|76007620|FG000|Overall Study|Withdrawal by Subject|2|||
42195799|NCT02761642|76007620|FG000|Overall Study|Non-compliant|7|||
42362302|NCT01968551|76211080|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
42362303|NCT01968551|76211081|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
42362304|NCT01968551|76211082|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
42362305|NCT01968551|76211080|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
42362306|NCT01968551|76211081|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
42362307|NCT01968551|76211082|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
42362308|NCT01968551|76211080|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
42362309|NCT01968551|76211081|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
42362310|NCT01968551|76211082|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
42362311|NCT01968551|76211080|FG000|Extension Phase|Adverse Event|0|||
42195800|NCT02761642|76007620|FG000|Overall Study|Death|3|||
42195801|NCT02761642|76007620|FG000|Overall Study|Lack of Efficacy|20|||
42195802|NCT02761642|76007620|FG000|Overall Study|Physician Decision|1|||
42195803|NCT02761642|76007620|FG000|Overall Study|Reason Unspecified|21|||
42195804|NCT00113555|76007624|FG000|Overall Study|Baseline Failure|59|||
42195805|NCT00113555|76007624|FG000|Overall Study|Permanently Explanted|7|||
42195806|NCT00113555|76007624|FG000|Overall Study|Death|1|||
42362312|NCT01968551|76211081|FG001|Extension Phase|Adverse Event|0|||
42362313|NCT01968551|76211082|FG002|Extension Phase|Adverse Event|2|||
42362314|NCT01968551|76211080|FG000|Extension Phase|Death|0|||
42362315|NCT01968551|76211081|FG001|Extension Phase|Death|1|||
42362316|NCT01968551|76211082|FG002|Extension Phase|Death|0|||
42362317|NCT01968551|76211080|FG000|Extension Phase|Withdrew Consent|0|||
42362318|NCT01968551|76211081|FG001|Extension Phase|Withdrew Consent|0|||
42195807|NCT00113555|76007624|FG000|Overall Study|Missed Followup|4|||
42195808|NCT00113555|76007624|FG000|Overall Study|Lost to Follow-up|8|||
42195809|NCT03189524|76007632|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
42362319|NCT01968551|76211082|FG002|Extension Phase|Withdrew Consent|1|||
42362320|NCT01968551|76211080|FG000|Extension Phase|Lost to Follow-up|1|||
42362321|NCT01968551|76211081|FG001|Extension Phase|Lost to Follow-up|0|||
42362322|NCT01968551|76211082|FG002|Extension Phase|Lost to Follow-up|1|||
42362323|NCT01707992|76211097|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
42362324|NCT01707992|76211098|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
42362325|NCT01707992|76211099|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
42362326|NCT01707992|76211100|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
42362327|NCT01707992|76211101|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
42362328|NCT01707992|76211102|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
42362329|NCT01707992|76211097|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
42362330|NCT01707992|76211098|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
42362331|NCT01707992|76211099|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
42362332|NCT01707992|76211100|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
42362333|NCT01707992|76211101|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
42362334|NCT01707992|76211102|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
42362335|NCT01707992|76211097|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
42362336|NCT01707992|76211098|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
42362337|NCT01707992|76211099|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
42362338|NCT01707992|76211100|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
42362339|NCT01707992|76211101|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
42362340|NCT01707992|76211102|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
42362341|NCT01707992|76211097|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
42362342|NCT01707992|76211098|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
42362343|NCT01707992|76211099|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
42362344|NCT01707992|76211100|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
42362345|NCT01707992|76211101|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
42362346|NCT01707992|76211102|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
42362347|NCT01707992|76211097|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
42362348|NCT01707992|76211098|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
42362349|NCT01707992|76211099|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
42362350|NCT01707992|76211100|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
42362351|NCT01707992|76211101|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
42362352|NCT01707992|76211102|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
42362353|NCT01707992|76211097|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
42362354|NCT01707992|76211098|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
42362355|NCT01707992|76211099|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
42362356|NCT01707992|76211100|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
42362357|NCT01707992|76211101|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
42362358|NCT01707992|76211102|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
42362359|NCT01707992|76211097|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
42362360|NCT01707992|76211098|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
42362361|NCT01707992|76211099|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
42362362|NCT01707992|76211100|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
42362363|NCT01707992|76211101|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
42362364|NCT01707992|76211102|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
42362365|NCT01707992|76211097|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
42362366|NCT01707992|76211098|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
42362367|NCT01707992|76211099|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
42362368|NCT01707992|76211100|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
42362369|NCT01707992|76211101|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
42362370|NCT01707992|76211102|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
42362371|NCT01707992|76211097|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
42362372|NCT01707992|76211098|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
42362373|NCT01707992|76211099|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
42362374|NCT01707992|76211100|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
42018444|NCT00996892|75825866|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
42362375|NCT01707992|76211101|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
42362376|NCT01707992|76211102|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
42362377|NCT01707992|76211097|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
42362378|NCT01707992|76211098|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
42362379|NCT01707992|76211099|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
42362380|NCT01707992|76211100|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
42362381|NCT01707992|76211101|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
42362382|NCT01707992|76211102|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
42362383|NCT01707992|76211097|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
42362384|NCT01707992|76211098|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
42362385|NCT01707992|76211099|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
42362386|NCT01707992|76211100|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
42362387|NCT01707992|76211101|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
42362388|NCT01707992|76211102|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
42362389|NCT01707992|76211097|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
42362390|NCT01707992|76211098|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
42362391|NCT01707992|76211099|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
42362392|NCT01707992|76211100|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
42362393|NCT01707992|76211101|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
42362394|NCT01707992|76211102|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
42362395|NCT01707992|76211097|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
42362396|NCT01707992|76211098|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
42362397|NCT01707992|76211099|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
42362398|NCT01707992|76211100|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
42362399|NCT01707992|76211101|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
42362400|NCT01707992|76211102|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
42362401|NCT01707992|76211097|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
42362402|NCT01707992|76211098|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
42100154|NCT00676338|75910777|FG001|Overall Study|Entry Criteria Not Met|2|||
42100155|NCT00676338|75910778|FG002|Overall Study|Entry Criteria Not Met|1|||
42100156|NCT00676338|75910779|FG003|Overall Study|Entry Criteria Not Met|1|||
42100157|NCT00676338|75910776|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
42100158|NCT00676338|75910777|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
42100159|NCT00676338|75910778|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
42100160|NCT00676338|75910779|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
42100161|NCT00382291|75910792|FG000|Overall Study|Adverse Event|1|||
42100162|NCT00382291|75910793|FG001|Overall Study|Adverse Event|2|||
42100163|NCT00382291|75910794|FG002|Overall Study|Adverse Event|2|||
42100164|NCT00382291|75910792|FG000|Overall Study|Protocol Violation|1|||
42362403|NCT01707992|76211099|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
42362404|NCT01707992|76211100|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
42100165|NCT00382291|75910793|FG001|Overall Study|Protocol Violation|0|||
42100166|NCT00382291|75910794|FG002|Overall Study|Protocol Violation|0|||
42100167|NCT00382291|75910792|FG000|Overall Study|Temporary study suspension|2|||
42100168|NCT00382291|75910793|FG001|Overall Study|Temporary study suspension|2|||
42100169|NCT00382291|75910794|FG002|Overall Study|Temporary study suspension|5|||
42100170|NCT00382291|75910792|FG000|Overall Study|Withdrawal by Subject|0|||
42100171|NCT00382291|75910793|FG001|Overall Study|Withdrawal by Subject|2|||
42100172|NCT00382291|75910794|FG002|Overall Study|Withdrawal by Subject|0|||
42100173|NCT00382291|75910792|FG000|Overall Study|Physician Decision|0|||
42100174|NCT00382291|75910793|FG001|Overall Study|Physician Decision|1|||
42100175|NCT00382291|75910794|FG002|Overall Study|Physician Decision|0|||
42100176|NCT00382291|75910792|FG000|Overall Study|Lack of Efficacy|0|||
42100177|NCT00382291|75910793|FG001|Overall Study|Lack of Efficacy|0|||
42100178|NCT00382291|75910794|FG002|Overall Study|Lack of Efficacy|1|||
42362405|NCT01707992|76211101|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
42362406|NCT01707992|76211102|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
42362407|NCT01707992|76211097|FG000|Active Treatment Phase (24 Months)|Death|0|||
42362408|NCT01707992|76211098|FG001|Active Treatment Phase (24 Months)|Death|0|||
42362409|NCT01707992|76211099|FG002|Active Treatment Phase (24 Months)|Death|0|||
42100179|NCT00547378|75910816|FG000|Randomized Cohort|Withdrawal by Subject|7|||
42100180|NCT00547378|75910817|FG001|Randomized Cohort|Withdrawal by Subject|5|||
42100181|NCT00547378|75910818|FG002|Randomized Cohort|Withdrawal by Subject|0|||
42100182|NCT00547378|75910816|FG000|Randomized Cohort|Death|0|||
42362410|NCT01707992|76211100|FG003|Active Treatment Phase (24 Months)|Death|2|||
42362411|NCT01707992|76211101|FG004|Active Treatment Phase (24 Months)|Death|0|||
42362412|NCT01707992|76211102|FG005|Active Treatment Phase (24 Months)|Death|0|||
42362413|NCT01707992|76211097|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
42362414|NCT01707992|76211098|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
42362415|NCT01707992|76211099|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
42362416|NCT01707992|76211100|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
42362417|NCT01707992|76211101|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
42362418|NCT01707992|76211102|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
42362419|NCT01707992|76211097|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
42362420|NCT01707992|76211098|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
42362421|NCT01707992|76211099|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
42362422|NCT01707992|76211100|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
42362423|NCT01707992|76211101|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
42362424|NCT01707992|76211102|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
42362425|NCT01707992|76211097|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
42362426|NCT01707992|76211098|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
42362427|NCT01707992|76211099|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
42362428|NCT01707992|76211100|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
42362429|NCT01707992|76211101|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
42362430|NCT01707992|76211102|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
42362431|NCT01707992|76211097|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
42362432|NCT01707992|76211098|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
42362433|NCT01707992|76211099|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
42362434|NCT01707992|76211100|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
42362435|NCT01707992|76211101|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
42362436|NCT01707992|76211102|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
42362437|NCT01946165|76211119|FG000|Overall Study|Physician Decision|2|||
42362438|NCT01946165|76211120|FG001|Overall Study|Physician Decision|0|||
42362439|NCT01946165|76211119|FG000|Overall Study|Withdrawal by Subject|0|||
42362440|NCT01946165|76211120|FG001|Overall Study|Withdrawal by Subject|2|||
42362441|NCT01707667|76211129|FG000|Period 1|expulsion of colonic sensor catheter|1|||
42362442|NCT01707667|76211130|FG001|Period 1|expulsion of colonic sensor catheter|0|||
42362443|NCT01959503|76211138|FG000|Overall Study|Death|2|||
42362444|NCT01959503|76211139|FG001|Overall Study|Death|1|||
42362445|NCT01959503|76211138|FG000|Overall Study|Randomized but not treated|1|||
42362446|NCT01959503|76211139|FG001|Overall Study|Randomized but not treated|1|||
42362447|NCT01605799|76211147|FG000|Overall Study|Withdrawal by Subject|2|||
42100183|NCT00547378|75910817|FG001|Randomized Cohort|Death|1|||
42100184|NCT00547378|75910818|FG002|Randomized Cohort|Death|0|||
42100185|NCT00547378|75910816|FG000|Randomized Cohort|Lost to Follow-up|1|||
42100186|NCT00547378|75910817|FG001|Randomized Cohort|Lost to Follow-up|0|||
42100187|NCT00547378|75910818|FG002|Randomized Cohort|Lost to Follow-up|0|||
42100188|NCT00547378|75910816|FG000|Randomized Cohort|Adverse Event|1|||
42100189|NCT00547378|75910817|FG001|Randomized Cohort|Adverse Event|0|||
42100190|NCT00547378|75910818|FG002|Randomized Cohort|Adverse Event|0|||
42100191|NCT00547378|75910816|FG000|Randomized Cohort|Other reasons|2|||
42100192|NCT00547378|75910817|FG001|Randomized Cohort|Other reasons|0|||
42100193|NCT00547378|75910818|FG002|Randomized Cohort|Other reasons|0|||
42362448|NCT01605799|76211148|FG001|Overall Study|Withdrawal by Subject|1|||
42362449|NCT01706575|76211154|FG000|Overall Study|Participant Withdrew Consent|4|||
42362450|NCT01706575|76211154|FG000|Overall Study|Lost to Follow-up|2|||
42362451|NCT01706575|76211154|FG000|Overall Study|Started but not Treated|6|||
42362452|NCT01959425|76211160|FG000|Overall Study|Withdrawal by Subject|5|||
42362453|NCT01959425|76211161|FG001|Overall Study|Withdrawal by Subject|4|||
42362454|NCT01959425|76211160|FG000|Overall Study|Lost to Follow-up|1|||
42362455|NCT01959425|76211161|FG001|Overall Study|Lost to Follow-up|0|||
42362456|NCT01959425|76211160|FG000|Overall Study|Discontinued Subjects|6|||
42362457|NCT01959425|76211161|FG001|Overall Study|Discontinued Subjects|4|||
42362458|NCT01725529|76211170|FG000|Overall Study|Adverse Event|1|||
42362459|NCT01725529|76211171|FG001|Overall Study|Adverse Event|0|||
42362460|NCT01725529|76211172|FG002|Overall Study|Adverse Event|0|||
42362461|NCT01725529|76211170|FG000|Overall Study|Lost to Follow-up|2|||
42362462|NCT01725529|76211171|FG001|Overall Study|Lost to Follow-up|1|||
42362463|NCT01725529|76211172|FG002|Overall Study|Lost to Follow-up|1|||
42362464|NCT01725529|76211170|FG000|Overall Study|Protocol Violation|0|||
42362465|NCT01725529|76211171|FG001|Overall Study|Protocol Violation|1|||
42362466|NCT01725529|76211172|FG002|Overall Study|Protocol Violation|1|||
42100194|NCT00547378|75910816|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
42362467|NCT01725529|76211170|FG000|Overall Study|Withdrawal by Subject|12|||
42100195|NCT00547378|75910817|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
42362468|NCT01725529|76211171|FG001|Overall Study|Withdrawal by Subject|14|||
42100196|NCT00547378|75910818|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
42362469|NCT01725529|76211172|FG002|Overall Study|Withdrawal by Subject|8|||
42362470|NCT01605097|76211180|FG000|Overall Study|Protocol Violation|1|||
42362471|NCT01605019|76211187|FG000|Overall Study|pt did not meet transplant endpoint|3|||
42362472|NCT01605019|76211188|FG001|Overall Study|pt did not meet transplant endpoint|0|||
42362473|NCT01705717|76211196|FG000|Overall Study|Adverse Event|2|||
42195810|NCT03189524|76007633|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
42195811|NCT03189524|76007634|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
42195812|NCT03189524|76007632|FG000|Overall Study|Death|2|||
42195813|NCT03189524|76007633|FG001|Overall Study|Death|2|||
42195814|NCT03189524|76007634|FG002|Overall Study|Death|1|||
42195815|NCT03189524|76007632|FG000|Overall Study|Lost to Follow-up|1|||
42195816|NCT03189524|76007633|FG001|Overall Study|Lost to Follow-up|0|||
42195817|NCT03189524|76007634|FG002|Overall Study|Lost to Follow-up|8|||
42195818|NCT03189524|76007632|FG000|Overall Study|Withdrawal by Subject|1|||
42195819|NCT03189524|76007633|FG001|Overall Study|Withdrawal by Subject|1|||
42195820|NCT03189524|76007634|FG002|Overall Study|Withdrawal by Subject|3|||
42195821|NCT03189524|76007632|FG000|Overall Study|Progressive Disease|0|||
42195822|NCT03189524|76007633|FG001|Overall Study|Progressive Disease|2|||
42195823|NCT03189524|76007634|FG002|Overall Study|Progressive Disease|0|||
42195824|NCT03600909|76007649|FG000|Overall Study|Not treated|0|||
42195825|NCT03600909|76007650|FG001|Overall Study|Not treated|3|||
42195826|NCT03600909|76007651|FG002|Overall Study|Not treated|0|||
42195827|NCT03189446|76007659|FG000|Overall Study|Adverse Event|2|||
42362474|NCT01705717|76211197|FG001|Overall Study|Adverse Event|2|||
42362475|NCT01705717|76211196|FG000|Overall Study|Lack of Efficacy|0|||
42362476|NCT01705717|76211197|FG001|Overall Study|Lack of Efficacy|1|||
42362477|NCT01705717|76211196|FG000|Overall Study|Other|0|||
42362478|NCT01705717|76211197|FG001|Overall Study|Other|2|||
42362479|NCT01744483|76211205|FG000|Overall Study|Death|9|||
42362480|NCT01744483|76211206|FG001|Overall Study|Death|4|||
42362481|NCT01744483|76211207|FG002|Overall Study|Death|11|||
42362482|NCT01744483|76211205|FG000|Overall Study|Lost to Follow-up|8|||
42362483|NCT01744483|76211206|FG001|Overall Study|Lost to Follow-up|9|||
42362484|NCT01744483|76211207|FG002|Overall Study|Lost to Follow-up|11|||
42018445|NCT00996892|75825867|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
42018446|NCT00996892|75825868|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
42018447|NCT00996892|75825869|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
42018448|NCT00996892|75825870|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
42018449|NCT00996892|75825871|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
42018450|NCT00996892|75825872|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
42362485|NCT01744483|76211205|FG000|Overall Study|Protocol Violation|1|||
42362486|NCT01744483|76211206|FG001|Overall Study|Protocol Violation|2|||
42362487|NCT01744483|76211207|FG002|Overall Study|Protocol Violation|1|||
42362488|NCT01744483|76211205|FG000|Overall Study|Withdrawal by Subject|4|||
42362489|NCT01744483|76211206|FG001|Overall Study|Withdrawal by Subject|6|||
42362490|NCT01744483|76211207|FG002|Overall Study|Withdrawal by Subject|2|||
42362491|NCT01744483|76211205|FG000|Overall Study|No ICU Admit|5|||
42362492|NCT01744483|76211206|FG001|Overall Study|No ICU Admit|1|||
42362493|NCT01744483|76211207|FG002|Overall Study|No ICU Admit|2|||
42362494|NCT01744483|76211205|FG000|Overall Study|Routed to OSH|2|||
42362495|NCT01744483|76211206|FG001|Overall Study|Routed to OSH|0|||
42362496|NCT01744483|76211207|FG002|Overall Study|Routed to OSH|1|||
42362497|NCT01744093|76211217|FG000|Overall Study|Withdrawal by Subject|6|||
42362498|NCT01744093|76211218|FG001|Overall Study|Withdrawal by Subject|1|||
42362499|NCT01725451|76211232|FG000|Period 1|Withdrawal by Subject|1|||
42362500|NCT01725451|76211233|FG001|Period 1|Withdrawal by Subject|0|||
42362501|NCT01725451|76211234|FG002|Period 1|Withdrawal by Subject|0|||
42362502|NCT01725451|76211235|FG003|Period 1|Withdrawal by Subject|0|||
42362503|NCT01725451|76211232|FG000|Washout From Period 3|Protocol Violation|0|||
42362504|NCT01725451|76211233|FG001|Washout From Period 3|Protocol Violation|0|||
42362505|NCT01725451|76211234|FG002|Washout From Period 3|Protocol Violation|1|||
42362506|NCT01725451|76211235|FG003|Washout From Period 3|Protocol Violation|0|||
42362507|NCT01725451|76211232|FG000|Washout From Period 3|Adverse Event|0|||
42362508|NCT01725451|76211233|FG001|Washout From Period 3|Adverse Event|1|||
42362509|NCT01725451|76211234|FG002|Washout From Period 3|Adverse Event|0|||
42195828|NCT03189446|76007659|FG000|Overall Study|Withdrawal by Subject|2|||
42195829|NCT03189446|76007659|FG000|Overall Study|Physician Decision|1|||
42362510|NCT01725451|76211235|FG003|Washout From Period 3|Adverse Event|0|||
42362511|NCT01725451|76211232|FG000|Period 4|Adverse Event|0|||
42362512|NCT01725451|76211233|FG001|Period 4|Adverse Event|0|||
42362513|NCT01725451|76211234|FG002|Period 4|Adverse Event|1|||
42362514|NCT01725451|76211235|FG003|Period 4|Adverse Event|0|||
42362515|NCT01707290|76211252|FG000|Overall Study|Adverse event (AE)|1|||
42362516|NCT01707290|76211253|FG001|Overall Study|Adverse event (AE)|0|||
42362517|NCT01707290|76211252|FG000|Overall Study|Physician Decision|1|||
42195830|NCT03212690|76007663|FG000|Overall Study|Protocol Violation|1|||
42195831|NCT03188120|76007667|FG000|Overall Study|Adverse Event|4|||
42362518|NCT01707290|76211253|FG001|Overall Study|Physician Decision|0|||
42362519|NCT01707290|76211252|FG000|Overall Study|Lost to Follow-up|3|||
42195832|NCT03188120|76007667|FG000|Overall Study|Insufficient Effectiveness|8|||
42195833|NCT03188120|76007667|FG000|Overall Study|Improved|12|||
42195834|NCT03188120|76007667|FG000|Overall Study|Lost to Follow-up|7|||
42195835|NCT03188120|76007667|FG000|Overall Study|Other than specified|3|||
42195836|NCT03188120|76007667|FG000|Overall Study|No visit after the first visit|13|||
42362520|NCT01707290|76211253|FG001|Overall Study|Lost to Follow-up|0|||
42362521|NCT01707290|76211252|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
42362522|NCT01707290|76211253|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
42362523|NCT01707290|76211252|FG000|Overall Study|Commercial drug available|60|||
42362524|NCT01707290|76211253|FG001|Overall Study|Commercial drug available|1|||
42362525|NCT01707290|76211252|FG000|Overall Study|Other unspecified|17|||
42362526|NCT01707290|76211253|FG001|Overall Study|Other unspecified|0|||
42362527|NCT01717040|76211264|FG000|Overall Study|Lost to Follow-up|2|||
42362528|NCT01717040|76211265|FG001|Overall Study|Lost to Follow-up|3|||
42362529|NCT01717040|76211264|FG000|Overall Study|Lack of Efficacy|1|||
42362530|NCT01717040|76211265|FG001|Overall Study|Lack of Efficacy|1|||
42362531|NCT01717040|76211264|FG000|Overall Study|Adverse Event|1|||
42362532|NCT01717040|76211265|FG001|Overall Study|Adverse Event|0|||
42362533|NCT01717040|76211264|FG000|Overall Study|Required Medication Change|0|||
42362534|NCT01717040|76211265|FG001|Overall Study|Required Medication Change|1|||
42362535|NCT01717040|76211264|FG000|Overall Study|New Substance Use Disorder|1|||
42362536|NCT01717040|76211265|FG001|Overall Study|New Substance Use Disorder|0|||
42362537|NCT01743469|76211292|FG000|Active Treatment Phase|Adverse Event|10|||
42362538|NCT01743469|76211293|FG001|Active Treatment Phase|Adverse Event|5|||
42362539|NCT01743469|76211294|FG002|Active Treatment Phase|Adverse Event|8|||
42362540|NCT01743469|76211295|FG003|Active Treatment Phase|Adverse Event|1|||
42362541|NCT01743469|76211292|FG000|Active Treatment Phase|Disease Progression|40|||
42362542|NCT01743469|76211293|FG001|Active Treatment Phase|Disease Progression|47|||
42362543|NCT01743469|76211294|FG002|Active Treatment Phase|Disease Progression|30|||
42362544|NCT01743469|76211295|FG003|Active Treatment Phase|Disease Progression|20|||
42362545|NCT01743469|76211292|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
42362546|NCT01743469|76211293|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
42362547|NCT01743469|76211294|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
42362548|NCT01743469|76211295|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
42362549|NCT01743469|76211292|FG000|Active Treatment Phase|Missing|1|||
42362550|NCT01743469|76211293|FG001|Active Treatment Phase|Missing|0|||
42362551|NCT01743469|76211294|FG002|Active Treatment Phase|Missing|0|||
42362552|NCT01743469|76211295|FG003|Active Treatment Phase|Missing|0|||
42362553|NCT01743469|76211292|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
42362554|NCT01743469|76211293|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
42362555|NCT01743469|76211294|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
42362556|NCT01743469|76211295|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
42195837|NCT02895945|76007673|FG000|Overall Study|Physician Decision|2|||
42195838|NCT02895945|76007674|FG001|Overall Study|Physician Decision|1|||
42195839|NCT02777554|76007682|FG000|Overall Study|Adverse Event|4|||
42195840|NCT02777554|76007683|FG001|Overall Study|Adverse Event|4|||
42195841|NCT02777554|76007684|FG002|Overall Study|Adverse Event|0|||
42195842|NCT02777554|76007685|FG003|Overall Study|Adverse Event|1|||
42195843|NCT02777554|76007686|FG004|Overall Study|Adverse Event|0|||
42362557|NCT01743469|76211292|FG000|Follow-up Period - Post-Treatment|Death|43|||
42362558|NCT01743469|76211293|FG001|Follow-up Period - Post-Treatment|Death|47|||
42362559|NCT01743469|76211294|FG002|Follow-up Period - Post-Treatment|Death|22|||
42362560|NCT01743469|76211295|FG003|Follow-up Period - Post-Treatment|Death|16|||
42362561|NCT01743469|76211292|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
42362562|NCT01743469|76211293|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
42362563|NCT01743469|76211294|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
42362564|NCT01743469|76211295|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
42362565|NCT01743001|76211307|FG000|Overall Study|Physician Decision|1|||
42362566|NCT01743001|76211308|FG001|Overall Study|Physician Decision|0|||
42362567|NCT01743001|76211307|FG000|Overall Study|Pregnancy|1|||
42362568|NCT01743001|76211308|FG001|Overall Study|Pregnancy|0|||
42100197|NCT00547378|75910816|FG000|All Implanted Cohort|Adverse Event|4|||
42100198|NCT00547378|75910817|FG001|All Implanted Cohort|Adverse Event|10|||
42100199|NCT00547378|75910818|FG002|All Implanted Cohort|Adverse Event|17|||
42100200|NCT00547378|75910816|FG000|All Implanted Cohort|Lost to Follow-up|0|||
42362569|NCT01743001|76211307|FG000|Overall Study|Death|1|||
42362570|NCT01743001|76211308|FG001|Overall Study|Death|0|||
42362571|NCT01704079|76211327|FG000|Overall Study|Withdrawal by Subject|5|||
42362572|NCT01704079|76211328|FG001|Overall Study|Withdrawal by Subject|7|||
42362573|NCT01704079|76211327|FG000|Overall Study|Lost to Follow-up|2|||
42362574|NCT01704079|76211328|FG001|Overall Study|Lost to Follow-up|5|||
42195844|NCT02777554|76007687|FG005|Overall Study|Adverse Event|0|||
42362575|NCT01704079|76211327|FG000|Overall Study|Adverse Event|4|||
42362576|NCT01704079|76211328|FG001|Overall Study|Adverse Event|7|||
42362577|NCT01704079|76211327|FG000|Overall Study|Protocol Violation|1|||
42362578|NCT01704079|76211328|FG001|Overall Study|Protocol Violation|0|||
42362579|NCT01704079|76211327|FG000|Overall Study|Subject noncompliance|2|||
42362580|NCT01704079|76211328|FG001|Overall Study|Subject noncompliance|3|||
42362581|NCT01704079|76211327|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
42362582|NCT01704079|76211328|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
42362583|NCT01703845|76211336|FG000|Overall Study|Adverse Event|1|||
42362584|NCT01703845|76211337|FG001|Overall Study|Adverse Event|0|||
42362585|NCT01703845|76211336|FG000|Overall Study|Protocol Violation|1|||
42362586|NCT01703845|76211337|FG001|Overall Study|Protocol Violation|0|||
42362587|NCT01703845|76211336|FG000|Overall Study|other than stated above|1|||
42362588|NCT01703845|76211337|FG001|Overall Study|other than stated above|0|||
42362589|NCT01724359|76211345|FG000|Overall Study|Adverse Event|10|||
42362590|NCT01724359|76211345|FG000|Overall Study|Death|1|||
42362591|NCT01724359|76211345|FG000|Overall Study|Other|20|||
42362592|NCT01703221|76211354|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
42362593|NCT01703221|76211355|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
42362594|NCT01703221|76211356|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
42362595|NCT01703221|76211354|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
42362596|NCT01703221|76211355|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
42362597|NCT01703221|76211356|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
42362598|NCT01703221|76211354|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
42362599|NCT01703221|76211355|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
42362600|NCT01703221|76211356|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
42362601|NCT01703221|76211354|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
42362602|NCT01703221|76211355|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
42362603|NCT01703221|76211356|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
42362604|NCT01703221|76211354|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
42362605|NCT01703221|76211355|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
42362606|NCT01703221|76211356|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
42362607|NCT01703221|76211354|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
42362608|NCT01703221|76211355|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
42362609|NCT01703221|76211356|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
42362610|NCT01703221|76211354|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
42362611|NCT01703221|76211355|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
42362612|NCT01703221|76211356|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
42362613|NCT01703221|76211354|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
42362614|NCT01703221|76211355|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
42362615|NCT01703221|76211356|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
42362616|NCT01722877|76211370|FG000|Overall Study|Death|1|||
42362617|NCT01722877|76211370|FG000|Overall Study|Lost to Follow-up|1|||
42362618|NCT01703065|76211415|FG000|Overall Study|Lack of Efficacy|1|||
42362619|NCT01703065|76211416|FG001|Overall Study|Lack of Efficacy|0|||
42362620|NCT01702987|76211429|FG000|Overall Study|Withdrawal by Subject|1|||
42362621|NCT01702987|76211430|FG001|Overall Study|Withdrawal by Subject|0|||
42362622|NCT01702519|76211451|FG000|Washout Period|Lost to Follow-up|1|||
42362623|NCT01702519|76211452|FG001|Washout Period|Lost to Follow-up|0|||
42362624|NCT01702519|76211451|FG000|Washout Period|Withdrawal by Subject|0|||
42362625|NCT01702519|76211452|FG001|Washout Period|Withdrawal by Subject|2|||
42362626|NCT01739803|76211464|FG000|Overall Study|Lost to Follow-up|9|||
42362627|NCT01739803|76211465|FG001|Overall Study|Lost to Follow-up|6|||
42362628|NCT01739335|76211477|FG000|Overall Study|Lost to Follow-up|7|||
42362629|NCT01739335|76211478|FG001|Overall Study|Lost to Follow-up|4|||
42362630|NCT01739335|76211477|FG000|Overall Study|Ineligible patient randomized|0|||
42362631|NCT01739335|76211478|FG001|Overall Study|Ineligible patient randomized|1|||
42362632|NCT01702363|76211503|FG000|Overall Study|Adverse Event|14|||
42362633|NCT01702363|76211503|FG000|Overall Study|Lack of Efficacy|4|||
42362634|NCT01702363|76211503|FG000|Overall Study|Withdrawal by Subject|2|||
42362635|NCT01722097|76211510|FG000|Overall Study|Patient sheets not returned|6|||
42362636|NCT01722097|76211511|FG001|Overall Study|Patient sheets not returned|5|||
42362637|NCT01701973|76211526|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
42362638|NCT01701973|76211527|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
42362639|NCT01701973|76211528|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
42362640|NCT01701973|76211529|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
42362641|NCT01701973|76211530|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
42362642|NCT01701973|76211531|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
42362643|NCT01701973|76211532|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
42362644|NCT01701973|76211533|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
42362645|NCT01721317|76211584|FG000|Overall Study|Study Closed / Terminated|2|||
42362646|NCT01721317|76211585|FG001|Overall Study|Study Closed / Terminated|2|||
42362647|NCT01721317|76211584|FG000|Overall Study|Physician Decision|0|||
42362648|NCT01721317|76211585|FG001|Overall Study|Physician Decision|1|||
42362649|NCT01721317|76211584|FG000|Overall Study|Withdrawal by Subject|0|||
42362650|NCT01721317|76211585|FG001|Overall Study|Withdrawal by Subject|1|||
42195845|NCT02777554|76007682|FG000|Overall Study|Withdrawal by Subject|3|||
42195846|NCT02777554|76007683|FG001|Overall Study|Withdrawal by Subject|1|||
42195847|NCT02777554|76007684|FG002|Overall Study|Withdrawal by Subject|1|||
42195848|NCT02777554|76007685|FG003|Overall Study|Withdrawal by Subject|0|||
42195849|NCT02777554|76007686|FG004|Overall Study|Withdrawal by Subject|0|||
42195850|NCT02777554|76007687|FG005|Overall Study|Withdrawal by Subject|0|||
42195851|NCT02777554|76007682|FG000|Overall Study|Discharged early due to hurricane|22|||
42195852|NCT02777554|76007683|FG001|Overall Study|Discharged early due to hurricane|20|||
42195853|NCT02777554|76007684|FG002|Overall Study|Discharged early due to hurricane|0|||
42195854|NCT02777554|76007685|FG003|Overall Study|Discharged early due to hurricane|0|||
42362651|NCT01701193|76211595|FG000|Overall Study|Withdrawal by Subject|2|||
42362652|NCT01701193|76211596|FG001|Overall Study|Withdrawal by Subject|2|||
42362653|NCT01701193|76211597|FG002|Overall Study|Withdrawal by Subject|1|||
42362654|NCT01701193|76211598|FG003|Overall Study|Withdrawal by Subject|2|||
42362655|NCT01701193|76211595|FG000|Overall Study|Adverse Event|1|||
42362656|NCT01701193|76211596|FG001|Overall Study|Adverse Event|0|||
42362657|NCT01701193|76211597|FG002|Overall Study|Adverse Event|0|||
42362658|NCT01701193|76211598|FG003|Overall Study|Adverse Event|0|||
42362659|NCT01959347|76211646|FG000|Overall Study|Protocol Violation|9|||
42362660|NCT01959347|76211647|FG001|Overall Study|Protocol Violation|7|||
42362661|NCT01959035|76211673|FG000|Overall Study|Adverse Event|5|||
42362662|NCT01959035|76211673|FG000|Overall Study|Withdrawal by Subject|4|||
42362663|NCT01959035|76211673|FG000|Overall Study|Lost to Follow-up|1|||
42362664|NCT01959035|76211673|FG000|Overall Study|Other (no primary reason given)|1|||
42362665|NCT01700959|76211683|FG000|Overall Study|Adverse Event|0|||
42362666|NCT01700959|76211684|FG001|Overall Study|Adverse Event|1|||
42362667|NCT01700959|76211685|FG002|Overall Study|Adverse Event|1|||
42362668|NCT01700959|76211686|FG003|Overall Study|Adverse Event|2|||
42362669|NCT01700959|76211687|FG004|Overall Study|Adverse Event|0|||
42362670|NCT01700959|76211688|FG005|Overall Study|Adverse Event|2|||
42362671|NCT01700959|76211683|FG000|Overall Study|Withdrawal by Subject|15|||
42362672|NCT01700959|76211684|FG001|Overall Study|Withdrawal by Subject|9|||
42362673|NCT01700959|76211685|FG002|Overall Study|Withdrawal by Subject|12|||
42362674|NCT01700959|76211686|FG003|Overall Study|Withdrawal by Subject|11|||
42362675|NCT01700959|76211687|FG004|Overall Study|Withdrawal by Subject|8|||
42362676|NCT01700959|76211688|FG005|Overall Study|Withdrawal by Subject|12|||
42362677|NCT01700959|76211683|FG000|Overall Study|Ineligible|2|||
42362678|NCT01700959|76211684|FG001|Overall Study|Ineligible|1|||
42362679|NCT01700959|76211685|FG002|Overall Study|Ineligible|2|||
42362680|NCT01700959|76211686|FG003|Overall Study|Ineligible|0|||
42362681|NCT01700959|76211687|FG004|Overall Study|Ineligible|0|||
42362682|NCT01700959|76211688|FG005|Overall Study|Ineligible|1|||
42362683|NCT01700959|76211683|FG000|Overall Study|Noncompliant|9|||
42362684|NCT01700959|76211684|FG001|Overall Study|Noncompliant|9|||
42362685|NCT01700959|76211685|FG002|Overall Study|Noncompliant|17|||
42362686|NCT01700959|76211686|FG003|Overall Study|Noncompliant|18|||
42362687|NCT01700959|76211687|FG004|Overall Study|Noncompliant|15|||
42362688|NCT01700959|76211688|FG005|Overall Study|Noncompliant|9|||
42362689|NCT01700959|76211683|FG000|Overall Study|Side effects|1|||
42100201|NCT00547378|75910817|FG001|All Implanted Cohort|Lost to Follow-up|1|||
42100202|NCT00547378|75910818|FG002|All Implanted Cohort|Lost to Follow-up|14|||
42100203|NCT00547378|75910816|FG000|All Implanted Cohort|Death|3|||
42100204|NCT00547378|75910817|FG001|All Implanted Cohort|Death|1|||
42100205|NCT00547378|75910818|FG002|All Implanted Cohort|Death|4|||
42100206|NCT00547378|75910816|FG000|All Implanted Cohort|Physician Decision|0|||
42100207|NCT00547378|75910817|FG001|All Implanted Cohort|Physician Decision|2|||
42100208|NCT00547378|75910818|FG002|All Implanted Cohort|Physician Decision|6|||
42100209|NCT00547378|75910816|FG000|All Implanted Cohort|Site closure|2|||
42100210|NCT00547378|75910817|FG001|All Implanted Cohort|Site closure|0|||
42100211|NCT00547378|75910818|FG002|All Implanted Cohort|Site closure|1|||
42100212|NCT00547378|75910816|FG000|All Implanted Cohort|Other reasons|1|||
42100213|NCT00547378|75910817|FG001|All Implanted Cohort|Other reasons|0|||
42100214|NCT00547378|75910818|FG002|All Implanted Cohort|Other reasons|1|||
42195855|NCT02777554|76007686|FG004|Overall Study|Discharged early due to hurricane|0|||
42195856|NCT02777554|76007687|FG005|Overall Study|Discharged early due to hurricane|0|||
42362690|NCT01700959|76211684|FG001|Overall Study|Side effects|4|||
42362691|NCT01700959|76211685|FG002|Overall Study|Side effects|8|||
42362692|NCT01700959|76211686|FG003|Overall Study|Side effects|4|||
42362693|NCT01700959|76211687|FG004|Overall Study|Side effects|4|||
42100215|NCT00381043|75910828|FG000|Overall Study|Lost to Follow-up|8|||
42195857|NCT02777554|76007682|FG000|Overall Study|Other - Miscellaneous|1|||
42195858|NCT02777554|76007683|FG001|Overall Study|Other - Miscellaneous|0|||
42195859|NCT02777554|76007684|FG002|Overall Study|Other - Miscellaneous|0|||
42362694|NCT01700959|76211688|FG005|Overall Study|Side effects|1|||
42362695|NCT01738477|76211710|FG000|Overall Study|Lost to Follow-up|1|||
42362696|NCT01738477|76211711|FG001|Overall Study|Lost to Follow-up|4|||
42362697|NCT01737931|76211727|FG000|Overall Study|Withdrawal by Subject|0|||
42362698|NCT01737931|76211728|FG001|Overall Study|Withdrawal by Subject|1|||
42362699|NCT01737931|76211729|FG002|Overall Study|Withdrawal by Subject|1|||
42362700|NCT01737931|76211727|FG000|Overall Study|Physician Decision|0|||
42362701|NCT01737931|76211728|FG001|Overall Study|Physician Decision|1|||
42362702|NCT01737931|76211729|FG002|Overall Study|Physician Decision|0|||
42362703|NCT01958489|76211735|FG000|Period 2|Adverse Event|0|||
42362704|NCT01958489|76211736|FG001|Period 2|Adverse Event|1|||
42362705|NCT01721161|76211749|FG000|Overall Study|Adverse Event|2|||
42362706|NCT01721161|76211750|FG001|Overall Study|Adverse Event|3|||
42362707|NCT01721161|76211749|FG000|Overall Study|Lost to Follow-up|1|||
42362708|NCT01721161|76211750|FG001|Overall Study|Lost to Follow-up|2|||
42362709|NCT01721161|76211749|FG000|Overall Study|Withdrawal by Subject|1|||
42362710|NCT01721161|76211750|FG001|Overall Study|Withdrawal by Subject|1|||
42362711|NCT01721161|76211749|FG000|Overall Study|Other|0|||
42362712|NCT01721161|76211750|FG001|Overall Study|Other|1|||
42362713|NCT01699867|76211757|FG000|Overall Study|Screening Failure|3|||
42362714|NCT01699789|76211776|FG000|Overall Study|Withdrawal by Subject|18|||
42362715|NCT01699789|76211777|FG001|Overall Study|Withdrawal by Subject|23|||
42362716|NCT01699789|76211776|FG000|Overall Study|Death|1|||
42362717|NCT01699789|76211777|FG001|Overall Study|Death|2|||
42362718|NCT01699789|76211776|FG000|Overall Study|Lost to Follow-up|83|||
42362719|NCT01699789|76211777|FG001|Overall Study|Lost to Follow-up|101|||
42362720|NCT01944839|76211800|FG000|Overall Study|Physician Decision|2|||
42362721|NCT01944839|76211801|FG001|Overall Study|Physician Decision|2|||
42362722|NCT01944839|76211800|FG000|Overall Study|Protocol Violation|0|||
42362723|NCT01944839|76211801|FG001|Overall Study|Protocol Violation|1|||
42362724|NCT01944839|76211800|FG000|Overall Study|Adverse Event|10|||
42362725|NCT01944839|76211801|FG001|Overall Study|Adverse Event|5|||
42362726|NCT01944839|76211800|FG000|Overall Study|Withdrawal by Subject|9|||
42362727|NCT01944839|76211801|FG001|Overall Study|Withdrawal by Subject|17|||
42100216|NCT00381043|75910829|FG001|Overall Study|Lost to Follow-up|6|||
42362728|NCT01944839|76211800|FG000|Overall Study|Lost to Follow-up|1|||
42362729|NCT01944839|76211801|FG001|Overall Study|Lost to Follow-up|0|||
42362730|NCT01944839|76211800|FG000|Overall Study|Subject non-compliance|0|||
42362731|NCT01944839|76211801|FG001|Overall Study|Subject non-compliance|3|||
42362732|NCT01944059|76211816|FG000|Overall Study|Lost to Follow-up|1|||
42362733|NCT01944059|76211816|FG000|Overall Study|Physician Decision|3|||
42362734|NCT01944059|76211816|FG000|Overall Study|Withdrawal by Subject|1|||
42362735|NCT01944059|76211816|FG000|Overall Study|Adverse Event|2|||
42362736|NCT01720225|76211823|FG000|Overall Study|Withdrawal by Subject|0|||
42362737|NCT01720225|76211824|FG001|Overall Study|Withdrawal by Subject|1|||
42362738|NCT01720225|76211823|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
42362739|NCT01720225|76211824|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
42362740|NCT01943591|76211832|FG000|Overall Study|Lost to Follow-up|3|||
42362741|NCT01943591|76211833|FG001|Overall Study|Lost to Follow-up|4|||
42362742|NCT01943591|76211832|FG000|Overall Study|Death|2|||
42362743|NCT01943591|76211833|FG001|Overall Study|Death|7|||
42362744|NCT01699087|76211839|FG000|Overall Study|Lost to Follow-up|7|||
42362745|NCT01699087|76211839|FG000|Overall Study|Screen failure (prior to treatment)|15|||
42362746|NCT01699087|76211839|FG000|Overall Study|Unable to make future visits|2|||
42362747|NCT01943435|76211847|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
42362748|NCT01943435|76211848|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
42362749|NCT01943435|76211849|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
42362750|NCT01943435|76211847|FG000|Intervention Period|Withdrawal by Subject|3|||
42362751|NCT01943435|76211848|FG001|Intervention Period|Withdrawal by Subject|3|||
42362752|NCT01943435|76211849|FG002|Intervention Period|Withdrawal by Subject|4|||
42362753|NCT01943435|76211847|FG000|2 Month Follow up|Lost to Follow-up|2|||
42362754|NCT01943435|76211848|FG001|2 Month Follow up|Lost to Follow-up|3|||
42362755|NCT01943435|76211849|FG002|2 Month Follow up|Lost to Follow-up|0|||
42362756|NCT01943435|76211847|FG000|6 Month Follow up|Lost to Follow-up|12|||
42362757|NCT01943435|76211848|FG001|6 Month Follow up|Lost to Follow-up|7|||
42362758|NCT01943435|76211849|FG002|6 Month Follow up|Lost to Follow-up|15|||
42362759|NCT01942733|76211867|FG000|Overall Study|Lost to Follow-up|1|||
42362760|NCT01942733|76211867|FG000|Overall Study|Non-compliance with IMP|1|||
42100217|NCT00381043|75910828|FG000|Overall Study|Withdrawal by Subject|3|||
42362761|NCT01942733|76211867|FG000|Overall Study|Administrative|1|||
42362762|NCT01957865|76211883|FG000|Overall Study|Found HIV negative|0|||
42362763|NCT01957865|76211884|FG001|Overall Study|Found HIV negative|0|||
42362764|NCT01957865|76211885|FG002|Overall Study|Found HIV negative|1|||
42362765|NCT01957865|76211883|FG000|Overall Study|Lost to Follow-up|0|||
42362766|NCT01957865|76211884|FG001|Overall Study|Lost to Follow-up|2|||
42100218|NCT00381043|75910829|FG001|Overall Study|Withdrawal by Subject|1|||
42362767|NCT01957865|76211885|FG002|Overall Study|Lost to Follow-up|2|||
42362768|NCT01957787|76211894|FG000|Overall Study|Death|18|||
42362769|NCT01957787|76211894|FG000|Overall Study|Lost to Follow-up|3|||
42362770|NCT01957787|76211894|FG000|Overall Study|Withdrawal by Subject|3|||
42362771|NCT01957787|76211894|FG000|Overall Study|Entered Hospice or Similar Program|2|||
42362772|NCT01957787|76211894|FG000|Overall Study|Index Tumor(s) Resected|2|||
42362773|NCT01957787|76211894|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
42362774|NCT01957787|76211894|FG000|Overall Study|Local therapy, not cryoablation|6|||
42362775|NCT01698775|76211900|FG000|Phase A|Adverse Event|2|||
42362776|NCT01698775|76211901|FG001|Phase A|Adverse Event|1|||
42362777|NCT01698775|76211900|FG000|Phase A|Death|1|||
42362778|NCT01698775|76211901|FG001|Phase A|Death|1|||
42362779|NCT01698775|76211900|FG000|Phase A|Lack of Efficacy|1|||
42362780|NCT01698775|76211901|FG001|Phase A|Lack of Efficacy|0|||
42362781|NCT01698775|76211900|FG000|Phase A|Lost to Follow-up|1|||
42362782|NCT01698775|76211901|FG001|Phase A|Lost to Follow-up|2|||
42362783|NCT01698775|76211900|FG000|Phase A|Protocol Violation|1|||
42362784|NCT01698775|76211901|FG001|Phase A|Protocol Violation|0|||
42362785|NCT01698775|76211900|FG000|Phase A|Withdrawal by Subject|3|||
42362786|NCT01698775|76211901|FG001|Phase A|Withdrawal by Subject|4|||
42362787|NCT01698775|76211900|FG000|Phase A|Kidney [transplant]|0|||
42362788|NCT01698775|76211901|FG001|Phase A|Kidney [transplant]|1|||
42362789|NCT01698775|76211900|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
42362790|NCT01698775|76211901|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
42362791|NCT01698775|76211900|FG000|Phase B|Adverse Event|6|||
42362792|NCT01698775|76211901|FG001|Phase B|Adverse Event|3|||
42362793|NCT01698775|76211900|FG000|Phase B|Death|0|||
42362794|NCT01698775|76211901|FG001|Phase B|Death|1|||
42362795|NCT01698775|76211900|FG000|Phase B|Lack of Efficacy|0|||
42362796|NCT01698775|76211901|FG001|Phase B|Lack of Efficacy|1|||
42362797|NCT01698775|76211900|FG000|Phase B|Lost to Follow-up|0|||
42362798|NCT01698775|76211901|FG001|Phase B|Lost to Follow-up|1|||
42362799|NCT01698775|76211900|FG000|Phase B|Physician Decision|1|||
42362800|NCT01698775|76211901|FG001|Phase B|Physician Decision|1|||
42362801|NCT01698775|76211900|FG000|Phase B|Protocol Violation|1|||
42362802|NCT01698775|76211901|FG001|Phase B|Protocol Violation|1|||
42362803|NCT01698775|76211900|FG000|Phase B|Withdrawal by Subject|6|||
42362804|NCT01698775|76211901|FG001|Phase B|Withdrawal by Subject|2|||
42362805|NCT01941095|76211911|FG000|Overall Study|Insufficient therapeutic response|13|||
42362806|NCT01941095|76211911|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
42362807|NCT01941095|76211911|FG000|Overall Study|Adverse Event|11|||
42362808|NCT01941095|76211911|FG000|Overall Study|Physician Decision|3|||
42362809|NCT01941095|76211911|FG000|Overall Study|Withdrawal by Subject|17|||
42362810|NCT01941095|76211911|FG000|Overall Study|Lost to Follow-up|10|||
42362811|NCT01957709|76211926|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
42362812|NCT01957553|76211943|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
42362813|NCT01957553|76211944|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
42362814|NCT01957553|76211943|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
42362815|NCT01957553|76211944|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
42362816|NCT01957553|76211943|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
42362817|NCT01957553|76211944|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
42362818|NCT01957553|76211943|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
42362819|NCT01957553|76211944|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
42362820|NCT01957553|76211943|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
42362821|NCT01957553|76211944|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
42362822|NCT01957553|76211943|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
42362823|NCT01957553|76211944|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
42362824|NCT01957553|76211943|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
42362825|NCT01957553|76211944|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
42100219|NCT00381043|75910828|FG000|Overall Study|wanted more care|0|||
42100220|NCT00381043|75910829|FG001|Overall Study|wanted more care|1|||
42100221|NCT00381043|75910828|FG000|Overall Study|incarcerated|1|||
42100222|NCT00381043|75910829|FG001|Overall Study|incarcerated|0|||
42100223|NCT00614991|75910841|FG000|Overall Study|Adverse Event|3|||
42100224|NCT00614991|75910842|FG001|Overall Study|Adverse Event|3|||
42100225|NCT00614991|75910843|FG002|Overall Study|Adverse Event|0|||
42100226|NCT00614991|75910844|FG003|Overall Study|Adverse Event|0|||
42100227|NCT00614991|75910845|FG004|Overall Study|Adverse Event|1|||
42362826|NCT01957553|76211943|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
42362827|NCT01957553|76211944|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
42362828|NCT01957553|76211943|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
42362829|NCT01957553|76211944|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
42362830|NCT01957475|76211969|FG000|Test Period 1|Withdrawal by Subject|1|||
42362831|NCT01957475|76211970|FG001|Test Period 1|Withdrawal by Subject|0|||
42362832|NCT01957475|76211969|FG000|Test Period 1|Other|1|||
42100228|NCT00614991|75910846|FG005|Overall Study|Adverse Event|0|||
42100229|NCT00360529|75910868|FG000|Overall Study|Adverse Event|10|||
42362833|NCT01957475|76211970|FG001|Test Period 1|Other|0|||
42362834|NCT01957475|76211969|FG000|Test Period 1|Lack of Efficacy|0|||
42362835|NCT01957475|76211970|FG001|Test Period 1|Lack of Efficacy|1|||
42362836|NCT01957475|76211969|FG000|Test Period 2|Adverse Event|1|||
42362837|NCT01957475|76211970|FG001|Test Period 2|Adverse Event|0|||
42362838|NCT01940939|76211978|FG000|Overall Study|Withdrawal by Subject|2|||
42100230|NCT00360529|75910869|FG001|Overall Study|Adverse Event|23|||
42362839|NCT01940939|76211979|FG001|Overall Study|Withdrawal by Subject|8|||
42362840|NCT01957397|76211985|FG000|Test Period 1|sudden leakage/small bag|1|||
42362841|NCT01957397|76211986|FG001|Test Period 1|sudden leakage/small bag|1|||
42362842|NCT01957397|76211985|FG000|Test Period 1|Withdrawal by Subject|1|||
42362843|NCT01957397|76211986|FG001|Test Period 1|Withdrawal by Subject|0|||
42362844|NCT01957397|76211985|FG000|Test Period 2|Adverse Event|0|||
42362845|NCT01957397|76211986|FG001|Test Period 2|Adverse Event|1|||
42362846|NCT01957397|76211985|FG000|Test Period 3|Adverse Event|1|||
42362847|NCT01957397|76211986|FG001|Test Period 3|Adverse Event|2|||
42362848|NCT01957397|76211985|FG000|Test Period 3|the adhesive did not work|1|||
42362849|NCT01957397|76211986|FG001|Test Period 3|the adhesive did not work|0|||
42362850|NCT01940705|76212000|FG000|Overall Study|Lost to Follow-up|1|||
42362851|NCT01940705|76212001|FG001|Overall Study|Lost to Follow-up|3|||
42362852|NCT01940705|76212002|FG002|Overall Study|Lost to Follow-up|2|||
42362853|NCT01940705|76212003|FG003|Overall Study|Lost to Follow-up|2|||
42362854|NCT01940705|76212000|FG000|Overall Study|Withdrawal by Subject|2|||
42362855|NCT01940705|76212001|FG001|Overall Study|Withdrawal by Subject|2|||
42362856|NCT01940705|76212002|FG002|Overall Study|Withdrawal by Subject|3|||
42362857|NCT01940705|76212003|FG003|Overall Study|Withdrawal by Subject|2|||
42362858|NCT01940705|76212000|FG000|Overall Study|Intervention not given|0|||
42362859|NCT01940705|76212001|FG001|Overall Study|Intervention not given|3|||
42362860|NCT01940705|76212002|FG002|Overall Study|Intervention not given|3|||
42362861|NCT01940705|76212003|FG003|Overall Study|Intervention not given|0|||
42362862|NCT01940705|76212000|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
42362863|NCT01940705|76212001|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
42362864|NCT01940705|76212002|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
42362865|NCT01940705|76212003|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
42362866|NCT01957163|76212028|FG000|Overall Study|Adverse Event|5|||
42362867|NCT01957163|76212029|FG001|Overall Study|Adverse Event|2|||
42362868|NCT01957163|76212030|FG002|Overall Study|Adverse Event|4|||
42362869|NCT01957163|76212028|FG000|Overall Study|Lack of Efficacy|5|||
42362870|NCT01957163|76212029|FG001|Overall Study|Lack of Efficacy|4|||
42362871|NCT01957163|76212030|FG002|Overall Study|Lack of Efficacy|9|||
42362872|NCT01957163|76212028|FG000|Overall Study|Protocol Violation|1|||
42362873|NCT01957163|76212029|FG001|Overall Study|Protocol Violation|2|||
42362874|NCT01957163|76212030|FG002|Overall Study|Protocol Violation|0|||
42362875|NCT01957163|76212028|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
42362876|NCT01957163|76212029|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
42362877|NCT01957163|76212030|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
42362878|NCT01957163|76212028|FG000|Overall Study|Lost to Follow-up|0|||
42362879|NCT01957163|76212029|FG001|Overall Study|Lost to Follow-up|1|||
42362880|NCT01957163|76212030|FG002|Overall Study|Lost to Follow-up|0|||
42362881|NCT01957163|76212028|FG000|Overall Study|Withdrawal by Subject|4|||
42362882|NCT01957163|76212029|FG001|Overall Study|Withdrawal by Subject|2|||
42362883|NCT01957163|76212030|FG002|Overall Study|Withdrawal by Subject|4|||
42362884|NCT01939223|76212084|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
42362885|NCT01939223|76212085|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
42362886|NCT01939223|76212084|FG000|Overall Study|Disease recurrence (radiological)|1|||
42362887|NCT01939223|76212085|FG001|Overall Study|Disease recurrence (radiological)|3|||
42362888|NCT01939223|76212084|FG000|Overall Study|Study stopped by Sponsor|5|||
42362889|NCT01939223|76212085|FG001|Overall Study|Study stopped by Sponsor|7|||
42362890|NCT01939223|76212084|FG000|Overall Study|Withdrawal by Subject|6|||
42362891|NCT01939223|76212085|FG001|Overall Study|Withdrawal by Subject|0|||
42362892|NCT01954745|76212130|FG000|Overall Study|Radiological Progression|11|||
42362893|NCT01954745|76212130|FG000|Overall Study|Clinical Progression|5|||
42362894|NCT01954745|76212130|FG000|Overall Study|Adverse Event|2|||
42362895|NCT01954745|76212130|FG000|Overall Study|Death|1|||
42362896|NCT01954121|76212145|FG000|Overall Study|Lack of Efficacy|94|||
42362897|NCT01954121|76212146|FG001|Overall Study|Lack of Efficacy|41|||
42362898|NCT01954121|76212145|FG000|Overall Study|Protocol Violation|0|||
42362899|NCT01954121|76212146|FG001|Overall Study|Protocol Violation|2|||
42362900|NCT01954121|76212145|FG000|Overall Study|Lost to Follow-up|5|||
42362901|NCT01954121|76212146|FG001|Overall Study|Lost to Follow-up|6|||
42362902|NCT01954121|76212145|FG000|Overall Study|Withdrawal by Subject|18|||
42362903|NCT01954121|76212146|FG001|Overall Study|Withdrawal by Subject|12|||
42362904|NCT01954121|76212145|FG000|Overall Study|Pregnancy|1|||
42362905|NCT01954121|76212146|FG001|Overall Study|Pregnancy|1|||
42362906|NCT01954121|76212145|FG000|Overall Study|AE, serious fatal|1|||
42362907|NCT01954121|76212146|FG001|Overall Study|AE, serious fatal|0|||
42362908|NCT01954121|76212145|FG000|Overall Study|AE, non-serious non-fatal|5|||
42362909|NCT01954121|76212146|FG001|Overall Study|AE, non-serious non-fatal|22|||
42362910|NCT01954121|76212145|FG000|Overall Study|SAE, non-fatal|1|||
42362911|NCT01954121|76212146|FG001|Overall Study|SAE, non-fatal|4|||
42362912|NCT01954121|76212145|FG000|Overall Study|Non-compliant with study procedures|1|||
42362913|NCT01954121|76212146|FG001|Overall Study|Non-compliant with study procedures|0|||
42362914|NCT01954121|76212145|FG000|Overall Study|Non-compliant patient|1|||
42362915|NCT01954121|76212146|FG001|Overall Study|Non-compliant patient|1|||
42362916|NCT01954121|76212145|FG000|Overall Study|Subject did not follow instructions|0|||
42362917|NCT01954121|76212146|FG001|Overall Study|Subject did not follow instructions|2|||
42362918|NCT01952015|76212181|FG000|Induction|Protocol Violation|1|||
42362919|NCT01952015|76212181|FG000|Maintenance|Adverse Event|2|||
42362920|NCT01952015|76212181|FG000|Treatment Period 3|Physician Decision|9|||
42362921|NCT01951703|76212214|FG000|First Intervention|Withdrawal by Subject|1|||
42362922|NCT01951703|76212215|FG001|First Intervention|Withdrawal by Subject|0|||
42362923|NCT01951703|76212214|FG000|First Intervention|Subject was not compliant|1|||
42362924|NCT01951703|76212215|FG001|First Intervention|Subject was not compliant|1|||
42362925|NCT01951703|76212214|FG000|First Intervention|Physician Decision|1|||
42362926|NCT01951703|76212215|FG001|First Intervention|Physician Decision|0|||
42362927|NCT01951703|76212214|FG000|Second Intervention|Protocol Violation|0|||
42362928|NCT01951703|76212215|FG001|Second Intervention|Protocol Violation|1|||
42362929|NCT01951703|76212214|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
42362930|NCT01951703|76212215|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
42362931|NCT01937351|76212241|FG000|Overall Study|Withdrawal by Subject|4|||
42362932|NCT01937351|76212242|FG001|Overall Study|Withdrawal by Subject|2|||
42362933|NCT01937351|76212241|FG000|Overall Study|Death|1|||
42362934|NCT01937351|76212242|FG001|Overall Study|Death|0|||
42362935|NCT01937351|76212241|FG000|Overall Study|Not treated w device, per protocol fail|4|||
42362936|NCT01937351|76212242|FG001|Overall Study|Not treated w device, per protocol fail|0|||
42362937|NCT01737697|76212275|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362938|NCT01737697|76212276|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
42362939|NCT01737697|76212277|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362940|NCT01737697|76212278|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
42362941|NCT01737697|76212279|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
42362942|NCT01737697|76212280|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362943|NCT01737697|76212281|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362944|NCT01737697|76212282|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362945|NCT01737697|76212283|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362946|NCT01737697|76212284|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362947|NCT01737697|76212285|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362948|NCT01737697|76212286|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362949|NCT01737697|76212287|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362950|NCT01737697|76212288|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362951|NCT01737697|76212289|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
42362952|NCT01737697|76212275|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
42100231|NCT00360529|75910870|FG002|Overall Study|Adverse Event|33|||
42100232|NCT00360529|75910868|FG000|Overall Study|Protocol Violation|3|||
42100233|NCT00360529|75910869|FG001|Overall Study|Protocol Violation|3|||
42100234|NCT00360529|75910870|FG002|Overall Study|Protocol Violation|11|||
42100235|NCT00360529|75910868|FG000|Overall Study|Lost to Follow-up|14|||
42100236|NCT00360529|75910869|FG001|Overall Study|Lost to Follow-up|10|||
42100237|NCT00360529|75910870|FG002|Overall Study|Lost to Follow-up|13|||
42100238|NCT00360529|75910868|FG000|Overall Study|Withdrawal by Subject|22|||
42100239|NCT00360529|75910869|FG001|Overall Study|Withdrawal by Subject|14|||
42100240|NCT00360529|75910870|FG002|Overall Study|Withdrawal by Subject|18|||
42100241|NCT00360529|75910868|FG000|Overall Study|Lack of Efficacy|8|||
42100242|NCT00360529|75910869|FG001|Overall Study|Lack of Efficacy|6|||
42100243|NCT00360529|75910870|FG002|Overall Study|Lack of Efficacy|5|||
42100244|NCT00360529|75910868|FG000|Overall Study|Reason discontinued not explained above|4|||
42100245|NCT00360529|75910869|FG001|Overall Study|Reason discontinued not explained above|9|||
42100246|NCT00360529|75910870|FG002|Overall Study|Reason discontinued not explained above|11|||
42100247|NCT00369577|75910881|FG000|Overall Study|Withdrawal by Subject|0|||
42100248|NCT00369577|75910882|FG001|Overall Study|Withdrawal by Subject|0|||
42100249|NCT00369577|75910883|FG002|Overall Study|Withdrawal by Subject|1|||
42100250|NCT00678288|75910893|FG000|Overall Study|Adverse Event|0|||
42100251|NCT00678288|75910894|FG001|Overall Study|Adverse Event|2|||
42100252|NCT00678288|75910893|FG000|Overall Study|Withdrawal by Subject|1|||
42100253|NCT00678288|75910894|FG001|Overall Study|Withdrawal by Subject|1|||
42362953|NCT01737697|76212276|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
42362954|NCT01737697|76212277|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
42362955|NCT01737697|76212278|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42362956|NCT01737697|76212279|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42362957|NCT01737697|76212280|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42362958|NCT01737697|76212281|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42362959|NCT01737697|76212282|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42195860|NCT02777554|76007685|FG003|Overall Study|Other - Miscellaneous|0|||
42195861|NCT02777554|76007686|FG004|Overall Study|Other - Miscellaneous|0|||
42195862|NCT02777554|76007687|FG005|Overall Study|Other - Miscellaneous|0|||
42195863|NCT03550209|76007711|FG000|Overall Study|Lost to Follow-up|1|||
42195864|NCT03550209|76007712|FG001|Overall Study|Lost to Follow-up|0|||
42195865|NCT03550209|76007713|FG002|Overall Study|Lost to Follow-up|1|||
42195866|NCT03550209|76007714|FG003|Overall Study|Lost to Follow-up|0|||
42195867|NCT03550209|76007711|FG000|Overall Study|Withdrawal by Subject|0|||
42195868|NCT03550209|76007712|FG001|Overall Study|Withdrawal by Subject|3|||
42195869|NCT03550209|76007713|FG002|Overall Study|Withdrawal by Subject|1|||
42195870|NCT03550209|76007714|FG003|Overall Study|Withdrawal by Subject|2|||
42195871|NCT03550209|76007711|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
42195872|NCT03550209|76007712|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
42195873|NCT03550209|76007713|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
42195874|NCT03550209|76007714|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
42195875|NCT03032510|76007726|FG000|Overall Study|Adverse Event|5|||
42195876|NCT03032510|76007727|FG001|Overall Study|Adverse Event|2|||
42195877|NCT03032510|76007726|FG000|Overall Study|Lost to Follow-up|8|||
42195878|NCT03032510|76007727|FG001|Overall Study|Lost to Follow-up|7|||
42195879|NCT03032510|76007726|FG000|Overall Study|Withdrawal by Subject|8|||
42195880|NCT03032510|76007727|FG001|Overall Study|Withdrawal by Subject|7|||
42195881|NCT03032510|76007726|FG000|Overall Study|Subject noncompliance|4|||
42195882|NCT03032510|76007727|FG001|Overall Study|Subject noncompliance|2|||
42195883|NCT03032510|76007726|FG000|Overall Study|Physician Decision|2|||
42195884|NCT03032510|76007727|FG001|Overall Study|Physician Decision|0|||
42195885|NCT03599349|76007737|FG000|Overall Study|Lost to Follow-up|1|||
42195886|NCT03599193|76007747|FG000|Overall Study|Adverse Event|0|||
42195887|NCT03599193|76007748|FG001|Overall Study|Adverse Event|2|||
42195888|NCT03599193|76007747|FG000|Overall Study|Withdrawal by Subject|1|||
42195889|NCT03599193|76007748|FG001|Overall Study|Withdrawal by Subject|0|||
42195890|NCT03599193|76007747|FG000|Overall Study|Protocol Violation|1|||
42195891|NCT03599193|76007748|FG001|Overall Study|Protocol Violation|0|||
42195892|NCT03599193|76007747|FG000|Overall Study|Lost to Follow-up|0|||
42195893|NCT03599193|76007748|FG001|Overall Study|Lost to Follow-up|1|||
42195894|NCT03166124|76007757|FG000|Treatment Period 1|Adverse Event|0|||
42195895|NCT03166124|76007758|FG001|Treatment Period 1|Adverse Event|0|||
42195896|NCT03166124|76007759|FG002|Treatment Period 1|Adverse Event|1|||
42195897|NCT03166124|76007760|FG003|Treatment Period 1|Adverse Event|0|||
42195898|NCT03166124|76007757|FG000|Wash-out Period|Withdrawal by Subject|0|||
42195899|NCT03166124|76007758|FG001|Wash-out Period|Withdrawal by Subject|1|||
42195900|NCT03166124|76007759|FG002|Wash-out Period|Withdrawal by Subject|0|||
42195901|NCT03166124|76007760|FG003|Wash-out Period|Withdrawal by Subject|1|||
42195902|NCT03166124|76007757|FG000|Wash-out Period|Adverse Event|0|||
42195903|NCT03166124|76007758|FG001|Wash-out Period|Adverse Event|1|||
42195904|NCT03166124|76007759|FG002|Wash-out Period|Adverse Event|1|||
42195905|NCT03166124|76007760|FG003|Wash-out Period|Adverse Event|0|||
42195906|NCT03567291|76007771|FG000|Period I|Adverse Event|14|||
42195907|NCT03567291|76007772|FG001|Period I|Adverse Event|0|||
42195908|NCT03567291|76007773|FG002|Period I|Adverse Event|0|||
42195909|NCT03567291|76007774|FG003|Period I|Adverse Event|0|||
42362960|NCT01737697|76212283|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42362961|NCT01737697|76212284|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42362962|NCT01737697|76212285|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42362963|NCT01737697|76212286|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42362964|NCT01737697|76212287|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42362965|NCT01737697|76212288|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42362966|NCT01737697|76212289|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
42362967|NCT01737697|76212275|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362968|NCT01737697|76212276|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362969|NCT01737697|76212277|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362970|NCT01737697|76212278|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
42100254|NCT00678288|75910893|FG000|Overall Study|Study terminated by the sponsor|2|||
42195910|NCT03567291|76007771|FG000|Period I|Protocol Violation|1|||
42195911|NCT03567291|76007772|FG001|Period I|Protocol Violation|0|||
42195912|NCT03567291|76007773|FG002|Period I|Protocol Violation|0|||
42195913|NCT03567291|76007774|FG003|Period I|Protocol Violation|0|||
42195914|NCT03567291|76007771|FG000|Period I|Withdrawal by Subject|23|||
42195915|NCT03567291|76007772|FG001|Period I|Withdrawal by Subject|0|||
42195916|NCT03567291|76007773|FG002|Period I|Withdrawal by Subject|0|||
42195917|NCT03567291|76007774|FG003|Period I|Withdrawal by Subject|0|||
42195918|NCT03567291|76007771|FG000|Period I|Lost to Follow-up|2|||
42195919|NCT03567291|76007772|FG001|Period I|Lost to Follow-up|0|||
42195920|NCT03567291|76007773|FG002|Period I|Lost to Follow-up|0|||
42362971|NCT01737697|76212279|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362972|NCT01737697|76212280|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
42195921|NCT03567291|76007774|FG003|Period I|Lost to Follow-up|0|||
42362973|NCT01737697|76212281|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362974|NCT01737697|76212282|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362975|NCT01737697|76212283|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362976|NCT01737697|76212284|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362977|NCT01737697|76212285|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362978|NCT01737697|76212286|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362979|NCT01737697|76212287|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362980|NCT01737697|76212288|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362981|NCT01737697|76212289|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
42362982|NCT01737697|76212275|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362983|NCT01737697|76212276|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
42362984|NCT01737697|76212277|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362985|NCT01737697|76212278|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362986|NCT01737697|76212279|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362987|NCT01737697|76212280|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362988|NCT01737697|76212281|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362989|NCT01737697|76212282|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362990|NCT01737697|76212283|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362991|NCT01737697|76212284|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362992|NCT01737697|76212285|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362993|NCT01737697|76212286|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362994|NCT01737697|76212287|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362995|NCT01737697|76212288|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362996|NCT01737697|76212289|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
42362997|NCT01737697|76212275|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42362998|NCT01737697|76212276|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42362999|NCT01737697|76212277|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363000|NCT01737697|76212278|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363001|NCT01737697|76212279|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
42363002|NCT01737697|76212280|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363003|NCT01737697|76212281|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363004|NCT01737697|76212282|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363005|NCT01737697|76212283|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363006|NCT01737697|76212284|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363007|NCT01737697|76212285|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363008|NCT01737697|76212286|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363009|NCT01737697|76212287|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363010|NCT01737697|76212288|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363011|NCT01737697|76212289|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
42363012|NCT01737697|76212275|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
42363013|NCT01737697|76212276|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
42363014|NCT01737697|76212277|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
42363015|NCT01737697|76212278|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
42363016|NCT01737697|76212279|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
42363017|NCT01737697|76212280|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
42363018|NCT01737697|76212281|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
42363019|NCT01737697|76212282|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
42363020|NCT01737697|76212283|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
42363021|NCT01737697|76212284|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
42363022|NCT01737697|76212285|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
42363023|NCT01737697|76212286|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
42363024|NCT01737697|76212287|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
42363025|NCT01737697|76212288|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
42363026|NCT01737697|76212289|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
42363027|NCT01737697|76212275|FG000|Subacute Phase|Adverse Event|0|||
42363028|NCT01737697|76212276|FG001|Subacute Phase|Adverse Event|0|||
42363029|NCT01737697|76212277|FG002|Subacute Phase|Adverse Event|0|||
42363030|NCT01737697|76212278|FG003|Subacute Phase|Adverse Event|0|||
42363031|NCT01737697|76212279|FG004|Subacute Phase|Adverse Event|0|||
42363032|NCT01737697|76212280|FG005|Subacute Phase|Adverse Event|1|||
42363033|NCT01737697|76212281|FG006|Subacute Phase|Adverse Event|1|||
42363034|NCT01737697|76212282|FG007|Subacute Phase|Adverse Event|1|||
42363035|NCT01737697|76212283|FG008|Subacute Phase|Adverse Event|1|||
42363036|NCT01737697|76212284|FG009|Subacute Phase|Adverse Event|1|||
42363037|NCT01737697|76212285|FG010|Subacute Phase|Adverse Event|4|||
42363038|NCT01737697|76212286|FG011|Subacute Phase|Adverse Event|1|||
42363039|NCT01737697|76212287|FG012|Subacute Phase|Adverse Event|1|||
42363040|NCT01737697|76212288|FG013|Subacute Phase|Adverse Event|0|||
42363041|NCT01737697|76212289|FG014|Subacute Phase|Adverse Event|0|||
42363042|NCT01737697|76212275|FG000|Subacute Phase|Withdrawal by Subject|0|||
42363043|NCT01737697|76212276|FG001|Subacute Phase|Withdrawal by Subject|0|||
42363044|NCT01737697|76212277|FG002|Subacute Phase|Withdrawal by Subject|0|||
42363045|NCT01737697|76212278|FG003|Subacute Phase|Withdrawal by Subject|0|||
42363046|NCT01737697|76212279|FG004|Subacute Phase|Withdrawal by Subject|0|||
42363047|NCT01737697|76212280|FG005|Subacute Phase|Withdrawal by Subject|1|||
42363048|NCT01737697|76212281|FG006|Subacute Phase|Withdrawal by Subject|0|||
42363049|NCT01737697|76212282|FG007|Subacute Phase|Withdrawal by Subject|2|||
42363050|NCT01737697|76212283|FG008|Subacute Phase|Withdrawal by Subject|0|||
42363051|NCT01737697|76212284|FG009|Subacute Phase|Withdrawal by Subject|1|||
42363052|NCT01737697|76212285|FG010|Subacute Phase|Withdrawal by Subject|0|||
42363053|NCT01737697|76212286|FG011|Subacute Phase|Withdrawal by Subject|1|||
42363054|NCT01737697|76212287|FG012|Subacute Phase|Withdrawal by Subject|1|||
42363055|NCT01737697|76212288|FG013|Subacute Phase|Withdrawal by Subject|1|||
42363056|NCT01737697|76212289|FG014|Subacute Phase|Withdrawal by Subject|0|||
42363057|NCT01737697|76212275|FG000|Subacute Phase|Lost to Follow-up|0|||
42363058|NCT01737697|76212276|FG001|Subacute Phase|Lost to Follow-up|0|||
42363059|NCT01737697|76212277|FG002|Subacute Phase|Lost to Follow-up|0|||
42363060|NCT01737697|76212278|FG003|Subacute Phase|Lost to Follow-up|0|||
42363061|NCT01737697|76212279|FG004|Subacute Phase|Lost to Follow-up|0|||
42363062|NCT01737697|76212280|FG005|Subacute Phase|Lost to Follow-up|0|||
42363063|NCT01737697|76212281|FG006|Subacute Phase|Lost to Follow-up|0|||
42363064|NCT01737697|76212282|FG007|Subacute Phase|Lost to Follow-up|0|||
42363065|NCT01737697|76212283|FG008|Subacute Phase|Lost to Follow-up|0|||
42363066|NCT01737697|76212284|FG009|Subacute Phase|Lost to Follow-up|0|||
42363067|NCT01737697|76212285|FG010|Subacute Phase|Lost to Follow-up|0|||
42363068|NCT01737697|76212286|FG011|Subacute Phase|Lost to Follow-up|0|||
42363069|NCT01737697|76212287|FG012|Subacute Phase|Lost to Follow-up|0|||
42363070|NCT01737697|76212288|FG013|Subacute Phase|Lost to Follow-up|0|||
42363071|NCT01737697|76212289|FG014|Subacute Phase|Lost to Follow-up|1|||
42363072|NCT01737697|76212275|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
42363073|NCT01737697|76212276|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
42363074|NCT01737697|76212277|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
42363075|NCT01737697|76212278|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
42363076|NCT01737697|76212279|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
42363077|NCT01737697|76212280|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
42363078|NCT01737697|76212281|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
42363079|NCT01737697|76212282|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
42363080|NCT01737697|76212283|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
42363081|NCT01737697|76212284|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
42363082|NCT01737697|76212285|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
42363083|NCT01737697|76212286|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
42363084|NCT01737697|76212287|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
42363085|NCT01737697|76212288|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
42363086|NCT01737697|76212289|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
42363087|NCT01737697|76212275|FG000|Subacute Phase|Protocol Violation|0|||
42363088|NCT01737697|76212276|FG001|Subacute Phase|Protocol Violation|0|||
42100255|NCT00678288|75910894|FG001|Overall Study|Study terminated by the sponsor|0|||
42100256|NCT00678288|75910893|FG000|Overall Study|Not compliant with study medication|0|||
42100257|NCT00678288|75910894|FG001|Overall Study|Not compliant with study medication|1|||
42100258|NCT00678288|75910893|FG000|Overall Study|Switch to commercial drug|0|||
42100259|NCT00678288|75910894|FG001|Overall Study|Switch to commercial drug|1|||
42100260|NCT00678288|75910893|FG000|Overall Study|Reason not reported|1|||
42100261|NCT00678288|75910894|FG001|Overall Study|Reason not reported|0|||
42100262|NCT00678288|75910893|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
42100263|NCT00678288|75910894|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
42100264|NCT00369343|75910902|FG000|Double-blind Phase|Adverse Event|19|||
42195922|NCT03567291|76007771|FG000|Period I|Terminated by sponsor|44|||
42363089|NCT01737697|76212277|FG002|Subacute Phase|Protocol Violation|0|||
42363090|NCT01737697|76212278|FG003|Subacute Phase|Protocol Violation|0|||
42363091|NCT01737697|76212279|FG004|Subacute Phase|Protocol Violation|0|||
42363092|NCT01737697|76212280|FG005|Subacute Phase|Protocol Violation|1|||
42363093|NCT01737697|76212281|FG006|Subacute Phase|Protocol Violation|0|||
42363094|NCT01737697|76212282|FG007|Subacute Phase|Protocol Violation|0|||
42363095|NCT01737697|76212283|FG008|Subacute Phase|Protocol Violation|0|||
42363096|NCT01737697|76212284|FG009|Subacute Phase|Protocol Violation|0|||
42363097|NCT01737697|76212285|FG010|Subacute Phase|Protocol Violation|1|||
42363098|NCT01737697|76212286|FG011|Subacute Phase|Protocol Violation|0|||
42100265|NCT00369343|75910903|FG001|Double-blind Phase|Adverse Event|4|||
42018451|NCT00996892|75825873|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
42018452|NCT00996892|75825874|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
42018453|NCT00996892|75825875|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
42363099|NCT01737697|76212287|FG012|Subacute Phase|Protocol Violation|0|||
42363100|NCT01737697|76212288|FG013|Subacute Phase|Protocol Violation|0|||
42363101|NCT01737697|76212289|FG014|Subacute Phase|Protocol Violation|0|||
42363102|NCT01737697|76212275|FG000|Subacute Phase|Physician Decision|0|||
42363103|NCT01737697|76212276|FG001|Subacute Phase|Physician Decision|0|||
42363104|NCT01737697|76212277|FG002|Subacute Phase|Physician Decision|0|||
42363105|NCT01737697|76212278|FG003|Subacute Phase|Physician Decision|0|||
42363106|NCT01737697|76212279|FG004|Subacute Phase|Physician Decision|0|||
42363107|NCT01737697|76212280|FG005|Subacute Phase|Physician Decision|0|||
42363108|NCT01737697|76212281|FG006|Subacute Phase|Physician Decision|0|||
42363109|NCT01737697|76212282|FG007|Subacute Phase|Physician Decision|0|||
42363110|NCT01737697|76212283|FG008|Subacute Phase|Physician Decision|1|||
42363111|NCT01737697|76212284|FG009|Subacute Phase|Physician Decision|0|||
42363112|NCT01737697|76212285|FG010|Subacute Phase|Physician Decision|0|||
42363113|NCT01737697|76212286|FG011|Subacute Phase|Physician Decision|0|||
42363114|NCT01737697|76212287|FG012|Subacute Phase|Physician Decision|0|||
42363115|NCT01737697|76212288|FG013|Subacute Phase|Physician Decision|0|||
42363116|NCT01737697|76212289|FG014|Subacute Phase|Physician Decision|0|||
42363117|NCT01737697|76212275|FG000|Subacute Phase|Death|0|||
42363118|NCT01737697|76212276|FG001|Subacute Phase|Death|0|||
42363119|NCT01737697|76212277|FG002|Subacute Phase|Death|0|||
42363120|NCT01737697|76212278|FG003|Subacute Phase|Death|0|||
42363121|NCT01737697|76212279|FG004|Subacute Phase|Death|0|||
42363122|NCT01737697|76212280|FG005|Subacute Phase|Death|0|||
42363123|NCT01737697|76212281|FG006|Subacute Phase|Death|0|||
42363124|NCT01737697|76212282|FG007|Subacute Phase|Death|0|||
42363125|NCT01737697|76212283|FG008|Subacute Phase|Death|0|||
42363126|NCT01737697|76212284|FG009|Subacute Phase|Death|0|||
42363127|NCT01737697|76212285|FG010|Subacute Phase|Death|1|||
42363128|NCT01737697|76212286|FG011|Subacute Phase|Death|0|||
42363129|NCT01737697|76212287|FG012|Subacute Phase|Death|0|||
42363130|NCT01737697|76212288|FG013|Subacute Phase|Death|0|||
42363131|NCT01737697|76212289|FG014|Subacute Phase|Death|0|||
42363132|NCT01682863|76212445|FG000|Overall Study|Subject/guardian decision|19|||
42363133|NCT01682863|76212446|FG001|Overall Study|Subject/guardian decision|12|||
42195923|NCT03567291|76007772|FG001|Period I|Terminated by sponsor|0|||
42195924|NCT03567291|76007773|FG002|Period I|Terminated by sponsor|0|||
42195925|NCT03567291|76007774|FG003|Period I|Terminated by sponsor|0|||
42195926|NCT03567291|76007771|FG000|Period I|Missing or unknown|7|||
42195927|NCT03567291|76007772|FG001|Period I|Missing or unknown|0|||
42195928|NCT03567291|76007773|FG002|Period I|Missing or unknown|0|||
42363134|NCT01682863|76212447|FG002|Overall Study|Subject/guardian decision|10|||
42363135|NCT01682863|76212445|FG000|Overall Study|Lost to Follow-up|5|||
42363136|NCT01682863|76212446|FG001|Overall Study|Lost to Follow-up|1|||
42363137|NCT01682863|76212447|FG002|Overall Study|Lost to Follow-up|6|||
42363138|NCT01682863|76212445|FG000|Overall Study|Death|1|||
42363139|NCT01682863|76212446|FG001|Overall Study|Death|3|||
42363140|NCT01682863|76212447|FG002|Overall Study|Death|4|||
42363141|NCT01682863|76212445|FG000|Overall Study|Protocol deviation|1|||
42363142|NCT01682863|76212446|FG001|Overall Study|Protocol deviation|0|||
42363143|NCT01682863|76212447|FG002|Overall Study|Protocol deviation|1|||
42363144|NCT01682863|76212445|FG000|Overall Study|Technical problems|1|||
42363145|NCT01682863|76212446|FG001|Overall Study|Technical problems|0|||
42363146|NCT01682863|76212447|FG002|Overall Study|Technical problems|0|||
42363147|NCT01682863|76212445|FG000|Overall Study|Adverse Event|0|||
42100266|NCT00369343|75910902|FG000|Double-blind Phase|Failed to return|2|||
42100267|NCT00369343|75910903|FG001|Double-blind Phase|Failed to return|0|||
42100268|NCT00369343|75910902|FG000|Double-blind Phase|Lost to Follow-up|9|||
42100269|NCT00369343|75910903|FG001|Double-blind Phase|Lost to Follow-up|2|||
42100270|NCT00369343|75910902|FG000|Double-blind Phase|Protocol Violation|2|||
42100271|NCT00369343|75910903|FG001|Double-blind Phase|Protocol Violation|0|||
42100272|NCT00369343|75910902|FG000|Double-blind Phase|Withdrawal by Subject|8|||
42100273|NCT00369343|75910903|FG001|Double-blind Phase|Withdrawal by Subject|6|||
42100274|NCT00369343|75910902|FG000|Double-blind Phase|Lack of Efficacy|0|||
42100275|NCT00369343|75910903|FG001|Double-blind Phase|Lack of Efficacy|4|||
42100276|NCT00369343|75910902|FG000|Double-blind Phase|Protocol deviation|4|||
42100277|NCT00369343|75910903|FG001|Double-blind Phase|Protocol deviation|0|||
42100278|NCT00369343|75910902|FG000|Open-label Phase|Adverse Event|19|||
42100279|NCT00369343|75910903|FG001|Open-label Phase|Adverse Event|7|||
42100280|NCT00369343|75910902|FG000|Open-label Phase|Failed to return|4|||
42100281|NCT00369343|75910903|FG001|Open-label Phase|Failed to return|0|||
42195929|NCT03567291|76007774|FG003|Period I|Missing or unknown|0|||
42195930|NCT03567291|76007771|FG000|Period II|Adverse Event|0|||
42195931|NCT03567291|76007772|FG001|Period II|Adverse Event|1|||
42363148|NCT01682863|76212446|FG001|Overall Study|Adverse Event|1|||
42363149|NCT01682863|76212447|FG002|Overall Study|Adverse Event|2|||
42363150|NCT01682863|76212445|FG000|Overall Study|Physician Decision|0|||
42363151|NCT01682863|76212446|FG001|Overall Study|Physician Decision|0|||
42363152|NCT01682863|76212447|FG002|Overall Study|Physician Decision|1|||
42363153|NCT01951625|76212460|FG000|Treatment Period|Protocol Violation|2|||
42363154|NCT01951625|76212461|FG001|Treatment Period|Protocol Violation|0|||
42363155|NCT01951625|76212462|FG002|Treatment Period|Protocol Violation|1|||
42363156|NCT01951625|76212463|FG003|Treatment Period|Protocol Violation|3|||
42195932|NCT03567291|76007773|FG002|Period II|Adverse Event|0|||
42195933|NCT03567291|76007774|FG003|Period II|Adverse Event|0|||
42195934|NCT03567291|76007771|FG000|Period II|Missing or unknown|0|||
42195935|NCT03567291|76007772|FG001|Period II|Missing or unknown|2|||
42100282|NCT00369343|75910902|FG000|Open-label Phase|Physician Decision|2|||
42100283|NCT00369343|75910903|FG001|Open-label Phase|Physician Decision|0|||
42100284|NCT00369343|75910902|FG000|Open-label Phase|Lost to Follow-up|5|||
42100285|NCT00369343|75910903|FG001|Open-label Phase|Lost to Follow-up|3|||
42100286|NCT00369343|75910902|FG000|Open-label Phase|inadvertently reported study completers|3|||
42100287|NCT00369343|75910903|FG001|Open-label Phase|inadvertently reported study completers|2|||
42195936|NCT03567291|76007773|FG002|Period II|Missing or unknown|1|||
42195937|NCT03567291|76007774|FG003|Period II|Missing or unknown|0|||
42195938|NCT03567291|76007771|FG000|Period III|Adverse Event|0|||
42195939|NCT03567291|76007772|FG001|Period III|Adverse Event|0|||
42195940|NCT03567291|76007773|FG002|Period III|Adverse Event|0|||
42363157|NCT01951625|76212464|FG004|Treatment Period|Protocol Violation|2|||
42363158|NCT01951625|76212460|FG000|Treatment Period|Physician Decision|0|||
42363159|NCT01951625|76212461|FG001|Treatment Period|Physician Decision|0|||
42363160|NCT01951625|76212462|FG002|Treatment Period|Physician Decision|0|||
42363161|NCT01951625|76212463|FG003|Treatment Period|Physician Decision|0|||
42363162|NCT01951625|76212464|FG004|Treatment Period|Physician Decision|1|||
42363163|NCT01951625|76212460|FG000|Treatment Period|Protocol driven decision point|0|||
42363164|NCT01951625|76212461|FG001|Treatment Period|Protocol driven decision point|5|||
42363165|NCT01951625|76212462|FG002|Treatment Period|Protocol driven decision point|0|||
42363166|NCT01951625|76212463|FG003|Treatment Period|Protocol driven decision point|2|||
42363167|NCT01951625|76212464|FG004|Treatment Period|Protocol driven decision point|1|||
42363168|NCT01951625|76212460|FG000|Treatment Period|Non compliance with study drug|1|||
42018454|NCT00996892|75825876|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
42018455|NCT00996892|75825877|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
42363169|NCT01951625|76212461|FG001|Treatment Period|Non compliance with study drug|2|||
42363170|NCT01951625|76212462|FG002|Treatment Period|Non compliance with study drug|2|||
42363171|NCT01951625|76212463|FG003|Treatment Period|Non compliance with study drug|0|||
42363172|NCT01951625|76212464|FG004|Treatment Period|Non compliance with study drug|0|||
42363173|NCT01951625|76212460|FG000|Treatment Period|Death|3|||
42363174|NCT01951625|76212461|FG001|Treatment Period|Death|2|||
42363175|NCT01951625|76212462|FG002|Treatment Period|Death|2|||
42363176|NCT01951625|76212463|FG003|Treatment Period|Death|1|||
42363177|NCT01951625|76212464|FG004|Treatment Period|Death|2|||
42363178|NCT01951625|76212460|FG000|Treatment Period|Adverse Event|7|||
42363179|NCT01951625|76212461|FG001|Treatment Period|Adverse Event|10|||
42363180|NCT01951625|76212462|FG002|Treatment Period|Adverse Event|9|||
42363181|NCT01951625|76212463|FG003|Treatment Period|Adverse Event|8|||
42363182|NCT01951625|76212464|FG004|Treatment Period|Adverse Event|8|||
42363183|NCT01951625|76212460|FG000|Treatment Period|Withdrawal by Subject|5|||
42363184|NCT01951625|76212461|FG001|Treatment Period|Withdrawal by Subject|2|||
42363185|NCT01951625|76212462|FG002|Treatment Period|Withdrawal by Subject|1|||
42363186|NCT01951625|76212463|FG003|Treatment Period|Withdrawal by Subject|7|||
42363187|NCT01951625|76212464|FG004|Treatment Period|Withdrawal by Subject|3|||
42363188|NCT01951625|76212460|FG000|Treatment Period|Lost to Follow-up|1|||
42018456|NCT00996892|75825878|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
42018457|NCT00996892|75825879|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
42018458|NCT00996892|75825880|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
42018459|NCT00996892|75825861|FG000|Expansion Stage 2|Disease Progression|0|||
42018460|NCT00996892|75825862|FG001|Expansion Stage 2|Disease Progression|0|||
42018461|NCT00996892|75825863|FG002|Expansion Stage 2|Disease Progression|0|||
42018462|NCT00996892|75825864|FG003|Expansion Stage 2|Disease Progression|0|||
42018463|NCT00996892|75825865|FG004|Expansion Stage 2|Disease Progression|0|||
42018464|NCT00996892|75825866|FG005|Expansion Stage 2|Disease Progression|0|||
42018465|NCT00996892|75825867|FG006|Expansion Stage 2|Disease Progression|0|||
42018466|NCT00996892|75825868|FG007|Expansion Stage 2|Disease Progression|0|||
42018467|NCT00996892|75825869|FG008|Expansion Stage 2|Disease Progression|0|||
42018468|NCT00996892|75825870|FG009|Expansion Stage 2|Disease Progression|0|||
42018469|NCT00996892|75825871|FG010|Expansion Stage 2|Disease Progression|0|||
42018470|NCT00996892|75825872|FG011|Expansion Stage 2|Disease Progression|0|||
42018471|NCT00996892|75825873|FG012|Expansion Stage 2|Disease Progression|0|||
42018472|NCT00996892|75825874|FG013|Expansion Stage 2|Disease Progression|0|||
42018473|NCT00996892|75825875|FG014|Expansion Stage 2|Disease Progression|0|||
42100288|NCT00369343|75910902|FG000|Open-label Phase|Protocol Violation|1|||
42195941|NCT03567291|76007774|FG003|Period III|Adverse Event|4|||
42363189|NCT01951625|76212461|FG001|Treatment Period|Lost to Follow-up|0|||
42363190|NCT01951625|76212462|FG002|Treatment Period|Lost to Follow-up|0|||
42363191|NCT01951625|76212463|FG003|Treatment Period|Lost to Follow-up|1|||
42363192|NCT01951625|76212464|FG004|Treatment Period|Lost to Follow-up|0|||
42363193|NCT01951625|76212460|FG000|Follow Up Period|Non-compliance with study drug|1|||
42363194|NCT01951625|76212461|FG001|Follow Up Period|Non-compliance with study drug|0|||
42363195|NCT01951625|76212462|FG002|Follow Up Period|Non-compliance with study drug|0|||
42363196|NCT01951625|76212463|FG003|Follow Up Period|Non-compliance with study drug|0|||
42363197|NCT01951625|76212464|FG004|Follow Up Period|Non-compliance with study drug|0|||
42363198|NCT01951625|76212460|FG000|Follow Up Period|Death|1|||
42363199|NCT01951625|76212461|FG001|Follow Up Period|Death|3|||
42363200|NCT01951625|76212462|FG002|Follow Up Period|Death|2|||
42363201|NCT01951625|76212463|FG003|Follow Up Period|Death|2|||
42363202|NCT01951625|76212464|FG004|Follow Up Period|Death|1|||
42363203|NCT01951625|76212460|FG000|Follow Up Period|Logistical difficulties|1|||
42363204|NCT01951625|76212461|FG001|Follow Up Period|Logistical difficulties|2|||
42363205|NCT01951625|76212462|FG002|Follow Up Period|Logistical difficulties|0|||
42363206|NCT01951625|76212463|FG003|Follow Up Period|Logistical difficulties|0|||
42363207|NCT01951625|76212464|FG004|Follow Up Period|Logistical difficulties|0|||
42363208|NCT01951625|76212460|FG000|Follow Up Period|Adverse Event|0|||
42363209|NCT01951625|76212461|FG001|Follow Up Period|Adverse Event|3|||
42363210|NCT01951625|76212462|FG002|Follow Up Period|Adverse Event|2|||
42363211|NCT01951625|76212463|FG003|Follow Up Period|Adverse Event|3|||
42363212|NCT01951625|76212464|FG004|Follow Up Period|Adverse Event|5|||
42363213|NCT01951625|76212460|FG000|Follow Up Period|Withdrawal by Subject|4|||
42363214|NCT01951625|76212461|FG001|Follow Up Period|Withdrawal by Subject|1|||
42363215|NCT01951625|76212462|FG002|Follow Up Period|Withdrawal by Subject|0|||
42363216|NCT01951625|76212463|FG003|Follow Up Period|Withdrawal by Subject|5|||
42363217|NCT01951625|76212464|FG004|Follow Up Period|Withdrawal by Subject|3|||
42363218|NCT01951625|76212460|FG000|Follow Up Period|Lost to Follow-up|1|||
42363219|NCT01951625|76212461|FG001|Follow Up Period|Lost to Follow-up|0|||
42363220|NCT01951625|76212462|FG002|Follow Up Period|Lost to Follow-up|0|||
42363221|NCT01951625|76212463|FG003|Follow Up Period|Lost to Follow-up|1|||
42363222|NCT01951625|76212464|FG004|Follow Up Period|Lost to Follow-up|1|||
42363223|NCT04400890|76212479|FG000|Overall Study|Withdrawal by Subject|3|||
42363224|NCT04400890|76212480|FG001|Overall Study|Withdrawal by Subject|2|||
42363225|NCT01936649|76212486|FG000|Overall Study|Withdrawal by Subject|4|||
42363226|NCT01936649|76212486|FG000|Overall Study|Physician Decision|2|||
42363227|NCT01936649|76212486|FG000|Overall Study|Protocol Violation|2|||
42363228|NCT01936649|76212486|FG000|Overall Study|Other than specified above|5|||
42363229|NCT01720069|76212493|FG000|Overall Study|Could not use e-diary correctly|0|||
42363230|NCT01720069|76212494|FG001|Overall Study|Could not use e-diary correctly|1|||
42363231|NCT01720069|76212495|FG002|Overall Study|Could not use e-diary correctly|1|||
42363232|NCT01720069|76212493|FG000|Overall Study|Randomised without baseline values|0|||
42363233|NCT01720069|76212494|FG001|Overall Study|Randomised without baseline values|0|||
42363234|NCT01720069|76212495|FG002|Overall Study|Randomised without baseline values|1|||
42363235|NCT01720069|76212493|FG000|Overall Study|Adverse Event|0|||
42363236|NCT01720069|76212494|FG001|Overall Study|Adverse Event|0|||
42363237|NCT01720069|76212495|FG002|Overall Study|Adverse Event|1|||
42363238|NCT01720069|76212493|FG000|Overall Study|Lack of Efficacy|0|||
42363239|NCT01720069|76212494|FG001|Overall Study|Lack of Efficacy|4|||
42363240|NCT01720069|76212495|FG002|Overall Study|Lack of Efficacy|0|||
42363241|NCT01720069|76212493|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
42363242|NCT01720069|76212494|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
42363243|NCT01720069|76212495|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
42363244|NCT01720069|76212493|FG000|Overall Study|Withdrawal by Subject|0|||
42363245|NCT01720069|76212494|FG001|Overall Study|Withdrawal by Subject|2|||
42363246|NCT01720069|76212495|FG002|Overall Study|Withdrawal by Subject|1|||
42363247|NCT01720069|76212493|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
42363248|NCT01720069|76212494|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
42363249|NCT01720069|76212495|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
42363250|NCT01720069|76212493|FG000|Overall Study|Non-compliance on using e-diary|0|||
42363251|NCT01720069|76212494|FG001|Overall Study|Non-compliance on using e-diary|0|||
42363252|NCT01720069|76212495|FG002|Overall Study|Non-compliance on using e-diary|1|||
42363253|NCT01720069|76212493|FG000|Overall Study|Lost to Follow-up|0|||
42363254|NCT01720069|76212494|FG001|Overall Study|Lost to Follow-up|0|||
42363255|NCT01720069|76212495|FG002|Overall Study|Lost to Follow-up|1|||
42100289|NCT00369343|75910903|FG001|Open-label Phase|Protocol Violation|3|||
42363256|NCT01719757|76212541|FG000|Overall Study|Adverse Event|38|||
42363257|NCT01719757|76212541|FG000|Overall Study|Withdrawal by Subject|15|||
42363258|NCT01719757|76212541|FG000|Overall Study|Lost to Follow-up|20|||
42363259|NCT01719757|76212541|FG000|Overall Study|Protocol Violation|1|||
42363260|NCT01719757|76212541|FG000|Overall Study|well controlled pain|27|||
42363261|NCT01718509|76212549|FG000|Overall Study|Lost to Follow-up|18|||
42363262|NCT01718509|76212550|FG001|Overall Study|Lost to Follow-up|15|||
42363263|NCT01718509|76212549|FG000|Overall Study|Withdrawal by Subject|7|||
42363264|NCT01718509|76212550|FG001|Overall Study|Withdrawal by Subject|13|||
42363265|NCT01718509|76212549|FG000|Overall Study|Adverse Event|5|||
42363266|NCT01718509|76212550|FG001|Overall Study|Adverse Event|7|||
42363267|NCT01718509|76212549|FG000|Overall Study|Other|13|||
42363268|NCT01718509|76212550|FG001|Overall Study|Other|11|||
42363269|NCT01718509|76212549|FG000|Overall Study|Protocol Violation|4|||
42363270|NCT01718509|76212550|FG001|Overall Study|Protocol Violation|2|||
42363271|NCT01718509|76212549|FG000|Overall Study|Lack of Efficacy|1|||
42363272|NCT01718509|76212550|FG001|Overall Study|Lack of Efficacy|0|||
42363273|NCT01604941|76212589|FG000|Overall Study|Adverse Event|1|||
42363274|NCT01604941|76212590|FG001|Overall Study|Adverse Event|2|||
42363275|NCT01604941|76212591|FG002|Overall Study|Adverse Event|0|||
42363276|NCT01604941|76212592|FG003|Overall Study|Adverse Event|0|||
42363277|NCT01604941|76212593|FG004|Overall Study|Adverse Event|1|||
42363278|NCT01604941|76212594|FG005|Overall Study|Adverse Event|5|||
42363279|NCT01604941|76212589|FG000|Overall Study|Non-compliance|1|||
42363280|NCT01604941|76212590|FG001|Overall Study|Non-compliance|0|||
42363281|NCT01604941|76212591|FG002|Overall Study|Non-compliance|0|||
42363282|NCT01604941|76212592|FG003|Overall Study|Non-compliance|0|||
42363283|NCT01604941|76212593|FG004|Overall Study|Non-compliance|0|||
42363284|NCT01604941|76212594|FG005|Overall Study|Non-compliance|0|||
42363285|NCT01604941|76212589|FG000|Overall Study|Participant Decision|0|||
42363286|NCT01604941|76212590|FG001|Overall Study|Participant Decision|0|||
42363287|NCT01604941|76212591|FG002|Overall Study|Participant Decision|0|||
42363288|NCT01604941|76212592|FG003|Overall Study|Participant Decision|0|||
42363289|NCT01604941|76212593|FG004|Overall Study|Participant Decision|0|||
42363290|NCT01604941|76212594|FG005|Overall Study|Participant Decision|2|||
42363291|NCT01604941|76212589|FG000|Overall Study|Early Study Termination|9|||
42363292|NCT01604941|76212590|FG001|Overall Study|Early Study Termination|2|||
42363293|NCT01604941|76212591|FG002|Overall Study|Early Study Termination|3|||
42363294|NCT01604941|76212592|FG003|Overall Study|Early Study Termination|3|||
42363295|NCT01604941|76212593|FG004|Overall Study|Early Study Termination|0|||
42363296|NCT01604941|76212594|FG005|Overall Study|Early Study Termination|0|||
42363297|NCT01604785|76212602|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
42363298|NCT01604785|76212603|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
42363299|NCT01681849|76212612|FG000|Overall Study|Protocol Violation|2|||
42363300|NCT01681849|76212613|FG001|Overall Study|Protocol Violation|0|||
42363301|NCT01681849|76212614|FG002|Overall Study|Protocol Violation|0|||
42363302|NCT01681849|76212612|FG000|Overall Study|Withdrawal by Subject|3|||
42363303|NCT01681849|76212613|FG001|Overall Study|Withdrawal by Subject|5|||
42363304|NCT01681849|76212614|FG002|Overall Study|Withdrawal by Subject|33|||
42363305|NCT01681849|76212612|FG000|Overall Study|Lost to Follow-up|3|||
42363306|NCT01681849|76212613|FG001|Overall Study|Lost to Follow-up|2|||
42100290|NCT00369343|75910902|FG000|Open-label Phase|Withdrawal by Subject|15|||
42100291|NCT00369343|75910903|FG001|Open-label Phase|Withdrawal by Subject|6|||
42100292|NCT00369343|75910902|FG000|Open-label Phase|Lack of Efficacy|4|||
42100293|NCT00369343|75910903|FG001|Open-label Phase|Lack of Efficacy|3|||
42100294|NCT00369343|75910902|FG000|Open-label Phase|Lack of continuance tolerability|3|||
42363307|NCT01681849|76212614|FG002|Overall Study|Lost to Follow-up|6|||
42363308|NCT01681771|76212623|FG000|Overall Study|Lost to Follow-up|4|||
42363309|NCT01681771|76212624|FG001|Overall Study|Lost to Follow-up|2|||
42363310|NCT04250350|76212630|FG000|Overall Study|Withdrawal by Subject|13|||
42363311|NCT04250350|76212630|FG000|Overall Study|Lost to Follow-up|8|||
42363312|NCT04250350|76212630|FG000|Overall Study|Adverse Event|5|||
42363313|NCT04250350|76212630|FG000|Overall Study|Lack of Efficacy|4|||
42363314|NCT04250350|76212630|FG000|Overall Study|Physician Decision|1|||
42363315|NCT04250350|76212630|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
42363316|NCT01718353|76212661|FG000|Overall Study|Lost to Follow-up|0|||
42363317|NCT01718353|76212662|FG001|Overall Study|Lost to Follow-up|1|||
42363318|NCT01718353|76212661|FG000|Overall Study|Principal Investigator's Decision|10|||
42363319|NCT01718353|76212662|FG001|Overall Study|Principal Investigator's Decision|4|||
42363320|NCT01718353|76212661|FG000|Overall Study|Randomized but not treated|2|||
42363321|NCT01718353|76212662|FG001|Overall Study|Randomized but not treated|0|||
42363322|NCT01716715|76212672|FG000|Overall Study|Never Treated|2|||
42018474|NCT00996892|75825876|FG015|Expansion Stage 2|Disease Progression|0|||
42018475|NCT00996892|75825877|FG016|Expansion Stage 2|Disease Progression|0|||
42018476|NCT00996892|75825878|FG017|Expansion Stage 2|Disease Progression|0|||
42018477|NCT00996892|75825879|FG018|Expansion Stage 2|Disease Progression|28|||
42018478|NCT00996892|75825880|FG019|Expansion Stage 2|Disease Progression|0|||
42018479|NCT00996892|75825861|FG000|Expansion Stage 2A|Adverse Event|0|||
42018480|NCT00996892|75825862|FG001|Expansion Stage 2A|Adverse Event|0|||
42018481|NCT00996892|75825863|FG002|Expansion Stage 2A|Adverse Event|0|||
42363323|NCT01716715|76212673|FG001|Overall Study|Never Treated|4|||
42363324|NCT01697449|76212681|FG000|Overall Study|Disease progression|47|||
42018482|NCT00996892|75825864|FG003|Expansion Stage 2A|Adverse Event|0|||
42363325|NCT01697449|76212681|FG000|Overall Study|Adverse Event|7|||
42363326|NCT01697449|76212681|FG000|Overall Study|Lost to Follow-up|5|||
42363327|NCT01697449|76212681|FG000|Overall Study|Withdrawal by Subject|2|||
42363328|NCT01697449|76212681|FG000|Overall Study|Physician Decision|1|||
42363329|NCT01697449|76212681|FG000|Overall Study|Death|2|||
42363330|NCT01697449|76212681|FG000|Overall Study|Other|1|||
42363331|NCT01697449|76212681|FG000|Overall Study|Missing|25|||
42363332|NCT01696279|76212688|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
42363333|NCT01696279|76212689|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
42363334|NCT01696279|76212690|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
42363335|NCT01696279|76212691|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
42363336|NCT01696279|76212688|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
42363337|NCT01696279|76212689|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
42363338|NCT01696279|76212690|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
42363339|NCT01696279|76212691|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
42363340|NCT01696279|76212688|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
42363341|NCT01696279|76212689|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
42363342|NCT01696279|76212690|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
42363343|NCT01696279|76212691|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
42363344|NCT01696279|76212688|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
42363345|NCT01696279|76212689|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
42363346|NCT01696279|76212690|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
42363347|NCT01696279|76212691|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
42363348|NCT01696279|76212688|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
42363349|NCT01696279|76212689|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
42363350|NCT01696279|76212690|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
42363351|NCT01696279|76212691|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
42363352|NCT01696279|76212688|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
42363353|NCT01696279|76212689|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
42363354|NCT01696279|76212690|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
42363355|NCT01696279|76212691|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
42363356|NCT01696279|76212688|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
42363357|NCT01696279|76212689|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
42363358|NCT01696279|76212690|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
42363359|NCT01696279|76212691|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
42363360|NCT01696279|76212688|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
42363361|NCT01696279|76212689|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
42363362|NCT01696279|76212690|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
42363363|NCT01696279|76212691|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
42363364|NCT01696279|76212688|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
42363365|NCT01696279|76212689|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
42363366|NCT01696279|76212690|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
42363367|NCT01696279|76212691|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
42363368|NCT01696279|76212688|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
42363369|NCT01696279|76212689|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
42363370|NCT01696279|76212690|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
42363371|NCT01696279|76212691|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
42363372|NCT01696279|76212688|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
42195942|NCT03567291|76007771|FG000|Period III|Withdrawal by Subject|0|||
42363373|NCT01696279|76212689|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
42363374|NCT01696279|76212690|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
42363375|NCT01696279|76212691|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
42363376|NCT01681069|76212702|FG000|Overall Study|Withdrawal by Subject|4|||
42363377|NCT01681069|76212703|FG001|Overall Study|Withdrawal by Subject|5|||
42363378|NCT01681069|76212702|FG000|Overall Study|Protocol Violation|1|||
42363379|NCT01681069|76212703|FG001|Overall Study|Protocol Violation|1|||
42363380|NCT01681069|76212702|FG000|Overall Study|Adverse Event|0|||
42363381|NCT01681069|76212703|FG001|Overall Study|Adverse Event|1|||
42363382|NCT01716559|76212709|FG000|Overall Study|Adverse Event|11|||
42363383|NCT01716559|76212709|FG000|Overall Study|Death|21|||
42195943|NCT03567291|76007772|FG001|Period III|Withdrawal by Subject|0|||
42195944|NCT03567291|76007773|FG002|Period III|Withdrawal by Subject|0|||
42363384|NCT01716559|76212709|FG000|Overall Study|Withdrawal by Subject|4|||
42363385|NCT01716559|76212709|FG000|Overall Study|Other withdrawal reason|75|||
42363386|NCT01936181|76212715|FG000|Randomised, Double-blind|Adverse Event|27|||
42363387|NCT01936181|76212716|FG001|Randomised, Double-blind|Adverse Event|21|||
42363388|NCT01936181|76212717|FG002|Randomised, Double-blind|Adverse Event|0|||
42195945|NCT03567291|76007774|FG003|Period III|Withdrawal by Subject|4|||
42195946|NCT03567291|76007771|FG000|Period III|Lost to Follow-up|0|||
42363389|NCT01936181|76212718|FG003|Randomised, Double-blind|Adverse Event|0|||
42363390|NCT01936181|76212715|FG000|Randomised, Double-blind|Protocol Violation|1|||
42363391|NCT01936181|76212716|FG001|Randomised, Double-blind|Protocol Violation|5|||
42363392|NCT01936181|76212717|FG002|Randomised, Double-blind|Protocol Violation|0|||
42363393|NCT01936181|76212718|FG003|Randomised, Double-blind|Protocol Violation|0|||
42363394|NCT01936181|76212715|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
42195947|NCT03567291|76007772|FG001|Period III|Lost to Follow-up|0|||
42195948|NCT03567291|76007773|FG002|Period III|Lost to Follow-up|0|||
42195949|NCT03567291|76007774|FG003|Period III|Lost to Follow-up|1|||
42195950|NCT03567291|76007771|FG000|Period III|Terminated by sponsor|0|||
42195951|NCT03567291|76007772|FG001|Period III|Terminated by sponsor|0|||
42195952|NCT03567291|76007773|FG002|Period III|Terminated by sponsor|0|||
42195953|NCT03567291|76007774|FG003|Period III|Terminated by sponsor|68|||
42195954|NCT03567291|76007771|FG000|Period III|Missing or unknown|0|||
42195955|NCT03567291|76007772|FG001|Period III|Missing or unknown|0|||
42195956|NCT03567291|76007773|FG002|Period III|Missing or unknown|0|||
42195957|NCT03567291|76007774|FG003|Period III|Missing or unknown|8|||
42363395|NCT01936181|76212716|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
42363396|NCT01936181|76212717|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
42363397|NCT01936181|76212718|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
42363398|NCT01936181|76212715|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
42363399|NCT01936181|76212716|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
42363400|NCT01936181|76212717|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
42363401|NCT01936181|76212718|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
42363402|NCT01936181|76212715|FG000|Randomised, Double-blind|Pregnancy|0|||
42363403|NCT01936181|76212716|FG001|Randomised, Double-blind|Pregnancy|1|||
42363404|NCT01936181|76212717|FG002|Randomised, Double-blind|Pregnancy|0|||
42363405|NCT01936181|76212718|FG003|Randomised, Double-blind|Pregnancy|0|||
42363406|NCT01936181|76212715|FG000|Randomised, Double-blind|Physician Decision|4|||
42363407|NCT01936181|76212716|FG001|Randomised, Double-blind|Physician Decision|4|||
42363408|NCT01936181|76212717|FG002|Randomised, Double-blind|Physician Decision|0|||
42363409|NCT01936181|76212718|FG003|Randomised, Double-blind|Physician Decision|0|||
42363410|NCT01936181|76212715|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
42363411|NCT01936181|76212716|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
42363412|NCT01936181|76212717|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
42363413|NCT01936181|76212718|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
42363414|NCT01936181|76212715|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
42363415|NCT01936181|76212716|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
42363416|NCT01936181|76212717|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
42363417|NCT01936181|76212718|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
42363418|NCT01936181|76212715|FG000|Transition-extension|Adverse Event|3|||
42363419|NCT01936181|76212716|FG001|Transition-extension|Adverse Event|0|||
42363420|NCT01936181|76212717|FG002|Transition-extension|Adverse Event|3|||
42363421|NCT01936181|76212718|FG003|Transition-extension|Adverse Event|1|||
42363422|NCT01936181|76212715|FG000|Transition-extension|Lost to Follow-up|3|||
42363423|NCT01936181|76212716|FG001|Transition-extension|Lost to Follow-up|0|||
42363424|NCT01936181|76212717|FG002|Transition-extension|Lost to Follow-up|1|||
42363425|NCT01936181|76212718|FG003|Transition-extension|Lost to Follow-up|2|||
42363426|NCT01936181|76212715|FG000|Transition-extension|Physician Decision|2|||
42363427|NCT01936181|76212716|FG001|Transition-extension|Physician Decision|0|||
42363428|NCT01936181|76212717|FG002|Transition-extension|Physician Decision|0|||
42363429|NCT01936181|76212718|FG003|Transition-extension|Physician Decision|1|||
42363430|NCT01936181|76212715|FG000|Transition-extension|Withdrawal by Subject|7|||
42363431|NCT01936181|76212716|FG001|Transition-extension|Withdrawal by Subject|0|||
42363432|NCT01936181|76212717|FG002|Transition-extension|Withdrawal by Subject|2|||
42363433|NCT01936181|76212718|FG003|Transition-extension|Withdrawal by Subject|1|||
42363434|NCT01696045|76212731|FG000|Overall Study|Study drug toxicity|1|||
42363435|NCT01696045|76212732|FG001|Overall Study|Study drug toxicity|5|||
42363436|NCT01696045|76212731|FG000|Overall Study|Disease progression|2|||
42363437|NCT01696045|76212732|FG001|Overall Study|Disease progression|2|||
42363438|NCT01716169|76212738|FG000|Overall Study|Adverse Event|1|||
42363439|NCT01716169|76212738|FG000|Overall Study|Lost to Follow-up|1|||
42363440|NCT01716169|76212738|FG000|Overall Study|Withdrawal by Subject|1|||
42363441|NCT01716169|76212738|FG000|Overall Study|inconsistent dressing application|1|||
42363442|NCT01935947|76212747|FG000|Overall Study|Adverse Event|0|||
42363443|NCT01935947|76212748|FG001|Overall Study|Adverse Event|2|||
42363444|NCT01935947|76212749|FG002|Overall Study|Adverse Event|0|||
42363445|NCT01935947|76212747|FG000|Overall Study|Diease Progression|2|||
42363446|NCT01935947|76212748|FG001|Overall Study|Diease Progression|2|||
42363447|NCT01935947|76212749|FG002|Overall Study|Diease Progression|2|||
42363448|NCT01935947|76212747|FG000|Overall Study|Death|1|||
42363449|NCT01935947|76212748|FG001|Overall Study|Death|0|||
42195958|NCT02777242|76007780|FG000|Overall Study|Other|2|||
42195959|NCT02777242|76007780|FG000|Overall Study|Lost to Follow-up|1|||
42195960|NCT02777242|76007780|FG000|Overall Study|Multiple|1|||
42363450|NCT01935947|76212749|FG002|Overall Study|Death|0|||
42363451|NCT01618019|76212762|FG000|Overall Study|Withdrawal by Subject|14|||
42195961|NCT02777242|76007780|FG000|Overall Study|Sponsor's request|1|||
42195962|NCT02777242|76007780|FG000|Overall Study|Withdrawal by Subject|1|||
42195963|NCT03212144|76007786|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
42195964|NCT03212144|76007787|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
42195965|NCT03212144|76007786|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
42363452|NCT01618019|76212763|FG001|Overall Study|Withdrawal by Subject|14|||
42363453|NCT01593787|76212772|FG000|Overall Study|Adverse Event|1|||
42363454|NCT01593787|76212773|FG001|Overall Study|Adverse Event|0|||
42363455|NCT01593787|76212774|FG002|Overall Study|Adverse Event|0|||
42363456|NCT01951157|76212787|FG000|Overall Study|Progressive Disease|12|||
42363457|NCT01951157|76212788|FG001|Overall Study|Progressive Disease|13|||
42363458|NCT01951157|76212789|FG002|Overall Study|Progressive Disease|10|||
42363459|NCT01951157|76212787|FG000|Overall Study|Treatment-unrelated AE|1|||
42363460|NCT01951157|76212788|FG001|Overall Study|Treatment-unrelated AE|0|||
42363461|NCT01951157|76212789|FG002|Overall Study|Treatment-unrelated AE|3|||
42363462|NCT01951157|76212787|FG000|Overall Study|Study Termination|0|||
42363463|NCT01951157|76212788|FG001|Overall Study|Study Termination|0|||
42363464|NCT01951157|76212789|FG002|Overall Study|Study Termination|1|||
42363465|NCT01951157|76212787|FG000|Overall Study|Physician Decision|5|||
42363466|NCT01951157|76212788|FG001|Overall Study|Physician Decision|3|||
42363467|NCT01951157|76212789|FG002|Overall Study|Physician Decision|2|||
42363468|NCT01951157|76212787|FG000|Overall Study|Non-treatmentrelated death|2|||
42363469|NCT01951157|76212788|FG001|Overall Study|Non-treatmentrelated death|2|||
42363470|NCT01951157|76212789|FG002|Overall Study|Non-treatmentrelated death|2|||
42363471|NCT01951157|76212787|FG000|Overall Study|No treated|0|||
42363472|NCT01951157|76212788|FG001|Overall Study|No treated|1|||
42363473|NCT01951157|76212789|FG002|Overall Study|No treated|0|||
42363474|NCT01951157|76212787|FG000|Overall Study|Treatment-related AE|2|||
42363475|NCT01951157|76212788|FG001|Overall Study|Treatment-related AE|0|||
42363476|NCT01951157|76212789|FG002|Overall Study|Treatment-related AE|4|||
42363477|NCT01951157|76212787|FG000|Overall Study|Consent withdrawn by subject|0|||
42363478|NCT01951157|76212788|FG001|Overall Study|Consent withdrawn by subject|1|||
42363479|NCT01951157|76212789|FG002|Overall Study|Consent withdrawn by subject|3|||
42363480|NCT01951157|76212787|FG000|Overall Study|Treatment-related death|0|||
42363481|NCT01951157|76212788|FG001|Overall Study|Treatment-related death|2|||
42363482|NCT01951157|76212789|FG002|Overall Study|Treatment-related death|0|||
42363483|NCT01363349|76212800|FG000|Overall Study|Adverse Event|6|||
42363484|NCT01363349|76212801|FG001|Overall Study|Adverse Event|7|||
42363485|NCT01363349|76212800|FG000|Overall Study|Lack of Efficacy|3|||
42363486|NCT01363349|76212801|FG001|Overall Study|Lack of Efficacy|10|||
42363487|NCT01363349|76212800|FG000|Overall Study|Non compliance/Protocol deviations|2|||
42363488|NCT01363349|76212801|FG001|Overall Study|Non compliance/Protocol deviations|2|||
42363489|NCT01363349|76212800|FG000|Overall Study|Withdrawal by Subject|14|||
42363490|NCT01363349|76212801|FG001|Overall Study|Withdrawal by Subject|6|||
42363491|NCT01363349|76212800|FG000|Overall Study|Lost to Follow-up|5|||
42363492|NCT01363349|76212801|FG001|Overall Study|Lost to Follow-up|6|||
42363493|NCT01363349|76212800|FG000|Overall Study|Not reported|36|||
42363494|NCT01363349|76212801|FG001|Overall Study|Not reported|37|||
42363495|NCT01363349|76212800|FG000|Overall Study|missing|1|||
42363496|NCT01363349|76212801|FG001|Overall Study|missing|2|||
42100295|NCT00369343|75910903|FG001|Open-label Phase|Lack of continuance tolerability|4|||
42100296|NCT00369343|75910902|FG000|Open-label Phase|did not take study drug|1|||
42100297|NCT00369343|75910903|FG001|Open-label Phase|did not take study drug|2|||
42100298|NCT00369265|75910918|FG000|Overall Study|Study terminated|4|||
42100299|NCT00369265|75910919|FG001|Overall Study|Study terminated|7|||
42100300|NCT00368875|75910925|FG000|Overall Study|Adverse Event|0|||
42100301|NCT00368875|75910926|FG001|Overall Study|Adverse Event|12|||
42100302|NCT00368875|75910925|FG000|Overall Study|Progressive disease|3|||
42100303|NCT00368875|75910926|FG001|Overall Study|Progressive disease|27|||
42195966|NCT03212144|76007787|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
42195967|NCT03566979|76007797|FG000|Overall Study|Withdrawal by Subject|2|||
42195968|NCT03566979|76007798|FG001|Overall Study|Withdrawal by Subject|0|||
42363497|NCT01933919|76212892|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
42363498|NCT01933919|76212893|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
42363499|NCT01933919|76212892|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
42363500|NCT01933919|76212893|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
42100304|NCT00368875|75910925|FG000|Overall Study|Withdrawal by Subject|2|||
42100305|NCT00368875|75910926|FG001|Overall Study|Withdrawal by Subject|6|||
42100306|NCT00368875|75910925|FG000|Overall Study|Other Reason|0|||
42195969|NCT03566979|76007799|FG002|Overall Study|Withdrawal by Subject|1|||
42363501|NCT01933919|76212892|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
42363502|NCT01933919|76212893|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
42363503|NCT01933919|76212892|FG000|Open-label Long-term Phase|Adverse Event|2|||
42100307|NCT00368875|75910926|FG001|Overall Study|Other Reason|2|||
42195970|NCT03566979|76007800|FG003|Overall Study|Withdrawal by Subject|1|||
42195971|NCT03566979|76007797|FG000|Overall Study|Lost to Follow-up|2|||
42363504|NCT01933919|76212893|FG001|Open-label Long-term Phase|Adverse Event|0|||
42100308|NCT00368875|75910925|FG000|Overall Study|Alternative Therapy|1|||
42100309|NCT00368875|75910926|FG001|Overall Study|Alternative Therapy|1|||
42100310|NCT00614055|75910935|FG000|Overall Study|Adverse Event|1|||
42100311|NCT00614055|75910936|FG001|Overall Study|Adverse Event|0|||
42195972|NCT03566979|76007798|FG001|Overall Study|Lost to Follow-up|7|||
42195973|NCT03566979|76007799|FG002|Overall Study|Lost to Follow-up|9|||
42195974|NCT03566979|76007800|FG003|Overall Study|Lost to Follow-up|5|||
42195975|NCT03566979|76007797|FG000|Overall Study|Adverse Event|1|||
42195976|NCT03566979|76007798|FG001|Overall Study|Adverse Event|0|||
42195977|NCT03566979|76007799|FG002|Overall Study|Adverse Event|0|||
42195978|NCT03566979|76007800|FG003|Overall Study|Adverse Event|0|||
42195979|NCT00116831|76007812|FG000|Overall Study|Adverse Event|14|||
42195980|NCT00116831|76007813|FG001|Overall Study|Adverse Event|16|||
42195981|NCT00116831|76007812|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
42195982|NCT00116831|76007813|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
42195983|NCT00116831|76007812|FG000|Overall Study|Lost to Follow-up|8|||
42195984|NCT00116831|76007813|FG001|Overall Study|Lost to Follow-up|6|||
42195985|NCT00116831|76007812|FG000|Overall Study|Protocol Violation|3|||
42195986|NCT00116831|76007813|FG001|Overall Study|Protocol Violation|6|||
42195987|NCT00116831|76007812|FG000|Overall Study|Hypoglycaemic events|1|||
42100312|NCT00614055|75910937|FG002|Overall Study|Adverse Event|0|||
42100313|NCT00614055|75910935|FG000|Overall Study|Protocol Violation|2|||
42100314|NCT00614055|75910936|FG001|Overall Study|Protocol Violation|2|||
42100315|NCT00614055|75910937|FG002|Overall Study|Protocol Violation|1|||
42100316|NCT00614055|75910935|FG000|Overall Study|Lack of Efficacy|0|||
42100317|NCT00614055|75910936|FG001|Overall Study|Lack of Efficacy|0|||
42100318|NCT00614055|75910937|FG002|Overall Study|Lack of Efficacy|2|||
42100319|NCT00614055|75910935|FG000|Overall Study|Unclassified|1|||
42100320|NCT00614055|75910936|FG001|Overall Study|Unclassified|4|||
42100321|NCT00614055|75910937|FG002|Overall Study|Unclassified|2|||
42100322|NCT00613821|75910950|FG000|Overall Study|Withdrawal by Subject|1|||
42100323|NCT00613821|75910951|FG001|Overall Study|Withdrawal by Subject|0|||
42100324|NCT00613821|75910950|FG000|Overall Study|Physician Decision|1|||
42100325|NCT00613821|75910951|FG001|Overall Study|Physician Decision|1|||
42100326|NCT00548548|75910959|FG000|Overall Study|Death|345|||
42100327|NCT00548548|75910960|FG001|Overall Study|Death|348|||
42100328|NCT00548548|75910959|FG000|Overall Study|Lost to Follow-up|17|||
42100329|NCT00548548|75910960|FG001|Overall Study|Lost to Follow-up|18|||
42100330|NCT00613509|75910968|FG000|Cycle 1|Adverse Event|2|||
42100331|NCT00613509|75910969|FG001|Cycle 1|Adverse Event|1|||
42100332|NCT00613509|75910968|FG000|Cycle 1|Disease Progression|2|||
42100333|NCT00613509|75910969|FG001|Cycle 1|Disease Progression|6|||
42100334|NCT00613509|75910968|FG000|Cycle 1|Unacceptable Toxicity|1|||
42100335|NCT00613509|75910969|FG001|Cycle 1|Unacceptable Toxicity|0|||
42100336|NCT00613509|75910968|FG000|Cycle 1|Other administrative reason|0|||
42100337|NCT00613509|75910969|FG001|Cycle 1|Other administrative reason|1|||
42100338|NCT00547300|75910994|FG000|Overall Study|Study was Administratively Terminated|25|||
42100339|NCT00547300|75910995|FG001|Overall Study|Study was Administratively Terminated|24|||
42100340|NCT00547300|75910994|FG000|Overall Study|Did not Meet Entry Criteria|0|||
42100341|NCT00547300|75910995|FG001|Overall Study|Did not Meet Entry Criteria|2|||
42100342|NCT00612807|75911003|FG000|Overall Study|Withdrawal by Subject|2|||
42100343|NCT00612807|75911004|FG001|Overall Study|Withdrawal by Subject|0|||
42100344|NCT00678210|75911014|FG000|Overall Study|Adverse Event|1|||
42100345|NCT00678210|75911015|FG001|Overall Study|Adverse Event|2|||
42195988|NCT00116831|76007813|FG001|Overall Study|Hypoglycaemic events|0|||
42195989|NCT00116831|76007812|FG000|Overall Study|Low haemoglobin on screening|1|||
42195990|NCT00116831|76007813|FG001|Overall Study|Low haemoglobin on screening|0|||
42195991|NCT00116831|76007812|FG000|Overall Study|Withdrawn investigational product|1|||
42195992|NCT00116831|76007813|FG001|Overall Study|Withdrawn investigational product|0|||
42195993|NCT00116831|76007812|FG000|Overall Study|Withdrawal by Subject|32|||
42195994|NCT00116831|76007813|FG001|Overall Study|Withdrawal by Subject|32|||
42100346|NCT00678210|75911016|FG002|Overall Study|Adverse Event|3|||
42100347|NCT00678210|75911017|FG003|Overall Study|Adverse Event|3|||
42100348|NCT00678210|75911014|FG000|Overall Study|Lack of Efficacy|2|||
42100349|NCT00678210|75911015|FG001|Overall Study|Lack of Efficacy|3|||
42100350|NCT00678210|75911016|FG002|Overall Study|Lack of Efficacy|1|||
42100351|NCT00678210|75911017|FG003|Overall Study|Lack of Efficacy|9|||
42100352|NCT00678210|75911014|FG000|Overall Study|Lost to Follow-up|4|||
42100353|NCT00678210|75911015|FG001|Overall Study|Lost to Follow-up|2|||
42100354|NCT00678210|75911016|FG002|Overall Study|Lost to Follow-up|0|||
42100355|NCT00678210|75911017|FG003|Overall Study|Lost to Follow-up|1|||
42195995|NCT00116831|76007812|FG000|Overall Study|Insufficient therapeutic effect|0|||
42195996|NCT00116831|76007813|FG001|Overall Study|Insufficient therapeutic effect|1|||
42100356|NCT00678210|75911014|FG000|Overall Study|Withdrawal by Subject|3|||
42100357|NCT00678210|75911015|FG001|Overall Study|Withdrawal by Subject|4|||
42195997|NCT00116831|76007812|FG000|Overall Study|Missing data for participant|1|||
42195998|NCT00116831|76007813|FG001|Overall Study|Missing data for participant|0|||
42195999|NCT02777086|76007821|FG000|Overall Study|Lost to Follow-up|96|||
42196000|NCT02777086|76007822|FG001|Overall Study|Lost to Follow-up|99|||
42196001|NCT03549429|76007830|FG000|Overall Study|Protocol Violation|5|||
42196002|NCT03549429|76007831|FG001|Overall Study|Protocol Violation|3|||
42196003|NCT02784704|76007841|FG000|Overall Study|Adverse Event|4|||
42196004|NCT02784704|76007842|FG001|Overall Study|Adverse Event|2|||
42196005|NCT02784704|76007841|FG000|Overall Study|Lost to Follow-up|6|||
42196006|NCT02784704|76007842|FG001|Overall Study|Lost to Follow-up|4|||
42196007|NCT02784704|76007841|FG000|Overall Study|Withdrawal by Subject|1|||
42363505|NCT01933919|76212892|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
42363506|NCT01933919|76212893|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
42363507|NCT01933919|76212892|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
42363508|NCT01933919|76212893|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
42363509|NCT01933919|76212892|FG000|Open-label Long-term Phase|Other|1|||
42363510|NCT01933919|76212893|FG001|Open-label Long-term Phase|Other|2|||
42363511|NCT01933217|76212922|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
42363512|NCT01933217|76212923|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
42363513|NCT01933217|76212922|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
42363514|NCT01933217|76212923|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
42363515|NCT01932437|76212933|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
42363516|NCT01932437|76212934|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
42363517|NCT01932437|76212935|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
42363518|NCT01932437|76212936|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
42363519|NCT01932437|76212937|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
42363520|NCT01932437|76212938|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
42363521|NCT01949051|76212959|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
42363522|NCT01949051|76212960|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
42363523|NCT01949051|76212961|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
42363524|NCT01949051|76212962|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
42100358|NCT00678210|75911016|FG002|Overall Study|Withdrawal by Subject|1|||
42100359|NCT00678210|75911017|FG003|Overall Study|Withdrawal by Subject|7|||
42363525|NCT01949051|76212963|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
42363526|NCT01949051|76212964|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
42363527|NCT01949051|76212959|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
42363528|NCT01949051|76212960|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42363529|NCT01949051|76212961|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42363530|NCT01949051|76212962|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42100360|NCT00678210|75911014|FG000|Overall Study|Other|1|||
42100361|NCT00678210|75911015|FG001|Overall Study|Other|0|||
42100362|NCT00678210|75911016|FG002|Overall Study|Other|1|||
42100363|NCT00678210|75911017|FG003|Overall Study|Other|0|||
42100364|NCT00611715|75911029|FG000|Overall Study|Disease Progression|24|||
42100365|NCT00611715|75911030|FG001|Overall Study|Disease Progression|4|||
42100366|NCT00611715|75911029|FG000|Overall Study|Withdrawal by Subject|5|||
42100367|NCT00611715|75911030|FG001|Overall Study|Withdrawal by Subject|1|||
42100368|NCT00611715|75911029|FG000|Overall Study|Adverse Event|9|||
42100369|NCT00611715|75911030|FG001|Overall Study|Adverse Event|1|||
42196008|NCT02784704|76007842|FG001|Overall Study|Withdrawal by Subject|3|||
42196009|NCT02784704|76007841|FG000|Overall Study|Subject Non Compliance|2|||
42196010|NCT02784704|76007842|FG001|Overall Study|Subject Non Compliance|0|||
42196011|NCT03566823|76007853|FG000|Overall Study|Lack of Efficacy|0|||
42196012|NCT03566823|76007854|FG001|Overall Study|Lack of Efficacy|1|||
42363531|NCT01949051|76212963|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42363532|NCT01949051|76212964|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42363533|NCT01949051|76212959|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
42100370|NCT00611715|75911029|FG000|Overall Study|Death|1|||
42100371|NCT00611715|75911030|FG001|Overall Study|Death|0|||
42196013|NCT03566823|76007855|FG002|Overall Study|Lack of Efficacy|0|||
42196014|NCT03566823|76007853|FG000|Overall Study|Withdrawal by Subject|1|||
42196015|NCT03566823|76007854|FG001|Overall Study|Withdrawal by Subject|2|||
42196016|NCT03566823|76007855|FG002|Overall Study|Withdrawal by Subject|0|||
42196017|NCT03566823|76007853|FG000|Overall Study|Adverse Event|1|||
42196018|NCT03566823|76007854|FG001|Overall Study|Adverse Event|0|||
42196019|NCT03566823|76007855|FG002|Overall Study|Adverse Event|2|||
42196020|NCT03549117|76007865|FG000|Overall Study|Withdrawal by Subject|1|||
42196021|NCT03549117|76007866|FG001|Overall Study|Withdrawal by Subject|0|||
42363534|NCT01949051|76212960|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
42363535|NCT01949051|76212961|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
42363536|NCT01949051|76212962|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
42363537|NCT01949051|76212963|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
42363538|NCT01949051|76212964|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
42363539|NCT01949051|76212959|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
42363540|NCT01949051|76212960|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
42363541|NCT01949051|76212961|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
42363542|NCT01949051|76212962|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
42363543|NCT01949051|76212963|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
42363544|NCT01949051|76212964|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
42363545|NCT01949051|76212959|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
42363546|NCT01949051|76212960|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
42363547|NCT01949051|76212961|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
42363548|NCT01949051|76212962|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
42363549|NCT01949051|76212963|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
42363550|NCT01949051|76212964|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
42363551|NCT01948427|76212977|FG000|Overall Study|Serious Adverse Event|3|||
42363552|NCT01948427|76212978|FG001|Overall Study|Serious Adverse Event|0|||
42363553|NCT01948427|76212979|FG002|Overall Study|Serious Adverse Event|0|||
42363554|NCT01948427|76212980|FG003|Overall Study|Serious Adverse Event|0|||
42363555|NCT01948427|76212981|FG004|Overall Study|Serious Adverse Event|1|||
42363556|NCT01948427|76212977|FG000|Overall Study|Investigator Request|0|||
42363557|NCT01948427|76212978|FG001|Overall Study|Investigator Request|8|||
42363558|NCT01948427|76212979|FG002|Overall Study|Investigator Request|0|||
42363559|NCT01948427|76212980|FG003|Overall Study|Investigator Request|0|||
42363560|NCT01948427|76212981|FG004|Overall Study|Investigator Request|6|||
42363561|NCT01948427|76212977|FG000|Overall Study|Lost to Follow-up|1|||
42363562|NCT01948427|76212978|FG001|Overall Study|Lost to Follow-up|0|||
42363563|NCT01948427|76212979|FG002|Overall Study|Lost to Follow-up|0|||
42363564|NCT01948427|76212980|FG003|Overall Study|Lost to Follow-up|0|||
42363565|NCT01948427|76212981|FG004|Overall Study|Lost to Follow-up|4|||
42363566|NCT01948427|76212977|FG000|Overall Study|Withdrawal by Subject|2|||
42363567|NCT01948427|76212978|FG001|Overall Study|Withdrawal by Subject|0|||
42363568|NCT01948427|76212979|FG002|Overall Study|Withdrawal by Subject|0|||
42363569|NCT01948427|76212980|FG003|Overall Study|Withdrawal by Subject|0|||
42363570|NCT01948427|76212981|FG004|Overall Study|Withdrawal by Subject|1|||
42363571|NCT01948427|76212977|FG000|Overall Study|Other, Not Specified|1|||
42363572|NCT01948427|76212978|FG001|Overall Study|Other, Not Specified|9|||
42363573|NCT01948427|76212979|FG002|Overall Study|Other, Not Specified|0|||
42363574|NCT01948427|76212980|FG003|Overall Study|Other, Not Specified|0|||
42363575|NCT01948427|76212981|FG004|Overall Study|Other, Not Specified|2|||
42363576|NCT01948193|76212998|FG000|Overall Study|Serious event|2|||
42363577|NCT01948193|76212998|FG000|Overall Study|Lost to Follow-up|7|||
42363578|NCT01694485|76213008|FG000|Overall Study|Withdrawal by Subject|20|||
42363579|NCT01694485|76213009|FG001|Overall Study|Withdrawal by Subject|6|||
42363580|NCT01694485|76213010|FG002|Overall Study|Withdrawal by Subject|7|||
42363581|NCT01694485|76213011|FG003|Overall Study|Withdrawal by Subject|25|||
42363582|NCT01694485|76213012|FG004|Overall Study|Withdrawal by Subject|18|||
42363583|NCT01694485|76213008|FG000|Overall Study|Sponsor Decision|3|||
42363584|NCT01694485|76213009|FG001|Overall Study|Sponsor Decision|0|||
42363585|NCT01694485|76213010|FG002|Overall Study|Sponsor Decision|0|||
42363586|NCT01694485|76213011|FG003|Overall Study|Sponsor Decision|2|||
42363587|NCT01694485|76213012|FG004|Overall Study|Sponsor Decision|0|||
42363588|NCT01694485|76213008|FG000|Overall Study|Lost to Follow-up|9|||
42363589|NCT01694485|76213009|FG001|Overall Study|Lost to Follow-up|1|||
42363590|NCT01694485|76213010|FG002|Overall Study|Lost to Follow-up|6|||
42363591|NCT01694485|76213011|FG003|Overall Study|Lost to Follow-up|10|||
42363592|NCT01694485|76213012|FG004|Overall Study|Lost to Follow-up|7|||
42196022|NCT03183908|76007874|FG000|Overall Study|Missing Symptom Diary Data|0|||
42363593|NCT01694485|76213008|FG000|Overall Study|Death|1|||
42363594|NCT01694485|76213009|FG001|Overall Study|Death|0|||
42363595|NCT01694485|76213010|FG002|Overall Study|Death|0|||
42363596|NCT01694485|76213011|FG003|Overall Study|Death|1|||
42363597|NCT01694485|76213012|FG004|Overall Study|Death|0|||
42363598|NCT01931735|76213033|FG000|Randomized Phase|Lost to Follow-up|2|||
42363599|NCT01931735|76213034|FG001|Randomized Phase|Lost to Follow-up|2|||
42363600|NCT01931735|76213035|FG002|Randomized Phase|Lost to Follow-up|5|||
42363601|NCT01931735|76213036|FG003|Randomized Phase|Lost to Follow-up|0|||
42363602|NCT01931735|76213033|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
42363603|NCT01931735|76213034|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
42363604|NCT01931735|76213035|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
42363605|NCT01931735|76213036|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
42363606|NCT01931735|76213033|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
42363607|NCT01931735|76213034|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
42363608|NCT01931735|76213035|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
42363609|NCT01931735|76213036|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
42196023|NCT03183908|76007875|FG001|Overall Study|Missing Symptom Diary Data|2|||
42196024|NCT03565887|76007887|FG000|Overall Study|Adverse Event|1|||
42196025|NCT03565887|76007888|FG001|Overall Study|Adverse Event|0|||
42196026|NCT03565887|76007887|FG000|Overall Study|Withdrawal by Subject|0|||
42196027|NCT03565887|76007888|FG001|Overall Study|Withdrawal by Subject|2|||
42196028|NCT03183518|76007894|FG000|Overall Study|Other (Not specified)|2|||
42196029|NCT03183518|76007894|FG000|Overall Study|Other (Withdrawal of consent)|1|||
42196030|NCT00116753|76007902|FG000|Overall Study|Adverse Event|16|||
42196031|NCT00116753|76007903|FG001|Overall Study|Adverse Event|10|||
42196032|NCT00116753|76007904|FG002|Overall Study|Adverse Event|7|||
42196033|NCT00116753|76007902|FG000|Overall Study|Withdrawal by Subject|11|||
42196034|NCT00116753|76007903|FG001|Overall Study|Withdrawal by Subject|12|||
42196035|NCT00116753|76007904|FG002|Overall Study|Withdrawal by Subject|8|||
42196036|NCT00116753|76007902|FG000|Overall Study|Lost to Follow-up|0|||
42196037|NCT00116753|76007903|FG001|Overall Study|Lost to Follow-up|2|||
42196038|NCT00116753|76007904|FG002|Overall Study|Lost to Follow-up|1|||
42196039|NCT00116753|76007902|FG000|Overall Study|Protocol Violation|0|||
42196040|NCT00116753|76007903|FG001|Overall Study|Protocol Violation|0|||
42196041|NCT00116753|76007904|FG002|Overall Study|Protocol Violation|1|||
42196042|NCT00116753|76007902|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
42196043|NCT00116753|76007903|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
42196044|NCT00116753|76007904|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
42196045|NCT00116753|76007902|FG000|Overall Study|Disease Progression|3|||
42196046|NCT00116753|76007903|FG001|Overall Study|Disease Progression|4|||
42196047|NCT00116753|76007904|FG002|Overall Study|Disease Progression|3|||
42196048|NCT00116753|76007902|FG000|Overall Study|Abnormal Echocardiogram|0|||
42196049|NCT00116753|76007903|FG001|Overall Study|Abnormal Echocardiogram|0|||
42196050|NCT00116753|76007904|FG002|Overall Study|Abnormal Echocardiogram|1|||
42196051|NCT00116753|76007902|FG000|Overall Study|Progressive Parkinson's Disease|1|||
42196052|NCT00116753|76007903|FG001|Overall Study|Progressive Parkinson's Disease|0|||
42196053|NCT00116753|76007904|FG002|Overall Study|Progressive Parkinson's Disease|0|||
42363610|NCT01930799|76213046|FG000|Overall Study|Withdrawal by Subject|3|||
42100372|NCT00611715|75911029|FG000|Overall Study|two patients are still on treatment|2|||
42100373|NCT00611715|75911030|FG001|Overall Study|two patients are still on treatment|0|||
42100374|NCT00677820|75911044|FG000|Overall Study|Lost to Follow-up|1|||
42100375|NCT00677820|75911045|FG001|Overall Study|Lost to Follow-up|0|||
42100376|NCT00611559|75911054|FG000|Overall Study|Lost to Follow-up|0|||
42100377|NCT00611559|75911055|FG001|Overall Study|Lost to Follow-up|1|||
42100378|NCT00611559|75911056|FG002|Overall Study|Lost to Follow-up|0|||
42100379|NCT00611559|75911054|FG000|Overall Study|Protocol Violation|1|||
42100380|NCT00611559|75911055|FG001|Overall Study|Protocol Violation|0|||
42100381|NCT00611559|75911056|FG002|Overall Study|Protocol Violation|1|||
42100382|NCT00611247|75911066|FG000|Overall Study|Death|1|||
42100383|NCT00611247|75911067|FG001|Overall Study|Death|5|||
42100384|NCT00611247|75911066|FG000|Overall Study|Lack of Efficacy|1|||
42100385|NCT00611247|75911067|FG001|Overall Study|Lack of Efficacy|16|||
42100386|NCT00675948|75911076|FG000|Overall Study|Adverse Event|23|||
42100387|NCT00675948|75911077|FG001|Overall Study|Adverse Event|1|||
42100388|NCT00675948|75911076|FG000|Overall Study|Lack of Efficacy|3|||
42100389|NCT00675948|75911077|FG001|Overall Study|Lack of Efficacy|0|||
42100390|NCT00675948|75911076|FG000|Overall Study|Withdrawal by Subject|7|||
42100391|NCT00675948|75911077|FG001|Overall Study|Withdrawal by Subject|0|||
42100392|NCT00675948|75911076|FG000|Overall Study|Lost to Follow-up|2|||
42100393|NCT00675948|75911077|FG001|Overall Study|Lost to Follow-up|0|||
42100394|NCT00675948|75911076|FG000|Overall Study|Protocol Violation|1|||
42100395|NCT00675948|75911077|FG001|Overall Study|Protocol Violation|0|||
42100396|NCT00675948|75911076|FG000|Overall Study|Pain under control|1|||
42100397|NCT00675948|75911077|FG001|Overall Study|Pain under control|0|||
42100398|NCT00675948|75911076|FG000|Overall Study|Sponsor decision|0|||
42196054|NCT00116753|76007902|FG000|Overall Study|Dosing Error|0|||
42100399|NCT00675948|75911077|FG001|Overall Study|Sponsor decision|1|||
42100400|NCT00675948|75911076|FG000|Overall Study|Patient died|1|||
42100401|NCT00675948|75911077|FG001|Overall Study|Patient died|0|||
42100402|NCT00675948|75911076|FG000|Overall Study|Patient unable to comply with diaries|1|||
42100403|NCT00675948|75911077|FG001|Overall Study|Patient unable to comply with diaries|0|||
42196055|NCT00116753|76007903|FG001|Overall Study|Dosing Error|1|||
42196056|NCT00116753|76007904|FG002|Overall Study|Dosing Error|0|||
42100404|NCT00675948|75911076|FG000|Overall Study|Patient feels unable to take medication|0|||
42196057|NCT00113399|76007914|FG000|Overall Study|Death|1|||
42196058|NCT00113399|76007915|FG001|Overall Study|Death|1|||
42196059|NCT00113399|76007914|FG000|Overall Study|Withdrawal by Subject|1|||
42196060|NCT00113399|76007915|FG001|Overall Study|Withdrawal by Subject|2|||
42196061|NCT00113399|76007914|FG000|Overall Study|Complete Response|0|||
42196062|NCT00113399|76007915|FG001|Overall Study|Complete Response|1|||
42196063|NCT00113399|76007914|FG000|Overall Study|Other|0|||
42196064|NCT00113399|76007915|FG001|Overall Study|Other|1|||
42196065|NCT00113087|76007923|FG000|Overall Study|Death or Transplant|14|||
42196066|NCT00113087|76007924|FG001|Overall Study|Death or Transplant|16|||
42196067|NCT00113087|76007923|FG000|Overall Study|Family or MD withdrew subject|10|||
42196068|NCT00113087|76007924|FG001|Overall Study|Family or MD withdrew subject|5|||
42196069|NCT00112463|76007930|FG000|Overall Study|Physician Decision|1|||
42100405|NCT00675948|75911077|FG001|Overall Study|Patient feels unable to take medication|1|||
42100406|NCT00610935|75911086|FG000|Overall Study|Lost to Follow-up|0|||
42100407|NCT00610935|75911087|FG001|Overall Study|Lost to Follow-up|1|||
42100408|NCT00610935|75911086|FG000|Overall Study|Withdrawal by Subject|0|||
42100409|NCT00610935|75911087|FG001|Overall Study|Withdrawal by Subject|2|||
42100410|NCT00610935|75911086|FG000|Overall Study|Sponsor Discontinuation|1|||
42100411|NCT00610935|75911087|FG001|Overall Study|Sponsor Discontinuation|0|||
42100412|NCT00610857|75911102|FG000|Overall Study|Not evaluable for response|2|||
42100413|NCT00672984|75911109|FG000|First Intervention|Adverse Event|5|||
42100414|NCT00672984|75911110|FG001|First Intervention|Adverse Event|0|||
42100415|NCT00672984|75911111|FG002|First Intervention|Adverse Event|0|||
42100416|NCT00672984|75911109|FG000|First Intervention|Withdrawal by Subject|1|||
42100417|NCT00672984|75911110|FG001|First Intervention|Withdrawal by Subject|2|||
42100418|NCT00672984|75911111|FG002|First Intervention|Withdrawal by Subject|2|||
42100419|NCT00672984|75911109|FG000|First Intervention|Sponsor decision|3|||
42100420|NCT00672984|75911110|FG001|First Intervention|Sponsor decision|0|||
42100421|NCT00672984|75911111|FG002|First Intervention|Sponsor decision|0|||
42100422|NCT00672984|75911109|FG000|Second Intervention|Non-compliance with facility policies|0|||
42100423|NCT00672984|75911110|FG001|Second Intervention|Non-compliance with facility policies|2|||
42100424|NCT00672984|75911111|FG002|Second Intervention|Non-compliance with facility policies|0|||
42100425|NCT00672984|75911109|FG000|Second Intervention|Withdrawal by Subject|0|||
42100426|NCT00672984|75911110|FG001|Second Intervention|Withdrawal by Subject|3|||
42100427|NCT00672984|75911111|FG002|Second Intervention|Withdrawal by Subject|0|||
42100428|NCT00672984|75911109|FG000|Second Intervention|Protocol Violation|0|||
42100429|NCT00672984|75911110|FG001|Second Intervention|Protocol Violation|1|||
42100430|NCT00672984|75911111|FG002|Second Intervention|Protocol Violation|1|||
42100431|NCT00672984|75911109|FG000|Third Intervention|Adverse Event|1|||
42100432|NCT00672984|75911110|FG001|Third Intervention|Adverse Event|0|||
42100433|NCT00672984|75911111|FG002|Third Intervention|Adverse Event|1|||
42100434|NCT00546364|75911124|FG000|Overall Study|Disease progression|5|||
42100435|NCT00546364|75911125|FG001|Overall Study|Disease progression|11|||
42100436|NCT00546364|75911126|FG002|Overall Study|Disease progression|8|||
42100437|NCT00546364|75911124|FG000|Overall Study|Completed and off treatment|1|||
42100438|NCT00546364|75911125|FG001|Overall Study|Completed and off treatment|0|||
42100439|NCT00546364|75911126|FG002|Overall Study|Completed and off treatment|2|||
42100440|NCT00546364|75911124|FG000|Overall Study|Administrative reason by sponsor|1|||
42100441|NCT00546364|75911125|FG001|Overall Study|Administrative reason by sponsor|0|||
42100442|NCT00546364|75911126|FG002|Overall Study|Administrative reason by sponsor|0|||
42100443|NCT00546364|75911124|FG000|Overall Study|Poor compliance/noncompliance|0|||
42100444|NCT00546364|75911125|FG001|Overall Study|Poor compliance/noncompliance|0|||
42100445|NCT00546364|75911126|FG002|Overall Study|Poor compliance/noncompliance|1|||
42100446|NCT00546364|75911124|FG000|Overall Study|No longer meets study criteria|1|||
42100447|NCT00546364|75911125|FG001|Overall Study|No longer meets study criteria|1|||
42100448|NCT00546364|75911126|FG002|Overall Study|No longer meets study criteria|0|||
42100449|NCT00546364|75911124|FG000|Overall Study|Withdrawal by Subject|5|||
42100450|NCT00546364|75911125|FG001|Overall Study|Withdrawal by Subject|6|||
42100451|NCT00546364|75911126|FG002|Overall Study|Withdrawal by Subject|3|||
42100452|NCT00546364|75911124|FG000|Overall Study|Prior taxotere|1|||
42100453|NCT00546364|75911125|FG001|Overall Study|Prior taxotere|0|||
42100454|NCT00546364|75911126|FG002|Overall Study|Prior taxotere|0|||
42100455|NCT00546364|75911124|FG000|Overall Study|Mixed response|1|||
42100456|NCT00546364|75911125|FG001|Overall Study|Mixed response|0|||
42363611|NCT01930799|76213046|FG000|Overall Study|Lost to Follow-up|5|||
42100457|NCT00546364|75911126|FG002|Overall Study|Mixed response|0|||
42100458|NCT00546364|75911124|FG000|Overall Study|Palliative treatment|1|||
42100459|NCT00546364|75911125|FG001|Overall Study|Palliative treatment|0|||
42100460|NCT00546364|75911126|FG002|Overall Study|Palliative treatment|1|||
42100461|NCT00546364|75911124|FG000|Overall Study|Target lesions resected|1|||
42100462|NCT00546364|75911125|FG001|Overall Study|Target lesions resected|0|||
42100463|NCT00546364|75911126|FG002|Overall Study|Target lesions resected|0|||
42100464|NCT00546364|75911124|FG000|Overall Study|Physician Decision|0|||
42100465|NCT00546364|75911125|FG001|Overall Study|Physician Decision|0|||
42100466|NCT00546364|75911126|FG002|Overall Study|Physician Decision|1|||
42100467|NCT00546364|75911124|FG000|Overall Study|Sponsor decision|0|||
42196070|NCT00112463|76007930|FG000|Overall Study|Progression|30|||
42196071|NCT00112463|76007930|FG000|Overall Study|Second Primary|1|||
42196072|NCT00112463|76007930|FG000|Overall Study|Toxicity|3|||
42100468|NCT00546364|75911125|FG001|Overall Study|Sponsor decision|0|||
42363612|NCT01947491|76213054|FG000|Overall Study|Lost to Follow-up|5|||
42363613|NCT01947491|76213055|FG001|Overall Study|Lost to Follow-up|3|||
42100469|NCT00546364|75911126|FG002|Overall Study|Sponsor decision|1|||
42100470|NCT05020327|75911145|FG000|Overall Study|Physician Decision|3|||
42100471|NCT05020327|75911146|FG001|Overall Study|Physician Decision|0|||
42100472|NCT05020327|75911147|FG002|Overall Study|Physician Decision|0|||
42100473|NCT05020327|75911145|FG000|Overall Study|Withdrawal by Subject|1|||
42100474|NCT05020327|75911146|FG001|Overall Study|Withdrawal by Subject|1|||
42100475|NCT05020327|75911147|FG002|Overall Study|Withdrawal by Subject|0|||
42100476|NCT05020327|75911145|FG000|Overall Study|personal/cultural, ineligible|12|||
42100477|NCT05020327|75911146|FG001|Overall Study|personal/cultural, ineligible|0|||
42100478|NCT05020327|75911147|FG002|Overall Study|personal/cultural, ineligible|0|||
42100479|NCT04907032|75911161|FG000|Overall Study|Withdrawal by Subject|7|||
42100480|NCT04907032|75911162|FG001|Overall Study|Withdrawal by Subject|1|||
42100481|NCT04739709|75911183|FG000|Overall Study|Physician Decision|1|||
42100482|NCT04739709|75911184|FG001|Overall Study|Physician Decision|0|||
42100483|NCT04710927|75911201|FG000|Overall Study|Lost to Follow-up|7|||
42100484|NCT04710927|75911202|FG001|Overall Study|Lost to Follow-up|6|||
42100485|NCT04710927|75911203|FG002|Overall Study|Lost to Follow-up|5|||
42100486|NCT04657666|75911214|FG000|Period 1|Withdrawal of participant consent|2|||
42100487|NCT04657666|75911215|FG001|Period 1|Withdrawal of participant consent|1|||
42100488|NCT04657666|75911214|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
42100489|NCT04657666|75911215|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
42100490|NCT04657666|75911214|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
42100491|NCT04657666|75911215|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
42100492|NCT04657666|75911214|FG000|Period 2|Other|2|||
42100493|NCT04657666|75911215|FG001|Period 2|Other|0|||
42100494|NCT04657666|75911214|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
42100495|NCT04657666|75911215|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
42100496|NCT04495829|75911234|FG000|Overall Study|Lost to Follow-up|2|||
42100497|NCT04495829|75911234|FG000|Overall Study|Inclusion criterion not met|3|||
42100498|NCT04101721|75911249|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
42100499|NCT04101721|75911250|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
42100500|NCT04101721|75911249|FG000|Overall Study|Death|0|||
42100501|NCT04101721|75911250|FG001|Overall Study|Death|1|||
42100502|NCT04101721|75911249|FG000|Overall Study|Lost to Follow-up|0|||
42100503|NCT04101721|75911250|FG001|Overall Study|Lost to Follow-up|3|||
42100504|NCT03864926|75911258|FG000|Overall Study|Death|0|||
42100505|NCT03864926|75911259|FG001|Overall Study|Death|2|||
42100506|NCT03623243|75911274|FG000|Overall Study|Adverse Event|15|||
42100507|NCT03623243|75911274|FG000|Overall Study|Guardian Decision|1|||
42100508|NCT03623243|75911274|FG000|Overall Study|New Therapy for Study Indication|1|||
42100509|NCT03623243|75911274|FG000|Overall Study|Protocol Deviation|3|||
42100510|NCT03623243|75911274|FG000|Overall Study|Physician Decision|4|||
42100511|NCT03623243|75911274|FG000|Overall Study|Patient Decision|15|||
42100512|NCT03258853|75911280|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
42100513|NCT03258853|75911281|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
42100514|NCT03006848|75911333|FG000|Overall Study|Adverse Event|1|||
42100515|NCT03006848|75911333|FG000|Overall Study|Physician Decision|1|||
42100516|NCT03006848|75911333|FG000|Overall Study|Lack of Efficacy|16|||
42100517|NCT02810444|75911371|FG000|Overall Study|Screen Failures|14|||
42100518|NCT02810444|75911371|FG000|Overall Study|Withdrawal by Subject|4|||
42100519|NCT02810444|75911371|FG000|Overall Study|Adverse Event|3|||
42100520|NCT02501096|75911397|FG000|Overall Study|Lost to Follow-up|0|||
42100521|NCT02501096|75911398|FG001|Overall Study|Lost to Follow-up|0|||
42100522|NCT02501096|75911399|FG002|Overall Study|Lost to Follow-up|0|||
42100523|NCT02501096|75911400|FG003|Overall Study|Lost to Follow-up|0|||
42100524|NCT02501096|75911401|FG004|Overall Study|Lost to Follow-up|1|||
42100525|NCT02501096|75911402|FG005|Overall Study|Lost to Follow-up|1|||
42100526|NCT02501096|75911403|FG006|Overall Study|Lost to Follow-up|3|||
42100527|NCT02501096|75911404|FG007|Overall Study|Lost to Follow-up|0|||
42100528|NCT02501096|75911405|FG008|Overall Study|Lost to Follow-up|0|||
42100529|NCT02501096|75911397|FG000|Overall Study|Withdrawal by Subject|1|||
42100530|NCT02501096|75911398|FG001|Overall Study|Withdrawal by Subject|0|||
42100531|NCT02501096|75911399|FG002|Overall Study|Withdrawal by Subject|7|||
42100532|NCT02501096|75911400|FG003|Overall Study|Withdrawal by Subject|13|||
42100533|NCT02501096|75911401|FG004|Overall Study|Withdrawal by Subject|2|||
42100534|NCT02501096|75911402|FG005|Overall Study|Withdrawal by Subject|2|||
42100535|NCT02501096|75911403|FG006|Overall Study|Withdrawal by Subject|2|||
42100536|NCT02501096|75911404|FG007|Overall Study|Withdrawal by Subject|3|||
42100537|NCT02501096|75911405|FG008|Overall Study|Withdrawal by Subject|0|||
42100538|NCT02501096|75911397|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
42100539|NCT02501096|75911398|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
42100540|NCT02501096|75911399|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
42100541|NCT02501096|75911400|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
42100542|NCT02501096|75911401|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
42196073|NCT00112463|76007930|FG000|Overall Study|Withdrawal by Subject|2|||
42196074|NCT00112463|76007930|FG000|Overall Study|Never started treatment|2|||
42196075|NCT03548415|76007940|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
42196076|NCT03548415|76007941|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
42196077|NCT03548415|76007942|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
42196078|NCT03548415|76007943|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
42196079|NCT03548415|76007944|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
42196080|NCT00112385|76007960|FG000|Overall Study|Lost to Follow-up|1|||
42196081|NCT00112385|76007961|FG001|Overall Study|Lost to Follow-up|0|||
42196082|NCT00112385|76007960|FG000|Overall Study|Withdrawal by Subject|0|||
42196083|NCT00112385|76007961|FG001|Overall Study|Withdrawal by Subject|1|||
42196084|NCT03548337|76007969|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
42363614|NCT01947491|76213056|FG002|Overall Study|Lost to Follow-up|1|||
42363615|NCT01947491|76213057|FG003|Overall Study|Lost to Follow-up|2|||
42363616|NCT01947491|76213054|FG000|Overall Study|Lack of Efficacy|1|||
42363617|NCT01947491|76213055|FG001|Overall Study|Lack of Efficacy|0|||
42363618|NCT01947491|76213056|FG002|Overall Study|Lack of Efficacy|0|||
42363619|NCT01947491|76213057|FG003|Overall Study|Lack of Efficacy|1|||
42363620|NCT01947491|76213054|FG000|Overall Study|Protocol Violation|1|||
42363621|NCT01947491|76213055|FG001|Overall Study|Protocol Violation|0|||
42363622|NCT01947491|76213056|FG002|Overall Study|Protocol Violation|0|||
42100543|NCT02501096|75911402|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
42100544|NCT02501096|75911403|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
42363623|NCT01947491|76213057|FG003|Overall Study|Protocol Violation|0|||
42363624|NCT01947491|76213054|FG000|Overall Study|Withdrawal by Subject|1|||
42363625|NCT01947491|76213055|FG001|Overall Study|Withdrawal by Subject|1|||
42363626|NCT01947491|76213056|FG002|Overall Study|Withdrawal by Subject|1|||
42363627|NCT01947491|76213057|FG003|Overall Study|Withdrawal by Subject|0|||
42363628|NCT01947491|76213054|FG000|Overall Study|Worsening of condition|0|||
42363629|NCT01947491|76213055|FG001|Overall Study|Worsening of condition|1|||
42100545|NCT02501096|75911404|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
42100546|NCT02501096|75911405|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
42100547|NCT02501096|75911397|FG000|Overall Study|Death|1|||
42100548|NCT02501096|75911398|FG001|Overall Study|Death|1|||
42100549|NCT02501096|75911399|FG002|Overall Study|Death|88|||
42100550|NCT02501096|75911400|FG003|Overall Study|Death|74|||
42100551|NCT02501096|75911401|FG004|Overall Study|Death|15|||
42100552|NCT02501096|75911402|FG005|Overall Study|Death|16|||
42100553|NCT02501096|75911403|FG006|Overall Study|Death|15|||
42100554|NCT02501096|75911404|FG007|Overall Study|Death|16|||
42100555|NCT02501096|75911405|FG008|Overall Study|Death|1|||
42100556|NCT01633541|75911439|FG000|Overall Study|Death|1|||
42100557|NCT01633541|75911440|FG001|Overall Study|Death|0|||
42100558|NCT01466036|75911450|FG000|Overall Study|Death|1|||
42100559|NCT01466036|75911451|FG001|Overall Study|Death|1|||
42100560|NCT01466036|75911450|FG000|Overall Study|Physician Decision|0|||
42100561|NCT01466036|75911451|FG001|Overall Study|Physician Decision|4|||
42196085|NCT03548337|76007970|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
42196086|NCT03548337|76007969|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
42196087|NCT03548337|76007970|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
42363630|NCT01947491|76213056|FG002|Overall Study|Worsening of condition|0|||
42363631|NCT01947491|76213057|FG003|Overall Study|Worsening of condition|0|||
42363632|NCT01947491|76213054|FG000|Overall Study|Adverse Event|0|||
42363633|NCT01947491|76213055|FG001|Overall Study|Adverse Event|1|||
42363634|NCT01947491|76213056|FG002|Overall Study|Adverse Event|0|||
42363635|NCT01947491|76213057|FG003|Overall Study|Adverse Event|2|||
42363636|NCT01715857|76213067|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
42363637|NCT01692301|76213073|FG000|Overall Study|Adverse Event|15|||
42100562|NCT01466036|75911450|FG000|Overall Study|Adverse Event|2|||
42100563|NCT01466036|75911451|FG001|Overall Study|Adverse Event|6|||
42100564|NCT01466036|75911450|FG000|Overall Study|Withdrawal by Subject|2|||
42100565|NCT01466036|75911451|FG001|Overall Study|Withdrawal by Subject|8|||
42100566|NCT01466036|75911450|FG000|Overall Study|progression/relapse|14|||
42100567|NCT01466036|75911451|FG001|Overall Study|progression/relapse|21|||
42363638|NCT01692301|76213074|FG001|Overall Study|Adverse Event|12|||
42100568|NCT01466036|75911450|FG000|Overall Study|prolonged treatment delay|1|||
42100569|NCT01466036|75911451|FG001|Overall Study|prolonged treatment delay|1|||
42100570|NCT01399372|75911460|FG000|Overall Study|Protocol Violation|3|||
42100571|NCT01399372|75911461|FG001|Overall Study|Protocol Violation|1|||
42100572|NCT01063517|75911469|FG000|Overall Study|Consent withdrawal|1|||
42100573|NCT01063517|75911470|FG001|Overall Study|Consent withdrawal|0|||
42196088|NCT03548337|76007969|FG000|Infant Series|Lost to Follow-up|2|||
42196089|NCT03548337|76007970|FG001|Infant Series|Lost to Follow-up|1|||
42363639|NCT01692301|76213073|FG000|Overall Study|Death|1|||
42363640|NCT01692301|76213074|FG001|Overall Study|Death|2|||
42363641|NCT01692301|76213073|FG000|Overall Study|Lack of Efficacy|0|||
42363642|NCT01692301|76213074|FG001|Overall Study|Lack of Efficacy|5|||
42363643|NCT01692301|76213073|FG000|Overall Study|Non-compliance with study treatment|1|||
42196090|NCT03548337|76007969|FG000|Infant Series|Adverse Event|0|||
42196091|NCT03548337|76007970|FG001|Infant Series|Adverse Event|2|||
42196092|NCT03548337|76007969|FG000|Infant Series|Randomized but Not Vaccinated|1|||
42196093|NCT03548337|76007970|FG001|Infant Series|Randomized but Not Vaccinated|0|||
42196094|NCT03548337|76007969|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
42196095|NCT03548337|76007970|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
42196096|NCT03596151|76007982|FG000|Overall Study|Withdrawal by Subject|1|||
42196097|NCT03547635|76007989|FG000|Overall Study|Adverse Event|5|||
42196098|NCT03547635|76007990|FG001|Overall Study|Adverse Event|2|||
42196099|NCT03547635|76007991|FG002|Overall Study|Adverse Event|3|||
42196100|NCT03547635|76007989|FG000|Overall Study|Lost to Follow-up|1|||
42196101|NCT03547635|76007990|FG001|Overall Study|Lost to Follow-up|3|||
42196102|NCT03547635|76007991|FG002|Overall Study|Lost to Follow-up|4|||
42196103|NCT03547635|76007989|FG000|Overall Study|Withdrawal by Subject|1|||
42196104|NCT03547635|76007990|FG001|Overall Study|Withdrawal by Subject|0|||
42196105|NCT03547635|76007991|FG002|Overall Study|Withdrawal by Subject|0|||
42196106|NCT03547635|76007989|FG000|Overall Study|Withdrawal By PI|0|||
42196107|NCT03547635|76007990|FG001|Overall Study|Withdrawal By PI|1|||
42196108|NCT03547635|76007991|FG002|Overall Study|Withdrawal By PI|0|||
42196109|NCT03547635|76007989|FG000|Overall Study|Withdrawal by Sponsor|0|||
42196110|NCT03547635|76007990|FG001|Overall Study|Withdrawal by Sponsor|0|||
42196111|NCT03547635|76007991|FG002|Overall Study|Withdrawal by Sponsor|1|||
42196112|NCT03547635|76007989|FG000|Overall Study|Errant Randomization before Treatment|0|||
42196113|NCT03547635|76007990|FG001|Overall Study|Errant Randomization before Treatment|1|||
42196114|NCT03547635|76007991|FG002|Overall Study|Errant Randomization before Treatment|0|||
42196115|NCT03547635|76007989|FG000|Overall Study|Withdrawal by Subject|1|||
42196116|NCT03547635|76007990|FG001|Overall Study|Withdrawal by Subject|0|||
42196117|NCT03547635|76007991|FG002|Overall Study|Withdrawal by Subject|0|||
42196118|NCT03182738|76008045|FG000|Overall Study|Lost to Follow-up|9|||
42196119|NCT03182738|76008046|FG001|Overall Study|Lost to Follow-up|3|||
42196120|NCT03182738|76008045|FG000|Overall Study|Pregnancy|0|||
42196121|NCT03182738|76008046|FG001|Overall Study|Pregnancy|1|||
42196122|NCT03182738|76008045|FG000|Overall Study|Withdrawal by Subject|0|||
42196123|NCT03182738|76008046|FG001|Overall Study|Withdrawal by Subject|1|||
42196124|NCT03547167|76008054|FG000|Overall Study|Withdrawal by Subject|34|||
42196125|NCT03547167|76008055|FG001|Overall Study|Withdrawal by Subject|12|||
42196126|NCT03547167|76008054|FG000|Overall Study|Screen Failure|0|||
42196127|NCT03547167|76008055|FG001|Overall Study|Screen Failure|1|||
42196128|NCT03547167|76008054|FG000|Overall Study|Lost to Follow-up|59|||
42196129|NCT03547167|76008055|FG001|Overall Study|Lost to Follow-up|15|||
42196130|NCT03547167|76008054|FG000|Overall Study|Death|4|||
42196131|NCT03547167|76008055|FG001|Overall Study|Death|2|||
42196132|NCT03560739|76008069|FG000|Overall Study|Adverse Event|0|||
42196133|NCT03560739|76008070|FG001|Overall Study|Adverse Event|1|||
42196134|NCT03560739|76008071|FG002|Overall Study|Adverse Event|0|||
42100574|NCT01063517|75911469|FG000|Overall Study|Study reached data cut-off|19|||
42196135|NCT03560739|76008072|FG003|Overall Study|Adverse Event|0|||
42196136|NCT00101686|76008092|FG000|Overall Study|Progressive Disease|37|||
42196137|NCT00101686|76008093|FG001|Overall Study|Progressive Disease|28|||
42196138|NCT00101686|76008094|FG002|Overall Study|Progressive Disease|37|||
42196139|NCT00101686|76008095|FG003|Overall Study|Progressive Disease|38|||
42196140|NCT00101686|76008096|FG004|Overall Study|Progressive Disease|28|||
42196141|NCT00101686|76008097|FG005|Overall Study|Progressive Disease|25|||
42196142|NCT00101686|76008098|FG006|Overall Study|Progressive Disease|5|||
42196143|NCT00101686|76008099|FG007|Overall Study|Progressive Disease|7|||
42018483|NCT00996892|75825865|FG004|Expansion Stage 2A|Adverse Event|0|||
42018484|NCT00996892|75825866|FG005|Expansion Stage 2A|Adverse Event|0|||
42018485|NCT00996892|75825867|FG006|Expansion Stage 2A|Adverse Event|0|||
42018486|NCT00996892|75825868|FG007|Expansion Stage 2A|Adverse Event|0|||
42018487|NCT00996892|75825869|FG008|Expansion Stage 2A|Adverse Event|0|||
42018488|NCT00996892|75825870|FG009|Expansion Stage 2A|Adverse Event|0|||
42018489|NCT00996892|75825871|FG010|Expansion Stage 2A|Adverse Event|0|||
42018490|NCT00996892|75825872|FG011|Expansion Stage 2A|Adverse Event|0|||
42018491|NCT00996892|75825873|FG012|Expansion Stage 2A|Adverse Event|0|||
42018492|NCT00996892|75825874|FG013|Expansion Stage 2A|Adverse Event|0|||
42018493|NCT00996892|75825875|FG014|Expansion Stage 2A|Adverse Event|0|||
42018494|NCT00996892|75825876|FG015|Expansion Stage 2A|Adverse Event|0|||
42018495|NCT00996892|75825877|FG016|Expansion Stage 2A|Adverse Event|0|||
42018496|NCT00996892|75825878|FG017|Expansion Stage 2A|Adverse Event|0|||
42018497|NCT00996892|75825879|FG018|Expansion Stage 2A|Adverse Event|0|||
42018498|NCT00996892|75825880|FG019|Expansion Stage 2A|Adverse Event|8|||
42018499|NCT00996892|75825861|FG000|Expansion Stage 2A|Physician Decision|0|||
42018500|NCT00996892|75825862|FG001|Expansion Stage 2A|Physician Decision|0|||
42018501|NCT00996892|75825863|FG002|Expansion Stage 2A|Physician Decision|0|||
42018502|NCT00996892|75825864|FG003|Expansion Stage 2A|Physician Decision|0|||
42018503|NCT00996892|75825865|FG004|Expansion Stage 2A|Physician Decision|0|||
42018504|NCT00996892|75825866|FG005|Expansion Stage 2A|Physician Decision|0|||
42018505|NCT00996892|75825867|FG006|Expansion Stage 2A|Physician Decision|0|||
42196144|NCT00101686|76008100|FG008|Overall Study|Progressive Disease|10|||
42196145|NCT00101686|76008101|FG009|Overall Study|Progressive Disease|8|||
42196146|NCT00101686|76008092|FG000|Overall Study|initiation other anti-cancer treatment|4|||
42196147|NCT00101686|76008093|FG001|Overall Study|initiation other anti-cancer treatment|3|||
42196148|NCT00101686|76008094|FG002|Overall Study|initiation other anti-cancer treatment|4|||
42196149|NCT00101686|76008095|FG003|Overall Study|initiation other anti-cancer treatment|3|||
42196150|NCT00101686|76008096|FG004|Overall Study|initiation other anti-cancer treatment|1|||
42196151|NCT00101686|76008097|FG005|Overall Study|initiation other anti-cancer treatment|1|||
42196152|NCT00101686|76008098|FG006|Overall Study|initiation other anti-cancer treatment|2|||
42196153|NCT00101686|76008099|FG007|Overall Study|initiation other anti-cancer treatment|2|||
42196154|NCT00101686|76008100|FG008|Overall Study|initiation other anti-cancer treatment|3|||
42363644|NCT01692301|76213074|FG001|Overall Study|Non-compliance with study treatment|2|||
42363645|NCT01692301|76213073|FG000|Overall Study|Protocol deviation|9|||
42363646|NCT01692301|76213074|FG001|Overall Study|Protocol deviation|2|||
42363647|NCT01692301|76213073|FG000|Overall Study|Patient/guardian decision|16|||
42363648|NCT01692301|76213074|FG001|Overall Study|Patient/guardian decision|15|||
42363649|NCT01692301|76213073|FG000|Overall Study|Technical problems|0|||
42363650|NCT01692301|76213074|FG001|Overall Study|Technical problems|1|||
42363651|NCT01692301|76213073|FG000|Overall Study|Physician Decision|2|||
42363652|NCT01692301|76213074|FG001|Overall Study|Physician Decision|2|||
42363653|NCT01692301|76213073|FG000|Overall Study|Lost to Follow-up|1|||
42363654|NCT01692301|76213074|FG001|Overall Study|Lost to Follow-up|1|||
42363655|NCT01592773|76213080|FG000|Overall Study|Study Terminated by Sponsor|582|||
42363656|NCT01592773|76213080|FG000|Overall Study|Withdrawal by Subject|35|||
42363657|NCT01592773|76213080|FG000|Overall Study|Lost to Follow-up|19|||
42363658|NCT01592773|76213080|FG000|Overall Study|Adverse Event|17|||
42363659|NCT01592773|76213080|FG000|Overall Study|Lack of Efficacy|9|||
42363660|NCT01592773|76213080|FG000|Overall Study|Protocol Violation|2|||
42363661|NCT01592773|76213080|FG000|Overall Study|Inclusion/exclusion not meet|1|||
42363662|NCT01592773|76213080|FG000|Overall Study|Other Reason|1|||
42363663|NCT01930175|76213087|FG000|Core Study|Lost to Follow-up|0|||
42363664|NCT01930175|76213088|FG001|Core Study|Lost to Follow-up|1|||
42363665|NCT01930175|76213089|FG002|Core Study|Lost to Follow-up|0|||
42363666|NCT01930175|76213087|FG000|Core Study|Adverse Event|0|||
42363667|NCT01930175|76213088|FG001|Core Study|Adverse Event|0|||
42363668|NCT01930175|76213089|FG002|Core Study|Adverse Event|1|||
42363669|NCT01592695|76213100|FG000|Overall Study|Lost to Follow-up|8|||
42363670|NCT01592695|76213101|FG001|Overall Study|Lost to Follow-up|4|||
42363671|NCT01929863|76213107|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
42363672|NCT01929863|76213108|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
42363673|NCT01929863|76213107|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
42363674|NCT01929863|76213108|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
42363675|NCT01929863|76213107|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
42363676|NCT01929863|76213108|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
42363677|NCT01918085|76213121|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
42363678|NCT01918085|76213122|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
42363679|NCT01714687|76213132|FG000|Overall Study|Withdrawal by Subject|1|||
42363680|NCT01714687|76213133|FG001|Overall Study|Withdrawal by Subject|0|||
42363681|NCT01714687|76213132|FG000|Overall Study|Lost to Follow-up|2|||
42363682|NCT01714687|76213133|FG001|Overall Study|Lost to Follow-up|4|||
42363683|NCT01714609|76213143|FG000|Overall Study|Protocol Violation|1|||
42363684|NCT01714609|76213144|FG001|Overall Study|Protocol Violation|0|||
42363685|NCT01929707|76213150|FG000|Intervention Period 1|Lost to Follow-up|0|||
42363686|NCT01929707|76213151|FG001|Intervention Period 1|Lost to Follow-up|0|||
42363687|NCT01929707|76213152|FG002|Intervention Period 1|Lost to Follow-up|0|||
42363688|NCT01929707|76213153|FG003|Intervention Period 1|Lost to Follow-up|1|||
42363689|NCT01929707|76213154|FG004|Intervention Period 1|Lost to Follow-up|0|||
42363690|NCT01929707|76213155|FG005|Intervention Period 1|Lost to Follow-up|0|||
42363691|NCT01929707|76213156|FG006|Intervention Period 1|Lost to Follow-up|0|||
42363692|NCT01929707|76213157|FG007|Intervention Period 1|Lost to Follow-up|0|||
42196155|NCT00101686|76008101|FG009|Overall Study|initiation other anti-cancer treatment|3|||
42363693|NCT01929707|76213150|FG000|Intervention Period 1|Withdrawal by Subject|0|||
42363694|NCT01929707|76213151|FG001|Intervention Period 1|Withdrawal by Subject|0|||
42363695|NCT01929707|76213152|FG002|Intervention Period 1|Withdrawal by Subject|0|||
42363696|NCT01929707|76213153|FG003|Intervention Period 1|Withdrawal by Subject|2|||
42363697|NCT01929707|76213154|FG004|Intervention Period 1|Withdrawal by Subject|0|||
42363698|NCT01929707|76213155|FG005|Intervention Period 1|Withdrawal by Subject|0|||
42363699|NCT01929707|76213156|FG006|Intervention Period 1|Withdrawal by Subject|0|||
42363700|NCT01929707|76213157|FG007|Intervention Period 1|Withdrawal by Subject|0|||
42363701|NCT01929707|76213150|FG000|Intervention Period 2|Withdrawal by Subject|0|||
42363702|NCT01929707|76213151|FG001|Intervention Period 2|Withdrawal by Subject|0|||
42363703|NCT01929707|76213152|FG002|Intervention Period 2|Withdrawal by Subject|0|||
42363704|NCT01929707|76213153|FG003|Intervention Period 2|Withdrawal by Subject|0|||
42363705|NCT01929707|76213154|FG004|Intervention Period 2|Withdrawal by Subject|0|||
42363706|NCT01929707|76213155|FG005|Intervention Period 2|Withdrawal by Subject|2|||
42363707|NCT01929707|76213156|FG006|Intervention Period 2|Withdrawal by Subject|0|||
42363708|NCT01929707|76213157|FG007|Intervention Period 2|Withdrawal by Subject|0|||
42100575|NCT01063517|75911470|FG001|Overall Study|Study reached data cut-off|7|||
42100576|NCT01063517|75911469|FG000|Overall Study|Lost to Follow-up|4|||
42100577|NCT01063517|75911470|FG001|Overall Study|Lost to Follow-up|3|||
42100578|NCT01063517|75911469|FG000|Overall Study|Withdrawal by Subject|1|||
42363709|NCT01714063|76213178|FG000|Overall Study|Equipment malfunction|2|||
42363710|NCT01929395|76213189|FG000|Overall Study|Did not complete - non-related toxicity|1|||
42363711|NCT01929395|76213190|FG001|Overall Study|Did not complete - non-related toxicity|0|||
42363712|NCT01929395|76213191|FG002|Overall Study|Did not complete - non-related toxicity|0|||
42363713|NCT01929395|76213189|FG000|Overall Study|Withdrawal by Subject|0|||
42363714|NCT01929395|76213190|FG001|Overall Study|Withdrawal by Subject|1|||
42363715|NCT01929395|76213191|FG002|Overall Study|Withdrawal by Subject|0|||
42363716|NCT01929395|76213189|FG000|Overall Study|Screen Fail|0|||
42363717|NCT01929395|76213190|FG001|Overall Study|Screen Fail|0|||
42363718|NCT01929395|76213191|FG002|Overall Study|Screen Fail|1|||
42363719|NCT01713283|76213203|FG000|Overall Study|Lack of Efficacy|10|||
42363720|NCT01713283|76213204|FG001|Overall Study|Lack of Efficacy|2|||
42363721|NCT01713283|76213203|FG000|Overall Study|Lost to Follow-up|1|||
42363722|NCT01713283|76213204|FG001|Overall Study|Lost to Follow-up|1|||
42363723|NCT01592383|76213214|FG000|Overall Study|Adverse Event|1|||
42363724|NCT01691521|76213222|FG000|Overall Study|Adverse Event|4|||
42363725|NCT01691521|76213223|FG001|Overall Study|Adverse Event|0|||
42363726|NCT01691521|76213224|FG002|Overall Study|Adverse Event|1|||
42363727|NCT01691521|76213222|FG000|Overall Study|Lack of Efficacy|1|||
42363728|NCT01691521|76213223|FG001|Overall Study|Lack of Efficacy|1|||
42363729|NCT01691521|76213224|FG002|Overall Study|Lack of Efficacy|2|||
42363730|NCT01691521|76213222|FG000|Overall Study|Protocol Violation|0|||
42363731|NCT01691521|76213223|FG001|Overall Study|Protocol Violation|3|||
42363732|NCT01691521|76213224|FG002|Overall Study|Protocol Violation|0|||
42363733|NCT01691521|76213222|FG000|Overall Study|Lost to Follow-up|0|||
42363734|NCT01691521|76213223|FG001|Overall Study|Lost to Follow-up|2|||
42363735|NCT01691521|76213224|FG002|Overall Study|Lost to Follow-up|2|||
42363736|NCT01691521|76213222|FG000|Overall Study|Physician Decision|2|||
42363737|NCT01691521|76213223|FG001|Overall Study|Physician Decision|1|||
42363738|NCT01691521|76213224|FG002|Overall Study|Physician Decision|0|||
42363739|NCT01691521|76213222|FG000|Overall Study|Withdrawal by Subject|5|||
42363740|NCT01691521|76213223|FG001|Overall Study|Withdrawal by Subject|9|||
42363741|NCT01691521|76213224|FG002|Overall Study|Withdrawal by Subject|4|||
42363742|NCT01929317|76213235|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
42363743|NCT01929317|76213236|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
42363744|NCT01929317|76213235|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
42363745|NCT01929317|76213236|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
42363746|NCT01929317|76213235|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
42363747|NCT01929317|76213236|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
42363748|NCT01929317|76213235|FG000|Long-term Phase|Adverse Event|5|||
42363749|NCT01929317|76213236|FG001|Long-term Phase|Adverse Event|1|||
42363750|NCT01929317|76213235|FG000|Long-term Phase|Physician Decision|3|||
42363751|NCT01929317|76213236|FG001|Long-term Phase|Physician Decision|0|||
42363752|NCT01929317|76213235|FG000|Long-term Phase|Withdrawal by Subject|4|||
42363753|NCT01929317|76213236|FG001|Long-term Phase|Withdrawal by Subject|0|||
42363754|NCT01929317|76213235|FG000|Long-term Phase|Protocol Violation|1|||
42363755|NCT01929317|76213236|FG001|Long-term Phase|Protocol Violation|0|||
42363756|NCT01929317|76213235|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
42100579|NCT01063517|75911470|FG001|Overall Study|Withdrawal by Subject|2|||
42100580|NCT01063517|75911469|FG000|Overall Study|Death|33|||
42100581|NCT01063517|75911470|FG001|Overall Study|Death|48|||
42100582|NCT00920621|75911480|FG000|Overall Study|Lost to Follow-up|16|||
42100583|NCT00920621|75911481|FG001|Overall Study|Lost to Follow-up|17|||
42100584|NCT00920621|75911482|FG002|Overall Study|Lost to Follow-up|19|||
42100585|NCT00920621|75911483|FG003|Overall Study|Lost to Follow-up|21|||
42100586|NCT00920621|75911480|FG000|Overall Study|Fetal/neonatal deaths|16|||
42100587|NCT00920621|75911481|FG001|Overall Study|Fetal/neonatal deaths|14|||
42100588|NCT00920621|75911482|FG002|Overall Study|Fetal/neonatal deaths|16|||
42100589|NCT00920621|75911483|FG003|Overall Study|Fetal/neonatal deaths|14|||
42100590|NCT00920621|75911480|FG000|Overall Study|Blood sample not collected|22|||
42363757|NCT01929317|76213236|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
42363758|NCT01929317|76213235|FG000|Long-term Phase|Study Closed/Terminated|5|||
42363759|NCT01929317|76213236|FG001|Long-term Phase|Study Closed/Terminated|3|||
42363760|NCT01711879|76213250|FG000|Overall Study|Death|1|||
42363761|NCT01711879|76213251|FG001|Overall Study|Death|0|||
42363762|NCT01689649|76213274|FG000|Overall Study|Lack of Efficacy|3|||
42363763|NCT01689649|76213274|FG000|Overall Study|Non-compliance|11|||
42363764|NCT01689649|76213274|FG000|Overall Study|Protocol Violation|3|||
42363765|NCT01689649|76213274|FG000|Overall Study|Lost to Follow-up|5|||
42363766|NCT01929083|76213278|FG000|Intervention 1|Lost to Follow-up|2|||
42363767|NCT01929083|76213279|FG001|Intervention 1|Lost to Follow-up|0|||
42363768|NCT01929083|76213278|FG000|Intervention 1|Nonadherent to study medications|1|||
42363769|NCT01929083|76213279|FG001|Intervention 1|Nonadherent to study medications|0|||
42363770|NCT01929083|76213278|FG000|Intervention 2|Adverse Event|0|||
42363771|NCT01929083|76213279|FG001|Intervention 2|Adverse Event|1|||
42363772|NCT01689337|76213285|FG000|Overall Study|Study Discontinuation|1|||
42363773|NCT01688635|76213291|FG000|Washout 1|Withdrawal by Subject|1|||
42363774|NCT01688635|76213292|FG001|Washout 1|Withdrawal by Subject|0|||
42363775|NCT01688635|76213291|FG000|Washout 1|Adverse Event|0|||
42363776|NCT01688635|76213292|FG001|Washout 1|Adverse Event|1|||
42363777|NCT01688635|76213291|FG000|Washout 1|Physician Decision|0|||
42363778|NCT01688635|76213292|FG001|Washout 1|Physician Decision|1|||
42363779|NCT01688635|76213291|FG000|Washout 2|Physician Decision|1|||
42363780|NCT01688635|76213292|FG001|Washout 2|Physician Decision|0|||
42363781|NCT01688635|76213291|FG000|Washout 2|Withdrawal by Subject|1|||
42363782|NCT01688635|76213292|FG001|Washout 2|Withdrawal by Subject|0|||
42363783|NCT01688635|76213291|FG000|Washout 2|Sponsor Decision|1|||
42363784|NCT01688635|76213292|FG001|Washout 2|Sponsor Decision|2|||
42363785|NCT01688635|76213291|FG000|Washout 3|Withdrawal by Subject|1|||
42363786|NCT01688635|76213292|FG001|Washout 3|Withdrawal by Subject|0|||
42363787|NCT01591681|76213299|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
42363788|NCT01591681|76213299|FG000|Overall Study|Failed to use system during run-in|1|||
42363789|NCT01711645|76213314|FG000|Overall Study|Withdrawal by Subject|8|||
42363790|NCT01711645|76213314|FG000|Overall Study|Lost to Follow-up|6|||
42363791|NCT01711645|76213314|FG000|Overall Study|Physician Decision|5|||
42363792|NCT01590433|76213329|FG000|Overall Study|Lost to Follow-up|20|||
42363793|NCT01590433|76213330|FG001|Overall Study|Lost to Follow-up|8|||
42363794|NCT01590433|76213329|FG000|Overall Study|Withdrawal by Subject|21|||
42363795|NCT01590433|76213330|FG001|Overall Study|Withdrawal by Subject|11|||
42363796|NCT01590433|76213329|FG000|Overall Study|Adverse Event|11|||
42363797|NCT01590433|76213330|FG001|Overall Study|Adverse Event|3|||
42363798|NCT01928927|76213347|FG000|Overall Study|Lost to Follow-up|1|||
42363799|NCT01928927|76213348|FG001|Overall Study|Lost to Follow-up|0|||
42363800|NCT01928927|76213347|FG000|Overall Study|Withdrawal by Subject|1|||
42363801|NCT01928927|76213348|FG001|Overall Study|Withdrawal by Subject|1|||
42363802|NCT01710709|76213369|FG000|Overall Study|Lost to Follow-up|29|||
42363803|NCT01710709|76213369|FG000|Overall Study|Adverse Event|48|||
42363804|NCT01710709|76213369|FG000|Overall Study|Participant met withdrawal criteria|33|||
42363805|NCT01710709|76213369|FG000|Overall Study|Participant withdrawn by investigator|2|||
42363806|NCT01710709|76213369|FG000|Overall Study|Withdrawal by Subject|53|||
42363807|NCT01710709|76213369|FG000|Overall Study|Protocol Violation|5|||
42363808|NCT01710709|76213369|FG000|Overall Study|Lack of Efficacy|3|||
42363809|NCT01617629|76213374|FG000|Overall Study|Death|2|||
42363810|NCT01617629|76213374|FG000|Overall Study|Investigator's Clinical Judgement|1|||
42363811|NCT01617629|76213374|FG000|Overall Study|Reason Not Specified|1|||
42363812|NCT01617629|76213374|FG000|Overall Study|Participant Withdrew Consent|2|||
42363813|NCT01686373|76213389|FG000|Overall Study|Lost to Follow-up|3|||
42363814|NCT01686373|76213390|FG001|Overall Study|Lost to Follow-up|0|||
42363815|NCT01686373|76213389|FG000|Overall Study|Withdrawal by Subject|0|||
42363816|NCT01686373|76213390|FG001|Overall Study|Withdrawal by Subject|1|||
42363817|NCT01686373|76213389|FG000|Overall Study|Adverse Event|0|||
42363818|NCT01686373|76213390|FG001|Overall Study|Adverse Event|1|||
42363819|NCT01709695|76213398|FG000|Overall Study|Withdrawal by Subject|1|||
42363820|NCT01709695|76213399|FG001|Overall Study|Withdrawal by Subject|1|||
42363821|NCT01685983|76213409|FG000|Overall Study|Adverse Event|7|||
42363822|NCT01685983|76213409|FG000|Overall Study|Death|1|||
42363823|NCT01685983|76213409|FG000|Overall Study|Withdrawal by Subject|19|||
42363824|NCT01685983|76213409|FG000|Overall Study|Protocol Violation|2|||
42363825|NCT01685983|76213409|FG000|Overall Study|Physician Decision|13|||
42363826|NCT01685983|76213409|FG000|Overall Study|Other|7|||
42363827|NCT01685983|76213409|FG000|Overall Study|Progressive Disease|32|||
42363828|NCT01685983|76213409|FG000|Overall Study|Noncompliance with Study Drug|1|||
42363829|NCT01685437|76213421|FG000|Overall Study|Withdrawal by Subject|22|||
42363830|NCT01685437|76213421|FG000|Overall Study|Lost to Follow-up|3|||
42363831|NCT01685437|76213421|FG000|Overall Study|Adverse Event|1|||
42363832|NCT01685437|76213421|FG000|Overall Study|Protocol Violation|4|||
42363833|NCT01685437|76213421|FG000|Overall Study|Unable to make visits due to work|1|||
42363834|NCT01685203|76213461|FG000|Overall Study|Lost to Follow-up|3|||
42363835|NCT01685203|76213462|FG001|Overall Study|Lost to Follow-up|3|||
42363836|NCT01685203|76213463|FG002|Overall Study|Lost to Follow-up|0|||
42363837|NCT01685203|76213464|FG003|Overall Study|Lost to Follow-up|1|||
42363838|NCT01685203|76213465|FG004|Overall Study|Lost to Follow-up|0|||
42363839|NCT01685203|76213466|FG005|Overall Study|Lost to Follow-up|0|||
42363840|NCT01685203|76213467|FG006|Overall Study|Lost to Follow-up|0|||
42363841|NCT01685203|76213461|FG000|Overall Study|Adverse Event|0|||
42363842|NCT01685203|76213462|FG001|Overall Study|Adverse Event|0|||
42363843|NCT01685203|76213463|FG002|Overall Study|Adverse Event|0|||
42363844|NCT01685203|76213464|FG003|Overall Study|Adverse Event|0|||
42363845|NCT01685203|76213465|FG004|Overall Study|Adverse Event|0|||
42363846|NCT01685203|76213466|FG005|Overall Study|Adverse Event|2|||
42363847|NCT01685203|76213467|FG006|Overall Study|Adverse Event|0|||
42363848|NCT01685203|76213461|FG000|Overall Study|Adverse event and withdrew consent|1|||
42363849|NCT01685203|76213462|FG001|Overall Study|Adverse event and withdrew consent|0|||
42363850|NCT01685203|76213463|FG002|Overall Study|Adverse event and withdrew consent|0|||
42363851|NCT01685203|76213464|FG003|Overall Study|Adverse event and withdrew consent|0|||
42363852|NCT01685203|76213465|FG004|Overall Study|Adverse event and withdrew consent|0|||
42363853|NCT01685203|76213466|FG005|Overall Study|Adverse event and withdrew consent|0|||
42363854|NCT01685203|76213467|FG006|Overall Study|Adverse event and withdrew consent|0|||
42363855|NCT01685203|76213461|FG000|Overall Study|Patient's decision|0|||
42363856|NCT01685203|76213462|FG001|Overall Study|Patient's decision|0|||
42363857|NCT01685203|76213463|FG002|Overall Study|Patient's decision|0|||
42363858|NCT01685203|76213464|FG003|Overall Study|Patient's decision|0|||
42363859|NCT01685203|76213465|FG004|Overall Study|Patient's decision|0|||
42363860|NCT01685203|76213466|FG005|Overall Study|Patient's decision|1|||
42196156|NCT00101686|76008092|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
42196157|NCT00101686|76008093|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
42196158|NCT00101686|76008094|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
42196159|NCT00101686|76008095|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
42196160|NCT00101686|76008096|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
42196161|NCT00101686|76008097|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
42196162|NCT00101686|76008098|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
42196163|NCT00101686|76008099|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
42196164|NCT00101686|76008100|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
42196165|NCT00101686|76008101|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
42196166|NCT00101686|76008092|FG000|Overall Study|unacceptable toxicity|3|||
42196167|NCT00101686|76008093|FG001|Overall Study|unacceptable toxicity|9|||
42196168|NCT00101686|76008094|FG002|Overall Study|unacceptable toxicity|10|||
42196169|NCT00101686|76008095|FG003|Overall Study|unacceptable toxicity|6|||
42196170|NCT00101686|76008096|FG004|Overall Study|unacceptable toxicity|16|||
42196171|NCT00101686|76008097|FG005|Overall Study|unacceptable toxicity|10|||
42196172|NCT00101686|76008098|FG006|Overall Study|unacceptable toxicity|4|||
42196173|NCT00101686|76008099|FG007|Overall Study|unacceptable toxicity|2|||
42196174|NCT00101686|76008100|FG008|Overall Study|unacceptable toxicity|1|||
42196175|NCT00101686|76008101|FG009|Overall Study|unacceptable toxicity|4|||
42363861|NCT01685203|76213467|FG006|Overall Study|Patient's decision|0|||
42363862|NCT01928771|76213486|FG000|Overall Study|Adverse Event|6|||
42363863|NCT01928771|76213487|FG001|Overall Study|Adverse Event|5|||
42363864|NCT01928771|76213488|FG002|Overall Study|Adverse Event|1|||
42363865|NCT01928771|76213486|FG000|Overall Study|Death|2|||
42363866|NCT01928771|76213487|FG001|Overall Study|Death|2|||
42363867|NCT01928771|76213488|FG002|Overall Study|Death|2|||
42196176|NCT00101686|76008092|FG000|Overall Study|Randomized but did not receive treament|1|||
42196177|NCT00101686|76008093|FG001|Overall Study|Randomized but did not receive treament|6|||
42363868|NCT01928771|76213486|FG000|Overall Study|Lost to Follow-up|5|||
42363869|NCT01928771|76213487|FG001|Overall Study|Lost to Follow-up|6|||
42363870|NCT01928771|76213488|FG002|Overall Study|Lost to Follow-up|3|||
42196178|NCT00101686|76008094|FG002|Overall Study|Randomized but did not receive treament|2|||
42196179|NCT00101686|76008095|FG003|Overall Study|Randomized but did not receive treament|2|||
42196180|NCT00101686|76008096|FG004|Overall Study|Randomized but did not receive treament|2|||
42196181|NCT00101686|76008097|FG005|Overall Study|Randomized but did not receive treament|2|||
42196182|NCT00101686|76008098|FG006|Overall Study|Randomized but did not receive treament|0|||
42196183|NCT00101686|76008099|FG007|Overall Study|Randomized but did not receive treament|1|||
42196184|NCT00101686|76008100|FG008|Overall Study|Randomized but did not receive treament|0|||
42196185|NCT00101686|76008101|FG009|Overall Study|Randomized but did not receive treament|1|||
42196186|NCT00101686|76008092|FG000|Overall Study|intercurrent non-cancer related illness|0|||
42196187|NCT00101686|76008093|FG001|Overall Study|intercurrent non-cancer related illness|0|||
42196188|NCT00101686|76008094|FG002|Overall Study|intercurrent non-cancer related illness|2|||
42196189|NCT00101686|76008095|FG003|Overall Study|intercurrent non-cancer related illness|0|||
42363871|NCT01928771|76213486|FG000|Overall Study|Withdrawal by Subject|20|||
42363872|NCT01928771|76213487|FG001|Overall Study|Withdrawal by Subject|15|||
42100591|NCT00920621|75911481|FG001|Overall Study|Blood sample not collected|14|||
42363873|NCT01928771|76213488|FG002|Overall Study|Withdrawal by Subject|17|||
42363874|NCT01928771|76213486|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
42100592|NCT00920621|75911482|FG002|Overall Study|Blood sample not collected|0|||
42196190|NCT00101686|76008096|FG004|Overall Study|intercurrent non-cancer related illness|1|||
42196191|NCT00101686|76008097|FG005|Overall Study|intercurrent non-cancer related illness|3|||
42196192|NCT00101686|76008098|FG006|Overall Study|intercurrent non-cancer related illness|1|||
42196193|NCT00101686|76008099|FG007|Overall Study|intercurrent non-cancer related illness|0|||
42196194|NCT00101686|76008100|FG008|Overall Study|intercurrent non-cancer related illness|1|||
42196195|NCT00101686|76008101|FG009|Overall Study|intercurrent non-cancer related illness|1|||
42196196|NCT00101686|76008092|FG000|Overall Study|Physician Decision|10|||
42196197|NCT00101686|76008093|FG001|Overall Study|Physician Decision|13|||
42196198|NCT00101686|76008094|FG002|Overall Study|Physician Decision|6|||
42196199|NCT00101686|76008095|FG003|Overall Study|Physician Decision|7|||
42363875|NCT01928771|76213487|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
42363876|NCT01928771|76213488|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
42363877|NCT01928771|76213486|FG000|Overall Study|Other Reasons|9|||
42363878|NCT01928771|76213487|FG001|Overall Study|Other Reasons|9|||
42363879|NCT01928771|76213488|FG002|Overall Study|Other Reasons|14|||
42363880|NCT01928771|76213486|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
42363881|NCT01928771|76213487|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
42363882|NCT01928771|76213488|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
42363883|NCT01589653|76213498|FG000|Overall Study|Protocol Violation|3|||
42363884|NCT01589653|76213499|FG001|Overall Study|Protocol Violation|1|||
42363885|NCT01589653|76213498|FG000|Overall Study|Withdrawal criteria|4|||
42363886|NCT01589653|76213499|FG001|Overall Study|Withdrawal criteria|7|||
42363887|NCT01589653|76213498|FG000|Overall Study|Unclassified|0|||
42363888|NCT01589653|76213499|FG001|Overall Study|Unclassified|3|||
42363889|NCT01928615|76213505|FG000|Overall Study|Study Terminated by Sponsor|2|||
42363890|NCT01589497|76213514|FG000|Overall Study|Withdrawal by Subject|0|||
42363891|NCT01589497|76213515|FG001|Overall Study|Withdrawal by Subject|1|||
42363892|NCT01589497|76213516|FG002|Overall Study|Withdrawal by Subject|0|||
42363893|NCT01589497|76213517|FG003|Overall Study|Withdrawal by Subject|1|||
42363894|NCT01589497|76213514|FG000|Overall Study|Death|1|||
42363895|NCT01589497|76213515|FG001|Overall Study|Death|0|||
42363896|NCT01589497|76213516|FG002|Overall Study|Death|0|||
42363897|NCT01589497|76213517|FG003|Overall Study|Death|0|||
42363898|NCT01589497|76213514|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
42363899|NCT01589497|76213515|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
42363900|NCT01589497|76213516|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
42363901|NCT01589497|76213517|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
42363902|NCT01928381|76213532|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
42363903|NCT01928381|76213533|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
42363904|NCT01928381|76213534|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
42363905|NCT01928381|76213535|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
42363906|NCT01928381|76213536|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
42363907|NCT01928381|76213537|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
42363908|NCT01928381|76213538|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
42363909|NCT01928381|76213532|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
42363910|NCT01928381|76213533|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
42363911|NCT01928381|76213534|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
42363912|NCT01928381|76213535|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
42363913|NCT01928381|76213536|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
42363914|NCT01928381|76213537|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
42196200|NCT00101686|76008096|FG004|Overall Study|Physician Decision|8|||
42196201|NCT00101686|76008097|FG005|Overall Study|Physician Decision|9|||
42196202|NCT00101686|76008098|FG006|Overall Study|Physician Decision|5|||
42196203|NCT00101686|76008099|FG007|Overall Study|Physician Decision|5|||
42196204|NCT00101686|76008100|FG008|Overall Study|Physician Decision|1|||
42196205|NCT00101686|76008101|FG009|Overall Study|Physician Decision|1|||
42196206|NCT00101686|76008092|FG000|Overall Study|Other|1|||
42196207|NCT00101686|76008093|FG001|Overall Study|Other|4|||
42196208|NCT00101686|76008094|FG002|Overall Study|Other|1|||
42196209|NCT00101686|76008095|FG003|Overall Study|Other|6|||
42196210|NCT00101686|76008096|FG004|Overall Study|Other|2|||
42196211|NCT00101686|76008097|FG005|Overall Study|Other|12|||
42196212|NCT00101686|76008098|FG006|Overall Study|Other|1|||
42196213|NCT00101686|76008099|FG007|Overall Study|Other|5|||
42196214|NCT00101686|76008100|FG008|Overall Study|Other|3|||
42363915|NCT01928381|76213538|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
42196215|NCT00101686|76008101|FG009|Overall Study|Other|3|||
42196216|NCT00101686|76008092|FG000|Overall Study|Withdrawal by Subject|9|||
42196217|NCT00101686|76008093|FG001|Overall Study|Withdrawal by Subject|8|||
42196218|NCT00101686|76008094|FG002|Overall Study|Withdrawal by Subject|6|||
42196219|NCT00101686|76008095|FG003|Overall Study|Withdrawal by Subject|8|||
42196220|NCT00101686|76008096|FG004|Overall Study|Withdrawal by Subject|8|||
42196221|NCT00101686|76008097|FG005|Overall Study|Withdrawal by Subject|7|||
42196222|NCT00101686|76008098|FG006|Overall Study|Withdrawal by Subject|7|||
42196223|NCT00101686|76008099|FG007|Overall Study|Withdrawal by Subject|7|||
42196224|NCT00101686|76008100|FG008|Overall Study|Withdrawal by Subject|8|||
42196225|NCT00101686|76008101|FG009|Overall Study|Withdrawal by Subject|9|||
42196226|NCT00101452|76008121|FG000|Overall Study|Adverse Event|2|||
42196227|NCT00101452|76008122|FG001|Overall Study|Adverse Event|0|||
42196228|NCT00101452|76008123|FG002|Overall Study|Adverse Event|1|||
42196229|NCT00101452|76008121|FG000|Overall Study|Lost to Follow-up|13|||
42196230|NCT00101452|76008122|FG001|Overall Study|Lost to Follow-up|8|||
42196231|NCT00101452|76008123|FG002|Overall Study|Lost to Follow-up|14|||
42196232|NCT00101452|76008121|FG000|Overall Study|Withdrawal by Subject|10|||
42196233|NCT00101452|76008122|FG001|Overall Study|Withdrawal by Subject|14|||
42196234|NCT00101452|76008123|FG002|Overall Study|Withdrawal by Subject|9|||
42196235|NCT00101452|76008121|FG000|Overall Study|Baseline Fail|2|||
42363916|NCT01928381|76213532|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
42363917|NCT01928381|76213533|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
42363918|NCT01928381|76213534|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
42363919|NCT01928381|76213535|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
42363920|NCT01928381|76213536|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
42363921|NCT01928381|76213537|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
42363922|NCT01928381|76213538|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
42363923|NCT01928381|76213532|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
42363924|NCT01928381|76213533|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
42363925|NCT01928381|76213534|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
42363926|NCT01928381|76213535|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
42363927|NCT01928381|76213536|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
42363928|NCT01928381|76213537|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
42363929|NCT01928381|76213538|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
42363930|NCT01928381|76213532|FG000|Part 1 - Pain Training|Protocol Violation|1|||
42363931|NCT01928381|76213533|FG001|Part 1 - Pain Training|Protocol Violation|0|||
42363932|NCT01928381|76213534|FG002|Part 1 - Pain Training|Protocol Violation|0|||
42363933|NCT01928381|76213535|FG003|Part 1 - Pain Training|Protocol Violation|0|||
42363934|NCT01928381|76213536|FG004|Part 1 - Pain Training|Protocol Violation|0|||
42363935|NCT01928381|76213537|FG005|Part 1 - Pain Training|Protocol Violation|0|||
42363936|NCT01928381|76213538|FG006|Part 1 - Pain Training|Protocol Violation|0|||
42018506|NCT00996892|75825868|FG007|Expansion Stage 2A|Physician Decision|0|||
42100593|NCT00920621|75911483|FG003|Overall Study|Blood sample not collected|0|||
42100594|NCT00612105|75911496|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
42100595|NCT00612105|75911497|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
42100596|NCT00612105|75911496|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
42100597|NCT00612105|75911497|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
42100598|NCT00612105|75911496|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
42100599|NCT00612105|75911497|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
42100600|NCT00612105|75911496|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
42100601|NCT00612105|75911497|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
42100602|NCT00612105|75911496|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
42100603|NCT00612105|75911497|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
42100604|NCT00612105|75911496|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
42100605|NCT00612105|75911497|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
42100606|NCT00612105|75911496|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
42100607|NCT00612105|75911497|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
42100608|NCT00612105|75911496|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
42100609|NCT00612105|75911497|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
42100610|NCT00612105|75911496|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
42100611|NCT00612105|75911497|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
42100612|NCT00612105|75911496|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
42100613|NCT00612105|75911497|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
42100614|NCT00612105|75911496|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
42196236|NCT00101452|76008122|FG001|Overall Study|Baseline Fail|1|||
42196237|NCT00101452|76008123|FG002|Overall Study|Baseline Fail|2|||
42196238|NCT00101452|76008121|FG000|Overall Study|Physician Decision|0|||
42196239|NCT00101452|76008122|FG001|Overall Study|Physician Decision|3|||
42363937|NCT01928381|76213532|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
42363938|NCT01928381|76213533|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
42018507|NCT00996892|75825869|FG008|Expansion Stage 2A|Physician Decision|0|||
42018508|NCT00996892|75825870|FG009|Expansion Stage 2A|Physician Decision|0|||
42018509|NCT00996892|75825871|FG010|Expansion Stage 2A|Physician Decision|0|||
42018510|NCT00996892|75825872|FG011|Expansion Stage 2A|Physician Decision|0|||
42018511|NCT00996892|75825873|FG012|Expansion Stage 2A|Physician Decision|0|||
42018512|NCT00996892|75825874|FG013|Expansion Stage 2A|Physician Decision|0|||
42018513|NCT00996892|75825875|FG014|Expansion Stage 2A|Physician Decision|0|||
42018514|NCT00996892|75825876|FG015|Expansion Stage 2A|Physician Decision|0|||
42363939|NCT01928381|76213534|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
42363940|NCT01928381|76213535|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
42363941|NCT01928381|76213536|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
42363942|NCT01928381|76213537|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
42363943|NCT01928381|76213538|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
42363944|NCT01928381|76213532|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
42363945|NCT01928381|76213533|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
42363946|NCT01928381|76213534|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
42363947|NCT01928381|76213535|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
42363948|NCT01928381|76213536|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
42363949|NCT01928381|76213537|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
42100615|NCT00612105|75911497|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
42100616|NCT00612105|75911496|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
42100617|NCT00612105|75911497|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
42100618|NCT00546052|75911503|FG000|Overall Study|Adverse Event|47|||
42100619|NCT00546052|75911503|FG000|Overall Study|Lost to Follow-up|144|||
42100620|NCT00546052|75911503|FG000|Overall Study|Protocol Violation|9|||
42100621|NCT00546052|75911503|FG000|Overall Study|Withdrawal by Subject|20|||
42100622|NCT00546052|75911503|FG000|Overall Study|Non Compliance|7|||
42100623|NCT00673920|75911518|FG000|Baseline up to Week 48|Withdrew consent|1|||
42100624|NCT00673920|75911519|FG001|Baseline up to Week 48|Withdrew consent|0|||
42100625|NCT00673920|75911520|FG002|Baseline up to Week 48|Withdrew consent|2|||
42100626|NCT00673920|75911521|FG003|Baseline up to Week 48|Withdrew consent|0|||
42100627|NCT00673920|75911522|FG004|Baseline up to Week 48|Withdrew consent|0|||
42100628|NCT00673920|75911523|FG005|Baseline up to Week 48|Withdrew consent|0|||
42100629|NCT00673920|75911524|FG006|Baseline up to Week 48|Withdrew consent|0|||
42100630|NCT00673920|75911525|FG007|Baseline up to Week 48|Withdrew consent|0|||
42100631|NCT00673920|75911518|FG000|Baseline up to Week 48|Refused treatment|1|||
42100632|NCT00673920|75911519|FG001|Baseline up to Week 48|Refused treatment|0|||
42100633|NCT00673920|75911520|FG002|Baseline up to Week 48|Refused treatment|0|||
42100634|NCT00673920|75911521|FG003|Baseline up to Week 48|Refused treatment|0|||
42100635|NCT00673920|75911522|FG004|Baseline up to Week 48|Refused treatment|0|||
42100636|NCT00673920|75911523|FG005|Baseline up to Week 48|Refused treatment|0|||
42100637|NCT00673920|75911524|FG006|Baseline up to Week 48|Refused treatment|0|||
42100638|NCT00673920|75911525|FG007|Baseline up to Week 48|Refused treatment|0|||
42100639|NCT00673920|75911518|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
42100640|NCT00673920|75911519|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
42100641|NCT00673920|75911520|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
42100642|NCT00673920|75911521|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
42100643|NCT00673920|75911522|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
42100644|NCT00673920|75911523|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
42100645|NCT00673920|75911524|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
42100646|NCT00673920|75911525|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
42100647|NCT00673920|75911518|FG000|Baseline up to Week 48|Protocol Violation|0|||
42196240|NCT00101452|76008123|FG002|Overall Study|Physician Decision|2|||
42363950|NCT01928381|76213538|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
42363951|NCT01928381|76213532|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
42363952|NCT01928381|76213533|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
42363953|NCT01928381|76213534|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
42363954|NCT01928381|76213535|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
42363955|NCT01928381|76213536|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
42363956|NCT01928381|76213537|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
42363957|NCT01928381|76213538|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
42363958|NCT01928381|76213532|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
42363959|NCT01928381|76213533|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
42363960|NCT01928381|76213534|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
42363961|NCT01928381|76213535|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
42363962|NCT01928381|76213536|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
42363963|NCT01928381|76213537|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
42100648|NCT00673920|75911519|FG001|Baseline up to Week 48|Protocol Violation|0|||
42100649|NCT00673920|75911520|FG002|Baseline up to Week 48|Protocol Violation|1|||
42100650|NCT00673920|75911521|FG003|Baseline up to Week 48|Protocol Violation|0|||
42100651|NCT00673920|75911522|FG004|Baseline up to Week 48|Protocol Violation|0|||
42100652|NCT00673920|75911523|FG005|Baseline up to Week 48|Protocol Violation|0|||
42100653|NCT00673920|75911524|FG006|Baseline up to Week 48|Protocol Violation|0|||
42100654|NCT00673920|75911525|FG007|Baseline up to Week 48|Protocol Violation|0|||
42196241|NCT00101452|76008121|FG000|Overall Study|Protocol Violation|2|||
42363964|NCT01928381|76213538|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
42363965|NCT01928381|76213532|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
42363966|NCT01928381|76213533|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
42363967|NCT01928381|76213534|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
42363968|NCT01928381|76213535|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
42363969|NCT01928381|76213536|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
42363970|NCT01928381|76213537|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
42363971|NCT01928381|76213538|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
42363972|NCT01928381|76213532|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
42363973|NCT01928381|76213533|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
42363974|NCT01928381|76213534|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
42363975|NCT01928381|76213535|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
42363976|NCT01928381|76213536|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
42363977|NCT01928381|76213537|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
42363978|NCT01928381|76213538|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
42363979|NCT01928381|76213532|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
42363980|NCT01928381|76213533|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
42363981|NCT01928381|76213534|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
42363982|NCT01928381|76213535|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
42363983|NCT01928381|76213536|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
42363984|NCT01928381|76213537|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
42363985|NCT01928381|76213538|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
42363986|NCT01928381|76213532|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
42363987|NCT01928381|76213533|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
42363988|NCT01928381|76213534|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
42363989|NCT01928381|76213535|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
42363990|NCT01928381|76213536|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
42363991|NCT01928381|76213537|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
42363992|NCT01928381|76213538|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
42363993|NCT01928381|76213532|FG000|Washout First Intervention|Protocol Violation|0|||
42363994|NCT01928381|76213533|FG001|Washout First Intervention|Protocol Violation|0|||
42363995|NCT01928381|76213534|FG002|Washout First Intervention|Protocol Violation|0|||
42363996|NCT01928381|76213535|FG003|Washout First Intervention|Protocol Violation|0|||
42363997|NCT01928381|76213536|FG004|Washout First Intervention|Protocol Violation|1|||
42363998|NCT01928381|76213537|FG005|Washout First Intervention|Protocol Violation|0|||
42363999|NCT01928381|76213538|FG006|Washout First Intervention|Protocol Violation|0|||
42364000|NCT01928381|76213532|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
42364001|NCT01928381|76213533|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
42364002|NCT01928381|76213534|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
42364003|NCT01928381|76213535|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
42364004|NCT01928381|76213536|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
42364005|NCT01928381|76213537|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
42364006|NCT01928381|76213538|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
42364007|NCT01928381|76213532|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
42364008|NCT01928381|76213533|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
42100655|NCT00673920|75911518|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
42100656|NCT00673920|75911519|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
42100657|NCT00673920|75911520|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
42100658|NCT00673920|75911521|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
42100659|NCT00673920|75911522|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
42100660|NCT00673920|75911523|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
42364009|NCT01928381|76213534|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
42364010|NCT01928381|76213535|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
42364011|NCT01928381|76213536|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
42364012|NCT01928381|76213537|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
42364013|NCT01928381|76213538|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
42364014|NCT01928225|76213550|FG000|Overall Study|Pregnancy|1|||
42364015|NCT01928225|76213551|FG001|Overall Study|Pregnancy|0|||
42364016|NCT01928225|76213550|FG000|Overall Study|basaloid cervical cancer|1|||
42364017|NCT01928225|76213551|FG001|Overall Study|basaloid cervical cancer|0|||
42364018|NCT01928225|76213550|FG000|Overall Study|Lost to Follow-up|1|||
42364019|NCT01928225|76213551|FG001|Overall Study|Lost to Follow-up|3|||
42364020|NCT01927757|76213558|FG000|Overall Study|Withdrawal by Subject|14|||
42364021|NCT01927757|76213558|FG000|Overall Study|Lost to Follow-up|2|||
42100661|NCT00673920|75911524|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
42100662|NCT00673920|75911525|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
42100663|NCT00673920|75911518|FG000|Baseline up to Week 48|Administrative/Other|0|||
42100664|NCT00673920|75911519|FG001|Baseline up to Week 48|Administrative/Other|1|||
42364022|NCT01927757|76213558|FG000|Overall Study|Decision by Sponsor|2|||
42364023|NCT01927757|76213558|FG000|Overall Study|Other|1|||
42364024|NCT01927757|76213558|FG000|Overall Study|Ethical Reasons|4|||
42100665|NCT00673920|75911520|FG002|Baseline up to Week 48|Administrative/Other|2|||
42100666|NCT00673920|75911521|FG003|Baseline up to Week 48|Administrative/Other|0|||
42100667|NCT00673920|75911522|FG004|Baseline up to Week 48|Administrative/Other|0|||
42364025|NCT01927367|76213568|FG000|Overall Study|Withdrawal by Subject|7|||
42364026|NCT01927367|76213569|FG001|Overall Study|Withdrawal by Subject|4|||
42364027|NCT01927367|76213568|FG000|Overall Study|No baseline data|0|||
42364028|NCT01927367|76213569|FG001|Overall Study|No baseline data|1|||
42364029|NCT01913639|76213575|FG000|Overall Study|Not Eligible|3|||
42364030|NCT01913483|76213581|FG000|Overall Study|Withdrawal by Subject|1|||
42364031|NCT01913483|76213582|FG001|Overall Study|Withdrawal by Subject|2|||
42364032|NCT01913483|76213581|FG000|Overall Study|Lost to Follow-up|6|||
42364033|NCT01913483|76213582|FG001|Overall Study|Lost to Follow-up|3|||
42364034|NCT01913483|76213581|FG000|Overall Study|Death|14|||
42364035|NCT01913483|76213582|FG001|Overall Study|Death|17|||
42364036|NCT01913405|76213588|FG000|Overall Study|Withdrawal by Subject|1|||
42364037|NCT01913405|76213588|FG000|Overall Study|Adverse Event|1|||
42364038|NCT01927055|76213608|FG000|Open-label|Adverse Event|6|||
42364039|NCT01927055|76213609|FG001|Open-label|Adverse Event|0|||
42364040|NCT01927055|76213610|FG002|Open-label|Adverse Event|0|||
42364041|NCT01927055|76213608|FG000|Open-label|Withdrawal by Subject|1|||
42364042|NCT01927055|76213609|FG001|Open-label|Withdrawal by Subject|0|||
42364043|NCT01927055|76213610|FG002|Open-label|Withdrawal by Subject|0|||
42364044|NCT01927055|76213608|FG000|Open-label|Study Stopped|4|||
42364045|NCT01927055|76213609|FG001|Open-label|Study Stopped|0|||
42364046|NCT01927055|76213610|FG002|Open-label|Study Stopped|0|||
42364047|NCT01927055|76213608|FG000|Open-label|Supine Hypertension|4|||
42364048|NCT01927055|76213609|FG001|Open-label|Supine Hypertension|0|||
42364049|NCT01927055|76213610|FG002|Open-label|Supine Hypertension|0|||
42364050|NCT01927055|76213608|FG000|Open-label|Difficulty attending study visits|1|||
42364051|NCT01927055|76213609|FG001|Open-label|Difficulty attending study visits|0|||
42364052|NCT01927055|76213610|FG002|Open-label|Difficulty attending study visits|0|||
42364053|NCT01927055|76213608|FG000|Double-Blind|Adverse Event|0|||
42364054|NCT01927055|76213609|FG001|Double-Blind|Adverse Event|1|||
42364055|NCT01927055|76213610|FG002|Double-Blind|Adverse Event|1|||
42364056|NCT01927055|76213608|FG000|Double-Blind|Protocol Violation|0|||
42364057|NCT01927055|76213609|FG001|Double-Blind|Protocol Violation|0|||
42364058|NCT01927055|76213610|FG002|Double-Blind|Protocol Violation|1|||
42364059|NCT01927055|76213608|FG000|Double-Blind|Withdrawal by Subject|0|||
42364060|NCT01927055|76213609|FG001|Double-Blind|Withdrawal by Subject|2|||
42364061|NCT01927055|76213610|FG002|Double-Blind|Withdrawal by Subject|3|||
42364062|NCT01927055|76213608|FG000|Double-Blind|Study Stopped|0|||
42364063|NCT01927055|76213609|FG001|Double-Blind|Study Stopped|7|||
42364064|NCT01927055|76213610|FG002|Double-Blind|Study Stopped|7|||
42364065|NCT01927055|76213608|FG000|Double-Blind|Supine Hypertension|0|||
42364066|NCT01927055|76213609|FG001|Double-Blind|Supine Hypertension|0|||
42364067|NCT01927055|76213610|FG002|Double-Blind|Supine Hypertension|1|||
42364068|NCT01927055|76213608|FG000|Double-Blind|Extended Vacation|0|||
42364069|NCT01927055|76213609|FG001|Double-Blind|Extended Vacation|1|||
42364070|NCT01927055|76213610|FG002|Double-Blind|Extended Vacation|0|||
42364071|NCT01913327|76213619|FG000|Overall Study|Withdrawal by Subject|0|||
42364072|NCT01913327|76213620|FG001|Overall Study|Withdrawal by Subject|1|||
42364073|NCT01926509|76213630|FG000|Overall Study|vital sign met discontinuation criteria|1|||
42364074|NCT01926509|76213631|FG001|Overall Study|vital sign met discontinuation criteria|0|||
42364075|NCT01926509|76213632|FG002|Overall Study|vital sign met discontinuation criteria|0|||
42364076|NCT01926509|76213633|FG003|Overall Study|vital sign met discontinuation criteria|0|||
42364077|NCT01926119|76213643|FG000|Overall Study|Withdrawal by Subject|1|||
42364078|NCT01912781|76213649|FG000|Overall Study|Withdrawal by Subject|2|||
42364079|NCT01912781|76213650|FG001|Overall Study|Withdrawal by Subject|0|||
42364080|NCT01925417|76213657|FG000|Overall Study|Withdrawal by Subject|2|||
42100668|NCT00673920|75911523|FG005|Baseline up to Week 48|Administrative/Other|0|||
42100669|NCT00673920|75911524|FG006|Baseline up to Week 48|Administrative/Other|0|||
42364081|NCT01925417|76213657|FG000|Overall Study|Death|1|||
42364082|NCT01911845|76213662|FG000|Overall Study|Adverse Event|2|||
42364083|NCT01911845|76213662|FG000|Overall Study|Lost to Follow-up|1|||
42018515|NCT00996892|75825877|FG016|Expansion Stage 2A|Physician Decision|0|||
42018516|NCT00996892|75825878|FG017|Expansion Stage 2A|Physician Decision|0|||
42018517|NCT00996892|75825879|FG018|Expansion Stage 2A|Physician Decision|0|||
42018518|NCT00996892|75825880|FG019|Expansion Stage 2A|Physician Decision|2|||
42018519|NCT00996892|75825861|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
42018520|NCT00996892|75825862|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
42018521|NCT00996892|75825863|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
42018522|NCT00996892|75825864|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
42364084|NCT01911845|76213662|FG000|Overall Study|Other (not specified)|3|||
42018523|NCT00996892|75825865|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
42364085|NCT01925183|76213670|FG000|Overall Study|Adverse Event|1|||
42364086|NCT01925183|76213671|FG001|Overall Study|Adverse Event|0|||
42364087|NCT01910519|76213679|FG000|Overall Study|Withdrawal by Subject|2|||
42364088|NCT01910519|76213680|FG001|Overall Study|Withdrawal by Subject|0|||
42364089|NCT01910519|76213679|FG000|Overall Study|Adverse Event|2|||
42364090|NCT01910519|76213680|FG001|Overall Study|Adverse Event|0|||
42364091|NCT01910441|76213688|FG000|Overall Study|Sponsor decision|0|||
42364092|NCT01910441|76213689|FG001|Overall Study|Sponsor decision|2|||
42364093|NCT01910441|76213688|FG000|Overall Study|Lost to Follow-up|6|||
42364094|NCT01910441|76213689|FG001|Overall Study|Lost to Follow-up|5|||
42364095|NCT01910441|76213688|FG000|Overall Study|Withdrawal by Subject|0|||
42364096|NCT01910441|76213689|FG001|Overall Study|Withdrawal by Subject|1|||
42364097|NCT01910441|76213688|FG000|Overall Study|Non-compliance|0|||
42196242|NCT00101452|76008122|FG001|Overall Study|Protocol Violation|1|||
42196243|NCT00101452|76008123|FG002|Overall Study|Protocol Violation|3|||
42196244|NCT00101452|76008121|FG000|Overall Study|Other|15|||
42196245|NCT00101452|76008122|FG001|Overall Study|Other|16|||
42196246|NCT00101452|76008123|FG002|Overall Study|Other|12|||
42196247|NCT03546621|76008139|FG000|Overall Study|Withdrawal by Subject|0|||
42364098|NCT01910441|76213689|FG001|Overall Study|Non-compliance|1|||
42364099|NCT01910441|76213688|FG000|Overall Study|Adverse Event|1|||
42364100|NCT01910441|76213689|FG001|Overall Study|Adverse Event|0|||
42364101|NCT01910441|76213688|FG000|Overall Study|Physician Decision|0|||
42364102|NCT01910441|76213689|FG001|Overall Study|Physician Decision|1|||
42364103|NCT01923467|76213695|FG000|Overall Study|Lost to Follow-up|62|||
42364104|NCT01923467|76213695|FG000|Overall Study|Subject non-interest|479|||
42364105|NCT01910129|76213701|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
42364106|NCT01910129|76213702|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
42364107|NCT01910129|76213703|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
42364108|NCT01910129|76213701|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
42364109|NCT01910129|76213702|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
42364110|NCT01910129|76213703|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
42364111|NCT01909973|76213723|FG000|Overall Study|Lost to Follow-up|1|||
42364112|NCT01909973|76213724|FG001|Overall Study|Lost to Follow-up|0|||
42364113|NCT01617005|76213730|FG000|Overall Study|Pregnancy|1|||
42364114|NCT01617005|76213730|FG000|Overall Study|Lack of motivation for treatment|1|||
42364115|NCT01925339|76213736|FG000|Overall Study|Adverse Event|2|||
42364116|NCT01925339|76213737|FG001|Overall Study|Adverse Event|0|||
42364117|NCT01908803|76213745|FG000|Overall Study|Adverse Event|1|||
42364118|NCT01908803|76213746|FG001|Overall Study|Adverse Event|0|||
42364119|NCT01908803|76213745|FG000|Overall Study|Physician Decision|0|||
42196248|NCT03546621|76008140|FG001|Overall Study|Withdrawal by Subject|1|||
42196249|NCT03546621|76008141|FG002|Overall Study|Withdrawal by Subject|2|||
42196250|NCT03546621|76008142|FG003|Overall Study|Withdrawal by Subject|1|||
42196251|NCT03546621|76008139|FG000|Overall Study|Lost to Follow-up|0|||
42196252|NCT03546621|76008140|FG001|Overall Study|Lost to Follow-up|1|||
42364120|NCT01908803|76213746|FG001|Overall Study|Physician Decision|1|||
42364121|NCT01908803|76213745|FG000|Overall Study|Withdrawal by Subject|1|||
42364122|NCT01908803|76213746|FG001|Overall Study|Withdrawal by Subject|0|||
42364123|NCT01908803|76213745|FG000|Overall Study|Randomization Error|1|||
42364124|NCT01908803|76213746|FG001|Overall Study|Randomization Error|0|||
42364125|NCT01908803|76213745|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
42364126|NCT01908803|76213746|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
42364127|NCT01908101|76213753|FG000|Overall Study|Physician Decision|1|||
42364128|NCT01908101|76213753|FG000|Overall Study|Withdrawal by Subject|1|||
42364129|NCT01908101|76213753|FG000|Overall Study|Incorrect Diagnosis|2|||
42364130|NCT01908101|76213753|FG000|Overall Study|Incorrect Starting Dose|1|||
42364131|NCT01908101|76213753|FG000|Overall Study|Did not complete the first cycle|4|||
42364132|NCT01923389|76213759|FG000|Overall Study|Protocol Violation|1|||
42364133|NCT01923389|76213760|FG001|Overall Study|Protocol Violation|0|||
42100670|NCT00673920|75911525|FG007|Baseline up to Week 48|Administrative/Other|0|||
42100671|NCT00673920|75911518|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
42100672|NCT00673920|75911519|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
42100673|NCT00673920|75911520|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
42100674|NCT00673920|75911521|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
42100675|NCT00673920|75911522|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
42100676|NCT00673920|75911523|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
42100677|NCT00673920|75911524|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
42196253|NCT03546621|76008141|FG002|Overall Study|Lost to Follow-up|0|||
42196254|NCT03546621|76008142|FG003|Overall Study|Lost to Follow-up|0|||
42364134|NCT01907087|76213767|FG000|Overall Study|Withdrawal by Subject|1|||
42100678|NCT00673920|75911525|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
42364135|NCT01616771|76213771|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
42364136|NCT01589185|76213785|FG000|Overall Study|Death|1|||
42196255|NCT03546621|76008139|FG000|Overall Study|Adverse Event|0|||
42364137|NCT01589185|76213786|FG001|Overall Study|Death|2|||
42364138|NCT01589185|76213787|FG002|Overall Study|Death|2|||
42196256|NCT03546621|76008140|FG001|Overall Study|Adverse Event|1|||
42196257|NCT03546621|76008141|FG002|Overall Study|Adverse Event|0|||
42364139|NCT01589185|76213788|FG003|Overall Study|Death|0|||
42364140|NCT01589185|76213789|FG004|Overall Study|Death|1|||
42364141|NCT01589185|76213785|FG000|Overall Study|Lost to Follow-up|1|||
42364142|NCT01589185|76213786|FG001|Overall Study|Lost to Follow-up|0|||
42364143|NCT01589185|76213787|FG002|Overall Study|Lost to Follow-up|2|||
42364144|NCT01589185|76213788|FG003|Overall Study|Lost to Follow-up|3|||
42364145|NCT01589185|76213789|FG004|Overall Study|Lost to Follow-up|0|||
42364146|NCT01588951|76213805|FG000|Overall Study|Ineligible in retrospect|0|||
42364147|NCT01588951|76213806|FG001|Overall Study|Ineligible in retrospect|0|||
42364148|NCT01588951|76213807|FG002|Overall Study|Ineligible in retrospect|1|||
42364149|NCT01709383|76213817|FG000|Overall Study|Lost to Follow-up|1|||
42364150|NCT01709383|76213818|FG001|Overall Study|Lost to Follow-up|0|||
42196258|NCT03546621|76008142|FG003|Overall Study|Adverse Event|1|||
42196259|NCT03546621|76008139|FG000|Overall Study|Progressive disease|0|||
42196260|NCT03546621|76008140|FG001|Overall Study|Progressive disease|0|||
42196261|NCT03546621|76008141|FG002|Overall Study|Progressive disease|0|||
42196262|NCT03546621|76008142|FG003|Overall Study|Progressive disease|1|||
42196263|NCT02761330|76008152|FG000|Treatment Week 1|Withdrawal by Subject|0|||
42196264|NCT02761330|76008153|FG001|Treatment Week 1|Withdrawal by Subject|0|||
42196265|NCT02761330|76008154|FG002|Treatment Week 1|Withdrawal by Subject|0|||
42196266|NCT02761330|76008155|FG003|Treatment Week 1|Withdrawal by Subject|1|||
42196267|NCT02761330|76008156|FG004|Treatment Week 1|Withdrawal by Subject|0|||
42196268|NCT02761330|76008157|FG005|Treatment Week 1|Withdrawal by Subject|1|||
42196269|NCT03559257|76008173|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
42196270|NCT03559257|76008174|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
42196271|NCT03559257|76008173|FG000|Double Blind Treatment Period|Protocol Violation|1|||
42196272|NCT03559257|76008174|FG001|Double Blind Treatment Period|Protocol Violation|4|||
42196273|NCT03559257|76008173|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
42196274|NCT03559257|76008174|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
42196275|NCT03559257|76008173|FG000|Double Blind Treatment Period|Adverse Event|0|||
42196276|NCT03559257|76008174|FG001|Double Blind Treatment Period|Adverse Event|1|||
42196277|NCT03559257|76008173|FG000|Double Blind Treatment Period|Screen Failure|0|||
42196278|NCT03559257|76008174|FG001|Double Blind Treatment Period|Screen Failure|1|||
42196279|NCT03559257|76008173|FG000|Open-label Treatment Period|Adverse Event|1|||
42196280|NCT03559257|76008174|FG001|Open-label Treatment Period|Adverse Event|4|||
42196281|NCT03559257|76008173|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
42196282|NCT03559257|76008174|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
42196283|NCT03559257|76008173|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
42196284|NCT03559257|76008174|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
42196285|NCT03559257|76008173|FG000|Open-label Treatment Period|Protocol Violation|2|||
42196286|NCT03559257|76008174|FG001|Open-label Treatment Period|Protocol Violation|0|||
42196287|NCT03559257|76008173|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
42196288|NCT03559257|76008174|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
42196289|NCT03559257|76008173|FG000|Open-label Treatment Period|Physician Decision|0|||
42196290|NCT03559257|76008174|FG001|Open-label Treatment Period|Physician Decision|1|||
42196291|NCT02892513|76008185|FG000|Overall Study|Withdrawal by Subject|0|||
42196292|NCT02892513|76008186|FG001|Overall Study|Withdrawal by Subject|1|||
42196293|NCT03558555|76008194|FG000|Overall Study|Lost to Follow-up|2|||
42196294|NCT03558555|76008195|FG001|Overall Study|Lost to Follow-up|1|||
42196295|NCT03541317|76008203|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
42196296|NCT03541317|76008204|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
42196297|NCT03541317|76008205|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
42196298|NCT03541317|76008206|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
42196299|NCT03541317|76008207|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
42196300|NCT03541317|76008208|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
42196301|NCT03557931|76008223|FG000|Overall Study|Adverse Event|4|||
42364151|NCT01588405|76213826|FG000|Overall Study|Adverse Event|1|||
42364152|NCT01588405|76213826|FG000|Overall Study|Clinical Worsening|1|||
42364153|NCT01923311|76213835|FG000|Overall Study|Pregnancy|1|||
42364154|NCT01923311|76213836|FG001|Overall Study|Pregnancy|0|||
42364155|NCT01923311|76213835|FG000|Overall Study|Investigator's Discretion|1|||
42364156|NCT01923311|76213836|FG001|Overall Study|Investigator's Discretion|0|||
42364157|NCT01923311|76213835|FG000|Overall Study|Non-Compliance with Study Drug|2|||
42364158|NCT01923311|76213836|FG001|Overall Study|Non-Compliance with Study Drug|1|||
42364159|NCT01923311|76213835|FG000|Overall Study|Withdrew Consent|1|||
42196302|NCT03557931|76008224|FG001|Overall Study|Adverse Event|6|||
42196303|NCT03557931|76008225|FG002|Overall Study|Adverse Event|1|||
42196304|NCT03557931|76008223|FG000|Overall Study|Lost to Follow-up|4|||
42364160|NCT01923311|76213836|FG001|Overall Study|Withdrew Consent|0|||
42364161|NCT01923311|76213835|FG000|Overall Study|Study Terminated by Sponsor|12|||
42100679|NCT00673920|75911518|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
42196305|NCT03557931|76008224|FG001|Overall Study|Lost to Follow-up|4|||
42196306|NCT03557931|76008225|FG002|Overall Study|Lost to Follow-up|1|||
42196307|NCT03557931|76008223|FG000|Overall Study|Protocol Violation|1|||
42196308|NCT03557931|76008224|FG001|Overall Study|Protocol Violation|4|||
42364162|NCT01923311|76213836|FG001|Overall Study|Study Terminated by Sponsor|0|||
42100680|NCT00673920|75911519|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
42196309|NCT03557931|76008225|FG002|Overall Study|Protocol Violation|1|||
42196310|NCT03557931|76008223|FG000|Overall Study|Withdrawal by Subject|14|||
42196311|NCT03557931|76008224|FG001|Overall Study|Withdrawal by Subject|0|||
42196312|NCT03557931|76008225|FG002|Overall Study|Withdrawal by Subject|7|||
42196313|NCT03557931|76008223|FG000|Overall Study|Miscellaneous|8|||
42196314|NCT03557931|76008224|FG001|Overall Study|Miscellaneous|5|||
42196315|NCT03557931|76008225|FG002|Overall Study|Miscellaneous|3|||
42196316|NCT03522675|76008235|FG000|Overall Study|Screen fail|1|||
42196317|NCT03522675|76008235|FG000|Overall Study|Non-reactive to histamine|1|||
42196318|NCT00294047|76008245|FG000|Month 48|Adverse Event|28|||
42196319|NCT00294047|76008246|FG001|Month 48|Adverse Event|13|||
42196320|NCT00294047|76008245|FG000|Month 48|Protocol Violation|4|||
42196321|NCT00294047|76008246|FG001|Month 48|Protocol Violation|4|||
42196322|NCT00294047|76008245|FG000|Month 48|Withdrawal by Subject|111|||
42196323|NCT00294047|76008246|FG001|Month 48|Withdrawal by Subject|115|||
42196324|NCT00294047|76008245|FG000|Month 48|Lost to Follow-up|272|||
42196325|NCT00294047|76008246|FG001|Month 48|Lost to Follow-up|287|||
42364163|NCT01603615|76213843|FG000|Overall Study|Did not Receive Treatment|7|||
42364164|NCT01603615|76213843|FG000|Overall Study|Lost to Follow-up|9|||
42364165|NCT01603615|76213843|FG000|Overall Study|Personal Reasons|17|||
42364166|NCT01603615|76213843|FG000|Overall Study|Other Miscellaneous|1|||
42364167|NCT01685047|76213847|FG000|Overall Study|Withdrawal by Subject|20|||
42364168|NCT01685047|76213847|FG000|Overall Study|Death|26|||
42364169|NCT01685047|76213847|FG000|Overall Study|Lost to Follow-up|8|||
42364170|NCT01685047|76213847|FG000|Overall Study|Physician Decision|25|||
42364171|NCT01685047|76213847|FG000|Overall Study|Adverse Event|5|||
42364172|NCT01685047|76213847|FG000|Overall Study|patient withdrawn by sponsor|1|||
42364173|NCT01905683|76213851|FG000|Overall Study|Protocol Violation|1|||
42364174|NCT01905683|76213851|FG000|Overall Study|Re-injection criteria not met; others|13|||
42364175|NCT01905683|76213851|FG000|Overall Study|Physician Decision|1|||
42364176|NCT01905683|76213851|FG000|Overall Study|Lack of Efficacy|8|||
42364177|NCT01905683|76213851|FG000|Overall Study|Withdrawal by Subject|20|||
42364178|NCT01905683|76213851|FG000|Overall Study|Adverse Event|4|||
42364179|NCT01905683|76213851|FG000|Overall Study|Lost to Follow-up|4|||
42364180|NCT01921829|76213857|FG000|Overall Study|Withdrawal by Subject|0|||
42364181|NCT01921829|76213858|FG001|Overall Study|Withdrawal by Subject|1|||
42364182|NCT01904903|76213864|FG000|Overall Study|Withdrawal by Subject|1|||
42364183|NCT01921517|76213870|FG000|Overall Study|Lost to Follow-up|5|||
42364184|NCT01921517|76213871|FG001|Overall Study|Lost to Follow-up|0|||
42364185|NCT01921517|76213870|FG000|Overall Study|Newly diagnosed health concern|2|||
42364186|NCT01921517|76213871|FG001|Overall Study|Newly diagnosed health concern|0|||
42364187|NCT01921517|76213870|FG000|Overall Study|Physician Decision|0|||
42364188|NCT01921517|76213871|FG001|Overall Study|Physician Decision|2|||
42364189|NCT01921517|76213870|FG000|Overall Study|Withdrawal by Subject|7|||
42364190|NCT01921517|76213871|FG001|Overall Study|Withdrawal by Subject|3|||
42364191|NCT01921517|76213870|FG000|Overall Study|Subject missed final imaging|1|||
42196326|NCT00294047|76008245|FG000|Month 48|Other|10|||
42196327|NCT00294047|76008246|FG001|Month 48|Other|14|||
42196328|NCT00294047|76008245|FG000|Month 84|Adverse Event|4|||
42196329|NCT00294047|76008246|FG001|Month 84|Adverse Event|2|||
42196330|NCT00294047|76008245|FG000|Month 84|Protocol Violation|1|||
42196331|NCT00294047|76008246|FG001|Month 84|Protocol Violation|1|||
42196332|NCT00294047|76008245|FG000|Month 84|Withdrawal by Subject|33|||
42196333|NCT00294047|76008246|FG001|Month 84|Withdrawal by Subject|31|||
42196334|NCT00294047|76008245|FG000|Month 84|Lost to Follow-up|187|||
42196335|NCT00294047|76008246|FG001|Month 84|Lost to Follow-up|190|||
42196336|NCT00294047|76008245|FG000|Month 84|Absent Cervix|2|||
42196337|NCT00294047|76008246|FG001|Month 84|Absent Cervix|0|||
42196338|NCT00294047|76008245|FG000|Month 84|Work related reasons|4|||
42196339|NCT00294047|76008246|FG001|Month 84|Work related reasons|2|||
42196340|NCT00294047|76008245|FG000|Month 84|Center closed, subject did not transfer|1|||
42196341|NCT00294047|76008246|FG001|Month 84|Center closed, subject did not transfer|0|||
42364192|NCT01921517|76213871|FG001|Overall Study|Subject missed final imaging|4|||
42364193|NCT01921205|76213879|FG000|Overall Study|Adverse Event|12|||
42364194|NCT01921205|76213880|FG001|Overall Study|Adverse Event|7|||
42364195|NCT01921205|76213879|FG000|Overall Study|Lack of Efficacy|1|||
42364196|NCT01921205|76213880|FG001|Overall Study|Lack of Efficacy|0|||
42364197|NCT01921205|76213879|FG000|Overall Study|Protocol Violation|1|||
42364198|NCT01921205|76213880|FG001|Overall Study|Protocol Violation|3|||
42196342|NCT00294047|76008245|FG000|Month 84|Family problems|2|||
42196343|NCT00294047|76008246|FG001|Month 84|Family problems|2|||
42196344|NCT00294047|76008245|FG000|Month 84|Lack of time|3|||
42196345|NCT00294047|76008246|FG001|Month 84|Lack of time|1|||
42196346|NCT00294047|76008245|FG000|Month 84|Personal reason|2|||
42196347|NCT00294047|76008246|FG001|Month 84|Personal reason|4|||
42364199|NCT01921205|76213879|FG000|Overall Study|Lost to Follow-up|1|||
42364200|NCT01921205|76213880|FG001|Overall Study|Lost to Follow-up|1|||
42364201|NCT01921205|76213879|FG000|Overall Study|Withdrawal by Subject|6|||
42364202|NCT01921205|76213880|FG001|Overall Study|Withdrawal by Subject|5|||
42196348|NCT00294047|76008245|FG000|Month 84|Subject does not want male physician|1|||
42364203|NCT01921205|76213879|FG000|Overall Study|Use Of Prohibited Medication|0|||
42364204|NCT01921205|76213880|FG001|Overall Study|Use Of Prohibited Medication|1|||
42364205|NCT01921205|76213879|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
42364206|NCT01921205|76213880|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
42364207|NCT01921205|76213879|FG000|Overall Study|Non Compliance Of The Parent|0|||
42364208|NCT01921205|76213880|FG001|Overall Study|Non Compliance Of The Parent|1|||
42364209|NCT01921205|76213879|FG000|Overall Study|Non Compliance Of Child|0|||
42364210|NCT01921205|76213880|FG001|Overall Study|Non Compliance Of Child|1|||
42364211|NCT01920893|76213888|FG000|Overall Study|Adverse Event|5|||
42364212|NCT01920893|76213889|FG001|Overall Study|Adverse Event|2|||
42364213|NCT01920893|76213888|FG000|Overall Study|Lack of Efficacy|2|||
42364214|NCT01920893|76213889|FG001|Overall Study|Lack of Efficacy|0|||
42364215|NCT01709305|76213896|FG000|Phase 1|Clinical Adverse Event|80|||
42364216|NCT01709305|76213897|FG001|Phase 1|Clinical Adverse Event|0|||
42364217|NCT01709305|76213898|FG002|Phase 1|Clinical Adverse Event|0|||
42364218|NCT01709305|76213899|FG003|Phase 1|Clinical Adverse Event|0|||
42364219|NCT01709305|76213900|FG004|Phase 1|Clinical Adverse Event|0|||
42364220|NCT01709305|76213896|FG000|Phase 1|Death|2|||
42364221|NCT01709305|76213897|FG001|Phase 1|Death|0|||
42364222|NCT01709305|76213898|FG002|Phase 1|Death|0|||
42364223|NCT01709305|76213899|FG003|Phase 1|Death|0|||
42364224|NCT01709305|76213900|FG004|Phase 1|Death|0|||
42364225|NCT01709305|76213896|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
42364226|NCT01709305|76213897|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
42364227|NCT01709305|76213898|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
42364228|NCT01709305|76213899|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
42364229|NCT01709305|76213900|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
42364230|NCT01709305|76213896|FG000|Phase 1|Laboratory Adverse Event|16|||
42364231|NCT01709305|76213897|FG001|Phase 1|Laboratory Adverse Event|0|||
42364232|NCT01709305|76213898|FG002|Phase 1|Laboratory Adverse Event|0|||
42364233|NCT01709305|76213899|FG003|Phase 1|Laboratory Adverse Event|0|||
42364234|NCT01709305|76213900|FG004|Phase 1|Laboratory Adverse Event|0|||
42364235|NCT01709305|76213896|FG000|Phase 1|Lost to Follow-up|147|||
42364236|NCT01709305|76213897|FG001|Phase 1|Lost to Follow-up|0|||
42364237|NCT01709305|76213898|FG002|Phase 1|Lost to Follow-up|0|||
42364238|NCT01709305|76213899|FG003|Phase 1|Lost to Follow-up|0|||
42364239|NCT01709305|76213900|FG004|Phase 1|Lost to Follow-up|0|||
42364240|NCT01709305|76213896|FG000|Phase 1|Travel, moving, etc.|30|||
42364241|NCT01709305|76213897|FG001|Phase 1|Travel, moving, etc.|0|||
42364242|NCT01709305|76213898|FG002|Phase 1|Travel, moving, etc.|0|||
42364243|NCT01709305|76213899|FG003|Phase 1|Travel, moving, etc.|0|||
42364244|NCT01709305|76213900|FG004|Phase 1|Travel, moving, etc.|0|||
42364245|NCT01709305|76213896|FG000|Phase 1|Physician Decision|13|||
42364246|NCT01709305|76213897|FG001|Phase 1|Physician Decision|0|||
42364247|NCT01709305|76213898|FG002|Phase 1|Physician Decision|0|||
42364248|NCT01709305|76213899|FG003|Phase 1|Physician Decision|0|||
42364249|NCT01709305|76213900|FG004|Phase 1|Physician Decision|0|||
42364250|NCT01709305|76213896|FG000|Phase 1|Protocol Violation|118|||
42364251|NCT01709305|76213897|FG001|Phase 1|Protocol Violation|0|||
42364252|NCT01709305|76213898|FG002|Phase 1|Protocol Violation|0|||
42364253|NCT01709305|76213899|FG003|Phase 1|Protocol Violation|0|||
42364254|NCT01709305|76213900|FG004|Phase 1|Protocol Violation|0|||
42364255|NCT01709305|76213896|FG000|Phase 1|Withdrawal by Subject|218|||
42364256|NCT01709305|76213897|FG001|Phase 1|Withdrawal by Subject|0|||
42364257|NCT01709305|76213898|FG002|Phase 1|Withdrawal by Subject|0|||
42364258|NCT01709305|76213899|FG003|Phase 1|Withdrawal by Subject|0|||
42364259|NCT01709305|76213900|FG004|Phase 1|Withdrawal by Subject|0|||
42364260|NCT01709305|76213896|FG000|Phase 2|Clinical Adverse Event|0|||
42364261|NCT01709305|76213897|FG001|Phase 2|Clinical Adverse Event|10|||
42364262|NCT01709305|76213898|FG002|Phase 2|Clinical Adverse Event|10|||
42364263|NCT01709305|76213899|FG003|Phase 2|Clinical Adverse Event|6|||
42364264|NCT01709305|76213900|FG004|Phase 2|Clinical Adverse Event|11|||
42364265|NCT01709305|76213896|FG000|Phase 2|Death|0|||
42364266|NCT01709305|76213897|FG001|Phase 2|Death|0|||
42364267|NCT01709305|76213898|FG002|Phase 2|Death|1|||
42364268|NCT01709305|76213899|FG003|Phase 2|Death|0|||
42364269|NCT01709305|76213900|FG004|Phase 2|Death|0|||
42364270|NCT01709305|76213896|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
42364271|NCT01709305|76213897|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
42364272|NCT01709305|76213898|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
42364273|NCT01709305|76213899|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
42364274|NCT01709305|76213900|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
42364275|NCT01709305|76213896|FG000|Phase 2|Laboratory Adverse Event|0|||
42364276|NCT01709305|76213897|FG001|Phase 2|Laboratory Adverse Event|1|||
42364277|NCT01709305|76213898|FG002|Phase 2|Laboratory Adverse Event|0|||
42364278|NCT01709305|76213899|FG003|Phase 2|Laboratory Adverse Event|1|||
42364279|NCT01709305|76213900|FG004|Phase 2|Laboratory Adverse Event|1|||
42364280|NCT01709305|76213896|FG000|Phase 2|Lost to Follow-up|0|||
42364281|NCT01709305|76213897|FG001|Phase 2|Lost to Follow-up|10|||
42364282|NCT01709305|76213898|FG002|Phase 2|Lost to Follow-up|6|||
42364283|NCT01709305|76213899|FG003|Phase 2|Lost to Follow-up|9|||
42364284|NCT01709305|76213900|FG004|Phase 2|Lost to Follow-up|5|||
42364285|NCT01709305|76213896|FG000|Phase 2|Travel, moving, etc.|0|||
42364286|NCT01709305|76213897|FG001|Phase 2|Travel, moving, etc.|2|||
42364287|NCT01709305|76213898|FG002|Phase 2|Travel, moving, etc.|3|||
42364288|NCT01709305|76213899|FG003|Phase 2|Travel, moving, etc.|3|||
42364289|NCT01709305|76213900|FG004|Phase 2|Travel, moving, etc.|5|||
42364290|NCT01709305|76213896|FG000|Phase 2|Physician Decision|0|||
42364291|NCT01709305|76213897|FG001|Phase 2|Physician Decision|2|||
42364292|NCT01709305|76213898|FG002|Phase 2|Physician Decision|0|||
42364293|NCT01709305|76213899|FG003|Phase 2|Physician Decision|1|||
42364294|NCT01709305|76213900|FG004|Phase 2|Physician Decision|2|||
42364295|NCT01709305|76213896|FG000|Phase 2|Protocol Violation|0|||
42364296|NCT01709305|76213897|FG001|Phase 2|Protocol Violation|19|||
42364297|NCT01709305|76213898|FG002|Phase 2|Protocol Violation|19|||
42364298|NCT01709305|76213899|FG003|Phase 2|Protocol Violation|13|||
42364299|NCT01709305|76213900|FG004|Phase 2|Protocol Violation|9|||
42364300|NCT01709305|76213896|FG000|Phase 2|Withdrawal by Subject|0|||
42364301|NCT01709305|76213897|FG001|Phase 2|Withdrawal by Subject|8|||
42364302|NCT01709305|76213898|FG002|Phase 2|Withdrawal by Subject|6|||
42364303|NCT01709305|76213899|FG003|Phase 2|Withdrawal by Subject|15|||
42364304|NCT01709305|76213900|FG004|Phase 2|Withdrawal by Subject|12|||
42364305|NCT01684423|76213920|FG000|Overall Study|Withdrawal by Subject|0|||
42364306|NCT01684423|76213921|FG001|Overall Study|Withdrawal by Subject|0|||
42364307|NCT01684423|76213922|FG002|Overall Study|Withdrawal by Subject|1|||
42364308|NCT01684423|76213923|FG003|Overall Study|Withdrawal by Subject|0|||
42364309|NCT01684423|76213924|FG004|Overall Study|Withdrawal by Subject|0|||
42364310|NCT01709227|76213940|FG000|Overall Study|Physician Decision|1|||
42364311|NCT01709227|76213941|FG001|Overall Study|Physician Decision|0|||
42364312|NCT01709227|76213940|FG000|Overall Study|Pleural Peritoneal communication|0|||
42364313|NCT01709227|76213941|FG001|Overall Study|Pleural Peritoneal communication|9|||
42364314|NCT01684033|76213948|FG000|Period 1, First 30 Days|Adverse Event|1|||
42364315|NCT01684033|76213949|FG001|Period 1, First 30 Days|Adverse Event|1|||
42364316|NCT01684033|76213948|FG000|Period 1, First 30 Days|Noncompliance|1|||
42364317|NCT01684033|76213949|FG001|Period 1, First 30 Days|Noncompliance|0|||
42364318|NCT01684033|76213948|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
42364319|NCT01684033|76213949|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
42364320|NCT01684033|76213948|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
42364321|NCT01684033|76213949|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
42364322|NCT01684033|76213948|FG000|Period 2, Second 30 Days|Adverse Event|1|||
42364323|NCT01684033|76213949|FG001|Period 2, Second 30 Days|Adverse Event|0|||
42364324|NCT01903811|76213990|FG000|Overall Study|No measurable disease|1|||
42196349|NCT00294047|76008246|FG001|Month 84|Subject does not want male physician|0|||
42196350|NCT00294047|76008245|FG000|Month 84|Transport reimbursement delayed|0|||
42196351|NCT00294047|76008246|FG001|Month 84|Transport reimbursement delayed|1|||
42196352|NCT00294047|76008245|FG000|Month 84|Unable to reach study site|1|||
42196353|NCT00294047|76008246|FG001|Month 84|Unable to reach study site|0|||
42196354|NCT00294047|76008245|FG000|Month 84|Under investigation locally|1|||
42196355|NCT00294047|76008246|FG001|Month 84|Under investigation locally|0|||
42196356|NCT00294047|76008245|FG000|Month 84|Visit missed|0|||
42196357|NCT00294047|76008246|FG001|Month 84|Visit missed|1|||
42196358|NCT00294047|76008245|FG000|Month 84|No consent for Month 84 Follow-up|731|||
42196359|NCT00294047|76008246|FG001|Month 84|No consent for Month 84 Follow-up|754|||
42196360|NCT00293813|76008256|FG000|Overall Study|Physician Decision|0|||
42364325|NCT01903811|76213991|FG001|Overall Study|No measurable disease|1|||
42364326|NCT01903811|76213990|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
42364327|NCT01903811|76213991|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
42364328|NCT01903811|76213990|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
42364329|NCT01903811|76213991|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
42364330|NCT01903811|76213990|FG000|Overall Study|Withdrawal by Subject|0|||
42364331|NCT01903811|76213991|FG001|Overall Study|Withdrawal by Subject|1|||
42364332|NCT01709149|76214008|FG000|Open-label Lead-in Phase|Adverse Event|109|||
42364333|NCT01709149|76214009|FG001|Open-label Lead-in Phase|Adverse Event|0|||
42364334|NCT01709149|76214010|FG002|Open-label Lead-in Phase|Adverse Event|0|||
42364335|NCT01709149|76214008|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
42364336|NCT01709149|76214009|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
42364337|NCT01709149|76214010|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
42364338|NCT01709149|76214008|FG000|Open-label Lead-in Phase|Death|1|||
42364339|NCT01709149|76214009|FG001|Open-label Lead-in Phase|Death|0|||
42364340|NCT01709149|76214010|FG002|Open-label Lead-in Phase|Death|0|||
42364341|NCT01709149|76214008|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
42364342|NCT01709149|76214009|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
42364343|NCT01709149|76214010|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
42364344|NCT01709149|76214008|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
42196361|NCT00293813|76008257|FG001|Overall Study|Physician Decision|1|||
42196362|NCT00293813|76008258|FG002|Overall Study|Physician Decision|0|||
42196363|NCT00293813|76008256|FG000|Overall Study|Adverse Event|3|||
42364345|NCT01709149|76214009|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
42364346|NCT01709149|76214010|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
42364347|NCT01709149|76214008|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
42364348|NCT01709149|76214009|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
42364349|NCT01709149|76214010|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
42364350|NCT01709149|76214008|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
42364351|NCT01709149|76214009|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
42364352|NCT01709149|76214010|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
42364353|NCT01709149|76214008|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
42364354|NCT01709149|76214009|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
42364355|NCT01709149|76214010|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
42364356|NCT01709149|76214008|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
42364357|NCT01709149|76214009|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
42364358|NCT01709149|76214010|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
42364359|NCT01709149|76214008|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
42364360|NCT01709149|76214009|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
42364361|NCT01709149|76214010|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
42364362|NCT01568593|76214019|FG000|Overall Study|Lack of Efficacy|4|||
42364363|NCT01568593|76214020|FG001|Overall Study|Lack of Efficacy|1|||
42364364|NCT01568593|76214019|FG000|Overall Study|Adverse Event|3|||
42364365|NCT01568593|76214020|FG001|Overall Study|Adverse Event|2|||
42364366|NCT01683565|76214028|FG000|Overall Study|Lost to Follow-up|2|||
42364367|NCT01683565|76214029|FG001|Overall Study|Lost to Follow-up|0|||
42364368|NCT01683565|76214028|FG000|Overall Study|Discontinued Intervention|1|||
42364369|NCT01683565|76214029|FG001|Overall Study|Discontinued Intervention|1|||
42018524|NCT00996892|75825866|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
42196364|NCT00293813|76008257|FG001|Overall Study|Adverse Event|1|||
42196365|NCT00293813|76008258|FG002|Overall Study|Adverse Event|1|||
42196366|NCT00293813|76008256|FG000|Overall Study|Withdrawal by Subject|7|||
42196367|NCT00293813|76008257|FG001|Overall Study|Withdrawal by Subject|4|||
42196368|NCT00293813|76008258|FG002|Overall Study|Withdrawal by Subject|4|||
42196369|NCT00293813|76008256|FG000|Overall Study|Lost to Follow-up|3|||
42196370|NCT00293813|76008257|FG001|Overall Study|Lost to Follow-up|2|||
42196371|NCT00293813|76008258|FG002|Overall Study|Lost to Follow-up|3|||
42196372|NCT00293813|76008256|FG000|Overall Study|Noncompliance|0|||
42196373|NCT00293813|76008257|FG001|Overall Study|Noncompliance|1|||
42196374|NCT00293813|76008258|FG002|Overall Study|Noncompliance|0|||
42196375|NCT00293579|76008266|FG000|Overall Study|Withdrawal by Subject|1|||
42196376|NCT00293423|76008273|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
42196377|NCT00293423|76008274|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
42196378|NCT00293423|76008273|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
42196379|NCT00293423|76008274|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
42196380|NCT00293423|76008273|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
42196381|NCT00293423|76008274|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
42196382|NCT00293423|76008273|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
42196383|NCT00293423|76008274|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
42196384|NCT00293423|76008273|FG000|Surgical Resection|processing error during surgical resection|1|||
42196385|NCT00293423|76008274|FG001|Surgical Resection|processing error during surgical resection|0|||
42196386|NCT00293423|76008273|FG000|Surgical Resection|Withdrawal by Subject|4|||
42196387|NCT00293423|76008274|FG001|Surgical Resection|Withdrawal by Subject|0|||
42196388|NCT00293423|76008273|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
42196389|NCT00293423|76008274|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
42196390|NCT03538743|76008289|FG000|Overall Study|Adverse Event|0|||
42196391|NCT03538743|76008290|FG001|Overall Study|Adverse Event|0|||
42196392|NCT03538743|76008291|FG002|Overall Study|Adverse Event|1|||
42196393|NCT03538743|76008292|FG003|Overall Study|Adverse Event|1|||
42196394|NCT03538743|76008293|FG004|Overall Study|Adverse Event|0|||
42196395|NCT03538743|76008294|FG005|Overall Study|Adverse Event|0|||
42196396|NCT03538743|76008295|FG006|Overall Study|Adverse Event|0|||
42196397|NCT03538743|76008296|FG007|Overall Study|Adverse Event|0|||
42196398|NCT03538743|76008297|FG008|Overall Study|Adverse Event|0|||
42196399|NCT03538743|76008289|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
42196400|NCT03538743|76008290|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
42196401|NCT03538743|76008291|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
42196402|NCT03538743|76008292|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
42196403|NCT03538743|76008293|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
42364370|NCT01903031|76214053|FG000|Overall Study|Not Able to Attend Clinic|1|||
42364371|NCT01903031|76214054|FG001|Overall Study|Not Able to Attend Clinic|1|||
42364372|NCT01903031|76214055|FG002|Overall Study|Not Able to Attend Clinic|0|||
42364373|NCT01903031|76214053|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
42196404|NCT03538743|76008294|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
42196405|NCT03538743|76008295|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
42196406|NCT03538743|76008296|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
42196407|NCT03538743|76008297|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
42196408|NCT03538743|76008289|FG000|Overall Study|Withdrawal by Subject|0|||
42196409|NCT03538743|76008290|FG001|Overall Study|Withdrawal by Subject|0|||
42196410|NCT03538743|76008291|FG002|Overall Study|Withdrawal by Subject|0|||
42196411|NCT03538743|76008292|FG003|Overall Study|Withdrawal by Subject|1|||
42196412|NCT03538743|76008293|FG004|Overall Study|Withdrawal by Subject|0|||
42196413|NCT03538743|76008294|FG005|Overall Study|Withdrawal by Subject|0|||
42196414|NCT03538743|76008295|FG006|Overall Study|Withdrawal by Subject|0|||
42196415|NCT03538743|76008296|FG007|Overall Study|Withdrawal by Subject|0|||
42196416|NCT03538743|76008297|FG008|Overall Study|Withdrawal by Subject|0|||
42196417|NCT03521817|76008327|FG000|Overall Study|Protocol Violation|0|||
42196418|NCT03521817|76008328|FG001|Overall Study|Protocol Violation|1|||
42196419|NCT03538431|76008334|FG000|Overall Study|Physician Decision|0|||
42196420|NCT03538431|76008335|FG001|Overall Study|Physician Decision|1|||
42196421|NCT03538431|76008334|FG000|Overall Study|Withdrawal by Subject|1|||
42196422|NCT03538431|76008335|FG001|Overall Study|Withdrawal by Subject|0|||
42196423|NCT03521193|76008345|FG000|Overall Study|Withdrawal by Subject|8|||
42196424|NCT03521193|76008346|FG001|Overall Study|Withdrawal by Subject|0|||
42196425|NCT03521193|76008345|FG000|Overall Study|non compliant to ASA treatment|8|||
42196426|NCT03521193|76008346|FG001|Overall Study|non compliant to ASA treatment|0|||
42196427|NCT00293267|76008355|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
42196428|NCT00293267|76008356|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
42196429|NCT00293267|76008355|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
42196430|NCT00293267|76008356|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
42196431|NCT00293267|76008355|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
42196432|NCT00293267|76008356|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
42196433|NCT00293267|76008355|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
42196434|NCT00293267|76008356|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
42196435|NCT00293267|76008355|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
42196436|NCT00293267|76008356|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
42196437|NCT00293267|76008355|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
42196438|NCT00293267|76008356|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
42196439|NCT00293267|76008355|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
42196440|NCT00293267|76008356|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
42196441|NCT00293267|76008355|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
42196442|NCT00293267|76008356|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
42196443|NCT00293267|76008355|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
42196444|NCT00293267|76008356|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
42196445|NCT00293267|76008355|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
42196446|NCT00293267|76008356|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
42196447|NCT00293267|76008355|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
42196448|NCT00293267|76008356|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
42196449|NCT00293267|76008355|FG000|Extension - Double-Blind Week 49-156|Death|3|||
42196450|NCT00293267|76008356|FG001|Extension - Double-Blind Week 49-156|Death|0|||
42196451|NCT00293267|76008355|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
42196452|NCT00293267|76008356|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
42196453|NCT00293267|76008355|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
42196454|NCT00293267|76008356|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
42196455|NCT00293267|76008355|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
42196456|NCT00293267|76008356|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
42196457|NCT00293267|76008355|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
42196458|NCT00293267|76008356|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
42196459|NCT00293267|76008355|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
42196460|NCT00293267|76008356|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
42196461|NCT00293267|76008355|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
42196462|NCT00293267|76008356|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
42196463|NCT00293267|76008355|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
42196464|NCT00293267|76008356|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
42196465|NCT00293267|76008355|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
42196466|NCT00293267|76008356|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
42196467|NCT00293267|76008355|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
42196468|NCT00293267|76008356|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
42196469|NCT00293267|76008355|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
42196470|NCT00293267|76008356|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
42364374|NCT01903031|76214054|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
42364375|NCT01903031|76214055|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
42196471|NCT00293267|76008355|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
42196472|NCT00293267|76008356|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
42196473|NCT00293267|76008355|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
42196474|NCT00293267|76008356|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
42196475|NCT00293267|76008355|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
42196476|NCT00293267|76008356|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
42196477|NCT00293267|76008355|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
42196478|NCT00293267|76008356|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
42196479|NCT00293267|76008355|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
42196480|NCT00293267|76008356|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
42196481|NCT00293267|76008355|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
42196482|NCT00293267|76008356|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
42196483|NCT03520959|76008366|FG000|Overall Study|Study terminated by Sponsor|0|||
42196484|NCT03520959|76008367|FG001|Overall Study|Study terminated by Sponsor|1|||
42196485|NCT03537261|76008375|FG000|Overall Study|Lost to Follow-up|4|||
42196486|NCT03537261|76008376|FG001|Overall Study|Lost to Follow-up|5|||
42364376|NCT01903031|76214053|FG000|Overall Study|Adverse Event|0|||
42364377|NCT01903031|76214054|FG001|Overall Study|Adverse Event|1|||
42364378|NCT01903031|76214055|FG002|Overall Study|Adverse Event|0|||
42364379|NCT01903031|76214053|FG000|Overall Study|Withdrawal by Subject|0|||
42364380|NCT01903031|76214054|FG001|Overall Study|Withdrawal by Subject|1|||
42364381|NCT01903031|76214055|FG002|Overall Study|Withdrawal by Subject|1|||
42364382|NCT01903031|76214053|FG000|Overall Study|Protocol Violation|0|||
42364383|NCT01903031|76214054|FG001|Overall Study|Protocol Violation|0|||
42364384|NCT01903031|76214055|FG002|Overall Study|Protocol Violation|2|||
42364385|NCT01903031|76214053|FG000|Overall Study|Lost to Follow-up|0|||
42364386|NCT01903031|76214054|FG001|Overall Study|Lost to Follow-up|0|||
42364387|NCT01903031|76214055|FG002|Overall Study|Lost to Follow-up|1|||
42364388|NCT01903031|76214053|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
42364389|NCT01903031|76214054|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
42364390|NCT01903031|76214055|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
42364391|NCT01616693|76214087|FG000|Evaluated for Safety|Physician Decision|1|||
42364392|NCT01616693|76214088|FG001|Evaluated for Safety|Physician Decision|0|||
42364393|NCT01616693|76214089|FG002|Evaluated for Safety|Physician Decision|1|||
42364394|NCT01616693|76214090|FG003|Evaluated for Safety|Physician Decision|0|||
42364395|NCT01616693|76214087|FG000|Received Both Vaccines|Adverse Event|2|||
42364396|NCT01616693|76214088|FG001|Received Both Vaccines|Adverse Event|0|||
42364397|NCT01616693|76214089|FG002|Received Both Vaccines|Adverse Event|0|||
42100681|NCT00673920|75911520|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
42100682|NCT00673920|75911521|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
42100683|NCT00673920|75911522|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
42100684|NCT00673920|75911523|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
42100685|NCT00673920|75911524|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
42100686|NCT00673920|75911525|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
42100687|NCT00673920|75911518|FG000|Week 24 to Week 48|Failure to return|0|||
42100688|NCT00673920|75911519|FG001|Week 24 to Week 48|Failure to return|0|||
42196487|NCT03537261|76008375|FG000|Overall Study|Withdrawal by Subject|4|||
42196488|NCT03537261|76008376|FG001|Overall Study|Withdrawal by Subject|6|||
42196489|NCT03537261|76008375|FG000|Overall Study|Did not return study questionnaires|0|||
42196490|NCT03537261|76008376|FG001|Overall Study|Did not return study questionnaires|1|||
42364398|NCT01616693|76214090|FG003|Received Both Vaccines|Adverse Event|0|||
42364399|NCT01616693|76214087|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
42364400|NCT01616693|76214088|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
42364401|NCT01616693|76214089|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
42364402|NCT01616693|76214090|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
42364403|NCT01616693|76214087|FG000|Received Both Vaccines|Lost to Follow-up|4|||
42364404|NCT01616693|76214088|FG001|Received Both Vaccines|Lost to Follow-up|3|||
42364405|NCT01616693|76214089|FG002|Received Both Vaccines|Lost to Follow-up|4|||
42364406|NCT01616693|76214090|FG003|Received Both Vaccines|Lost to Follow-up|4|||
42364407|NCT01616693|76214087|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
42364408|NCT01616693|76214088|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
42364409|NCT01616693|76214089|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
42364410|NCT01616693|76214090|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
42364411|NCT01616459|76214197|FG000|Overall Study|Adverse Event|1|||
42364412|NCT01616459|76214198|FG001|Overall Study|Adverse Event|1|||
42196491|NCT03536949|76008384|FG000|Overall Study|Adverse Event|4|||
42196492|NCT03536949|76008385|FG001|Overall Study|Adverse Event|0|||
42364413|NCT01616459|76214199|FG002|Overall Study|Adverse Event|2|||
42364414|NCT01616459|76214200|FG003|Overall Study|Adverse Event|0|||
42364415|NCT01616459|76214197|FG000|Overall Study|Lost to Follow-up|1|||
42364416|NCT01616459|76214198|FG001|Overall Study|Lost to Follow-up|11|||
42364417|NCT01616459|76214199|FG002|Overall Study|Lost to Follow-up|3|||
42196493|NCT03536949|76008384|FG000|Overall Study|Lost to Follow-up|2|||
42196494|NCT03536949|76008385|FG001|Overall Study|Lost to Follow-up|1|||
42196495|NCT03536949|76008384|FG000|Overall Study|Withdrawal by Subject|6|||
42196496|NCT03536949|76008385|FG001|Overall Study|Withdrawal by Subject|0|||
42196497|NCT03536949|76008384|FG000|Overall Study|Non-compliance|2|||
42364418|NCT01616459|76214200|FG003|Overall Study|Lost to Follow-up|2|||
42364419|NCT01616459|76214197|FG000|Overall Study|Protocol Violation|0|||
42364420|NCT01616459|76214198|FG001|Overall Study|Protocol Violation|0|||
42364421|NCT01616459|76214199|FG002|Overall Study|Protocol Violation|0|||
42364422|NCT01616459|76214200|FG003|Overall Study|Protocol Violation|2|||
42364423|NCT01616459|76214197|FG000|Overall Study|Withdrawal by Subject|2|||
42364424|NCT01616459|76214198|FG001|Overall Study|Withdrawal by Subject|4|||
42364425|NCT01616459|76214199|FG002|Overall Study|Withdrawal by Subject|4|||
42364426|NCT01616459|76214200|FG003|Overall Study|Withdrawal by Subject|4|||
42364427|NCT01616459|76214197|FG000|Overall Study|Other reason|0|||
42364428|NCT01616459|76214198|FG001|Overall Study|Other reason|1|||
42364429|NCT01616459|76214199|FG002|Overall Study|Other reason|1|||
42364430|NCT01616459|76214200|FG003|Overall Study|Other reason|0|||
42364431|NCT01919801|76214217|FG000|Overall Study|Withdrawal by Subject|1|||
42364432|NCT01919801|76214218|FG001|Overall Study|Withdrawal by Subject|0|||
42364433|NCT01919801|76214217|FG000|Overall Study|Physician Decision|0|||
42364434|NCT01919801|76214218|FG001|Overall Study|Physician Decision|1|||
42100689|NCT00673920|75911520|FG002|Week 24 to Week 48|Failure to return|0|||
42100690|NCT00673920|75911521|FG003|Week 24 to Week 48|Failure to return|0|||
42100691|NCT00673920|75911522|FG004|Week 24 to Week 48|Failure to return|0|||
42100692|NCT00673920|75911523|FG005|Week 24 to Week 48|Failure to return|1|||
42100693|NCT00673920|75911524|FG006|Week 24 to Week 48|Failure to return|0|||
42100694|NCT00673920|75911525|FG007|Week 24 to Week 48|Failure to return|0|||
42100695|NCT00673920|75911518|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
42100696|NCT00673920|75911519|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
42100697|NCT00673920|75911520|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
42100698|NCT00673920|75911521|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
42100699|NCT00673920|75911522|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
42100700|NCT00673920|75911523|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
42100701|NCT00673920|75911524|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
42100702|NCT00673920|75911525|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
42100703|NCT00673920|75911518|FG000|Week 24 to Week 48|Death|0|||
42100704|NCT00673920|75911519|FG001|Week 24 to Week 48|Death|0|||
42100705|NCT00673920|75911520|FG002|Week 24 to Week 48|Death|0|||
42100706|NCT00673920|75911521|FG003|Week 24 to Week 48|Death|0|||
42100707|NCT00673920|75911522|FG004|Week 24 to Week 48|Death|0|||
42100708|NCT00673920|75911523|FG005|Week 24 to Week 48|Death|1|||
42100709|NCT00673920|75911524|FG006|Week 24 to Week 48|Death|0|||
42100710|NCT00673920|75911525|FG007|Week 24 to Week 48|Death|0|||
42100711|NCT00673920|75911518|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
42100712|NCT00673920|75911519|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
42100713|NCT00673920|75911520|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
42100714|NCT00673920|75911521|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
42100715|NCT00673920|75911522|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
42196498|NCT03536949|76008385|FG001|Overall Study|Non-compliance|1|||
42196499|NCT03588741|76008391|FG000|Overall Study|Withdrawal by Subject|1|||
42196500|NCT00111917|76008397|FG000|Overall Study|Withdrawal by Subject|1|||
42196501|NCT00111917|76008398|FG001|Overall Study|Withdrawal by Subject|1|||
42196502|NCT03520569|76008408|FG000|Overall Study|Withdrawal by Subject|1|||
42196503|NCT00111839|76008421|FG000|Overall Study|Disease Progression|30|||
42196504|NCT00111839|76008422|FG001|Overall Study|Disease Progression|33|||
42196505|NCT00111839|76008423|FG002|Overall Study|Disease Progression|33|||
42196506|NCT00111839|76008421|FG000|Overall Study|Adverse Event|5|||
42364435|NCT01919801|76214217|FG000|Overall Study|Lost to Follow-up|0|||
42196507|NCT00111839|76008422|FG001|Overall Study|Adverse Event|3|||
42196508|NCT00111839|76008423|FG002|Overall Study|Adverse Event|1|||
42100716|NCT00673920|75911523|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
42100717|NCT00673920|75911524|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
42100718|NCT00673920|75911525|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
42196509|NCT00111839|76008421|FG000|Overall Study|Protocol Violation|2|||
42100719|NCT00379795|75911552|FG000|Overall Study|Death|31|||
42100720|NCT00379795|75911553|FG001|Overall Study|Death|8|||
42196510|NCT00111839|76008422|FG001|Overall Study|Protocol Violation|4|||
42196511|NCT00111839|76008423|FG002|Overall Study|Protocol Violation|2|||
42364436|NCT01919801|76214218|FG001|Overall Study|Lost to Follow-up|1|||
42364437|NCT01919801|76214217|FG000|Overall Study|Other|0|||
42364438|NCT01919801|76214218|FG001|Overall Study|Other|1|||
42196512|NCT00111839|76008421|FG000|Overall Study|Death|1|||
42196513|NCT00111839|76008422|FG001|Overall Study|Death|1|||
42196514|NCT00111839|76008423|FG002|Overall Study|Death|6|||
42196515|NCT00111839|76008421|FG000|Overall Study|Withdrawal by Subject|2|||
42196516|NCT00111839|76008422|FG001|Overall Study|Withdrawal by Subject|2|||
42196517|NCT00111839|76008423|FG002|Overall Study|Withdrawal by Subject|2|||
42196518|NCT00111839|76008421|FG000|Overall Study|Lost to Follow-up|1|||
42196519|NCT00111839|76008422|FG001|Overall Study|Lost to Follow-up|0|||
42196520|NCT00111839|76008423|FG002|Overall Study|Lost to Follow-up|0|||
42196521|NCT00111839|76008421|FG000|Overall Study|Logistical Constraint|1|||
42196522|NCT00111839|76008422|FG001|Overall Study|Logistical Constraint|0|||
42196523|NCT00111839|76008423|FG002|Overall Study|Logistical Constraint|0|||
42196524|NCT00111839|76008421|FG000|Overall Study|Other|6|||
42196525|NCT00111839|76008422|FG001|Overall Study|Other|3|||
42196526|NCT00111839|76008423|FG002|Overall Study|Other|3|||
42196527|NCT00111839|76008421|FG000|Overall Study|Randomized but Not Treated|0|||
42196528|NCT00111839|76008422|FG001|Overall Study|Randomized but Not Treated|0|||
42196529|NCT00111839|76008423|FG002|Overall Study|Randomized but Not Treated|2|||
42196530|NCT00111761|76008433|FG000|Part 1|Physician Decision|0|||
42196531|NCT00111761|76008434|FG001|Part 1|Physician Decision|1|||
42196532|NCT00111761|76008433|FG000|Part 1|Death|0|||
42196533|NCT00111761|76008434|FG001|Part 1|Death|2|||
42196534|NCT00111761|76008433|FG000|Part 1|Other|0|||
42196535|NCT00111761|76008434|FG001|Part 1|Other|1|||
42196536|NCT00111761|76008433|FG000|Part 1|Withdrawal by Subject|0|||
42196537|NCT00111761|76008434|FG001|Part 1|Withdrawal by Subject|1|||
42196538|NCT00111761|76008433|FG000|Part 2|Adverse Event|1|||
42364439|NCT01919723|76214226|FG000|Overall Study|Blood Samples Hemolyzed|2|||
42364440|NCT01919723|76214227|FG001|Overall Study|Blood Samples Hemolyzed|2|||
42364441|NCT01919489|76214235|FG000|Overall Study|Rejected the need of injections|4|||
42364442|NCT01919489|76214236|FG001|Overall Study|Rejected the need of injections|7|||
42364443|NCT01919489|76214235|FG000|Overall Study|Adverse Event|10|||
42364444|NCT01919489|76214236|FG001|Overall Study|Adverse Event|0|||
42364445|NCT01919489|76214235|FG000|Overall Study|Hospital readmission|2|||
42364446|NCT01919489|76214236|FG001|Overall Study|Hospital readmission|9|||
42364447|NCT01919489|76214235|FG000|Overall Study|Death|2|||
42364448|NCT01919489|76214236|FG001|Overall Study|Death|1|||
42364449|NCT01919489|76214235|FG000|Overall Study|Lost to Follow-up|38|||
42364450|NCT01919489|76214236|FG001|Overall Study|Lost to Follow-up|27|||
42364451|NCT01919411|76214244|FG000|Overall Study|Lost to Follow-up|2|||
42364452|NCT01919411|76214245|FG001|Overall Study|Lost to Follow-up|4|||
42364453|NCT01919411|76214244|FG000|Overall Study|Physician Decision|1|||
42364454|NCT01919411|76214245|FG001|Overall Study|Physician Decision|0|||
42364455|NCT01919411|76214244|FG000|Overall Study|Protocol Violation|2|||
42364456|NCT01919411|76214245|FG001|Overall Study|Protocol Violation|1|||
42364457|NCT01901393|76214253|FG000|Overall Study|Adverse Event|1|||
42364458|NCT01901393|76214254|FG001|Overall Study|Adverse Event|0|||
42364459|NCT01890707|76214262|FG000|Overall Study|Lost to Follow-up|1|||
42364460|NCT01890707|76214263|FG001|Overall Study|Lost to Follow-up|1|||
42364461|NCT01900691|76214269|FG000|Overall Study|Death|7|||
42364462|NCT01900691|76214269|FG000|Overall Study|Lost to Follow-up|4|||
42364463|NCT01900691|76214269|FG000|Overall Study|Study Device Not Placed|3|||
42364464|NCT01900691|76214269|FG000|Overall Study|Non study stent placed|2|||
42364465|NCT01900691|76214269|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
42364466|NCT01900691|76214269|FG000|Overall Study|Complete stent migration through digestive tract|1|||
42364467|NCT01890473|76214276|FG000|Overall Study|Lost to Follow-up|1|||
42364468|NCT01890473|76214277|FG001|Overall Study|Lost to Follow-up|0|||
42364469|NCT01890473|76214276|FG000|Overall Study|Poor/non-compliance|1|||
42364470|NCT01890473|76214277|FG001|Overall Study|Poor/non-compliance|0|||
42364471|NCT01889069|76214287|FG000|Overall Study|Death|18|||
42364472|NCT01889069|76214287|FG000|Overall Study|Progression of Disease|14|||
42364473|NCT01889069|76214287|FG000|Overall Study|Lost to Follow-up|6|||
42196539|NCT00111761|76008434|FG001|Part 2|Adverse Event|0|||
42364474|NCT01889069|76214287|FG000|Overall Study|Other|4|||
42364475|NCT01889069|76214287|FG000|Overall Study|Consent Withdrawal|3|||
42364476|NCT02533180|76214299|FG000|Overall Study|Death|0|||
42196540|NCT00111761|76008433|FG000|Part 2|Physician Decision|1|||
42364477|NCT02533180|76214300|FG001|Overall Study|Death|2|||
42196541|NCT00111761|76008434|FG001|Part 2|Physician Decision|0|||
42196542|NCT00111761|76008433|FG000|Part 2|Death|1|||
42196543|NCT00111761|76008434|FG001|Part 2|Death|0|||
42196544|NCT00111761|76008433|FG000|Part 2|Disease progression|3|||
42196545|NCT00111761|76008434|FG001|Part 2|Disease progression|0|||
42364478|NCT02533180|76214299|FG000|Overall Study|Lost to Follow-up|0|||
42364479|NCT02533180|76214300|FG001|Overall Study|Lost to Follow-up|1|||
42364480|NCT02533180|76214299|FG000|Overall Study|Physician Decision|0|||
42364481|NCT02533180|76214300|FG001|Overall Study|Physician Decision|1|||
42196546|NCT00111761|76008433|FG000|Part 2|Protocol-specified criteria|1|||
42196547|NCT00111761|76008434|FG001|Part 2|Protocol-specified criteria|0|||
42196548|NCT00111761|76008433|FG000|Part 2|Other|1|||
42364482|NCT02533180|76214299|FG000|Overall Study|Withdrawal by Subject|2|||
42364483|NCT02533180|76214300|FG001|Overall Study|Withdrawal by Subject|5|||
42364484|NCT02533180|76214299|FG000|Overall Study|Screen Failure|37|||
42364485|NCT02533180|76214300|FG001|Overall Study|Screen Failure|0|||
42364486|NCT02533180|76214299|FG000|Overall Study|Protocol Deviation|0|||
42364487|NCT02533180|76214300|FG001|Overall Study|Protocol Deviation|1|||
42364488|NCT02533180|76214299|FG000|Overall Study|Non-compliance|0|||
42364489|NCT02533180|76214300|FG001|Overall Study|Non-compliance|1|||
42364490|NCT01739348|76214338|FG000|Part I (Base Study)|Adverse Event|41|||
42364491|NCT01739348|76214339|FG001|Part I (Base Study)|Adverse Event|52|||
42364492|NCT01739348|76214340|FG002|Part I (Base Study)|Adverse Event|8|||
42364493|NCT01739348|76214341|FG003|Part I (Base Study)|Adverse Event|33|||
42364494|NCT01739348|76214338|FG000|Part I (Base Study)|Death|10|||
42364495|NCT01739348|76214339|FG001|Part I (Base Study)|Death|7|||
42364496|NCT01739348|76214340|FG002|Part I (Base Study)|Death|2|||
42364497|NCT01739348|76214341|FG003|Part I (Base Study)|Death|8|||
42364498|NCT01739348|76214338|FG000|Part I (Base Study)|Lack of Efficacy|3|||
42364499|NCT01739348|76214339|FG001|Part I (Base Study)|Lack of Efficacy|8|||
42364500|NCT01739348|76214340|FG002|Part I (Base Study)|Lack of Efficacy|0|||
42364501|NCT01739348|76214341|FG003|Part I (Base Study)|Lack of Efficacy|7|||
42364502|NCT01739348|76214338|FG000|Part I (Base Study)|Lost to Follow-up|4|||
42364503|NCT01739348|76214339|FG001|Part I (Base Study)|Lost to Follow-up|2|||
42364504|NCT01739348|76214340|FG002|Part I (Base Study)|Lost to Follow-up|4|||
42364505|NCT01739348|76214341|FG003|Part I (Base Study)|Lost to Follow-up|4|||
42364506|NCT01739348|76214338|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
42364507|NCT01739348|76214339|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
42364508|NCT01739348|76214340|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
42364509|NCT01739348|76214341|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
42364510|NCT01739348|76214338|FG000|Part I (Base Study)|Physician Decision|10|||
42364511|NCT01739348|76214339|FG001|Part I (Base Study)|Physician Decision|7|||
42364512|NCT01739348|76214340|FG002|Part I (Base Study)|Physician Decision|1|||
42364513|NCT01739348|76214341|FG003|Part I (Base Study)|Physician Decision|4|||
42364514|NCT01739348|76214338|FG000|Part I (Base Study)|Protocol Violation|2|||
42364515|NCT01739348|76214339|FG001|Part I (Base Study)|Protocol Violation|0|||
42364516|NCT01739348|76214340|FG002|Part I (Base Study)|Protocol Violation|1|||
42364517|NCT01739348|76214341|FG003|Part I (Base Study)|Protocol Violation|2|||
42364518|NCT01739348|76214338|FG000|Part I (Base Study)|Screen Failure|2|||
42364519|NCT01739348|76214339|FG001|Part I (Base Study)|Screen Failure|0|||
42364520|NCT01739348|76214340|FG002|Part I (Base Study)|Screen Failure|0|||
42364521|NCT01739348|76214341|FG003|Part I (Base Study)|Screen Failure|0|||
42364522|NCT01739348|76214338|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
42364523|NCT01739348|76214339|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
42364524|NCT01739348|76214340|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
42364525|NCT01739348|76214341|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
42364526|NCT01739348|76214338|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
42364527|NCT01739348|76214339|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
42364528|NCT01739348|76214340|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
42364529|NCT01739348|76214341|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
42364530|NCT01739348|76214338|FG000|Part I (Base Study)|Participant Moved|4|||
42364531|NCT01739348|76214339|FG001|Part I (Base Study)|Participant Moved|3|||
42364532|NCT01739348|76214340|FG002|Part I (Base Study)|Participant Moved|1|||
42364533|NCT01739348|76214341|FG003|Part I (Base Study)|Participant Moved|7|||
42364534|NCT01739348|76214338|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
42364535|NCT01739348|76214339|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
42364536|NCT01739348|76214340|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
42364537|NCT01739348|76214341|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
42364538|NCT01739348|76214338|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
42364539|NCT01739348|76214339|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
42364540|NCT01739348|76214340|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
42364541|NCT01739348|76214341|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
42364542|NCT01739348|76214338|FG000|Part II (Extension Study)|Adverse Event|10|||
42364543|NCT01739348|76214339|FG001|Part II (Extension Study)|Adverse Event|11|||
42364544|NCT01739348|76214340|FG002|Part II (Extension Study)|Adverse Event|7|||
42364545|NCT01739348|76214341|FG003|Part II (Extension Study)|Adverse Event|26|||
42364546|NCT01739348|76214338|FG000|Part II (Extension Study)|Death|3|||
42364547|NCT01739348|76214339|FG001|Part II (Extension Study)|Death|3|||
42364548|NCT01739348|76214340|FG002|Part II (Extension Study)|Death|2|||
42364549|NCT01739348|76214341|FG003|Part II (Extension Study)|Death|6|||
42364550|NCT01739348|76214338|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
42364551|NCT01739348|76214339|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
42364552|NCT01739348|76214340|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
42364553|NCT01739348|76214341|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
42364554|NCT01739348|76214338|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
42364555|NCT01739348|76214339|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
42364556|NCT01739348|76214340|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
42364557|NCT01739348|76214341|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
42364558|NCT01739348|76214338|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
42364559|NCT01739348|76214339|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
42364560|NCT01739348|76214340|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
42364561|NCT01739348|76214341|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
42364562|NCT01739348|76214338|FG000|Part II (Extension Study)|Physician Decision|7|||
42364563|NCT01739348|76214339|FG001|Part II (Extension Study)|Physician Decision|11|||
42364564|NCT01739348|76214340|FG002|Part II (Extension Study)|Physician Decision|6|||
42364565|NCT01739348|76214341|FG003|Part II (Extension Study)|Physician Decision|12|||
42364566|NCT01739348|76214338|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
42364567|NCT01739348|76214339|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
42364568|NCT01739348|76214340|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
42364569|NCT01739348|76214341|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
42364570|NCT01739348|76214338|FG000|Part II (Extension Study)|Participant Moved|3|||
42364571|NCT01739348|76214339|FG001|Part II (Extension Study)|Participant Moved|3|||
42364572|NCT01739348|76214340|FG002|Part II (Extension Study)|Participant Moved|0|||
42364573|NCT01739348|76214341|FG003|Part II (Extension Study)|Participant Moved|3|||
42364574|NCT01739348|76214338|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
42364575|NCT01739348|76214339|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
42364576|NCT01739348|76214340|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
42364577|NCT01739348|76214341|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
42364578|NCT01739348|76214338|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
42364579|NCT01739348|76214339|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
42364580|NCT01739348|76214340|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
42364581|NCT01739348|76214341|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
42364582|NCT01738646|76214373|FG000|Overall Study|Still Receiving Treatment|2|||
42364583|NCT01716104|76214380|FG000|Overall Study|Do not meet inclusion criteria|6|||
42364584|NCT01716104|76214381|FG001|Overall Study|Do not meet inclusion criteria|7|||
42364585|NCT04426695|76214461|FG000|Overall Study|Death|2|||
42364586|NCT04426695|76214462|FG001|Overall Study|Death|0|||
42364587|NCT04426695|76214463|FG002|Overall Study|Death|1|||
42364588|NCT04426695|76214464|FG003|Overall Study|Death|27|||
42364589|NCT04426695|76214465|FG004|Overall Study|Death|25|||
42364590|NCT04426695|76214466|FG005|Overall Study|Death|21|||
42364591|NCT04426695|76214467|FG006|Overall Study|Death|42|||
42364592|NCT04426695|76214468|FG007|Overall Study|Death|23|||
42364593|NCT04426695|76214469|FG008|Overall Study|Death|37|||
42364594|NCT04426695|76214470|FG009|Overall Study|Death|14|||
42364595|NCT04426695|76214471|FG010|Overall Study|Death|8|||
42364596|NCT04426695|76214472|FG011|Overall Study|Death|7|||
42364597|NCT04426695|76214473|FG012|Overall Study|Death|13|||
42364598|NCT04426695|76214474|FG013|Overall Study|Death|25|||
42364599|NCT04426695|76214475|FG014|Overall Study|Death|19|||
42364600|NCT04426695|76214476|FG015|Overall Study|Death|7|||
42364601|NCT04426695|76214477|FG016|Overall Study|Death|8|||
42364602|NCT04426695|76214478|FG017|Overall Study|Death|4|||
42364603|NCT04426695|76214461|FG000|Overall Study|Lost to Follow-up|2|||
42364604|NCT04426695|76214462|FG001|Overall Study|Lost to Follow-up|4|||
42364605|NCT04426695|76214463|FG002|Overall Study|Lost to Follow-up|1|||
42364606|NCT04426695|76214464|FG003|Overall Study|Lost to Follow-up|19|||
42100721|NCT00379795|75911554|FG002|Overall Study|Death|6|||
42100722|NCT00379795|75911555|FG003|Overall Study|Death|4|||
42100723|NCT00379795|75911556|FG004|Overall Study|Death|7|||
42100724|NCT00379795|75911552|FG000|Overall Study|Adverse Event|17|||
42100725|NCT00379795|75911553|FG001|Overall Study|Adverse Event|3|||
42364607|NCT04426695|76214465|FG004|Overall Study|Lost to Follow-up|10|||
42364608|NCT04426695|76214466|FG005|Overall Study|Lost to Follow-up|14|||
42364609|NCT04426695|76214467|FG006|Overall Study|Lost to Follow-up|5|||
42364610|NCT04426695|76214468|FG007|Overall Study|Lost to Follow-up|14|||
42364611|NCT04426695|76214469|FG008|Overall Study|Lost to Follow-up|10|||
42364612|NCT04426695|76214470|FG009|Overall Study|Lost to Follow-up|11|||
42364613|NCT04426695|76214471|FG010|Overall Study|Lost to Follow-up|12|||
42364614|NCT04426695|76214472|FG011|Overall Study|Lost to Follow-up|6|||
42100726|NCT00379795|75911554|FG002|Overall Study|Adverse Event|3|||
42100727|NCT00379795|75911555|FG003|Overall Study|Adverse Event|1|||
42100728|NCT00379795|75911556|FG004|Overall Study|Adverse Event|4|||
42100729|NCT00379795|75911552|FG000|Overall Study|Lost to Follow-up|8|||
42100730|NCT00379795|75911553|FG001|Overall Study|Lost to Follow-up|1|||
42100731|NCT00379795|75911554|FG002|Overall Study|Lost to Follow-up|2|||
42100732|NCT00379795|75911555|FG003|Overall Study|Lost to Follow-up|1|||
42100733|NCT00379795|75911556|FG004|Overall Study|Lost to Follow-up|4|||
42100734|NCT00379795|75911552|FG000|Overall Study|Physician Decision|25|||
42364615|NCT04426695|76214473|FG012|Overall Study|Lost to Follow-up|2|||
42364616|NCT04426695|76214474|FG013|Overall Study|Lost to Follow-up|2|||
42364617|NCT04426695|76214475|FG014|Overall Study|Lost to Follow-up|2|||
42364618|NCT04426695|76214476|FG015|Overall Study|Lost to Follow-up|0|||
42100735|NCT00379795|75911553|FG001|Overall Study|Physician Decision|0|||
42196549|NCT00111761|76008434|FG001|Part 2|Other|0|||
42196550|NCT03519867|76008450|FG000|Overall Study|Adverse Event|1|||
42196551|NCT03519867|76008451|FG001|Overall Study|Adverse Event|1|||
42196552|NCT03519867|76008452|FG002|Overall Study|Adverse Event|0|||
42196553|NCT03519867|76008453|FG003|Overall Study|Adverse Event|0|||
42196554|NCT03519867|76008454|FG004|Overall Study|Adverse Event|0|||
42196555|NCT03519867|76008455|FG005|Overall Study|Adverse Event|0|||
42196556|NCT03519867|76008456|FG006|Overall Study|Adverse Event|0|||
42196557|NCT03519867|76008457|FG007|Overall Study|Adverse Event|0|||
42196558|NCT03519867|76008458|FG008|Overall Study|Adverse Event|0|||
42196559|NCT03519867|76008459|FG009|Overall Study|Adverse Event|0|||
42196560|NCT03519867|76008450|FG000|Overall Study|Protocol Violation|0|||
42196561|NCT03519867|76008451|FG001|Overall Study|Protocol Violation|0|||
42364619|NCT04426695|76214477|FG016|Overall Study|Lost to Follow-up|0|||
42364620|NCT04426695|76214478|FG017|Overall Study|Lost to Follow-up|0|||
42364621|NCT04426695|76214461|FG000|Overall Study|Participant Decision|1|||
42364622|NCT04426695|76214462|FG001|Overall Study|Participant Decision|2|||
42364623|NCT04426695|76214463|FG002|Overall Study|Participant Decision|2|||
42364624|NCT04426695|76214464|FG003|Overall Study|Participant Decision|12|||
42364625|NCT04426695|76214465|FG004|Overall Study|Participant Decision|18|||
42364626|NCT04426695|76214466|FG005|Overall Study|Participant Decision|22|||
42364627|NCT04426695|76214467|FG006|Overall Study|Participant Decision|13|||
42364628|NCT04426695|76214468|FG007|Overall Study|Participant Decision|13|||
42364629|NCT04426695|76214469|FG008|Overall Study|Participant Decision|10|||
42364630|NCT04426695|76214470|FG009|Overall Study|Participant Decision|15|||
42364631|NCT04426695|76214471|FG010|Overall Study|Participant Decision|16|||
42364632|NCT04426695|76214472|FG011|Overall Study|Participant Decision|17|||
42364633|NCT04426695|76214473|FG012|Overall Study|Participant Decision|2|||
42364634|NCT04426695|76214474|FG013|Overall Study|Participant Decision|1|||
42364635|NCT04426695|76214475|FG014|Overall Study|Participant Decision|2|||
42364636|NCT04426695|76214476|FG015|Overall Study|Participant Decision|0|||
42364637|NCT04426695|76214477|FG016|Overall Study|Participant Decision|0|||
42364638|NCT04426695|76214478|FG017|Overall Study|Participant Decision|0|||
42364639|NCT04426695|76214461|FG000|Overall Study|Adverse Event|0|||
42364640|NCT04426695|76214462|FG001|Overall Study|Adverse Event|0|||
42364641|NCT04426695|76214463|FG002|Overall Study|Adverse Event|0|||
42364642|NCT04426695|76214464|FG003|Overall Study|Adverse Event|0|||
42364643|NCT04426695|76214465|FG004|Overall Study|Adverse Event|0|||
42364644|NCT04426695|76214466|FG005|Overall Study|Adverse Event|0|||
42364645|NCT04426695|76214467|FG006|Overall Study|Adverse Event|0|||
42364646|NCT04426695|76214468|FG007|Overall Study|Adverse Event|1|||
42364647|NCT04426695|76214469|FG008|Overall Study|Adverse Event|0|||
42364648|NCT04426695|76214470|FG009|Overall Study|Adverse Event|0|||
42364649|NCT04426695|76214471|FG010|Overall Study|Adverse Event|1|||
42364650|NCT04426695|76214472|FG011|Overall Study|Adverse Event|1|||
42364651|NCT04426695|76214473|FG012|Overall Study|Adverse Event|0|||
42364652|NCT04426695|76214474|FG013|Overall Study|Adverse Event|0|||
42364653|NCT04426695|76214475|FG014|Overall Study|Adverse Event|0|||
42364654|NCT04426695|76214476|FG015|Overall Study|Adverse Event|0|||
42364655|NCT04426695|76214477|FG016|Overall Study|Adverse Event|0|||
42364656|NCT04426695|76214478|FG017|Overall Study|Adverse Event|0|||
42364657|NCT04426695|76214461|FG000|Overall Study|Sponsor Request|0|||
42364658|NCT04426695|76214462|FG001|Overall Study|Sponsor Request|0|||
42364659|NCT04426695|76214463|FG002|Overall Study|Sponsor Request|0|||
42364660|NCT04426695|76214464|FG003|Overall Study|Sponsor Request|0|||
42364661|NCT04426695|76214465|FG004|Overall Study|Sponsor Request|0|||
42364662|NCT04426695|76214466|FG005|Overall Study|Sponsor Request|0|||
42364663|NCT04426695|76214467|FG006|Overall Study|Sponsor Request|1|||
42364664|NCT04426695|76214468|FG007|Overall Study|Sponsor Request|0|||
42364665|NCT04426695|76214469|FG008|Overall Study|Sponsor Request|0|||
42364666|NCT04426695|76214470|FG009|Overall Study|Sponsor Request|0|||
42364667|NCT04426695|76214471|FG010|Overall Study|Sponsor Request|0|||
42364668|NCT04426695|76214472|FG011|Overall Study|Sponsor Request|0|||
42364669|NCT04426695|76214473|FG012|Overall Study|Sponsor Request|0|||
42364670|NCT04426695|76214474|FG013|Overall Study|Sponsor Request|0|||
42364671|NCT04426695|76214475|FG014|Overall Study|Sponsor Request|0|||
42364672|NCT04426695|76214476|FG015|Overall Study|Sponsor Request|0|||
42364673|NCT04426695|76214477|FG016|Overall Study|Sponsor Request|0|||
42364674|NCT04426695|76214478|FG017|Overall Study|Sponsor Request|0|||
42364675|NCT04426695|76214461|FG000|Overall Study|Physician Decision|0|||
42364676|NCT04426695|76214462|FG001|Overall Study|Physician Decision|0|||
42196562|NCT03519867|76008452|FG002|Overall Study|Protocol Violation|0|||
42196563|NCT03519867|76008453|FG003|Overall Study|Protocol Violation|0|||
42196564|NCT03519867|76008454|FG004|Overall Study|Protocol Violation|0|||
42196565|NCT03519867|76008455|FG005|Overall Study|Protocol Violation|1|||
42364677|NCT04426695|76214463|FG002|Overall Study|Physician Decision|0|||
42364678|NCT04426695|76214464|FG003|Overall Study|Physician Decision|0|||
42196566|NCT03519867|76008456|FG006|Overall Study|Protocol Violation|0|||
42364679|NCT04426695|76214465|FG004|Overall Study|Physician Decision|0|||
42364680|NCT04426695|76214466|FG005|Overall Study|Physician Decision|0|||
42364681|NCT04426695|76214467|FG006|Overall Study|Physician Decision|0|||
42364682|NCT04426695|76214468|FG007|Overall Study|Physician Decision|0|||
42364683|NCT04426695|76214469|FG008|Overall Study|Physician Decision|0|||
42364684|NCT04426695|76214470|FG009|Overall Study|Physician Decision|1|||
42364685|NCT04426695|76214471|FG010|Overall Study|Physician Decision|0|||
42364686|NCT04426695|76214472|FG011|Overall Study|Physician Decision|0|||
42364687|NCT04426695|76214473|FG012|Overall Study|Physician Decision|1|||
42364688|NCT04426695|76214474|FG013|Overall Study|Physician Decision|0|||
42364689|NCT04426695|76214475|FG014|Overall Study|Physician Decision|0|||
42364690|NCT04426695|76214476|FG015|Overall Study|Physician Decision|0|||
42364691|NCT04426695|76214477|FG016|Overall Study|Physician Decision|0|||
42364692|NCT04426695|76214478|FG017|Overall Study|Physician Decision|0|||
42364693|NCT04426695|76214461|FG000|Overall Study|Randomized but Never Treated|3|||
42364694|NCT04426695|76214462|FG001|Overall Study|Randomized but Never Treated|1|||
42364695|NCT04426695|76214463|FG002|Overall Study|Randomized but Never Treated|0|||
42364696|NCT04426695|76214464|FG003|Overall Study|Randomized but Never Treated|4|||
42364697|NCT04426695|76214465|FG004|Overall Study|Randomized but Never Treated|5|||
42364698|NCT04426695|76214466|FG005|Overall Study|Randomized but Never Treated|5|||
42100736|NCT00379795|75911554|FG002|Overall Study|Physician Decision|2|||
42100737|NCT00379795|75911555|FG003|Overall Study|Physician Decision|2|||
42100738|NCT00379795|75911556|FG004|Overall Study|Physician Decision|2|||
42100739|NCT00379795|75911552|FG000|Overall Study|Withdrawal by Subject|94|||
42100740|NCT00379795|75911553|FG001|Overall Study|Withdrawal by Subject|11|||
42100741|NCT00379795|75911554|FG002|Overall Study|Withdrawal by Subject|19|||
42364699|NCT04426695|76214467|FG006|Overall Study|Randomized but Never Treated|4|||
42364700|NCT04426695|76214468|FG007|Overall Study|Randomized but Never Treated|6|||
42364701|NCT04426695|76214469|FG008|Overall Study|Randomized but Never Treated|6|||
42364702|NCT04426695|76214470|FG009|Overall Study|Randomized but Never Treated|3|||
42364703|NCT04426695|76214471|FG010|Overall Study|Randomized but Never Treated|3|||
42364704|NCT04426695|76214472|FG011|Overall Study|Randomized but Never Treated|6|||
42364705|NCT04426695|76214473|FG012|Overall Study|Randomized but Never Treated|1|||
42364706|NCT04426695|76214474|FG013|Overall Study|Randomized but Never Treated|2|||
42364707|NCT04426695|76214475|FG014|Overall Study|Randomized but Never Treated|0|||
42364708|NCT04426695|76214476|FG015|Overall Study|Randomized but Never Treated|0|||
42364709|NCT04426695|76214477|FG016|Overall Study|Randomized but Never Treated|0|||
42100742|NCT00379795|75911555|FG003|Overall Study|Withdrawal by Subject|7|||
42100743|NCT00379795|75911556|FG004|Overall Study|Withdrawal by Subject|14|||
42196567|NCT03519867|76008457|FG007|Overall Study|Protocol Violation|0|||
42196568|NCT03519867|76008458|FG008|Overall Study|Protocol Violation|0|||
42196569|NCT03519867|76008459|FG009|Overall Study|Protocol Violation|0|||
42196570|NCT03519867|76008450|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
42196571|NCT03519867|76008451|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
42196572|NCT03519867|76008452|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
42196573|NCT03519867|76008453|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
42196574|NCT03519867|76008454|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
42100744|NCT00379795|75911552|FG000|Overall Study|Subject non-compliance|7|||
42100745|NCT00379795|75911553|FG001|Overall Study|Subject non-compliance|2|||
42100746|NCT00379795|75911554|FG002|Overall Study|Subject non-compliance|0|||
42100747|NCT00379795|75911555|FG003|Overall Study|Subject non-compliance|0|||
42100748|NCT00379795|75911556|FG004|Overall Study|Subject non-compliance|1|||
42100749|NCT00379795|75911552|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
42100750|NCT00379795|75911553|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
42100751|NCT00379795|75911554|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
42100752|NCT00379795|75911555|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
42100753|NCT00379795|75911556|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
42100754|NCT00379795|75911552|FG000|Overall Study|Subjects condition mandated intervention|34|||
42100755|NCT00379795|75911553|FG001|Overall Study|Subjects condition mandated intervention|9|||
42100756|NCT00379795|75911554|FG002|Overall Study|Subjects condition mandated intervention|7|||
42100757|NCT00379795|75911555|FG003|Overall Study|Subjects condition mandated intervention|5|||
42196575|NCT03519867|76008455|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
42196576|NCT03519867|76008456|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
42364710|NCT04426695|76214478|FG017|Overall Study|Randomized but Never Treated|0|||
42100758|NCT00379795|75911556|FG004|Overall Study|Subjects condition mandated intervention|7|||
42100759|NCT00379795|75911552|FG000|Overall Study|Sponsor's decision|257|||
42196577|NCT03519867|76008457|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
42196578|NCT03519867|76008458|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
42364711|NCT01838200|76214555|FG000|Overall Study|Adverse Event|0|||
42364712|NCT01838200|76214556|FG001|Overall Study|Adverse Event|2|||
42364713|NCT01838200|76214555|FG000|Overall Study|Progressive disease|3|||
42364714|NCT01838200|76214556|FG001|Overall Study|Progressive disease|0|||
42100760|NCT00379795|75911553|FG001|Overall Study|Sponsor's decision|17|||
42100761|NCT00379795|75911554|FG002|Overall Study|Sponsor's decision|54|||
42100762|NCT00379795|75911555|FG003|Overall Study|Sponsor's decision|47|||
42196579|NCT03519867|76008459|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
42196580|NCT03519867|76008450|FG000|Overall Study|Admin. of other reversal agent|1|||
42196581|NCT03519867|76008451|FG001|Overall Study|Admin. of other reversal agent|1|||
42196582|NCT03519867|76008452|FG002|Overall Study|Admin. of other reversal agent|0|||
42196583|NCT03519867|76008453|FG003|Overall Study|Admin. of other reversal agent|0|||
42196584|NCT03519867|76008454|FG004|Overall Study|Admin. of other reversal agent|0|||
42196585|NCT03519867|76008455|FG005|Overall Study|Admin. of other reversal agent|1|||
42364715|NCT03219034|76214599|FG000|Overall Study|Lost to Follow-up|9|||
42364716|NCT03219034|76214600|FG001|Overall Study|Lost to Follow-up|13|||
42364717|NCT03219034|76214599|FG000|Overall Study|Additional dental work needed|1|||
42364718|NCT03219034|76214600|FG001|Overall Study|Additional dental work needed|0|||
42364719|NCT03219034|76214599|FG000|Overall Study|UPPP Surgery|1|||
42364720|NCT03219034|76214600|FG001|Overall Study|UPPP Surgery|0|||
42364721|NCT03219034|76214599|FG000|Overall Study|Dental sensitivity|0|||
42364722|NCT03219034|76214600|FG001|Overall Study|Dental sensitivity|1|||
42364723|NCT03219034|76214599|FG000|Overall Study|Death in family|0|||
42364724|NCT03219034|76214600|FG001|Overall Study|Death in family|1|||
42364725|NCT01706198|76214624|FG000|Overall Study|Adverse Event|12|||
42364726|NCT01706198|76214625|FG001|Overall Study|Adverse Event|15|||
42364727|NCT01706198|76214624|FG000|Overall Study|Protocol Violation|7|||
42364728|NCT01706198|76214625|FG001|Overall Study|Protocol Violation|5|||
42100763|NCT00379795|75911556|FG004|Overall Study|Sponsor's decision|10|||
42100764|NCT00610155|75911571|FG000|Period 1|Withdrawal by Subject|0|||
42364729|NCT01706198|76214624|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
42364730|NCT01706198|76214625|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
42364731|NCT01706198|76214624|FG000|Overall Study|Lost to Follow-up|97|||
42364732|NCT01706198|76214625|FG001|Overall Study|Lost to Follow-up|93|||
42364733|NCT01706198|76214624|FG000|Overall Study|Physician Decision|23|||
42364734|NCT01706198|76214625|FG001|Overall Study|Physician Decision|37|||
42364735|NCT01706198|76214624|FG000|Overall Study|Withdrawal by Subject|23|||
42364736|NCT01706198|76214625|FG001|Overall Study|Withdrawal by Subject|31|||
42364737|NCT01705730|76214631|FG000|Overall Study|Lack of Efficacy|1|||
42364738|NCT01705730|76214631|FG000|Overall Study|Adverse Event|3|||
42364739|NCT01705730|76214631|FG000|Overall Study|Lost to Follow-up|1|||
42364740|NCT01705730|76214631|FG000|Overall Study|Reason not Specified|4|||
42364741|NCT01705652|76214637|FG000|Overall Study|Adverse Event|1|||
42364742|NCT01705652|76214638|FG001|Overall Study|Adverse Event|0|||
42364743|NCT01705652|76214637|FG000|Overall Study|Withdrawal by Subject|1|||
42364744|NCT01705652|76214638|FG001|Overall Study|Withdrawal by Subject|2|||
42364745|NCT01705652|76214637|FG000|Overall Study|non-compliance|1|||
42364746|NCT01705652|76214638|FG001|Overall Study|non-compliance|1|||
42364747|NCT01705574|76214666|FG000|Double-Blind Phase|Lost to Follow-up|12|||
42100765|NCT00610155|75911572|FG001|Period 1|Withdrawal by Subject|0|||
42100766|NCT00610155|75911573|FG002|Period 1|Withdrawal by Subject|1|||
42100767|NCT00610155|75911574|FG003|Period 1|Withdrawal by Subject|0|||
42100768|NCT00610155|75911575|FG004|Period 1|Withdrawal by Subject|0|||
42100769|NCT00610155|75911576|FG005|Period 1|Withdrawal by Subject|0|||
42100770|NCT00610155|75911571|FG000|Period 3|Adverse Event|1|||
42100771|NCT00610155|75911572|FG001|Period 3|Adverse Event|0|||
42100772|NCT00610155|75911573|FG002|Period 3|Adverse Event|0|||
42100773|NCT00610155|75911574|FG003|Period 3|Adverse Event|0|||
42100774|NCT00610155|75911575|FG004|Period 3|Adverse Event|0|||
42364748|NCT01705574|76214667|FG001|Double-Blind Phase|Lost to Follow-up|16|||
42364749|NCT01705574|76214668|FG002|Double-Blind Phase|Lost to Follow-up|0|||
42364750|NCT01705574|76214669|FG003|Double-Blind Phase|Lost to Follow-up|0|||
42364751|NCT01705574|76214666|FG000|Double-Blind Phase|Adverse Event|3|||
42364752|NCT01705574|76214667|FG001|Double-Blind Phase|Adverse Event|10|||
42364753|NCT01705574|76214668|FG002|Double-Blind Phase|Adverse Event|0|||
42364754|NCT01705574|76214669|FG003|Double-Blind Phase|Adverse Event|0|||
42364755|NCT01705574|76214666|FG000|Double-Blind Phase|Withdrew Consent|8|||
42364756|NCT01705574|76214667|FG001|Double-Blind Phase|Withdrew Consent|5|||
42364757|NCT01705574|76214668|FG002|Double-Blind Phase|Withdrew Consent|0|||
42364758|NCT01705574|76214669|FG003|Double-Blind Phase|Withdrew Consent|0|||
42364759|NCT01705574|76214666|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
42364760|NCT01705574|76214667|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
42100775|NCT00610155|75911576|FG005|Period 3|Adverse Event|0|||
42100776|NCT00674700|75911587|FG000|Year 1|Adverse Event|17|||
42364761|NCT01705574|76214668|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
42364762|NCT01705574|76214669|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
42364763|NCT01705574|76214666|FG000|Double-Blind Phase|Pregnancy|1|||
42364764|NCT01705574|76214667|FG001|Double-Blind Phase|Pregnancy|1|||
42364765|NCT01705574|76214668|FG002|Double-Blind Phase|Pregnancy|0|||
42100777|NCT00674700|75911588|FG001|Year 1|Adverse Event|20|||
42100778|NCT00674700|75911589|FG002|Year 1|Adverse Event|5|||
42100779|NCT00674700|75911587|FG000|Year 1|Withdrawal by Subject|7|||
42100780|NCT00674700|75911588|FG001|Year 1|Withdrawal by Subject|7|||
42100781|NCT00674700|75911589|FG002|Year 1|Withdrawal by Subject|6|||
42100782|NCT00674700|75911587|FG000|Year 1|Any other reason not above-mentioned|7|||
42364766|NCT01705574|76214669|FG003|Double-Blind Phase|Pregnancy|0|||
42364767|NCT01705574|76214666|FG000|Double-Blind Phase|Protocol Violation|1|||
42364768|NCT01705574|76214667|FG001|Double-Blind Phase|Protocol Violation|0|||
42364769|NCT01705574|76214668|FG002|Double-Blind Phase|Protocol Violation|0|||
42364770|NCT01705574|76214669|FG003|Double-Blind Phase|Protocol Violation|0|||
42364771|NCT01705574|76214666|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
42364772|NCT01705574|76214667|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
42364773|NCT01705574|76214668|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
42364774|NCT01705574|76214669|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
42364775|NCT01705574|76214666|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
42196586|NCT03519867|76008456|FG006|Overall Study|Admin. of other reversal agent|0|||
42196587|NCT03519867|76008457|FG007|Overall Study|Admin. of other reversal agent|0|||
42196588|NCT03519867|76008458|FG008|Overall Study|Admin. of other reversal agent|0|||
42196589|NCT03519867|76008459|FG009|Overall Study|Admin. of other reversal agent|0|||
42364776|NCT01705574|76214667|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
42364777|NCT01705574|76214668|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
42364778|NCT01705574|76214669|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
42364779|NCT01705574|76214666|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
42364780|NCT01705574|76214667|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
42364781|NCT01705574|76214668|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
42364782|NCT01705574|76214669|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
42364783|NCT01705574|76214666|FG000|Open-Label Extension Phase|Adverse Event|3|||
42364784|NCT01705574|76214667|FG001|Open-Label Extension Phase|Adverse Event|0|||
42364785|NCT01705574|76214668|FG002|Open-Label Extension Phase|Adverse Event|0|||
42364786|NCT01705574|76214669|FG003|Open-Label Extension Phase|Adverse Event|1|||
42364787|NCT01705574|76214666|FG000|Open-Label Extension Phase|Death|2|||
42364788|NCT01705574|76214667|FG001|Open-Label Extension Phase|Death|0|||
42364789|NCT01705574|76214668|FG002|Open-Label Extension Phase|Death|1|||
42364790|NCT01705574|76214669|FG003|Open-Label Extension Phase|Death|0|||
42364791|NCT01705574|76214666|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
42364792|NCT01705574|76214667|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
42364793|NCT01705574|76214668|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
42364794|NCT01705574|76214669|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
42364795|NCT01705574|76214666|FG000|Open-Label Extension Phase|Physician Decision|0|||
42364796|NCT01705574|76214667|FG001|Open-Label Extension Phase|Physician Decision|0|||
42364797|NCT01705574|76214668|FG002|Open-Label Extension Phase|Physician Decision|2|||
42364798|NCT01705574|76214669|FG003|Open-Label Extension Phase|Physician Decision|0|||
42364799|NCT01705574|76214666|FG000|Open-Label Extension Phase|Pregnancy|0|||
42364800|NCT01705574|76214667|FG001|Open-Label Extension Phase|Pregnancy|0|||
42100783|NCT00674700|75911588|FG001|Year 1|Any other reason not above-mentioned|7|||
42100784|NCT00674700|75911589|FG002|Year 1|Any other reason not above-mentioned|6|||
42100785|NCT00674700|75911587|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
42100786|NCT00674700|75911588|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
42100787|NCT00674700|75911589|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
42100788|NCT00674700|75911587|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
42100789|NCT00674700|75911588|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
42100790|NCT00674700|75911589|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
42196590|NCT03519867|76008450|FG000|Overall Study|Reason not provided|1|||
42196591|NCT03519867|76008451|FG001|Overall Study|Reason not provided|1|||
42196592|NCT03519867|76008452|FG002|Overall Study|Reason not provided|1|||
42196593|NCT03519867|76008453|FG003|Overall Study|Reason not provided|1|||
42364801|NCT01705574|76214668|FG002|Open-Label Extension Phase|Pregnancy|1|||
42364802|NCT01705574|76214669|FG003|Open-Label Extension Phase|Pregnancy|1|||
42364803|NCT01737710|76214690|FG000|Overall Study|Lost to Follow-up|0|||
42196594|NCT03519867|76008454|FG004|Overall Study|Reason not provided|0|||
42364804|NCT01737710|76214691|FG001|Overall Study|Lost to Follow-up|2|||
42364805|NCT01737710|76214692|FG002|Overall Study|Lost to Follow-up|2|||
42364806|NCT01737710|76214693|FG003|Overall Study|Lost to Follow-up|0|||
42364807|NCT01737710|76214694|FG004|Overall Study|Lost to Follow-up|0|||
42364808|NCT01737710|76214690|FG000|Overall Study|Withdrawal by Subject|1|||
42364809|NCT01737710|76214691|FG001|Overall Study|Withdrawal by Subject|1|||
42364810|NCT01737710|76214692|FG002|Overall Study|Withdrawal by Subject|1|||
42364811|NCT01737710|76214693|FG003|Overall Study|Withdrawal by Subject|0|||
42364812|NCT01737710|76214694|FG004|Overall Study|Withdrawal by Subject|0|||
42364813|NCT01737710|76214690|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
42196595|NCT03519867|76008455|FG005|Overall Study|Reason not provided|1|||
42364814|NCT01737710|76214691|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
42364815|NCT01737710|76214692|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
42364816|NCT01737710|76214693|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
42364817|NCT01737710|76214694|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
42364818|NCT01682876|76214709|FG000|Overall Study|Administrative reason|4|||
42364819|NCT01682876|76214710|FG001|Overall Study|Administrative reason|4|||
42364820|NCT01682876|76214711|FG002|Overall Study|Administrative reason|0|||
42364821|NCT01682876|76214712|FG003|Overall Study|Administrative reason|3|||
42364822|NCT01682876|76214709|FG000|Overall Study|Adverse Event|0|||
42364823|NCT01682876|76214710|FG001|Overall Study|Adverse Event|0|||
42364824|NCT01682876|76214711|FG002|Overall Study|Adverse Event|0|||
42364825|NCT01682876|76214712|FG003|Overall Study|Adverse Event|1|||
42364826|NCT01682876|76214709|FG000|Overall Study|Lost to Follow-up|11|||
42364827|NCT01682876|76214710|FG001|Overall Study|Lost to Follow-up|15|||
42364828|NCT01682876|76214711|FG002|Overall Study|Lost to Follow-up|9|||
42364829|NCT01682876|76214712|FG003|Overall Study|Lost to Follow-up|11|||
42364830|NCT01682876|76214709|FG000|Overall Study|Protocol Violation|1|||
42364831|NCT01682876|76214710|FG001|Overall Study|Protocol Violation|1|||
42364832|NCT01682876|76214711|FG002|Overall Study|Protocol Violation|1|||
42364833|NCT01682876|76214712|FG003|Overall Study|Protocol Violation|1|||
42364834|NCT01682876|76214709|FG000|Overall Study|Withdrawal by Subject|4|||
42364835|NCT01682876|76214710|FG001|Overall Study|Withdrawal by Subject|0|||
42364836|NCT01682876|76214711|FG002|Overall Study|Withdrawal by Subject|0|||
42364837|NCT01682876|76214712|FG003|Overall Study|Withdrawal by Subject|2|||
42364838|NCT01682876|76214709|FG000|Overall Study|Other|1|||
42364839|NCT01682876|76214710|FG001|Overall Study|Other|0|||
42364840|NCT01682876|76214711|FG002|Overall Study|Other|1|||
42364841|NCT01682876|76214712|FG003|Overall Study|Other|1|||
42364842|NCT01682720|76214729|FG000|Overall Study|Randomized but Not Treated|0|||
42364843|NCT01682720|76214730|FG001|Overall Study|Randomized but Not Treated|1|||
42196596|NCT03519867|76008456|FG006|Overall Study|Reason not provided|0|||
42196597|NCT03519867|76008457|FG007|Overall Study|Reason not provided|1|||
42196598|NCT03519867|76008458|FG008|Overall Study|Reason not provided|1|||
42196599|NCT03519867|76008459|FG009|Overall Study|Reason not provided|0|||
42196600|NCT03519087|76008483|FG000|Clinic Evaluation|Physician Decision|15|||
42196601|NCT03519087|76008484|FG001|Clinic Evaluation|Physician Decision|18|||
42196602|NCT03519087|76008485|FG002|Clinic Evaluation|Physician Decision|0|||
42196603|NCT03519087|76008486|FG003|Clinic Evaluation|Physician Decision|0|||
42364844|NCT01682720|76214731|FG002|Overall Study|Randomized but Not Treated|1|||
42364845|NCT01682720|76214732|FG003|Overall Study|Randomized but Not Treated|0|||
42364846|NCT01682720|76214729|FG000|Overall Study|Terminated by Sponsor|83|||
42364847|NCT01682720|76214730|FG001|Overall Study|Terminated by Sponsor|0|||
42364848|NCT01682720|76214731|FG002|Overall Study|Terminated by Sponsor|0|||
42364849|NCT01682720|76214732|FG003|Overall Study|Terminated by Sponsor|0|||
42364850|NCT01682720|76214729|FG000|Overall Study|Efficacy Failure|0|||
42364851|NCT01682720|76214730|FG001|Overall Study|Efficacy Failure|3|||
42364852|NCT01682720|76214731|FG002|Overall Study|Efficacy Failure|3|||
42364853|NCT01682720|76214732|FG003|Overall Study|Efficacy Failure|30|||
42364854|NCT01682720|76214729|FG000|Overall Study|Lost to Follow-up|1|||
42364855|NCT01682720|76214730|FG001|Overall Study|Lost to Follow-up|1|||
42364856|NCT01682720|76214731|FG002|Overall Study|Lost to Follow-up|0|||
42364857|NCT01682720|76214732|FG003|Overall Study|Lost to Follow-up|6|||
42364858|NCT01682720|76214729|FG000|Overall Study|Subject Withdrew Consent|0|||
42196604|NCT03519087|76008487|FG004|Clinic Evaluation|Physician Decision|0|||
42364859|NCT01682720|76214730|FG001|Overall Study|Subject Withdrew Consent|0|||
42364860|NCT01682720|76214731|FG002|Overall Study|Subject Withdrew Consent|2|||
42364861|NCT01682720|76214732|FG003|Overall Study|Subject Withdrew Consent|2|||
42364862|NCT01682720|76214729|FG000|Overall Study|Adverse Event|1|||
42364863|NCT01682720|76214730|FG001|Overall Study|Adverse Event|0|||
42364864|NCT01682720|76214731|FG002|Overall Study|Adverse Event|1|||
42364865|NCT01682720|76214732|FG003|Overall Study|Adverse Event|1|||
42364866|NCT01714544|76214751|FG000|Overall Study|Lost to Follow-up|1|||
42364867|NCT01714544|76214751|FG000|Overall Study|Physician Decision|1|||
42364868|NCT01714544|76214751|FG000|Overall Study|Withdrawal by Subject|1|||
42364869|NCT01703858|76214758|FG000|Overall Study|Withdrawal by Subject|0|||
42364870|NCT01703858|76214759|FG001|Overall Study|Withdrawal by Subject|1|||
42364871|NCT01703858|76214760|FG002|Overall Study|Withdrawal by Subject|0|||
42364872|NCT01714310|76214776|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
42364873|NCT01714310|76214777|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
42364874|NCT01714310|76214778|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
42364875|NCT01714310|76214776|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
42364876|NCT01714310|76214777|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
42364877|NCT01714310|76214778|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
42364878|NCT01714310|76214776|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
42364879|NCT01714310|76214777|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
42364880|NCT01714310|76214778|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
42364881|NCT01714310|76214776|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
42364882|NCT01714310|76214777|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
42364883|NCT01714310|76214778|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
42364884|NCT01713998|76214799|FG000|Overall Study|Lost to Follow-up|2|||
42364885|NCT01713998|76214800|FG001|Overall Study|Lost to Follow-up|0|||
42364886|NCT01713998|76214801|FG002|Overall Study|Lost to Follow-up|2|||
42364887|NCT01713998|76214799|FG000|Overall Study|Withdrawal by Subject|1|||
42364888|NCT01713998|76214800|FG001|Overall Study|Withdrawal by Subject|0|||
42364889|NCT01713998|76214801|FG002|Overall Study|Withdrawal by Subject|0|||
42364890|NCT01681628|76214811|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
42364891|NCT01681628|76214812|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
42364892|NCT01681628|76214811|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
42196605|NCT03519087|76008483|FG000|Clinic Evaluation|Protocol Violation|1|||
42364893|NCT01681628|76214812|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
42364894|NCT01681628|76214811|FG000|19 Months Follow-up|Death|1|||
42364895|NCT01681628|76214812|FG001|19 Months Follow-up|Death|0|||
42364896|NCT01681628|76214811|FG000|19 Months Follow-up|Lost to Follow-up|61|||
42364897|NCT01681628|76214812|FG001|19 Months Follow-up|Lost to Follow-up|43|||
42364898|NCT00016354|76214834|FG000|Overall Study|Lack of Efficacy|0|||
42364899|NCT00016354|76214835|FG001|Overall Study|Lack of Efficacy|0|||
42364900|NCT00016354|76214836|FG002|Overall Study|Lack of Efficacy|0|||
42364901|NCT00016354|76214837|FG003|Overall Study|Lack of Efficacy|0|||
42364902|NCT00016354|76214838|FG004|Overall Study|Lack of Efficacy|0|||
42364903|NCT00016354|76214839|FG005|Overall Study|Lack of Efficacy|0|||
42364904|NCT00016354|76214840|FG006|Overall Study|Lack of Efficacy|0|||
42364905|NCT00016354|76214841|FG007|Overall Study|Lack of Efficacy|1|||
42364906|NCT01681472|76214849|FG000|Overall Study|Adverse Event|0|||
42364907|NCT01681472|76214850|FG001|Overall Study|Adverse Event|1|||
42364908|NCT01681472|76214851|FG002|Overall Study|Adverse Event|0|||
42364909|NCT01681472|76214852|FG003|Overall Study|Adverse Event|0|||
42364910|NCT01049308|76214881|FG000|Pill Counts|Withdrawal by Subject|83|||
42196606|NCT03519087|76008484|FG001|Clinic Evaluation|Protocol Violation|0|||
42196607|NCT03519087|76008485|FG002|Clinic Evaluation|Protocol Violation|0|||
42196608|NCT03519087|76008486|FG003|Clinic Evaluation|Protocol Violation|0|||
42196609|NCT03519087|76008487|FG004|Clinic Evaluation|Protocol Violation|0|||
42196610|NCT03519087|76008483|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
42196611|NCT03519087|76008484|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
42196612|NCT03519087|76008485|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
42196613|NCT03519087|76008486|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
42364911|NCT01713686|76214888|FG000|Overall Study|Lost to Follow-up|9|||
42364912|NCT01713686|76214888|FG000|Overall Study|Withdrawal by Subject|6|||
42364913|NCT01047436|76214894|FG000|Overall Study|Protocol Violation|1|||
42364914|NCT01047436|76214895|FG001|Overall Study|Protocol Violation|0|||
42364915|NCT01681004|76214903|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
42364916|NCT01681004|76214904|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
42364917|NCT01681004|76214903|FG000|Study Completion|Lost to Follow-up|8|||
42364918|NCT01681004|76214904|FG001|Study Completion|Lost to Follow-up|3|||
42364919|NCT01681004|76214903|FG000|Study Completion|Physician Decision|1|||
42364920|NCT01681004|76214904|FG001|Study Completion|Physician Decision|3|||
42364921|NCT01681004|76214903|FG000|Study Completion|Site Termination|2|||
42364922|NCT01681004|76214904|FG001|Study Completion|Site Termination|1|||
42364923|NCT01681004|76214903|FG000|Study Completion|Death|1|||
42364924|NCT01681004|76214904|FG001|Study Completion|Death|1|||
42364925|NCT01046110|76214916|FG000|Overall Study|Adverse Event|9|||
42364926|NCT01046110|76214917|FG001|Overall Study|Adverse Event|2|||
42364927|NCT01046110|76214916|FG000|Overall Study|Lack of Efficacy|0|||
42364928|NCT01046110|76214917|FG001|Overall Study|Lack of Efficacy|1|||
42364929|NCT01046110|76214916|FG000|Overall Study|Protocol Violation|7|||
42364930|NCT01046110|76214917|FG001|Overall Study|Protocol Violation|12|||
42364931|NCT01046110|76214916|FG000|Overall Study|Withdrawal Criteria|3|||
42364932|NCT01046110|76214917|FG001|Overall Study|Withdrawal Criteria|5|||
42364933|NCT01046110|76214916|FG000|Overall Study|Unclassified|36|||
42364934|NCT01046110|76214917|FG001|Overall Study|Unclassified|35|||
42364935|NCT01713530|76214925|FG000|Overall Study|Adverse Event|0|||
42196614|NCT03519087|76008487|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
42364936|NCT01713530|76214926|FG001|Overall Study|Adverse Event|5|||
42364937|NCT01713530|76214925|FG000|Overall Study|Withdrawal criteria|21|||
42364938|NCT01713530|76214926|FG001|Overall Study|Withdrawal criteria|12|||
42364939|NCT01713530|76214925|FG000|Overall Study|Unclassified|4|||
42364940|NCT01713530|76214926|FG001|Overall Study|Unclassified|2|||
42364941|NCT01045798|76214934|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
42364942|NCT01045798|76214935|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
42364943|NCT01045798|76214934|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
42364944|NCT01045798|76214935|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
42364945|NCT01045798|76214934|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
42364946|NCT01045798|76214935|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
42364947|NCT01045798|76214934|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
42364948|NCT01045798|76214935|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
42364949|NCT01712984|76214948|FG000|Overall Study|Adverse Event|0|||
42364950|NCT01712984|76214949|FG001|Overall Study|Adverse Event|0|||
42364951|NCT01712984|76214950|FG002|Overall Study|Adverse Event|1|||
42364952|NCT01712984|76214948|FG000|Overall Study|Protocol Violation|2|||
42364953|NCT01712984|76214949|FG001|Overall Study|Protocol Violation|0|||
42364954|NCT01712984|76214950|FG002|Overall Study|Protocol Violation|1|||
42364955|NCT01712984|76214948|FG000|Overall Study|Lost to Follow-up|8|||
42364956|NCT01712984|76214949|FG001|Overall Study|Lost to Follow-up|10|||
42100791|NCT00674700|75911587|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
42100792|NCT00674700|75911588|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
42100793|NCT00674700|75911589|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
42100794|NCT00546910|75911599|FG000|Overall Study|Adverse Event|2|||
42100795|NCT00546910|75911600|FG001|Overall Study|Adverse Event|3|||
42100796|NCT00546910|75911599|FG000|Overall Study|Lack of Efficacy|5|||
42100797|NCT00546910|75911600|FG001|Overall Study|Lack of Efficacy|7|||
42100798|NCT00546910|75911599|FG000|Overall Study|Physician Decision|0|||
42100799|NCT00546910|75911600|FG001|Overall Study|Physician Decision|1|||
42100800|NCT00546910|75911599|FG000|Overall Study|Withdrawal by Subject|2|||
42100801|NCT00546910|75911600|FG001|Overall Study|Withdrawal by Subject|0|||
42100802|NCT00379639|75911611|FG000|Overall Study|Disease Progression|3|||
42100803|NCT00379639|75911612|FG001|Overall Study|Disease Progression|3|||
42100804|NCT00379639|75911613|FG002|Overall Study|Disease Progression|3|||
42100805|NCT00379639|75911614|FG003|Overall Study|Disease Progression|4|||
42100806|NCT00379639|75911615|FG004|Overall Study|Disease Progression|4|||
42100807|NCT00379639|75911611|FG000|Overall Study|Physician Decision|0|||
42100808|NCT00379639|75911612|FG001|Overall Study|Physician Decision|2|||
42100809|NCT00379639|75911613|FG002|Overall Study|Physician Decision|1|||
42100810|NCT00379639|75911614|FG003|Overall Study|Physician Decision|1|||
42100811|NCT00379639|75911615|FG004|Overall Study|Physician Decision|0|||
42100812|NCT00379639|75911611|FG000|Overall Study|Symptomatic Deterioration|0|||
42100813|NCT00379639|75911612|FG001|Overall Study|Symptomatic Deterioration|0|||
42100814|NCT00379639|75911613|FG002|Overall Study|Symptomatic Deterioration|1|||
42364957|NCT01712984|76214950|FG002|Overall Study|Lost to Follow-up|1|||
42364958|NCT01712984|76214948|FG000|Overall Study|Withdrawal by Subject|6|||
42364959|NCT01712984|76214949|FG001|Overall Study|Withdrawal by Subject|6|||
42364960|NCT01712984|76214950|FG002|Overall Study|Withdrawal by Subject|7|||
42364961|NCT01042678|76214961|FG000|Overall Study|Physician Decision|1|||
42364962|NCT01042678|76214962|FG001|Overall Study|Physician Decision|0|||
42364963|NCT01042678|76214963|FG002|Overall Study|Physician Decision|0|||
42364964|NCT01042678|76214964|FG003|Overall Study|Physician Decision|0|||
42364965|NCT01042678|76214965|FG004|Overall Study|Physician Decision|0|||
42364966|NCT01042678|76214966|FG005|Overall Study|Physician Decision|0|||
42364967|NCT01042600|76214976|FG000|Overall Study|Ineligible|1|||
42364968|NCT01042600|76214977|FG001|Overall Study|Ineligible|0|||
42364969|NCT01041976|76214986|FG000|Overall Study|Withdrawal by Subject|3|||
42100815|NCT00379639|75911614|FG003|Overall Study|Symptomatic Deterioration|0|||
42100816|NCT00379639|75911615|FG004|Overall Study|Symptomatic Deterioration|1|||
42100817|NCT00379639|75911611|FG000|Overall Study|Adverse Event|0|||
42100818|NCT00379639|75911612|FG001|Overall Study|Adverse Event|0|||
42100819|NCT00379639|75911613|FG002|Overall Study|Adverse Event|1|||
42100820|NCT00379639|75911614|FG003|Overall Study|Adverse Event|0|||
42100821|NCT00379639|75911615|FG004|Overall Study|Adverse Event|1|||
42100822|NCT00379639|75911611|FG000|Overall Study|Lost to Follow-up|0|||
42100823|NCT00379639|75911612|FG001|Overall Study|Lost to Follow-up|0|||
42100824|NCT00379639|75911613|FG002|Overall Study|Lost to Follow-up|0|||
42100825|NCT00379639|75911614|FG003|Overall Study|Lost to Follow-up|1|||
42364970|NCT01041976|76214987|FG001|Overall Study|Withdrawal by Subject|0|||
42364971|NCT01041976|76214986|FG000|Overall Study|Incarceration|2|||
42364972|NCT01041976|76214987|FG001|Overall Study|Incarceration|0|||
42364973|NCT01041976|76214986|FG000|Overall Study|Death|0|||
42364974|NCT01041976|76214987|FG001|Overall Study|Death|4|||
42364975|NCT01712516|76215013|FG000|Overall Study|Technical problems|0|||
42100826|NCT00379639|75911615|FG004|Overall Study|Lost to Follow-up|0|||
42364976|NCT01712516|76215014|FG001|Overall Study|Technical problems|0|||
42364977|NCT01712516|76215015|FG002|Overall Study|Technical problems|0|||
42364978|NCT01712516|76215016|FG003|Overall Study|Technical problems|2|||
42364979|NCT01712516|76215013|FG000|Overall Study|Lost to Follow-up|0|||
42364980|NCT01712516|76215014|FG001|Overall Study|Lost to Follow-up|0|||
42364981|NCT01712516|76215015|FG002|Overall Study|Lost to Follow-up|2|||
42364982|NCT01712516|76215016|FG003|Overall Study|Lost to Follow-up|1|||
42364983|NCT01712516|76215013|FG000|Overall Study|Death|0|||
42364984|NCT01712516|76215014|FG001|Overall Study|Death|1|||
42364985|NCT01712516|76215015|FG002|Overall Study|Death|0|||
42364986|NCT01712516|76215016|FG003|Overall Study|Death|0|||
42364987|NCT01712516|76215013|FG000|Overall Study|Protocol deviation|1|||
42364988|NCT01712516|76215014|FG001|Overall Study|Protocol deviation|0|||
42364989|NCT01712516|76215015|FG002|Overall Study|Protocol deviation|1|||
42364990|NCT01712516|76215016|FG003|Overall Study|Protocol deviation|0|||
42364991|NCT01712516|76215013|FG000|Overall Study|Physician Decision|2|||
42364992|NCT01712516|76215014|FG001|Overall Study|Physician Decision|0|||
42364993|NCT01712516|76215015|FG002|Overall Study|Physician Decision|0|||
42364994|NCT01712516|76215016|FG003|Overall Study|Physician Decision|1|||
42364995|NCT01712516|76215013|FG000|Overall Study|Withdrawal by Subject|3|||
42364996|NCT01712516|76215014|FG001|Overall Study|Withdrawal by Subject|9|||
42364997|NCT01712516|76215015|FG002|Overall Study|Withdrawal by Subject|3|||
42364998|NCT01712516|76215016|FG003|Overall Study|Withdrawal by Subject|9|||
42364999|NCT01703000|76215026|FG000|Overall Study|Death|1|||
42365000|NCT01040728|76215030|FG000|Overall Study|Adverse Event|4|||
42365001|NCT01040728|76215031|FG001|Overall Study|Adverse Event|8|||
42365002|NCT01040728|76215032|FG002|Overall Study|Adverse Event|0|||
42365003|NCT01040728|76215033|FG003|Overall Study|Adverse Event|4|||
42365004|NCT01040728|76215030|FG000|Overall Study|Withdrawal by Subject|0|||
42365005|NCT01040728|76215031|FG001|Overall Study|Withdrawal by Subject|1|||
42365006|NCT01040728|76215032|FG002|Overall Study|Withdrawal by Subject|1|||
42365007|NCT01040728|76215033|FG003|Overall Study|Withdrawal by Subject|0|||
42365008|NCT01040728|76215030|FG000|Overall Study|Protocol Violation|0|||
42365009|NCT01040728|76215031|FG001|Overall Study|Protocol Violation|0|||
42365010|NCT01040728|76215032|FG002|Overall Study|Protocol Violation|0|||
42365011|NCT01040728|76215033|FG003|Overall Study|Protocol Violation|1|||
42365012|NCT01040728|76215030|FG000|Overall Study|Lack of Efficacy|0|||
42365013|NCT01040728|76215031|FG001|Overall Study|Lack of Efficacy|1|||
42365014|NCT01040728|76215032|FG002|Overall Study|Lack of Efficacy|0|||
42365015|NCT01040728|76215033|FG003|Overall Study|Lack of Efficacy|1|||
42365016|NCT01040728|76215030|FG000|Overall Study|Other reasons not listed above|0|||
42365017|NCT01040728|76215031|FG001|Overall Study|Other reasons not listed above|1|||
42365018|NCT01040728|76215032|FG002|Overall Study|Other reasons not listed above|0|||
42365019|NCT01040728|76215033|FG003|Overall Study|Other reasons not listed above|0|||
42365020|NCT01593020|76215051|FG000|Overall Study|Adverse Event|1|||
42365021|NCT01593020|76215052|FG001|Overall Study|Adverse Event|1|||
42365022|NCT01593020|76215051|FG000|Overall Study|Death|0|||
42365023|NCT01593020|76215052|FG001|Overall Study|Death|1|||
42365024|NCT01593020|76215051|FG000|Overall Study|Ineligible|1|||
42365025|NCT01593020|76215052|FG001|Overall Study|Ineligible|0|||
42365026|NCT01040260|76215060|FG000|Overall Study|Withdrawal by Subject|12|||
42365027|NCT01040260|76215061|FG001|Overall Study|Withdrawal by Subject|6|||
42365028|NCT01040260|76215060|FG000|Overall Study|Lost to Follow-up|3|||
42365029|NCT01040260|76215061|FG001|Overall Study|Lost to Follow-up|5|||
42365030|NCT01712438|76215067|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
42365031|NCT01712438|76215067|FG000|Overall Study|Ongoing ITI treatment|6|||
42365032|NCT01712438|76215067|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
42365033|NCT01712438|76215067|FG000|Overall Study|Prematurely Discontinued|25|||
42365034|NCT01712204|76215078|FG000|Overall Study|Adverse Event|3|||
42365035|NCT01712204|76215079|FG001|Overall Study|Adverse Event|1|||
42365036|NCT01712204|76215078|FG000|Overall Study|Withdrawal by Subject|3|||
42365037|NCT01712204|76215079|FG001|Overall Study|Withdrawal by Subject|3|||
42365038|NCT01712204|76215078|FG000|Overall Study|Lost to Follow-up|1|||
42365039|NCT01712204|76215079|FG001|Overall Study|Lost to Follow-up|0|||
42365040|NCT01712204|76215078|FG000|Overall Study|Protocol Violation|1|||
42365041|NCT01712204|76215079|FG001|Overall Study|Protocol Violation|1|||
42365042|NCT01592864|76215087|FG000|Overall Study|Withdrawal by Subject|0|||
42365043|NCT01592864|76215088|FG001|Overall Study|Withdrawal by Subject|1|||
42365044|NCT01592786|76215094|FG000|Overall Study|Adverse Event|60|||
42365045|NCT01592786|76215094|FG000|Overall Study|Lack of Efficacy|19|||
42365046|NCT01592786|76215094|FG000|Overall Study|Protocol Violation|14|||
42365047|NCT01592786|76215094|FG000|Overall Study|Withdrawal by Subject|23|||
42365048|NCT01592786|76215094|FG000|Overall Study|Lost to Follow-up|19|||
42365049|NCT01592786|76215094|FG000|Overall Study|Other|3|||
42365050|NCT01711736|76215100|FG000|Overall Study|Lost to Follow-up|4|||
42365051|NCT01711736|76215101|FG001|Overall Study|Lost to Follow-up|1|||
42365052|NCT01711736|76215100|FG000|Overall Study|Withdrawal by Subject|6|||
42365053|NCT01711736|76215101|FG001|Overall Study|Withdrawal by Subject|6|||
42365054|NCT01711736|76215100|FG000|Overall Study|Migrated/moved from study area|2|||
42365055|NCT01711736|76215101|FG001|Overall Study|Migrated/moved from study area|1|||
42365056|NCT01592708|76215110|FG000|Overall Study|Protocol Violation|3|||
42365057|NCT01592708|76215111|FG001|Overall Study|Protocol Violation|0|||
42365058|NCT01042522|76215122|FG000|Overall Study|Adverse Event|1|||
42365059|NCT01042522|76215123|FG001|Overall Study|Adverse Event|2|||
42365060|NCT01042522|76215122|FG000|Overall Study|Disease Progression|5|||
42365061|NCT01042522|76215123|FG001|Overall Study|Disease Progression|0|||
42365062|NCT01042522|76215122|FG000|Overall Study|Death|1|||
42100827|NCT00379639|75911611|FG000|Overall Study|Other|0|||
42100828|NCT00379639|75911612|FG001|Overall Study|Other|0|||
42100829|NCT00379639|75911613|FG002|Overall Study|Other|3|||
42100830|NCT00379639|75911614|FG003|Overall Study|Other|0|||
42100831|NCT00379639|75911615|FG004|Overall Study|Other|0|||
42100832|NCT03948334|75911629|FG000|Overall Study|Adverse Event|1|||
42365063|NCT01042522|76215123|FG001|Overall Study|Death|0|||
42365064|NCT01042522|76215122|FG000|Overall Study|Patient Refused|0|||
42196615|NCT03519087|76008483|FG000|Re-randomization for Treatment|Not appropriate|2|||
42196616|NCT03519087|76008484|FG001|Re-randomization for Treatment|Not appropriate|3|||
42196617|NCT03519087|76008485|FG002|Re-randomization for Treatment|Not appropriate|0|||
42196618|NCT03519087|76008486|FG003|Re-randomization for Treatment|Not appropriate|0|||
42196619|NCT03519087|76008487|FG004|Re-randomization for Treatment|Not appropriate|0|||
42196620|NCT03519087|76008483|FG000|Laboratory Testing|Lost to Follow-up|0|||
42365065|NCT01042522|76215123|FG001|Overall Study|Patient Refused|3|||
42365066|NCT01042522|76215122|FG000|Overall Study|Withdrawal by Subject|1|||
42365067|NCT01042522|76215123|FG001|Overall Study|Withdrawal by Subject|1|||
42365068|NCT01702844|76215129|FG000|Overall Study|Adverse Event|9|||
42365069|NCT01702844|76215129|FG000|Overall Study|Death|1|||
42365070|NCT01702844|76215129|FG000|Overall Study|Withdrawal by Subject|3|||
42365071|NCT01702844|76215129|FG000|Overall Study|Physician Decision|6|||
42365072|NCT01702532|76215135|FG000|Overall Study|Adverse Event|0|||
42365073|NCT01702532|76215136|FG001|Overall Study|Adverse Event|1|||
42365074|NCT01702454|76215145|FG000|Overall Study|Consent withdrawal|0|||
42365075|NCT01702454|76215146|FG001|Overall Study|Consent withdrawal|1|||
42365076|NCT01702454|76215145|FG000|Overall Study|Migrated/moved from study area|0|||
42365077|NCT01702454|76215146|FG001|Overall Study|Migrated/moved from study area|1|||
42365078|NCT01702454|76215145|FG000|Overall Study|Lost to Follow-up|3|||
42365079|NCT01702454|76215146|FG001|Overall Study|Lost to Follow-up|6|||
42365080|NCT01702298|76215159|FG000|Overall Study|Withdrawal by Subject|1|||
42365081|NCT01701362|76215165|FG000|Overall Study|Adverse events not related to study drug|1|||
42365082|NCT01701362|76215166|FG001|Overall Study|Adverse events not related to study drug|6|||
42365083|NCT01701362|76215165|FG000|Overall Study|Adverse events related to study drug|12|||
42365084|NCT01701362|76215166|FG001|Overall Study|Adverse events related to study drug|10|||
42365085|NCT01701362|76215165|FG000|Overall Study|Protocol Violation|5|||
42365086|NCT01701362|76215166|FG001|Overall Study|Protocol Violation|3|||
42365087|NCT01701362|76215165|FG000|Overall Study|No longer willing to participate|8|||
42365088|NCT01701362|76215166|FG001|Overall Study|No longer willing to participate|14|||
42365089|NCT01701362|76215165|FG000|Overall Study|Lost to Follow-up|6|||
42365090|NCT01701362|76215166|FG001|Overall Study|Lost to Follow-up|9|||
42365091|NCT01701362|76215165|FG000|Overall Study|Insufficient clinical response|6|||
42365092|NCT01701362|76215166|FG001|Overall Study|Insufficient clinical response|6|||
42365093|NCT01701362|76215165|FG000|Overall Study|Death|0|||
42365094|NCT01701362|76215166|FG001|Overall Study|Death|1|||
42365095|NCT01701362|76215165|FG000|Overall Study|Randomized but not treated|1|||
42196621|NCT03519087|76008484|FG001|Laboratory Testing|Lost to Follow-up|0|||
42365096|NCT01701362|76215166|FG001|Overall Study|Randomized but not treated|2|||
42365097|NCT01701362|76215165|FG000|Overall Study|Reasons other than those mentioned above|3|||
42365098|NCT01701362|76215166|FG001|Overall Study|Reasons other than those mentioned above|5|||
42100833|NCT03948334|75911630|FG001|Overall Study|Adverse Event|4|||
42100834|NCT03948334|75911629|FG000|Overall Study|Lack of Efficacy|2|||
42100835|NCT03948334|75911630|FG001|Overall Study|Lack of Efficacy|0|||
42100836|NCT03948334|75911629|FG000|Overall Study|Lost to Follow-up|1|||
42196622|NCT03519087|76008485|FG002|Laboratory Testing|Lost to Follow-up|2|||
42196623|NCT03519087|76008486|FG003|Laboratory Testing|Lost to Follow-up|3|||
42196624|NCT03519087|76008487|FG004|Laboratory Testing|Lost to Follow-up|6|||
42365099|NCT01710800|76215195|FG000|Overall Study|Withdrawal by Subject|21|||
42365100|NCT01710800|76215195|FG000|Overall Study|Protocol Violation|1|||
42365101|NCT01710020|76215201|FG000|Period 1|Protocol Violation|1|||
42365102|NCT01700348|76215207|FG000|Overall Study|Withdrawal by Subject|22|||
42365103|NCT01700348|76215207|FG000|Overall Study|Lost to Follow-up|1|||
42365104|NCT01700192|76215215|FG000|Overall Study|Adverse Event|73|||
42365105|NCT01700192|76215216|FG001|Overall Study|Adverse Event|18|||
42365106|NCT01700192|76215215|FG000|Overall Study|Lack of Efficacy|1|||
42100837|NCT03948334|75911630|FG001|Overall Study|Lost to Follow-up|0|||
42100838|NCT03948334|75911629|FG000|Overall Study|Physician Decision|1|||
42196625|NCT03519087|76008483|FG000|Laboratory Testing|Protocol Violation|0|||
42365107|NCT01700192|76215216|FG001|Overall Study|Lack of Efficacy|0|||
42365108|NCT01700192|76215215|FG000|Overall Study|Lost to Follow-up|42|||
42365109|NCT01700192|76215216|FG001|Overall Study|Lost to Follow-up|29|||
42365110|NCT01700192|76215215|FG000|Overall Study|Noncompliance with study drug|0|||
42365111|NCT01700192|76215216|FG001|Overall Study|Noncompliance with study drug|5|||
42365112|NCT01700192|76215215|FG000|Overall Study|Physician Decision|2|||
42365113|NCT01700192|76215216|FG001|Overall Study|Physician Decision|3|||
42196626|NCT03519087|76008484|FG001|Laboratory Testing|Protocol Violation|0|||
42365114|NCT01700192|76215215|FG000|Overall Study|Pregnancy|1|||
42196627|NCT03519087|76008485|FG002|Laboratory Testing|Protocol Violation|0|||
42365115|NCT01700192|76215216|FG001|Overall Study|Pregnancy|4|||
42365116|NCT01700192|76215215|FG000|Overall Study|Progressive disease|1|||
42365117|NCT01700192|76215216|FG001|Overall Study|Progressive disease|0|||
42365118|NCT01700192|76215215|FG000|Overall Study|Protocol Violation|3|||
42365119|NCT01700192|76215216|FG001|Overall Study|Protocol Violation|4|||
42365120|NCT01700192|76215215|FG000|Overall Study|Technical problems|0|||
42365121|NCT01700192|76215216|FG001|Overall Study|Technical problems|1|||
42365122|NCT01700192|76215215|FG000|Overall Study|Withdrawal by Subject|56|||
42365123|NCT01700192|76215216|FG001|Overall Study|Withdrawal by Subject|64|||
42365124|NCT01700192|76215215|FG000|Overall Study|Never received study drug|1|||
42365125|NCT01700192|76215216|FG001|Overall Study|Never received study drug|0|||
42365126|NCT01709864|76215233|FG000|Overall Study|Physician Decision|0|||
42365127|NCT01709864|76215234|FG001|Overall Study|Physician Decision|1|||
42365128|NCT01709864|76215233|FG000|Overall Study|subject/guardian decision|5|||
42365129|NCT01709864|76215234|FG001|Overall Study|subject/guardian decision|6|||
42365130|NCT01709864|76215233|FG000|Overall Study|Lost to Follow-up|1|||
42365131|NCT01709864|76215234|FG001|Overall Study|Lost to Follow-up|0|||
42365132|NCT01709864|76215233|FG000|Overall Study|non-compliance with study treatment|1|||
42365133|NCT01709864|76215234|FG001|Overall Study|non-compliance with study treatment|1|||
42365134|NCT01709864|76215233|FG000|Overall Study|Adverse Event|0|||
42365135|NCT01709864|76215234|FG001|Overall Study|Adverse Event|2|||
42365136|NCT01709864|76215233|FG000|Overall Study|Death|0|||
42365137|NCT01709864|76215234|FG001|Overall Study|Death|1|||
42365138|NCT01709708|76215242|FG000|Overall Study|Protocol Violation|1|||
42365139|NCT01709708|76215243|FG001|Overall Study|Protocol Violation|2|||
42365140|NCT01709318|76215266|FG000|Overall Study|Adverse Event|3|||
42365141|NCT01709318|76215267|FG001|Overall Study|Adverse Event|4|||
42365142|NCT01709318|76215268|FG002|Overall Study|Adverse Event|2|||
42365143|NCT01709318|76215269|FG003|Overall Study|Adverse Event|2|||
42365144|NCT01709318|76215270|FG004|Overall Study|Adverse Event|0|||
42365145|NCT01709318|76215271|FG005|Overall Study|Adverse Event|1|||
42365146|NCT01709318|76215272|FG006|Overall Study|Adverse Event|2|||
42365147|NCT01709318|76215266|FG000|Overall Study|Lost to Follow-up|2|||
42365148|NCT01709318|76215267|FG001|Overall Study|Lost to Follow-up|0|||
42365149|NCT01709318|76215268|FG002|Overall Study|Lost to Follow-up|0|||
42365150|NCT01709318|76215269|FG003|Overall Study|Lost to Follow-up|0|||
42365151|NCT01709318|76215270|FG004|Overall Study|Lost to Follow-up|1|||
42365152|NCT01709318|76215271|FG005|Overall Study|Lost to Follow-up|1|||
42365153|NCT01709318|76215272|FG006|Overall Study|Lost to Follow-up|1|||
42365154|NCT01709318|76215266|FG000|Overall Study|Non-compliance with Study Drug|0|||
42365155|NCT01709318|76215267|FG001|Overall Study|Non-compliance with Study Drug|2|||
42365156|NCT01709318|76215268|FG002|Overall Study|Non-compliance with Study Drug|1|||
42196628|NCT03519087|76008486|FG003|Laboratory Testing|Protocol Violation|1|||
42196629|NCT03519087|76008487|FG004|Laboratory Testing|Protocol Violation|0|||
42196630|NCT02763046|76008506|FG000|Overall Study|Adverse Event|5|||
42196631|NCT02763046|76008507|FG001|Overall Study|Adverse Event|4|||
42196632|NCT02763046|76008508|FG002|Overall Study|Adverse Event|0|||
42196633|NCT02763046|76008506|FG000|Overall Study|Lack of Efficacy|1|||
42100839|NCT03948334|75911630|FG001|Overall Study|Physician Decision|0|||
42196634|NCT02763046|76008507|FG001|Overall Study|Lack of Efficacy|1|||
42196635|NCT02763046|76008508|FG002|Overall Study|Lack of Efficacy|3|||
42365157|NCT01709318|76215269|FG003|Overall Study|Non-compliance with Study Drug|1|||
42365158|NCT01709318|76215270|FG004|Overall Study|Non-compliance with Study Drug|0|||
42365159|NCT01709318|76215271|FG005|Overall Study|Non-compliance with Study Drug|0|||
42365160|NCT01709318|76215272|FG006|Overall Study|Non-compliance with Study Drug|2|||
42365161|NCT01709318|76215266|FG000|Overall Study|Physician Decision|0|||
42365162|NCT01709318|76215267|FG001|Overall Study|Physician Decision|0|||
42365163|NCT01709318|76215268|FG002|Overall Study|Physician Decision|0|||
42365164|NCT01709318|76215269|FG003|Overall Study|Physician Decision|0|||
42365165|NCT01709318|76215270|FG004|Overall Study|Physician Decision|0|||
42365166|NCT01709318|76215271|FG005|Overall Study|Physician Decision|0|||
42365167|NCT01709318|76215272|FG006|Overall Study|Physician Decision|1|||
42018525|NCT00996892|75825867|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
42018526|NCT00996892|75825868|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
42018527|NCT00996892|75825869|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
42018528|NCT00996892|75825870|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
42018529|NCT00996892|75825871|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
42018530|NCT00996892|75825872|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
42018531|NCT00996892|75825873|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
42018532|NCT00996892|75825874|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
42018533|NCT00996892|75825875|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
42100840|NCT03948334|75911629|FG000|Overall Study|Pregnancy|0|||
42196636|NCT02763046|76008506|FG000|Overall Study|Physician Decision|1|||
42365168|NCT01709318|76215266|FG000|Overall Study|Pregnancy|0|||
42365169|NCT01709318|76215267|FG001|Overall Study|Pregnancy|0|||
42365170|NCT01709318|76215268|FG002|Overall Study|Pregnancy|0|||
42365171|NCT01709318|76215269|FG003|Overall Study|Pregnancy|0|||
42365172|NCT01709318|76215270|FG004|Overall Study|Pregnancy|1|||
42365173|NCT01709318|76215271|FG005|Overall Study|Pregnancy|0|||
42365174|NCT01709318|76215272|FG006|Overall Study|Pregnancy|0|||
42365175|NCT01709318|76215266|FG000|Overall Study|Protocol Violation|0|||
42365176|NCT01709318|76215267|FG001|Overall Study|Protocol Violation|0|||
42365177|NCT01709318|76215268|FG002|Overall Study|Protocol Violation|0|||
42365178|NCT01709318|76215269|FG003|Overall Study|Protocol Violation|0|||
42365179|NCT01709318|76215270|FG004|Overall Study|Protocol Violation|2|||
42365180|NCT01709318|76215271|FG005|Overall Study|Protocol Violation|0|||
42365181|NCT01709318|76215272|FG006|Overall Study|Protocol Violation|1|||
42365182|NCT01709318|76215266|FG000|Overall Study|Technical Problems|1|||
42365183|NCT01709318|76215267|FG001|Overall Study|Technical Problems|0|||
42365184|NCT01709318|76215268|FG002|Overall Study|Technical Problems|0|||
42365185|NCT01709318|76215269|FG003|Overall Study|Technical Problems|0|||
42365186|NCT01709318|76215270|FG004|Overall Study|Technical Problems|0|||
42365187|NCT01709318|76215271|FG005|Overall Study|Technical Problems|0|||
42100841|NCT03948334|75911630|FG001|Overall Study|Pregnancy|1|||
42100842|NCT03948334|75911629|FG000|Overall Study|Protocol Deviation|1|||
42100843|NCT03948334|75911630|FG001|Overall Study|Protocol Deviation|0|||
42100844|NCT03948334|75911629|FG000|Overall Study|Study terminated by Sponsor|50|||
42100845|NCT03948334|75911630|FG001|Overall Study|Study terminated by Sponsor|51|||
42100846|NCT03948334|75911629|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
42100847|NCT03948334|75911630|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
42100848|NCT00609765|75911644|FG000|Overall Study|Study ended prior to 12 months|1|||
42100849|NCT00608829|75911648|FG000|Overall Study|Death|6|||
42100850|NCT00608829|75911648|FG000|Overall Study|Withdrawal by Subject|4|||
42100851|NCT00608829|75911648|FG000|Overall Study|Subject refuses to follow up or return.|5|||
42100852|NCT00545818|75911654|FG000|Overall Study|Protocol Violation|1|||
42100853|NCT00545818|75911655|FG001|Overall Study|Protocol Violation|0|||
42100854|NCT00545818|75911654|FG000|Overall Study|Adverse Event|1|||
42100855|NCT00545818|75911655|FG001|Overall Study|Adverse Event|1|||
42100856|NCT00545818|75911654|FG000|Overall Study|Lost to Follow-up|1|||
42100857|NCT00545818|75911655|FG001|Overall Study|Lost to Follow-up|6|||
42100858|NCT00674154|75911663|FG000|Overall Study|Withdrawal by Subject|3|||
42100859|NCT00674154|75911664|FG001|Overall Study|Withdrawal by Subject|1|||
42100860|NCT00674154|75911663|FG000|Overall Study|Did not want parathyroidectomy|0|||
42100861|NCT00674154|75911664|FG001|Overall Study|Did not want parathyroidectomy|2|||
42100862|NCT00608517|75911673|FG000|Overall Study|Death|1|||
42100863|NCT00608517|75911674|FG001|Overall Study|Death|0|||
42100864|NCT00608517|75911675|FG002|Overall Study|Death|0|||
42100865|NCT00608205|75911686|FG000|Overall Study|Adverse Event|3|||
42100866|NCT00608205|75911687|FG001|Overall Study|Adverse Event|2|||
42100867|NCT00608205|75911686|FG000|Overall Study|Patient non-compliant|0|||
42100868|NCT00608205|75911687|FG001|Overall Study|Patient non-compliant|1|||
42100869|NCT00670800|75911697|FG000|Overall Study|2 controls were insulin resistant|0|||
42100870|NCT00670800|75911698|FG001|Overall Study|2 controls were insulin resistant|2|||
42365188|NCT01709318|76215272|FG006|Overall Study|Technical Problems|0|||
42365189|NCT01709318|76215266|FG000|Overall Study|Withdrawal by Subject|3|||
42365190|NCT01709318|76215267|FG001|Overall Study|Withdrawal by Subject|0|||
42365191|NCT01709318|76215268|FG002|Overall Study|Withdrawal by Subject|3|||
42365192|NCT01709318|76215269|FG003|Overall Study|Withdrawal by Subject|3|||
42365193|NCT01709318|76215270|FG004|Overall Study|Withdrawal by Subject|0|||
42365194|NCT01709318|76215271|FG005|Overall Study|Withdrawal by Subject|2|||
42365195|NCT01709318|76215272|FG006|Overall Study|Withdrawal by Subject|4|||
42365196|NCT01709318|76215266|FG000|Overall Study|Other Protocol Specified Criteria|0|||
42365197|NCT01709318|76215267|FG001|Overall Study|Other Protocol Specified Criteria|1|||
42365198|NCT01709318|76215268|FG002|Overall Study|Other Protocol Specified Criteria|0|||
42365199|NCT01709318|76215269|FG003|Overall Study|Other Protocol Specified Criteria|0|||
42365200|NCT01709318|76215270|FG004|Overall Study|Other Protocol Specified Criteria|0|||
42365201|NCT01709318|76215271|FG005|Overall Study|Other Protocol Specified Criteria|0|||
42365202|NCT01709318|76215272|FG006|Overall Study|Other Protocol Specified Criteria|0|||
42365203|NCT01699178|76215290|FG000|Overall Study|Adverse Event|1|||
42365204|NCT01699178|76215291|FG001|Overall Study|Adverse Event|5|||
42100871|NCT00607893|75911708|FG000|Overall Study|Lost to Follow-up|4|||
42100872|NCT00607893|75911709|FG001|Overall Study|Lost to Follow-up|0|||
42100873|NCT00607893|75911708|FG000|Overall Study|withdrew due to loss of interest|0|||
42100874|NCT00607893|75911709|FG001|Overall Study|withdrew due to loss of interest|1|||
42100875|NCT00607893|75911708|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
42365205|NCT01699178|76215290|FG000|Overall Study|Lost to Follow-up|1|||
42365206|NCT01699178|76215291|FG001|Overall Study|Lost to Follow-up|6|||
42365207|NCT01699178|76215290|FG000|Overall Study|Non-compliance with Study Drug|3|||
42365208|NCT01699178|76215291|FG001|Overall Study|Non-compliance with Study Drug|1|||
42100876|NCT00607893|75911709|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
42196637|NCT02763046|76008507|FG001|Overall Study|Physician Decision|0|||
42196638|NCT02763046|76008508|FG002|Overall Study|Physician Decision|1|||
42196639|NCT02763046|76008506|FG000|Overall Study|Subject/guardian decision|2|||
42196640|NCT02763046|76008507|FG001|Overall Study|Subject/guardian decision|0|||
42196641|NCT02763046|76008508|FG002|Overall Study|Subject/guardian decision|4|||
42365209|NCT01699178|76215290|FG000|Overall Study|Physician Decision|1|||
42365210|NCT01699178|76215291|FG001|Overall Study|Physician Decision|0|||
42365211|NCT01699178|76215290|FG000|Overall Study|Withdrawal by Subject|4|||
42365212|NCT01699178|76215291|FG001|Overall Study|Withdrawal by Subject|12|||
42365213|NCT01699178|76215290|FG000|Overall Study|Hematocrit >54%|1|||
42365214|NCT01699178|76215291|FG001|Overall Study|Hematocrit >54%|1|||
42365215|NCT01699178|76215290|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
42365216|NCT01699178|76215291|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
42365217|NCT01699178|76215290|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
42365218|NCT01699178|76215291|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
42365219|NCT01683409|76215302|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
42365220|NCT01683409|76215303|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
42365221|NCT01683409|76215304|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
42365222|NCT01683409|76215305|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
42365223|NCT01683409|76215306|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
42365224|NCT01683409|76215302|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
42365225|NCT01683409|76215303|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
42365226|NCT01683409|76215304|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
42365227|NCT01683409|76215305|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
42365228|NCT01683409|76215306|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
42365229|NCT01683409|76215302|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
42365230|NCT01683409|76215303|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
42365231|NCT01683409|76215304|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
42365232|NCT01683409|76215305|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
42365233|NCT01683409|76215306|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
42365234|NCT01683409|76215302|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
42365235|NCT01683409|76215303|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
42365236|NCT01683409|76215304|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
42365237|NCT01683409|76215305|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
42365238|NCT01683409|76215306|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
42365239|NCT01683409|76215302|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
42365240|NCT01683409|76215303|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
42365241|NCT01683409|76215304|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
42365242|NCT01683409|76215305|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
42365243|NCT01683409|76215306|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
42365244|NCT01683409|76215302|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
42365245|NCT01683409|76215303|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
42365246|NCT01683409|76215304|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
42365247|NCT01683409|76215305|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
42365248|NCT01683409|76215306|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
42365249|NCT01683409|76215302|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
42365250|NCT01683409|76215303|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
42365251|NCT01683409|76215304|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
42365252|NCT01683409|76215305|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
42365253|NCT01683409|76215306|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
42365254|NCT01683409|76215302|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
42365255|NCT01683409|76215303|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
42365256|NCT01683409|76215304|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
42365257|NCT01683409|76215305|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
42365258|NCT01683409|76215306|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
42365259|NCT01683409|76215302|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
42365260|NCT01683409|76215303|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
42365261|NCT01683409|76215304|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
42365262|NCT01683409|76215305|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
42365263|NCT01683409|76215306|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
42365264|NCT01683409|76215302|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
42100877|NCT00607893|75911708|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
42100878|NCT00607893|75911709|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
42100879|NCT00607893|75911708|FG000|Overall Study|Declined to be treated|1|||
42196642|NCT03518073|76008525|FG000|Overall Study|Adverse Event|2|||
42365265|NCT01683409|76215303|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
42365266|NCT01683409|76215304|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
42365267|NCT01683409|76215305|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
42365268|NCT01683409|76215306|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
42196643|NCT03518073|76008526|FG001|Overall Study|Adverse Event|4|||
42196644|NCT03518073|76008527|FG002|Overall Study|Adverse Event|2|||
42100880|NCT00607893|75911709|FG001|Overall Study|Declined to be treated|0|||
42100881|NCT00607893|75911708|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
42100882|NCT00607893|75911709|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
42100883|NCT00571038|75911719|FG000|Overall Study|Lost to Follow-up|1|||
42100884|NCT00571038|75911720|FG001|Overall Study|Lost to Follow-up|4|||
42100885|NCT00571038|75911719|FG000|Overall Study|Death|7|||
42100886|NCT00571038|75911720|FG001|Overall Study|Death|5|||
42100887|NCT00571038|75911719|FG000|Overall Study|Withdrawal by Subject|1|||
42100888|NCT00571038|75911720|FG001|Overall Study|Withdrawal by Subject|3|||
42100889|NCT00571038|75911719|FG000|Overall Study|Moved out of state|2|||
42100890|NCT00571038|75911720|FG001|Overall Study|Moved out of state|2|||
42100891|NCT00545740|75911730|FG000|Overall Study|Lack of Efficacy|34|||
42100892|NCT00545740|75911731|FG001|Overall Study|Lack of Efficacy|35|||
42100893|NCT00545740|75911732|FG002|Overall Study|Lack of Efficacy|47|||
42100894|NCT00545740|75911733|FG003|Overall Study|Lack of Efficacy|36|||
42100895|NCT00545740|75911730|FG000|Overall Study|Withdrawal by Subject|17|||
42100896|NCT00545740|75911731|FG001|Overall Study|Withdrawal by Subject|15|||
42100897|NCT00545740|75911732|FG002|Overall Study|Withdrawal by Subject|16|||
42100898|NCT00545740|75911733|FG003|Overall Study|Withdrawal by Subject|18|||
42100899|NCT00545740|75911730|FG000|Overall Study|Adverse Event|10|||
42100900|NCT00545740|75911731|FG001|Overall Study|Adverse Event|18|||
42100901|NCT00545740|75911732|FG002|Overall Study|Adverse Event|19|||
42100902|NCT00545740|75911733|FG003|Overall Study|Adverse Event|9|||
42100903|NCT00545740|75911730|FG000|Overall Study|Lost to Follow-up|7|||
42100904|NCT00545740|75911731|FG001|Overall Study|Lost to Follow-up|5|||
42100905|NCT00545740|75911732|FG002|Overall Study|Lost to Follow-up|5|||
42100906|NCT00545740|75911733|FG003|Overall Study|Lost to Follow-up|6|||
42100907|NCT00545740|75911730|FG000|Overall Study|Protocol Violation|1|||
42100908|NCT00545740|75911731|FG001|Overall Study|Protocol Violation|3|||
42100909|NCT00545740|75911732|FG002|Overall Study|Protocol Violation|1|||
42100910|NCT00545740|75911733|FG003|Overall Study|Protocol Violation|0|||
42100911|NCT00545740|75911730|FG000|Overall Study|Non-compliance|0|||
42100912|NCT00545740|75911731|FG001|Overall Study|Non-compliance|2|||
42100913|NCT00545740|75911732|FG002|Overall Study|Non-compliance|1|||
42100914|NCT00545740|75911733|FG003|Overall Study|Non-compliance|0|||
42100915|NCT00545740|75911730|FG000|Overall Study|Moved|2|||
42100916|NCT00545740|75911731|FG001|Overall Study|Moved|0|||
42100917|NCT00545740|75911732|FG002|Overall Study|Moved|1|||
42100918|NCT00545740|75911733|FG003|Overall Study|Moved|0|||
42100919|NCT00545740|75911730|FG000|Overall Study|Diverticulitis attack|0|||
42100920|NCT00545740|75911731|FG001|Overall Study|Diverticulitis attack|0|||
42100921|NCT00545740|75911732|FG002|Overall Study|Diverticulitis attack|1|||
42100922|NCT00545740|75911733|FG003|Overall Study|Diverticulitis attack|1|||
42100923|NCT00545740|75911730|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
42100924|NCT00545740|75911731|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
42100925|NCT00545740|75911732|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
42100926|NCT00545740|75911733|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
42100927|NCT00545740|75911730|FG000|Overall Study|Site closure|1|||
42100928|NCT00545740|75911731|FG001|Overall Study|Site closure|0|||
42100929|NCT00545740|75911732|FG002|Overall Study|Site closure|0|||
42100930|NCT00545740|75911733|FG003|Overall Study|Site closure|0|||
42100931|NCT00545740|75911730|FG000|Overall Study|Missed visit|1|||
42100932|NCT00545740|75911731|FG001|Overall Study|Missed visit|0|||
42365269|NCT01683409|76215302|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
42365270|NCT01683409|76215303|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
42365271|NCT01683409|76215304|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
42365272|NCT01683409|76215305|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
42365273|NCT01683409|76215306|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
42365274|NCT01699022|76215332|FG000|Overall Study|Early discontinuation from the study|3|||
42100933|NCT00545740|75911732|FG002|Overall Study|Missed visit|0|||
42100934|NCT00545740|75911733|FG003|Overall Study|Missed visit|0|||
42100935|NCT00545740|75911730|FG000|Overall Study|Physician Decision|0|||
42100936|NCT00545740|75911731|FG001|Overall Study|Physician Decision|0|||
42100937|NCT00545740|75911732|FG002|Overall Study|Physician Decision|3|||
42100938|NCT00545740|75911733|FG003|Overall Study|Physician Decision|0|||
42100939|NCT00545740|75911730|FG000|Overall Study|Accepted only monthly telephone calls|1|||
42365275|NCT01683019|76215340|FG000|Overall Study|Withdrawal by Subject|2|||
42100940|NCT00545740|75911731|FG001|Overall Study|Accepted only monthly telephone calls|0|||
42100941|NCT00545740|75911732|FG002|Overall Study|Accepted only monthly telephone calls|0|||
42365276|NCT01683019|76215341|FG001|Overall Study|Withdrawal by Subject|1|||
42365277|NCT01683019|76215342|FG002|Overall Study|Withdrawal by Subject|4|||
42365278|NCT01709162|76215352|FG000|Overall Study|Disease progression|3|||
42100942|NCT00545740|75911733|FG003|Overall Study|Accepted only monthly telephone calls|0|||
42100943|NCT00545740|75911730|FG000|Overall Study|Sponsor decision|0|||
42365279|NCT01709162|76215353|FG001|Overall Study|Disease progression|3|||
42365280|NCT01709162|76215352|FG000|Overall Study|Study drug toxicity|2|||
42365281|NCT01709162|76215353|FG001|Overall Study|Study drug toxicity|0|||
42365282|NCT01709162|76215352|FG000|Overall Study|Administrative reason by sponsor|0|||
42365283|NCT01709162|76215353|FG001|Overall Study|Administrative reason by sponsor|1|||
42365284|NCT01709162|76215352|FG000|Overall Study|Other|1|||
42365285|NCT01709162|76215353|FG001|Overall Study|Other|0|||
42365286|NCT01709162|76215352|FG000|Overall Study|Withdrawal by Subject|0|||
42365287|NCT01709162|76215353|FG001|Overall Study|Withdrawal by Subject|1|||
42365288|NCT01698554|76215363|FG000|Overall Study|Adverse Event|2|||
42365289|NCT01698554|76215364|FG001|Overall Study|Adverse Event|5|||
42365290|NCT01698554|76215365|FG002|Overall Study|Adverse Event|0|||
42365291|NCT01698554|76215366|FG003|Overall Study|Adverse Event|1|||
42365292|NCT01698554|76215363|FG000|Overall Study|Lost to Follow-up|1|||
42365293|NCT01698554|76215364|FG001|Overall Study|Lost to Follow-up|0|||
42365294|NCT01698554|76215365|FG002|Overall Study|Lost to Follow-up|0|||
42365295|NCT01698554|76215366|FG003|Overall Study|Lost to Follow-up|0|||
42365296|NCT01698554|76215363|FG000|Overall Study|Personal Reasons|0|||
42365297|NCT01698554|76215364|FG001|Overall Study|Personal Reasons|5|||
42365298|NCT01698554|76215365|FG002|Overall Study|Personal Reasons|1|||
42365299|NCT01698554|76215366|FG003|Overall Study|Personal Reasons|1|||
42365300|NCT01698554|76215363|FG000|Overall Study|Protocol Violation|2|||
42365301|NCT01698554|76215364|FG001|Overall Study|Protocol Violation|0|||
42365302|NCT01698554|76215365|FG002|Overall Study|Protocol Violation|1|||
42365303|NCT01698554|76215366|FG003|Overall Study|Protocol Violation|0|||
42365304|NCT01698554|76215363|FG000|Overall Study|Other Miscellaneous Reasons|1|||
42365305|NCT01698554|76215364|FG001|Overall Study|Other Miscellaneous Reasons|0|||
42365306|NCT01698554|76215365|FG002|Overall Study|Other Miscellaneous Reasons|0|||
42196645|NCT03518073|76008525|FG000|Overall Study|Death|2|||
42196646|NCT03518073|76008526|FG001|Overall Study|Death|1|||
42196647|NCT03518073|76008527|FG002|Overall Study|Death|3|||
42196648|NCT03518073|76008525|FG000|Overall Study|Lost to Follow-up|1|||
42196649|NCT03518073|76008526|FG001|Overall Study|Lost to Follow-up|0|||
42196650|NCT03518073|76008527|FG002|Overall Study|Lost to Follow-up|1|||
42196651|NCT03518073|76008525|FG000|Overall Study|Physician Decision|5|||
42196652|NCT03518073|76008526|FG001|Overall Study|Physician Decision|0|||
42196653|NCT03518073|76008527|FG002|Overall Study|Physician Decision|2|||
42196654|NCT03518073|76008525|FG000|Overall Study|Progressive disease|1|||
42196655|NCT03518073|76008526|FG001|Overall Study|Progressive disease|1|||
42196656|NCT03518073|76008527|FG002|Overall Study|Progressive disease|1|||
42196657|NCT03518073|76008525|FG000|Overall Study|Protocol Violation|1|||
42196658|NCT03518073|76008526|FG001|Overall Study|Protocol Violation|0|||
42196659|NCT03518073|76008527|FG002|Overall Study|Protocol Violation|0|||
42196660|NCT03518073|76008525|FG000|Overall Study|Withdrawal by Subject|30|||
42196661|NCT03518073|76008526|FG001|Overall Study|Withdrawal by Subject|34|||
42196662|NCT03518073|76008527|FG002|Overall Study|Withdrawal by Subject|29|||
42196663|NCT03518073|76008525|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
42365307|NCT01698554|76215366|FG003|Overall Study|Other Miscellaneous Reasons|0|||
42365308|NCT01698320|76215378|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
42365309|NCT01698320|76215379|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
42365310|NCT01698320|76215380|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
42365311|NCT01698320|76215378|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
42365312|NCT01698320|76215379|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
42365313|NCT01698320|76215380|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
42365314|NCT01698320|76215378|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
42365315|NCT01698320|76215379|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
42365316|NCT01698320|76215380|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
42365317|NCT01698320|76215378|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
42365318|NCT01698320|76215379|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
42365319|NCT01698320|76215380|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
42365320|NCT01698320|76215378|FG000|12-Week Double-Blind Period|Adverse Event|0|||
42365321|NCT01698320|76215379|FG001|12-Week Double-Blind Period|Adverse Event|1|||
42365322|NCT01698320|76215380|FG002|12-Week Double-Blind Period|Adverse Event|1|||
42365323|NCT01698320|76215378|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
42365324|NCT01698320|76215379|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
42365325|NCT01698320|76215380|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
42365326|NCT01698320|76215378|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
42365327|NCT01698320|76215379|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
42365328|NCT01698320|76215380|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
42365329|NCT01698320|76215378|FG000|12-Week Double-Blind Period|Pregnancy|0|||
42196664|NCT03518073|76008526|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
42196665|NCT03518073|76008527|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
42196666|NCT03518073|76008525|FG000|Overall Study|Covid-19|1|||
42196667|NCT03518073|76008526|FG001|Overall Study|Covid-19|2|||
42196668|NCT03518073|76008527|FG002|Overall Study|Covid-19|1|||
42196669|NCT02759692|76008537|FG000|Period 1|Test article no longer available|1|||
42365330|NCT01698320|76215379|FG001|12-Week Double-Blind Period|Pregnancy|1|||
42365331|NCT01698320|76215380|FG002|12-Week Double-Blind Period|Pregnancy|1|||
42365332|NCT01698320|76215378|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
42365333|NCT01698320|76215379|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
42365334|NCT01698320|76215380|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
42365335|NCT01698320|76215378|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
42365336|NCT01698320|76215379|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
42365337|NCT01698320|76215380|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
42365338|NCT01698320|76215378|FG000|40-Week Open-Label Period|Adverse Event|0|||
42365339|NCT01698320|76215379|FG001|40-Week Open-Label Period|Adverse Event|3|||
42365340|NCT01698320|76215380|FG002|40-Week Open-Label Period|Adverse Event|2|||
42365341|NCT01698320|76215378|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
42365342|NCT01698320|76215379|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
42365343|NCT01698320|76215380|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
42365344|NCT01698320|76215378|FG000|40-Week Open-Label Period|Pregnancy|0|||
42365345|NCT01698320|76215379|FG001|40-Week Open-Label Period|Pregnancy|2|||
42365346|NCT01698320|76215380|FG002|40-Week Open-Label Period|Pregnancy|1|||
42365347|NCT01698320|76215378|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
42365348|NCT01698320|76215379|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
42365349|NCT01698320|76215380|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
42365350|NCT01698320|76215378|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
42365351|NCT01698320|76215379|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
42365352|NCT01698320|76215380|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
42365353|NCT01697696|76215398|FG000|Overall Study|Study terminated by sponsor|0|||
42365354|NCT01697696|76215399|FG001|Overall Study|Study terminated by sponsor|3|||
42365355|NCT01697696|76215398|FG000|Overall Study|Protocol deviation|1|||
42365356|NCT01697696|76215399|FG001|Overall Study|Protocol deviation|0|||
42365357|NCT01697696|76215398|FG000|Overall Study|Physician Decision|1|||
42365358|NCT01697696|76215399|FG001|Overall Study|Physician Decision|0|||
42365359|NCT01697696|76215398|FG000|Overall Study|Death|4|||
42365360|NCT01697696|76215399|FG001|Overall Study|Death|2|||
42365361|NCT01697696|76215398|FG000|Overall Study|Lost to Follow-up|10|||
42365362|NCT01697696|76215399|FG001|Overall Study|Lost to Follow-up|7|||
42365363|NCT01697696|76215398|FG000|Overall Study|Subject/guardian decision|31|||
42365364|NCT01697696|76215399|FG001|Overall Study|Subject/guardian decision|35|||
42365365|NCT01569152|76215407|FG000|Phase IIa, Period 1|Early Escape|5|||
42365366|NCT01569152|76215408|FG001|Phase IIa, Period 1|Early Escape|22|||
42365367|NCT01569152|76215409|FG002|Phase IIa, Period 1|Early Escape|0|||
42365368|NCT01569152|76215407|FG000|Phase IIa, Period 1|Adverse Event|4|||
42365369|NCT01569152|76215408|FG001|Phase IIa, Period 1|Adverse Event|0|||
42100944|NCT00545740|75911731|FG001|Overall Study|Sponsor decision|1|||
42100945|NCT00545740|75911732|FG002|Overall Study|Sponsor decision|0|||
42100946|NCT00545740|75911733|FG003|Overall Study|Sponsor decision|0|||
42365370|NCT01569152|76215409|FG002|Phase IIa, Period 1|Adverse Event|0|||
42365371|NCT01569152|76215407|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
42365372|NCT01569152|76215408|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
42365373|NCT01569152|76215409|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
42365374|NCT01569152|76215407|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
42365375|NCT01569152|76215408|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
42365376|NCT01569152|76215409|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
42365377|NCT01569152|76215407|FG000|Phase IIa, Period 1|Protocol Violation|0|||
42365378|NCT01569152|76215408|FG001|Phase IIa, Period 1|Protocol Violation|1|||
42365379|NCT01569152|76215409|FG002|Phase IIa, Period 1|Protocol Violation|0|||
42365380|NCT01569152|76215407|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
42365381|NCT01569152|76215408|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
42365382|NCT01569152|76215409|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
42365383|NCT01569152|76215407|FG000|Safety Extension, Period 3|Adverse Event|0|||
42365384|NCT01569152|76215408|FG001|Safety Extension, Period 3|Adverse Event|0|||
42365385|NCT01569152|76215409|FG002|Safety Extension, Period 3|Adverse Event|4|||
42365386|NCT01569152|76215407|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
42365387|NCT01569152|76215408|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
42365388|NCT01569152|76215409|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
42365389|NCT01569152|76215407|FG000|Safety Extension, Period 3|Physician Decision|0|||
42365390|NCT01569152|76215408|FG001|Safety Extension, Period 3|Physician Decision|0|||
42365391|NCT01569152|76215409|FG002|Safety Extension, Period 3|Physician Decision|2|||
42365392|NCT01569152|76215407|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
42365393|NCT01569152|76215408|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
42365394|NCT01569152|76215409|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
42365395|NCT01569074|76215434|FG000|Overall Study|Study stopped|6|||
42365396|NCT01569074|76215435|FG001|Overall Study|Study stopped|6|||
42365397|NCT01569074|76215436|FG002|Overall Study|Study stopped|8|||
42365398|NCT01569074|76215437|FG003|Overall Study|Study stopped|7|||
42365399|NCT01569074|76215438|FG004|Overall Study|Study stopped|7|||
42365400|NCT01569074|76215434|FG000|Overall Study|Study-specific discontinuation criteria|0|||
42365401|NCT01569074|76215435|FG001|Overall Study|Study-specific discontinuation criteria|1|||
42365402|NCT01569074|76215436|FG002|Overall Study|Study-specific discontinuation criteria|0|||
42365403|NCT01569074|76215437|FG003|Overall Study|Study-specific discontinuation criteria|0|||
42365404|NCT01569074|76215438|FG004|Overall Study|Study-specific discontinuation criteria|0|||
42365405|NCT01569074|76215434|FG000|Overall Study|Severe non-compliance to protocol|0|||
42365406|NCT01569074|76215435|FG001|Overall Study|Severe non-compliance to protocol|0|||
42365407|NCT01569074|76215436|FG002|Overall Study|Severe non-compliance to protocol|1|||
42365408|NCT01569074|76215437|FG003|Overall Study|Severe non-compliance to protocol|0|||
42365409|NCT01569074|76215438|FG004|Overall Study|Severe non-compliance to protocol|0|||
42365410|NCT01569074|76215434|FG000|Overall Study|eg change in circumstances|0|||
42365411|NCT01569074|76215435|FG001|Overall Study|eg change in circumstances|2|||
42365412|NCT01569074|76215436|FG002|Overall Study|eg change in circumstances|0|||
42365413|NCT01569074|76215437|FG003|Overall Study|eg change in circumstances|1|||
42365414|NCT01569074|76215438|FG004|Overall Study|eg change in circumstances|1|||
42365415|NCT01569074|76215434|FG000|Overall Study|Adverse Event|1|||
42365416|NCT01569074|76215435|FG001|Overall Study|Adverse Event|0|||
42365417|NCT01569074|76215436|FG002|Overall Study|Adverse Event|3|||
42365418|NCT01569074|76215437|FG003|Overall Study|Adverse Event|0|||
42365419|NCT01569074|76215438|FG004|Overall Study|Adverse Event|0|||
42365420|NCT01604408|76215456|FG000|Treatment Period 1|Protocol Violation|0|||
42365421|NCT01604408|76215457|FG001|Treatment Period 1|Protocol Violation|1|||
42365422|NCT01604408|76215456|FG000|Treatment Period 2|Withdrawal by Subject|1|||
42365423|NCT01604408|76215457|FG001|Treatment Period 2|Withdrawal by Subject|1|||
42365424|NCT01604408|76215456|FG000|Treatment Period 2|Protocol Violation|1|||
42365425|NCT01604408|76215457|FG001|Treatment Period 2|Protocol Violation|0|||
42365426|NCT01604408|76215456|FG000|Treatment Period 2|Adverse Event|0|||
42365427|NCT01604408|76215457|FG001|Treatment Period 2|Adverse Event|1|||
42365428|NCT01604408|76215456|FG000|Treatment Period 3|Protocol Violation|1|||
42365429|NCT01604408|76215457|FG001|Treatment Period 3|Protocol Violation|1|||
42365430|NCT01604408|76215456|FG000|Treatment Period 3|Adverse Event|0|||
42365431|NCT01604408|76215457|FG001|Treatment Period 3|Adverse Event|3|||
42365432|NCT01604408|76215456|FG000|Treatment Period 3|Withdrawal by Subject|3|||
42365433|NCT01604408|76215457|FG001|Treatment Period 3|Withdrawal by Subject|1|||
42365434|NCT01604408|76215456|FG000|Treatment Period 3|Sponsor Decision|1|||
42365435|NCT01604408|76215457|FG001|Treatment Period 3|Sponsor Decision|0|||
42365436|NCT01604408|76215456|FG000|Treatment Period 4|Death|1|||
42365437|NCT01604408|76215457|FG001|Treatment Period 4|Death|0|||
42365438|NCT01604408|76215456|FG000|Treatment Period 4|Withdrawal by Subject|2|||
42365439|NCT01604408|76215457|FG001|Treatment Period 4|Withdrawal by Subject|1|||
42365440|NCT01604408|76215456|FG000|Treatment Period 4|Adverse Event|0|||
42365441|NCT01604408|76215457|FG001|Treatment Period 4|Adverse Event|1|||
42365442|NCT01604408|76215456|FG000|Treatment Period 5|Adverse Event|4|||
42365443|NCT01604408|76215457|FG001|Treatment Period 5|Adverse Event|0|||
42365444|NCT01604408|76215456|FG000|Treatment Period 6|Lost to Follow-up|0|||
42365445|NCT01604408|76215457|FG001|Treatment Period 6|Lost to Follow-up|1|||
42365446|NCT01604408|76215456|FG000|Treatment Period 6|Adverse Event|2|||
42365447|NCT01604408|76215457|FG001|Treatment Period 6|Adverse Event|0|||
42100947|NCT00545740|75911730|FG000|Overall Study|Lack of time|0|||
42365448|NCT01604408|76215456|FG000|Treatment Period 6|Sponsor decision|0|||
42365449|NCT01604408|76215457|FG001|Treatment Period 6|Sponsor decision|1|||
42365450|NCT01604408|76215456|FG000|Observation Period|Adverse Event|1|||
42365451|NCT01604408|76215457|FG001|Observation Period|Adverse Event|1|||
42365452|NCT01604408|76215456|FG000|Observation Period|Withdrawal by Subject|0|||
42365453|NCT01604408|76215457|FG001|Observation Period|Withdrawal by Subject|2|||
42365454|NCT01567826|76215465|FG000|Overall Study|Lost to Follow-up|3|||
42365455|NCT01567826|76215466|FG001|Overall Study|Lost to Follow-up|2|||
42365456|NCT01697462|76215474|FG000|Overall Study|Disease Progression|1|||
42365457|NCT01697462|76215474|FG000|Overall Study|Adverse Event|6|||
42365458|NCT01697462|76215474|FG000|Overall Study|Lost to Follow-up|21|||
42365459|NCT01697462|76215474|FG000|Overall Study|Withdrawal by Subject|12|||
42365460|NCT01697462|76215474|FG000|Overall Study|Investigator Decision|21|||
42365461|NCT01697462|76215474|FG000|Overall Study|Death|1|||
42365462|NCT01697462|76215474|FG000|Overall Study|Other|10|||
42365463|NCT01697462|76215474|FG000|Overall Study|Missing|5|||
42365464|NCT01592240|76215630|FG000|Overall Study|Adverse Event|1|||
42365465|NCT01592240|76215631|FG001|Overall Study|Adverse Event|0|||
42365466|NCT01592240|76215632|FG002|Overall Study|Adverse Event|0|||
42365467|NCT01592240|76215633|FG003|Overall Study|Adverse Event|1|||
42365468|NCT01592240|76215634|FG004|Overall Study|Adverse Event|1|||
42365469|NCT01592240|76215635|FG005|Overall Study|Adverse Event|0|||
42365470|NCT01592240|76215636|FG006|Overall Study|Adverse Event|0|||
42365471|NCT01592240|76215630|FG000|Overall Study|Death|0|||
42365472|NCT01592240|76215631|FG001|Overall Study|Death|1|||
42365473|NCT01592240|76215632|FG002|Overall Study|Death|0|||
42365474|NCT01592240|76215633|FG003|Overall Study|Death|0|||
42365475|NCT01592240|76215634|FG004|Overall Study|Death|0|||
42365476|NCT01592240|76215635|FG005|Overall Study|Death|0|||
42365477|NCT01592240|76215636|FG006|Overall Study|Death|0|||
42365478|NCT01592240|76215630|FG000|Overall Study|Lost to Follow-up|1|||
42365479|NCT01592240|76215631|FG001|Overall Study|Lost to Follow-up|3|||
42365480|NCT01592240|76215632|FG002|Overall Study|Lost to Follow-up|1|||
42365481|NCT01592240|76215633|FG003|Overall Study|Lost to Follow-up|0|||
42365482|NCT01592240|76215634|FG004|Overall Study|Lost to Follow-up|3|||
42365483|NCT01592240|76215635|FG005|Overall Study|Lost to Follow-up|2|||
42365484|NCT01592240|76215636|FG006|Overall Study|Lost to Follow-up|0|||
42365485|NCT01592240|76215630|FG000|Overall Study|Protocol Violation|0|||
42365486|NCT01592240|76215631|FG001|Overall Study|Protocol Violation|0|||
42365487|NCT01592240|76215632|FG002|Overall Study|Protocol Violation|0|||
42100948|NCT00545740|75911731|FG001|Overall Study|Lack of time|1|||
42100949|NCT00545740|75911732|FG002|Overall Study|Lack of time|0|||
42100950|NCT00545740|75911733|FG003|Overall Study|Lack of time|0|||
42100951|NCT00545740|75911730|FG000|Overall Study|Non-adherence to visits|0|||
42100952|NCT00545740|75911731|FG001|Overall Study|Non-adherence to visits|1|||
42100953|NCT00545740|75911732|FG002|Overall Study|Non-adherence to visits|0|||
42100954|NCT00545740|75911733|FG003|Overall Study|Non-adherence to visits|0|||
42100955|NCT00545740|75911730|FG000|Overall Study|Patient difficulties|0|||
42100956|NCT00545740|75911731|FG001|Overall Study|Patient difficulties|1|||
42100957|NCT00545740|75911732|FG002|Overall Study|Patient difficulties|0|||
42100958|NCT00545740|75911733|FG003|Overall Study|Patient difficulties|0|||
42100959|NCT00545740|75911730|FG000|Overall Study|Husband against study|0|||
42100960|NCT00545740|75911731|FG001|Overall Study|Husband against study|0|||
42100961|NCT00545740|75911732|FG002|Overall Study|Husband against study|1|||
42100962|NCT00545740|75911733|FG003|Overall Study|Husband against study|0|||
42100963|NCT00609609|75911745|FG000|Overall Study|Withdrawal by Subject|2|||
42100964|NCT00609609|75911746|FG001|Overall Study|Withdrawal by Subject|0|||
42100965|NCT00609609|75911745|FG000|Overall Study|Progression|4|||
42100966|NCT00609609|75911746|FG001|Overall Study|Progression|2|||
42100967|NCT00673452|75911754|FG000|Acute Double-Blind Phase|Adverse Event|41|||
42100968|NCT00673452|75911755|FG001|Acute Double-Blind Phase|Adverse Event|24|||
42100969|NCT00673452|75911754|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
42100970|NCT00673452|75911755|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
42100971|NCT00673452|75911754|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
42100972|NCT00673452|75911755|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
42100973|NCT00673452|75911754|FG000|Acute Double-Blind Phase|Physician Decision|0|||
42100974|NCT00673452|75911755|FG001|Acute Double-Blind Phase|Physician Decision|6|||
42100975|NCT00673452|75911754|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
42100976|NCT00673452|75911755|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
42100977|NCT00673452|75911754|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
42100978|NCT00673452|75911755|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
42100979|NCT00673452|75911754|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
42100980|NCT00673452|75911755|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
42196670|NCT02759692|76008538|FG001|Period 1|Test article no longer available|1|||
42365488|NCT01592240|76215633|FG003|Overall Study|Protocol Violation|0|||
42100981|NCT00673452|75911754|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
42100982|NCT00673452|75911755|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
42365489|NCT01592240|76215634|FG004|Overall Study|Protocol Violation|0|||
42365490|NCT01592240|76215635|FG005|Overall Study|Protocol Violation|1|||
42365491|NCT01592240|76215636|FG006|Overall Study|Protocol Violation|0|||
42100983|NCT00673452|75911754|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
42365492|NCT01592240|76215630|FG000|Overall Study|Withdrawal by Subject|0|||
42365493|NCT01592240|76215631|FG001|Overall Study|Withdrawal by Subject|4|||
42365494|NCT01592240|76215632|FG002|Overall Study|Withdrawal by Subject|4|||
42365495|NCT01592240|76215633|FG003|Overall Study|Withdrawal by Subject|1|||
42365496|NCT01592240|76215634|FG004|Overall Study|Withdrawal by Subject|3|||
42365497|NCT01592240|76215635|FG005|Overall Study|Withdrawal by Subject|0|||
42365498|NCT01592240|76215636|FG006|Overall Study|Withdrawal by Subject|2|||
42365499|NCT01592240|76215630|FG000|Overall Study|Other|0|||
42365500|NCT01592240|76215631|FG001|Overall Study|Other|3|||
42365501|NCT01592240|76215632|FG002|Overall Study|Other|1|||
42365502|NCT01592240|76215633|FG003|Overall Study|Other|1|||
42365503|NCT01592240|76215634|FG004|Overall Study|Other|0|||
42365504|NCT01592240|76215635|FG005|Overall Study|Other|0|||
42365505|NCT01592240|76215636|FG006|Overall Study|Other|1|||
42365506|NCT01592240|76215630|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
42365507|NCT01592240|76215631|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
42365508|NCT01592240|76215632|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
42196671|NCT02759692|76008537|FG000|Period 1|No longer meets eligibility criteria.|1|||
42196672|NCT02759692|76008538|FG001|Period 1|No longer meets eligibility criteria.|0|||
42365509|NCT01592240|76215633|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
42365510|NCT01592240|76215634|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
42365511|NCT01592240|76215635|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
42365512|NCT01592240|76215636|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
42365513|NCT01591616|76215679|FG000|Overall Study|Withdrawal by Subject|1|||
42365514|NCT01591460|76215835|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
42365515|NCT01591460|76215835|FG000|Overall Study|Futility Rule (Week 12)|7|||
42365516|NCT01591460|76215835|FG000|Overall Study|Futility Rule (Week 24)|3|||
42365517|NCT01591460|76215835|FG000|Overall Study|Rebound or Breakthrough|3|||
42365518|NCT01591460|76215835|FG000|Overall Study|Treatment Discontinued by Error|1|||
42365519|NCT01591460|76215835|FG000|Overall Study|Lost to Follow-up|1|||
42365520|NCT01591460|76215835|FG000|Overall Study|Noncompliance|1|||
42365521|NCT01591460|76215835|FG000|Overall Study|Participant Refusal|3|||
42365522|NCT01591460|76215835|FG000|Overall Study|Withdrawal by Subject|1|||
42365523|NCT01591460|76215835|FG000|Overall Study|Protocol Violation|1|||
42365524|NCT01591382|76215858|FG000|Overall Study|Discharged Prior to Study Completion|2|||
42365525|NCT01591382|76215859|FG001|Overall Study|Discharged Prior to Study Completion|1|||
42365526|NCT01591382|76215858|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
42365527|NCT01591382|76215859|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
42365528|NCT01696214|76215877|FG000|Overall Study|Lost to Follow-up|1|||
42365529|NCT01696214|76215878|FG001|Overall Study|Lost to Follow-up|0|||
42365530|NCT01696214|76215879|FG002|Overall Study|Lost to Follow-up|0|||
42365531|NCT01696214|76215880|FG003|Overall Study|Lost to Follow-up|0|||
42365532|NCT01543087|76215913|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
42365533|NCT01543087|76215914|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
42365534|NCT01543087|76215915|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
42365535|NCT01543087|76215916|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
42365536|NCT01543087|76215917|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
42365537|NCT01543087|76215918|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
42365538|NCT01543087|76215913|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
42365539|NCT01543087|76215914|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
42365540|NCT01543087|76215915|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
42365541|NCT01543087|76215916|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
42196673|NCT02759692|76008537|FG000|Period 1|Miss-Randomized|1|||
42196674|NCT02759692|76008538|FG001|Period 1|Miss-Randomized|1|||
42196675|NCT02759692|76008537|FG000|Period 2|Lost to Follow-up|1|||
42196676|NCT02759692|76008538|FG001|Period 2|Lost to Follow-up|0|||
42196677|NCT02759692|76008537|FG000|Period 2|Test article no longer available|0|||
42196678|NCT02759692|76008538|FG001|Period 2|Test article no longer available|1|||
42196679|NCT03586167|76008546|FG000|Overall Study|Other|1|||
42196680|NCT03586167|76008547|FG001|Overall Study|Other|0|||
42196681|NCT02762578|76008555|FG000|Overall Study|Adverse Event|1|||
42196682|NCT02762578|76008556|FG001|Overall Study|Adverse Event|6|||
42196683|NCT02762578|76008555|FG000|Overall Study|Protocol Violation|4|||
42196684|NCT02762578|76008556|FG001|Overall Study|Protocol Violation|2|||
42365542|NCT01543087|76215917|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
42365543|NCT01543087|76215918|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
42365544|NCT01543087|76215913|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
42365545|NCT01543087|76215914|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
42365546|NCT01543087|76215915|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
42100984|NCT00673452|75911755|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
42100985|NCT00673452|75911754|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
42365547|NCT01543087|76215916|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
42365548|NCT01543087|76215917|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
42196685|NCT02762578|76008555|FG000|Overall Study|Withdrawal by Subject|4|||
42196686|NCT02762578|76008556|FG001|Overall Study|Withdrawal by Subject|2|||
42196687|NCT02762578|76008555|FG000|Overall Study|Unclassified|6|||
42196688|NCT02762578|76008556|FG001|Overall Study|Unclassified|0|||
42365549|NCT01543087|76215918|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
42365550|NCT01543087|76215913|FG000|Stage 1 (48 Months)|Other than specified|5|||
42365551|NCT01543087|76215914|FG001|Stage 1 (48 Months)|Other than specified|0|||
42365552|NCT01543087|76215915|FG002|Stage 1 (48 Months)|Other than specified|9|||
42365553|NCT01543087|76215916|FG003|Stage 1 (48 Months)|Other than specified|0|||
42365554|NCT01543087|76215917|FG004|Stage 1 (48 Months)|Other than specified|0|||
42365555|NCT01543087|76215918|FG005|Stage 1 (48 Months)|Other than specified|0|||
42365556|NCT01543087|76215913|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
42365557|NCT01543087|76215914|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
42365558|NCT01543087|76215915|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
42365559|NCT01543087|76215916|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
42365560|NCT01543087|76215917|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
42365561|NCT01543087|76215918|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
42365562|NCT01543087|76215913|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
42365563|NCT01543087|76215914|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
42365564|NCT01543087|76215915|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
42365565|NCT01543087|76215916|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
42365566|NCT01543087|76215917|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
42365567|NCT01543087|76215918|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
42365568|NCT01543087|76215913|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
42365569|NCT01543087|76215914|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
42365570|NCT01543087|76215915|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
42365571|NCT01543087|76215916|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
42365572|NCT01543087|76215917|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
42365573|NCT01543087|76215918|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
42365574|NCT01696058|76215956|FG000|Overall Study|Adverse Event|21|||
42365575|NCT01696058|76215957|FG001|Overall Study|Adverse Event|11|||
42365576|NCT01696058|76215956|FG000|Overall Study|Lack of Efficacy|2|||
42365577|NCT01696058|76215957|FG001|Overall Study|Lack of Efficacy|3|||
42365578|NCT01696058|76215956|FG000|Overall Study|Protocol Violation|9|||
42365579|NCT01696058|76215957|FG001|Overall Study|Protocol Violation|3|||
42365580|NCT01696058|76215956|FG000|Overall Study|Lost to Follow-up|2|||
42365581|NCT01696058|76215957|FG001|Overall Study|Lost to Follow-up|5|||
42365582|NCT01696058|76215956|FG000|Overall Study|Withdrawal by Subject|4|||
42365583|NCT01696058|76215957|FG001|Overall Study|Withdrawal by Subject|6|||
42365584|NCT01696058|76215956|FG000|Overall Study|Other reason prematurely discontinued|5|||
42365585|NCT01696058|76215957|FG001|Overall Study|Other reason prematurely discontinued|3|||
42365586|NCT01695746|76215963|FG000|Overall Study|Adverse Event|1|||
42365587|NCT01695746|76215963|FG000|Overall Study|Non-compliance by the participant|3|||
42365588|NCT01695746|76215963|FG000|Overall Study|Protocol Violation|5|||
42365589|NCT01695746|76215963|FG000|Overall Study|Participant not willing to participate|3|||
42365590|NCT01694420|76215974|FG000|Overall Study|Lost to Follow-up|3|||
42365591|NCT01675479|76216145|FG000|Overall Study|Lost to Follow-up|11|||
42365592|NCT00089973|76216276|FG000|Overall Study|Adverse Event|3|||
42365593|NCT00089973|76216276|FG000|Overall Study|Withdrawal by Subject|1|||
42365594|NCT00089973|76216276|FG000|Overall Study|Disease progression|45|||
42365595|NCT00089973|76216276|FG000|Overall Study|Death|1|||
42365596|NCT00089661|76216294|FG000|Overall Study|Adverse Event|0|||
42365597|NCT00089661|76216295|FG001|Overall Study|Adverse Event|2|||
42365598|NCT00089661|76216294|FG000|Overall Study|Death|1|||
42365599|NCT00089661|76216295|FG001|Overall Study|Death|0|||
42365600|NCT00089661|76216294|FG000|Overall Study|Lost to Follow-up|0|||
42365601|NCT00089661|76216295|FG001|Overall Study|Lost to Follow-up|3|||
42365602|NCT00089661|76216294|FG000|Overall Study|Withdrawal by Subject|11|||
42365603|NCT00089661|76216295|FG001|Overall Study|Withdrawal by Subject|9|||
42365604|NCT00089661|76216294|FG000|Overall Study|Disease progression|1|||
42365605|NCT00089661|76216295|FG001|Overall Study|Disease progression|3|||
42365606|NCT00089661|76216294|FG000|Overall Study|Ineligibility determined|4|||
42365607|NCT00089661|76216295|FG001|Overall Study|Ineligibility determined|4|||
42365608|NCT00089661|76216294|FG000|Overall Study|Noncompliance|2|||
42365609|NCT00089661|76216295|FG001|Overall Study|Noncompliance|4|||
42196689|NCT03514641|76008566|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
42196690|NCT03514641|76008567|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
42196691|NCT03514641|76008568|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
42365610|NCT00089661|76216294|FG000|Overall Study|Other|2|||
42365611|NCT00089661|76216295|FG001|Overall Study|Other|1|||
42365612|NCT00089583|76216312|FG000|Overall Study|Adverse Event|0|||
42365613|NCT00089583|76216313|FG001|Overall Study|Adverse Event|3|||
42365614|NCT00089583|76216312|FG000|Overall Study|Insufficient Viral Load Response|5|||
42365615|NCT00089583|76216313|FG001|Overall Study|Insufficient Viral Load Response|5|||
42365616|NCT00089583|76216312|FG000|Overall Study|Withdrawal by Subject|0|||
42365617|NCT00089583|76216313|FG001|Overall Study|Withdrawal by Subject|4|||
42365618|NCT00089583|76216312|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
42365619|NCT00089583|76216313|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
42365620|NCT00089583|76216312|FG000|Overall Study|Participant Refused Study Medication|0|||
42365621|NCT00089583|76216313|FG001|Overall Study|Participant Refused Study Medication|2|||
42365622|NCT00089583|76216312|FG000|Overall Study|Non-Compliance|0|||
42365623|NCT00089583|76216313|FG001|Overall Study|Non-Compliance|4|||
42365624|NCT00089583|76216312|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
42365625|NCT00089583|76216313|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
42365626|NCT00089583|76216312|FG000|Overall Study|Participant Management Criteria Met|0|||
42365627|NCT00089583|76216313|FG001|Overall Study|Participant Management Criteria Met|1|||
42365628|NCT00089583|76216312|FG000|Overall Study|Reason Not Provided|0|||
42365629|NCT00089583|76216313|FG001|Overall Study|Reason Not Provided|1|||
42365630|NCT00089583|76216312|FG000|Overall Study|Protocol Violation|0|||
42365631|NCT00089583|76216313|FG001|Overall Study|Protocol Violation|3|||
42365632|NCT00089583|76216312|FG000|Overall Study|Principal Investigator Decision|0|||
42365633|NCT00089583|76216313|FG001|Overall Study|Principal Investigator Decision|10|||
42365634|NCT00089583|76216312|FG000|Overall Study|Start of Disallowed Medication|0|||
42365635|NCT00089583|76216313|FG001|Overall Study|Start of Disallowed Medication|1|||
42365636|NCT00089583|76216312|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
42365637|NCT00089583|76216313|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
42365638|NCT00089583|76216312|FG000|Overall Study|Participant Incarcerated|0|||
42365639|NCT00089583|76216313|FG001|Overall Study|Participant Incarcerated|1|||
42365640|NCT00088881|76216325|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
42365641|NCT00088881|76216325|FG000|Step 1 - R-CHOP|Adverse Event|1|||
42365642|NCT00088881|76216325|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
42365643|NCT00088881|76216325|FG000|Step 1 - R-CHOP|Physician Decision|1|||
42365644|NCT00088881|76216325|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
42365645|NCT00088881|76216325|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
42365646|NCT00088881|76216325|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
42365647|NCT00087555|76216373|FG000|Overall Study|Adverse Event|3|||
42365648|NCT00087555|76216374|FG001|Overall Study|Adverse Event|6|||
42365649|NCT00087555|76216375|FG002|Overall Study|Adverse Event|14|||
42365650|NCT00087555|76216373|FG000|Overall Study|Lost to Follow-up|0|||
42365651|NCT00087555|76216374|FG001|Overall Study|Lost to Follow-up|1|||
42365652|NCT00087555|76216375|FG002|Overall Study|Lost to Follow-up|1|||
42365653|NCT00087555|76216373|FG000|Overall Study|Non - Compliance|1|||
42365654|NCT00087555|76216374|FG001|Overall Study|Non - Compliance|0|||
42365655|NCT00087555|76216375|FG002|Overall Study|Non - Compliance|0|||
42365656|NCT00087555|76216373|FG000|Overall Study|Protocol Violation|0|||
42365657|NCT00087555|76216374|FG001|Overall Study|Protocol Violation|0|||
42365658|NCT00087555|76216375|FG002|Overall Study|Protocol Violation|2|||
42365659|NCT00087555|76216373|FG000|Overall Study|Screen Failure|1|||
42365660|NCT00087555|76216374|FG001|Overall Study|Screen Failure|1|||
42365661|NCT00087555|76216375|FG002|Overall Study|Screen Failure|0|||
42365662|NCT00087555|76216373|FG000|Overall Study|Pregnancy|0|||
42365663|NCT00087555|76216374|FG001|Overall Study|Pregnancy|1|||
42365664|NCT00087555|76216375|FG002|Overall Study|Pregnancy|1|||
42365665|NCT00087555|76216373|FG000|Overall Study|Withdrawal by Subject|3|||
42365666|NCT00087555|76216374|FG001|Overall Study|Withdrawal by Subject|2|||
42365667|NCT00087555|76216375|FG002|Overall Study|Withdrawal by Subject|1|||
42365668|NCT00087555|76216373|FG000|Overall Study|Lack of Efficacy|2|||
42365669|NCT00087555|76216374|FG001|Overall Study|Lack of Efficacy|0|||
42365670|NCT00087555|76216375|FG002|Overall Study|Lack of Efficacy|1|||
42365671|NCT00087555|76216373|FG000|Overall Study|Non Compliance|0|||
42365672|NCT00087555|76216374|FG001|Overall Study|Non Compliance|0|||
42365673|NCT00087555|76216375|FG002|Overall Study|Non Compliance|1|||
42365674|NCT00087555|76216373|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
42365675|NCT00087555|76216374|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
42365676|NCT00087555|76216375|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
42365677|NCT00087555|76216373|FG000|Overall Study|Patient wanted to go back on Med|1|||
42365678|NCT00087555|76216374|FG001|Overall Study|Patient wanted to go back on Med|0|||
42365679|NCT00087555|76216375|FG002|Overall Study|Patient wanted to go back on Med|0|||
42365680|NCT00086619|76216398|FG000|Overall Study|Withdrawal by Subject|6|||
42365681|NCT00086619|76216399|FG001|Overall Study|Withdrawal by Subject|6|||
42365682|NCT00086619|76216398|FG000|Overall Study|Adverse Event|8|||
42365683|NCT00086619|76216399|FG001|Overall Study|Adverse Event|10|||
42365684|NCT00086619|76216398|FG000|Overall Study|Protocol Violation|1|||
42365685|NCT00086619|76216399|FG001|Overall Study|Protocol Violation|1|||
42365686|NCT00085917|76216412|FG000|Overall Study|Adverse Event|4|||
42365687|NCT00085917|76216413|FG001|Overall Study|Adverse Event|3|||
42365688|NCT00084747|76216419|FG000|Overall Study|Relapsed|8|||
42365689|NCT00084747|76216419|FG000|Overall Study|Death|3|||
42365690|NCT00084747|76216419|FG000|Overall Study|Withdrawal by Subject|2|||
42365691|NCT00081159|76216454|FG000|Overall Study|Withdrawal by Subject|0|||
42365692|NCT00081159|76216455|FG001|Overall Study|Withdrawal by Subject|3|||
42365693|NCT00081159|76216454|FG000|Overall Study|Myelosuppression prior to treatment|0|||
42365694|NCT00081159|76216455|FG001|Overall Study|Myelosuppression prior to treatment|1|||
42365695|NCT00081159|76216454|FG000|Overall Study|Lost to Follow-up|2|||
42365696|NCT00081159|76216455|FG001|Overall Study|Lost to Follow-up|1|||
42365697|NCT00080223|76216470|FG000|Overall Study|Adverse Event|23|||
42365698|NCT00080223|76216470|FG000|Overall Study|Death|21|||
42196692|NCT03514641|76008569|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
42196693|NCT03514641|76008566|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
42196694|NCT03514641|76008567|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
42196695|NCT03514641|76008568|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
42196696|NCT03514641|76008569|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
42196697|NCT03514641|76008566|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
42196698|NCT03514641|76008567|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
42196699|NCT03514641|76008568|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
42196700|NCT03514641|76008569|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
42196701|NCT03514641|76008566|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
42196702|NCT03514641|76008567|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
42196703|NCT03514641|76008568|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
42196704|NCT03514641|76008569|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
42365699|NCT00080223|76216470|FG000|Overall Study|Withdrawal by Subject|13|||
42365700|NCT00080223|76216470|FG000|Overall Study|Lung Transplantation|9|||
42365701|NCT00080223|76216470|FG000|Overall Study|Non-compliance With Study Treatment|7|||
42365702|NCT00080223|76216470|FG000|Overall Study|Participant unwilling to continue|2|||
42365703|NCT00080223|76216470|FG000|Overall Study|Physician Decision|1|||
42365704|NCT01899053|76217081|FG000|Overall Study|Progressive Disease|4|||
42365705|NCT01899053|76217082|FG001|Overall Study|Progressive Disease|0|||
42365706|NCT01899053|76217083|FG002|Overall Study|Progressive Disease|3|||
42365707|NCT01899053|76217084|FG003|Overall Study|Progressive Disease|0|||
42365708|NCT01899053|76217085|FG004|Overall Study|Progressive Disease|3|||
42365709|NCT01899053|76217086|FG005|Overall Study|Progressive Disease|1|||
42365710|NCT01899053|76217087|FG006|Overall Study|Progressive Disease|1|||
42365711|NCT01899053|76217088|FG007|Overall Study|Progressive Disease|1|||
42365712|NCT01899053|76217089|FG008|Overall Study|Progressive Disease|4|||
42365713|NCT01899053|76217090|FG009|Overall Study|Progressive Disease|3|||
42365714|NCT01899053|76217091|FG010|Overall Study|Progressive Disease|12|||
42365715|NCT01899053|76217092|FG011|Overall Study|Progressive Disease|5|||
42365716|NCT01899053|76217093|FG012|Overall Study|Progressive Disease|8|||
42365717|NCT01899053|76217094|FG013|Overall Study|Progressive Disease|17|||
42365718|NCT01899053|76217081|FG000|Overall Study|Adverse Event|1|||
42365719|NCT01899053|76217082|FG001|Overall Study|Adverse Event|1|||
42365720|NCT01899053|76217083|FG002|Overall Study|Adverse Event|1|||
42365721|NCT01899053|76217084|FG003|Overall Study|Adverse Event|3|||
42365722|NCT01899053|76217085|FG004|Overall Study|Adverse Event|1|||
42365723|NCT01899053|76217086|FG005|Overall Study|Adverse Event|1|||
42365724|NCT01899053|76217087|FG006|Overall Study|Adverse Event|1|||
42365725|NCT01899053|76217088|FG007|Overall Study|Adverse Event|0|||
42365726|NCT01899053|76217089|FG008|Overall Study|Adverse Event|2|||
42365727|NCT01899053|76217090|FG009|Overall Study|Adverse Event|0|||
42365728|NCT01899053|76217091|FG010|Overall Study|Adverse Event|3|||
42365729|NCT01899053|76217092|FG011|Overall Study|Adverse Event|1|||
42365730|NCT01899053|76217093|FG012|Overall Study|Adverse Event|2|||
42365731|NCT01899053|76217094|FG013|Overall Study|Adverse Event|2|||
42365732|NCT01899053|76217081|FG000|Overall Study|Reason Not Specified|0|||
42365733|NCT01899053|76217082|FG001|Overall Study|Reason Not Specified|0|||
42365734|NCT01899053|76217083|FG002|Overall Study|Reason Not Specified|0|||
42365735|NCT01899053|76217084|FG003|Overall Study|Reason Not Specified|0|||
42365736|NCT01899053|76217085|FG004|Overall Study|Reason Not Specified|0|||
42365737|NCT01899053|76217086|FG005|Overall Study|Reason Not Specified|0|||
42365738|NCT01899053|76217087|FG006|Overall Study|Reason Not Specified|1|||
42365739|NCT01899053|76217088|FG007|Overall Study|Reason Not Specified|0|||
42365740|NCT01899053|76217089|FG008|Overall Study|Reason Not Specified|0|||
42365741|NCT01899053|76217090|FG009|Overall Study|Reason Not Specified|0|||
42196705|NCT03514641|76008566|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
42365742|NCT01899053|76217091|FG010|Overall Study|Reason Not Specified|0|||
42365743|NCT01899053|76217092|FG011|Overall Study|Reason Not Specified|0|||
42196706|NCT03514641|76008567|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
42196707|NCT03514641|76008568|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
42365744|NCT01899053|76217093|FG012|Overall Study|Reason Not Specified|1|||
42365745|NCT01899053|76217094|FG013|Overall Study|Reason Not Specified|0|||
42365746|NCT01899053|76217081|FG000|Overall Study|Withdrawal by Subject|1|||
42365747|NCT01899053|76217082|FG001|Overall Study|Withdrawal by Subject|1|||
42365748|NCT01899053|76217083|FG002|Overall Study|Withdrawal by Subject|2|||
42365749|NCT01899053|76217084|FG003|Overall Study|Withdrawal by Subject|0|||
42365750|NCT01899053|76217085|FG004|Overall Study|Withdrawal by Subject|2|||
42365751|NCT01899053|76217086|FG005|Overall Study|Withdrawal by Subject|0|||
42365752|NCT01899053|76217087|FG006|Overall Study|Withdrawal by Subject|0|||
42365753|NCT01899053|76217088|FG007|Overall Study|Withdrawal by Subject|1|||
42365754|NCT01899053|76217089|FG008|Overall Study|Withdrawal by Subject|0|||
42365755|NCT01899053|76217090|FG009|Overall Study|Withdrawal by Subject|0|||
42196708|NCT03514641|76008569|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
42196709|NCT03514641|76008566|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
42196710|NCT03514641|76008567|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
42196711|NCT03514641|76008568|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
42196712|NCT03514641|76008569|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
42196713|NCT03514641|76008566|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
42196714|NCT03514641|76008567|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
42196715|NCT03514641|76008568|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
42196716|NCT03514641|76008569|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
42196717|NCT03514641|76008566|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
42100986|NCT00673452|75911755|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
42100987|NCT00673452|75911754|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
42100988|NCT00673452|75911755|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
42100989|NCT00673452|75911754|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
42100990|NCT00673452|75911755|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
42100991|NCT00673452|75911754|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
42100992|NCT00673452|75911755|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
42100993|NCT00673452|75911754|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
42100994|NCT00673452|75911755|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
42100995|NCT00673452|75911754|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
42100996|NCT00673452|75911755|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
42100997|NCT00545584|75911764|FG000|Overall Study|Only one reason for discontinuation|62|||
42100998|NCT00545584|75911765|FG001|Overall Study|Only one reason for discontinuation|61|||
42100999|NCT00545584|75911766|FG002|Overall Study|Only one reason for discontinuation|48|||
42101000|NCT00545584|75911764|FG000|Overall Study|Two or more reasons for discontinuation|17|||
42101001|NCT00545584|75911765|FG001|Overall Study|Two or more reasons for discontinuation|19|||
42101002|NCT00545584|75911766|FG002|Overall Study|Two or more reasons for discontinuation|8|||
42101003|NCT00378703|75911778|FG000|Overall Study|Disease progression|59|||
42101004|NCT00378703|75911779|FG001|Overall Study|Disease progression|43|||
42101005|NCT00378703|75911780|FG002|Overall Study|Disease progression|48|||
42101006|NCT00378703|75911781|FG003|Overall Study|Disease progression|49|||
42101007|NCT00378703|75911778|FG000|Overall Study|Adverse Event|11|||
42101008|NCT00378703|75911779|FG001|Overall Study|Adverse Event|17|||
42101009|NCT00378703|75911780|FG002|Overall Study|Adverse Event|20|||
42101010|NCT00378703|75911781|FG003|Overall Study|Adverse Event|18|||
42101011|NCT00378703|75911778|FG000|Overall Study|Death|2|||
42101012|NCT00378703|75911779|FG001|Overall Study|Death|2|||
42101013|NCT00378703|75911780|FG002|Overall Study|Death|4|||
42101014|NCT00378703|75911781|FG003|Overall Study|Death|3|||
42101015|NCT00378703|75911778|FG000|Overall Study|Withdrawal by Subject|4|||
42101016|NCT00378703|75911779|FG001|Overall Study|Withdrawal by Subject|8|||
42101017|NCT00378703|75911780|FG002|Overall Study|Withdrawal by Subject|5|||
42101018|NCT00378703|75911781|FG003|Overall Study|Withdrawal by Subject|7|||
42101019|NCT00378703|75911778|FG000|Overall Study|Physician Decision|1|||
42101020|NCT00378703|75911779|FG001|Overall Study|Physician Decision|4|||
42101021|NCT00378703|75911780|FG002|Overall Study|Physician Decision|1|||
42101022|NCT00378703|75911781|FG003|Overall Study|Physician Decision|0|||
42101023|NCT00378703|75911778|FG000|Overall Study|Alternative therapy|4|||
42101024|NCT00378703|75911779|FG001|Overall Study|Alternative therapy|2|||
42101025|NCT00378703|75911780|FG002|Overall Study|Alternative therapy|0|||
42101026|NCT00378703|75911781|FG003|Overall Study|Alternative therapy|0|||
42101027|NCT00378703|75911778|FG000|Overall Study|Other complicated disease|0|||
42101028|NCT00378703|75911779|FG001|Overall Study|Other complicated disease|2|||
42101029|NCT00378703|75911780|FG002|Overall Study|Other complicated disease|2|||
42101030|NCT00378703|75911781|FG003|Overall Study|Other complicated disease|0|||
42101031|NCT00378703|75911778|FG000|Overall Study|Symptomatic deterioration|0|||
42101032|NCT00378703|75911779|FG001|Overall Study|Symptomatic deterioration|1|||
42101033|NCT00378703|75911780|FG002|Overall Study|Symptomatic deterioration|0|||
42101034|NCT00378703|75911781|FG003|Overall Study|Symptomatic deterioration|2|||
42196718|NCT03514641|76008567|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
42101035|NCT00378703|75911778|FG000|Overall Study|Surgery|1|||
42101036|NCT00378703|75911779|FG001|Overall Study|Surgery|0|||
42101037|NCT00378703|75911780|FG002|Overall Study|Surgery|0|||
42101038|NCT00378703|75911781|FG003|Overall Study|Surgery|1|||
42101039|NCT00378703|75911778|FG000|Overall Study|Joint decision of physician and patient|1|||
42196719|NCT03514641|76008568|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
42196720|NCT03514641|76008569|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
42101040|NCT00378703|75911779|FG001|Overall Study|Joint decision of physician and patient|0|||
42101041|NCT00378703|75911780|FG002|Overall Study|Joint decision of physician and patient|0|||
42101042|NCT00378703|75911781|FG003|Overall Study|Joint decision of physician and patient|0|||
42101043|NCT00378703|75911778|FG000|Overall Study|Adverse events and progressive disease|0|||
42101044|NCT00378703|75911779|FG001|Overall Study|Adverse events and progressive disease|0|||
42101045|NCT00378703|75911780|FG002|Overall Study|Adverse events and progressive disease|0|||
42365756|NCT01899053|76217091|FG010|Overall Study|Withdrawal by Subject|0|||
42365757|NCT01899053|76217092|FG011|Overall Study|Withdrawal by Subject|0|||
42365758|NCT01899053|76217093|FG012|Overall Study|Withdrawal by Subject|1|||
42365759|NCT01899053|76217094|FG013|Overall Study|Withdrawal by Subject|1|||
42365760|NCT01899053|76217081|FG000|Overall Study|Protocol Violation|0|||
42365761|NCT01899053|76217082|FG001|Overall Study|Protocol Violation|0|||
42365762|NCT01899053|76217083|FG002|Overall Study|Protocol Violation|1|||
42365763|NCT01899053|76217084|FG003|Overall Study|Protocol Violation|0|||
42365764|NCT01899053|76217085|FG004|Overall Study|Protocol Violation|0|||
42365765|NCT01899053|76217086|FG005|Overall Study|Protocol Violation|0|||
42365766|NCT01899053|76217087|FG006|Overall Study|Protocol Violation|0|||
42365767|NCT01899053|76217088|FG007|Overall Study|Protocol Violation|0|||
42365768|NCT01899053|76217089|FG008|Overall Study|Protocol Violation|0|||
42365769|NCT01899053|76217090|FG009|Overall Study|Protocol Violation|0|||
42365770|NCT01899053|76217091|FG010|Overall Study|Protocol Violation|0|||
42365771|NCT01899053|76217092|FG011|Overall Study|Protocol Violation|0|||
42365772|NCT01899053|76217093|FG012|Overall Study|Protocol Violation|0|||
42365773|NCT01899053|76217094|FG013|Overall Study|Protocol Violation|0|||
42365774|NCT01899053|76217081|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
42365775|NCT01899053|76217082|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
42365776|NCT01899053|76217083|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
42365777|NCT01899053|76217084|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
42365778|NCT01899053|76217085|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
42365779|NCT01899053|76217086|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
42365780|NCT01899053|76217087|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
42365781|NCT01899053|76217088|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
42365782|NCT01899053|76217089|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
42365783|NCT01899053|76217090|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
42365784|NCT01899053|76217091|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
42365785|NCT01899053|76217092|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
42365786|NCT01899053|76217093|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
42365787|NCT01899053|76217094|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
42365788|NCT01899053|76217081|FG000|Overall Study|Symptomatic Deterioration|0|||
42365789|NCT01899053|76217082|FG001|Overall Study|Symptomatic Deterioration|0|||
42365790|NCT01899053|76217083|FG002|Overall Study|Symptomatic Deterioration|0|||
42365791|NCT01899053|76217084|FG003|Overall Study|Symptomatic Deterioration|0|||
42365792|NCT01899053|76217085|FG004|Overall Study|Symptomatic Deterioration|0|||
42365793|NCT01899053|76217086|FG005|Overall Study|Symptomatic Deterioration|1|||
42365794|NCT01899053|76217087|FG006|Overall Study|Symptomatic Deterioration|0|||
42365795|NCT01899053|76217088|FG007|Overall Study|Symptomatic Deterioration|1|||
42365796|NCT01899053|76217089|FG008|Overall Study|Symptomatic Deterioration|0|||
42365797|NCT01899053|76217090|FG009|Overall Study|Symptomatic Deterioration|0|||
42365798|NCT01899053|76217091|FG010|Overall Study|Symptomatic Deterioration|0|||
42365799|NCT01899053|76217092|FG011|Overall Study|Symptomatic Deterioration|1|||
42365800|NCT01899053|76217093|FG012|Overall Study|Symptomatic Deterioration|2|||
42365801|NCT01899053|76217094|FG013|Overall Study|Symptomatic Deterioration|0|||
42365802|NCT01888367|76217199|FG000|Overall Study|Physician Decision|3|||
42365803|NCT01888367|76217200|FG001|Overall Study|Physician Decision|4|||
42365804|NCT01888367|76217201|FG002|Overall Study|Physician Decision|2|||
42365805|NCT01888367|76217199|FG000|Overall Study|Death|2|||
42365806|NCT01888367|76217200|FG001|Overall Study|Death|0|||
42365807|NCT01888367|76217201|FG002|Overall Study|Death|1|||
42365808|NCT01888367|76217199|FG000|Overall Study|Withdrawal by Subject|1|||
42365809|NCT01888367|76217200|FG001|Overall Study|Withdrawal by Subject|0|||
42365810|NCT01888367|76217201|FG002|Overall Study|Withdrawal by Subject|1|||
42365811|NCT01888367|76217199|FG000|Overall Study|Lost to Follow-up|1|||
42365812|NCT01888367|76217200|FG001|Overall Study|Lost to Follow-up|1|||
42365813|NCT01888367|76217201|FG002|Overall Study|Lost to Follow-up|0|||
42365814|NCT01888367|76217199|FG000|Overall Study|Protocol Violation|0|||
42365815|NCT01888367|76217200|FG001|Overall Study|Protocol Violation|0|||
42365816|NCT01888367|76217201|FG002|Overall Study|Protocol Violation|1|||
42365817|NCT01888367|76217199|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
42365818|NCT01888367|76217200|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
42365819|NCT01888367|76217201|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
42365820|NCT01898195|76217227|FG000|Smoking Abstinence|Did not have good measurements|35|||
42365821|NCT01898195|76217228|FG001|Smoking Abstinence|Did not have good measurements|38|||
42365822|NCT01898195|76217229|FG002|Smoking Abstinence|Did not have good measurements|36|||
42365823|NCT01897727|76217243|FG000|Overall Study|Exclusion: central sleep apnea|0|||
42365824|NCT01897727|76217244|FG001|Overall Study|Exclusion: central sleep apnea|1|||
42365825|NCT01897493|76217250|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
42365826|NCT01887353|76217259|FG000|Overall Study|Study stopped early|4|||
42365827|NCT01887353|76217260|FG001|Overall Study|Study stopped early|3|||
42365828|NCT01896869|76217282|FG000|Overall Study|Withdrawal by Subject|0|||
42365829|NCT01896869|76217283|FG001|Overall Study|Withdrawal by Subject|6|||
42365830|NCT01896869|76217282|FG000|Overall Study|Lost to Follow-up|1|||
42365831|NCT01896869|76217283|FG001|Overall Study|Lost to Follow-up|0|||
42365832|NCT01896557|76217293|FG000|Clopidogrel Alone|Adverse Event|1|||
42365833|NCT01896557|76217294|FG001|Clopidogrel Alone|Adverse Event|0|||
42365834|NCT01896557|76217293|FG000|Clopidogrel + GI Protector|low adherence|1|||
42365835|NCT01896557|76217294|FG001|Clopidogrel + GI Protector|low adherence|1|||
42365836|NCT01896557|76217293|FG000|Clopidogrel + GI Protector|Reading error|1|||
42365837|NCT01896557|76217294|FG001|Clopidogrel + GI Protector|Reading error|3|||
42365838|NCT01886105|76217309|FG000|Overall Study|Lack of Efficacy|3|||
42365839|NCT01895777|76217338|FG000|Overall Study|Adverse Event|1|||
42365840|NCT01895777|76217339|FG001|Overall Study|Adverse Event|2|||
42365841|NCT01895777|76217338|FG000|Overall Study|Lost to Follow-up|2|||
42365842|NCT01895777|76217339|FG001|Overall Study|Lost to Follow-up|0|||
42365843|NCT01895777|76217338|FG000|Overall Study|Not treated|1|||
42365844|NCT01895777|76217339|FG001|Overall Study|Not treated|0|||
42365845|NCT01895777|76217338|FG000|Overall Study|Other reasons|3|||
42365846|NCT01895777|76217339|FG001|Overall Study|Other reasons|2|||
42365847|NCT01895777|76217338|FG000|Overall Study|Non-compliance with the CTP|2|||
42365848|NCT01895777|76217339|FG001|Overall Study|Non-compliance with the CTP|1|||
42365849|NCT01885559|76217367|FG000|Overall Study|Lost to Follow-up|15|||
42365850|NCT01885559|76217368|FG001|Overall Study|Lost to Follow-up|16|||
42365851|NCT01885559|76217367|FG000|Overall Study|Less than full participation|9|||
42365852|NCT01885559|76217368|FG001|Overall Study|Less than full participation|19|||
42365853|NCT01885559|76217367|FG000|Overall Study|Protocol Violation|0|||
42365854|NCT01885559|76217368|FG001|Overall Study|Protocol Violation|1|||
42365855|NCT01884545|76217378|FG000|Overall Study|Lost to Follow-up|6|||
42365856|NCT01884545|76217379|FG001|Overall Study|Lost to Follow-up|4|||
42365857|NCT01884545|76217380|FG002|Overall Study|Lost to Follow-up|9|||
42365858|NCT01884545|76217381|FG003|Overall Study|Lost to Follow-up|4|||
42365859|NCT01884545|76217378|FG000|Overall Study|Patient withdrawn|7|||
42365860|NCT01884545|76217379|FG001|Overall Study|Patient withdrawn|12|||
42365861|NCT01884545|76217380|FG002|Overall Study|Patient withdrawn|5|||
42365862|NCT01884545|76217381|FG003|Overall Study|Patient withdrawn|5|||
42365863|NCT01884545|76217378|FG000|Overall Study|Non-adherence|0|||
42365864|NCT01884545|76217379|FG001|Overall Study|Non-adherence|2|||
42365865|NCT01884545|76217380|FG002|Overall Study|Non-adherence|0|||
42365866|NCT01884545|76217381|FG003|Overall Study|Non-adherence|0|||
42365867|NCT01895543|76217391|FG000|Overall Study|Withdrawal by Subject|43|||
42365868|NCT01895543|76217391|FG000|Overall Study|Lost to Follow-up|25|||
42365869|NCT01895543|76217391|FG000|Overall Study|Adverse Event|28|||
42365870|NCT01895543|76217391|FG000|Overall Study|Subject's substantial non-compliance|6|||
42365871|NCT01895543|76217391|FG000|Overall Study|Protocol Violation|1|||
42365872|NCT01895543|76217391|FG000|Overall Study|Physician Decision|2|||
42365873|NCT01895543|76217391|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
42365874|NCT04828161|76217488|FG000|Overall Study|Withdrawal by Subject|0|||
42365875|NCT04828161|76217489|FG001|Overall Study|Withdrawal by Subject|3|||
42365876|NCT04828161|76217490|FG002|Overall Study|Withdrawal by Subject|3|||
42365877|NCT04828161|76217491|FG003|Overall Study|Withdrawal by Subject|4|||
42365878|NCT04828161|76217488|FG000|Overall Study|Lost to Follow-up|1|||
42196721|NCT03514641|76008566|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
42196722|NCT03514641|76008567|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
42196723|NCT03514641|76008568|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
42196724|NCT03514641|76008569|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
42365879|NCT04828161|76217489|FG001|Overall Study|Lost to Follow-up|4|||
42365880|NCT04828161|76217490|FG002|Overall Study|Lost to Follow-up|2|||
42365881|NCT04828161|76217491|FG003|Overall Study|Lost to Follow-up|2|||
42365882|NCT04828161|76217488|FG000|Overall Study|Other|2|||
42365883|NCT04828161|76217489|FG001|Overall Study|Other|0|||
42365884|NCT04828161|76217490|FG002|Overall Study|Other|2|||
42365885|NCT04828161|76217491|FG003|Overall Study|Other|0|||
42365886|NCT04828161|76217488|FG000|Overall Study|Death|0|||
42365887|NCT04828161|76217489|FG001|Overall Study|Death|0|||
42365888|NCT04828161|76217490|FG002|Overall Study|Death|0|||
42101046|NCT00378703|75911781|FG003|Overall Study|Adverse events and progressive disease|1|||
42196725|NCT03514641|76008566|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
42196726|NCT03514641|76008567|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
42365889|NCT04828161|76217491|FG003|Overall Study|Death|2|||
42365890|NCT01895309|76217589|FG000|Overall Study|Adverse Event|13|||
42365891|NCT01895309|76217590|FG001|Overall Study|Adverse Event|17|||
42365892|NCT01895309|76217589|FG000|Overall Study|Protocol Violation|1|||
42365893|NCT01895309|76217590|FG001|Overall Study|Protocol Violation|0|||
42365894|NCT01895309|76217589|FG000|Overall Study|Lack of Efficacy|1|||
42365895|NCT01895309|76217590|FG001|Overall Study|Lack of Efficacy|3|||
42365896|NCT01895309|76217589|FG000|Overall Study|Lost to Follow-up|1|||
42365897|NCT01895309|76217590|FG001|Overall Study|Lost to Follow-up|3|||
42365898|NCT01895309|76217589|FG000|Overall Study|Physician Decision|15|||
42365899|NCT01895309|76217590|FG001|Overall Study|Physician Decision|10|||
42365900|NCT01895309|76217589|FG000|Overall Study|Withdrawal by Subject|9|||
42365901|NCT01895309|76217590|FG001|Overall Study|Withdrawal by Subject|18|||
42365902|NCT01884311|76217600|FG000|Overall Study|Withdrawal by Subject|3|||
42365903|NCT01884311|76217600|FG000|Overall Study|withdrew consent due to AEs|1|||
42365904|NCT01884311|76217600|FG000|Overall Study|Precautionary measure|1|||
42365905|NCT01884077|76217640|FG000|Overall Study|screen fail|0|||
42365906|NCT01884077|76217641|FG001|Overall Study|screen fail|2|||
42365907|NCT01884077|76217640|FG000|Overall Study|canceled surgery|2|||
42365908|NCT01884077|76217641|FG001|Overall Study|canceled surgery|0|||
42365909|NCT01884077|76217640|FG000|Overall Study|Lost to Follow-up|0|||
42365910|NCT01884077|76217641|FG001|Overall Study|Lost to Follow-up|4|||
42365911|NCT01884077|76217640|FG000|Overall Study|study closed|6|||
42365912|NCT01884077|76217641|FG001|Overall Study|study closed|4|||
42365913|NCT01894919|76217660|FG000|Overall Study|Withdrawal by Subject|1|||
42365914|NCT01894919|76217661|FG001|Overall Study|Withdrawal by Subject|0|||
42365915|NCT01894919|76217662|FG002|Overall Study|Withdrawal by Subject|0|||
42365916|NCT01894919|76217663|FG003|Overall Study|Withdrawal by Subject|0|||
42365917|NCT01894919|76217664|FG004|Overall Study|Withdrawal by Subject|1|||
42365918|NCT01894919|76217665|FG005|Overall Study|Withdrawal by Subject|0|||
42365919|NCT01894919|76217666|FG006|Overall Study|Withdrawal by Subject|0|||
42365920|NCT01894919|76217667|FG007|Overall Study|Withdrawal by Subject|0|||
42365921|NCT01894919|76217668|FG008|Overall Study|Withdrawal by Subject|0|||
42365922|NCT01894919|76217669|FG009|Overall Study|Withdrawal by Subject|1|||
42365923|NCT01894919|76217670|FG010|Overall Study|Withdrawal by Subject|1|||
42365924|NCT01894919|76217671|FG011|Overall Study|Withdrawal by Subject|0|||
42365925|NCT01894919|76217672|FG012|Overall Study|Withdrawal by Subject|0|||
42365926|NCT01894919|76217660|FG000|Overall Study|Adverse Event|0|||
42365927|NCT01894919|76217661|FG001|Overall Study|Adverse Event|0|||
42365928|NCT01894919|76217662|FG002|Overall Study|Adverse Event|0|||
42365929|NCT01894919|76217663|FG003|Overall Study|Adverse Event|0|||
42365930|NCT01894919|76217664|FG004|Overall Study|Adverse Event|0|||
42365931|NCT01894919|76217665|FG005|Overall Study|Adverse Event|0|||
42365932|NCT01894919|76217666|FG006|Overall Study|Adverse Event|0|||
42365933|NCT01894919|76217667|FG007|Overall Study|Adverse Event|0|||
42365934|NCT01894919|76217668|FG008|Overall Study|Adverse Event|0|||
42365935|NCT01894919|76217669|FG009|Overall Study|Adverse Event|0|||
42365936|NCT01894919|76217670|FG010|Overall Study|Adverse Event|1|||
42365937|NCT01894919|76217671|FG011|Overall Study|Adverse Event|0|||
42365938|NCT01894919|76217672|FG012|Overall Study|Adverse Event|0|||
42365939|NCT01894919|76217660|FG000|Overall Study|Other-Unspecified|1|||
42365940|NCT01894919|76217661|FG001|Overall Study|Other-Unspecified|0|||
42365941|NCT01894919|76217662|FG002|Overall Study|Other-Unspecified|0|||
42365942|NCT01894919|76217663|FG003|Overall Study|Other-Unspecified|0|||
42365943|NCT01894919|76217664|FG004|Overall Study|Other-Unspecified|0|||
42365944|NCT01894919|76217665|FG005|Overall Study|Other-Unspecified|0|||
42365945|NCT01894919|76217666|FG006|Overall Study|Other-Unspecified|0|||
42365946|NCT01894919|76217667|FG007|Overall Study|Other-Unspecified|0|||
42365947|NCT01894919|76217668|FG008|Overall Study|Other-Unspecified|0|||
42365948|NCT01894919|76217669|FG009|Overall Study|Other-Unspecified|0|||
42365949|NCT01894919|76217670|FG010|Overall Study|Other-Unspecified|0|||
42365950|NCT01894919|76217671|FG011|Overall Study|Other-Unspecified|0|||
42365951|NCT01894919|76217672|FG012|Overall Study|Other-Unspecified|0|||
42365952|NCT01894919|76217660|FG000|Overall Study|Lost to Follow-up|0|||
42365953|NCT01894919|76217661|FG001|Overall Study|Lost to Follow-up|0|||
42365954|NCT01894919|76217662|FG002|Overall Study|Lost to Follow-up|0|||
42365955|NCT01894919|76217663|FG003|Overall Study|Lost to Follow-up|0|||
42365956|NCT01894919|76217664|FG004|Overall Study|Lost to Follow-up|2|||
42365957|NCT01894919|76217665|FG005|Overall Study|Lost to Follow-up|0|||
42365958|NCT01894919|76217666|FG006|Overall Study|Lost to Follow-up|0|||
42365959|NCT01894919|76217667|FG007|Overall Study|Lost to Follow-up|0|||
42365960|NCT01894919|76217668|FG008|Overall Study|Lost to Follow-up|0|||
42365961|NCT01894919|76217669|FG009|Overall Study|Lost to Follow-up|0|||
42365962|NCT01894919|76217670|FG010|Overall Study|Lost to Follow-up|0|||
42365963|NCT01894919|76217671|FG011|Overall Study|Lost to Follow-up|0|||
42365964|NCT01894919|76217672|FG012|Overall Study|Lost to Follow-up|0|||
42365965|NCT01894841|76217716|FG000|Overall Study|Withdrawal by Subject|9|||
42365966|NCT01894841|76217717|FG001|Overall Study|Withdrawal by Subject|4|||
42365967|NCT01894841|76217716|FG000|Overall Study|Withdrawn by investigator|2|||
42365968|NCT01894841|76217717|FG001|Overall Study|Withdrawn by investigator|2|||
42365969|NCT01894841|76217716|FG000|Overall Study|Lost to Follow-up|7|||
42365970|NCT01894841|76217717|FG001|Overall Study|Lost to Follow-up|3|||
42365971|NCT01894607|76217727|FG000|Overall Study|Ineligible|1|||
42365972|NCT01883453|76217733|FG000|Overall Study|No episode of common cold|25|||
42365973|NCT01883453|76217734|FG001|Overall Study|No episode of common cold|23|||
42365974|NCT01882985|76217768|FG000|Overall Study|Lost to Follow-up|1|||
42365975|NCT01882985|76217768|FG000|Overall Study|Withdrawal by Subject|1|||
42365976|NCT01893905|76217781|FG000|Overall Study|Withdrawal by Subject|1|||
42365977|NCT01893905|76217782|FG001|Overall Study|Withdrawal by Subject|0|||
42365978|NCT01893905|76217781|FG000|Overall Study|Adverse Event|9|||
42365979|NCT01893905|76217782|FG001|Overall Study|Adverse Event|3|||
42365980|NCT01893905|76217781|FG000|Overall Study|Lack of Efficacy|5|||
42365981|NCT01893905|76217782|FG001|Overall Study|Lack of Efficacy|7|||
42365982|NCT01893905|76217781|FG000|Overall Study|Lost to Follow-up|1|||
42365983|NCT01893905|76217782|FG001|Overall Study|Lost to Follow-up|0|||
42365984|NCT01893905|76217781|FG000|Overall Study|Protocol Violation|6|||
42365985|NCT01893905|76217782|FG001|Overall Study|Protocol Violation|1|||
42365986|NCT01893905|76217781|FG000|Overall Study|Lack of adherence to treatment|2|||
42365987|NCT01893905|76217782|FG001|Overall Study|Lack of adherence to treatment|0|||
42365988|NCT01893905|76217781|FG000|Overall Study|Other reason|1|||
42365989|NCT01893905|76217782|FG001|Overall Study|Other reason|3|||
42365990|NCT01893827|76217795|FG000|Overall Study|Lost to Follow-up|19|||
42365991|NCT01893827|76217796|FG001|Overall Study|Lost to Follow-up|26|||
42365992|NCT01882907|76217804|FG000|Overall Study|Adverse Event|3|||
42365993|NCT01882907|76217805|FG001|Overall Study|Adverse Event|1|||
42365994|NCT01882907|76217804|FG000|Overall Study|Lack of Efficacy|0|||
42365995|NCT01882907|76217805|FG001|Overall Study|Lack of Efficacy|3|||
42365996|NCT01882907|76217804|FG000|Overall Study|Lost to Follow-up|1|||
42365997|NCT01882907|76217805|FG001|Overall Study|Lost to Follow-up|4|||
42365998|NCT01882907|76217804|FG000|Overall Study|Protocol Violation|10|||
42365999|NCT01882907|76217805|FG001|Overall Study|Protocol Violation|14|||
42366000|NCT01882907|76217804|FG000|Overall Study|Withdrawal by Subject|0|||
42366001|NCT01882907|76217805|FG001|Overall Study|Withdrawal by Subject|6|||
42366002|NCT01893281|76217827|FG000|Overall Study|Adverse Event|1|||
42366003|NCT01893281|76217827|FG000|Overall Study|Protocol Violation|1|||
42366004|NCT01893281|76217827|FG000|Overall Study|Withdrawal by Subject|1|||
42366005|NCT01893203|76217831|FG000|Overall Study|Withdrawal by Subject|1|||
42366006|NCT01882829|76217835|FG000|Overall Study|Adverse Event|4|||
42366007|NCT01882829|76217835|FG000|Overall Study|Protocol Violation|1|||
42366008|NCT01882829|76217835|FG000|Overall Study|Withdrawal by Subject|1|||
42366009|NCT01882439|76217919|FG000|Overall Study|Adverse event related to study drug|3|||
42366010|NCT01882439|76217920|FG001|Overall Study|Adverse event related to study drug|8|||
42366011|NCT01882439|76217921|FG002|Overall Study|Adverse event related to study drug|1|||
42366012|NCT01882439|76217922|FG003|Overall Study|Adverse event related to study drug|2|||
42366013|NCT01882439|76217919|FG000|Overall Study|Pregnancy|0|||
42366014|NCT01882439|76217920|FG001|Overall Study|Pregnancy|1|||
42366015|NCT01882439|76217921|FG002|Overall Study|Pregnancy|0|||
42366016|NCT01882439|76217922|FG003|Overall Study|Pregnancy|0|||
42366017|NCT01882439|76217919|FG000|Overall Study|Protocol Violation|2|||
42366018|NCT01882439|76217920|FG001|Overall Study|Protocol Violation|2|||
42366019|NCT01882439|76217921|FG002|Overall Study|Protocol Violation|0|||
42366020|NCT01882439|76217922|FG003|Overall Study|Protocol Violation|1|||
42366021|NCT01882439|76217919|FG000|Overall Study|No longer willing to participate|1|||
42366022|NCT01882439|76217920|FG001|Overall Study|No longer willing to participate|4|||
42366023|NCT01882439|76217921|FG002|Overall Study|No longer willing to participate|2|||
42366024|NCT01882439|76217922|FG003|Overall Study|No longer willing to participate|3|||
42366025|NCT01882439|76217919|FG000|Overall Study|Medication error with no associated AE|0|||
42366026|NCT01882439|76217920|FG001|Overall Study|Medication error with no associated AE|0|||
42366027|NCT01882439|76217921|FG002|Overall Study|Medication error with no associated AE|2|||
42366028|NCT01882439|76217922|FG003|Overall Study|Medication error with no associated AE|0|||
42366029|NCT01882439|76217919|FG000|Overall Study|Insufficient clinical response|1|||
42366030|NCT01882439|76217920|FG001|Overall Study|Insufficient clinical response|4|||
42366031|NCT01882439|76217921|FG002|Overall Study|Insufficient clinical response|4|||
42366032|NCT01882439|76217922|FG003|Overall Study|Insufficient clinical response|2|||
42366033|NCT01882439|76217919|FG000|Overall Study|Adverse event unrelated to study drug|2|||
42101047|NCT00378703|75911778|FG000|Overall Study|Relocation|0|||
42101048|NCT00378703|75911779|FG001|Overall Study|Relocation|0|||
42101049|NCT00378703|75911780|FG002|Overall Study|Relocation|1|||
42101050|NCT00378703|75911781|FG003|Overall Study|Relocation|0|||
42101051|NCT00378703|75911778|FG000|Overall Study|Ineligible|4|||
42101052|NCT00378703|75911779|FG001|Overall Study|Ineligible|7|||
42101053|NCT00378703|75911780|FG002|Overall Study|Ineligible|7|||
42366034|NCT01882439|76217920|FG001|Overall Study|Adverse event unrelated to study drug|2|||
42366035|NCT01882439|76217921|FG002|Overall Study|Adverse event unrelated to study drug|1|||
42366036|NCT01882439|76217922|FG003|Overall Study|Adverse event unrelated to study drug|1|||
42366037|NCT01892657|76217969|FG000|Overall Study|Withdrawal by Subject|6|||
42366038|NCT01892657|76217969|FG000|Overall Study|Protocol Violation|12|||
42101054|NCT00378703|75911781|FG003|Overall Study|Ineligible|7|||
42366039|NCT01881737|76217996|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
42366040|NCT01881737|76217996|FG000|Overall Study|Withdrawal by Subject|1|||
42101055|NCT00378703|75911778|FG000|Overall Study|Never started treatment|1|||
42366041|NCT01881737|76217996|FG000|Overall Study|Worsening of baseline behavior|1|||
42366042|NCT01892501|76218032|FG000|Overall Study|Protocol Violation|2|||
42366043|NCT01892501|76218032|FG000|Overall Study|Puncture not carried out|9|||
42366044|NCT01892501|76218032|FG000|Overall Study|Radiological monitoring not carried out|5|||
42366045|NCT01892501|76218032|FG000|Overall Study|Non-contributory histological result|12|||
42366046|NCT01892345|76218047|FG000|Overall Study|Adverse Event|0|||
42366047|NCT01892345|76218048|FG001|Overall Study|Adverse Event|2|||
42366048|NCT01892345|76218047|FG000|Overall Study|Death|1|||
42366049|NCT01892345|76218048|FG001|Overall Study|Death|0|||
42366050|NCT01892345|76218047|FG000|Overall Study|Lost to Follow-up|3|||
42366051|NCT01892345|76218048|FG001|Overall Study|Lost to Follow-up|0|||
42366052|NCT01892345|76218047|FG000|Overall Study|Withdrawal by Subject|12|||
42366053|NCT01892345|76218048|FG001|Overall Study|Withdrawal by Subject|1|||
42366054|NCT01892189|76218125|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
42366055|NCT01892189|76218126|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
42366056|NCT01892189|76218127|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
42366057|NCT01892189|76218128|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
42366058|NCT01892189|76218129|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
42366059|NCT01892189|76218130|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
42366060|NCT01892189|76218131|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
42366061|NCT01892189|76218132|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
42366062|NCT01892189|76218133|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
42366063|NCT01892189|76218125|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42366064|NCT01892189|76218126|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42366065|NCT01892189|76218127|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
42366066|NCT01892189|76218128|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
42366067|NCT01892189|76218129|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42366068|NCT01892189|76218130|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42366069|NCT01892189|76218131|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
42366070|NCT01892189|76218132|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42366071|NCT01892189|76218133|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
42366072|NCT01892189|76218125|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
42366073|NCT01892189|76218126|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
42366074|NCT01892189|76218127|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
42366075|NCT01892189|76218128|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
42366076|NCT01892189|76218129|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
42366077|NCT01892189|76218130|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
42366078|NCT01892189|76218131|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
42366079|NCT01892189|76218132|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
42366080|NCT01892189|76218133|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
42366081|NCT01881425|76218164|FG000|Overall Study|Death|5|||
42366082|NCT01881425|76218165|FG001|Overall Study|Death|1|||
42366083|NCT01881425|76218164|FG000|Overall Study|Withdrawal by Subject|8|||
42366084|NCT01881425|76218165|FG001|Overall Study|Withdrawal by Subject|3|||
42366085|NCT01881425|76218164|FG000|Overall Study|Physician Decision|2|||
42366086|NCT01881425|76218165|FG001|Overall Study|Physician Decision|1|||
42366087|NCT01881425|76218164|FG000|Overall Study|Adverse Event|3|||
42366088|NCT01881425|76218165|FG001|Overall Study|Adverse Event|0|||
42366089|NCT01881425|76218164|FG000|Overall Study|General Anesthesia panic attack|0|||
42366090|NCT01881425|76218165|FG001|Overall Study|General Anesthesia panic attack|1|||
42366091|NCT01881425|76218164|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
42366092|NCT01881425|76218165|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
42366093|NCT01881425|76218164|FG000|Overall Study|Lost to Follow-up|7|||
42366094|NCT01881425|76218165|FG001|Overall Study|Lost to Follow-up|2|||
42366095|NCT01891721|76218184|FG000|Overall Study|Lost to Follow-up|10|||
42366096|NCT01891721|76218185|FG001|Overall Study|Lost to Follow-up|5|||
42366097|NCT01891721|76218186|FG002|Overall Study|Lost to Follow-up|1|||
42366098|NCT01880957|76218205|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
42366099|NCT01880957|76218206|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
42366100|NCT01880957|76218205|FG000|Overall Study|Lost to Follow-up|11|||
42366101|NCT01880957|76218206|FG001|Overall Study|Lost to Follow-up|0|||
42366102|NCT01880957|76218205|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
42366103|NCT01880957|76218206|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
42366104|NCT04152837|76218221|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
42366105|NCT04152837|76218221|FG000|Maintenance Period|Adverse Event|1|||
42366106|NCT04152837|76218221|FG000|Maintenance Period|Withdrawal by Subject|1|||
42366107|NCT04152837|76218221|FG000|Maintenance Period|Sponsor Termination of Study|2|||
42366108|NCT01879553|76218240|FG000|Overall Study|Withdrawal by Subject|1|||
42366109|NCT01879553|76218241|FG001|Overall Study|Withdrawal by Subject|0|||
42366110|NCT01890785|76218262|FG000|Third Intervention|Withdrawal by Subject|0|||
42366111|NCT01890785|76218263|FG001|Third Intervention|Withdrawal by Subject|1|||
42101056|NCT00378703|75911779|FG001|Overall Study|Never started treatment|4|||
42366112|NCT01890785|76218264|FG002|Third Intervention|Withdrawal by Subject|0|||
42366113|NCT01890785|76218265|FG003|Third Intervention|Withdrawal by Subject|0|||
42366114|NCT01890785|76218266|FG004|Third Intervention|Withdrawal by Subject|0|||
42366115|NCT01890785|76218267|FG005|Third Intervention|Withdrawal by Subject|0|||
42366116|NCT01878383|76218291|FG000|Overall Study|Lost to Follow-up|0|||
42366117|NCT01878383|76218292|FG001|Overall Study|Lost to Follow-up|1499|||
42366118|NCT01878149|76218300|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
42366119|NCT01878149|76218301|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
42366120|NCT01863953|76218323|FG000|Overall Study|Adverse Event|0|||
42366121|NCT01863953|76218324|FG001|Overall Study|Adverse Event|0|||
42366122|NCT01863953|76218325|FG002|Overall Study|Adverse Event|1|||
42366123|NCT03049449|76218601|FG000|Overall Study|Did not receive treatment.|0|||
42366124|NCT03049449|76218602|FG001|Overall Study|Did not receive treatment.|0|||
42366125|NCT03049449|76218603|FG002|Overall Study|Did not receive treatment.|0|||
42366126|NCT03049449|76218604|FG003|Overall Study|Did not receive treatment.|0|||
42366127|NCT03049449|76218605|FG004|Overall Study|Did not receive treatment.|0|||
42366128|NCT03049449|76218606|FG005|Overall Study|Did not receive treatment.|0|||
42366129|NCT03049449|76218607|FG006|Overall Study|Did not receive treatment.|0|||
42366130|NCT03049449|76218608|FG007|Overall Study|Did not receive treatment.|0|||
42366131|NCT03049449|76218609|FG008|Overall Study|Did not receive treatment.|1|||
42366132|NCT03049449|76218610|FG009|Overall Study|Did not receive treatment.|0|||
42366133|NCT03049449|76218601|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
42366134|NCT03049449|76218602|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
42366135|NCT03049449|76218603|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
42366136|NCT03049449|76218604|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
42366137|NCT03049449|76218605|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
42366138|NCT03049449|76218606|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
42366139|NCT03049449|76218607|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
42366140|NCT03049449|76218608|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
42366141|NCT03049449|76218609|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
42366142|NCT03049449|76218610|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
42366143|NCT03049449|76218601|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
42366144|NCT03049449|76218602|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
42366145|NCT03049449|76218603|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
42366146|NCT03049449|76218604|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
42366147|NCT03049449|76218605|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
42366148|NCT03049449|76218606|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
42366149|NCT03049449|76218607|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
42366150|NCT03049449|76218608|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
42366151|NCT03049449|76218609|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
42366152|NCT03049449|76218610|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
42366153|NCT02989857|76218733|FG000|Randomization Phase|Not Treated|3|||
42366154|NCT02989857|76218734|FG001|Randomization Phase|Not Treated|2|||
42366155|NCT02989857|76218735|FG002|Randomization Phase|Not Treated|0|||
42366156|NCT01877915|76218746|FG000|Overall Study|Lost to Follow-up|10|||
42366157|NCT01877915|76218747|FG001|Overall Study|Lost to Follow-up|9|||
42366158|NCT01877915|76218746|FG000|Overall Study|Withdrawal by Subject|42|||
42366159|NCT01877915|76218747|FG001|Overall Study|Withdrawal by Subject|55|||
42366160|NCT01877915|76218746|FG000|Overall Study|Other|2|||
42366161|NCT01877915|76218747|FG001|Overall Study|Other|4|||
42366162|NCT01876979|76218755|FG000|Overall Study|Physician Decision|2|||
42366163|NCT01876979|76218756|FG001|Overall Study|Physician Decision|3|||
42366164|NCT01860989|76218762|FG000|Overall Study|Unsatisfactory therapeutic|5|||
42366165|NCT01860677|76218778|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
42366166|NCT01860677|76218779|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
42366167|NCT01876901|76218797|FG000|Overall Study|Protocol Violation|10|||
42366168|NCT01876901|76218798|FG001|Overall Study|Protocol Violation|2|||
42366169|NCT01876901|76218797|FG000|Overall Study|No or other surgical intervention|7|||
42366170|NCT01876901|76218798|FG001|Overall Study|No or other surgical intervention|5|||
42366171|NCT01876823|76218805|FG000|Overall Study|Withdrawal by Subject|5|||
42366172|NCT01876823|76218805|FG000|Overall Study|Physician Decision|2|||
42366173|NCT01876823|76218805|FG000|Overall Study|Patients moved|2|||
42366174|NCT01876511|76218812|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
42366175|NCT01876511|76218813|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
42366176|NCT01876511|76218814|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
42366177|NCT01876511|76218812|FG000|Overall Study|Death (unrelated)|3|||
42196727|NCT03514641|76008568|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
42366178|NCT01876511|76218813|FG001|Overall Study|Death (unrelated)|0|||
42366179|NCT01876511|76218814|FG002|Overall Study|Death (unrelated)|2|||
42366180|NCT01876511|76218812|FG000|Overall Study|Drug-related Toxicity|5|||
42366181|NCT01876511|76218813|FG001|Overall Study|Drug-related Toxicity|1|||
42366182|NCT01876511|76218814|FG002|Overall Study|Drug-related Toxicity|6|||
42366183|NCT01876511|76218812|FG000|Overall Study|Patient Decision|3|||
42366184|NCT01876511|76218813|FG001|Overall Study|Patient Decision|0|||
42366185|NCT01876511|76218814|FG002|Overall Study|Patient Decision|6|||
42366186|NCT01876511|76218812|FG000|Overall Study|Physician Decision|1|||
42366187|NCT01876511|76218813|FG001|Overall Study|Physician Decision|0|||
42366188|NCT01876511|76218814|FG002|Overall Study|Physician Decision|1|||
42366189|NCT01993719|76218829|FG000|First Drug Administration|Not treated|1|||
42366190|NCT01993719|76218830|FG001|First Drug Administration|Not treated|0|||
42366191|NCT01993719|76218831|FG002|First Drug Administration|Not treated|0|||
42366192|NCT01993719|76218832|FG003|First Drug Administration|Not treated|0|||
42366193|NCT01993719|76218833|FG004|First Drug Administration|Not treated|0|||
42366194|NCT00638235|76218875|FG000|Overall Study|Lost to Follow-up|31|||
42366195|NCT00638235|76218876|FG001|Overall Study|Lost to Follow-up|3|||
42366196|NCT00638235|76218877|FG002|Overall Study|Lost to Follow-up|18|||
42366197|NCT00638235|76218878|FG003|Overall Study|Lost to Follow-up|10|||
42366198|NCT00638235|76218879|FG004|Overall Study|Lost to Follow-up|13|||
42366199|NCT00638235|76218880|FG005|Overall Study|Lost to Follow-up|26|||
42366200|NCT00638235|76218881|FG006|Overall Study|Lost to Follow-up|0|||
42366201|NCT00638235|76218882|FG007|Overall Study|Lost to Follow-up|1|||
42366202|NCT00638235|76218883|FG008|Overall Study|Lost to Follow-up|18|||
42366203|NCT00638157|76218912|FG000|Overall Study|Adverse Event|0|||
42366204|NCT00638157|76218913|FG001|Overall Study|Adverse Event|1|||
42366205|NCT00638157|76218912|FG000|Overall Study|Clinical (symptomatic) failure|1|||
42366206|NCT00638157|76218913|FG001|Overall Study|Clinical (symptomatic) failure|1|||
42366207|NCT00638157|76218912|FG000|Overall Study|Microbiological failure|1|||
42366208|NCT00638157|76218913|FG001|Overall Study|Microbiological failure|0|||
42366209|NCT00638157|76218912|FG000|Overall Study|Lost to Follow-up|1|||
42366210|NCT00638157|76218913|FG001|Overall Study|Lost to Follow-up|0|||
42366211|NCT00638157|76218912|FG000|Overall Study|Physician Decision|1|||
42366212|NCT00638157|76218913|FG001|Overall Study|Physician Decision|0|||
42366213|NCT00638157|76218912|FG000|Overall Study|Other|1|||
42366214|NCT00638157|76218913|FG001|Overall Study|Other|2|||
42366215|NCT00638157|76218912|FG000|Overall Study|Randomized, not treated|2|||
42366216|NCT00638157|76218913|FG001|Overall Study|Randomized, not treated|0|||
42366217|NCT00637377|76218924|FG000|Overall Study|Adverse Event|2|||
42366218|NCT00637377|76218925|FG001|Overall Study|Adverse Event|6|||
42366219|NCT00637377|76218926|FG002|Overall Study|Adverse Event|8|||
42366220|NCT00637377|76218927|FG003|Overall Study|Adverse Event|9|||
42366221|NCT00637377|76218924|FG000|Overall Study|Death|1|||
42366222|NCT00637377|76218925|FG001|Overall Study|Death|3|||
42366223|NCT00637377|76218926|FG002|Overall Study|Death|2|||
42366224|NCT00637377|76218927|FG003|Overall Study|Death|1|||
42366225|NCT00637377|76218924|FG000|Overall Study|Lack of Efficacy|0|||
42366226|NCT00637377|76218925|FG001|Overall Study|Lack of Efficacy|0|||
42366227|NCT00637377|76218926|FG002|Overall Study|Lack of Efficacy|1|||
42366228|NCT00637377|76218927|FG003|Overall Study|Lack of Efficacy|1|||
42366229|NCT00637377|76218924|FG000|Overall Study|Lost to Follow-up|4|||
42366230|NCT00637377|76218925|FG001|Overall Study|Lost to Follow-up|1|||
42366231|NCT00637377|76218926|FG002|Overall Study|Lost to Follow-up|2|||
42366232|NCT00637377|76218927|FG003|Overall Study|Lost to Follow-up|2|||
42366233|NCT00637377|76218924|FG000|Overall Study|Protocol Violation|2|||
42366234|NCT00637377|76218925|FG001|Overall Study|Protocol Violation|1|||
42366235|NCT00637377|76218926|FG002|Overall Study|Protocol Violation|1|||
42366236|NCT00637377|76218927|FG003|Overall Study|Protocol Violation|0|||
42366237|NCT00637377|76218924|FG000|Overall Study|Withdrawal by Subject|11|||
42366238|NCT00637377|76218925|FG001|Overall Study|Withdrawal by Subject|15|||
42366239|NCT00637377|76218926|FG002|Overall Study|Withdrawal by Subject|13|||
42366240|NCT00637377|76218927|FG003|Overall Study|Withdrawal by Subject|11|||
42366241|NCT00637377|76218924|FG000|Overall Study|Other (no further information available)|7|||
42366242|NCT00637377|76218925|FG001|Overall Study|Other (no further information available)|6|||
42366243|NCT00637377|76218926|FG002|Overall Study|Other (no further information available)|10|||
42196728|NCT03514641|76008569|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
42366244|NCT00637377|76218927|FG003|Overall Study|Other (no further information available)|5|||
42366245|NCT00636987|76218937|FG000|Overall Study|Death|44|||
42366246|NCT00636987|76218937|FG000|Overall Study|Explanted|13|||
42366247|NCT00636987|76218937|FG000|Overall Study|Lost to Follow-up|63|||
42366248|NCT00636987|76218937|FG000|Overall Study|5 year visit window not complete|69|||
42366249|NCT00636441|76219092|FG000|Overall Study|Adverse Event|0|||
42366250|NCT00636441|76219093|FG001|Overall Study|Adverse Event|1|||
42366251|NCT00636441|76219094|FG002|Overall Study|Adverse Event|1|||
42366252|NCT00636441|76219095|FG003|Overall Study|Adverse Event|0|||
42366253|NCT00636441|76219096|FG004|Overall Study|Adverse Event|0|||
42366254|NCT00636441|76219097|FG005|Overall Study|Adverse Event|1|||
42366255|NCT00636441|76219098|FG006|Overall Study|Adverse Event|0|||
42366256|NCT00636441|76219092|FG000|Overall Study|Late, ineligible|0|||
42366257|NCT00636441|76219093|FG001|Overall Study|Late, ineligible|0|||
42366258|NCT00636441|76219094|FG002|Overall Study|Late, ineligible|0|||
42366259|NCT00636441|76219095|FG003|Overall Study|Late, ineligible|0|||
42366260|NCT00636441|76219096|FG004|Overall Study|Late, ineligible|0|||
42366261|NCT00636441|76219097|FG005|Overall Study|Late, ineligible|0|||
42366262|NCT00636441|76219098|FG006|Overall Study|Late, ineligible|1|||
42366263|NCT00636441|76219092|FG000|Overall Study|Screen Failure|0|||
42366264|NCT00636441|76219093|FG001|Overall Study|Screen Failure|0|||
42366265|NCT00636441|76219094|FG002|Overall Study|Screen Failure|0|||
42366266|NCT00636441|76219095|FG003|Overall Study|Screen Failure|0|||
42366267|NCT00636441|76219096|FG004|Overall Study|Screen Failure|0|||
42366268|NCT00636441|76219097|FG005|Overall Study|Screen Failure|0|||
42366269|NCT00636441|76219098|FG006|Overall Study|Screen Failure|17|||
42366270|NCT00636363|76219121|FG000|Overall Study|Conjunctivitis|0|||
42366271|NCT00636363|76219122|FG001|Overall Study|Conjunctivitis|0|||
42366272|NCT00636363|76219123|FG002|Overall Study|Conjunctivitis|1|||
42366273|NCT00636363|76219121|FG000|Overall Study|Adverse Event|0|||
42366274|NCT00636363|76219122|FG001|Overall Study|Adverse Event|0|||
42366275|NCT00636363|76219123|FG002|Overall Study|Adverse Event|1|||
42366276|NCT00636363|76219121|FG000|Overall Study|Positive slit lamp finding|0|||
42366277|NCT00636363|76219122|FG001|Overall Study|Positive slit lamp finding|2|||
42366278|NCT00636363|76219123|FG002|Overall Study|Positive slit lamp finding|1|||
42366279|NCT00636363|76219121|FG000|Overall Study|Study related symptoms/complaints|8|||
42366280|NCT00636363|76219122|FG001|Overall Study|Study related symptoms/complaints|7|||
42366281|NCT00636363|76219123|FG002|Overall Study|Study related symptoms/complaints|4|||
42366282|NCT00636363|76219121|FG000|Overall Study|Met ineligibility criteria|0|||
42366283|NCT00636363|76219122|FG001|Overall Study|Met ineligibility criteria|0|||
42366284|NCT00636363|76219123|FG002|Overall Study|Met ineligibility criteria|3|||
42366285|NCT00636363|76219121|FG000|Overall Study|Missed > 1 visit|0|||
42366286|NCT00636363|76219122|FG001|Overall Study|Missed > 1 visit|1|||
42366287|NCT00636363|76219123|FG002|Overall Study|Missed > 1 visit|3|||
42366288|NCT00636363|76219121|FG000|Overall Study|Lack of motivation|1|||
42366289|NCT00636363|76219122|FG001|Overall Study|Lack of motivation|0|||
42366290|NCT00636363|76219123|FG002|Overall Study|Lack of motivation|1|||
42366291|NCT00636363|76219121|FG000|Overall Study|Protocol Violation|0|||
42366292|NCT00636363|76219122|FG001|Overall Study|Protocol Violation|3|||
42366293|NCT00636363|76219123|FG002|Overall Study|Protocol Violation|0|||
42366294|NCT00636363|76219121|FG000|Overall Study|Lost to Follow-up|3|||
42366295|NCT00636363|76219122|FG001|Overall Study|Lost to Follow-up|4|||
42366296|NCT00636363|76219123|FG002|Overall Study|Lost to Follow-up|2|||
42366297|NCT00636363|76219121|FG000|Overall Study|Withdrawal by Subject|1|||
42366298|NCT00636363|76219122|FG001|Overall Study|Withdrawal by Subject|3|||
42366299|NCT00636363|76219123|FG002|Overall Study|Withdrawal by Subject|2|||
42366300|NCT00636207|76219165|FG000|Overall Study|Adverse Event|1|||
42366301|NCT00636207|76219166|FG001|Overall Study|Adverse Event|0|||
42366302|NCT00636207|76219167|FG002|Overall Study|Adverse Event|0|||
42366303|NCT00636207|76219168|FG003|Overall Study|Adverse Event|0|||
42366304|NCT00636207|76219169|FG004|Overall Study|Adverse Event|0|||
42366305|NCT00636207|76219170|FG005|Overall Study|Adverse Event|0|||
42366306|NCT00636207|76219171|FG006|Overall Study|Adverse Event|0|||
42366307|NCT00636207|76219165|FG000|Overall Study|Withdrawal by Subject|0|||
42366308|NCT00636207|76219166|FG001|Overall Study|Withdrawal by Subject|1|||
42366309|NCT00636207|76219167|FG002|Overall Study|Withdrawal by Subject|0|||
42366310|NCT00636207|76219168|FG003|Overall Study|Withdrawal by Subject|0|||
42366311|NCT00636207|76219169|FG004|Overall Study|Withdrawal by Subject|1|||
42366312|NCT00636207|76219170|FG005|Overall Study|Withdrawal by Subject|0|||
42366313|NCT00636207|76219171|FG006|Overall Study|Withdrawal by Subject|0|||
42366314|NCT00635661|76219192|FG000|Overall Study|Withdrawal by Subject|4|||
42196729|NCT03514641|76008566|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
42196730|NCT03514641|76008567|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
42196731|NCT03514641|76008568|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
42366315|NCT00635427|76219281|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
42366316|NCT00635427|76219282|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
42366317|NCT00635427|76219283|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
42366318|NCT00635427|76219284|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
42366319|NCT00635427|76219285|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
42366320|NCT00635427|76219281|FG000|Overall Study|Death|0|||
42196732|NCT03514641|76008569|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
42366321|NCT00635427|76219282|FG001|Overall Study|Death|0|||
42366322|NCT00635427|76219283|FG002|Overall Study|Death|0|||
42366323|NCT00635427|76219284|FG003|Overall Study|Death|1|||
42366324|NCT00635427|76219285|FG004|Overall Study|Death|0|||
42366325|NCT00635427|76219281|FG000|Overall Study|Termination Of Study By Sponsor|12|||
42366326|NCT00635427|76219282|FG001|Overall Study|Termination Of Study By Sponsor|6|||
42366327|NCT00635427|76219283|FG002|Overall Study|Termination Of Study By Sponsor|10|||
42366328|NCT00635427|76219284|FG003|Overall Study|Termination Of Study By Sponsor|6|||
42366329|NCT00635427|76219285|FG004|Overall Study|Termination Of Study By Sponsor|6|||
42366330|NCT00635427|76219281|FG000|Overall Study|Withdrawal Of Consent|0|||
42366331|NCT00635427|76219282|FG001|Overall Study|Withdrawal Of Consent|0|||
42366332|NCT00635427|76219283|FG002|Overall Study|Withdrawal Of Consent|0|||
42366333|NCT00635427|76219284|FG003|Overall Study|Withdrawal Of Consent|2|||
42366334|NCT00635427|76219285|FG004|Overall Study|Withdrawal Of Consent|2|||
42366335|NCT00635349|76219297|FG000|Overall Study|Other|8|||
42366336|NCT00635349|76219298|FG001|Overall Study|Other|6|||
42366337|NCT00635349|76219297|FG000|Overall Study|Protocol Violation|18|||
42366338|NCT00635349|76219298|FG001|Overall Study|Protocol Violation|22|||
42366339|NCT00635349|76219297|FG000|Overall Study|Withdrawal by Subject|3|||
42366340|NCT00635349|76219298|FG001|Overall Study|Withdrawal by Subject|8|||
42366341|NCT00635349|76219297|FG000|Overall Study|Lost to Follow-up|4|||
42366342|NCT00635349|76219298|FG001|Overall Study|Lost to Follow-up|3|||
42366343|NCT00635349|76219297|FG000|Overall Study|Adverse Event|11|||
42366344|NCT00635349|76219298|FG001|Overall Study|Adverse Event|9|||
42366345|NCT00634803|76219307|FG000|Overall Study|Lost to Follow-up|6|||
42366346|NCT00634803|76219308|FG001|Overall Study|Lost to Follow-up|7|||
42366347|NCT00634803|76219309|FG002|Overall Study|Lost to Follow-up|7|||
42366348|NCT01217385|76219325|FG000|Overall Study|Withdrawal by Subject|3|||
42366349|NCT01217385|76219325|FG000|Overall Study|DOSI not performed/not eval|12|||
42366350|NCT01217385|76219325|FG000|Overall Study|Central Path not Available|1|||
42366351|NCT01217385|76219325|FG000|Overall Study|Normal Breast TOI not available|10|||
42101057|NCT00378703|75911780|FG002|Overall Study|Never started treatment|0|||
42101058|NCT00378703|75911781|FG003|Overall Study|Never started treatment|0|||
42101059|NCT00378703|75911778|FG000|Overall Study|Other|1|||
42101060|NCT00378703|75911779|FG001|Overall Study|Other|1|||
42101061|NCT00378703|75911780|FG002|Overall Study|Other|2|||
42101062|NCT00378703|75911781|FG003|Overall Study|Other|3|||
42101063|NCT00368641|75911797|FG000|Overall Study|Adverse Event|2|||
42101064|NCT00368641|75911798|FG001|Overall Study|Adverse Event|1|||
42101065|NCT00368641|75911797|FG000|Overall Study|Death|1|||
42101066|NCT00368641|75911798|FG001|Overall Study|Death|0|||
42101067|NCT00368641|75911797|FG000|Overall Study|Withdrawal by Subject|1|||
42101068|NCT00368641|75911798|FG001|Overall Study|Withdrawal by Subject|0|||
42366352|NCT01378104|76219677|FG000|Overall Study|Adverse Event|8|||
42366353|NCT01378104|76219678|FG001|Overall Study|Adverse Event|8|||
42366354|NCT01378104|76219677|FG000|Overall Study|Lack of Efficacy|7|||
42366355|NCT01378104|76219678|FG001|Overall Study|Lack of Efficacy|5|||
42366356|NCT01378104|76219677|FG000|Overall Study|Withdrawal by Subject|12|||
42366357|NCT01378104|76219678|FG001|Overall Study|Withdrawal by Subject|13|||
42366358|NCT01379274|76219719|FG000|Overall Study|funding withdrawn|1|||
42366359|NCT00634569|76219920|FG000|Overall Study|Withdrawal by Subject|0|||
42366360|NCT00634569|76219921|FG001|Overall Study|Withdrawal by Subject|4|||
42366361|NCT00634569|76219920|FG000|Overall Study|Physician Decision|0|||
42366362|NCT00634569|76219921|FG001|Overall Study|Physician Decision|1|||
42366363|NCT00634179|76219966|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
42366364|NCT03877926|76220041|FG000|Overall Study|Adverse Event|1|||
42366365|NCT03877926|76220042|FG001|Overall Study|Adverse Event|0|||
42366366|NCT03877926|76220043|FG002|Overall Study|Adverse Event|0|||
42366367|NCT03877926|76220044|FG003|Overall Study|Adverse Event|0|||
42366368|NCT03877926|76220041|FG000|Overall Study|Death|2|||
42366369|NCT03877926|76220042|FG001|Overall Study|Death|2|||
42366370|NCT03877926|76220043|FG002|Overall Study|Death|2|||
42366371|NCT03877926|76220044|FG003|Overall Study|Death|0|||
42366372|NCT03877926|76220041|FG000|Overall Study|Lost to Follow-up|41|||
42366373|NCT03877926|76220042|FG001|Overall Study|Lost to Follow-up|52|||
42366374|NCT03877926|76220043|FG002|Overall Study|Lost to Follow-up|45|||
42366375|NCT03877926|76220044|FG003|Overall Study|Lost to Follow-up|17|||
42366376|NCT03877926|76220041|FG000|Overall Study|Physician Decision|2|||
42366377|NCT03877926|76220042|FG001|Overall Study|Physician Decision|0|||
42366378|NCT03877926|76220043|FG002|Overall Study|Physician Decision|2|||
42366379|NCT03877926|76220044|FG003|Overall Study|Physician Decision|0|||
42366380|NCT03877926|76220041|FG000|Overall Study|Withdrawal by Subject|18|||
42366381|NCT03877926|76220042|FG001|Overall Study|Withdrawal by Subject|21|||
42366382|NCT03877926|76220043|FG002|Overall Study|Withdrawal by Subject|12|||
42366383|NCT03877926|76220044|FG003|Overall Study|Withdrawal by Subject|4|||
42366384|NCT03877926|76220041|FG000|Overall Study|Other - Various|4|||
42366385|NCT03877926|76220042|FG001|Overall Study|Other - Various|1|||
42366386|NCT03877926|76220043|FG002|Overall Study|Other - Various|1|||
42366387|NCT03877926|76220044|FG003|Overall Study|Other - Various|0|||
42366388|NCT03877926|76220041|FG000|Overall Study|Not Treated|3|||
42366389|NCT03877926|76220042|FG001|Overall Study|Not Treated|1|||
42366390|NCT03877926|76220043|FG002|Overall Study|Not Treated|1|||
42366391|NCT03877926|76220044|FG003|Overall Study|Not Treated|0|||
42366392|NCT02874144|76220256|FG000|Overall Study|Lost to Follow-up|3|||
42101069|NCT00368641|75911797|FG000|Overall Study|Sponsor decision to terminate study|2|||
42366393|NCT02874144|76220257|FG001|Overall Study|Lost to Follow-up|5|||
42366394|NCT02611830|76220287|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
42366395|NCT02611830|76220288|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
42366396|NCT02611830|76220289|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
42366397|NCT02611830|76220290|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
42101070|NCT00368641|75911798|FG001|Overall Study|Sponsor decision to terminate study|5|||
42101071|NCT00608985|75911808|FG000|Overall Study|Adverse Event|2|||
42101072|NCT00608985|75911809|FG001|Overall Study|Adverse Event|7|||
42101073|NCT00608985|75911810|FG002|Overall Study|Adverse Event|4|||
42101074|NCT00608985|75911811|FG003|Overall Study|Adverse Event|6|||
42101075|NCT00608985|75911808|FG000|Overall Study|Administrative/Other|7|||
42101076|NCT00608985|75911809|FG001|Overall Study|Administrative/Other|4|||
42101077|NCT00608985|75911810|FG002|Overall Study|Administrative/Other|1|||
42101078|NCT00608985|75911811|FG003|Overall Study|Administrative/Other|2|||
42101079|NCT00608985|75911808|FG000|Overall Study|Withdrawal of Consent|5|||
42101080|NCT00608985|75911809|FG001|Overall Study|Withdrawal of Consent|1|||
42101081|NCT00608985|75911810|FG002|Overall Study|Withdrawal of Consent|1|||
42101082|NCT00608985|75911811|FG003|Overall Study|Withdrawal of Consent|1|||
42101083|NCT00608985|75911808|FG000|Overall Study|Lost to Follow-up|2|||
42101084|NCT00608985|75911809|FG001|Overall Study|Lost to Follow-up|1|||
42101085|NCT00608985|75911810|FG002|Overall Study|Lost to Follow-up|0|||
42101086|NCT00608985|75911811|FG003|Overall Study|Lost to Follow-up|0|||
42101087|NCT00368251|75911824|FG000|Overall Study|SAE, non-fatal|1|||
42101088|NCT00368251|75911825|FG001|Overall Study|SAE, non-fatal|0|||
42101089|NCT00368251|75911826|FG002|Overall Study|SAE, non-fatal|0|||
42101090|NCT00368251|75911824|FG000|Overall Study|AE, non-serious non-fatal|0|||
42101091|NCT00368251|75911825|FG001|Overall Study|AE, non-serious non-fatal|0|||
42101092|NCT00368251|75911826|FG002|Overall Study|AE, non-serious non-fatal|1|||
42101093|NCT00378079|75911837|FG000|Overall Study|Lost to Follow-up|6|||
42101094|NCT00378079|75911838|FG001|Overall Study|Lost to Follow-up|1|||
42101095|NCT00378079|75911839|FG002|Overall Study|Lost to Follow-up|0|||
42101096|NCT03936244|75911849|FG000|Overall Study|Lost to Follow-up|5|||
42101097|NCT03936244|75911850|FG001|Overall Study|Lost to Follow-up|1|||
42101098|NCT03936244|75911849|FG000|Overall Study|Physician Decision|7|||
42101099|NCT03936244|75911850|FG001|Overall Study|Physician Decision|3|||
42101100|NCT03923530|75911857|FG000|Overall Study|Withdrawal by Subject|1|||
42101101|NCT03923530|75911857|FG000|Overall Study|screen failure|3|||
42101102|NCT00608907|75911864|FG000|Overall Study|Adverse Event|6|||
42101103|NCT00608907|75911865|FG001|Overall Study|Adverse Event|0|||
42101104|NCT00608907|75911866|FG002|Overall Study|Adverse Event|1|||
42101105|NCT00608907|75911864|FG000|Overall Study|Death|1|||
42101106|NCT00608907|75911865|FG001|Overall Study|Death|0|||
42101107|NCT00608907|75911866|FG002|Overall Study|Death|0|||
42101108|NCT00608907|75911864|FG000|Overall Study|Withdrawal by Subject|4|||
42101109|NCT00608907|75911865|FG001|Overall Study|Withdrawal by Subject|0|||
42101110|NCT00608907|75911866|FG002|Overall Study|Withdrawal by Subject|0|||
42101111|NCT00608907|75911864|FG000|Overall Study|Progressive Disease|1|||
42101112|NCT00608907|75911865|FG001|Overall Study|Progressive Disease|0|||
42101113|NCT00608907|75911866|FG002|Overall Study|Progressive Disease|0|||
42101114|NCT00377611|75911876|FG000|Overall Study|Adverse Event|2|||
42101115|NCT00377611|75911877|FG001|Overall Study|Adverse Event|9|||
42101116|NCT00377611|75911876|FG000|Overall Study|Protocol Violation|2|||
42101117|NCT00377611|75911877|FG001|Overall Study|Protocol Violation|0|||
42101118|NCT00377611|75911876|FG000|Overall Study|Withdrawal by Subject|0|||
42101119|NCT00377611|75911877|FG001|Overall Study|Withdrawal by Subject|5|||
42101120|NCT00377611|75911876|FG000|Overall Study|Lost to Follow-up|18|||
42101121|NCT00377611|75911877|FG001|Overall Study|Lost to Follow-up|16|||
42366398|NCT02611830|76220287|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
42366399|NCT02611830|76220288|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
42366400|NCT02611830|76220289|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
42366401|NCT02611830|76220290|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
42366402|NCT02611830|76220287|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
42366403|NCT02611830|76220288|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
42366404|NCT02611830|76220289|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
42101122|NCT00377611|75911876|FG000|Overall Study|Other|0|||
42101123|NCT00377611|75911877|FG001|Overall Study|Other|3|||
42101124|NCT00545272|75911890|FG000|Overall Study|Protocol deviation|0|||
42101125|NCT00545272|75911891|FG001|Overall Study|Protocol deviation|1|||
42366405|NCT02611830|76220290|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
42101126|NCT00545272|75911892|FG002|Overall Study|Protocol deviation|0|||
42101127|NCT00545272|75911893|FG003|Overall Study|Protocol deviation|1|||
42101128|NCT00545272|75911894|FG004|Overall Study|Protocol deviation|0|||
42101129|NCT00545272|75911895|FG005|Overall Study|Protocol deviation|1|||
42101130|NCT00545272|75911890|FG000|Overall Study|Adverse Event|0|||
42101131|NCT00545272|75911891|FG001|Overall Study|Adverse Event|0|||
42101132|NCT00545272|75911892|FG002|Overall Study|Adverse Event|1|||
42101133|NCT00545272|75911893|FG003|Overall Study|Adverse Event|0|||
42101134|NCT00545272|75911894|FG004|Overall Study|Adverse Event|0|||
42101135|NCT00545272|75911895|FG005|Overall Study|Adverse Event|1|||
42366406|NCT02611830|76220287|FG000|OL Induction Phase|Lack of Efficacy|9|||
42366407|NCT02611830|76220288|FG001|OL Induction Phase|Lack of Efficacy|0|||
42366408|NCT02611830|76220289|FG002|OL Induction Phase|Lack of Efficacy|0|||
42366409|NCT02611830|76220290|FG003|OL Induction Phase|Lack of Efficacy|0|||
42366410|NCT02611830|76220287|FG000|OL Induction Phase|Reason not specified|3|||
42366411|NCT02611830|76220288|FG001|OL Induction Phase|Reason not specified|0|||
42366412|NCT02611830|76220289|FG002|OL Induction Phase|Reason not specified|0|||
42366413|NCT02611830|76220290|FG003|OL Induction Phase|Reason not specified|0|||
42366414|NCT02611830|76220287|FG000|Maintenance Phase|Lack of Efficacy|0|||
42366415|NCT02611830|76220288|FG001|Maintenance Phase|Lack of Efficacy|29|||
42366416|NCT02611830|76220289|FG002|Maintenance Phase|Lack of Efficacy|18|||
42366417|NCT02611830|76220290|FG003|Maintenance Phase|Lack of Efficacy|6|||
42366418|NCT02611830|76220287|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
42366419|NCT02611830|76220288|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
42366420|NCT02611830|76220289|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
42366421|NCT02611830|76220290|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
42366422|NCT02611830|76220287|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
42366423|NCT02611830|76220288|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
42366424|NCT02611830|76220289|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
42366425|NCT02611830|76220290|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
42366426|NCT02611830|76220287|FG000|Maintenance Phase|Lost to Follow-up|0|||
42366427|NCT02611830|76220288|FG001|Maintenance Phase|Lost to Follow-up|0|||
42366428|NCT02611830|76220289|FG002|Maintenance Phase|Lost to Follow-up|0|||
42366429|NCT02611830|76220290|FG003|Maintenance Phase|Lost to Follow-up|1|||
42366430|NCT02611830|76220287|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
42366431|NCT02611830|76220288|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
42366432|NCT02611830|76220289|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
42366433|NCT02611830|76220290|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
42366434|NCT02611830|76220287|FG000|Maintenance Phase|Pregnancy|0|||
42366435|NCT02611830|76220288|FG001|Maintenance Phase|Pregnancy|0|||
42366436|NCT02611830|76220289|FG002|Maintenance Phase|Pregnancy|1|||
42366437|NCT02611830|76220290|FG003|Maintenance Phase|Pregnancy|0|||
42366438|NCT02611830|76220287|FG000|Maintenance Phase|Reason not specified|0|||
42366439|NCT02611830|76220288|FG001|Maintenance Phase|Reason not specified|1|||
42366440|NCT02611830|76220289|FG002|Maintenance Phase|Reason not specified|4|||
42366441|NCT02611830|76220290|FG003|Maintenance Phase|Reason not specified|0|||
42366442|NCT01328574|76220476|FG000|Overall Study|Refused further treatment|1|||
42366443|NCT01328496|76220598|FG000|Overall Study|Significant Change in Health Status|1|||
42366444|NCT01328496|76220599|FG001|Overall Study|Significant Change in Health Status|0|||
42366445|NCT02734212|76220719|FG000|Overall Study|Lost to Follow-up|5|||
42366446|NCT02734212|76220720|FG001|Overall Study|Lost to Follow-up|10|||
42366447|NCT03786432|76220766|FG000|Overall Study|Screen Failure after consent|1|||
42366448|NCT03786432|76220766|FG000|Overall Study|Lost to Follow-up|4|||
42366449|NCT03786432|76220766|FG000|Overall Study|did not complete 12 month CT scan|1|||
42366450|NCT04604184|76220802|FG000|Overall Study|Adverse Event|5|||
42366451|NCT04604184|76220803|FG001|Overall Study|Adverse Event|5|||
42366452|NCT04604184|76220802|FG000|Overall Study|Death|2|||
42366453|NCT04604184|76220803|FG001|Overall Study|Death|1|||
42366454|NCT04604184|76220802|FG000|Overall Study|Withdrawal by Subject|1|||
42366455|NCT04604184|76220803|FG001|Overall Study|Withdrawal by Subject|3|||
42366456|NCT04604184|76220802|FG000|Overall Study|Not treated|2|||
42366457|NCT04604184|76220803|FG001|Overall Study|Not treated|2|||
42366458|NCT04604184|76220802|FG000|Overall Study|Due to sponsor decision|9|||
42366459|NCT04604184|76220803|FG001|Overall Study|Due to sponsor decision|7|||
42366460|NCT04604184|76220802|FG000|Overall Study|Physician Decision|0|||
42366461|NCT04604184|76220803|FG001|Overall Study|Physician Decision|1|||
42366462|NCT04604184|76220802|FG000|Overall Study|Transfer to healthcare|1|||
42366463|NCT04604184|76220803|FG001|Overall Study|Transfer to healthcare|0|||
42366464|NCT01859741|76220974|FG000|Overall Study|Death|3|||
42366465|NCT01859741|76220975|FG001|Overall Study|Death|2|||
42366466|NCT01859741|76220976|FG002|Overall Study|Death|4|||
42366467|NCT01859741|76220977|FG003|Overall Study|Death|3|||
42366468|NCT01859741|76220978|FG004|Overall Study|Death|5|||
42366469|NCT01859741|76220979|FG005|Overall Study|Death|4|||
42366470|NCT01859741|76220980|FG006|Overall Study|Death|51|||
42366471|NCT01859741|76220981|FG007|Overall Study|Death|51|||
42366472|NCT01859741|76220974|FG000|Overall Study|Lost to Follow-up|0|||
42366473|NCT01859741|76220975|FG001|Overall Study|Lost to Follow-up|0|||
42366474|NCT01859741|76220976|FG002|Overall Study|Lost to Follow-up|0|||
42366475|NCT01859741|76220977|FG003|Overall Study|Lost to Follow-up|0|||
42366476|NCT01859741|76220978|FG004|Overall Study|Lost to Follow-up|0|||
42366477|NCT01859741|76220979|FG005|Overall Study|Lost to Follow-up|1|||
42366478|NCT01859741|76220980|FG006|Overall Study|Lost to Follow-up|0|||
42366479|NCT01859741|76220981|FG007|Overall Study|Lost to Follow-up|4|||
42366480|NCT01859741|76220974|FG000|Overall Study|Withdrawal by Subject|0|||
42366481|NCT01859741|76220975|FG001|Overall Study|Withdrawal by Subject|1|||
42366482|NCT01859741|76220976|FG002|Overall Study|Withdrawal by Subject|2|||
42366483|NCT01859741|76220977|FG003|Overall Study|Withdrawal by Subject|0|||
42366484|NCT01859741|76220978|FG004|Overall Study|Withdrawal by Subject|0|||
42366485|NCT01859741|76220979|FG005|Overall Study|Withdrawal by Subject|1|||
42366486|NCT01859741|76220980|FG006|Overall Study|Withdrawal by Subject|1|||
42366487|NCT01859741|76220981|FG007|Overall Study|Withdrawal by Subject|1|||
42366488|NCT01859741|76220974|FG000|Overall Study|Study Terminated by Sponsor|0|||
42366489|NCT01859741|76220975|FG001|Overall Study|Study Terminated by Sponsor|0|||
42366490|NCT01859741|76220976|FG002|Overall Study|Study Terminated by Sponsor|0|||
42366491|NCT01859741|76220977|FG003|Overall Study|Study Terminated by Sponsor|0|||
42366492|NCT01859741|76220978|FG004|Overall Study|Study Terminated by Sponsor|1|||
42366493|NCT01859741|76220979|FG005|Overall Study|Study Terminated by Sponsor|0|||
42366494|NCT01859741|76220980|FG006|Overall Study|Study Terminated by Sponsor|16|||
42366495|NCT01859741|76220981|FG007|Overall Study|Study Terminated by Sponsor|14|||
42366496|NCT01859741|76220974|FG000|Overall Study|Other|0|||
42366497|NCT01859741|76220975|FG001|Overall Study|Other|0|||
42366498|NCT01859741|76220976|FG002|Overall Study|Other|0|||
42366499|NCT01859741|76220977|FG003|Overall Study|Other|0|||
42366500|NCT01859741|76220978|FG004|Overall Study|Other|0|||
42366501|NCT01859741|76220979|FG005|Overall Study|Other|0|||
42366502|NCT01859741|76220980|FG006|Overall Study|Other|2|||
42366503|NCT01859741|76220981|FG007|Overall Study|Other|0|||
42366504|NCT01859507|76221027|FG000|Overall Study|left the country|4|||
42366505|NCT01876043|76221032|FG000|Overall Study|Death|1|||
42366506|NCT01876043|76221032|FG000|Overall Study|Withdrawal by Subject|1|||
42366507|NCT01875731|76221038|FG000|Overall Study|Fail to obtain lab sample|1|||
42366508|NCT01875731|76221039|FG001|Overall Study|Fail to obtain lab sample|0|||
42366509|NCT01873859|76221047|FG000|Overall Study|Withdrawal by Subject|0|||
42366510|NCT01873859|76221048|FG001|Overall Study|Withdrawal by Subject|4|||
42366511|NCT01857869|76221065|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
42366512|NCT01857869|76221066|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
42366513|NCT01857869|76221067|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
42366514|NCT01857869|76221068|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
42366515|NCT01857869|76221069|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
42366516|NCT01857869|76221070|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
42366517|NCT01857869|76221071|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
42366518|NCT01857869|76221072|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
42366519|NCT01857869|76221073|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
42366520|NCT01857869|76221074|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
42366521|NCT01857869|76221065|FG000|Primary/Challenge Phase|Pregnancy|1|||
42366522|NCT01857869|76221066|FG001|Primary/Challenge Phase|Pregnancy|0|||
42366523|NCT01857869|76221067|FG002|Primary/Challenge Phase|Pregnancy|0|||
42366524|NCT01857869|76221068|FG003|Primary/Challenge Phase|Pregnancy|0|||
42366525|NCT01857869|76221069|FG004|Primary/Challenge Phase|Pregnancy|0|||
42366526|NCT01857869|76221070|FG005|Primary/Challenge Phase|Pregnancy|0|||
42366527|NCT01857869|76221071|FG006|Primary/Challenge Phase|Pregnancy|0|||
42366528|NCT01857869|76221072|FG007|Primary/Challenge Phase|Pregnancy|0|||
42366529|NCT01857869|76221073|FG008|Primary/Challenge Phase|Pregnancy|0|||
42366530|NCT01857869|76221074|FG009|Primary/Challenge Phase|Pregnancy|0|||
42366531|NCT01857869|76221065|FG000|Primary/Challenge Phase|Protocol Violation|1|||
42366532|NCT01857869|76221066|FG001|Primary/Challenge Phase|Protocol Violation|0|||
42366533|NCT01857869|76221067|FG002|Primary/Challenge Phase|Protocol Violation|0|||
42366534|NCT01857869|76221068|FG003|Primary/Challenge Phase|Protocol Violation|0|||
42366535|NCT01857869|76221069|FG004|Primary/Challenge Phase|Protocol Violation|0|||
42366536|NCT01857869|76221070|FG005|Primary/Challenge Phase|Protocol Violation|0|||
42366537|NCT01857869|76221071|FG006|Primary/Challenge Phase|Protocol Violation|0|||
42366538|NCT01857869|76221072|FG007|Primary/Challenge Phase|Protocol Violation|0|||
42366539|NCT01857869|76221073|FG008|Primary/Challenge Phase|Protocol Violation|0|||
42366540|NCT01857869|76221074|FG009|Primary/Challenge Phase|Protocol Violation|0|||
42366541|NCT01857869|76221065|FG000|Primary/Challenge Phase|Other|1|||
42366542|NCT01857869|76221066|FG001|Primary/Challenge Phase|Other|1|||
42366543|NCT01857869|76221067|FG002|Primary/Challenge Phase|Other|0|||
42366544|NCT01857869|76221068|FG003|Primary/Challenge Phase|Other|0|||
42366545|NCT01857869|76221069|FG004|Primary/Challenge Phase|Other|0|||
42366546|NCT01857869|76221070|FG005|Primary/Challenge Phase|Other|0|||
42366547|NCT01857869|76221071|FG006|Primary/Challenge Phase|Other|0|||
42366548|NCT01857869|76221072|FG007|Primary/Challenge Phase|Other|0|||
42366549|NCT01857869|76221073|FG008|Primary/Challenge Phase|Other|0|||
42366550|NCT01857869|76221074|FG009|Primary/Challenge Phase|Other|0|||
42366551|NCT01857869|76221065|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
42366552|NCT01857869|76221066|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
42366553|NCT01857869|76221067|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
42366554|NCT01857869|76221068|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
42366555|NCT01857869|76221069|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
42366556|NCT01857869|76221070|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
42366557|NCT01857869|76221071|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
42366558|NCT01857869|76221072|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
42366559|NCT01857869|76221073|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
42366560|NCT01857869|76221074|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
42366561|NCT01857869|76221065|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
42366562|NCT01857869|76221066|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
42366563|NCT01857869|76221067|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
42366564|NCT01857869|76221068|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
42366565|NCT01857869|76221069|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
42366566|NCT01857869|76221070|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
42366567|NCT01857869|76221071|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
42366568|NCT01857869|76221072|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
42366569|NCT01857869|76221073|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
42366570|NCT01857869|76221074|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
42366571|NCT04452318|76221162|FG000|Overall Study|Physician Decision|1|||
42366572|NCT04452318|76221163|FG001|Overall Study|Physician Decision|2|||
42366573|NCT04452318|76221164|FG002|Overall Study|Physician Decision|0|||
42366574|NCT04452318|76221165|FG003|Overall Study|Physician Decision|2|||
42366575|NCT04452318|76221166|FG004|Overall Study|Physician Decision|0|||
42366576|NCT04452318|76221167|FG005|Overall Study|Physician Decision|2|||
42366577|NCT04452318|76221168|FG006|Overall Study|Physician Decision|5|||
42366578|NCT04452318|76221162|FG000|Overall Study|Death|2|||
42366579|NCT04452318|76221163|FG001|Overall Study|Death|3|||
42366580|NCT04452318|76221164|FG002|Overall Study|Death|0|||
42366581|NCT04452318|76221165|FG003|Overall Study|Death|0|||
42366582|NCT04452318|76221166|FG004|Overall Study|Death|0|||
42366583|NCT04452318|76221167|FG005|Overall Study|Death|0|||
42366584|NCT04452318|76221168|FG006|Overall Study|Death|0|||
42366585|NCT04452318|76221162|FG000|Overall Study|Lost to Follow-up|38|||
42366586|NCT04452318|76221163|FG001|Overall Study|Lost to Follow-up|28|||
42366587|NCT04452318|76221164|FG002|Overall Study|Lost to Follow-up|0|||
42366588|NCT04452318|76221165|FG003|Overall Study|Lost to Follow-up|3|||
42366589|NCT04452318|76221166|FG004|Overall Study|Lost to Follow-up|3|||
42366590|NCT04452318|76221167|FG005|Overall Study|Lost to Follow-up|2|||
42366591|NCT04452318|76221168|FG006|Overall Study|Lost to Follow-up|1|||
42366592|NCT04452318|76221162|FG000|Overall Study|Withdrawal by Subject|46|||
42366593|NCT04452318|76221163|FG001|Overall Study|Withdrawal by Subject|40|||
42366594|NCT04452318|76221164|FG002|Overall Study|Withdrawal by Subject|0|||
42366595|NCT04452318|76221165|FG003|Overall Study|Withdrawal by Subject|18|||
42366596|NCT04452318|76221166|FG004|Overall Study|Withdrawal by Subject|6|||
42366597|NCT04452318|76221167|FG005|Overall Study|Withdrawal by Subject|8|||
42366598|NCT04452318|76221168|FG006|Overall Study|Withdrawal by Subject|6|||
42366599|NCT00634101|76221345|FG000|Overall Study|Study Terminated|3|||
42366600|NCT00634101|76221346|FG001|Overall Study|Study Terminated|3|||
42366601|NCT00634101|76221345|FG000|Overall Study|Lost to Follow-up|2|||
42366602|NCT00634101|76221346|FG001|Overall Study|Lost to Follow-up|0|||
42366603|NCT00633477|76221363|FG000|Overall Study|Death|1|||
42366604|NCT00633477|76221364|FG001|Overall Study|Death|0|||
42366605|NCT00633477|76221363|FG000|Overall Study|Randomized but not treated|1|||
42366606|NCT00633477|76221364|FG001|Overall Study|Randomized but not treated|0|||
42366607|NCT00331773|76221389|FG000|Overall Study|Withdrawal by Subject|6|||
42366608|NCT00331773|76221390|FG001|Overall Study|Withdrawal by Subject|4|||
42366609|NCT00331773|76221389|FG000|Overall Study|Protocol Violation|10|||
42366610|NCT00331773|76221390|FG001|Overall Study|Protocol Violation|3|||
42018534|NCT00996892|75825876|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
42366611|NCT00633243|76221423|FG000|Overall Study|Withdrawal by Subject|0|||
42366612|NCT00633243|76221424|FG001|Overall Study|Withdrawal by Subject|1|||
42366613|NCT00633243|76221423|FG000|Overall Study|incarceration|0|||
42366614|NCT00633243|76221424|FG001|Overall Study|incarceration|2|||
42366615|NCT00633243|76221423|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
42018535|NCT00996892|75825877|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
42366616|NCT00633243|76221424|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
42366617|NCT00633243|76221423|FG000|Overall Study|Not comfortable with self-injecting|0|||
42366618|NCT00633243|76221424|FG001|Overall Study|Not comfortable with self-injecting|1|||
42366619|NCT00633243|76221423|FG000|Overall Study|Mental Health--Depression|0|||
42366620|NCT00633243|76221424|FG001|Overall Study|Mental Health--Depression|1|||
42366621|NCT00633243|76221423|FG000|Overall Study|Couldn't tolerate side-effects|1|||
42366622|NCT00633243|76221424|FG001|Overall Study|Couldn't tolerate side-effects|1|||
42366623|NCT01872689|76221434|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
42366624|NCT01872689|76221435|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
42366625|NCT01872689|76221436|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
42366626|NCT01872689|76221437|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
42366627|NCT01872689|76221434|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
42366628|NCT01872689|76221435|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
42366629|NCT01872689|76221436|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
42366630|NCT01872689|76221437|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
42366631|NCT01872689|76221434|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
42366632|NCT01872689|76221435|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
42366633|NCT01872689|76221436|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
42366634|NCT01872689|76221437|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
42366635|NCT01872689|76221434|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
42366636|NCT01872689|76221435|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
42366637|NCT01872689|76221436|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
42366638|NCT01872689|76221437|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
42366639|NCT01872689|76221434|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
42366640|NCT01872689|76221435|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
42366641|NCT01872689|76221436|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
42366642|NCT01872689|76221437|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
42366643|NCT01872689|76221434|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
42366644|NCT01872689|76221435|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
42366645|NCT01872689|76221436|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
42366646|NCT01872689|76221437|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
42366647|NCT01872689|76221434|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
42366648|NCT01872689|76221435|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
42366649|NCT01872689|76221436|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
42018536|NCT00996892|75825878|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
42018537|NCT00996892|75825879|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
42018538|NCT00996892|75825880|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
42018539|NCT00996892|75825861|FG000|Expansion Stage 2A|Disease Progression|0|||
42366650|NCT01872689|76221437|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
42366651|NCT01872689|76221434|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
42366652|NCT01872689|76221435|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
42366653|NCT01872689|76221436|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
42366654|NCT01872689|76221437|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
42366655|NCT01872689|76221434|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
42366656|NCT01872689|76221435|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
42366657|NCT01872689|76221436|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
42366658|NCT01872689|76221437|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
42366659|NCT01872689|76221434|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
42366660|NCT01872689|76221435|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
42366661|NCT01872689|76221436|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
42366662|NCT01872689|76221437|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
42366663|NCT01872689|76221434|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
42366664|NCT01872689|76221435|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
42366665|NCT01872689|76221436|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
42366666|NCT01872689|76221437|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
42366667|NCT01872689|76221434|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
42366668|NCT01872689|76221435|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
42366669|NCT01872689|76221436|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
42366670|NCT01872689|76221437|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
42366671|NCT01872689|76221434|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
42366672|NCT01872689|76221435|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
42366673|NCT01872689|76221436|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
42366674|NCT01872689|76221437|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
42366675|NCT01872689|76221434|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
42366676|NCT01872689|76221435|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
42366677|NCT01872689|76221436|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
42366678|NCT01872689|76221437|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
42366679|NCT00632931|76221450|FG000|Part 1, Period 1|Protocol Violation|1|||
42366680|NCT00632931|76221451|FG001|Part 1, Period 1|Protocol Violation|0|||
42366681|NCT00632931|76221452|FG002|Part 1, Period 1|Protocol Violation|0|||
42366682|NCT00632931|76221450|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
42366683|NCT00632931|76221451|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
42366684|NCT00632931|76221452|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
42366685|NCT00632931|76221450|FG000|Part 2|Adverse Event|0|||
42366686|NCT00632931|76221451|FG001|Part 2|Adverse Event|0|||
42366687|NCT00632931|76221452|FG002|Part 2|Adverse Event|3|||
42366688|NCT00632931|76221450|FG000|Part 2|Death|0|||
42366689|NCT00632931|76221451|FG001|Part 2|Death|0|||
42366690|NCT00632931|76221452|FG002|Part 2|Death|1|||
42366691|NCT00632931|76221450|FG000|Part 2|Lack of Efficacy|0|||
42366692|NCT00632931|76221451|FG001|Part 2|Lack of Efficacy|0|||
42366693|NCT00632931|76221452|FG002|Part 2|Lack of Efficacy|17|||
42366694|NCT00632931|76221450|FG000|Part 2|Withdrawal by Subject|0|||
42366695|NCT00632931|76221451|FG001|Part 2|Withdrawal by Subject|0|||
42366696|NCT00632931|76221452|FG002|Part 2|Withdrawal by Subject|3|||
42366697|NCT01857323|76221457|FG000|Overall Study|Adverse Event|1|||
42366698|NCT01857323|76221457|FG000|Overall Study|Withdrawal by Subject|3|||
42366699|NCT01857323|76221457|FG000|Overall Study|Non-compliance|1|||
42366700|NCT01857323|76221457|FG000|Overall Study|Protocol Violation|6|||
42101136|NCT00545272|75911890|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42101137|NCT00545272|75911891|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42101138|NCT00545272|75911892|FG002|Overall Study|Abnormal laboratory value(s)|0|||
42366701|NCT01857323|76221457|FG000|Overall Study|Lost to Follow-up|1|||
42366702|NCT01857323|76221457|FG000|Overall Study|Other|4|||
42366703|NCT01857323|76221457|FG000|Overall Study|Did not complete 180 doses|48|||
42366704|NCT00632541|76221461|FG000|Overall Study|Adverse Event|7|||
42366705|NCT01872611|76221467|FG000|Overall Study|Adverse Event|3|||
42366706|NCT01872611|76221468|FG001|Overall Study|Adverse Event|1|||
42366707|NCT01872611|76221467|FG000|Overall Study|Adverse Event, prior to treatment|0|||
42366708|NCT01872611|76221468|FG001|Overall Study|Adverse Event, prior to treatment|1|||
42366709|NCT01872611|76221467|FG000|Overall Study|Death|0|||
42366710|NCT01872611|76221468|FG001|Overall Study|Death|1|||
42366711|NCT01872611|76221467|FG000|Overall Study|Death, prior to treatment|0|||
42366712|NCT01872611|76221468|FG001|Overall Study|Death, prior to treatment|1|||
42366713|NCT01872611|76221467|FG000|Overall Study|Lost to Follow-up|8|||
42101139|NCT00545272|75911893|FG003|Overall Study|Abnormal laboratory value(s)|0|||
42101140|NCT00545272|75911894|FG004|Overall Study|Abnormal laboratory value(s)|0|||
42101141|NCT00545272|75911895|FG005|Overall Study|Abnormal laboratory value(s)|1|||
42101142|NCT00545272|75911890|FG000|Overall Study|Abnormal test procedure result(s)|0|||
42101143|NCT00545272|75911891|FG001|Overall Study|Abnormal test procedure result(s)|0|||
42101144|NCT00545272|75911892|FG002|Overall Study|Abnormal test procedure result(s)|0|||
42101145|NCT00545272|75911893|FG003|Overall Study|Abnormal test procedure result(s)|0|||
42101146|NCT00545272|75911894|FG004|Overall Study|Abnormal test procedure result(s)|1|||
42101147|NCT00545272|75911895|FG005|Overall Study|Abnormal test procedure result(s)|0|||
42101148|NCT00545272|75911890|FG000|Overall Study|Lost to Follow-up|0|||
42101149|NCT00545272|75911891|FG001|Overall Study|Lost to Follow-up|0|||
42101150|NCT00545272|75911892|FG002|Overall Study|Lost to Follow-up|0|||
42101151|NCT00545272|75911893|FG003|Overall Study|Lost to Follow-up|0|||
42101152|NCT00545272|75911894|FG004|Overall Study|Lost to Follow-up|1|||
42101153|NCT00545272|75911895|FG005|Overall Study|Lost to Follow-up|0|||
42101154|NCT00377455|75911909|FG000|Overall Study|Withdrawal by Subject|1|||
42101155|NCT00377299|75911915|FG000|Overall Study|Lost to Follow-up|14|||
42101156|NCT00377299|75911916|FG001|Overall Study|Lost to Follow-up|19|||
42101157|NCT00377299|75911915|FG000|Overall Study|Adverse Event|0|||
42101158|NCT00377299|75911916|FG001|Overall Study|Adverse Event|1|||
42101159|NCT00377299|75911915|FG000|Overall Study|Withdrawal by Subject|5|||
42101160|NCT00377299|75911916|FG001|Overall Study|Withdrawal by Subject|4|||
42101161|NCT00376675|75911934|FG000|Overall Study|Withdrawal by Subject|9|||
42101162|NCT00376675|75911935|FG001|Overall Study|Withdrawal by Subject|2|||
42101163|NCT00376675|75911934|FG000|Overall Study|Adverse Event|10|||
42101164|NCT00376675|75911935|FG001|Overall Study|Adverse Event|5|||
42101165|NCT00376675|75911934|FG000|Overall Study|Other Reason|1|||
42101166|NCT00376675|75911935|FG001|Overall Study|Other Reason|7|||
42101167|NCT03931330|75911941|FG000|Overall Study|Physician Decision|1|||
42101168|NCT00367237|75911948|FG000|Overall Study|Adverse Event|7|||
42101169|NCT00367237|75911949|FG001|Overall Study|Adverse Event|2|||
42101170|NCT00367237|75911948|FG000|Overall Study|Lost to Follow-up|1|||
42101171|NCT00367237|75911949|FG001|Overall Study|Lost to Follow-up|0|||
42101172|NCT00367237|75911948|FG000|Overall Study|Withdrawal by Subject|0|||
42366714|NCT01872611|76221468|FG001|Overall Study|Lost to Follow-up|1|||
42366715|NCT01872611|76221467|FG000|Overall Study|Physician Decision|1|||
42366716|NCT01872611|76221468|FG001|Overall Study|Physician Decision|0|||
42366717|NCT01872611|76221467|FG000|Overall Study|Withdrawal by Subject|6|||
42366718|NCT01872611|76221468|FG001|Overall Study|Withdrawal by Subject|1|||
42101173|NCT00367237|75911949|FG001|Overall Study|Withdrawal by Subject|4|||
42366719|NCT01872611|76221467|FG000|Overall Study|Reason not provided|6|||
42366720|NCT01872611|76221468|FG001|Overall Study|Reason not provided|6|||
42366721|NCT03089853|76221478|FG000|Overall Study|Lost to Follow-up|2|||
42366722|NCT03089853|76221479|FG001|Overall Study|Lost to Follow-up|1|||
42366723|NCT03086967|76221487|FG000|Overall Study|Screen Failure|2|||
42366724|NCT03086967|76221488|FG001|Overall Study|Screen Failure|2|||
42366725|NCT01856543|76221496|FG000|Overall Study|Treatment discontinued|6|||
42366726|NCT01856543|76221497|FG001|Overall Study|Treatment discontinued|3|||
42101174|NCT00367237|75911948|FG000|Overall Study|Protocol Violation|2|||
42101175|NCT00367237|75911949|FG001|Overall Study|Protocol Violation|5|||
42366727|NCT01856543|76221496|FG000|Overall Study|Withdrawn before start|7|||
42366728|NCT01856543|76221497|FG001|Overall Study|Withdrawn before start|3|||
42366729|NCT00632463|76221507|FG000|Overall Study|Adverse Event|0|||
42366730|NCT00632463|76221508|FG001|Overall Study|Adverse Event|1|||
42366731|NCT00632463|76221509|FG002|Overall Study|Adverse Event|0|||
42366732|NCT00632229|76221519|FG000|Overall Study|Adverse Event|6|||
42366733|NCT00632229|76221520|FG001|Overall Study|Adverse Event|0|||
42366734|NCT00632229|76221519|FG000|Overall Study|Lost to Follow-up|0|||
42366735|NCT00632229|76221520|FG001|Overall Study|Lost to Follow-up|3|||
42366736|NCT00632229|76221519|FG000|Overall Study|Lack of Efficacy|0|||
42366737|NCT00632229|76221520|FG001|Overall Study|Lack of Efficacy|2|||
42366738|NCT00632229|76221519|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
42366739|NCT00632229|76221520|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
42366740|NCT00631137|76221528|FG000|Overall Study|Withdrawal by Subject|1|||
42366741|NCT00631137|76221529|FG001|Overall Study|Withdrawal by Subject|0|||
42366742|NCT00630825|76221548|FG000|Overall Study|Adverse Event|4|||
42366743|NCT00630825|76221549|FG001|Overall Study|Adverse Event|4|||
42366744|NCT00630825|76221550|FG002|Overall Study|Adverse Event|3|||
42366745|NCT00630825|76221551|FG003|Overall Study|Adverse Event|1|||
42366746|NCT00630825|76221548|FG000|Overall Study|Entry Criteria Not Met|1|||
42366747|NCT00630825|76221549|FG001|Overall Study|Entry Criteria Not Met|0|||
42366748|NCT00630825|76221550|FG002|Overall Study|Entry Criteria Not Met|2|||
42366749|NCT00630825|76221551|FG003|Overall Study|Entry Criteria Not Met|1|||
42366750|NCT00630825|76221548|FG000|Overall Study|Lost to Follow-up|1|||
42366751|NCT00630825|76221549|FG001|Overall Study|Lost to Follow-up|1|||
42366752|NCT00630825|76221550|FG002|Overall Study|Lost to Follow-up|1|||
42366753|NCT00630825|76221551|FG003|Overall Study|Lost to Follow-up|1|||
42366754|NCT00630825|76221548|FG000|Overall Study|Physician Decision|1|||
42366755|NCT00630825|76221549|FG001|Overall Study|Physician Decision|0|||
42366756|NCT00630825|76221550|FG002|Overall Study|Physician Decision|0|||
42366757|NCT00630825|76221551|FG003|Overall Study|Physician Decision|0|||
42366758|NCT00630825|76221548|FG000|Overall Study|Withdrawal by Subject|2|||
42366759|NCT00630825|76221549|FG001|Overall Study|Withdrawal by Subject|2|||
42366760|NCT00630825|76221550|FG002|Overall Study|Withdrawal by Subject|2|||
42366761|NCT00630825|76221551|FG003|Overall Study|Withdrawal by Subject|3|||
42366762|NCT04075734|76221848|FG000|Overall Study|Lost to Follow-up|1|||
42366763|NCT04075734|76221849|FG001|Overall Study|Lost to Follow-up|1|||
42366764|NCT04075734|76221850|FG002|Overall Study|Lost to Follow-up|0|||
42366765|NCT04075734|76221848|FG000|Overall Study|Withdrawal by Subject|3|||
42366766|NCT04075734|76221849|FG001|Overall Study|Withdrawal by Subject|0|||
42366767|NCT04075734|76221850|FG002|Overall Study|Withdrawal by Subject|0|||
42366768|NCT00989781|76221895|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
42366769|NCT00989781|76221896|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
42366770|NCT00989235|76221937|FG000|Overall Study|Death|0|||
42366771|NCT00989235|76221938|FG001|Overall Study|Death|1|||
42366772|NCT00989235|76221937|FG000|Overall Study|Adverse Event|0|||
42366773|NCT00989235|76221938|FG001|Overall Study|Adverse Event|1|||
42366774|NCT00989235|76221937|FG000|Overall Study|Lack of Efficacy|1|||
42366775|NCT00989235|76221938|FG001|Overall Study|Lack of Efficacy|0|||
42366776|NCT00989235|76221937|FG000|Overall Study|Withdrawal of Consent|1|||
42366777|NCT00989235|76221938|FG001|Overall Study|Withdrawal of Consent|1|||
42366778|NCT00989235|76221937|FG000|Overall Study|Desire to Become Pregnant|1|||
42366779|NCT00989235|76221938|FG001|Overall Study|Desire to Become Pregnant|0|||
42366780|NCT00989235|76221937|FG000|Overall Study|Randomized by Mistake|0|||
42366781|NCT00989235|76221938|FG001|Overall Study|Randomized by Mistake|2|||
42366782|NCT00989235|76221937|FG000|Overall Study|Lost to Follow-up|0|||
42366783|NCT00989235|76221938|FG001|Overall Study|Lost to Follow-up|1|||
42366784|NCT04969198|76221958|FG000|Overall Study|Withdrawal by Subject|20|||
42366785|NCT04969198|76221958|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
42366786|NCT04969198|76221958|FG000|Overall Study|Lost to Follow-up|20|||
42366787|NCT04778059|76221985|FG000|Overall Study|Death|2|||
42366788|NCT04778059|76221986|FG001|Overall Study|Death|2|||
42366789|NCT04778059|76221987|FG002|Overall Study|Death|1|||
42366790|NCT04778059|76221988|FG003|Overall Study|Death|1|||
42366791|NCT04778059|76221989|FG004|Overall Study|Death|1|||
42366792|NCT04778059|76221985|FG000|Overall Study|Lost to Follow-up|0|||
42366793|NCT04778059|76221986|FG001|Overall Study|Lost to Follow-up|0|||
42366794|NCT04778059|76221987|FG002|Overall Study|Lost to Follow-up|0|||
42366795|NCT04778059|76221988|FG003|Overall Study|Lost to Follow-up|0|||
42366796|NCT04778059|76221989|FG004|Overall Study|Lost to Follow-up|1|||
42366797|NCT04778059|76221985|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
42366798|NCT04778059|76221986|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
42366799|NCT04778059|76221987|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
42366800|NCT04778059|76221988|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
42366801|NCT04778059|76221989|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
42366802|NCT04621227|76222001|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
42366803|NCT04621227|76222001|FG000|Period 3 (29 Days)|Adverse Event|1|||
42366804|NCT04621227|76222001|FG000|Period 8 (2 Days)|Adverse Event|1|||
42366805|NCT04597918|76222025|FG000|Overall Study|Withdrawal by Subject|6|||
42366806|NCT04597918|76222025|FG000|Overall Study|Lost to Follow-up|3|||
42366807|NCT04597918|76222025|FG000|Overall Study|Death|1|||
42366808|NCT04317586|76222029|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
42366809|NCT04317586|76222029|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
42366810|NCT04102098|76222035|FG000|Main Study Period|Ongoing in study|302|||
42366811|NCT04102098|76222036|FG001|Main Study Period|Ongoing in study|291|||
42366812|NCT04102098|76222035|FG000|Main Study Period|Death|20|||
42366813|NCT04102098|76222036|FG001|Main Study Period|Death|27|||
42366814|NCT04102098|76222035|FG000|Main Study Period|Lost to Follow-up|1|||
42366815|NCT04102098|76222036|FG001|Main Study Period|Lost to Follow-up|1|||
42366816|NCT04102098|76222035|FG000|Main Study Period|Physician Decision|0|||
42366817|NCT04102098|76222036|FG001|Main Study Period|Physician Decision|1|||
42366818|NCT04102098|76222035|FG000|Main Study Period|Withdrawal by Subject|11|||
42366819|NCT04102098|76222036|FG001|Main Study Period|Withdrawal by Subject|14|||
42366820|NCT04102098|76222035|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
42366821|NCT04102098|76222036|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
42366822|NCT04102098|76222035|FG000|Crossover: AS Who Crossed Over|Death|11|||
42366823|NCT04102098|76222036|FG001|Crossover: AS Who Crossed Over|Death|0|||
42366824|NCT04102098|76222035|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
42366825|NCT04102098|76222036|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
42366826|NCT03964493|76222046|FG000|Overall Study|Withdrawal by Subject|4|||
42366827|NCT03964493|76222047|FG001|Overall Study|Withdrawal by Subject|1|||
42366828|NCT03964493|76222046|FG000|Overall Study|Lost to Follow-up|13|||
42366829|NCT03964493|76222047|FG001|Overall Study|Lost to Follow-up|4|||
42366830|NCT03846804|76222066|FG000|Overall Study|Refused blood draw|1|||
42366831|NCT03846804|76222066|FG000|Overall Study|Protocol Violation|1|||
42366832|NCT03807440|76222075|FG000|Overall Study|No documentation of index date 2|320|||
42366833|NCT03807440|76222075|FG000|Overall Study|No informed consent for index date 2|117|||
42366834|NCT03746522|76222152|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
42366835|NCT03746522|76222153|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
42366836|NCT03746522|76222154|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
42366837|NCT03746522|76222152|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
42366838|NCT03746522|76222153|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
42366839|NCT03746522|76222154|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
42366840|NCT03746522|76222152|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
42366841|NCT03746522|76222153|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
42366842|NCT03746522|76222154|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
42366843|NCT03746522|76222152|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
42366844|NCT03746522|76222153|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
42366845|NCT03746522|76222154|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
42366846|NCT03746522|76222152|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
42366847|NCT03746522|76222153|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
42366848|NCT03746522|76222154|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
42366849|NCT03710161|76222162|FG000|Overall Study|Study halted due to COVID pandemic|3|||
42366850|NCT03710161|76222163|FG001|Overall Study|Study halted due to COVID pandemic|2|||
42366851|NCT03478956|76222181|FG000|Overall Study|Adverse Event|1|||
42366852|NCT03478956|76222182|FG001|Overall Study|Adverse Event|0|||
42366853|NCT03478956|76222181|FG000|Overall Study|Withdrawal by Subject|0|||
42366854|NCT03478956|76222182|FG001|Overall Study|Withdrawal by Subject|1|||
42366855|NCT03478956|76222181|FG000|Overall Study|Ongoing in the Study|11|||
42366856|NCT03478956|76222182|FG001|Overall Study|Ongoing in the Study|11|||
42366857|NCT03347110|76222188|FG000|Overall Study|Other (Participant is incarcerated)|1|||
42366858|NCT03347110|76222188|FG000|Overall Study|Withdrawal by Subject|9|||
42366859|NCT03347110|76222188|FG000|Overall Study|Lost to Follow-up|1|||
42366860|NCT03347110|76222188|FG000|Overall Study|Lack of Efficacy|2|||
42366861|NCT03347110|76222188|FG000|Overall Study|Adverse Event, non-fatal|9|||
42366862|NCT02951052|76222196|FG000|Overall Study|Adverse Event|13|||
42366863|NCT02951052|76222197|FG001|Overall Study|Adverse Event|5|||
42366864|NCT02951052|76222196|FG000|Overall Study|Withdrawal by Subject|1|||
42366865|NCT02951052|76222197|FG001|Overall Study|Withdrawal by Subject|5|||
42366866|NCT02951052|76222196|FG000|Overall Study|Physician Decision|2|||
42366867|NCT02951052|76222197|FG001|Overall Study|Physician Decision|0|||
42366868|NCT02951052|76222196|FG000|Overall Study|Lost to Follow-up|1|||
42366869|NCT02951052|76222197|FG001|Overall Study|Lost to Follow-up|1|||
42366870|NCT02951052|76222196|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
42366871|NCT02951052|76222197|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
42366872|NCT02951052|76222196|FG000|Overall Study|Protocol Violation|5|||
42366873|NCT02951052|76222197|FG001|Overall Study|Protocol Violation|3|||
42366874|NCT02951052|76222196|FG000|Overall Study|Lack of Efficacy|3|||
42366875|NCT02951052|76222197|FG001|Overall Study|Lack of Efficacy|4|||
42366876|NCT02951052|76222196|FG000|Overall Study|Ongoing|1|||
42366877|NCT02951052|76222197|FG001|Overall Study|Ongoing|0|||
42366878|NCT02768792|76222220|FG000|Overall Study|Adverse Event|1|||
42366879|NCT02688400|76222226|FG000|Overall Study|Protocol Violation|2|||
42366880|NCT02688400|76222227|FG001|Overall Study|Protocol Violation|5|||
42366881|NCT02688400|76222226|FG000|Overall Study|Lack of Efficacy|7|||
42366882|NCT02688400|76222227|FG001|Overall Study|Lack of Efficacy|7|||
42366883|NCT02688400|76222226|FG000|Overall Study|Adverse Event|21|||
42366884|NCT02688400|76222227|FG001|Overall Study|Adverse Event|12|||
42366885|NCT02688400|76222226|FG000|Overall Study|Withdrawal by Subject|15|||
42366886|NCT02688400|76222227|FG001|Overall Study|Withdrawal by Subject|13|||
42366887|NCT02688400|76222226|FG000|Overall Study|No study medication intake|1|||
42366888|NCT02688400|76222227|FG001|Overall Study|No study medication intake|4|||
42366889|NCT02688400|76222226|FG000|Overall Study|Lost to Follow-up|0|||
42366890|NCT02688400|76222227|FG001|Overall Study|Lost to Follow-up|3|||
42366891|NCT02039843|76222240|FG000|Randomization and Observation Period|Adverse Event|2|||
42366892|NCT02039843|76222241|FG001|Randomization and Observation Period|Adverse Event|0|||
42366893|NCT02039843|76222240|FG000|Randomization and Observation Period|Death|1|||
42366894|NCT02039843|76222241|FG001|Randomization and Observation Period|Death|0|||
42366895|NCT02039843|76222240|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
42366896|NCT02039843|76222241|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
42366897|NCT02039843|76222240|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
42366898|NCT02039843|76222241|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
42101176|NCT00544882|75911957|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
42101177|NCT00544882|75911958|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
42101178|NCT00544882|75911959|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
42101179|NCT00544882|75911957|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
42101180|NCT00544882|75911958|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
42101181|NCT00544882|75911959|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
42101182|NCT00544882|75911957|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
42101183|NCT00544882|75911958|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
42101184|NCT00544882|75911959|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
42101185|NCT00544882|75911957|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
42101186|NCT00544882|75911958|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
42101187|NCT00544882|75911959|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
42101188|NCT00544882|75911957|FG000|Cycle 3: Follow-up|Noncompliance|0|||
42101189|NCT00544882|75911958|FG001|Cycle 3: Follow-up|Noncompliance|1|||
42101190|NCT00544882|75911959|FG002|Cycle 3: Follow-up|Noncompliance|0|||
42101191|NCT00544882|75911957|FG000|Cycle 3: Follow-up|Pregnancy|0|||
42101192|NCT00544882|75911958|FG001|Cycle 3: Follow-up|Pregnancy|1|||
42101193|NCT00544882|75911959|FG002|Cycle 3: Follow-up|Pregnancy|0|||
42101194|NCT00606801|75911967|FG000|Intervention|Protocol Violation|3|||
42101195|NCT00606801|75911968|FG001|Intervention|Protocol Violation|3|||
42101196|NCT00606177|75911980|FG000|Overall Study|Adverse Event|9|||
42101197|NCT00606177|75911981|FG001|Overall Study|Adverse Event|5|||
42101198|NCT00606177|75911980|FG000|Overall Study|Lack of Efficacy|3|||
42101199|NCT00606177|75911981|FG001|Overall Study|Lack of Efficacy|7|||
42101200|NCT00606177|75911980|FG000|Overall Study|Physician Decision|1|||
42101201|NCT00606177|75911981|FG001|Overall Study|Physician Decision|0|||
42101202|NCT00606177|75911980|FG000|Overall Study|Protocol Violation|1|||
42101203|NCT00606177|75911981|FG001|Overall Study|Protocol Violation|4|||
42101204|NCT00606177|75911980|FG000|Overall Study|Withdrawal by Subject|5|||
42101205|NCT00606177|75911981|FG001|Overall Study|Withdrawal by Subject|6|||
42101206|NCT00606177|75911980|FG000|Overall Study|Progression to depressive phase|6|||
42101207|NCT00606177|75911981|FG001|Overall Study|Progression to depressive phase|1|||
42366899|NCT02039843|76222240|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
42366900|NCT02039843|76222241|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
42366901|NCT02039843|76222240|FG000|Pairing With a Study Dog|Death|1|||
42366902|NCT02039843|76222241|FG001|Pairing With a Study Dog|Death|0|||
42366903|NCT02039843|76222240|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
42366904|NCT02039843|76222241|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
42366905|NCT02039843|76222240|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
42366906|NCT02039843|76222241|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
42366907|NCT02039843|76222240|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
42366908|NCT02039843|76222241|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
42101208|NCT00606177|75911980|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
42196733|NCT03514641|76008566|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
42101209|NCT00606177|75911981|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
42101210|NCT00606177|75911980|FG000|Overall Study|Change of residence or other commitments|1|||
42101211|NCT00606177|75911981|FG001|Overall Study|Change of residence or other commitments|1|||
42366909|NCT02004275|76222255|FG000|Phase 1|Ineligible|0|||
42366910|NCT02004275|76222256|FG001|Phase 1|Ineligible|0|||
42366911|NCT02004275|76222257|FG002|Phase 1|Ineligible|0|||
42366912|NCT02004275|76222258|FG003|Phase 1|Ineligible|1|||
42366913|NCT02004275|76222259|FG004|Phase 1|Ineligible|1|||
42366914|NCT02004275|76222260|FG005|Phase 1|Ineligible|0|||
42366915|NCT02004275|76222255|FG000|Phase 1|Protocol Violation|0|||
42366916|NCT02004275|76222256|FG001|Phase 1|Protocol Violation|0|||
42366917|NCT02004275|76222257|FG002|Phase 1|Protocol Violation|0|||
42366918|NCT02004275|76222258|FG003|Phase 1|Protocol Violation|1|||
42366919|NCT02004275|76222259|FG004|Phase 1|Protocol Violation|0|||
42366920|NCT02004275|76222260|FG005|Phase 1|Protocol Violation|5|||
42366921|NCT02004275|76222255|FG000|Phase 2 Part 1|Ineligible|6|||
42366922|NCT02004275|76222256|FG001|Phase 2 Part 1|Ineligible|9|||
42366923|NCT02004275|76222257|FG002|Phase 2 Part 1|Ineligible|0|||
42366924|NCT02004275|76222258|FG003|Phase 2 Part 1|Ineligible|0|||
42366925|NCT02004275|76222259|FG004|Phase 2 Part 1|Ineligible|0|||
42366926|NCT02004275|76222260|FG005|Phase 2 Part 1|Ineligible|0|||
42366927|NCT02004275|76222255|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
42366928|NCT02004275|76222256|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
42366929|NCT02004275|76222257|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
42366930|NCT02004275|76222258|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
42366931|NCT02004275|76222259|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
42366932|NCT02004275|76222260|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
42366933|NCT01559129|76222286|FG000|Treatment Phase|Adverse Event|0|||
42366934|NCT01559129|76222287|FG001|Treatment Phase|Adverse Event|2|||
42366935|NCT01559129|76222286|FG000|Treatment Phase|Progressive Disease|1|||
42366936|NCT01559129|76222287|FG001|Treatment Phase|Progressive Disease|1|||
42366937|NCT01559129|76222286|FG000|Treatment Phase|Lack of Efficacy|0|||
42366938|NCT01559129|76222287|FG001|Treatment Phase|Lack of Efficacy|1|||
42366939|NCT01559129|76222286|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
42366940|NCT01559129|76222287|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
42366941|NCT01559129|76222286|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
42366942|NCT01559129|76222287|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
42366943|NCT01559129|76222286|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
42366944|NCT01559129|76222287|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
42366945|NCT01559129|76222286|FG000|Open-label Extension Period|Adverse Event|1|||
42366946|NCT01559129|76222287|FG001|Open-label Extension Period|Adverse Event|0|||
42366947|NCT01559129|76222286|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
42366948|NCT01559129|76222287|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
42366949|NCT00355238|76222312|FG000|Overall Study|Adverse event unrelated to study drug|2|||
42366950|NCT00355238|76222313|FG001|Overall Study|Adverse event unrelated to study drug|2|||
42366951|NCT00355238|76222314|FG002|Overall Study|Adverse event unrelated to study drug|0|||
42366952|NCT00355238|76222315|FG003|Overall Study|Adverse event unrelated to study drug|1|||
42366953|NCT00355238|76222312|FG000|Overall Study|Death|1|||
42366954|NCT00355238|76222313|FG001|Overall Study|Death|0|||
42366955|NCT00355238|76222314|FG002|Overall Study|Death|0|||
42366956|NCT00355238|76222315|FG003|Overall Study|Death|0|||
42366957|NCT00355238|76222312|FG000|Overall Study|Disease progression|37|||
42366958|NCT00355238|76222313|FG001|Overall Study|Disease progression|36|||
42366959|NCT00355238|76222314|FG002|Overall Study|Disease progression|16|||
42366960|NCT00355238|76222315|FG003|Overall Study|Disease progression|11|||
42366961|NCT00355238|76222312|FG000|Overall Study|Study drug toxicity|11|||
42366962|NCT00355238|76222313|FG001|Overall Study|Study drug toxicity|7|||
42366963|NCT00355238|76222314|FG002|Overall Study|Study drug toxicity|5|||
42366964|NCT00355238|76222315|FG003|Overall Study|Study drug toxicity|2|||
42366965|NCT00355238|76222312|FG000|Overall Study|Participant withdrew consent|3|||
42366966|NCT00355238|76222313|FG001|Overall Study|Participant withdrew consent|1|||
42366967|NCT00355238|76222314|FG002|Overall Study|Participant withdrew consent|0|||
42366968|NCT00355238|76222315|FG003|Overall Study|Participant withdrew consent|0|||
42366969|NCT00355238|76222312|FG000|Overall Study|Participant request to discontinue study treatment|1|||
42366970|NCT00355238|76222313|FG001|Overall Study|Participant request to discontinue study treatment|0|||
42366971|NCT00355238|76222314|FG002|Overall Study|Participant request to discontinue study treatment|1|||
42366972|NCT00355238|76222315|FG003|Overall Study|Participant request to discontinue study treatment|0|||
42366973|NCT00303303|76222330|FG000|Overall Study|Withdrawal by Subject|0|||
42366974|NCT00303303|76222331|FG001|Overall Study|Withdrawal by Subject|0|||
42366975|NCT00303303|76222332|FG002|Overall Study|Withdrawal by Subject|1|||
42366976|NCT00988533|76222377|FG000|Overall Study|Lost to Follow-up|3|||
42366977|NCT03633396|76222409|FG000|Overall Study|Withdrawal by Subject|4|||
42366978|NCT03633396|76222410|FG001|Overall Study|Withdrawal by Subject|4|||
42366979|NCT03633396|76222409|FG000|Overall Study|Adverse Event|1|||
42101212|NCT00359281|75911996|FG000|Overall Study|Adverse Event|1|||
42366980|NCT03633396|76222410|FG001|Overall Study|Adverse Event|1|||
42366981|NCT03633396|76222409|FG000|Overall Study|Lack of Efficacy|1|||
42366982|NCT03633396|76222410|FG001|Overall Study|Lack of Efficacy|0|||
42366983|NCT03633396|76222409|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
42366984|NCT03633396|76222410|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
42366985|NCT00988065|76222423|FG000|Overall Study|Adverse Event|4|||
42366986|NCT00988065|76222424|FG001|Overall Study|Adverse Event|10|||
42366987|NCT00988065|76222425|FG002|Overall Study|Adverse Event|2|||
42366988|NCT00988065|76222423|FG000|Overall Study|Lost to Follow-up|1|||
42366989|NCT00988065|76222424|FG001|Overall Study|Lost to Follow-up|2|||
42366990|NCT00988065|76222425|FG002|Overall Study|Lost to Follow-up|2|||
42366991|NCT00988065|76222423|FG000|Overall Study|Subject withdrew consent|3|||
42366992|NCT00988065|76222424|FG001|Overall Study|Subject withdrew consent|5|||
42366993|NCT00988065|76222425|FG002|Overall Study|Subject withdrew consent|2|||
42366994|NCT00988065|76222423|FG000|Overall Study|Noncompliance with protocol|5|||
42366995|NCT00988065|76222424|FG001|Overall Study|Noncompliance with protocol|6|||
42366996|NCT00988065|76222425|FG002|Overall Study|Noncompliance with protocol|9|||
42366997|NCT00987831|76222449|FG000|Overall Study|Never flared in 12 months|1|||
42366998|NCT00987831|76222450|FG001|Overall Study|Never flared in 12 months|0|||
42366999|NCT00987831|76222451|FG002|Overall Study|Never flared in 12 months|0|||
42367000|NCT00987831|76222449|FG000|Overall Study|Lost to Follow-up|0|||
42367001|NCT00987831|76222450|FG001|Overall Study|Lost to Follow-up|3|||
42367002|NCT00987831|76222451|FG002|Overall Study|Lost to Follow-up|0|||
42367003|NCT00986973|76222482|FG000|Overall Study|Withdrawn by study team|1|||
42367004|NCT00986427|76222489|FG000|Overall Study|Lost to Follow-up|2|||
42367005|NCT00986427|76222490|FG001|Overall Study|Lost to Follow-up|0|||
42367006|NCT00986427|76222489|FG000|Overall Study|Lack of Efficacy|1|||
42367007|NCT00986427|76222490|FG001|Overall Study|Lack of Efficacy|0|||
42367008|NCT00986427|76222489|FG000|Overall Study|Withdrawal by Subject|1|||
42367009|NCT00986427|76222490|FG001|Overall Study|Withdrawal by Subject|0|||
42367010|NCT00986349|76222500|FG000|Overall Study|Unsuccessful implant procedure|3|||
42367011|NCT00986349|76222500|FG000|Overall Study|Adverse Event|2|||
42367012|NCT00986349|76222500|FG000|Overall Study|Physician Decision|1|||
42367013|NCT00986349|76222500|FG000|Overall Study|device migration|1|||
42367014|NCT00985959|76222523|FG000|Overall Study|Adverse Event|0|||
42367015|NCT00985959|76222524|FG001|Overall Study|Adverse Event|0|||
42367016|NCT00985959|76222525|FG002|Overall Study|Adverse Event|19|||
42367017|NCT00985959|76222523|FG000|Overall Study|Withdrawal by Subject|0|||
42367018|NCT00985959|76222524|FG001|Overall Study|Withdrawal by Subject|0|||
42367019|NCT00985959|76222525|FG002|Overall Study|Withdrawal by Subject|8|||
42367020|NCT00985959|76222523|FG000|Overall Study|Progressive disease|1|||
42367021|NCT00985959|76222524|FG001|Overall Study|Progressive disease|2|||
42367022|NCT00985959|76222525|FG002|Overall Study|Progressive disease|8|||
42367023|NCT00985959|76222523|FG000|Overall Study|Unrecovered toxicity|0|||
42367024|NCT00985959|76222524|FG001|Overall Study|Unrecovered toxicity|0|||
42367025|NCT00985959|76222525|FG002|Overall Study|Unrecovered toxicity|7|||
42367026|NCT00985959|76222523|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
42367027|NCT00985959|76222524|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
42367028|NCT00985959|76222525|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
42367029|NCT00985959|76222523|FG000|Overall Study|Complete response observed over 2 cycles|0|||
42367030|NCT00985959|76222524|FG001|Overall Study|Complete response observed over 2 cycles|1|||
42367031|NCT00985959|76222525|FG002|Overall Study|Complete response observed over 2 cycles|4|||
42367032|NCT00985959|76222523|FG000|Overall Study|Other|0|||
42101213|NCT00359281|75911997|FG001|Overall Study|Adverse Event|0|||
42367033|NCT00985959|76222524|FG001|Overall Study|Other|0|||
42367034|NCT00985959|76222525|FG002|Overall Study|Other|11|||
42367035|NCT00985725|76222541|FG000|Overall Study|Adverse Event|4|||
42367036|NCT00985725|76222542|FG001|Overall Study|Adverse Event|1|||
42367037|NCT00985725|76222541|FG000|Overall Study|Protocol Violation|1|||
42367038|NCT00985725|76222542|FG001|Overall Study|Protocol Violation|3|||
42367039|NCT00985725|76222541|FG000|Overall Study|Withdrawal by Subject|4|||
42367040|NCT00985725|76222542|FG001|Overall Study|Withdrawal by Subject|4|||
42367041|NCT00985725|76222541|FG000|Overall Study|Lost to Follow-up|1|||
42367042|NCT00985725|76222542|FG001|Overall Study|Lost to Follow-up|1|||
42367043|NCT00985725|76222541|FG000|Overall Study|Lack of Efficacy|0|||
42367044|NCT00985725|76222542|FG001|Overall Study|Lack of Efficacy|1|||
42101214|NCT00359281|75911998|FG002|Overall Study|Adverse Event|0|||
42101215|NCT00359281|75911999|FG003|Overall Study|Adverse Event|0|||
42101216|NCT00359281|75912000|FG004|Overall Study|Adverse Event|0|||
42101217|NCT00359281|75912001|FG005|Overall Study|Adverse Event|0|||
42101218|NCT00359281|75912002|FG006|Overall Study|Adverse Event|1|||
42101219|NCT00359281|75912003|FG007|Overall Study|Adverse Event|0|||
42101220|NCT00359281|75912004|FG008|Overall Study|Adverse Event|0|||
42367045|NCT00985725|76222541|FG000|Overall Study|Non-compliance|1|||
42367046|NCT00985725|76222542|FG001|Overall Study|Non-compliance|2|||
42367047|NCT00985725|76222541|FG000|Overall Study|Out-of-window visits|0|||
42367048|NCT00985725|76222542|FG001|Overall Study|Out-of-window visits|1|||
42367049|NCT00985491|76222557|FG000|Overall Study|Adverse Event|8|||
42367050|NCT00985491|76222557|FG000|Overall Study|device migration|7|||
42367051|NCT00985491|76222557|FG000|Overall Study|Withdrawal by Subject|1|||
42367052|NCT00985491|76222557|FG000|Overall Study|implant failure|3|||
42367053|NCT00984867|76222592|FG000|Overall Study|Adverse Event|3|||
42367054|NCT00984867|76222593|FG001|Overall Study|Adverse Event|7|||
42367055|NCT00984867|76222592|FG000|Overall Study|Death|1|||
42367056|NCT00984867|76222593|FG001|Overall Study|Death|0|||
42367057|NCT00984867|76222592|FG000|Overall Study|Withdrawal by Subject|13|||
42367058|NCT00984867|76222593|FG001|Overall Study|Withdrawal by Subject|4|||
42367059|NCT00984867|76222592|FG000|Overall Study|Lost to Follow-up|3|||
42367060|NCT00984867|76222593|FG001|Overall Study|Lost to Follow-up|4|||
42367061|NCT00984867|76222592|FG000|Overall Study|Poor/non-compliance|0|||
42367062|NCT00984867|76222593|FG001|Overall Study|Poor/non-compliance|1|||
42367063|NCT00984867|76222592|FG000|Overall Study|Subject no longer meets study criteria|1|||
42367064|NCT00984867|76222593|FG001|Overall Study|Subject no longer meets study criteria|1|||
42367065|NCT00984867|76222592|FG000|Overall Study|site closing|1|||
42367066|NCT00984867|76222593|FG001|Overall Study|site closing|0|||
42367067|NCT00984867|76222592|FG000|Overall Study|lack of efficacy and subject compliance|1|||
42367068|NCT00984867|76222593|FG001|Overall Study|lack of efficacy and subject compliance|0|||
42367069|NCT00984009|76222633|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
42367070|NCT00983931|76222640|FG000|14 Day Washout Period|Physician Decision|1|||
42367071|NCT00983853|76222652|FG000|Overall Study|Lost to Follow-up|1|||
42367072|NCT00983853|76222653|FG001|Overall Study|Lost to Follow-up|1|||
42367073|NCT00983853|76222654|FG002|Overall Study|Lost to Follow-up|2|||
42367074|NCT00983853|76222655|FG003|Overall Study|Lost to Follow-up|2|||
42367075|NCT00983853|76222656|FG004|Overall Study|Lost to Follow-up|2|||
42367076|NCT00983853|76222657|FG005|Overall Study|Lost to Follow-up|1|||
42367077|NCT00983853|76222652|FG000|Overall Study|Withdrawal by Subject|0|||
42367078|NCT00983853|76222653|FG001|Overall Study|Withdrawal by Subject|0|||
42367079|NCT00983853|76222654|FG002|Overall Study|Withdrawal by Subject|1|||
42367080|NCT00983853|76222655|FG003|Overall Study|Withdrawal by Subject|0|||
42367081|NCT00983853|76222656|FG004|Overall Study|Withdrawal by Subject|1|||
42367082|NCT00983853|76222657|FG005|Overall Study|Withdrawal by Subject|0|||
42367083|NCT00983853|76222652|FG000|Overall Study|Unable to come to study follow-up visits|0|||
42367084|NCT00983853|76222653|FG001|Overall Study|Unable to come to study follow-up visits|1|||
42367085|NCT00983853|76222654|FG002|Overall Study|Unable to come to study follow-up visits|0|||
42367086|NCT00983853|76222655|FG003|Overall Study|Unable to come to study follow-up visits|0|||
42367087|NCT00983853|76222656|FG004|Overall Study|Unable to come to study follow-up visits|0|||
42367088|NCT00983853|76222657|FG005|Overall Study|Unable to come to study follow-up visits|0|||
42367089|NCT00983073|76222673|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
42367090|NCT00983073|76222673|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
42367091|NCT00983073|76222673|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
42367092|NCT00983073|76222673|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
42367093|NCT00983073|76222673|FG000|Titration and Optimal Dose Period|Other reason|4|||
42367094|NCT00983073|76222673|FG000|Maintenance Period|Adverse Event|5|||
42367095|NCT00983073|76222673|FG000|Maintenance Period|Withdrawal by Subject|2|||
42367096|NCT00983073|76222673|FG000|Maintenance Period|Lack of Efficacy|2|||
42367097|NCT00983073|76222673|FG000|Maintenance Period|Other Reason|7|||
42367098|NCT00982137|76222682|FG000|Overall Study|Lost to Follow-up|0|||
42367099|NCT00982137|76222683|FG001|Overall Study|Lost to Follow-up|0|||
42367100|NCT00982137|76222684|FG002|Overall Study|Lost to Follow-up|0|||
42367101|NCT00982137|76222685|FG003|Overall Study|Lost to Follow-up|1|||
42367102|NCT00982137|76222682|FG000|Overall Study|Withdrawal by Subject|0|||
42367103|NCT00982137|76222683|FG001|Overall Study|Withdrawal by Subject|1|||
42367104|NCT00982137|76222684|FG002|Overall Study|Withdrawal by Subject|0|||
42367105|NCT00982137|76222685|FG003|Overall Study|Withdrawal by Subject|0|||
42367106|NCT00981747|76222702|FG000|Losartan|Withdrawal by Subject|1|||
42367107|NCT00981747|76222702|FG000|Losartan|Death|1|||
42367108|NCT00981747|76222702|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
42367109|NCT01856309|76222857|FG000|Overall Study|Death|4|||
42367110|NCT01856309|76222858|FG001|Overall Study|Death|6|||
42367111|NCT01856309|76222859|FG002|Overall Study|Death|11|||
42018540|NCT00996892|75825862|FG001|Expansion Stage 2A|Disease Progression|0|||
42018541|NCT00996892|75825863|FG002|Expansion Stage 2A|Disease Progression|0|||
42367112|NCT01856309|76222860|FG003|Overall Study|Death|6|||
42367113|NCT01856309|76222857|FG000|Overall Study|Lost to Follow-up|6|||
42367114|NCT01856309|76222858|FG001|Overall Study|Lost to Follow-up|2|||
42367115|NCT01856309|76222859|FG002|Overall Study|Lost to Follow-up|4|||
42367116|NCT01856309|76222860|FG003|Overall Study|Lost to Follow-up|8|||
42367117|NCT01856309|76222857|FG000|Overall Study|Withdrawal by Subject|11|||
42367118|NCT01856309|76222858|FG001|Overall Study|Withdrawal by Subject|13|||
42367119|NCT01856309|76222859|FG002|Overall Study|Withdrawal by Subject|28|||
42367120|NCT01856309|76222860|FG003|Overall Study|Withdrawal by Subject|26|||
42367121|NCT01856309|76222857|FG000|Overall Study|Other|227|||
42367122|NCT01856309|76222858|FG001|Overall Study|Other|225|||
42367123|NCT01856309|76222859|FG002|Overall Study|Other|447|||
42367124|NCT01856309|76222860|FG003|Overall Study|Other|469|||
42367125|NCT01856309|76222857|FG000|Overall Study|Lack of Efficacy|14|||
42367126|NCT01856309|76222858|FG001|Overall Study|Lack of Efficacy|9|||
42367127|NCT01856309|76222859|FG002|Overall Study|Lack of Efficacy|40|||
42367128|NCT01856309|76222860|FG003|Overall Study|Lack of Efficacy|25|||
42367129|NCT01856309|76222857|FG000|Overall Study|Adverse Event|31|||
42367130|NCT01856309|76222858|FG001|Overall Study|Adverse Event|31|||
42367131|NCT01856309|76222859|FG002|Overall Study|Adverse Event|55|||
42367132|NCT01856309|76222860|FG003|Overall Study|Adverse Event|65|||
42367133|NCT01856309|76222857|FG000|Overall Study|Pregnancy|0|||
42367134|NCT01856309|76222858|FG001|Overall Study|Pregnancy|0|||
42367135|NCT01856309|76222859|FG002|Overall Study|Pregnancy|0|||
42367136|NCT01856309|76222860|FG003|Overall Study|Pregnancy|1|||
42367137|NCT01856309|76222857|FG000|Overall Study|Physician Decision|6|||
42367138|NCT01856309|76222858|FG001|Overall Study|Physician Decision|1|||
42367139|NCT01856309|76222859|FG002|Overall Study|Physician Decision|6|||
42367140|NCT01856309|76222860|FG003|Overall Study|Physician Decision|8|||
42367141|NCT01856309|76222857|FG000|Overall Study|Noncompliance With Study Drug|0|||
42367142|NCT01856309|76222858|FG001|Overall Study|Noncompliance With Study Drug|1|||
42367143|NCT01856309|76222859|FG002|Overall Study|Noncompliance With Study Drug|4|||
42367144|NCT01856309|76222860|FG003|Overall Study|Noncompliance With Study Drug|1|||
42367145|NCT01855919|76223058|FG000|Overall Study|Adverse Event|16|||
42367146|NCT01855919|76223059|FG001|Overall Study|Adverse Event|8|||
42367147|NCT01855919|76223058|FG000|Overall Study|Lack of Efficacy|1|||
42367148|NCT01855919|76223059|FG001|Overall Study|Lack of Efficacy|3|||
42367149|NCT01855919|76223058|FG000|Overall Study|Withdrawal by Subject|4|||
42367150|NCT01855919|76223059|FG001|Overall Study|Withdrawal by Subject|10|||
42367151|NCT01855919|76223058|FG000|Overall Study|Entry Criteria Not Met|1|||
42367152|NCT01855919|76223059|FG001|Overall Study|Entry Criteria Not Met|1|||
42367153|NCT01855919|76223058|FG000|Overall Study|Protocol Violation|1|||
42367154|NCT01855919|76223059|FG001|Overall Study|Protocol Violation|4|||
42367155|NCT01871519|76223075|FG000|Overall Study|Death|26|||
42367156|NCT01871519|76223075|FG000|Overall Study|Lost to Follow-up|15|||
42101221|NCT00359281|75911996|FG000|Overall Study|Withdrawal by Subject|0|||
42018542|NCT00996892|75825864|FG003|Expansion Stage 2A|Disease Progression|0|||
42018543|NCT00996892|75825865|FG004|Expansion Stage 2A|Disease Progression|0|||
42018544|NCT00996892|75825866|FG005|Expansion Stage 2A|Disease Progression|0|||
42018545|NCT00996892|75825867|FG006|Expansion Stage 2A|Disease Progression|0|||
42018546|NCT00996892|75825868|FG007|Expansion Stage 2A|Disease Progression|0|||
42018547|NCT00996892|75825869|FG008|Expansion Stage 2A|Disease Progression|0|||
42018548|NCT00996892|75825870|FG009|Expansion Stage 2A|Disease Progression|0|||
42018549|NCT00996892|75825871|FG010|Expansion Stage 2A|Disease Progression|0|||
42018550|NCT00996892|75825872|FG011|Expansion Stage 2A|Disease Progression|0|||
42018551|NCT00996892|75825873|FG012|Expansion Stage 2A|Disease Progression|0|||
42018552|NCT00996892|75825874|FG013|Expansion Stage 2A|Disease Progression|0|||
42018553|NCT00996892|75825875|FG014|Expansion Stage 2A|Disease Progression|0|||
42018554|NCT00996892|75825876|FG015|Expansion Stage 2A|Disease Progression|0|||
42018555|NCT00996892|75825877|FG016|Expansion Stage 2A|Disease Progression|0|||
42018556|NCT00996892|75825878|FG017|Expansion Stage 2A|Disease Progression|0|||
42018557|NCT00996892|75825879|FG018|Expansion Stage 2A|Disease Progression|0|||
42018558|NCT00996892|75825880|FG019|Expansion Stage 2A|Disease Progression|31|||
42018559|NCT01257581|75825944|FG000|Overall Study|Early Termination|3|||
42018560|NCT01257581|75825945|FG001|Overall Study|Early Termination|1|||
42018561|NCT01257581|75825946|FG002|Overall Study|Early Termination|2|||
42018562|NCT01257581|75825944|FG000|Overall Study|Death|2|||
42018563|NCT01257581|75825945|FG001|Overall Study|Death|2|||
42018564|NCT01257581|75825946|FG002|Overall Study|Death|4|||
42101222|NCT00359281|75911997|FG001|Overall Study|Withdrawal by Subject|0|||
42196734|NCT03514641|76008567|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
42196735|NCT03514641|76008568|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
42196736|NCT03514641|76008569|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
42196737|NCT00100828|76008581|FG000|Overall Study|Physician Decision|6|||
42196738|NCT00100048|76008590|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
42196739|NCT00100048|76008591|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
42018565|NCT01257503|75825956|FG000|Overall Study|Lost to Follow-up|7|||
42101223|NCT00359281|75911998|FG002|Overall Study|Withdrawal by Subject|0|||
42101224|NCT00359281|75911999|FG003|Overall Study|Withdrawal by Subject|0|||
42101225|NCT00359281|75912000|FG004|Overall Study|Withdrawal by Subject|0|||
42101226|NCT00359281|75912001|FG005|Overall Study|Withdrawal by Subject|0|||
42196740|NCT00100048|76008592|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
42196741|NCT00100048|76008593|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
42196742|NCT00100048|76008594|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
42367157|NCT01871519|76223075|FG000|Overall Study|Withdrawal by Subject|49|||
42367158|NCT01871285|76223082|FG000|First Intervention (1 Day)|Adverse Event|1|||
42367159|NCT01871285|76223083|FG001|First Intervention (1 Day)|Adverse Event|0|||
42367160|NCT01871285|76223084|FG002|First Intervention (1 Day)|Adverse Event|0|||
42367161|NCT01871285|76223085|FG003|First Intervention (1 Day)|Adverse Event|0|||
42367162|NCT01871285|76223082|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
42101227|NCT00359281|75912002|FG006|Overall Study|Withdrawal by Subject|1|||
42018566|NCT01257503|75825957|FG001|Overall Study|Lost to Follow-up|10|||
42367163|NCT01871285|76223083|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
42367164|NCT01871285|76223084|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
42367165|NCT01871285|76223085|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
42367166|NCT01870973|76223111|FG000|Overall Study|Lost to Follow-up|10|||
42367167|NCT01870973|76223112|FG001|Overall Study|Lost to Follow-up|3|||
42367168|NCT01854827|76223131|FG000|Overall Study|Death|1|||
42367169|NCT01854047|76223274|FG000|Overall Study|Lack of Efficacy|1|||
42367170|NCT01854047|76223275|FG001|Overall Study|Lack of Efficacy|0|||
42367171|NCT01854047|76223276|FG002|Overall Study|Lack of Efficacy|0|||
42367172|NCT01854047|76223277|FG003|Overall Study|Lack of Efficacy|0|||
42367173|NCT01854047|76223278|FG004|Overall Study|Lack of Efficacy|0|||
42367174|NCT01854047|76223274|FG000|Overall Study|Poor compliance to protocol|3|||
42367175|NCT01854047|76223275|FG001|Overall Study|Poor compliance to protocol|0|||
42367176|NCT01854047|76223276|FG002|Overall Study|Poor compliance to protocol|2|||
42367177|NCT01854047|76223277|FG003|Overall Study|Poor compliance to protocol|0|||
42367178|NCT01854047|76223278|FG004|Overall Study|Poor compliance to protocol|0|||
42367179|NCT01854047|76223274|FG000|Overall Study|Adverse Event|5|||
42367180|NCT01854047|76223275|FG001|Overall Study|Adverse Event|4|||
42367181|NCT01854047|76223276|FG002|Overall Study|Adverse Event|6|||
42367182|NCT01854047|76223277|FG003|Overall Study|Adverse Event|10|||
42367183|NCT01854047|76223278|FG004|Overall Study|Adverse Event|7|||
42367184|NCT01854047|76223274|FG000|Overall Study|Randomized but not treated|0|||
42367185|NCT01854047|76223275|FG001|Overall Study|Randomized but not treated|1|||
42367186|NCT01854047|76223276|FG002|Overall Study|Randomized but not treated|2|||
42367187|NCT01854047|76223277|FG003|Overall Study|Randomized but not treated|0|||
42367188|NCT01854047|76223278|FG004|Overall Study|Randomized but not treated|4|||
42367189|NCT01854047|76223274|FG000|Overall Study|Other than specified above|3|||
42367190|NCT01854047|76223275|FG001|Overall Study|Other than specified above|3|||
42367191|NCT01854047|76223276|FG002|Overall Study|Other than specified above|3|||
42367192|NCT01854047|76223277|FG003|Overall Study|Other than specified above|5|||
42367193|NCT01854047|76223278|FG004|Overall Study|Other than specified above|8|||
42367194|NCT01870739|76223324|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
42367195|NCT01870739|76223325|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
42367196|NCT01870739|76223324|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
42367197|NCT01870739|76223325|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
42367198|NCT01870739|76223324|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
42367199|NCT01870739|76223325|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
42367200|NCT01870739|76223324|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
42367201|NCT01870739|76223325|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
42367202|NCT01870739|76223324|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
42367203|NCT01870739|76223325|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
42367204|NCT01870739|76223324|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
42367205|NCT01870739|76223325|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
42367206|NCT01870739|76223324|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
42367207|NCT01870739|76223325|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
42367208|NCT01613417|76223352|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
42367209|NCT01613417|76223353|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
42367210|NCT01870583|76223381|FG000|Overall Study|Protocol Violation|0|||
42367211|NCT01870583|76223382|FG001|Overall Study|Protocol Violation|5|||
42367212|NCT01870583|76223383|FG002|Overall Study|Protocol Violation|3|||
42367213|NCT01870583|76223381|FG000|Overall Study|Lost to Follow-up|11|||
42367214|NCT01870583|76223382|FG001|Overall Study|Lost to Follow-up|13|||
42367215|NCT01870583|76223383|FG002|Overall Study|Lost to Follow-up|5|||
42367216|NCT01869959|76223441|FG000|Randomization Period|Physician Decision|0|||
42367217|NCT01869959|76223442|FG001|Randomization Period|Physician Decision|0|||
42367218|NCT01869959|76223443|FG002|Randomization Period|Physician Decision|0|||
42367219|NCT01869959|76223444|FG003|Randomization Period|Physician Decision|0|||
42367220|NCT01869959|76223445|FG004|Randomization Period|Physician Decision|1|||
42367221|NCT01869959|76223441|FG000|Treatment Period|Adverse Event|1|||
42367222|NCT01869959|76223442|FG001|Treatment Period|Adverse Event|0|||
42367223|NCT01869959|76223443|FG002|Treatment Period|Adverse Event|3|||
42367224|NCT01869959|76223444|FG003|Treatment Period|Adverse Event|1|||
42367225|NCT01869959|76223445|FG004|Treatment Period|Adverse Event|0|||
42367226|NCT01869959|76223441|FG000|Treatment Period|Sponsor decision|0|||
42367227|NCT01869959|76223442|FG001|Treatment Period|Sponsor decision|1|||
42367228|NCT01869959|76223443|FG002|Treatment Period|Sponsor decision|0|||
42367229|NCT01869959|76223444|FG003|Treatment Period|Sponsor decision|1|||
42018567|NCT01257503|75825956|FG000|Overall Study|Over 5 years old at enrollment|0|||
42018568|NCT01257503|75825957|FG001|Overall Study|Over 5 years old at enrollment|1|||
42101228|NCT00359281|75912003|FG007|Overall Study|Withdrawal by Subject|0|||
42367230|NCT01869959|76223445|FG004|Treatment Period|Sponsor decision|0|||
42367231|NCT01869959|76223441|FG000|Treatment Period|Withdrawal by Subject|0|||
42367232|NCT01869959|76223442|FG001|Treatment Period|Withdrawal by Subject|1|||
42367233|NCT01869959|76223443|FG002|Treatment Period|Withdrawal by Subject|0|||
42367234|NCT01869959|76223444|FG003|Treatment Period|Withdrawal by Subject|0|||
42367235|NCT01869959|76223445|FG004|Treatment Period|Withdrawal by Subject|0|||
42101229|NCT00359281|75912004|FG008|Overall Study|Withdrawal by Subject|0|||
42101230|NCT00366535|75912033|FG000|First Phase: 12 Weeks|Adverse Event|1|||
42101231|NCT00366535|75912034|FG001|First Phase: 12 Weeks|Adverse Event|3|||
42101232|NCT00366535|75912033|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
42101233|NCT00366535|75912034|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
42101234|NCT00366535|75912033|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
42101235|NCT00366535|75912034|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
42101236|NCT00366535|75912033|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
42101237|NCT00366535|75912034|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
42101238|NCT00350545|75912048|FG000|Overall Study|Withdrawal by Subject|2|||
42101239|NCT00349921|75912056|FG000|First Spinal Injection|Physician Decision|1|||
42101240|NCT00349921|75912057|FG001|First Spinal Injection|Physician Decision|0|||
42101241|NCT00349921|75912058|FG002|First Spinal Injection|Physician Decision|0|||
42101242|NCT00349921|75912059|FG003|First Spinal Injection|Physician Decision|0|||
42101243|NCT00349921|75912056|FG000|First Spinal Injection|Adverse Event|0|||
42101244|NCT00349921|75912057|FG001|First Spinal Injection|Adverse Event|0|||
42101245|NCT00349921|75912058|FG002|First Spinal Injection|Adverse Event|1|||
42101246|NCT00349921|75912059|FG003|First Spinal Injection|Adverse Event|0|||
42101247|NCT00606021|75912070|FG000|Induction Phase|Death|73|||
42101248|NCT00606021|75912071|FG001|Induction Phase|Death|0|||
42101249|NCT00606021|75912072|FG002|Induction Phase|Death|0|||
42101250|NCT00606021|75912070|FG000|Induction Phase|Physician Decision|2|||
42101251|NCT00606021|75912071|FG001|Induction Phase|Physician Decision|0|||
42101252|NCT00606021|75912072|FG002|Induction Phase|Physician Decision|0|||
42101253|NCT00606021|75912070|FG000|Induction Phase|Withdrawal by Subject|2|||
42101254|NCT00606021|75912071|FG001|Induction Phase|Withdrawal by Subject|0|||
42101255|NCT00606021|75912072|FG002|Induction Phase|Withdrawal by Subject|0|||
42101256|NCT00606021|75912070|FG000|Induction Phase|Lost to Follow-up|10|||
42101257|NCT00606021|75912071|FG001|Induction Phase|Lost to Follow-up|0|||
42101258|NCT00606021|75912072|FG002|Induction Phase|Lost to Follow-up|0|||
42101259|NCT00606021|75912070|FG000|Maintenance Phase|Death|0|||
42101260|NCT00606021|75912071|FG001|Maintenance Phase|Death|17|||
42101261|NCT00606021|75912072|FG002|Maintenance Phase|Death|15|||
42101262|NCT00606021|75912070|FG000|Maintenance Phase|Physician Decision|0|||
42101263|NCT00606021|75912071|FG001|Maintenance Phase|Physician Decision|1|||
42101264|NCT00606021|75912072|FG002|Maintenance Phase|Physician Decision|0|||
42101265|NCT00606021|75912070|FG000|Maintenance Phase|Lost to Follow-up|0|||
42101266|NCT00606021|75912071|FG001|Maintenance Phase|Lost to Follow-up|5|||
42101267|NCT00606021|75912072|FG002|Maintenance Phase|Lost to Follow-up|2|||
42101268|NCT00337675|75912083|FG000|Overall Study|Adverse Event|10|||
42101269|NCT00337675|75912084|FG001|Overall Study|Adverse Event|9|||
42101270|NCT00337675|75912085|FG002|Overall Study|Adverse Event|19|||
42101271|NCT00337675|75912083|FG000|Overall Study|Lack of Efficacy|10|||
42101272|NCT00337675|75912084|FG001|Overall Study|Lack of Efficacy|7|||
42101273|NCT00337675|75912085|FG002|Overall Study|Lack of Efficacy|9|||
42101274|NCT00337675|75912083|FG000|Overall Study|Lost to Follow-up|22|||
42101275|NCT00337675|75912084|FG001|Overall Study|Lost to Follow-up|19|||
42101276|NCT00337675|75912085|FG002|Overall Study|Lost to Follow-up|17|||
42101277|NCT00337675|75912083|FG000|Overall Study|Physician Decision|9|||
42101278|NCT00337675|75912084|FG001|Overall Study|Physician Decision|17|||
42101279|NCT00337675|75912085|FG002|Overall Study|Physician Decision|14|||
42101280|NCT00337675|75912083|FG000|Overall Study|Protocol Violation|21|||
42101281|NCT00337675|75912084|FG001|Overall Study|Protocol Violation|24|||
42101282|NCT00337675|75912085|FG002|Overall Study|Protocol Violation|19|||
42101283|NCT00337675|75912083|FG000|Overall Study|Withdrawal by Subject|25|||
42101284|NCT00337675|75912084|FG001|Overall Study|Withdrawal by Subject|25|||
42101285|NCT00337675|75912085|FG002|Overall Study|Withdrawal by Subject|19|||
42101286|NCT00337675|75912083|FG000|Overall Study|Progressive Disease|0|||
42101287|NCT00337675|75912084|FG001|Overall Study|Progressive Disease|2|||
42367236|NCT01613027|76223506|FG000|Overall Study|Lost to Follow-up|5|||
42367237|NCT01613027|76223506|FG000|Overall Study|Switched Physician|1|||
42367238|NCT01613027|76223506|FG000|Overall Study|Lack of Efficacy|1|||
42367239|NCT01613027|76223506|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
42367240|NCT01869725|76223524|FG000|Overall Study|ineligible after registration|1|||
42367241|NCT01869725|76223524|FG000|Overall Study|Death|1|||
42367242|NCT01869725|76223524|FG000|Overall Study|Lost to Follow-up|2|||
42367243|NCT01851863|76223545|FG000|Overall Study|Did not receive study medication|2|||
42367244|NCT01851863|76223546|FG001|Overall Study|Did not receive study medication|5|||
42367245|NCT01851863|76223547|FG002|Overall Study|Did not receive study medication|3|||
42101288|NCT00337675|75912085|FG002|Overall Study|Progressive Disease|0|||
42101289|NCT00337675|75912083|FG000|Overall Study|Trial Terminated|0|||
42101290|NCT00337675|75912084|FG001|Overall Study|Trial Terminated|0|||
42101291|NCT00337675|75912085|FG002|Overall Study|Trial Terminated|2|||
42101292|NCT00337285|75912093|FG000|Overall Study|Withdrawal by Subject|42|||
42367246|NCT01851863|76223548|FG003|Overall Study|Did not receive study medication|0|||
42101293|NCT00337285|75912093|FG000|Overall Study|Lost to Follow-up|41|||
42367247|NCT01851863|76223545|FG000|Overall Study|Lost to Follow-up|3|||
42367248|NCT01851863|76223546|FG001|Overall Study|Lost to Follow-up|4|||
42367249|NCT01851863|76223547|FG002|Overall Study|Lost to Follow-up|2|||
42367250|NCT01851863|76223548|FG003|Overall Study|Lost to Follow-up|3|||
42367251|NCT01850615|76223576|FG000|Overall Study|Protocol Violation|4|||
42367252|NCT01850615|76223577|FG001|Overall Study|Protocol Violation|1|||
42367253|NCT01850615|76223576|FG000|Overall Study|Adverse Event|2|||
42367254|NCT01850615|76223577|FG001|Overall Study|Adverse Event|1|||
42367255|NCT01850615|76223576|FG000|Overall Study|Withdrawal by Subject|3|||
42367256|NCT01850615|76223577|FG001|Overall Study|Withdrawal by Subject|1|||
42367257|NCT01850615|76223576|FG000|Overall Study|Lost to Follow-up|0|||
42367258|NCT01850615|76223577|FG001|Overall Study|Lost to Follow-up|1|||
42367259|NCT01850615|76223576|FG000|Overall Study|Unclassified|0|||
42367260|NCT01850615|76223577|FG001|Overall Study|Unclassified|1|||
42367261|NCT01868477|76223662|FG000|Overall Study|Adverse Event|2|||
42367262|NCT01868477|76223663|FG001|Overall Study|Adverse Event|4|||
42367263|NCT01868477|76223662|FG000|Overall Study|Disease progression|1|||
42367264|NCT01868477|76223663|FG001|Overall Study|Disease progression|1|||
42367265|NCT01868477|76223662|FG000|Overall Study|Withdrawal by Subject|1|||
42367266|NCT01868477|76223663|FG001|Overall Study|Withdrawal by Subject|0|||
42367267|NCT01849289|76223678|FG000|Overall Study|Adverse Event|3|||
42367268|NCT01849289|76223679|FG001|Overall Study|Adverse Event|3|||
42367269|NCT01849289|76223678|FG000|Overall Study|Protocol Violation|3|||
42367270|NCT01849289|76223679|FG001|Overall Study|Protocol Violation|3|||
42367271|NCT01849289|76223678|FG000|Overall Study|Withdrawal criteria|1|||
42367272|NCT01849289|76223679|FG001|Overall Study|Withdrawal criteria|0|||
42367273|NCT01849289|76223678|FG000|Overall Study|Unclassified|25|||
42367274|NCT01849289|76223679|FG001|Overall Study|Unclassified|18|||
42367275|NCT01868243|76223687|FG000|Overall Study|Death|0|||
42367276|NCT01868243|76223688|FG001|Overall Study|Death|1|||
42367277|NCT01611935|76223696|FG000|Overall Study|Family Declined Participation|1|||
42367278|NCT01611935|76223697|FG001|Overall Study|Family Declined Participation|0|||
42367279|NCT01868165|76223703|FG000|Overall Study|Withdrawal by Subject|36|||
42367280|NCT01868165|76223703|FG000|Overall Study|Physician Decision|2|||
42367281|NCT01868165|76223703|FG000|Overall Study|Lost to Follow-up|3|||
42367282|NCT01868165|76223703|FG000|Overall Study|Death|4|||
42367283|NCT01868009|76223742|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
42367284|NCT01868009|76223743|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
42367285|NCT01868009|76223742|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
42367286|NCT01868009|76223743|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
42367287|NCT01868009|76223742|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
42367288|NCT01868009|76223743|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
42367289|NCT01849055|76223797|FG000|Overall Study|Withdrawal by Subject|0|||
42367290|NCT01849055|76223798|FG001|Overall Study|Withdrawal by Subject|0|||
42367291|NCT01849055|76223799|FG002|Overall Study|Withdrawal by Subject|1|||
42367292|NCT01849055|76223800|FG003|Overall Study|Withdrawal by Subject|0|||
42367293|NCT01849055|76223801|FG004|Overall Study|Withdrawal by Subject|0|||
42367294|NCT01849055|76223802|FG005|Overall Study|Withdrawal by Subject|0|||
42367295|NCT01848353|76223828|FG000|Phase 1|Withdrawal by Subject|3|||
42367296|NCT01848353|76223829|FG001|Phase 1|Withdrawal by Subject|1|||
42367297|NCT01848353|76223830|FG002|Phase 1|Withdrawal by Subject|0|||
42367298|NCT01848353|76223831|FG003|Phase 1|Withdrawal by Subject|0|||
42367299|NCT01848353|76223828|FG000|Phase 2|Withdrawal by Subject|3|||
42367300|NCT01848353|76223829|FG001|Phase 2|Withdrawal by Subject|2|||
42367301|NCT01848353|76223830|FG002|Phase 2|Withdrawal by Subject|0|||
42367302|NCT01848353|76223831|FG003|Phase 2|Withdrawal by Subject|0|||
42367303|NCT01848353|76223828|FG000|Phase 3|Withdrawal by Subject|1|||
42367304|NCT01848353|76223829|FG001|Phase 3|Withdrawal by Subject|1|||
42367305|NCT01848353|76223830|FG002|Phase 3|Withdrawal by Subject|0|||
42367306|NCT01848353|76223831|FG003|Phase 3|Withdrawal by Subject|0|||
42367307|NCT01847885|76223860|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
42367308|NCT01847885|76223861|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
42367309|NCT01847885|76223862|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
42367310|NCT01847885|76223860|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
42367311|NCT01847885|76223861|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
42367312|NCT01847885|76223862|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
42367313|NCT01847885|76223860|FG000|Initial Enrollment (Consented)|Screen failure|39|||
42367314|NCT01847885|76223861|FG001|Initial Enrollment (Consented)|Screen failure|0|||
42367315|NCT01847885|76223862|FG002|Initial Enrollment (Consented)|Screen failure|0|||
42367316|NCT01847885|76223860|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
42367317|NCT01847885|76223861|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
42367318|NCT01847885|76223862|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
42367319|NCT01847885|76223860|FG000|Randomization|Protocol Violation|0|||
42367320|NCT01847885|76223861|FG001|Randomization|Protocol Violation|1|||
42367321|NCT01847885|76223862|FG002|Randomization|Protocol Violation|0|||
42367322|NCT01847885|76223860|FG000|Randomization|Withdrawal by Subject|0|||
42367323|NCT01847885|76223861|FG001|Randomization|Withdrawal by Subject|0|||
42367324|NCT01847885|76223862|FG002|Randomization|Withdrawal by Subject|2|||
42367325|NCT01847885|76223860|FG000|Randomization|Screen Failure|0|||
42367326|NCT01847885|76223861|FG001|Randomization|Screen Failure|3|||
42367327|NCT01847885|76223862|FG002|Randomization|Screen Failure|0|||
42367328|NCT01867307|76223900|FG000|Overall Study|Protocol Violation|2|||
42367329|NCT01867307|76223901|FG001|Overall Study|Protocol Violation|0|||
42367330|NCT01867307|76223900|FG000|Overall Study|Other Adverse Event|1|||
42367331|NCT01867307|76223901|FG001|Overall Study|Other Adverse Event|3|||
42367332|NCT01845077|76223910|FG000|Washout Period|Lost to Follow-up|0|||
42367333|NCT01845077|76223911|FG001|Washout Period|Lost to Follow-up|1|||
42367334|NCT01845077|76223912|FG002|Washout Period|Lost to Follow-up|0|||
42367335|NCT01845077|76223913|FG003|Washout Period|Lost to Follow-up|1|||
42367336|NCT01845077|76223914|FG004|Washout Period|Lost to Follow-up|0|||
42367337|NCT01845077|76223915|FG005|Washout Period|Lost to Follow-up|1|||
42367338|NCT01845077|76223910|FG000|Washout Period|Adverse Event|1|||
42367339|NCT01845077|76223911|FG001|Washout Period|Adverse Event|0|||
42367340|NCT01845077|76223912|FG002|Washout Period|Adverse Event|0|||
42367341|NCT01845077|76223913|FG003|Washout Period|Adverse Event|0|||
42367342|NCT01845077|76223914|FG004|Washout Period|Adverse Event|0|||
42367343|NCT01845077|76223915|FG005|Washout Period|Adverse Event|0|||
42367344|NCT01845077|76223910|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
42367345|NCT01845077|76223911|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
42367346|NCT01845077|76223912|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
42367347|NCT01845077|76223913|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
42367348|NCT01845077|76223914|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
42367349|NCT01845077|76223915|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
42367350|NCT01845077|76223910|FG000|Washout Period|Protocol Violation|0|||
42367351|NCT01845077|76223911|FG001|Washout Period|Protocol Violation|0|||
42367352|NCT01845077|76223912|FG002|Washout Period|Protocol Violation|0|||
42367353|NCT01845077|76223913|FG003|Washout Period|Protocol Violation|1|||
42367354|NCT01845077|76223914|FG004|Washout Period|Protocol Violation|1|||
42367355|NCT01845077|76223915|FG005|Washout Period|Protocol Violation|0|||
42367356|NCT01866917|76223932|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
42367357|NCT01866917|76223933|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
42367358|NCT01844765|76224068|FG000|Overall Study|Adverse Event|6|||
42367359|NCT01844765|76224069|FG001|Overall Study|Adverse Event|8|||
42367360|NCT01844765|76224068|FG000|Overall Study|Withdrawal by Subject|2|||
42367361|NCT01844765|76224069|FG001|Overall Study|Withdrawal by Subject|3|||
42367362|NCT01844765|76224068|FG000|Overall Study|Disease progression|1|||
42367363|NCT01844765|76224069|FG001|Overall Study|Disease progression|0|||
42367364|NCT01844765|76224068|FG000|Overall Study|Administrative problems|3|||
42367365|NCT01844765|76224069|FG001|Overall Study|Administrative problems|4|||
42367366|NCT01844765|76224068|FG000|Overall Study|Protocol deviation|2|||
42367367|NCT01844765|76224069|FG001|Overall Study|Protocol deviation|0|||
42367368|NCT01844765|76224068|FG000|Overall Study|Untreated|1|||
42367369|NCT01844765|76224069|FG001|Overall Study|Untreated|0|||
42367370|NCT01866293|76224084|FG000|Overall Study|Adverse Event|2|||
42101294|NCT00337285|75912093|FG000|Overall Study|Adverse Event|28|||
42101295|NCT00337285|75912093|FG000|Overall Study|Protocol Violation|27|||
42101296|NCT00337285|75912093|FG000|Overall Study|Lack of Efficacy|11|||
42101297|NCT00337285|75912093|FG000|Overall Study|Death|1|||
42101298|NCT00337285|75912093|FG000|Overall Study|Physician Decision|1|||
42196743|NCT00100048|76008595|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
42367371|NCT01844687|76224088|FG000|Visit 1|Protocol Violation|3|||
42101299|NCT00337285|75912093|FG000|Overall Study|Lack of protocol compliance|7|||
42101300|NCT00605865|75912097|FG000|Overall Study|Protocol Violation|115|||
42101301|NCT00348673|75912137|FG000|Stage 1|Randomized but not Treated|0|||
42101302|NCT00348673|75912138|FG001|Stage 1|Randomized but not Treated|0|||
42101303|NCT00348673|75912139|FG002|Stage 1|Randomized but not Treated|1|||
42101304|NCT00348673|75912140|FG003|Stage 1|Randomized but not Treated|0|||
42367372|NCT01844687|76224088|FG000|Visit 1|Lost to Follow-up|5|||
42101305|NCT00348673|75912141|FG004|Stage 1|Randomized but not Treated|0|||
42367373|NCT01844687|76224088|FG000|Visit 2|Withdrawal by Subject|1|||
42367374|NCT01844687|76224088|FG000|Visit 2|Protocol Violation|1|||
42367375|NCT01844687|76224088|FG000|Visit 3|Lost to Follow-up|1|||
42101306|NCT00348673|75912142|FG005|Stage 1|Randomized but not Treated|0|||
42101307|NCT00348673|75912143|FG006|Stage 1|Randomized but not Treated|0|||
42367376|NCT01844687|76224088|FG000|Visit 3|Withdrawal by Subject|3|||
42367377|NCT01844687|76224088|FG000|Visit 3|child care problems|1|||
42101308|NCT00348673|75912144|FG007|Stage 1|Randomized but not Treated|0|||
42101309|NCT00348673|75912145|FG008|Stage 1|Randomized but not Treated|0|||
42101310|NCT00337207|75912163|FG000|Overall Study|Withdrawal by Subject|3|||
42367378|NCT01844687|76224088|FG000|Visit 4|Pregnancy|1|||
42367379|NCT01844687|76224088|FG000|Visit 4|Lost to Follow-up|1|||
42367380|NCT01844687|76224088|FG000|Visit 4|Withdrawal by Subject|2|||
42367381|NCT01844531|76224114|FG000|Overall Study|Withdrawal by Subject|0|||
42367382|NCT01844531|76224115|FG001|Overall Study|Withdrawal by Subject|1|||
42367383|NCT01844531|76224116|FG002|Overall Study|Withdrawal by Subject|0|||
42367384|NCT01844531|76224117|FG003|Overall Study|Withdrawal by Subject|0|||
42367385|NCT01844375|76224129|FG000|Overall Study|Protocol Violation|1|||
42367386|NCT01844375|76224130|FG001|Overall Study|Protocol Violation|1|||
42367387|NCT02367456|76224139|FG000|Overall Study|Death|8|||
42367388|NCT02367456|76224140|FG001|Overall Study|Death|24|||
42367389|NCT02367456|76224141|FG002|Overall Study|Death|17|||
42367390|NCT02367456|76224139|FG000|Overall Study|Lost to Follow-up|1|||
42367391|NCT02367456|76224140|FG001|Overall Study|Lost to Follow-up|3|||
42367392|NCT02367456|76224141|FG002|Overall Study|Lost to Follow-up|1|||
42367393|NCT02367456|76224139|FG000|Overall Study|Other reason|3|||
42367394|NCT02367456|76224140|FG001|Overall Study|Other reason|3|||
42367395|NCT02367456|76224141|FG002|Overall Study|Other reason|9|||
42101311|NCT00604695|75912170|FG000|Overall Study|Did not receive first bolus.|0|||
42101312|NCT00604695|75912171|FG001|Overall Study|Did not receive first bolus.|4|||
42101313|NCT00348595|75912179|FG000|Overall Study|Adverse Event|5|||
42101314|NCT00348595|75912180|FG001|Overall Study|Adverse Event|8|||
42101315|NCT00337129|75912186|FG000|Overall Study|Adverse Event|4|||
42101316|NCT00337129|75912186|FG000|Overall Study|Withdrawal by Subject|1|||
42101317|NCT00337129|75912186|FG000|Overall Study|Lack of Efficacy|32|||
42101318|NCT00337129|75912186|FG000|Overall Study|Death|2|||
42101319|NCT00337129|75912186|FG000|Overall Study|not protocol specified|1|||
42101320|NCT00605085|75912192|FG000|Overall Study|Withdrawal by Subject|8|||
42101321|NCT00605085|75912193|FG001|Overall Study|Withdrawal by Subject|5|||
42101322|NCT00605085|75912192|FG000|Overall Study|Adverse Event|9|||
42101323|NCT00605085|75912193|FG001|Overall Study|Adverse Event|5|||
42101324|NCT00605085|75912192|FG000|Overall Study|Pregnancy|2|||
42101325|NCT00605085|75912193|FG001|Overall Study|Pregnancy|0|||
42101326|NCT00605085|75912192|FG000|Overall Study|Protocol Violation|3|||
42101327|NCT00605085|75912193|FG001|Overall Study|Protocol Violation|2|||
42101328|NCT00605085|75912192|FG000|Overall Study|Lost to Follow-up|10|||
42101329|NCT00605085|75912193|FG001|Overall Study|Lost to Follow-up|5|||
42101330|NCT00605085|75912192|FG000|Overall Study|administrative reasons|18|||
42101331|NCT00605085|75912193|FG001|Overall Study|administrative reasons|8|||
42101332|NCT00348283|75912201|FG000|Induction|Adverse Event|0|||
42101333|NCT00348283|75912202|FG001|Induction|Adverse Event|2|||
42101334|NCT00348283|75912201|FG000|Induction|Protocol Violation|0|||
42101335|NCT00348283|75912202|FG001|Induction|Protocol Violation|4|||
42101336|NCT00348283|75912201|FG000|Double Blind|Adverse Event|2|||
42101337|NCT00348283|75912202|FG001|Double Blind|Adverse Event|5|||
42101338|NCT00348283|75912201|FG000|Double Blind|Withdrawal by Subject|1|||
42101339|NCT00348283|75912202|FG001|Double Blind|Withdrawal by Subject|1|||
42101340|NCT00348283|75912201|FG000|Double Blind|Protocol Violation|0|||
42101341|NCT00348283|75912202|FG001|Double Blind|Protocol Violation|1|||
42101342|NCT00348283|75912201|FG000|Double Blind|Lack of Efficacy|2|||
42101343|NCT00348283|75912202|FG001|Double Blind|Lack of Efficacy|2|||
42101344|NCT00348283|75912201|FG000|Double Blind|Pregnancy|0|||
42101345|NCT00348283|75912202|FG001|Double Blind|Pregnancy|1|||
42101346|NCT00348283|75912201|FG000|Open Label|Adverse Event|0|||
42101347|NCT00348283|75912202|FG001|Open Label|Adverse Event|8|||
42101348|NCT00348283|75912201|FG000|Open Label|Withdrawal by Subject|0|||
42101349|NCT00348283|75912202|FG001|Open Label|Withdrawal by Subject|4|||
42101350|NCT00348283|75912201|FG000|Open Label|Lost to Follow-up|0|||
42101351|NCT00348283|75912202|FG001|Open Label|Lost to Follow-up|1|||
42101352|NCT00348283|75912201|FG000|Open Label|Lack of Efficacy|0|||
42101353|NCT00348283|75912202|FG001|Open Label|Lack of Efficacy|13|||
42101354|NCT00348283|75912201|FG000|Open Label|Administrative reasons|0|||
42101355|NCT00348283|75912202|FG001|Open Label|Administrative reasons|5|||
42101356|NCT00348283|75912201|FG000|Open Label|Subject moved to the United States|0|||
42101357|NCT00348283|75912202|FG001|Open Label|Subject moved to the United States|1|||
42101358|NCT00348283|75912201|FG000|Open Label|Pregnancy|0|||
42101359|NCT00348283|75912202|FG001|Open Label|Pregnancy|1|||
42101360|NCT00348283|75912201|FG000|Open Label|Sponsor decision|0|||
42101361|NCT00348283|75912202|FG001|Open Label|Sponsor decision|1|||
42101362|NCT00336895|75912208|FG000|Overall Study|diarrhea|1|||
42101363|NCT00336895|75912208|FG000|Overall Study|nausea and upset stomach|1|||
42101364|NCT00336895|75912208|FG000|Overall Study|Physician Decision|1|||
42101365|NCT00336895|75912208|FG000|Overall Study|screen failed|1|||
42101366|NCT00336583|75912212|FG000|Overall Study|Lost to Follow-up|1|||
42101367|NCT00336583|75912212|FG000|Overall Study|Death|1|||
42101368|NCT00336505|75912218|FG000|Overall Study|Adverse Event|10|||
42367396|NCT02367456|76224139|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
42367397|NCT02367456|76224140|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
42367398|NCT02367456|76224141|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
42367399|NCT01865747|76224172|FG000|Overall Study (ITT)|Adverse Event|32|||
42101369|NCT00336505|75912219|FG001|Overall Study|Adverse Event|9|||
42101370|NCT00336505|75912218|FG000|Overall Study|Lack of Efficacy|8|||
42101371|NCT00336505|75912219|FG001|Overall Study|Lack of Efficacy|4|||
42367400|NCT01865747|76224173|FG001|Overall Study (ITT)|Adverse Event|31|||
42367401|NCT01865747|76224172|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
42367402|NCT01865747|76224173|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
42367403|NCT01865747|76224172|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
42367404|NCT01865747|76224173|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
42367405|NCT01865747|76224172|FG000|Overall Study (ITT)|Protocol Violation|1|||
42367406|NCT01865747|76224173|FG001|Overall Study (ITT)|Protocol Violation|1|||
42367407|NCT01865747|76224172|FG000|Overall Study (ITT)|Physician Decision|5|||
42367408|NCT01865747|76224173|FG001|Overall Study (ITT)|Physician Decision|2|||
42367409|NCT01865747|76224172|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
42367410|NCT01865747|76224173|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
42367411|NCT01865747|76224172|FG000|Overall Study (ITT)|Sponsor Decision|0|||
42367412|NCT01865747|76224173|FG001|Overall Study (ITT)|Sponsor Decision|1|||
42367413|NCT01865747|76224172|FG000|Overall Study (ITT)|Progressive Disease|122|||
42367414|NCT01865747|76224173|FG001|Overall Study (ITT)|Progressive Disease|158|||
42367415|NCT01865747|76224172|FG000|Overall Study (ITT)|Reason Not Provided|0|||
42367416|NCT01865747|76224173|FG001|Overall Study (ITT)|Reason Not Provided|1|||
42367417|NCT01865747|76224172|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
42367418|NCT01865747|76224173|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
42367419|NCT01865747|76224172|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
42367420|NCT01865747|76224173|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
42367421|NCT01865747|76224172|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
42367422|NCT01865747|76224173|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
42367423|NCT01865747|76224172|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
42367424|NCT01865747|76224173|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
42367425|NCT01865747|76224172|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
42367426|NCT01865747|76224173|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
42367427|NCT01865747|76224172|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
42367428|NCT01865747|76224173|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
42367429|NCT01865747|76224172|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
42367430|NCT01865747|76224173|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
42367431|NCT01865747|76224172|FG000|Primary Intent to Treat (PITT)|Other|0|||
42367432|NCT01865747|76224173|FG001|Primary Intent to Treat (PITT)|Other|1|||
42367433|NCT01843673|76224214|FG000|Overall Study|Lack of Efficacy|2|||
42367434|NCT01843673|76224214|FG000|Overall Study|Withdrawal by Subject|4|||
42367435|NCT01843205|76224233|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
42367436|NCT01843205|76224234|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
42367437|NCT01835015|76224321|FG000|Overall Study|Adverse Event|0|||
42367438|NCT01835015|76224322|FG001|Overall Study|Adverse Event|0|||
42367439|NCT01835015|76224323|FG002|Overall Study|Adverse Event|1|||
42367440|NCT01835015|76224324|FG003|Overall Study|Adverse Event|0|||
42367441|NCT01835015|76224325|FG004|Overall Study|Adverse Event|0|||
42367442|NCT01842581|76224353|FG000|Overall Study|Adverse Event|6|||
42367443|NCT01842581|76224354|FG001|Overall Study|Adverse Event|4|||
42367444|NCT01842581|76224353|FG000|Overall Study|HE breakthrough|26|||
42367445|NCT01842581|76224354|FG001|Overall Study|HE breakthrough|13|||
42367446|NCT01842581|76224353|FG000|Overall Study|Liver transplant|2|||
42367447|NCT01842581|76224354|FG001|Overall Study|Liver transplant|0|||
42367448|NCT01842581|76224353|FG000|Overall Study|Lost to Follow-up|2|||
42367449|NCT01842581|76224354|FG001|Overall Study|Lost to Follow-up|5|||
42367450|NCT01842581|76224353|FG000|Overall Study|Withdrawal by Subject|5|||
42367451|NCT01842581|76224354|FG001|Overall Study|Withdrawal by Subject|7|||
42367452|NCT01842581|76224353|FG000|Overall Study|Other than specified|3|||
42367453|NCT01842581|76224354|FG001|Overall Study|Other than specified|1|||
42367454|NCT01833533|76224362|FG000|Overall Study|Adverse Event|0|||
42367455|NCT01833533|76224363|FG001|Overall Study|Adverse Event|1|||
42367456|NCT01833533|76224362|FG000|Overall Study|Lost to Follow-up|4|||
42367457|NCT01833533|76224363|FG001|Overall Study|Lost to Follow-up|9|||
42367458|NCT01833533|76224362|FG000|Overall Study|To Enter an Extension Study|0|||
42367459|NCT01833533|76224363|FG001|Overall Study|To Enter an Extension Study|4|||
42367460|NCT01833533|76224362|FG000|Overall Study|Other|2|||
42367461|NCT01833533|76224363|FG001|Overall Study|Other|7|||
42367462|NCT01833455|76224371|FG000|Overall Study|Withdrawal by Subject|1|||
42367463|NCT01833455|76224372|FG001|Overall Study|Withdrawal by Subject|0|||
42367464|NCT01833143|76224390|FG000|Overall Study|Not Treated|1|||
42101372|NCT00336505|75912218|FG000|Overall Study|Lost to Follow-up|7|||
42101373|NCT00336505|75912219|FG001|Overall Study|Lost to Follow-up|4|||
42367465|NCT01841567|76224394|FG000|Overall Study|Adverse Event|3|||
42367466|NCT01833065|76224401|FG000|Overall Study|Adverse Event|6|||
42367467|NCT01833065|76224402|FG001|Overall Study|Adverse Event|1|||
42367468|NCT01833065|76224403|FG002|Overall Study|Adverse Event|0|||
42367469|NCT01833065|76224404|FG003|Overall Study|Adverse Event|2|||
42367470|NCT01833065|76224405|FG004|Overall Study|Adverse Event|3|||
42367471|NCT01833065|76224401|FG000|Overall Study|Protocol Violation|1|||
42367472|NCT01833065|76224402|FG001|Overall Study|Protocol Violation|0|||
42367473|NCT01833065|76224403|FG002|Overall Study|Protocol Violation|0|||
42367474|NCT01833065|76224404|FG003|Overall Study|Protocol Violation|0|||
42367475|NCT01833065|76224405|FG004|Overall Study|Protocol Violation|2|||
42367476|NCT01833065|76224401|FG000|Overall Study|Lost to Follow-up|1|||
42367477|NCT01833065|76224402|FG001|Overall Study|Lost to Follow-up|0|||
42367478|NCT01833065|76224403|FG002|Overall Study|Lost to Follow-up|0|||
42367479|NCT01833065|76224404|FG003|Overall Study|Lost to Follow-up|0|||
42367480|NCT01833065|76224405|FG004|Overall Study|Lost to Follow-up|3|||
42367481|NCT01833065|76224401|FG000|Overall Study|Withdrawal by Subject|6|||
42367482|NCT01833065|76224402|FG001|Overall Study|Withdrawal by Subject|2|||
42367483|NCT01833065|76224403|FG002|Overall Study|Withdrawal by Subject|4|||
42367484|NCT01833065|76224404|FG003|Overall Study|Withdrawal by Subject|3|||
42367485|NCT01833065|76224405|FG004|Overall Study|Withdrawal by Subject|11|||
42367486|NCT01833065|76224401|FG000|Overall Study|Subject's substantial non-compliance|0|||
42367487|NCT01833065|76224402|FG001|Overall Study|Subject's substantial non-compliance|1|||
42367488|NCT01833065|76224403|FG002|Overall Study|Subject's substantial non-compliance|0|||
42367489|NCT01833065|76224404|FG003|Overall Study|Subject's substantial non-compliance|0|||
42367490|NCT01833065|76224405|FG004|Overall Study|Subject's substantial non-compliance|0|||
42367491|NCT01833065|76224401|FG000|Overall Study|Trial terminated by sponsor|8|||
42367492|NCT01833065|76224402|FG001|Overall Study|Trial terminated by sponsor|8|||
42367493|NCT01833065|76224403|FG002|Overall Study|Trial terminated by sponsor|7|||
42367494|NCT01833065|76224404|FG003|Overall Study|Trial terminated by sponsor|3|||
42367495|NCT01833065|76224405|FG004|Overall Study|Trial terminated by sponsor|13|||
42367496|NCT01833065|76224401|FG000|Overall Study|Others|2|||
42367497|NCT01833065|76224402|FG001|Overall Study|Others|1|||
42367498|NCT01833065|76224403|FG002|Overall Study|Others|1|||
42367499|NCT01833065|76224404|FG003|Overall Study|Others|1|||
42367500|NCT01833065|76224405|FG004|Overall Study|Others|4|||
42367501|NCT01831817|76224419|FG000|Overall Study|Lost to Follow-up|1|||
42367502|NCT01831817|76224420|FG001|Overall Study|Lost to Follow-up|0|||
42367503|NCT01831817|76224421|FG002|Overall Study|Lost to Follow-up|0|||
42367504|NCT01831817|76224422|FG003|Overall Study|Lost to Follow-up|0|||
42367505|NCT01831817|76224419|FG000|Overall Study|Withdrawl of Consent|3|||
42367506|NCT01831817|76224420|FG001|Overall Study|Withdrawl of Consent|0|||
42367507|NCT01831817|76224421|FG002|Overall Study|Withdrawl of Consent|0|||
42367508|NCT01831817|76224422|FG003|Overall Study|Withdrawl of Consent|0|||
42367509|NCT01840943|76224447|FG000|Overall Study|Withdrawal by Subject|5|||
42367510|NCT01840943|76224448|FG001|Overall Study|Withdrawal by Subject|6|||
42367511|NCT01840943|76224447|FG000|Overall Study|Physician Decision|4|||
42367512|NCT01840943|76224448|FG001|Overall Study|Physician Decision|2|||
42367513|NCT01840943|76224447|FG000|Overall Study|Lost to Follow-up|4|||
42367514|NCT01840943|76224448|FG001|Overall Study|Lost to Follow-up|4|||
42367515|NCT01840163|76224456|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
42367516|NCT01840163|76224457|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
42367517|NCT01840163|76224456|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
42367518|NCT01840163|76224457|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
42367519|NCT01840163|76224456|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
42367520|NCT01840163|76224457|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
42367521|NCT01831427|76224610|FG000|Overall Study|Adverse Event|0|||
42367522|NCT01831427|76224611|FG001|Overall Study|Adverse Event|1|||
42367523|NCT01831427|76224612|FG002|Overall Study|Adverse Event|0|||
42367524|NCT01831427|76224613|FG003|Overall Study|Adverse Event|0|||
42367525|NCT01831427|76224614|FG004|Overall Study|Adverse Event|0|||
42367526|NCT01831427|76224615|FG005|Overall Study|Adverse Event|1|||
42367527|NCT01831427|76224616|FG006|Overall Study|Adverse Event|0|||
42367528|NCT01831427|76224617|FG007|Overall Study|Adverse Event|1|||
42367529|NCT01831427|76224618|FG008|Overall Study|Adverse Event|0|||
42367530|NCT01831427|76224619|FG009|Overall Study|Adverse Event|0|||
42367531|NCT01831427|76224620|FG010|Overall Study|Adverse Event|2|||
42367532|NCT01831427|76224610|FG000|Overall Study|Investigator's Discretion|0|||
42367533|NCT01831427|76224611|FG001|Overall Study|Investigator's Discretion|0|||
42367534|NCT01831427|76224612|FG002|Overall Study|Investigator's Discretion|0|||
42367535|NCT01831427|76224613|FG003|Overall Study|Investigator's Discretion|1|||
42367536|NCT01831427|76224614|FG004|Overall Study|Investigator's Discretion|0|||
42367537|NCT01831427|76224615|FG005|Overall Study|Investigator's Discretion|0|||
42367538|NCT01831427|76224616|FG006|Overall Study|Investigator's Discretion|0|||
42367539|NCT01831427|76224617|FG007|Overall Study|Investigator's Discretion|0|||
42367540|NCT01831427|76224618|FG008|Overall Study|Investigator's Discretion|0|||
42367541|NCT01831427|76224619|FG009|Overall Study|Investigator's Discretion|0|||
42367542|NCT01831427|76224620|FG010|Overall Study|Investigator's Discretion|0|||
42367543|NCT01831427|76224610|FG000|Overall Study|Withdrew Consent|0|||
42367544|NCT01831427|76224611|FG001|Overall Study|Withdrew Consent|0|||
42367545|NCT01831427|76224612|FG002|Overall Study|Withdrew Consent|0|||
42367546|NCT01831427|76224613|FG003|Overall Study|Withdrew Consent|0|||
42367547|NCT01831427|76224614|FG004|Overall Study|Withdrew Consent|0|||
42367548|NCT01831427|76224615|FG005|Overall Study|Withdrew Consent|0|||
42367549|NCT01831427|76224616|FG006|Overall Study|Withdrew Consent|2|||
42367550|NCT01831427|76224617|FG007|Overall Study|Withdrew Consent|0|||
42367551|NCT01831427|76224618|FG008|Overall Study|Withdrew Consent|0|||
42367552|NCT01831427|76224619|FG009|Overall Study|Withdrew Consent|1|||
42367553|NCT01831427|76224620|FG010|Overall Study|Withdrew Consent|1|||
42367554|NCT01830881|76224666|FG000|Overall Study|Changed decision to have an abortion|0|||
42367555|NCT01830881|76224667|FG001|Overall Study|Changed decision to have an abortion|1|||
42367556|NCT01838681|76224703|FG000|Period A|Adverse Event|39|||
42367557|NCT01838681|76224704|FG001|Period A|Adverse Event|0|||
42367558|NCT01838681|76224705|FG002|Period A|Adverse Event|0|||
42367559|NCT01838681|76224706|FG003|Period A|Adverse Event|0|||
42367560|NCT01838681|76224703|FG000|Period A|Lack of Efficacy|21|||
42367561|NCT01838681|76224704|FG001|Period A|Lack of Efficacy|0|||
42367562|NCT01838681|76224705|FG002|Period A|Lack of Efficacy|0|||
42367563|NCT01838681|76224706|FG003|Period A|Lack of Efficacy|0|||
42367564|NCT01838681|76224703|FG000|Period A|Early response|148|||
42367565|NCT01838681|76224704|FG001|Period A|Early response|0|||
42367566|NCT01838681|76224705|FG002|Period A|Early response|0|||
42367567|NCT01838681|76224706|FG003|Period A|Early response|0|||
42367568|NCT01838681|76224703|FG000|Period A|Withdrawal by Subject|70|||
42367569|NCT01838681|76224704|FG001|Period A|Withdrawal by Subject|0|||
42367570|NCT01838681|76224705|FG002|Period A|Withdrawal by Subject|0|||
42367571|NCT01838681|76224706|FG003|Period A|Withdrawal by Subject|0|||
42367572|NCT01838681|76224703|FG000|Period A|Protocol Violation|16|||
42367573|NCT01838681|76224704|FG001|Period A|Protocol Violation|0|||
42367574|NCT01838681|76224705|FG002|Period A|Protocol Violation|0|||
42367575|NCT01838681|76224706|FG003|Period A|Protocol Violation|0|||
42367576|NCT01838681|76224703|FG000|Period A|Non-compliance with IMP|6|||
42367577|NCT01838681|76224704|FG001|Period A|Non-compliance with IMP|0|||
42367578|NCT01838681|76224705|FG002|Period A|Non-compliance with IMP|0|||
42367579|NCT01838681|76224706|FG003|Period A|Non-compliance with IMP|0|||
42367580|NCT01838681|76224703|FG000|Period A|Lost to Follow-up|4|||
42367581|NCT01838681|76224704|FG001|Period A|Lost to Follow-up|0|||
42367582|NCT01838681|76224705|FG002|Period A|Lost to Follow-up|0|||
42367583|NCT01838681|76224706|FG003|Period A|Lost to Follow-up|0|||
42367584|NCT01838681|76224703|FG000|Period A|Withdrawal before treatment|4|||
42367585|NCT01838681|76224704|FG001|Period A|Withdrawal before treatment|0|||
42367586|NCT01838681|76224705|FG002|Period A|Withdrawal before treatment|0|||
42367587|NCT01838681|76224706|FG003|Period A|Withdrawal before treatment|0|||
42367588|NCT01838681|76224703|FG000|Period A|Administrative or other reasons|17|||
42367589|NCT01838681|76224704|FG001|Period A|Administrative or other reasons|0|||
42367590|NCT01838681|76224705|FG002|Period A|Administrative or other reasons|0|||
42367591|NCT01838681|76224706|FG003|Period A|Administrative or other reasons|0|||
42367592|NCT01838681|76224703|FG000|Period B/A+|Adverse Event|0|||
42367593|NCT01838681|76224704|FG001|Period B/A+|Adverse Event|13|||
42367594|NCT01838681|76224705|FG002|Period B/A+|Adverse Event|27|||
42367595|NCT01838681|76224706|FG003|Period B/A+|Adverse Event|16|||
42367596|NCT01838681|76224703|FG000|Period B/A+|Lack of Efficacy|0|||
42367597|NCT01838681|76224704|FG001|Period B/A+|Lack of Efficacy|9|||
42367598|NCT01838681|76224705|FG002|Period B/A+|Lack of Efficacy|11|||
42367599|NCT01838681|76224706|FG003|Period B/A+|Lack of Efficacy|6|||
42367600|NCT01838681|76224703|FG000|Period B/A+|Withdrawal by Subject|0|||
42367601|NCT01838681|76224704|FG001|Period B/A+|Withdrawal by Subject|28|||
42367602|NCT01838681|76224705|FG002|Period B/A+|Withdrawal by Subject|35|||
42367603|NCT01838681|76224706|FG003|Period B/A+|Withdrawal by Subject|47|||
42367604|NCT01838681|76224703|FG000|Period B/A+|Protocol Violation|0|||
42367605|NCT01838681|76224704|FG001|Period B/A+|Protocol Violation|1|||
42367606|NCT01838681|76224705|FG002|Period B/A+|Protocol Violation|4|||
42367607|NCT01838681|76224706|FG003|Period B/A+|Protocol Violation|6|||
42367608|NCT01838681|76224703|FG000|Period B/A+|Non-compliance with IMP|0|||
42367609|NCT01838681|76224704|FG001|Period B/A+|Non-compliance with IMP|2|||
42367610|NCT01838681|76224705|FG002|Period B/A+|Non-compliance with IMP|3|||
42367611|NCT01838681|76224706|FG003|Period B/A+|Non-compliance with IMP|3|||
42367612|NCT01838681|76224703|FG000|Period B/A+|Lost to Follow-up|0|||
42367613|NCT01838681|76224704|FG001|Period B/A+|Lost to Follow-up|2|||
42367614|NCT01838681|76224705|FG002|Period B/A+|Lost to Follow-up|5|||
42367615|NCT01838681|76224706|FG003|Period B/A+|Lost to Follow-up|11|||
42367616|NCT01838681|76224703|FG000|Period B/A+|Withdrawal before treatment|0|||
42367617|NCT01838681|76224704|FG001|Period B/A+|Withdrawal before treatment|1|||
42367618|NCT01838681|76224705|FG002|Period B/A+|Withdrawal before treatment|0|||
42367619|NCT01838681|76224706|FG003|Period B/A+|Withdrawal before treatment|0|||
42367620|NCT01838681|76224703|FG000|Period B/A+|Administrative or other reasons|0|||
42367621|NCT01838681|76224704|FG001|Period B/A+|Administrative or other reasons|6|||
42367622|NCT01838681|76224705|FG002|Period B/A+|Administrative or other reasons|10|||
42367623|NCT01838681|76224706|FG003|Period B/A+|Administrative or other reasons|28|||
42367624|NCT01611857|76224764|FG000|Overall Study|Withdrawal by Subject|0|||
42367625|NCT01611857|76224765|FG001|Overall Study|Withdrawal by Subject|2|||
42367626|NCT01829477|76224788|FG000|Overall Study|Study Terminated by Sponsor|15|||
42367627|NCT01829477|76224789|FG001|Overall Study|Study Terminated by Sponsor|15|||
42367628|NCT01829477|76224788|FG000|Overall Study|Withdrawal by Subject|1|||
42367629|NCT01829477|76224789|FG001|Overall Study|Withdrawal by Subject|0|||
42367630|NCT01611155|76224805|FG000|Overall Study|Adverse Event|1|||
42367631|NCT01611155|76224806|FG001|Overall Study|Adverse Event|1|||
42367632|NCT01611155|76224805|FG000|Overall Study|Refused further treatment|6|||
42367633|NCT01611155|76224806|FG001|Overall Study|Refused further treatment|4|||
42367634|NCT01611155|76224805|FG000|Overall Study|Disease progression|1|||
42367635|NCT01611155|76224806|FG001|Overall Study|Disease progression|0|||
42367636|NCT01611155|76224805|FG000|Overall Study|Withdrawal by Subject|1|||
42367637|NCT01611155|76224806|FG001|Overall Study|Withdrawal by Subject|0|||
42367638|NCT01611155|76224805|FG000|Overall Study|Alternative treatment|0|||
42367639|NCT01611155|76224806|FG001|Overall Study|Alternative treatment|1|||
42367640|NCT01611155|76224805|FG000|Overall Study|Ineligible patient|0|||
42367641|NCT01611155|76224806|FG001|Overall Study|Ineligible patient|1|||
42367642|NCT01829243|76224821|FG000|First Intervention|Screen Failure|4|||
42367643|NCT01829243|76224822|FG001|First Intervention|Screen Failure|2|||
42367644|NCT01838447|76224832|FG000|Overall Study|Change in surgical plan|1|||
42367645|NCT01838447|76224833|FG001|Overall Study|Change in surgical plan|2|||
42367646|NCT01838447|76224832|FG000|Overall Study|Withdrawal by Subject|1|||
42367647|NCT01838447|76224833|FG001|Overall Study|Withdrawal by Subject|1|||
42367648|NCT01829165|76224841|FG000|Overall Study|Did not complete intervention|2|||
42367649|NCT01829165|76224842|FG001|Overall Study|Did not complete intervention|0|||
42018569|NCT01257503|75825956|FG000|Overall Study|strep culture positive at enrollment|1|||
42367650|NCT01838213|76224850|FG000|Overall Study|Ineligible|166|||
42367651|NCT01838213|76224851|FG001|Overall Study|Ineligible|191|||
42367652|NCT01837823|76224857|FG000|Overall Study|Lost to Follow-up|6|||
42367653|NCT01828073|76224867|FG000|Overall Study|Lost to Follow-up|1|||
42367654|NCT01828073|76224868|FG001|Overall Study|Lost to Follow-up|2|||
42367655|NCT03819114|76224888|FG000|Overall Study|Protocol Violation|0|||
42367656|NCT03819114|76224889|FG001|Overall Study|Protocol Violation|1|||
42367657|NCT03819114|76224890|FG002|Overall Study|Protocol Violation|1|||
42367658|NCT03819114|76224891|FG003|Overall Study|Protocol Violation|0|||
42367659|NCT03819114|76224888|FG000|Overall Study|Lost to Follow-up|0|||
42367660|NCT03819114|76224889|FG001|Overall Study|Lost to Follow-up|0|||
42367661|NCT03819114|76224890|FG002|Overall Study|Lost to Follow-up|1|||
42367662|NCT03819114|76224891|FG003|Overall Study|Lost to Follow-up|0|||
42367663|NCT01827839|76224903|FG000|Overall Study|Adverse Event|1|||
42367664|NCT01827839|76224903|FG000|Overall Study|Consent Withdrawal|2|||
42367665|NCT01827371|76224918|FG000|Overall Study|Adverse Event|0|||
42367666|NCT01827371|76224919|FG001|Overall Study|Adverse Event|0|||
42367667|NCT01827371|76224920|FG002|Overall Study|Adverse Event|4|||
42367668|NCT01827371|76224921|FG003|Overall Study|Adverse Event|2|||
42367669|NCT01827371|76224918|FG000|Overall Study|Lost to Follow-up|0|||
42367670|NCT01827371|76224919|FG001|Overall Study|Lost to Follow-up|2|||
42367671|NCT01827371|76224920|FG002|Overall Study|Lost to Follow-up|0|||
42367672|NCT01827371|76224921|FG003|Overall Study|Lost to Follow-up|4|||
42367673|NCT01827371|76224918|FG000|Overall Study|Protocol Violation|1|||
42367674|NCT01827371|76224919|FG001|Overall Study|Protocol Violation|0|||
42367675|NCT01827371|76224920|FG002|Overall Study|Protocol Violation|0|||
42367676|NCT01827371|76224921|FG003|Overall Study|Protocol Violation|0|||
42367677|NCT01827371|76224918|FG000|Overall Study|Withdrawal by Subject|1|||
42367678|NCT01827371|76224919|FG001|Overall Study|Withdrawal by Subject|2|||
42367679|NCT01827371|76224920|FG002|Overall Study|Withdrawal by Subject|2|||
42367680|NCT01827371|76224921|FG003|Overall Study|Withdrawal by Subject|3|||
42367681|NCT01827371|76224918|FG000|Overall Study|Physician Decision|0|||
42367682|NCT01827371|76224919|FG001|Overall Study|Physician Decision|1|||
42367683|NCT01827371|76224920|FG002|Overall Study|Physician Decision|0|||
42367684|NCT01827371|76224921|FG003|Overall Study|Physician Decision|1|||
42367685|NCT01827371|76224918|FG000|Overall Study|Temporary study halt to vaccinations|11|||
42367686|NCT01827371|76224919|FG001|Overall Study|Temporary study halt to vaccinations|2|||
42367687|NCT01827371|76224920|FG002|Overall Study|Temporary study halt to vaccinations|5|||
42367688|NCT01827371|76224921|FG003|Overall Study|Temporary study halt to vaccinations|13|||
42367689|NCT04409262|76225100|FG000|Overall Study|Adverse Event|0|||
42367690|NCT04409262|76225101|FG001|Overall Study|Adverse Event|2|||
42367691|NCT04409262|76225100|FG000|Overall Study|Death|55|||
42367692|NCT04409262|76225101|FG001|Overall Study|Death|97|||
42367693|NCT04409262|76225100|FG000|Overall Study|Lost to Follow-up|12|||
42367694|NCT04409262|76225101|FG001|Overall Study|Lost to Follow-up|23|||
42367695|NCT04409262|76225100|FG000|Overall Study|Lack of Staff|0|||
42367696|NCT04409262|76225101|FG001|Overall Study|Lack of Staff|1|||
42367697|NCT04409262|76225100|FG000|Overall Study|Protocol Violation|3|||
42367698|NCT04409262|76225101|FG001|Overall Study|Protocol Violation|1|||
42367699|NCT04409262|76225100|FG000|Overall Study|Withdrawal by Subject|5|||
42367700|NCT04409262|76225101|FG001|Overall Study|Withdrawal by Subject|10|||
42367701|NCT04305912|76225145|FG000|First Intervention|COVID-19 Suspension|2|||
42367702|NCT04305912|76225146|FG001|First Intervention|COVID-19 Suspension|0|||
42367703|NCT04305912|76225145|FG000|First Intervention|Withdrawal by Subject|0|||
42367704|NCT04305912|76225146|FG001|First Intervention|Withdrawal by Subject|1|||
42367705|NCT04305912|76225145|FG000|Second Intervention|Adverse Event|0|||
42367706|NCT04305912|76225146|FG001|Second Intervention|Adverse Event|1|||
42367707|NCT00782184|76225375|FG000|Overall Study|Adverse Event|1|||
42367708|NCT00782184|76225376|FG001|Overall Study|Adverse Event|2|||
42367709|NCT00782184|76225375|FG000|Overall Study|Protocol Violation|0|||
42367710|NCT00782184|76225376|FG001|Overall Study|Protocol Violation|1|||
42367711|NCT00782184|76225375|FG000|Overall Study|Withdrawal by Subject|3|||
42367712|NCT00782184|76225376|FG001|Overall Study|Withdrawal by Subject|2|||
42367713|NCT02731638|76225412|FG000|Overall Study|Lost to Follow-up|6|||
42367714|NCT02731638|76225413|FG001|Overall Study|Lost to Follow-up|9|||
42367715|NCT03730662|76225860|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
42367716|NCT03730662|76225861|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
42367717|NCT03730662|76225862|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
42367718|NCT03730662|76225863|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
42367719|NCT03730662|76225860|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
42367720|NCT03730662|76225861|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
42367721|NCT03730662|76225862|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
42367722|NCT03730662|76225863|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
42367723|NCT03730662|76225860|FG000|Treatment Period (52 Weeks)|Death|6|||
42367724|NCT03730662|76225861|FG001|Treatment Period (52 Weeks)|Death|2|||
42367725|NCT03730662|76225862|FG002|Treatment Period (52 Weeks)|Death|2|||
42367726|NCT03730662|76225863|FG003|Treatment Period (52 Weeks)|Death|9|||
42367727|NCT03730662|76225860|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
42367728|NCT03730662|76225861|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
42367729|NCT03730662|76225862|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
42367730|NCT03730662|76225863|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
42367731|NCT03730662|76225860|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
42367732|NCT03730662|76225861|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
42367733|NCT03730662|76225862|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
42367734|NCT03730662|76225863|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
42367735|NCT03730662|76225860|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
42367736|NCT03730662|76225861|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
42367737|NCT03730662|76225862|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
42367738|NCT03730662|76225863|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
42367739|NCT03730662|76225860|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
42367740|NCT03730662|76225861|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
42367741|NCT03730662|76225862|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
42367742|NCT03730662|76225863|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
42367743|NCT03730662|76225860|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
42367744|NCT03730662|76225861|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
42367745|NCT03730662|76225862|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
42367746|NCT03730662|76225863|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
42367747|NCT03730662|76225860|FG000|Variable Treatment Period|Adverse Event|1|||
42367748|NCT03730662|76225861|FG001|Variable Treatment Period|Adverse Event|2|||
42367749|NCT03730662|76225862|FG002|Variable Treatment Period|Adverse Event|0|||
42367750|NCT03730662|76225863|FG003|Variable Treatment Period|Adverse Event|7|||
42367751|NCT03730662|76225860|FG000|Variable Treatment Period|Death|9|||
42367752|NCT03730662|76225861|FG001|Variable Treatment Period|Death|0|||
42367753|NCT03730662|76225862|FG002|Variable Treatment Period|Death|6|||
42367754|NCT03730662|76225863|FG003|Variable Treatment Period|Death|26|||
42367755|NCT03730662|76225860|FG000|Variable Treatment Period|Lost to Follow-up|2|||
42367756|NCT03730662|76225861|FG001|Variable Treatment Period|Lost to Follow-up|1|||
42367757|NCT03730662|76225862|FG002|Variable Treatment Period|Lost to Follow-up|4|||
42367758|NCT03730662|76225863|FG003|Variable Treatment Period|Lost to Follow-up|11|||
42367759|NCT03730662|76225860|FG000|Variable Treatment Period|Personal Reason|0|||
42367760|NCT03730662|76225861|FG001|Variable Treatment Period|Personal Reason|2|||
42367761|NCT03730662|76225862|FG002|Variable Treatment Period|Personal Reason|1|||
42367762|NCT03730662|76225863|FG003|Variable Treatment Period|Personal Reason|6|||
42367763|NCT03730662|76225860|FG000|Variable Treatment Period|Physician Decision|0|||
42367764|NCT03730662|76225861|FG001|Variable Treatment Period|Physician Decision|0|||
42367765|NCT03730662|76225862|FG002|Variable Treatment Period|Physician Decision|0|||
42367766|NCT03730662|76225863|FG003|Variable Treatment Period|Physician Decision|3|||
42367767|NCT03730662|76225860|FG000|Variable Treatment Period|Protocol Violation|0|||
42367768|NCT03730662|76225861|FG001|Variable Treatment Period|Protocol Violation|1|||
42367769|NCT03730662|76225862|FG002|Variable Treatment Period|Protocol Violation|1|||
42367770|NCT03730662|76225863|FG003|Variable Treatment Period|Protocol Violation|1|||
42367771|NCT03730662|76225860|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
42367772|NCT03730662|76225861|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
42367773|NCT03730662|76225862|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
42367774|NCT03730662|76225863|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
42367775|NCT03185832|76225961|FG000|Overall Study|Death|9|||
42367776|NCT03185832|76225962|FG001|Overall Study|Death|14|||
42367777|NCT03185832|76225963|FG002|Overall Study|Death|9|||
42367778|NCT03185832|76225964|FG003|Overall Study|Death|7|||
42367779|NCT03185832|76225961|FG000|Overall Study|Withdrawn - vital status available|0|||
42367780|NCT03185832|76225962|FG001|Overall Study|Withdrawn - vital status available|1|||
42367781|NCT03185832|76225963|FG002|Overall Study|Withdrawn - vital status available|1|||
42367782|NCT03185832|76225964|FG003|Overall Study|Withdrawn - vital status available|4|||
42367783|NCT04569786|76226016|FG000|Overall Study|Lost to Follow-up|1|||
42367784|NCT04569786|76226017|FG001|Overall Study|Lost to Follow-up|0|||
42367785|NCT04569786|76226018|FG002|Overall Study|Lost to Follow-up|4|||
42367786|NCT04569786|76226019|FG003|Overall Study|Lost to Follow-up|1|||
42367787|NCT04569786|76226020|FG004|Overall Study|Lost to Follow-up|0|||
42367788|NCT04569786|76226016|FG000|Overall Study|Withdrawal by Subject|0|||
42367789|NCT04569786|76226017|FG001|Overall Study|Withdrawal by Subject|0|||
42367790|NCT04569786|76226018|FG002|Overall Study|Withdrawal by Subject|0|||
42367791|NCT04569786|76226019|FG003|Overall Study|Withdrawal by Subject|5|||
42367792|NCT04569786|76226020|FG004|Overall Study|Withdrawal by Subject|1|||
42367793|NCT04569786|76226016|FG000|Overall Study|Physician Decision|0|||
42367794|NCT04569786|76226017|FG001|Overall Study|Physician Decision|0|||
42367795|NCT04569786|76226018|FG002|Overall Study|Physician Decision|0|||
42367796|NCT04569786|76226019|FG003|Overall Study|Physician Decision|1|||
42367797|NCT04569786|76226020|FG004|Overall Study|Physician Decision|0|||
42367798|NCT01826981|76226196|FG000|Overall Study|Lack of Efficacy|0|||
42367799|NCT01826981|76226197|FG001|Overall Study|Lack of Efficacy|1|||
42367800|NCT01826981|76226198|FG002|Overall Study|Lack of Efficacy|0|||
42367801|NCT01826981|76226199|FG003|Overall Study|Lack of Efficacy|0|||
42367802|NCT01826981|76226200|FG004|Overall Study|Lack of Efficacy|5|||
42367803|NCT01826981|76226201|FG005|Overall Study|Lack of Efficacy|0|||
42367804|NCT01826981|76226202|FG006|Overall Study|Lack of Efficacy|0|||
42367805|NCT01826981|76226203|FG007|Overall Study|Lack of Efficacy|8|||
42367806|NCT01826981|76226204|FG008|Overall Study|Lack of Efficacy|7|||
42367807|NCT01826981|76226205|FG009|Overall Study|Lack of Efficacy|0|||
42367808|NCT01826981|76226206|FG010|Overall Study|Lack of Efficacy|1|||
42367809|NCT01826981|76226207|FG011|Overall Study|Lack of Efficacy|0|||
42367810|NCT01826981|76226208|FG012|Overall Study|Lack of Efficacy|0|||
42367811|NCT01826981|76226209|FG013|Overall Study|Lack of Efficacy|3|||
42367812|NCT01826981|76226210|FG014|Overall Study|Lack of Efficacy|0|||
42367813|NCT01826981|76226196|FG000|Overall Study|Lost to Follow-up|0|||
42367814|NCT01826981|76226197|FG001|Overall Study|Lost to Follow-up|0|||
42367815|NCT01826981|76226198|FG002|Overall Study|Lost to Follow-up|0|||
42367816|NCT01826981|76226199|FG003|Overall Study|Lost to Follow-up|0|||
42367817|NCT01826981|76226200|FG004|Overall Study|Lost to Follow-up|1|||
42367818|NCT01826981|76226201|FG005|Overall Study|Lost to Follow-up|1|||
42367819|NCT01826981|76226202|FG006|Overall Study|Lost to Follow-up|0|||
42367820|NCT01826981|76226203|FG007|Overall Study|Lost to Follow-up|1|||
42367821|NCT01826981|76226204|FG008|Overall Study|Lost to Follow-up|0|||
42367822|NCT01826981|76226205|FG009|Overall Study|Lost to Follow-up|1|||
42367823|NCT01826981|76226206|FG010|Overall Study|Lost to Follow-up|1|||
42367824|NCT01826981|76226207|FG011|Overall Study|Lost to Follow-up|1|||
42367825|NCT01826981|76226208|FG012|Overall Study|Lost to Follow-up|1|||
42367826|NCT01826981|76226209|FG013|Overall Study|Lost to Follow-up|0|||
42367827|NCT01826981|76226210|FG014|Overall Study|Lost to Follow-up|0|||
42367828|NCT01826981|76226196|FG000|Overall Study|Withdrew Consent|0|||
42367829|NCT01826981|76226197|FG001|Overall Study|Withdrew Consent|0|||
42367830|NCT01826981|76226198|FG002|Overall Study|Withdrew Consent|0|||
42367831|NCT01826981|76226199|FG003|Overall Study|Withdrew Consent|0|||
42367832|NCT01826981|76226200|FG004|Overall Study|Withdrew Consent|0|||
42367833|NCT01826981|76226201|FG005|Overall Study|Withdrew Consent|0|||
42367834|NCT01826981|76226202|FG006|Overall Study|Withdrew Consent|1|||
42367835|NCT01826981|76226203|FG007|Overall Study|Withdrew Consent|1|||
42367836|NCT01826981|76226204|FG008|Overall Study|Withdrew Consent|0|||
42367837|NCT01826981|76226205|FG009|Overall Study|Withdrew Consent|0|||
42367838|NCT01826981|76226206|FG010|Overall Study|Withdrew Consent|0|||
42367839|NCT01826981|76226207|FG011|Overall Study|Withdrew Consent|1|||
42367840|NCT01826981|76226208|FG012|Overall Study|Withdrew Consent|0|||
42367841|NCT01826981|76226209|FG013|Overall Study|Withdrew Consent|1|||
42367842|NCT01826981|76226210|FG014|Overall Study|Withdrew Consent|0|||
42367843|NCT01826981|76226196|FG000|Overall Study|Adverse Event|0|||
42367844|NCT01826981|76226197|FG001|Overall Study|Adverse Event|0|||
42367845|NCT01826981|76226198|FG002|Overall Study|Adverse Event|0|||
42367846|NCT01826981|76226199|FG003|Overall Study|Adverse Event|0|||
42367847|NCT01826981|76226200|FG004|Overall Study|Adverse Event|1|||
42367848|NCT01826981|76226201|FG005|Overall Study|Adverse Event|0|||
42367849|NCT01826981|76226202|FG006|Overall Study|Adverse Event|0|||
42367850|NCT01826981|76226203|FG007|Overall Study|Adverse Event|0|||
42367851|NCT01826981|76226204|FG008|Overall Study|Adverse Event|0|||
42367852|NCT01826981|76226205|FG009|Overall Study|Adverse Event|0|||
42367853|NCT01826981|76226206|FG010|Overall Study|Adverse Event|0|||
42367854|NCT01826981|76226207|FG011|Overall Study|Adverse Event|0|||
42367855|NCT01826981|76226208|FG012|Overall Study|Adverse Event|0|||
42367856|NCT01826981|76226209|FG013|Overall Study|Adverse Event|0|||
42367857|NCT01826981|76226210|FG014|Overall Study|Adverse Event|0|||
42367858|NCT01826981|76226196|FG000|Overall Study|Upper G-I Haemorrhage|0|||
42367859|NCT01826981|76226197|FG001|Overall Study|Upper G-I Haemorrhage|0|||
42367860|NCT01826981|76226198|FG002|Overall Study|Upper G-I Haemorrhage|0|||
42367861|NCT01826981|76226199|FG003|Overall Study|Upper G-I Haemorrhage|0|||
42367862|NCT01826981|76226200|FG004|Overall Study|Upper G-I Haemorrhage|0|||
42367863|NCT01826981|76226201|FG005|Overall Study|Upper G-I Haemorrhage|0|||
42367864|NCT01826981|76226202|FG006|Overall Study|Upper G-I Haemorrhage|0|||
42367865|NCT01826981|76226203|FG007|Overall Study|Upper G-I Haemorrhage|0|||
42367866|NCT01826981|76226204|FG008|Overall Study|Upper G-I Haemorrhage|0|||
42367867|NCT01826981|76226205|FG009|Overall Study|Upper G-I Haemorrhage|0|||
42367868|NCT01826981|76226206|FG010|Overall Study|Upper G-I Haemorrhage|0|||
42367869|NCT01826981|76226207|FG011|Overall Study|Upper G-I Haemorrhage|0|||
42367870|NCT01826981|76226208|FG012|Overall Study|Upper G-I Haemorrhage|0|||
42367871|NCT01826981|76226209|FG013|Overall Study|Upper G-I Haemorrhage|1|||
42101374|NCT00336505|75912218|FG000|Overall Study|Withdrawal by Subject|5|||
42101375|NCT00336505|75912219|FG001|Overall Study|Withdrawal by Subject|3|||
42101376|NCT00336505|75912218|FG000|Overall Study|Other|7|||
42101377|NCT00336505|75912219|FG001|Overall Study|Other|7|||
42367872|NCT01826981|76226210|FG014|Overall Study|Upper G-I Haemorrhage|0|||
42367873|NCT01826981|76226196|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367874|NCT01826981|76226197|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367875|NCT01826981|76226198|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367876|NCT01826981|76226199|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367877|NCT01826981|76226200|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367878|NCT01826981|76226201|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367879|NCT01826981|76226202|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367880|NCT01826981|76226203|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
42367881|NCT01826981|76226204|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367882|NCT01826981|76226205|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367883|NCT01826981|76226206|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367884|NCT01826981|76226207|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367885|NCT01826981|76226208|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
42101378|NCT00357877|75912227|FG000|Overall Study|Death|2|||
42367886|NCT01826981|76226209|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367887|NCT01826981|76226210|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
42367888|NCT01804049|76226282|FG000|Overall Study|Adverse Event|2|||
42367889|NCT01804049|76226283|FG001|Overall Study|Adverse Event|10|||
42367890|NCT01804049|76226282|FG000|Overall Study|Lost to Follow-up|2|||
42367891|NCT01804049|76226283|FG001|Overall Study|Lost to Follow-up|1|||
42367892|NCT01804049|76226282|FG000|Overall Study|Decreased interest/personal|4|||
42367893|NCT01804049|76226283|FG001|Overall Study|Decreased interest/personal|5|||
42367894|NCT01804049|76226282|FG000|Overall Study|Other health concerns|2|||
42367895|NCT01804049|76226283|FG001|Overall Study|Other health concerns|7|||
42367896|NCT01804049|76226282|FG000|Overall Study|Moved out of area|0|||
42367897|NCT01804049|76226283|FG001|Overall Study|Moved out of area|7|||
42367898|NCT01804049|76226282|FG000|Overall Study|other MD recommended|1|||
42367899|NCT01804049|76226283|FG001|Overall Study|other MD recommended|1|||
42367900|NCT01804049|76226282|FG000|Overall Study|Enrollment in dual studies|0|||
42367901|NCT01804049|76226283|FG001|Overall Study|Enrollment in dual studies|1|||
42367902|NCT01826825|76226293|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
42367903|NCT01826825|76226294|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
42367904|NCT01803737|76226304|FG000|Overall Study|Lack of Time|1|||
42367905|NCT01803737|76226305|FG001|Overall Study|Lack of Time|0|||
42367906|NCT01803737|76226304|FG000|Overall Study|Medical Reason|0|||
42367907|NCT01803737|76226305|FG001|Overall Study|Medical Reason|1|||
42367908|NCT01803737|76226304|FG000|Overall Study|Lost to Follow-up|0|||
42367909|NCT01803737|76226305|FG001|Overall Study|Lost to Follow-up|2|||
42367910|NCT01826201|76226311|FG000|Overall Study|Non compliance with protocol|4|||
42367911|NCT01803269|76226342|FG000|Overall Study|Withdrawal by Subject|3|||
42367912|NCT01803269|76226343|FG001|Overall Study|Withdrawal by Subject|0|||
42367913|NCT01803269|76226344|FG002|Overall Study|Withdrawal by Subject|0|||
42367914|NCT01802879|76226352|FG000|Overall Study|Administrative problems|2|||
42367915|NCT01802879|76226352|FG000|Overall Study|Disease progression|6|||
42367916|NCT01825577|76226356|FG000|Overall Study|Physician Decision|2|||
42367917|NCT01825577|76226356|FG000|Overall Study|Withdrawal by Subject|1|||
42367918|NCT01825577|76226356|FG000|Overall Study|Withdrawn by family members|2|||
42367919|NCT01825577|76226356|FG000|Overall Study|Lack of Efficacy|3|||
42367920|NCT01802411|76226362|FG000|Overall Study|Death|2|||
42367921|NCT01802411|76226363|FG001|Overall Study|Death|1|||
42367922|NCT01802411|76226362|FG000|Overall Study|Adverse Event|2|||
42367923|NCT01802411|76226363|FG001|Overall Study|Adverse Event|7|||
42367924|NCT01802411|76226362|FG000|Overall Study|Lack of Efficacy|8|||
42367925|NCT01802411|76226363|FG001|Overall Study|Lack of Efficacy|10|||
42367926|NCT01802411|76226362|FG000|Overall Study|Withdrawal by Subject|0|||
42367927|NCT01802411|76226363|FG001|Overall Study|Withdrawal by Subject|2|||
42367928|NCT01802411|76226362|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
42367929|NCT01802411|76226363|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
42367930|NCT01802411|76226362|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
42367931|NCT01802411|76226363|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
42367932|NCT01802411|76226362|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
42367933|NCT01802411|76226363|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
42367934|NCT02963610|76226404|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
42367935|NCT01802333|76226625|FG000|Overall Study|Ineligible|2|||
42367936|NCT01802333|76226626|FG001|Overall Study|Ineligible|6|||
42367937|NCT01802333|76226627|FG002|Overall Study|Ineligible|8|||
42367938|NCT01802333|76226625|FG000|Overall Study|Adverse Event|1|||
42367939|NCT01802333|76226626|FG001|Overall Study|Adverse Event|8|||
42367940|NCT01802333|76226627|FG002|Overall Study|Adverse Event|8|||
42367941|NCT01802333|76226625|FG000|Overall Study|Withdrawal by Subject|6|||
42367942|NCT01802333|76226626|FG001|Overall Study|Withdrawal by Subject|6|||
42367943|NCT01802333|76226627|FG002|Overall Study|Withdrawal by Subject|5|||
42367944|NCT01802333|76226625|FG000|Overall Study|Progression/relapse|1|||
42367945|NCT01802333|76226626|FG001|Overall Study|Progression/relapse|3|||
42367946|NCT01802333|76226627|FG002|Overall Study|Progression/relapse|0|||
42367947|NCT01802333|76226625|FG000|Overall Study|Death|7|||
42367948|NCT01802333|76226626|FG001|Overall Study|Death|14|||
42367949|NCT01802333|76226627|FG002|Overall Study|Death|13|||
42367950|NCT01802333|76226625|FG000|Overall Study|Other - not protocol specified|32|||
42367951|NCT01802333|76226626|FG001|Overall Study|Other - not protocol specified|22|||
42367952|NCT01802333|76226627|FG002|Overall Study|Other - not protocol specified|24|||
42367953|NCT01802333|76226625|FG000|Overall Study|Did not start treatment|0|||
42367954|NCT01802333|76226626|FG001|Overall Study|Did not start treatment|2|||
42367955|NCT01802333|76226627|FG002|Overall Study|Did not start treatment|5|||
42367956|NCT00980655|76226672|FG000|Overall Study|Adverse Event|13|||
42367957|NCT00980655|76226673|FG001|Overall Study|Adverse Event|31|||
42367958|NCT00980655|76226672|FG000|Overall Study|Death|0|||
42367959|NCT00980655|76226673|FG001|Overall Study|Death|7|||
42367960|NCT00980655|76226672|FG000|Overall Study|Protocol Violation|2|||
42367961|NCT00980655|76226673|FG001|Overall Study|Protocol Violation|7|||
42367962|NCT00980655|76226672|FG000|Overall Study|Withdrawal by Subject|0|||
42367963|NCT00980655|76226673|FG001|Overall Study|Withdrawal by Subject|4|||
42367964|NCT00980655|76226672|FG000|Overall Study|Lost to Follow-up|0|||
42367965|NCT00980655|76226673|FG001|Overall Study|Lost to Follow-up|1|||
42367966|NCT00980655|76226672|FG000|Overall Study|Parent/legal guardian request|1|||
42367967|NCT00980655|76226673|FG001|Overall Study|Parent/legal guardian request|0|||
42367968|NCT00980655|76226672|FG000|Overall Study|Other|0|||
42367969|NCT00980655|76226673|FG001|Overall Study|Other|1|||
42367970|NCT01801865|76226715|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
42367971|NCT01801865|76226715|FG000|Overall Study|Physician Decision|7|||
42367972|NCT00980343|76226725|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
42367973|NCT00980343|76226726|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
42367974|NCT01801475|76226736|FG000|Overall Study|Withdrawal by Subject|0|||
42367975|NCT01801475|76226737|FG001|Overall Study|Withdrawal by Subject|0|||
42367976|NCT01801475|76226738|FG002|Overall Study|Withdrawal by Subject|0|||
42367977|NCT01801475|76226739|FG003|Overall Study|Withdrawal by Subject|0|||
42367978|NCT01801475|76226740|FG004|Overall Study|Withdrawal by Subject|1|||
42367979|NCT01822925|76226799|FG000|Overall Study|Adverse Event|1|||
42367980|NCT01822925|76226800|FG001|Overall Study|Adverse Event|1|||
42367981|NCT01822925|76226801|FG002|Overall Study|Adverse Event|1|||
42367982|NCT01822925|76226802|FG003|Overall Study|Adverse Event|1|||
42367983|NCT01822925|76226799|FG000|Overall Study|Lost to Follow-up|0|||
42367984|NCT01822925|76226800|FG001|Overall Study|Lost to Follow-up|1|||
42367985|NCT01822925|76226801|FG002|Overall Study|Lost to Follow-up|0|||
42367986|NCT01822925|76226802|FG003|Overall Study|Lost to Follow-up|0|||
42367987|NCT01822925|76226799|FG000|Overall Study|Protocol Violation|1|||
42367988|NCT01822925|76226800|FG001|Overall Study|Protocol Violation|0|||
42367989|NCT01822925|76226801|FG002|Overall Study|Protocol Violation|0|||
42367990|NCT01822925|76226802|FG003|Overall Study|Protocol Violation|1|||
42367991|NCT01822925|76226799|FG000|Overall Study|Withdrawal by Subject|2|||
42367992|NCT01822925|76226800|FG001|Overall Study|Withdrawal by Subject|0|||
42367993|NCT01822925|76226801|FG002|Overall Study|Withdrawal by Subject|2|||
42367994|NCT01822925|76226802|FG003|Overall Study|Withdrawal by Subject|2|||
42367995|NCT01822925|76226799|FG000|Overall Study|Taking prohibited medication|2|||
42367996|NCT01822925|76226800|FG001|Overall Study|Taking prohibited medication|0|||
42367997|NCT01822925|76226801|FG002|Overall Study|Taking prohibited medication|0|||
42367998|NCT01822925|76226802|FG003|Overall Study|Taking prohibited medication|1|||
42367999|NCT01801007|76226835|FG000|Overall Study|Adverse Event|2|||
42368000|NCT01801007|76226835|FG000|Overall Study|Lost to Follow-up|4|||
42368001|NCT01801007|76226835|FG000|Overall Study|Withdrawal by Subject|5|||
42368002|NCT01822691|76226839|FG000|Overall Study|Withdrawal by Subject|2|||
42368003|NCT01822535|76226845|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
42368004|NCT01822535|76226846|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
42368005|NCT01822535|76226845|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
42368006|NCT01822535|76226846|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
42368007|NCT01822535|76226845|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
42101379|NCT00357877|75912228|FG001|Overall Study|Death|1|||
42101380|NCT00357877|75912227|FG000|Overall Study|Lost to Follow-up|20|||
42101381|NCT00357877|75912228|FG001|Overall Study|Lost to Follow-up|23|||
42101382|NCT00357877|75912227|FG000|Overall Study|Withdrawal by Subject|3|||
42101383|NCT00357877|75912228|FG001|Overall Study|Withdrawal by Subject|3|||
42101384|NCT00357877|75912227|FG000|Overall Study|Administrative withdrawal|1|||
42101385|NCT00357877|75912228|FG001|Overall Study|Administrative withdrawal|1|||
42101386|NCT00357877|75912227|FG000|Overall Study|Other|0|||
42368008|NCT01822535|76226846|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
42368009|NCT01799993|76226932|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
42368010|NCT01799993|76226933|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
42368011|NCT01799993|76226932|FG000|Overall Study|Death|61|||
42368012|NCT01799993|76226933|FG001|Overall Study|Death|45|||
42368013|NCT01799993|76226932|FG000|Overall Study|Withdrawal by Subject|23|||
42368014|NCT01799993|76226933|FG001|Overall Study|Withdrawal by Subject|24|||
42368015|NCT01799993|76226932|FG000|Overall Study|Lost to Follow-up|5|||
42368016|NCT01799993|76226933|FG001|Overall Study|Lost to Follow-up|8|||
42368017|NCT01799993|76226932|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
42368018|NCT01799993|76226933|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
42368019|NCT01799993|76226932|FG000|Overall Study|Protocol driven decision point|0|||
42368020|NCT01799993|76226933|FG001|Overall Study|Protocol driven decision point|3|||
42368021|NCT01799993|76226932|FG000|Overall Study|Protocol Violation|1|||
42368022|NCT01799993|76226933|FG001|Overall Study|Protocol Violation|1|||
42368023|NCT01799993|76226932|FG000|Overall Study|Deterioration of general conditions|2|||
42368024|NCT01799993|76226933|FG001|Overall Study|Deterioration of general conditions|0|||
42368025|NCT01799993|76226932|FG000|Overall Study|Screen failure|0|||
42368026|NCT01799993|76226933|FG001|Overall Study|Screen failure|1|||
42368027|NCT01799993|76226932|FG000|Overall Study|Adverse Event|1|||
42368028|NCT01799993|76226933|FG001|Overall Study|Adverse Event|0|||
42368029|NCT01799993|76226932|FG000|Overall Study|Lack of Efficacy|1|||
42368030|NCT01799993|76226933|FG001|Overall Study|Lack of Efficacy|0|||
42368031|NCT01799993|76226932|FG000|Overall Study|Recovery|0|||
42368032|NCT01799993|76226933|FG001|Overall Study|Recovery|1|||
42368033|NCT01799993|76226932|FG000|Overall Study|Logistical difficulties|1|||
42368034|NCT01799993|76226933|FG001|Overall Study|Logistical difficulties|0|||
42368035|NCT01799993|76226932|FG000|Overall Study|Protocol deviation|1|||
42368036|NCT01799993|76226933|FG001|Overall Study|Protocol deviation|0|||
42368037|NCT01799993|76226932|FG000|Overall Study|Non-compliance with medical device|1|||
42368038|NCT01799993|76226933|FG001|Overall Study|Non-compliance with medical device|0|||
42368039|NCT01799993|76226932|FG000|Overall Study|Withdrawal by parent/guardian|0|||
42368040|NCT01799993|76226933|FG001|Overall Study|Withdrawal by parent/guardian|1|||
42368041|NCT01799993|76226932|FG000|Overall Study|Other|1|||
42368042|NCT01799993|76226933|FG001|Overall Study|Other|0|||
42368043|NCT01799993|76226932|FG000|Overall Study|Subject didn't return for follow-up|0|||
42368044|NCT01799993|76226933|FG001|Overall Study|Subject didn't return for follow-up|1|||
42368045|NCT01822223|76226950|FG000|Overall Study|Death|0|||
42368046|NCT01822223|76226951|FG001|Overall Study|Death|1|||
42368047|NCT02228382|76227037|FG000|Overall Study|Death|5|||
42368048|NCT02228382|76227038|FG001|Overall Study|Death|7|||
42368049|NCT02228382|76227039|FG002|Overall Study|Death|5|||
42368050|NCT02228382|76227040|FG003|Overall Study|Death|0|||
42368051|NCT02228382|76227041|FG004|Overall Study|Death|2|||
42368052|NCT02228382|76227037|FG000|Overall Study|Participant refused further follow-up|0|||
42368053|NCT02228382|76227038|FG001|Overall Study|Participant refused further follow-up|0|||
42368054|NCT02228382|76227039|FG002|Overall Study|Participant refused further follow-up|1|||
42368055|NCT02228382|76227040|FG003|Overall Study|Participant refused further follow-up|0|||
42368056|NCT02228382|76227041|FG004|Overall Study|Participant refused further follow-up|0|||
42368057|NCT02228382|76227037|FG000|Overall Study|Study terminated by sponsor|3|||
42368058|NCT02228382|76227038|FG001|Overall Study|Study terminated by sponsor|5|||
42368059|NCT02228382|76227039|FG002|Overall Study|Study terminated by sponsor|7|||
42368060|NCT02228382|76227040|FG003|Overall Study|Study terminated by sponsor|0|||
42368061|NCT02228382|76227041|FG004|Overall Study|Study terminated by sponsor|0|||
42368062|NCT02228382|76227037|FG000|Overall Study|Lost to Follow-up|0|||
42368063|NCT02228382|76227038|FG001|Overall Study|Lost to Follow-up|0|||
42368064|NCT02228382|76227039|FG002|Overall Study|Lost to Follow-up|3|||
42368065|NCT02228382|76227040|FG003|Overall Study|Lost to Follow-up|1|||
42368066|NCT02228382|76227041|FG004|Overall Study|Lost to Follow-up|0|||
42368067|NCT02228382|76227037|FG000|Overall Study|Withdrawal by Subject|0|||
42368068|NCT02228382|76227038|FG001|Overall Study|Withdrawal by Subject|3|||
42368069|NCT02228382|76227039|FG002|Overall Study|Withdrawal by Subject|2|||
42368070|NCT02228382|76227040|FG003|Overall Study|Withdrawal by Subject|1|||
42368071|NCT02228382|76227041|FG004|Overall Study|Withdrawal by Subject|0|||
42368072|NCT02228382|76227037|FG000|Overall Study|Other|2|||
42368073|NCT02228382|76227038|FG001|Overall Study|Other|3|||
42368074|NCT02228382|76227039|FG002|Overall Study|Other|3|||
42368075|NCT02228382|76227040|FG003|Overall Study|Other|0|||
42368076|NCT02228382|76227041|FG004|Overall Study|Other|0|||
42368077|NCT01900002|76227085|FG000|Overall Study|Withdrawal by Subject|2|||
42368078|NCT01900002|76227085|FG000|Overall Study|ineligible for Y-90|4|||
42368079|NCT01377012|76227115|FG000|Core Study|Study terminated by Sponsor|47|||
42368080|NCT01377012|76227116|FG001|Core Study|Study terminated by Sponsor|54|||
42368081|NCT01377012|76227117|FG002|Core Study|Study terminated by Sponsor|46|||
42368082|NCT01377012|76227115|FG000|Core Study|Technical problems|1|||
42368083|NCT01377012|76227116|FG001|Core Study|Technical problems|0|||
42368084|NCT01377012|76227117|FG002|Core Study|Technical problems|0|||
42368085|NCT01377012|76227115|FG000|Core Study|Withdrawal by Subject|15|||
42368086|NCT01377012|76227116|FG001|Core Study|Withdrawal by Subject|23|||
42368087|NCT01377012|76227117|FG002|Core Study|Withdrawal by Subject|18|||
42368088|NCT01377012|76227115|FG000|Core Study|Protocol Violation|7|||
42368089|NCT01377012|76227116|FG001|Core Study|Protocol Violation|3|||
42368090|NCT01377012|76227117|FG002|Core Study|Protocol Violation|2|||
42368091|NCT01377012|76227115|FG000|Core Study|Pregnancy|0|||
42368092|NCT01377012|76227116|FG001|Core Study|Pregnancy|0|||
42368093|NCT01377012|76227117|FG002|Core Study|Pregnancy|1|||
42368094|NCT01377012|76227115|FG000|Core Study|Physician Decision|5|||
42368095|NCT01377012|76227116|FG001|Core Study|Physician Decision|4|||
42368096|NCT01377012|76227117|FG002|Core Study|Physician Decision|10|||
42368097|NCT01377012|76227115|FG000|Core Study|Non-Compliant with study treatment|0|||
42368098|NCT01377012|76227116|FG001|Core Study|Non-Compliant with study treatment|0|||
42368099|NCT01377012|76227117|FG002|Core Study|Non-Compliant with study treatment|1|||
42368100|NCT01377012|76227115|FG000|Core Study|No Longer require treatment|0|||
42368101|NCT01377012|76227116|FG001|Core Study|No Longer require treatment|0|||
42368102|NCT01377012|76227117|FG002|Core Study|No Longer require treatment|1|||
42368103|NCT01377012|76227115|FG000|Core Study|Lost to Follow-up|7|||
42368104|NCT01377012|76227116|FG001|Core Study|Lost to Follow-up|5|||
42368105|NCT01377012|76227117|FG002|Core Study|Lost to Follow-up|4|||
42368106|NCT01377012|76227115|FG000|Core Study|Lack of Efficacy|41|||
42101387|NCT00357877|75912228|FG001|Overall Study|Other|2|||
42101388|NCT00335959|75912236|FG000|Overall Study|Adverse Event|2|||
42101389|NCT00335959|75912236|FG000|Overall Study|Ineligible|1|||
42196744|NCT00100048|76008590|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
42196745|NCT00100048|76008591|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
42196746|NCT00100048|76008592|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
42196747|NCT00100048|76008593|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
42196748|NCT00100048|76008594|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
42196749|NCT00100048|76008595|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
42196750|NCT00100048|76008590|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
42368107|NCT01377012|76227116|FG001|Core Study|Lack of Efficacy|28|||
42368108|NCT01377012|76227117|FG002|Core Study|Lack of Efficacy|37|||
42368109|NCT01377012|76227115|FG000|Core Study|Death|1|||
42368110|NCT01377012|76227116|FG001|Core Study|Death|1|||
42368111|NCT01377012|76227117|FG002|Core Study|Death|1|||
42368112|NCT01377012|76227115|FG000|Core Study|Adverse Event|10|||
42368113|NCT01377012|76227116|FG001|Core Study|Adverse Event|14|||
42368114|NCT01377012|76227117|FG002|Core Study|Adverse Event|13|||
42101390|NCT00670488|75912251|FG000|Overall Study|Adverse Event|0|||
42101391|NCT00670488|75912252|FG001|Overall Study|Adverse Event|7|||
42101392|NCT00670488|75912253|FG002|Overall Study|Adverse Event|0|||
42368115|NCT01377012|76227115|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
42368116|NCT01377012|76227116|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
42368117|NCT01377012|76227117|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
42368118|NCT01377012|76227115|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
42368119|NCT01377012|76227116|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
42368120|NCT01377012|76227117|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
42368121|NCT01377012|76227115|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
42368122|NCT01377012|76227116|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
42368123|NCT01377012|76227117|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
42368124|NCT01377012|76227115|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
42368125|NCT01377012|76227116|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
42368126|NCT01377012|76227117|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
42368127|NCT01377012|76227115|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
42368128|NCT01377012|76227116|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
42368129|NCT01377012|76227117|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
42368130|NCT01377012|76227115|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
42368131|NCT01377012|76227116|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
42368132|NCT01377012|76227117|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
42368133|NCT01376310|76227366|FG000|Overall Study|Study closed/terminated|1|||
42368134|NCT01376310|76227367|FG001|Overall Study|Study closed/terminated|2|||
42368135|NCT01376310|76227366|FG000|Overall Study|Withdrawal by Subject|8|||
42368136|NCT01376310|76227367|FG001|Overall Study|Withdrawal by Subject|2|||
42368137|NCT01376310|76227366|FG000|Overall Study|Physician Decision|26|||
42368138|NCT01376310|76227367|FG001|Overall Study|Physician Decision|7|||
42368139|NCT01376310|76227366|FG000|Overall Study|Lost to Follow-up|1|||
42368140|NCT01376310|76227367|FG001|Overall Study|Lost to Follow-up|0|||
42368141|NCT01949506|76227373|FG000|Overall Study|Physician Decision|1|||
42101393|NCT00670488|75912254|FG003|Overall Study|Adverse Event|3|||
42101394|NCT00670488|75912255|FG004|Overall Study|Adverse Event|1|||
42368142|NCT00709098|76227470|FG000|Double-blind Period|Withdrawal of consent|3|||
42368143|NCT00709098|76227471|FG001|Double-blind Period|Withdrawal of consent|3|||
42368144|NCT00709098|76227472|FG002|Double-blind Period|Withdrawal of consent|0|||
42368145|NCT00709098|76227470|FG000|Double-blind Period|Administrative reason|1|||
42368146|NCT00709098|76227471|FG001|Double-blind Period|Administrative reason|3|||
42368147|NCT00709098|76227472|FG002|Double-blind Period|Administrative reason|0|||
42368148|NCT00709098|76227470|FG000|Double-blind Period|Death|1|||
42368149|NCT00709098|76227471|FG001|Double-blind Period|Death|1|||
42368150|NCT00709098|76227472|FG002|Double-blind Period|Death|0|||
42368151|NCT00709098|76227470|FG000|Double-blind Period|Lost to Follow-up|1|||
42368152|NCT00709098|76227471|FG001|Double-blind Period|Lost to Follow-up|1|||
42368153|NCT00709098|76227472|FG002|Double-blind Period|Lost to Follow-up|0|||
42368154|NCT00709098|76227470|FG000|Open-label Period|Withdrawal of consent|0|||
42368155|NCT00709098|76227471|FG001|Open-label Period|Withdrawal of consent|0|||
42368156|NCT00709098|76227472|FG002|Open-label Period|Withdrawal of consent|7|||
42368157|NCT00709098|76227470|FG000|Open-label Period|Administrative reason|0|||
42368158|NCT00709098|76227471|FG001|Open-label Period|Administrative reason|0|||
42368159|NCT00709098|76227472|FG002|Open-label Period|Administrative reason|5|||
42368160|NCT00709098|76227470|FG000|Open-label Period|Death|0|||
42368161|NCT00709098|76227471|FG001|Open-label Period|Death|0|||
42368162|NCT00709098|76227472|FG002|Open-label Period|Death|1|||
42368163|NCT00709098|76227470|FG000|Open-label Period|Lost to Follow-up|0|||
42368164|NCT00709098|76227471|FG001|Open-label Period|Lost to Follow-up|0|||
42368165|NCT00709098|76227472|FG002|Open-label Period|Lost to Follow-up|1|||
42368166|NCT01376700|76227481|FG000|Overall Study|Sponsor terminated study early|8|||
42368167|NCT01376700|76227481|FG000|Overall Study|Low or high titer inhibitor|8|||
42368168|NCT01797965|76227492|FG000|Overall Study|Adverse Event|104|||
42368169|NCT01797965|76227493|FG001|Overall Study|Adverse Event|129|||
42368170|NCT01797965|76227494|FG002|Overall Study|Adverse Event|4|||
42368171|NCT01797965|76227495|FG003|Overall Study|Adverse Event|21|||
42368172|NCT01797965|76227492|FG000|Overall Study|Lost to Follow-up|9|||
42368173|NCT01797965|76227493|FG001|Overall Study|Lost to Follow-up|8|||
42368174|NCT01797965|76227494|FG002|Overall Study|Lost to Follow-up|1|||
42368175|NCT01797965|76227495|FG003|Overall Study|Lost to Follow-up|2|||
42368176|NCT01797965|76227492|FG000|Overall Study|Consent withdrawn|130|||
42368177|NCT01797965|76227493|FG001|Overall Study|Consent withdrawn|117|||
42368178|NCT01797965|76227494|FG002|Overall Study|Consent withdrawn|3|||
42368179|NCT01797965|76227495|FG003|Overall Study|Consent withdrawn|35|||
42368180|NCT01797965|76227492|FG000|Overall Study|Investigator decision|21|||
42368181|NCT01797965|76227493|FG001|Overall Study|Investigator decision|15|||
42368182|NCT01797965|76227494|FG002|Overall Study|Investigator decision|0|||
42368183|NCT01797965|76227495|FG003|Overall Study|Investigator decision|0|||
42368184|NCT01797965|76227492|FG000|Overall Study|Death|2|||
42368185|NCT01797965|76227493|FG001|Overall Study|Death|4|||
42368186|NCT01797965|76227494|FG002|Overall Study|Death|0|||
42368187|NCT01797965|76227495|FG003|Overall Study|Death|0|||
42368188|NCT01797965|76227492|FG000|Overall Study|Disease progression, defined by protocol|3|||
42368189|NCT01797965|76227493|FG001|Overall Study|Disease progression, defined by protocol|1|||
42368190|NCT01797965|76227494|FG002|Overall Study|Disease progression, defined by protocol|0|||
42368191|NCT01797965|76227495|FG003|Overall Study|Disease progression, defined by protocol|0|||
42368192|NCT01797965|76227492|FG000|Overall Study|Reason Not Specified|280|||
42368193|NCT01797965|76227493|FG001|Overall Study|Reason Not Specified|295|||
42368194|NCT01797965|76227494|FG002|Overall Study|Reason Not Specified|0|||
42368195|NCT01797965|76227495|FG003|Overall Study|Reason Not Specified|15|||
42368196|NCT01376388|76227540|FG000|Overall Study|Adverse Event|13|||
42368197|NCT01376388|76227540|FG000|Overall Study|Lack of Efficacy|2|||
42368198|NCT01376388|76227540|FG000|Overall Study|Withdrawal by Subject|3|||
42368199|NCT01821677|76227557|FG000|Overall Study|Adverse Event|4|||
42368200|NCT01821677|76227558|FG001|Overall Study|Adverse Event|6|||
42368201|NCT01821677|76227559|FG002|Overall Study|Adverse Event|5|||
42368202|NCT01821677|76227557|FG000|Overall Study|Physician Decision|1|||
42368203|NCT01821677|76227558|FG001|Overall Study|Physician Decision|4|||
42368204|NCT01821677|76227559|FG002|Overall Study|Physician Decision|1|||
42368205|NCT01821677|76227557|FG000|Overall Study|Non-compliance|0|||
42368206|NCT01821677|76227558|FG001|Overall Study|Non-compliance|1|||
42368207|NCT01821677|76227559|FG002|Overall Study|Non-compliance|2|||
42368208|NCT01821677|76227557|FG000|Overall Study|Lost to Follow-up|2|||
42368209|NCT01821677|76227558|FG001|Overall Study|Lost to Follow-up|1|||
42368210|NCT01821677|76227559|FG002|Overall Study|Lost to Follow-up|3|||
42368211|NCT01821677|76227557|FG000|Overall Study|Protocol Violation|0|||
42368212|NCT01821677|76227558|FG001|Overall Study|Protocol Violation|0|||
42368213|NCT01821677|76227559|FG002|Overall Study|Protocol Violation|2|||
42368214|NCT01821677|76227557|FG000|Overall Study|Withdrawal by Subject|7|||
42368215|NCT01821677|76227558|FG001|Overall Study|Withdrawal by Subject|3|||
42368216|NCT01821677|76227559|FG002|Overall Study|Withdrawal by Subject|2|||
42368217|NCT01821677|76227557|FG000|Overall Study|Other|9|||
42368218|NCT01821677|76227558|FG001|Overall Study|Other|0|||
42368219|NCT01821677|76227559|FG002|Overall Study|Other|0|||
42368220|NCT01797731|76227570|FG000|Overall Study|Didn't have proper radiographs required|3|||
42368221|NCT01797731|76227571|FG001|Overall Study|Didn't have proper radiographs required|3|||
42368222|NCT00709722|76227577|FG000|Overall Study|Adverse Event|1|||
42368223|NCT01820585|76227598|FG000|Overall Study|Adverse Event|9|||
42368224|NCT01820585|76227599|FG001|Overall Study|Adverse Event|13|||
42368225|NCT01820585|76227600|FG002|Overall Study|Adverse Event|23|||
42368226|NCT01820585|76227601|FG003|Overall Study|Adverse Event|34|||
42368227|NCT01820585|76227598|FG000|Overall Study|Lack of Efficacy|9|||
42368228|NCT01820585|76227599|FG001|Overall Study|Lack of Efficacy|7|||
42368229|NCT01820585|76227600|FG002|Overall Study|Lack of Efficacy|5|||
42368230|NCT01820585|76227601|FG003|Overall Study|Lack of Efficacy|1|||
42368231|NCT01820585|76227598|FG000|Overall Study|Withdrawal by Subject|3|||
42368232|NCT01820585|76227599|FG001|Overall Study|Withdrawal by Subject|7|||
42368233|NCT01820585|76227600|FG002|Overall Study|Withdrawal by Subject|3|||
42368234|NCT01820585|76227601|FG003|Overall Study|Withdrawal by Subject|8|||
42368235|NCT01820585|76227598|FG000|Overall Study|Lost to Follow-up|3|||
42368236|NCT01820585|76227599|FG001|Overall Study|Lost to Follow-up|3|||
42368237|NCT01820585|76227600|FG002|Overall Study|Lost to Follow-up|0|||
42368238|NCT01820585|76227601|FG003|Overall Study|Lost to Follow-up|3|||
42368239|NCT01820585|76227598|FG000|Overall Study|Protocol Violation|3|||
42368240|NCT01820585|76227599|FG001|Overall Study|Protocol Violation|1|||
42368241|NCT01820585|76227600|FG002|Overall Study|Protocol Violation|1|||
42368242|NCT01820585|76227601|FG003|Overall Study|Protocol Violation|1|||
42368243|NCT01820585|76227598|FG000|Overall Study|Subject non-compliance|0|||
42368244|NCT01820585|76227599|FG001|Overall Study|Subject non-compliance|0|||
42368245|NCT01820585|76227600|FG002|Overall Study|Subject non-compliance|1|||
42368246|NCT01820585|76227601|FG003|Overall Study|Subject non-compliance|2|||
42368247|NCT01820585|76227598|FG000|Overall Study|at sponsor request|0|||
42368248|NCT01820585|76227599|FG001|Overall Study|at sponsor request|0|||
42368249|NCT01820585|76227600|FG002|Overall Study|at sponsor request|1|||
42368250|NCT01820585|76227601|FG003|Overall Study|at sponsor request|0|||
42368251|NCT01820585|76227598|FG000|Overall Study|Pregnancy|0|||
42368252|NCT01820585|76227599|FG001|Overall Study|Pregnancy|1|||
42368253|NCT01820585|76227600|FG002|Overall Study|Pregnancy|0|||
42368254|NCT01820585|76227601|FG003|Overall Study|Pregnancy|0|||
42368255|NCT01797263|76227613|FG000|Overall Study|Withdrawal by Subject|21|||
42368256|NCT01797263|76227614|FG001|Overall Study|Withdrawal by Subject|25|||
42368257|NCT01797263|76227613|FG000|Overall Study|Death|1|||
42368258|NCT01797263|76227614|FG001|Overall Study|Death|0|||
42368259|NCT01797263|76227613|FG000|Overall Study|Lost to Follow-up|15|||
42368260|NCT01797263|76227614|FG001|Overall Study|Lost to Follow-up|15|||
42368261|NCT01797185|76227669|FG000|Overall Study|Adverse Event|5|||
42368262|NCT01797185|76227670|FG001|Overall Study|Adverse Event|15|||
42368263|NCT01797185|76227671|FG002|Overall Study|Adverse Event|6|||
42368264|NCT01797185|76227669|FG000|Overall Study|Withdrawal by Subject|6|||
42368265|NCT01797185|76227670|FG001|Overall Study|Withdrawal by Subject|9|||
42368266|NCT01797185|76227671|FG002|Overall Study|Withdrawal by Subject|5|||
42368267|NCT01797185|76227669|FG000|Overall Study|Site terminated|8|||
42368268|NCT01797185|76227670|FG001|Overall Study|Site terminated|4|||
42368269|NCT01797185|76227671|FG002|Overall Study|Site terminated|0|||
42368270|NCT01797185|76227669|FG000|Overall Study|Lost to Follow-up|2|||
42368271|NCT01797185|76227670|FG001|Overall Study|Lost to Follow-up|6|||
42368272|NCT01797185|76227671|FG002|Overall Study|Lost to Follow-up|1|||
42368273|NCT01797185|76227669|FG000|Overall Study|Withdrawn per sponsor|5|||
42368274|NCT01797185|76227670|FG001|Overall Study|Withdrawn per sponsor|0|||
42368275|NCT01797185|76227671|FG002|Overall Study|Withdrawn per sponsor|0|||
42368276|NCT01797185|76227669|FG000|Overall Study|Physician Decision|1|||
42368277|NCT01797185|76227670|FG001|Overall Study|Physician Decision|3|||
42368278|NCT01797185|76227671|FG002|Overall Study|Physician Decision|0|||
42368279|NCT01797185|76227669|FG000|Overall Study|Protocol Violation|1|||
42368280|NCT01797185|76227670|FG001|Overall Study|Protocol Violation|1|||
42368281|NCT01797185|76227671|FG002|Overall Study|Protocol Violation|0|||
42368282|NCT01819727|76227727|FG000|Overall Study|Adverse Event|8|||
42101395|NCT00670488|75912256|FG005|Overall Study|Adverse Event|1|||
42101396|NCT00670488|75912257|FG006|Overall Study|Adverse Event|5|||
42101397|NCT00670488|75912258|FG007|Overall Study|Adverse Event|1|||
42368283|NCT01819727|76227728|FG001|Overall Study|Adverse Event|9|||
42368284|NCT01819727|76227727|FG000|Overall Study|Death|1|||
42368285|NCT01819727|76227728|FG001|Overall Study|Death|0|||
42368286|NCT01819727|76227727|FG000|Overall Study|Lost to Follow-up|1|||
42368287|NCT01819727|76227728|FG001|Overall Study|Lost to Follow-up|1|||
42368288|NCT01819727|76227727|FG000|Overall Study|Physician Decision|3|||
42368289|NCT01819727|76227728|FG001|Overall Study|Physician Decision|2|||
42368290|NCT01819727|76227727|FG000|Overall Study|Pregnancy|1|||
42368291|NCT01819727|76227728|FG001|Overall Study|Pregnancy|0|||
42368292|NCT01819727|76227727|FG000|Overall Study|Protocol Violation|0|||
42368293|NCT01819727|76227728|FG001|Overall Study|Protocol Violation|2|||
42368294|NCT01819727|76227727|FG000|Overall Study|Study Terminated by Sponsor|0|||
42368295|NCT01819727|76227728|FG001|Overall Study|Study Terminated by Sponsor|1|||
42368296|NCT01819727|76227727|FG000|Overall Study|Withdrawal by Subject|6|||
42368297|NCT01819727|76227728|FG001|Overall Study|Withdrawal by Subject|11|||
42368298|NCT01819727|76227727|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
42368299|NCT01819727|76227728|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
42368300|NCT01819727|76227727|FG000|Overall Study|Quit due to lack of health benifits|0|||
42368301|NCT01819727|76227728|FG001|Overall Study|Quit due to lack of health benifits|1|||
42368302|NCT01795937|76227787|FG000|Overall Study|Withdrawal by Subject|1|||
42368303|NCT01795937|76227788|FG001|Overall Study|Withdrawal by Subject|0|||
42368304|NCT01795937|76227789|FG002|Overall Study|Withdrawal by Subject|0|||
42368305|NCT01795937|76227787|FG000|Overall Study|Physician Decision|0|||
42368306|NCT01795937|76227788|FG001|Overall Study|Physician Decision|1|||
42368307|NCT01795937|76227789|FG002|Overall Study|Physician Decision|0|||
42368308|NCT01817777|76227831|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
42368309|NCT01817777|76227832|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
42368310|NCT01817777|76227833|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
42368311|NCT01817777|76227831|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
42368312|NCT01817777|76227832|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
42368313|NCT01817777|76227833|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
42368314|NCT01817777|76227831|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
42368315|NCT01817777|76227832|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
42368316|NCT01817777|76227833|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
42368317|NCT01817777|76227831|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
42368318|NCT01817777|76227832|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
42368319|NCT01817777|76227833|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
42368320|NCT01817777|76227831|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
42368321|NCT01817777|76227832|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
42368322|NCT01817777|76227833|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
42368323|NCT01795547|76227859|FG000|Overall Study|Adverse Event|16|||
42368324|NCT01795547|76227860|FG001|Overall Study|Adverse Event|27|||
42368325|NCT01795547|76227859|FG000|Overall Study|Lack of Efficacy|8|||
42368326|NCT01795547|76227860|FG001|Overall Study|Lack of Efficacy|3|||
42368327|NCT01795547|76227859|FG000|Overall Study|Protocol Violation|6|||
42368328|NCT01795547|76227860|FG001|Overall Study|Protocol Violation|4|||
42368329|NCT01795547|76227859|FG000|Overall Study|Lost to Follow-up|2|||
42368330|NCT01795547|76227860|FG001|Overall Study|Lost to Follow-up|5|||
42368331|NCT01795547|76227859|FG000|Overall Study|Withdrawal of consent|7|||
42368332|NCT01795547|76227860|FG001|Overall Study|Withdrawal of consent|12|||
42368333|NCT01795547|76227859|FG000|Overall Study|Not Treated|4|||
42368334|NCT01795547|76227860|FG001|Overall Study|Not Treated|10|||
42368335|NCT01795547|76227859|FG000|Overall Study|Non-compliance with IMP|1|||
42368336|NCT01795547|76227860|FG001|Overall Study|Non-compliance with IMP|1|||
42368337|NCT01795547|76227859|FG000|Overall Study|Others|4|||
42368338|NCT01795547|76227860|FG001|Overall Study|Others|1|||
42368339|NCT01795547|76227859|FG000|Overall Study|Not stated|0|||
42368340|NCT01795547|76227860|FG001|Overall Study|Not stated|1|||
42368341|NCT01794923|76227886|FG000|Overall Study|Adverse Event|0|||
42368342|NCT01794923|76227887|FG001|Overall Study|Adverse Event|0|||
42368343|NCT01794923|76227888|FG002|Overall Study|Adverse Event|1|||
42368344|NCT01794845|76227896|FG000|Overall Study|Withdrawal by Subject|1|||
42368345|NCT01794689|76227904|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
42368346|NCT01794689|76227905|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
42368347|NCT01794689|76227906|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
42368348|NCT01794689|76227907|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
42368349|NCT01794689|76227904|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
42101398|NCT00670488|75912259|FG008|Overall Study|Adverse Event|0|||
42101399|NCT00670488|75912260|FG009|Overall Study|Adverse Event|1|||
42101400|NCT00670488|75912251|FG000|Overall Study|Physician Decision|1|||
42101401|NCT00670488|75912252|FG001|Overall Study|Physician Decision|9|||
42101402|NCT00670488|75912253|FG002|Overall Study|Physician Decision|0|||
42101403|NCT00670488|75912254|FG003|Overall Study|Physician Decision|1|||
42101404|NCT00670488|75912255|FG004|Overall Study|Physician Decision|0|||
42101405|NCT00670488|75912256|FG005|Overall Study|Physician Decision|0|||
42101406|NCT00670488|75912257|FG006|Overall Study|Physician Decision|0|||
42101407|NCT00670488|75912258|FG007|Overall Study|Physician Decision|0|||
42101408|NCT00670488|75912259|FG008|Overall Study|Physician Decision|0|||
42101409|NCT00670488|75912260|FG009|Overall Study|Physician Decision|0|||
42101410|NCT00670488|75912251|FG000|Overall Study|Progressive Disease|2|||
42368350|NCT01794689|76227905|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
42368351|NCT01794689|76227906|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
42368352|NCT01794689|76227907|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
42368353|NCT01794689|76227904|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
42368354|NCT01794689|76227905|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
42368355|NCT01794689|76227906|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
42368356|NCT01794689|76227907|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
42101411|NCT00670488|75912252|FG001|Overall Study|Progressive Disease|41|||
42101412|NCT00670488|75912253|FG002|Overall Study|Progressive Disease|3|||
42368357|NCT01794689|76227904|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
42101413|NCT00670488|75912254|FG003|Overall Study|Progressive Disease|2|||
42101414|NCT00670488|75912255|FG004|Overall Study|Progressive Disease|2|||
42101415|NCT00670488|75912256|FG005|Overall Study|Progressive Disease|4|||
42101416|NCT00670488|75912257|FG006|Overall Study|Progressive Disease|11|||
42101417|NCT00670488|75912258|FG007|Overall Study|Progressive Disease|2|||
42101418|NCT00670488|75912259|FG008|Overall Study|Progressive Disease|2|||
42101419|NCT00670488|75912260|FG009|Overall Study|Progressive Disease|1|||
42101420|NCT00670488|75912251|FG000|Overall Study|Withdrawal by Subject|0|||
42101421|NCT00670488|75912252|FG001|Overall Study|Withdrawal by Subject|1|||
42101422|NCT00670488|75912253|FG002|Overall Study|Withdrawal by Subject|0|||
42101423|NCT00670488|75912254|FG003|Overall Study|Withdrawal by Subject|1|||
42101424|NCT00670488|75912255|FG004|Overall Study|Withdrawal by Subject|0|||
42101425|NCT00670488|75912256|FG005|Overall Study|Withdrawal by Subject|0|||
42101426|NCT00670488|75912257|FG006|Overall Study|Withdrawal by Subject|1|||
42101427|NCT00670488|75912258|FG007|Overall Study|Withdrawal by Subject|0|||
42101428|NCT00670488|75912259|FG008|Overall Study|Withdrawal by Subject|1|||
42101429|NCT00670488|75912260|FG009|Overall Study|Withdrawal by Subject|0|||
42101430|NCT00671658|75912282|FG000|Overall Study|Physician Decision|5|||
42101431|NCT00542386|75912292|FG000|Overall Study|Adverse Event|1|||
42101432|NCT00542386|75912293|FG001|Overall Study|Adverse Event|7|||
42101433|NCT00542386|75912294|FG002|Overall Study|Adverse Event|7|||
42101434|NCT00542386|75912295|FG003|Overall Study|Adverse Event|8|||
42101435|NCT00542386|75912296|FG004|Overall Study|Adverse Event|13|||
42101436|NCT00542386|75912297|FG005|Overall Study|Adverse Event|4|||
42101437|NCT00542386|75912292|FG000|Overall Study|Death|0|||
42101438|NCT00542386|75912293|FG001|Overall Study|Death|0|||
42101439|NCT00542386|75912294|FG002|Overall Study|Death|1|||
42101440|NCT00542386|75912295|FG003|Overall Study|Death|2|||
42101441|NCT00542386|75912296|FG004|Overall Study|Death|1|||
42101442|NCT00542386|75912297|FG005|Overall Study|Death|2|||
42101443|NCT00542386|75912292|FG000|Overall Study|Lack of Efficacy|32|||
42101444|NCT00542386|75912293|FG001|Overall Study|Lack of Efficacy|12|||
42101445|NCT00542386|75912294|FG002|Overall Study|Lack of Efficacy|10|||
42101446|NCT00542386|75912295|FG003|Overall Study|Lack of Efficacy|13|||
42101447|NCT00542386|75912296|FG004|Overall Study|Lack of Efficacy|7|||
42101448|NCT00542386|75912297|FG005|Overall Study|Lack of Efficacy|31|||
42101449|NCT00542386|75912292|FG000|Overall Study|Physician Decision|1|||
42101450|NCT00542386|75912293|FG001|Overall Study|Physician Decision|0|||
42101451|NCT00542386|75912294|FG002|Overall Study|Physician Decision|0|||
42368358|NCT01794689|76227905|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
42368359|NCT01794689|76227906|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
42368360|NCT01794689|76227907|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
42368361|NCT01794299|76227923|FG000|Overall Study|ATIR manufacturing not possible|1|||
42101452|NCT00542386|75912295|FG003|Overall Study|Physician Decision|1|||
42101453|NCT00542386|75912296|FG004|Overall Study|Physician Decision|0|||
42101454|NCT00542386|75912297|FG005|Overall Study|Physician Decision|0|||
42101455|NCT00542386|75912292|FG000|Overall Study|Protocol Violation|0|||
42101456|NCT00542386|75912293|FG001|Overall Study|Protocol Violation|0|||
42368362|NCT01794299|76227923|FG000|Overall Study|Death|14|||
42368363|NCT01794299|76227923|FG000|Overall Study|Graft failure|1|||
42101457|NCT00542386|75912294|FG002|Overall Study|Protocol Violation|1|||
42368364|NCT01794299|76227923|FG000|Overall Study|ATIR batch rejected|2|||
42368365|NCT01794299|76227923|FG000|Overall Study|Relapse|2|||
42368366|NCT01794299|76227923|FG000|Overall Study|Discontinued from active follow-up|1|||
42368367|NCT01794299|76227923|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
42368368|NCT01817075|76227929|FG000|Overall Study|Adverse Event|7|||
42368369|NCT01817075|76227930|FG001|Overall Study|Adverse Event|5|||
42368370|NCT01817075|76227929|FG000|Overall Study|Physician Decision|9|||
42368371|NCT01817075|76227930|FG001|Overall Study|Physician Decision|12|||
42368372|NCT01817075|76227929|FG000|Overall Study|Withdrawal by Subject|31|||
42368373|NCT01817075|76227930|FG001|Overall Study|Withdrawal by Subject|15|||
42368374|NCT01817075|76227929|FG000|Overall Study|Received Sorafenib after enrollment|0|||
42368375|NCT01817075|76227930|FG001|Overall Study|Received Sorafenib after enrollment|1|||
42368376|NCT01817075|76227929|FG000|Overall Study|Ineligible|0|||
42368377|NCT01817075|76227930|FG001|Overall Study|Ineligible|2|||
42368378|NCT01816763|76227939|FG000|Overall Study|The main reason for an incomplete survey|4|||
42368379|NCT01816763|76227940|FG001|Overall Study|The main reason for an incomplete survey|15|||
42368380|NCT01816763|76227941|FG002|Overall Study|The main reason for an incomplete survey|11|||
42368381|NCT01816685|76227954|FG000|Overall Study|Lost to Follow-up|7|||
42368382|NCT01816685|76227955|FG001|Overall Study|Lost to Follow-up|9|||
42368383|NCT01816685|76227954|FG000|Overall Study|Surgery Cancelled|3|||
42368384|NCT01816685|76227955|FG001|Overall Study|Surgery Cancelled|2|||
42368385|NCT00708552|76227986|FG000|Overall Study|Adverse Event|10|||
42368386|NCT00708552|76227987|FG001|Overall Study|Adverse Event|3|||
42368387|NCT00708552|76227988|FG002|Overall Study|Adverse Event|4|||
42368388|NCT00708552|76227989|FG003|Overall Study|Adverse Event|6|||
42368389|NCT00708552|76227986|FG000|Overall Study|Lack of Efficacy|0|||
42368390|NCT00708552|76227987|FG001|Overall Study|Lack of Efficacy|4|||
42368391|NCT00708552|76227988|FG002|Overall Study|Lack of Efficacy|1|||
42368392|NCT00708552|76227989|FG003|Overall Study|Lack of Efficacy|0|||
42368393|NCT00708552|76227986|FG000|Overall Study|Protocol Violation|0|||
42368394|NCT00708552|76227987|FG001|Overall Study|Protocol Violation|0|||
42368395|NCT00708552|76227988|FG002|Overall Study|Protocol Violation|2|||
42368396|NCT00708552|76227989|FG003|Overall Study|Protocol Violation|4|||
42368397|NCT00708552|76227986|FG000|Overall Study|Lost to Follow-up|4|||
42368398|NCT00708552|76227987|FG001|Overall Study|Lost to Follow-up|2|||
42368399|NCT00708552|76227988|FG002|Overall Study|Lost to Follow-up|0|||
42368400|NCT00708552|76227989|FG003|Overall Study|Lost to Follow-up|1|||
42368401|NCT00708552|76227986|FG000|Overall Study|Physician Decision|1|||
42368402|NCT00708552|76227987|FG001|Overall Study|Physician Decision|2|||
42368403|NCT00708552|76227988|FG002|Overall Study|Physician Decision|0|||
42368404|NCT00708552|76227989|FG003|Overall Study|Physician Decision|0|||
42368405|NCT00708552|76227986|FG000|Overall Study|Withdrawal by Subject|12|||
42368406|NCT00708552|76227987|FG001|Overall Study|Withdrawal by Subject|7|||
42368407|NCT00708552|76227988|FG002|Overall Study|Withdrawal by Subject|8|||
42368408|NCT00708552|76227989|FG003|Overall Study|Withdrawal by Subject|10|||
42368409|NCT01816295|76228119|FG000|Double Blind Phase|Adverse Event|11|||
42368410|NCT01816295|76228120|FG001|Double Blind Phase|Adverse Event|8|||
42368411|NCT01816295|76228119|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
42368412|NCT01816295|76228120|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
42368413|NCT01816295|76228119|FG000|Double Blind Phase|Lost to Follow-up|3|||
42368414|NCT01816295|76228120|FG001|Double Blind Phase|Lost to Follow-up|5|||
42368415|NCT01816295|76228119|FG000|Double Blind Phase|Physician Decision|2|||
42368416|NCT01816295|76228120|FG001|Double Blind Phase|Physician Decision|2|||
42368417|NCT01816295|76228119|FG000|Double Blind Phase|Protocol Violation|17|||
42368418|NCT01816295|76228120|FG001|Double Blind Phase|Protocol Violation|11|||
42368419|NCT01816295|76228119|FG000|Double Blind Phase|Sponsor Decision|8|||
42368420|NCT01816295|76228120|FG001|Double Blind Phase|Sponsor Decision|8|||
42368421|NCT01816295|76228119|FG000|Double Blind Phase|Withdrawal by Subject|22|||
42368422|NCT01816295|76228120|FG001|Double Blind Phase|Withdrawal by Subject|20|||
42368423|NCT01816295|76228119|FG000|OLE Phase|Adverse Event|17|||
42368424|NCT01816295|76228120|FG001|OLE Phase|Adverse Event|15|||
42368425|NCT01816295|76228119|FG000|OLE Phase|Death|1|||
42368426|NCT01816295|76228120|FG001|OLE Phase|Death|0|||
42368427|NCT01816295|76228119|FG000|OLE Phase|Entry Criteria Not Met|3|||
42368428|NCT01816295|76228120|FG001|OLE Phase|Entry Criteria Not Met|5|||
42368429|NCT01816295|76228119|FG000|OLE Phase|Lost to Follow-up|5|||
42368430|NCT01816295|76228120|FG001|OLE Phase|Lost to Follow-up|5|||
42368431|NCT01816295|76228119|FG000|OLE Phase|Physician Decision|3|||
42368432|NCT01816295|76228120|FG001|OLE Phase|Physician Decision|1|||
42368433|NCT01816295|76228119|FG000|OLE Phase|Protocol Violation|4|||
42368434|NCT01816295|76228120|FG001|OLE Phase|Protocol Violation|4|||
42368435|NCT01816295|76228119|FG000|OLE Phase|Sponsor Decision|7|||
42368436|NCT01816295|76228120|FG001|OLE Phase|Sponsor Decision|9|||
42368437|NCT01816295|76228119|FG000|OLE Phase|Withdrawal by Subject|10|||
42368438|NCT01816295|76228120|FG001|OLE Phase|Withdrawal by Subject|10|||
42368439|NCT01816295|76228119|FG000|OLE Phase|Lack of Efficacy|3|||
42368440|NCT01816295|76228120|FG001|OLE Phase|Lack of Efficacy|7|||
42368441|NCT01610297|76228145|FG000|Overall Study|Lost to Follow-up|1|||
42368442|NCT01793051|76228156|FG000|Overall Study|Withdrawal by Subject|6|||
42368443|NCT01793051|76228157|FG001|Overall Study|Withdrawal by Subject|4|||
42368444|NCT01793051|76228156|FG000|Overall Study|Adverse Event|0|||
42368445|NCT01793051|76228157|FG001|Overall Study|Adverse Event|2|||
42368446|NCT01793051|76228156|FG000|Overall Study|Too ill to continue|1|||
42368447|NCT01793051|76228157|FG001|Overall Study|Too ill to continue|0|||
42368448|NCT01793051|76228156|FG000|Overall Study|Switched chemo|1|||
42368449|NCT01793051|76228157|FG001|Overall Study|Switched chemo|1|||
42368450|NCT01793051|76228156|FG000|Overall Study|Lack of compliance|1|||
42368451|NCT01793051|76228157|FG001|Overall Study|Lack of compliance|0|||
42368452|NCT01793051|76228156|FG000|Overall Study|Requested to be removed from the study|1|||
42368453|NCT01793051|76228157|FG001|Overall Study|Requested to be removed from the study|1|||
42368454|NCT01816061|76228190|FG000|Overall Study|Lost to Follow-up|13|||
42368455|NCT01816061|76228191|FG001|Overall Study|Lost to Follow-up|24|||
42368456|NCT01792115|76228217|FG000|Overall Study|Lost to Follow-up|0|||
42368457|NCT01792115|76228218|FG001|Overall Study|Lost to Follow-up|1|||
42368458|NCT01792115|76228219|FG002|Overall Study|Lost to Follow-up|0|||
42368459|NCT01791803|76228231|FG000|Overall Study|Withdrawal by Subject|0|||
42368460|NCT01791803|76228232|FG001|Overall Study|Withdrawal by Subject|0|||
42368461|NCT01791803|76228233|FG002|Overall Study|Withdrawal by Subject|0|||
42101458|NCT00542386|75912295|FG003|Overall Study|Protocol Violation|0|||
42368462|NCT01791803|76228234|FG003|Overall Study|Withdrawal by Subject|2|||
42368463|NCT01791803|76228231|FG000|Overall Study|Physician Decision|0|||
42368464|NCT01791803|76228232|FG001|Overall Study|Physician Decision|2|||
42368465|NCT01791803|76228233|FG002|Overall Study|Physician Decision|0|||
42368466|NCT01791803|76228234|FG003|Overall Study|Physician Decision|1|||
42368467|NCT01791803|76228231|FG000|Overall Study|Death|0|||
42368468|NCT01791803|76228232|FG001|Overall Study|Death|0|||
42368469|NCT01791803|76228233|FG002|Overall Study|Death|2|||
42368470|NCT01791803|76228234|FG003|Overall Study|Death|2|||
42368471|NCT01791725|76228259|FG000|Overall Study|Withdrawal by Subject|0|||
42368472|NCT01791725|76228260|FG001|Overall Study|Withdrawal by Subject|1|||
42368473|NCT01791725|76228261|FG002|Overall Study|Withdrawal by Subject|0|||
42368474|NCT01791413|76228271|FG000|Overall Study|Lost to Follow-up|5|||
42368475|NCT01791413|76228272|FG001|Overall Study|Lost to Follow-up|1|||
42368476|NCT01610063|76228285|FG000|Overall Study|Lost to Follow-up|42|||
42368477|NCT01610063|76228286|FG001|Overall Study|Lost to Follow-up|20|||
42368478|NCT01813721|76228292|FG000|Overall Study|Ineligibility determined|63|||
42368479|NCT01813721|76228292|FG000|Overall Study|Withdrawal by Subject|1|||
42368480|NCT01790633|76228316|FG000|Overall Study|Protocol Violation|1|||
42368481|NCT01790633|76228317|FG001|Overall Study|Protocol Violation|2|||
42368482|NCT01790633|76228316|FG000|Overall Study|Did not have serology performed|47|||
42368483|NCT01790633|76228317|FG001|Overall Study|Did not have serology performed|0|||
42368484|NCT01790633|76228316|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
42368485|NCT01790633|76228317|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
42368486|NCT01788215|76228326|FG000|Overall Study|Withdrawal by Subject|0|||
42368487|NCT01788215|76228327|FG001|Overall Study|Withdrawal by Subject|1|||
42368488|NCT01788215|76228326|FG000|Overall Study|Lost to Follow-up|2|||
42368489|NCT01788215|76228327|FG001|Overall Study|Lost to Follow-up|0|||
42368490|NCT01787825|76228333|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
42368491|NCT01787825|76228334|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
42368492|NCT01787825|76228333|FG000|Overall Study|Data Not Analyzable|5|||
42368493|NCT01787825|76228334|FG001|Overall Study|Data Not Analyzable|1|||
42368494|NCT01813019|76228343|FG000|Overall Study|Adverse Event|0|||
42368495|NCT01813019|76228344|FG001|Overall Study|Adverse Event|3|||
42101459|NCT00542386|75912296|FG004|Overall Study|Protocol Violation|0|||
42368496|NCT01813019|76228343|FG000|Overall Study|Withdrawal by Subject|3|||
42368497|NCT01813019|76228344|FG001|Overall Study|Withdrawal by Subject|2|||
42368498|NCT01813019|76228343|FG000|Overall Study|administrative problems|2|||
42368499|NCT01813019|76228344|FG001|Overall Study|administrative problems|0|||
42368500|NCT01813019|76228343|FG000|Overall Study|Protocol Deviation|2|||
42368501|NCT01813019|76228344|FG001|Overall Study|Protocol Deviation|1|||
42368502|NCT01787591|76228352|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
42368503|NCT01787591|76228353|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
42368504|NCT01787591|76228354|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
42368505|NCT01787591|76228355|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
42368506|NCT01812707|76228370|FG000|Overall Study|Adverse Event|0|||
42368507|NCT01812707|76228371|FG001|Overall Study|Adverse Event|0|||
42368508|NCT01812707|76228372|FG002|Overall Study|Adverse Event|0|||
42368509|NCT01812707|76228373|FG003|Overall Study|Adverse Event|2|||
42368510|NCT01812707|76228370|FG000|Overall Study|Poor compliance to protocol|1|||
42368511|NCT01812707|76228371|FG001|Overall Study|Poor compliance to protocol|0|||
42368512|NCT01812707|76228372|FG002|Overall Study|Poor compliance to protocol|0|||
42368513|NCT01812707|76228373|FG003|Overall Study|Poor compliance to protocol|0|||
42368514|NCT01812707|76228370|FG000|Overall Study|Consent withdrawn by participant|1|||
42368515|NCT01812707|76228371|FG001|Overall Study|Consent withdrawn by participant|0|||
42368516|NCT01812707|76228372|FG002|Overall Study|Consent withdrawn by participant|0|||
42368517|NCT01812707|76228373|FG003|Overall Study|Consent withdrawn by participant|0|||
42368518|NCT01787279|76228384|FG000|Overall Study|Lost to Follow-up|2|||
42368519|NCT01787279|76228384|FG000|Overall Study|Lack of Efficacy|1|||
42368520|NCT02728206|76228388|FG000|Overall Study|Death|1|||
42368521|NCT01811225|76228392|FG000|Treatment Period 1|Adverse Event|2|||
42368522|NCT01811225|76228393|FG001|Treatment Period 1|Adverse Event|3|||
42368523|NCT01811225|76228392|FG000|Treatment Period 1|Lost to Follow-up|12|||
42368524|NCT01811225|76228393|FG001|Treatment Period 1|Lost to Follow-up|8|||
42368525|NCT01811225|76228392|FG000|Treatment Period 1|transporation|1|||
42101460|NCT00542386|75912297|FG005|Overall Study|Protocol Violation|4|||
42101461|NCT00542386|75912292|FG000|Overall Study|Withdrawal by Subject|5|||
42101462|NCT00542386|75912293|FG001|Overall Study|Withdrawal by Subject|8|||
42101463|NCT00542386|75912294|FG002|Overall Study|Withdrawal by Subject|10|||
42101464|NCT00542386|75912295|FG003|Overall Study|Withdrawal by Subject|11|||
42101465|NCT00542386|75912296|FG004|Overall Study|Withdrawal by Subject|15|||
42101466|NCT00542386|75912297|FG005|Overall Study|Withdrawal by Subject|7|||
42101467|NCT00542386|75912292|FG000|Overall Study|Other Reasons|4|||
42101468|NCT00542386|75912293|FG001|Overall Study|Other Reasons|1|||
42101469|NCT00542386|75912294|FG002|Overall Study|Other Reasons|4|||
42101470|NCT00542386|75912295|FG003|Overall Study|Other Reasons|3|||
42101471|NCT00542386|75912296|FG004|Overall Study|Other Reasons|4|||
42101472|NCT00542386|75912297|FG005|Overall Study|Other Reasons|2|||
42101473|NCT00604383|75912313|FG000|Overall Study|Withdrawal by Subject|33|||
42101474|NCT00604383|75912314|FG001|Overall Study|Withdrawal by Subject|31|||
42101475|NCT00604383|75912313|FG000|Overall Study|Lost to Follow-up|24|||
42101476|NCT00604383|75912314|FG001|Overall Study|Lost to Follow-up|19|||
42101477|NCT00604383|75912313|FG000|Overall Study|Death|14|||
42101478|NCT00604383|75912314|FG001|Overall Study|Death|22|||
42101479|NCT00604383|75912313|FG000|Overall Study|Adverse Event|16|||
42101480|NCT00604383|75912314|FG001|Overall Study|Adverse Event|9|||
42101481|NCT00604383|75912313|FG000|Overall Study|Physician Decision|0|||
42101482|NCT00604383|75912314|FG001|Overall Study|Physician Decision|3|||
42101483|NCT00333775|75912323|FG000|Overall Study|Death|144|||
42368526|NCT01811225|76228393|FG001|Treatment Period 1|transporation|0|||
42368527|NCT01811225|76228392|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
42368528|NCT01811225|76228393|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
42368529|NCT01811225|76228392|FG000|Treatment Period 2|Lost to Follow-up|1|||
42101484|NCT00333775|75912324|FG001|Overall Study|Death|149|||
42368530|NCT01811225|76228393|FG001|Treatment Period 2|Lost to Follow-up|2|||
42368531|NCT01811225|76228392|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
42101485|NCT00333775|75912325|FG002|Overall Study|Death|143|||
42101486|NCT00333775|75912323|FG000|Overall Study|In Follow-up When Study Stopped|87|||
42101487|NCT00333775|75912324|FG001|Overall Study|In Follow-up When Study Stopped|92|||
42101488|NCT00333775|75912325|FG002|Overall Study|In Follow-up When Study Stopped|96|||
42368532|NCT01811225|76228393|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
42368533|NCT01809197|76228401|FG000|Overall Study|Lost to Follow-up|4|||
42368534|NCT01809197|76228402|FG001|Overall Study|Lost to Follow-up|2|||
42368535|NCT01809197|76228401|FG000|Overall Study|Adverse Event|2|||
42368536|NCT01809197|76228402|FG001|Overall Study|Adverse Event|3|||
42368537|NCT01809197|76228401|FG000|Overall Study|Failed slit lamp exam|1|||
42101489|NCT00333775|75912323|FG000|Overall Study|Lost to Follow-up|10|||
42101490|NCT00333775|75912324|FG001|Overall Study|Lost to Follow-up|7|||
42368538|NCT01809197|76228402|FG001|Overall Study|Failed slit lamp exam|0|||
42368539|NCT01809197|76228401|FG000|Overall Study|Non-Compliance|1|||
42368540|NCT01809197|76228402|FG001|Overall Study|Non-Compliance|1|||
42368541|NCT01809197|76228401|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
42018570|NCT01257503|75825957|FG001|Overall Study|strep culture positive at enrollment|0|||
42018571|NCT00995566|75825963|FG000|Overall Study|Adverse Event|2|||
42368542|NCT01809197|76228402|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
42368543|NCT01809197|76228401|FG000|Overall Study|Withdrawal by Subject|1|||
42368544|NCT01809197|76228402|FG001|Overall Study|Withdrawal by Subject|1|||
42368545|NCT01809197|76228401|FG000|Overall Study|Product not available|0|||
42368546|NCT01809197|76228402|FG001|Overall Study|Product not available|1|||
42101491|NCT00333775|75912325|FG002|Overall Study|Lost to Follow-up|8|||
42101492|NCT00605475|75912343|FG000|Overall Study|Abnormal Laboratory Values|0|||
42368547|NCT01786109|76228411|FG000|Overall Study|fail manometry barostat tube placement|1|||
42368548|NCT01786109|76228412|FG001|Overall Study|fail manometry barostat tube placement|0|||
42018572|NCT00995566|75825963|FG000|Overall Study|Early study termination|52|||
42018573|NCT01257425|75825969|FG000|Overall Study|Lack of Efficacy|3|||
42101493|NCT00605475|75912344|FG001|Overall Study|Abnormal Laboratory Values|0|||
42101494|NCT00605475|75912345|FG002|Overall Study|Abnormal Laboratory Values|0|||
42101495|NCT00605475|75912346|FG003|Overall Study|Abnormal Laboratory Values|0|||
42101496|NCT00605475|75912347|FG004|Overall Study|Abnormal Laboratory Values|0|||
42101497|NCT00605475|75912348|FG005|Overall Study|Abnormal Laboratory Values|0|||
42101498|NCT00605475|75912349|FG006|Overall Study|Abnormal Laboratory Values|0|||
42101499|NCT00605475|75912350|FG007|Overall Study|Abnormal Laboratory Values|0|||
42101500|NCT00605475|75912351|FG008|Overall Study|Abnormal Laboratory Values|1|||
42101501|NCT00605475|75912352|FG009|Overall Study|Abnormal Laboratory Values|0|||
42101502|NCT00605475|75912343|FG000|Overall Study|Administrative problems|0|||
42101503|NCT00605475|75912344|FG001|Overall Study|Administrative problems|0|||
42101504|NCT00605475|75912345|FG002|Overall Study|Administrative problems|0|||
42101505|NCT00605475|75912346|FG003|Overall Study|Administrative problems|0|||
42101506|NCT00605475|75912347|FG004|Overall Study|Administrative problems|0|||
42101507|NCT00605475|75912348|FG005|Overall Study|Administrative problems|0|||
42101508|NCT00605475|75912349|FG006|Overall Study|Administrative problems|1|||
42101509|NCT00605475|75912350|FG007|Overall Study|Administrative problems|0|||
42101510|NCT00605475|75912351|FG008|Overall Study|Administrative problems|0|||
42101511|NCT00605475|75912352|FG009|Overall Study|Administrative problems|0|||
42101512|NCT00605475|75912343|FG000|Overall Study|Lost to Follow-up|0|||
42101513|NCT00605475|75912344|FG001|Overall Study|Lost to Follow-up|0|||
42101514|NCT00605475|75912345|FG002|Overall Study|Lost to Follow-up|0|||
42018574|NCT01257425|75825970|FG001|Overall Study|Lack of Efficacy|3|||
42018575|NCT01257425|75825969|FG000|Overall Study|Adverse Event|1|||
42018576|NCT01257425|75825970|FG001|Overall Study|Adverse Event|1|||
42018577|NCT01257425|75825969|FG000|Overall Study|Protocol Violation|1|||
42018578|NCT01257425|75825970|FG001|Overall Study|Protocol Violation|1|||
42018579|NCT01257425|75825969|FG000|Overall Study|Withdrawal by Subject|0|||
42018580|NCT01257425|75825970|FG001|Overall Study|Withdrawal by Subject|1|||
42018581|NCT01257425|75825969|FG000|Overall Study|Death|1|||
42018582|NCT01257425|75825970|FG001|Overall Study|Death|0|||
42018583|NCT00995488|75825976|FG000|Overall Study|Withdrawal by Subject|1|||
42018584|NCT01256879|75825980|FG000|Overall Study|Withdrawal by Subject|1|||
42018585|NCT01125189|75825993|FG000|Treatment Period|Lack of Efficacy|15|||
42018586|NCT01125189|75825994|FG001|Treatment Period|Lack of Efficacy|18|||
42018587|NCT01125189|75825995|FG002|Treatment Period|Lack of Efficacy|25|||
42018588|NCT01125189|75825993|FG000|Treatment Period|Adverse Event|7|||
42018589|NCT01125189|75825994|FG001|Treatment Period|Adverse Event|8|||
42101515|NCT00605475|75912346|FG003|Overall Study|Lost to Follow-up|0|||
42101516|NCT00605475|75912347|FG004|Overall Study|Lost to Follow-up|0|||
42101517|NCT00605475|75912348|FG005|Overall Study|Lost to Follow-up|0|||
42101518|NCT00605475|75912349|FG006|Overall Study|Lost to Follow-up|0|||
42101519|NCT00605475|75912350|FG007|Overall Study|Lost to Follow-up|0|||
42101520|NCT00605475|75912351|FG008|Overall Study|Lost to Follow-up|1|||
42101521|NCT00605475|75912352|FG009|Overall Study|Lost to Follow-up|1|||
42101522|NCT00605475|75912343|FG000|Overall Study|Protocol Violation|0|||
42101523|NCT00605475|75912344|FG001|Overall Study|Protocol Violation|0|||
42101524|NCT00605475|75912345|FG002|Overall Study|Protocol Violation|0|||
42101525|NCT00605475|75912346|FG003|Overall Study|Protocol Violation|0|||
42101526|NCT00605475|75912347|FG004|Overall Study|Protocol Violation|1|||
42101527|NCT00605475|75912348|FG005|Overall Study|Protocol Violation|0|||
42101528|NCT00605475|75912349|FG006|Overall Study|Protocol Violation|0|||
42101529|NCT00605475|75912350|FG007|Overall Study|Protocol Violation|0|||
42101530|NCT00605475|75912351|FG008|Overall Study|Protocol Violation|0|||
42101531|NCT00605475|75912352|FG009|Overall Study|Protocol Violation|0|||
42101532|NCT00605475|75912343|FG000|Overall Study|Withdrawal by Subject|0|||
42101533|NCT00605475|75912344|FG001|Overall Study|Withdrawal by Subject|0|||
42101534|NCT00605475|75912345|FG002|Overall Study|Withdrawal by Subject|0|||
42101535|NCT00605475|75912346|FG003|Overall Study|Withdrawal by Subject|0|||
42101536|NCT00605475|75912347|FG004|Overall Study|Withdrawal by Subject|0|||
42101537|NCT00605475|75912348|FG005|Overall Study|Withdrawal by Subject|2|||
42101538|NCT00605475|75912349|FG006|Overall Study|Withdrawal by Subject|0|||
42101539|NCT00605475|75912350|FG007|Overall Study|Withdrawal by Subject|0|||
42101540|NCT00605475|75912351|FG008|Overall Study|Withdrawal by Subject|0|||
42101541|NCT00605475|75912352|FG009|Overall Study|Withdrawal by Subject|1|||
42101542|NCT00333619|75912397|FG000|Overall Study|Death|12|||
42101543|NCT00333619|75912398|FG001|Overall Study|Death|6|||
42101544|NCT00333619|75912397|FG000|Overall Study|Withdrawal by Subject|6|||
42101545|NCT00333619|75912398|FG001|Overall Study|Withdrawal by Subject|1|||
42101546|NCT00333619|75912397|FG000|Overall Study|Lost to Follow-up|3|||
42101547|NCT00333619|75912398|FG001|Overall Study|Lost to Follow-up|3|||
42101548|NCT00605319|75912406|FG000|Overall Study|Adverse Event|6|||
42101549|NCT00333229|75912418|FG000|Overall Study|Lack of Efficacy|0|||
42101550|NCT00333229|75912419|FG001|Overall Study|Lack of Efficacy|1|||
42101551|NCT00332839|75912427|FG000|Core (Months 0 - 12)|Administrative problems|1|||
42101552|NCT00332839|75912428|FG001|Core (Months 0 - 12)|Administrative problems|1|||
42101553|NCT00332839|75912427|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
42101554|NCT00332839|75912428|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
42101555|NCT00332839|75912427|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
42101556|NCT00332839|75912428|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
42101557|NCT00332839|75912427|FG000|Core (Months 0 - 12)|Adverse Event|5|||
42101558|NCT00332839|75912428|FG001|Core (Months 0 - 12)|Adverse Event|15|||
42101559|NCT00332839|75912427|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
42101560|NCT00332839|75912428|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
42101561|NCT00332839|75912427|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
42101562|NCT00332839|75912428|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
42101563|NCT00332839|75912427|FG000|Follow-up (Months 12 - 60)|Death|1|||
42101564|NCT00332839|75912428|FG001|Follow-up (Months 12 - 60)|Death|1|||
42101565|NCT00357097|75912436|FG000|Overall Study|Did not meet inclusion criteria|5|||
42101566|NCT00357097|75912437|FG001|Overall Study|Did not meet inclusion criteria|3|||
42101567|NCT00357097|75912436|FG000|Overall Study|Adverse Event|34|||
42101568|NCT00357097|75912437|FG001|Overall Study|Adverse Event|6|||
42101569|NCT00357097|75912436|FG000|Overall Study|Withdrawal by Subject|8|||
42101570|NCT00357097|75912437|FG001|Overall Study|Withdrawal by Subject|7|||
42101571|NCT00357097|75912436|FG000|Overall Study|Non-compliance|1|||
42101572|NCT00357097|75912437|FG001|Overall Study|Non-compliance|2|||
42101573|NCT00357097|75912436|FG000|Overall Study|Lack of Efficacy|2|||
42101574|NCT00357097|75912437|FG001|Overall Study|Lack of Efficacy|8|||
42101575|NCT00357097|75912436|FG000|Overall Study|Met Exclusion Criteria|3|||
42101576|NCT00357097|75912437|FG001|Overall Study|Met Exclusion Criteria|1|||
42101577|NCT00357097|75912436|FG000|Overall Study|Other|1|||
42101578|NCT00357097|75912437|FG001|Overall Study|Other|1|||
42101579|NCT00357097|75912436|FG000|Overall Study|Increase of RLS Symptoms|0|||
42101580|NCT00357097|75912437|FG001|Overall Study|Increase of RLS Symptoms|1|||
42101581|NCT00356863|75912445|FG000|Overall Study|Death|16|||
42101582|NCT00356863|75912446|FG001|Overall Study|Death|32|||
42101583|NCT00356863|75912445|FG000|Overall Study|Lost to Follow-up|76|||
42101584|NCT00356863|75912446|FG001|Overall Study|Lost to Follow-up|43|||
42101585|NCT00355615|75912469|FG000|Randomized Double Blind Period|Adverse Event|1|||
42368549|NCT01786109|76228413|FG002|Overall Study|fail manometry barostat tube placement|0|||
42101586|NCT00355615|75912470|FG001|Randomized Double Blind Period|Adverse Event|0|||
42101587|NCT00355615|75912471|FG002|Randomized Double Blind Period|Adverse Event|0|||
42101588|NCT00355615|75912472|FG003|Randomized Double Blind Period|Adverse Event|0|||
42101589|NCT00355615|75912473|FG004|Randomized Double Blind Period|Adverse Event|0|||
42101590|NCT00355615|75912469|FG000|Randomized Double Blind Period|Protocol Violation|0|||
42196751|NCT00100048|76008591|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
42368550|NCT01786109|76228411|FG000|Overall Study|unrelated illness|0|||
42368551|NCT01786109|76228412|FG001|Overall Study|unrelated illness|0|||
42368552|NCT01786109|76228413|FG002|Overall Study|unrelated illness|1|||
42368553|NCT01786109|76228411|FG000|Overall Study|adverse effects colon preparation|0|||
42368554|NCT01786109|76228412|FG001|Overall Study|adverse effects colon preparation|0|||
42368555|NCT01786109|76228413|FG002|Overall Study|adverse effects colon preparation|1|||
42368556|NCT02728830|76228497|FG000|Overall Study|Exclusionary Surgery|9|||
42368557|NCT02728830|76228497|FG000|Overall Study|Exclusionary Pathology|6|||
42368558|NCT02728830|76228497|FG000|Overall Study|Physician Decision|3|||
42368559|NCT02728830|76228497|FG000|Overall Study|Withdrawal by Subject|2|||
42368560|NCT02728830|76228497|FG000|Overall Study|Lost to Follow-up|1|||
42368561|NCT02728830|76228497|FG000|Overall Study|Exclusionary Lab Values|1|||
42368562|NCT02728830|76228497|FG000|Overall Study|Contraindicated Illness|1|||
42368563|NCT02728830|76228497|FG000|Overall Study|Language Barrier|1|||
42368564|NCT02728596|76228551|FG000|Overall Study|Refusal unrelated to adverse event|3|||
42368565|NCT02728596|76228552|FG001|Overall Study|Refusal unrelated to adverse event|6|||
42368566|NCT02728596|76228553|FG002|Overall Study|Refusal unrelated to adverse event|7|||
42368567|NCT02728596|76228554|FG003|Overall Study|Refusal unrelated to adverse event|7|||
42368568|NCT02728596|76228551|FG000|Overall Study|Death|44|||
42368569|NCT02728596|76228552|FG001|Overall Study|Death|42|||
42368570|NCT02728596|76228553|FG002|Overall Study|Death|123|||
42368571|NCT02728596|76228554|FG003|Overall Study|Death|68|||
42368572|NCT00708162|76228928|FG000|Randomized Phase|Randomized but Not Treated|7|||
42368573|NCT00708162|76228929|FG001|Randomized Phase|Randomized but Not Treated|5|||
42368574|NCT00708162|76228928|FG000|Randomized Phase|Participant Noncompliance|40|||
42368575|NCT00708162|76228929|FG001|Randomized Phase|Participant Noncompliance|32|||
42368576|NCT00708162|76228928|FG000|Randomized Phase|Lost to Follow-up|34|||
42368577|NCT00708162|76228929|FG001|Randomized Phase|Lost to Follow-up|34|||
42368578|NCT00708162|76228928|FG000|Randomized Phase|Withdrew Consent|31|||
42368579|NCT00708162|76228929|FG001|Randomized Phase|Withdrew Consent|22|||
42368580|NCT00708162|76228928|FG000|Randomized Phase|Lack of Efficacy|14|||
42368581|NCT00708162|76228929|FG001|Randomized Phase|Lack of Efficacy|19|||
42368582|NCT00708162|76228928|FG000|Randomized Phase|Protocol Violation|10|||
42368583|NCT00708162|76228929|FG001|Randomized Phase|Protocol Violation|11|||
42368584|NCT00708162|76228928|FG000|Randomized Phase|Adverse Event|8|||
42368585|NCT00708162|76228929|FG001|Randomized Phase|Adverse Event|12|||
42368586|NCT00708162|76228928|FG000|Randomized Phase|Investigator's Discretion|7|||
42368587|NCT00708162|76228929|FG001|Randomized Phase|Investigator's Discretion|10|||
42368588|NCT00708162|76228928|FG000|Randomized Phase|Death|2|||
42368589|NCT00708162|76228929|FG001|Randomized Phase|Death|9|||
42368590|NCT00708162|76228928|FG000|Randomized Phase|Pregnancy|3|||
42368591|NCT00708162|76228929|FG001|Randomized Phase|Pregnancy|0|||
42368592|NCT00708162|76228928|FG000|Open-Label Phase|Lost to Follow-up|10|||
42368593|NCT00708162|76228929|FG001|Open-Label Phase|Lost to Follow-up|8|||
42368594|NCT00708162|76228928|FG000|Open-Label Phase|Withdrew Consent|12|||
42368595|NCT00708162|76228929|FG001|Open-Label Phase|Withdrew Consent|6|||
42368596|NCT00708162|76228928|FG000|Open-Label Phase|Participant Noncompliance|7|||
42368597|NCT00708162|76228929|FG001|Open-Label Phase|Participant Noncompliance|7|||
42368598|NCT00708162|76228928|FG000|Open-Label Phase|Lack of Efficacy|7|||
42368599|NCT00708162|76228929|FG001|Open-Label Phase|Lack of Efficacy|4|||
42368600|NCT00708162|76228928|FG000|Open-Label Phase|Investigator's Discretion|3|||
42368601|NCT00708162|76228929|FG001|Open-Label Phase|Investigator's Discretion|2|||
42368602|NCT00708162|76228928|FG000|Open-Label Phase|Death|3|||
42368603|NCT00708162|76228929|FG001|Open-Label Phase|Death|1|||
42368604|NCT00708162|76228928|FG000|Open-Label Phase|Adverse Event|1|||
42368605|NCT00708162|76228929|FG001|Open-Label Phase|Adverse Event|2|||
42368606|NCT00708162|76228928|FG000|Open-Label Phase|Other|1|||
42368607|NCT00708162|76228929|FG001|Open-Label Phase|Other|0|||
42368608|NCT02245672|76229014|FG000|Overall Study|Adverse Event|4|||
42368609|NCT02245672|76229015|FG001|Overall Study|Adverse Event|4|||
42368610|NCT02245672|76229016|FG002|Overall Study|Adverse Event|4|||
42368611|NCT02245672|76229014|FG000|Overall Study|Lost to Follow-up|3|||
42018590|NCT01125189|75825995|FG002|Treatment Period|Adverse Event|8|||
42368612|NCT02245672|76229015|FG001|Overall Study|Lost to Follow-up|5|||
42018591|NCT01125189|75825993|FG000|Treatment Period|Withdrawal by Subject|3|||
42368613|NCT02245672|76229016|FG002|Overall Study|Lost to Follow-up|1|||
42368614|NCT02245672|76229014|FG000|Overall Study|Withdrawal by Subject|6|||
42368615|NCT02245672|76229015|FG001|Overall Study|Withdrawal by Subject|3|||
42368616|NCT02245672|76229016|FG002|Overall Study|Withdrawal by Subject|0|||
42368617|NCT02245672|76229014|FG000|Overall Study|Randomized in error (not treated)|0|||
42368618|NCT02245672|76229015|FG001|Overall Study|Randomized in error (not treated)|1|||
42018592|NCT01125189|75825994|FG001|Treatment Period|Withdrawal by Subject|1|||
42018593|NCT01125189|75825995|FG002|Treatment Period|Withdrawal by Subject|1|||
42018594|NCT01125189|75825993|FG000|Treatment Period|Death|1|||
42018595|NCT01125189|75825994|FG001|Treatment Period|Death|0|||
42368619|NCT02245672|76229016|FG002|Overall Study|Randomized in error (not treated)|0|||
42101591|NCT00355615|75912470|FG001|Randomized Double Blind Period|Protocol Violation|0|||
42101592|NCT00355615|75912471|FG002|Randomized Double Blind Period|Protocol Violation|1|||
42101593|NCT00355615|75912472|FG003|Randomized Double Blind Period|Protocol Violation|1|||
42101594|NCT00355615|75912473|FG004|Randomized Double Blind Period|Protocol Violation|0|||
42101595|NCT00355615|75912469|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
42101596|NCT00355615|75912470|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
42101597|NCT00355615|75912471|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
42101598|NCT00355615|75912472|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
42101599|NCT00355615|75912473|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
42101600|NCT00355615|75912469|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
42101601|NCT00355615|75912470|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
42101602|NCT00355615|75912471|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
42101603|NCT00355615|75912472|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
42101604|NCT00355615|75912473|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
42101605|NCT00355615|75912469|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
42101606|NCT00355615|75912470|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
42101607|NCT00355615|75912471|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
42101608|NCT00355615|75912472|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
42101609|NCT00355615|75912473|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
42101610|NCT00355615|75912469|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
42101611|NCT00355615|75912470|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
42101612|NCT00355615|75912471|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
42101613|NCT00355615|75912472|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
42101614|NCT00355615|75912473|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
42101615|NCT00347269|75912486|FG000|Overall Study|Lost to Follow-up|74|||
42101616|NCT00347269|75912487|FG001|Overall Study|Lost to Follow-up|65|||
42101617|NCT00347269|75912486|FG000|Overall Study|Withdrawal by Subject|18|||
42101618|NCT00347269|75912487|FG001|Overall Study|Withdrawal by Subject|38|||
42101619|NCT00347269|75912486|FG000|Overall Study|Death|2|||
42101620|NCT00347269|75912487|FG001|Overall Study|Death|3|||
42101621|NCT00544648|75912495|FG000|Overall Study|Withdrawal by Subject|1|||
42101622|NCT00544648|75912496|FG001|Overall Study|Withdrawal by Subject|0|||
42101623|NCT00544648|75912495|FG000|Overall Study|Adverse Event|1|||
42101624|NCT00544648|75912496|FG001|Overall Study|Adverse Event|1|||
42101625|NCT00544648|75912495|FG000|Overall Study|progression of disease|1|||
42101626|NCT00544648|75912496|FG001|Overall Study|progression of disease|0|||
42101627|NCT00346333|75912506|FG000|Overall Study|Death|1|||
42101628|NCT00346333|75912507|FG001|Overall Study|Death|0|||
42101629|NCT00346333|75912506|FG000|Overall Study|unwilling or unable to continue|4|||
42101630|NCT00346333|75912507|FG001|Overall Study|unwilling or unable to continue|8|||
42196752|NCT00100048|76008592|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
42196753|NCT00100048|76008593|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
42196754|NCT00100048|76008594|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
42196755|NCT00100048|76008595|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
42196756|NCT00100048|76008590|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
42196757|NCT00100048|76008591|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
42196758|NCT00100048|76008592|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
42196759|NCT00100048|76008593|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
42196760|NCT00100048|76008594|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
42196761|NCT00100048|76008595|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
42196762|NCT00100048|76008590|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
42196763|NCT00100048|76008591|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
42196764|NCT00100048|76008592|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
42196765|NCT00100048|76008593|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
42196766|NCT00100048|76008594|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
42368620|NCT00706992|76229161|FG000|Overall Study|Study termination|5|||
42018596|NCT01125189|75825995|FG002|Treatment Period|Death|0|||
42018597|NCT01125189|75825993|FG000|Treatment Period|Lost to Follow-up|1|||
42018598|NCT01125189|75825994|FG001|Treatment Period|Lost to Follow-up|2|||
42018599|NCT01125189|75825995|FG002|Treatment Period|Lost to Follow-up|1|||
42018600|NCT01125189|75825993|FG000|Treatment Period|Poor compliance/noncompliance|0|||
42018601|NCT01125189|75825994|FG001|Treatment Period|Poor compliance/noncompliance|1|||
42018602|NCT01125189|75825995|FG002|Treatment Period|Poor compliance/noncompliance|0|||
42018603|NCT01125189|75825993|FG000|Treatment Period|Participants requested to discontinue|1|||
42018604|NCT01125189|75825994|FG001|Treatment Period|Participants requested to discontinue|3|||
42018605|NCT01125189|75825995|FG002|Treatment Period|Participants requested to discontinue|4|||
42018606|NCT01125189|75825993|FG000|Treatment Period|Other reasons|1|||
42018607|NCT01125189|75825994|FG001|Treatment Period|Other reasons|1|||
42018608|NCT01125189|75825995|FG002|Treatment Period|Other reasons|0|||
42101631|NCT00330967|75912517|FG000|Overall Study|Withdrawal by Subject|0|||
42101632|NCT00330967|75912518|FG001|Overall Study|Withdrawal by Subject|5|||
42101633|NCT00330967|75912517|FG000|Overall Study|Physician Decision|0|||
42101634|NCT00330967|75912518|FG001|Overall Study|Physician Decision|9|||
42101635|NCT00330343|75912524|FG000|Overall Study|Lost to Follow-up|5|||
42101636|NCT00330187|75912532|FG000|Overall Study|Lost to Follow-up|12|||
42101637|NCT00330187|75912533|FG001|Overall Study|Lost to Follow-up|13|||
42101638|NCT00330187|75912534|FG002|Overall Study|Lost to Follow-up|14|||
42101639|NCT00330187|75912535|FG003|Overall Study|Lost to Follow-up|10|||
42101640|NCT00330187|75912532|FG000|Overall Study|Withdrawal by Subject|8|||
42101641|NCT00330187|75912533|FG001|Overall Study|Withdrawal by Subject|5|||
42101642|NCT00330187|75912534|FG002|Overall Study|Withdrawal by Subject|4|||
42101643|NCT00330187|75912535|FG003|Overall Study|Withdrawal by Subject|4|||
42101644|NCT03914950|75912545|FG000|Overall Study|Physician Decision|54|||
42101645|NCT00329797|75912557|FG000|Overall Study|Protocol Violation|1|||
42101646|NCT00329797|75912558|FG001|Overall Study|Protocol Violation|0|||
42101647|NCT00329797|75912557|FG000|Overall Study|Withdrawal by Subject|6|||
42101648|NCT00329797|75912558|FG001|Overall Study|Withdrawal by Subject|6|||
42101649|NCT00541450|75912566|FG000|Phase A|Adverse Event|3|||
42101650|NCT00541450|75912567|FG001|Phase A|Adverse Event|0|||
42101651|NCT00541450|75912566|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
42101652|NCT00541450|75912567|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
42101653|NCT00541450|75912566|FG000|Phase A|Hyperglycemia|0|||
42101654|NCT00541450|75912567|FG001|Phase A|Hyperglycemia|1|||
42101655|NCT00541450|75912566|FG000|Phase A|Lost to Follow-up|6|||
42101656|NCT00541450|75912567|FG001|Phase A|Lost to Follow-up|4|||
42101657|NCT00541450|75912566|FG000|Phase A|Physician Decision|2|||
42101658|NCT00541450|75912567|FG001|Phase A|Physician Decision|0|||
42101659|NCT00541450|75912566|FG000|Phase A|Protocol Violation|2|||
42101660|NCT00541450|75912567|FG001|Phase A|Protocol Violation|3|||
42101661|NCT00541450|75912566|FG000|Phase A|Withdrawal by Subject|7|||
42101662|NCT00541450|75912567|FG001|Phase A|Withdrawal by Subject|7|||
42101663|NCT00541450|75912566|FG000|Phase B|Adverse Event|6|||
42101664|NCT00541450|75912567|FG001|Phase B|Adverse Event|6|||
42101665|NCT00541450|75912566|FG000|Phase B|Hyperglycemia|10|||
42101666|NCT00541450|75912567|FG001|Phase B|Hyperglycemia|9|||
42101667|NCT00541450|75912566|FG000|Phase B|Lost to Follow-up|6|||
42101668|NCT00541450|75912567|FG001|Phase B|Lost to Follow-up|4|||
42101669|NCT00541450|75912566|FG000|Phase B|Physician Decision|4|||
42101670|NCT00541450|75912567|FG001|Phase B|Physician Decision|2|||
42101671|NCT00541450|75912566|FG000|Phase B|Pregnancy|0|||
42101672|NCT00541450|75912567|FG001|Phase B|Pregnancy|1|||
42101673|NCT00541450|75912566|FG000|Phase B|Protocol Violation|3|||
42101674|NCT00541450|75912567|FG001|Phase B|Protocol Violation|3|||
42101675|NCT00541450|75912566|FG000|Phase B|Withdrawal by Subject|8|||
42101676|NCT00541450|75912567|FG001|Phase B|Withdrawal by Subject|6|||
42101677|NCT00355147|75912579|FG000|Overall Study|Lost to Follow-up|10|||
42196767|NCT00100048|76008595|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
42018609|NCT01125189|75825993|FG000|Treatment Period|Completed 24 week treatment period only|2|||
42018610|NCT01125189|75825994|FG001|Treatment Period|Completed 24 week treatment period only|1|||
42018611|NCT01125189|75825995|FG002|Treatment Period|Completed 24 week treatment period only|2|||
42018612|NCT01125189|75825993|FG000|Follow up Period|Withdrawal by Subject|3|||
42018613|NCT01125189|75825994|FG001|Follow up Period|Withdrawal by Subject|2|||
42018614|NCT01125189|75825995|FG002|Follow up Period|Withdrawal by Subject|5|||
42018615|NCT01125189|75825993|FG000|Follow up Period|Death|1|||
42018616|NCT01125189|75825994|FG001|Follow up Period|Death|0|||
42018617|NCT01125189|75825995|FG002|Follow up Period|Death|0|||
42018618|NCT01125189|75825993|FG000|Follow up Period|Lost to Follow-up|12|||
42018619|NCT01125189|75825994|FG001|Follow up Period|Lost to Follow-up|9|||
42018620|NCT01125189|75825995|FG002|Follow up Period|Lost to Follow-up|6|||
42018621|NCT01125189|75825993|FG000|Follow up Period|Other reasons|4|||
42018622|NCT01125189|75825994|FG001|Follow up Period|Other reasons|4|||
42018623|NCT01125189|75825995|FG002|Follow up Period|Other reasons|5|||
42018624|NCT01256567|75826006|FG000|Overall Study|Withdrawal by Subject|1|||
42018625|NCT00996736|75826013|FG000|Overall Study|Death|1|||
42101678|NCT00355147|75912580|FG001|Overall Study|Lost to Follow-up|8|||
42101679|NCT00355147|75912579|FG000|Overall Study|Withdrawal by Subject|8|||
42101680|NCT00355147|75912580|FG001|Overall Study|Withdrawal by Subject|12|||
42101681|NCT00540124|75912593|FG000|Overall Study|Adverse Event|0|||
42101682|NCT00540124|75912594|FG001|Overall Study|Adverse Event|2|||
42101683|NCT00540124|75912595|FG002|Overall Study|Adverse Event|1|||
42101684|NCT00540124|75912593|FG000|Overall Study|Entry Criteria Not Met|2|||
42101685|NCT00540124|75912594|FG001|Overall Study|Entry Criteria Not Met|0|||
42101686|NCT00540124|75912595|FG002|Overall Study|Entry Criteria Not Met|0|||
42196768|NCT00100048|76008590|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
42018626|NCT00996736|75826014|FG001|Overall Study|Death|1|||
42101687|NCT00540124|75912593|FG000|Overall Study|Lack of Efficacy|1|||
42101688|NCT00540124|75912594|FG001|Overall Study|Lack of Efficacy|0|||
42101689|NCT00540124|75912595|FG002|Overall Study|Lack of Efficacy|0|||
42101690|NCT00540124|75912593|FG000|Overall Study|Withdrawal by Subject|1|||
42101691|NCT00540124|75912594|FG001|Overall Study|Withdrawal by Subject|1|||
42101692|NCT00540124|75912595|FG002|Overall Study|Withdrawal by Subject|0|||
42101693|NCT00540046|75912605|FG000|Overall Study|Lost to Follow-up|33|||
42101694|NCT00540046|75912606|FG001|Overall Study|Lost to Follow-up|23|||
42101695|NCT00689936|75912617|FG000|Active Treatment Phase|Adverse Event|68|||
42101696|NCT00689936|75912618|FG001|Active Treatment Phase|Adverse Event|71|||
42101697|NCT00689936|75912619|FG002|Active Treatment Phase|Adverse Event|76|||
42101698|NCT00689936|75912617|FG000|Active Treatment Phase|Disease Progression|273|||
42101699|NCT00689936|75912618|FG001|Active Treatment Phase|Disease Progression|362|||
42101700|NCT00689936|75912619|FG002|Active Treatment Phase|Disease Progression|339|||
42101701|NCT00689936|75912617|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
42101702|NCT00689936|75912618|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
42101703|NCT00689936|75912619|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
42101704|NCT00689936|75912617|FG000|Active Treatment Phase|Death|60|||
42101705|NCT00689936|75912618|FG001|Active Treatment Phase|Death|28|||
42101706|NCT00689936|75912619|FG002|Active Treatment Phase|Death|37|||
42101707|NCT00689936|75912617|FG000|Active Treatment Phase|Lost to Follow-up|0|||
42101708|NCT00689936|75912618|FG001|Active Treatment Phase|Lost to Follow-up|2|||
42101709|NCT00689936|75912619|FG002|Active Treatment Phase|Lost to Follow-up|2|||
42101710|NCT00689936|75912617|FG000|Active Treatment Phase|Protocol Violation|2|||
42101711|NCT00689936|75912618|FG001|Active Treatment Phase|Protocol Violation|2|||
42101712|NCT00689936|75912619|FG002|Active Treatment Phase|Protocol Violation|4|||
42101713|NCT00689936|75912617|FG000|Active Treatment Phase|Study Close Out|64|||
42101714|NCT00689936|75912618|FG001|Active Treatment Phase|Study Close Out|26|||
42101715|NCT00689936|75912619|FG002|Active Treatment Phase|Study Close Out|21|||
42101716|NCT00689936|75912617|FG000|Active Treatment Phase|Miscellaneous|52|||
42101717|NCT00689936|75912618|FG001|Active Treatment Phase|Miscellaneous|34|||
42101718|NCT00689936|75912619|FG002|Active Treatment Phase|Miscellaneous|47|||
42101719|NCT00689936|75912617|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
42101720|NCT00689936|75912618|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
42101721|NCT00689936|75912619|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
42101722|NCT00671034|75912630|FG000|Overall Study|Adverse Event|5|||
42101723|NCT00671034|75912631|FG001|Overall Study|Adverse Event|7|||
42101724|NCT00671034|75912632|FG002|Overall Study|Adverse Event|1|||
42101725|NCT00671034|75912630|FG000|Overall Study|Death|3|||
42101726|NCT00671034|75912631|FG001|Overall Study|Death|2|||
42101727|NCT00671034|75912632|FG002|Overall Study|Death|1|||
42101728|NCT00671034|75912630|FG000|Overall Study|Physician Decision|12|||
42101729|NCT00671034|75912631|FG001|Overall Study|Physician Decision|4|||
42101730|NCT00671034|75912632|FG002|Overall Study|Physician Decision|5|||
42101731|NCT00671034|75912630|FG000|Overall Study|VHR ALL feature|8|||
42101732|NCT00671034|75912631|FG001|Overall Study|VHR ALL feature|3|||
42101733|NCT00671034|75912632|FG002|Overall Study|VHR ALL feature|5|||
42101734|NCT00671034|75912630|FG000|Overall Study|Refusal|5|||
42101735|NCT00671034|75912631|FG001|Overall Study|Refusal|3|||
42101736|NCT00671034|75912632|FG002|Overall Study|Refusal|5|||
42101737|NCT00671034|75912630|FG000|Overall Study|includes Alternative therapy, etc.|6|||
42101738|NCT00671034|75912631|FG001|Overall Study|includes Alternative therapy, etc.|1|||
42101739|NCT00671034|75912632|FG002|Overall Study|includes Alternative therapy, etc.|7|||
42101740|NCT02679508|75912643|FG000|Healing Phase|Protocol Violation|1|||
42101741|NCT02679508|75912644|FG001|Healing Phase|Protocol Violation|1|||
42196769|NCT00100048|76008591|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
42196770|NCT00100048|76008592|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
42196771|NCT00100048|76008593|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
42196772|NCT00100048|76008594|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
42196773|NCT00100048|76008595|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
42196774|NCT00100048|76008590|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
42196775|NCT00100048|76008591|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
42196776|NCT00100048|76008592|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
42196777|NCT00100048|76008593|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
42368621|NCT00706992|76229162|FG001|Overall Study|Study termination|5|||
42368622|NCT00706992|76229163|FG002|Overall Study|Study termination|6|||
42368623|NCT00706992|76229164|FG003|Overall Study|Study termination|2|||
42368624|NCT00706992|76229165|FG004|Overall Study|Study termination|3|||
42368625|NCT00706992|76229166|FG005|Overall Study|Study termination|2|||
42101742|NCT02679508|75912643|FG000|Healing Phase|Lost to Follow-up|1|||
42101743|NCT02679508|75912644|FG001|Healing Phase|Lost to Follow-up|0|||
42101744|NCT02679508|75912643|FG000|Maintenance Phase|Adverse Event|12|||
42101745|NCT02679508|75912644|FG001|Maintenance Phase|Adverse Event|2|||
42101746|NCT02679508|75912643|FG000|Maintenance Phase|Lost to Follow-up|0|||
42101747|NCT02679508|75912644|FG001|Maintenance Phase|Lost to Follow-up|1|||
42101748|NCT02679508|75912643|FG000|Maintenance Phase|Withdrawal by Subject|15|||
42101749|NCT02679508|75912644|FG001|Maintenance Phase|Withdrawal by Subject|8|||
42101750|NCT02679508|75912643|FG000|Maintenance Phase|Other|5|||
42101751|NCT02679508|75912644|FG001|Maintenance Phase|Other|4|||
42101752|NCT04404478|75912652|FG000|Overall Study|Withdrawal by Subject|1|||
42101753|NCT04404478|75912653|FG001|Overall Study|Withdrawal by Subject|3|||
42101754|NCT00539734|75912661|FG000|Overall Study|Protocol Violation|1|||
42101755|NCT03907072|75912668|FG000|Overall Study|Study Terminated by Sponsor|2|||
42101756|NCT03907072|75912669|FG001|Overall Study|Study Terminated by Sponsor|2|||
42101757|NCT03907072|75912670|FG002|Overall Study|Study Terminated by Sponsor|2|||
42101758|NCT00329719|75912695|FG000|Overall Study|Lost to Follow-up|0|||
42101759|NCT00329719|75912696|FG001|Overall Study|Lost to Follow-up|0|||
42101760|NCT00329719|75912697|FG002|Overall Study|Lost to Follow-up|0|||
42101761|NCT00329719|75912698|FG003|Overall Study|Lost to Follow-up|1|||
42101762|NCT00329641|75912708|FG000|Overall Study|Did not start treatment|1|||
42101763|NCT00329641|75912708|FG000|Overall Study|Not eligible|1|||
42101764|NCT00329641|75912708|FG000|Overall Study|Adverse Event|3|||
42101765|NCT00329641|75912708|FG000|Overall Study|Other reason, not protocol specified|1|||
42101766|NCT00329407|75912722|FG000|Overall Study|Withdrawal by Subject|1|||
42368626|NCT00706992|76229167|FG006|Overall Study|Study termination|3|||
42368627|NCT00706992|76229161|FG000|Overall Study|Disease progression before treatment|0|||
42368628|NCT00706992|76229162|FG001|Overall Study|Disease progression before treatment|0|||
42368629|NCT00706992|76229163|FG002|Overall Study|Disease progression before treatment|0|||
42368630|NCT00706992|76229164|FG003|Overall Study|Disease progression before treatment|0|||
42368631|NCT00706992|76229165|FG004|Overall Study|Disease progression before treatment|1|||
42368632|NCT00706992|76229166|FG005|Overall Study|Disease progression before treatment|0|||
42368633|NCT00706992|76229167|FG006|Overall Study|Disease progression before treatment|0|||
42368634|NCT01785875|76229220|FG000|Overall Study|Withdrawal by Subject|41|||
42368635|NCT01785875|76229221|FG001|Overall Study|Withdrawal by Subject|34|||
42368636|NCT01785875|76229222|FG002|Overall Study|Withdrawal by Subject|36|||
42368637|NCT01785875|76229220|FG000|Overall Study|Lost to Follow-up|19|||
42368638|NCT01785875|76229221|FG001|Overall Study|Lost to Follow-up|22|||
42368639|NCT01785875|76229222|FG002|Overall Study|Lost to Follow-up|6|||
42368640|NCT01785875|76229220|FG000|Overall Study|Death|27|||
42368641|NCT01785875|76229221|FG001|Overall Study|Death|16|||
42368642|NCT01785875|76229222|FG002|Overall Study|Death|7|||
42368643|NCT01785875|76229220|FG000|Overall Study|Sponsor Decision|0|||
42368644|NCT01785875|76229221|FG001|Overall Study|Sponsor Decision|2|||
42368645|NCT01785875|76229222|FG002|Overall Study|Sponsor Decision|0|||
42368646|NCT01785875|76229220|FG000|Overall Study|Protocol Specified Criteria|207|||
42368647|NCT01785875|76229221|FG001|Overall Study|Protocol Specified Criteria|214|||
42368648|NCT01785875|76229222|FG002|Overall Study|Protocol Specified Criteria|55|||
42368649|NCT01785875|76229220|FG000|Overall Study|Missing|0|||
42368650|NCT01785875|76229221|FG001|Overall Study|Missing|1|||
42368651|NCT01785875|76229222|FG002|Overall Study|Missing|3|||
42368652|NCT05567393|76229251|FG000|Overall Study|Voluntary Withdrawal|0|||
42368653|NCT05567393|76229252|FG001|Overall Study|Voluntary Withdrawal|0|||
42368654|NCT05567393|76229253|FG002|Overall Study|Voluntary Withdrawal|0|||
42368655|NCT05567393|76229254|FG003|Overall Study|Voluntary Withdrawal|0|||
42368656|NCT05567393|76229255|FG004|Overall Study|Voluntary Withdrawal|0|||
42368657|NCT05567393|76229256|FG005|Overall Study|Voluntary Withdrawal|0|||
42196778|NCT00100048|76008594|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
42196779|NCT00100048|76008595|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
42368658|NCT05567393|76229257|FG006|Overall Study|Voluntary Withdrawal|0|||
42101767|NCT00328783|75912726|FG000|Overall Study|Could not tolerate ABC|21|||
42101768|NCT00328783|75912726|FG000|Overall Study|No heart in RT field|4|||
42101769|NCT00328783|75912726|FG000|Overall Study|Withdrawal by Subject|1|||
42101770|NCT00567489|75912734|FG000|Overall Study|Adverse Event|6|||
42101771|NCT00567489|75912735|FG001|Overall Study|Adverse Event|14|||
42101772|NCT00567489|75912734|FG000|Overall Study|Physician Decision|0|||
42101773|NCT00567489|75912735|FG001|Overall Study|Physician Decision|4|||
42101774|NCT00567489|75912734|FG000|Overall Study|Withdrawal by Subject|0|||
42368659|NCT05567393|76229258|FG007|Overall Study|Voluntary Withdrawal|0|||
42368660|NCT05567393|76229259|FG008|Overall Study|Voluntary Withdrawal|0|||
42368661|NCT05567393|76229260|FG009|Overall Study|Voluntary Withdrawal|0|||
42101775|NCT00567489|75912735|FG001|Overall Study|Withdrawal by Subject|2|||
42101776|NCT00567489|75912734|FG000|Overall Study|Renal Transplantation|0|||
42368662|NCT05567393|76229261|FG010|Overall Study|Voluntary Withdrawal|0|||
42368663|NCT05567393|76229262|FG011|Overall Study|Voluntary Withdrawal|0|||
42101777|NCT00567489|75912735|FG001|Overall Study|Renal Transplantation|3|||
42101778|NCT00567489|75912734|FG000|Overall Study|Other|1|||
42101779|NCT00567489|75912735|FG001|Overall Study|Other|0|||
42101780|NCT00669942|75912753|FG000|Parts 2 and 3|Adverse Event|0|||
42368664|NCT05567393|76229263|FG012|Overall Study|Voluntary Withdrawal|0|||
42368665|NCT05567393|76229264|FG013|Overall Study|Voluntary Withdrawal|1|||
42368666|NCT05567393|76229265|FG014|Overall Study|Voluntary Withdrawal|0|||
42368667|NCT05567393|76229266|FG015|Overall Study|Voluntary Withdrawal|0|||
42101781|NCT00669942|75912754|FG001|Parts 2 and 3|Adverse Event|0|||
42101782|NCT00669942|75912755|FG002|Parts 2 and 3|Adverse Event|0|||
42101783|NCT00669942|75912756|FG003|Parts 2 and 3|Adverse Event|0|||
42101784|NCT00669942|75912757|FG004|Parts 2 and 3|Adverse Event|0|||
42101785|NCT00669942|75912758|FG005|Parts 2 and 3|Adverse Event|0|||
42101786|NCT00669942|75912759|FG006|Parts 2 and 3|Adverse Event|0|||
42101787|NCT00669942|75912760|FG007|Parts 2 and 3|Adverse Event|2|||
42101788|NCT00669942|75912761|FG008|Parts 2 and 3|Adverse Event|1|||
42101789|NCT00669942|75912762|FG009|Parts 2 and 3|Adverse Event|0|||
42101790|NCT00669942|75912763|FG010|Parts 2 and 3|Adverse Event|0|||
42101791|NCT00669942|75912764|FG011|Parts 2 and 3|Adverse Event|0|||
42101792|NCT00669942|75912753|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
42101793|NCT00669942|75912754|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
42101794|NCT00669942|75912755|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
42101795|NCT00669942|75912756|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
42101796|NCT00669942|75912757|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
42101797|NCT00669942|75912758|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
42101798|NCT00669942|75912759|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
42101799|NCT00669942|75912760|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
42101800|NCT00669942|75912761|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
42101801|NCT00669942|75912762|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
42101802|NCT00669942|75912763|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
42101803|NCT00669942|75912764|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
42101804|NCT00669942|75912753|FG000|Parts 2 and 3|Protocol Violation|0|||
42101805|NCT00669942|75912754|FG001|Parts 2 and 3|Protocol Violation|0|||
42101806|NCT00669942|75912755|FG002|Parts 2 and 3|Protocol Violation|0|||
42101807|NCT00669942|75912756|FG003|Parts 2 and 3|Protocol Violation|0|||
42101808|NCT00669942|75912757|FG004|Parts 2 and 3|Protocol Violation|0|||
42101809|NCT00669942|75912758|FG005|Parts 2 and 3|Protocol Violation|1|||
42101810|NCT00669942|75912759|FG006|Parts 2 and 3|Protocol Violation|0|||
42101811|NCT00669942|75912760|FG007|Parts 2 and 3|Protocol Violation|0|||
42101812|NCT00669942|75912761|FG008|Parts 2 and 3|Protocol Violation|0|||
42101813|NCT00669942|75912762|FG009|Parts 2 and 3|Protocol Violation|0|||
42101814|NCT00669942|75912763|FG010|Parts 2 and 3|Protocol Violation|0|||
42101815|NCT00669942|75912764|FG011|Parts 2 and 3|Protocol Violation|0|||
42101816|NCT00669864|75912787|FG000|Overall Study|Lost to Follow-up|2|||
42101817|NCT00669864|75912787|FG000|Overall Study|Protocol Violation|2|||
42101818|NCT00669864|75912787|FG000|Overall Study|Withdrawal by Subject|3|||
42101819|NCT00669864|75912787|FG000|Overall Study|Other|2|||
42101820|NCT00668148|75912791|FG000|Overall Study|Adverse Event|5|||
42101821|NCT00668148|75912791|FG000|Overall Study|Subject Non-compliance|1|||
42101822|NCT00668148|75912791|FG000|Overall Study|Progressive Disease Before Treatment|2|||
42101823|NCT00668148|75912791|FG000|Overall Study|Withdrawal of Consent|2|||
42101824|NCT00667992|75912808|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
42101825|NCT00667992|75912809|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
42101826|NCT00667992|75912808|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
42101827|NCT00667992|75912809|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
42101828|NCT00667992|75912808|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
42101829|NCT00667992|75912809|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
42101830|NCT00667992|75912808|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
42101831|NCT00667992|75912809|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
42101832|NCT00667992|75912808|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
42101833|NCT00667992|75912809|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
42101834|NCT00667992|75912808|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
42101835|NCT00667992|75912809|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
42101836|NCT00667992|75912808|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
42101837|NCT00667992|75912809|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
42101838|NCT00667992|75912808|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
42101839|NCT00667992|75912809|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
42101840|NCT00667992|75912808|FG000|Wash-out|Not within one doubling dilution|4|||
42101841|NCT00667992|75912809|FG001|Wash-out|Not within one doubling dilution|3|||
42101842|NCT00667992|75912808|FG000|Wash-out|Failure to wash-out|2|||
42101843|NCT00667992|75912809|FG001|Wash-out|Failure to wash-out|2|||
42101844|NCT00667992|75912808|FG000|Wash-out|Withdrawal by Subject|1|||
42101845|NCT00667992|75912809|FG001|Wash-out|Withdrawal by Subject|0|||
42101846|NCT00667992|75912808|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
42101847|NCT00667992|75912809|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
42101848|NCT00667992|75912808|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
42101849|NCT00667992|75912809|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
42196780|NCT00100048|76008590|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
42196781|NCT00100048|76008591|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
42196782|NCT00100048|76008592|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
42196783|NCT00100048|76008593|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
42196784|NCT00100048|76008594|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
42101850|NCT00669396|75912827|FG000|Overall Study|Lost to Follow-up|10|||
42101851|NCT00669396|75912828|FG001|Overall Study|Lost to Follow-up|12|||
42101852|NCT00669318|75912834|FG000|Overall Study|Withdrawal by Subject|2|||
42101853|NCT00669240|75912838|FG000|Overall Study|Lack of Efficacy|33|||
42101854|NCT00669240|75912838|FG000|Overall Study|Withdrawal by Subject|42|||
42101855|NCT00669240|75912838|FG000|Overall Study|Lost to Follow-up|34|||
42101856|NCT00669240|75912838|FG000|Overall Study|Adverse Event|21|||
42101857|NCT00669240|75912838|FG000|Overall Study|Other|19|||
42101858|NCT00669240|75912838|FG000|Overall Study|Enrolled but not treated|15|||
42101859|NCT00669240|75912838|FG000|Overall Study|Enrolled but no dosing record|1|||
42101860|NCT00669162|75912842|FG000|Overall Study|Withdrawal by Subject|1|||
42101861|NCT00666588|75912859|FG000|Overall Study|ineligible|2|||
42101862|NCT00666588|75912860|FG001|Overall Study|ineligible|0|||
42101863|NCT00666588|75912861|FG002|Overall Study|ineligible|0|||
42101864|NCT00666588|75912862|FG003|Overall Study|ineligible|2|||
42101865|NCT00666588|75912859|FG000|Overall Study|inevaluable|2|||
42101866|NCT00666588|75912860|FG001|Overall Study|inevaluable|0|||
42101867|NCT00666588|75912861|FG002|Overall Study|inevaluable|0|||
42101868|NCT00666588|75912862|FG003|Overall Study|inevaluable|0|||
42101869|NCT00689390|75912874|FG000|Overall Study|Adverse Event|19|||
42101870|NCT00689390|75912875|FG001|Overall Study|Adverse Event|0|||
42101871|NCT00689390|75912874|FG000|Overall Study|Lost to Follow-up|179|||
42101872|NCT00689390|75912875|FG001|Overall Study|Lost to Follow-up|7|||
42101873|NCT00689390|75912874|FG000|Overall Study|Withdrawal by Subject|117|||
42101874|NCT00689390|75912875|FG001|Overall Study|Withdrawal by Subject|3|||
42101875|NCT00689390|75912874|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
42101876|NCT00689390|75912875|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
42101877|NCT00689390|75912874|FG000|Overall Study|Non-Compliance With Protocol|21|||
42101878|NCT00689390|75912875|FG001|Overall Study|Non-Compliance With Protocol|0|||
42101879|NCT00689390|75912874|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
42101880|NCT00689390|75912875|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
42101881|NCT00689390|75912874|FG000|Overall Study|Administrative|37|||
42101882|NCT00689390|75912875|FG001|Overall Study|Administrative|0|||
42101883|NCT00567879|75912892|FG000|Overall Study|Adverse Event|2|||
42101884|NCT00567879|75912893|FG001|Overall Study|Adverse Event|0|||
42101885|NCT00567879|75912894|FG002|Overall Study|Adverse Event|1|||
42101886|NCT00567879|75912895|FG003|Overall Study|Adverse Event|0|||
42101887|NCT00567879|75912896|FG004|Overall Study|Adverse Event|1|||
42101888|NCT00567879|75912897|FG005|Overall Study|Adverse Event|0|||
42101889|NCT00567879|75912892|FG000|Overall Study|Abnormal test procedure(s)|0|||
42101890|NCT00567879|75912893|FG001|Overall Study|Abnormal test procedure(s)|0|||
42101891|NCT00567879|75912894|FG002|Overall Study|Abnormal test procedure(s)|1|||
42101892|NCT00567879|75912895|FG003|Overall Study|Abnormal test procedure(s)|0|||
42101893|NCT00567879|75912896|FG004|Overall Study|Abnormal test procedure(s)|0|||
42101894|NCT00567879|75912897|FG005|Overall Study|Abnormal test procedure(s)|0|||
42101895|NCT00567879|75912892|FG000|Overall Study|Withdrawal by Subject|0|||
42101896|NCT00567879|75912893|FG001|Overall Study|Withdrawal by Subject|0|||
42101897|NCT00567879|75912894|FG002|Overall Study|Withdrawal by Subject|3|||
42196785|NCT00100048|76008595|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
42196786|NCT02757430|76008620|FG000|Overall Study|Physician Decision|6|||
42196787|NCT02757430|76008620|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
42196788|NCT02757430|76008620|FG000|Overall Study|No informed consent|1|||
42196789|NCT02757430|76008620|FG000|Overall Study|No procedure performed|2|||
42196790|NCT02757352|76008636|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
42196791|NCT02757352|76008637|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
42196792|NCT02757352|76008638|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
42196793|NCT02757352|76008639|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
42196794|NCT02757352|76008640|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
42196795|NCT02757352|76008641|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
42196796|NCT02757352|76008642|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
42196797|NCT02757352|76008643|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
42196798|NCT02757352|76008644|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
42196799|NCT02757352|76008645|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
42101898|NCT00567879|75912895|FG003|Overall Study|Withdrawal by Subject|1|||
42101899|NCT00567879|75912896|FG004|Overall Study|Withdrawal by Subject|0|||
42101900|NCT00567879|75912897|FG005|Overall Study|Withdrawal by Subject|0|||
42101901|NCT00567879|75912892|FG000|Overall Study|New cancer therapy|0|||
42101902|NCT00567879|75912893|FG001|Overall Study|New cancer therapy|0|||
42101903|NCT00567879|75912894|FG002|Overall Study|New cancer therapy|1|||
42101904|NCT00567879|75912895|FG003|Overall Study|New cancer therapy|0|||
42101905|NCT00567879|75912896|FG004|Overall Study|New cancer therapy|0|||
42101906|NCT00567879|75912897|FG005|Overall Study|New cancer therapy|0|||
42101907|NCT00567879|75912892|FG000|Overall Study|Disease progression|5|||
42101908|NCT00567879|75912893|FG001|Overall Study|Disease progression|7|||
42101909|NCT00567879|75912894|FG002|Overall Study|Disease progression|15|||
42101910|NCT00567879|75912895|FG003|Overall Study|Disease progression|5|||
42101911|NCT00567879|75912896|FG004|Overall Study|Disease progression|11|||
42101912|NCT00567879|75912897|FG005|Overall Study|Disease progression|3|||
42101913|NCT00603915|75912915|FG000|Overall Study|Physician Decision|1|||
42101914|NCT00603837|75912921|FG000|Overall Study|Physician Decision|3|||
42101915|NCT00603837|75912922|FG001|Overall Study|Physician Decision|0|||
42101916|NCT00667602|75912931|FG000|Overall Study|Withdrawal by Subject|4|||
42101917|NCT00667602|75912932|FG001|Overall Study|Withdrawal by Subject|9|||
42101918|NCT00667602|75912933|FG002|Overall Study|Withdrawal by Subject|10|||
42101919|NCT00667602|75912931|FG000|Overall Study|Lost to Follow-up|4|||
42101920|NCT00667602|75912932|FG001|Overall Study|Lost to Follow-up|5|||
42101921|NCT00667602|75912933|FG002|Overall Study|Lost to Follow-up|6|||
42368668|NCT05567393|76229267|FG016|Overall Study|Voluntary Withdrawal|0|||
42368669|NCT05567393|76229268|FG017|Overall Study|Voluntary Withdrawal|0|||
42368670|NCT04973085|76229341|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
42101922|NCT00667602|75912931|FG000|Overall Study|Administrative reason|0|||
42101923|NCT00667602|75912932|FG001|Overall Study|Administrative reason|0|||
42101924|NCT00667602|75912933|FG002|Overall Study|Administrative reason|2|||
42101925|NCT00667602|75912931|FG000|Overall Study|Protocol Violation|0|||
42101926|NCT00667602|75912932|FG001|Overall Study|Protocol Violation|1|||
42101927|NCT00667602|75912933|FG002|Overall Study|Protocol Violation|0|||
42101928|NCT00691028|75912949|FG000|Open-label Period|Adverse Event|0|||
42101929|NCT00691028|75912950|FG001|Open-label Period|Adverse Event|0|||
42101930|NCT00691028|75912951|FG002|Open-label Period|Adverse Event|0|||
42101931|NCT00691028|75912952|FG003|Open-label Period|Adverse Event|16|||
42101932|NCT00691028|75912949|FG000|Open-label Period|Withdrawal by Subject|0|||
42101933|NCT00691028|75912950|FG001|Open-label Period|Withdrawal by Subject|0|||
42101934|NCT00691028|75912951|FG002|Open-label Period|Withdrawal by Subject|0|||
42101935|NCT00691028|75912952|FG003|Open-label Period|Withdrawal by Subject|3|||
42101936|NCT00691028|75912949|FG000|Open-label Period|not come to a hospital|0|||
42101937|NCT00691028|75912950|FG001|Open-label Period|not come to a hospital|0|||
42101938|NCT00691028|75912951|FG002|Open-label Period|not come to a hospital|0|||
42101939|NCT00691028|75912952|FG003|Open-label Period|not come to a hospital|1|||
42101940|NCT00691028|75912949|FG000|Double-blind Period|Adverse Event|8|||
42101941|NCT00691028|75912950|FG001|Double-blind Period|Adverse Event|9|||
42101942|NCT00691028|75912951|FG002|Double-blind Period|Adverse Event|6|||
42101943|NCT00691028|75912952|FG003|Double-blind Period|Adverse Event|0|||
42101944|NCT00691028|75912949|FG000|Double-blind Period|Lack of Efficacy|4|||
42101945|NCT00691028|75912950|FG001|Double-blind Period|Lack of Efficacy|3|||
42101946|NCT00691028|75912951|FG002|Double-blind Period|Lack of Efficacy|2|||
42101947|NCT00691028|75912952|FG003|Double-blind Period|Lack of Efficacy|0|||
42101948|NCT00691028|75912949|FG000|Double-blind Period|Withdrawal by Subject|1|||
42101949|NCT00691028|75912950|FG001|Double-blind Period|Withdrawal by Subject|0|||
42101950|NCT00691028|75912951|FG002|Double-blind Period|Withdrawal by Subject|1|||
42101951|NCT00691028|75912952|FG003|Double-blind Period|Withdrawal by Subject|0|||
42101952|NCT00691028|75912949|FG000|Double-blind Period|not come to a hospital.|0|||
42101953|NCT00691028|75912950|FG001|Double-blind Period|not come to a hospital.|1|||
42101954|NCT00691028|75912951|FG002|Double-blind Period|not come to a hospital.|0|||
42101955|NCT00691028|75912952|FG003|Double-blind Period|not come to a hospital.|0|||
42101956|NCT00690794|75912966|FG000|Overall Study|Adverse Event|12|||
42101957|NCT00690794|75912967|FG001|Overall Study|Adverse Event|10|||
42101958|NCT00690794|75912966|FG000|Overall Study|Lost to Follow-up|1|||
42101959|NCT00690794|75912967|FG001|Overall Study|Lost to Follow-up|4|||
42101960|NCT00690794|75912966|FG000|Overall Study|Withdrawal by Subject|0|||
42368671|NCT04973085|76229342|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
42368672|NCT04542070|76229392|FG000|Overall Study|Adverse Event|10|||
42018627|NCT00996736|75826013|FG000|Overall Study|Lost to Follow-up|15|||
42018628|NCT00996736|75826014|FG001|Overall Study|Lost to Follow-up|14|||
42018629|NCT00996736|75826013|FG000|Overall Study|Visit not within 3-month window|5|||
42018630|NCT00996736|75826014|FG001|Overall Study|Visit not within 3-month window|3|||
42018631|NCT00996658|75826022|FG000|Overall Study|Adverse Event|2|||
42018632|NCT00996658|75826023|FG001|Overall Study|Adverse Event|5|||
42018633|NCT00996658|75826022|FG000|Overall Study|Protocol Violation|0|||
42018634|NCT00996658|75826023|FG001|Overall Study|Protocol Violation|1|||
42018635|NCT00996658|75826022|FG000|Overall Study|Lost to Follow-up|2|||
42018636|NCT00996658|75826023|FG001|Overall Study|Lost to Follow-up|5|||
42018637|NCT00996658|75826022|FG000|Overall Study|Non-compliance issues|3|||
42018638|NCT00996658|75826023|FG001|Overall Study|Non-compliance issues|3|||
42018639|NCT00996658|75826022|FG000|Overall Study|Other|9|||
42018640|NCT00996658|75826023|FG001|Overall Study|Other|7|||
42368673|NCT04542070|76229393|FG001|Overall Study|Adverse Event|3|||
42018641|NCT01124643|75826029|FG000|Overall Study|Death|1|||
42101961|NCT00690794|75912967|FG001|Overall Study|Withdrawal by Subject|9|||
42101962|NCT00690794|75912966|FG000|Overall Study|Protocol Violation|6|||
42101963|NCT00690794|75912967|FG001|Overall Study|Protocol Violation|7|||
42101964|NCT00690794|75912966|FG000|Overall Study|Noncompliance|1|||
42101965|NCT00690794|75912967|FG001|Overall Study|Noncompliance|2|||
42101966|NCT00690794|75912966|FG000|Overall Study|Other not specified|1|||
42101967|NCT00690794|75912967|FG001|Overall Study|Other not specified|3|||
42101968|NCT00666276|75912973|FG000|Overall Study|Protocol Violation|34|||
42101969|NCT00567255|75912998|FG000|Overall Study|Adverse Event|241|||
42101970|NCT00567255|75912999|FG001|Overall Study|Adverse Event|68|||
42101971|NCT00567255|75912998|FG000|Overall Study|Lost to Follow-up|77|||
42101972|NCT00567255|75912999|FG001|Overall Study|Lost to Follow-up|48|||
42101973|NCT00567255|75912998|FG000|Overall Study|Withdrawal by Subject|75|||
42101974|NCT00567255|75912999|FG001|Overall Study|Withdrawal by Subject|56|||
42101975|NCT00567255|75912998|FG000|Overall Study|Lack of Efficacy|19|||
42101976|NCT00567255|75912999|FG001|Overall Study|Lack of Efficacy|33|||
42101977|NCT00567255|75912998|FG000|Overall Study|Protocol Violation|20|||
42101978|NCT00567255|75912999|FG001|Overall Study|Protocol Violation|8|||
42101979|NCT00567255|75912998|FG000|Overall Study|Pregnancy|6|||
42101980|NCT00567255|75912999|FG001|Overall Study|Pregnancy|0|||
42101981|NCT00567255|75912998|FG000|Overall Study|Drug noncompliance,moved,other|25|||
42101982|NCT00567255|75912999|FG001|Overall Study|Drug noncompliance,moved,other|15|||
42101983|NCT00667446|75913007|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
42101984|NCT00667446|75913008|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
42101985|NCT00667446|75913007|FG000|Treatment Period (36 Months)|Other|2|||
42101986|NCT00667446|75913008|FG001|Treatment Period (36 Months)|Other|2|||
42101987|NCT00667446|75913007|FG000|Treatment Period (36 Months)|Personal reasons|2|||
42101988|NCT00667446|75913008|FG001|Treatment Period (36 Months)|Personal reasons|2|||
42101989|NCT00667446|75913007|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
42101990|NCT00667446|75913008|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
42101991|NCT00667446|75913007|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
42101992|NCT00667446|75913008|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
42101993|NCT00667446|75913007|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
42101994|NCT00667446|75913008|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
42101995|NCT00667446|75913007|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
42101996|NCT00667446|75913008|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
42101997|NCT00667446|75913007|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
42101998|NCT00667446|75913008|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
42101999|NCT00667446|75913007|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
42102000|NCT00667446|75913008|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
42102001|NCT00688844|75913014|FG000|Overall Study|Lost to Follow-up|10|||
42102002|NCT00667368|75913020|FG000|Overall Study|Lost to Follow-up|176|||
42102003|NCT00667368|75913021|FG001|Overall Study|Lost to Follow-up|155|||
42102004|NCT00667368|75913020|FG000|Overall Study|Discontinued early|24|||
42102005|NCT00667368|75913021|FG001|Overall Study|Discontinued early|17|||
42102006|NCT00567567|75913030|FG000|Overall Study|Adverse Event|0|||
42102007|NCT00567567|75913031|FG001|Overall Study|Adverse Event|2|||
42102008|NCT00567567|75913032|FG002|Overall Study|Adverse Event|5|||
42102009|NCT00567567|75913030|FG000|Overall Study|Death|8|||
42102010|NCT00567567|75913031|FG001|Overall Study|Death|1|||
42102011|NCT00567567|75913032|FG002|Overall Study|Death|5|||
42102012|NCT00567567|75913030|FG000|Overall Study|Lack of Efficacy|16|||
42102013|NCT00567567|75913031|FG001|Overall Study|Lack of Efficacy|17|||
42102014|NCT00567567|75913032|FG002|Overall Study|Lack of Efficacy|48|||
42102015|NCT00567567|75913030|FG000|Overall Study|Lost to Follow-up|0|||
42102016|NCT00567567|75913031|FG001|Overall Study|Lost to Follow-up|0|||
42102017|NCT00567567|75913032|FG002|Overall Study|Lost to Follow-up|1|||
42102018|NCT00567567|75913030|FG000|Overall Study|Physician Decision|16|||
42102019|NCT00567567|75913031|FG001|Overall Study|Physician Decision|18|||
42102020|NCT00567567|75913032|FG002|Overall Study|Physician Decision|84|||
42102021|NCT00567567|75913030|FG000|Overall Study|Withdrawal by Subject|0|||
42102022|NCT00567567|75913031|FG001|Overall Study|Withdrawal by Subject|0|||
42102023|NCT00567567|75913032|FG002|Overall Study|Withdrawal by Subject|2|||
42102024|NCT00567567|75913030|FG000|Overall Study|Ineligible|4|||
42102025|NCT00567567|75913031|FG001|Overall Study|Ineligible|0|||
42102026|NCT00567567|75913032|FG002|Overall Study|Ineligible|9|||
42102027|NCT00567567|75913030|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
42102028|NCT00567567|75913031|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
42102029|NCT00567567|75913032|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
42102030|NCT00567567|75913030|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
42368674|NCT04542070|76229394|FG002|Overall Study|Adverse Event|1|||
42102031|NCT00567567|75913031|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
42102032|NCT00567567|75913032|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
42102033|NCT00567567|75913030|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
42368675|NCT04542070|76229392|FG000|Overall Study|Lack of Efficacy|1|||
42368676|NCT04542070|76229393|FG001|Overall Study|Lack of Efficacy|2|||
42368677|NCT04542070|76229394|FG002|Overall Study|Lack of Efficacy|0|||
42102034|NCT00567567|75913031|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
42102035|NCT00567567|75913032|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
42102036|NCT00666198|75913042|FG000|Overall Study|Protocol Violation|10|||
42102037|NCT00666198|75913042|FG000|Overall Study|No Visit After First Day of Treatment|13|||
42368678|NCT04542070|76229392|FG000|Overall Study|Lost to Follow-up|3|||
42102038|NCT00666198|75913042|FG000|Overall Study|Safety Not Assessable|6|||
42102039|NCT00666198|75913042|FG000|Overall Study|No Drug Administration|4|||
42102040|NCT00664560|75913049|FG000|Overall Study|Adverse Event|19|||
42102041|NCT00664560|75913050|FG001|Overall Study|Adverse Event|16|||
42102042|NCT00664560|75913051|FG002|Overall Study|Adverse Event|7|||
42102043|NCT00664560|75913049|FG000|Overall Study|Withdrawal by Subject|9|||
42102044|NCT00664560|75913050|FG001|Overall Study|Withdrawal by Subject|13|||
42102045|NCT00664560|75913051|FG002|Overall Study|Withdrawal by Subject|7|||
42102046|NCT00664560|75913049|FG000|Overall Study|Lost to Follow-up|0|||
42102047|NCT00664560|75913050|FG001|Overall Study|Lost to Follow-up|2|||
42102048|NCT00664560|75913051|FG002|Overall Study|Lost to Follow-up|0|||
42102049|NCT00664560|75913049|FG000|Overall Study|Other|11|||
42102050|NCT00664560|75913050|FG001|Overall Study|Other|4|||
42102051|NCT00664560|75913051|FG002|Overall Study|Other|5|||
42102052|NCT00566709|75913061|FG000|Overall Study|Protocol Violation|5|||
42102053|NCT00566709|75913062|FG001|Overall Study|Protocol Violation|0|||
42102054|NCT00688688|75913071|FG000|Overall Study|Eligibility criterion not met|7|||
42102055|NCT00688688|75913072|FG001|Overall Study|Eligibility criterion not met|7|||
42102056|NCT00688688|75913073|FG002|Overall Study|Eligibility criterion not met|10|||
42102057|NCT00688688|75913071|FG000|Overall Study|Adverse Event|52|||
42102058|NCT00688688|75913072|FG001|Overall Study|Adverse Event|51|||
42102059|NCT00688688|75913073|FG002|Overall Study|Adverse Event|50|||
42102060|NCT00688688|75913071|FG000|Overall Study|Lack of Efficacy|34|||
42102061|NCT00688688|75913072|FG001|Overall Study|Lack of Efficacy|25|||
42102062|NCT00688688|75913073|FG002|Overall Study|Lack of Efficacy|45|||
42102063|NCT00688688|75913071|FG000|Overall Study|Withdrawal by Subject|66|||
42102064|NCT00688688|75913072|FG001|Overall Study|Withdrawal by Subject|75|||
42102065|NCT00688688|75913073|FG002|Overall Study|Withdrawal by Subject|65|||
42102066|NCT00688688|75913071|FG000|Overall Study|Lost to Follow-up|14|||
42102067|NCT00688688|75913072|FG001|Overall Study|Lost to Follow-up|7|||
42102068|NCT00688688|75913073|FG002|Overall Study|Lost to Follow-up|7|||
42102069|NCT00688688|75913071|FG000|Overall Study|Protocol Violation|6|||
42102070|NCT00688688|75913072|FG001|Overall Study|Protocol Violation|9|||
42102071|NCT00688688|75913073|FG002|Overall Study|Protocol Violation|11|||
42102072|NCT00688688|75913071|FG000|Overall Study|Randomized but never received study drug|1|||
42102073|NCT00688688|75913072|FG001|Overall Study|Randomized but never received study drug|0|||
42102074|NCT00688688|75913073|FG002|Overall Study|Randomized but never received study drug|0|||
42102075|NCT00688688|75913071|FG000|Overall Study|Non-compliance with study procedures|5|||
42102076|NCT00688688|75913072|FG001|Overall Study|Non-compliance with study procedures|3|||
42102077|NCT00688688|75913073|FG002|Overall Study|Non-compliance with study procedures|4|||
42102078|NCT00688688|75913071|FG000|Overall Study|Taking exclusionary medications|1|||
42102079|NCT00688688|75913072|FG001|Overall Study|Taking exclusionary medications|0|||
42102080|NCT00688688|75913073|FG002|Overall Study|Taking exclusionary medications|0|||
42102081|NCT00688688|75913071|FG000|Overall Study|Site closure|0|||
42102082|NCT00688688|75913072|FG001|Overall Study|Site closure|1|||
42102083|NCT00688688|75913073|FG002|Overall Study|Site closure|0|||
42102084|NCT00688688|75913071|FG000|Overall Study|Violation of exclusion criterion|0|||
42102085|NCT00688688|75913072|FG001|Overall Study|Violation of exclusion criterion|1|||
42102086|NCT00688688|75913073|FG002|Overall Study|Violation of exclusion criterion|0|||
42102087|NCT00664326|75913081|FG000|Overall Study|Adverse Event|14|||
42102088|NCT00664326|75913081|FG000|Overall Study|Noncompliance with study medication|3|||
42102089|NCT00664326|75913081|FG000|Overall Study|Withdrawal by Subject|1|||
42102090|NCT00664326|75913081|FG000|Overall Study|Physician Decision|1|||
42102091|NCT00664326|75913081|FG000|Overall Study|Other Reasons|3|||
42102092|NCT00664326|75913081|FG000|Overall Study|Death|2|||
42102093|NCT00664326|75913081|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
42102094|NCT00686972|75913085|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
42102095|NCT00665652|75913089|FG000|Overall Study|Adverse Event|4|||
42102096|NCT00665652|75913089|FG000|Overall Study|Death|1|||
42102097|NCT00665652|75913089|FG000|Overall Study|No longer met inclusion criteria.|1|||
42102098|NCT00566631|75913093|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
42102099|NCT00566631|75913093|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
42368679|NCT04542070|76229393|FG001|Overall Study|Lost to Follow-up|4|||
42368680|NCT04542070|76229394|FG002|Overall Study|Lost to Follow-up|2|||
42368681|NCT04542070|76229392|FG000|Overall Study|Physician Decision|1|||
42102100|NCT00566631|75913093|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
42102101|NCT00566631|75913093|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
42102102|NCT00566631|75913093|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
42102103|NCT00566631|75913093|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
42102104|NCT00566631|75913093|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
42102105|NCT00566631|75913093|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
42102106|NCT00566631|75913093|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
42102107|NCT00566631|75913093|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
42102108|NCT00566631|75913093|FG000|Part 2: Extension Phase|Adverse Event|11|||
42368682|NCT04542070|76229393|FG001|Overall Study|Physician Decision|0|||
42102109|NCT00566631|75913093|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
42102110|NCT00566631|75913093|FG000|Part 2: Extension Phase|Death|1|||
42102111|NCT00566631|75913093|FG000|Part 2: Extension Phase|Other|5|||
42102112|NCT00661830|75913099|FG000|Overall Study|Death|37|||
42102113|NCT00661830|75913100|FG001|Overall Study|Death|33|||
42102114|NCT00661830|75913099|FG000|Overall Study|Lost to Follow-up|1|||
42102115|NCT00661830|75913100|FG001|Overall Study|Lost to Follow-up|3|||
42102116|NCT00661830|75913099|FG000|Overall Study|Withdrawal by Subject|1|||
42102117|NCT00661830|75913100|FG001|Overall Study|Withdrawal by Subject|1|||
42102118|NCT00661830|75913099|FG000|Overall Study|Other reason|1|||
42102119|NCT00661830|75913100|FG001|Overall Study|Other reason|5|||
42102120|NCT00540592|75913116|FG000|Overall Study|Adverse Event|0|||
42102121|NCT00540592|75913117|FG001|Overall Study|Adverse Event|1|||
42102122|NCT00540592|75913118|FG002|Overall Study|Adverse Event|0|||
42102123|NCT00540592|75913119|FG003|Overall Study|Adverse Event|0|||
42102124|NCT00540592|75913120|FG004|Overall Study|Adverse Event|1|||
42102125|NCT00540592|75913121|FG005|Overall Study|Adverse Event|0|||
42102126|NCT00540592|75913122|FG006|Overall Study|Adverse Event|0|||
42102127|NCT00540592|75913123|FG007|Overall Study|Adverse Event|1|||
42102128|NCT00540592|75913124|FG008|Overall Study|Adverse Event|1|||
42102129|NCT00540592|75913125|FG009|Overall Study|Adverse Event|2|||
42102130|NCT00540592|75913116|FG000|Overall Study|Lost to Follow-up|2|||
42102131|NCT00540592|75913117|FG001|Overall Study|Lost to Follow-up|0|||
42102132|NCT00540592|75913118|FG002|Overall Study|Lost to Follow-up|0|||
42102133|NCT00540592|75913119|FG003|Overall Study|Lost to Follow-up|0|||
42102134|NCT00540592|75913120|FG004|Overall Study|Lost to Follow-up|0|||
42102135|NCT00540592|75913121|FG005|Overall Study|Lost to Follow-up|0|||
42102136|NCT00540592|75913122|FG006|Overall Study|Lost to Follow-up|0|||
42102137|NCT00540592|75913123|FG007|Overall Study|Lost to Follow-up|0|||
42102138|NCT00540592|75913124|FG008|Overall Study|Lost to Follow-up|0|||
42102139|NCT00540592|75913125|FG009|Overall Study|Lost to Follow-up|0|||
42102140|NCT00540592|75913116|FG000|Overall Study|Withdrawal by Subject|0|||
42102141|NCT00540592|75913117|FG001|Overall Study|Withdrawal by Subject|0|||
42102142|NCT00540592|75913118|FG002|Overall Study|Withdrawal by Subject|1|||
42102143|NCT00540592|75913119|FG003|Overall Study|Withdrawal by Subject|1|||
42102144|NCT00540592|75913120|FG004|Overall Study|Withdrawal by Subject|0|||
42102145|NCT00540592|75913121|FG005|Overall Study|Withdrawal by Subject|0|||
42102146|NCT00540592|75913122|FG006|Overall Study|Withdrawal by Subject|0|||
42102147|NCT00540592|75913123|FG007|Overall Study|Withdrawal by Subject|0|||
42102148|NCT00540592|75913124|FG008|Overall Study|Withdrawal by Subject|0|||
42102149|NCT00540592|75913125|FG009|Overall Study|Withdrawal by Subject|0|||
42102150|NCT03970395|75913149|FG000|Overall Study|Withdrawal by Subject|3|||
42102151|NCT03970395|75913150|FG001|Overall Study|Withdrawal by Subject|4|||
42102152|NCT03970395|75913149|FG000|Overall Study|Lost to Follow-up|4|||
42102153|NCT03970395|75913150|FG001|Overall Study|Lost to Follow-up|8|||
42102154|NCT00565773|75913160|FG000|Overall Study|Withdrawal by Subject|1|||
42102155|NCT00565773|75913160|FG000|Overall Study|Physician Decision|1|||
42102156|NCT00570492|75913166|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
42102157|NCT00570492|75913167|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
42102158|NCT00570492|75913168|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
42102159|NCT00570492|75913166|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
42102160|NCT00570492|75913167|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
42102161|NCT00570492|75913168|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
42102162|NCT00570492|75913166|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
42102163|NCT00570492|75913167|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
42102164|NCT00570492|75913168|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
42102165|NCT00570492|75913166|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
42102166|NCT00570492|75913167|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
42102167|NCT00570492|75913168|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
42102168|NCT00570492|75913166|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
42102169|NCT00570492|75913167|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
42196800|NCT02757352|76008636|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
42196801|NCT02757352|76008637|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
42102170|NCT00570492|75913168|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
42102171|NCT00570492|75913166|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
42102172|NCT00570492|75913167|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
42102173|NCT00570492|75913168|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
42102174|NCT00570492|75913166|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
42102175|NCT00570492|75913167|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
42102176|NCT00570492|75913168|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
42196802|NCT02757352|76008638|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
42196803|NCT02757352|76008639|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
42102177|NCT00570492|75913166|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
42102178|NCT00570492|75913167|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
42102179|NCT00570492|75913168|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
42102180|NCT00570492|75913166|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
42102181|NCT00570492|75913167|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
42102182|NCT00570492|75913168|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
42102183|NCT00570492|75913166|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
42102184|NCT00570492|75913167|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
42102185|NCT00570492|75913168|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
42102186|NCT00570492|75913166|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
42102187|NCT00570492|75913167|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
42102188|NCT00570492|75913168|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
42102189|NCT00570492|75913166|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
42102190|NCT00570492|75913167|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
42102191|NCT00570492|75913168|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
42102192|NCT00570492|75913166|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
42102193|NCT00570492|75913167|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
42102194|NCT00570492|75913168|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
42102195|NCT00570492|75913166|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
42102196|NCT00570492|75913167|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
42102197|NCT00570492|75913168|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
42102198|NCT00571922|75913176|FG000|Overall Study|Completion unknown|36|||
42102199|NCT00571922|75913177|FG001|Overall Study|Completion unknown|36|||
42102200|NCT00686894|75913183|FG000|Overall Study|Relapse|2|||
42102201|NCT00686894|75913183|FG000|Overall Study|Protocol Violation|4|||
42102202|NCT00328627|75913199|FG000|Overall Study|Hyperglycemic Rescue|41|||
42102203|NCT00328627|75913200|FG001|Overall Study|Hyperglycemic Rescue|18|||
42102204|NCT00328627|75913201|FG002|Overall Study|Hyperglycemic Rescue|16|||
42102205|NCT00328627|75913202|FG003|Overall Study|Hyperglycemic Rescue|13|||
42102206|NCT00328627|75913203|FG004|Overall Study|Hyperglycemic Rescue|6|||
42102207|NCT00328627|75913204|FG005|Overall Study|Hyperglycemic Rescue|5|||
42102208|NCT00328627|75913205|FG006|Overall Study|Hyperglycemic Rescue|19|||
42102209|NCT00328627|75913206|FG007|Overall Study|Hyperglycemic Rescue|6|||
42102210|NCT00328627|75913207|FG008|Overall Study|Hyperglycemic Rescue|6|||
42102211|NCT00328627|75913208|FG009|Overall Study|Hyperglycemic Rescue|11|||
42102212|NCT00328627|75913209|FG010|Overall Study|Hyperglycemic Rescue|3|||
42102213|NCT00328627|75913210|FG011|Overall Study|Hyperglycemic Rescue|2|||
42102214|NCT00328627|75913199|FG000|Overall Study|Adverse Event|3|||
42102215|NCT00328627|75913200|FG001|Overall Study|Adverse Event|1|||
42102216|NCT00328627|75913201|FG002|Overall Study|Adverse Event|2|||
42102217|NCT00328627|75913202|FG003|Overall Study|Adverse Event|3|||
42102218|NCT00328627|75913203|FG004|Overall Study|Adverse Event|1|||
42102219|NCT00328627|75913204|FG005|Overall Study|Adverse Event|2|||
42102220|NCT00328627|75913205|FG006|Overall Study|Adverse Event|1|||
42102221|NCT00328627|75913206|FG007|Overall Study|Adverse Event|2|||
42102222|NCT00328627|75913207|FG008|Overall Study|Adverse Event|0|||
42102223|NCT00328627|75913208|FG009|Overall Study|Adverse Event|7|||
42102224|NCT00328627|75913209|FG010|Overall Study|Adverse Event|5|||
42102225|NCT00328627|75913210|FG011|Overall Study|Adverse Event|4|||
42102226|NCT00328627|75913199|FG000|Overall Study|Protocol Violation|2|||
42102227|NCT00328627|75913200|FG001|Overall Study|Protocol Violation|2|||
42102228|NCT00328627|75913201|FG002|Overall Study|Protocol Violation|2|||
42102229|NCT00328627|75913202|FG003|Overall Study|Protocol Violation|8|||
42102230|NCT00328627|75913203|FG004|Overall Study|Protocol Violation|5|||
42102231|NCT00328627|75913204|FG005|Overall Study|Protocol Violation|5|||
42102232|NCT00328627|75913205|FG006|Overall Study|Protocol Violation|6|||
42102233|NCT00328627|75913206|FG007|Overall Study|Protocol Violation|2|||
42102234|NCT00328627|75913207|FG008|Overall Study|Protocol Violation|1|||
42102235|NCT00328627|75913208|FG009|Overall Study|Protocol Violation|4|||
42102236|NCT00328627|75913209|FG010|Overall Study|Protocol Violation|6|||
42196804|NCT02757352|76008640|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
42196805|NCT02757352|76008641|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
42196806|NCT02757352|76008642|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
42368683|NCT04542070|76229394|FG002|Overall Study|Physician Decision|1|||
42368684|NCT04542070|76229392|FG000|Overall Study|Withdrawal by Subject|5|||
42368685|NCT04542070|76229393|FG001|Overall Study|Withdrawal by Subject|8|||
42368686|NCT04542070|76229394|FG002|Overall Study|Withdrawal by Subject|9|||
42368687|NCT04542070|76229392|FG000|Overall Study|Protocol Deviation|2|||
42368688|NCT04542070|76229393|FG001|Overall Study|Protocol Deviation|6|||
42368689|NCT04542070|76229394|FG002|Overall Study|Protocol Deviation|1|||
42368690|NCT04542070|76229392|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
42102237|NCT00328627|75913210|FG011|Overall Study|Protocol Violation|2|||
42102238|NCT00328627|75913199|FG000|Overall Study|Lost to Follow-up|4|||
42102239|NCT00328627|75913200|FG001|Overall Study|Lost to Follow-up|2|||
42102240|NCT00328627|75913201|FG002|Overall Study|Lost to Follow-up|2|||
42102241|NCT00328627|75913202|FG003|Overall Study|Lost to Follow-up|4|||
42102242|NCT00328627|75913203|FG004|Overall Study|Lost to Follow-up|0|||
42102243|NCT00328627|75913204|FG005|Overall Study|Lost to Follow-up|2|||
42102244|NCT00328627|75913205|FG006|Overall Study|Lost to Follow-up|3|||
42102245|NCT00328627|75913206|FG007|Overall Study|Lost to Follow-up|0|||
42102246|NCT00328627|75913207|FG008|Overall Study|Lost to Follow-up|3|||
42102247|NCT00328627|75913208|FG009|Overall Study|Lost to Follow-up|2|||
42102248|NCT00328627|75913209|FG010|Overall Study|Lost to Follow-up|0|||
42102249|NCT00328627|75913210|FG011|Overall Study|Lost to Follow-up|1|||
42102250|NCT00328627|75913199|FG000|Overall Study|Withdrawal by Subject|5|||
42102251|NCT00328627|75913200|FG001|Overall Study|Withdrawal by Subject|4|||
42102252|NCT00328627|75913201|FG002|Overall Study|Withdrawal by Subject|5|||
42102253|NCT00328627|75913202|FG003|Overall Study|Withdrawal by Subject|6|||
42102254|NCT00328627|75913203|FG004|Overall Study|Withdrawal by Subject|2|||
42102255|NCT00328627|75913204|FG005|Overall Study|Withdrawal by Subject|5|||
42102256|NCT00328627|75913205|FG006|Overall Study|Withdrawal by Subject|4|||
42102257|NCT00328627|75913206|FG007|Overall Study|Withdrawal by Subject|4|||
42102258|NCT00328627|75913207|FG008|Overall Study|Withdrawal by Subject|4|||
42102259|NCT00328627|75913208|FG009|Overall Study|Withdrawal by Subject|5|||
42102260|NCT00328627|75913209|FG010|Overall Study|Withdrawal by Subject|2|||
42102261|NCT00328627|75913210|FG011|Overall Study|Withdrawal by Subject|7|||
42102262|NCT00328627|75913199|FG000|Overall Study|Pregnancy|0|||
42102263|NCT00328627|75913200|FG001|Overall Study|Pregnancy|1|||
42102264|NCT00328627|75913201|FG002|Overall Study|Pregnancy|0|||
42102265|NCT00328627|75913202|FG003|Overall Study|Pregnancy|0|||
42102266|NCT00328627|75913203|FG004|Overall Study|Pregnancy|0|||
42102267|NCT00328627|75913204|FG005|Overall Study|Pregnancy|0|||
42368691|NCT04542070|76229393|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
42368692|NCT04542070|76229394|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
42368693|NCT04538950|76229403|FG000|Overall Study|Pulmonary Issues|2|||
42368694|NCT04538950|76229403|FG000|Overall Study|illness|2|||
42368695|NCT04445688|76229416|FG000|Washout (One Week)|Adverse Event|2|||
42368696|NCT04445688|76229416|FG000|Washout (One Week)|Withdrawal by Subject|1|||
42368697|NCT04382755|76229426|FG000|Overall Study|Withdrawal by Subject|1|||
42368698|NCT04382755|76229427|FG001|Overall Study|Withdrawal by Subject|0|||
42368699|NCT04382755|76229426|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
42368700|NCT04382755|76229427|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
42368701|NCT04382755|76229426|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
42368702|NCT04382755|76229427|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
42368703|NCT04322539|76229436|FG000|Overall Study|Withdrawal of consent|14|||
42368704|NCT04322539|76229437|FG001|Overall Study|Withdrawal of consent|8|||
42368705|NCT04322539|76229436|FG000|Overall Study|Death|317|||
42368706|NCT04322539|76229437|FG001|Overall Study|Death|173|||
42368707|NCT04322539|76229436|FG000|Overall Study|Adverse Event|1|||
42368708|NCT04322539|76229437|FG001|Overall Study|Adverse Event|0|||
42368709|NCT04322539|76229436|FG000|Overall Study|Lost to Follow-up|3|||
42368710|NCT04322539|76229437|FG001|Overall Study|Lost to Follow-up|0|||
42368711|NCT04322539|76229436|FG000|Overall Study|Other|2|||
42368712|NCT04322539|76229437|FG001|Overall Study|Other|3|||
42368713|NCT04322539|76229436|FG000|Overall Study|Ongoing|124|||
42368714|NCT04322539|76229437|FG001|Overall Study|Ongoing|46|||
42368715|NCT03928418|76229472|FG000|Overall Study|Lost to Follow-up|5|||
42368716|NCT03928418|76229473|FG001|Overall Study|Lost to Follow-up|3|||
42368717|NCT03928418|76229474|FG002|Overall Study|Lost to Follow-up|5|||
42368718|NCT03928418|76229472|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
42102268|NCT00328627|75913205|FG006|Overall Study|Pregnancy|0|||
42102269|NCT00328627|75913206|FG007|Overall Study|Pregnancy|0|||
42102270|NCT00328627|75913207|FG008|Overall Study|Pregnancy|0|||
42102271|NCT00328627|75913208|FG009|Overall Study|Pregnancy|0|||
42102272|NCT00328627|75913209|FG010|Overall Study|Pregnancy|0|||
42102273|NCT00328627|75913210|FG011|Overall Study|Pregnancy|0|||
42102274|NCT00328627|75913199|FG000|Overall Study|Physician Decision|4|||
42102275|NCT00328627|75913200|FG001|Overall Study|Physician Decision|3|||
42102276|NCT00328627|75913201|FG002|Overall Study|Physician Decision|1|||
42102277|NCT00328627|75913202|FG003|Overall Study|Physician Decision|2|||
42102278|NCT00328627|75913203|FG004|Overall Study|Physician Decision|1|||
42368719|NCT03928418|76229473|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
42368720|NCT03928418|76229474|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
42368721|NCT03782376|76229527|FG000|Overall Study|Lost to Follow-up|2|||
42368722|NCT03782376|76229528|FG001|Overall Study|Lost to Follow-up|2|||
42102279|NCT00328627|75913204|FG005|Overall Study|Physician Decision|1|||
42102280|NCT00328627|75913205|FG006|Overall Study|Physician Decision|1|||
42102281|NCT00328627|75913206|FG007|Overall Study|Physician Decision|0|||
42102282|NCT00328627|75913207|FG008|Overall Study|Physician Decision|3|||
42102283|NCT00328627|75913208|FG009|Overall Study|Physician Decision|2|||
42102284|NCT00328627|75913209|FG010|Overall Study|Physician Decision|1|||
42102285|NCT00328627|75913210|FG011|Overall Study|Physician Decision|0|||
42102286|NCT00328627|75913199|FG000|Overall Study|Other|0|||
42102287|NCT00328627|75913200|FG001|Overall Study|Other|0|||
42102288|NCT00328627|75913201|FG002|Overall Study|Other|0|||
42102289|NCT00328627|75913202|FG003|Overall Study|Other|1|||
42102290|NCT00328627|75913203|FG004|Overall Study|Other|0|||
42102291|NCT00328627|75913204|FG005|Overall Study|Other|0|||
42102292|NCT00328627|75913205|FG006|Overall Study|Other|1|||
42102293|NCT00328627|75913206|FG007|Overall Study|Other|0|||
42102294|NCT00328627|75913207|FG008|Overall Study|Other|0|||
42102295|NCT00328627|75913208|FG009|Overall Study|Other|1|||
42102296|NCT00328627|75913209|FG010|Overall Study|Other|1|||
42102297|NCT00328627|75913210|FG011|Overall Study|Other|0|||
42102298|NCT03977727|75913246|FG000|Second Treatment|Lost to Follow-up|0|||
42102299|NCT03977727|75913247|FG001|Second Treatment|Lost to Follow-up|3|||
42102300|NCT00663858|75913256|FG000|Overall Study|Adverse Event|9|||
42102301|NCT00663858|75913257|FG001|Overall Study|Adverse Event|1|||
42102302|NCT00663858|75913258|FG002|Overall Study|Adverse Event|6|||
42102303|NCT00663858|75913256|FG000|Overall Study|Lack of Efficacy|5|||
42102304|NCT00663858|75913257|FG001|Overall Study|Lack of Efficacy|1|||
42102305|NCT00663858|75913258|FG002|Overall Study|Lack of Efficacy|3|||
42102306|NCT00663858|75913256|FG000|Overall Study|Withdrawal by Subject|7|||
42102307|NCT00663858|75913257|FG001|Overall Study|Withdrawal by Subject|3|||
42102308|NCT00663858|75913258|FG002|Overall Study|Withdrawal by Subject|3|||
42102309|NCT00663858|75913256|FG000|Overall Study|Protocol Violation|5|||
42102310|NCT00663858|75913257|FG001|Overall Study|Protocol Violation|3|||
42102311|NCT00663858|75913258|FG002|Overall Study|Protocol Violation|4|||
42102312|NCT00663858|75913256|FG000|Overall Study|Other|8|||
42102313|NCT00663858|75913257|FG001|Overall Study|Other|2|||
42102314|NCT00663858|75913258|FG002|Overall Study|Other|4|||
42102315|NCT00659880|75913266|FG000|Overall Study|Lost to Follow-up|5|||
42102316|NCT00683774|75913273|FG000|Overall Study|Withdrawal by Subject|0|||
42102317|NCT00683774|75913274|FG001|Overall Study|Withdrawal by Subject|1|||
42102318|NCT00683774|75913273|FG000|Overall Study|Physician Decision|3|||
42102319|NCT00683774|75913274|FG001|Overall Study|Physician Decision|0|||
42102320|NCT00354679|75913280|FG000|Overall Study|Patient Not Treated|1|||
42102321|NCT00683696|75913286|FG000|Overall Study|Withdrawn due to study closure|337|||
42102322|NCT00683696|75913287|FG001|Overall Study|Withdrawn due to study closure|338|||
42102323|NCT00683696|75913286|FG000|Overall Study|Withdrawn prior to study closure|13|||
42102324|NCT00683696|75913287|FG001|Overall Study|Withdrawn prior to study closure|28|||
42102325|NCT00683696|75913286|FG000|Overall Study|Lost to Follow-up|5|||
42102326|NCT00683696|75913287|FG001|Overall Study|Lost to Follow-up|6|||
42102327|NCT00683696|75913286|FG000|Overall Study|Vital status follow-up only|3|||
42102328|NCT00683696|75913287|FG001|Overall Study|Vital status follow-up only|3|||
42102329|NCT00683696|75913286|FG000|Overall Study|Death|46|||
42102330|NCT00683696|75913287|FG001|Overall Study|Death|30|||
42102331|NCT00345631|75913297|FG000|Overall Study|Withdrawal by Subject|1|||
42102332|NCT00345631|75913298|FG001|Overall Study|Withdrawal by Subject|0|||
42102333|NCT00345631|75913299|FG002|Overall Study|Withdrawal by Subject|1|||
42102334|NCT00345631|75913297|FG000|Overall Study|Adverse Event|0|||
42102335|NCT00345631|75913298|FG001|Overall Study|Adverse Event|1|||
42102336|NCT00345631|75913299|FG002|Overall Study|Adverse Event|0|||
42102337|NCT00345631|75913297|FG000|Overall Study|Lost to Follow-up|3|||
42102338|NCT00345631|75913298|FG001|Overall Study|Lost to Follow-up|7|||
42102339|NCT00345631|75913299|FG002|Overall Study|Lost to Follow-up|4|||
42368723|NCT03782376|76229527|FG000|Overall Study|Withdrawal by Subject|7|||
42368724|NCT03782376|76229528|FG001|Overall Study|Withdrawal by Subject|11|||
42102340|NCT00345631|75913297|FG000|Overall Study|Other reasons|0|||
42102341|NCT00345631|75913298|FG001|Overall Study|Other reasons|0|||
42196807|NCT02757352|76008643|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
42102342|NCT00345631|75913299|FG002|Overall Study|Other reasons|1|||
42102343|NCT00540514|75913311|FG000|Overall Study|Still on treatment|3|||
42196808|NCT02757352|76008644|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
42196809|NCT02757352|76008645|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
42196810|NCT02757352|76008636|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
42368725|NCT03782376|76229527|FG000|Overall Study|Death|1|||
42102344|NCT00540514|75913312|FG001|Overall Study|Still on treatment|0|||
42102345|NCT00540514|75913311|FG000|Overall Study|Unacceptable Toxicity|61|||
42102346|NCT00540514|75913312|FG001|Overall Study|Unacceptable Toxicity|62|||
42102347|NCT00540514|75913311|FG000|Overall Study|Adverse Event|20|||
42102348|NCT00540514|75913312|FG001|Overall Study|Adverse Event|24|||
42102349|NCT00540514|75913311|FG000|Overall Study|Physician Decision|86|||
42102350|NCT00540514|75913312|FG001|Overall Study|Physician Decision|99|||
42102351|NCT00540514|75913311|FG000|Overall Study|Protocol Deviation|3|||
42102352|NCT00540514|75913312|FG001|Overall Study|Protocol Deviation|4|||
42102353|NCT00540514|75913311|FG000|Overall Study|Lost to Follow-up|1|||
42102354|NCT00540514|75913312|FG001|Overall Study|Lost to Follow-up|1|||
42102355|NCT00540514|75913311|FG000|Overall Study|Withdrawal by Subject|65|||
42102356|NCT00540514|75913312|FG001|Overall Study|Withdrawal by Subject|67|||
42102357|NCT00540514|75913311|FG000|Overall Study|Excluded prior to treatment|7|||
42102358|NCT00540514|75913312|FG001|Overall Study|Excluded prior to treatment|7|||
42102359|NCT00540514|75913311|FG000|Overall Study|Paclitaxel not available|0|||
42102360|NCT00540514|75913312|FG001|Overall Study|Paclitaxel not available|2|||
42102361|NCT00663702|75913321|FG000|Overall Study|Adverse Event|8|||
42102362|NCT00663702|75913322|FG001|Overall Study|Adverse Event|4|||
42102363|NCT00663702|75913321|FG000|Overall Study|Withdrawal by Subject|3|||
42102364|NCT00663702|75913322|FG001|Overall Study|Withdrawal by Subject|1|||
42102365|NCT00663702|75913321|FG000|Overall Study|Pregnancy|0|||
42102366|NCT00663702|75913322|FG001|Overall Study|Pregnancy|1|||
42102367|NCT00663702|75913321|FG000|Overall Study|Lost to Follow-up|3|||
42102368|NCT00663702|75913322|FG001|Overall Study|Lost to Follow-up|0|||
42102369|NCT00663702|75913321|FG000|Overall Study|Death|1|||
42102370|NCT00663702|75913322|FG001|Overall Study|Death|1|||
42196811|NCT02757352|76008637|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
42102371|NCT00663702|75913321|FG000|Overall Study|Lack of Efficacy|3|||
42102372|NCT00663702|75913322|FG001|Overall Study|Lack of Efficacy|3|||
42196812|NCT02757352|76008638|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
42196813|NCT02757352|76008639|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
42196814|NCT02757352|76008640|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
42196815|NCT02757352|76008641|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
42196816|NCT02757352|76008642|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
42196817|NCT02757352|76008643|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
42196818|NCT02757352|76008644|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
42196819|NCT02757352|76008645|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
42196820|NCT02757352|76008636|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
42196821|NCT02757352|76008637|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
42196822|NCT02757352|76008638|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
42196823|NCT02757352|76008639|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
42196824|NCT02757352|76008640|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
42196825|NCT02757352|76008641|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
42196826|NCT02757352|76008642|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
42196827|NCT02757352|76008643|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
42196828|NCT02757352|76008644|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
42196829|NCT02757352|76008645|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
42196830|NCT02757352|76008636|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196831|NCT02757352|76008637|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
42196832|NCT02757352|76008638|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196833|NCT02757352|76008639|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196834|NCT02757352|76008640|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196835|NCT02757352|76008641|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196836|NCT02757352|76008642|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196837|NCT02757352|76008643|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196838|NCT02757352|76008644|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196839|NCT02757352|76008645|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196840|NCT02757352|76008636|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
42196841|NCT02757352|76008637|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
42196842|NCT02757352|76008638|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
42368726|NCT03782376|76229528|FG001|Overall Study|Death|0|||
42102373|NCT00683618|75913331|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
42102374|NCT00683618|75913332|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
42368727|NCT03782376|76229527|FG000|Overall Study|Other|16|||
42368728|NCT03782376|76229528|FG001|Overall Study|Other|17|||
42368729|NCT03757130|76229542|FG000|Overall Study|Lost to Follow-up|0|||
42368730|NCT03757130|76229543|FG001|Overall Study|Lost to Follow-up|0|||
42368731|NCT03757130|76229544|FG002|Overall Study|Lost to Follow-up|0|||
42368732|NCT03757130|76229545|FG003|Overall Study|Lost to Follow-up|1|||
42368733|NCT03757130|76229546|FG004|Overall Study|Lost to Follow-up|0|||
42368734|NCT03757130|76229547|FG005|Overall Study|Lost to Follow-up|0|||
42368735|NCT03757130|76229548|FG006|Overall Study|Lost to Follow-up|0|||
42368736|NCT03757130|76229549|FG007|Overall Study|Lost to Follow-up|1|||
42368737|NCT03757130|76229542|FG000|Overall Study|Withdrawal by Subject|0|||
42368738|NCT03757130|76229543|FG001|Overall Study|Withdrawal by Subject|0|||
42368739|NCT03757130|76229544|FG002|Overall Study|Withdrawal by Subject|0|||
42368740|NCT03757130|76229545|FG003|Overall Study|Withdrawal by Subject|0|||
42368741|NCT03757130|76229546|FG004|Overall Study|Withdrawal by Subject|0|||
42368742|NCT03757130|76229547|FG005|Overall Study|Withdrawal by Subject|0|||
42102375|NCT00683618|75913333|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
42196843|NCT02757352|76008639|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196844|NCT02757352|76008640|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196845|NCT02757352|76008641|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196846|NCT02757352|76008642|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196847|NCT02757352|76008643|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196848|NCT02757352|76008644|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196849|NCT02757352|76008645|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196850|NCT02757352|76008636|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
42196851|NCT02757352|76008637|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
42196852|NCT02757352|76008638|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
42196853|NCT02757352|76008639|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
42196854|NCT02757352|76008640|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
42196855|NCT02757352|76008641|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
42196856|NCT02757352|76008642|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
42196857|NCT02757352|76008643|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
42196858|NCT02757352|76008644|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
42196859|NCT02757352|76008645|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
42196860|NCT02757352|76008636|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
42196861|NCT02757352|76008637|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
42196862|NCT02757352|76008638|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
42196863|NCT02757352|76008639|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
42196864|NCT02757352|76008640|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
42368743|NCT03757130|76229548|FG006|Overall Study|Withdrawal by Subject|1|||
42368744|NCT03757130|76229549|FG007|Overall Study|Withdrawal by Subject|0|||
42368745|NCT03555565|76229590|FG000|Overall Study|Case Report Forms Uncollected|2|||
42368746|NCT03555565|76229590|FG000|Overall Study|Protocol Deviation|13|||
42368747|NCT03553836|76229596|FG000|Overall Study|Ongoing in Study|460|||
42196865|NCT02757352|76008641|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
42196866|NCT02757352|76008642|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
42196867|NCT02757352|76008643|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
42196868|NCT02757352|76008644|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
42196869|NCT02757352|76008645|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
42196870|NCT02757352|76008636|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196871|NCT02757352|76008637|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196872|NCT02757352|76008638|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196873|NCT02757352|76008639|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
42196874|NCT02757352|76008640|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
42196875|NCT02757352|76008641|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
42196876|NCT02757352|76008642|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42368748|NCT03553836|76229597|FG001|Overall Study|Ongoing in Study|459|||
42102376|NCT00683618|75913331|FG000|Randomised Treatment Period|Protocol Violation|0|||
42102377|NCT00683618|75913332|FG001|Randomised Treatment Period|Protocol Violation|1|||
42102378|NCT00683618|75913333|FG002|Randomised Treatment Period|Protocol Violation|0|||
42102379|NCT00683618|75913331|FG000|Randomised Treatment Period|Adverse Event|2|||
42102380|NCT00683618|75913332|FG001|Randomised Treatment Period|Adverse Event|0|||
42102381|NCT00683618|75913333|FG002|Randomised Treatment Period|Adverse Event|2|||
42102382|NCT00683618|75913331|FG000|Randomised Treatment Period|Reason not provided|0|||
42102383|NCT00683618|75913332|FG001|Randomised Treatment Period|Reason not provided|0|||
42102384|NCT00683618|75913333|FG002|Randomised Treatment Period|Reason not provided|2|||
42102385|NCT00683618|75913331|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
42102386|NCT00683618|75913332|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
42102387|NCT00683618|75913333|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
42102388|NCT00683618|75913331|FG000|Extension Treatment Period|Adverse Event|1|||
42102389|NCT00683618|75913332|FG001|Extension Treatment Period|Adverse Event|0|||
42102390|NCT00683618|75913333|FG002|Extension Treatment Period|Adverse Event|0|||
42102391|NCT00683618|75913331|FG000|Extension Treatment Period|Protocol Violation|1|||
42102392|NCT00683618|75913332|FG001|Extension Treatment Period|Protocol Violation|0|||
42102393|NCT00683618|75913333|FG002|Extension Treatment Period|Protocol Violation|0|||
42102394|NCT00688064|75913345|FG000|Overall Study|Protocol Violation|0|||
42102395|NCT00688064|75913346|FG001|Overall Study|Protocol Violation|1|||
42102396|NCT00688064|75913345|FG000|Overall Study|Adverse Event|2|||
42102397|NCT00688064|75913346|FG001|Overall Study|Adverse Event|4|||
42102398|NCT00688064|75913345|FG000|Overall Study|Withdrawal by Subject|7|||
42102399|NCT00688064|75913346|FG001|Overall Study|Withdrawal by Subject|7|||
42102400|NCT00688064|75913345|FG000|Overall Study|Lost to Follow-up|10|||
42102401|NCT00688064|75913346|FG001|Overall Study|Lost to Follow-up|10|||
42102402|NCT00688064|75913345|FG000|Overall Study|Lack of Efficacy|0|||
42102403|NCT00688064|75913346|FG001|Overall Study|Lack of Efficacy|1|||
42102404|NCT00688064|75913345|FG000|Overall Study|Pregnancy|1|||
42102405|NCT00688064|75913346|FG001|Overall Study|Pregnancy|0|||
42102406|NCT00688064|75913345|FG000|Overall Study|Any other reasons|1|||
42102407|NCT00688064|75913346|FG001|Overall Study|Any other reasons|3|||
42102408|NCT00663234|75913352|FG000|Overall Study|Not willing to adhere to requirements|1|||
42102409|NCT00683384|75913360|FG000|Overall Study|Death|1|||
42102410|NCT00683384|75913360|FG000|Overall Study|Adverse Event|1|||
42102411|NCT00326911|75913366|FG000|Overall Study|Hospitalization prior to treatment|0|||
42102412|NCT00326911|75913367|FG001|Overall Study|Hospitalization prior to treatment|1|||
42102413|NCT00326911|75913366|FG000|Overall Study|Physician decision prior to treatment|1|||
42102414|NCT00326911|75913367|FG001|Overall Study|Physician decision prior to treatment|0|||
42102415|NCT00326911|75913366|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
42102416|NCT00326911|75913367|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
42102417|NCT00540436|75913373|FG000|First 12-Week Treatment Period|Adverse Event|1|||
42102418|NCT00540436|75913373|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
42102419|NCT00540436|75913373|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
42102420|NCT00540436|75913373|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
42102421|NCT00687440|75913377|FG000|Overall Study|Adverse Event|3|||
42102422|NCT00687440|75913377|FG000|Overall Study|Lost to Follow-up|3|||
42102423|NCT00687440|75913377|FG000|Overall Study|Lack of Efficacy|2|||
42102424|NCT00687440|75913377|FG000|Overall Study|Death|2|||
42102425|NCT00687440|75913377|FG000|Overall Study|Other|1|||
42102426|NCT00687440|75913377|FG000|Overall Study|Missing|1|||
42102427|NCT00659490|75913384|FG000|Overall Study|Lost to Follow-up|2|||
42102428|NCT00659490|75913385|FG001|Overall Study|Lost to Follow-up|0|||
42102429|NCT00659490|75913386|FG002|Overall Study|Lost to Follow-up|1|||
42102430|NCT00539500|75913394|FG000|Overall Study|Disease Progression|1|||
42102431|NCT00539500|75913394|FG000|Overall Study|Lost to Follow-up|2|||
42102432|NCT00662532|75913400|FG000|Overall Study|Adverse Event|0|||
42102433|NCT00662532|75913401|FG001|Overall Study|Adverse Event|1|||
42102434|NCT00662532|75913400|FG000|Overall Study|Lost to Follow-up|0|||
42102435|NCT00662532|75913401|FG001|Overall Study|Lost to Follow-up|1|||
42196877|NCT02757352|76008643|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196878|NCT02757352|76008644|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196879|NCT02757352|76008645|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
42196880|NCT02757352|76008636|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
42196881|NCT02757352|76008637|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
42196882|NCT02757352|76008638|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
42196883|NCT02757352|76008639|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
42196884|NCT02757352|76008640|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
42196885|NCT02757352|76008641|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
42196886|NCT02757352|76008642|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
42196887|NCT02757352|76008643|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
42196888|NCT02757352|76008644|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
42196889|NCT02757352|76008645|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
42196890|NCT02757352|76008636|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
42196891|NCT02757352|76008637|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
42196892|NCT02757352|76008638|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
42196893|NCT02757352|76008639|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
42196894|NCT02757352|76008640|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
42196895|NCT02757352|76008641|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
42196896|NCT02757352|76008642|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
42196897|NCT02757352|76008643|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
42196898|NCT02757352|76008644|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
42196899|NCT02757352|76008645|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
42196900|NCT02757352|76008636|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196901|NCT02757352|76008637|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196902|NCT02757352|76008638|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196903|NCT02757352|76008639|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
42196904|NCT02757352|76008640|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
42196905|NCT02757352|76008641|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
42196906|NCT02757352|76008642|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196907|NCT02757352|76008643|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196908|NCT02757352|76008644|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196909|NCT02757352|76008645|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
42196910|NCT02757352|76008636|FG000|Follow-Up Period|Adverse Event|0|||
42196911|NCT02757352|76008637|FG001|Follow-Up Period|Adverse Event|0|||
42196912|NCT02757352|76008638|FG002|Follow-Up Period|Adverse Event|0|||
42196913|NCT02757352|76008639|FG003|Follow-Up Period|Adverse Event|0|||
42196914|NCT02757352|76008640|FG004|Follow-Up Period|Adverse Event|0|||
42196915|NCT02757352|76008641|FG005|Follow-Up Period|Adverse Event|0|||
42102436|NCT00686036|75913409|FG000|Overall Study|Adverse Event|3|||
42102437|NCT00686036|75913410|FG001|Overall Study|Adverse Event|0|||
42102438|NCT00686036|75913409|FG000|Overall Study|Withdrawal by Subject|3|||
42102439|NCT00686036|75913410|FG001|Overall Study|Withdrawal by Subject|1|||
42102440|NCT00686036|75913409|FG000|Overall Study|Study terminated by AstraZeneca|2|||
42102441|NCT00686036|75913410|FG001|Overall Study|Study terminated by AstraZeneca|1|||
42102442|NCT00686036|75913409|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
42102443|NCT00686036|75913410|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
42102444|NCT00686036|75913409|FG000|Overall Study|Other reasons not identified|0|||
42102445|NCT00686036|75913410|FG001|Overall Study|Other reasons not identified|4|||
42196916|NCT02757352|76008642|FG006|Follow-Up Period|Adverse Event|1|||
42196917|NCT02757352|76008643|FG007|Follow-Up Period|Adverse Event|0|||
42196918|NCT02757352|76008644|FG008|Follow-Up Period|Adverse Event|2|||
42196919|NCT02757352|76008645|FG009|Follow-Up Period|Adverse Event|0|||
42196920|NCT02757352|76008636|FG000|Follow-Up Period|Lost to Follow-up|0|||
42196921|NCT02757352|76008637|FG001|Follow-Up Period|Lost to Follow-up|0|||
42196922|NCT02757352|76008638|FG002|Follow-Up Period|Lost to Follow-up|0|||
42196923|NCT02757352|76008639|FG003|Follow-Up Period|Lost to Follow-up|0|||
42196924|NCT02757352|76008640|FG004|Follow-Up Period|Lost to Follow-up|0|||
42196925|NCT02757352|76008641|FG005|Follow-Up Period|Lost to Follow-up|0|||
42196926|NCT02757352|76008642|FG006|Follow-Up Period|Lost to Follow-up|0|||
42196927|NCT02757352|76008643|FG007|Follow-Up Period|Lost to Follow-up|0|||
42196928|NCT02757352|76008644|FG008|Follow-Up Period|Lost to Follow-up|1|||
42196929|NCT02757352|76008645|FG009|Follow-Up Period|Lost to Follow-up|0|||
42196930|NCT02757352|76008636|FG000|Follow-Up Period|Lack of Efficacy|0|||
42196931|NCT02757352|76008637|FG001|Follow-Up Period|Lack of Efficacy|0|||
42196932|NCT02757352|76008638|FG002|Follow-Up Period|Lack of Efficacy|0|||
42196933|NCT02757352|76008639|FG003|Follow-Up Period|Lack of Efficacy|0|||
42102446|NCT00682448|75913418|FG000|Overall Study|Adverse Event|1|||
42102447|NCT00682448|75913419|FG001|Overall Study|Adverse Event|2|||
42196934|NCT02757352|76008640|FG004|Follow-Up Period|Lack of Efficacy|0|||
42196935|NCT02757352|76008641|FG005|Follow-Up Period|Lack of Efficacy|0|||
42196936|NCT02757352|76008642|FG006|Follow-Up Period|Lack of Efficacy|0|||
42196937|NCT02757352|76008643|FG007|Follow-Up Period|Lack of Efficacy|0|||
42196938|NCT02757352|76008644|FG008|Follow-Up Period|Lack of Efficacy|1|||
42196939|NCT02757352|76008645|FG009|Follow-Up Period|Lack of Efficacy|1|||
42196940|NCT02757352|76008636|FG000|Follow-Up Period|Withdrawal by Subject|0|||
42196941|NCT02757352|76008637|FG001|Follow-Up Period|Withdrawal by Subject|0|||
42196942|NCT02757352|76008638|FG002|Follow-Up Period|Withdrawal by Subject|0|||
42196943|NCT02757352|76008639|FG003|Follow-Up Period|Withdrawal by Subject|0|||
42196944|NCT02757352|76008640|FG004|Follow-Up Period|Withdrawal by Subject|0|||
42196945|NCT02757352|76008641|FG005|Follow-Up Period|Withdrawal by Subject|0|||
42196946|NCT02757352|76008642|FG006|Follow-Up Period|Withdrawal by Subject|0|||
42196947|NCT02757352|76008643|FG007|Follow-Up Period|Withdrawal by Subject|1|||
42196948|NCT02757352|76008644|FG008|Follow-Up Period|Withdrawal by Subject|6|||
42196949|NCT02757352|76008645|FG009|Follow-Up Period|Withdrawal by Subject|2|||
42196950|NCT04588480|76008678|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
42196951|NCT04588480|76008679|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
42196952|NCT04588480|76008680|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
42196953|NCT04588480|76008678|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
42196954|NCT04588480|76008679|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
42196955|NCT04588480|76008680|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
42196956|NCT02756650|76008687|FG000|Overall Study|Physician Decision|1|||
42196957|NCT02756650|76008687|FG000|Overall Study|Adverse Event|1|||
42196958|NCT00110357|76008693|FG000|Overall Study|Deterioration without progression|2|||
42196959|NCT00110357|76008694|FG001|Overall Study|Deterioration without progression|0|||
42196960|NCT00110357|76008693|FG000|Overall Study|Disease progression/relapse|20|||
42196961|NCT00110357|76008694|FG001|Overall Study|Disease progression/relapse|15|||
42196962|NCT00110357|76008693|FG000|Overall Study|Study Closure|1|||
42196963|NCT00110357|76008694|FG001|Overall Study|Study Closure|0|||
42196964|NCT00110357|76008693|FG000|Overall Study|Study Drug Toxicity|1|||
42196965|NCT00110357|76008694|FG001|Overall Study|Study Drug Toxicity|3|||
42196966|NCT00110357|76008693|FG000|Overall Study|Withdrawal by Subject|3|||
42196967|NCT00110357|76008694|FG001|Overall Study|Withdrawal by Subject|1|||
42196968|NCT02752906|76008729|FG000|Overall Study|Protocol Violation|2|||
42196969|NCT02752906|76008730|FG001|Overall Study|Protocol Violation|1|||
42196970|NCT02752906|76008729|FG000|Overall Study|Withdrawal by Subject|2|||
42196971|NCT02752906|76008730|FG001|Overall Study|Withdrawal by Subject|2|||
42196972|NCT02752906|76008729|FG000|Overall Study|Lost to Follow-up|3|||
42196973|NCT02752906|76008730|FG001|Overall Study|Lost to Follow-up|2|||
42196974|NCT02756338|76008736|FG000|Overall Study|Withdrawn by Investigator|1|||
42196975|NCT02756338|76008736|FG000|Overall Study|Device Replaced with Pacemaker|4|||
42196976|NCT00293033|76008740|FG000|Open-label Titration Period|Adverse Event|10|||
42196977|NCT00293033|76008740|FG000|Open-label Titration Period|Death|3|||
42196978|NCT00293033|76008740|FG000|Open-label Titration Period|Lack of Efficacy|5|||
42196979|NCT00293033|76008740|FG000|Open-label Titration Period|Protocol Violation|2|||
42196980|NCT00293033|76008740|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
42196981|NCT00293033|76008740|FG000|Open-label Titration Period|Noncompliance and other|27|||
42196982|NCT00293033|76008740|FG000|Double-blind Treatment Period|Adverse Event|3|||
42196983|NCT00293033|76008740|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
42196984|NCT00293033|76008740|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
42196985|NCT00293033|76008740|FG000|Double-blind Treatment Period|Noncompliance|4|||
42368749|NCT03553836|76229596|FG000|Overall Study|Withdrawal by Subject|9|||
42102448|NCT00682448|75913418|FG000|Overall Study|Lack of Efficacy|1|||
42102449|NCT00682448|75913419|FG001|Overall Study|Lack of Efficacy|0|||
42102450|NCT00682448|75913418|FG000|Overall Study|Lost to Follow-up|1|||
42102451|NCT00682448|75913419|FG001|Overall Study|Lost to Follow-up|3|||
42102452|NCT00682448|75913418|FG000|Overall Study|Pregnancy|0|||
42102453|NCT00682448|75913419|FG001|Overall Study|Pregnancy|1|||
42102454|NCT00682448|75913418|FG000|Overall Study|Withdrawal by Subject|2|||
42102455|NCT00682448|75913419|FG001|Overall Study|Withdrawal by Subject|0|||
42102456|NCT00681824|75913428|FG000|Overall Study|withdrawn by investigator|0|||
42102457|NCT00681824|75913429|FG001|Overall Study|withdrawn by investigator|0|||
42102458|NCT00681824|75913430|FG002|Overall Study|withdrawn by investigator|1|||
42102459|NCT00681824|75913428|FG000|Overall Study|scheduling conflict|1|||
42102460|NCT00681824|75913429|FG001|Overall Study|scheduling conflict|0|||
42196986|NCT02756182|76008748|FG000|Overall Study|StudyTechnical Difficulties|4|||
42196987|NCT03823703|76008757|FG000|Overall Study|Sponsor request|0|||
42196988|NCT03823703|76008758|FG001|Overall Study|Sponsor request|3|||
42196989|NCT03823703|76008759|FG002|Overall Study|Sponsor request|4|||
42196990|NCT03823703|76008757|FG000|Overall Study|Adverse Event|3|||
42196991|NCT03823703|76008758|FG001|Overall Study|Adverse Event|1|||
42196992|NCT03823703|76008759|FG002|Overall Study|Adverse Event|0|||
42196993|NCT03823703|76008757|FG000|Overall Study|Withdrawal by Subject|0|||
42196994|NCT03823703|76008758|FG001|Overall Study|Withdrawal by Subject|1|||
42196995|NCT03823703|76008759|FG002|Overall Study|Withdrawal by Subject|0|||
42196996|NCT00109577|76008769|FG000|Overall Study|Withdrawal by Subject|3|||
42196997|NCT00109577|76008770|FG001|Overall Study|Withdrawal by Subject|3|||
42368750|NCT03553836|76229597|FG001|Overall Study|Withdrawal by Subject|10|||
42368751|NCT03553836|76229596|FG000|Overall Study|Lost to Follow-up|1|||
42368752|NCT03553836|76229597|FG001|Overall Study|Lost to Follow-up|3|||
42368753|NCT03553836|76229596|FG000|Overall Study|Death|17|||
42196998|NCT02755090|76008778|FG000|Overall Study|equipment malfunction|1|||
42196999|NCT02755090|76008779|FG001|Overall Study|equipment malfunction|0|||
42197000|NCT00109343|76008788|FG000|Overall Study|Adverse Event|1|||
42197001|NCT00109343|76008789|FG001|Overall Study|Adverse Event|0|||
42197002|NCT00109343|76008790|FG002|Overall Study|Adverse Event|2|||
42197003|NCT00109343|76008788|FG000|Overall Study|Lack of Efficacy|1|||
42197004|NCT00109343|76008789|FG001|Overall Study|Lack of Efficacy|0|||
42197005|NCT00109343|76008790|FG002|Overall Study|Lack of Efficacy|0|||
42197006|NCT00109343|76008788|FG000|Overall Study|Lost to Follow-up|35|||
42197007|NCT00109343|76008789|FG001|Overall Study|Lost to Follow-up|20|||
42197008|NCT00109343|76008790|FG002|Overall Study|Lost to Follow-up|14|||
42197009|NCT00109343|76008788|FG000|Overall Study|Protocol Violation|1|||
42197010|NCT00109343|76008789|FG001|Overall Study|Protocol Violation|2|||
42197011|NCT00109343|76008790|FG002|Overall Study|Protocol Violation|2|||
42197012|NCT00109343|76008788|FG000|Overall Study|Withdrawal by Subject|15|||
42197013|NCT00109343|76008789|FG001|Overall Study|Withdrawal by Subject|11|||
42197014|NCT00109343|76008790|FG002|Overall Study|Withdrawal by Subject|10|||
42197015|NCT00109343|76008788|FG000|Overall Study|Subject Moved|6|||
42197016|NCT00109343|76008789|FG001|Overall Study|Subject Moved|2|||
42197017|NCT00109343|76008790|FG002|Overall Study|Subject Moved|1|||
42197018|NCT00109343|76008788|FG000|Overall Study|Other|5|||
42197019|NCT00109343|76008789|FG001|Overall Study|Other|2|||
42368754|NCT03553836|76229597|FG001|Overall Study|Death|17|||
42368755|NCT03519386|76229607|FG000|Overall Study|Withdrawal by Subject|4|||
42368756|NCT03519386|76229608|FG001|Overall Study|Withdrawal by Subject|1|||
42368757|NCT03519386|76229609|FG002|Overall Study|Withdrawal by Subject|2|||
42368758|NCT03519386|76229607|FG000|Overall Study|Physician Decision|1|||
42368759|NCT03519386|76229608|FG001|Overall Study|Physician Decision|1|||
42368760|NCT03519386|76229609|FG002|Overall Study|Physician Decision|1|||
42368761|NCT03519386|76229607|FG000|Overall Study|Lost to Follow-up|0|||
42368762|NCT03519386|76229608|FG001|Overall Study|Lost to Follow-up|1|||
42368763|NCT03519386|76229609|FG002|Overall Study|Lost to Follow-up|1|||
42368764|NCT03519386|76229607|FG000|Overall Study|Death|1|||
42368765|NCT03519386|76229608|FG001|Overall Study|Death|0|||
42368766|NCT03519386|76229609|FG002|Overall Study|Death|4|||
42368767|NCT03519386|76229607|FG000|Overall Study|Adverse Event|2|||
42368768|NCT03519386|76229608|FG001|Overall Study|Adverse Event|1|||
42368769|NCT03519386|76229609|FG002|Overall Study|Adverse Event|2|||
42368770|NCT03519386|76229607|FG000|Overall Study|Explanted|2|||
42368771|NCT03519386|76229608|FG001|Overall Study|Explanted|1|||
42368772|NCT03519386|76229609|FG002|Overall Study|Explanted|0|||
42368773|NCT03519386|76229607|FG000|Overall Study|Ongoing in study|190|||
42368774|NCT03519386|76229608|FG001|Overall Study|Ongoing in study|192|||
42368775|NCT03519386|76229609|FG002|Overall Study|Ongoing in study|183|||
42368776|NCT03369665|76229626|FG000|Overall Study|Adverse Event|3|||
42368777|NCT03369665|76229626|FG000|Overall Study|Lost to Follow-up|7|||
42368778|NCT03369665|76229626|FG000|Overall Study|Withdrawal by Subject|15|||
42368779|NCT03369665|76229626|FG000|Overall Study|Progression Disease|2|||
42368780|NCT03369665|76229626|FG000|Overall Study|Not classified|3|||
42368781|NCT03317405|76229644|FG000|Overall Study|Withdrawal by Subject|1|||
42368782|NCT03317405|76229645|FG001|Overall Study|Withdrawal by Subject|0|||
42197020|NCT00109343|76008790|FG002|Overall Study|Other|1|||
42197021|NCT00108485|76008800|FG000|Overall Study|Withdrawal by Subject|3|||
42368783|NCT03317405|76229646|FG002|Overall Study|Withdrawal by Subject|0|||
42368784|NCT03317405|76229644|FG000|Overall Study|Physician Decision|0|||
42368785|NCT03317405|76229645|FG001|Overall Study|Physician Decision|0|||
42368786|NCT03317405|76229646|FG002|Overall Study|Physician Decision|1|||
42368787|NCT03317405|76229644|FG000|Overall Study|Surgery Rescheduled|0|||
42197022|NCT00108485|76008801|FG001|Overall Study|Withdrawal by Subject|0|||
42197023|NCT00108485|76008800|FG000|Overall Study|Lost to Follow-up|0|||
42197024|NCT00108485|76008801|FG001|Overall Study|Lost to Follow-up|2|||
42197025|NCT00107783|76008809|FG000|Overall Study|Adverse Event|0|||
42368788|NCT03317405|76229645|FG001|Overall Study|Surgery Rescheduled|1|||
42368789|NCT03317405|76229646|FG002|Overall Study|Surgery Rescheduled|0|||
42368790|NCT03304249|76229660|FG000|Overall Study|Lost to Follow-up|8|||
42368791|NCT03304249|76229661|FG001|Overall Study|Lost to Follow-up|10|||
42368792|NCT03304249|76229660|FG000|Overall Study|Withdrawal by Subject|12|||
42197026|NCT00107783|76008810|FG001|Overall Study|Adverse Event|2|||
42197027|NCT00107783|76008809|FG000|Overall Study|Death|0|||
42197028|NCT00107783|76008810|FG001|Overall Study|Death|1|||
42197029|NCT00107783|76008809|FG000|Overall Study|Withdrawal by Subject|2|||
42197030|NCT00107783|76008810|FG001|Overall Study|Withdrawal by Subject|0|||
42197031|NCT00107783|76008809|FG000|Overall Study|Second hip replacement|1|||
42197032|NCT00107783|76008810|FG001|Overall Study|Second hip replacement|1|||
42197033|NCT00095303|76008818|FG000|Main Study|Lost to Follow-up|91|||
42197034|NCT00095303|76008819|FG001|Main Study|Lost to Follow-up|87|||
42197035|NCT00095303|76008818|FG000|Follow Up Study|Lost to Follow-up|59|||
42197036|NCT00095303|76008819|FG001|Follow Up Study|Lost to Follow-up|58|||
42197037|NCT00105521|76008829|FG000|Overall Study|Other|1|||
42197038|NCT00105521|76008830|FG001|Overall Study|Other|1|||
42197039|NCT00105521|76008831|FG002|Overall Study|Other|2|||
42197040|NCT00105521|76008832|FG003|Overall Study|Other|0|||
42197041|NCT00105521|76008829|FG000|Overall Study|Adverse Event|10|||
42197042|NCT00105521|76008830|FG001|Overall Study|Adverse Event|4|||
42197043|NCT00105521|76008831|FG002|Overall Study|Adverse Event|10|||
42197044|NCT00105521|76008832|FG003|Overall Study|Adverse Event|8|||
42197045|NCT00105521|76008829|FG000|Overall Study|Withdrawal by Subject|1|||
42197046|NCT00105521|76008830|FG001|Overall Study|Withdrawal by Subject|0|||
42197047|NCT00105521|76008831|FG002|Overall Study|Withdrawal by Subject|1|||
42197048|NCT00105521|76008832|FG003|Overall Study|Withdrawal by Subject|4|||
42197049|NCT00105521|76008829|FG000|Overall Study|Lack of Efficacy|0|||
42197050|NCT00105521|76008830|FG001|Overall Study|Lack of Efficacy|0|||
42197051|NCT00105521|76008831|FG002|Overall Study|Lack of Efficacy|0|||
42197052|NCT00105521|76008832|FG003|Overall Study|Lack of Efficacy|1|||
42197053|NCT00105521|76008829|FG000|Overall Study|Protocol Violation|3|||
42197054|NCT00105521|76008830|FG001|Overall Study|Protocol Violation|5|||
42197055|NCT00105521|76008831|FG002|Overall Study|Protocol Violation|4|||
42197056|NCT00105521|76008832|FG003|Overall Study|Protocol Violation|4|||
42197057|NCT00105521|76008829|FG000|Overall Study|Lost to Follow-up|0|||
42197058|NCT00105521|76008830|FG001|Overall Study|Lost to Follow-up|1|||
42197059|NCT00105521|76008831|FG002|Overall Study|Lost to Follow-up|0|||
42197060|NCT00105521|76008832|FG003|Overall Study|Lost to Follow-up|0|||
42197061|NCT00291551|76008842|FG000|Overall Study|Death|7|||
42197062|NCT00291551|76008842|FG000|Overall Study|Withdrawal by Subject|6|||
42197063|NCT02752048|76008871|FG000|Overall Study|Withdrawal by Subject|0|||
42197064|NCT02752048|76008872|FG001|Overall Study|Withdrawal by Subject|0|||
42197065|NCT02752048|76008873|FG002|Overall Study|Withdrawal by Subject|3|||
42197066|NCT00095147|76008888|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
42197067|NCT00095147|76008889|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
42197068|NCT00095147|76008890|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
42197069|NCT00095147|76008891|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
42197070|NCT00095147|76008892|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
42197071|NCT00095147|76008888|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
42197072|NCT00095147|76008889|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
42197073|NCT00095147|76008890|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
42197074|NCT00095147|76008891|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
42197075|NCT00095147|76008892|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
42197076|NCT00095147|76008888|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
42197077|NCT00095147|76008889|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
42197078|NCT00095147|76008890|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
42197079|NCT00095147|76008891|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
42197080|NCT00095147|76008892|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
42197081|NCT00095147|76008888|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
42197082|NCT00095147|76008889|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
42197083|NCT00095147|76008890|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
42197084|NCT00095147|76008891|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
42197085|NCT00095147|76008892|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
42197086|NCT00095147|76008888|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
42197087|NCT00095147|76008889|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
42197088|NCT00095147|76008890|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
42197089|NCT00095147|76008891|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
42197090|NCT00095147|76008892|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
42197091|NCT00095147|76008888|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
42197092|NCT00095147|76008889|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
42197093|NCT00095147|76008890|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
42197094|NCT00095147|76008891|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
42197095|NCT00095147|76008892|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
42197096|NCT00095147|76008888|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
42197097|NCT00095147|76008889|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
42197098|NCT00095147|76008890|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
42197099|NCT00095147|76008891|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
42197100|NCT00095147|76008892|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
42197101|NCT00095147|76008888|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
42197102|NCT00095147|76008889|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
42197103|NCT00095147|76008890|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
42197104|NCT00095147|76008891|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
42197105|NCT00095147|76008892|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
42197106|NCT00095147|76008888|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
42197107|NCT00095147|76008889|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
42197108|NCT00095147|76008890|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
42368793|NCT03304249|76229661|FG001|Overall Study|Withdrawal by Subject|2|||
42368794|NCT03304249|76229660|FG000|Overall Study|Moved Out of District|4|||
42368795|NCT03304249|76229661|FG001|Overall Study|Moved Out of District|2|||
42368796|NCT03181893|76229717|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
42368797|NCT03181893|76229718|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
42368798|NCT03181893|76229719|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
42368799|NCT03181893|76229720|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
42368800|NCT03181893|76229721|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
42368801|NCT03181893|76229722|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
42368802|NCT03181893|76229723|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
42368803|NCT03181893|76229724|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
42368804|NCT03181893|76229725|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
42368805|NCT03181893|76229726|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
42368806|NCT03181893|76229727|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
42368807|NCT03181893|76229717|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
42368808|NCT03181893|76229718|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
42368809|NCT03181893|76229719|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
42368810|NCT03181893|76229720|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
42368811|NCT03181893|76229721|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
42368812|NCT03181893|76229722|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
42368813|NCT03181893|76229723|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
42368814|NCT03181893|76229724|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
42368815|NCT03181893|76229725|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
42368816|NCT03181893|76229726|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
42368817|NCT03181893|76229727|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
42368818|NCT03181893|76229717|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
42368819|NCT03181893|76229718|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
42368820|NCT03181893|76229719|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
42368821|NCT03181893|76229720|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
42368822|NCT03181893|76229721|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
42368823|NCT03181893|76229722|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
42368824|NCT03181893|76229723|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
42368825|NCT03181893|76229724|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
42368826|NCT03181893|76229725|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
42368827|NCT03181893|76229726|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
42368828|NCT03181893|76229727|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
42368829|NCT03181893|76229717|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
42368830|NCT03181893|76229718|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
42368831|NCT03181893|76229719|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
42368832|NCT03181893|76229720|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
42368833|NCT03181893|76229721|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
42368834|NCT03181893|76229722|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
42368835|NCT03181893|76229723|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
42368836|NCT03181893|76229724|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
42368837|NCT03181893|76229725|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
42368838|NCT03181893|76229726|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
42368839|NCT03181893|76229727|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
42368840|NCT03181893|76229717|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
42368841|NCT03181893|76229718|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
42368842|NCT03181893|76229719|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
42368843|NCT03181893|76229720|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
42197109|NCT00095147|76008891|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
42197110|NCT00095147|76008892|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
42368844|NCT03181893|76229721|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
42368845|NCT03181893|76229722|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
42197111|NCT00095147|76008888|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
42197112|NCT00095147|76008889|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
42368846|NCT03181893|76229723|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
42368847|NCT03181893|76229724|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
42197113|NCT00095147|76008890|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
42197114|NCT00095147|76008891|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
42197115|NCT00095147|76008892|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
42197116|NCT00095147|76008888|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
42197117|NCT00095147|76008889|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
42197118|NCT00095147|76008890|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
42197119|NCT00095147|76008891|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
42197120|NCT00095147|76008892|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
42197121|NCT00095147|76008888|FG000|Long-term Extension Period|Death|0|||
42197122|NCT00095147|76008889|FG001|Long-term Extension Period|Death|0|||
42197123|NCT00095147|76008890|FG002|Long-term Extension Period|Death|0|||
42197124|NCT00095147|76008891|FG003|Long-term Extension Period|Death|0|||
42197125|NCT00095147|76008892|FG004|Long-term Extension Period|Death|3|||
42197126|NCT00095147|76008888|FG000|Long-term Extension Period|Adverse Event|0|||
42197127|NCT00095147|76008889|FG001|Long-term Extension Period|Adverse Event|0|||
42197128|NCT00095147|76008890|FG002|Long-term Extension Period|Adverse Event|0|||
42197129|NCT00095147|76008891|FG003|Long-term Extension Period|Adverse Event|0|||
42197130|NCT00095147|76008892|FG004|Long-term Extension Period|Adverse Event|11|||
42018642|NCT01256411|75826037|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
42018643|NCT01256411|75826038|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
42018644|NCT01256411|75826039|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
42102461|NCT00681824|75913430|FG002|Overall Study|scheduling conflict|0|||
42102462|NCT00681824|75913428|FG000|Overall Study|Death|0|||
42102463|NCT00681824|75913429|FG001|Overall Study|Death|1|||
42102464|NCT00681824|75913430|FG002|Overall Study|Death|0|||
42102465|NCT00681668|75913438|FG000|Overall Study|Protocol Violation|1|||
42102466|NCT00681668|75913438|FG000|Overall Study|Withdrawal by Subject|1|||
42102467|NCT00539188|75913444|FG000|Overall Study|Withdrawal by Subject|1|||
42102468|NCT00539188|75913445|FG001|Overall Study|Withdrawal by Subject|0|||
42102469|NCT00539188|75913444|FG000|Overall Study|Lost to Follow-up|2|||
42102470|NCT00539188|75913445|FG001|Overall Study|Lost to Follow-up|1|||
42102471|NCT00681590|75913453|FG000|Overall Study|Withdrawal by Subject|2|||
42102472|NCT00681590|75913454|FG001|Overall Study|Withdrawal by Subject|12|||
42102473|NCT04980456|75913462|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
42102474|NCT04980456|75913463|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
42102475|NCT04980456|75913462|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
42102476|NCT04980456|75913463|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
42102477|NCT04980456|75913462|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
42102478|NCT04980456|75913463|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
42102479|NCT04980456|75913462|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
42102480|NCT04980456|75913463|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
42102481|NCT00326599|75913476|FG000|Overall Study|Withdrawal by Subject|1|||
42102482|NCT00326599|75913477|FG001|Overall Study|Withdrawal by Subject|0|||
42102483|NCT00326599|75913478|FG002|Overall Study|Withdrawal by Subject|5|||
42102484|NCT00326599|75913479|FG003|Overall Study|Withdrawal by Subject|2|||
42102485|NCT00326599|75913476|FG000|Overall Study|Adverse Event|1|||
42102486|NCT00326599|75913477|FG001|Overall Study|Adverse Event|0|||
42102487|NCT00326599|75913478|FG002|Overall Study|Adverse Event|32|||
42102488|NCT00326599|75913479|FG003|Overall Study|Adverse Event|3|||
42102489|NCT00326599|75913476|FG000|Overall Study|Disease Progression|3|||
42102490|NCT00326599|75913477|FG001|Overall Study|Disease Progression|1|||
42102491|NCT00326599|75913478|FG002|Overall Study|Disease Progression|13|||
42102492|NCT00326599|75913479|FG003|Overall Study|Disease Progression|11|||
42102493|NCT00326599|75913476|FG000|Overall Study|Alternate Treatment|1|||
42102494|NCT00326599|75913477|FG001|Overall Study|Alternate Treatment|0|||
42102495|NCT00326599|75913478|FG002|Overall Study|Alternate Treatment|0|||
42102496|NCT00326599|75913479|FG003|Overall Study|Alternate Treatment|0|||
42102497|NCT00326599|75913476|FG000|Overall Study|Death|0|||
42018645|NCT01256411|75826040|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
42018646|NCT01256411|75826041|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
42018647|NCT01256411|75826042|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
42018648|NCT01256411|75826037|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
42018649|NCT01256411|75826038|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
42018650|NCT01256411|75826039|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
42102498|NCT00326599|75913477|FG001|Overall Study|Death|0|||
42102499|NCT00326599|75913478|FG002|Overall Study|Death|1|||
42102500|NCT00326599|75913479|FG003|Overall Study|Death|2|||
42102501|NCT00326599|75913476|FG000|Overall Study|Other Unspecified Reason|0|||
42102502|NCT00326599|75913477|FG001|Overall Study|Other Unspecified Reason|0|||
42102503|NCT00326599|75913478|FG002|Overall Study|Other Unspecified Reason|2|||
42102504|NCT00326599|75913479|FG003|Overall Study|Other Unspecified Reason|1|||
42102505|NCT00539032|75913490|FG000|Overall Study|Withdrawal by Subject|2|||
42102506|NCT00539032|75913491|FG001|Overall Study|Withdrawal by Subject|1|||
42102507|NCT00685802|75913497|FG000|Washout Period of 7 Days|Protocol Violation|2|||
42102508|NCT00685802|75913498|FG001|Washout Period of 7 Days|Protocol Violation|0|||
42102509|NCT00685802|75913497|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
42102510|NCT00685802|75913498|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
42102511|NCT00354601|75913504|FG000|Overall Study|Protocol Violation|1|||
42102512|NCT00354601|75913504|FG000|Overall Study|progression|1|||
42102513|NCT03827473|75913510|FG000|Overall Study|Withdrawal by Subject|1|||
42102514|NCT03827473|75913511|FG001|Overall Study|Withdrawal by Subject|0|||
42102515|NCT00345397|75913517|FG000|Overall Study|Death|1|||
42102516|NCT00326209|75913522|FG000|Overall Study|Adverse Event|28|||
42102517|NCT00326209|75913522|FG000|Overall Study|Withdrawal by Subject|22|||
42102518|NCT00326209|75913522|FG000|Overall Study|Lack of Efficacy|31|||
42102519|NCT00326209|75913522|FG000|Overall Study|Lost to Follow-up|18|||
42102520|NCT00326209|75913522|FG000|Overall Study|Participant non-compliant|6|||
42102521|NCT00326209|75913522|FG000|Overall Study|Sponsor closed study|173|||
42102522|NCT00326209|75913522|FG000|Overall Study|Prohibited medication use|1|||
42102523|NCT00326209|75913522|FG000|Overall Study|Violation of entry criteria|1|||
42102524|NCT00326209|75913522|FG000|Overall Study|Withdrawn in error|1|||
42102525|NCT00326209|75913522|FG000|Overall Study|Pregnancy|1|||
42102526|NCT00537940|75913528|FG000|Overall Study|Adverse Event|20|||
42102527|NCT00537940|75913529|FG001|Overall Study|Adverse Event|19|||
42102528|NCT00537940|75913528|FG000|Overall Study|Lack of Efficacy|8|||
42102529|NCT00537940|75913529|FG001|Overall Study|Lack of Efficacy|16|||
42102530|NCT00537940|75913528|FG000|Overall Study|Lost to Follow-up|23|||
42102531|NCT00537940|75913529|FG001|Overall Study|Lost to Follow-up|29|||
42102532|NCT00537940|75913528|FG000|Overall Study|Withdrawal by Subject|113|||
42102533|NCT00537940|75913529|FG001|Overall Study|Withdrawal by Subject|95|||
42102534|NCT00537940|75913528|FG000|Overall Study|Protocol Violation|6|||
42102535|NCT00537940|75913529|FG001|Overall Study|Protocol Violation|4|||
42102536|NCT00537940|75913528|FG000|Overall Study|Pregnancy|1|||
42102537|NCT00537940|75913529|FG001|Overall Study|Pregnancy|1|||
42102538|NCT00537940|75913528|FG000|Overall Study|Study terminated by sponsor|2|||
42102539|NCT00537940|75913529|FG001|Overall Study|Study terminated by sponsor|3|||
42102540|NCT00537940|75913528|FG000|Overall Study|Other|10|||
42102541|NCT00537940|75913529|FG001|Overall Study|Other|12|||
42197131|NCT00095147|76008888|FG000|Long-term Extension Period|Lack of Efficacy|0|||
42197132|NCT00095147|76008889|FG001|Long-term Extension Period|Lack of Efficacy|0|||
42197133|NCT00095147|76008890|FG002|Long-term Extension Period|Lack of Efficacy|0|||
42197134|NCT00095147|76008891|FG003|Long-term Extension Period|Lack of Efficacy|0|||
42197135|NCT00095147|76008892|FG004|Long-term Extension Period|Lack of Efficacy|9|||
42197136|NCT00095147|76008888|FG000|Long-term Extension Period|Lost to Follow-up|0|||
42197137|NCT00095147|76008889|FG001|Long-term Extension Period|Lost to Follow-up|0|||
42197138|NCT00095147|76008890|FG002|Long-term Extension Period|Lost to Follow-up|0|||
42102542|NCT00661362|75913537|FG000|Overall Study|Adverse Event|5|||
42102543|NCT00661362|75913538|FG001|Overall Study|Adverse Event|4|||
42102544|NCT00661362|75913537|FG000|Overall Study|Incorrect enrollment|2|||
42102545|NCT00661362|75913538|FG001|Overall Study|Incorrect enrollment|0|||
42102546|NCT00661362|75913537|FG000|Overall Study|Study specific discontinuation criteria|4|||
42102547|NCT00661362|75913538|FG001|Overall Study|Study specific discontinuation criteria|11|||
42102548|NCT00661362|75913537|FG000|Overall Study|Withdrawal by Subject|13|||
42102549|NCT00661362|75913538|FG001|Overall Study|Withdrawal by Subject|23|||
42102550|NCT00661362|75913537|FG000|Overall Study|Lost to Follow-up|3|||
42102551|NCT00661362|75913538|FG001|Overall Study|Lost to Follow-up|1|||
42102552|NCT00661362|75913537|FG000|Overall Study|Severe non-compliance to protocol|0|||
42102553|NCT00661362|75913538|FG001|Overall Study|Severe non-compliance to protocol|1|||
42102554|NCT00661362|75913537|FG000|Overall Study|Safety reasons|1|||
42102555|NCT00661362|75913538|FG001|Overall Study|Safety reasons|0|||
42102556|NCT00661362|75913537|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
42102557|NCT00661362|75913538|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
42102558|NCT00325897|75913546|FG000|Overall Study|Lost to Follow-up|12|||
42197139|NCT00095147|76008891|FG003|Long-term Extension Period|Lost to Follow-up|0|||
42197140|NCT00095147|76008892|FG004|Long-term Extension Period|Lost to Follow-up|6|||
42197141|NCT00095147|76008888|FG000|Long-term Extension Period|Withdrawal of consent|0|||
42197142|NCT00095147|76008889|FG001|Long-term Extension Period|Withdrawal of consent|0|||
42197143|NCT00095147|76008890|FG002|Long-term Extension Period|Withdrawal of consent|0|||
42197144|NCT00095147|76008891|FG003|Long-term Extension Period|Withdrawal of consent|0|||
42197145|NCT00095147|76008892|FG004|Long-term Extension Period|Withdrawal of consent|12|||
42197146|NCT00095147|76008888|FG000|Long-term Extension Period|Pregnancy|0|||
42197147|NCT00095147|76008889|FG001|Long-term Extension Period|Pregnancy|0|||
42197148|NCT00095147|76008890|FG002|Long-term Extension Period|Pregnancy|0|||
42197149|NCT00095147|76008891|FG003|Long-term Extension Period|Pregnancy|0|||
42197150|NCT00095147|76008892|FG004|Long-term Extension Period|Pregnancy|1|||
42102559|NCT00325897|75913547|FG001|Overall Study|Lost to Follow-up|13|||
42102560|NCT00344773|75913556|FG000|Overall Study|Adverse Event|2|||
42102561|NCT00344773|75913556|FG000|Overall Study|Objective Disease Progression|16|||
42102562|NCT00344773|75913556|FG000|Overall Study|Withdrawal by Subject|1|||
42102563|NCT00344773|75913556|FG000|Overall Study|Not Eligible for the study|2|||
42102564|NCT00325819|75913562|FG000|Overall Study|Study product lost in mail|2|||
42102565|NCT00325819|75913563|FG001|Overall Study|Study product lost in mail|1|||
42102566|NCT00325819|75913562|FG000|Overall Study|Did not take a dose of study product|4|||
42102567|NCT00325819|75913563|FG001|Overall Study|Did not take a dose of study product|9|||
42102568|NCT00325819|75913562|FG000|Overall Study|Lost to Follow-up|3|||
42102569|NCT00325819|75913563|FG001|Overall Study|Lost to Follow-up|3|||
42102570|NCT00687362|75913571|FG000|Overall Study|Protocol Violation|2|||
42102571|NCT00687362|75913571|FG000|Overall Study|Withdrawal by Subject|1|||
42102572|NCT00325195|75913578|FG000|Randomized|Not dosed|5|||
42102573|NCT00325195|75913579|FG001|Randomized|Not dosed|5|||
42102574|NCT00325195|75913580|FG002|Randomized|Not dosed|3|||
42102575|NCT00325195|75913578|FG000|Received Intervention: ITT Population|Adverse Event|15|||
42102576|NCT00325195|75913579|FG001|Received Intervention: ITT Population|Adverse Event|17|||
42102577|NCT00325195|75913580|FG002|Received Intervention: ITT Population|Adverse Event|1|||
42102578|NCT00325195|75913578|FG000|Received Intervention: ITT Population|Death|3|||
42102579|NCT00325195|75913579|FG001|Received Intervention: ITT Population|Death|1|||
42102580|NCT00325195|75913580|FG002|Received Intervention: ITT Population|Death|0|||
42102581|NCT00325195|75913578|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
42102582|NCT00325195|75913579|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
42102583|NCT00325195|75913580|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
42102584|NCT00325195|75913578|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
42102585|NCT00325195|75913579|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
42102586|NCT00325195|75913580|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
42102587|NCT00325195|75913578|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
42102588|NCT00325195|75913579|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
42102589|NCT00325195|75913580|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
42102590|NCT03976401|75913594|FG000|Overall Study|Adverse Event|2|||
42102591|NCT03976401|75913595|FG001|Overall Study|Adverse Event|0|||
42102592|NCT03976401|75913596|FG002|Overall Study|Adverse Event|4|||
42102593|NCT03976401|75913597|FG003|Overall Study|Adverse Event|1|||
42102594|NCT03976401|75913598|FG004|Overall Study|Adverse Event|1|||
42102595|NCT03976401|75913599|FG005|Overall Study|Adverse Event|0|||
42102596|NCT03976401|75913594|FG000|Overall Study|Withdrawal by Subject|0|||
42102597|NCT03976401|75913595|FG001|Overall Study|Withdrawal by Subject|1|||
42102598|NCT03976401|75913596|FG002|Overall Study|Withdrawal by Subject|0|||
42102599|NCT03976401|75913597|FG003|Overall Study|Withdrawal by Subject|0|||
42102600|NCT03976401|75913598|FG004|Overall Study|Withdrawal by Subject|0|||
42102601|NCT03976401|75913599|FG005|Overall Study|Withdrawal by Subject|1|||
42102602|NCT03976401|75913594|FG000|Overall Study|Physician Decision|0|||
42102603|NCT03976401|75913595|FG001|Overall Study|Physician Decision|0|||
42102604|NCT03976401|75913596|FG002|Overall Study|Physician Decision|1|||
42102605|NCT03976401|75913597|FG003|Overall Study|Physician Decision|0|||
42102606|NCT03976401|75913598|FG004|Overall Study|Physician Decision|0|||
42102607|NCT03976401|75913599|FG005|Overall Study|Physician Decision|0|||
42102608|NCT03976401|75913594|FG000|Overall Study|Lost to Follow-up|1|||
42102609|NCT03976401|75913595|FG001|Overall Study|Lost to Follow-up|2|||
42102610|NCT03976401|75913596|FG002|Overall Study|Lost to Follow-up|0|||
42102611|NCT03976401|75913597|FG003|Overall Study|Lost to Follow-up|0|||
42102612|NCT03976401|75913598|FG004|Overall Study|Lost to Follow-up|0|||
42102613|NCT03976401|75913599|FG005|Overall Study|Lost to Follow-up|0|||
42102614|NCT03976401|75913594|FG000|Overall Study|Protocol Violation|0|||
42102615|NCT03976401|75913595|FG001|Overall Study|Protocol Violation|1|||
42102616|NCT03976401|75913596|FG002|Overall Study|Protocol Violation|0|||
42102617|NCT03976401|75913597|FG003|Overall Study|Protocol Violation|0|||
42102618|NCT03976401|75913598|FG004|Overall Study|Protocol Violation|0|||
42102619|NCT03976401|75913599|FG005|Overall Study|Protocol Violation|0|||
42102620|NCT03976401|75913594|FG000|Overall Study|Withdrew Consent|0|||
42102621|NCT03976401|75913595|FG001|Overall Study|Withdrew Consent|0|||
42102622|NCT03976401|75913596|FG002|Overall Study|Withdrew Consent|0|||
42102623|NCT03976401|75913597|FG003|Overall Study|Withdrew Consent|1|||
42102624|NCT03976401|75913598|FG004|Overall Study|Withdrew Consent|0|||
42102625|NCT03976401|75913599|FG005|Overall Study|Withdrew Consent|0|||
42102626|NCT00685334|75913615|FG000|Overall Study|Withdrawal by Subject|5|||
42102627|NCT00685334|75913616|FG001|Overall Study|Withdrawal by Subject|6|||
42102628|NCT00685334|75913615|FG000|Overall Study|Lost to Follow-up|4|||
42102629|NCT00685334|75913616|FG001|Overall Study|Lost to Follow-up|0|||
42102630|NCT00685334|75913615|FG000|Overall Study|Chose to enter hospital|1|||
42102631|NCT00685334|75913616|FG001|Overall Study|Chose to enter hospital|1|||
42102632|NCT00325039|75913624|FG000|Overall Study|Lost to Follow-up|18|||
42102633|NCT00325039|75913625|FG001|Overall Study|Lost to Follow-up|14|||
42197151|NCT00095147|76008888|FG000|Long-term Extension Period|No longer meets study criteria|0|||
42197152|NCT00095147|76008889|FG001|Long-term Extension Period|No longer meets study criteria|0|||
42197153|NCT00095147|76008890|FG002|Long-term Extension Period|No longer meets study criteria|0|||
42197154|NCT00095147|76008891|FG003|Long-term Extension Period|No longer meets study criteria|0|||
42197155|NCT00095147|76008892|FG004|Long-term Extension Period|No longer meets study criteria|1|||
42197156|NCT00095147|76008888|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
42197157|NCT00095147|76008889|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
42197158|NCT00095147|76008890|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
42197159|NCT00095147|76008891|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
42197160|NCT00095147|76008892|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
42197161|NCT00095147|76008888|FG000|Long-term Extension Period|Leaving country|0|||
42197162|NCT00095147|76008889|FG001|Long-term Extension Period|Leaving country|0|||
42197163|NCT00095147|76008890|FG002|Long-term Extension Period|Leaving country|0|||
42197164|NCT00095147|76008891|FG003|Long-term Extension Period|Leaving country|0|||
42197165|NCT00095147|76008892|FG004|Long-term Extension Period|Leaving country|1|||
42197166|NCT02751502|76008910|FG000|Overall Study|Lack of funding|4|||
42197167|NCT02257918|76008917|FG000|Overall Study|Lost to Follow-up|4|||
42197168|NCT02257918|76008918|FG001|Overall Study|Lost to Follow-up|1|||
42197169|NCT02257918|76008919|FG002|Overall Study|Lost to Follow-up|0|||
42197170|NCT02257918|76008917|FG000|Overall Study|Withdrawal by Subject|0|||
42197171|NCT02257918|76008918|FG001|Overall Study|Withdrawal by Subject|0|||
42197172|NCT02257918|76008919|FG002|Overall Study|Withdrawal by Subject|1|||
42197173|NCT02257918|76008917|FG000|Overall Study|Pregnancy|0|||
42197174|NCT02257918|76008918|FG001|Overall Study|Pregnancy|0|||
42197175|NCT02257918|76008919|FG002|Overall Study|Pregnancy|1|||
42197176|NCT02751424|76008936|FG000|Part 2|Adverse Event|0|||
42197177|NCT02751424|76008937|FG001|Part 2|Adverse Event|0|||
42197178|NCT02751424|76008938|FG002|Part 2|Adverse Event|0|||
42197179|NCT02751424|76008939|FG003|Part 2|Adverse Event|0|||
42197180|NCT02751424|76008940|FG004|Part 2|Adverse Event|0|||
42197181|NCT02751424|76008941|FG005|Part 2|Adverse Event|0|||
42197182|NCT02751424|76008942|FG006|Part 2|Adverse Event|0|||
42197183|NCT02751424|76008943|FG007|Part 2|Adverse Event|5|||
42197184|NCT02751424|76008944|FG008|Part 2|Adverse Event|0|||
42197185|NCT00094835|76008974|FG000|Overall Study|Physician Decision|1|||
42197186|NCT00094835|76008975|FG001|Overall Study|Physician Decision|0|||
42197187|NCT00094835|76008976|FG002|Overall Study|Physician Decision|0|||
42197188|NCT00094835|76008977|FG003|Overall Study|Physician Decision|0|||
42197189|NCT00094835|76008978|FG004|Overall Study|Physician Decision|0|||
42197190|NCT00094835|76008979|FG005|Overall Study|Physician Decision|1|||
42197191|NCT00094835|76008980|FG006|Overall Study|Physician Decision|0|||
42197192|NCT00094835|76008974|FG000|Overall Study|Withdrawal by Subject|0|||
42197193|NCT00094835|76008975|FG001|Overall Study|Withdrawal by Subject|0|||
42197194|NCT00094835|76008976|FG002|Overall Study|Withdrawal by Subject|0|||
42197195|NCT00094835|76008977|FG003|Overall Study|Withdrawal by Subject|0|||
42197196|NCT00094835|76008978|FG004|Overall Study|Withdrawal by Subject|0|||
42197197|NCT00094835|76008979|FG005|Overall Study|Withdrawal by Subject|0|||
42197198|NCT00094835|76008980|FG006|Overall Study|Withdrawal by Subject|1|||
42197199|NCT00094835|76008974|FG000|Overall Study|Lost to Follow-up|0|||
42197200|NCT00094835|76008975|FG001|Overall Study|Lost to Follow-up|0|||
42197201|NCT00094835|76008976|FG002|Overall Study|Lost to Follow-up|0|||
42197202|NCT00094835|76008977|FG003|Overall Study|Lost to Follow-up|0|||
42197203|NCT00094835|76008978|FG004|Overall Study|Lost to Follow-up|1|||
42197204|NCT00094835|76008979|FG005|Overall Study|Lost to Follow-up|0|||
42197205|NCT00094835|76008980|FG006|Overall Study|Lost to Follow-up|0|||
42197206|NCT00094835|76008974|FG000|Overall Study|Death|1|||
42197207|NCT00094835|76008975|FG001|Overall Study|Death|0|||
42197208|NCT00094835|76008976|FG002|Overall Study|Death|0|||
42197209|NCT00094835|76008977|FG003|Overall Study|Death|0|||
42197210|NCT00094835|76008978|FG004|Overall Study|Death|1|||
42197211|NCT00094835|76008979|FG005|Overall Study|Death|0|||
42197212|NCT00094835|76008980|FG006|Overall Study|Death|0|||
42197213|NCT00094835|76008974|FG000|Overall Study|Non-compliance|1|||
42197214|NCT00094835|76008975|FG001|Overall Study|Non-compliance|2|||
42197215|NCT00094835|76008976|FG002|Overall Study|Non-compliance|2|||
42197216|NCT00094835|76008977|FG003|Overall Study|Non-compliance|0|||
42368848|NCT03181893|76229725|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
42197217|NCT00094835|76008978|FG004|Overall Study|Non-compliance|2|||
42197218|NCT00094835|76008979|FG005|Overall Study|Non-compliance|2|||
42197219|NCT00094835|76008980|FG006|Overall Study|Non-compliance|1|||
42197220|NCT00094835|76008974|FG000|Overall Study|Other|1|||
42197221|NCT00094835|76008975|FG001|Overall Study|Other|1|||
42197222|NCT00094835|76008976|FG002|Overall Study|Other|1|||
42197223|NCT00094835|76008977|FG003|Overall Study|Other|1|||
42197224|NCT00094835|76008978|FG004|Overall Study|Other|0|||
42197225|NCT00094835|76008979|FG005|Overall Study|Other|0|||
42197226|NCT00094835|76008980|FG006|Overall Study|Other|0|||
42197227|NCT00094757|76009004|FG000|Overall Study|Adverse Event|11|||
42197228|NCT00094757|76009005|FG001|Overall Study|Adverse Event|9|||
42197229|NCT00094757|76009006|FG002|Overall Study|Adverse Event|6|||
42197230|NCT00094757|76009004|FG000|Overall Study|Lack of Efficacy|11|||
42197231|NCT00094757|76009005|FG001|Overall Study|Lack of Efficacy|15|||
42197232|NCT00094757|76009006|FG002|Overall Study|Lack of Efficacy|8|||
42197233|NCT00094757|76009004|FG000|Overall Study|Lost to Follow-up|3|||
42197234|NCT00094757|76009005|FG001|Overall Study|Lost to Follow-up|5|||
42197235|NCT00094757|76009006|FG002|Overall Study|Lost to Follow-up|6|||
42197236|NCT00094757|76009004|FG000|Overall Study|Patient Moved|2|||
42197237|NCT00094757|76009005|FG001|Overall Study|Patient Moved|1|||
42197238|NCT00094757|76009006|FG002|Overall Study|Patient Moved|1|||
42197239|NCT00094757|76009004|FG000|Overall Study|Protocol Violation|8|||
42197240|NCT00094757|76009005|FG001|Overall Study|Protocol Violation|5|||
42197241|NCT00094757|76009006|FG002|Overall Study|Protocol Violation|3|||
42197242|NCT00094757|76009004|FG000|Overall Study|Withdrawal by Subject|14|||
42197243|NCT00094757|76009005|FG001|Overall Study|Withdrawal by Subject|21|||
42197244|NCT00094757|76009006|FG002|Overall Study|Withdrawal by Subject|5|||
42197245|NCT00094757|76009004|FG000|Overall Study|Other|3|||
42197246|NCT00094757|76009005|FG001|Overall Study|Other|3|||
42197247|NCT00094757|76009006|FG002|Overall Study|Other|1|||
42197248|NCT00094757|76009004|FG000|Overall Study|Protocol specified discontinuation|1|||
42197249|NCT00094757|76009005|FG001|Overall Study|Protocol specified discontinuation|3|||
42197250|NCT00094757|76009006|FG002|Overall Study|Protocol specified discontinuation|0|||
42197251|NCT04378114|76009014|FG000|Overall Study|Withdrawal by Subject|5|||
42197252|NCT00082433|76009023|FG000|Overall Study|Adverse Event|12|||
42197253|NCT00082433|76009024|FG001|Overall Study|Adverse Event|17|||
42197254|NCT00082433|76009023|FG000|Overall Study|Death|8|||
42197255|NCT00082433|76009024|FG001|Overall Study|Death|18|||
42197256|NCT00082433|76009023|FG000|Overall Study|Disease Progression/Relapse|270|||
42197257|NCT00082433|76009024|FG001|Overall Study|Disease Progression/Relapse|388|||
42197258|NCT00082433|76009023|FG000|Overall Study|Physician Decision|50|||
42197259|NCT00082433|76009024|FG001|Overall Study|Physician Decision|61|||
42197260|NCT00082433|76009023|FG000|Overall Study|Lost to Follow-up|1|||
42197261|NCT00082433|76009024|FG001|Overall Study|Lost to Follow-up|2|||
42197262|NCT00082433|76009023|FG000|Overall Study|Study Drug Toxicity|179|||
42197263|NCT00082433|76009024|FG001|Overall Study|Study Drug Toxicity|66|||
42197264|NCT00082433|76009023|FG000|Overall Study|Withdrawal by Subject|55|||
42197265|NCT00082433|76009024|FG001|Overall Study|Withdrawal by Subject|30|||
42197266|NCT00082433|76009023|FG000|Overall Study|Still On Treatment|2|||
42197267|NCT00082433|76009024|FG001|Overall Study|Still On Treatment|1|||
42197268|NCT00082433|76009023|FG000|Overall Study|Not Treated|12|||
42197269|NCT00082433|76009024|FG001|Overall Study|Not Treated|11|||
42197270|NCT00082433|76009023|FG000|Overall Study|Ineligible|2|||
42197271|NCT00082433|76009024|FG001|Overall Study|Ineligible|1|||
42197272|NCT00082433|76009023|FG000|Overall Study|Noncompliance|2|||
42102634|NCT00344461|75913631|FG000|Overall Study|Adverse Event|6|||
42102635|NCT00344461|75913631|FG000|Overall Study|Death|1|||
42102636|NCT00344461|75913631|FG000|Overall Study|Lack of Efficacy|2|||
42102637|NCT00344461|75913631|FG000|Overall Study|Lost to Follow-up|2|||
42102638|NCT00344461|75913631|FG000|Overall Study|Physician Decision|2|||
42102639|NCT00344461|75913631|FG000|Overall Study|Protocol Violation|6|||
42102640|NCT00344461|75913631|FG000|Overall Study|Withdrawal by Subject|2|||
42102641|NCT00685178|75913640|FG000|Overall Study|Adverse Event|1|||
42102642|NCT00685178|75913641|FG001|Overall Study|Adverse Event|5|||
42102643|NCT00685178|75913642|FG002|Overall Study|Adverse Event|2|||
42102644|NCT00685178|75913643|FG003|Overall Study|Adverse Event|4|||
42102645|NCT00685178|75913640|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
42102646|NCT00685178|75913641|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
42102647|NCT00685178|75913642|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
42102648|NCT00685178|75913643|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
42102649|NCT00685178|75913640|FG000|Overall Study|voluntary study discharge|4|||
42102650|NCT00685178|75913641|FG001|Overall Study|voluntary study discharge|5|||
42102651|NCT00685178|75913642|FG002|Overall Study|voluntary study discharge|1|||
42102652|NCT00685178|75913643|FG003|Overall Study|voluntary study discharge|1|||
42102653|NCT00685178|75913640|FG000|Overall Study|incarcerated|1|||
42102654|NCT00685178|75913641|FG001|Overall Study|incarcerated|3|||
42197273|NCT00082433|76009024|FG001|Overall Study|Noncompliance|1|||
42197274|NCT00082433|76009023|FG000|Overall Study|New primary cancer|1|||
42197275|NCT00082433|76009024|FG001|Overall Study|New primary cancer|0|||
42197276|NCT00082433|76009023|FG000|Overall Study|Impending surgery|0|||
42197277|NCT00082433|76009024|FG001|Overall Study|Impending surgery|1|||
42197278|NCT00094445|76009030|FG000|Overall Study|Withdrawal by Subject|3|||
42197279|NCT00094445|76009030|FG000|Overall Study|Lost to Follow-up|1|||
42197280|NCT00094445|76009030|FG000|Overall Study|Progressive Disease|2|||
42102655|NCT00685178|75913642|FG002|Overall Study|incarcerated|7|||
42102656|NCT00685178|75913643|FG003|Overall Study|incarcerated|0|||
42102657|NCT00685178|75913640|FG000|Overall Study|administrative (disciplinary) discharge|0|||
42197281|NCT00082355|76009034|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
42197282|NCT00082355|76009034|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
42197283|NCT00082355|76009034|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
42197284|NCT00094055|76009038|FG000|Overall Study|Adverse Event|11|||
42197285|NCT00094055|76009038|FG000|Overall Study|Death|4|||
42197286|NCT00094055|76009038|FG000|Overall Study|Lack of Efficacy|17|||
42197287|NCT00094055|76009038|FG000|Overall Study|Lost to Follow-up|2|||
42197288|NCT00094055|76009038|FG000|Overall Study|progressive disease|2|||
42197289|NCT00094055|76009038|FG000|Overall Study|clinical progression|1|||
42197290|NCT00094055|76009038|FG000|Overall Study|roll-over to another study|14|||
42197291|NCT00094055|76009038|FG000|Overall Study|Withdrawal by Subject|9|||
42197292|NCT00099983|76009044|FG000|Overall Study|Lost to Follow-up|2|||
42197293|NCT00099983|76009045|FG001|Overall Study|Lost to Follow-up|3|||
42197294|NCT00099983|76009044|FG000|Overall Study|Missing Source Documents|14|||
42197295|NCT00099983|76009045|FG001|Overall Study|Missing Source Documents|15|||
42197296|NCT00099983|76009044|FG000|Overall Study|Withdrawal by Subject|3|||
42197297|NCT00099983|76009045|FG001|Overall Study|Withdrawal by Subject|2|||
42197298|NCT00099983|76009044|FG000|Overall Study|Adverse Event|1|||
42197299|NCT00099983|76009045|FG001|Overall Study|Adverse Event|1|||
42197300|NCT00099983|76009044|FG000|Overall Study|Lack of Efficacy|0|||
42197301|NCT00099983|76009045|FG001|Overall Study|Lack of Efficacy|1|||
42197302|NCT00099983|76009044|FG000|Overall Study|Unable to return for appointments|1|||
42197303|NCT00099983|76009045|FG001|Overall Study|Unable to return for appointments|1|||
42197304|NCT00099983|76009044|FG000|Overall Study|Moved|1|||
42197305|NCT00099983|76009045|FG001|Overall Study|Moved|0|||
42197306|NCT00099983|76009044|FG000|Overall Study|Other psychiatric problem|1|||
42197307|NCT00099983|76009045|FG001|Overall Study|Other psychiatric problem|0|||
42197308|NCT00099983|76009044|FG000|Overall Study|Incarcerated|0|||
42197309|NCT00099983|76009045|FG001|Overall Study|Incarcerated|1|||
42197310|NCT00099983|76009044|FG000|Overall Study|Intolerant of burden of visits|0|||
42197311|NCT00099983|76009045|FG001|Overall Study|Intolerant of burden of visits|1|||
42197312|NCT00099983|76009044|FG000|Overall Study|Other issue|1|||
42197313|NCT00099983|76009045|FG001|Overall Study|Other issue|0|||
42197314|NCT00099359|76009054|FG000|Overall Study|Death|11|||
42197315|NCT00099359|76009055|FG001|Overall Study|Death|15|||
42197316|NCT00099359|76009056|FG002|Overall Study|Death|17|||
42197317|NCT00099359|76009054|FG000|Overall Study|Withdrawal by Subject|19|||
42197318|NCT00099359|76009055|FG001|Overall Study|Withdrawal by Subject|19|||
42197319|NCT00099359|76009056|FG002|Overall Study|Withdrawal by Subject|23|||
42197320|NCT00099359|76009054|FG000|Overall Study|Lost to Follow-up|15|||
42197321|NCT00099359|76009055|FG001|Overall Study|Lost to Follow-up|24|||
42197322|NCT00099359|76009056|FG002|Overall Study|Lost to Follow-up|24|||
42197323|NCT00099359|76009054|FG000|Overall Study|moved out of area|9|||
42197324|NCT00099359|76009055|FG001|Overall Study|moved out of area|7|||
42197325|NCT00099359|76009056|FG002|Overall Study|moved out of area|4|||
42197326|NCT00092495|76009078|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
42197327|NCT00092495|76009079|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
42197328|NCT00092495|76009080|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
42102658|NCT00685178|75913641|FG001|Overall Study|administrative (disciplinary) discharge|1|||
42102659|NCT00685178|75913642|FG002|Overall Study|administrative (disciplinary) discharge|0|||
42102660|NCT00685178|75913643|FG003|Overall Study|administrative (disciplinary) discharge|2|||
42102661|NCT00685178|75913640|FG000|Overall Study|Pregnancy|0|||
42102662|NCT00685178|75913641|FG001|Overall Study|Pregnancy|0|||
42102663|NCT00685178|75913642|FG002|Overall Study|Pregnancy|0|||
42102664|NCT00685178|75913643|FG003|Overall Study|Pregnancy|1|||
42102665|NCT00537394|75913656|FG000|First Year of Follow-up|Death|7|||
42102666|NCT00537394|75913657|FG001|First Year of Follow-up|Death|0|||
42102667|NCT00537394|75913658|FG002|First Year of Follow-up|Death|0|||
42197329|NCT00092495|76009081|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
42197330|NCT00092495|76009082|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
42197331|NCT00092495|76009078|FG000|Base Study Vaccination Period|Extended|0|||
42197332|NCT00092495|76009079|FG001|Base Study Vaccination Period|Extended|0|||
42197333|NCT00092495|76009080|FG002|Base Study Vaccination Period|Extended|0|||
42197334|NCT00092495|76009081|FG003|Base Study Vaccination Period|Extended|1|||
42197335|NCT00092495|76009082|FG004|Base Study Vaccination Period|Extended|0|||
42197336|NCT00092495|76009078|FG000|Base Study Vaccination Period|*Clinical AE|1|||
42197337|NCT00092495|76009079|FG001|Base Study Vaccination Period|*Clinical AE|0|||
42102668|NCT00537394|75913656|FG000|First Year of Follow-up|Severe debilitation|1|||
42197338|NCT00092495|76009080|FG002|Base Study Vaccination Period|*Clinical AE|1|||
42197339|NCT00092495|76009081|FG003|Base Study Vaccination Period|*Clinical AE|2|||
42197340|NCT00092495|76009082|FG004|Base Study Vaccination Period|*Clinical AE|0|||
42197341|NCT00092495|76009078|FG000|Base Study Vaccination Period|*Other reasons|1|||
42197342|NCT00092495|76009079|FG001|Base Study Vaccination Period|*Other reasons|0|||
42102669|NCT00537394|75913657|FG001|First Year of Follow-up|Severe debilitation|0|||
42102670|NCT00537394|75913658|FG002|First Year of Follow-up|Severe debilitation|1|||
42197343|NCT00092495|76009080|FG002|Base Study Vaccination Period|*Other reasons|0|||
42197344|NCT00092495|76009081|FG003|Base Study Vaccination Period|*Other reasons|1|||
42197345|NCT00092495|76009082|FG004|Base Study Vaccination Period|*Other reasons|0|||
42197346|NCT00092495|76009078|FG000|Base Study Vaccination Period|*Pregnancy|0|||
42197347|NCT00092495|76009079|FG001|Base Study Vaccination Period|*Pregnancy|2|||
42197348|NCT00092495|76009080|FG002|Base Study Vaccination Period|*Pregnancy|5|||
42197349|NCT00092495|76009081|FG003|Base Study Vaccination Period|*Pregnancy|7|||
42197350|NCT00092495|76009082|FG004|Base Study Vaccination Period|*Pregnancy|0|||
42197351|NCT00092495|76009078|FG000|Base Study Vaccination Period|Adverse Event|1|||
42197352|NCT00092495|76009079|FG001|Base Study Vaccination Period|Adverse Event|0|||
42197353|NCT00092495|76009080|FG002|Base Study Vaccination Period|Adverse Event|0|||
42197354|NCT00092495|76009081|FG003|Base Study Vaccination Period|Adverse Event|3|||
42197355|NCT00092495|76009082|FG004|Base Study Vaccination Period|Adverse Event|0|||
42197356|NCT00092495|76009078|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
42197357|NCT00092495|76009079|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
42197358|NCT00092495|76009080|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
42197359|NCT00092495|76009081|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
42197360|NCT00092495|76009082|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
42197361|NCT00092495|76009078|FG000|Base Study Vaccination Period|Moved|3|||
42197362|NCT00092495|76009079|FG001|Base Study Vaccination Period|Moved|1|||
42197363|NCT00092495|76009080|FG002|Base Study Vaccination Period|Moved|2|||
42197364|NCT00092495|76009081|FG003|Base Study Vaccination Period|Moved|2|||
42197365|NCT00092495|76009082|FG004|Base Study Vaccination Period|Moved|0|||
42197366|NCT00092495|76009078|FG000|Base Study Vaccination Period|Other|1|||
42197367|NCT00092495|76009079|FG001|Base Study Vaccination Period|Other|1|||
42197368|NCT00092495|76009080|FG002|Base Study Vaccination Period|Other|0|||
42197369|NCT00092495|76009081|FG003|Base Study Vaccination Period|Other|2|||
42197370|NCT00092495|76009082|FG004|Base Study Vaccination Period|Other|0|||
42197371|NCT00092495|76009078|FG000|Base Study Vaccination Period|Pregnancy|2|||
42197372|NCT00092495|76009079|FG001|Base Study Vaccination Period|Pregnancy|0|||
42197373|NCT00092495|76009080|FG002|Base Study Vaccination Period|Pregnancy|0|||
42197374|NCT00092495|76009081|FG003|Base Study Vaccination Period|Pregnancy|0|||
42197375|NCT00092495|76009082|FG004|Base Study Vaccination Period|Pregnancy|0|||
42197376|NCT00092495|76009078|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
42197377|NCT00092495|76009079|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
42197378|NCT00092495|76009080|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
42197379|NCT00092495|76009081|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
42197380|NCT00092495|76009082|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
42197381|NCT00092495|76009078|FG000|Base Study Vaccination Period|Protocol Violation|1|||
42197382|NCT00092495|76009079|FG001|Base Study Vaccination Period|Protocol Violation|0|||
42197383|NCT00092495|76009080|FG002|Base Study Vaccination Period|Protocol Violation|0|||
42197384|NCT00092495|76009081|FG003|Base Study Vaccination Period|Protocol Violation|0|||
42197385|NCT00092495|76009082|FG004|Base Study Vaccination Period|Protocol Violation|0|||
42197386|NCT00092495|76009078|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
42197387|NCT00092495|76009079|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
42197388|NCT00092495|76009080|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
42197389|NCT00092495|76009081|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
42197390|NCT00092495|76009082|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
42197391|NCT00092495|76009078|FG000|Base Study Follow-up Period|Extended|0|||
42197392|NCT00092495|76009079|FG001|Base Study Follow-up Period|Extended|0|||
42197393|NCT00092495|76009080|FG002|Base Study Follow-up Period|Extended|1|||
42197394|NCT00092495|76009081|FG003|Base Study Follow-up Period|Extended|2|||
42197395|NCT00092495|76009082|FG004|Base Study Follow-up Period|Extended|0|||
42197396|NCT00092495|76009078|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
42197397|NCT00092495|76009079|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
42197398|NCT00092495|76009080|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
42197399|NCT00092495|76009081|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
42197400|NCT00092495|76009082|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
42197401|NCT00092495|76009078|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
42197402|NCT00092495|76009079|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
42197403|NCT00092495|76009080|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
42197404|NCT00092495|76009081|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
42197405|NCT00092495|76009082|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
42197406|NCT00092417|76009097|FG000|Overall Study|Lost to Follow-up|2|||
42197407|NCT00092417|76009098|FG001|Overall Study|Lost to Follow-up|0|||
42197408|NCT00092417|76009097|FG000|Overall Study|Withdrawal by Subject|2|||
42197409|NCT00092417|76009098|FG001|Overall Study|Withdrawal by Subject|1|||
42197410|NCT00092417|76009097|FG000|Overall Study|Other|1|||
42197411|NCT00092417|76009098|FG001|Overall Study|Other|0|||
42197412|NCT00091949|76009106|FG000|Overall Study|Withdrawal by Subject|117|||
42197413|NCT00091949|76009107|FG001|Overall Study|Withdrawal by Subject|110|||
42197414|NCT00091949|76009106|FG000|Overall Study|Lost to Follow-up|58|||
42197415|NCT00091949|76009107|FG001|Overall Study|Lost to Follow-up|41|||
42197416|NCT02258542|76009117|FG000|Overall Study|eg. not made to the visit|7|||
42197417|NCT02258542|76009118|FG001|Overall Study|eg. not made to the visit|4|||
42197418|NCT02258542|76009119|FG002|Overall Study|eg. not made to the visit|0|||
42197419|NCT02258542|76009120|FG003|Overall Study|eg. not made to the visit|1|||
42197420|NCT02258542|76009117|FG000|Overall Study|study specific discount. criteria|1|||
42197421|NCT02258542|76009118|FG001|Overall Study|study specific discount. criteria|1|||
42197422|NCT02258542|76009119|FG002|Overall Study|study specific discount. criteria|0|||
42197423|NCT02258542|76009120|FG003|Overall Study|study specific discount. criteria|0|||
42197424|NCT02258542|76009117|FG000|Overall Study|Withdrawal by Subject|20|||
42197425|NCT02258542|76009118|FG001|Overall Study|Withdrawal by Subject|20|||
42197426|NCT02258542|76009119|FG002|Overall Study|Withdrawal by Subject|7|||
42197427|NCT02258542|76009120|FG003|Overall Study|Withdrawal by Subject|1|||
42197428|NCT02258542|76009117|FG000|Overall Study|Lost to Follow-up|5|||
42197429|NCT02258542|76009118|FG001|Overall Study|Lost to Follow-up|12|||
42197430|NCT02258542|76009119|FG002|Overall Study|Lost to Follow-up|1|||
42197431|NCT02258542|76009120|FG003|Overall Study|Lost to Follow-up|2|||
42197432|NCT02258542|76009117|FG000|Overall Study|Death|5|||
42197433|NCT02258542|76009118|FG001|Overall Study|Death|4|||
42197434|NCT02258542|76009119|FG002|Overall Study|Death|0|||
42197435|NCT02258542|76009120|FG003|Overall Study|Death|1|||
42197436|NCT02258542|76009117|FG000|Overall Study|Adverse Event|3|||
42197437|NCT02258542|76009118|FG001|Overall Study|Adverse Event|4|||
42197438|NCT02258542|76009119|FG002|Overall Study|Adverse Event|0|||
42197439|NCT02258542|76009120|FG003|Overall Study|Adverse Event|0|||
42197440|NCT02258542|76009117|FG000|Overall Study|Protocol Violation|1|||
42197441|NCT02258542|76009118|FG001|Overall Study|Protocol Violation|2|||
42197442|NCT02258542|76009119|FG002|Overall Study|Protocol Violation|0|||
42197443|NCT02258542|76009120|FG003|Overall Study|Protocol Violation|0|||
42197444|NCT02258542|76009117|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42197445|NCT02258542|76009118|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
42197446|NCT02258542|76009119|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
42197447|NCT02258542|76009120|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
42197448|NCT00091793|76009150|FG000|Overall Study|Adverse Event|1|||
42197449|NCT00091793|76009151|FG001|Overall Study|Adverse Event|2|||
42197450|NCT00091793|76009150|FG000|Overall Study|Withdrawal by Subject|10|||
42197451|NCT00091793|76009151|FG001|Overall Study|Withdrawal by Subject|15|||
42197452|NCT00091793|76009150|FG000|Overall Study|Ineligibility determined|2|||
42197453|NCT00091793|76009151|FG001|Overall Study|Ineligibility determined|0|||
42197454|NCT00091793|76009150|FG000|Overall Study|Lost to Follow-up|7|||
42197455|NCT00091793|76009151|FG001|Overall Study|Lost to Follow-up|5|||
42197456|NCT00091793|76009150|FG000|Overall Study|Noncompliance|2|||
42197457|NCT00091793|76009151|FG001|Overall Study|Noncompliance|0|||
42197458|NCT00091793|76009150|FG000|Overall Study|Other|2|||
42197459|NCT00091793|76009151|FG001|Overall Study|Other|0|||
42197460|NCT00098813|76009157|FG000|Overall Study|Death|8|||
42197461|NCT00098813|76009157|FG000|Overall Study|Protocol Violation|1|||
42197462|NCT00098813|76009157|FG000|Overall Study|Withdrawal by Subject|7|||
42197463|NCT00098813|76009157|FG000|Overall Study|Progression of Disease|1|||
42368849|NCT03181893|76229726|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
42368850|NCT03181893|76229727|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
42368851|NCT03180840|76229752|FG000|Overall Study|Withdrawal by Subject|1|||
42368852|NCT03064035|76229763|FG000|Overall Study|Did not receive allocated intervention|4|||
42368853|NCT03064035|76229764|FG001|Overall Study|Did not receive allocated intervention|2|||
42197464|NCT00098813|76009157|FG000|Overall Study|Other complicating disease|1|||
42197465|NCT00098813|76009157|FG000|Overall Study|Reversal of RAI resistance|1|||
42197466|NCT00090857|76009163|FG000|Overall Study|Lost to Follow-up|0|||
42197467|NCT00090857|76009164|FG001|Overall Study|Lost to Follow-up|1|||
42197468|NCT00090857|76009163|FG000|Overall Study|Withdrawal by Subject|2|||
42197469|NCT00090857|76009164|FG001|Overall Study|Withdrawal by Subject|0|||
42197470|NCT00090857|76009163|FG000|Overall Study|Adverse Event|2|||
42197471|NCT00090857|76009164|FG001|Overall Study|Adverse Event|2|||
42197472|NCT00090779|76009176|FG000|Step 1|Withdrawal by Subject|4|||
42197473|NCT00090779|76009177|FG001|Step 1|Withdrawal by Subject|2|||
42197474|NCT00090779|76009176|FG000|Step 1|Lost to Follow-up|3|||
42197475|NCT00090779|76009177|FG001|Step 1|Lost to Follow-up|2|||
42197476|NCT00090779|76009176|FG000|Step 1|Death|0|||
42197477|NCT00090779|76009177|FG001|Step 1|Death|2|||
42197478|NCT00090779|76009176|FG000|Step 1|Physician Decision|1|||
42368854|NCT03064035|76229763|FG000|Overall Study|Lost to Follow-up|1|||
42368855|NCT03064035|76229764|FG001|Overall Study|Lost to Follow-up|1|||
42368856|NCT03014206|76229777|FG000|Overall Study|Registration Violation|12|||
42197479|NCT00090779|76009177|FG001|Step 1|Physician Decision|0|||
42197480|NCT00090779|76009176|FG000|Step 1|Pregnancy|1|||
42197481|NCT00090779|76009177|FG001|Step 1|Pregnancy|0|||
42197482|NCT00090779|76009176|FG000|Step 1|Non-compliance to study requirements|0|||
42197483|NCT00090779|76009177|FG001|Step 1|Non-compliance to study requirements|1|||
42197484|NCT00090779|76009176|FG000|Step 1|Subject relocated|2|||
42197485|NCT00090779|76009177|FG001|Step 1|Subject relocated|8|||
42197486|NCT00090779|76009176|FG000|Step 2|Off study per study closure|6|||
42197487|NCT00090779|76009177|FG001|Step 2|Off study per study closure|16|||
42197488|NCT00090779|76009176|FG000|Step 2|Subject relocated|0|||
42197489|NCT00090779|76009177|FG001|Step 2|Subject relocated|1|||
42197490|NCT00090779|76009176|FG000|Step 2|Non-compliance to study requirements|0|||
42197491|NCT00090779|76009177|FG001|Step 2|Non-compliance to study requirements|1|||
42197492|NCT00090779|76009176|FG000|Step 3|Initiation of ART and off extended study|3|||
42197493|NCT00090779|76009177|FG001|Step 3|Initiation of ART and off extended study|2|||
42197494|NCT00090779|76009176|FG000|Step 3|Off extended study due to study closure|4|||
42197495|NCT00090779|76009177|FG001|Step 3|Off extended study due to study closure|3|||
42197496|NCT00098345|76009183|FG000|Overall Study|Adverse Event|7|||
42197497|NCT00098345|76009183|FG000|Overall Study|Withdrawal by Subject|2|||
42197498|NCT00098345|76009183|FG000|Overall Study|progression|4|||
42197499|NCT02224456|76009187|FG000|Overall Study|Lack of Efficacy|1|||
42197500|NCT02224456|76009187|FG000|Overall Study|Lost to Follow-up|15|||
42197501|NCT02224456|76009187|FG000|Overall Study|Withdrawal by Subject|9|||
42197502|NCT02224456|76009187|FG000|Overall Study|Physician Decision|3|||
42197503|NCT02224456|76009187|FG000|Overall Study|Death|2|||
42197504|NCT02224456|76009187|FG000|Overall Study|Pregnancy|4|||
42368857|NCT02822573|76229792|FG000|Overall Study|Lost to Follow-up|5|||
42368858|NCT02822573|76229793|FG001|Overall Study|Lost to Follow-up|3|||
42368859|NCT02822573|76229792|FG000|Overall Study|Physician Decision|1|||
42197505|NCT02224456|76009187|FG000|Overall Study|Protocol Violation|1|||
42197506|NCT02224456|76009187|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
42197507|NCT00097721|76009193|FG000|Overall Study|Adverse Event|8|||
42197508|NCT00097721|76009194|FG001|Overall Study|Adverse Event|1|||
42197509|NCT00097721|76009193|FG000|Overall Study|Withdrawal by Subject|6|||
42197510|NCT00097721|76009194|FG001|Overall Study|Withdrawal by Subject|1|||
42197511|NCT00097721|76009193|FG000|Overall Study|Progressive Disease|55|||
42197512|NCT00097721|76009194|FG001|Overall Study|Progressive Disease|27|||
42197513|NCT00097721|76009193|FG000|Overall Study|Physician Decision|1|||
42197514|NCT00097721|76009194|FG001|Overall Study|Physician Decision|3|||
42197515|NCT00097721|76009193|FG000|Overall Study|Reason not given|1|||
42197516|NCT00097721|76009194|FG001|Overall Study|Reason not given|1|||
42197517|NCT03553498|76009202|FG000|Overall Study|Missing primary outcome|1|||
42197518|NCT03553498|76009203|FG001|Overall Study|Missing primary outcome|2|||
42197519|NCT00096941|76009209|FG000|Overall Study|disease progression|3|||
42197520|NCT00096785|76009215|FG000|Overall Study|Lost to Follow-up|1|||
42197521|NCT00096785|76009216|FG001|Overall Study|Lost to Follow-up|0|||
42197522|NCT00096785|76009215|FG000|Overall Study|Withdrawal by Subject|0|||
42197523|NCT00096785|76009216|FG001|Overall Study|Withdrawal by Subject|1|||
42368860|NCT02822573|76229793|FG001|Overall Study|Physician Decision|1|||
42368861|NCT02822573|76229792|FG000|Overall Study|Withdrawal by Subject|9|||
42368862|NCT02822573|76229793|FG001|Overall Study|Withdrawal by Subject|5|||
42368863|NCT02822573|76229792|FG000|Overall Study|Protocol Violation|6|||
42368864|NCT02822573|76229793|FG001|Overall Study|Protocol Violation|4|||
42368865|NCT02822573|76229792|FG000|Overall Study|Too sick or ill|2|||
42368866|NCT02822573|76229793|FG001|Overall Study|Too sick or ill|1|||
42368867|NCT02822573|76229792|FG000|Overall Study|Disease Progression|1|||
42368868|NCT02822573|76229793|FG001|Overall Study|Disease Progression|1|||
42368869|NCT02822573|76229792|FG000|Overall Study|No reason given|6|||
42368870|NCT02822573|76229793|FG001|Overall Study|No reason given|4|||
42368871|NCT02795676|76229801|FG000|Overall Study|Adverse Event|2|||
42368872|NCT02795676|76229802|FG001|Overall Study|Adverse Event|0|||
42368873|NCT02795676|76229801|FG000|Overall Study|Withdrawal by Subject|3|||
42368874|NCT02795676|76229802|FG001|Overall Study|Withdrawal by Subject|1|||
42368875|NCT02784535|76229808|FG000|Overall Study|Adverse Event|1|||
42368876|NCT02784535|76229809|FG001|Overall Study|Adverse Event|0|||
42197524|NCT00096785|76009215|FG000|Overall Study|Relocated|1|||
42197525|NCT00096785|76009216|FG001|Overall Study|Relocated|0|||
42197526|NCT03285178|76009251|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
42197527|NCT03285178|76009252|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
42197528|NCT03285178|76009253|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
42197529|NCT03285178|76009254|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
42368877|NCT02784535|76229808|FG000|Overall Study|Withdrawal by Subject|0|||
42368878|NCT02784535|76229809|FG001|Overall Study|Withdrawal by Subject|1|||
42368879|NCT02784535|76229808|FG000|Overall Study|Physician Decision|0|||
42368880|NCT02784535|76229809|FG001|Overall Study|Physician Decision|1|||
42368881|NCT02617511|76229820|FG000|Overall Study|Withdrawal by Subject|1|||
42368882|NCT02617511|76229821|FG001|Overall Study|Withdrawal by Subject|0|||
42197530|NCT03285178|76009255|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
42368883|NCT02587234|76229829|FG000|Overall Study|Withdrawal by Subject|1|||
42368884|NCT02587234|76229830|FG001|Overall Study|Withdrawal by Subject|1|||
42197531|NCT03285178|76009256|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
42197532|NCT03285178|76009257|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
42197533|NCT03285178|76009251|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
42197534|NCT03285178|76009252|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
42197535|NCT03285178|76009253|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
42197536|NCT03285178|76009254|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
42197537|NCT03285178|76009255|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
42197538|NCT03285178|76009256|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
42197539|NCT03285178|76009257|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
42197540|NCT03285178|76009251|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
42197541|NCT03285178|76009252|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
42197542|NCT03285178|76009253|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
42197543|NCT03285178|76009254|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
42197544|NCT03285178|76009255|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
42197545|NCT03285178|76009256|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
42197546|NCT03285178|76009257|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
42197547|NCT03285178|76009251|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
42197548|NCT03285178|76009252|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
42197549|NCT03285178|76009253|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
42197550|NCT03285178|76009254|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
42197551|NCT03285178|76009255|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
42197552|NCT03285178|76009256|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
42197553|NCT03285178|76009257|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
42197554|NCT03285178|76009251|FG000|Single-Blind Run-In Period|Physician Decision|2|||
42197555|NCT03285178|76009252|FG001|Single-Blind Run-In Period|Physician Decision|0|||
42197556|NCT03285178|76009253|FG002|Single-Blind Run-In Period|Physician Decision|0|||
42197557|NCT03285178|76009254|FG003|Single-Blind Run-In Period|Physician Decision|0|||
42197558|NCT03285178|76009255|FG004|Single-Blind Run-In Period|Physician Decision|0|||
42197559|NCT03285178|76009256|FG005|Single-Blind Run-In Period|Physician Decision|0|||
42197560|NCT03285178|76009257|FG006|Single-Blind Run-In Period|Physician Decision|0|||
42102671|NCT00537394|75913656|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
42102672|NCT00537394|75913657|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
42102673|NCT00537394|75913658|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
42102674|NCT00537394|75913656|FG000|First Year of Follow-up|Lost to Follow-up|1|||
42102675|NCT00537394|75913657|FG001|First Year of Follow-up|Lost to Follow-up|5|||
42102676|NCT00537394|75913658|FG002|First Year of Follow-up|Lost to Follow-up|1|||
42102677|NCT00537394|75913656|FG000|2nd Year of Follow-up|Death|4|||
42102678|NCT00537394|75913657|FG001|2nd Year of Follow-up|Death|1|||
42102679|NCT00537394|75913658|FG002|2nd Year of Follow-up|Death|2|||
42102680|NCT00537394|75913656|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
42102681|NCT00537394|75913657|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
42197561|NCT03285178|76009251|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
42197562|NCT03285178|76009252|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
42197563|NCT03285178|76009253|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
42197564|NCT03285178|76009254|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
42197565|NCT03285178|76009255|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
42197566|NCT03285178|76009256|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
42197567|NCT03285178|76009257|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
42197568|NCT03285178|76009251|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42197569|NCT03285178|76009252|FG001|Double-Blind Treatment Period|Adverse Event|0|||
42197570|NCT03285178|76009253|FG002|Double-Blind Treatment Period|Adverse Event|0|||
42197571|NCT03285178|76009254|FG003|Double-Blind Treatment Period|Adverse Event|0|||
42197572|NCT03285178|76009255|FG004|Double-Blind Treatment Period|Adverse Event|0|||
42197573|NCT03285178|76009256|FG005|Double-Blind Treatment Period|Adverse Event|0|||
42197574|NCT03285178|76009257|FG006|Double-Blind Treatment Period|Adverse Event|2|||
42197575|NCT03285178|76009251|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
42197576|NCT03285178|76009252|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
42197577|NCT03285178|76009253|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
42197578|NCT03285178|76009254|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
42102682|NCT00537394|75913658|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
42102683|NCT00537394|75913656|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
42102684|NCT00537394|75913657|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
42197579|NCT03285178|76009255|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
42197580|NCT03285178|76009256|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
42197581|NCT03285178|76009257|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
42197582|NCT03285178|76009251|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42197583|NCT03285178|76009252|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42197584|NCT03285178|76009253|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
42197585|NCT03285178|76009254|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
42197586|NCT03285178|76009255|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42197587|NCT03285178|76009256|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
42197588|NCT03285178|76009257|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
42197589|NCT03285178|76009251|FG000|Double-Blind Treatment Period|COVID-19|0|||
42197590|NCT03285178|76009252|FG001|Double-Blind Treatment Period|COVID-19|0|||
42197591|NCT03285178|76009253|FG002|Double-Blind Treatment Period|COVID-19|1|||
42197592|NCT03285178|76009254|FG003|Double-Blind Treatment Period|COVID-19|0|||
42197593|NCT03285178|76009255|FG004|Double-Blind Treatment Period|COVID-19|0|||
42197594|NCT03285178|76009256|FG005|Double-Blind Treatment Period|COVID-19|0|||
42197595|NCT03285178|76009257|FG006|Double-Blind Treatment Period|COVID-19|0|||
42197596|NCT00090545|76009281|FG000|Overall Study|Disease progression on study|21|||
42197597|NCT00090545|76009282|FG001|Overall Study|Disease progression on study|17|||
42197598|NCT00090545|76009281|FG000|Overall Study|Refused further treatment|1|||
42197599|NCT00090545|76009282|FG001|Overall Study|Refused further treatment|4|||
42197600|NCT00090545|76009281|FG000|Overall Study|Death|0|||
42197601|NCT00090545|76009282|FG001|Overall Study|Death|1|||
42197602|NCT00090545|76009281|FG000|Overall Study|Adverse Event|0|||
42197603|NCT00090545|76009282|FG001|Overall Study|Adverse Event|2|||
42197604|NCT03249376|76009292|FG000|Overall Study|Adverse Event|11|||
42197605|NCT03249376|76009293|FG001|Overall Study|Adverse Event|5|||
42197606|NCT03249376|76009292|FG000|Overall Study|Lack of Efficacy|2|||
42197607|NCT03249376|76009293|FG001|Overall Study|Lack of Efficacy|4|||
42197608|NCT03249376|76009292|FG000|Overall Study|Protocol Violation|3|||
42197609|NCT03249376|76009293|FG001|Overall Study|Protocol Violation|2|||
42197610|NCT03249376|76009292|FG000|Overall Study|Physician Decision|0|||
42197611|NCT03249376|76009293|FG001|Overall Study|Physician Decision|2|||
42197612|NCT03249376|76009292|FG000|Overall Study|Withdrawal by Subject|3|||
42197613|NCT03249376|76009293|FG001|Overall Study|Withdrawal by Subject|9|||
42197614|NCT03249376|76009292|FG000|Overall Study|LTFU|2|||
42197615|NCT03249376|76009293|FG001|Overall Study|LTFU|1|||
42197616|NCT00070109|76009304|FG000|Overall Study|Death|1|||
42197617|NCT00070109|76009305|FG001|Overall Study|Death|1|||
42368885|NCT02587234|76229829|FG000|Overall Study|Lost to Follow-up|0|||
42368886|NCT02587234|76229830|FG001|Overall Study|Lost to Follow-up|2|||
42018651|NCT01256411|75826040|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
42018652|NCT01256411|75826041|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
42018653|NCT01256411|75826042|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
42018654|NCT01256411|75826037|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
42018655|NCT01256411|75826038|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
42018656|NCT01256411|75826039|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
42018657|NCT01256411|75826040|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
42018658|NCT01256411|75826041|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
42102685|NCT00537394|75913658|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
42102686|NCT00537394|75913656|FG000|2nd Year of Follow-up|Clinic site closure|1|||
42102687|NCT00537394|75913657|FG001|2nd Year of Follow-up|Clinic site closure|0|||
42102688|NCT00537394|75913658|FG002|2nd Year of Follow-up|Clinic site closure|0|||
42102689|NCT00352885|75913666|FG000|Overall Study|Withdrawal by Subject|0|||
42102690|NCT00352885|75913667|FG001|Overall Study|Withdrawal by Subject|3|||
42102691|NCT00352885|75913666|FG000|Overall Study|Development of major depression|0|||
42102692|NCT00352885|75913667|FG001|Overall Study|Development of major depression|1|||
42102693|NCT00352885|75913666|FG000|Overall Study|Progression of metastatic melanoma|5|||
42102694|NCT00352885|75913667|FG001|Overall Study|Progression of metastatic melanoma|3|||
42102695|NCT00352885|75913666|FG000|Overall Study|Side effects of IL-2 administration|1|||
42102696|NCT00352885|75913667|FG001|Overall Study|Side effects of IL-2 administration|0|||
42102697|NCT00660660|75913675|FG000|Overall Study|Adverse Event|1|||
42197618|NCT00070109|76009306|FG002|Overall Study|Death|0|||
42197619|NCT00070109|76009307|FG003|Overall Study|Death|0|||
42018659|NCT01256411|75826042|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
42018660|NCT01256411|75826037|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
42018661|NCT01256411|75826038|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
42018662|NCT01256411|75826039|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
42018663|NCT01256411|75826040|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
42018664|NCT01256411|75826041|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
42102698|NCT00660660|75913676|FG001|Overall Study|Adverse Event|0|||
42197620|NCT00070109|76009308|FG004|Overall Study|Death|1|||
42197621|NCT00070109|76009304|FG000|Overall Study|Lack of Efficacy|6|||
42197622|NCT00070109|76009305|FG001|Overall Study|Lack of Efficacy|4|||
42197623|NCT00070109|76009306|FG002|Overall Study|Lack of Efficacy|5|||
42197624|NCT00070109|76009307|FG003|Overall Study|Lack of Efficacy|15|||
42197625|NCT00070109|76009308|FG004|Overall Study|Lack of Efficacy|5|||
42197626|NCT00070109|76009304|FG000|Overall Study|Physician Decision|1|||
42197627|NCT00070109|76009305|FG001|Overall Study|Physician Decision|0|||
42197628|NCT00070109|76009306|FG002|Overall Study|Physician Decision|0|||
42197629|NCT00070109|76009307|FG003|Overall Study|Physician Decision|0|||
42197630|NCT00070109|76009308|FG004|Overall Study|Physician Decision|0|||
42197631|NCT00070109|76009304|FG000|Overall Study|Withdrawal by Subject|0|||
42197632|NCT00070109|76009305|FG001|Overall Study|Withdrawal by Subject|1|||
42197633|NCT00070109|76009306|FG002|Overall Study|Withdrawal by Subject|1|||
42197634|NCT00070109|76009307|FG003|Overall Study|Withdrawal by Subject|0|||
42197635|NCT00070109|76009308|FG004|Overall Study|Withdrawal by Subject|0|||
42197636|NCT00070109|76009304|FG000|Overall Study|Adverse Event|0|||
42197637|NCT00070109|76009305|FG001|Overall Study|Adverse Event|0|||
42197638|NCT00070109|76009306|FG002|Overall Study|Adverse Event|2|||
42197639|NCT00070109|76009307|FG003|Overall Study|Adverse Event|4|||
42197640|NCT00070109|76009308|FG004|Overall Study|Adverse Event|2|||
42197641|NCT00070109|76009304|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
42197642|NCT00070109|76009305|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
42197643|NCT00070109|76009306|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
42197644|NCT00070109|76009307|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
42197645|NCT00070109|76009308|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
42197646|NCT00090233|76009329|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
42197647|NCT00090233|76009330|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
42197648|NCT00090233|76009329|FG000|Overall Study|Adverse Event|214|||
42197649|NCT00090233|76009330|FG001|Overall Study|Adverse Event|198|||
42197650|NCT00090233|76009329|FG000|Overall Study|Lost to Follow-up|68|||
42197651|NCT00090233|76009330|FG001|Overall Study|Lost to Follow-up|95|||
42197652|NCT00090233|76009329|FG000|Overall Study|Protocol Violation|960|||
42197653|NCT00090233|76009330|FG001|Overall Study|Protocol Violation|1022|||
42197654|NCT00090233|76009329|FG000|Overall Study|Withdrawal by Subject|182|||
42197655|NCT00090233|76009330|FG001|Overall Study|Withdrawal by Subject|211|||
42197656|NCT00090233|76009329|FG000|Overall Study|Moved|203|||
42197657|NCT00090233|76009330|FG001|Overall Study|Moved|189|||
42197658|NCT00090233|76009329|FG000|Overall Study|Other|1211|||
42197659|NCT00090233|76009330|FG001|Overall Study|Other|1160|||
42197660|NCT00090233|76009329|FG000|Overall Study|Data not available at data cut-off point|1552|||
42197661|NCT00090233|76009330|FG001|Overall Study|Data not available at data cut-off point|1563|||
42197662|NCT00069953|76009340|FG000|Overall Study|Protocol Violation|2|||
42197663|NCT02750800|76009350|FG000|Overall Study|Adverse Event|18|||
42197664|NCT02750800|76009350|FG000|Overall Study|Lost to Follow-up|12|||
42368887|NCT02184195|76229838|FG000|Overall Study|Patient decision|5|||
42368888|NCT02184195|76229839|FG001|Overall Study|Patient decision|2|||
42368889|NCT02184195|76229838|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42368890|NCT02184195|76229839|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
42368891|NCT02184195|76229838|FG000|Overall Study|Death|67|||
42368892|NCT02184195|76229839|FG001|Overall Study|Death|44|||
42368893|NCT02184195|76229838|FG000|Overall Study|Lost to Follow-up|1|||
42368894|NCT02184195|76229839|FG001|Overall Study|Lost to Follow-up|5|||
42368895|NCT02184195|76229838|FG000|Overall Study|Other|0|||
42197665|NCT02750800|76009350|FG000|Overall Study|Investigator decision|53|||
42197666|NCT02750800|76009350|FG000|Overall Study|Patient request|12|||
42197667|NCT02750800|76009350|FG000|Overall Study|Other, not specified|3|||
42197668|NCT01329562|76009370|FG000|Overall Study|Protocol Violation|5|||
42197669|NCT01329562|76009371|FG001|Overall Study|Protocol Violation|3|||
42197670|NCT01329562|76009370|FG000|Overall Study|Lost to Follow-up|1|||
42197671|NCT01329562|76009371|FG001|Overall Study|Lost to Follow-up|1|||
42197672|NCT01329562|76009370|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
42368896|NCT02184195|76229839|FG001|Overall Study|Other|3|||
42368897|NCT02181413|76229847|FG000|Overall Study|Adverse Event|7|||
42197673|NCT01329562|76009371|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
42197674|NCT01329562|76009370|FG000|Overall Study|Physician Decision|0|||
42197675|NCT01329562|76009371|FG001|Overall Study|Physician Decision|1|||
42197676|NCT00069641|76009382|FG000|Overall Study|Death|1|||
42197677|NCT00069641|76009383|FG001|Overall Study|Death|0|||
42197678|NCT00069641|76009384|FG002|Overall Study|Death|1|||
42197679|NCT03653026|76009395|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
42197680|NCT03653026|76009396|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
42197681|NCT03653026|76009397|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
42197682|NCT03653026|76009398|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
42368898|NCT02181413|76229848|FG001|Overall Study|Adverse Event|24|||
42197683|NCT03653026|76009395|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
42197684|NCT03653026|76009396|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
42197685|NCT03653026|76009397|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
42368899|NCT02181413|76229847|FG000|Overall Study|Progressive Disease|121|||
42368900|NCT02181413|76229848|FG001|Overall Study|Progressive Disease|143|||
42368901|NCT02181413|76229847|FG000|Overall Study|Withdrawal by Subject|5|||
42368902|NCT02181413|76229848|FG001|Overall Study|Withdrawal by Subject|8|||
42368903|NCT02181413|76229847|FG000|Overall Study|Reason Not Specified|19|||
42368904|NCT02181413|76229848|FG001|Overall Study|Reason Not Specified|20|||
42368905|NCT02181413|76229847|FG000|Overall Study|Ongoing Study Treatment|0|||
42368906|NCT02181413|76229848|FG001|Overall Study|Ongoing Study Treatment|1|||
42368907|NCT02181413|76229847|FG000|Overall Study|Lost to Follow-up|0|||
42368908|NCT02181413|76229848|FG001|Overall Study|Lost to Follow-up|1|||
42368909|NCT02152631|76229856|FG000|Overall Study|Adverse Event|32|||
42368910|NCT02152631|76229857|FG001|Overall Study|Adverse Event|4|||
42368911|NCT02152631|76229856|FG000|Overall Study|Withdrawal by Subject|13|||
42197686|NCT03653026|76009398|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
42197687|NCT03653026|76009395|FG000|Part 1: Placebo-controlled Period|Other|0|||
42197688|NCT03653026|76009396|FG001|Part 1: Placebo-controlled Period|Other|3|||
42197689|NCT03653026|76009397|FG002|Part 1: Placebo-controlled Period|Other|0|||
42197690|NCT03653026|76009398|FG003|Part 1: Placebo-controlled Period|Other|0|||
42197691|NCT03653026|76009395|FG000|Part 2: Open-label Extension|Adverse Event|0|||
42197692|NCT03653026|76009396|FG001|Part 2: Open-label Extension|Adverse Event|0|||
42197693|NCT03653026|76009397|FG002|Part 2: Open-label Extension|Adverse Event|1|||
42197694|NCT03653026|76009398|FG003|Part 2: Open-label Extension|Adverse Event|1|||
42197695|NCT03653026|76009395|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
42197696|NCT03653026|76009396|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
42197697|NCT03653026|76009397|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
42197698|NCT03653026|76009398|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
42197699|NCT03653026|76009395|FG000|Part 2: Open-label Extension|Other|0|||
42197700|NCT03653026|76009396|FG001|Part 2: Open-label Extension|Other|0|||
42197701|NCT03653026|76009397|FG002|Part 2: Open-label Extension|Other|1|||
42197702|NCT03653026|76009398|FG003|Part 2: Open-label Extension|Other|2|||
42197703|NCT01329328|76009409|FG000|Overall Study|Withdrawal by Subject|2|||
42197704|NCT01329328|76009410|FG001|Overall Study|Withdrawal by Subject|4|||
42197705|NCT01329328|76009411|FG002|Overall Study|Withdrawal by Subject|3|||
42197706|NCT01337986|76009421|FG000|Overall Study|Adverse Event|2|||
42197707|NCT01337986|76009422|FG001|Overall Study|Adverse Event|2|||
42197708|NCT01337986|76009421|FG000|Overall Study|Lost to Follow-up|1|||
42197709|NCT01337986|76009422|FG001|Overall Study|Lost to Follow-up|0|||
42197710|NCT01337986|76009421|FG000|Overall Study|Protocol Violation|0|||
42197711|NCT01337986|76009422|FG001|Overall Study|Protocol Violation|3|||
42197712|NCT01337674|76009446|FG000|Treatment Period 1|Adverse Event|0|||
42197713|NCT01337674|76009447|FG001|Treatment Period 1|Adverse Event|1|||
42197714|NCT01337674|76009448|FG002|Treatment Period 1|Adverse Event|0|||
42368912|NCT02152631|76229857|FG001|Overall Study|Withdrawal by Subject|16|||
42368913|NCT02152631|76229856|FG000|Overall Study|Noncompliance with study drug|1|||
42368914|NCT02152631|76229857|FG001|Overall Study|Noncompliance with study drug|0|||
42368915|NCT02152631|76229856|FG000|Overall Study|Physician Decision|1|||
42368916|NCT02152631|76229857|FG001|Overall Study|Physician Decision|2|||
42368917|NCT02152631|76229856|FG000|Overall Study|Lost to Follow-up|0|||
42368918|NCT02152631|76229857|FG001|Overall Study|Lost to Follow-up|1|||
42368919|NCT02152631|76229856|FG000|Overall Study|On Treatment|19|||
42368920|NCT02152631|76229857|FG001|Overall Study|On Treatment|3|||
42368921|NCT02151981|76229865|FG000|Overall Study|Death|184|||
42368922|NCT02151981|76229866|FG001|Overall Study|Death|88|||
42368923|NCT02151981|76229865|FG000|Overall Study|Lost to Follow-up|7|||
42368924|NCT02151981|76229866|FG001|Overall Study|Lost to Follow-up|1|||
42368925|NCT02151981|76229865|FG000|Overall Study|Withdrawal by Subject|27|||
42368926|NCT02151981|76229866|FG001|Overall Study|Withdrawal by Subject|21|||
42368927|NCT02151981|76229865|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
42368928|NCT02151981|76229866|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
42197715|NCT01337674|76009449|FG003|Treatment Period 1|Adverse Event|0|||
42197716|NCT01337674|76009446|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
42368929|NCT02151981|76229865|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
42368930|NCT02151981|76229866|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
42197717|NCT01337674|76009447|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
42197718|NCT01337674|76009448|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
42197719|NCT01337674|76009449|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
42197720|NCT01337674|76009446|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42368931|NCT02151981|76229865|FG000|Overall Study|Patient had no clinical benefit|1|||
42368932|NCT02151981|76229866|FG001|Overall Study|Patient had no clinical benefit|0|||
42368933|NCT02151981|76229865|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
42368934|NCT02151981|76229866|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
42197721|NCT01337674|76009447|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42197722|NCT01337674|76009448|FG002|Treatment Period 2|Withdrawal by Subject|1|||
42197723|NCT01337674|76009449|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42197724|NCT02750410|76009464|FG000|Double-Blind Treatment Period|Adverse Event|2|||
42197725|NCT02750410|76009465|FG001|Double-Blind Treatment Period|Adverse Event|2|||
42197726|NCT02750410|76009464|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42197727|NCT02750410|76009465|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
42197728|NCT02750410|76009464|FG000|Open-Label Extension Period|Adverse Event|5|||
42197729|NCT02750410|76009465|FG001|Open-Label Extension Period|Adverse Event|3|||
42197730|NCT02750410|76009464|FG000|Open-Label Extension Period|Protocol Violation|0|||
42197731|NCT02750410|76009465|FG001|Open-Label Extension Period|Protocol Violation|1|||
42197732|NCT02750410|76009464|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
42197733|NCT02750410|76009465|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
42197734|NCT02750332|76009475|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42197735|NCT02750332|76009476|FG001|Treatment Period 1|Withdrawal by Subject|1|||
42197736|NCT01337596|76009491|FG000|Overall Study|Withdrawal by Subject|0|||
42197737|NCT01337596|76009492|FG001|Overall Study|Withdrawal by Subject|0|||
42197738|NCT01337596|76009493|FG002|Overall Study|Withdrawal by Subject|0|||
42197739|NCT01337596|76009494|FG003|Overall Study|Withdrawal by Subject|0|||
42197740|NCT01337596|76009495|FG004|Overall Study|Withdrawal by Subject|2|||
42197741|NCT01337596|76009496|FG005|Overall Study|Withdrawal by Subject|0|||
42197742|NCT01337596|76009497|FG006|Overall Study|Withdrawal by Subject|0|||
42197743|NCT01337596|76009498|FG007|Overall Study|Withdrawal by Subject|0|||
42197744|NCT01337596|76009499|FG008|Overall Study|Withdrawal by Subject|0|||
42197745|NCT00069095|76009528|FG000|Primary Treatment Phase|Ongoing|0|||
42197746|NCT00069095|76009529|FG001|Primary Treatment Phase|Ongoing|0|||
42197747|NCT00069095|76009530|FG002|Primary Treatment Phase|Ongoing|5|||
42197748|NCT00069095|76009531|FG003|Primary Treatment Phase|Ongoing|7|||
42197749|NCT00069095|76009532|FG004|Primary Treatment Phase|Ongoing|7|||
42197750|NCT00069095|76009533|FG005|Primary Treatment Phase|Ongoing|4|||
42197751|NCT00069095|76009528|FG000|Primary Treatment Phase|Admin/Other|29|||
42197752|NCT00069095|76009529|FG001|Primary Treatment Phase|Admin/Other|38|||
42197753|NCT00069095|76009530|FG002|Primary Treatment Phase|Admin/Other|31|||
42197754|NCT00069095|76009531|FG003|Primary Treatment Phase|Admin/Other|45|||
42197755|NCT00069095|76009532|FG004|Primary Treatment Phase|Admin/Other|48|||
42197756|NCT00069095|76009533|FG005|Primary Treatment Phase|Admin/Other|42|||
42197757|NCT00069095|76009528|FG000|Primary Treatment Phase|Adverse Event|99|||
42197758|NCT00069095|76009529|FG001|Primary Treatment Phase|Adverse Event|92|||
42197759|NCT00069095|76009530|FG002|Primary Treatment Phase|Adverse Event|71|||
42197760|NCT00069095|76009531|FG003|Primary Treatment Phase|Adverse Event|72|||
42197761|NCT00069095|76009532|FG004|Primary Treatment Phase|Adverse Event|109|||
42197762|NCT00069095|76009533|FG005|Primary Treatment Phase|Adverse Event|101|||
42197763|NCT00069095|76009528|FG000|Primary Treatment Phase|Death|14|||
42197764|NCT00069095|76009529|FG001|Primary Treatment Phase|Death|8|||
42197765|NCT00069095|76009530|FG002|Primary Treatment Phase|Death|2|||
42197766|NCT00069095|76009531|FG003|Primary Treatment Phase|Death|5|||
42197767|NCT00069095|76009532|FG004|Primary Treatment Phase|Death|8|||
42197768|NCT00069095|76009533|FG005|Primary Treatment Phase|Death|8|||
42197769|NCT00069095|76009528|FG000|Primary Treatment Phase|Failure to return|5|||
42197770|NCT00069095|76009529|FG001|Primary Treatment Phase|Failure to return|5|||
42197771|NCT00069095|76009530|FG002|Primary Treatment Phase|Failure to return|0|||
42197772|NCT00069095|76009531|FG003|Primary Treatment Phase|Failure to return|0|||
42197773|NCT00069095|76009532|FG004|Primary Treatment Phase|Failure to return|0|||
42197774|NCT00069095|76009533|FG005|Primary Treatment Phase|Failure to return|2|||
42197775|NCT00069095|76009528|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
42197776|NCT00069095|76009529|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
42197777|NCT00069095|76009530|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
42197778|NCT00069095|76009531|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
42197779|NCT00069095|76009532|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
42197780|NCT00069095|76009533|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
42197781|NCT00069095|76009528|FG000|Primary Treatment Phase|Refused treatment|15|||
42197782|NCT00069095|76009529|FG001|Primary Treatment Phase|Refused treatment|26|||
42197783|NCT00069095|76009530|FG002|Primary Treatment Phase|Refused treatment|17|||
42197784|NCT00069095|76009531|FG003|Primary Treatment Phase|Refused treatment|31|||
42197785|NCT00069095|76009532|FG004|Primary Treatment Phase|Refused treatment|24|||
42197786|NCT00069095|76009533|FG005|Primary Treatment Phase|Refused treatment|27|||
42197787|NCT00069095|76009528|FG000|Primary Treatment Phase|Withdrew|2|||
42197788|NCT00069095|76009529|FG001|Primary Treatment Phase|Withdrew|3|||
42197789|NCT00069095|76009530|FG002|Primary Treatment Phase|Withdrew|8|||
42197790|NCT00069095|76009531|FG003|Primary Treatment Phase|Withdrew|2|||
42197791|NCT00069095|76009532|FG004|Primary Treatment Phase|Withdrew|4|||
42102699|NCT00660660|75913675|FG000|Overall Study|Lost to Follow-up|0|||
42197792|NCT00069095|76009533|FG005|Primary Treatment Phase|Withdrew|9|||
42197793|NCT00069095|76009528|FG000|Primary Treatment Phase|Other Violation|0|||
42197794|NCT00069095|76009529|FG001|Primary Treatment Phase|Other Violation|1|||
42197795|NCT00069095|76009530|FG002|Primary Treatment Phase|Other Violation|1|||
42197796|NCT00069095|76009531|FG003|Primary Treatment Phase|Other Violation|1|||
42197797|NCT00069095|76009532|FG004|Primary Treatment Phase|Other Violation|0|||
42197798|NCT00069095|76009533|FG005|Primary Treatment Phase|Other Violation|1|||
42197799|NCT00069095|76009528|FG000|Primary Treatment Phase|Violation criteria|0|||
42197800|NCT00069095|76009529|FG001|Primary Treatment Phase|Violation criteria|2|||
42197801|NCT00069095|76009530|FG002|Primary Treatment Phase|Violation criteria|4|||
42197802|NCT00069095|76009531|FG003|Primary Treatment Phase|Violation criteria|3|||
42197803|NCT00069095|76009532|FG004|Primary Treatment Phase|Violation criteria|1|||
42197804|NCT00069095|76009533|FG005|Primary Treatment Phase|Violation criteria|5|||
42197805|NCT00069095|76009528|FG000|Post-study Treatment Phase|Missing reason|1|||
42197806|NCT00069095|76009529|FG001|Post-study Treatment Phase|Missing reason|3|||
42197807|NCT00069095|76009530|FG002|Post-study Treatment Phase|Missing reason|12|||
42197808|NCT00069095|76009531|FG003|Post-study Treatment Phase|Missing reason|8|||
42197809|NCT00069095|76009532|FG004|Post-study Treatment Phase|Missing reason|18|||
42197810|NCT00069095|76009533|FG005|Post-study Treatment Phase|Missing reason|17|||
42197811|NCT00069095|76009528|FG000|Post-study Treatment Phase|Adverse Event|2|||
42197812|NCT00069095|76009529|FG001|Post-study Treatment Phase|Adverse Event|3|||
42197813|NCT00069095|76009530|FG002|Post-study Treatment Phase|Adverse Event|1|||
42197814|NCT00069095|76009531|FG003|Post-study Treatment Phase|Adverse Event|0|||
42197815|NCT00069095|76009532|FG004|Post-study Treatment Phase|Adverse Event|5|||
42197816|NCT00069095|76009533|FG005|Post-study Treatment Phase|Adverse Event|1|||
42197817|NCT00069095|76009528|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
42197818|NCT00069095|76009529|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
42197819|NCT00069095|76009530|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
42197820|NCT00069095|76009531|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
42197821|NCT00069095|76009532|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
42197822|NCT00069095|76009533|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
42197823|NCT00069095|76009528|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
42197824|NCT00069095|76009529|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
42197825|NCT00069095|76009530|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
42197826|NCT00069095|76009531|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
42197827|NCT00069095|76009532|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
42197828|NCT00069095|76009533|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
42197829|NCT00069095|76009528|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
42197830|NCT00069095|76009529|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
42197831|NCT00069095|76009530|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
42197832|NCT00069095|76009531|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
42197833|NCT00069095|76009532|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
42197834|NCT00069095|76009533|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
42197835|NCT00069095|76009528|FG000|Post-study Treatment Phase|Participant had complete response|1|||
42197836|NCT00069095|76009529|FG001|Post-study Treatment Phase|Participant had complete response|1|||
42197837|NCT00069095|76009530|FG002|Post-study Treatment Phase|Participant had complete response|0|||
42197838|NCT00069095|76009531|FG003|Post-study Treatment Phase|Participant had complete response|0|||
42197839|NCT00069095|76009532|FG004|Post-study Treatment Phase|Participant had complete response|0|||
42197840|NCT00069095|76009533|FG005|Post-study Treatment Phase|Participant had complete response|0|||
42197841|NCT00069095|76009528|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
42197842|NCT00069095|76009529|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
42197843|NCT00069095|76009530|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
42197844|NCT00069095|76009531|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
42368935|NCT02151981|76229865|FG000|Overall Study|Study terminated|0|||
42368936|NCT02151981|76229866|FG001|Overall Study|Study terminated|1|||
42368937|NCT01981720|76229885|FG000|Overall Study|Adverse Event|1|||
42368938|NCT01981720|76229885|FG000|Overall Study|Withdrawal by Subject|3|||
42197845|NCT00069095|76009532|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
42197846|NCT00069095|76009533|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
42197847|NCT00069095|76009528|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
42368939|NCT01981720|76229885|FG000|Overall Study|Pregnancy|1|||
42368940|NCT01974440|76229895|FG000|Overall Study|Lost to Follow-up|8|||
42368941|NCT01974440|76229896|FG001|Overall Study|Lost to Follow-up|7|||
42368942|NCT01974440|76229895|FG000|Overall Study|Withdrawal by Subject|20|||
42368943|NCT01974440|76229896|FG001|Overall Study|Withdrawal by Subject|19|||
42368944|NCT01974440|76229895|FG000|Overall Study|Ongoing|112|||
42368945|NCT01974440|76229896|FG001|Overall Study|Ongoing|116|||
42368946|NCT01802281|76229913|FG000|Overall Study|Death|1|||
42368947|NCT01802281|76229914|FG001|Overall Study|Death|2|||
42368948|NCT01802281|76229913|FG000|Overall Study|Withdrawal by Subject|2|||
42368949|NCT01802281|76229914|FG001|Overall Study|Withdrawal by Subject|1|||
42368950|NCT01802281|76229913|FG000|Overall Study|Ineligible|5|||
42197848|NCT00069095|76009529|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
42197849|NCT00069095|76009530|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
42197850|NCT00069095|76009531|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
42197851|NCT00069095|76009532|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
42197852|NCT00069095|76009533|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
42197853|NCT00069095|76009528|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
42197854|NCT00069095|76009529|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
42197855|NCT00069095|76009530|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
42197856|NCT00069095|76009531|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
42197857|NCT00069095|76009532|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
42197858|NCT00069095|76009533|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
42197859|NCT00069095|76009528|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
42197860|NCT00069095|76009529|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
42197861|NCT00069095|76009530|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
42197862|NCT00069095|76009531|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
42197863|NCT00069095|76009532|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
42197864|NCT00069095|76009533|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
42197865|NCT00069095|76009528|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
42197866|NCT00069095|76009529|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
42197867|NCT00069095|76009530|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
42197868|NCT00069095|76009531|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
42197869|NCT00069095|76009532|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
42197870|NCT00069095|76009533|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
42197871|NCT00069095|76009528|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
42197872|NCT00069095|76009529|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
42197873|NCT00069095|76009530|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
42197874|NCT00069095|76009531|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
42368951|NCT01802281|76229914|FG001|Overall Study|Ineligible|3|||
42368952|NCT01678898|76229937|FG000|PB-102-F01|Adverse Event|0|||
42368953|NCT01678898|76229938|FG001|PB-102-F01|Adverse Event|1|||
42368954|NCT01678898|76229939|FG002|PB-102-F01|Adverse Event|0|||
42102700|NCT00660660|75913676|FG001|Overall Study|Lost to Follow-up|6|||
42102701|NCT00660660|75913675|FG000|Overall Study|Lack of Efficacy|0|||
42102702|NCT00660660|75913676|FG001|Overall Study|Lack of Efficacy|2|||
42102703|NCT00660660|75913675|FG000|Overall Study|Withdrawal by Subject|3|||
42102704|NCT00660660|75913676|FG001|Overall Study|Withdrawal by Subject|0|||
42102705|NCT00660660|75913675|FG000|Overall Study|Incorrect enrollment and other|0|||
42102706|NCT00660660|75913676|FG001|Overall Study|Incorrect enrollment and other|1|||
42102707|NCT00660660|75913675|FG000|Overall Study|New medication after randomization|1|||
42102708|NCT00660660|75913676|FG001|Overall Study|New medication after randomization|0|||
42102709|NCT00344305|75913684|FG000|Overall Study|Lost to Follow-up|2|||
42102710|NCT00344305|75913685|FG001|Overall Study|Lost to Follow-up|0|||
42102711|NCT00344305|75913684|FG000|Overall Study|Participant was not contacted in window|0|||
42102712|NCT00344305|75913685|FG001|Overall Study|Participant was not contacted in window|1|||
42102713|NCT00660816|75913694|FG000|Overall Study|Adverse Event|1|||
42102714|NCT00660816|75913695|FG001|Overall Study|Adverse Event|2|||
42102715|NCT00660816|75913694|FG000|Overall Study|Withdrawal by Subject|1|||
42102716|NCT00660816|75913695|FG001|Overall Study|Withdrawal by Subject|0|||
42102717|NCT00660816|75913694|FG000|Overall Study|Death|0|||
42102718|NCT00660816|75913695|FG001|Overall Study|Death|2|||
42102719|NCT00660816|75913694|FG000|Overall Study|Lack of Efficacy|1|||
42102720|NCT00660816|75913695|FG001|Overall Study|Lack of Efficacy|0|||
42102721|NCT00660816|75913694|FG000|Overall Study|Physician Decision|0|||
42102722|NCT00660816|75913695|FG001|Overall Study|Physician Decision|2|||
42102723|NCT00660816|75913694|FG000|Overall Study|Protocol Violation|1|||
42102724|NCT00660816|75913695|FG001|Overall Study|Protocol Violation|0|||
42102725|NCT00660816|75913694|FG000|Overall Study|Disease Progression|16|||
42102726|NCT00660816|75913695|FG001|Overall Study|Disease Progression|12|||
42102727|NCT00660816|75913694|FG000|Overall Study|Complicating Disease|0|||
42102728|NCT00660816|75913695|FG001|Overall Study|Complicating Disease|1|||
42102729|NCT00576056|75913701|FG000|Overall Study|Adverse Event|1|||
42368955|NCT01678898|76229937|FG000|PB-102-F01|Physician Decision|0|||
42102730|NCT00576056|75913701|FG000|Overall Study|Death|1|||
42102731|NCT00576056|75913701|FG000|Overall Study|Lack of Efficacy|1|||
42102732|NCT00576056|75913701|FG000|Overall Study|Withdrawal by Subject|2|||
42102733|NCT00576056|75913701|FG000|Overall Study|did not meet eligibility criteria|8|||
42102734|NCT00576056|75913701|FG000|Overall Study|Physician Decision|1|||
42102735|NCT00575510|75913708|FG000|Overall Study|Lost to Follow-up|4|||
42102736|NCT00575510|75913709|FG001|Overall Study|Lost to Follow-up|6|||
42197875|NCT00069095|76009532|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
42197876|NCT00069095|76009533|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
42197877|NCT00069095|76009528|FG000|Post-study Treatment Phase|Surgery|0|||
42197878|NCT00069095|76009529|FG001|Post-study Treatment Phase|Surgery|0|||
42197879|NCT00069095|76009530|FG002|Post-study Treatment Phase|Surgery|0|||
42197880|NCT00069095|76009531|FG003|Post-study Treatment Phase|Surgery|1|||
42197881|NCT00069095|76009532|FG004|Post-study Treatment Phase|Surgery|1|||
42197882|NCT00069095|76009533|FG005|Post-study Treatment Phase|Surgery|0|||
42197883|NCT00069095|76009528|FG000|Post-study Treatment Phase|Death|0|||
42197884|NCT00069095|76009529|FG001|Post-study Treatment Phase|Death|0|||
42197885|NCT00069095|76009530|FG002|Post-study Treatment Phase|Death|0|||
42197886|NCT00069095|76009531|FG003|Post-study Treatment Phase|Death|0|||
42197887|NCT00069095|76009532|FG004|Post-study Treatment Phase|Death|1|||
42197888|NCT00069095|76009533|FG005|Post-study Treatment Phase|Death|0|||
42197889|NCT00069095|76009528|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
42197890|NCT00069095|76009529|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
42197891|NCT00069095|76009530|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
42197892|NCT00069095|76009531|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
42197893|NCT00069095|76009532|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
42197894|NCT00069095|76009533|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
42197895|NCT00069095|76009528|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
42197896|NCT00069095|76009529|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
42197897|NCT00069095|76009530|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
42197898|NCT00069095|76009531|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
42197899|NCT00069095|76009532|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
42197900|NCT00069095|76009533|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
42197901|NCT00069095|76009528|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
42197902|NCT00069095|76009529|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
42197903|NCT00069095|76009530|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
42197904|NCT00069095|76009531|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
42197905|NCT00069095|76009532|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
42197906|NCT00069095|76009533|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
42197907|NCT00069095|76009528|FG000|Post-study Treatment Phase|Investigator decision|0|||
42197908|NCT00069095|76009529|FG001|Post-study Treatment Phase|Investigator decision|0|||
42197909|NCT00069095|76009530|FG002|Post-study Treatment Phase|Investigator decision|0|||
42197910|NCT00069095|76009531|FG003|Post-study Treatment Phase|Investigator decision|0|||
42197911|NCT00069095|76009532|FG004|Post-study Treatment Phase|Investigator decision|0|||
42197912|NCT00069095|76009533|FG005|Post-study Treatment Phase|Investigator decision|1|||
42197913|NCT00069095|76009528|FG000|Follow-up Phase|Death|174|||
42197914|NCT00069095|76009529|FG001|Follow-up Phase|Death|206|||
42197915|NCT00069095|76009530|FG002|Follow-up Phase|Death|120|||
42197916|NCT00069095|76009531|FG003|Follow-up Phase|Death|112|||
42197917|NCT00069095|76009532|FG004|Follow-up Phase|Death|92|||
42197918|NCT00069095|76009533|FG005|Follow-up Phase|Death|101|||
42197919|NCT00086411|76009549|FG000|Overall Study|Lost to Follow-up|11|||
42197920|NCT00086411|76009550|FG001|Overall Study|Lost to Follow-up|11|||
42197921|NCT00086411|76009551|FG002|Overall Study|Lost to Follow-up|13|||
42197922|NCT00086411|76009552|FG003|Overall Study|Lost to Follow-up|12|||
42197923|NCT00068237|76009563|FG000|Overall Study|Ineligible|3|||
42197924|NCT00068237|76009563|FG000|Overall Study|No protocol treatment received|2|||
42197925|NCT00055601|76009569|FG000|Overall Study|Protocol Violation|1|||
42197926|NCT00055601|76009570|FG001|Overall Study|Protocol Violation|1|||
42197927|NCT00055601|76009569|FG000|Overall Study|No protocol treatment received|1|||
42197928|NCT00055601|76009570|FG001|Overall Study|No protocol treatment received|1|||
42197929|NCT03806231|76009578|FG000|Overall Study|Physician Decision|1|||
42197930|NCT03806231|76009579|FG001|Overall Study|Physician Decision|0|||
42197931|NCT03806231|76009578|FG000|Overall Study|Withdrawal by Subject|1|||
42197932|NCT03806231|76009579|FG001|Overall Study|Withdrawal by Subject|0|||
42197933|NCT00054275|76009585|FG000|Overall Study|Withdrawal by Subject|4|||
42197934|NCT00054275|76009585|FG000|Overall Study|Adverse Event|5|||
42197935|NCT00054275|76009585|FG000|Overall Study|Progressive disease in cycle 1|1|||
42197936|NCT00054275|76009585|FG000|Overall Study|Physician Decision|1|||
42197937|NCT00053417|76009593|FG000|Overall Study|Adverse Event|1|||
42197938|NCT00053417|76009594|FG001|Overall Study|Adverse Event|0|||
42368956|NCT01678898|76229938|FG001|PB-102-F01|Physician Decision|1|||
42368957|NCT01678898|76229939|FG002|PB-102-F01|Physician Decision|0|||
42368958|NCT01485861|76229966|FG000|Phase Ib|Death|1|||
42197939|NCT00053417|76009595|FG002|Overall Study|Adverse Event|1|||
42197940|NCT00053417|76009596|FG003|Overall Study|Adverse Event|5|||
42197941|NCT00053417|76009593|FG000|Overall Study|Non-Compliance|0|||
42197942|NCT00053417|76009594|FG001|Overall Study|Non-Compliance|0|||
42197943|NCT00053417|76009595|FG002|Overall Study|Non-Compliance|0|||
42197944|NCT00053417|76009596|FG003|Overall Study|Non-Compliance|1|||
42368959|NCT01485861|76229967|FG001|Phase Ib|Death|0|||
42368960|NCT01485861|76229968|FG002|Phase Ib|Death|0|||
42102737|NCT00575510|75913710|FG002|Overall Study|Lost to Follow-up|9|||
42102738|NCT00575510|75913708|FG000|Overall Study|Withdrawal by Subject|1|||
42102739|NCT00575510|75913709|FG001|Overall Study|Withdrawal by Subject|0|||
42102740|NCT00575510|75913710|FG002|Overall Study|Withdrawal by Subject|0|||
42102741|NCT00575510|75913708|FG000|Overall Study|Clinic Called Patient|7|||
42102742|NCT00575510|75913709|FG001|Overall Study|Clinic Called Patient|7|||
42102743|NCT00575510|75913710|FG002|Overall Study|Clinic Called Patient|7|||
42102744|NCT00575510|75913708|FG000|Overall Study|Pregnancy|0|||
42102745|NCT00575510|75913709|FG001|Overall Study|Pregnancy|0|||
42102746|NCT00575510|75913710|FG002|Overall Study|Pregnancy|1|||
42102747|NCT02636439|75913721|FG000|Overall Study|Adverse Event|2|||
42102748|NCT02636439|75913722|FG001|Overall Study|Adverse Event|2|||
42102749|NCT02636439|75913721|FG000|Overall Study|Lost to Follow-up|1|||
42102750|NCT02636439|75913722|FG001|Overall Study|Lost to Follow-up|0|||
42102751|NCT02636439|75913721|FG000|Overall Study|Non-compliance|1|||
42102752|NCT02636439|75913722|FG001|Overall Study|Non-compliance|1|||
42102753|NCT02636439|75913721|FG000|Overall Study|Personal reasons|2|||
42102754|NCT02636439|75913722|FG001|Overall Study|Personal reasons|0|||
42102755|NCT00343915|75913730|FG000|Primary Study|Withdrawal by Subject|1|||
42102756|NCT00343915|75913731|FG001|Primary Study|Withdrawal by Subject|0|||
42102757|NCT00343915|75913730|FG000|Primary Study|Lost to Follow-up|2|||
42102758|NCT00343915|75913731|FG001|Primary Study|Lost to Follow-up|3|||
42102759|NCT00343915|75913730|FG000|Primary Study|Other|1|||
42102760|NCT00343915|75913731|FG001|Primary Study|Other|0|||
42102761|NCT00575666|75913742|FG000|Overall Study|Withdrawal by Subject|3|||
42102762|NCT00575666|75913743|FG001|Overall Study|Withdrawal by Subject|2|||
42102763|NCT00575666|75913742|FG000|Overall Study|Physician Decision|1|||
42102764|NCT00575666|75913743|FG001|Overall Study|Physician Decision|1|||
42102765|NCT00658632|75913751|FG000|Overall Study|Adverse Event|13|||
42102766|NCT00658632|75913752|FG001|Overall Study|Adverse Event|11|||
42102767|NCT00658632|75913751|FG000|Overall Study|Lost to Follow-up|25|||
42102768|NCT00658632|75913752|FG001|Overall Study|Lost to Follow-up|23|||
42102769|NCT00658632|75913751|FG000|Overall Study|Withdrawal by Subject|10|||
42102770|NCT00658632|75913752|FG001|Overall Study|Withdrawal by Subject|7|||
42102771|NCT00658632|75913751|FG000|Overall Study|Lack of Efficacy|0|||
42102772|NCT00658632|75913752|FG001|Overall Study|Lack of Efficacy|1|||
42102773|NCT00658632|75913751|FG000|Overall Study|Withdrawal of consent|8|||
42102774|NCT00658632|75913752|FG001|Overall Study|Withdrawal of consent|14|||
42102775|NCT00658632|75913751|FG000|Overall Study|Pregnancy|1|||
42102776|NCT00658632|75913752|FG001|Overall Study|Pregnancy|1|||
42102777|NCT00658632|75913751|FG000|Overall Study|Other|7|||
42102778|NCT00658632|75913752|FG001|Overall Study|Other|8|||
42102779|NCT00677534|75913758|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
42102780|NCT00677534|75913758|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
42102781|NCT00677534|75913758|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
42102782|NCT00660348|75913764|FG000|Overall Study|Withdrawal by Subject|1|||
42102783|NCT00660348|75913765|FG001|Overall Study|Withdrawal by Subject|0|||
42102784|NCT00660192|75913773|FG000|Overall Study|Lost to Follow-up|2|||
42102785|NCT00660192|75913774|FG001|Overall Study|Lost to Follow-up|3|||
42102786|NCT00571688|75913782|FG000|Overall Study|Lost to Follow-up|3|||
42102787|NCT00571688|75913783|FG001|Overall Study|Lost to Follow-up|6|||
42102788|NCT00571688|75913782|FG000|Overall Study|subject did not tolerate Consta|1|||
42368961|NCT01485861|76229969|FG003|Phase Ib|Death|0|||
42102789|NCT00571688|75913783|FG001|Overall Study|subject did not tolerate Consta|0|||
42102790|NCT00571688|75913782|FG000|Overall Study|subject moved out of the area|1|||
42102791|NCT00571688|75913783|FG001|Overall Study|subject moved out of the area|0|||
42102792|NCT00343291|75913791|FG000|Overall Study|Adverse Event|13|||
42197945|NCT00053417|76009593|FG000|Overall Study|Withdrawal by Subject|0|||
42197946|NCT00053417|76009594|FG001|Overall Study|Withdrawal by Subject|1|||
42102793|NCT00343291|75913792|FG001|Overall Study|Adverse Event|13|||
42102794|NCT00343291|75913791|FG000|Overall Study|Death|3|||
42102795|NCT00343291|75913792|FG001|Overall Study|Death|2|||
42102796|NCT00343291|75913791|FG000|Overall Study|Progressive disease|33|||
42102797|NCT00343291|75913792|FG001|Overall Study|Progressive disease|34|||
42102798|NCT00343291|75913791|FG000|Overall Study|Withdrawal by Subject|0|||
42102799|NCT00343291|75913792|FG001|Overall Study|Withdrawal by Subject|2|||
42102800|NCT00343291|75913791|FG000|Overall Study|Other|8|||
42102801|NCT00343291|75913792|FG001|Overall Study|Other|5|||
42102802|NCT00658788|75913798|FG000|Overall Study|Adverse Event|11|||
42102803|NCT00658788|75913798|FG000|Overall Study|Withdrawal by Subject|13|||
42102804|NCT00658788|75913798|FG000|Overall Study|Lost to Follow-up|18|||
42368962|NCT01485861|76229970|FG004|Phase Ib|Death|0|||
42197947|NCT00053417|76009595|FG002|Overall Study|Withdrawal by Subject|0|||
42197948|NCT00053417|76009596|FG003|Overall Study|Withdrawal by Subject|0|||
42197949|NCT00053417|76009593|FG000|Overall Study|Lost to Follow-up|1|||
42197950|NCT00053417|76009594|FG001|Overall Study|Lost to Follow-up|1|||
42197951|NCT00053417|76009595|FG002|Overall Study|Lost to Follow-up|0|||
42197952|NCT00053417|76009596|FG003|Overall Study|Lost to Follow-up|0|||
42197953|NCT00052715|76009606|FG000|Overall Study|wrong histology|1|||
42197954|NCT00051311|76009612|FG000|Overall Study|Starting new study|0|||
42197955|NCT00051311|76009613|FG001|Overall Study|Starting new study|1|||
42197956|NCT00051311|76009612|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
42197957|NCT00051311|76009613|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
42197958|NCT00051311|76009612|FG000|Overall Study|Death of recipient|8|||
42197959|NCT00051311|76009613|FG001|Overall Study|Death of recipient|8|||
42197960|NCT00051311|76009612|FG000|Overall Study|Recipient taken off study|4|||
42197961|NCT00051311|76009613|FG001|Overall Study|Recipient taken off study|4|||
42197962|NCT00049673|76009619|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
42197963|NCT00049673|76009620|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
42197964|NCT00049127|76009631|FG000|Overall Study|Withdrawal by Subject|0|||
42197965|NCT00049127|76009632|FG001|Overall Study|Withdrawal by Subject|0|||
42197966|NCT00049127|76009633|FG002|Overall Study|Withdrawal by Subject|1|||
42197967|NCT00049127|76009634|FG003|Overall Study|Withdrawal by Subject|0|||
42197968|NCT00049127|76009635|FG004|Overall Study|Withdrawal by Subject|0|||
42197969|NCT00066365|76009649|FG000|Overall Study|Adverse Event|1|||
42197970|NCT00066365|76009650|FG001|Overall Study|Adverse Event|0|||
42197971|NCT00066365|76009649|FG000|Overall Study|Lack of Efficacy|15|||
42197972|NCT00066365|76009650|FG001|Overall Study|Lack of Efficacy|12|||
42197973|NCT00066365|76009649|FG000|Overall Study|Physician Decision|1|||
42197974|NCT00066365|76009650|FG001|Overall Study|Physician Decision|0|||
42197975|NCT00066365|76009649|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
42197976|NCT00066365|76009650|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
42197977|NCT00066365|76009649|FG000|Overall Study|Ineligible|4|||
42197978|NCT00066365|76009650|FG001|Overall Study|Ineligible|2|||
42197979|NCT00048581|76009660|FG000|Double-Blind Period|Adverse Event|9|||
42197980|NCT00048581|76009661|FG001|Double-Blind Period|Adverse Event|5|||
42197981|NCT00048581|76009662|FG002|Double-Blind Period|Adverse Event|0|||
42197982|NCT00048581|76009660|FG000|Double-Blind Period|Lack of Efficacy|14|||
42197983|NCT00048581|76009661|FG001|Double-Blind Period|Lack of Efficacy|27|||
42368963|NCT01485861|76229971|FG005|Phase Ib|Death|0|||
42368964|NCT01485861|76229966|FG000|Phase Ib|Physician Decision|1|||
42368965|NCT01485861|76229967|FG001|Phase Ib|Physician Decision|1|||
42368966|NCT01485861|76229968|FG002|Phase Ib|Physician Decision|0|||
42368967|NCT01485861|76229969|FG003|Phase Ib|Physician Decision|0|||
42368968|NCT01485861|76229970|FG004|Phase Ib|Physician Decision|0|||
42368969|NCT01485861|76229971|FG005|Phase Ib|Physician Decision|0|||
42368970|NCT01485861|76229966|FG000|Phase Ib|Adverse Event|0|||
42368971|NCT01485861|76229967|FG001|Phase Ib|Adverse Event|4|||
42368972|NCT01485861|76229968|FG002|Phase Ib|Adverse Event|0|||
42368973|NCT01485861|76229969|FG003|Phase Ib|Adverse Event|0|||
42368974|NCT01485861|76229970|FG004|Phase Ib|Adverse Event|0|||
42368975|NCT01485861|76229971|FG005|Phase Ib|Adverse Event|0|||
42368976|NCT01485861|76229966|FG000|Phase Ib|Progression of disease|5|||
42368977|NCT01485861|76229967|FG001|Phase Ib|Progression of disease|0|||
42368978|NCT01485861|76229968|FG002|Phase Ib|Progression of disease|0|||
42368979|NCT01485861|76229969|FG003|Phase Ib|Progression of disease|0|||
42368980|NCT01485861|76229970|FG004|Phase Ib|Progression of disease|0|||
42368981|NCT01485861|76229971|FG005|Phase Ib|Progression of disease|0|||
42368982|NCT01485861|76229966|FG000|Phase Ib|Other|3|||
42368983|NCT01485861|76229967|FG001|Phase Ib|Other|0|||
42368984|NCT01485861|76229968|FG002|Phase Ib|Other|0|||
42368985|NCT01485861|76229969|FG003|Phase Ib|Other|0|||
42368986|NCT01485861|76229970|FG004|Phase Ib|Other|0|||
42197984|NCT00048581|76009662|FG002|Double-Blind Period|Lack of Efficacy|0|||
42197985|NCT00048581|76009660|FG000|Double-Blind Period|Lost to Follow-up|5|||
42197986|NCT00048581|76009661|FG001|Double-Blind Period|Lost to Follow-up|0|||
42368987|NCT01485861|76229971|FG005|Phase Ib|Other|0|||
42368988|NCT01485861|76229966|FG000|Phase Ib|Withdrawal by Subject|4|||
42368989|NCT01485861|76229967|FG001|Phase Ib|Withdrawal by Subject|1|||
42197987|NCT00048581|76009662|FG002|Double-Blind Period|Lost to Follow-up|0|||
42368990|NCT01485861|76229968|FG002|Phase Ib|Withdrawal by Subject|0|||
42197988|NCT00048581|76009660|FG000|Double-Blind Period|Withdrawal by Subject|5|||
42197989|NCT00048581|76009661|FG001|Double-Blind Period|Withdrawal by Subject|2|||
42368991|NCT01485861|76229969|FG003|Phase Ib|Withdrawal by Subject|0|||
42368992|NCT01485861|76229970|FG004|Phase Ib|Withdrawal by Subject|0|||
42368993|NCT01485861|76229971|FG005|Phase Ib|Withdrawal by Subject|0|||
42368994|NCT01485861|76229966|FG000|Phase II|Death|0|||
42368995|NCT01485861|76229967|FG001|Phase II|Death|0|||
42368996|NCT01485861|76229968|FG002|Phase II|Death|67|||
42197990|NCT00048581|76009662|FG002|Double-Blind Period|Withdrawal by Subject|0|||
42197991|NCT00048581|76009660|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
42197992|NCT00048581|76009661|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
42197993|NCT00048581|76009662|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
42197994|NCT00048581|76009660|FG000|Double-Blind Period|Investigator Decision|1|||
42197995|NCT00048581|76009661|FG001|Double-Blind Period|Investigator Decision|0|||
42197996|NCT00048581|76009662|FG002|Double-Blind Period|Investigator Decision|0|||
42197997|NCT00048581|76009660|FG000|Open-Label Period|Death|0|||
42197998|NCT00048581|76009661|FG001|Open-Label Period|Death|0|||
42197999|NCT00048581|76009662|FG002|Open-Label Period|Death|4|||
42198000|NCT00048581|76009660|FG000|Open-Label Period|Adverse Event|0|||
42198001|NCT00048581|76009661|FG001|Open-Label Period|Adverse Event|0|||
42198002|NCT00048581|76009662|FG002|Open-Label Period|Adverse Event|37|||
42198003|NCT00048581|76009660|FG000|Open-Label Period|Lack of Efficacy|0|||
42198004|NCT00048581|76009661|FG001|Open-Label Period|Lack of Efficacy|0|||
42198005|NCT00048581|76009662|FG002|Open-Label Period|Lack of Efficacy|69|||
42198006|NCT00048581|76009660|FG000|Open-Label Period|Lost to Follow-up|0|||
42198007|NCT00048581|76009661|FG001|Open-Label Period|Lost to Follow-up|0|||
42198008|NCT00048581|76009662|FG002|Open-Label Period|Lost to Follow-up|14|||
42198009|NCT00048581|76009660|FG000|Open-Label Period|Withdrawal by Subject|0|||
42198010|NCT00048581|76009661|FG001|Open-Label Period|Withdrawal by Subject|0|||
42198011|NCT00048581|76009662|FG002|Open-Label Period|Withdrawal by Subject|20|||
42198012|NCT00048581|76009660|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
42198013|NCT00048581|76009661|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
42198014|NCT00048581|76009662|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
42198015|NCT00048581|76009660|FG000|Open-Label Period|Poor/Non-compliance|0|||
42198016|NCT00048581|76009661|FG001|Open-Label Period|Poor/Non-compliance|0|||
42198017|NCT00048581|76009662|FG002|Open-Label Period|Poor/Non-compliance|5|||
42198018|NCT00048581|76009660|FG000|Open-Label Period|Pregnancy|0|||
42198019|NCT00048581|76009661|FG001|Open-Label Period|Pregnancy|0|||
42198020|NCT00048581|76009662|FG002|Open-Label Period|Pregnancy|7|||
42198021|NCT00048581|76009660|FG000|Open-Label Period|Study Site Closure|0|||
42198022|NCT00048581|76009661|FG001|Open-Label Period|Study Site Closure|0|||
42198023|NCT00048581|76009662|FG002|Open-Label Period|Study Site Closure|2|||
42198024|NCT00048581|76009660|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
42198025|NCT00048581|76009661|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
42368997|NCT01485861|76229969|FG003|Phase II|Death|71|||
42102805|NCT00658788|75913798|FG000|Overall Study|Treatment Discontinuation|32|||
42102806|NCT04829214|75913813|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
42102807|NCT04829214|75913814|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
42102808|NCT04829214|75913813|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
42102809|NCT04829214|75913814|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
42102810|NCT00562965|75913824|FG000|Overall Study|Withdrawal by Subject|0|||
42102811|NCT00562965|75913825|FG001|Overall Study|Withdrawal by Subject|1|||
42102812|NCT00562965|75913824|FG000|Overall Study|Death|2|||
42102813|NCT00562965|75913825|FG001|Overall Study|Death|4|||
42102814|NCT00562965|75913824|FG000|Overall Study|Lost to Follow-up|1|||
42102815|NCT00562965|75913825|FG001|Overall Study|Lost to Follow-up|0|||
42102816|NCT00562965|75913824|FG000|Overall Study|Other|0|||
42102817|NCT00562965|75913825|FG001|Overall Study|Other|1|||
42102818|NCT00537082|75913834|FG000|Overall Study|Adverse Event|6|||
42102819|NCT00537082|75913835|FG001|Overall Study|Adverse Event|6|||
42102820|NCT00537082|75913836|FG002|Overall Study|Adverse Event|3|||
42102821|NCT00537082|75913834|FG000|Overall Study|Protocol Violation|0|||
42102822|NCT00537082|75913835|FG001|Overall Study|Protocol Violation|2|||
42102823|NCT00537082|75913836|FG002|Overall Study|Protocol Violation|1|||
42102824|NCT00537082|75913834|FG000|Overall Study|Lack of Efficacy|0|||
42102825|NCT00537082|75913835|FG001|Overall Study|Lack of Efficacy|0|||
42198026|NCT00048581|76009662|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
42198027|NCT00048581|76009660|FG000|Open-Label Period|Problem With Transportation To Site|0|||
42198028|NCT00048581|76009661|FG001|Open-Label Period|Problem With Transportation To Site|0|||
42198029|NCT00048581|76009662|FG002|Open-Label Period|Problem With Transportation To Site|1|||
42198030|NCT00048581|76009660|FG000|Open-Label Period|Primary Investigator Retired|0|||
42198031|NCT00048581|76009661|FG001|Open-Label Period|Primary Investigator Retired|0|||
42368998|NCT01485861|76229970|FG004|Phase II|Death|68|||
42368999|NCT01485861|76229971|FG005|Phase II|Death|0|||
42369000|NCT01485861|76229966|FG000|Phase II|Progression of Disease|0|||
42369001|NCT01485861|76229967|FG001|Phase II|Progression of Disease|0|||
42369002|NCT01485861|76229968|FG002|Phase II|Progression of Disease|1|||
42102826|NCT00537082|75913836|FG002|Overall Study|Lack of Efficacy|2|||
42102827|NCT00537082|75913834|FG000|Overall Study|Withdrawal by Subject|0|||
42102828|NCT00537082|75913835|FG001|Overall Study|Withdrawal by Subject|1|||
42102829|NCT00537082|75913836|FG002|Overall Study|Withdrawal by Subject|0|||
42198032|NCT00048581|76009662|FG002|Open-Label Period|Primary Investigator Retired|2|||
42369003|NCT01485861|76229969|FG003|Phase II|Progression of Disease|0|||
42198033|NCT00048581|76009660|FG000|Open-Label Period|Study Ended By Sponsor|0|||
42198034|NCT00048581|76009661|FG001|Open-Label Period|Study Ended By Sponsor|0|||
42198035|NCT00048581|76009662|FG002|Open-Label Period|Study Ended By Sponsor|1|||
42198036|NCT00048347|76009675|FG000|Overall Study|Screen failure|2|||
42198037|NCT00065507|76009681|FG000|Overall Study|Death|16|||
42198038|NCT00065507|76009682|FG001|Overall Study|Death|17|||
42198039|NCT00065507|76009681|FG000|Overall Study|Adverse Event|4|||
42198040|NCT00065507|76009682|FG001|Overall Study|Adverse Event|3|||
42198041|NCT00065507|76009681|FG000|Overall Study|Lack of Efficacy|0|||
42198042|NCT00065507|76009682|FG001|Overall Study|Lack of Efficacy|6|||
42198043|NCT00065507|76009681|FG000|Overall Study|Poor/Non-compliance|3|||
42198044|NCT00065507|76009682|FG001|Overall Study|Poor/Non-compliance|2|||
42198045|NCT00065507|76009681|FG000|Overall Study|Lost to Follow-up|3|||
42198046|NCT00065507|76009682|FG001|Overall Study|Lost to Follow-up|0|||
42198047|NCT00065507|76009681|FG000|Overall Study|Subject Withdrew Consent|2|||
42102830|NCT00537082|75913834|FG000|Overall Study|Discontinued before initiating treatment|3|||
42102831|NCT00537082|75913835|FG001|Overall Study|Discontinued before initiating treatment|0|||
42102832|NCT00537082|75913836|FG002|Overall Study|Discontinued before initiating treatment|0|||
42102833|NCT03828487|75913844|FG000|Overall Study|Physician Decision|1|||
42102834|NCT00324961|75913848|FG000|Overall Study|Adverse Event|5|||
42102835|NCT00324961|75913848|FG000|Overall Study|Consent Withdrawn|11|||
42102836|NCT00324961|75913848|FG000|Overall Study|Lost to Follow-up|22|||
42102837|NCT00324961|75913848|FG000|Overall Study|Protocol Violation|3|||
42102838|NCT00324961|75913848|FG000|Overall Study|Other|2|||
42102839|NCT00324649|75913856|FG000|Overall Study|Adverse Event|1|||
42102840|NCT00324649|75913857|FG001|Overall Study|Adverse Event|4|||
42102841|NCT00324649|75913856|FG000|Overall Study|Withdrawal by Subject|0|||
42102842|NCT00324649|75913857|FG001|Overall Study|Withdrawal by Subject|1|||
42102843|NCT00324649|75913856|FG000|Overall Study|Noncompliance|1|||
42102844|NCT00324649|75913857|FG001|Overall Study|Noncompliance|0|||
42102845|NCT00656370|75913863|FG000|Overall Study|Screen Failures|7|||
42102846|NCT00656370|75913863|FG000|Overall Study|Alternates|3|||
42102847|NCT00680186|75913871|FG000|Overall Study|Adverse Event|47|||
42102848|NCT00680186|75913872|FG001|Overall Study|Adverse Event|44|||
42102849|NCT00680186|75913871|FG000|Overall Study|Protocol Violation|31|||
42102850|NCT00680186|75913872|FG001|Overall Study|Protocol Violation|26|||
42102851|NCT00680186|75913871|FG000|Overall Study|Lost to Follow-up|11|||
42102852|NCT00680186|75913872|FG001|Overall Study|Lost to Follow-up|6|||
42102853|NCT00680186|75913871|FG000|Overall Study|Withdrawal by Subject|32|||
42102854|NCT00680186|75913872|FG001|Overall Study|Withdrawal by Subject|39|||
42102855|NCT00680186|75913871|FG000|Overall Study|Other|4|||
42102856|NCT00680186|75913872|FG001|Overall Study|Other|1|||
42102857|NCT00656292|75913880|FG000|Overall Study|Withdrawal by Subject|2|||
42102858|NCT00656292|75913881|FG001|Overall Study|Withdrawal by Subject|3|||
42102859|NCT00656292|75913880|FG000|Overall Study|Screen failure|1|||
42102860|NCT00656292|75913881|FG001|Overall Study|Screen failure|2|||
42102861|NCT00352417|75913889|FG000|Overall Study|Adverse Event|1|||
42102862|NCT00352417|75913890|FG001|Overall Study|Adverse Event|0|||
42102863|NCT00352417|75913889|FG000|Overall Study|Protocol Violation|0|||
42102864|NCT00352417|75913890|FG001|Overall Study|Protocol Violation|2|||
42102865|NCT00352417|75913889|FG000|Overall Study|Withdrawal by Subject|1|||
42102866|NCT00352417|75913890|FG001|Overall Study|Withdrawal by Subject|2|||
42102867|NCT00352417|75913889|FG000|Overall Study|Lost to Follow-up|1|||
42102868|NCT00352417|75913890|FG001|Overall Study|Lost to Follow-up|0|||
42102869|NCT00352417|75913889|FG000|Overall Study|Schedule Change|2|||
42102870|NCT00352417|75913890|FG001|Overall Study|Schedule Change|1|||
42102871|NCT00323869|75913896|FG000|Overall Study|Death|1|||
42102872|NCT00323557|75913902|FG000|Overall Study|Physician Decision|1|||
42102873|NCT00323557|75913903|FG001|Overall Study|Physician Decision|0|||
42102874|NCT00558363|75913912|FG000|Overall Study|Physician Decision|18|||
42102875|NCT00558363|75913913|FG001|Overall Study|Physician Decision|4|||
42102876|NCT00558363|75913912|FG000|Overall Study|Withdrawal by Subject|11|||
42102877|NCT00558363|75913913|FG001|Overall Study|Withdrawal by Subject|4|||
42102878|NCT00558363|75913912|FG000|Overall Study|Adverse Event|5|||
42102879|NCT00558363|75913913|FG001|Overall Study|Adverse Event|5|||
42102880|NCT00558363|75913912|FG000|Overall Study|Lack of Efficacy|2|||
42102881|NCT00558363|75913913|FG001|Overall Study|Lack of Efficacy|2|||
42102882|NCT00558363|75913912|FG000|Overall Study|Protocol Violation|2|||
42102883|NCT00558363|75913913|FG001|Overall Study|Protocol Violation|1|||
42102884|NCT00558363|75913912|FG000|Overall Study|Lost to Follow-up|0|||
42102885|NCT00558363|75913913|FG001|Overall Study|Lost to Follow-up|1|||
42102886|NCT00558363|75913912|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
42102887|NCT00558363|75913913|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
42102888|NCT00558363|75913912|FG000|Overall Study|Randomized in Error|1|||
42102889|NCT00558363|75913913|FG001|Overall Study|Randomized in Error|2|||
42198048|NCT00065507|76009682|FG001|Overall Study|Subject Withdrew Consent|1|||
42198049|NCT00065507|76009681|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
42198050|NCT00065507|76009682|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
42198051|NCT00065429|76009699|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
42198052|NCT00065429|76009700|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
42198053|NCT00065429|76009701|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
42198054|NCT00065429|76009702|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
42198055|NCT00065429|76009703|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
42198056|NCT00065429|76009704|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
42198057|NCT00065429|76009705|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
42198058|NCT00065429|76009699|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
42198059|NCT00065429|76009700|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
42198060|NCT00065429|76009701|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
42198061|NCT00065429|76009702|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
42198062|NCT00065429|76009703|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
42198063|NCT00065429|76009704|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
42198064|NCT00065429|76009705|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
42198065|NCT00065429|76009699|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
42198066|NCT00065429|76009700|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
42198067|NCT00065429|76009701|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
42198068|NCT00065429|76009702|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
42198069|NCT00065429|76009703|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
42198070|NCT00065429|76009704|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
42198071|NCT00065429|76009705|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
42198072|NCT00065429|76009699|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
42198073|NCT00065429|76009700|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
42198074|NCT00065429|76009701|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
42198075|NCT00065429|76009702|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
42198076|NCT00065429|76009703|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
42198077|NCT00065429|76009704|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
42198078|NCT00065429|76009705|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
42198079|NCT00065429|76009699|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
42198080|NCT00065429|76009700|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
42198081|NCT00065429|76009701|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
42198082|NCT00065429|76009702|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
42198083|NCT00065429|76009703|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
42198084|NCT00065429|76009704|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
42198085|NCT00065429|76009705|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
42198086|NCT00065429|76009699|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
42198087|NCT00065429|76009700|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
42198088|NCT00065429|76009701|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
42198089|NCT00065429|76009702|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
42198090|NCT00065429|76009703|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
42198091|NCT00065429|76009704|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
42198092|NCT00065429|76009705|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
42198093|NCT00065429|76009699|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
42198094|NCT00065429|76009700|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
42198095|NCT00065429|76009701|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
42198096|NCT00065429|76009702|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
42198097|NCT00065429|76009703|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
42198098|NCT00065429|76009704|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
42198099|NCT00065429|76009705|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
42198100|NCT00048035|76009722|FG000|Core Period|Early Withdrawals|4|||
42198101|NCT00048035|76009723|FG001|Core Period|Early Withdrawals|2|||
42369004|NCT01485861|76229970|FG004|Phase II|Progression of Disease|0|||
42369005|NCT01485861|76229971|FG005|Phase II|Progression of Disease|0|||
42369006|NCT01485861|76229966|FG000|Phase II|Other|0|||
42369007|NCT01485861|76229967|FG001|Phase II|Other|0|||
42369008|NCT01485861|76229968|FG002|Phase II|Other|0|||
42369009|NCT01485861|76229969|FG003|Phase II|Other|1|||
42369010|NCT01485861|76229970|FG004|Phase II|Other|0|||
42369011|NCT01485861|76229971|FG005|Phase II|Other|0|||
42369012|NCT01485861|76229966|FG000|Phase II|Withdrawal by Subject|0|||
42369013|NCT01485861|76229967|FG001|Phase II|Withdrawal by Subject|0|||
42369014|NCT01485861|76229968|FG002|Phase II|Withdrawal by Subject|6|||
42369015|NCT01485861|76229969|FG003|Phase II|Withdrawal by Subject|3|||
42369016|NCT01485861|76229970|FG004|Phase II|Withdrawal by Subject|4|||
42369017|NCT01485861|76229971|FG005|Phase II|Withdrawal by Subject|0|||
42018665|NCT01256411|75826042|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
42198102|NCT00048035|76009724|FG002|Core Period|Early Withdrawals|1|||
42198103|NCT00048035|76009725|FG003|Core Period|Early Withdrawals|1|||
42198104|NCT00048035|76009726|FG004|Core Period|Early Withdrawals|1|||
42369018|NCT01485861|76229966|FG000|Phase II|Lost to Follow-up|0|||
42369019|NCT01485861|76229967|FG001|Phase II|Lost to Follow-up|0|||
42369020|NCT01485861|76229968|FG002|Phase II|Lost to Follow-up|2|||
42369021|NCT01485861|76229969|FG003|Phase II|Lost to Follow-up|3|||
42369022|NCT01485861|76229970|FG004|Phase II|Lost to Follow-up|5|||
42198105|NCT00048035|76009727|FG005|Core Period|Early Withdrawals|1|||
42198106|NCT00048035|76009728|FG006|Core Period|Early Withdrawals|0|||
42198107|NCT00048035|76009729|FG007|Core Period|Early Withdrawals|0|||
42198108|NCT00048035|76009722|FG000|Extension Year 1|Early Withdrawals|0|||
42198109|NCT00048035|76009723|FG001|Extension Year 1|Early Withdrawals|0|||
42198110|NCT00048035|76009724|FG002|Extension Year 1|Early Withdrawals|0|||
42198111|NCT00048035|76009725|FG003|Extension Year 1|Early Withdrawals|0|||
42198112|NCT00048035|76009726|FG004|Extension Year 1|Early Withdrawals|0|||
42198113|NCT00048035|76009727|FG005|Extension Year 1|Early Withdrawals|0|||
42198114|NCT00048035|76009728|FG006|Extension Year 1|Early Withdrawals|11|||
42198115|NCT00048035|76009729|FG007|Extension Year 1|Early Withdrawals|11|||
42198116|NCT00048035|76009722|FG000|Extension Year 2|Early Withdrawals|0|||
42198117|NCT00048035|76009723|FG001|Extension Year 2|Early Withdrawals|0|||
42198118|NCT00048035|76009724|FG002|Extension Year 2|Early Withdrawals|0|||
42198119|NCT00048035|76009725|FG003|Extension Year 2|Early Withdrawals|0|||
42198120|NCT00048035|76009726|FG004|Extension Year 2|Early Withdrawals|0|||
42198121|NCT00048035|76009727|FG005|Extension Year 2|Early Withdrawals|0|||
42198122|NCT00048035|76009728|FG006|Extension Year 2|Early Withdrawals|3|||
42198123|NCT00048035|76009729|FG007|Extension Year 2|Early Withdrawals|3|||
42198124|NCT00047879|76009746|FG000|Overall Study|Progressive disease|4|||
42198125|NCT00047879|76009747|FG001|Overall Study|Progressive disease|3|||
42198126|NCT00064337|76009753|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
42198127|NCT00064337|76009753|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
42198128|NCT00064337|76009753|FG000|PBSCC or Induction/PBSCC|Progression|3|||
42198129|NCT00064337|76009753|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
42198130|NCT00064337|76009753|FG000|PBSCC or Induction/PBSCC|Death|2|||
42198131|NCT00064337|76009753|FG000|Transplant|Adverse Event|9|||
42198132|NCT00064337|76009753|FG000|Transplant|Not protocol-specified|5|||
42198133|NCT00064337|76009753|FG000|Transplant|Death|3|||
42198134|NCT00064337|76009753|FG000|Transplant|Patient Refusal|2|||
42198135|NCT00064337|76009753|FG000|Transplant|Progression|2|||
42198136|NCT00064337|76009753|FG000|Maintenance|Adverse Event|3|||
42198137|NCT00064337|76009753|FG000|Maintenance|Progression|2|||
42198138|NCT00064337|76009753|FG000|Maintenance|On treatment at time of analysis|2|||
42198139|NCT00064337|76009753|FG000|Maintenance|Not protocol-specified|2|||
42198140|NCT00064337|76009753|FG000|Maintenance|Death|1|||
42198141|NCT00064259|76009760|FG000|Overall Study|Adverse Event|1|||
42198142|NCT00064259|76009761|FG001|Overall Study|Adverse Event|0|||
42198143|NCT00064259|76009762|FG002|Overall Study|Adverse Event|0|||
42198144|NCT00064259|76009763|FG003|Overall Study|Adverse Event|1|||
42198145|NCT00044213|76009772|FG000|Overall Study|Withdrawal by Subject|50|||
42198146|NCT00044213|76009773|FG001|Overall Study|Withdrawal by Subject|65|||
42198147|NCT00044213|76009774|FG002|Overall Study|Withdrawal by Subject|91|||
42198148|NCT00044213|76009775|FG003|Overall Study|Withdrawal by Subject|83|||
42198149|NCT00044213|76009772|FG000|Overall Study|Death|42|||
42198150|NCT00044213|76009773|FG001|Overall Study|Death|42|||
42369023|NCT01485861|76229971|FG005|Phase II|Lost to Follow-up|0|||
42369024|NCT01485861|76229966|FG000|Phase II|Study Ended|0|||
42369025|NCT01485861|76229967|FG001|Phase II|Study Ended|0|||
42369026|NCT01485861|76229968|FG002|Phase II|Study Ended|7|||
42369027|NCT01485861|76229969|FG003|Phase II|Study Ended|8|||
42369028|NCT01485861|76229970|FG004|Phase II|Study Ended|6|||
42369029|NCT01485861|76229971|FG005|Phase II|Study Ended|0|||
42369030|NCT01485861|76229966|FG000|Safety Phase|Death|0|||
42369031|NCT01485861|76229967|FG001|Safety Phase|Death|0|||
42369032|NCT01485861|76229968|FG002|Safety Phase|Death|0|||
42369033|NCT01485861|76229969|FG003|Safety Phase|Death|0|||
42369034|NCT01485861|76229970|FG004|Safety Phase|Death|0|||
42369035|NCT01485861|76229971|FG005|Safety Phase|Death|2|||
42369036|NCT01485861|76229966|FG000|Safety Phase|Adverse Event|0|||
42369037|NCT01485861|76229967|FG001|Safety Phase|Adverse Event|0|||
42369038|NCT01485861|76229968|FG002|Safety Phase|Adverse Event|0|||
42369039|NCT01485861|76229969|FG003|Safety Phase|Adverse Event|0|||
42369040|NCT01485861|76229970|FG004|Safety Phase|Adverse Event|0|||
42198151|NCT00044213|76009774|FG002|Overall Study|Death|42|||
42198152|NCT00044213|76009775|FG003|Overall Study|Death|49|||
42369041|NCT01485861|76229971|FG005|Safety Phase|Adverse Event|1|||
42369042|NCT01485861|76229966|FG000|Safety Phase|Other|0|||
42369043|NCT01485861|76229967|FG001|Safety Phase|Other|0|||
42198153|NCT00044213|76009772|FG000|Overall Study|Lost to Follow-up|8|||
42198154|NCT00044213|76009773|FG001|Overall Study|Lost to Follow-up|5|||
42198155|NCT00044213|76009774|FG002|Overall Study|Lost to Follow-up|5|||
42198156|NCT00044213|76009775|FG003|Overall Study|Lost to Follow-up|4|||
42198157|NCT00064025|76009785|FG000|Overall Study|Ineligible|4|||
42198158|NCT00064025|76009785|FG000|Overall Study|Inevaluable|3|||
42198159|NCT00043979|76009793|FG000|Period 1|recipient with progressive disease|7|||
42198160|NCT00043979|76009794|FG001|Period 1|recipient with progressive disease|4|||
42198161|NCT00043979|76009795|FG002|Period 1|recipient with progressive disease|3|||
42198162|NCT00039377|76009812|FG000|Initial Registration|Adverse Event|2|||
42369044|NCT01485861|76229968|FG002|Safety Phase|Other|0|||
42369045|NCT01485861|76229969|FG003|Safety Phase|Other|0|||
42369046|NCT01485861|76229970|FG004|Safety Phase|Other|0|||
42198163|NCT00039377|76009813|FG001|Initial Registration|Adverse Event|0|||
42198164|NCT00039377|76009814|FG002|Initial Registration|Adverse Event|0|||
42198165|NCT00039377|76009815|FG003|Initial Registration|Adverse Event|0|||
42369047|NCT01485861|76229971|FG005|Safety Phase|Other|5|||
42369048|NCT01485861|76229966|FG000|Safety Phase|Progression of Disease|0|||
42369049|NCT01485861|76229967|FG001|Safety Phase|Progression of Disease|0|||
42369050|NCT01485861|76229968|FG002|Safety Phase|Progression of Disease|0|||
42369051|NCT01485861|76229969|FG003|Safety Phase|Progression of Disease|0|||
42369052|NCT01485861|76229970|FG004|Safety Phase|Progression of Disease|0|||
42102890|NCT00558363|75913912|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
42102891|NCT00558363|75913913|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
42102892|NCT00323479|75913919|FG000|Overall Study|Adverse Event|2|||
42102893|NCT00323479|75913919|FG000|Overall Study|Withdrawal by Subject|2|||
42102894|NCT00323479|75913919|FG000|Overall Study|Protocol Violation|3|||
42102895|NCT00323479|75913919|FG000|Overall Study|house moving|1|||
42198166|NCT00039377|76009812|FG000|Initial Registration|Relapsed|6|||
42198167|NCT00039377|76009813|FG001|Initial Registration|Relapsed|0|||
42369053|NCT01485861|76229971|FG005|Safety Phase|Progression of Disease|9|||
42369054|NCT01485861|76229966|FG000|Safety Phase|Withdrawal by Subject|0|||
42369055|NCT01485861|76229967|FG001|Safety Phase|Withdrawal by Subject|0|||
42369056|NCT01485861|76229968|FG002|Safety Phase|Withdrawal by Subject|0|||
42369057|NCT01485861|76229969|FG003|Safety Phase|Withdrawal by Subject|0|||
42198168|NCT00039377|76009814|FG002|Initial Registration|Relapsed|0|||
42198169|NCT00039377|76009815|FG003|Initial Registration|Relapsed|0|||
42198170|NCT00039377|76009812|FG000|Initial Registration|Received non-protocol therapy|11|||
42198171|NCT00039377|76009813|FG001|Initial Registration|Received non-protocol therapy|0|||
42198172|NCT00039377|76009814|FG002|Initial Registration|Received non-protocol therapy|0|||
42198173|NCT00039377|76009815|FG003|Initial Registration|Received non-protocol therapy|0|||
42198174|NCT00039377|76009812|FG000|Initial Registration|Withdrawal by Subject|3|||
42198175|NCT00039377|76009813|FG001|Initial Registration|Withdrawal by Subject|0|||
42198176|NCT00039377|76009814|FG002|Initial Registration|Withdrawal by Subject|0|||
42198177|NCT00039377|76009815|FG003|Initial Registration|Withdrawal by Subject|0|||
42198178|NCT00154102|76009825|FG000|Overall Study|investigational study phase ongoing|7|||
42198179|NCT00154102|76009826|FG001|Overall Study|investigational study phase ongoing|2|||
42369058|NCT01485861|76229970|FG004|Safety Phase|Withdrawal by Subject|0|||
42369059|NCT01485861|76229971|FG005|Safety Phase|Withdrawal by Subject|6|||
42369060|NCT01485861|76229966|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
42369061|NCT01485861|76229967|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
42369062|NCT01485861|76229968|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
42369063|NCT01485861|76229969|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
42369064|NCT01485861|76229970|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
42369065|NCT01485861|76229971|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
42369066|NCT01101438|76230005|FG000|Overall Study|Withdrawal by Subject|8|||
42369067|NCT01101438|76230006|FG001|Overall Study|Withdrawal by Subject|9|||
42369068|NCT00966979|76230016|FG000|Overall Study|Death|1|||
42369069|NCT00966979|76230016|FG000|Overall Study|Lost to Follow-up|6|||
42369070|NCT00966979|76230016|FG000|Overall Study|Withdrawal by Subject|14|||
42369071|NCT00966979|76230016|FG000|Overall Study|Adverse Event|5|||
42369072|NCT00966979|76230016|FG000|Overall Study|Sponsor terminated early|49|||
42369073|NCT00966979|76230016|FG000|Overall Study|Censored because surgery not done|2|||
42369074|NCT00966979|76230016|FG000|Overall Study|Censored because study device was not implanted|14|||
42369075|NCT00966979|76230016|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
42369076|NCT00931606|76230034|FG000|Overall Study|Death|1|||
42369077|NCT00931606|76230035|FG001|Overall Study|Death|3|||
42369078|NCT00931606|76230036|FG002|Overall Study|Death|2|||
42369079|NCT00931606|76230037|FG003|Overall Study|Death|0|||
42369080|NCT00931606|76230034|FG000|Overall Study|Lost to Follow-up|0|||
42369081|NCT00931606|76230035|FG001|Overall Study|Lost to Follow-up|1|||
42369082|NCT00931606|76230036|FG002|Overall Study|Lost to Follow-up|0|||
42369083|NCT00931606|76230037|FG003|Overall Study|Lost to Follow-up|0|||
42369084|NCT00931606|76230034|FG000|Overall Study|Physician Decision|0|||
42369085|NCT00931606|76230035|FG001|Overall Study|Physician Decision|0|||
42369086|NCT00931606|76230036|FG002|Overall Study|Physician Decision|3|||
42369087|NCT00931606|76230037|FG003|Overall Study|Physician Decision|0|||
42369088|NCT00931606|76230034|FG000|Overall Study|Sponsor Decision|1|||
42369089|NCT00931606|76230035|FG001|Overall Study|Sponsor Decision|4|||
42369090|NCT00931606|76230036|FG002|Overall Study|Sponsor Decision|0|||
42369091|NCT00931606|76230037|FG003|Overall Study|Sponsor Decision|2|||
42102896|NCT00352105|75913923|FG000|Overall Study|Death|5|||
42102897|NCT00352105|75913923|FG000|Overall Study|Withdrawal by Subject|5|||
42198180|NCT03687502|76009849|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
42369092|NCT00931606|76230034|FG000|Overall Study|Withdrawal by Subject|3|||
42369093|NCT00931606|76230035|FG001|Overall Study|Withdrawal by Subject|1|||
42369094|NCT00931606|76230036|FG002|Overall Study|Withdrawal by Subject|1|||
42369095|NCT00931606|76230037|FG003|Overall Study|Withdrawal by Subject|1|||
42198181|NCT03687502|76009849|FG000|Overall Study|Lumason not available|1|||
42198182|NCT03654976|76009857|FG000|Overall Study|Withdrawal by Subject|12|||
42198183|NCT03654976|76009858|FG001|Overall Study|Withdrawal by Subject|11|||
42198184|NCT03654976|76009857|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
42198185|NCT03654976|76009858|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
42198186|NCT03654976|76009857|FG000|Overall Study|Adverse Event|5|||
42198187|NCT03654976|76009858|FG001|Overall Study|Adverse Event|0|||
42198188|NCT03654976|76009857|FG000|Overall Study|Lost to Follow-up|2|||
42198189|NCT03654976|76009858|FG001|Overall Study|Lost to Follow-up|0|||
42198190|NCT03654976|76009857|FG000|Overall Study|Lack of Efficacy|0|||
42198191|NCT03654976|76009858|FG001|Overall Study|Lack of Efficacy|1|||
42369096|NCT00706914|76230108|FG000|Overall Study|Lack of Efficacy|0|||
42369097|NCT00706914|76230109|FG001|Overall Study|Lack of Efficacy|1|||
42369098|NCT00706914|76230110|FG002|Overall Study|Lack of Efficacy|0|||
42369099|NCT00706914|76230108|FG000|Overall Study|Lost to Follow-up|1|||
42369100|NCT00706914|76230109|FG001|Overall Study|Lost to Follow-up|0|||
42369101|NCT00706914|76230110|FG002|Overall Study|Lost to Follow-up|0|||
42369102|NCT00706914|76230108|FG000|Overall Study|Adverse Event|2|||
42369103|NCT00706914|76230109|FG001|Overall Study|Adverse Event|2|||
42369104|NCT00706914|76230110|FG002|Overall Study|Adverse Event|0|||
42369105|NCT00706914|76230108|FG000|Overall Study|Protocol Violation|3|||
42369106|NCT00706914|76230109|FG001|Overall Study|Protocol Violation|1|||
42369107|NCT00706914|76230110|FG002|Overall Study|Protocol Violation|1|||
42369108|NCT01808651|76230217|FG000|Study Period 1|Lost to Follow-up|1|||
42369109|NCT01808651|76230218|FG001|Study Period 1|Lost to Follow-up|3|||
42369110|NCT01808651|76230219|FG002|Study Period 1|Lost to Follow-up|0|||
42369111|NCT01808651|76230217|FG000|Study Period 1|Protocol Violation|1|||
42369112|NCT01808651|76230218|FG001|Study Period 1|Protocol Violation|0|||
42369113|NCT01808651|76230219|FG002|Study Period 1|Protocol Violation|1|||
42369114|NCT01808651|76230217|FG000|Study Period 1|Physician Decision|3|||
42369115|NCT01808651|76230218|FG001|Study Period 1|Physician Decision|2|||
42369116|NCT01808651|76230219|FG002|Study Period 1|Physician Decision|0|||
42369117|NCT01808651|76230217|FG000|Study Period 1|Lack of Efficacy|2|||
42102898|NCT00352105|75913923|FG000|Overall Study|Lack of Efficacy|9|||
42102899|NCT00352105|75913923|FG000|Overall Study|Adverse Event|19|||
42102900|NCT00352105|75913923|FG000|Overall Study|Protocol Violation|2|||
42102901|NCT00350779|75913929|FG000|Overall Study|Adverse Event|4|||
42102902|NCT00350779|75913930|FG001|Overall Study|Adverse Event|2|||
42102903|NCT00350779|75913929|FG000|Overall Study|Lack of Efficacy|0|||
42102904|NCT00350779|75913930|FG001|Overall Study|Lack of Efficacy|4|||
42102905|NCT00350779|75913929|FG000|Overall Study|Lost to Follow-up|2|||
42102906|NCT00350779|75913930|FG001|Overall Study|Lost to Follow-up|0|||
42102907|NCT00350779|75913929|FG000|Overall Study|Physician Decision|2|||
42102908|NCT00350779|75913930|FG001|Overall Study|Physician Decision|4|||
42102909|NCT00350779|75913929|FG000|Overall Study|Protocol Violation|3|||
42102910|NCT00350779|75913930|FG001|Overall Study|Protocol Violation|1|||
42102911|NCT00350779|75913929|FG000|Overall Study|Withdrawal by Subject|9|||
42102912|NCT00350779|75913930|FG001|Overall Study|Withdrawal by Subject|8|||
42102913|NCT00350779|75913929|FG000|Overall Study|Patient Moved|2|||
42102914|NCT00350779|75913930|FG001|Overall Study|Patient Moved|1|||
42102915|NCT00350779|75913929|FG000|Overall Study|Non-compliance with study procedures|0|||
42102916|NCT00350779|75913930|FG001|Overall Study|Non-compliance with study procedures|1|||
42102917|NCT00350623|75913941|FG000|Overall Study|Lost to Follow-up|8|||
42102918|NCT00350623|75913942|FG001|Overall Study|Lost to Follow-up|3|||
42102919|NCT00350623|75913943|FG002|Overall Study|Lost to Follow-up|4|||
42102920|NCT00350623|75913941|FG000|Overall Study|Withdrawal by Subject|0|||
42102921|NCT00350623|75913942|FG001|Overall Study|Withdrawal by Subject|1|||
42102922|NCT00350623|75913943|FG002|Overall Study|Withdrawal by Subject|1|||
42102923|NCT00350623|75913941|FG000|Overall Study|patient traveling outside the country|0|||
42102924|NCT00350623|75913942|FG001|Overall Study|patient traveling outside the country|0|||
42198192|NCT00035555|76009867|FG000|Overall Study|Adverse Event|5|||
42369118|NCT01808651|76230218|FG001|Study Period 1|Lack of Efficacy|1|||
42369119|NCT01808651|76230219|FG002|Study Period 1|Lack of Efficacy|0|||
42369120|NCT01808651|76230217|FG000|Study Period 1|Adverse Event|10|||
42369121|NCT01808651|76230218|FG001|Study Period 1|Adverse Event|4|||
42369122|NCT01808651|76230219|FG002|Study Period 1|Adverse Event|1|||
42369123|NCT01808651|76230217|FG000|Study Period 1|Participant Decision|9|||
42369124|NCT01808651|76230218|FG001|Study Period 1|Participant Decision|7|||
42369125|NCT01808651|76230219|FG002|Study Period 1|Participant Decision|3|||
42102925|NCT00350623|75913943|FG002|Overall Study|patient traveling outside the country|1|||
42198193|NCT00035555|76009868|FG001|Overall Study|Adverse Event|8|||
42198194|NCT00035555|76009869|FG002|Overall Study|Adverse Event|9|||
42198195|NCT00035555|76009867|FG000|Overall Study|Allograft loss|1|||
42102926|NCT00656136|75913953|FG000|Overall Study|Progressive disease|177|||
42102927|NCT00656136|75913954|FG001|Overall Study|Progressive disease|322|||
42198196|NCT00035555|76009868|FG001|Overall Study|Allograft loss|1|||
42369126|NCT00706134|76230284|FG000|Overall Study|Adverse Event|8|||
42369127|NCT00706134|76230285|FG001|Overall Study|Adverse Event|7|||
42369128|NCT00706134|76230286|FG002|Overall Study|Adverse Event|2|||
42369129|NCT00706134|76230287|FG003|Overall Study|Adverse Event|3|||
42369130|NCT00706134|76230284|FG000|Overall Study|Lost to Follow-up|0|||
42369131|NCT00706134|76230285|FG001|Overall Study|Lost to Follow-up|1|||
42369132|NCT00706134|76230286|FG002|Overall Study|Lost to Follow-up|0|||
42369133|NCT00706134|76230287|FG003|Overall Study|Lost to Follow-up|0|||
42369134|NCT00706134|76230284|FG000|Overall Study|Protocol Violation|0|||
42369135|NCT00706134|76230285|FG001|Overall Study|Protocol Violation|6|||
42369136|NCT00706134|76230286|FG002|Overall Study|Protocol Violation|0|||
42369137|NCT00706134|76230287|FG003|Overall Study|Protocol Violation|3|||
42369138|NCT00706134|76230284|FG000|Overall Study|Withdrawal by Subject|1|||
42369139|NCT00706134|76230285|FG001|Overall Study|Withdrawal by Subject|2|||
42369140|NCT00706134|76230286|FG002|Overall Study|Withdrawal by Subject|1|||
42369141|NCT00706134|76230287|FG003|Overall Study|Withdrawal by Subject|0|||
42369142|NCT00706134|76230284|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
42369143|NCT00706134|76230285|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
42369144|NCT00706134|76230286|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
42369145|NCT00706134|76230287|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
42369146|NCT00706134|76230284|FG000|Overall Study|Did not meet study criteria|2|||
42369147|NCT00706134|76230285|FG001|Overall Study|Did not meet study criteria|0|||
42369148|NCT00706134|76230286|FG002|Overall Study|Did not meet study criteria|0|||
42369149|NCT00706134|76230287|FG003|Overall Study|Did not meet study criteria|0|||
42369150|NCT01808573|76230299|FG000|Overall Study|Death|212|||
42369151|NCT01808573|76230300|FG001|Overall Study|Death|240|||
42369152|NCT01808573|76230299|FG000|Overall Study|Withdrawal by Subject|12|||
42369153|NCT01808573|76230300|FG001|Overall Study|Withdrawal by Subject|10|||
42369154|NCT01808573|76230299|FG000|Overall Study|Lost to Follow-up|3|||
42369155|NCT01808573|76230300|FG001|Overall Study|Lost to Follow-up|0|||
42369156|NCT01808573|76230299|FG000|Overall Study|Discontinuation of study by sponsor|79|||
42369157|NCT01808573|76230300|FG001|Overall Study|Discontinuation of study by sponsor|64|||
42369158|NCT01808573|76230299|FG000|Overall Study|Randomized in Error|1|||
42369159|NCT01808573|76230300|FG001|Overall Study|Randomized in Error|0|||
42369160|NCT02246530|76230327|FG000|Overall Study|Lost to Follow-up|4|||
42369161|NCT02246530|76230328|FG001|Overall Study|Lost to Follow-up|0|||
42369162|NCT01808339|76230334|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
42369163|NCT01808339|76230335|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
42369164|NCT01808339|76230336|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
42369165|NCT01808339|76230337|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
42369166|NCT01808339|76230338|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
42369167|NCT01808339|76230339|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
42369168|NCT01808339|76230334|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42369169|NCT01808339|76230335|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
42369170|NCT01808339|76230336|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42369171|NCT01808339|76230337|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
42369172|NCT01808339|76230338|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42369173|NCT01808339|76230339|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
42369174|NCT01808339|76230334|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
42369175|NCT01808339|76230335|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
42369176|NCT01808339|76230336|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
42369177|NCT01808339|76230337|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
42369178|NCT01808339|76230338|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
42369179|NCT01808339|76230339|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
42369180|NCT02727660|76230389|FG000|Overall Study|Lack of Efficacy|40|||
42369181|NCT02727660|76230390|FG001|Overall Study|Lack of Efficacy|40|||
42369182|NCT02727660|76230391|FG002|Overall Study|Lack of Efficacy|70|||
42369183|NCT02727660|76230389|FG000|Overall Study|Adverse Event|28|||
42369184|NCT02727660|76230390|FG001|Overall Study|Adverse Event|21|||
42369185|NCT02727660|76230391|FG002|Overall Study|Adverse Event|32|||
42369186|NCT02727660|76230389|FG000|Overall Study|Withdrawal by Subject|26|||
42369187|NCT02727660|76230390|FG001|Overall Study|Withdrawal by Subject|25|||
42369188|NCT02727660|76230391|FG002|Overall Study|Withdrawal by Subject|30|||
42369189|NCT02727660|76230389|FG000|Overall Study|Physician Decision|3|||
42369190|NCT02727660|76230390|FG001|Overall Study|Physician Decision|8|||
42369191|NCT02727660|76230391|FG002|Overall Study|Physician Decision|14|||
42369192|NCT02727660|76230389|FG000|Overall Study|Lost to Follow-up|5|||
42369193|NCT02727660|76230390|FG001|Overall Study|Lost to Follow-up|9|||
42369194|NCT02727660|76230391|FG002|Overall Study|Lost to Follow-up|8|||
42369195|NCT02727660|76230389|FG000|Overall Study|Protocol Violation|7|||
42369196|NCT02727660|76230390|FG001|Overall Study|Protocol Violation|5|||
42369197|NCT02727660|76230391|FG002|Overall Study|Protocol Violation|5|||
42369198|NCT02727660|76230389|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
42198197|NCT00035555|76009869|FG002|Overall Study|Allograft loss|2|||
42198198|NCT00035555|76009867|FG000|Overall Study|Death|0|||
42198199|NCT00035555|76009868|FG001|Overall Study|Death|0|||
42198200|NCT00035555|76009869|FG002|Overall Study|Death|2|||
42198201|NCT00035555|76009867|FG000|Overall Study|Lost to Follow-up|0|||
42198202|NCT00035555|76009868|FG001|Overall Study|Lost to Follow-up|0|||
42198203|NCT00035555|76009869|FG002|Overall Study|Lost to Follow-up|1|||
42198204|NCT00035555|76009867|FG000|Overall Study|Noncompliance|0|||
42198205|NCT00035555|76009868|FG001|Overall Study|Noncompliance|1|||
42198206|NCT00035555|76009869|FG002|Overall Study|Noncompliance|1|||
42198207|NCT00035555|76009867|FG000|Overall Study|Prohibited medication|1|||
42198208|NCT00035555|76009868|FG001|Overall Study|Prohibited medication|1|||
42198209|NCT00035555|76009869|FG002|Overall Study|Prohibited medication|0|||
42198210|NCT00035555|76009867|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
42198211|NCT00035555|76009868|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
42198212|NCT00035555|76009869|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
42198213|NCT00035555|76009867|FG000|Overall Study|Withdrawal by Subject|2|||
42198214|NCT00035555|76009868|FG001|Overall Study|Withdrawal by Subject|0|||
42198215|NCT00035555|76009869|FG002|Overall Study|Withdrawal by Subject|2|||
42198216|NCT00035555|76009867|FG000|Overall Study|Investigator deemed not a good candidate|0|||
42198217|NCT00035555|76009868|FG001|Overall Study|Investigator deemed not a good candidate|0|||
42198218|NCT00035555|76009869|FG002|Overall Study|Investigator deemed not a good candidate|1|||
42198219|NCT00035555|76009867|FG000|Overall Study|Received cyclosporin in error|0|||
42198220|NCT00035555|76009868|FG001|Overall Study|Received cyclosporin in error|0|||
42198221|NCT00035555|76009869|FG002|Overall Study|Received cyclosporin in error|1|||
42198222|NCT03894046|76009881|FG000|Overall Study|Protocol Violation|1|||
42198223|NCT03894046|76009882|FG001|Overall Study|Protocol Violation|0|||
42198224|NCT03894046|76009883|FG002|Overall Study|Protocol Violation|0|||
42198225|NCT03894046|76009881|FG000|Overall Study|Adverse Event|0|||
42198226|NCT03894046|76009882|FG001|Overall Study|Adverse Event|1|||
42198227|NCT03894046|76009883|FG002|Overall Study|Adverse Event|0|||
42198228|NCT03894046|76009881|FG000|Overall Study|Withdrawal by Subject|2|||
42198229|NCT03894046|76009882|FG001|Overall Study|Withdrawal by Subject|3|||
42198230|NCT03894046|76009883|FG002|Overall Study|Withdrawal by Subject|1|||
42198231|NCT03894046|76009881|FG000|Overall Study|Death|15|||
42198232|NCT03894046|76009882|FG001|Overall Study|Death|21|||
42198233|NCT03894046|76009883|FG002|Overall Study|Death|4|||
42198234|NCT03894046|76009881|FG000|Overall Study|No growth of ABC|2|||
42198235|NCT03894046|76009882|FG001|Overall Study|No growth of ABC|1|||
42198236|NCT03894046|76009883|FG002|Overall Study|No growth of ABC|0|||
42198237|NCT03894046|76009881|FG000|Overall Study|Physician Decision|1|||
42198238|NCT03894046|76009882|FG001|Overall Study|Physician Decision|1|||
42198239|NCT03894046|76009883|FG002|Overall Study|Physician Decision|1|||
42198240|NCT03894046|76009881|FG000|Overall Study|Prohibited concomitant medication|1|||
42198241|NCT03894046|76009882|FG001|Overall Study|Prohibited concomitant medication|0|||
42198242|NCT03894046|76009883|FG002|Overall Study|Prohibited concomitant medication|0|||
42198243|NCT03894046|76009881|FG000|Overall Study|Transferred to other arm/group|1|||
42198244|NCT03894046|76009882|FG001|Overall Study|Transferred to other arm/group|1|||
42198245|NCT03894046|76009883|FG002|Overall Study|Transferred to other arm/group|0|||
42198246|NCT00033371|76009892|FG000|Overall Study|Adverse Event|1|||
42198247|NCT00033371|76009893|FG001|Overall Study|Adverse Event|5|||
42198248|NCT00033371|76009892|FG000|Overall Study|Lost to Follow-up|2|||
42198249|NCT00033371|76009893|FG001|Overall Study|Lost to Follow-up|1|||
42198250|NCT00033371|76009892|FG000|Overall Study|Withdrawal by Subject|3|||
42198251|NCT00033371|76009893|FG001|Overall Study|Withdrawal by Subject|3|||
42102928|NCT00656136|75913953|FG000|Overall Study|Other Adverse Event|5|||
42102929|NCT00656136|75913954|FG001|Overall Study|Other Adverse Event|51|||
42102930|NCT00656136|75913953|FG000|Overall Study|Protocol Violation|2|||
42102931|NCT00656136|75913954|FG001|Overall Study|Protocol Violation|3|||
42102932|NCT00656136|75913953|FG000|Overall Study|Patient refused to take study medication|7|||
42102933|NCT00656136|75913954|FG001|Overall Study|Patient refused to take study medication|10|||
42198252|NCT00033371|76009892|FG000|Overall Study|Disease Progression|0|||
42198253|NCT00033371|76009893|FG001|Overall Study|Disease Progression|1|||
42198254|NCT00081731|76009905|FG000|Overall Study|scientific integrity issue|8|||
42198255|NCT00081731|76009906|FG001|Overall Study|scientific integrity issue|8|||
42198256|NCT00079937|76009914|FG000|Overall Study|Adverse Event|2|||
42198257|NCT00079937|76009915|FG001|Overall Study|Adverse Event|1|||
42198258|NCT00079937|76009914|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42198259|NCT00079937|76009915|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42198260|NCT00079937|76009914|FG000|Overall Study|Subject no longer requires study drug|3|||
42198261|NCT00079937|76009915|FG001|Overall Study|Subject no longer requires study drug|0|||
42198262|NCT00079937|76009914|FG000|Overall Study|Protocol Violation|8|||
42198263|NCT00079937|76009915|FG001|Overall Study|Protocol Violation|6|||
42198264|NCT00079937|76009914|FG000|Overall Study|Withdrawal by Subject|21|||
42198265|NCT00079937|76009915|FG001|Overall Study|Withdrawal by Subject|7|||
42198266|NCT00079937|76009914|FG000|Overall Study|Lost to Follow-up|12|||
42198267|NCT00079937|76009915|FG001|Overall Study|Lost to Follow-up|5|||
42198268|NCT00079937|76009914|FG000|Overall Study|Administrative problems|22|||
42198269|NCT00079937|76009915|FG001|Overall Study|Administrative problems|11|||
42198270|NCT00909610|76009923|FG000|Period: First Intervention|Adverse Event|0|||
42198271|NCT00909610|76009924|FG001|Period: First Intervention|Adverse Event|1|||
42198272|NCT00909610|76009923|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
42198273|NCT00909610|76009924|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
42198274|NCT00909610|76009923|FG000|Period: Second Intervention|Adverse Event|1|||
42198275|NCT00909610|76009924|FG001|Period: Second Intervention|Adverse Event|0|||
42198276|NCT03126110|76009946|FG000|Phase 1|Death|2|||
42198277|NCT03126110|76009947|FG001|Phase 1|Death|2|||
42198278|NCT03126110|76009948|FG002|Phase 1|Death|4|||
42198279|NCT03126110|76009949|FG003|Phase 1|Death|3|||
42198280|NCT03126110|76009950|FG004|Phase 1|Death|4|||
42198281|NCT03126110|76009951|FG005|Phase 1|Death|4|||
42198282|NCT03126110|76009952|FG006|Phase 1|Death|3|||
42198283|NCT03126110|76009953|FG007|Phase 1|Death|4|||
42198284|NCT03126110|76009954|FG008|Phase 1|Death|5|||
42198285|NCT03126110|76009955|FG009|Phase 1|Death|2|||
42198286|NCT03126110|76009956|FG010|Phase 1|Death|6|||
42198287|NCT03126110|76009957|FG011|Phase 1|Death|0|||
42198288|NCT03126110|76009958|FG012|Phase 1|Death|0|||
42198289|NCT03126110|76009959|FG013|Phase 1|Death|0|||
42198290|NCT03126110|76009960|FG014|Phase 1|Death|0|||
42198291|NCT03126110|76009961|FG015|Phase 1|Death|0|||
42198292|NCT03126110|76009962|FG016|Phase 1|Death|0|||
42198293|NCT03126110|76009946|FG000|Phase 1|Lost to Follow-up|0|||
42198294|NCT03126110|76009947|FG001|Phase 1|Lost to Follow-up|1|||
42198295|NCT03126110|76009948|FG002|Phase 1|Lost to Follow-up|0|||
42198296|NCT03126110|76009949|FG003|Phase 1|Lost to Follow-up|0|||
42198297|NCT03126110|76009950|FG004|Phase 1|Lost to Follow-up|0|||
42198298|NCT03126110|76009951|FG005|Phase 1|Lost to Follow-up|0|||
42198299|NCT03126110|76009952|FG006|Phase 1|Lost to Follow-up|0|||
42198300|NCT03126110|76009953|FG007|Phase 1|Lost to Follow-up|0|||
42198301|NCT03126110|76009954|FG008|Phase 1|Lost to Follow-up|1|||
42198302|NCT03126110|76009955|FG009|Phase 1|Lost to Follow-up|0|||
42198303|NCT03126110|76009956|FG010|Phase 1|Lost to Follow-up|0|||
42198304|NCT03126110|76009957|FG011|Phase 1|Lost to Follow-up|0|||
42198305|NCT03126110|76009958|FG012|Phase 1|Lost to Follow-up|0|||
42198306|NCT03126110|76009959|FG013|Phase 1|Lost to Follow-up|0|||
42198307|NCT03126110|76009960|FG014|Phase 1|Lost to Follow-up|0|||
42198308|NCT03126110|76009961|FG015|Phase 1|Lost to Follow-up|0|||
42198309|NCT03126110|76009962|FG016|Phase 1|Lost to Follow-up|0|||
42198310|NCT03126110|76009946|FG000|Phase 1|Withdrawal by Subject|1|||
42198311|NCT03126110|76009947|FG001|Phase 1|Withdrawal by Subject|0|||
42198312|NCT03126110|76009948|FG002|Phase 1|Withdrawal by Subject|0|||
42198313|NCT03126110|76009949|FG003|Phase 1|Withdrawal by Subject|1|||
42198314|NCT03126110|76009950|FG004|Phase 1|Withdrawal by Subject|1|||
42198315|NCT03126110|76009951|FG005|Phase 1|Withdrawal by Subject|0|||
42198316|NCT03126110|76009952|FG006|Phase 1|Withdrawal by Subject|0|||
42198317|NCT03126110|76009953|FG007|Phase 1|Withdrawal by Subject|0|||
42198318|NCT03126110|76009954|FG008|Phase 1|Withdrawal by Subject|2|||
42198319|NCT03126110|76009955|FG009|Phase 1|Withdrawal by Subject|1|||
42198320|NCT03126110|76009956|FG010|Phase 1|Withdrawal by Subject|0|||
42198321|NCT03126110|76009957|FG011|Phase 1|Withdrawal by Subject|0|||
42198322|NCT03126110|76009958|FG012|Phase 1|Withdrawal by Subject|0|||
42198323|NCT03126110|76009959|FG013|Phase 1|Withdrawal by Subject|0|||
42198324|NCT03126110|76009960|FG014|Phase 1|Withdrawal by Subject|0|||
42198325|NCT03126110|76009961|FG015|Phase 1|Withdrawal by Subject|0|||
42198326|NCT03126110|76009962|FG016|Phase 1|Withdrawal by Subject|0|||
42198327|NCT03126110|76009946|FG000|Phase 1|Safety follow-up no longer necessary|1|||
42198328|NCT03126110|76009947|FG001|Phase 1|Safety follow-up no longer necessary|0|||
42198329|NCT03126110|76009948|FG002|Phase 1|Safety follow-up no longer necessary|0|||
42369199|NCT02727660|76230390|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
42369200|NCT02727660|76230391|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
42198330|NCT03126110|76009949|FG003|Phase 1|Safety follow-up no longer necessary|0|||
42198331|NCT03126110|76009950|FG004|Phase 1|Safety follow-up no longer necessary|0|||
42198332|NCT03126110|76009951|FG005|Phase 1|Safety follow-up no longer necessary|0|||
42198333|NCT03126110|76009952|FG006|Phase 1|Safety follow-up no longer necessary|0|||
42198334|NCT03126110|76009953|FG007|Phase 1|Safety follow-up no longer necessary|0|||
42198335|NCT03126110|76009954|FG008|Phase 1|Safety follow-up no longer necessary|0|||
42198336|NCT03126110|76009955|FG009|Phase 1|Safety follow-up no longer necessary|0|||
42198337|NCT03126110|76009956|FG010|Phase 1|Safety follow-up no longer necessary|0|||
42198338|NCT03126110|76009957|FG011|Phase 1|Safety follow-up no longer necessary|0|||
42198339|NCT03126110|76009958|FG012|Phase 1|Safety follow-up no longer necessary|0|||
42198340|NCT03126110|76009959|FG013|Phase 1|Safety follow-up no longer necessary|0|||
42198341|NCT03126110|76009960|FG014|Phase 1|Safety follow-up no longer necessary|0|||
42198342|NCT03126110|76009961|FG015|Phase 1|Safety follow-up no longer necessary|0|||
42198343|NCT03126110|76009962|FG016|Phase 1|Safety follow-up no longer necessary|0|||
42198344|NCT03126110|76009946|FG000|Phase 1|Survival follow-up no longer necessary|0|||
42198345|NCT03126110|76009947|FG001|Phase 1|Survival follow-up no longer necessary|0|||
42198346|NCT03126110|76009948|FG002|Phase 1|Survival follow-up no longer necessary|1|||
42198347|NCT03126110|76009949|FG003|Phase 1|Survival follow-up no longer necessary|0|||
42198348|NCT03126110|76009950|FG004|Phase 1|Survival follow-up no longer necessary|0|||
42198349|NCT03126110|76009951|FG005|Phase 1|Survival follow-up no longer necessary|0|||
42198350|NCT03126110|76009952|FG006|Phase 1|Survival follow-up no longer necessary|0|||
42198351|NCT03126110|76009953|FG007|Phase 1|Survival follow-up no longer necessary|0|||
42198352|NCT03126110|76009954|FG008|Phase 1|Survival follow-up no longer necessary|0|||
42198353|NCT03126110|76009955|FG009|Phase 1|Survival follow-up no longer necessary|0|||
42198354|NCT03126110|76009956|FG010|Phase 1|Survival follow-up no longer necessary|0|||
42198355|NCT03126110|76009957|FG011|Phase 1|Survival follow-up no longer necessary|0|||
42198356|NCT03126110|76009958|FG012|Phase 1|Survival follow-up no longer necessary|0|||
42198357|NCT03126110|76009959|FG013|Phase 1|Survival follow-up no longer necessary|0|||
42198358|NCT03126110|76009960|FG014|Phase 1|Survival follow-up no longer necessary|0|||
42198359|NCT03126110|76009961|FG015|Phase 1|Survival follow-up no longer necessary|0|||
42198360|NCT03126110|76009962|FG016|Phase 1|Survival follow-up no longer necessary|0|||
42369201|NCT02727660|76230389|FG000|Overall Study|Administrative Reasons|2|||
42369202|NCT02727660|76230390|FG001|Overall Study|Administrative Reasons|3|||
42369203|NCT02727660|76230391|FG002|Overall Study|Administrative Reasons|4|||
42369204|NCT01784861|76230405|FG000|Overall Study|Adverse Event|0|||
42369205|NCT01784861|76230406|FG001|Overall Study|Adverse Event|0|||
42369206|NCT01784861|76230407|FG002|Overall Study|Adverse Event|1|||
42369207|NCT01784861|76230408|FG003|Overall Study|Adverse Event|2|||
42369208|NCT01784861|76230409|FG004|Overall Study|Adverse Event|1|||
42369209|NCT01784861|76230410|FG005|Overall Study|Adverse Event|0|||
42369210|NCT01784861|76230405|FG000|Overall Study|Withdrawal by Subject|0|||
42369211|NCT01784861|76230406|FG001|Overall Study|Withdrawal by Subject|0|||
42369212|NCT01784861|76230407|FG002|Overall Study|Withdrawal by Subject|0|||
42369213|NCT01784861|76230408|FG003|Overall Study|Withdrawal by Subject|1|||
42369214|NCT01784861|76230409|FG004|Overall Study|Withdrawal by Subject|0|||
42369215|NCT01784861|76230410|FG005|Overall Study|Withdrawal by Subject|0|||
42369216|NCT01784861|76230405|FG000|Overall Study|Physician Decision|0|||
42369217|NCT01784861|76230406|FG001|Overall Study|Physician Decision|0|||
42369218|NCT01784861|76230407|FG002|Overall Study|Physician Decision|0|||
42369219|NCT01784861|76230408|FG003|Overall Study|Physician Decision|2|||
42369220|NCT01784861|76230409|FG004|Overall Study|Physician Decision|0|||
42369221|NCT01784861|76230410|FG005|Overall Study|Physician Decision|1|||
42369222|NCT02727192|76230484|FG000|Overall Study|Lost to Follow-up|1|||
42369223|NCT02727192|76230485|FG001|Overall Study|Lost to Follow-up|0|||
42369224|NCT02727192|76230486|FG002|Overall Study|Lost to Follow-up|0|||
42369225|NCT00705666|76230506|FG000|Overall Study|No post-treatment questionnaire|279|||
42369226|NCT00705666|76230506|FG000|Overall Study|Withdrawal by Subject|21|||
42369227|NCT00705666|76230506|FG000|Overall Study|Physician Decision|7|||
42369228|NCT00705666|76230506|FG000|Overall Study|Lost to Follow-up|5|||
42369229|NCT00705666|76230506|FG000|Overall Study|Death|1|||
42369230|NCT00705666|76230506|FG000|Overall Study|Adverse Event|4|||
42369231|NCT00705666|76230506|FG000|Overall Study|Other|12|||
42369232|NCT00705666|76230506|FG000|Overall Study|Other|2|||
42369233|NCT00705666|76230506|FG000|Overall Study|Lack of data|3|||
42369234|NCT00705666|76230506|FG000|Overall Study|Untreated|5|||
42369235|NCT02725866|76230665|FG000|Overall Study|Failure to return|6|||
42369236|NCT02725866|76230665|FG000|Overall Study|Withdrew consent|3|||
42369237|NCT02725866|76230665|FG000|Overall Study|Insufficient virological response|1|||
42369238|NCT02725866|76230665|FG000|Overall Study|Other, not specified|4|||
42369239|NCT02726022|76230701|FG000|Overall Study|Adverse Event|14|||
42369240|NCT02726022|76230701|FG000|Overall Study|Treatment Failure|8|||
42369241|NCT02726022|76230701|FG000|Overall Study|Poor Compliance|13|||
42369242|NCT02726022|76230701|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
42369243|NCT02725788|76230716|FG000|Overall Study|Lost to Follow-up|1|||
42369244|NCT02725788|76230717|FG001|Overall Study|Lost to Follow-up|1|||
42369245|NCT02725788|76230716|FG000|Overall Study|Protocol Violation|0|||
42369246|NCT02725788|76230717|FG001|Overall Study|Protocol Violation|1|||
42369247|NCT02725710|76230856|FG000|Overall Study|Lost to Follow-up|1|||
42369248|NCT02725710|76230857|FG001|Overall Study|Lost to Follow-up|0|||
42369249|NCT02724462|76230888|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
42369250|NCT02724462|76230889|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
42198361|NCT03126110|76009946|FG000|Phase 2|Study terminated by the sponsor|0|||
42198362|NCT03126110|76009947|FG001|Phase 2|Study terminated by the sponsor|0|||
42369251|NCT02724462|76230888|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
42369252|NCT02724462|76230889|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
42369253|NCT02724462|76230888|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
42369254|NCT02724462|76230889|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
42369255|NCT02724462|76230888|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
42369256|NCT02724462|76230889|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
42369257|NCT02724462|76230888|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
42369258|NCT02724462|76230889|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
42369259|NCT02724462|76230888|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
42369260|NCT02724462|76230889|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
42369261|NCT02725476|76230946|FG000|Overall Study|Physician Decision|2|||
42369262|NCT02725476|76230947|FG001|Overall Study|Physician Decision|0|||
42369263|NCT02725476|76230946|FG000|Overall Study|Adverse Event|1|||
42369264|NCT02725476|76230947|FG001|Overall Study|Adverse Event|1|||
42369265|NCT02725008|76231052|FG000|Overall Study|Lost to Follow-up|7|||
42369266|NCT02725008|76231053|FG001|Overall Study|Lost to Follow-up|9|||
42369267|NCT02725008|76231052|FG000|Overall Study|Withdrawal by Subject|2|||
42369268|NCT02725008|76231053|FG001|Overall Study|Withdrawal by Subject|2|||
42369269|NCT02725008|76231052|FG000|Overall Study|Admitted to hospital|0|||
42369270|NCT02725008|76231053|FG001|Overall Study|Admitted to hospital|1|||
42369271|NCT01807949|76231325|FG000|Overall Study|Adverse Event|1|||
42369272|NCT01807949|76231326|FG001|Overall Study|Adverse Event|2|||
42369273|NCT01807949|76231327|FG002|Overall Study|Adverse Event|2|||
42369274|NCT01807949|76231325|FG000|Overall Study|Withdrawal by Subject|1|||
42369275|NCT01807949|76231326|FG001|Overall Study|Withdrawal by Subject|2|||
42369276|NCT01807949|76231327|FG002|Overall Study|Withdrawal by Subject|2|||
42369277|NCT01807949|76231325|FG000|Overall Study|Non-Compliance|0|||
42369278|NCT01807949|76231326|FG001|Overall Study|Non-Compliance|0|||
42369279|NCT01807949|76231327|FG002|Overall Study|Non-Compliance|1|||
42369280|NCT01807949|76231325|FG000|Overall Study|Undefined|0|||
42369281|NCT01807949|76231326|FG001|Overall Study|Undefined|1|||
42369282|NCT01807949|76231327|FG002|Overall Study|Undefined|2|||
42369283|NCT01807949|76231325|FG000|Overall Study|Randomized But Not Treated|0|||
42102934|NCT00656136|75913953|FG000|Overall Study|Unknown and others|4|||
42102935|NCT00656136|75913954|FG001|Overall Study|Unknown and others|4|||
42102936|NCT00676520|75913960|FG000|Overall Study|Withdrawal by Subject|163|||
42198363|NCT03126110|76009948|FG002|Phase 2|Study terminated by the sponsor|0|||
42198364|NCT03126110|76009949|FG003|Phase 2|Study terminated by the sponsor|0|||
42198365|NCT03126110|76009950|FG004|Phase 2|Study terminated by the sponsor|0|||
42198366|NCT03126110|76009951|FG005|Phase 2|Study terminated by the sponsor|0|||
42369284|NCT01807949|76231326|FG001|Overall Study|Randomized But Not Treated|2|||
42369285|NCT01807949|76231327|FG002|Overall Study|Randomized But Not Treated|2|||
42369286|NCT01806779|76231339|FG000|Overall Study|Physician Decision|2|||
42369287|NCT01806779|76231340|FG001|Overall Study|Physician Decision|0|||
42369288|NCT01806779|76231341|FG002|Overall Study|Physician Decision|1|||
42369289|NCT01806779|76231339|FG000|Overall Study|Lack of Efficacy|1|||
42369290|NCT01806779|76231340|FG001|Overall Study|Lack of Efficacy|1|||
42369291|NCT01806779|76231341|FG002|Overall Study|Lack of Efficacy|0|||
42369292|NCT01806779|76231339|FG000|Overall Study|Lost to Follow-up|19|||
42369293|NCT01806779|76231340|FG001|Overall Study|Lost to Follow-up|20|||
42369294|NCT01806779|76231341|FG002|Overall Study|Lost to Follow-up|0|||
42369295|NCT01806779|76231339|FG000|Overall Study|Withdrawal by Subject|20|||
42102937|NCT00676520|75913960|FG000|Overall Study|Lost to Follow-up|162|||
42102938|NCT00676520|75913960|FG000|Overall Study|Death|159|||
42102939|NCT00676520|75913960|FG000|Overall Study|Physician Decision|20|||
42369296|NCT01806779|76231340|FG001|Overall Study|Withdrawal by Subject|23|||
42369297|NCT01806779|76231341|FG002|Overall Study|Withdrawal by Subject|22|||
42369298|NCT01607957|76231415|FG000|Overall Study|Not treated|1|||
42369299|NCT01607957|76231416|FG001|Overall Study|Not treated|1|||
42369300|NCT01607957|76231415|FG000|Overall Study|Death|367|||
42018666|NCT01256411|75826037|FG000|Extension by Maximum Treatment|Adverse Event|4|||
42018667|NCT01256411|75826038|FG001|Extension by Maximum Treatment|Adverse Event|2|||
42018668|NCT01256411|75826039|FG002|Extension by Maximum Treatment|Adverse Event|1|||
42102940|NCT00676520|75913960|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
42102941|NCT00676520|75913960|FG000|Overall Study|Other Reason|18|||
42102942|NCT00652938|75913972|FG000|Overall Study|Adverse Event|1|||
42102943|NCT00652938|75913973|FG001|Overall Study|Adverse Event|0|||
42102944|NCT00652938|75913974|FG002|Overall Study|Adverse Event|2|||
42102945|NCT00652938|75913972|FG000|Overall Study|Withdrawal by Subject|0|||
42102946|NCT00652938|75913973|FG001|Overall Study|Withdrawal by Subject|6|||
42018669|NCT01256411|75826040|FG003|Extension by Maximum Treatment|Adverse Event|0|||
42018670|NCT01256411|75826041|FG004|Extension by Maximum Treatment|Adverse Event|0|||
42018671|NCT01256411|75826042|FG005|Extension by Maximum Treatment|Adverse Event|0|||
42018672|NCT01256411|75826037|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
42018673|NCT01256411|75826038|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
42018674|NCT01256411|75826039|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
42102947|NCT00652938|75913974|FG002|Overall Study|Withdrawal by Subject|1|||
42198367|NCT03126110|76009952|FG006|Phase 2|Study terminated by the sponsor|0|||
42198368|NCT03126110|76009953|FG007|Phase 2|Study terminated by the sponsor|0|||
42369301|NCT01607957|76231416|FG001|Overall Study|Death|211|||
42369302|NCT01607957|76231415|FG000|Overall Study|Lost to Follow-up|3|||
42369303|NCT01607957|76231416|FG001|Overall Study|Lost to Follow-up|3|||
42369304|NCT01607957|76231415|FG000|Overall Study|Participant refusal|1|||
42198369|NCT03126110|76009954|FG008|Phase 2|Study terminated by the sponsor|0|||
42198370|NCT03126110|76009955|FG009|Phase 2|Study terminated by the sponsor|0|||
42198371|NCT03126110|76009956|FG010|Phase 2|Study terminated by the sponsor|0|||
42198372|NCT03126110|76009957|FG011|Phase 2|Study terminated by the sponsor|0|||
42198373|NCT03126110|76009958|FG012|Phase 2|Study terminated by the sponsor|0|||
42198374|NCT03126110|76009959|FG013|Phase 2|Study terminated by the sponsor|4|||
42198375|NCT03126110|76009960|FG014|Phase 2|Study terminated by the sponsor|0|||
42198376|NCT03126110|76009961|FG015|Phase 2|Study terminated by the sponsor|0|||
42198377|NCT03126110|76009962|FG016|Phase 2|Study terminated by the sponsor|0|||
42198378|NCT03126110|76009946|FG000|Phase 2|Withdrawal by Subject|0|||
42198379|NCT03126110|76009947|FG001|Phase 2|Withdrawal by Subject|0|||
42198380|NCT03126110|76009948|FG002|Phase 2|Withdrawal by Subject|0|||
42198381|NCT03126110|76009949|FG003|Phase 2|Withdrawal by Subject|0|||
42369305|NCT01607957|76231416|FG001|Overall Study|Participant refusal|0|||
42369306|NCT01806623|76231436|FG000|Overall Study|Withdrawal by Subject|1|||
42369307|NCT01806623|76231436|FG000|Overall Study|Adverse Event|1|||
42369308|NCT01806623|76231436|FG000|Overall Study|Did not meet the inclusion criteria|56|||
42369309|NCT01806545|76231442|FG000|Overall Study|Adverse Event|2|||
42369310|NCT01806545|76231443|FG001|Overall Study|Adverse Event|3|||
42369311|NCT01806545|76231442|FG000|Overall Study|Lost to Follow-up|1|||
42369312|NCT01806545|76231443|FG001|Overall Study|Lost to Follow-up|0|||
42369313|NCT01806545|76231442|FG000|Overall Study|Withdrawal by Subject|3|||
42369314|NCT01806545|76231443|FG001|Overall Study|Withdrawal by Subject|2|||
42369315|NCT01806389|76231449|FG000|Overall Study|Withdrawal by Subject|4|||
42369316|NCT01781975|76231718|FG000|Overall Study|Death|1|||
42369317|NCT01781975|76231719|FG001|Overall Study|Death|0|||
42369318|NCT01781975|76231718|FG000|Overall Study|Withdrawal by Subject|1|||
42369319|NCT01781975|76231719|FG001|Overall Study|Withdrawal by Subject|1|||
42369320|NCT01804673|76231740|FG000|Overall Study|Adverse Event|4|||
42369321|NCT01804673|76231740|FG000|Overall Study|Withdrawal by Subject|1|||
42369322|NCT01804673|76231740|FG000|Overall Study|Lack of Efficacy|9|||
42369323|NCT01804673|76231740|FG000|Overall Study|Change to Oral Therapy|37|||
42369324|NCT01804673|76231740|FG000|Overall Study|No Further Therapy Required|84|||
42369325|NCT01804673|76231740|FG000|Overall Study|Use of Prohibited Medication|1|||
42369326|NCT01804673|76231740|FG000|Overall Study|Other|4|||
42369327|NCT01774097|76231750|FG000|Overall Study|Withdrawal by Subject|1|||
42369328|NCT01774097|76231751|FG001|Overall Study|Withdrawal by Subject|1|||
42369329|NCT01774097|76231750|FG000|Overall Study|Adverse Event|1|||
42369330|NCT01774097|76231751|FG001|Overall Study|Adverse Event|1|||
42369331|NCT02859558|76231825|FG000|Step 1|Not Eligible|0|||
42369332|NCT02859558|76231826|FG001|Step 1|Not Eligible|0|||
42369333|NCT02859558|76231827|FG002|Step 1|Not Eligible|0|||
42369334|NCT02859558|76231828|FG003|Step 1|Not Eligible|0|||
42369335|NCT02859558|76231829|FG004|Step 1|Not Eligible|3|||
42369336|NCT02859558|76231825|FG000|Step 1|Lost to Follow-up|1|||
42369337|NCT02859558|76231826|FG001|Step 1|Lost to Follow-up|3|||
42369338|NCT02859558|76231827|FG002|Step 1|Lost to Follow-up|3|||
42369339|NCT02859558|76231828|FG003|Step 1|Lost to Follow-up|0|||
42369340|NCT02859558|76231829|FG004|Step 1|Lost to Follow-up|0|||
42369341|NCT02859558|76231825|FG000|Step 1|Did Not Return to Clinic|2|||
42369342|NCT02859558|76231826|FG001|Step 1|Did Not Return to Clinic|3|||
42369343|NCT02859558|76231827|FG002|Step 1|Did Not Return to Clinic|4|||
42369344|NCT02859558|76231828|FG003|Step 1|Did Not Return to Clinic|0|||
42369345|NCT02859558|76231829|FG004|Step 1|Did Not Return to Clinic|0|||
42369346|NCT02859558|76231825|FG000|Step 1|Moved|0|||
42369347|NCT02859558|76231826|FG001|Step 1|Moved|1|||
42198382|NCT03126110|76009950|FG004|Phase 2|Withdrawal by Subject|0|||
42369348|NCT02859558|76231827|FG002|Step 1|Moved|1|||
42369349|NCT02859558|76231828|FG003|Step 1|Moved|0|||
42018675|NCT01256411|75826040|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
42198383|NCT03126110|76009951|FG005|Phase 2|Withdrawal by Subject|0|||
42198384|NCT03126110|76009952|FG006|Phase 2|Withdrawal by Subject|0|||
42198385|NCT03126110|76009953|FG007|Phase 2|Withdrawal by Subject|0|||
42369350|NCT02859558|76231829|FG004|Step 1|Moved|0|||
42369351|NCT02859558|76231825|FG000|Step 1|Withdrawal By Participant|1|||
42369352|NCT02859558|76231826|FG001|Step 1|Withdrawal By Participant|2|||
42369353|NCT02859558|76231827|FG002|Step 1|Withdrawal By Participant|1|||
42369354|NCT02859558|76231828|FG003|Step 1|Withdrawal By Participant|0|||
42369355|NCT02859558|76231829|FG004|Step 1|Withdrawal By Participant|0|||
42369356|NCT02859558|76231825|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
42369357|NCT02859558|76231826|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
42369358|NCT02859558|76231827|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
42369359|NCT02859558|76231828|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
42369360|NCT02859558|76231829|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
42369361|NCT02859558|76231825|FG000|Step 1|Incarceration|0|||
42198386|NCT03126110|76009954|FG008|Phase 2|Withdrawal by Subject|0|||
42198387|NCT03126110|76009955|FG009|Phase 2|Withdrawal by Subject|0|||
42198388|NCT03126110|76009956|FG010|Phase 2|Withdrawal by Subject|0|||
42198389|NCT03126110|76009957|FG011|Phase 2|Withdrawal by Subject|1|||
42198390|NCT03126110|76009958|FG012|Phase 2|Withdrawal by Subject|3|||
42198391|NCT03126110|76009959|FG013|Phase 2|Withdrawal by Subject|3|||
42198392|NCT03126110|76009960|FG014|Phase 2|Withdrawal by Subject|2|||
42198393|NCT03126110|76009961|FG015|Phase 2|Withdrawal by Subject|1|||
42198394|NCT03126110|76009962|FG016|Phase 2|Withdrawal by Subject|0|||
42369362|NCT02859558|76231826|FG001|Step 1|Incarceration|1|||
42369363|NCT02859558|76231827|FG002|Step 1|Incarceration|0|||
42369364|NCT02859558|76231828|FG003|Step 1|Incarceration|0|||
42369365|NCT02859558|76231829|FG004|Step 1|Incarceration|0|||
42369366|NCT02859558|76231825|FG000|Step 1|Non-Adherence to Study Drug|2|||
42369367|NCT02859558|76231826|FG001|Step 1|Non-Adherence to Study Drug|0|||
42369368|NCT02859558|76231827|FG002|Step 1|Non-Adherence to Study Drug|1|||
42369369|NCT02859558|76231828|FG003|Step 1|Non-Adherence to Study Drug|0|||
42369370|NCT02859558|76231829|FG004|Step 1|Non-Adherence to Study Drug|0|||
42369371|NCT02859558|76231825|FG000|Step 1|Non-Adherence to Study Requirements|3|||
42369372|NCT02859558|76231826|FG001|Step 1|Non-Adherence to Study Requirements|1|||
42369373|NCT02859558|76231827|FG002|Step 1|Non-Adherence to Study Requirements|0|||
42369374|NCT02859558|76231828|FG003|Step 1|Non-Adherence to Study Requirements|0|||
42369375|NCT02859558|76231829|FG004|Step 1|Non-Adherence to Study Requirements|0|||
42369376|NCT02859558|76231825|FG000|Step 1|Virologic Failure|2|||
42369377|NCT02859558|76231826|FG001|Step 1|Virologic Failure|1|||
42369378|NCT02859558|76231827|FG002|Step 1|Virologic Failure|1|||
42369379|NCT02859558|76231828|FG003|Step 1|Virologic Failure|0|||
42369380|NCT02859558|76231829|FG004|Step 1|Virologic Failure|0|||
42369381|NCT02859558|76231825|FG000|Step 2|Active On Study|23|||
42369382|NCT02859558|76231826|FG001|Step 2|Active On Study|38|||
42369383|NCT02859558|76231827|FG002|Step 2|Active On Study|20|||
42369384|NCT02859558|76231828|FG003|Step 2|Active On Study|0|||
42369385|NCT02859558|76231829|FG004|Step 2|Active On Study|0|||
42369386|NCT02859558|76231825|FG000|Step 2|Did Not Return to Clinic|2|||
42369387|NCT02859558|76231826|FG001|Step 2|Did Not Return to Clinic|0|||
42369388|NCT02859558|76231827|FG002|Step 2|Did Not Return to Clinic|0|||
42369389|NCT02859558|76231828|FG003|Step 2|Did Not Return to Clinic|0|||
42369390|NCT02859558|76231829|FG004|Step 2|Did Not Return to Clinic|0|||
42369391|NCT02859558|76231825|FG000|Step 2|Unexpected Closure of Site|0|||
42369392|NCT02859558|76231826|FG001|Step 2|Unexpected Closure of Site|1|||
42369393|NCT02859558|76231827|FG002|Step 2|Unexpected Closure of Site|1|||
42369394|NCT02859558|76231828|FG003|Step 2|Unexpected Closure of Site|0|||
42369395|NCT02859558|76231829|FG004|Step 2|Unexpected Closure of Site|0|||
42369396|NCT00705432|76231880|FG000|Treatment Period|Adverse Event|45|||
42369397|NCT00705432|76231881|FG001|Treatment Period|Adverse Event|37|||
42369398|NCT00705432|76231882|FG002|Treatment Period|Adverse Event|51|||
42369399|NCT00705432|76231883|FG003|Treatment Period|Adverse Event|12|||
42369400|NCT00705432|76231884|FG004|Treatment Period|Adverse Event|8|||
42369401|NCT00705432|76231885|FG005|Treatment Period|Adverse Event|9|||
42102948|NCT00652938|75913972|FG000|Overall Study|Lost to Follow-up|0|||
42102949|NCT00652938|75913973|FG001|Overall Study|Lost to Follow-up|0|||
42102950|NCT00652938|75913974|FG002|Overall Study|Lost to Follow-up|2|||
42102951|NCT00652938|75913972|FG000|Overall Study|fear of blood sampling|0|||
42102952|NCT00652938|75913973|FG001|Overall Study|fear of blood sampling|1|||
42102953|NCT00652938|75913974|FG002|Overall Study|fear of blood sampling|0|||
42102954|NCT00322621|75913982|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
42102955|NCT00322621|75913983|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
42102956|NCT00322621|75913984|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
42102957|NCT00322621|75913982|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
42102958|NCT00322621|75913983|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
42102959|NCT00322621|75913984|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
42102960|NCT00322621|75913982|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
42102961|NCT00322621|75913983|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
42102962|NCT00322621|75913984|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
42102963|NCT00322621|75913982|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
42102964|NCT00322621|75913983|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
42369402|NCT00705432|76231880|FG000|Treatment Period|Treatment failure|92|||
42369403|NCT00705432|76231881|FG001|Treatment Period|Treatment failure|42|||
42369404|NCT00705432|76231882|FG002|Treatment Period|Treatment failure|33|||
42369405|NCT00705432|76231883|FG003|Treatment Period|Treatment failure|25|||
42369406|NCT00705432|76231884|FG004|Treatment Period|Treatment failure|13|||
42369407|NCT00705432|76231885|FG005|Treatment Period|Treatment failure|14|||
42369408|NCT00705432|76231880|FG000|Treatment Period|Non medical reason|26|||
42369409|NCT00705432|76231881|FG001|Treatment Period|Non medical reason|32|||
42102965|NCT00322621|75913984|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
42102966|NCT00322621|75913982|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
42102967|NCT00322621|75913983|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
42102968|NCT00322621|75913984|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
42102969|NCT00322621|75913982|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
42369410|NCT00705432|76231882|FG002|Treatment Period|Non medical reason|37|||
42369411|NCT00705432|76231883|FG003|Treatment Period|Non medical reason|4|||
42369412|NCT00705432|76231884|FG004|Treatment Period|Non medical reason|7|||
42369413|NCT00705432|76231885|FG005|Treatment Period|Non medical reason|7|||
42369414|NCT00705432|76231880|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
42369415|NCT00705432|76231881|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
42369416|NCT00705432|76231882|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
42369417|NCT00705432|76231883|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
42369418|NCT00705432|76231884|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
42369419|NCT00705432|76231885|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
42369420|NCT00705432|76231880|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
42369421|NCT00705432|76231881|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
42369422|NCT00705432|76231882|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
42369423|NCT00705432|76231883|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
42369424|NCT00705432|76231884|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
42369425|NCT00705432|76231885|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
42102970|NCT00322621|75913983|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
42102971|NCT00322621|75913984|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
42102972|NCT00322621|75913982|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
42102973|NCT00322621|75913983|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
42102974|NCT00322621|75913984|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
42102975|NCT00322621|75913982|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
42102976|NCT00322621|75913983|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
42102977|NCT00322621|75913984|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
42102978|NCT00322621|75913982|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
42102979|NCT00322621|75913983|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
42102980|NCT00322621|75913984|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
42102981|NCT00322621|75913982|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
42102982|NCT00322621|75913983|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
42102983|NCT00322621|75913984|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
42102984|NCT00322621|75913982|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
42102985|NCT00322621|75913983|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
42102986|NCT00322621|75913984|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
42102987|NCT00575042|75913997|FG000|Overall Study|Adverse Event|2|||
42102988|NCT00575042|75913997|FG000|Overall Study|Lost to Follow-up|1|||
42102989|NCT00676208|75914004|FG000|Overall Study|Lost to Follow-up|0|||
42102990|NCT00676208|75914005|FG001|Overall Study|Lost to Follow-up|2|||
42102991|NCT00676208|75914004|FG000|Overall Study|Incomplete data|2|||
42102992|NCT00676208|75914005|FG001|Overall Study|Incomplete data|4|||
42102993|NCT00656058|75914013|FG000|Overall Study|Withdrawal by Subject|2|||
42102994|NCT00656058|75914013|FG000|Overall Study|Withdrawal by Subject|4|||
42102995|NCT00537316|75914023|FG000|Part 1|Adverse Event|7|||
42102996|NCT00537316|75914024|FG001|Part 1|Adverse Event|11|||
42102997|NCT00537316|75914025|FG002|Part 1|Adverse Event|8|||
42102998|NCT00537316|75914026|FG003|Part 1|Adverse Event|0|||
42102999|NCT00537316|75914027|FG004|Part 1|Adverse Event|0|||
42103000|NCT00537316|75914028|FG005|Part 1|Adverse Event|0|||
42103001|NCT00537316|75914029|FG006|Part 1|Adverse Event|0|||
42103002|NCT00537316|75914023|FG000|Part 1|Protocol defined clinical event|1|||
42103003|NCT00537316|75914024|FG001|Part 1|Protocol defined clinical event|0|||
42103004|NCT00537316|75914025|FG002|Part 1|Protocol defined clinical event|0|||
42103005|NCT00537316|75914026|FG003|Part 1|Protocol defined clinical event|0|||
42103006|NCT00537316|75914027|FG004|Part 1|Protocol defined clinical event|0|||
42103007|NCT00537316|75914028|FG005|Part 1|Protocol defined clinical event|0|||
42103008|NCT00537316|75914029|FG006|Part 1|Protocol defined clinical event|0|||
42103009|NCT00537316|75914023|FG000|Part 1|Lost to Follow-up|1|||
42103010|NCT00537316|75914024|FG001|Part 1|Lost to Follow-up|0|||
42103011|NCT00537316|75914025|FG002|Part 1|Lost to Follow-up|0|||
42103012|NCT00537316|75914026|FG003|Part 1|Lost to Follow-up|0|||
42103013|NCT00537316|75914027|FG004|Part 1|Lost to Follow-up|0|||
42103014|NCT00537316|75914028|FG005|Part 1|Lost to Follow-up|0|||
42103015|NCT00537316|75914029|FG006|Part 1|Lost to Follow-up|0|||
42103016|NCT00537316|75914023|FG000|Part 1|Withdrawal by Subject|3|||
42103017|NCT00537316|75914024|FG001|Part 1|Withdrawal by Subject|8|||
42103018|NCT00537316|75914025|FG002|Part 1|Withdrawal by Subject|4|||
42198395|NCT03126110|76009946|FG000|Phase 2|Lost to Follow-up|0|||
42198396|NCT03126110|76009947|FG001|Phase 2|Lost to Follow-up|0|||
42198397|NCT03126110|76009948|FG002|Phase 2|Lost to Follow-up|0|||
42103019|NCT00537316|75914026|FG003|Part 1|Withdrawal by Subject|0|||
42103020|NCT00537316|75914027|FG004|Part 1|Withdrawal by Subject|0|||
42103021|NCT00537316|75914028|FG005|Part 1|Withdrawal by Subject|0|||
42198398|NCT03126110|76009949|FG003|Phase 2|Lost to Follow-up|0|||
42198399|NCT03126110|76009950|FG004|Phase 2|Lost to Follow-up|0|||
42198400|NCT03126110|76009951|FG005|Phase 2|Lost to Follow-up|0|||
42198401|NCT03126110|76009952|FG006|Phase 2|Lost to Follow-up|0|||
42198402|NCT03126110|76009953|FG007|Phase 2|Lost to Follow-up|0|||
42198403|NCT03126110|76009954|FG008|Phase 2|Lost to Follow-up|0|||
42198404|NCT03126110|76009955|FG009|Phase 2|Lost to Follow-up|0|||
42198405|NCT03126110|76009956|FG010|Phase 2|Lost to Follow-up|0|||
42198406|NCT03126110|76009957|FG011|Phase 2|Lost to Follow-up|1|||
42198407|NCT03126110|76009958|FG012|Phase 2|Lost to Follow-up|1|||
42198408|NCT03126110|76009959|FG013|Phase 2|Lost to Follow-up|1|||
42198409|NCT03126110|76009960|FG014|Phase 2|Lost to Follow-up|2|||
42198410|NCT03126110|76009961|FG015|Phase 2|Lost to Follow-up|0|||
42198411|NCT03126110|76009962|FG016|Phase 2|Lost to Follow-up|0|||
42198412|NCT03126110|76009946|FG000|Phase 2|Death|0|||
42198413|NCT03126110|76009947|FG001|Phase 2|Death|0|||
42198414|NCT03126110|76009948|FG002|Phase 2|Death|0|||
42198415|NCT03126110|76009949|FG003|Phase 2|Death|0|||
42198416|NCT03126110|76009950|FG004|Phase 2|Death|0|||
42198417|NCT03126110|76009951|FG005|Phase 2|Death|0|||
42198418|NCT03126110|76009952|FG006|Phase 2|Death|0|||
42198419|NCT03126110|76009953|FG007|Phase 2|Death|0|||
42198420|NCT03126110|76009954|FG008|Phase 2|Death|0|||
42198421|NCT03126110|76009955|FG009|Phase 2|Death|0|||
42198422|NCT03126110|76009956|FG010|Phase 2|Death|0|||
42198423|NCT03126110|76009957|FG011|Phase 2|Death|6|||
42198424|NCT03126110|76009958|FG012|Phase 2|Death|12|||
42198425|NCT03126110|76009959|FG013|Phase 2|Death|25|||
42198426|NCT03126110|76009960|FG014|Phase 2|Death|11|||
42198427|NCT03126110|76009961|FG015|Phase 2|Death|3|||
42198428|NCT03126110|76009962|FG016|Phase 2|Death|2|||
42198429|NCT03126110|76009946|FG000|Phase 2|Progressive Disease|0|||
42198430|NCT03126110|76009947|FG001|Phase 2|Progressive Disease|0|||
42198431|NCT03126110|76009948|FG002|Phase 2|Progressive Disease|0|||
42198432|NCT03126110|76009949|FG003|Phase 2|Progressive Disease|0|||
42198433|NCT03126110|76009950|FG004|Phase 2|Progressive Disease|0|||
42198434|NCT03126110|76009951|FG005|Phase 2|Progressive Disease|0|||
42198435|NCT03126110|76009952|FG006|Phase 2|Progressive Disease|0|||
42198436|NCT03126110|76009953|FG007|Phase 2|Progressive Disease|0|||
42198437|NCT03126110|76009954|FG008|Phase 2|Progressive Disease|0|||
42198438|NCT03126110|76009955|FG009|Phase 2|Progressive Disease|0|||
42198439|NCT03126110|76009956|FG010|Phase 2|Progressive Disease|0|||
42198440|NCT03126110|76009957|FG011|Phase 2|Progressive Disease|0|||
42198441|NCT03126110|76009958|FG012|Phase 2|Progressive Disease|0|||
42198442|NCT03126110|76009959|FG013|Phase 2|Progressive Disease|1|||
42198443|NCT03126110|76009960|FG014|Phase 2|Progressive Disease|0|||
42198444|NCT03126110|76009961|FG015|Phase 2|Progressive Disease|0|||
42198445|NCT03126110|76009962|FG016|Phase 2|Progressive Disease|0|||
42198446|NCT03126110|76009946|FG000|Phase 2|Started new treatment|0|||
42198447|NCT03126110|76009947|FG001|Phase 2|Started new treatment|0|||
42198448|NCT03126110|76009948|FG002|Phase 2|Started new treatment|0|||
42198449|NCT03126110|76009949|FG003|Phase 2|Started new treatment|0|||
42198450|NCT03126110|76009950|FG004|Phase 2|Started new treatment|0|||
42198451|NCT03126110|76009951|FG005|Phase 2|Started new treatment|0|||
42198452|NCT03126110|76009952|FG006|Phase 2|Started new treatment|0|||
42198453|NCT03126110|76009953|FG007|Phase 2|Started new treatment|0|||
42369426|NCT00704964|76231896|FG000|Overall Study|Not completed on time|328|||
42369427|NCT00704808|76231912|FG000|Overall Study|Discontinued prior to starting treatment|14|||
42369428|NCT00704808|76231912|FG000|Overall Study|Death|7|||
42369429|NCT00704808|76231912|FG000|Overall Study|Tumor progression|80|||
42369430|NCT00704808|76231912|FG000|Overall Study|Patient's decision|11|||
42369431|NCT00704808|76231912|FG000|Overall Study|Early therapy discontinuation|16|||
42369432|NCT00704808|76231912|FG000|Overall Study|Adverse Event|1|||
42369433|NCT00704808|76231912|FG000|Overall Study|Lost to Follow-up|1|||
42198454|NCT03126110|76009954|FG008|Phase 2|Started new treatment|0|||
42198455|NCT03126110|76009955|FG009|Phase 2|Started new treatment|0|||
42198456|NCT03126110|76009956|FG010|Phase 2|Started new treatment|0|||
42198457|NCT03126110|76009957|FG011|Phase 2|Started new treatment|0|||
42198458|NCT03126110|76009958|FG012|Phase 2|Started new treatment|0|||
42198459|NCT03126110|76009959|FG013|Phase 2|Started new treatment|0|||
42198460|NCT03126110|76009960|FG014|Phase 2|Started new treatment|1|||
42198461|NCT03126110|76009961|FG015|Phase 2|Started new treatment|0|||
42369434|NCT00704808|76231912|FG000|Overall Study|Treatment change|1|||
42198462|NCT03126110|76009962|FG016|Phase 2|Started new treatment|0|||
42198463|NCT00905164|76010012|FG000|Period 1|Protocol Violation|0|||
42369435|NCT01375608|76231947|FG000|Overall Study|Withdrawal by Subject|2|||
42198464|NCT00905164|76010013|FG001|Period 1|Protocol Violation|1|||
42198465|NCT03181958|76010020|FG000|Overall Study|Lost to Follow-up|17|||
42198466|NCT03181958|76010021|FG001|Overall Study|Lost to Follow-up|21|||
42198467|NCT03181958|76010022|FG002|Overall Study|Lost to Follow-up|15|||
42198468|NCT03165110|76010030|FG000|Overall Study|Anroid phone software incompatibility|1|||
42198469|NCT00079781|76010037|FG000|Pre-implant Period|Withdrawal by Subject|2|||
42198470|NCT00079781|76010038|FG001|Pre-implant Period|Withdrawal by Subject|0|||
42198471|NCT00079781|76010039|FG002|Pre-implant Period|Withdrawal by Subject|0|||
42198472|NCT00079781|76010037|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
42198473|NCT00079781|76010038|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
42198474|NCT00079781|76010039|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
42198475|NCT00079781|76010037|FG000|Follow-up Period|Withdrawal by Subject|3|||
42198476|NCT00079781|76010038|FG001|Follow-up Period|Withdrawal by Subject|0|||
42198477|NCT00079781|76010039|FG002|Follow-up Period|Withdrawal by Subject|1|||
42198478|NCT00079781|76010037|FG000|Follow-up Period|Lost to Follow-up|1|||
42198479|NCT00079781|76010038|FG001|Follow-up Period|Lost to Follow-up|0|||
42198480|NCT00079781|76010039|FG002|Follow-up Period|Lost to Follow-up|0|||
42198481|NCT00079781|76010037|FG000|Follow-up Period|Death|0|||
42198482|NCT00079781|76010038|FG001|Follow-up Period|Death|0|||
42198483|NCT00079781|76010039|FG002|Follow-up Period|Death|1|||
42198484|NCT03176966|76010047|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
42198485|NCT03176966|76010048|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
42198486|NCT03176966|76010047|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
42198487|NCT03176966|76010048|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
42198488|NCT03176966|76010047|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
42198489|NCT03176966|76010048|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
42198490|NCT03176966|76010047|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
42198491|NCT03176966|76010048|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
42198492|NCT03176966|76010047|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
42198493|NCT03176966|76010048|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
42198494|NCT03176966|76010047|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
42198495|NCT03176966|76010048|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
42369436|NCT00704418|76231962|FG000|Overall Study|Withdrawal by Subject|2|||
42369437|NCT00704418|76231963|FG001|Overall Study|Withdrawal by Subject|0|||
42369438|NCT00704418|76231962|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
42369439|NCT00704418|76231963|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
42369440|NCT00704340|76232032|FG000|Overall Study|Lost to Follow-up|2|||
42103022|NCT00537316|75914029|FG006|Part 1|Withdrawal by Subject|0|||
42103023|NCT00537316|75914023|FG000|Part 1|Protocol Violation|1|||
42103024|NCT00537316|75914024|FG001|Part 1|Protocol Violation|5|||
42103025|NCT00537316|75914025|FG002|Part 1|Protocol Violation|1|||
42198496|NCT03176966|76010047|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
42198497|NCT03176966|76010048|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
42369441|NCT00704340|76232033|FG001|Overall Study|Lost to Follow-up|1|||
42369442|NCT00704340|76232032|FG000|Overall Study|Death|0|||
42369443|NCT00704340|76232033|FG001|Overall Study|Death|1|||
42369444|NCT00552058|76232041|FG000|Overall Study|Adverse Event|8|||
42369445|NCT00552058|76232042|FG001|Overall Study|Adverse Event|7|||
42018676|NCT01256411|75826041|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
42018677|NCT01256411|75826042|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
42018678|NCT01256411|75826037|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
42018679|NCT01256411|75826038|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
42018680|NCT01256411|75826039|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
42018681|NCT01256411|75826040|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
42018682|NCT01256411|75826041|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
42018683|NCT01256411|75826042|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
42018684|NCT01256411|75826037|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
42018685|NCT01256411|75826038|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
42018686|NCT01256411|75826039|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
42018687|NCT01256411|75826040|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
42018688|NCT01256411|75826041|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
42018689|NCT01256411|75826042|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
42018690|NCT01256411|75826037|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
42018691|NCT01256411|75826038|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
42018692|NCT01256411|75826039|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
42018693|NCT01256411|75826040|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
42018694|NCT01256411|75826041|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
42018695|NCT01256411|75826042|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
42018696|NCT01256411|75826037|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
42018697|NCT01256411|75826038|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
42018698|NCT01256411|75826039|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
42018699|NCT01256411|75826040|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
42018700|NCT01256411|75826041|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
42018701|NCT01256411|75826042|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
42198498|NCT03175562|76010054|FG000|Overall Study|Adverse Event|1|||
42198499|NCT03175562|76010054|FG000|Overall Study|Lost to Follow-up|3|||
42198500|NCT03175562|76010054|FG000|Overall Study|Withdrawal by Subject|7|||
42198501|NCT03175562|76010054|FG000|Overall Study|Other (Not Specified)|5|||
42198502|NCT00079391|76010061|FG000|Overall Study|Withdrawal by Subject|1|||
42198503|NCT03209570|76010069|FG000|Overall Study|Death|1|||
42198504|NCT03209570|76010070|FG001|Overall Study|Death|0|||
42198505|NCT03209570|76010069|FG000|Overall Study|Incomplete Data|8|||
42198506|NCT03209570|76010070|FG001|Overall Study|Incomplete Data|10|||
42198507|NCT03209570|76010069|FG000|Overall Study|Protocol Violation|1|||
42198508|NCT03209570|76010070|FG001|Overall Study|Protocol Violation|0|||
42198509|NCT03209570|76010069|FG000|Overall Study|Withdrawal by Subject|0|||
42198510|NCT03209570|76010070|FG001|Overall Study|Withdrawal by Subject|3|||
42198511|NCT03209492|76010076|FG000|Overall Study|Case Report Forms Uncollected|5|||
42198512|NCT03208244|76010080|FG000|Overall Study|Death|1|||
42198513|NCT03175172|76010084|FG000|Overall Study|Death|3|||
42198514|NCT03175172|76010084|FG000|Overall Study|Withdrawal by Subject|3|||
42198515|NCT03175172|76010084|FG000|Overall Study|Lost to Follow-up|1|||
42198516|NCT03175172|76010084|FG000|Overall Study|Study Terminated by Sponsor|3|||
42198517|NCT03172364|76010090|FG000|Overall Study|Adverse Event|1|||
42198518|NCT03172364|76010091|FG001|Overall Study|Adverse Event|1|||
42198519|NCT03172364|76010090|FG000|Overall Study|Protocol Violation|1|||
42198520|NCT03172364|76010091|FG001|Overall Study|Protocol Violation|0|||
42198521|NCT00078767|76010099|FG000|Overall Study|Withdrawal by Subject|1|||
42198522|NCT00078767|76010100|FG001|Overall Study|Withdrawal by Subject|1|||
42198523|NCT03208088|76010106|FG000|Period 2|Withdrawal by Subject|0|||
42198524|NCT03208088|76010107|FG001|Period 2|Withdrawal by Subject|0|||
42198525|NCT03208088|76010108|FG002|Period 2|Withdrawal by Subject|0|||
42198526|NCT03208088|76010109|FG003|Period 2|Withdrawal by Subject|0|||
42198527|NCT03208088|76010110|FG004|Period 2|Withdrawal by Subject|0|||
42198528|NCT03208088|76010111|FG005|Period 2|Withdrawal by Subject|0|||
42198529|NCT03208088|76010112|FG006|Period 2|Withdrawal by Subject|0|||
42198530|NCT03208088|76010113|FG007|Period 2|Withdrawal by Subject|0|||
42198531|NCT03208088|76010114|FG008|Period 2|Withdrawal by Subject|1|||
42198532|NCT03208088|76010115|FG009|Period 2|Withdrawal by Subject|0|||
42198533|NCT03208088|76010106|FG000|Period 3|Unsatisfactory Test Article|0|||
42198534|NCT03208088|76010107|FG001|Period 3|Unsatisfactory Test Article|0|||
42198535|NCT03208088|76010108|FG002|Period 3|Unsatisfactory Test Article|0|||
42198536|NCT03208088|76010109|FG003|Period 3|Unsatisfactory Test Article|1|||
42198537|NCT03208088|76010110|FG004|Period 3|Unsatisfactory Test Article|0|||
42198538|NCT03208088|76010111|FG005|Period 3|Unsatisfactory Test Article|0|||
42198539|NCT03208088|76010112|FG006|Period 3|Unsatisfactory Test Article|0|||
42198540|NCT03208088|76010113|FG007|Period 3|Unsatisfactory Test Article|0|||
42198541|NCT03208088|76010114|FG008|Period 3|Unsatisfactory Test Article|0|||
42198542|NCT03208088|76010115|FG009|Period 3|Unsatisfactory Test Article|0|||
42198543|NCT03208088|76010106|FG000|Period 4|Unsatisfactory Test Article|0|||
42198544|NCT03208088|76010107|FG001|Period 4|Unsatisfactory Test Article|0|||
42198545|NCT03208088|76010108|FG002|Period 4|Unsatisfactory Test Article|0|||
42198546|NCT03208088|76010109|FG003|Period 4|Unsatisfactory Test Article|1|||
42198547|NCT03208088|76010110|FG004|Period 4|Unsatisfactory Test Article|0|||
42198548|NCT03208088|76010111|FG005|Period 4|Unsatisfactory Test Article|0|||
42198549|NCT03208088|76010112|FG006|Period 4|Unsatisfactory Test Article|0|||
42198550|NCT03208088|76010113|FG007|Period 4|Unsatisfactory Test Article|0|||
42198551|NCT03208088|76010114|FG008|Period 4|Unsatisfactory Test Article|0|||
42198552|NCT03208088|76010115|FG009|Period 4|Unsatisfactory Test Article|0|||
42198553|NCT00078377|76010130|FG000|Overall Study|Adverse Event|2|||
42198554|NCT00078377|76010131|FG001|Overall Study|Adverse Event|5|||
42198555|NCT00078377|76010132|FG002|Overall Study|Adverse Event|1|||
42198556|NCT00078377|76010130|FG000|Overall Study|Lack of Efficacy|2|||
42198557|NCT00078377|76010131|FG001|Overall Study|Lack of Efficacy|0|||
42198558|NCT00078377|76010132|FG002|Overall Study|Lack of Efficacy|2|||
42198559|NCT00078377|76010130|FG000|Overall Study|Lost to Follow-up|0|||
42198560|NCT00078377|76010131|FG001|Overall Study|Lost to Follow-up|1|||
42198561|NCT00078377|76010132|FG002|Overall Study|Lost to Follow-up|1|||
42198562|NCT00078377|76010130|FG000|Overall Study|Physician Decision|2|||
42198563|NCT00078377|76010131|FG001|Overall Study|Physician Decision|0|||
42198564|NCT00078377|76010132|FG002|Overall Study|Physician Decision|0|||
42198565|NCT00078377|76010130|FG000|Overall Study|Withdrawal by Subject|3|||
42198566|NCT00078377|76010131|FG001|Overall Study|Withdrawal by Subject|4|||
42198567|NCT00078377|76010132|FG002|Overall Study|Withdrawal by Subject|4|||
42198568|NCT00078377|76010130|FG000|Overall Study|Miscellaneous|2|||
42198569|NCT00078377|76010131|FG001|Overall Study|Miscellaneous|6|||
42198570|NCT00078377|76010132|FG002|Overall Study|Miscellaneous|1|||
42198571|NCT00886600|76010145|FG000|Double-blind Monotherapy|Adverse Event|1|||
42198572|NCT00886600|76010146|FG001|Double-blind Monotherapy|Adverse Event|1|||
42198573|NCT00886600|76010147|FG002|Double-blind Monotherapy|Adverse Event|1|||
42198574|NCT00886600|76010148|FG003|Double-blind Monotherapy|Adverse Event|1|||
42198575|NCT00886600|76010145|FG000|Double-blind Monotherapy|Protocol Violation|0|||
42198576|NCT00886600|76010146|FG001|Double-blind Monotherapy|Protocol Violation|0|||
42198577|NCT00886600|76010147|FG002|Double-blind Monotherapy|Protocol Violation|0|||
42198578|NCT00886600|76010148|FG003|Double-blind Monotherapy|Protocol Violation|1|||
42198579|NCT00886600|76010145|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
42198580|NCT00886600|76010146|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
42198581|NCT00886600|76010147|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
42198582|NCT00886600|76010148|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
42198583|NCT00886600|76010145|FG000|Combination Therapy Period|Adverse Event|0|||
42198584|NCT00886600|76010146|FG001|Combination Therapy Period|Adverse Event|0|||
42198585|NCT00886600|76010147|FG002|Combination Therapy Period|Adverse Event|1|||
42198586|NCT00886600|76010148|FG003|Combination Therapy Period|Adverse Event|0|||
42198587|NCT00886600|76010145|FG000|Combination Therapy Period|Protocol Violation|0|||
42198588|NCT00886600|76010146|FG001|Combination Therapy Period|Protocol Violation|0|||
42198589|NCT00886600|76010147|FG002|Combination Therapy Period|Protocol Violation|1|||
42198590|NCT00886600|76010148|FG003|Combination Therapy Period|Protocol Violation|0|||
42198591|NCT03172130|76010156|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
42198592|NCT03172130|76010157|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
42198593|NCT00870688|76010173|FG000|Overall Study|Lost to Follow-up|2|||
42198594|NCT00870688|76010173|FG000|Overall Study|Death, Unrelated|1|||
42198595|NCT00870688|76010173|FG000|Overall Study|Granules in the Stools|1|||
42198596|NCT00869128|76010176|FG000|Overall Study|lack of Compliance|6|||
42198597|NCT00869128|76010177|FG001|Overall Study|lack of Compliance|6|||
42198598|NCT00077675|76010183|FG000|Overall Study|Adverse Event|1|||
42198599|NCT00077675|76010184|FG001|Overall Study|Adverse Event|2|||
42198600|NCT00077675|76010183|FG000|Overall Study|Lost to Follow-up|6|||
42198601|NCT00077675|76010184|FG001|Overall Study|Lost to Follow-up|3|||
42198602|NCT00077675|76010183|FG000|Overall Study|Withdrawal by Subject|1|||
42198603|NCT00077675|76010184|FG001|Overall Study|Withdrawal by Subject|0|||
42198604|NCT00077675|76010183|FG000|Overall Study|Other|0|||
42198605|NCT00077675|76010184|FG001|Overall Study|Other|1|||
42198606|NCT00077675|76010183|FG000|Overall Study|Never received study treatment|3|||
42198607|NCT00077675|76010184|FG001|Overall Study|Never received study treatment|3|||
42198608|NCT02576444|76010201|FG000|Overall Study|Death|1|||
42198609|NCT02576444|76010202|FG001|Overall Study|Death|1|||
42198610|NCT02576444|76010203|FG002|Overall Study|Death|0|||
42198611|NCT02576444|76010204|FG003|Overall Study|Death|0|||
42198612|NCT02576444|76010201|FG000|Overall Study|Withdrawal by Subject|0|||
42198613|NCT02576444|76010202|FG001|Overall Study|Withdrawal by Subject|0|||
42198614|NCT02576444|76010203|FG002|Overall Study|Withdrawal by Subject|2|||
42198615|NCT02576444|76010204|FG003|Overall Study|Withdrawal by Subject|0|||
42198616|NCT02576444|76010201|FG000|Overall Study|Adverse Event|0|||
42198617|NCT02576444|76010202|FG001|Overall Study|Adverse Event|0|||
42198618|NCT02576444|76010203|FG002|Overall Study|Adverse Event|1|||
42198619|NCT02576444|76010204|FG003|Overall Study|Adverse Event|0|||
42198620|NCT02576444|76010201|FG000|Overall Study|Physician Decision|0|||
42198621|NCT02576444|76010202|FG001|Overall Study|Physician Decision|0|||
42198622|NCT02576444|76010203|FG002|Overall Study|Physician Decision|1|||
42198623|NCT02576444|76010204|FG003|Overall Study|Physician Decision|0|||
42198624|NCT00850174|76010215|FG000|Washout: One Week|Withdrawal by Subject|0|||
42198625|NCT00850174|76010216|FG001|Washout: One Week|Withdrawal by Subject|2|||
42198626|NCT00850174|76010215|FG000|Second Intervention|Withdrawal by Subject|1|||
42198627|NCT00850174|76010216|FG001|Second Intervention|Withdrawal by Subject|0|||
42103026|NCT00537316|75914026|FG003|Part 1|Protocol Violation|0|||
42103027|NCT00537316|75914027|FG004|Part 1|Protocol Violation|0|||
42103028|NCT00537316|75914028|FG005|Part 1|Protocol Violation|0|||
42103029|NCT00537316|75914029|FG006|Part 1|Protocol Violation|0|||
42103030|NCT00537316|75914023|FG000|Part 1|Did not meet protocol eligibility|1|||
42103031|NCT00537316|75914024|FG001|Part 1|Did not meet protocol eligibility|3|||
42103032|NCT00537316|75914025|FG002|Part 1|Did not meet protocol eligibility|2|||
42103033|NCT00537316|75914026|FG003|Part 1|Did not meet protocol eligibility|0|||
42103034|NCT00537316|75914027|FG004|Part 1|Did not meet protocol eligibility|0|||
42198628|NCT00077207|76010227|FG000|Overall Study|Adverse Event|5|||
42198629|NCT00077207|76010227|FG000|Overall Study|Lack of Efficacy|12|||
42198630|NCT00077207|76010227|FG000|Overall Study|Physician Decision|6|||
42198631|NCT00077207|76010227|FG000|Overall Study|Withdrawal by Subject|6|||
42198632|NCT00077207|76010227|FG000|Overall Study|Ineligible|1|||
42198633|NCT03206918|76010232|FG000|Overall Study|Death|11|||
42369446|NCT00552058|76232041|FG000|Overall Study|Lack of Efficacy|1|||
42103035|NCT00537316|75914028|FG005|Part 1|Did not meet protocol eligibility|0|||
42198634|NCT03206918|76010232|FG000|Overall Study|Withdrawal by Subject|5|||
42198635|NCT03206918|76010232|FG000|Overall Study|Study terminated by sponsor|12|||
42198636|NCT03206918|76010232|FG000|Overall Study|Lost to Follow-up|3|||
42198637|NCT03206918|76010232|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
42198638|NCT03206216|76010239|FG000|Overall Study|Withdrawal by Subject|0|||
42198639|NCT03206216|76010240|FG001|Overall Study|Withdrawal by Subject|1|||
42198640|NCT03169244|76010248|FG000|Overall Study|Lost to Follow-up|1|||
42103036|NCT00537316|75914029|FG006|Part 1|Did not meet protocol eligibility|0|||
42198641|NCT03169244|76010249|FG001|Overall Study|Lost to Follow-up|2|||
42198642|NCT03169244|76010248|FG000|Overall Study|Adverse Event|1|||
42198643|NCT03169244|76010249|FG001|Overall Study|Adverse Event|0|||
42198644|NCT03169244|76010248|FG000|Overall Study|Withdrawal by Subject|2|||
42198645|NCT03169244|76010249|FG001|Overall Study|Withdrawal by Subject|2|||
42198646|NCT03169244|76010248|FG000|Overall Study|Physician Decision|1|||
42198647|NCT03169244|76010249|FG001|Overall Study|Physician Decision|0|||
42198648|NCT02486042|76010257|FG000|Overall Study|Physician Decision|1|||
42198649|NCT02486042|76010258|FG001|Overall Study|Physician Decision|7|||
42198650|NCT02486042|76010257|FG000|Overall Study|Hospital transfer|2|||
42198651|NCT02486042|76010258|FG001|Overall Study|Hospital transfer|2|||
42198652|NCT02486042|76010257|FG000|Overall Study|Withdrawal by Subject|0|||
42198653|NCT02486042|76010258|FG001|Overall Study|Withdrawal by Subject|2|||
42198654|NCT00057941|76010266|FG000|Overall Study|Death|1|||
42198655|NCT00057941|76010267|FG001|Overall Study|Death|2|||
42198656|NCT00057941|76010266|FG000|Overall Study|Adverse Event|7|||
42198657|NCT00057941|76010267|FG001|Overall Study|Adverse Event|9|||
42198658|NCT00057941|76010266|FG000|Overall Study|Lack of Efficacy|54|||
42198659|NCT00057941|76010267|FG001|Overall Study|Lack of Efficacy|53|||
42198660|NCT00057941|76010266|FG000|Overall Study|Withdrawal by Subject|6|||
42198661|NCT00057941|76010267|FG001|Overall Study|Withdrawal by Subject|1|||
42198662|NCT00057941|76010266|FG000|Overall Study|still on treatment|3|||
42198663|NCT00057941|76010267|FG001|Overall Study|still on treatment|1|||
42198664|NCT00057941|76010266|FG000|Overall Study|insurance, symptomatic deterioration|1|||
42198665|NCT00057941|76010267|FG001|Overall Study|insurance, symptomatic deterioration|3|||
42198666|NCT00057941|76010266|FG000|Overall Study|Ineligible|2|||
42198667|NCT00057941|76010267|FG001|Overall Study|Ineligible|5|||
42198668|NCT00075881|76010282|FG000|Overall Study|Lack of Efficacy|18|||
42198669|NCT00075881|76010282|FG000|Overall Study|Adverse Event|7|||
42198670|NCT00075881|76010282|FG000|Overall Study|Death|1|||
42198671|NCT00075881|76010282|FG000|Overall Study|Withdrawal by Subject|2|||
42198672|NCT00075881|76010282|FG000|Overall Study|Protocol Violation|4|||
42198673|NCT00075881|76010282|FG000|Overall Study|other complicating disease|3|||
42198674|NCT00075881|76010282|FG000|Overall Study|other|4|||
42198675|NCT00075881|76010282|FG000|Overall Study|missing data|2|||
42198676|NCT00075881|76010282|FG000|Overall Study|Ineligible|1|||
42198677|NCT00075881|76010282|FG000|Overall Study|never start protocol therapy|1|||
42198678|NCT00838630|76010290|FG000|First Intervention|Adverse Event|1|||
42198679|NCT00838630|76010291|FG001|First Intervention|Adverse Event|0|||
42198680|NCT00838630|76010290|FG000|Washout: 7 Days|Protocol Violation|1|||
42198681|NCT00838630|76010291|FG001|Washout: 7 Days|Protocol Violation|0|||
42198682|NCT02996474|76010295|FG000|Overall Study|Physician Decision|5|||
42198683|NCT03667924|76010302|FG000|Baseline Completed|Lost to Follow-up|0|||
42198684|NCT03667924|76010303|FG001|Baseline Completed|Lost to Follow-up|2|||
42198685|NCT03667924|76010304|FG002|Baseline Completed|Lost to Follow-up|0|||
42198686|NCT03667924|76010302|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
42198687|NCT03667924|76010303|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
42198688|NCT03667924|76010304|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
42198689|NCT03667924|76010302|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
42198690|NCT03667924|76010303|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
42198691|NCT03667924|76010304|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
42198692|NCT03667924|76010302|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
42198693|NCT03667924|76010303|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
42198694|NCT03667924|76010304|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
42198695|NCT03667924|76010302|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
42198696|NCT03667924|76010303|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
42198697|NCT03667924|76010304|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
42198698|NCT03667924|76010302|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
42198699|NCT03667924|76010303|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
42198700|NCT03667924|76010304|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
42198701|NCT03667924|76010302|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
42198702|NCT03667924|76010303|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
42369447|NCT00552058|76232042|FG001|Overall Study|Lack of Efficacy|5|||
42018702|NCT00996580|75826056|FG000|Overall Study|Adverse Event|466|||
42198703|NCT03667924|76010304|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
42198704|NCT03205046|76010316|FG000|Overall Study|Death|10|||
42198705|NCT03205046|76010317|FG001|Overall Study|Death|6|||
42198706|NCT03205046|76010316|FG000|Overall Study|Withdrawal by Subject|1|||
42198707|NCT03205046|76010317|FG001|Overall Study|Withdrawal by Subject|2|||
42198708|NCT03205046|76010316|FG000|Overall Study|Lost to Follow-up|0|||
42369448|NCT00552058|76232041|FG000|Overall Study|Lost to Follow-up|1|||
42369449|NCT00552058|76232042|FG001|Overall Study|Lost to Follow-up|0|||
42018703|NCT00996580|75826056|FG000|Overall Study|Lost to Follow-up|480|||
42198709|NCT03205046|76010317|FG001|Overall Study|Lost to Follow-up|1|||
42198710|NCT03205046|76010316|FG000|Overall Study|Study terminated by sponsor|2|||
42198711|NCT03205046|76010317|FG001|Overall Study|Study terminated by sponsor|1|||
42198712|NCT02339090|76010325|FG000|Overall Study|Adverse Event|1|||
42198713|NCT02339090|76010326|FG001|Overall Study|Adverse Event|0|||
42198714|NCT02339090|76010325|FG000|Overall Study|Lost to Follow-up|0|||
42198715|NCT02339090|76010326|FG001|Overall Study|Lost to Follow-up|1|||
42198716|NCT02339090|76010325|FG000|Overall Study|Non-compliance With Study Drug|0|||
42198717|NCT02339090|76010326|FG001|Overall Study|Non-compliance With Study Drug|1|||
42198718|NCT02339090|76010325|FG000|Overall Study|Withdrawal by Subject|2|||
42198719|NCT02339090|76010326|FG001|Overall Study|Withdrawal by Subject|1|||
42198720|NCT02339090|76010325|FG000|Overall Study|Poor Growth|3|||
42198721|NCT02339090|76010326|FG001|Overall Study|Poor Growth|0|||
42198722|NCT02339090|76010325|FG000|Overall Study|Randomized but not treated|0|||
42198723|NCT02339090|76010326|FG001|Overall Study|Randomized but not treated|2|||
42198724|NCT03331562|76010345|FG000|Overall Study|Adverse Event|2|||
42198725|NCT03331562|76010346|FG001|Overall Study|Adverse Event|0|||
42198726|NCT03331562|76010345|FG000|Overall Study|Death|1|||
42198727|NCT03331562|76010346|FG001|Overall Study|Death|0|||
42198728|NCT02038634|76010358|FG000|Overall Study|Lost to Follow-up|0|||
42198729|NCT02038634|76010359|FG001|Overall Study|Lost to Follow-up|1|||
42198730|NCT00836056|76010367|FG000|First Intervention|Adverse Event|1|||
42198731|NCT00836056|76010368|FG001|First Intervention|Adverse Event|0|||
42198732|NCT03200912|76010375|FG000|Overall Study|Adverse Event|3|||
42198733|NCT03200912|76010376|FG001|Overall Study|Adverse Event|0|||
42198734|NCT03200912|76010377|FG002|Overall Study|Adverse Event|0|||
42198735|NCT03200912|76010375|FG000|Overall Study|Withdrawal by Subject|1|||
42198736|NCT03200912|76010376|FG001|Overall Study|Withdrawal by Subject|2|||
42198737|NCT03200912|76010377|FG002|Overall Study|Withdrawal by Subject|4|||
42198738|NCT03200912|76010375|FG000|Overall Study|Non-compliance with study drug|0|||
42198739|NCT03200912|76010376|FG001|Overall Study|Non-compliance with study drug|1|||
42198740|NCT03200912|76010377|FG002|Overall Study|Non-compliance with study drug|0|||
42198741|NCT00835666|76010387|FG000|Washout|Protocol Violation|1|||
42198742|NCT00835666|76010388|FG001|Washout|Protocol Violation|0|||
42198743|NCT00835666|76010387|FG000|Washout|Withdrawal by Subject|1|||
42198744|NCT00835666|76010388|FG001|Washout|Withdrawal by Subject|0|||
42198745|NCT03200366|76010402|FG000|Patient Navigation Intervention Given|Death|0|||
42198746|NCT03200366|76010403|FG001|Patient Navigation Intervention Given|Death|2|||
42103037|NCT00537316|75914023|FG000|Part 1|Administrative|0|||
42103038|NCT00537316|75914024|FG001|Part 1|Administrative|0|||
42103039|NCT00537316|75914025|FG002|Part 1|Administrative|2|||
42103040|NCT00537316|75914026|FG003|Part 1|Administrative|0|||
42103041|NCT00537316|75914027|FG004|Part 1|Administrative|0|||
42103042|NCT00537316|75914028|FG005|Part 1|Administrative|0|||
42103043|NCT00537316|75914029|FG006|Part 1|Administrative|0|||
42103044|NCT00537316|75914023|FG000|Part 2|Never entered follow-up|0|||
42103045|NCT00537316|75914024|FG001|Part 2|Never entered follow-up|0|||
42103046|NCT00537316|75914025|FG002|Part 2|Never entered follow-up|0|||
42103047|NCT00537316|75914026|FG003|Part 2|Never entered follow-up|0|||
42103048|NCT00537316|75914027|FG004|Part 2|Never entered follow-up|0|||
42103049|NCT00537316|75914028|FG005|Part 2|Never entered follow-up|0|||
42103050|NCT00537316|75914029|FG006|Part 2|Never entered follow-up|1|||
42103051|NCT00537316|75914023|FG000|Part 2|Adverse Event|4|||
42103052|NCT00537316|75914024|FG001|Part 2|Adverse Event|0|||
42103053|NCT00537316|75914025|FG002|Part 2|Adverse Event|2|||
42103054|NCT00537316|75914026|FG003|Part 2|Adverse Event|0|||
42103055|NCT00537316|75914027|FG004|Part 2|Adverse Event|0|||
42103056|NCT00537316|75914028|FG005|Part 2|Adverse Event|0|||
42103057|NCT00537316|75914029|FG006|Part 2|Adverse Event|0|||
42103058|NCT00537316|75914023|FG000|Part 2|Lost to Follow-up|1|||
42103059|NCT00537316|75914024|FG001|Part 2|Lost to Follow-up|0|||
42198747|NCT03200366|76010404|FG002|Patient Navigation Intervention Given|Death|0|||
42198748|NCT03200366|76010402|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
42198749|NCT03200366|76010403|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
42198750|NCT03200366|76010404|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
42198751|NCT03200366|76010402|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
42103060|NCT00537316|75914025|FG002|Part 2|Lost to Follow-up|2|||
42198752|NCT03200366|76010403|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
42198753|NCT03200366|76010404|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
42198754|NCT03200366|76010402|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
42198755|NCT03200366|76010403|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
42198756|NCT03200366|76010404|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
42198757|NCT03200366|76010402|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
42369450|NCT00552058|76232041|FG000|Overall Study|Withdrawal by Subject|4|||
42103061|NCT00537316|75914026|FG003|Part 2|Lost to Follow-up|0|||
42103062|NCT00537316|75914027|FG004|Part 2|Lost to Follow-up|0|||
42103063|NCT00537316|75914028|FG005|Part 2|Lost to Follow-up|0|||
42198758|NCT03200366|76010403|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
42198759|NCT03200366|76010404|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
42198760|NCT03200366|76010402|FG000|6 Month Post-Baseline Interview|Death|1|||
42369451|NCT00552058|76232042|FG001|Overall Study|Withdrawal by Subject|4|||
42369452|NCT00552058|76232041|FG000|Overall Study|Other: Protocol Violation|0|||
42369453|NCT00552058|76232042|FG001|Overall Study|Other: Protocol Violation|1|||
42369454|NCT00552058|76232041|FG000|Overall Study|Other: Non Compliance|1|||
42369455|NCT00552058|76232042|FG001|Overall Study|Other: Non Compliance|2|||
42369456|NCT00552058|76232041|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
42369457|NCT00552058|76232042|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
42369458|NCT00552058|76232041|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
42369459|NCT00552058|76232042|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
42369460|NCT00552058|76232041|FG000|Overall Study|Other: Positive Stool Result|0|||
42369461|NCT00552058|76232042|FG001|Overall Study|Other: Positive Stool Result|1|||
42369462|NCT00552058|76232041|FG000|Overall Study|Other: Randomized in error|0|||
42369463|NCT00552058|76232042|FG001|Overall Study|Other: Randomized in error|1|||
42369464|NCT00552058|76232041|FG000|Overall Study|Other: Sponsors Decision|0|||
42369465|NCT00552058|76232042|FG001|Overall Study|Other: Sponsors Decision|1|||
42369466|NCT00552058|76232041|FG000|Overall Study|Other: Early Roll Over|1|||
42369467|NCT00552058|76232042|FG001|Overall Study|Other: Early Roll Over|0|||
42369468|NCT00550732|76232071|FG000|Overall Study|Death|4|||
42369469|NCT00550732|76232071|FG000|Overall Study|Withdrawal by Subject|2|||
42369470|NCT00550732|76232071|FG000|Overall Study|Physician Decision|2|||
42369471|NCT00550732|76232071|FG000|Overall Study|Lost to Follow-up|1|||
42369472|NCT00550732|76232071|FG000|Overall Study|Palliative care|1|||
42369473|NCT00550732|76232071|FG000|Overall Study|Adverse Event|1|||
42369474|NCT00550420|76232085|FG000|Overall Study|Adverse Event|28|||
42369475|NCT00550420|76232085|FG000|Overall Study|Lost to Follow-up|8|||
42369476|NCT00550420|76232085|FG000|Overall Study|Protocol Violation|11|||
42369477|NCT00550420|76232085|FG000|Overall Study|Withdrawal by Subject|30|||
42369478|NCT00550420|76232085|FG000|Overall Study|Still in study at termination|206|||
42369479|NCT00550420|76232085|FG000|Overall Study|Missing|2|||
42369480|NCT00550420|76232085|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
42369481|NCT00550420|76232085|FG000|Overall Study|Investigators opinion|1|||
42369482|NCT00550420|76232085|FG000|Overall Study|Lack of curative effect|1|||
42369483|NCT00550420|76232085|FG000|Overall Study|Unethical stop of enrollment|2|||
42369484|NCT00550420|76232085|FG000|Overall Study|Caregiver's decision to withdraw|1|||
42369485|NCT00550420|76232085|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
42369486|NCT00550420|76232085|FG000|Overall Study|Exclusion criteria|1|||
42369487|NCT00550420|76232085|FG000|Overall Study|Prohibited medicine|1|||
42369488|NCT00558064|76232097|FG000|Overall Study|Adverse Event|3|||
42369489|NCT00558064|76232098|FG001|Overall Study|Adverse Event|2|||
42369490|NCT00558064|76232097|FG000|Overall Study|Lack of Efficacy|0|||
42369491|NCT00558064|76232098|FG001|Overall Study|Lack of Efficacy|1|||
42369492|NCT00558064|76232097|FG000|Overall Study|Protocol Violation|1|||
42369493|NCT00558064|76232098|FG001|Overall Study|Protocol Violation|0|||
42369494|NCT00558064|76232097|FG000|Overall Study|Lost to Follow-up|0|||
42369495|NCT00558064|76232098|FG001|Overall Study|Lost to Follow-up|1|||
42369496|NCT00558064|76232097|FG000|Overall Study|Withdrawal by Subject|0|||
42369497|NCT00558064|76232098|FG001|Overall Study|Withdrawal by Subject|1|||
42369498|NCT00558064|76232097|FG000|Overall Study|No visit within allowance period|1|||
42369499|NCT00558064|76232098|FG001|Overall Study|No visit within allowance period|0|||
42369500|NCT00557830|76232107|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
42369501|NCT00557830|76232108|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
42369502|NCT00557830|76232109|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
42369503|NCT00557830|76232107|FG000|Screening Treatment Phase|Adverse Event|2|||
42369504|NCT00557830|76232108|FG001|Screening Treatment Phase|Adverse Event|0|||
42369505|NCT00557830|76232109|FG002|Screening Treatment Phase|Adverse Event|0|||
42369506|NCT00557830|76232107|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
42369507|NCT00557830|76232108|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
42103064|NCT00537316|75914029|FG006|Part 2|Lost to Follow-up|0|||
42198761|NCT03200366|76010403|FG001|6 Month Post-Baseline Interview|Death|1|||
42198762|NCT03200366|76010404|FG002|6 Month Post-Baseline Interview|Death|1|||
42198763|NCT03200366|76010402|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
42198764|NCT03200366|76010403|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
42198765|NCT03200366|76010404|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
42369508|NCT00557830|76232109|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
42369509|NCT00557440|76232120|FG000|Treatment Period 1|Adverse Event|0|||
42369510|NCT00557440|76232121|FG001|Treatment Period 1|Adverse Event|0|||
42369511|NCT00557440|76232122|FG002|Treatment Period 1|Adverse Event|1|||
42369512|NCT00556894|76232133|FG000|Overall Study|Adverse Event|2|||
42198766|NCT03200366|76010402|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
42369513|NCT00556894|76232134|FG001|Overall Study|Adverse Event|3|||
42369514|NCT00556894|76232135|FG002|Overall Study|Adverse Event|3|||
42198767|NCT03200366|76010403|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
42198768|NCT03200366|76010404|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
42198769|NCT03200366|76010402|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
42198770|NCT03200366|76010403|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
42198771|NCT03200366|76010404|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
42369515|NCT00556894|76232133|FG000|Overall Study|Death|1|||
42369516|NCT00556894|76232134|FG001|Overall Study|Death|0|||
42369517|NCT00556894|76232135|FG002|Overall Study|Death|0|||
42369518|NCT00556894|76232133|FG000|Overall Study|regulatory decision in Bulgaria|10|||
42369519|NCT00556894|76232134|FG001|Overall Study|regulatory decision in Bulgaria|14|||
42369520|NCT00556894|76232135|FG002|Overall Study|regulatory decision in Bulgaria|13|||
42369521|NCT00556894|76232133|FG000|Overall Study|Change in therapy|2|||
42369522|NCT00556894|76232134|FG001|Overall Study|Change in therapy|1|||
42369523|NCT00556894|76232135|FG002|Overall Study|Change in therapy|2|||
42369524|NCT00556894|76232133|FG000|Overall Study|Withdrawal by Subject|1|||
42369525|NCT00556894|76232134|FG001|Overall Study|Withdrawal by Subject|1|||
42369526|NCT00556894|76232135|FG002|Overall Study|Withdrawal by Subject|1|||
42369527|NCT02722044|76232143|FG000|Overall Study|Adverse Event|2|||
42369528|NCT02722044|76232143|FG000|Overall Study|Physician Decision|1|||
42369529|NCT02722044|76232143|FG000|Overall Study|Withdrawal by Subject|1|||
42369530|NCT02722044|76232143|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
42369531|NCT00556426|76232148|FG000|Overall Study|Withdrawal by Subject|3|||
42369532|NCT00556426|76232148|FG000|Overall Study|Death|6|||
42369533|NCT00555568|76232156|FG000|Overall Study|Lost to Follow-up|26|||
42369534|NCT00555568|76232157|FG001|Overall Study|Lost to Follow-up|16|||
42369535|NCT00555568|76232158|FG002|Overall Study|Lost to Follow-up|16|||
42369536|NCT00702702|76232169|FG000|Overall Study|Study prematurely terminated|56|||
42369537|NCT02721966|76232180|FG000|Overall Study|Protocol Violation|1|||
42369538|NCT02721966|76232181|FG001|Overall Study|Protocol Violation|0|||
42369539|NCT02721966|76232182|FG002|Overall Study|Protocol Violation|0|||
42369540|NCT02721966|76232183|FG003|Overall Study|Protocol Violation|0|||
42369541|NCT02721966|76232184|FG004|Overall Study|Protocol Violation|0|||
42369542|NCT02721966|76232180|FG000|Overall Study|Withdrawal by Subject|9|||
42369543|NCT02721966|76232181|FG001|Overall Study|Withdrawal by Subject|2|||
42369544|NCT02721966|76232182|FG002|Overall Study|Withdrawal by Subject|3|||
42369545|NCT02721966|76232183|FG003|Overall Study|Withdrawal by Subject|7|||
42369546|NCT02721966|76232184|FG004|Overall Study|Withdrawal by Subject|0|||
42369547|NCT02721966|76232180|FG000|Overall Study|Adverse Event|4|||
42369548|NCT02721966|76232181|FG001|Overall Study|Adverse Event|4|||
42369549|NCT02721966|76232182|FG002|Overall Study|Adverse Event|3|||
42369550|NCT02721966|76232183|FG003|Overall Study|Adverse Event|0|||
42369551|NCT02721966|76232184|FG004|Overall Study|Adverse Event|0|||
42198772|NCT03200366|76010402|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
42198773|NCT03200366|76010403|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
42198774|NCT03200366|76010404|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
42369552|NCT02721966|76232180|FG000|Overall Study|Death|1|||
42198775|NCT03200366|76010402|FG000|9 Month Post-Baseline Interview|Death|1|||
42198776|NCT03200366|76010403|FG001|9 Month Post-Baseline Interview|Death|1|||
42198777|NCT03200366|76010404|FG002|9 Month Post-Baseline Interview|Death|1|||
42198778|NCT03200366|76010402|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
42198779|NCT03200366|76010403|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
42198780|NCT03200366|76010404|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
42198781|NCT03200366|76010402|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
42198782|NCT03200366|76010403|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
42198783|NCT03200366|76010404|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
42198784|NCT03200366|76010402|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
42198785|NCT03200366|76010403|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
42198786|NCT03200366|76010404|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
42198787|NCT00835354|76010416|FG000|First Intervention|Adverse Event|0|||
42198788|NCT00835354|76010417|FG001|First Intervention|Adverse Event|1|||
42198789|NCT00835042|76010448|FG000|First Intervention|Withdrawal by Subject|3|||
42198790|NCT00835042|76010449|FG001|First Intervention|Withdrawal by Subject|0|||
42198791|NCT00835042|76010448|FG000|First Intervention|Adverse Event|1|||
42198792|NCT00835042|76010449|FG001|First Intervention|Adverse Event|2|||
42198793|NCT00835042|76010448|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
42369553|NCT02721966|76232181|FG001|Overall Study|Death|0|||
42369554|NCT02721966|76232182|FG002|Overall Study|Death|0|||
42369555|NCT02721966|76232183|FG003|Overall Study|Death|0|||
42369556|NCT02721966|76232184|FG004|Overall Study|Death|0|||
42369557|NCT02721966|76232180|FG000|Overall Study|Lack of Efficacy|7|||
42198794|NCT00835042|76010449|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
42198795|NCT00834418|76010486|FG000|Overall Study|Adverse Event|0|||
42198796|NCT00834418|76010487|FG001|Overall Study|Adverse Event|2|||
42198797|NCT00834340|76010493|FG000|Washout|Adverse Event|1|||
42369558|NCT02721966|76232181|FG001|Overall Study|Lack of Efficacy|4|||
42198798|NCT00834340|76010494|FG001|Washout|Adverse Event|0|||
42198799|NCT00834340|76010493|FG000|Washout|Withdrawal by Subject|1|||
42198800|NCT00834340|76010494|FG001|Washout|Withdrawal by Subject|0|||
42198801|NCT00151996|76010500|FG000|Overall Study|Adverse Event|3|||
42198802|NCT00151996|76010501|FG001|Overall Study|Adverse Event|2|||
42369559|NCT02721966|76232182|FG002|Overall Study|Lack of Efficacy|0|||
42369560|NCT02721966|76232183|FG003|Overall Study|Lack of Efficacy|0|||
42369561|NCT02721966|76232184|FG004|Overall Study|Lack of Efficacy|0|||
42369562|NCT02721966|76232180|FG000|Overall Study|Lost to Follow-up|0|||
42369563|NCT02721966|76232181|FG001|Overall Study|Lost to Follow-up|0|||
42369564|NCT02721966|76232182|FG002|Overall Study|Lost to Follow-up|3|||
42369565|NCT02721966|76232183|FG003|Overall Study|Lost to Follow-up|0|||
42369566|NCT02721966|76232184|FG004|Overall Study|Lost to Follow-up|0|||
42369567|NCT02721966|76232180|FG000|Overall Study|Physician Decision|1|||
42369568|NCT02721966|76232181|FG001|Overall Study|Physician Decision|1|||
42369569|NCT02721966|76232182|FG002|Overall Study|Physician Decision|0|||
42369570|NCT02721966|76232183|FG003|Overall Study|Physician Decision|0|||
42369571|NCT02721966|76232184|FG004|Overall Study|Physician Decision|0|||
42369572|NCT02721966|76232180|FG000|Overall Study|Pregnancy|1|||
42369573|NCT02721966|76232181|FG001|Overall Study|Pregnancy|0|||
42369574|NCT02721966|76232182|FG002|Overall Study|Pregnancy|0|||
42369575|NCT02721966|76232183|FG003|Overall Study|Pregnancy|0|||
42369576|NCT02721966|76232184|FG004|Overall Study|Pregnancy|0|||
42369577|NCT02721966|76232180|FG000|Overall Study|Did not continue to period 2|5|||
42369578|NCT02721966|76232181|FG001|Overall Study|Did not continue to period 2|12|||
42369579|NCT02721966|76232182|FG002|Overall Study|Did not continue to period 2|0|||
42369580|NCT02721966|76232183|FG003|Overall Study|Did not continue to period 2|0|||
42369581|NCT02721966|76232184|FG004|Overall Study|Did not continue to period 2|5|||
42369582|NCT00553462|76232192|FG000|Overall Study|Adverse Event|4|||
42369583|NCT00553462|76232192|FG000|Overall Study|Progression|4|||
42369584|NCT00553462|76232192|FG000|Overall Study|Withdrawal by Subject|5|||
42369585|NCT00553462|76232192|FG000|Overall Study|Physician Decision|1|||
42369586|NCT00553150|76232198|FG000|Overall Study|Withdrawal by Subject|0|||
42369587|NCT00553150|76232199|FG001|Overall Study|Withdrawal by Subject|0|||
42369588|NCT00553150|76232200|FG002|Overall Study|Withdrawal by Subject|0|||
42369589|NCT00553150|76232201|FG003|Overall Study|Withdrawal by Subject|2|||
42369590|NCT00553150|76232198|FG000|Overall Study|Protocol Violation|0|||
42369591|NCT00553150|76232199|FG001|Overall Study|Protocol Violation|0|||
42369592|NCT00553150|76232200|FG002|Overall Study|Protocol Violation|0|||
42369593|NCT00553150|76232201|FG003|Overall Study|Protocol Violation|1|||
42369594|NCT00553150|76232198|FG000|Overall Study|Ineligible|0|||
42369595|NCT00553150|76232199|FG001|Overall Study|Ineligible|0|||
42369596|NCT00553150|76232200|FG002|Overall Study|Ineligible|0|||
42369597|NCT00553150|76232201|FG003|Overall Study|Ineligible|1|||
42198803|NCT00151996|76010500|FG000|Overall Study|Withdrawal by Subject|1|||
42198804|NCT00151996|76010501|FG001|Overall Study|Withdrawal by Subject|1|||
42198805|NCT00151996|76010500|FG000|Overall Study|Protocol Violation|1|||
42198806|NCT00151996|76010501|FG001|Overall Study|Protocol Violation|2|||
42198807|NCT00151996|76010500|FG000|Overall Study|Sponsor's decision|0|||
42198808|NCT00151996|76010501|FG001|Overall Study|Sponsor's decision|2|||
42198809|NCT00830206|76010509|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
42198810|NCT00830206|76010510|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
42198811|NCT00829504|76010516|FG000|First Intervention|Adverse Event|1|||
42198812|NCT00829504|76010517|FG001|First Intervention|Adverse Event|0|||
42369598|NCT03301350|76232209|FG000|Overall Study|Withdrawal by Subject|4|||
42369599|NCT03301350|76232209|FG000|Overall Study|Adverse Event|1|||
42369600|NCT03301350|76232209|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
42369601|NCT03301350|76232209|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
42369602|NCT03301350|76232209|FG000|Overall Study|no detail provided|1|||
42369603|NCT04735432|76232216|FG000|Overall Study|Other - due to personal reason|1|||
42369604|NCT04735432|76232217|FG001|Overall Study|Other - due to personal reason|0|||
42369605|NCT04735432|76232216|FG000|Overall Study|Adverse Event|2|||
42369606|NCT04735432|76232217|FG001|Overall Study|Adverse Event|0|||
42369607|NCT02722278|76232226|FG000|Overall Study|Withdrawal by Subject|5|||
42369608|NCT02722278|76232227|FG001|Overall Study|Withdrawal by Subject|3|||
42369609|NCT02722278|76232226|FG000|Overall Study|Adverse Event|4|||
42369610|NCT02722278|76232227|FG001|Overall Study|Adverse Event|1|||
42198813|NCT00829504|76010516|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
42198814|NCT00829504|76010517|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
42369611|NCT02722278|76232226|FG000|Overall Study|Lost to Follow-up|2|||
42369612|NCT02722278|76232227|FG001|Overall Study|Lost to Follow-up|0|||
42369613|NCT02722278|76232226|FG000|Overall Study|Protocol Violation|1|||
42369614|NCT02722278|76232227|FG001|Overall Study|Protocol Violation|0|||
42198815|NCT00829504|76010516|FG000|Second Intervention|Physician Decision|1|||
42198816|NCT00829504|76010517|FG001|Second Intervention|Physician Decision|0|||
42369615|NCT02722278|76232226|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
42369616|NCT02722278|76232227|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
42369617|NCT02722278|76232226|FG000|Overall Study|Subject declined after tx assignment|0|||
42198817|NCT00829426|76010523|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
42198818|NCT00829426|76010524|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
42198819|NCT00152464|76010530|FG000|Overall Study|Adverse Event|3|||
42198820|NCT00152464|76010531|FG001|Overall Study|Adverse Event|6|||
42198821|NCT00152464|76010530|FG000|Overall Study|Lost to Follow-up|8|||
42198822|NCT00152464|76010531|FG001|Overall Study|Lost to Follow-up|4|||
42198823|NCT00152464|76010530|FG000|Overall Study|Protocol Violation|3|||
42198824|NCT00152464|76010531|FG001|Overall Study|Protocol Violation|1|||
42198825|NCT00152464|76010530|FG000|Overall Study|Withdrawal by Subject|21|||
42198826|NCT00152464|76010531|FG001|Overall Study|Withdrawal by Subject|22|||
42198827|NCT00152464|76010530|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
42198828|NCT00152464|76010531|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
42198829|NCT00152464|76010530|FG000|Overall Study|Eczema deterioration|0|||
42198830|NCT00152464|76010531|FG001|Overall Study|Eczema deterioration|1|||
42198831|NCT00152464|76010530|FG000|Overall Study|Parent decision|1|||
42198832|NCT00152464|76010531|FG001|Overall Study|Parent decision|1|||
42198833|NCT00152464|76010530|FG000|Overall Study|Investigator decision|1|||
42198834|NCT00152464|76010531|FG001|Overall Study|Investigator decision|0|||
42198835|NCT00152464|76010530|FG000|Overall Study|Lack of Efficacy|1|||
42198836|NCT00152464|76010531|FG001|Overall Study|Lack of Efficacy|0|||
42198837|NCT00152464|76010530|FG000|Overall Study|Eczema poorly controlled|1|||
42198838|NCT00152464|76010531|FG001|Overall Study|Eczema poorly controlled|0|||
42198839|NCT00152464|76010530|FG000|Overall Study|Patient relocated|1|||
42198840|NCT00152464|76010531|FG001|Overall Study|Patient relocated|0|||
42198841|NCT00674440|76010537|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
42198842|NCT00674440|76010537|FG000|Overall Study|did not have surgery, so unevaluable|7|||
42198843|NCT00674440|76010537|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
42198844|NCT02742766|76010561|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198845|NCT02742766|76010562|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198846|NCT02742766|76010563|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198847|NCT02742766|76010564|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198848|NCT02742766|76010565|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198849|NCT02742766|76010566|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198850|NCT02742766|76010567|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198851|NCT02742766|76010568|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198852|NCT02742766|76010569|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198853|NCT02742766|76010570|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198854|NCT02742766|76010571|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198855|NCT02742766|76010572|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42369618|NCT02722278|76232227|FG001|Overall Study|Subject declined after tx assignment|1|||
42369619|NCT02722278|76232226|FG000|Overall Study|Site closure not study related|0|||
42369620|NCT02722278|76232227|FG001|Overall Study|Site closure not study related|1|||
42369621|NCT00703092|76232235|FG000|Overall Study|Withdrawal by Subject|2|||
42369622|NCT02720484|76232239|FG000|Treatment on Study|Adverse Event|1|||
42369623|NCT02720484|76232239|FG000|Treatment on Study|Withdrawal by Subject|1|||
42369624|NCT02720484|76232239|FG000|Treatment on Study|Progressive Disease|4|||
42369625|NCT02720484|76232239|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
42369626|NCT02720484|76232239|FG000|Follow Up for 2 Years|Death|3|||
42369627|NCT02720484|76232239|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
42369628|NCT02715804|76232245|FG000|Overall Study|Death|222|||
42369629|NCT02715804|76232246|FG001|Overall Study|Death|106|||
42369630|NCT02715804|76232245|FG000|Overall Study|Withdrawal by Subject|5|||
42369631|NCT02715804|76232246|FG001|Overall Study|Withdrawal by Subject|4|||
42369632|NCT02715804|76232245|FG000|Overall Study|Other than specified|2|||
42369633|NCT02715804|76232246|FG001|Overall Study|Other than specified|3|||
42369634|NCT02717832|76232252|FG000|Overall Study|Inability to place IV|3|||
42369635|NCT02717754|76232263|FG000|Overall Study|Incorrect Infusion Duration|0|||
42369636|NCT02717754|76232264|FG001|Overall Study|Incorrect Infusion Duration|0|||
42103065|NCT00537316|75914023|FG000|Part 2|Withdrawal by Subject|5|||
42103066|NCT00537316|75914024|FG001|Part 2|Withdrawal by Subject|1|||
42103067|NCT00537316|75914025|FG002|Part 2|Withdrawal by Subject|4|||
42103068|NCT00537316|75914026|FG003|Part 2|Withdrawal by Subject|0|||
42103069|NCT00537316|75914027|FG004|Part 2|Withdrawal by Subject|0|||
42103070|NCT00537316|75914028|FG005|Part 2|Withdrawal by Subject|0|||
42103071|NCT00537316|75914029|FG006|Part 2|Withdrawal by Subject|0|||
42103072|NCT00537316|75914023|FG000|Part 2|Administrative|16|||
42103073|NCT00537316|75914024|FG001|Part 2|Administrative|8|||
42103074|NCT00537316|75914025|FG002|Part 2|Administrative|24|||
42198856|NCT02742766|76010573|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198857|NCT02742766|76010574|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
42103075|NCT00537316|75914026|FG003|Part 2|Administrative|3|||
42198858|NCT02742766|76010575|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198859|NCT02742766|76010576|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198860|NCT02742766|76010577|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198861|NCT02742766|76010578|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198862|NCT02742766|76010579|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
42198863|NCT02742766|76010561|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198864|NCT02742766|76010562|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198865|NCT02742766|76010563|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198866|NCT02742766|76010564|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198867|NCT02742766|76010565|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198868|NCT02742766|76010566|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198869|NCT02742766|76010567|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198870|NCT02742766|76010568|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198871|NCT02742766|76010569|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198872|NCT02742766|76010570|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198873|NCT02742766|76010571|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198874|NCT02742766|76010572|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198875|NCT02742766|76010573|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
42198876|NCT02742766|76010574|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
42198877|NCT02742766|76010575|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198878|NCT02742766|76010576|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
42198879|NCT02742766|76010577|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198880|NCT02742766|76010578|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198881|NCT02742766|76010579|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
42198882|NCT01468922|76010657|FG000|Overall Study|Screening failure|0|||
42198883|NCT01468922|76010658|FG001|Overall Study|Screening failure|0|||
42198884|NCT01468922|76010659|FG002|Overall Study|Screening failure|0|||
42198885|NCT01468922|76010660|FG003|Overall Study|Screening failure|0|||
42198886|NCT01468922|76010661|FG004|Overall Study|Screening failure|0|||
42198887|NCT01468922|76010662|FG005|Overall Study|Screening failure|0|||
42198888|NCT01468922|76010663|FG006|Overall Study|Screening failure|0|||
42198889|NCT01468922|76010664|FG007|Overall Study|Screening failure|0|||
42198890|NCT01468922|76010665|FG008|Overall Study|Screening failure|1|||
42198891|NCT01468922|76010657|FG000|Overall Study|Per patient choice|1|||
42198892|NCT01468922|76010658|FG001|Overall Study|Per patient choice|0|||
42198893|NCT01468922|76010659|FG002|Overall Study|Per patient choice|0|||
42198894|NCT01468922|76010660|FG003|Overall Study|Per patient choice|0|||
42198895|NCT01468922|76010661|FG004|Overall Study|Per patient choice|0|||
42198896|NCT01468922|76010662|FG005|Overall Study|Per patient choice|0|||
42198897|NCT01468922|76010663|FG006|Overall Study|Per patient choice|0|||
42198898|NCT01468922|76010664|FG007|Overall Study|Per patient choice|0|||
42198899|NCT01468922|76010665|FG008|Overall Study|Per patient choice|0|||
42198900|NCT01468922|76010657|FG000|Overall Study|Switched to alternative treatment|1|||
42198901|NCT01468922|76010658|FG001|Overall Study|Switched to alternative treatment|0|||
42198902|NCT01468922|76010659|FG002|Overall Study|Switched to alternative treatment|0|||
42198903|NCT01468922|76010660|FG003|Overall Study|Switched to alternative treatment|0|||
42198904|NCT01468922|76010661|FG004|Overall Study|Switched to alternative treatment|1|||
42198905|NCT01468922|76010662|FG005|Overall Study|Switched to alternative treatment|0|||
42198906|NCT01468922|76010663|FG006|Overall Study|Switched to alternative treatment|0|||
42198907|NCT01468922|76010664|FG007|Overall Study|Switched to alternative treatment|0|||
42198908|NCT01468922|76010665|FG008|Overall Study|Switched to alternative treatment|0|||
42198909|NCT01468922|76010657|FG000|Overall Study|Enrolled on new protocol|0|||
42198910|NCT01468922|76010658|FG001|Overall Study|Enrolled on new protocol|0|||
42198911|NCT01468922|76010659|FG002|Overall Study|Enrolled on new protocol|0|||
42198912|NCT01468922|76010660|FG003|Overall Study|Enrolled on new protocol|0|||
42198913|NCT01468922|76010661|FG004|Overall Study|Enrolled on new protocol|1|||
42198914|NCT01468922|76010662|FG005|Overall Study|Enrolled on new protocol|0|||
42198915|NCT01468922|76010663|FG006|Overall Study|Enrolled on new protocol|0|||
42198916|NCT01468922|76010664|FG007|Overall Study|Enrolled on new protocol|0|||
42198917|NCT01468922|76010665|FG008|Overall Study|Enrolled on new protocol|0|||
42198918|NCT01468922|76010657|FG000|Overall Study|Adverse Event|0|||
42198919|NCT01468922|76010658|FG001|Overall Study|Adverse Event|0|||
42369637|NCT02717754|76232265|FG002|Overall Study|Incorrect Infusion Duration|0|||
42369638|NCT02717754|76232266|FG003|Overall Study|Incorrect Infusion Duration|10|||
42369639|NCT02717754|76232267|FG004|Overall Study|Incorrect Infusion Duration|20|||
42369640|NCT02717754|76232268|FG005|Overall Study|Incorrect Infusion Duration|20|||
42369641|NCT02717130|76232278|FG000|Overall Study|Withdrawal by Subject|1|||
42198920|NCT01468922|76010659|FG002|Overall Study|Adverse Event|0|||
42198921|NCT01468922|76010660|FG003|Overall Study|Adverse Event|0|||
42198922|NCT01468922|76010661|FG004|Overall Study|Adverse Event|0|||
42198923|NCT01468922|76010662|FG005|Overall Study|Adverse Event|0|||
42198924|NCT01468922|76010663|FG006|Overall Study|Adverse Event|0|||
42198925|NCT01468922|76010664|FG007|Overall Study|Adverse Event|1|||
42198926|NCT01468922|76010665|FG008|Overall Study|Adverse Event|0|||
42198927|NCT01468922|76010657|FG000|Overall Study|Infection of blood|0|||
42198928|NCT01468922|76010658|FG001|Overall Study|Infection of blood|0|||
42198929|NCT01468922|76010659|FG002|Overall Study|Infection of blood|0|||
42198930|NCT01468922|76010660|FG003|Overall Study|Infection of blood|0|||
42369642|NCT02717130|76232278|FG000|Overall Study|Adverse Event|1|||
42198931|NCT01468922|76010661|FG004|Overall Study|Infection of blood|0|||
42198932|NCT01468922|76010662|FG005|Overall Study|Infection of blood|0|||
42198933|NCT01468922|76010663|FG006|Overall Study|Infection of blood|0|||
42198934|NCT01468922|76010664|FG007|Overall Study|Infection of blood|1|||
42198935|NCT01468922|76010665|FG008|Overall Study|Infection of blood|0|||
42198936|NCT01468922|76010657|FG000|Overall Study|Patient choice - surgery|0|||
42369643|NCT02717130|76232278|FG000|Overall Study|Physician Decision|1|||
42369644|NCT02717130|76232278|FG000|Overall Study|Study Closure|4|||
42369645|NCT02192502|76232298|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
42369646|NCT02192502|76232299|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
42369647|NCT02192502|76232298|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
42369648|NCT02192502|76232299|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
42369649|NCT02192502|76232298|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
42369650|NCT02192502|76232299|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
42369651|NCT01781429|76232320|FG000|Overall Study|Death|0|||
42369652|NCT01781429|76232321|FG001|Overall Study|Death|0|||
42369653|NCT01781429|76232322|FG002|Overall Study|Death|0|||
42369654|NCT01781429|76232323|FG003|Overall Study|Death|0|||
42369655|NCT01781429|76232324|FG004|Overall Study|Death|0|||
42369656|NCT01781429|76232325|FG005|Overall Study|Death|0|||
42369657|NCT01781429|76232326|FG006|Overall Study|Death|0|||
42369658|NCT01781429|76232327|FG007|Overall Study|Death|0|||
42369659|NCT01781429|76232328|FG008|Overall Study|Death|0|||
42369660|NCT01781429|76232329|FG009|Overall Study|Death|1|||
42369661|NCT01781429|76232330|FG010|Overall Study|Death|0|||
42369662|NCT01781429|76232331|FG011|Overall Study|Death|0|||
42369663|NCT01781429|76232332|FG012|Overall Study|Death|1|||
42369664|NCT01781429|76232333|FG013|Overall Study|Death|0|||
42369665|NCT01781429|76232334|FG014|Overall Study|Death|1|||
42369666|NCT01781429|76232335|FG015|Overall Study|Death|0|||
42369667|NCT01781429|76232320|FG000|Overall Study|Withdrawal by Subject|0|||
42369668|NCT01781429|76232321|FG001|Overall Study|Withdrawal by Subject|0|||
42369669|NCT01781429|76232322|FG002|Overall Study|Withdrawal by Subject|0|||
42369670|NCT01781429|76232323|FG003|Overall Study|Withdrawal by Subject|0|||
42369671|NCT01781429|76232324|FG004|Overall Study|Withdrawal by Subject|0|||
42369672|NCT01781429|76232325|FG005|Overall Study|Withdrawal by Subject|0|||
42369673|NCT01781429|76232326|FG006|Overall Study|Withdrawal by Subject|0|||
42369674|NCT01781429|76232327|FG007|Overall Study|Withdrawal by Subject|0|||
42369675|NCT01781429|76232328|FG008|Overall Study|Withdrawal by Subject|1|||
42369676|NCT01781429|76232329|FG009|Overall Study|Withdrawal by Subject|3|||
42369677|NCT01781429|76232330|FG010|Overall Study|Withdrawal by Subject|1|||
42369678|NCT01781429|76232331|FG011|Overall Study|Withdrawal by Subject|1|||
42369679|NCT01781429|76232332|FG012|Overall Study|Withdrawal by Subject|5|||
42369680|NCT01781429|76232333|FG013|Overall Study|Withdrawal by Subject|2|||
42369681|NCT01781429|76232334|FG014|Overall Study|Withdrawal by Subject|3|||
42369682|NCT01781429|76232335|FG015|Overall Study|Withdrawal by Subject|0|||
42369683|NCT01781429|76232320|FG000|Overall Study|Disease Progression|1|||
42369684|NCT01781429|76232321|FG001|Overall Study|Disease Progression|0|||
42369685|NCT01781429|76232322|FG002|Overall Study|Disease Progression|1|||
42369686|NCT01781429|76232323|FG003|Overall Study|Disease Progression|1|||
42369687|NCT01781429|76232324|FG004|Overall Study|Disease Progression|1|||
42369688|NCT01781429|76232325|FG005|Overall Study|Disease Progression|4|||
42369689|NCT01781429|76232326|FG006|Overall Study|Disease Progression|7|||
42369690|NCT01781429|76232327|FG007|Overall Study|Disease Progression|4|||
42369691|NCT01781429|76232328|FG008|Overall Study|Disease Progression|6|||
42369692|NCT01781429|76232329|FG009|Overall Study|Disease Progression|15|||
42369693|NCT01781429|76232330|FG010|Overall Study|Disease Progression|15|||
42369694|NCT01781429|76232331|FG011|Overall Study|Disease Progression|15|||
42369695|NCT01781429|76232332|FG012|Overall Study|Disease Progression|15|||
42369696|NCT01781429|76232333|FG013|Overall Study|Disease Progression|4|||
42369697|NCT01781429|76232334|FG014|Overall Study|Disease Progression|11|||
42369698|NCT01781429|76232335|FG015|Overall Study|Disease Progression|0|||
42369699|NCT01781429|76232320|FG000|Overall Study|Unacceptable Toxicity|0|||
42369700|NCT01781429|76232321|FG001|Overall Study|Unacceptable Toxicity|0|||
42369701|NCT01781429|76232322|FG002|Overall Study|Unacceptable Toxicity|0|||
42369702|NCT01781429|76232323|FG003|Overall Study|Unacceptable Toxicity|0|||
42369703|NCT01781429|76232324|FG004|Overall Study|Unacceptable Toxicity|0|||
42369704|NCT01781429|76232325|FG005|Overall Study|Unacceptable Toxicity|0|||
42369705|NCT01781429|76232326|FG006|Overall Study|Unacceptable Toxicity|0|||
42369706|NCT01781429|76232327|FG007|Overall Study|Unacceptable Toxicity|0|||
42369707|NCT01781429|76232328|FG008|Overall Study|Unacceptable Toxicity|0|||
42369708|NCT01781429|76232329|FG009|Overall Study|Unacceptable Toxicity|0|||
42369709|NCT01781429|76232330|FG010|Overall Study|Unacceptable Toxicity|0|||
42369710|NCT01781429|76232331|FG011|Overall Study|Unacceptable Toxicity|2|||
42369711|NCT01781429|76232332|FG012|Overall Study|Unacceptable Toxicity|0|||
42369712|NCT01781429|76232333|FG013|Overall Study|Unacceptable Toxicity|0|||
42198937|NCT01468922|76010658|FG001|Overall Study|Patient choice - surgery|0|||
42198938|NCT01468922|76010659|FG002|Overall Study|Patient choice - surgery|0|||
42198939|NCT01468922|76010660|FG003|Overall Study|Patient choice - surgery|0|||
42198940|NCT01468922|76010661|FG004|Overall Study|Patient choice - surgery|0|||
42198941|NCT01468922|76010662|FG005|Overall Study|Patient choice - surgery|0|||
42198942|NCT01468922|76010663|FG006|Overall Study|Patient choice - surgery|0|||
42198943|NCT01468922|76010664|FG007|Overall Study|Patient choice - surgery|1|||
42198944|NCT01468922|76010665|FG008|Overall Study|Patient choice - surgery|0|||
42198945|NCT01468922|76010657|FG000|Overall Study|Refused further treatment|0|||
42198946|NCT01468922|76010658|FG001|Overall Study|Refused further treatment|0|||
42198947|NCT01468922|76010659|FG002|Overall Study|Refused further treatment|0|||
42198948|NCT01468922|76010660|FG003|Overall Study|Refused further treatment|0|||
42198949|NCT01468922|76010661|FG004|Overall Study|Refused further treatment|0|||
42198950|NCT01468922|76010662|FG005|Overall Study|Refused further treatment|0|||
42198951|NCT01468922|76010663|FG006|Overall Study|Refused further treatment|0|||
42198952|NCT01468922|76010664|FG007|Overall Study|Refused further treatment|1|||
42198953|NCT01468922|76010665|FG008|Overall Study|Refused further treatment|0|||
42198954|NCT01381094|76010688|FG000|Overall Study|Adverse Event|1|||
42198955|NCT01381094|76010689|FG001|Overall Study|Adverse Event|2|||
42198956|NCT01381094|76010690|FG002|Overall Study|Adverse Event|0|||
42198957|NCT01381094|76010691|FG003|Overall Study|Adverse Event|1|||
42198958|NCT01381094|76010692|FG004|Overall Study|Adverse Event|0|||
42198959|NCT01381094|76010688|FG000|Overall Study|Lost to Follow-up|0|||
42198960|NCT01381094|76010689|FG001|Overall Study|Lost to Follow-up|0|||
42198961|NCT01381094|76010690|FG002|Overall Study|Lost to Follow-up|0|||
42198962|NCT01381094|76010691|FG003|Overall Study|Lost to Follow-up|0|||
42198963|NCT01381094|76010692|FG004|Overall Study|Lost to Follow-up|1|||
42198964|NCT01381094|76010688|FG000|Overall Study|Withdrawal of informed consent|0|||
42198965|NCT01381094|76010689|FG001|Overall Study|Withdrawal of informed consent|1|||
42198966|NCT01381094|76010690|FG002|Overall Study|Withdrawal of informed consent|0|||
42198967|NCT01381094|76010691|FG003|Overall Study|Withdrawal of informed consent|0|||
42198968|NCT01381094|76010692|FG004|Overall Study|Withdrawal of informed consent|0|||
42198969|NCT01381094|76010688|FG000|Overall Study|Participant given Aranesp injection|1|||
42198970|NCT01381094|76010689|FG001|Overall Study|Participant given Aranesp injection|0|||
42198971|NCT01381094|76010690|FG002|Overall Study|Participant given Aranesp injection|0|||
42198972|NCT01381094|76010691|FG003|Overall Study|Participant given Aranesp injection|0|||
42198973|NCT01381094|76010692|FG004|Overall Study|Participant given Aranesp injection|0|||
42198974|NCT03197558|76010704|FG000|Overall Study|Tubes not placed|1|||
42198975|NCT03197324|76010710|FG000|Overall Study|Adverse Event|0|||
42198976|NCT03197324|76010711|FG001|Overall Study|Adverse Event|1|||
42198977|NCT03162614|76010723|FG000|Overall Study|Lost to Follow-up|2|||
42198978|NCT03162614|76010724|FG001|Overall Study|Lost to Follow-up|1|||
42198979|NCT03162614|76010725|FG002|Overall Study|Lost to Follow-up|1|||
42198980|NCT03162614|76010726|FG003|Overall Study|Lost to Follow-up|1|||
42198981|NCT03162614|76010727|FG004|Overall Study|Lost to Follow-up|2|||
42198982|NCT03162614|76010728|FG005|Overall Study|Lost to Follow-up|0|||
42198983|NCT03162614|76010723|FG000|Overall Study|Protocol Violation|0|||
42198984|NCT03162614|76010724|FG001|Overall Study|Protocol Violation|1|||
42198985|NCT03162614|76010725|FG002|Overall Study|Protocol Violation|0|||
42198986|NCT03162614|76010726|FG003|Overall Study|Protocol Violation|1|||
42198987|NCT03162614|76010727|FG004|Overall Study|Protocol Violation|0|||
42369713|NCT01781429|76232334|FG014|Overall Study|Unacceptable Toxicity|0|||
42369714|NCT01781429|76232335|FG015|Overall Study|Unacceptable Toxicity|0|||
42369715|NCT01781429|76232320|FG000|Overall Study|Patient Condition Changed|0|||
42369716|NCT01781429|76232321|FG001|Overall Study|Patient Condition Changed|0|||
42369717|NCT01781429|76232322|FG002|Overall Study|Patient Condition Changed|0|||
42369718|NCT01781429|76232323|FG003|Overall Study|Patient Condition Changed|0|||
42103076|NCT00537316|75914027|FG004|Part 2|Administrative|1|||
42103077|NCT00537316|75914028|FG005|Part 2|Administrative|4|||
42103078|NCT00537316|75914029|FG006|Part 2|Administrative|1|||
42103079|NCT03827395|75914050|FG000|Overall Study|Lost to Follow-up|1|||
42103080|NCT03827395|75914051|FG001|Overall Study|Lost to Follow-up|0|||
42103081|NCT03827395|75914050|FG000|Overall Study|Protocol Violation|1|||
42103082|NCT03827395|75914051|FG001|Overall Study|Protocol Violation|0|||
42103083|NCT03827395|75914050|FG000|Overall Study|Became ineligible after enrollment|1|||
42103084|NCT03827395|75914051|FG001|Overall Study|Became ineligible after enrollment|2|||
42103085|NCT00655980|75914060|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
42103086|NCT00655980|75914061|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
42103087|NCT00655980|75914062|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
42103088|NCT00679172|75914078|FG000|Overall Study|Non-compliance|1|||
42198988|NCT03162614|76010728|FG005|Overall Study|Protocol Violation|0|||
42198989|NCT03162614|76010723|FG000|Overall Study|Withdrawal by Subject|2|||
42198990|NCT03162614|76010724|FG001|Overall Study|Withdrawal by Subject|1|||
42198991|NCT03162614|76010725|FG002|Overall Study|Withdrawal by Subject|1|||
42198992|NCT03162614|76010726|FG003|Overall Study|Withdrawal by Subject|1|||
42369719|NCT01781429|76232324|FG004|Overall Study|Patient Condition Changed|0|||
42103089|NCT00679172|75914079|FG001|Overall Study|Non-compliance|1|||
42369720|NCT01781429|76232325|FG005|Overall Study|Patient Condition Changed|0|||
42198993|NCT03162614|76010727|FG004|Overall Study|Withdrawal by Subject|0|||
42198994|NCT03162614|76010728|FG005|Overall Study|Withdrawal by Subject|0|||
42198995|NCT03162614|76010723|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
42198996|NCT03162614|76010724|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
42198997|NCT03162614|76010725|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
42198998|NCT03162614|76010726|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
42198999|NCT03162614|76010727|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
42199000|NCT03162614|76010728|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
42199001|NCT03160898|76010746|FG000|Overall Study|Adverse Event|4|||
42199002|NCT03160898|76010747|FG001|Overall Study|Adverse Event|8|||
42199003|NCT03160898|76010748|FG002|Overall Study|Adverse Event|7|||
42199004|NCT03160898|76010749|FG003|Overall Study|Adverse Event|10|||
42199005|NCT03160898|76010746|FG000|Overall Study|Death|1|||
42199006|NCT03160898|76010747|FG001|Overall Study|Death|0|||
42199007|NCT03160898|76010748|FG002|Overall Study|Death|0|||
42199008|NCT03160898|76010749|FG003|Overall Study|Death|1|||
42199009|NCT03160898|76010746|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
42199010|NCT03160898|76010747|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
42199011|NCT03160898|76010748|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
42199012|NCT03160898|76010749|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
42199013|NCT03160898|76010746|FG000|Overall Study|Lost to Follow-up|1|||
42199014|NCT03160898|76010747|FG001|Overall Study|Lost to Follow-up|1|||
42199015|NCT03160898|76010748|FG002|Overall Study|Lost to Follow-up|1|||
42199016|NCT03160898|76010749|FG003|Overall Study|Lost to Follow-up|2|||
42199017|NCT03160898|76010746|FG000|Overall Study|Physician Decision|1|||
42199018|NCT03160898|76010747|FG001|Overall Study|Physician Decision|0|||
42199019|NCT03160898|76010748|FG002|Overall Study|Physician Decision|0|||
42199020|NCT03160898|76010749|FG003|Overall Study|Physician Decision|1|||
42199021|NCT03160898|76010746|FG000|Overall Study|Progressive Disease|4|||
42199022|NCT03160898|76010747|FG001|Overall Study|Progressive Disease|1|||
42199023|NCT03160898|76010748|FG002|Overall Study|Progressive Disease|2|||
42199024|NCT03160898|76010749|FG003|Overall Study|Progressive Disease|1|||
42199025|NCT03160898|76010746|FG000|Overall Study|Protocol Violation|1|||
42199026|NCT03160898|76010747|FG001|Overall Study|Protocol Violation|0|||
42199027|NCT03160898|76010748|FG002|Overall Study|Protocol Violation|2|||
42199028|NCT03160898|76010749|FG003|Overall Study|Protocol Violation|0|||
42199029|NCT03160898|76010746|FG000|Overall Study|Sponsor Discretion|2|||
42199030|NCT03160898|76010747|FG001|Overall Study|Sponsor Discretion|0|||
42199031|NCT03160898|76010748|FG002|Overall Study|Sponsor Discretion|0|||
42199032|NCT03160898|76010749|FG003|Overall Study|Sponsor Discretion|0|||
42199033|NCT03160898|76010746|FG000|Overall Study|Withdrawal by Subject|1|||
42199034|NCT03160898|76010747|FG001|Overall Study|Withdrawal by Subject|3|||
42199035|NCT03160898|76010748|FG002|Overall Study|Withdrawal by Subject|2|||
42199036|NCT03160898|76010749|FG003|Overall Study|Withdrawal by Subject|1|||
42199037|NCT03160898|76010746|FG000|Overall Study|Other|2|||
42199038|NCT03160898|76010747|FG001|Overall Study|Other|0|||
42199039|NCT03160898|76010748|FG002|Overall Study|Other|2|||
42199040|NCT03160898|76010749|FG003|Overall Study|Other|2|||
42199041|NCT03193736|76010760|FG000|Overall Study|Death|2|||
42199042|NCT03193736|76010760|FG000|Overall Study|Withdrawal by Subject|1|||
42199043|NCT03193736|76010760|FG000|Overall Study|Lost to Follow-up|1|||
42199044|NCT03193736|76010760|FG000|Overall Study|implant not received|1|||
42199045|NCT03192488|76010768|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
42199046|NCT03192488|76010769|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
42199047|NCT03192488|76010770|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
42199048|NCT03192488|76010771|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
42199049|NCT03192488|76010772|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
42199050|NCT03192488|76010773|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
42199051|NCT03192488|76010768|FG000|Third Intervention (d1)|Adverse Event|0|||
42199052|NCT03192488|76010769|FG001|Third Intervention (d1)|Adverse Event|0|||
42369721|NCT01781429|76232326|FG006|Overall Study|Patient Condition Changed|0|||
42369722|NCT01781429|76232327|FG007|Overall Study|Patient Condition Changed|0|||
42199053|NCT03192488|76010770|FG002|Third Intervention (d1)|Adverse Event|0|||
42103090|NCT00679172|75914080|FG002|Overall Study|Non-compliance|0|||
42199054|NCT03192488|76010771|FG003|Third Intervention (d1)|Adverse Event|0|||
42199055|NCT03192488|76010772|FG004|Third Intervention (d1)|Adverse Event|1|||
42199056|NCT03192488|76010773|FG005|Third Intervention (d1)|Adverse Event|0|||
42199057|NCT01642004|76010789|FG000|Randomization|Adverse Event unrelated to study drug|1|||
42199058|NCT01642004|76010790|FG001|Randomization|Adverse Event unrelated to study drug|0|||
42199059|NCT01642004|76010789|FG000|Randomization|Participant withdrew consent|1|||
42199060|NCT01642004|76010790|FG001|Randomization|Participant withdrew consent|6|||
42199061|NCT01642004|76010789|FG000|Randomization|No longer meets study criteria|2|||
42199062|NCT01642004|76010790|FG001|Randomization|No longer meets study criteria|2|||
42199063|NCT01642004|76010789|FG000|Treatment|Disease progression|95|||
42199064|NCT01642004|76010790|FG001|Treatment|Disease progression|79|||
42199065|NCT01642004|76010789|FG000|Treatment|Study drug toxicity|10|||
42369723|NCT01781429|76232328|FG008|Overall Study|Patient Condition Changed|0|||
42199066|NCT01642004|76010790|FG001|Treatment|Study drug toxicity|13|||
42199067|NCT01642004|76010789|FG000|Treatment|Death|1|||
42199068|NCT01642004|76010790|FG001|Treatment|Death|1|||
42199069|NCT01642004|76010789|FG000|Treatment|Adverse event unrelated to study drug|9|||
42199070|NCT01642004|76010790|FG001|Treatment|Adverse event unrelated to study drug|13|||
42199071|NCT01642004|76010789|FG000|Treatment|Maximum clinical benefit|1|||
42199072|NCT01642004|76010790|FG001|Treatment|Maximum clinical benefit|9|||
42199073|NCT01642004|76010789|FG000|Treatment|Poor/non-compliance|1|||
42199074|NCT01642004|76010790|FG001|Treatment|Poor/non-compliance|0|||
42199075|NCT01642004|76010789|FG000|Treatment|No longer meets study criteria|1|||
42199076|NCT01642004|76010790|FG001|Treatment|No longer meets study criteria|2|||
42199077|NCT01642004|76010789|FG000|Treatment|Other reasons|2|||
42199078|NCT01642004|76010790|FG001|Treatment|Other reasons|0|||
42199079|NCT01642004|76010789|FG000|Treatment|Not reported|0|||
42199080|NCT01642004|76010790|FG001|Treatment|Not reported|3|||
42199081|NCT01642004|76010789|FG000|Treatment|Participant request to discontinue study treatment|6|||
42199082|NCT01642004|76010790|FG001|Treatment|Participant request to discontinue study treatment|4|||
42199083|NCT01642004|76010789|FG000|Treatment|Participant withdrew consent|5|||
42199084|NCT01642004|76010790|FG001|Treatment|Participant withdrew consent|5|||
42199085|NCT00042289|76010846|FG000|Overall Study|Lost to Follow-up|3|||
42199086|NCT00042289|76010847|FG001|Overall Study|Lost to Follow-up|0|||
42199087|NCT00042289|76010848|FG002|Overall Study|Lost to Follow-up|0|||
42199088|NCT00042289|76010849|FG003|Overall Study|Lost to Follow-up|1|||
42199089|NCT00042289|76010850|FG004|Overall Study|Lost to Follow-up|3|||
42199090|NCT00042289|76010851|FG005|Overall Study|Lost to Follow-up|3|||
42369724|NCT01781429|76232329|FG009|Overall Study|Patient Condition Changed|4|||
42369725|NCT01781429|76232330|FG010|Overall Study|Patient Condition Changed|0|||
42369726|NCT01781429|76232331|FG011|Overall Study|Patient Condition Changed|1|||
42369727|NCT01781429|76232332|FG012|Overall Study|Patient Condition Changed|0|||
42369728|NCT01781429|76232333|FG013|Overall Study|Patient Condition Changed|1|||
42369729|NCT01781429|76232334|FG014|Overall Study|Patient Condition Changed|0|||
42369730|NCT01781429|76232335|FG015|Overall Study|Patient Condition Changed|0|||
42369731|NCT01781429|76232320|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
42369732|NCT01781429|76232321|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
42369733|NCT01781429|76232322|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
42369734|NCT01781429|76232323|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
42369735|NCT01781429|76232324|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
42369736|NCT01781429|76232325|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
42369737|NCT01781429|76232326|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
42369738|NCT01781429|76232327|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
42369739|NCT01781429|76232328|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
42369740|NCT01781429|76232329|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
42369741|NCT01781429|76232330|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
42369742|NCT01781429|76232331|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
42369743|NCT01781429|76232332|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
42369744|NCT01781429|76232333|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
42103091|NCT00679172|75914081|FG003|Overall Study|Non-compliance|1|||
42103092|NCT00679172|75914082|FG004|Overall Study|Non-compliance|0|||
42103093|NCT00679172|75914078|FG000|Overall Study|Other not specified|0|||
42103094|NCT00679172|75914079|FG001|Overall Study|Other not specified|0|||
42103095|NCT00679172|75914080|FG002|Overall Study|Other not specified|1|||
42103096|NCT00679172|75914081|FG003|Overall Study|Other not specified|0|||
42103097|NCT00679172|75914082|FG004|Overall Study|Other not specified|0|||
42103098|NCT00676130|75914099|FG000|Overall Study|Lost to Follow-up|0|||
42103099|NCT00676130|75914100|FG001|Overall Study|Lost to Follow-up|1|||
42103100|NCT00676130|75914099|FG000|Overall Study|Found ineligible|3|||
42103101|NCT00676130|75914100|FG001|Overall Study|Found ineligible|2|||
42103102|NCT00676130|75914099|FG000|Overall Study|Withdrawal by Subject|0|||
42103103|NCT00676130|75914100|FG001|Overall Study|Withdrawal by Subject|1|||
42103104|NCT00676052|75914112|FG000|Overall Study|Adverse Event|0|||
42103105|NCT00676052|75914113|FG001|Overall Study|Adverse Event|1|||
42103106|NCT00676052|75914114|FG002|Overall Study|Adverse Event|1|||
42103107|NCT00676052|75914115|FG003|Overall Study|Adverse Event|2|||
42103108|NCT00676052|75914116|FG004|Overall Study|Adverse Event|2|||
42103109|NCT00676052|75914117|FG005|Overall Study|Adverse Event|2|||
42103110|NCT00676052|75914112|FG000|Overall Study|Lack of Efficacy|2|||
42103111|NCT00676052|75914113|FG001|Overall Study|Lack of Efficacy|2|||
42103112|NCT00676052|75914114|FG002|Overall Study|Lack of Efficacy|1|||
42103113|NCT00676052|75914115|FG003|Overall Study|Lack of Efficacy|1|||
42103114|NCT00676052|75914116|FG004|Overall Study|Lack of Efficacy|2|||
42103115|NCT00676052|75914117|FG005|Overall Study|Lack of Efficacy|1|||
42199091|NCT00042289|76010852|FG006|Overall Study|Lost to Follow-up|6|||
42199092|NCT00042289|76010853|FG007|Overall Study|Lost to Follow-up|1|||
42199093|NCT00042289|76010854|FG008|Overall Study|Lost to Follow-up|1|||
42103116|NCT00676052|75914112|FG000|Overall Study|Protocol Violation|5|||
42103117|NCT00676052|75914113|FG001|Overall Study|Protocol Violation|3|||
42103118|NCT00676052|75914114|FG002|Overall Study|Protocol Violation|2|||
42199094|NCT00042289|76010855|FG009|Overall Study|Lost to Follow-up|0|||
42199095|NCT00042289|76010856|FG010|Overall Study|Lost to Follow-up|0|||
42199096|NCT00042289|76010857|FG011|Overall Study|Lost to Follow-up|0|||
42199097|NCT00042289|76010858|FG012|Overall Study|Lost to Follow-up|0|||
42199098|NCT00042289|76010859|FG013|Overall Study|Lost to Follow-up|0|||
42199099|NCT00042289|76010860|FG014|Overall Study|Lost to Follow-up|0|||
42199100|NCT00042289|76010861|FG015|Overall Study|Lost to Follow-up|1|||
42199101|NCT00042289|76010862|FG016|Overall Study|Lost to Follow-up|1|||
42369745|NCT01781429|76232334|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
42369746|NCT01781429|76232335|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
42369747|NCT01781429|76232320|FG000|Overall Study|Enrolled, but not treated|0|||
42369748|NCT01781429|76232321|FG001|Overall Study|Enrolled, but not treated|0|||
42369749|NCT01781429|76232322|FG002|Overall Study|Enrolled, but not treated|0|||
42369750|NCT01781429|76232323|FG003|Overall Study|Enrolled, but not treated|0|||
42369751|NCT01781429|76232324|FG004|Overall Study|Enrolled, but not treated|0|||
42369752|NCT01781429|76232325|FG005|Overall Study|Enrolled, but not treated|0|||
42369753|NCT01781429|76232326|FG006|Overall Study|Enrolled, but not treated|0|||
42369754|NCT01781429|76232327|FG007|Overall Study|Enrolled, but not treated|0|||
42369755|NCT01781429|76232328|FG008|Overall Study|Enrolled, but not treated|0|||
42369756|NCT01781429|76232329|FG009|Overall Study|Enrolled, but not treated|0|||
42369757|NCT01781429|76232330|FG010|Overall Study|Enrolled, but not treated|1|||
42369758|NCT01781429|76232331|FG011|Overall Study|Enrolled, but not treated|0|||
42369759|NCT01781429|76232332|FG012|Overall Study|Enrolled, but not treated|0|||
42369760|NCT01781429|76232333|FG013|Overall Study|Enrolled, but not treated|0|||
42369761|NCT01781429|76232334|FG014|Overall Study|Enrolled, but not treated|0|||
42369762|NCT01781429|76232335|FG015|Overall Study|Enrolled, but not treated|0|||
42369763|NCT01773473|76232370|FG000|Overall Study|Adverse Event|3|||
42369764|NCT01773473|76232371|FG001|Overall Study|Adverse Event|2|||
42369765|NCT01773473|76232370|FG000|Overall Study|Protocol Violation|0|||
42103119|NCT00676052|75914115|FG003|Overall Study|Protocol Violation|2|||
42103120|NCT00676052|75914116|FG004|Overall Study|Protocol Violation|1|||
42103121|NCT00676052|75914117|FG005|Overall Study|Protocol Violation|2|||
42103122|NCT00676052|75914112|FG000|Overall Study|Lost to Follow-up|0|||
42103123|NCT00676052|75914113|FG001|Overall Study|Lost to Follow-up|0|||
42103124|NCT00676052|75914114|FG002|Overall Study|Lost to Follow-up|0|||
42103125|NCT00676052|75914115|FG003|Overall Study|Lost to Follow-up|0|||
42103126|NCT00676052|75914116|FG004|Overall Study|Lost to Follow-up|1|||
42103127|NCT00676052|75914117|FG005|Overall Study|Lost to Follow-up|0|||
42103128|NCT00676052|75914112|FG000|Overall Study|Physician Decision|1|||
42103129|NCT00676052|75914113|FG001|Overall Study|Physician Decision|1|||
42103130|NCT00676052|75914114|FG002|Overall Study|Physician Decision|1|||
42103131|NCT00676052|75914115|FG003|Overall Study|Physician Decision|0|||
42103132|NCT00676052|75914116|FG004|Overall Study|Physician Decision|0|||
42103133|NCT00676052|75914117|FG005|Overall Study|Physician Decision|1|||
42103134|NCT00676052|75914112|FG000|Overall Study|Withdrawal by Subject|1|||
42103135|NCT00676052|75914113|FG001|Overall Study|Withdrawal by Subject|0|||
42103136|NCT00676052|75914114|FG002|Overall Study|Withdrawal by Subject|1|||
42103137|NCT00676052|75914115|FG003|Overall Study|Withdrawal by Subject|0|||
42103138|NCT00676052|75914116|FG004|Overall Study|Withdrawal by Subject|0|||
42103139|NCT00676052|75914117|FG005|Overall Study|Withdrawal by Subject|0|||
42103140|NCT00535288|75914136|FG000|Overall Study|Adverse Event|20|||
42103141|NCT00535288|75914137|FG001|Overall Study|Adverse Event|19|||
42103142|NCT00535288|75914138|FG002|Overall Study|Adverse Event|25|||
42103143|NCT00535288|75914139|FG003|Overall Study|Adverse Event|20|||
42103144|NCT00535288|75914140|FG004|Overall Study|Adverse Event|30|||
42103145|NCT00535288|75914136|FG000|Overall Study|Lost to Follow-up|0|||
42103146|NCT00535288|75914137|FG001|Overall Study|Lost to Follow-up|3|||
42103147|NCT00535288|75914138|FG002|Overall Study|Lost to Follow-up|0|||
42103148|NCT00535288|75914139|FG003|Overall Study|Lost to Follow-up|0|||
42103149|NCT00535288|75914140|FG004|Overall Study|Lost to Follow-up|0|||
42103150|NCT00535288|75914136|FG000|Overall Study|Lack of Efficacy|26|||
42103151|NCT00535288|75914137|FG001|Overall Study|Lack of Efficacy|3|||
42103152|NCT00535288|75914138|FG002|Overall Study|Lack of Efficacy|4|||
42103153|NCT00535288|75914139|FG003|Overall Study|Lack of Efficacy|4|||
42103154|NCT00535288|75914140|FG004|Overall Study|Lack of Efficacy|7|||
42103155|NCT00535288|75914136|FG000|Overall Study|Unwilling to cooperate|6|||
42103156|NCT00535288|75914137|FG001|Overall Study|Unwilling to cooperate|6|||
42103157|NCT00535288|75914138|FG002|Overall Study|Unwilling to cooperate|3|||
42103158|NCT00535288|75914139|FG003|Overall Study|Unwilling to cooperate|3|||
42103159|NCT00535288|75914140|FG004|Overall Study|Unwilling to cooperate|4|||
42199102|NCT00042289|76010863|FG017|Overall Study|Lost to Follow-up|0|||
42103160|NCT00535288|75914136|FG000|Overall Study|Other|2|||
42103161|NCT00535288|75914137|FG001|Overall Study|Other|1|||
42103162|NCT00535288|75914138|FG002|Overall Study|Other|1|||
42103163|NCT00535288|75914139|FG003|Overall Study|Other|2|||
42103164|NCT00535288|75914140|FG004|Overall Study|Other|1|||
42103165|NCT03904420|75914159|FG000|Overall Study|Study terminated|2|||
42103166|NCT03904420|75914160|FG001|Overall Study|Study terminated|2|||
42199103|NCT00042289|76010864|FG018|Overall Study|Lost to Follow-up|3|||
42199104|NCT00042289|76010865|FG019|Overall Study|Lost to Follow-up|2|||
42199105|NCT00042289|76010866|FG020|Overall Study|Lost to Follow-up|0|||
42199106|NCT00042289|76010867|FG021|Overall Study|Lost to Follow-up|0|||
42199107|NCT00042289|76010868|FG022|Overall Study|Lost to Follow-up|0|||
42199108|NCT00042289|76010869|FG023|Overall Study|Lost to Follow-up|0|||
42199109|NCT00042289|76010870|FG024|Overall Study|Lost to Follow-up|0|||
42199110|NCT00042289|76010871|FG025|Overall Study|Lost to Follow-up|0|||
42199111|NCT00042289|76010872|FG026|Overall Study|Lost to Follow-up|2|||
42199112|NCT00042289|76010873|FG027|Overall Study|Lost to Follow-up|2|||
42369766|NCT01773473|76232371|FG001|Overall Study|Protocol Violation|4|||
42369767|NCT01773473|76232370|FG000|Overall Study|Physician Decision|3|||
42369768|NCT01773473|76232371|FG001|Overall Study|Physician Decision|5|||
42369769|NCT01773473|76232370|FG000|Overall Study|Sponsor Decision|2|||
42369770|NCT01773473|76232371|FG001|Overall Study|Sponsor Decision|0|||
42369771|NCT01773473|76232370|FG000|Overall Study|Lack of Efficacy|0|||
42369772|NCT01773473|76232371|FG001|Overall Study|Lack of Efficacy|1|||
42369773|NCT01773473|76232370|FG000|Overall Study|Non-Compliance with study drug|1|||
42369774|NCT01773473|76232371|FG001|Overall Study|Non-Compliance with study drug|4|||
42369775|NCT01773473|76232370|FG000|Overall Study|Withdrawal by Subject|5|||
42369776|NCT01773473|76232371|FG001|Overall Study|Withdrawal by Subject|3|||
42369777|NCT01773473|76232370|FG000|Overall Study|Lost to Follow-up|2|||
42369778|NCT01773473|76232371|FG001|Overall Study|Lost to Follow-up|0|||
42369779|NCT01772693|76232379|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
42369780|NCT01772693|76232380|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
42369781|NCT01772693|76232379|FG000|Overall Study|Withdrawal by Subject|2|||
42369782|NCT01772693|76232380|FG001|Overall Study|Withdrawal by Subject|0|||
42369783|NCT01772693|76232379|FG000|Overall Study|Alternative Treatment|2|||
42369784|NCT01772693|76232380|FG001|Overall Study|Alternative Treatment|0|||
42369785|NCT01779869|76232386|FG000|Overall Study|Physician Decision|2|||
42369786|NCT01772537|76232393|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
42369787|NCT01772537|76232394|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
42369788|NCT01772537|76232395|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
42369789|NCT01772147|76232408|FG000|Overall Study|Adverse Event|13|||
42369790|NCT01772147|76232409|FG001|Overall Study|Adverse Event|10|||
42369791|NCT01772147|76232410|FG002|Overall Study|Adverse Event|6|||
42199113|NCT00042289|76010874|FG028|Overall Study|Lost to Follow-up|2|||
42199114|NCT00042289|76010875|FG029|Overall Study|Lost to Follow-up|0|||
42369792|NCT01772147|76232408|FG000|Overall Study|Withdrew Consent|7|||
42369793|NCT01772147|76232409|FG001|Overall Study|Withdrew Consent|8|||
42369794|NCT01772147|76232410|FG002|Overall Study|Withdrew Consent|4|||
42369795|NCT01772147|76232408|FG000|Overall Study|Lost to Follow-up|1|||
42369796|NCT01772147|76232409|FG001|Overall Study|Lost to Follow-up|0|||
42369797|NCT01772147|76232410|FG002|Overall Study|Lost to Follow-up|1|||
42369798|NCT01772147|76232408|FG000|Overall Study|Protocol Deviation|2|||
42369799|NCT01772147|76232409|FG001|Overall Study|Protocol Deviation|1|||
42369800|NCT01772147|76232410|FG002|Overall Study|Protocol Deviation|1|||
42103167|NCT00675506|75914168|FG000|Overall Study|Lost to Follow-up|1|||
42199115|NCT00042289|76010876|FG030|Overall Study|Lost to Follow-up|0|||
42199116|NCT00042289|76010877|FG031|Overall Study|Lost to Follow-up|2|||
42199117|NCT00042289|76010878|FG032|Overall Study|Lost to Follow-up|1|||
42199118|NCT00042289|76010879|FG033|Overall Study|Lost to Follow-up|1|||
42199119|NCT00042289|76010880|FG034|Overall Study|Lost to Follow-up|1|||
42199120|NCT00042289|76010881|FG035|Overall Study|Lost to Follow-up|2|||
42199121|NCT00042289|76010882|FG036|Overall Study|Lost to Follow-up|1|||
42199122|NCT00042289|76010883|FG037|Overall Study|Lost to Follow-up|1|||
42199123|NCT00042289|76010884|FG038|Overall Study|Lost to Follow-up|0|||
42199124|NCT00042289|76010885|FG039|Overall Study|Lost to Follow-up|5|||
42199125|NCT00042289|76010886|FG040|Overall Study|Lost to Follow-up|0|||
42199126|NCT00042289|76010887|FG041|Overall Study|Lost to Follow-up|2|||
42199127|NCT00042289|76010888|FG042|Overall Study|Lost to Follow-up|2|||
42199128|NCT00042289|76010889|FG043|Overall Study|Lost to Follow-up|0|||
42199129|NCT00042289|76010890|FG044|Overall Study|Lost to Follow-up|0|||
42199130|NCT00042289|76010891|FG045|Overall Study|Lost to Follow-up|1|||
42199131|NCT00042289|76010892|FG046|Overall Study|Lost to Follow-up|0|||
42199132|NCT00042289|76010846|FG000|Overall Study|Other reason|0|||
42199133|NCT00042289|76010847|FG001|Overall Study|Other reason|0|||
42369801|NCT01772147|76232408|FG000|Overall Study|Lack of Efficacy|8|||
42369802|NCT01772147|76232409|FG001|Overall Study|Lack of Efficacy|6|||
42369803|NCT01772147|76232410|FG002|Overall Study|Lack of Efficacy|6|||
42369804|NCT01771913|76232420|FG000|Overall Study|Withdrawal by Subject|1|||
42199134|NCT00042289|76010848|FG002|Overall Study|Other reason|0|||
42369805|NCT01771913|76232421|FG001|Overall Study|Withdrawal by Subject|0|||
42369806|NCT01606787|76232429|FG000|Overall Study|Withdrawal by Subject|4|||
42369807|NCT01606787|76232430|FG001|Overall Study|Withdrawal by Subject|5|||
42199135|NCT00042289|76010849|FG003|Overall Study|Other reason|2|||
42199136|NCT00042289|76010850|FG004|Overall Study|Other reason|0|||
42199137|NCT00042289|76010851|FG005|Overall Study|Other reason|0|||
42199138|NCT00042289|76010852|FG006|Overall Study|Other reason|0|||
42199139|NCT00042289|76010853|FG007|Overall Study|Other reason|0|||
42199140|NCT00042289|76010854|FG008|Overall Study|Other reason|0|||
42199141|NCT00042289|76010855|FG009|Overall Study|Other reason|0|||
42199142|NCT00042289|76010856|FG010|Overall Study|Other reason|0|||
42199143|NCT00042289|76010857|FG011|Overall Study|Other reason|0|||
42199144|NCT00042289|76010858|FG012|Overall Study|Other reason|0|||
42199145|NCT00042289|76010859|FG013|Overall Study|Other reason|0|||
42199146|NCT00042289|76010860|FG014|Overall Study|Other reason|0|||
42199147|NCT00042289|76010861|FG015|Overall Study|Other reason|0|||
42199148|NCT00042289|76010862|FG016|Overall Study|Other reason|0|||
42199149|NCT00042289|76010863|FG017|Overall Study|Other reason|0|||
42199150|NCT00042289|76010864|FG018|Overall Study|Other reason|1|||
42199151|NCT00042289|76010865|FG019|Overall Study|Other reason|0|||
42199152|NCT00042289|76010866|FG020|Overall Study|Other reason|0|||
42199153|NCT00042289|76010867|FG021|Overall Study|Other reason|0|||
42199154|NCT00042289|76010868|FG022|Overall Study|Other reason|0|||
42199155|NCT00042289|76010869|FG023|Overall Study|Other reason|1|||
42199156|NCT00042289|76010870|FG024|Overall Study|Other reason|0|||
42199157|NCT00042289|76010871|FG025|Overall Study|Other reason|0|||
42199158|NCT00042289|76010872|FG026|Overall Study|Other reason|1|||
42199159|NCT00042289|76010873|FG027|Overall Study|Other reason|0|||
42199160|NCT00042289|76010874|FG028|Overall Study|Other reason|3|||
42199161|NCT00042289|76010875|FG029|Overall Study|Other reason|0|||
42199162|NCT00042289|76010876|FG030|Overall Study|Other reason|0|||
42199163|NCT00042289|76010877|FG031|Overall Study|Other reason|1|||
42199164|NCT00042289|76010878|FG032|Overall Study|Other reason|0|||
42199165|NCT00042289|76010879|FG033|Overall Study|Other reason|1|||
42199166|NCT00042289|76010880|FG034|Overall Study|Other reason|0|||
42199167|NCT00042289|76010881|FG035|Overall Study|Other reason|2|||
42199168|NCT00042289|76010882|FG036|Overall Study|Other reason|0|||
42199169|NCT00042289|76010883|FG037|Overall Study|Other reason|0|||
42199170|NCT00042289|76010884|FG038|Overall Study|Other reason|0|||
42199171|NCT00042289|76010885|FG039|Overall Study|Other reason|0|||
42199172|NCT00042289|76010886|FG040|Overall Study|Other reason|0|||
42199173|NCT00042289|76010887|FG041|Overall Study|Other reason|0|||
42199174|NCT00042289|76010888|FG042|Overall Study|Other reason|0|||
42199175|NCT00042289|76010889|FG043|Overall Study|Other reason|1|||
42199176|NCT00042289|76010890|FG044|Overall Study|Other reason|0|||
42199177|NCT00042289|76010891|FG045|Overall Study|Other reason|0|||
42199178|NCT00042289|76010892|FG046|Overall Study|Other reason|0|||
42199179|NCT00042289|76010846|FG000|Overall Study|Severe debilitation, unable to continue|0|||
42199180|NCT00042289|76010847|FG001|Overall Study|Severe debilitation, unable to continue|0|||
42199181|NCT00042289|76010848|FG002|Overall Study|Severe debilitation, unable to continue|0|||
42199182|NCT00042289|76010849|FG003|Overall Study|Severe debilitation, unable to continue|0|||
42199183|NCT00042289|76010850|FG004|Overall Study|Severe debilitation, unable to continue|0|||
42199184|NCT00042289|76010851|FG005|Overall Study|Severe debilitation, unable to continue|0|||
42199185|NCT00042289|76010852|FG006|Overall Study|Severe debilitation, unable to continue|0|||
42199186|NCT00042289|76010853|FG007|Overall Study|Severe debilitation, unable to continue|0|||
42199187|NCT00042289|76010854|FG008|Overall Study|Severe debilitation, unable to continue|0|||
42199188|NCT00042289|76010855|FG009|Overall Study|Severe debilitation, unable to continue|0|||
42199189|NCT00042289|76010856|FG010|Overall Study|Severe debilitation, unable to continue|0|||
42199190|NCT00042289|76010857|FG011|Overall Study|Severe debilitation, unable to continue|0|||
42199191|NCT00042289|76010858|FG012|Overall Study|Severe debilitation, unable to continue|0|||
42369808|NCT01606787|76232429|FG000|Overall Study|Surgery canceled|0|||
42369809|NCT01606787|76232430|FG001|Overall Study|Surgery canceled|2|||
42369810|NCT01778855|76232438|FG000|Overall Study|Death|0|||
42103168|NCT00675506|75914169|FG001|Overall Study|Lost to Follow-up|5|||
42103169|NCT00675506|75914168|FG000|Overall Study|Lost interest|3|||
42103170|NCT00675506|75914169|FG001|Overall Study|Lost interest|5|||
42103171|NCT00675506|75914168|FG000|Overall Study|Elevated fasting glucose|2|||
42103172|NCT00675506|75914169|FG001|Overall Study|Elevated fasting glucose|1|||
42103173|NCT00675506|75914168|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
42103174|NCT00675506|75914169|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
42103175|NCT00675506|75914168|FG000|Overall Study|Elevated IGF-1|2|||
42199192|NCT00042289|76010859|FG013|Overall Study|Severe debilitation, unable to continue|0|||
42199193|NCT00042289|76010860|FG014|Overall Study|Severe debilitation, unable to continue|0|||
42199194|NCT00042289|76010861|FG015|Overall Study|Severe debilitation, unable to continue|0|||
42103176|NCT00675506|75914169|FG001|Overall Study|Elevated IGF-1|0|||
42199195|NCT00042289|76010862|FG016|Overall Study|Severe debilitation, unable to continue|0|||
42199196|NCT00042289|76010863|FG017|Overall Study|Severe debilitation, unable to continue|0|||
42199197|NCT00042289|76010864|FG018|Overall Study|Severe debilitation, unable to continue|0|||
42199198|NCT00042289|76010865|FG019|Overall Study|Severe debilitation, unable to continue|0|||
42103177|NCT00675506|75914168|FG000|Overall Study|Hypersensitivity Reaction|1|||
42199199|NCT00042289|76010866|FG020|Overall Study|Severe debilitation, unable to continue|0|||
42199200|NCT00042289|76010867|FG021|Overall Study|Severe debilitation, unable to continue|1|||
42199201|NCT00042289|76010868|FG022|Overall Study|Severe debilitation, unable to continue|0|||
42199202|NCT00042289|76010869|FG023|Overall Study|Severe debilitation, unable to continue|1|||
42199203|NCT00042289|76010870|FG024|Overall Study|Severe debilitation, unable to continue|0|||
42199204|NCT00042289|76010871|FG025|Overall Study|Severe debilitation, unable to continue|0|||
42199205|NCT00042289|76010872|FG026|Overall Study|Severe debilitation, unable to continue|0|||
42199206|NCT00042289|76010873|FG027|Overall Study|Severe debilitation, unable to continue|1|||
42199207|NCT00042289|76010874|FG028|Overall Study|Severe debilitation, unable to continue|0|||
42199208|NCT00042289|76010875|FG029|Overall Study|Severe debilitation, unable to continue|0|||
42199209|NCT00042289|76010876|FG030|Overall Study|Severe debilitation, unable to continue|0|||
42199210|NCT00042289|76010877|FG031|Overall Study|Severe debilitation, unable to continue|1|||
42199211|NCT00042289|76010878|FG032|Overall Study|Severe debilitation, unable to continue|1|||
42199212|NCT00042289|76010879|FG033|Overall Study|Severe debilitation, unable to continue|0|||
42199213|NCT00042289|76010880|FG034|Overall Study|Severe debilitation, unable to continue|0|||
42199214|NCT00042289|76010881|FG035|Overall Study|Severe debilitation, unable to continue|0|||
42199215|NCT00042289|76010882|FG036|Overall Study|Severe debilitation, unable to continue|0|||
42199216|NCT00042289|76010883|FG037|Overall Study|Severe debilitation, unable to continue|0|||
42199217|NCT00042289|76010884|FG038|Overall Study|Severe debilitation, unable to continue|0|||
42369811|NCT01778855|76232439|FG001|Overall Study|Death|1|||
42369812|NCT01777997|76232445|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
42369813|NCT01777997|76232445|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
42369814|NCT01777997|76232445|FG000|Weeks 48 to 72/96 on ART|Death|1|||
42369815|NCT01777997|76232445|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
42369816|NCT01770509|76232451|FG000|Overall Study|Injury|0|||
42369817|NCT01770509|76232452|FG001|Overall Study|Injury|1|||
42369818|NCT01770509|76232451|FG000|Overall Study|Lost to Follow-up|1|||
42369819|NCT01770509|76232452|FG001|Overall Study|Lost to Follow-up|2|||
42369820|NCT01770353|76232460|FG000|Overall Study|Progressive disease|2|||
42369821|NCT01770353|76232461|FG001|Overall Study|Progressive disease|1|||
42369822|NCT01770353|76232460|FG000|Overall Study|Adverse Event|0|||
42369823|NCT01770353|76232461|FG001|Overall Study|Adverse Event|1|||
42369824|NCT01770353|76232460|FG000|Overall Study|Protocol Violation|1|||
42369825|NCT01770353|76232461|FG001|Overall Study|Protocol Violation|0|||
42369826|NCT01770353|76232460|FG000|Overall Study|Physician Decision|0|||
42199218|NCT00042289|76010885|FG039|Overall Study|Severe debilitation, unable to continue|0|||
42199219|NCT00042289|76010886|FG040|Overall Study|Severe debilitation, unable to continue|0|||
42199220|NCT00042289|76010887|FG041|Overall Study|Severe debilitation, unable to continue|0|||
42199221|NCT00042289|76010888|FG042|Overall Study|Severe debilitation, unable to continue|0|||
42199222|NCT00042289|76010889|FG043|Overall Study|Severe debilitation, unable to continue|0|||
42199223|NCT00042289|76010890|FG044|Overall Study|Severe debilitation, unable to continue|0|||
42199224|NCT00042289|76010891|FG045|Overall Study|Severe debilitation, unable to continue|0|||
42199225|NCT00042289|76010892|FG046|Overall Study|Severe debilitation, unable to continue|0|||
42199226|NCT00042289|76010846|FG000|Overall Study|Site closed|0|||
42199227|NCT00042289|76010847|FG001|Overall Study|Site closed|0|||
42199228|NCT00042289|76010848|FG002|Overall Study|Site closed|0|||
42199229|NCT00042289|76010849|FG003|Overall Study|Site closed|0|||
42199230|NCT00042289|76010850|FG004|Overall Study|Site closed|0|||
42199231|NCT00042289|76010851|FG005|Overall Study|Site closed|0|||
42199232|NCT00042289|76010852|FG006|Overall Study|Site closed|0|||
42199233|NCT00042289|76010853|FG007|Overall Study|Site closed|0|||
42199234|NCT00042289|76010854|FG008|Overall Study|Site closed|0|||
42018704|NCT00996580|75826056|FG000|Overall Study|Noncompliance with the protocol|137|||
42018705|NCT00996580|75826056|FG000|Overall Study|Physician Decision|5|||
42199235|NCT00042289|76010855|FG009|Overall Study|Site closed|0|||
42199236|NCT00042289|76010856|FG010|Overall Study|Site closed|0|||
42199237|NCT00042289|76010857|FG011|Overall Study|Site closed|0|||
42199238|NCT00042289|76010858|FG012|Overall Study|Site closed|0|||
42018706|NCT00996580|75826056|FG000|Overall Study|Pregnancy|68|||
42018707|NCT00996580|75826056|FG000|Overall Study|Protocol Violation|16|||
42018708|NCT00996580|75826056|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
42018709|NCT00996580|75826056|FG000|Overall Study|Withdrawal by Subject|217|||
42018710|NCT00996580|75826056|FG000|Overall Study|Other|29|||
42018711|NCT01124175|75826065|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
42018712|NCT01124175|75826066|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
42018713|NCT01256177|75826074|FG000|Overall Study|Withdrawal by Subject|23|||
42018714|NCT01256177|75826075|FG001|Overall Study|Withdrawal by Subject|22|||
42018715|NCT01256177|75826074|FG000|Overall Study|Lost to Follow-up|2|||
42018716|NCT01256177|75826075|FG001|Overall Study|Lost to Follow-up|2|||
42018717|NCT01256177|75826074|FG000|Overall Study|Adverse Event|8|||
42199239|NCT00042289|76010859|FG013|Overall Study|Site closed|0|||
42199240|NCT00042289|76010860|FG014|Overall Study|Site closed|0|||
42018718|NCT01256177|75826075|FG001|Overall Study|Adverse Event|9|||
42018719|NCT01256177|75826074|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
42369827|NCT01770353|76232461|FG001|Overall Study|Physician Decision|3|||
42199241|NCT00042289|76010861|FG015|Overall Study|Site closed|0|||
42199242|NCT00042289|76010862|FG016|Overall Study|Site closed|0|||
42199243|NCT00042289|76010863|FG017|Overall Study|Site closed|0|||
42199244|NCT00042289|76010864|FG018|Overall Study|Site closed|0|||
42199245|NCT00042289|76010865|FG019|Overall Study|Site closed|0|||
42199246|NCT00042289|76010866|FG020|Overall Study|Site closed|0|||
42199247|NCT00042289|76010867|FG021|Overall Study|Site closed|0|||
42199248|NCT00042289|76010868|FG022|Overall Study|Site closed|0|||
42199249|NCT00042289|76010869|FG023|Overall Study|Site closed|0|||
42199250|NCT00042289|76010870|FG024|Overall Study|Site closed|0|||
42199251|NCT00042289|76010871|FG025|Overall Study|Site closed|0|||
42199252|NCT00042289|76010872|FG026|Overall Study|Site closed|0|||
42199253|NCT00042289|76010873|FG027|Overall Study|Site closed|0|||
42199254|NCT00042289|76010874|FG028|Overall Study|Site closed|0|||
42199255|NCT00042289|76010875|FG029|Overall Study|Site closed|0|||
42199256|NCT00042289|76010876|FG030|Overall Study|Site closed|0|||
42199257|NCT00042289|76010877|FG031|Overall Study|Site closed|3|||
42199258|NCT00042289|76010878|FG032|Overall Study|Site closed|0|||
42199259|NCT00042289|76010879|FG033|Overall Study|Site closed|0|||
42199260|NCT00042289|76010880|FG034|Overall Study|Site closed|0|||
42199261|NCT00042289|76010881|FG035|Overall Study|Site closed|0|||
42199262|NCT00042289|76010882|FG036|Overall Study|Site closed|1|||
42199263|NCT00042289|76010883|FG037|Overall Study|Site closed|0|||
42199264|NCT00042289|76010884|FG038|Overall Study|Site closed|0|||
42199265|NCT00042289|76010885|FG039|Overall Study|Site closed|0|||
42199266|NCT00042289|76010886|FG040|Overall Study|Site closed|0|||
42199267|NCT00042289|76010887|FG041|Overall Study|Site closed|0|||
42199268|NCT00042289|76010888|FG042|Overall Study|Site closed|1|||
42199269|NCT00042289|76010889|FG043|Overall Study|Site closed|0|||
42199270|NCT00042289|76010890|FG044|Overall Study|Site closed|0|||
42199271|NCT00042289|76010891|FG045|Overall Study|Site closed|0|||
42199272|NCT00042289|76010892|FG046|Overall Study|Site closed|0|||
42199273|NCT00042289|76010846|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
42199274|NCT00042289|76010847|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
42199275|NCT00042289|76010848|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
42199276|NCT00042289|76010849|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
42199277|NCT00042289|76010850|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
42199278|NCT00042289|76010851|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
42199279|NCT00042289|76010852|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
42199280|NCT00042289|76010853|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
42199281|NCT00042289|76010854|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
42199282|NCT00042289|76010855|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
42199283|NCT00042289|76010856|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
42199284|NCT00042289|76010857|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
42199285|NCT00042289|76010858|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
42199286|NCT00042289|76010859|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
42199287|NCT00042289|76010860|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
42199288|NCT00042289|76010861|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
42199289|NCT00042289|76010862|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
42199290|NCT00042289|76010863|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
42199291|NCT00042289|76010864|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
42199292|NCT00042289|76010865|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
42199293|NCT00042289|76010866|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
42199294|NCT00042289|76010867|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
42199295|NCT00042289|76010868|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
42199296|NCT00042289|76010869|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
42199297|NCT00042289|76010870|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
42199298|NCT00042289|76010871|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
42199299|NCT00042289|76010872|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
42199300|NCT00042289|76010873|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
42199301|NCT00042289|76010874|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
42199302|NCT00042289|76010875|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
42199303|NCT00042289|76010876|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
42369828|NCT01770353|76232460|FG000|Overall Study|Clinical deterioration|3|||
42369829|NCT01770353|76232461|FG001|Overall Study|Clinical deterioration|6|||
42369830|NCT01770353|76232460|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
42103178|NCT00675506|75914169|FG001|Overall Study|Hypersensitivity Reaction|0|||
42199304|NCT00042289|76010877|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
42199305|NCT00042289|76010878|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
42199306|NCT00042289|76010879|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
42199307|NCT00042289|76010880|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
42103179|NCT00675506|75914168|FG000|Overall Study|Disclosed history of cancer|1|||
42369831|NCT01770353|76232461|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
42369832|NCT01777763|76232477|FG000|Overall Study|Adverse Event|2|||
42369833|NCT01777763|76232478|FG001|Overall Study|Adverse Event|32|||
42369834|NCT01777763|76232477|FG000|Overall Study|Protocol Violation|1|||
42369835|NCT01777763|76232478|FG001|Overall Study|Protocol Violation|7|||
42369836|NCT01777763|76232477|FG000|Overall Study|Withdrawal by Subject|0|||
42369837|NCT01777763|76232478|FG001|Overall Study|Withdrawal by Subject|2|||
42369838|NCT01777763|76232477|FG000|Overall Study|Treatment Failure|1|||
42369839|NCT01777763|76232478|FG001|Overall Study|Treatment Failure|6|||
42369840|NCT01769339|76232484|FG000|Overall Study|Lost to Follow-up|42|||
42369841|NCT01769339|76232484|FG000|Overall Study|Adverse Event|1|||
42369842|NCT01769105|76232490|FG000|First Intervention|Protocol Violation|2|||
42369843|NCT01769105|76232491|FG001|First Intervention|Protocol Violation|2|||
42369844|NCT01769105|76232490|FG000|Cross-over|Lost to Follow-up|5|||
42369845|NCT01769105|76232491|FG001|Cross-over|Lost to Follow-up|0|||
42369846|NCT01777139|76232499|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
42369847|NCT01777139|76232500|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
42369848|NCT01777139|76232499|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
42103180|NCT00675506|75914169|FG001|Overall Study|Disclosed history of cancer|0|||
42103181|NCT00675506|75914168|FG000|Overall Study|Declined participation|1|||
42103182|NCT00675506|75914169|FG001|Overall Study|Declined participation|0|||
42103183|NCT00675506|75914168|FG000|Overall Study|Schedule conflict|0|||
42103184|NCT00675506|75914169|FG001|Overall Study|Schedule conflict|1|||
42103185|NCT03895840|75914176|FG000|Overall Study|Withdrawal by Subject|21|||
42103186|NCT00310375|75914182|FG000|Primary Reporting Phase|Adverse Event|28|||
42103187|NCT00310375|75914183|FG001|Primary Reporting Phase|Adverse Event|22|||
42103188|NCT00310375|75914184|FG002|Primary Reporting Phase|Adverse Event|0|||
42103189|NCT00310375|75914182|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
42103190|NCT00310375|75914183|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
42103191|NCT00310375|75914184|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
42103192|NCT00310375|75914182|FG000|Primary Reporting Phase|Pregnancy|2|||
42103193|NCT00310375|75914183|FG001|Primary Reporting Phase|Pregnancy|2|||
42103194|NCT00310375|75914184|FG002|Primary Reporting Phase|Pregnancy|0|||
42103195|NCT00310375|75914182|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
42103196|NCT00310375|75914183|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
42103197|NCT00310375|75914184|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
42103198|NCT00310375|75914182|FG000|Primary Reporting Phase|Protocol Violation|8|||
42103199|NCT00310375|75914183|FG001|Primary Reporting Phase|Protocol Violation|5|||
42103200|NCT00310375|75914184|FG002|Primary Reporting Phase|Protocol Violation|0|||
42103201|NCT00310375|75914182|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
42103202|NCT00310375|75914183|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
42199308|NCT00042289|76010881|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
42199309|NCT00042289|76010882|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
42199310|NCT00042289|76010883|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
42199311|NCT00042289|76010884|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
42199312|NCT00042289|76010885|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
42199313|NCT00042289|76010886|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
42199314|NCT00042289|76010887|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
42199315|NCT00042289|76010888|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
42199316|NCT00042289|76010889|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
42199317|NCT00042289|76010890|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
42199318|NCT00042289|76010891|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
42199319|NCT00042289|76010892|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
42199320|NCT00042289|76010846|FG000|Overall Study|Protocol Violation|0|||
42199321|NCT00042289|76010847|FG001|Overall Study|Protocol Violation|0|||
42199322|NCT00042289|76010848|FG002|Overall Study|Protocol Violation|0|||
42199323|NCT00042289|76010849|FG003|Overall Study|Protocol Violation|0|||
42199324|NCT00042289|76010850|FG004|Overall Study|Protocol Violation|0|||
42369849|NCT01777139|76232500|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
42103203|NCT00310375|75914184|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
42103204|NCT00310375|75914182|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
42199325|NCT00042289|76010851|FG005|Overall Study|Protocol Violation|1|||
42199326|NCT00042289|76010852|FG006|Overall Study|Protocol Violation|0|||
42199327|NCT00042289|76010853|FG007|Overall Study|Protocol Violation|1|||
42199328|NCT00042289|76010854|FG008|Overall Study|Protocol Violation|0|||
42199329|NCT00042289|76010855|FG009|Overall Study|Protocol Violation|0|||
42199330|NCT00042289|76010856|FG010|Overall Study|Protocol Violation|0|||
42199331|NCT00042289|76010857|FG011|Overall Study|Protocol Violation|0|||
42199332|NCT00042289|76010858|FG012|Overall Study|Protocol Violation|0|||
42199333|NCT00042289|76010859|FG013|Overall Study|Protocol Violation|0|||
42199334|NCT00042289|76010860|FG014|Overall Study|Protocol Violation|0|||
42199335|NCT00042289|76010861|FG015|Overall Study|Protocol Violation|0|||
42199336|NCT00042289|76010862|FG016|Overall Study|Protocol Violation|0|||
42199337|NCT00042289|76010863|FG017|Overall Study|Protocol Violation|0|||
42199338|NCT00042289|76010864|FG018|Overall Study|Protocol Violation|0|||
42199339|NCT00042289|76010865|FG019|Overall Study|Protocol Violation|0|||
42103205|NCT00310375|75914183|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
42103206|NCT00310375|75914184|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
42103207|NCT00310375|75914182|FG000|Primary Reporting Phase|Physician Decision|5|||
42103208|NCT00310375|75914183|FG001|Primary Reporting Phase|Physician Decision|3|||
42103209|NCT00310375|75914184|FG002|Primary Reporting Phase|Physician Decision|0|||
42103210|NCT00310375|75914182|FG000|Primary Reporting Phase|Request of the sponsor|2|||
42103211|NCT00310375|75914183|FG001|Primary Reporting Phase|Request of the sponsor|2|||
42103212|NCT00310375|75914184|FG002|Primary Reporting Phase|Request of the sponsor|0|||
42103213|NCT00310375|75914182|FG000|Primary Reporting Phase|Failed to return|1|||
42103214|NCT00310375|75914183|FG001|Primary Reporting Phase|Failed to return|3|||
42103215|NCT00310375|75914184|FG002|Primary Reporting Phase|Failed to return|0|||
42103216|NCT00310375|75914182|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
42103217|NCT00310375|75914183|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
42103218|NCT00310375|75914184|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
42103219|NCT00310375|75914182|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
42103220|NCT00310375|75914183|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
42103221|NCT00310375|75914184|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
42103222|NCT00310375|75914182|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
42103223|NCT00310375|75914183|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
42103224|NCT00310375|75914184|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
42103225|NCT00310375|75914182|FG000|Primary Reporting Phase|Site closure|3|||
42103226|NCT00310375|75914183|FG001|Primary Reporting Phase|Site closure|0|||
42103227|NCT00310375|75914184|FG002|Primary Reporting Phase|Site closure|0|||
42103228|NCT00310375|75914182|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
42103229|NCT00310375|75914183|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
42103230|NCT00310375|75914184|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
42103231|NCT00310375|75914182|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
42103232|NCT00310375|75914183|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
42103233|NCT00310375|75914184|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
42103234|NCT00310375|75914182|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
42103235|NCT00310375|75914183|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
42103236|NCT00310375|75914184|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
42103237|NCT00310375|75914182|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
42103238|NCT00310375|75914183|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
42103239|NCT00310375|75914184|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
42103240|NCT00309907|75914193|FG000|Overall Study|Death|4|||
42103241|NCT00309907|75914193|FG000|Overall Study|Physician Decision|1|||
42103242|NCT00309907|75914193|FG000|Overall Study|Ineligible|11|||
42103243|NCT00309907|75914193|FG000|Overall Study|Major infectious event|4|||
42103244|NCT00655824|75914198|FG000|Overall Study|Adverse Event|3|||
42103245|NCT00655824|75914198|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
42103246|NCT00655824|75914198|FG000|Overall Study|Protocol Violation|1|||
42103247|NCT00655824|75914198|FG000|Overall Study|Withdrawal by Subject|4|||
42103248|NCT00655824|75914198|FG000|Overall Study|Deterioration of Trial Disease|2|||
42103249|NCT00575588|75914204|FG000|Overall Study|Adverse Event|11|||
42103250|NCT00575588|75914205|FG001|Overall Study|Adverse Event|13|||
42103251|NCT00575588|75914204|FG000|Overall Study|Withdrawal by Subject|27|||
42103252|NCT00575588|75914205|FG001|Overall Study|Withdrawal by Subject|31|||
42103253|NCT00575588|75914204|FG000|Overall Study|Lost to Follow-up|1|||
42103254|NCT00575588|75914205|FG001|Overall Study|Lost to Follow-up|3|||
42103255|NCT00575588|75914204|FG000|Overall Study|Death|4|||
42199340|NCT00042289|76010866|FG020|Overall Study|Protocol Violation|0|||
42199341|NCT00042289|76010867|FG021|Overall Study|Protocol Violation|0|||
42199342|NCT00042289|76010868|FG022|Overall Study|Protocol Violation|0|||
42199343|NCT00042289|76010869|FG023|Overall Study|Protocol Violation|1|||
42199344|NCT00042289|76010870|FG024|Overall Study|Protocol Violation|1|||
42199345|NCT00042289|76010871|FG025|Overall Study|Protocol Violation|0|||
42199346|NCT00042289|76010872|FG026|Overall Study|Protocol Violation|2|||
42199347|NCT00042289|76010873|FG027|Overall Study|Protocol Violation|0|||
42199348|NCT00042289|76010874|FG028|Overall Study|Protocol Violation|0|||
42199349|NCT00042289|76010875|FG029|Overall Study|Protocol Violation|0|||
42199350|NCT00042289|76010876|FG030|Overall Study|Protocol Violation|1|||
42199351|NCT00042289|76010877|FG031|Overall Study|Protocol Violation|0|||
42199352|NCT00042289|76010878|FG032|Overall Study|Protocol Violation|0|||
42199353|NCT00042289|76010879|FG033|Overall Study|Protocol Violation|0|||
42199354|NCT00042289|76010880|FG034|Overall Study|Protocol Violation|0|||
42199355|NCT00042289|76010881|FG035|Overall Study|Protocol Violation|0|||
42199356|NCT00042289|76010882|FG036|Overall Study|Protocol Violation|0|||
42199357|NCT00042289|76010883|FG037|Overall Study|Protocol Violation|0|||
42199358|NCT00042289|76010884|FG038|Overall Study|Protocol Violation|0|||
42199359|NCT00042289|76010885|FG039|Overall Study|Protocol Violation|0|||
42199360|NCT00042289|76010886|FG040|Overall Study|Protocol Violation|0|||
42199361|NCT00042289|76010887|FG041|Overall Study|Protocol Violation|1|||
42199362|NCT00042289|76010888|FG042|Overall Study|Protocol Violation|1|||
42199363|NCT00042289|76010889|FG043|Overall Study|Protocol Violation|1|||
42199364|NCT00042289|76010890|FG044|Overall Study|Protocol Violation|0|||
42199365|NCT00042289|76010891|FG045|Overall Study|Protocol Violation|0|||
42199366|NCT00042289|76010892|FG046|Overall Study|Protocol Violation|0|||
42199367|NCT00042289|76010846|FG000|Overall Study|Withdrawal by Subject|4|||
42199368|NCT00042289|76010847|FG001|Overall Study|Withdrawal by Subject|1|||
42199369|NCT00042289|76010848|FG002|Overall Study|Withdrawal by Subject|0|||
42199370|NCT00042289|76010849|FG003|Overall Study|Withdrawal by Subject|2|||
42199371|NCT00042289|76010850|FG004|Overall Study|Withdrawal by Subject|0|||
42199372|NCT00042289|76010851|FG005|Overall Study|Withdrawal by Subject|2|||
42199373|NCT00042289|76010852|FG006|Overall Study|Withdrawal by Subject|0|||
42199374|NCT00042289|76010853|FG007|Overall Study|Withdrawal by Subject|0|||
42199375|NCT00042289|76010854|FG008|Overall Study|Withdrawal by Subject|0|||
42199376|NCT00042289|76010855|FG009|Overall Study|Withdrawal by Subject|1|||
42199377|NCT00042289|76010856|FG010|Overall Study|Withdrawal by Subject|0|||
42199378|NCT00042289|76010857|FG011|Overall Study|Withdrawal by Subject|0|||
42199379|NCT00042289|76010858|FG012|Overall Study|Withdrawal by Subject|2|||
42199380|NCT00042289|76010859|FG013|Overall Study|Withdrawal by Subject|0|||
42199381|NCT00042289|76010860|FG014|Overall Study|Withdrawal by Subject|0|||
42199382|NCT00042289|76010861|FG015|Overall Study|Withdrawal by Subject|0|||
42199383|NCT00042289|76010862|FG016|Overall Study|Withdrawal by Subject|0|||
42199384|NCT00042289|76010863|FG017|Overall Study|Withdrawal by Subject|0|||
42199385|NCT00042289|76010864|FG018|Overall Study|Withdrawal by Subject|0|||
42199386|NCT00042289|76010865|FG019|Overall Study|Withdrawal by Subject|0|||
42199387|NCT00042289|76010866|FG020|Overall Study|Withdrawal by Subject|0|||
42199388|NCT00042289|76010867|FG021|Overall Study|Withdrawal by Subject|1|||
42199389|NCT00042289|76010868|FG022|Overall Study|Withdrawal by Subject|1|||
42199390|NCT00042289|76010869|FG023|Overall Study|Withdrawal by Subject|1|||
42199391|NCT00042289|76010870|FG024|Overall Study|Withdrawal by Subject|0|||
42199392|NCT00042289|76010871|FG025|Overall Study|Withdrawal by Subject|0|||
42199393|NCT00042289|76010872|FG026|Overall Study|Withdrawal by Subject|1|||
42199394|NCT00042289|76010873|FG027|Overall Study|Withdrawal by Subject|0|||
42199395|NCT00042289|76010874|FG028|Overall Study|Withdrawal by Subject|2|||
42199396|NCT00042289|76010875|FG029|Overall Study|Withdrawal by Subject|0|||
42199397|NCT00042289|76010876|FG030|Overall Study|Withdrawal by Subject|0|||
42199398|NCT00042289|76010877|FG031|Overall Study|Withdrawal by Subject|1|||
42199399|NCT00042289|76010878|FG032|Overall Study|Withdrawal by Subject|2|||
42199400|NCT00042289|76010879|FG033|Overall Study|Withdrawal by Subject|1|||
42103256|NCT00575588|75914205|FG001|Overall Study|Death|2|||
42103257|NCT00575588|75914204|FG000|Overall Study|Incorrect enrollment|8|||
42103258|NCT00575588|75914205|FG001|Overall Study|Incorrect enrollment|4|||
42103259|NCT00575588|75914204|FG000|Overall Study|Study specific discontinuation criteria|203|||
42103260|NCT00575588|75914205|FG001|Overall Study|Study specific discontinuation criteria|218|||
42103261|NCT00575588|75914204|FG000|Overall Study|Severe non-compliance to protocol|5|||
42103262|NCT00575588|75914205|FG001|Overall Study|Severe non-compliance to protocol|7|||
42103263|NCT00575588|75914204|FG000|Overall Study|Safety reasons|2|||
42103264|NCT00575588|75914205|FG001|Overall Study|Safety reasons|1|||
42103265|NCT00575588|75914204|FG000|Overall Study|Elevated triglyceride|1|||
42103266|NCT00575588|75914205|FG001|Overall Study|Elevated triglyceride|0|||
42199401|NCT00042289|76010880|FG034|Overall Study|Withdrawal by Subject|0|||
42199402|NCT00042289|76010881|FG035|Overall Study|Withdrawal by Subject|0|||
42199403|NCT00042289|76010882|FG036|Overall Study|Withdrawal by Subject|0|||
42199404|NCT00042289|76010883|FG037|Overall Study|Withdrawal by Subject|1|||
42199405|NCT00042289|76010884|FG038|Overall Study|Withdrawal by Subject|0|||
42199406|NCT00042289|76010885|FG039|Overall Study|Withdrawal by Subject|0|||
42199407|NCT00042289|76010886|FG040|Overall Study|Withdrawal by Subject|0|||
42199408|NCT00042289|76010887|FG041|Overall Study|Withdrawal by Subject|0|||
42199409|NCT00042289|76010888|FG042|Overall Study|Withdrawal by Subject|1|||
42369850|NCT01777139|76232499|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
42103267|NCT00575588|75914204|FG000|Overall Study|Patient moved|1|||
42199410|NCT00042289|76010889|FG043|Overall Study|Withdrawal by Subject|0|||
42199411|NCT00042289|76010890|FG044|Overall Study|Withdrawal by Subject|0|||
42199412|NCT00042289|76010891|FG045|Overall Study|Withdrawal by Subject|0|||
42199413|NCT00042289|76010892|FG046|Overall Study|Withdrawal by Subject|0|||
42199414|NCT02886728|76011064|FG000|Overall Study|Withdrew Consent|31|||
42199415|NCT02886728|76011065|FG001|Overall Study|Withdrew Consent|13|||
42199416|NCT02886728|76011066|FG002|Overall Study|Withdrew Consent|11|||
42199417|NCT02886728|76011067|FG003|Overall Study|Withdrew Consent|47|||
42199418|NCT02886728|76011064|FG000|Overall Study|Lost to Follow-up|12|||
42199419|NCT02886728|76011065|FG001|Overall Study|Lost to Follow-up|6|||
42199420|NCT02886728|76011066|FG002|Overall Study|Lost to Follow-up|13|||
42199421|NCT02886728|76011067|FG003|Overall Study|Lost to Follow-up|12|||
42199422|NCT02886728|76011064|FG000|Overall Study|Adverse Event|13|||
42199423|NCT02886728|76011065|FG001|Overall Study|Adverse Event|5|||
42199424|NCT02886728|76011066|FG002|Overall Study|Adverse Event|5|||
42199425|NCT02886728|76011067|FG003|Overall Study|Adverse Event|11|||
42199426|NCT02886728|76011064|FG000|Overall Study|Investigator's Discretion|11|||
42199427|NCT02886728|76011065|FG001|Overall Study|Investigator's Discretion|7|||
42369851|NCT01777139|76232500|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
42369852|NCT01777139|76232499|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
42369853|NCT01777139|76232500|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
42369854|NCT01777139|76232499|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
42369855|NCT01777139|76232500|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
42369856|NCT01777139|76232499|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
42369857|NCT01777139|76232500|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
42369858|NCT01777139|76232499|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
42369859|NCT01777139|76232500|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
42369860|NCT01777139|76232499|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
42369861|NCT01777139|76232500|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
42369862|NCT01768637|76232509|FG000|Overall Study|Lost to Follow-up|2|||
42369863|NCT01768637|76232510|FG001|Overall Study|Lost to Follow-up|7|||
42369864|NCT01768637|76232509|FG000|Overall Study|Difficult blood draw|1|||
42369865|NCT01768637|76232510|FG001|Overall Study|Difficult blood draw|0|||
42369866|NCT01768559|76232519|FG000|Overall Study|Randomized but not treated|0|||
42369867|NCT01768559|76232520|FG001|Overall Study|Randomized but not treated|0|||
42369868|NCT01768559|76232521|FG002|Overall Study|Randomized but not treated|1|||
42369869|NCT01768559|76232519|FG000|Overall Study|Adverse Event|15|||
42369870|NCT01768559|76232520|FG001|Overall Study|Adverse Event|2|||
42369871|NCT01768559|76232521|FG002|Overall Study|Adverse Event|5|||
42369872|NCT01768559|76232519|FG000|Overall Study|Lack of Efficacy|6|||
42369873|NCT01768559|76232520|FG001|Overall Study|Lack of Efficacy|4|||
42369874|NCT01768559|76232521|FG002|Overall Study|Lack of Efficacy|0|||
42369875|NCT01768559|76232519|FG000|Overall Study|Poor compliance to protocol|0|||
42369876|NCT01768559|76232520|FG001|Overall Study|Poor compliance to protocol|3|||
42369877|NCT01768559|76232521|FG002|Overall Study|Poor compliance to protocol|2|||
42369878|NCT01768559|76232519|FG000|Overall Study|Other than specified|9|||
42369879|NCT01768559|76232520|FG001|Overall Study|Other than specified|8|||
42369880|NCT01768559|76232521|FG002|Overall Study|Other than specified|5|||
42369881|NCT00983619|76232545|FG000|Overall Study|Lost to Follow-up|0|||
42369882|NCT00983619|76232546|FG001|Overall Study|Lost to Follow-up|1|||
42369883|NCT00983619|76232547|FG002|Overall Study|Lost to Follow-up|0|||
42369884|NCT00983619|76232548|FG003|Overall Study|Lost to Follow-up|0|||
42369885|NCT00983619|76232549|FG004|Overall Study|Lost to Follow-up|0|||
42369886|NCT00983619|76232550|FG005|Overall Study|Lost to Follow-up|2|||
42369887|NCT00983619|76232551|FG006|Overall Study|Lost to Follow-up|0|||
42369888|NCT00983619|76232552|FG007|Overall Study|Lost to Follow-up|0|||
42369889|NCT00983619|76232553|FG008|Overall Study|Lost to Follow-up|0|||
42369890|NCT00983619|76232554|FG009|Overall Study|Lost to Follow-up|0|||
42369891|NCT00983619|76232555|FG010|Overall Study|Lost to Follow-up|0|||
42369892|NCT00983619|76232556|FG011|Overall Study|Lost to Follow-up|2|||
42369893|NCT00983619|76232545|FG000|Overall Study|Withdrawal by Subject|2|||
42369894|NCT00983619|76232546|FG001|Overall Study|Withdrawal by Subject|1|||
42369895|NCT00983619|76232547|FG002|Overall Study|Withdrawal by Subject|1|||
42369896|NCT00983619|76232548|FG003|Overall Study|Withdrawal by Subject|3|||
42369897|NCT00983619|76232549|FG004|Overall Study|Withdrawal by Subject|1|||
42369898|NCT00983619|76232550|FG005|Overall Study|Withdrawal by Subject|23|||
42369899|NCT00983619|76232551|FG006|Overall Study|Withdrawal by Subject|0|||
42369900|NCT00983619|76232552|FG007|Overall Study|Withdrawal by Subject|0|||
42369901|NCT00983619|76232553|FG008|Overall Study|Withdrawal by Subject|0|||
42103268|NCT00575588|75914205|FG001|Overall Study|Patient moved|3|||
42199428|NCT02886728|76011066|FG002|Overall Study|Investigator's Discretion|5|||
42199429|NCT02886728|76011067|FG003|Overall Study|Investigator's Discretion|11|||
42199430|NCT02886728|76011064|FG000|Overall Study|Death|3|||
42199431|NCT02886728|76011065|FG001|Overall Study|Death|1|||
42199432|NCT02886728|76011066|FG002|Overall Study|Death|0|||
42199433|NCT02886728|76011067|FG003|Overall Study|Death|0|||
42199434|NCT02886728|76011064|FG000|Overall Study|Protocol Violation|0|||
42199435|NCT02886728|76011065|FG001|Overall Study|Protocol Violation|0|||
42199436|NCT02886728|76011066|FG002|Overall Study|Protocol Violation|0|||
42199437|NCT02886728|76011067|FG003|Overall Study|Protocol Violation|4|||
42199438|NCT02886728|76011064|FG000|Overall Study|Non-Compliance with Study Drug|1|||
42199439|NCT02886728|76011065|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42199440|NCT02886728|76011066|FG002|Overall Study|Non-Compliance with Study Drug|1|||
42199441|NCT02886728|76011067|FG003|Overall Study|Non-Compliance with Study Drug|0|||
42199442|NCT02886728|76011064|FG000|Overall Study|Pregnancy|0|||
42199443|NCT02886728|76011065|FG001|Overall Study|Pregnancy|0|||
42199444|NCT02886728|76011066|FG002|Overall Study|Pregnancy|1|||
42199445|NCT02886728|76011067|FG003|Overall Study|Pregnancy|0|||
42199446|NCT02886728|76011064|FG000|Overall Study|Randomized but Not Dosed|1|||
42199447|NCT02886728|76011065|FG001|Overall Study|Randomized but Not Dosed|0|||
42199448|NCT02886728|76011066|FG002|Overall Study|Randomized but Not Dosed|0|||
42199449|NCT02886728|76011067|FG003|Overall Study|Randomized but Not Dosed|2|||
42199450|NCT00039871|76011077|FG000|Overall Study|Adverse Event|165|||
42199451|NCT00039871|76011077|FG000|Overall Study|Lost to Follow-up|18|||
42199452|NCT00039871|76011077|FG000|Overall Study|Protocol Violation|24|||
42199453|NCT00039871|76011077|FG000|Overall Study|Withdrawal by Subject|97|||
42199454|NCT00039871|76011077|FG000|Overall Study|Did not meet eligibility criteria|11|||
42199455|NCT00039871|76011077|FG000|Overall Study|Administrative|1|||
42199456|NCT00039871|76011077|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
42199457|NCT00039871|76011077|FG000|Overall Study|Never entered follow-up|7|||
42199458|NCT00015457|76011081|FG000|First Intervention|Adverse Event|0|||
42199459|NCT00015457|76011082|FG001|First Intervention|Adverse Event|2|||
42199460|NCT00015457|76011081|FG000|First Intervention|Lack of Efficacy|0|||
42199461|NCT00015457|76011082|FG001|First Intervention|Lack of Efficacy|1|||
42199462|NCT00015457|76011081|FG000|Second Intervention|Withdrawal by Subject|1|||
42199463|NCT00015457|76011082|FG001|Second Intervention|Withdrawal by Subject|0|||
42199464|NCT03191630|76011095|FG000|Overall Study|Lost to Follow-up|7|||
42199465|NCT03191630|76011096|FG001|Overall Study|Lost to Follow-up|7|||
42199466|NCT03191552|76011107|FG000|Overall Study|Lost to Follow-up|1|||
42199467|NCT03191552|76011108|FG001|Overall Study|Lost to Follow-up|0|||
42199468|NCT03191552|76011109|FG002|Overall Study|Lost to Follow-up|0|||
42199469|NCT03191552|76011107|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
42199470|NCT03191552|76011108|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
42199471|NCT03191552|76011109|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
42199472|NCT03191396|76011123|FG000|Overall Study|Lost to Follow-up|0|||
42199473|NCT03191396|76011124|FG001|Overall Study|Lost to Follow-up|3|||
42199474|NCT03191396|76011123|FG000|Overall Study|Withdrawal by Subject|3|||
42199475|NCT03191396|76011124|FG001|Overall Study|Withdrawal by Subject|2|||
42199476|NCT00007345|76011132|FG000|Overall Study|Refused further treatment|0|||
42199477|NCT00007345|76011133|FG001|Overall Study|Refused further treatment|7|||
42199478|NCT00007345|76011132|FG000|Overall Study|Switched to alternative treatment|0|||
42199479|NCT00007345|76011133|FG001|Overall Study|Switched to alternative treatment|3|||
42199480|NCT00007345|76011132|FG000|Overall Study|Intercurrent illness|1|||
42199481|NCT00007345|76011133|FG001|Overall Study|Intercurrent illness|0|||
42199482|NCT00007345|76011132|FG000|Overall Study|Death on study|1|||
42199483|NCT00007345|76011133|FG001|Overall Study|Death on study|1|||
42199484|NCT03405662|76011141|FG000|Overall Study|COVID-19 restriction|1|||
42199485|NCT03405662|76011142|FG001|Overall Study|COVID-19 restriction|0|||
42199486|NCT03405662|76011141|FG000|Overall Study|unblinding|0|||
42199487|NCT03405662|76011142|FG001|Overall Study|unblinding|1|||
42199488|NCT03405662|76011141|FG000|Overall Study|placement in memory care facility|0|||
42199489|NCT03405662|76011142|FG001|Overall Study|placement in memory care facility|2|||
42199490|NCT00031447|76011150|FG000|Overall Study|Lost to Follow-up|0|||
42199491|NCT00031447|76011151|FG001|Overall Study|Lost to Follow-up|1|||
42199492|NCT00031447|76011150|FG000|Overall Study|Non-compliant|1|||
42199493|NCT00031447|76011151|FG001|Overall Study|Non-compliant|1|||
42199494|NCT00031447|76011150|FG000|Overall Study|Re-activation of Disease|2|||
42369902|NCT00983619|76232554|FG009|Overall Study|Withdrawal by Subject|0|||
42199495|NCT00031447|76011151|FG001|Overall Study|Re-activation of Disease|1|||
42199496|NCT00031447|76011150|FG000|Overall Study|Disruption of blinded study drug supply|7|||
42199497|NCT00031447|76011151|FG001|Overall Study|Disruption of blinded study drug supply|4|||
42199498|NCT00006409|76011163|FG000|Baseline|Protocol Violation|48|||
42199499|NCT00006409|76011164|FG001|Baseline|Protocol Violation|70|||
42199500|NCT00006409|76011165|FG002|Baseline|Protocol Violation|0|||
42199501|NCT00006409|76011166|FG003|Baseline|Protocol Violation|0|||
42199502|NCT00006409|76011167|FG004|Baseline|Protocol Violation|0|||
42199503|NCT00006409|76011168|FG005|Baseline|Protocol Violation|0|||
42199504|NCT00006409|76011163|FG000|Post-2 Year Intervention|Protocol Violation|0|||
42199505|NCT00006409|76011164|FG001|Post-2 Year Intervention|Protocol Violation|0|||
42199506|NCT00006409|76011165|FG002|Post-2 Year Intervention|Protocol Violation|251|||
42199507|NCT00006409|76011166|FG003|Post-2 Year Intervention|Protocol Violation|168|||
42369903|NCT00983619|76232555|FG010|Overall Study|Withdrawal by Subject|1|||
42199508|NCT00006409|76011167|FG004|Post-2 Year Intervention|Protocol Violation|0|||
42199509|NCT00006409|76011168|FG005|Post-2 Year Intervention|Protocol Violation|0|||
42199510|NCT00006409|76011163|FG000|Post-3 Year Intervention|Protocol Violation|0|||
42199511|NCT00006409|76011164|FG001|Post-3 Year Intervention|Protocol Violation|0|||
42199512|NCT00006409|76011165|FG002|Post-3 Year Intervention|Protocol Violation|0|||
42199513|NCT00006409|76011166|FG003|Post-3 Year Intervention|Protocol Violation|0|||
42199514|NCT00006409|76011167|FG004|Post-3 Year Intervention|Protocol Violation|62|||
42199515|NCT00006409|76011168|FG005|Post-3 Year Intervention|Protocol Violation|62|||
42199516|NCT00006289|76011184|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
42199517|NCT00006289|76011185|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
42199518|NCT00006289|76011184|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
42199519|NCT00006289|76011185|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
42199520|NCT00005947|76011203|FG000|Overall Study|Death|54|||
42369904|NCT00983619|76232556|FG011|Overall Study|Withdrawal by Subject|1|||
42369905|NCT00983619|76232545|FG000|Overall Study|Death|0|||
42369906|NCT00983619|76232546|FG001|Overall Study|Death|2|||
42369907|NCT00983619|76232547|FG002|Overall Study|Death|2|||
42369908|NCT00983619|76232548|FG003|Overall Study|Death|1|||
42369909|NCT00983619|76232549|FG004|Overall Study|Death|2|||
42369910|NCT00983619|76232550|FG005|Overall Study|Death|30|||
42369911|NCT00983619|76232551|FG006|Overall Study|Death|1|||
42369912|NCT00983619|76232552|FG007|Overall Study|Death|0|||
42369913|NCT00983619|76232553|FG008|Overall Study|Death|1|||
42369914|NCT00983619|76232554|FG009|Overall Study|Death|2|||
42369915|NCT00983619|76232555|FG010|Overall Study|Death|9|||
42369916|NCT00983619|76232556|FG011|Overall Study|Death|8|||
42369917|NCT00983619|76232545|FG000|Overall Study|Other|1|||
42369918|NCT00983619|76232546|FG001|Overall Study|Other|0|||
42369919|NCT00983619|76232547|FG002|Overall Study|Other|0|||
42369920|NCT00983619|76232548|FG003|Overall Study|Other|1|||
42369921|NCT00983619|76232549|FG004|Overall Study|Other|0|||
42369922|NCT00983619|76232550|FG005|Overall Study|Other|12|||
42369923|NCT00983619|76232551|FG006|Overall Study|Other|2|||
42369924|NCT00983619|76232552|FG007|Overall Study|Other|2|||
42369925|NCT00983619|76232553|FG008|Overall Study|Other|0|||
42369926|NCT00983619|76232554|FG009|Overall Study|Other|1|||
42369927|NCT00983619|76232555|FG010|Overall Study|Other|1|||
42369928|NCT00983619|76232556|FG011|Overall Study|Other|0|||
42369929|NCT01767857|76232604|FG000|Overall Study|Adverse Event|27|||
42369930|NCT01767857|76232605|FG001|Overall Study|Adverse Event|7|||
42369931|NCT01767857|76232604|FG000|Overall Study|Death|28|||
42369932|NCT01767857|76232605|FG001|Overall Study|Death|13|||
42369933|NCT01767857|76232604|FG000|Overall Study|Lack of Efficacy|299|||
42369934|NCT01767857|76232605|FG001|Overall Study|Lack of Efficacy|151|||
42369935|NCT01767857|76232604|FG000|Overall Study|Lost to Follow-up|1|||
42369936|NCT01767857|76232605|FG001|Overall Study|Lost to Follow-up|1|||
42369937|NCT01767857|76232604|FG000|Overall Study|Withdrawal by Subject|38|||
42369938|NCT01767857|76232605|FG001|Overall Study|Withdrawal by Subject|18|||
42369939|NCT01767857|76232604|FG000|Overall Study|Physician Decision|17|||
42369940|NCT01767857|76232605|FG001|Overall Study|Physician Decision|10|||
42369941|NCT01767857|76232604|FG000|Overall Study|Protocol Terminated|1|||
42199521|NCT00005947|76011204|FG001|Overall Study|Death|40|||
42199522|NCT00005947|76011203|FG000|Overall Study|Patient Refused to Continue|2|||
42199523|NCT00005947|76011204|FG001|Overall Study|Patient Refused to Continue|1|||
42199524|NCT00005947|76011203|FG000|Overall Study|Site Closure|1|||
42199525|NCT00005947|76011204|FG001|Overall Study|Site Closure|0|||
42199526|NCT00005047|76011216|FG000|Overall Study|Withdrawal by Subject|12|||
42199527|NCT00005047|76011217|FG001|Overall Study|Withdrawal by Subject|0|||
42199528|NCT00005047|76011218|FG002|Overall Study|Withdrawal by Subject|0|||
42199529|NCT00005047|76011219|FG003|Overall Study|Withdrawal by Subject|0|||
42199530|NCT00005047|76011216|FG000|Overall Study|Adverse Event|5|||
42199531|NCT00005047|76011217|FG001|Overall Study|Adverse Event|0|||
42199532|NCT00005047|76011218|FG002|Overall Study|Adverse Event|0|||
42199533|NCT00005047|76011219|FG003|Overall Study|Adverse Event|0|||
42369942|NCT01767857|76232605|FG001|Overall Study|Protocol Terminated|0|||
42369943|NCT01767857|76232604|FG000|Overall Study|Randomized But Never Treated|19|||
42369944|NCT01767857|76232605|FG001|Overall Study|Randomized But Never Treated|13|||
42369945|NCT01775501|76232612|FG000|Overall Study|Discontinued prior to treatment|1|||
42369946|NCT01775189|76232641|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42369947|NCT01775189|76232642|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
42369948|NCT01775189|76232643|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42369949|NCT01775189|76232644|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42369950|NCT01775189|76232645|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42369951|NCT01775189|76232646|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42369952|NCT01775189|76232647|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
42199534|NCT00005047|76011216|FG000|Overall Study|Lost to Follow-up|1|||
42199535|NCT00005047|76011217|FG001|Overall Study|Lost to Follow-up|0|||
42199536|NCT00005047|76011218|FG002|Overall Study|Lost to Follow-up|0|||
42199537|NCT00005047|76011219|FG003|Overall Study|Lost to Follow-up|0|||
42199538|NCT00005047|76011216|FG000|Overall Study|Lack of Efficacy|1|||
42199539|NCT00005047|76011217|FG001|Overall Study|Lack of Efficacy|0|||
42199540|NCT00005047|76011218|FG002|Overall Study|Lack of Efficacy|0|||
42199541|NCT00005047|76011219|FG003|Overall Study|Lack of Efficacy|0|||
42199542|NCT00003901|76011229|FG000|Overall Study|Adverse Event|1|||
42199543|NCT00003901|76011229|FG000|Overall Study|Withdrawal by Subject|1|||
42199544|NCT00003901|76011229|FG000|Overall Study|Ineligible|6|||
42199545|NCT00003901|76011229|FG000|Overall Study|CT Scan not within protocol requirement|2|||
42199546|NCT00003901|76011229|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
42199547|NCT00003901|76011229|FG000|Overall Study|Medical problems|6|||
42199548|NCT00003895|76011238|FG000|Overall Study|Adverse Event|4|||
42199549|NCT00003895|76011239|FG001|Overall Study|Adverse Event|0|||
42199550|NCT00003895|76011238|FG000|Overall Study|Lack of Efficacy|1|||
42199551|NCT00003895|76011239|FG001|Overall Study|Lack of Efficacy|1|||
42199552|NCT00003895|76011238|FG000|Overall Study|Patient Vacation|2|||
42199553|NCT00003895|76011239|FG001|Overall Study|Patient Vacation|0|||
42199554|NCT00003895|76011238|FG000|Overall Study|Withdrawal by Subject|0|||
42199555|NCT00003895|76011239|FG001|Overall Study|Withdrawal by Subject|3|||
42199556|NCT03800173|76011250|FG000|Overall Study|Lost to Follow-up|0|||
42199557|NCT03800173|76011251|FG001|Overall Study|Lost to Follow-up|0|||
42199558|NCT03800173|76011252|FG002|Overall Study|Lost to Follow-up|0|||
42199559|NCT03800173|76011253|FG003|Overall Study|Lost to Follow-up|0|||
42199560|NCT03800173|76011254|FG004|Overall Study|Lost to Follow-up|1|||
42199561|NCT00003631|76011273|FG000|Overall Study|Patient not treated|1|||
42199562|NCT00003631|76011274|FG001|Overall Study|Patient not treated|0|||
42199563|NCT00003631|76011275|FG002|Overall Study|Patient not treated|1|||
42199564|NCT00003631|76011273|FG000|Overall Study|Protocol Violation|1|||
42199565|NCT00003631|76011274|FG001|Overall Study|Protocol Violation|0|||
42199566|NCT00003631|76011275|FG002|Overall Study|Protocol Violation|0|||
42199567|NCT00003631|76011273|FG000|Overall Study|Adverse Event|1|||
42199568|NCT00003631|76011274|FG001|Overall Study|Adverse Event|1|||
42199569|NCT00003631|76011275|FG002|Overall Study|Adverse Event|5|||
42199570|NCT00003631|76011273|FG000|Overall Study|Death|0|||
42199571|NCT00003631|76011274|FG001|Overall Study|Death|0|||
42199572|NCT00003631|76011275|FG002|Overall Study|Death|1|||
42199573|NCT00003631|76011273|FG000|Overall Study|Evaluable for toxicity only|0|||
42199574|NCT00003631|76011274|FG001|Overall Study|Evaluable for toxicity only|0|||
42199575|NCT00003631|76011275|FG002|Overall Study|Evaluable for toxicity only|2|||
42199576|NCT00003535|76011283|FG000|Overall Study|Not evaluable|5|||
42199577|NCT00003511|76011287|FG000|Overall Study|Not evaluable|4|||
42199578|NCT00003499|76011291|FG000|Overall Study|Not evaluable|8|||
42199579|NCT00003487|76011295|FG000|Overall Study|Not evaluable|2|||
42199580|NCT00003475|76011299|FG000|Overall Study|Not evaluable|13|||
42199581|NCT00003457|76011304|FG000|Overall Study|Not evaluable|9|||
42199582|NCT00030901|76011310|FG000|Initial Registration|Ineligible|167|||
42199583|NCT00030901|76011311|FG001|Initial Registration|Ineligible|0|||
42199584|NCT00030901|76011312|FG002|Initial Registration|Ineligible|0|||
42369953|NCT01775189|76232641|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42369954|NCT01775189|76232642|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
42369955|NCT01775189|76232643|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42369956|NCT01775189|76232644|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42369957|NCT01775189|76232645|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42369958|NCT01775189|76232646|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42369959|NCT01775189|76232647|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
42369960|NCT01775189|76232641|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
42369961|NCT01775189|76232642|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
42369962|NCT01775189|76232643|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
42199585|NCT00030901|76011310|FG000|Randomization|Adverse Event|0|||
42199586|NCT00030901|76011311|FG001|Randomization|Adverse Event|11|||
42199587|NCT00030901|76011312|FG002|Randomization|Adverse Event|7|||
42103269|NCT00575588|75914204|FG000|Overall Study|Impossible to determine HbA1c|0|||
42199588|NCT00030901|76011310|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
42199589|NCT00030901|76011311|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
42199590|NCT00030901|76011312|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
42199591|NCT00030901|76011310|FG000|Randomization|Progression/Relapse|0|||
42199592|NCT00030901|76011311|FG001|Randomization|Progression/Relapse|22|||
42199593|NCT00030901|76011312|FG002|Randomization|Progression/Relapse|21|||
42199594|NCT00030901|76011310|FG000|Randomization|Death|0|||
42199595|NCT00030901|76011311|FG001|Randomization|Death|1|||
42199596|NCT00030901|76011312|FG002|Randomization|Death|3|||
42199597|NCT00030901|76011310|FG000|Randomization|Other|0|||
42199598|NCT00030901|76011311|FG001|Randomization|Other|36|||
42199599|NCT00030901|76011312|FG002|Randomization|Other|33|||
42199600|NCT00030901|76011310|FG000|Randomization|Ineligible|0|||
42199601|NCT00030901|76011311|FG001|Randomization|Ineligible|15|||
42199602|NCT00030901|76011312|FG002|Randomization|Ineligible|14|||
42199603|NCT00003199|76011318|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
42199604|NCT00003199|76011318|FG000|Overall Study|Lack of insurance clearance|2|||
42199605|NCT00003199|76011318|FG000|Overall Study|Screen fail|15|||
42199606|NCT00030823|76011322|FG000|Overall Study|Withdrawal by Subject|1|||
42199607|NCT00001849|76011326|FG000|Overall Study|Death|4|||
42199608|NCT00001849|76011326|FG000|Overall Study|Lost to Follow-up|2|||
42199609|NCT00001849|76011326|FG000|Overall Study|Withdrawal by Subject|2|||
42199610|NCT00001849|76011326|FG000|Overall Study|tumor remained occult|6|||
42199611|NCT01342952|76011343|FG000|Overall Study|Adverse Event|0|||
42199612|NCT01342952|76011344|FG001|Overall Study|Adverse Event|5|||
42199613|NCT01342952|76011345|FG002|Overall Study|Adverse Event|1|||
42199614|NCT01342952|76011346|FG003|Overall Study|Adverse Event|0|||
42199615|NCT01342952|76011343|FG000|Overall Study|Lost to Follow-up|0|||
42199616|NCT01342952|76011344|FG001|Overall Study|Lost to Follow-up|2|||
42199617|NCT01342952|76011345|FG002|Overall Study|Lost to Follow-up|0|||
42199618|NCT01342952|76011346|FG003|Overall Study|Lost to Follow-up|0|||
42199619|NCT01342952|76011343|FG000|Overall Study|Withdrawal by Subject|1|||
42199620|NCT01342952|76011344|FG001|Overall Study|Withdrawal by Subject|1|||
42199621|NCT01342952|76011345|FG002|Overall Study|Withdrawal by Subject|0|||
42199622|NCT01342952|76011346|FG003|Overall Study|Withdrawal by Subject|0|||
42199623|NCT01342952|76011343|FG000|Overall Study|Physician Decision|3|||
42199624|NCT01342952|76011344|FG001|Overall Study|Physician Decision|3|||
42199625|NCT01342952|76011345|FG002|Overall Study|Physician Decision|1|||
42199626|NCT01342952|76011346|FG003|Overall Study|Physician Decision|0|||
42199627|NCT02886884|76011373|FG000|Follow-up|Withdrawal by Subject|0|||
42199628|NCT02886884|76011374|FG001|Follow-up|Withdrawal by Subject|0|||
42199629|NCT02886884|76011375|FG002|Follow-up|Withdrawal by Subject|0|||
42199630|NCT02886884|76011376|FG003|Follow-up|Withdrawal by Subject|1|||
42199631|NCT01240694|76011395|FG000|Overall Study|Adverse Event|9|||
42199632|NCT01240694|76011395|FG000|Overall Study|Lack of Efficacy|6|||
42199633|NCT01240694|76011395|FG000|Overall Study|Withdrawal by Subject|6|||
42199634|NCT01240694|76011395|FG000|Overall Study|Protocol Violation|2|||
42199635|NCT01240694|76011395|FG000|Overall Study|Lost to Follow-up|2|||
42199636|NCT01240694|76011395|FG000|Overall Study|Other than specified|3|||
42199637|NCT01240694|76011395|FG000|Overall Study|Withdrawn due to early study termination|107|||
42199638|NCT03162224|76011402|FG000|Overall Study|Death|4|||
42199639|NCT03162224|76011403|FG001|Overall Study|Death|5|||
42199640|NCT03162224|76011404|FG002|Overall Study|Death|8|||
42199641|NCT03162224|76011402|FG000|Overall Study|Withdrawal by Subject|1|||
42199642|NCT03162224|76011403|FG001|Overall Study|Withdrawal by Subject|0|||
42199643|NCT03162224|76011404|FG002|Overall Study|Withdrawal by Subject|1|||
42199644|NCT03162224|76011402|FG000|Overall Study|Lost to Follow-up|0|||
42199645|NCT03162224|76011403|FG001|Overall Study|Lost to Follow-up|1|||
42199646|NCT03162224|76011404|FG002|Overall Study|Lost to Follow-up|0|||
42199647|NCT03162224|76011402|FG000|Overall Study|Other|6|||
42199648|NCT03162224|76011403|FG001|Overall Study|Other|2|||
42199649|NCT03162224|76011404|FG002|Overall Study|Other|1|||
42199650|NCT02886338|76011443|FG000|Overall Study|Withdrawal by Subject|1|||
42199651|NCT00004124|76011449|FG000|Overall Study|Received no protocol therapy|12|||
42369963|NCT01775189|76232644|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
42369964|NCT01775189|76232645|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
42369965|NCT01775189|76232646|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
42369966|NCT01775189|76232647|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
42369967|NCT01775189|76232641|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
42369968|NCT01775189|76232642|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
42103270|NCT00575588|75914205|FG001|Overall Study|Impossible to determine HbA1c|1|||
42103271|NCT00675428|75914213|FG000|Overall Study|Disease Progression|2|||
42103272|NCT00675428|75914214|FG001|Overall Study|Disease Progression|2|||
42103273|NCT00675428|75914213|FG000|Overall Study|No Disease Response After Cycle 6|0|||
42103274|NCT00675428|75914214|FG001|Overall Study|No Disease Response After Cycle 6|1|||
42199652|NCT00004124|76011450|FG001|Overall Study|Received no protocol therapy|20|||
42199653|NCT00383552|76011460|FG000|Overall Study|Adverse Event|7|||
42199654|NCT00383552|76011461|FG001|Overall Study|Adverse Event|6|||
42199655|NCT00383552|76011462|FG002|Overall Study|Adverse Event|9|||
42199656|NCT00383552|76011463|FG003|Overall Study|Adverse Event|6|||
42199657|NCT00383552|76011460|FG000|Overall Study|Lack of Efficacy|4|||
42199658|NCT00383552|76011461|FG001|Overall Study|Lack of Efficacy|13|||
42199659|NCT00383552|76011462|FG002|Overall Study|Lack of Efficacy|29|||
42199660|NCT00383552|76011463|FG003|Overall Study|Lack of Efficacy|42|||
42199661|NCT00383552|76011460|FG000|Overall Study|Lost to Follow-up|0|||
42199662|NCT00383552|76011461|FG001|Overall Study|Lost to Follow-up|1|||
42199663|NCT00383552|76011462|FG002|Overall Study|Lost to Follow-up|5|||
42199664|NCT00383552|76011463|FG003|Overall Study|Lost to Follow-up|1|||
42199665|NCT00383552|76011460|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
42199666|NCT00383552|76011461|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
42199667|NCT00383552|76011462|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
42199668|NCT00383552|76011463|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
42199669|NCT00383552|76011460|FG000|Overall Study|Did not wish to continue (related)|1|||
42199670|NCT00383552|76011461|FG001|Overall Study|Did not wish to continue (related)|0|||
42199671|NCT00383552|76011462|FG002|Overall Study|Did not wish to continue (related)|2|||
42199672|NCT00383552|76011463|FG003|Overall Study|Did not wish to continue (related)|3|||
42199673|NCT00383552|76011460|FG000|Overall Study|Noncompliance with the protocol|11|||
42199674|NCT00383552|76011461|FG001|Overall Study|Noncompliance with the protocol|6|||
42199675|NCT00383552|76011462|FG002|Overall Study|Noncompliance with the protocol|8|||
42199676|NCT00383552|76011463|FG003|Overall Study|Noncompliance with the protocol|10|||
42199677|NCT00383552|76011460|FG000|Overall Study|Did not meet protocol eligibility|8|||
42199678|NCT00383552|76011461|FG001|Overall Study|Did not meet protocol eligibility|6|||
42199679|NCT00383552|76011462|FG002|Overall Study|Did not meet protocol eligibility|2|||
42199680|NCT00383552|76011463|FG003|Overall Study|Did not meet protocol eligibility|3|||
42199681|NCT00383552|76011460|FG000|Overall Study|Administrative|1|||
42199682|NCT00383552|76011461|FG001|Overall Study|Administrative|0|||
42199683|NCT00383552|76011462|FG002|Overall Study|Administrative|1|||
42199684|NCT00383552|76011463|FG003|Overall Study|Administrative|1|||
42199685|NCT03158012|76011480|FG000|Overall Study|Withdrawal by Subject|0|||
42199686|NCT03158012|76011481|FG001|Overall Study|Withdrawal by Subject|1|||
42199687|NCT01776424|76011490|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
42199688|NCT01776424|76011491|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
42199689|NCT01776424|76011492|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
42199690|NCT01776424|76011490|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
42199691|NCT01776424|76011491|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
42199692|NCT01776424|76011492|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
42199693|NCT01776424|76011490|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
42199694|NCT01776424|76011491|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
42199695|NCT01776424|76011492|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
42199696|NCT01776424|76011490|FG000|LTOLE Part (Open Label)|Refused|5|||
42199697|NCT01776424|76011491|FG001|LTOLE Part (Open Label)|Refused|2|||
42199698|NCT01776424|76011492|FG002|LTOLE Part (Open Label)|Refused|11|||
42199699|NCT01776424|76011490|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
42199700|NCT01776424|76011491|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
42199701|NCT01776424|76011492|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
42199702|NCT03799627|76011518|FG000|Overall Study|Adverse Event|1|||
42199703|NCT03799627|76011519|FG001|Overall Study|Adverse Event|2|||
42199704|NCT03799627|76011520|FG002|Overall Study|Adverse Event|0|||
42199705|NCT03799627|76011521|FG003|Overall Study|Adverse Event|0|||
42199706|NCT03799627|76011522|FG004|Overall Study|Adverse Event|2|||
42199707|NCT03799627|76011523|FG005|Overall Study|Adverse Event|5|||
42199708|NCT03799627|76011524|FG006|Overall Study|Adverse Event|0|||
42199709|NCT03799627|76011525|FG007|Overall Study|Adverse Event|2|||
42199710|NCT03799627|76011526|FG008|Overall Study|Adverse Event|0|||
42199711|NCT03799627|76011518|FG000|Overall Study|Physician Decision|2|||
42199712|NCT03799627|76011519|FG001|Overall Study|Physician Decision|2|||
42199713|NCT03799627|76011520|FG002|Overall Study|Physician Decision|0|||
42199714|NCT03799627|76011521|FG003|Overall Study|Physician Decision|0|||
42199715|NCT03799627|76011522|FG004|Overall Study|Physician Decision|2|||
42199716|NCT03799627|76011523|FG005|Overall Study|Physician Decision|2|||
42199717|NCT03799627|76011524|FG006|Overall Study|Physician Decision|0|||
42199718|NCT03799627|76011525|FG007|Overall Study|Physician Decision|0|||
42103275|NCT00675428|75914213|FG000|Overall Study|Physician Decision|1|||
42103276|NCT00675428|75914214|FG001|Overall Study|Physician Decision|0|||
42103277|NCT00557505|75914238|FG000|Overall Study|Death|0|||
42103278|NCT00557505|75914239|FG001|Overall Study|Death|0|||
42103279|NCT00557505|75914240|FG002|Overall Study|Death|0|||
42103280|NCT00557505|75914241|FG003|Overall Study|Death|0|||
42103281|NCT00557505|75914242|FG004|Overall Study|Death|0|||
42103282|NCT00557505|75914243|FG005|Overall Study|Death|0|||
42199719|NCT03799627|76011526|FG008|Overall Study|Physician Decision|0|||
42199720|NCT03799627|76011518|FG000|Overall Study|Withdrawal by Subject|1|||
42199721|NCT03799627|76011519|FG001|Overall Study|Withdrawal by Subject|1|||
42199722|NCT03799627|76011520|FG002|Overall Study|Withdrawal by Subject|0|||
42199723|NCT03799627|76011521|FG003|Overall Study|Withdrawal by Subject|2|||
42199724|NCT03799627|76011522|FG004|Overall Study|Withdrawal by Subject|0|||
42199725|NCT03799627|76011523|FG005|Overall Study|Withdrawal by Subject|3|||
42199726|NCT03799627|76011524|FG006|Overall Study|Withdrawal by Subject|0|||
42199727|NCT03799627|76011525|FG007|Overall Study|Withdrawal by Subject|0|||
42199728|NCT03799627|76011526|FG008|Overall Study|Withdrawal by Subject|0|||
42199729|NCT03799627|76011518|FG000|Overall Study|Lack of Efficacy|0|||
42199730|NCT03799627|76011519|FG001|Overall Study|Lack of Efficacy|0|||
42199731|NCT03799627|76011520|FG002|Overall Study|Lack of Efficacy|0|||
42199732|NCT03799627|76011521|FG003|Overall Study|Lack of Efficacy|1|||
42199733|NCT03799627|76011522|FG004|Overall Study|Lack of Efficacy|0|||
42103283|NCT00557505|75914244|FG006|Overall Study|Death|0|||
42103284|NCT00557505|75914245|FG007|Overall Study|Death|0|||
42103285|NCT00557505|75914246|FG008|Overall Study|Death|1|||
42103286|NCT00557505|75914238|FG000|Overall Study|Adverse Event|0|||
42103287|NCT00557505|75914239|FG001|Overall Study|Adverse Event|0|||
42103288|NCT00557505|75914240|FG002|Overall Study|Adverse Event|1|||
42103289|NCT00557505|75914241|FG003|Overall Study|Adverse Event|0|||
42103290|NCT00557505|75914242|FG004|Overall Study|Adverse Event|0|||
42103291|NCT00557505|75914243|FG005|Overall Study|Adverse Event|0|||
42199734|NCT03799627|76011523|FG005|Overall Study|Lack of Efficacy|0|||
42199735|NCT03799627|76011524|FG006|Overall Study|Lack of Efficacy|0|||
42199736|NCT03799627|76011525|FG007|Overall Study|Lack of Efficacy|0|||
42199737|NCT03799627|76011526|FG008|Overall Study|Lack of Efficacy|0|||
42199738|NCT03799627|76011518|FG000|Overall Study|Lost to Follow-up|0|||
42199739|NCT03799627|76011519|FG001|Overall Study|Lost to Follow-up|0|||
42199740|NCT03799627|76011520|FG002|Overall Study|Lost to Follow-up|0|||
42199741|NCT03799627|76011521|FG003|Overall Study|Lost to Follow-up|0|||
42199742|NCT03799627|76011522|FG004|Overall Study|Lost to Follow-up|0|||
42199743|NCT03799627|76011523|FG005|Overall Study|Lost to Follow-up|0|||
42199744|NCT03799627|76011524|FG006|Overall Study|Lost to Follow-up|1|||
42199745|NCT03799627|76011525|FG007|Overall Study|Lost to Follow-up|0|||
42199746|NCT03799627|76011526|FG008|Overall Study|Lost to Follow-up|1|||
42199747|NCT03799627|76011518|FG000|Overall Study|Death|0|||
42199748|NCT03799627|76011519|FG001|Overall Study|Death|0|||
42199749|NCT03799627|76011520|FG002|Overall Study|Death|0|||
42199750|NCT03799627|76011521|FG003|Overall Study|Death|1|||
42199751|NCT03799627|76011522|FG004|Overall Study|Death|0|||
42199752|NCT03799627|76011523|FG005|Overall Study|Death|0|||
42199753|NCT03799627|76011524|FG006|Overall Study|Death|0|||
42199754|NCT03799627|76011525|FG007|Overall Study|Death|0|||
42199755|NCT03799627|76011526|FG008|Overall Study|Death|0|||
42199756|NCT03799627|76011518|FG000|Overall Study|Study Drug Put on Hold|1|||
42199757|NCT03799627|76011519|FG001|Overall Study|Study Drug Put on Hold|0|||
42199758|NCT03799627|76011520|FG002|Overall Study|Study Drug Put on Hold|0|||
42199759|NCT03799627|76011521|FG003|Overall Study|Study Drug Put on Hold|0|||
42199760|NCT03799627|76011522|FG004|Overall Study|Study Drug Put on Hold|0|||
42199761|NCT03799627|76011523|FG005|Overall Study|Study Drug Put on Hold|0|||
42199762|NCT03799627|76011524|FG006|Overall Study|Study Drug Put on Hold|0|||
42199763|NCT03799627|76011525|FG007|Overall Study|Study Drug Put on Hold|0|||
42199764|NCT03799627|76011526|FG008|Overall Study|Study Drug Put on Hold|0|||
42369969|NCT01775189|76232643|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
42369970|NCT01775189|76232644|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
42369971|NCT01775189|76232645|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
42369972|NCT01775189|76232646|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
42199765|NCT03799627|76011518|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
42199766|NCT03799627|76011519|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
42369973|NCT01775189|76232647|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
42369974|NCT01775189|76232641|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
42369975|NCT01775189|76232642|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
42369976|NCT01775189|76232643|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
42369977|NCT01775189|76232644|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
42369978|NCT01775189|76232645|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
42369979|NCT01775189|76232646|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
42369980|NCT01775189|76232647|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
42369981|NCT01775189|76232641|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
42369982|NCT01775189|76232642|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
42199767|NCT03799627|76011520|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
42199768|NCT03799627|76011521|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
42199769|NCT03799627|76011522|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
42369983|NCT01775189|76232643|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
42369984|NCT01775189|76232644|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
42369985|NCT01775189|76232645|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
42103292|NCT00557505|75914244|FG006|Overall Study|Adverse Event|1|||
42103293|NCT00557505|75914245|FG007|Overall Study|Adverse Event|0|||
42199770|NCT03799627|76011523|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
42199771|NCT03799627|76011524|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
42199772|NCT03799627|76011525|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
42199773|NCT03799627|76011526|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
42103294|NCT00557505|75914246|FG008|Overall Study|Adverse Event|0|||
42199774|NCT03799627|76011518|FG000|Overall Study|Kidney Transplantation|1|||
42199775|NCT03799627|76011519|FG001|Overall Study|Kidney Transplantation|0|||
42199776|NCT03799627|76011520|FG002|Overall Study|Kidney Transplantation|0|||
42199777|NCT03799627|76011521|FG003|Overall Study|Kidney Transplantation|1|||
42199778|NCT03799627|76011522|FG004|Overall Study|Kidney Transplantation|1|||
42199779|NCT03799627|76011523|FG005|Overall Study|Kidney Transplantation|0|||
42199780|NCT03799627|76011524|FG006|Overall Study|Kidney Transplantation|0|||
42199781|NCT03799627|76011525|FG007|Overall Study|Kidney Transplantation|0|||
42199782|NCT03799627|76011526|FG008|Overall Study|Kidney Transplantation|0|||
42199783|NCT03799627|76011518|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
42199784|NCT03799627|76011519|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
42199785|NCT03799627|76011520|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
42199786|NCT03799627|76011521|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
42199787|NCT03799627|76011522|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
42199788|NCT03799627|76011523|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
42199789|NCT03799627|76011524|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
42199790|NCT03799627|76011525|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
42199791|NCT03799627|76011526|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
42199792|NCT03799627|76011518|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
42199793|NCT03799627|76011519|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
42199794|NCT03799627|76011520|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
42199795|NCT03799627|76011521|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
42199796|NCT03799627|76011522|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
42199797|NCT03799627|76011523|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
42199798|NCT03799627|76011524|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
42199799|NCT03799627|76011525|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
42199800|NCT03799627|76011526|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
42199801|NCT03799627|76011518|FG000|Overall Study|Met Exclusion Criteria|0|||
42199802|NCT03799627|76011519|FG001|Overall Study|Met Exclusion Criteria|0|||
42199803|NCT03799627|76011520|FG002|Overall Study|Met Exclusion Criteria|0|||
42199804|NCT03799627|76011521|FG003|Overall Study|Met Exclusion Criteria|1|||
42199805|NCT03799627|76011522|FG004|Overall Study|Met Exclusion Criteria|0|||
42199806|NCT03799627|76011523|FG005|Overall Study|Met Exclusion Criteria|0|||
42199807|NCT03799627|76011524|FG006|Overall Study|Met Exclusion Criteria|0|||
42199808|NCT03799627|76011525|FG007|Overall Study|Met Exclusion Criteria|0|||
42199809|NCT03799627|76011526|FG008|Overall Study|Met Exclusion Criteria|0|||
42199810|NCT03799627|76011518|FG000|Overall Study|Investigational Product Noncompliance|0|||
42199811|NCT03799627|76011519|FG001|Overall Study|Investigational Product Noncompliance|0|||
42199812|NCT03799627|76011520|FG002|Overall Study|Investigational Product Noncompliance|0|||
42199813|NCT03799627|76011521|FG003|Overall Study|Investigational Product Noncompliance|1|||
42199814|NCT03799627|76011522|FG004|Overall Study|Investigational Product Noncompliance|0|||
42199815|NCT03799627|76011523|FG005|Overall Study|Investigational Product Noncompliance|0|||
42199816|NCT03799627|76011524|FG006|Overall Study|Investigational Product Noncompliance|0|||
42199817|NCT03799627|76011525|FG007|Overall Study|Investigational Product Noncompliance|0|||
42199818|NCT03799627|76011526|FG008|Overall Study|Investigational Product Noncompliance|0|||
42199819|NCT03799627|76011518|FG000|Overall Study|Participant Relocation|0|||
42199820|NCT03799627|76011519|FG001|Overall Study|Participant Relocation|0|||
42199821|NCT03799627|76011520|FG002|Overall Study|Participant Relocation|0|||
42199822|NCT03799627|76011521|FG003|Overall Study|Participant Relocation|1|||
42199823|NCT03799627|76011522|FG004|Overall Study|Participant Relocation|0|||
42199824|NCT03799627|76011523|FG005|Overall Study|Participant Relocation|1|||
42199825|NCT03799627|76011524|FG006|Overall Study|Participant Relocation|0|||
42199826|NCT03799627|76011525|FG007|Overall Study|Participant Relocation|0|||
42199827|NCT03799627|76011526|FG008|Overall Study|Participant Relocation|0|||
42199828|NCT03799627|76011518|FG000|Overall Study|Eurofin Issue|0|||
42199829|NCT03799627|76011519|FG001|Overall Study|Eurofin Issue|0|||
42199830|NCT03799627|76011520|FG002|Overall Study|Eurofin Issue|0|||
42199831|NCT03799627|76011521|FG003|Overall Study|Eurofin Issue|0|||
42199832|NCT03799627|76011522|FG004|Overall Study|Eurofin Issue|1|||
42199833|NCT03799627|76011523|FG005|Overall Study|Eurofin Issue|0|||
42199834|NCT03799627|76011524|FG006|Overall Study|Eurofin Issue|0|||
42199835|NCT03799627|76011525|FG007|Overall Study|Eurofin Issue|0|||
42199836|NCT03799627|76011526|FG008|Overall Study|Eurofin Issue|0|||
42199837|NCT03799627|76011518|FG000|Overall Study|Noncompliance with Site Instructions|0|||
42199838|NCT03799627|76011519|FG001|Overall Study|Noncompliance with Site Instructions|0|||
42199839|NCT03799627|76011520|FG002|Overall Study|Noncompliance with Site Instructions|0|||
42199840|NCT03799627|76011521|FG003|Overall Study|Noncompliance with Site Instructions|0|||
42199841|NCT03799627|76011522|FG004|Overall Study|Noncompliance with Site Instructions|1|||
42199842|NCT03799627|76011523|FG005|Overall Study|Noncompliance with Site Instructions|0|||
42199843|NCT03799627|76011524|FG006|Overall Study|Noncompliance with Site Instructions|0|||
42199844|NCT03799627|76011525|FG007|Overall Study|Noncompliance with Site Instructions|0|||
42199845|NCT03799627|76011526|FG008|Overall Study|Noncompliance with Site Instructions|0|||
42199846|NCT03799627|76011518|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
42199847|NCT03799627|76011519|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
42199848|NCT03799627|76011520|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
42199849|NCT03799627|76011521|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
42199850|NCT03799627|76011522|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
42199851|NCT03799627|76011523|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
42199852|NCT03799627|76011524|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
42199853|NCT03799627|76011525|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
42199854|NCT03799627|76011526|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
42199855|NCT03799627|76011518|FG000|Overall Study|Changes In Hemoglobin Values|1|||
42199856|NCT03799627|76011519|FG001|Overall Study|Changes In Hemoglobin Values|2|||
42199857|NCT03799627|76011520|FG002|Overall Study|Changes In Hemoglobin Values|1|||
42199858|NCT03799627|76011521|FG003|Overall Study|Changes In Hemoglobin Values|0|||
42199859|NCT03799627|76011522|FG004|Overall Study|Changes In Hemoglobin Values|0|||
42199860|NCT03799627|76011523|FG005|Overall Study|Changes In Hemoglobin Values|2|||
42199861|NCT03799627|76011524|FG006|Overall Study|Changes In Hemoglobin Values|1|||
42199862|NCT03799627|76011525|FG007|Overall Study|Changes In Hemoglobin Values|0|||
42199863|NCT03799627|76011526|FG008|Overall Study|Changes In Hemoglobin Values|1|||
42199864|NCT00756574|76011567|FG000|Overall Study|Withdrawal by Subject|9|||
42199865|NCT00756574|76011568|FG001|Overall Study|Withdrawal by Subject|7|||
42199866|NCT00756574|76011567|FG000|Overall Study|Lost to Follow-up|4|||
42199867|NCT00756574|76011568|FG001|Overall Study|Lost to Follow-up|4|||
42199868|NCT02743780|76011577|FG000|Part 3 (7 Days)|Adverse Event|0|||
42199869|NCT02743780|76011578|FG001|Part 3 (7 Days)|Adverse Event|0|||
42199870|NCT02743780|76011579|FG002|Part 3 (7 Days)|Adverse Event|1|||
42199871|NCT02743780|76011580|FG003|Part 3 (7 Days)|Adverse Event|0|||
42199872|NCT02743780|76011581|FG004|Part 3 (7 Days)|Adverse Event|0|||
42199873|NCT02880956|76011605|FG000|Overall Study|Adverse Event|3|||
42199874|NCT02880956|76011606|FG001|Overall Study|Adverse Event|6|||
42199875|NCT02880956|76011607|FG002|Overall Study|Adverse Event|5|||
42199876|NCT02880956|76011608|FG003|Overall Study|Adverse Event|4|||
42199877|NCT02880956|76011605|FG000|Overall Study|Withdrawal by Subject|9|||
42199878|NCT02880956|76011606|FG001|Overall Study|Withdrawal by Subject|4|||
42199879|NCT02880956|76011607|FG002|Overall Study|Withdrawal by Subject|6|||
42199880|NCT02880956|76011608|FG003|Overall Study|Withdrawal by Subject|11|||
42199881|NCT02880956|76011605|FG000|Overall Study|Lost to Follow-up|0|||
42199882|NCT02880956|76011606|FG001|Overall Study|Lost to Follow-up|1|||
42199883|NCT02880956|76011607|FG002|Overall Study|Lost to Follow-up|0|||
42199884|NCT02880956|76011608|FG003|Overall Study|Lost to Follow-up|0|||
42199885|NCT02880956|76011605|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
42199886|NCT02880956|76011606|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
42199887|NCT02880956|76011607|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
42199888|NCT02880956|76011608|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
42199889|NCT02880956|76011605|FG000|Overall Study|Other, Not Specified|4|||
42199890|NCT02880956|76011606|FG001|Overall Study|Other, Not Specified|2|||
42199891|NCT02880956|76011607|FG002|Overall Study|Other, Not Specified|0|||
42199892|NCT02880956|76011608|FG003|Overall Study|Other, Not Specified|3|||
42199893|NCT01352416|76011625|FG000|Overall Study|Physician Decision|1|||
42199894|NCT01352416|76011626|FG001|Overall Study|Physician Decision|2|||
42199895|NCT01352416|76011627|FG002|Overall Study|Physician Decision|2|||
42199896|NCT01352416|76011628|FG003|Overall Study|Physician Decision|1|||
42199897|NCT00439738|76011640|FG000|Overall Study|Withdrawal by Subject|16|||
42199898|NCT00439738|76011641|FG001|Overall Study|Withdrawal by Subject|13|||
42199899|NCT00439738|76011640|FG000|Overall Study|Adverse Event|6|||
42199900|NCT00439738|76011641|FG001|Overall Study|Adverse Event|4|||
42199901|NCT00439738|76011640|FG000|Overall Study|Lost to Follow-up|5|||
42199902|NCT00439738|76011641|FG001|Overall Study|Lost to Follow-up|6|||
42199903|NCT00439738|76011640|FG000|Overall Study|Protocol Violation|6|||
42199904|NCT00439738|76011641|FG001|Overall Study|Protocol Violation|3|||
42199905|NCT00439738|76011640|FG000|Overall Study|Lack of Efficacy|2|||
42199906|NCT00439738|76011641|FG001|Overall Study|Lack of Efficacy|2|||
42199907|NCT00439738|76011640|FG000|Overall Study|Abnormal Lab Values|1|||
42199908|NCT00439738|76011641|FG001|Overall Study|Abnormal Lab Values|0|||
42199909|NCT00338104|76011648|FG000|Overall Study|Protocol Violation|2|||
42199910|NCT00338104|76011649|FG001|Overall Study|Protocol Violation|1|||
42199911|NCT00338104|76011650|FG002|Overall Study|Protocol Violation|3|||
42199912|NCT05593913|76011655|FG000|Overall Study|Insufficient image quality|39|||
42199913|NCT05166603|76011685|FG000|Overall Study|Withdrawal by Subject|68|||
42199914|NCT05166603|76011686|FG001|Overall Study|Withdrawal by Subject|0|||
42199915|NCT05049122|76011692|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
42199916|NCT05049122|76011692|FG000|Overall Study|Participant moved|1|||
42199917|NCT05049122|76011692|FG000|Overall Study|At the direction of the doctor|1|||
42199918|NCT04969263|76011700|FG000|Overall Study|Death|1|||
42199919|NCT04969263|76011700|FG000|Overall Study|Lost to Follow-up|2|||
42199920|NCT04969263|76011700|FG000|Overall Study|Withdrawal by Subject|5|||
42199921|NCT04969263|76011700|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
42199922|NCT04964063|76011704|FG000|Overall Study|Adverse Event|4|||
42199923|NCT04964063|76011704|FG000|Overall Study|Lost to Follow-up|47|||
42199924|NCT04964063|76011704|FG000|Overall Study|Withdrawal by Subject|5|||
42199925|NCT04964063|76011704|FG000|Overall Study|Baseline Tasks Expired|41|||
42199926|NCT04964063|76011704|FG000|Overall Study|Participant withdrawn in error|1|||
42199927|NCT04744831|76011711|FG000|Overall Study|Progressive Disease|31|||
42199928|NCT04744831|76011712|FG001|Overall Study|Progressive Disease|27|||
42199929|NCT04744831|76011713|FG002|Overall Study|Progressive Disease|25|||
42199930|NCT04744831|76011711|FG000|Overall Study|Adverse Event|3|||
42199931|NCT04744831|76011712|FG001|Overall Study|Adverse Event|3|||
42199932|NCT04744831|76011713|FG002|Overall Study|Adverse Event|3|||
42199933|NCT04744831|76011711|FG000|Overall Study|Clinical Progression|3|||
42199934|NCT04744831|76011712|FG001|Overall Study|Clinical Progression|2|||
42199935|NCT04744831|76011713|FG002|Overall Study|Clinical Progression|5|||
42199936|NCT04744831|76011711|FG000|Overall Study|Other|0|||
42199937|NCT04744831|76011712|FG001|Overall Study|Other|2|||
42199938|NCT04744831|76011713|FG002|Overall Study|Other|1|||
42199939|NCT04744831|76011711|FG000|Overall Study|Death|0|||
42199940|NCT04744831|76011712|FG001|Overall Study|Death|2|||
42199941|NCT04744831|76011713|FG002|Overall Study|Death|1|||
42199942|NCT04642079|76011724|FG000|Overall Study|Lost to Follow-up|2|||
42199943|NCT04642079|76011725|FG001|Overall Study|Lost to Follow-up|5|||
42199944|NCT04642079|76011726|FG002|Overall Study|Lost to Follow-up|2|||
42199945|NCT04642079|76011727|FG003|Overall Study|Lost to Follow-up|0|||
42199946|NCT04642079|76011724|FG000|Overall Study|Withdrawal by Subject|0|||
42199947|NCT04642079|76011725|FG001|Overall Study|Withdrawal by Subject|4|||
42199948|NCT04642079|76011726|FG002|Overall Study|Withdrawal by Subject|1|||
42199949|NCT04642079|76011727|FG003|Overall Study|Withdrawal by Subject|2|||
42199950|NCT04642079|76011724|FG000|Overall Study|Other|0|||
42199951|NCT04642079|76011725|FG001|Overall Study|Other|0|||
42199952|NCT04642079|76011726|FG002|Overall Study|Other|0|||
42199953|NCT04642079|76011727|FG003|Overall Study|Other|1|||
42199954|NCT04642079|76011724|FG000|Overall Study|No longer met eligibility criteria|1|||
42199955|NCT04642079|76011725|FG001|Overall Study|No longer met eligibility criteria|0|||
42199956|NCT04642079|76011726|FG002|Overall Study|No longer met eligibility criteria|1|||
42199957|NCT04642079|76011727|FG003|Overall Study|No longer met eligibility criteria|1|||
42199958|NCT04232124|76011772|FG000|Overall Study|Lost to Follow-up|3|||
42199959|NCT03529110|76011786|FG000|Overall Study|Progressive Disease|66|||
42199960|NCT03529110|76011787|FG001|Overall Study|Progressive Disease|158|||
42199961|NCT03529110|76011786|FG000|Overall Study|Clinical Progression|4|||
42199962|NCT03529110|76011787|FG001|Overall Study|Clinical Progression|12|||
42199963|NCT03529110|76011786|FG000|Overall Study|Adverse Event|35|||
42199964|NCT03529110|76011787|FG001|Overall Study|Adverse Event|17|||
42199965|NCT03529110|76011786|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
42199966|NCT03529110|76011787|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
42199967|NCT03529110|76011786|FG000|Overall Study|Lack of Efficacy|3|||
42199968|NCT03529110|76011787|FG001|Overall Study|Lack of Efficacy|3|||
42199969|NCT03529110|76011786|FG000|Overall Study|Physician Decision|2|||
42199970|NCT03529110|76011787|FG001|Overall Study|Physician Decision|8|||
42369986|NCT01775189|76232646|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
42369987|NCT01775189|76232647|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
42369988|NCT01770743|76232713|FG000|Overall Study|Adverse Event|1|||
42369989|NCT01770743|76232714|FG001|Overall Study|Adverse Event|0|||
42369990|NCT01770743|76232715|FG002|Overall Study|Adverse Event|0|||
42103295|NCT00557505|75914238|FG000|Overall Study|Global deterioration of health|1|||
42103296|NCT00557505|75914239|FG001|Overall Study|Global deterioration of health|0|||
42199971|NCT03529110|76011786|FG000|Overall Study|Miscellaneous|2|||
42199972|NCT03529110|76011787|FG001|Overall Study|Miscellaneous|5|||
42199973|NCT03524092|76011797|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
42199974|NCT03524092|76011798|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
42199975|NCT03524092|76011799|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
42199976|NCT03524092|76011800|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
42199977|NCT03524092|76011801|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
42199978|NCT03524092|76011802|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
42199979|NCT03524092|76011797|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
42369991|NCT01770743|76232716|FG003|Overall Study|Adverse Event|0|||
42369992|NCT01770743|76232717|FG004|Overall Study|Adverse Event|0|||
42199980|NCT03524092|76011798|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
42199981|NCT03524092|76011799|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
42199982|NCT03524092|76011800|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
42369993|NCT01770743|76232713|FG000|Overall Study|Withdrawal by Subject|0|||
42199983|NCT03524092|76011801|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
42199984|NCT03524092|76011802|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
42199985|NCT03524092|76011797|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
42199986|NCT03524092|76011798|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
42199987|NCT03524092|76011799|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
42199988|NCT03524092|76011800|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
42199989|NCT03524092|76011801|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
42199990|NCT03524092|76011802|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
42199991|NCT03524092|76011797|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
42199992|NCT03524092|76011798|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
42199993|NCT03524092|76011799|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
42199994|NCT03524092|76011800|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
42199995|NCT03524092|76011801|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
42199996|NCT03524092|76011802|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
42199997|NCT03524092|76011797|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
42199998|NCT03524092|76011798|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
42199999|NCT03524092|76011799|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
42200000|NCT03524092|76011800|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
42200001|NCT03524092|76011801|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
42200002|NCT03524092|76011802|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
42200003|NCT03524092|76011797|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
42200004|NCT03524092|76011798|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
42200005|NCT03524092|76011799|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
42200006|NCT03524092|76011800|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
42200007|NCT03524092|76011801|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
42200008|NCT03524092|76011802|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
42200009|NCT03524092|76011797|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
42200010|NCT03524092|76011798|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
42200011|NCT03524092|76011799|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
42200012|NCT03524092|76011800|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
42200013|NCT03524092|76011801|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
42200014|NCT03524092|76011802|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
42200015|NCT03524092|76011797|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
42200016|NCT03524092|76011798|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
42200017|NCT03524092|76011799|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
42200018|NCT03524092|76011800|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
42200019|NCT03524092|76011801|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
42200020|NCT03524092|76011802|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
42200021|NCT03524092|76011797|FG000|Loss of Response Rescue Period|Adverse Event|0|||
42200022|NCT03524092|76011798|FG001|Loss of Response Rescue Period|Adverse Event|0|||
42200023|NCT03524092|76011799|FG002|Loss of Response Rescue Period|Adverse Event|0|||
42200024|NCT03524092|76011800|FG003|Loss of Response Rescue Period|Adverse Event|2|||
42200025|NCT03524092|76011801|FG004|Loss of Response Rescue Period|Adverse Event|0|||
42200026|NCT03524092|76011802|FG005|Loss of Response Rescue Period|Adverse Event|0|||
42200027|NCT03524092|76011797|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
42200028|NCT03524092|76011798|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
42200029|NCT03524092|76011799|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
42200030|NCT03524092|76011800|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
42200031|NCT03524092|76011801|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
42200032|NCT03524092|76011802|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
42200033|NCT03524092|76011797|FG000|Loss of Response Rescue Period|Pregnancy|0|||
42200034|NCT03524092|76011798|FG001|Loss of Response Rescue Period|Pregnancy|0|||
42200035|NCT03524092|76011799|FG002|Loss of Response Rescue Period|Pregnancy|0|||
42200036|NCT03524092|76011800|FG003|Loss of Response Rescue Period|Pregnancy|1|||
42200037|NCT03524092|76011801|FG004|Loss of Response Rescue Period|Pregnancy|0|||
42200038|NCT03524092|76011802|FG005|Loss of Response Rescue Period|Pregnancy|0|||
42200039|NCT03524092|76011797|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
42200040|NCT03524092|76011798|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
42200041|NCT03524092|76011799|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
42200042|NCT03524092|76011800|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
42200043|NCT03524092|76011801|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
42200044|NCT03524092|76011802|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
42200045|NCT03524092|76011797|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
42200046|NCT03524092|76011798|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
42200047|NCT03524092|76011799|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
42200048|NCT03524092|76011800|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
42200049|NCT03524092|76011801|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
42200050|NCT03524092|76011802|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
42200051|NCT03524092|76011797|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
42200052|NCT03524092|76011798|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
42200053|NCT03524092|76011799|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
42200054|NCT03524092|76011800|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
42200055|NCT03524092|76011801|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
42200056|NCT03524092|76011802|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
42200057|NCT03524092|76011797|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
42200058|NCT03524092|76011798|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
42200059|NCT03524092|76011799|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
42200060|NCT03524092|76011800|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
42200061|NCT03524092|76011801|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
42200062|NCT03524092|76011802|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
42200063|NCT03524092|76011797|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
42200064|NCT03524092|76011798|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
42200065|NCT03524092|76011799|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
42200066|NCT03524092|76011800|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
42200067|NCT03524092|76011801|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
42200068|NCT03524092|76011802|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
42200069|NCT03524092|76011797|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
42200070|NCT03524092|76011798|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
42200071|NCT03524092|76011799|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
42200072|NCT03524092|76011800|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
42200073|NCT03524092|76011801|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
42200074|NCT03524092|76011802|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
42200075|NCT03524092|76011797|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
42200076|NCT03524092|76011798|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
42200077|NCT03524092|76011799|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
42200078|NCT03524092|76011800|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
42200079|NCT03524092|76011801|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
42200080|NCT03524092|76011802|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
42200081|NCT03524092|76011797|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
42200082|NCT03524092|76011798|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
42103297|NCT00557505|75914240|FG002|Overall Study|Global deterioration of health|0|||
42103298|NCT00557505|75914241|FG003|Overall Study|Global deterioration of health|0|||
42103299|NCT00557505|75914242|FG004|Overall Study|Global deterioration of health|0|||
42103300|NCT00557505|75914243|FG005|Overall Study|Global deterioration of health|0|||
42103301|NCT00557505|75914244|FG006|Overall Study|Global deterioration of health|0|||
42103302|NCT00557505|75914245|FG007|Overall Study|Global deterioration of health|0|||
42103303|NCT00557505|75914246|FG008|Overall Study|Global deterioration of health|0|||
42103304|NCT00557505|75914238|FG000|Overall Study|Objective progression or relapse|2|||
42103305|NCT00557505|75914239|FG001|Overall Study|Objective progression or relapse|3|||
42103306|NCT00557505|75914240|FG002|Overall Study|Objective progression or relapse|3|||
42103307|NCT00557505|75914241|FG003|Overall Study|Objective progression or relapse|2|||
42103308|NCT00557505|75914242|FG004|Overall Study|Objective progression or relapse|2|||
42103309|NCT00557505|75914243|FG005|Overall Study|Objective progression or relapse|3|||
42103310|NCT00557505|75914244|FG006|Overall Study|Objective progression or relapse|2|||
42103311|NCT00557505|75914245|FG007|Overall Study|Objective progression or relapse|5|||
42103312|NCT00557505|75914246|FG008|Overall Study|Objective progression or relapse|15|||
42103313|NCT00557505|75914238|FG000|Overall Study|Withdrawal by Subject|0|||
42103314|NCT00557505|75914239|FG001|Overall Study|Withdrawal by Subject|0|||
42103315|NCT00557505|75914240|FG002|Overall Study|Withdrawal by Subject|0|||
42103316|NCT00557505|75914241|FG003|Overall Study|Withdrawal by Subject|1|||
42103317|NCT00557505|75914242|FG004|Overall Study|Withdrawal by Subject|0|||
42200083|NCT03524092|76011799|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
42369994|NCT01770743|76232714|FG001|Overall Study|Withdrawal by Subject|0|||
42103318|NCT00557505|75914243|FG005|Overall Study|Withdrawal by Subject|0|||
42103319|NCT00557505|75914244|FG006|Overall Study|Withdrawal by Subject|0|||
42103320|NCT00557505|75914245|FG007|Overall Study|Withdrawal by Subject|0|||
42103321|NCT00557505|75914246|FG008|Overall Study|Withdrawal by Subject|1|||
42103322|NCT00674570|75914272|FG000|Overall Study|Withdrawal by Subject|0|||
42369995|NCT01770743|76232715|FG002|Overall Study|Withdrawal by Subject|1|||
42369996|NCT01770743|76232716|FG003|Overall Study|Withdrawal by Subject|1|||
42369997|NCT01770743|76232717|FG004|Overall Study|Withdrawal by Subject|1|||
42369998|NCT01770743|76232713|FG000|Overall Study|Lost to Follow-up|0|||
42369999|NCT01770743|76232714|FG001|Overall Study|Lost to Follow-up|2|||
42370000|NCT01770743|76232715|FG002|Overall Study|Lost to Follow-up|0|||
42370001|NCT01770743|76232716|FG003|Overall Study|Lost to Follow-up|0|||
42370002|NCT01770743|76232717|FG004|Overall Study|Lost to Follow-up|1|||
42370003|NCT01770743|76232713|FG000|Overall Study|Sponsor Terminated Subject|1|||
42370004|NCT01770743|76232714|FG001|Overall Study|Sponsor Terminated Subject|0|||
42370005|NCT01770743|76232715|FG002|Overall Study|Sponsor Terminated Subject|0|||
42370006|NCT01770743|76232716|FG003|Overall Study|Sponsor Terminated Subject|1|||
42370007|NCT01770743|76232717|FG004|Overall Study|Sponsor Terminated Subject|0|||
42370008|NCT01770743|76232713|FG000|Overall Study|Moving Out of State|0|||
42370009|NCT01770743|76232714|FG001|Overall Study|Moving Out of State|1|||
42370010|NCT01770743|76232715|FG002|Overall Study|Moving Out of State|0|||
42370011|NCT01770743|76232716|FG003|Overall Study|Moving Out of State|0|||
42370012|NCT01770743|76232717|FG004|Overall Study|Moving Out of State|0|||
42370013|NCT01767467|76232813|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
42370014|NCT01767467|76232814|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
42370015|NCT01767467|76232813|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
42370016|NCT01767467|76232814|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
42370017|NCT01767467|76232813|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
42370018|NCT01767467|76232814|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
42370019|NCT01767467|76232813|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
42370020|NCT01767467|76232814|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
42370021|NCT01767467|76232813|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
42370022|NCT01767467|76232814|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
42370023|NCT01767467|76232813|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
42370024|NCT01767467|76232814|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
42370025|NCT01767467|76232813|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
42370026|NCT01767467|76232814|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
42370027|NCT01767467|76232813|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
42370028|NCT01767467|76232814|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
42370029|NCT01767467|76232813|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
42370030|NCT01767467|76232814|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
42370031|NCT01767467|76232813|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
42370032|NCT01767467|76232814|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
42370033|NCT01767467|76232813|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
42370034|NCT01767467|76232814|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
42370035|NCT01767467|76232813|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
42370036|NCT01767467|76232814|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
42370037|NCT01767467|76232813|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
42370038|NCT01767467|76232814|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
42370039|NCT01767467|76232813|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
42370040|NCT01767467|76232814|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
42370041|NCT04126083|76232887|FG000|Overall Study|Withdrawal by Subject|1|||
42370042|NCT01766921|76232927|FG000|Overall Study|Administrative Reason|5|||
42370043|NCT01766921|76232928|FG001|Overall Study|Administrative Reason|5|||
42370044|NCT01766921|76232927|FG000|Overall Study|Death|1|||
42370045|NCT01766921|76232928|FG001|Overall Study|Death|1|||
42370046|NCT01766921|76232927|FG000|Overall Study|Lost to Follow-up|1|||
42370047|NCT01766921|76232928|FG001|Overall Study|Lost to Follow-up|3|||
42370048|NCT01766921|76232927|FG000|Overall Study|Unclassified|2|||
42370049|NCT01766921|76232928|FG001|Overall Study|Unclassified|2|||
42370050|NCT01766921|76232927|FG000|Overall Study|Protocol Violation|1|||
42370051|NCT01766921|76232928|FG001|Overall Study|Protocol Violation|1|||
42370052|NCT01766921|76232927|FG000|Overall Study|Withdrawal by Subject|14|||
42370053|NCT01766921|76232928|FG001|Overall Study|Withdrawal by Subject|5|||
42370054|NCT01774799|76232946|FG000|Overall Study|Lost to Follow-up|1|||
42370055|NCT01774799|76232947|FG001|Overall Study|Lost to Follow-up|1|||
42370056|NCT01774799|76232948|FG002|Overall Study|Lost to Follow-up|0|||
42370057|NCT01774799|76232949|FG003|Overall Study|Lost to Follow-up|0|||
42370058|NCT01765751|76232991|FG000|Overall Study|Lost to Follow-up|0|||
42370059|NCT01765751|76232992|FG001|Overall Study|Lost to Follow-up|2|||
42370060|NCT01765751|76232993|FG002|Overall Study|Lost to Follow-up|1|||
42370061|NCT01736657|76233013|FG000|Overall Study|insufficient vascular access|1|||
42370062|NCT01736579|76233028|FG000|Overall Study|Termination of Study by Sponsor|2|||
42370063|NCT01736579|76233029|FG001|Overall Study|Termination of Study by Sponsor|2|||
42370064|NCT01765673|76233060|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
42370065|NCT01764659|76233067|FG000|Overall Study|Death|1|||
42200084|NCT03524092|76011800|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
42200085|NCT03524092|76011801|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
42200086|NCT03524092|76011802|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
42200087|NCT03524092|76011797|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
42200088|NCT03524092|76011798|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
42200089|NCT03524092|76011799|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
42200090|NCT03524092|76011800|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
42200091|NCT03524092|76011801|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
42200092|NCT03524092|76011802|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
42200093|NCT03524092|76011797|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
42200094|NCT03524092|76011798|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
42200095|NCT03524092|76011799|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
42200096|NCT03524092|76011800|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
42200097|NCT03524092|76011801|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
42200098|NCT03524092|76011802|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
42200099|NCT03524092|76011797|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
42200100|NCT03524092|76011798|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
42200101|NCT03524092|76011799|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
42200102|NCT03524092|76011800|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
42200103|NCT03524092|76011801|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
42200104|NCT03524092|76011802|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
42200105|NCT03524092|76011797|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
42200106|NCT03524092|76011798|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
42200107|NCT03524092|76011799|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
42200108|NCT03524092|76011800|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
42200109|NCT03524092|76011801|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
42200110|NCT03524092|76011802|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
42200111|NCT03518086|76011815|FG000|Overall Study|Adverse Event|23|||
42200112|NCT03518086|76011816|FG001|Overall Study|Adverse Event|15|||
42200113|NCT03518086|76011817|FG002|Overall Study|Adverse Event|0|||
42200114|NCT03518086|76011818|FG003|Overall Study|Adverse Event|0|||
42200115|NCT03518086|76011815|FG000|Overall Study|Withdrawal by Subject|8|||
42200116|NCT03518086|76011816|FG001|Overall Study|Withdrawal by Subject|5|||
42200117|NCT03518086|76011817|FG002|Overall Study|Withdrawal by Subject|0|||
42200118|NCT03518086|76011818|FG003|Overall Study|Withdrawal by Subject|0|||
42200119|NCT03518086|76011815|FG000|Overall Study|Lack of Efficacy|5|||
42200120|NCT03518086|76011816|FG001|Overall Study|Lack of Efficacy|5|||
42200121|NCT03518086|76011817|FG002|Overall Study|Lack of Efficacy|0|||
42200122|NCT03518086|76011818|FG003|Overall Study|Lack of Efficacy|0|||
42200123|NCT03518086|76011815|FG000|Overall Study|Protocol Violation|1|||
42200124|NCT03518086|76011816|FG001|Overall Study|Protocol Violation|5|||
42200125|NCT03518086|76011817|FG002|Overall Study|Protocol Violation|0|||
42200126|NCT03518086|76011818|FG003|Overall Study|Protocol Violation|0|||
42200127|NCT03518086|76011815|FG000|Overall Study|Lost to Follow-up|0|||
42200128|NCT03518086|76011816|FG001|Overall Study|Lost to Follow-up|3|||
42200129|NCT03518086|76011817|FG002|Overall Study|Lost to Follow-up|0|||
42200130|NCT03518086|76011818|FG003|Overall Study|Lost to Follow-up|0|||
42200131|NCT03518086|76011815|FG000|Overall Study|Insufficient Diary Data|0|||
42200132|NCT03518086|76011816|FG001|Overall Study|Insufficient Diary Data|2|||
42200133|NCT03518086|76011817|FG002|Overall Study|Insufficient Diary Data|0|||
42200134|NCT03518086|76011818|FG003|Overall Study|Insufficient Diary Data|0|||
42200135|NCT03518086|76011815|FG000|Overall Study|Non- compliance to Protocol|0|||
42200136|NCT03518086|76011816|FG001|Overall Study|Non- compliance to Protocol|1|||
42200137|NCT03518086|76011817|FG002|Overall Study|Non- compliance to Protocol|0|||
42200138|NCT03518086|76011818|FG003|Overall Study|Non- compliance to Protocol|0|||
42200139|NCT03518086|76011815|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
42200140|NCT03518086|76011816|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
42200141|NCT03518086|76011817|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
42200142|NCT03518086|76011818|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
42200143|NCT03518086|76011815|FG000|Overall Study|Site Terminated by Sponsor|0|||
42200144|NCT03518086|76011816|FG001|Overall Study|Site Terminated by Sponsor|1|||
42200145|NCT03518086|76011817|FG002|Overall Study|Site Terminated by Sponsor|0|||
42200146|NCT03518086|76011818|FG003|Overall Study|Site Terminated by Sponsor|0|||
42200147|NCT03358472|76011828|FG000|Overall Study|Death|6|||
42200148|NCT03358472|76011829|FG001|Overall Study|Death|3|||
42200149|NCT03358472|76011830|FG002|Overall Study|Death|10|||
42200150|NCT03358472|76011828|FG000|Overall Study|Physician Decision|0|||
42200151|NCT03358472|76011829|FG001|Overall Study|Physician Decision|1|||
42200152|NCT03358472|76011830|FG002|Overall Study|Physician Decision|0|||
42200153|NCT03358472|76011828|FG000|Overall Study|Withdrawal by Subject|0|||
42200154|NCT03358472|76011829|FG001|Overall Study|Withdrawal by Subject|0|||
42200155|NCT03358472|76011830|FG002|Overall Study|Withdrawal by Subject|1|||
42200156|NCT03358472|76011828|FG000|Overall Study|On-going at clinical cut off date|9|||
42200157|NCT03358472|76011829|FG001|Overall Study|On-going at clinical cut off date|6|||
42200158|NCT03358472|76011830|FG002|Overall Study|On-going at clinical cut off date|5|||
42200159|NCT03099382|76011855|FG000|Overall Study|Protocol Violation|2|||
42200160|NCT03099382|76011856|FG001|Overall Study|Protocol Violation|3|||
42200161|NCT02939287|76011865|FG000|Overall Study|met exclusion criteria|1|||
42200162|NCT02939287|76011866|FG001|Overall Study|met exclusion criteria|1|||
42200163|NCT02939287|76011867|FG002|Overall Study|met exclusion criteria|1|||
42200164|NCT02939287|76011865|FG000|Overall Study|Did not complete survey|2|||
42200165|NCT02939287|76011866|FG001|Overall Study|Did not complete survey|2|||
42200166|NCT02939287|76011867|FG002|Overall Study|Did not complete survey|0|||
42200167|NCT02939287|76011865|FG000|Overall Study|Withdrawal by Subject|1|||
42200168|NCT02939287|76011866|FG001|Overall Study|Withdrawal by Subject|1|||
42200169|NCT02939287|76011867|FG002|Overall Study|Withdrawal by Subject|0|||
42200170|NCT02771275|76011892|FG000|Overall Study|Reoperation|3|||
42200171|NCT02771275|76011892|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
42200172|NCT02564900|76011920|FG000|Dose Escalation|Progressive disease per RECIST|2|||
42200173|NCT02564900|76011921|FG001|Dose Escalation|Progressive disease per RECIST|3|||
42200174|NCT02564900|76011922|FG002|Dose Escalation|Progressive disease per RECIST|3|||
42200175|NCT02564900|76011923|FG003|Dose Escalation|Progressive disease per RECIST|3|||
42200176|NCT02564900|76011924|FG004|Dose Escalation|Progressive disease per RECIST|3|||
42200177|NCT02564900|76011925|FG005|Dose Escalation|Progressive disease per RECIST|1|||
42200178|NCT02564900|76011926|FG006|Dose Escalation|Progressive disease per RECIST|0|||
42200179|NCT02564900|76011927|FG007|Dose Escalation|Progressive disease per RECIST|0|||
42200180|NCT02564900|76011928|FG008|Dose Escalation|Progressive disease per RECIST|0|||
42200181|NCT02564900|76011929|FG009|Dose Escalation|Progressive disease per RECIST|0|||
42200182|NCT02564900|76011930|FG010|Dose Escalation|Progressive disease per RECIST|0|||
42200183|NCT02564900|76011931|FG011|Dose Escalation|Progressive disease per RECIST|0|||
42200184|NCT02564900|76011932|FG012|Dose Escalation|Progressive disease per RECIST|0|||
42200185|NCT02564900|76011933|FG013|Dose Escalation|Progressive disease per RECIST|0|||
42200186|NCT02564900|76011934|FG014|Dose Escalation|Progressive disease per RECIST|0|||
42200187|NCT02564900|76011920|FG000|Dose Escalation|Ongoing|1|||
42200188|NCT02564900|76011921|FG001|Dose Escalation|Ongoing|0|||
42200189|NCT02564900|76011922|FG002|Dose Escalation|Ongoing|0|||
42200190|NCT02564900|76011923|FG003|Dose Escalation|Ongoing|2|||
42200191|NCT02564900|76011924|FG004|Dose Escalation|Ongoing|2|||
42200192|NCT02564900|76011925|FG005|Dose Escalation|Ongoing|2|||
42200193|NCT02564900|76011926|FG006|Dose Escalation|Ongoing|0|||
42200194|NCT02564900|76011927|FG007|Dose Escalation|Ongoing|0|||
42200195|NCT02564900|76011928|FG008|Dose Escalation|Ongoing|0|||
42200196|NCT02564900|76011929|FG009|Dose Escalation|Ongoing|0|||
42200197|NCT02564900|76011930|FG010|Dose Escalation|Ongoing|0|||
42200198|NCT02564900|76011931|FG011|Dose Escalation|Ongoing|0|||
42200199|NCT02564900|76011932|FG012|Dose Escalation|Ongoing|0|||
42200200|NCT02564900|76011933|FG013|Dose Escalation|Ongoing|0|||
42200201|NCT02564900|76011934|FG014|Dose Escalation|Ongoing|0|||
42200202|NCT02564900|76011920|FG000|Dose Escalation|Adverse Event|0|||
42200203|NCT02564900|76011921|FG001|Dose Escalation|Adverse Event|0|||
42200204|NCT02564900|76011922|FG002|Dose Escalation|Adverse Event|0|||
42200205|NCT02564900|76011923|FG003|Dose Escalation|Adverse Event|1|||
42200206|NCT02564900|76011924|FG004|Dose Escalation|Adverse Event|1|||
42200207|NCT02564900|76011925|FG005|Dose Escalation|Adverse Event|3|||
42200208|NCT02564900|76011926|FG006|Dose Escalation|Adverse Event|0|||
42200209|NCT02564900|76011927|FG007|Dose Escalation|Adverse Event|0|||
42200210|NCT02564900|76011928|FG008|Dose Escalation|Adverse Event|0|||
42200211|NCT02564900|76011929|FG009|Dose Escalation|Adverse Event|0|||
42200212|NCT02564900|76011930|FG010|Dose Escalation|Adverse Event|0|||
42200213|NCT02564900|76011931|FG011|Dose Escalation|Adverse Event|0|||
42200214|NCT02564900|76011932|FG012|Dose Escalation|Adverse Event|0|||
42200215|NCT02564900|76011933|FG013|Dose Escalation|Adverse Event|0|||
42200216|NCT02564900|76011934|FG014|Dose Escalation|Adverse Event|0|||
42200217|NCT02564900|76011920|FG000|Dose Expansion|Progressive disease per RECIST|0|||
42200218|NCT02564900|76011921|FG001|Dose Expansion|Progressive disease per RECIST|0|||
42370066|NCT01764659|76233067|FG000|Overall Study|Physician Decision|1|||
42370067|NCT01736189|76233073|FG000|Overall Study|Violation of registration criteria|41|||
42370068|NCT01736189|76233073|FG000|Overall Study|Protocol Violation|4|||
42370069|NCT01736189|76233073|FG000|Overall Study|Criteria and protocol violations|1|||
42200219|NCT02564900|76011922|FG002|Dose Expansion|Progressive disease per RECIST|0|||
42200220|NCT02564900|76011923|FG003|Dose Expansion|Progressive disease per RECIST|0|||
42370070|NCT01735175|76233105|FG000|Overall Study|Withdrawal by Subject|9|||
42200221|NCT02564900|76011924|FG004|Dose Expansion|Progressive disease per RECIST|0|||
42200222|NCT02564900|76011925|FG005|Dose Expansion|Progressive disease per RECIST|0|||
42200223|NCT02564900|76011926|FG006|Dose Expansion|Progressive disease per RECIST|19|||
42200224|NCT02564900|76011927|FG007|Dose Expansion|Progressive disease per RECIST|17|||
42200225|NCT02564900|76011928|FG008|Dose Expansion|Progressive disease per RECIST|8|||
42370071|NCT01735175|76233106|FG001|Overall Study|Withdrawal by Subject|2|||
42370072|NCT01735175|76233105|FG000|Overall Study|Lost to Follow-up|4|||
42200226|NCT02564900|76011929|FG009|Dose Expansion|Progressive disease per RECIST|16|||
42103323|NCT00674570|75914273|FG001|Overall Study|Withdrawal by Subject|2|||
42103324|NCT00674570|75914274|FG002|Overall Study|Withdrawal by Subject|0|||
42103325|NCT00561951|75914285|FG000|Overall Study|Adverse Event|11|||
42103326|NCT00561951|75914286|FG001|Overall Study|Adverse Event|14|||
42103327|NCT00561951|75914287|FG002|Overall Study|Adverse Event|14|||
42103328|NCT00561951|75914285|FG000|Overall Study|Lack of Efficacy|5|||
42200227|NCT02564900|76011930|FG010|Dose Expansion|Progressive disease per RECIST|13|||
42200228|NCT02564900|76011931|FG011|Dose Expansion|Progressive disease per RECIST|19|||
42200229|NCT02564900|76011932|FG012|Dose Expansion|Progressive disease per RECIST|10|||
42200230|NCT02564900|76011933|FG013|Dose Expansion|Progressive disease per RECIST|13|||
42200231|NCT02564900|76011934|FG014|Dose Expansion|Progressive disease per RECIST|11|||
42200232|NCT02564900|76011920|FG000|Dose Expansion|Clinical progression|0|||
42200233|NCT02564900|76011921|FG001|Dose Expansion|Clinical progression|0|||
42200234|NCT02564900|76011922|FG002|Dose Expansion|Clinical progression|0|||
42200235|NCT02564900|76011923|FG003|Dose Expansion|Clinical progression|0|||
42200236|NCT02564900|76011924|FG004|Dose Expansion|Clinical progression|0|||
42200237|NCT02564900|76011925|FG005|Dose Expansion|Clinical progression|0|||
42200238|NCT02564900|76011926|FG006|Dose Expansion|Clinical progression|5|||
42200239|NCT02564900|76011927|FG007|Dose Expansion|Clinical progression|12|||
42200240|NCT02564900|76011928|FG008|Dose Expansion|Clinical progression|0|||
42200241|NCT02564900|76011929|FG009|Dose Expansion|Clinical progression|3|||
42200242|NCT02564900|76011930|FG010|Dose Expansion|Clinical progression|2|||
42200243|NCT02564900|76011931|FG011|Dose Expansion|Clinical progression|0|||
42200244|NCT02564900|76011932|FG012|Dose Expansion|Clinical progression|1|||
42200245|NCT02564900|76011933|FG013|Dose Expansion|Clinical progression|3|||
42200246|NCT02564900|76011934|FG014|Dose Expansion|Clinical progression|1|||
42200247|NCT02564900|76011920|FG000|Dose Expansion|Adverse Event|0|||
42200248|NCT02564900|76011921|FG001|Dose Expansion|Adverse Event|0|||
42200249|NCT02564900|76011922|FG002|Dose Expansion|Adverse Event|0|||
42200250|NCT02564900|76011923|FG003|Dose Expansion|Adverse Event|0|||
42200251|NCT02564900|76011924|FG004|Dose Expansion|Adverse Event|0|||
42200252|NCT02564900|76011925|FG005|Dose Expansion|Adverse Event|0|||
42200253|NCT02564900|76011926|FG006|Dose Expansion|Adverse Event|9|||
42200254|NCT02564900|76011927|FG007|Dose Expansion|Adverse Event|22|||
42200255|NCT02564900|76011928|FG008|Dose Expansion|Adverse Event|0|||
42200256|NCT02564900|76011929|FG009|Dose Expansion|Adverse Event|11|||
42200257|NCT02564900|76011930|FG010|Dose Expansion|Adverse Event|0|||
42200258|NCT02564900|76011931|FG011|Dose Expansion|Adverse Event|5|||
42200259|NCT02564900|76011932|FG012|Dose Expansion|Adverse Event|2|||
42200260|NCT02564900|76011933|FG013|Dose Expansion|Adverse Event|2|||
42200261|NCT02564900|76011934|FG014|Dose Expansion|Adverse Event|1|||
42200262|NCT02564900|76011920|FG000|Dose Expansion|Ongoing|0|||
42200263|NCT02564900|76011921|FG001|Dose Expansion|Ongoing|0|||
42370073|NCT01735175|76233106|FG001|Overall Study|Lost to Follow-up|2|||
42370074|NCT01735175|76233105|FG000|Overall Study|Death|3|||
42370075|NCT01735175|76233106|FG001|Overall Study|Death|2|||
42370076|NCT01735175|76233105|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
42370077|NCT01735175|76233106|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
42370078|NCT01762943|76233118|FG000|Overall Study|Physician Decision|1|||
42370079|NCT01762943|76233119|FG001|Overall Study|Physician Decision|1|||
42370080|NCT01762943|76233118|FG000|Overall Study|Protocol Violation|1|||
42370081|NCT01762943|76233119|FG001|Overall Study|Protocol Violation|0|||
42370082|NCT01762943|76233118|FG000|Overall Study|Withdrawal by Subject|2|||
42370083|NCT01762943|76233119|FG001|Overall Study|Withdrawal by Subject|1|||
42370084|NCT01734785|76233182|FG000|Open-Label Period|Adverse Event|0|||
42370085|NCT01734785|76233183|FG001|Open-Label Period|Adverse Event|0|||
42370086|NCT01734785|76233184|FG002|Open-Label Period|Adverse Event|0|||
42370087|NCT01734785|76233185|FG003|Open-Label Period|Adverse Event|9|||
42370088|NCT01734785|76233182|FG000|Open-Label Period|Lack of Efficacy|0|||
42370089|NCT01734785|76233183|FG001|Open-Label Period|Lack of Efficacy|0|||
42370090|NCT01734785|76233184|FG002|Open-Label Period|Lack of Efficacy|0|||
42370091|NCT01734785|76233185|FG003|Open-Label Period|Lack of Efficacy|1|||
42370092|NCT01734785|76233182|FG000|Open-Label Period|Protocol Violation|0|||
42103329|NCT00561951|75914286|FG001|Overall Study|Lack of Efficacy|3|||
42103330|NCT00561951|75914287|FG002|Overall Study|Lack of Efficacy|2|||
42103331|NCT00561951|75914285|FG000|Overall Study|Lost to Follow-up|1|||
42103332|NCT00561951|75914286|FG001|Overall Study|Lost to Follow-up|1|||
42103333|NCT00561951|75914287|FG002|Overall Study|Lost to Follow-up|0|||
42200264|NCT02564900|76011922|FG002|Dose Expansion|Ongoing|0|||
42370093|NCT01734785|76233183|FG001|Open-Label Period|Protocol Violation|0|||
42103334|NCT00561951|75914285|FG000|Overall Study|Withdrawal by Subject|10|||
42103335|NCT00561951|75914286|FG001|Overall Study|Withdrawal by Subject|9|||
42200265|NCT02564900|76011923|FG003|Dose Expansion|Ongoing|0|||
42200266|NCT02564900|76011924|FG004|Dose Expansion|Ongoing|0|||
42200267|NCT02564900|76011925|FG005|Dose Expansion|Ongoing|0|||
42370094|NCT01734785|76233184|FG002|Open-Label Period|Protocol Violation|0|||
42370095|NCT01734785|76233185|FG003|Open-Label Period|Protocol Violation|13|||
42200268|NCT02564900|76011926|FG006|Dose Expansion|Ongoing|9|||
42200269|NCT02564900|76011927|FG007|Dose Expansion|Ongoing|10|||
42200270|NCT02564900|76011928|FG008|Dose Expansion|Ongoing|11|||
42200271|NCT02564900|76011929|FG009|Dose Expansion|Ongoing|3|||
42200272|NCT02564900|76011930|FG010|Dose Expansion|Ongoing|0|||
42200273|NCT02564900|76011931|FG011|Dose Expansion|Ongoing|0|||
42200274|NCT02564900|76011932|FG012|Dose Expansion|Ongoing|4|||
42200275|NCT02564900|76011933|FG013|Dose Expansion|Ongoing|0|||
42200276|NCT02564900|76011934|FG014|Dose Expansion|Ongoing|6|||
42200277|NCT02564900|76011920|FG000|Dose Expansion|Death|0|||
42200278|NCT02564900|76011921|FG001|Dose Expansion|Death|0|||
42200279|NCT02564900|76011922|FG002|Dose Expansion|Death|0|||
42200280|NCT02564900|76011923|FG003|Dose Expansion|Death|0|||
42200281|NCT02564900|76011924|FG004|Dose Expansion|Death|0|||
42200282|NCT02564900|76011925|FG005|Dose Expansion|Death|0|||
42200283|NCT02564900|76011926|FG006|Dose Expansion|Death|1|||
42200284|NCT02564900|76011927|FG007|Dose Expansion|Death|0|||
42200285|NCT02564900|76011928|FG008|Dose Expansion|Death|0|||
42200286|NCT02564900|76011929|FG009|Dose Expansion|Death|0|||
42200287|NCT02564900|76011930|FG010|Dose Expansion|Death|1|||
42200288|NCT02564900|76011931|FG011|Dose Expansion|Death|0|||
42200289|NCT02564900|76011932|FG012|Dose Expansion|Death|1|||
42370096|NCT01734785|76233182|FG000|Open-Label Period|Lost to Follow-up|0|||
42370097|NCT01734785|76233183|FG001|Open-Label Period|Lost to Follow-up|0|||
42370098|NCT01734785|76233184|FG002|Open-Label Period|Lost to Follow-up|0|||
42370099|NCT01734785|76233185|FG003|Open-Label Period|Lost to Follow-up|14|||
42370100|NCT01734785|76233182|FG000|Open-Label Period|Withdrawal by Subject|0|||
42103336|NCT00561951|75914287|FG002|Overall Study|Withdrawal by Subject|10|||
42103337|NCT00561951|75914285|FG000|Overall Study|Protocol Violation|4|||
42103338|NCT00561951|75914286|FG001|Overall Study|Protocol Violation|3|||
42103339|NCT00561951|75914287|FG002|Overall Study|Protocol Violation|4|||
42103340|NCT00561951|75914285|FG000|Overall Study|Physician Decision|1|||
42103341|NCT00561951|75914286|FG001|Overall Study|Physician Decision|0|||
42103342|NCT00561951|75914287|FG002|Overall Study|Physician Decision|0|||
42103343|NCT00561951|75914285|FG000|Overall Study|Pregnancy|0|||
42103344|NCT00561951|75914286|FG001|Overall Study|Pregnancy|1|||
42103345|NCT00561951|75914287|FG002|Overall Study|Pregnancy|0|||
42103346|NCT00561951|75914285|FG000|Overall Study|Meet Withdrawal Criterion|0|||
42103347|NCT00561951|75914286|FG001|Overall Study|Meet Withdrawal Criterion|1|||
42103348|NCT00561951|75914287|FG002|Overall Study|Meet Withdrawal Criterion|1|||
42103349|NCT00561951|75914285|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
42103350|NCT00561951|75914286|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
42103351|NCT00561951|75914287|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
42103352|NCT00322387|75914297|FG000|Treatment Period|Adverse Event|0|||
42103353|NCT00322387|75914298|FG001|Treatment Period|Adverse Event|1|||
42103354|NCT00322387|75914297|FG000|Follow-up Period|Final assessment not done|1|||
42103355|NCT00322387|75914298|FG001|Follow-up Period|Final assessment not done|3|||
42103356|NCT00322387|75914297|FG000|Follow-up Period|Death|1|||
42103357|NCT00322387|75914298|FG001|Follow-up Period|Death|0|||
42370101|NCT01734785|76233183|FG001|Open-Label Period|Withdrawal by Subject|0|||
42370102|NCT01734785|76233184|FG002|Open-Label Period|Withdrawal by Subject|0|||
42370103|NCT01734785|76233185|FG003|Open-Label Period|Withdrawal by Subject|12|||
42370104|NCT01734785|76233182|FG000|Open-Label Period|Other Reasons|0|||
42370105|NCT01734785|76233183|FG001|Open-Label Period|Other Reasons|0|||
42370106|NCT01734785|76233184|FG002|Open-Label Period|Other Reasons|0|||
42370107|NCT01734785|76233185|FG003|Open-Label Period|Other Reasons|224|||
42370108|NCT01734785|76233182|FG000|Double-Blind Period|Adverse Event|0|||
42370109|NCT01734785|76233183|FG001|Double-Blind Period|Adverse Event|3|||
42370110|NCT01734785|76233184|FG002|Double-Blind Period|Adverse Event|2|||
42370111|NCT01734785|76233185|FG003|Double-Blind Period|Adverse Event|0|||
42370112|NCT01734785|76233182|FG000|Double-Blind Period|Lack of Efficacy|0|||
42370113|NCT01734785|76233183|FG001|Double-Blind Period|Lack of Efficacy|1|||
42370114|NCT01734785|76233184|FG002|Double-Blind Period|Lack of Efficacy|0|||
42200290|NCT02564900|76011933|FG013|Dose Expansion|Death|1|||
42200291|NCT02564900|76011934|FG014|Dose Expansion|Death|0|||
42200292|NCT02564900|76011920|FG000|Dose Expansion|Withdrawal by Subject|0|||
42370115|NCT01734785|76233185|FG003|Double-Blind Period|Lack of Efficacy|0|||
42370116|NCT01734785|76233182|FG000|Double-Blind Period|Protocol Violation|0|||
42370117|NCT01734785|76233183|FG001|Double-Blind Period|Protocol Violation|1|||
42370118|NCT01734785|76233184|FG002|Double-Blind Period|Protocol Violation|1|||
42103358|NCT00561015|75914321|FG000|Overall Study|Adverse Event|0|||
42103359|NCT00561015|75914322|FG001|Overall Study|Adverse Event|0|||
42103360|NCT00561015|75914323|FG002|Overall Study|Adverse Event|0|||
42103361|NCT00561015|75914324|FG003|Overall Study|Adverse Event|0|||
42103362|NCT00561015|75914325|FG004|Overall Study|Adverse Event|1|||
42200293|NCT02564900|76011921|FG001|Dose Expansion|Withdrawal by Subject|0|||
42200294|NCT02564900|76011922|FG002|Dose Expansion|Withdrawal by Subject|0|||
42200295|NCT02564900|76011923|FG003|Dose Expansion|Withdrawal by Subject|0|||
42200296|NCT02564900|76011924|FG004|Dose Expansion|Withdrawal by Subject|0|||
42370119|NCT01734785|76233185|FG003|Double-Blind Period|Protocol Violation|0|||
42200297|NCT02564900|76011925|FG005|Dose Expansion|Withdrawal by Subject|0|||
42200298|NCT02564900|76011926|FG006|Dose Expansion|Withdrawal by Subject|4|||
42200299|NCT02564900|76011927|FG007|Dose Expansion|Withdrawal by Subject|0|||
42200300|NCT02564900|76011928|FG008|Dose Expansion|Withdrawal by Subject|0|||
42200301|NCT02564900|76011929|FG009|Dose Expansion|Withdrawal by Subject|0|||
42200302|NCT02564900|76011930|FG010|Dose Expansion|Withdrawal by Subject|1|||
42200303|NCT02564900|76011931|FG011|Dose Expansion|Withdrawal by Subject|0|||
42200304|NCT02564900|76011932|FG012|Dose Expansion|Withdrawal by Subject|0|||
42200305|NCT02564900|76011933|FG013|Dose Expansion|Withdrawal by Subject|1|||
42200306|NCT02564900|76011934|FG014|Dose Expansion|Withdrawal by Subject|1|||
42200307|NCT02564900|76011920|FG000|Dose Expansion|Other|0|||
42200308|NCT02564900|76011921|FG001|Dose Expansion|Other|0|||
42200309|NCT02564900|76011922|FG002|Dose Expansion|Other|0|||
42200310|NCT02564900|76011923|FG003|Dose Expansion|Other|0|||
42200311|NCT02564900|76011924|FG004|Dose Expansion|Other|0|||
42200312|NCT02564900|76011925|FG005|Dose Expansion|Other|0|||
42200313|NCT02564900|76011926|FG006|Dose Expansion|Other|1|||
42200314|NCT02564900|76011927|FG007|Dose Expansion|Other|0|||
42200315|NCT02564900|76011928|FG008|Dose Expansion|Other|1|||
42200316|NCT02564900|76011929|FG009|Dose Expansion|Other|0|||
42200317|NCT02564900|76011930|FG010|Dose Expansion|Other|0|||
42200318|NCT02564900|76011931|FG011|Dose Expansion|Other|0|||
42200319|NCT02564900|76011932|FG012|Dose Expansion|Other|0|||
42200320|NCT02564900|76011933|FG013|Dose Expansion|Other|0|||
42200321|NCT02564900|76011934|FG014|Dose Expansion|Other|1|||
42200322|NCT02564900|76011920|FG000|Dose Expansion|Did not receive treatment|0|||
42200323|NCT02564900|76011921|FG001|Dose Expansion|Did not receive treatment|0|||
42200324|NCT02564900|76011922|FG002|Dose Expansion|Did not receive treatment|0|||
42200325|NCT02564900|76011923|FG003|Dose Expansion|Did not receive treatment|0|||
42200326|NCT02564900|76011924|FG004|Dose Expansion|Did not receive treatment|0|||
42200327|NCT02564900|76011925|FG005|Dose Expansion|Did not receive treatment|0|||
42200328|NCT02564900|76011926|FG006|Dose Expansion|Did not receive treatment|1|||
42200329|NCT02564900|76011927|FG007|Dose Expansion|Did not receive treatment|1|||
42200330|NCT02564900|76011928|FG008|Dose Expansion|Did not receive treatment|0|||
42200331|NCT02564900|76011929|FG009|Dose Expansion|Did not receive treatment|0|||
42200332|NCT02564900|76011930|FG010|Dose Expansion|Did not receive treatment|0|||
42200333|NCT02564900|76011931|FG011|Dose Expansion|Did not receive treatment|0|||
42200334|NCT02564900|76011932|FG012|Dose Expansion|Did not receive treatment|0|||
42200335|NCT02564900|76011933|FG013|Dose Expansion|Did not receive treatment|0|||
42200336|NCT02564900|76011934|FG014|Dose Expansion|Did not receive treatment|1|||
42200337|NCT02470091|76011977|FG000|Overall Study|Withdrawal by Subject|1|||
42200338|NCT02470091|76011978|FG001|Overall Study|Withdrawal by Subject|0|||
42200339|NCT02470091|76011977|FG000|Overall Study|Ineligible|0|||
42200340|NCT02470091|76011978|FG001|Overall Study|Ineligible|2|||
42200341|NCT02451943|76011988|FG000|Overall Study|On Treatment|4|||
42200342|NCT02451943|76011989|FG001|Overall Study|On Treatment|4|||
42200343|NCT02451943|76011988|FG000|Overall Study|Withdrawal by Subject|13|||
42200344|NCT02451943|76011989|FG001|Overall Study|Withdrawal by Subject|16|||
42200345|NCT02451943|76011988|FG000|Overall Study|Lost to Follow-up|3|||
42200346|NCT02451943|76011989|FG001|Overall Study|Lost to Follow-up|4|||
42200347|NCT02432196|76011995|FG000|Overall Study|Exit - did not receive study device|1|||
42200348|NCT02432196|76011995|FG000|Overall Study|Death|2|||
42200349|NCT02432196|76011995|FG000|Overall Study|Reoperation|3|||
42200350|NCT02163733|76012014|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
42200351|NCT02163733|76012015|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
42200352|NCT02163733|76012016|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
42200353|NCT02163733|76012014|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
42200354|NCT02163733|76012015|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
42200355|NCT02163733|76012016|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
42200356|NCT01391832|76012034|FG000|Overall Study|Withdrawal by Subject|21|||
42200357|NCT01391832|76012035|FG001|Overall Study|Withdrawal by Subject|22|||
42200358|NCT01391832|76012034|FG000|Overall Study|Lost to Follow-up|0|||
42200359|NCT01391832|76012035|FG001|Overall Study|Lost to Follow-up|1|||
42370120|NCT01734785|76233182|FG000|Double-Blind Period|Lost to Follow-up|2|||
42200360|NCT05590000|76012041|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
42200361|NCT05333965|76012049|FG000|First Intervention|Adverse Event|0|||
42200362|NCT05333965|76012050|FG001|First Intervention|Adverse Event|1|||
42200363|NCT05333965|76012049|FG000|First Intervention|Withdrawal by Subject|0|||
42200364|NCT05333965|76012050|FG001|First Intervention|Withdrawal by Subject|1|||
42200365|NCT05109702|76012067|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
42370121|NCT01734785|76233183|FG001|Double-Blind Period|Lost to Follow-up|4|||
42200366|NCT05109702|76012068|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
42200367|NCT05109702|76012069|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
42370122|NCT01734785|76233184|FG002|Double-Blind Period|Lost to Follow-up|2|||
42370123|NCT01734785|76233185|FG003|Double-Blind Period|Lost to Follow-up|0|||
42370124|NCT01734785|76233182|FG000|Double-Blind Period|Withdrawal by Subject|2|||
42200368|NCT05109702|76012067|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
42200369|NCT05109702|76012068|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
42200370|NCT05109702|76012069|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
42200371|NCT05109702|76012067|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
42200372|NCT05109702|76012068|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
42200373|NCT05109702|76012069|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
42200374|NCT05109702|76012067|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
42200375|NCT05109702|76012068|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
42200376|NCT05109702|76012069|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
42200377|NCT05109702|76012067|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
42200378|NCT05109702|76012068|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
42200379|NCT05109702|76012069|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
42200380|NCT04699461|76012082|FG000|Overall Study|Withdrawal by Subject|1|||
42200381|NCT04699461|76012083|FG001|Overall Study|Withdrawal by Subject|0|||
42200382|NCT04699461|76012082|FG000|Overall Study|Study termination by sponsor|2|||
42200383|NCT04699461|76012083|FG001|Overall Study|Study termination by sponsor|1|||
42200384|NCT04699461|76012082|FG000|Overall Study|Death|1|||
42200385|NCT04699461|76012083|FG001|Overall Study|Death|0|||
42200386|NCT04699461|76012082|FG000|Overall Study|Radiographic progression|0|||
42200387|NCT04699461|76012083|FG001|Overall Study|Radiographic progression|1|||
42200388|NCT04399551|76012089|FG000|Overall Study|Adverse Event|15|||
42200389|NCT04399551|76012089|FG000|Overall Study|Withdrawal by Subject|6|||
42200390|NCT04399551|76012089|FG000|Overall Study|Physician Decision|3|||
42200391|NCT04399551|76012089|FG000|Overall Study|Lost to Follow-up|2|||
42200392|NCT04399551|76012089|FG000|Overall Study|Protocol Deviation|2|||
42200393|NCT04343235|76012120|FG000|Overall Study|Lost to Follow-up|3|||
42200394|NCT04343235|76012121|FG001|Overall Study|Lost to Follow-up|2|||
42200395|NCT04338321|76012129|FG000|Overall Study|Adverse Event|4|||
42200396|NCT04338321|76012130|FG001|Overall Study|Adverse Event|10|||
42200397|NCT04338321|76012129|FG000|Overall Study|Death|1|||
42200398|NCT04338321|76012130|FG001|Overall Study|Death|1|||
42370125|NCT01734785|76233183|FG001|Double-Blind Period|Withdrawal by Subject|0|||
42370126|NCT01734785|76233184|FG002|Double-Blind Period|Withdrawal by Subject|0|||
42370127|NCT01734785|76233185|FG003|Double-Blind Period|Withdrawal by Subject|0|||
42370128|NCT01734785|76233182|FG000|Double-Blind Period|Not treated|1|||
42370129|NCT01734785|76233183|FG001|Double-Blind Period|Not treated|0|||
42370130|NCT01734785|76233184|FG002|Double-Blind Period|Not treated|0|||
42370131|NCT01734785|76233185|FG003|Double-Blind Period|Not treated|0|||
42370132|NCT01734395|76233194|FG000|Overall Study|Other|65|||
42370133|NCT01734395|76233194|FG000|Overall Study|Lost to Follow-up|287|||
42370134|NCT01734395|76233194|FG000|Overall Study|Lack of Efficacy|5|||
42370135|NCT01734395|76233194|FG000|Overall Study|Adverse Event|40|||
42370136|NCT01734395|76233194|FG000|Overall Study|Withdrawal by Subject|10|||
42103363|NCT00561015|75914326|FG005|Overall Study|Adverse Event|0|||
42103364|NCT00561015|75914321|FG000|Overall Study|Lost to Follow-up|2|||
42103365|NCT00561015|75914322|FG001|Overall Study|Lost to Follow-up|0|||
42103366|NCT00561015|75914323|FG002|Overall Study|Lost to Follow-up|0|||
42103367|NCT00561015|75914324|FG003|Overall Study|Lost to Follow-up|1|||
42103368|NCT00561015|75914325|FG004|Overall Study|Lost to Follow-up|0|||
42103369|NCT00561015|75914326|FG005|Overall Study|Lost to Follow-up|3|||
42200399|NCT04338321|76012129|FG000|Overall Study|Lost to Follow-up|4|||
42200400|NCT04338321|76012130|FG001|Overall Study|Lost to Follow-up|9|||
42200401|NCT04338321|76012129|FG000|Overall Study|Withdrawal by Subject|45|||
42200402|NCT04338321|76012130|FG001|Overall Study|Withdrawal by Subject|69|||
42200403|NCT04338321|76012129|FG000|Overall Study|Physician Decision|5|||
42200404|NCT04338321|76012130|FG001|Overall Study|Physician Decision|9|||
42200405|NCT04338321|76012129|FG000|Overall Study|Other|3|||
42370137|NCT01734395|76233194|FG000|Overall Study|Missing the reasons for not completed|3|||
42370138|NCT01597505|76233228|FG000|Overall Study|Physician Decision|5|||
42370139|NCT01597505|76233229|FG001|Overall Study|Physician Decision|0|||
42370140|NCT01597505|76233228|FG000|Overall Study|Adverse Event|19|||
42370141|NCT01597505|76233229|FG001|Overall Study|Adverse Event|7|||
42370142|NCT01597505|76233228|FG000|Overall Study|Lost to Follow-up|4|||
42370143|NCT01597505|76233229|FG001|Overall Study|Lost to Follow-up|2|||
42370144|NCT01597505|76233228|FG000|Overall Study|Withdrawal by Subject|10|||
42370145|NCT01597505|76233229|FG001|Overall Study|Withdrawal by Subject|18|||
42370146|NCT01597505|76233228|FG000|Overall Study|Other|5|||
42103370|NCT00561015|75914321|FG000|Overall Study|Participant non-compliance|2|||
42103371|NCT00561015|75914322|FG001|Overall Study|Participant non-compliance|0|||
42370147|NCT01597505|76233229|FG001|Overall Study|Other|6|||
42200406|NCT04338321|76012130|FG001|Overall Study|Other|10|||
42200407|NCT04303780|76012138|FG000|Overall Study|Death|104|||
42200408|NCT04303780|76012139|FG001|Overall Study|Death|85|||
42200409|NCT04303780|76012138|FG000|Overall Study|Lost to Follow-up|5|||
42200410|NCT04303780|76012139|FG001|Overall Study|Lost to Follow-up|2|||
42200411|NCT04303780|76012138|FG000|Overall Study|Withdrawal by Subject|12|||
42370148|NCT01597505|76233228|FG000|Overall Study|Missing|1|||
42370149|NCT01597505|76233229|FG001|Overall Study|Missing|0|||
42200412|NCT04303780|76012139|FG001|Overall Study|Withdrawal by Subject|39|||
42200413|NCT04303780|76012138|FG000|Overall Study|Ongoing in study|50|||
42200414|NCT04303780|76012139|FG001|Overall Study|Ongoing in study|45|||
42200415|NCT04068181|76012150|FG000|Overall Study|Withdrawal by Subject|2|||
42200416|NCT04068181|76012151|FG001|Overall Study|Withdrawal by Subject|0|||
42200417|NCT04068181|76012152|FG002|Overall Study|Withdrawal by Subject|0|||
42200418|NCT04068181|76012153|FG003|Overall Study|Withdrawal by Subject|0|||
42200419|NCT04068181|76012150|FG000|Overall Study|Lost to Follow-up|1|||
42200420|NCT04068181|76012151|FG001|Overall Study|Lost to Follow-up|0|||
42200421|NCT04068181|76012152|FG002|Overall Study|Lost to Follow-up|0|||
42200422|NCT04068181|76012153|FG003|Overall Study|Lost to Follow-up|0|||
42200423|NCT04068181|76012150|FG000|Overall Study|Death|8|||
42200424|NCT04068181|76012151|FG001|Overall Study|Death|8|||
42200425|NCT04068181|76012152|FG002|Overall Study|Death|4|||
42200426|NCT04068181|76012153|FG003|Overall Study|Death|2|||
42200427|NCT04068181|76012150|FG000|Overall Study|Continuing Study|16|||
42370150|NCT01760447|76233268|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
42370151|NCT01760447|76233269|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
42370152|NCT01760447|76233270|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
42370153|NCT01760447|76233271|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
42370154|NCT01760447|76233268|FG000|Weeks 0-20|Withdrawal by Subject|2|||
42370155|NCT01760447|76233269|FG001|Weeks 0-20|Withdrawal by Subject|0|||
42370156|NCT01760447|76233270|FG002|Weeks 0-20|Withdrawal by Subject|1|||
42370157|NCT01760447|76233271|FG003|Weeks 0-20|Withdrawal by Subject|0|||
42370158|NCT01760447|76233268|FG000|Weeks 0-20|Lost to Follow-up|1|||
42370159|NCT01760447|76233269|FG001|Weeks 0-20|Lost to Follow-up|0|||
42370160|NCT01760447|76233270|FG002|Weeks 0-20|Lost to Follow-up|1|||
42370161|NCT01760447|76233271|FG003|Weeks 0-20|Lost to Follow-up|1|||
42370162|NCT01760447|76233268|FG000|Weeks 0-20|Randomized but not treated|0|||
42370163|NCT01760447|76233269|FG001|Weeks 0-20|Randomized but not treated|0|||
42370164|NCT01760447|76233270|FG002|Weeks 0-20|Randomized but not treated|2|||
42370165|NCT01760447|76233271|FG003|Weeks 0-20|Randomized but not treated|0|||
42370166|NCT01760447|76233268|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
42370167|NCT01760447|76233269|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
42370168|NCT01760447|76233270|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
42370169|NCT01760447|76233271|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
42370170|NCT01760447|76233268|FG000|Weeks 20-54|Withdrawal by Subject|2|||
42370171|NCT01760447|76233269|FG001|Weeks 20-54|Withdrawal by Subject|1|||
42370172|NCT01760447|76233270|FG002|Weeks 20-54|Withdrawal by Subject|1|||
42370173|NCT01760447|76233271|FG003|Weeks 20-54|Withdrawal by Subject|2|||
42370174|NCT01760447|76233268|FG000|Weeks 20-54|Lost to Follow-up|0|||
42370175|NCT01760447|76233269|FG001|Weeks 20-54|Lost to Follow-up|0|||
42370176|NCT01760447|76233270|FG002|Weeks 20-54|Lost to Follow-up|1|||
42370177|NCT01760447|76233271|FG003|Weeks 20-54|Lost to Follow-up|2|||
42370178|NCT01732913|76233360|FG000|Overall Study|Study Terminated by Sponsor|105|||
42370179|NCT01732913|76233361|FG001|Overall Study|Study Terminated by Sponsor|55|||
42370180|NCT01732913|76233360|FG000|Overall Study|Withdrawal by Subject|27|||
42103372|NCT00561015|75914323|FG002|Overall Study|Participant non-compliance|0|||
42103373|NCT00561015|75914324|FG003|Overall Study|Participant non-compliance|0|||
42103374|NCT00561015|75914325|FG004|Overall Study|Participant non-compliance|0|||
42103375|NCT00561015|75914326|FG005|Overall Study|Participant non-compliance|0|||
42103376|NCT00560937|75914346|FG000|Overall Study|Withdrawal by Subject|0|||
42103377|NCT00560937|75914347|FG001|Overall Study|Withdrawal by Subject|1|||
42103378|NCT00560937|75914346|FG000|Overall Study|Physician Decision|1|||
42103379|NCT00560937|75914347|FG001|Overall Study|Physician Decision|1|||
42200428|NCT04068181|76012151|FG001|Overall Study|Continuing Study|7|||
42370181|NCT01732913|76233361|FG001|Overall Study|Withdrawal by Subject|4|||
42370182|NCT01732913|76233360|FG000|Overall Study|Physician Decision|14|||
42370183|NCT01732913|76233361|FG001|Overall Study|Physician Decision|7|||
42370184|NCT01732913|76233360|FG000|Overall Study|Other|7|||
42370185|NCT01732913|76233361|FG001|Overall Study|Other|1|||
42370186|NCT01732913|76233360|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
42103380|NCT00561795|75914355|FG000|Overall Study|Adverse Event|3|||
42200429|NCT04068181|76012152|FG002|Overall Study|Continuing Study|11|||
42370187|NCT01732913|76233361|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
42370188|NCT01732835|76233392|FG000|6-month Primary Endpoint|Did not receive device|19|||
42370189|NCT01732835|76233392|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
42370190|NCT01732835|76233392|FG000|6-month Primary Endpoint|Adverse Event|3|||
42370191|NCT01732835|76233392|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
42370192|NCT01732835|76233392|FG000|2-year Extended Follow-up|Adverse Event|3|||
42370193|NCT01732835|76233392|FG000|2-year Extended Follow-up|Death|1|||
42103381|NCT00561795|75914356|FG001|Overall Study|Adverse Event|3|||
42103382|NCT00561795|75914357|FG002|Overall Study|Adverse Event|0|||
42200430|NCT04068181|76012153|FG003|Overall Study|Continuing Study|13|||
42200431|NCT03910673|76012182|FG000|Overall Study|Adverse Event|0|||
42200432|NCT03910673|76012183|FG001|Overall Study|Adverse Event|0|||
42200433|NCT03910673|76012184|FG002|Overall Study|Adverse Event|0|||
42200434|NCT03910673|76012185|FG003|Overall Study|Adverse Event|2|||
42370194|NCT01759511|76233446|FG000|Overall Study|Adverse Event|4|||
42370195|NCT01759511|76233446|FG000|Overall Study|Death|2|||
42370196|NCT01759511|76233446|FG000|Overall Study|Lack of Efficacy|2|||
42370197|NCT01759511|76233446|FG000|Overall Study|Physician Decision|1|||
42370198|NCT01759511|76233446|FG000|Overall Study|Progressive Disease|5|||
42370199|NCT01759511|76233446|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
42370200|NCT01759511|76233446|FG000|Overall Study|Study Terminated by Sponsor|13|||
42370201|NCT01759511|76233446|FG000|Overall Study|Withdrawal by Subject|3|||
42370202|NCT01732757|76233464|FG000|Overall Study|Lost to Follow-up|1|||
42370203|NCT01732757|76233465|FG001|Overall Study|Lost to Follow-up|0|||
42370204|NCT01732757|76233466|FG002|Overall Study|Lost to Follow-up|0|||
42370205|NCT01758731|76233474|FG000|Overall Study|Physician Decision|1|||
42370206|NCT01606319|76233484|FG000|Overall Study|Lost to Follow-up|17|||
42370207|NCT01606319|76233485|FG001|Overall Study|Lost to Follow-up|14|||
42370208|NCT01606319|76233484|FG000|Overall Study|Withdrawal by Subject|9|||
42370209|NCT01606319|76233485|FG001|Overall Study|Withdrawal by Subject|12|||
42370210|NCT01606319|76233484|FG000|Overall Study|Physician Decision|1|||
42370211|NCT01606319|76233485|FG001|Overall Study|Physician Decision|2|||
42370212|NCT01606319|76233484|FG000|Overall Study|Lack of Efficacy|6|||
42370213|NCT01606319|76233485|FG001|Overall Study|Lack of Efficacy|8|||
42370214|NCT01606319|76233484|FG000|Overall Study|Adverse Event|1|||
42370215|NCT01606319|76233485|FG001|Overall Study|Adverse Event|4|||
42370216|NCT01757405|76233493|FG000|Overall Study|Lost to Follow-up|1|||
42370217|NCT01757405|76233494|FG001|Overall Study|Lost to Follow-up|1|||
42370218|NCT01757405|76233493|FG000|Overall Study|Withdrawal by Subject|0|||
42370219|NCT01757405|76233494|FG001|Overall Study|Withdrawal by Subject|1|||
42370220|NCT01455597|76233500|FG000|Overall Study|Adverse Event|7|||
42370221|NCT01455597|76233501|FG001|Overall Study|Adverse Event|0|||
42370222|NCT01455597|76233502|FG002|Overall Study|Adverse Event|5|||
42370223|NCT01455597|76233503|FG003|Overall Study|Adverse Event|1|||
42370224|NCT01455597|76233500|FG000|Overall Study|Lack of Efficacy|0|||
42370225|NCT01455597|76233501|FG001|Overall Study|Lack of Efficacy|1|||
42370226|NCT01455597|76233502|FG002|Overall Study|Lack of Efficacy|2|||
42370227|NCT01455597|76233503|FG003|Overall Study|Lack of Efficacy|0|||
42370228|NCT01455597|76233500|FG000|Overall Study|Lost to Follow-up|3|||
42370229|NCT01455597|76233501|FG001|Overall Study|Lost to Follow-up|0|||
42370230|NCT01455597|76233502|FG002|Overall Study|Lost to Follow-up|2|||
42370231|NCT01455597|76233503|FG003|Overall Study|Lost to Follow-up|1|||
42370232|NCT01455597|76233500|FG000|Overall Study|Withdrew Consent|6|||
42370233|NCT01455597|76233501|FG001|Overall Study|Withdrew Consent|5|||
42370234|NCT01455597|76233502|FG002|Overall Study|Withdrew Consent|8|||
42370235|NCT01455597|76233503|FG003|Overall Study|Withdrew Consent|5|||
42370236|NCT01455597|76233500|FG000|Overall Study|Reason not Specified|1|||
42370237|NCT01455597|76233501|FG001|Overall Study|Reason not Specified|2|||
42370238|NCT01455597|76233502|FG002|Overall Study|Reason not Specified|3|||
42370239|NCT01455597|76233503|FG003|Overall Study|Reason not Specified|3|||
42370240|NCT01757171|76233526|FG000|Overall Study|Adverse Event|5|||
42370241|NCT01757171|76233527|FG001|Overall Study|Adverse Event|1|||
42370242|NCT01757171|76233526|FG000|Overall Study|Disease Progression|1|||
42370243|NCT01757171|76233527|FG001|Overall Study|Disease Progression|0|||
42370244|NCT01757171|76233526|FG000|Overall Study|Hospitalization|1|||
42370245|NCT01757171|76233527|FG001|Overall Study|Hospitalization|0|||
42370246|NCT01757171|76233526|FG000|Overall Study|ECOG decline|1|||
42370247|NCT01757171|76233527|FG001|Overall Study|ECOG decline|0|||
42370248|NCT01756235|76233533|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
42370249|NCT01730729|76233537|FG000|Overall Study|Adverse Event|1|||
42370250|NCT01730729|76233537|FG000|Overall Study|Death|1|||
42370251|NCT01730729|76233537|FG000|Overall Study|Progressive Disease|12|||
42370252|NCT01756157|76233541|FG000|First Intervention Period|Withdrawal by Subject|1|||
42370253|NCT01756157|76233542|FG001|First Intervention Period|Withdrawal by Subject|0|||
42370254|NCT01756157|76233541|FG000|First Intervention Period|Lost to Follow-up|0|||
42370255|NCT01756157|76233542|FG001|First Intervention Period|Lost to Follow-up|2|||
42370256|NCT01756079|76233548|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
42370257|NCT01756079|76233548|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
42370258|NCT01756079|76233548|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
42370259|NCT01756079|76233548|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
42370260|NCT01756079|76233548|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
42370261|NCT04967885|76233555|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
42370262|NCT04967885|76233556|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
42370263|NCT04967885|76233555|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
42370264|NCT04967885|76233556|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
42370265|NCT04967885|76233555|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
42370266|NCT04967885|76233556|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
42370267|NCT04967885|76233555|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
42370268|NCT04967885|76233556|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
42370269|NCT04967885|76233555|FG000|EMI-II Intervention|Lost to Follow-up|14|||
42200435|NCT03910673|76012186|FG004|Overall Study|Adverse Event|0|||
42200436|NCT03781167|76012196|FG000|Overall Study|Adverse Event|23|||
42200437|NCT03781167|76012197|FG001|Overall Study|Adverse Event|25|||
42200438|NCT03781167|76012196|FG000|Overall Study|Withdrew consent|16|||
42200439|NCT03781167|76012197|FG001|Overall Study|Withdrew consent|12|||
42200440|NCT03781167|76012196|FG000|Overall Study|Lost to Follow-up|0|||
42200441|NCT03781167|76012197|FG001|Overall Study|Lost to Follow-up|1|||
42200442|NCT03781167|76012196|FG000|Overall Study|Lack of Efficacy|4|||
42200443|NCT03781167|76012197|FG001|Overall Study|Lack of Efficacy|5|||
42200444|NCT03781167|76012196|FG000|Overall Study|Difficulty with drug delivery system|2|||
42200445|NCT03781167|76012197|FG001|Overall Study|Difficulty with drug delivery system|3|||
42200446|NCT03781167|76012196|FG000|Overall Study|Other, not specified|2|||
42200447|NCT03781167|76012197|FG001|Overall Study|Other, not specified|2|||
42200448|NCT03689712|76012245|FG000|Overall Study|Adverse Event|1|||
42200449|NCT03689712|76012246|FG001|Overall Study|Adverse Event|0|||
42200450|NCT03689712|76012245|FG000|Overall Study|Death|20|||
42200451|NCT03689712|76012246|FG001|Overall Study|Death|10|||
42200452|NCT03689712|76012245|FG000|Overall Study|Lost to Follow-up|6|||
42200453|NCT03689712|76012246|FG001|Overall Study|Lost to Follow-up|6|||
42200454|NCT03689712|76012245|FG000|Overall Study|Other|1|||
42200455|NCT03689712|76012246|FG001|Overall Study|Other|0|||
42200456|NCT03689712|76012245|FG000|Overall Study|Patient Non-Compliance|0|||
42200457|NCT03689712|76012246|FG001|Overall Study|Patient Non-Compliance|1|||
42200458|NCT03689712|76012245|FG000|Overall Study|Withdrawal by Subject|20|||
42200459|NCT03689712|76012246|FG001|Overall Study|Withdrawal by Subject|4|||
42200460|NCT03689712|76012245|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
42200461|NCT03689712|76012246|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
42200462|NCT03689712|76012245|FG000|Overall Study|Randomized but not Treated|13|||
42200463|NCT03689712|76012246|FG001|Overall Study|Randomized but not Treated|7|||
42200464|NCT03689712|76012245|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
42200465|NCT03689712|76012246|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
42200466|NCT03679624|76012254|FG000|Overall Study|Adverse Event|1|||
42200467|NCT03679624|76012255|FG001|Overall Study|Adverse Event|0|||
42200468|NCT03602586|76012261|FG000|Overall Study|Withdrawal by Subject|3|||
42200469|NCT03399552|76012274|FG000|Overall Study|No evidence of disease|1|||
42200470|NCT03399552|76012274|FG000|Overall Study|Unevaluable|1|||
42200471|NCT03370276|76012281|FG000|Overall Study|Death|0|||
42200472|NCT03370276|76012282|FG001|Overall Study|Death|2|||
42200473|NCT03370276|76012283|FG002|Overall Study|Death|5|||
42200474|NCT03312231|76012322|FG000|Overall Study|Lost to Follow-up|2|||
42200475|NCT03312231|76012323|FG001|Overall Study|Lost to Follow-up|6|||
42200476|NCT03312231|76012324|FG002|Overall Study|Lost to Follow-up|1|||
42200477|NCT03312231|76012325|FG003|Overall Study|Lost to Follow-up|3|||
42200478|NCT03312231|76012326|FG004|Overall Study|Lost to Follow-up|1|||
42200479|NCT03312231|76012322|FG000|Overall Study|Withdrawal by Subject|0|||
42200480|NCT03312231|76012323|FG001|Overall Study|Withdrawal by Subject|3|||
42200481|NCT03312231|76012324|FG002|Overall Study|Withdrawal by Subject|1|||
42200482|NCT03312231|76012325|FG003|Overall Study|Withdrawal by Subject|0|||
42200483|NCT03312231|76012326|FG004|Overall Study|Withdrawal by Subject|0|||
42200484|NCT03312231|76012322|FG000|Overall Study|Death|0|||
42200485|NCT03312231|76012323|FG001|Overall Study|Death|1|||
42200486|NCT03312231|76012324|FG002|Overall Study|Death|1|||
42200487|NCT03312231|76012325|FG003|Overall Study|Death|0|||
42200488|NCT03312231|76012326|FG004|Overall Study|Death|0|||
42200489|NCT03312231|76012322|FG000|Overall Study|Study Vaccination not Received|1|||
42200490|NCT03312231|76012323|FG001|Overall Study|Study Vaccination not Received|1|||
42200491|NCT03312231|76012324|FG002|Overall Study|Study Vaccination not Received|1|||
42200492|NCT03312231|76012325|FG003|Overall Study|Study Vaccination not Received|0|||
42200493|NCT03312231|76012326|FG004|Overall Study|Study Vaccination not Received|0|||
42200494|NCT03294590|76012340|FG000|Overall Study|Lost to Follow-up|105|||
42200495|NCT03294590|76012341|FG001|Overall Study|Lost to Follow-up|107|||
42200496|NCT03292731|76012352|FG000|Overall Study|Protocol Violation|4|||
42200497|NCT03292731|76012353|FG001|Overall Study|Protocol Violation|11|||
42200498|NCT03292731|76012354|FG002|Overall Study|Protocol Violation|1|||
42200499|NCT03277313|76012379|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
42370270|NCT04967885|76233556|FG001|EMI-II Intervention|Lost to Follow-up|10|||
42370271|NCT04571060|76233573|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
42370272|NCT04571060|76233574|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
42370273|NCT04571060|76233573|FG000|Overall Study|Never treated migraine|47|||
42370274|NCT04571060|76233574|FG001|Overall Study|Never treated migraine|36|||
42370275|NCT04571060|76233573|FG000|Overall Study|Protocol Violation|4|||
42200500|NCT03277313|76012380|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
42200501|NCT03277313|76012379|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
42200502|NCT03277313|76012380|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
42200503|NCT03277313|76012379|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
42200504|NCT03277313|76012380|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
42370276|NCT04571060|76233574|FG001|Overall Study|Protocol Violation|2|||
42200505|NCT03277313|76012379|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
42200506|NCT03277313|76012380|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
42200507|NCT03277313|76012379|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
42200508|NCT03277313|76012380|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
42200509|NCT03206073|76012392|FG000|Overall Study|Participant Noncompliance|0|||
42200510|NCT03206073|76012393|FG001|Overall Study|Participant Noncompliance|1|||
42200511|NCT03206073|76012394|FG002|Overall Study|Participant Noncompliance|0|||
42200512|NCT03206073|76012395|FG003|Overall Study|Participant Noncompliance|0|||
42200513|NCT03206073|76012392|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
42200514|NCT03206073|76012393|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
42200515|NCT03206073|76012394|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
42200516|NCT03206073|76012395|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
42200517|NCT03206073|76012392|FG000|Overall Study|Death|0|||
42200518|NCT03206073|76012393|FG001|Overall Study|Death|0|||
42200519|NCT03206073|76012394|FG002|Overall Study|Death|1|||
42200520|NCT03206073|76012395|FG003|Overall Study|Death|0|||
42200521|NCT03206073|76012392|FG000|Overall Study|Taken off active treatment|0|||
42200522|NCT03206073|76012393|FG001|Overall Study|Taken off active treatment|0|||
42200523|NCT03206073|76012394|FG002|Overall Study|Taken off active treatment|3|||
42200524|NCT03206073|76012395|FG003|Overall Study|Taken off active treatment|0|||
42200525|NCT03193801|76012405|FG000|Overall Study|Physician Decision|2|||
42200526|NCT03193801|76012405|FG000|Overall Study|Withdrawal by Subject|1|||
42200527|NCT02973997|76012411|FG000|Overall Study|Withdrawal by Subject|4|||
42200528|NCT02973997|76012412|FG001|Overall Study|Withdrawal by Subject|0|||
42200529|NCT02973997|76012411|FG000|Overall Study|Adverse Event|4|||
42200530|NCT02973997|76012412|FG001|Overall Study|Adverse Event|1|||
42200531|NCT02973997|76012411|FG000|Overall Study|Disease Progression|11|||
42200532|NCT02973997|76012412|FG001|Overall Study|Disease Progression|20|||
42200533|NCT02973997|76012411|FG000|Overall Study|Alternative Therapy|3|||
42200534|NCT02973997|76012412|FG001|Overall Study|Alternative Therapy|0|||
42200535|NCT02973997|76012411|FG000|Overall Study|Other complicating disease|0|||
42200536|NCT02973997|76012412|FG001|Overall Study|Other complicating disease|1|||
42200537|NCT02973997|76012411|FG000|Overall Study|Death|0|||
42200538|NCT02973997|76012412|FG001|Overall Study|Death|1|||
42200539|NCT02941926|76012420|FG000|Core Phase|Progressive disease|1109|||
42370277|NCT04571060|76233573|FG000|Overall Study|Withdrawal by Subject|6|||
42370278|NCT04571060|76233574|FG001|Overall Study|Withdrawal by Subject|2|||
42370279|NCT04571060|76233573|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
42370280|NCT04571060|76233574|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
42370281|NCT04512066|76233584|FG000|Double-blind Treatment Period|Adverse Event|6|||
42370282|NCT04512066|76233585|FG001|Double-blind Treatment Period|Adverse Event|4|||
42370283|NCT04512066|76233586|FG002|Double-blind Treatment Period|Adverse Event|5|||
42370284|NCT04512066|76233587|FG003|Double-blind Treatment Period|Adverse Event|1|||
42103383|NCT00561795|75914358|FG003|Overall Study|Adverse Event|0|||
42103384|NCT00561795|75914355|FG000|Overall Study|Study Closed/Terminated|0|||
42103385|NCT00561795|75914356|FG001|Overall Study|Study Closed/Terminated|3|||
42103386|NCT00561795|75914357|FG002|Overall Study|Study Closed/Terminated|0|||
42103387|NCT00561795|75914358|FG003|Overall Study|Study Closed/Terminated|0|||
42103388|NCT00561795|75914355|FG000|Overall Study|Physician Decision|1|||
42103389|NCT00561795|75914356|FG001|Overall Study|Physician Decision|0|||
42103390|NCT00561795|75914357|FG002|Overall Study|Physician Decision|0|||
42103391|NCT00561795|75914358|FG003|Overall Study|Physician Decision|0|||
42103392|NCT00652626|75914373|FG000|Initial Treatment Phase|Adverse Event|0|||
42200540|NCT02941926|76012420|FG000|Core Phase|Adverse Event|504|||
42200541|NCT02941926|76012420|FG000|Core Phase|Subject/guardian decision|127|||
42370285|NCT04512066|76233588|FG004|Double-blind Treatment Period|Adverse Event|0|||
42370286|NCT04512066|76233589|FG005|Double-blind Treatment Period|Adverse Event|0|||
42370287|NCT04512066|76233584|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
42370288|NCT04512066|76233585|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
42370289|NCT04512066|76233586|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
42370290|NCT04512066|76233587|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
42370291|NCT04512066|76233588|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
42370292|NCT04512066|76233589|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
42370293|NCT04512066|76233584|FG000|Double-blind Treatment Period|Physician Decision|1|||
42200542|NCT02941926|76012420|FG000|Core Phase|Physician Decision|112|||
42200543|NCT02941926|76012420|FG000|Core Phase|Death|46|||
42200544|NCT02941926|76012420|FG000|Core Phase|Protocol deviation|34|||
42370294|NCT04512066|76233585|FG001|Double-blind Treatment Period|Physician Decision|0|||
42370295|NCT04512066|76233586|FG002|Double-blind Treatment Period|Physician Decision|1|||
42370296|NCT04512066|76233587|FG003|Double-blind Treatment Period|Physician Decision|0|||
42200545|NCT02941926|76012420|FG000|Core Phase|Lost to Follow-up|8|||
42200546|NCT02941926|76012420|FG000|Core Phase|Technical problems|5|||
42200547|NCT02941926|76012420|FG000|Extension Phase|Physician Decision|155|||
42200548|NCT02941926|76012420|FG000|Extension Phase|Progressive disease|115|||
42200549|NCT02941926|76012420|FG000|Extension Phase|Adverse Event|13|||
42200550|NCT02941926|76012420|FG000|Extension Phase|Subject/Guardian decision|12|||
42200551|NCT02941926|76012420|FG000|Extension Phase|Death|6|||
42200552|NCT02846415|76012431|FG000|Overall Study|Lost to Follow-up|2|||
42200553|NCT02846415|76012432|FG001|Overall Study|Lost to Follow-up|0|||
42200554|NCT02846415|76012431|FG000|Overall Study|Withdrawal by Subject|1|||
42200555|NCT02846415|76012432|FG001|Overall Study|Withdrawal by Subject|1|||
42200556|NCT02671435|76012461|FG000|Overall Study|Death|1|||
42200557|NCT02671435|76012462|FG001|Overall Study|Death|3|||
42200558|NCT02671435|76012463|FG002|Overall Study|Death|0|||
42200559|NCT02671435|76012464|FG003|Overall Study|Death|16|||
42200560|NCT02671435|76012465|FG004|Overall Study|Death|14|||
42200561|NCT02671435|76012466|FG005|Overall Study|Death|29|||
42200562|NCT02671435|76012467|FG006|Overall Study|Death|34|||
42200563|NCT02671435|76012468|FG007|Overall Study|Death|28|||
42200564|NCT02671435|76012469|FG008|Overall Study|Death|19|||
42200565|NCT02671435|76012470|FG009|Overall Study|Death|10|||
42200566|NCT02671435|76012471|FG010|Overall Study|Death|8|||
42200567|NCT02671435|76012472|FG011|Overall Study|Death|29|||
42200568|NCT02671435|76012473|FG012|Overall Study|Death|29|||
42200569|NCT02671435|76012474|FG013|Overall Study|Death|29|||
42200570|NCT02671435|76012475|FG014|Overall Study|Death|27|||
42200571|NCT02671435|76012461|FG000|Overall Study|Lost to Follow-up|0|||
42200572|NCT02671435|76012462|FG001|Overall Study|Lost to Follow-up|0|||
42200573|NCT02671435|76012463|FG002|Overall Study|Lost to Follow-up|1|||
42200574|NCT02671435|76012464|FG003|Overall Study|Lost to Follow-up|0|||
42200575|NCT02671435|76012465|FG004|Overall Study|Lost to Follow-up|1|||
42200576|NCT02671435|76012466|FG005|Overall Study|Lost to Follow-up|1|||
42200577|NCT02671435|76012467|FG006|Overall Study|Lost to Follow-up|2|||
42200578|NCT02671435|76012468|FG007|Overall Study|Lost to Follow-up|2|||
42200579|NCT02671435|76012469|FG008|Overall Study|Lost to Follow-up|0|||
42200580|NCT02671435|76012470|FG009|Overall Study|Lost to Follow-up|2|||
42200581|NCT02671435|76012471|FG010|Overall Study|Lost to Follow-up|0|||
42200582|NCT02671435|76012472|FG011|Overall Study|Lost to Follow-up|3|||
42200583|NCT02671435|76012473|FG012|Overall Study|Lost to Follow-up|3|||
42200584|NCT02671435|76012474|FG013|Overall Study|Lost to Follow-up|2|||
42200585|NCT02671435|76012475|FG014|Overall Study|Lost to Follow-up|0|||
42200586|NCT02671435|76012461|FG000|Overall Study|Withdrawal by Subject|2|||
42370297|NCT04512066|76233588|FG004|Double-blind Treatment Period|Physician Decision|0|||
42370298|NCT04512066|76233589|FG005|Double-blind Treatment Period|Physician Decision|0|||
42370299|NCT04512066|76233584|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
42370300|NCT04512066|76233585|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
42370301|NCT04512066|76233586|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
42103393|NCT00652626|75914374|FG001|Initial Treatment Phase|Adverse Event|0|||
42103394|NCT00652626|75914375|FG002|Initial Treatment Phase|Adverse Event|0|||
42103395|NCT00652626|75914376|FG003|Initial Treatment Phase|Adverse Event|0|||
42103396|NCT00652626|75914377|FG004|Initial Treatment Phase|Adverse Event|1|||
42103397|NCT00652626|75914378|FG005|Initial Treatment Phase|Adverse Event|0|||
42103398|NCT00652626|75914379|FG006|Initial Treatment Phase|Adverse Event|0|||
42103399|NCT00652626|75914373|FG000|Initial Treatment Phase|Protocol Violation|0|||
42103400|NCT00652626|75914374|FG001|Initial Treatment Phase|Protocol Violation|0|||
42103401|NCT00652626|75914375|FG002|Initial Treatment Phase|Protocol Violation|0|||
42103402|NCT00652626|75914376|FG003|Initial Treatment Phase|Protocol Violation|1|||
42370302|NCT04512066|76233587|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
42103403|NCT00652626|75914377|FG004|Initial Treatment Phase|Protocol Violation|0|||
42103404|NCT00652626|75914378|FG005|Initial Treatment Phase|Protocol Violation|0|||
42103405|NCT00652626|75914379|FG006|Initial Treatment Phase|Protocol Violation|0|||
42103406|NCT00652626|75914373|FG000|Initial Treatment Phase|Physician Decision|0|||
42200587|NCT02671435|76012462|FG001|Overall Study|Withdrawal by Subject|0|||
42370303|NCT04512066|76233588|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
42370304|NCT04512066|76233589|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
42370305|NCT04512066|76233584|FG000|Extension Period|Adverse Event|0|||
42370306|NCT04512066|76233585|FG001|Extension Period|Adverse Event|1|||
42370307|NCT04512066|76233586|FG002|Extension Period|Adverse Event|4|||
42103407|NCT00652626|75914374|FG001|Initial Treatment Phase|Physician Decision|0|||
42103408|NCT00652626|75914375|FG002|Initial Treatment Phase|Physician Decision|0|||
42200588|NCT02671435|76012463|FG002|Overall Study|Withdrawal by Subject|2|||
42200589|NCT02671435|76012464|FG003|Overall Study|Withdrawal by Subject|2|||
42200590|NCT02671435|76012465|FG004|Overall Study|Withdrawal by Subject|2|||
42200591|NCT02671435|76012466|FG005|Overall Study|Withdrawal by Subject|7|||
42200592|NCT02671435|76012467|FG006|Overall Study|Withdrawal by Subject|2|||
42200593|NCT02671435|76012468|FG007|Overall Study|Withdrawal by Subject|7|||
42200594|NCT02671435|76012469|FG008|Overall Study|Withdrawal by Subject|1|||
42200595|NCT02671435|76012470|FG009|Overall Study|Withdrawal by Subject|1|||
42200596|NCT02671435|76012471|FG010|Overall Study|Withdrawal by Subject|2|||
42370308|NCT04512066|76233587|FG003|Extension Period|Adverse Event|3|||
42370309|NCT04512066|76233588|FG004|Extension Period|Adverse Event|1|||
42200597|NCT02671435|76012472|FG011|Overall Study|Withdrawal by Subject|4|||
42200598|NCT02671435|76012473|FG012|Overall Study|Withdrawal by Subject|4|||
42200599|NCT02671435|76012474|FG013|Overall Study|Withdrawal by Subject|4|||
42200600|NCT02671435|76012475|FG014|Overall Study|Withdrawal by Subject|2|||
42200601|NCT02671435|76012461|FG000|Overall Study|Un-specified|0|||
42200602|NCT02671435|76012462|FG001|Overall Study|Un-specified|0|||
42200603|NCT02671435|76012463|FG002|Overall Study|Un-specified|0|||
42200604|NCT02671435|76012464|FG003|Overall Study|Un-specified|0|||
42200605|NCT02671435|76012465|FG004|Overall Study|Un-specified|1|||
42200606|NCT02671435|76012466|FG005|Overall Study|Un-specified|3|||
42200607|NCT02671435|76012467|FG006|Overall Study|Un-specified|2|||
42200608|NCT02671435|76012468|FG007|Overall Study|Un-specified|3|||
42200609|NCT02671435|76012469|FG008|Overall Study|Un-specified|0|||
42200610|NCT02671435|76012470|FG009|Overall Study|Un-specified|5|||
42200611|NCT02671435|76012471|FG010|Overall Study|Un-specified|8|||
42200612|NCT02671435|76012472|FG011|Overall Study|Un-specified|4|||
42200613|NCT02671435|76012473|FG012|Overall Study|Un-specified|5|||
42200614|NCT02671435|76012474|FG013|Overall Study|Un-specified|9|||
42200615|NCT02671435|76012475|FG014|Overall Study|Un-specified|8|||
42200616|NCT02519348|76012537|FG000|Overall Study|Death|31|||
42200617|NCT02519348|76012538|FG001|Overall Study|Death|74|||
42200618|NCT02519348|76012539|FG002|Overall Study|Death|47|||
42200619|NCT02519348|76012540|FG003|Overall Study|Death|54|||
42200620|NCT02519348|76012541|FG004|Overall Study|Death|63|||
42200621|NCT02519348|76012542|FG005|Overall Study|Death|18|||
42200622|NCT02519348|76012543|FG006|Overall Study|Death|2|||
42200623|NCT02519348|76012544|FG007|Overall Study|Death|5|||
42200624|NCT02519348|76012545|FG008|Overall Study|Death|5|||
42200625|NCT02519348|76012537|FG000|Overall Study|Withdrawal by Subject|4|||
42200626|NCT02519348|76012538|FG001|Overall Study|Withdrawal by Subject|7|||
42200627|NCT02519348|76012539|FG002|Overall Study|Withdrawal by Subject|4|||
42200628|NCT02519348|76012540|FG003|Overall Study|Withdrawal by Subject|3|||
42200629|NCT02519348|76012541|FG004|Overall Study|Withdrawal by Subject|3|||
42200630|NCT02519348|76012542|FG005|Overall Study|Withdrawal by Subject|2|||
42200631|NCT02519348|76012543|FG006|Overall Study|Withdrawal by Subject|0|||
42200632|NCT02519348|76012544|FG007|Overall Study|Withdrawal by Subject|0|||
42200633|NCT02519348|76012545|FG008|Overall Study|Withdrawal by Subject|1|||
42200634|NCT02519348|76012537|FG000|Overall Study|Lost to Follow-up|0|||
42200635|NCT02519348|76012538|FG001|Overall Study|Lost to Follow-up|0|||
42200636|NCT02519348|76012539|FG002|Overall Study|Lost to Follow-up|1|||
42200637|NCT02519348|76012540|FG003|Overall Study|Lost to Follow-up|0|||
42200638|NCT02519348|76012541|FG004|Overall Study|Lost to Follow-up|2|||
42200639|NCT02519348|76012542|FG005|Overall Study|Lost to Follow-up|1|||
42200640|NCT02519348|76012543|FG006|Overall Study|Lost to Follow-up|1|||
42200641|NCT02519348|76012544|FG007|Overall Study|Lost to Follow-up|0|||
42200642|NCT02519348|76012545|FG008|Overall Study|Lost to Follow-up|0|||
42200643|NCT02519348|76012537|FG000|Overall Study|Other|0|||
42200644|NCT02519348|76012538|FG001|Overall Study|Other|3|||
42200645|NCT02519348|76012539|FG002|Overall Study|Other|0|||
42200646|NCT02519348|76012540|FG003|Overall Study|Other|0|||
42200647|NCT02519348|76012541|FG004|Overall Study|Other|1|||
42200648|NCT02519348|76012542|FG005|Overall Study|Other|0|||
42200649|NCT02519348|76012543|FG006|Overall Study|Other|0|||
42200650|NCT02519348|76012544|FG007|Overall Study|Other|0|||
42200651|NCT02519348|76012545|FG008|Overall Study|Other|0|||
42200652|NCT02519348|76012537|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
42200653|NCT02519348|76012538|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
42200654|NCT02519348|76012539|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
42200655|NCT02519348|76012540|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
42200656|NCT02519348|76012541|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
42200657|NCT02519348|76012542|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
42200658|NCT02519348|76012543|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
42200659|NCT02519348|76012544|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
42200660|NCT02519348|76012545|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
42200661|NCT02485639|76012566|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
42200662|NCT02485639|76012566|FG000|Overall Study|Early termination|4|||
42200663|NCT02485639|76012566|FG000|Overall Study|Withdrawal by Subject|4|||
42200664|NCT02418949|76012574|FG000|Overall Study|Withdrawal by Subject|1|||
42200665|NCT02418949|76012575|FG001|Overall Study|Withdrawal by Subject|0|||
42200666|NCT02418949|76012576|FG002|Overall Study|Withdrawal by Subject|1|||
42200667|NCT02418949|76012577|FG003|Overall Study|Withdrawal by Subject|1|||
42200668|NCT02418949|76012574|FG000|Overall Study|Lost to Follow-up|1|||
42200669|NCT02418949|76012575|FG001|Overall Study|Lost to Follow-up|0|||
42200670|NCT02418949|76012576|FG002|Overall Study|Lost to Follow-up|1|||
42200671|NCT02418949|76012577|FG003|Overall Study|Lost to Follow-up|0|||
42200672|NCT02418949|76012574|FG000|Overall Study|Physician Decision|1|||
42200673|NCT02418949|76012575|FG001|Overall Study|Physician Decision|1|||
42200674|NCT02418949|76012576|FG002|Overall Study|Physician Decision|1|||
42200675|NCT02418949|76012577|FG003|Overall Study|Physician Decision|0|||
42200676|NCT02383433|76012587|FG000|Overall Study|Disease progression|2|||
42200677|NCT02336074|76012602|FG000|Overall Study|Adverse Event|0|||
42200678|NCT02336074|76012603|FG001|Overall Study|Adverse Event|2|||
42200679|NCT02255435|76012638|FG000|Overall Study|Patient's Limited Time Availability|0|||
42200680|NCT02255435|76012639|FG001|Overall Study|Patient's Limited Time Availability|0|||
42200681|NCT02255435|76012640|FG002|Overall Study|Patient's Limited Time Availability|0|||
42200682|NCT02255435|76012641|FG003|Overall Study|Patient's Limited Time Availability|0|||
42200683|NCT02255435|76012642|FG004|Overall Study|Patient's Limited Time Availability|0|||
42200684|NCT02255435|76012643|FG005|Overall Study|Patient's Limited Time Availability|0|||
42200685|NCT02255435|76012644|FG006|Overall Study|Patient's Limited Time Availability|0|||
42370310|NCT04512066|76233589|FG005|Extension Period|Adverse Event|3|||
42370311|NCT04512066|76233584|FG000|Extension Period|Death|0|||
42370312|NCT04512066|76233585|FG001|Extension Period|Death|0|||
42370313|NCT04512066|76233586|FG002|Extension Period|Death|0|||
42370314|NCT04512066|76233587|FG003|Extension Period|Death|0|||
42370315|NCT04512066|76233588|FG004|Extension Period|Death|0|||
42370316|NCT04512066|76233589|FG005|Extension Period|Death|1|||
42370317|NCT04512066|76233584|FG000|Extension Period|Lack of Efficacy|0|||
42370318|NCT04512066|76233585|FG001|Extension Period|Lack of Efficacy|4|||
42370319|NCT04512066|76233586|FG002|Extension Period|Lack of Efficacy|4|||
42370320|NCT04512066|76233587|FG003|Extension Period|Lack of Efficacy|1|||
42370321|NCT04512066|76233588|FG004|Extension Period|Lack of Efficacy|3|||
42370322|NCT04512066|76233589|FG005|Extension Period|Lack of Efficacy|3|||
42370323|NCT04512066|76233584|FG000|Extension Period|Lost to Follow-up|0|||
42370324|NCT04512066|76233585|FG001|Extension Period|Lost to Follow-up|1|||
42370325|NCT04512066|76233586|FG002|Extension Period|Lost to Follow-up|5|||
42370326|NCT04512066|76233587|FG003|Extension Period|Lost to Follow-up|2|||
42370327|NCT04512066|76233588|FG004|Extension Period|Lost to Follow-up|3|||
42370328|NCT04512066|76233589|FG005|Extension Period|Lost to Follow-up|2|||
42370329|NCT04512066|76233584|FG000|Extension Period|Non-compliance with study drug|0|||
42370330|NCT04512066|76233585|FG001|Extension Period|Non-compliance with study drug|1|||
42370331|NCT04512066|76233586|FG002|Extension Period|Non-compliance with study drug|0|||
42370332|NCT04512066|76233587|FG003|Extension Period|Non-compliance with study drug|0|||
42370333|NCT04512066|76233588|FG004|Extension Period|Non-compliance with study drug|0|||
42370334|NCT04512066|76233589|FG005|Extension Period|Non-compliance with study drug|1|||
42370335|NCT04512066|76233584|FG000|Extension Period|Other|0|||
42370336|NCT04512066|76233585|FG001|Extension Period|Other|2|||
42370337|NCT04512066|76233586|FG002|Extension Period|Other|0|||
42370338|NCT04512066|76233587|FG003|Extension Period|Other|0|||
42370339|NCT04512066|76233588|FG004|Extension Period|Other|0|||
42370340|NCT04512066|76233589|FG005|Extension Period|Other|0|||
42370341|NCT04512066|76233584|FG000|Extension Period|Physician Decision|0|||
42370342|NCT04512066|76233585|FG001|Extension Period|Physician Decision|2|||
42103409|NCT00652626|75914376|FG003|Initial Treatment Phase|Physician Decision|0|||
42103410|NCT00652626|75914377|FG004|Initial Treatment Phase|Physician Decision|1|||
42200686|NCT02255435|76012645|FG007|Overall Study|Patient's Limited Time Availability|1|||
42200687|NCT02255435|76012646|FG008|Overall Study|Patient's Limited Time Availability|0|||
42200688|NCT02255435|76012647|FG009|Overall Study|Patient's Limited Time Availability|0|||
42370343|NCT04512066|76233586|FG002|Extension Period|Physician Decision|0|||
42370344|NCT04512066|76233587|FG003|Extension Period|Physician Decision|1|||
42370345|NCT04512066|76233588|FG004|Extension Period|Physician Decision|1|||
42370346|NCT04512066|76233589|FG005|Extension Period|Physician Decision|0|||
42370347|NCT04512066|76233584|FG000|Extension Period|Withdrawal by Subject|0|||
42370348|NCT04512066|76233585|FG001|Extension Period|Withdrawal by Subject|3|||
42370349|NCT04512066|76233586|FG002|Extension Period|Withdrawal by Subject|7|||
42370350|NCT04512066|76233587|FG003|Extension Period|Withdrawal by Subject|11|||
42370351|NCT04512066|76233588|FG004|Extension Period|Withdrawal by Subject|8|||
42370352|NCT04512066|76233589|FG005|Extension Period|Withdrawal by Subject|4|||
42370353|NCT04426318|76233611|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
42370354|NCT04426318|76233612|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
42370355|NCT04356963|76233627|FG000|First Session|Withdrawal by Subject|1|||
42370356|NCT04356963|76233627|FG000|Second Session|Withdrawal by Subject|3|||
42370357|NCT04356963|76233627|FG000|Second Session|Lost to Follow-up|1|||
42200689|NCT02255435|76012638|FG000|Overall Study|Withdrawal by Subject|0|||
42370358|NCT04356963|76233627|FG000|Third Session|Lost to Follow-up|6|||
42370359|NCT04356963|76233627|FG000|Third Session|Withdrawal by Subject|1|||
42370360|NCT03941483|76233640|FG000|Overall Study|Miscellaneous|2|||
42370361|NCT03941483|76233641|FG001|Overall Study|Miscellaneous|3|||
42370362|NCT03941483|76233642|FG002|Overall Study|Miscellaneous|0|||
42370363|NCT03941483|76233640|FG000|Overall Study|Study Terminated by Sponsor|1|||
42370364|NCT03941483|76233641|FG001|Overall Study|Study Terminated by Sponsor|0|||
42370365|NCT03941483|76233642|FG002|Overall Study|Study Terminated by Sponsor|0|||
42370366|NCT03941483|76233640|FG000|Overall Study|Withdrawal by Subject|1|||
42370367|NCT03941483|76233641|FG001|Overall Study|Withdrawal by Subject|4|||
42370368|NCT03941483|76233642|FG002|Overall Study|Withdrawal by Subject|1|||
42370369|NCT03941483|76233640|FG000|Overall Study|Lost to Follow-up|2|||
42370370|NCT03941483|76233641|FG001|Overall Study|Lost to Follow-up|1|||
42370371|NCT03941483|76233642|FG002|Overall Study|Lost to Follow-up|8|||
42370372|NCT03941483|76233640|FG000|Overall Study|Death|3|||
42370373|NCT03941483|76233641|FG001|Overall Study|Death|2|||
42370374|NCT03941483|76233642|FG002|Overall Study|Death|6|||
42370375|NCT03689855|76233678|FG000|Overall Study|Adverse Event|3|||
42370376|NCT03689855|76233678|FG000|Overall Study|Withdrawal by Subject|1|||
42370377|NCT03635996|76233682|FG000|Overall Study|Study terminated by Sponsor|94|||
42370378|NCT03635996|76233682|FG000|Overall Study|Withdrawal by Subject|20|||
42370379|NCT03635996|76233682|FG000|Overall Study|Ablation|26|||
42370380|NCT03635996|76233682|FG000|Overall Study|Adverse Event|7|||
42370381|NCT03635996|76233682|FG000|Overall Study|Physician Decision|3|||
42370382|NCT03635996|76233682|FG000|Overall Study|Prohibited medication|5|||
42370383|NCT03635996|76233682|FG000|Overall Study|Did not meet eligibility criteria|5|||
42370384|NCT03635996|76233682|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
42370385|NCT03635996|76233682|FG000|Overall Study|Protocol Violation|1|||
42370386|NCT03635996|76233682|FG000|Overall Study|Lost to Follow-up|1|||
42370387|NCT03595878|76233689|FG000|Overall Study|Death|2|||
42370388|NCT03595878|76233690|FG001|Overall Study|Death|1|||
42370389|NCT03595878|76233691|FG002|Overall Study|Death|0|||
42370390|NCT03595878|76233689|FG000|Overall Study|Disease progression|2|||
42370391|NCT03595878|76233690|FG001|Overall Study|Disease progression|1|||
42370392|NCT03595878|76233691|FG002|Overall Study|Disease progression|2|||
42370393|NCT03168464|76233737|FG000|Overall Study|Death|9|||
42370394|NCT03168464|76233737|FG000|Overall Study|Progression of disease|6|||
42370395|NCT02818920|76233741|FG000|Overall Study|Unresectable|4|||
42370396|NCT02818920|76233741|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
42370397|NCT02818920|76233741|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
42370398|NCT02818920|76233741|FG000|Overall Study|Adverse Event|3|||
42370399|NCT02818920|76233741|FG000|Overall Study|Developed Other Disease|1|||
42370400|NCT02818920|76233741|FG000|Overall Study|Refused Further Treatment|1|||
42370401|NCT01454401|76233767|FG000|Overall Study|Death|1|||
42370402|NCT01454401|76233767|FG000|Overall Study|hospitalised|1|||
42370403|NCT01454401|76233767|FG000|Overall Study|osteomyelitis|2|||
42370404|NCT01454401|76233767|FG000|Overall Study|non-adherence|1|||
42370405|NCT01344018|76233773|FG000|Overall Study|Death|22|||
42370406|NCT01344018|76233774|FG001|Overall Study|Death|25|||
42370407|NCT01344018|76233773|FG000|Overall Study|Lost to Follow-up|4|||
42370408|NCT01344018|76233774|FG001|Overall Study|Lost to Follow-up|7|||
42370409|NCT01755767|76233807|FG000|Overall Study|Progressive Disease|8|||
42370410|NCT01755767|76233808|FG001|Overall Study|Progressive Disease|7|||
42370411|NCT01755767|76233809|FG002|Overall Study|Progressive Disease|91|||
42370412|NCT01755767|76233810|FG003|Overall Study|Progressive Disease|43|||
42370413|NCT01755767|76233807|FG000|Overall Study|Clinical Disease Progression|4|||
42370414|NCT01755767|76233808|FG001|Overall Study|Clinical Disease Progression|2|||
42370415|NCT01755767|76233809|FG002|Overall Study|Clinical Disease Progression|29|||
42370416|NCT01755767|76233810|FG003|Overall Study|Clinical Disease Progression|20|||
42370417|NCT01755767|76233807|FG000|Overall Study|Radiographic Disease Progression|9|||
42370418|NCT01755767|76233808|FG001|Overall Study|Radiographic Disease Progression|4|||
42370419|NCT01755767|76233809|FG002|Overall Study|Radiographic Disease Progression|44|||
42370420|NCT01755767|76233810|FG003|Overall Study|Radiographic Disease Progression|27|||
42370421|NCT01755767|76233807|FG000|Overall Study|Adverse Event|6|||
42370422|NCT01755767|76233808|FG001|Overall Study|Adverse Event|0|||
42370423|NCT01755767|76233809|FG002|Overall Study|Adverse Event|28|||
42370424|NCT01755767|76233810|FG003|Overall Study|Adverse Event|11|||
42370425|NCT01755767|76233807|FG000|Overall Study|Death|1|||
42370426|NCT01755767|76233808|FG001|Overall Study|Death|2|||
42370427|NCT01755767|76233809|FG002|Overall Study|Death|15|||
42370428|NCT01755767|76233810|FG003|Overall Study|Death|4|||
42370429|NCT01755767|76233807|FG000|Overall Study|Subject Decision|0|||
42370430|NCT01755767|76233808|FG001|Overall Study|Subject Decision|0|||
42370431|NCT01755767|76233809|FG002|Overall Study|Subject Decision|10|||
42370432|NCT01755767|76233810|FG003|Overall Study|Subject Decision|3|||
42370433|NCT01755767|76233807|FG000|Overall Study|Withdrawal by Subject|0|||
42370434|NCT01755767|76233808|FG001|Overall Study|Withdrawal by Subject|0|||
42370435|NCT01755767|76233809|FG002|Overall Study|Withdrawal by Subject|2|||
42370436|NCT01755767|76233810|FG003|Overall Study|Withdrawal by Subject|1|||
42370437|NCT01755767|76233807|FG000|Overall Study|Other|0|||
42370438|NCT01755767|76233808|FG001|Overall Study|Other|0|||
42370439|NCT01755767|76233809|FG002|Overall Study|Other|2|||
42370440|NCT01755767|76233810|FG003|Overall Study|Other|3|||
42370441|NCT01755767|76233807|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
42370442|NCT01755767|76233808|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
42370443|NCT01755767|76233809|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
42370444|NCT01755767|76233810|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
42370445|NCT01730339|76233906|FG000|Overall Study|Withdrawal by Subject|3|||
42370446|NCT01730339|76233907|FG001|Overall Study|Withdrawal by Subject|2|||
42370447|NCT01730339|76233906|FG000|Overall Study|Lost to Follow-up|1|||
42370448|NCT01730339|76233907|FG001|Overall Study|Lost to Follow-up|1|||
42370449|NCT01730339|76233906|FG000|Overall Study|Un-specified|1|||
42370450|NCT01730339|76233907|FG001|Overall Study|Un-specified|0|||
42370451|NCT01754753|76233964|FG000|Overall Study|Study close|43|||
42370452|NCT01754753|76233965|FG001|Overall Study|Study close|44|||
42370453|NCT01754753|76233964|FG000|Overall Study|Lost to Follow-up|9|||
42370454|NCT01754753|76233965|FG001|Overall Study|Lost to Follow-up|5|||
42370455|NCT01729871|76233973|FG000|Overall Study|Adverse Event|7|||
42370456|NCT01729871|76233974|FG001|Overall Study|Adverse Event|7|||
42370457|NCT01729871|76233973|FG000|Overall Study|Death|0|||
42370458|NCT01729871|76233974|FG001|Overall Study|Death|1|||
42370459|NCT01729871|76233973|FG000|Overall Study|Lack of Efficacy|0|||
42370460|NCT01729871|76233974|FG001|Overall Study|Lack of Efficacy|1|||
42370461|NCT01729871|76233973|FG000|Overall Study|Physician Decision|0|||
42370462|NCT01729871|76233974|FG001|Overall Study|Physician Decision|2|||
42370463|NCT01729871|76233973|FG000|Overall Study|Protocol Violation|1|||
42370464|NCT01729871|76233974|FG001|Overall Study|Protocol Violation|0|||
42370465|NCT01729871|76233973|FG000|Overall Study|Withdrawal by Subject|0|||
42370466|NCT01729871|76233974|FG001|Overall Study|Withdrawal by Subject|3|||
42370467|NCT01729871|76233973|FG000|Overall Study|Other|4|||
42370468|NCT01729871|76233974|FG001|Overall Study|Other|9|||
42370469|NCT02611323|76233991|FG000|Overall Study|Death|3|||
42370470|NCT02611323|76233992|FG001|Overall Study|Death|1|||
42370471|NCT02611323|76233993|FG002|Overall Study|Death|0|||
42370472|NCT02611323|76233994|FG003|Overall Study|Death|0|||
42370473|NCT02611323|76233995|FG004|Overall Study|Death|1|||
42370474|NCT02611323|76233996|FG005|Overall Study|Death|1|||
42370475|NCT02611323|76233997|FG006|Overall Study|Death|8|||
42370476|NCT02611323|76233998|FG007|Overall Study|Death|0|||
42370477|NCT02611323|76233999|FG008|Overall Study|Death|4|||
42370478|NCT02611323|76234000|FG009|Overall Study|Death|6|||
42370479|NCT02611323|76234001|FG010|Overall Study|Death|26|||
42370480|NCT02611323|76233991|FG000|Overall Study|Lost to Follow-up|1|||
42370481|NCT02611323|76233992|FG001|Overall Study|Lost to Follow-up|0|||
42370482|NCT02611323|76233993|FG002|Overall Study|Lost to Follow-up|0|||
42370483|NCT02611323|76233994|FG003|Overall Study|Lost to Follow-up|0|||
42370484|NCT02611323|76233995|FG004|Overall Study|Lost to Follow-up|0|||
42370485|NCT02611323|76233996|FG005|Overall Study|Lost to Follow-up|0|||
42370486|NCT02611323|76233997|FG006|Overall Study|Lost to Follow-up|3|||
42103411|NCT00652626|75914378|FG005|Initial Treatment Phase|Physician Decision|0|||
42200690|NCT02255435|76012639|FG001|Overall Study|Withdrawal by Subject|0|||
42200691|NCT02255435|76012640|FG002|Overall Study|Withdrawal by Subject|0|||
42200692|NCT02255435|76012641|FG003|Overall Study|Withdrawal by Subject|0|||
42200693|NCT02255435|76012642|FG004|Overall Study|Withdrawal by Subject|0|||
42200694|NCT02255435|76012643|FG005|Overall Study|Withdrawal by Subject|0|||
42200695|NCT02255435|76012644|FG006|Overall Study|Withdrawal by Subject|0|||
42200696|NCT02255435|76012645|FG007|Overall Study|Withdrawal by Subject|0|||
42200697|NCT02255435|76012646|FG008|Overall Study|Withdrawal by Subject|1|||
42200698|NCT02255435|76012647|FG009|Overall Study|Withdrawal by Subject|4|||
42370487|NCT02611323|76233998|FG007|Overall Study|Lost to Follow-up|0|||
42370488|NCT02611323|76233999|FG008|Overall Study|Lost to Follow-up|0|||
42370489|NCT02611323|76234000|FG009|Overall Study|Lost to Follow-up|0|||
42370490|NCT02611323|76234001|FG010|Overall Study|Lost to Follow-up|2|||
42370491|NCT02611323|76233991|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
42370492|NCT02611323|76233992|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
42370493|NCT02611323|76233993|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
42370494|NCT02611323|76233994|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
42370495|NCT02611323|76233995|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
42370496|NCT02611323|76233996|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
42370497|NCT02611323|76233997|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
42370498|NCT02611323|76233998|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
42370499|NCT02611323|76233999|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
42370500|NCT02611323|76234000|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
42370501|NCT02611323|76234001|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
42370502|NCT02611323|76233991|FG000|Overall Study|Progressive Disease|0|||
42370503|NCT02611323|76233992|FG001|Overall Study|Progressive Disease|0|||
42200699|NCT02255435|76012638|FG000|Overall Study|Administrative reasons|0|||
42200700|NCT02255435|76012639|FG001|Overall Study|Administrative reasons|0|||
42200701|NCT02255435|76012640|FG002|Overall Study|Administrative reasons|0|||
42200702|NCT02255435|76012641|FG003|Overall Study|Administrative reasons|0|||
42200703|NCT02255435|76012642|FG004|Overall Study|Administrative reasons|0|||
42200704|NCT02255435|76012643|FG005|Overall Study|Administrative reasons|0|||
42370504|NCT02611323|76233993|FG002|Overall Study|Progressive Disease|0|||
42370505|NCT02611323|76233994|FG003|Overall Study|Progressive Disease|0|||
42370506|NCT02611323|76233995|FG004|Overall Study|Progressive Disease|0|||
42370507|NCT02611323|76233996|FG005|Overall Study|Progressive Disease|0|||
42370508|NCT02611323|76233997|FG006|Overall Study|Progressive Disease|0|||
42370509|NCT02611323|76233998|FG007|Overall Study|Progressive Disease|0|||
42370510|NCT02611323|76233999|FG008|Overall Study|Progressive Disease|0|||
42370511|NCT02611323|76234000|FG009|Overall Study|Progressive Disease|0|||
42370512|NCT02611323|76234001|FG010|Overall Study|Progressive Disease|1|||
42370513|NCT02611323|76233991|FG000|Overall Study|Withdrawal by Subject|1|||
42370514|NCT02611323|76233992|FG001|Overall Study|Withdrawal by Subject|0|||
42370515|NCT02611323|76233993|FG002|Overall Study|Withdrawal by Subject|0|||
42370516|NCT02611323|76233994|FG003|Overall Study|Withdrawal by Subject|0|||
42370517|NCT02611323|76233995|FG004|Overall Study|Withdrawal by Subject|0|||
42370518|NCT02611323|76233996|FG005|Overall Study|Withdrawal by Subject|0|||
42370519|NCT02611323|76233997|FG006|Overall Study|Withdrawal by Subject|0|||
42370520|NCT02611323|76233998|FG007|Overall Study|Withdrawal by Subject|1|||
42370521|NCT02611323|76233999|FG008|Overall Study|Withdrawal by Subject|0|||
42370522|NCT02611323|76234000|FG009|Overall Study|Withdrawal by Subject|1|||
42370523|NCT02611323|76234001|FG010|Overall Study|Withdrawal by Subject|0|||
42370524|NCT01729559|76234040|FG000|Overall Study|Protocol Violation|31|||
42370525|NCT01729559|76234041|FG001|Overall Study|Protocol Violation|28|||
42370526|NCT01728779|76234060|FG000|Overall Study|Withdrawal by Subject|1|||
42370527|NCT01728623|76234071|FG000|Overall Study|Disease progression|26|||
42370528|NCT01728623|76234071|FG000|Overall Study|Adverse Event|1|||
42370529|NCT01728623|76234071|FG000|Overall Study|Withdrawal by Subject|1|||
42370530|NCT01754129|76234078|FG000|Overall Study|Death|13|||
42370531|NCT01754129|76234078|FG000|Overall Study|Duodopa discontinuation|9|||
42370532|NCT01754129|76234078|FG000|Overall Study|Lost to Follow-up|7|||
42370533|NCT01754129|76234078|FG000|Overall Study|Withdrew consent|1|||
42370534|NCT01754129|76234078|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
42370535|NCT01728077|76234091|FG000|Overall Study|Lack of Efficacy|3|||
42370536|NCT01728077|76234092|FG001|Overall Study|Lack of Efficacy|1|||
42370537|NCT01728077|76234091|FG000|Overall Study|Lost to Follow-up|1|||
42370538|NCT01728077|76234092|FG001|Overall Study|Lost to Follow-up|0|||
42370539|NCT01728077|76234091|FG000|Overall Study|Subject choice|2|||
42370540|NCT01728077|76234092|FG001|Overall Study|Subject choice|3|||
42370541|NCT01728077|76234091|FG000|Overall Study|Death|0|||
42370542|NCT01728077|76234092|FG001|Overall Study|Death|1|||
42370543|NCT01728077|76234091|FG000|Overall Study|Patient moving|1|||
42370544|NCT01728077|76234092|FG001|Overall Study|Patient moving|0|||
42370545|NCT01728077|76234091|FG000|Overall Study|Non compliance|1|||
42370546|NCT01728077|76234092|FG001|Overall Study|Non compliance|0|||
42370547|NCT01606007|76234111|FG000|Overall Study|Reason 'Other' in the protocol|0|||
42370548|NCT01606007|76234112|FG001|Overall Study|Reason 'Other' in the protocol|1|||
42370549|NCT01606007|76234113|FG002|Overall Study|Reason 'Other' in the protocol|1|||
42370550|NCT01606007|76234111|FG000|Overall Study|Pregnancy|0|||
42370551|NCT01606007|76234112|FG001|Overall Study|Pregnancy|1|||
42370552|NCT01606007|76234113|FG002|Overall Study|Pregnancy|1|||
42370553|NCT01606007|76234111|FG000|Overall Study|Withdrawal by Subject|8|||
42370554|NCT01606007|76234112|FG001|Overall Study|Withdrawal by Subject|6|||
42370555|NCT01606007|76234113|FG002|Overall Study|Withdrawal by Subject|1|||
42370556|NCT01606007|76234111|FG000|Overall Study|Adverse Event|0|||
42370557|NCT01606007|76234112|FG001|Overall Study|Adverse Event|1|||
42370558|NCT01606007|76234113|FG002|Overall Study|Adverse Event|1|||
42370559|NCT01606007|76234111|FG000|Overall Study|discontinue study treatment|0|||
42370560|NCT01606007|76234112|FG001|Overall Study|discontinue study treatment|2|||
42370561|NCT01606007|76234113|FG002|Overall Study|discontinue study treatment|1|||
42370562|NCT01606007|76234111|FG000|Overall Study|Lost to Follow-up|6|||
42370563|NCT01606007|76234112|FG001|Overall Study|Lost to Follow-up|8|||
42370564|NCT01606007|76234113|FG002|Overall Study|Lost to Follow-up|5|||
42370565|NCT01606007|76234111|FG000|Overall Study|Poor/Non-compliance|1|||
42370566|NCT01606007|76234112|FG001|Overall Study|Poor/Non-compliance|0|||
42370567|NCT01606007|76234113|FG002|Overall Study|Poor/Non-compliance|0|||
42370568|NCT01753193|76234192|FG000|Overall Study|Withdrawal by Subject|23|||
42370569|NCT01753193|76234192|FG000|Overall Study|Lost to Follow-up|6|||
42370570|NCT01753193|76234192|FG000|Overall Study|Death|1|||
42370571|NCT01753193|76234192|FG000|Overall Study|Other|16|||
42370572|NCT01727297|76234239|FG000|Overall Study|Death|13|||
42370573|NCT01727297|76234240|FG001|Overall Study|Death|0|||
42370574|NCT01727297|76234239|FG000|Overall Study|Protocol Violation|1|||
42370575|NCT01727297|76234240|FG001|Overall Study|Protocol Violation|10|||
42370576|NCT01727297|76234239|FG000|Overall Study|Adverse Event|3|||
42370577|NCT01727297|76234240|FG001|Overall Study|Adverse Event|1|||
42370578|NCT01727297|76234239|FG000|Overall Study|Lost to Follow-up|11|||
42370579|NCT01727297|76234240|FG001|Overall Study|Lost to Follow-up|0|||
42370580|NCT01727297|76234239|FG000|Overall Study|Withdrawal by Subject|26|||
42370581|NCT01727297|76234240|FG001|Overall Study|Withdrawal by Subject|27|||
42370582|NCT01727297|76234239|FG000|Overall Study|Physician Decision|19|||
42370583|NCT01727297|76234240|FG001|Overall Study|Physician Decision|5|||
42370584|NCT01727297|76234239|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
42370585|NCT01727297|76234240|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
42370586|NCT01753115|76234256|FG000|Overall Study|Lost to Follow-up|3|||
42370587|NCT01753115|76234257|FG001|Overall Study|Lost to Follow-up|6|||
42370588|NCT01753115|76234258|FG002|Overall Study|Lost to Follow-up|8|||
42370589|NCT01753115|76234256|FG000|Overall Study|Withdrawal by Subject|6|||
42370590|NCT01753115|76234257|FG001|Overall Study|Withdrawal by Subject|5|||
42370591|NCT01753115|76234258|FG002|Overall Study|Withdrawal by Subject|6|||
42370592|NCT01753115|76234256|FG000|Overall Study|Subject non-compliant|3|||
42370593|NCT01753115|76234257|FG001|Overall Study|Subject non-compliant|3|||
42370594|NCT01753115|76234258|FG002|Overall Study|Subject non-compliant|0|||
42370595|NCT01753115|76234256|FG000|Overall Study|Used excluded drug|0|||
42370596|NCT01753115|76234257|FG001|Overall Study|Used excluded drug|1|||
42370597|NCT01753115|76234258|FG002|Overall Study|Used excluded drug|0|||
42370598|NCT01727141|76234279|FG000|Overall Study|Physician Decision|0|||
42370599|NCT01727141|76234280|FG001|Overall Study|Physician Decision|1|||
42370600|NCT01727141|76234281|FG002|Overall Study|Physician Decision|0|||
42370601|NCT01727141|76234282|FG003|Overall Study|Physician Decision|2|||
42370602|NCT01727141|76234279|FG000|Overall Study|Lost to Follow-up|0|||
42370603|NCT01727141|76234280|FG001|Overall Study|Lost to Follow-up|2|||
42370604|NCT01727141|76234281|FG002|Overall Study|Lost to Follow-up|0|||
42370605|NCT01727141|76234282|FG003|Overall Study|Lost to Follow-up|0|||
42370606|NCT01727141|76234279|FG000|Overall Study|Death|0|||
42370607|NCT01727141|76234280|FG001|Overall Study|Death|1|||
42370608|NCT01727141|76234281|FG002|Overall Study|Death|1|||
42370609|NCT01727141|76234282|FG003|Overall Study|Death|1|||
42370610|NCT01727141|76234279|FG000|Overall Study|Protocol deviation|1|||
42370611|NCT01727141|76234280|FG001|Overall Study|Protocol deviation|1|||
42370612|NCT01727141|76234281|FG002|Overall Study|Protocol deviation|0|||
42370613|NCT01727141|76234282|FG003|Overall Study|Protocol deviation|1|||
42370614|NCT01727141|76234279|FG000|Overall Study|Withdrawal by Subject|4|||
42370615|NCT01727141|76234280|FG001|Overall Study|Withdrawal by Subject|4|||
42370616|NCT01727141|76234281|FG002|Overall Study|Withdrawal by Subject|2|||
42370617|NCT01727141|76234282|FG003|Overall Study|Withdrawal by Subject|11|||
42370618|NCT01726517|76234306|FG000|Overall Study|Withdrawal by Subject|0|||
42370619|NCT01726517|76234307|FG001|Overall Study|Withdrawal by Subject|0|||
42370620|NCT01726517|76234308|FG002|Overall Study|Withdrawal by Subject|1|||
42370621|NCT01726517|76234309|FG003|Overall Study|Withdrawal by Subject|0|||
42370622|NCT01726517|76234310|FG004|Overall Study|Withdrawal by Subject|0|||
42370623|NCT01752023|76234324|FG000|Overall Study|Physician Decision|2|||
42370624|NCT01752023|76234325|FG001|Overall Study|Physician Decision|1|||
42370625|NCT01726049|76234337|FG000|Overall Study|Death|1|||
42370626|NCT01726049|76234338|FG001|Overall Study|Death|1|||
42370627|NCT01726049|76234337|FG000|Overall Study|Adverse Event|4|||
42370628|NCT01726049|76234338|FG001|Overall Study|Adverse Event|1|||
42370629|NCT01726049|76234337|FG000|Overall Study|refused second HC|0|||
42370630|NCT01726049|76234338|FG001|Overall Study|refused second HC|2|||
42370631|NCT01605617|76234359|FG000|First Intervention|Adverse Event|0|||
42370632|NCT01605617|76234360|FG001|First Intervention|Adverse Event|1|||
42370633|NCT01605617|76234359|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
42370634|NCT01605617|76234360|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
42370635|NCT01751867|76234377|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
42370636|NCT01751867|76234378|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
42370637|NCT01751867|76234377|FG000|Overall Study|Diease Progression|4|||
42370638|NCT01751867|76234378|FG001|Overall Study|Diease Progression|18|||
42370639|NCT01751867|76234377|FG000|Overall Study|Adverse Event|8|||
42370640|NCT01751867|76234378|FG001|Overall Study|Adverse Event|15|||
42370641|NCT01751867|76234377|FG000|Overall Study|Poor Compliance|0|||
42370642|NCT01751867|76234378|FG001|Overall Study|Poor Compliance|5|||
42370643|NCT01751867|76234377|FG000|Overall Study|Withdrawal by Subject|3|||
42370644|NCT01751867|76234378|FG001|Overall Study|Withdrawal by Subject|1|||
42370645|NCT01751867|76234377|FG000|Overall Study|Physician Decision|4|||
42370646|NCT01751867|76234378|FG001|Overall Study|Physician Decision|7|||
42370647|NCT01751867|76234377|FG000|Overall Study|Protocol Violation|0|||
42370648|NCT01751867|76234378|FG001|Overall Study|Protocol Violation|2|||
42370649|NCT01751867|76234377|FG000|Overall Study|Death|0|||
42370650|NCT01751867|76234378|FG001|Overall Study|Death|5|||
42370651|NCT01751867|76234377|FG000|Overall Study|Other|11|||
42370652|NCT01751867|76234378|FG001|Overall Study|Other|37|||
42370653|NCT01751867|76234377|FG000|Overall Study|Randomized but not treated.|2|||
42370654|NCT01751867|76234378|FG001|Overall Study|Randomized but not treated.|1|||
42370655|NCT01751165|76234404|FG000|Overall Study|Adverse event, serious fatal|1|||
42370656|NCT01751165|76234405|FG001|Overall Study|Adverse event, serious fatal|0|||
42370657|NCT01751165|76234406|FG002|Overall Study|Adverse event, serious fatal|1|||
42370658|NCT01751165|76234404|FG000|Overall Study|Withdrawal by Subject|0|||
42370659|NCT01751165|76234405|FG001|Overall Study|Withdrawal by Subject|0|||
42370660|NCT01751165|76234406|FG002|Overall Study|Withdrawal by Subject|1|||
42370661|NCT01751165|76234404|FG000|Overall Study|Serious adverse event|0|||
42370662|NCT01751165|76234405|FG001|Overall Study|Serious adverse event|2|||
42370663|NCT01751165|76234406|FG002|Overall Study|Serious adverse event|0|||
42370664|NCT01751165|76234404|FG000|Overall Study|Lost to Follow-up|1|||
42370665|NCT01751165|76234405|FG001|Overall Study|Lost to Follow-up|1|||
42370666|NCT01751165|76234406|FG002|Overall Study|Lost to Follow-up|1|||
42370667|NCT01751087|76234431|FG000|Overall Study|Withdrawal by Subject|1|||
42370668|NCT01751087|76234432|FG001|Overall Study|Withdrawal by Subject|0|||
42370669|NCT01751087|76234433|FG002|Overall Study|Withdrawal by Subject|0|||
42370670|NCT01751087|76234431|FG000|Overall Study|Physician Decision|0|||
42370671|NCT01751087|76234432|FG001|Overall Study|Physician Decision|0|||
42370672|NCT01751087|76234433|FG002|Overall Study|Physician Decision|1|||
42370673|NCT01750697|76234441|FG000|Overall Study|Transferred Back to Local Hospital|1|||
42370674|NCT01750697|76234441|FG000|Overall Study|Physician and Family Decision|1|||
42370675|NCT01750697|76234441|FG000|Overall Study|Transferred to Adult Services|5|||
42370676|NCT01750697|76234441|FG000|Overall Study|Physician Decision|1|||
42370677|NCT01750697|76234441|FG000|Overall Study|Withdrawal by Subject|1|||
42370678|NCT01750229|76234452|FG000|Randomized Crossover Phase|Adverse Event|1|||
42370679|NCT01750229|76234452|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
42370680|NCT01750229|76234452|FG000|Long-term Follow-up Phase|Adverse Event|2|||
42370681|NCT01750229|76234452|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
42370682|NCT01724489|76234464|FG000|Overall Study|Adverse Event|8|||
42370683|NCT01724489|76234465|FG001|Overall Study|Adverse Event|3|||
42370684|NCT01724489|76234464|FG000|Overall Study|Surgery, medication|1|||
42370685|NCT01724489|76234465|FG001|Overall Study|Surgery, medication|1|||
42370686|NCT01724489|76234464|FG000|Overall Study|Lost to Follow-up|1|||
42370687|NCT01724489|76234465|FG001|Overall Study|Lost to Follow-up|2|||
42370688|NCT01724489|76234464|FG000|Overall Study|Withdrawal by Subject|6|||
42370689|NCT01724489|76234465|FG001|Overall Study|Withdrawal by Subject|6|||
42370690|NCT01724177|76234480|FG000|Overall Study|Adverse Event|8|||
42370691|NCT01724177|76234480|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
42370692|NCT01724177|76234480|FG000|Overall Study|Nervous participant|1|||
42370693|NCT01724177|76234480|FG000|Overall Study|Serious Adverse Event Related|1|||
42370694|NCT04378270|76234495|FG000|Overall Study|Lack of Efficacy|1|||
42370695|NCT04378270|76234495|FG000|Overall Study|Withdrawal by Subject|1|||
42370696|NCT04378270|76234495|FG000|Overall Study|Screen Failure|1|||
42370697|NCT04378270|76234495|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
42370698|NCT01724021|76234501|FG000|Overall Study|Adverse Event|11|||
42370699|NCT01724021|76234502|FG001|Overall Study|Adverse Event|6|||
42370700|NCT01724021|76234501|FG000|Overall Study|Death|46|||
42370701|NCT01724021|76234502|FG001|Overall Study|Death|58|||
42370702|NCT01724021|76234501|FG000|Overall Study|Participant request/ Withdrew consent|18|||
42370703|NCT01724021|76234502|FG001|Overall Study|Participant request/ Withdrew consent|14|||
42370704|NCT01724021|76234501|FG000|Overall Study|Lost to Follow-up|15|||
42370705|NCT01724021|76234502|FG001|Overall Study|Lost to Follow-up|15|||
42370706|NCT01724021|76234501|FG000|Overall Study|Reason Not Specified|36|||
42370707|NCT01724021|76234502|FG001|Overall Study|Reason Not Specified|39|||
42370708|NCT01724021|76234501|FG000|Overall Study|Missing|1|||
42370709|NCT01724021|76234502|FG001|Overall Study|Missing|1|||
42370710|NCT01723397|76234516|FG000|Study Period 1|Protocol Violation|0|||
42370711|NCT01723397|76234517|FG001|Study Period 1|Protocol Violation|1|||
42370712|NCT01723397|76234516|FG000|Study Period 2|Protocol Violation|0|||
42370713|NCT01723397|76234517|FG001|Study Period 2|Protocol Violation|1|||
42370714|NCT01723163|76234525|FG000|Treatment Phase|Withdrawal by Subject|14|||
42370715|NCT01723163|76234526|FG001|Treatment Phase|Withdrawal by Subject|6|||
42370716|NCT01723163|76234525|FG000|Treatment Phase|Withdrawal by PI|5|||
42370717|NCT01723163|76234526|FG001|Treatment Phase|Withdrawal by PI|1|||
42370718|NCT01723163|76234525|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
42370719|NCT01723163|76234526|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
42370720|NCT01723163|76234525|FG000|3-Month Follow-up|Unable to Contact|12|||
42370721|NCT01723163|76234526|FG001|3-Month Follow-up|Unable to Contact|19|||
42370722|NCT01723163|76234525|FG000|6-Month Follow-up|Death|1|||
42370723|NCT01723163|76234526|FG001|6-Month Follow-up|Death|0|||
42370724|NCT01723163|76234525|FG000|6-Month Follow-up|Unable to Contact|17|||
42370725|NCT01723163|76234526|FG001|6-Month Follow-up|Unable to Contact|15|||
42370726|NCT01723163|76234525|FG000|12-Month Follow-up|Death|1|||
42370727|NCT01723163|76234526|FG001|12-Month Follow-up|Death|0|||
42370728|NCT01723163|76234525|FG000|12-Month Follow-up|Unable to Contact|23|||
42370729|NCT01723163|76234526|FG001|12-Month Follow-up|Unable to Contact|28|||
42370730|NCT01722071|76234536|FG000|Overall Study|Protocol Violation|1|||
42370731|NCT01722071|76234537|FG001|Overall Study|Protocol Violation|0|||
42370732|NCT01721759|76234543|FG000|Treatment Period|Disease Progression|85|||
42370733|NCT01721759|76234543|FG000|Treatment Period|Study drug toxicity|14|||
42370734|NCT01721759|76234543|FG000|Treatment Period|Death|1|||
42370735|NCT01721759|76234543|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
42370736|NCT01721759|76234543|FG000|Treatment Period|Participant request to withdraw|3|||
42370737|NCT01721759|76234543|FG000|Treatment Period|Other Reasons|3|||
42370738|NCT01721759|76234543|FG000|End of Study Period|Participant Withdrew Consent|5|||
42370739|NCT01721759|76234543|FG000|End of Study Period|Death|101|||
42370740|NCT01721759|76234543|FG000|End of Study Period|Lost to Follow-up|1|||
42370741|NCT01721759|76234543|FG000|End of Study Period|Other Reasons|10|||
42370742|NCT01721369|76234552|FG000|Overall Study|Not initial etiological diagnosis|12|||
42370743|NCT01721057|76234614|FG000|Treatment Period|Withdrawal by Subject|11|||
42370744|NCT01721057|76234615|FG001|Treatment Period|Withdrawal by Subject|5|||
42370745|NCT01721057|76234616|FG002|Treatment Period|Withdrawal by Subject|8|||
42370746|NCT01721057|76234617|FG003|Treatment Period|Withdrawal by Subject|0|||
42370747|NCT01721057|76234618|FG004|Treatment Period|Withdrawal by Subject|0|||
42370748|NCT01721057|76234619|FG005|Treatment Period|Withdrawal by Subject|0|||
42370749|NCT01721057|76234620|FG006|Treatment Period|Withdrawal by Subject|0|||
42370750|NCT01721057|76234614|FG000|Treatment Period|Adverse Event|7|||
42370751|NCT01721057|76234615|FG001|Treatment Period|Adverse Event|10|||
42370752|NCT01721057|76234616|FG002|Treatment Period|Adverse Event|12|||
42370753|NCT01721057|76234617|FG003|Treatment Period|Adverse Event|0|||
42370754|NCT01721057|76234618|FG004|Treatment Period|Adverse Event|0|||
42370755|NCT01721057|76234619|FG005|Treatment Period|Adverse Event|0|||
42370756|NCT01721057|76234620|FG006|Treatment Period|Adverse Event|0|||
42370757|NCT01721057|76234614|FG000|Treatment Period|Lack of Efficacy|7|||
42370758|NCT01721057|76234615|FG001|Treatment Period|Lack of Efficacy|3|||
42370759|NCT01721057|76234616|FG002|Treatment Period|Lack of Efficacy|0|||
42370760|NCT01721057|76234617|FG003|Treatment Period|Lack of Efficacy|0|||
42370761|NCT01721057|76234618|FG004|Treatment Period|Lack of Efficacy|0|||
42370762|NCT01721057|76234619|FG005|Treatment Period|Lack of Efficacy|0|||
42370763|NCT01721057|76234620|FG006|Treatment Period|Lack of Efficacy|0|||
42370764|NCT01721057|76234614|FG000|Treatment Period|Lost to Follow-up|1|||
42370765|NCT01721057|76234615|FG001|Treatment Period|Lost to Follow-up|0|||
42370766|NCT01721057|76234616|FG002|Treatment Period|Lost to Follow-up|0|||
42370767|NCT01721057|76234617|FG003|Treatment Period|Lost to Follow-up|0|||
42370768|NCT01721057|76234618|FG004|Treatment Period|Lost to Follow-up|0|||
42370769|NCT01721057|76234619|FG005|Treatment Period|Lost to Follow-up|0|||
42370770|NCT01721057|76234620|FG006|Treatment Period|Lost to Follow-up|0|||
42370771|NCT01721057|76234614|FG000|Treatment Period|Physician Decision|0|||
42370772|NCT01721057|76234615|FG001|Treatment Period|Physician Decision|1|||
42370773|NCT01721057|76234616|FG002|Treatment Period|Physician Decision|3|||
42370774|NCT01721057|76234617|FG003|Treatment Period|Physician Decision|0|||
42370775|NCT01721057|76234618|FG004|Treatment Period|Physician Decision|0|||
42370776|NCT01721057|76234619|FG005|Treatment Period|Physician Decision|0|||
42370777|NCT01721057|76234620|FG006|Treatment Period|Physician Decision|0|||
42370778|NCT01721057|76234614|FG000|Treatment Period|Death|2|||
42370779|NCT01721057|76234615|FG001|Treatment Period|Death|0|||
42370780|NCT01721057|76234616|FG002|Treatment Period|Death|0|||
42370781|NCT01721057|76234617|FG003|Treatment Period|Death|0|||
42370782|NCT01721057|76234618|FG004|Treatment Period|Death|0|||
42370783|NCT01721057|76234619|FG005|Treatment Period|Death|0|||
42370784|NCT01721057|76234620|FG006|Treatment Period|Death|0|||
42370785|NCT01721057|76234614|FG000|Rescue Period|Adverse Event|0|||
42370786|NCT01721057|76234615|FG001|Rescue Period|Adverse Event|0|||
42370787|NCT01721057|76234616|FG002|Rescue Period|Adverse Event|0|||
42370788|NCT01721057|76234617|FG003|Rescue Period|Adverse Event|1|||
42370789|NCT01721057|76234618|FG004|Rescue Period|Adverse Event|0|||
42370790|NCT01721057|76234619|FG005|Rescue Period|Adverse Event|0|||
42370791|NCT01721057|76234620|FG006|Rescue Period|Adverse Event|0|||
42370792|NCT01721057|76234614|FG000|Rescue Period|Lack of Efficacy|0|||
42370793|NCT01721057|76234615|FG001|Rescue Period|Lack of Efficacy|0|||
42370794|NCT01721057|76234616|FG002|Rescue Period|Lack of Efficacy|0|||
42370795|NCT01721057|76234617|FG003|Rescue Period|Lack of Efficacy|2|||
42370796|NCT01721057|76234618|FG004|Rescue Period|Lack of Efficacy|0|||
42370797|NCT01721057|76234619|FG005|Rescue Period|Lack of Efficacy|0|||
42370798|NCT01721057|76234620|FG006|Rescue Period|Lack of Efficacy|0|||
42370799|NCT04570384|76234649|FG000|Overall Study|Adverse Event|2|||
42370800|NCT04570384|76234650|FG001|Overall Study|Adverse Event|1|||
42370801|NCT04570384|76234649|FG000|Overall Study|Death|2|||
42370802|NCT04570384|76234650|FG001|Overall Study|Death|5|||
42370803|NCT04570384|76234649|FG000|Overall Study|Lost to Follow-up|1|||
42370804|NCT04570384|76234650|FG001|Overall Study|Lost to Follow-up|0|||
42370805|NCT04570384|76234649|FG000|Overall Study|Other|1|||
42370806|NCT04570384|76234650|FG001|Overall Study|Other|0|||
42370807|NCT04570384|76234649|FG000|Overall Study|Protocol Violation|0|||
42370808|NCT04570384|76234650|FG001|Overall Study|Protocol Violation|1|||
42370809|NCT04570384|76234649|FG000|Overall Study|Sponsor Decision|1|||
42370810|NCT04570384|76234650|FG001|Overall Study|Sponsor Decision|0|||
42370811|NCT04570384|76234649|FG000|Overall Study|Withdrawal by Subject|4|||
42370812|NCT04570384|76234650|FG001|Overall Study|Withdrawal by Subject|2|||
42370813|NCT02563522|76234703|FG000|Overall Study|Adverse Event|2|||
42370814|NCT02563522|76234704|FG001|Overall Study|Adverse Event|3|||
42370815|NCT02563522|76234703|FG000|Overall Study|Lost to Follow-up|1|||
42370816|NCT02563522|76234704|FG001|Overall Study|Lost to Follow-up|0|||
42370817|NCT02563522|76234703|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
42370818|NCT02563522|76234704|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
42370819|NCT03578146|76234716|FG000|Overall Study|Did Not Receive Treatment|1|||
42370820|NCT03578146|76234717|FG001|Overall Study|Did Not Receive Treatment|0|||
42370821|NCT03578146|76234718|FG002|Overall Study|Did Not Receive Treatment|0|||
42370822|NCT03578146|76234719|FG003|Overall Study|Did Not Receive Treatment|0|||
42370823|NCT03578146|76234720|FG004|Overall Study|Did Not Receive Treatment|0|||
42370824|NCT03578146|76234721|FG005|Overall Study|Did Not Receive Treatment|2|||
42370825|NCT03578146|76234716|FG000|Overall Study|Lost to Follow-up|0|||
42370826|NCT03578146|76234717|FG001|Overall Study|Lost to Follow-up|1|||
42370827|NCT03578146|76234718|FG002|Overall Study|Lost to Follow-up|1|||
42370828|NCT03578146|76234719|FG003|Overall Study|Lost to Follow-up|0|||
42370829|NCT03578146|76234720|FG004|Overall Study|Lost to Follow-up|0|||
42370830|NCT03578146|76234721|FG005|Overall Study|Lost to Follow-up|1|||
42370831|NCT02716896|76234737|FG000|Overall Study|Physician Decision|0|||
42370832|NCT02716896|76234738|FG001|Overall Study|Physician Decision|1|||
42370833|NCT02715726|76234793|FG000|Overall Study|Adverse Event|2|||
42370834|NCT02715726|76234794|FG001|Overall Study|Adverse Event|6|||
42370835|NCT02715726|76234793|FG000|Overall Study|Protocol Violation|1|||
42370836|NCT02715726|76234794|FG001|Overall Study|Protocol Violation|0|||
42370837|NCT02715726|76234793|FG000|Overall Study|Death|2|||
42370838|NCT02715726|76234794|FG001|Overall Study|Death|1|||
42370839|NCT02715726|76234793|FG000|Overall Study|Participant moved|1|||
42370840|NCT02715726|76234794|FG001|Overall Study|Participant moved|3|||
42370841|NCT02715726|76234793|FG000|Overall Study|Other than specified above|11|||
42370842|NCT02715726|76234794|FG001|Overall Study|Other than specified above|15|||
42370843|NCT02715726|76234793|FG000|Overall Study|Randomized but not treated|1|||
42370844|NCT02715726|76234794|FG001|Overall Study|Randomized but not treated|2|||
42370845|NCT04248816|76234807|FG000|Overall Study|Ineligible post-randomization|7|||
42370846|NCT04248816|76234808|FG001|Overall Study|Ineligible post-randomization|21|||
42370847|NCT04248816|76234809|FG002|Overall Study|Ineligible post-randomization|25|||
42370848|NCT02314156|76234846|FG000|Overall Study|Adverse Event|1|||
42370849|NCT02314156|76234847|FG001|Overall Study|Adverse Event|0|||
42370850|NCT02314156|76234846|FG000|Overall Study|Withdrawal by Subject|1|||
42370851|NCT02314156|76234847|FG001|Overall Study|Withdrawal by Subject|0|||
42370852|NCT02716584|76235062|FG000|Overall Study|Lost to Follow-up|8|||
42370853|NCT02716584|76235063|FG001|Overall Study|Lost to Follow-up|5|||
42370854|NCT02716194|76235144|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
42370855|NCT02716194|76235145|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
42370856|NCT02716194|76235146|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
42370857|NCT03773484|76235216|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
42370858|NCT02715258|76235399|FG000|Overall Study|Withdrawal by Subject|6|||
42370859|NCT02715258|76235400|FG001|Overall Study|Withdrawal by Subject|1|||
42370860|NCT02715258|76235399|FG000|Overall Study|Lost to Follow-up|7|||
42370861|NCT02715258|76235400|FG001|Overall Study|Lost to Follow-up|1|||
42370862|NCT02715258|76235399|FG000|Overall Study|Terminated by Sponsor|0|||
42370863|NCT02715258|76235400|FG001|Overall Study|Terminated by Sponsor|1|||
42370864|NCT02715258|76235399|FG000|Overall Study|Death|0|||
42370865|NCT02715258|76235400|FG001|Overall Study|Death|1|||
42370866|NCT02715258|76235399|FG000|Overall Study|Subject non-compliant|1|||
42370867|NCT02715258|76235400|FG001|Overall Study|Subject non-compliant|1|||
42370868|NCT02715258|76235399|FG000|Overall Study|GCP violation|2|||
42370869|NCT02715258|76235400|FG001|Overall Study|GCP violation|1|||
42370870|NCT02714868|76235425|FG000|Overall Study|Withdrawal by Subject|3|||
42370871|NCT02714868|76235426|FG001|Overall Study|Withdrawal by Subject|0|||
42370872|NCT02714868|76235425|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
42370873|NCT02714868|76235426|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
42370874|NCT02714868|76235425|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
42370875|NCT02714868|76235426|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
42370876|NCT02713542|76235741|FG000|Overall Study|Use of prohibited medication|14|||
42370877|NCT02713542|76235742|FG001|Overall Study|Use of prohibited medication|5|||
42370878|NCT02713542|76235741|FG000|Overall Study|Withdrawal by Subject|4|||
42370879|NCT02713542|76235742|FG001|Overall Study|Withdrawal by Subject|1|||
42370880|NCT03548220|76235826|FG000|Overall Study|Lost to Follow-up|1|||
42370881|NCT03548220|76235827|FG001|Overall Study|Lost to Follow-up|0|||
42370882|NCT03548220|76235828|FG002|Overall Study|Lost to Follow-up|0|||
42370883|NCT03548220|76235829|FG003|Overall Study|Lost to Follow-up|0|||
42370884|NCT02712996|76235864|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
42370885|NCT02712996|76235865|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
42370886|NCT00701064|76235981|FG000|Overall Study|Protocol Violation|1|||
42370887|NCT00701064|76235982|FG001|Overall Study|Protocol Violation|1|||
42370888|NCT00701064|76235981|FG000|Overall Study|Withdrawal by Subject|1|||
42370889|NCT00701064|76235982|FG001|Overall Study|Withdrawal by Subject|1|||
42370890|NCT00701064|76235981|FG000|Overall Study|initiated other PTSD treatment|2|||
42370891|NCT00701064|76235982|FG001|Overall Study|initiated other PTSD treatment|2|||
42370892|NCT05779072|76235990|FG000|Overall Study|Lost to Follow-up|0|||
42370893|NCT05779072|76235991|FG001|Overall Study|Lost to Follow-up|1|||
42370894|NCT05779072|76235990|FG000|Overall Study|Withdrawal by Subject|1|||
42370895|NCT05779072|76235991|FG001|Overall Study|Withdrawal by Subject|5|||
42370896|NCT05089682|76236006|FG000|Overall Study|Withdrawal by Subject|2|||
42370897|NCT05055128|76236015|FG000|Overall Study|Adverse Event|0|||
42370898|NCT05055128|76236016|FG001|Overall Study|Adverse Event|0|||
42370899|NCT05055128|76236017|FG002|Overall Study|Adverse Event|0|||
42370900|NCT05055128|76236018|FG003|Overall Study|Adverse Event|1|||
42370901|NCT05055128|76236019|FG004|Overall Study|Adverse Event|1|||
42370902|NCT05055128|76236015|FG000|Overall Study|Protocol Violation|0|||
42370903|NCT05055128|76236016|FG001|Overall Study|Protocol Violation|0|||
42370904|NCT05055128|76236017|FG002|Overall Study|Protocol Violation|0|||
42370905|NCT05055128|76236018|FG003|Overall Study|Protocol Violation|1|||
42370906|NCT05055128|76236019|FG004|Overall Study|Protocol Violation|0|||
42370907|NCT05055128|76236015|FG000|Overall Study|Withdrawal by Subject|5|||
42370908|NCT05055128|76236016|FG001|Overall Study|Withdrawal by Subject|2|||
42370909|NCT05055128|76236017|FG002|Overall Study|Withdrawal by Subject|2|||
42370910|NCT05055128|76236018|FG003|Overall Study|Withdrawal by Subject|4|||
42370911|NCT05055128|76236019|FG004|Overall Study|Withdrawal by Subject|2|||
42370912|NCT05055128|76236015|FG000|Overall Study|Randomized By Mistake|0|||
42370913|NCT05055128|76236016|FG001|Overall Study|Randomized By Mistake|1|||
42370914|NCT05055128|76236017|FG002|Overall Study|Randomized By Mistake|0|||
42370915|NCT05055128|76236018|FG003|Overall Study|Randomized By Mistake|0|||
42370916|NCT05055128|76236019|FG004|Overall Study|Randomized By Mistake|0|||
42370917|NCT05055128|76236015|FG000|Overall Study|Other|1|||
42370918|NCT05055128|76236016|FG001|Overall Study|Other|0|||
42370919|NCT05055128|76236017|FG002|Overall Study|Other|0|||
42370920|NCT05055128|76236018|FG003|Overall Study|Other|0|||
42370921|NCT05055128|76236019|FG004|Overall Study|Other|0|||
42370922|NCT05038020|76236035|FG000|Overall Study|Early Termination|3|||
42370923|NCT05038020|76236036|FG001|Overall Study|Early Termination|0|||
42370924|NCT04796610|76236051|FG000|Overall Study|Withdrawal by Subject|1|||
42370925|NCT04796610|76236052|FG001|Overall Study|Withdrawal by Subject|0|||
42370926|NCT04796610|76236053|FG002|Overall Study|Withdrawal by Subject|0|||
42370927|NCT04796610|76236054|FG003|Overall Study|Withdrawal by Subject|0|||
42370928|NCT04796610|76236051|FG000|Overall Study|Lost to Follow-up|2|||
42370929|NCT04796610|76236052|FG001|Overall Study|Lost to Follow-up|0|||
42370930|NCT04796610|76236053|FG002|Overall Study|Lost to Follow-up|1|||
42370931|NCT04796610|76236054|FG003|Overall Study|Lost to Follow-up|1|||
42370932|NCT04702997|76236064|FG000|Overall Study|Withdrawal by Subject|1|||
42370933|NCT04702997|76236065|FG001|Overall Study|Withdrawal by Subject|1|||
42370934|NCT04173494|76236086|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
42370935|NCT04173494|76236087|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
42370936|NCT04173494|76236086|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
42370937|NCT04173494|76236087|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
42370938|NCT04173494|76236086|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
42370939|NCT04173494|76236087|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
42370940|NCT04173494|76236086|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
42370941|NCT04173494|76236087|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
42370942|NCT04173494|76236086|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
42370943|NCT04173494|76236087|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
42370944|NCT04173494|76236086|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
42370945|NCT04173494|76236087|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
42370946|NCT04173494|76236086|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
42370947|NCT04173494|76236087|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
42370948|NCT04173494|76236086|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
42370949|NCT04173494|76236087|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
42370950|NCT04173494|76236086|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
42370951|NCT04173494|76236087|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
42370952|NCT04173494|76236086|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
42370953|NCT04173494|76236087|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
42370954|NCT04173494|76236086|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
42370955|NCT04173494|76236087|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
42370956|NCT04173494|76236086|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
42370957|NCT04173494|76236087|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
42370958|NCT04173494|76236086|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
42370959|NCT04173494|76236087|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
42370960|NCT04173494|76236086|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
42370961|NCT04173494|76236087|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
42370962|NCT04173494|76236086|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
42370963|NCT04173494|76236087|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
42370964|NCT04173494|76236086|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
42370965|NCT04173494|76236087|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
42370966|NCT03920215|76236112|FG000|Overall Study|Lost to Follow-up|1|||
42370967|NCT03920215|76236113|FG001|Overall Study|Lost to Follow-up|2|||
42370968|NCT03920215|76236114|FG002|Overall Study|Lost to Follow-up|0|||
42370969|NCT03920215|76236115|FG003|Overall Study|Lost to Follow-up|0|||
42370970|NCT03920215|76236112|FG000|Overall Study|Death|0|||
42370971|NCT03920215|76236113|FG001|Overall Study|Death|0|||
42370972|NCT03920215|76236114|FG002|Overall Study|Death|0|||
42370973|NCT03920215|76236115|FG003|Overall Study|Death|1|||
42370974|NCT03878134|76236125|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
42370975|NCT03874429|76236131|FG000|Overall Study|Adverse Event|2|||
42370976|NCT03874429|76236132|FG001|Overall Study|Adverse Event|2|||
42370977|NCT03874429|76236131|FG000|Overall Study|Lack of Efficacy|0|||
42370978|NCT03874429|76236132|FG001|Overall Study|Lack of Efficacy|1|||
42370979|NCT03874429|76236131|FG000|Overall Study|Covid-19 pandemic|4|||
42370980|NCT03874429|76236132|FG001|Overall Study|Covid-19 pandemic|2|||
42370981|NCT03733730|76236162|FG000|Overall Study|Lost to Follow-up|1|||
42370982|NCT03733730|76236163|FG001|Overall Study|Lost to Follow-up|32|||
42370983|NCT03733730|76236162|FG000|Overall Study|Other|1|||
42370984|NCT03733730|76236163|FG001|Overall Study|Other|0|||
42370985|NCT03733730|76236162|FG000|Overall Study|Adverse Event|0|||
42370986|NCT03733730|76236163|FG001|Overall Study|Adverse Event|4|||
42370987|NCT03733730|76236162|FG000|Overall Study|Death|0|||
42370988|NCT03733730|76236163|FG001|Overall Study|Death|5|||
42370989|NCT03733730|76236162|FG000|Overall Study|Withdrawal by Subject|0|||
42370990|NCT03733730|76236163|FG001|Overall Study|Withdrawal by Subject|8|||
42370991|NCT03713632|76236180|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
42370992|NCT03713632|76236181|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
42370993|NCT03713632|76236182|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
42200705|NCT02255435|76012644|FG006|Overall Study|Administrative reasons|0|||
42200706|NCT02255435|76012645|FG007|Overall Study|Administrative reasons|0|||
42200707|NCT02255435|76012646|FG008|Overall Study|Administrative reasons|0|||
42200708|NCT02255435|76012647|FG009|Overall Study|Administrative reasons|2|||
42200709|NCT02229825|76012671|FG000|Overall Study|Personal Reasons|0|||
42200710|NCT02229825|76012672|FG001|Overall Study|Personal Reasons|1|||
42200711|NCT02229825|76012671|FG000|Overall Study|Refused continuing medication|7|||
42200712|NCT02229825|76012672|FG001|Overall Study|Refused continuing medication|6|||
42200713|NCT02229825|76012671|FG000|Overall Study|Lost to Follow-up|1|||
42200714|NCT02229825|76012672|FG001|Overall Study|Lost to Follow-up|2|||
42370994|NCT03713632|76236183|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
42370995|NCT03713632|76236184|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
42370996|NCT03713632|76236180|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
42370997|NCT03713632|76236181|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
42370998|NCT03713632|76236182|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
42370999|NCT03713632|76236183|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
42371000|NCT03713632|76236184|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
42371001|NCT03713632|76236180|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
42371002|NCT03713632|76236181|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
42371003|NCT03713632|76236182|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
42371004|NCT03713632|76236183|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
42200715|NCT02229825|76012671|FG000|Overall Study|Protocol Violation|1|||
42200716|NCT02229825|76012672|FG001|Overall Study|Protocol Violation|1|||
42200717|NCT02229825|76012671|FG000|Overall Study|Lack of Efficacy|4|||
42200718|NCT02229825|76012672|FG001|Overall Study|Lack of Efficacy|10|||
42371005|NCT03713632|76236184|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
42371006|NCT03713632|76236180|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
42200719|NCT02229825|76012671|FG000|Overall Study|Adverse Event|11|||
42200720|NCT02229825|76012672|FG001|Overall Study|Adverse Event|9|||
42371007|NCT03713632|76236181|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
42371008|NCT03713632|76236182|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
42371009|NCT03713632|76236183|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
42371010|NCT03713632|76236184|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
42371011|NCT03713632|76236180|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
42371012|NCT03713632|76236181|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
42371013|NCT03713632|76236182|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
42371014|NCT03713632|76236183|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
42371015|NCT03713632|76236184|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
42371016|NCT03713632|76236180|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
42371017|NCT03713632|76236181|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
42371018|NCT03713632|76236182|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
42371019|NCT03713632|76236183|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
42371020|NCT03713632|76236184|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
42371021|NCT03713632|76236180|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
42371022|NCT03713632|76236181|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
42371023|NCT03713632|76236182|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
42371024|NCT03713632|76236183|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
42371025|NCT03713632|76236184|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
42371026|NCT03713632|76236180|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
42371027|NCT03713632|76236181|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
42371028|NCT03713632|76236182|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
42371029|NCT03713632|76236183|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
42371030|NCT03713632|76236184|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
42371031|NCT03713632|76236180|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
42371032|NCT03713632|76236181|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
42371033|NCT03713632|76236182|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
42371034|NCT03713632|76236183|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
42371035|NCT03713632|76236184|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
42371036|NCT03713632|76236180|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
42371037|NCT03713632|76236181|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
42371038|NCT03713632|76236182|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
42371039|NCT03713632|76236183|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
42371040|NCT03713632|76236184|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
42371041|NCT03713632|76236180|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
42371042|NCT03713632|76236181|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
42371043|NCT03713632|76236182|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
42371044|NCT03713632|76236183|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
42371045|NCT03713632|76236184|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
42371046|NCT03713632|76236180|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
42371047|NCT03713632|76236181|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
42371048|NCT03713632|76236182|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
42371049|NCT03713632|76236183|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
42371050|NCT03713632|76236184|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
42371051|NCT03713632|76236180|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
42371052|NCT03713632|76236181|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
42371053|NCT03713632|76236182|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
42371054|NCT03713632|76236183|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
42371055|NCT03713632|76236184|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
42371056|NCT03713632|76236180|FG000|Treatment Period 2 (After Week 16)|Death|0|||
42371057|NCT03713632|76236181|FG001|Treatment Period 2 (After Week 16)|Death|1|||
42371058|NCT03713632|76236182|FG002|Treatment Period 2 (After Week 16)|Death|0|||
42371059|NCT03713632|76236183|FG003|Treatment Period 2 (After Week 16)|Death|0|||
42371060|NCT03713632|76236184|FG004|Treatment Period 2 (After Week 16)|Death|0|||
42371061|NCT03713632|76236180|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
42371062|NCT03713632|76236181|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
42371063|NCT03713632|76236182|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
42371064|NCT03713632|76236183|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
42371065|NCT03713632|76236184|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
42371066|NCT03517436|76236206|FG000|Overall Study|Death|3|||
42371067|NCT03517436|76236206|FG000|Overall Study|Withdrawal by Subject|4|||
42371068|NCT03517436|76236206|FG000|Overall Study|Did not receive study valve.|1|||
42371069|NCT03237286|76236213|FG000|Overall Study|Withdrawal by Subject|1|||
42371070|NCT03237286|76236214|FG001|Overall Study|Withdrawal by Subject|0|||
42371071|NCT03237286|76236215|FG002|Overall Study|Withdrawal by Subject|2|||
42371072|NCT03237286|76236213|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
42371073|NCT03237286|76236214|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
42371074|NCT03237286|76236215|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
42371075|NCT03170349|76236222|FG000|At 30 Days Follow-up|Death|1|||
42371076|NCT03170349|76236222|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
42371077|NCT03170349|76236222|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
42371078|NCT03170349|76236222|FG000|At 6 Months Follow-up|Death|3|||
42371079|NCT03170349|76236222|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
42371080|NCT03170349|76236222|FG000|At 1 Year Follow-up|Death|6|||
42371081|NCT03170349|76236222|FG000|At 2 Year Follow-up|Missed Visit|4|||
42371082|NCT03170349|76236222|FG000|At 2 Year Follow-up|Death|13|||
42371083|NCT03170349|76236222|FG000|At 2 Year Follow-up|Withdrawal by Subject|1|||
42371084|NCT02836236|76236242|FG000|Overall Study|Randomized but Never Treated|1|||
42371085|NCT02836236|76236243|FG001|Overall Study|Randomized but Never Treated|0|||
42371086|NCT02836236|76236242|FG000|Overall Study|Withdrew Consent|2|||
42371087|NCT02836236|76236243|FG001|Overall Study|Withdrew Consent|0|||
42371088|NCT02836236|76236242|FG000|Overall Study|Adverse Event|0|||
42371089|NCT02836236|76236243|FG001|Overall Study|Adverse Event|1|||
42371090|NCT02836236|76236242|FG000|Overall Study|Investigator's Discretion|1|||
42371091|NCT02836236|76236243|FG001|Overall Study|Investigator's Discretion|0|||
42371092|NCT02836236|76236242|FG000|Overall Study|Still on Study|101|||
42371093|NCT02836236|76236243|FG001|Overall Study|Still on Study|49|||
42371094|NCT02670525|76236251|FG000|Overall Study|Death|94|||
42371095|NCT02670525|76236252|FG001|Overall Study|Death|14|||
42371096|NCT02670525|76236251|FG000|Overall Study|Lost to Follow-up|4|||
42371097|NCT02670525|76236252|FG001|Overall Study|Lost to Follow-up|1|||
42371098|NCT02670525|76236251|FG000|Overall Study|Subject withdrew consent|1|||
42371099|NCT02670525|76236252|FG001|Overall Study|Subject withdrew consent|0|||
42371100|NCT02670525|76236251|FG000|Overall Study|Unknown, data entry delayed|123|||
42371101|NCT02670525|76236252|FG001|Overall Study|Unknown, data entry delayed|78|||
42371102|NCT02394795|76236260|FG000|Overall Study|Adverse Event|92|||
42371103|NCT02394795|76236261|FG001|Overall Study|Adverse Event|70|||
42371104|NCT02394795|76236260|FG000|Overall Study|Lost to Follow-up|0|||
42371105|NCT02394795|76236261|FG001|Overall Study|Lost to Follow-up|1|||
42371106|NCT02394795|76236260|FG000|Overall Study|Withdrawal by Subject|17|||
42371107|NCT02394795|76236261|FG001|Overall Study|Withdrawal by Subject|26|||
42371108|NCT02394795|76236260|FG000|Overall Study|Lack of Efficacy|181|||
42371109|NCT02394795|76236261|FG001|Overall Study|Lack of Efficacy|211|||
42371110|NCT02394795|76236260|FG000|Overall Study|Death|4|||
42371111|NCT02394795|76236261|FG001|Overall Study|Death|5|||
42371112|NCT02394795|76236260|FG000|Overall Study|Physician Decision|109|||
42371113|NCT02394795|76236261|FG001|Overall Study|Physician Decision|93|||
42371114|NCT02255422|76236274|FG000|Overall Study|Withdrawal by Subject|0|||
42371115|NCT02255422|76236275|FG001|Overall Study|Withdrawal by Subject|0|||
42371116|NCT02255422|76236276|FG002|Overall Study|Withdrawal by Subject|0|||
42371117|NCT02255422|76236277|FG003|Overall Study|Withdrawal by Subject|0|||
42371118|NCT02255422|76236278|FG004|Overall Study|Withdrawal by Subject|0|||
42371119|NCT02255422|76236279|FG005|Overall Study|Withdrawal by Subject|0|||
42371120|NCT02255422|76236280|FG006|Overall Study|Withdrawal by Subject|2|||
42371121|NCT02255422|76236274|FG000|Overall Study|Lost to Follow-up|0|||
42371122|NCT02255422|76236275|FG001|Overall Study|Lost to Follow-up|0|||
42371123|NCT02255422|76236276|FG002|Overall Study|Lost to Follow-up|1|||
42371124|NCT02255422|76236277|FG003|Overall Study|Lost to Follow-up|0|||
42371125|NCT02255422|76236278|FG004|Overall Study|Lost to Follow-up|0|||
42371126|NCT02255422|76236279|FG005|Overall Study|Lost to Follow-up|0|||
42371127|NCT02255422|76236280|FG006|Overall Study|Lost to Follow-up|0|||
42371128|NCT02142959|76236299|FG000|Overall Study|Adverse Event|1|||
42371129|NCT02142959|76236300|FG001|Overall Study|Adverse Event|0|||
42371130|NCT02142959|76236301|FG002|Overall Study|Adverse Event|0|||
42371131|NCT02142959|76236299|FG000|Overall Study|Death|0|||
42371132|NCT02142959|76236300|FG001|Overall Study|Death|1|||
42371133|NCT02142959|76236301|FG002|Overall Study|Death|0|||
42371134|NCT02142959|76236299|FG000|Overall Study|Withdrawal by Subject|3|||
42371135|NCT02142959|76236300|FG001|Overall Study|Withdrawal by Subject|1|||
42371136|NCT02142959|76236301|FG002|Overall Study|Withdrawal by Subject|3|||
42371137|NCT02142959|76236299|FG000|Overall Study|Administrative Reasons|1|||
42371138|NCT02142959|76236300|FG001|Overall Study|Administrative Reasons|0|||
42371139|NCT02142959|76236301|FG002|Overall Study|Administrative Reasons|1|||
42371140|NCT02142959|76236299|FG000|Overall Study|Missing|0|||
42371141|NCT02142959|76236300|FG001|Overall Study|Missing|1|||
42200721|NCT02229825|76012671|FG000|Overall Study|Not treated|0|||
42371142|NCT02142959|76236301|FG002|Overall Study|Missing|0|||
42371143|NCT02142959|76236299|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
42371144|NCT02142959|76236300|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
42371145|NCT02142959|76236301|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
42371146|NCT02142959|76236299|FG000|Overall Study|Patient didn't complete end of study visit|0|||
42371147|NCT02142959|76236300|FG001|Overall Study|Patient didn't complete end of study visit|0|||
42371148|NCT02142959|76236301|FG002|Overall Study|Patient didn't complete end of study visit|1|||
42371149|NCT02128113|76236312|FG000|Overall Study|Withdrawal by Subject|3|||
42371150|NCT02128113|76236313|FG001|Overall Study|Withdrawal by Subject|1|||
42371151|NCT02128113|76236314|FG002|Overall Study|Withdrawal by Subject|0|||
42371152|NCT02128113|76236312|FG000|Overall Study|Protocol Violation|0|||
42371153|NCT02128113|76236313|FG001|Overall Study|Protocol Violation|1|||
42371154|NCT02128113|76236314|FG002|Overall Study|Protocol Violation|0|||
42371155|NCT02128113|76236312|FG000|Overall Study|Surgery cancelled|0|||
42371156|NCT02128113|76236313|FG001|Overall Study|Surgery cancelled|1|||
42371157|NCT02128113|76236314|FG002|Overall Study|Surgery cancelled|0|||
42371158|NCT02128113|76236312|FG000|Overall Study|Adverse Event|0|||
42371159|NCT02128113|76236313|FG001|Overall Study|Adverse Event|0|||
42371160|NCT02128113|76236314|FG002|Overall Study|Adverse Event|1|||
42371161|NCT02036970|76236351|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
42371162|NCT02036970|76236352|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
42371163|NCT02036970|76236353|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
42371164|NCT02036970|76236354|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
42371165|NCT02036970|76236355|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
42371166|NCT02036970|76236356|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
42371167|NCT02036970|76236357|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
42371168|NCT02036970|76236358|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
42371169|NCT02036970|76236359|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
42371170|NCT02036970|76236360|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
42371171|NCT02036970|76236351|FG000|Part 1: Day 1 Through Week 16|Death|0|||
42371172|NCT02036970|76236352|FG001|Part 1: Day 1 Through Week 16|Death|0|||
42371173|NCT02036970|76236353|FG002|Part 1: Day 1 Through Week 16|Death|0|||
42371174|NCT02036970|76236354|FG003|Part 1: Day 1 Through Week 16|Death|0|||
42371175|NCT02036970|76236355|FG004|Part 1: Day 1 Through Week 16|Death|0|||
42371176|NCT02036970|76236356|FG005|Part 1: Day 1 Through Week 16|Death|0|||
42371177|NCT02036970|76236357|FG006|Part 1: Day 1 Through Week 16|Death|0|||
42371178|NCT02036970|76236358|FG007|Part 1: Day 1 Through Week 16|Death|0|||
42371179|NCT02036970|76236359|FG008|Part 1: Day 1 Through Week 16|Death|1|||
42371180|NCT02036970|76236360|FG009|Part 1: Day 1 Through Week 16|Death|0|||
42371181|NCT02036970|76236351|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
42371182|NCT02036970|76236352|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
42371183|NCT02036970|76236353|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
42371184|NCT02036970|76236354|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
42371185|NCT02036970|76236355|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
42371186|NCT02036970|76236356|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
42371187|NCT02036970|76236357|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
42371188|NCT02036970|76236358|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
42371189|NCT02036970|76236359|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
42371190|NCT02036970|76236360|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
42371191|NCT02036970|76236351|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
42371192|NCT02036970|76236352|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
42371193|NCT02036970|76236353|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
42371194|NCT02036970|76236354|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
42371195|NCT02036970|76236355|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
42371196|NCT02036970|76236356|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
42371197|NCT02036970|76236357|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
42371198|NCT02036970|76236358|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
42371199|NCT02036970|76236359|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
42371200|NCT02036970|76236360|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
42371201|NCT02036970|76236351|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
42371202|NCT02036970|76236352|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
42371203|NCT02036970|76236353|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
42371204|NCT02036970|76236354|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
42371205|NCT02036970|76236355|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
42371206|NCT02036970|76236356|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
42371207|NCT02036970|76236357|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
42371208|NCT02036970|76236358|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
42371209|NCT02036970|76236359|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
42371210|NCT02036970|76236360|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
42371211|NCT02036970|76236351|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
42371212|NCT02036970|76236352|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
42371213|NCT02036970|76236353|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
42371214|NCT02036970|76236354|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
42371215|NCT02036970|76236355|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
42371216|NCT02036970|76236356|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
42371217|NCT02036970|76236357|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
42371218|NCT02036970|76236358|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
42371219|NCT02036970|76236359|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
42371220|NCT02036970|76236360|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
42371221|NCT02036970|76236351|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
42371222|NCT02036970|76236352|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
42371223|NCT02036970|76236353|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
42371224|NCT02036970|76236354|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
42371225|NCT02036970|76236355|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
42371226|NCT02036970|76236356|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
42371227|NCT02036970|76236357|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
42371228|NCT02036970|76236358|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
42371229|NCT02036970|76236359|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
42371230|NCT02036970|76236360|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
42371231|NCT02036970|76236351|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
42371232|NCT02036970|76236352|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
42371233|NCT02036970|76236353|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
42371234|NCT02036970|76236354|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
42371235|NCT02036970|76236355|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
42371236|NCT02036970|76236356|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
42371237|NCT02036970|76236357|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
42371238|NCT02036970|76236358|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
42371239|NCT02036970|76236359|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
42371240|NCT02036970|76236360|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
42371241|NCT02036970|76236351|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
42371242|NCT02036970|76236352|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
42371243|NCT02036970|76236353|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
42371244|NCT02036970|76236354|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
42371245|NCT02036970|76236355|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
42371246|NCT02036970|76236356|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
42371247|NCT02036970|76236357|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
42371248|NCT02036970|76236358|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
42371249|NCT02036970|76236359|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
42371250|NCT02036970|76236360|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
42371251|NCT01748825|76236550|FG000|Dose Escalation|Refused further treatment|2|||
42371252|NCT01748825|76236551|FG001|Dose Escalation|Refused further treatment|2|||
42371253|NCT01748825|76236552|FG002|Dose Escalation|Refused further treatment|0|||
42371254|NCT01748825|76236553|FG003|Dose Escalation|Refused further treatment|0|||
42371255|NCT01748825|76236554|FG004|Dose Escalation|Refused further treatment|1|||
42371256|NCT01748825|76236555|FG005|Dose Escalation|Refused further treatment|2|||
42371257|NCT01748825|76236556|FG006|Dose Escalation|Refused further treatment|0|||
42371258|NCT01748825|76236557|FG007|Dose Escalation|Refused further treatment|0|||
42371259|NCT01748825|76236558|FG008|Dose Escalation|Refused further treatment|0|||
42371260|NCT01748825|76236559|FG009|Dose Escalation|Refused further treatment|0|||
42371261|NCT01748825|76236550|FG000|Dose Escalation|Switched to alternative treatment|0|||
42371262|NCT01748825|76236551|FG001|Dose Escalation|Switched to alternative treatment|0|||
42371263|NCT01748825|76236552|FG002|Dose Escalation|Switched to alternative treatment|0|||
42371264|NCT01748825|76236553|FG003|Dose Escalation|Switched to alternative treatment|1|||
42371265|NCT01748825|76236554|FG004|Dose Escalation|Switched to alternative treatment|0|||
42371266|NCT01748825|76236555|FG005|Dose Escalation|Switched to alternative treatment|0|||
42371267|NCT01748825|76236556|FG006|Dose Escalation|Switched to alternative treatment|0|||
42371268|NCT01748825|76236557|FG007|Dose Escalation|Switched to alternative treatment|0|||
42371269|NCT01748825|76236558|FG008|Dose Escalation|Switched to alternative treatment|0|||
42371270|NCT01748825|76236559|FG009|Dose Escalation|Switched to alternative treatment|0|||
42371271|NCT01748825|76236550|FG000|Dose Escalation|Adverse Event|0|||
42371272|NCT01748825|76236551|FG001|Dose Escalation|Adverse Event|0|||
42371273|NCT01748825|76236552|FG002|Dose Escalation|Adverse Event|0|||
42371274|NCT01748825|76236553|FG003|Dose Escalation|Adverse Event|0|||
42371275|NCT01748825|76236554|FG004|Dose Escalation|Adverse Event|0|||
42371276|NCT01748825|76236555|FG005|Dose Escalation|Adverse Event|0|||
42371277|NCT01748825|76236556|FG006|Dose Escalation|Adverse Event|1|||
42371278|NCT01748825|76236557|FG007|Dose Escalation|Adverse Event|0|||
42371279|NCT01748825|76236558|FG008|Dose Escalation|Adverse Event|0|||
42371280|NCT01748825|76236559|FG009|Dose Escalation|Adverse Event|0|||
42371281|NCT01748825|76236550|FG000|Dose Expansion|Refused further treatment|0|||
42371282|NCT01748825|76236551|FG001|Dose Expansion|Refused further treatment|0|||
42371283|NCT01748825|76236552|FG002|Dose Expansion|Refused further treatment|0|||
42371284|NCT01748825|76236553|FG003|Dose Expansion|Refused further treatment|0|||
42371285|NCT01748825|76236554|FG004|Dose Expansion|Refused further treatment|0|||
42371286|NCT01748825|76236555|FG005|Dose Expansion|Refused further treatment|0|||
42371287|NCT01748825|76236556|FG006|Dose Expansion|Refused further treatment|0|||
42371288|NCT01748825|76236557|FG007|Dose Expansion|Refused further treatment|0|||
42371289|NCT01748825|76236558|FG008|Dose Expansion|Refused further treatment|1|||
42371290|NCT01748825|76236559|FG009|Dose Expansion|Refused further treatment|1|||
42371291|NCT01748825|76236550|FG000|Dose Expansion|Switched to alternative treatment|0|||
42371292|NCT01748825|76236551|FG001|Dose Expansion|Switched to alternative treatment|0|||
42371293|NCT01748825|76236552|FG002|Dose Expansion|Switched to alternative treatment|0|||
42371294|NCT01748825|76236553|FG003|Dose Expansion|Switched to alternative treatment|0|||
42371295|NCT01748825|76236554|FG004|Dose Expansion|Switched to alternative treatment|0|||
42371296|NCT01748825|76236555|FG005|Dose Expansion|Switched to alternative treatment|0|||
42371297|NCT01748825|76236556|FG006|Dose Expansion|Switched to alternative treatment|0|||
42371298|NCT01748825|76236557|FG007|Dose Expansion|Switched to alternative treatment|0|||
42371299|NCT01748825|76236558|FG008|Dose Expansion|Switched to alternative treatment|0|||
42371300|NCT01748825|76236559|FG009|Dose Expansion|Switched to alternative treatment|1|||
42371301|NCT01748825|76236550|FG000|Dose Expansion|Adverse Event|0|||
42371302|NCT01748825|76236551|FG001|Dose Expansion|Adverse Event|0|||
42371303|NCT01748825|76236552|FG002|Dose Expansion|Adverse Event|0|||
42371304|NCT01748825|76236553|FG003|Dose Expansion|Adverse Event|0|||
42371305|NCT01748825|76236554|FG004|Dose Expansion|Adverse Event|0|||
42371306|NCT01748825|76236555|FG005|Dose Expansion|Adverse Event|0|||
42371307|NCT01748825|76236556|FG006|Dose Expansion|Adverse Event|0|||
42371308|NCT01748825|76236557|FG007|Dose Expansion|Adverse Event|0|||
42371309|NCT01748825|76236558|FG008|Dose Expansion|Adverse Event|0|||
42371310|NCT01748825|76236559|FG009|Dose Expansion|Adverse Event|3|||
42371311|NCT01748825|76236550|FG000|Dose Expansion|Physician Decision|0|||
42371312|NCT01748825|76236551|FG001|Dose Expansion|Physician Decision|0|||
42371313|NCT01748825|76236552|FG002|Dose Expansion|Physician Decision|0|||
42371314|NCT01748825|76236553|FG003|Dose Expansion|Physician Decision|0|||
42371315|NCT01748825|76236554|FG004|Dose Expansion|Physician Decision|0|||
42371316|NCT01748825|76236555|FG005|Dose Expansion|Physician Decision|0|||
42371317|NCT01748825|76236556|FG006|Dose Expansion|Physician Decision|0|||
42371318|NCT01748825|76236557|FG007|Dose Expansion|Physician Decision|0|||
42371319|NCT01748825|76236558|FG008|Dose Expansion|Physician Decision|1|||
42371320|NCT01748825|76236559|FG009|Dose Expansion|Physician Decision|0|||
42371321|NCT01720667|76236621|FG000|Overall Study|Adverse Event|1|||
42371322|NCT01720667|76236622|FG001|Overall Study|Adverse Event|1|||
42371323|NCT01720667|76236621|FG000|Overall Study|Withdrawal by Subject|3|||
42371324|NCT01720667|76236622|FG001|Overall Study|Withdrawal by Subject|0|||
42371325|NCT01720043|76236630|FG000|Overall Study|Withdrawal by Subject|1|||
42371326|NCT00700752|76236634|FG000|First Intervention|Withdrawal by Subject|0|||
42371327|NCT00700752|76236635|FG001|First Intervention|Withdrawal by Subject|2|||
42371328|NCT01747811|76236652|FG000|Overall Study|Lack of Efficacy|2|||
42371329|NCT01747811|76236653|FG001|Overall Study|Lack of Efficacy|4|||
42200722|NCT02229825|76012672|FG001|Overall Study|Not treated|1|||
42200723|NCT02112916|76012693|FG000|Overall Study|Adverse Event|6|||
42200724|NCT02112916|76012694|FG001|Overall Study|Adverse Event|9|||
42200725|NCT02112916|76012695|FG002|Overall Study|Adverse Event|3|||
42200726|NCT02112916|76012696|FG003|Overall Study|Adverse Event|2|||
42200727|NCT02112916|76012693|FG000|Overall Study|Death|9|||
42371330|NCT01747655|76236661|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
42371331|NCT01747655|76236662|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
42371332|NCT01747655|76236661|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
42371333|NCT01747655|76236662|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
42371334|NCT01747655|76236661|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
42371335|NCT01747655|76236662|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
42371336|NCT01718483|76236670|FG000|Overall Study|Withdrawal by Subject|14|||
42371337|NCT01718483|76236671|FG001|Overall Study|Withdrawal by Subject|12|||
42371338|NCT01718483|76236670|FG000|Overall Study|Adverse Event|5|||
42371339|NCT01718483|76236671|FG001|Overall Study|Adverse Event|12|||
42371340|NCT01718483|76236670|FG000|Overall Study|Lost to Follow-up|8|||
42371341|NCT01718483|76236671|FG001|Overall Study|Lost to Follow-up|3|||
42371342|NCT01718483|76236670|FG000|Overall Study|Protocol Violation|4|||
42371343|NCT01718483|76236671|FG001|Overall Study|Protocol Violation|2|||
42371344|NCT01718483|76236670|FG000|Overall Study|Other|1|||
42371345|NCT01718483|76236671|FG001|Overall Study|Other|4|||
42371346|NCT01718483|76236670|FG000|Overall Study|Pregnancy|1|||
42103412|NCT00652626|75914379|FG006|Initial Treatment Phase|Physician Decision|0|||
42103413|NCT00652626|75914373|FG000|Initial Treatment Phase|Sponsor Request|0|||
42103414|NCT00652626|75914374|FG001|Initial Treatment Phase|Sponsor Request|0|||
42200728|NCT02112916|76012694|FG001|Overall Study|Death|9|||
42200729|NCT02112916|76012695|FG002|Overall Study|Death|3|||
42371347|NCT01718483|76236671|FG001|Overall Study|Pregnancy|1|||
42371348|NCT01718483|76236670|FG000|Overall Study|Lack of Efficacy|1|||
42371349|NCT01718483|76236671|FG001|Overall Study|Lack of Efficacy|0|||
42371350|NCT01717859|76236677|FG000|Overall Study|Adverse Event|5|||
42371351|NCT01717859|76236677|FG000|Overall Study|Moved out of state|1|||
42371352|NCT01717859|76236677|FG000|Overall Study|Patient concerned about mental health|1|||
42371353|NCT01717859|76236677|FG000|Overall Study|Lost to Follow-up|1|||
42371354|NCT01717859|76236677|FG000|Overall Study|Withdrawal by Subject|2|||
42371355|NCT01747499|76236970|FG000|Overall Study|Steroid refractory aGvHD|1|||
42371356|NCT01747499|76236971|FG001|Overall Study|Steroid refractory aGvHD|0|||
42371357|NCT01747499|76236972|FG002|Overall Study|Steroid refractory aGvHD|0|||
42371358|NCT01747499|76236973|FG003|Overall Study|Steroid refractory aGvHD|1|||
42371359|NCT01747499|76236974|FG004|Overall Study|Steroid refractory aGvHD|4|||
42371360|NCT01747499|76236970|FG000|Overall Study|Physician Decision|0|||
42371361|NCT01747499|76236971|FG001|Overall Study|Physician Decision|1|||
42371362|NCT01747499|76236972|FG002|Overall Study|Physician Decision|0|||
42371363|NCT01747499|76236973|FG003|Overall Study|Physician Decision|0|||
42371364|NCT01747499|76236974|FG004|Overall Study|Physician Decision|2|||
42371365|NCT01747499|76236970|FG000|Overall Study|Death|0|||
42371366|NCT01747499|76236971|FG001|Overall Study|Death|0|||
42371367|NCT01747499|76236972|FG002|Overall Study|Death|0|||
42371368|NCT01747499|76236973|FG003|Overall Study|Death|1|||
42371369|NCT01747499|76236974|FG004|Overall Study|Death|1|||
42371370|NCT01747499|76236970|FG000|Overall Study|Withdrawal by Subject|0|||
42371371|NCT01747499|76236971|FG001|Overall Study|Withdrawal by Subject|0|||
42371372|NCT01747499|76236972|FG002|Overall Study|Withdrawal by Subject|0|||
42371373|NCT01747499|76236973|FG003|Overall Study|Withdrawal by Subject|0|||
42371374|NCT01747499|76236974|FG004|Overall Study|Withdrawal by Subject|6|||
42371375|NCT01747499|76236970|FG000|Overall Study|Developed AML and death|0|||
42371376|NCT01747499|76236971|FG001|Overall Study|Developed AML and death|0|||
42371377|NCT01747499|76236972|FG002|Overall Study|Developed AML and death|0|||
42371378|NCT01747499|76236973|FG003|Overall Study|Developed AML and death|0|||
42371379|NCT01747499|76236974|FG004|Overall Study|Developed AML and death|1|||
42371380|NCT01747499|76236970|FG000|Overall Study|Determined not to be eligible|0|||
42371381|NCT01747499|76236971|FG001|Overall Study|Determined not to be eligible|0|||
42371382|NCT01747499|76236972|FG002|Overall Study|Determined not to be eligible|0|||
42371383|NCT01747499|76236973|FG003|Overall Study|Determined not to be eligible|0|||
42371384|NCT01747499|76236974|FG004|Overall Study|Determined not to be eligible|1|||
42371385|NCT01717391|76237006|FG000|Overall Study|Withdrawal by Subject|5|||
42371386|NCT01717391|76237006|FG000|Overall Study|Physician Decision|1|||
42371387|NCT01717391|76237006|FG000|Overall Study|FLT technical failure|3|||
42371388|NCT01746017|76237149|FG000|Period 1|Withdrawal by Subject|0|||
42371389|NCT01746017|76237150|FG001|Period 1|Withdrawal by Subject|0|||
42371390|NCT01746017|76237151|FG002|Period 1|Withdrawal by Subject|0|||
42371391|NCT01746017|76237152|FG003|Period 1|Withdrawal by Subject|0|||
42371392|NCT01746017|76237153|FG004|Period 1|Withdrawal by Subject|0|||
42371393|NCT01746017|76237154|FG005|Period 1|Withdrawal by Subject|0|||
42371394|NCT01746017|76237155|FG006|Period 1|Withdrawal by Subject|1|||
42371395|NCT01746017|76237156|FG007|Period 1|Withdrawal by Subject|0|||
42371396|NCT01746017|76237157|FG008|Period 1|Withdrawal by Subject|0|||
42371397|NCT01746017|76237158|FG009|Period 1|Withdrawal by Subject|0|||
42371398|NCT01746017|76237159|FG010|Period 1|Withdrawal by Subject|0|||
42371399|NCT01746017|76237149|FG000|Period 3|Withdrawal by Subject|0|||
42371400|NCT01746017|76237150|FG001|Period 3|Withdrawal by Subject|0|||
42371401|NCT01746017|76237151|FG002|Period 3|Withdrawal by Subject|0|||
42371402|NCT01746017|76237152|FG003|Period 3|Withdrawal by Subject|0|||
42371403|NCT01746017|76237153|FG004|Period 3|Withdrawal by Subject|0|||
42371404|NCT01746017|76237154|FG005|Period 3|Withdrawal by Subject|1|||
42371405|NCT01746017|76237155|FG006|Period 3|Withdrawal by Subject|0|||
42371406|NCT01746017|76237156|FG007|Period 3|Withdrawal by Subject|0|||
42371407|NCT01746017|76237157|FG008|Period 3|Withdrawal by Subject|0|||
42371408|NCT01746017|76237158|FG009|Period 3|Withdrawal by Subject|0|||
42371409|NCT01746017|76237159|FG010|Period 3|Withdrawal by Subject|0|||
42371410|NCT01717313|76237221|FG000|Phase A (Weeks 0 to 24)|Death|0|||
42371411|NCT01717313|76237222|FG001|Phase A (Weeks 0 to 24)|Death|1|||
42371412|NCT01717313|76237221|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
42371413|NCT01717313|76237222|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
42371414|NCT01717313|76237221|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
42371415|NCT01717313|76237222|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
42371416|NCT01717313|76237221|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
42371417|NCT01717313|76237222|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
42371418|NCT01717313|76237221|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
42371419|NCT01717313|76237222|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
42371420|NCT01717313|76237221|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
42371421|NCT01717313|76237222|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
42371422|NCT01717313|76237221|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
42371423|NCT01717313|76237222|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
42371424|NCT01717313|76237221|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
42371425|NCT01717313|76237222|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
42371426|NCT01717313|76237221|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
42371427|NCT01717313|76237222|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
42371428|NCT01745393|76237234|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
42371429|NCT01745393|76237235|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
42371430|NCT01745393|76237234|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
42371431|NCT01745393|76237235|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
42371432|NCT01745393|76237234|FG000|12-month Follow-up|Lost to Follow-up|6|||
42371433|NCT01745393|76237235|FG001|12-month Follow-up|Lost to Follow-up|5|||
42371434|NCT01744691|76237266|FG000|Overall Study|Progressive Disease|18|||
42371435|NCT01744691|76237266|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
42371436|NCT01744691|76237266|FG000|Overall Study|Withdrawal of consent for treatment|3|||
42371437|NCT01744691|76237266|FG000|Overall Study|Physician Decision|4|||
42371438|NCT01716533|76237301|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
42371439|NCT01716533|76237302|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
42371440|NCT01716533|76237303|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
42371441|NCT01716533|76237304|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
42371442|NCT01716533|76237301|FG000|Overall Study|Withdrawal by Subject|0|||
42371443|NCT01716533|76237302|FG001|Overall Study|Withdrawal by Subject|0|||
42371444|NCT01716533|76237303|FG002|Overall Study|Withdrawal by Subject|0|||
42371445|NCT01716533|76237304|FG003|Overall Study|Withdrawal by Subject|5|||
42371446|NCT01716533|76237301|FG000|Overall Study|Death|0|||
42371447|NCT01716533|76237302|FG001|Overall Study|Death|0|||
42200730|NCT02112916|76012696|FG003|Overall Study|Death|4|||
42200731|NCT02112916|76012693|FG000|Overall Study|Lost to Follow-up|1|||
42200732|NCT02112916|76012694|FG001|Overall Study|Lost to Follow-up|0|||
42371448|NCT01716533|76237303|FG002|Overall Study|Death|0|||
42371449|NCT01716533|76237304|FG003|Overall Study|Death|2|||
42371450|NCT01716533|76237301|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
42371451|NCT01716533|76237302|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
42371452|NCT01716533|76237303|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
42371453|NCT01716533|76237304|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
42371454|NCT01375374|76237318|FG000|Overall Study|Adverse Event|1|||
42371455|NCT01743989|76237916|FG000|Treatment Phase|Unstable MR4.0|0|||
42371456|NCT01743989|76237917|FG001|Treatment Phase|Unstable MR4.0|6|||
42371457|NCT01743989|76237918|FG002|Treatment Phase|Unstable MR4.0|263|||
42371458|NCT01743989|76237916|FG000|Treatment Phase|Adverse Event|0|||
42371459|NCT01743989|76237917|FG001|Treatment Phase|Adverse Event|4|||
42371460|NCT01743989|76237918|FG002|Treatment Phase|Adverse Event|67|||
42371461|NCT01743989|76237916|FG000|Treatment Phase|Withdrawal by Subject|1|||
42371462|NCT01743989|76237917|FG001|Treatment Phase|Withdrawal by Subject|3|||
42371463|NCT01743989|76237918|FG002|Treatment Phase|Withdrawal by Subject|28|||
42371464|NCT01743989|76237916|FG000|Treatment Phase|Death|0|||
42371465|NCT01743989|76237917|FG001|Treatment Phase|Death|1|||
42371466|NCT01743989|76237918|FG002|Treatment Phase|Death|3|||
42371467|NCT01743989|76237916|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
42371468|NCT01743989|76237917|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
42371469|NCT01743989|76237918|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
42371470|NCT01743989|76237916|FG000|Treatment Phase|Protocol deviation|0|||
42371471|NCT01743989|76237917|FG001|Treatment Phase|Protocol deviation|0|||
42371472|NCT01743989|76237918|FG002|Treatment Phase|Protocol deviation|3|||
42371473|NCT01743989|76237916|FG000|Treatment Phase|Pregnancy|0|||
42371474|NCT01743989|76237917|FG001|Treatment Phase|Pregnancy|0|||
42371475|NCT01743989|76237918|FG002|Treatment Phase|Pregnancy|2|||
42371476|NCT01743989|76237916|FG000|Treatment Phase|Lost to Follow-up|0|||
42371477|NCT01743989|76237917|FG001|Treatment Phase|Lost to Follow-up|0|||
42371478|NCT01743989|76237918|FG002|Treatment Phase|Lost to Follow-up|2|||
42371479|NCT01743989|76237916|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
42371480|NCT01743989|76237917|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
42371481|NCT01743989|76237918|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
42371482|NCT01743989|76237916|FG000|Treatment Phase|Administrative problems|0|||
42371483|NCT01743989|76237917|FG001|Treatment Phase|Administrative problems|0|||
42371484|NCT01743989|76237918|FG002|Treatment Phase|Administrative problems|1|||
42371485|NCT01743989|76237916|FG000|Treatment Phase|New cancer (CML) therapy|0|||
42371486|NCT01743989|76237917|FG001|Treatment Phase|New cancer (CML) therapy|1|||
42371487|NCT01743989|76237918|FG002|Treatment Phase|New cancer (CML) therapy|0|||
42371488|NCT01743989|76237916|FG000|Treatment Phase|Physician Decision|0|||
42371489|NCT01743989|76237917|FG001|Treatment Phase|Physician Decision|0|||
42371490|NCT01743989|76237918|FG002|Treatment Phase|Physician Decision|3|||
42371491|NCT01743989|76237916|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
42371492|NCT01743989|76237917|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
42200733|NCT02112916|76012695|FG002|Overall Study|Lost to Follow-up|0|||
42200734|NCT02112916|76012696|FG003|Overall Study|Lost to Follow-up|0|||
42371493|NCT01743989|76237918|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
42371494|NCT01743989|76237916|FG000|Treatment Phase|Not randomized by mistake|0|||
42371495|NCT01743989|76237917|FG001|Treatment Phase|Not randomized by mistake|0|||
42371496|NCT01743989|76237918|FG002|Treatment Phase|Not randomized by mistake|1|||
42371497|NCT01743989|76237916|FG000|Treatment Phase|Included by mistake|0|||
42371498|NCT01743989|76237917|FG001|Treatment Phase|Included by mistake|0|||
42371499|NCT01743989|76237918|FG002|Treatment Phase|Included by mistake|1|||
42371500|NCT01743989|76237916|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
42371501|NCT01743989|76237917|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
42371502|NCT01743989|76237918|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
42371503|NCT01743989|76237916|FG000|TFR Phase|Adverse Event|0|||
42371504|NCT01743989|76237917|FG001|TFR Phase|Adverse Event|1|||
42371505|NCT01743989|76237918|FG002|TFR Phase|Adverse Event|0|||
42371506|NCT01743989|76237916|FG000|TFR Phase|Lost to Follow-up|0|||
42371507|NCT01743989|76237917|FG001|TFR Phase|Lost to Follow-up|2|||
42371508|NCT01743989|76237918|FG002|TFR Phase|Lost to Follow-up|0|||
42371509|NCT01743989|76237916|FG000|TFR Phase|Physician Decision|0|||
42371510|NCT01743989|76237917|FG001|TFR Phase|Physician Decision|1|||
42371511|NCT01743989|76237918|FG002|TFR Phase|Physician Decision|0|||
42371512|NCT01743989|76237916|FG000|TFR Phase|Logistical problems|0|||
42371513|NCT01743989|76237917|FG001|TFR Phase|Logistical problems|2|||
42371514|NCT01743989|76237918|FG002|TFR Phase|Logistical problems|0|||
42371515|NCT01743989|76237916|FG000|TFR Phase|Protocol deviation|0|||
42371516|NCT01743989|76237917|FG001|TFR Phase|Protocol deviation|1|||
42371517|NCT01743989|76237918|FG002|TFR Phase|Protocol deviation|0|||
42371518|NCT01743989|76237916|FG000|TFR Phase|Withdrawal by Subject|0|||
42371519|NCT01743989|76237917|FG001|TFR Phase|Withdrawal by Subject|2|||
42371520|NCT01743989|76237918|FG002|TFR Phase|Withdrawal by Subject|0|||
42371521|NCT01743989|76237916|FG000|Re-treatment Phase|Adverse Event|8|||
42371522|NCT01743989|76237917|FG001|Re-treatment Phase|Adverse Event|4|||
42371523|NCT01743989|76237918|FG002|Re-treatment Phase|Adverse Event|0|||
42371524|NCT01743989|76237916|FG000|Re-treatment Phase|Death|1|||
42371525|NCT01743989|76237917|FG001|Re-treatment Phase|Death|1|||
42371526|NCT01743989|76237918|FG002|Re-treatment Phase|Death|0|||
42371527|NCT01743989|76237916|FG000|Re-treatment Phase|Administrative problems|1|||
42371528|NCT01743989|76237917|FG001|Re-treatment Phase|Administrative problems|1|||
42371529|NCT01743989|76237918|FG002|Re-treatment Phase|Administrative problems|0|||
42371530|NCT01743989|76237916|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
42371531|NCT01743989|76237917|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
42371532|NCT01743989|76237918|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
42371533|NCT01743989|76237916|FG000|Re-treatment Phase|Unstable MR|1|||
42371534|NCT01743989|76237917|FG001|Re-treatment Phase|Unstable MR|0|||
42371535|NCT01743989|76237918|FG002|Re-treatment Phase|Unstable MR|0|||
42371536|NCT01743989|76237916|FG000|Re-treatment Phase|Physician Decision|0|||
42371537|NCT01743989|76237917|FG001|Re-treatment Phase|Physician Decision|1|||
42371538|NCT01743989|76237918|FG002|Re-treatment Phase|Physician Decision|0|||
42371539|NCT01743989|76237916|FG000|Re-treatment Phase|Lost to Follow-up|0|||
42371540|NCT01743989|76237917|FG001|Re-treatment Phase|Lost to Follow-up|1|||
42371541|NCT01743989|76237918|FG002|Re-treatment Phase|Lost to Follow-up|0|||
42371542|NCT01605461|76237951|FG000|Overall Study|Lost to Follow-up|3|||
42371543|NCT01605461|76237951|FG000|Overall Study|Withdrawal by Subject|1|||
42371544|NCT01742897|76237955|FG000|Overall Study|Adverse Event|3|||
42371545|NCT01742897|76237955|FG000|Overall Study|Withdrawal by Subject|1|||
42371546|NCT01742897|76237955|FG000|Overall Study|Other|1|||
42371547|NCT01715831|76237959|FG000|Overall Study|Adverse Event|1|||
42371548|NCT01741259|76237965|FG000|Overall Study|Protocol Violation|6|||
42371549|NCT01741259|76237966|FG001|Overall Study|Protocol Violation|4|||
42371550|NCT01741259|76237965|FG000|Overall Study|Withdrawal by Subject|0|||
42371551|NCT01741259|76237966|FG001|Overall Study|Withdrawal by Subject|2|||
42371552|NCT01715129|76237972|FG000|Overall Study|Adverse Event, fatal|1|||
42371553|NCT01715129|76237972|FG000|Overall Study|Lack of Efficacy|3|||
42371554|NCT01715129|76237972|FG000|Overall Study|Protocol Violation|1|||
42371555|NCT01715129|76237972|FG000|Overall Study|Consent Withdrawn|2|||
42371556|NCT01715129|76237972|FG000|Overall Study|Lost to Follow-up|1|||
42371557|NCT01715129|76237972|FG000|Overall Study|Other|1|||
42371558|NCT01740791|76238065|FG000|Overall Study|Randomized but never treated|5|||
42371559|NCT01740791|76238066|FG001|Overall Study|Randomized but never treated|3|||
42371560|NCT01740791|76238067|FG002|Overall Study|Randomized but never treated|2|||
42371561|NCT01740791|76238068|FG003|Overall Study|Randomized but never treated|2|||
42371562|NCT01740791|76238069|FG004|Overall Study|Randomized but never treated|1|||
42371563|NCT01740791|76238070|FG005|Overall Study|Randomized but never treated|3|||
42371564|NCT01740791|76238065|FG000|Overall Study|Lost to Follow-up|2|||
42371565|NCT01740791|76238066|FG001|Overall Study|Lost to Follow-up|0|||
42371566|NCT01740791|76238067|FG002|Overall Study|Lost to Follow-up|2|||
42371567|NCT01740791|76238068|FG003|Overall Study|Lost to Follow-up|3|||
42371568|NCT01740791|76238069|FG004|Overall Study|Lost to Follow-up|2|||
42371569|NCT01740791|76238070|FG005|Overall Study|Lost to Follow-up|3|||
42371570|NCT01740791|76238065|FG000|Overall Study|Withdrew Consent|4|||
42371571|NCT01740791|76238066|FG001|Overall Study|Withdrew Consent|0|||
42371572|NCT01740791|76238067|FG002|Overall Study|Withdrew Consent|1|||
42371573|NCT01740791|76238068|FG003|Overall Study|Withdrew Consent|2|||
42371574|NCT01740791|76238069|FG004|Overall Study|Withdrew Consent|0|||
42371575|NCT01740791|76238070|FG005|Overall Study|Withdrew Consent|3|||
42371576|NCT01740791|76238065|FG000|Overall Study|Investigator's discretion|1|||
42371577|NCT01740791|76238066|FG001|Overall Study|Investigator's discretion|0|||
42371578|NCT01740791|76238067|FG002|Overall Study|Investigator's discretion|1|||
42371579|NCT01740791|76238068|FG003|Overall Study|Investigator's discretion|0|||
42371580|NCT01740791|76238069|FG004|Overall Study|Investigator's discretion|0|||
42371581|NCT01740791|76238070|FG005|Overall Study|Investigator's discretion|1|||
42371582|NCT01740791|76238065|FG000|Overall Study|Adverse Event|0|||
42371583|NCT01740791|76238066|FG001|Overall Study|Adverse Event|0|||
42371584|NCT01740791|76238067|FG002|Overall Study|Adverse Event|0|||
42371585|NCT01740791|76238068|FG003|Overall Study|Adverse Event|0|||
42371586|NCT01740791|76238069|FG004|Overall Study|Adverse Event|0|||
42371587|NCT01740791|76238070|FG005|Overall Study|Adverse Event|1|||
42371588|NCT01740323|76238127|FG000|Overall Study|Adverse Event|1|||
42371589|NCT01740323|76238128|FG001|Overall Study|Adverse Event|0|||
42371590|NCT01740323|76238127|FG000|Overall Study|Randomized but did not take study drug|1|||
42371591|NCT01740323|76238128|FG001|Overall Study|Randomized but did not take study drug|0|||
42371592|NCT01740089|76238146|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
42371593|NCT01740089|76238147|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
42371594|NCT01740089|76238148|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
42371595|NCT01740089|76238146|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
42371596|NCT01740089|76238147|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
42371597|NCT01740089|76238148|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
42371598|NCT01740089|76238146|FG000|After 12 Weeks|Lack of Efficacy|3|||
42371599|NCT01740089|76238147|FG001|After 12 Weeks|Lack of Efficacy|1|||
42371600|NCT01740089|76238148|FG002|After 12 Weeks|Lack of Efficacy|4|||
42371601|NCT01740089|76238146|FG000|After 12 Weeks|Adverse Event|2|||
42371602|NCT01740089|76238147|FG001|After 12 Weeks|Adverse Event|0|||
42371603|NCT01740089|76238148|FG002|After 12 Weeks|Adverse Event|5|||
42371604|NCT01740089|76238146|FG000|After 12 Weeks|Protocol Violation|1|||
42371605|NCT01740089|76238147|FG001|After 12 Weeks|Protocol Violation|1|||
42371606|NCT01740089|76238148|FG002|After 12 Weeks|Protocol Violation|1|||
42371607|NCT01740089|76238146|FG000|After 12 Weeks|Withdrawal by Subject|1|||
42371608|NCT01740089|76238147|FG001|After 12 Weeks|Withdrawal by Subject|1|||
42371609|NCT01740089|76238148|FG002|After 12 Weeks|Withdrawal by Subject|1|||
42371610|NCT01739933|76238159|FG000|Overall Study|Death|89|||
42371611|NCT01739933|76238160|FG001|Overall Study|Death|86|||
42371612|NCT01739933|76238159|FG000|Overall Study|Withdrawal by Subject|10|||
42371613|NCT01739933|76238160|FG001|Overall Study|Withdrawal by Subject|8|||
42371614|NCT01739933|76238159|FG000|Overall Study|Lost to Follow-up|3|||
42371615|NCT01739933|76238160|FG001|Overall Study|Lost to Follow-up|10|||
42371616|NCT01739933|76238159|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
42371617|NCT01739933|76238160|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
42371618|NCT01738919|76238177|FG000|Overall Study|Lost to Follow-up|1|||
42371619|NCT01738919|76238178|FG001|Overall Study|Lost to Follow-up|0|||
42371620|NCT01738919|76238177|FG000|Overall Study|Immigrated|0|||
42371621|NCT01738919|76238178|FG001|Overall Study|Immigrated|1|||
42371622|NCT01738919|76238177|FG000|Overall Study|Withdrawal by Subject|0|||
42371623|NCT01738919|76238178|FG001|Overall Study|Withdrawal by Subject|1|||
42371624|NCT01738919|76238177|FG000|Overall Study|Not treated in accordance to guidelines|0|||
42371625|NCT01738919|76238178|FG001|Overall Study|Not treated in accordance to guidelines|1|||
42371626|NCT01712399|76238199|FG000|Overall Study|Lost to Follow-up|1|||
42371627|NCT01712399|76238199|FG000|Overall Study|Withdrawal by Subject|39|||
42371628|NCT01712399|76238199|FG000|Overall Study|Death|1|||
42371629|NCT01712399|76238199|FG000|Overall Study|Adverse Event|11|||
42371630|NCT01712399|76238199|FG000|Overall Study|Study closure|345|||
42371631|NCT03225846|76238306|FG000|Overall Study|Adverse Event|0|||
42371632|NCT03225846|76238307|FG001|Overall Study|Adverse Event|0|||
42371633|NCT03225846|76238308|FG002|Overall Study|Adverse Event|0|||
42371634|NCT03225846|76238309|FG003|Overall Study|Adverse Event|0|||
42371635|NCT03225846|76238310|FG004|Overall Study|Adverse Event|0|||
42371636|NCT03225846|76238311|FG005|Overall Study|Adverse Event|0|||
42371637|NCT03225846|76238312|FG006|Overall Study|Adverse Event|6|||
42371638|NCT03225846|76238306|FG000|Overall Study|Withdrawal by Subject|0|||
42371639|NCT03225846|76238307|FG001|Overall Study|Withdrawal by Subject|1|||
42371640|NCT03225846|76238308|FG002|Overall Study|Withdrawal by Subject|0|||
42200735|NCT02112916|76012693|FG000|Overall Study|Physician Decision|94|||
42371641|NCT03225846|76238309|FG003|Overall Study|Withdrawal by Subject|0|||
42371642|NCT03225846|76238310|FG004|Overall Study|Withdrawal by Subject|0|||
42371643|NCT03225846|76238311|FG005|Overall Study|Withdrawal by Subject|0|||
42371644|NCT03225846|76238312|FG006|Overall Study|Withdrawal by Subject|0|||
42371645|NCT03225846|76238306|FG000|Overall Study|Death|0|||
42371646|NCT03225846|76238307|FG001|Overall Study|Death|1|||
42371647|NCT03225846|76238308|FG002|Overall Study|Death|0|||
42371648|NCT03225846|76238309|FG003|Overall Study|Death|0|||
42371649|NCT03225846|76238310|FG004|Overall Study|Death|0|||
42371650|NCT03225846|76238311|FG005|Overall Study|Death|0|||
42371651|NCT03225846|76238312|FG006|Overall Study|Death|0|||
42371652|NCT03225846|76238306|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
42371653|NCT03225846|76238307|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
42371654|NCT03225846|76238308|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
42371655|NCT03225846|76238309|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
42371656|NCT03225846|76238310|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
42371657|NCT03225846|76238311|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
42371658|NCT03225846|76238312|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
42371659|NCT03225846|76238306|FG000|Overall Study|Patient decision|0|||
42371660|NCT03225846|76238307|FG001|Overall Study|Patient decision|0|||
42371661|NCT03225846|76238308|FG002|Overall Study|Patient decision|0|||
42371662|NCT03225846|76238309|FG003|Overall Study|Patient decision|0|||
42371663|NCT03225846|76238310|FG004|Overall Study|Patient decision|0|||
42371664|NCT03225846|76238311|FG005|Overall Study|Patient decision|0|||
42371665|NCT03225846|76238312|FG006|Overall Study|Patient decision|1|||
42371666|NCT01712009|76238377|FG000|Overall Study|Withdrawal by Subject|24|||
42371667|NCT01712009|76238378|FG001|Overall Study|Withdrawal by Subject|15|||
42371668|NCT01712009|76238379|FG002|Overall Study|Withdrawal by Subject|8|||
42371669|NCT01712009|76238377|FG000|Overall Study|Lost to Follow-up|2|||
42371670|NCT01712009|76238378|FG001|Overall Study|Lost to Follow-up|0|||
42371671|NCT01712009|76238379|FG002|Overall Study|Lost to Follow-up|1|||
42371672|NCT01712009|76238377|FG000|Overall Study|Decision by Sponsor|12|||
42371673|NCT01712009|76238378|FG001|Overall Study|Decision by Sponsor|14|||
42371674|NCT01712009|76238379|FG002|Overall Study|Decision by Sponsor|12|||
42371675|NCT01711853|76238408|FG000|Overall Study|Not treated|3|||
42371676|NCT01708187|76238414|FG000|Overall Study|Lost to Follow-up|0|||
42371677|NCT01708187|76238415|FG001|Overall Study|Lost to Follow-up|1|||
42371678|NCT01740401|76238491|FG000|Overall Study|Progression of disease|6|||
42371679|NCT01740401|76238491|FG000|Overall Study|Adverse Event|2|||
42371680|NCT01740401|76238491|FG000|Overall Study|Did not reach primary endpoint|2|||
42371681|NCT01711619|76238512|FG000|Overall Study|Early study termination|10|||
42371682|NCT01711619|76238513|FG001|Overall Study|Early study termination|14|||
42371683|NCT01711619|76238512|FG000|Overall Study|Withdrawal by Subject|3|||
42371684|NCT01711619|76238513|FG001|Overall Study|Withdrawal by Subject|7|||
42371685|NCT01711619|76238512|FG000|Overall Study|Protocol Violation|2|||
42371686|NCT01711619|76238513|FG001|Overall Study|Protocol Violation|3|||
42371687|NCT01711619|76238512|FG000|Overall Study|Adverse Event|2|||
42371688|NCT01711619|76238513|FG001|Overall Study|Adverse Event|0|||
42371689|NCT01711619|76238512|FG000|Overall Study|Lost to Follow-up|1|||
42371690|NCT01711619|76238513|FG001|Overall Study|Lost to Follow-up|0|||
42371691|NCT01710527|76238528|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
42371692|NCT01710527|76238529|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
42371693|NCT01706939|76238537|FG000|Pre Randomization|Screen Failure|1|||
42371694|NCT01706939|76238538|FG001|Pre Randomization|Screen Failure|0|||
42371695|NCT01706939|76238539|FG002|Pre Randomization|Screen Failure|0|||
42371696|NCT01706939|76238537|FG000|Pre Randomization|Ineligible for Randomization|1|||
42371697|NCT01706939|76238538|FG001|Pre Randomization|Ineligible for Randomization|0|||
42371698|NCT01706939|76238539|FG002|Pre Randomization|Ineligible for Randomization|0|||
42371699|NCT01706939|76238537|FG000|Pre Randomization|Withdrawal by Subject|1|||
42371700|NCT01706939|76238538|FG001|Pre Randomization|Withdrawal by Subject|0|||
42371701|NCT01706939|76238539|FG002|Pre Randomization|Withdrawal by Subject|0|||
42371702|NCT01706939|76238537|FG000|Randomization|Insufficient QoL survey compliance|0|||
42371703|NCT01706939|76238538|FG001|Randomization|Insufficient QoL survey compliance|1|||
42371704|NCT01706939|76238539|FG002|Randomization|Insufficient QoL survey compliance|1|||
42371705|NCT01706939|76238537|FG000|Randomization|Progression of disease|0|||
42371706|NCT01706939|76238538|FG001|Randomization|Progression of disease|2|||
42371707|NCT01706939|76238539|FG002|Randomization|Progression of disease|1|||
42371708|NCT01709903|76238548|FG000|Overall Study|administrative problems|2|||
42371709|NCT01709903|76238549|FG001|Overall Study|administrative problems|6|||
42371710|NCT01709903|76238548|FG000|Overall Study|Abnormal test procedure results|1|||
42371711|NCT01709903|76238549|FG001|Overall Study|Abnormal test procedure results|0|||
42103415|NCT00652626|75914375|FG002|Initial Treatment Phase|Sponsor Request|1|||
42103416|NCT00652626|75914376|FG003|Initial Treatment Phase|Sponsor Request|0|||
42103417|NCT00652626|75914377|FG004|Initial Treatment Phase|Sponsor Request|0|||
42103418|NCT00652626|75914378|FG005|Initial Treatment Phase|Sponsor Request|0|||
42371712|NCT01709903|76238548|FG000|Overall Study|In ability to use device|1|||
42371713|NCT01709903|76238549|FG001|Overall Study|In ability to use device|1|||
42371714|NCT01709903|76238548|FG000|Overall Study|no longer needed study drug|0|||
42371715|NCT01709903|76238549|FG001|Overall Study|no longer needed study drug|1|||
42371716|NCT01709903|76238548|FG000|Overall Study|Lost to Follow-up|0|||
42371717|NCT01709903|76238549|FG001|Overall Study|Lost to Follow-up|2|||
42371718|NCT01709903|76238548|FG000|Overall Study|Death|2|||
42371719|NCT01709903|76238549|FG001|Overall Study|Death|0|||
42371720|NCT01709903|76238548|FG000|Overall Study|Protocol Violation|3|||
42371721|NCT01709903|76238549|FG001|Overall Study|Protocol Violation|2|||
42371722|NCT01709903|76238548|FG000|Overall Study|Lack of Efficacy|3|||
42371723|NCT01709903|76238549|FG001|Overall Study|Lack of Efficacy|3|||
42371724|NCT01709903|76238548|FG000|Overall Study|Withdrawal by Subject|6|||
42371725|NCT01709903|76238549|FG001|Overall Study|Withdrawal by Subject|6|||
42371726|NCT01709903|76238548|FG000|Overall Study|Adverse Event|11|||
42371727|NCT01709903|76238549|FG001|Overall Study|Adverse Event|18|||
42371728|NCT04492618|76238555|FG000|Overall Study|Withdrawal by Subject|1|||
42371729|NCT04978090|76238559|FG000|Overall Study|unable to adequately fit device|2|||
42371730|NCT04677504|76238565|FG000|Overall Study|Death|31|||
42371731|NCT04677504|76238566|FG001|Overall Study|Death|24|||
42371732|NCT04677504|76238565|FG000|Overall Study|Progressive Disease|1|||
42371733|NCT04677504|76238566|FG001|Overall Study|Progressive Disease|0|||
42371734|NCT04677504|76238565|FG000|Overall Study|Symptomatic Deterioration|1|||
42371735|NCT04677504|76238566|FG001|Overall Study|Symptomatic Deterioration|0|||
42371736|NCT04677504|76238565|FG000|Overall Study|Withdrawal by Subject|2|||
42371737|NCT04677504|76238566|FG001|Overall Study|Withdrawal by Subject|5|||
42371738|NCT04677504|76238565|FG000|Overall Study|Ongoing in study|48|||
42371739|NCT04677504|76238566|FG001|Overall Study|Ongoing in study|50|||
42371740|NCT04635631|76238574|FG000|Overall Study|Adverse Event|1|||
42371741|NCT04635631|76238574|FG000|Overall Study|Progressive disease|13|||
42371742|NCT04635631|76238574|FG000|Overall Study|Withdrawal by Subject|1|||
42371743|NCT04269395|76238591|FG000|Overall Study|Lost to Follow-up|1|||
42371744|NCT04269395|76238592|FG001|Overall Study|Lost to Follow-up|0|||
42371745|NCT04269395|76238591|FG000|Overall Study|Study terminated by Sponsor|13|||
42371746|NCT04269395|76238592|FG001|Overall Study|Study terminated by Sponsor|10|||
42371747|NCT04143594|76238602|FG000|Overall Study|Still on study|48|||
42371748|NCT04143594|76238603|FG001|Overall Study|Still on study|42|||
42371749|NCT04143594|76238604|FG002|Overall Study|Still on study|48|||
42371750|NCT04143594|76238605|FG003|Overall Study|Still on study|18|||
42371751|NCT04143594|76238602|FG000|Overall Study|Withdrew consent|0|||
42371752|NCT04143594|76238603|FG001|Overall Study|Withdrew consent|6|||
42371753|NCT04143594|76238604|FG002|Overall Study|Withdrew consent|1|||
42371754|NCT04143594|76238605|FG003|Overall Study|Withdrew consent|1|||
42371755|NCT04143594|76238602|FG000|Overall Study|Lost to Follow-up|2|||
42371756|NCT04143594|76238603|FG001|Overall Study|Lost to Follow-up|2|||
42371757|NCT04143594|76238604|FG002|Overall Study|Lost to Follow-up|3|||
42371758|NCT04143594|76238605|FG003|Overall Study|Lost to Follow-up|0|||
42371759|NCT04143594|76238602|FG000|Overall Study|Investigator's discretion|1|||
42371760|NCT04143594|76238603|FG001|Overall Study|Investigator's discretion|2|||
42371761|NCT04143594|76238604|FG002|Overall Study|Investigator's discretion|0|||
42371762|NCT04143594|76238605|FG003|Overall Study|Investigator's discretion|0|||
42371763|NCT04143594|76238602|FG000|Overall Study|Lack of Efficacy|0|||
42371764|NCT04143594|76238603|FG001|Overall Study|Lack of Efficacy|1|||
42371765|NCT04143594|76238604|FG002|Overall Study|Lack of Efficacy|0|||
42371766|NCT04143594|76238605|FG003|Overall Study|Lack of Efficacy|0|||
42371767|NCT04143594|76238602|FG000|Overall Study|Protocol Violation|0|||
42371768|NCT04143594|76238603|FG001|Overall Study|Protocol Violation|0|||
42371769|NCT04143594|76238604|FG002|Overall Study|Protocol Violation|0|||
42371770|NCT04143594|76238605|FG003|Overall Study|Protocol Violation|1|||
42371771|NCT04046549|76238622|FG000|Overall Study|Adverse Event|1|||
42371772|NCT04046549|76238622|FG000|Overall Study|Physician Decision|1|||
42371773|NCT04046549|76238622|FG000|Overall Study|Withdrawal by Subject|3|||
42371774|NCT04046549|76238622|FG000|Overall Study|Other, Not Specified|5|||
42371775|NCT03403205|76238631|FG000|Overall Study|Randomized but not treated|1|||
42371776|NCT03403205|76238632|FG001|Overall Study|Randomized but not treated|0|||
42371777|NCT03403205|76238633|FG002|Overall Study|Randomized but not treated|4|||
42371778|NCT03403205|76238634|FG003|Overall Study|Randomized but not treated|2|||
42371779|NCT03403205|76238631|FG000|Overall Study|Withdrawal by Subject|4|||
42371780|NCT03403205|76238632|FG001|Overall Study|Withdrawal by Subject|2|||
42371781|NCT03403205|76238633|FG002|Overall Study|Withdrawal by Subject|2|||
42371782|NCT03403205|76238634|FG003|Overall Study|Withdrawal by Subject|1|||
42371783|NCT03403205|76238631|FG000|Overall Study|Adverse Event|4|||
42371784|NCT03403205|76238632|FG001|Overall Study|Adverse Event|0|||
42371785|NCT03403205|76238633|FG002|Overall Study|Adverse Event|1|||
42371786|NCT03403205|76238634|FG003|Overall Study|Adverse Event|0|||
42371787|NCT03403205|76238631|FG000|Overall Study|Death|1|||
42371788|NCT03403205|76238632|FG001|Overall Study|Death|0|||
42371789|NCT03403205|76238633|FG002|Overall Study|Death|1|||
42371790|NCT03403205|76238634|FG003|Overall Study|Death|0|||
42371791|NCT03403205|76238631|FG000|Overall Study|Lost to Follow-up|1|||
42371792|NCT03403205|76238632|FG001|Overall Study|Lost to Follow-up|1|||
42371793|NCT03403205|76238633|FG002|Overall Study|Lost to Follow-up|0|||
42371794|NCT03403205|76238634|FG003|Overall Study|Lost to Follow-up|0|||
42371795|NCT03403205|76238631|FG000|Overall Study|Pregnancy|1|||
42371796|NCT03403205|76238632|FG001|Overall Study|Pregnancy|0|||
42371797|NCT03403205|76238633|FG002|Overall Study|Pregnancy|0|||
42371798|NCT03403205|76238634|FG003|Overall Study|Pregnancy|0|||
42371799|NCT03403205|76238631|FG000|Overall Study|Protocol Deviation|0|||
42371800|NCT03403205|76238632|FG001|Overall Study|Protocol Deviation|1|||
42371801|NCT03403205|76238633|FG002|Overall Study|Protocol Deviation|0|||
42371802|NCT03403205|76238634|FG003|Overall Study|Protocol Deviation|0|||
42371803|NCT03375112|76238646|FG000|Overall Study|Withdrawal by Subject|3|||
42371804|NCT03375112|76238647|FG001|Overall Study|Withdrawal by Subject|0|||
42371805|NCT03122106|76238653|FG000|Overall Study|Not enough tissue|1|||
42371806|NCT03122106|76238653|FG000|Overall Study|Disease progression during screening|2|||
42371807|NCT03122106|76238653|FG000|Overall Study|Poor RNA quality for vaccine|1|||
42371808|NCT02923739|76238661|FG000|Overall Study|Withdrawal by Subject|2|||
42371809|NCT02923739|76238662|FG001|Overall Study|Withdrawal by Subject|0|||
42371810|NCT02923739|76238663|FG002|Overall Study|Withdrawal by Subject|0|||
42371811|NCT02923739|76238664|FG003|Overall Study|Withdrawal by Subject|0|||
42371812|NCT02923739|76238661|FG000|Overall Study|Failed Screening|3|||
42371813|NCT02923739|76238662|FG001|Overall Study|Failed Screening|0|||
42371814|NCT02923739|76238663|FG002|Overall Study|Failed Screening|0|||
42371815|NCT02923739|76238664|FG003|Overall Study|Failed Screening|0|||
42371816|NCT02920892|76238676|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
42371817|NCT02920892|76238677|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
42371818|NCT02920892|76238678|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
42371819|NCT02920892|76238676|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
42371820|NCT02920892|76238677|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
42371821|NCT02920892|76238678|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
42371822|NCT02920892|76238676|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
42371823|NCT02920892|76238677|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
42371824|NCT02920892|76238678|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
42371825|NCT02920892|76238676|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
42371826|NCT02920892|76238677|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
42371827|NCT02920892|76238678|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
42103419|NCT00652626|75914379|FG006|Initial Treatment Phase|Sponsor Request|0|||
42200736|NCT02112916|76012694|FG001|Overall Study|Physician Decision|72|||
42371828|NCT02920892|76238676|FG000|Placebo-Controlled Period|Physician Decision|0|||
42371829|NCT02920892|76238677|FG001|Placebo-Controlled Period|Physician Decision|0|||
42371830|NCT02920892|76238678|FG002|Placebo-Controlled Period|Physician Decision|1|||
42371831|NCT02920892|76238676|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
42371832|NCT02920892|76238677|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
42371833|NCT02920892|76238678|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
42371834|NCT02920892|76238676|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
42371835|NCT02920892|76238677|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
42371836|NCT02920892|76238678|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
42371837|NCT02920892|76238676|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
42371838|NCT02920892|76238677|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
42371839|NCT02920892|76238678|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
42371840|NCT02509052|76238689|FG000|Overall Study|Non compliance|0|||
42371841|NCT02509052|76238690|FG001|Overall Study|Non compliance|0|||
42371842|NCT02509052|76238691|FG002|Overall Study|Non compliance|1|||
42371843|NCT02365597|76238704|FG000|Overall Study|Lost to Follow-up|0|||
42371844|NCT02365597|76238705|FG001|Overall Study|Lost to Follow-up|1|||
42371845|NCT02365597|76238706|FG002|Overall Study|Lost to Follow-up|0|||
42371846|NCT02365597|76238707|FG003|Overall Study|Lost to Follow-up|1|||
42371847|NCT02365597|76238704|FG000|Overall Study|Withdrawal by Subject|1|||
42371848|NCT02365597|76238705|FG001|Overall Study|Withdrawal by Subject|8|||
42371849|NCT02365597|76238706|FG002|Overall Study|Withdrawal by Subject|5|||
42371850|NCT02365597|76238707|FG003|Overall Study|Withdrawal by Subject|1|||
42371851|NCT02365597|76238704|FG000|Overall Study|Sponsor's decision|1|||
42371852|NCT02365597|76238705|FG001|Overall Study|Sponsor's decision|3|||
42371853|NCT02365597|76238706|FG002|Overall Study|Sponsor's decision|13|||
42200737|NCT02112916|76012695|FG002|Overall Study|Physician Decision|24|||
42200738|NCT02112916|76012696|FG003|Overall Study|Physician Decision|15|||
42371854|NCT02365597|76238707|FG003|Overall Study|Sponsor's decision|0|||
42371855|NCT02365597|76238704|FG000|Overall Study|Other|0|||
42371856|NCT02365597|76238705|FG001|Overall Study|Other|4|||
42371857|NCT02365597|76238706|FG002|Overall Study|Other|0|||
42371858|NCT02365597|76238707|FG003|Overall Study|Other|0|||
42371859|NCT02365597|76238704|FG000|Overall Study|Enrolled but not treated|0|||
42371860|NCT02365597|76238705|FG001|Overall Study|Enrolled but not treated|1|||
42371861|NCT02365597|76238706|FG002|Overall Study|Enrolled but not treated|1|||
42371862|NCT02365597|76238707|FG003|Overall Study|Enrolled but not treated|0|||
42371863|NCT02365597|76238704|FG000|Overall Study|Ongoing|0|||
42371864|NCT02365597|76238705|FG001|Overall Study|Ongoing|0|||
42371865|NCT02365597|76238706|FG002|Overall Study|Ongoing|0|||
42371866|NCT02365597|76238707|FG003|Overall Study|Ongoing|17|||
42103420|NCT00652626|75914373|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
42103421|NCT00652626|75914374|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
42200739|NCT02112916|76012693|FG000|Overall Study|Withdrawal by Subject|5|||
42371867|NCT02220894|76238724|FG000|Overall Study|Adverse Event|127|||
42371868|NCT02220894|76238725|FG001|Overall Study|Adverse Event|74|||
42371869|NCT02220894|76238724|FG000|Overall Study|Death|418|||
42371870|NCT02220894|76238725|FG001|Overall Study|Death|508|||
42371871|NCT02220894|76238724|FG000|Overall Study|Lost to Follow-up|0|||
42103422|NCT00652626|75914375|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
42200740|NCT02112916|76012694|FG001|Overall Study|Withdrawal by Subject|3|||
42371872|NCT02220894|76238725|FG001|Overall Study|Lost to Follow-up|4|||
42371873|NCT02220894|76238724|FG000|Overall Study|Site Terminated by Sponsor|2|||
42371874|NCT02220894|76238725|FG001|Overall Study|Site Terminated by Sponsor|0|||
42371875|NCT02220894|76238724|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
42371876|NCT02220894|76238725|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
42371877|NCT02220894|76238724|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42371878|NCT02220894|76238725|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
42371879|NCT02220894|76238724|FG000|Overall Study|Withdrawal by Subject|10|||
42371880|NCT02220894|76238725|FG001|Overall Study|Withdrawal by Subject|9|||
42371881|NCT02068092|76238732|FG000|Overall Study|Physician Decision|2|||
42371882|NCT02068092|76238732|FG000|Overall Study|Adverse Event|2|||
42371883|NCT02068092|76238732|FG000|Overall Study|Lost to Follow-up|4|||
42371884|NCT02068092|76238732|FG000|Overall Study|Withdrawal by Subject|2|||
42371885|NCT01959672|76238736|FG000|Overall Study|Death|1|||
42371886|NCT00071760|76238764|FG000|Overall Study|Adverse Event|2|||
42371887|NCT00071760|76238765|FG001|Overall Study|Adverse Event|1|||
42371888|NCT00071760|76238764|FG000|Overall Study|Lost to Follow-up|0|||
42371889|NCT00071760|76238765|FG001|Overall Study|Lost to Follow-up|3|||
42371890|NCT00071760|76238764|FG000|Overall Study|Protocol Violation|1|||
42371891|NCT00071760|76238765|FG001|Overall Study|Protocol Violation|0|||
42371892|NCT00071760|76238764|FG000|Overall Study|Withdrawal by Subject|0|||
42371893|NCT00071760|76238765|FG001|Overall Study|Withdrawal by Subject|1|||
42371894|NCT00071760|76238764|FG000|Overall Study|Insufficient Viral Load Response|1|||
42371895|NCT00071760|76238765|FG001|Overall Study|Insufficient Viral Load Response|1|||
42371896|NCT00071760|76238764|FG000|Overall Study|Lack of availability of RTV|1|||
42371897|NCT00071760|76238765|FG001|Overall Study|Lack of availability of RTV|0|||
42371898|NCT00071760|76238764|FG000|Overall Study|Physician Decision|2|||
42371899|NCT00071760|76238765|FG001|Overall Study|Physician Decision|1|||
42371900|NCT00071760|76238764|FG000|Overall Study|Relocation|0|||
42371901|NCT00071760|76238765|FG001|Overall Study|Relocation|1|||
42371902|NCT01605227|76238783|FG000|Overall Study|Did not receive study treatment|2|||
42371903|NCT01605227|76238784|FG001|Overall Study|Did not receive study treatment|3|||
42371904|NCT01605227|76238783|FG000|Overall Study|Adverse Event|228|||
42371905|NCT01605227|76238784|FG001|Overall Study|Adverse Event|42|||
42371906|NCT01605227|76238783|FG000|Overall Study|Progressive Disease|132|||
42371907|NCT01605227|76238784|FG001|Overall Study|Progressive Disease|128|||
42371908|NCT01605227|76238783|FG000|Overall Study|Clinical Deterioration|227|||
42371909|NCT01605227|76238784|FG001|Overall Study|Clinical Deterioration|133|||
42371910|NCT01605227|76238783|FG000|Overall Study|Lost to Follow-up|1|||
42371911|NCT01605227|76238784|FG001|Overall Study|Lost to Follow-up|0|||
42371912|NCT01605227|76238783|FG000|Overall Study|Protocol Violation|1|||
42371913|NCT01605227|76238784|FG001|Overall Study|Protocol Violation|0|||
42371914|NCT01605227|76238783|FG000|Overall Study|Physician Decision|9|||
42371915|NCT01605227|76238784|FG001|Overall Study|Physician Decision|7|||
42371916|NCT01605227|76238783|FG000|Overall Study|Withdrawal by Subject|18|||
42371917|NCT01605227|76238784|FG001|Overall Study|Withdrawal by Subject|14|||
42371918|NCT01605227|76238783|FG000|Overall Study|Sponsor Decision|2|||
42371919|NCT01605227|76238784|FG001|Overall Study|Sponsor Decision|0|||
42371920|NCT01605227|76238783|FG000|Overall Study|Started New Therapy|1|||
42371921|NCT01605227|76238784|FG001|Overall Study|Started New Therapy|0|||
42371922|NCT01605227|76238783|FG000|Overall Study|Subject Decision|0|||
42371923|NCT01605227|76238784|FG001|Overall Study|Subject Decision|1|||
42371924|NCT01605227|76238783|FG000|Overall Study|Dose Held >6 weeks|0|||
42371925|NCT01605227|76238784|FG001|Overall Study|Dose Held >6 weeks|1|||
42371926|NCT01709513|76238793|FG000|Overall Study|Randomized but not treated|0|||
42371927|NCT01709513|76238794|FG001|Overall Study|Randomized but not treated|1|||
42371928|NCT01709513|76238795|FG002|Overall Study|Randomized but not treated|0|||
42371929|NCT01709513|76238793|FG000|Overall Study|Adverse Event|16|||
42371930|NCT01709513|76238794|FG001|Overall Study|Adverse Event|31|||
42371931|NCT01709513|76238795|FG002|Overall Study|Adverse Event|23|||
42371932|NCT01709513|76238793|FG000|Overall Study|Poor compliance to protocol|2|||
42371933|NCT01709513|76238794|FG001|Overall Study|Poor compliance to protocol|0|||
42371934|NCT01709513|76238795|FG002|Overall Study|Poor compliance to protocol|0|||
42103423|NCT00652626|75914376|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
42103424|NCT00652626|75914377|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
42103425|NCT00652626|75914378|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
42103426|NCT00652626|75914379|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
42371935|NCT01709513|76238793|FG000|Overall Study|Other|3|||
42371936|NCT01709513|76238794|FG001|Overall Study|Other|11|||
42371937|NCT01709513|76238795|FG002|Overall Study|Other|7|||
42371938|NCT01605071|76238808|FG000|Overall Study|Withdrawal by Subject|3|||
42371939|NCT01605071|76238809|FG001|Overall Study|Withdrawal by Subject|2|||
42371940|NCT02710422|76238819|FG000|Overall Study|Termination of study|9|||
42371941|NCT02710422|76238820|FG001|Overall Study|Termination of study|9|||
42371942|NCT01706159|76238830|FG000|Overall Study|Withdrawal Criteria|2|||
42371943|NCT01706159|76238831|FG001|Overall Study|Withdrawal Criteria|1|||
42371944|NCT01706159|76238830|FG000|Overall Study|Unclassified|6|||
42371945|NCT01706159|76238831|FG001|Overall Study|Unclassified|1|||
42371946|NCT01706003|76238839|FG000|Overall Study|Withdrawal by Subject|2|||
42371947|NCT01706003|76238840|FG001|Overall Study|Withdrawal by Subject|0|||
42371948|NCT01706003|76238839|FG000|Overall Study|Not scheduled|3|||
42371949|NCT01706003|76238840|FG001|Overall Study|Not scheduled|0|||
42371950|NCT01706003|76238839|FG000|Overall Study|Lost to Follow-up|6|||
42371951|NCT01706003|76238840|FG001|Overall Study|Lost to Follow-up|4|||
42371952|NCT01705691|76238848|FG000|Overall Study|Death|1|||
42371953|NCT01705691|76238849|FG001|Overall Study|Death|2|||
42371954|NCT01705691|76238848|FG000|Overall Study|Withdrawal by Subject|1|||
42371955|NCT01705691|76238849|FG001|Overall Study|Withdrawal by Subject|2|||
42371956|NCT01705691|76238848|FG000|Overall Study|Lost to Follow-up|1|||
42371957|NCT01705691|76238849|FG001|Overall Study|Lost to Follow-up|1|||
42371958|NCT01705691|76238848|FG000|Overall Study|Other|0|||
42371959|NCT01705691|76238849|FG001|Overall Study|Other|1|||
42371960|NCT03766906|76238855|FG000|Overall Study|Withdrawal by Subject|6|||
42371961|NCT01705145|76238859|FG000|Part B|Adverse Event|1|||
42371962|NCT01704755|76238877|FG000|Overall Study|Adverse Event|4|||
42371963|NCT01704755|76238878|FG001|Overall Study|Adverse Event|1|||
42371964|NCT01704755|76238877|FG000|Overall Study|Lost to Follow-up|3|||
42371965|NCT01704755|76238878|FG001|Overall Study|Lost to Follow-up|4|||
42371966|NCT01704755|76238877|FG000|Overall Study|Withdrew consent|1|||
42371967|NCT01704755|76238878|FG001|Overall Study|Withdrew consent|1|||
42371968|NCT01704755|76238877|FG000|Overall Study|Other (not specified)|3|||
42371969|NCT01704755|76238878|FG001|Overall Study|Other (not specified)|1|||
42371970|NCT01704755|76238877|FG000|Overall Study|Withdrew consent and personal issues|1|||
42371971|NCT01704755|76238878|FG001|Overall Study|Withdrew consent and personal issues|0|||
42371972|NCT01704599|76238884|FG000|Overall Study|Adverse Event|1|||
42371973|NCT03599518|76238916|FG000|Overall Study|Clinical progression|0|||
42371974|NCT03599518|76238917|FG001|Overall Study|Clinical progression|0|||
42371975|NCT03599518|76238918|FG002|Overall Study|Clinical progression|0|||
42371976|NCT03599518|76238919|FG003|Overall Study|Clinical progression|0|||
42371977|NCT03599518|76238920|FG004|Overall Study|Clinical progression|1|||
42371978|NCT03599518|76238916|FG000|Overall Study|Adverse Event|0|||
42371979|NCT03599518|76238917|FG001|Overall Study|Adverse Event|0|||
42371980|NCT03599518|76238918|FG002|Overall Study|Adverse Event|0|||
42371981|NCT03599518|76238919|FG003|Overall Study|Adverse Event|0|||
42371982|NCT03599518|76238920|FG004|Overall Study|Adverse Event|1|||
42371983|NCT03599518|76238916|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
42371984|NCT03599518|76238917|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
42371985|NCT03599518|76238918|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
42371986|NCT03599518|76238919|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
42371987|NCT03599518|76238920|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
42371988|NCT03599518|76238916|FG000|Overall Study|Participant withdrawal from study treatment|0|||
42371989|NCT03599518|76238917|FG001|Overall Study|Participant withdrawal from study treatment|0|||
42371990|NCT03599518|76238918|FG002|Overall Study|Participant withdrawal from study treatment|1|||
42371991|NCT03599518|76238919|FG003|Overall Study|Participant withdrawal from study treatment|0|||
42371992|NCT03599518|76238920|FG004|Overall Study|Participant withdrawal from study treatment|0|||
42371993|NCT02709486|76238997|FG000|Overall Study|Adverse Event|2|||
42371994|NCT02709486|76238998|FG001|Overall Study|Adverse Event|5|||
42371995|NCT02709486|76238999|FG002|Overall Study|Adverse Event|3|||
42371996|NCT02709486|76238997|FG000|Overall Study|Death|0|||
42371997|NCT02709486|76238998|FG001|Overall Study|Death|0|||
42371998|NCT02709486|76238999|FG002|Overall Study|Death|2|||
42371999|NCT02709486|76238997|FG000|Overall Study|Insufficient clinical response|7|||
42372000|NCT02709486|76238998|FG001|Overall Study|Insufficient clinical response|3|||
42372001|NCT02709486|76238999|FG002|Overall Study|Insufficient clinical response|3|||
42372002|NCT02709486|76238997|FG000|Overall Study|Lost to Follow-up|3|||
42372003|NCT02709486|76238998|FG001|Overall Study|Lost to Follow-up|2|||
42200741|NCT02112916|76012695|FG002|Overall Study|Withdrawal by Subject|1|||
42372004|NCT02709486|76238999|FG002|Overall Study|Lost to Follow-up|2|||
42372005|NCT02709486|76238997|FG000|Overall Study|Other|0|||
42372006|NCT02709486|76238998|FG001|Overall Study|Other|2|||
42372007|NCT02709486|76238999|FG002|Overall Study|Other|3|||
42372008|NCT02709486|76238997|FG000|Overall Study|Withdrawal by Subject|32|||
42372009|NCT02709486|76238998|FG001|Overall Study|Withdrawal by Subject|22|||
42372010|NCT02709486|76238999|FG002|Overall Study|Withdrawal by Subject|32|||
42372011|NCT03110770|76239016|FG000|Overall Study|Death|1|||
42372012|NCT03110770|76239017|FG001|Overall Study|Death|0|||
42372013|NCT03110770|76239018|FG002|Overall Study|Death|0|||
42372014|NCT03110770|76239019|FG003|Overall Study|Death|1|||
42372015|NCT03110770|76239020|FG004|Overall Study|Death|0|||
42372016|NCT03110770|76239016|FG000|Overall Study|Enrolled but did not receive product|0|||
42372017|NCT03110770|76239017|FG001|Overall Study|Enrolled but did not receive product|0|||
42372018|NCT03110770|76239018|FG002|Overall Study|Enrolled but did not receive product|0|||
42372019|NCT03110770|76239019|FG003|Overall Study|Enrolled but did not receive product|8|||
42372020|NCT03110770|76239020|FG004|Overall Study|Enrolled but did not receive product|7|||
42372021|NCT03110770|76239016|FG000|Overall Study|Lost to Follow-up|0|||
42372022|NCT03110770|76239017|FG001|Overall Study|Lost to Follow-up|0|||
42372023|NCT03110770|76239018|FG002|Overall Study|Lost to Follow-up|0|||
42372024|NCT03110770|76239019|FG003|Overall Study|Lost to Follow-up|53|||
42372025|NCT03110770|76239020|FG004|Overall Study|Lost to Follow-up|45|||
42372026|NCT03110770|76239016|FG000|Overall Study|Investigator Decision|0|||
42372027|NCT03110770|76239017|FG001|Overall Study|Investigator Decision|0|||
42372028|NCT03110770|76239018|FG002|Overall Study|Investigator Decision|0|||
42372029|NCT03110770|76239019|FG003|Overall Study|Investigator Decision|5|||
42372030|NCT03110770|76239020|FG004|Overall Study|Investigator Decision|3|||
42372031|NCT03110770|76239016|FG000|Overall Study|Withdrawal by Subject|0|||
42372032|NCT03110770|76239017|FG001|Overall Study|Withdrawal by Subject|0|||
42372033|NCT03110770|76239018|FG002|Overall Study|Withdrawal by Subject|0|||
42372034|NCT03110770|76239019|FG003|Overall Study|Withdrawal by Subject|24|||
42372035|NCT03110770|76239020|FG004|Overall Study|Withdrawal by Subject|24|||
42372036|NCT03110770|76239016|FG000|Overall Study|Moved from area|5|||
42372037|NCT03110770|76239017|FG001|Overall Study|Moved from area|0|||
42372038|NCT03110770|76239018|FG002|Overall Study|Moved from area|2|||
42372039|NCT03110770|76239019|FG003|Overall Study|Moved from area|42|||
42372040|NCT03110770|76239020|FG004|Overall Study|Moved from area|43|||
42372041|NCT03110770|76239016|FG000|Overall Study|Illness/Injury unrelated to product|0|||
42372042|NCT03110770|76239017|FG001|Overall Study|Illness/Injury unrelated to product|0|||
42372043|NCT03110770|76239018|FG002|Overall Study|Illness/Injury unrelated to product|0|||
42372044|NCT03110770|76239019|FG003|Overall Study|Illness/Injury unrelated to product|0|||
42372045|NCT03110770|76239020|FG004|Overall Study|Illness/Injury unrelated to product|1|||
42372046|NCT00703326|76239226|FG000|Overall Study|Lost to Follow-up|47|||
42372047|NCT00703326|76239227|FG001|Overall Study|Lost to Follow-up|18|||
42372048|NCT00703326|76239226|FG000|Overall Study|Withdrawal by Subject|54|||
42372049|NCT00703326|76239227|FG001|Overall Study|Withdrawal by Subject|20|||
42372050|NCT00703326|76239226|FG000|Overall Study|Adverse Event|1|||
42372051|NCT00703326|76239227|FG001|Overall Study|Adverse Event|0|||
42372052|NCT04868500|76239280|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
42372053|NCT04868500|76239281|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
42372054|NCT04868500|76239280|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
42372055|NCT04868500|76239281|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
42372056|NCT04372186|76239289|FG000|Overall Study|Death|24|||
42372057|NCT04372186|76239290|FG001|Overall Study|Death|11|||
42372058|NCT04372186|76239289|FG000|Overall Study|Transferred to a different facility for care|0|||
42372059|NCT04372186|76239290|FG001|Overall Study|Transferred to a different facility for care|2|||
42372060|NCT04317040|76239320|FG000|Overall Study|Lost to Follow-up|2|||
42372061|NCT04317040|76239321|FG001|Overall Study|Lost to Follow-up|0|||
42372062|NCT04317040|76239320|FG000|Overall Study|Death|16|||
42372063|NCT04317040|76239321|FG001|Overall Study|Death|18|||
42372064|NCT04317040|76239320|FG000|Overall Study|Withdrawal by Subject|0|||
42372065|NCT04317040|76239321|FG001|Overall Study|Withdrawal by Subject|1|||
42372066|NCT04317040|76239320|FG000|Overall Study|Incomplete assessments|0|||
42372067|NCT04317040|76239321|FG001|Overall Study|Incomplete assessments|1|||
42372068|NCT00703014|76239401|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
42372069|NCT00703014|76239402|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
42372070|NCT00703014|76239403|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
42372071|NCT00703014|76239404|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
42372072|NCT00703014|76239401|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
42372073|NCT00703014|76239402|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
42372074|NCT00703014|76239403|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
42372075|NCT00703014|76239404|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
42372076|NCT03915496|76239452|FG000|Overall Study|Adverse Event|2|||
42372077|NCT03915496|76239453|FG001|Overall Study|Adverse Event|1|||
42372078|NCT03915496|76239454|FG002|Overall Study|Adverse Event|2|||
42372079|NCT02709330|76239471|FG000|Overall Study|Death|5|||
42372080|NCT02709330|76239472|FG001|Overall Study|Death|0|||
42372081|NCT02709330|76239471|FG000|Overall Study|Lost to Follow-up|2|||
42372082|NCT02709330|76239472|FG001|Overall Study|Lost to Follow-up|0|||
42372083|NCT02709330|76239471|FG000|Overall Study|Physician Decision|2|||
42372084|NCT02709330|76239472|FG001|Overall Study|Physician Decision|0|||
42372085|NCT02709330|76239471|FG000|Overall Study|Withdrawal by Subject|4|||
42372086|NCT02709330|76239472|FG001|Overall Study|Withdrawal by Subject|0|||
42372087|NCT02709096|76239480|FG000|Overall Study|non-compliance|1|||
42372088|NCT02709096|76239481|FG001|Overall Study|non-compliance|1|||
42372089|NCT01372410|76239487|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
42372090|NCT01372410|76239488|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
42372091|NCT01372410|76239489|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
42372092|NCT01372410|76239490|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
42372093|NCT01372410|76239491|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
42372094|NCT01372410|76239492|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
42372095|NCT01372410|76239493|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
42372096|NCT01372410|76239494|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
42372097|NCT01372410|76239487|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
42372098|NCT01372410|76239488|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
42372099|NCT01372410|76239489|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
42372100|NCT01372410|76239490|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
42372101|NCT01372410|76239491|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
42372102|NCT01372410|76239492|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
42372103|NCT01372410|76239493|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
42372104|NCT01372410|76239494|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
42372105|NCT01372410|76239487|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42372106|NCT01372410|76239488|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42372107|NCT01372410|76239489|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42372108|NCT01372410|76239490|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42372109|NCT01372410|76239491|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
42372110|NCT01372410|76239492|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42372111|NCT01372410|76239493|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42372112|NCT01372410|76239494|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
42372113|NCT01372410|76239487|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
42372114|NCT01372410|76239488|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
42372115|NCT01372410|76239489|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
42372116|NCT01372410|76239490|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
42372117|NCT01372410|76239491|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
42372118|NCT01372410|76239492|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
42372119|NCT01372410|76239493|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
42372120|NCT01372410|76239494|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
42372121|NCT01372410|76239487|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
42372122|NCT01372410|76239488|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
42372123|NCT01372410|76239489|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
42372124|NCT01372410|76239490|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
42372125|NCT01372410|76239491|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
42372126|NCT01372410|76239492|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
42372127|NCT01372410|76239493|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
42372128|NCT01372410|76239494|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
42372129|NCT01372410|76239487|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
42372130|NCT01372410|76239488|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
42372131|NCT01372410|76239489|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
42372132|NCT01372410|76239490|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
42372133|NCT01372410|76239491|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
42372134|NCT01372410|76239492|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
42372135|NCT01372410|76239493|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
42372136|NCT01372410|76239494|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
42372137|NCT01372410|76239487|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
42372138|NCT01372410|76239488|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
42372139|NCT01372410|76239489|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
42372140|NCT01372410|76239490|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
42372141|NCT01372410|76239491|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
42372142|NCT01372410|76239492|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
42372143|NCT01372410|76239493|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
42372144|NCT01372410|76239494|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
42372145|NCT01372410|76239487|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
42372146|NCT01372410|76239488|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
42372147|NCT01372410|76239489|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
42372148|NCT01372410|76239490|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
42372149|NCT01372410|76239491|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
42372150|NCT01372410|76239492|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
42372151|NCT01372410|76239493|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
42372152|NCT01372410|76239494|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
42372153|NCT01372410|76239487|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
42372154|NCT01372410|76239488|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
42372155|NCT01372410|76239489|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
42372156|NCT01372410|76239490|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
42372157|NCT01372410|76239491|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
42372158|NCT01372410|76239492|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
42372159|NCT01372410|76239493|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
42372160|NCT01372410|76239494|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
42372161|NCT01372410|76239487|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
42372162|NCT01372410|76239488|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
42372163|NCT01372410|76239489|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
42372164|NCT01372410|76239490|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
42372165|NCT01372410|76239491|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
42372166|NCT01372410|76239492|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
42372167|NCT01372410|76239493|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
42372168|NCT01372410|76239494|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
42372169|NCT01704287|76239532|FG000|Initial Treatment Period|Death|139|||
42372170|NCT01704287|76239533|FG001|Initial Treatment Period|Death|129|||
42372171|NCT01704287|76239534|FG002|Initial Treatment Period|Death|71|||
42372172|NCT01704287|76239535|FG003|Initial Treatment Period|Death|0|||
42372173|NCT01704287|76239536|FG004|Initial Treatment Period|Death|0|||
42372174|NCT01704287|76239532|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
42372175|NCT01704287|76239533|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
42372176|NCT01704287|76239534|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
42372177|NCT01704287|76239535|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
42372178|NCT01704287|76239536|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
42372179|NCT01704287|76239532|FG000|Initial Treatment Period|Lost to Follow-up|5|||
42372180|NCT01704287|76239533|FG001|Initial Treatment Period|Lost to Follow-up|3|||
42372181|NCT01704287|76239534|FG002|Initial Treatment Period|Lost to Follow-up|0|||
42372182|NCT01704287|76239535|FG003|Initial Treatment Period|Lost to Follow-up|0|||
42372183|NCT01704287|76239536|FG004|Initial Treatment Period|Lost to Follow-up|0|||
42372184|NCT01704287|76239532|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
42372185|NCT01704287|76239533|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
42372186|NCT01704287|76239534|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
42372187|NCT01704287|76239535|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
42372188|NCT01704287|76239536|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
42372189|NCT01704287|76239532|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
42372190|NCT01704287|76239533|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
42372191|NCT01704287|76239534|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
42372192|NCT01704287|76239535|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
42372193|NCT01704287|76239536|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
42372194|NCT01704287|76239532|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
42372195|NCT01704287|76239533|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
42372196|NCT01704287|76239534|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
42372197|NCT01704287|76239535|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
42372198|NCT01704287|76239536|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
42372199|NCT01704287|76239532|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
42372200|NCT01704287|76239533|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
42372201|NCT01704287|76239534|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
42372202|NCT01704287|76239535|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
42372203|NCT01704287|76239536|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
42372204|NCT01682837|76239564|FG000|Baseline|Withdrawal by Subject|5|||
42372205|NCT01703819|76239601|FG000|Overall Study|Adverse Event|0|||
42372206|NCT01703819|76239602|FG001|Overall Study|Adverse Event|1|||
42372207|NCT01703819|76239601|FG000|Overall Study|Withdrawal by Subject|0|||
42372208|NCT01703819|76239602|FG001|Overall Study|Withdrawal by Subject|1|||
42372209|NCT01682759|76239614|FG000|Overall Study|Death|2|||
42372210|NCT01682759|76239615|FG001|Overall Study|Death|1|||
42372211|NCT01682759|76239614|FG000|Overall Study|Lost to Follow-up|10|||
42372212|NCT01682759|76239615|FG001|Overall Study|Lost to Follow-up|13|||
42372213|NCT01682759|76239614|FG000|Overall Study|Physician Decision|1|||
42372214|NCT01682759|76239615|FG001|Overall Study|Physician Decision|1|||
42372215|NCT01682759|76239614|FG000|Overall Study|Withdrawal by Subject|56|||
42372216|NCT01682759|76239615|FG001|Overall Study|Withdrawal by Subject|55|||
42372217|NCT01682681|76239625|FG000|Overall Study|Lack of Efficacy|62|||
42372218|NCT01682681|76239625|FG000|Overall Study|Withdrawal by Subject|1|||
42372219|NCT01682681|76239625|FG000|Overall Study|Moved to other hospital|10|||
42372220|NCT01682681|76239625|FG000|Overall Study|Lost to Follow-up|174|||
42372221|NCT01682681|76239625|FG000|Overall Study|Adverse Event|46|||
42372222|NCT01682681|76239625|FG000|Overall Study|tapering of topiramate|5|||
42372223|NCT01682681|76239625|FG000|Overall Study|Other|21|||
42372224|NCT01682681|76239625|FG000|Overall Study|Low compliance|13|||
42372225|NCT01682603|76239629|FG000|Overall Study|Lost to Follow-up|3|||
42372226|NCT01682213|76239645|FG000|Overall Study|Withdrawal by Subject|2|||
42372227|NCT01703741|76239654|FG000|Overall Study|Withdrawal by Subject|6|||
42372228|NCT01703741|76239654|FG000|Overall Study|Adverse Event|2|||
42372229|NCT01703741|76239654|FG000|Overall Study|Physician Decision|2|||
42372230|NCT01703741|76239654|FG000|Overall Study|Protocol Violation|1|||
42372231|NCT01703741|76239654|FG000|Overall Study|Lost to Follow-up|3|||
42372232|NCT01703741|76239654|FG000|Overall Study|Subject did not want to continue|2|||
42372233|NCT01703741|76239654|FG000|Overall Study|Subject cannot comply with study visits|1|||
42372234|NCT01703741|76239654|FG000|Overall Study|Subject started testosterone injections|1|||
42372235|NCT01681511|76239660|FG000|Overall Study|No Treatment Received|1|||
42372236|NCT01681511|76239661|FG001|Overall Study|No Treatment Received|3|||
42372237|NCT01681511|76239660|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
42372238|NCT01681511|76239661|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
42372239|NCT01681511|76239660|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
42372240|NCT01681511|76239661|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
42372241|NCT01681511|76239660|FG000|Overall Study|No Daily Urine Sample Collected|0|||
42372242|NCT01681511|76239661|FG001|Overall Study|No Daily Urine Sample Collected|1|||
42372243|NCT01681511|76239660|FG000|Overall Study|No post-catheter sample collected|11|||
42372244|NCT01681511|76239661|FG001|Overall Study|No post-catheter sample collected|4|||
42372245|NCT01681433|76239669|FG000|Overall Study|Lack of Efficacy|23|||
42372246|NCT01681433|76239670|FG001|Overall Study|Lack of Efficacy|23|||
42372247|NCT01681433|76239669|FG000|Overall Study|Withdrawal by Subject|5|||
42372248|NCT01681433|76239670|FG001|Overall Study|Withdrawal by Subject|5|||
42372249|NCT01681433|76239669|FG000|Overall Study|Protocol Violation|2|||
42372250|NCT01681433|76239670|FG001|Overall Study|Protocol Violation|0|||
42372251|NCT01681433|76239669|FG000|Overall Study|Adverse Event|2|||
42372252|NCT01681433|76239670|FG001|Overall Study|Adverse Event|4|||
42372253|NCT01681433|76239669|FG000|Overall Study|Lost to Follow-up|0|||
42372254|NCT01681433|76239670|FG001|Overall Study|Lost to Follow-up|1|||
42372255|NCT01681277|76239681|FG000|Overall Study|Adverse Event|1|||
42372256|NCT01681277|76239682|FG001|Overall Study|Adverse Event|0|||
42372257|NCT01681277|76239683|FG002|Overall Study|Adverse Event|0|||
42372258|NCT01681277|76239684|FG003|Overall Study|Adverse Event|0|||
42372259|NCT01681277|76239685|FG004|Overall Study|Adverse Event|0|||
42372260|NCT01703117|76239703|FG000|Overall Study|Adverse Event|4|||
42372261|NCT01703117|76239704|FG001|Overall Study|Adverse Event|3|||
42372262|NCT01703117|76239703|FG000|Overall Study|Withdrawal by Subject|0|||
42372263|NCT01703117|76239704|FG001|Overall Study|Withdrawal by Subject|1|||
42372264|NCT01702961|76239712|FG000|Overall Study|Additional treatment|3|||
42372265|NCT01702961|76239712|FG000|Overall Study|Progressive disease|5|||
42372266|NCT01702961|76239712|FG000|Overall Study|Relapse|20|||
42372267|NCT01702961|76239712|FG000|Overall Study|Death|6|||
42372268|NCT01702961|76239712|FG000|Overall Study|Lost to Follow-up|2|||
42372269|NCT01702961|76239712|FG000|Overall Study|Ongoing|11|||
42372270|NCT01593917|76239716|FG000|Overall Study|Death|67|||
42372271|NCT01593917|76239716|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
42372272|NCT01593917|76239716|FG000|Overall Study|Withdrawal by Subject|23|||
42372273|NCT01593917|76239716|FG000|Overall Study|Lost to Follow-up|12|||
42372274|NCT01593917|76239716|FG000|Overall Study|Protocol Violation|5|||
42372275|NCT01593917|76239716|FG000|Overall Study|Physician Decision|3|||
42372276|NCT01593761|76239720|FG000|Overall Study|Lost to Follow-up|1|||
42372277|NCT01593761|76239720|FG000|Overall Study|culture negative for MRSA at baseline|5|||
42372278|NCT01593761|76239720|FG000|Overall Study|positive for hepatitis C virus|1|||
42372279|NCT01593761|76239720|FG000|Overall Study|secondary cellulitis|1|||
42372280|NCT02706834|76239741|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
42372281|NCT02706834|76239742|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
42372282|NCT02706834|76239743|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
42372283|NCT02706834|76239744|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
42372284|NCT02706834|76239745|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
42372285|NCT02706834|76239746|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
42372286|NCT02706834|76239747|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
42372287|NCT02706834|76239748|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
42372288|NCT02706834|76239749|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
42372289|NCT02706834|76239750|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
42372290|NCT02706834|76239751|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
42372291|NCT02706834|76239741|FG000|Overall Study|Lost to Follow-up|0|||
42372292|NCT02706834|76239742|FG001|Overall Study|Lost to Follow-up|0|||
42372293|NCT02706834|76239743|FG002|Overall Study|Lost to Follow-up|1|||
42372294|NCT02706834|76239744|FG003|Overall Study|Lost to Follow-up|0|||
42372295|NCT02706834|76239745|FG004|Overall Study|Lost to Follow-up|0|||
42372296|NCT02706834|76239746|FG005|Overall Study|Lost to Follow-up|0|||
42372297|NCT02706834|76239747|FG006|Overall Study|Lost to Follow-up|0|||
42372298|NCT02706834|76239748|FG007|Overall Study|Lost to Follow-up|0|||
42103427|NCT00652626|75914373|FG000|Extension Phase|Withdrawal by Subject|0|||
42372299|NCT02706834|76239749|FG008|Overall Study|Lost to Follow-up|0|||
42372300|NCT02706834|76239750|FG009|Overall Study|Lost to Follow-up|0|||
42372301|NCT02706834|76239751|FG010|Overall Study|Lost to Follow-up|0|||
42372302|NCT02706834|76239741|FG000|Overall Study|Voluntary Withdrawal|1|||
42372303|NCT02706834|76239742|FG001|Overall Study|Voluntary Withdrawal|0|||
42372304|NCT02706834|76239743|FG002|Overall Study|Voluntary Withdrawal|0|||
42372305|NCT02706834|76239744|FG003|Overall Study|Voluntary Withdrawal|0|||
42372306|NCT02706834|76239745|FG004|Overall Study|Voluntary Withdrawal|0|||
42372307|NCT02706834|76239746|FG005|Overall Study|Voluntary Withdrawal|0|||
42372308|NCT02706834|76239747|FG006|Overall Study|Voluntary Withdrawal|0|||
42372309|NCT02706834|76239748|FG007|Overall Study|Voluntary Withdrawal|0|||
42372310|NCT02706834|76239749|FG008|Overall Study|Voluntary Withdrawal|0|||
42372311|NCT02706834|76239750|FG009|Overall Study|Voluntary Withdrawal|1|||
42372312|NCT02706834|76239751|FG010|Overall Study|Voluntary Withdrawal|0|||
42372313|NCT02706834|76239741|FG000|Overall Study|Other Reason Not Specified|1|||
42372314|NCT02706834|76239742|FG001|Overall Study|Other Reason Not Specified|0|||
42372315|NCT02706834|76239743|FG002|Overall Study|Other Reason Not Specified|0|||
42372316|NCT02706834|76239744|FG003|Overall Study|Other Reason Not Specified|0|||
42372317|NCT02706834|76239745|FG004|Overall Study|Other Reason Not Specified|1|||
42372318|NCT02706834|76239746|FG005|Overall Study|Other Reason Not Specified|0|||
42372319|NCT02706834|76239747|FG006|Overall Study|Other Reason Not Specified|0|||
42372320|NCT02706834|76239748|FG007|Overall Study|Other Reason Not Specified|0|||
42372321|NCT02706834|76239749|FG008|Overall Study|Other Reason Not Specified|0|||
42372322|NCT02706834|76239750|FG009|Overall Study|Other Reason Not Specified|0|||
42372323|NCT02706834|76239751|FG010|Overall Study|Other Reason Not Specified|0|||
42372324|NCT01702025|76239800|FG000|Overall Study|Equipment failure|1|||
42372325|NCT01702025|76239801|FG001|Overall Study|Equipment failure|0|||
42372326|NCT01702025|76239802|FG002|Overall Study|Equipment failure|0|||
42372327|NCT01702025|76239803|FG003|Overall Study|Equipment failure|0|||
42372328|NCT01702025|76239800|FG000|Overall Study|Adverse Event|1|||
42372329|NCT01702025|76239801|FG001|Overall Study|Adverse Event|1|||
42372330|NCT01702025|76239802|FG002|Overall Study|Adverse Event|1|||
42372331|NCT01702025|76239803|FG003|Overall Study|Adverse Event|0|||
42372332|NCT01592747|76239820|FG000|Overall Study|Loss of Therapeutic Response|107|||
42372333|NCT01592747|76239821|FG001|Overall Study|Loss of Therapeutic Response|108|||
42372334|NCT01592747|76239822|FG002|Overall Study|Loss of Therapeutic Response|100|||
42372335|NCT01592747|76239820|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
42372336|NCT01592747|76239821|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
42372337|NCT01592747|76239822|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
42372338|NCT01592747|76239820|FG000|Overall Study|Adverse Event|1|||
42372339|NCT01592747|76239821|FG001|Overall Study|Adverse Event|0|||
42372340|NCT01592747|76239822|FG002|Overall Study|Adverse Event|0|||
42372341|NCT01592747|76239820|FG000|Overall Study|Protocol Violation|4|||
42372342|NCT01592747|76239821|FG001|Overall Study|Protocol Violation|0|||
42372343|NCT01592747|76239822|FG002|Overall Study|Protocol Violation|4|||
42372344|NCT01592747|76239820|FG000|Overall Study|Lack of Efficacy|0|||
42372345|NCT01592747|76239821|FG001|Overall Study|Lack of Efficacy|1|||
42372346|NCT01592747|76239822|FG002|Overall Study|Lack of Efficacy|0|||
42372347|NCT01592747|76239820|FG000|Overall Study|Withdrawal by Subject|2|||
42372348|NCT01592747|76239821|FG001|Overall Study|Withdrawal by Subject|0|||
42372349|NCT01592747|76239822|FG002|Overall Study|Withdrawal by Subject|2|||
42372350|NCT01592747|76239820|FG000|Overall Study|Lost to Follow-up|1|||
42372351|NCT01592747|76239821|FG001|Overall Study|Lost to Follow-up|0|||
42372352|NCT01592747|76239822|FG002|Overall Study|Lost to Follow-up|1|||
42372353|NCT01592747|76239820|FG000|Overall Study|Other Reasons|1|||
42372354|NCT01592747|76239821|FG001|Overall Study|Other Reasons|1|||
42372355|NCT01592747|76239822|FG002|Overall Study|Other Reasons|0|||
42372356|NCT02051608|76239835|FG000|Part 1: Double Blind Treatment|Death|3|||
42372357|NCT02051608|76239836|FG001|Part 1: Double Blind Treatment|Death|3|||
42372358|NCT02051608|76239837|FG002|Part 1: Double Blind Treatment|Death|0|||
42372359|NCT02051608|76239838|FG003|Part 1: Double Blind Treatment|Death|0|||
42372360|NCT02051608|76239835|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
42372361|NCT02051608|76239836|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
42372362|NCT02051608|76239837|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
42372363|NCT02051608|76239838|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
42372364|NCT02051608|76239835|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
42372365|NCT02051608|76239836|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
42372366|NCT02051608|76239837|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
42372367|NCT02051608|76239838|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
42372368|NCT02051608|76239835|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
42372369|NCT02051608|76239836|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
42372370|NCT02051608|76239837|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
42372371|NCT02051608|76239838|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
42372372|NCT02051608|76239835|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
42372373|NCT02051608|76239836|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
42372374|NCT02051608|76239837|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
42372375|NCT02051608|76239838|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
42372376|NCT02051608|76239835|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
42372377|NCT02051608|76239836|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
42372378|NCT02051608|76239837|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
42372379|NCT02051608|76239838|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
42372380|NCT02051608|76239835|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
42372381|NCT02051608|76239836|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
42372382|NCT02051608|76239837|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
42372383|NCT02051608|76239838|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
42372384|NCT02051608|76239835|FG000|Part 1: Double Blind Treatment|Other|6|||
42372385|NCT02051608|76239836|FG001|Part 1: Double Blind Treatment|Other|3|||
42372386|NCT02051608|76239837|FG002|Part 1: Double Blind Treatment|Other|0|||
42372387|NCT02051608|76239838|FG003|Part 1: Double Blind Treatment|Other|0|||
42372388|NCT02051608|76239835|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
42372389|NCT02051608|76239836|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
42372390|NCT02051608|76239837|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
42372391|NCT02051608|76239838|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
42372392|NCT02051608|76239835|FG000|Part 2: Open-label Extension|Adverse Event|0|||
42372393|NCT02051608|76239836|FG001|Part 2: Open-label Extension|Adverse Event|0|||
42372394|NCT02051608|76239837|FG002|Part 2: Open-label Extension|Adverse Event|6|||
42372395|NCT02051608|76239838|FG003|Part 2: Open-label Extension|Adverse Event|8|||
42372396|NCT02051608|76239835|FG000|Part 2: Open-label Extension|Death|0|||
42372397|NCT02051608|76239836|FG001|Part 2: Open-label Extension|Death|0|||
42372398|NCT02051608|76239837|FG002|Part 2: Open-label Extension|Death|7|||
42372399|NCT02051608|76239838|FG003|Part 2: Open-label Extension|Death|4|||
42372400|NCT02051608|76239835|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
42372401|NCT02051608|76239836|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
42372402|NCT02051608|76239837|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
42372403|NCT02051608|76239838|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
42372404|NCT02051608|76239835|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
42372405|NCT02051608|76239836|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
42372406|NCT02051608|76239837|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
42372407|NCT02051608|76239838|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
42372408|NCT02051608|76239835|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
42372409|NCT02051608|76239836|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
42372410|NCT02051608|76239837|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
42372411|NCT02051608|76239838|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
42372412|NCT02051608|76239835|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
42372413|NCT02051608|76239836|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
42372414|NCT02051608|76239837|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
42372415|NCT02051608|76239838|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
42372416|NCT02051608|76239835|FG000|Part 2: Open-label Extension|Physician Decision|0|||
42372417|NCT02051608|76239836|FG001|Part 2: Open-label Extension|Physician Decision|0|||
42372418|NCT02051608|76239837|FG002|Part 2: Open-label Extension|Physician Decision|8|||
42372419|NCT02051608|76239838|FG003|Part 2: Open-label Extension|Physician Decision|5|||
42372420|NCT02051608|76239835|FG000|Part 2: Open-label Extension|Other|0|||
42372421|NCT02051608|76239836|FG001|Part 2: Open-label Extension|Other|0|||
42372422|NCT02051608|76239837|FG002|Part 2: Open-label Extension|Other|9|||
42372423|NCT02051608|76239838|FG003|Part 2: Open-label Extension|Other|9|||
42372424|NCT02705586|76239851|FG000|Overall Study|Health Issues|2|||
42372425|NCT02705586|76239851|FG000|Overall Study|Transportation Difficulties|5|||
42372426|NCT02705586|76239851|FG000|Overall Study|Vacation/Planned Absence|1|||
42372427|NCT01592045|76239857|FG000|Overall Study|Disease Progression|1|||
42372428|NCT01592045|76239858|FG001|Overall Study|Disease Progression|1|||
42372429|NCT01592045|76239857|FG000|Overall Study|Adverse Event|1|||
42372430|NCT01592045|76239858|FG001|Overall Study|Adverse Event|1|||
42372431|NCT01592045|76239857|FG000|Overall Study|Withdrawal by Subject|1|||
42372432|NCT01592045|76239858|FG001|Overall Study|Withdrawal by Subject|0|||
42372433|NCT01592045|76239857|FG000|Overall Study|Moved out of country|2|||
42372434|NCT01592045|76239858|FG001|Overall Study|Moved out of country|0|||
42372435|NCT01591499|76239866|FG000|Baseline Visit|Withdrawal by Subject|0|||
42372436|NCT01591499|76239867|FG001|Baseline Visit|Withdrawal by Subject|2|||
42372437|NCT01591499|76239868|FG002|Baseline Visit|Withdrawal by Subject|0|||
42372438|NCT01591499|76239869|FG003|Baseline Visit|Withdrawal by Subject|2|||
42372439|NCT01591499|76239866|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
42372440|NCT01591499|76239867|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
42372441|NCT01591499|76239868|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
42372442|NCT01591499|76239869|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
42372443|NCT01591499|76239866|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
42372444|NCT01591499|76239867|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
42372445|NCT01591499|76239868|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
42372446|NCT01591499|76239869|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
42372447|NCT01590797|76239895|FG000|Overall Study|Adverse Event|4|||
42372448|NCT01590797|76239896|FG001|Overall Study|Adverse Event|3|||
42372449|NCT01590797|76239895|FG000|Overall Study|Lack of Efficacy|0|||
42372450|NCT01590797|76239896|FG001|Overall Study|Lack of Efficacy|2|||
42372451|NCT01590797|76239895|FG000|Overall Study|Lost to Follow-up|0|||
42372452|NCT01590797|76239896|FG001|Overall Study|Lost to Follow-up|1|||
42372453|NCT01590797|76239895|FG000|Overall Study|Protocol Violation|4|||
42372454|NCT01590797|76239896|FG001|Overall Study|Protocol Violation|1|||
42372455|NCT01590797|76239895|FG000|Overall Study|Withdrawal by Subject|7|||
42372456|NCT01590797|76239896|FG001|Overall Study|Withdrawal by Subject|5|||
42372457|NCT01590797|76239895|FG000|Overall Study|Other Protocol Specified Criteria|2|||
42372458|NCT01590797|76239896|FG001|Overall Study|Other Protocol Specified Criteria|4|||
42372459|NCT01590563|76239902|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
42372460|NCT01701401|76239911|FG000|Overall Study|Randomized But Not Treated|3|||
42372461|NCT01701401|76239912|FG001|Overall Study|Randomized But Not Treated|1|||
42372462|NCT01701401|76239913|FG002|Overall Study|Randomized But Not Treated|0|||
42372463|NCT01701401|76239914|FG003|Overall Study|Randomized But Not Treated|1|||
42372464|NCT01701401|76239911|FG000|Overall Study|Lost to Follow-up|5|||
42372465|NCT01701401|76239912|FG001|Overall Study|Lost to Follow-up|5|||
42372466|NCT01701401|76239913|FG002|Overall Study|Lost to Follow-up|1|||
42372467|NCT01701401|76239914|FG003|Overall Study|Lost to Follow-up|3|||
42372468|NCT01701401|76239911|FG000|Overall Study|Withdrew Consent|0|||
42372469|NCT01701401|76239912|FG001|Overall Study|Withdrew Consent|3|||
42372470|NCT01701401|76239913|FG002|Overall Study|Withdrew Consent|1|||
42372471|NCT01701401|76239914|FG003|Overall Study|Withdrew Consent|2|||
42372472|NCT01701401|76239911|FG000|Overall Study|Lack of Efficacy|1|||
42372473|NCT01701401|76239912|FG001|Overall Study|Lack of Efficacy|0|||
42372474|NCT01701401|76239913|FG002|Overall Study|Lack of Efficacy|2|||
42372475|NCT01701401|76239914|FG003|Overall Study|Lack of Efficacy|0|||
42372476|NCT01701401|76239911|FG000|Overall Study|Adverse Event|1|||
42372477|NCT01701401|76239912|FG001|Overall Study|Adverse Event|0|||
42372478|NCT01701401|76239913|FG002|Overall Study|Adverse Event|0|||
42372479|NCT01701401|76239914|FG003|Overall Study|Adverse Event|0|||
42372480|NCT01701401|76239911|FG000|Overall Study|Protocol Violation|0|||
42372481|NCT01701401|76239912|FG001|Overall Study|Protocol Violation|0|||
42372482|NCT01701401|76239913|FG002|Overall Study|Protocol Violation|1|||
42372483|NCT01701401|76239914|FG003|Overall Study|Protocol Violation|0|||
42372484|NCT01701245|76239926|FG000|Overall Study|Protocol Violation|1|||
42372485|NCT01701245|76239927|FG001|Overall Study|Protocol Violation|3|||
42372486|NCT01701245|76239926|FG000|Overall Study|Did not complete the open label period|11|||
42372487|NCT01701245|76239927|FG001|Overall Study|Did not complete the open label period|12|||
42372488|NCT01590017|76239933|FG000|Overall Study|Adverse Event|1|||
42372489|NCT01590017|76239933|FG000|Overall Study|Withdrawal by Subject|1|||
42372490|NCT01590017|76239933|FG000|Overall Study|Lack of Efficacy|1|||
42372491|NCT01590017|76239933|FG000|Overall Study|Physician Decision|1|||
42372492|NCT01700621|76239939|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
42372493|NCT01700621|76239940|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
42372494|NCT01700621|76239939|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
42372495|NCT01700621|76239940|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
42372496|NCT01700621|76239939|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
42372497|NCT01700621|76239940|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
42372498|NCT01589237|76239951|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
42372499|NCT01589237|76239952|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
42372500|NCT01589237|76239953|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
42372501|NCT01589237|76239954|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
42372502|NCT01589237|76239951|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
42372503|NCT01589237|76239952|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
42372504|NCT01589237|76239953|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
42372505|NCT01589237|76239954|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
42372506|NCT01589237|76239951|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
42372507|NCT01589237|76239952|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
42372508|NCT01589237|76239953|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
42372509|NCT01589237|76239954|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
42372510|NCT01589237|76239951|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
42372511|NCT01589237|76239952|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
42372512|NCT01589237|76239953|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
42372513|NCT01589237|76239954|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
42372514|NCT01700387|76239970|FG000|Overall Study|Withdrawal by Subject|1|||
42372515|NCT01700387|76239971|FG001|Overall Study|Withdrawal by Subject|2|||
42372516|NCT01700387|76239970|FG000|Overall Study|Adverse Event|1|||
42372517|NCT01700387|76239971|FG001|Overall Study|Adverse Event|1|||
42372518|NCT01700387|76239970|FG000|Overall Study|Lost to Follow-up|2|||
42372519|NCT01700387|76239971|FG001|Overall Study|Lost to Follow-up|1|||
42372520|NCT01699685|76239983|FG000|Period 1|Adverse Event|1|||
42372521|NCT01699685|76239984|FG001|Period 1|Adverse Event|1|||
42372522|NCT01699685|76239983|FG000|Period 1|Medical or ethical, noncompliance|2|||
42372523|NCT01699685|76239984|FG001|Period 1|Medical or ethical, noncompliance|0|||
42372524|NCT01699685|76239983|FG000|Period 1|Other|0|||
42372525|NCT01699685|76239984|FG001|Period 1|Other|1|||
42372526|NCT01699685|76239983|FG000|Period 1|Patient request|0|||
42372527|NCT01699685|76239984|FG001|Period 1|Patient request|1|||
42372528|NCT01699685|76239983|FG000|Period 2|Lost to Follow-up|1|||
42372529|NCT01699685|76239984|FG001|Period 2|Lost to Follow-up|0|||
42372530|NCT01587989|76239992|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
42372531|NCT01587989|76239993|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
42372532|NCT01587989|76239994|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
42372533|NCT01587989|76239992|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
42372534|NCT01587989|76239993|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
42372535|NCT01587989|76239994|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
42372536|NCT01587989|76239992|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
42372537|NCT01587989|76239993|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
42372538|NCT01587989|76239994|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
42372539|NCT01587989|76239992|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
42372540|NCT01587989|76239993|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
42372541|NCT01587989|76239994|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
42372542|NCT01587989|76239992|FG000|Randomized Study Treatment|Screening failure|0|||
42372543|NCT01587989|76239993|FG001|Randomized Study Treatment|Screening failure|1|||
42372544|NCT01587989|76239994|FG002|Randomized Study Treatment|Screening failure|0|||
42372545|NCT01587989|76239992|FG000|Randomized Study Treatment|Physician Decision|0|||
42372546|NCT01587989|76239993|FG001|Randomized Study Treatment|Physician Decision|0|||
42372547|NCT01587989|76239994|FG002|Randomized Study Treatment|Physician Decision|1|||
42372548|NCT01697969|76240000|FG000|Overall Study|Did not meet inc/exc criteria|3|||
42372549|NCT01586819|76240007|FG000|Overall Study|Withdrawal by Subject|1|||
42372550|NCT01586819|76240008|FG001|Overall Study|Withdrawal by Subject|0|||
42372551|NCT01697579|76240019|FG000|Base Study-Cycle 1|Adverse Event|1|||
42372552|NCT01697579|76240020|FG001|Base Study-Cycle 1|Adverse Event|0|||
42372553|NCT01697579|76240021|FG002|Base Study-Cycle 1|Adverse Event|0|||
42372554|NCT01697579|76240022|FG003|Base Study-Cycle 1|Adverse Event|0|||
42372555|NCT01697579|76240023|FG004|Base Study-Cycle 1|Adverse Event|0|||
42372556|NCT01697579|76240024|FG005|Base Study-Cycle 1|Adverse Event|0|||
42372557|NCT01697579|76240025|FG006|Base Study-Cycle 1|Adverse Event|0|||
42372558|NCT01697579|76240019|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
42372559|NCT01697579|76240020|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
42372560|NCT01697579|76240021|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
42372561|NCT01697579|76240022|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
42372562|NCT01697579|76240023|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
42372563|NCT01697579|76240024|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
42372564|NCT01697579|76240025|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
42372565|NCT01697579|76240019|FG000|Base Study-Cycle 1|Protocol Violation|0|||
42372566|NCT01697579|76240020|FG001|Base Study-Cycle 1|Protocol Violation|0|||
42372567|NCT01697579|76240021|FG002|Base Study-Cycle 1|Protocol Violation|0|||
42372568|NCT01697579|76240022|FG003|Base Study-Cycle 1|Protocol Violation|0|||
42372569|NCT01697579|76240023|FG004|Base Study-Cycle 1|Protocol Violation|3|||
42372570|NCT01697579|76240024|FG005|Base Study-Cycle 1|Protocol Violation|0|||
42372571|NCT01697579|76240025|FG006|Base Study-Cycle 1|Protocol Violation|0|||
42372572|NCT01697579|76240019|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
42372573|NCT01697579|76240020|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
42372574|NCT01697579|76240021|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
42372575|NCT01697579|76240022|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
42372576|NCT01697579|76240023|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
42372577|NCT01697579|76240024|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
42372578|NCT01697579|76240025|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
42372579|NCT01697579|76240019|FG000|Base Study-Cycle 1|Technical Problems|0|||
42372580|NCT01697579|76240020|FG001|Base Study-Cycle 1|Technical Problems|0|||
42372581|NCT01697579|76240021|FG002|Base Study-Cycle 1|Technical Problems|1|||
42372582|NCT01697579|76240022|FG003|Base Study-Cycle 1|Technical Problems|1|||
42372583|NCT01697579|76240023|FG004|Base Study-Cycle 1|Technical Problems|0|||
42372584|NCT01697579|76240024|FG005|Base Study-Cycle 1|Technical Problems|0|||
42372585|NCT01697579|76240025|FG006|Base Study-Cycle 1|Technical Problems|0|||
42200742|NCT02112916|76012696|FG003|Overall Study|Withdrawal by Subject|1|||
42200743|NCT02112916|76012693|FG000|Overall Study|Ineligible|4|||
42200744|NCT02112916|76012694|FG001|Overall Study|Ineligible|8|||
42200745|NCT02112916|76012695|FG002|Overall Study|Ineligible|3|||
42200746|NCT02112916|76012696|FG003|Overall Study|Ineligible|8|||
42200747|NCT02112916|76012693|FG000|Overall Study|Inevaluable|6|||
42200748|NCT02112916|76012694|FG001|Overall Study|Inevaluable|4|||
42200749|NCT02112916|76012695|FG002|Overall Study|Inevaluable|5|||
42200750|NCT02112916|76012696|FG003|Overall Study|Inevaluable|5|||
42200751|NCT02112916|76012693|FG000|Overall Study|Refusal of further protocol therapy|19|||
42372586|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Death|0|||
42372587|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Death|0|||
42372588|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Death|0|||
42372589|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Death|0|||
42372590|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Death|0|||
42200752|NCT02112916|76012694|FG001|Overall Study|Refusal of further protocol therapy|16|||
42200753|NCT02112916|76012695|FG002|Overall Study|Refusal of further protocol therapy|1|||
42200754|NCT02112916|76012696|FG003|Overall Study|Refusal of further protocol therapy|7|||
42372591|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Death|0|||
42372592|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Death|2|||
42372593|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
42372594|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
42372595|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
42372596|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
42372597|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
42372598|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
42372599|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
42372600|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
42372601|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
42372602|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
42372603|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
42372604|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
42372605|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
42372606|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
42372607|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
42372608|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
42372609|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
42372610|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
42372611|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
42372612|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
42372613|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
42372614|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
42372615|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
42372616|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
42372617|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
42372618|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
42372619|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
42372620|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
42372621|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
42372622|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
42372623|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
42372624|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
42372625|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
42372626|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
42372627|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
42372628|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
42372629|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
42103428|NCT00652626|75914374|FG001|Extension Phase|Withdrawal by Subject|0|||
42372630|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
42372631|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
42372632|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
42372633|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
42372634|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
42372635|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
42372636|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
42372637|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
42372638|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
42372639|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
42372640|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
42372641|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
42372642|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
42372643|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
42372644|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
42372645|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
42372646|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
42372647|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
42372648|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
42372649|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
42372650|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
42372651|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
42372652|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
42372653|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
42372654|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
42372655|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
42372656|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
42372657|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
42372658|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
42372659|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
42372660|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
42372661|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
42372662|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
42372663|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
42372664|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
42372665|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
42372666|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
42372667|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
42372668|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
42372669|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
42372670|NCT01697579|76240019|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
42372671|NCT01697579|76240020|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
42372672|NCT01697579|76240021|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
42372673|NCT01697579|76240022|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
42372674|NCT01697579|76240023|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
42372675|NCT01697579|76240024|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
42372676|NCT01697579|76240025|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
42372677|NCT01586195|76240053|FG000|Overall Study|Death|11|||
42372678|NCT01586195|76240053|FG000|Overall Study|Withdrawal of Consent|5|||
42372679|NCT01586195|76240053|FG000|Overall Study|Started new anti-melanoma therapy|1|||
42200755|NCT02112916|76012693|FG000|Overall Study|Development of SMN|1|||
42200756|NCT02112916|76012694|FG001|Overall Study|Development of SMN|0|||
42200757|NCT02112916|76012695|FG002|Overall Study|Development of SMN|0|||
42372680|NCT01586195|76240053|FG000|Overall Study|Reason not specified|9|||
42372681|NCT01585961|76240057|FG000|Overall Study|Death|6|||
42372682|NCT01585961|76240057|FG000|Overall Study|Physician Decision|1|||
42372683|NCT01585961|76240057|FG000|Overall Study|Decision to use non-study catheter|1|||
42372684|NCT01585961|76240057|FG000|Overall Study|Withdrawal by Subject|1|||
42372685|NCT01585961|76240057|FG000|Overall Study|Lost to Follow-up|23|||
42372686|NCT01585961|76240057|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
42372687|NCT01697501|76240061|FG000|Overall Study|Protocol Violation|2|||
42372688|NCT01697345|76240074|FG000|Overall Study|Withdrawal by Subject|1|||
42372689|NCT01697267|76240143|FG000|Overall Study|Death|3|||
42372690|NCT01697267|76240144|FG001|Overall Study|Death|1|||
42372691|NCT01697267|76240143|FG000|Overall Study|Withdrawal by Subject|5|||
42372692|NCT01697267|76240144|FG001|Overall Study|Withdrawal by Subject|5|||
42372693|NCT01697267|76240143|FG000|Overall Study|Adverse Event|2|||
42372694|NCT01697267|76240144|FG001|Overall Study|Adverse Event|1|||
42372695|NCT01697267|76240143|FG000|Overall Study|Lost to Follow-up|2|||
42372696|NCT01697267|76240144|FG001|Overall Study|Lost to Follow-up|4|||
42372697|NCT01697267|76240143|FG000|Overall Study|Physician Decision|2|||
42372698|NCT01697267|76240144|FG001|Overall Study|Physician Decision|4|||
42372699|NCT01696955|76240206|FG000|Main Study|Protocol Violation|1|||
42372700|NCT01696955|76240207|FG001|Main Study|Protocol Violation|0|||
42372701|NCT01696955|76240206|FG000|Main Study|Withdrawal by Subject|1|||
42372702|NCT01696955|76240207|FG001|Main Study|Withdrawal by Subject|1|||
42372703|NCT02702388|76240231|FG000|Overall Study|Disease Progression|18|||
42372704|NCT02702388|76240232|FG001|Overall Study|Disease Progression|25|||
42372705|NCT02702388|76240231|FG000|Overall Study|Withdrawal by Subject|9|||
42372706|NCT02702388|76240232|FG001|Overall Study|Withdrawal by Subject|7|||
42372707|NCT02702388|76240231|FG000|Overall Study|Adverse Event|11|||
42372708|NCT02702388|76240232|FG001|Overall Study|Adverse Event|15|||
42372709|NCT02702388|76240231|FG000|Overall Study|Other|2|||
42372710|NCT02702388|76240232|FG001|Overall Study|Other|4|||
42372711|NCT01696877|76240258|FG000|Overall Study|Adverse Event|0|||
42372712|NCT01696877|76240259|FG001|Overall Study|Adverse Event|1|||
42372713|NCT02703636|76240446|FG000|Overall Study|Adverse Event|14|||
42372714|NCT02703636|76240446|FG000|Overall Study|Study stopped by sponsor|1|||
42372715|NCT02703636|76240446|FG000|Overall Study|Withdrawal by Subject|1|||
42372716|NCT02703324|76240674|FG000|Period Two|Withdrawal by Subject|0|||
42372717|NCT02703324|76240675|FG001|Period Two|Withdrawal by Subject|0|||
42372718|NCT02703324|76240676|FG002|Period Two|Withdrawal by Subject|1|||
42372719|NCT02703324|76240677|FG003|Period Two|Withdrawal by Subject|0|||
42372720|NCT02703324|76240678|FG004|Period Two|Withdrawal by Subject|0|||
42372721|NCT02703324|76240679|FG005|Period Two|Withdrawal by Subject|0|||
42372722|NCT02701764|76240690|FG000|Overall Study|Lost to Follow-up|0|||
42372723|NCT02701764|76240691|FG001|Overall Study|Lost to Follow-up|1|||
42372724|NCT01696643|76240872|FG000|Overall Study|Adverse Event|15|||
42372725|NCT01696643|76240873|FG001|Overall Study|Adverse Event|7|||
42372726|NCT01696643|76240872|FG000|Overall Study|Death|1|||
42372727|NCT01696643|76240873|FG001|Overall Study|Death|2|||
42372728|NCT01696643|76240872|FG000|Overall Study|Lack of Efficacy|3|||
42372729|NCT01696643|76240873|FG001|Overall Study|Lack of Efficacy|0|||
42372730|NCT01696643|76240872|FG000|Overall Study|Lost to Follow-up|67|||
42372731|NCT01696643|76240873|FG001|Overall Study|Lost to Follow-up|67|||
42372732|NCT01696643|76240872|FG000|Overall Study|Physician Decision|3|||
42372733|NCT01696643|76240873|FG001|Overall Study|Physician Decision|2|||
42372734|NCT01696643|76240872|FG000|Overall Study|Pregnancy|0|||
42372735|NCT01696643|76240873|FG001|Overall Study|Pregnancy|1|||
42372736|NCT01696643|76240872|FG000|Overall Study|Protocol Violation|7|||
42372737|NCT01696643|76240873|FG001|Overall Study|Protocol Violation|7|||
42372738|NCT01696643|76240872|FG000|Overall Study|Study Terminated by Sponsor|286|||
42372739|NCT01696643|76240873|FG001|Overall Study|Study Terminated by Sponsor|294|||
42372740|NCT01696643|76240872|FG000|Overall Study|Withdrawal by Subject|142|||
42372741|NCT01696643|76240873|FG001|Overall Study|Withdrawal by Subject|149|||
42372742|NCT01696643|76240872|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
42372743|NCT01696643|76240873|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
42372744|NCT01696643|76240872|FG000|Overall Study|Site Error|2|||
42372745|NCT01696643|76240873|FG001|Overall Study|Site Error|1|||
42372746|NCT01696643|76240872|FG000|Overall Study|Participant Incarcerated|0|||
42372747|NCT01696643|76240873|FG001|Overall Study|Participant Incarcerated|1|||
42372748|NCT01696643|76240872|FG000|Overall Study|Medical Monitor Decision|0|||
42372749|NCT01696643|76240873|FG001|Overall Study|Medical Monitor Decision|2|||
42372750|NCT01696643|76240872|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
42372751|NCT01696643|76240873|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
42372752|NCT01695317|76240885|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
42372753|NCT01695317|76240886|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
42372754|NCT01695317|76240885|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
42372755|NCT01695317|76240886|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
42372756|NCT02701296|76240942|FG000|Overall Study|Incomplete Data|0|||
42372757|NCT02701296|76240943|FG001|Overall Study|Incomplete Data|2|||
42372758|NCT01582451|76240960|FG000|Overall Study|Adverse Event|1|||
42372759|NCT01582451|76240961|FG001|Overall Study|Adverse Event|3|||
42372760|NCT01582451|76240960|FG000|Overall Study|Death|3|||
42372761|NCT01582451|76240961|FG001|Overall Study|Death|3|||
42372762|NCT01582451|76240960|FG000|Overall Study|Lost to Follow-up|0|||
42372763|NCT01582451|76240961|FG001|Overall Study|Lost to Follow-up|2|||
42372764|NCT01582451|76240960|FG000|Overall Study|Protocol Violation|11|||
42372765|NCT01582451|76240961|FG001|Overall Study|Protocol Violation|3|||
42372766|NCT01582451|76240960|FG000|Overall Study|Withdrawal by Subject|13|||
42372767|NCT01582451|76240961|FG001|Overall Study|Withdrawal by Subject|9|||
42372768|NCT01582451|76240960|FG000|Overall Study|Physician Decision|3|||
42372769|NCT01582451|76240961|FG001|Overall Study|Physician Decision|0|||
42372770|NCT01582451|76240960|FG000|Overall Study|Sponsor Decision|1|||
42372771|NCT01582451|76240961|FG001|Overall Study|Sponsor Decision|0|||
42372772|NCT02700984|76241045|FG000|Overall Study|Death|2|||
42372773|NCT02700984|76241046|FG001|Overall Study|Death|1|||
42372774|NCT02700984|76241045|FG000|Overall Study|Lost to Follow-up|2|||
42372775|NCT02700984|76241046|FG001|Overall Study|Lost to Follow-up|1|||
42372776|NCT02700984|76241045|FG000|Overall Study|Physician Decision|0|||
42372777|NCT02700984|76241046|FG001|Overall Study|Physician Decision|1|||
42372778|NCT02700984|76241045|FG000|Overall Study|Withdrawal by Subject|8|||
42372779|NCT02700984|76241046|FG001|Overall Study|Withdrawal by Subject|9|||
42372780|NCT02700984|76241045|FG000|Overall Study|Reason not specified|3|||
42372781|NCT02700984|76241046|FG001|Overall Study|Reason not specified|2|||
42372782|NCT02696850|76241120|FG000|Overall Study|Withdrawal by Subject|3|||
42372783|NCT02696850|76241121|FG001|Overall Study|Withdrawal by Subject|3|||
42372784|NCT02696850|76241120|FG000|Overall Study|Lost to Follow-up|8|||
42372785|NCT02696850|76241121|FG001|Overall Study|Lost to Follow-up|5|||
42372786|NCT02698410|76241275|FG000|Overall Study|Adverse Event|2|||
42372787|NCT02698410|76241275|FG000|Overall Study|Withdrawal by Subject|1|||
42372788|NCT02698410|76241275|FG000|Overall Study|Other|1|||
42372789|NCT02699892|76241279|FG000|Overall Study|Other|36|||
42200758|NCT02112916|76012696|FG003|Overall Study|Development of SMN|1|||
42200759|NCT02112916|76012693|FG000|Overall Study|Relapse/Progression|10|||
42200760|NCT02112916|76012694|FG001|Overall Study|Relapse/Progression|18|||
42200761|NCT02112916|76012695|FG002|Overall Study|Relapse/Progression|15|||
42200762|NCT02112916|76012696|FG003|Overall Study|Relapse/Progression|2|||
42200763|NCT02112916|76012693|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
42200764|NCT02112916|76012694|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
42200765|NCT02112916|76012695|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
42200766|NCT02112916|76012696|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
42200767|NCT02112916|76012693|FG000|Overall Study|Still on Therapy|44|||
42200768|NCT02112916|76012694|FG001|Overall Study|Still on Therapy|47|||
42372790|NCT02698176|76241286|FG000|Overall Study|Progressive disease|4|||
42372791|NCT02698176|76241287|FG001|Overall Study|Progressive disease|3|||
42372792|NCT02698176|76241288|FG002|Overall Study|Progressive disease|1|||
42372793|NCT02698176|76241289|FG003|Overall Study|Progressive disease|0|||
42372794|NCT02698176|76241286|FG000|Overall Study|Adverse Event|2|||
42372795|NCT02698176|76241287|FG001|Overall Study|Adverse Event|0|||
42372796|NCT02698176|76241288|FG002|Overall Study|Adverse Event|0|||
42372797|NCT02698176|76241289|FG003|Overall Study|Adverse Event|0|||
42372798|NCT02698176|76241286|FG000|Overall Study|Clinical progression|3|||
42372799|NCT02698176|76241287|FG001|Overall Study|Clinical progression|0|||
42372800|NCT02698176|76241288|FG002|Overall Study|Clinical progression|0|||
42372801|NCT02698176|76241289|FG003|Overall Study|Clinical progression|0|||
42372802|NCT02693418|76241305|FG000|Overall Study|Lost to Follow-up|1|||
42372803|NCT02693418|76241306|FG001|Overall Study|Lost to Follow-up|2|||
42372804|NCT02693418|76241307|FG002|Overall Study|Lost to Follow-up|0|||
42372805|NCT02693418|76241308|FG003|Overall Study|Lost to Follow-up|0|||
42372806|NCT02693418|76241309|FG004|Overall Study|Lost to Follow-up|0|||
42372807|NCT02693418|76241305|FG000|Overall Study|Menses during study period|0|||
42372808|NCT02693418|76241306|FG001|Overall Study|Menses during study period|0|||
42372809|NCT02693418|76241307|FG002|Overall Study|Menses during study period|2|||
42200769|NCT02112916|76012695|FG002|Overall Study|Still on Therapy|3|||
42200770|NCT02112916|76012696|FG003|Overall Study|Still on Therapy|2|||
42372810|NCT02693418|76241308|FG003|Overall Study|Menses during study period|0|||
42372811|NCT02693418|76241309|FG004|Overall Study|Menses during study period|0|||
42372812|NCT02693106|76241342|FG000|Overall Study|No time|3|||
42372813|NCT02546986|76241354|FG000|Treatment Period|Progressive Disease|20|||
42372814|NCT02546986|76241355|FG001|Treatment Period|Progressive Disease|22|||
42372815|NCT02546986|76241354|FG000|Treatment Period|Adverse Event|14|||
42372816|NCT02546986|76241355|FG001|Treatment Period|Adverse Event|6|||
42372817|NCT02546986|76241354|FG000|Treatment Period|Symptomatic Deterioration|4|||
42372818|NCT02546986|76241355|FG001|Treatment Period|Symptomatic Deterioration|3|||
42372819|NCT02546986|76241354|FG000|Treatment Period|Death|3|||
42372820|NCT02546986|76241355|FG001|Treatment Period|Death|4|||
42372821|NCT02546986|76241354|FG000|Treatment Period|Physician Decision|1|||
42372822|NCT02546986|76241355|FG001|Treatment Period|Physician Decision|2|||
42372823|NCT02546986|76241354|FG000|Treatment Period|Protocol Violation|1|||
42372824|NCT02546986|76241355|FG001|Treatment Period|Protocol Violation|0|||
42372825|NCT02546986|76241354|FG000|Treatment Period|Withdrawal by Subject|1|||
42372826|NCT02546986|76241355|FG001|Treatment Period|Withdrawal by Subject|1|||
42372827|NCT02546986|76241354|FG000|Treatment Period|Non-compliance with Study Drug|0|||
42372828|NCT02546986|76241355|FG001|Treatment Period|Non-compliance with Study Drug|1|||
42372829|NCT02546986|76241354|FG000|Treatment Period|Study Terminated by Sponsor|0|||
42372830|NCT02546986|76241355|FG001|Treatment Period|Study Terminated by Sponsor|1|||
42372831|NCT02546986|76241354|FG000|Treatment Period|Miscellaneous|7|||
42372832|NCT02546986|76241355|FG001|Treatment Period|Miscellaneous|9|||
42372833|NCT02546986|76241354|FG000|Survival Follow-Up Phase|Missing Status|3|||
42372834|NCT02546986|76241355|FG001|Survival Follow-Up Phase|Missing Status|5|||
42372835|NCT02546986|76241354|FG000|Survival Follow-Up Phase|Death|18|||
42372836|NCT02546986|76241355|FG001|Survival Follow-Up Phase|Death|12|||
42372837|NCT02546986|76241354|FG000|Survival Follow-Up Phase|Alive|13|||
42372838|NCT02546986|76241355|FG001|Survival Follow-Up Phase|Alive|16|||
42372839|NCT02546986|76241354|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
42372840|NCT02546986|76241355|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
42372841|NCT02689206|76241366|FG000|Overall Study|Adverse Event|0|||
42372842|NCT02689206|76241367|FG001|Overall Study|Adverse Event|0|||
42372843|NCT02689206|76241368|FG002|Overall Study|Adverse Event|1|||
42372844|NCT02689206|76241369|FG003|Overall Study|Adverse Event|0|||
42372845|NCT02689206|76241370|FG004|Overall Study|Adverse Event|2|||
42372846|NCT02689206|76241366|FG000|Overall Study|Protocol Violation|1|||
42372847|NCT02689206|76241367|FG001|Overall Study|Protocol Violation|0|||
42372848|NCT02689206|76241368|FG002|Overall Study|Protocol Violation|0|||
42372849|NCT02689206|76241369|FG003|Overall Study|Protocol Violation|1|||
42372850|NCT02689206|76241370|FG004|Overall Study|Protocol Violation|2|||
42372851|NCT02689206|76241366|FG000|Overall Study|Other: Reached stopping criteria|0|||
42372852|NCT02689206|76241367|FG001|Overall Study|Other: Reached stopping criteria|1|||
42372853|NCT02689206|76241368|FG002|Overall Study|Other: Reached stopping criteria|2|||
42372854|NCT02689206|76241369|FG003|Overall Study|Other: Reached stopping criteria|3|||
42372855|NCT02689206|76241370|FG004|Overall Study|Other: Reached stopping criteria|4|||
42372856|NCT02689206|76241366|FG000|Overall Study|Physician Decision|1|||
42372857|NCT02689206|76241367|FG001|Overall Study|Physician Decision|0|||
42372858|NCT02689206|76241368|FG002|Overall Study|Physician Decision|0|||
42372859|NCT02689206|76241369|FG003|Overall Study|Physician Decision|0|||
42372860|NCT02689206|76241370|FG004|Overall Study|Physician Decision|0|||
42372861|NCT02689206|76241366|FG000|Overall Study|Withdrawal by Subject|1|||
42372862|NCT02689206|76241367|FG001|Overall Study|Withdrawal by Subject|0|||
42372863|NCT02689206|76241368|FG002|Overall Study|Withdrawal by Subject|1|||
42372864|NCT02689206|76241369|FG003|Overall Study|Withdrawal by Subject|0|||
42372865|NCT02689206|76241370|FG004|Overall Study|Withdrawal by Subject|0|||
42372866|NCT01695239|76241390|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
42372867|NCT01695239|76241391|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
42372868|NCT01695239|76241392|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
42372869|NCT01695239|76241393|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
42372870|NCT01695239|76241394|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
42372871|NCT01695239|76241395|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
42372872|NCT01695239|76241396|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
42372873|NCT01695239|76241397|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
42372874|NCT01695239|76241398|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
42372875|NCT01695239|76241399|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
42372876|NCT01695239|76241400|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
42372877|NCT01695239|76241401|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
42372878|NCT01695239|76241402|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
42372879|NCT01695239|76241403|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
42372880|NCT01695239|76241390|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
42372881|NCT01695239|76241391|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
42372882|NCT01695239|76241392|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
42372883|NCT01695239|76241393|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
42372884|NCT01695239|76241394|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
42372885|NCT01695239|76241395|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
42372886|NCT01695239|76241396|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
42372887|NCT01695239|76241397|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
42372888|NCT01695239|76241398|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
42372889|NCT01695239|76241399|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
42372890|NCT01695239|76241400|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
42372891|NCT01695239|76241401|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
42372892|NCT01695239|76241402|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
42372893|NCT01695239|76241403|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
42372894|NCT01695239|76241390|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
42372895|NCT01695239|76241391|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372896|NCT01695239|76241392|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
42372897|NCT01695239|76241393|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372898|NCT01695239|76241394|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372899|NCT01695239|76241395|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372900|NCT01695239|76241396|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372901|NCT01695239|76241397|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372902|NCT01695239|76241398|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372903|NCT01695239|76241399|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372904|NCT01695239|76241400|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372905|NCT01695239|76241401|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372906|NCT01695239|76241402|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372907|NCT01695239|76241403|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
42372908|NCT01695239|76241390|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
42372909|NCT01695239|76241391|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
42372910|NCT01695239|76241392|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
42372911|NCT01695239|76241393|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
42372912|NCT01695239|76241394|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
42372913|NCT01695239|76241395|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
42372914|NCT01695239|76241396|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
42372915|NCT01695239|76241397|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
42372916|NCT01695239|76241398|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
42372917|NCT01695239|76241399|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
42372918|NCT01695239|76241400|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
42372919|NCT01695239|76241401|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
42372920|NCT01695239|76241402|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
42372921|NCT01695239|76241403|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
42372922|NCT01695239|76241390|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
42372923|NCT01695239|76241391|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372924|NCT01695239|76241392|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
42372925|NCT01695239|76241393|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372926|NCT01695239|76241394|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372927|NCT01695239|76241395|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372928|NCT01695239|76241396|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372929|NCT01695239|76241397|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372930|NCT01695239|76241398|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372931|NCT01695239|76241399|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372932|NCT01695239|76241400|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372933|NCT01695239|76241401|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372934|NCT01695239|76241402|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372935|NCT01695239|76241403|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
42372936|NCT01695239|76241390|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
42372937|NCT01695239|76241391|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372938|NCT01695239|76241392|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
42372939|NCT01695239|76241393|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372940|NCT01695239|76241394|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372941|NCT01695239|76241395|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372942|NCT01695239|76241396|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372943|NCT01695239|76241397|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372944|NCT01695239|76241398|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372945|NCT01695239|76241399|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372946|NCT01695239|76241400|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372947|NCT01695239|76241401|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372948|NCT01695239|76241402|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372949|NCT01695239|76241403|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
42372950|NCT01695239|76241390|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
42372951|NCT01695239|76241391|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42372952|NCT01695239|76241392|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42372953|NCT01695239|76241393|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42372954|NCT01695239|76241394|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42103429|NCT00652626|75914375|FG002|Extension Phase|Withdrawal by Subject|0|||
42103430|NCT00652626|75914376|FG003|Extension Phase|Withdrawal by Subject|0|||
42372955|NCT01695239|76241395|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42018720|NCT01256177|75826075|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
42103431|NCT00652626|75914377|FG004|Extension Phase|Withdrawal by Subject|0|||
42372956|NCT01695239|76241396|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42372957|NCT01695239|76241397|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42372958|NCT01695239|76241398|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42372959|NCT01695239|76241399|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42372960|NCT01695239|76241400|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42372961|NCT01695239|76241401|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42372962|NCT01695239|76241402|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42372963|NCT01695239|76241403|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
42372964|NCT01695239|76241390|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372965|NCT01695239|76241391|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372966|NCT01695239|76241392|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372967|NCT01695239|76241393|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372968|NCT01695239|76241394|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372969|NCT01695239|76241395|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372970|NCT01695239|76241396|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372971|NCT01695239|76241397|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
42372972|NCT01695239|76241398|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372973|NCT01695239|76241399|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372974|NCT01695239|76241400|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372975|NCT01695239|76241401|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372976|NCT01695239|76241402|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372977|NCT01695239|76241403|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
42372978|NCT01695239|76241390|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372979|NCT01695239|76241391|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372980|NCT01695239|76241392|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372981|NCT01695239|76241393|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372982|NCT01695239|76241394|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372983|NCT01695239|76241395|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372984|NCT01695239|76241396|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372985|NCT01695239|76241397|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
42372986|NCT01695239|76241398|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372987|NCT01695239|76241399|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372988|NCT01695239|76241400|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372989|NCT01695239|76241401|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372990|NCT01695239|76241402|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372991|NCT01695239|76241403|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
42372992|NCT01695239|76241390|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42372993|NCT01695239|76241391|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42372994|NCT01695239|76241392|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42372995|NCT01695239|76241393|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42372996|NCT01695239|76241394|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42372997|NCT01695239|76241395|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42372998|NCT01695239|76241396|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42372999|NCT01695239|76241397|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
42373000|NCT01695239|76241398|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42373001|NCT01695239|76241399|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42373002|NCT01695239|76241400|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42373003|NCT01695239|76241401|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42373004|NCT01695239|76241402|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42373005|NCT01695239|76241403|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
42373006|NCT01695239|76241390|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373007|NCT01695239|76241391|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373008|NCT01695239|76241392|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373009|NCT01695239|76241393|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373010|NCT01695239|76241394|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373011|NCT01695239|76241395|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373012|NCT01695239|76241396|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373013|NCT01695239|76241397|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373014|NCT01695239|76241398|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
42373015|NCT01695239|76241399|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
42373016|NCT01695239|76241400|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373017|NCT01695239|76241401|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373018|NCT01695239|76241402|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373019|NCT01695239|76241403|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
42373020|NCT01695239|76241390|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
42373021|NCT01695239|76241391|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
42373022|NCT01695239|76241392|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
42373023|NCT01695239|76241393|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
42373024|NCT01695239|76241394|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
42373025|NCT01695239|76241395|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
42373026|NCT01695239|76241396|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
42373027|NCT01695239|76241397|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
42373028|NCT01695239|76241398|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
42373029|NCT01695239|76241399|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
42373030|NCT01695239|76241400|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
42373031|NCT01695239|76241401|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
42373032|NCT01695239|76241402|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
42373033|NCT01695239|76241403|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
42373034|NCT01695239|76241390|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373035|NCT01695239|76241391|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373036|NCT01695239|76241392|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373037|NCT01695239|76241393|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373038|NCT01695239|76241394|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373039|NCT01695239|76241395|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373040|NCT01695239|76241396|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373041|NCT01695239|76241397|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373042|NCT01695239|76241398|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
42373043|NCT01695239|76241399|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
42373044|NCT01695239|76241400|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373045|NCT01695239|76241401|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373046|NCT01695239|76241402|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373047|NCT01695239|76241403|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
42373048|NCT01695239|76241390|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
42373049|NCT01695239|76241391|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
42373050|NCT01695239|76241392|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
42373051|NCT01695239|76241393|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
42373052|NCT01695239|76241394|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
42373053|NCT01695239|76241395|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
42373054|NCT01695239|76241396|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
42373055|NCT01695239|76241397|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
42373056|NCT01695239|76241398|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
42373057|NCT01695239|76241399|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
42373058|NCT01695239|76241400|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
42373059|NCT01695239|76241401|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
42373060|NCT01695239|76241402|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
42373061|NCT01695239|76241403|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
42373062|NCT01695239|76241390|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373063|NCT01695239|76241391|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373064|NCT01695239|76241392|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373065|NCT01695239|76241393|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373066|NCT01695239|76241394|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373067|NCT01695239|76241395|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373068|NCT01695239|76241396|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373069|NCT01695239|76241397|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373070|NCT01695239|76241398|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
42373071|NCT01695239|76241399|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
42373072|NCT01695239|76241400|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373073|NCT01695239|76241401|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373074|NCT01695239|76241402|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373075|NCT01695239|76241403|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
42373076|NCT01695239|76241390|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42373077|NCT01695239|76241391|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42200771|NCT02112916|76012693|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
42200772|NCT02112916|76012694|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
42373078|NCT01695239|76241392|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42373079|NCT01695239|76241393|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42200773|NCT02112916|76012695|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
42373080|NCT01695239|76241394|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42373081|NCT01695239|76241395|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42373082|NCT01695239|76241396|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42373083|NCT01695239|76241397|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42373084|NCT01695239|76241398|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
42373085|NCT01695239|76241399|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
42373086|NCT01695239|76241400|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42373087|NCT01695239|76241401|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42373088|NCT01695239|76241402|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42373089|NCT01695239|76241403|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
42373090|NCT01695239|76241390|FG000|Extension Long-Term Extension Periods|Death|0|||
42373091|NCT01695239|76241391|FG001|Extension Long-Term Extension Periods|Death|0|||
42373092|NCT01695239|76241392|FG002|Extension Long-Term Extension Periods|Death|0|||
42373093|NCT01695239|76241393|FG003|Extension Long-Term Extension Periods|Death|0|||
42373094|NCT01695239|76241394|FG004|Extension Long-Term Extension Periods|Death|0|||
42373095|NCT01695239|76241395|FG005|Extension Long-Term Extension Periods|Death|0|||
42373096|NCT01695239|76241396|FG006|Extension Long-Term Extension Periods|Death|0|||
42373097|NCT01695239|76241397|FG007|Extension Long-Term Extension Periods|Death|0|||
42373098|NCT01695239|76241398|FG008|Extension Long-Term Extension Periods|Death|1|||
42373099|NCT01695239|76241399|FG009|Extension Long-Term Extension Periods|Death|0|||
42373100|NCT01695239|76241400|FG010|Extension Long-Term Extension Periods|Death|0|||
42373101|NCT01695239|76241401|FG011|Extension Long-Term Extension Periods|Death|0|||
42373102|NCT01695239|76241402|FG012|Extension Long-Term Extension Periods|Death|0|||
42373103|NCT01695239|76241403|FG013|Extension Long-Term Extension Periods|Death|0|||
42373104|NCT01695239|76241390|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42373105|NCT01695239|76241391|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42373106|NCT01695239|76241392|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42373107|NCT01695239|76241393|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42373108|NCT01695239|76241394|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42373109|NCT01695239|76241395|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42373110|NCT01695239|76241396|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42373111|NCT01695239|76241397|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42373112|NCT01695239|76241398|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42373113|NCT01695239|76241399|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42373114|NCT01695239|76241400|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
42373115|NCT01695239|76241401|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
42373116|NCT01695239|76241402|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
42373117|NCT01695239|76241403|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
42373118|NCT01695239|76241390|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373119|NCT01695239|76241391|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373120|NCT01695239|76241392|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373121|NCT01695239|76241393|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373122|NCT01695239|76241394|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373123|NCT01695239|76241395|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373124|NCT01695239|76241396|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373125|NCT01695239|76241397|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373126|NCT01695239|76241398|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373127|NCT01695239|76241399|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373128|NCT01695239|76241400|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373129|NCT01695239|76241401|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
42373130|NCT01695239|76241402|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
42373131|NCT01695239|76241403|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
42373132|NCT01695239|76241390|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373133|NCT01695239|76241391|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373134|NCT01695239|76241392|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373135|NCT01695239|76241393|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373136|NCT01695239|76241394|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373137|NCT01695239|76241395|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373138|NCT01695239|76241396|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373139|NCT01695239|76241397|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373140|NCT01695239|76241398|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373141|NCT01695239|76241399|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373142|NCT01695239|76241400|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373143|NCT01695239|76241401|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373144|NCT01695239|76241402|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
42373145|NCT01695239|76241403|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
42373146|NCT01695239|76241390|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373147|NCT01695239|76241391|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373148|NCT01695239|76241392|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373149|NCT01695239|76241393|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373150|NCT01695239|76241394|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373151|NCT01695239|76241395|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373152|NCT01695239|76241396|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373153|NCT01695239|76241397|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373154|NCT01695239|76241398|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373155|NCT01695239|76241399|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373156|NCT01695239|76241400|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373157|NCT01695239|76241401|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373158|NCT01695239|76241402|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
42373159|NCT01695239|76241403|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
42373160|NCT02163694|76241427|FG000|Overall Study|Adverse event- related to progression|3|||
42373161|NCT02163694|76241428|FG001|Overall Study|Adverse event- related to progression|8|||
42373162|NCT02163694|76241427|FG000|Overall Study|Adverse event- not related to progression|7|||
42373163|NCT02163694|76241428|FG001|Overall Study|Adverse event- not related to progression|17|||
42373164|NCT02163694|76241427|FG000|Overall Study|Withdrew consent|8|||
42373165|NCT02163694|76241428|FG001|Overall Study|Withdrew consent|21|||
42373166|NCT02163694|76241427|FG000|Overall Study|Lost to Follow-up|1|||
42373167|NCT02163694|76241428|FG001|Overall Study|Lost to Follow-up|2|||
42373168|NCT02163694|76241427|FG000|Overall Study|Progressive disease per protocol|122|||
42373169|NCT02163694|76241428|FG001|Overall Study|Progressive disease per protocol|197|||
42373170|NCT02163694|76241427|FG000|Overall Study|Other, not specified|13|||
42373171|NCT02163694|76241428|FG001|Overall Study|Other, not specified|22|||
42373172|NCT01694849|76241462|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
42373173|NCT01694849|76241463|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
42373174|NCT01694849|76241464|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
42373175|NCT01694849|76241462|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
42373176|NCT01694849|76241463|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
42373177|NCT01694849|76241464|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
42373178|NCT01694849|76241462|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
42373179|NCT01694849|76241463|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
42373180|NCT01694849|76241464|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
42373181|NCT01694849|76241462|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
42373182|NCT01694849|76241463|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
42373183|NCT01694849|76241464|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
42373184|NCT01694849|76241462|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
42373185|NCT01694849|76241463|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
42373186|NCT01694849|76241464|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
42373187|NCT01694849|76241462|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
42373188|NCT01694849|76241463|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
42373189|NCT01694849|76241464|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
42373190|NCT01694849|76241462|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
42373191|NCT01694849|76241463|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
42373192|NCT01694849|76241464|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
42373193|NCT01694849|76241462|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
42373194|NCT01694849|76241463|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
42373195|NCT01694849|76241464|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
42373196|NCT01694771|76241513|FG000|Overall Study|Adverse Event|18|||
42373197|NCT01694771|76241514|FG001|Overall Study|Adverse Event|16|||
42373198|NCT01694771|76241513|FG000|Overall Study|Lack of Efficacy|1|||
42373199|NCT01694771|76241514|FG001|Overall Study|Lack of Efficacy|0|||
42373200|NCT01694771|76241513|FG000|Overall Study|Non compliance protocol|7|||
42373201|NCT01694771|76241514|FG001|Overall Study|Non compliance protocol|6|||
42373202|NCT01694771|76241513|FG000|Overall Study|Lost to Follow-up|2|||
42373203|NCT01694771|76241514|FG001|Overall Study|Lost to Follow-up|3|||
42373204|NCT01694771|76241513|FG000|Overall Study|Consent withdrawn|7|||
42373205|NCT01694771|76241514|FG001|Overall Study|Consent withdrawn|9|||
42373206|NCT01694771|76241513|FG000|Overall Study|Other reasons|5|||
42373207|NCT01694771|76241514|FG001|Overall Study|Other reasons|6|||
42373208|NCT01582061|76241543|FG000|Overall Study|Lack of Efficacy|3|||
42373209|NCT01582061|76241544|FG001|Overall Study|Lack of Efficacy|23|||
42373210|NCT01582061|76241543|FG000|Overall Study|Adverse Event|12|||
42373211|NCT01582061|76241544|FG001|Overall Study|Adverse Event|8|||
42373212|NCT01582061|76241543|FG000|Overall Study|Withdrawal by Subject|10|||
42373213|NCT01582061|76241544|FG001|Overall Study|Withdrawal by Subject|4|||
42373214|NCT01582061|76241543|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42373215|NCT01582061|76241544|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42373216|NCT01582061|76241543|FG000|Overall Study|Death|0|||
42373217|NCT01582061|76241544|FG001|Overall Study|Death|1|||
42373218|NCT01582061|76241543|FG000|Overall Study|condition no longer requires study drug|1|||
42373219|NCT01582061|76241544|FG001|Overall Study|condition no longer requires study drug|0|||
42373220|NCT01582061|76241543|FG000|Overall Study|Lost to Follow-up|1|||
42373221|NCT01582061|76241544|FG001|Overall Study|Lost to Follow-up|0|||
42373222|NCT01693523|76241563|FG000|Overall Study|Adverse Event|2|||
42373223|NCT01693523|76241564|FG001|Overall Study|Adverse Event|1|||
42373224|NCT01693523|76241565|FG002|Overall Study|Adverse Event|0|||
42373225|NCT01693523|76241563|FG000|Overall Study|Death|0|||
42373226|NCT01693523|76241564|FG001|Overall Study|Death|1|||
42373227|NCT01693523|76241565|FG002|Overall Study|Death|1|||
42373228|NCT01693523|76241563|FG000|Overall Study|Lost to Follow-up|0|||
42373229|NCT01693523|76241564|FG001|Overall Study|Lost to Follow-up|0|||
42373230|NCT01693523|76241565|FG002|Overall Study|Lost to Follow-up|4|||
42373231|NCT01693523|76241563|FG000|Overall Study|Physician Decision|0|||
42373232|NCT01693523|76241564|FG001|Overall Study|Physician Decision|0|||
42373233|NCT01693523|76241565|FG002|Overall Study|Physician Decision|1|||
42373234|NCT01693523|76241563|FG000|Overall Study|Withdrawal by Subject|1|||
42373235|NCT01693523|76241564|FG001|Overall Study|Withdrawal by Subject|2|||
42373236|NCT01693523|76241565|FG002|Overall Study|Withdrawal by Subject|2|||
42373237|NCT01693523|76241563|FG000|Overall Study|Lack of compliance study medication|1|||
42373238|NCT01693523|76241564|FG001|Overall Study|Lack of compliance study medication|2|||
42373239|NCT01693523|76241565|FG002|Overall Study|Lack of compliance study medication|0|||
42373240|NCT01693523|76241563|FG000|Overall Study|Chemotherapy was held|1|||
42373241|NCT01693523|76241564|FG001|Overall Study|Chemotherapy was held|2|||
42373242|NCT01693523|76241565|FG002|Overall Study|Chemotherapy was held|0|||
42373243|NCT01581593|76241581|FG000|Overall Study|Withdrawal by Subject|1|||
42373244|NCT01581281|76241592|FG000|Overall Study|Early Study Closure|15|||
42373245|NCT01581281|76241593|FG001|Overall Study|Early Study Closure|6|||
42373246|NCT01581281|76241594|FG002|Overall Study|Early Study Closure|12|||
42373247|NCT02692716|76241605|FG000|Overall Study|Lost to Follow-up|2|||
42373248|NCT02692716|76241606|FG001|Overall Study|Lost to Follow-up|5|||
42373249|NCT02692716|76241605|FG000|Overall Study|Withdrawal by Subject|3|||
42373250|NCT02692716|76241606|FG001|Overall Study|Withdrawal by Subject|1|||
42373251|NCT01580969|76241615|FG000|Overall Study|Physician Decision|3|||
42373252|NCT01580969|76241616|FG001|Overall Study|Physician Decision|0|||
42373253|NCT01580969|76241617|FG002|Overall Study|Physician Decision|0|||
42373254|NCT01693367|76241627|FG000|Overall Study|Withdrawal by Subject|1|||
42373255|NCT01693367|76241628|FG001|Overall Study|Withdrawal by Subject|1|||
42373256|NCT01693367|76241627|FG000|Overall Study|Physician Decision|0|||
42373257|NCT01693367|76241628|FG001|Overall Study|Physician Decision|1|||
42373258|NCT02696226|76241638|FG000|Overall Study|Study terminated - lack of enrollment|1|||
42373259|NCT02696226|76241639|FG001|Overall Study|Study terminated - lack of enrollment|0|||
42373260|NCT02696226|76241640|FG002|Overall Study|Study terminated - lack of enrollment|2|||
42103432|NCT00652626|75914378|FG005|Extension Phase|Withdrawal by Subject|2|||
42373261|NCT02696226|76241641|FG003|Overall Study|Study terminated - lack of enrollment|0|||
42373262|NCT01692275|76241657|FG000|Overall Study|Lost to Follow-up|57|||
42373263|NCT01692275|76241658|FG001|Overall Study|Lost to Follow-up|48|||
42373264|NCT01692275|76241657|FG000|Overall Study|Withdrawal by Subject|9|||
42373265|NCT01692275|76241658|FG001|Overall Study|Withdrawal by Subject|11|||
42373266|NCT02692560|76241678|FG000|Overall Study|Withdrawal by Subject|0|||
42373267|NCT02692560|76241679|FG001|Overall Study|Withdrawal by Subject|6|||
42373268|NCT02688192|76241687|FG000|Overall Study|Lost to Follow-up|11|||
42373269|NCT02688192|76241688|FG001|Overall Study|Lost to Follow-up|5|||
42373270|NCT02688192|76241687|FG000|Overall Study|Physician Decision|1|||
42373271|NCT02688192|76241688|FG001|Overall Study|Physician Decision|0|||
42373272|NCT01579565|76241697|FG000|Randomized|Adverse Event|1|||
42373273|NCT01579565|76241698|FG001|Randomized|Adverse Event|3|||
42373274|NCT01579565|76241697|FG000|Randomized|Withdrawal by Subject|3|||
42373275|NCT01579565|76241698|FG001|Randomized|Withdrawal by Subject|0|||
42373276|NCT01579565|76241697|FG000|Randomized|inadequate preoperative pupil dilation|0|||
42373277|NCT01579565|76241698|FG001|Randomized|inadequate preoperative pupil dilation|1|||
42373278|NCT01579565|76241697|FG000|Randomized|prohibited preoperative eating|1|||
42373279|NCT01579565|76241698|FG001|Randomized|prohibited preoperative eating|0|||
42373280|NCT01579565|76241697|FG000|Randomized|prohibited preoperative medication|0|||
42373281|NCT01579565|76241698|FG001|Randomized|prohibited preoperative medication|1|||
42373282|NCT01579565|76241697|FG000|Treated|Physician Decision|0|||
42373283|NCT01579565|76241698|FG001|Treated|Physician Decision|1|||
42373284|NCT01579565|76241697|FG000|Treated|Lost to Follow-up|2|||
42373285|NCT01579565|76241698|FG001|Treated|Lost to Follow-up|1|||
42373286|NCT01579565|76241697|FG000|Treated|declined to return for final visit|0|||
42373287|NCT01579565|76241698|FG001|Treated|declined to return for final visit|1|||
42373288|NCT01578785|76241708|FG000|Overall Study|Withdrawal by Subject|0|||
42373289|NCT01578785|76241709|FG001|Overall Study|Withdrawal by Subject|1|||
42373290|NCT01578785|76241708|FG000|Overall Study|Study terminated by sponsor|59|||
42373291|NCT01578785|76241709|FG001|Overall Study|Study terminated by sponsor|118|||
42373292|NCT02692482|76241717|FG000|Overall Study|Death|2|||
42373293|NCT02692482|76241718|FG001|Overall Study|Death|2|||
42373294|NCT02692482|76241717|FG000|Overall Study|Withdrawal by Subject|1|||
42373295|NCT02692482|76241718|FG001|Overall Study|Withdrawal by Subject|2|||
42373296|NCT01578551|76241727|FG000|Overall Study|Adverse Event|1|||
42373297|NCT01578551|76241728|FG001|Overall Study|Adverse Event|0|||
42373298|NCT01692197|76241735|FG000|Overall Study|Failed Screening|3|||
42373299|NCT01692119|76241742|FG000|Overall Study|Protocol Violation|3|||
42373300|NCT01692119|76241743|FG001|Overall Study|Protocol Violation|1|||
42373301|NCT01692119|76241742|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
42373302|NCT01692119|76241743|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
42373303|NCT01691885|76241749|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
42373304|NCT01691885|76241750|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
42373305|NCT01691885|76241749|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
42373306|NCT01691885|76241750|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
42373307|NCT01587703|76241783|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
42373308|NCT01587703|76241784|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373309|NCT01587703|76241785|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373310|NCT01587703|76241786|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373311|NCT01587703|76241787|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373312|NCT01587703|76241788|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373313|NCT01587703|76241789|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373314|NCT01587703|76241790|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373315|NCT01587703|76241791|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373316|NCT01587703|76241792|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373317|NCT01587703|76241793|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373318|NCT01587703|76241794|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373319|NCT01587703|76241795|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373320|NCT01587703|76241796|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373321|NCT01587703|76241797|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373322|NCT01587703|76241798|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373323|NCT01587703|76241799|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373324|NCT01587703|76241800|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373325|NCT01587703|76241801|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
42373326|NCT01587703|76241783|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373327|NCT01587703|76241784|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373328|NCT01587703|76241785|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373329|NCT01587703|76241786|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373330|NCT01587703|76241787|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373331|NCT01587703|76241788|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
42373332|NCT01587703|76241789|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373333|NCT01587703|76241790|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
42373334|NCT01587703|76241791|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373335|NCT01587703|76241792|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373336|NCT01587703|76241793|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373337|NCT01587703|76241794|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373338|NCT01587703|76241795|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373339|NCT01587703|76241796|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373340|NCT01587703|76241797|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373341|NCT01587703|76241798|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373342|NCT01587703|76241799|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373343|NCT01587703|76241800|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373344|NCT01587703|76241801|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
42373345|NCT01587703|76241783|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373346|NCT01587703|76241784|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373347|NCT01587703|76241785|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373348|NCT01587703|76241786|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373349|NCT01587703|76241787|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373350|NCT01587703|76241788|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373351|NCT01587703|76241789|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
42373352|NCT01587703|76241790|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373353|NCT01587703|76241791|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373354|NCT01587703|76241792|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373355|NCT01587703|76241793|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373356|NCT01587703|76241794|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373357|NCT01587703|76241795|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373358|NCT01587703|76241796|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373359|NCT01587703|76241797|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373360|NCT01587703|76241798|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373361|NCT01587703|76241799|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373362|NCT01587703|76241800|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373363|NCT01587703|76241801|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
42373364|NCT01587703|76241783|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
42373365|NCT01587703|76241784|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
42373366|NCT01587703|76241785|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
42373367|NCT01587703|76241786|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
42373368|NCT01587703|76241787|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
42373369|NCT01587703|76241788|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
42373370|NCT01587703|76241789|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
42373371|NCT01587703|76241790|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
42373372|NCT01587703|76241791|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
42103433|NCT00652626|75914379|FG006|Extension Phase|Withdrawal by Subject|0|||
42103434|NCT00652626|75914373|FG000|Extension Phase|Adverse Event|0|||
42103435|NCT00652626|75914374|FG001|Extension Phase|Adverse Event|0|||
42103436|NCT00652626|75914375|FG002|Extension Phase|Adverse Event|0|||
42103437|NCT00652626|75914376|FG003|Extension Phase|Adverse Event|0|||
42103438|NCT00652626|75914377|FG004|Extension Phase|Adverse Event|0|||
42103439|NCT00652626|75914378|FG005|Extension Phase|Adverse Event|2|||
42103440|NCT00652626|75914379|FG006|Extension Phase|Adverse Event|1|||
42103441|NCT00652626|75914373|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
42103442|NCT00652626|75914374|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
42103443|NCT00652626|75914375|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
42103444|NCT00652626|75914376|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
42103445|NCT00652626|75914377|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
42103446|NCT00652626|75914378|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
42103447|NCT00652626|75914379|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
42103448|NCT00652626|75914373|FG000|Extension Phase|Physician Decision|0|||
42103449|NCT00652626|75914374|FG001|Extension Phase|Physician Decision|0|||
42103450|NCT00652626|75914375|FG002|Extension Phase|Physician Decision|0|||
42103451|NCT00652626|75914376|FG003|Extension Phase|Physician Decision|0|||
42103452|NCT00652626|75914377|FG004|Extension Phase|Physician Decision|0|||
42103453|NCT00652626|75914378|FG005|Extension Phase|Physician Decision|1|||
42103454|NCT00652626|75914379|FG006|Extension Phase|Physician Decision|1|||
42103455|NCT00652626|75914373|FG000|Extension Phase|Death|0|||
42373373|NCT01587703|76241792|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
42373374|NCT01587703|76241793|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
42103456|NCT00652626|75914374|FG001|Extension Phase|Death|0|||
42103457|NCT00652626|75914375|FG002|Extension Phase|Death|0|||
42103458|NCT00652626|75914376|FG003|Extension Phase|Death|0|||
42103459|NCT00652626|75914377|FG004|Extension Phase|Death|0|||
42103460|NCT00652626|75914378|FG005|Extension Phase|Death|1|||
42103461|NCT00652626|75914379|FG006|Extension Phase|Death|1|||
42103462|NCT00560703|75914399|FG000|Overall Study|Adverse Event|0|||
42103463|NCT00560703|75914400|FG001|Overall Study|Adverse Event|2|||
42103464|NCT00560703|75914399|FG000|Overall Study|Protocol Violation|0|||
42103465|NCT00560703|75914400|FG001|Overall Study|Protocol Violation|2|||
42103466|NCT00560703|75914399|FG000|Overall Study|Withdrawal by Subject|0|||
42103467|NCT00560703|75914400|FG001|Overall Study|Withdrawal by Subject|1|||
42373375|NCT01587703|76241794|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
42373376|NCT01587703|76241795|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
42373377|NCT01587703|76241796|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
42373378|NCT01587703|76241797|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
42373379|NCT01587703|76241798|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
42373380|NCT01587703|76241799|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
42373381|NCT01587703|76241800|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
42373382|NCT01587703|76241801|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
42373383|NCT01587703|76241783|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373384|NCT01587703|76241784|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373385|NCT01587703|76241785|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373386|NCT01587703|76241786|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373387|NCT01587703|76241787|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373388|NCT01587703|76241788|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373389|NCT01587703|76241789|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373390|NCT01587703|76241790|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373391|NCT01587703|76241791|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
42373392|NCT01587703|76241792|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
42373393|NCT01587703|76241793|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
42373394|NCT01587703|76241794|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373395|NCT01587703|76241795|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373396|NCT01587703|76241796|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373397|NCT01587703|76241797|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373398|NCT01587703|76241798|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373399|NCT01587703|76241799|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373400|NCT01587703|76241800|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373401|NCT01587703|76241801|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
42373402|NCT01587703|76241783|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373403|NCT01587703|76241784|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373404|NCT01587703|76241785|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373405|NCT01587703|76241786|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373406|NCT01587703|76241787|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373407|NCT01587703|76241788|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373408|NCT01587703|76241789|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373409|NCT01587703|76241790|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373410|NCT01587703|76241791|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
42373411|NCT01587703|76241792|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373412|NCT01587703|76241793|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
42373413|NCT01587703|76241794|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373414|NCT01587703|76241795|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373415|NCT01587703|76241796|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373416|NCT01587703|76241797|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373417|NCT01587703|76241798|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373418|NCT01587703|76241799|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373419|NCT01587703|76241800|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373420|NCT01587703|76241801|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
42373421|NCT01587703|76241783|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373422|NCT01587703|76241784|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373423|NCT01587703|76241785|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373424|NCT01587703|76241786|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373425|NCT01587703|76241787|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373426|NCT01587703|76241788|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373427|NCT01587703|76241789|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42103468|NCT00560703|75914399|FG000|Overall Study|non-compliance|0|||
42103469|NCT00560703|75914400|FG001|Overall Study|non-compliance|1|||
42373428|NCT01587703|76241790|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42103470|NCT00308737|75914409|FG000|Overall Study|Adverse Event|104|||
42373429|NCT01587703|76241791|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373430|NCT01587703|76241792|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
42373431|NCT01587703|76241793|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
42373432|NCT01587703|76241794|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373433|NCT01587703|76241795|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373434|NCT01587703|76241796|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373435|NCT01587703|76241797|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373436|NCT01587703|76241798|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373437|NCT01587703|76241799|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373438|NCT01587703|76241800|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373439|NCT01587703|76241801|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
42373440|NCT01587703|76241783|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373441|NCT01587703|76241784|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373442|NCT01587703|76241785|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373443|NCT01587703|76241786|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373444|NCT01587703|76241787|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373445|NCT01587703|76241788|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373446|NCT01587703|76241789|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373447|NCT01587703|76241790|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373448|NCT01587703|76241791|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
42373449|NCT01587703|76241792|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373450|NCT01587703|76241793|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373451|NCT01587703|76241794|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373452|NCT01587703|76241795|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373453|NCT01587703|76241796|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373454|NCT01587703|76241797|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373455|NCT01587703|76241798|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373456|NCT01587703|76241799|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373457|NCT01587703|76241800|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373458|NCT01587703|76241801|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
42373459|NCT01587703|76241783|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373460|NCT01587703|76241784|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373461|NCT01587703|76241785|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373462|NCT01587703|76241786|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373463|NCT01587703|76241787|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373464|NCT01587703|76241788|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373465|NCT01587703|76241789|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373466|NCT01587703|76241790|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373467|NCT01587703|76241791|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373468|NCT01587703|76241792|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373469|NCT01587703|76241793|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373470|NCT01587703|76241794|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373471|NCT01587703|76241795|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373472|NCT01587703|76241796|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373473|NCT01587703|76241797|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373474|NCT01587703|76241798|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373475|NCT01587703|76241799|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373476|NCT01587703|76241800|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
42373477|NCT01587703|76241801|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
42373478|NCT01587703|76241783|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373479|NCT01587703|76241784|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373480|NCT01587703|76241785|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373481|NCT01587703|76241786|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373482|NCT01587703|76241787|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373483|NCT01587703|76241788|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373484|NCT01587703|76241789|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373485|NCT01587703|76241790|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373486|NCT01587703|76241791|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373487|NCT01587703|76241792|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373488|NCT01587703|76241793|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42200774|NCT02112916|76012696|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
42200775|NCT02112916|76012693|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
42200776|NCT02112916|76012694|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
42200777|NCT02112916|76012695|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
42373489|NCT01587703|76241794|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373490|NCT01587703|76241795|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373491|NCT01587703|76241796|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373492|NCT01587703|76241797|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373493|NCT01587703|76241798|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373494|NCT01587703|76241799|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
42373495|NCT01587703|76241800|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
42373496|NCT01587703|76241801|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
42373497|NCT01587703|76241783|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373498|NCT01587703|76241784|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373499|NCT01587703|76241785|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373500|NCT01587703|76241786|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373501|NCT01587703|76241787|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373502|NCT01587703|76241788|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373503|NCT01587703|76241789|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373504|NCT01587703|76241790|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373505|NCT01587703|76241791|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373506|NCT01587703|76241792|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373507|NCT01587703|76241793|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373508|NCT01587703|76241794|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373509|NCT01587703|76241795|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373510|NCT01587703|76241796|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373511|NCT01587703|76241797|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373512|NCT01587703|76241798|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
42373513|NCT01587703|76241799|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373514|NCT01587703|76241800|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373515|NCT01587703|76241801|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
42373516|NCT01587703|76241783|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373517|NCT01587703|76241784|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373518|NCT01587703|76241785|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373519|NCT01587703|76241786|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373520|NCT01587703|76241787|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373521|NCT01587703|76241788|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373522|NCT01587703|76241789|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373523|NCT01587703|76241790|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373524|NCT01587703|76241791|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373525|NCT01587703|76241792|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373526|NCT01587703|76241793|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373527|NCT01587703|76241794|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
42373528|NCT01587703|76241795|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373529|NCT01587703|76241796|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373530|NCT01587703|76241797|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
42373531|NCT01587703|76241798|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373532|NCT01587703|76241799|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373533|NCT01587703|76241800|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373534|NCT01587703|76241801|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
42373535|NCT01587703|76241783|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373536|NCT01587703|76241784|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373537|NCT01587703|76241785|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373538|NCT01587703|76241786|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42200778|NCT02112916|76012696|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
42200779|NCT02057718|76012713|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
42373539|NCT01587703|76241787|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373540|NCT01587703|76241788|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373541|NCT01587703|76241789|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373542|NCT01587703|76241790|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373543|NCT01587703|76241791|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373544|NCT01587703|76241792|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373545|NCT01587703|76241793|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373546|NCT01587703|76241794|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
42373547|NCT01587703|76241795|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
42373548|NCT01587703|76241796|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
42200780|NCT02057718|76012714|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
42200781|NCT02057718|76012713|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
42373549|NCT01587703|76241797|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
42200782|NCT02057718|76012714|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
42373550|NCT01587703|76241798|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
42373551|NCT01587703|76241799|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
42373552|NCT01587703|76241800|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373553|NCT01587703|76241801|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
42373554|NCT01587703|76241783|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373555|NCT01587703|76241784|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373556|NCT01587703|76241785|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373557|NCT01587703|76241786|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373558|NCT01587703|76241787|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373559|NCT01587703|76241788|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373560|NCT01587703|76241789|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373561|NCT01587703|76241790|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373562|NCT01587703|76241791|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373563|NCT01587703|76241792|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373564|NCT01587703|76241793|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373565|NCT01587703|76241794|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
42373566|NCT01587703|76241795|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
42373567|NCT01587703|76241796|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
42373568|NCT01587703|76241797|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
42373569|NCT01587703|76241798|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
42373570|NCT01587703|76241799|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
42373571|NCT01587703|76241800|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373572|NCT01587703|76241801|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
42373573|NCT01587703|76241783|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373574|NCT01587703|76241784|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373575|NCT01587703|76241785|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373576|NCT01587703|76241786|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373577|NCT01587703|76241787|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373578|NCT01587703|76241788|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373579|NCT01587703|76241789|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373580|NCT01587703|76241790|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373581|NCT01587703|76241791|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373582|NCT01587703|76241792|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373583|NCT01587703|76241793|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373584|NCT01587703|76241794|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
42373585|NCT01587703|76241795|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373586|NCT01587703|76241796|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373587|NCT01587703|76241797|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373588|NCT01587703|76241798|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373589|NCT01587703|76241799|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373590|NCT01587703|76241800|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373591|NCT01587703|76241801|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
42373592|NCT01577381|76241864|FG000|Overall Study|Discontinued|2|||
42373593|NCT01577381|76241865|FG001|Overall Study|Discontinued|1|||
42373594|NCT01577381|76241866|FG002|Overall Study|Discontinued|2|||
42373595|NCT01577381|76241867|FG003|Overall Study|Discontinued|2|||
42373596|NCT01577381|76241864|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
42373597|NCT01577381|76241865|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
42373598|NCT01577381|76241866|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
42018721|NCT01256177|75826074|FG000|Overall Study|Condition under Investigation Worsened|1|||
42018722|NCT01256177|75826075|FG001|Overall Study|Condition under Investigation Worsened|0|||
42018723|NCT01256177|75826074|FG000|Overall Study|Lack of Efficacy|11|||
42018724|NCT01256177|75826075|FG001|Overall Study|Lack of Efficacy|2|||
42018725|NCT01256177|75826074|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
42018726|NCT01256177|75826075|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
42018727|NCT00999544|75826081|FG000|Overall Study|Withdrawal by Subject|1|||
42018728|NCT01124097|75826118|FG000|Overall Study|Withdrawal by Subject|4|||
42018729|NCT01124097|75826119|FG001|Overall Study|Withdrawal by Subject|3|||
42018730|NCT01124097|75826120|FG002|Overall Study|Withdrawal by Subject|2|||
42018731|NCT01124097|75826121|FG003|Overall Study|Withdrawal by Subject|3|||
42018732|NCT01124097|75826118|FG000|Overall Study|Lack of Efficacy|2|||
42018733|NCT01124097|75826119|FG001|Overall Study|Lack of Efficacy|3|||
42018734|NCT01124097|75826120|FG002|Overall Study|Lack of Efficacy|1|||
42018735|NCT01124097|75826121|FG003|Overall Study|Lack of Efficacy|3|||
42018736|NCT01124097|75826118|FG000|Overall Study|Adverse Event|24|||
42373599|NCT01577381|76241867|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
42373600|NCT02686164|76241877|FG000|Overall Study|Adverse Event|1|||
42373601|NCT02686164|76241877|FG000|Overall Study|Withdrawal of consent|1|||
42373602|NCT02686164|76241877|FG000|Overall Study|Clinical progression|1|||
42018737|NCT01124097|75826119|FG001|Overall Study|Adverse Event|15|||
42018738|NCT01124097|75826120|FG002|Overall Study|Adverse Event|15|||
42373603|NCT01691105|76241898|FG000|1 Month Follow-up|Lost to Follow-up|41|||
42373604|NCT01691105|76241899|FG001|1 Month Follow-up|Lost to Follow-up|38|||
42373605|NCT01691105|76241898|FG000|1 Month Follow-up|Death|2|||
42373606|NCT01691105|76241899|FG001|1 Month Follow-up|Death|3|||
42373607|NCT01691105|76241898|FG000|6 Month Follow-up|Lost to Follow-up|39|||
42373608|NCT01691105|76241899|FG001|6 Month Follow-up|Lost to Follow-up|58|||
42373609|NCT01691105|76241898|FG000|6 Month Follow-up|Death|13|||
42373610|NCT01691105|76241899|FG001|6 Month Follow-up|Death|13|||
42373611|NCT01691105|76241898|FG000|12 Month Follow-up|Lost to Follow-up|50|||
42373612|NCT01691105|76241899|FG001|12 Month Follow-up|Lost to Follow-up|71|||
42373613|NCT01691105|76241898|FG000|12 Month Follow-up|Death|22|||
42373614|NCT01691105|76241899|FG001|12 Month Follow-up|Death|30|||
42373615|NCT01691105|76241898|FG000|12 Month Biochemical Verification|Death|22|||
42373616|NCT01691105|76241899|FG001|12 Month Biochemical Verification|Death|30|||
42373617|NCT01691105|76241898|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
42373618|NCT01691105|76241899|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
42373619|NCT01691105|76241898|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
42373620|NCT01691105|76241899|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
42373621|NCT02685072|76241907|FG000|Treatment Period|Lost to Follow-up|12|||
42373622|NCT02685072|76241908|FG001|Treatment Period|Lost to Follow-up|6|||
42373623|NCT02685072|76241907|FG000|Treatment Period|Withdrawal by Subject|1|||
42373624|NCT02685072|76241908|FG001|Treatment Period|Withdrawal by Subject|3|||
42373625|NCT02685072|76241907|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
42373626|NCT02685072|76241908|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
42373627|NCT02695524|76241978|FG000|Overall Study|Lost to Follow-up|3|||
42373628|NCT02695524|76241979|FG001|Overall Study|Lost to Follow-up|2|||
42373629|NCT02695524|76241978|FG000|Overall Study|Death|0|||
42373630|NCT02695524|76241979|FG001|Overall Study|Death|1|||
42373631|NCT01576367|76241985|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
42373632|NCT01576367|76241985|FG000|Overall Study|Moved to commercial use after 6 months|1|||
42373633|NCT01689857|76241996|FG000|Overall Study|Lost to Follow-up|5|||
42103471|NCT00308737|75914410|FG001|Overall Study|Adverse Event|9|||
42103472|NCT00308737|75914411|FG002|Overall Study|Adverse Event|0|||
42103473|NCT00308737|75914409|FG000|Overall Study|Death|4|||
42103474|NCT00308737|75914410|FG001|Overall Study|Death|3|||
42103475|NCT00308737|75914411|FG002|Overall Study|Death|0|||
42103476|NCT00308737|75914409|FG000|Overall Study|Lost to Follow-up|56|||
42103477|NCT00308737|75914410|FG001|Overall Study|Lost to Follow-up|80|||
42103478|NCT00308737|75914411|FG002|Overall Study|Lost to Follow-up|5|||
42373634|NCT01689857|76241997|FG001|Overall Study|Lost to Follow-up|2|||
42373635|NCT01587079|76242012|FG000|Overall Study|Protocol-specified criteria|9|||
42373636|NCT01587079|76242012|FG000|Overall Study|Protocol Violation|5|||
42373637|NCT01587079|76242012|FG000|Overall Study|Lost to Follow-up|2|||
42373638|NCT01587079|76242012|FG000|Overall Study|Physician Decision|2|||
42373639|NCT01587079|76242012|FG000|Overall Study|Withdrawal by Subject|7|||
42373640|NCT01587079|76242012|FG000|Overall Study|Adverse Event|14|||
42373641|NCT01587001|76242065|FG000|Overall Study|Lost to Follow-up|2|||
42373642|NCT01587001|76242066|FG001|Overall Study|Lost to Follow-up|0|||
42373643|NCT01587001|76242065|FG000|Overall Study|Insufficient samples to complete testing|4|||
42373644|NCT01587001|76242066|FG001|Overall Study|Insufficient samples to complete testing|1|||
42373645|NCT01568047|76242096|FG000|Overall Study|Ineligibility|1|||
42373646|NCT01568047|76242097|FG001|Overall Study|Ineligibility|0|||
42373647|NCT01568047|76242098|FG002|Overall Study|Ineligibility|0|||
42373648|NCT01568047|76242099|FG003|Overall Study|Ineligibility|0|||
42373649|NCT01568047|76242096|FG000|Overall Study|Withdrawal by Subject|0|||
42373650|NCT01568047|76242097|FG001|Overall Study|Withdrawal by Subject|1|||
42373651|NCT01568047|76242098|FG002|Overall Study|Withdrawal by Subject|0|||
42373652|NCT01568047|76242099|FG003|Overall Study|Withdrawal by Subject|0|||
42373653|NCT01568047|76242096|FG000|Overall Study|Adverse Event|0|||
42373654|NCT01568047|76242097|FG001|Overall Study|Adverse Event|0|||
42373655|NCT01568047|76242098|FG002|Overall Study|Adverse Event|1|||
42373656|NCT01568047|76242099|FG003|Overall Study|Adverse Event|1|||
42373657|NCT01688999|76242112|FG000|Overall Study|Withdrawal by Subject|5|||
42103479|NCT00308737|75914409|FG000|Overall Study|Physician Decision|15|||
42103480|NCT00308737|75914410|FG001|Overall Study|Physician Decision|2|||
42103481|NCT00308737|75914411|FG002|Overall Study|Physician Decision|1|||
42373658|NCT01688999|76242113|FG001|Overall Study|Withdrawal by Subject|1|||
42373659|NCT01688999|76242114|FG002|Overall Study|Withdrawal by Subject|1|||
42373660|NCT01688999|76242112|FG000|Overall Study|Adverse Event|2|||
42373661|NCT01688999|76242113|FG001|Overall Study|Adverse Event|0|||
42103482|NCT00308737|75914409|FG000|Overall Study|Protocol Violation|34|||
42103483|NCT00308737|75914410|FG001|Overall Study|Protocol Violation|9|||
42373662|NCT01688999|76242114|FG002|Overall Study|Adverse Event|2|||
42373663|NCT01688999|76242112|FG000|Overall Study|Ineligible/Not treated|1|||
42373664|NCT01688999|76242113|FG001|Overall Study|Ineligible/Not treated|0|||
42373665|NCT01688999|76242114|FG002|Overall Study|Ineligible/Not treated|0|||
42373666|NCT01541917|76242138|FG000|Overall Study|Lost to Follow-up|2|||
42373667|NCT01541917|76242139|FG001|Overall Study|Lost to Follow-up|2|||
42373668|NCT01541917|76242138|FG000|Overall Study|Withdrawal by Subject|13|||
42373669|NCT01541917|76242139|FG001|Overall Study|Withdrawal by Subject|7|||
42373670|NCT01688921|76242159|FG000|Overall Study|Lost to Follow-up|7|||
42373671|NCT01688921|76242160|FG001|Overall Study|Lost to Follow-up|13|||
42373672|NCT01688921|76242159|FG000|Overall Study|Physician Decision|6|||
42373673|NCT01688921|76242160|FG001|Overall Study|Physician Decision|1|||
42373674|NCT01688921|76242159|FG000|Overall Study|Protocol Violation|0|||
42373675|NCT01688921|76242160|FG001|Overall Study|Protocol Violation|1|||
42373676|NCT01688921|76242159|FG000|Overall Study|informed consent|3|||
42373677|NCT01688921|76242160|FG001|Overall Study|informed consent|0|||
42373678|NCT01541371|76242182|FG000|Overall Study|Withdrawal by Subject|14|||
42373679|NCT01541371|76242182|FG000|Overall Study|Lost to Follow-up|21|||
42373680|NCT01541371|76242182|FG000|Overall Study|Adverse Event|15|||
42373681|NCT01541371|76242182|FG000|Overall Study|Lack of Efficacy|12|||
42373682|NCT01541371|76242182|FG000|Overall Study|Protocol Violation|6|||
42373683|NCT01541371|76242182|FG000|Overall Study|Study medication non-compliance|3|||
42373684|NCT01541371|76242182|FG000|Overall Study|Other|6|||
42373685|NCT01687673|76242215|FG000|Overall Study|Physician Decision|1|||
42373686|NCT01687595|76242295|FG000|Overall Study|Withdrawal by Subject|8|||
42373687|NCT01687595|76242296|FG001|Overall Study|Withdrawal by Subject|0|||
42373688|NCT01687595|76242295|FG000|Overall Study|Lost to Follow-up|3|||
42373689|NCT01687595|76242296|FG001|Overall Study|Lost to Follow-up|1|||
42373690|NCT01687595|76242295|FG000|Overall Study|Investigator's decision|1|||
42373691|NCT01687595|76242296|FG001|Overall Study|Investigator's decision|0|||
42373692|NCT01687595|76242295|FG000|Overall Study|Sponsor's decision|1|||
42373693|NCT01687595|76242296|FG001|Overall Study|Sponsor's decision|0|||
42373694|NCT01687595|76242295|FG000|Overall Study|Noncompliance|1|||
42373695|NCT01687595|76242296|FG001|Overall Study|Noncompliance|2|||
42373696|NCT01687595|76242295|FG000|Overall Study|Other than specified|56|||
42373697|NCT01687595|76242296|FG001|Overall Study|Other than specified|7|||
42373698|NCT01687283|76242304|FG000|Overall Study|Adverse Event|11|||
42373699|NCT01687283|76242305|FG001|Overall Study|Adverse Event|4|||
42373700|NCT01687283|76242304|FG000|Overall Study|Lack of Efficacy|3|||
42373701|NCT01687283|76242305|FG001|Overall Study|Lack of Efficacy|1|||
42373702|NCT01687283|76242304|FG000|Overall Study|Protocol Violation|1|||
42373703|NCT01687283|76242305|FG001|Overall Study|Protocol Violation|3|||
42373704|NCT01687283|76242304|FG000|Overall Study|protocol defined stopping criteria|8|||
42373705|NCT01687283|76242305|FG001|Overall Study|protocol defined stopping criteria|10|||
42373706|NCT01687283|76242304|FG000|Overall Study|Lost to Follow-up|1|||
42373707|NCT01687283|76242305|FG001|Overall Study|Lost to Follow-up|1|||
42373708|NCT01687283|76242304|FG000|Overall Study|Investigator discretion|2|||
42373709|NCT01687283|76242305|FG001|Overall Study|Investigator discretion|0|||
42373710|NCT01687283|76242304|FG000|Overall Study|Withdrawal by Subject|9|||
42373711|NCT01687283|76242305|FG001|Overall Study|Withdrawal by Subject|8|||
42373712|NCT02684370|76242314|FG000|Part A|Adverse Event|2|||
42373713|NCT02684370|76242315|FG001|Part A|Adverse Event|0|||
42373714|NCT02684370|76242316|FG002|Part A|Adverse Event|1|||
42373715|NCT02684370|76242317|FG003|Part A|Adverse Event|0|||
42373716|NCT02684370|76242318|FG004|Part A|Adverse Event|0|||
42373717|NCT02684370|76242319|FG005|Part A|Adverse Event|0|||
42373718|NCT02684370|76242314|FG000|Part A|Lost to Follow-up|1|||
42373719|NCT02684370|76242315|FG001|Part A|Lost to Follow-up|1|||
42373720|NCT02684370|76242316|FG002|Part A|Lost to Follow-up|0|||
42373721|NCT02684370|76242317|FG003|Part A|Lost to Follow-up|0|||
42373722|NCT02684370|76242318|FG004|Part A|Lost to Follow-up|0|||
42373723|NCT02684370|76242319|FG005|Part A|Lost to Follow-up|0|||
42373724|NCT02684370|76242314|FG000|Part A|Subject Withdrawal|1|||
42373725|NCT02684370|76242315|FG001|Part A|Subject Withdrawal|0|||
42373726|NCT02684370|76242316|FG002|Part A|Subject Withdrawal|3|||
42373727|NCT02684370|76242317|FG003|Part A|Subject Withdrawal|0|||
42373728|NCT02684370|76242318|FG004|Part A|Subject Withdrawal|0|||
42373729|NCT02684370|76242319|FG005|Part A|Subject Withdrawal|0|||
42373730|NCT02684370|76242314|FG000|Part A|Other|0|||
42373731|NCT02684370|76242315|FG001|Part A|Other|0|||
42373732|NCT02684370|76242316|FG002|Part A|Other|1|||
42373733|NCT02684370|76242317|FG003|Part A|Other|0|||
42373734|NCT02684370|76242318|FG004|Part A|Other|0|||
42373735|NCT02684370|76242319|FG005|Part A|Other|0|||
42373736|NCT02684370|76242314|FG000|Part B|Adverse Event|0|||
42373737|NCT02684370|76242315|FG001|Part B|Adverse Event|0|||
42373738|NCT02684370|76242316|FG002|Part B|Adverse Event|0|||
42373739|NCT02684370|76242317|FG003|Part B|Adverse Event|0|||
42373740|NCT02684370|76242318|FG004|Part B|Adverse Event|2|||
42373741|NCT02684370|76242319|FG005|Part B|Adverse Event|1|||
42373742|NCT02684370|76242314|FG000|Part B|Lost to Follow-up|0|||
42373743|NCT02684370|76242315|FG001|Part B|Lost to Follow-up|0|||
42373744|NCT02684370|76242316|FG002|Part B|Lost to Follow-up|0|||
42373745|NCT02684370|76242317|FG003|Part B|Lost to Follow-up|1|||
42373746|NCT02684370|76242318|FG004|Part B|Lost to Follow-up|2|||
42373747|NCT02684370|76242319|FG005|Part B|Lost to Follow-up|5|||
42373748|NCT02684370|76242314|FG000|Part B|Subject Withdrawal|0|||
42373749|NCT02684370|76242315|FG001|Part B|Subject Withdrawal|0|||
42373750|NCT02684370|76242316|FG002|Part B|Subject Withdrawal|0|||
42373751|NCT02684370|76242317|FG003|Part B|Subject Withdrawal|1|||
42373752|NCT02684370|76242318|FG004|Part B|Subject Withdrawal|1|||
42373753|NCT02684370|76242319|FG005|Part B|Subject Withdrawal|2|||
42373754|NCT01686581|76242346|FG000|Overall Study|Side-effects or Health Problems|15|||
42373755|NCT01686581|76242346|FG000|Overall Study|Lack of Efficacy|90|||
42373756|NCT01686581|76242346|FG000|Overall Study|Participant Concerned about Risks|6|||
42373757|NCT01686581|76242346|FG000|Overall Study|Thinks Injections Too Painful|8|||
42373758|NCT01686581|76242346|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
42373759|NCT01686581|76242346|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
42373760|NCT01686581|76242346|FG000|Overall Study|Thinks it is Inconvenient|17|||
42373761|NCT01686581|76242346|FG000|Overall Study|Other Miscellaneous Reasons|36|||
42373762|NCT01686581|76242346|FG000|Overall Study|Reason Missing|1|||
42373763|NCT02691936|76242364|FG000|Overall Study|Withdrawal by Subject|2|||
42373764|NCT02691936|76242365|FG001|Overall Study|Withdrawal by Subject|5|||
42373765|NCT01685801|76242412|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
42373766|NCT01685801|76242413|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
42373767|NCT01685801|76242414|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
42373768|NCT01685801|76242415|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
42373769|NCT01685801|76242412|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
42373770|NCT01685801|76242413|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
42373771|NCT01685801|76242414|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
42373772|NCT01685801|76242415|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
42373773|NCT01353222|76242434|FG000|Overall Study|Death|30|||
42373774|NCT01353222|76242435|FG001|Overall Study|Death|30|||
42373775|NCT01353222|76242434|FG000|Overall Study|Withdrawal by Subject|8|||
42373776|NCT01353222|76242435|FG001|Overall Study|Withdrawal by Subject|5|||
42373777|NCT01353222|76242434|FG000|Overall Study|Study Terminated|31|||
42373778|NCT01353222|76242435|FG001|Overall Study|Study Terminated|37|||
42373779|NCT01353222|76242434|FG000|Overall Study|Site closed research department|1|||
42373780|NCT01353222|76242435|FG001|Overall Study|Site closed research department|0|||
42373781|NCT01684943|76242465|FG000|Overall Study|Inadequate Venous Access|3|||
42373782|NCT01684943|76242466|FG001|Overall Study|Inadequate Venous Access|0|||
42373783|NCT01684943|76242467|FG002|Overall Study|Inadequate Venous Access|0|||
42373784|NCT01684943|76242465|FG000|Overall Study|Principal Investigator Determination|1|||
42373785|NCT01684943|76242466|FG001|Overall Study|Principal Investigator Determination|0|||
42373786|NCT01684943|76242467|FG002|Overall Study|Principal Investigator Determination|0|||
42373787|NCT01684943|76242465|FG000|Overall Study|Excluded from Analysis|1|||
42373788|NCT01684943|76242466|FG001|Overall Study|Excluded from Analysis|1|||
42373789|NCT01684943|76242467|FG002|Overall Study|Excluded from Analysis|1|||
42373790|NCT01684943|76242465|FG000|Overall Study|Lost to Follow-up|3|||
42373791|NCT01684943|76242466|FG001|Overall Study|Lost to Follow-up|0|||
42373792|NCT01684943|76242467|FG002|Overall Study|Lost to Follow-up|0|||
42373793|NCT01684943|76242465|FG000|Overall Study|Planning Pregnancy|1|||
42373794|NCT01684943|76242466|FG001|Overall Study|Planning Pregnancy|0|||
42373795|NCT01684943|76242467|FG002|Overall Study|Planning Pregnancy|0|||
42373796|NCT01683383|76242482|FG000|Overall Study|Infant was not transported|1|||
42373797|NCT01683383|76242483|FG001|Overall Study|Infant was not transported|0|||
42373798|NCT02694744|76242491|FG000|Overall Study|Adverse Event|2|||
42373799|NCT02694744|76242492|FG001|Overall Study|Adverse Event|1|||
42373800|NCT02694744|76242491|FG000|Overall Study|Withdrawal by Subject|2|||
42373801|NCT02694744|76242492|FG001|Overall Study|Withdrawal by Subject|1|||
42373802|NCT02694744|76242491|FG000|Overall Study|Physician Decision|1|||
42373803|NCT02694744|76242492|FG001|Overall Study|Physician Decision|2|||
42373804|NCT02694744|76242491|FG000|Overall Study|Lost to Follow-up|1|||
42373805|NCT02694744|76242492|FG001|Overall Study|Lost to Follow-up|0|||
42373806|NCT02694744|76242491|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
42373807|NCT02694744|76242492|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
42373808|NCT01683071|76242506|FG000|Part 1|Lack of Efficacy|1|||
42373809|NCT01683071|76242507|FG001|Part 1|Lack of Efficacy|0|||
42373810|NCT01683071|76242508|FG002|Part 1|Lack of Efficacy|0|||
42373811|NCT01683071|76242509|FG003|Part 1|Lack of Efficacy|3|||
42373812|NCT01683071|76242510|FG004|Part 1|Lack of Efficacy|0|||
42373813|NCT01683071|76242511|FG005|Part 1|Lack of Efficacy|0|||
42373814|NCT01683071|76242506|FG000|Part 1|Withdrawal by Subject|1|||
42373815|NCT01683071|76242507|FG001|Part 1|Withdrawal by Subject|2|||
42373816|NCT01683071|76242508|FG002|Part 1|Withdrawal by Subject|2|||
42373817|NCT01683071|76242509|FG003|Part 1|Withdrawal by Subject|1|||
42373818|NCT01683071|76242510|FG004|Part 1|Withdrawal by Subject|0|||
42373819|NCT01683071|76242511|FG005|Part 1|Withdrawal by Subject|0|||
42373820|NCT01683071|76242506|FG000|Part 1|Surgery Cancelled|1|||
42373821|NCT01683071|76242507|FG001|Part 1|Surgery Cancelled|0|||
42373822|NCT01683071|76242508|FG002|Part 1|Surgery Cancelled|0|||
42373823|NCT01683071|76242509|FG003|Part 1|Surgery Cancelled|0|||
42373824|NCT01683071|76242510|FG004|Part 1|Surgery Cancelled|0|||
42373825|NCT01683071|76242511|FG005|Part 1|Surgery Cancelled|0|||
42373826|NCT01683071|76242506|FG000|Part 1|Did not receive study drug|1|||
42373827|NCT01683071|76242507|FG001|Part 1|Did not receive study drug|0|||
42373828|NCT01683071|76242508|FG002|Part 1|Did not receive study drug|0|||
42373829|NCT01683071|76242509|FG003|Part 1|Did not receive study drug|1|||
42373830|NCT01683071|76242510|FG004|Part 1|Did not receive study drug|0|||
42373831|NCT01683071|76242511|FG005|Part 1|Did not receive study drug|0|||
42373832|NCT01683071|76242506|FG000|Part 1|Early termination; met exclusion criteria|0|||
42373833|NCT01683071|76242507|FG001|Part 1|Early termination; met exclusion criteria|2|||
42373834|NCT01683071|76242508|FG002|Part 1|Early termination; met exclusion criteria|1|||
42373835|NCT01683071|76242509|FG003|Part 1|Early termination; met exclusion criteria|0|||
42373836|NCT01683071|76242510|FG004|Part 1|Early termination; met exclusion criteria|0|||
42373837|NCT01683071|76242511|FG005|Part 1|Early termination; met exclusion criteria|0|||
42373838|NCT01683071|76242506|FG000|Part 2|Lack of Efficacy|0|||
42373839|NCT01683071|76242507|FG001|Part 2|Lack of Efficacy|0|||
42373840|NCT01683071|76242508|FG002|Part 2|Lack of Efficacy|0|||
42373841|NCT01683071|76242509|FG003|Part 2|Lack of Efficacy|0|||
42373842|NCT01683071|76242510|FG004|Part 2|Lack of Efficacy|3|||
42373843|NCT01683071|76242511|FG005|Part 2|Lack of Efficacy|4|||
42373844|NCT01683071|76242506|FG000|Part 2|Lost to Follow-up|0|||
42373845|NCT01683071|76242507|FG001|Part 2|Lost to Follow-up|0|||
42373846|NCT01683071|76242508|FG002|Part 2|Lost to Follow-up|0|||
42373847|NCT01683071|76242509|FG003|Part 2|Lost to Follow-up|0|||
42373848|NCT01683071|76242510|FG004|Part 2|Lost to Follow-up|2|||
42373849|NCT01683071|76242511|FG005|Part 2|Lost to Follow-up|0|||
42373850|NCT01683071|76242506|FG000|Part 2|Withdrawal by Subject|0|||
42373851|NCT01683071|76242507|FG001|Part 2|Withdrawal by Subject|0|||
42373852|NCT01683071|76242508|FG002|Part 2|Withdrawal by Subject|0|||
42373853|NCT01683071|76242509|FG003|Part 2|Withdrawal by Subject|0|||
42373854|NCT01683071|76242510|FG004|Part 2|Withdrawal by Subject|3|||
42373855|NCT01683071|76242511|FG005|Part 2|Withdrawal by Subject|3|||
42373856|NCT01683071|76242506|FG000|Part 2|Surgery cancelled|0|||
42373857|NCT01683071|76242507|FG001|Part 2|Surgery cancelled|0|||
42373858|NCT01683071|76242508|FG002|Part 2|Surgery cancelled|0|||
42373859|NCT01683071|76242509|FG003|Part 2|Surgery cancelled|0|||
42373860|NCT01683071|76242510|FG004|Part 2|Surgery cancelled|4|||
42103484|NCT00308737|75914411|FG002|Overall Study|Protocol Violation|5|||
42373861|NCT01683071|76242511|FG005|Part 2|Surgery cancelled|2|||
42373862|NCT01683071|76242506|FG000|Part 2|Did not receive study drug|0|||
42373863|NCT01683071|76242507|FG001|Part 2|Did not receive study drug|0|||
42103485|NCT00308737|75914409|FG000|Overall Study|Withdrawal by Subject|218|||
42373864|NCT01683071|76242508|FG002|Part 2|Did not receive study drug|0|||
42373865|NCT01683071|76242509|FG003|Part 2|Did not receive study drug|0|||
42373866|NCT01683071|76242510|FG004|Part 2|Did not receive study drug|2|||
42373867|NCT01683071|76242511|FG005|Part 2|Did not receive study drug|1|||
42373868|NCT01683071|76242506|FG000|Part 2|Met exclusion criterion|0|||
42373869|NCT01683071|76242507|FG001|Part 2|Met exclusion criterion|0|||
42373870|NCT01683071|76242508|FG002|Part 2|Met exclusion criterion|0|||
42373871|NCT01683071|76242509|FG003|Part 2|Met exclusion criterion|0|||
42373872|NCT01683071|76242510|FG004|Part 2|Met exclusion criterion|1|||
42373873|NCT01683071|76242511|FG005|Part 2|Met exclusion criterion|1|||
42373874|NCT01683071|76242506|FG000|Part 2|Protocol deviation|0|||
42373875|NCT01683071|76242507|FG001|Part 2|Protocol deviation|0|||
42373876|NCT01683071|76242508|FG002|Part 2|Protocol deviation|0|||
42373877|NCT01683071|76242509|FG003|Part 2|Protocol deviation|0|||
42373878|NCT01683071|76242510|FG004|Part 2|Protocol deviation|1|||
42373879|NCT01683071|76242511|FG005|Part 2|Protocol deviation|2|||
42373880|NCT01683071|76242506|FG000|Part 2|Withdrawal by investigator decision|0|||
42373881|NCT01683071|76242507|FG001|Part 2|Withdrawal by investigator decision|0|||
42373882|NCT01683071|76242508|FG002|Part 2|Withdrawal by investigator decision|0|||
42373883|NCT01683071|76242509|FG003|Part 2|Withdrawal by investigator decision|0|||
42373884|NCT01683071|76242510|FG004|Part 2|Withdrawal by investigator decision|1|||
42373885|NCT01683071|76242511|FG005|Part 2|Withdrawal by investigator decision|2|||
42373886|NCT01567865|76242535|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
42373887|NCT01567865|76242536|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
42373888|NCT01567865|76242537|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
42373889|NCT01567865|76242538|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
42373890|NCT01567865|76242535|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
42373891|NCT01567865|76242536|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
42373892|NCT01567865|76242537|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
42373893|NCT01567865|76242538|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
42373894|NCT01567163|76242549|FG000|Overall Study|Progressive Disease|2|||
42373895|NCT01567163|76242549|FG000|Overall Study|Lost to Follow-up|2|||
42373896|NCT01567085|76242558|FG000|Overall Study|Death|6|||
42373897|NCT01567085|76242558|FG000|Overall Study|Adverse Event|6|||
42373898|NCT01567085|76242558|FG000|Overall Study|Lost to Follow-up|3|||
42373899|NCT01567085|76242558|FG000|Overall Study|Graft loss|2|||
42373900|NCT01567085|76242558|FG000|Overall Study|Renal transplantectomy|1|||
42373901|NCT01567085|76242558|FG000|Overall Study|Returned to chronic dialysis|1|||
42373902|NCT01567085|76242558|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
42373903|NCT01566773|76242562|FG000|Overall Study|Protocol specified criteria|4|||
42373904|NCT01566773|76242562|FG000|Overall Study|Protocol Violation|4|||
42373905|NCT01566773|76242562|FG000|Overall Study|Withdrawal by Subject|9|||
42373906|NCT01566773|76242562|FG000|Overall Study|Administrative reason|1|||
42373907|NCT01566773|76242562|FG000|Overall Study|Adverse Event|10|||
42373908|NCT01566773|76242562|FG000|Overall Study|Physician Decision|2|||
42373909|NCT01566149|76242584|FG000|Overall Study|Adverse Event|0|||
42373910|NCT01566149|76242585|FG001|Overall Study|Adverse Event|1|||
42373911|NCT01566149|76242584|FG000|Overall Study|Non-compliance with study medication|2|||
42373912|NCT01566149|76242585|FG001|Overall Study|Non-compliance with study medication|0|||
42373913|NCT01566149|76242584|FG000|Overall Study|Protocol Violation|0|||
42373914|NCT01566149|76242585|FG001|Overall Study|Protocol Violation|1|||
42373915|NCT01566149|76242584|FG000|Overall Study|Withdrawal by Subject|1|||
42373916|NCT01566149|76242585|FG001|Overall Study|Withdrawal by Subject|0|||
42373917|NCT01565993|76242593|FG000|Overall Study|Physician Decision|0|||
42373918|NCT01565993|76242594|FG001|Overall Study|Physician Decision|3|||
42373919|NCT01565291|76242602|FG000|Overall Study|Withdrawal by Subject|1|||
42373920|NCT01565291|76242603|FG001|Overall Study|Withdrawal by Subject|0|||
42373921|NCT02691702|76242620|FG000|Overall Study|Adverse Event|1|||
42373922|NCT02691702|76242621|FG001|Overall Study|Adverse Event|0|||
42373923|NCT02691702|76242622|FG002|Overall Study|Adverse Event|0|||
42373924|NCT02691702|76242623|FG003|Overall Study|Adverse Event|0|||
42373925|NCT02691702|76242624|FG004|Overall Study|Adverse Event|0|||
42373926|NCT02691702|76242625|FG005|Overall Study|Adverse Event|0|||
42373927|NCT02691702|76242626|FG006|Overall Study|Adverse Event|0|||
42373928|NCT02691702|76242627|FG007|Overall Study|Adverse Event|0|||
42373929|NCT02691702|76242628|FG008|Overall Study|Adverse Event|1|||
42373930|NCT02691702|76242629|FG009|Overall Study|Adverse Event|0|||
42373931|NCT02691702|76242630|FG010|Overall Study|Adverse Event|1|||
42373932|NCT02691702|76242620|FG000|Overall Study|Lost to Follow-up|0|||
42373933|NCT02691702|76242621|FG001|Overall Study|Lost to Follow-up|0|||
42373934|NCT02691702|76242622|FG002|Overall Study|Lost to Follow-up|1|||
42373935|NCT02691702|76242623|FG003|Overall Study|Lost to Follow-up|0|||
42373936|NCT02691702|76242624|FG004|Overall Study|Lost to Follow-up|0|||
42373937|NCT02691702|76242625|FG005|Overall Study|Lost to Follow-up|2|||
42373938|NCT02691702|76242626|FG006|Overall Study|Lost to Follow-up|0|||
42373939|NCT02691702|76242627|FG007|Overall Study|Lost to Follow-up|0|||
42373940|NCT02691702|76242628|FG008|Overall Study|Lost to Follow-up|0|||
42373941|NCT02691702|76242629|FG009|Overall Study|Lost to Follow-up|0|||
42373942|NCT02691702|76242630|FG010|Overall Study|Lost to Follow-up|1|||
42373943|NCT02691702|76242620|FG000|Overall Study|Withdrawal by Subject|1|||
42373944|NCT02691702|76242621|FG001|Overall Study|Withdrawal by Subject|1|||
42373945|NCT02691702|76242622|FG002|Overall Study|Withdrawal by Subject|0|||
42373946|NCT02691702|76242623|FG003|Overall Study|Withdrawal by Subject|0|||
42373947|NCT02691702|76242624|FG004|Overall Study|Withdrawal by Subject|0|||
42373948|NCT02691702|76242625|FG005|Overall Study|Withdrawal by Subject|1|||
42373949|NCT02691702|76242626|FG006|Overall Study|Withdrawal by Subject|2|||
42373950|NCT02691702|76242627|FG007|Overall Study|Withdrawal by Subject|0|||
42373951|NCT02691702|76242628|FG008|Overall Study|Withdrawal by Subject|0|||
42373952|NCT02691702|76242629|FG009|Overall Study|Withdrawal by Subject|0|||
42373953|NCT02691702|76242630|FG010|Overall Study|Withdrawal by Subject|0|||
42373954|NCT02691702|76242620|FG000|Overall Study|Other|0|||
42373955|NCT02691702|76242621|FG001|Overall Study|Other|0|||
42373956|NCT02691702|76242622|FG002|Overall Study|Other|0|||
42373957|NCT02691702|76242623|FG003|Overall Study|Other|0|||
42373958|NCT02691702|76242624|FG004|Overall Study|Other|0|||
42373959|NCT02691702|76242625|FG005|Overall Study|Other|0|||
42373960|NCT02691702|76242626|FG006|Overall Study|Other|1|||
42373961|NCT02691702|76242627|FG007|Overall Study|Other|0|||
42373962|NCT02691702|76242628|FG008|Overall Study|Other|1|||
42373963|NCT02691702|76242629|FG009|Overall Study|Other|0|||
42373964|NCT02691702|76242630|FG010|Overall Study|Other|0|||
42373965|NCT02691702|76242620|FG000|Overall Study|Protocol Violation|0|||
42373966|NCT02691702|76242621|FG001|Overall Study|Protocol Violation|0|||
42373967|NCT02691702|76242622|FG002|Overall Study|Protocol Violation|0|||
42373968|NCT02691702|76242623|FG003|Overall Study|Protocol Violation|0|||
42373969|NCT02691702|76242624|FG004|Overall Study|Protocol Violation|0|||
42373970|NCT02691702|76242625|FG005|Overall Study|Protocol Violation|0|||
42373971|NCT02691702|76242626|FG006|Overall Study|Protocol Violation|0|||
42373972|NCT02691702|76242627|FG007|Overall Study|Protocol Violation|0|||
42373973|NCT02691702|76242628|FG008|Overall Study|Protocol Violation|0|||
42373974|NCT02691702|76242629|FG009|Overall Study|Protocol Violation|2|||
42373975|NCT02691702|76242630|FG010|Overall Study|Protocol Violation|0|||
42373976|NCT01564277|76242664|FG000|Overall Study|Protocol Violation|0|||
42373977|NCT01564277|76242665|FG001|Overall Study|Protocol Violation|1|||
42373978|NCT01564277|76242664|FG000|Overall Study|Physician Decision|1|||
42373979|NCT01564277|76242665|FG001|Overall Study|Physician Decision|0|||
42373980|NCT02679222|76242671|FG000|Overall Study|No time for project|1|||
42373981|NCT01563185|76242683|FG000|Overall Study|Withdrawal by Subject|1|||
42373982|NCT01563185|76242683|FG000|Overall Study|Non-Compliance with study drug|1|||
42373983|NCT03305848|76242687|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
42373984|NCT03305848|76242687|FG000|Overall Study|Physician Decision|2|||
42373985|NCT01563029|76242696|FG000|Overall Study|Adverse Event|1|||
42373986|NCT01563029|76242697|FG001|Overall Study|Adverse Event|0|||
42373987|NCT01563029|76242698|FG002|Overall Study|Adverse Event|1|||
42373988|NCT01563029|76242699|FG003|Overall Study|Adverse Event|2|||
42373989|NCT01563029|76242700|FG004|Overall Study|Adverse Event|1|||
42373990|NCT01563029|76242696|FG000|Overall Study|Lack of Efficacy|42|||
42373991|NCT01563029|76242697|FG001|Overall Study|Lack of Efficacy|16|||
42373992|NCT01563029|76242698|FG002|Overall Study|Lack of Efficacy|23|||
42373993|NCT01563029|76242699|FG003|Overall Study|Lack of Efficacy|21|||
42373994|NCT01563029|76242700|FG004|Overall Study|Lack of Efficacy|19|||
42373995|NCT01563029|76242696|FG000|Overall Study|Protocol Violation|1|||
42373996|NCT01563029|76242697|FG001|Overall Study|Protocol Violation|2|||
42373997|NCT01563029|76242698|FG002|Overall Study|Protocol Violation|3|||
42373998|NCT01563029|76242699|FG003|Overall Study|Protocol Violation|1|||
42373999|NCT01563029|76242700|FG004|Overall Study|Protocol Violation|3|||
42374000|NCT01563029|76242696|FG000|Overall Study|Protocol defined stopping criteria|1|||
42374001|NCT01563029|76242697|FG001|Overall Study|Protocol defined stopping criteria|0|||
42374002|NCT01563029|76242698|FG002|Overall Study|Protocol defined stopping criteria|0|||
42374003|NCT01563029|76242699|FG003|Overall Study|Protocol defined stopping criteria|0|||
42374004|NCT01563029|76242700|FG004|Overall Study|Protocol defined stopping criteria|0|||
42374005|NCT01563029|76242696|FG000|Overall Study|Lost to Follow-up|1|||
42374006|NCT01563029|76242697|FG001|Overall Study|Lost to Follow-up|0|||
42374007|NCT01563029|76242698|FG002|Overall Study|Lost to Follow-up|1|||
42374008|NCT01563029|76242699|FG003|Overall Study|Lost to Follow-up|1|||
42374009|NCT01563029|76242700|FG004|Overall Study|Lost to Follow-up|1|||
42374010|NCT01563029|76242696|FG000|Overall Study|Physician Decision|3|||
42374011|NCT01563029|76242697|FG001|Overall Study|Physician Decision|5|||
42374012|NCT01563029|76242698|FG002|Overall Study|Physician Decision|2|||
42374013|NCT01563029|76242699|FG003|Overall Study|Physician Decision|4|||
42374014|NCT01563029|76242700|FG004|Overall Study|Physician Decision|2|||
42374015|NCT01563029|76242696|FG000|Overall Study|Withdrawal by Subject|4|||
42374016|NCT01563029|76242697|FG001|Overall Study|Withdrawal by Subject|1|||
42374017|NCT01563029|76242698|FG002|Overall Study|Withdrawal by Subject|3|||
42374018|NCT01563029|76242699|FG003|Overall Study|Withdrawal by Subject|4|||
42374019|NCT01563029|76242700|FG004|Overall Study|Withdrawal by Subject|3|||
42374020|NCT01562873|76242713|FG000|Overall Study|Disease Progression per RECIST|10|||
42374021|NCT01562873|76242714|FG001|Overall Study|Disease Progression per RECIST|0|||
42374022|NCT01562873|76242713|FG000|Overall Study|Adverse Event|1|||
42374023|NCT01562873|76242714|FG001|Overall Study|Adverse Event|0|||
42374024|NCT01562873|76242713|FG000|Overall Study|Clinical Disease Progression|9|||
42374025|NCT01562873|76242714|FG001|Overall Study|Clinical Disease Progression|0|||
42374026|NCT01562873|76242713|FG000|Overall Study|Clinical PD and adverse event|1|||
42374027|NCT01562873|76242714|FG001|Overall Study|Clinical PD and adverse event|0|||
42374028|NCT03273712|76242718|FG000|Overall Study|Death|5|||
42374029|NCT03273712|76242718|FG000|Overall Study|Adverse Event|1|||
42374030|NCT03273712|76242718|FG000|Overall Study|Disease Progression|1|||
42374031|NCT01562327|76242723|FG000|Overall Study|Adverse Event|2|||
42374032|NCT01562327|76242723|FG000|Overall Study|Lack of Efficacy|1|||
42374033|NCT01562327|76242723|FG000|Overall Study|Participant drop-out|1|||
42374034|NCT01562327|76242723|FG000|Overall Study|Infusion not received at 6 month window|4|||
42374035|NCT01561313|76242730|FG000|Overall Study|Withdrawal by Subject|1|||
42374036|NCT01561313|76242731|FG001|Overall Study|Withdrawal by Subject|0|||
42374037|NCT01561313|76242730|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
42374038|NCT01561313|76242731|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
42374039|NCT01561079|76242737|FG000|Overall Study|Physician Decision|17|||
42374040|NCT01561079|76242737|FG000|Overall Study|Withdrawal by Subject|59|||
42374041|NCT01561079|76242737|FG000|Overall Study|Protocol Violation|2|||
42374042|NCT01559675|76242782|FG000|Overall Study|Protocol Violation|1|||
42374043|NCT01559675|76242783|FG001|Overall Study|Protocol Violation|2|||
42374044|NCT01559675|76242782|FG000|Overall Study|2nd operation on same patient excluded|14|||
42374045|NCT01559675|76242783|FG001|Overall Study|2nd operation on same patient excluded|12|||
42374046|NCT01374906|76242791|FG000|Overall Study|Abnormal laboratory value(s)|0|||
42374047|NCT01374906|76242792|FG001|Overall Study|Abnormal laboratory value(s)|3|||
42374048|NCT01374906|76242791|FG000|Overall Study|Administrative problems|2|||
42374049|NCT01374906|76242792|FG001|Overall Study|Administrative problems|2|||
42374050|NCT01374906|76242791|FG000|Overall Study|Adverse Event|10|||
42374051|NCT01374906|76242792|FG001|Overall Study|Adverse Event|11|||
42374052|NCT01374906|76242791|FG000|Overall Study|Death|0|||
42374053|NCT01374906|76242792|FG001|Overall Study|Death|2|||
42374054|NCT01374906|76242791|FG000|Overall Study|Protocol Violation|2|||
42374055|NCT01374906|76242792|FG001|Overall Study|Protocol Violation|2|||
42374056|NCT01374906|76242791|FG000|Overall Study|Withdrawal by Subject|15|||
42374057|NCT01374906|76242792|FG001|Overall Study|Withdrawal by Subject|9|||
42374058|NCT01374906|76242791|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
42374059|NCT01374906|76242792|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
42374060|NCT02683746|76242822|FG000|Overall Study|Adverse Event|3|||
42374061|NCT02683746|76242823|FG001|Overall Study|Adverse Event|2|||
42374062|NCT02683746|76242822|FG000|Overall Study|Lost to Follow-up|5|||
42374063|NCT02683746|76242823|FG001|Overall Study|Lost to Follow-up|6|||
42374064|NCT02683746|76242822|FG000|Overall Study|Withdrawal by Subject|6|||
42374065|NCT02683746|76242823|FG001|Overall Study|Withdrawal by Subject|5|||
42374066|NCT02683746|76242822|FG000|Overall Study|Physician Decision|2|||
42374067|NCT02683746|76242823|FG001|Overall Study|Physician Decision|1|||
42374068|NCT02691468|76242831|FG000|Overall Study|Bronchial blocker use|2|||
42374069|NCT02691468|76242832|FG001|Overall Study|Bronchial blocker use|1|||
42374070|NCT02691468|76242831|FG000|Overall Study|Lost to Follow-up|2|||
42374071|NCT02691468|76242832|FG001|Overall Study|Lost to Follow-up|1|||
42374072|NCT02691468|76242831|FG000|Overall Study|Failure to advance FOB|2|||
42374073|NCT02691468|76242832|FG001|Overall Study|Failure to advance FOB|0|||
42374074|NCT02678676|76242840|FG000|Overall Study|Death|619|||
42374075|NCT02678676|76242841|FG001|Overall Study|Death|649|||
42374076|NCT02678676|76242840|FG000|Overall Study|Withdrawal by Subject|13|||
42374077|NCT02678676|76242841|FG001|Overall Study|Withdrawal by Subject|5|||
42374078|NCT02678676|76242840|FG000|Overall Study|Lost to Follow-up|171|||
42374079|NCT02678676|76242841|FG001|Overall Study|Lost to Follow-up|151|||
42374080|NCT02678676|76242840|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
42374081|NCT02678676|76242841|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
42374082|NCT01558739|76242847|FG000|Overall Study|Adverse Event|7|||
42374083|NCT01558739|76242847|FG000|Overall Study|Withdrawal by Subject|2|||
42374084|NCT01558739|76242847|FG000|Overall Study|Death|3|||
42103486|NCT00308737|75914410|FG001|Overall Study|Withdrawal by Subject|166|||
42374085|NCT01558739|76242847|FG000|Overall Study|Disease Progression|4|||
42374086|NCT01558739|76242847|FG000|Overall Study|Protocol Violation|1|||
42374087|NCT02683668|76242851|FG000|Period 2|Withdrawal by Subject|0|||
42374088|NCT02683668|76242852|FG001|Period 2|Withdrawal by Subject|1|||
42374089|NCT02683668|76242853|FG002|Period 2|Withdrawal by Subject|0|||
42374090|NCT02678286|76242861|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
42374091|NCT02678286|76242862|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
42018739|NCT01124097|75826121|FG003|Overall Study|Adverse Event|7|||
42374092|NCT02678286|76242861|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
42374093|NCT02678286|76242862|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
42374094|NCT02678286|76242861|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
42374095|NCT02678286|76242862|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
42374096|NCT02678286|76242861|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
42374097|NCT02678286|76242862|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
42374098|NCT02678286|76242861|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
42374099|NCT02678286|76242862|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
42374100|NCT02682264|76242870|FG000|Overall Study|Withdrawal by Subject|56|||
42374101|NCT02682264|76242871|FG001|Overall Study|Withdrawal by Subject|45|||
42374102|NCT02682264|76242870|FG000|Overall Study|Lost to Follow-up|49|||
42374103|NCT02682264|76242871|FG001|Overall Study|Lost to Follow-up|41|||
42374104|NCT02682264|76242870|FG000|Overall Study|Lack of Efficacy|14|||
42374105|NCT02682264|76242871|FG001|Overall Study|Lack of Efficacy|16|||
42374106|NCT02682264|76242870|FG000|Overall Study|Withdrawal by Parent|6|||
42374107|NCT02682264|76242871|FG001|Overall Study|Withdrawal by Parent|7|||
42374108|NCT02682264|76242870|FG000|Overall Study|Adverse Event|9|||
42374109|NCT02682264|76242871|FG001|Overall Study|Adverse Event|0|||
42374110|NCT02682264|76242870|FG000|Overall Study|Noncompliance with study drug|1|||
42374111|NCT02682264|76242871|FG001|Overall Study|Noncompliance with study drug|4|||
42374112|NCT02682264|76242870|FG000|Overall Study|Pregnancy|1|||
42374113|NCT02682264|76242871|FG001|Overall Study|Pregnancy|2|||
42374114|NCT02682264|76242870|FG000|Overall Study|Recovery|1|||
42374115|NCT02682264|76242871|FG001|Overall Study|Recovery|2|||
42374116|NCT02682264|76242870|FG000|Overall Study|Progressive Disease|1|||
42374117|NCT02682264|76242871|FG001|Overall Study|Progressive Disease|0|||
42374118|NCT02682264|76242870|FG000|Overall Study|Technical Problems|0|||
42374119|NCT02682264|76242871|FG001|Overall Study|Technical Problems|1|||
42374120|NCT02682264|76242870|FG000|Overall Study|Moved abroad and unable to continue|0|||
42374121|NCT02682264|76242871|FG001|Overall Study|Moved abroad and unable to continue|3|||
42374122|NCT02682264|76242870|FG000|Overall Study|Stopped test article application|0|||
42374123|NCT02682264|76242871|FG001|Overall Study|Stopped test article application|1|||
42374124|NCT01566721|76242879|FG000|Treatment Period|Withdrawal by Subject|35|||
42374125|NCT01566721|76242880|FG001|Treatment Period|Withdrawal by Subject|9|||
42374126|NCT01566721|76242879|FG000|Treatment Period|Disease Progression/Recurrence|37|||
42374127|NCT01566721|76242880|FG001|Treatment Period|Disease Progression/Recurrence|13|||
42374128|NCT01566721|76242879|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
42374129|NCT01566721|76242880|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
42374130|NCT01566721|76242879|FG000|Treatment Period|Other|13|||
42374131|NCT01566721|76242880|FG001|Treatment Period|Other|2|||
42374132|NCT01566721|76242879|FG000|Treatment Period|Lack of Compliance|5|||
42374133|NCT01566721|76242880|FG001|Treatment Period|Lack of Compliance|1|||
42374134|NCT01566721|76242879|FG000|Treatment Period|Adverse Event|100|||
42374135|NCT01566721|76242880|FG001|Treatment Period|Adverse Event|30|||
42374136|NCT01566721|76242879|FG000|Treatment Period|Pregnancy|1|||
42374137|NCT01566721|76242880|FG001|Treatment Period|Pregnancy|0|||
42374138|NCT01566721|76242879|FG000|Safety Follow-up|Physician Decision|6|||
42374139|NCT01566721|76242880|FG001|Safety Follow-up|Physician Decision|4|||
42374140|NCT01566721|76242879|FG000|Safety Follow-up|Lost to Follow-up|101|||
42374141|NCT01566721|76242880|FG001|Safety Follow-up|Lost to Follow-up|48|||
42374142|NCT01566721|76242879|FG000|Safety Follow-up|Withdrawal by Subject|155|||
42374143|NCT01566721|76242880|FG001|Safety Follow-up|Withdrawal by Subject|49|||
42374144|NCT01566721|76242879|FG000|Safety Follow-up|Death|28|||
42374145|NCT01566721|76242880|FG001|Safety Follow-up|Death|4|||
42374146|NCT01566721|76242879|FG000|Safety Follow-up|Non-compliance|7|||
42374147|NCT01566721|76242880|FG001|Safety Follow-up|Non-compliance|3|||
42374148|NCT01566721|76242879|FG000|Safety Follow-up|Protocol Violation|7|||
42374149|NCT01566721|76242880|FG001|Safety Follow-up|Protocol Violation|0|||
42374150|NCT01566721|76242879|FG000|Safety Follow-up|Site closure|2|||
42374151|NCT01566721|76242880|FG001|Safety Follow-up|Site closure|3|||
42374152|NCT01566721|76242879|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
42103487|NCT00308737|75914411|FG002|Overall Study|Withdrawal by Subject|18|||
42103488|NCT00308737|75914409|FG000|Overall Study|Various|32|||
42374153|NCT01566721|76242880|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
42374154|NCT01566721|76242879|FG000|Safety Follow-up|Missing|7|||
42103489|NCT00308737|75914410|FG001|Overall Study|Various|20|||
42103490|NCT00308737|75914411|FG002|Overall Study|Various|8|||
42374155|NCT01566721|76242880|FG001|Safety Follow-up|Missing|2|||
42374156|NCT01566721|76242879|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
42374157|NCT01566721|76242880|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
42374158|NCT01566721|76242879|FG000|Safety Follow-up|Sponsor decision|1|||
42374159|NCT01566721|76242880|FG001|Safety Follow-up|Sponsor decision|0|||
42374160|NCT01566721|76242879|FG000|Safety Follow-up|Adverse Event|8|||
42374161|NCT01566721|76242880|FG001|Safety Follow-up|Adverse Event|4|||
42374162|NCT01541215|76242895|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
42374163|NCT01541215|76242896|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
42374164|NCT01541215|76242895|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
42374165|NCT01541215|76242896|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
42374166|NCT01541215|76242895|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
42374167|NCT01541215|76242896|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
42374168|NCT01541215|76242895|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
42374169|NCT01541215|76242896|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
42374170|NCT01541215|76242895|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
42374171|NCT01541215|76242896|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
42374172|NCT01541215|76242895|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
42374173|NCT01541215|76242896|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
42374174|NCT01540981|76242908|FG000|Overall Study|Withdrawal by Subject|1|||
42374175|NCT01540981|76242909|FG001|Overall Study|Withdrawal by Subject|0|||
42374176|NCT01585987|76242917|FG000|Randomized|Withdrawal by Subject|0|||
42374177|NCT01585987|76242918|FG001|Randomized|Withdrawal by Subject|4|||
42374178|NCT01585987|76242917|FG000|Randomized|No longer met criteria|0|||
42374179|NCT01585987|76242918|FG001|Randomized|No longer met criteria|2|||
42374180|NCT01585987|76242917|FG000|Treated|Disease Progression|39|||
42374181|NCT01585987|76242918|FG001|Treated|Disease Progression|36|||
42374182|NCT01585987|76242917|FG000|Treated|Study Drug Toxicity|9|||
42374183|NCT01585987|76242918|FG001|Treated|Study Drug Toxicity|5|||
42374184|NCT01585987|76242917|FG000|Treated|Adverse Event|3|||
42374185|NCT01585987|76242918|FG001|Treated|Adverse Event|0|||
42374186|NCT01585987|76242917|FG000|Treated|Withdrawal by Subject|1|||
42374187|NCT01585987|76242918|FG001|Treated|Withdrawal by Subject|2|||
42374188|NCT01585987|76242917|FG000|Treated|Death|1|||
42374189|NCT01585987|76242918|FG001|Treated|Death|0|||
42374190|NCT01585987|76242917|FG000|Treated|Lost to Follow-up|0|||
42374191|NCT01585987|76242918|FG001|Treated|Lost to Follow-up|1|||
42374192|NCT01585987|76242917|FG000|Treated|Maximum Clinical Benefit|0|||
42374193|NCT01585987|76242918|FG001|Treated|Maximum Clinical Benefit|1|||
42374194|NCT01585987|76242917|FG000|Treated|Non-Specified|1|||
42374195|NCT01585987|76242918|FG001|Treated|Non-Specified|2|||
42374196|NCT01585987|76242917|FG000|Treated|Subject Request|0|||
42374197|NCT01585987|76242918|FG001|Treated|Subject Request|1|||
42374198|NCT01585987|76242917|FG000|Treated|Poor/Non-Compliance|0|||
42374199|NCT01585987|76242918|FG001|Treated|Poor/Non-Compliance|1|||
42374200|NCT01585831|76242927|FG000|Overall Study|Physician Decision|0|||
42374201|NCT01585831|76242928|FG001|Overall Study|Physician Decision|1|||
42374202|NCT01585831|76242927|FG000|Overall Study|Withdrawal by Subject|2|||
42374203|NCT01585831|76242928|FG001|Overall Study|Withdrawal by Subject|1|||
42374204|NCT01565941|76242936|FG000|Overall Study|Withdrawn by parent/guardian|3|||
42374205|NCT01565941|76242937|FG001|Overall Study|Withdrawn by parent/guardian|2|||
42374206|NCT01565941|76242936|FG000|Overall Study|Randomized; did not receive intevention|8|||
42374207|NCT01565941|76242937|FG001|Overall Study|Randomized; did not receive intevention|2|||
42374208|NCT01558271|76242948|FG000|Overall Study|Adverse Event|6|||
42374209|NCT01558271|76242949|FG001|Overall Study|Adverse Event|3|||
42374210|NCT01558271|76242950|FG002|Overall Study|Adverse Event|4|||
42374211|NCT01558271|76242948|FG000|Overall Study|Lost to Follow-up|1|||
42374212|NCT01558271|76242949|FG001|Overall Study|Lost to Follow-up|0|||
42374213|NCT01558271|76242950|FG002|Overall Study|Lost to Follow-up|0|||
42374214|NCT01558271|76242948|FG000|Overall Study|Protocol Violation|1|||
42374215|NCT01558271|76242949|FG001|Overall Study|Protocol Violation|0|||
42374216|NCT01558271|76242950|FG002|Overall Study|Protocol Violation|0|||
42374217|NCT01558271|76242948|FG000|Overall Study|Withdrawal by Subject|10|||
42374218|NCT01558271|76242949|FG001|Overall Study|Withdrawal by Subject|6|||
42374219|NCT01558271|76242950|FG002|Overall Study|Withdrawal by Subject|12|||
42374220|NCT01558271|76242948|FG000|Overall Study|Physician Decision|0|||
42103491|NCT00655746|75914419|FG000|Overall Study|Withdrawal by Subject|1|||
42103492|NCT00338455|75914429|FG000|Overall Study|Death|2|||
42103493|NCT00338455|75914430|FG001|Overall Study|Death|1|||
42103494|NCT00338455|75914429|FG000|Overall Study|Physician Decision|1|||
42103495|NCT00338455|75914430|FG001|Overall Study|Physician Decision|0|||
42103496|NCT00651924|75914438|FG000|Overall Study|Withdrawal by PI|0|||
42103497|NCT00651924|75914439|FG001|Overall Study|Withdrawal by PI|2|||
42103498|NCT00651924|75914438|FG000|Overall Study|Withdrawal by Subject|0|||
42374221|NCT01558271|76242949|FG001|Overall Study|Physician Decision|2|||
42103499|NCT00651924|75914439|FG001|Overall Study|Withdrawal by Subject|5|||
42103500|NCT00678392|75914447|FG000|Overall Study|Adverse Event|0|||
42374222|NCT01558271|76242950|FG002|Overall Study|Physician Decision|1|||
42103501|NCT00678392|75914448|FG001|Overall Study|Adverse Event|6|||
42374223|NCT01565707|76242966|FG000|Overall Study|Adverse Event|1|||
42374224|NCT01565707|76242967|FG001|Overall Study|Adverse Event|6|||
42374225|NCT01565707|76242968|FG002|Overall Study|Adverse Event|2|||
42374226|NCT01565707|76242969|FG003|Overall Study|Adverse Event|1|||
42374227|NCT01565707|76242966|FG000|Overall Study|Lost to Follow-up|1|||
42374228|NCT01565707|76242967|FG001|Overall Study|Lost to Follow-up|0|||
42374229|NCT01565707|76242968|FG002|Overall Study|Lost to Follow-up|0|||
42374230|NCT01565707|76242969|FG003|Overall Study|Lost to Follow-up|0|||
42374231|NCT01565707|76242966|FG000|Overall Study|Protocol Violation|1|||
42374232|NCT01565707|76242967|FG001|Overall Study|Protocol Violation|0|||
42374233|NCT01565707|76242968|FG002|Overall Study|Protocol Violation|0|||
42374234|NCT01565707|76242969|FG003|Overall Study|Protocol Violation|1|||
42374235|NCT01565707|76242966|FG000|Overall Study|Withdrawal by Subject|3|||
42374236|NCT01565707|76242967|FG001|Overall Study|Withdrawal by Subject|1|||
42374237|NCT01565707|76242968|FG002|Overall Study|Withdrawal by Subject|1|||
42374238|NCT01565707|76242969|FG003|Overall Study|Withdrawal by Subject|1|||
42374239|NCT01565707|76242966|FG000|Overall Study|Randomized but not evaluable|2|||
42374240|NCT01565707|76242967|FG001|Overall Study|Randomized but not evaluable|0|||
42374241|NCT01565707|76242968|FG002|Overall Study|Randomized but not evaluable|0|||
42374242|NCT01565707|76242969|FG003|Overall Study|Randomized but not evaluable|0|||
42374243|NCT01565707|76242966|FG000|Overall Study|Miscellaneous|1|||
42374244|NCT01565707|76242967|FG001|Overall Study|Miscellaneous|1|||
42374245|NCT01565707|76242968|FG002|Overall Study|Miscellaneous|0|||
42374246|NCT01565707|76242969|FG003|Overall Study|Miscellaneous|2|||
42374247|NCT01557569|76242988|FG000|Overall Study|Adverse Event|2|||
42374248|NCT01557569|76242989|FG001|Overall Study|Adverse Event|0|||
42374249|NCT01557569|76242988|FG000|Overall Study|high blood pressure|0|||
42374250|NCT01557569|76242989|FG001|Overall Study|high blood pressure|1|||
42374251|NCT01557569|76242988|FG000|Overall Study|Withdrawal by Subject|3|||
42374252|NCT01557569|76242989|FG001|Overall Study|Withdrawal by Subject|5|||
42374253|NCT01557569|76242988|FG000|Overall Study|noncompliance with rules of residential|0|||
42374254|NCT01557569|76242989|FG001|Overall Study|noncompliance with rules of residential|1|||
42374255|NCT01538719|76242997|FG000|Overall Study|Lost to Follow-up|2|||
42374256|NCT01538719|76242998|FG001|Overall Study|Lost to Follow-up|0|||
42374257|NCT01537783|76243006|FG000|Overall Study|Lost to Follow-up|11|||
42374258|NCT01537783|76243007|FG001|Overall Study|Lost to Follow-up|2|||
42374259|NCT01556165|76243015|FG000|Overall Study|Adverse Event|5|||
42374260|NCT01556165|76243016|FG001|Overall Study|Adverse Event|3|||
42374261|NCT01556165|76243015|FG000|Overall Study|Protocol Violation|0|||
42374262|NCT01556165|76243016|FG001|Overall Study|Protocol Violation|3|||
42374263|NCT01556165|76243015|FG000|Overall Study|Withdrawal of Consent|7|||
42374264|NCT01556165|76243016|FG001|Overall Study|Withdrawal of Consent|1|||
42374265|NCT01537549|76243022|FG000|Overall Study|Lost to Follow-up|1|||
42374266|NCT01537549|76243022|FG000|Overall Study|Withdrawal by Subject|2|||
42374267|NCT01555931|76243030|FG000|Overall Study|Lost to Follow-up|2|||
42374268|NCT01555931|76243031|FG001|Overall Study|Lost to Follow-up|5|||
42374269|NCT01583179|76243039|FG000|Overall Study|Screen failure|1|||
42374270|NCT01583179|76243040|FG001|Overall Study|Screen failure|2|||
42374271|NCT01582945|76243046|FG000|Overall Study|Intolerable side-effects|1|||
42374272|NCT01582945|76243046|FG000|Overall Study|Scheduling conflicts|1|||
42374273|NCT01565083|76243052|FG000|Overall Study|Withdrawal by Subject|6|||
42374274|NCT01565083|76243053|FG001|Overall Study|Withdrawal by Subject|4|||
42374275|NCT01565083|76243052|FG000|Overall Study|Lost to Follow-up|2|||
42374276|NCT01565083|76243053|FG001|Overall Study|Lost to Follow-up|7|||
42374277|NCT01565083|76243052|FG000|Overall Study|Death|22|||
42374278|NCT01565083|76243053|FG001|Overall Study|Death|23|||
42374279|NCT01565083|76243052|FG000|Overall Study|Other|3|||
42374280|NCT01565083|76243053|FG001|Overall Study|Other|5|||
42374281|NCT01582789|76243059|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
42374282|NCT01582789|76243060|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
42374283|NCT01537393|76243070|FG000|Overall Study|Exclude prior to study|32|||
42374284|NCT01537393|76243071|FG001|Overall Study|Exclude prior to study|44|||
42374285|NCT01537393|76243070|FG000|Overall Study|Death|20|||
42374286|NCT01537393|76243071|FG001|Overall Study|Death|32|||
42374287|NCT01537393|76243070|FG000|Overall Study|Withdrawal by Subject|18|||
42374288|NCT01537393|76243071|FG001|Overall Study|Withdrawal by Subject|17|||
42374289|NCT01537393|76243070|FG000|Overall Study|Lost to Follow-up|53|||
42374290|NCT01537393|76243071|FG001|Overall Study|Lost to Follow-up|48|||
42374291|NCT01537393|76243070|FG000|Overall Study|Failure - Regrafted|28|||
42018740|NCT01124097|75826118|FG000|Overall Study|Protocol Violation|2|||
42103502|NCT00678392|75914447|FG000|Overall Study|Death|280|||
42200783|NCT02057718|76012713|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
42200784|NCT02057718|76012714|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
42200785|NCT02057718|76012713|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
42374292|NCT01537393|76243071|FG001|Overall Study|Failure - Regrafted|43|||
42374293|NCT01537393|76243070|FG000|Overall Study|Failure - Not regrafted|2|||
42374294|NCT01537393|76243071|FG001|Overall Study|Failure - Not regrafted|6|||
42374295|NCT01537393|76243070|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
42374296|NCT01537393|76243071|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
42374297|NCT01555151|76243081|FG000|Overall Study|Withdrawal by Subject|6|||
42374298|NCT01555151|76243082|FG001|Overall Study|Withdrawal by Subject|2|||
42374299|NCT01555151|76243083|FG002|Overall Study|Withdrawal by Subject|0|||
42374300|NCT01555151|76243084|FG003|Overall Study|Withdrawal by Subject|2|||
42374301|NCT01555151|76243081|FG000|Overall Study|Administrative|3|||
42374302|NCT01555151|76243082|FG001|Overall Study|Administrative|1|||
42374303|NCT01555151|76243083|FG002|Overall Study|Administrative|2|||
42374304|NCT01555151|76243084|FG003|Overall Study|Administrative|0|||
42374305|NCT01555151|76243081|FG000|Overall Study|Protocol Violation|3|||
42374306|NCT01555151|76243082|FG001|Overall Study|Protocol Violation|3|||
42374307|NCT01555151|76243083|FG002|Overall Study|Protocol Violation|3|||
42374308|NCT01555151|76243084|FG003|Overall Study|Protocol Violation|5|||
42374309|NCT01555151|76243081|FG000|Overall Study|Adverse Event|1|||
42374310|NCT01555151|76243082|FG001|Overall Study|Adverse Event|2|||
42374311|NCT01555151|76243083|FG002|Overall Study|Adverse Event|1|||
42374312|NCT01555151|76243084|FG003|Overall Study|Adverse Event|2|||
42374313|NCT01555151|76243081|FG000|Overall Study|Lost to Follow-up|0|||
42374314|NCT01555151|76243082|FG001|Overall Study|Lost to Follow-up|0|||
42374315|NCT01555151|76243083|FG002|Overall Study|Lost to Follow-up|0|||
42374316|NCT01555151|76243084|FG003|Overall Study|Lost to Follow-up|1|||
42374317|NCT01537081|76243098|FG000|Overall Study|Adverse Event|5|||
42374318|NCT01537081|76243099|FG001|Overall Study|Adverse Event|2|||
42374319|NCT01537081|76243100|FG002|Overall Study|Adverse Event|2|||
42374320|NCT01537081|76243098|FG000|Overall Study|Lack of Efficacy|2|||
42374321|NCT01537081|76243099|FG001|Overall Study|Lack of Efficacy|1|||
42374322|NCT01537081|76243100|FG002|Overall Study|Lack of Efficacy|0|||
42374323|NCT01537081|76243098|FG000|Overall Study|Lost to Follow-up|17|||
42374324|NCT01537081|76243099|FG001|Overall Study|Lost to Follow-up|15|||
42374325|NCT01537081|76243100|FG002|Overall Study|Lost to Follow-up|9|||
42374326|NCT01537081|76243098|FG000|Overall Study|Protocol Violation|3|||
42374327|NCT01537081|76243099|FG001|Overall Study|Protocol Violation|2|||
42374328|NCT01537081|76243100|FG002|Overall Study|Protocol Violation|2|||
42374329|NCT01537081|76243098|FG000|Overall Study|Withdrawal by Subject|6|||
42374330|NCT01537081|76243099|FG001|Overall Study|Withdrawal by Subject|11|||
42374331|NCT01537081|76243100|FG002|Overall Study|Withdrawal by Subject|3|||
42374332|NCT01537081|76243098|FG000|Overall Study|Physician Decision|5|||
42374333|NCT01537081|76243099|FG001|Overall Study|Physician Decision|6|||
42374334|NCT01537081|76243100|FG002|Overall Study|Physician Decision|0|||
42374335|NCT01537081|76243098|FG000|Overall Study|Sponsor decision|0|||
42374336|NCT01537081|76243099|FG001|Overall Study|Sponsor decision|1|||
42374337|NCT01537081|76243100|FG002|Overall Study|Sponsor decision|0|||
42374338|NCT01537081|76243098|FG000|Overall Study|Assigned but never dosed|1|||
42374339|NCT01537081|76243099|FG001|Overall Study|Assigned but never dosed|0|||
42374340|NCT01537081|76243100|FG002|Overall Study|Assigned but never dosed|0|||
42374341|NCT01564459|76243112|FG000|Run-In|Adverse Event|7|||
42374342|NCT01564459|76243113|FG001|Run-In|Adverse Event|0|||
42374343|NCT01564459|76243114|FG002|Run-In|Adverse Event|0|||
42374344|NCT01564459|76243112|FG000|Run-In|Lost to Follow-up|1|||
42374345|NCT01564459|76243113|FG001|Run-In|Lost to Follow-up|0|||
42374346|NCT01564459|76243114|FG002|Run-In|Lost to Follow-up|0|||
42374347|NCT01564459|76243112|FG000|Run-In|Non-compliance with study drug|2|||
42374348|NCT01564459|76243113|FG001|Run-In|Non-compliance with study drug|0|||
42374349|NCT01564459|76243114|FG002|Run-In|Non-compliance with study drug|0|||
42374350|NCT01564459|76243112|FG000|Run-In|Protocol Violation|1|||
42374351|NCT01564459|76243113|FG001|Run-In|Protocol Violation|0|||
42374352|NCT01564459|76243114|FG002|Run-In|Protocol Violation|0|||
42374353|NCT01564459|76243112|FG000|Run-In|Withdrawal by Subject|1|||
42374354|NCT01564459|76243113|FG001|Run-In|Withdrawal by Subject|0|||
42374355|NCT01564459|76243114|FG002|Run-In|Withdrawal by Subject|0|||
42374356|NCT01564459|76243112|FG000|Double-blind Treatment|Adverse Event|0|||
42374357|NCT01564459|76243113|FG001|Double-blind Treatment|Adverse Event|0|||
42374358|NCT01564459|76243114|FG002|Double-blind Treatment|Adverse Event|1|||
42374359|NCT01555073|76243129|FG000|Overall Study|Lost to Follow-up|1|||
42374360|NCT01555073|76243130|FG001|Overall Study|Lost to Follow-up|2|||
42374361|NCT01555073|76243131|FG002|Overall Study|Lost to Follow-up|0|||
42374362|NCT01555073|76243132|FG003|Overall Study|Lost to Follow-up|5|||
42374363|NCT01582243|76243142|FG000|Overall Study|Withdrawal by Subject|1|||
42374364|NCT01582243|76243142|FG000|Overall Study|Adverse Event|1|||
42374365|NCT01582243|76243142|FG000|Overall Study|Lost to Follow-up|1|||
42374366|NCT01536535|76243148|FG000|Overall Study|Withdrawal by Subject|10|||
42374367|NCT01536535|76243149|FG001|Overall Study|Withdrawal by Subject|5|||
42374368|NCT01536535|76243148|FG000|Overall Study|Lost to Follow-up|4|||
42374369|NCT01536535|76243149|FG001|Overall Study|Lost to Follow-up|6|||
42374370|NCT01536535|76243148|FG000|Overall Study|Physician Decision|1|||
42374371|NCT01536535|76243149|FG001|Overall Study|Physician Decision|1|||
42374372|NCT01536535|76243148|FG000|Overall Study|Participant moved|0|||
42374373|NCT01536535|76243149|FG001|Overall Study|Participant moved|1|||
42374374|NCT01554527|76243159|FG000|Overall Study|Withdrawal by Subject|1|||
42374375|NCT01554527|76243160|FG001|Overall Study|Withdrawal by Subject|0|||
42374376|NCT01554527|76243161|FG002|Overall Study|Withdrawal by Subject|3|||
42374377|NCT01554527|76243159|FG000|Overall Study|Lost to Follow-up|0|||
42374378|NCT01554527|76243160|FG001|Overall Study|Lost to Follow-up|0|||
42374379|NCT01554527|76243161|FG002|Overall Study|Lost to Follow-up|4|||
42374380|NCT01554527|76243159|FG000|Overall Study|Physician Decision|0|||
42374381|NCT01554527|76243160|FG001|Overall Study|Physician Decision|0|||
42374382|NCT01554527|76243161|FG002|Overall Study|Physician Decision|1|||
42374383|NCT01563913|76243172|FG000|Overall Study|Physician Decision|1|||
42374384|NCT01563913|76243173|FG001|Overall Study|Physician Decision|0|||
42374385|NCT01563913|76243172|FG000|Overall Study|Spouse Passed Away|1|||
42374386|NCT01563913|76243173|FG001|Overall Study|Spouse Passed Away|0|||
42374387|NCT01553747|76243182|FG000|Overall Study|Protocol Violation|0|||
42374388|NCT01553747|76243183|FG001|Overall Study|Protocol Violation|2|||
42374389|NCT01553747|76243184|FG002|Overall Study|Protocol Violation|0|||
42374390|NCT01553747|76243182|FG000|Overall Study|Voluntarily withdrew|70|||
42374391|NCT01553747|76243183|FG001|Overall Study|Voluntarily withdrew|66|||
42374392|NCT01553747|76243184|FG002|Overall Study|Voluntarily withdrew|74|||
42374393|NCT01553747|76243182|FG000|Overall Study|Adverse event or SAE|32|||
42374394|NCT01553747|76243183|FG001|Overall Study|Adverse event or SAE|28|||
42374395|NCT01553747|76243184|FG002|Overall Study|Adverse event or SAE|19|||
42374396|NCT01553747|76243182|FG000|Overall Study|Physician decision: other|10|||
42374397|NCT01553747|76243183|FG001|Overall Study|Physician decision: other|8|||
42374398|NCT01553747|76243184|FG002|Overall Study|Physician decision: other|7|||
42374399|NCT01553747|76243182|FG000|Overall Study|Lost to Follow-up|11|||
42374400|NCT01553747|76243183|FG001|Overall Study|Lost to Follow-up|5|||
42374401|NCT01553747|76243184|FG002|Overall Study|Lost to Follow-up|6|||
42374402|NCT01553747|76243182|FG000|Overall Study|Sponsor decision, specify|7|||
42374403|NCT01553747|76243183|FG001|Overall Study|Sponsor decision, specify|5|||
42374404|NCT01553747|76243184|FG002|Overall Study|Sponsor decision, specify|0|||
42374405|NCT01553747|76243182|FG000|Overall Study|Physician decision: lack of efficacy|1|||
42374406|NCT01553747|76243183|FG001|Overall Study|Physician decision: lack of efficacy|5|||
42374407|NCT01553747|76243184|FG002|Overall Study|Physician decision: lack of efficacy|3|||
42374408|NCT01536379|76243197|FG000|Overall Study|Adverse Event|1|||
42374409|NCT01536379|76243198|FG001|Overall Study|Adverse Event|2|||
42374410|NCT01536379|76243197|FG000|Overall Study|Withdrawal by Subject|1|||
42374411|NCT01536379|76243198|FG001|Overall Study|Withdrawal by Subject|1|||
42374412|NCT01536145|76243204|FG000|Overall Study|Progressive disease|3|||
42374413|NCT01536145|76243205|FG001|Overall Study|Progressive disease|4|||
42374414|NCT01536145|76243206|FG002|Overall Study|Progressive disease|1|||
42374415|NCT01536145|76243207|FG003|Overall Study|Progressive disease|2|||
42374416|NCT01536145|76243208|FG004|Overall Study|Progressive disease|1|||
42374417|NCT01536145|76243209|FG005|Overall Study|Progressive disease|2|||
42374418|NCT01536145|76243210|FG006|Overall Study|Progressive disease|1|||
42374419|NCT01536145|76243211|FG007|Overall Study|Progressive disease|2|||
42374420|NCT01536145|76243212|FG008|Overall Study|Progressive disease|1|||
42374421|NCT01536145|76243213|FG009|Overall Study|Progressive disease|3|||
42374422|NCT01536145|76243214|FG010|Overall Study|Progressive disease|3|||
42374423|NCT01536145|76243204|FG000|Overall Study|Withdrawal by Subject|0|||
42374424|NCT01536145|76243205|FG001|Overall Study|Withdrawal by Subject|0|||
42374425|NCT01536145|76243206|FG002|Overall Study|Withdrawal by Subject|1|||
42374426|NCT01536145|76243207|FG003|Overall Study|Withdrawal by Subject|0|||
42374427|NCT01536145|76243208|FG004|Overall Study|Withdrawal by Subject|0|||
42374428|NCT01536145|76243209|FG005|Overall Study|Withdrawal by Subject|1|||
42374429|NCT01536145|76243210|FG006|Overall Study|Withdrawal by Subject|0|||
42374430|NCT01536145|76243211|FG007|Overall Study|Withdrawal by Subject|0|||
42374431|NCT01536145|76243212|FG008|Overall Study|Withdrawal by Subject|2|||
42374432|NCT01536145|76243213|FG009|Overall Study|Withdrawal by Subject|0|||
42374433|NCT01536145|76243214|FG010|Overall Study|Withdrawal by Subject|2|||
42374434|NCT01536145|76243204|FG000|Overall Study|Other|0|||
42374435|NCT01536145|76243205|FG001|Overall Study|Other|0|||
42374436|NCT01536145|76243206|FG002|Overall Study|Other|0|||
42374437|NCT01536145|76243207|FG003|Overall Study|Other|0|||
42374438|NCT01536145|76243208|FG004|Overall Study|Other|1|||
42374439|NCT01536145|76243209|FG005|Overall Study|Other|0|||
42374440|NCT01536145|76243210|FG006|Overall Study|Other|0|||
42374441|NCT01536145|76243211|FG007|Overall Study|Other|0|||
42374442|NCT01536145|76243212|FG008|Overall Study|Other|0|||
42374443|NCT01536145|76243213|FG009|Overall Study|Other|3|||
42374444|NCT01536145|76243214|FG010|Overall Study|Other|2|||
42374445|NCT01536145|76243204|FG000|Overall Study|Death|0|||
42374446|NCT01536145|76243205|FG001|Overall Study|Death|0|||
42374447|NCT01536145|76243206|FG002|Overall Study|Death|0|||
42374448|NCT01536145|76243207|FG003|Overall Study|Death|0|||
42018741|NCT01124097|75826119|FG001|Overall Study|Protocol Violation|0|||
42103503|NCT00678392|75914448|FG001|Overall Study|Death|269|||
42103504|NCT00678392|75914447|FG000|Overall Study|Lost to Follow-up|15|||
42374449|NCT01536145|76243208|FG004|Overall Study|Death|0|||
42374450|NCT01536145|76243209|FG005|Overall Study|Death|0|||
42374451|NCT01536145|76243210|FG006|Overall Study|Death|1|||
42374452|NCT01536145|76243211|FG007|Overall Study|Death|0|||
42374453|NCT01536145|76243212|FG008|Overall Study|Death|0|||
42374454|NCT01536145|76243213|FG009|Overall Study|Death|0|||
42374455|NCT01536145|76243214|FG010|Overall Study|Death|0|||
42374456|NCT01536145|76243204|FG000|Overall Study|Adverse Event|0|||
42374457|NCT01536145|76243205|FG001|Overall Study|Adverse Event|0|||
42374458|NCT01536145|76243206|FG002|Overall Study|Adverse Event|0|||
42374459|NCT01536145|76243207|FG003|Overall Study|Adverse Event|0|||
42374460|NCT01536145|76243208|FG004|Overall Study|Adverse Event|0|||
42374461|NCT01536145|76243209|FG005|Overall Study|Adverse Event|0|||
42374462|NCT01536145|76243210|FG006|Overall Study|Adverse Event|0|||
42374463|NCT01536145|76243211|FG007|Overall Study|Adverse Event|2|||
42374464|NCT01536145|76243212|FG008|Overall Study|Adverse Event|0|||
42374465|NCT01536145|76243213|FG009|Overall Study|Adverse Event|0|||
42374466|NCT01536145|76243214|FG010|Overall Study|Adverse Event|3|||
42374467|NCT01536067|76243245|FG000|Overall Study|Disease Progression|1|||
42374468|NCT01582009|76243249|FG000|Overall Study|Withdrawal by Subject|1|||
42374469|NCT01582009|76243249|FG000|Overall Study|Physician Decision|1|||
42374470|NCT01553591|76243256|FG000|Overall Study|Voluntarily withdrew|94|||
42374471|NCT01553591|76243257|FG001|Overall Study|Voluntarily withdrew|79|||
42374472|NCT01553591|76243258|FG002|Overall Study|Voluntarily withdrew|96|||
42374473|NCT01553591|76243256|FG000|Overall Study|Adverse Event|36|||
42374474|NCT01553591|76243257|FG001|Overall Study|Adverse Event|45|||
42374475|NCT01553591|76243258|FG002|Overall Study|Adverse Event|16|||
42374476|NCT01553591|76243256|FG000|Overall Study|Lost to Follow-up|25|||
42374477|NCT01553591|76243257|FG001|Overall Study|Lost to Follow-up|23|||
42374478|NCT01553591|76243258|FG002|Overall Study|Lost to Follow-up|16|||
42374479|NCT01553591|76243256|FG000|Overall Study|Physician decision: other|11|||
42374480|NCT01553591|76243257|FG001|Overall Study|Physician decision: other|14|||
42374481|NCT01553591|76243258|FG002|Overall Study|Physician decision: other|16|||
42374482|NCT01553591|76243256|FG000|Overall Study|Physician decision: lack of efficacy|2|||
42374483|NCT01553591|76243257|FG001|Overall Study|Physician decision: lack of efficacy|3|||
42374484|NCT01553591|76243258|FG002|Overall Study|Physician decision: lack of efficacy|7|||
42374485|NCT01553591|76243256|FG000|Overall Study|Protocol Violation|3|||
42374486|NCT01553591|76243257|FG001|Overall Study|Protocol Violation|4|||
42374487|NCT01553591|76243258|FG002|Overall Study|Protocol Violation|4|||
42374488|NCT01553591|76243256|FG000|Overall Study|Sponsor decision|1|||
42374489|NCT01553591|76243257|FG001|Overall Study|Sponsor decision|0|||
42374490|NCT01553591|76243258|FG002|Overall Study|Sponsor decision|3|||
42374491|NCT01553591|76243256|FG000|Overall Study|Randomized and never dispensed drug|0|||
42374492|NCT01553591|76243257|FG001|Overall Study|Randomized and never dispensed drug|1|||
42374493|NCT01553591|76243258|FG002|Overall Study|Randomized and never dispensed drug|0|||
42374494|NCT01581931|76243266|FG000|Washout|Adverse Event|0|||
42374495|NCT01581931|76243267|FG001|Washout|Adverse Event|1|||
42374496|NCT01581619|76243273|FG000|Overall Study|Withdrawal by Subject|1|||
42374497|NCT01581619|76243273|FG000|Overall Study|Lost to Follow-up|1|||
42374498|NCT01581307|76243279|FG000|Overall Study|Withdrawal by Subject|1|||
42374499|NCT01580995|76243285|FG000|Overall Study|Lost to Follow-up|2|||
42374500|NCT01580995|76243286|FG001|Overall Study|Lost to Follow-up|2|||
42374501|NCT01535599|76243294|FG000|Overall Study|Adverse Event|6|||
42374502|NCT01535599|76243295|FG001|Overall Study|Adverse Event|15|||
42374503|NCT01535599|76243294|FG000|Overall Study|Lost to Follow-up|3|||
42374504|NCT01535599|76243295|FG001|Overall Study|Lost to Follow-up|4|||
42374505|NCT01535599|76243294|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
42374506|NCT01535599|76243295|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
42374507|NCT01535599|76243294|FG000|Overall Study|Treatment Failure|33|||
42374508|NCT01535599|76243295|FG001|Overall Study|Treatment Failure|66|||
42374509|NCT01535599|76243294|FG000|Overall Study|BL Culture + for Group A Strep|0|||
42374510|NCT01535599|76243295|FG001|Overall Study|BL Culture + for Group A Strep|1|||
42374511|NCT01535599|76243294|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
42374512|NCT01535599|76243295|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
42374513|NCT01535599|76243294|FG000|Overall Study|Randomized in Error|2|||
42374514|NCT01535599|76243295|FG001|Overall Study|Randomized in Error|4|||
42374515|NCT01535599|76243294|FG000|Overall Study|Did not use product|1|||
42374516|NCT01535599|76243295|FG001|Overall Study|Did not use product|0|||
42374517|NCT01535599|76243294|FG000|Overall Study|Other|1|||
42374518|NCT01535599|76243295|FG001|Overall Study|Other|0|||
42374519|NCT01535599|76243294|FG000|Overall Study|Stopped medication|0|||
42374520|NCT01535599|76243295|FG001|Overall Study|Stopped medication|1|||
42374521|NCT01535599|76243294|FG000|Overall Study|Noncompliance|0|||
42374522|NCT01535599|76243295|FG001|Overall Study|Noncompliance|1|||
42374523|NCT01553279|76243303|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
42374524|NCT01553279|76243304|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
42374525|NCT01553279|76243303|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
42103505|NCT00678392|75914448|FG001|Overall Study|Lost to Follow-up|13|||
42374526|NCT01553279|76243304|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
42374527|NCT01553279|76243303|FG000|Interim Period|Withdrawal by Subject|2|||
42374528|NCT01553279|76243304|FG001|Interim Period|Withdrawal by Subject|2|||
42374529|NCT01553279|76243303|FG000|Interim Period|Lost to Follow-up|1|||
42374530|NCT01553279|76243304|FG001|Interim Period|Lost to Follow-up|0|||
42374531|NCT01553279|76243303|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
42374532|NCT01553279|76243304|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
42374533|NCT01553279|76243303|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
42374534|NCT01553279|76243304|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
42374535|NCT01562743|76243311|FG000|Overall Study|Adverse Event|29|||
42374536|NCT01562743|76243311|FG000|Overall Study|Lack of Efficacy|3|||
42374537|NCT01562743|76243311|FG000|Overall Study|Withdrawal by Subject|13|||
42374538|NCT01562743|76243311|FG000|Overall Study|Protocol Violation|1|||
42374539|NCT01562743|76243311|FG000|Overall Study|Discontinuation criteria|2|||
42374540|NCT01562743|76243311|FG000|Overall Study|Lost to Follow-up|2|||
42374541|NCT01562743|76243311|FG000|Overall Study|Physician Decision|2|||
42374542|NCT01535443|76243315|FG000|Overall Study|Physician Decision|3|||
42374543|NCT01535287|76243322|FG000|Overall Study|drug not prepared in time|5|||
42374544|NCT01535287|76243323|FG001|Overall Study|drug not prepared in time|6|||
42374545|NCT01551173|76243331|FG000|Overall Study|Withdrawal by Subject|11|||
42374546|NCT01551173|76243332|FG001|Overall Study|Withdrawal by Subject|16|||
42374547|NCT01551173|76243331|FG000|Overall Study|Adverse Event|7|||
42374548|NCT01551173|76243332|FG001|Overall Study|Adverse Event|6|||
42374549|NCT01551173|76243331|FG000|Overall Study|Lost to Follow-up|5|||
42374550|NCT01551173|76243332|FG001|Overall Study|Lost to Follow-up|7|||
42374551|NCT01551173|76243331|FG000|Overall Study|Other|5|||
42374552|NCT01551173|76243332|FG001|Overall Study|Other|3|||
42374553|NCT01549613|76243341|FG000|Overall Study|Lost to Follow-up|11|||
42374554|NCT01549613|76243342|FG001|Overall Study|Lost to Follow-up|11|||
42374555|NCT01548599|76243350|FG000|Overall Study|Lost to Follow-up|0|||
42374556|NCT01548599|76243351|FG001|Overall Study|Lost to Follow-up|1|||
42374557|NCT01548599|76243350|FG000|Overall Study|Withdrawal by Subject|4|||
42374558|NCT01548599|76243351|FG001|Overall Study|Withdrawal by Subject|0|||
42374559|NCT01548599|76243350|FG000|Overall Study|Death|2|||
42374560|NCT01548599|76243351|FG001|Overall Study|Death|1|||
42374561|NCT01548287|76243364|FG000|Screening|No reason provided|0|||
42374562|NCT01548287|76243365|FG001|Screening|No reason provided|0|||
42374563|NCT01548287|76243366|FG002|Screening|No reason provided|0|||
42374564|NCT01548287|76243367|FG003|Screening|No reason provided|0|||
42374565|NCT01548287|76243368|FG004|Screening|No reason provided|9|||
42374566|NCT01548287|76243364|FG000|Screening|Did not meet eligibility criteria|0|||
42374567|NCT01548287|76243365|FG001|Screening|Did not meet eligibility criteria|0|||
42374568|NCT01548287|76243366|FG002|Screening|Did not meet eligibility criteria|0|||
42374569|NCT01548287|76243367|FG003|Screening|Did not meet eligibility criteria|0|||
42374570|NCT01548287|76243368|FG004|Screening|Did not meet eligibility criteria|74|||
42374571|NCT01548287|76243364|FG000|Randomized Period|Did not meet inclusion criteria|0|||
42374572|NCT01548287|76243365|FG001|Randomized Period|Did not meet inclusion criteria|0|||
42374573|NCT01548287|76243366|FG002|Randomized Period|Did not meet inclusion criteria|2|||
42374574|NCT01548287|76243367|FG003|Randomized Period|Did not meet inclusion criteria|0|||
42374575|NCT01548287|76243368|FG004|Randomized Period|Did not meet inclusion criteria|0|||
42374576|NCT01548287|76243364|FG000|Randomized Period|Adverse Event|0|||
42374577|NCT01548287|76243365|FG001|Randomized Period|Adverse Event|2|||
42374578|NCT01548287|76243366|FG002|Randomized Period|Adverse Event|5|||
42374579|NCT01548287|76243367|FG003|Randomized Period|Adverse Event|0|||
42374580|NCT01548287|76243368|FG004|Randomized Period|Adverse Event|0|||
42374581|NCT01546883|76243378|FG000|Overall Study|Withdrawal by Subject|3|||
42374582|NCT01546883|76243378|FG000|Overall Study|Adverse Event|4|||
42374583|NCT01546883|76243378|FG000|Overall Study|Lost to Follow-up|2|||
42374584|NCT01546883|76243378|FG000|Overall Study|early closure of study|2|||
42374585|NCT01546883|76243378|FG000|Overall Study|other unrelated illness|1|||
42374586|NCT01546649|76243384|FG000|Overall Study|Adverse Event|4|||
42374587|NCT01546649|76243385|FG001|Overall Study|Adverse Event|5|||
42374588|NCT01546649|76243384|FG000|Overall Study|Protocol Violation|1|||
42374589|NCT01546649|76243385|FG001|Overall Study|Protocol Violation|0|||
42374590|NCT01546649|76243384|FG000|Overall Study|Lack of Efficacy|1|||
42374591|NCT01546649|76243385|FG001|Overall Study|Lack of Efficacy|0|||
42374592|NCT01546649|76243384|FG000|Overall Study|Recurrence|1|||
42374593|NCT01546649|76243385|FG001|Overall Study|Recurrence|1|||
42374594|NCT01546649|76243384|FG000|Overall Study|Discovery of secondary cancer|0|||
42374595|NCT01546649|76243385|FG001|Overall Study|Discovery of secondary cancer|1|||
42374596|NCT01546649|76243384|FG000|Overall Study|Withdrawal by Subject|1|||
42374597|NCT01546649|76243385|FG001|Overall Study|Withdrawal by Subject|2|||
42374598|NCT01544309|76243393|FG000|Overall Study|Withdrawal by Subject|12|||
42374599|NCT01544309|76243394|FG001|Overall Study|Withdrawal by Subject|7|||
42374600|NCT01544309|76243393|FG000|Overall Study|Protocol Violation|2|||
42374601|NCT01544309|76243394|FG001|Overall Study|Protocol Violation|1|||
42374602|NCT01544309|76243393|FG000|Overall Study|Physician Decision|4|||
42374603|NCT01544309|76243394|FG001|Overall Study|Physician Decision|1|||
42374604|NCT01544309|76243393|FG000|Overall Study|Not performed pre-dose examination|1|||
42374605|NCT01544309|76243394|FG001|Overall Study|Not performed pre-dose examination|2|||
42374606|NCT01544309|76243393|FG000|Overall Study|Administered prohibit prior medication|1|||
42374607|NCT01544309|76243394|FG001|Overall Study|Administered prohibit prior medication|0|||
42374608|NCT01544153|76243406|FG000|Overall Study|Under 18|0|||
42374609|NCT01544153|76243407|FG001|Overall Study|Under 18|1|||
42374610|NCT01544153|76243408|FG002|Overall Study|Under 18|0|||
42374611|NCT01544153|76243409|FG003|Overall Study|Under 18|0|||
42374612|NCT01544153|76243406|FG000|Overall Study|Non-smoker|0|||
42374613|NCT01544153|76243407|FG001|Overall Study|Non-smoker|0|||
42374614|NCT01544153|76243408|FG002|Overall Study|Non-smoker|1|||
42374615|NCT01544153|76243409|FG003|Overall Study|Non-smoker|0|||
42374616|NCT01543685|76243424|FG000|Overall Study|Lack of Efficacy|1|||
42374617|NCT01543685|76243425|FG001|Overall Study|Lack of Efficacy|2|||
42374618|NCT01543685|76243426|FG002|Overall Study|Lack of Efficacy|2|||
42374619|NCT01543685|76243427|FG003|Overall Study|Lack of Efficacy|0|||
42374620|NCT01543685|76243428|FG004|Overall Study|Lack of Efficacy|2|||
42374621|NCT01543685|76243424|FG000|Overall Study|Adverse Event|2|||
42374622|NCT01543685|76243425|FG001|Overall Study|Adverse Event|1|||
42374623|NCT01543685|76243426|FG002|Overall Study|Adverse Event|0|||
42374624|NCT01543685|76243427|FG003|Overall Study|Adverse Event|0|||
42374625|NCT01543685|76243428|FG004|Overall Study|Adverse Event|2|||
42374626|NCT01541969|76243442|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
42374627|NCT01541969|76243443|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
42374628|NCT01541969|76243442|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
42374629|NCT01541969|76243443|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
42374630|NCT01541969|76243442|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
42374631|NCT01541969|76243443|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
42374632|NCT01541969|76243442|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
42374633|NCT01541969|76243443|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
42374634|NCT01541969|76243442|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
42374635|NCT01541969|76243443|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
42374636|NCT01541969|76243442|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
42374637|NCT01541969|76243443|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
42374638|NCT01541969|76243442|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
42374639|NCT01541969|76243443|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
42374640|NCT01541969|76243442|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
42374641|NCT01541969|76243443|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
42374642|NCT01541969|76243442|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
42374643|NCT01541969|76243443|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
42374644|NCT01541969|76243442|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
42374645|NCT01541969|76243443|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
42374646|NCT01540565|76243452|FG000|Overall Study|Ineligible|2|||
42374647|NCT01540487|76243458|FG000|Overall Study|Protocol Violation|1|||
42374648|NCT01540487|76243459|FG001|Overall Study|Protocol Violation|0|||
42374649|NCT01539317|76243471|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
42374650|NCT01539317|76243472|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
42374651|NCT01539239|76243483|FG000|Overall Study|Death|5|||
42374652|NCT01539239|76243484|FG001|Overall Study|Death|5|||
42374653|NCT01539239|76243483|FG000|Overall Study|Lost to Follow-up|7|||
42374654|NCT01539239|76243484|FG001|Overall Study|Lost to Follow-up|12|||
42374655|NCT01539083|76243490|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
42374656|NCT01539083|76243491|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
42374657|NCT01539083|76243492|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
42374658|NCT01539083|76243490|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
42374659|NCT01539083|76243491|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
42374660|NCT01539083|76243492|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
42374661|NCT01539083|76243490|FG000|Before Randomization (VCD Induction)|Death|6|||
42374662|NCT01539083|76243491|FG001|Before Randomization (VCD Induction)|Death|0|||
42374663|NCT01539083|76243492|FG002|Before Randomization (VCD Induction)|Death|0|||
42374664|NCT01539083|76243490|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
42374665|NCT01539083|76243491|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
42374666|NCT01539083|76243492|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
42374667|NCT01539083|76243490|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
42374668|NCT01539083|76243491|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
42374669|NCT01539083|76243492|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
42374670|NCT01539083|76243490|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
42374671|NCT01539083|76243491|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
42374672|NCT01539083|76243492|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
42018742|NCT01124097|75826120|FG002|Overall Study|Protocol Violation|2|||
42018743|NCT01124097|75826121|FG003|Overall Study|Protocol Violation|1|||
42018744|NCT01124097|75826118|FG000|Overall Study|Physician Decision|2|||
42374673|NCT01539083|76243490|FG000|Before Randomization (VCD Induction)|Other|5|||
42374674|NCT01539083|76243491|FG001|Before Randomization (VCD Induction)|Other|0|||
42374675|NCT01539083|76243492|FG002|Before Randomization (VCD Induction)|Other|0|||
42374676|NCT01539083|76243490|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
42374677|NCT01539083|76243491|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
42374678|NCT01539083|76243492|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
42374679|NCT01539083|76243490|FG000|After Randomization (TP and VTP)|Other|0|||
42374680|NCT01539083|76243491|FG001|After Randomization (TP and VTP)|Other|1|||
42374681|NCT01539083|76243492|FG002|After Randomization (TP and VTP)|Other|1|||
42374682|NCT01539083|76243490|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
42374683|NCT01539083|76243491|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
42374684|NCT01539083|76243492|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
42374685|NCT01539083|76243490|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
42374686|NCT01539083|76243491|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
42374687|NCT01539083|76243492|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
42374688|NCT01539083|76243490|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
42374689|NCT01539083|76243491|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
42374690|NCT01539083|76243492|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
42374691|NCT01539083|76243490|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
42374692|NCT01539083|76243491|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
42374693|NCT01539083|76243492|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
42374694|NCT01539083|76243490|FG000|After Randomization (TP and VTP)|Death|0|||
42374695|NCT01539083|76243491|FG001|After Randomization (TP and VTP)|Death|6|||
42374696|NCT01539083|76243492|FG002|After Randomization (TP and VTP)|Death|11|||
42374697|NCT01537211|76243501|FG000|Overall Study|Lost to Follow-up|0|||
42374698|NCT01537211|76243502|FG001|Overall Study|Lost to Follow-up|1|||
42374699|NCT01537133|76243516|FG000|Overall Study|Withdrawal by Subject|2|||
42374700|NCT01537133|76243517|FG001|Overall Study|Withdrawal by Subject|0|||
42374701|NCT01537133|76243518|FG002|Overall Study|Withdrawal by Subject|0|||
42374702|NCT01537133|76243519|FG003|Overall Study|Withdrawal by Subject|0|||
42374703|NCT01537133|76243516|FG000|Overall Study|Lost to Follow-up|1|||
42374704|NCT01537133|76243517|FG001|Overall Study|Lost to Follow-up|0|||
42374705|NCT01537133|76243518|FG002|Overall Study|Lost to Follow-up|0|||
42374706|NCT01537133|76243519|FG003|Overall Study|Lost to Follow-up|0|||
42374707|NCT01536587|76243527|FG000|Overall Study|Adverse Event|2|||
42374708|NCT01536119|76243533|FG000|Overall Study|Lost to Follow-up|17|||
42374709|NCT01536119|76243534|FG001|Overall Study|Lost to Follow-up|14|||
42374710|NCT01535729|76243540|FG000|Overall Study|Withdrawal by Subject|2|||
42374711|NCT01535729|76243540|FG000|Overall Study|Disease progression|230|||
42374712|NCT01535729|76243540|FG000|Overall Study|Discontinued treatment|25|||
42374713|NCT01535729|76243540|FG000|Overall Study|Lost to Follow-up|8|||
42374714|NCT01535729|76243540|FG000|Overall Study|Death|52|||
42374715|NCT01535729|76243540|FG000|Overall Study|Other|19|||
42374716|NCT01535729|76243540|FG000|Overall Study|Did not sign informed consent|1|||
42374717|NCT01535729|76243540|FG000|Overall Study|No previous chemotherapy|33|||
42374718|NCT01535729|76243540|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
42374719|NCT01535729|76243540|FG000|Overall Study|Protocol Violation|11|||
42374720|NCT01535729|76243540|FG000|Overall Study|Screening failure|1|||
42374721|NCT01535729|76243540|FG000|Overall Study|Not treated|9|||
42374722|NCT01535729|76243540|FG000|Overall Study|No participant record available|5|||
42374723|NCT01535261|76243544|FG000|Overall Study|Physician Decision|8|||
42374724|NCT01535261|76243544|FG000|Overall Study|Protocol Violation|3|||
42374725|NCT01535261|76243544|FG000|Overall Study|Death|5|||
42374726|NCT01535261|76243544|FG000|Overall Study|Lost to Follow-up|8|||
42374727|NCT01535261|76243544|FG000|Overall Study|Withdrawal by Subject|14|||
42374728|NCT01535261|76243544|FG000|Overall Study|Adverse Event|12|||
42374729|NCT01534637|76243548|FG000|Overall Study|Physician Decision|3|||
42374730|NCT01534637|76243548|FG000|Overall Study|Lack of Efficacy|3|||
42374731|NCT01534637|76243548|FG000|Overall Study|Withdrawal by Subject|1|||
42374732|NCT01534637|76243548|FG000|Overall Study|Adverse Event|1|||
42374733|NCT01534637|76243548|FG000|Overall Study|Liver Mets before treatment|1|||
42374734|NCT02655016|76243554|FG000|Overall Study|Disease progression|6|||
42374735|NCT02655016|76243555|FG001|Overall Study|Disease progression|4|||
42374736|NCT02655016|76243554|FG000|Overall Study|Site closed|0|||
42374737|NCT02655016|76243555|FG001|Overall Study|Site closed|1|||
42374738|NCT02655016|76243554|FG000|Overall Study|Death|30|||
42200786|NCT02057718|76012714|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
42374739|NCT02655016|76243555|FG001|Overall Study|Death|48|||
42374740|NCT02655016|76243554|FG000|Overall Study|Lost to Follow-up|1|||
42018745|NCT01124097|75826119|FG001|Overall Study|Physician Decision|1|||
42374741|NCT02655016|76243555|FG001|Overall Study|Lost to Follow-up|1|||
42374742|NCT02655016|76243554|FG000|Overall Study|Withdrawal by Subject|18|||
42374743|NCT02655016|76243555|FG001|Overall Study|Withdrawal by Subject|36|||
42374744|NCT01533935|76243562|FG000|Overall Study|Adverse Event|5|||
42374745|NCT01533935|76243563|FG001|Overall Study|Adverse Event|7|||
42374746|NCT01533935|76243564|FG002|Overall Study|Adverse Event|1|||
42374747|NCT01533935|76243565|FG003|Overall Study|Adverse Event|5|||
42374748|NCT01533935|76243566|FG004|Overall Study|Adverse Event|3|||
42374749|NCT01533935|76243562|FG000|Overall Study|Protocol Violation|0|||
42374750|NCT01533935|76243563|FG001|Overall Study|Protocol Violation|2|||
42374751|NCT01533935|76243564|FG002|Overall Study|Protocol Violation|0|||
42374752|NCT01533935|76243565|FG003|Overall Study|Protocol Violation|0|||
42374753|NCT01533935|76243566|FG004|Overall Study|Protocol Violation|0|||
42374754|NCT01533935|76243562|FG000|Overall Study|Lost to Follow-up|0|||
42374755|NCT01533935|76243563|FG001|Overall Study|Lost to Follow-up|0|||
42374756|NCT01533935|76243564|FG002|Overall Study|Lost to Follow-up|1|||
42374757|NCT01533935|76243565|FG003|Overall Study|Lost to Follow-up|0|||
42374758|NCT01533935|76243566|FG004|Overall Study|Lost to Follow-up|0|||
42374759|NCT01533935|76243562|FG000|Overall Study|Withdrawal by Subject|0|||
42374760|NCT01533935|76243563|FG001|Overall Study|Withdrawal by Subject|4|||
42374761|NCT01533935|76243564|FG002|Overall Study|Withdrawal by Subject|5|||
42374762|NCT01533935|76243565|FG003|Overall Study|Withdrawal by Subject|2|||
42374763|NCT01533935|76243566|FG004|Overall Study|Withdrawal by Subject|4|||
42374764|NCT01533935|76243562|FG000|Overall Study|Other reason not defined above|1|||
42374765|NCT01533935|76243563|FG001|Overall Study|Other reason not defined above|0|||
42374766|NCT01533935|76243564|FG002|Overall Study|Other reason not defined above|1|||
42374767|NCT01533935|76243565|FG003|Overall Study|Other reason not defined above|0|||
42374768|NCT01533935|76243566|FG004|Overall Study|Other reason not defined above|1|||
42374769|NCT01532999|76243580|FG000|Overall Study|Lost to Follow-up|14|||
42374770|NCT01532999|76243581|FG001|Overall Study|Lost to Follow-up|8|||
42374771|NCT01532999|76243580|FG000|Overall Study|Physician Decision|1|||
42374772|NCT01532999|76243581|FG001|Overall Study|Physician Decision|2|||
42374773|NCT01532999|76243580|FG000|Overall Study|Withdrawal by Subject|5|||
42374774|NCT01532999|76243581|FG001|Overall Study|Withdrawal by Subject|0|||
42374775|NCT01532999|76243580|FG000|Overall Study|Relocated|2|||
42374776|NCT01532999|76243581|FG001|Overall Study|Relocated|0|||
42374777|NCT01532999|76243580|FG000|Overall Study|should not have been randomized|1|||
42374778|NCT01532999|76243581|FG001|Overall Study|should not have been randomized|0|||
42374779|NCT01532999|76243580|FG000|Overall Study|substantial noncompliance|2|||
42374780|NCT01532999|76243581|FG001|Overall Study|substantial noncompliance|0|||
42374781|NCT01532999|76243580|FG000|Overall Study|no show for week 9 assessments|6|||
42374782|NCT01532999|76243581|FG001|Overall Study|no show for week 9 assessments|4|||
42374783|NCT01532999|76243580|FG000|Overall Study|Adverse Event|0|||
42374784|NCT01532999|76243581|FG001|Overall Study|Adverse Event|1|||
42374785|NCT01532999|76243580|FG000|Overall Study|incarcerated|0|||
42374786|NCT01532999|76243581|FG001|Overall Study|incarcerated|1|||
42374787|NCT01532999|76243580|FG000|Overall Study|New job|0|||
42374788|NCT01532999|76243581|FG001|Overall Study|New job|2|||
42374789|NCT01532921|76243587|FG000|Overall Study|Death|3|||
42374790|NCT01532921|76243587|FG000|Overall Study|Withdrawal by Subject|2|||
42374791|NCT01532921|76243587|FG000|Overall Study|Lost to Follow-up|3|||
42374792|NCT01532921|76243587|FG000|Overall Study|Physician Decision|7|||
42374793|NCT01532921|76243587|FG000|Overall Study|Device was explanted during procedure|1|||
42374794|NCT01532687|76243597|FG000|Overall Study|Death|2|||
42374795|NCT01532687|76243598|FG001|Overall Study|Death|0|||
42374796|NCT01532687|76243597|FG000|Overall Study|Adverse Event|6|||
42374797|NCT01532687|76243598|FG001|Overall Study|Adverse Event|1|||
42374798|NCT01532687|76243597|FG000|Overall Study|Withdrawal by Subject|1|||
42374799|NCT01532687|76243598|FG001|Overall Study|Withdrawal by Subject|0|||
42374800|NCT01532687|76243597|FG000|Overall Study|Physician Decision|2|||
42374801|NCT01532687|76243598|FG001|Overall Study|Physician Decision|1|||
42374802|NCT01532687|76243597|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
42374803|NCT01532687|76243598|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
42374804|NCT02677116|76243615|FG000|Overall Study|Adverse Event|0|||
42374805|NCT02677116|76243616|FG001|Overall Study|Adverse Event|1|||
42374806|NCT02677116|76243617|FG002|Overall Study|Adverse Event|0|||
42374807|NCT02677116|76243618|FG003|Overall Study|Adverse Event|0|||
42374808|NCT02677116|76243619|FG004|Overall Study|Adverse Event|0|||
42374809|NCT02677116|76243620|FG005|Overall Study|Adverse Event|1|||
42374810|NCT02677116|76243621|FG006|Overall Study|Adverse Event|1|||
42374811|NCT02677116|76243622|FG007|Overall Study|Adverse Event|0|||
42374812|NCT02677116|76243623|FG008|Overall Study|Adverse Event|0|||
42374813|NCT02677116|76243615|FG000|Overall Study|Physician Decision|0|||
42374814|NCT02677116|76243616|FG001|Overall Study|Physician Decision|2|||
42374815|NCT02677116|76243617|FG002|Overall Study|Physician Decision|3|||
42374816|NCT02677116|76243618|FG003|Overall Study|Physician Decision|2|||
42374817|NCT02677116|76243619|FG004|Overall Study|Physician Decision|1|||
42374818|NCT02677116|76243620|FG005|Overall Study|Physician Decision|3|||
42374819|NCT02677116|76243621|FG006|Overall Study|Physician Decision|1|||
42374820|NCT02677116|76243622|FG007|Overall Study|Physician Decision|1|||
42374821|NCT02677116|76243623|FG008|Overall Study|Physician Decision|2|||
42374822|NCT02677116|76243615|FG000|Overall Study|Withdrawal by parent or guardian|2|||
42374823|NCT02677116|76243616|FG001|Overall Study|Withdrawal by parent or guardian|1|||
42374824|NCT02677116|76243617|FG002|Overall Study|Withdrawal by parent or guardian|0|||
42374825|NCT02677116|76243618|FG003|Overall Study|Withdrawal by parent or guardian|1|||
42374826|NCT02677116|76243619|FG004|Overall Study|Withdrawal by parent or guardian|0|||
42374827|NCT02677116|76243620|FG005|Overall Study|Withdrawal by parent or guardian|0|||
42374828|NCT02677116|76243621|FG006|Overall Study|Withdrawal by parent or guardian|2|||
42374829|NCT02677116|76243622|FG007|Overall Study|Withdrawal by parent or guardian|1|||
42374830|NCT02677116|76243623|FG008|Overall Study|Withdrawal by parent or guardian|0|||
42374831|NCT02677116|76243615|FG000|Overall Study|Withdrawal by Subject|1|||
42374832|NCT02677116|76243616|FG001|Overall Study|Withdrawal by Subject|0|||
42374833|NCT02677116|76243617|FG002|Overall Study|Withdrawal by Subject|0|||
42374834|NCT02677116|76243618|FG003|Overall Study|Withdrawal by Subject|0|||
42374835|NCT02677116|76243619|FG004|Overall Study|Withdrawal by Subject|0|||
42374836|NCT02677116|76243620|FG005|Overall Study|Withdrawal by Subject|0|||
42374837|NCT02677116|76243621|FG006|Overall Study|Withdrawal by Subject|0|||
42374838|NCT02677116|76243622|FG007|Overall Study|Withdrawal by Subject|0|||
42374839|NCT02677116|76243623|FG008|Overall Study|Withdrawal by Subject|0|||
42374840|NCT02689518|76243666|FG000|Overall Study|Withdrawal by Subject|3|||
42374841|NCT02681094|76243673|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
42374842|NCT02681094|76243674|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
42374843|NCT02681094|76243675|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
42374844|NCT02681094|76243673|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
42374845|NCT02681094|76243674|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
42374846|NCT02681094|76243675|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
42374847|NCT02681094|76243673|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
42374848|NCT02681094|76243674|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
42374849|NCT02681094|76243675|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
42374850|NCT02681094|76243673|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
42374851|NCT02681094|76243674|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
42374852|NCT02681094|76243675|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
42374853|NCT02681094|76243673|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
42374854|NCT02681094|76243674|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
42374855|NCT02681094|76243675|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
42374856|NCT02681094|76243673|FG000|1 -Modified Enrolled Participants Set|Other|6|||
42374857|NCT02681094|76243674|FG001|1 -Modified Enrolled Participants Set|Other|6|||
42374858|NCT02681094|76243675|FG002|1 -Modified Enrolled Participants Set|Other|7|||
42374859|NCT02681094|76243673|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
42374860|NCT02681094|76243674|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
42374861|NCT02681094|76243675|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
42374862|NCT02681094|76243673|FG000|2 - Enrolled Participants Set|Participant decision|7|||
42374863|NCT02681094|76243674|FG001|2 - Enrolled Participants Set|Participant decision|10|||
42374864|NCT02681094|76243675|FG002|2 - Enrolled Participants Set|Participant decision|9|||
42374865|NCT02681094|76243673|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
42374866|NCT02681094|76243674|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
42374867|NCT02681094|76243675|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
42374868|NCT02681094|76243673|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
42374869|NCT02681094|76243674|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
42374870|NCT02681094|76243675|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
42374871|NCT02681094|76243673|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
42374872|NCT02681094|76243674|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
42374873|NCT02681094|76243675|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
42374874|NCT02681094|76243673|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
42374875|NCT02681094|76243674|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
42374876|NCT02681094|76243675|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
42374877|NCT02681094|76243673|FG000|2 - Enrolled Participants Set|Other|6|||
42374878|NCT02681094|76243674|FG001|2 - Enrolled Participants Set|Other|6|||
42374879|NCT02681094|76243675|FG002|2 - Enrolled Participants Set|Other|7|||
42374880|NCT02681094|76243673|FG000|2 - Enrolled Participants Set|No treatment given|0|||
42374881|NCT02681094|76243674|FG001|2 - Enrolled Participants Set|No treatment given|1|||
42374882|NCT02681094|76243675|FG002|2 - Enrolled Participants Set|No treatment given|1|||
42103506|NCT00678392|75914447|FG000|Overall Study|Objective Progression or Relapse|3|||
42200787|NCT02057718|76012713|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
42374883|NCT02689284|76243686|FG000|Overall Study|Adverse Event|1|||
42374884|NCT02689284|76243687|FG001|Overall Study|Adverse Event|8|||
42374885|NCT02689284|76243686|FG000|Overall Study|Death|0|||
42374886|NCT02689284|76243687|FG001|Overall Study|Death|1|||
42374887|NCT02689284|76243686|FG000|Overall Study|Physician Decision|1|||
42374888|NCT02689284|76243687|FG001|Overall Study|Physician Decision|2|||
42374889|NCT02689284|76243686|FG000|Overall Study|Withdrawal by Subject|0|||
42374890|NCT02689284|76243687|FG001|Overall Study|Withdrawal by Subject|1|||
42374891|NCT02689284|76243686|FG000|Overall Study|progression of cancer|1|||
42374892|NCT02689284|76243687|FG001|Overall Study|progression of cancer|72|||
42374893|NCT02689284|76243686|FG000|Overall Study|decreased heart function|0|||
42374894|NCT02689284|76243687|FG001|Overall Study|decreased heart function|1|||
42374895|NCT02689284|76243686|FG000|Overall Study|concern for anemia|0|||
42374896|NCT02689284|76243687|FG001|Overall Study|concern for anemia|1|||
42374897|NCT02689284|76243686|FG000|Overall Study|no measurable cancer for evaluation|0|||
42374898|NCT02689284|76243687|FG001|Overall Study|no measurable cancer for evaluation|1|||
42374899|NCT02676882|76243696|FG000|Overall Study|Adverse Event|1|||
42374900|NCT02676882|76243697|FG001|Overall Study|Adverse Event|0|||
42374901|NCT02676882|76243696|FG000|Overall Study|Lost to Follow-up|1|||
42374902|NCT02676882|76243697|FG001|Overall Study|Lost to Follow-up|0|||
42374903|NCT02676882|76243696|FG000|Overall Study|Withdrawal by Subject|1|||
42374904|NCT02676882|76243697|FG001|Overall Study|Withdrawal by Subject|2|||
42374905|NCT02674386|76243706|FG000|Overall Study|Lost to Follow-up|0|||
42374906|NCT02674386|76243707|FG001|Overall Study|Lost to Follow-up|1|||
42374907|NCT02674386|76243708|FG002|Overall Study|Lost to Follow-up|1|||
42374908|NCT02674386|76243706|FG000|Overall Study|Withdrawal by Subject|0|||
42374909|NCT02674386|76243707|FG001|Overall Study|Withdrawal by Subject|4|||
42374910|NCT02674386|76243708|FG002|Overall Study|Withdrawal by Subject|0|||
42374911|NCT02674386|76243706|FG000|Overall Study|Other|0|||
42374912|NCT02674386|76243707|FG001|Overall Study|Other|1|||
42374913|NCT02674386|76243708|FG002|Overall Study|Other|0|||
42374914|NCT02674386|76243706|FG000|Overall Study|Enrolled but not evaluated|0|||
42374915|NCT02674386|76243707|FG001|Overall Study|Enrolled but not evaluated|4|||
42374916|NCT02674386|76243708|FG002|Overall Study|Enrolled but not evaluated|0|||
42374917|NCT02680002|76243727|FG000|Overall Study|Lost to Follow-up|5|||
42374918|NCT02680002|76243728|FG001|Overall Study|Lost to Follow-up|1|||
42374919|NCT02680002|76243729|FG002|Overall Study|Lost to Follow-up|4|||
42374920|NCT02680002|76243730|FG003|Overall Study|Lost to Follow-up|2|||
42374921|NCT02680002|76243731|FG004|Overall Study|Lost to Follow-up|0|||
42374922|NCT02680002|76243732|FG005|Overall Study|Lost to Follow-up|2|||
42374923|NCT02680002|76243727|FG000|Overall Study|Physician Decision|5|||
42374924|NCT02680002|76243728|FG001|Overall Study|Physician Decision|1|||
42374925|NCT02680002|76243729|FG002|Overall Study|Physician Decision|1|||
42374926|NCT02680002|76243730|FG003|Overall Study|Physician Decision|1|||
42374927|NCT02680002|76243731|FG004|Overall Study|Physician Decision|1|||
42374928|NCT02680002|76243732|FG005|Overall Study|Physician Decision|1|||
42374929|NCT02680002|76243727|FG000|Overall Study|Protocol Violation|1|||
42374930|NCT02680002|76243728|FG001|Overall Study|Protocol Violation|0|||
42374931|NCT02680002|76243729|FG002|Overall Study|Protocol Violation|1|||
42374932|NCT02680002|76243730|FG003|Overall Study|Protocol Violation|0|||
42374933|NCT02680002|76243731|FG004|Overall Study|Protocol Violation|1|||
42374934|NCT02680002|76243732|FG005|Overall Study|Protocol Violation|2|||
42200788|NCT02057718|76012714|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
42200789|NCT02057718|76012713|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
42374935|NCT02680002|76243727|FG000|Overall Study|Withdrawal by Subject|0|||
42374936|NCT02680002|76243728|FG001|Overall Study|Withdrawal by Subject|0|||
42374937|NCT02680002|76243729|FG002|Overall Study|Withdrawal by Subject|1|||
42374938|NCT02680002|76243730|FG003|Overall Study|Withdrawal by Subject|0|||
42374939|NCT02680002|76243731|FG004|Overall Study|Withdrawal by Subject|2|||
42374940|NCT02680002|76243732|FG005|Overall Study|Withdrawal by Subject|2|||
42374941|NCT02680002|76243727|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
42374942|NCT02680002|76243728|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
42374943|NCT02680002|76243729|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
42374944|NCT02680002|76243730|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
42374945|NCT02680002|76243731|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
42018746|NCT01124097|75826120|FG002|Overall Study|Physician Decision|0|||
42374946|NCT02680002|76243732|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
42374947|NCT02680002|76243727|FG000|Overall Study|Other|0|||
42374948|NCT02680002|76243728|FG001|Overall Study|Other|1|||
42374949|NCT02680002|76243729|FG002|Overall Study|Other|0|||
42374950|NCT02680002|76243730|FG003|Overall Study|Other|0|||
42374951|NCT02680002|76243731|FG004|Overall Study|Other|1|||
42374952|NCT02680002|76243732|FG005|Overall Study|Other|0|||
42374953|NCT02680002|76243727|FG000|Overall Study|Adverse Event|0|||
42374954|NCT02680002|76243728|FG001|Overall Study|Adverse Event|0|||
42374955|NCT02680002|76243729|FG002|Overall Study|Adverse Event|0|||
42374956|NCT02680002|76243730|FG003|Overall Study|Adverse Event|0|||
42374957|NCT02680002|76243731|FG004|Overall Study|Adverse Event|1|||
42374958|NCT02680002|76243732|FG005|Overall Study|Adverse Event|2|||
42374959|NCT04557384|76243749|FG000|Overall Study|Study Terminated by Sponsor|1|||
42374960|NCT04557384|76243749|FG000|Overall Study|Death|1|||
42374961|NCT02673684|76243755|FG000|Overall Study|Study not completed d/t loss of funding|9|||
42374962|NCT02673684|76243756|FG001|Overall Study|Study not completed d/t loss of funding|8|||
42374963|NCT02675634|76243764|FG000|Test Period 1|Adverse Event|0|||
42374964|NCT02675634|76243765|FG001|Test Period 1|Adverse Event|1|||
42374965|NCT02675634|76243766|FG002|Test Period 1|Adverse Event|0|||
42374966|NCT02675634|76243767|FG003|Test Period 1|Adverse Event|1|||
42374967|NCT02675634|76243768|FG004|Test Period 1|Adverse Event|0|||
42374968|NCT02675634|76243769|FG005|Test Period 1|Adverse Event|0|||
42374969|NCT02675634|76243764|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
42374970|NCT02675634|76243765|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
42374971|NCT02675634|76243766|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
42374972|NCT02675634|76243767|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
42374973|NCT02675634|76243768|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
42374974|NCT02675634|76243769|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
42374975|NCT02675634|76243764|FG000|Test Period 2|Lack of Efficacy|1|||
42374976|NCT02675634|76243765|FG001|Test Period 2|Lack of Efficacy|0|||
42374977|NCT02675634|76243766|FG002|Test Period 2|Lack of Efficacy|0|||
42374978|NCT02675634|76243767|FG003|Test Period 2|Lack of Efficacy|0|||
42374979|NCT02675634|76243768|FG004|Test Period 2|Lack of Efficacy|0|||
42374980|NCT02675634|76243769|FG005|Test Period 2|Lack of Efficacy|0|||
42374981|NCT02675634|76243764|FG000|Test Period 2|Adverse Event|0|||
42374982|NCT02675634|76243765|FG001|Test Period 2|Adverse Event|0|||
42374983|NCT02675634|76243766|FG002|Test Period 2|Adverse Event|0|||
42374984|NCT02675634|76243767|FG003|Test Period 2|Adverse Event|0|||
42374985|NCT02675634|76243768|FG004|Test Period 2|Adverse Event|0|||
42374986|NCT02675634|76243769|FG005|Test Period 2|Adverse Event|1|||
42374987|NCT02671500|76243777|FG000|Overall Study|Lack of Efficacy|12|||
42374988|NCT02671500|76243777|FG000|Overall Study|Lost to Follow-up|2|||
42018747|NCT01124097|75826121|FG003|Overall Study|Physician Decision|0|||
42374989|NCT02671422|76243785|FG000|Overall Study|Lost to Follow-up|1|||
42374990|NCT02671422|76243785|FG000|Overall Study|Adverse Event|68|||
42374991|NCT02671422|76243785|FG000|Overall Study|Lack of Efficacy|1|||
42374992|NCT02671422|76243785|FG000|Overall Study|Lost to Follow-up|4|||
42374993|NCT02671422|76243785|FG000|Overall Study|Withdrawal by Subject|7|||
42374994|NCT02671422|76243785|FG000|Overall Study|Progressive Disease|156|||
42374995|NCT02671422|76243785|FG000|Overall Study|Worsening of Disease|4|||
42374996|NCT02671422|76243785|FG000|Overall Study|Sponsor decision|5|||
42374997|NCT02671422|76243785|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
42374998|NCT02671422|76243785|FG000|Overall Study|Not treated with Vargatef®|3|||
42374999|NCT02671422|76243785|FG000|Overall Study|Other not defined above|3|||
42375000|NCT02671266|76243791|FG000|Overall Study|Withdrawal by Subject|1|||
42375001|NCT02671266|76243792|FG001|Overall Study|Withdrawal by Subject|1|||
42375002|NCT03320070|76243800|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
42375003|NCT03320070|76243801|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
42375004|NCT03320070|76243800|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
42375005|NCT03320070|76243801|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
42375006|NCT03320070|76243800|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
42375007|NCT03320070|76243801|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
42375008|NCT03320070|76243800|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
42375009|NCT03320070|76243801|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
42375010|NCT03320070|76243800|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
42375011|NCT03320070|76243801|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
42200790|NCT02057718|76012714|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
42200791|NCT02057718|76012713|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
42200792|NCT02057718|76012714|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
42200793|NCT02057718|76012713|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
42375012|NCT03320070|76243800|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
42375013|NCT03320070|76243801|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
42375014|NCT02667912|76243812|FG000|Overall Study|Death|3|||
42375015|NCT02667912|76243813|FG001|Overall Study|Death|1|||
42375016|NCT02667912|76243812|FG000|Overall Study|Withdrawal by Subject|1|||
42375017|NCT02667912|76243813|FG001|Overall Study|Withdrawal by Subject|2|||
42375018|NCT02667912|76243812|FG000|Overall Study|Withdrawal by Subject|1|||
42375019|NCT02667912|76243813|FG001|Overall Study|Withdrawal by Subject|0|||
42375020|NCT01373346|76243819|FG000|Overall Study|Death|1|||
42375021|NCT03284424|76243830|FG000|Overall Study|Death|56|||
42375022|NCT03284424|76243831|FG001|Overall Study|Death|13|||
42375023|NCT03284424|76243830|FG000|Overall Study|Lost to Follow-up|1|||
42375024|NCT03284424|76243831|FG001|Overall Study|Lost to Follow-up|0|||
42375025|NCT03284424|76243830|FG000|Overall Study|Physician Decision|1|||
42375026|NCT03284424|76243831|FG001|Overall Study|Physician Decision|0|||
42375027|NCT03284424|76243830|FG000|Overall Study|Withdrawal by Subject|3|||
42375028|NCT03284424|76243831|FG001|Overall Study|Withdrawal by Subject|2|||
42375029|NCT03284424|76243830|FG000|Overall Study|Ongoing in study|44|||
42375030|NCT03284424|76243831|FG001|Overall Study|Ongoing in study|39|||
42375031|NCT02674854|76243839|FG000|Overall Study|Adverse Event|17|||
42375032|NCT02674854|76243840|FG001|Overall Study|Adverse Event|15|||
42375033|NCT02674854|76243841|FG002|Overall Study|Adverse Event|5|||
42375034|NCT02674854|76243839|FG000|Overall Study|Withdrawal by Subject|1|||
42375035|NCT02674854|76243840|FG001|Overall Study|Withdrawal by Subject|5|||
42375036|NCT02674854|76243841|FG002|Overall Study|Withdrawal by Subject|4|||
42375037|NCT02674854|76243839|FG000|Overall Study|No-compliant subject|1|||
42375038|NCT02674854|76243840|FG001|Overall Study|No-compliant subject|0|||
42375039|NCT02674854|76243841|FG002|Overall Study|No-compliant subject|1|||
42375040|NCT02674854|76243839|FG000|Overall Study|Lost to Follow-up|1|||
42375041|NCT02674854|76243840|FG001|Overall Study|Lost to Follow-up|0|||
42375042|NCT02674854|76243841|FG002|Overall Study|Lost to Follow-up|2|||
42375043|NCT02674854|76243839|FG000|Overall Study|Lack of Efficacy|0|||
42375044|NCT02674854|76243840|FG001|Overall Study|Lack of Efficacy|3|||
42375045|NCT02674854|76243841|FG002|Overall Study|Lack of Efficacy|0|||
42375046|NCT02674854|76243839|FG000|Overall Study|Disallowed Concurrent Medication|2|||
42375047|NCT02674854|76243840|FG001|Overall Study|Disallowed Concurrent Medication|2|||
42375048|NCT02674854|76243841|FG002|Overall Study|Disallowed Concurrent Medication|0|||
42375049|NCT02674854|76243839|FG000|Overall Study|Protocol Violation|1|||
42375050|NCT02674854|76243840|FG001|Overall Study|Protocol Violation|1|||
42375051|NCT02674854|76243841|FG002|Overall Study|Protocol Violation|2|||
42375052|NCT02674854|76243839|FG000|Overall Study|Death|0|||
42375053|NCT02674854|76243840|FG001|Overall Study|Death|1|||
42018748|NCT01123941|75826133|FG000|Overall Study|Lost to Follow-up|2|||
42375054|NCT02674854|76243841|FG002|Overall Study|Death|0|||
42375055|NCT02674854|76243839|FG000|Overall Study|Subject missed V6.2|1|||
42375056|NCT02674854|76243840|FG001|Overall Study|Subject missed V6.2|0|||
42375057|NCT02674854|76243841|FG002|Overall Study|Subject missed V6.2|0|||
42375058|NCT02667288|76243849|FG000|Overall Study|Protocol Violation|5|||
42375059|NCT02667288|76243849|FG000|Overall Study|Lost to Follow-up|3|||
42375060|NCT02667288|76243849|FG000|Overall Study|Withdrawal by Subject|5|||
42375061|NCT02670330|76243855|FG000|Overall Study|Protocol Deviation|1|||
42375062|NCT02670330|76243856|FG001|Overall Study|Protocol Deviation|0|||
42375063|NCT02670330|76243855|FG000|Overall Study|Study Terminated By Sponsor|36|||
42375064|NCT02670330|76243856|FG001|Overall Study|Study Terminated By Sponsor|43|||
42375065|NCT02670330|76243855|FG000|Overall Study|Adverse Event|1|||
42375066|NCT02670330|76243856|FG001|Overall Study|Adverse Event|3|||
42375067|NCT02670330|76243855|FG000|Overall Study|Withdrawal by Subject|34|||
42375068|NCT02670330|76243856|FG001|Overall Study|Withdrawal by Subject|29|||
42375069|NCT02670330|76243855|FG000|Overall Study|Lost to Follow-up|3|||
42375070|NCT02670330|76243856|FG001|Overall Study|Lost to Follow-up|2|||
42375071|NCT02669940|76243864|FG000|Overall Study|Failure to return|0|||
42375072|NCT02669940|76243865|FG001|Overall Study|Failure to return|3|||
42375073|NCT02669940|76243864|FG000|Overall Study|Insufficient follow-up data|1|||
42375074|NCT02669940|76243865|FG001|Overall Study|Insufficient follow-up data|0|||
42375075|NCT02669862|76243881|FG000|Overall Study|Lost to Follow-up|0|||
42375076|NCT02669862|76243882|FG001|Overall Study|Lost to Follow-up|2|||
42375077|NCT02669862|76243883|FG002|Overall Study|Lost to Follow-up|1|||
42375078|NCT02669862|76243881|FG000|Overall Study|Withdrawal by Subject|2|||
42375079|NCT02669862|76243882|FG001|Overall Study|Withdrawal by Subject|2|||
42375080|NCT02669862|76243883|FG002|Overall Study|Withdrawal by Subject|3|||
42375081|NCT02669862|76243881|FG000|Overall Study|moved|0|||
42375082|NCT02669862|76243882|FG001|Overall Study|moved|1|||
42375083|NCT02669862|76243883|FG002|Overall Study|moved|0|||
42375084|NCT02669862|76243881|FG000|Overall Study|Protocol Violation|0|||
42375085|NCT02669862|76243882|FG001|Overall Study|Protocol Violation|0|||
42375086|NCT02669862|76243883|FG002|Overall Study|Protocol Violation|1|||
42375087|NCT01531673|76243907|FG000|Overall Study|Non-Compliance|0|||
42375088|NCT01531673|76243908|FG001|Overall Study|Non-Compliance|0|||
42375089|NCT01531673|76243909|FG002|Overall Study|Non-Compliance|0|||
42375090|NCT01531673|76243910|FG003|Overall Study|Non-Compliance|0|||
42375091|NCT01531673|76243911|FG004|Overall Study|Non-Compliance|0|||
42375092|NCT01531673|76243912|FG005|Overall Study|Non-Compliance|1|||
42375093|NCT01531673|76243913|FG006|Overall Study|Non-Compliance|0|||
42375094|NCT01531673|76243914|FG007|Overall Study|Non-Compliance|0|||
42375095|NCT01531673|76243915|FG008|Overall Study|Non-Compliance|0|||
42375096|NCT01531673|76243916|FG009|Overall Study|Non-Compliance|0|||
42375097|NCT01531673|76243917|FG010|Overall Study|Non-Compliance|0|||
42375098|NCT01531673|76243918|FG011|Overall Study|Non-Compliance|0|||
42375099|NCT01531673|76243919|FG012|Overall Study|Non-Compliance|0|||
42375100|NCT01531673|76243907|FG000|Overall Study|Adverse Event|0|||
42375101|NCT01531673|76243908|FG001|Overall Study|Adverse Event|1|||
42375102|NCT01531673|76243909|FG002|Overall Study|Adverse Event|0|||
42375103|NCT01531673|76243910|FG003|Overall Study|Adverse Event|0|||
42375104|NCT01531673|76243911|FG004|Overall Study|Adverse Event|0|||
42375105|NCT01531673|76243912|FG005|Overall Study|Adverse Event|0|||
42375106|NCT01531673|76243913|FG006|Overall Study|Adverse Event|0|||
42375107|NCT01531673|76243914|FG007|Overall Study|Adverse Event|0|||
42375108|NCT01531673|76243915|FG008|Overall Study|Adverse Event|0|||
42375109|NCT01531673|76243916|FG009|Overall Study|Adverse Event|0|||
42375110|NCT01531673|76243917|FG010|Overall Study|Adverse Event|0|||
42375111|NCT01531673|76243918|FG011|Overall Study|Adverse Event|0|||
42375112|NCT01531673|76243919|FG012|Overall Study|Adverse Event|0|||
42375113|NCT01531673|76243907|FG000|Overall Study|Lost to Follow-up|0|||
42375114|NCT01531673|76243908|FG001|Overall Study|Lost to Follow-up|0|||
42375115|NCT01531673|76243909|FG002|Overall Study|Lost to Follow-up|0|||
42375116|NCT01531673|76243910|FG003|Overall Study|Lost to Follow-up|0|||
42375117|NCT01531673|76243911|FG004|Overall Study|Lost to Follow-up|1|||
42375118|NCT01531673|76243912|FG005|Overall Study|Lost to Follow-up|0|||
42375119|NCT01531673|76243913|FG006|Overall Study|Lost to Follow-up|0|||
42375120|NCT01531673|76243914|FG007|Overall Study|Lost to Follow-up|0|||
42375121|NCT01531673|76243915|FG008|Overall Study|Lost to Follow-up|0|||
42375122|NCT01531673|76243916|FG009|Overall Study|Lost to Follow-up|0|||
42375123|NCT01531673|76243917|FG010|Overall Study|Lost to Follow-up|0|||
42375124|NCT01531673|76243918|FG011|Overall Study|Lost to Follow-up|0|||
42375125|NCT01531673|76243919|FG012|Overall Study|Lost to Follow-up|0|||
42375126|NCT01531673|76243907|FG000|Overall Study|Other|0|||
42375127|NCT01531673|76243908|FG001|Overall Study|Other|0|||
42375128|NCT01531673|76243909|FG002|Overall Study|Other|0|||
42375129|NCT01531673|76243910|FG003|Overall Study|Other|1|||
42375130|NCT01531673|76243911|FG004|Overall Study|Other|0|||
42375131|NCT01531673|76243912|FG005|Overall Study|Other|0|||
42375132|NCT01531673|76243913|FG006|Overall Study|Other|0|||
42375133|NCT01531673|76243914|FG007|Overall Study|Other|0|||
42375134|NCT01531673|76243915|FG008|Overall Study|Other|0|||
42375135|NCT01531673|76243916|FG009|Overall Study|Other|1|||
42375136|NCT01531673|76243917|FG010|Overall Study|Other|0|||
42375137|NCT01531673|76243918|FG011|Overall Study|Other|0|||
42375138|NCT01531673|76243919|FG012|Overall Study|Other|0|||
42375139|NCT01531205|76243971|FG000|Overall Study|Did not proceed to surgery|1|||
42375140|NCT01529645|76243987|FG000|Overall Study|Lost to Follow-up|0|||
42375141|NCT01529645|76243988|FG001|Overall Study|Lost to Follow-up|1|||
42375142|NCT01529645|76243989|FG002|Overall Study|Lost to Follow-up|1|||
42375143|NCT01529645|76243990|FG003|Overall Study|Lost to Follow-up|1|||
42375144|NCT01529645|76243991|FG004|Overall Study|Lost to Follow-up|1|||
42375145|NCT01529645|76243992|FG005|Overall Study|Lost to Follow-up|0|||
42375146|NCT01529645|76243993|FG006|Overall Study|Lost to Follow-up|2|||
42375147|NCT01529645|76243994|FG007|Overall Study|Lost to Follow-up|0|||
42375148|NCT01529645|76243995|FG008|Overall Study|Lost to Follow-up|1|||
42375149|NCT01529645|76243996|FG009|Overall Study|Lost to Follow-up|0|||
42375150|NCT01529645|76243987|FG000|Overall Study|SAE - Premature contractions|0|||
42375151|NCT01529645|76243988|FG001|Overall Study|SAE - Premature contractions|0|||
42375152|NCT01529645|76243989|FG002|Overall Study|SAE - Premature contractions|1|||
42375153|NCT01529645|76243990|FG003|Overall Study|SAE - Premature contractions|0|||
42018749|NCT01123941|75826134|FG001|Overall Study|Lost to Follow-up|1|||
42200794|NCT02057718|76012714|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
42375154|NCT01529645|76243991|FG004|Overall Study|SAE - Premature contractions|0|||
42375155|NCT01529645|76243992|FG005|Overall Study|SAE - Premature contractions|0|||
42375156|NCT01529645|76243993|FG006|Overall Study|SAE - Premature contractions|0|||
42375157|NCT01529645|76243994|FG007|Overall Study|SAE - Premature contractions|0|||
42375158|NCT01529645|76243995|FG008|Overall Study|SAE - Premature contractions|0|||
42375159|NCT01529645|76243996|FG009|Overall Study|SAE - Premature contractions|0|||
42375160|NCT01529645|76243987|FG000|Overall Study|Withdrawal by Subject|2|||
42375161|NCT01529645|76243988|FG001|Overall Study|Withdrawal by Subject|0|||
42375162|NCT01529645|76243989|FG002|Overall Study|Withdrawal by Subject|0|||
42375163|NCT01529645|76243990|FG003|Overall Study|Withdrawal by Subject|1|||
42375164|NCT01529645|76243991|FG004|Overall Study|Withdrawal by Subject|1|||
42375165|NCT01529645|76243992|FG005|Overall Study|Withdrawal by Subject|1|||
42375166|NCT01529645|76243993|FG006|Overall Study|Withdrawal by Subject|0|||
42375167|NCT01529645|76243994|FG007|Overall Study|Withdrawal by Subject|0|||
42375168|NCT01529645|76243995|FG008|Overall Study|Withdrawal by Subject|0|||
42375169|NCT01529645|76243996|FG009|Overall Study|Withdrawal by Subject|0|||
42375170|NCT01528787|76244030|FG000|Overall Study|Withdrawal by Subject|0|||
42375171|NCT01528787|76244031|FG001|Overall Study|Withdrawal by Subject|0|||
42375172|NCT01528787|76244032|FG002|Overall Study|Withdrawal by Subject|0|||
42375173|NCT01528787|76244033|FG003|Overall Study|Withdrawal by Subject|1|||
42375174|NCT01528787|76244030|FG000|Overall Study|Family Emergency|0|||
42375175|NCT01528787|76244031|FG001|Overall Study|Family Emergency|0|||
42375176|NCT01528787|76244032|FG002|Overall Study|Family Emergency|1|||
42375177|NCT01528787|76244033|FG003|Overall Study|Family Emergency|0|||
42375178|NCT01528709|76244045|FG000|Overall Study|Death|2|||
42375179|NCT01528709|76244046|FG001|Overall Study|Death|0|||
42375180|NCT01528709|76244045|FG000|Overall Study|Withdrawal by Subject|10|||
42375181|NCT01528709|76244046|FG001|Overall Study|Withdrawal by Subject|15|||
42375182|NCT01528709|76244045|FG000|Overall Study|allergy|1|||
42375183|NCT01528709|76244046|FG001|Overall Study|allergy|0|||
42375184|NCT01527383|76244054|FG000|Overall Study|Adverse Event|5|||
42375185|NCT01527383|76244055|FG001|Overall Study|Adverse Event|0|||
42375186|NCT01527383|76244054|FG000|Overall Study|Lost to Follow-up|3|||
42375187|NCT01527383|76244055|FG001|Overall Study|Lost to Follow-up|0|||
42375188|NCT01527383|76244054|FG000|Overall Study|Physician Decision|2|||
42375189|NCT01527383|76244055|FG001|Overall Study|Physician Decision|0|||
42375190|NCT01527383|76244054|FG000|Overall Study|Pregnancy|1|||
42375191|NCT01527383|76244055|FG001|Overall Study|Pregnancy|0|||
42375192|NCT01527383|76244054|FG000|Overall Study|Protocol Violation|1|||
42375193|NCT01527383|76244055|FG001|Overall Study|Protocol Violation|0|||
42375194|NCT01527383|76244054|FG000|Overall Study|Screen failure|1|||
42375195|NCT01527383|76244055|FG001|Overall Study|Screen failure|0|||
42375196|NCT01527383|76244054|FG000|Overall Study|Participant moved|0|||
42375197|NCT01527383|76244055|FG001|Overall Study|Participant moved|1|||
42375198|NCT01527383|76244054|FG000|Overall Study|Withdrawal by Subject|2|||
42375199|NCT01527383|76244055|FG001|Overall Study|Withdrawal by Subject|3|||
42375200|NCT01526057|76244064|FG000|Overall Study|Withdrawal by Subject|3|||
42375201|NCT01526057|76244065|FG001|Overall Study|Withdrawal by Subject|2|||
42200795|NCT02057718|76012713|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
42200796|NCT02057718|76012714|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
42375202|NCT01526057|76244066|FG002|Overall Study|Withdrawal by Subject|2|||
42375203|NCT01526057|76244064|FG000|Overall Study|Adverse Event|3|||
42375204|NCT01526057|76244065|FG001|Overall Study|Adverse Event|1|||
42375205|NCT01526057|76244066|FG002|Overall Study|Adverse Event|1|||
42375206|NCT01526057|76244064|FG000|Overall Study|Death|1|||
42375207|NCT01526057|76244065|FG001|Overall Study|Death|0|||
42375208|NCT01526057|76244066|FG002|Overall Study|Death|0|||
42375209|NCT01526057|76244064|FG000|Overall Study|Lost to Follow-up|1|||
42375210|NCT01526057|76244065|FG001|Overall Study|Lost to Follow-up|0|||
42375211|NCT01526057|76244066|FG002|Overall Study|Lost to Follow-up|1|||
42375212|NCT01526057|76244064|FG000|Overall Study|Other|1|||
42375213|NCT01526057|76244065|FG001|Overall Study|Other|0|||
42375214|NCT01526057|76244066|FG002|Overall Study|Other|1|||
42375215|NCT01526057|76244064|FG000|Overall Study|Protocol Violation|0|||
42375216|NCT01526057|76244065|FG001|Overall Study|Protocol Violation|0|||
42375217|NCT01526057|76244066|FG002|Overall Study|Protocol Violation|1|||
42375218|NCT01525901|76244078|FG000|Period 2: 12 Weeks|Adverse Event|0|||
42375219|NCT01525901|76244079|FG001|Period 2: 12 Weeks|Adverse Event|1|||
42375220|NCT01525901|76244080|FG002|Period 2: 12 Weeks|Adverse Event|0|||
42375221|NCT01525901|76244081|FG003|Period 2: 12 Weeks|Adverse Event|0|||
42375222|NCT01525589|76244194|FG000|Overall Study|Non-treatment-related AE|1|||
42375223|NCT01525589|76244195|FG001|Overall Study|Non-treatment-related AE|0|||
42375224|NCT01525589|76244196|FG002|Overall Study|Non-treatment-related AE|0|||
42375225|NCT01525589|76244194|FG000|Overall Study|Progressive disease|48|||
42375226|NCT01525589|76244195|FG001|Overall Study|Progressive disease|15|||
42375227|NCT01525589|76244196|FG002|Overall Study|Progressive disease|29|||
42375228|NCT01525589|76244194|FG000|Overall Study|Never treated|2|||
42375229|NCT01525589|76244195|FG001|Overall Study|Never treated|0|||
42375230|NCT01525589|76244196|FG002|Overall Study|Never treated|0|||
42375231|NCT01525589|76244194|FG000|Overall Study|Physician Decision|4|||
42375232|NCT01525589|76244195|FG001|Overall Study|Physician Decision|2|||
42375233|NCT01525589|76244196|FG002|Overall Study|Physician Decision|2|||
42375234|NCT01525589|76244194|FG000|Overall Study|Death|0|||
42375235|NCT01525589|76244195|FG001|Overall Study|Death|0|||
42375236|NCT01525589|76244196|FG002|Overall Study|Death|2|||
42375237|NCT01525589|76244194|FG000|Overall Study|Treatment-related AE|1|||
42375238|NCT01525589|76244195|FG001|Overall Study|Treatment-related AE|1|||
42375239|NCT01525589|76244196|FG002|Overall Study|Treatment-related AE|2|||
42375240|NCT01525589|76244194|FG000|Overall Study|Other reasons|0|||
42375241|NCT01525589|76244195|FG001|Overall Study|Other reasons|1|||
42375242|NCT01525589|76244196|FG002|Overall Study|Other reasons|0|||
42375243|NCT01525589|76244194|FG000|Overall Study|Withdrawal by Subject|0|||
42375244|NCT01525589|76244195|FG001|Overall Study|Withdrawal by Subject|1|||
42375245|NCT01525589|76244196|FG002|Overall Study|Withdrawal by Subject|0|||
42375246|NCT01524887|76244207|FG000|Overall Study|Withdrawal by Subject|6|||
42375247|NCT01524887|76244208|FG001|Overall Study|Withdrawal by Subject|2|||
42375248|NCT01524887|76244209|FG002|Overall Study|Withdrawal by Subject|3|||
42375249|NCT01524887|76244207|FG000|Overall Study|Adverse Event|5|||
42375250|NCT01524887|76244208|FG001|Overall Study|Adverse Event|1|||
42375251|NCT01524887|76244209|FG002|Overall Study|Adverse Event|1|||
42375252|NCT01524887|76244207|FG000|Overall Study|Protocol Violation|0|||
42375253|NCT01524887|76244208|FG001|Overall Study|Protocol Violation|0|||
42375254|NCT01524887|76244209|FG002|Overall Study|Protocol Violation|1|||
42375255|NCT01524887|76244207|FG000|Overall Study|Study termination|73|||
42375256|NCT01524887|76244208|FG001|Overall Study|Study termination|87|||
42375257|NCT01524887|76244209|FG002|Overall Study|Study termination|79|||
42375258|NCT01524887|76244207|FG000|Overall Study|Withdrawal by Caregiver|0|||
42375259|NCT01524887|76244208|FG001|Overall Study|Withdrawal by Caregiver|0|||
42375260|NCT01524887|76244209|FG002|Overall Study|Withdrawal by Caregiver|2|||
42375261|NCT01524887|76244207|FG000|Overall Study|Use of prohibited medication|1|||
42375262|NCT01524887|76244208|FG001|Overall Study|Use of prohibited medication|0|||
42375263|NCT01524887|76244209|FG002|Overall Study|Use of prohibited medication|0|||
42375264|NCT01523873|76244235|FG000|Overall Study|Protocol Violation|422|||
42375265|NCT01522235|76244260|FG000|Overall Study|Physician Decision|1|||
42375266|NCT01522235|76244261|FG001|Overall Study|Physician Decision|1|||
42375267|NCT01521923|76244298|FG000|Overall Study|AE, serious fatal|1|||
42375268|NCT01521923|76244299|FG001|Overall Study|AE, serious fatal|0|||
42375269|NCT01521923|76244300|FG002|Overall Study|AE, serious fatal|0|||
42375270|NCT01521923|76244301|FG003|Overall Study|AE, serious fatal|0|||
42375271|NCT01521923|76244298|FG000|Overall Study|SAE, non-fatal|0|||
42375272|NCT01521923|76244299|FG001|Overall Study|SAE, non-fatal|2|||
42375273|NCT01521923|76244300|FG002|Overall Study|SAE, non-fatal|2|||
42375274|NCT01521923|76244301|FG003|Overall Study|SAE, non-fatal|0|||
42375275|NCT01521923|76244298|FG000|Overall Study|AE, non-serious, non-fatal|1|||
42375276|NCT01521923|76244299|FG001|Overall Study|AE, non-serious, non-fatal|3|||
42375277|NCT01521923|76244300|FG002|Overall Study|AE, non-serious, non-fatal|6|||
42375278|NCT01521923|76244301|FG003|Overall Study|AE, non-serious, non-fatal|2|||
42375279|NCT01521923|76244298|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
42375280|NCT01521923|76244299|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
42375281|NCT01521923|76244300|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
42375282|NCT01521923|76244301|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
42103507|NCT00678392|75914448|FG001|Overall Study|Objective Progression or Relapse|8|||
42103508|NCT00678392|75914447|FG000|Overall Study|Sponsor's Decision|1|||
42375283|NCT01521923|76244298|FG000|Overall Study|Lack of Efficacy|1|||
42375284|NCT01521923|76244299|FG001|Overall Study|Lack of Efficacy|1|||
42375285|NCT01521923|76244300|FG002|Overall Study|Lack of Efficacy|0|||
42375286|NCT01521923|76244301|FG003|Overall Study|Lack of Efficacy|0|||
42375287|NCT01521923|76244298|FG000|Overall Study|Protocol Violation|0|||
42375288|NCT01521923|76244299|FG001|Overall Study|Protocol Violation|0|||
42375289|NCT01521923|76244300|FG002|Overall Study|Protocol Violation|1|||
42375290|NCT01521923|76244301|FG003|Overall Study|Protocol Violation|0|||
42375291|NCT01521923|76244298|FG000|Overall Study|Lost to Follow-up|1|||
42375292|NCT01521923|76244299|FG001|Overall Study|Lost to Follow-up|0|||
42375293|NCT01521923|76244300|FG002|Overall Study|Lost to Follow-up|2|||
42375294|NCT01521923|76244301|FG003|Overall Study|Lost to Follow-up|1|||
42375295|NCT01521923|76244298|FG000|Overall Study|Withdrawal by Subject|1|||
42375296|NCT01521923|76244299|FG001|Overall Study|Withdrawal by Subject|1|||
42375297|NCT01521923|76244300|FG002|Overall Study|Withdrawal by Subject|1|||
42375298|NCT01521923|76244301|FG003|Overall Study|Withdrawal by Subject|2|||
42375299|NCT01521923|76244298|FG000|Overall Study|Other|2|||
42375300|NCT01521923|76244299|FG001|Overall Study|Other|1|||
42375301|NCT01521923|76244300|FG002|Overall Study|Other|3|||
42375302|NCT01521923|76244301|FG003|Overall Study|Other|6|||
42375303|NCT01521923|76244298|FG000|Overall Study|AE, captured in Period 1|0|||
42375304|NCT01521923|76244299|FG001|Overall Study|AE, captured in Period 1|1|||
42375305|NCT01521923|76244300|FG002|Overall Study|AE, captured in Period 1|0|||
42375306|NCT01521923|76244301|FG003|Overall Study|AE, captured in Period 1|1|||
42375307|NCT01520987|76244425|FG000|Overall Study|Withdrawal by Subject|1|||
42375308|NCT01520987|76244426|FG001|Overall Study|Withdrawal by Subject|0|||
42375309|NCT01520987|76244427|FG002|Overall Study|Withdrawal by Subject|0|||
42375310|NCT01520987|76244428|FG003|Overall Study|Withdrawal by Subject|0|||
42375311|NCT01520987|76244429|FG004|Overall Study|Withdrawal by Subject|0|||
42375312|NCT01520987|76244430|FG005|Overall Study|Withdrawal by Subject|1|||
42375313|NCT01520987|76244431|FG006|Overall Study|Withdrawal by Subject|0|||
42375314|NCT01520987|76244432|FG007|Overall Study|Withdrawal by Subject|0|||
42375315|NCT01562275|76244506|FG000|Stage 1|Adverse Event|0|||
42375316|NCT01562275|76244507|FG001|Stage 1|Adverse Event|0|||
42375317|NCT01562275|76244508|FG002|Stage 1|Adverse Event|0|||
42375318|NCT01562275|76244509|FG003|Stage 1|Adverse Event|1|||
42375319|NCT01562275|76244510|FG004|Stage 1|Adverse Event|1|||
42375320|NCT01562275|76244511|FG005|Stage 1|Adverse Event|0|||
42375321|NCT01562275|76244512|FG006|Stage 1|Adverse Event|0|||
42375322|NCT01562275|76244513|FG007|Stage 1|Adverse Event|0|||
42375323|NCT01562275|76244514|FG008|Stage 1|Adverse Event|0|||
42375324|NCT01562275|76244515|FG009|Stage 1|Adverse Event|1|||
42375325|NCT01562275|76244516|FG010|Stage 1|Adverse Event|0|||
42375326|NCT01562275|76244517|FG011|Stage 1|Adverse Event|0|||
42375327|NCT01562275|76244518|FG012|Stage 1|Adverse Event|0|||
42375328|NCT01562275|76244506|FG000|Stage 1|Death|1|||
42375329|NCT01562275|76244507|FG001|Stage 1|Death|0|||
42375330|NCT01562275|76244508|FG002|Stage 1|Death|0|||
42375331|NCT01562275|76244509|FG003|Stage 1|Death|0|||
42375332|NCT01562275|76244510|FG004|Stage 1|Death|0|||
42375333|NCT01562275|76244511|FG005|Stage 1|Death|0|||
42375334|NCT01562275|76244512|FG006|Stage 1|Death|0|||
42375335|NCT01562275|76244513|FG007|Stage 1|Death|0|||
42375336|NCT01562275|76244514|FG008|Stage 1|Death|0|||
42375337|NCT01562275|76244515|FG009|Stage 1|Death|0|||
42375338|NCT01562275|76244516|FG010|Stage 1|Death|0|||
42375339|NCT01562275|76244517|FG011|Stage 1|Death|0|||
42375340|NCT01562275|76244518|FG012|Stage 1|Death|0|||
42375341|NCT01562275|76244506|FG000|Stage 1|Non Compliance|0|||
42375342|NCT01562275|76244507|FG001|Stage 1|Non Compliance|0|||
42375343|NCT01562275|76244508|FG002|Stage 1|Non Compliance|1|||
42375344|NCT01562275|76244509|FG003|Stage 1|Non Compliance|0|||
42375345|NCT01562275|76244510|FG004|Stage 1|Non Compliance|0|||
42375346|NCT01562275|76244511|FG005|Stage 1|Non Compliance|0|||
42375347|NCT01562275|76244512|FG006|Stage 1|Non Compliance|0|||
42375348|NCT01562275|76244513|FG007|Stage 1|Non Compliance|0|||
42375349|NCT01562275|76244514|FG008|Stage 1|Non Compliance|0|||
42375350|NCT01562275|76244515|FG009|Stage 1|Non Compliance|0|||
42375351|NCT01562275|76244516|FG010|Stage 1|Non Compliance|0|||
42375352|NCT01562275|76244517|FG011|Stage 1|Non Compliance|0|||
42375353|NCT01562275|76244518|FG012|Stage 1|Non Compliance|0|||
42375354|NCT01562275|76244506|FG000|Stage 1|Physician Decision|0|||
42375355|NCT01562275|76244507|FG001|Stage 1|Physician Decision|0|||
42375356|NCT01562275|76244508|FG002|Stage 1|Physician Decision|0|||
42375357|NCT01562275|76244509|FG003|Stage 1|Physician Decision|0|||
42375358|NCT01562275|76244510|FG004|Stage 1|Physician Decision|1|||
42375359|NCT01562275|76244511|FG005|Stage 1|Physician Decision|0|||
42375360|NCT01562275|76244512|FG006|Stage 1|Physician Decision|1|||
42375361|NCT01562275|76244513|FG007|Stage 1|Physician Decision|0|||
42375362|NCT01562275|76244514|FG008|Stage 1|Physician Decision|1|||
42375363|NCT01562275|76244515|FG009|Stage 1|Physician Decision|0|||
42375364|NCT01562275|76244516|FG010|Stage 1|Physician Decision|0|||
42375365|NCT01562275|76244517|FG011|Stage 1|Physician Decision|0|||
42375366|NCT01562275|76244518|FG012|Stage 1|Physician Decision|0|||
42375367|NCT01562275|76244506|FG000|Stage 1|Progression of Disease|2|||
42375368|NCT01562275|76244507|FG001|Stage 1|Progression of Disease|6|||
42200797|NCT02057718|76012713|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
42200798|NCT02057718|76012714|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
42375369|NCT01562275|76244508|FG002|Stage 1|Progression of Disease|2|||
42375370|NCT01562275|76244509|FG003|Stage 1|Progression of Disease|1|||
42375371|NCT01562275|76244510|FG004|Stage 1|Progression of Disease|2|||
42375372|NCT01562275|76244511|FG005|Stage 1|Progression of Disease|4|||
42375373|NCT01562275|76244512|FG006|Stage 1|Progression of Disease|1|||
42375374|NCT01562275|76244513|FG007|Stage 1|Progression of Disease|7|||
42375375|NCT01562275|76244514|FG008|Stage 1|Progression of Disease|2|||
42375376|NCT01562275|76244515|FG009|Stage 1|Progression of Disease|5|||
42375377|NCT01562275|76244516|FG010|Stage 1|Progression of Disease|3|||
42375378|NCT01562275|76244517|FG011|Stage 1|Progression of Disease|0|||
42375379|NCT01562275|76244518|FG012|Stage 1|Progression of Disease|0|||
42375380|NCT01562275|76244506|FG000|Stage 1|Withdrawal by Subject|0|||
42375381|NCT01562275|76244507|FG001|Stage 1|Withdrawal by Subject|1|||
42375382|NCT01562275|76244508|FG002|Stage 1|Withdrawal by Subject|0|||
42103509|NCT00678392|75914448|FG001|Overall Study|Sponsor's Decision|2|||
42103510|NCT00678392|75914447|FG000|Overall Study|Withdrawal by Subject|4|||
42103511|NCT00678392|75914448|FG001|Overall Study|Withdrawal by Subject|4|||
42103512|NCT00678392|75914447|FG000|Overall Study|Randomized But Not Treated|2|||
42375383|NCT01562275|76244509|FG003|Stage 1|Withdrawal by Subject|2|||
42375384|NCT01562275|76244510|FG004|Stage 1|Withdrawal by Subject|0|||
42375385|NCT01562275|76244511|FG005|Stage 1|Withdrawal by Subject|0|||
42375386|NCT01562275|76244512|FG006|Stage 1|Withdrawal by Subject|1|||
42375387|NCT01562275|76244513|FG007|Stage 1|Withdrawal by Subject|0|||
42375388|NCT01562275|76244514|FG008|Stage 1|Withdrawal by Subject|0|||
42375389|NCT01562275|76244515|FG009|Stage 1|Withdrawal by Subject|1|||
42375390|NCT01562275|76244516|FG010|Stage 1|Withdrawal by Subject|0|||
42375391|NCT01562275|76244517|FG011|Stage 1|Withdrawal by Subject|0|||
42375392|NCT01562275|76244518|FG012|Stage 1|Withdrawal by Subject|0|||
42375393|NCT01562275|76244506|FG000|Stage 2|Death|0|||
42375394|NCT01562275|76244507|FG001|Stage 2|Death|0|||
42375395|NCT01562275|76244508|FG002|Stage 2|Death|0|||
42375396|NCT01562275|76244509|FG003|Stage 2|Death|0|||
42375397|NCT01562275|76244510|FG004|Stage 2|Death|0|||
42375398|NCT01562275|76244511|FG005|Stage 2|Death|0|||
42375399|NCT01562275|76244512|FG006|Stage 2|Death|0|||
42375400|NCT01562275|76244513|FG007|Stage 2|Death|0|||
42375401|NCT01562275|76244514|FG008|Stage 2|Death|0|||
42375402|NCT01562275|76244515|FG009|Stage 2|Death|0|||
42375403|NCT01562275|76244516|FG010|Stage 2|Death|0|||
42375404|NCT01562275|76244517|FG011|Stage 2|Death|2|||
42375405|NCT01562275|76244518|FG012|Stage 2|Death|1|||
42375406|NCT01562275|76244506|FG000|Stage 2|Progression of Disease|0|||
42375407|NCT01562275|76244507|FG001|Stage 2|Progression of Disease|0|||
42375408|NCT01562275|76244508|FG002|Stage 2|Progression of Disease|0|||
42375409|NCT01562275|76244509|FG003|Stage 2|Progression of Disease|0|||
42375410|NCT01562275|76244510|FG004|Stage 2|Progression of Disease|0|||
42375411|NCT01562275|76244511|FG005|Stage 2|Progression of Disease|0|||
42375412|NCT01562275|76244512|FG006|Stage 2|Progression of Disease|0|||
42375413|NCT01562275|76244513|FG007|Stage 2|Progression of Disease|0|||
42375414|NCT01562275|76244514|FG008|Stage 2|Progression of Disease|0|||
42375415|NCT01562275|76244515|FG009|Stage 2|Progression of Disease|0|||
42375416|NCT01562275|76244516|FG010|Stage 2|Progression of Disease|0|||
42375417|NCT01562275|76244517|FG011|Stage 2|Progression of Disease|12|||
42375418|NCT01562275|76244518|FG012|Stage 2|Progression of Disease|4|||
42375419|NCT01535053|76244550|FG000|Overall Study|Ineligible|1|||
42375420|NCT01535053|76244551|FG001|Overall Study|Ineligible|2|||
42375421|NCT01534663|76244559|FG000|Overall Study|Lost to Follow-up|0|||
42375422|NCT01534663|76244560|FG001|Overall Study|Lost to Follow-up|2|||
42375423|NCT01534663|76244559|FG000|Overall Study|Adverse Event|2|||
42375424|NCT01534663|76244560|FG001|Overall Study|Adverse Event|1|||
42375425|NCT01520909|76244568|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
42375426|NCT01520909|76244569|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
42375427|NCT01520909|76244570|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
42375428|NCT01520909|76244568|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
42375429|NCT01520909|76244569|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
42375430|NCT01520909|76244570|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
42375431|NCT01520909|76244568|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
42375432|NCT01520909|76244569|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
42103513|NCT00678392|75914448|FG001|Overall Study|Randomized But Not Treated|7|||
42103514|NCT00678392|75914447|FG000|Overall Study|Other|56|||
42103515|NCT00678392|75914448|FG001|Overall Study|Other|53|||
42103516|NCT00308581|75914454|FG000|Induction Phase|Adverse Event|0|||
42103517|NCT00308581|75914455|FG001|Induction Phase|Adverse Event|0|||
42103518|NCT00308581|75914456|FG002|Induction Phase|Adverse Event|37|||
42103519|NCT00308581|75914454|FG000|Induction Phase|Lack of Efficacy|0|||
42103520|NCT00308581|75914455|FG001|Induction Phase|Lack of Efficacy|0|||
42375433|NCT01520909|76244570|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
42375434|NCT01520909|76244568|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
42375435|NCT01520909|76244569|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
42375436|NCT01520909|76244570|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
42375437|NCT01520363|76244592|FG000|Overall Study|Withdrawal by Subject|2|||
42375438|NCT01520363|76244593|FG001|Overall Study|Withdrawal by Subject|0|||
42375439|NCT01578499|76244625|FG000|Overall Study|Reason not Specified|0|||
42375440|NCT01578499|76244626|FG001|Overall Study|Reason not Specified|1|||
42103521|NCT00308581|75914456|FG002|Induction Phase|Lack of Efficacy|121|||
42103522|NCT00308581|75914454|FG000|Induction Phase|Withdrawal by Subject|0|||
42375441|NCT01578499|76244625|FG000|Overall Study|Lost to Follow-up|2|||
42375442|NCT01578499|76244626|FG001|Overall Study|Lost to Follow-up|1|||
42375443|NCT01578499|76244625|FG000|Overall Study|Withdrawal by Subject|10|||
42375444|NCT01578499|76244626|FG001|Overall Study|Withdrawal by Subject|16|||
42375445|NCT01578499|76244625|FG000|Overall Study|Death|20|||
42375446|NCT01578499|76244626|FG001|Overall Study|Death|25|||
42375447|NCT01578499|76244625|FG000|Overall Study|Died and End of Study Page not Completed|2|||
42375448|NCT01578499|76244626|FG001|Overall Study|Died and End of Study Page not Completed|0|||
42375449|NCT01578187|76244636|FG000|Usability Phase|Withdrawal by Subject|1|||
42375450|NCT01561963|76244642|FG000|Overall Study|Adverse Event|1|||
42375451|NCT01576783|76244653|FG000|Overall Study|Change in Medical Care|1|||
42375452|NCT01576783|76244654|FG001|Overall Study|Change in Medical Care|0|||
42375453|NCT01576783|76244653|FG000|Overall Study|Lost to Follow-up|14|||
42375454|NCT01576783|76244654|FG001|Overall Study|Lost to Follow-up|16|||
42375455|NCT01576783|76244653|FG000|Overall Study|Withdrawal by Subject|5|||
42375456|NCT01576783|76244654|FG001|Overall Study|Withdrawal by Subject|1|||
42375457|NCT01534351|76244663|FG000|Overall Study|Study Terminated Early|1|||
42375458|NCT01534351|76244664|FG001|Overall Study|Study Terminated Early|0|||
42375459|NCT01534351|76244665|FG002|Overall Study|Study Terminated Early|0|||
42375460|NCT01534273|76244677|FG000|Period 1|Physician Decision|0|||
42375461|NCT01534273|76244678|FG001|Period 1|Physician Decision|0|||
42375462|NCT01534273|76244679|FG002|Period 1|Physician Decision|0|||
42375463|NCT01534273|76244680|FG003|Period 1|Physician Decision|1|||
42375464|NCT01534273|76244681|FG004|Period 1|Physician Decision|0|||
42375465|NCT01534273|76244682|FG005|Period 1|Physician Decision|0|||
42375466|NCT01534273|76244683|FG006|Period 1|Physician Decision|0|||
42375467|NCT01534195|76244706|FG000|Overall Study|Withdrawal by Subject|1|||
42375468|NCT01534195|76244707|FG001|Overall Study|Withdrawal by Subject|1|||
42375469|NCT01560949|76244713|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
42375470|NCT01560949|76244713|FG000|Surgery Phase|Physician Decision|3|||
42375471|NCT01372878|76244721|FG000|Overall Study|Withdrawal by Subject|63|||
42375472|NCT01372878|76244721|FG000|Overall Study|Protocol Violation|17|||
42375473|NCT01372878|76244721|FG000|Overall Study|incomplete study procedure|104|||
42375474|NCT01533493|76244727|FG000|Overall Study|Adverse Event|2|||
42375475|NCT01533493|76244728|FG001|Overall Study|Adverse Event|1|||
42375476|NCT01533493|76244727|FG000|Overall Study|Withdrawal by Subject|1|||
42375477|NCT01533493|76244728|FG001|Overall Study|Withdrawal by Subject|2|||
42375478|NCT01533493|76244727|FG000|Overall Study|Lost to Follow-up|2|||
42375479|NCT01533493|76244728|FG001|Overall Study|Lost to Follow-up|0|||
42375480|NCT01533181|76244804|FG000|Overall Study|Disease progression pre-active treatment|0|||
42375481|NCT01533181|76244805|FG001|Overall Study|Disease progression pre-active treatment|1|||
42375482|NCT01533181|76244804|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
42375483|NCT01533181|76244805|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
42375484|NCT02669082|76244811|FG000|Overall Study|Adverse Event|1|||
42375485|NCT02668692|76244875|FG000|Overall Study|Adverse Event|1|||
42375486|NCT02668692|76244876|FG001|Overall Study|Adverse Event|0|||
42375487|NCT02662764|76244890|FG000|Overall Study|Adverse Event|6|||
42375488|NCT02662764|76244890|FG000|Overall Study|Lack of Efficacy|8|||
42375489|NCT02662764|76244890|FG000|Overall Study|Protocol Violation|1|||
42375490|NCT02662764|76244890|FG000|Overall Study|Withdrawal by Subject|5|||
42375491|NCT02662764|76244890|FG000|Overall Study|Device failure|4|||
42375492|NCT02662764|76244890|FG000|Overall Study|Patient changed treatment|1|||
42375493|NCT02662764|76244890|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
42375494|NCT01519817|76244899|FG000|Overall Study|Withdrawal by Subject|1|||
42375495|NCT01519817|76244900|FG001|Overall Study|Withdrawal by Subject|0|||
42200799|NCT02057718|76012713|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
42375496|NCT01519817|76244901|FG002|Overall Study|Withdrawal by Subject|0|||
42375497|NCT01519817|76244902|FG003|Overall Study|Withdrawal by Subject|0|||
42375498|NCT01519817|76244899|FG000|Overall Study|Off study due to infection|0|||
42375499|NCT01519817|76244900|FG001|Overall Study|Off study due to infection|0|||
42375500|NCT01519817|76244901|FG002|Overall Study|Off study due to infection|0|||
42375501|NCT01519817|76244902|FG003|Overall Study|Off study due to infection|1|||
42375502|NCT01519661|76244912|FG000|Overall Study|Protocol deviation|6|||
42375503|NCT01519661|76244912|FG000|Overall Study|Lost to Follow-up|3|||
42375504|NCT01519661|76244912|FG000|Overall Study|Withdrawal by Subject|17|||
42375505|NCT01519661|76244912|FG000|Overall Study|Lack of Efficacy|6|||
42375506|NCT01519661|76244912|FG000|Overall Study|Adverse Event|29|||
42375507|NCT01519427|76244917|FG000|Overall Study|disease progression|2|||
42375508|NCT01518257|76244923|FG000|Overall Study|Lost to Follow-up|1|||
42375509|NCT01518257|76244924|FG001|Overall Study|Lost to Follow-up|0|||
42375510|NCT01518257|76244923|FG000|Overall Study|Other Miscellaneous Reason|1|||
42375511|NCT01518257|76244924|FG001|Overall Study|Other Miscellaneous Reason|0|||
42375512|NCT02668302|76244932|FG000|Overall Study|Withdrawal by Subject|1|||
42375513|NCT02668302|76244933|FG001|Overall Study|Withdrawal by Subject|0|||
42375514|NCT01517867|76244941|FG000|Overall Study|never started treatment|29|||
42375515|NCT01517867|76244942|FG001|Overall Study|never started treatment|32|||
42375516|NCT01517867|76244941|FG000|Overall Study|Withdrawal by Subject|34|||
42375517|NCT01517867|76244942|FG001|Overall Study|Withdrawal by Subject|30|||
42375518|NCT01517867|76244941|FG000|Overall Study|Still in treatment at study end|0|||
42375519|NCT01517867|76244942|FG001|Overall Study|Still in treatment at study end|3|||
42375520|NCT01514357|76244950|FG000|Overall Study|Screen failure|2|||
42375521|NCT01514357|76244951|FG001|Overall Study|Screen failure|0|||
42375522|NCT01514357|76244950|FG000|Overall Study|Withdrawal by Subject|2|||
42375523|NCT01514357|76244951|FG001|Overall Study|Withdrawal by Subject|0|||
42375524|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
42375525|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
42375526|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
42375527|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
42375528|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
42375529|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
42375530|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
42375531|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
42375532|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
42375533|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
42103523|NCT00308581|75914455|FG001|Induction Phase|Withdrawal by Subject|0|||
42103524|NCT00308581|75914456|FG002|Induction Phase|Withdrawal by Subject|5|||
42375534|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
42375535|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
42375536|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
42375537|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
42375538|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
42375539|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
42375540|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
42375541|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
42375542|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
42375543|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
42375544|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
42375545|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
42375546|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
42375547|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
42375548|NCT01532869|76244959|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
42375549|NCT01532869|76244960|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
42375550|NCT01532869|76244959|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
42375551|NCT01532869|76244960|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
42375552|NCT01532869|76244959|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
42375553|NCT01532869|76244960|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
42375554|NCT01532869|76244959|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
42375555|NCT01532869|76244960|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
42375556|NCT01532869|76244959|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
42375557|NCT01532869|76244960|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
42375558|NCT01531387|76244973|FG000|Overall Study|Early termination of study|11|||
42375559|NCT01531387|76244974|FG001|Overall Study|Early termination of study|11|||
42375560|NCT01531153|76244983|FG000|Overall Study|Withdrawal by Subject|10|||
42375561|NCT01531153|76244984|FG001|Overall Study|Withdrawal by Subject|9|||
42375562|NCT01531153|76244985|FG002|Overall Study|Withdrawal by Subject|15|||
42375563|NCT01529749|76245000|FG000|Overall Study|Lost to Follow-up|0|||
42375564|NCT01529749|76245001|FG001|Overall Study|Lost to Follow-up|1|||
42375565|NCT01529749|76245002|FG002|Overall Study|Lost to Follow-up|1|||
42375566|NCT01529749|76245003|FG003|Overall Study|Lost to Follow-up|0|||
42375567|NCT01529749|76245000|FG000|Overall Study|Physician Decision|0|||
42375568|NCT01529749|76245001|FG001|Overall Study|Physician Decision|0|||
42375569|NCT01529749|76245002|FG002|Overall Study|Physician Decision|0|||
42375570|NCT01529749|76245003|FG003|Overall Study|Physician Decision|1|||
42375571|NCT01529749|76245000|FG000|Overall Study|Withdrawal by Subject|0|||
42375572|NCT01529749|76245001|FG001|Overall Study|Withdrawal by Subject|1|||
42375573|NCT01529749|76245002|FG002|Overall Study|Withdrawal by Subject|1|||
42375574|NCT01529749|76245003|FG003|Overall Study|Withdrawal by Subject|0|||
42375575|NCT01529749|76245000|FG000|Overall Study|Protocol Violation|0|||
42375576|NCT01529749|76245001|FG001|Overall Study|Protocol Violation|0|||
42375577|NCT01529749|76245002|FG002|Overall Study|Protocol Violation|0|||
42375578|NCT01529749|76245003|FG003|Overall Study|Protocol Violation|1|||
42375579|NCT01529515|76245015|FG000|TRANSITION PHASE|Adverse Event|16|||
42103525|NCT00308581|75914454|FG000|Induction Phase|Unknown reason|0|||
42375580|NCT01529515|76245016|FG001|TRANSITION PHASE|Adverse Event|0|||
42375581|NCT01529515|76245017|FG002|TRANSITION PHASE|Adverse Event|0|||
42375582|NCT01529515|76245018|FG003|TRANSITION PHASE|Adverse Event|0|||
42103526|NCT00308581|75914455|FG001|Induction Phase|Unknown reason|0|||
42375583|NCT01529515|76245015|FG000|TRANSITION PHASE|Death|1|||
42375584|NCT01529515|76245016|FG001|TRANSITION PHASE|Death|0|||
42375585|NCT01529515|76245017|FG002|TRANSITION PHASE|Death|0|||
42375586|NCT01529515|76245018|FG003|TRANSITION PHASE|Death|0|||
42375587|NCT01529515|76245015|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
42375588|NCT01529515|76245016|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
42375589|NCT01529515|76245017|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
42375590|NCT01529515|76245018|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
42375591|NCT01529515|76245015|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
42375592|NCT01529515|76245016|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
42375593|NCT01529515|76245017|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
42375594|NCT01529515|76245018|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
42375595|NCT01529515|76245015|FG000|TRANSITION PHASE|Protocol Violation|4|||
42375596|NCT01529515|76245016|FG001|TRANSITION PHASE|Protocol Violation|0|||
42375597|NCT01529515|76245017|FG002|TRANSITION PHASE|Protocol Violation|0|||
42375598|NCT01529515|76245018|FG003|TRANSITION PHASE|Protocol Violation|0|||
42375599|NCT01529515|76245015|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
42375600|NCT01529515|76245016|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
42375601|NCT01529515|76245017|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
42375602|NCT01529515|76245018|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
42375603|NCT01529515|76245015|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
42375604|NCT01529515|76245016|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
42375605|NCT01529515|76245017|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
42375606|NCT01529515|76245018|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
42375607|NCT01529515|76245015|FG000|TRANSITION PHASE|Other|9|||
42375608|NCT01529515|76245016|FG001|TRANSITION PHASE|Other|0|||
42375609|NCT01529515|76245017|FG002|TRANSITION PHASE|Other|0|||
42375610|NCT01529515|76245018|FG003|TRANSITION PHASE|Other|0|||
42375611|NCT01529515|76245015|FG000|MAINTENANCE PHASE|Adverse Event|0|||
42375612|NCT01529515|76245016|FG001|MAINTENANCE PHASE|Adverse Event|10|||
42375613|NCT01529515|76245017|FG002|MAINTENANCE PHASE|Adverse Event|0|||
42375614|NCT01529515|76245018|FG003|MAINTENANCE PHASE|Adverse Event|0|||
42375615|NCT01529515|76245015|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
42375616|NCT01529515|76245016|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
42375617|NCT01529515|76245017|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
42375618|NCT01529515|76245018|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
42375619|NCT01529515|76245015|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
42375620|NCT01529515|76245016|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
42375621|NCT01529515|76245017|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
42375622|NCT01529515|76245018|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
42375623|NCT01529515|76245015|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
42375624|NCT01529515|76245016|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
42375625|NCT01529515|76245017|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
42375626|NCT01529515|76245018|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
42375627|NCT01529515|76245015|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
42375628|NCT01529515|76245016|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
42375629|NCT01529515|76245017|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
42375630|NCT01529515|76245018|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
42375631|NCT01529515|76245015|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
42375632|NCT01529515|76245016|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
42375633|NCT01529515|76245017|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
42375634|NCT01529515|76245018|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
42375635|NCT01529515|76245015|FG000|MAINTENANCE PHASE|Other|0|||
42375636|NCT01529515|76245016|FG001|MAINTENANCE PHASE|Other|10|||
42375637|NCT01529515|76245017|FG002|MAINTENANCE PHASE|Other|0|||
42375638|NCT01529515|76245018|FG003|MAINTENANCE PHASE|Other|0|||
42375639|NCT01529515|76245015|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
42375640|NCT01529515|76245016|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
42375641|NCT01529515|76245017|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
42375642|NCT01529515|76245018|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
42375643|NCT01529515|76245015|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
42375644|NCT01529515|76245016|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
42375645|NCT01529515|76245017|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
42375646|NCT01529515|76245018|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
42103527|NCT00308581|75914456|FG002|Induction Phase|Unknown reason|3|||
42375647|NCT01529515|76245015|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
42375648|NCT01529515|76245016|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
42375649|NCT01529515|76245017|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
42375650|NCT01529515|76245018|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
42375651|NCT01529515|76245015|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
42375652|NCT01529515|76245016|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
42375653|NCT01529515|76245017|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
42375654|NCT01529515|76245018|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
42375655|NCT01529515|76245015|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
42375656|NCT01529515|76245016|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
42375657|NCT01529515|76245017|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
42375658|NCT01529515|76245018|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
42375659|NCT01529515|76245015|FG000|DOUBLE BLIND PHASE|Other|0|||
42375660|NCT01529515|76245016|FG001|DOUBLE BLIND PHASE|Other|0|||
42375661|NCT01529515|76245017|FG002|DOUBLE BLIND PHASE|Other|9|||
42375662|NCT01529515|76245018|FG003|DOUBLE BLIND PHASE|Other|2|||
42375663|NCT01528969|76245027|FG000|Overall Study|absent from the school at baseline|2|||
42375664|NCT01528969|76245028|FG001|Overall Study|absent from the school at baseline|0|||
42375665|NCT01514201|76245038|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
42375666|NCT01514201|76245039|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
42375667|NCT01514201|76245040|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
42375668|NCT01514201|76245041|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
42375669|NCT01514201|76245038|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
42375670|NCT01514201|76245039|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
42375671|NCT01514201|76245040|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
42375672|NCT01514201|76245041|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
42375673|NCT01514201|76245038|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
42375674|NCT01514201|76245039|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
42375675|NCT01514201|76245040|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
42375676|NCT01514201|76245041|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
42375677|NCT01514201|76245038|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
42375678|NCT01514201|76245039|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
42375679|NCT01514201|76245040|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
42375680|NCT01514201|76245041|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
42375681|NCT01514201|76245038|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
42375682|NCT01514201|76245039|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
42375683|NCT01514201|76245040|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
42375684|NCT01514201|76245041|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
42375685|NCT01514201|76245038|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
42375686|NCT01514201|76245039|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
42375687|NCT01514201|76245040|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
42375688|NCT01514201|76245041|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
42375689|NCT01514201|76245038|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
42375690|NCT01514201|76245039|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
42375691|NCT01514201|76245040|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
42375692|NCT01514201|76245041|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
42375693|NCT01514201|76245038|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
42375694|NCT01514201|76245039|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
42375695|NCT01514201|76245040|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
42375696|NCT01514201|76245041|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
42375697|NCT01514201|76245038|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
42375698|NCT01514201|76245039|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
42375699|NCT01514201|76245040|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
42375700|NCT01514201|76245041|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
42375701|NCT01514201|76245038|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
42375702|NCT01514201|76245039|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
42375703|NCT01514201|76245040|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
42375704|NCT01514201|76245041|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
42375705|NCT01514201|76245038|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
42375706|NCT01514201|76245039|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
42375707|NCT01514201|76245040|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
42375708|NCT01514201|76245041|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
42375709|NCT01514201|76245038|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
42375710|NCT01514201|76245039|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
42375711|NCT01514201|76245040|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
42375712|NCT01514201|76245041|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
42375713|NCT02666664|76245063|FG000|Overall Study|Physician Decision|0|||
42375714|NCT02666664|76245064|FG001|Overall Study|Physician Decision|1|||
42375715|NCT02666664|76245063|FG000|Overall Study|Protocol Violation|0|||
42375716|NCT02666664|76245064|FG001|Overall Study|Protocol Violation|2|||
42375717|NCT02666664|76245063|FG000|Overall Study|Other|0|||
42375718|NCT02666664|76245064|FG001|Overall Study|Other|1|||
42375719|NCT02666664|76245063|FG000|Overall Study|Adverse Event|12|||
42375720|NCT02666664|76245064|FG001|Overall Study|Adverse Event|37|||
42375721|NCT02666664|76245063|FG000|Overall Study|Withdrawal by participant|23|||
42375722|NCT02666664|76245064|FG001|Overall Study|Withdrawal by participant|40|||
42375723|NCT02666664|76245063|FG000|Overall Study|Sponsor decision|0|||
42375724|NCT02666664|76245064|FG001|Overall Study|Sponsor decision|1|||
42375725|NCT02666664|76245063|FG000|Overall Study|Lost to Follow-up|1|||
42375726|NCT02666664|76245064|FG001|Overall Study|Lost to Follow-up|2|||
42375727|NCT01528735|76245072|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
42375728|NCT01528735|76245073|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
42375729|NCT01528735|76245072|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
42375730|NCT01528735|76245073|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
42375731|NCT02661594|76245085|FG000|Overall Study|Protocol Violation|1|||
42375732|NCT02661594|76245086|FG001|Overall Study|Protocol Violation|0|||
42375733|NCT02661594|76245087|FG002|Overall Study|Protocol Violation|1|||
42375734|NCT02661594|76245088|FG003|Overall Study|Protocol Violation|0|||
42375735|NCT01528345|76245100|FG000|Overall Study|Adverse Event|10|||
42375736|NCT01528345|76245101|FG001|Overall Study|Adverse Event|1|||
42375737|NCT01528345|76245100|FG000|Overall Study|Death|1|||
42375738|NCT01528345|76245101|FG001|Overall Study|Death|1|||
42375739|NCT01528345|76245100|FG000|Overall Study|Non-compliance with study treatment|1|||
42375740|NCT01528345|76245101|FG001|Overall Study|Non-compliance with study treatment|0|||
42375741|NCT01528345|76245100|FG000|Overall Study|Progressive Disease|26|||
42375742|NCT01528345|76245101|FG001|Overall Study|Progressive Disease|40|||
42375743|NCT01528345|76245100|FG000|Overall Study|Study Terminated by Sponsor|4|||
42375744|NCT01528345|76245101|FG001|Overall Study|Study Terminated by Sponsor|8|||
42375745|NCT01528345|76245100|FG000|Overall Study|Subject/Guardian Decision|5|||
42375746|NCT01528345|76245101|FG001|Overall Study|Subject/Guardian Decision|0|||
42375747|NCT01513967|76245115|FG000|Overall Study|Pregnancy|0|||
42375748|NCT01513967|76245116|FG001|Overall Study|Pregnancy|0|||
42375749|NCT01513967|76245117|FG002|Overall Study|Pregnancy|0|||
42375750|NCT01513967|76245118|FG003|Overall Study|Pregnancy|0|||
42375751|NCT01513967|76245119|FG004|Overall Study|Pregnancy|0|||
42375752|NCT01513967|76245120|FG005|Overall Study|Pregnancy|0|||
42375753|NCT01513967|76245121|FG006|Overall Study|Pregnancy|1|||
42375754|NCT01513967|76245122|FG007|Overall Study|Pregnancy|0|||
42375755|NCT01513967|76245115|FG000|Overall Study|missed a study visit|0|||
42375756|NCT01513967|76245116|FG001|Overall Study|missed a study visit|0|||
42375757|NCT01513967|76245117|FG002|Overall Study|missed a study visit|0|||
42375758|NCT01513967|76245118|FG003|Overall Study|missed a study visit|0|||
42375759|NCT01513967|76245119|FG004|Overall Study|missed a study visit|0|||
42375760|NCT01513967|76245120|FG005|Overall Study|missed a study visit|0|||
42375761|NCT01513967|76245121|FG006|Overall Study|missed a study visit|1|||
42375762|NCT01513967|76245122|FG007|Overall Study|missed a study visit|0|||
42375763|NCT01513967|76245115|FG000|Overall Study|excluded due to positive drug screen|0|||
42375764|NCT01513967|76245116|FG001|Overall Study|excluded due to positive drug screen|0|||
42375765|NCT01513967|76245117|FG002|Overall Study|excluded due to positive drug screen|0|||
42375766|NCT01513967|76245118|FG003|Overall Study|excluded due to positive drug screen|0|||
42375767|NCT01513967|76245119|FG004|Overall Study|excluded due to positive drug screen|0|||
42375768|NCT01513967|76245120|FG005|Overall Study|excluded due to positive drug screen|0|||
42375769|NCT01513967|76245121|FG006|Overall Study|excluded due to positive drug screen|0|||
42375770|NCT01513967|76245122|FG007|Overall Study|excluded due to positive drug screen|2|||
42375771|NCT01513967|76245115|FG000|Overall Study|Physician Decision|0|||
42375772|NCT01513967|76245116|FG001|Overall Study|Physician Decision|0|||
42375773|NCT01513967|76245117|FG002|Overall Study|Physician Decision|0|||
42375774|NCT01513967|76245118|FG003|Overall Study|Physician Decision|0|||
42375775|NCT01513967|76245119|FG004|Overall Study|Physician Decision|0|||
42375776|NCT01513967|76245120|FG005|Overall Study|Physician Decision|1|||
42375777|NCT01513967|76245121|FG006|Overall Study|Physician Decision|0|||
42375778|NCT01513967|76245122|FG007|Overall Study|Physician Decision|0|||
42375779|NCT01511939|76245166|FG000|Overall Study|Withdrawal by Subject|2|||
42375780|NCT01511939|76245167|FG001|Overall Study|Withdrawal by Subject|1|||
42375781|NCT01511939|76245168|FG002|Overall Study|Withdrawal by Subject|0|||
42375782|NCT01576705|76245180|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
42375783|NCT01576705|76245181|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
42375784|NCT01576705|76245182|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
42375785|NCT01576705|76245183|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
42375786|NCT01576705|76245180|FG000|Overall Study|invalid ICF|0|||
42375787|NCT01576705|76245181|FG001|Overall Study|invalid ICF|1|||
42375788|NCT01576705|76245182|FG002|Overall Study|invalid ICF|0|||
42375789|NCT01576705|76245183|FG003|Overall Study|invalid ICF|0|||
42375790|NCT02666430|76245195|FG000|Period 1|Lost to Follow-up|1|||
42375791|NCT02666430|76245196|FG001|Period 1|Lost to Follow-up|0|||
42375792|NCT02666430|76245195|FG000|Period 1|Adverse Event|0|||
42375793|NCT02666430|76245196|FG001|Period 1|Adverse Event|1|||
42375794|NCT02666430|76245195|FG000|Period 2|Withdrawal by Subject|1|||
42375795|NCT02666430|76245196|FG001|Period 2|Withdrawal by Subject|4|||
42375796|NCT02666430|76245195|FG000|Period 3|Lost to Follow-up|1|||
42375797|NCT02666430|76245196|FG001|Period 3|Lost to Follow-up|0|||
42375798|NCT01576549|76245202|FG000|Overall Study|Sponsor Decision|2|||
42375799|NCT01576159|76245215|FG000|Overall Study|Withdrawal by Subject|0|||
42375800|NCT01576159|76245216|FG001|Overall Study|Withdrawal by Subject|1|||
42375801|NCT01576159|76245217|FG002|Overall Study|Withdrawal by Subject|0|||
42375802|NCT01576159|76245218|FG003|Overall Study|Withdrawal by Subject|0|||
42375803|NCT01576159|76245215|FG000|Overall Study|Physician Decision|0|||
42375804|NCT01576159|76245216|FG001|Overall Study|Physician Decision|0|||
42375805|NCT01576159|76245217|FG002|Overall Study|Physician Decision|1|||
42375806|NCT01576159|76245218|FG003|Overall Study|Physician Decision|0|||
42375807|NCT01576159|76245215|FG000|Overall Study|Lost to Follow-up|0|||
42375808|NCT01576159|76245216|FG001|Overall Study|Lost to Follow-up|0|||
42375809|NCT01576159|76245217|FG002|Overall Study|Lost to Follow-up|0|||
42375810|NCT01576159|76245218|FG003|Overall Study|Lost to Follow-up|1|||
42375811|NCT01576159|76245215|FG000|Overall Study|Protocol Violation|1|||
42375812|NCT01576159|76245216|FG001|Overall Study|Protocol Violation|0|||
42375813|NCT01576159|76245217|FG002|Overall Study|Protocol Violation|0|||
42375814|NCT01576159|76245218|FG003|Overall Study|Protocol Violation|0|||
42375815|NCT01510769|76245249|FG000|Overall Study|Adverse Event|7|||
42375816|NCT01510769|76245250|FG001|Overall Study|Adverse Event|6|||
42375817|NCT01510769|76245251|FG002|Overall Study|Adverse Event|4|||
42375818|NCT01510769|76245249|FG000|Overall Study|Gout Flare|0|||
42375819|NCT01510769|76245250|FG001|Overall Study|Gout Flare|3|||
42375820|NCT01510769|76245251|FG002|Overall Study|Gout Flare|1|||
42375821|NCT01510769|76245249|FG000|Overall Study|Protocol Violation|11|||
42375822|NCT01510769|76245250|FG001|Overall Study|Protocol Violation|10|||
42375823|NCT01510769|76245251|FG002|Overall Study|Protocol Violation|9|||
42375824|NCT01510769|76245249|FG000|Overall Study|Lost to Follow-up|5|||
42375825|NCT01510769|76245250|FG001|Overall Study|Lost to Follow-up|1|||
42375826|NCT01510769|76245251|FG002|Overall Study|Lost to Follow-up|5|||
42375827|NCT01510769|76245249|FG000|Overall Study|Withdrawal by Subject|3|||
42375828|NCT01510769|76245250|FG001|Overall Study|Withdrawal by Subject|4|||
42375829|NCT01510769|76245251|FG002|Overall Study|Withdrawal by Subject|3|||
42375830|NCT01510769|76245249|FG000|Overall Study|Death|1|||
42375831|NCT01510769|76245250|FG001|Overall Study|Death|1|||
42375832|NCT01510769|76245251|FG002|Overall Study|Death|0|||
42375833|NCT01575769|76245259|FG000|Overall Study|Adverse Event|1|||
42375834|NCT01575769|76245259|FG000|Overall Study|Study terminated by sponsor|40|||
42375835|NCT01510145|76245265|FG000|Overall Study|Adverse Event|6|||
42375836|NCT01510145|76245265|FG000|Overall Study|Lost to Follow-up|5|||
42375837|NCT01510145|76245265|FG000|Overall Study|Withdrawal by Subject|6|||
42375838|NCT01510145|76245265|FG000|Overall Study|Relative reported subject withdrew|1|||
42375839|NCT01528033|76245271|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
42375840|NCT01528033|76245272|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
42375841|NCT01528033|76245271|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
42375842|NCT01528033|76245272|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
42375843|NCT01528033|76245271|FG000|Primary Endpoint Assessment ITT|Death|2|||
42375844|NCT01528033|76245272|FG001|Primary Endpoint Assessment ITT|Death|2|||
42375845|NCT01528033|76245271|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
42375846|NCT01528033|76245272|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
42375847|NCT01528033|76245271|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
42375848|NCT01528033|76245272|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
42375849|NCT01528033|76245271|FG000|Follow Up|No data available|46|||
42375850|NCT01528033|76245272|FG001|Follow Up|No data available|44|||
42375851|NCT01560871|76245289|FG000|Overall Study|transportation issues|2|||
42375852|NCT01560871|76245290|FG001|Overall Study|transportation issues|1|||
42375853|NCT01560871|76245289|FG000|Overall Study|relocation|1|||
42375854|NCT01560871|76245290|FG001|Overall Study|relocation|0|||
42103528|NCT00308581|75914454|FG000|Randomized Maintenance Phase|Adverse Event|10|||
42103529|NCT00308581|75914455|FG001|Randomized Maintenance Phase|Adverse Event|17|||
42375855|NCT01560871|76245289|FG000|Overall Study|readmission to a hospital|2|||
42375856|NCT01560871|76245290|FG001|Overall Study|readmission to a hospital|1|||
42375857|NCT01560871|76245289|FG000|Overall Study|Lost to Follow-up|1|||
42375858|NCT01560871|76245290|FG001|Overall Study|Lost to Follow-up|0|||
42375859|NCT01509053|76245297|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
42375860|NCT01509053|76245297|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
42375861|NCT01509053|76245297|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
42375862|NCT01509053|76245297|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
42375863|NCT01509053|76245297|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
42375864|NCT01509053|76245297|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
42375865|NCT01560403|76245311|FG000|Overall Study|Lost to Follow-up|0|||
42375866|NCT01560403|76245312|FG001|Overall Study|Lost to Follow-up|1|||
42375867|NCT01527487|76245359|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
42375868|NCT01527487|76245360|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
42375869|NCT01527487|76245359|FG000|Overall Study|Disease Progression|4|||
42375870|NCT01527487|76245360|FG001|Overall Study|Disease Progression|1|||
42375871|NCT01527487|76245359|FG000|Overall Study|Adverse Event|1|||
42375872|NCT01527487|76245360|FG001|Overall Study|Adverse Event|1|||
42375873|NCT01527487|76245359|FG000|Overall Study|Death|0|||
42375874|NCT01527487|76245360|FG001|Overall Study|Death|1|||
42375875|NCT01506947|76245371|FG000|Overall Study|Lost to Follow-up|7|||
42375876|NCT01506947|76245371|FG000|Overall Study|Adverse Event|5|||
42375877|NCT01506947|76245371|FG000|Overall Study|Death|1|||
42375878|NCT01506947|76245371|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
42375879|NCT02665338|76245388|FG000|Overall Study|Withdrawal by Subject|0|||
42375880|NCT02665338|76245389|FG001|Overall Study|Withdrawal by Subject|1|||
42375881|NCT01506479|76245398|FG000|Overall Study|Lost to Follow-up|1|||
42375882|NCT01506479|76245399|FG001|Overall Study|Lost to Follow-up|2|||
42375883|NCT01506479|76245400|FG002|Overall Study|Lost to Follow-up|2|||
42375884|NCT01506479|76245398|FG000|Overall Study|Withdrawal by Subject|1|||
42375885|NCT01506479|76245399|FG001|Overall Study|Withdrawal by Subject|2|||
42375886|NCT01506479|76245400|FG002|Overall Study|Withdrawal by Subject|1|||
42375887|NCT01506479|76245398|FG000|Overall Study|Missing assessment|1|||
42375888|NCT01506479|76245399|FG001|Overall Study|Missing assessment|0|||
42375889|NCT01506479|76245400|FG002|Overall Study|Missing assessment|0|||
42375890|NCT01506479|76245398|FG000|Overall Study|Adverse Event|0|||
42375891|NCT01506479|76245399|FG001|Overall Study|Adverse Event|1|||
42375892|NCT01506479|76245400|FG002|Overall Study|Adverse Event|0|||
42375893|NCT01506323|76245424|FG000|Overall Study|Lost to Follow-up|5|||
42375894|NCT01506323|76245425|FG001|Overall Study|Lost to Follow-up|4|||
42375895|NCT01506323|76245424|FG000|Overall Study|Withdrawal by Subject|4|||
42375896|NCT01506323|76245425|FG001|Overall Study|Withdrawal by Subject|4|||
42375897|NCT01506323|76245424|FG000|Overall Study|Lack of Efficacy|1|||
42375898|NCT01506323|76245425|FG001|Overall Study|Lack of Efficacy|3|||
42375899|NCT01506323|76245424|FG000|Overall Study|Moved out of area|5|||
42375900|NCT01506323|76245425|FG001|Overall Study|Moved out of area|2|||
42375901|NCT01506323|76245424|FG000|Overall Study|Schedule or Transportation conflict|8|||
42375902|NCT01506323|76245425|FG001|Overall Study|Schedule or Transportation conflict|0|||
42375903|NCT01506323|76245424|FG000|Overall Study|Started another treatment|1|||
42375904|NCT01506323|76245425|FG001|Overall Study|Started another treatment|0|||
42103530|NCT00308581|75914456|FG002|Randomized Maintenance Phase|Adverse Event|0|||
42375905|NCT01505387|76245438|FG000|Overall Study|Protocol Violation|1|||
42375906|NCT01505387|76245439|FG001|Overall Study|Protocol Violation|0|||
42375907|NCT01505387|76245438|FG000|Overall Study|Withdrawal by Subject|1|||
42375908|NCT01505387|76245439|FG001|Overall Study|Withdrawal by Subject|1|||
42375909|NCT01504841|76245527|FG000|Overall Study|Withdrawal by Subject|1|||
42375910|NCT01504841|76245528|FG001|Overall Study|Withdrawal by Subject|1|||
42375911|NCT01504841|76245529|FG002|Overall Study|Withdrawal by Subject|0|||
42375912|NCT01502423|76245542|FG000|Overall Study|Withdrawal by Subject|0|||
42375913|NCT01502423|76245543|FG001|Overall Study|Withdrawal by Subject|1|||
42375914|NCT01502033|76245549|FG000|Overall Study|1 participant had scalp discomfort|1|||
42375915|NCT01502033|76245549|FG000|Overall Study|1 participant had worsening depression|1|||
42375916|NCT01502033|76245549|FG000|Overall Study|1 participant went back to school|1|||
42375917|NCT01500629|76245557|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
42375918|NCT01500629|76245558|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
42375919|NCT01500317|76245574|FG000|Overall Study|Withdrawal by Subject|3|||
42375920|NCT01500317|76245575|FG001|Overall Study|Withdrawal by Subject|2|||
42375921|NCT01500317|76245576|FG002|Overall Study|Withdrawal by Subject|0|||
42375922|NCT01500083|76245631|FG000|Overall Study|Adverse Event|4|||
42375923|NCT01500083|76245632|FG001|Overall Study|Adverse Event|17|||
42375924|NCT01500083|76245631|FG000|Overall Study|Death|0|||
42103531|NCT00308581|75914454|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
42103532|NCT00308581|75914455|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
42103533|NCT00308581|75914456|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
42103534|NCT00308581|75914454|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
42103535|NCT00308581|75914455|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
42103536|NCT00308581|75914456|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
42103537|NCT00308581|75914454|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
42103538|NCT00308581|75914455|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
42103539|NCT00308581|75914456|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
42103540|NCT00308581|75914454|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
42103541|NCT00308581|75914455|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
42103542|NCT00308581|75914456|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
42103543|NCT00308581|75914454|FG000|Randomized Maintenance Phase|Unknown reason|3|||
42103544|NCT00308581|75914455|FG001|Randomized Maintenance Phase|Unknown reason|0|||
42103545|NCT00308581|75914456|FG002|Randomized Maintenance Phase|Unknown reason|0|||
42103546|NCT00678080|75914466|FG000|Overall Study|Physician Decision|2|||
42103547|NCT00678080|75914467|FG001|Overall Study|Physician Decision|0|||
42103548|NCT00678080|75914466|FG000|Overall Study|Lost to Follow-up|1|||
42103549|NCT00678080|75914467|FG001|Overall Study|Lost to Follow-up|0|||
42103550|NCT00678080|75914466|FG000|Overall Study|Withdrawal by Subject|0|||
42103551|NCT00678080|75914467|FG001|Overall Study|Withdrawal by Subject|1|||
42103552|NCT00658320|75914475|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
42103553|NCT00658320|75914476|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
42103554|NCT00658320|75914475|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
42103555|NCT00658320|75914476|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
42103556|NCT00658320|75914475|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
42103557|NCT00658320|75914476|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
42103558|NCT00658320|75914475|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
42103559|NCT00658320|75914476|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
42103560|NCT00322153|75914486|FG000|Overall Study|Adverse Event|21|||
42375925|NCT01500083|76245632|FG001|Overall Study|Death|2|||
42375926|NCT01500083|76245631|FG000|Overall Study|Lost to Follow-up|1|||
42375927|NCT01500083|76245632|FG001|Overall Study|Lost to Follow-up|0|||
42375928|NCT01500083|76245631|FG000|Overall Study|Withdrawal of Consent|0|||
42375929|NCT01500083|76245632|FG001|Overall Study|Withdrawal of Consent|1|||
42375930|NCT01500083|76245631|FG000|Overall Study|Disease Progression|2|||
42375931|NCT01500083|76245632|FG001|Overall Study|Disease Progression|10|||
42375932|NCT01500083|76245631|FG000|Overall Study|Investigator Discretion|3|||
42375933|NCT01500083|76245632|FG001|Overall Study|Investigator Discretion|8|||
42375934|NCT01500083|76245631|FG000|Overall Study|Other Reasons|2|||
42375935|NCT01500083|76245632|FG001|Overall Study|Other Reasons|5|||
42375936|NCT01499849|76245662|FG000|Overall Study|Adverse Event|28|||
42375937|NCT01499849|76245663|FG001|Overall Study|Adverse Event|32|||
42375938|NCT01499849|76245662|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
42375939|NCT01499849|76245663|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
42375940|NCT01499849|76245662|FG000|Overall Study|Withdrawal by Subject|43|||
42375941|NCT01499849|76245663|FG001|Overall Study|Withdrawal by Subject|43|||
42375942|NCT01499849|76245662|FG000|Overall Study|Death|5|||
42375943|NCT01499849|76245663|FG001|Overall Study|Death|7|||
42375944|NCT01499849|76245662|FG000|Overall Study|Disease Progression|11|||
42375945|NCT01499849|76245663|FG001|Overall Study|Disease Progression|10|||
42375946|NCT01499849|76245662|FG000|Overall Study|Protocol Violation|11|||
42375947|NCT01499849|76245663|FG001|Overall Study|Protocol Violation|11|||
42375948|NCT01499849|76245662|FG000|Overall Study|Physician Decision|20|||
42375949|NCT01499849|76245663|FG001|Overall Study|Physician Decision|19|||
42375950|NCT01499849|76245662|FG000|Overall Study|Lack of Efficacy|3|||
42375951|NCT01499849|76245663|FG001|Overall Study|Lack of Efficacy|4|||
42103561|NCT00322153|75914487|FG001|Overall Study|Adverse Event|34|||
42375952|NCT01499849|76245662|FG000|Overall Study|Lost to Follow-up|6|||
42375953|NCT01499849|76245663|FG001|Overall Study|Lost to Follow-up|3|||
42375954|NCT01499849|76245662|FG000|Overall Study|Other Reasons|27|||
42375955|NCT01499849|76245663|FG001|Overall Study|Other Reasons|30|||
42375956|NCT01499303|76245682|FG000|Overall Study|Ongoing|2|||
42375957|NCT01499303|76245683|FG001|Overall Study|Ongoing|1|||
42375958|NCT01499303|76245682|FG000|Overall Study|Withdrawal by Subject|0|||
42375959|NCT01499303|76245683|FG001|Overall Study|Withdrawal by Subject|1|||
42375960|NCT01499303|76245682|FG000|Overall Study|Adverse Event|1|||
42375961|NCT01499303|76245683|FG001|Overall Study|Adverse Event|4|||
42375962|NCT01499303|76245682|FG000|Overall Study|Other|0|||
42375963|NCT01499303|76245683|FG001|Overall Study|Other|1|||
42375964|NCT01498679|76245704|FG000|Overall Study|Adverse Event|1|||
42375965|NCT01498679|76245705|FG001|Overall Study|Adverse Event|4|||
42375966|NCT01498679|76245704|FG000|Overall Study|Lack of Efficacy|72|||
42375967|NCT01498679|76245705|FG001|Overall Study|Lack of Efficacy|12|||
42375968|NCT01498679|76245704|FG000|Overall Study|Protocol Violation|4|||
42375969|NCT01498679|76245705|FG001|Overall Study|Protocol Violation|0|||
42375970|NCT01498679|76245704|FG000|Overall Study|Physician Decision|0|||
42375971|NCT01498679|76245705|FG001|Overall Study|Physician Decision|2|||
42375972|NCT01498679|76245704|FG000|Overall Study|Withdrawal by Subject|12|||
42375973|NCT01498679|76245705|FG001|Overall Study|Withdrawal by Subject|4|||
42375974|NCT01526785|76245728|FG000|Overall Study|Study Terminated by Sponsor|8|||
42375975|NCT01526785|76245728|FG000|Overall Study|Death|2|||
42375976|NCT01526785|76245728|FG000|Overall Study|Physician Decision|1|||
42375977|NCT01526785|76245728|FG000|Overall Study|Withdrawal by Subject|2|||
42375978|NCT01559389|76245734|FG000|Overall Study|Withdrawal by Subject|20|||
42375979|NCT01559389|76245735|FG001|Overall Study|Withdrawal by Subject|20|||
42375980|NCT01526551|76245745|FG000|Overall Study|Lack of returned parental consent form|424|||
42375981|NCT01559311|76245823|FG000|Overall Study|Protocol Violation|0|||
42375982|NCT01559311|76245824|FG001|Overall Study|Protocol Violation|0|||
42375983|NCT01559311|76245825|FG002|Overall Study|Protocol Violation|2|||
42375984|NCT01559311|76245823|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
42375985|NCT01559311|76245824|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
42375986|NCT01559311|76245825|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
42375987|NCT01559311|76245823|FG000|Overall Study|Withdrawal by Subject|2|||
42375988|NCT01559311|76245824|FG001|Overall Study|Withdrawal by Subject|1|||
42375989|NCT01559311|76245825|FG002|Overall Study|Withdrawal by Subject|0|||
42375990|NCT01559311|76245823|FG000|Overall Study|Death|0|||
42375991|NCT01559311|76245824|FG001|Overall Study|Death|2|||
42375992|NCT01559311|76245825|FG002|Overall Study|Death|3|||
42375993|NCT01559311|76245823|FG000|Overall Study|Lost to Follow-up|0|||
42375994|NCT01559311|76245824|FG001|Overall Study|Lost to Follow-up|3|||
42375995|NCT01559311|76245825|FG002|Overall Study|Lost to Follow-up|2|||
42375996|NCT01559311|76245823|FG000|Overall Study|Adverse Event|0|||
42375997|NCT01559311|76245824|FG001|Overall Study|Adverse Event|0|||
42375998|NCT01559311|76245825|FG002|Overall Study|Adverse Event|1|||
42375999|NCT01498445|76245848|FG000|Overall Study|Lack of Efficacy|0|||
42376000|NCT01498445|76245849|FG001|Overall Study|Lack of Efficacy|0|||
42376001|NCT01498445|76245850|FG002|Overall Study|Lack of Efficacy|1|||
42376002|NCT01498445|76245851|FG003|Overall Study|Lack of Efficacy|2|||
42376003|NCT01498445|76245852|FG004|Overall Study|Lack of Efficacy|0|||
42376004|NCT01498445|76245853|FG005|Overall Study|Lack of Efficacy|0|||
42376005|NCT01498445|76245848|FG000|Overall Study|Screen Failure|0|||
42376006|NCT01498445|76245849|FG001|Overall Study|Screen Failure|0|||
42376007|NCT01498445|76245850|FG002|Overall Study|Screen Failure|0|||
42376008|NCT01498445|76245851|FG003|Overall Study|Screen Failure|0|||
42376009|NCT01498445|76245852|FG004|Overall Study|Screen Failure|1|||
42376010|NCT01498445|76245853|FG005|Overall Study|Screen Failure|1|||
42376011|NCT01558297|76245870|FG000|Overall Study|Withdrawal by Subject|2|||
42376012|NCT01558297|76245871|FG001|Overall Study|Withdrawal by Subject|2|||
42376013|NCT01558297|76245872|FG002|Overall Study|Withdrawal by Subject|1|||
42376014|NCT01525849|76245882|FG000|Overall Study|Lost to Follow-up|3|||
42376015|NCT01525849|76245883|FG001|Overall Study|Lost to Follow-up|2|||
42376016|NCT01525849|76245882|FG000|Overall Study|Withdrawal by Subject|1|||
42376017|NCT01525849|76245883|FG001|Overall Study|Withdrawal by Subject|9|||
42376018|NCT01525849|76245882|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
42376019|NCT01525849|76245883|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
42376020|NCT01525849|76245882|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
42376021|NCT01525849|76245883|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
42376022|NCT01525615|76245902|FG000|Overall Study|Adverse Event|11|||
42376023|NCT01525615|76245903|FG001|Overall Study|Adverse Event|7|||
42376024|NCT01525615|76245904|FG002|Overall Study|Adverse Event|5|||
42376025|NCT01525615|76245902|FG000|Overall Study|Lost to Follow-up|1|||
42376026|NCT01525615|76245903|FG001|Overall Study|Lost to Follow-up|0|||
42376027|NCT01525615|76245904|FG002|Overall Study|Lost to Follow-up|0|||
42376028|NCT01525615|76245902|FG000|Overall Study|Withdrawal by Subject|1|||
42376029|NCT01525615|76245903|FG001|Overall Study|Withdrawal by Subject|0|||
42376030|NCT01525615|76245904|FG002|Overall Study|Withdrawal by Subject|0|||
42376031|NCT01525615|76245902|FG000|Overall Study|Other reason not described above|1|||
42376032|NCT01525615|76245903|FG001|Overall Study|Other reason not described above|0|||
42376033|NCT01525615|76245904|FG002|Overall Study|Other reason not described above|1|||
42376034|NCT01525225|76245946|FG000|Enrollment|No longer met study criteria|1|||
42376035|NCT01525225|76245946|FG000|Enrollment|Other|1|||
42376036|NCT01524991|76245963|FG000|Overall Study|Adverse Event|12|||
42376037|NCT01524991|76245963|FG000|Overall Study|Death|1|||
42376038|NCT01524991|76245963|FG000|Overall Study|Disease ProgressionDu|17|||
42376039|NCT01524991|76245963|FG000|Overall Study|Other complicating disease|1|||
42376040|NCT01524991|76245963|FG000|Overall Study|Withdrawal by Subject|2|||
42376041|NCT01524991|76245963|FG000|Overall Study|Symptomatic Deterioration|1|||
42376042|NCT01524913|76245970|FG000|Overall Study|Lost to Follow-up|4|||
42376043|NCT01524913|76245971|FG001|Overall Study|Lost to Follow-up|0|||
42376044|NCT01524913|76245972|FG002|Overall Study|Lost to Follow-up|0|||
42376045|NCT01524679|76245982|FG000|Overall Study|Lost to Follow-up|1|||
42376046|NCT01524679|76245983|FG001|Overall Study|Lost to Follow-up|4|||
42376047|NCT01524679|76245982|FG000|Overall Study|Withdrawal by Subject|4|||
42376048|NCT01524679|76245983|FG001|Overall Study|Withdrawal by Subject|4|||
42376049|NCT01524679|76245982|FG000|Overall Study|Adverse Event|9|||
42376050|NCT01524679|76245983|FG001|Overall Study|Adverse Event|0|||
42376051|NCT01524679|76245982|FG000|Overall Study|Protocol Violation|1|||
42376052|NCT01524679|76245983|FG001|Overall Study|Protocol Violation|0|||
42376053|NCT01524679|76245982|FG000|Overall Study|Lack of Efficacy|2|||
42376054|NCT01524679|76245983|FG001|Overall Study|Lack of Efficacy|0|||
42376055|NCT01524679|76245982|FG000|Overall Study|e.g.wish for children, relocation|6|||
42376056|NCT01524679|76245983|FG001|Overall Study|e.g.wish for children, relocation|1|||
42376057|NCT01524289|76246000|FG000|Overall Study|Lost to Follow-up|0|||
42376058|NCT01524289|76246001|FG001|Overall Study|Lost to Follow-up|1|||
42376059|NCT01524289|76246000|FG000|Overall Study|Physician Decision|1|||
42376060|NCT01524289|76246001|FG001|Overall Study|Physician Decision|0|||
42376061|NCT01524289|76246000|FG000|Overall Study|Protocol Violation|5|||
42376062|NCT01524289|76246001|FG001|Overall Study|Protocol Violation|1|||
42376063|NCT01524289|76246000|FG000|Overall Study|Withdrawal by Subject|11|||
42376064|NCT01524289|76246001|FG001|Overall Study|Withdrawal by Subject|7|||
42376065|NCT01524289|76246000|FG000|Overall Study|Adverse Event|12|||
42376066|NCT01524289|76246001|FG001|Overall Study|Adverse Event|5|||
42376067|NCT01524289|76246000|FG000|Overall Study|Did not take study medication|1|||
42376068|NCT01524289|76246001|FG001|Overall Study|Did not take study medication|0|||
42376069|NCT01498289|76246011|FG000|Overall Study|Adverse Event|16|||
42376070|NCT01498289|76246012|FG001|Overall Study|Adverse Event|18|||
42376071|NCT01498289|76246011|FG000|Overall Study|Death|6|||
42376072|NCT01498289|76246012|FG001|Overall Study|Death|8|||
42376073|NCT01498289|76246011|FG000|Overall Study|Withdrawal unrelated to AE|16|||
42376074|NCT01498289|76246012|FG001|Overall Study|Withdrawal unrelated to AE|16|||
42376075|NCT01498289|76246011|FG000|Overall Study|Progression/relapse|53|||
42376076|NCT01498289|76246012|FG001|Overall Study|Progression/relapse|59|||
42376077|NCT01498289|76246011|FG000|Overall Study|Not protocol specified|7|||
42376078|NCT01498289|76246012|FG001|Overall Study|Not protocol specified|2|||
42376079|NCT01498289|76246011|FG000|Overall Study|Reason under review|0|||
42376080|NCT01498289|76246012|FG001|Overall Study|Reason under review|1|||
42376081|NCT01524133|76246025|FG000|Treatment Phase|Withdrawal by Subject|13|||
42376082|NCT01524133|76246026|FG001|Treatment Phase|Withdrawal by Subject|28|||
42376083|NCT01524133|76246027|FG002|Treatment Phase|Withdrawal by Subject|31|||
42376084|NCT01524133|76246025|FG000|Treatment Phase|Physician Decision|6|||
42376085|NCT01524133|76246026|FG001|Treatment Phase|Physician Decision|3|||
42376086|NCT01524133|76246027|FG002|Treatment Phase|Physician Decision|3|||
42376087|NCT01524133|76246025|FG000|Treatment Phase|Lost to Follow-up|0|||
42376088|NCT01524133|76246026|FG001|Treatment Phase|Lost to Follow-up|1|||
42376089|NCT01524133|76246027|FG002|Treatment Phase|Lost to Follow-up|2|||
42376090|NCT01524133|76246025|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
42376091|NCT01524133|76246026|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
42376092|NCT01524133|76246027|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
42376093|NCT01524133|76246025|FG000|Overall Study 52 Weeks|Physician Decision|1|||
42376094|NCT01524133|76246026|FG001|Overall Study 52 Weeks|Physician Decision|0|||
42376095|NCT01524133|76246027|FG002|Overall Study 52 Weeks|Physician Decision|2|||
42376096|NCT01524133|76246025|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
42376097|NCT01524133|76246026|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
42103562|NCT00322153|75914486|FG000|Overall Study|Protocol Violation|6|||
42103563|NCT00322153|75914487|FG001|Overall Study|Protocol Violation|14|||
42103564|NCT00322153|75914486|FG000|Overall Study|Withdrawal by Subject|18|||
42103565|NCT00322153|75914487|FG001|Overall Study|Withdrawal by Subject|10|||
42103566|NCT00322153|75914486|FG000|Overall Study|Lack of Efficacy|8|||
42376098|NCT01524133|76246027|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
42376099|NCT04304534|76246061|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
42376100|NCT04304534|76246062|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
42376101|NCT04304534|76246063|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
42376102|NCT04304534|76246064|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
42376103|NCT04304534|76246061|FG000|Overall Study|Non-Compliance with study drug|0|||
42376104|NCT04304534|76246062|FG001|Overall Study|Non-Compliance with study drug|1|||
42376105|NCT04304534|76246063|FG002|Overall Study|Non-Compliance with study drug|1|||
42376106|NCT04304534|76246064|FG003|Overall Study|Non-Compliance with study drug|1|||
42376107|NCT04304534|76246061|FG000|Overall Study|Lost to Follow-up|0|||
42376108|NCT04304534|76246062|FG001|Overall Study|Lost to Follow-up|1|||
42376109|NCT04304534|76246063|FG002|Overall Study|Lost to Follow-up|2|||
42376110|NCT04304534|76246064|FG003|Overall Study|Lost to Follow-up|3|||
42376111|NCT04304534|76246061|FG000|Overall Study|Unspecific|4|||
42376112|NCT04304534|76246062|FG001|Overall Study|Unspecific|2|||
42376113|NCT04304534|76246063|FG002|Overall Study|Unspecific|2|||
42376114|NCT04304534|76246064|FG003|Overall Study|Unspecific|2|||
42376115|NCT04304534|76246061|FG000|Overall Study|Technical Problems|2|||
42376116|NCT04304534|76246062|FG001|Overall Study|Technical Problems|2|||
42376117|NCT04304534|76246063|FG002|Overall Study|Technical Problems|3|||
42376118|NCT04304534|76246064|FG003|Overall Study|Technical Problems|4|||
42376119|NCT04304534|76246061|FG000|Overall Study|Death|7|||
42376120|NCT04304534|76246062|FG001|Overall Study|Death|2|||
42376121|NCT04304534|76246063|FG002|Overall Study|Death|4|||
42376122|NCT04304534|76246064|FG003|Overall Study|Death|3|||
42376123|NCT04304534|76246061|FG000|Overall Study|Withdrawal by Subject|7|||
42376124|NCT04304534|76246062|FG001|Overall Study|Withdrawal by Subject|2|||
42376125|NCT04304534|76246063|FG002|Overall Study|Withdrawal by Subject|7|||
42376126|NCT04304534|76246064|FG003|Overall Study|Withdrawal by Subject|4|||
42376127|NCT04304534|76246061|FG000|Overall Study|Physician Decision|4|||
42376128|NCT04304534|76246062|FG001|Overall Study|Physician Decision|9|||
42376129|NCT04304534|76246063|FG002|Overall Study|Physician Decision|9|||
42376130|NCT04304534|76246064|FG003|Overall Study|Physician Decision|5|||
42376131|NCT04304534|76246061|FG000|Overall Study|Subject Decision|34|||
42376132|NCT04304534|76246062|FG001|Overall Study|Subject Decision|25|||
42376133|NCT04304534|76246063|FG002|Overall Study|Subject Decision|25|||
42376134|NCT04304534|76246064|FG003|Overall Study|Subject Decision|26|||
42376135|NCT04304534|76246061|FG000|Overall Study|Adverse Event|35|||
42376136|NCT04304534|76246062|FG001|Overall Study|Adverse Event|40|||
42376137|NCT04304534|76246063|FG002|Overall Study|Adverse Event|39|||
42376138|NCT04304534|76246064|FG003|Overall Study|Adverse Event|44|||
42376139|NCT04223609|76246077|FG000|Overall Study|Adverse Event|0|||
42376140|NCT04223609|76246078|FG001|Overall Study|Adverse Event|1|||
42376141|NCT04223609|76246077|FG000|Overall Study|Missed last visit|0|||
42376142|NCT04223609|76246078|FG001|Overall Study|Missed last visit|1|||
42376143|NCT04176458|76246084|FG000|Overall Study|Covid 19|4|||
42376144|NCT03941548|76246090|FG000|Overall Study|Adverse Event|0|||
42376145|NCT03941548|76246091|FG001|Overall Study|Adverse Event|1|||
42376146|NCT03941548|76246090|FG000|Overall Study|Lost to Follow-up|0|||
42376147|NCT03941548|76246091|FG001|Overall Study|Lost to Follow-up|1|||
42376148|NCT03941548|76246090|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
42376149|NCT03941548|76246091|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
42376150|NCT03925727|76246100|FG000|Overall Study|Adverse Event|4|||
42376151|NCT03925727|76246101|FG001|Overall Study|Adverse Event|0|||
42376152|NCT03925727|76246102|FG002|Overall Study|Adverse Event|3|||
42376153|NCT03925727|76246100|FG000|Overall Study|Protocol Violation|1|||
42376154|NCT03925727|76246101|FG001|Overall Study|Protocol Violation|2|||
42376155|NCT03925727|76246102|FG002|Overall Study|Protocol Violation|2|||
42376156|NCT03925727|76246100|FG000|Overall Study|Withdrawal by Subject|3|||
42376157|NCT03925727|76246101|FG001|Overall Study|Withdrawal by Subject|2|||
42376158|NCT03925727|76246102|FG002|Overall Study|Withdrawal by Subject|4|||
42376159|NCT03925727|76246100|FG000|Overall Study|Administrative Reasons|3|||
42376160|NCT03925727|76246101|FG001|Overall Study|Administrative Reasons|1|||
42376161|NCT03925727|76246102|FG002|Overall Study|Administrative Reasons|2|||
42376162|NCT03925727|76246100|FG000|Overall Study|Randomized in error or Disqualified|8|||
42376163|NCT03925727|76246101|FG001|Overall Study|Randomized in error or Disqualified|1|||
42376164|NCT03925727|76246102|FG002|Overall Study|Randomized in error or Disqualified|7|||
42376165|NCT03387150|76246119|FG000|Overall Study|Withdrawal by Subject|3|||
42376166|NCT03387150|76246120|FG001|Overall Study|Withdrawal by Subject|0|||
42376167|NCT03387150|76246121|FG002|Overall Study|Withdrawal by Subject|3|||
42376168|NCT03387150|76246122|FG003|Overall Study|Withdrawal by Subject|4|||
42376169|NCT03387150|76246123|FG004|Overall Study|Withdrawal by Subject|1|||
42103567|NCT00322153|75914487|FG001|Overall Study|Lack of Efficacy|3|||
42103568|NCT00322153|75914486|FG000|Overall Study|Lost to Follow-up|5|||
42103569|NCT00322153|75914487|FG001|Overall Study|Lost to Follow-up|4|||
42376170|NCT03387150|76246124|FG005|Overall Study|Withdrawal by Subject|2|||
42376171|NCT03387150|76246125|FG006|Overall Study|Withdrawal by Subject|0|||
42376172|NCT03387150|76246119|FG000|Overall Study|Lost to Follow-up|3|||
42376173|NCT03387150|76246120|FG001|Overall Study|Lost to Follow-up|2|||
42376174|NCT03387150|76246121|FG002|Overall Study|Lost to Follow-up|2|||
42376175|NCT03387150|76246122|FG003|Overall Study|Lost to Follow-up|3|||
42376176|NCT03387150|76246123|FG004|Overall Study|Lost to Follow-up|3|||
42376177|NCT03387150|76246124|FG005|Overall Study|Lost to Follow-up|3|||
42103570|NCT00322153|75914486|FG000|Overall Study|Withdrawn for other reasons|5|||
42376178|NCT03387150|76246125|FG006|Overall Study|Lost to Follow-up|0|||
42376179|NCT03387150|76246119|FG000|Overall Study|Participant unable to adhere to visit|0|||
42376180|NCT03387150|76246120|FG001|Overall Study|Participant unable to adhere to visit|1|||
42376181|NCT03387150|76246121|FG002|Overall Study|Participant unable to adhere to visit|0|||
42376182|NCT03387150|76246122|FG003|Overall Study|Participant unable to adhere to visit|0|||
42376183|NCT03387150|76246123|FG004|Overall Study|Participant unable to adhere to visit|2|||
42376184|NCT03387150|76246124|FG005|Overall Study|Participant unable to adhere to visit|2|||
42376185|NCT03387150|76246125|FG006|Overall Study|Participant unable to adhere to visit|0|||
42376186|NCT03289208|76246157|FG000|Overall Study|Adverse Event|1|||
42376187|NCT03289208|76246158|FG001|Overall Study|Adverse Event|0|||
42376188|NCT03289208|76246159|FG002|Overall Study|Adverse Event|0|||
42376189|NCT03244059|76246169|FG000|Specific Aim 1|Physician Decision|1|||
42376190|NCT03244059|76246170|FG001|Specific Aim 1|Physician Decision|0|||
42376191|NCT03244059|76246169|FG000|Specific Aim 2|Physician Decision|1|||
42376192|NCT03244059|76246170|FG001|Specific Aim 2|Physician Decision|0|||
42376193|NCT03036566|76246176|FG000|Overall Study|Lost to Follow-up|3|||
42376194|NCT02754141|76246207|FG000|Overall Study|Disease progression|11|||
42376195|NCT02754141|76246208|FG001|Overall Study|Disease progression|7|||
42376196|NCT02754141|76246209|FG002|Overall Study|Disease progression|8|||
42376197|NCT02754141|76246210|FG003|Overall Study|Disease progression|5|||
42376198|NCT02754141|76246211|FG004|Overall Study|Disease progression|7|||
42376199|NCT02754141|76246212|FG005|Overall Study|Disease progression|7|||
42376200|NCT02754141|76246213|FG006|Overall Study|Disease progression|7|||
42376201|NCT02754141|76246214|FG007|Overall Study|Disease progression|6|||
42376202|NCT02754141|76246215|FG008|Overall Study|Disease progression|11|||
42376203|NCT02754141|76246216|FG009|Overall Study|Disease progression|16|||
42376204|NCT02754141|76246217|FG010|Overall Study|Disease progression|18|||
42376205|NCT02754141|76246218|FG011|Overall Study|Disease progression|13|||
42376206|NCT02754141|76246219|FG012|Overall Study|Disease progression|10|||
42376207|NCT02754141|76246220|FG013|Overall Study|Disease progression|12|||
42376208|NCT02754141|76246221|FG014|Overall Study|Disease progression|12|||
42376209|NCT02754141|76246222|FG015|Overall Study|Disease progression|14|||
42376210|NCT02754141|76246223|FG016|Overall Study|Disease progression|0|||
42376211|NCT02754141|76246224|FG017|Overall Study|Disease progression|1|||
42376212|NCT02754141|76246207|FG000|Overall Study|Study drug toxicity|1|||
42376213|NCT02754141|76246208|FG001|Overall Study|Study drug toxicity|1|||
42376214|NCT02754141|76246209|FG002|Overall Study|Study drug toxicity|0|||
42376215|NCT02754141|76246210|FG003|Overall Study|Study drug toxicity|0|||
42376216|NCT02754141|76246211|FG004|Overall Study|Study drug toxicity|0|||
42376217|NCT02754141|76246212|FG005|Overall Study|Study drug toxicity|0|||
42376218|NCT02754141|76246213|FG006|Overall Study|Study drug toxicity|0|||
42376219|NCT02754141|76246214|FG007|Overall Study|Study drug toxicity|0|||
42376220|NCT02754141|76246215|FG008|Overall Study|Study drug toxicity|0|||
42376221|NCT02754141|76246216|FG009|Overall Study|Study drug toxicity|0|||
42376222|NCT02754141|76246217|FG010|Overall Study|Study drug toxicity|2|||
42376223|NCT02754141|76246218|FG011|Overall Study|Study drug toxicity|1|||
42376224|NCT02754141|76246219|FG012|Overall Study|Study drug toxicity|1|||
42376225|NCT02754141|76246220|FG013|Overall Study|Study drug toxicity|0|||
42376226|NCT02754141|76246221|FG014|Overall Study|Study drug toxicity|0|||
42376227|NCT02754141|76246222|FG015|Overall Study|Study drug toxicity|0|||
42376228|NCT02754141|76246223|FG016|Overall Study|Study drug toxicity|0|||
42376229|NCT02754141|76246224|FG017|Overall Study|Study drug toxicity|0|||
42376230|NCT02754141|76246207|FG000|Overall Study|AE unrelated to study drug|1|||
42376231|NCT02754141|76246208|FG001|Overall Study|AE unrelated to study drug|1|||
42376232|NCT02754141|76246209|FG002|Overall Study|AE unrelated to study drug|0|||
42376233|NCT02754141|76246210|FG003|Overall Study|AE unrelated to study drug|1|||
42376234|NCT02754141|76246211|FG004|Overall Study|AE unrelated to study drug|3|||
42376235|NCT02754141|76246212|FG005|Overall Study|AE unrelated to study drug|2|||
42376236|NCT02754141|76246213|FG006|Overall Study|AE unrelated to study drug|1|||
42200800|NCT02057718|76012714|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
42200801|NCT01981551|76012720|FG000|Overall Study|Refused further treatment|8|||
42376237|NCT02754141|76246214|FG007|Overall Study|AE unrelated to study drug|0|||
42376238|NCT02754141|76246215|FG008|Overall Study|AE unrelated to study drug|0|||
42376239|NCT02754141|76246216|FG009|Overall Study|AE unrelated to study drug|0|||
42376240|NCT02754141|76246217|FG010|Overall Study|AE unrelated to study drug|0|||
42200802|NCT01981551|76012720|FG000|Overall Study|Adverse Event|1|||
42200803|NCT01750281|76012727|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
42200804|NCT01750281|76012728|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
42376241|NCT02754141|76246218|FG011|Overall Study|AE unrelated to study drug|0|||
42103571|NCT00322153|75914487|FG001|Overall Study|Withdrawn for other reasons|4|||
42200805|NCT01750281|76012729|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
42376242|NCT02754141|76246219|FG012|Overall Study|AE unrelated to study drug|0|||
42376243|NCT02754141|76246220|FG013|Overall Study|AE unrelated to study drug|0|||
42376244|NCT02754141|76246221|FG014|Overall Study|AE unrelated to study drug|0|||
42376245|NCT02754141|76246222|FG015|Overall Study|AE unrelated to study drug|0|||
42376246|NCT02754141|76246223|FG016|Overall Study|AE unrelated to study drug|0|||
42376247|NCT02754141|76246224|FG017|Overall Study|AE unrelated to study drug|0|||
42376248|NCT02754141|76246207|FG000|Overall Study|Request to discontinue|0|||
42376249|NCT02754141|76246208|FG001|Overall Study|Request to discontinue|0|||
42376250|NCT02754141|76246209|FG002|Overall Study|Request to discontinue|0|||
42376251|NCT02754141|76246210|FG003|Overall Study|Request to discontinue|0|||
42376252|NCT02754141|76246211|FG004|Overall Study|Request to discontinue|0|||
42376253|NCT02754141|76246212|FG005|Overall Study|Request to discontinue|0|||
42376254|NCT02754141|76246213|FG006|Overall Study|Request to discontinue|0|||
42376255|NCT02754141|76246214|FG007|Overall Study|Request to discontinue|0|||
42376256|NCT02754141|76246215|FG008|Overall Study|Request to discontinue|1|||
42376257|NCT02754141|76246216|FG009|Overall Study|Request to discontinue|0|||
42376258|NCT02754141|76246217|FG010|Overall Study|Request to discontinue|0|||
42376259|NCT02754141|76246218|FG011|Overall Study|Request to discontinue|0|||
42376260|NCT02754141|76246219|FG012|Overall Study|Request to discontinue|0|||
42376261|NCT02754141|76246220|FG013|Overall Study|Request to discontinue|1|||
42376262|NCT02754141|76246221|FG014|Overall Study|Request to discontinue|1|||
42376263|NCT02754141|76246222|FG015|Overall Study|Request to discontinue|0|||
42376264|NCT02754141|76246223|FG016|Overall Study|Request to discontinue|0|||
42376265|NCT02754141|76246224|FG017|Overall Study|Request to discontinue|0|||
42376266|NCT02754141|76246207|FG000|Overall Study|Withdrew consent|0|||
42376267|NCT02754141|76246208|FG001|Overall Study|Withdrew consent|0|||
42376268|NCT02754141|76246209|FG002|Overall Study|Withdrew consent|0|||
42376269|NCT02754141|76246210|FG003|Overall Study|Withdrew consent|0|||
42376270|NCT02754141|76246211|FG004|Overall Study|Withdrew consent|0|||
42376271|NCT02754141|76246212|FG005|Overall Study|Withdrew consent|0|||
42376272|NCT02754141|76246213|FG006|Overall Study|Withdrew consent|0|||
42376273|NCT02754141|76246214|FG007|Overall Study|Withdrew consent|0|||
42376274|NCT02754141|76246215|FG008|Overall Study|Withdrew consent|0|||
42376275|NCT02754141|76246216|FG009|Overall Study|Withdrew consent|1|||
42376276|NCT02754141|76246217|FG010|Overall Study|Withdrew consent|0|||
42376277|NCT02754141|76246218|FG011|Overall Study|Withdrew consent|0|||
42376278|NCT02754141|76246219|FG012|Overall Study|Withdrew consent|0|||
42376279|NCT02754141|76246220|FG013|Overall Study|Withdrew consent|0|||
42376280|NCT02754141|76246221|FG014|Overall Study|Withdrew consent|0|||
42376281|NCT02754141|76246222|FG015|Overall Study|Withdrew consent|0|||
42376282|NCT02754141|76246223|FG016|Overall Study|Withdrew consent|0|||
42376283|NCT02754141|76246224|FG017|Overall Study|Withdrew consent|0|||
42376284|NCT02754141|76246207|FG000|Overall Study|Maximum clinical benefit|0|||
42376285|NCT02754141|76246208|FG001|Overall Study|Maximum clinical benefit|0|||
42376286|NCT02754141|76246209|FG002|Overall Study|Maximum clinical benefit|0|||
42376287|NCT02754141|76246210|FG003|Overall Study|Maximum clinical benefit|1|||
42376288|NCT02754141|76246211|FG004|Overall Study|Maximum clinical benefit|0|||
42376289|NCT02754141|76246212|FG005|Overall Study|Maximum clinical benefit|0|||
42376290|NCT02754141|76246213|FG006|Overall Study|Maximum clinical benefit|0|||
42376291|NCT02754141|76246214|FG007|Overall Study|Maximum clinical benefit|0|||
42376292|NCT02754141|76246215|FG008|Overall Study|Maximum clinical benefit|0|||
42376293|NCT02754141|76246216|FG009|Overall Study|Maximum clinical benefit|0|||
42376294|NCT02754141|76246217|FG010|Overall Study|Maximum clinical benefit|0|||
42376295|NCT02754141|76246218|FG011|Overall Study|Maximum clinical benefit|0|||
42376296|NCT02754141|76246219|FG012|Overall Study|Maximum clinical benefit|0|||
42376297|NCT02754141|76246220|FG013|Overall Study|Maximum clinical benefit|0|||
42376298|NCT02754141|76246221|FG014|Overall Study|Maximum clinical benefit|0|||
42376299|NCT02754141|76246222|FG015|Overall Study|Maximum clinical benefit|0|||
42376300|NCT02754141|76246223|FG016|Overall Study|Maximum clinical benefit|0|||
42376301|NCT02754141|76246224|FG017|Overall Study|Maximum clinical benefit|0|||
42376302|NCT02754141|76246207|FG000|Overall Study|No longer meets study criteria|0|||
42376303|NCT02754141|76246208|FG001|Overall Study|No longer meets study criteria|0|||
42376304|NCT02754141|76246209|FG002|Overall Study|No longer meets study criteria|0|||
42376305|NCT02754141|76246210|FG003|Overall Study|No longer meets study criteria|1|||
42376306|NCT02754141|76246211|FG004|Overall Study|No longer meets study criteria|0|||
42376307|NCT02754141|76246212|FG005|Overall Study|No longer meets study criteria|0|||
42376308|NCT02754141|76246213|FG006|Overall Study|No longer meets study criteria|0|||
42376309|NCT02754141|76246214|FG007|Overall Study|No longer meets study criteria|0|||
42376310|NCT02754141|76246215|FG008|Overall Study|No longer meets study criteria|0|||
42376311|NCT02754141|76246216|FG009|Overall Study|No longer meets study criteria|0|||
42376312|NCT02754141|76246217|FG010|Overall Study|No longer meets study criteria|0|||
42376313|NCT02754141|76246218|FG011|Overall Study|No longer meets study criteria|0|||
42376314|NCT02754141|76246219|FG012|Overall Study|No longer meets study criteria|0|||
42376315|NCT02754141|76246220|FG013|Overall Study|No longer meets study criteria|0|||
42376316|NCT02754141|76246221|FG014|Overall Study|No longer meets study criteria|0|||
42376317|NCT02754141|76246222|FG015|Overall Study|No longer meets study criteria|0|||
42376318|NCT02754141|76246223|FG016|Overall Study|No longer meets study criteria|0|||
42376319|NCT02754141|76246224|FG017|Overall Study|No longer meets study criteria|0|||
42376320|NCT02754141|76246207|FG000|Overall Study|Other reasons|0|||
42376321|NCT02754141|76246208|FG001|Overall Study|Other reasons|0|||
42200806|NCT01750281|76012727|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
42376322|NCT02754141|76246209|FG002|Overall Study|Other reasons|0|||
42376323|NCT02754141|76246210|FG003|Overall Study|Other reasons|0|||
42376324|NCT02754141|76246211|FG004|Overall Study|Other reasons|0|||
42376325|NCT02754141|76246212|FG005|Overall Study|Other reasons|0|||
42376326|NCT02754141|76246213|FG006|Overall Study|Other reasons|0|||
42376327|NCT02754141|76246214|FG007|Overall Study|Other reasons|1|||
42376328|NCT02754141|76246215|FG008|Overall Study|Other reasons|0|||
42376329|NCT02754141|76246216|FG009|Overall Study|Other reasons|0|||
42376330|NCT02754141|76246217|FG010|Overall Study|Other reasons|0|||
42376331|NCT02754141|76246218|FG011|Overall Study|Other reasons|0|||
42376332|NCT02754141|76246219|FG012|Overall Study|Other reasons|2|||
42376333|NCT02754141|76246220|FG013|Overall Study|Other reasons|0|||
42376334|NCT02754141|76246221|FG014|Overall Study|Other reasons|0|||
42376335|NCT02754141|76246222|FG015|Overall Study|Other reasons|0|||
42376336|NCT02754141|76246223|FG016|Overall Study|Other reasons|0|||
42376337|NCT02754141|76246224|FG017|Overall Study|Other reasons|0|||
42376338|NCT02754141|76246207|FG000|Overall Study|Completed treatment as per protocol|0|||
42376339|NCT02754141|76246208|FG001|Overall Study|Completed treatment as per protocol|1|||
42376340|NCT02754141|76246209|FG002|Overall Study|Completed treatment as per protocol|0|||
42376341|NCT02754141|76246210|FG003|Overall Study|Completed treatment as per protocol|0|||
42376342|NCT02754141|76246211|FG004|Overall Study|Completed treatment as per protocol|0|||
42376343|NCT02754141|76246212|FG005|Overall Study|Completed treatment as per protocol|0|||
42376344|NCT02754141|76246213|FG006|Overall Study|Completed treatment as per protocol|0|||
42376345|NCT02754141|76246214|FG007|Overall Study|Completed treatment as per protocol|0|||
42376346|NCT02754141|76246215|FG008|Overall Study|Completed treatment as per protocol|0|||
42376347|NCT02754141|76246216|FG009|Overall Study|Completed treatment as per protocol|0|||
42376348|NCT02754141|76246217|FG010|Overall Study|Completed treatment as per protocol|0|||
42376349|NCT02754141|76246218|FG011|Overall Study|Completed treatment as per protocol|0|||
42376350|NCT02754141|76246219|FG012|Overall Study|Completed treatment as per protocol|1|||
42376351|NCT02754141|76246220|FG013|Overall Study|Completed treatment as per protocol|0|||
42376352|NCT02754141|76246221|FG014|Overall Study|Completed treatment as per protocol|0|||
42376353|NCT02754141|76246222|FG015|Overall Study|Completed treatment as per protocol|0|||
42376354|NCT02754141|76246223|FG016|Overall Study|Completed treatment as per protocol|0|||
42376355|NCT02754141|76246224|FG017|Overall Study|Completed treatment as per protocol|0|||
42376356|NCT02754141|76246207|FG000|Overall Study|Not completing monotherapy|0|||
42376357|NCT02754141|76246208|FG001|Overall Study|Not completing monotherapy|0|||
42376358|NCT02754141|76246209|FG002|Overall Study|Not completing monotherapy|0|||
42376359|NCT02754141|76246210|FG003|Overall Study|Not completing monotherapy|0|||
42376360|NCT02754141|76246211|FG004|Overall Study|Not completing monotherapy|0|||
42376361|NCT02754141|76246212|FG005|Overall Study|Not completing monotherapy|0|||
42376362|NCT02754141|76246213|FG006|Overall Study|Not completing monotherapy|0|||
42376363|NCT02754141|76246214|FG007|Overall Study|Not completing monotherapy|0|||
42376364|NCT02754141|76246215|FG008|Overall Study|Not completing monotherapy|0|||
42376365|NCT02754141|76246216|FG009|Overall Study|Not completing monotherapy|0|||
42376366|NCT02754141|76246217|FG010|Overall Study|Not completing monotherapy|0|||
42376367|NCT02754141|76246218|FG011|Overall Study|Not completing monotherapy|0|||
42376368|NCT02754141|76246219|FG012|Overall Study|Not completing monotherapy|0|||
42376369|NCT02754141|76246220|FG013|Overall Study|Not completing monotherapy|1|||
42376370|NCT02754141|76246221|FG014|Overall Study|Not completing monotherapy|0|||
42376371|NCT02754141|76246222|FG015|Overall Study|Not completing monotherapy|0|||
42376372|NCT02754141|76246223|FG016|Overall Study|Not completing monotherapy|0|||
42376373|NCT02754141|76246224|FG017|Overall Study|Not completing monotherapy|0|||
42376374|NCT02659059|76246303|FG000|Overall Study|Other reasons|6|||
42376375|NCT02659059|76246304|FG001|Overall Study|Other reasons|1|||
42376376|NCT02659059|76246303|FG000|Overall Study|Disease Progression|143|||
42376377|NCT02659059|76246304|FG001|Overall Study|Disease Progression|16|||
42376378|NCT02659059|76246303|FG000|Overall Study|Study Drug toxicity|56|||
42376379|NCT02659059|76246304|FG001|Overall Study|Study Drug toxicity|9|||
42376380|NCT02659059|76246303|FG000|Overall Study|Death|3|||
42376381|NCT02659059|76246304|FG001|Overall Study|Death|1|||
42376382|NCT02659059|76246303|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
42376383|NCT02659059|76246304|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
42376384|NCT02659059|76246303|FG000|Overall Study|Participant request to discontinue study treatment|5|||
42376385|NCT02659059|76246304|FG001|Overall Study|Participant request to discontinue study treatment|0|||
42376386|NCT02659059|76246303|FG000|Overall Study|Participant withdrew consent|6|||
42376387|NCT02659059|76246304|FG001|Overall Study|Participant withdrew consent|1|||
42376388|NCT01164891|76246319|FG000|Overall Study|Disease Progression|5|||
42376389|NCT01164891|76246319|FG000|Overall Study|Adverse Event|1|||
42376390|NCT01497899|76246328|FG000|Double-Blind Phase|Randomized but not Treated|1|||
42376391|NCT01497899|76246329|FG001|Double-Blind Phase|Randomized but not Treated|0|||
42376392|NCT01497899|76246330|FG002|Double-Blind Phase|Randomized but not Treated|0|||
42376393|NCT01497899|76246331|FG003|Double-Blind Phase|Randomized but not Treated|0|||
42376394|NCT01497899|76246328|FG000|Double-Blind Phase|Adverse Event|1|||
42376395|NCT01497899|76246329|FG001|Double-Blind Phase|Adverse Event|0|||
42376396|NCT01497899|76246330|FG002|Double-Blind Phase|Adverse Event|0|||
42376397|NCT01497899|76246331|FG003|Double-Blind Phase|Adverse Event|0|||
42376398|NCT01497899|76246328|FG000|Double-Blind Phase|Lack of Efficacy|0|||
42376399|NCT01497899|76246329|FG001|Double-Blind Phase|Lack of Efficacy|1|||
42376400|NCT01497899|76246330|FG002|Double-Blind Phase|Lack of Efficacy|0|||
42376401|NCT01497899|76246331|FG003|Double-Blind Phase|Lack of Efficacy|0|||
42376402|NCT01497899|76246328|FG000|Double-Blind Phase|Investigator's Discretion|1|||
42376403|NCT01497899|76246329|FG001|Double-Blind Phase|Investigator's Discretion|0|||
42376404|NCT01497899|76246330|FG002|Double-Blind Phase|Investigator's Discretion|0|||
42376405|NCT01497899|76246331|FG003|Double-Blind Phase|Investigator's Discretion|0|||
42376406|NCT01497899|76246328|FG000|Double-Blind Phase|Withdrew Consent|0|||
42376407|NCT01497899|76246329|FG001|Double-Blind Phase|Withdrew Consent|1|||
42376408|NCT01497899|76246330|FG002|Double-Blind Phase|Withdrew Consent|0|||
42376409|NCT01497899|76246331|FG003|Double-Blind Phase|Withdrew Consent|0|||
42376410|NCT01497899|76246328|FG000|Double-Blind Phase|Lost to Follow-up|3|||
42376411|NCT01497899|76246329|FG001|Double-Blind Phase|Lost to Follow-up|2|||
42376412|NCT01497899|76246330|FG002|Double-Blind Phase|Lost to Follow-up|0|||
42376413|NCT01497899|76246331|FG003|Double-Blind Phase|Lost to Follow-up|0|||
42376414|NCT01497899|76246328|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
42376415|NCT01497899|76246329|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
42376416|NCT01497899|76246330|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
42376417|NCT01497899|76246331|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
42376418|NCT01497899|76246328|FG000|Open-Label Extension Phase|Adverse Event|1|||
42376419|NCT01497899|76246329|FG001|Open-Label Extension Phase|Adverse Event|0|||
42376420|NCT01497899|76246330|FG002|Open-Label Extension Phase|Adverse Event|0|||
42376421|NCT01497899|76246331|FG003|Open-Label Extension Phase|Adverse Event|0|||
42376422|NCT01497899|76246328|FG000|Open-Label Extension Phase|Death|1|||
42376423|NCT01497899|76246329|FG001|Open-Label Extension Phase|Death|0|||
42376424|NCT01497899|76246330|FG002|Open-Label Extension Phase|Death|0|||
42376425|NCT01497899|76246331|FG003|Open-Label Extension Phase|Death|0|||
42376426|NCT01497899|76246328|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
42376427|NCT01497899|76246329|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
42376428|NCT01497899|76246330|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
42376429|NCT01497899|76246331|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
42376430|NCT01497899|76246328|FG000|Open-Label Extension Phase|Pregnancy|0|||
42376431|NCT01497899|76246329|FG001|Open-Label Extension Phase|Pregnancy|1|||
42376432|NCT01497899|76246330|FG002|Open-Label Extension Phase|Pregnancy|1|||
42376433|NCT01497899|76246331|FG003|Open-Label Extension Phase|Pregnancy|0|||
42376434|NCT01497899|76246328|FG000|Open-Label Extension Phase|Protocol Violation|0|||
42376435|NCT01497899|76246329|FG001|Open-Label Extension Phase|Protocol Violation|0|||
42376436|NCT01497899|76246330|FG002|Open-Label Extension Phase|Protocol Violation|1|||
42376437|NCT01497899|76246331|FG003|Open-Label Extension Phase|Protocol Violation|0|||
42376438|NCT01497899|76246328|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
42376439|NCT01497899|76246329|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
42376440|NCT01497899|76246330|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
42376441|NCT01497899|76246331|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
42376442|NCT01497275|76246338|FG000|Overall Study|Death|1|||
42376443|NCT01497275|76246338|FG000|Overall Study|Adverse Event|1|||
42376444|NCT01557517|76246344|FG000|Overall Study|Death|1|||
42376445|NCT01557517|76246345|FG001|Overall Study|Death|0|||
42376446|NCT01557517|76246344|FG000|Overall Study|Refused further treatment|0|||
42376447|NCT01557517|76246345|FG001|Overall Study|Refused further treatment|2|||
42376448|NCT01557517|76246344|FG000|Overall Study|Adverse Event|0|||
42376449|NCT01557517|76246345|FG001|Overall Study|Adverse Event|2|||
42376450|NCT01557517|76246344|FG000|Overall Study|Pt declined before treatment started|1|||
42376451|NCT01557517|76246345|FG001|Overall Study|Pt declined before treatment started|0|||
42376452|NCT01497197|76246360|FG000|Overall Study|Lost to Follow-up|1|||
42376453|NCT01497197|76246361|FG001|Overall Study|Lost to Follow-up|0|||
42376454|NCT01497197|76246360|FG000|Overall Study|Protocol Violation|0|||
42376455|NCT01497197|76246361|FG001|Overall Study|Protocol Violation|2|||
42200807|NCT01750281|76012728|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
42200808|NCT01750281|76012729|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
42376456|NCT01497197|76246360|FG000|Overall Study|Withdrawal by Subject|2|||
42376457|NCT01497197|76246361|FG001|Overall Study|Withdrawal by Subject|1|||
42376458|NCT01497197|76246360|FG000|Overall Study|Excessive/lack of response to treatment|1|||
42376459|NCT01497197|76246361|FG001|Overall Study|Excessive/lack of response to treatment|0|||
42376460|NCT01497197|76246360|FG000|Overall Study|Risk of OHSS|1|||
42376461|NCT01497197|76246361|FG001|Overall Study|Risk of OHSS|0|||
42376462|NCT01497197|76246360|FG000|Overall Study|No oocytes retrieved|3|||
42376463|NCT01497197|76246361|FG001|Overall Study|No oocytes retrieved|2|||
42376464|NCT01497197|76246360|FG000|Overall Study|No fertilisation|6|||
42376465|NCT01497197|76246361|FG001|Overall Study|No fertilisation|5|||
42376466|NCT01497197|76246360|FG000|Overall Study|Intention to freeze all embryos|0|||
42376467|NCT01497197|76246361|FG001|Overall Study|Intention to freeze all embryos|1|||
42376468|NCT01497197|76246360|FG000|Overall Study|All embryos discarded|0|||
42376469|NCT01497197|76246361|FG001|Overall Study|All embryos discarded|3|||
42376470|NCT01497197|76246360|FG000|Overall Study|Other|3|||
42376471|NCT01497197|76246361|FG001|Overall Study|Other|1|||
42376472|NCT01496885|76246367|FG000|Overall Study|Lost to Follow-up|13|||
42376473|NCT01496885|76246367|FG000|Overall Study|Withdrawal by Subject|7|||
42376474|NCT01496885|76246367|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
42376475|NCT01496885|76246367|FG000|Overall Study|Death|1|||
42376476|NCT01557283|76246371|FG000|Overall Study|Lost to Follow-up|7|||
42376477|NCT01557283|76246371|FG000|Overall Study|Non-responder|19|||
42376478|NCT01557283|76246371|FG000|Overall Study|Adverse Event|7|||
42376479|NCT01557283|76246371|FG000|Overall Study|Lack of Efficacy|1|||
42376480|NCT01557283|76246371|FG000|Overall Study|Non-compliance|1|||
42376481|NCT01557283|76246371|FG000|Overall Study|Withdrawal by Subject|1|||
42376482|NCT01557283|76246371|FG000|Overall Study|Participant's weight too high for dose|1|||
42376483|NCT01557283|76246371|FG000|Overall Study|Worsening of psoriasis|1|||
42376484|NCT01557283|76246371|FG000|Overall Study|Other|6|||
42376485|NCT01523743|76246388|FG000|Period 1|Adverse Event|1|||
42376486|NCT01523743|76246389|FG001|Period 1|Adverse Event|0|||
42376487|NCT01523743|76246388|FG000|Period 1|Withdrawal by Subject|6|||
42376488|NCT01523743|76246389|FG001|Period 1|Withdrawal by Subject|2|||
42376489|NCT01523743|76246388|FG000|Period 1|Lost to Follow-up|1|||
42376490|NCT01523743|76246389|FG001|Period 1|Lost to Follow-up|0|||
42376491|NCT01523743|76246388|FG000|Period 1|Lack of Efficacy|1|||
42376492|NCT01523743|76246389|FG001|Period 1|Lack of Efficacy|0|||
42376493|NCT01523743|76246388|FG000|Period 1|Felt unable to empty bladder|1|||
42376494|NCT01523743|76246389|FG001|Period 1|Felt unable to empty bladder|0|||
42376495|NCT01523743|76246388|FG000|Period 2|Withdrawal by Subject|0|||
42376496|NCT01523743|76246389|FG001|Period 2|Withdrawal by Subject|2|||
42376497|NCT01523743|76246388|FG000|Period 2|Adverse Event|1|||
42376498|NCT01523743|76246389|FG001|Period 2|Adverse Event|0|||
42376499|NCT01496807|76246404|FG000|Overall Study|Progressive Disease|21|||
42376500|NCT01496807|76246404|FG000|Overall Study|Participant preference/toxicity|8|||
42376501|NCT01496807|76246404|FG000|Overall Study|Change in diagnosis|1|||
42376502|NCT01496183|76246410|FG000|Overall Study|Physician Decision|3|||
42376503|NCT01496183|76246411|FG001|Overall Study|Physician Decision|1|||
42376504|NCT01496183|76246410|FG000|Overall Study|Withdrawal by Subject|0|||
42376505|NCT01496183|76246411|FG001|Overall Study|Withdrawal by Subject|1|||
42376506|NCT01495793|76246418|FG000|Overall Study|Lost to Follow-up|1|||
42376507|NCT01495793|76246418|FG000|Overall Study|Violation of inclusion criteria|1|||
42376508|NCT01494467|76246424|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
42376509|NCT01494467|76246425|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
42376510|NCT01494467|76246424|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
42376511|NCT01494467|76246425|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
42376512|NCT01494467|76246424|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
42376513|NCT01494467|76246425|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
42376514|NCT01494467|76246424|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
42376515|NCT01494467|76246425|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
42376516|NCT01494467|76246424|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
42376517|NCT01494467|76246425|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
42376518|NCT01494467|76246424|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
42376519|NCT01494467|76246425|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
42376520|NCT01494467|76246424|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
42376521|NCT01494467|76246425|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
42376522|NCT01494467|76246424|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
42103572|NCT00657618|75914493|FG000|Overall Study|Adverse Event|32|||
42103573|NCT00657618|75914493|FG000|Overall Study|Withdrawal by Subject|8|||
42376523|NCT01494467|76246425|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
42376524|NCT01494467|76246424|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
42376525|NCT01494467|76246425|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
42376526|NCT01494467|76246424|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
42376527|NCT01494467|76246425|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
42376528|NCT01494467|76246424|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
42376529|NCT01494467|76246425|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
42376530|NCT01494467|76246424|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
42376531|NCT01494467|76246425|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
42376532|NCT01494467|76246424|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
42376533|NCT01494467|76246425|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
42376534|NCT01494467|76246424|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
42376535|NCT01494467|76246425|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
42376536|NCT01493687|76246439|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
42376537|NCT01493687|76246440|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
42376538|NCT01493687|76246439|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
42376539|NCT01493687|76246440|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
42376540|NCT01493687|76246439|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
42376541|NCT01493687|76246440|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
42376542|NCT01493687|76246439|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
42376543|NCT01493687|76246440|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
42376544|NCT01493687|76246439|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
42376545|NCT01493687|76246440|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
42376546|NCT01493687|76246439|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
42376547|NCT01493687|76246440|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
42376548|NCT01493687|76246439|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
42376549|NCT01493687|76246440|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
42376550|NCT01493687|76246439|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
42376551|NCT01493687|76246440|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
42376552|NCT01493687|76246439|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
42376553|NCT01493687|76246440|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
42376554|NCT01493687|76246439|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
42376555|NCT01493687|76246440|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
42376556|NCT01493687|76246439|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
42376557|NCT01493687|76246440|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
42376558|NCT01493687|76246439|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
42376559|NCT01493687|76246440|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
42376560|NCT01493687|76246439|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
42376561|NCT01493687|76246440|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
42376562|NCT01493687|76246439|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
42376563|NCT01493687|76246440|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
42376564|NCT01493687|76246439|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
42376565|NCT01493687|76246440|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
42376566|NCT01523587|76246472|FG000|Overall Study|Other than listed|5|||
42376567|NCT01523587|76246473|FG001|Overall Study|Other than listed|5|||
42376568|NCT01523587|76246472|FG000|Overall Study|Worsening of underlying cancer disease|19|||
42376569|NCT01523587|76246473|FG001|Overall Study|Worsening of underlying cancer disease|34|||
42376570|NCT01523587|76246472|FG000|Overall Study|Adverse Event|68|||
42376571|NCT01523587|76246473|FG001|Overall Study|Adverse Event|52|||
42376572|NCT01523587|76246472|FG000|Overall Study|Protocol Violation|5|||
42376573|NCT01523587|76246473|FG001|Overall Study|Protocol Violation|3|||
42376574|NCT01523587|76246472|FG000|Overall Study|Lost to Follow-up|2|||
42376575|NCT01523587|76246473|FG001|Overall Study|Lost to Follow-up|2|||
42376576|NCT01523587|76246472|FG000|Overall Study|Withdrawal by Subject|28|||
42376577|NCT01523587|76246473|FG001|Overall Study|Withdrawal by Subject|20|||
42376578|NCT01523587|76246472|FG000|Overall Study|Withdrew due to Progressive disease|265|||
42376579|NCT01523587|76246473|FG001|Overall Study|Withdrew due to Progressive disease|279|||
42376580|NCT01523587|76246472|FG000|Overall Study|Randomised but bot treated|6|||
42376581|NCT01523587|76246473|FG001|Overall Study|Randomised but bot treated|2|||
42376582|NCT01493531|76246502|FG000|Overall Study|Adverse Event|4|||
42376583|NCT01493531|76246503|FG001|Overall Study|Adverse Event|12|||
42376584|NCT01493531|76246504|FG002|Overall Study|Adverse Event|9|||
42376585|NCT01493531|76246502|FG000|Overall Study|Gout flare|3|||
42376586|NCT01493531|76246503|FG001|Overall Study|Gout flare|0|||
42376587|NCT01493531|76246504|FG002|Overall Study|Gout flare|2|||
42376588|NCT01493531|76246502|FG000|Overall Study|Protocol Violation|8|||
42376589|NCT01493531|76246503|FG001|Overall Study|Protocol Violation|15|||
42376590|NCT01493531|76246504|FG002|Overall Study|Protocol Violation|12|||
42376591|NCT01493531|76246502|FG000|Overall Study|Sponsor terminated study|5|||
42376592|NCT01493531|76246503|FG001|Overall Study|Sponsor terminated study|2|||
42376593|NCT01493531|76246504|FG002|Overall Study|Sponsor terminated study|3|||
42376594|NCT01493531|76246502|FG000|Overall Study|Lost to Follow-up|5|||
42376595|NCT01493531|76246503|FG001|Overall Study|Lost to Follow-up|7|||
42376596|NCT01493531|76246504|FG002|Overall Study|Lost to Follow-up|11|||
42376597|NCT01493531|76246502|FG000|Overall Study|Withdrawal by Subject|16|||
42376598|NCT01493531|76246503|FG001|Overall Study|Withdrawal by Subject|13|||
42376599|NCT01493531|76246504|FG002|Overall Study|Withdrawal by Subject|11|||
42376600|NCT01493531|76246502|FG000|Overall Study|Death|0|||
42376601|NCT01493531|76246503|FG001|Overall Study|Death|1|||
42376602|NCT01493531|76246504|FG002|Overall Study|Death|0|||
42376603|NCT01523275|76246528|FG000|Overall Study|Lost to Follow-up|1|||
42376604|NCT01523275|76246529|FG001|Overall Study|Lost to Follow-up|2|||
42376605|NCT01523275|76246528|FG000|Overall Study|Withdrawal by Subject|1|||
42376606|NCT01523275|76246529|FG001|Overall Study|Withdrawal by Subject|0|||
42376607|NCT01492439|76246546|FG000|Overall Study|Withdrew from RTE|4|||
42376608|NCT01492439|76246547|FG001|Overall Study|Withdrew from RTE|9|||
42376609|NCT01572727|76246582|FG000|Overall Study|Adverse Event|43|||
42376610|NCT01572727|76246583|FG001|Overall Study|Adverse Event|15|||
42376611|NCT01572727|76246582|FG000|Overall Study|Lost to Follow-up|1|||
42376612|NCT01572727|76246583|FG001|Overall Study|Lost to Follow-up|1|||
42376613|NCT01572727|76246582|FG000|Overall Study|Physician Decision|23|||
42376614|NCT01572727|76246583|FG001|Overall Study|Physician Decision|9|||
42376615|NCT01572727|76246582|FG000|Overall Study|Progressive disease|59|||
42376616|NCT01572727|76246583|FG001|Overall Study|Progressive disease|82|||
42376617|NCT01572727|76246582|FG000|Overall Study|Protocol Violation|0|||
42376618|NCT01572727|76246583|FG001|Overall Study|Protocol Violation|1|||
42376619|NCT01572727|76246582|FG000|Overall Study|Study terminated by sponsor|61|||
42376620|NCT01572727|76246583|FG001|Overall Study|Study terminated by sponsor|83|||
42376621|NCT01572727|76246582|FG000|Overall Study|Parent/guardian decision|14|||
42376622|NCT01572727|76246583|FG001|Overall Study|Parent/guardian decision|9|||
42376623|NCT01572727|76246582|FG000|Overall Study|Death|2|||
42376624|NCT01572727|76246583|FG001|Overall Study|Death|2|||
42376625|NCT01572727|76246582|FG000|Overall Study|Untreated|4|||
42376626|NCT01572727|76246583|FG001|Overall Study|Untreated|7|||
42376627|NCT01522651|76246630|FG000|Overall Study|Adverse Event|3|||
42376628|NCT01522651|76246631|FG001|Overall Study|Adverse Event|4|||
42376629|NCT01522651|76246632|FG002|Overall Study|Adverse Event|4|||
42376630|NCT01522651|76246633|FG003|Overall Study|Adverse Event|5|||
42376631|NCT01522651|76246634|FG004|Overall Study|Adverse Event|4|||
42376632|NCT01522651|76246630|FG000|Overall Study|Cardioversion|1|||
42376633|NCT01522651|76246631|FG001|Overall Study|Cardioversion|0|||
42376634|NCT01522651|76246632|FG002|Overall Study|Cardioversion|0|||
42376635|NCT01522651|76246633|FG003|Overall Study|Cardioversion|0|||
42376636|NCT01522651|76246634|FG004|Overall Study|Cardioversion|0|||
42376637|NCT01522651|76246630|FG000|Overall Study|Device Malfunction|0|||
42376638|NCT01522651|76246631|FG001|Overall Study|Device Malfunction|1|||
42376639|NCT01522651|76246632|FG002|Overall Study|Device Malfunction|0|||
42376640|NCT01522651|76246633|FG003|Overall Study|Device Malfunction|0|||
42376641|NCT01522651|76246634|FG004|Overall Study|Device Malfunction|0|||
42376642|NCT01522651|76246630|FG000|Overall Study|Investigator's Discretion|0|||
42376643|NCT01522651|76246631|FG001|Overall Study|Investigator's Discretion|1|||
42376644|NCT01522651|76246632|FG002|Overall Study|Investigator's Discretion|0|||
42376645|NCT01522651|76246633|FG003|Overall Study|Investigator's Discretion|0|||
42376646|NCT01522651|76246634|FG004|Overall Study|Investigator's Discretion|0|||
42376647|NCT01522651|76246630|FG000|Overall Study|Protocol Violation|3|||
42376648|NCT01522651|76246631|FG001|Overall Study|Protocol Violation|0|||
42376649|NCT01522651|76246632|FG002|Overall Study|Protocol Violation|0|||
42376650|NCT01522651|76246633|FG003|Overall Study|Protocol Violation|0|||
42376651|NCT01522651|76246634|FG004|Overall Study|Protocol Violation|0|||
42376652|NCT01522651|76246630|FG000|Overall Study|Reason Not Specified|0|||
42376653|NCT01522651|76246631|FG001|Overall Study|Reason Not Specified|0|||
42376654|NCT01522651|76246632|FG002|Overall Study|Reason Not Specified|0|||
42376655|NCT01522651|76246633|FG003|Overall Study|Reason Not Specified|1|||
42376656|NCT01522651|76246634|FG004|Overall Study|Reason Not Specified|0|||
42376657|NCT01522651|76246630|FG000|Overall Study|Participant Non-Compliance|1|||
42376658|NCT01522651|76246631|FG001|Overall Study|Participant Non-Compliance|0|||
42376659|NCT01522651|76246632|FG002|Overall Study|Participant Non-Compliance|0|||
42376660|NCT01522651|76246633|FG003|Overall Study|Participant Non-Compliance|0|||
42376661|NCT01522651|76246634|FG004|Overall Study|Participant Non-Compliance|0|||
42376662|NCT01522651|76246630|FG000|Overall Study|Withdrew Consent|1|||
42376663|NCT01522651|76246631|FG001|Overall Study|Withdrew Consent|1|||
42376664|NCT01522651|76246632|FG002|Overall Study|Withdrew Consent|0|||
42376665|NCT01522651|76246633|FG003|Overall Study|Withdrew Consent|1|||
42376666|NCT01522651|76246634|FG004|Overall Study|Withdrew Consent|1|||
42376667|NCT01522651|76246630|FG000|Overall Study|Randomized but Never Treated|0|||
42376668|NCT01522651|76246631|FG001|Overall Study|Randomized but Never Treated|1|||
42376669|NCT01522651|76246632|FG002|Overall Study|Randomized but Never Treated|0|||
42376670|NCT01522651|76246633|FG003|Overall Study|Randomized but Never Treated|1|||
42376671|NCT01522651|76246634|FG004|Overall Study|Randomized but Never Treated|1|||
42376672|NCT01554241|76246661|FG000|Overall Study|Death|3|||
42376673|NCT01554241|76246662|FG001|Overall Study|Death|1|||
42376674|NCT01554241|76246663|FG002|Overall Study|Death|1|||
42376675|NCT01554241|76246664|FG003|Overall Study|Death|0|||
42376676|NCT01554241|76246661|FG000|Overall Study|protocol specified renal stone|0|||
42376677|NCT01554241|76246662|FG001|Overall Study|protocol specified renal stone|0|||
42376678|NCT01554241|76246663|FG002|Overall Study|protocol specified renal stone|0|||
42376679|NCT01554241|76246664|FG003|Overall Study|protocol specified renal stone|1|||
42376680|NCT01554241|76246661|FG000|Overall Study|protocol specified change in eGFR|0|||
42376681|NCT01554241|76246662|FG001|Overall Study|protocol specified change in eGFR|0|||
42376682|NCT01554241|76246663|FG002|Overall Study|protocol specified change in eGFR|1|||
42376683|NCT01554241|76246664|FG003|Overall Study|protocol specified change in eGFR|0|||
42376684|NCT01554241|76246661|FG000|Overall Study|Withdrawal by Subject|0|||
42376685|NCT01554241|76246662|FG001|Overall Study|Withdrawal by Subject|0|||
42376686|NCT01554241|76246663|FG002|Overall Study|Withdrawal by Subject|2|||
42376687|NCT01554241|76246664|FG003|Overall Study|Withdrawal by Subject|0|||
42376688|NCT01521559|76246676|FG000|Overall Study|Adverse Event|0|||
42376689|NCT01521559|76246677|FG001|Overall Study|Adverse Event|4|||
42376690|NCT01521559|76246676|FG000|Overall Study|Death|1|||
42376691|NCT01521559|76246677|FG001|Overall Study|Death|0|||
42376692|NCT01521559|76246676|FG000|Overall Study|Withdrawal by Subject|9|||
42376693|NCT01521559|76246677|FG001|Overall Study|Withdrawal by Subject|11|||
42376694|NCT01521559|76246676|FG000|Overall Study|Lost to Follow-up|3|||
42376695|NCT01521559|76246677|FG001|Overall Study|Lost to Follow-up|1|||
42376696|NCT01521559|76246676|FG000|Overall Study|Protocol Violation|1|||
42376697|NCT01521559|76246677|FG001|Overall Study|Protocol Violation|0|||
42376698|NCT01521559|76246676|FG000|Overall Study|Other|1|||
42376699|NCT01521559|76246677|FG001|Overall Study|Other|2|||
42376700|NCT01554163|76246686|FG000|Overall Study|Adverse Event|3|||
42376701|NCT01554163|76246687|FG001|Overall Study|Adverse Event|0|||
42376702|NCT01554163|76246686|FG000|Overall Study|Lack of Efficacy|1|||
42376703|NCT01554163|76246687|FG001|Overall Study|Lack of Efficacy|0|||
42376704|NCT01554163|76246686|FG000|Overall Study|Lost to Follow-up|1|||
42376705|NCT01554163|76246687|FG001|Overall Study|Lost to Follow-up|0|||
42376706|NCT01554163|76246686|FG000|Overall Study|Non-Compliance With Study Drug|1|||
42376707|NCT01554163|76246687|FG001|Overall Study|Non-Compliance With Study Drug|1|||
42376708|NCT01554163|76246686|FG000|Overall Study|Protocol Violation|0|||
42376709|NCT01554163|76246687|FG001|Overall Study|Protocol Violation|4|||
42376710|NCT01554163|76246686|FG000|Overall Study|Withdrawal by Subject|1|||
42376711|NCT01554163|76246687|FG001|Overall Study|Withdrawal by Subject|5|||
42376712|NCT01554163|76246686|FG000|Overall Study|Not Treated|1|||
42376713|NCT01554163|76246687|FG001|Overall Study|Not Treated|0|||
42376714|NCT01553851|76246693|FG000|Overall Study|Adverse Event|2|||
42376715|NCT01553851|76246693|FG000|Overall Study|constipation|1|||
42376716|NCT01552915|76246713|FG000|Overall Study|Adverse Event|3|||
42376717|NCT01552915|76246714|FG001|Overall Study|Adverse Event|14|||
42376718|NCT01552915|76246715|FG002|Overall Study|Adverse Event|3|||
42376719|NCT01552915|76246713|FG000|Overall Study|Lost to Follow-up|4|||
42376720|NCT01552915|76246714|FG001|Overall Study|Lost to Follow-up|6|||
42376721|NCT01552915|76246715|FG002|Overall Study|Lost to Follow-up|5|||
42376722|NCT01552915|76246713|FG000|Overall Study|Withdrawal by Subject|6|||
42376723|NCT01552915|76246714|FG001|Overall Study|Withdrawal by Subject|4|||
42376724|NCT01552915|76246715|FG002|Overall Study|Withdrawal by Subject|5|||
42376725|NCT01552915|76246713|FG000|Overall Study|Protocol Violation|0|||
42376726|NCT01552915|76246714|FG001|Overall Study|Protocol Violation|4|||
42376727|NCT01552915|76246715|FG002|Overall Study|Protocol Violation|4|||
42376728|NCT01552915|76246713|FG000|Overall Study|Lack of Efficacy|8|||
42376729|NCT01552915|76246714|FG001|Overall Study|Lack of Efficacy|1|||
42376730|NCT01552915|76246715|FG002|Overall Study|Lack of Efficacy|4|||
42376731|NCT01552915|76246713|FG000|Overall Study|Other|2|||
42376732|NCT01552915|76246714|FG001|Overall Study|Other|0|||
42376733|NCT01552915|76246715|FG002|Overall Study|Other|6|||
42376734|NCT01552681|76246744|FG000|Overall Study|Withdrawal by Subject|4|||
42376735|NCT01552681|76246745|FG001|Overall Study|Withdrawal by Subject|0|||
42103574|NCT00657618|75914493|FG000|Overall Study|negative for leishmaniasis|2|||
42376736|NCT01552681|76246744|FG000|Overall Study|Physician Decision|1|||
42376737|NCT01552681|76246745|FG001|Overall Study|Physician Decision|0|||
42376738|NCT01552681|76246744|FG000|Overall Study|Subject moved away|0|||
42376739|NCT01552681|76246745|FG001|Overall Study|Subject moved away|1|||
42376740|NCT01570387|76246777|FG000|Overall Study|Adverse Event|1|||
42376741|NCT01570387|76246778|FG001|Overall Study|Adverse Event|0|||
42376742|NCT01570387|76246779|FG002|Overall Study|Adverse Event|0|||
42376743|NCT01570387|76246780|FG003|Overall Study|Adverse Event|0|||
42376744|NCT01570387|76246777|FG000|Overall Study|Death|0|||
42376745|NCT01570387|76246778|FG001|Overall Study|Death|0|||
42376746|NCT01570387|76246779|FG002|Overall Study|Death|0|||
42376747|NCT01570387|76246780|FG003|Overall Study|Death|1|||
42376748|NCT01570387|76246777|FG000|Overall Study|Withdrawal by Subject|0|||
42376749|NCT01570387|76246778|FG001|Overall Study|Withdrawal by Subject|0|||
42376750|NCT01570387|76246779|FG002|Overall Study|Withdrawal by Subject|0|||
42376751|NCT01570387|76246780|FG003|Overall Study|Withdrawal by Subject|1|||
42376752|NCT01570309|76246789|FG000|Overall Study|Withdrawal by Subject|3|||
42376753|NCT01570309|76246790|FG001|Overall Study|Withdrawal by Subject|3|||
42376754|NCT01519921|76246802|FG000|Overall Study|Adverse Event|10|||
42376755|NCT01519921|76246803|FG001|Overall Study|Adverse Event|9|||
42376756|NCT01519921|76246802|FG000|Overall Study|Lack of Efficacy|4|||
42376757|NCT01519921|76246803|FG001|Overall Study|Lack of Efficacy|3|||
42376758|NCT01519921|76246802|FG000|Overall Study|Withdrawal by Subject|3|||
42376759|NCT01519921|76246803|FG001|Overall Study|Withdrawal by Subject|0|||
42376760|NCT01519921|76246802|FG000|Overall Study|Lost to Follow-up|2|||
42376761|NCT01519921|76246803|FG001|Overall Study|Lost to Follow-up|1|||
42376762|NCT01519921|76246802|FG000|Overall Study|Treatment refusal|2|||
42376763|NCT01519921|76246803|FG001|Overall Study|Treatment refusal|1|||
42376764|NCT01519921|76246802|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
42376765|NCT01519921|76246803|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
42376766|NCT01519765|76246811|FG000|Overall Study|Adverse Event|0|||
42376767|NCT01519765|76246812|FG001|Overall Study|Adverse Event|1|||
42376768|NCT01519765|76246811|FG000|Overall Study|Lack of Efficacy|2|||
42376769|NCT01519765|76246812|FG001|Overall Study|Lack of Efficacy|0|||
42376770|NCT01519765|76246811|FG000|Overall Study|Protocol Violation|1|||
42376771|NCT01519765|76246812|FG001|Overall Study|Protocol Violation|0|||
42376772|NCT01519765|76246811|FG000|Overall Study|Withdrawal by Subject|0|||
42376773|NCT01519765|76246812|FG001|Overall Study|Withdrawal by Subject|1|||
42376774|NCT01552603|76246819|FG000|Overall Study|Physician Decision|1|||
42376775|NCT01552369|76246825|FG000|Overall Study|Did not consent to extended follow up|8|||
42376776|NCT01552369|76246826|FG001|Overall Study|Did not consent to extended follow up|9|||
42376777|NCT01552057|76246836|FG000|Overall Study|Adverse Event|14|||
42376778|NCT01552057|76246837|FG001|Overall Study|Adverse Event|15|||
42376779|NCT01552057|76246836|FG000|Overall Study|Lack of Efficacy|8|||
42376780|NCT01552057|76246837|FG001|Overall Study|Lack of Efficacy|23|||
42376781|NCT01552057|76246836|FG000|Overall Study|Withdrawal by Subject|5|||
42103575|NCT00657618|75914493|FG000|Overall Study|didn't start due to schedule conflicts|1|||
42103576|NCT00657540|75914499|FG000|Overall Study|Lost to Follow-up|1|||
42103577|NCT00657540|75914500|FG001|Overall Study|Lost to Follow-up|4|||
42103578|NCT00672620|75914510|FG000|Overall Study|Adverse Event|7|||
42103579|NCT00672620|75914511|FG001|Overall Study|Adverse Event|7|||
42103580|NCT00672620|75914512|FG002|Overall Study|Adverse Event|12|||
42103581|NCT00672620|75914513|FG003|Overall Study|Adverse Event|17|||
42103582|NCT00672620|75914510|FG000|Overall Study|Lack of Efficacy|1|||
42103583|NCT00672620|75914511|FG001|Overall Study|Lack of Efficacy|2|||
42103584|NCT00672620|75914512|FG002|Overall Study|Lack of Efficacy|2|||
42103585|NCT00672620|75914513|FG003|Overall Study|Lack of Efficacy|0|||
42103586|NCT00672620|75914510|FG000|Overall Study|Noncompliance with Study Drug|3|||
42103587|NCT00672620|75914511|FG001|Overall Study|Noncompliance with Study Drug|4|||
42103588|NCT00672620|75914512|FG002|Overall Study|Noncompliance with Study Drug|0|||
42103589|NCT00672620|75914513|FG003|Overall Study|Noncompliance with Study Drug|2|||
42376782|NCT01552057|76246837|FG001|Overall Study|Withdrawal by Subject|8|||
42376783|NCT01552057|76246836|FG000|Overall Study|Entry Criteria Not Met|2|||
42376784|NCT01552057|76246837|FG001|Overall Study|Entry Criteria Not Met|2|||
42376785|NCT01552057|76246836|FG000|Overall Study|Physician Decision|1|||
42376786|NCT01552057|76246837|FG001|Overall Study|Physician Decision|0|||
42376787|NCT01551745|76246843|FG000|Overall Study|Withdrawal by Subject|1|||
42376788|NCT01551745|76246843|FG000|Overall Study|Disease Progression|2|||
42376789|NCT01551355|76246853|FG000|Overall Study|Lost to Follow-up|51|||
42376790|NCT01551355|76246854|FG001|Overall Study|Lost to Follow-up|49|||
42376791|NCT01551355|76246855|FG002|Overall Study|Lost to Follow-up|34|||
42376792|NCT01551355|76246856|FG003|Overall Study|Lost to Follow-up|24|||
42376793|NCT01551355|76246857|FG004|Overall Study|Lost to Follow-up|9|||
42376794|NCT01551355|76246858|FG005|Overall Study|Lost to Follow-up|6|||
42376795|NCT01569841|76246866|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
42376796|NCT01569841|76246867|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
42376797|NCT01569763|76246877|FG000|Overall Study|Lack of Efficacy|2|||
42376798|NCT01569763|76246878|FG001|Overall Study|Lack of Efficacy|7|||
42103590|NCT00672620|75914510|FG000|Overall Study|Protocol Deviations|5|||
42103591|NCT00672620|75914511|FG001|Overall Study|Protocol Deviations|7|||
42376799|NCT01569763|76246877|FG000|Overall Study|Adverse Event|1|||
42376800|NCT01569763|76246878|FG001|Overall Study|Adverse Event|0|||
42376801|NCT01550965|76246884|FG000|Overall Study|Adverse Event|26|||
42376802|NCT01550965|76246884|FG000|Overall Study|Withdrawal by Subject|10|||
42376803|NCT01550965|76246884|FG000|Overall Study|Lost to Follow-up|2|||
42376804|NCT01550965|76246884|FG000|Overall Study|Lack of Efficacy|59|||
42376805|NCT01550965|76246884|FG000|Overall Study|Other|13|||
42376806|NCT01569295|76247005|FG000|Overall Study|Progressive Disease|75|||
42376807|NCT01569295|76247006|FG001|Overall Study|Progressive Disease|139|||
42376808|NCT01569295|76247005|FG000|Overall Study|Adverse Event|39|||
42376809|NCT01569295|76247006|FG001|Overall Study|Adverse Event|14|||
42376810|NCT01569295|76247005|FG000|Overall Study|Withdrawal by Subject|25|||
42103592|NCT00672620|75914512|FG002|Overall Study|Protocol Deviations|2|||
42376811|NCT01569295|76247006|FG001|Overall Study|Withdrawal by Subject|12|||
42376812|NCT01569295|76247005|FG000|Overall Study|Death|19|||
42376813|NCT01569295|76247006|FG001|Overall Study|Death|15|||
42376814|NCT01569295|76247005|FG000|Overall Study|Physician Decision|13|||
42376815|NCT01569295|76247006|FG001|Overall Study|Physician Decision|18|||
42376816|NCT01569295|76247005|FG000|Overall Study|Study Terminated by Sponsor|24|||
42376817|NCT01569295|76247006|FG001|Overall Study|Study Terminated by Sponsor|2|||
42376818|NCT01569295|76247005|FG000|Overall Study|Other Reason not Specified|3|||
42376819|NCT01569295|76247006|FG001|Overall Study|Other Reason not Specified|5|||
42376820|NCT01569295|76247005|FG000|Overall Study|Non-Compliance with Study Drug|6|||
42376821|NCT01569295|76247006|FG001|Overall Study|Non-Compliance with Study Drug|1|||
42376822|NCT01569295|76247005|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
42376823|NCT01569295|76247006|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
42376824|NCT01569295|76247005|FG000|Overall Study|Lost to Follow-up|1|||
42376825|NCT01569295|76247006|FG001|Overall Study|Lost to Follow-up|1|||
42376826|NCT01549951|76247063|FG000|Overall Study|Adverse Event|15|||
42376827|NCT01549951|76247063|FG000|Overall Study|Withdrawal by Subject|2|||
42376828|NCT01549951|76247063|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
42376829|NCT01549951|76247063|FG000|Overall Study|Progressive disease|29|||
42376830|NCT01549951|76247063|FG000|Overall Study|Symptomatic deterioration|1|||
42376831|NCT01549951|76247063|FG000|Overall Study|Other|2|||
42376832|NCT01517893|76247069|FG000|Overall Study|Withdrawal by Subject|3|||
42376833|NCT01517893|76247070|FG001|Overall Study|Withdrawal by Subject|0|||
42376834|NCT01489891|76247078|FG000|Overall Study|Endoscopy failure|1|||
42376835|NCT01489891|76247079|FG001|Overall Study|Endoscopy failure|0|||
42376836|NCT04062240|76247161|FG000|Overall Study|equipment malfunction|1|||
42376837|NCT02790138|76247167|FG000|Overall Study|Adverse Event|5|||
42376838|NCT02790138|76247168|FG001|Overall Study|Adverse Event|2|||
42376839|NCT02790138|76247167|FG000|Overall Study|Significant Protocol Deviation|0|||
42376840|NCT02790138|76247168|FG001|Overall Study|Significant Protocol Deviation|1|||
42376841|NCT02790138|76247167|FG000|Overall Study|Lost to Follow-up|1|||
42376842|NCT02790138|76247168|FG001|Overall Study|Lost to Follow-up|0|||
42376843|NCT02790138|76247167|FG000|Overall Study|Voluntary Withdrawal|8|||
42376844|NCT02790138|76247168|FG001|Overall Study|Voluntary Withdrawal|9|||
42376845|NCT02790138|76247167|FG000|Overall Study|Lack of Efficacy|6|||
42376846|NCT02790138|76247168|FG001|Overall Study|Lack of Efficacy|7|||
42376847|NCT02790138|76247167|FG000|Overall Study|Reason not Specified|1|||
42376848|NCT02790138|76247168|FG001|Overall Study|Reason not Specified|0|||
42376849|NCT05385224|76247321|FG000|Overall Study|Unable to swallow capsule|2|||
42376850|NCT05385224|76247321|FG000|Overall Study|Withdrawal by Subject|2|||
42376851|NCT05385224|76247321|FG000|Overall Study|Did not meet study criteria|1|||
42376852|NCT04710979|76247327|FG000|Overall Study|Lost to Follow-up|2|||
42376853|NCT04710979|76247328|FG001|Overall Study|Lost to Follow-up|4|||
42376854|NCT04710979|76247327|FG000|Overall Study|Withdrawal by Subject|1|||
42376855|NCT04710979|76247328|FG001|Overall Study|Withdrawal by Subject|0|||
42376856|NCT04682639|76247338|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
42376857|NCT04682639|76247339|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
42376858|NCT04682639|76247340|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
42376859|NCT04682639|76247341|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
42376860|NCT04682639|76247342|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
42376861|NCT04682639|76247338|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
42376862|NCT04682639|76247339|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
42376863|NCT04682639|76247340|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
42376864|NCT04682639|76247341|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
42376865|NCT04682639|76247342|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
42376866|NCT04682639|76247338|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
42376867|NCT04682639|76247339|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
42376868|NCT04682639|76247340|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42376869|NCT04682639|76247341|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42376870|NCT04682639|76247342|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
42376871|NCT04682639|76247338|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
42376872|NCT04682639|76247339|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
42376873|NCT04682639|76247340|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
42376874|NCT04682639|76247341|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
42376875|NCT04682639|76247342|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
42376876|NCT04682639|76247338|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
42376877|NCT04682639|76247339|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
42376878|NCT04682639|76247340|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
42376879|NCT04682639|76247341|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
42376880|NCT04682639|76247342|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
42103593|NCT00672620|75914513|FG003|Overall Study|Protocol Deviations|5|||
42376881|NCT04682639|76247338|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
42376882|NCT04682639|76247339|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
42376883|NCT04682639|76247340|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
42376884|NCT04682639|76247341|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
42376885|NCT04682639|76247342|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
42376886|NCT04682639|76247338|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
42376887|NCT04682639|76247339|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
42376888|NCT04682639|76247340|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
42376889|NCT04682639|76247341|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
42376890|NCT04682639|76247342|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
42376891|NCT04682639|76247338|FG000|OLE Period (28 Weeks)|Other|1|||
42376892|NCT04682639|76247339|FG001|OLE Period (28 Weeks)|Other|2|||
42376893|NCT04682639|76247340|FG002|OLE Period (28 Weeks)|Other|0|||
42376894|NCT04682639|76247341|FG003|OLE Period (28 Weeks)|Other|0|||
42376895|NCT04682639|76247342|FG004|OLE Period (28 Weeks)|Other|1|||
42376896|NCT04682639|76247338|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
42376897|NCT04682639|76247339|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
42376898|NCT04682639|76247340|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
42376899|NCT04682639|76247341|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
42376900|NCT04682639|76247342|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
42376901|NCT04682639|76247338|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
42376902|NCT04682639|76247339|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
42376903|NCT04682639|76247340|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
42376904|NCT04682639|76247341|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
42376905|NCT04682639|76247342|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
42376906|NCT04682639|76247338|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
42376907|NCT04682639|76247339|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
42376908|NCT04682639|76247340|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
42376909|NCT04682639|76247341|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
42376910|NCT04682639|76247342|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
42376911|NCT04682639|76247338|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
42376912|NCT04682639|76247339|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
42376913|NCT04682639|76247340|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
42376914|NCT04682639|76247341|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
42376915|NCT04682639|76247342|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
42376916|NCT04470050|76247361|FG000|Double-blind Treatment Phase|Adverse Event|0|||
42376917|NCT04470050|76247362|FG001|Double-blind Treatment Phase|Adverse Event|0|||
42376918|NCT04470050|76247363|FG002|Double-blind Treatment Phase|Adverse Event|0|||
42376919|NCT04470050|76247364|FG003|Double-blind Treatment Phase|Adverse Event|1|||
42376920|NCT04470050|76247365|FG004|Double-blind Treatment Phase|Adverse Event|0|||
42376921|NCT04470050|76247366|FG005|Double-blind Treatment Phase|Adverse Event|0|||
42376922|NCT04470050|76247367|FG006|Double-blind Treatment Phase|Adverse Event|0|||
42376923|NCT04470050|76247361|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
42376924|NCT04470050|76247362|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
42376925|NCT04470050|76247363|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
42376926|NCT04470050|76247364|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
42376927|NCT04470050|76247365|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
42376928|NCT04470050|76247366|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
42376929|NCT04470050|76247367|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
42376930|NCT04470050|76247361|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
42376931|NCT04470050|76247362|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
42376932|NCT04470050|76247363|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
42200809|NCT01750281|76012727|FG000|Overall Study|Did not receive treatment|0|||
42200810|NCT01750281|76012728|FG001|Overall Study|Did not receive treatment|1|||
42376933|NCT04470050|76247364|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
42376934|NCT04470050|76247365|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
42376935|NCT04470050|76247366|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
42376936|NCT04470050|76247367|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
42376937|NCT03887052|76247499|FG000|Overall Study|Adverse Event|2|||
42376938|NCT03887052|76247499|FG000|Overall Study|Physician Decision|2|||
42200811|NCT01750281|76012729|FG002|Overall Study|Did not receive treatment|0|||
42200812|NCT01205061|76012739|FG000|Overall Study|Adverse Event|4|||
42376939|NCT03887052|76247499|FG000|Overall Study|Withdrawal by Subject|3|||
42376940|NCT03887052|76247499|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
42200813|NCT01205061|76012739|FG000|Overall Study|Withdrawal by Subject|11|||
42376941|NCT03887052|76247499|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
42376942|NCT03758066|76247503|FG000|Overall Study|Lost to Follow-up|14|||
42376943|NCT03728933|76247522|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
42376944|NCT03728933|76247523|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
42376945|NCT03728933|76247524|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
42376946|NCT03728933|76247522|FG000|Overall Study|Withdrawal by Subject|0|||
42376947|NCT03728933|76247523|FG001|Overall Study|Withdrawal by Subject|0|||
42376948|NCT03728933|76247524|FG002|Overall Study|Withdrawal by Subject|1|||
42376949|NCT03728933|76247522|FG000|Overall Study|Lost to Follow-up|0|||
42376950|NCT03728933|76247523|FG001|Overall Study|Lost to Follow-up|1|||
42376951|NCT03728933|76247524|FG002|Overall Study|Lost to Follow-up|0|||
42376952|NCT03728933|76247522|FG000|Overall Study|Adverse Event|1|||
42376953|NCT03728933|76247523|FG001|Overall Study|Adverse Event|0|||
42376954|NCT03728933|76247524|FG002|Overall Study|Adverse Event|0|||
42376955|NCT03599713|76247543|FG000|Overall Study|Death|26|||
42376956|NCT03599713|76247544|FG001|Overall Study|Death|3|||
42376957|NCT03599713|76247543|FG000|Overall Study|Withdrawal by Subject|6|||
42376958|NCT03599713|76247544|FG001|Overall Study|Withdrawal by Subject|0|||
42376959|NCT03599713|76247543|FG000|Overall Study|Ongoing|69|||
42376960|NCT03599713|76247544|FG001|Overall Study|Ongoing|3|||
42376961|NCT03557281|76247561|FG000|Overall Study|Investigator discretion|0|||
42376962|NCT03557281|76247562|FG001|Overall Study|Investigator discretion|0|||
42376963|NCT03557281|76247563|FG002|Overall Study|Investigator discretion|1|||
42376964|NCT03557281|76247564|FG003|Overall Study|Investigator discretion|0|||
42376965|NCT03557281|76247565|FG004|Overall Study|Investigator discretion|0|||
42376966|NCT03557281|76247561|FG000|Overall Study|Withdrawal by Subject|0|||
42376967|NCT03557281|76247562|FG001|Overall Study|Withdrawal by Subject|1|||
42376968|NCT03557281|76247563|FG002|Overall Study|Withdrawal by Subject|1|||
42376969|NCT03557281|76247564|FG003|Overall Study|Withdrawal by Subject|1|||
42376970|NCT03557281|76247565|FG004|Overall Study|Withdrawal by Subject|2|||
42376971|NCT03557281|76247561|FG000|Overall Study|Randomized, but did not receive treatment|0|||
42376972|NCT03557281|76247562|FG001|Overall Study|Randomized, but did not receive treatment|0|||
42376973|NCT03557281|76247563|FG002|Overall Study|Randomized, but did not receive treatment|0|||
42376974|NCT03557281|76247564|FG003|Overall Study|Randomized, but did not receive treatment|0|||
42376975|NCT03557281|76247565|FG004|Overall Study|Randomized, but did not receive treatment|1|||
42376976|NCT03538041|76247583|FG000|12-Week Treatment Period|Adverse Event|1|||
42376977|NCT03538041|76247584|FG001|12-Week Treatment Period|Adverse Event|1|||
42376978|NCT03538041|76247583|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
42376979|NCT03538041|76247584|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
42376980|NCT03538041|76247583|FG000|Treatment Extension Period|Adverse Event|4|||
42376981|NCT03538041|76247584|FG001|Treatment Extension Period|Adverse Event|0|||
42376982|NCT03538041|76247583|FG000|Treatment Extension Period|Physician Decision|1|||
42376983|NCT03538041|76247584|FG001|Treatment Extension Period|Physician Decision|0|||
42376984|NCT03538041|76247583|FG000|Treatment Extension Period|Lack of Efficacy|1|||
42376985|NCT03538041|76247584|FG001|Treatment Extension Period|Lack of Efficacy|3|||
42376986|NCT03538041|76247583|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
42376987|NCT03538041|76247584|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
42376988|NCT03260894|76247599|FG000|Overall Study|Death|6|||
42376989|NCT03260894|76247600|FG001|Overall Study|Death|8|||
42376990|NCT03260894|76247599|FG000|Overall Study|Withdrawal by Subject|4|||
42376991|NCT03260894|76247600|FG001|Overall Study|Withdrawal by Subject|11|||
42376992|NCT03260894|76247599|FG000|Overall Study|On-going at clinical cut off date|36|||
42376993|NCT03260894|76247600|FG001|Overall Study|On-going at clinical cut off date|31|||
42200814|NCT01205061|76012739|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
42200815|NCT01205061|76012739|FG000|Overall Study|Lost to Follow-up|9|||
42200816|NCT01205061|76012739|FG000|Overall Study|Other|1|||
42376994|NCT03197935|76247608|FG000|Overall Study|Death due to any cause|26|||
42376995|NCT03197935|76247609|FG001|Overall Study|Death due to any cause|15|||
42376996|NCT03197935|76247608|FG000|Overall Study|Lost to Follow-up|3|||
42376997|NCT03197935|76247609|FG001|Overall Study|Lost to Follow-up|5|||
42376998|NCT03197935|76247608|FG000|Overall Study|Physician Decision|2|||
42376999|NCT03197935|76247609|FG001|Overall Study|Physician Decision|1|||
42377000|NCT03197935|76247608|FG000|Overall Study|Withdrawal by Subject|16|||
42377001|NCT03197935|76247609|FG001|Overall Study|Withdrawal by Subject|8|||
42377002|NCT03144674|76247621|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
42377003|NCT03144674|76247622|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
42377004|NCT03144674|76247623|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
42377005|NCT03144674|76247624|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
42377006|NCT03144674|76247621|FG000|Overall Study|Death|3|||
42377007|NCT03144674|76247622|FG001|Overall Study|Death|1|||
42377008|NCT03144674|76247623|FG002|Overall Study|Death|1|||
42377009|NCT03144674|76247624|FG003|Overall Study|Death|10|||
42200817|NCT01108237|76012747|FG000|Overall Study|No alignment data|2|||
42377010|NCT03144674|76247621|FG000|Overall Study|Lost to Follow-up|0|||
42377011|NCT03144674|76247622|FG001|Overall Study|Lost to Follow-up|1|||
42377012|NCT03144674|76247623|FG002|Overall Study|Lost to Follow-up|1|||
42377013|NCT03144674|76247624|FG003|Overall Study|Lost to Follow-up|1|||
42377014|NCT03144674|76247621|FG000|Overall Study|Withdrawal by Participant|0|||
42377015|NCT03144674|76247622|FG001|Overall Study|Withdrawal by Participant|0|||
42377016|NCT03144674|76247623|FG002|Overall Study|Withdrawal by Participant|0|||
42377017|NCT03144674|76247624|FG003|Overall Study|Withdrawal by Participant|3|||
42377018|NCT03144674|76247621|FG000|Overall Study|Reason not Specified|0|||
42377019|NCT03144674|76247622|FG001|Overall Study|Reason not Specified|0|||
42377020|NCT03144674|76247623|FG002|Overall Study|Reason not Specified|2|||
42377021|NCT03144674|76247624|FG003|Overall Study|Reason not Specified|4|||
42377022|NCT03136965|76247642|FG000|Overall Study|Lost to Follow-up|0|||
42377023|NCT03136965|76247643|FG001|Overall Study|Lost to Follow-up|1|||
42377024|NCT03136965|76247644|FG002|Overall Study|Lost to Follow-up|0|||
42377025|NCT03115151|76247654|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
42377026|NCT03115151|76247655|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
42377027|NCT03115151|76247654|FG000|Overall Study|Epidural catheter removal|1|||
42377028|NCT03115151|76247655|FG001|Overall Study|Epidural catheter removal|0|||
42377029|NCT03115151|76247654|FG000|Overall Study|Withdrawal by Subject|0|||
42377030|NCT03115151|76247655|FG001|Overall Study|Withdrawal by Subject|1|||
42377031|NCT03115151|76247654|FG000|Overall Study|Intervention not received according to the protocol.|1|||
42377032|NCT03115151|76247655|FG001|Overall Study|Intervention not received according to the protocol.|1|||
42377033|NCT03115151|76247654|FG000|Overall Study|Physician Decision|1|||
42377034|NCT03115151|76247655|FG001|Overall Study|Physician Decision|0|||
42377035|NCT03115151|76247654|FG000|Overall Study|Randomization not applied|1|||
42377036|NCT03115151|76247655|FG001|Overall Study|Randomization not applied|1|||
42377037|NCT03068130|76247661|FG000|Overall Study|Adverse Event|19|||
42377038|NCT03068130|76247661|FG000|Overall Study|Death|14|||
42377039|NCT03068130|76247661|FG000|Overall Study|Lost to Follow-up|4|||
42377040|NCT03068130|76247661|FG000|Overall Study|Withdrawal by Subject|26|||
42377041|NCT03068130|76247661|FG000|Overall Study|Administrative Reasons|3|||
42377042|NCT03068130|76247661|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
42377043|NCT03068130|76247661|FG000|Overall Study|Study terminated by sponsor|194|||
42377044|NCT03019185|76247668|FG000|Overall Study|Lost to Follow-up|3|||
42377045|NCT03019185|76247669|FG001|Overall Study|Lost to Follow-up|0|||
42377046|NCT03019185|76247670|FG002|Overall Study|Lost to Follow-up|2|||
42377047|NCT03019185|76247668|FG000|Overall Study|Withdrawal by Subject|1|||
42377048|NCT03019185|76247669|FG001|Overall Study|Withdrawal by Subject|1|||
42377049|NCT03019185|76247670|FG002|Overall Study|Withdrawal by Subject|0|||
42377050|NCT03019185|76247668|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
42377051|NCT03019185|76247669|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
42377052|NCT03019185|76247670|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
42377053|NCT03019185|76247668|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
42377054|NCT03019185|76247669|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
42377055|NCT03019185|76247670|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
42377056|NCT02908685|76247690|FG000|Part 1 Exploratory|Withdrawal by Subject|0|||
42103594|NCT00672620|75914510|FG000|Overall Study|Withdrawal of Consent|6|||
42103595|NCT00672620|75914511|FG001|Overall Study|Withdrawal of Consent|12|||
42103596|NCT00672620|75914512|FG002|Overall Study|Withdrawal of Consent|5|||
42103597|NCT00672620|75914513|FG003|Overall Study|Withdrawal of Consent|6|||
42103598|NCT00672620|75914510|FG000|Overall Study|Lost to Follow-up|8|||
42103599|NCT00672620|75914511|FG001|Overall Study|Lost to Follow-up|19|||
42200818|NCT01108237|76012748|FG001|Overall Study|No alignment data|15|||
42103600|NCT00672620|75914512|FG002|Overall Study|Lost to Follow-up|8|||
42103601|NCT00672620|75914513|FG003|Overall Study|Lost to Follow-up|11|||
42103602|NCT00672620|75914510|FG000|Overall Study|Reason not Specified|3|||
42103603|NCT00672620|75914511|FG001|Overall Study|Reason not Specified|3|||
42103604|NCT00672620|75914512|FG002|Overall Study|Reason not Specified|2|||
42200819|NCT01108237|76012747|FG000|Overall Study|Did not meet criteria for analysis|7|||
42200820|NCT01108237|76012748|FG001|Overall Study|Did not meet criteria for analysis|0|||
42377057|NCT02908685|76247691|FG001|Part 1 Exploratory|Withdrawal by Subject|1|||
42377058|NCT02908685|76247692|FG002|Part 1 Exploratory|Withdrawal by Subject|0|||
42377059|NCT02908685|76247693|FG003|Part 1 Exploratory|Withdrawal by Subject|0|||
42377060|NCT02908685|76247694|FG004|Part 1 Exploratory|Withdrawal by Subject|0|||
42377061|NCT02908685|76247695|FG005|Part 1 Exploratory|Withdrawal by Subject|0|||
42377062|NCT02908685|76247696|FG006|Part 1 Exploratory|Withdrawal by Subject|0|||
42377063|NCT02908685|76247697|FG007|Part 1 Exploratory|Withdrawal by Subject|0|||
42377064|NCT02908685|76247698|FG008|Part 1 Exploratory|Withdrawal by Subject|0|||
42377065|NCT02908685|76247699|FG009|Part 1 Exploratory|Withdrawal by Subject|0|||
42103605|NCT00672620|75914513|FG003|Overall Study|Reason not Specified|1|||
42103606|NCT00673790|75914526|FG000|Overall Study|Adverse Event|23|||
42103607|NCT00673790|75914527|FG001|Overall Study|Adverse Event|14|||
42377066|NCT02908685|76247700|FG010|Part 1 Exploratory|Withdrawal by Subject|0|||
42377067|NCT02908685|76247701|FG011|Part 1 Exploratory|Withdrawal by Subject|0|||
42377068|NCT02908685|76247690|FG000|Part 2 Confirmatory|Changed to Spinraza|0|||
42377069|NCT02908685|76247691|FG001|Part 2 Confirmatory|Changed to Spinraza|0|||
42377070|NCT02908685|76247692|FG002|Part 2 Confirmatory|Changed to Spinraza|0|||
42377071|NCT02908685|76247693|FG003|Part 2 Confirmatory|Changed to Spinraza|0|||
42377072|NCT02908685|76247694|FG004|Part 2 Confirmatory|Changed to Spinraza|0|||
42377073|NCT02908685|76247695|FG005|Part 2 Confirmatory|Changed to Spinraza|0|||
42377074|NCT02908685|76247696|FG006|Part 2 Confirmatory|Changed to Spinraza|0|||
42377075|NCT02908685|76247697|FG007|Part 2 Confirmatory|Changed to Spinraza|0|||
42377076|NCT02908685|76247698|FG008|Part 2 Confirmatory|Changed to Spinraza|0|||
42377077|NCT02908685|76247699|FG009|Part 2 Confirmatory|Changed to Spinraza|0|||
42377078|NCT02908685|76247700|FG010|Part 2 Confirmatory|Changed to Spinraza|2|||
42377079|NCT02908685|76247701|FG011|Part 2 Confirmatory|Changed to Spinraza|1|||
42377080|NCT02908685|76247690|FG000|Part 2 Confirmatory|Changed to other treatment|0|||
42377081|NCT02908685|76247691|FG001|Part 2 Confirmatory|Changed to other treatment|0|||
42377082|NCT02908685|76247692|FG002|Part 2 Confirmatory|Changed to other treatment|0|||
42377083|NCT02908685|76247693|FG003|Part 2 Confirmatory|Changed to other treatment|0|||
42377084|NCT02908685|76247694|FG004|Part 2 Confirmatory|Changed to other treatment|0|||
42377085|NCT02908685|76247695|FG005|Part 2 Confirmatory|Changed to other treatment|0|||
42377086|NCT02908685|76247696|FG006|Part 2 Confirmatory|Changed to other treatment|0|||
42377087|NCT02908685|76247697|FG007|Part 2 Confirmatory|Changed to other treatment|0|||
42377088|NCT02908685|76247698|FG008|Part 2 Confirmatory|Changed to other treatment|0|||
42377089|NCT02908685|76247699|FG009|Part 2 Confirmatory|Changed to other treatment|0|||
42377090|NCT02908685|76247700|FG010|Part 2 Confirmatory|Changed to other treatment|1|||
42377091|NCT02908685|76247701|FG011|Part 2 Confirmatory|Changed to other treatment|0|||
42377092|NCT02772276|76247731|FG000|Overall Study|Lost to Follow-up|0|||
42377093|NCT02772276|76247732|FG001|Overall Study|Lost to Follow-up|0|||
42377094|NCT02772276|76247733|FG002|Overall Study|Lost to Follow-up|0|||
42377095|NCT02772276|76247734|FG003|Overall Study|Lost to Follow-up|0|||
42377096|NCT02772276|76247735|FG004|Overall Study|Lost to Follow-up|0|||
42377097|NCT02772276|76247736|FG005|Overall Study|Lost to Follow-up|0|||
42377098|NCT02772276|76247737|FG006|Overall Study|Lost to Follow-up|1|||
42377099|NCT02772276|76247738|FG007|Overall Study|Lost to Follow-up|0|||
42377100|NCT02772276|76247739|FG008|Overall Study|Lost to Follow-up|0|||
42377101|NCT02772276|76247740|FG009|Overall Study|Lost to Follow-up|0|||
42377102|NCT02772276|76247741|FG010|Overall Study|Lost to Follow-up|0|||
42377103|NCT02772276|76247742|FG011|Overall Study|Lost to Follow-up|0|||
42377104|NCT02772276|76247743|FG012|Overall Study|Lost to Follow-up|0|||
42377105|NCT02772276|76247731|FG000|Overall Study|Withdrew consent|0|||
42377106|NCT02772276|76247732|FG001|Overall Study|Withdrew consent|0|||
42377107|NCT02772276|76247733|FG002|Overall Study|Withdrew consent|0|||
42377108|NCT02772276|76247734|FG003|Overall Study|Withdrew consent|0|||
42377109|NCT02772276|76247735|FG004|Overall Study|Withdrew consent|0|||
42377110|NCT02772276|76247736|FG005|Overall Study|Withdrew consent|0|||
42377111|NCT02772276|76247737|FG006|Overall Study|Withdrew consent|0|||
42377112|NCT02772276|76247738|FG007|Overall Study|Withdrew consent|1|||
42377113|NCT02772276|76247739|FG008|Overall Study|Withdrew consent|0|||
42377114|NCT02772276|76247740|FG009|Overall Study|Withdrew consent|0|||
42377115|NCT02772276|76247741|FG010|Overall Study|Withdrew consent|0|||
42377116|NCT02772276|76247742|FG011|Overall Study|Withdrew consent|0|||
42377117|NCT02772276|76247743|FG012|Overall Study|Withdrew consent|0|||
42377118|NCT02601313|76247796|FG000|Overall Study|Death|2|||
42377119|NCT02601313|76247797|FG001|Overall Study|Death|16|||
42377120|NCT02601313|76247798|FG002|Overall Study|Death|4|||
42377121|NCT02601313|76247796|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
42377122|NCT02601313|76247797|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
42377123|NCT02601313|76247798|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
42377124|NCT02601313|76247796|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
42377125|NCT02601313|76247797|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
42377126|NCT02601313|76247798|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
42377127|NCT02601313|76247796|FG000|Overall Study|Still on study|0|||
42377128|NCT02601313|76247797|FG001|Overall Study|Still on study|52|||
42377129|NCT02601313|76247798|FG002|Overall Study|Still on study|10|||
42377130|NCT02601313|76247796|FG000|Overall Study|Enrolled, did not initiate AC|4|||
42377131|NCT02601313|76247797|FG001|Overall Study|Enrolled, did not initiate AC|0|||
42377132|NCT02601313|76247798|FG002|Overall Study|Enrolled, did not initiate AC|0|||
42377133|NCT02550652|76247808|FG000|Overall Study|Death|1|||
42377134|NCT02550652|76247809|FG001|Overall Study|Death|4|||
42377135|NCT02550652|76247808|FG000|Overall Study|Lack of Efficacy|1|||
42377136|NCT02550652|76247809|FG001|Overall Study|Lack of Efficacy|0|||
42377137|NCT02550652|76247808|FG000|Overall Study|Withdrawal by Subject|3|||
42377138|NCT02550652|76247809|FG001|Overall Study|Withdrawal by Subject|7|||
42377139|NCT02550652|76247808|FG000|Overall Study|Post Trial Access|1|||
42377140|NCT02550652|76247809|FG001|Overall Study|Post Trial Access|0|||
42377141|NCT02550652|76247808|FG000|Overall Study|Lost to Follow-up|1|||
42377142|NCT02550652|76247809|FG001|Overall Study|Lost to Follow-up|3|||
42377143|NCT02550652|76247808|FG000|Overall Study|Physician Decision|0|||
42377144|NCT02550652|76247809|FG001|Overall Study|Physician Decision|2|||
42377145|NCT02550652|76247808|FG000|Overall Study|Ongoing in safety/B-cell follow-up period|14|||
42377146|NCT02550652|76247809|FG001|Overall Study|Ongoing in safety/B-cell follow-up period|5|||
42377147|NCT02484443|76247815|FG000|Overall Study|Lack of Efficacy|28|||
42377148|NCT02484443|76247815|FG000|Overall Study|Physician Decision|2|||
42377149|NCT02484443|76247815|FG000|Overall Study|Ineligible|2|||
42377150|NCT01385176|76247843|FG000|Randomization Phase|Death|1|||
42377151|NCT01385176|76247844|FG001|Randomization Phase|Death|2|||
42377152|NCT01385176|76247843|FG000|6-18 Month All VNS Active|Death|1|||
42377153|NCT01385176|76247844|FG001|6-18 Month All VNS Active|Death|2|||
42377154|NCT01385176|76247843|FG000|6-18 Month All VNS Active|Physician Decision|0|||
42377155|NCT01385176|76247844|FG001|6-18 Month All VNS Active|Physician Decision|1|||
42377156|NCT01385176|76247843|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
42377157|NCT01385176|76247844|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
42377158|NCT01385176|76247843|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
42377159|NCT01385176|76247844|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
42377160|NCT01041027|76247859|FG000|Overall Study|Withdrawal by Subject|2|||
42377161|NCT01041027|76247859|FG000|Overall Study|Protocol Violation|1|||
42377162|NCT01041027|76247859|FG000|Overall Study|Delayed Radiation Therapy|1|||
42377163|NCT01041027|76247859|FG000|Overall Study|Adverse Event|4|||
42377164|NCT00389610|76247865|FG000|Overall Study|Disease Progression|0|||
42377165|NCT00389610|76247866|FG001|Overall Study|Disease Progression|19|||
42377166|NCT00389610|76247865|FG000|Overall Study|Death|0|||
42377167|NCT00389610|76247866|FG001|Overall Study|Death|1|||
42377168|NCT00389610|76247865|FG000|Overall Study|Physician Decision|0|||
42377169|NCT00389610|76247866|FG001|Overall Study|Physician Decision|1|||
42377170|NCT00389610|76247865|FG000|Overall Study|Withdrawal by Subject|0|||
42377171|NCT00389610|76247866|FG001|Overall Study|Withdrawal by Subject|1|||
42377172|NCT01489189|76247874|FG000|Overall Study|Withdrawal by Subject|20|||
42377173|NCT01489189|76247875|FG001|Overall Study|Withdrawal by Subject|23|||
42377174|NCT01489189|76247874|FG000|Overall Study|Death|10|||
42377175|NCT01489189|76247875|FG001|Overall Study|Death|8|||
42377176|NCT01489189|76247874|FG000|Overall Study|Missed Visit|1|||
42377177|NCT01489189|76247875|FG001|Overall Study|Missed Visit|4|||
42377178|NCT01549873|76247884|FG000|Overall Study|Physician Decision|0|||
42377179|NCT01549873|76247885|FG001|Overall Study|Physician Decision|1|||
42377180|NCT01489111|76247891|FG000|Overall Study|Withdrawal criterion|1|||
42377181|NCT01488487|76247895|FG000|Overall Study|Adverse Event|6|||
42377182|NCT01488487|76247895|FG000|Overall Study|Death|1|||
42377183|NCT01488487|76247895|FG000|Overall Study|Withdrawal by Subject|2|||
42377184|NCT01488097|76247899|FG000|Overall Study|Lost to Follow-up|1|||
42377185|NCT01516879|76247905|FG000|Overall Study|Withdrawal by Subject|9|||
42377186|NCT01516879|76247906|FG001|Overall Study|Withdrawal by Subject|11|||
42377187|NCT01516879|76247905|FG000|Overall Study|Death|0|||
42377188|NCT01516879|76247906|FG001|Overall Study|Death|2|||
42377189|NCT01516879|76247905|FG000|Overall Study|Lost to Follow-up|2|||
42377190|NCT01516879|76247906|FG001|Overall Study|Lost to Follow-up|11|||
42377191|NCT01516879|76247905|FG000|Overall Study|Other|5|||
42377192|NCT01516879|76247906|FG001|Overall Study|Other|10|||
42377193|NCT01515865|76247912|FG000|Part A (Open-label)|Other|3|||
42377194|NCT01515865|76247913|FG001|Part A (Open-label)|Other|0|||
42377195|NCT01515865|76247914|FG002|Part A (Open-label)|Other|0|||
42377196|NCT01515865|76247912|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
42377197|NCT01515865|76247913|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
42377198|NCT01515865|76247914|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
42377199|NCT01515865|76247912|FG000|Part B (Open-label)|Other|1|||
42377200|NCT01515865|76247913|FG001|Part B (Open-label)|Other|0|||
42377201|NCT01515865|76247914|FG002|Part B (Open-label)|Other|0|||
42377202|NCT01547299|76247924|FG000|Overall Study|Withdrawal by Subject|2|||
42377203|NCT01547299|76247925|FG001|Overall Study|Withdrawal by Subject|2|||
42377204|NCT01515475|76247935|FG000|Overall Study|Lost to Follow-up|20|||
42377205|NCT01515475|76247936|FG001|Overall Study|Lost to Follow-up|15|||
42377206|NCT01515475|76247937|FG002|Overall Study|Lost to Follow-up|12|||
42377207|NCT01515475|76247938|FG003|Overall Study|Lost to Follow-up|12|||
42377208|NCT01515319|76248024|FG000|Overall Study|Withdrawal by Subject|0|||
42377209|NCT01515319|76248025|FG001|Overall Study|Withdrawal by Subject|0|||
42377210|NCT01515319|76248026|FG002|Overall Study|Withdrawal by Subject|0|||
42377211|NCT01515319|76248027|FG003|Overall Study|Withdrawal by Subject|0|||
42377212|NCT01515319|76248028|FG004|Overall Study|Withdrawal by Subject|0|||
42377213|NCT01515319|76248029|FG005|Overall Study|Withdrawal by Subject|0|||
42377214|NCT01515319|76248030|FG006|Overall Study|Withdrawal by Subject|1|||
42377215|NCT01515319|76248031|FG007|Overall Study|Withdrawal by Subject|0|||
42377216|NCT01515319|76248032|FG008|Overall Study|Withdrawal by Subject|0|||
42377217|NCT01515319|76248033|FG009|Overall Study|Withdrawal by Subject|0|||
42377218|NCT01515319|76248024|FG000|Overall Study|Adverse Event|0|||
42377219|NCT01515319|76248025|FG001|Overall Study|Adverse Event|0|||
42377220|NCT01515319|76248026|FG002|Overall Study|Adverse Event|0|||
42377221|NCT01515319|76248027|FG003|Overall Study|Adverse Event|0|||
42377222|NCT01515319|76248028|FG004|Overall Study|Adverse Event|0|||
42377223|NCT01515319|76248029|FG005|Overall Study|Adverse Event|0|||
42377224|NCT01515319|76248030|FG006|Overall Study|Adverse Event|0|||
42377225|NCT01515319|76248031|FG007|Overall Study|Adverse Event|0|||
42377226|NCT01515319|76248032|FG008|Overall Study|Adverse Event|3|||
42377227|NCT01515319|76248033|FG009|Overall Study|Adverse Event|0|||
42377228|NCT01515319|76248024|FG000|Overall Study|Protocol Violation|0|||
42377229|NCT01515319|76248025|FG001|Overall Study|Protocol Violation|0|||
42377230|NCT01515319|76248026|FG002|Overall Study|Protocol Violation|0|||
42377231|NCT01515319|76248027|FG003|Overall Study|Protocol Violation|0|||
42377232|NCT01515319|76248028|FG004|Overall Study|Protocol Violation|0|||
42377233|NCT01515319|76248029|FG005|Overall Study|Protocol Violation|0|||
42377234|NCT01515319|76248030|FG006|Overall Study|Protocol Violation|0|||
42377235|NCT01515319|76248031|FG007|Overall Study|Protocol Violation|0|||
42377236|NCT01515319|76248032|FG008|Overall Study|Protocol Violation|2|||
42377237|NCT01515319|76248033|FG009|Overall Study|Protocol Violation|0|||
42377238|NCT01492361|76248070|FG000|Overall Study|Withdrawal by Subject|281|||
42377239|NCT01492361|76248071|FG001|Overall Study|Withdrawal by Subject|297|||
42377240|NCT01492361|76248070|FG000|Overall Study|Physician Decision|12|||
42377241|NCT01492361|76248071|FG001|Overall Study|Physician Decision|12|||
42377242|NCT01492361|76248070|FG000|Overall Study|Lost to Follow-up|6|||
42377243|NCT01492361|76248071|FG001|Overall Study|Lost to Follow-up|13|||
42377244|NCT01492361|76248070|FG000|Overall Study|Other than specified above|106|||
42377245|NCT01492361|76248071|FG001|Overall Study|Other than specified above|138|||
42377246|NCT01514461|76248150|FG000|Overall Study|Adverse Event|2|||
42377247|NCT01514461|76248151|FG001|Overall Study|Adverse Event|1|||
42377248|NCT01514461|76248152|FG002|Overall Study|Adverse Event|3|||
42377249|NCT01514461|76248150|FG000|Overall Study|Physician Decision|1|||
42377250|NCT01514461|76248151|FG001|Overall Study|Physician Decision|1|||
42377251|NCT01514461|76248152|FG002|Overall Study|Physician Decision|0|||
42377252|NCT01514461|76248150|FG000|Overall Study|Patient/guardian decision|1|||
42377253|NCT01514461|76248151|FG001|Overall Study|Patient/guardian decision|1|||
42377254|NCT01514461|76248152|FG002|Overall Study|Patient/guardian decision|1|||
42377255|NCT01514461|76248150|FG000|Overall Study|Death|1|||
42377256|NCT01514461|76248151|FG001|Overall Study|Death|0|||
42377257|NCT01514461|76248152|FG002|Overall Study|Death|0|||
42377258|NCT01491737|76248198|FG000|Overall Study|Withdrawal by Subject|20|||
42377259|NCT01491737|76248199|FG001|Overall Study|Withdrawal by Subject|17|||
42377260|NCT01491737|76248198|FG000|Overall Study|Lost to Follow-up|2|||
42377261|NCT01491737|76248199|FG001|Overall Study|Lost to Follow-up|10|||
42377262|NCT01491737|76248198|FG000|Overall Study|Death|63|||
42377263|NCT01491737|76248199|FG001|Overall Study|Death|57|||
42377264|NCT01491737|76248198|FG000|Overall Study|Study Termination by Sponsor|36|||
42377265|NCT01491737|76248199|FG001|Overall Study|Study Termination by Sponsor|36|||
42377266|NCT01491737|76248198|FG000|Overall Study|Reason Not Specified|8|||
42377267|NCT01491737|76248199|FG001|Overall Study|Reason Not Specified|9|||
42377268|NCT01487863|76248211|FG000|Overall Study|Death|19|||
42377269|NCT01487863|76248212|FG001|Overall Study|Death|19|||
42377270|NCT01487161|76248231|FG000|Overall Study|Adverse Event|1|||
42377271|NCT01487161|76248232|FG001|Overall Study|Adverse Event|0|||
42377272|NCT01487161|76248233|FG002|Overall Study|Adverse Event|0|||
42377273|NCT01487161|76248234|FG003|Overall Study|Adverse Event|0|||
42377274|NCT01487161|76248231|FG000|Overall Study|Withdrawal by Subject|1|||
42377275|NCT01487161|76248232|FG001|Overall Study|Withdrawal by Subject|1|||
42377276|NCT01487161|76248233|FG002|Overall Study|Withdrawal by Subject|1|||
42377277|NCT01487161|76248234|FG003|Overall Study|Withdrawal by Subject|2|||
42377278|NCT01487161|76248231|FG000|Overall Study|missing data|0|||
42377279|NCT01487161|76248232|FG001|Overall Study|missing data|1|||
42377280|NCT01487161|76248233|FG002|Overall Study|missing data|0|||
42377281|NCT01487161|76248234|FG003|Overall Study|missing data|0|||
42377282|NCT01491035|76248289|FG000|Overall Study|Lost to Follow-up|0|||
42377283|NCT01491035|76248290|FG001|Overall Study|Lost to Follow-up|0|||
42377284|NCT01491035|76248291|FG002|Overall Study|Lost to Follow-up|0|||
42377285|NCT01491035|76248292|FG003|Overall Study|Lost to Follow-up|0|||
42377286|NCT01491035|76248293|FG004|Overall Study|Lost to Follow-up|1|||
42377287|NCT01491035|76248294|FG005|Overall Study|Lost to Follow-up|0|||
42377288|NCT01491035|76248295|FG006|Overall Study|Lost to Follow-up|0|||
42377289|NCT01491035|76248296|FG007|Overall Study|Lost to Follow-up|0|||
42377290|NCT01488071|76248320|FG000|Overall Study|Adverse Event|15|||
42377291|NCT01488071|76248321|FG001|Overall Study|Adverse Event|23|||
42377292|NCT01488071|76248320|FG000|Overall Study|Lack of Efficacy|11|||
42377293|NCT01488071|76248321|FG001|Overall Study|Lack of Efficacy|17|||
42377294|NCT01488071|76248320|FG000|Overall Study|Non-compliance with study drug|2|||
42377295|NCT01488071|76248321|FG001|Overall Study|Non-compliance with study drug|0|||
42377296|NCT01488071|76248320|FG000|Overall Study|Protocol Violation|5|||
42377297|NCT01488071|76248321|FG001|Overall Study|Protocol Violation|7|||
42377298|NCT01488071|76248320|FG000|Overall Study|Withdrawal of Consent|14|||
42377299|NCT01488071|76248321|FG001|Overall Study|Withdrawal of Consent|12|||
42377300|NCT01488071|76248320|FG000|Overall Study|Lost to Follow-up|1|||
42377301|NCT01488071|76248321|FG001|Overall Study|Lost to Follow-up|0|||
42377302|NCT01488071|76248320|FG000|Overall Study|Administrative or Other Reason(s)|5|||
42377303|NCT01488071|76248321|FG001|Overall Study|Administrative or Other Reason(s)|4|||
42377304|NCT01487525|76248329|FG000|Overall Study|Withdrawal by Subject|0|||
42377305|NCT01487525|76248330|FG001|Overall Study|Withdrawal by Subject|1|||
42377306|NCT01486199|76248338|FG000|Two Year Period Between Study Days|Physician Decision|1|||
42377307|NCT01486199|76248339|FG001|Two Year Period Between Study Days|Physician Decision|0|||
42377308|NCT01485887|76248345|FG000|Overall Study|Withdrawal by Subject|2|||
42377309|NCT01485887|76248345|FG000|Overall Study|Adverse Event|8|||
42377310|NCT01485887|76248345|FG000|Overall Study|Deterioration of primary disease|1|||
42377311|NCT01485887|76248345|FG000|Overall Study|Primary disease markedly improved|1|||
42377312|NCT01546519|76248353|FG000|Overall Study|Adverse Event|0|||
42377313|NCT01546519|76248354|FG001|Overall Study|Adverse Event|0|||
42200821|NCT00736450|76012777|FG000|Overall Study|Not ABC gene eligible|19|||
42200822|NCT00736450|76012777|FG000|Overall Study|Withdrawal by Subject|5|||
42200823|NCT00736450|76012777|FG000|Overall Study|Physician Decision|1|||
42200824|NCT00571662|76012798|FG000|Overall Study|Withdrawal by Subject|2|||
42377314|NCT01546519|76248355|FG002|Overall Study|Adverse Event|1|||
42377315|NCT01546519|76248356|FG003|Overall Study|Adverse Event|1|||
42377316|NCT01546519|76248353|FG000|Overall Study|Death|0|||
42377317|NCT01546519|76248354|FG001|Overall Study|Death|1|||
42377318|NCT01546519|76248355|FG002|Overall Study|Death|3|||
42377319|NCT01546519|76248356|FG003|Overall Study|Death|1|||
42377320|NCT01546519|76248353|FG000|Overall Study|related to disease progression|2|||
42377321|NCT01546519|76248354|FG001|Overall Study|related to disease progression|2|||
42377322|NCT01546519|76248355|FG002|Overall Study|related to disease progression|2|||
42377323|NCT01546519|76248356|FG003|Overall Study|related to disease progression|1|||
42377324|NCT01546519|76248353|FG000|Overall Study|Physician Decision|6|||
42377325|NCT01546519|76248354|FG001|Overall Study|Physician Decision|5|||
42377326|NCT01546519|76248355|FG002|Overall Study|Physician Decision|2|||
42377327|NCT01546519|76248356|FG003|Overall Study|Physician Decision|3|||
42377328|NCT01546519|76248353|FG000|Overall Study|Withdrawal by Subject|1|||
42200825|NCT00571662|76012798|FG000|Overall Study|psychiatric instability|1|||
42103608|NCT00673790|75914528|FG002|Overall Study|Adverse Event|2|||
42103609|NCT00673790|75914526|FG000|Overall Study|Lack of Efficacy|2|||
42103610|NCT00673790|75914527|FG001|Overall Study|Lack of Efficacy|2|||
42103611|NCT00673790|75914528|FG002|Overall Study|Lack of Efficacy|2|||
42377329|NCT01546519|76248354|FG001|Overall Study|Withdrawal by Subject|0|||
42377330|NCT01546519|76248355|FG002|Overall Study|Withdrawal by Subject|0|||
42377331|NCT01546519|76248356|FG003|Overall Study|Withdrawal by Subject|0|||
42377332|NCT01484951|76248370|FG000|Overall Study|Adverse Event|3|||
42377333|NCT01484951|76248370|FG000|Overall Study|Personal Reasons|1|||
42377334|NCT01484951|76248370|FG000|Overall Study|Non-Compliance|1|||
42377335|NCT01484873|76248374|FG000|Overall Study|Withdrawal by Subject|2|||
42377336|NCT01486927|76248379|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
42377337|NCT01486927|76248379|FG000|Overall Study|Physician Decision|1|||
42377338|NCT01486927|76248379|FG000|Overall Study|50 Exposure days not reached|2|||
42377339|NCT01486927|76248379|FG000|Overall Study|Withdrawal by Subject|8|||
42377340|NCT01486927|76248379|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
42377341|NCT01513759|76248412|FG000|Overall Study|Protocol Violation|4|||
42377342|NCT01513759|76248412|FG000|Overall Study|Death during catheter placement|1|||
42377343|NCT01484561|76248418|FG000|Overall Study|Lack of Efficacy|3|||
42377344|NCT01484561|76248419|FG001|Overall Study|Lack of Efficacy|1|||
42377345|NCT01484561|76248418|FG000|Overall Study|Lost to Follow-up|1|||
42377346|NCT01484561|76248419|FG001|Overall Study|Lost to Follow-up|0|||
42377347|NCT01484561|76248418|FG000|Overall Study|Withdrawal by Subject|3|||
42377348|NCT01484561|76248419|FG001|Overall Study|Withdrawal by Subject|0|||
42377349|NCT01484561|76248418|FG000|Overall Study|Other|1|||
42103612|NCT00673790|75914526|FG000|Overall Study|Protocol Violation|6|||
42103613|NCT00673790|75914527|FG001|Overall Study|Protocol Violation|9|||
42103614|NCT00673790|75914528|FG002|Overall Study|Protocol Violation|1|||
42103615|NCT00673790|75914526|FG000|Overall Study|Withdrawal by Subject|7|||
42103616|NCT00673790|75914527|FG001|Overall Study|Withdrawal by Subject|4|||
42103617|NCT00673790|75914528|FG002|Overall Study|Withdrawal by Subject|1|||
42103618|NCT00673790|75914526|FG000|Overall Study|Lost to Follow-up|6|||
42103619|NCT00673790|75914527|FG001|Overall Study|Lost to Follow-up|6|||
42103620|NCT00673790|75914528|FG002|Overall Study|Lost to Follow-up|5|||
42103621|NCT00673790|75914526|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
42103622|NCT00673790|75914527|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
42103623|NCT00673790|75914528|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
42103624|NCT00673790|75914526|FG000|Overall Study|Poor compliance|1|||
42103625|NCT00673790|75914527|FG001|Overall Study|Poor compliance|0|||
42377350|NCT01484561|76248419|FG001|Overall Study|Other|1|||
42377351|NCT01484561|76248418|FG000|Overall Study|Adverse Event|1|||
42377352|NCT01484561|76248419|FG001|Overall Study|Adverse Event|4|||
42377353|NCT01546207|76248425|FG000|Overall Study|Death|1|||
42200826|NCT00571662|76012798|FG000|Overall Study|Adverse Event|5|||
42377354|NCT01513291|76248431|FG000|Treatment Period|Adverse Event|8|||
42377355|NCT01513291|76248432|FG001|Treatment Period|Adverse Event|4|||
42377356|NCT01513291|76248433|FG002|Treatment Period|Adverse Event|0|||
42377357|NCT01513291|76248434|FG003|Treatment Period|Adverse Event|0|||
42377358|NCT01513291|76248435|FG004|Treatment Period|Adverse Event|0|||
42377359|NCT01513291|76248431|FG000|Treatment Period|Lack of Efficacy|3|||
42377360|NCT01513291|76248432|FG001|Treatment Period|Lack of Efficacy|0|||
42377361|NCT01513291|76248433|FG002|Treatment Period|Lack of Efficacy|0|||
42377362|NCT01513291|76248434|FG003|Treatment Period|Lack of Efficacy|0|||
42377363|NCT01513291|76248435|FG004|Treatment Period|Lack of Efficacy|0|||
42377364|NCT01513291|76248431|FG000|Treatment Period|Lost to Follow-up|2|||
42377365|NCT01513291|76248432|FG001|Treatment Period|Lost to Follow-up|3|||
42377366|NCT01513291|76248433|FG002|Treatment Period|Lost to Follow-up|0|||
42377367|NCT01513291|76248434|FG003|Treatment Period|Lost to Follow-up|0|||
42377368|NCT01513291|76248435|FG004|Treatment Period|Lost to Follow-up|0|||
42377369|NCT01513291|76248431|FG000|Treatment Period|Physician Decision|1|||
42377370|NCT01513291|76248432|FG001|Treatment Period|Physician Decision|0|||
42377371|NCT01513291|76248433|FG002|Treatment Period|Physician Decision|0|||
42377372|NCT01513291|76248434|FG003|Treatment Period|Physician Decision|0|||
42377373|NCT01513291|76248435|FG004|Treatment Period|Physician Decision|0|||
42377374|NCT01513291|76248431|FG000|Treatment Period|Protocol Violation|1|||
42377375|NCT01513291|76248432|FG001|Treatment Period|Protocol Violation|2|||
42377376|NCT01513291|76248433|FG002|Treatment Period|Protocol Violation|0|||
42377377|NCT01513291|76248434|FG003|Treatment Period|Protocol Violation|0|||
42377378|NCT01513291|76248435|FG004|Treatment Period|Protocol Violation|0|||
42377379|NCT01513291|76248431|FG000|Treatment Period|Withdrawal by Subject|8|||
42377380|NCT01513291|76248432|FG001|Treatment Period|Withdrawal by Subject|5|||
42377381|NCT01513291|76248433|FG002|Treatment Period|Withdrawal by Subject|0|||
42377382|NCT01513291|76248434|FG003|Treatment Period|Withdrawal by Subject|0|||
42377383|NCT01513291|76248435|FG004|Treatment Period|Withdrawal by Subject|0|||
42377384|NCT01513291|76248431|FG000|Treatment Period|Randomized not treated|0|||
42377385|NCT01513291|76248432|FG001|Treatment Period|Randomized not treated|2|||
42377386|NCT01513291|76248433|FG002|Treatment Period|Randomized not treated|0|||
42377387|NCT01513291|76248434|FG003|Treatment Period|Randomized not treated|0|||
42377388|NCT01513291|76248435|FG004|Treatment Period|Randomized not treated|0|||
42377389|NCT01513291|76248431|FG000|Run-out Period|Lost to Follow-up|0|||
42377390|NCT01513291|76248432|FG001|Run-out Period|Lost to Follow-up|0|||
42377391|NCT01513291|76248433|FG002|Run-out Period|Lost to Follow-up|0|||
42377392|NCT01513291|76248434|FG003|Run-out Period|Lost to Follow-up|1|||
42377393|NCT01513291|76248435|FG004|Run-out Period|Lost to Follow-up|0|||
42377394|NCT01513291|76248431|FG000|Run-out Period|Withdrawal by Subject|0|||
42377395|NCT01513291|76248432|FG001|Run-out Period|Withdrawal by Subject|0|||
42377396|NCT01513291|76248433|FG002|Run-out Period|Withdrawal by Subject|0|||
42377397|NCT01513291|76248434|FG003|Run-out Period|Withdrawal by Subject|1|||
42377398|NCT01513291|76248435|FG004|Run-out Period|Withdrawal by Subject|0|||
42377399|NCT01483937|76248449|FG000|Overall Study|Withdrawal by Subject|4|||
42377400|NCT01483937|76248450|FG001|Overall Study|Withdrawal by Subject|3|||
42377401|NCT01483625|76248461|FG000|Overall Study|Adverse Event|1|||
42377402|NCT01483625|76248462|FG001|Overall Study|Adverse Event|1|||
42377403|NCT01483625|76248461|FG000|Overall Study|Refused to continue medication|2|||
42377404|NCT01483625|76248462|FG001|Overall Study|Refused to continue medication|1|||
42377405|NCT01483625|76248461|FG000|Overall Study|Due to other reason|1|||
42377406|NCT01483625|76248462|FG001|Overall Study|Due to other reason|0|||
42377407|NCT01485991|76248470|FG000|Overall Study|Adverse Event|0|||
42377408|NCT01485991|76248471|FG001|Overall Study|Adverse Event|4|||
42377409|NCT01485991|76248470|FG000|Overall Study|Lost to Follow-up|13|||
42377410|NCT01485991|76248471|FG001|Overall Study|Lost to Follow-up|10|||
42377411|NCT01485991|76248470|FG000|Overall Study|Withdrawal by Subject|13|||
42377412|NCT01485991|76248471|FG001|Overall Study|Withdrawal by Subject|20|||
42377413|NCT01485991|76248470|FG000|Overall Study|randomized but not treated|6|||
42377414|NCT01485991|76248471|FG001|Overall Study|randomized but not treated|2|||
42377415|NCT01482767|76248503|FG000|Overall Study|Death|1|||
42377416|NCT01482767|76248504|FG001|Overall Study|Death|1|||
42377417|NCT01482767|76248503|FG000|Overall Study|Withdrawal by Subject|7|||
42377418|NCT01482767|76248504|FG001|Overall Study|Withdrawal by Subject|5|||
42377419|NCT01482767|76248503|FG000|Overall Study|Lost to Follow-up|12|||
42377420|NCT01482767|76248504|FG001|Overall Study|Lost to Follow-up|6|||
42377421|NCT01482767|76248503|FG000|Overall Study|Adverse Event|0|||
42377422|NCT01482767|76248504|FG001|Overall Study|Adverse Event|3|||
42377423|NCT01482767|76248503|FG000|Overall Study|Site closure|22|||
42377424|NCT01482767|76248504|FG001|Overall Study|Site closure|14|||
42377425|NCT01482767|76248503|FG000|Overall Study|Non-adherence to study requirements|4|||
42377426|NCT01482767|76248504|FG001|Overall Study|Non-adherence to study requirements|7|||
42377427|NCT01482767|76248503|FG000|Overall Study|Alternate HCV treatment|7|||
42377428|NCT01482767|76248504|FG001|Overall Study|Alternate HCV treatment|8|||
42377429|NCT01482767|76248503|FG000|Overall Study|Ineligible|0|||
42377430|NCT01482767|76248504|FG001|Overall Study|Ineligible|5|||
42377431|NCT01482767|76248503|FG000|Overall Study|Nurse error|1|||
42377432|NCT01482767|76248504|FG001|Overall Study|Nurse error|0|||
42377433|NCT01482221|76248533|FG000|Overall Study|Lack of Efficacy|1|||
42377434|NCT01482221|76248534|FG001|Overall Study|Lack of Efficacy|0|||
42377435|NCT01482221|76248535|FG002|Overall Study|Lack of Efficacy|1|||
42377436|NCT01482221|76248533|FG000|Overall Study|Lost to Follow-up|3|||
42377437|NCT01482221|76248534|FG001|Overall Study|Lost to Follow-up|2|||
42377438|NCT01482221|76248535|FG002|Overall Study|Lost to Follow-up|1|||
42377439|NCT01482221|76248533|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
42377440|NCT01482221|76248534|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
42377441|NCT01482221|76248535|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
42377442|NCT01482221|76248533|FG000|Overall Study|Condition under Investigation Worsened|3|||
42377443|NCT01482221|76248534|FG001|Overall Study|Condition under Investigation Worsened|2|||
42377444|NCT01482221|76248535|FG002|Overall Study|Condition under Investigation Worsened|4|||
42377445|NCT01482221|76248533|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
42377446|NCT01482221|76248534|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
42377447|NCT01482221|76248535|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
42377448|NCT01482221|76248533|FG000|Overall Study|Adverse Event|1|||
42377449|NCT01482221|76248534|FG001|Overall Study|Adverse Event|7|||
42377450|NCT01482221|76248535|FG002|Overall Study|Adverse Event|3|||
42377451|NCT01482221|76248533|FG000|Overall Study|Withdrawal by Subject|10|||
42377452|NCT01482221|76248534|FG001|Overall Study|Withdrawal by Subject|7|||
42377453|NCT01482221|76248535|FG002|Overall Study|Withdrawal by Subject|12|||
42377454|NCT01482221|76248533|FG000|Overall Study|Incorrect randomization|0|||
42377455|NCT01482221|76248534|FG001|Overall Study|Incorrect randomization|1|||
42377456|NCT01482221|76248535|FG002|Overall Study|Incorrect randomization|0|||
42377457|NCT01482221|76248533|FG000|Overall Study|Physician Decision|0|||
42377458|NCT01482221|76248534|FG001|Overall Study|Physician Decision|1|||
42377459|NCT01482221|76248535|FG002|Overall Study|Physician Decision|0|||
42377460|NCT01482065|76248545|FG000|Overall Study|Withdrawal by Subject|0|||
42377461|NCT01482065|76248546|FG001|Overall Study|Withdrawal by Subject|1|||
42377462|NCT01545817|76248561|FG000|Pazopanib|Disease progression|51|||
42377463|NCT01545817|76248562|FG001|Pazopanib|Disease progression|0|||
42377464|NCT01545817|76248561|FG000|Pazopanib|Adverse Event|19|||
42377465|NCT01545817|76248562|FG001|Pazopanib|Adverse Event|0|||
42377466|NCT01545817|76248561|FG000|Pazopanib|Other reason|4|||
42377467|NCT01545817|76248562|FG001|Pazopanib|Other reason|0|||
42377468|NCT01545817|76248561|FG000|Everolimus|Other reason|0|||
42377469|NCT01545817|76248562|FG001|Everolimus|Other reason|7|||
42377470|NCT01545817|76248561|FG000|Everolimus|Disease progression|0|||
42377471|NCT01545817|76248562|FG001|Everolimus|Disease progression|25|||
42377472|NCT01545817|76248561|FG000|Everolimus|Adverse Event|0|||
42377473|NCT01545817|76248562|FG001|Everolimus|Adverse Event|6|||
42377474|NCT01512979|76248581|FG000|Overall Study|Adverse Event|2|||
42377475|NCT01512979|76248582|FG001|Overall Study|Adverse Event|2|||
42377476|NCT01512979|76248581|FG000|Overall Study|Protocol Violation|1|||
42377477|NCT01512979|76248582|FG001|Overall Study|Protocol Violation|4|||
42377478|NCT01512979|76248581|FG000|Overall Study|Lost to Follow-up|2|||
42377479|NCT01512979|76248582|FG001|Overall Study|Lost to Follow-up|5|||
42377480|NCT01512979|76248581|FG000|Overall Study|Withdrawal by Subject|1|||
42377481|NCT01512979|76248582|FG001|Overall Study|Withdrawal by Subject|2|||
42377482|NCT01512979|76248581|FG000|Overall Study|Reason other than stated above|13|||
42377483|NCT01512979|76248582|FG001|Overall Study|Reason other than stated above|9|||
42377484|NCT01512745|76248594|FG000|Overall Study|Adverse Event|22|||
42377485|NCT01512745|76248595|FG001|Overall Study|Adverse Event|3|||
42377486|NCT01512745|76248594|FG000|Overall Study|Death|9|||
42377487|NCT01512745|76248595|FG001|Overall Study|Death|13|||
42377488|NCT01512745|76248594|FG000|Overall Study|Withdrawal by Subject|2|||
42377489|NCT01512745|76248595|FG001|Overall Study|Withdrawal by Subject|2|||
42377490|NCT01512745|76248594|FG000|Overall Study|Lost to Follow-up|4|||
42377491|NCT01512745|76248595|FG001|Overall Study|Lost to Follow-up|0|||
42377492|NCT01512745|76248594|FG000|Overall Study|Lack of Efficacy|2|||
42377493|NCT01512745|76248595|FG001|Overall Study|Lack of Efficacy|2|||
42377494|NCT01512745|76248594|FG000|Overall Study|Protocol Violation|1|||
42377495|NCT01512745|76248595|FG001|Overall Study|Protocol Violation|0|||
42377496|NCT01478321|76248601|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
42377497|NCT01478321|76248601|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
42377498|NCT01478321|76248601|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
42377499|NCT01478321|76248601|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
42377500|NCT01478321|76248601|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
42377501|NCT01478321|76248601|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
42377502|NCT01478321|76248601|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
42377503|NCT01478321|76248601|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
42377504|NCT01544491|76248607|FG000|Overall Study|Withdrawal by Subject|3|||
42377505|NCT01544491|76248608|FG001|Overall Study|Withdrawal by Subject|2|||
42377506|NCT01544491|76248607|FG000|Overall Study|Lost to Follow-up|0|||
42377507|NCT01544491|76248608|FG001|Overall Study|Lost to Follow-up|1|||
42377508|NCT01544491|76248607|FG000|Overall Study|administrative problems|2|||
42377509|NCT01544491|76248608|FG001|Overall Study|administrative problems|0|||
42377510|NCT01478087|76248627|FG000|Overall Study|due to sponsor closing study|1|||
42377511|NCT01477853|76248645|FG000|Phase A|Adverse Event|1|||
42377512|NCT01477853|76248646|FG001|Phase A|Adverse Event|2|||
42377513|NCT01477853|76248647|FG002|Phase A|Adverse Event|2|||
42377514|NCT01477853|76248645|FG000|Phase A|Lost to Follow-up|4|||
42377515|NCT01477853|76248646|FG001|Phase A|Lost to Follow-up|3|||
42377516|NCT01477853|76248647|FG002|Phase A|Lost to Follow-up|2|||
42377517|NCT01477853|76248645|FG000|Phase A|Physician Decision|1|||
42377518|NCT01477853|76248646|FG001|Phase A|Physician Decision|0|||
42377519|NCT01477853|76248647|FG002|Phase A|Physician Decision|1|||
42377520|NCT01477853|76248645|FG000|Phase A|Study terminated by sponsor|37|||
42377521|NCT01477853|76248646|FG001|Phase A|Study terminated by sponsor|40|||
42377522|NCT01477853|76248647|FG002|Phase A|Study terminated by sponsor|39|||
42377523|NCT01477853|76248645|FG000|Phase B|Lost to Follow-up|0|||
42377524|NCT01477853|76248646|FG001|Phase B|Lost to Follow-up|1|||
42377525|NCT01477853|76248647|FG002|Phase B|Lost to Follow-up|0|||
42377526|NCT01477853|76248645|FG000|Phase B|Study terminated by sponsor|12|||
42377527|NCT01477853|76248646|FG001|Phase B|Study terminated by sponsor|10|||
42377528|NCT01477853|76248647|FG002|Phase B|Study terminated by sponsor|11|||
42377529|NCT01511419|76248679|FG000|Dose 2|Physician Decision|1|||
42377530|NCT01511419|76248680|FG001|Dose 2|Physician Decision|0|||
42377531|NCT01511107|76248742|FG000|Overall Study|Ineligible|3|||
42377532|NCT01511107|76248743|FG001|Overall Study|Ineligible|2|||
42377533|NCT01511107|76248742|FG000|Overall Study|Lost to Follow-up|10|||
42377534|NCT01511107|76248743|FG001|Overall Study|Lost to Follow-up|19|||
42377535|NCT01511107|76248742|FG000|Overall Study|Withdrawal by Subject|9|||
42377536|NCT01511107|76248743|FG001|Overall Study|Withdrawal by Subject|20|||
42377537|NCT01484977|76248778|FG000|Overall Study|Adverse Event|8|||
42377538|NCT01484977|76248778|FG000|Overall Study|Lack of Efficacy|4|||
42377539|NCT01484977|76248778|FG000|Overall Study|Protocol Violation|6|||
42377540|NCT01484977|76248778|FG000|Overall Study|Lost to Follow-up|1|||
42377541|NCT01484977|76248778|FG000|Overall Study|Withdrawal by Subject|4|||
42377542|NCT01484977|76248778|FG000|Overall Study|Subject Protocol Non-compliant|1|||
42377543|NCT01484977|76248778|FG000|Overall Study|Moving Overseas|1|||
42377544|NCT01484977|76248778|FG000|Overall Study|Low White Blood Cell Count|1|||
42377545|NCT01484977|76248778|FG000|Overall Study|Lack of Compliance|1|||
42377546|NCT01475825|76248858|FG000|Overall Study|Adverse Event|41|||
42377547|NCT01475825|76248859|FG001|Overall Study|Adverse Event|15|||
42377548|NCT01475825|76248860|FG002|Overall Study|Adverse Event|27|||
42377549|NCT01475825|76248861|FG003|Overall Study|Adverse Event|11|||
42377550|NCT01475825|76248858|FG000|Overall Study|Death|1|||
42377551|NCT01475825|76248859|FG001|Overall Study|Death|0|||
42377552|NCT01475825|76248860|FG002|Overall Study|Death|1|||
42377553|NCT01475825|76248861|FG003|Overall Study|Death|0|||
42377554|NCT01475825|76248858|FG000|Overall Study|Lack of Efficacy|0|||
42377555|NCT01475825|76248859|FG001|Overall Study|Lack of Efficacy|0|||
42377556|NCT01475825|76248860|FG002|Overall Study|Lack of Efficacy|1|||
42377557|NCT01475825|76248861|FG003|Overall Study|Lack of Efficacy|0|||
42377558|NCT01475825|76248858|FG000|Overall Study|Lost to Follow-up|0|||
42377559|NCT01475825|76248859|FG001|Overall Study|Lost to Follow-up|0|||
42377560|NCT01475825|76248860|FG002|Overall Study|Lost to Follow-up|3|||
42377561|NCT01475825|76248861|FG003|Overall Study|Lost to Follow-up|1|||
42377562|NCT01475825|76248858|FG000|Overall Study|Non-compliance with Study Drug|1|||
42377563|NCT01475825|76248859|FG001|Overall Study|Non-compliance with Study Drug|2|||
42377564|NCT01475825|76248860|FG002|Overall Study|Non-compliance with Study Drug|4|||
42377565|NCT01475825|76248861|FG003|Overall Study|Non-compliance with Study Drug|0|||
42377566|NCT01475825|76248858|FG000|Overall Study|Other: Not available|0|||
42377567|NCT01475825|76248859|FG001|Overall Study|Other: Not available|0|||
42377568|NCT01475825|76248860|FG002|Overall Study|Other: Not available|2|||
42377569|NCT01475825|76248861|FG003|Overall Study|Other: Not available|0|||
42377570|NCT01475825|76248858|FG000|Overall Study|Protocol Violation|1|||
42377571|NCT01475825|76248859|FG001|Overall Study|Protocol Violation|0|||
42377572|NCT01475825|76248860|FG002|Overall Study|Protocol Violation|0|||
42377573|NCT01475825|76248861|FG003|Overall Study|Protocol Violation|0|||
42377574|NCT01475825|76248858|FG000|Overall Study|Physician Decision|0|||
42377575|NCT01475825|76248859|FG001|Overall Study|Physician Decision|1|||
42377576|NCT01475825|76248860|FG002|Overall Study|Physician Decision|0|||
42377577|NCT01475825|76248861|FG003|Overall Study|Physician Decision|0|||
42377578|NCT01475825|76248858|FG000|Overall Study|Withdrawal by Subject|8|||
42377579|NCT01475825|76248859|FG001|Overall Study|Withdrawal by Subject|3|||
42377580|NCT01475825|76248860|FG002|Overall Study|Withdrawal by Subject|11|||
42377581|NCT01475825|76248861|FG003|Overall Study|Withdrawal by Subject|7|||
42377582|NCT01475825|76248858|FG000|Overall Study|Did not enter OLC|15|||
42377583|NCT01475825|76248859|FG001|Overall Study|Did not enter OLC|11|||
42377584|NCT01475825|76248860|FG002|Overall Study|Did not enter OLC|15|||
42377585|NCT01475825|76248861|FG003|Overall Study|Did not enter OLC|11|||
42377586|NCT01484431|76248883|FG000|Period 1: High Dose|Physician Decision|0|||
42377587|NCT01484431|76248884|FG001|Period 1: High Dose|Physician Decision|1|||
42377588|NCT01484431|76248885|FG002|Period 1: High Dose|Physician Decision|0|||
42377589|NCT01484431|76248883|FG000|Period 2|Death|0|||
42377590|NCT01484431|76248884|FG001|Period 2|Death|1|||
42377591|NCT01484431|76248885|FG002|Period 2|Death|1|||
42377592|NCT01484431|76248883|FG000|Period 2|Physician Decision|0|||
42377593|NCT01484431|76248884|FG001|Period 2|Physician Decision|0|||
42377594|NCT01484431|76248885|FG002|Period 2|Physician Decision|1|||
42377595|NCT01484431|76248883|FG000|Period 2|Non-Compliance with Study Drug|1|||
42377596|NCT01484431|76248884|FG001|Period 2|Non-Compliance with Study Drug|0|||
42377597|NCT01484431|76248885|FG002|Period 2|Non-Compliance with Study Drug|0|||
42377598|NCT01473953|76248933|FG000|Overall Study|Other|1|||
42377599|NCT01473953|76248934|FG001|Overall Study|Other|0|||
42377600|NCT01473953|76248935|FG002|Overall Study|Other|0|||
42377601|NCT01473953|76248936|FG003|Overall Study|Other|0|||
42377602|NCT01473953|76248937|FG004|Overall Study|Other|0|||
42377603|NCT01510717|76248951|FG000|Overall Study|Adverse Event|1|||
42377604|NCT01510717|76248952|FG001|Overall Study|Adverse Event|2|||
42377605|NCT01510717|76248951|FG000|Overall Study|Death|1|||
42377606|NCT01510717|76248952|FG001|Overall Study|Death|0|||
42377607|NCT01510717|76248951|FG000|Overall Study|Lost to Follow-up|0|||
42377608|NCT01510717|76248952|FG001|Overall Study|Lost to Follow-up|1|||
42377609|NCT01510717|76248951|FG000|Overall Study|Withdrawal by Subject|0|||
42377610|NCT01510717|76248952|FG001|Overall Study|Withdrawal by Subject|2|||
42377611|NCT01473563|76248968|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
42377612|NCT01484275|76248986|FG000|Overall Study|Study terminated by sponsor|28|||
42377613|NCT01484275|76248987|FG001|Overall Study|Study terminated by sponsor|32|||
42377614|NCT01484275|76248986|FG000|Overall Study|Other|10|||
42377615|NCT01484275|76248987|FG001|Overall Study|Other|0|||
42377616|NCT01484275|76248986|FG000|Overall Study|Death|3|||
42377617|NCT01484275|76248987|FG001|Overall Study|Death|4|||
42377618|NCT01484275|76248986|FG000|Overall Study|Withdrawal by Subject|1|||
42377619|NCT01484275|76248987|FG001|Overall Study|Withdrawal by Subject|5|||
42377620|NCT01484275|76248986|FG000|Overall Study|Lost to Follow-up|1|||
42377621|NCT01484275|76248987|FG001|Overall Study|Lost to Follow-up|1|||
42377622|NCT01544335|76248993|FG000|Overall Study|Lost to Follow-up|27|||
42377623|NCT01544335|76248993|FG000|Overall Study|Death|4|||
42377624|NCT01544335|76248993|FG000|Overall Study|Disease progression|3|||
42377625|NCT01544335|76248993|FG000|Overall Study|Baseline Measurements not Available|19|||
42377626|NCT01484197|76248997|FG000|Treatment Period 1|Adverse Event|1|||
42377627|NCT01484197|76248998|FG001|Treatment Period 1|Adverse Event|0|||
42377628|NCT01484197|76248999|FG002|Treatment Period 1|Adverse Event|0|||
42377629|NCT01484197|76249000|FG003|Treatment Period 1|Adverse Event|0|||
42377630|NCT01484197|76248997|FG000|Treatment Period 2|Subject withdrew consent|0|||
42377631|NCT01484197|76248998|FG001|Treatment Period 2|Subject withdrew consent|0|||
42377632|NCT01484197|76248999|FG002|Treatment Period 2|Subject withdrew consent|0|||
42377633|NCT01484197|76249000|FG003|Treatment Period 2|Subject withdrew consent|1|||
42377634|NCT01473407|76249012|FG000|Overall Study|Physician Decision|1|||
42377635|NCT01473407|76249013|FG001|Overall Study|Physician Decision|4|||
42377636|NCT01473407|76249012|FG000|Overall Study|Lost to Follow-up|10|||
42377637|NCT01473407|76249013|FG001|Overall Study|Lost to Follow-up|4|||
42377638|NCT01473407|76249012|FG000|Overall Study|Adverse Event|8|||
42377639|NCT01473407|76249013|FG001|Overall Study|Adverse Event|8|||
42377640|NCT01473407|76249012|FG000|Overall Study|Randomization Error|3|||
42377641|NCT01473407|76249013|FG001|Overall Study|Randomization Error|1|||
42377642|NCT01473407|76249012|FG000|Overall Study|Withdrawal by Subject|4|||
42377643|NCT01473407|76249013|FG001|Overall Study|Withdrawal by Subject|7|||
42377644|NCT01473407|76249012|FG000|Overall Study|Kidney Transplant|7|||
42377645|NCT01473407|76249013|FG001|Overall Study|Kidney Transplant|6|||
42377646|NCT01473407|76249012|FG000|Overall Study|Vacation/Travel|1|||
42377647|NCT01473407|76249013|FG001|Overall Study|Vacation/Travel|1|||
42377648|NCT01473407|76249012|FG000|Overall Study|Elevated Hemoglobin|1|||
42377649|NCT01473407|76249013|FG001|Overall Study|Elevated Hemoglobin|0|||
42377650|NCT01473407|76249012|FG000|Overall Study|Patient Received Aranesp|1|||
42377651|NCT01473407|76249013|FG001|Overall Study|Patient Received Aranesp|0|||
42377652|NCT01473407|76249012|FG000|Overall Study|Patient Lost Green Card Status|1|||
42377653|NCT01473407|76249013|FG001|Overall Study|Patient Lost Green Card Status|0|||
42377654|NCT01473407|76249012|FG000|Overall Study|Temperature Excursion|2|||
42377655|NCT01473407|76249013|FG001|Overall Study|Temperature Excursion|3|||
42377656|NCT01473407|76249012|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
42377657|NCT01473407|76249013|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
42377658|NCT01473407|76249012|FG000|Overall Study|Sponsor's Decision|10|||
42377659|NCT01473407|76249013|FG001|Overall Study|Sponsor's Decision|10|||
42377660|NCT01473407|76249012|FG000|Overall Study|Site Closure|1|||
42377661|NCT01473407|76249013|FG001|Overall Study|Site Closure|0|||
42377662|NCT01472939|76249023|FG000|Overall Study|Adverse Event|3|||
42377663|NCT01472939|76249024|FG001|Overall Study|Adverse Event|7|||
42377664|NCT01472939|76249025|FG002|Overall Study|Adverse Event|7|||
42377665|NCT01472939|76249026|FG003|Overall Study|Adverse Event|14|||
42377666|NCT01472939|76249023|FG000|Overall Study|Lack of Efficacy|1|||
42377667|NCT01472939|76249024|FG001|Overall Study|Lack of Efficacy|0|||
42377668|NCT01472939|76249025|FG002|Overall Study|Lack of Efficacy|0|||
42377669|NCT01472939|76249026|FG003|Overall Study|Lack of Efficacy|1|||
42377670|NCT01472939|76249023|FG000|Overall Study|Lost to Follow-up|3|||
42377671|NCT01472939|76249024|FG001|Overall Study|Lost to Follow-up|0|||
42377672|NCT01472939|76249025|FG002|Overall Study|Lost to Follow-up|2|||
42377673|NCT01472939|76249026|FG003|Overall Study|Lost to Follow-up|0|||
42377674|NCT01472939|76249023|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
42377675|NCT01472939|76249024|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
42377676|NCT01472939|76249025|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
42377677|NCT01472939|76249026|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
42377678|NCT01472939|76249023|FG000|Overall Study|Prohibited Medication|0|||
42377679|NCT01472939|76249024|FG001|Overall Study|Prohibited Medication|1|||
42377680|NCT01472939|76249025|FG002|Overall Study|Prohibited Medication|0|||
42377681|NCT01472939|76249026|FG003|Overall Study|Prohibited Medication|0|||
42377682|NCT01472939|76249023|FG000|Overall Study|Withdrawal By PI|1|||
42377683|NCT01472939|76249024|FG001|Overall Study|Withdrawal By PI|0|||
42377684|NCT01472939|76249025|FG002|Overall Study|Withdrawal By PI|0|||
42200827|NCT04500769|76012821|FG000|Overall Study|Withdrawal by Subject|5|||
42200828|NCT04446377|76012827|FG000|Overall Study|Withdrawal by Subject|6|||
42200829|NCT04446377|76012828|FG001|Overall Study|Withdrawal by Subject|1|||
42200830|NCT04446377|76012827|FG000|Overall Study|Physician Decision|1|||
42200831|NCT04446377|76012828|FG001|Overall Study|Physician Decision|1|||
42200832|NCT04446377|76012827|FG000|Overall Study|Lost to Follow-up|0|||
42200833|NCT04446377|76012828|FG001|Overall Study|Lost to Follow-up|2|||
42377685|NCT01472939|76249026|FG003|Overall Study|Withdrawal By PI|0|||
42377686|NCT01472939|76249023|FG000|Overall Study|Protocol Violation|3|||
42377687|NCT01472939|76249024|FG001|Overall Study|Protocol Violation|3|||
42377688|NCT01472939|76249025|FG002|Overall Study|Protocol Violation|0|||
42377689|NCT01472939|76249026|FG003|Overall Study|Protocol Violation|1|||
42377690|NCT01472939|76249023|FG000|Overall Study|Withdrawal by Subject|9|||
42377691|NCT01472939|76249024|FG001|Overall Study|Withdrawal by Subject|3|||
42377692|NCT01472939|76249025|FG002|Overall Study|Withdrawal by Subject|1|||
42377693|NCT01472939|76249026|FG003|Overall Study|Withdrawal by Subject|4|||
42377694|NCT01544179|76249041|FG000|Overall Study|Death|50|||
42377695|NCT01544179|76249042|FG001|Overall Study|Death|37|||
42377696|NCT01544179|76249041|FG000|Overall Study|Lost to Follow-up|0|||
42377697|NCT01544179|76249042|FG001|Overall Study|Lost to Follow-up|1|||
42377698|NCT01544179|76249041|FG000|Overall Study|Adverse Event|0|||
42377699|NCT01544179|76249042|FG001|Overall Study|Adverse Event|1|||
42377700|NCT01544179|76249041|FG000|Overall Study|Withdrawal by Subject|12|||
42377701|NCT01544179|76249042|FG001|Overall Study|Withdrawal by Subject|7|||
42377702|NCT01544179|76249041|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
42377703|NCT01544179|76249042|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
42377704|NCT01483651|76249048|FG000|Overall Study|Withdrawal by Subject|0|||
42377705|NCT01483651|76249049|FG001|Overall Study|Withdrawal by Subject|1|||
42377706|NCT01483651|76249050|FG002|Overall Study|Withdrawal by Subject|1|||
42377707|NCT01483651|76249051|FG003|Overall Study|Withdrawal by Subject|0|||
42377708|NCT01483651|76249052|FG004|Overall Study|Withdrawal by Subject|0|||
42377709|NCT01483651|76249053|FG005|Overall Study|Withdrawal by Subject|1|||
42377710|NCT01464307|76249063|FG000|Main Period|Death|0|||
42377711|NCT01464307|76249064|FG001|Main Period|Death|1|||
42377712|NCT01464307|76249063|FG000|Main Period|Adverse Event|6|||
42377713|NCT01464307|76249064|FG001|Main Period|Adverse Event|1|||
42377714|NCT01464307|76249063|FG000|Main Period|Lack of Efficacy|2|||
42377715|NCT01464307|76249064|FG001|Main Period|Lack of Efficacy|0|||
42377716|NCT01464307|76249063|FG000|Main Period|Withdrawal by Subject|5|||
42377717|NCT01464307|76249064|FG001|Main Period|Withdrawal by Subject|2|||
42377718|NCT01464307|76249063|FG000|Main Period|Predefined discontinuation criteria|2|||
42377719|NCT01464307|76249064|FG001|Main Period|Predefined discontinuation criteria|1|||
42377720|NCT01464307|76249063|FG000|Open-Label Extension Period|Adverse Event|15|||
42377721|NCT01464307|76249064|FG001|Open-Label Extension Period|Adverse Event|0|||
42377722|NCT01464307|76249063|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
42377723|NCT01464307|76249064|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
42377724|NCT01464307|76249063|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
42377725|NCT01464307|76249064|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
42377726|NCT01464307|76249063|FG000|Open-Label Extension Period|Death|1|||
42377727|NCT01464307|76249064|FG001|Open-Label Extension Period|Death|0|||
42377728|NCT01464307|76249063|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
42377729|NCT01464307|76249064|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
42377730|NCT01464307|76249063|FG000|Open-Label Extension Period|Non-compliance|9|||
42377731|NCT01464307|76249064|FG001|Open-Label Extension Period|Non-compliance|0|||
42377732|NCT01464307|76249063|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
42377733|NCT01464307|76249064|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
42377734|NCT01483183|76249081|FG000|Overall Study|Physician Decision|0|||
42377735|NCT01483183|76249082|FG001|Overall Study|Physician Decision|0|||
42377736|NCT01483183|76249083|FG002|Overall Study|Physician Decision|0|||
42377737|NCT01483183|76249084|FG003|Overall Study|Physician Decision|0|||
42377738|NCT01483183|76249085|FG004|Overall Study|Physician Decision|0|||
42377739|NCT01483183|76249086|FG005|Overall Study|Physician Decision|0|||
42377740|NCT01483183|76249087|FG006|Overall Study|Physician Decision|2|||
42377741|NCT01483183|76249088|FG007|Overall Study|Physician Decision|0|||
42377742|NCT01483183|76249089|FG008|Overall Study|Physician Decision|0|||
42377743|NCT01483183|76249090|FG009|Overall Study|Physician Decision|0|||
42377744|NCT01483183|76249081|FG000|Overall Study|Withdrawal by Subject|0|||
42377745|NCT01483183|76249082|FG001|Overall Study|Withdrawal by Subject|0|||
42377746|NCT01483183|76249083|FG002|Overall Study|Withdrawal by Subject|0|||
42103626|NCT00673790|75914528|FG002|Overall Study|Poor compliance|0|||
42103627|NCT00673790|75914526|FG000|Overall Study|Participated in two Nebivolol studies|0|||
42377747|NCT01483183|76249084|FG003|Overall Study|Withdrawal by Subject|0|||
42200834|NCT04446377|76012827|FG000|Overall Study|Not eligible|0|||
42377748|NCT01483183|76249085|FG004|Overall Study|Withdrawal by Subject|0|||
42377749|NCT01483183|76249086|FG005|Overall Study|Withdrawal by Subject|0|||
42103628|NCT00673790|75914527|FG001|Overall Study|Participated in two Nebivolol studies|0|||
42377750|NCT01483183|76249087|FG006|Overall Study|Withdrawal by Subject|0|||
42377751|NCT01483183|76249088|FG007|Overall Study|Withdrawal by Subject|0|||
42377752|NCT01483183|76249089|FG008|Overall Study|Withdrawal by Subject|0|||
42377753|NCT01483183|76249090|FG009|Overall Study|Withdrawal by Subject|1|||
42377754|NCT01483027|76249120|FG000|Overall Study|Administrative Reasons|2|||
42377755|NCT01483027|76249121|FG001|Overall Study|Administrative Reasons|1|||
42377756|NCT01483027|76249120|FG000|Overall Study|Withdrawal by Subject|21|||
42103629|NCT00673790|75914528|FG002|Overall Study|Participated in two Nebivolol studies|1|||
42377757|NCT01483027|76249121|FG001|Overall Study|Withdrawal by Subject|32|||
42377758|NCT01483027|76249120|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
42377759|NCT01483027|76249121|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
42377760|NCT01483027|76249120|FG000|Overall Study|Lost to Follow-up|1|||
42377761|NCT01483027|76249121|FG001|Overall Study|Lost to Follow-up|1|||
42377762|NCT01483027|76249120|FG000|Overall Study|Adverse Event|0|||
42377763|NCT01483027|76249121|FG001|Overall Study|Adverse Event|1|||
42377764|NCT01483027|76249120|FG000|Overall Study|Withdrawal by Subject|0|||
42377765|NCT01483027|76249121|FG001|Overall Study|Withdrawal by Subject|1|||
42377766|NCT01463683|76249130|FG000|Overall Study|Adverse Event|2|||
42377767|NCT01463683|76249131|FG001|Overall Study|Adverse Event|0|||
42377768|NCT01463683|76249132|FG002|Overall Study|Adverse Event|0|||
42377769|NCT01463683|76249130|FG000|Overall Study|Lost to Follow-up|10|||
42377770|NCT01463683|76249131|FG001|Overall Study|Lost to Follow-up|9|||
42377771|NCT01463683|76249132|FG002|Overall Study|Lost to Follow-up|7|||
42377772|NCT01463683|76249130|FG000|Overall Study|Physician Decision|0|||
42377773|NCT01463683|76249131|FG001|Overall Study|Physician Decision|3|||
42377774|NCT01463683|76249132|FG002|Overall Study|Physician Decision|1|||
42377775|NCT01463683|76249130|FG000|Overall Study|Pregnancy|2|||
42377776|NCT01463683|76249131|FG001|Overall Study|Pregnancy|2|||
42377777|NCT01463683|76249132|FG002|Overall Study|Pregnancy|1|||
42377778|NCT01463683|76249130|FG000|Overall Study|Withdrawal by Subject|5|||
42377779|NCT01463683|76249131|FG001|Overall Study|Withdrawal by Subject|17|||
42377780|NCT01463683|76249132|FG002|Overall Study|Withdrawal by Subject|2|||
42377781|NCT01482169|76249140|FG000|Overall Study|Physician Decision|2|||
42377782|NCT01481779|76249149|FG000|Overall Study|Adverse Event|23|||
42377783|NCT01481779|76249150|FG001|Overall Study|Adverse Event|5|||
42377784|NCT01481779|76249149|FG000|Overall Study|Lost to Follow-up|3|||
42377785|NCT01481779|76249150|FG001|Overall Study|Lost to Follow-up|2|||
42377786|NCT01481779|76249149|FG000|Overall Study|Protocol Violation|2|||
42377787|NCT01481779|76249150|FG001|Overall Study|Protocol Violation|3|||
42377788|NCT01481779|76249149|FG000|Overall Study|Withdrawal by Subject|26|||
42377789|NCT01481779|76249150|FG001|Overall Study|Withdrawal by Subject|13|||
42377790|NCT01481779|76249149|FG000|Overall Study|Physician Decision|13|||
42377791|NCT01481779|76249150|FG001|Overall Study|Physician Decision|4|||
42377792|NCT01481779|76249149|FG000|Overall Study|Sponsor Decision|3|||
42377793|NCT01481779|76249150|FG001|Overall Study|Sponsor Decision|1|||
42377794|NCT01463527|76249158|FG000|Overall Study|Protocol Violation|1|||
42377795|NCT01463527|76249159|FG001|Overall Study|Protocol Violation|1|||
42377796|NCT01463527|76249158|FG000|Overall Study|Crying >20% of sedation|5|||
42377797|NCT01463527|76249159|FG001|Overall Study|Crying >20% of sedation|6|||
42377798|NCT01509547|76249167|FG000|Overall Study|Lost to Follow-up|24|||
42377799|NCT01509547|76249168|FG001|Overall Study|Lost to Follow-up|14|||
42377800|NCT01509547|76249167|FG000|Overall Study|Withdrawal by Subject|11|||
42377801|NCT01509547|76249168|FG001|Overall Study|Withdrawal by Subject|24|||
42377802|NCT01509547|76249167|FG000|Overall Study|Physician Decision|0|||
42377803|NCT01509547|76249168|FG001|Overall Study|Physician Decision|1|||
42377804|NCT01509079|76249176|FG000|Overall Study|Lack of Efficacy|0|||
42377805|NCT01509079|76249177|FG001|Overall Study|Lack of Efficacy|2|||
42377806|NCT01509079|76249176|FG000|Overall Study|started an excluded medication|0|||
42377807|NCT01509079|76249177|FG001|Overall Study|started an excluded medication|1|||
42377808|NCT01463293|76249186|FG000|Overall Study|Lost to Follow-up|1|||
42377809|NCT01463293|76249187|FG001|Overall Study|Lost to Follow-up|4|||
42377810|NCT01463293|76249188|FG002|Overall Study|Lost to Follow-up|5|||
42377811|NCT01463293|76249186|FG000|Overall Study|Adverse Event|1|||
42377812|NCT01463293|76249187|FG001|Overall Study|Adverse Event|2|||
42377813|NCT01463293|76249188|FG002|Overall Study|Adverse Event|0|||
42377814|NCT01463293|76249186|FG000|Overall Study|Withdrawal by Subject|4|||
42377815|NCT01463293|76249187|FG001|Overall Study|Withdrawal by Subject|10|||
42377816|NCT01463293|76249188|FG002|Overall Study|Withdrawal by Subject|5|||
42377817|NCT01463293|76249186|FG000|Overall Study|Other|0|||
42377818|NCT01463293|76249187|FG001|Overall Study|Other|0|||
42377819|NCT01463293|76249188|FG002|Overall Study|Other|2|||
42377820|NCT01479985|76249219|FG000|Overall Study|Tablet malfunction, no data saved|1|||
42377821|NCT01479985|76249220|FG001|Overall Study|Tablet malfunction, no data saved|1|||
42377822|NCT01479985|76249219|FG000|Overall Study|No decisional conflict scale responses|0|||
42377823|NCT01479985|76249220|FG001|Overall Study|No decisional conflict scale responses|2|||
42377824|NCT01479985|76249219|FG000|Overall Study|No post-visit survey|5|||
42377825|NCT01479985|76249220|FG001|Overall Study|No post-visit survey|3|||
42377826|NCT01462435|76249234|FG000|Overall Study|Lack of Efficacy|1|||
42377827|NCT01462435|76249235|FG001|Overall Study|Lack of Efficacy|0|||
42377828|NCT01462435|76249236|FG002|Overall Study|Lack of Efficacy|0|||
42377829|NCT01462435|76249237|FG003|Overall Study|Lack of Efficacy|3|||
42377830|NCT01462435|76249234|FG000|Overall Study|Physician Decision|0|||
42377831|NCT01462435|76249235|FG001|Overall Study|Physician Decision|0|||
42377832|NCT01462435|76249236|FG002|Overall Study|Physician Decision|1|||
42377833|NCT01462435|76249237|FG003|Overall Study|Physician Decision|0|||
42377834|NCT01462435|76249234|FG000|Overall Study|Withdrawal by Subject|0|||
42377835|NCT01462435|76249235|FG001|Overall Study|Withdrawal by Subject|0|||
42377836|NCT01462435|76249236|FG002|Overall Study|Withdrawal by Subject|0|||
42377837|NCT01462435|76249237|FG003|Overall Study|Withdrawal by Subject|1|||
42377838|NCT01462435|76249234|FG000|Overall Study|Lost to Follow-up|0|||
42377839|NCT01462435|76249235|FG001|Overall Study|Lost to Follow-up|0|||
42377840|NCT01462435|76249236|FG002|Overall Study|Lost to Follow-up|0|||
42377841|NCT01462435|76249237|FG003|Overall Study|Lost to Follow-up|1|||
42377842|NCT01472081|76249253|FG000|Overall Study|Continuing treatment at time of analysis|1|||
42377843|NCT01472081|76249254|FG001|Overall Study|Continuing treatment at time of analysis|4|||
42377844|NCT01472081|76249255|FG002|Overall Study|Continuing treatment at time of analysis|1|||
42377845|NCT01472081|76249256|FG003|Overall Study|Continuing treatment at time of analysis|8|||
42377846|NCT01472081|76249257|FG004|Overall Study|Continuing treatment at time of analysis|9|||
42377847|NCT01472081|76249258|FG005|Overall Study|Continuing treatment at time of analysis|0|||
42377848|NCT01472081|76249253|FG000|Overall Study|Disease Progression|4|||
42377849|NCT01472081|76249254|FG001|Overall Study|Disease Progression|10|||
42377850|NCT01472081|76249255|FG002|Overall Study|Disease Progression|12|||
42377851|NCT01472081|76249256|FG003|Overall Study|Disease Progression|31|||
42377852|NCT01472081|76249257|FG004|Overall Study|Disease Progression|22|||
42377853|NCT01472081|76249258|FG005|Overall Study|Disease Progression|3|||
42377854|NCT01472081|76249253|FG000|Overall Study|Study drug toxicity|2|||
42377855|NCT01472081|76249254|FG001|Overall Study|Study drug toxicity|9|||
42377856|NCT01472081|76249255|FG002|Overall Study|Study drug toxicity|4|||
42377857|NCT01472081|76249256|FG003|Overall Study|Study drug toxicity|6|||
42377858|NCT01472081|76249257|FG004|Overall Study|Study drug toxicity|13|||
42377859|NCT01472081|76249258|FG005|Overall Study|Study drug toxicity|2|||
42377860|NCT01472081|76249253|FG000|Overall Study|Death|0|||
42377861|NCT01472081|76249254|FG001|Overall Study|Death|0|||
42377862|NCT01472081|76249255|FG002|Overall Study|Death|0|||
42377863|NCT01472081|76249256|FG003|Overall Study|Death|0|||
42377864|NCT01472081|76249257|FG004|Overall Study|Death|1|||
42377865|NCT01472081|76249258|FG005|Overall Study|Death|0|||
42377866|NCT01472081|76249253|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
42377867|NCT01472081|76249254|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
42377868|NCT01472081|76249255|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
42377869|NCT01472081|76249256|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
42377870|NCT01472081|76249257|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
42377871|NCT01472081|76249258|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
42377872|NCT01472081|76249253|FG000|Overall Study|Withdrawal by Subject|0|||
42377873|NCT01472081|76249254|FG001|Overall Study|Withdrawal by Subject|0|||
42377874|NCT01472081|76249255|FG002|Overall Study|Withdrawal by Subject|0|||
42377875|NCT01472081|76249256|FG003|Overall Study|Withdrawal by Subject|0|||
42377876|NCT01472081|76249257|FG004|Overall Study|Withdrawal by Subject|0|||
42377877|NCT01472081|76249258|FG005|Overall Study|Withdrawal by Subject|1|||
42377878|NCT01472081|76249253|FG000|Overall Study|Poor/non-compliance|0|||
42377879|NCT01472081|76249254|FG001|Overall Study|Poor/non-compliance|0|||
42377880|NCT01472081|76249255|FG002|Overall Study|Poor/non-compliance|1|||
42377881|NCT01472081|76249256|FG003|Overall Study|Poor/non-compliance|0|||
42377882|NCT01472081|76249257|FG004|Overall Study|Poor/non-compliance|1|||
42377883|NCT01472081|76249258|FG005|Overall Study|Poor/non-compliance|0|||
42377884|NCT01472081|76249253|FG000|Overall Study|No longer meets study criteria|0|||
42377885|NCT01472081|76249254|FG001|Overall Study|No longer meets study criteria|0|||
42377886|NCT01472081|76249255|FG002|Overall Study|No longer meets study criteria|1|||
42377887|NCT01472081|76249256|FG003|Overall Study|No longer meets study criteria|0|||
42377888|NCT01472081|76249257|FG004|Overall Study|No longer meets study criteria|0|||
42377889|NCT01472081|76249258|FG005|Overall Study|No longer meets study criteria|0|||
42377890|NCT01472081|76249253|FG000|Overall Study|Subject request to discontinue treatment|0|||
42377891|NCT01472081|76249254|FG001|Overall Study|Subject request to discontinue treatment|3|||
42377892|NCT01472081|76249255|FG002|Overall Study|Subject request to discontinue treatment|1|||
42377893|NCT01472081|76249256|FG003|Overall Study|Subject request to discontinue treatment|1|||
42377894|NCT01472081|76249257|FG004|Overall Study|Subject request to discontinue treatment|0|||
42377895|NCT01472081|76249258|FG005|Overall Study|Subject request to discontinue treatment|0|||
42377896|NCT01471691|76249273|FG000|Overall Study|Lack of Efficacy|0|||
42377897|NCT01471691|76249274|FG001|Overall Study|Lack of Efficacy|1|||
42377898|NCT01471379|76249283|FG000|Overall Study|Adverse Event|1|||
42377899|NCT01471379|76249284|FG001|Overall Study|Adverse Event|0|||
42377900|NCT01471379|76249285|FG002|Overall Study|Adverse Event|0|||
42377901|NCT01471379|76249283|FG000|Overall Study|Study terminated|0|||
42377902|NCT01471379|76249284|FG001|Overall Study|Study terminated|1|||
42377903|NCT01471379|76249285|FG002|Overall Study|Study terminated|0|||
42377904|NCT01470989|76249296|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
42377905|NCT01470989|76249297|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
42377906|NCT01470989|76249296|FG000|Overall Study|Adverse Event|2|||
42377907|NCT01470989|76249297|FG001|Overall Study|Adverse Event|5|||
42377908|NCT01470989|76249296|FG000|Overall Study|Abnormal laboratory value|1|||
42377909|NCT01470989|76249297|FG001|Overall Study|Abnormal laboratory value|1|||
42377910|NCT01470989|76249296|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42377911|NCT01470989|76249297|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
42377912|NCT01470989|76249296|FG000|Overall Study|Withdrawal by Subject|19|||
42377913|NCT01470989|76249297|FG001|Overall Study|Withdrawal by Subject|17|||
42377914|NCT01470989|76249296|FG000|Overall Study|Lost to Follow-up|18|||
42377915|NCT01470989|76249297|FG001|Overall Study|Lost to Follow-up|13|||
42377916|NCT01470989|76249296|FG000|Overall Study|Administrative problems|2|||
42377917|NCT01470989|76249297|FG001|Overall Study|Administrative problems|4|||
42377918|NCT01470989|76249296|FG000|Overall Study|Death|2|||
42377919|NCT01470989|76249297|FG001|Overall Study|Death|2|||
42377920|NCT01470989|76249296|FG000|Overall Study|Protocol deviation|1|||
42377921|NCT01470989|76249297|FG001|Overall Study|Protocol deviation|2|||
42377922|NCT01470599|76249307|FG000|Overall Study|Did not meet entrance criteria|1|||
42377923|NCT01470599|76249308|FG001|Overall Study|Did not meet entrance criteria|0|||
42377924|NCT01470599|76249307|FG000|Overall Study|Lost to Follow-up|2|||
42377925|NCT01470599|76249308|FG001|Overall Study|Lost to Follow-up|1|||
42377926|NCT01470599|76249307|FG000|Overall Study|Withdrawal by Subject|3|||
42377927|NCT01470599|76249308|FG001|Overall Study|Withdrawal by Subject|4|||
42377928|NCT01470599|76249307|FG000|Overall Study|Other|1|||
42377929|NCT01470599|76249308|FG001|Overall Study|Other|0|||
42377930|NCT01470599|76249307|FG000|Overall Study|Protocol Violation|3|||
42377931|NCT01470599|76249308|FG001|Overall Study|Protocol Violation|1|||
42377932|NCT01470599|76249307|FG000|Overall Study|Adverse event related to study drug|2|||
42377933|NCT01470599|76249308|FG001|Overall Study|Adverse event related to study drug|5|||
42377934|NCT01470599|76249307|FG000|Overall Study|Insufficient clinical response|6|||
42377935|NCT01470599|76249308|FG001|Overall Study|Insufficient clinical response|27|||
42377936|NCT01470599|76249307|FG000|Overall Study|Adverse event not related to study drug|1|||
42377937|NCT01470599|76249308|FG001|Overall Study|Adverse event not related to study drug|5|||
42377938|NCT01469819|76249314|FG000|Overall Study|Withdrawal by Subject|1|||
42377939|NCT01469819|76249314|FG000|Overall Study|Did not meet inclusionary criteria|2|||
42377940|NCT01469819|76249314|FG000|Overall Study|Could not swallow SmartPill|2|||
42377941|NCT01469819|76249314|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
42377942|NCT01507831|76249326|FG000|Overall Study|Randomized but not treated|0|||
42377943|NCT01507831|76249327|FG001|Overall Study|Randomized but not treated|3|||
42377944|NCT01507831|76249326|FG000|Overall Study|Adverse Event|48|||
42377945|NCT01507831|76249327|FG001|Overall Study|Adverse Event|113|||
42377946|NCT01507831|76249326|FG000|Overall Study|Death|6|||
42377947|NCT01507831|76249327|FG001|Overall Study|Death|2|||
42377948|NCT01507831|76249326|FG000|Overall Study|Poor compliance to protocol|38|||
42377949|NCT01507831|76249327|FG001|Overall Study|Poor compliance to protocol|60|||
42377950|NCT01507831|76249326|FG000|Overall Study|Physician Decision|0|||
42377951|NCT01507831|76249327|FG001|Overall Study|Physician Decision|4|||
42377952|NCT01507831|76249326|FG000|Overall Study|Participant moved|5|||
42377953|NCT01507831|76249327|FG001|Overall Study|Participant moved|19|||
42377954|NCT01507831|76249326|FG000|Overall Study|Consent withdrawn by participant|34|||
42377955|NCT01507831|76249327|FG001|Overall Study|Consent withdrawn by participant|72|||
42377956|NCT01507831|76249326|FG000|Overall Study|Related to study drug administration|5|||
42377957|NCT01507831|76249327|FG001|Overall Study|Related to study drug administration|14|||
42377958|NCT01507831|76249326|FG000|Overall Study|Last visit outside protocol visit window|51|||
42377959|NCT01507831|76249327|FG001|Overall Study|Last visit outside protocol visit window|143|||
42377960|NCT01507831|76249326|FG000|Overall Study|Selection criteria finally not met|0|||
42377961|NCT01507831|76249327|FG001|Overall Study|Selection criteria finally not met|1|||
42377962|NCT01507831|76249326|FG000|Overall Study|Site closure|0|||
42377963|NCT01507831|76249327|FG001|Overall Study|Site closure|3|||
42377964|NCT01507831|76249326|FG000|Overall Study|Potential lost to follow-up|3|||
42377965|NCT01507831|76249327|FG001|Overall Study|Potential lost to follow-up|0|||
42377966|NCT01507831|76249326|FG000|Overall Study|Other|3|||
42377967|NCT01507831|76249327|FG001|Overall Study|Other|6|||
42377968|NCT01479595|76249335|FG000|Overall Study|Protocol deviation|0|||
42377969|NCT01479595|76249336|FG001|Overall Study|Protocol deviation|1|||
42377970|NCT01479595|76249335|FG000|Overall Study|Adverse Event|2|||
42377971|NCT01479595|76249336|FG001|Overall Study|Adverse Event|1|||
42377972|NCT01462357|76249345|FG000|Overall Study|Death|0|||
42377973|NCT01462357|76249346|FG001|Overall Study|Death|0|||
42377974|NCT01462357|76249347|FG002|Overall Study|Death|1|||
42377975|NCT01462357|76249345|FG000|Overall Study|Withdrawal by Subject|3|||
42377976|NCT01462357|76249346|FG001|Overall Study|Withdrawal by Subject|11|||
42377977|NCT01462357|76249347|FG002|Overall Study|Withdrawal by Subject|3|||
42377978|NCT01462357|76249345|FG000|Overall Study|Migrated/moved from study area|2|||
42377979|NCT01462357|76249346|FG001|Overall Study|Migrated/moved from study area|3|||
42377980|NCT01462357|76249347|FG002|Overall Study|Migrated/moved from study area|1|||
42377981|NCT01462357|76249345|FG000|Overall Study|Lost to Follow-up|3|||
42377982|NCT01462357|76249346|FG001|Overall Study|Lost to Follow-up|5|||
42377983|NCT01462357|76249347|FG002|Overall Study|Lost to Follow-up|7|||
42377984|NCT01479439|76249358|FG000|Overall Study|Adverse Event|1|||
42377985|NCT01479439|76249359|FG001|Overall Study|Adverse Event|0|||
42377986|NCT01479439|76249360|FG002|Overall Study|Adverse Event|0|||
42377987|NCT01479439|76249358|FG000|Overall Study|Lost to Follow-up|0|||
42377988|NCT01479439|76249359|FG001|Overall Study|Lost to Follow-up|1|||
42377989|NCT01479439|76249360|FG002|Overall Study|Lost to Follow-up|0|||
42377990|NCT01479439|76249358|FG000|Overall Study|Protocol Violation|0|||
42377991|NCT01479439|76249359|FG001|Overall Study|Protocol Violation|0|||
42377992|NCT01479439|76249360|FG002|Overall Study|Protocol Violation|2|||
42377993|NCT01478971|76249371|FG000|Standard of Care Period|Adverse Event|1|||
42377994|NCT01478971|76249371|FG000|Standard of Care Period|Withdrawal by Subject|3|||
42377995|NCT01478971|76249371|FG000|Standard of Care Period|Death|8|||
42377996|NCT01478971|76249371|FG000|Standard of Care Period|Lost to Follow-up|9|||
42377997|NCT01478971|76249371|FG000|Standard of Care Period|Other|4|||
42377998|NCT01478971|76249371|FG000|Peginesatide Treatment Period|Adverse Event|1|||
42377999|NCT01478971|76249371|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
42378000|NCT01478971|76249371|FG000|Peginesatide Treatment Period|Death|4|||
42378001|NCT01478971|76249371|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
42378002|NCT01478971|76249371|FG000|Peginesatide Treatment Period|Other|4|||
42378003|NCT01507051|76249383|FG000|Overall Study|Withdrawal by Subject|1|||
42378004|NCT01507051|76249384|FG001|Overall Study|Withdrawal by Subject|3|||
42378005|NCT01507051|76249385|FG002|Overall Study|Withdrawal by Subject|1|||
42378006|NCT01507051|76249386|FG003|Overall Study|Withdrawal by Subject|6|||
42378007|NCT01507051|76249383|FG000|Overall Study|Physician Decision|0|||
42378008|NCT01507051|76249384|FG001|Overall Study|Physician Decision|0|||
42378009|NCT01507051|76249385|FG002|Overall Study|Physician Decision|0|||
42378010|NCT01507051|76249386|FG003|Overall Study|Physician Decision|1|||
42378011|NCT01507051|76249383|FG000|Overall Study|Adverse Event|1|||
42378012|NCT01507051|76249384|FG001|Overall Study|Adverse Event|0|||
42378013|NCT01507051|76249385|FG002|Overall Study|Adverse Event|0|||
42378014|NCT01507051|76249386|FG003|Overall Study|Adverse Event|0|||
42378015|NCT01478347|76249396|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
42378016|NCT01478347|76249396|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
42378017|NCT01478347|76249396|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
42378018|NCT01478113|76249402|FG000|Overall Study|Withdrawal by Subject|0|||
42378019|NCT01478113|76249403|FG001|Overall Study|Withdrawal by Subject|1|||
42378020|NCT01478113|76249402|FG000|Overall Study|Physician Decision|1|||
42378021|NCT01478113|76249403|FG001|Overall Study|Physician Decision|0|||
42378022|NCT01506271|76249414|FG000|Overall Study|Progressive disease|0|||
42378023|NCT01506271|76249415|FG001|Overall Study|Progressive disease|1|||
42378024|NCT01506271|76249416|FG002|Overall Study|Progressive disease|0|||
42378025|NCT01506271|76249414|FG000|Overall Study|Protocol Violation|3|||
42378026|NCT01506271|76249415|FG001|Overall Study|Protocol Violation|1|||
42378027|NCT01506271|76249416|FG002|Overall Study|Protocol Violation|0|||
42378028|NCT01506271|76249414|FG000|Overall Study|Death|0|||
42378029|NCT01506271|76249415|FG001|Overall Study|Death|1|||
42378030|NCT01506271|76249416|FG002|Overall Study|Death|0|||
42378031|NCT01506271|76249414|FG000|Overall Study|Adverse Event|0|||
42378032|NCT01506271|76249415|FG001|Overall Study|Adverse Event|2|||
42378033|NCT01506271|76249416|FG002|Overall Study|Adverse Event|0|||
42378034|NCT01506271|76249414|FG000|Overall Study|Insufficient supply of study drug|1|||
42378035|NCT01506271|76249415|FG001|Overall Study|Insufficient supply of study drug|0|||
42378036|NCT01506271|76249416|FG002|Overall Study|Insufficient supply of study drug|0|||
42378037|NCT01506271|76249414|FG000|Overall Study|Withdrawal by Subject|0|||
42378038|NCT01506271|76249415|FG001|Overall Study|Withdrawal by Subject|1|||
42378039|NCT01506271|76249416|FG002|Overall Study|Withdrawal by Subject|1|||
42378040|NCT01506271|76249414|FG000|Overall Study|Lost to Follow-up|0|||
42378041|NCT01506271|76249415|FG001|Overall Study|Lost to Follow-up|1|||
42378042|NCT01506271|76249416|FG002|Overall Study|Lost to Follow-up|2|||
42378043|NCT01506193|76249427|FG000|Overall Study|Protocol Violation|1|||
42378044|NCT01506193|76249428|FG001|Overall Study|Protocol Violation|0|||
42378045|NCT01506193|76249429|FG002|Overall Study|Protocol Violation|1|||
42378046|NCT01506193|76249427|FG000|Overall Study|Migrated/moved from study area|0|||
42378047|NCT01506193|76249428|FG001|Overall Study|Migrated/moved from study area|0|||
42378048|NCT01506193|76249429|FG002|Overall Study|Migrated/moved from study area|1|||
42378049|NCT01506193|76249427|FG000|Overall Study|Adverse event, non-fatal|0|||
42378050|NCT01506193|76249428|FG001|Overall Study|Adverse event, non-fatal|0|||
42378051|NCT01506193|76249429|FG002|Overall Study|Adverse event, non-fatal|1|||
42378052|NCT01506193|76249427|FG000|Overall Study|Withdrawal by Subject|5|||
42378053|NCT01506193|76249428|FG001|Overall Study|Withdrawal by Subject|1|||
42378054|NCT01506193|76249429|FG002|Overall Study|Withdrawal by Subject|8|||
42378055|NCT01506193|76249427|FG000|Overall Study|Lost to Follow-up|8|||
42378056|NCT01506193|76249428|FG001|Overall Study|Lost to Follow-up|3|||
42378057|NCT01506193|76249429|FG002|Overall Study|Lost to Follow-up|3|||
42378058|NCT01505881|76249440|FG000|Overall Study|Adverse Event|0|||
42378059|NCT01505881|76249441|FG001|Overall Study|Adverse Event|1|||
42378060|NCT01505881|76249440|FG000|Overall Study|Lost to Follow-up|2|||
42378061|NCT01505881|76249441|FG001|Overall Study|Lost to Follow-up|0|||
42378062|NCT01505881|76249440|FG000|Overall Study|Withdrawal by Subject|2|||
42378063|NCT01505881|76249441|FG001|Overall Study|Withdrawal by Subject|0|||
42103630|NCT00673790|75914526|FG000|Overall Study|Unconfirmed pregnancy|0|||
42378064|NCT01462045|76249451|FG000|Overall Study|Family matter|0|||
42378065|NCT01462045|76249452|FG001|Overall Study|Family matter|1|||
42378066|NCT01462045|76249453|FG002|Overall Study|Family matter|0|||
42378067|NCT01505647|76249463|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
42378068|NCT01505647|76249464|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
42378069|NCT01505647|76249463|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
42378070|NCT01505647|76249464|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
42378071|NCT01505647|76249463|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
42378072|NCT01505647|76249464|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
42378073|NCT01505647|76249463|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
42378074|NCT01505647|76249464|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
42378075|NCT01505647|76249463|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
42378076|NCT01505647|76249464|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
42378077|NCT01461811|76249472|FG000|Overall Study|Adverse Event|2|||
42103631|NCT00673790|75914527|FG001|Overall Study|Unconfirmed pregnancy|1|||
42378078|NCT01461811|76249473|FG001|Overall Study|Adverse Event|1|||
42378079|NCT01461811|76249472|FG000|Overall Study|Subject decision unrelated to an AE|1|||
42378080|NCT01461811|76249473|FG001|Overall Study|Subject decision unrelated to an AE|1|||
42378081|NCT01461811|76249472|FG000|Overall Study|Noncompliance|1|||
42378082|NCT01461811|76249473|FG001|Overall Study|Noncompliance|1|||
42378083|NCT01505491|76249482|FG000|Overall Study|Other reason not listed|1|||
42378084|NCT01505491|76249483|FG001|Overall Study|Other reason not listed|0|||
42378085|NCT01505491|76249484|FG002|Overall Study|Other reason not listed|0|||
42378086|NCT01505491|76249482|FG000|Overall Study|Withdrawal by Subject|1|||
42378087|NCT01505491|76249483|FG001|Overall Study|Withdrawal by Subject|1|||
42200835|NCT04446377|76012828|FG001|Overall Study|Not eligible|1|||
42200836|NCT04398368|76012838|FG000|Overall Study|Withdrawal by Subject|2|||
42200837|NCT04275297|76012844|FG000|Overall Study|Lost to Follow-up|1|||
42200838|NCT04275297|76012845|FG001|Overall Study|Lost to Follow-up|1|||
42200839|NCT04247282|76012855|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
42378088|NCT01505491|76249484|FG002|Overall Study|Withdrawal by Subject|4|||
42378089|NCT01505491|76249482|FG000|Overall Study|Lost to Follow-up|0|||
42378090|NCT01505491|76249483|FG001|Overall Study|Lost to Follow-up|0|||
42378091|NCT01505491|76249484|FG002|Overall Study|Lost to Follow-up|1|||
42378092|NCT01504867|76249494|FG000|Overall Study|Inclusion criteria not met|2|||
42378093|NCT01504867|76249495|FG001|Overall Study|Inclusion criteria not met|2|||
42378094|NCT01504867|76249494|FG000|Overall Study|Consent revoked|5|||
42378095|NCT01504867|76249495|FG001|Overall Study|Consent revoked|1|||
42378096|NCT01476475|76249503|FG000|Overall Study|Adverse Event|6|||
42378097|NCT01476475|76249504|FG001|Overall Study|Adverse Event|0|||
42378098|NCT01476475|76249503|FG000|Overall Study|Poor compliance to protocol|1|||
42378099|NCT01476475|76249504|FG001|Overall Study|Poor compliance to protocol|1|||
42378100|NCT01476475|76249503|FG000|Overall Study|Other reasons|4|||
42378101|NCT01476475|76249504|FG001|Overall Study|Other reasons|2|||
42378102|NCT01475851|76249513|FG000|Overall Study|Protocol defined stopping criteria|1|||
42378103|NCT01475851|76249514|FG001|Overall Study|Protocol defined stopping criteria|0|||
42378104|NCT01460719|76249520|FG000|Overall Study|Adverse Event|1|||
42378105|NCT01460719|76249520|FG000|Overall Study|Withdrawal by Subject|1|||
42378106|NCT01468181|76249590|FG000|Overall Study|Adverse Event|8|||
42378107|NCT01468181|76249591|FG001|Overall Study|Adverse Event|1|||
42378108|NCT01468181|76249592|FG002|Overall Study|Adverse Event|6|||
42378109|NCT01468181|76249593|FG003|Overall Study|Adverse Event|2|||
42378110|NCT01468181|76249594|FG004|Overall Study|Adverse Event|2|||
42378111|NCT01468181|76249590|FG000|Overall Study|Protocol Violation|2|||
42378112|NCT01468181|76249591|FG001|Overall Study|Protocol Violation|0|||
42378113|NCT01468181|76249592|FG002|Overall Study|Protocol Violation|1|||
42378114|NCT01468181|76249593|FG003|Overall Study|Protocol Violation|0|||
42378115|NCT01468181|76249594|FG004|Overall Study|Protocol Violation|1|||
42378116|NCT01468181|76249590|FG000|Overall Study|Physician Decision|0|||
42378117|NCT01468181|76249591|FG001|Overall Study|Physician Decision|0|||
42378118|NCT01468181|76249592|FG002|Overall Study|Physician Decision|0|||
42378119|NCT01468181|76249593|FG003|Overall Study|Physician Decision|1|||
42378120|NCT01468181|76249594|FG004|Overall Study|Physician Decision|1|||
42378121|NCT01468181|76249590|FG000|Overall Study|Lost to Follow-up|0|||
42378122|NCT01468181|76249591|FG001|Overall Study|Lost to Follow-up|0|||
42378123|NCT01468181|76249592|FG002|Overall Study|Lost to Follow-up|1|||
42378124|NCT01468181|76249593|FG003|Overall Study|Lost to Follow-up|0|||
42378125|NCT01468181|76249594|FG004|Overall Study|Lost to Follow-up|1|||
42378126|NCT01468181|76249590|FG000|Overall Study|Withdrawal by Subject|0|||
42378127|NCT01468181|76249591|FG001|Overall Study|Withdrawal by Subject|1|||
42378128|NCT01468181|76249592|FG002|Overall Study|Withdrawal by Subject|0|||
42378129|NCT01468181|76249593|FG003|Overall Study|Withdrawal by Subject|0|||
42378130|NCT01468181|76249594|FG004|Overall Study|Withdrawal by Subject|0|||
42378131|NCT01693562|76249629|FG000|Escalation Phase|Withdrawal by Subject|0|||
42378132|NCT01693562|76249630|FG001|Escalation Phase|Withdrawal by Subject|1|||
42378133|NCT01693562|76249631|FG002|Escalation Phase|Withdrawal by Subject|0|||
42378134|NCT01693562|76249632|FG003|Escalation Phase|Withdrawal by Subject|0|||
42378135|NCT01693562|76249633|FG004|Escalation Phase|Withdrawal by Subject|0|||
42378136|NCT01693562|76249634|FG005|Escalation Phase|Withdrawal by Subject|2|||
42378137|NCT01693562|76249635|FG006|Escalation Phase|Withdrawal by Subject|0|||
42103632|NCT00673790|75914528|FG002|Overall Study|Unconfirmed pregnancy|0|||
42103633|NCT00673790|75914526|FG000|Overall Study|Randomization criteria not met|0|||
42103634|NCT00673790|75914527|FG001|Overall Study|Randomization criteria not met|1|||
42103635|NCT00673790|75914528|FG002|Overall Study|Randomization criteria not met|0|||
42103636|NCT00657150|75914539|FG000|Overall Study|Adverse Event|19|||
42103637|NCT00657150|75914540|FG001|Overall Study|Adverse Event|10|||
42103638|NCT00657150|75914539|FG000|Overall Study|Non-compliant with protocol|5|||
42103639|NCT00657150|75914540|FG001|Overall Study|Non-compliant with protocol|9|||
42103640|NCT00657150|75914539|FG000|Overall Study|Lost to Follow-up|2|||
42378138|NCT01693562|76249636|FG007|Escalation Phase|Withdrawal by Subject|0|||
42378139|NCT01693562|76249637|FG008|Escalation Phase|Withdrawal by Subject|0|||
42378140|NCT01693562|76249638|FG009|Escalation Phase|Withdrawal by Subject|0|||
42378141|NCT01693562|76249639|FG010|Escalation Phase|Withdrawal by Subject|0|||
42378142|NCT01693562|76249640|FG011|Escalation Phase|Withdrawal by Subject|0|||
42378143|NCT01693562|76249641|FG012|Escalation Phase|Withdrawal by Subject|0|||
42378144|NCT01693562|76249642|FG013|Escalation Phase|Withdrawal by Subject|0|||
42378145|NCT01693562|76249643|FG014|Escalation Phase|Withdrawal by Subject|0|||
42378146|NCT01693562|76249644|FG015|Escalation Phase|Withdrawal by Subject|0|||
42378147|NCT01693562|76249645|FG016|Escalation Phase|Withdrawal by Subject|0|||
42378148|NCT01693562|76249646|FG017|Escalation Phase|Withdrawal by Subject|0|||
42378149|NCT01693562|76249647|FG018|Escalation Phase|Withdrawal by Subject|0|||
42378150|NCT01693562|76249648|FG019|Escalation Phase|Withdrawal by Subject|0|||
42378151|NCT01693562|76249649|FG020|Escalation Phase|Withdrawal by Subject|0|||
42378152|NCT01693562|76249650|FG021|Escalation Phase|Withdrawal by Subject|0|||
42378153|NCT01693562|76249651|FG022|Escalation Phase|Withdrawal by Subject|0|||
42378154|NCT01693562|76249629|FG000|Escalation Phase|Death|4|||
42378155|NCT01693562|76249630|FG001|Escalation Phase|Death|2|||
42378156|NCT01693562|76249631|FG002|Escalation Phase|Death|0|||
42378157|NCT01693562|76249632|FG003|Escalation Phase|Death|3|||
42378158|NCT01693562|76249633|FG004|Escalation Phase|Death|6|||
42378159|NCT01693562|76249634|FG005|Escalation Phase|Death|4|||
42378160|NCT01693562|76249635|FG006|Escalation Phase|Death|0|||
42378161|NCT01693562|76249636|FG007|Escalation Phase|Death|0|||
42378162|NCT01693562|76249637|FG008|Escalation Phase|Death|0|||
42378163|NCT01693562|76249638|FG009|Escalation Phase|Death|0|||
42378164|NCT01693562|76249639|FG010|Escalation Phase|Death|0|||
42378165|NCT01693562|76249640|FG011|Escalation Phase|Death|0|||
42378166|NCT01693562|76249641|FG012|Escalation Phase|Death|0|||
42378167|NCT01693562|76249642|FG013|Escalation Phase|Death|0|||
42378168|NCT01693562|76249643|FG014|Escalation Phase|Death|0|||
42378169|NCT01693562|76249644|FG015|Escalation Phase|Death|0|||
42378170|NCT01693562|76249645|FG016|Escalation Phase|Death|0|||
42378171|NCT01693562|76249646|FG017|Escalation Phase|Death|0|||
42378172|NCT01693562|76249647|FG018|Escalation Phase|Death|0|||
42378173|NCT01693562|76249648|FG019|Escalation Phase|Death|0|||
42378174|NCT01693562|76249649|FG020|Escalation Phase|Death|0|||
42378175|NCT01693562|76249650|FG021|Escalation Phase|Death|0|||
42378176|NCT01693562|76249651|FG022|Escalation Phase|Death|0|||
42378177|NCT01693562|76249629|FG000|Escalation Phase|Lost to Follow-up|0|||
42378178|NCT01693562|76249630|FG001|Escalation Phase|Lost to Follow-up|1|||
42378179|NCT01693562|76249631|FG002|Escalation Phase|Lost to Follow-up|1|||
42378180|NCT01693562|76249632|FG003|Escalation Phase|Lost to Follow-up|0|||
42378181|NCT01693562|76249633|FG004|Escalation Phase|Lost to Follow-up|0|||
42378182|NCT01693562|76249634|FG005|Escalation Phase|Lost to Follow-up|0|||
42378183|NCT01693562|76249635|FG006|Escalation Phase|Lost to Follow-up|0|||
42018750|NCT01123395|75826140|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
42018751|NCT01123395|75826141|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
42018752|NCT01255787|75826151|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
42018753|NCT01255787|75826152|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
42018754|NCT01255787|75826153|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
42018755|NCT01255787|75826154|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
42018756|NCT01255787|75826151|FG000|Overall Study|Major Protocol Deviation|1|||
42018757|NCT01255787|75826152|FG001|Overall Study|Major Protocol Deviation|1|||
42018758|NCT01255787|75826153|FG002|Overall Study|Major Protocol Deviation|0|||
42103641|NCT00657150|75914540|FG001|Overall Study|Lost to Follow-up|0|||
42103642|NCT00657150|75914539|FG000|Overall Study|Withdrawal by Subject|51|||
42103643|NCT00657150|75914540|FG001|Overall Study|Withdrawal by Subject|36|||
42103644|NCT00657150|75914539|FG000|Overall Study|Other|38|||
42103645|NCT00657150|75914540|FG001|Overall Study|Other|38|||
42103646|NCT00657150|75914539|FG000|Treatment|Adverse Event|60|||
42018759|NCT01255787|75826154|FG003|Overall Study|Major Protocol Deviation|4|||
42018760|NCT01255787|75826151|FG000|Overall Study|Lost to Follow-up|1|||
42018761|NCT01255787|75826152|FG001|Overall Study|Lost to Follow-up|2|||
42018762|NCT01255787|75826153|FG002|Overall Study|Lost to Follow-up|4|||
42018763|NCT01255787|75826154|FG003|Overall Study|Lost to Follow-up|2|||
42018764|NCT01255787|75826151|FG000|Overall Study|Withdrawal of Consent|3|||
42103647|NCT00657150|75914540|FG001|Treatment|Adverse Event|53|||
42018765|NCT01255787|75826152|FG001|Overall Study|Withdrawal of Consent|9|||
42378184|NCT01693562|76249636|FG007|Escalation Phase|Lost to Follow-up|0|||
42103648|NCT00657150|75914539|FG000|Treatment|Non-compliant with protocol|10|||
42103649|NCT00657150|75914540|FG001|Treatment|Non-compliant with protocol|9|||
42103650|NCT00657150|75914539|FG000|Treatment|Lost to Follow-up|1|||
42103651|NCT00657150|75914540|FG001|Treatment|Lost to Follow-up|0|||
42103652|NCT00657150|75914539|FG000|Treatment|Withdrawal by Subject|23|||
42103653|NCT00657150|75914540|FG001|Treatment|Withdrawal by Subject|20|||
42103654|NCT00657150|75914539|FG000|Treatment|Other|13|||
42103655|NCT00657150|75914540|FG001|Treatment|Other|15|||
42103656|NCT00670748|75914550|FG000|Overall Study|Death during treatment|1|||
42103657|NCT00670748|75914551|FG001|Overall Study|Death during treatment|1|||
42103658|NCT00670748|75914552|FG002|Overall Study|Death during treatment|1|||
42103659|NCT00670748|75914553|FG003|Overall Study|Death during treatment|0|||
42103660|NCT00670748|75914550|FG000|Overall Study|Not off study|2|||
42103661|NCT00670748|75914551|FG001|Overall Study|Not off study|1|||
42103662|NCT00670748|75914552|FG002|Overall Study|Not off study|1|||
42103663|NCT00670748|75914553|FG003|Overall Study|Not off study|1|||
42103664|NCT00646776|75914565|FG000|Overall Study|Adverse Event|1|||
42103665|NCT00646776|75914566|FG001|Overall Study|Adverse Event|9|||
42103666|NCT00646776|75914565|FG000|Overall Study|Investigator discretion|0|||
42103667|NCT00646776|75914566|FG001|Overall Study|Investigator discretion|4|||
42103668|NCT00655668|75914575|FG000|Overall Study|Adverse Event|6|||
42103669|NCT00655668|75914575|FG000|Overall Study|Death|5|||
42103670|NCT00655668|75914575|FG000|Overall Study|Disease Progression|27|||
42103671|NCT00655668|75914575|FG000|Overall Study|Study Terminated|9|||
42103672|NCT00655668|75914575|FG000|Overall Study|Other|1|||
42103673|NCT00655668|75914575|FG000|Overall Study|New Lymphoma Treatment Started|4|||
42103674|NCT00655668|75914575|FG000|Overall Study|Withdrawal by Subject|2|||
42103675|NCT00569166|75914582|FG000|Overall Study|Withdrawal by Subject|7|||
42103676|NCT00569166|75914583|FG001|Overall Study|Withdrawal by Subject|5|||
42103677|NCT00569166|75914584|FG002|Overall Study|Withdrawal by Subject|3|||
42103678|NCT00569166|75914582|FG000|Overall Study|Lost to Follow-up|2|||
42103679|NCT00569166|75914583|FG001|Overall Study|Lost to Follow-up|1|||
42103680|NCT00569166|75914584|FG002|Overall Study|Lost to Follow-up|1|||
42103681|NCT00655356|75914594|FG000|Overall Study|Withdrawal by Subject|3|||
42103682|NCT00655356|75914595|FG001|Overall Study|Withdrawal by Subject|4|||
42103683|NCT00655356|75914594|FG000|Overall Study|Sponsor Request|10|||
42103684|NCT00655356|75914595|FG001|Overall Study|Sponsor Request|4|||
42103685|NCT00655356|75914594|FG000|Overall Study|Adverse Event|1|||
42103686|NCT00655356|75914595|FG001|Overall Study|Adverse Event|1|||
42103687|NCT00655356|75914594|FG000|Overall Study|Protocol Violation|2|||
42103688|NCT00655356|75914595|FG001|Overall Study|Protocol Violation|1|||
42103689|NCT00655356|75914594|FG000|Overall Study|Other Reason|1|||
42103690|NCT00655356|75914595|FG001|Overall Study|Other Reason|0|||
42103691|NCT00571064|75914601|FG000|Overall Study|Adverse Event|13|||
42103692|NCT00571064|75914601|FG000|Overall Study|Protocol Violation|4|||
42103693|NCT00571064|75914601|FG000|Overall Study|Withdrawal by Subject|2|||
42103694|NCT00571064|75914601|FG000|Overall Study|Other|2|||
42103695|NCT03895372|75914614|FG000|Investigational Treatment Period|Adverse Event|1|||
42103696|NCT03895372|75914615|FG001|Investigational Treatment Period|Adverse Event|0|||
42103697|NCT03895372|75914616|FG002|Investigational Treatment Period|Adverse Event|0|||
42103698|NCT03895372|75914617|FG003|Investigational Treatment Period|Adverse Event|0|||
42103699|NCT03895372|75914618|FG004|Investigational Treatment Period|Adverse Event|0|||
42103700|NCT03895372|75914619|FG005|Investigational Treatment Period|Adverse Event|0|||
42378185|NCT01693562|76249637|FG008|Escalation Phase|Lost to Follow-up|0|||
42103701|NCT03895372|75914620|FG006|Investigational Treatment Period|Adverse Event|4|||
42103702|NCT03895372|75914621|FG007|Investigational Treatment Period|Adverse Event|3|||
42103703|NCT03895372|75914614|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
42103704|NCT03895372|75914615|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
42103705|NCT03895372|75914616|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
42103706|NCT03895372|75914617|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
42103707|NCT03895372|75914618|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
42103708|NCT03895372|75914619|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
42103709|NCT03895372|75914620|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
42103710|NCT03895372|75914621|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
42103711|NCT03895372|75914614|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
42103712|NCT03895372|75914615|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
42103713|NCT03895372|75914616|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
42103714|NCT03895372|75914617|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
42103715|NCT03895372|75914618|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
42103716|NCT03895372|75914619|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
42103717|NCT03895372|75914620|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
42103718|NCT03895372|75914621|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
42103719|NCT03895372|75914614|FG000|Investigational Treatment Period|Other|0|||
42103720|NCT03895372|75914615|FG001|Investigational Treatment Period|Other|0|||
42378186|NCT01693562|76249638|FG009|Escalation Phase|Lost to Follow-up|0|||
42378187|NCT01693562|76249639|FG010|Escalation Phase|Lost to Follow-up|0|||
42103721|NCT03895372|75914616|FG002|Investigational Treatment Period|Other|0|||
42103722|NCT03895372|75914617|FG003|Investigational Treatment Period|Other|0|||
42103723|NCT03895372|75914618|FG004|Investigational Treatment Period|Other|0|||
42103724|NCT03895372|75914619|FG005|Investigational Treatment Period|Other|1|||
42103725|NCT03895372|75914620|FG006|Investigational Treatment Period|Other|0|||
42103726|NCT03895372|75914621|FG007|Investigational Treatment Period|Other|2|||
42103727|NCT03895372|75914614|FG000|Investigational Treatment Period|Protocol Violation|0|||
42103728|NCT03895372|75914615|FG001|Investigational Treatment Period|Protocol Violation|0|||
42103729|NCT03895372|75914616|FG002|Investigational Treatment Period|Protocol Violation|0|||
42103730|NCT03895372|75914617|FG003|Investigational Treatment Period|Protocol Violation|1|||
42103731|NCT03895372|75914618|FG004|Investigational Treatment Period|Protocol Violation|0|||
42103732|NCT03895372|75914619|FG005|Investigational Treatment Period|Protocol Violation|0|||
42103733|NCT03895372|75914620|FG006|Investigational Treatment Period|Protocol Violation|0|||
42103734|NCT03895372|75914621|FG007|Investigational Treatment Period|Protocol Violation|0|||
42103735|NCT03895372|75914614|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
42103736|NCT03895372|75914615|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
42103737|NCT03895372|75914616|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
42103738|NCT03895372|75914617|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
42103739|NCT03895372|75914618|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
42103740|NCT03895372|75914619|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
42103741|NCT03895372|75914620|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
42103742|NCT03895372|75914621|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
42103743|NCT03895372|75914614|FG000|Extension Treatment Period|Adverse Event|0|||
42103744|NCT03895372|75914615|FG001|Extension Treatment Period|Adverse Event|1|||
42103745|NCT03895372|75914616|FG002|Extension Treatment Period|Adverse Event|0|||
42103746|NCT03895372|75914617|FG003|Extension Treatment Period|Adverse Event|1|||
42103747|NCT03895372|75914618|FG004|Extension Treatment Period|Adverse Event|0|||
42103748|NCT03895372|75914619|FG005|Extension Treatment Period|Adverse Event|0|||
42103749|NCT03895372|75914620|FG006|Extension Treatment Period|Adverse Event|3|||
42103750|NCT03895372|75914621|FG007|Extension Treatment Period|Adverse Event|3|||
42103751|NCT03895372|75914614|FG000|Extension Treatment Period|Other|1|||
42103752|NCT03895372|75914615|FG001|Extension Treatment Period|Other|3|||
42103753|NCT03895372|75914616|FG002|Extension Treatment Period|Other|0|||
42103754|NCT03895372|75914617|FG003|Extension Treatment Period|Other|0|||
42103755|NCT03895372|75914618|FG004|Extension Treatment Period|Other|1|||
42103756|NCT03895372|75914619|FG005|Extension Treatment Period|Other|0|||
42103757|NCT03895372|75914620|FG006|Extension Treatment Period|Other|0|||
42103758|NCT03895372|75914621|FG007|Extension Treatment Period|Other|2|||
42103759|NCT03895372|75914614|FG000|Extension Treatment Period|Pregnancy|0|||
42103760|NCT03895372|75914615|FG001|Extension Treatment Period|Pregnancy|0|||
42103761|NCT03895372|75914616|FG002|Extension Treatment Period|Pregnancy|0|||
42103762|NCT03895372|75914617|FG003|Extension Treatment Period|Pregnancy|0|||
42103763|NCT03895372|75914618|FG004|Extension Treatment Period|Pregnancy|1|||
42103764|NCT03895372|75914619|FG005|Extension Treatment Period|Pregnancy|0|||
42103765|NCT03895372|75914620|FG006|Extension Treatment Period|Pregnancy|0|||
42103766|NCT03895372|75914621|FG007|Extension Treatment Period|Pregnancy|0|||
42103767|NCT03895372|75914614|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
42103768|NCT03895372|75914615|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
42103769|NCT03895372|75914616|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
42103770|NCT03895372|75914617|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
42103771|NCT03895372|75914618|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
42103772|NCT03895372|75914619|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
42103773|NCT03895372|75914620|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
42103774|NCT03895372|75914621|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
42103775|NCT00669110|75914646|FG000|Overall Study|Adverse Event|4|||
42103776|NCT00669110|75914647|FG001|Overall Study|Adverse Event|3|||
42103777|NCT00669110|75914646|FG000|Overall Study|Caregiver request|3|||
42103778|NCT00669110|75914647|FG001|Overall Study|Caregiver request|2|||
42103779|NCT00669110|75914646|FG000|Overall Study|Physician Decision|0|||
42103780|NCT00669110|75914647|FG001|Overall Study|Physician Decision|1|||
42103781|NCT00669110|75914646|FG000|Overall Study|Lost to Follow-up|1|||
42103782|NCT00669110|75914647|FG001|Overall Study|Lost to Follow-up|0|||
42103783|NCT00669110|75914646|FG000|Overall Study|Protocol Violation|0|||
42103784|NCT00669110|75914647|FG001|Overall Study|Protocol Violation|5|||
42103785|NCT00669110|75914646|FG000|Overall Study|Withdrawal by Subject|0|||
42103786|NCT00669110|75914647|FG001|Overall Study|Withdrawal by Subject|2|||
42103787|NCT00654732|75914655|FG000|Overall Study|Adverse Event|4|||
42103788|NCT00654732|75914656|FG001|Overall Study|Adverse Event|6|||
42103789|NCT00649428|75914664|FG000|Overall Study|Adverse Event|2|||
42103790|NCT00649428|75914665|FG001|Overall Study|Adverse Event|2|||
42103791|NCT00649428|75914664|FG000|Overall Study|Withdrawal by Subject|6|||
42103792|NCT00649428|75914665|FG001|Overall Study|Withdrawal by Subject|6|||
42103793|NCT00649428|75914664|FG000|Overall Study|Lost to Follow-up|1|||
42103794|NCT00649428|75914665|FG001|Overall Study|Lost to Follow-up|3|||
42103795|NCT00649428|75914664|FG000|Overall Study|Insufficient manufacturing yield|5|||
42103796|NCT00649428|75914665|FG001|Overall Study|Insufficient manufacturing yield|1|||
42200840|NCT04247282|76012856|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
42200841|NCT04247282|76012857|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
42200842|NCT04247282|76012858|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
42200843|NCT04247282|76012855|FG000|Overall Study|Refused further treatment|0|||
42200844|NCT04247282|76012856|FG001|Overall Study|Refused further treatment|1|||
42200845|NCT04247282|76012857|FG002|Overall Study|Refused further treatment|0|||
42200846|NCT04247282|76012858|FG003|Overall Study|Refused further treatment|0|||
42200847|NCT04224688|76012869|FG000|Overall Study|Withdrawal by Subject|1|||
42200848|NCT04224688|76012870|FG001|Overall Study|Withdrawal by Subject|3|||
42200849|NCT04224688|76012869|FG000|Overall Study|Lack of Efficacy|1|||
42200850|NCT04224688|76012870|FG001|Overall Study|Lack of Efficacy|1|||
42200851|NCT04224688|76012869|FG000|Overall Study|Adverse event, not fatal|0|||
42200852|NCT04224688|76012870|FG001|Overall Study|Adverse event, not fatal|2|||
42200853|NCT04224688|76012869|FG000|Overall Study|COVID-19|0|||
42200854|NCT04224688|76012870|FG001|Overall Study|COVID-19|1|||
42200855|NCT04200456|76012878|FG000|Overall Study|Physician Decision|0|||
42200856|NCT04200456|76012879|FG001|Overall Study|Physician Decision|1|||
42200857|NCT04200456|76012878|FG000|Overall Study|Withdrawal by Subject|2|||
42200858|NCT04200456|76012879|FG001|Overall Study|Withdrawal by Subject|2|||
42200859|NCT04200456|76012878|FG000|Overall Study|Lack of Efficacy|1|||
42200860|NCT04200456|76012879|FG001|Overall Study|Lack of Efficacy|1|||
42200861|NCT04200456|76012878|FG000|Overall Study|Adverse event, non-fatal|0|||
42200862|NCT04200456|76012879|FG001|Overall Study|Adverse event, non-fatal|1|||
42200863|NCT04200456|76012878|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
42200864|NCT04200456|76012879|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
42200865|NCT03766685|76012889|FG000|Overall Study|Lost to Follow-up|1|||
42200866|NCT03766685|76012890|FG001|Overall Study|Lost to Follow-up|1|||
42200867|NCT03766685|76012891|FG002|Overall Study|Lost to Follow-up|0|||
42200868|NCT03766685|76012892|FG003|Overall Study|Lost to Follow-up|0|||
42200869|NCT03766685|76012889|FG000|Overall Study|Adverse Event, not fatal|0|||
42200870|NCT03766685|76012890|FG001|Overall Study|Adverse Event, not fatal|1|||
42200871|NCT03766685|76012891|FG002|Overall Study|Adverse Event, not fatal|0|||
42200872|NCT03766685|76012892|FG003|Overall Study|Adverse Event, not fatal|1|||
42200873|NCT03766685|76012889|FG000|Overall Study|Withdrawal by Subject|0|||
42200874|NCT03766685|76012890|FG001|Overall Study|Withdrawal by Subject|2|||
42200875|NCT03766685|76012891|FG002|Overall Study|Withdrawal by Subject|0|||
42200876|NCT03766685|76012892|FG003|Overall Study|Withdrawal by Subject|0|||
42200877|NCT03766685|76012889|FG000|Overall Study|Protocol Violation|0|||
42200878|NCT03766685|76012890|FG001|Overall Study|Protocol Violation|1|||
42200879|NCT03766685|76012891|FG002|Overall Study|Protocol Violation|0|||
42200880|NCT03766685|76012892|FG003|Overall Study|Protocol Violation|0|||
42200881|NCT03766685|76012889|FG000|Overall Study|Non-compliance|0|||
42200882|NCT03766685|76012890|FG001|Overall Study|Non-compliance|2|||
42200883|NCT03766685|76012891|FG002|Overall Study|Non-compliance|0|||
42200884|NCT03766685|76012892|FG003|Overall Study|Non-compliance|0|||
42200885|NCT03654274|76012906|FG000|Overall Study|Adverse Event|19|||
42200886|NCT03654274|76012907|FG001|Overall Study|Adverse Event|23|||
42200887|NCT03654274|76012908|FG002|Overall Study|Adverse Event|24|||
42200888|NCT03654274|76012906|FG000|Overall Study|Protocol Deviation|0|||
42200889|NCT03654274|76012907|FG001|Overall Study|Protocol Deviation|2|||
42200890|NCT03654274|76012908|FG002|Overall Study|Protocol Deviation|0|||
42200891|NCT03654274|76012906|FG000|Overall Study|Lost to Follow-up|8|||
42200892|NCT03654274|76012907|FG001|Overall Study|Lost to Follow-up|6|||
42200893|NCT03654274|76012908|FG002|Overall Study|Lost to Follow-up|5|||
42200894|NCT03654274|76012906|FG000|Overall Study|Withdrawal by Subject|46|||
42200895|NCT03654274|76012907|FG001|Overall Study|Withdrawal by Subject|25|||
42200896|NCT03654274|76012908|FG002|Overall Study|Withdrawal by Subject|33|||
42378188|NCT01693562|76249640|FG011|Escalation Phase|Lost to Follow-up|0|||
42200897|NCT03654274|76012906|FG000|Overall Study|Lack of Efficacy|4|||
42200898|NCT03654274|76012907|FG001|Overall Study|Lack of Efficacy|5|||
42200899|NCT03654274|76012908|FG002|Overall Study|Lack of Efficacy|7|||
42200900|NCT03654274|76012906|FG000|Overall Study|Pregnancy|2|||
42200901|NCT03654274|76012907|FG001|Overall Study|Pregnancy|2|||
42200902|NCT03654274|76012908|FG002|Overall Study|Pregnancy|1|||
42200903|NCT03654274|76012906|FG000|Overall Study|Other|27|||
42200904|NCT03654274|76012907|FG001|Overall Study|Other|29|||
42200905|NCT03654274|76012908|FG002|Overall Study|Other|32|||
42200906|NCT03654274|76012906|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
42200907|NCT03654274|76012907|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
42200908|NCT03654274|76012908|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
42200909|NCT03533686|76012926|FG000|Overall Study|Withdrawal by Subject|1|||
42103797|NCT00649428|75914664|FG000|Overall Study|Protocol Violation|6|||
42103798|NCT00649428|75914665|FG001|Overall Study|Protocol Violation|2|||
42103799|NCT00649428|75914664|FG000|Overall Study|Physician Decision|0|||
42103800|NCT00649428|75914665|FG001|Overall Study|Physician Decision|1|||
42103801|NCT00669032|75914674|FG000|Overall Study|Lost to Follow-up|6|||
42103802|NCT00669032|75914675|FG001|Overall Study|Lost to Follow-up|5|||
42103803|NCT00669032|75914674|FG000|Overall Study|Lack of Efficacy|8|||
42103804|NCT00669032|75914675|FG001|Overall Study|Lack of Efficacy|19|||
42103805|NCT00669032|75914674|FG000|Overall Study|Withdrawal by Subject|12|||
42103806|NCT00669032|75914675|FG001|Overall Study|Withdrawal by Subject|13|||
42103807|NCT00669032|75914674|FG000|Overall Study|Adverse Event|12|||
42103808|NCT00669032|75914675|FG001|Overall Study|Adverse Event|16|||
42103809|NCT00669032|75914674|FG000|Overall Study|Physician Decision|1|||
42103810|NCT00669032|75914675|FG001|Overall Study|Physician Decision|1|||
42103811|NCT00669032|75914674|FG000|Overall Study|No fulfilment of the selection criteria|5|||
42103812|NCT00669032|75914675|FG001|Overall Study|No fulfilment of the selection criteria|5|||
42103813|NCT00654498|75914683|FG000|Overall Study|Not Treated|1|||
42103814|NCT00654498|75914684|FG001|Overall Study|Not Treated|0|||
42103815|NCT00654498|75914683|FG000|Overall Study|Adverse Event|6|||
42103816|NCT00654498|75914684|FG001|Overall Study|Adverse Event|1|||
42103817|NCT00654498|75914683|FG000|Overall Study|Protocol Violation|1|||
42103818|NCT00654498|75914684|FG001|Overall Study|Protocol Violation|1|||
42103819|NCT00654498|75914683|FG000|Overall Study|Lost to Follow-up|1|||
42103820|NCT00654498|75914684|FG001|Overall Study|Lost to Follow-up|5|||
42103821|NCT00654498|75914683|FG000|Overall Study|Withdrawal by Subject|1|||
42103822|NCT00654498|75914684|FG001|Overall Study|Withdrawal by Subject|0|||
42103823|NCT00654498|75914683|FG000|Overall Study|Other reason not defined above|4|||
42103824|NCT00654498|75914684|FG001|Overall Study|Other reason not defined above|5|||
42103825|NCT00670046|75914692|FG000|Overall Study|Lost to Follow-up|1|||
42103826|NCT00670046|75914693|FG001|Overall Study|Lost to Follow-up|1|||
42103827|NCT00670046|75914692|FG000|Overall Study|Withdrawal by Subject|0|||
42103828|NCT00670046|75914693|FG001|Overall Study|Withdrawal by Subject|1|||
42103829|NCT00560391|75914704|FG000|Overall Study|Still on treatment|0|||
42103830|NCT00560391|75914705|FG001|Overall Study|Still on treatment|0|||
42103831|NCT00560391|75914706|FG002|Overall Study|Still on treatment|0|||
42103832|NCT00560391|75914707|FG003|Overall Study|Still on treatment|1|||
42103833|NCT00560391|75914708|FG004|Overall Study|Still on treatment|2|||
42103834|NCT00537238|75914723|FG000|Overall Study|Death|1|||
42103835|NCT00537238|75914724|FG001|Overall Study|Death|2|||
42103836|NCT00537238|75914723|FG000|Overall Study|Adverse Event|31|||
42103837|NCT00537238|75914724|FG001|Overall Study|Adverse Event|22|||
42103838|NCT00537238|75914723|FG000|Overall Study|Lack of Efficacy|20|||
42103839|NCT00537238|75914724|FG001|Overall Study|Lack of Efficacy|21|||
42103840|NCT00537238|75914723|FG000|Overall Study|Lost to Follow-up|12|||
42103841|NCT00537238|75914724|FG001|Overall Study|Lost to Follow-up|8|||
42103842|NCT00537238|75914723|FG000|Overall Study|Withdrawal by Subject|51|||
42103843|NCT00537238|75914724|FG001|Overall Study|Withdrawal by Subject|47|||
42103844|NCT00537238|75914723|FG000|Overall Study|Protocol Violation|15|||
42103845|NCT00537238|75914724|FG001|Overall Study|Protocol Violation|19|||
42103846|NCT00537238|75914723|FG000|Overall Study|Does not meet entrance criteria|0|||
42103847|NCT00537238|75914724|FG001|Overall Study|Does not meet entrance criteria|2|||
42103848|NCT00537238|75914723|FG000|Overall Study|Other|44|||
42103849|NCT00537238|75914724|FG001|Overall Study|Other|52|||
42103850|NCT03966885|75914732|FG000|Overall Study|Death|1|||
42103851|NCT03966885|75914733|FG001|Overall Study|Death|0|||
42103852|NCT03966885|75914732|FG000|Overall Study|Lost to Follow-up|1|||
42103853|NCT03966885|75914733|FG001|Overall Study|Lost to Follow-up|2|||
42103854|NCT03966885|75914732|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
42103855|NCT03966885|75914733|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
42103856|NCT03966885|75914732|FG000|Overall Study|Moved from study area.|0|||
42103857|NCT03966885|75914733|FG001|Overall Study|Moved from study area.|2|||
42103858|NCT03965403|75914740|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
42103859|NCT00552669|75914746|FG000|Overall Study|Death|3|||
42103860|NCT00552669|75914747|FG001|Overall Study|Death|7|||
42103861|NCT00552513|75914755|FG000|Overall Study|Lost to Follow-up|5|||
42103862|NCT00552513|75914756|FG001|Overall Study|Lost to Follow-up|1|||
42103863|NCT00560313|75914764|FG000|Overall Study|Adverse Events or Death|2|||
42103864|NCT00560313|75914764|FG000|Overall Study|Withdrawal by Subject|2|||
42103865|NCT00560313|75914764|FG000|Overall Study|Lost to Follow-up|1|||
42103866|NCT00560313|75914764|FG000|Overall Study|Protocol Violation|1|||
42103867|NCT00667862|75914783|FG000|Overall Study|Adverse Event|9|||
42103868|NCT00667862|75914783|FG000|Overall Study|Death|1|||
42103869|NCT00667862|75914783|FG000|Overall Study|Disease Progression|22|||
42103870|NCT00667862|75914783|FG000|Overall Study|Withdrawal by Subject|3|||
42103871|NCT00535132|75914789|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
42103872|NCT00535132|75914790|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
42103873|NCT00535132|75914789|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
42103874|NCT00535132|75914790|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
42103875|NCT00570908|75914798|FG000|Overall Study|Adverse Event|5|||
42103876|NCT00570908|75914798|FG000|Overall Study|Withdrawal by Subject|2|||
42103877|NCT00321919|75914804|FG000|Overall Study|Adverse Event|17|||
42103878|NCT00321919|75914805|FG001|Overall Study|Adverse Event|10|||
42103879|NCT00321919|75914804|FG000|Overall Study|Death|21|||
42103880|NCT00321919|75914805|FG001|Overall Study|Death|17|||
42103881|NCT00321919|75914804|FG000|Overall Study|Insufficient Therapeutic Response|1|||
42103882|NCT00321919|75914805|FG001|Overall Study|Insufficient Therapeutic Response|0|||
42103883|NCT00321919|75914804|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
42103884|NCT00321919|75914805|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
42103885|NCT00321919|75914804|FG000|Overall Study|Refused Treatment|23|||
42103886|NCT00321919|75914805|FG001|Overall Study|Refused Treatment|14|||
42103887|NCT00321919|75914804|FG000|Overall Study|Other Protocol Violation|2|||
42103888|NCT00321919|75914805|FG001|Overall Study|Other Protocol Violation|3|||
42103889|NCT00321919|75914804|FG000|Overall Study|Failure to Return|3|||
42103890|NCT00321919|75914805|FG001|Overall Study|Failure to Return|1|||
42103891|NCT00321919|75914804|FG000|Overall Study|Other withdrawal reason|7|||
42103892|NCT00321919|75914805|FG001|Overall Study|Other withdrawal reason|6|||
42103893|NCT00781391|75914815|FG000|Overall Study|never received study drug|24|||
42103894|NCT00781391|75914816|FG001|Overall Study|never received study drug|23|||
42103895|NCT00781391|75914817|FG002|Overall Study|never received study drug|32|||
42103896|NCT00781391|75914815|FG000|Overall Study|Protocol Violation|19|||
42103897|NCT00781391|75914816|FG001|Overall Study|Protocol Violation|17|||
42103898|NCT00781391|75914817|FG002|Overall Study|Protocol Violation|20|||
42103899|NCT00781391|75914815|FG000|Overall Study|Death|789|||
42103900|NCT00781391|75914816|FG001|Overall Study|Death|730|||
42103901|NCT00781391|75914817|FG002|Overall Study|Death|706|||
42103902|NCT00781391|75914815|FG000|Overall Study|Withdrawal by Subject|47|||
42103903|NCT00781391|75914816|FG001|Overall Study|Withdrawal by Subject|37|||
42103904|NCT00781391|75914817|FG002|Overall Study|Withdrawal by Subject|25|||
42103905|NCT00781391|75914815|FG000|Overall Study|Lost to Follow-up|0|||
42103906|NCT00781391|75914816|FG001|Overall Study|Lost to Follow-up|0|||
42200910|NCT03533686|76012927|FG001|Overall Study|Withdrawal by Subject|0|||
42200911|NCT03533686|76012928|FG002|Overall Study|Withdrawal by Subject|0|||
42200912|NCT03533686|76012929|FG003|Overall Study|Withdrawal by Subject|3|||
42200913|NCT03533686|76012930|FG004|Overall Study|Withdrawal by Subject|5|||
42200914|NCT03533686|76012931|FG005|Overall Study|Withdrawal by Subject|1|||
42200915|NCT03533686|76012926|FG000|Overall Study|Lost to Follow-up|0|||
42200916|NCT03533686|76012927|FG001|Overall Study|Lost to Follow-up|1|||
42200917|NCT03533686|76012928|FG002|Overall Study|Lost to Follow-up|0|||
42200918|NCT03533686|76012929|FG003|Overall Study|Lost to Follow-up|0|||
42200919|NCT03533686|76012930|FG004|Overall Study|Lost to Follow-up|2|||
42200920|NCT03533686|76012931|FG005|Overall Study|Lost to Follow-up|0|||
42200921|NCT03533686|76012926|FG000|Overall Study|Screen Failure|0|||
42200922|NCT03533686|76012927|FG001|Overall Study|Screen Failure|0|||
42200923|NCT03533686|76012928|FG002|Overall Study|Screen Failure|0|||
42200924|NCT03533686|76012929|FG003|Overall Study|Screen Failure|2|||
42103907|NCT00781391|75914817|FG002|Overall Study|Lost to Follow-up|1|||
42103908|NCT00534976|75914827|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
42103909|NCT00534976|75914828|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
42200925|NCT03533686|76012930|FG004|Overall Study|Screen Failure|0|||
42200926|NCT03533686|76012931|FG005|Overall Study|Screen Failure|0|||
42200927|NCT03154359|76012989|FG000|Overall Study|Adverse Event|1|||
42378189|NCT01693562|76249641|FG012|Escalation Phase|Lost to Follow-up|0|||
42200928|NCT03154359|76012989|FG000|Overall Study|Lack of Efficacy|2|||
42200929|NCT03154359|76012989|FG000|Overall Study|Lost to Follow-up|3|||
42200930|NCT03154359|76012989|FG000|Overall Study|Physician Decision|3|||
42200931|NCT03154359|76012989|FG000|Overall Study|Protocol Violation|4|||
42200932|NCT03154359|76012989|FG000|Overall Study|Withdrawal by Subject|5|||
42378190|NCT01693562|76249642|FG013|Escalation Phase|Lost to Follow-up|0|||
42378191|NCT01693562|76249643|FG014|Escalation Phase|Lost to Follow-up|0|||
42378192|NCT01693562|76249644|FG015|Escalation Phase|Lost to Follow-up|0|||
42378193|NCT01693562|76249645|FG016|Escalation Phase|Lost to Follow-up|0|||
42378194|NCT01693562|76249646|FG017|Escalation Phase|Lost to Follow-up|0|||
42378195|NCT01693562|76249647|FG018|Escalation Phase|Lost to Follow-up|0|||
42200933|NCT03154359|76012989|FG000|Overall Study|Disruption of study due to COVID-19|4|||
42378196|NCT01693562|76249648|FG019|Escalation Phase|Lost to Follow-up|0|||
42200934|NCT03135834|76013008|FG000|Stage 1|Adverse Event|1|||
42103910|NCT00534976|75914827|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
42103911|NCT00534976|75914828|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
42103912|NCT00534976|75914827|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
42103913|NCT00534976|75914828|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
42103914|NCT00321763|75914838|FG000|Overall Study|Adverse Event|1|||
42103915|NCT00321763|75914839|FG001|Overall Study|Adverse Event|1|||
42103916|NCT00321763|75914840|FG002|Overall Study|Adverse Event|0|||
42103917|NCT00321763|75914841|FG003|Overall Study|Adverse Event|1|||
42103918|NCT00321763|75914838|FG000|Overall Study|Withdrawal by Subject|2|||
42103919|NCT00321763|75914839|FG001|Overall Study|Withdrawal by Subject|0|||
42103920|NCT00321763|75914840|FG002|Overall Study|Withdrawal by Subject|1|||
42378197|NCT01693562|76249649|FG020|Escalation Phase|Lost to Follow-up|0|||
42378198|NCT01693562|76249650|FG021|Escalation Phase|Lost to Follow-up|0|||
42378199|NCT01693562|76249651|FG022|Escalation Phase|Lost to Follow-up|0|||
42378200|NCT01693562|76249629|FG000|Escalation Phase|Other|0|||
42378201|NCT01693562|76249630|FG001|Escalation Phase|Other|0|||
42378202|NCT01693562|76249631|FG002|Escalation Phase|Other|2|||
42378203|NCT01693562|76249632|FG003|Escalation Phase|Other|0|||
42378204|NCT01693562|76249633|FG004|Escalation Phase|Other|0|||
42378205|NCT01693562|76249634|FG005|Escalation Phase|Other|1|||
42378206|NCT01693562|76249635|FG006|Escalation Phase|Other|0|||
42378207|NCT01693562|76249636|FG007|Escalation Phase|Other|0|||
42378208|NCT01693562|76249637|FG008|Escalation Phase|Other|0|||
42378209|NCT01693562|76249638|FG009|Escalation Phase|Other|0|||
42378210|NCT01693562|76249639|FG010|Escalation Phase|Other|0|||
42378211|NCT01693562|76249640|FG011|Escalation Phase|Other|0|||
42378212|NCT01693562|76249641|FG012|Escalation Phase|Other|0|||
42378213|NCT01693562|76249642|FG013|Escalation Phase|Other|0|||
42378214|NCT01693562|76249643|FG014|Escalation Phase|Other|0|||
42378215|NCT01693562|76249644|FG015|Escalation Phase|Other|0|||
42378216|NCT01693562|76249645|FG016|Escalation Phase|Other|0|||
42378217|NCT01693562|76249646|FG017|Escalation Phase|Other|0|||
42378218|NCT01693562|76249647|FG018|Escalation Phase|Other|0|||
42378219|NCT01693562|76249648|FG019|Escalation Phase|Other|0|||
42378220|NCT01693562|76249649|FG020|Escalation Phase|Other|0|||
42378221|NCT01693562|76249650|FG021|Escalation Phase|Other|0|||
42378222|NCT01693562|76249651|FG022|Escalation Phase|Other|0|||
42378223|NCT01693562|76249629|FG000|Exploration Phase|Withdrawal by Subject|0|||
42378224|NCT01693562|76249630|FG001|Exploration Phase|Withdrawal by Subject|0|||
42378225|NCT01693562|76249631|FG002|Exploration Phase|Withdrawal by Subject|0|||
42378226|NCT01693562|76249632|FG003|Exploration Phase|Withdrawal by Subject|0|||
42378227|NCT01693562|76249633|FG004|Exploration Phase|Withdrawal by Subject|0|||
42378228|NCT01693562|76249634|FG005|Exploration Phase|Withdrawal by Subject|0|||
42378229|NCT01693562|76249635|FG006|Exploration Phase|Withdrawal by Subject|2|||
42378230|NCT01693562|76249636|FG007|Exploration Phase|Withdrawal by Subject|0|||
42378231|NCT01693562|76249637|FG008|Exploration Phase|Withdrawal by Subject|0|||
42378232|NCT01693562|76249638|FG009|Exploration Phase|Withdrawal by Subject|0|||
42378233|NCT01693562|76249639|FG010|Exploration Phase|Withdrawal by Subject|0|||
42378234|NCT01693562|76249640|FG011|Exploration Phase|Withdrawal by Subject|0|||
42378235|NCT01693562|76249641|FG012|Exploration Phase|Withdrawal by Subject|0|||
42378236|NCT01693562|76249642|FG013|Exploration Phase|Withdrawal by Subject|0|||
42378237|NCT01693562|76249643|FG014|Exploration Phase|Withdrawal by Subject|0|||
42378238|NCT01693562|76249644|FG015|Exploration Phase|Withdrawal by Subject|0|||
42378239|NCT01693562|76249645|FG016|Exploration Phase|Withdrawal by Subject|0|||
42378240|NCT01693562|76249646|FG017|Exploration Phase|Withdrawal by Subject|0|||
42103921|NCT00321763|75914841|FG003|Overall Study|Withdrawal by Subject|0|||
42103922|NCT00321763|75914838|FG000|Overall Study|Lost to Follow-up|3|||
42103923|NCT00321763|75914839|FG001|Overall Study|Lost to Follow-up|1|||
42103924|NCT00321763|75914840|FG002|Overall Study|Lost to Follow-up|5|||
42103925|NCT00321763|75914841|FG003|Overall Study|Lost to Follow-up|4|||
42378241|NCT01693562|76249647|FG018|Exploration Phase|Withdrawal by Subject|0|||
42378242|NCT01693562|76249648|FG019|Exploration Phase|Withdrawal by Subject|0|||
42378243|NCT01693562|76249649|FG020|Exploration Phase|Withdrawal by Subject|0|||
42378244|NCT01693562|76249650|FG021|Exploration Phase|Withdrawal by Subject|0|||
42378245|NCT01693562|76249651|FG022|Exploration Phase|Withdrawal by Subject|0|||
42378246|NCT01693562|76249629|FG000|Exploration Phase|Death|0|||
42378247|NCT01693562|76249630|FG001|Exploration Phase|Death|0|||
42378248|NCT01693562|76249631|FG002|Exploration Phase|Death|0|||
42378249|NCT01693562|76249632|FG003|Exploration Phase|Death|0|||
42378250|NCT01693562|76249633|FG004|Exploration Phase|Death|0|||
42378251|NCT01693562|76249634|FG005|Exploration Phase|Death|0|||
42378252|NCT01693562|76249635|FG006|Exploration Phase|Death|17|||
42378253|NCT01693562|76249636|FG007|Exploration Phase|Death|0|||
42378254|NCT01693562|76249637|FG008|Exploration Phase|Death|0|||
42378255|NCT01693562|76249638|FG009|Exploration Phase|Death|0|||
42378256|NCT01693562|76249639|FG010|Exploration Phase|Death|0|||
42378257|NCT01693562|76249640|FG011|Exploration Phase|Death|0|||
42378258|NCT01693562|76249641|FG012|Exploration Phase|Death|0|||
42378259|NCT01693562|76249642|FG013|Exploration Phase|Death|0|||
42378260|NCT01693562|76249643|FG014|Exploration Phase|Death|0|||
42378261|NCT01693562|76249644|FG015|Exploration Phase|Death|0|||
42378262|NCT01693562|76249645|FG016|Exploration Phase|Death|0|||
42378263|NCT01693562|76249646|FG017|Exploration Phase|Death|0|||
42378264|NCT01693562|76249647|FG018|Exploration Phase|Death|0|||
42378265|NCT01693562|76249648|FG019|Exploration Phase|Death|0|||
42378266|NCT01693562|76249649|FG020|Exploration Phase|Death|0|||
42378267|NCT01693562|76249650|FG021|Exploration Phase|Death|0|||
42378268|NCT01693562|76249651|FG022|Exploration Phase|Death|0|||
42378269|NCT01693562|76249629|FG000|Exploration Phase|Other|0|||
42378270|NCT01693562|76249630|FG001|Exploration Phase|Other|0|||
42378271|NCT01693562|76249631|FG002|Exploration Phase|Other|0|||
42378272|NCT01693562|76249632|FG003|Exploration Phase|Other|0|||
42378273|NCT01693562|76249633|FG004|Exploration Phase|Other|0|||
42378274|NCT01693562|76249634|FG005|Exploration Phase|Other|0|||
42378275|NCT01693562|76249635|FG006|Exploration Phase|Other|2|||
42378276|NCT01693562|76249636|FG007|Exploration Phase|Other|0|||
42378277|NCT01693562|76249637|FG008|Exploration Phase|Other|0|||
42378278|NCT01693562|76249638|FG009|Exploration Phase|Other|0|||
42378279|NCT01693562|76249639|FG010|Exploration Phase|Other|0|||
42378280|NCT01693562|76249640|FG011|Exploration Phase|Other|0|||
42378281|NCT01693562|76249641|FG012|Exploration Phase|Other|0|||
42378282|NCT01693562|76249642|FG013|Exploration Phase|Other|0|||
42378283|NCT01693562|76249643|FG014|Exploration Phase|Other|0|||
42378284|NCT01693562|76249644|FG015|Exploration Phase|Other|0|||
42378285|NCT01693562|76249645|FG016|Exploration Phase|Other|0|||
42378286|NCT01693562|76249646|FG017|Exploration Phase|Other|0|||
42378287|NCT01693562|76249647|FG018|Exploration Phase|Other|0|||
42378288|NCT01693562|76249648|FG019|Exploration Phase|Other|0|||
42378289|NCT01693562|76249649|FG020|Exploration Phase|Other|0|||
42200935|NCT03135834|76013009|FG001|Stage 1|Adverse Event|2|||
42200936|NCT03135834|76013010|FG002|Stage 1|Adverse Event|2|||
42200937|NCT03135834|76013011|FG003|Stage 1|Adverse Event|1|||
42378290|NCT01693562|76249650|FG021|Exploration Phase|Other|0|||
42378291|NCT01693562|76249651|FG022|Exploration Phase|Other|0|||
42378292|NCT01693562|76249629|FG000|Expansion Phase|Withdrawal by Subject|0|||
42378293|NCT01693562|76249630|FG001|Expansion Phase|Withdrawal by Subject|0|||
42378294|NCT01693562|76249631|FG002|Expansion Phase|Withdrawal by Subject|0|||
42378295|NCT01693562|76249632|FG003|Expansion Phase|Withdrawal by Subject|0|||
42378296|NCT01693562|76249633|FG004|Expansion Phase|Withdrawal by Subject|0|||
42378297|NCT01693562|76249634|FG005|Expansion Phase|Withdrawal by Subject|0|||
42378298|NCT01693562|76249635|FG006|Expansion Phase|Withdrawal by Subject|0|||
42378299|NCT01693562|76249636|FG007|Expansion Phase|Withdrawal by Subject|16|||
42378300|NCT01693562|76249637|FG008|Expansion Phase|Withdrawal by Subject|2|||
42378301|NCT01693562|76249638|FG009|Expansion Phase|Withdrawal by Subject|54|||
42378302|NCT01693562|76249639|FG010|Expansion Phase|Withdrawal by Subject|2|||
42378303|NCT01693562|76249640|FG011|Expansion Phase|Withdrawal by Subject|2|||
42378304|NCT01693562|76249641|FG012|Expansion Phase|Withdrawal by Subject|3|||
42378305|NCT01693562|76249642|FG013|Expansion Phase|Withdrawal by Subject|5|||
42378306|NCT01693562|76249643|FG014|Expansion Phase|Withdrawal by Subject|16|||
42378307|NCT01693562|76249644|FG015|Expansion Phase|Withdrawal by Subject|7|||
42378308|NCT01693562|76249645|FG016|Expansion Phase|Withdrawal by Subject|40|||
42378309|NCT01693562|76249646|FG017|Expansion Phase|Withdrawal by Subject|4|||
42378310|NCT01693562|76249647|FG018|Expansion Phase|Withdrawal by Subject|8|||
42378311|NCT01693562|76249648|FG019|Expansion Phase|Withdrawal by Subject|3|||
42378312|NCT01693562|76249649|FG020|Expansion Phase|Withdrawal by Subject|1|||
42378313|NCT01693562|76249650|FG021|Expansion Phase|Withdrawal by Subject|8|||
42378314|NCT01693562|76249651|FG022|Expansion Phase|Withdrawal by Subject|1|||
42378315|NCT01693562|76249629|FG000|Expansion Phase|Death|0|||
42378316|NCT01693562|76249630|FG001|Expansion Phase|Death|0|||
42378317|NCT01693562|76249631|FG002|Expansion Phase|Death|0|||
42378318|NCT01693562|76249632|FG003|Expansion Phase|Death|0|||
42378319|NCT01693562|76249633|FG004|Expansion Phase|Death|0|||
42378320|NCT01693562|76249634|FG005|Expansion Phase|Death|0|||
42378321|NCT01693562|76249635|FG006|Expansion Phase|Death|0|||
42378322|NCT01693562|76249636|FG007|Expansion Phase|Death|42|||
42378323|NCT01693562|76249637|FG008|Expansion Phase|Death|17|||
42378324|NCT01693562|76249638|FG009|Expansion Phase|Death|208|||
42378325|NCT01693562|76249639|FG010|Expansion Phase|Death|30|||
42378326|NCT01693562|76249640|FG011|Expansion Phase|Death|8|||
42378327|NCT01693562|76249641|FG012|Expansion Phase|Death|19|||
42378328|NCT01693562|76249642|FG013|Expansion Phase|Death|42|||
42378329|NCT01693562|76249643|FG014|Expansion Phase|Death|23|||
42378330|NCT01693562|76249644|FG015|Expansion Phase|Death|23|||
42378331|NCT01693562|76249645|FG016|Expansion Phase|Death|128|||
42378332|NCT01693562|76249646|FG017|Expansion Phase|Death|16|||
42378333|NCT01693562|76249647|FG018|Expansion Phase|Death|36|||
42378334|NCT01693562|76249648|FG019|Expansion Phase|Death|16|||
42378335|NCT01693562|76249649|FG020|Expansion Phase|Death|17|||
42378336|NCT01693562|76249650|FG021|Expansion Phase|Death|35|||
42378337|NCT01693562|76249651|FG022|Expansion Phase|Death|7|||
42378338|NCT01693562|76249629|FG000|Expansion Phase|Lost to Follow-up|0|||
42378339|NCT01693562|76249630|FG001|Expansion Phase|Lost to Follow-up|0|||
42378340|NCT01693562|76249631|FG002|Expansion Phase|Lost to Follow-up|0|||
42378341|NCT01693562|76249632|FG003|Expansion Phase|Lost to Follow-up|0|||
42378342|NCT01693562|76249633|FG004|Expansion Phase|Lost to Follow-up|0|||
42378343|NCT01693562|76249634|FG005|Expansion Phase|Lost to Follow-up|0|||
42378344|NCT01693562|76249635|FG006|Expansion Phase|Lost to Follow-up|0|||
42378345|NCT01693562|76249636|FG007|Expansion Phase|Lost to Follow-up|1|||
42378346|NCT01693562|76249637|FG008|Expansion Phase|Lost to Follow-up|2|||
42378347|NCT01693562|76249638|FG009|Expansion Phase|Lost to Follow-up|10|||
42378348|NCT01693562|76249639|FG010|Expansion Phase|Lost to Follow-up|4|||
42378349|NCT01693562|76249640|FG011|Expansion Phase|Lost to Follow-up|4|||
42378350|NCT01693562|76249641|FG012|Expansion Phase|Lost to Follow-up|1|||
42378351|NCT01693562|76249642|FG013|Expansion Phase|Lost to Follow-up|3|||
42378352|NCT01693562|76249643|FG014|Expansion Phase|Lost to Follow-up|0|||
42378353|NCT01693562|76249644|FG015|Expansion Phase|Lost to Follow-up|1|||
42378354|NCT01693562|76249645|FG016|Expansion Phase|Lost to Follow-up|1|||
42378355|NCT01693562|76249646|FG017|Expansion Phase|Lost to Follow-up|0|||
42378356|NCT01693562|76249647|FG018|Expansion Phase|Lost to Follow-up|2|||
42378357|NCT01693562|76249648|FG019|Expansion Phase|Lost to Follow-up|1|||
42378358|NCT01693562|76249649|FG020|Expansion Phase|Lost to Follow-up|2|||
42378359|NCT01693562|76249650|FG021|Expansion Phase|Lost to Follow-up|2|||
42378360|NCT01693562|76249651|FG022|Expansion Phase|Lost to Follow-up|1|||
42378361|NCT01693562|76249629|FG000|Expansion Phase|Other|0|||
42378362|NCT01693562|76249630|FG001|Expansion Phase|Other|0|||
42378363|NCT01693562|76249631|FG002|Expansion Phase|Other|0|||
42378364|NCT01693562|76249632|FG003|Expansion Phase|Other|0|||
42378365|NCT01693562|76249633|FG004|Expansion Phase|Other|0|||
42378366|NCT01693562|76249634|FG005|Expansion Phase|Other|0|||
42378367|NCT01693562|76249635|FG006|Expansion Phase|Other|0|||
42378368|NCT01693562|76249636|FG007|Expansion Phase|Other|3|||
42378369|NCT01693562|76249637|FG008|Expansion Phase|Other|1|||
42378370|NCT01693562|76249638|FG009|Expansion Phase|Other|28|||
42378371|NCT01693562|76249639|FG010|Expansion Phase|Other|4|||
42378372|NCT01693562|76249640|FG011|Expansion Phase|Other|7|||
42378373|NCT01693562|76249641|FG012|Expansion Phase|Other|0|||
42378374|NCT01693562|76249642|FG013|Expansion Phase|Other|1|||
42378375|NCT01693562|76249643|FG014|Expansion Phase|Other|1|||
42378376|NCT01693562|76249644|FG015|Expansion Phase|Other|0|||
42378377|NCT01693562|76249645|FG016|Expansion Phase|Other|28|||
42378378|NCT01693562|76249646|FG017|Expansion Phase|Other|0|||
42378379|NCT01693562|76249647|FG018|Expansion Phase|Other|1|||
42378380|NCT01693562|76249648|FG019|Expansion Phase|Other|0|||
42378381|NCT01693562|76249649|FG020|Expansion Phase|Other|1|||
42378382|NCT01693562|76249650|FG021|Expansion Phase|Other|17|||
42378383|NCT01693562|76249651|FG022|Expansion Phase|Other|1|||
42378384|NCT01467713|76249748|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
42378385|NCT01467713|76249749|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
42378386|NCT01467713|76249750|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
42378387|NCT01467713|76249751|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
42378388|NCT01467713|76249748|FG000|Overall Study|Major Protocol Deviation|2|||
42378389|NCT01467713|76249749|FG001|Overall Study|Major Protocol Deviation|4|||
42378390|NCT01467713|76249750|FG002|Overall Study|Major Protocol Deviation|4|||
42378391|NCT01467713|76249751|FG003|Overall Study|Major Protocol Deviation|1|||
42378392|NCT01467713|76249748|FG000|Overall Study|Lost to Follow-up|9|||
42378393|NCT01467713|76249749|FG001|Overall Study|Lost to Follow-up|12|||
42378394|NCT01467713|76249750|FG002|Overall Study|Lost to Follow-up|6|||
42378395|NCT01467713|76249751|FG003|Overall Study|Lost to Follow-up|9|||
42378396|NCT01467713|76249748|FG000|Overall Study|Voluntary Withdrawal|18|||
42378397|NCT01467713|76249749|FG001|Overall Study|Voluntary Withdrawal|14|||
42378398|NCT01467713|76249750|FG002|Overall Study|Voluntary Withdrawal|21|||
42378399|NCT01467713|76249751|FG003|Overall Study|Voluntary Withdrawal|20|||
42378400|NCT01467713|76249748|FG000|Overall Study|Study Termination|23|||
42378401|NCT01467713|76249749|FG001|Overall Study|Study Termination|33|||
42378402|NCT01467713|76249750|FG002|Overall Study|Study Termination|28|||
42378403|NCT01467713|76249751|FG003|Overall Study|Study Termination|29|||
42378404|NCT01467713|76249748|FG000|Overall Study|Pregnancy|0|||
42378405|NCT01467713|76249749|FG001|Overall Study|Pregnancy|1|||
42378406|NCT01467713|76249750|FG002|Overall Study|Pregnancy|1|||
42378407|NCT01467713|76249751|FG003|Overall Study|Pregnancy|3|||
42378408|NCT01467713|76249748|FG000|Overall Study|Relapse|35|||
42378409|NCT01467713|76249749|FG001|Overall Study|Relapse|25|||
42378410|NCT01467713|76249750|FG002|Overall Study|Relapse|28|||
42378411|NCT01467713|76249751|FG003|Overall Study|Relapse|35|||
42378412|NCT01467713|76249748|FG000|Overall Study|Reason not Specified|6|||
42378413|NCT01467713|76249749|FG001|Overall Study|Reason not Specified|11|||
42378414|NCT01467713|76249750|FG002|Overall Study|Reason not Specified|8|||
42378415|NCT01467713|76249751|FG003|Overall Study|Reason not Specified|7|||
42378416|NCT01693250|76249781|FG000|Overall Study|Lost to Follow-up|2|||
42378417|NCT01693250|76249782|FG001|Overall Study|Lost to Follow-up|2|||
42103926|NCT00308113|75914857|FG000|Overall Study|Protocol closure|0|||
42103927|NCT00308113|75914858|FG001|Overall Study|Protocol closure|0|||
42103928|NCT00308113|75914859|FG002|Overall Study|Protocol closure|0|||
42103929|NCT00308113|75914860|FG003|Overall Study|Protocol closure|1|||
42103930|NCT00307801|75914876|FG000|Overall Study|Adverse Event|12|||
42103931|NCT00307801|75914877|FG001|Overall Study|Adverse Event|4|||
42103932|NCT00307801|75914876|FG000|Overall Study|Withdrawal by Subject|9|||
42103933|NCT00307801|75914877|FG001|Overall Study|Withdrawal by Subject|4|||
42103934|NCT00307801|75914876|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
42103935|NCT00307801|75914877|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
42103936|NCT00307801|75914876|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
42103937|NCT00307801|75914877|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
42378418|NCT01590758|76249805|FG000|Overall Study|Withdrawal by Subject|0|||
42378419|NCT01590758|76249806|FG001|Overall Study|Withdrawal by Subject|3|||
42378420|NCT01590758|76249805|FG000|Overall Study|Physician Decision|1|||
42378421|NCT01590758|76249806|FG001|Overall Study|Physician Decision|2|||
42378422|NCT01590758|76249805|FG000|Overall Study|Lost to Follow-up|4|||
42378423|NCT01590758|76249806|FG001|Overall Study|Lost to Follow-up|2|||
42378424|NCT01590212|76249815|FG000|Overall Study|Withdrawal by Subject|2|||
42378425|NCT01590212|76249816|FG001|Overall Study|Withdrawal by Subject|2|||
42378426|NCT01590212|76249817|FG002|Overall Study|Withdrawal by Subject|2|||
42378427|NCT01590212|76249815|FG000|Overall Study|Lost to Follow-up|1|||
42378428|NCT01590212|76249816|FG001|Overall Study|Lost to Follow-up|2|||
42378429|NCT01590212|76249817|FG002|Overall Study|Lost to Follow-up|3|||
42378430|NCT01692938|76249828|FG000|Overall Study|Protocol Deviation|1|||
42378431|NCT01692938|76249829|FG001|Overall Study|Protocol Deviation|1|||
42378432|NCT01692938|76249828|FG000|Overall Study|Study completed prior to site completion|3|||
42378433|NCT01692938|76249829|FG001|Overall Study|Study completed prior to site completion|3|||
42378434|NCT01692782|76249842|FG000|Overall Study|Adverse Event|12|||
42378435|NCT01692782|76249843|FG001|Overall Study|Adverse Event|32|||
42378436|NCT01692782|76249844|FG002|Overall Study|Adverse Event|2|||
42378437|NCT01692782|76249842|FG000|Overall Study|Lack of Efficacy|1|||
42378438|NCT01692782|76249843|FG001|Overall Study|Lack of Efficacy|2|||
42378439|NCT01692782|76249844|FG002|Overall Study|Lack of Efficacy|0|||
42378440|NCT01692782|76249842|FG000|Overall Study|Lost to Follow-up|2|||
42378441|NCT01692782|76249843|FG001|Overall Study|Lost to Follow-up|7|||
42378442|NCT01692782|76249844|FG002|Overall Study|Lost to Follow-up|1|||
42378443|NCT01692782|76249842|FG000|Overall Study|Pregnancy|1|||
42378444|NCT01692782|76249843|FG001|Overall Study|Pregnancy|0|||
42378445|NCT01692782|76249844|FG002|Overall Study|Pregnancy|0|||
42378446|NCT01692782|76249842|FG000|Overall Study|Protocol Violation|1|||
42378447|NCT01692782|76249843|FG001|Overall Study|Protocol Violation|0|||
42378448|NCT01692782|76249844|FG002|Overall Study|Protocol Violation|2|||
42378449|NCT01692782|76249842|FG000|Overall Study|Non-complance with study drug|0|||
42378450|NCT01692782|76249843|FG001|Overall Study|Non-complance with study drug|4|||
42378451|NCT01692782|76249844|FG002|Overall Study|Non-complance with study drug|1|||
42378452|NCT01692782|76249842|FG000|Overall Study|Non-compliant with study visits|0|||
42378453|NCT01692782|76249843|FG001|Overall Study|Non-compliant with study visits|0|||
42378454|NCT01692782|76249844|FG002|Overall Study|Non-compliant with study visits|1|||
42378455|NCT01692782|76249842|FG000|Overall Study|SAE not related to study drug|0|||
42378456|NCT01692782|76249843|FG001|Overall Study|SAE not related to study drug|1|||
42378457|NCT01692782|76249844|FG002|Overall Study|SAE not related to study drug|0|||
42378458|NCT01692782|76249842|FG000|Overall Study|Withdrawal by Subject|3|||
42103938|NCT00307801|75914876|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
42103939|NCT00307801|75914877|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
42103940|NCT00307801|75914876|FG000|Overall Study|Wrong Randomization|1|||
42103941|NCT00307801|75914877|FG001|Overall Study|Wrong Randomization|0|||
42103942|NCT00307801|75914876|FG000|Overall Study|Lack of Efficacy|0|||
42103943|NCT00307801|75914877|FG001|Overall Study|Lack of Efficacy|2|||
42103944|NCT00307801|75914876|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
42103945|NCT00307801|75914877|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
42200938|NCT03135834|76013008|FG000|Stage 1|Death|1|||
42200939|NCT03135834|76013009|FG001|Stage 1|Death|0|||
42200940|NCT03135834|76013010|FG002|Stage 1|Death|0|||
42378459|NCT01692782|76249843|FG001|Overall Study|Withdrawal by Subject|10|||
42103946|NCT00307801|75914876|FG000|Overall Study|Frustration with e-diary|1|||
42103947|NCT00307801|75914877|FG001|Overall Study|Frustration with e-diary|0|||
42103948|NCT00307801|75914876|FG000|Overall Study|Protocol Violation|3|||
42103949|NCT00307801|75914877|FG001|Overall Study|Protocol Violation|2|||
42103950|NCT00307801|75914876|FG000|Overall Study|No reason specified|2|||
42103951|NCT00307801|75914877|FG001|Overall Study|No reason specified|0|||
42103952|NCT00307801|75914876|FG000|Overall Study|Pregnancy|0|||
42103953|NCT00307801|75914877|FG001|Overall Study|Pregnancy|1|||
42103954|NCT00671060|75914886|FG000|Overall Study|Protocol Violation|1|||
42103955|NCT00671060|75914887|FG001|Overall Study|Protocol Violation|0|||
42103956|NCT00671060|75914886|FG000|Overall Study|Physician Decision|0|||
42103957|NCT00671060|75914887|FG001|Overall Study|Physician Decision|1|||
42103958|NCT00654420|75914897|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
42103959|NCT00654420|75914898|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
42103960|NCT00654420|75914899|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
42103961|NCT00654420|75914900|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
42103962|NCT00654420|75914897|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
42103963|NCT00654420|75914898|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
42103964|NCT00654420|75914899|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
42103965|NCT00654420|75914900|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
42103966|NCT00654420|75914897|FG000|Phase II|Adverse Event|0|||
42103967|NCT00654420|75914898|FG001|Phase II|Adverse Event|0|||
42103968|NCT00654420|75914899|FG002|Phase II|Adverse Event|3|||
42103969|NCT00654420|75914900|FG003|Phase II|Adverse Event|3|||
42103970|NCT00654420|75914897|FG000|Phase II|Lost to Follow-up|0|||
42103971|NCT00654420|75914898|FG001|Phase II|Lost to Follow-up|0|||
42103972|NCT00654420|75914899|FG002|Phase II|Lost to Follow-up|0|||
42103973|NCT00654420|75914900|FG003|Phase II|Lost to Follow-up|1|||
42103974|NCT00654420|75914897|FG000|Phase II|Physician Decision|0|||
42103975|NCT00654420|75914898|FG001|Phase II|Physician Decision|0|||
42103976|NCT00654420|75914899|FG002|Phase II|Physician Decision|0|||
42103977|NCT00654420|75914900|FG003|Phase II|Physician Decision|4|||
42103978|NCT00654420|75914897|FG000|Phase II|Progressive Disease|0|||
42103979|NCT00654420|75914898|FG001|Phase II|Progressive Disease|0|||
42103980|NCT00654420|75914899|FG002|Phase II|Progressive Disease|29|||
42103981|NCT00654420|75914900|FG003|Phase II|Progressive Disease|29|||
42103982|NCT00654420|75914897|FG000|Phase II|Withdrawal by Subject|0|||
42103983|NCT00654420|75914898|FG001|Phase II|Withdrawal by Subject|0|||
42103984|NCT00654420|75914899|FG002|Phase II|Withdrawal by Subject|4|||
42103985|NCT00654420|75914900|FG003|Phase II|Withdrawal by Subject|1|||
42103986|NCT00654420|75914897|FG000|Phase II|Missing Disposition Record|0|||
42103987|NCT00654420|75914898|FG001|Phase II|Missing Disposition Record|0|||
42103988|NCT00654420|75914899|FG002|Phase II|Missing Disposition Record|1|||
42103989|NCT00654420|75914900|FG003|Phase II|Missing Disposition Record|0|||
42103990|NCT00307489|75914912|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
42103991|NCT00307489|75914913|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
42103992|NCT00307489|75914912|FG000|Baseline Through Week 48|Physician Decision|1|||
42103993|NCT00307489|75914913|FG001|Baseline Through Week 48|Physician Decision|0|||
42103994|NCT00307489|75914912|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
42103995|NCT00307489|75914913|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
42103996|NCT00307489|75914912|FG000|Week 48 Through Week 168|Adverse Event|1|||
42103997|NCT00307489|75914913|FG001|Week 48 Through Week 168|Adverse Event|0|||
42103998|NCT00307489|75914912|FG000|Week 48 Through Week 168|Physician Decision|1|||
42103999|NCT00307489|75914913|FG001|Week 48 Through Week 168|Physician Decision|0|||
42104000|NCT00307489|75914912|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
42104001|NCT00307489|75914913|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
42104002|NCT00307489|75914912|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
42104003|NCT00307489|75914913|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
42104004|NCT00307489|75914912|FG000|Week 48 Through Week 168|Death|0|||
42104005|NCT00307489|75914913|FG001|Week 48 Through Week 168|Death|1|||
42104006|NCT00307489|75914912|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
42104007|NCT00307489|75914913|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
42104008|NCT00307489|75914912|FG000|Week 48 Through Week 168|Seroconversion|1|||
42104009|NCT00307489|75914913|FG001|Week 48 Through Week 168|Seroconversion|0|||
42104010|NCT00645840|75914919|FG000|Overall Study|Protocol Violation|3|||
42200941|NCT03135834|76013011|FG003|Stage 1|Death|0|||
42104011|NCT00307333|75914925|FG000|Overall Study|Lost to Follow-up|11|||
42104012|NCT00307333|75914926|FG001|Overall Study|Lost to Follow-up|3|||
42104013|NCT00762359|75914934|FG000|Overall Study|Adverse Event|20|||
42104014|NCT00762359|75914935|FG001|Overall Study|Adverse Event|23|||
42104015|NCT00762359|75914934|FG000|Overall Study|Protocol Violation|21|||
42378460|NCT01692782|76249844|FG002|Overall Study|Withdrawal by Subject|3|||
42104016|NCT00762359|75914935|FG001|Overall Study|Protocol Violation|13|||
42104017|NCT00762359|75914934|FG000|Overall Study|Withdrawal by Subject|13|||
42104018|NCT00762359|75914935|FG001|Overall Study|Withdrawal by Subject|10|||
42104019|NCT00762359|75914934|FG000|Overall Study|Lack of Efficacy|0|||
42200942|NCT03135834|76013008|FG000|Stage 1|Lost to Follow-up|17|||
42104020|NCT00762359|75914935|FG001|Overall Study|Lack of Efficacy|4|||
42104021|NCT00762359|75914934|FG000|Overall Study|Institution closed|2|||
42104022|NCT00762359|75914935|FG001|Overall Study|Institution closed|3|||
42104023|NCT00762359|75914934|FG000|Overall Study|Physician Decision|2|||
42104024|NCT00762359|75914935|FG001|Overall Study|Physician Decision|3|||
42104025|NCT00762359|75914934|FG000|Overall Study|Removal|0|||
42104026|NCT00762359|75914935|FG001|Overall Study|Removal|1|||
42104027|NCT00762359|75914934|FG000|Overall Study|Withdrew consent|1|||
42104028|NCT00762359|75914935|FG001|Overall Study|Withdrew consent|0|||
42104029|NCT00654186|75914941|FG000|Overall Study|Withdrawal by Subject|5|||
42104030|NCT00761969|75914947|FG000|Overall Study|Death|112|||
42104031|NCT00761969|75914948|FG001|Overall Study|Death|47|||
42104032|NCT00761969|75914947|FG000|Overall Study|Lost to Follow-up|88|||
42104033|NCT00761969|75914948|FG001|Overall Study|Lost to Follow-up|93|||
42104034|NCT00761891|75914959|FG000|Overall Study|Withdrawal by Subject|10|||
42104035|NCT00321685|75914964|FG000|Overall Study|Adverse Event|18|||
42104036|NCT00321685|75914964|FG000|Overall Study|Death|2|||
42104037|NCT00321685|75914964|FG000|Overall Study|Withdrawal by Subject|8|||
42104038|NCT00321685|75914964|FG000|Overall Study|Alternative therapy|1|||
42104039|NCT00321685|75914964|FG000|Overall Study|Complicating disese|1|||
42104040|NCT00321685|75914964|FG000|Overall Study|Other|5|||
42104041|NCT00321685|75914964|FG000|Overall Study|Not start protocol therapy|2|||
42104042|NCT00321685|75914964|FG000|Overall Study|Ineligible|2|||
42104043|NCT03902392|75914970|FG000|Overall Study|Lost to Follow-up|7|||
42104044|NCT03902392|75914971|FG001|Overall Study|Lost to Follow-up|7|||
42104045|NCT00306787|75914979|FG000|Overall Study|Discontinued without taking study drug|208|||
42104046|NCT00306787|75914980|FG001|Overall Study|Discontinued without taking study drug|215|||
42104047|NCT00306787|75914979|FG000|Overall Study|Adverse Event|1|||
42104048|NCT00306787|75914980|FG001|Overall Study|Adverse Event|1|||
42104049|NCT00306787|75914979|FG000|Overall Study|Lack of Efficacy|1|||
42104050|NCT00306787|75914980|FG001|Overall Study|Lack of Efficacy|0|||
42104051|NCT00306787|75914979|FG000|Overall Study|Protocol Violation|8|||
42104052|NCT00306787|75914980|FG001|Overall Study|Protocol Violation|10|||
42104053|NCT00306787|75914979|FG000|Overall Study|Withdrawal by Subject|2|||
42104054|NCT00306787|75914980|FG001|Overall Study|Withdrawal by Subject|9|||
42104055|NCT00306787|75914979|FG000|Overall Study|Lost to Follow-up|9|||
42104056|NCT00306787|75914980|FG001|Overall Study|Lost to Follow-up|6|||
42104057|NCT00306787|75914979|FG000|Overall Study|Administrative problems|4|||
42104058|NCT00306787|75914980|FG001|Overall Study|Administrative problems|0|||
42104059|NCT00306787|75914979|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42104060|NCT00306787|75914980|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42104061|NCT00769067|75914988|FG000|Overall Study|Death|89|||
42104062|NCT00769067|75914989|FG001|Overall Study|Death|86|||
42104063|NCT00769067|75914988|FG000|Overall Study|Lost to Follow-up|3|||
42104064|NCT00769067|75914989|FG001|Overall Study|Lost to Follow-up|1|||
42104065|NCT00769067|75914988|FG000|Overall Study|Study terminated by sponsor|1|||
42104066|NCT00769067|75914989|FG001|Overall Study|Study terminated by sponsor|3|||
42104067|NCT00769067|75914988|FG000|Overall Study|Other|1|||
42104068|NCT00769067|75914989|FG001|Overall Study|Other|3|||
42104069|NCT00769067|75914988|FG000|Overall Study|Withdrawal by Subject|0|||
42104070|NCT00769067|75914989|FG001|Overall Study|Withdrawal by Subject|1|||
42104071|NCT00321373|75914999|FG000|Overall Study|Adverse Event|0|||
42104072|NCT00321373|75915000|FG001|Overall Study|Adverse Event|0|||
42104073|NCT00321373|75915001|FG002|Overall Study|Adverse Event|1|||
42104074|NCT00321373|75914999|FG000|Overall Study|Lost to Follow-up|1|||
42104075|NCT00321373|75915000|FG001|Overall Study|Lost to Follow-up|0|||
42104076|NCT00321373|75915001|FG002|Overall Study|Lost to Follow-up|1|||
42104077|NCT00321373|75914999|FG000|Overall Study|Withdrawal by Subject|1|||
42104078|NCT00321373|75915000|FG001|Overall Study|Withdrawal by Subject|0|||
42104079|NCT00321373|75915001|FG002|Overall Study|Withdrawal by Subject|0|||
42104080|NCT00321373|75914999|FG000|Overall Study|Other|0|||
42104081|NCT00321373|75915000|FG001|Overall Study|Other|0|||
42104082|NCT00321373|75915001|FG002|Overall Study|Other|1|||
42104083|NCT00667394|75915011|FG000|Overall Study|Adverse Event|3|||
42104084|NCT00667394|75915012|FG001|Overall Study|Adverse Event|0|||
42104085|NCT00667394|75915011|FG000|Overall Study|Progressive disease|1|||
42104086|NCT00667394|75915012|FG001|Overall Study|Progressive disease|0|||
42104087|NCT00761735|75915018|FG000|Overall Study|Lost to Follow-up|6|||
42104088|NCT00761735|75915018|FG000|Overall Study|Withdrawal by Subject|6|||
42104089|NCT00761735|75915018|FG000|Overall Study|Non-compliance with protocol|1|||
42104090|NCT00761735|75915018|FG000|Overall Study|Administrative|1|||
42104091|NCT00569946|75915026|FG000|Overall Study|Adverse Event|16|||
42104092|NCT00569946|75915026|FG000|Overall Study|Objective Progression or Relapse|42|||
42104093|NCT00569946|75915026|FG000|Overall Study|Global Deterioration of Health Status|1|||
42104094|NCT00645528|75915030|FG000|Overall Study|Did not show up for Visit 2|7|||
42104095|NCT00295633|75915037|FG000|Overall Study|Lack of Efficacy|19|||
42104096|NCT00295633|75915038|FG001|Overall Study|Lack of Efficacy|7|||
42104097|NCT00295633|75915039|FG002|Overall Study|Lack of Efficacy|16|||
42104098|NCT00295633|75915037|FG000|Overall Study|Withdrawal of consent by subject|16|||
42104099|NCT00295633|75915038|FG001|Overall Study|Withdrawal of consent by subject|16|||
42104100|NCT00295633|75915039|FG002|Overall Study|Withdrawal of consent by subject|26|||
42104101|NCT00295633|75915037|FG000|Overall Study|Adverse Event|9|||
42104102|NCT00295633|75915038|FG001|Overall Study|Adverse Event|17|||
42104103|NCT00295633|75915039|FG002|Overall Study|Adverse Event|9|||
42104104|NCT00295633|75915037|FG000|Overall Study|Lost to Follow-up|6|||
42104105|NCT00295633|75915038|FG001|Overall Study|Lost to Follow-up|11|||
42104106|NCT00295633|75915039|FG002|Overall Study|Lost to Follow-up|7|||
42104107|NCT00295633|75915037|FG000|Overall Study|Physician Decision|9|||
42104108|NCT00295633|75915038|FG001|Overall Study|Physician Decision|10|||
42104109|NCT00295633|75915039|FG002|Overall Study|Physician Decision|8|||
42104110|NCT00295633|75915037|FG000|Overall Study|Poor/Noncompliance|2|||
42104111|NCT00295633|75915038|FG001|Overall Study|Poor/Noncompliance|2|||
42104112|NCT00295633|75915039|FG002|Overall Study|Poor/Noncompliance|6|||
42104113|NCT00295633|75915037|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
42104114|NCT00295633|75915038|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
42104115|NCT00295633|75915039|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
42104116|NCT00295633|75915037|FG000|Overall Study|Death|1|||
42104117|NCT00295633|75915038|FG001|Overall Study|Death|1|||
42104118|NCT00295633|75915039|FG002|Overall Study|Death|0|||
42104119|NCT00295633|75915037|FG000|Overall Study|Administrative reason by sponsor|0|||
42104120|NCT00295633|75915038|FG001|Overall Study|Administrative reason by sponsor|0|||
42104121|NCT00295633|75915039|FG002|Overall Study|Administrative reason by sponsor|1|||
42104122|NCT00570674|75915047|FG000|Overall Study|Withdrawal by Subject|0|||
42200943|NCT03135834|76013009|FG001|Stage 1|Lost to Follow-up|24|||
42200944|NCT03135834|76013010|FG002|Stage 1|Lost to Follow-up|21|||
42200945|NCT03135834|76013011|FG003|Stage 1|Lost to Follow-up|38|||
42200946|NCT03135834|76013008|FG000|Stage 1|No longer met eligibility criteria|1|||
42200947|NCT03135834|76013009|FG001|Stage 1|No longer met eligibility criteria|6|||
42200948|NCT03135834|76013010|FG002|Stage 1|No longer met eligibility criteria|2|||
42200949|NCT03135834|76013011|FG003|Stage 1|No longer met eligibility criteria|5|||
42200950|NCT03135834|76013008|FG000|Stage 1|Other|0|||
42200951|NCT03135834|76013009|FG001|Stage 1|Other|2|||
42200952|NCT03135834|76013010|FG002|Stage 1|Other|1|||
42200953|NCT03135834|76013011|FG003|Stage 1|Other|0|||
42200954|NCT03135834|76013008|FG000|Stage 1|Physician Decision|0|||
42200955|NCT03135834|76013009|FG001|Stage 1|Physician Decision|1|||
42200956|NCT03135834|76013010|FG002|Stage 1|Physician Decision|0|||
42200957|NCT03135834|76013011|FG003|Stage 1|Physician Decision|0|||
42200958|NCT03135834|76013008|FG000|Stage 1|Pregnancy|0|||
42200959|NCT03135834|76013009|FG001|Stage 1|Pregnancy|4|||
42200960|NCT03135834|76013010|FG002|Stage 1|Pregnancy|2|||
42200961|NCT03135834|76013011|FG003|Stage 1|Pregnancy|4|||
42200962|NCT03135834|76013008|FG000|Stage 1|Protocol Violation|1|||
42200963|NCT03135834|76013009|FG001|Stage 1|Protocol Violation|1|||
42200964|NCT03135834|76013010|FG002|Stage 1|Protocol Violation|2|||
42200965|NCT03135834|76013011|FG003|Stage 1|Protocol Violation|1|||
42200966|NCT03135834|76013008|FG000|Stage 1|Withdrawal by parent/guardian|2|||
42200967|NCT03135834|76013009|FG001|Stage 1|Withdrawal by parent/guardian|10|||
42378461|NCT01692626|76249852|FG000|Overall Study|Death|0|||
42378462|NCT01692626|76249853|FG001|Overall Study|Death|1|||
42200968|NCT03135834|76013010|FG002|Stage 1|Withdrawal by parent/guardian|2|||
42378463|NCT01692626|76249852|FG000|Overall Study|Adverse Event|2|||
42200969|NCT03135834|76013011|FG003|Stage 1|Withdrawal by parent/guardian|1|||
42200970|NCT03135834|76013008|FG000|Stage 1|Withdrawal by Subject|16|||
42200971|NCT03135834|76013009|FG001|Stage 1|Withdrawal by Subject|22|||
42104123|NCT00570674|75915048|FG001|Overall Study|Withdrawal by Subject|0|||
42104124|NCT00570674|75915049|FG002|Overall Study|Withdrawal by Subject|1|||
42104125|NCT00570674|75915050|FG003|Overall Study|Withdrawal by Subject|0|||
42104126|NCT00570674|75915051|FG004|Overall Study|Withdrawal by Subject|0|||
42104127|NCT00570674|75915052|FG005|Overall Study|Withdrawal by Subject|0|||
42104128|NCT00570674|75915053|FG006|Overall Study|Withdrawal by Subject|0|||
42200972|NCT03135834|76013010|FG002|Stage 1|Withdrawal by Subject|7|||
42378464|NCT01692626|76249853|FG001|Overall Study|Adverse Event|3|||
42200973|NCT03135834|76013011|FG003|Stage 1|Withdrawal by Subject|10|||
42104129|NCT00768989|75915066|FG000|Prior to Week 24|Withdrawal by Subject|1|||
42104130|NCT00768989|75915067|FG001|Prior to Week 24|Withdrawal by Subject|0|||
42104131|NCT00768989|75915066|FG000|Prior to Week 24|Adverse Event|3|||
42104132|NCT00768989|75915067|FG001|Prior to Week 24|Adverse Event|0|||
42104133|NCT00768989|75915066|FG000|Prior to Week 24|Lost to Follow-up|0|||
42104134|NCT00768989|75915067|FG001|Prior to Week 24|Lost to Follow-up|1|||
42104135|NCT00768989|75915066|FG000|Prior to Week 24|Protocol Violation|0|||
42104136|NCT00768989|75915067|FG001|Prior to Week 24|Protocol Violation|2|||
42104137|NCT00768989|75915066|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
42104138|NCT00768989|75915067|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
42104139|NCT00768989|75915066|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
42104140|NCT00768989|75915067|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
42104141|NCT00768989|75915066|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
42104142|NCT00768989|75915067|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
42104143|NCT00768989|75915066|FG000|On or After Week 36|Lack of Efficacy|1|||
42104144|NCT00768989|75915067|FG001|On or After Week 36|Lack of Efficacy|0|||
42104145|NCT00768989|75915066|FG000|On or After Week 36|Adverse Event|0|||
42104146|NCT00768989|75915067|FG001|On or After Week 36|Adverse Event|1|||
42104147|NCT00768989|75915066|FG000|On or After Week 36|Lost to Follow-up|1|||
42104148|NCT00768989|75915067|FG001|On or After Week 36|Lost to Follow-up|0|||
42104149|NCT00768989|75915066|FG000|On or After Week 36|Poor Compliance|1|||
42104150|NCT00768989|75915067|FG001|On or After Week 36|Poor Compliance|0|||
42104151|NCT00768989|75915066|FG000|On or After Week 36|Protocol Violation|1|||
42104152|NCT00768989|75915067|FG001|On or After Week 36|Protocol Violation|0|||
42104153|NCT00768989|75915066|FG000|On or After Week 36|Did not attend termination visit|2|||
42104154|NCT00768989|75915067|FG001|On or After Week 36|Did not attend termination visit|0|||
42104155|NCT00768989|75915066|FG000|On or After Week 36|Sponsor Termination|45|||
42104156|NCT00768989|75915067|FG001|On or After Week 36|Sponsor Termination|26|||
42104157|NCT00305773|75915077|FG000|Overall Study|Death|3|||
42104158|NCT00305773|75915078|FG001|Overall Study|Death|2|||
42104159|NCT00305773|75915077|FG000|Overall Study|Adverse Event|1|||
42104160|NCT00305773|75915078|FG001|Overall Study|Adverse Event|2|||
42104161|NCT00305773|75915077|FG000|Overall Study|Alternative Treatment|4|||
42104162|NCT00305773|75915078|FG001|Overall Study|Alternative Treatment|4|||
42104163|NCT00305773|75915077|FG000|Overall Study|Physician Decision|1|||
42104164|NCT00305773|75915078|FG001|Overall Study|Physician Decision|1|||
42104165|NCT00305773|75915077|FG000|Overall Study|Withdrawal by Subject|1|||
42104166|NCT00305773|75915078|FG001|Overall Study|Withdrawal by Subject|4|||
42104167|NCT00305773|75915077|FG000|Overall Study|Disease Progression|1|||
42104168|NCT00305773|75915078|FG001|Overall Study|Disease Progression|3|||
42104169|NCT00305773|75915077|FG000|Overall Study|All other reasons|3|||
42104170|NCT00305773|75915078|FG001|Overall Study|All other reasons|2|||
42104171|NCT00305695|75915086|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
42104172|NCT00305695|75915087|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
42104173|NCT00305695|75915086|FG000|Overall Study|Did not have baseline scan|1|||
42104174|NCT00305695|75915087|FG001|Overall Study|Did not have baseline scan|1|||
42104175|NCT00647556|75915095|FG000|Overall Study|Adverse Event|0|||
42104176|NCT00647556|75915096|FG001|Overall Study|Adverse Event|1|||
42104177|NCT00647556|75915095|FG000|Overall Study|Lost to Follow-up|1|||
42104178|NCT00647556|75915096|FG001|Overall Study|Lost to Follow-up|0|||
42104179|NCT00647556|75915095|FG000|Overall Study|Protocol Violation|0|||
42104180|NCT00647556|75915096|FG001|Overall Study|Protocol Violation|1|||
42104181|NCT00647556|75915095|FG000|Overall Study|Withdrawal by Subject|1|||
42104182|NCT00647556|75915096|FG001|Overall Study|Withdrawal by Subject|0|||
42104183|NCT00647556|75915095|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
42104184|NCT00647556|75915096|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
42104185|NCT00320593|75915104|FG000|Overall Study|Lost to Follow-up|3|||
42104186|NCT00320593|75915105|FG001|Overall Study|Lost to Follow-up|0|||
42104187|NCT00320593|75915104|FG000|Overall Study|Moved to another state|1|||
42104188|NCT00320593|75915105|FG001|Overall Study|Moved to another state|0|||
42104189|NCT00320593|75915104|FG000|Overall Study|Withdrawal by Subject|2|||
42104190|NCT00320593|75915105|FG001|Overall Study|Withdrawal by Subject|1|||
42104191|NCT00320593|75915104|FG000|Overall Study|Withdrawal by clinical center|1|||
42104192|NCT00320593|75915105|FG001|Overall Study|Withdrawal by clinical center|0|||
42104193|NCT00320515|75915111|FG000|Overall Study|Death|33|||
42104194|NCT00320515|75915111|FG000|Overall Study|Lost to Follow-up|6|||
42104195|NCT00320515|75915111|FG000|Overall Study|Physician Decision|2|||
42104196|NCT00320515|75915111|FG000|Overall Study|Withdrawal by Subject|8|||
42104197|NCT00662012|75915115|FG000|Overall Study|Lost to Follow-up|85|||
42104198|NCT00662012|75915115|FG000|Overall Study|Death|1|||
42200974|NCT03135834|76013008|FG000|Stage 1|Randomized but not Vaccinated|0|||
42200975|NCT03135834|76013009|FG001|Stage 1|Randomized but not Vaccinated|3|||
42104199|NCT00662012|75915115|FG000|Overall Study|Withdrawal by Subject|1|||
42104200|NCT00661778|75915119|FG000|Overall Study|Disease Progression|23|||
42104201|NCT00661778|75915119|FG000|Overall Study|Adverse Event|18|||
42104202|NCT00661778|75915119|FG000|Overall Study|Reason not Specified|6|||
42104203|NCT00661778|75915119|FG000|Overall Study|Protocol Violation|2|||
42104204|NCT00661778|75915119|FG000|Overall Study|Withdrawal of Consent|1|||
42104205|NCT00319735|75915123|FG000|Overall Study|Death|2|||
42104206|NCT00653328|75915128|FG000|Overall Study|Withdrawal by Subject|1|||
42104207|NCT00653328|75915128|FG000|Overall Study|Adverse Event|2|||
42104208|NCT00653328|75915128|FG000|Overall Study|Disease progression|10|||
42104209|NCT00653328|75915128|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
42104210|NCT00642642|75915141|FG000|Treatment & Follow Up|Adverse Event|2|||
42104211|NCT00642642|75915141|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
42104212|NCT00642642|75915141|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
42104213|NCT00534352|75915151|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
42104214|NCT00534352|75915151|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
42104215|NCT00534352|75915151|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
42104216|NCT00534352|75915151|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
42104217|NCT00534352|75915151|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
42104218|NCT00534352|75915151|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
42104219|NCT00642174|75915166|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
42104220|NCT00642174|75915167|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
42104221|NCT00665366|75915175|FG000|Overall Study|Lack of Efficacy|11|||
42104222|NCT00665366|75915176|FG001|Overall Study|Lack of Efficacy|10|||
42104223|NCT00665366|75915175|FG000|Overall Study|Adverse Event|25|||
42104224|NCT00665366|75915176|FG001|Overall Study|Adverse Event|23|||
42104225|NCT00665366|75915175|FG000|Overall Study|Withdrawal by Subject|11|||
42104226|NCT00665366|75915176|FG001|Overall Study|Withdrawal by Subject|14|||
42104227|NCT00665366|75915175|FG000|Overall Study|Lost to Follow-up|3|||
42104228|NCT00665366|75915176|FG001|Overall Study|Lost to Follow-up|5|||
42104229|NCT00665366|75915175|FG000|Overall Study|Poor compliance/noncompliance|3|||
42104230|NCT00665366|75915176|FG001|Overall Study|Poor compliance/noncompliance|5|||
42104231|NCT00665366|75915175|FG000|Overall Study|Pregnancy|1|||
42104232|NCT00665366|75915176|FG001|Overall Study|Pregnancy|0|||
42104233|NCT00665366|75915175|FG000|Overall Study|No longer meets study criteria|0|||
42104234|NCT00665366|75915176|FG001|Overall Study|No longer meets study criteria|1|||
42104235|NCT00665366|75915175|FG000|Overall Study|Other reasons|4|||
42104236|NCT00665366|75915176|FG001|Overall Study|Other reasons|1|||
42104237|NCT00642018|75915206|FG000|Overall Study|Adverse Event|11|||
42104238|NCT00642018|75915207|FG001|Overall Study|Adverse Event|36|||
42104239|NCT00642018|75915206|FG000|Overall Study|Withdrawal by Subject|4|||
42104240|NCT00642018|75915207|FG001|Overall Study|Withdrawal by Subject|10|||
42104241|NCT00642018|75915206|FG000|Overall Study|Progressive Disease|13|||
42104242|NCT00642018|75915207|FG001|Overall Study|Progressive Disease|18|||
42104243|NCT00642018|75915206|FG000|Overall Study|Physician Decision|0|||
42104244|NCT00642018|75915207|FG001|Overall Study|Physician Decision|10|||
42104245|NCT00642018|75915206|FG000|Overall Study|Protocol Violation|0|||
42104246|NCT00642018|75915207|FG001|Overall Study|Protocol Violation|1|||
42104247|NCT00642018|75915206|FG000|Overall Study|Death|0|||
42104248|NCT00642018|75915207|FG001|Overall Study|Death|3|||
42104249|NCT00642018|75915206|FG000|Overall Study|Entry Criteria Not Met|0|||
42104250|NCT00642018|75915207|FG001|Overall Study|Entry Criteria Not Met|1|||
42104251|NCT00532948|75915217|FG000|Overall Study|Protocol Violation|1|||
42104252|NCT00532948|75915218|FG001|Overall Study|Protocol Violation|0|||
42104253|NCT00532948|75915219|FG002|Overall Study|Protocol Violation|0|||
42104254|NCT00532948|75915217|FG000|Overall Study|Death|3|||
42104255|NCT00532948|75915218|FG001|Overall Study|Death|3|||
42104256|NCT00532948|75915219|FG002|Overall Study|Death|4|||
42104257|NCT00532948|75915217|FG000|Overall Study|Violation of selection criteria at entry|0|||
42104258|NCT00532948|75915218|FG001|Overall Study|Violation of selection criteria at entry|1|||
42104259|NCT00532948|75915219|FG002|Overall Study|Violation of selection criteria at entry|0|||
42104260|NCT00532948|75915217|FG000|Overall Study|Failure to return|0|||
42104261|NCT00532948|75915218|FG001|Overall Study|Failure to return|1|||
42104262|NCT00532948|75915219|FG002|Overall Study|Failure to return|0|||
42104263|NCT00641706|75915233|FG000|Overall Study|Adverse Event|2|||
42104264|NCT00641706|75915234|FG001|Overall Study|Adverse Event|1|||
42104265|NCT00641706|75915233|FG000|Overall Study|Withdrawal by Subject|6|||
42200976|NCT03135834|76013010|FG002|Stage 1|Randomized but not Vaccinated|1|||
42200977|NCT03135834|76013011|FG003|Stage 1|Randomized but not Vaccinated|6|||
42104266|NCT00641706|75915234|FG001|Overall Study|Withdrawal by Subject|1|||
42104267|NCT00641706|75915233|FG000|Overall Study|Clinical Decline|1|||
42104268|NCT00641706|75915234|FG001|Overall Study|Clinical Decline|0|||
42104269|NCT00641706|75915233|FG000|Overall Study|Lead Investigator Decision|0|||
42104270|NCT00641706|75915234|FG001|Overall Study|Lead Investigator Decision|1|||
42104271|NCT00644358|75915240|FG000|Overall Study|Adverse Event|124|||
42104272|NCT00644358|75915240|FG000|Overall Study|Lost to Follow-up|105|||
42104273|NCT00644358|75915240|FG000|Overall Study|Consent Withdrawal|64|||
42104274|NCT00644358|75915240|FG000|Overall Study|Lack of Effectiveness|39|||
42104275|NCT00644358|75915240|FG000|Overall Study|Protocol Violation|5|||
42200978|NCT03135834|76013008|FG000|Stage 2|Lost to Follow-up|0|||
42104276|NCT00644358|75915240|FG000|Overall Study|Noncompliance|14|||
42104277|NCT00644358|75915240|FG000|Overall Study|Other Unspecified|11|||
42104278|NCT00640926|75915247|FG000|Overall Study|Adverse Event|2|||
42104279|NCT00640926|75915248|FG001|Overall Study|Adverse Event|3|||
42104280|NCT00640926|75915249|FG002|Overall Study|Adverse Event|2|||
42104281|NCT00640926|75915247|FG000|Overall Study|Lack of Efficacy|0|||
42104282|NCT00640926|75915248|FG001|Overall Study|Lack of Efficacy|2|||
42104283|NCT00640926|75915249|FG002|Overall Study|Lack of Efficacy|1|||
42104284|NCT00640926|75915247|FG000|Overall Study|Protocol Violation|2|||
42104285|NCT00640926|75915248|FG001|Overall Study|Protocol Violation|0|||
42104286|NCT00640926|75915249|FG002|Overall Study|Protocol Violation|2|||
42104287|NCT00640926|75915247|FG000|Overall Study|Lost to Follow-up|3|||
42104288|NCT00640926|75915248|FG001|Overall Study|Lost to Follow-up|1|||
42104289|NCT00640926|75915249|FG002|Overall Study|Lost to Follow-up|2|||
42104290|NCT00640926|75915247|FG000|Overall Study|Withdrawal by Subject|1|||
42104291|NCT00640926|75915248|FG001|Overall Study|Withdrawal by Subject|0|||
42104292|NCT00640926|75915249|FG002|Overall Study|Withdrawal by Subject|1|||
42104293|NCT03892564|75915257|FG000|Overall Study|Withdrawal by Subject|2|||
42104294|NCT03891862|75915264|FG000|Open-label Period|Adverse Event|2|||
42104295|NCT03891862|75915265|FG001|Open-label Period|Adverse Event|0|||
42104296|NCT03891862|75915266|FG002|Open-label Period|Adverse Event|0|||
42104297|NCT03891862|75915264|FG000|Open-label Period|Protocol Violation|5|||
42104298|NCT03891862|75915265|FG001|Open-label Period|Protocol Violation|0|||
42104299|NCT03891862|75915266|FG002|Open-label Period|Protocol Violation|0|||
42104300|NCT03891862|75915264|FG000|Open-label Period|Withdrawal by Subject|6|||
42104301|NCT03891862|75915265|FG001|Open-label Period|Withdrawal by Subject|0|||
42104302|NCT03891862|75915266|FG002|Open-label Period|Withdrawal by Subject|0|||
42104303|NCT03891862|75915264|FG000|Open-label Period|Death|1|||
42104304|NCT03891862|75915265|FG001|Open-label Period|Death|0|||
42104305|NCT03891862|75915266|FG002|Open-label Period|Death|0|||
42104306|NCT03891862|75915264|FG000|Open-label Period|Lost to Follow-up|2|||
42104307|NCT03891862|75915265|FG001|Open-label Period|Lost to Follow-up|0|||
42104308|NCT03891862|75915266|FG002|Open-label Period|Lost to Follow-up|0|||
42104309|NCT03891862|75915264|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
42104310|NCT03891862|75915265|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
42104311|NCT03891862|75915266|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
42104312|NCT03891862|75915264|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
42104313|NCT03891862|75915265|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
42104314|NCT03891862|75915266|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
42104315|NCT03891862|75915264|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
42104316|NCT03891862|75915265|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
42104317|NCT03891862|75915266|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
42104318|NCT03891862|75915264|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
42104319|NCT03891862|75915265|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
42104320|NCT03891862|75915266|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
42104321|NCT00640614|75915275|FG000|Overall Study|Lost to Follow-up|1|||
42104322|NCT00640614|75915276|FG001|Overall Study|Lost to Follow-up|0|||
42104323|NCT00761657|75915314|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
42104324|NCT00761657|75915315|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
42104325|NCT00761657|75915316|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
42104326|NCT00761657|75915317|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
42104327|NCT00761657|75915318|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
42104328|NCT00761657|75915319|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
42104329|NCT00761657|75915320|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
42104330|NCT00761657|75915321|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
42104331|NCT00761657|75915322|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
42104332|NCT00761657|75915314|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
42104333|NCT00761657|75915315|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
42104334|NCT00761657|75915316|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
42104335|NCT00761657|75915317|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
42104336|NCT00761657|75915318|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
42104337|NCT00761657|75915319|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
42104338|NCT00761657|75915320|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
42104339|NCT00761657|75915321|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
42104340|NCT00761657|75915322|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
42104341|NCT00761657|75915314|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
42104342|NCT00761657|75915315|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
42104343|NCT00761657|75915316|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
42104344|NCT00761657|75915317|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
42104345|NCT00761657|75915318|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
42104346|NCT00761657|75915319|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
42104347|NCT00761657|75915320|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
42104348|NCT00761657|75915321|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
42104349|NCT00761657|75915322|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
42104350|NCT00761657|75915314|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
42104351|NCT00761657|75915315|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
42104352|NCT00761657|75915316|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
42104353|NCT00761657|75915317|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
42104354|NCT00761657|75915318|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
42104355|NCT00761657|75915319|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
42104356|NCT00761657|75915320|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
42104357|NCT00761657|75915321|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
42104358|NCT00761657|75915322|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
42104359|NCT00319501|75915354|FG000|Double-blind Period|Withdrawal by Subject|0|||
42104360|NCT00319501|75915355|FG001|Double-blind Period|Withdrawal by Subject|3|||
42104361|NCT00319501|75915354|FG000|Double-blind Period|Sponsor Request|1|||
42104362|NCT00319501|75915355|FG001|Double-blind Period|Sponsor Request|0|||
42104363|NCT00319501|75915354|FG000|Double-blind Period|Did not receive treatment|42|||
42104364|NCT00319501|75915355|FG001|Double-blind Period|Did not receive treatment|29|||
42104365|NCT00319501|75915354|FG000|Open-label Period|Adverse Event|5|||
42104366|NCT00319501|75915355|FG001|Open-label Period|Adverse Event|0|||
42104367|NCT00319501|75915354|FG000|Open-label Period|Protocol Violation|6|||
42104368|NCT00319501|75915355|FG001|Open-label Period|Protocol Violation|0|||
42104369|NCT00319501|75915354|FG000|Open-label Period|Withdrawal by Subject|38|||
42104370|NCT00319501|75915355|FG001|Open-label Period|Withdrawal by Subject|0|||
42104371|NCT00319501|75915354|FG000|Open-label Period|Principal Investigator decision|6|||
42104372|NCT00319501|75915355|FG001|Open-label Period|Principal Investigator decision|0|||
42104373|NCT00319501|75915354|FG000|Open-label Period|Sponsor request|12|||
42104374|NCT00319501|75915355|FG001|Open-label Period|Sponsor request|0|||
42104375|NCT00319501|75915354|FG000|Open-label Period|Lost to Follow-up|5|||
42104376|NCT00319501|75915355|FG001|Open-label Period|Lost to Follow-up|0|||
42104377|NCT00319501|75915354|FG000|Open-label Period|Did not receive treatment|33|||
42104378|NCT00319501|75915355|FG001|Open-label Period|Did not receive treatment|0|||
42104379|NCT00319501|75915354|FG000|Open-label Period|Other|11|||
42104380|NCT00319501|75915355|FG001|Open-label Period|Other|0|||
42104381|NCT00319501|75915354|FG000|Open-label Extension Period|Adverse Event|2|||
42104382|NCT00319501|75915355|FG001|Open-label Extension Period|Adverse Event|0|||
42104383|NCT00319501|75915354|FG000|Open-label Extension Period|Did not receive treatment|18|||
42104384|NCT00319501|75915355|FG001|Open-label Extension Period|Did not receive treatment|0|||
42104385|NCT00319501|75915354|FG000|Open-label Extension Period|Other|1|||
42104386|NCT00319501|75915355|FG001|Open-label Extension Period|Other|0|||
42104387|NCT00319501|75915354|FG000|Open-label Extension Period|Principal investigator decision|2|||
42104388|NCT00319501|75915355|FG001|Open-label Extension Period|Principal investigator decision|0|||
42104389|NCT00319501|75915354|FG000|Open-label Extension Period|Sponsor request|26|||
42104390|NCT00319501|75915355|FG001|Open-label Extension Period|Sponsor request|0|||
42104391|NCT00319501|75915354|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
42104392|NCT00319501|75915355|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
42104393|NCT00761579|75915366|FG000|Overall Study|Adverse Event|10|||
42104394|NCT00761579|75915366|FG000|Overall Study|Death|2|||
42104395|NCT00761579|75915366|FG000|Overall Study|Lack of Efficacy|21|||
42104396|NCT00761579|75915366|FG000|Overall Study|Lost to Follow-up|16|||
42104397|NCT00761579|75915366|FG000|Overall Study|Pregnancy|1|||
42104398|NCT00761579|75915366|FG000|Overall Study|Withdrawal by Subject|34|||
42104399|NCT00761579|75915366|FG000|Overall Study|Lack of compliance|2|||
42104400|NCT00761579|75915366|FG000|Overall Study|Protocol deviation|1|||
42104401|NCT00761579|75915366|FG000|Overall Study|Drug overdose|1|||
42104402|NCT00761579|75915366|FG000|Overall Study|Aggravation of depression|1|||
42104403|NCT00761579|75915366|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
42104404|NCT00761579|75915366|FG000|Overall Study|Lost survey form|1|||
42104405|NCT00761579|75915366|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
42104406|NCT00627042|75915372|FG000|Overall Study|Withdrawal by Subject|2|||
42104407|NCT00319111|75915376|FG000|Overall Study|Adverse Event|20|||
42104408|NCT00319111|75915376|FG000|Overall Study|Withdrawal of consent|11|||
42104409|NCT00319111|75915376|FG000|Overall Study|Death|9|||
42104410|NCT00319111|75915376|FG000|Overall Study|Lack of clinical improvement|4|||
42104411|NCT00319111|75915376|FG000|Overall Study|Administrative|2|||
42104412|NCT00319111|75915376|FG000|Overall Study|Treatment failure|1|||
42104413|NCT00640224|75915384|FG000|Overall Study|Lost to Follow-up|5|||
42104414|NCT00640224|75915385|FG001|Overall Study|Lost to Follow-up|2|||
42104415|NCT00640224|75915386|FG002|Overall Study|Lost to Follow-up|0|||
42104416|NCT00640224|75915387|FG003|Overall Study|Lost to Follow-up|0|||
42104417|NCT00640224|75915384|FG000|Overall Study|Withdrawal by Subject|1|||
42104418|NCT00640224|75915385|FG001|Overall Study|Withdrawal by Subject|0|||
42104419|NCT00640224|75915386|FG002|Overall Study|Withdrawal by Subject|0|||
42104420|NCT00640224|75915387|FG003|Overall Study|Withdrawal by Subject|0|||
42104421|NCT00640224|75915384|FG000|Overall Study|Headaches|0|||
42104422|NCT00640224|75915385|FG001|Overall Study|Headaches|1|||
42104423|NCT00640224|75915386|FG002|Overall Study|Headaches|0|||
42104424|NCT00640224|75915387|FG003|Overall Study|Headaches|0|||
42104425|NCT00318643|75915402|FG000|Overall Study|Adverse Event|0|||
42104426|NCT00318643|75915403|FG001|Overall Study|Adverse Event|0|||
42104427|NCT00318643|75915404|FG002|Overall Study|Adverse Event|0|||
42104428|NCT00318643|75915405|FG003|Overall Study|Adverse Event|0|||
42104429|NCT00318643|75915406|FG004|Overall Study|Adverse Event|1|||
42104430|NCT00318643|75915402|FG000|Overall Study|Participant's Decision|0|||
42104431|NCT00318643|75915403|FG001|Overall Study|Participant's Decision|0|||
42104432|NCT00318643|75915404|FG002|Overall Study|Participant's Decision|0|||
42104433|NCT00318643|75915405|FG003|Overall Study|Participant's Decision|0|||
42104434|NCT00318643|75915406|FG004|Overall Study|Participant's Decision|1|||
42104435|NCT00318643|75915402|FG000|Overall Study|Investigator's Decision|0|||
42104436|NCT00318643|75915403|FG001|Overall Study|Investigator's Decision|0|||
42104437|NCT00318643|75915404|FG002|Overall Study|Investigator's Decision|0|||
42104438|NCT00318643|75915405|FG003|Overall Study|Investigator's Decision|0|||
42104439|NCT00318643|75915406|FG004|Overall Study|Investigator's Decision|1|||
42104440|NCT00318565|75915419|FG000|Overall Study|Excluded per protocol|24|||
42104441|NCT00304915|75915425|FG000|Overall Study|Lost to Follow-up|11|||
42104442|NCT00304915|75915426|FG001|Overall Study|Lost to Follow-up|11|||
42104443|NCT00304915|75915425|FG000|Overall Study|Death|4|||
42104444|NCT00304915|75915426|FG001|Overall Study|Death|5|||
42104445|NCT00304915|75915425|FG000|Overall Study|Withdrawal by Subject|3|||
42104446|NCT00304915|75915426|FG001|Overall Study|Withdrawal by Subject|0|||
42104447|NCT03687970|75915434|FG000|Overall Study|visit scheduling conflicts|2|||
42104448|NCT03687970|75915435|FG001|Overall Study|visit scheduling conflicts|0|||
42104449|NCT00530920|75915446|FG000|Overall Study|Randomized but not treated|0|||
42104450|NCT00530920|75915447|FG001|Overall Study|Randomized but not treated|2|||
42104451|NCT00530920|75915448|FG002|Overall Study|Randomized but not treated|0|||
42104452|NCT00530920|75915446|FG000|Overall Study|Adverse Event|0|||
42104453|NCT00530920|75915447|FG001|Overall Study|Adverse Event|0|||
42104454|NCT00530920|75915448|FG002|Overall Study|Adverse Event|3|||
42104455|NCT00530920|75915446|FG000|Overall Study|Withdrawal by Subject|0|||
42104456|NCT00530920|75915447|FG001|Overall Study|Withdrawal by Subject|0|||
42104457|NCT00530920|75915448|FG002|Overall Study|Withdrawal by Subject|1|||
42104458|NCT03878758|75915457|FG000|Overall Study|Withdrawal by Subject|1|||
42104459|NCT03878758|75915457|FG000|Overall Study|Protocol defined|2|||
42104460|NCT03878758|75915457|FG000|Overall Study|Improper consent documentation|1|||
42104461|NCT03878602|75915472|FG000|Overall Study|cord blood donation|7|||
42104462|NCT03878602|75915473|FG001|Overall Study|cord blood donation|1|||
42104463|NCT03878602|75915472|FG000|Overall Study|incomplete data collection|2|||
42104464|NCT03878602|75915473|FG001|Overall Study|incomplete data collection|0|||
42104465|NCT00768755|75915485|FG000|Phase 1|Death|6|||
42104466|NCT00768755|75915486|FG001|Phase 1|Death|0|||
42104467|NCT00768755|75915487|FG002|Phase 1|Death|0|||
42104468|NCT00768755|75915488|FG003|Phase 1|Death|0|||
42104469|NCT00768755|75915485|FG000|Phase 1|Other|4|||
42104470|NCT00768755|75915486|FG001|Phase 1|Other|0|||
42104471|NCT00768755|75915487|FG002|Phase 1|Other|0|||
42104472|NCT00768755|75915488|FG003|Phase 1|Other|0|||
42104473|NCT00768755|75915485|FG000|Phase 2|Death|0|||
42104474|NCT00768755|75915486|FG001|Phase 2|Death|37|||
42104475|NCT00768755|75915487|FG002|Phase 2|Death|48|||
42104476|NCT00768755|75915488|FG003|Phase 2|Death|31|||
42104477|NCT00768755|75915485|FG000|Phase 2|Protocol Violation|0|||
42104478|NCT00768755|75915486|FG001|Phase 2|Protocol Violation|2|||
42104479|NCT00768755|75915487|FG002|Phase 2|Protocol Violation|0|||
42104480|NCT00768755|75915488|FG003|Phase 2|Protocol Violation|1|||
42104481|NCT00768755|75915485|FG000|Phase 2|Lost to Follow-up|0|||
42104482|NCT00768755|75915486|FG001|Phase 2|Lost to Follow-up|1|||
42104483|NCT00768755|75915487|FG002|Phase 2|Lost to Follow-up|1|||
42104484|NCT00768755|75915488|FG003|Phase 2|Lost to Follow-up|4|||
42104485|NCT00768755|75915485|FG000|Phase 2|Withdrawal by Subject|0|||
42104486|NCT00768755|75915486|FG001|Phase 2|Withdrawal by Subject|1|||
42104487|NCT00768755|75915487|FG002|Phase 2|Withdrawal by Subject|0|||
42104488|NCT00768755|75915488|FG003|Phase 2|Withdrawal by Subject|1|||
42104489|NCT00768755|75915485|FG000|Phase 2|Other|0|||
42104490|NCT00768755|75915486|FG001|Phase 2|Other|1|||
42104491|NCT00768755|75915487|FG002|Phase 2|Other|2|||
42104492|NCT00768755|75915488|FG003|Phase 2|Other|4|||
42104493|NCT00768755|75915485|FG000|Phase 2|Study Terminated by Sponsor|0|||
42104494|NCT00768755|75915486|FG001|Phase 2|Study Terminated by Sponsor|13|||
42104495|NCT00768755|75915487|FG002|Phase 2|Study Terminated by Sponsor|7|||
42104496|NCT00768755|75915488|FG003|Phase 2|Study Terminated by Sponsor|14|||
42104497|NCT00768755|75915485|FG000|Phase 2|Randomized but not treated|0|||
42104498|NCT00768755|75915486|FG001|Phase 2|Randomized but not treated|0|||
42104499|NCT00768755|75915487|FG002|Phase 2|Randomized but not treated|0|||
42104500|NCT00768755|75915488|FG003|Phase 2|Randomized but not treated|2|||
42104501|NCT00530842|75915499|FG000|Overall Study|Adverse Event|10|||
42104502|NCT00530842|75915500|FG001|Overall Study|Adverse Event|6|||
42104503|NCT00530842|75915499|FG000|Overall Study|Lack of Efficacy|2|||
42104504|NCT00530842|75915500|FG001|Overall Study|Lack of Efficacy|1|||
42104505|NCT00530842|75915499|FG000|Overall Study|Lost to Follow-up|0|||
42104506|NCT00530842|75915500|FG001|Overall Study|Lost to Follow-up|4|||
42104507|NCT00530842|75915499|FG000|Overall Study|Protocol Violation|3|||
42104508|NCT00530842|75915500|FG001|Overall Study|Protocol Violation|2|||
42104509|NCT00530842|75915499|FG000|Overall Study|Withdrawal by Subject|4|||
42104510|NCT00530842|75915500|FG001|Overall Study|Withdrawal by Subject|5|||
42104511|NCT00530842|75915499|FG000|Overall Study|Individual different reasons|4|||
42104512|NCT00530842|75915500|FG001|Overall Study|Individual different reasons|3|||
42104513|NCT00530842|75915499|FG000|Period 1|Adverse Event|7|||
42104514|NCT00530842|75915500|FG001|Period 1|Adverse Event|3|||
42104515|NCT00530842|75915499|FG000|Period 1|Lack of Efficacy|1|||
42104516|NCT00530842|75915500|FG001|Period 1|Lack of Efficacy|1|||
42104517|NCT00530842|75915499|FG000|Period 1|Protocol Violation|2|||
42104518|NCT00530842|75915500|FG001|Period 1|Protocol Violation|1|||
42104519|NCT00530842|75915499|FG000|Period 1|Withdrawal by Subject|2|||
42104520|NCT00530842|75915500|FG001|Period 1|Withdrawal by Subject|3|||
42104521|NCT00530842|75915499|FG000|Period 1|Individual different reasons|2|||
42104522|NCT00530842|75915500|FG001|Period 1|Individual different reasons|3|||
42104523|NCT00530842|75915499|FG000|Period 2|Adverse Event|3|||
42104524|NCT00530842|75915500|FG001|Period 2|Adverse Event|3|||
42104525|NCT00530842|75915499|FG000|Period 2|Lack of Efficacy|1|||
42104526|NCT00530842|75915500|FG001|Period 2|Lack of Efficacy|0|||
42104527|NCT00530842|75915499|FG000|Period 2|Lost to Follow-up|0|||
42104528|NCT00530842|75915500|FG001|Period 2|Lost to Follow-up|4|||
42104529|NCT00530842|75915499|FG000|Period 2|Protocol Violation|1|||
42104530|NCT00530842|75915500|FG001|Period 2|Protocol Violation|0|||
42104531|NCT00530842|75915499|FG000|Period 2|Withdrawal by Subject|1|||
42104532|NCT00530842|75915500|FG001|Period 2|Withdrawal by Subject|2|||
42104533|NCT00530842|75915499|FG000|Period 2|Individual different reasons|2|||
42104534|NCT00530842|75915500|FG001|Period 2|Individual different reasons|0|||
42104535|NCT03882424|75915511|FG000|Overall Study|Lost to Follow-up|3|||
42104536|NCT03882424|75915512|FG001|Overall Study|Lost to Follow-up|0|||
42104537|NCT03882424|75915513|FG002|Overall Study|Lost to Follow-up|0|||
42104538|NCT03882424|75915511|FG000|Overall Study|schedule conflict|1|||
42104539|NCT03882424|75915512|FG001|Overall Study|schedule conflict|0|||
42104540|NCT03882424|75915513|FG002|Overall Study|schedule conflict|0|||
42200979|NCT03135834|76013009|FG001|Stage 2|Lost to Follow-up|1|||
42200980|NCT03135834|76013010|FG002|Stage 2|Lost to Follow-up|0|||
42200981|NCT03135834|76013011|FG003|Stage 2|Lost to Follow-up|0|||
42200982|NCT03135834|76013008|FG000|Stage 2|Withdrawal by Subject|0|||
42200983|NCT03135834|76013009|FG001|Stage 2|Withdrawal by Subject|1|||
42200984|NCT03135834|76013010|FG002|Stage 2|Withdrawal by Subject|0|||
42200985|NCT03135834|76013011|FG003|Stage 2|Withdrawal by Subject|0|||
42200986|NCT03135834|76013008|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
42200987|NCT03135834|76013009|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
42200988|NCT03135834|76013010|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
42200989|NCT03135834|76013011|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
42200990|NCT03135834|76013008|FG000|Stage 2|Did not receive Booster Vaccination|1|||
42200991|NCT03135834|76013009|FG001|Stage 2|Did not receive Booster Vaccination|1|||
42200992|NCT03135834|76013010|FG002|Stage 2|Did not receive Booster Vaccination|0|||
42200993|NCT03135834|76013011|FG003|Stage 2|Did not receive Booster Vaccination|0|||
42200994|NCT03130777|76013044|FG000|Overall Study|Death|0|||
42200995|NCT03130777|76013045|FG001|Overall Study|Death|1|||
42200996|NCT03130777|76013044|FG000|Overall Study|Did not meet eligibility criteria|1|||
42200997|NCT03130777|76013045|FG001|Overall Study|Did not meet eligibility criteria|0|||
42200998|NCT02207725|76013086|FG000|Overall Study|Did Not Receive Treatment|0|||
42200999|NCT02207725|76013087|FG001|Overall Study|Did Not Receive Treatment|1|||
42201000|NCT02207725|76013088|FG002|Overall Study|Did Not Receive Treatment|1|||
42201001|NCT02207725|76013089|FG003|Overall Study|Did Not Receive Treatment|1|||
42201002|NCT00968799|76013123|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
42201003|NCT02883452|76013133|FG000|Overall Study|Withdrawal by Subject|1|||
42104541|NCT03879772|75915526|FG000|Overall Study|Adverse Event|2|||
42104542|NCT03879772|75915527|FG001|Overall Study|Adverse Event|2|||
42104543|NCT03879772|75915528|FG002|Overall Study|Adverse Event|3|||
42104544|NCT03879772|75915529|FG003|Overall Study|Adverse Event|4|||
42201004|NCT02883452|76013134|FG001|Overall Study|Withdrawal by Subject|1|||
42201005|NCT02883452|76013135|FG002|Overall Study|Withdrawal by Subject|3|||
42201006|NCT02883452|76013136|FG003|Overall Study|Withdrawal by Subject|0|||
42201007|NCT02883452|76013137|FG004|Overall Study|Withdrawal by Subject|2|||
42378465|NCT01692626|76249852|FG000|Overall Study|Protocol Violation|1|||
42378466|NCT01692626|76249853|FG001|Overall Study|Protocol Violation|2|||
42104545|NCT03879772|75915530|FG004|Overall Study|Adverse Event|3|||
42104546|NCT03879772|75915526|FG000|Overall Study|Treatment Failure|1|||
42104547|NCT03879772|75915527|FG001|Overall Study|Treatment Failure|0|||
42104548|NCT03879772|75915528|FG002|Overall Study|Treatment Failure|0|||
42104549|NCT03879772|75915529|FG003|Overall Study|Treatment Failure|2|||
42104550|NCT03879772|75915530|FG004|Overall Study|Treatment Failure|1|||
42104551|NCT03879772|75915526|FG000|Overall Study|Lost to Follow-up|0|||
42104552|NCT03879772|75915527|FG001|Overall Study|Lost to Follow-up|0|||
42104553|NCT03879772|75915528|FG002|Overall Study|Lost to Follow-up|0|||
42104554|NCT03879772|75915529|FG003|Overall Study|Lost to Follow-up|0|||
42104555|NCT03879772|75915530|FG004|Overall Study|Lost to Follow-up|1|||
42104556|NCT03879772|75915526|FG000|Overall Study|Withdrawal by Subject|0|||
42104557|NCT03879772|75915527|FG001|Overall Study|Withdrawal by Subject|1|||
42104558|NCT03879772|75915528|FG002|Overall Study|Withdrawal by Subject|3|||
42104559|NCT03879772|75915529|FG003|Overall Study|Withdrawal by Subject|1|||
42104560|NCT03879772|75915530|FG004|Overall Study|Withdrawal by Subject|1|||
42104561|NCT03879772|75915526|FG000|Overall Study|Protocol Violation|0|||
42104562|NCT03879772|75915527|FG001|Overall Study|Protocol Violation|0|||
42104563|NCT03879772|75915528|FG002|Overall Study|Protocol Violation|3|||
42104564|NCT03879772|75915529|FG003|Overall Study|Protocol Violation|1|||
42104565|NCT03879772|75915530|FG004|Overall Study|Protocol Violation|2|||
42104566|NCT03879772|75915526|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
42104567|NCT03879772|75915527|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
42104568|NCT03879772|75915528|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
42104569|NCT03879772|75915529|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
42104570|NCT03879772|75915530|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
42201008|NCT02883452|76013138|FG005|Overall Study|Withdrawal by Subject|5|||
42201009|NCT02883452|76013133|FG000|Overall Study|Disease progression|1|||
42201010|NCT02883452|76013134|FG001|Overall Study|Disease progression|0|||
42201011|NCT02883452|76013135|FG002|Overall Study|Disease progression|0|||
42201012|NCT02883452|76013136|FG003|Overall Study|Disease progression|1|||
42201013|NCT02883452|76013137|FG004|Overall Study|Disease progression|4|||
42201014|NCT02883452|76013138|FG005|Overall Study|Disease progression|5|||
42201015|NCT02883452|76013133|FG000|Overall Study|Adverse Event|2|||
42201016|NCT02883452|76013134|FG001|Overall Study|Adverse Event|1|||
42201017|NCT02883452|76013135|FG002|Overall Study|Adverse Event|1|||
42201018|NCT02883452|76013136|FG003|Overall Study|Adverse Event|1|||
42201019|NCT02883452|76013137|FG004|Overall Study|Adverse Event|1|||
42201020|NCT02883452|76013138|FG005|Overall Study|Adverse Event|3|||
42201021|NCT02883452|76013133|FG000|Overall Study|Physician Decision|0|||
42201022|NCT02883452|76013134|FG001|Overall Study|Physician Decision|0|||
42201023|NCT02883452|76013135|FG002|Overall Study|Physician Decision|0|||
42201024|NCT02883452|76013136|FG003|Overall Study|Physician Decision|0|||
42201025|NCT02883452|76013137|FG004|Overall Study|Physician Decision|4|||
42201026|NCT02883452|76013138|FG005|Overall Study|Physician Decision|1|||
42201027|NCT02883452|76013133|FG000|Overall Study|Death|1|||
42201028|NCT02883452|76013134|FG001|Overall Study|Death|0|||
42201029|NCT02883452|76013135|FG002|Overall Study|Death|1|||
42201030|NCT02883452|76013136|FG003|Overall Study|Death|0|||
42201031|NCT02883452|76013137|FG004|Overall Study|Death|0|||
42201032|NCT02883452|76013138|FG005|Overall Study|Death|0|||
42201033|NCT02883452|76013133|FG000|Overall Study|Other|0|||
42201034|NCT02883452|76013134|FG001|Overall Study|Other|0|||
42201035|NCT02883452|76013135|FG002|Overall Study|Other|0|||
42201036|NCT02883452|76013136|FG003|Overall Study|Other|0|||
42201037|NCT02883452|76013137|FG004|Overall Study|Other|0|||
42201038|NCT02883452|76013138|FG005|Overall Study|Other|1|||
42201039|NCT00151372|76013155|FG000|Overall Study|Death|12|||
42201040|NCT00151372|76013156|FG001|Overall Study|Death|11|||
42201041|NCT00151372|76013155|FG000|Overall Study|Lost to Follow-up|5|||
42201042|NCT00151372|76013156|FG001|Overall Study|Lost to Follow-up|5|||
42201043|NCT00151372|76013155|FG000|Overall Study|Too sick medically to continue|5|||
42201044|NCT00151372|76013156|FG001|Overall Study|Too sick medically to continue|6|||
42201045|NCT00151372|76013155|FG000|Overall Study|Withdrawal by Subject|7|||
42201046|NCT00151372|76013156|FG001|Overall Study|Withdrawal by Subject|7|||
42201047|NCT02603809|76013168|FG000|Overall Study|Withdrawal by Subject|4|||
42201048|NCT02603809|76013169|FG001|Overall Study|Withdrawal by Subject|1|||
42201049|NCT02603809|76013170|FG002|Overall Study|Withdrawal by Subject|2|||
42201050|NCT02603809|76013171|FG003|Overall Study|Withdrawal by Subject|3|||
42201051|NCT02603809|76013172|FG004|Overall Study|Withdrawal by Subject|3|||
42201052|NCT02603809|76013173|FG005|Overall Study|Withdrawal by Subject|4|||
42378467|NCT01692626|76249852|FG000|Overall Study|Withdrawal by Subject|1|||
42378468|NCT01692626|76249853|FG001|Overall Study|Withdrawal by Subject|0|||
42201053|NCT02603809|76013168|FG000|Overall Study|Lost to Follow-up|2|||
42201054|NCT02603809|76013169|FG001|Overall Study|Lost to Follow-up|3|||
42201055|NCT02603809|76013170|FG002|Overall Study|Lost to Follow-up|1|||
42104571|NCT00642954|75915547|FG000|Overall Study|Progressive Disease|3|||
42201056|NCT02603809|76013171|FG003|Overall Study|Lost to Follow-up|4|||
42201057|NCT02603809|76013172|FG004|Overall Study|Lost to Follow-up|2|||
42201058|NCT02603809|76013173|FG005|Overall Study|Lost to Follow-up|2|||
42201059|NCT02603809|76013168|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
42201060|NCT02603809|76013169|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
42104572|NCT00642954|75915548|FG001|Overall Study|Progressive Disease|3|||
42104573|NCT00642954|75915549|FG002|Overall Study|Progressive Disease|3|||
42104574|NCT00642954|75915550|FG003|Overall Study|Progressive Disease|3|||
42104575|NCT00642954|75915551|FG004|Overall Study|Progressive Disease|9|||
42201061|NCT02603809|76013170|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
42201062|NCT02603809|76013171|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
42104576|NCT00642954|75915547|FG000|Overall Study|Withdrawal by Subject|0|||
42104577|NCT00642954|75915548|FG001|Overall Study|Withdrawal by Subject|0|||
42104578|NCT00642954|75915549|FG002|Overall Study|Withdrawal by Subject|0|||
42104579|NCT00642954|75915550|FG003|Overall Study|Withdrawal by Subject|0|||
42104580|NCT00642954|75915551|FG004|Overall Study|Withdrawal by Subject|1|||
42104581|NCT00642954|75915547|FG000|Overall Study|Adverse Event|1|||
42104582|NCT00642954|75915548|FG001|Overall Study|Adverse Event|1|||
42104583|NCT00642954|75915549|FG002|Overall Study|Adverse Event|0|||
42104584|NCT00642954|75915550|FG003|Overall Study|Adverse Event|0|||
42104585|NCT00642954|75915551|FG004|Overall Study|Adverse Event|6|||
42104586|NCT00640146|75915565|FG000|Overall Study|Adverse Event|2|||
42104587|NCT00640146|75915566|FG001|Overall Study|Adverse Event|0|||
42104588|NCT00640146|75915565|FG000|Overall Study|Lost to Follow-up|0|||
42104589|NCT00640146|75915566|FG001|Overall Study|Lost to Follow-up|1|||
42104590|NCT00640146|75915565|FG000|Overall Study|Lack of Efficacy|0|||
42104591|NCT00640146|75915566|FG001|Overall Study|Lack of Efficacy|1|||
42104592|NCT00640146|75915565|FG000|Overall Study|Withdrawal by Subject|1|||
42104593|NCT00640146|75915566|FG001|Overall Study|Withdrawal by Subject|1|||
42104594|NCT00640146|75915565|FG000|Overall Study|Randomized but not treated|1|||
42104595|NCT00640146|75915566|FG001|Overall Study|Randomized but not treated|3|||
42104596|NCT00317473|75915578|FG000|Overall Study|Withdrawal by Subject|2|||
42104597|NCT00317473|75915579|FG001|Overall Study|Withdrawal by Subject|1|||
42104598|NCT00317473|75915580|FG002|Overall Study|Withdrawal by Subject|2|||
42104599|NCT00317473|75915581|FG003|Overall Study|Withdrawal by Subject|1|||
42104600|NCT00317473|75915582|FG004|Overall Study|Withdrawal by Subject|3|||
42104601|NCT00317473|75915583|FG005|Overall Study|Withdrawal by Subject|1|||
42104602|NCT00317473|75915578|FG000|Overall Study|Relocation|1|||
42104603|NCT00317473|75915579|FG001|Overall Study|Relocation|0|||
42104604|NCT00317473|75915580|FG002|Overall Study|Relocation|1|||
42104605|NCT00317473|75915581|FG003|Overall Study|Relocation|1|||
42104606|NCT00317473|75915582|FG004|Overall Study|Relocation|5|||
42104607|NCT00317473|75915583|FG005|Overall Study|Relocation|2|||
42104608|NCT00317473|75915578|FG000|Overall Study|Death|1|||
42104609|NCT00317473|75915579|FG001|Overall Study|Death|0|||
42104610|NCT00317473|75915580|FG002|Overall Study|Death|0|||
42104611|NCT00317473|75915581|FG003|Overall Study|Death|0|||
42104612|NCT00317473|75915582|FG004|Overall Study|Death|0|||
42104613|NCT00317473|75915583|FG005|Overall Study|Death|0|||
42104614|NCT00317473|75915578|FG000|Overall Study|Other|0|||
42104615|NCT00317473|75915579|FG001|Overall Study|Other|2|||
42104616|NCT00317473|75915580|FG002|Overall Study|Other|0|||
42104617|NCT00317473|75915581|FG003|Overall Study|Other|0|||
42104618|NCT00317473|75915582|FG004|Overall Study|Other|0|||
42104619|NCT00317473|75915583|FG005|Overall Study|Other|0|||
42104620|NCT00530218|75915607|FG000|Overall Study|CMV Not Detected|13|||
42104621|NCT00530218|75915607|FG000|Overall Study|Death|12|||
42104622|NCT00761267|75915617|FG000|Overall Study|Death|1|||
42104623|NCT00761267|75915618|FG001|Overall Study|Death|2|||
42104624|NCT00761267|75915619|FG002|Overall Study|Death|5|||
42104625|NCT00761267|75915617|FG000|Overall Study|Lost to Follow-up|0|||
42104626|NCT00761267|75915618|FG001|Overall Study|Lost to Follow-up|0|||
42104627|NCT00761267|75915619|FG002|Overall Study|Lost to Follow-up|1|||
42104628|NCT00761267|75915617|FG000|Overall Study|Randomized but not treated|1|||
42104629|NCT00761267|75915618|FG001|Overall Study|Randomized but not treated|1|||
42104630|NCT00761267|75915619|FG002|Overall Study|Randomized but not treated|0|||
42104631|NCT00761267|75915617|FG000|Overall Study|Withdrawal by Subject|0|||
42104632|NCT00761267|75915618|FG001|Overall Study|Withdrawal by Subject|1|||
42104633|NCT00761267|75915619|FG002|Overall Study|Withdrawal by Subject|0|||
42104634|NCT00303667|75915640|FG000|Overall Study|Death|0|||
42104635|NCT00303667|75915641|FG001|Overall Study|Death|4|||
42104636|NCT00761189|75915647|FG000|Overall Study|Adverse Event|42|||
42104637|NCT00761189|75915647|FG000|Overall Study|Lack of Efficacy|45|||
42104638|NCT00761189|75915647|FG000|Overall Study|Lost to Follow-up|36|||
42104639|NCT00761189|75915647|FG000|Overall Study|Withdrawal by Subject|49|||
42104640|NCT00761189|75915647|FG000|Overall Study|Other|13|||
42104641|NCT00529516|75915654|FG000|Overall Study|Adverse Event|2|||
42104642|NCT00529516|75915655|FG001|Overall Study|Adverse Event|1|||
42104643|NCT00529516|75915656|FG002|Overall Study|Adverse Event|0|||
42104644|NCT00529516|75915654|FG000|Overall Study|Withdrawal by Subject|1|||
42104645|NCT00529516|75915655|FG001|Overall Study|Withdrawal by Subject|1|||
42104646|NCT00529516|75915656|FG002|Overall Study|Withdrawal by Subject|0|||
42104647|NCT00529516|75915654|FG000|Overall Study|Lost to Follow-up|0|||
42104648|NCT00529516|75915655|FG001|Overall Study|Lost to Follow-up|0|||
42104649|NCT00529516|75915656|FG002|Overall Study|Lost to Follow-up|1|||
42104650|NCT00316693|75915666|FG000|Overall Study|Adverse Event|6|||
42104651|NCT00316693|75915667|FG001|Overall Study|Adverse Event|1|||
42104652|NCT00316693|75915666|FG000|Overall Study|Protocol Violation|1|||
42104653|NCT00316693|75915667|FG001|Overall Study|Protocol Violation|0|||
42104654|NCT00316693|75915666|FG000|Overall Study|Withdrawal by Subject|6|||
42104655|NCT00316693|75915667|FG001|Overall Study|Withdrawal by Subject|6|||
42104656|NCT00316693|75915666|FG000|Overall Study|Lost to Follow-up|26|||
42104657|NCT00316693|75915667|FG001|Overall Study|Lost to Follow-up|34|||
42104658|NCT00316693|75915666|FG000|Overall Study|Other|38|||
42104659|NCT00316693|75915667|FG001|Overall Study|Other|44|||
42104660|NCT00316303|75915675|FG000|Overall Study|Lost to Follow-up|11|||
42104661|NCT00316303|75915676|FG001|Overall Study|Lost to Follow-up|16|||
42104662|NCT00760877|75915687|FG000|Overall Study|Protocol Violation|1|||
42104663|NCT00760877|75915688|FG001|Overall Study|Protocol Violation|0|||
42104664|NCT00760877|75915687|FG000|Overall Study|Non-compliance with protocol treatment|2|||
42104665|NCT00760877|75915688|FG001|Overall Study|Non-compliance with protocol treatment|1|||
42104666|NCT00760877|75915687|FG000|Overall Study|Pregnancy|1|||
42104667|NCT00760877|75915688|FG001|Overall Study|Pregnancy|4|||
42104668|NCT00760877|75915687|FG000|Overall Study|Death|2|||
42104669|NCT00760877|75915688|FG001|Overall Study|Death|1|||
42104670|NCT00760877|75915687|FG000|Overall Study|Withdrawal by Subject|7|||
42104671|NCT00760877|75915688|FG001|Overall Study|Withdrawal by Subject|3|||
42104672|NCT00760877|75915687|FG000|Overall Study|Adverse Event|19|||
42104673|NCT00760877|75915688|FG001|Overall Study|Adverse Event|12|||
42104674|NCT00760877|75915687|FG000|Overall Study|Participant diagnosed with AML|0|||
42104675|NCT00760877|75915688|FG001|Overall Study|Participant diagnosed with AML|1|||
42104676|NCT00760877|75915687|FG000|Overall Study|Participant not eligible to cross-over|0|||
42104677|NCT00760877|75915688|FG001|Overall Study|Participant not eligible to cross-over|1|||
42104678|NCT00760877|75915687|FG000|Overall Study|Physician Decision|1|||
42104679|NCT00760877|75915688|FG001|Overall Study|Physician Decision|2|||
42104680|NCT00760877|75915687|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
42104681|NCT00760877|75915688|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
42104682|NCT00760877|75915687|FG000|Overall Study|Treatment failure|1|||
42104683|NCT00760877|75915688|FG001|Overall Study|Treatment failure|0|||
42104684|NCT00302731|75915699|FG000|Overall Study|Lost to Follow-up|1|||
42104685|NCT00302731|75915700|FG001|Overall Study|Lost to Follow-up|2|||
42104686|NCT00302731|75915701|FG002|Overall Study|Lost to Follow-up|0|||
42104687|NCT00302731|75915702|FG003|Overall Study|Lost to Follow-up|0|||
42104688|NCT00302731|75915699|FG000|Overall Study|Adverse Event|0|||
42104689|NCT00302731|75915700|FG001|Overall Study|Adverse Event|2|||
42104690|NCT00302731|75915701|FG002|Overall Study|Adverse Event|2|||
42104691|NCT00302731|75915702|FG003|Overall Study|Adverse Event|0|||
42104692|NCT00302731|75915699|FG000|Overall Study|Withdrawal by Subject|1|||
42104693|NCT00302731|75915700|FG001|Overall Study|Withdrawal by Subject|1|||
42104694|NCT00302731|75915701|FG002|Overall Study|Withdrawal by Subject|0|||
42104695|NCT00302731|75915702|FG003|Overall Study|Withdrawal by Subject|0|||
42104696|NCT00302731|75915699|FG000|Overall Study|Protocol Violation|1|||
42104697|NCT00302731|75915700|FG001|Overall Study|Protocol Violation|0|||
42104698|NCT00302731|75915701|FG002|Overall Study|Protocol Violation|0|||
42104699|NCT00302731|75915702|FG003|Overall Study|Protocol Violation|0|||
42104700|NCT00302731|75915699|FG000|Overall Study|cancer unrelated to study discovered|1|||
42104701|NCT00302731|75915700|FG001|Overall Study|cancer unrelated to study discovered|0|||
42104702|NCT00302731|75915701|FG002|Overall Study|cancer unrelated to study discovered|1|||
42104703|NCT00302731|75915702|FG003|Overall Study|cancer unrelated to study discovered|0|||
42104704|NCT00780143|75915712|FG000|Overall Study|Progressive disease|1|||
42104705|NCT00780143|75915712|FG000|Overall Study|Toxicity|1|||
42104706|NCT00780143|75915712|FG000|Overall Study|Adverse Event|1|||
42104707|NCT00779909|75915720|FG000|Overall Study|Lost to Follow-up|1|||
42104708|NCT00779909|75915721|FG001|Overall Study|Lost to Follow-up|0|||
42104709|NCT00779909|75915722|FG002|Overall Study|Lost to Follow-up|0|||
42104710|NCT00779909|75915723|FG003|Overall Study|Lost to Follow-up|1|||
42104711|NCT00779909|75915720|FG000|Overall Study|Withdrawal by Subject|0|||
42104712|NCT00779909|75915721|FG001|Overall Study|Withdrawal by Subject|1|||
42104713|NCT00779909|75915722|FG002|Overall Study|Withdrawal by Subject|0|||
42104714|NCT00779909|75915723|FG003|Overall Study|Withdrawal by Subject|0|||
42104715|NCT00302107|75915742|FG000|Overall Study|Lost to Follow-up|6|||
42104716|NCT00302107|75915743|FG001|Overall Study|Lost to Follow-up|5|||
42104717|NCT00302107|75915742|FG000|Overall Study|Protocol Violation|1|||
42104718|NCT00302107|75915743|FG001|Overall Study|Protocol Violation|0|||
42104719|NCT00302107|75915742|FG000|Overall Study|Relocation|0|||
42104720|NCT00302107|75915743|FG001|Overall Study|Relocation|1|||
42104721|NCT00302107|75915742|FG000|Overall Study|Withdrawal by Subject|0|||
42104722|NCT00302107|75915743|FG001|Overall Study|Withdrawal by Subject|3|||
42104723|NCT00302107|75915742|FG000|Overall Study|Adverse Event|1|||
42104724|NCT00302107|75915743|FG001|Overall Study|Adverse Event|0|||
42104725|NCT00760487|75915749|FG000|Overall Study|Unilateral implantation|3|||
42104726|NCT00316225|75915753|FG000|Overall Study|Adverse Event|2|||
42104727|NCT00316225|75915753|FG000|Overall Study|Physician Decision|3|||
42104728|NCT00316225|75915753|FG000|Overall Study|Progressive Disease|15|||
42104729|NCT00316225|75915753|FG000|Overall Study|Withdrawal by Subject|3|||
42104730|NCT00316225|75915753|FG000|Overall Study|Death|2|||
42104731|NCT00586703|75915757|FG000|Overall Study|Death|12|||
42104732|NCT00586625|75915763|FG000|Overall Study|Adverse Event|6|||
42104733|NCT00586625|75915764|FG001|Overall Study|Adverse Event|6|||
42104734|NCT00586625|75915763|FG000|Overall Study|Protocol Violation|3|||
42104735|NCT00586625|75915764|FG001|Overall Study|Protocol Violation|0|||
42104736|NCT00586625|75915763|FG000|Overall Study|Withdrawal by Subject|32|||
42104737|NCT00586625|75915764|FG001|Overall Study|Withdrawal by Subject|10|||
42104738|NCT00586625|75915763|FG000|Overall Study|Subject non-compliance|0|||
42104739|NCT00586625|75915764|FG001|Overall Study|Subject non-compliance|1|||
42104740|NCT00586625|75915763|FG000|Overall Study|Subject unable to return for visit|2|||
42104741|NCT00586625|75915764|FG001|Overall Study|Subject unable to return for visit|0|||
42104742|NCT00636168|75915772|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
42104743|NCT00636168|75915773|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
42104744|NCT00636168|75915772|FG000|Randomized to Study Drug|Adverse Event|1|||
42104745|NCT00636168|75915773|FG001|Randomized to Study Drug|Adverse Event|0|||
42104746|NCT00636168|75915772|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
42104747|NCT00636168|75915773|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
42104748|NCT00636168|75915772|FG000|Treated With Study Drug|Recurrence of disease|135|||
42104749|NCT00636168|75915773|FG001|Treated With Study Drug|Recurrence of disease|282|||
42104750|NCT00636168|75915772|FG000|Treated With Study Drug|Adverse Event|250|||
42104751|NCT00636168|75915773|FG001|Treated With Study Drug|Adverse Event|22|||
42104752|NCT00636168|75915772|FG000|Treated With Study Drug|Participant withdrew consent|16|||
42104753|NCT00636168|75915773|FG001|Treated With Study Drug|Participant withdrew consent|21|||
42104754|NCT00636168|75915772|FG000|Treated With Study Drug|Poor/non-compliance|1|||
42104755|NCT00636168|75915773|FG001|Treated With Study Drug|Poor/non-compliance|3|||
42104756|NCT00636168|75915772|FG000|Treated With Study Drug|Death|3|||
42104757|NCT00636168|75915773|FG001|Treated With Study Drug|Death|0|||
42104758|NCT00636168|75915772|FG000|Treated With Study Drug|Pregnancy|1|||
42104759|NCT00636168|75915773|FG001|Treated With Study Drug|Pregnancy|0|||
42104760|NCT00636168|75915772|FG000|Treated With Study Drug|No longer meets study criteria|1|||
42104761|NCT00636168|75915773|FG001|Treated With Study Drug|No longer meets study criteria|0|||
42104762|NCT00636168|75915772|FG000|Treated With Study Drug|Other reason|1|||
42104763|NCT00636168|75915773|FG001|Treated With Study Drug|Other reason|3|||
42104764|NCT00636168|75915772|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
42104765|NCT00636168|75915773|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
42104766|NCT00636168|75915772|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
42378469|NCT01475461|76249879|FG000|Run-in Period|Not meet eligibility criteria|16|||
42378470|NCT01475461|76249880|FG001|Run-in Period|Not meet eligibility criteria|0|||
42378471|NCT01475461|76249881|FG002|Run-in Period|Not meet eligibility criteria|0|||
42378472|NCT01475461|76249882|FG003|Run-in Period|Not meet eligibility criteria|0|||
42378473|NCT01475461|76249883|FG004|Run-in Period|Not meet eligibility criteria|0|||
42378474|NCT01475461|76249884|FG005|Run-in Period|Not meet eligibility criteria|0|||
42378475|NCT01475461|76249885|FG006|Run-in Period|Not meet eligibility criteria|0|||
42378476|NCT01475461|76249879|FG000|Run-in Period|Lost to Follow-up|7|||
42378477|NCT01475461|76249880|FG001|Run-in Period|Lost to Follow-up|0|||
42104767|NCT00636168|75915773|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
42104768|NCT00636168|75915772|FG000|Long Term Follow-Up|Death|8|||
42104769|NCT00636168|75915773|FG001|Long Term Follow-Up|Death|9|||
42104770|NCT00759941|75915781|FG000|Overall Study|Use of medication|1|||
42104771|NCT00759941|75915782|FG001|Overall Study|Use of medication|0|||
42104772|NCT00759941|75915781|FG000|Overall Study|Adverse Event|1|||
42104773|NCT00759941|75915782|FG001|Overall Study|Adverse Event|0|||
42104774|NCT00759941|75915781|FG000|Overall Study|Exited in error by site|1|||
42104775|NCT00759941|75915782|FG001|Overall Study|Exited in error by site|1|||
42104776|NCT00528424|75915788|FG000|Overall Study|Lost to Follow-up|13|||
42104777|NCT00528424|75915788|FG000|Overall Study|Withdrew consent|2|||
42104778|NCT00528424|75915788|FG000|Overall Study|Administrative reason|2|||
42104779|NCT00528424|75915788|FG000|Overall Study|Other|12|||
42104780|NCT00315445|75915795|FG000|Overall Study|Adverse Event|7|||
42104781|NCT00315445|75915796|FG001|Overall Study|Adverse Event|12|||
42104782|NCT00315445|75915797|FG002|Overall Study|Adverse Event|15|||
42104783|NCT00315445|75915795|FG000|Overall Study|Lack of Efficacy|16|||
42104784|NCT00315445|75915796|FG001|Overall Study|Lack of Efficacy|1|||
42104785|NCT00315445|75915797|FG002|Overall Study|Lack of Efficacy|7|||
42104786|NCT00315445|75915795|FG000|Overall Study|Lost to Follow-up|1|||
42104787|NCT00315445|75915796|FG001|Overall Study|Lost to Follow-up|0|||
42104788|NCT00315445|75915797|FG002|Overall Study|Lost to Follow-up|1|||
42104789|NCT00315445|75915795|FG000|Overall Study|Protocol Violation|2|||
42104790|NCT00315445|75915796|FG001|Overall Study|Protocol Violation|0|||
42104791|NCT00315445|75915797|FG002|Overall Study|Protocol Violation|1|||
42104792|NCT00315445|75915795|FG000|Overall Study|Other|1|||
42104793|NCT00315445|75915796|FG001|Overall Study|Other|3|||
42104794|NCT00315445|75915797|FG002|Overall Study|Other|0|||
42104795|NCT03687736|75915805|FG000|Overall Study|Lost to Follow-up|7|||
42104796|NCT03687736|75915805|FG000|Overall Study|Withdrawal by Subject|3|||
42378478|NCT01475461|76249881|FG002|Run-in Period|Lost to Follow-up|0|||
42104797|NCT00779675|75915811|FG000|Treatment Period|Adverse Event|87|||
42104798|NCT00779675|75915811|FG000|Treatment Period|Treatment Failure|80|||
42104799|NCT00779675|75915811|FG000|Treatment Period|Transferred to Another Study|38|||
42104800|NCT00779675|75915811|FG000|Treatment Period|Lost to Follow-up|23|||
42104801|NCT00779675|75915811|FG000|Treatment Period|Withdrawal by Subject|46|||
42104802|NCT00779675|75915811|FG000|Treatment Period|Protocol Violation|54|||
42104803|NCT00779675|75915811|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
42104804|NCT00779675|75915811|FG000|Treatment Period|Administrative|3|||
42104805|NCT00779675|75915811|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
42104806|NCT00779675|75915811|FG000|Extended Treatment Period|Protocol Violation|13|||
42104807|NCT00779675|75915811|FG000|Extended Treatment Period|Adverse Event|6|||
42104808|NCT00779675|75915811|FG000|Extended Treatment Period|Treatment Failure|11|||
42104809|NCT00779675|75915811|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
42104810|NCT00779675|75915811|FG000|Extended Treatment Period|Lost to Follow-up|6|||
42104811|NCT00759863|75915821|FG000|Overall Study|Death, moved, or lost contact|20|||
42104812|NCT00759863|75915822|FG001|Overall Study|Death, moved, or lost contact|18|||
42104813|NCT00759785|75915830|FG000|Overall Study|Participant sample not evaluable|11|||
42104814|NCT00759785|75915831|FG001|Overall Study|Participant sample not evaluable|2|||
42104815|NCT00759785|75915830|FG000|Overall Study|Participant sample lost|0|||
42104816|NCT00759785|75915831|FG001|Overall Study|Participant sample lost|1|||
42104817|NCT00759785|75915830|FG000|Overall Study|Protocol Violation|1|||
42104818|NCT00759785|75915831|FG001|Overall Study|Protocol Violation|0|||
42104819|NCT00759785|75915830|FG000|Overall Study|Physician Decision|0|||
42104820|NCT00759785|75915831|FG001|Overall Study|Physician Decision|1|||
42104821|NCT00759785|75915830|FG000|Overall Study|Withdrawal by Subject|0|||
42104822|NCT00759785|75915831|FG001|Overall Study|Withdrawal by Subject|1|||
42104823|NCT00300781|75915839|FG000|Overall Study|Disease Progression|55|||
42104824|NCT00300781|75915840|FG001|Overall Study|Disease Progression|52|||
42104825|NCT00300781|75915839|FG000|Overall Study|Adverse Event|5|||
42104826|NCT00300781|75915840|FG001|Overall Study|Adverse Event|6|||
42104827|NCT00300781|75915839|FG000|Overall Study|Withdrawal by Subject|1|||
42104828|NCT00300781|75915840|FG001|Overall Study|Withdrawal by Subject|2|||
42104829|NCT00300781|75915839|FG000|Overall Study|Physician Decision|1|||
42104830|NCT00300781|75915840|FG001|Overall Study|Physician Decision|0|||
42104831|NCT00300781|75915839|FG000|Overall Study|Not Recorded|0|||
42104832|NCT00300781|75915840|FG001|Overall Study|Not Recorded|1|||
42104833|NCT00300781|75915839|FG000|Overall Study|Symptomatic Deterioration|1|||
42104834|NCT00300781|75915840|FG001|Overall Study|Symptomatic Deterioration|0|||
42104835|NCT00300781|75915839|FG000|Overall Study|Lost to Follow-up|0|||
42104836|NCT00300781|75915840|FG001|Overall Study|Lost to Follow-up|1|||
42104837|NCT00315055|75915848|FG000|Overall Study|Protocol Violation|2|||
42104838|NCT00315055|75915849|FG001|Overall Study|Protocol Violation|4|||
42104839|NCT00315055|75915848|FG000|Overall Study|Lost to Follow-up|1|||
42104840|NCT00315055|75915849|FG001|Overall Study|Lost to Follow-up|1|||
42104841|NCT00528970|75915861|FG000|Overall Study|Adverse Event|6|||
42104842|NCT00528970|75915862|FG001|Overall Study|Adverse Event|8|||
42104843|NCT00528970|75915863|FG002|Overall Study|Adverse Event|5|||
42104844|NCT00528970|75915861|FG000|Overall Study|Lost to Follow-up|0|||
42104845|NCT00528970|75915862|FG001|Overall Study|Lost to Follow-up|0|||
42104846|NCT00528970|75915863|FG002|Overall Study|Lost to Follow-up|1|||
42104847|NCT00528970|75915861|FG000|Overall Study|Other than specified|2|||
42104848|NCT00528970|75915862|FG001|Overall Study|Other than specified|3|||
42104849|NCT00528970|75915863|FG002|Overall Study|Other than specified|3|||
42104850|NCT00528970|75915861|FG000|Overall Study|Protocol Violation|2|||
42104851|NCT00528970|75915862|FG001|Overall Study|Protocol Violation|1|||
42104852|NCT00528970|75915863|FG002|Overall Study|Protocol Violation|4|||
42104853|NCT00528970|75915861|FG000|Overall Study|Lack of Efficacy|0|||
42104854|NCT00528970|75915862|FG001|Overall Study|Lack of Efficacy|0|||
42104855|NCT00528970|75915863|FG002|Overall Study|Lack of Efficacy|1|||
42104856|NCT00528970|75915861|FG000|Overall Study|Withdrawal by Subject|4|||
42104857|NCT00528970|75915862|FG001|Overall Study|Withdrawal by Subject|3|||
42104858|NCT00528970|75915863|FG002|Overall Study|Withdrawal by Subject|5|||
42104859|NCT00528970|75915861|FG000|Overall Study|Randomized but not treated|0|||
42104860|NCT00528970|75915862|FG001|Overall Study|Randomized but not treated|0|||
42104861|NCT00528970|75915863|FG002|Overall Study|Randomized but not treated|1|||
42201063|NCT02603809|76013172|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
42201064|NCT02603809|76013173|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
42201065|NCT02603809|76013168|FG000|Overall Study|Physician Decision|0|||
42104862|NCT00759395|75915873|FG000|Overall Study|Adverse Event|1|||
42104863|NCT00759395|75915874|FG001|Overall Study|Adverse Event|0|||
42104864|NCT00759395|75915873|FG000|Overall Study|Withdrawal by Subject|1|||
42201066|NCT02603809|76013169|FG001|Overall Study|Physician Decision|0|||
42201067|NCT02603809|76013170|FG002|Overall Study|Physician Decision|0|||
42104865|NCT00759395|75915874|FG001|Overall Study|Withdrawal by Subject|0|||
42104866|NCT00759395|75915873|FG000|Overall Study|Lack of Efficacy|0|||
42104867|NCT00759395|75915874|FG001|Overall Study|Lack of Efficacy|2|||
42104868|NCT00293293|75915882|FG000|Overall Study|Withdrawal by Subject|1|||
42201068|NCT02603809|76013171|FG003|Overall Study|Physician Decision|1|||
42104869|NCT00293293|75915883|FG001|Overall Study|Withdrawal by Subject|1|||
42104870|NCT00293293|75915882|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
42104871|NCT00293293|75915883|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
42104872|NCT00293293|75915882|FG000|Overall Study|Patient discontinued chemotherapy|0|||
42104873|NCT00293293|75915883|FG001|Overall Study|Patient discontinued chemotherapy|1|||
42104874|NCT04864639|75915890|FG000|Overall Study|Death|1|||
42104875|NCT04864639|75915890|FG000|Overall Study|Lost to Follow-up|1|||
42104876|NCT04245449|75915916|FG000|Overall Study|COVID shutdown|7|||
42104877|NCT03887221|75915926|FG000|Overall Study|Protocol Violation|1|||
42104878|NCT03887221|75915927|FG001|Overall Study|Protocol Violation|0|||
42104879|NCT02782741|75915947|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
42104880|NCT02782741|75915948|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
42104881|NCT02782741|75915947|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
42104882|NCT02782741|75915948|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
42104883|NCT02782741|75915947|FG000|Open-label Long-term: Week 50 to 145|Adverse Event|2|||
42104884|NCT02782741|75915948|FG001|Open-label Long-term: Week 50 to 145|Adverse Event|1|||
42104885|NCT02782741|75915947|FG000|Open-label Long-term: Week 50 to 145|Other|1|||
42104886|NCT02782741|75915948|FG001|Open-label Long-term: Week 50 to 145|Other|0|||
42104887|NCT02782741|75915947|FG000|Open-label Long-term: Week 50 to 145|Ongoing|48|||
42104888|NCT02782741|75915948|FG001|Open-label Long-term: Week 50 to 145|Ongoing|43|||
42104889|NCT02771626|75915964|FG000|Overall Study|Adverse Event|1|||
42104890|NCT02771626|75915965|FG001|Overall Study|Adverse Event|5|||
42104891|NCT02771626|75915966|FG002|Overall Study|Adverse Event|3|||
42104892|NCT02771626|75915967|FG003|Overall Study|Adverse Event|0|||
42104893|NCT02771626|75915968|FG004|Overall Study|Adverse Event|1|||
42104894|NCT02771626|75915969|FG005|Overall Study|Adverse Event|1|||
42104895|NCT02771626|75915964|FG000|Overall Study|Radiologic Disease Progression|6|||
42104896|NCT02771626|75915965|FG001|Overall Study|Radiologic Disease Progression|13|||
42104897|NCT02771626|75915966|FG002|Overall Study|Radiologic Disease Progression|10|||
42104898|NCT02771626|75915967|FG003|Overall Study|Radiologic Disease Progression|7|||
42104899|NCT02771626|75915968|FG004|Overall Study|Radiologic Disease Progression|28|||
42104900|NCT02771626|75915969|FG005|Overall Study|Radiologic Disease Progression|15|||
42104901|NCT02771626|75915964|FG000|Overall Study|Symptomatic Deterioration|0|||
42104902|NCT02771626|75915965|FG001|Overall Study|Symptomatic Deterioration|4|||
42104903|NCT02771626|75915966|FG002|Overall Study|Symptomatic Deterioration|2|||
42104904|NCT02771626|75915967|FG003|Overall Study|Symptomatic Deterioration|0|||
42104905|NCT02771626|75915968|FG004|Overall Study|Symptomatic Deterioration|5|||
42104906|NCT02771626|75915969|FG005|Overall Study|Symptomatic Deterioration|2|||
42104907|NCT02771626|75915964|FG000|Overall Study|Participant Request|0|||
42104908|NCT02771626|75915965|FG001|Overall Study|Participant Request|1|||
42104909|NCT02771626|75915966|FG002|Overall Study|Participant Request|0|||
42104910|NCT02771626|75915967|FG003|Overall Study|Participant Request|2|||
42104911|NCT02771626|75915968|FG004|Overall Study|Participant Request|0|||
42104912|NCT02771626|75915969|FG005|Overall Study|Participant Request|1|||
42104913|NCT02771626|75915964|FG000|Overall Study|Investigator Decision|0|||
42104914|NCT02771626|75915965|FG001|Overall Study|Investigator Decision|1|||
42104915|NCT02771626|75915966|FG002|Overall Study|Investigator Decision|0|||
42104916|NCT02771626|75915967|FG003|Overall Study|Investigator Decision|0|||
42104917|NCT02771626|75915968|FG004|Overall Study|Investigator Decision|1|||
42104918|NCT02771626|75915969|FG005|Overall Study|Investigator Decision|0|||
42104919|NCT02771626|75915964|FG000|Overall Study|Study Termination by Sponsor|0|||
42104920|NCT02771626|75915965|FG001|Overall Study|Study Termination by Sponsor|2|||
42104921|NCT02771626|75915966|FG002|Overall Study|Study Termination by Sponsor|1|||
42104922|NCT02771626|75915967|FG003|Overall Study|Study Termination by Sponsor|0|||
42104923|NCT02771626|75915968|FG004|Overall Study|Study Termination by Sponsor|1|||
42104924|NCT02771626|75915969|FG005|Overall Study|Study Termination by Sponsor|0|||
42104925|NCT02771626|75915964|FG000|Overall Study|Informed Consent Withdrawn|0|||
42104926|NCT02771626|75915965|FG001|Overall Study|Informed Consent Withdrawn|0|||
42104927|NCT02771626|75915966|FG002|Overall Study|Informed Consent Withdrawn|1|||
42104928|NCT02771626|75915967|FG003|Overall Study|Informed Consent Withdrawn|0|||
42104929|NCT02771626|75915968|FG004|Overall Study|Informed Consent Withdrawn|1|||
42104930|NCT02771626|75915969|FG005|Overall Study|Informed Consent Withdrawn|1|||
42104931|NCT02771626|75915964|FG000|Overall Study|Other, Not Specified|1|||
42104932|NCT02771626|75915965|FG001|Overall Study|Other, Not Specified|0|||
42104933|NCT02771626|75915966|FG002|Overall Study|Other, Not Specified|0|||
42104934|NCT02771626|75915967|FG003|Overall Study|Other, Not Specified|0|||
42104935|NCT02771626|75915968|FG004|Overall Study|Other, Not Specified|0|||
42104936|NCT02771626|75915969|FG005|Overall Study|Other, Not Specified|1|||
42104937|NCT01464164|75915990|FG000|Overall Study|Screen failure|0|||
42104938|NCT01464164|75915991|FG001|Overall Study|Screen failure|1|||
42104939|NCT01464164|75915992|FG002|Overall Study|Screen failure|2|||
42104940|NCT01464164|75915993|FG003|Overall Study|Screen failure|0|||
42104941|NCT01464164|75915994|FG004|Overall Study|Screen failure|0|||
42104942|NCT01464164|75915995|FG005|Overall Study|Screen failure|0|||
42104943|NCT01464164|75915996|FG006|Overall Study|Screen failure|0|||
42378479|NCT01475461|76249882|FG003|Run-in Period|Lost to Follow-up|0|||
42378480|NCT01475461|76249883|FG004|Run-in Period|Lost to Follow-up|0|||
42104944|NCT01464164|75915990|FG000|Overall Study|Physician Decision|0|||
42104945|NCT01464164|75915991|FG001|Overall Study|Physician Decision|1|||
42104946|NCT01464164|75915992|FG002|Overall Study|Physician Decision|0|||
42104947|NCT01464164|75915993|FG003|Overall Study|Physician Decision|0|||
42104948|NCT01464164|75915994|FG004|Overall Study|Physician Decision|0|||
42104949|NCT01464164|75915995|FG005|Overall Study|Physician Decision|0|||
42104950|NCT01464164|75915996|FG006|Overall Study|Physician Decision|2|||
42104951|NCT00568776|75916039|FG000|Overall Study|Adverse Event|8|||
42104952|NCT00568776|75916040|FG001|Overall Study|Adverse Event|8|||
42104953|NCT00568776|75916041|FG002|Overall Study|Adverse Event|10|||
42104954|NCT00568776|75916042|FG003|Overall Study|Adverse Event|8|||
42104955|NCT00568776|75916039|FG000|Overall Study|Death|0|||
42104956|NCT00568776|75916040|FG001|Overall Study|Death|1|||
42104957|NCT00568776|75916041|FG002|Overall Study|Death|4|||
42104958|NCT00568776|75916042|FG003|Overall Study|Death|3|||
42104959|NCT00568776|75916039|FG000|Overall Study|Physician Decision|0|||
42104960|NCT00568776|75916040|FG001|Overall Study|Physician Decision|2|||
42104961|NCT00568776|75916041|FG002|Overall Study|Physician Decision|0|||
42104962|NCT00568776|75916042|FG003|Overall Study|Physician Decision|0|||
42104963|NCT00568776|75916039|FG000|Overall Study|Lack of Efficacy|2|||
42104964|NCT00568776|75916040|FG001|Overall Study|Lack of Efficacy|2|||
42104965|NCT00568776|75916041|FG002|Overall Study|Lack of Efficacy|2|||
42104966|NCT00568776|75916042|FG003|Overall Study|Lack of Efficacy|4|||
42104967|NCT00568776|75916039|FG000|Overall Study|Lost to Follow-up|1|||
42104968|NCT00568776|75916040|FG001|Overall Study|Lost to Follow-up|1|||
42104969|NCT00568776|75916041|FG002|Overall Study|Lost to Follow-up|1|||
42104970|NCT00568776|75916042|FG003|Overall Study|Lost to Follow-up|1|||
42104971|NCT00568776|75916039|FG000|Overall Study|Protocol Violation|1|||
42104972|NCT00568776|75916040|FG001|Overall Study|Protocol Violation|0|||
42104973|NCT00568776|75916041|FG002|Overall Study|Protocol Violation|1|||
42104974|NCT00568776|75916042|FG003|Overall Study|Protocol Violation|1|||
42104975|NCT00568776|75916039|FG000|Overall Study|Withdrawal by Subject|13|||
42104976|NCT00568776|75916040|FG001|Overall Study|Withdrawal by Subject|15|||
42104977|NCT00568776|75916041|FG002|Overall Study|Withdrawal by Subject|13|||
42104978|NCT00568776|75916042|FG003|Overall Study|Withdrawal by Subject|7|||
42104979|NCT00568776|75916039|FG000|Overall Study|Loss of Caregiver|0|||
42104980|NCT00568776|75916040|FG001|Overall Study|Loss of Caregiver|2|||
42104981|NCT00568776|75916041|FG002|Overall Study|Loss of Caregiver|1|||
42104982|NCT00568776|75916042|FG003|Overall Study|Loss of Caregiver|2|||
42104983|NCT00568776|75916039|FG000|Overall Study|Sponsor Decision|2|||
42104984|NCT00568776|75916040|FG001|Overall Study|Sponsor Decision|2|||
42104985|NCT00568776|75916041|FG002|Overall Study|Sponsor Decision|41|||
42104986|NCT00568776|75916042|FG003|Overall Study|Sponsor Decision|42|||
42104987|NCT00568776|75916039|FG000|Overall Study|Miscellaeneous|3|||
42104988|NCT00568776|75916040|FG001|Overall Study|Miscellaeneous|3|||
42104989|NCT00568776|75916041|FG002|Overall Study|Miscellaeneous|1|||
42104990|NCT00568776|75916042|FG003|Overall Study|Miscellaeneous|4|||
42104991|NCT00758771|75916054|FG000|Overall Study|Withdrawal by Subject|1|||
42104992|NCT00758771|75916055|FG001|Overall Study|Withdrawal by Subject|1|||
42104993|NCT00758771|75916054|FG000|Overall Study|Did not meet eligibility criteria|2|||
42104994|NCT00758771|75916055|FG001|Overall Study|Did not meet eligibility criteria|4|||
42104995|NCT00635154|75916061|FG000|Overall Study|Alternative Treatment|8|||
42104996|NCT00635154|75916061|FG000|Overall Study|Other|4|||
42104997|NCT00635154|75916061|FG000|Overall Study|Still on treatment|21|||
42104998|NCT00778895|75916070|FG000|Active Phase|Adverse Event|3|||
42104999|NCT00778895|75916071|FG001|Active Phase|Adverse Event|1|||
42105000|NCT00778895|75916072|FG002|Active Phase|Adverse Event|0|||
42105001|NCT00778895|75916070|FG000|Active Phase|Withdrawal by Subject|1|||
42105002|NCT00778895|75916071|FG001|Active Phase|Withdrawal by Subject|4|||
42105003|NCT00778895|75916072|FG002|Active Phase|Withdrawal by Subject|0|||
42105004|NCT00778895|75916070|FG000|Active Phase|Lost to Follow-up|1|||
42105005|NCT00778895|75916071|FG001|Active Phase|Lost to Follow-up|1|||
42105006|NCT00778895|75916072|FG002|Active Phase|Lost to Follow-up|0|||
42105007|NCT00778895|75916070|FG000|Active Phase|Other|2|||
42378481|NCT01475461|76249884|FG005|Run-in Period|Lost to Follow-up|0|||
42105008|NCT00778895|75916071|FG001|Active Phase|Other|0|||
42105009|NCT00778895|75916072|FG002|Active Phase|Other|0|||
42105010|NCT00778895|75916070|FG000|ESFU Phase|Adverse Event|2|||
42105011|NCT00778895|75916071|FG001|ESFU Phase|Adverse Event|1|||
42105012|NCT00778895|75916072|FG002|ESFU Phase|Adverse Event|0|||
42105013|NCT00778895|75916070|FG000|ESFU Phase|Withdrawal by Subject|1|||
42105014|NCT00778895|75916071|FG001|ESFU Phase|Withdrawal by Subject|4|||
42105015|NCT00778895|75916072|FG002|ESFU Phase|Withdrawal by Subject|0|||
42105016|NCT00778895|75916070|FG000|ESFU Phase|Lost to Follow-up|6|||
42105017|NCT00778895|75916071|FG001|ESFU Phase|Lost to Follow-up|7|||
42105018|NCT00778895|75916072|FG002|ESFU Phase|Lost to Follow-up|2|||
42105019|NCT00778895|75916070|FG000|ESFU Phase|Other|2|||
42105020|NCT00778895|75916071|FG001|ESFU Phase|Other|0|||
42105021|NCT00778895|75916072|FG002|ESFU Phase|Other|0|||
42105022|NCT00293215|75916083|FG000|Overall Study|Progressive disease|3|||
42105023|NCT00293215|75916084|FG001|Overall Study|Progressive disease|1|||
42105024|NCT00293215|75916083|FG000|Overall Study|Adverse Event|2|||
42105025|NCT00293215|75916084|FG001|Overall Study|Adverse Event|2|||
42105026|NCT00778817|75916090|FG000|Overall Study|Adverse Event|2|||
42105027|NCT00778817|75916090|FG000|Overall Study|Withdrawal by Subject|2|||
42105028|NCT00293059|75916096|FG000|Overall Study|Adverse Event|12|||
42105029|NCT00293059|75916097|FG001|Overall Study|Adverse Event|4|||
42105030|NCT00293059|75916096|FG000|Overall Study|Lack of Efficacy|2|||
42105031|NCT00293059|75916097|FG001|Overall Study|Lack of Efficacy|0|||
42105032|NCT00293059|75916096|FG000|Overall Study|Lost to Follow-up|2|||
42105033|NCT00293059|75916097|FG001|Overall Study|Lost to Follow-up|3|||
42105034|NCT00293059|75916096|FG000|Overall Study|Pregnancy|1|||
42105035|NCT00293059|75916097|FG001|Overall Study|Pregnancy|1|||
42105036|NCT00293059|75916096|FG000|Overall Study|Protocol Violation|2|||
42105037|NCT00293059|75916097|FG001|Overall Study|Protocol Violation|0|||
42105038|NCT00293059|75916096|FG000|Overall Study|Withdrawal by Subject|11|||
42105039|NCT00293059|75916097|FG001|Overall Study|Withdrawal by Subject|5|||
42105040|NCT00293059|75916096|FG000|Overall Study|Participant moved out of state|1|||
42105041|NCT00293059|75916097|FG001|Overall Study|Participant moved out of state|0|||
42105042|NCT00293059|75916096|FG000|Overall Study|Participant stopped study drug|1|||
42105043|NCT00293059|75916097|FG001|Overall Study|Participant stopped study drug|0|||
42105044|NCT00293059|75916096|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
42105045|NCT00293059|75916097|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
42105046|NCT00293059|75916096|FG000|Overall Study|missing|3|||
42105047|NCT00293059|75916097|FG001|Overall Study|missing|5|||
42105048|NCT00756275|75916105|FG000|Overall Study|Lost to Follow-up|25|||
42105049|NCT00756275|75916106|FG001|Overall Study|Lost to Follow-up|21|||
42105050|NCT00756275|75916105|FG000|Overall Study|Withdrawal by Subject|4|||
42105051|NCT00756275|75916106|FG001|Overall Study|Withdrawal by Subject|7|||
42105052|NCT00758459|75916114|FG000|Overall Study|Adverse Event|3|||
42105053|NCT00758459|75916115|FG001|Overall Study|Adverse Event|2|||
42105054|NCT00758459|75916114|FG000|Overall Study|Protocol Violation|0|||
42105055|NCT00758459|75916115|FG001|Overall Study|Protocol Violation|1|||
42105056|NCT00758459|75916114|FG000|Overall Study|Withdrawal by Subject|0|||
42105057|NCT00758459|75916115|FG001|Overall Study|Withdrawal by Subject|1|||
42105058|NCT00298831|75916121|FG000|Overall Study|Adverse Event|1|||
42105059|NCT00298831|75916121|FG000|Overall Study|Lost to Follow-up|3|||
42105060|NCT00298831|75916121|FG000|Overall Study|Withdrawal by Subject|1|||
42105061|NCT00298831|75916121|FG000|Overall Study|Participants did not receive treatment|27|||
42105062|NCT00758069|75916128|FG000|Overall Study|Lack of Efficacy|0|||
42105063|NCT00758069|75916129|FG001|Overall Study|Lack of Efficacy|0|||
42105064|NCT00758069|75916130|FG002|Overall Study|Lack of Efficacy|1|||
42105065|NCT00758069|75916128|FG000|Overall Study|Incorrect Study Drug|1|||
42105066|NCT00758069|75916129|FG001|Overall Study|Incorrect Study Drug|0|||
42105067|NCT00758069|75916130|FG002|Overall Study|Incorrect Study Drug|0|||
42105068|NCT00311623|75916141|FG000|Overall Study|Physician Decision|0|||
42105069|NCT00311623|75916142|FG001|Overall Study|Physician Decision|0|||
42105070|NCT00311623|75916143|FG002|Overall Study|Physician Decision|2|||
42105071|NCT00528112|75916154|FG000|Treatment up to 3 Years|Adverse Event|313|||
42105072|NCT00528112|75916155|FG001|Treatment up to 3 Years|Adverse Event|278|||
42105073|NCT00528112|75916154|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
42105074|NCT00528112|75916155|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
42105075|NCT00528112|75916154|FG000|Treatment up to 3 Years|Protocol Violation|16|||
42105076|NCT00528112|75916155|FG001|Treatment up to 3 Years|Protocol Violation|16|||
42105077|NCT00528112|75916154|FG000|Treatment up to 3 Years|Death|0|||
42105078|NCT00528112|75916155|FG001|Treatment up to 3 Years|Death|1|||
42105079|NCT00528112|75916154|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
42105080|NCT00528112|75916155|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
42105081|NCT00528112|75916154|FG000|Treatment up to 3 Years|Pregnancy|9|||
42105082|NCT00528112|75916155|FG001|Treatment up to 3 Years|Pregnancy|10|||
42105083|NCT00528112|75916154|FG000|Treatment up to 3 Years|Other reasons|186|||
42105084|NCT00528112|75916155|FG001|Treatment up to 3 Years|Other reasons|186|||
42105085|NCT00528112|75916154|FG000|Extension Phase|Withdrawal by Subject|0|||
42105086|NCT00528112|75916155|FG001|Extension Phase|Withdrawal by Subject|3|||
42105087|NCT00528112|75916154|FG000|Extension Phase|Other reasons|0|||
42105088|NCT00528112|75916155|FG001|Extension Phase|Other reasons|100|||
42105089|NCT00528112|75916154|FG000|Extension Phase|Pregnancy|0|||
42105090|NCT00528112|75916155|FG001|Extension Phase|Pregnancy|3|||
42105091|NCT00528112|75916154|FG000|Extension Phase|Lost to Follow-up|0|||
42378482|NCT01475461|76249885|FG006|Run-in Period|Lost to Follow-up|0|||
42105092|NCT00528112|75916155|FG001|Extension Phase|Lost to Follow-up|12|||
42105093|NCT00528112|75916154|FG000|Extension Phase|Death|0|||
42105094|NCT00528112|75916155|FG001|Extension Phase|Death|1|||
42105095|NCT00528112|75916154|FG000|Extension Phase|Adverse Event|0|||
42105096|NCT00528112|75916155|FG001|Extension Phase|Adverse Event|36|||
42378483|NCT01475461|76249879|FG000|Run-in Period|Withdrawal by Subject|11|||
42105097|NCT00528112|75916154|FG000|Extension Phase|Protocol Violation|0|||
42105098|NCT00528112|75916155|FG001|Extension Phase|Protocol Violation|2|||
42105099|NCT00633594|75916166|FG000|Overall Study|Adverse Event|0|||
42105100|NCT00633594|75916167|FG001|Overall Study|Adverse Event|4|||
42105101|NCT00633594|75916168|FG002|Overall Study|Adverse Event|7|||
42105102|NCT00633594|75916166|FG000|Overall Study|Death|0|||
42105103|NCT00633594|75916167|FG001|Overall Study|Death|1|||
42105104|NCT00633594|75916168|FG002|Overall Study|Death|2|||
42105105|NCT00633594|75916166|FG000|Overall Study|Disease Progression|0|||
42105106|NCT00633594|75916167|FG001|Overall Study|Disease Progression|0|||
42105107|NCT00633594|75916168|FG002|Overall Study|Disease Progression|1|||
42105108|NCT00755807|75916181|FG000|Acute Phase|Adverse Event|16|||
42105109|NCT00755807|75916182|FG001|Acute Phase|Adverse Event|5|||
42105110|NCT00755807|75916181|FG000|Acute Phase|Protocol Violation|1|||
42105111|NCT00755807|75916182|FG001|Acute Phase|Protocol Violation|3|||
42105112|NCT00755807|75916181|FG000|Acute Phase|Withdrawal by Subject|1|||
42105113|NCT00755807|75916182|FG001|Acute Phase|Withdrawal by Subject|2|||
42105114|NCT00755807|75916181|FG000|Acute Phase|Lack of Efficacy|0|||
42105115|NCT00755807|75916182|FG001|Acute Phase|Lack of Efficacy|1|||
42105116|NCT00755807|75916181|FG000|Acute Phase|Physician Decision|0|||
42105117|NCT00755807|75916182|FG001|Acute Phase|Physician Decision|1|||
42105118|NCT00755807|75916181|FG000|Open-label Extension Phase|Adverse Event|7|||
42105119|NCT00755807|75916182|FG001|Open-label Extension Phase|Adverse Event|7|||
42105120|NCT00755807|75916181|FG000|Open-label Extension Phase|Protocol Violation|5|||
42105121|NCT00755807|75916182|FG001|Open-label Extension Phase|Protocol Violation|2|||
42105122|NCT00755807|75916181|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
42105123|NCT00755807|75916182|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
42105124|NCT00755807|75916181|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
42105125|NCT00755807|75916182|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
42105126|NCT00755807|75916181|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
42105127|NCT00755807|75916182|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
42105128|NCT00755807|75916181|FG000|Open-label Extension Phase|Sponsor Decision|0|||
42105129|NCT00755807|75916182|FG001|Open-label Extension Phase|Sponsor Decision|1|||
42105130|NCT00631410|75916194|FG000|Overall Study|Adverse Event|1|||
42105131|NCT00631410|75916195|FG001|Overall Study|Adverse Event|3|||
42105132|NCT00631410|75916194|FG000|Overall Study|Objective Progression or Relapse|4|||
42105133|NCT00631410|75916195|FG001|Overall Study|Objective Progression or Relapse|3|||
42105134|NCT00631410|75916194|FG000|Overall Study|Surgery|1|||
42105135|NCT00631410|75916195|FG001|Overall Study|Surgery|0|||
42105136|NCT03686176|75916207|FG000|Overall Study|Procedure cancelled|1|||
42105137|NCT03686176|75916208|FG001|Overall Study|Procedure cancelled|0|||
42105138|NCT03686176|75916209|FG002|Overall Study|Procedure cancelled|0|||
42105139|NCT03686176|75916207|FG000|Overall Study|VR Malfunction|1|||
42105140|NCT03686176|75916208|FG001|Overall Study|VR Malfunction|0|||
42105141|NCT03686176|75916209|FG002|Overall Study|VR Malfunction|0|||
42105142|NCT00755417|75916220|FG000|Overall Study|Adverse Event|28|||
42105143|NCT00755417|75916221|FG001|Overall Study|Adverse Event|20|||
42105144|NCT00755417|75916222|FG002|Overall Study|Adverse Event|7|||
42105145|NCT00755417|75916220|FG000|Overall Study|Lack of Efficacy|8|||
42105146|NCT00755417|75916221|FG001|Overall Study|Lack of Efficacy|4|||
42105147|NCT00755417|75916222|FG002|Overall Study|Lack of Efficacy|9|||
42105148|NCT00755417|75916220|FG000|Overall Study|Protocol Violation|2|||
42105149|NCT00755417|75916221|FG001|Overall Study|Protocol Violation|1|||
42105150|NCT00755417|75916222|FG002|Overall Study|Protocol Violation|1|||
42105151|NCT00755417|75916220|FG000|Overall Study|Lost to Follow-up|3|||
42105152|NCT00755417|75916221|FG001|Overall Study|Lost to Follow-up|0|||
42105153|NCT00755417|75916222|FG002|Overall Study|Lost to Follow-up|1|||
42105154|NCT00755417|75916220|FG000|Overall Study|Withdrawal by Subject|12|||
42105155|NCT00755417|75916221|FG001|Overall Study|Withdrawal by Subject|12|||
42105156|NCT00755417|75916222|FG002|Overall Study|Withdrawal by Subject|12|||
42105157|NCT00755417|75916220|FG000|Overall Study|Not specified or missing data|9|||
42105158|NCT00755417|75916221|FG001|Overall Study|Not specified or missing data|18|||
42105159|NCT00755417|75916222|FG002|Overall Study|Not specified or missing data|12|||
42105160|NCT03685708|75916233|FG000|Overall Study|Withdrawal by Subject|0|||
42201069|NCT02603809|76013172|FG004|Overall Study|Physician Decision|2|||
42201070|NCT02603809|76013173|FG005|Overall Study|Physician Decision|1|||
42201071|NCT02603809|76013168|FG000|Overall Study|Adverse Event|3|||
42201072|NCT02603809|76013169|FG001|Overall Study|Adverse Event|0|||
42105161|NCT03685708|75916234|FG001|Overall Study|Withdrawal by Subject|0|||
42201073|NCT02603809|76013170|FG002|Overall Study|Adverse Event|2|||
42105162|NCT03685708|75916235|FG002|Overall Study|Withdrawal by Subject|1|||
42105163|NCT03685708|75916233|FG000|Overall Study|Screen Fail|0|||
42105164|NCT03685708|75916234|FG001|Overall Study|Screen Fail|1|||
42105165|NCT03685708|75916235|FG002|Overall Study|Screen Fail|1|||
42105166|NCT03685708|75916233|FG000|Overall Study|COVID 19 Pandemic|1|||
42105167|NCT03685708|75916234|FG001|Overall Study|COVID 19 Pandemic|1|||
42105168|NCT03685708|75916235|FG002|Overall Study|COVID 19 Pandemic|6|||
42105169|NCT03685708|75916233|FG000|Overall Study|Disease Progression|0|||
42105170|NCT03685708|75916234|FG001|Overall Study|Disease Progression|0|||
42105171|NCT03685708|75916235|FG002|Overall Study|Disease Progression|1|||
42201074|NCT02603809|76013171|FG003|Overall Study|Adverse Event|2|||
42105172|NCT03684928|75916243|FG000|First Intervention|Lost to Follow-up|0|||
42105173|NCT03684928|75916244|FG001|First Intervention|Lost to Follow-up|1|||
42105174|NCT03684928|75916243|FG000|First Intervention|Withdrawal by Subject|0|||
42105175|NCT03684928|75916244|FG001|First Intervention|Withdrawal by Subject|2|||
42105176|NCT03684928|75916243|FG000|Second Intervention|Soft Tissue Injury|1|||
42105177|NCT03684928|75916244|FG001|Second Intervention|Soft Tissue Injury|0|||
42105178|NCT00777803|75916252|FG000|Overall Study|Lost to Follow-up|12|||
42105179|NCT00777803|75916253|FG001|Overall Study|Lost to Follow-up|5|||
42105180|NCT00777803|75916252|FG000|Overall Study|Adverse Event|1|||
42105181|NCT00777803|75916253|FG001|Overall Study|Adverse Event|0|||
42105182|NCT00777803|75916252|FG000|Overall Study|Non-compliance|2|||
42105183|NCT00777803|75916253|FG001|Overall Study|Non-compliance|2|||
42105184|NCT00527488|75916263|FG000|Overall Study|Withdrawn prior to dosing|0|||
42105185|NCT00527488|75916264|FG001|Overall Study|Withdrawn prior to dosing|1|||
42105186|NCT00527488|75916265|FG002|Overall Study|Withdrawn prior to dosing|1|||
42105187|NCT00527488|75916266|FG003|Overall Study|Withdrawn prior to dosing|0|||
42105188|NCT00527332|75916278|FG000|Overall Study|Protocol Violation|4|||
42105189|NCT00527332|75916279|FG001|Overall Study|Protocol Violation|8|||
42105190|NCT00527332|75916278|FG000|Overall Study|Withdrew consent|5|||
42105191|NCT00527332|75916279|FG001|Overall Study|Withdrew consent|1|||
42105192|NCT00752609|75916287|FG000|Overall Study|Adverse Event|2|||
42105193|NCT00752609|75916288|FG001|Overall Study|Adverse Event|2|||
42105194|NCT00752609|75916287|FG000|Overall Study|Withdrawal by Subject|3|||
42105195|NCT00752609|75916288|FG001|Overall Study|Withdrawal by Subject|0|||
42105196|NCT00752609|75916287|FG000|Overall Study|Physician Decision|1|||
42105197|NCT00752609|75916288|FG001|Overall Study|Physician Decision|0|||
42105198|NCT00752609|75916287|FG000|Overall Study|Death|1|||
42105199|NCT00752609|75916288|FG001|Overall Study|Death|0|||
42105200|NCT00752609|75916287|FG000|Overall Study|Met exclusion criteria|1|||
42105201|NCT00752609|75916288|FG001|Overall Study|Met exclusion criteria|0|||
42105202|NCT00752609|75916287|FG000|Overall Study|Received Aranesp in error|1|||
42105203|NCT00752609|75916288|FG001|Overall Study|Received Aranesp in error|0|||
42105204|NCT03684304|75916299|FG000|Overall Study|Lost to Follow-up|19|||
42105205|NCT03684304|75916300|FG001|Overall Study|Lost to Follow-up|17|||
42105206|NCT00629772|75916308|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
42105207|NCT00629772|75916309|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
42105208|NCT00629772|75916308|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
42105209|NCT00629772|75916309|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
42105210|NCT00526630|75916316|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
42105211|NCT00526630|75916317|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
42105212|NCT00526630|75916316|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
42105213|NCT00526630|75916317|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
42105214|NCT00755183|75916327|FG000|Overall Study|Adverse Event|5|||
42105215|NCT00755183|75916328|FG001|Overall Study|Adverse Event|2|||
42105216|NCT00755183|75916327|FG000|Overall Study|Protocol Violation|0|||
42105217|NCT00755183|75916328|FG001|Overall Study|Protocol Violation|1|||
42105218|NCT00755183|75916327|FG000|Overall Study|Withdrawal by Subject|0|||
42105219|NCT00755183|75916328|FG001|Overall Study|Withdrawal by Subject|2|||
42105220|NCT00755183|75916327|FG000|Overall Study|Administrative|2|||
42105221|NCT00755183|75916328|FG001|Overall Study|Administrative|1|||
42105222|NCT00755105|75916339|FG000|Overall Study|Withdrawal by Subject|9|||
42105223|NCT00755105|75916340|FG001|Overall Study|Withdrawal by Subject|11|||
42105224|NCT00755105|75916341|FG002|Overall Study|Withdrawal by Subject|4|||
42105225|NCT00526162|75916349|FG000|Overall Study|Device not implanted|3|||
42105226|NCT03875482|75916359|FG000|Overall Study|Adverse Event|0|||
42105227|NCT03875482|75916360|FG001|Overall Study|Adverse Event|1|||
42105228|NCT03875482|75916359|FG000|Overall Study|Withdrew consent|5|||
42105229|NCT03875482|75916360|FG001|Overall Study|Withdrew consent|6|||
42105230|NCT03875482|75916359|FG000|Overall Study|Lost to Follow-up|8|||
42105231|NCT03875482|75916360|FG001|Overall Study|Lost to Follow-up|2|||
42105232|NCT03875482|75916359|FG000|Overall Study|Lack of Efficacy|0|||
42105233|NCT03875482|75916360|FG001|Overall Study|Lack of Efficacy|11|||
42105234|NCT00754793|75916368|FG000|Overall Study|voluntary withdrawn from study|0|||
42201075|NCT02603809|76013172|FG004|Overall Study|Adverse Event|1|||
42201076|NCT02603809|76013173|FG005|Overall Study|Adverse Event|1|||
42201077|NCT02603809|76013168|FG000|Overall Study|Lack of Efficacy|0|||
42201078|NCT02603809|76013169|FG001|Overall Study|Lack of Efficacy|1|||
42201079|NCT02603809|76013170|FG002|Overall Study|Lack of Efficacy|0|||
42201080|NCT02603809|76013171|FG003|Overall Study|Lack of Efficacy|0|||
42105235|NCT00754793|75916369|FG001|Overall Study|voluntary withdrawn from study|1|||
42105236|NCT00586469|75916377|FG000|Overall Study|Adverse Event|0|||
42201081|NCT02603809|76013172|FG004|Overall Study|Lack of Efficacy|0|||
42105237|NCT00586469|75916378|FG001|Overall Study|Adverse Event|1|||
42105238|NCT00626028|75916386|FG000|Overall Study|Adverse Event|1|||
42105239|NCT00626028|75916387|FG001|Overall Study|Adverse Event|1|||
42201082|NCT02603809|76013173|FG005|Overall Study|Lack of Efficacy|1|||
42201083|NCT02741596|76013204|FG000|Overall Study|Adverse Event|1|||
42105240|NCT00626028|75916386|FG000|Overall Study|Device Failure|0|||
42105241|NCT00626028|75916387|FG001|Overall Study|Device Failure|1|||
42105242|NCT00626028|75916386|FG000|Overall Study|Physician Decision|2|||
42105243|NCT00626028|75916387|FG001|Overall Study|Physician Decision|1|||
42105244|NCT00626028|75916386|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
42105245|NCT00626028|75916387|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
42105246|NCT00777257|75916396|FG000|Overall Study|Adverse Event|3|||
42105247|NCT00777257|75916397|FG001|Overall Study|Adverse Event|1|||
42105248|NCT00777257|75916398|FG002|Overall Study|Adverse Event|0|||
42105249|NCT00777257|75916396|FG000|Overall Study|Lost to Follow-up|3|||
42105250|NCT00777257|75916397|FG001|Overall Study|Lost to Follow-up|3|||
42105251|NCT00777257|75916398|FG002|Overall Study|Lost to Follow-up|2|||
42105252|NCT00777257|75916396|FG000|Overall Study|Protocol Violation|2|||
42105253|NCT00777257|75916397|FG001|Overall Study|Protocol Violation|2|||
42105254|NCT00777257|75916398|FG002|Overall Study|Protocol Violation|2|||
42105255|NCT00777257|75916396|FG000|Overall Study|Withdrawal by Subject|3|||
42105256|NCT00777257|75916397|FG001|Overall Study|Withdrawal by Subject|6|||
42105257|NCT00777257|75916398|FG002|Overall Study|Withdrawal by Subject|5|||
42105258|NCT00628758|75916408|FG000|Overall Study|Adverse Event|2|||
42105259|NCT00628758|75916409|FG001|Overall Study|Adverse Event|3|||
42105260|NCT00628758|75916408|FG000|Overall Study|Withdrawal by Subject|6|||
42105261|NCT00628758|75916409|FG001|Overall Study|Withdrawal by Subject|3|||
42105262|NCT00628758|75916408|FG000|Overall Study|Death|1|||
42105263|NCT00628758|75916409|FG001|Overall Study|Death|0|||
42105264|NCT00628758|75916408|FG000|Overall Study|Protocol Violation|5|||
42105265|NCT00628758|75916409|FG001|Overall Study|Protocol Violation|1|||
42105266|NCT00628758|75916408|FG000|Overall Study|Lost to Follow-up|25|||
42105267|NCT00628758|75916409|FG001|Overall Study|Lost to Follow-up|31|||
42105268|NCT00628758|75916408|FG000|Overall Study|Pregnancy|2|||
42105269|NCT00628758|75916409|FG001|Overall Study|Pregnancy|2|||
42105270|NCT00628758|75916408|FG000|Overall Study|Investigator Moved|3|||
42105271|NCT00628758|75916409|FG001|Overall Study|Investigator Moved|0|||
42105272|NCT00628758|75916408|FG000|Overall Study|Treatment Failure|0|||
42105273|NCT00628758|75916409|FG001|Overall Study|Treatment Failure|2|||
42105274|NCT04491604|75916417|FG000|Overall Study|Withdrawal by Subject|3|||
42105275|NCT00628446|75916422|FG000|Overall Study|Lost to Follow-up|3|||
42105276|NCT00628446|75916422|FG000|Overall Study|Withdrawal by Subject|1|||
42105277|NCT00628446|75916422|FG000|Overall Study|Protocol Violation|3|||
42105278|NCT00754559|75916427|FG000|Overall Study|Adverse Event|15|||
42105279|NCT00754559|75916427|FG000|Overall Study|Protocol Violation|11|||
42105280|NCT00754559|75916427|FG000|Overall Study|Lack of Efficacy|10|||
42105281|NCT00754559|75916427|FG000|Overall Study|Lost to Follow-up|2|||
42105282|NCT00754559|75916427|FG000|Overall Study|Administrative reason|1|||
42105283|NCT00754559|75916427|FG000|Overall Study|Other|5|||
42105284|NCT00754559|75916427|FG000|Overall Study|Withdrawal by Subject|3|||
42105285|NCT00525148|75916438|FG000|Overall Study|Other Adverse Event|3|||
42105286|NCT00525148|75916439|FG001|Overall Study|Other Adverse Event|5|||
42105287|NCT00525148|75916440|FG002|Overall Study|Other Adverse Event|1|||
42105288|NCT00525148|75916441|FG003|Overall Study|Other Adverse Event|8|||
42105289|NCT00525148|75916438|FG000|Overall Study|Progressive disease|18|||
42105290|NCT00525148|75916439|FG001|Overall Study|Progressive disease|30|||
42105291|NCT00525148|75916440|FG002|Overall Study|Progressive disease|6|||
42105292|NCT00525148|75916441|FG003|Overall Study|Progressive disease|49|||
42105293|NCT00525148|75916438|FG000|Overall Study|Refused continuation of study medication|0|||
42105294|NCT00525148|75916439|FG001|Overall Study|Refused continuation of study medication|2|||
42105295|NCT00525148|75916440|FG002|Overall Study|Refused continuation of study medication|0|||
42105296|NCT00525148|75916441|FG003|Overall Study|Refused continuation of study medication|1|||
42105297|NCT00525148|75916438|FG000|Overall Study|Other than stated|2|||
42105298|NCT00525148|75916439|FG001|Overall Study|Other than stated|1|||
42105299|NCT00525148|75916440|FG002|Overall Study|Other than stated|0|||
42105300|NCT00525148|75916441|FG003|Overall Study|Other than stated|3|||
42105301|NCT00754325|75916453|FG000|Initial Treatment|Continuing Active Treatment|4|||
42105302|NCT00754325|75916454|FG001|Initial Treatment|Continuing Active Treatment|5|||
42105303|NCT00754325|75916453|FG000|Initial Treatment|Adverse Event|7|||
42105304|NCT00754325|75916454|FG001|Initial Treatment|Adverse Event|6|||
42105305|NCT00754325|75916453|FG000|Initial Treatment|Withdrawal by Subject|2|||
42105306|NCT00754325|75916454|FG001|Initial Treatment|Withdrawal by Subject|2|||
42105307|NCT00754325|75916453|FG000|Initial Treatment|Physician Decision|2|||
42105308|NCT00754325|75916454|FG001|Initial Treatment|Physician Decision|0|||
42105309|NCT00754325|75916453|FG000|Initial Treatment|Sponsor Request|0|||
42105310|NCT00754325|75916454|FG001|Initial Treatment|Sponsor Request|1|||
42105311|NCT00754325|75916453|FG000|Initial Treatment|Disease Progression|35|||
42105312|NCT00754325|75916454|FG001|Initial Treatment|Disease Progression|35|||
42105313|NCT00524680|75916465|FG000|Overall Study|progression|0|||
42105314|NCT00524680|75916466|FG001|Overall Study|progression|0|||
42105315|NCT00524680|75916467|FG002|Overall Study|progression|0|||
42105316|NCT00524680|75916468|FG003|Overall Study|progression|1|||
42105317|NCT00524680|75916465|FG000|Overall Study|Adverse Event|2|||
42105318|NCT00524680|75916466|FG001|Overall Study|Adverse Event|0|||
42105319|NCT00524680|75916467|FG002|Overall Study|Adverse Event|0|||
42105320|NCT00524680|75916468|FG003|Overall Study|Adverse Event|1|||
42105321|NCT00524680|75916465|FG000|Overall Study|Other|0|||
42105322|NCT00524680|75916466|FG001|Overall Study|Other|1|||
42105323|NCT00524680|75916467|FG002|Overall Study|Other|2|||
42105324|NCT00524680|75916468|FG003|Overall Study|Other|3|||
42105325|NCT00524680|75916465|FG000|Overall Study|Withdrawal by Subject|1|||
42105326|NCT00524680|75916466|FG001|Overall Study|Withdrawal by Subject|0|||
42105327|NCT00524680|75916467|FG002|Overall Study|Withdrawal by Subject|1|||
42105328|NCT00524680|75916468|FG003|Overall Study|Withdrawal by Subject|1|||
42105329|NCT00628212|75916482|FG000|Overall Study|Adverse Event|2|||
42105330|NCT00628212|75916483|FG001|Overall Study|Adverse Event|0|||
42105331|NCT00628212|75916484|FG002|Overall Study|Adverse Event|1|||
42105332|NCT00628212|75916485|FG003|Overall Study|Adverse Event|2|||
42105333|NCT00628212|75916482|FG000|Overall Study|Physician Decision|1|||
42105334|NCT00628212|75916483|FG001|Overall Study|Physician Decision|1|||
42105335|NCT00628212|75916484|FG002|Overall Study|Physician Decision|2|||
42105336|NCT00628212|75916485|FG003|Overall Study|Physician Decision|3|||
42105337|NCT00298363|75916498|FG000|Overall Study|Lost to Follow-up|0|||
42105338|NCT00298363|75916499|FG001|Overall Study|Lost to Follow-up|0|||
42105339|NCT00298363|75916500|FG002|Overall Study|Lost to Follow-up|1|||
42105340|NCT00298363|75916498|FG000|Overall Study|Physician Decision|4|||
42105341|NCT00298363|75916499|FG001|Overall Study|Physician Decision|1|||
42105342|NCT00298363|75916500|FG002|Overall Study|Physician Decision|0|||
42105343|NCT00298363|75916498|FG000|Overall Study|Protocol Violation|1|||
42105344|NCT00298363|75916499|FG001|Overall Study|Protocol Violation|1|||
42105345|NCT00298363|75916500|FG002|Overall Study|Protocol Violation|0|||
42105346|NCT00298363|75916498|FG000|Overall Study|Withdrawal by Subject|5|||
42105347|NCT00298363|75916499|FG001|Overall Study|Withdrawal by Subject|1|||
42105348|NCT00298363|75916500|FG002|Overall Study|Withdrawal by Subject|3|||
42105349|NCT00298363|75916498|FG000|Overall Study|Adverse Event|5|||
42105350|NCT00298363|75916499|FG001|Overall Study|Adverse Event|2|||
42105351|NCT00298363|75916500|FG002|Overall Study|Adverse Event|2|||
42105352|NCT00298363|75916498|FG000|Overall Study|Lack of Efficacy|2|||
42105353|NCT00298363|75916499|FG001|Overall Study|Lack of Efficacy|3|||
42105354|NCT00298363|75916500|FG002|Overall Study|Lack of Efficacy|0|||
42105355|NCT00524368|75916516|FG000|Overall Study|Adverse Event|10|||
42105356|NCT00524368|75916517|FG001|Overall Study|Adverse Event|12|||
42105357|NCT00524368|75916516|FG000|Overall Study|Lost to Follow-up|9|||
42105358|NCT00524368|75916517|FG001|Overall Study|Lost to Follow-up|13|||
42105359|NCT00524368|75916516|FG000|Overall Study|Withdrawal by Subject|4|||
42105360|NCT00524368|75916517|FG001|Overall Study|Withdrawal by Subject|5|||
42105361|NCT00524368|75916516|FG000|Overall Study|Non-compliant|8|||
42105362|NCT00524368|75916517|FG001|Overall Study|Non-compliant|9|||
42105363|NCT00524368|75916516|FG000|Overall Study|Reached a Virologic Endpoint|3|||
42105364|NCT00524368|75916517|FG001|Overall Study|Reached a Virologic Endpoint|2|||
42105365|NCT00524368|75916516|FG000|Overall Study|Sponsor's Decision|2|||
42105366|NCT00524368|75916517|FG001|Overall Study|Sponsor's Decision|0|||
42105367|NCT00524368|75916516|FG000|Overall Study|Ineligible to Continue the study|2|||
42105368|NCT00524368|75916517|FG001|Overall Study|Ineligible to Continue the study|5|||
42105369|NCT00524368|75916516|FG000|Overall Study|Other|3|||
42105370|NCT00524368|75916517|FG001|Overall Study|Other|2|||
42105371|NCT00777101|75916525|FG000|Overall Study|Death|48|||
42105372|NCT00777101|75916526|FG001|Overall Study|Death|43|||
42105373|NCT00777101|75916525|FG000|Overall Study|Withdrawal by Subject|11|||
42105374|NCT00777101|75916526|FG001|Overall Study|Withdrawal by Subject|6|||
42105375|NCT00777101|75916525|FG000|Overall Study|Lost to Follow-up|2|||
42105376|NCT00777101|75916526|FG001|Overall Study|Lost to Follow-up|1|||
42105377|NCT00777101|75916525|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
42105378|NCT00777101|75916526|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
42105379|NCT00777101|75916525|FG000|Overall Study|Failed to Return|0|||
42105380|NCT00777101|75916526|FG001|Overall Study|Failed to Return|1|||
42105381|NCT00297427|75916535|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
42105382|NCT00297427|75916536|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
42105383|NCT00297427|75916535|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
42105384|NCT00297427|75916536|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
42105385|NCT00297427|75916535|FG000|Phase 1: Initial Intervention|Death|0|||
42105386|NCT00297427|75916536|FG001|Phase 1: Initial Intervention|Death|1|||
42105387|NCT00297427|75916535|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
42105388|NCT00297427|75916536|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
42105389|NCT00297427|75916535|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
42105390|NCT00297427|75916536|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
42105391|NCT00297427|75916535|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
42105392|NCT00297427|75916536|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
42105393|NCT00297427|75916535|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
42105394|NCT00297427|75916536|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
42105395|NCT00297427|75916535|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
42105396|NCT00297427|75916536|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
42105397|NCT00524134|75916550|FG000|Overall Study|Withdrawal by Subject|1|||
42105398|NCT00524134|75916550|FG000|Overall Study|Physician Decision|1|||
42105399|NCT00777023|75916557|FG000|Overall Study|Adverse Event|15|||
42105400|NCT00777023|75916558|FG001|Overall Study|Adverse Event|21|||
42105401|NCT00777023|75916559|FG002|Overall Study|Adverse Event|8|||
42105402|NCT00777023|75916557|FG000|Overall Study|Lack of Efficacy|1|||
42105403|NCT00777023|75916558|FG001|Overall Study|Lack of Efficacy|0|||
42105404|NCT00777023|75916559|FG002|Overall Study|Lack of Efficacy|14|||
42105405|NCT00777023|75916557|FG000|Overall Study|Protocol Violation|2|||
42105406|NCT00777023|75916558|FG001|Overall Study|Protocol Violation|1|||
42105407|NCT00777023|75916559|FG002|Overall Study|Protocol Violation|1|||
42105408|NCT00777023|75916557|FG000|Overall Study|Lost to Follow-up|2|||
42105409|NCT00777023|75916558|FG001|Overall Study|Lost to Follow-up|3|||
42105410|NCT00777023|75916559|FG002|Overall Study|Lost to Follow-up|3|||
42105411|NCT00777023|75916557|FG000|Overall Study|Death|0|||
42105412|NCT00777023|75916558|FG001|Overall Study|Death|1|||
42105413|NCT00777023|75916559|FG002|Overall Study|Death|0|||
42105414|NCT00777023|75916557|FG000|Overall Study|Withdrawal by Subject|7|||
42105415|NCT00777023|75916558|FG001|Overall Study|Withdrawal by Subject|7|||
42105416|NCT00777023|75916559|FG002|Overall Study|Withdrawal by Subject|8|||
42105417|NCT00777023|75916557|FG000|Overall Study|Missing data|1|||
42105418|NCT00777023|75916558|FG001|Overall Study|Missing data|1|||
42105419|NCT00777023|75916559|FG002|Overall Study|Missing data|0|||
42105420|NCT00777023|75916557|FG000|Overall Study|Reasons not specified|4|||
42105421|NCT00777023|75916558|FG001|Overall Study|Reasons not specified|4|||
42105422|NCT00777023|75916559|FG002|Overall Study|Reasons not specified|2|||
42105423|NCT00777023|75916557|FG000|Overall Study|Last dose date unknown|3|||
42105424|NCT00777023|75916558|FG001|Overall Study|Last dose date unknown|3|||
42105425|NCT00777023|75916559|FG002|Overall Study|Last dose date unknown|1|||
42105426|NCT00297037|75916569|FG000|Overall Study|Withdrawal by Subject|2|||
42105427|NCT00297037|75916570|FG001|Overall Study|Withdrawal by Subject|0|||
42105428|NCT00292981|75916578|FG000|Overall Study|Adverse Event|1|||
42105429|NCT00292981|75916578|FG000|Overall Study|Lost to Follow-up|13|||
42105430|NCT00292981|75916578|FG000|Overall Study|Withdrawal by Subject|22|||
42105431|NCT00292981|75916578|FG000|Overall Study|Other|3|||
42105432|NCT00296725|75916582|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
42105433|NCT00296725|75916582|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
42105434|NCT00296725|75916582|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
42105435|NCT00625872|75916590|FG000|Overall Study|Withdrawal by Subject|1|||
42105436|NCT00625872|75916591|FG001|Overall Study|Withdrawal by Subject|0|||
42105437|NCT00625872|75916590|FG000|Overall Study|Does not meet inclusion criteria|1|||
42105438|NCT00625872|75916591|FG001|Overall Study|Does not meet inclusion criteria|0|||
42105439|NCT00625872|75916590|FG000|Overall Study|Terminated by sponsor|2|||
42105440|NCT00625872|75916591|FG001|Overall Study|Terminated by sponsor|5|||
42105441|NCT00625872|75916590|FG000|Overall Study|Randomized but not treated|0|||
42105442|NCT00625872|75916591|FG001|Overall Study|Randomized but not treated|1|||
42105443|NCT00523978|75916599|FG000|Overall Study|Withdrawal by Subject|3|||
42105444|NCT00523978|75916600|FG001|Overall Study|Withdrawal by Subject|7|||
42105445|NCT00523978|75916599|FG000|Overall Study|Screen Failures|5|||
42105446|NCT00523978|75916600|FG001|Overall Study|Screen Failures|1|||
42105447|NCT00523978|75916599|FG000|Overall Study|Death|1|||
42105448|NCT00523978|75916600|FG001|Overall Study|Death|0|||
42105449|NCT00296647|75916612|FG000|Overall Study|Death|4|||
42105450|NCT00296647|75916613|FG001|Overall Study|Death|1|||
42105451|NCT00296647|75916614|FG002|Overall Study|Death|2|||
42105452|NCT00296647|75916615|FG003|Overall Study|Death|1|||
42105453|NCT00296647|75916616|FG004|Overall Study|Death|1|||
42105454|NCT00296647|75916612|FG000|Overall Study|Withdrawal by Subject|28|||
42105455|NCT00296647|75916613|FG001|Overall Study|Withdrawal by Subject|27|||
42105456|NCT00296647|75916614|FG002|Overall Study|Withdrawal by Subject|32|||
42105457|NCT00296647|75916615|FG003|Overall Study|Withdrawal by Subject|16|||
42105458|NCT00296647|75916616|FG004|Overall Study|Withdrawal by Subject|19|||
42105459|NCT00754013|75916630|FG000|Overall Study|Lost to Follow-up|1|||
42105460|NCT00754013|75916631|FG001|Overall Study|Lost to Follow-up|1|||
42378484|NCT01475461|76249880|FG001|Run-in Period|Withdrawal by Subject|0|||
42378485|NCT01475461|76249881|FG002|Run-in Period|Withdrawal by Subject|0|||
42105461|NCT00754013|75916630|FG000|Overall Study|didn't return after study termed|3|||
42105462|NCT00754013|75916631|FG001|Overall Study|didn't return after study termed|4|||
42105463|NCT00523744|75916637|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
42105464|NCT00523744|75916637|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
42105465|NCT00523744|75916637|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
42105466|NCT00523744|75916637|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
42105467|NCT00523744|75916637|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
42105468|NCT00523744|75916637|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
42378486|NCT01475461|76249882|FG003|Run-in Period|Withdrawal by Subject|0|||
42105469|NCT00752219|75916655|FG000|Overall Study|Clinical failure|0|||
42105470|NCT00752219|75916656|FG001|Overall Study|Clinical failure|1|||
42105471|NCT00752219|75916655|FG000|Overall Study|Adverse Event|5|||
42105472|NCT00752219|75916656|FG001|Overall Study|Adverse Event|3|||
42105473|NCT00752219|75916655|FG000|Overall Study|Protocol deviation|1|||
42105474|NCT00752219|75916656|FG001|Overall Study|Protocol deviation|0|||
42105475|NCT00752219|75916655|FG000|Overall Study|Lost to Follow-up|1|||
42105476|NCT00752219|75916656|FG001|Overall Study|Lost to Follow-up|2|||
42105477|NCT00752219|75916655|FG000|Overall Study|Randomized but not treated|1|||
42105478|NCT00752219|75916656|FG001|Overall Study|Randomized but not treated|0|||
42105479|NCT00752219|75916655|FG000|Overall Study|Other|3|||
42105480|NCT00752219|75916656|FG001|Overall Study|Other|0|||
42105481|NCT00622908|75916664|FG000|Overall Study|Protocol Violation|1|||
42105482|NCT00622908|75916665|FG001|Overall Study|Protocol Violation|0|||
42105483|NCT00622908|75916664|FG000|Overall Study|Adverse Event|0|||
42105484|NCT00622908|75916665|FG001|Overall Study|Adverse Event|1|||
42105485|NCT00622908|75916664|FG000|Overall Study|Lack of Efficacy|1|||
42105486|NCT00622908|75916665|FG001|Overall Study|Lack of Efficacy|7|||
42105487|NCT00622908|75916664|FG000|Overall Study|Lost to Follow-up|1|||
42105488|NCT00622908|75916665|FG001|Overall Study|Lost to Follow-up|0|||
42105489|NCT00622908|75916664|FG000|Overall Study|Refusal|0|||
42105490|NCT00622908|75916665|FG001|Overall Study|Refusal|1|||
42105491|NCT00622908|75916664|FG000|Overall Study|Termination by study sponser|0|||
42105492|NCT00622908|75916665|FG001|Overall Study|Termination by study sponser|1|||
42105493|NCT00296491|75916675|FG000|Overall Study|Low Pollen Counts|18|||
42105494|NCT00296491|75916676|FG001|Overall Study|Low Pollen Counts|26|||
42105495|NCT00296491|75916677|FG002|Overall Study|Low Pollen Counts|25|||
42105496|NCT00296491|75916678|FG003|Overall Study|Low Pollen Counts|16|||
42105497|NCT00296491|75916675|FG000|Overall Study|Protocol Violation|4|||
42105498|NCT00296491|75916676|FG001|Overall Study|Protocol Violation|6|||
42105499|NCT00296491|75916677|FG002|Overall Study|Protocol Violation|2|||
42105500|NCT00296491|75916678|FG003|Overall Study|Protocol Violation|3|||
42201084|NCT02741596|76013205|FG001|Overall Study|Adverse Event|5|||
42201085|NCT02741596|76013204|FG000|Overall Study|Lost to Follow-up|1|||
42201086|NCT02741596|76013205|FG001|Overall Study|Lost to Follow-up|1|||
42201087|NCT02741596|76013204|FG000|Overall Study|Physician Decision|2|||
42201088|NCT02741596|76013205|FG001|Overall Study|Physician Decision|1|||
42201089|NCT02741596|76013204|FG000|Overall Study|Pregnancy|3|||
42201090|NCT02741596|76013205|FG001|Overall Study|Pregnancy|1|||
42201091|NCT02741596|76013204|FG000|Overall Study|Other (Unspecified)|0|||
42201092|NCT02741596|76013205|FG001|Overall Study|Other (Unspecified)|3|||
42201093|NCT02741596|76013204|FG000|Overall Study|Subject withdrawn-Other|17|||
42201094|NCT02741596|76013205|FG001|Overall Study|Subject withdrawn-Other|4|||
42201095|NCT02741596|76013204|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
42201096|NCT02741596|76013205|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
42201097|NCT03147248|76013217|FG000|Overall Study|Adverse Event|0|||
42201098|NCT03147248|76013218|FG001|Overall Study|Adverse Event|2|||
42201099|NCT03147248|76013219|FG002|Overall Study|Adverse Event|2|||
42201100|NCT03147248|76013220|FG003|Overall Study|Adverse Event|2|||
42201101|NCT03147248|76013221|FG004|Overall Study|Adverse Event|6|||
42201102|NCT03147248|76013222|FG005|Overall Study|Adverse Event|11|||
42201103|NCT03147248|76013217|FG000|Overall Study|Disease progression|1|||
42201104|NCT03147248|76013218|FG001|Overall Study|Disease progression|0|||
42201105|NCT03147248|76013219|FG002|Overall Study|Disease progression|0|||
42201106|NCT03147248|76013220|FG003|Overall Study|Disease progression|0|||
42201107|NCT03147248|76013221|FG004|Overall Study|Disease progression|0|||
42201108|NCT03147248|76013222|FG005|Overall Study|Disease progression|2|||
42201109|NCT03147248|76013217|FG000|Overall Study|Withdrawal by Subject|0|||
42201110|NCT03147248|76013218|FG001|Overall Study|Withdrawal by Subject|0|||
42201111|NCT03147248|76013219|FG002|Overall Study|Withdrawal by Subject|0|||
42201112|NCT03147248|76013220|FG003|Overall Study|Withdrawal by Subject|0|||
42201113|NCT03147248|76013221|FG004|Overall Study|Withdrawal by Subject|12|||
42201114|NCT03147248|76013222|FG005|Overall Study|Withdrawal by Subject|9|||
42201115|NCT03147248|76013217|FG000|Overall Study|Protocol Violation|0|||
42201116|NCT03147248|76013218|FG001|Overall Study|Protocol Violation|0|||
42105501|NCT00296491|75916675|FG000|Overall Study|Adverse Event|1|||
42105502|NCT00296491|75916676|FG001|Overall Study|Adverse Event|3|||
42105503|NCT00296491|75916677|FG002|Overall Study|Adverse Event|1|||
42105504|NCT00296491|75916678|FG003|Overall Study|Adverse Event|4|||
42105505|NCT00296491|75916675|FG000|Overall Study|Withdrawn due to Asthma|0|||
42105506|NCT00296491|75916676|FG001|Overall Study|Withdrawn due to Asthma|0|||
42105507|NCT00296491|75916677|FG002|Overall Study|Withdrawn due to Asthma|0|||
42105508|NCT00296491|75916678|FG003|Overall Study|Withdrawn due to Asthma|4|||
42201117|NCT03147248|76013219|FG002|Overall Study|Protocol Violation|0|||
42201118|NCT03147248|76013220|FG003|Overall Study|Protocol Violation|0|||
42201119|NCT03147248|76013221|FG004|Overall Study|Protocol Violation|2|||
42201120|NCT03147248|76013222|FG005|Overall Study|Protocol Violation|0|||
42201121|NCT03147248|76013217|FG000|Overall Study|Lost to Follow-up|0|||
42201122|NCT03147248|76013218|FG001|Overall Study|Lost to Follow-up|0|||
42201123|NCT03147248|76013219|FG002|Overall Study|Lost to Follow-up|0|||
42201124|NCT03147248|76013220|FG003|Overall Study|Lost to Follow-up|0|||
42201125|NCT03147248|76013221|FG004|Overall Study|Lost to Follow-up|2|||
42201126|NCT03147248|76013222|FG005|Overall Study|Lost to Follow-up|0|||
42201127|NCT03147248|76013217|FG000|Overall Study|Pregnancy|0|||
42201128|NCT03147248|76013218|FG001|Overall Study|Pregnancy|0|||
42201129|NCT03147248|76013219|FG002|Overall Study|Pregnancy|0|||
42201130|NCT03147248|76013220|FG003|Overall Study|Pregnancy|0|||
42201131|NCT03147248|76013221|FG004|Overall Study|Pregnancy|1|||
42201132|NCT03147248|76013222|FG005|Overall Study|Pregnancy|0|||
42201133|NCT03147248|76013217|FG000|Overall Study|Death|0|||
42201134|NCT03147248|76013218|FG001|Overall Study|Death|0|||
42201135|NCT03147248|76013219|FG002|Overall Study|Death|0|||
42201136|NCT03147248|76013220|FG003|Overall Study|Death|0|||
42201137|NCT03147248|76013221|FG004|Overall Study|Death|0|||
42201138|NCT03147248|76013222|FG005|Overall Study|Death|4|||
42201139|NCT03147248|76013217|FG000|Overall Study|Physician Decision|0|||
42201140|NCT03147248|76013218|FG001|Overall Study|Physician Decision|0|||
42201141|NCT03147248|76013219|FG002|Overall Study|Physician Decision|0|||
42201142|NCT03147248|76013220|FG003|Overall Study|Physician Decision|0|||
42201143|NCT03147248|76013221|FG004|Overall Study|Physician Decision|2|||
42201144|NCT03147248|76013222|FG005|Overall Study|Physician Decision|4|||
42201145|NCT03147248|76013217|FG000|Overall Study|Prolonged Dosing Interval|0|||
42201146|NCT03147248|76013218|FG001|Overall Study|Prolonged Dosing Interval|0|||
42201147|NCT03147248|76013219|FG002|Overall Study|Prolonged Dosing Interval|0|||
42201148|NCT03147248|76013220|FG003|Overall Study|Prolonged Dosing Interval|0|||
42201149|NCT03147248|76013221|FG004|Overall Study|Prolonged Dosing Interval|1|||
42201150|NCT03147248|76013222|FG005|Overall Study|Prolonged Dosing Interval|1|||
42201151|NCT03796039|76013238|FG000|Overall Study|Death|2|||
42201152|NCT03796039|76013239|FG001|Overall Study|Death|1|||
42201153|NCT03796039|76013238|FG000|Overall Study|Withdrawal by Subject|7|||
42201154|NCT03796039|76013239|FG001|Overall Study|Withdrawal by Subject|4|||
42201155|NCT03151304|76013245|FG000|Overall Study|Termination of study by Sponsor|23|||
42201156|NCT03151304|76013245|FG000|Overall Study|missing|3|||
42201157|NCT03151304|76013245|FG000|Overall Study|Withdrawal by Subject|8|||
42201158|NCT03151304|76013245|FG000|Overall Study|multiple reasons|30|||
42201159|NCT03152552|76013254|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
42201160|NCT03152552|76013255|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
42201161|NCT03152552|76013256|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
42201162|NCT03152552|76013257|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
42201163|NCT03152552|76013258|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
42201164|NCT03152552|76013254|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
42201165|NCT03152552|76013255|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
42201166|NCT03152552|76013256|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
42201167|NCT03152552|76013257|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
42201168|NCT03152552|76013258|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
42201169|NCT03152552|76013254|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
42201170|NCT03152552|76013255|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
42201171|NCT03152552|76013256|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
42201172|NCT03152552|76013257|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
42201173|NCT03152552|76013258|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
42105509|NCT00296491|75916675|FG000|Overall Study|Withdrawal by Subject|7|||
42105510|NCT00296491|75916676|FG001|Overall Study|Withdrawal by Subject|3|||
42105511|NCT00296491|75916677|FG002|Overall Study|Withdrawal by Subject|3|||
42105512|NCT00296491|75916678|FG003|Overall Study|Withdrawal by Subject|2|||
42105513|NCT00296491|75916675|FG000|Overall Study|Non-Compliance|12|||
42105514|NCT00296491|75916676|FG001|Overall Study|Non-Compliance|13|||
42105515|NCT00296491|75916677|FG002|Overall Study|Non-Compliance|10|||
42105516|NCT00296491|75916678|FG003|Overall Study|Non-Compliance|14|||
42105517|NCT00296491|75916675|FG000|Overall Study|Lost to Follow-up|0|||
42105518|NCT00296491|75916676|FG001|Overall Study|Lost to Follow-up|2|||
42105519|NCT00296491|75916677|FG002|Overall Study|Lost to Follow-up|2|||
42105520|NCT00296491|75916678|FG003|Overall Study|Lost to Follow-up|0|||
42201174|NCT03152552|76013254|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42201175|NCT03152552|76013255|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42201176|NCT03152552|76013256|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
42201177|NCT03152552|76013257|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42201178|NCT03152552|76013258|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
42201179|NCT03152552|76013254|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
42201180|NCT03152552|76013255|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
42105521|NCT00747617|75916697|FG000|Overall Study|Lost to Follow-up|3|||
42105522|NCT00747617|75916698|FG001|Overall Study|Lost to Follow-up|1|||
42105523|NCT00296335|75916706|FG000|Overall Study|Recurrence|3|||
42105524|NCT00296335|75916707|FG001|Overall Study|Recurrence|51|||
42201181|NCT03152552|76013256|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
42201182|NCT03152552|76013257|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
42201183|NCT03152552|76013258|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
42201184|NCT03152552|76013254|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
42201185|NCT03152552|76013255|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
42201186|NCT03152552|76013256|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
42201187|NCT03152552|76013257|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
42201188|NCT03152552|76013258|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
42201189|NCT03152552|76013254|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
42201190|NCT03152552|76013255|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
42201191|NCT03152552|76013256|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
42201192|NCT03152552|76013257|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
42201193|NCT03152552|76013258|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
42201194|NCT03151226|76013271|FG000|Overall Study|Withdrawal by Subject|2|||
42201195|NCT03151226|76013271|FG000|Overall Study|not wear device correctly|1|||
42201196|NCT03151148|76013277|FG000|Overall Study|Lost to Follow-up|1|||
42201197|NCT03151148|76013278|FG001|Overall Study|Lost to Follow-up|0|||
42201198|NCT03151148|76013277|FG000|Overall Study|Withdrawal by Subject|1|||
42201199|NCT03151148|76013278|FG001|Overall Study|Withdrawal by Subject|0|||
42201200|NCT02741518|76013287|FG000|Overall Study|Withdrawal by Subject|1|||
42201201|NCT02741518|76013288|FG001|Overall Study|Withdrawal by Subject|1|||
42201202|NCT03145766|76013299|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
42105525|NCT00296335|75916706|FG000|Overall Study|Adverse Event|17|||
42105526|NCT00296335|75916707|FG001|Overall Study|Adverse Event|27|||
42105527|NCT00296335|75916706|FG000|Overall Study|Lost to Follow-up|7|||
42105528|NCT00296335|75916707|FG001|Overall Study|Lost to Follow-up|33|||
42201203|NCT03145766|76013300|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
42201204|NCT03145766|76013301|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
42201205|NCT03145766|76013302|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
42201206|NCT03145766|76013303|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
42201207|NCT03145766|76013299|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
42201208|NCT03145766|76013300|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
42201209|NCT03145766|76013301|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
42201210|NCT03145766|76013302|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
42201211|NCT03145766|76013303|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
42201212|NCT03145766|76013299|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
42201213|NCT03145766|76013300|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
42201214|NCT03145766|76013301|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
42201215|NCT03145766|76013302|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
42201216|NCT03145766|76013303|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
42201217|NCT03145766|76013299|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
42201218|NCT03145766|76013300|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
42201219|NCT03145766|76013301|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
42378487|NCT01475461|76249883|FG004|Run-in Period|Withdrawal by Subject|0|||
42378488|NCT01475461|76249884|FG005|Run-in Period|Withdrawal by Subject|0|||
42378489|NCT01475461|76249885|FG006|Run-in Period|Withdrawal by Subject|0|||
42105529|NCT00296335|75916706|FG000|Overall Study|Physician Decision|3|||
42105530|NCT00296335|75916707|FG001|Overall Study|Physician Decision|11|||
42105531|NCT00747461|75916715|FG000|Overall Study|study terminated by sponsor|5|||
42105532|NCT03683758|75916722|FG000|Overall Study|Non-study commitment conflict|1|||
42105533|NCT03683758|75916723|FG001|Overall Study|Non-study commitment conflict|3|||
42105534|NCT03683758|75916722|FG000|Overall Study|Illness preventing participation|1|||
42105535|NCT03683758|75916723|FG001|Overall Study|Illness preventing participation|0|||
42105536|NCT03683758|75916722|FG000|Overall Study|Adverse Event|1|||
42105537|NCT03683758|75916723|FG001|Overall Study|Adverse Event|0|||
42105538|NCT00522418|75916731|FG000|Overall Study|Local IRB Consent Violation|5|||
42105539|NCT00522418|75916732|FG001|Overall Study|Local IRB Consent Violation|5|||
42105540|NCT00522418|75916731|FG000|Overall Study|Early Study Termination|46|||
42105541|NCT00522418|75916732|FG001|Overall Study|Early Study Termination|47|||
42105542|NCT00522418|75916731|FG000|Overall Study|Noncompliance|2|||
42105543|NCT00522418|75916732|FG001|Overall Study|Noncompliance|2|||
42105544|NCT00522418|75916731|FG000|Overall Study|Reason Not Specified|3|||
42105545|NCT00522418|75916732|FG001|Overall Study|Reason Not Specified|1|||
42105546|NCT00522418|75916731|FG000|Overall Study|Consent Withdraw|1|||
42105547|NCT00522418|75916732|FG001|Overall Study|Consent Withdraw|2|||
42105548|NCT00522418|75916731|FG000|Overall Study|Lack of Efficacy|0|||
42201220|NCT03145766|76013302|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
42201221|NCT03145766|76013303|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
42201222|NCT03145766|76013299|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
42105549|NCT00522418|75916732|FG001|Overall Study|Lack of Efficacy|1|||
42105550|NCT00624780|75916746|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
42201223|NCT03145766|76013300|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
42201224|NCT03145766|76013301|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
42201225|NCT03145766|76013302|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
42201226|NCT03145766|76013303|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
42201227|NCT03145766|76013299|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
42201228|NCT03145766|76013300|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
42201229|NCT03145766|76013301|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
42201230|NCT03145766|76013302|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
42201231|NCT03145766|76013303|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
42201232|NCT03145766|76013299|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
42201233|NCT03145766|76013300|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
42201234|NCT03145766|76013301|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
42378490|NCT01475461|76249879|FG000|Run-in Period|Other|3|||
42378491|NCT01475461|76249880|FG001|Run-in Period|Other|0|||
42378492|NCT01475461|76249881|FG002|Run-in Period|Other|0|||
42378493|NCT01475461|76249882|FG003|Run-in Period|Other|0|||
42378494|NCT01475461|76249883|FG004|Run-in Period|Other|0|||
42378495|NCT01475461|76249884|FG005|Run-in Period|Other|0|||
42378496|NCT01475461|76249885|FG006|Run-in Period|Other|0|||
42378497|NCT01475461|76249879|FG000|Run-in Period|Protocol Violation|4|||
42378498|NCT01475461|76249880|FG001|Run-in Period|Protocol Violation|0|||
42378499|NCT01475461|76249881|FG002|Run-in Period|Protocol Violation|0|||
42378500|NCT01475461|76249882|FG003|Run-in Period|Protocol Violation|0|||
42378501|NCT01475461|76249883|FG004|Run-in Period|Protocol Violation|0|||
42378502|NCT01475461|76249884|FG005|Run-in Period|Protocol Violation|0|||
42378503|NCT01475461|76249885|FG006|Run-in Period|Protocol Violation|0|||
42378504|NCT01475461|76249879|FG000|Treatment Period|Death|0|||
42378505|NCT01475461|76249880|FG001|Treatment Period|Death|0|||
42378506|NCT01475461|76249881|FG002|Treatment Period|Death|0|||
42378507|NCT01475461|76249882|FG003|Treatment Period|Death|1|||
42378508|NCT01475461|76249883|FG004|Treatment Period|Death|0|||
42378509|NCT01475461|76249884|FG005|Treatment Period|Death|0|||
42378510|NCT01475461|76249885|FG006|Treatment Period|Death|0|||
42378511|NCT01475461|76249879|FG000|Treatment Period|Lost to Follow-up|0|||
42378512|NCT01475461|76249880|FG001|Treatment Period|Lost to Follow-up|3|||
42378513|NCT01475461|76249881|FG002|Treatment Period|Lost to Follow-up|2|||
42378514|NCT01475461|76249882|FG003|Treatment Period|Lost to Follow-up|3|||
42378515|NCT01475461|76249883|FG004|Treatment Period|Lost to Follow-up|1|||
42378516|NCT01475461|76249884|FG005|Treatment Period|Lost to Follow-up|2|||
42378517|NCT01475461|76249885|FG006|Treatment Period|Lost to Follow-up|1|||
42378518|NCT01475461|76249879|FG000|Treatment Period|Withdrawal by Subject|0|||
42378519|NCT01475461|76249880|FG001|Treatment Period|Withdrawal by Subject|2|||
42378520|NCT01475461|76249881|FG002|Treatment Period|Withdrawal by Subject|2|||
42378521|NCT01475461|76249882|FG003|Treatment Period|Withdrawal by Subject|0|||
42378522|NCT01475461|76249883|FG004|Treatment Period|Withdrawal by Subject|2|||
42378523|NCT01475461|76249884|FG005|Treatment Period|Withdrawal by Subject|2|||
42378524|NCT01475461|76249885|FG006|Treatment Period|Withdrawal by Subject|0|||
42378525|NCT01475461|76249879|FG000|Treatment Period|Other|0|||
42378526|NCT01475461|76249880|FG001|Treatment Period|Other|1|||
42378527|NCT01475461|76249881|FG002|Treatment Period|Other|0|||
42378528|NCT01475461|76249882|FG003|Treatment Period|Other|0|||
42378529|NCT01475461|76249883|FG004|Treatment Period|Other|0|||
42378530|NCT01475461|76249884|FG005|Treatment Period|Other|0|||
42378531|NCT01475461|76249885|FG006|Treatment Period|Other|0|||
42378532|NCT01475461|76249879|FG000|Treatment Period|Protocol Violation|0|||
42378533|NCT01475461|76249880|FG001|Treatment Period|Protocol Violation|1|||
42378534|NCT01475461|76249881|FG002|Treatment Period|Protocol Violation|0|||
42378535|NCT01475461|76249882|FG003|Treatment Period|Protocol Violation|0|||
42378536|NCT01475461|76249883|FG004|Treatment Period|Protocol Violation|0|||
42378537|NCT01475461|76249884|FG005|Treatment Period|Protocol Violation|0|||
42378538|NCT01475461|76249885|FG006|Treatment Period|Protocol Violation|1|||
42378539|NCT01475461|76249879|FG000|Treatment Period|Lack of Efficacy|0|||
42378540|NCT01475461|76249880|FG001|Treatment Period|Lack of Efficacy|2|||
42378541|NCT01475461|76249881|FG002|Treatment Period|Lack of Efficacy|0|||
42378542|NCT01475461|76249882|FG003|Treatment Period|Lack of Efficacy|2|||
42378543|NCT01475461|76249883|FG004|Treatment Period|Lack of Efficacy|1|||
42378544|NCT01475461|76249884|FG005|Treatment Period|Lack of Efficacy|1|||
42378545|NCT01475461|76249885|FG006|Treatment Period|Lack of Efficacy|0|||
42378546|NCT01475461|76249879|FG000|Treatment Period|Medication Error|0|||
42378547|NCT01475461|76249880|FG001|Treatment Period|Medication Error|0|||
42378548|NCT01475461|76249881|FG002|Treatment Period|Medication Error|0|||
42378549|NCT01475461|76249882|FG003|Treatment Period|Medication Error|1|||
42378550|NCT01475461|76249883|FG004|Treatment Period|Medication Error|0|||
42378551|NCT01475461|76249884|FG005|Treatment Period|Medication Error|0|||
42378552|NCT01475461|76249885|FG006|Treatment Period|Medication Error|0|||
42378553|NCT01475461|76249879|FG000|Treatment Period|Adverse Event|0|||
42201235|NCT03145766|76013302|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
42201236|NCT03145766|76013303|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
42201237|NCT03145064|76013316|FG000|Overall Study|Death|24|||
42201238|NCT03145064|76013316|FG000|Overall Study|Lost to Follow-up|3|||
42201239|NCT03145064|76013316|FG000|Overall Study|Withdrawal by Subject|6|||
42201240|NCT03145064|76013316|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
42201241|NCT03145064|76013316|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
42201242|NCT03787615|76013341|FG000|Overall Study|Withdrawal by Subject|2|||
42201243|NCT03787615|76013341|FG000|Overall Study|Lost to Follow-up|2|||
42201244|NCT03784963|76013350|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
42201245|NCT03784963|76013351|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
42201246|NCT03784963|76013352|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
42201247|NCT03784963|76013353|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
42201248|NCT03787303|76013363|FG000|Overall Study|Death|1|||
42201249|NCT03787303|76013363|FG000|Overall Study|Premature Termination of Study|1|||
42201250|NCT04170296|76013369|FG000|Overall Study|Adverse Event|1|||
42201251|NCT04170296|76013370|FG001|Overall Study|Adverse Event|0|||
42201252|NCT04170296|76013369|FG000|Overall Study|Withdrawal by Subject|3|||
42201253|NCT04170296|76013370|FG001|Overall Study|Withdrawal by Subject|2|||
42201254|NCT04170296|76013369|FG000|Overall Study|Lost to Follow-up|4|||
42201255|NCT04170296|76013370|FG001|Overall Study|Lost to Follow-up|2|||
42201256|NCT03141788|76013406|FG000|Overall Study|Lost to Follow-up|1|||
42201257|NCT03141788|76013406|FG000|Overall Study|Protocol Violation|3|||
42201258|NCT03141788|76013406|FG000|Overall Study|Withdrawal by Subject|4|||
42201259|NCT03781375|76013415|FG000|Double-blind Phase|Adverse Event|0|||
42201260|NCT03781375|76013416|FG001|Double-blind Phase|Adverse Event|1|||
42201261|NCT03781375|76013415|FG000|Double-blind Phase|Lack of Response|6|||
42201262|NCT03781375|76013416|FG001|Double-blind Phase|Lack of Response|2|||
42201263|NCT03781375|76013415|FG000|Double-blind Phase|Other|1|||
42201264|NCT03781375|76013416|FG001|Double-blind Phase|Other|3|||
42201265|NCT03781375|76013415|FG000|Open-label Phase|Protocol Issues|0|||
42201266|NCT03781375|76013416|FG001|Open-label Phase|Protocol Issues|1|||
42201267|NCT03781375|76013415|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
42201268|NCT03781375|76013416|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
42201269|NCT03781375|76013415|FG000|Open-label Phase|Other|2|||
42201270|NCT03781375|76013416|FG001|Open-label Phase|Other|2|||
42201271|NCT03779503|76013423|FG000|First Intervention|Adverse Event|0|||
42201272|NCT03779503|76013424|FG001|First Intervention|Adverse Event|1|||
42201273|NCT03779503|76013423|FG000|First Intervention|Withdrawal by Subject|1|||
42201274|NCT03779503|76013424|FG001|First Intervention|Withdrawal by Subject|0|||
42201275|NCT03150056|76013436|FG000|Overall Study|Withdrawal by Subject|0|||
42201276|NCT03150056|76013437|FG001|Overall Study|Withdrawal by Subject|0|||
42201277|NCT03150056|76013438|FG002|Overall Study|Withdrawal by Subject|0|||
42201278|NCT03150056|76013439|FG003|Overall Study|Withdrawal by Subject|0|||
42201279|NCT03150056|76013440|FG004|Overall Study|Withdrawal by Subject|0|||
42201280|NCT03150056|76013441|FG005|Overall Study|Withdrawal by Subject|2|||
42201281|NCT03150056|76013436|FG000|Overall Study|Study terminated by Sponsor|1|||
42201282|NCT03150056|76013437|FG001|Overall Study|Study terminated by Sponsor|3|||
42201283|NCT03150056|76013438|FG002|Overall Study|Study terminated by Sponsor|1|||
42201284|NCT03150056|76013439|FG003|Overall Study|Study terminated by Sponsor|1|||
42201285|NCT03150056|76013440|FG004|Overall Study|Study terminated by Sponsor|5|||
42201286|NCT03150056|76013441|FG005|Overall Study|Study terminated by Sponsor|6|||
42201287|NCT03150056|76013436|FG000|Overall Study|Death|9|||
42201288|NCT03150056|76013437|FG001|Overall Study|Death|2|||
42201289|NCT03150056|76013438|FG002|Overall Study|Death|2|||
42201290|NCT03150056|76013439|FG003|Overall Study|Death|7|||
42201291|NCT03150056|76013440|FG004|Overall Study|Death|8|||
42201292|NCT03150056|76013441|FG005|Overall Study|Death|10|||
42201293|NCT02640664|76013461|FG000|Epoch 1|Withdrawal of informed consent|1|||
42201294|NCT02640664|76013462|FG001|Epoch 1|Withdrawal of informed consent|0|||
42201295|NCT02640664|76013463|FG002|Epoch 1|Withdrawal of informed consent|0|||
42201296|NCT02640664|76013461|FG000|Epoch 1|Death|0|||
42201297|NCT02640664|76013462|FG001|Epoch 1|Death|0|||
42201298|NCT02640664|76013463|FG002|Epoch 1|Death|1|||
42201299|NCT02640664|76013461|FG000|Epoch 2|Withdrawal of informed consent|3|||
42201300|NCT02640664|76013462|FG001|Epoch 2|Withdrawal of informed consent|4|||
42201301|NCT02640664|76013463|FG002|Epoch 2|Withdrawal of informed consent|2|||
42201302|NCT02640664|76013461|FG000|Epoch 2|Subject/guardian decision|0|||
42201303|NCT02640664|76013462|FG001|Epoch 2|Subject/guardian decision|2|||
42201304|NCT02640664|76013463|FG002|Epoch 2|Subject/guardian decision|2|||
42201305|NCT02640664|76013461|FG000|Epoch 2|Lost to Follow-up|3|||
42201306|NCT02640664|76013462|FG001|Epoch 2|Lost to Follow-up|4|||
42201307|NCT02640664|76013463|FG002|Epoch 2|Lost to Follow-up|1|||
42201308|NCT02640664|76013461|FG000|Epoch 2|Death|0|||
42201309|NCT02640664|76013462|FG001|Epoch 2|Death|0|||
42201310|NCT02640664|76013463|FG002|Epoch 2|Death|1|||
42201311|NCT00812006|76013475|FG000|Overall Study|Lost to Follow-up|0|||
42201312|NCT00812006|76013476|FG001|Overall Study|Lost to Follow-up|0|||
42201313|NCT00812006|76013477|FG002|Overall Study|Lost to Follow-up|2|||
42201314|NCT00812006|76013475|FG000|Overall Study|Physician Decision|0|||
42201315|NCT00812006|76013476|FG001|Overall Study|Physician Decision|0|||
42201316|NCT00812006|76013477|FG002|Overall Study|Physician Decision|1|||
42201317|NCT00812006|76013475|FG000|Overall Study|Withdrawal by Subject|2|||
42201318|NCT00812006|76013476|FG001|Overall Study|Withdrawal by Subject|1|||
42201319|NCT00812006|76013477|FG002|Overall Study|Withdrawal by Subject|1|||
42201320|NCT00812006|76013475|FG000|Overall Study|Lack of Qualifying Event|4|||
42201321|NCT00812006|76013476|FG001|Overall Study|Lack of Qualifying Event|2|||
42201322|NCT00812006|76013477|FG002|Overall Study|Lack of Qualifying Event|2|||
42201323|NCT04988308|76013511|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
42201324|NCT04988308|76013512|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
42201325|NCT04988308|76013513|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
42201326|NCT04988308|76013514|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
42201327|NCT04988308|76013515|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
42201328|NCT04988308|76013516|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
42201329|NCT04988308|76013511|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
42201330|NCT04988308|76013512|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
42201331|NCT04988308|76013513|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
42201332|NCT04988308|76013514|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
42201333|NCT04988308|76013515|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
42201334|NCT04988308|76013516|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
42201335|NCT04988308|76013511|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
42201336|NCT04988308|76013512|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
42201337|NCT04988308|76013513|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
42201338|NCT04988308|76013514|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
42201339|NCT04988308|76013515|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
42201340|NCT04988308|76013516|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
42201341|NCT04988308|76013511|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
42201342|NCT04988308|76013512|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
42201343|NCT04988308|76013513|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
42201344|NCT04988308|76013514|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
42201345|NCT04988308|76013515|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
42201346|NCT04988308|76013516|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
42201347|NCT04988308|76013511|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
42201348|NCT04988308|76013512|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
42201349|NCT04988308|76013513|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
42201350|NCT04988308|76013514|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
42201351|NCT04988308|76013515|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
42201352|NCT04988308|76013516|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
42201353|NCT04988308|76013511|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
42201354|NCT04988308|76013512|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
42201355|NCT04988308|76013513|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
42201356|NCT04988308|76013514|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
42201357|NCT04988308|76013515|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
42201358|NCT04988308|76013516|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
42201359|NCT04988308|76013511|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
42201360|NCT04988308|76013512|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
42201361|NCT04988308|76013513|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
42201362|NCT04988308|76013514|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
42378554|NCT01475461|76249880|FG001|Treatment Period|Adverse Event|0|||
42378555|NCT01475461|76249881|FG002|Treatment Period|Adverse Event|0|||
42105551|NCT00624780|75916747|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
42105552|NCT00624780|75916748|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
42105553|NCT00624780|75916749|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
42105554|NCT00624780|75916750|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
42105555|NCT00624780|75916751|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
42105556|NCT00624780|75916746|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
42105557|NCT00624780|75916747|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
42105558|NCT00624780|75916748|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
42105559|NCT00624780|75916749|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
42105560|NCT00624780|75916750|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
42105561|NCT00624780|75916751|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
42105562|NCT00624780|75916746|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
42201363|NCT04988308|76013515|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
42201364|NCT04988308|76013516|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
42201365|NCT04988308|76013511|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
42201366|NCT04988308|76013512|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
42201367|NCT04988308|76013513|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
42201368|NCT04988308|76013514|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
42201369|NCT04988308|76013515|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
42201370|NCT04988308|76013516|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
42201371|NCT04988308|76013511|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
42201372|NCT04988308|76013512|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
42201373|NCT04988308|76013513|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
42201374|NCT04988308|76013514|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
42201375|NCT04988308|76013515|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
42201376|NCT04988308|76013516|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
42201377|NCT04737109|76013529|FG000|Study Treatment|Disease Progression|5|||
42201378|NCT04737109|76013530|FG001|Study Treatment|Disease Progression|0|||
42201379|NCT04737109|76013531|FG002|Study Treatment|Disease Progression|0|||
42201380|NCT04737109|76013532|FG003|Study Treatment|Disease Progression|0|||
42201381|NCT04737109|76013529|FG000|Study Treatment|Death on study|1|||
42201382|NCT04737109|76013530|FG001|Study Treatment|Death on study|0|||
42201383|NCT04737109|76013531|FG002|Study Treatment|Death on study|0|||
42201384|NCT04737109|76013532|FG003|Study Treatment|Death on study|0|||
42201385|NCT04582669|76013550|FG000|Overall Study|Subject missed appointment(s).|1|||
42201386|NCT04582669|76013551|FG001|Overall Study|Subject missed appointment(s).|0|||
42201387|NCT04582669|76013552|FG002|Overall Study|Subject missed appointment(s).|1|||
42201388|NCT04582669|76013553|FG003|Overall Study|Subject missed appointment(s).|2|||
42201389|NCT04582669|76013550|FG000|Overall Study|Protocol Violation|0|||
42201390|NCT04582669|76013551|FG001|Overall Study|Protocol Violation|1|||
42201391|NCT04582669|76013552|FG002|Overall Study|Protocol Violation|1|||
42201392|NCT04582669|76013553|FG003|Overall Study|Protocol Violation|0|||
42201393|NCT04560309|76013565|FG000|Overall Study|Meet drop out criteria|1|||
42201394|NCT04560309|76013566|FG001|Overall Study|Meet drop out criteria|1|||
42201395|NCT04535986|76013574|FG000|Overall Study|Death|4|||
42201396|NCT04535986|76013575|FG001|Overall Study|Death|5|||
42201397|NCT04535986|76013574|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
42201398|NCT04535986|76013575|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
42105563|NCT00624780|75916747|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
42105564|NCT00624780|75916748|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
42105565|NCT00624780|75916749|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
42105566|NCT00624780|75916750|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
42105567|NCT00624780|75916751|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
42105568|NCT00624780|75916746|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
42105569|NCT00624780|75916747|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
42105570|NCT00624780|75916748|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
42105571|NCT00624780|75916749|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
42105572|NCT00624780|75916750|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
42105573|NCT00624780|75916751|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
42105574|NCT00624780|75916746|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
42105575|NCT00624780|75916747|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
42105576|NCT00624780|75916748|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
42105577|NCT00624780|75916749|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
42105578|NCT00624780|75916750|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
42105579|NCT00624780|75916751|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
42105580|NCT00624780|75916746|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
42105581|NCT00624780|75916747|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
42105582|NCT00624780|75916748|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
42105583|NCT00624780|75916749|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
42105584|NCT00624780|75916750|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
42105585|NCT00624780|75916751|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
42105586|NCT00624780|75916746|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
42105587|NCT00624780|75916747|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
42105588|NCT00624780|75916748|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
42105589|NCT00624780|75916749|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
42105590|NCT00624780|75916750|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
42105591|NCT00624780|75916751|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
42201399|NCT04535986|76013574|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
42201400|NCT04535986|76013575|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
42201401|NCT04535986|76013574|FG000|Overall Study|Adverse Event|10|||
42201402|NCT04535986|76013575|FG001|Overall Study|Adverse Event|1|||
42105592|NCT00624780|75916746|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
42105593|NCT00624780|75916747|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
42105594|NCT00624780|75916748|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
42105595|NCT00624780|75916749|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
42105596|NCT00624780|75916750|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
42105597|NCT00624780|75916751|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
42105598|NCT00624780|75916746|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
42105599|NCT00624780|75916747|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
42105600|NCT00624780|75916748|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
42105601|NCT00624780|75916749|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
42105602|NCT00624780|75916750|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
42105603|NCT00624780|75916751|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
42105604|NCT00624780|75916746|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
42105605|NCT00624780|75916747|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
42105606|NCT00624780|75916748|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
42105607|NCT00624780|75916749|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
42378556|NCT01475461|76249882|FG003|Treatment Period|Adverse Event|1|||
42105608|NCT00624780|75916750|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
42105609|NCT00624780|75916751|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
42105610|NCT00624780|75916746|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
42105611|NCT00624780|75916747|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
42105612|NCT00624780|75916748|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
42105613|NCT00624780|75916749|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
42105614|NCT00624780|75916750|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
42105615|NCT00624780|75916751|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
42105616|NCT00624780|75916746|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
42105617|NCT00624780|75916747|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
42105618|NCT00624780|75916748|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
42105619|NCT00624780|75916749|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
42105620|NCT00624780|75916750|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
42105621|NCT00624780|75916751|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
42105622|NCT00624780|75916746|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
42105623|NCT00624780|75916747|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
42105624|NCT00624780|75916748|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
42105625|NCT00624780|75916749|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
42105626|NCT00624780|75916750|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
42105627|NCT00624780|75916751|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
42105628|NCT00624780|75916746|FG000|Follow-up (Week 26)|Death|0|||
42105629|NCT00624780|75916747|FG001|Follow-up (Week 26)|Death|0|||
42105630|NCT00624780|75916748|FG002|Follow-up (Week 26)|Death|1|||
42105631|NCT00624780|75916749|FG003|Follow-up (Week 26)|Death|0|||
42105632|NCT00624780|75916750|FG004|Follow-up (Week 26)|Death|0|||
42105633|NCT00624780|75916751|FG005|Follow-up (Week 26)|Death|0|||
42105634|NCT00624780|75916746|FG000|Follow-up (Week 26)|Adverse Event|0|||
42105635|NCT00624780|75916747|FG001|Follow-up (Week 26)|Adverse Event|0|||
42105636|NCT00624780|75916748|FG002|Follow-up (Week 26)|Adverse Event|0|||
42105637|NCT00624780|75916749|FG003|Follow-up (Week 26)|Adverse Event|0|||
42105638|NCT00624780|75916750|FG004|Follow-up (Week 26)|Adverse Event|1|||
42105639|NCT00624780|75916751|FG005|Follow-up (Week 26)|Adverse Event|0|||
42201403|NCT04535986|76013574|FG000|Overall Study|Lack of Efficacy|3|||
42201404|NCT04535986|76013575|FG001|Overall Study|Lack of Efficacy|2|||
42201405|NCT04535986|76013574|FG000|Overall Study|Investigator discretion|3|||
42201406|NCT04535986|76013575|FG001|Overall Study|Investigator discretion|0|||
42201407|NCT04535986|76013574|FG000|Overall Study|Withdrawal by Subject|32|||
42201408|NCT04535986|76013575|FG001|Overall Study|Withdrawal by Subject|14|||
42201409|NCT04535986|76013574|FG000|Overall Study|Lost to Follow-up|5|||
42201410|NCT04535986|76013575|FG001|Overall Study|Lost to Follow-up|3|||
42201411|NCT04535986|76013574|FG000|Overall Study|Other|7|||
42201412|NCT04535986|76013575|FG001|Overall Study|Other|3|||
42201413|NCT04187196|76013585|FG000|Overall Study|Screen Failure|2|||
42105640|NCT00624780|75916746|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
42105641|NCT00624780|75916747|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
42105642|NCT00624780|75916748|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
42105643|NCT00624780|75916749|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
42105644|NCT00624780|75916750|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
42201414|NCT04187196|76013586|FG001|Overall Study|Screen Failure|0|||
42105645|NCT00624780|75916751|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
42105646|NCT00624780|75916746|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
42105647|NCT00624780|75916747|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
42105648|NCT00624780|75916748|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
42201415|NCT04091971|76013592|FG000|Overall Study|Withdrawal by Subject|1|||
42201416|NCT04091971|76013592|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
42378557|NCT01475461|76249883|FG004|Treatment Period|Adverse Event|0|||
42201417|NCT04091971|76013592|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
42201418|NCT03902613|76013621|FG000|Overall Study|Physician Decision|1|||
42201419|NCT03299842|76013669|FG000|Overall Study|Caregiver withdrew consent|2|||
42201420|NCT03299842|76013669|FG000|Overall Study|Child would not keep the watch on|3|||
42201421|NCT03237611|76013673|FG000|Overall Study|Withdrawal by Subject|1|||
42201422|NCT03237611|76013673|FG000|Overall Study|Ineligible|1|||
42201423|NCT03104374|76013680|FG000|Overall Study|Adverse Event|7|||
42201424|NCT03104374|76013681|FG001|Overall Study|Adverse Event|6|||
42201425|NCT03104374|76013682|FG002|Overall Study|Adverse Event|12|||
42201426|NCT03104374|76013683|FG003|Overall Study|Adverse Event|15|||
42201427|NCT03104374|76013680|FG000|Overall Study|Withdrawal by Subject|18|||
42201428|NCT03104374|76013681|FG001|Overall Study|Withdrawal by Subject|10|||
42201429|NCT03104374|76013682|FG002|Overall Study|Withdrawal by Subject|10|||
42201430|NCT03104374|76013683|FG003|Overall Study|Withdrawal by Subject|17|||
42201431|NCT03104374|76013680|FG000|Overall Study|Lost to Follow-up|4|||
42201432|NCT03104374|76013681|FG001|Overall Study|Lost to Follow-up|4|||
42201433|NCT03104374|76013682|FG002|Overall Study|Lost to Follow-up|6|||
42201434|NCT03104374|76013683|FG003|Overall Study|Lost to Follow-up|8|||
42201435|NCT03104374|76013680|FG000|Overall Study|Lack of Efficacy|6|||
42201436|NCT03104374|76013681|FG001|Overall Study|Lack of Efficacy|7|||
42201437|NCT03104374|76013682|FG002|Overall Study|Lack of Efficacy|12|||
42201438|NCT03104374|76013683|FG003|Overall Study|Lack of Efficacy|6|||
42201439|NCT03104374|76013680|FG000|Overall Study|Other|2|||
42201440|NCT03104374|76013681|FG001|Overall Study|Other|2|||
42201441|NCT03104374|76013682|FG002|Overall Study|Other|4|||
42201442|NCT03104374|76013683|FG003|Overall Study|Other|7|||
42201443|NCT03043313|76013716|FG000|Overall Study|Withdrawal by Subject|4|||
42201444|NCT03043313|76013717|FG001|Overall Study|Withdrawal by Subject|1|||
42201445|NCT03043313|76013718|FG002|Overall Study|Withdrawal by Subject|1|||
42201446|NCT03043313|76013716|FG000|Overall Study|Lost to Follow-up|1|||
42201447|NCT03043313|76013717|FG001|Overall Study|Lost to Follow-up|0|||
42201448|NCT03043313|76013718|FG002|Overall Study|Lost to Follow-up|0|||
42201449|NCT03043313|76013716|FG000|Overall Study|Death|26|||
42201450|NCT03043313|76013717|FG001|Overall Study|Death|13|||
42201451|NCT03043313|76013718|FG002|Overall Study|Death|8|||
42201452|NCT03043313|76013716|FG000|Overall Study|On Treatment|7|||
42201453|NCT03043313|76013717|FG001|Overall Study|On Treatment|12|||
42201454|NCT03043313|76013718|FG002|Overall Study|On Treatment|11|||
42201455|NCT03043313|76013716|FG000|Overall Study|In follow up|7|||
42201456|NCT03043313|76013717|FG001|Overall Study|In follow up|15|||
42201457|NCT03043313|76013718|FG002|Overall Study|In follow up|11|||
42201458|NCT02834780|76013738|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
42201459|NCT02834780|76013739|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
42201460|NCT02834780|76013740|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
42201461|NCT02834780|76013741|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
42201462|NCT02834780|76013742|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
42201463|NCT02834780|76013743|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
42201464|NCT02834780|76013744|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
42201465|NCT02834780|76013745|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
42201466|NCT02834780|76013746|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
42201467|NCT02834780|76013747|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
42201468|NCT02834780|76013748|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
42201469|NCT02834780|76013749|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
42201470|NCT02834780|76013750|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
42201471|NCT02834780|76013738|FG000|Overall Study|Withdrawal by Subject|0|||
42201472|NCT02834780|76013739|FG001|Overall Study|Withdrawal by Subject|0|||
42201473|NCT02834780|76013740|FG002|Overall Study|Withdrawal by Subject|1|||
42201474|NCT02834780|76013741|FG003|Overall Study|Withdrawal by Subject|0|||
42201475|NCT02834780|76013742|FG004|Overall Study|Withdrawal by Subject|0|||
42201476|NCT02834780|76013743|FG005|Overall Study|Withdrawal by Subject|0|||
42201477|NCT02834780|76013744|FG006|Overall Study|Withdrawal by Subject|0|||
42201478|NCT02834780|76013745|FG007|Overall Study|Withdrawal by Subject|0|||
42201479|NCT02834780|76013746|FG008|Overall Study|Withdrawal by Subject|0|||
42201480|NCT02834780|76013747|FG009|Overall Study|Withdrawal by Subject|0|||
42201481|NCT02834780|76013748|FG010|Overall Study|Withdrawal by Subject|1|||
42201482|NCT02834780|76013749|FG011|Overall Study|Withdrawal by Subject|0|||
42201483|NCT02834780|76013750|FG012|Overall Study|Withdrawal by Subject|0|||
42201484|NCT02834780|76013738|FG000|Overall Study|Adverse Event|0|||
42201485|NCT02834780|76013739|FG001|Overall Study|Adverse Event|0|||
42201486|NCT02834780|76013740|FG002|Overall Study|Adverse Event|0|||
42201487|NCT02834780|76013741|FG003|Overall Study|Adverse Event|0|||
42201488|NCT02834780|76013742|FG004|Overall Study|Adverse Event|1|||
42201489|NCT02834780|76013743|FG005|Overall Study|Adverse Event|0|||
42201490|NCT02834780|76013744|FG006|Overall Study|Adverse Event|1|||
42201491|NCT02834780|76013745|FG007|Overall Study|Adverse Event|1|||
42201492|NCT02834780|76013746|FG008|Overall Study|Adverse Event|0|||
42201493|NCT02834780|76013747|FG009|Overall Study|Adverse Event|2|||
42378558|NCT01475461|76249884|FG005|Treatment Period|Adverse Event|0|||
42378559|NCT01475461|76249885|FG006|Treatment Period|Adverse Event|0|||
42378560|NCT01589822|76249921|FG000|Overall Study|Withdrawal by Subject|1|||
42378561|NCT01589822|76249922|FG001|Overall Study|Withdrawal by Subject|2|||
42378562|NCT01589822|76249923|FG002|Overall Study|Withdrawal by Subject|0|||
42378563|NCT01589822|76249921|FG000|Overall Study|Death|1|||
42378564|NCT01589822|76249922|FG001|Overall Study|Death|0|||
42378565|NCT01589822|76249923|FG002|Overall Study|Death|0|||
42378566|NCT01589822|76249921|FG000|Overall Study|Missed 90 day visit|2|||
42378567|NCT01589822|76249922|FG001|Overall Study|Missed 90 day visit|1|||
42378568|NCT01589822|76249923|FG002|Overall Study|Missed 90 day visit|1|||
42378569|NCT01565642|76249935|FG000|Overall Study|Withdrawal by Subject|2|||
42378570|NCT01565642|76249936|FG001|Overall Study|Withdrawal by Subject|1|||
42378571|NCT01475071|76249942|FG000|Overall Study|Physician Decision|1|||
42378572|NCT01475071|76249942|FG000|Overall Study|Withdrawal by Subject|6|||
42378573|NCT01475071|76249942|FG000|Overall Study|Lost to Follow-up|1|||
42378574|NCT01474993|76249950|FG000|Overall Study|Lost to Follow-up|1|||
42378575|NCT01474993|76249951|FG001|Overall Study|Lost to Follow-up|2|||
42378576|NCT01474993|76249950|FG000|Overall Study|Adverse Event|0|||
42378577|NCT01474993|76249951|FG001|Overall Study|Adverse Event|1|||
42378578|NCT01691768|76249961|FG000|Overall Study|Death|0|||
42378579|NCT01691768|76249962|FG001|Overall Study|Death|2|||
42378580|NCT01691768|76249961|FG000|Overall Study|Lost to Follow-up|4|||
42378581|NCT01691768|76249962|FG001|Overall Study|Lost to Follow-up|3|||
42378582|NCT01691768|76249961|FG000|Overall Study|Withdrawal by Subject|10|||
42378583|NCT01691768|76249962|FG001|Overall Study|Withdrawal by Subject|9|||
42378584|NCT01691768|76249961|FG000|Overall Study|Relocated|0|||
42378585|NCT01691768|76249962|FG001|Overall Study|Relocated|1|||
42378586|NCT01691768|76249961|FG000|Overall Study|Investigator decision|1|||
42378587|NCT01691768|76249962|FG001|Overall Study|Investigator decision|1|||
42378588|NCT01503229|76249969|FG000|Overall Study|Withdrew consent|1|||
42378589|NCT01691612|76249973|FG000|Overall Study|deemed ineligible after 1st visit|6|||
42378590|NCT01691612|76249973|FG000|Overall Study|Adverse Event|1|||
42378591|NCT01565564|76249979|FG000|Overall Study|Lost to Follow-up|5|||
42378592|NCT01565564|76249980|FG001|Overall Study|Lost to Follow-up|1|||
42378593|NCT01460407|76249986|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
42201494|NCT02834780|76013748|FG010|Overall Study|Adverse Event|0|||
42201495|NCT02834780|76013749|FG011|Overall Study|Adverse Event|3|||
42201496|NCT02834780|76013750|FG012|Overall Study|Adverse Event|2|||
42201497|NCT02834780|76013738|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
42201498|NCT02834780|76013739|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
42201499|NCT02834780|76013740|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
42201500|NCT02834780|76013741|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
42201501|NCT02834780|76013742|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
42201502|NCT02834780|76013743|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
42201503|NCT02834780|76013744|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
42201504|NCT02834780|76013745|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
42201505|NCT02834780|76013746|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
42201506|NCT02834780|76013747|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
42201507|NCT02834780|76013748|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
42201508|NCT02834780|76013749|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
42201509|NCT02834780|76013750|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
42201510|NCT02834780|76013738|FG000|Overall Study|Other|1|||
42201511|NCT02834780|76013739|FG001|Overall Study|Other|0|||
42201512|NCT02834780|76013740|FG002|Overall Study|Other|1|||
42201513|NCT02834780|76013741|FG003|Overall Study|Other|2|||
42201514|NCT02834780|76013742|FG004|Overall Study|Other|0|||
42201515|NCT02834780|76013743|FG005|Overall Study|Other|0|||
42201516|NCT02834780|76013744|FG006|Overall Study|Other|0|||
42201517|NCT02834780|76013745|FG007|Overall Study|Other|0|||
42201518|NCT02834780|76013746|FG008|Overall Study|Other|0|||
42201519|NCT02834780|76013747|FG009|Overall Study|Other|0|||
42201520|NCT02834780|76013748|FG010|Overall Study|Other|0|||
42201521|NCT02834780|76013749|FG011|Overall Study|Other|0|||
42378594|NCT01460407|76249987|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
42378595|NCT01502371|76249999|FG000|Overall Study|Withdrawal by Subject|1|||
42378596|NCT01502371|76250000|FG001|Overall Study|Withdrawal by Subject|2|||
42378597|NCT01502371|76250001|FG002|Overall Study|Withdrawal by Subject|1|||
42378598|NCT01502371|76250002|FG003|Overall Study|Withdrawal by Subject|1|||
42201522|NCT02834780|76013750|FG012|Overall Study|Other|1|||
42378599|NCT01502371|76250003|FG004|Overall Study|Withdrawal by Subject|1|||
42378600|NCT01502371|76249999|FG000|Overall Study|Adverse Event|2|||
42378601|NCT01502371|76250000|FG001|Overall Study|Adverse Event|1|||
42378602|NCT01502371|76250001|FG002|Overall Study|Adverse Event|0|||
42201523|NCT02829957|76013786|FG000|Overall Study|Lost to Follow-up|2|||
42201524|NCT02829957|76013787|FG001|Overall Study|Lost to Follow-up|1|||
42201525|NCT01984346|76013806|FG000|Overall Study|Physician Decision|4|||
42201526|NCT01984346|76013807|FG001|Overall Study|Physician Decision|2|||
42201527|NCT01984346|76013806|FG000|Overall Study|Withdrawal by Subject|2|||
42201528|NCT01984346|76013807|FG001|Overall Study|Withdrawal by Subject|2|||
42201529|NCT01984346|76013806|FG000|Overall Study|Enrollment Closed|8|||
42201530|NCT01984346|76013807|FG001|Overall Study|Enrollment Closed|1|||
42201531|NCT01984346|76013806|FG000|Overall Study|Insurance Coverage|1|||
42201532|NCT01984346|76013807|FG001|Overall Study|Insurance Coverage|0|||
42201533|NCT01984346|76013806|FG000|Overall Study|Intra-operative Exclusion|2|||
42201534|NCT01984346|76013807|FG001|Overall Study|Intra-operative Exclusion|0|||
42201535|NCT03772327|76013845|FG000|Overall Study|Lost to Follow-up|3|||
42201536|NCT03772327|76013846|FG001|Overall Study|Lost to Follow-up|4|||
42201537|NCT03772327|76013845|FG000|Overall Study|Withdrawal by Subject|2|||
42201538|NCT03772327|76013846|FG001|Overall Study|Withdrawal by Subject|3|||
42201539|NCT04364763|76013889|FG000|Overall Study|Death|1|||
42201540|NCT04364763|76013890|FG001|Overall Study|Death|2|||
42201541|NCT04364763|76013889|FG000|Overall Study|Lost to Follow-up|1|||
42201542|NCT04364763|76013890|FG001|Overall Study|Lost to Follow-up|0|||
42201543|NCT04247815|76013907|FG000|Overall Study|Adverse Event|1|||
42201544|NCT04247815|76013908|FG001|Overall Study|Adverse Event|0|||
42201545|NCT04247815|76013907|FG000|Overall Study|Withdrawal by Subject|1|||
42201546|NCT04247815|76013908|FG001|Overall Study|Withdrawal by Subject|0|||
42201547|NCT04247815|76013907|FG000|Overall Study|Protocol Violation|0|||
42201548|NCT04247815|76013908|FG001|Overall Study|Protocol Violation|1|||
42201549|NCT03432819|76013943|FG000|Overall Study|Lost to Follow-up|2|||
42201550|NCT03432819|76013944|FG001|Overall Study|Lost to Follow-up|2|||
42201551|NCT03432819|76013943|FG000|Overall Study|Withdrawal by Subject|5|||
42201552|NCT03432819|76013944|FG001|Overall Study|Withdrawal by Subject|3|||
42201553|NCT03272347|76013972|FG000|Overall Study|Death|0|||
42201554|NCT03272347|76013973|FG001|Overall Study|Death|0|||
42201555|NCT03272347|76013974|FG002|Overall Study|Death|0|||
42201556|NCT03272347|76013975|FG003|Overall Study|Death|1|||
42201557|NCT03272347|76013972|FG000|Overall Study|Lost to Follow-up|1|||
42201558|NCT03272347|76013973|FG001|Overall Study|Lost to Follow-up|3|||
42201559|NCT03272347|76013974|FG002|Overall Study|Lost to Follow-up|5|||
42201560|NCT03272347|76013975|FG003|Overall Study|Lost to Follow-up|1|||
42201561|NCT03272347|76013972|FG000|Overall Study|Physician Decision|4|||
42201562|NCT03272347|76013973|FG001|Overall Study|Physician Decision|2|||
42201563|NCT03272347|76013974|FG002|Overall Study|Physician Decision|5|||
42201564|NCT03272347|76013975|FG003|Overall Study|Physician Decision|4|||
42201565|NCT03272347|76013972|FG000|Overall Study|Screen Failure|1|||
42201566|NCT03272347|76013973|FG001|Overall Study|Screen Failure|0|||
42201567|NCT03272347|76013974|FG002|Overall Study|Screen Failure|0|||
42201568|NCT03272347|76013975|FG003|Overall Study|Screen Failure|0|||
42201569|NCT03272347|76013972|FG000|Overall Study|Withdrawal by Subject|5|||
42201570|NCT03272347|76013973|FG001|Overall Study|Withdrawal by Subject|1|||
42201571|NCT03272347|76013974|FG002|Overall Study|Withdrawal by Subject|2|||
42201572|NCT03272347|76013975|FG003|Overall Study|Withdrawal by Subject|1|||
42105649|NCT00624780|75916749|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
42105650|NCT00624780|75916750|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
42105651|NCT00624780|75916751|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
42105652|NCT00624780|75916746|FG000|Follow-up (Week 26)|Other|1|||
42105653|NCT00624780|75916747|FG001|Follow-up (Week 26)|Other|1|||
42105654|NCT00624780|75916748|FG002|Follow-up (Week 26)|Other|0|||
42105655|NCT00624780|75916749|FG003|Follow-up (Week 26)|Other|0|||
42105656|NCT00624780|75916750|FG004|Follow-up (Week 26)|Other|0|||
42105657|NCT00624780|75916751|FG005|Follow-up (Week 26)|Other|0|||
42105658|NCT00750893|75916768|FG000|Overall Study|Adverse Event|5|||
42105659|NCT00750893|75916768|FG000|Overall Study|Withdrawal by Subject|10|||
42105660|NCT00750893|75916768|FG000|Overall Study|Lost to Follow-up|510|||
42105661|NCT00750893|75916768|FG000|Overall Study|Other|17|||
42105662|NCT00753623|75916774|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
42105663|NCT00753623|75916775|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
42201573|NCT03259568|76013997|FG000|Overall Study|Participant performance was low|3|||
42201574|NCT03239470|76014007|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
42201575|NCT03239470|76014008|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
42105664|NCT00753623|75916774|FG000|Phase I (14 Days)|Physician Decision|1|||
42105665|NCT00753623|75916775|FG001|Phase I (14 Days)|Physician Decision|2|||
42201576|NCT03167723|76014014|FG000|Overall Study|Protocol Violation|4|||
42201577|NCT03167723|76014015|FG001|Overall Study|Protocol Violation|6|||
42105666|NCT00753623|75916774|FG000|Phase I (14 Days)|Adverse Event|0|||
42105667|NCT00753623|75916775|FG001|Phase I (14 Days)|Adverse Event|1|||
42105668|NCT00753623|75916774|FG000|Washout (7 Days)|Physician Decision|1|||
42201578|NCT03103152|76014027|FG000|Overall Study|Physician Decision|5|||
42201579|NCT03103152|76014028|FG001|Overall Study|Physician Decision|2|||
42201580|NCT03103152|76014029|FG002|Overall Study|Physician Decision|6|||
42105669|NCT00753623|75916775|FG001|Washout (7 Days)|Physician Decision|0|||
42105670|NCT00753623|75916774|FG000|Phase II (14 Days)|Physician Decision|0|||
42105671|NCT00753623|75916775|FG001|Phase II (14 Days)|Physician Decision|1|||
42105672|NCT00750737|75916783|FG000|Overall Study|Withdrawal by Subject|3|||
42105673|NCT00750737|75916784|FG001|Overall Study|Withdrawal by Subject|3|||
42105674|NCT00622440|75916792|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
42105675|NCT00622440|75916793|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
42105676|NCT00622440|75916792|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
42105677|NCT00622440|75916793|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
42105678|NCT00622440|75916792|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
42105679|NCT00622440|75916793|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
42105680|NCT00622440|75916792|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
42105681|NCT00622440|75916793|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
42105682|NCT00744653|75916799|FG000|Overall Study|antineoplastic treatment|11|||
42105683|NCT00744653|75916799|FG000|Overall Study|Death|1|||
42105684|NCT00744653|75916799|FG000|Overall Study|Lost to Follow-up|1|||
42105685|NCT00744653|75916799|FG000|Overall Study|Physician Decision|3|||
42105686|NCT00311311|75916806|FG000|Overall Study|Adverse Event|3|||
42105687|NCT00311311|75916807|FG001|Overall Study|Adverse Event|2|||
42105688|NCT00311311|75916806|FG000|Overall Study|Withdrawal by Subject|1|||
42105689|NCT00311311|75916807|FG001|Overall Study|Withdrawal by Subject|1|||
42105690|NCT00311311|75916806|FG000|Overall Study|Noncompliance|0|||
42105691|NCT00311311|75916807|FG001|Overall Study|Noncompliance|1|||
42105692|NCT00311311|75916806|FG000|Overall Study|Study Termination by Sponsor|3|||
42105693|NCT00311311|75916807|FG001|Overall Study|Study Termination by Sponsor|4|||
42105694|NCT00311311|75916806|FG000|Overall Study|Death|1|||
42105695|NCT00311311|75916807|FG001|Overall Study|Death|0|||
42105696|NCT00311311|75916806|FG000|Overall Study|Lack of ancillary assistance|0|||
42201581|NCT03103152|76014030|FG003|Overall Study|Physician Decision|3|||
42201582|NCT03103152|76014031|FG004|Overall Study|Physician Decision|3|||
42201583|NCT03103152|76014032|FG005|Overall Study|Physician Decision|1|||
42201584|NCT03103152|76014027|FG000|Overall Study|Protocol Violation|2|||
42201585|NCT03103152|76014028|FG001|Overall Study|Protocol Violation|2|||
42201586|NCT03103152|76014029|FG002|Overall Study|Protocol Violation|1|||
42201587|NCT03103152|76014030|FG003|Overall Study|Protocol Violation|2|||
42201588|NCT03103152|76014031|FG004|Overall Study|Protocol Violation|1|||
42201589|NCT03103152|76014032|FG005|Overall Study|Protocol Violation|1|||
42201590|NCT03103152|76014027|FG000|Overall Study|Inter-current illness|0|||
42201591|NCT03103152|76014028|FG001|Overall Study|Inter-current illness|0|||
42201592|NCT03103152|76014029|FG002|Overall Study|Inter-current illness|1|||
42201593|NCT03103152|76014030|FG003|Overall Study|Inter-current illness|0|||
42201594|NCT03103152|76014031|FG004|Overall Study|Inter-current illness|0|||
42201595|NCT03103152|76014032|FG005|Overall Study|Inter-current illness|0|||
42201596|NCT03103152|76014027|FG000|Overall Study|Death|0|||
42201597|NCT03103152|76014028|FG001|Overall Study|Death|1|||
42201598|NCT03103152|76014029|FG002|Overall Study|Death|0|||
42201599|NCT03103152|76014030|FG003|Overall Study|Death|0|||
42201600|NCT03103152|76014031|FG004|Overall Study|Death|0|||
42201601|NCT03103152|76014032|FG005|Overall Study|Death|0|||
42201602|NCT03103152|76014027|FG000|Overall Study|Adverse Event|0|||
42201603|NCT03103152|76014028|FG001|Overall Study|Adverse Event|0|||
42201604|NCT03103152|76014029|FG002|Overall Study|Adverse Event|1|||
42201605|NCT03103152|76014030|FG003|Overall Study|Adverse Event|0|||
42201606|NCT03103152|76014031|FG004|Overall Study|Adverse Event|0|||
42201607|NCT03103152|76014032|FG005|Overall Study|Adverse Event|1|||
42201608|NCT03103152|76014027|FG000|Overall Study|Withdrawal by Subject|1|||
42201609|NCT03103152|76014028|FG001|Overall Study|Withdrawal by Subject|0|||
42201610|NCT03103152|76014029|FG002|Overall Study|Withdrawal by Subject|1|||
42201611|NCT03103152|76014030|FG003|Overall Study|Withdrawal by Subject|1|||
42201612|NCT03103152|76014031|FG004|Overall Study|Withdrawal by Subject|1|||
42201613|NCT03103152|76014032|FG005|Overall Study|Withdrawal by Subject|1|||
42201614|NCT03103152|76014027|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
42201615|NCT03103152|76014028|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
42201616|NCT03103152|76014029|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
42201617|NCT03103152|76014030|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
42105697|NCT00311311|75916807|FG001|Overall Study|Lack of ancillary assistance|1|||
42105698|NCT00521404|75916813|FG000|Overall Study|Adverse Event|13|||
42105699|NCT00521404|75916813|FG000|Overall Study|Disease Progression|33|||
42105700|NCT00521404|75916813|FG000|Overall Study|Investigator decision|5|||
42201618|NCT03103152|76014031|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
42201619|NCT03103152|76014032|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
42201620|NCT03103152|76014027|FG000|Overall Study|Unacceptable side effects|0|||
42201621|NCT03103152|76014028|FG001|Overall Study|Unacceptable side effects|0|||
42201622|NCT03103152|76014029|FG002|Overall Study|Unacceptable side effects|0|||
42201623|NCT03103152|76014030|FG003|Overall Study|Unacceptable side effects|0|||
42201624|NCT03103152|76014031|FG004|Overall Study|Unacceptable side effects|0|||
42201625|NCT03103152|76014032|FG005|Overall Study|Unacceptable side effects|1|||
42201626|NCT03103152|76014027|FG000|Overall Study|Lost to Follow-up|0|||
42201627|NCT03103152|76014028|FG001|Overall Study|Lost to Follow-up|1|||
42201628|NCT03103152|76014029|FG002|Overall Study|Lost to Follow-up|0|||
42201629|NCT03103152|76014030|FG003|Overall Study|Lost to Follow-up|1|||
42201630|NCT03103152|76014031|FG004|Overall Study|Lost to Follow-up|0|||
42201631|NCT03103152|76014032|FG005|Overall Study|Lost to Follow-up|1|||
42201632|NCT03103152|76014027|FG000|Overall Study|Testicular pain|0|||
42201633|NCT03103152|76014028|FG001|Overall Study|Testicular pain|0|||
42201634|NCT03103152|76014029|FG002|Overall Study|Testicular pain|0|||
42201635|NCT03103152|76014030|FG003|Overall Study|Testicular pain|1|||
42201636|NCT03103152|76014031|FG004|Overall Study|Testicular pain|0|||
42201637|NCT03103152|76014032|FG005|Overall Study|Testicular pain|0|||
42201638|NCT03033901|76014046|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
42201639|NCT03033901|76014046|FG000|Overall Study|Refused PSG|23|||
42201640|NCT03033901|76014046|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
42201641|NCT03033901|76014046|FG000|Overall Study|Missing Oximetry Data|3|||
42201642|NCT02315196|76014089|FG000|Overall Study|Withdrew consent|9|||
42201643|NCT02059005|76014095|FG000|Overall Study|Death|1|||
42201644|NCT02059005|76014096|FG001|Overall Study|Death|3|||
42201645|NCT02059005|76014095|FG000|Overall Study|Lost to Follow-up|19|||
42201646|NCT02059005|76014096|FG001|Overall Study|Lost to Follow-up|19|||
42201647|NCT02059005|76014095|FG000|Overall Study|Incarceration|0|||
42201648|NCT02059005|76014096|FG001|Overall Study|Incarceration|1|||
42201649|NCT02059005|76014095|FG000|Overall Study|Inpatient|0|||
42201650|NCT02059005|76014096|FG001|Overall Study|Inpatient|1|||
42201651|NCT01393821|76014106|FG000|Overall Study|Cancel|1|||
42201652|NCT01393821|76014107|FG001|Overall Study|Cancel|1|||
42201653|NCT01393821|76014106|FG000|Overall Study|not evaluable for primary endpoint|4|||
42201654|NCT01393821|76014107|FG001|Overall Study|not evaluable for primary endpoint|2|||
42201655|NCT00496873|76014119|FG000|Overall Study|Ineligible|2|||
42201656|NCT00496873|76014119|FG000|Overall Study|Death|2|||
42201657|NCT00496873|76014119|FG000|Overall Study|Withdrawal by Subject|3|||
42201658|NCT00492778|76014125|FG000|Overall Study|Ineligible by Pathology Review|8|||
42201659|NCT00492778|76014126|FG001|Overall Study|Ineligible by Pathology Review|1|||
42201660|NCT03775681|76014160|FG000|Overall Study|Physician Decision|3|||
42201661|NCT03774823|76014166|FG000|Overall Study|Withdrawal by Subject|1|||
42201662|NCT03774823|76014167|FG001|Overall Study|Withdrawal by Subject|1|||
42201663|NCT03149042|76014173|FG000|Overall Study|Invasive FFR not performed|21|||
42201664|NCT03149042|76014173|FG000|Overall Study|Poor CT Image Quality|1|||
42201665|NCT03149042|76014173|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
42201666|NCT03496012|76014181|FG000|Overall Study|Withdrawal by Subject|2|||
42201667|NCT03496012|76014182|FG001|Overall Study|Withdrawal by Subject|0|||
42201668|NCT03496012|76014183|FG002|Overall Study|Withdrawal by Subject|2|||
42201669|NCT03496012|76014181|FG000|Overall Study|Adverse Event|0|||
42201670|NCT03496012|76014182|FG001|Overall Study|Adverse Event|0|||
42201671|NCT03496012|76014183|FG002|Overall Study|Adverse Event|1|||
42201672|NCT03496012|76014181|FG000|Overall Study|Reason Not Specified|2|||
42201673|NCT03496012|76014182|FG001|Overall Study|Reason Not Specified|0|||
42201674|NCT03496012|76014183|FG002|Overall Study|Reason Not Specified|1|||
42201675|NCT03774433|76014191|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
42201676|NCT05061992|76014206|FG000|Overall Study|Excess bowel movements|1|||
42201677|NCT05061992|76014207|FG001|Overall Study|Excess bowel movements|0|||
42201678|NCT05061992|76014206|FG000|Overall Study|Complications of Medical Care|1|||
42201679|NCT05061992|76014207|FG001|Overall Study|Complications of Medical Care|0|||
42201680|NCT05061992|76014206|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
42201681|NCT05061992|76014207|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
42201682|NCT05061992|76014206|FG000|Overall Study|Withdrawal by Subject|0|||
42201683|NCT05061992|76014207|FG001|Overall Study|Withdrawal by Subject|1|||
42201684|NCT04814823|76014222|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
42201685|NCT04762160|76014239|FG000|Overall Study|Study terminated early due to business reasons|5|||
42201686|NCT04625972|76014245|FG000|Overall Study|Death|3|||
42201687|NCT04625972|76014246|FG001|Overall Study|Death|2|||
42201688|NCT04625972|76014245|FG000|Overall Study|Lost to Follow-up|82|||
42201689|NCT04625972|76014246|FG001|Overall Study|Lost to Follow-up|38|||
42201690|NCT04625972|76014245|FG000|Overall Study|Physician Decision|2|||
42201691|NCT04625972|76014246|FG001|Overall Study|Physician Decision|0|||
42201692|NCT04625972|76014245|FG000|Overall Study|Protocol Violation|0|||
42201693|NCT04625972|76014246|FG001|Overall Study|Protocol Violation|1|||
42201694|NCT04625972|76014245|FG000|Overall Study|Withdrawal by Subject|37|||
42201695|NCT04625972|76014246|FG001|Overall Study|Withdrawal by Subject|24|||
42201696|NCT04625972|76014245|FG000|Overall Study|Not specified elsewhere|8|||
42201697|NCT04625972|76014246|FG001|Overall Study|Not specified elsewhere|6|||
42201698|NCT04482647|76014252|FG000|Overall Study|Time constraints|2|||
42201699|NCT04482647|76014252|FG000|Overall Study|Health issues|1|||
42201700|NCT04482647|76014252|FG000|Overall Study|Death in the family|1|||
42201701|NCT04482647|76014252|FG000|Overall Study|Disliked the intervention|1|||
42201702|NCT04482647|76014252|FG000|Overall Study|No reasons specified|7|||
42201703|NCT04429503|76014259|FG000|Overall Study|Non-compliance with protocol by the subject|1|||
42201704|NCT04429503|76014260|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
42201705|NCT04429503|76014261|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
42201706|NCT04429503|76014259|FG000|Overall Study|Adverse Event|0|||
42201707|NCT04429503|76014260|FG001|Overall Study|Adverse Event|4|||
42201708|NCT04429503|76014261|FG002|Overall Study|Adverse Event|2|||
42201709|NCT04429503|76014259|FG000|Overall Study|Decision by the investigator/sponsor|0|||
42201710|NCT04429503|76014260|FG001|Overall Study|Decision by the investigator/sponsor|6|||
42201711|NCT04429503|76014261|FG002|Overall Study|Decision by the investigator/sponsor|2|||
42201712|NCT04429503|76014259|FG000|Overall Study|Withdrawal by Subject|4|||
42201713|NCT04429503|76014260|FG001|Overall Study|Withdrawal by Subject|12|||
42201714|NCT04429503|76014261|FG002|Overall Study|Withdrawal by Subject|2|||
42201715|NCT04429503|76014259|FG000|Overall Study|Lost to Follow-up|2|||
42201716|NCT04429503|76014260|FG001|Overall Study|Lost to Follow-up|8|||
42201717|NCT04429503|76014261|FG002|Overall Study|Lost to Follow-up|2|||
42201718|NCT04429503|76014259|FG000|Overall Study|Death|5|||
42201719|NCT04429503|76014260|FG001|Overall Study|Death|9|||
42201720|NCT04429503|76014261|FG002|Overall Study|Death|4|||
42201721|NCT04408924|76014269|FG000|Overall Study|On Study Treatment|3|||
42201722|NCT04408924|76014269|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|14|||
42201723|NCT04408924|76014269|FG000|Overall Study|Lost to Follow-up|1|||
42201724|NCT04408924|76014269|FG000|Overall Study|Withdrawal by Subject|7|||
42201725|NCT04400487|76014273|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
42201726|NCT04400487|76014273|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
42201727|NCT04400487|76014273|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
42201728|NCT04258254|76014281|FG000|Overall Study|Withdrawal by Subject|0|||
42201729|NCT04258254|76014282|FG001|Overall Study|Withdrawal by Subject|1|||
42201730|NCT04258254|76014283|FG002|Overall Study|Withdrawal by Subject|0|||
42201731|NCT04247594|76014291|FG000|Overall Study|Withdrawal by Subject|4|||
42201732|NCT03954704|76014342|FG000|Overall Study|Death|1|||
42201733|NCT03954704|76014343|FG001|Overall Study|Death|1|||
42201734|NCT03954704|76014344|FG002|Overall Study|Death|1|||
42378603|NCT01502371|76250002|FG003|Overall Study|Adverse Event|4|||
42378604|NCT01502371|76250003|FG004|Overall Study|Adverse Event|3|||
42378605|NCT01502371|76249999|FG000|Overall Study|Treatment Failure|22|||
42378606|NCT01502371|76250000|FG001|Overall Study|Treatment Failure|20|||
42378607|NCT01502371|76250001|FG002|Overall Study|Treatment Failure|12|||
42378608|NCT01502371|76250002|FG003|Overall Study|Treatment Failure|19|||
42378609|NCT01502371|76250003|FG004|Overall Study|Treatment Failure|30|||
42378610|NCT01502371|76249999|FG000|Overall Study|Lack of Efficacy|3|||
42378611|NCT01502371|76250000|FG001|Overall Study|Lack of Efficacy|3|||
42378612|NCT01502371|76250001|FG002|Overall Study|Lack of Efficacy|2|||
42378613|NCT01502371|76250002|FG003|Overall Study|Lack of Efficacy|2|||
42378614|NCT01502371|76250003|FG004|Overall Study|Lack of Efficacy|4|||
42378615|NCT01502371|76249999|FG000|Overall Study|Physician Decision|3|||
42378616|NCT01502371|76250000|FG001|Overall Study|Physician Decision|0|||
42378617|NCT01502371|76250001|FG002|Overall Study|Physician Decision|0|||
42378618|NCT01502371|76250002|FG003|Overall Study|Physician Decision|0|||
42378619|NCT01502371|76250003|FG004|Overall Study|Physician Decision|1|||
42378620|NCT01502371|76249999|FG000|Overall Study|Noncompliance with Study Drug|0|||
42378621|NCT01502371|76250000|FG001|Overall Study|Noncompliance with Study Drug|0|||
42378622|NCT01502371|76250001|FG002|Overall Study|Noncompliance with Study Drug|1|||
42378623|NCT01502371|76250002|FG003|Overall Study|Noncompliance with Study Drug|2|||
42378624|NCT01502371|76250003|FG004|Overall Study|Noncompliance with Study Drug|1|||
42378625|NCT01502371|76249999|FG000|Overall Study|Technical Problems|1|||
42378626|NCT01502371|76250000|FG001|Overall Study|Technical Problems|0|||
42378627|NCT01502371|76250001|FG002|Overall Study|Technical Problems|2|||
42378628|NCT01502371|76250002|FG003|Overall Study|Technical Problems|4|||
42378629|NCT01502371|76250003|FG004|Overall Study|Technical Problems|1|||
42378630|NCT01502371|76249999|FG000|Overall Study|Protocol Violation|9|||
42378631|NCT01502371|76250000|FG001|Overall Study|Protocol Violation|5|||
42378632|NCT01502371|76250001|FG002|Overall Study|Protocol Violation|6|||
42378633|NCT01502371|76250002|FG003|Overall Study|Protocol Violation|5|||
42378634|NCT01502371|76250003|FG004|Overall Study|Protocol Violation|10|||
42378635|NCT01502371|76249999|FG000|Overall Study|Excluded Medication|0|||
42378636|NCT01502371|76250000|FG001|Overall Study|Excluded Medication|1|||
42378637|NCT01502371|76250001|FG002|Overall Study|Excluded Medication|1|||
42201735|NCT03954704|76014345|FG003|Overall Study|Death|3|||
42201736|NCT03954704|76014346|FG004|Overall Study|Death|2|||
42201737|NCT03954704|76014347|FG005|Overall Study|Death|2|||
42201738|NCT03954704|76014348|FG006|Overall Study|Death|0|||
42201739|NCT03954704|76014342|FG000|Overall Study|Withdrew Consent|0|||
42378638|NCT01502371|76250002|FG003|Overall Study|Excluded Medication|0|||
42378639|NCT01502371|76250003|FG004|Overall Study|Excluded Medication|1|||
42378640|NCT01588496|76250019|FG000|Overall Study|Withdrawal by Subject|0|||
42378641|NCT01588496|76250020|FG001|Overall Study|Withdrawal by Subject|1|||
42378642|NCT01588496|76250021|FG002|Overall Study|Withdrawal by Subject|0|||
42378643|NCT01502293|76250032|FG000|Overall Study|Progressive Disease|20|||
42378644|NCT01502293|76250033|FG001|Overall Study|Progressive Disease|12|||
42378645|NCT01502293|76250034|FG002|Overall Study|Progressive Disease|2|||
42378646|NCT01502293|76250032|FG000|Overall Study|Withdrawal by Subject|3|||
42378647|NCT01502293|76250033|FG001|Overall Study|Withdrawal by Subject|3|||
42378648|NCT01502293|76250034|FG002|Overall Study|Withdrawal by Subject|1|||
42378649|NCT01502293|76250032|FG000|Overall Study|Adverse Event|0|||
42378650|NCT01502293|76250033|FG001|Overall Study|Adverse Event|2|||
42378651|NCT01502293|76250034|FG002|Overall Study|Adverse Event|0|||
42378652|NCT01502293|76250032|FG000|Overall Study|Reason Not Specified|2|||
42378653|NCT01502293|76250033|FG001|Overall Study|Reason Not Specified|0|||
42378654|NCT01502293|76250034|FG002|Overall Study|Reason Not Specified|0|||
42378655|NCT01502293|76250032|FG000|Overall Study|Physician Decision|0|||
42378656|NCT01502293|76250033|FG001|Overall Study|Physician Decision|0|||
42378657|NCT01502293|76250034|FG002|Overall Study|Physician Decision|1|||
42378658|NCT01474681|76250047|FG000|Overall Study|Death|0|||
42378659|NCT01474681|76250048|FG001|Overall Study|Death|3|||
42378660|NCT01474681|76250049|FG002|Overall Study|Death|2|||
42378661|NCT01474681|76250050|FG003|Overall Study|Death|6|||
42378662|NCT01459783|76250066|FG000|Baseline to 6 Months|Death|1|||
42378663|NCT01459783|76250067|FG001|Baseline to 6 Months|Death|0|||
42378664|NCT01459783|76250066|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
42378665|NCT01459783|76250067|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
42378666|NCT01459783|76250066|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
42378667|NCT01459783|76250067|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
42378668|NCT01459783|76250066|FG000|6 Months to 12 Months|Death|0|||
42378669|NCT01459783|76250067|FG001|6 Months to 12 Months|Death|1|||
42378670|NCT01459783|76250066|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
42378671|NCT01459783|76250067|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
42378672|NCT01459783|76250066|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
42378673|NCT01459783|76250067|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
42378674|NCT01459783|76250066|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
42378675|NCT01459783|76250067|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
42378676|NCT01588184|76250079|FG000|Overall Study|Death|1|||
42378677|NCT01588184|76250080|FG001|Overall Study|Death|0|||
42378678|NCT01588184|76250081|FG002|Overall Study|Death|0|||
42378679|NCT01588184|76250082|FG003|Overall Study|Death|1|||
42378680|NCT01588184|76250083|FG004|Overall Study|Death|1|||
42378681|NCT01588184|76250084|FG005|Overall Study|Death|1|||
42378682|NCT01588184|76250079|FG000|Overall Study|Withdrawal by Subject|2|||
42378683|NCT01588184|76250080|FG001|Overall Study|Withdrawal by Subject|4|||
42378684|NCT01588184|76250081|FG002|Overall Study|Withdrawal by Subject|0|||
42378685|NCT01588184|76250082|FG003|Overall Study|Withdrawal by Subject|1|||
42378686|NCT01588184|76250083|FG004|Overall Study|Withdrawal by Subject|0|||
42378687|NCT01588184|76250084|FG005|Overall Study|Withdrawal by Subject|0|||
42201740|NCT03954704|76014343|FG001|Overall Study|Withdrew Consent|0|||
42201741|NCT03954704|76014344|FG002|Overall Study|Withdrew Consent|1|||
42201742|NCT03954704|76014345|FG003|Overall Study|Withdrew Consent|0|||
42201743|NCT03954704|76014346|FG004|Overall Study|Withdrew Consent|0|||
42201744|NCT03954704|76014347|FG005|Overall Study|Withdrew Consent|1|||
42378688|NCT01588184|76250079|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
42378689|NCT01588184|76250080|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
42378690|NCT01588184|76250081|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
42378691|NCT01588184|76250082|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
42378692|NCT01588184|76250083|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
42378693|NCT01588184|76250084|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
42378694|NCT01588184|76250079|FG000|Overall Study|multiple reasons|0|||
42378695|NCT01588184|76250080|FG001|Overall Study|multiple reasons|3|||
42105701|NCT00521404|75916813|FG000|Overall Study|Withdrawal of consent|3|||
42201745|NCT03954704|76014348|FG006|Overall Study|Withdrew Consent|0|||
42378696|NCT01588184|76250081|FG002|Overall Study|multiple reasons|0|||
42378697|NCT01588184|76250082|FG003|Overall Study|multiple reasons|1|||
42378698|NCT01588184|76250083|FG004|Overall Study|multiple reasons|0|||
42378699|NCT01588184|76250084|FG005|Overall Study|multiple reasons|0|||
42378700|NCT01588106|76250100|FG000|Overall Study|Withdrawal by Subject|5|||
42378701|NCT01588106|76250101|FG001|Overall Study|Withdrawal by Subject|4|||
42378702|NCT01564862|76250110|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
42378703|NCT01564862|76250111|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
42378704|NCT01564862|76250112|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
42378705|NCT01564862|76250110|FG000|Overall Study|Major Protocol Deviation|3|||
42378706|NCT01564862|76250111|FG001|Overall Study|Major Protocol Deviation|3|||
42378707|NCT01564862|76250112|FG002|Overall Study|Major Protocol Deviation|4|||
42201746|NCT03954704|76014342|FG000|Overall Study|Lost to Follow-up|0|||
42201747|NCT03954704|76014343|FG001|Overall Study|Lost to Follow-up|0|||
42201748|NCT03954704|76014344|FG002|Overall Study|Lost to Follow-up|0|||
42201749|NCT03954704|76014345|FG003|Overall Study|Lost to Follow-up|0|||
42378708|NCT01564862|76250110|FG000|Overall Study|Lost to Follow-up|10|||
42201750|NCT03954704|76014346|FG004|Overall Study|Lost to Follow-up|0|||
42378709|NCT01564862|76250111|FG001|Overall Study|Lost to Follow-up|8|||
42378710|NCT01564862|76250112|FG002|Overall Study|Lost to Follow-up|6|||
42378711|NCT01564862|76250110|FG000|Overall Study|Voluntary Withdrawal|9|||
42378712|NCT01564862|76250111|FG001|Overall Study|Voluntary Withdrawal|6|||
42378713|NCT01564862|76250112|FG002|Overall Study|Voluntary Withdrawal|8|||
42378714|NCT01564862|76250110|FG000|Overall Study|Lack of Efficacy|1|||
42378715|NCT01564862|76250111|FG001|Overall Study|Lack of Efficacy|5|||
42378716|NCT01564862|76250112|FG002|Overall Study|Lack of Efficacy|6|||
42378717|NCT01564862|76250110|FG000|Overall Study|Other reason(s)|1|||
42378718|NCT01564862|76250111|FG001|Overall Study|Other reason(s)|0|||
42378719|NCT01564862|76250112|FG002|Overall Study|Other reason(s)|0|||
42378720|NCT01691378|76250122|FG000|Overall Study|Withdrawal by Subject|2|||
42378721|NCT01691378|76250123|FG001|Overall Study|Withdrawal by Subject|0|||
42378722|NCT01691378|76250122|FG000|Overall Study|Lost to Follow-up|5|||
42378723|NCT01691378|76250123|FG001|Overall Study|Lost to Follow-up|2|||
42378724|NCT01467479|76250132|FG000|Overall Study|No Study Medication|1|||
42201751|NCT03954704|76014347|FG005|Overall Study|Lost to Follow-up|0|||
42201752|NCT03954704|76014348|FG006|Overall Study|Lost to Follow-up|1|||
42378725|NCT01467479|76250133|FG001|Overall Study|No Study Medication|0|||
42378726|NCT01467479|76250134|FG002|Overall Study|No Study Medication|2|||
42378727|NCT01467479|76250132|FG000|Overall Study|Adverse Event|1|||
42378728|NCT01467479|76250133|FG001|Overall Study|Adverse Event|2|||
42378729|NCT01467479|76250134|FG002|Overall Study|Adverse Event|0|||
42378730|NCT01467479|76250132|FG000|Overall Study|Death|0|||
42105702|NCT00521404|75916813|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
42105703|NCT00521404|75916813|FG000|Overall Study|Other|7|||
42105704|NCT00311155|75916817|FG000|Overall Study|Adverse Event|21|||
42105705|NCT00311155|75916817|FG000|Overall Study|Withdrawal by Subject|17|||
42105706|NCT00311155|75916817|FG000|Overall Study|Did not meet entry criteria|55|||
42105707|NCT00274651|75916823|FG000|Overall Study|Adverse Event|6|||
42105708|NCT00274651|75916824|FG001|Overall Study|Adverse Event|3|||
42105709|NCT00274651|75916823|FG000|Overall Study|Lack of Efficacy|13|||
42105710|NCT00274651|75916824|FG001|Overall Study|Lack of Efficacy|6|||
42105711|NCT00274651|75916823|FG000|Overall Study|Death|1|||
42105712|NCT00274651|75916824|FG001|Overall Study|Death|3|||
42105713|NCT00274651|75916823|FG000|Overall Study|Withdrawal by Subject|0|||
42105714|NCT00274651|75916824|FG001|Overall Study|Withdrawal by Subject|1|||
42105715|NCT00274651|75916823|FG000|Overall Study|Physician Decision|8|||
42105716|NCT00274651|75916824|FG001|Overall Study|Physician Decision|7|||
42105717|NCT00274261|75916833|FG000|Overall Study|Adverse Event|19|||
42105718|NCT00274261|75916834|FG001|Overall Study|Adverse Event|11|||
42105719|NCT00274261|75916833|FG000|Overall Study|Pregnancy|114|||
42105720|NCT00274261|75916834|FG001|Overall Study|Pregnancy|83|||
42105721|NCT00274261|75916833|FG000|Overall Study|Withdrawal by Subject|179|||
42105722|NCT00274261|75916834|FG001|Overall Study|Withdrawal by Subject|126|||
42105723|NCT00274261|75916833|FG000|Overall Study|Protocol Violation|71|||
42105724|NCT00274261|75916834|FG001|Overall Study|Protocol Violation|42|||
42105725|NCT00274261|75916833|FG000|Overall Study|Lost to Follow-up|106|||
42105726|NCT00274261|75916834|FG001|Overall Study|Lost to Follow-up|75|||
42105727|NCT00624468|75916844|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
42105728|NCT00624468|75916845|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
42105729|NCT00624468|75916846|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
42105730|NCT00624468|75916847|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
42105731|NCT00624468|75916844|FG000|Double-blind Period|Withdrew Prematurely|1|||
42105732|NCT00624468|75916845|FG001|Double-blind Period|Withdrew Prematurely|1|||
42105733|NCT00624468|75916846|FG002|Double-blind Period|Withdrew Prematurely|0|||
42105734|NCT00624468|75916847|FG003|Double-blind Period|Withdrew Prematurely|0|||
42105735|NCT00624468|75916844|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
42105736|NCT00624468|75916845|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
42105737|NCT00624468|75916846|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
42105738|NCT00624468|75916847|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
42105739|NCT00624468|75916844|FG000|Safety Follow-up (SFU) Period|Other|0|||
42105740|NCT00624468|75916845|FG001|Safety Follow-up (SFU) Period|Other|0|||
42105741|NCT00624468|75916846|FG002|Safety Follow-up (SFU) Period|Other|1|||
42105742|NCT00624468|75916847|FG003|Safety Follow-up (SFU) Period|Other|1|||
42105743|NCT00521014|75916855|FG000|Overall Study|Inevaluable, not treated|1|||
42105744|NCT00560235|75916862|FG000|Phase 1|Discontinued|8|||
42105745|NCT00560235|75916863|FG001|Phase 1|Discontinued|0|||
42105746|NCT00560235|75916864|FG002|Phase 1|Discontinued|0|||
42105747|NCT00560235|75916862|FG000|Phase 1B|Discontinued|0|||
42105748|NCT00560235|75916863|FG001|Phase 1B|Discontinued|19|||
42105749|NCT00560235|75916864|FG002|Phase 1B|Discontinued|0|||
42105750|NCT00560235|75916862|FG000|Phase 2|Discontinued|0|||
42105751|NCT00560235|75916863|FG001|Phase 2|Discontinued|0|||
42105752|NCT00560235|75916864|FG002|Phase 2|Discontinued|96|||
42105753|NCT00560235|75916862|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
42105754|NCT00560235|75916863|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
42105755|NCT00560235|75916864|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
42105756|NCT00291577|75916882|FG000|Overall Study|Adverse Event|1|||
42105757|NCT00291577|75916882|FG000|Overall Study|Other|4|||
42105758|NCT00291577|75916882|FG000|Overall Study|Withdrawal by Subject|2|||
42105759|NCT00291577|75916882|FG000|Overall Study|Lack of Efficacy|14|||
42105760|NCT00520936|75916894|FG000|Overall Study|Physician Decision|0|||
42105761|NCT00520936|75916895|FG001|Overall Study|Physician Decision|2|||
42105762|NCT00520936|75916896|FG002|Overall Study|Physician Decision|1|||
42105763|NCT00520936|75916897|FG003|Overall Study|Physician Decision|0|||
42105764|NCT00520936|75916898|FG004|Overall Study|Physician Decision|0|||
42105765|NCT00520936|75916899|FG005|Overall Study|Physician Decision|0|||
42105766|NCT00520936|75916900|FG006|Overall Study|Physician Decision|0|||
42105767|NCT00520936|75916901|FG007|Overall Study|Physician Decision|0|||
42105768|NCT00520936|75916894|FG000|Overall Study|Withdrawal by Subject|0|||
42105769|NCT00520936|75916895|FG001|Overall Study|Withdrawal by Subject|0|||
42105770|NCT00520936|75916896|FG002|Overall Study|Withdrawal by Subject|0|||
42105771|NCT00520936|75916897|FG003|Overall Study|Withdrawal by Subject|0|||
42105772|NCT00520936|75916898|FG004|Overall Study|Withdrawal by Subject|0|||
42105773|NCT00520936|75916899|FG005|Overall Study|Withdrawal by Subject|0|||
42105774|NCT00520936|75916900|FG006|Overall Study|Withdrawal by Subject|0|||
42105775|NCT00520936|75916901|FG007|Overall Study|Withdrawal by Subject|1|||
42105776|NCT00520936|75916894|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
42105777|NCT00520936|75916895|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
42105778|NCT00520936|75916896|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
42105779|NCT00520936|75916897|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
42105780|NCT00520936|75916898|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
42105781|NCT00520936|75916899|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
42105782|NCT00520936|75916900|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
42105783|NCT00520936|75916901|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
42105784|NCT00520936|75916894|FG000|Overall Study|Death|0|||
42105785|NCT00520936|75916895|FG001|Overall Study|Death|0|||
42105786|NCT00520936|75916896|FG002|Overall Study|Death|0|||
42105787|NCT00520936|75916897|FG003|Overall Study|Death|0|||
42105788|NCT00520936|75916898|FG004|Overall Study|Death|0|||
42105789|NCT00520936|75916899|FG005|Overall Study|Death|0|||
42105790|NCT00520936|75916900|FG006|Overall Study|Death|1|||
42105791|NCT00520936|75916901|FG007|Overall Study|Death|0|||
42105792|NCT00520936|75916894|FG000|Overall Study|Protocol Violation|0|||
42105793|NCT00520936|75916895|FG001|Overall Study|Protocol Violation|1|||
42105794|NCT00520936|75916896|FG002|Overall Study|Protocol Violation|1|||
42105795|NCT00520936|75916897|FG003|Overall Study|Protocol Violation|0|||
42105796|NCT00520936|75916898|FG004|Overall Study|Protocol Violation|1|||
42105797|NCT00520936|75916899|FG005|Overall Study|Protocol Violation|0|||
42105798|NCT00520936|75916900|FG006|Overall Study|Protocol Violation|1|||
42105799|NCT00520936|75916901|FG007|Overall Study|Protocol Violation|0|||
42105800|NCT03867760|75916914|FG000|Overall Study|Lost to Follow-up|2|||
42105801|NCT03867760|75916915|FG001|Overall Study|Lost to Follow-up|3|||
42105802|NCT03867760|75916914|FG000|Overall Study|Withdrawal by Subject|1|||
42105803|NCT03867760|75916915|FG001|Overall Study|Withdrawal by Subject|2|||
42105804|NCT03867760|75916914|FG000|Overall Study|subject could not meet study logistics|3|||
42105805|NCT03867760|75916915|FG001|Overall Study|subject could not meet study logistics|3|||
42105806|NCT03865732|75916925|FG000|Overall Study|Adverse Event|0|||
42105807|NCT03865732|75916926|FG001|Overall Study|Adverse Event|1|||
42105808|NCT00520546|75916933|FG000|Overall Study|Withdrawal by Subject|1|||
42105809|NCT00520546|75916933|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
42105810|NCT00555009|75916944|FG000|Overall Study|Withdrawal by Subject|0|||
42105811|NCT00555009|75916945|FG001|Overall Study|Withdrawal by Subject|1|||
42105812|NCT00555009|75916944|FG000|Overall Study|Terminated by Sponsor|2|||
42105813|NCT00555009|75916945|FG001|Overall Study|Terminated by Sponsor|5|||
42105814|NCT00623766|75916953|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
42105815|NCT00623766|75916954|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
42105816|NCT00623766|75916953|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
42105817|NCT00623766|75916954|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
42105818|NCT00623766|75916953|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
42105819|NCT00623766|75916954|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
42105820|NCT00623766|75916953|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
42105821|NCT00623766|75916954|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
42201753|NCT03954704|76014342|FG000|Overall Study|Study Terminated by Sponsor|0|||
42201754|NCT03954704|76014343|FG001|Overall Study|Study Terminated by Sponsor|0|||
42378731|NCT01467479|76250133|FG001|Overall Study|Death|0|||
42378732|NCT01467479|76250134|FG002|Overall Study|Death|1|||
42105822|NCT00623766|75916953|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
42105823|NCT00623766|75916954|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
42105824|NCT00550407|75916966|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
42105825|NCT00550407|75916967|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
42105826|NCT00550407|75916968|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
42105827|NCT00550407|75916966|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
42201755|NCT03954704|76014344|FG002|Overall Study|Study Terminated by Sponsor|1|||
42201756|NCT03954704|76014345|FG003|Overall Study|Study Terminated by Sponsor|0|||
42201757|NCT03954704|76014346|FG004|Overall Study|Study Terminated by Sponsor|1|||
42201758|NCT03954704|76014347|FG005|Overall Study|Study Terminated by Sponsor|4|||
42201759|NCT03954704|76014348|FG006|Overall Study|Study Terminated by Sponsor|2|||
42201760|NCT03954704|76014342|FG000|Overall Study|Enrolled but not Treated|0|||
42201761|NCT03954704|76014343|FG001|Overall Study|Enrolled but not Treated|0|||
42105828|NCT00550407|75916967|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
42201762|NCT03954704|76014344|FG002|Overall Study|Enrolled but not Treated|0|||
42201763|NCT03954704|76014345|FG003|Overall Study|Enrolled but not Treated|0|||
42201764|NCT03954704|76014346|FG004|Overall Study|Enrolled but not Treated|0|||
42378733|NCT01467479|76250132|FG000|Overall Study|Lost to Follow-up|2|||
42378734|NCT01467479|76250133|FG001|Overall Study|Lost to Follow-up|5|||
42378735|NCT01467479|76250134|FG002|Overall Study|Lost to Follow-up|3|||
42378736|NCT01467479|76250132|FG000|Overall Study|Withdrawal of Consent|3|||
42378737|NCT01467479|76250133|FG001|Overall Study|Withdrawal of Consent|7|||
42378738|NCT01467479|76250134|FG002|Overall Study|Withdrawal of Consent|7|||
42378739|NCT01467479|76250132|FG000|Overall Study|Study Terminated by Sponsor|1|||
42378740|NCT01467479|76250133|FG001|Overall Study|Study Terminated by Sponsor|3|||
42378741|NCT01467479|76250134|FG002|Overall Study|Study Terminated by Sponsor|3|||
42378742|NCT01467479|76250132|FG000|Overall Study|Other|1|||
42378743|NCT01467479|76250133|FG001|Overall Study|Other|0|||
42378744|NCT01467479|76250134|FG002|Overall Study|Other|0|||
42105829|NCT00550407|75916968|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
42105830|NCT00550407|75916966|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
42378745|NCT01466387|76250149|FG000|Overall Study|Adverse Event|0|||
42378746|NCT01466387|76250150|FG001|Overall Study|Adverse Event|0|||
42378747|NCT01466387|76250151|FG002|Overall Study|Adverse Event|1|||
42378748|NCT01466387|76250152|FG003|Overall Study|Adverse Event|1|||
42378749|NCT01466387|76250153|FG004|Overall Study|Adverse Event|0|||
42378750|NCT01466387|76250154|FG005|Overall Study|Adverse Event|0|||
42378751|NCT01466387|76250149|FG000|Overall Study|Lost to Follow-up|0|||
42378752|NCT01466387|76250150|FG001|Overall Study|Lost to Follow-up|0|||
42378753|NCT01466387|76250151|FG002|Overall Study|Lost to Follow-up|0|||
42378754|NCT01466387|76250152|FG003|Overall Study|Lost to Follow-up|0|||
42378755|NCT01466387|76250153|FG004|Overall Study|Lost to Follow-up|0|||
42378756|NCT01466387|76250154|FG005|Overall Study|Lost to Follow-up|1|||
42378757|NCT01466387|76250149|FG000|Overall Study|Protocol Violation|1|||
42378758|NCT01466387|76250150|FG001|Overall Study|Protocol Violation|0|||
42378759|NCT01466387|76250151|FG002|Overall Study|Protocol Violation|0|||
42378760|NCT01466387|76250152|FG003|Overall Study|Protocol Violation|1|||
42378761|NCT01466387|76250153|FG004|Overall Study|Protocol Violation|0|||
42378762|NCT01466387|76250154|FG005|Overall Study|Protocol Violation|0|||
42378763|NCT01564784|76250285|FG000|Overall Study|Other|1|||
42378764|NCT01564784|76250286|FG001|Overall Study|Other|0|||
42378765|NCT01564784|76250285|FG000|Overall Study|Subject refused further follow-up|1|||
42378766|NCT01564784|76250286|FG001|Overall Study|Subject refused further follow-up|6|||
42378767|NCT01564784|76250285|FG000|Overall Study|Lost to Follow-up|1|||
42378768|NCT01564784|76250286|FG001|Overall Study|Lost to Follow-up|1|||
42378769|NCT01564784|76250285|FG000|Overall Study|Death|131|||
42378770|NCT01564784|76250286|FG001|Overall Study|Death|126|||
42378771|NCT01564394|76250337|FG000|Overall Study|Withdrawal by Subject|6|||
42378772|NCT01564394|76250338|FG001|Overall Study|Withdrawal by Subject|10|||
42378773|NCT01690988|76250352|FG000|Overall Study|Withdrawal by Subject|2|||
42378774|NCT01690988|76250353|FG001|Overall Study|Withdrawal by Subject|2|||
42378775|NCT01690988|76250354|FG002|Overall Study|Withdrawal by Subject|3|||
42378776|NCT01690988|76250352|FG000|Overall Study|Physician Decision|0|||
42378777|NCT01690988|76250353|FG001|Overall Study|Physician Decision|0|||
42378778|NCT01690988|76250354|FG002|Overall Study|Physician Decision|1|||
42378779|NCT01690988|76250352|FG000|Overall Study|Operation Cancelled|1|||
42378780|NCT01690988|76250353|FG001|Overall Study|Operation Cancelled|1|||
42378781|NCT01690988|76250354|FG002|Overall Study|Operation Cancelled|0|||
42378782|NCT01690988|76250352|FG000|Overall Study|Determined ineligible|1|||
42378783|NCT01690988|76250353|FG001|Overall Study|Determined ineligible|0|||
42378784|NCT01690988|76250354|FG002|Overall Study|Determined ineligible|0|||
42378785|NCT01690988|76250352|FG000|Overall Study|Death|1|||
42378786|NCT01690988|76250353|FG001|Overall Study|Death|1|||
42378787|NCT01690988|76250354|FG002|Overall Study|Death|1|||
42378788|NCT01690988|76250352|FG000|Overall Study|Sedated|1|||
42378789|NCT01690988|76250353|FG001|Overall Study|Sedated|1|||
42378790|NCT01690988|76250354|FG002|Overall Study|Sedated|2|||
42378791|NCT01466153|76250385|FG000|Overall Study|Disease Progression|2|||
42378792|NCT01466153|76250386|FG001|Overall Study|Disease Progression|2|||
42378793|NCT01466153|76250387|FG002|Overall Study|Disease Progression|0|||
42378794|NCT01466153|76250385|FG000|Overall Study|Adverse Event|14|||
42378795|NCT01466153|76250386|FG001|Overall Study|Adverse Event|13|||
42378796|NCT01466153|76250387|FG002|Overall Study|Adverse Event|17|||
42378797|NCT01466153|76250385|FG000|Overall Study|Withdrawal of Consent|2|||
42378798|NCT01466153|76250386|FG001|Overall Study|Withdrawal of Consent|0|||
42378799|NCT01466153|76250387|FG002|Overall Study|Withdrawal of Consent|0|||
42378800|NCT01466153|76250385|FG000|Overall Study|Investigator Discretion|3|||
42378801|NCT01466153|76250386|FG001|Overall Study|Investigator Discretion|2|||
42378802|NCT01466153|76250387|FG002|Overall Study|Investigator Discretion|2|||
42378803|NCT01466153|76250385|FG000|Overall Study|Randomized-Not Treated|2|||
42105831|NCT00550407|75916967|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
42378804|NCT01466153|76250386|FG001|Overall Study|Randomized-Not Treated|3|||
42378805|NCT01466153|76250387|FG002|Overall Study|Randomized-Not Treated|4|||
42201765|NCT03954704|76014347|FG005|Overall Study|Enrolled but not Treated|1|||
42378806|NCT01466153|76250385|FG000|Overall Study|Other-Unspecified|6|||
42378807|NCT01466153|76250386|FG001|Overall Study|Other-Unspecified|4|||
42378808|NCT01466153|76250387|FG002|Overall Study|Other-Unspecified|2|||
42378809|NCT01474291|76250408|FG000|Overall Study|Not Evaluable for Efficacy|26|||
42378810|NCT01474291|76250408|FG000|Overall Study|Lack of Treatment Efficacy|88|||
42378811|NCT01474291|76250408|FG000|Overall Study|Adverse Event|53|||
42378812|NCT01474291|76250408|FG000|Overall Study|Lost to Follow-up|29|||
42378813|NCT01474291|76250408|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
42378814|NCT01474291|76250408|FG000|Overall Study|No Reason Reported|10|||
42378815|NCT01474291|76250408|FG000|Overall Study|Death|2|||
42378816|NCT01465997|76250417|FG000|Overall Study|Adverse Event|12|||
42378817|NCT01465997|76250418|FG001|Overall Study|Adverse Event|22|||
42378818|NCT01465997|76250417|FG000|Overall Study|Lack of Efficacy|13|||
42378819|NCT01465997|76250418|FG001|Overall Study|Lack of Efficacy|1|||
42378820|NCT01465997|76250417|FG000|Overall Study|Protocol Violation|1|||
42018766|NCT01255787|75826153|FG002|Overall Study|Withdrawal of Consent|3|||
42018767|NCT01255787|75826154|FG003|Overall Study|Withdrawal of Consent|4|||
42018768|NCT01255787|75826151|FG000|Overall Study|Pregnancy|0|||
42018769|NCT01255787|75826152|FG001|Overall Study|Pregnancy|0|||
42018770|NCT01255787|75826153|FG002|Overall Study|Pregnancy|0|||
42018771|NCT01255787|75826154|FG003|Overall Study|Pregnancy|1|||
42018772|NCT01255787|75826151|FG000|Overall Study|Lack of Efficacy|2|||
42378821|NCT01465997|76250418|FG001|Overall Study|Protocol Violation|4|||
42378822|NCT01465997|76250417|FG000|Overall Study|Lost to Follow-up|6|||
42018773|NCT01255787|75826152|FG001|Overall Study|Lack of Efficacy|2|||
42018774|NCT01255787|75826153|FG002|Overall Study|Lack of Efficacy|2|||
42018775|NCT01255787|75826154|FG003|Overall Study|Lack of Efficacy|2|||
42018776|NCT01255787|75826151|FG000|Overall Study|Noncompliance with Study Drug|3|||
42018777|NCT01255787|75826152|FG001|Overall Study|Noncompliance with Study Drug|1|||
42018778|NCT01255787|75826153|FG002|Overall Study|Noncompliance with Study Drug|0|||
42018779|NCT01255787|75826154|FG003|Overall Study|Noncompliance with Study Drug|0|||
42105832|NCT00550407|75916968|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
42105833|NCT00550407|75916966|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
42105834|NCT00550407|75916967|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
42105835|NCT00550407|75916968|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
42105836|NCT00550407|75916966|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
42105837|NCT00550407|75916967|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
42105838|NCT00550407|75916968|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
42105839|NCT00550407|75916966|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
42105840|NCT00550407|75916967|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
42105841|NCT00550407|75916968|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
42105842|NCT00550407|75916966|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
42105843|NCT00550407|75916967|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
42105844|NCT00550407|75916968|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
42105845|NCT00550407|75916966|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
42105846|NCT00550407|75916967|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
42105847|NCT00550407|75916968|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
42105848|NCT00550407|75916966|FG000|26-Week Randomized Phase|Adverse Event|0|||
42105849|NCT00550407|75916967|FG001|26-Week Randomized Phase|Adverse Event|5|||
42105850|NCT00550407|75916968|FG002|26-Week Randomized Phase|Adverse Event|2|||
42105851|NCT00550407|75916966|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
42378823|NCT01465997|76250418|FG001|Overall Study|Lost to Follow-up|9|||
42018780|NCT01123161|75826166|FG000|Overall Study|Lost to Follow-up|1|||
42018781|NCT01123161|75826167|FG001|Overall Study|Lost to Follow-up|0|||
42018782|NCT01123161|75826166|FG000|Overall Study|Withdrawal by Subject|1|||
42018783|NCT01123161|75826167|FG001|Overall Study|Withdrawal by Subject|0|||
42105852|NCT00550407|75916967|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
42105853|NCT00550407|75916968|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
42105854|NCT00550407|75916966|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
42105855|NCT00550407|75916967|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
42105856|NCT00550407|75916968|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
42105857|NCT00550407|75916966|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
42105858|NCT00550407|75916967|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
42105859|NCT00550407|75916968|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
42105860|NCT00531934|75916978|FG000|Overall Study|Adverse Event|4|||
42105861|NCT00531934|75916979|FG001|Overall Study|Adverse Event|8|||
42105862|NCT00531934|75916978|FG000|Overall Study|Progression|52|||
42105863|NCT00531934|75916979|FG001|Overall Study|Progression|42|||
42105864|NCT00531934|75916978|FG000|Overall Study|Death|7|||
42105865|NCT00531934|75916979|FG001|Overall Study|Death|10|||
42105866|NCT00531934|75916978|FG000|Overall Study|Withdrawal by Subject|1|||
42105867|NCT00531934|75916979|FG001|Overall Study|Withdrawal by Subject|1|||
42105868|NCT00531934|75916978|FG000|Overall Study|Other|2|||
42105869|NCT00531934|75916979|FG001|Overall Study|Other|2|||
42105870|NCT00549939|75916988|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
42105871|NCT00549939|75916989|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
42105872|NCT00549939|75916990|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
42105873|NCT00549939|75916988|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
42105874|NCT00549939|75916989|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
42105875|NCT00549939|75916990|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
42105876|NCT00549939|75916988|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
42105877|NCT00549939|75916989|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
42105878|NCT00549939|75916990|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
42105879|NCT00549939|75916988|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
42105880|NCT00549939|75916989|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
42105881|NCT00549939|75916990|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
42105882|NCT00549939|75916988|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
42105883|NCT00549939|75916989|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
42105884|NCT00549939|75916990|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
42105885|NCT00549939|75916988|FG000|40-week Open Label Treatment Period|Other|0|||
42105886|NCT00549939|75916989|FG001|40-week Open Label Treatment Period|Other|1|||
42105887|NCT00549939|75916990|FG002|40-week Open Label Treatment Period|Other|4|||
42105888|NCT00272779|75917002|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
42105889|NCT00272779|75917003|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
42105890|NCT00272779|75917002|FG000|Baseline Through Week 48|Death before Week 48|4|||
42105891|NCT00272779|75917003|FG001|Baseline Through Week 48|Death before Week 48|4|||
42105892|NCT00272779|75917002|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
42105893|NCT00272779|75917003|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
42105894|NCT00272779|75917002|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
42105895|NCT00272779|75917003|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
42105896|NCT00272779|75917002|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
42105897|NCT00272779|75917003|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
42105898|NCT00272779|75917002|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
42018784|NCT01255631|75826178|FG000|Overall Study|poor enrollment, no data analyzed|9|||
42018785|NCT01255631|75826179|FG001|Overall Study|poor enrollment, no data analyzed|6|||
42018786|NCT00999466|75826188|FG000|Main Part|Withdrawal by Subject|0|||
42018787|NCT00999466|75826189|FG001|Main Part|Withdrawal by Subject|0|||
42018788|NCT00999466|75826190|FG002|Main Part|Withdrawal by Subject|2|||
42018789|NCT00999466|75826188|FG000|Main Part|Adverse Event|0|||
42018790|NCT00999466|75826189|FG001|Main Part|Adverse Event|4|||
42018791|NCT00999466|75826190|FG002|Main Part|Adverse Event|2|||
42018792|NCT01255163|75826200|FG000|Overall Study|Withdrawal by Subject|1|||
42018793|NCT01255163|75826201|FG001|Overall Study|Withdrawal by Subject|0|||
42018794|NCT01255163|75826200|FG000|Overall Study|Lost to Follow-up|2|||
42018795|NCT01255163|75826201|FG001|Overall Study|Lost to Follow-up|0|||
42018796|NCT01255163|75826200|FG000|Overall Study|Adverse Event|0|||
42018797|NCT01255163|75826201|FG001|Overall Study|Adverse Event|2|||
42018798|NCT01255163|75826200|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
42018799|NCT01255163|75826201|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
42018800|NCT01123083|75826211|FG000|Overall Study|Investigator recommendation|1|||
42018801|NCT01123083|75826212|FG001|Overall Study|Investigator recommendation|1|||
42018802|NCT01123083|75826211|FG000|Overall Study|Administrative reasons|0|||
42018803|NCT01123083|75826212|FG001|Overall Study|Administrative reasons|4|||
42105899|NCT00272779|75917003|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
42105900|NCT00272779|75917002|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
42105901|NCT00272779|75917003|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
42105902|NCT00272779|75917002|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
42105903|NCT00272779|75917003|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
42105904|NCT00272779|75917002|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
42105905|NCT00272779|75917003|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
42105906|NCT00272779|75917002|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
42105907|NCT00272779|75917003|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
42105908|NCT00272779|75917002|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
42105909|NCT00272779|75917003|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
42105910|NCT00272779|75917002|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
42105911|NCT00272779|75917003|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
42105912|NCT00272779|75917002|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
42105913|NCT00272779|75917003|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
42105914|NCT00272779|75917002|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
42105915|NCT00272779|75917003|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
42105916|NCT00272779|75917002|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
42105917|NCT00272779|75917003|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
42105918|NCT00272779|75917002|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
42105919|NCT00272779|75917003|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
42105920|NCT00272779|75917002|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
42105921|NCT00272779|75917003|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
42105922|NCT00272779|75917002|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
42105923|NCT00272779|75917003|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
42105924|NCT00272779|75917002|FG000|Baseline Through Week 48|Continuing treatment|385|||
42105925|NCT00272779|75917003|FG001|Baseline Through Week 48|Continuing treatment|368|||
42105926|NCT00272779|75917002|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
42105927|NCT00272779|75917003|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
42105928|NCT00272779|75917002|FG000|Baseline Through Week 48|Never treated|2|||
42105929|NCT00272779|75917003|FG001|Baseline Through Week 48|Never treated|3|||
42105930|NCT00272779|75917002|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
42105931|NCT00272779|75917003|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
42105932|NCT00272779|75917002|FG000|Baseline Through Week 96|Death before Week 96|6|||
42105933|NCT00272779|75917003|FG001|Baseline Through Week 96|Death before Week 96|5|||
42105934|NCT00272779|75917002|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
42105935|NCT00272779|75917003|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
42105936|NCT00272779|75917002|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
42105937|NCT00272779|75917003|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
42105938|NCT00272779|75917002|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
42105939|NCT00272779|75917003|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
42105940|NCT00272779|75917002|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
42105941|NCT00272779|75917003|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
42105942|NCT00272779|75917002|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
42105943|NCT00272779|75917003|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
42105944|NCT00272779|75917002|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
42105945|NCT00272779|75917003|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
42105946|NCT00272779|75917002|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
42105947|NCT00272779|75917003|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
42105948|NCT00272779|75917002|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
42105949|NCT00272779|75917003|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
42105950|NCT00272779|75917002|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
42105951|NCT00272779|75917003|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
42105952|NCT00272779|75917002|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
42105953|NCT00272779|75917003|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
42105954|NCT00272779|75917002|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
42105955|NCT00272779|75917003|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
42105956|NCT00272779|75917002|FG000|Baseline Through Week 96|Never treated|2|||
42105957|NCT00272779|75917003|FG001|Baseline Through Week 96|Never treated|3|||
42105958|NCT00272779|75917002|FG000|Baseline Through Week 96|Continuing on treatment|61|||
42105959|NCT00272779|75917003|FG001|Baseline Through Week 96|Continuing on treatment|38|||
42105960|NCT00511810|75917012|FG000|Overall Study|Lost to Follow-up|1|||
42105961|NCT00511810|75917013|FG001|Overall Study|Lost to Follow-up|2|||
42105962|NCT00511810|75917012|FG000|Overall Study|Lack of Efficacy|0|||
42105963|NCT00511810|75917013|FG001|Overall Study|Lack of Efficacy|2|||
42105964|NCT00511810|75917012|FG000|Overall Study|Refused second scn|0|||
42105965|NCT00511810|75917013|FG001|Overall Study|Refused second scn|1|||
42105966|NCT00291499|75917021|FG000|Overall Study|Adverse Event|3|||
42105967|NCT00291499|75917022|FG001|Overall Study|Adverse Event|8|||
42105968|NCT00291499|75917021|FG000|Overall Study|Change to other therapy|2|||
42105969|NCT00291499|75917022|FG001|Overall Study|Change to other therapy|1|||
42105970|NCT00291499|75917021|FG000|Overall Study|Intercurrent illness|1|||
42105971|NCT00291499|75917022|FG001|Overall Study|Intercurrent illness|0|||
42105972|NCT00291499|75917021|FG000|Overall Study|Protocol Violation|2|||
42105973|NCT00291499|75917022|FG001|Overall Study|Protocol Violation|2|||
42105974|NCT00291499|75917021|FG000|Overall Study|Other reasons|1|||
42105975|NCT00291499|75917022|FG001|Overall Study|Other reasons|4|||
42105976|NCT00553605|75917030|FG000|Overall Study|Did not meet entrance criteria|1|||
42105977|NCT00553605|75917031|FG001|Overall Study|Did not meet entrance criteria|3|||
42105978|NCT00553605|75917030|FG000|Overall Study|Did not receive full dose|1|||
42105979|NCT00553605|75917031|FG001|Overall Study|Did not receive full dose|0|||
42105980|NCT00553605|75917030|FG000|Overall Study|Randomized but not treated|2|||
42105981|NCT00553605|75917031|FG001|Overall Study|Randomized but not treated|0|||
42105982|NCT00621582|75917037|FG000|Overall Study|Adverse Event|7|||
42105983|NCT00621582|75917037|FG000|Overall Study|Protocol Violation|57|||
42105984|NCT00621582|75917037|FG000|Overall Study|Lost to Follow-up|24|||
42105985|NCT00621582|75917037|FG000|Overall Study|issues not identified by investigators|18|||
42105986|NCT00744497|75917043|FG000|Overall Study|Withdrawal by Subject|21|||
42105987|NCT00744497|75917044|FG001|Overall Study|Withdrawal by Subject|18|||
42105988|NCT00744497|75917043|FG000|Overall Study|Death|11|||
42105989|NCT00744497|75917044|FG001|Overall Study|Death|9|||
42105990|NCT00744497|75917043|FG000|Overall Study|Lost to Follow-up|4|||
42105991|NCT00744497|75917044|FG001|Overall Study|Lost to Follow-up|2|||
42105992|NCT00744497|75917043|FG000|Overall Study|Poor compliance/noncompliance|9|||
42105993|NCT00744497|75917044|FG001|Overall Study|Poor compliance/noncompliance|5|||
42105994|NCT00744497|75917043|FG000|Overall Study|No longer meets study criteria|7|||
42105995|NCT00744497|75917044|FG001|Overall Study|No longer meets study criteria|3|||
42105996|NCT00744497|75917043|FG000|Overall Study|Administrative Reason By Sponsor|25|||
42105997|NCT00744497|75917044|FG001|Overall Study|Administrative Reason By Sponsor|8|||
42105998|NCT00744497|75917043|FG000|Overall Study|Disease progression|312|||
42105999|NCT00744497|75917044|FG001|Overall Study|Disease progression|219|||
42106000|NCT00744497|75917043|FG000|Overall Study|Study drug toxicity|68|||
42106001|NCT00744497|75917044|FG001|Overall Study|Study drug toxicity|141|||
42106002|NCT00744497|75917043|FG000|Overall Study|Adverse event unrelated to study drug|78|||
42106003|NCT00744497|75917044|FG001|Overall Study|Adverse event unrelated to study drug|122|||
42106004|NCT00744497|75917043|FG000|Overall Study|Patient requested to stop study drug|65|||
42106005|NCT00744497|75917044|FG001|Overall Study|Patient requested to stop study drug|80|||
42106006|NCT00744497|75917043|FG000|Overall Study|Maximum clinical benefit|141|||
42106007|NCT00744497|75917044|FG001|Overall Study|Maximum clinical benefit|142|||
42106008|NCT00744497|75917043|FG000|Overall Study|Not defined|19|||
42106009|NCT00744497|75917044|FG001|Overall Study|Not defined|13|||
42106010|NCT00747227|75917052|FG000|Overall Study|Death|3|||
42106011|NCT00747227|75917053|FG001|Overall Study|Death|1|||
42106012|NCT00747227|75917052|FG000|Overall Study|Withdrawal by Subject|1|||
42106013|NCT00747227|75917053|FG001|Overall Study|Withdrawal by Subject|0|||
42106014|NCT00747227|75917052|FG000|Overall Study|Lost to Follow-up|1|||
42106015|NCT00747227|75917053|FG001|Overall Study|Lost to Follow-up|2|||
42106016|NCT00747227|75917052|FG000|Overall Study|Illness|1|||
42106017|NCT00747227|75917053|FG001|Overall Study|Illness|1|||
42106018|NCT00747149|75917061|FG000|Overall Study|Adverse Event|0|||
42106019|NCT00747149|75917062|FG001|Overall Study|Adverse Event|15|||
42106020|NCT00747149|75917061|FG000|Overall Study|Lost to Follow-up|0|||
42106021|NCT00747149|75917062|FG001|Overall Study|Lost to Follow-up|10|||
42106022|NCT00747149|75917061|FG000|Overall Study|Withdrawal by Subject|0|||
42106023|NCT00747149|75917062|FG001|Overall Study|Withdrawal by Subject|6|||
42106024|NCT00747149|75917061|FG000|Overall Study|Did not receive treatment|0|||
42106025|NCT00747149|75917062|FG001|Overall Study|Did not receive treatment|1|||
42106026|NCT00747149|75917061|FG000|Overall Study|Incorrect enrollment|0|||
42106027|NCT00747149|75917062|FG001|Overall Study|Incorrect enrollment|6|||
42106028|NCT00747149|75917061|FG000|Overall Study|Severe non-compliance to protocol|0|||
42106029|NCT00747149|75917062|FG001|Overall Study|Severe non-compliance to protocol|1|||
42106030|NCT00747149|75917061|FG000|Overall Study|Not reported|1|||
42106031|NCT00747149|75917062|FG001|Overall Study|Not reported|4|||
42106032|NCT00271609|75917076|FG000|Overall Study|Adverse Event|11|||
42106033|NCT00271609|75917077|FG001|Overall Study|Adverse Event|3|||
42106034|NCT00271609|75917076|FG000|Overall Study|Withdrawal by Subject|2|||
42106035|NCT00271609|75917077|FG001|Overall Study|Withdrawal by Subject|0|||
42106036|NCT00548847|75917083|FG000|Overall Study|Disease progression|7|||
42106037|NCT00290407|75917087|FG000|Overall Study|Physician Decision|2|||
42106038|NCT00749411|75917093|FG000|Overall Study|Adverse Event|0|||
42106039|NCT00749411|75917094|FG001|Overall Study|Adverse Event|2|||
42106040|NCT00749411|75917093|FG000|Overall Study|Lack of Efficacy|0|||
42106041|NCT00749411|75917094|FG001|Overall Study|Lack of Efficacy|1|||
42106042|NCT00749411|75917093|FG000|Overall Study|Protocol Violation|1|||
42106043|NCT00749411|75917094|FG001|Overall Study|Protocol Violation|1|||
42106044|NCT00749411|75917093|FG000|Overall Study|Protocol-defined stopping criteria|0|||
42106045|NCT00749411|75917094|FG001|Overall Study|Protocol-defined stopping criteria|1|||
42106046|NCT03958149|75917102|FG000|Overall Study|Withdrawal by Subject|0|||
42106047|NCT03958149|75917103|FG001|Overall Study|Withdrawal by Subject|1|||
42106048|NCT00549549|75917117|FG000|Overall Study|Adverse Event|5|||
42106049|NCT00549549|75917118|FG001|Overall Study|Adverse Event|3|||
42106050|NCT00549549|75917119|FG002|Overall Study|Adverse Event|1|||
42106051|NCT00549549|75917120|FG003|Overall Study|Adverse Event|9|||
42106052|NCT00549549|75917117|FG000|Overall Study|Lack of Efficacy|9|||
42106053|NCT00549549|75917118|FG001|Overall Study|Lack of Efficacy|6|||
42106054|NCT00549549|75917119|FG002|Overall Study|Lack of Efficacy|4|||
42106055|NCT00549549|75917120|FG003|Overall Study|Lack of Efficacy|2|||
42106056|NCT00549549|75917117|FG000|Overall Study|Lost to Follow-up|1|||
42106057|NCT00549549|75917118|FG001|Overall Study|Lost to Follow-up|0|||
42106058|NCT00549549|75917119|FG002|Overall Study|Lost to Follow-up|1|||
42106059|NCT00549549|75917120|FG003|Overall Study|Lost to Follow-up|2|||
42106060|NCT00549549|75917117|FG000|Overall Study|Withdrawal by Subject|0|||
42106061|NCT00549549|75917118|FG001|Overall Study|Withdrawal by Subject|4|||
42106062|NCT00549549|75917119|FG002|Overall Study|Withdrawal by Subject|1|||
42106063|NCT00549549|75917120|FG003|Overall Study|Withdrawal by Subject|0|||
42106064|NCT00549549|75917117|FG000|Overall Study|Other|9|||
42106065|NCT00549549|75917118|FG001|Overall Study|Other|9|||
42106066|NCT00549549|75917119|FG002|Overall Study|Other|9|||
42106067|NCT00549549|75917120|FG003|Overall Study|Other|11|||
42106068|NCT00549549|75917117|FG000|Overall Study|Randomized but not treated|0|||
42106069|NCT00549549|75917118|FG001|Overall Study|Randomized but not treated|0|||
42106070|NCT00549549|75917119|FG002|Overall Study|Randomized but not treated|1|||
42106071|NCT00549549|75917120|FG003|Overall Study|Randomized but not treated|1|||
42106072|NCT00270205|75917134|FG000|Overall Study|Lost to Follow-up|1|||
42106073|NCT00270205|75917135|FG001|Overall Study|Lost to Follow-up|0|||
42106074|NCT00270205|75917136|FG002|Overall Study|Lost to Follow-up|0|||
42106075|NCT00270205|75917137|FG003|Overall Study|Lost to Follow-up|1|||
42106076|NCT00622284|75917149|FG000|Overall Study|Lack of Efficacy|45|||
42106077|NCT00622284|75917150|FG001|Overall Study|Lack of Efficacy|15|||
42106078|NCT00622284|75917149|FG000|Overall Study|Adverse Event|61|||
42106079|NCT00622284|75917150|FG001|Overall Study|Adverse Event|90|||
42106080|NCT00622284|75917149|FG000|Overall Study|Protocol Violation|12|||
42106081|NCT00622284|75917150|FG001|Overall Study|Protocol Violation|5|||
42106082|NCT00622284|75917149|FG000|Overall Study|Lost to Follow-up|11|||
42106083|NCT00622284|75917150|FG001|Overall Study|Lost to Follow-up|13|||
42106084|NCT00622284|75917149|FG000|Overall Study|Withdrawal by Subject|27|||
42106085|NCT00622284|75917150|FG001|Overall Study|Withdrawal by Subject|24|||
42106086|NCT00622284|75917149|FG000|Overall Study|Other reason (not specified)|33|||
42106087|NCT00622284|75917150|FG001|Overall Study|Other reason (not specified)|24|||
42018804|NCT01123083|75826211|FG000|Overall Study|Lost to Follow-up|2|||
42018805|NCT01123083|75826212|FG001|Overall Study|Lost to Follow-up|6|||
42018806|NCT01123083|75826211|FG000|Overall Study|Adverse Event|1|||
42018807|NCT01123083|75826212|FG001|Overall Study|Adverse Event|0|||
42018808|NCT01123083|75826211|FG000|Overall Study|Withdrew for another reason not covered|0|||
42018809|NCT01123083|75826212|FG001|Overall Study|Withdrew for another reason not covered|1|||
42106088|NCT00269113|75917158|FG000|Overall Study|Adverse Event|14|||
42106089|NCT00269113|75917159|FG001|Overall Study|Adverse Event|7|||
42106090|NCT00269113|75917158|FG000|Overall Study|Lack of Efficacy|35|||
42106091|NCT00269113|75917159|FG001|Overall Study|Lack of Efficacy|18|||
42106092|NCT00269113|75917158|FG000|Overall Study|Early Improvement|2|||
42106093|NCT00269113|75917159|FG001|Overall Study|Early Improvement|0|||
42106094|NCT00269113|75917158|FG000|Overall Study|Withdrawal by Subject|0|||
42106095|NCT00269113|75917159|FG001|Overall Study|Withdrawal by Subject|2|||
42106096|NCT00269113|75917158|FG000|Overall Study|Death|6|||
42106097|NCT00269113|75917159|FG001|Overall Study|Death|2|||
42106098|NCT00269113|75917158|FG000|Overall Study|Lost to Follow-up|2|||
42106099|NCT00269113|75917159|FG001|Overall Study|Lost to Follow-up|1|||
42106100|NCT00269113|75917158|FG000|Overall Study|Protocol Violation|15|||
42106101|NCT00269113|75917159|FG001|Overall Study|Protocol Violation|5|||
42106102|NCT00269113|75917158|FG000|Overall Study|Other|0|||
42106103|NCT00269113|75917159|FG001|Overall Study|Other|2|||
42106104|NCT00291187|75917169|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
42106105|NCT00291187|75917170|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
42106106|NCT00291187|75917171|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
42106107|NCT00291187|75917172|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
42106108|NCT00546819|75917188|FG000|Overall Study|Adverse Event|2|||
42201766|NCT03954704|76014348|FG006|Overall Study|Enrolled but not Treated|0|||
42201767|NCT03653390|76014389|FG000|Overall Study|Lost to Follow-up|12|||
42201768|NCT03653390|76014390|FG001|Overall Study|Lost to Follow-up|8|||
42018810|NCT01123083|75826211|FG000|Overall Study|Participant/legal representative request|7|||
42018811|NCT01123083|75826212|FG001|Overall Study|Participant/legal representative request|3|||
42018812|NCT01254305|75826221|FG000|Overall Study|Adverse Event|6|||
42106109|NCT00546819|75917189|FG001|Overall Study|Adverse Event|3|||
42106110|NCT00546819|75917188|FG000|Overall Study|Lost to Follow-up|2|||
42106111|NCT00546819|75917189|FG001|Overall Study|Lost to Follow-up|1|||
42106112|NCT00546819|75917188|FG000|Overall Study|Withdrawal by Subject|4|||
42106113|NCT00546819|75917189|FG001|Overall Study|Withdrawal by Subject|2|||
42106114|NCT00621504|75917197|FG000|Overall Study|Adverse Event|1|||
42106115|NCT00621504|75917198|FG001|Overall Study|Adverse Event|3|||
42106116|NCT00621504|75917197|FG000|Overall Study|At the request of sponsor/investigator|1|||
42106117|NCT00621504|75917198|FG001|Overall Study|At the request of sponsor/investigator|0|||
42106118|NCT00621504|75917197|FG000|Overall Study|Withdrew consent|9|||
42106119|NCT00621504|75917198|FG001|Overall Study|Withdrew consent|6|||
42106120|NCT00621504|75917197|FG000|Overall Study|Lost to Follow-up|8|||
42106121|NCT00621504|75917198|FG001|Overall Study|Lost to Follow-up|10|||
42106122|NCT00621504|75917197|FG000|Overall Study|Other|1|||
42106123|NCT00621504|75917198|FG001|Overall Study|Other|0|||
42106124|NCT00621504|75917197|FG000|Overall Study|Death|6|||
42106125|NCT00621504|75917198|FG001|Overall Study|Death|6|||
42106126|NCT00548145|75917206|FG000|Overall Study|Death|0|||
42106127|NCT00548145|75917207|FG001|Overall Study|Death|1|||
42106128|NCT00548145|75917206|FG000|Overall Study|Withdrawal by Subject|0|||
42106129|NCT00548145|75917207|FG001|Overall Study|Withdrawal by Subject|2|||
42106130|NCT00548145|75917206|FG000|Overall Study|Physician Decision|1|||
42106131|NCT00548145|75917207|FG001|Overall Study|Physician Decision|1|||
42106132|NCT00547911|75917217|FG000|Overall Study|Adverse Event|0|||
42106133|NCT00547911|75917218|FG001|Overall Study|Adverse Event|0|||
42106134|NCT00547911|75917219|FG002|Overall Study|Adverse Event|0|||
42106135|NCT00547911|75917220|FG003|Overall Study|Adverse Event|1|||
42106136|NCT00547911|75917221|FG004|Overall Study|Adverse Event|0|||
42106137|NCT00547911|75917222|FG005|Overall Study|Adverse Event|0|||
42106138|NCT00289783|75917237|FG000|Primary Phase|Adverse Event|10|||
42106139|NCT00289783|75917238|FG001|Primary Phase|Adverse Event|1|||
42106140|NCT00289783|75917237|FG000|Primary Phase|Protocol Violation|27|||
42106141|NCT00289783|75917238|FG001|Primary Phase|Protocol Violation|6|||
42106142|NCT00289783|75917237|FG000|Primary Phase|Withdrawal by Subject|93|||
42106143|NCT00289783|75917238|FG001|Primary Phase|Withdrawal by Subject|40|||
42106144|NCT00289783|75917237|FG000|Primary Phase|Lost to Follow-up|60|||
42106145|NCT00289783|75917238|FG001|Primary Phase|Lost to Follow-up|14|||
42106146|NCT00289783|75917237|FG000|Primary Phase|Migration from the study area|26|||
42106147|NCT00289783|75917238|FG001|Primary Phase|Migration from the study area|10|||
42106148|NCT00289783|75917237|FG000|Primary Phase|Other|32|||
42106149|NCT00289783|75917238|FG001|Primary Phase|Other|12|||
42106150|NCT00289783|75917237|FG000|Fourth Dose Phase|Adverse Event|1|||
42106151|NCT00289783|75917238|FG001|Fourth Dose Phase|Adverse Event|0|||
42106152|NCT00289783|75917237|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
42106153|NCT00289783|75917238|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
42106154|NCT00289783|75917237|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
42106155|NCT00289783|75917238|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
42106156|NCT00289783|75917237|FG000|Fourth Dose Phase|Migration from the study area|1|||
42106157|NCT00289783|75917238|FG001|Fourth Dose Phase|Migration from the study area|1|||
42106158|NCT00289783|75917237|FG000|Fourth Dose Phase|Other|22|||
42106159|NCT00289783|75917238|FG001|Fourth Dose Phase|Other|10|||
42106160|NCT00574080|75917254|FG000|Overall Study|Death|10|||
42106161|NCT00574080|75917255|FG001|Overall Study|Death|10|||
42106162|NCT00267865|75917261|FG000|Induction Treatment|Died before completing.|2|||
42106163|NCT00267865|75917261|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
42106164|NCT00546117|75917267|FG000|Overall Study|Withdrawal by Subject|3|||
42106165|NCT00546117|75917268|FG001|Overall Study|Withdrawal by Subject|0|||
42106166|NCT00546117|75917267|FG000|Overall Study|Inability to schedule follow-up visit|1|||
42106167|NCT00546117|75917268|FG001|Overall Study|Inability to schedule follow-up visit|0|||
42106168|NCT00251719|75917279|FG000|Overall Study|Adverse Event|14|||
42106169|NCT00251719|75917280|FG001|Overall Study|Adverse Event|8|||
42106170|NCT00251719|75917281|FG002|Overall Study|Adverse Event|7|||
42106171|NCT00251719|75917279|FG000|Overall Study|Protocol Violation|1|||
42106172|NCT00251719|75917280|FG001|Overall Study|Protocol Violation|1|||
42106173|NCT00251719|75917281|FG002|Overall Study|Protocol Violation|1|||
42106174|NCT00251719|75917279|FG000|Overall Study|Lost to Follow-up|5|||
42106175|NCT00251719|75917280|FG001|Overall Study|Lost to Follow-up|11|||
42106176|NCT00251719|75917281|FG002|Overall Study|Lost to Follow-up|8|||
42106177|NCT00251719|75917279|FG000|Overall Study|Withdrawal by Subject|14|||
42106178|NCT00251719|75917280|FG001|Overall Study|Withdrawal by Subject|12|||
42106179|NCT00251719|75917281|FG002|Overall Study|Withdrawal by Subject|11|||
42201769|NCT03653390|76014391|FG002|Overall Study|Lost to Follow-up|7|||
42106180|NCT00251719|75917279|FG000|Overall Study|Lack of Efficacy|2|||
42106181|NCT00251719|75917280|FG001|Overall Study|Lack of Efficacy|1|||
42106182|NCT00251719|75917281|FG002|Overall Study|Lack of Efficacy|0|||
42106183|NCT00251719|75917279|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
42106184|NCT00251719|75917280|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
42201770|NCT03653390|76014389|FG000|Overall Study|Withdrawal by Subject|6|||
42106185|NCT00251719|75917281|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
42106186|NCT00251719|75917279|FG000|Overall Study|Investigator decision|1|||
42106187|NCT00251719|75917280|FG001|Overall Study|Investigator decision|1|||
42106188|NCT00251719|75917281|FG002|Overall Study|Investigator decision|0|||
42106189|NCT00251719|75917279|FG000|Overall Study|Noncompliance|2|||
42106190|NCT00251719|75917280|FG001|Overall Study|Noncompliance|3|||
42106191|NCT00251719|75917281|FG002|Overall Study|Noncompliance|1|||
42106192|NCT00251719|75917279|FG000|Overall Study|Barrett's esophagus|2|||
42106193|NCT00251719|75917280|FG001|Overall Study|Barrett's esophagus|2|||
42106194|NCT00251719|75917281|FG002|Overall Study|Barrett's esophagus|0|||
42106195|NCT03952143|75917291|FG000|Lead-In Period|Adverse Event|2|||
42106196|NCT03952143|75917292|FG001|Lead-In Period|Adverse Event|0|||
42106197|NCT03952143|75917293|FG002|Lead-In Period|Adverse Event|0|||
42106198|NCT03952143|75917291|FG000|Lead-In Period|Lack of Efficacy|2|||
42106199|NCT03952143|75917292|FG001|Lead-In Period|Lack of Efficacy|0|||
42106200|NCT03952143|75917293|FG002|Lead-In Period|Lack of Efficacy|0|||
42106201|NCT03952143|75917291|FG000|Lead-In Period|Physician Decision|5|||
42106202|NCT03952143|75917292|FG001|Lead-In Period|Physician Decision|0|||
42106203|NCT03952143|75917293|FG002|Lead-In Period|Physician Decision|0|||
42106204|NCT03952143|75917291|FG000|Lead-In Period|Protocol Violation|5|||
42106205|NCT03952143|75917292|FG001|Lead-In Period|Protocol Violation|0|||
42106206|NCT03952143|75917293|FG002|Lead-In Period|Protocol Violation|0|||
42106207|NCT03952143|75917291|FG000|Lead-In Period|Withdrawal by Subject|19|||
42106208|NCT03952143|75917292|FG001|Lead-In Period|Withdrawal by Subject|0|||
42106209|NCT03952143|75917293|FG002|Lead-In Period|Withdrawal by Subject|0|||
42106210|NCT03952143|75917291|FG000|Treatment Period|Adverse Event|0|||
42106211|NCT03952143|75917292|FG001|Treatment Period|Adverse Event|0|||
42106212|NCT03952143|75917293|FG002|Treatment Period|Adverse Event|1|||
42106213|NCT03952143|75917291|FG000|Treatment Period|Lost to Follow-up|0|||
42106214|NCT03952143|75917292|FG001|Treatment Period|Lost to Follow-up|2|||
42106215|NCT03952143|75917293|FG002|Treatment Period|Lost to Follow-up|0|||
42106216|NCT03952143|75917291|FG000|Treatment Period|Physician Decision|0|||
42106217|NCT03952143|75917292|FG001|Treatment Period|Physician Decision|0|||
42106218|NCT03952143|75917293|FG002|Treatment Period|Physician Decision|2|||
42106219|NCT03952143|75917291|FG000|Treatment Period|Protocol Violation|0|||
42106220|NCT03952143|75917292|FG001|Treatment Period|Protocol Violation|0|||
42106221|NCT03952143|75917293|FG002|Treatment Period|Protocol Violation|1|||
42106222|NCT03952143|75917291|FG000|Treatment Period|Withdrawal by Subject|0|||
42106223|NCT03952143|75917292|FG001|Treatment Period|Withdrawal by Subject|5|||
42106224|NCT03952143|75917293|FG002|Treatment Period|Withdrawal by Subject|26|||
42106225|NCT03952143|75917291|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
42106226|NCT03952143|75917292|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
42106227|NCT03952143|75917293|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
42106228|NCT03952143|75917291|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
42106229|NCT03952143|75917292|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
42106230|NCT03952143|75917293|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
42106231|NCT00267007|75917302|FG000|Overall Study|Withdrawal by Subject|6|||
42106232|NCT00267007|75917303|FG001|Overall Study|Withdrawal by Subject|0|||
42106233|NCT00267007|75917302|FG000|Overall Study|Lost to Follow-up|1|||
42106234|NCT00267007|75917303|FG001|Overall Study|Lost to Follow-up|0|||
42106235|NCT00267007|75917302|FG000|Overall Study|Non-compliance|0|||
42106236|NCT00267007|75917303|FG001|Overall Study|Non-compliance|1|||
42106237|NCT00267007|75917302|FG000|Overall Study|Adverse Event|1|||
42106238|NCT00267007|75917303|FG001|Overall Study|Adverse Event|0|||
42106239|NCT03943095|75917311|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
42106240|NCT03943095|75917312|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
42106241|NCT03943095|75917311|FG000|Overall Study|Withdrawal by Subject|1|||
42106242|NCT03943095|75917312|FG001|Overall Study|Withdrawal by Subject|0|||
42106243|NCT00251641|75917321|FG000|Overall Study|Adverse Event|80|||
42106244|NCT00251641|75917322|FG001|Overall Study|Adverse Event|8|||
42106245|NCT00251641|75917321|FG000|Overall Study|Lack of Efficacy|2|||
42106246|NCT00251641|75917322|FG001|Overall Study|Lack of Efficacy|1|||
42106247|NCT00251641|75917321|FG000|Overall Study|Progression of Disease|0|||
42106248|NCT00251641|75917322|FG001|Overall Study|Progression of Disease|2|||
42106249|NCT00251641|75917321|FG000|Overall Study|Lost to Follow-up|3|||
42106250|NCT00251641|75917322|FG001|Overall Study|Lost to Follow-up|3|||
42106251|NCT00251641|75917321|FG000|Overall Study|Withdrawal by Subject|6|||
42106252|NCT00251641|75917322|FG001|Overall Study|Withdrawal by Subject|8|||
42106253|NCT00251641|75917321|FG000|Overall Study|Protocol Violation|10|||
42106254|NCT00251641|75917322|FG001|Overall Study|Protocol Violation|2|||
42106255|NCT00251641|75917321|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
42106256|NCT00251641|75917322|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
42106257|NCT00251641|75917321|FG000|Overall Study|Switched Treatment|9|||
42106258|NCT00251641|75917322|FG001|Overall Study|Switched Treatment|63|||
42106259|NCT00250705|75917330|FG000|Overall Study|Lack of Efficacy|2|||
42106260|NCT00266695|75917336|FG000|Overall Study|Adverse Event|1|||
42106261|NCT00266695|75917336|FG000|Overall Study|Death|9|||
42106262|NCT00266695|75917336|FG000|Overall Study|Physician Decision|1|||
42106263|NCT00266695|75917336|FG000|Overall Study|Lost to Follow-up|3|||
42106264|NCT00266695|75917336|FG000|Overall Study|Withdrawal by Subject|15|||
42106265|NCT00620022|75917340|FG000|Treatment Period 1|Adverse Event|4|||
42106266|NCT00620022|75917341|FG001|Treatment Period 1|Adverse Event|6|||
42106267|NCT00620022|75917340|FG000|Treatment Period 1|Subject withdrew consent|1|||
42106268|NCT00620022|75917341|FG001|Treatment Period 1|Subject withdrew consent|0|||
42106269|NCT00620022|75917340|FG000|Treatment Period 2|Adverse Event|2|||
42106270|NCT00620022|75917341|FG001|Treatment Period 2|Adverse Event|2|||
42106271|NCT00547521|75917349|FG000|Short Term Study (4 Months)|Adverse Event|1|||
42106272|NCT00547521|75917350|FG001|Short Term Study (4 Months)|Adverse Event|0|||
42106273|NCT00547521|75917349|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
42106274|NCT00547521|75917350|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
42106275|NCT00547521|75917349|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
42106276|NCT00547521|75917350|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
42106277|NCT00547521|75917349|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
42106278|NCT00547521|75917350|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
42106279|NCT00547521|75917349|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
42106280|NCT00547521|75917350|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
42106281|NCT00547521|75917349|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
42106282|NCT00547521|75917350|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
42106283|NCT00547521|75917349|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
42106284|NCT00547521|75917350|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
42106285|NCT00547521|75917349|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
42106286|NCT00547521|75917350|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
42106287|NCT00547521|75917349|FG000|Long Term Extension (LTE) Study|Other|0|||
42106288|NCT00547521|75917350|FG001|Long Term Extension (LTE) Study|Other|2|||
42106289|NCT00547521|75917349|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
42106290|NCT00547521|75917350|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
42106291|NCT00266227|75917365|FG000|Initial Treatment|Adverse Event|0|||
42106292|NCT00266227|75917366|FG001|Initial Treatment|Adverse Event|0|||
42106293|NCT00266227|75917367|FG002|Initial Treatment|Adverse Event|13|||
42106294|NCT00266227|75917365|FG000|Initial Treatment|Lost to Follow-up|0|||
42106295|NCT00266227|75917366|FG001|Initial Treatment|Lost to Follow-up|0|||
42106296|NCT00266227|75917367|FG002|Initial Treatment|Lost to Follow-up|6|||
42106297|NCT00266227|75917365|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
42106298|NCT00266227|75917366|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
42106299|NCT00266227|75917367|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
42106300|NCT00266227|75917365|FG000|Initial Treatment|Physician decision to withdraw|0|||
42106301|NCT00266227|75917366|FG001|Initial Treatment|Physician decision to withdraw|0|||
42106302|NCT00266227|75917367|FG002|Initial Treatment|Physician decision to withdraw|12|||
42106303|NCT00266227|75917365|FG000|Initial Treatment|Pregnancy|0|||
42106304|NCT00266227|75917366|FG001|Initial Treatment|Pregnancy|0|||
42106305|NCT00266227|75917367|FG002|Initial Treatment|Pregnancy|1|||
42106306|NCT00266227|75917365|FG000|Retreatment: Up to Week 48|Death|1|||
42106307|NCT00266227|75917366|FG001|Retreatment: Up to Week 48|Death|0|||
42106308|NCT00266227|75917367|FG002|Retreatment: Up to Week 48|Death|0|||
42106309|NCT00266227|75917365|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
42106310|NCT00266227|75917366|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
42106311|NCT00266227|75917367|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
42106312|NCT00266227|75917365|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
42106313|NCT00266227|75917366|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
42106314|NCT00266227|75917367|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
42106315|NCT00266227|75917365|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
42106316|NCT00266227|75917366|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
42106317|NCT00266227|75917367|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
42106318|NCT00266227|75917365|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
42106319|NCT00266227|75917366|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
42106320|NCT00266227|75917367|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
42106321|NCT00266227|75917365|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
42106322|NCT00266227|75917366|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
42106323|NCT00266227|75917367|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
42106324|NCT00266227|75917365|FG000|Retreatment: Week 48 to Week 72|Death|1|||
42106325|NCT00266227|75917366|FG001|Retreatment: Week 48 to Week 72|Death|1|||
42106326|NCT00266227|75917367|FG002|Retreatment: Week 48 to Week 72|Death|0|||
42106327|NCT00266227|75917365|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
42106328|NCT00266227|75917366|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
42106329|NCT00266227|75917367|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
42106330|NCT00266227|75917365|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
42106331|NCT00266227|75917366|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
42106332|NCT00266227|75917367|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
42106333|NCT00266227|75917365|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
42106334|NCT00266227|75917366|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
42201771|NCT03653390|76014390|FG001|Overall Study|Withdrawal by Subject|1|||
42106335|NCT00266227|75917367|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
42106336|NCT00266227|75917365|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
42106337|NCT00266227|75917366|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
42201772|NCT03653390|76014391|FG002|Overall Study|Withdrawal by Subject|1|||
42201773|NCT03653390|76014389|FG000|Overall Study|Death|1|||
42201774|NCT03653390|76014390|FG001|Overall Study|Death|0|||
42201775|NCT03653390|76014391|FG002|Overall Study|Death|0|||
42201776|NCT03653390|76014389|FG000|Overall Study|Paper Survey Lost|1|||
42201777|NCT03653390|76014390|FG001|Overall Study|Paper Survey Lost|0|||
42201778|NCT03653390|76014391|FG002|Overall Study|Paper Survey Lost|0|||
42378824|NCT01465997|76250417|FG000|Overall Study|Withdrawal by Subject|32|||
42378825|NCT01465997|76250418|FG001|Overall Study|Withdrawal by Subject|35|||
42378826|NCT01465997|76250417|FG000|Overall Study|investigator's decision|1|||
42378827|NCT01465997|76250418|FG001|Overall Study|investigator's decision|1|||
42378828|NCT01465997|76250417|FG000|Overall Study|Death|0|||
42378829|NCT01465997|76250418|FG001|Overall Study|Death|1|||
42378830|NCT01465997|76250417|FG000|Overall Study|sponsor's decision|1|||
42378831|NCT01465997|76250418|FG001|Overall Study|sponsor's decision|1|||
42378832|NCT01465997|76250417|FG000|Overall Study|subject withdrew consent|1|||
42378833|NCT01465997|76250418|FG001|Overall Study|subject withdrew consent|0|||
42378834|NCT01465997|76250417|FG000|Overall Study|local lab unblinded site|1|||
42378835|NCT01465997|76250418|FG001|Overall Study|local lab unblinded site|0|||
42378836|NCT01465997|76250417|FG000|Overall Study|withdrew before follow-up|0|||
42378837|NCT01465997|76250418|FG001|Overall Study|withdrew before follow-up|13|||
42378838|NCT01465997|76250417|FG000|Overall Study|decision by site staff|0|||
42378839|NCT01465997|76250418|FG001|Overall Study|decision by site staff|1|||
42378840|NCT01465997|76250417|FG000|Overall Study|subject left participation SP0993|0|||
42378841|NCT01465997|76250418|FG001|Overall Study|subject left participation SP0993|1|||
42378842|NCT01465763|76250439|FG000|Overall Study|Withdrawal by Subject|4|||
42378843|NCT01465763|76250440|FG001|Overall Study|Withdrawal by Subject|0|||
42378844|NCT01465763|76250441|FG002|Overall Study|Withdrawal by Subject|1|||
42378845|NCT01465763|76250439|FG000|Overall Study|Insufficient Clinical Response|11|||
42201803|NCT03366844|76014436|FG000|Overall Study|Physician Decision|1|||
42201804|NCT03366844|76014436|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
42201805|NCT03238248|76014456|FG000|Overall Study|Death|5|||
42201806|NCT03238248|76014456|FG000|Overall Study|Withdrawal by Subject|7|||
42201807|NCT03238248|76014456|FG000|Overall Study|Participant proceeding to transplant|10|||
42201808|NCT03238248|76014456|FG000|Overall Study|Lack of Efficacy|4|||
42201809|NCT03238248|76014456|FG000|Overall Study|Physician Decision|3|||
42201810|NCT03238248|76014456|FG000|Overall Study|Transitioning to another study|1|||
42201811|NCT03238248|76014456|FG000|Overall Study|No longer benefiting|1|||
42201812|NCT03238248|76014456|FG000|Overall Study|Other complicating disease|1|||
42201813|NCT03238248|76014456|FG000|Overall Study|Adverse Event|5|||
42201814|NCT03238248|76014456|FG000|Overall Study|Disease progression|26|||
42201815|NCT03238248|76014456|FG000|Overall Study|N/A participant is still on treatment|1|||
42201816|NCT03238248|76014456|FG000|Overall Study|Decline in condition|1|||
42106338|NCT00266227|75917367|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
42106339|NCT00287365|75917376|FG000|Overall Study|sample not acquired|13|||
42106340|NCT00573768|75917384|FG000|Overall Study|Adverse Event|1|||
42106341|NCT00573768|75917385|FG001|Overall Study|Adverse Event|1|||
42106342|NCT00573768|75917386|FG002|Overall Study|Adverse Event|2|||
42106343|NCT00573768|75917384|FG000|Overall Study|Protocol Violation|1|||
42106344|NCT00573768|75917385|FG001|Overall Study|Protocol Violation|0|||
42106345|NCT00573768|75917386|FG002|Overall Study|Protocol Violation|1|||
42106346|NCT00573768|75917384|FG000|Overall Study|Withdrawal by Subject|0|||
42106347|NCT00573768|75917385|FG001|Overall Study|Withdrawal by Subject|1|||
42106348|NCT00573768|75917386|FG002|Overall Study|Withdrawal by Subject|0|||
42106349|NCT00573768|75917384|FG000|Overall Study|Lost to Follow-up|0|||
42106350|NCT00573768|75917385|FG001|Overall Study|Lost to Follow-up|0|||
42106351|NCT00573768|75917386|FG002|Overall Study|Lost to Follow-up|1|||
42106352|NCT00547365|75917394|FG000|Overall Study|Physician Decision|1|||
42106353|NCT00547365|75917394|FG000|Overall Study|Lost to Follow-up|1|||
42106354|NCT00547365|75917394|FG000|Overall Study|Protocol Violation|2|||
42106355|NCT00547365|75917394|FG000|Overall Study|death (not related to study)|4|||
42106356|NCT00619866|75917402|FG000|Weeks 1 - 12|Adverse Event|0|||
42201817|NCT03238248|76014456|FG000|Overall Study|Alternative therapy|2|||
42201818|NCT02739035|76014480|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
42201819|NCT02739035|76014481|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
42201820|NCT02739035|76014480|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
42201821|NCT02739035|76014481|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
42201822|NCT02739035|76014480|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
42201823|NCT02739035|76014481|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
42201824|NCT02739035|76014480|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
42106357|NCT00619866|75917403|FG001|Weeks 1 - 12|Adverse Event|1|||
42106358|NCT00619866|75917404|FG002|Weeks 1 - 12|Adverse Event|2|||
42201825|NCT02739035|76014481|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
42201826|NCT02657434|76014501|FG000|Overall Study|Study Terminated By Sponsor|64|||
42201827|NCT02657434|76014502|FG001|Overall Study|Study Terminated By Sponsor|82|||
42201828|NCT02657434|76014501|FG000|Overall Study|Death|189|||
42201829|NCT02657434|76014502|FG001|Overall Study|Death|190|||
42201830|NCT02657434|76014501|FG000|Overall Study|Lost to Follow-up|2|||
42201831|NCT02657434|76014502|FG001|Overall Study|Lost to Follow-up|2|||
42201832|NCT02657434|76014501|FG000|Overall Study|Randomization by Error|2|||
42201833|NCT02657434|76014502|FG001|Overall Study|Randomization by Error|0|||
42201834|NCT02657434|76014501|FG000|Overall Study|Withdrawal by Subject|28|||
42201835|NCT02657434|76014502|FG001|Overall Study|Withdrawal by Subject|17|||
42201836|NCT02657434|76014501|FG000|Overall Study|Protocol Violation|1|||
42201837|NCT02657434|76014502|FG001|Overall Study|Protocol Violation|0|||
42201838|NCT02657434|76014501|FG000|Overall Study|Physician Decision|0|||
42201839|NCT02657434|76014502|FG001|Overall Study|Physician Decision|1|||
42201840|NCT02656290|76014509|FG000|Overall Study|Lost to Follow-up|1|||
42201841|NCT02656290|76014509|FG000|Overall Study|Reintervention|3|||
42201842|NCT02255149|76014521|FG000|Overall Study|Lost to Follow-up|2|||
42201843|NCT02255149|76014521|FG000|Overall Study|Withdrawal by Subject|1|||
42201844|NCT02255149|76014521|FG000|Overall Study|Withdrawal by PI|1|||
42201845|NCT02255149|76014521|FG000|Overall Study|Implant Failure|1|||
42201846|NCT02180867|76014532|FG000|Overall Study|Adverse Event|3|||
42201847|NCT02180867|76014533|FG001|Overall Study|Adverse Event|4|||
42201848|NCT02180867|76014534|FG002|Overall Study|Adverse Event|1|||
42201849|NCT02180867|76014535|FG003|Overall Study|Adverse Event|5|||
42201850|NCT02180867|76014536|FG004|Overall Study|Adverse Event|0|||
42201851|NCT02180867|76014537|FG005|Overall Study|Adverse Event|0|||
42201852|NCT02180867|76014538|FG006|Overall Study|Adverse Event|0|||
42201853|NCT02180867|76014532|FG000|Overall Study|Death|0|||
42201854|NCT02180867|76014533|FG001|Overall Study|Death|0|||
42201855|NCT02180867|76014534|FG002|Overall Study|Death|0|||
42201856|NCT02180867|76014535|FG003|Overall Study|Death|0|||
42201857|NCT02180867|76014536|FG004|Overall Study|Death|1|||
42201858|NCT02180867|76014537|FG005|Overall Study|Death|0|||
42201859|NCT02180867|76014538|FG006|Overall Study|Death|0|||
42201860|NCT02180867|76014532|FG000|Overall Study|Lack of Efficacy|0|||
42201861|NCT02180867|76014533|FG001|Overall Study|Lack of Efficacy|2|||
42201862|NCT02180867|76014534|FG002|Overall Study|Lack of Efficacy|0|||
42201863|NCT02180867|76014535|FG003|Overall Study|Lack of Efficacy|1|||
42201864|NCT02180867|76014536|FG004|Overall Study|Lack of Efficacy|6|||
42201865|NCT02180867|76014537|FG005|Overall Study|Lack of Efficacy|0|||
42201866|NCT02180867|76014538|FG006|Overall Study|Lack of Efficacy|1|||
42201867|NCT02180867|76014532|FG000|Overall Study|Physician Decision|1|||
42201868|NCT02180867|76014533|FG001|Overall Study|Physician Decision|3|||
42201869|NCT02180867|76014534|FG002|Overall Study|Physician Decision|1|||
42201870|NCT02180867|76014535|FG003|Overall Study|Physician Decision|10|||
42201871|NCT02180867|76014536|FG004|Overall Study|Physician Decision|9|||
42201872|NCT02180867|76014537|FG005|Overall Study|Physician Decision|3|||
42201873|NCT02180867|76014538|FG006|Overall Study|Physician Decision|4|||
42201874|NCT02180867|76014532|FG000|Overall Study|Withdrawal by Subject|0|||
42201875|NCT02180867|76014533|FG001|Overall Study|Withdrawal by Subject|0|||
42201876|NCT02180867|76014534|FG002|Overall Study|Withdrawal by Subject|0|||
42201877|NCT02180867|76014535|FG003|Overall Study|Withdrawal by Subject|1|||
42201878|NCT02180867|76014536|FG004|Overall Study|Withdrawal by Subject|1|||
42201879|NCT02180867|76014537|FG005|Overall Study|Withdrawal by Subject|0|||
42201880|NCT02180867|76014538|FG006|Overall Study|Withdrawal by Subject|0|||
42201881|NCT02180867|76014532|FG000|Overall Study|Ineligible|1|||
42201882|NCT02180867|76014533|FG001|Overall Study|Ineligible|2|||
42201883|NCT02180867|76014534|FG002|Overall Study|Ineligible|0|||
42201884|NCT02180867|76014535|FG003|Overall Study|Ineligible|3|||
42201885|NCT02180867|76014536|FG004|Overall Study|Ineligible|5|||
42201886|NCT02180867|76014537|FG005|Overall Study|Ineligible|0|||
42201887|NCT02180867|76014538|FG006|Overall Study|Ineligible|0|||
42201888|NCT02180867|76014532|FG000|Overall Study|Repeat Eligibility Studies|0|||
42201889|NCT02180867|76014533|FG001|Overall Study|Repeat Eligibility Studies|0|||
42201890|NCT02180867|76014534|FG002|Overall Study|Repeat Eligibility Studies|0|||
42201891|NCT02180867|76014535|FG003|Overall Study|Repeat Eligibility Studies|0|||
42201892|NCT02180867|76014536|FG004|Overall Study|Repeat Eligibility Studies|1|||
42201893|NCT02180867|76014537|FG005|Overall Study|Repeat Eligibility Studies|0|||
42201894|NCT02180867|76014538|FG006|Overall Study|Repeat Eligibility Studies|0|||
42201895|NCT02180867|76014532|FG000|Overall Study|Refusal of further protocol therapy|1|||
42201896|NCT02180867|76014533|FG001|Overall Study|Refusal of further protocol therapy|0|||
42201897|NCT02180867|76014534|FG002|Overall Study|Refusal of further protocol therapy|2|||
42201898|NCT02180867|76014535|FG003|Overall Study|Refusal of further protocol therapy|6|||
42201899|NCT02180867|76014536|FG004|Overall Study|Refusal of further protocol therapy|4|||
42201900|NCT02180867|76014537|FG005|Overall Study|Refusal of further protocol therapy|0|||
42201901|NCT02180867|76014538|FG006|Overall Study|Refusal of further protocol therapy|0|||
42201902|NCT02101853|76014574|FG000|Block 1 Induction|Adverse Event|11|||
42201903|NCT02101853|76014575|FG001|Block 1 Induction|Adverse Event|0|||
42201904|NCT02101853|76014576|FG002|Block 1 Induction|Adverse Event|0|||
42201905|NCT02101853|76014577|FG003|Block 1 Induction|Adverse Event|0|||
42201906|NCT02101853|76014578|FG004|Block 1 Induction|Adverse Event|0|||
42201907|NCT02101853|76014579|FG005|Block 1 Induction|Adverse Event|0|||
42201908|NCT02101853|76014574|FG000|Block 1 Induction|Death|20|||
42201909|NCT02101853|76014575|FG001|Block 1 Induction|Death|0|||
42201910|NCT02101853|76014576|FG002|Block 1 Induction|Death|0|||
42201911|NCT02101853|76014577|FG003|Block 1 Induction|Death|0|||
42201912|NCT02101853|76014578|FG004|Block 1 Induction|Death|0|||
42201913|NCT02101853|76014579|FG005|Block 1 Induction|Death|0|||
42201914|NCT02101853|76014574|FG000|Block 1 Induction|Lack of Efficacy|6|||
42201915|NCT02101853|76014575|FG001|Block 1 Induction|Lack of Efficacy|0|||
42201916|NCT02101853|76014576|FG002|Block 1 Induction|Lack of Efficacy|0|||
42201917|NCT02101853|76014577|FG003|Block 1 Induction|Lack of Efficacy|0|||
42201918|NCT02101853|76014578|FG004|Block 1 Induction|Lack of Efficacy|0|||
42201919|NCT02101853|76014579|FG005|Block 1 Induction|Lack of Efficacy|0|||
42201920|NCT02101853|76014574|FG000|Block 1 Induction|Physician Decision|61|||
42201921|NCT02101853|76014575|FG001|Block 1 Induction|Physician Decision|0|||
42201922|NCT02101853|76014576|FG002|Block 1 Induction|Physician Decision|0|||
42201923|NCT02101853|76014577|FG003|Block 1 Induction|Physician Decision|0|||
42201924|NCT02101853|76014578|FG004|Block 1 Induction|Physician Decision|0|||
42201925|NCT02101853|76014579|FG005|Block 1 Induction|Physician Decision|0|||
42201926|NCT02101853|76014574|FG000|Block 1 Induction|Protocol Violation|2|||
42201927|NCT02101853|76014575|FG001|Block 1 Induction|Protocol Violation|0|||
42201928|NCT02101853|76014576|FG002|Block 1 Induction|Protocol Violation|0|||
42201929|NCT02101853|76014577|FG003|Block 1 Induction|Protocol Violation|0|||
42201930|NCT02101853|76014578|FG004|Block 1 Induction|Protocol Violation|0|||
42201931|NCT02101853|76014579|FG005|Block 1 Induction|Protocol Violation|0|||
42201932|NCT02101853|76014574|FG000|Block 1 Induction|Withdrawal by Subject|65|||
42201933|NCT02101853|76014575|FG001|Block 1 Induction|Withdrawal by Subject|0|||
42201934|NCT02101853|76014576|FG002|Block 1 Induction|Withdrawal by Subject|0|||
42201935|NCT02101853|76014577|FG003|Block 1 Induction|Withdrawal by Subject|0|||
42201936|NCT02101853|76014578|FG004|Block 1 Induction|Withdrawal by Subject|0|||
42201937|NCT02101853|76014579|FG005|Block 1 Induction|Withdrawal by Subject|0|||
42201938|NCT02101853|76014574|FG000|Block 1 Induction|Ineligible|8|||
42201939|NCT02101853|76014575|FG001|Block 1 Induction|Ineligible|0|||
42201940|NCT02101853|76014576|FG002|Block 1 Induction|Ineligible|0|||
42201941|NCT02101853|76014577|FG003|Block 1 Induction|Ineligible|0|||
42201942|NCT02101853|76014578|FG004|Block 1 Induction|Ineligible|0|||
42201943|NCT02101853|76014579|FG005|Block 1 Induction|Ineligible|0|||
42201944|NCT02101853|76014574|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
42201945|NCT02101853|76014575|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
42201946|NCT02101853|76014576|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
42201947|NCT02101853|76014577|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
42201948|NCT02101853|76014578|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
42201949|NCT02101853|76014579|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
42201950|NCT02101853|76014574|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
42201951|NCT02101853|76014575|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
42201952|NCT02101853|76014576|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
42201953|NCT02101853|76014577|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
42201954|NCT02101853|76014578|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
42201955|NCT02101853|76014579|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
42201956|NCT02101853|76014574|FG000|Post Induction Randomization|Adverse Event|0|||
42201957|NCT02101853|76014575|FG001|Post Induction Randomization|Adverse Event|3|||
42201958|NCT02101853|76014576|FG002|Post Induction Randomization|Adverse Event|8|||
42201959|NCT02101853|76014577|FG003|Post Induction Randomization|Adverse Event|4|||
42201960|NCT02101853|76014578|FG004|Post Induction Randomization|Adverse Event|4|||
42201961|NCT02101853|76014579|FG005|Post Induction Randomization|Adverse Event|0|||
42201962|NCT02101853|76014574|FG000|Post Induction Randomization|Death|0|||
42201963|NCT02101853|76014575|FG001|Post Induction Randomization|Death|9|||
42201964|NCT02101853|76014576|FG002|Post Induction Randomization|Death|2|||
42201965|NCT02101853|76014577|FG003|Post Induction Randomization|Death|2|||
42201966|NCT02101853|76014578|FG004|Post Induction Randomization|Death|0|||
42201967|NCT02101853|76014579|FG005|Post Induction Randomization|Death|0|||
42201968|NCT02101853|76014574|FG000|Post Induction Randomization|Lack of Efficacy|0|||
42201969|NCT02101853|76014575|FG001|Post Induction Randomization|Lack of Efficacy|14|||
42201970|NCT02101853|76014576|FG002|Post Induction Randomization|Lack of Efficacy|23|||
42018813|NCT01254305|75826222|FG001|Overall Study|Adverse Event|3|||
42201971|NCT02101853|76014577|FG003|Post Induction Randomization|Lack of Efficacy|18|||
42201972|NCT02101853|76014578|FG004|Post Induction Randomization|Lack of Efficacy|21|||
42201973|NCT02101853|76014579|FG005|Post Induction Randomization|Lack of Efficacy|0|||
42201974|NCT02101853|76014574|FG000|Post Induction Randomization|Physician Decision|0|||
42201975|NCT02101853|76014575|FG001|Post Induction Randomization|Physician Decision|43|||
42201976|NCT02101853|76014576|FG002|Post Induction Randomization|Physician Decision|23|||
42201977|NCT02101853|76014577|FG003|Post Induction Randomization|Physician Decision|14|||
42201978|NCT02101853|76014578|FG004|Post Induction Randomization|Physician Decision|14|||
42201979|NCT02101853|76014579|FG005|Post Induction Randomization|Physician Decision|0|||
42201980|NCT02101853|76014574|FG000|Post Induction Randomization|Protocol Violation|0|||
42201981|NCT02101853|76014575|FG001|Post Induction Randomization|Protocol Violation|3|||
42106359|NCT00619866|75917405|FG003|Weeks 1 - 12|Adverse Event|0|||
42106360|NCT00619866|75917406|FG004|Weeks 1 - 12|Adverse Event|0|||
42106361|NCT00619866|75917402|FG000|Weeks 1 - 12|Non-compliance|0|||
42106362|NCT00619866|75917403|FG001|Weeks 1 - 12|Non-compliance|0|||
42106363|NCT00619866|75917404|FG002|Weeks 1 - 12|Non-compliance|1|||
42106364|NCT00619866|75917405|FG003|Weeks 1 - 12|Non-compliance|0|||
42106365|NCT00619866|75917406|FG004|Weeks 1 - 12|Non-compliance|0|||
42106366|NCT00619866|75917402|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
42106367|NCT00619866|75917403|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
42106368|NCT00619866|75917404|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
42106369|NCT00619866|75917405|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
42106370|NCT00619866|75917406|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
42106371|NCT00619866|75917402|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
42106372|NCT00619866|75917403|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
42106373|NCT00619866|75917404|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
42106374|NCT00619866|75917405|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
42106375|NCT00619866|75917406|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
42106376|NCT00619866|75917402|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
42106377|NCT00619866|75917403|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
42106378|NCT00619866|75917404|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
42106379|NCT00619866|75917405|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
42106380|NCT00619866|75917406|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
42106381|NCT00619866|75917402|FG000|Weeks 1 - 12|Sponsor Decision|0|||
42106382|NCT00619866|75917403|FG001|Weeks 1 - 12|Sponsor Decision|1|||
42018814|NCT01254305|75826223|FG002|Overall Study|Adverse Event|2|||
42018815|NCT01254305|75826221|FG000|Overall Study|Lack of Efficacy|1|||
42018816|NCT01254305|75826222|FG001|Overall Study|Lack of Efficacy|0|||
42018817|NCT01254305|75826223|FG002|Overall Study|Lack of Efficacy|1|||
42018818|NCT01254305|75826221|FG000|Overall Study|Protocol Violation|1|||
42018819|NCT01254305|75826222|FG001|Overall Study|Protocol Violation|7|||
42018820|NCT01254305|75826223|FG002|Overall Study|Protocol Violation|3|||
42018821|NCT01254305|75826221|FG000|Overall Study|Withdrawal by Subject|4|||
42018822|NCT01254305|75826222|FG001|Overall Study|Withdrawal by Subject|2|||
42018823|NCT01254305|75826223|FG002|Overall Study|Withdrawal by Subject|4|||
42018824|NCT01254305|75826221|FG000|Overall Study|Lost to Follow-up|10|||
42018825|NCT01254305|75826222|FG001|Overall Study|Lost to Follow-up|6|||
42018826|NCT01254305|75826223|FG002|Overall Study|Lost to Follow-up|5|||
42018827|NCT01254305|75826221|FG000|Overall Study|Other Reasons|0|||
42018828|NCT01254305|75826222|FG001|Overall Study|Other Reasons|0|||
42378846|NCT01465763|76250440|FG001|Overall Study|Insufficient Clinical Response|0|||
42378847|NCT01465763|76250441|FG002|Overall Study|Insufficient Clinical Response|1|||
42378848|NCT01465763|76250439|FG000|Overall Study|Adverse Event|9|||
42378849|NCT01465763|76250440|FG001|Overall Study|Adverse Event|0|||
42378850|NCT01465763|76250441|FG002|Overall Study|Adverse Event|1|||
42378851|NCT01465763|76250439|FG000|Overall Study|Other|2|||
42378852|NCT01465763|76250440|FG001|Overall Study|Other|0|||
42378853|NCT01465763|76250441|FG002|Overall Study|Other|0|||
42378854|NCT01465763|76250439|FG000|Overall Study|Protocol Violation|4|||
42378855|NCT01465763|76250440|FG001|Overall Study|Protocol Violation|1|||
42378856|NCT01465763|76250441|FG002|Overall Study|Protocol Violation|1|||
42378857|NCT01465763|76250439|FG000|Overall Study|Death|1|||
42378858|NCT01465763|76250440|FG001|Overall Study|Death|0|||
42378859|NCT01465763|76250441|FG002|Overall Study|Death|0|||
42378860|NCT01690520|76250474|FG000|Overall Study|Death|25|||
42378861|NCT01690520|76250475|FG001|Overall Study|Death|21|||
42378862|NCT01690520|76250474|FG000|Overall Study|Lost to Follow-up|2|||
42378863|NCT01690520|76250475|FG001|Overall Study|Lost to Follow-up|3|||
42378864|NCT01690520|76250474|FG000|Overall Study|Withdrawal by Subject|2|||
42378865|NCT01690520|76250475|FG001|Overall Study|Withdrawal by Subject|0|||
42378866|NCT01690520|76250474|FG000|Overall Study|Relapse|0|||
42378867|NCT01690520|76250475|FG001|Overall Study|Relapse|1|||
42378868|NCT01690520|76250474|FG000|Overall Study|Other|0|||
42378869|NCT01690520|76250475|FG001|Overall Study|Other|1|||
42378870|NCT01690520|76250474|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
42378871|NCT01690520|76250475|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
42378872|NCT01563536|76250496|FG000|Overall Study|Withdrawal by Subject|0|||
42378873|NCT01563536|76250497|FG001|Overall Study|Withdrawal by Subject|2|||
42378874|NCT01563536|76250496|FG000|Overall Study|Lost to Follow-up|1|||
42378875|NCT01563536|76250497|FG001|Overall Study|Lost to Follow-up|0|||
42378876|NCT01690130|76250505|FG000|Overall Study|Subject have cancelled visit.|1|||
42378877|NCT01690130|76250506|FG001|Overall Study|Subject have cancelled visit.|0|||
42378878|NCT01690052|76250512|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
42378879|NCT01690052|76250513|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
42378880|NCT01689974|76250540|FG000|Overall Study|Termination of Study|5|||
42378881|NCT01689974|76250541|FG001|Overall Study|Termination of Study|5|||
42378882|NCT01587014|76250547|FG000|Overall Study|Death|2|||
42378883|NCT01458535|76250651|FG000|Overall Study|Other|0|||
42378884|NCT01458535|76250652|FG001|Overall Study|Other|0|||
42378885|NCT01458535|76250653|FG002|Overall Study|Other|0|||
42378886|NCT01458535|76250654|FG003|Overall Study|Other|0|||
42378887|NCT01458535|76250655|FG004|Overall Study|Other|1|||
42378888|NCT01458535|76250656|FG005|Overall Study|Other|1|||
42378889|NCT01458535|76250651|FG000|Overall Study|Withdrawal by Subject|0|||
42378890|NCT01458535|76250652|FG001|Overall Study|Withdrawal by Subject|0|||
42378891|NCT01458535|76250653|FG002|Overall Study|Withdrawal by Subject|2|||
42378892|NCT01458535|76250654|FG003|Overall Study|Withdrawal by Subject|0|||
42378893|NCT01458535|76250655|FG004|Overall Study|Withdrawal by Subject|1|||
42378894|NCT01458535|76250656|FG005|Overall Study|Withdrawal by Subject|1|||
42018829|NCT01254305|75826223|FG002|Overall Study|Other Reasons|2|||
42018830|NCT01122927|75826234|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
42018831|NCT01122927|75826235|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
42018832|NCT01122927|75826234|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
42018833|NCT01122927|75826235|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
42018834|NCT01122927|75826234|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
42378895|NCT01458535|76250651|FG000|Overall Study|Lost to Follow-up|0|||
42378896|NCT01458535|76250652|FG001|Overall Study|Lost to Follow-up|2|||
42378897|NCT01458535|76250653|FG002|Overall Study|Lost to Follow-up|0|||
42378898|NCT01458535|76250654|FG003|Overall Study|Lost to Follow-up|3|||
42378899|NCT01458535|76250655|FG004|Overall Study|Lost to Follow-up|2|||
42378900|NCT01458535|76250656|FG005|Overall Study|Lost to Follow-up|2|||
42378901|NCT01458535|76250651|FG000|Overall Study|Adverse Event|0|||
42378902|NCT01458535|76250652|FG001|Overall Study|Adverse Event|0|||
42378903|NCT01458535|76250653|FG002|Overall Study|Adverse Event|0|||
42378904|NCT01458535|76250654|FG003|Overall Study|Adverse Event|1|||
42378905|NCT01458535|76250655|FG004|Overall Study|Adverse Event|0|||
42378906|NCT01458535|76250656|FG005|Overall Study|Adverse Event|0|||
42378907|NCT01464827|76250684|FG000|Overall Study|Adverse Event|0|||
42378908|NCT01464827|76250685|FG001|Overall Study|Adverse Event|0|||
42378909|NCT01464827|76250686|FG002|Overall Study|Adverse Event|0|||
42378910|NCT01464827|76250687|FG003|Overall Study|Adverse Event|0|||
42378911|NCT01464827|76250688|FG004|Overall Study|Adverse Event|0|||
42378912|NCT01464827|76250689|FG005|Overall Study|Adverse Event|0|||
42378913|NCT01464827|76250690|FG006|Overall Study|Adverse Event|0|||
42378914|NCT01464827|76250691|FG007|Overall Study|Adverse Event|0|||
42378915|NCT01464827|76250692|FG008|Overall Study|Adverse Event|0|||
42378916|NCT01464827|76250693|FG009|Overall Study|Adverse Event|0|||
42378917|NCT01464827|76250694|FG010|Overall Study|Adverse Event|0|||
42378918|NCT01464827|76250695|FG011|Overall Study|Adverse Event|0|||
42378919|NCT01464827|76250696|FG012|Overall Study|Adverse Event|1|||
42378920|NCT01464827|76250697|FG013|Overall Study|Adverse Event|0|||
42378921|NCT01464827|76250684|FG000|Overall Study|Withdrawal by Subject|1|||
42378922|NCT01464827|76250685|FG001|Overall Study|Withdrawal by Subject|0|||
42378923|NCT01464827|76250686|FG002|Overall Study|Withdrawal by Subject|0|||
42378924|NCT01464827|76250687|FG003|Overall Study|Withdrawal by Subject|0|||
42378925|NCT01464827|76250688|FG004|Overall Study|Withdrawal by Subject|1|||
42378926|NCT01464827|76250689|FG005|Overall Study|Withdrawal by Subject|0|||
42378927|NCT01464827|76250690|FG006|Overall Study|Withdrawal by Subject|0|||
42378928|NCT01464827|76250691|FG007|Overall Study|Withdrawal by Subject|1|||
42378929|NCT01464827|76250692|FG008|Overall Study|Withdrawal by Subject|0|||
42378930|NCT01464827|76250693|FG009|Overall Study|Withdrawal by Subject|0|||
42378931|NCT01464827|76250694|FG010|Overall Study|Withdrawal by Subject|0|||
42378932|NCT01464827|76250695|FG011|Overall Study|Withdrawal by Subject|0|||
42378933|NCT01464827|76250696|FG012|Overall Study|Withdrawal by Subject|0|||
42378934|NCT01464827|76250697|FG013|Overall Study|Withdrawal by Subject|0|||
42378935|NCT01464827|76250684|FG000|Overall Study|Lost to Follow-up|0|||
42378936|NCT01464827|76250685|FG001|Overall Study|Lost to Follow-up|2|||
42378937|NCT01464827|76250686|FG002|Overall Study|Lost to Follow-up|0|||
42378938|NCT01464827|76250687|FG003|Overall Study|Lost to Follow-up|2|||
42378939|NCT01464827|76250688|FG004|Overall Study|Lost to Follow-up|3|||
42378940|NCT01464827|76250689|FG005|Overall Study|Lost to Follow-up|1|||
42378941|NCT01464827|76250690|FG006|Overall Study|Lost to Follow-up|2|||
42378942|NCT01464827|76250691|FG007|Overall Study|Lost to Follow-up|2|||
42378943|NCT01464827|76250692|FG008|Overall Study|Lost to Follow-up|0|||
42378944|NCT01464827|76250693|FG009|Overall Study|Lost to Follow-up|0|||
42378945|NCT01464827|76250694|FG010|Overall Study|Lost to Follow-up|0|||
42378946|NCT01464827|76250695|FG011|Overall Study|Lost to Follow-up|1|||
42378947|NCT01464827|76250696|FG012|Overall Study|Lost to Follow-up|0|||
42378948|NCT01464827|76250697|FG013|Overall Study|Lost to Follow-up|1|||
42378949|NCT01464827|76250684|FG000|Overall Study|Other|2|||
42378950|NCT01464827|76250685|FG001|Overall Study|Other|3|||
42378951|NCT01464827|76250686|FG002|Overall Study|Other|0|||
42378952|NCT01464827|76250687|FG003|Overall Study|Other|2|||
42378953|NCT01464827|76250688|FG004|Overall Study|Other|3|||
42378954|NCT01464827|76250689|FG005|Overall Study|Other|0|||
42378955|NCT01464827|76250690|FG006|Overall Study|Other|1|||
42378956|NCT01464827|76250691|FG007|Overall Study|Other|0|||
42378957|NCT01464827|76250692|FG008|Overall Study|Other|3|||
42378958|NCT01464827|76250693|FG009|Overall Study|Other|1|||
42378959|NCT01464827|76250694|FG010|Overall Study|Other|2|||
42378960|NCT01464827|76250695|FG011|Overall Study|Other|0|||
42378961|NCT01464827|76250696|FG012|Overall Study|Other|1|||
42378962|NCT01464827|76250697|FG013|Overall Study|Other|0|||
42378963|NCT01464827|76250684|FG000|Overall Study|Not Treated|0|||
42378964|NCT01464827|76250685|FG001|Overall Study|Not Treated|2|||
42378965|NCT01464827|76250686|FG002|Overall Study|Not Treated|0|||
42378966|NCT01464827|76250687|FG003|Overall Study|Not Treated|0|||
42378967|NCT01464827|76250688|FG004|Overall Study|Not Treated|1|||
42378968|NCT01464827|76250689|FG005|Overall Study|Not Treated|0|||
42201982|NCT02101853|76014576|FG002|Post Induction Randomization|Protocol Violation|0|||
42201983|NCT02101853|76014577|FG003|Post Induction Randomization|Protocol Violation|0|||
42106383|NCT00619866|75917404|FG002|Weeks 1 - 12|Sponsor Decision|0|||
42378969|NCT01464827|76250690|FG006|Overall Study|Not Treated|1|||
42378970|NCT01464827|76250691|FG007|Overall Study|Not Treated|0|||
42378971|NCT01464827|76250692|FG008|Overall Study|Not Treated|0|||
42378972|NCT01464827|76250693|FG009|Overall Study|Not Treated|2|||
42378973|NCT01464827|76250694|FG010|Overall Study|Not Treated|0|||
42378974|NCT01464827|76250695|FG011|Overall Study|Not Treated|1|||
42378975|NCT01464827|76250696|FG012|Overall Study|Not Treated|0|||
42378976|NCT01464827|76250697|FG013|Overall Study|Not Treated|2|||
42378977|NCT01463111|76250738|FG000|Overall Study|Withdrawal by Subject|2|||
42378978|NCT01463111|76250738|FG000|Overall Study|Lost to Follow-up|5|||
42378979|NCT01463111|76250738|FG000|Overall Study|Physician Decision|2|||
42378980|NCT01463033|76250744|FG000|Overall Study|Lost to Follow-up|4|||
42378981|NCT01463033|76250745|FG001|Overall Study|Lost to Follow-up|4|||
42378982|NCT01463033|76250744|FG000|Overall Study|Death|3|||
42378983|NCT01463033|76250745|FG001|Overall Study|Death|2|||
42378984|NCT01461707|76250754|FG000|Overall Study|Withdrawal by Subject|1|||
42378985|NCT01461707|76250755|FG001|Overall Study|Withdrawal by Subject|0|||
42378986|NCT01461551|76250764|FG000|Overall Study|Physician Decision|2|||
42378987|NCT01461551|76250765|FG001|Overall Study|Physician Decision|1|||
42378988|NCT01461551|76250766|FG002|Overall Study|Physician Decision|2|||
42378989|NCT01461005|76250774|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
42378990|NCT01460381|76250781|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
42378991|NCT01460381|76250782|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
42378992|NCT01473589|76250866|FG000|Overall Study|Adverse Event|1|||
42378993|NCT01473589|76250867|FG001|Overall Study|Adverse Event|1|||
42378994|NCT01473589|76250866|FG000|Overall Study|Death|2|||
42378995|NCT01473589|76250867|FG001|Overall Study|Death|0|||
42378996|NCT01473589|76250866|FG000|Overall Study|Lost to Follow-up|2|||
42378997|NCT01473589|76250867|FG001|Overall Study|Lost to Follow-up|2|||
42378998|NCT01473589|76250866|FG000|Overall Study|Protocol Violation|1|||
42378999|NCT01473589|76250867|FG001|Overall Study|Protocol Violation|0|||
42379000|NCT01473589|76250866|FG000|Overall Study|Withdrawal by Subject|5|||
42379001|NCT01473589|76250867|FG001|Overall Study|Withdrawal by Subject|11|||
42379002|NCT01473589|76250866|FG000|Overall Study|Physician Decision|0|||
42018835|NCT01122927|75826235|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
42018836|NCT01122927|75826234|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
42018837|NCT01122927|75826235|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
42018838|NCT01122927|75826234|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
42018839|NCT01122927|75826235|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
42018840|NCT01122927|75826234|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
42018841|NCT01122927|75826235|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
42018842|NCT01122927|75826234|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
42018843|NCT01122927|75826235|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
42379003|NCT01473589|76250867|FG001|Overall Study|Physician Decision|1|||
42379004|NCT01473589|76250866|FG000|Overall Study|Entry criteria not met|0|||
42379005|NCT01473589|76250867|FG001|Overall Study|Entry criteria not met|1|||
42379006|NCT01500187|76250886|FG000|Overall Study|Lost to Follow-up|6|||
42379007|NCT01500187|76250887|FG001|Overall Study|Lost to Follow-up|0|||
42379008|NCT01500031|76250905|FG000|Overall Study|Death|1|||
42379009|NCT01500031|76250905|FG000|Overall Study|Withdrawal by Subject|4|||
42379010|NCT01473355|76250918|FG000|Overall Study|Protocol Violation|2|||
42379011|NCT01473355|76250918|FG000|Overall Study|Adverse Event|2|||
42379012|NCT01473355|76250918|FG000|Overall Study|Lost to Follow-up|2|||
42379013|NCT01472965|76250928|FG000|Overall Study|Withdrawal by Subject|1|||
42379014|NCT01472965|76250929|FG001|Overall Study|Withdrawal by Subject|0|||
42379015|NCT01457053|76250939|FG000|Overall Study|Unable to undergo selected treatment|1|||
42379016|NCT01457053|76250940|FG001|Overall Study|Unable to undergo selected treatment|1|||
42379017|NCT01472341|76250955|FG000|Overall Study|Started insulin therapy|55|||
42379018|NCT01472341|76250955|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
42379019|NCT01472341|76250955|FG000|Overall Study|Withdrawal by Subject|39|||
42379020|NCT01472341|76250955|FG000|Overall Study|Lost to Follow-up|52|||
42379021|NCT01472341|76250955|FG000|Overall Study|Laboratory parameters unavailable|25|||
42379022|NCT01472341|76250955|FG000|Overall Study|Death|9|||
42379023|NCT01472185|76250961|FG000|Overall Study|Randomized but Not Treated|0|||
42379024|NCT01472185|76250962|FG001|Overall Study|Randomized but Not Treated|1|||
42379025|NCT01472185|76250961|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
42379026|NCT01472185|76250962|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
42379027|NCT01472185|76250961|FG000|Overall Study|Hyperglycemia|5|||
42379028|NCT01472185|76250962|FG001|Overall Study|Hyperglycemia|2|||
42379029|NCT01472185|76250961|FG000|Overall Study|Investigator's Discretion|3|||
42379030|NCT01472185|76250962|FG001|Overall Study|Investigator's Discretion|1|||
42379031|NCT01472185|76250961|FG000|Overall Study|Lost to Follow-up|4|||
42379032|NCT01472185|76250962|FG001|Overall Study|Lost to Follow-up|1|||
42379033|NCT01472185|76250961|FG000|Overall Study|Protocol Violation|5|||
42379034|NCT01472185|76250962|FG001|Overall Study|Protocol Violation|1|||
42379035|NCT01472185|76250961|FG000|Overall Study|Subject Noncompliance|8|||
42379036|NCT01472185|76250962|FG001|Overall Study|Subject Noncompliance|15|||
42379037|NCT01472185|76250961|FG000|Overall Study|Subject Withdrew Consent|6|||
42379038|NCT01472185|76250962|FG001|Overall Study|Subject Withdrew Consent|3|||
42379039|NCT01456897|76250983|FG000|Overall Study|Adverse Event|19|||
42379040|NCT01456897|76250984|FG001|Overall Study|Adverse Event|22|||
42379041|NCT01456897|76250983|FG000|Overall Study|Protocol Violation|3|||
42379042|NCT01456897|76250984|FG001|Overall Study|Protocol Violation|4|||
42379043|NCT01456897|76250983|FG000|Overall Study|Physician Decision|5|||
42379044|NCT01456897|76250984|FG001|Overall Study|Physician Decision|3|||
42379045|NCT01456897|76250983|FG000|Overall Study|Withdrawal by Subject|44|||
42379046|NCT01456897|76250984|FG001|Overall Study|Withdrawal by Subject|17|||
42379047|NCT01456897|76250983|FG000|Overall Study|Lack of Efficacy|4|||
42379048|NCT01456897|76250984|FG001|Overall Study|Lack of Efficacy|11|||
42379049|NCT01456195|76250997|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
42379050|NCT01456195|76250998|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
42379051|NCT01456195|76250999|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
42379052|NCT01456195|76250997|FG000|Overall Study|Lost to Follow-up|3|||
42379053|NCT01456195|76250998|FG001|Overall Study|Lost to Follow-up|1|||
42379054|NCT01456195|76250999|FG002|Overall Study|Lost to Follow-up|3|||
42379055|NCT01456195|76250997|FG000|Overall Study|Voluntary Withdrawal|5|||
42379056|NCT01456195|76250998|FG001|Overall Study|Voluntary Withdrawal|3|||
42379057|NCT01456195|76250999|FG002|Overall Study|Voluntary Withdrawal|7|||
42379058|NCT01456195|76250997|FG000|Overall Study|Lack of Efficacy|0|||
42379059|NCT01456195|76250998|FG001|Overall Study|Lack of Efficacy|1|||
42379060|NCT01456195|76250999|FG002|Overall Study|Lack of Efficacy|0|||
42379061|NCT01456195|76250997|FG000|Overall Study|Other Reasons|2|||
42379062|NCT01456195|76250998|FG001|Overall Study|Other Reasons|1|||
42379063|NCT01456195|76250999|FG002|Overall Study|Other Reasons|3|||
42379064|NCT01456039|76251063|FG000|Phase 1 (First Step)|Disease Progression|1|||
42379065|NCT01456039|76251064|FG001|Phase 1 (First Step)|Disease Progression|1|||
42379066|NCT01456039|76251065|FG002|Phase 1 (First Step)|Disease Progression|0|||
42379067|NCT01456039|76251063|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
42379068|NCT01456039|76251064|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
42379069|NCT01456039|76251065|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
42379070|NCT01456039|76251063|FG000|Phase 1 (First Step)|Adverse Event|0|||
42379071|NCT01456039|76251064|FG001|Phase 1 (First Step)|Adverse Event|3|||
42379072|NCT01456039|76251065|FG002|Phase 1 (First Step)|Adverse Event|0|||
42379073|NCT01456039|76251063|FG000|Phase 1 (First Step)|Other|0|||
42379074|NCT01456039|76251064|FG001|Phase 1 (First Step)|Other|1|||
42379075|NCT01456039|76251065|FG002|Phase 1 (First Step)|Other|0|||
42379076|NCT01456039|76251063|FG000|Phase 2 (Second Step)|Disease Progression|0|||
42379077|NCT01456039|76251064|FG001|Phase 2 (Second Step)|Disease Progression|0|||
42379078|NCT01456039|76251065|FG002|Phase 2 (Second Step)|Disease Progression|17|||
42379079|NCT01456039|76251063|FG000|Phase 2 (Second Step)|Adverse Event|0|||
42379080|NCT01456039|76251064|FG001|Phase 2 (Second Step)|Adverse Event|0|||
42379081|NCT01456039|76251065|FG002|Phase 2 (Second Step)|Adverse Event|10|||
42379082|NCT01456039|76251063|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
42379083|NCT01456039|76251064|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
42379084|NCT01456039|76251065|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
42379085|NCT01456039|76251063|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
42379086|NCT01456039|76251064|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
42379087|NCT01456039|76251065|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
42379088|NCT01456039|76251063|FG000|Phase 2 (Second Step)|Other|0|||
42379089|NCT01456039|76251064|FG001|Phase 2 (Second Step)|Other|0|||
42379090|NCT01456039|76251065|FG002|Phase 2 (Second Step)|Other|1|||
42379091|NCT01455415|76251083|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
42379092|NCT01455415|76251084|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
42379093|NCT01455415|76251083|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
42379094|NCT01455415|76251084|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
42379095|NCT01455415|76251083|FG000|Period 1|Drug Error not Associated to AE|0|||
42379096|NCT01455415|76251084|FG001|Period 1|Drug Error not Associated to AE|1|||
42379097|NCT01455415|76251083|FG000|Period 1|AE Not Related to Study Drug|2|||
42379098|NCT01455415|76251084|FG001|Period 1|AE Not Related to Study Drug|6|||
42379099|NCT01455415|76251083|FG000|Period 1|Withdrawal by Subject|4|||
42379100|NCT01455415|76251084|FG001|Period 1|Withdrawal by Subject|5|||
42379101|NCT01455415|76251083|FG000|Period 1|Unspecified Reason|1|||
42379102|NCT01455415|76251084|FG001|Period 1|Unspecified Reason|1|||
42379103|NCT01455415|76251083|FG000|Period 1|Protocol Violation|0|||
42379104|NCT01455415|76251084|FG001|Period 1|Protocol Violation|2|||
42379105|NCT01455415|76251083|FG000|Washout|AE Related to Study Drug|2|||
42379106|NCT01455415|76251084|FG001|Washout|AE Related to Study Drug|0|||
42379107|NCT01455415|76251083|FG000|Washout|Lost to Follow-up|1|||
42379108|NCT01455415|76251084|FG001|Washout|Lost to Follow-up|0|||
42379109|NCT01455415|76251083|FG000|Washout|Drug Error not Associated to AE|2|||
42379110|NCT01455415|76251084|FG001|Washout|Drug Error not Associated to AE|1|||
42379111|NCT01455415|76251083|FG000|Washout|AE Not Related to Study Drug|2|||
42379112|NCT01455415|76251084|FG001|Washout|AE Not Related to Study Drug|3|||
42379113|NCT01455415|76251083|FG000|Washout|Unspecified Reason|1|||
42379114|NCT01455415|76251084|FG001|Washout|Unspecified Reason|2|||
42379115|NCT01455415|76251083|FG000|Washout|Protocol Violation|0|||
42379116|NCT01455415|76251084|FG001|Washout|Protocol Violation|1|||
42379117|NCT01455415|76251083|FG000|Period 2|AE Related to Study Drug|1|||
42379118|NCT01455415|76251084|FG001|Period 2|AE Related to Study Drug|2|||
42379119|NCT01455415|76251083|FG000|Period 2|Lost to Follow-up|2|||
42379120|NCT01455415|76251084|FG001|Period 2|Lost to Follow-up|1|||
42379121|NCT01455415|76251083|FG000|Period 2|AE Not Related to Study Drug|2|||
42379122|NCT01455415|76251084|FG001|Period 2|AE Not Related to Study Drug|1|||
42379123|NCT01455415|76251083|FG000|Period 2|Lack of Efficacy|2|||
42379124|NCT01455415|76251084|FG001|Period 2|Lack of Efficacy|0|||
42379125|NCT01455415|76251083|FG000|Period 2|Withdrawal by Subject|2|||
42379126|NCT01455415|76251084|FG001|Period 2|Withdrawal by Subject|3|||
42379127|NCT01455415|76251083|FG000|Period 2|Unspecified Reason|2|||
42379128|NCT01455415|76251084|FG001|Period 2|Unspecified Reason|3|||
42379129|NCT01455415|76251083|FG000|Period 2|Protocol Violation|2|||
42379130|NCT01455415|76251084|FG001|Period 2|Protocol Violation|0|||
42379131|NCT01455415|76251083|FG000|Follow-up|AE Related to Study Drug|0|||
42379132|NCT01455415|76251084|FG001|Follow-up|AE Related to Study Drug|1|||
42379133|NCT01455415|76251083|FG000|Follow-up|Lack of Efficacy|0|||
42379134|NCT01455415|76251084|FG001|Follow-up|Lack of Efficacy|1|||
42379135|NCT01455415|76251083|FG000|Follow-up|Withdrawal by Subject|2|||
42379136|NCT01455415|76251084|FG001|Follow-up|Withdrawal by Subject|0|||
42379137|NCT01455415|76251083|FG000|Follow-up|Unspecified Reason|1|||
42379138|NCT01455415|76251084|FG001|Follow-up|Unspecified Reason|0|||
42379139|NCT01471171|76251090|FG000|Treatment Period 1|Adverse Event|4|||
42379140|NCT01471171|76251091|FG001|Treatment Period 1|Adverse Event|1|||
42379141|NCT01471171|76251090|FG000|Treatment Period 2|Adverse Event|1|||
42379142|NCT01471171|76251091|FG001|Treatment Period 2|Adverse Event|0|||
42379143|NCT01471093|76251099|FG000|Overall Study|Adverse Event|1|||
42379144|NCT01471093|76251100|FG001|Overall Study|Adverse Event|0|||
42379145|NCT01471093|76251101|FG002|Overall Study|Adverse Event|0|||
42106384|NCT00619866|75917405|FG003|Weeks 1 - 12|Sponsor Decision|0|||
42379146|NCT01471093|76251102|FG003|Overall Study|Adverse Event|0|||
42379147|NCT01471015|76251111|FG000|Overall Study|Death|0|||
42106385|NCT00619866|75917406|FG004|Weeks 1 - 12|Sponsor Decision|0|||
42106386|NCT00619866|75917402|FG000|Weeks 13 - 24|Adverse Event|0|||
42379148|NCT01471015|76251112|FG001|Overall Study|Death|1|||
42379149|NCT01471015|76251113|FG002|Overall Study|Death|1|||
42379150|NCT01497067|76251121|FG000|Overall Study|Lost to Follow-up|56|||
42106387|NCT00619866|75917403|FG001|Weeks 13 - 24|Adverse Event|0|||
42379151|NCT01497067|76251121|FG000|Overall Study|Adverse Event|3|||
42379152|NCT01497067|76251121|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
42379153|NCT01497067|76251121|FG000|Overall Study|Other|13|||
42379154|NCT01470469|76251151|FG000|Overall Study|Withdrawal by Subject|4|||
42379155|NCT01470469|76251152|FG001|Overall Study|Withdrawal by Subject|6|||
42379156|NCT01470469|76251151|FG000|Overall Study|Lack of Efficacy|1|||
42379157|NCT01470469|76251152|FG001|Overall Study|Lack of Efficacy|7|||
42379158|NCT01470469|76251151|FG000|Overall Study|Adverse Event|0|||
42379159|NCT01470469|76251152|FG001|Overall Study|Adverse Event|7|||
42379160|NCT01470469|76251151|FG000|Overall Study|Lost to Follow-up|2|||
42379161|NCT01470469|76251152|FG001|Overall Study|Lost to Follow-up|2|||
42379162|NCT01470469|76251151|FG000|Overall Study|Protocol Violation|1|||
42379163|NCT01470469|76251152|FG001|Overall Study|Protocol Violation|1|||
42379164|NCT01470469|76251151|FG000|Overall Study|Other|2|||
42379165|NCT01470469|76251152|FG001|Overall Study|Other|1|||
42379166|NCT01470001|76251160|FG000|Overall Study|Lost to Follow-up|1|||
42379167|NCT01470001|76251161|FG001|Overall Study|Lost to Follow-up|1|||
42379168|NCT01470001|76251160|FG000|Overall Study|Physician Decision|2|||
42379169|NCT01470001|76251161|FG001|Overall Study|Physician Decision|0|||
42379170|NCT01470001|76251160|FG000|Overall Study|Withdrawal by Subject|2|||
42379171|NCT01470001|76251161|FG001|Overall Study|Withdrawal by Subject|1|||
42379172|NCT01469377|76251170|FG000|Overall Study|Protocol Deviation|7|||
42379173|NCT01469377|76251171|FG001|Overall Study|Protocol Deviation|10|||
42379174|NCT01469377|76251172|FG002|Overall Study|Protocol Deviation|10|||
42379175|NCT01469377|76251170|FG000|Overall Study|Lost to Follow-up|3|||
42379176|NCT01469377|76251171|FG001|Overall Study|Lost to Follow-up|2|||
42379177|NCT01469377|76251172|FG002|Overall Study|Lost to Follow-up|5|||
42379178|NCT01469377|76251170|FG000|Overall Study|Withdrawal of Consent|12|||
42379179|NCT01469377|76251171|FG001|Overall Study|Withdrawal of Consent|14|||
42379180|NCT01469377|76251172|FG002|Overall Study|Withdrawal of Consent|15|||
42379181|NCT01469377|76251170|FG000|Overall Study|Adverse Event|8|||
42379182|NCT01469377|76251171|FG001|Overall Study|Adverse Event|18|||
42379183|NCT01469377|76251172|FG002|Overall Study|Adverse Event|36|||
42379184|NCT01469377|76251170|FG000|Overall Study|Insufficient Therapeutic Response|3|||
42379185|NCT01469377|76251171|FG001|Overall Study|Insufficient Therapeutic Response|4|||
42379186|NCT01469377|76251172|FG002|Overall Study|Insufficient Therapeutic Response|0|||
42379187|NCT01469377|76251170|FG000|Overall Study|Other Miscellaneous Reasons|2|||
42379188|NCT01469377|76251171|FG001|Overall Study|Other Miscellaneous Reasons|0|||
42379189|NCT01469377|76251172|FG002|Overall Study|Other Miscellaneous Reasons|0|||
42379190|NCT01469221|76251182|FG000|Double Blind Phase|Protocol Violation|1|||
42379191|NCT01469221|76251183|FG001|Double Blind Phase|Protocol Violation|0|||
42379192|NCT01469221|76251184|FG002|Double Blind Phase|Protocol Violation|0|||
42379193|NCT01469221|76251182|FG000|Double Blind Phase|Physician Decision|1|||
42379194|NCT01469221|76251183|FG001|Double Blind Phase|Physician Decision|1|||
42379195|NCT01469221|76251184|FG002|Double Blind Phase|Physician Decision|0|||
42379196|NCT01469221|76251182|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
42379197|NCT01469221|76251183|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
42379198|NCT01469221|76251184|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
42379199|NCT01453855|76251193|FG000|Overall Study|Adverse Event|3|||
42379200|NCT01453855|76251194|FG001|Overall Study|Adverse Event|4|||
42379201|NCT01453855|76251193|FG000|Overall Study|Lost to Follow-up|2|||
42379202|NCT01453855|76251194|FG001|Overall Study|Lost to Follow-up|1|||
42379203|NCT01453855|76251193|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
42379204|NCT01453855|76251194|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
42379205|NCT01453855|76251193|FG000|Overall Study|Noncompliance|1|||
42379206|NCT01453855|76251194|FG001|Overall Study|Noncompliance|0|||
42379207|NCT01453855|76251193|FG000|Overall Study|Inadequate Control of IOP|1|||
42379208|NCT01453855|76251194|FG001|Overall Study|Inadequate Control of IOP|5|||
42379209|NCT01453855|76251193|FG000|Overall Study|Other|0|||
42379210|NCT01453855|76251194|FG001|Overall Study|Other|1|||
42379211|NCT01469065|76251205|FG000|Overall Study|Lack of Efficacy|0|||
42379212|NCT01469065|76251206|FG001|Overall Study|Lack of Efficacy|0|||
42379213|NCT01469065|76251207|FG002|Overall Study|Lack of Efficacy|0|||
42379214|NCT01469065|76251208|FG003|Overall Study|Lack of Efficacy|0|||
42379215|NCT01469065|76251209|FG004|Overall Study|Lack of Efficacy|1|||
42379216|NCT01469065|76251205|FG000|Overall Study|Other|0|||
42379217|NCT01469065|76251206|FG001|Overall Study|Other|1|||
42379218|NCT01469065|76251207|FG002|Overall Study|Other|0|||
42379219|NCT01469065|76251208|FG003|Overall Study|Other|0|||
42379220|NCT01469065|76251209|FG004|Overall Study|Other|0|||
42379221|NCT01586624|76251233|FG000|Overall Study|Adverse Event|3|||
42379222|NCT01586624|76251234|FG001|Overall Study|Adverse Event|0|||
42379223|NCT01586624|76251235|FG002|Overall Study|Adverse Event|2|||
42379224|NCT01586624|76251236|FG003|Overall Study|Adverse Event|1|||
42379225|NCT01586624|76251237|FG004|Overall Study|Adverse Event|3|||
42379226|NCT01586624|76251238|FG005|Overall Study|Adverse Event|3|||
42379227|NCT01586624|76251239|FG006|Overall Study|Adverse Event|2|||
42379228|NCT01586624|76251240|FG007|Overall Study|Adverse Event|3|||
42379229|NCT01586624|76251233|FG000|Overall Study|Physician Decision|0|||
42379230|NCT01586624|76251234|FG001|Overall Study|Physician Decision|1|||
42379231|NCT01586624|76251235|FG002|Overall Study|Physician Decision|1|||
42379232|NCT01586624|76251236|FG003|Overall Study|Physician Decision|0|||
42379233|NCT01586624|76251237|FG004|Overall Study|Physician Decision|2|||
42379234|NCT01586624|76251238|FG005|Overall Study|Physician Decision|0|||
42379235|NCT01586624|76251239|FG006|Overall Study|Physician Decision|1|||
42379236|NCT01586624|76251240|FG007|Overall Study|Physician Decision|1|||
42379237|NCT01586624|76251233|FG000|Overall Study|Withdrawal by Subject|0|||
42379238|NCT01586624|76251234|FG001|Overall Study|Withdrawal by Subject|0|||
42379239|NCT01586624|76251235|FG002|Overall Study|Withdrawal by Subject|0|||
42379240|NCT01586624|76251236|FG003|Overall Study|Withdrawal by Subject|1|||
42379241|NCT01586624|76251237|FG004|Overall Study|Withdrawal by Subject|0|||
42379242|NCT01586624|76251238|FG005|Overall Study|Withdrawal by Subject|0|||
42379243|NCT01586624|76251239|FG006|Overall Study|Withdrawal by Subject|0|||
42379244|NCT01586624|76251240|FG007|Overall Study|Withdrawal by Subject|0|||
42379245|NCT01586624|76251233|FG000|Overall Study|Evidence of disease progression|1|||
42379246|NCT01586624|76251234|FG001|Overall Study|Evidence of disease progression|3|||
42379247|NCT01586624|76251235|FG002|Overall Study|Evidence of disease progression|2|||
42379248|NCT01586624|76251236|FG003|Overall Study|Evidence of disease progression|5|||
42379249|NCT01586624|76251237|FG004|Overall Study|Evidence of disease progression|3|||
42379250|NCT01586624|76251238|FG005|Overall Study|Evidence of disease progression|5|||
42379251|NCT01586624|76251239|FG006|Overall Study|Evidence of disease progression|4|||
42379252|NCT01586624|76251240|FG007|Overall Study|Evidence of disease progression|6|||
42379253|NCT01586624|76251233|FG000|Overall Study|Screen failure (no treatment received)|0|||
42379254|NCT01586624|76251234|FG001|Overall Study|Screen failure (no treatment received)|0|||
42379255|NCT01586624|76251235|FG002|Overall Study|Screen failure (no treatment received)|0|||
42379256|NCT01586624|76251236|FG003|Overall Study|Screen failure (no treatment received)|0|||
42379257|NCT01586624|76251237|FG004|Overall Study|Screen failure (no treatment received)|0|||
42379258|NCT01586624|76251238|FG005|Overall Study|Screen failure (no treatment received)|0|||
42379259|NCT01586624|76251239|FG006|Overall Study|Screen failure (no treatment received)|1|||
42379260|NCT01586624|76251240|FG007|Overall Study|Screen failure (no treatment received)|0|||
42379261|NCT01586156|76251262|FG000|Overall Study|Pregnancy|0|||
42379262|NCT01586156|76251263|FG001|Overall Study|Pregnancy|1|||
42379263|NCT01586156|76251264|FG002|Overall Study|Pregnancy|0|||
42379264|NCT01459913|76251276|FG000|Overall Study|Adverse Event|0|||
42379265|NCT01459913|76251277|FG001|Overall Study|Adverse Event|0|||
42379266|NCT01459913|76251278|FG002|Overall Study|Adverse Event|0|||
42379267|NCT01459913|76251279|FG003|Overall Study|Adverse Event|3|||
42379268|NCT01459913|76251276|FG000|Overall Study|Withdrawal by Subject|4|||
42379269|NCT01459913|76251277|FG001|Overall Study|Withdrawal by Subject|0|||
42379270|NCT01459913|76251278|FG002|Overall Study|Withdrawal by Subject|0|||
42379271|NCT01459913|76251279|FG003|Overall Study|Withdrawal by Subject|5|||
42379272|NCT01459913|76251276|FG000|Overall Study|Lost to Follow-up|7|||
42379273|NCT01459913|76251277|FG001|Overall Study|Lost to Follow-up|4|||
42379274|NCT01459913|76251278|FG002|Overall Study|Lost to Follow-up|1|||
42379275|NCT01459913|76251279|FG003|Overall Study|Lost to Follow-up|8|||
42379276|NCT01459913|76251276|FG000|Overall Study|Death|0|||
42379277|NCT01459913|76251277|FG001|Overall Study|Death|0|||
42379278|NCT01459913|76251278|FG002|Overall Study|Death|0|||
42379279|NCT01459913|76251279|FG003|Overall Study|Death|1|||
42379280|NCT01459913|76251276|FG000|Overall Study|Non- Compliance|0|||
42379281|NCT01459913|76251277|FG001|Overall Study|Non- Compliance|0|||
42379282|NCT01459913|76251278|FG002|Overall Study|Non- Compliance|0|||
42379283|NCT01459913|76251279|FG003|Overall Study|Non- Compliance|3|||
42379284|NCT01459913|76251276|FG000|Overall Study|Physician Decision|0|||
42379285|NCT01459913|76251277|FG001|Overall Study|Physician Decision|1|||
42379286|NCT01459913|76251278|FG002|Overall Study|Physician Decision|0|||
42379287|NCT01459913|76251279|FG003|Overall Study|Physician Decision|0|||
42379288|NCT01459913|76251276|FG000|Overall Study|Study Terminated by Sponsor|30|||
42379289|NCT01459913|76251277|FG001|Overall Study|Study Terminated by Sponsor|15|||
42379290|NCT01459913|76251278|FG002|Overall Study|Study Terminated by Sponsor|9|||
42379291|NCT01459913|76251279|FG003|Overall Study|Study Terminated by Sponsor|11|||
42379292|NCT01459913|76251276|FG000|Overall Study|Other|0|||
42379293|NCT01459913|76251277|FG001|Overall Study|Other|0|||
42379294|NCT01459913|76251278|FG002|Overall Study|Other|3|||
42379295|NCT01459913|76251279|FG003|Overall Study|Other|1|||
42379296|NCT01459913|76251276|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
42379297|NCT01459913|76251277|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
42379298|NCT01459913|76251278|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
42379299|NCT01459913|76251279|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
42379300|NCT01458587|76251293|FG000|Overall Study|Withdrawal by Subject|1|||
42379301|NCT01458587|76251294|FG001|Overall Study|Withdrawal by Subject|0|||
42379302|NCT01458275|76251305|FG000|Overall Study|Adverse Event|3|||
42379303|NCT01458275|76251306|FG001|Overall Study|Adverse Event|4|||
42379304|NCT01458275|76251307|FG002|Overall Study|Adverse Event|1|||
42379305|NCT01458275|76251305|FG000|Overall Study|Lost to Follow-up|3|||
42106388|NCT00619866|75917404|FG002|Weeks 13 - 24|Adverse Event|2|||
42379306|NCT01458275|76251306|FG001|Overall Study|Lost to Follow-up|2|||
42379307|NCT01458275|76251307|FG002|Overall Study|Lost to Follow-up|5|||
42379308|NCT01458275|76251305|FG000|Overall Study|Protocol Violation|5|||
42379309|NCT01458275|76251306|FG001|Overall Study|Protocol Violation|5|||
42379310|NCT01458275|76251307|FG002|Overall Study|Protocol Violation|2|||
42379311|NCT01458275|76251305|FG000|Overall Study|Withdrawal by Subject|3|||
42379312|NCT01458275|76251306|FG001|Overall Study|Withdrawal by Subject|2|||
42379313|NCT01458275|76251307|FG002|Overall Study|Withdrawal by Subject|1|||
42379314|NCT01458119|76251317|FG000|Overall Study|Physician Decision|4|||
42379315|NCT01458119|76251317|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
42379316|NCT01458119|76251317|FG000|Overall Study|Pregnancy|1|||
42379317|NCT01458119|76251317|FG000|Overall Study|Death|2|||
42379318|NCT01458119|76251317|FG000|Overall Study|Adverse Event|1|||
42379319|NCT01458119|76251317|FG000|Overall Study|Consent Withdrawn by Participant|8|||
42379320|NCT01458119|76251317|FG000|Overall Study|Non-compliance With Study Drug|3|||
42379321|NCT01688726|76251332|FG000|Overall Study|Adverse Event|1|||
42379322|NCT01688726|76251333|FG001|Overall Study|Adverse Event|0|||
42379323|NCT01688726|76251332|FG000|Overall Study|Relocated abroad|0|||
42379324|NCT01688726|76251333|FG001|Overall Study|Relocated abroad|1|||
42379325|NCT01585766|76251349|FG000|Overall Study|Withdrawal by Subject|0|||
42379326|NCT01585766|76251350|FG001|Overall Study|Withdrawal by Subject|1|||
42379327|NCT01585766|76251351|FG002|Overall Study|Withdrawal by Subject|1|||
42379328|NCT01585766|76251352|FG003|Overall Study|Withdrawal by Subject|0|||
42379329|NCT01585766|76251353|FG004|Overall Study|Withdrawal by Subject|0|||
42379330|NCT01585766|76251354|FG005|Overall Study|Withdrawal by Subject|0|||
42379331|NCT01585766|76251349|FG000|Overall Study|Death|0|||
42379332|NCT01585766|76251350|FG001|Overall Study|Death|1|||
42379333|NCT01585766|76251351|FG002|Overall Study|Death|0|||
42379334|NCT01585766|76251352|FG003|Overall Study|Death|0|||
42379335|NCT01585766|76251353|FG004|Overall Study|Death|0|||
42379336|NCT01585766|76251354|FG005|Overall Study|Death|0|||
42379337|NCT01585766|76251349|FG000|Overall Study|Physician Decision|0|||
42379338|NCT01585766|76251350|FG001|Overall Study|Physician Decision|0|||
42379339|NCT01585766|76251351|FG002|Overall Study|Physician Decision|1|||
42379340|NCT01585766|76251352|FG003|Overall Study|Physician Decision|0|||
42379341|NCT01585766|76251353|FG004|Overall Study|Physician Decision|0|||
42379342|NCT01585766|76251354|FG005|Overall Study|Physician Decision|0|||
42379343|NCT01562444|76251378|FG000|Overall Study|Did not meet entry criteria|2|||
42379344|NCT01562444|76251379|FG001|Overall Study|Did not meet entry criteria|0|||
42379345|NCT01562444|76251380|FG002|Overall Study|Did not meet entry criteria|3|||
42379346|NCT01562444|76251378|FG000|Overall Study|Did not comply with blood draw schedule|1|||
42379347|NCT01562444|76251379|FG001|Overall Study|Did not comply with blood draw schedule|0|||
42379348|NCT01562444|76251380|FG002|Overall Study|Did not comply with blood draw schedule|1|||
42379349|NCT01562444|76251378|FG000|Overall Study|Unavailable serological results|0|||
42379350|NCT01562444|76251379|FG001|Overall Study|Unavailable serological results|2|||
42379351|NCT01562444|76251380|FG002|Overall Study|Unavailable serological results|2|||
42379352|NCT01562444|76251378|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
42379353|NCT01562444|76251379|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
42379354|NCT01562444|76251380|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
42379355|NCT01562444|76251378|FG000|Overall Study|Protocol forbidden medication|1|||
42379356|NCT01562444|76251379|FG001|Overall Study|Protocol forbidden medication|0|||
42379357|NCT01562444|76251380|FG002|Overall Study|Protocol forbidden medication|0|||
42379358|NCT01457339|76251390|FG000|Period 3 (100 mg)|Adverse Event|0|||
42379359|NCT01457339|76251391|FG001|Period 3 (100 mg)|Adverse Event|1|||
42379360|NCT01457339|76251390|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
42379361|NCT01457339|76251391|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
42379362|NCT01457339|76251390|FG000|Period 6 (250 mg)|Family Emergency|1|||
42379363|NCT01457339|76251391|FG001|Period 6 (250 mg)|Family Emergency|0|||
42379364|NCT01457339|76251390|FG000|Period 6 (250 mg)|Personal appointment|0|||
42379365|NCT01457339|76251391|FG001|Period 6 (250 mg)|Personal appointment|1|||
42379366|NCT01456949|76251414|FG000|Enrollment|PI death- incomplete data|6|||
42379367|NCT01456949|76251414|FG000|Enrollment|Death|1|||
42379368|NCT01456949|76251414|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
42379369|NCT01456949|76251414|FG000|Enrollment|Physician Decision|10|||
42379370|NCT01456949|76251414|FG000|Enrollment|Withdrawal by Subject|7|||
42379371|NCT01456949|76251414|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
42379372|NCT01456949|76251414|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
42379373|NCT01456949|76251414|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
42379374|NCT01456949|76251414|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
42379375|NCT01456949|76251414|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
42379376|NCT01456949|76251414|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
42379377|NCT01456949|76251414|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
42379378|NCT01456949|76251414|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
42379379|NCT01456169|76251421|FG000|Overall Study|Adverse Event|1|||
42379380|NCT01456169|76251422|FG001|Overall Study|Adverse Event|2|||
42379381|NCT01456169|76251423|FG002|Overall Study|Adverse Event|7|||
42379382|NCT01456169|76251421|FG000|Overall Study|Major Protocol Deviation|3|||
42379383|NCT01456169|76251422|FG001|Overall Study|Major Protocol Deviation|2|||
42379384|NCT01456169|76251423|FG002|Overall Study|Major Protocol Deviation|3|||
42379385|NCT01456169|76251421|FG000|Overall Study|Voluntary Withdrawal|3|||
42379386|NCT01456169|76251422|FG001|Overall Study|Voluntary Withdrawal|0|||
42379387|NCT01456169|76251423|FG002|Overall Study|Voluntary Withdrawal|2|||
42379388|NCT01456169|76251421|FG000|Overall Study|Lack of Efficacy|2|||
42379389|NCT01456169|76251422|FG001|Overall Study|Lack of Efficacy|0|||
42379390|NCT01456169|76251423|FG002|Overall Study|Lack of Efficacy|0|||
42379391|NCT01456169|76251421|FG000|Overall Study|Other|1|||
42379392|NCT01456169|76251422|FG001|Overall Study|Other|1|||
42379393|NCT01456169|76251423|FG002|Overall Study|Other|0|||
42379394|NCT01454531|76251432|FG000|Overall Study|Adverse Event|14|||
42379395|NCT01454531|76251432|FG000|Overall Study|Withdrawal by Subject|5|||
42379396|NCT01454531|76251432|FG000|Overall Study|Lost to Follow-up|1|||
42379397|NCT01454531|76251432|FG000|Overall Study|Physician Decision|1|||
42379398|NCT01454531|76251432|FG000|Overall Study|Delay in IMP administration|1|||
42379399|NCT01454531|76251432|FG000|Overall Study|Other|1|||
42379400|NCT01454063|76251438|FG000|Randomized|Adverse Event|1|||
42379401|NCT01454063|76251439|FG001|Randomized|Adverse Event|1|||
42379402|NCT01454063|76251438|FG000|Randomized|Protocol Violation|0|||
42379403|NCT01454063|76251439|FG001|Randomized|Protocol Violation|1|||
42379404|NCT01453595|76251448|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
42379405|NCT01453595|76251449|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
42379406|NCT01453595|76251450|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
42379407|NCT01453439|76251458|FG000|Treatment Phase|Withdrawal by Subject|13|||
42379408|NCT01453439|76251459|FG001|Treatment Phase|Withdrawal by Subject|10|||
42379409|NCT01453439|76251458|FG000|Treatment Phase|Suicidal Ideation|2|||
42379410|NCT01453439|76251459|FG001|Treatment Phase|Suicidal Ideation|0|||
42379411|NCT01453439|76251458|FG000|Treatment Phase|Need for higher level of care|1|||
42379412|NCT01453439|76251459|FG001|Treatment Phase|Need for higher level of care|1|||
42379413|NCT01453439|76251458|FG000|Treatment Phase|Therapist conflict of interest|1|||
42379414|NCT01453439|76251459|FG001|Treatment Phase|Therapist conflict of interest|0|||
42379415|NCT01453439|76251458|FG000|Follow-up|Withdrawal by Subject|0|||
42379416|NCT01453439|76251459|FG001|Follow-up|Withdrawal by Subject|1|||
42379417|NCT01453439|76251458|FG000|Follow-up|Lost to Follow-up|5|||
42379418|NCT01453439|76251459|FG001|Follow-up|Lost to Follow-up|10|||
42379419|NCT01453361|76251465|FG000|Overall Study|Disease Progression|6|||
42379420|NCT01453361|76251465|FG000|Overall Study|Screen-Failures|10|||
42379421|NCT01585298|76251469|FG000|Overall Study|Study completion was not documented.|1|||
42379422|NCT01585298|76251469|FG000|Overall Study|Protocol deviation|1|||
42379423|NCT01585298|76251469|FG000|Overall Study|Administrative problems|4|||
42379424|NCT01585298|76251469|FG000|Overall Study|Lost to Follow-up|2|||
42379425|NCT01585298|76251469|FG000|Overall Study|Withdrawal by Subject|4|||
42379426|NCT01585298|76251469|FG000|Overall Study|Abnormal test procedure results|1|||
42379427|NCT01585298|76251469|FG000|Overall Study|Adverse Event|24|||
42379428|NCT01453205|76251476|FG000|Overall Study|Lost to Follow-up|3|||
42379429|NCT01453205|76251477|FG001|Overall Study|Lost to Follow-up|0|||
42379430|NCT01453205|76251478|FG002|Overall Study|Lost to Follow-up|1|||
42379431|NCT01453205|76251476|FG000|Overall Study|Withdrawal by Subject|8|||
42379432|NCT01453205|76251477|FG001|Overall Study|Withdrawal by Subject|3|||
42379433|NCT01453205|76251478|FG002|Overall Study|Withdrawal by Subject|0|||
42379434|NCT01453205|76251476|FG000|Overall Study|Death|24|||
42379435|NCT01453205|76251477|FG001|Overall Study|Death|22|||
42379436|NCT01453205|76251478|FG002|Overall Study|Death|18|||
42379437|NCT01453205|76251476|FG000|Overall Study|Other|45|||
42379438|NCT01453205|76251477|FG001|Overall Study|Other|27|||
42379439|NCT01453205|76251478|FG002|Overall Study|Other|35|||
42379440|NCT01453049|76251491|FG000|Overall Study|Protocol Violation|2|||
42379441|NCT01453049|76251492|FG001|Overall Study|Protocol Violation|5|||
42379442|NCT01453049|76251491|FG000|Overall Study|Lost to Follow-up|2|||
42379443|NCT01453049|76251492|FG001|Overall Study|Lost to Follow-up|1|||
42379444|NCT01453049|76251491|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
42379445|NCT01453049|76251492|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
42379446|NCT01453049|76251491|FG000|Overall Study|Withdrawal by Subject|1|||
42379447|NCT01453049|76251492|FG001|Overall Study|Withdrawal by Subject|0|||
42379448|NCT01453049|76251491|FG000|Overall Study|Randomized in Error|1|||
42379449|NCT01453049|76251492|FG001|Overall Study|Randomized in Error|0|||
42379450|NCT01452347|76251500|FG000|Overall Study|Adverse Event|2|||
42379451|NCT01452347|76251501|FG001|Overall Study|Adverse Event|1|||
42379452|NCT01452347|76251500|FG000|Overall Study|Non compliance protocol|2|||
42379453|NCT01452347|76251501|FG001|Overall Study|Non compliance protocol|0|||
42379454|NCT01452347|76251500|FG000|Overall Study|Lost to Follow-up|2|||
42379455|NCT01452347|76251501|FG001|Overall Study|Lost to Follow-up|0|||
42379456|NCT01452347|76251500|FG000|Overall Study|Withdrawal by Subject|3|||
42379457|NCT01452347|76251501|FG001|Overall Study|Withdrawal by Subject|3|||
42379458|NCT01452347|76251500|FG000|Overall Study|Not treated|6|||
42379459|NCT01452347|76251501|FG001|Overall Study|Not treated|3|||
42379460|NCT01452347|76251500|FG000|Overall Study|Other reason not defined above|2|||
42379461|NCT01452347|76251501|FG001|Overall Study|Other reason not defined above|0|||
42379462|NCT01451723|76251511|FG000|Overall Study|study halted|6|||
42379463|NCT01451723|76251512|FG001|Overall Study|study halted|5|||
42379464|NCT01451645|76251520|FG000|Overall Study|Protocol Violation|1|||
42379465|NCT01451645|76251521|FG001|Overall Study|Protocol Violation|0|||
42379466|NCT01451645|76251520|FG000|Overall Study|Adverse Event|0|||
42379467|NCT01451645|76251521|FG001|Overall Study|Adverse Event|3|||
42379468|NCT01451645|76251520|FG000|Overall Study|Withdrawal by Subject|4|||
42379469|NCT01451645|76251521|FG001|Overall Study|Withdrawal by Subject|2|||
42379470|NCT01451645|76251520|FG000|Overall Study|Lost to Follow-up|4|||
42379471|NCT01451645|76251521|FG001|Overall Study|Lost to Follow-up|3|||
42379472|NCT01450943|76251530|FG000|Overall Study|Screen failure, loss to follow-up|2|||
42379473|NCT01450943|76251531|FG001|Overall Study|Screen failure, loss to follow-up|7|||
42379474|NCT01450943|76251532|FG002|Overall Study|Screen failure, loss to follow-up|6|||
42379475|NCT01450631|76251546|FG000|Overall Study|Lost to Follow-up|2|||
42379476|NCT01450631|76251547|FG001|Overall Study|Lost to Follow-up|4|||
42379477|NCT01450631|76251546|FG000|Overall Study|Withdrawal by Subject|1|||
42379478|NCT01450631|76251547|FG001|Overall Study|Withdrawal by Subject|0|||
42379479|NCT01450007|76251556|FG000|Overall Study|Late exclusion before treatment|2|||
42379480|NCT01450007|76251557|FG001|Overall Study|Late exclusion before treatment|3|||
42379481|NCT01450007|76251558|FG002|Overall Study|Late exclusion before treatment|2|||
42379482|NCT01450007|76251556|FG000|Overall Study|Protocol Violation|0|||
42379483|NCT01450007|76251557|FG001|Overall Study|Protocol Violation|1|||
42379484|NCT01450007|76251558|FG002|Overall Study|Protocol Violation|1|||
42379485|NCT01450007|76251556|FG000|Overall Study|Adverse Event|0|||
42379486|NCT01450007|76251557|FG001|Overall Study|Adverse Event|1|||
42379487|NCT01450007|76251558|FG002|Overall Study|Adverse Event|0|||
42379488|NCT01496365|76251573|FG000|Overall Study|Adverse Event|2|||
42379489|NCT01496365|76251574|FG001|Overall Study|Adverse Event|3|||
42379490|NCT01496365|76251575|FG002|Overall Study|Adverse Event|3|||
42379491|NCT01496365|76251576|FG003|Overall Study|Adverse Event|2|||
42379492|NCT01496365|76251577|FG004|Overall Study|Adverse Event|5|||
42379493|NCT01496365|76251578|FG005|Overall Study|Adverse Event|6|||
42379494|NCT01496365|76251579|FG006|Overall Study|Adverse Event|4|||
42379495|NCT01496365|76251573|FG000|Overall Study|Withdrawal by Subject|6|||
42379496|NCT01496365|76251574|FG001|Overall Study|Withdrawal by Subject|6|||
42379497|NCT01496365|76251575|FG002|Overall Study|Withdrawal by Subject|0|||
42379498|NCT01496365|76251576|FG003|Overall Study|Withdrawal by Subject|1|||
42379499|NCT01496365|76251577|FG004|Overall Study|Withdrawal by Subject|3|||
42379500|NCT01496365|76251578|FG005|Overall Study|Withdrawal by Subject|2|||
42379501|NCT01496365|76251579|FG006|Overall Study|Withdrawal by Subject|1|||
42379502|NCT01496365|76251573|FG000|Overall Study|Protocol Violation|2|||
42379503|NCT01496365|76251574|FG001|Overall Study|Protocol Violation|1|||
42379504|NCT01496365|76251575|FG002|Overall Study|Protocol Violation|1|||
42379505|NCT01496365|76251576|FG003|Overall Study|Protocol Violation|0|||
42379506|NCT01496365|76251577|FG004|Overall Study|Protocol Violation|0|||
42379507|NCT01496365|76251578|FG005|Overall Study|Protocol Violation|1|||
42379508|NCT01496365|76251579|FG006|Overall Study|Protocol Violation|0|||
42379509|NCT01496365|76251573|FG000|Overall Study|Lack of Efficacy|1|||
42379510|NCT01496365|76251574|FG001|Overall Study|Lack of Efficacy|0|||
42379511|NCT01496365|76251575|FG002|Overall Study|Lack of Efficacy|0|||
42379512|NCT01496365|76251576|FG003|Overall Study|Lack of Efficacy|0|||
42379513|NCT01496365|76251577|FG004|Overall Study|Lack of Efficacy|0|||
42379514|NCT01496365|76251578|FG005|Overall Study|Lack of Efficacy|1|||
42379515|NCT01496365|76251579|FG006|Overall Study|Lack of Efficacy|0|||
42379516|NCT01496365|76251573|FG000|Overall Study|Lost to Follow-up|0|||
42379517|NCT01496365|76251574|FG001|Overall Study|Lost to Follow-up|1|||
42379518|NCT01496365|76251575|FG002|Overall Study|Lost to Follow-up|0|||
42379519|NCT01496365|76251576|FG003|Overall Study|Lost to Follow-up|0|||
42379520|NCT01496365|76251577|FG004|Overall Study|Lost to Follow-up|2|||
42379521|NCT01496365|76251578|FG005|Overall Study|Lost to Follow-up|0|||
42379522|NCT01496365|76251579|FG006|Overall Study|Lost to Follow-up|0|||
42379523|NCT01496365|76251573|FG000|Overall Study|Other|4|||
42379524|NCT01496365|76251574|FG001|Overall Study|Other|4|||
42379525|NCT01496365|76251575|FG002|Overall Study|Other|2|||
42379526|NCT01496365|76251576|FG003|Overall Study|Other|1|||
42379527|NCT01496365|76251577|FG004|Overall Study|Other|3|||
42379528|NCT01496365|76251578|FG005|Overall Study|Other|0|||
42379529|NCT01496365|76251579|FG006|Overall Study|Other|1|||
42379530|NCT01496287|76251595|FG000|Overall Study|Lost to Follow-up|1|||
42379531|NCT01496287|76251595|FG000|Overall Study|Incomplete anesthesia|5|||
42379532|NCT01495975|76251602|FG000|Overall Study|Lost to Follow-up|1|||
42379533|NCT01495975|76251603|FG001|Overall Study|Lost to Follow-up|0|||
42379534|NCT01468987|76251611|FG000|Overall Study|Adverse Event|12|||
42379535|NCT01468987|76251612|FG001|Overall Study|Adverse Event|9|||
42379536|NCT01468987|76251611|FG000|Overall Study|Death|4|||
42379537|NCT01468987|76251612|FG001|Overall Study|Death|1|||
42379538|NCT01468987|76251611|FG000|Overall Study|Lost to Follow-up|10|||
42379539|NCT01468987|76251612|FG001|Overall Study|Lost to Follow-up|5|||
42379540|NCT01468987|76251611|FG000|Overall Study|Protocol Violation|8|||
42379541|NCT01468987|76251612|FG001|Overall Study|Protocol Violation|2|||
42379542|NCT01468987|76251611|FG000|Overall Study|Withdrawal by Subject|28|||
42379543|NCT01468987|76251612|FG001|Overall Study|Withdrawal by Subject|28|||
42379544|NCT01468987|76251611|FG000|Overall Study|Physician Decision|8|||
42379545|NCT01468987|76251612|FG001|Overall Study|Physician Decision|15|||
42379546|NCT01468987|76251611|FG000|Overall Study|Sponsor Decision|1|||
42379547|NCT01468987|76251612|FG001|Overall Study|Sponsor Decision|0|||
42379548|NCT01687712|76251622|FG000|Cycle 1|Not Biochemically Pregnant|386|||
42379549|NCT01687712|76251623|FG001|Cycle 1|Not Biochemically Pregnant|348|||
42379550|NCT01687712|76251622|FG000|Cycle 1|Early Pregnancy Loss|43|||
42379551|NCT01687712|76251623|FG001|Cycle 1|Early Pregnancy Loss|60|||
42379552|NCT01687712|76251622|FG000|Cycle 1|Ectopic Pregnancy|5|||
42379553|NCT01687712|76251623|FG001|Cycle 1|Ectopic Pregnancy|5|||
42379554|NCT01687712|76251622|FG000|Cycle 1|Heterotropic Pregnancy|1|||
42379555|NCT01687712|76251623|FG001|Cycle 1|Heterotropic Pregnancy|0|||
42379556|NCT01687712|76251622|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
42379557|NCT01687712|76251623|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
42379558|NCT01687712|76251622|FG000|Cycle 1|Abortion|3|||
42379559|NCT01687712|76251623|FG001|Cycle 1|Abortion|0|||
42379560|NCT01687712|76251622|FG000|Cycle 1|Intrauterine Fetal Death|0|||
42379561|NCT01687712|76251623|FG001|Cycle 1|Intrauterine Fetal Death|1|||
42379562|NCT01687712|76251622|FG000|Cycle 1|Lost to Follow-up|1|||
42379563|NCT01687712|76251623|FG001|Cycle 1|Lost to Follow-up|1|||
42379564|NCT01687712|76251622|FG000|Cycle 2|Not Biochemically Pregnant|74|||
42379565|NCT01687712|76251623|FG001|Cycle 2|Not Biochemically Pregnant|77|||
42379566|NCT01687712|76251622|FG000|Cycle 2|Early Pregnancy Loss|18|||
42379567|NCT01687712|76251623|FG001|Cycle 2|Early Pregnancy Loss|16|||
42379568|NCT01687712|76251622|FG000|Cycle 2|Ectopic Pregnancy|0|||
42379569|NCT01687712|76251623|FG001|Cycle 2|Ectopic Pregnancy|1|||
42379570|NCT01687712|76251622|FG000|Cycle 2|Still Birth|1|||
42379571|NCT01687712|76251623|FG001|Cycle 2|Still Birth|0|||
42379572|NCT01687712|76251622|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
42379573|NCT01687712|76251623|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
42379574|NCT01687712|76251622|FG000|Cycle 3|Not Biochemically Pregnant|21|||
42379575|NCT01687712|76251623|FG001|Cycle 3|Not Biochemically Pregnant|22|||
42379576|NCT01687712|76251622|FG000|Cycle 3|Early Pregnancy Loss|1|||
42379577|NCT01687712|76251623|FG001|Cycle 3|Early Pregnancy Loss|2|||
42379578|NCT01687712|76251622|FG000|Cycle 3|Ectopic Pregnancy|1|||
42379579|NCT01687712|76251623|FG001|Cycle 3|Ectopic Pregnancy|0|||
42379580|NCT01687712|76251622|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
42379581|NCT01687712|76251623|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
42379582|NCT01603628|76251636|FG000|Overall Study|Personal Reasons|1|||
42379583|NCT01603628|76251637|FG001|Overall Study|Personal Reasons|1|||
42379584|NCT01603628|76251638|FG002|Overall Study|Personal Reasons|2|||
42379585|NCT01603628|76251636|FG000|Overall Study|Protocol Violation|1|||
42379586|NCT01603628|76251637|FG001|Overall Study|Protocol Violation|1|||
42379587|NCT01603628|76251638|FG002|Overall Study|Protocol Violation|0|||
42379588|NCT01603628|76251636|FG000|Overall Study|Lost to Follow-up|0|||
42379589|NCT01603628|76251637|FG001|Overall Study|Lost to Follow-up|1|||
42379590|NCT01603628|76251638|FG002|Overall Study|Lost to Follow-up|0|||
42379591|NCT01603628|76251636|FG000|Overall Study|Other Miscellaneous Reason|1|||
42379592|NCT01603628|76251637|FG001|Overall Study|Other Miscellaneous Reason|0|||
42379593|NCT01603628|76251638|FG002|Overall Study|Other Miscellaneous Reason|0|||
42379594|NCT01453153|76251649|FG000|Overall Study|Physician Decision|0|||
42379595|NCT01453153|76251650|FG001|Overall Study|Physician Decision|0|||
42379596|NCT01453153|76251651|FG002|Overall Study|Physician Decision|1|||
42379597|NCT01453153|76251649|FG000|Overall Study|Progressive Disease|3|||
42379598|NCT01453153|76251650|FG001|Overall Study|Progressive Disease|2|||
42379599|NCT01453153|76251651|FG002|Overall Study|Progressive Disease|16|||
42379600|NCT01453153|76251649|FG000|Overall Study|Withdrawal by Subject|0|||
42379601|NCT01453153|76251650|FG001|Overall Study|Withdrawal by Subject|1|||
42379602|NCT01453153|76251651|FG002|Overall Study|Withdrawal by Subject|2|||
42379603|NCT01453153|76251649|FG000|Overall Study|Adverse Event|1|||
42379604|NCT01453153|76251650|FG001|Overall Study|Adverse Event|1|||
42379605|NCT01453153|76251651|FG002|Overall Study|Adverse Event|1|||
42379606|NCT01584440|76251665|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
42379607|NCT01584440|76251666|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
42379608|NCT01584440|76251667|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
42379609|NCT01584440|76251668|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
42379610|NCT01584440|76251669|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
42379611|NCT01584440|76251665|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
42379612|NCT01584440|76251666|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
42379613|NCT01584440|76251667|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
42379614|NCT01584440|76251668|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
42379615|NCT01584440|76251669|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
42379616|NCT01584440|76251665|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
42379617|NCT01584440|76251666|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
42379618|NCT01584440|76251667|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
42379619|NCT01584440|76251668|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
42379620|NCT01584440|76251669|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
42379621|NCT01584440|76251665|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
42379622|NCT01584440|76251666|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
42379623|NCT01584440|76251667|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
42379624|NCT01584440|76251668|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
42379625|NCT01584440|76251669|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
42379626|NCT01584440|76251665|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
42379627|NCT01584440|76251666|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
42379628|NCT01584440|76251667|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
42379629|NCT01584440|76251668|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
42379630|NCT01584440|76251669|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
42379631|NCT01584440|76251665|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
42379632|NCT01584440|76251666|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
42379633|NCT01584440|76251667|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
42379634|NCT01584440|76251668|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
42379635|NCT01584440|76251669|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
42379636|NCT01584440|76251665|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
42379637|NCT01584440|76251666|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
42379638|NCT01584440|76251667|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
42379639|NCT01584440|76251668|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
42379640|NCT01584440|76251669|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
42379641|NCT01584440|76251665|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
42379642|NCT01584440|76251666|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
42379643|NCT01584440|76251667|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
42379644|NCT01584440|76251668|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
42379645|NCT01584440|76251669|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
42379646|NCT01584440|76251665|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
42379647|NCT01584440|76251666|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
42379648|NCT01584440|76251667|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
42379649|NCT01584440|76251668|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
42379650|NCT01584440|76251669|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
42379651|NCT01687478|76251684|FG000|Overall Study|Adverse Event|3|||
42379652|NCT01687478|76251685|FG001|Overall Study|Adverse Event|10|||
42379653|NCT01687478|76251684|FG000|Overall Study|Lost to Follow-up|1|||
42379654|NCT01687478|76251685|FG001|Overall Study|Lost to Follow-up|3|||
42379655|NCT01687478|76251684|FG000|Overall Study|Protocol Violation|0|||
42379656|NCT01687478|76251685|FG001|Overall Study|Protocol Violation|2|||
42379657|NCT01687478|76251684|FG000|Overall Study|Withdrawal by Subject|21|||
42379658|NCT01687478|76251685|FG001|Overall Study|Withdrawal by Subject|19|||
42379659|NCT01687478|76251684|FG000|Overall Study|Physician Decision|1|||
42379660|NCT01687478|76251685|FG001|Overall Study|Physician Decision|3|||
42379661|NCT01687478|76251684|FG000|Overall Study|Entry Criteria Not Met|6|||
42379662|NCT01687478|76251685|FG001|Overall Study|Entry Criteria Not Met|2|||
42379663|NCT01468909|76251693|FG000|Overall Study|Never Treated|2|||
42379664|NCT01468909|76251694|FG001|Overall Study|Never Treated|2|||
42379665|NCT01468597|76251700|FG000|Overall Study|Found ineligible|17|||
42379666|NCT01468597|76251700|FG000|Overall Study|concomitant valves|12|||
42379667|NCT01468597|76251700|FG000|Overall Study|off-pump CABG|1|||
42379668|NCT01468597|76251700|FG000|Overall Study|no platelet function data|5|||
42379669|NCT01687166|76251708|FG000|Overall Study|Attempt subject|2|||
42379670|NCT01687166|76251709|FG001|Overall Study|Attempt subject|3|||
42379671|NCT01687166|76251710|FG002|Overall Study|Attempt subject|2|||
42379672|NCT01687166|76251711|FG003|Overall Study|Attempt subject|0|||
42379673|NCT01687166|76251708|FG000|Overall Study|Did not meet eligibility criteria|4|||
42379674|NCT01687166|76251709|FG001|Overall Study|Did not meet eligibility criteria|6|||
42379675|NCT01687166|76251710|FG002|Overall Study|Did not meet eligibility criteria|1|||
42379676|NCT01687166|76251711|FG003|Overall Study|Did not meet eligibility criteria|1|||
42379677|NCT01687166|76251708|FG000|Overall Study|Adverse Event|2|||
42379678|NCT01687166|76251709|FG001|Overall Study|Adverse Event|1|||
42379679|NCT01687166|76251710|FG002|Overall Study|Adverse Event|0|||
42379680|NCT01687166|76251711|FG003|Overall Study|Adverse Event|0|||
42379681|NCT01687166|76251708|FG000|Overall Study|Physician Decision|3|||
42106389|NCT00619866|75917405|FG003|Weeks 13 - 24|Adverse Event|1|||
42379682|NCT01687166|76251709|FG001|Overall Study|Physician Decision|2|||
42379683|NCT01687166|76251710|FG002|Overall Study|Physician Decision|1|||
42379684|NCT01687166|76251711|FG003|Overall Study|Physician Decision|0|||
42379685|NCT01687166|76251708|FG000|Overall Study|Withdrawal by Subject|11|||
42379686|NCT01687166|76251709|FG001|Overall Study|Withdrawal by Subject|4|||
42379687|NCT01687166|76251710|FG002|Overall Study|Withdrawal by Subject|3|||
42379688|NCT01687166|76251711|FG003|Overall Study|Withdrawal by Subject|0|||
42379689|NCT01687166|76251708|FG000|Overall Study|Lost to Follow-up|2|||
42379690|NCT01687166|76251709|FG001|Overall Study|Lost to Follow-up|5|||
42379691|NCT01687166|76251710|FG002|Overall Study|Lost to Follow-up|1|||
42379692|NCT01687166|76251711|FG003|Overall Study|Lost to Follow-up|0|||
42379693|NCT01687166|76251708|FG000|Overall Study|Equipment/Device Availability|0|||
42379694|NCT01687166|76251709|FG001|Overall Study|Equipment/Device Availability|1|||
42379695|NCT01687166|76251710|FG002|Overall Study|Equipment/Device Availability|0|||
42379696|NCT01687166|76251711|FG003|Overall Study|Equipment/Device Availability|0|||
42379697|NCT01687166|76251708|FG000|Overall Study|Death|1|||
42379698|NCT01687166|76251709|FG001|Overall Study|Death|1|||
42379699|NCT01687166|76251710|FG002|Overall Study|Death|0|||
42379700|NCT01687166|76251711|FG003|Overall Study|Death|0|||
42379701|NCT01687166|76251708|FG000|Overall Study|Protocol Violation|1|||
42379702|NCT01687166|76251709|FG001|Overall Study|Protocol Violation|1|||
42379703|NCT01687166|76251710|FG002|Overall Study|Protocol Violation|1|||
42379704|NCT01687166|76251711|FG003|Overall Study|Protocol Violation|0|||
42379705|NCT01687166|76251708|FG000|Overall Study|Subject moved out of state|0|||
42379706|NCT01687166|76251709|FG001|Overall Study|Subject moved out of state|1|||
42379707|NCT01687166|76251710|FG002|Overall Study|Subject moved out of state|0|||
42379708|NCT01687166|76251711|FG003|Overall Study|Subject moved out of state|0|||
42379709|NCT01687166|76251708|FG000|Overall Study|Patient unable to be compliant|1|||
42379710|NCT01687166|76251709|FG001|Overall Study|Patient unable to be compliant|0|||
42379711|NCT01687166|76251710|FG002|Overall Study|Patient unable to be compliant|0|||
42379712|NCT01687166|76251711|FG003|Overall Study|Patient unable to be compliant|0|||
42379713|NCT01687166|76251708|FG000|Overall Study|Physician choice to use different device|1|||
42379714|NCT01687166|76251709|FG001|Overall Study|Physician choice to use different device|2|||
42379715|NCT01687166|76251710|FG002|Overall Study|Physician choice to use different device|4|||
42379716|NCT01687166|76251711|FG003|Overall Study|Physician choice to use different device|0|||
42379717|NCT01687166|76251708|FG000|Overall Study|Insurance|0|||
42379718|NCT01687166|76251709|FG001|Overall Study|Insurance|0|||
42379719|NCT01687166|76251710|FG002|Overall Study|Insurance|1|||
42379720|NCT01687166|76251711|FG003|Overall Study|Insurance|1|||
42379721|NCT01561976|76251725|FG000|Period 1|Adverse Event|0|||
42379722|NCT01561976|76251726|FG001|Period 1|Adverse Event|0|||
42379723|NCT01561976|76251727|FG002|Period 1|Adverse Event|1|||
42379724|NCT01561976|76251728|FG003|Period 1|Adverse Event|0|||
42379725|NCT01561976|76251729|FG004|Period 1|Adverse Event|0|||
42379726|NCT01561976|76251730|FG005|Period 1|Adverse Event|0|||
42379727|NCT01561976|76251725|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
42379728|NCT01561976|76251726|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
42379729|NCT01561976|76251727|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
42379730|NCT01561976|76251728|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
42379731|NCT01561976|76251729|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
42379732|NCT01561976|76251730|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
42379733|NCT01561976|76251725|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42379734|NCT01561976|76251726|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42379735|NCT01561976|76251727|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42379736|NCT01561976|76251728|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42379737|NCT01561976|76251729|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
42379738|NCT01561976|76251730|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
42379739|NCT01561976|76251725|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
42379740|NCT01561976|76251726|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
42379741|NCT01561976|76251727|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
42379742|NCT01561976|76251728|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
42379743|NCT01561976|76251729|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
42379744|NCT01561976|76251730|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
42379745|NCT01686932|76251740|FG000|Period 1|Adverse Event|1|||
42379746|NCT01686932|76251741|FG001|Period 1|Adverse Event|1|||
42379747|NCT01468207|76251749|FG000|Treatment Period 1|Adverse Event|1|||
42379748|NCT01468207|76251750|FG001|Treatment Period 1|Adverse Event|0|||
42379749|NCT01468207|76251751|FG002|Treatment Period 1|Adverse Event|0|||
42379750|NCT01468207|76251752|FG003|Treatment Period 1|Adverse Event|0|||
42379751|NCT01468207|76251753|FG004|Treatment Period 1|Adverse Event|0|||
42379752|NCT01468207|76251754|FG005|Treatment Period 1|Adverse Event|0|||
42379753|NCT01468207|76251749|FG000|Treatment Period 1|Protocol Violation|1|||
42379754|NCT01468207|76251750|FG001|Treatment Period 1|Protocol Violation|1|||
42379755|NCT01468207|76251751|FG002|Treatment Period 1|Protocol Violation|0|||
42379756|NCT01468207|76251752|FG003|Treatment Period 1|Protocol Violation|0|||
42379757|NCT01468207|76251753|FG004|Treatment Period 1|Protocol Violation|0|||
42379758|NCT01468207|76251754|FG005|Treatment Period 1|Protocol Violation|0|||
42379759|NCT01468207|76251749|FG000|Treatment Period 1|Withdrawal by Subject|5|||
42379760|NCT01468207|76251750|FG001|Treatment Period 1|Withdrawal by Subject|4|||
42379761|NCT01468207|76251751|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42379762|NCT01468207|76251752|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42379763|NCT01468207|76251753|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42379764|NCT01468207|76251754|FG005|Treatment Period 1|Withdrawal by Subject|0|||
42379765|NCT01468207|76251749|FG000|Treatment Period 1|Lost to Follow-up|2|||
42379766|NCT01468207|76251750|FG001|Treatment Period 1|Lost to Follow-up|1|||
42379767|NCT01468207|76251751|FG002|Treatment Period 1|Lost to Follow-up|0|||
42379768|NCT01468207|76251752|FG003|Treatment Period 1|Lost to Follow-up|0|||
42379769|NCT01468207|76251753|FG004|Treatment Period 1|Lost to Follow-up|0|||
42379770|NCT01468207|76251754|FG005|Treatment Period 1|Lost to Follow-up|0|||
42379771|NCT01468207|76251749|FG000|Treatment Period 1|Other|0|||
42379772|NCT01468207|76251750|FG001|Treatment Period 1|Other|2|||
42379773|NCT01468207|76251751|FG002|Treatment Period 1|Other|0|||
42379774|NCT01468207|76251752|FG003|Treatment Period 1|Other|0|||
42379775|NCT01468207|76251753|FG004|Treatment Period 1|Other|0|||
42379776|NCT01468207|76251754|FG005|Treatment Period 1|Other|0|||
42379777|NCT01468207|76251749|FG000|Treatment Period 2|Adverse Event|0|||
42379778|NCT01468207|76251750|FG001|Treatment Period 2|Adverse Event|0|||
42379779|NCT01468207|76251751|FG002|Treatment Period 2|Adverse Event|6|||
42379780|NCT01468207|76251752|FG003|Treatment Period 2|Adverse Event|1|||
42379781|NCT01468207|76251753|FG004|Treatment Period 2|Adverse Event|2|||
42379782|NCT01468207|76251754|FG005|Treatment Period 2|Adverse Event|1|||
42379783|NCT01468207|76251749|FG000|Treatment Period 2|Lack of Efficacy|0|||
42379784|NCT01468207|76251750|FG001|Treatment Period 2|Lack of Efficacy|0|||
42379785|NCT01468207|76251751|FG002|Treatment Period 2|Lack of Efficacy|1|||
42379786|NCT01468207|76251752|FG003|Treatment Period 2|Lack of Efficacy|1|||
42379787|NCT01468207|76251753|FG004|Treatment Period 2|Lack of Efficacy|0|||
42379788|NCT01468207|76251754|FG005|Treatment Period 2|Lack of Efficacy|2|||
42379789|NCT01468207|76251749|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42379790|NCT01468207|76251750|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42379791|NCT01468207|76251751|FG002|Treatment Period 2|Withdrawal by Subject|5|||
42379792|NCT01468207|76251752|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42379793|NCT01468207|76251753|FG004|Treatment Period 2|Withdrawal by Subject|0|||
42379794|NCT01468207|76251754|FG005|Treatment Period 2|Withdrawal by Subject|2|||
42379795|NCT01468207|76251749|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
42379796|NCT01468207|76251750|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
42379797|NCT01468207|76251751|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
42379798|NCT01468207|76251752|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
42379799|NCT01468207|76251753|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
42379800|NCT01468207|76251754|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
42379801|NCT01468207|76251749|FG000|Treatment Period 2|Lost to Follow-up|0|||
42379802|NCT01468207|76251750|FG001|Treatment Period 2|Lost to Follow-up|0|||
42379803|NCT01468207|76251751|FG002|Treatment Period 2|Lost to Follow-up|5|||
42379804|NCT01468207|76251752|FG003|Treatment Period 2|Lost to Follow-up|1|||
42379805|NCT01468207|76251753|FG004|Treatment Period 2|Lost to Follow-up|0|||
42379806|NCT01468207|76251754|FG005|Treatment Period 2|Lost to Follow-up|0|||
42379807|NCT01468207|76251749|FG000|Treatment Period 2|Other|0|||
42379808|NCT01468207|76251750|FG001|Treatment Period 2|Other|0|||
42379809|NCT01468207|76251751|FG002|Treatment Period 2|Other|5|||
42379810|NCT01468207|76251752|FG003|Treatment Period 2|Other|1|||
42379811|NCT01468207|76251753|FG004|Treatment Period 2|Other|1|||
42379812|NCT01468207|76251754|FG005|Treatment Period 2|Other|2|||
42379813|NCT01494649|76251774|FG000|Overall Study|Lost to Follow-up|0|||
42379814|NCT01494649|76251775|FG001|Overall Study|Lost to Follow-up|1|||
42379815|NCT01686152|76251786|FG000|Overall Study|Withdrawal by Subject|11|||
42379816|NCT01686152|76251787|FG001|Overall Study|Withdrawal by Subject|11|||
42379817|NCT01686152|76251788|FG002|Overall Study|Withdrawal by Subject|3|||
42379818|NCT01686152|76251786|FG000|Overall Study|Drug Code Unblinded|0|||
42379819|NCT01686152|76251787|FG001|Overall Study|Drug Code Unblinded|1|||
42379820|NCT01686152|76251788|FG002|Overall Study|Drug Code Unblinded|0|||
42379821|NCT01686152|76251786|FG000|Overall Study|Protocol Violation|6|||
42379822|NCT01686152|76251787|FG001|Overall Study|Protocol Violation|1|||
42379823|NCT01686152|76251788|FG002|Overall Study|Protocol Violation|0|||
42379824|NCT01686152|76251786|FG000|Overall Study|Adverse Event|12|||
42379825|NCT01686152|76251787|FG001|Overall Study|Adverse Event|11|||
42379826|NCT01686152|76251788|FG002|Overall Study|Adverse Event|0|||
42379827|NCT01686152|76251786|FG000|Overall Study|Lack of Efficacy|0|||
42379828|NCT01686152|76251787|FG001|Overall Study|Lack of Efficacy|0|||
42379829|NCT01686152|76251788|FG002|Overall Study|Lack of Efficacy|1|||
42379830|NCT01686152|76251786|FG000|Overall Study|IP Non-compliance|5|||
42379831|NCT01686152|76251787|FG001|Overall Study|IP Non-compliance|5|||
42379832|NCT01686152|76251788|FG002|Overall Study|IP Non-compliance|0|||
42379833|NCT01686152|76251786|FG000|Overall Study|Lost to Follow-up|7|||
42379834|NCT01686152|76251787|FG001|Overall Study|Lost to Follow-up|6|||
42379835|NCT01686152|76251788|FG002|Overall Study|Lost to Follow-up|5|||
42379836|NCT01452919|76251796|FG000|Open-Label Treatment|Adverse Event|5|||
42379837|NCT01452919|76251797|FG001|Open-Label Treatment|Adverse Event|0|||
42379838|NCT01452919|76251798|FG002|Open-Label Treatment|Adverse Event|0|||
42379839|NCT01452919|76251796|FG000|Open-Label Treatment|Lost to Follow-up|4|||
42379840|NCT01452919|76251797|FG001|Open-Label Treatment|Lost to Follow-up|0|||
42379841|NCT01452919|76251798|FG002|Open-Label Treatment|Lost to Follow-up|0|||
42379842|NCT01452919|76251796|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
42379843|NCT01452919|76251797|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
42379844|NCT01452919|76251798|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
42379845|NCT01452919|76251796|FG000|Open-Label Treatment|Protocol Violation|4|||
42379846|NCT01452919|76251797|FG001|Open-Label Treatment|Protocol Violation|0|||
42379847|NCT01452919|76251798|FG002|Open-Label Treatment|Protocol Violation|0|||
42379848|NCT01452919|76251796|FG000|Open-Label Treatment|Sponsor Decision|1|||
42379849|NCT01452919|76251797|FG001|Open-Label Treatment|Sponsor Decision|0|||
42379850|NCT01452919|76251798|FG002|Open-Label Treatment|Sponsor Decision|0|||
42379851|NCT01452919|76251796|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
42379852|NCT01452919|76251797|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
42379853|NCT01452919|76251798|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
42379854|NCT01452919|76251796|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
42379855|NCT01452919|76251797|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
42379856|NCT01452919|76251798|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
42379857|NCT01452919|76251796|FG000|Randomization Treatment|Adverse Event|0|||
42379858|NCT01452919|76251797|FG001|Randomization Treatment|Adverse Event|0|||
42379859|NCT01452919|76251798|FG002|Randomization Treatment|Adverse Event|2|||
42379860|NCT01452919|76251796|FG000|Randomization Treatment|Sponsor Decision|0|||
42379861|NCT01452919|76251797|FG001|Randomization Treatment|Sponsor Decision|1|||
42379862|NCT01452919|76251798|FG002|Randomization Treatment|Sponsor Decision|0|||
42379863|NCT01452919|76251796|FG000|Randomization Treatment|Withdrawal by Subject|0|||
42379864|NCT01452919|76251797|FG001|Randomization Treatment|Withdrawal by Subject|1|||
42379865|NCT01452919|76251798|FG002|Randomization Treatment|Withdrawal by Subject|0|||
42379866|NCT01452919|76251796|FG000|Randomization Treatment|Subject is moving or has moved|0|||
42379867|NCT01452919|76251797|FG001|Randomization Treatment|Subject is moving or has moved|1|||
42379868|NCT01452919|76251798|FG002|Randomization Treatment|Subject is moving or has moved|0|||
42379869|NCT01582178|76251810|FG000|Overall Study|Physician Decision|6|||
42379870|NCT01582178|76251811|FG001|Overall Study|Physician Decision|5|||
42379871|NCT01561898|76251821|FG000|Overall Study|Withdrawal by Subject|0|||
42379872|NCT01561898|76251822|FG001|Overall Study|Withdrawal by Subject|8|||
42379873|NCT01561898|76251823|FG002|Overall Study|Withdrawal by Subject|12|||
42379874|NCT01561898|76251824|FG003|Overall Study|Withdrawal by Subject|5|||
42379875|NCT01561898|76251821|FG000|Overall Study|Lack of Efficacy|0|||
42379876|NCT01561898|76251822|FG001|Overall Study|Lack of Efficacy|8|||
42379877|NCT01561898|76251823|FG002|Overall Study|Lack of Efficacy|10|||
42379878|NCT01561898|76251824|FG003|Overall Study|Lack of Efficacy|5|||
42106390|NCT00619866|75917406|FG004|Weeks 13 - 24|Adverse Event|0|||
42106391|NCT00619866|75917402|FG000|Weeks 13 - 24|Protocol Deviation|0|||
42106392|NCT00619866|75917403|FG001|Weeks 13 - 24|Protocol Deviation|0|||
42106393|NCT00619866|75917404|FG002|Weeks 13 - 24|Protocol Deviation|0|||
42106394|NCT00619866|75917405|FG003|Weeks 13 - 24|Protocol Deviation|1|||
42106395|NCT00619866|75917406|FG004|Weeks 13 - 24|Protocol Deviation|0|||
42106396|NCT00619866|75917402|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
42106397|NCT00619866|75917403|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
42106398|NCT00619866|75917404|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
42106399|NCT00619866|75917405|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
42106400|NCT00619866|75917406|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
42106401|NCT00619866|75917402|FG000|Weeks 13 - 24|Non-compliance|0|||
42106402|NCT00619866|75917403|FG001|Weeks 13 - 24|Non-compliance|1|||
42106403|NCT00619866|75917404|FG002|Weeks 13 - 24|Non-compliance|1|||
42379879|NCT01561898|76251821|FG000|Overall Study|Worsening of complications|0|||
42379880|NCT01561898|76251822|FG001|Overall Study|Worsening of complications|1|||
42379881|NCT01561898|76251823|FG002|Overall Study|Worsening of complications|0|||
42379882|NCT01561898|76251824|FG003|Overall Study|Worsening of complications|0|||
42379883|NCT01561898|76251821|FG000|Overall Study|Lost to Follow-up|0|||
42379884|NCT01561898|76251822|FG001|Overall Study|Lost to Follow-up|0|||
42379885|NCT01561898|76251823|FG002|Overall Study|Lost to Follow-up|1|||
42379886|NCT01561898|76251824|FG003|Overall Study|Lost to Follow-up|0|||
42379887|NCT01561898|76251821|FG000|Overall Study|Adverse Event|1|||
42379888|NCT01561898|76251822|FG001|Overall Study|Adverse Event|19|||
42106404|NCT00619866|75917405|FG003|Weeks 13 - 24|Non-compliance|0|||
42106405|NCT00619866|75917406|FG004|Weeks 13 - 24|Non-compliance|0|||
42379889|NCT01561898|76251823|FG002|Overall Study|Adverse Event|14|||
42379890|NCT01561898|76251824|FG003|Overall Study|Adverse Event|9|||
42379891|NCT01561898|76251821|FG000|Overall Study|Physician Decision|1|||
42106406|NCT00619866|75917402|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
42106407|NCT00619866|75917403|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
42379892|NCT01561898|76251822|FG001|Overall Study|Physician Decision|5|||
42379893|NCT01561898|76251823|FG002|Overall Study|Physician Decision|7|||
42379894|NCT01561898|76251824|FG003|Overall Study|Physician Decision|1|||
42379895|NCT01685840|76251834|FG000|Overall Study|Death|77|||
42379896|NCT01685840|76251835|FG001|Overall Study|Death|66|||
42379897|NCT01685840|76251834|FG000|Overall Study|Lost to Follow-up|27|||
42379898|NCT01685840|76251835|FG001|Overall Study|Lost to Follow-up|25|||
42379899|NCT01685840|76251834|FG000|Overall Study|Physician Decision|3|||
42379900|NCT01685840|76251835|FG001|Overall Study|Physician Decision|7|||
42379901|NCT01685840|76251834|FG000|Overall Study|Withdrawal by Subject|14|||
42379902|NCT01685840|76251835|FG001|Overall Study|Withdrawal by Subject|17|||
42379903|NCT01685840|76251834|FG000|Overall Study|Futility|197|||
42379904|NCT01685840|76251835|FG001|Overall Study|Futility|200|||
42379905|NCT01685840|76251834|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
42379906|NCT01685840|76251835|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
42379907|NCT01452529|76251845|FG000|Run-in Period|Adverse Event|96|||
42379908|NCT01452529|76251846|FG001|Run-in Period|Adverse Event|0|||
42379909|NCT01452529|76251847|FG002|Run-in Period|Adverse Event|0|||
42379910|NCT01452529|76251845|FG000|Run-in Period|Withdrawal by Subject|49|||
42379911|NCT01452529|76251846|FG001|Run-in Period|Withdrawal by Subject|0|||
42379912|NCT01452529|76251847|FG002|Run-in Period|Withdrawal by Subject|0|||
42379913|NCT01452529|76251845|FG000|Run-in Period|Lost to Follow-up|19|||
42379914|NCT01452529|76251846|FG001|Run-in Period|Lost to Follow-up|0|||
42379915|NCT01452529|76251847|FG002|Run-in Period|Lost to Follow-up|0|||
42379916|NCT01452529|76251845|FG000|Run-in Period|Lack of Efficacy|46|||
42379917|NCT01452529|76251846|FG001|Run-in Period|Lack of Efficacy|0|||
42379918|NCT01452529|76251847|FG002|Run-in Period|Lack of Efficacy|0|||
42379919|NCT01452529|76251845|FG000|Run-in Period|Confirmed or suspected diversion|23|||
42379920|NCT01452529|76251846|FG001|Run-in Period|Confirmed or suspected diversion|0|||
42379921|NCT01452529|76251847|FG002|Run-in Period|Confirmed or suspected diversion|0|||
42379922|NCT01452529|76251845|FG000|Run-in Period|Administrative|21|||
42379923|NCT01452529|76251846|FG001|Run-in Period|Administrative|0|||
42379924|NCT01452529|76251847|FG002|Run-in Period|Administrative|0|||
42379925|NCT01452529|76251845|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
42379926|NCT01452529|76251846|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
42379927|NCT01452529|76251847|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
42379928|NCT01452529|76251845|FG000|Double-blind (DB) Period|Adverse Event|0|||
42379929|NCT01452529|76251846|FG001|Double-blind (DB) Period|Adverse Event|18|||
42379930|NCT01452529|76251847|FG002|Double-blind (DB) Period|Adverse Event|11|||
42379931|NCT01452529|76251845|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
42379932|NCT01452529|76251846|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
42379933|NCT01452529|76251847|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
42379934|NCT01452529|76251845|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
42379935|NCT01452529|76251846|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
42379936|NCT01452529|76251847|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
42379937|NCT01452529|76251845|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
42379938|NCT01452529|76251846|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
42379939|NCT01452529|76251847|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
42379940|NCT01452529|76251845|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
42379941|NCT01452529|76251846|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
42379942|NCT01452529|76251847|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
42379943|NCT01452529|76251845|FG000|Double-blind (DB) Period|Administrative|0|||
42379944|NCT01452529|76251846|FG001|Double-blind (DB) Period|Administrative|11|||
42379945|NCT01452529|76251847|FG002|Double-blind (DB) Period|Administrative|7|||
42379946|NCT01685606|76251854|FG000|Overall Study|Withdrawal by Subject|1|||
42379947|NCT01685372|76251860|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
42379948|NCT01685372|76251861|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
42379949|NCT01685216|76251867|FG000|Overall Study|Did not receive study drug|1|||
42379950|NCT01685138|76251871|FG000|Overall Study|Lost to Follow-up|1|||
42379951|NCT01685138|76251871|FG000|Overall Study|Protocol Violation|1|||
42379952|NCT01685138|76251871|FG000|Overall Study|No longer requires treatment|1|||
42379953|NCT01685138|76251871|FG000|Overall Study|Subject/guardian decision|2|||
42379954|NCT01685138|76251871|FG000|Overall Study|Physician Decision|6|||
42379955|NCT01685138|76251871|FG000|Overall Study|Death|10|||
42379956|NCT01685138|76251871|FG000|Overall Study|Adverse Event|18|||
42379957|NCT01685138|76251871|FG000|Overall Study|Progressive disease|53|||
42379958|NCT01685060|76251875|FG000|Overall Study|Rollover patients|16|||
42379959|NCT01685060|76251875|FG000|Overall Study|Adverse Event|12|||
42379960|NCT01685060|76251875|FG000|Overall Study|Progressive disease|69|||
42379961|NCT01685060|76251875|FG000|Overall Study|Physician Decision|14|||
42379962|NCT01685060|76251875|FG000|Overall Study|Subject/guardian decision|20|||
42379963|NCT01685060|76251875|FG000|Overall Study|Lost to Follow-up|1|||
42379964|NCT01685060|76251875|FG000|Overall Study|Death|8|||
42379965|NCT01582100|76251879|FG000|Overall Study|Adverse Event|1|||
42379966|NCT01582100|76251879|FG000|Overall Study|Withdrawal by Subject|1|||
42379967|NCT01579916|76251885|FG000|Overall Study|Lost to Follow-up|6|||
42379968|NCT01579916|76251886|FG001|Overall Study|Lost to Follow-up|1|||
42379969|NCT01579916|76251885|FG000|Overall Study|Withdrawal by Subject|1|||
42379970|NCT01579916|76251886|FG001|Overall Study|Withdrawal by Subject|1|||
42379971|NCT01579916|76251885|FG000|Overall Study|Death|1|||
42379972|NCT01579916|76251886|FG001|Overall Study|Death|0|||
42379973|NCT01684202|76251896|FG000|Dose-escalation Period|Adverse Event|0|||
42379974|NCT01684202|76251897|FG001|Dose-escalation Period|Adverse Event|1|||
42379975|NCT01684202|76251898|FG002|Dose-escalation Period|Adverse Event|0|||
42379976|NCT01684202|76251899|FG003|Dose-escalation Period|Adverse Event|0|||
42379977|NCT01684202|76251896|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
42379978|NCT01684202|76251897|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
42379979|NCT01684202|76251898|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
42379980|NCT01684202|76251899|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
42379981|NCT01684202|76251896|FG000|Maintenance Period|Adverse Event|1|||
42379982|NCT01684202|76251897|FG001|Maintenance Period|Adverse Event|1|||
42379983|NCT01684202|76251898|FG002|Maintenance Period|Adverse Event|1|||
42379984|NCT01684202|76251899|FG003|Maintenance Period|Adverse Event|1|||
42379985|NCT01684202|76251896|FG000|Maintenance Period|Physician Decision|0|||
42379986|NCT01684202|76251897|FG001|Maintenance Period|Physician Decision|1|||
42379987|NCT01684202|76251898|FG002|Maintenance Period|Physician Decision|0|||
42379988|NCT01684202|76251899|FG003|Maintenance Period|Physician Decision|0|||
42379989|NCT01684202|76251896|FG000|Maintenance Period|Withdrawal by Subject|0|||
42379990|NCT01684202|76251897|FG001|Maintenance Period|Withdrawal by Subject|1|||
42379991|NCT01684202|76251898|FG002|Maintenance Period|Withdrawal by Subject|0|||
42379992|NCT01684202|76251899|FG003|Maintenance Period|Withdrawal by Subject|0|||
42379993|NCT01684046|76251909|FG000|Period 1, First 30 Days|Adverse Event|0|||
42379994|NCT01684046|76251910|FG001|Period 1, First 30 Days|Adverse Event|2|||
42379995|NCT01559090|76251919|FG000|Stage I|Withdrawal by Subject|2|||
42379996|NCT01559090|76251920|FG001|Stage I|Withdrawal by Subject|2|||
42379997|NCT01559090|76251921|FG002|Stage I|Withdrawal by Subject|3|||
42379998|NCT01559090|76251919|FG000|Stage II|Withdrawal by Subject|1|||
42379999|NCT01559090|76251920|FG001|Stage II|Withdrawal by Subject|0|||
42380000|NCT01559090|76251921|FG002|Stage II|Withdrawal by Subject|0|||
42380001|NCT01683266|76251931|FG000|Overall Study|Adverse Event|5|||
42380002|NCT01683266|76251932|FG001|Overall Study|Adverse Event|4|||
42380003|NCT01683266|76251931|FG000|Overall Study|Lack of Efficacy|5|||
42380004|NCT01683266|76251932|FG001|Overall Study|Lack of Efficacy|2|||
42380005|NCT01683266|76251931|FG000|Overall Study|Protocol Violation|13|||
42380006|NCT01683266|76251932|FG001|Overall Study|Protocol Violation|6|||
42380007|NCT01683266|76251931|FG000|Overall Study|Personal Reason|17|||
42380008|NCT01683266|76251932|FG001|Overall Study|Personal Reason|25|||
42380009|NCT01683266|76251931|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
42380010|NCT01683266|76251932|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
42380011|NCT01683266|76251931|FG000|Overall Study|Lost to Follow-up|5|||
42380012|NCT01683266|76251932|FG001|Overall Study|Lost to Follow-up|0|||
42380013|NCT01683266|76251931|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
42380014|NCT01683266|76251932|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
42380015|NCT01683266|76251931|FG000|Overall Study|Nonserious Hypoglycemia|0|||
42380016|NCT01683266|76251932|FG001|Overall Study|Nonserious Hypoglycemia|3|||
42380017|NCT01683266|76251931|FG000|Overall Study|Perceived Lack of Efficacy|1|||
42380018|NCT01683266|76251932|FG001|Overall Study|Perceived Lack of Efficacy|1|||
42380019|NCT01683266|76251931|FG000|Overall Study|Possibly Hypoglycemia|1|||
42380020|NCT01683266|76251932|FG001|Overall Study|Possibly Hypoglycemia|0|||
42380021|NCT01683266|76251931|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
42380022|NCT01683266|76251932|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
42380023|NCT01467661|76251938|FG000|Overall Study|Adverse Event|16|||
42380024|NCT01467661|76251938|FG000|Overall Study|Withdrawal by Subject|1|||
42380025|NCT01467661|76251938|FG000|Overall Study|Lack of Efficacy|3|||
42380026|NCT01467661|76251938|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
42380027|NCT01577186|76251944|FG000|Overall Study|Adverse Event|23|||
42380028|NCT01577186|76251944|FG000|Overall Study|Death|1|||
42380029|NCT01577186|76251944|FG000|Overall Study|Lost to Follow-up|28|||
42380030|NCT01577186|76251944|FG000|Overall Study|Withdrawal by Subject|35|||
42380031|NCT01577186|76251944|FG000|Overall Study|Insufficient Response|18|||
42380032|NCT01577186|76251944|FG000|Overall Study|Ineligible to Continue|15|||
42380033|NCT01577186|76251944|FG000|Overall Study|Non-Compliant|8|||
42380034|NCT01577186|76251944|FG000|Overall Study|Other|2|||
42380035|NCT01559012|76251950|FG000|Overall Study|Withdrawal by Subject|0|||
42380036|NCT01559012|76251951|FG001|Overall Study|Withdrawal by Subject|1|||
42380037|NCT01451827|76251976|FG000|Overall Study|Adverse Event|2|||
42380038|NCT01451827|76251977|FG001|Overall Study|Adverse Event|0|||
42380039|NCT01451827|76251978|FG002|Overall Study|Adverse Event|1|||
42380040|NCT01451827|76251979|FG003|Overall Study|Adverse Event|1|||
42380041|NCT01451827|76251976|FG000|Overall Study|Protocol deviation|1|||
42380042|NCT01451827|76251977|FG001|Overall Study|Protocol deviation|0|||
42380043|NCT01451827|76251978|FG002|Overall Study|Protocol deviation|0|||
42380044|NCT01451827|76251979|FG003|Overall Study|Protocol deviation|0|||
42380045|NCT01451827|76251976|FG000|Overall Study|Lost to Follow-up|0|||
42380046|NCT01451827|76251977|FG001|Overall Study|Lost to Follow-up|3|||
42380047|NCT01451827|76251978|FG002|Overall Study|Lost to Follow-up|0|||
42380048|NCT01451827|76251979|FG003|Overall Study|Lost to Follow-up|2|||
42380049|NCT01451827|76251976|FG000|Overall Study|Participant met withdrawal criteria|0|||
42380050|NCT01451827|76251977|FG001|Overall Study|Participant met withdrawal criteria|2|||
42380051|NCT01451827|76251978|FG002|Overall Study|Participant met withdrawal criteria|0|||
42380052|NCT01451827|76251979|FG003|Overall Study|Participant met withdrawal criteria|0|||
42380053|NCT01451827|76251976|FG000|Overall Study|Withdrawal by Subject|0|||
42380054|NCT01451827|76251977|FG001|Overall Study|Withdrawal by Subject|0|||
42380055|NCT01451827|76251978|FG002|Overall Study|Withdrawal by Subject|1|||
42380056|NCT01451827|76251979|FG003|Overall Study|Withdrawal by Subject|1|||
42380057|NCT01557920|76251989|FG000|Overall Study|Withdrawal by Subject|2|||
42380058|NCT01557920|76251990|FG001|Overall Study|Withdrawal by Subject|3|||
42380059|NCT01557920|76251989|FG000|Overall Study|Lack of Efficacy|1|||
42380060|NCT01557920|76251990|FG001|Overall Study|Lack of Efficacy|0|||
42380061|NCT01688882|76252025|FG000|Overall Study|Adverse Event|1|||
42380062|NCT01688882|76252026|FG001|Overall Study|Adverse Event|0|||
42380063|NCT01688882|76252025|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42380064|NCT01688882|76252026|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
42380065|NCT01688882|76252025|FG000|Overall Study|Administrative problems|1|||
42380066|NCT01688882|76252026|FG001|Overall Study|Administrative problems|0|||
42380067|NCT01467583|76252039|FG000|Overall Study|Death|1|||
42380068|NCT01467583|76252040|FG001|Overall Study|Death|1|||
42380069|NCT01467583|76252041|FG002|Overall Study|Death|0|||
42380070|NCT01467583|76252039|FG000|Overall Study|Withdrawal by Subject|1|||
42380071|NCT01467583|76252040|FG001|Overall Study|Withdrawal by Subject|0|||
42380072|NCT01467583|76252041|FG002|Overall Study|Withdrawal by Subject|0|||
42380073|NCT01467583|76252039|FG000|Overall Study|Protocol Violation|0|||
42380074|NCT01467583|76252040|FG001|Overall Study|Protocol Violation|0|||
42380075|NCT01467583|76252041|FG002|Overall Study|Protocol Violation|2|||
42380076|NCT01576718|76252058|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
42380077|NCT01576718|76252059|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42380078|NCT01576718|76252060|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42380079|NCT01576718|76252061|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42380080|NCT01576718|76252062|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42380081|NCT01576718|76252063|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42380082|NCT01576718|76252064|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
42380083|NCT01576718|76252058|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
42380084|NCT01576718|76252059|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42380085|NCT01576718|76252060|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42380086|NCT01576718|76252061|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42380087|NCT01576718|76252062|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42380088|NCT01576718|76252063|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42380089|NCT01576718|76252064|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
42380090|NCT01576718|76252058|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
42380091|NCT01576718|76252059|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42380092|NCT01576718|76252060|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42380093|NCT01576718|76252061|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42380094|NCT01576718|76252062|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42380095|NCT01576718|76252063|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42380096|NCT01576718|76252064|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
42380097|NCT01576718|76252058|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
42380098|NCT01576718|76252059|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42380099|NCT01576718|76252060|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42380100|NCT01576718|76252061|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42380101|NCT01576718|76252062|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42380102|NCT01576718|76252063|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42380103|NCT01576718|76252064|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
42380104|NCT01576718|76252058|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
42380105|NCT01576718|76252059|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42380106|NCT01576718|76252060|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42380107|NCT01576718|76252061|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42380108|NCT01576718|76252062|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42380109|NCT01576718|76252063|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42380110|NCT01576718|76252064|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
42380111|NCT01576718|76252058|FG000|Treatment Period|Adverse Event|0|||
42380112|NCT01576718|76252059|FG001|Treatment Period|Adverse Event|1|||
42380113|NCT01576718|76252060|FG002|Treatment Period|Adverse Event|1|||
42380114|NCT01576718|76252061|FG003|Treatment Period|Adverse Event|1|||
42380115|NCT01576718|76252062|FG004|Treatment Period|Adverse Event|1|||
42380116|NCT01576718|76252063|FG005|Treatment Period|Adverse Event|1|||
42380117|NCT01576718|76252064|FG006|Treatment Period|Adverse Event|0|||
42380118|NCT01576718|76252058|FG000|Treatment Period|Withdrawal by Subject|0|||
42380119|NCT01576718|76252059|FG001|Treatment Period|Withdrawal by Subject|1|||
42380120|NCT01576718|76252060|FG002|Treatment Period|Withdrawal by Subject|1|||
42380121|NCT01576718|76252061|FG003|Treatment Period|Withdrawal by Subject|0|||
42380122|NCT01576718|76252062|FG004|Treatment Period|Withdrawal by Subject|2|||
42380123|NCT01576718|76252063|FG005|Treatment Period|Withdrawal by Subject|4|||
42380124|NCT01576718|76252064|FG006|Treatment Period|Withdrawal by Subject|2|||
42380125|NCT01576718|76252058|FG000|Treatment Period|Physician Decision|0|||
42380126|NCT01576718|76252059|FG001|Treatment Period|Physician Decision|1|||
42380127|NCT01576718|76252060|FG002|Treatment Period|Physician Decision|1|||
42380128|NCT01576718|76252061|FG003|Treatment Period|Physician Decision|1|||
42380129|NCT01576718|76252062|FG004|Treatment Period|Physician Decision|1|||
42380130|NCT01576718|76252063|FG005|Treatment Period|Physician Decision|0|||
42380131|NCT01576718|76252064|FG006|Treatment Period|Physician Decision|0|||
42380132|NCT01576718|76252058|FG000|Treatment Period|Protocol Violation|0|||
42380133|NCT01576718|76252059|FG001|Treatment Period|Protocol Violation|5|||
42380134|NCT01576718|76252060|FG002|Treatment Period|Protocol Violation|4|||
42380135|NCT01576718|76252061|FG003|Treatment Period|Protocol Violation|10|||
42380136|NCT01576718|76252062|FG004|Treatment Period|Protocol Violation|6|||
42380137|NCT01576718|76252063|FG005|Treatment Period|Protocol Violation|8|||
42380138|NCT01576718|76252064|FG006|Treatment Period|Protocol Violation|12|||
42380139|NCT01576718|76252058|FG000|Treatment Period|Sponsor request|0|||
42380140|NCT01576718|76252059|FG001|Treatment Period|Sponsor request|1|||
42380141|NCT01576718|76252060|FG002|Treatment Period|Sponsor request|0|||
42380142|NCT01576718|76252061|FG003|Treatment Period|Sponsor request|0|||
42380143|NCT01576718|76252062|FG004|Treatment Period|Sponsor request|0|||
42380144|NCT01576718|76252063|FG005|Treatment Period|Sponsor request|1|||
42380145|NCT01576718|76252064|FG006|Treatment Period|Sponsor request|0|||
42380146|NCT01576718|76252058|FG000|Treatment Period|Met stopping criteria|0|||
42380147|NCT01576718|76252059|FG001|Treatment Period|Met stopping criteria|16|||
42380148|NCT01576718|76252060|FG002|Treatment Period|Met stopping criteria|13|||
42380149|NCT01576718|76252061|FG003|Treatment Period|Met stopping criteria|19|||
42380150|NCT01576718|76252062|FG004|Treatment Period|Met stopping criteria|16|||
42380151|NCT01576718|76252063|FG005|Treatment Period|Met stopping criteria|33|||
42380152|NCT01576718|76252064|FG006|Treatment Period|Met stopping criteria|15|||
42380153|NCT01576718|76252058|FG000|Treatment Period|Lost to Follow-up|0|||
42380154|NCT01576718|76252059|FG001|Treatment Period|Lost to Follow-up|0|||
42380155|NCT01576718|76252060|FG002|Treatment Period|Lost to Follow-up|0|||
42380156|NCT01576718|76252061|FG003|Treatment Period|Lost to Follow-up|0|||
42380157|NCT01576718|76252062|FG004|Treatment Period|Lost to Follow-up|1|||
42380158|NCT01576718|76252063|FG005|Treatment Period|Lost to Follow-up|0|||
42380159|NCT01576718|76252064|FG006|Treatment Period|Lost to Follow-up|0|||
42380160|NCT01576718|76252058|FG000|Treatment Period|Noncompliance to study medication|0|||
42380161|NCT01576718|76252059|FG001|Treatment Period|Noncompliance to study medication|0|||
42380162|NCT01576718|76252060|FG002|Treatment Period|Noncompliance to study medication|0|||
42380163|NCT01576718|76252061|FG003|Treatment Period|Noncompliance to study medication|0|||
42380164|NCT01576718|76252062|FG004|Treatment Period|Noncompliance to study medication|0|||
42380165|NCT01576718|76252063|FG005|Treatment Period|Noncompliance to study medication|1|||
42380166|NCT01576718|76252064|FG006|Treatment Period|Noncompliance to study medication|1|||
42380167|NCT01493557|76252081|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
42380168|NCT01493557|76252082|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
42380169|NCT01493557|76252083|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
42380170|NCT01493557|76252081|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
42380171|NCT01493557|76252082|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
42380172|NCT01493557|76252083|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
42380173|NCT01493557|76252081|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
42380174|NCT01493557|76252082|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
42380175|NCT01493557|76252083|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
42380176|NCT01493557|76252081|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
42380177|NCT01493557|76252082|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
42380178|NCT01493557|76252083|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
42380179|NCT01493557|76252081|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
42380180|NCT01493557|76252082|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
42380181|NCT01493557|76252083|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
42380182|NCT01493557|76252081|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
42380183|NCT01493557|76252082|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
42380184|NCT01493557|76252083|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
42380185|NCT01493557|76252081|FG000|Not Randomized to Management Strategies|Early termination|0|||
42380186|NCT01493557|76252082|FG001|Not Randomized to Management Strategies|Early termination|0|||
42380187|NCT01493557|76252083|FG002|Not Randomized to Management Strategies|Early termination|34|||
42380188|NCT01493557|76252081|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
42380189|NCT01493557|76252082|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
42380190|NCT01493557|76252083|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
42380191|NCT01493557|76252081|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
42380192|NCT01493557|76252082|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
42380193|NCT01493557|76252083|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
42380194|NCT01493557|76252081|FG000|Randomized to Management Strategies|Other adverse event|8|||
42380195|NCT01493557|76252082|FG001|Randomized to Management Strategies|Other adverse event|5|||
42380196|NCT01493557|76252083|FG002|Randomized to Management Strategies|Other adverse event|0|||
42380197|NCT01493557|76252081|FG000|Randomized to Management Strategies|Protocol Violation|3|||
42380198|NCT01493557|76252082|FG001|Randomized to Management Strategies|Protocol Violation|0|||
42380199|NCT01493557|76252083|FG002|Randomized to Management Strategies|Protocol Violation|0|||
42380200|NCT01493557|76252081|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
42380201|NCT01493557|76252082|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
42380202|NCT01493557|76252083|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
42106408|NCT00619866|75917404|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
42380203|NCT01493557|76252081|FG000|Randomized to Management Strategies|Other than stated above|1|||
42380204|NCT01493557|76252082|FG001|Randomized to Management Strategies|Other than stated above|3|||
42380205|NCT01493557|76252083|FG002|Randomized to Management Strategies|Other than stated above|0|||
42380206|NCT01493557|76252081|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
42380207|NCT01493557|76252082|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
42380208|NCT01493557|76252083|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
42380209|NCT01493557|76252081|FG000|Adding the Second Strategy|Other adverse event|1|||
42380210|NCT01493557|76252082|FG001|Adding the Second Strategy|Other adverse event|2|||
42380211|NCT01493557|76252083|FG002|Adding the Second Strategy|Other adverse event|0|||
42380212|NCT01493557|76252081|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
42380213|NCT01493557|76252082|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
42380214|NCT01493557|76252083|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
42380215|NCT01451749|76252092|FG000|Overall Study|Protocol Violation|14|||
42380216|NCT01451749|76252093|FG001|Overall Study|Protocol Violation|7|||
42380217|NCT01451749|76252092|FG000|Overall Study|Lost to Follow-up|15|||
42380218|NCT01451749|76252093|FG001|Overall Study|Lost to Follow-up|5|||
42380219|NCT01451749|76252092|FG000|Overall Study|Meet the exclusion criteria,and|1|||
42380220|NCT01451749|76252093|FG001|Overall Study|Meet the exclusion criteria,and|1|||
42380221|NCT01451749|76252092|FG000|Overall Study|Adverse Event|2|||
42380222|NCT01451749|76252093|FG001|Overall Study|Adverse Event|0|||
42380223|NCT01451749|76252092|FG000|Overall Study|Withdrawal by Subject|0|||
42380224|NCT01451749|76252093|FG001|Overall Study|Withdrawal by Subject|1|||
42380225|NCT01576484|76252103|FG000|Overall Study|Adverse Event|1|||
42380226|NCT01576484|76252104|FG001|Overall Study|Adverse Event|1|||
42380227|NCT01576484|76252103|FG000|Overall Study|Protocol Violation|0|||
42106409|NCT00619866|75917405|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
42380228|NCT01576484|76252104|FG001|Overall Study|Protocol Violation|2|||
42380229|NCT01576484|76252103|FG000|Overall Study|Sponsor Decision|2|||
42380230|NCT01576484|76252104|FG001|Overall Study|Sponsor Decision|8|||
42380231|NCT01576484|76252103|FG000|Overall Study|Withdrawal by Subject|0|||
42380232|NCT01576484|76252104|FG001|Overall Study|Withdrawal by Subject|3|||
42380233|NCT01576484|76252103|FG000|Overall Study|Other|2|||
42380234|NCT01576484|76252104|FG001|Overall Study|Other|5|||
42380235|NCT01467505|76252114|FG000|Overall Study|Adverse Event|1|||
42380236|NCT01467505|76252115|FG001|Overall Study|Adverse Event|0|||
42380237|NCT01467505|76252114|FG000|Overall Study|Withdrawal by Subject|4|||
42380238|NCT01467505|76252115|FG001|Overall Study|Withdrawal by Subject|0|||
42380239|NCT01467505|76252114|FG000|Overall Study|Study Terminated by Sponsor|28|||
42380240|NCT01467505|76252115|FG001|Overall Study|Study Terminated by Sponsor|3|||
42380241|NCT01467271|76252121|FG000|Overall Study|Death|84|||
42380242|NCT01467271|76252121|FG000|Overall Study|Lost to Follow-up|83|||
42380243|NCT01467271|76252121|FG000|Overall Study|Retraction of patient's consent|21|||
42380244|NCT01467271|76252121|FG000|Overall Study|Other reason|14|||
42380245|NCT01449929|76252127|FG000|Randomization Phase 96 Week|Adverse Event|5|||
42380246|NCT01449929|76252128|FG001|Randomization Phase 96 Week|Adverse Event|13|||
42380247|NCT01449929|76252129|FG002|Randomization Phase 96 Week|Adverse Event|0|||
42380248|NCT01449929|76252127|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
42380249|NCT01449929|76252128|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
42380250|NCT01449929|76252129|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
42380251|NCT01449929|76252127|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
42380252|NCT01449929|76252128|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
42380253|NCT01449929|76252129|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
42380254|NCT01449929|76252127|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
42380255|NCT01449929|76252128|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
42380256|NCT01449929|76252129|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
42380257|NCT01449929|76252127|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
42380258|NCT01449929|76252128|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
42380259|NCT01449929|76252129|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
42380260|NCT01449929|76252127|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
42380261|NCT01449929|76252128|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
42380262|NCT01449929|76252129|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
42380263|NCT01449929|76252127|FG000|Randomization Phase 96 Week|Physician Decision|2|||
42380264|NCT01449929|76252128|FG001|Randomization Phase 96 Week|Physician Decision|3|||
42380265|NCT01449929|76252129|FG002|Randomization Phase 96 Week|Physician Decision|0|||
42380266|NCT01449929|76252127|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
42380267|NCT01449929|76252128|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
42380268|NCT01449929|76252129|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
42380269|NCT01449929|76252127|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
42380270|NCT01449929|76252128|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
42380271|NCT01449929|76252129|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
42380272|NCT01449929|76252127|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
42380273|NCT01449929|76252128|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
42380274|NCT01449929|76252129|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
42380275|NCT01449929|76252127|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
42380276|NCT01449929|76252128|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
42380277|NCT01449929|76252129|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
42380278|NCT01449539|76252139|FG000|Overall Study|Withdrawal by Subject|3|||
42380279|NCT01449539|76252139|FG000|Overall Study|Toxicity not study related|1|||
42380280|NCT01451515|76252146|FG000|Overall Study|Death|0|||
42380281|NCT01451515|76252147|FG001|Overall Study|Death|1|||
42380282|NCT01451515|76252148|FG002|Overall Study|Death|0|||
42380283|NCT01451515|76252146|FG000|Overall Study|Withdrawal by Subject|0|||
42380284|NCT01451515|76252147|FG001|Overall Study|Withdrawal by Subject|1|||
42380285|NCT01451515|76252148|FG002|Overall Study|Withdrawal by Subject|0|||
42380286|NCT01451515|76252146|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
42380287|NCT01451515|76252147|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
42380288|NCT01451515|76252148|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
42380289|NCT01451515|76252146|FG000|Overall Study|Relapse (except CNS)|1|||
42380290|NCT01451515|76252147|FG001|Overall Study|Relapse (except CNS)|1|||
42380291|NCT01451515|76252148|FG002|Overall Study|Relapse (except CNS)|0|||
42380292|NCT01466881|76252159|FG000|Overall Study|Ineligible|5|||
42380293|NCT01466881|76252159|FG000|Overall Study|Adverse Event|6|||
42380294|NCT01466881|76252159|FG000|Overall Study|Progression/relapse|20|||
42380295|NCT01466881|76252159|FG000|Overall Study|Death|4|||
42380296|NCT01466881|76252159|FG000|Overall Study|Other reason not protocol specified|5|||
42380297|NCT01576406|76252171|FG000|Overall Study|Lost to Follow-up|1|||
42380298|NCT01576406|76252172|FG001|Overall Study|Lost to Follow-up|2|||
42380299|NCT01576406|76252173|FG002|Overall Study|Lost to Follow-up|0|||
42380300|NCT01576406|76252174|FG003|Overall Study|Lost to Follow-up|0|||
42380301|NCT01576406|76252175|FG004|Overall Study|Lost to Follow-up|0|||
42380302|NCT01576406|76252176|FG005|Overall Study|Lost to Follow-up|0|||
42380303|NCT01576406|76252171|FG000|Overall Study|Death|3|||
42380304|NCT01576406|76252172|FG001|Overall Study|Death|4|||
42380305|NCT01576406|76252173|FG002|Overall Study|Death|8|||
42380306|NCT01576406|76252174|FG003|Overall Study|Death|5|||
42380307|NCT01576406|76252175|FG004|Overall Study|Death|7|||
42380308|NCT01576406|76252176|FG005|Overall Study|Death|9|||
42380309|NCT01576406|76252171|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
42380310|NCT01576406|76252172|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
42380311|NCT01576406|76252173|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
42380312|NCT01576406|76252174|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
42380313|NCT01576406|76252175|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
42380314|NCT01576406|76252176|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
42380315|NCT01576406|76252171|FG000|Overall Study|Withdrawal the consent|2|||
42380316|NCT01576406|76252172|FG001|Overall Study|Withdrawal the consent|2|||
42380317|NCT01576406|76252173|FG002|Overall Study|Withdrawal the consent|5|||
42380318|NCT01576406|76252174|FG003|Overall Study|Withdrawal the consent|1|||
42380319|NCT01576406|76252175|FG004|Overall Study|Withdrawal the consent|1|||
42380320|NCT01576406|76252176|FG005|Overall Study|Withdrawal the consent|3|||
42380321|NCT01576406|76252171|FG000|Overall Study|Other|0|||
42380322|NCT01576406|76252172|FG001|Overall Study|Other|0|||
42380323|NCT01576406|76252173|FG002|Overall Study|Other|2|||
42380324|NCT01576406|76252174|FG003|Overall Study|Other|2|||
42380325|NCT01576406|76252175|FG004|Overall Study|Other|0|||
42380326|NCT01576406|76252176|FG005|Overall Study|Other|0|||
42380327|NCT01576172|76252192|FG000|Overall Study|Ineligible|2|||
42380328|NCT01576172|76252193|FG001|Overall Study|Ineligible|1|||
42380329|NCT01576172|76252192|FG000|Overall Study|Withdrawal by Subject|2|||
42380330|NCT01576172|76252193|FG001|Overall Study|Withdrawal by Subject|0|||
42380331|NCT01576172|76252192|FG000|Overall Study|Insurance issue|1|||
42380332|NCT01576172|76252193|FG001|Overall Study|Insurance issue|0|||
42380333|NCT01542788|76252203|FG000|Overall Study|Randomized but Not Treated|2|||
42380334|NCT01542788|76252204|FG001|Overall Study|Randomized but Not Treated|0|||
42380335|NCT01542788|76252203|FG000|Overall Study|Lack of Efficacy|41|||
42380336|NCT01542788|76252204|FG001|Overall Study|Lack of Efficacy|71|||
42380337|NCT01542788|76252203|FG000|Overall Study|Lost to Follow-up|5|||
42380338|NCT01542788|76252204|FG001|Overall Study|Lost to Follow-up|0|||
42380339|NCT01542788|76252203|FG000|Overall Study|Death|3|||
42380340|NCT01542788|76252204|FG001|Overall Study|Death|0|||
42380341|NCT01542788|76252203|FG000|Overall Study|Protocol Violation|2|||
42380342|NCT01542788|76252204|FG001|Overall Study|Protocol Violation|0|||
42380343|NCT01542788|76252203|FG000|Overall Study|Physician Decision|1|||
42380344|NCT01542788|76252204|FG001|Overall Study|Physician Decision|0|||
42380345|NCT01542788|76252203|FG000|Overall Study|Withdrawal by Subject|1|||
42380346|NCT01542788|76252204|FG001|Overall Study|Withdrawal by Subject|0|||
42380347|NCT01542632|76252216|FG000|Overall Study|Withdrawal of Consent|0|||
42380348|NCT01542632|76252217|FG001|Overall Study|Withdrawal of Consent|0|||
42380349|NCT01542632|76252218|FG002|Overall Study|Withdrawal of Consent|0|||
42380350|NCT01542632|76252219|FG003|Overall Study|Withdrawal of Consent|2|||
42380351|NCT01542632|76252220|FG004|Overall Study|Withdrawal of Consent|3|||
42380352|NCT01542632|76252221|FG005|Overall Study|Withdrawal of Consent|0|||
42380353|NCT01542632|76252216|FG000|Overall Study|Adverse Event|0|||
42380354|NCT01542632|76252217|FG001|Overall Study|Adverse Event|0|||
42380355|NCT01542632|76252218|FG002|Overall Study|Adverse Event|1|||
42201984|NCT02101853|76014578|FG004|Post Induction Randomization|Protocol Violation|0|||
42201985|NCT02101853|76014579|FG005|Post Induction Randomization|Protocol Violation|0|||
42380356|NCT01542632|76252219|FG003|Overall Study|Adverse Event|0|||
42380357|NCT01542632|76252220|FG004|Overall Study|Adverse Event|0|||
42380358|NCT01542632|76252221|FG005|Overall Study|Adverse Event|0|||
42380359|NCT01542632|76252216|FG000|Overall Study|Lost to Follow-up|0|||
42380360|NCT01542632|76252217|FG001|Overall Study|Lost to Follow-up|1|||
42380361|NCT01542632|76252218|FG002|Overall Study|Lost to Follow-up|0|||
42380362|NCT01542632|76252219|FG003|Overall Study|Lost to Follow-up|0|||
42380363|NCT01542632|76252220|FG004|Overall Study|Lost to Follow-up|0|||
42380364|NCT01542632|76252221|FG005|Overall Study|Lost to Follow-up|0|||
42380365|NCT01542632|76252216|FG000|Overall Study|Sponsor/Investigator Decision|0|||
42380366|NCT01542632|76252217|FG001|Overall Study|Sponsor/Investigator Decision|0|||
42380367|NCT01542632|76252218|FG002|Overall Study|Sponsor/Investigator Decision|0|||
42380368|NCT01542632|76252219|FG003|Overall Study|Sponsor/Investigator Decision|0|||
42106410|NCT00619866|75917406|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
42380369|NCT01542632|76252220|FG004|Overall Study|Sponsor/Investigator Decision|1|||
42380370|NCT01542632|76252221|FG005|Overall Study|Sponsor/Investigator Decision|0|||
42380371|NCT01557842|76252242|FG000|Overall Study|Lost to Follow-up|0|||
42380372|NCT01557842|76252243|FG001|Overall Study|Lost to Follow-up|1|||
42380373|NCT01557842|76252242|FG000|Overall Study|Death|1|||
42380374|NCT01557842|76252243|FG001|Overall Study|Death|0|||
42106411|NCT03937479|75917434|FG000|Overall Study|Adverse Event|2|||
42380375|NCT01557842|76252242|FG000|Overall Study|Lack of Efficacy|0|||
42380376|NCT01557842|76252243|FG001|Overall Study|Lack of Efficacy|1|||
42380377|NCT01557842|76252242|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
42380378|NCT01557842|76252243|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
42380379|NCT01557842|76252242|FG000|Overall Study|Study Terminated by Sponsor|3|||
42380380|NCT01557842|76252243|FG001|Overall Study|Study Terminated by Sponsor|4|||
42380381|NCT01557842|76252242|FG000|Overall Study|Not Ablated|2|||
42380382|NCT01557842|76252243|FG001|Overall Study|Not Ablated|0|||
42380383|NCT01541930|76252249|FG000|Overall Study|Withdrawal by Subject|1|||
42380384|NCT01576016|76252266|FG000|Lead Safety|Death|132|||
42380385|NCT01576016|76252267|FG001|Lead Safety|Death|0|||
42380386|NCT01576016|76252266|FG000|Lead Safety|Withdrawal by Subject|81|||
42380387|NCT01576016|76252267|FG001|Lead Safety|Withdrawal by Subject|0|||
42380388|NCT01576016|76252266|FG000|Lead Safety|System Explanted without Replacement|24|||
42380389|NCT01576016|76252267|FG001|Lead Safety|System Explanted without Replacement|0|||
42380390|NCT01576016|76252266|FG000|Lead Safety|Physician Decision|14|||
42380391|NCT01576016|76252267|FG001|Lead Safety|Physician Decision|0|||
42380392|NCT01576016|76252266|FG000|Lead Safety|Lost to Follow-up|13|||
42380393|NCT01576016|76252267|FG001|Lead Safety|Lost to Follow-up|0|||
42380394|NCT01576016|76252266|FG000|Lead Safety|Unsuccessful implant|2|||
42380395|NCT01576016|76252267|FG001|Lead Safety|Unsuccessful implant|0|||
42380396|NCT01576016|76252266|FG000|Lead Safety|Sponsor request|1|||
42380397|NCT01576016|76252267|FG001|Lead Safety|Sponsor request|0|||
42380398|NCT01576016|76252266|FG000|Lead Safety|Device replaced with CRT-D|1|||
42380399|NCT01576016|76252267|FG001|Lead Safety|Device replaced with CRT-D|0|||
42380400|NCT01576016|76252266|FG000|Lead Safety|Patient on Palliative Care|1|||
42380401|NCT01576016|76252267|FG001|Lead Safety|Patient on Palliative Care|0|||
42380402|NCT01576016|76252266|FG000|Lead Safety|Patient noncompliance|1|||
42380403|NCT01576016|76252267|FG001|Lead Safety|Patient noncompliance|0|||
42380404|NCT01576016|76252266|FG000|Lead Safety|Too far from study site|1|||
42380405|NCT01576016|76252267|FG001|Lead Safety|Too far from study site|0|||
42380406|NCT01576016|76252266|FG000|Lead Safety|System deactivated|1|||
42380407|NCT01576016|76252267|FG001|Lead Safety|System deactivated|0|||
42380408|NCT01576016|76252266|FG000|Lead Safety|Patient no longer followed by study PI|1|||
42380409|NCT01576016|76252267|FG001|Lead Safety|Patient no longer followed by study PI|0|||
42380410|NCT01576016|76252266|FG000|MRI Safety|Withdrawal by Subject|0|||
42380411|NCT01576016|76252267|FG001|MRI Safety|Withdrawal by Subject|10|||
42380412|NCT01576016|76252266|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
42380413|NCT01576016|76252267|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
42380414|NCT01576016|76252266|FG000|MRI Safety|Has not yet completed MRI scan|0|||
42380415|NCT01576016|76252267|FG001|MRI Safety|Has not yet completed MRI scan|56|||
42380416|NCT01576016|76252266|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
42380417|NCT01576016|76252267|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
42380418|NCT01540838|76252277|FG000|Overall Study|Open nasogastric tube|9|||
42380419|NCT01540838|76252278|FG001|Overall Study|Open nasogastric tube|7|||
42380420|NCT01540838|76252277|FG000|Overall Study|Treatment doses missing|8|||
42380421|NCT01540838|76252278|FG001|Overall Study|Treatment doses missing|12|||
42380422|NCT01540838|76252277|FG000|Overall Study|Additional antibiotic treatment|1|||
42380423|NCT01540838|76252278|FG001|Overall Study|Additional antibiotic treatment|2|||
42380424|NCT01540838|76252277|FG000|Overall Study|Died before treatment initiation|1|||
42380425|NCT01540838|76252278|FG001|Overall Study|Died before treatment initiation|1|||
42380426|NCT01540838|76252277|FG000|Overall Study|Not BM. Other treatment|3|||
42380427|NCT01540838|76252278|FG001|Overall Study|Not BM. Other treatment|1|||
42380428|NCT01451437|76252293|FG000|Overall Study|Adverse Event|0|||
42380429|NCT01451437|76252294|FG001|Overall Study|Adverse Event|0|||
42380430|NCT01451437|76252295|FG002|Overall Study|Adverse Event|0|||
42380431|NCT01451437|76252296|FG003|Overall Study|Adverse Event|0|||
42380432|NCT01451437|76252297|FG004|Overall Study|Adverse Event|0|||
42380433|NCT01451437|76252298|FG005|Overall Study|Adverse Event|1|||
42380434|NCT01451437|76252299|FG006|Overall Study|Adverse Event|1|||
42380435|NCT01451437|76252300|FG007|Overall Study|Adverse Event|2|||
42380436|NCT01451437|76252301|FG008|Overall Study|Adverse Event|1|||
42380437|NCT01451437|76252293|FG000|Overall Study|Physician Decision|1|||
42380438|NCT01451437|76252294|FG001|Overall Study|Physician Decision|1|||
42380439|NCT01451437|76252295|FG002|Overall Study|Physician Decision|2|||
42380440|NCT01451437|76252296|FG003|Overall Study|Physician Decision|0|||
42380441|NCT01451437|76252297|FG004|Overall Study|Physician Decision|0|||
42380442|NCT01451437|76252298|FG005|Overall Study|Physician Decision|0|||
42380443|NCT01451437|76252299|FG006|Overall Study|Physician Decision|0|||
42380444|NCT01451437|76252300|FG007|Overall Study|Physician Decision|0|||
42380445|NCT01451437|76252301|FG008|Overall Study|Physician Decision|0|||
42380446|NCT01451437|76252293|FG000|Overall Study|Disease Progression|0|||
42380447|NCT01451437|76252294|FG001|Overall Study|Disease Progression|0|||
42380448|NCT01451437|76252295|FG002|Overall Study|Disease Progression|1|||
42380449|NCT01451437|76252296|FG003|Overall Study|Disease Progression|1|||
42380450|NCT01451437|76252297|FG004|Overall Study|Disease Progression|3|||
42380451|NCT01451437|76252298|FG005|Overall Study|Disease Progression|2|||
42380452|NCT01451437|76252299|FG006|Overall Study|Disease Progression|3|||
42380453|NCT01451437|76252300|FG007|Overall Study|Disease Progression|1|||
42380454|NCT01451437|76252301|FG008|Overall Study|Disease Progression|3|||
42380455|NCT01451437|76252293|FG000|Overall Study|Protocol Violation|0|||
42380456|NCT01451437|76252294|FG001|Overall Study|Protocol Violation|0|||
42380457|NCT01451437|76252295|FG002|Overall Study|Protocol Violation|0|||
42380458|NCT01451437|76252296|FG003|Overall Study|Protocol Violation|0|||
42380459|NCT01451437|76252297|FG004|Overall Study|Protocol Violation|0|||
42380460|NCT01451437|76252298|FG005|Overall Study|Protocol Violation|0|||
42380461|NCT01451437|76252299|FG006|Overall Study|Protocol Violation|1|||
42380462|NCT01451437|76252300|FG007|Overall Study|Protocol Violation|0|||
42380463|NCT01451437|76252301|FG008|Overall Study|Protocol Violation|0|||
42380464|NCT01451437|76252293|FG000|Overall Study|Withdrawal by Subject|0|||
42380465|NCT01451437|76252294|FG001|Overall Study|Withdrawal by Subject|0|||
42380466|NCT01451437|76252295|FG002|Overall Study|Withdrawal by Subject|0|||
42380467|NCT01451437|76252296|FG003|Overall Study|Withdrawal by Subject|0|||
42380468|NCT01451437|76252297|FG004|Overall Study|Withdrawal by Subject|1|||
42380469|NCT01451437|76252298|FG005|Overall Study|Withdrawal by Subject|0|||
42380470|NCT01451437|76252299|FG006|Overall Study|Withdrawal by Subject|1|||
42380471|NCT01451437|76252300|FG007|Overall Study|Withdrawal by Subject|0|||
42380472|NCT01451437|76252301|FG008|Overall Study|Withdrawal by Subject|0|||
42380473|NCT01451203|76252332|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
42380474|NCT01451203|76252333|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
42380475|NCT01451203|76252332|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
42380476|NCT01451203|76252333|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
42380477|NCT01451203|76252332|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
42380478|NCT01451203|76252333|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
42380479|NCT01451203|76252332|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
42380480|NCT01451203|76252333|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
42380481|NCT01451203|76252332|FG000|Double-blind Treatment Period|Adverse Event|6|||
42380482|NCT01451203|76252333|FG001|Double-blind Treatment Period|Adverse Event|9|||
42380483|NCT01451203|76252332|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
42380484|NCT01451203|76252333|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
42380485|NCT01451203|76252332|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
42380486|NCT01451203|76252333|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
42380487|NCT01451203|76252332|FG000|Double-blind Treatment Period|Investigator decision|2|||
42380488|NCT01451203|76252333|FG001|Double-blind Treatment Period|Investigator decision|0|||
42380489|NCT01451203|76252332|FG000|Post-treatment Period|Consent withdrawn|2|||
42380490|NCT01451203|76252333|FG001|Post-treatment Period|Consent withdrawn|4|||
42380491|NCT01451203|76252332|FG000|Post-treatment Period|Lack of Efficacy|12|||
42380492|NCT01451203|76252333|FG001|Post-treatment Period|Lack of Efficacy|28|||
42380493|NCT01451203|76252332|FG000|Post-treatment Period|Adverse Event|0|||
42380494|NCT01451203|76252333|FG001|Post-treatment Period|Adverse Event|1|||
42380495|NCT01451203|76252332|FG000|Post-treatment Period|Investigator decision|0|||
42380496|NCT01451203|76252333|FG001|Post-treatment Period|Investigator decision|1|||
42380497|NCT01556438|76252341|FG000|Overall Study|Adverse Event|4|||
42380498|NCT01556438|76252342|FG001|Overall Study|Adverse Event|2|||
42380499|NCT01556438|76252341|FG000|Overall Study|Sponsor Decision|0|||
42380500|NCT01556438|76252342|FG001|Overall Study|Sponsor Decision|2|||
42380501|NCT01556438|76252341|FG000|Overall Study|Progressive Disease|0|||
42380502|NCT01556438|76252342|FG001|Overall Study|Progressive Disease|6|||
42380503|NCT01556438|76252341|FG000|Overall Study|Death|0|||
42380504|NCT01556438|76252342|FG001|Overall Study|Death|1|||
42380505|NCT01554176|76252368|FG000|Treatment Phase|Protocol Violation|1|||
42380506|NCT01554176|76252369|FG001|Treatment Phase|Protocol Violation|2|||
42380507|NCT01554176|76252370|FG002|Treatment Phase|Protocol Violation|0|||
42380508|NCT01554176|76252371|FG003|Treatment Phase|Protocol Violation|0|||
42380509|NCT01554176|76252372|FG004|Treatment Phase|Protocol Violation|0|||
42380510|NCT01554176|76252368|FG000|Treatment Phase|Physician Decision|1|||
42380511|NCT01554176|76252369|FG001|Treatment Phase|Physician Decision|1|||
42380512|NCT01554176|76252370|FG002|Treatment Phase|Physician Decision|0|||
42380513|NCT01554176|76252371|FG003|Treatment Phase|Physician Decision|0|||
42380514|NCT01554176|76252372|FG004|Treatment Phase|Physician Decision|0|||
42380515|NCT01554176|76252368|FG000|Treatment Phase|Lack of Efficacy|0|||
42380516|NCT01554176|76252369|FG001|Treatment Phase|Lack of Efficacy|1|||
42380517|NCT01554176|76252370|FG002|Treatment Phase|Lack of Efficacy|0|||
42380518|NCT01554176|76252371|FG003|Treatment Phase|Lack of Efficacy|0|||
42380519|NCT01554176|76252372|FG004|Treatment Phase|Lack of Efficacy|0|||
42380520|NCT01554176|76252368|FG000|Treatment Phase|Adverse event, non-fatal|1|||
42380521|NCT01554176|76252369|FG001|Treatment Phase|Adverse event, non-fatal|1|||
42380522|NCT01554176|76252370|FG002|Treatment Phase|Adverse event, non-fatal|0|||
42380523|NCT01554176|76252371|FG003|Treatment Phase|Adverse event, non-fatal|0|||
42380524|NCT01554176|76252372|FG004|Treatment Phase|Adverse event, non-fatal|0|||
42380525|NCT01554176|76252368|FG000|Treatment Phase|Non-compliance with study drug|1|||
42380526|NCT01554176|76252369|FG001|Treatment Phase|Non-compliance with study drug|0|||
42380527|NCT01554176|76252370|FG002|Treatment Phase|Non-compliance with study drug|0|||
42380528|NCT01554176|76252371|FG003|Treatment Phase|Non-compliance with study drug|0|||
42380529|NCT01554176|76252372|FG004|Treatment Phase|Non-compliance with study drug|0|||
42380530|NCT01554176|76252368|FG000|Treatment Phase|Withdrawal by Subject|1|||
42380531|NCT01554176|76252369|FG001|Treatment Phase|Withdrawal by Subject|0|||
42380532|NCT01554176|76252370|FG002|Treatment Phase|Withdrawal by Subject|0|||
42380533|NCT01554176|76252371|FG003|Treatment Phase|Withdrawal by Subject|0|||
42380534|NCT01554176|76252372|FG004|Treatment Phase|Withdrawal by Subject|0|||
42380535|NCT01554176|76252368|FG000|Treatment Phase|Lost to Follow-up|3|||
42380536|NCT01554176|76252369|FG001|Treatment Phase|Lost to Follow-up|0|||
42380537|NCT01554176|76252370|FG002|Treatment Phase|Lost to Follow-up|0|||
42380538|NCT01554176|76252371|FG003|Treatment Phase|Lost to Follow-up|0|||
42380539|NCT01554176|76252372|FG004|Treatment Phase|Lost to Follow-up|0|||
42380540|NCT01554176|76252368|FG000|Run-out Phase|Protocol Violation|0|||
42380541|NCT01554176|76252369|FG001|Run-out Phase|Protocol Violation|0|||
42380542|NCT01554176|76252370|FG002|Run-out Phase|Protocol Violation|0|||
42380543|NCT01554176|76252371|FG003|Run-out Phase|Protocol Violation|1|||
42380544|NCT01554176|76252372|FG004|Run-out Phase|Protocol Violation|0|||
42380545|NCT01466491|76252388|FG000|Overall Study|Protocol Violation|0|||
42380546|NCT01466491|76252389|FG001|Overall Study|Protocol Violation|3|||
42380547|NCT01466491|76252390|FG002|Overall Study|Protocol Violation|2|||
42380548|NCT01466491|76252391|FG003|Overall Study|Protocol Violation|0|||
42380549|NCT01466491|76252388|FG000|Overall Study|Missing Data|0|||
42380550|NCT01466491|76252389|FG001|Overall Study|Missing Data|0|||
42380551|NCT01466491|76252390|FG002|Overall Study|Missing Data|1|||
42380552|NCT01466491|76252391|FG003|Overall Study|Missing Data|0|||
42380553|NCT01466179|76252401|FG000|Overall Study|Ongoing in core study|2|||
42380554|NCT01466179|76252401|FG000|Overall Study|Physician Decision|46|||
42380555|NCT01466179|76252401|FG000|Overall Study|Progressive disease|43|||
42380556|NCT01466179|76252401|FG000|Overall Study|Adverse Event|32|||
42380557|NCT01466179|76252401|FG000|Overall Study|Disease relapse|23|||
42380558|NCT01466179|76252401|FG000|Overall Study|Lack of Efficacy|14|||
42380559|NCT01466179|76252401|FG000|Overall Study|Death|7|||
42380560|NCT01466179|76252401|FG000|Overall Study|Withdrawal by Subject|7|||
42380561|NCT01466179|76252401|FG000|Overall Study|Protocol Violation|2|||
42380562|NCT01466179|76252401|FG000|Overall Study|Other|3|||
42380563|NCT01493089|76252410|FG000|Overall Study|Protocol Violation|2|||
42380564|NCT01493089|76252411|FG001|Overall Study|Protocol Violation|2|||
42380565|NCT01493089|76252410|FG000|Overall Study|Withdrawal by Subject|1|||
42380566|NCT01493089|76252411|FG001|Overall Study|Withdrawal by Subject|0|||
42380567|NCT01493089|76252410|FG000|Overall Study|Physician Decision|0|||
42380568|NCT01493089|76252411|FG001|Overall Study|Physician Decision|1|||
42380569|NCT01450813|76252423|FG000|Overall Study|Physician Decision|1|||
42380570|NCT01450813|76252424|FG001|Overall Study|Physician Decision|1|||
42380571|NCT01450813|76252425|FG002|Overall Study|Physician Decision|0|||
42380572|NCT01450813|76252426|FG003|Overall Study|Physician Decision|3|||
42380573|NCT01539512|76252440|FG000|Overall Study|Adverse Event|9|||
42380574|NCT01539512|76252441|FG001|Overall Study|Adverse Event|7|||
42380575|NCT01539512|76252440|FG000|Overall Study|Physician Decision|1|||
42380576|NCT01539512|76252441|FG001|Overall Study|Physician Decision|1|||
42380577|NCT01539512|76252440|FG000|Overall Study|Withdrawal by Subject|12|||
42380578|NCT01539512|76252441|FG001|Overall Study|Withdrawal by Subject|5|||
42380579|NCT01539512|76252440|FG000|Overall Study|Richter's Transformation|1|||
42380580|NCT01539512|76252441|FG001|Overall Study|Richter's Transformation|0|||
42380581|NCT01449955|76252449|FG000|Overall Study|Withdrawal by Subject|1|||
42380582|NCT01449955|76252450|FG001|Overall Study|Withdrawal by Subject|2|||
42380583|NCT01574612|76252463|FG000|Overall Study|Adverse Event|3|||
42380584|NCT01574612|76252463|FG000|Overall Study|non compliant with drug|2|||
42380585|NCT01574612|76252463|FG000|Overall Study|Withdrawal by Subject|1|||
42380586|NCT01574612|76252463|FG000|Overall Study|Lost to Follow-up|2|||
42380587|NCT01573910|76252469|FG000|Overall Study|Adverse Event|4|||
42380588|NCT01573910|76252470|FG001|Overall Study|Adverse Event|4|||
42380589|NCT01573910|76252469|FG000|Overall Study|Lost to Follow-up|2|||
42380590|NCT01573910|76252470|FG001|Overall Study|Lost to Follow-up|1|||
42380591|NCT01573910|76252469|FG000|Overall Study|Withdrawal by Subject|0|||
42380592|NCT01573910|76252470|FG001|Overall Study|Withdrawal by Subject|1|||
42380593|NCT01573910|76252469|FG000|Overall Study|Protocol Violation|3|||
42380594|NCT01573910|76252470|FG001|Overall Study|Protocol Violation|0|||
42380595|NCT01573910|76252469|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
42380596|NCT01573910|76252470|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
42380597|NCT01491919|76252479|FG000|Overall Study|Insufficient PK sampling|1|||
42380598|NCT01491919|76252480|FG001|Overall Study|Insufficient PK sampling|2|||
42380599|NCT01491919|76252481|FG002|Overall Study|Insufficient PK sampling|1|||
42380600|NCT01573442|76252493|FG000|Overall Study|Cancels|9|||
42380601|NCT01573442|76252494|FG001|Overall Study|Cancels|10|||
42380602|NCT01491841|76252563|FG000|Overall Study|Screen Failure|10|||
42380603|NCT01491841|76252563|FG000|Overall Study|Withdrawal by Subject|1|||
42380604|NCT01553318|76252582|FG000|Overall Study|Protocol Violation|3|||
42380605|NCT01553318|76252583|FG001|Overall Study|Protocol Violation|2|||
42380606|NCT01572740|76252602|FG000|Overall Study|Adverse Event|1|||
42380607|NCT01572740|76252603|FG001|Overall Study|Adverse Event|1|||
42380608|NCT01572740|76252602|FG000|Overall Study|Withdrawal by Subject|1|||
42380609|NCT01572740|76252603|FG001|Overall Study|Withdrawal by Subject|1|||
42380610|NCT01572740|76252602|FG000|Overall Study|unclassified|4|||
42380611|NCT01572740|76252603|FG001|Overall Study|unclassified|3|||
42380612|NCT01491607|76252613|FG000|Overall Study|Lost to Follow-up|7|||
42380613|NCT01491607|76252613|FG000|Overall Study|Withdrawal by Subject|3|||
42380614|NCT01449721|76252696|FG000|Overall Study|Physician Decision|0|||
42380615|NCT01449721|76252697|FG001|Overall Study|Physician Decision|1|||
42380616|NCT01449721|76252696|FG000|Overall Study|Physician Decision|0|||
42380617|NCT01449721|76252697|FG001|Overall Study|Physician Decision|1|||
42380618|NCT01553084|76252706|FG000|Overall Study|Withdrawal by Subject|15|||
42380619|NCT01553084|76252707|FG001|Overall Study|Withdrawal by Subject|13|||
42380620|NCT01553084|76252708|FG002|Overall Study|Withdrawal by Subject|35|||
42380621|NCT01536860|76252718|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
42380622|NCT01536860|76252719|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
42380623|NCT01536860|76252720|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
42380624|NCT01552928|76252732|FG000|Period 3|Adverse Event|0|||
42380625|NCT01552928|76252733|FG001|Period 3|Adverse Event|0|||
42380626|NCT01552928|76252734|FG002|Period 3|Adverse Event|1|||
42380627|NCT01552928|76252735|FG003|Period 3|Adverse Event|0|||
42380628|NCT01448707|76252754|FG000|Overall Study|Adverse Event|3|||
42380629|NCT01448707|76252755|FG001|Overall Study|Adverse Event|1|||
42380630|NCT01448707|76252754|FG000|Overall Study|Lost to Follow-up|2|||
42380631|NCT01448707|76252755|FG001|Overall Study|Lost to Follow-up|6|||
42380632|NCT01448707|76252754|FG000|Overall Study|Withdrawal by Subject|6|||
42380633|NCT01448707|76252755|FG001|Overall Study|Withdrawal by Subject|7|||
42380634|NCT01448707|76252754|FG000|Overall Study|Other|7|||
42380635|NCT01448707|76252755|FG001|Overall Study|Other|4|||
42380636|NCT01536704|76252761|FG000|Washout Period 1|Withdrawal by Subject|1|||
42380637|NCT01536704|76252762|FG001|Washout Period 1|Withdrawal by Subject|2|||
42380638|NCT01536704|76252763|FG002|Washout Period 1|Withdrawal by Subject|0|||
42380639|NCT01536704|76252764|FG003|Washout Period 1|Withdrawal by Subject|0|||
42380640|NCT01536704|76252761|FG000|Washout Period 2|Adverse Event|1|||
42380641|NCT01536704|76252762|FG001|Washout Period 2|Adverse Event|0|||
42380642|NCT01536704|76252763|FG002|Washout Period 2|Adverse Event|0|||
42380643|NCT01536704|76252764|FG003|Washout Period 2|Adverse Event|0|||
42380644|NCT01536704|76252761|FG000|Washout Period 2|Withdrawal by Subject|0|||
42380645|NCT01536704|76252762|FG001|Washout Period 2|Withdrawal by Subject|0|||
42380646|NCT01536704|76252763|FG002|Washout Period 2|Withdrawal by Subject|0|||
42380647|NCT01536704|76252764|FG003|Washout Period 2|Withdrawal by Subject|1|||
42380648|NCT01536704|76252761|FG000|Period 3|Adverse Event|0|||
42380649|NCT01536704|76252762|FG001|Period 3|Adverse Event|0|||
42380650|NCT01536704|76252763|FG002|Period 3|Adverse Event|0|||
42380651|NCT01536704|76252764|FG003|Period 3|Adverse Event|1|||
42106412|NCT03937479|75917435|FG001|Overall Study|Adverse Event|3|||
42380652|NCT01536704|76252761|FG000|Washout Period 3|Adverse Event|0|||
42380653|NCT01536704|76252762|FG001|Washout Period 3|Adverse Event|0|||
42380654|NCT01536704|76252763|FG002|Washout Period 3|Adverse Event|1|||
42380655|NCT01536704|76252764|FG003|Washout Period 3|Adverse Event|0|||
42380656|NCT01552772|76252778|FG000|Overall Study|Lost to Follow-up|2|||
42106413|NCT03937479|75917436|FG002|Overall Study|Adverse Event|0|||
42106414|NCT03937479|75917437|FG003|Overall Study|Adverse Event|0|||
42201986|NCT02101853|76014574|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
42380657|NCT01552772|76252778|FG000|Overall Study|Adverse Event|1|||
42380658|NCT01552772|76252778|FG000|Overall Study|Protocol Deviation|1|||
42380659|NCT01552694|76252785|FG000|Overall Study|Lost to Follow-up|0|||
42380660|NCT01552694|76252786|FG001|Overall Study|Lost to Follow-up|1|||
42380661|NCT01552694|76252785|FG000|Overall Study|Protocol Violation|0|||
42380662|NCT01552694|76252786|FG001|Overall Study|Protocol Violation|1|||
42201987|NCT02101853|76014575|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
42201988|NCT02101853|76014576|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
42380663|NCT01464931|76252794|FG000|Overall Study|Withdrawal by Subject|1|||
42380664|NCT01464931|76252795|FG001|Overall Study|Withdrawal by Subject|0|||
42380665|NCT01536392|76252820|FG000|Overall Study|Adverse Event|2|||
42380666|NCT01536392|76252821|FG001|Overall Study|Adverse Event|2|||
42380667|NCT01536392|76252820|FG000|Overall Study|Physician Decision|2|||
42380668|NCT01536392|76252821|FG001|Overall Study|Physician Decision|3|||
42380669|NCT01536392|76252820|FG000|Overall Study|Withdrawal by Subject|3|||
42380670|NCT01536392|76252821|FG001|Overall Study|Withdrawal by Subject|6|||
42380671|NCT01536392|76252820|FG000|Overall Study|Non Compliance|3|||
42380672|NCT01536392|76252821|FG001|Overall Study|Non Compliance|4|||
42380673|NCT01536392|76252820|FG000|Overall Study|Completed therapy early|3|||
42380674|NCT01536392|76252821|FG001|Overall Study|Completed therapy early|0|||
42380675|NCT01464619|76252829|FG000|Overall Study|Lost to Follow-up|3|||
42380676|NCT01464619|76252830|FG001|Overall Study|Lost to Follow-up|4|||
42380677|NCT01490125|76252896|FG000|Period I|Adverse Event|4|||
42380678|NCT01490125|76252897|FG001|Period I|Adverse Event|1|||
42380679|NCT01490125|76252898|FG002|Period I|Adverse Event|1|||
42380680|NCT01490125|76252899|FG003|Period I|Adverse Event|3|||
42380681|NCT01490125|76252900|FG004|Period I|Adverse Event|2|||
42380682|NCT01490125|76252901|FG005|Period I|Adverse Event|4|||
42380683|NCT01490125|76252896|FG000|Period I|Protocol Violation|1|||
42380684|NCT01490125|76252897|FG001|Period I|Protocol Violation|1|||
42380685|NCT01490125|76252898|FG002|Period I|Protocol Violation|1|||
42380686|NCT01490125|76252899|FG003|Period I|Protocol Violation|1|||
42380687|NCT01490125|76252900|FG004|Period I|Protocol Violation|0|||
42380688|NCT01490125|76252901|FG005|Period I|Protocol Violation|0|||
42380689|NCT01490125|76252896|FG000|Period I|Withdrawal by Subject|1|||
42380690|NCT01490125|76252897|FG001|Period I|Withdrawal by Subject|3|||
42380691|NCT01490125|76252898|FG002|Period I|Withdrawal by Subject|2|||
42380692|NCT01490125|76252899|FG003|Period I|Withdrawal by Subject|1|||
42380693|NCT01490125|76252900|FG004|Period I|Withdrawal by Subject|2|||
42380694|NCT01490125|76252901|FG005|Period I|Withdrawal by Subject|1|||
42380695|NCT01490125|76252896|FG000|Period II|Adverse Event|2|||
42380696|NCT01490125|76252897|FG001|Period II|Adverse Event|3|||
42380697|NCT01490125|76252898|FG002|Period II|Adverse Event|2|||
42380698|NCT01490125|76252899|FG003|Period II|Adverse Event|2|||
42380699|NCT01490125|76252900|FG004|Period II|Adverse Event|4|||
42380700|NCT01490125|76252901|FG005|Period II|Adverse Event|2|||
42380701|NCT01490125|76252896|FG000|Period II|Protocol Violation|0|||
42380702|NCT01490125|76252897|FG001|Period II|Protocol Violation|0|||
42380703|NCT01490125|76252898|FG002|Period II|Protocol Violation|1|||
42380704|NCT01490125|76252899|FG003|Period II|Protocol Violation|1|||
42380705|NCT01490125|76252900|FG004|Period II|Protocol Violation|0|||
42380706|NCT01490125|76252901|FG005|Period II|Protocol Violation|0|||
42380707|NCT01490125|76252896|FG000|Period II|Lost to Follow-up|0|||
42380708|NCT01490125|76252897|FG001|Period II|Lost to Follow-up|1|||
42380709|NCT01490125|76252898|FG002|Period II|Lost to Follow-up|0|||
42380710|NCT01490125|76252899|FG003|Period II|Lost to Follow-up|0|||
42380711|NCT01490125|76252900|FG004|Period II|Lost to Follow-up|0|||
42380712|NCT01490125|76252901|FG005|Period II|Lost to Follow-up|0|||
42380713|NCT01490125|76252896|FG000|Period II|Withdrawal by Subject|1|||
42380714|NCT01490125|76252897|FG001|Period II|Withdrawal by Subject|0|||
42380715|NCT01490125|76252898|FG002|Period II|Withdrawal by Subject|0|||
42380716|NCT01490125|76252899|FG003|Period II|Withdrawal by Subject|0|||
42380717|NCT01490125|76252900|FG004|Period II|Withdrawal by Subject|0|||
42380718|NCT01490125|76252901|FG005|Period II|Withdrawal by Subject|0|||
42380719|NCT01490125|76252896|FG000|Period III|Adverse Event|3|||
42380720|NCT01490125|76252897|FG001|Period III|Adverse Event|1|||
42380721|NCT01490125|76252898|FG002|Period III|Adverse Event|0|||
42380722|NCT01490125|76252899|FG003|Period III|Adverse Event|1|||
42380723|NCT01490125|76252900|FG004|Period III|Adverse Event|0|||
42380724|NCT01490125|76252901|FG005|Period III|Adverse Event|0|||
42380725|NCT01490125|76252896|FG000|Period III|Death|0|||
42380726|NCT01490125|76252897|FG001|Period III|Death|0|||
42380727|NCT01490125|76252898|FG002|Period III|Death|0|||
42380728|NCT01490125|76252899|FG003|Period III|Death|1|||
42380729|NCT01490125|76252900|FG004|Period III|Death|0|||
42201989|NCT02101853|76014577|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
42201990|NCT02101853|76014578|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
42380730|NCT01490125|76252901|FG005|Period III|Death|0|||
42380731|NCT01490125|76252896|FG000|Period III|Lack of Efficacy|0|||
42380732|NCT01490125|76252897|FG001|Period III|Lack of Efficacy|0|||
42380733|NCT01490125|76252898|FG002|Period III|Lack of Efficacy|0|||
42380734|NCT01490125|76252899|FG003|Period III|Lack of Efficacy|0|||
42380735|NCT01490125|76252900|FG004|Period III|Lack of Efficacy|1|||
42380736|NCT01490125|76252901|FG005|Period III|Lack of Efficacy|0|||
42380737|NCT01446913|76252912|FG000|Overall Study|Significant illness|1|||
42380738|NCT01446913|76252913|FG001|Overall Study|Significant illness|1|||
42380739|NCT01446913|76252914|FG002|Overall Study|Significant illness|1|||
42380740|NCT01446913|76252912|FG000|Overall Study|Withdrawal by Subject|5|||
42380741|NCT01446913|76252913|FG001|Overall Study|Withdrawal by Subject|3|||
42380742|NCT01446913|76252914|FG002|Overall Study|Withdrawal by Subject|5|||
42201991|NCT02101853|76014579|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
42380743|NCT01446913|76252912|FG000|Overall Study|Physician Decision|0|||
42380744|NCT01446913|76252913|FG001|Overall Study|Physician Decision|0|||
42380745|NCT01446913|76252914|FG002|Overall Study|Physician Decision|2|||
42380746|NCT01446913|76252912|FG000|Overall Study|Lost to Follow-up|3|||
42380747|NCT01446913|76252913|FG001|Overall Study|Lost to Follow-up|5|||
42380748|NCT01446913|76252914|FG002|Overall Study|Lost to Follow-up|3|||
42380749|NCT01420549|76252945|FG000|Overall Study|Adverse Event|1|||
42380750|NCT01420549|76252946|FG001|Overall Study|Adverse Event|1|||
42380751|NCT01420549|76252945|FG000|Overall Study|Lost to Follow-up|2|||
42380752|NCT01420549|76252946|FG001|Overall Study|Lost to Follow-up|2|||
42380753|NCT01420549|76252945|FG000|Overall Study|Protocol Violation|0|||
42380754|NCT01420549|76252946|FG001|Overall Study|Protocol Violation|1|||
42380755|NCT01420549|76252945|FG000|Overall Study|Non-adherence to medication|4|||
42380756|NCT01420549|76252946|FG001|Overall Study|Non-adherence to medication|1|||
42380757|NCT01440595|76252967|FG000|Overall Study|Lost to Follow-up|0|||
42380758|NCT01440595|76252968|FG001|Overall Study|Lost to Follow-up|1|||
42380759|NCT01440595|76252969|FG002|Overall Study|Lost to Follow-up|0|||
42380760|NCT01440595|76252967|FG000|Overall Study|Study terminated by sponsor.|1|||
42380761|NCT01440595|76252968|FG001|Overall Study|Study terminated by sponsor.|2|||
42380762|NCT01440595|76252969|FG002|Overall Study|Study terminated by sponsor.|1|||
42380763|NCT01440517|76252975|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
42380764|NCT01440283|76252979|FG000|Overall Study|Death|3|||
42380765|NCT01440283|76252979|FG000|Overall Study|Withdrawal by Subject|4|||
42380766|NCT01440283|76252979|FG000|Overall Study|Physician Decision|3|||
42380767|NCT01440049|76252989|FG000|Overall Study|Adverse Event|5|||
42380768|NCT01439971|76253050|FG000|Overall Study|Required number in cohort dosed|0|||
42380769|NCT01439971|76253051|FG001|Overall Study|Required number in cohort dosed|1|||
42380770|NCT01439971|76253052|FG002|Overall Study|Required number in cohort dosed|2|||
42380771|NCT01439971|76253053|FG003|Overall Study|Required number in cohort dosed|0|||
42380772|NCT01439971|76253054|FG004|Overall Study|Required number in cohort dosed|1|||
42380773|NCT01447927|76253117|FG000|Overall Study|Adverse Event|4|||
42380774|NCT01447927|76253118|FG001|Overall Study|Adverse Event|3|||
42380775|NCT01447927|76253117|FG000|Overall Study|Withdrawal by Subject|1|||
42380776|NCT01447927|76253118|FG001|Overall Study|Withdrawal by Subject|0|||
42380777|NCT01551758|76253140|FG000|Overall Study|Adverse Event|29|||
42201992|NCT02101853|76014574|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
42380778|NCT01551758|76253141|FG001|Overall Study|Adverse Event|43|||
42201993|NCT02101853|76014575|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
42018844|NCT01122927|75826234|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
42380779|NCT01551758|76253140|FG000|Overall Study|Lack of Efficacy|0|||
42380780|NCT01551758|76253141|FG001|Overall Study|Lack of Efficacy|1|||
42380781|NCT01551758|76253140|FG000|Overall Study|Protocol Violation|5|||
42380782|NCT01551758|76253141|FG001|Overall Study|Protocol Violation|6|||
42380783|NCT01551758|76253140|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
42380784|NCT01551758|76253141|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
42380785|NCT01551758|76253140|FG000|Overall Study|Lost to Follow-up|29|||
42380786|NCT01551758|76253141|FG001|Overall Study|Lost to Follow-up|25|||
42380787|NCT01551758|76253140|FG000|Overall Study|Physician Decision|9|||
42380788|NCT01551758|76253141|FG001|Overall Study|Physician Decision|3|||
42380789|NCT01551758|76253140|FG000|Overall Study|Withdrawal by Subject|14|||
42380790|NCT01551758|76253141|FG001|Overall Study|Withdrawal by Subject|17|||
42380791|NCT01449461|76253344|FG000|Overall Study|Adverse Event|0|||
42380792|NCT01449461|76253345|FG001|Overall Study|Adverse Event|3|||
42380793|NCT01449461|76253346|FG002|Overall Study|Adverse Event|2|||
42380794|NCT01449461|76253347|FG003|Overall Study|Adverse Event|3|||
42380795|NCT01449461|76253348|FG004|Overall Study|Adverse Event|4|||
42380796|NCT01449461|76253349|FG005|Overall Study|Adverse Event|4|||
42380797|NCT01449461|76253344|FG000|Overall Study|Death|0|||
42380798|NCT01449461|76253345|FG001|Overall Study|Death|2|||
42380799|NCT01449461|76253346|FG002|Overall Study|Death|0|||
42380800|NCT01449461|76253347|FG003|Overall Study|Death|0|||
42380801|NCT01449461|76253348|FG004|Overall Study|Death|7|||
42380802|NCT01449461|76253349|FG005|Overall Study|Death|1|||
42380803|NCT01449461|76253344|FG000|Overall Study|Physician Decision|0|||
42380804|NCT01449461|76253345|FG001|Overall Study|Physician Decision|1|||
42380805|NCT01449461|76253346|FG002|Overall Study|Physician Decision|0|||
42380806|NCT01449461|76253347|FG003|Overall Study|Physician Decision|4|||
42380807|NCT01449461|76253348|FG004|Overall Study|Physician Decision|1|||
42380808|NCT01449461|76253349|FG005|Overall Study|Physician Decision|0|||
42380809|NCT01449461|76253344|FG000|Overall Study|Documented Progressive Disease|4|||
42380810|NCT01449461|76253345|FG001|Overall Study|Documented Progressive Disease|7|||
42106415|NCT03937479|75917438|FG004|Overall Study|Adverse Event|1|||
42106416|NCT03937479|75917434|FG000|Overall Study|Withdrawal by Subject|3|||
42106417|NCT03937479|75917435|FG001|Overall Study|Withdrawal by Subject|5|||
42106418|NCT03937479|75917436|FG002|Overall Study|Withdrawal by Subject|2|||
42106419|NCT03937479|75917437|FG003|Overall Study|Withdrawal by Subject|2|||
42106420|NCT03937479|75917438|FG004|Overall Study|Withdrawal by Subject|1|||
42106421|NCT03937479|75917434|FG000|Overall Study|Protocol Violation|5|||
42106422|NCT03937479|75917435|FG001|Overall Study|Protocol Violation|6|||
42106423|NCT03937479|75917436|FG002|Overall Study|Protocol Violation|4|||
42106424|NCT03937479|75917437|FG003|Overall Study|Protocol Violation|3|||
42106425|NCT03937479|75917438|FG004|Overall Study|Protocol Violation|2|||
42380811|NCT01449461|76253346|FG002|Overall Study|Documented Progressive Disease|14|||
42380812|NCT01449461|76253347|FG003|Overall Study|Documented Progressive Disease|15|||
42380813|NCT01449461|76253348|FG004|Overall Study|Documented Progressive Disease|24|||
42380814|NCT01449461|76253349|FG005|Overall Study|Documented Progressive Disease|5|||
42380815|NCT01449461|76253344|FG000|Overall Study|Clinical Progressive Disease|2|||
42380816|NCT01449461|76253345|FG001|Overall Study|Clinical Progressive Disease|2|||
42380817|NCT01449461|76253346|FG002|Overall Study|Clinical Progressive Disease|0|||
42380818|NCT01449461|76253347|FG003|Overall Study|Clinical Progressive Disease|3|||
42380819|NCT01449461|76253348|FG004|Overall Study|Clinical Progressive Disease|4|||
42380820|NCT01449461|76253349|FG005|Overall Study|Clinical Progressive Disease|2|||
42380821|NCT01449461|76253344|FG000|Overall Study|Protocol Violation|0|||
42380822|NCT01449461|76253345|FG001|Overall Study|Protocol Violation|0|||
42380823|NCT01449461|76253346|FG002|Overall Study|Protocol Violation|0|||
42380824|NCT01449461|76253347|FG003|Overall Study|Protocol Violation|1|||
42380825|NCT01449461|76253348|FG004|Overall Study|Protocol Violation|0|||
42380826|NCT01449461|76253349|FG005|Overall Study|Protocol Violation|0|||
42380827|NCT01449461|76253344|FG000|Overall Study|Site Terminated by Sponsor|0|||
42380828|NCT01449461|76253345|FG001|Overall Study|Site Terminated by Sponsor|1|||
42380829|NCT01449461|76253346|FG002|Overall Study|Site Terminated by Sponsor|2|||
42380830|NCT01449461|76253347|FG003|Overall Study|Site Terminated by Sponsor|3|||
42380831|NCT01449461|76253348|FG004|Overall Study|Site Terminated by Sponsor|4|||
42380832|NCT01449461|76253349|FG005|Overall Study|Site Terminated by Sponsor|1|||
42380833|NCT01449461|76253344|FG000|Overall Study|Withdrawal by Subject|0|||
42380834|NCT01449461|76253345|FG001|Overall Study|Withdrawal by Subject|1|||
42380835|NCT01449461|76253346|FG002|Overall Study|Withdrawal by Subject|0|||
42380836|NCT01449461|76253347|FG003|Overall Study|Withdrawal by Subject|0|||
42380837|NCT01449461|76253348|FG004|Overall Study|Withdrawal by Subject|2|||
42380838|NCT01449461|76253349|FG005|Overall Study|Withdrawal by Subject|1|||
42380839|NCT01449461|76253344|FG000|Overall Study|Reason not Specified|0|||
42380840|NCT01449461|76253345|FG001|Overall Study|Reason not Specified|1|||
42380841|NCT01449461|76253346|FG002|Overall Study|Reason not Specified|0|||
42380842|NCT01449461|76253347|FG003|Overall Study|Reason not Specified|3|||
42380843|NCT01449461|76253348|FG004|Overall Study|Reason not Specified|2|||
42380844|NCT01449461|76253349|FG005|Overall Study|Reason not Specified|1|||
42380845|NCT01572038|76253385|FG000|Overall Study|Death|648|||
42380846|NCT01572038|76253385|FG000|Overall Study|Withdrawal by Subject|204|||
42380847|NCT01572038|76253385|FG000|Overall Study|Lost to Follow-up|81|||
42380848|NCT01572038|76253385|FG000|Overall Study|Physician Decision|20|||
42380849|NCT01572038|76253385|FG000|Overall Study|Patient Decision|14|||
42106426|NCT03937479|75917434|FG000|Overall Study|Lost to Follow-up|0|||
42106427|NCT03937479|75917435|FG001|Overall Study|Lost to Follow-up|1|||
42106428|NCT03937479|75917436|FG002|Overall Study|Lost to Follow-up|0|||
42106429|NCT03937479|75917437|FG003|Overall Study|Lost to Follow-up|1|||
42106430|NCT03937479|75917438|FG004|Overall Study|Lost to Follow-up|0|||
42106431|NCT03937479|75917434|FG000|Overall Study|Physician Decision|0|||
42106432|NCT03937479|75917435|FG001|Overall Study|Physician Decision|0|||
42106433|NCT03937479|75917436|FG002|Overall Study|Physician Decision|1|||
42106434|NCT03937479|75917437|FG003|Overall Study|Physician Decision|0|||
42106435|NCT03937479|75917438|FG004|Overall Study|Physician Decision|1|||
42106436|NCT00619476|75917454|FG000|Overall Study|Adverse Event|12|||
42106437|NCT00619476|75917455|FG001|Overall Study|Adverse Event|6|||
42106438|NCT00619476|75917456|FG002|Overall Study|Adverse Event|12|||
42106439|NCT00619476|75917457|FG003|Overall Study|Adverse Event|16|||
42106440|NCT00619476|75917454|FG000|Overall Study|Lack of Efficacy|6|||
42106441|NCT00619476|75917455|FG001|Overall Study|Lack of Efficacy|1|||
42106442|NCT00619476|75917456|FG002|Overall Study|Lack of Efficacy|1|||
42106443|NCT00619476|75917457|FG003|Overall Study|Lack of Efficacy|4|||
42106444|NCT00619476|75917454|FG000|Overall Study|Protocol Violation|5|||
42106445|NCT00619476|75917455|FG001|Overall Study|Protocol Violation|4|||
42106446|NCT00619476|75917456|FG002|Overall Study|Protocol Violation|4|||
42106447|NCT00619476|75917457|FG003|Overall Study|Protocol Violation|9|||
42106448|NCT00619476|75917454|FG000|Overall Study|Lost to Follow-up|1|||
42106449|NCT00619476|75917455|FG001|Overall Study|Lost to Follow-up|2|||
42106450|NCT00619476|75917456|FG002|Overall Study|Lost to Follow-up|0|||
42106451|NCT00619476|75917457|FG003|Overall Study|Lost to Follow-up|1|||
42106452|NCT00619476|75917454|FG000|Overall Study|Investigator Discretion|2|||
42106453|NCT00619476|75917455|FG001|Overall Study|Investigator Discretion|2|||
42106454|NCT00619476|75917456|FG002|Overall Study|Investigator Discretion|2|||
42106455|NCT00619476|75917457|FG003|Overall Study|Investigator Discretion|0|||
42106456|NCT00619476|75917454|FG000|Overall Study|Withdrawal by Subject|5|||
42106457|NCT00619476|75917455|FG001|Overall Study|Withdrawal by Subject|7|||
42106458|NCT00619476|75917456|FG002|Overall Study|Withdrawal by Subject|5|||
42106459|NCT00619476|75917457|FG003|Overall Study|Withdrawal by Subject|4|||
42106460|NCT00618072|75917470|FG000|Overall Study|Lost to Follow-up|2|||
42106461|NCT00618072|75917471|FG001|Overall Study|Lost to Follow-up|0|||
42106462|NCT00618072|75917472|FG002|Overall Study|Lost to Follow-up|3|||
42106463|NCT00618072|75917470|FG000|Overall Study|Physician Decision|0|||
42106464|NCT00618072|75917471|FG001|Overall Study|Physician Decision|1|||
42106465|NCT00618072|75917472|FG002|Overall Study|Physician Decision|1|||
42106466|NCT00666926|75917480|FG000|Overall Study|Adverse Event|0|||
42106467|NCT00666926|75917481|FG001|Overall Study|Adverse Event|0|||
42106468|NCT00666926|75917482|FG002|Overall Study|Adverse Event|0|||
42106469|NCT00666926|75917483|FG003|Overall Study|Adverse Event|0|||
42106470|NCT00666926|75917484|FG004|Overall Study|Adverse Event|0|||
42106471|NCT00666926|75917485|FG005|Overall Study|Adverse Event|0|||
42106472|NCT00666926|75917486|FG006|Overall Study|Adverse Event|0|||
42106473|NCT00666926|75917487|FG007|Overall Study|Adverse Event|0|||
42106474|NCT00666926|75917488|FG008|Overall Study|Adverse Event|0|||
42106475|NCT00666926|75917489|FG009|Overall Study|Adverse Event|2|||
42106476|NCT00666926|75917490|FG010|Overall Study|Adverse Event|2|||
42106477|NCT00666926|75917491|FG011|Overall Study|Adverse Event|2|||
42106478|NCT00666926|75917492|FG012|Overall Study|Adverse Event|0|||
42106479|NCT00666926|75917493|FG013|Overall Study|Adverse Event|1|||
42106480|NCT00666926|75917494|FG014|Overall Study|Adverse Event|0|||
42018845|NCT01122927|75826235|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
42106481|NCT00666926|75917495|FG015|Overall Study|Adverse Event|0|||
42106482|NCT00666926|75917480|FG000|Overall Study|Laboratory abnormality|0|||
42106483|NCT00666926|75917481|FG001|Overall Study|Laboratory abnormality|0|||
42106484|NCT00666926|75917482|FG002|Overall Study|Laboratory abnormality|0|||
42106485|NCT00666926|75917483|FG003|Overall Study|Laboratory abnormality|0|||
42106486|NCT00666926|75917484|FG004|Overall Study|Laboratory abnormality|0|||
42380850|NCT01572038|76253385|FG000|Overall Study|Progressive Disease|8|||
42380851|NCT01572038|76253385|FG000|Overall Study|Site Closed Before Completing Form|6|||
42380852|NCT01572038|76253385|FG000|Overall Study|Enrolled into Another Trial|3|||
42380853|NCT01572038|76253385|FG000|Overall Study|Participated in Another Trial|3|||
42380854|NCT01572038|76253385|FG000|Overall Study|Termination by Sponsor|2|||
42380855|NCT01572038|76253385|FG000|Overall Study|Patient Deterioration|1|||
42380856|NCT01572038|76253385|FG000|Overall Study|Sponsor Decision|1|||
42380857|NCT01448213|76253413|FG000|Overall Study|Lost to Follow-up|12|||
42380858|NCT01448213|76253414|FG001|Overall Study|Lost to Follow-up|10|||
42380859|NCT01448213|76253413|FG000|Overall Study|Adverse Event|4|||
42380860|NCT01448213|76253414|FG001|Overall Study|Adverse Event|10|||
42380861|NCT01448213|76253413|FG000|Overall Study|Protocol Violation|1|||
42380862|NCT01448213|76253414|FG001|Overall Study|Protocol Violation|2|||
42380863|NCT01448057|76253431|FG000|Overall Study|Protocol Violation|3|||
42380864|NCT01448057|76253432|FG001|Overall Study|Protocol Violation|2|||
42380865|NCT01448057|76253431|FG000|Overall Study|Lost to Follow-up|3|||
42380866|NCT01448057|76253432|FG001|Overall Study|Lost to Follow-up|0|||
42380867|NCT01448057|76253431|FG000|Overall Study|Adverse Event|0|||
42380868|NCT01448057|76253432|FG001|Overall Study|Adverse Event|2|||
42380869|NCT01448057|76253431|FG000|Overall Study|Withdrawal by Subject|2|||
42380870|NCT01448057|76253432|FG001|Overall Study|Withdrawal by Subject|0|||
42380871|NCT01447433|76253440|FG000|Overall Study|Lost to Follow-up|0|||
42380872|NCT01447433|76253441|FG001|Overall Study|Lost to Follow-up|2|||
42380873|NCT01447433|76253440|FG000|Overall Study|Withdrawal by Subject|3|||
42106487|NCT00666926|75917485|FG005|Overall Study|Laboratory abnormality|0|||
42201994|NCT02101853|76014576|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
42201995|NCT02101853|76014577|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
42201996|NCT02101853|76014578|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
42201997|NCT02101853|76014579|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
42106488|NCT00666926|75917486|FG006|Overall Study|Laboratory abnormality|0|||
42106489|NCT00666926|75917487|FG007|Overall Study|Laboratory abnormality|0|||
42106490|NCT00666926|75917488|FG008|Overall Study|Laboratory abnormality|0|||
42106491|NCT00666926|75917489|FG009|Overall Study|Laboratory abnormality|0|||
42106492|NCT00666926|75917490|FG010|Overall Study|Laboratory abnormality|1|||
42106493|NCT00666926|75917491|FG011|Overall Study|Laboratory abnormality|0|||
42106494|NCT00666926|75917492|FG012|Overall Study|Laboratory abnormality|0|||
42106495|NCT00666926|75917493|FG013|Overall Study|Laboratory abnormality|0|||
42106496|NCT00666926|75917494|FG014|Overall Study|Laboratory abnormality|0|||
42106497|NCT00666926|75917495|FG015|Overall Study|Laboratory abnormality|1|||
42106498|NCT00666926|75917480|FG000|Overall Study|Lack of Efficacy|0|||
42106499|NCT00666926|75917481|FG001|Overall Study|Lack of Efficacy|0|||
42106500|NCT00666926|75917482|FG002|Overall Study|Lack of Efficacy|0|||
42106501|NCT00666926|75917483|FG003|Overall Study|Lack of Efficacy|0|||
42106502|NCT00666926|75917484|FG004|Overall Study|Lack of Efficacy|0|||
42106503|NCT00666926|75917485|FG005|Overall Study|Lack of Efficacy|1|||
42106504|NCT00666926|75917486|FG006|Overall Study|Lack of Efficacy|0|||
42106505|NCT00666926|75917487|FG007|Overall Study|Lack of Efficacy|0|||
42106506|NCT00666926|75917488|FG008|Overall Study|Lack of Efficacy|0|||
42106507|NCT00666926|75917489|FG009|Overall Study|Lack of Efficacy|0|||
42106508|NCT00666926|75917490|FG010|Overall Study|Lack of Efficacy|0|||
42106509|NCT00666926|75917491|FG011|Overall Study|Lack of Efficacy|1|||
42106510|NCT00666926|75917492|FG012|Overall Study|Lack of Efficacy|0|||
42106511|NCT00666926|75917493|FG013|Overall Study|Lack of Efficacy|0|||
42106512|NCT00666926|75917494|FG014|Overall Study|Lack of Efficacy|0|||
42106513|NCT00666926|75917495|FG015|Overall Study|Lack of Efficacy|0|||
42106514|NCT00666926|75917480|FG000|Overall Study|Lost to Follow-up|0|||
42106515|NCT00666926|75917481|FG001|Overall Study|Lost to Follow-up|0|||
42106516|NCT00666926|75917482|FG002|Overall Study|Lost to Follow-up|0|||
42106517|NCT00666926|75917483|FG003|Overall Study|Lost to Follow-up|1|||
42106518|NCT00666926|75917484|FG004|Overall Study|Lost to Follow-up|0|||
42106519|NCT00666926|75917485|FG005|Overall Study|Lost to Follow-up|0|||
42106520|NCT00666926|75917486|FG006|Overall Study|Lost to Follow-up|0|||
42106521|NCT00666926|75917487|FG007|Overall Study|Lost to Follow-up|0|||
42106522|NCT00666926|75917488|FG008|Overall Study|Lost to Follow-up|0|||
42106523|NCT00666926|75917489|FG009|Overall Study|Lost to Follow-up|0|||
42106524|NCT00666926|75917490|FG010|Overall Study|Lost to Follow-up|0|||
42106525|NCT00666926|75917491|FG011|Overall Study|Lost to Follow-up|0|||
42106526|NCT00666926|75917492|FG012|Overall Study|Lost to Follow-up|0|||
42106527|NCT00666926|75917493|FG013|Overall Study|Lost to Follow-up|0|||
42106528|NCT00666926|75917494|FG014|Overall Study|Lost to Follow-up|0|||
42106529|NCT00666926|75917495|FG015|Overall Study|Lost to Follow-up|0|||
42106530|NCT00666926|75917480|FG000|Overall Study|Other|2|||
42106531|NCT00666926|75917481|FG001|Overall Study|Other|4|||
42106532|NCT00666926|75917482|FG002|Overall Study|Other|3|||
42106533|NCT00666926|75917483|FG003|Overall Study|Other|3|||
42106534|NCT00666926|75917484|FG004|Overall Study|Other|3|||
42106535|NCT00666926|75917485|FG005|Overall Study|Other|3|||
42106536|NCT00666926|75917486|FG006|Overall Study|Other|4|||
42106537|NCT00666926|75917487|FG007|Overall Study|Other|0|||
42106538|NCT00666926|75917488|FG008|Overall Study|Other|3|||
42106539|NCT00666926|75917489|FG009|Overall Study|Other|5|||
42106540|NCT00666926|75917490|FG010|Overall Study|Other|3|||
42106541|NCT00666926|75917491|FG011|Overall Study|Other|26|||
42106542|NCT00666926|75917492|FG012|Overall Study|Other|3|||
42106543|NCT00666926|75917493|FG013|Overall Study|Other|2|||
42106544|NCT00666926|75917494|FG014|Overall Study|Other|4|||
42106545|NCT00666926|75917495|FG015|Overall Study|Other|4|||
42106546|NCT00666926|75917480|FG000|Overall Study|Withdrawal by Subject|0|||
42106547|NCT00666926|75917481|FG001|Overall Study|Withdrawal by Subject|0|||
42106548|NCT00666926|75917482|FG002|Overall Study|Withdrawal by Subject|0|||
42106549|NCT00666926|75917483|FG003|Overall Study|Withdrawal by Subject|0|||
42106550|NCT00666926|75917484|FG004|Overall Study|Withdrawal by Subject|0|||
42106551|NCT00666926|75917485|FG005|Overall Study|Withdrawal by Subject|0|||
42106552|NCT00666926|75917486|FG006|Overall Study|Withdrawal by Subject|0|||
42106553|NCT00666926|75917487|FG007|Overall Study|Withdrawal by Subject|1|||
42106554|NCT00666926|75917488|FG008|Overall Study|Withdrawal by Subject|0|||
42106555|NCT00666926|75917489|FG009|Overall Study|Withdrawal by Subject|3|||
42106556|NCT00666926|75917490|FG010|Overall Study|Withdrawal by Subject|0|||
42106557|NCT00666926|75917491|FG011|Overall Study|Withdrawal by Subject|3|||
42106558|NCT00666926|75917492|FG012|Overall Study|Withdrawal by Subject|0|||
42106559|NCT00666926|75917493|FG013|Overall Study|Withdrawal by Subject|1|||
42106560|NCT00666926|75917494|FG014|Overall Study|Withdrawal by Subject|3|||
42106561|NCT00666926|75917495|FG015|Overall Study|Withdrawal by Subject|3|||
42106562|NCT00666926|75917480|FG000|Overall Study|Death|0|||
42106563|NCT00666926|75917481|FG001|Overall Study|Death|0|||
42106564|NCT00666926|75917482|FG002|Overall Study|Death|0|||
42106565|NCT00666926|75917483|FG003|Overall Study|Death|0|||
42106566|NCT00666926|75917484|FG004|Overall Study|Death|0|||
42106567|NCT00666926|75917485|FG005|Overall Study|Death|0|||
42106568|NCT00666926|75917486|FG006|Overall Study|Death|0|||
42106569|NCT00666926|75917487|FG007|Overall Study|Death|0|||
42106570|NCT00666926|75917488|FG008|Overall Study|Death|0|||
42106571|NCT00666926|75917489|FG009|Overall Study|Death|0|||
42106572|NCT00666926|75917490|FG010|Overall Study|Death|0|||
42106573|NCT00666926|75917491|FG011|Overall Study|Death|1|||
42106574|NCT00666926|75917492|FG012|Overall Study|Death|0|||
42106575|NCT00666926|75917493|FG013|Overall Study|Death|0|||
42106576|NCT00666926|75917494|FG014|Overall Study|Death|0|||
42106577|NCT00666926|75917495|FG015|Overall Study|Death|0|||
42106578|NCT03861052|75917550|FG000|Overall Study|Adverse Event|1|||
42201998|NCT02101853|76014574|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
42106579|NCT03861052|75917551|FG001|Overall Study|Adverse Event|1|||
42106580|NCT03861052|75917552|FG002|Overall Study|Adverse Event|2|||
42106581|NCT03861052|75917553|FG003|Overall Study|Adverse Event|4|||
42106582|NCT03861052|75917550|FG000|Overall Study|Lost to Follow-up|0|||
42106583|NCT03861052|75917551|FG001|Overall Study|Lost to Follow-up|0|||
42106584|NCT03861052|75917552|FG002|Overall Study|Lost to Follow-up|0|||
42106585|NCT03861052|75917553|FG003|Overall Study|Lost to Follow-up|1|||
42106586|NCT03861052|75917550|FG000|Overall Study|Physician Decision|0|||
42106587|NCT03861052|75917551|FG001|Overall Study|Physician Decision|1|||
42201999|NCT02101853|76014575|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
42106588|NCT03861052|75917552|FG002|Overall Study|Physician Decision|0|||
42106589|NCT03861052|75917553|FG003|Overall Study|Physician Decision|0|||
42106590|NCT03861052|75917550|FG000|Overall Study|Withdrawal by Subject|2|||
42106591|NCT03861052|75917551|FG001|Overall Study|Withdrawal by Subject|5|||
42106592|NCT03861052|75917552|FG002|Overall Study|Withdrawal by Subject|3|||
42106593|NCT03861052|75917553|FG003|Overall Study|Withdrawal by Subject|0|||
42106594|NCT03861052|75917550|FG000|Overall Study|Relocation to other city|1|||
42106595|NCT03861052|75917551|FG001|Overall Study|Relocation to other city|0|||
42106596|NCT03861052|75917552|FG002|Overall Study|Relocation to other city|0|||
42106597|NCT03861052|75917553|FG003|Overall Study|Relocation to other city|0|||
42106598|NCT00664742|75917568|FG000|Overall Study|Withdrawn due to adverse events|3|||
42380874|NCT01447433|76253441|FG001|Overall Study|Withdrawal by Subject|3|||
42380875|NCT01447433|76253440|FG000|Overall Study|Protocol Violation|1|||
42380876|NCT01447433|76253441|FG001|Overall Study|Protocol Violation|1|||
42106599|NCT00664742|75917568|FG000|Overall Study|Withdrawal by Subject|31|||
42106600|NCT00664742|75917568|FG000|Overall Study|Lost to Follow-up|92|||
42202000|NCT02101853|76014576|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
42202001|NCT02101853|76014577|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
42380877|NCT01446965|76253449|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
42106601|NCT00511342|75917574|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
42106602|NCT00511342|75917575|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
42106603|NCT00511342|75917574|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
42106604|NCT00511342|75917575|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
42106605|NCT00511342|75917574|FG000|Overall Study|Pregnancy|0|||
42106606|NCT00511342|75917575|FG001|Overall Study|Pregnancy|1|||
42106607|NCT00511342|75917574|FG000|Overall Study|Pregnancy wish|0|||
42106608|NCT00511342|75917575|FG001|Overall Study|Pregnancy wish|1|||
42106609|NCT00511342|75917574|FG000|Overall Study|Lost to Follow-up|1|||
42106610|NCT00511342|75917575|FG001|Overall Study|Lost to Follow-up|5|||
42106611|NCT00511342|75917574|FG000|Overall Study|Other Reason|2|||
42106612|NCT00511342|75917575|FG001|Overall Study|Other Reason|2|||
42106613|NCT03931785|75917585|FG000|Overall Study|Lost to Follow-up|4|||
42106614|NCT03931785|75917586|FG001|Overall Study|Lost to Follow-up|1|||
42106615|NCT03931785|75917587|FG002|Overall Study|Lost to Follow-up|4|||
42106616|NCT03931785|75917588|FG003|Overall Study|Lost to Follow-up|3|||
42106617|NCT03931785|75917585|FG000|Overall Study|Adverse Event|1|||
42106618|NCT03931785|75917586|FG001|Overall Study|Adverse Event|0|||
42106619|NCT03931785|75917587|FG002|Overall Study|Adverse Event|3|||
42106620|NCT03931785|75917588|FG003|Overall Study|Adverse Event|4|||
42106621|NCT03931785|75917585|FG000|Overall Study|Protocol Violation|0|||
42106622|NCT03931785|75917586|FG001|Overall Study|Protocol Violation|1|||
42106623|NCT03931785|75917587|FG002|Overall Study|Protocol Violation|0|||
42106624|NCT03931785|75917588|FG003|Overall Study|Protocol Violation|0|||
42106625|NCT03931785|75917585|FG000|Overall Study|Noncompliance With Study drug|0|||
42106626|NCT03931785|75917586|FG001|Overall Study|Noncompliance With Study drug|1|||
42106627|NCT03931785|75917587|FG002|Overall Study|Noncompliance With Study drug|0|||
42106628|NCT03931785|75917588|FG003|Overall Study|Noncompliance With Study drug|0|||
42106629|NCT03931785|75917585|FG000|Overall Study|Other Not specified|0|||
42106630|NCT03931785|75917586|FG001|Overall Study|Other Not specified|2|||
42106631|NCT03931785|75917587|FG002|Overall Study|Other Not specified|2|||
42106632|NCT03931785|75917588|FG003|Overall Study|Other Not specified|2|||
42106633|NCT03931785|75917585|FG000|Overall Study|Withdrawal by Subject|0|||
42106634|NCT03931785|75917586|FG001|Overall Study|Withdrawal by Subject|2|||
42106635|NCT03931785|75917587|FG002|Overall Study|Withdrawal by Subject|4|||
42106636|NCT03931785|75917588|FG003|Overall Study|Withdrawal by Subject|1|||
42106637|NCT03931785|75917585|FG000|Overall Study|Pregnancy|0|||
42106638|NCT03931785|75917586|FG001|Overall Study|Pregnancy|0|||
42106639|NCT03931785|75917587|FG002|Overall Study|Pregnancy|0|||
42106640|NCT03931785|75917588|FG003|Overall Study|Pregnancy|1|||
42106641|NCT00666536|75917600|FG000|Overall Study|Adverse Event|9|||
42106642|NCT00666536|75917601|FG001|Overall Study|Adverse Event|19|||
42106643|NCT00666536|75917600|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
42106644|NCT00666536|75917601|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42106645|NCT00666536|75917600|FG000|Overall Study|Protocol deviation(s)|8|||
42106646|NCT00666536|75917601|FG001|Overall Study|Protocol deviation(s)|6|||
42106647|NCT00666536|75917600|FG000|Overall Study|Withdrawal by Subject|10|||
42106648|NCT00666536|75917601|FG001|Overall Study|Withdrawal by Subject|9|||
42106649|NCT00666536|75917600|FG000|Overall Study|Lost to Follow-up|4|||
42106650|NCT00666536|75917601|FG001|Overall Study|Lost to Follow-up|3|||
42106651|NCT00519532|75917607|FG000|Overall Study|Adverse Event|11|||
42106652|NCT00519532|75917607|FG000|Overall Study|Withdrawal by Subject|5|||
42106653|NCT00519532|75917607|FG000|Overall Study|Lost to Follow-up|2|||
42106654|NCT00666458|75917613|FG000|Overall Study|Adverse Event|8|||
42106655|NCT00666458|75917614|FG001|Overall Study|Adverse Event|7|||
42106656|NCT00666458|75917613|FG000|Overall Study|Withdrawal by Subject|5|||
42106657|NCT00666458|75917614|FG001|Overall Study|Withdrawal by Subject|4|||
42106658|NCT00666458|75917613|FG000|Overall Study|Lost to Follow-up|0|||
42106659|NCT00666458|75917614|FG001|Overall Study|Lost to Follow-up|3|||
42106660|NCT00666458|75917613|FG000|Overall Study|Administrative reason by sponsor|1|||
42106661|NCT00666458|75917614|FG001|Overall Study|Administrative reason by sponsor|1|||
42106662|NCT00666458|75917613|FG000|Overall Study|Incorrect enrollment|7|||
42106663|NCT00666458|75917614|FG001|Overall Study|Incorrect enrollment|1|||
42106664|NCT00666458|75917613|FG000|Overall Study|Study specific discontinuation criteria|14|||
42106665|NCT00666458|75917614|FG001|Overall Study|Study specific discontinuation criteria|7|||
42106666|NCT00666458|75917613|FG000|Overall Study|Severe non-compliance to the protocol|1|||
42106667|NCT00666458|75917614|FG001|Overall Study|Severe non-compliance to the protocol|1|||
42106668|NCT00666458|75917613|FG000|Overall Study|Safety reasons|1|||
42106669|NCT00666458|75917614|FG001|Overall Study|Safety reasons|0|||
42106670|NCT00666458|75917613|FG000|Overall Study|Medical history of anemia|1|||
42106671|NCT00666458|75917614|FG001|Overall Study|Medical history of anemia|0|||
42106672|NCT00511108|75917624|FG000|Overall Study|Adverse Event|2|||
42106673|NCT00511108|75917625|FG001|Overall Study|Adverse Event|0|||
42106674|NCT00511108|75917626|FG002|Overall Study|Adverse Event|1|||
42106675|NCT00511108|75917627|FG003|Overall Study|Adverse Event|2|||
42106676|NCT00511108|75917624|FG000|Overall Study|Lost to Follow-up|0|||
42106677|NCT00511108|75917625|FG001|Overall Study|Lost to Follow-up|2|||
42106678|NCT00511108|75917626|FG002|Overall Study|Lost to Follow-up|1|||
42106679|NCT00511108|75917627|FG003|Overall Study|Lost to Follow-up|0|||
42106680|NCT00511108|75917624|FG000|Overall Study|Physician Decision|0|||
42106681|NCT00511108|75917625|FG001|Overall Study|Physician Decision|0|||
42106682|NCT00511108|75917626|FG002|Overall Study|Physician Decision|0|||
42106683|NCT00511108|75917627|FG003|Overall Study|Physician Decision|1|||
42106684|NCT00511108|75917624|FG000|Overall Study|Withdrawal by Subject|4|||
42106685|NCT00511108|75917625|FG001|Overall Study|Withdrawal by Subject|0|||
42106686|NCT00511108|75917626|FG002|Overall Study|Withdrawal by Subject|3|||
42106687|NCT00511108|75917627|FG003|Overall Study|Withdrawal by Subject|2|||
42106688|NCT00510952|75917639|FG000|Overall Study|Adverse Event|1|||
42106689|NCT00510952|75917640|FG001|Overall Study|Adverse Event|0|||
42106690|NCT00510952|75917639|FG000|Overall Study|Entry Criteria Not Met|3|||
42106691|NCT00510952|75917640|FG001|Overall Study|Entry Criteria Not Met|1|||
42106692|NCT00510952|75917639|FG000|Overall Study|Lost to Follow-up|5|||
42106693|NCT00510952|75917640|FG001|Overall Study|Lost to Follow-up|3|||
42106694|NCT00510952|75917639|FG000|Overall Study|Physician Decision|1|||
42106695|NCT00510952|75917640|FG001|Overall Study|Physician Decision|1|||
42106696|NCT00510952|75917639|FG000|Overall Study|Protocol Violation|7|||
42106697|NCT00510952|75917640|FG001|Overall Study|Protocol Violation|4|||
42106698|NCT00510952|75917639|FG000|Overall Study|Sponsor Decision|1|||
42106699|NCT00510952|75917640|FG001|Overall Study|Sponsor Decision|0|||
42106700|NCT00510952|75917639|FG000|Overall Study|Withdrawal by Subject|6|||
42106701|NCT00510952|75917640|FG001|Overall Study|Withdrawal by Subject|7|||
42106702|NCT00510952|75917639|FG000|Overall Study|Did Not Receive Study Drug|2|||
42106703|NCT00510952|75917640|FG001|Overall Study|Did Not Receive Study Drug|0|||
42106704|NCT00617604|75917648|FG000|Overall Study|Death|2|||
42106705|NCT00617604|75917649|FG001|Overall Study|Death|1|||
42106706|NCT00617604|75917648|FG000|Overall Study|Lost to Follow-up|1|||
42106707|NCT00617604|75917649|FG001|Overall Study|Lost to Follow-up|0|||
42106708|NCT00617604|75917648|FG000|Overall Study|Miscellaneous Reasons|8|||
42106709|NCT00617604|75917649|FG001|Overall Study|Miscellaneous Reasons|10|||
42106710|NCT00617604|75917648|FG000|Overall Study|Withdrawal by Subject|4|||
42106711|NCT00617604|75917649|FG001|Overall Study|Withdrawal by Subject|6|||
42106712|NCT00617604|75917648|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
42106713|NCT00617604|75917649|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
42106714|NCT00661622|75917657|FG000|Overall Study|Protocol Violation|1|||
42106715|NCT00661622|75917658|FG001|Overall Study|Protocol Violation|0|||
42106716|NCT04093752|75917669|FG000|Overall Study|Adverse Event|7|||
42106717|NCT04093752|75917670|FG001|Overall Study|Adverse Event|19|||
42106718|NCT04093752|75917671|FG002|Overall Study|Adverse Event|18|||
42106719|NCT04093752|75917672|FG003|Overall Study|Adverse Event|4|||
42106720|NCT04093752|75917669|FG000|Overall Study|Withdrawal by Subject|6|||
42106721|NCT04093752|75917670|FG001|Overall Study|Withdrawal by Subject|6|||
42106722|NCT04093752|75917671|FG002|Overall Study|Withdrawal by Subject|8|||
42106723|NCT04093752|75917672|FG003|Overall Study|Withdrawal by Subject|20|||
42106724|NCT04093752|75917669|FG000|Overall Study|Lost to Follow-up|2|||
42106725|NCT04093752|75917670|FG001|Overall Study|Lost to Follow-up|1|||
42106726|NCT04093752|75917671|FG002|Overall Study|Lost to Follow-up|1|||
42106727|NCT04093752|75917672|FG003|Overall Study|Lost to Follow-up|1|||
42106728|NCT04093752|75917669|FG000|Overall Study|Death|0|||
42106729|NCT04093752|75917670|FG001|Overall Study|Death|0|||
42106730|NCT04093752|75917671|FG002|Overall Study|Death|1|||
42106731|NCT04093752|75917672|FG003|Overall Study|Death|2|||
42106732|NCT04093752|75917669|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
42106733|NCT04093752|75917670|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
42106734|NCT04093752|75917671|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
42106735|NCT04093752|75917672|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
42106736|NCT04093752|75917669|FG000|Overall Study|Covid 19|0|||
42106737|NCT04093752|75917670|FG001|Overall Study|Covid 19|0|||
42106738|NCT04093752|75917671|FG002|Overall Study|Covid 19|0|||
42106739|NCT04093752|75917672|FG003|Overall Study|Covid 19|1|||
42106740|NCT04093752|75917669|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
42106741|NCT04093752|75917670|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
42106742|NCT04093752|75917671|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
42106743|NCT04093752|75917672|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
42106744|NCT04093752|75917669|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
42106745|NCT04093752|75917670|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
42106746|NCT04093752|75917671|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
42106747|NCT04093752|75917672|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
42106748|NCT04093752|75917669|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
42106749|NCT04093752|75917670|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
42106750|NCT04093752|75917671|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
42106751|NCT04093752|75917672|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
42106752|NCT03928821|75917690|FG000|Overall Study|Death|0|||
42106753|NCT03928821|75917691|FG001|Overall Study|Death|1|||
42106754|NCT03928821|75917692|FG002|Overall Study|Death|0|||
42106755|NCT03928821|75917693|FG003|Overall Study|Death|0|||
42106756|NCT03928821|75917690|FG000|Overall Study|Lost to Follow-up|0|||
42106757|NCT03928821|75917691|FG001|Overall Study|Lost to Follow-up|2|||
42106758|NCT03928821|75917692|FG002|Overall Study|Lost to Follow-up|3|||
42106759|NCT03928821|75917693|FG003|Overall Study|Lost to Follow-up|0|||
42106760|NCT03928821|75917690|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
42106761|NCT03928821|75917691|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
42106762|NCT03928821|75917692|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
42106763|NCT03928821|75917693|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
42106764|NCT00666224|75917705|FG000|Double-Blind|Adverse Event|15|||
42106765|NCT00666224|75917706|FG001|Double-Blind|Adverse Event|5|||
42106766|NCT00666224|75917705|FG000|Double-Blind|Lost to Follow-up|2|||
42106767|NCT00666224|75917706|FG001|Double-Blind|Lost to Follow-up|2|||
42106768|NCT00666224|75917705|FG000|Double-Blind|Withdrawal by Subject|18|||
42106769|NCT00666224|75917706|FG001|Double-Blind|Withdrawal by Subject|14|||
42106770|NCT00666224|75917705|FG000|Double-Blind|Physician Decision|0|||
42106771|NCT00666224|75917706|FG001|Double-Blind|Physician Decision|3|||
42106772|NCT00666224|75917705|FG000|Double-Blind|Sponsor decision|1|||
42106773|NCT00666224|75917706|FG001|Double-Blind|Sponsor decision|0|||
42106774|NCT00666224|75917705|FG000|Double-Blind|Pregnancy|3|||
42106775|NCT00666224|75917706|FG001|Double-Blind|Pregnancy|2|||
42106776|NCT00666224|75917705|FG000|Double-Blind|Noncompliance|1|||
42106777|NCT00666224|75917706|FG001|Double-Blind|Noncompliance|0|||
42106778|NCT00666224|75917705|FG000|Double-Blind|Death|1|||
42106779|NCT00666224|75917706|FG001|Double-Blind|Death|0|||
42106780|NCT00666224|75917705|FG000|Double-Blind|Undefined/Unknown|4|||
42106781|NCT00666224|75917706|FG001|Double-Blind|Undefined/Unknown|1|||
42106782|NCT00666224|75917705|FG000|Open-Label|Adverse Event|8|||
42106783|NCT00666224|75917706|FG001|Open-Label|Adverse Event|43|||
42106784|NCT00666224|75917705|FG000|Open-Label|Lost to Follow-up|4|||
42106785|NCT00666224|75917706|FG001|Open-Label|Lost to Follow-up|5|||
42106786|NCT00666224|75917705|FG000|Open-Label|Withdrawal by Subject|12|||
42106787|NCT00666224|75917706|FG001|Open-Label|Withdrawal by Subject|25|||
42106788|NCT00666224|75917705|FG000|Open-Label|Physician Decision|7|||
42106789|NCT00666224|75917706|FG001|Open-Label|Physician Decision|5|||
42106790|NCT00666224|75917705|FG000|Open-Label|Pregnancy|1|||
42106791|NCT00666224|75917706|FG001|Open-Label|Pregnancy|5|||
42106792|NCT00666224|75917705|FG000|Open-Label|Noncompliance|2|||
42106793|NCT00666224|75917706|FG001|Open-Label|Noncompliance|1|||
42106794|NCT00666224|75917705|FG000|Open-Label|Undefined/Unknown|1|||
42106795|NCT00666224|75917706|FG001|Open-Label|Undefined/Unknown|1|||
42106796|NCT00663962|75917715|FG000|Overall Study|somnolence|1|||
42106797|NCT00663962|75917716|FG001|Overall Study|somnolence|0|||
42106798|NCT00265759|75917728|FG000|Overall Study|Withdrawal by Subject|0|||
42106799|NCT00265759|75917729|FG001|Overall Study|Withdrawal by Subject|1|||
42106800|NCT00265759|75917730|FG002|Overall Study|Withdrawal by Subject|2|||
42106801|NCT00265759|75917731|FG003|Overall Study|Withdrawal by Subject|2|||
42106802|NCT00265759|75917728|FG000|Overall Study|Cancel|0|||
42106803|NCT00265759|75917729|FG001|Overall Study|Cancel|0|||
42106804|NCT00265759|75917730|FG002|Overall Study|Cancel|0|||
42106805|NCT00265759|75917731|FG003|Overall Study|Cancel|3|||
42106806|NCT00265759|75917728|FG000|Overall Study|Ineligible|0|||
42106807|NCT00265759|75917729|FG001|Overall Study|Ineligible|0|||
42106808|NCT00265759|75917730|FG002|Overall Study|Ineligible|0|||
42106809|NCT00265759|75917731|FG003|Overall Study|Ineligible|1|||
42106810|NCT00265759|75917728|FG000|Overall Study|Bilateral disease|0|||
42106811|NCT00265759|75917729|FG001|Overall Study|Bilateral disease|0|||
42106812|NCT00265759|75917730|FG002|Overall Study|Bilateral disease|0|||
42106813|NCT00265759|75917731|FG003|Overall Study|Bilateral disease|2|||
42106814|NCT00265759|75917728|FG000|Overall Study|Discontinued due to intolerability|0|||
42106815|NCT00265759|75917729|FG001|Overall Study|Discontinued due to intolerability|0|||
42106816|NCT00265759|75917730|FG002|Overall Study|Discontinued due to intolerability|0|||
42106817|NCT00265759|75917731|FG003|Overall Study|Discontinued due to intolerability|1|||
42106818|NCT00744263|75917744|FG000|Overall Study|Death|3006|||
42106819|NCT00744263|75917745|FG001|Overall Study|Death|3005|||
42106820|NCT00744263|75917744|FG000|Overall Study|Lost to Follow-up|2038|||
42106821|NCT00744263|75917745|FG001|Overall Study|Lost to Follow-up|2135|||
42106822|NCT00744263|75917744|FG000|Overall Study|Withdrawal by Subject|166|||
42106823|NCT00744263|75917745|FG001|Overall Study|Withdrawal by Subject|150|||
42106824|NCT00744263|75917744|FG000|Overall Study|Physician Decision|20|||
42106825|NCT00744263|75917745|FG001|Overall Study|Physician Decision|23|||
42106826|NCT00744263|75917744|FG000|Overall Study|Protocol Violation|3|||
42106827|NCT00744263|75917745|FG001|Overall Study|Protocol Violation|5|||
42106828|NCT00744263|75917744|FG000|Overall Study|Adverse Event|1|||
42106829|NCT00744263|75917745|FG001|Overall Study|Adverse Event|0|||
42106830|NCT00744263|75917744|FG000|Overall Study|Other|2|||
42106831|NCT00744263|75917745|FG001|Overall Study|Other|2|||
42106832|NCT00618774|75917755|FG000|Overall Study|Adverse Event|5|||
42106833|NCT00618774|75917756|FG001|Overall Study|Adverse Event|3|||
42106834|NCT00618774|75917755|FG000|Overall Study|Withdrawal by Subject|1|||
42106835|NCT00618774|75917756|FG001|Overall Study|Withdrawal by Subject|0|||
42106836|NCT00545571|75917762|FG000|Overall Study|Administrative Reasons|1|||
42106837|NCT00545571|75917762|FG000|Overall Study|Adverse Event|2|||
42106838|NCT00545571|75917762|FG000|Overall Study|Death|5|||
42106839|NCT00545571|75917762|FG000|Overall Study|Lack of Efficacy|1|||
42106840|NCT00545571|75917762|FG000|Overall Study|Protocol Violation|2|||
42106841|NCT00545571|75917762|FG000|Overall Study|Refused Treatment|1|||
42106842|NCT00545571|75917762|FG000|Overall Study|Screen Failure|16|||
42106843|NCT00545571|75917762|FG000|Overall Study|Transfusion|12|||
42106844|NCT00545571|75917762|FG000|Overall Study|Early Termination of Study|24|||
42106845|NCT00545571|75917762|FG000|Overall Study|Kidney Transplantation|3|||
42106846|NCT00748709|75917766|FG000|Overall Study|Progressive disease|15|||
42106847|NCT00748709|75917766|FG000|Overall Study|Drug reducing Toxity|2|||
42106848|NCT00748709|75917766|FG000|Overall Study|Other Adverse Event|1|||
42106849|NCT00748709|75917766|FG000|Overall Study|Withdrawal by Subject|1|||
42106850|NCT00748709|75917766|FG000|Overall Study|Other Reasons|1|||
42106851|NCT00263887|75917772|FG000|Overall Study|Withdrawal by Subject|1|||
42106852|NCT00263887|75917773|FG001|Overall Study|Withdrawal by Subject|1|||
42106853|NCT00263887|75917772|FG000|Overall Study|Lung transplantation|1|||
42106854|NCT00263887|75917773|FG001|Overall Study|Lung transplantation|2|||
42106855|NCT00263887|75917772|FG000|Overall Study|Too ill to attend visit|1|||
42106856|NCT00263887|75917773|FG001|Overall Study|Too ill to attend visit|0|||
42106857|NCT00263887|75917772|FG000|Overall Study|Adverse Event|0|||
42106858|NCT00263887|75917773|FG001|Overall Study|Adverse Event|2|||
42106859|NCT00263887|75917772|FG000|Overall Study|Disease progression|0|||
42106860|NCT00263887|75917773|FG001|Overall Study|Disease progression|1|||
42106861|NCT00263887|75917772|FG000|Overall Study|Lack of Efficacy|0|||
42106862|NCT00263887|75917773|FG001|Overall Study|Lack of Efficacy|1|||
42106863|NCT00748553|75917781|FG000|Overall Study|Adverse Event|0|||
42106864|NCT00748553|75917782|FG001|Overall Study|Adverse Event|1|||
42106865|NCT00748553|75917781|FG000|Overall Study|disease progression|2|||
42106866|NCT00748553|75917782|FG001|Overall Study|disease progression|0|||
42106867|NCT00748553|75917781|FG000|Overall Study|noncompliance|1|||
42106868|NCT00748553|75917782|FG001|Overall Study|noncompliance|0|||
42106869|NCT00661388|75917787|FG000|Overall Study|Adverse Event|14|||
42106870|NCT00661388|75917787|FG000|Overall Study|Protocol Violation|7|||
42106871|NCT00661388|75917787|FG000|Overall Study|Renal transplantation|1|||
42106872|NCT00661388|75917787|FG000|Overall Study|Dialysis initiation|1|||
42106873|NCT00661388|75917787|FG000|Overall Study|Administrative reasons|1|||
42106874|NCT00743483|75917791|FG000|Baseline Period|Physician Decision|1|||
42106875|NCT00743483|75917791|FG000|Treatment Period|Adverse Event|1|||
42106876|NCT00263575|75917795|FG000|Titration Period|Adverse Event|14|||
42106877|NCT00263575|75917795|FG000|Titration Period|Withdrawal by Subject|10|||
42106878|NCT00263575|75917795|FG000|Titration Period|Protocol Violation|9|||
42106879|NCT00263575|75917795|FG000|Titration Period|Sponsor Decision|2|||
42106880|NCT00263575|75917795|FG000|Titration Period|Other|2|||
42106881|NCT00263575|75917795|FG000|Titration Period|Lack of Efficacy|6|||
42106882|NCT00263575|75917795|FG000|Maintence Period|Adverse Event|23|||
42106883|NCT00263575|75917795|FG000|Maintence Period|Withdrawal by Subject|8|||
42106884|NCT00263575|75917795|FG000|Maintence Period|Protocol Violation|4|||
42106885|NCT00263575|75917795|FG000|Maintence Period|Lack of Efficacy|4|||
42106886|NCT00263575|75917795|FG000|Maintence Period|Physician Decision|6|||
42106887|NCT00263575|75917795|FG000|Maintence Period|Lost to Follow-up|1|||
42106888|NCT00263575|75917795|FG000|Maintence Period|Sponsor Decision|24|||
42106889|NCT00263575|75917795|FG000|Maintence Period|Other|7|||
42106890|NCT00748241|75917801|FG000|Overall Study|Implant failure|1|||
42106891|NCT00748241|75917801|FG000|Overall Study|Lost to Follow-up|5|||
42106892|NCT00748241|75917801|FG000|Overall Study|Death|2|||
42106893|NCT00570128|75917807|FG000|Overall Study|Adverse Event|1|||
42106894|NCT00570128|75917808|FG001|Overall Study|Adverse Event|0|||
42106895|NCT00570128|75917807|FG000|Overall Study|Lost to Follow-up|1|||
42106896|NCT00570128|75917808|FG001|Overall Study|Lost to Follow-up|0|||
42106897|NCT00570128|75917807|FG000|Overall Study|Withdrawal by Subject|2|||
42106898|NCT00570128|75917808|FG001|Overall Study|Withdrawal by Subject|0|||
42106899|NCT00743249|75917816|FG000|Overall Study|Adverse Event|0|||
42106900|NCT00743249|75917817|FG001|Overall Study|Adverse Event|4|||
42106901|NCT00743249|75917816|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
42106902|NCT00743249|75917817|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
42106903|NCT00743249|75917816|FG000|Overall Study|Unsuccessful insertion of stent|2|||
42106904|NCT00743249|75917817|FG001|Overall Study|Unsuccessful insertion of stent|1|||
42106905|NCT00262951|75917823|FG000|Overall Study|Progressive disease/relapse|3|||
42106906|NCT00262951|75917823|FG000|Overall Study|Adverse Event|7|||
42106907|NCT00262951|75917823|FG000|Overall Study|Death|1|||
42106908|NCT00262951|75917823|FG000|Overall Study|Withdrawal by Subject|1|||
42106909|NCT00262951|75917823|FG000|Overall Study|Alternative treatment|3|||
42106910|NCT00262951|75917823|FG000|Overall Study|Off treatment for other disease|1|||
42106911|NCT00262873|75917827|FG000|Overall Study|Adverse Event|3|||
42106912|NCT00262873|75917827|FG000|Overall Study|Withdrawal by Subject|5|||
42106913|NCT00573534|75917831|FG000|Overall Study|oppositional behavior|3|||
42106914|NCT00260533|75917838|FG000|Overall Study|Other|3|||
42106915|NCT00260533|75917839|FG001|Overall Study|Other|3|||
42106916|NCT03945981|75917845|FG000|Overall Study|Lost to Follow-up|12|||
42106917|NCT03945981|75917845|FG000|Overall Study|Physician Decision|4|||
42106918|NCT03945981|75917845|FG000|Overall Study|Withdrawal by Subject|6|||
42106919|NCT03945981|75917845|FG000|Overall Study|Protocol Violation|1|||
42106920|NCT00745901|75917872|FG000|Overall Study|Adverse Event|3|||
42106921|NCT00745901|75917873|FG001|Overall Study|Adverse Event|4|||
42106922|NCT00745901|75917872|FG000|Overall Study|Protocol Violation|0|||
42106923|NCT00745901|75917873|FG001|Overall Study|Protocol Violation|1|||
42106924|NCT00745901|75917872|FG000|Overall Study|Withdrawal by Subject|1|||
42106925|NCT00745901|75917873|FG001|Overall Study|Withdrawal by Subject|0|||
42106926|NCT00745901|75917872|FG000|Overall Study|Lost to Follow-up|7|||
42106927|NCT00745901|75917873|FG001|Overall Study|Lost to Follow-up|4|||
42106928|NCT00745901|75917872|FG000|Overall Study|Pregnancy|2|||
42106929|NCT00745901|75917873|FG001|Overall Study|Pregnancy|4|||
42106930|NCT00745901|75917872|FG000|Overall Study|Lack of compliance|2|||
42106931|NCT00745901|75917873|FG001|Overall Study|Lack of compliance|2|||
42106932|NCT00745901|75917872|FG000|Overall Study|Patient's next menses did not start with|1|||
42106933|NCT00745901|75917873|FG001|Overall Study|Patient's next menses did not start with|0|||
42106934|NCT00745901|75917872|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
42106935|NCT00745901|75917873|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
42106936|NCT00745901|75917872|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
42106937|NCT00745901|75917873|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
42106938|NCT00745901|75917872|FG000|Overall Study|Patient didn't take any study medication|7|||
42106939|NCT00745901|75917873|FG001|Overall Study|Patient didn't take any study medication|3|||
42106940|NCT00286429|75917882|FG000|Overall Study|Adverse Event|4|||
42106941|NCT00286429|75917883|FG001|Overall Study|Adverse Event|1|||
42106942|NCT00286429|75917884|FG002|Overall Study|Adverse Event|6|||
42106943|NCT00286429|75917882|FG000|Overall Study|Lack of Efficacy|52|||
42106944|NCT00286429|75917883|FG001|Overall Study|Lack of Efficacy|27|||
42106945|NCT00286429|75917884|FG002|Overall Study|Lack of Efficacy|25|||
42106946|NCT00286429|75917882|FG000|Overall Study|Lost to Follow-up|2|||
42106947|NCT00286429|75917883|FG001|Overall Study|Lost to Follow-up|4|||
42106948|NCT00286429|75917884|FG002|Overall Study|Lost to Follow-up|3|||
42106949|NCT00286429|75917882|FG000|Overall Study|Physician Decision|10|||
42106950|NCT00286429|75917883|FG001|Overall Study|Physician Decision|7|||
42106951|NCT00286429|75917884|FG002|Overall Study|Physician Decision|7|||
42106952|NCT00286429|75917882|FG000|Overall Study|Protocol Violation|3|||
42106953|NCT00286429|75917883|FG001|Overall Study|Protocol Violation|5|||
42106954|NCT00286429|75917884|FG002|Overall Study|Protocol Violation|4|||
42106955|NCT00286429|75917882|FG000|Overall Study|Withdrawal by Subject|3|||
42106956|NCT00286429|75917883|FG001|Overall Study|Withdrawal by Subject|2|||
42106957|NCT00286429|75917884|FG002|Overall Study|Withdrawal by Subject|6|||
42106958|NCT00286429|75917882|FG000|Overall Study|Administrative Error|1|||
42106959|NCT00286429|75917883|FG001|Overall Study|Administrative Error|1|||
42106960|NCT00286429|75917884|FG002|Overall Study|Administrative Error|1|||
42106961|NCT00286429|75917882|FG000|Overall Study|Administrative Decision|0|||
42106962|NCT00286429|75917883|FG001|Overall Study|Administrative Decision|1|||
42106963|NCT00286429|75917884|FG002|Overall Study|Administrative Decision|0|||
42106964|NCT00665444|75917892|FG000|Overall Study|Physician Decision|1|||
42106965|NCT00665444|75917892|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
42106966|NCT03926169|75917899|FG000|Period A|Adverse Event|2|||
42106967|NCT03926169|75917900|FG001|Period A|Adverse Event|2|||
42106968|NCT03926169|75917901|FG002|Period A|Adverse Event|1|||
42106969|NCT03926169|75917899|FG000|Period A|Withdrawal by Subject|2|||
42106970|NCT03926169|75917900|FG001|Period A|Withdrawal by Subject|2|||
42106971|NCT03926169|75917901|FG002|Period A|Withdrawal by Subject|2|||
42106972|NCT03926169|75917899|FG000|Period A|Lost to Follow-up|3|||
42106973|NCT03926169|75917900|FG001|Period A|Lost to Follow-up|1|||
42106974|NCT03926169|75917901|FG002|Period A|Lost to Follow-up|0|||
42106975|NCT03926169|75917899|FG000|Period A|Lack of Efficacy|0|||
42106976|NCT03926169|75917900|FG001|Period A|Lack of Efficacy|2|||
42106977|NCT03926169|75917901|FG002|Period A|Lack of Efficacy|2|||
42106978|NCT03926169|75917899|FG000|Period A|COVID-19 Infection|0|||
42106979|NCT03926169|75917900|FG001|Period A|COVID-19 Infection|1|||
42106980|NCT03926169|75917901|FG002|Period A|COVID-19 Infection|0|||
42106981|NCT03926169|75917899|FG000|Period A|COVID-19 Logistical Restrictions|0|||
42106982|NCT03926169|75917900|FG001|Period A|COVID-19 Logistical Restrictions|2|||
42106983|NCT03926169|75917901|FG002|Period A|COVID-19 Logistical Restrictions|1|||
42106984|NCT03926169|75917899|FG000|Period A|Other, Not Specified|1|||
42106985|NCT03926169|75917900|FG001|Period A|Other, Not Specified|0|||
42106986|NCT03926169|75917901|FG002|Period A|Other, Not Specified|0|||
42106987|NCT03926169|75917899|FG000|Period B|Adverse Event|3|||
42106988|NCT03926169|75917900|FG001|Period B|Adverse Event|1|||
42106989|NCT03926169|75917901|FG002|Period B|Adverse Event|1|||
42106990|NCT03926169|75917899|FG000|Period B|Withdrawal by Subject|1|||
42106991|NCT03926169|75917900|FG001|Period B|Withdrawal by Subject|3|||
42106992|NCT03926169|75917901|FG002|Period B|Withdrawal by Subject|0|||
42106993|NCT03926169|75917899|FG000|Period B|Lack of Efficacy|3|||
42106994|NCT03926169|75917900|FG001|Period B|Lack of Efficacy|1|||
42106995|NCT03926169|75917901|FG002|Period B|Lack of Efficacy|1|||
42106996|NCT03926169|75917899|FG000|Period B|Lost to Follow-up|1|||
42106997|NCT03926169|75917900|FG001|Period B|Lost to Follow-up|1|||
42106998|NCT03926169|75917901|FG002|Period B|Lost to Follow-up|4|||
42106999|NCT03926169|75917899|FG000|Period B|Other, Not Specified|62|||
42107000|NCT03926169|75917900|FG001|Period B|Other, Not Specified|57|||
42107001|NCT03926169|75917901|FG002|Period B|Other, Not Specified|65|||
42107002|NCT00285649|75917915|FG000|Overall Study|Lost to Follow-up|6|||
42107003|NCT00285649|75917916|FG001|Overall Study|Lost to Follow-up|4|||
42107004|NCT00285649|75917917|FG002|Overall Study|Lost to Follow-up|4|||
42107005|NCT00285649|75917915|FG000|Overall Study|Withdrawal by Subject|3|||
42107006|NCT00285649|75917916|FG001|Overall Study|Withdrawal by Subject|2|||
42107007|NCT00285649|75917917|FG002|Overall Study|Withdrawal by Subject|2|||
42107008|NCT00745823|75917927|FG000|Overall Study|Adverse Event|5|||
42107009|NCT00745823|75917928|FG001|Overall Study|Adverse Event|3|||
42107010|NCT00745823|75917927|FG000|Overall Study|Lack of Efficacy|20|||
42107011|NCT00745823|75917928|FG001|Overall Study|Lack of Efficacy|6|||
42107012|NCT00745823|75917927|FG000|Overall Study|Lost to Follow-up|10|||
42107013|NCT00745823|75917928|FG001|Overall Study|Lost to Follow-up|11|||
42107014|NCT00745823|75917927|FG000|Overall Study|Physician Decision|10|||
42107015|NCT00745823|75917928|FG001|Overall Study|Physician Decision|5|||
42107016|NCT00745823|75917927|FG000|Overall Study|Pregnancy|0|||
42107017|NCT00745823|75917928|FG001|Overall Study|Pregnancy|4|||
42107018|NCT00745823|75917927|FG000|Overall Study|Withdrawal by Subject|14|||
42107019|NCT00745823|75917928|FG001|Overall Study|Withdrawal by Subject|8|||
42107020|NCT00745823|75917927|FG000|Overall Study|Study Terminated by Sponsor|326|||
42107021|NCT00745823|75917928|FG001|Overall Study|Study Terminated by Sponsor|349|||
42107022|NCT00663260|75917939|FG000|Overall Study|Lack of Efficacy|2|||
42107023|NCT00663260|75917940|FG001|Overall Study|Lack of Efficacy|0|||
42107024|NCT00663260|75917941|FG002|Overall Study|Lack of Efficacy|0|||
42107025|NCT00663260|75917939|FG000|Overall Study|Adverse Event|12|||
42107026|NCT00663260|75917940|FG001|Overall Study|Adverse Event|7|||
42107027|NCT00663260|75917941|FG002|Overall Study|Adverse Event|6|||
42107028|NCT00663260|75917939|FG000|Overall Study|Withdrawal by Subject|3|||
42107029|NCT00663260|75917940|FG001|Overall Study|Withdrawal by Subject|1|||
42107030|NCT00663260|75917941|FG002|Overall Study|Withdrawal by Subject|6|||
42107031|NCT00663260|75917939|FG000|Overall Study|Death|1|||
42107032|NCT00663260|75917940|FG001|Overall Study|Death|0|||
42107033|NCT00663260|75917941|FG002|Overall Study|Death|1|||
42107034|NCT00663260|75917939|FG000|Overall Study|Lost to Follow-up|0|||
42107035|NCT00663260|75917940|FG001|Overall Study|Lost to Follow-up|1|||
42107036|NCT00663260|75917941|FG002|Overall Study|Lost to Follow-up|0|||
42107037|NCT00663260|75917939|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
42107038|NCT00663260|75917940|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
42107039|NCT00663260|75917941|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
42107040|NCT00740597|75917949|FG000|Overall Study|insurance would not cover treatment|1|||
42107041|NCT00284089|75917957|FG000|Multiple Dose Phase|Adverse Event|1|||
42107042|NCT00284089|75917958|FG001|Multiple Dose Phase|Adverse Event|0|||
42107043|NCT00284089|75917959|FG002|Multiple Dose Phase|Adverse Event|1|||
42107044|NCT00284089|75917960|FG003|Multiple Dose Phase|Adverse Event|1|||
42107045|NCT00284089|75917957|FG000|Multiple Dose Phase|Protocol Violation|0|||
42107046|NCT00284089|75917958|FG001|Multiple Dose Phase|Protocol Violation|0|||
42107047|NCT00284089|75917959|FG002|Multiple Dose Phase|Protocol Violation|1|||
42107048|NCT00284089|75917960|FG003|Multiple Dose Phase|Protocol Violation|0|||
42107049|NCT00284089|75917957|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
42107050|NCT00284089|75917958|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
42107051|NCT00284089|75917959|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
42107052|NCT00284089|75917960|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
42107053|NCT00284089|75917957|FG000|Multiple Dose Phase|Death|0|||
42107054|NCT00284089|75917958|FG001|Multiple Dose Phase|Death|0|||
42107055|NCT00284089|75917959|FG002|Multiple Dose Phase|Death|1|||
42107056|NCT00284089|75917960|FG003|Multiple Dose Phase|Death|1|||
42107057|NCT00284089|75917957|FG000|Extension Phase|Adverse Event|0|||
42107058|NCT00284089|75917958|FG001|Extension Phase|Adverse Event|0|||
42107059|NCT00284089|75917959|FG002|Extension Phase|Adverse Event|2|||
42107060|NCT00284089|75917960|FG003|Extension Phase|Adverse Event|2|||
42107061|NCT00284089|75917957|FG000|Extension Phase|condition no longer requires study drug|2|||
42107062|NCT00284089|75917958|FG001|Extension Phase|condition no longer requires study drug|0|||
42107063|NCT00284089|75917959|FG002|Extension Phase|condition no longer requires study drug|2|||
42107064|NCT00284089|75917960|FG003|Extension Phase|condition no longer requires study drug|7|||
42107065|NCT00284089|75917957|FG000|Extension Phase|Protocol Violation|0|||
42107066|NCT00284089|75917958|FG001|Extension Phase|Protocol Violation|0|||
42107067|NCT00284089|75917959|FG002|Extension Phase|Protocol Violation|1|||
42107068|NCT00284089|75917960|FG003|Extension Phase|Protocol Violation|0|||
42107069|NCT00284089|75917957|FG000|Extension Phase|Withdrawal by Subject|0|||
42107070|NCT00284089|75917958|FG001|Extension Phase|Withdrawal by Subject|0|||
42107071|NCT00284089|75917959|FG002|Extension Phase|Withdrawal by Subject|1|||
42107072|NCT00284089|75917960|FG003|Extension Phase|Withdrawal by Subject|3|||
42107073|NCT00659984|75917970|FG000|Overall Study|Adverse Event|1|||
42107074|NCT00283387|75917984|FG000|First Intervention|Subject non-compliant|1|||
42107075|NCT00283387|75917985|FG001|First Intervention|Subject non-compliant|1|||
42107076|NCT00283387|75917984|FG000|First Intervention|Withdrawal by Subject|0|||
42107077|NCT00283387|75917985|FG001|First Intervention|Withdrawal by Subject|1|||
42107078|NCT00282919|75917991|FG000|Overall Study|Lack of Efficacy|4|||
42107079|NCT00282919|75917991|FG000|Overall Study|Withdrawal by Subject|1|||
42107080|NCT00282919|75917991|FG000|Overall Study|Asymptomatic Parasitemia|2|||
42107081|NCT00282295|75917998|FG000|Overall Study|Adverse Event|0|||
42107082|NCT00282295|75917999|FG001|Overall Study|Adverse Event|1|||
42107083|NCT00282295|75918000|FG002|Overall Study|Adverse Event|0|||
42107084|NCT00282295|75917998|FG000|Overall Study|Serious Adverse Events|0|||
42107085|NCT00282295|75917999|FG001|Overall Study|Serious Adverse Events|0|||
42107086|NCT00282295|75918000|FG002|Overall Study|Serious Adverse Events|1|||
42107087|NCT00282295|75917998|FG000|Overall Study|Protocol Violation|0|||
42107088|NCT00282295|75917999|FG001|Overall Study|Protocol Violation|2|||
42107089|NCT00282295|75918000|FG002|Overall Study|Protocol Violation|1|||
42107090|NCT00282295|75917998|FG000|Overall Study|Withdrawal by Subject|2|||
42107091|NCT00282295|75917999|FG001|Overall Study|Withdrawal by Subject|6|||
42107092|NCT00282295|75918000|FG002|Overall Study|Withdrawal by Subject|4|||
42107093|NCT00282295|75917998|FG000|Overall Study|Lost to Follow-up|1|||
42107094|NCT00282295|75917999|FG001|Overall Study|Lost to Follow-up|7|||
42107095|NCT00282295|75918000|FG002|Overall Study|Lost to Follow-up|2|||
42107096|NCT00282295|75917998|FG000|Overall Study|Other|0|||
42107097|NCT00282295|75917999|FG001|Overall Study|Other|1|||
42107098|NCT00282295|75918000|FG002|Overall Study|Other|0|||
42107099|NCT00742781|75918013|FG000|Overall Study|Withdrawal by Subject|3|||
42107100|NCT00663026|75918021|FG000|Overall Study|Lost to Follow-up|1|||
42107101|NCT00663026|75918022|FG001|Overall Study|Lost to Follow-up|0|||
42107102|NCT00663026|75918023|FG002|Overall Study|Lost to Follow-up|0|||
42107103|NCT00663026|75918021|FG000|Overall Study|Other|1|||
42107104|NCT00663026|75918022|FG001|Overall Study|Other|2|||
42107105|NCT00663026|75918023|FG002|Overall Study|Other|0|||
42107106|NCT00663026|75918021|FG000|Overall Study|Adverse Event|0|||
42107107|NCT00663026|75918022|FG001|Overall Study|Adverse Event|2|||
42107108|NCT00663026|75918023|FG002|Overall Study|Adverse Event|3|||
42107109|NCT00663026|75918021|FG000|Overall Study|Caregiver Request|0|||
42107110|NCT00663026|75918022|FG001|Overall Study|Caregiver Request|2|||
42107111|NCT00663026|75918023|FG002|Overall Study|Caregiver Request|0|||
42107112|NCT00663026|75918021|FG000|Overall Study|Withdrawal by Subject|0|||
42107113|NCT00663026|75918022|FG001|Overall Study|Withdrawal by Subject|0|||
42107114|NCT00663026|75918023|FG002|Overall Study|Withdrawal by Subject|1|||
42107115|NCT00280735|75918033|FG000|Overall Study|Adverse Event|5|||
42107116|NCT00280735|75918033|FG000|Overall Study|Lack of Efficacy|3|||
42107117|NCT00280735|75918033|FG000|Overall Study|Withdrawal by Subject|8|||
42107118|NCT00280735|75918033|FG000|Overall Study|Intercurrent Illness|2|||
42107119|NCT00260065|75918041|FG000|Overall Study|Progressive Disease|22|||
42107120|NCT00260065|75918041|FG000|Overall Study|Adverse Event|17|||
42107121|NCT00260065|75918041|FG000|Overall Study|Death|13|||
42107122|NCT00260065|75918041|FG000|Overall Study|Withdrawal by Subject|13|||
42107123|NCT00260065|75918041|FG000|Overall Study|Physician Decision|19|||
42107124|NCT00260065|75918041|FG000|Overall Study|Not otherwise specified|8|||
42107125|NCT00260065|75918041|FG000|Overall Study|Medication Noncompliance|1|||
42107126|NCT00506350|75918054|FG000|Overall Study|Serious Adverse Event|1|||
42107127|NCT00506350|75918055|FG001|Overall Study|Serious Adverse Event|0|||
42107128|NCT00506350|75918056|FG002|Overall Study|Serious Adverse Event|0|||
42107129|NCT00506350|75918057|FG003|Overall Study|Serious Adverse Event|0|||
42107130|NCT00506350|75918058|FG004|Overall Study|Serious Adverse Event|0|||
42107131|NCT00506350|75918059|FG005|Overall Study|Serious Adverse Event|0|||
42107132|NCT00506350|75918060|FG006|Overall Study|Serious Adverse Event|0|||
42107133|NCT00506350|75918061|FG007|Overall Study|Serious Adverse Event|0|||
42107134|NCT00506350|75918062|FG008|Overall Study|Serious Adverse Event|0|||
42107135|NCT00506350|75918054|FG000|Overall Study|Adverse Event|0|||
42107136|NCT00506350|75918055|FG001|Overall Study|Adverse Event|0|||
42107137|NCT00506350|75918056|FG002|Overall Study|Adverse Event|0|||
42107138|NCT00506350|75918057|FG003|Overall Study|Adverse Event|0|||
42107139|NCT00506350|75918058|FG004|Overall Study|Adverse Event|0|||
42107140|NCT00506350|75918059|FG005|Overall Study|Adverse Event|0|||
42107141|NCT00506350|75918060|FG006|Overall Study|Adverse Event|0|||
42107142|NCT00506350|75918061|FG007|Overall Study|Adverse Event|1|||
42107143|NCT00506350|75918062|FG008|Overall Study|Adverse Event|1|||
42107144|NCT00506350|75918054|FG000|Overall Study|Protocol Violation|0|||
42107145|NCT00506350|75918055|FG001|Overall Study|Protocol Violation|0|||
42107146|NCT00506350|75918056|FG002|Overall Study|Protocol Violation|1|||
42107147|NCT00506350|75918057|FG003|Overall Study|Protocol Violation|0|||
42107148|NCT00506350|75918058|FG004|Overall Study|Protocol Violation|0|||
42107149|NCT00506350|75918059|FG005|Overall Study|Protocol Violation|0|||
42107150|NCT00506350|75918060|FG006|Overall Study|Protocol Violation|1|||
42107151|NCT00506350|75918061|FG007|Overall Study|Protocol Violation|0|||
42107152|NCT00506350|75918062|FG008|Overall Study|Protocol Violation|0|||
42107153|NCT00506350|75918054|FG000|Overall Study|Withdrawal by Subject|0|||
42107154|NCT00506350|75918055|FG001|Overall Study|Withdrawal by Subject|1|||
42107155|NCT00506350|75918056|FG002|Overall Study|Withdrawal by Subject|1|||
42107156|NCT00506350|75918057|FG003|Overall Study|Withdrawal by Subject|1|||
42107157|NCT00506350|75918058|FG004|Overall Study|Withdrawal by Subject|4|||
42107158|NCT00506350|75918059|FG005|Overall Study|Withdrawal by Subject|1|||
42107159|NCT00506350|75918060|FG006|Overall Study|Withdrawal by Subject|1|||
42107160|NCT00506350|75918061|FG007|Overall Study|Withdrawal by Subject|2|||
42107161|NCT00506350|75918062|FG008|Overall Study|Withdrawal by Subject|0|||
42107162|NCT00506350|75918054|FG000|Overall Study|Lost to Follow-up|1|||
42107163|NCT00506350|75918055|FG001|Overall Study|Lost to Follow-up|1|||
42107164|NCT00506350|75918056|FG002|Overall Study|Lost to Follow-up|1|||
42107165|NCT00506350|75918057|FG003|Overall Study|Lost to Follow-up|1|||
42107166|NCT00506350|75918058|FG004|Overall Study|Lost to Follow-up|2|||
42107167|NCT00506350|75918059|FG005|Overall Study|Lost to Follow-up|1|||
42107168|NCT00506350|75918060|FG006|Overall Study|Lost to Follow-up|0|||
42107169|NCT00506350|75918061|FG007|Overall Study|Lost to Follow-up|0|||
42107170|NCT00506350|75918062|FG008|Overall Study|Lost to Follow-up|2|||
42107171|NCT00506350|75918054|FG000|Overall Study|Medical Reason|0|||
42107172|NCT00506350|75918055|FG001|Overall Study|Medical Reason|0|||
42107173|NCT00506350|75918056|FG002|Overall Study|Medical Reason|0|||
42107174|NCT00506350|75918057|FG003|Overall Study|Medical Reason|0|||
42107175|NCT00506350|75918058|FG004|Overall Study|Medical Reason|1|||
42107176|NCT00506350|75918059|FG005|Overall Study|Medical Reason|0|||
42107177|NCT00506350|75918060|FG006|Overall Study|Medical Reason|0|||
42107178|NCT00506350|75918061|FG007|Overall Study|Medical Reason|0|||
42107179|NCT00506350|75918062|FG008|Overall Study|Medical Reason|0|||
42107180|NCT00506350|75918054|FG000|Overall Study|Other|1|||
42107181|NCT00506350|75918055|FG001|Overall Study|Other|1|||
42107182|NCT00506350|75918056|FG002|Overall Study|Other|3|||
42107183|NCT00506350|75918057|FG003|Overall Study|Other|0|||
42107184|NCT00506350|75918058|FG004|Overall Study|Other|3|||
42107185|NCT00506350|75918059|FG005|Overall Study|Other|0|||
42107186|NCT00506350|75918060|FG006|Overall Study|Other|0|||
42107187|NCT00506350|75918061|FG007|Overall Study|Other|2|||
42107188|NCT00506350|75918062|FG008|Overall Study|Other|2|||
42107189|NCT00258895|75918091|FG000|Overall Study|Lost to Follow-up|3|||
42107190|NCT00258895|75918092|FG001|Overall Study|Lost to Follow-up|1|||
42107191|NCT00258895|75918091|FG000|Overall Study|Protocol Violation|6|||
42107192|NCT00258895|75918092|FG001|Overall Study|Protocol Violation|2|||
42107193|NCT00258895|75918091|FG000|Overall Study|Withdrawal by Subject|1|||
42107194|NCT00258895|75918092|FG001|Overall Study|Withdrawal by Subject|0|||
42107195|NCT00742625|75918098|FG000|Remission Induction|Progression|6|||
42107196|NCT00742625|75918098|FG000|Remission Induction|Failed induction|8|||
42107197|NCT00742625|75918098|FG000|Remission Induction|Adverse Event|3|||
42107198|NCT00742625|75918098|FG000|Remission Induction|Death|10|||
42107199|NCT00742625|75918098|FG000|Remission Induction|Refusal|5|||
42107200|NCT00742625|75918098|FG000|Remission Induction|Non protocol treatment|17|||
42107201|NCT00742625|75918098|FG000|Remission Induction|Other, not specified|5|||
42107202|NCT00742625|75918098|FG000|Consolidation|Progression|5|||
42107203|NCT00742625|75918098|FG000|Consolidation|Adverse Event|1|||
42107204|NCT00742625|75918098|FG000|Consolidation|Death|1|||
42107205|NCT00742625|75918098|FG000|Consolidation|Refused|1|||
42107206|NCT00742625|75918098|FG000|Consolidation|Non protocol therapy|13|||
42107207|NCT00618618|75918109|FG000|Overall Study|Patient Request|0|||
42107208|NCT00618618|75918110|FG001|Overall Study|Patient Request|0|||
42107209|NCT00618618|75918111|FG002|Overall Study|Patient Request|2|||
42107210|NCT00618618|75918112|FG003|Overall Study|Patient Request|0|||
42107211|NCT00618618|75918109|FG000|Overall Study|Inability to Complete Study Procedures|0|||
42107212|NCT00618618|75918110|FG001|Overall Study|Inability to Complete Study Procedures|1|||
42107213|NCT00618618|75918111|FG002|Overall Study|Inability to Complete Study Procedures|0|||
42107214|NCT00618618|75918112|FG003|Overall Study|Inability to Complete Study Procedures|0|||
42107215|NCT00618618|75918109|FG000|Overall Study|Lost to Follow-up|3|||
42107216|NCT00618618|75918110|FG001|Overall Study|Lost to Follow-up|0|||
42107217|NCT00618618|75918111|FG002|Overall Study|Lost to Follow-up|0|||
42107218|NCT00618618|75918112|FG003|Overall Study|Lost to Follow-up|1|||
42107219|NCT00618618|75918109|FG000|Overall Study|Non-compliance|1|||
42107220|NCT00618618|75918110|FG001|Overall Study|Non-compliance|1|||
42107221|NCT00618618|75918111|FG002|Overall Study|Non-compliance|0|||
42107222|NCT00618618|75918112|FG003|Overall Study|Non-compliance|0|||
42107223|NCT00618618|75918109|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
42107224|NCT00618618|75918110|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
42107225|NCT00618618|75918111|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
42107226|NCT00618618|75918112|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
42107227|NCT00618618|75918109|FG000|Overall Study|Death|0|||
42107228|NCT00618618|75918110|FG001|Overall Study|Death|1|||
42107229|NCT00618618|75918111|FG002|Overall Study|Death|0|||
42107230|NCT00618618|75918112|FG003|Overall Study|Death|0|||
42107231|NCT00246805|75918125|FG000|Phase 1|Lost to Follow-up|1|||
42107232|NCT00246805|75918126|FG001|Phase 1|Lost to Follow-up|0|||
42107233|NCT00519376|75918132|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107234|NCT00519376|75918133|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107235|NCT00519376|75918134|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107236|NCT00519376|75918135|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107237|NCT00519376|75918136|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107238|NCT00519376|75918137|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107239|NCT00519376|75918138|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107240|NCT00519376|75918139|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107241|NCT00519376|75918140|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107242|NCT00519376|75918141|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107243|NCT00519376|75918142|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107244|NCT00519376|75918143|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107245|NCT00519376|75918144|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
42107246|NCT00519376|75918145|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107247|NCT00519376|75918146|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107248|NCT00519376|75918147|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
42107249|NCT00519376|75918132|FG000|Treatment Period 4|Lost to Follow-up|0|||
42107250|NCT00519376|75918133|FG001|Treatment Period 4|Lost to Follow-up|0|||
42107251|NCT00519376|75918134|FG002|Treatment Period 4|Lost to Follow-up|1|||
42107252|NCT00519376|75918135|FG003|Treatment Period 4|Lost to Follow-up|0|||
42107253|NCT00519376|75918136|FG004|Treatment Period 4|Lost to Follow-up|0|||
42107254|NCT00519376|75918137|FG005|Treatment Period 4|Lost to Follow-up|0|||
42107255|NCT00519376|75918138|FG006|Treatment Period 4|Lost to Follow-up|0|||
42107256|NCT00519376|75918139|FG007|Treatment Period 4|Lost to Follow-up|0|||
42107257|NCT00519376|75918140|FG008|Treatment Period 4|Lost to Follow-up|0|||
42107258|NCT00519376|75918141|FG009|Treatment Period 4|Lost to Follow-up|0|||
42107259|NCT00519376|75918142|FG010|Treatment Period 4|Lost to Follow-up|0|||
42107260|NCT00519376|75918143|FG011|Treatment Period 4|Lost to Follow-up|0|||
42107261|NCT00519376|75918144|FG012|Treatment Period 4|Lost to Follow-up|0|||
42107262|NCT00519376|75918145|FG013|Treatment Period 4|Lost to Follow-up|0|||
42107263|NCT00519376|75918146|FG014|Treatment Period 4|Lost to Follow-up|0|||
42107264|NCT00519376|75918147|FG015|Treatment Period 4|Lost to Follow-up|0|||
42107265|NCT00745121|75918161|FG000|Overall Study|Death|3|||
42107266|NCT00745121|75918162|FG001|Overall Study|Death|0|||
42107267|NCT00745121|75918161|FG000|Overall Study|Adverse Event|1|||
42107268|NCT00745121|75918162|FG001|Overall Study|Adverse Event|0|||
42107269|NCT00745121|75918161|FG000|Overall Study|Lost to Follow-up|1|||
42107270|NCT00745121|75918162|FG001|Overall Study|Lost to Follow-up|0|||
42107271|NCT00745121|75918161|FG000|Overall Study|Withdrawal by Subject|4|||
42107272|NCT00745121|75918162|FG001|Overall Study|Withdrawal by Subject|2|||
42107273|NCT00740051|75918170|FG000|Overall Study|Lack of Efficacy|2|||
42107274|NCT00740051|75918171|FG001|Overall Study|Lack of Efficacy|5|||
42107275|NCT00740051|75918170|FG000|Overall Study|Adverse Event|1|||
42107276|NCT00740051|75918171|FG001|Overall Study|Adverse Event|4|||
42107277|NCT00740051|75918170|FG000|Overall Study|Protocol Violation|2|||
42107278|NCT00740051|75918171|FG001|Overall Study|Protocol Violation|6|||
42107279|NCT00740051|75918170|FG000|Overall Study|Lost to Follow-up|3|||
42107280|NCT00740051|75918171|FG001|Overall Study|Lost to Follow-up|8|||
42107281|NCT00740051|75918170|FG000|Overall Study|Withdrawal by Subject|6|||
42107282|NCT00740051|75918171|FG001|Overall Study|Withdrawal by Subject|8|||
42107283|NCT00740051|75918170|FG000|Overall Study|Other reason (not specified)|4|||
42107284|NCT00740051|75918171|FG001|Overall Study|Other reason (not specified)|1|||
42107285|NCT00518986|75918180|FG000|Overall Study|Adverse Event|12|||
42107286|NCT00518986|75918181|FG001|Overall Study|Adverse Event|7|||
42107287|NCT00518986|75918180|FG000|Overall Study|Lack of Efficacy|0|||
42107288|NCT00518986|75918181|FG001|Overall Study|Lack of Efficacy|2|||
42107289|NCT00518986|75918180|FG000|Overall Study|Lost to Follow-up|3|||
42107290|NCT00518986|75918181|FG001|Overall Study|Lost to Follow-up|2|||
42107291|NCT00518986|75918180|FG000|Overall Study|Physician Decision|0|||
42107292|NCT00518986|75918181|FG001|Overall Study|Physician Decision|3|||
42107293|NCT00518986|75918180|FG000|Overall Study|Protocol Violation|5|||
42107294|NCT00518986|75918181|FG001|Overall Study|Protocol Violation|7|||
42107295|NCT00518986|75918180|FG000|Overall Study|Withdrawal by Subject|4|||
42107296|NCT00518986|75918181|FG001|Overall Study|Withdrawal by Subject|4|||
42107297|NCT00518986|75918180|FG000|Overall Study|Non-Specific|2|||
42107298|NCT00518986|75918181|FG001|Overall Study|Non-Specific|1|||
42107299|NCT00742391|75918189|FG000|Overall Study|Adverse Event|2|||
42107300|NCT00742391|75918190|FG001|Overall Study|Adverse Event|1|||
42107301|NCT00742391|75918189|FG000|Overall Study|Lost to Follow-up|1|||
42107302|NCT00742391|75918190|FG001|Overall Study|Lost to Follow-up|0|||
42107303|NCT00742391|75918189|FG000|Overall Study|Protocol Violation|1|||
42107304|NCT00742391|75918190|FG001|Overall Study|Protocol Violation|0|||
42107305|NCT00742235|75918198|FG000|Overall Study|Lost to Follow-up|0|||
42107306|NCT00742235|75918199|FG001|Overall Study|Lost to Follow-up|31|||
42107307|NCT00742079|75918207|FG000|Overall Study|Lost to Follow-up|0|||
42107308|NCT00742079|75918208|FG001|Overall Study|Lost to Follow-up|1|||
42107309|NCT00662792|75918214|FG000|Period 1|Personal Reasons|0|||
42107310|NCT00662792|75918215|FG001|Period 1|Personal Reasons|0|||
42107311|NCT00662792|75918216|FG002|Period 1|Personal Reasons|1|||
42107312|NCT00662792|75918217|FG003|Period 1|Personal Reasons|0|||
42107313|NCT00662792|75918214|FG000|Period 1|Refused continuing medication|0|||
42107314|NCT00662792|75918215|FG001|Period 1|Refused continuing medication|1|||
42107315|NCT00662792|75918216|FG002|Period 1|Refused continuing medication|1|||
42107316|NCT00662792|75918217|FG003|Period 1|Refused continuing medication|0|||
42107317|NCT00662792|75918214|FG000|Period 1|Lost to Follow-up|1|||
42107318|NCT00662792|75918215|FG001|Period 1|Lost to Follow-up|0|||
42107319|NCT00662792|75918216|FG002|Period 1|Lost to Follow-up|0|||
42107320|NCT00662792|75918217|FG003|Period 1|Lost to Follow-up|0|||
42107321|NCT00662792|75918214|FG000|Period 1|Other adverse event (AE)|0|||
42107322|NCT00662792|75918215|FG001|Period 1|Other adverse event (AE)|2|||
42107323|NCT00662792|75918216|FG002|Period 1|Other adverse event (AE)|0|||
42107324|NCT00662792|75918217|FG003|Period 1|Other adverse event (AE)|0|||
42107325|NCT00662792|75918214|FG000|Period 1|Worsening of disease under study (AE)|1|||
42107326|NCT00662792|75918215|FG001|Period 1|Worsening of disease under study (AE)|3|||
42107327|NCT00662792|75918216|FG002|Period 1|Worsening of disease under study (AE)|2|||
42107328|NCT00662792|75918217|FG003|Period 1|Worsening of disease under study (AE)|0|||
42107329|NCT00662792|75918214|FG000|Period 1|Not treated|0|||
42107330|NCT00662792|75918215|FG001|Period 1|Not treated|1|||
42107331|NCT00662792|75918216|FG002|Period 1|Not treated|0|||
42107332|NCT00662792|75918217|FG003|Period 1|Not treated|0|||
42107333|NCT00662792|75918214|FG000|Period 2|Worsening of disease under study|1|||
42107334|NCT00662792|75918215|FG001|Period 2|Worsening of disease under study|0|||
42107335|NCT00662792|75918216|FG002|Period 2|Worsening of disease under study|0|||
42107336|NCT00662792|75918217|FG003|Period 2|Worsening of disease under study|3|||
42107337|NCT00662792|75918214|FG000|Period 3|Refused continuing medication|1|||
42107338|NCT00662792|75918215|FG001|Period 3|Refused continuing medication|0|||
42107339|NCT00662792|75918216|FG002|Period 3|Refused continuing medication|1|||
42107340|NCT00662792|75918217|FG003|Period 3|Refused continuing medication|0|||
42107341|NCT00662792|75918214|FG000|Period 3|Other adverse event (AE)|0|||
42107342|NCT00662792|75918215|FG001|Period 3|Other adverse event (AE)|0|||
42107343|NCT00662792|75918216|FG002|Period 3|Other adverse event (AE)|1|||
42107344|NCT00662792|75918217|FG003|Period 3|Other adverse event (AE)|1|||
42107345|NCT00662792|75918214|FG000|Period 4|Refused continuing medication|0|||
42107346|NCT00662792|75918215|FG001|Period 4|Refused continuing medication|1|||
42107347|NCT00662792|75918216|FG002|Period 4|Refused continuing medication|0|||
42107348|NCT00662792|75918217|FG003|Period 4|Refused continuing medication|0|||
42107349|NCT00662792|75918214|FG000|Period 4|Other adverse event (AE)|1|||
42107350|NCT00662792|75918215|FG001|Period 4|Other adverse event (AE)|0|||
42107351|NCT00662792|75918216|FG002|Period 4|Other adverse event (AE)|0|||
42107352|NCT00662792|75918217|FG003|Period 4|Other adverse event (AE)|0|||
42107353|NCT00662792|75918214|FG000|Period 4|Worsening of disease under study (AE)|0|||
42107354|NCT00662792|75918215|FG001|Period 4|Worsening of disease under study (AE)|0|||
42107355|NCT00662792|75918216|FG002|Period 4|Worsening of disease under study (AE)|0|||
42107356|NCT00662792|75918217|FG003|Period 4|Worsening of disease under study (AE)|1|||
42380878|NCT01446965|76253450|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
42202002|NCT02101853|76014578|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
42107357|NCT00742001|75918232|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
42107358|NCT00742001|75918233|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
42107359|NCT00742001|75918234|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
42107360|NCT00616902|75918247|FG000|Overall Study|Termination of study|6|||
42107361|NCT00616902|75918248|FG001|Overall Study|Termination of study|6|||
42107362|NCT00741611|75918257|FG000|Overall Study|Death|0|||
42107363|NCT00741611|75918258|FG001|Overall Study|Death|0|||
42107364|NCT00741611|75918259|FG002|Overall Study|Death|1|||
42107365|NCT00741611|75918257|FG000|Overall Study|Withdrawal by Subject|0|||
42107366|NCT00741611|75918258|FG001|Overall Study|Withdrawal by Subject|2|||
42107367|NCT00741611|75918259|FG002|Overall Study|Withdrawal by Subject|2|||
42107368|NCT00662558|75918270|FG000|Overall Study|Adverse Event|21|||
42107369|NCT00662558|75918271|FG001|Overall Study|Adverse Event|59|||
42107370|NCT00662558|75918270|FG000|Overall Study|Lack of Efficacy|4|||
42107371|NCT00662558|75918271|FG001|Overall Study|Lack of Efficacy|7|||
42107372|NCT00662558|75918270|FG000|Overall Study|Lost to Follow-up|13|||
42107373|NCT00662558|75918271|FG001|Overall Study|Lost to Follow-up|10|||
42107374|NCT00662558|75918270|FG000|Overall Study|Other|9|||
42107375|NCT00662558|75918271|FG001|Overall Study|Other|14|||
42107376|NCT00662558|75918270|FG000|Overall Study|Withdrawal by Subject|7|||
42107377|NCT00662558|75918271|FG001|Overall Study|Withdrawal by Subject|12|||
42107378|NCT00662558|75918270|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
42107379|NCT00662558|75918271|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
42107380|NCT00739973|75918286|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
42107381|NCT00739973|75918287|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
42107382|NCT00739973|75918288|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
42107383|NCT00739973|75918289|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
42107384|NCT00739973|75918290|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
42107385|NCT00739973|75918291|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
42107386|NCT00739973|75918292|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
42107387|NCT00739973|75918293|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
42107388|NCT00739973|75918294|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
42107389|NCT00739973|75918286|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
42107390|NCT00739973|75918287|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
42107391|NCT00739973|75918288|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
42107392|NCT00739973|75918289|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
42107393|NCT00739973|75918290|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
42107394|NCT00739973|75918291|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
42107395|NCT00739973|75918292|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
42107396|NCT00739973|75918293|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
42107397|NCT00739973|75918294|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
42107398|NCT00739973|75918286|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
42107399|NCT00739973|75918287|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
42107400|NCT00739973|75918288|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
42107401|NCT00739973|75918289|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
42107402|NCT00739973|75918290|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
42107403|NCT00739973|75918291|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
42107404|NCT00739973|75918292|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
42107405|NCT00739973|75918293|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
42107406|NCT00739973|75918294|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
42107407|NCT00739973|75918286|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
42107408|NCT00739973|75918287|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
42107409|NCT00739973|75918288|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
42107410|NCT00739973|75918289|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
42107411|NCT00739973|75918290|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
42107412|NCT00739973|75918291|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
42107413|NCT00739973|75918292|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
42380879|NCT01446965|76253449|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
42380880|NCT01446965|76253450|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
42380881|NCT01446809|76253458|FG000|Overall Study|Adverse Event|0|||
42380882|NCT01446809|76253459|FG001|Overall Study|Adverse Event|0|||
42380883|NCT01446809|76253460|FG002|Overall Study|Adverse Event|1|||
42380884|NCT01446809|76253458|FG000|Overall Study|Failure to complete study procedures|0|||
42380885|NCT01446809|76253459|FG001|Overall Study|Failure to complete study procedures|0|||
42380886|NCT01446809|76253460|FG002|Overall Study|Failure to complete study procedures|1|||
42380887|NCT01446419|76253471|FG000|Overall Study|Death|1|||
42380888|NCT01446419|76253472|FG001|Overall Study|Death|0|||
42380889|NCT01446419|76253471|FG000|Overall Study|Withdrawal by Subject|1|||
42380890|NCT01446419|76253472|FG001|Overall Study|Withdrawal by Subject|1|||
42380891|NCT01446419|76253471|FG000|Overall Study|Terminated per protocol|3|||
42380892|NCT01446419|76253472|FG001|Overall Study|Terminated per protocol|0|||
42380893|NCT01445951|76253481|FG000|Overall Study|Adverse Event|16|||
42380894|NCT01445951|76253482|FG001|Overall Study|Adverse Event|9|||
42380895|NCT01445951|76253483|FG002|Overall Study|Adverse Event|0|||
42380896|NCT01445951|76253481|FG000|Overall Study|Protocol Violation|2|||
42380897|NCT01445951|76253482|FG001|Overall Study|Protocol Violation|2|||
42380898|NCT01445951|76253483|FG002|Overall Study|Protocol Violation|2|||
42380899|NCT01445951|76253481|FG000|Overall Study|Withdrawal by Subject|21|||
42380900|NCT01445951|76253482|FG001|Overall Study|Withdrawal by Subject|16|||
42380901|NCT01445951|76253483|FG002|Overall Study|Withdrawal by Subject|8|||
42380902|NCT01445951|76253481|FG000|Overall Study|Physician Decision|3|||
42380903|NCT01445951|76253482|FG001|Overall Study|Physician Decision|1|||
42380904|NCT01445951|76253483|FG002|Overall Study|Physician Decision|0|||
42380905|NCT01445951|76253481|FG000|Overall Study|Lost to Follow-up|1|||
42380906|NCT01445951|76253482|FG001|Overall Study|Lost to Follow-up|2|||
42380907|NCT01445951|76253483|FG002|Overall Study|Lost to Follow-up|4|||
42380908|NCT01445951|76253481|FG000|Overall Study|Pregnancy|0|||
42380909|NCT01445951|76253482|FG001|Overall Study|Pregnancy|1|||
42380910|NCT01445951|76253483|FG002|Overall Study|Pregnancy|4|||
42380911|NCT01445951|76253481|FG000|Overall Study|Death|0|||
42380912|NCT01445951|76253482|FG001|Overall Study|Death|0|||
42380913|NCT01445951|76253483|FG002|Overall Study|Death|1|||
42380914|NCT01445951|76253481|FG000|Overall Study|Non-compliance with study drug|1|||
42380915|NCT01445951|76253482|FG001|Overall Study|Non-compliance with study drug|2|||
42380916|NCT01445951|76253483|FG002|Overall Study|Non-compliance with study drug|0|||
42380917|NCT01445951|76253481|FG000|Overall Study|Non-compliance with protocol|0|||
42380918|NCT01445951|76253482|FG001|Overall Study|Non-compliance with protocol|1|||
42380919|NCT01445951|76253483|FG002|Overall Study|Non-compliance with protocol|0|||
42380920|NCT01445951|76253481|FG000|Overall Study|Sponsor decision - subject travel|0|||
42380921|NCT01445951|76253482|FG001|Overall Study|Sponsor decision - subject travel|1|||
42107414|NCT00739973|75918293|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
42107415|NCT00739973|75918294|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
42107416|NCT00739973|75918286|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
42107417|NCT00739973|75918287|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
42107418|NCT00739973|75918288|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
42107419|NCT00739973|75918289|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
42107420|NCT00739973|75918290|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
42107421|NCT00739973|75918291|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
42107422|NCT00739973|75918292|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
42107423|NCT00739973|75918293|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
42107424|NCT00739973|75918294|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
42107425|NCT00739973|75918286|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
42107426|NCT00739973|75918287|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
42107427|NCT00739973|75918288|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
42107428|NCT00739973|75918289|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
42107429|NCT00739973|75918290|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
42107430|NCT00739973|75918291|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
42107431|NCT00739973|75918292|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
42107432|NCT00739973|75918293|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
42107433|NCT00739973|75918294|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
42107434|NCT00739973|75918286|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
42380922|NCT01445951|76253483|FG002|Overall Study|Sponsor decision - subject travel|0|||
42380923|NCT01445951|76253481|FG000|Overall Study|Cough|0|||
42380924|NCT01445951|76253482|FG001|Overall Study|Cough|1|||
42380925|NCT01445951|76253483|FG002|Overall Study|Cough|0|||
42380926|NCT01444781|76253498|FG000|Overall Study|Lost to Follow-up|0|||
42380927|NCT01444781|76253499|FG001|Overall Study|Lost to Follow-up|3|||
42380928|NCT01444781|76253500|FG002|Overall Study|Lost to Follow-up|1|||
42107435|NCT00739973|75918287|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
42107436|NCT00739973|75918288|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
42107437|NCT00739973|75918289|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
42107438|NCT00739973|75918290|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
42107439|NCT00739973|75918291|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
42107440|NCT00739973|75918292|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
42107441|NCT00739973|75918293|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
42107442|NCT00739973|75918294|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
42107443|NCT00739973|75918286|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
42107444|NCT00739973|75918287|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
42107445|NCT00739973|75918288|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
42107446|NCT00739973|75918289|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
42107447|NCT00739973|75918290|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
42107448|NCT00739973|75918291|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
42107449|NCT00739973|75918292|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
42107450|NCT00739973|75918293|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
42107451|NCT00739973|75918294|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
42107452|NCT00739973|75918286|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
42107453|NCT00739973|75918287|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
42107454|NCT00739973|75918288|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
42107455|NCT00739973|75918289|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
42107456|NCT00739973|75918290|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
42107457|NCT00739973|75918291|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
42107458|NCT00739973|75918292|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
42107459|NCT00739973|75918293|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
42107460|NCT00739973|75918294|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
42107461|NCT00739973|75918286|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
42107462|NCT00739973|75918287|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
42107463|NCT00739973|75918288|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
42107464|NCT00739973|75918289|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
42107465|NCT00739973|75918290|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
42107466|NCT00739973|75918291|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
42107467|NCT00739973|75918292|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
42107468|NCT00739973|75918293|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
42107469|NCT00739973|75918294|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
42107470|NCT00739973|75918286|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
42107471|NCT00739973|75918287|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
42107472|NCT00739973|75918288|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
42107473|NCT00739973|75918289|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
42107474|NCT00739973|75918290|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
42107475|NCT00739973|75918291|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
42107476|NCT00739973|75918292|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
42107477|NCT00739973|75918293|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
42107478|NCT00739973|75918294|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
42107479|NCT00739973|75918286|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
42107480|NCT00739973|75918287|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
42107481|NCT00739973|75918288|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
42107482|NCT00739973|75918289|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
42107483|NCT00739973|75918290|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
42107484|NCT00739973|75918291|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
42107485|NCT00739973|75918292|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
42107486|NCT00739973|75918293|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
42107487|NCT00739973|75918294|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
42107488|NCT00739973|75918286|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
42107489|NCT00739973|75918287|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
42107490|NCT00739973|75918288|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
42107491|NCT00739973|75918289|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
42107492|NCT00739973|75918290|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
42107493|NCT00739973|75918291|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
42107494|NCT00739973|75918292|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
42107495|NCT00739973|75918293|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
42107496|NCT00739973|75918294|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
42107497|NCT00739973|75918286|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
42107498|NCT00739973|75918287|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
42107499|NCT00739973|75918288|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
42107500|NCT00739973|75918289|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
42107501|NCT00739973|75918290|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
42107502|NCT00739973|75918291|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
42107503|NCT00739973|75918292|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
42107504|NCT00739973|75918293|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
42107505|NCT00739973|75918294|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
42107506|NCT00739973|75918286|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
42107507|NCT00739973|75918287|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
42107508|NCT00739973|75918288|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
42107509|NCT00739973|75918289|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
42107510|NCT00739973|75918290|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
42107511|NCT00739973|75918291|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
42107512|NCT00739973|75918292|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
42107513|NCT00739973|75918293|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
42107514|NCT00739973|75918294|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
42107515|NCT00739973|75918286|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
42107516|NCT00739973|75918287|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
42202003|NCT02101853|76014579|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
42202004|NCT02101853|76014574|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
42202005|NCT02101853|76014575|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
42202006|NCT02101853|76014576|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
42202007|NCT02101853|76014577|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
42202008|NCT02101853|76014578|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
42202009|NCT02101853|76014579|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
42202010|NCT02101853|76014574|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
42202011|NCT02101853|76014575|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
42202012|NCT02101853|76014576|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
42202013|NCT02101853|76014577|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
42202014|NCT02101853|76014578|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
42202015|NCT02101853|76014579|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
42202016|NCT02101853|76014574|FG000|Blinatumomab Salvage Therapy|Death|0|||
42202017|NCT02101853|76014575|FG001|Blinatumomab Salvage Therapy|Death|0|||
42202018|NCT02101853|76014576|FG002|Blinatumomab Salvage Therapy|Death|0|||
42202019|NCT02101853|76014577|FG003|Blinatumomab Salvage Therapy|Death|0|||
42202020|NCT02101853|76014578|FG004|Blinatumomab Salvage Therapy|Death|0|||
42202021|NCT02101853|76014579|FG005|Blinatumomab Salvage Therapy|Death|2|||
42202022|NCT02101853|76014574|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
42202023|NCT02101853|76014575|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
42202024|NCT02101853|76014576|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
42202025|NCT02101853|76014577|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
42202026|NCT02101853|76014578|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
42202027|NCT02101853|76014579|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
42202028|NCT02101853|76014574|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
42202029|NCT02101853|76014575|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
42202030|NCT02101853|76014576|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
42202031|NCT02101853|76014577|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
42202032|NCT02101853|76014578|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
42202033|NCT02101853|76014579|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
42202034|NCT02101853|76014574|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
42202035|NCT02101853|76014575|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
42202036|NCT02101853|76014576|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
42202037|NCT02101853|76014577|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
42107517|NCT00739973|75918288|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
42107518|NCT00739973|75918289|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
42202038|NCT02101853|76014578|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
42202039|NCT02101853|76014579|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
42202040|NCT01236560|76014601|FG000|Overall Study|Adverse Event|0|||
42202041|NCT01236560|76014602|FG001|Overall Study|Adverse Event|2|||
42202042|NCT01236560|76014603|FG002|Overall Study|Adverse Event|1|||
42202043|NCT01236560|76014604|FG003|Overall Study|Adverse Event|3|||
42202044|NCT01236560|76014605|FG004|Overall Study|Adverse Event|0|||
42202045|NCT01236560|76014606|FG005|Overall Study|Adverse Event|0|||
42202046|NCT01236560|76014601|FG000|Overall Study|Death|0|||
42202047|NCT01236560|76014602|FG001|Overall Study|Death|1|||
42202048|NCT01236560|76014603|FG002|Overall Study|Death|0|||
42202049|NCT01236560|76014604|FG003|Overall Study|Death|1|||
42202050|NCT01236560|76014605|FG004|Overall Study|Death|0|||
42202051|NCT01236560|76014606|FG005|Overall Study|Death|0|||
42202052|NCT01236560|76014601|FG000|Overall Study|Lost to Follow-up|0|||
42202053|NCT01236560|76014602|FG001|Overall Study|Lost to Follow-up|1|||
42202054|NCT01236560|76014603|FG002|Overall Study|Lost to Follow-up|1|||
42202055|NCT01236560|76014604|FG003|Overall Study|Lost to Follow-up|0|||
42202056|NCT01236560|76014605|FG004|Overall Study|Lost to Follow-up|0|||
42202057|NCT01236560|76014606|FG005|Overall Study|Lost to Follow-up|0|||
42202058|NCT01236560|76014601|FG000|Overall Study|Physician Decision|0|||
42202059|NCT01236560|76014602|FG001|Overall Study|Physician Decision|1|||
42202060|NCT01236560|76014603|FG002|Overall Study|Physician Decision|8|||
42202061|NCT01236560|76014604|FG003|Overall Study|Physician Decision|0|||
42202062|NCT01236560|76014605|FG004|Overall Study|Physician Decision|0|||
42202063|NCT01236560|76014606|FG005|Overall Study|Physician Decision|0|||
42202064|NCT01236560|76014601|FG000|Overall Study|Withdrawal by Subject|0|||
42202065|NCT01236560|76014602|FG001|Overall Study|Withdrawal by Subject|0|||
42202066|NCT01236560|76014603|FG002|Overall Study|Withdrawal by Subject|1|||
42202067|NCT01236560|76014604|FG003|Overall Study|Withdrawal by Subject|2|||
42202068|NCT01236560|76014605|FG004|Overall Study|Withdrawal by Subject|0|||
42202069|NCT01236560|76014606|FG005|Overall Study|Withdrawal by Subject|0|||
42202070|NCT01236560|76014601|FG000|Overall Study|Progressive disease|5|||
42202071|NCT01236560|76014602|FG001|Overall Study|Progressive disease|19|||
42202072|NCT01236560|76014603|FG002|Overall Study|Progressive disease|9|||
42107519|NCT00739973|75918290|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
42107520|NCT00739973|75918291|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
42107521|NCT00739973|75918292|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
42107522|NCT00739973|75918293|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
42107523|NCT00739973|75918294|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
42107524|NCT00739973|75918286|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
42107525|NCT00739973|75918287|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
42202073|NCT01236560|76014604|FG003|Overall Study|Progressive disease|16|||
42202074|NCT01236560|76014605|FG004|Overall Study|Progressive disease|0|||
42202075|NCT01236560|76014606|FG005|Overall Study|Progressive disease|0|||
42202076|NCT01193842|76014621|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
42202077|NCT01193842|76014622|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
42202078|NCT01193842|76014623|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
42202079|NCT01193842|76014624|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
42202080|NCT01193842|76014625|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
42202081|NCT01193842|76014621|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
42202082|NCT01193842|76014622|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
42202083|NCT01193842|76014623|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
42202084|NCT01193842|76014624|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
42202085|NCT01193842|76014625|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
42202086|NCT01193842|76014621|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
42202087|NCT01193842|76014622|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
42202088|NCT01193842|76014623|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
42202089|NCT01193842|76014624|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
42202090|NCT01193842|76014625|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
42202091|NCT01193842|76014621|FG000|Phase II: Randomized Groups|Death|0|||
42202092|NCT01193842|76014622|FG001|Phase II: Randomized Groups|Death|0|||
42202093|NCT01193842|76014623|FG002|Phase II: Randomized Groups|Death|0|||
42202094|NCT01193842|76014624|FG003|Phase II: Randomized Groups|Death|1|||
42202095|NCT01193842|76014625|FG004|Phase II: Randomized Groups|Death|1|||
42202096|NCT01193842|76014621|FG000|Phase II: Randomized Groups|Adverse Event|0|||
42202097|NCT01193842|76014622|FG001|Phase II: Randomized Groups|Adverse Event|0|||
42202098|NCT01193842|76014623|FG002|Phase II: Randomized Groups|Adverse Event|0|||
42202099|NCT01193842|76014624|FG003|Phase II: Randomized Groups|Adverse Event|5|||
42202100|NCT01193842|76014625|FG004|Phase II: Randomized Groups|Adverse Event|3|||
42107526|NCT00739973|75918288|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
42202101|NCT01193842|76014621|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
42202102|NCT01193842|76014622|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
42202103|NCT01193842|76014623|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
42202104|NCT01193842|76014624|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
42202105|NCT01193842|76014625|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
42202106|NCT01193842|76014621|FG000|Phase II: Randomized Groups|Ineligible|0|||
42202107|NCT01193842|76014622|FG001|Phase II: Randomized Groups|Ineligible|0|||
42202108|NCT01193842|76014623|FG002|Phase II: Randomized Groups|Ineligible|0|||
42202109|NCT01193842|76014624|FG003|Phase II: Randomized Groups|Ineligible|0|||
42202110|NCT01193842|76014625|FG004|Phase II: Randomized Groups|Ineligible|1|||
42202111|NCT01193842|76014621|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
42202112|NCT01193842|76014622|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
42202113|NCT01193842|76014623|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
42202114|NCT01193842|76014624|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
42202115|NCT01193842|76014625|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
42202116|NCT00855465|76014649|FG000|Treatment Period|Adverse Event|4|||
42202117|NCT00855465|76014650|FG001|Treatment Period|Adverse Event|2|||
42202118|NCT00855465|76014649|FG000|Treatment Period|Death|2|||
42202119|NCT00855465|76014650|FG001|Treatment Period|Death|2|||
42202120|NCT00855465|76014649|FG000|Treatment Period|Lack of Efficacy|2|||
42202121|NCT00855465|76014650|FG001|Treatment Period|Lack of Efficacy|1|||
42202122|NCT00855465|76014649|FG000|Treatment Period|Non-compliance|1|||
42202123|NCT00855465|76014650|FG001|Treatment Period|Non-compliance|0|||
42202124|NCT00855465|76014649|FG000|Treatment Period|Protocol Violation|2|||
42202125|NCT00855465|76014650|FG001|Treatment Period|Protocol Violation|0|||
42202126|NCT00855465|76014649|FG000|Treatment Period|Withdrawal by Subject|2|||
42202127|NCT00855465|76014650|FG001|Treatment Period|Withdrawal by Subject|0|||
42202128|NCT00855465|76014649|FG000|Treatment Period|Not treated|1|||
42202129|NCT00855465|76014650|FG001|Treatment Period|Not treated|0|||
42202130|NCT00855465|76014649|FG000|Follow-up Period (FUP)|Adverse Event|0|||
42202131|NCT00855465|76014650|FG001|Follow-up Period (FUP)|Adverse Event|1|||
42202132|NCT00855465|76014649|FG000|Follow-up Period (FUP)|Death|0|||
42202133|NCT00855465|76014650|FG001|Follow-up Period (FUP)|Death|1|||
42202134|NCT00855465|76014649|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
42202135|NCT00855465|76014650|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
42202136|NCT00855465|76014649|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
42202137|NCT00855465|76014650|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
42202138|NCT00855465|76014649|FG000|Follow-up Period (FUP)|Missing|1|||
42202139|NCT00855465|76014650|FG001|Follow-up Period (FUP)|Missing|0|||
42202140|NCT00770809|76014659|FG000|Overall Study|Adverse Event|9|||
42202141|NCT00770809|76014660|FG001|Overall Study|Adverse Event|1|||
42202142|NCT00770809|76014661|FG002|Overall Study|Adverse Event|12|||
42202143|NCT00770809|76014659|FG000|Overall Study|Death|1|||
42202144|NCT00770809|76014660|FG001|Overall Study|Death|0|||
42202145|NCT00770809|76014661|FG002|Overall Study|Death|0|||
42202146|NCT00770809|76014659|FG000|Overall Study|Withdrawal by Subject|3|||
42202147|NCT00770809|76014660|FG001|Overall Study|Withdrawal by Subject|3|||
42202148|NCT00770809|76014661|FG002|Overall Study|Withdrawal by Subject|7|||
42202149|NCT00770809|76014659|FG000|Overall Study|Progression|2|||
42202150|NCT00770809|76014660|FG001|Overall Study|Progression|2|||
42202151|NCT00770809|76014661|FG002|Overall Study|Progression|0|||
42202152|NCT00770809|76014659|FG000|Overall Study|Complicating illness|0|||
42202153|NCT00770809|76014660|FG001|Overall Study|Complicating illness|0|||
42202154|NCT00770809|76014661|FG002|Overall Study|Complicating illness|1|||
42202155|NCT00770809|76014659|FG000|Overall Study|Other Medical Reasons|2|||
42202156|NCT00770809|76014660|FG001|Overall Study|Other Medical Reasons|4|||
42202157|NCT00770809|76014661|FG002|Overall Study|Other Medical Reasons|3|||
42202158|NCT00602641|76014671|FG000|Overall Study|Never started protocol therapy|6|||
42202159|NCT00602641|76014672|FG001|Overall Study|Never started protocol therapy|2|||
42202160|NCT00602641|76014671|FG000|Overall Study|Still on treatment at time of analysis|8|||
42202161|NCT00602641|76014672|FG001|Overall Study|Still on treatment at time of analysis|15|||
42202162|NCT00602641|76014671|FG000|Overall Study|Adverse Event|62|||
42202163|NCT00602641|76014672|FG001|Overall Study|Adverse Event|53|||
42202164|NCT00602641|76014671|FG000|Overall Study|Disease progression|38|||
42202165|NCT00602641|76014672|FG001|Overall Study|Disease progression|55|||
42202166|NCT00602641|76014671|FG000|Overall Study|Death|6|||
42202167|NCT00602641|76014672|FG001|Overall Study|Death|5|||
42202168|NCT00602641|76014671|FG000|Overall Study|Withdrawal by Subject|15|||
42202169|NCT00602641|76014672|FG001|Overall Study|Withdrawal by Subject|12|||
42202170|NCT00602641|76014671|FG000|Overall Study|Alternative therapy|5|||
42202171|NCT00602641|76014672|FG001|Overall Study|Alternative therapy|2|||
42202172|NCT00602641|76014671|FG000|Overall Study|Other Complicating Disease|5|||
42202173|NCT00602641|76014672|FG001|Overall Study|Other Complicating Disease|2|||
42202174|NCT00602641|76014671|FG000|Overall Study|Physician Decision|5|||
42202175|NCT00602641|76014672|FG001|Overall Study|Physician Decision|4|||
42202176|NCT00602641|76014671|FG000|Overall Study|Administrative Closure|1|||
42202177|NCT00602641|76014672|FG001|Overall Study|Administrative Closure|1|||
42202178|NCT00602641|76014671|FG000|Overall Study|Other|3|||
42202179|NCT00602641|76014672|FG001|Overall Study|Other|1|||
42202180|NCT00569127|76014680|FG000|Overall Study|Adverse Event|57|||
42202181|NCT00569127|76014681|FG001|Overall Study|Adverse Event|47|||
42202182|NCT00569127|76014680|FG000|Overall Study|Withdrawal by Subject|13|||
42202183|NCT00569127|76014681|FG001|Overall Study|Withdrawal by Subject|27|||
42202184|NCT00569127|76014680|FG000|Overall Study|Progression|99|||
42202185|NCT00569127|76014681|FG001|Overall Study|Progression|100|||
42202186|NCT00569127|76014680|FG000|Overall Study|Death|4|||
42202187|NCT00569127|76014681|FG001|Overall Study|Death|3|||
42202188|NCT00569127|76014680|FG000|Overall Study|Other|20|||
42202189|NCT00569127|76014681|FG001|Overall Study|Other|19|||
42202190|NCT00569127|76014680|FG000|Overall Study|Lost to Follow-up|0|||
42202191|NCT00569127|76014681|FG001|Overall Study|Lost to Follow-up|3|||
42202192|NCT00569127|76014680|FG000|Overall Study|Not Eligible|14|||
42202193|NCT00569127|76014681|FG001|Overall Study|Not Eligible|11|||
42202194|NCT00569127|76014680|FG000|Overall Study|Still on Treatment|7|||
42202195|NCT00569127|76014681|FG001|Overall Study|Still on Treatment|3|||
42202196|NCT00098475|76014700|FG000|Step 1|Progressive disease|33|||
42202197|NCT00098475|76014701|FG001|Step 1|Progressive disease|35|||
42202198|NCT00098475|76014702|FG002|Step 1|Progressive disease|2|||
42202199|NCT00098475|76014703|FG003|Step 1|Progressive disease|1|||
42202200|NCT00098475|76014700|FG000|Step 1|Adverse Event|56|||
42202201|NCT00098475|76014701|FG001|Step 1|Adverse Event|37|||
42202202|NCT00098475|76014702|FG002|Step 1|Adverse Event|0|||
42202203|NCT00098475|76014703|FG003|Step 1|Adverse Event|1|||
42202204|NCT00098475|76014700|FG000|Step 1|Death|8|||
42202205|NCT00098475|76014701|FG001|Step 1|Death|5|||
42202206|NCT00098475|76014702|FG002|Step 1|Death|0|||
42202207|NCT00098475|76014703|FG003|Step 1|Death|1|||
42202208|NCT00098475|76014700|FG000|Step 1|Withdrawal by Subject|14|||
42202209|NCT00098475|76014701|FG001|Step 1|Withdrawal by Subject|11|||
42202210|NCT00098475|76014702|FG002|Step 1|Withdrawal by Subject|0|||
42202211|NCT00098475|76014703|FG003|Step 1|Withdrawal by Subject|0|||
42202212|NCT00098475|76014700|FG000|Step 1|Physician Decision|5|||
42202213|NCT00098475|76014701|FG001|Step 1|Physician Decision|2|||
42202214|NCT00098475|76014702|FG002|Step 1|Physician Decision|0|||
42202215|NCT00098475|76014703|FG003|Step 1|Physician Decision|0|||
42202216|NCT00098475|76014700|FG000|Step 1|Alternative therapy|31|||
42202217|NCT00098475|76014701|FG001|Step 1|Alternative therapy|43|||
42202218|NCT00098475|76014702|FG002|Step 1|Alternative therapy|1|||
42202219|NCT00098475|76014703|FG003|Step 1|Alternative therapy|0|||
42202220|NCT00098475|76014700|FG000|Step 1|Other disease|2|||
42202221|NCT00098475|76014701|FG001|Step 1|Other disease|1|||
42202222|NCT00098475|76014702|FG002|Step 1|Other disease|1|||
42202223|NCT00098475|76014703|FG003|Step 1|Other disease|0|||
42202224|NCT00098475|76014700|FG000|Step 1|Never started treatment|0|||
42202225|NCT00098475|76014701|FG001|Step 1|Never started treatment|2|||
42202226|NCT00098475|76014702|FG002|Step 1|Never started treatment|0|||
42202227|NCT00098475|76014703|FG003|Step 1|Never started treatment|0|||
42202228|NCT00098475|76014700|FG000|Step 1|Still on treatment as of this analysis|14|||
42202229|NCT00098475|76014701|FG001|Step 1|Still on treatment as of this analysis|27|||
42202230|NCT00098475|76014702|FG002|Step 1|Still on treatment as of this analysis|0|||
42202231|NCT00098475|76014703|FG003|Step 1|Still on treatment as of this analysis|0|||
42202232|NCT00098475|76014700|FG000|Step 1|Knee surgery|1|||
42202233|NCT00098475|76014701|FG001|Step 1|Knee surgery|0|||
42202234|NCT00098475|76014702|FG002|Step 1|Knee surgery|0|||
42202235|NCT00098475|76014703|FG003|Step 1|Knee surgery|0|||
42202236|NCT00098475|76014700|FG000|Step 1|Complications|1|||
42202237|NCT00098475|76014701|FG001|Step 1|Complications|0|||
42202238|NCT00098475|76014702|FG002|Step 1|Complications|0|||
42202239|NCT00098475|76014703|FG003|Step 1|Complications|0|||
42202240|NCT00098475|76014700|FG000|Step 1|Cannot comply due to other tx|0|||
42202241|NCT00098475|76014701|FG001|Step 1|Cannot comply due to other tx|1|||
42202242|NCT00098475|76014702|FG002|Step 1|Cannot comply due to other tx|0|||
42202243|NCT00098475|76014703|FG003|Step 1|Cannot comply due to other tx|0|||
42202244|NCT00098475|76014700|FG000|Step 1|Both patient and physician's decision|2|||
42202245|NCT00098475|76014701|FG001|Step 1|Both patient and physician's decision|1|||
42202246|NCT00098475|76014702|FG002|Step 1|Both patient and physician's decision|0|||
42202247|NCT00098475|76014703|FG003|Step 1|Both patient and physician's decision|0|||
42202248|NCT00098475|76014700|FG000|Step 1|Incorrect disease assessment|2|||
42202249|NCT00098475|76014701|FG001|Step 1|Incorrect disease assessment|0|||
42380929|NCT01444781|76253498|FG000|Overall Study|Withdrawal by Subject|3|||
42202250|NCT00098475|76014702|FG002|Step 1|Incorrect disease assessment|0|||
42202251|NCT00098475|76014703|FG003|Step 1|Incorrect disease assessment|0|||
42202252|NCT00098475|76014700|FG000|Step 1|Off treatment for > specified timeframe|1|||
42202253|NCT00098475|76014701|FG001|Step 1|Off treatment for > specified timeframe|1|||
42202254|NCT00098475|76014702|FG002|Step 1|Off treatment for > specified timeframe|0|||
42202255|NCT00098475|76014703|FG003|Step 1|Off treatment for > specified timeframe|0|||
42202256|NCT00098475|76014700|FG000|Step 1|Declining performance status|0|||
42202257|NCT00098475|76014701|FG001|Step 1|Declining performance status|1|||
42202258|NCT00098475|76014702|FG002|Step 1|Declining performance status|0|||
42202259|NCT00098475|76014703|FG003|Step 1|Declining performance status|0|||
42202260|NCT00098475|76014700|FG000|Step 1|Insurance issue|0|||
42202261|NCT00098475|76014701|FG001|Step 1|Insurance issue|1|||
42202262|NCT00098475|76014702|FG002|Step 1|Insurance issue|0|||
42202263|NCT00098475|76014703|FG003|Step 1|Insurance issue|0|||
42202264|NCT00098475|76014700|FG000|Step 1|Rising paraprotein|0|||
42202265|NCT00098475|76014701|FG001|Step 1|Rising paraprotein|1|||
42202266|NCT00098475|76014702|FG002|Step 1|Rising paraprotein|0|||
42202267|NCT00098475|76014703|FG003|Step 1|Rising paraprotein|0|||
42202268|NCT00098475|76014700|FG000|Step 1|Referred to other physicians|0|||
42202269|NCT00098475|76014701|FG001|Step 1|Referred to other physicians|1|||
42202270|NCT00098475|76014702|FG002|Step 1|Referred to other physicians|0|||
42202271|NCT00098475|76014703|FG003|Step 1|Referred to other physicians|0|||
42202272|NCT00098475|76014700|FG000|Step 1|Criteria to continue treatment not met|0|||
42202273|NCT00098475|76014701|FG001|Step 1|Criteria to continue treatment not met|1|||
42202274|NCT00098475|76014702|FG002|Step 1|Criteria to continue treatment not met|0|||
42202275|NCT00098475|76014703|FG003|Step 1|Criteria to continue treatment not met|0|||
42202276|NCT00098475|76014700|FG000|Step 1|Misinterpretation of lab data|0|||
42202277|NCT00098475|76014701|FG001|Step 1|Misinterpretation of lab data|1|||
42202278|NCT00098475|76014702|FG002|Step 1|Misinterpretation of lab data|0|||
42202279|NCT00098475|76014703|FG003|Step 1|Misinterpretation of lab data|0|||
42202280|NCT00098475|76014700|FG000|Step 1|Patient fell with fracture|1|||
42202281|NCT00098475|76014701|FG001|Step 1|Patient fell with fracture|0|||
42202282|NCT00098475|76014702|FG002|Step 1|Patient fell with fracture|0|||
42202283|NCT00098475|76014703|FG003|Step 1|Patient fell with fracture|0|||
42202284|NCT00098475|76014700|FG000|Step 1|Not documented|0|||
42202285|NCT00098475|76014701|FG001|Step 1|Not documented|1|||
42202286|NCT00098475|76014702|FG002|Step 1|Not documented|0|||
42202287|NCT00098475|76014703|FG003|Step 1|Not documented|0|||
42202288|NCT00098475|76014700|FG000|Step 2|Disease progression|1|||
42202289|NCT00098475|76014701|FG001|Step 2|Disease progression|4|||
42202290|NCT00098475|76014702|FG002|Step 2|Disease progression|0|||
42202291|NCT00098475|76014703|FG003|Step 2|Disease progression|0|||
42202292|NCT00098475|76014700|FG000|Step 2|Adverse Event|2|||
42202293|NCT00098475|76014701|FG001|Step 2|Adverse Event|0|||
42202294|NCT00098475|76014702|FG002|Step 2|Adverse Event|0|||
42202295|NCT00098475|76014703|FG003|Step 2|Adverse Event|0|||
42202296|NCT00098475|76014700|FG000|Step 2|Withdrawal by Subject|0|||
42202297|NCT00098475|76014701|FG001|Step 2|Withdrawal by Subject|2|||
42202298|NCT00098475|76014702|FG002|Step 2|Withdrawal by Subject|0|||
42202299|NCT00098475|76014703|FG003|Step 2|Withdrawal by Subject|0|||
42202300|NCT00098475|76014700|FG000|Step 2|Physician Decision|0|||
42202301|NCT00098475|76014701|FG001|Step 2|Physician Decision|1|||
42202302|NCT00098475|76014702|FG002|Step 2|Physician Decision|0|||
42202303|NCT00098475|76014703|FG003|Step 2|Physician Decision|0|||
42202304|NCT00098475|76014700|FG000|Step 2|Alternative therapy|1|||
42202305|NCT00098475|76014701|FG001|Step 2|Alternative therapy|2|||
42202306|NCT00098475|76014702|FG002|Step 2|Alternative therapy|0|||
42202307|NCT00098475|76014703|FG003|Step 2|Alternative therapy|0|||
42202308|NCT00098475|76014700|FG000|Step 2|Never started treatment|1|||
42202309|NCT00098475|76014701|FG001|Step 2|Never started treatment|1|||
42202310|NCT00098475|76014702|FG002|Step 2|Never started treatment|0|||
42202311|NCT00098475|76014703|FG003|Step 2|Never started treatment|0|||
42202312|NCT03136484|76014719|FG000|Overall Study|Withdrawal by Subject|19|||
42202313|NCT03136484|76014720|FG001|Overall Study|Withdrawal by Subject|14|||
42202314|NCT03136484|76014719|FG000|Overall Study|Lost to Follow-up|7|||
42202315|NCT03136484|76014720|FG001|Overall Study|Lost to Follow-up|8|||
42202316|NCT03136484|76014719|FG000|Overall Study|Death|1|||
42202317|NCT03136484|76014720|FG001|Overall Study|Death|0|||
42202318|NCT03922711|76014729|FG000|Overall Study|Adverse Event|3|||
42107527|NCT00739973|75918289|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
42107528|NCT00739973|75918290|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
42107529|NCT00739973|75918291|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
42107530|NCT00739973|75918292|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
42107531|NCT00739973|75918293|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
42107532|NCT00739973|75918294|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
42107533|NCT00510874|75918329|FG000|Overall Study|Withdrawal by Subject|1|||
42107534|NCT00510874|75918330|FG001|Overall Study|Withdrawal by Subject|1|||
42107535|NCT00510874|75918331|FG002|Overall Study|Withdrawal by Subject|0|||
42107536|NCT00510874|75918332|FG003|Overall Study|Withdrawal by Subject|0|||
42107537|NCT00510874|75918333|FG004|Overall Study|Withdrawal by Subject|3|||
42107538|NCT00510874|75918334|FG005|Overall Study|Withdrawal by Subject|0|||
42107539|NCT00510874|75918335|FG006|Overall Study|Withdrawal by Subject|0|||
42202319|NCT03922711|76014730|FG001|Overall Study|Adverse Event|2|||
42202320|NCT03922711|76014731|FG002|Overall Study|Adverse Event|2|||
42202321|NCT03922711|76014729|FG000|Overall Study|Protocol Violation|1|||
42202322|NCT03922711|76014730|FG001|Overall Study|Protocol Violation|0|||
42202323|NCT03922711|76014731|FG002|Overall Study|Protocol Violation|0|||
42202324|NCT03922711|76014729|FG000|Overall Study|Withdrawal by Subject|0|||
42202325|NCT03922711|76014730|FG001|Overall Study|Withdrawal by Subject|3|||
42202326|NCT03922711|76014731|FG002|Overall Study|Withdrawal by Subject|1|||
42202327|NCT03922711|76014729|FG000|Overall Study|Not further specified|0|||
42018846|NCT01122927|75826234|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
42018847|NCT01122927|75826235|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
42018848|NCT01122927|75826234|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
42018849|NCT01122927|75826235|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
42018850|NCT01122927|75826234|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
42018851|NCT01122927|75826235|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
42018852|NCT01122927|75826234|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
42018853|NCT01122927|75826235|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
42018854|NCT01254227|75826245|FG000|Overall Study|Withdrawal by Subject|6|||
42018855|NCT01254227|75826245|FG000|Overall Study|Lost to Follow-up|6|||
42018856|NCT01254227|75826245|FG000|Overall Study|Adverse Event|5|||
42107540|NCT00510874|75918329|FG000|Overall Study|Lost to Follow-up|2|||
42202328|NCT03922711|76014730|FG001|Overall Study|Not further specified|0|||
42202329|NCT03922711|76014731|FG002|Overall Study|Not further specified|1|||
42202330|NCT02877680|76014740|FG000|Overall Study|Lost to Follow-up|1|||
42202331|NCT02877680|76014741|FG001|Overall Study|Lost to Follow-up|1|||
42202332|NCT03141086|76014753|FG000|Overall Study|Study Terminated By Sponsor|1|||
42202333|NCT03141086|76014754|FG001|Overall Study|Study Terminated By Sponsor|1|||
42202334|NCT03141086|76014753|FG000|Overall Study|Withdrawal by Subject|0|||
42202335|NCT03141086|76014754|FG001|Overall Study|Withdrawal by Subject|1|||
42202336|NCT03141086|76014753|FG000|Overall Study|Protocol Violation|0|||
42202337|NCT03141086|76014754|FG001|Overall Study|Protocol Violation|1|||
42202338|NCT03141086|76014753|FG000|Overall Study|Adverse Event|0|||
42202339|NCT03141086|76014754|FG001|Overall Study|Adverse Event|2|||
42202340|NCT03135548|76014763|FG000|Overall Study|Lost to Follow-up|3|||
42202341|NCT03135548|76014764|FG001|Overall Study|Lost to Follow-up|0|||
42202342|NCT03135548|76014765|FG002|Overall Study|Lost to Follow-up|0|||
42202343|NCT03135548|76014763|FG000|Overall Study|Withdrawal by Subject|2|||
42202344|NCT03135548|76014764|FG001|Overall Study|Withdrawal by Subject|2|||
42107541|NCT00510874|75918330|FG001|Overall Study|Lost to Follow-up|3|||
42107542|NCT00510874|75918331|FG002|Overall Study|Lost to Follow-up|1|||
42107543|NCT00510874|75918332|FG003|Overall Study|Lost to Follow-up|3|||
42107544|NCT00510874|75918333|FG004|Overall Study|Lost to Follow-up|4|||
42107545|NCT00510874|75918334|FG005|Overall Study|Lost to Follow-up|0|||
42107546|NCT00510874|75918335|FG006|Overall Study|Lost to Follow-up|1|||
42107547|NCT00739661|75918354|FG000|Overall Study|Adverse Event|2|||
42107548|NCT00739661|75918355|FG001|Overall Study|Adverse Event|0|||
42107549|NCT00739661|75918354|FG000|Overall Study|Physician decision to withdraw patient|1|||
42107550|NCT00739661|75918355|FG001|Overall Study|Physician decision to withdraw patient|0|||
42107551|NCT00739661|75918354|FG000|Overall Study|Patient decision to withdraw|9|||
42107552|NCT00739661|75918355|FG001|Overall Study|Patient decision to withdraw|4|||
42107553|NCT00739661|75918354|FG000|Overall Study|Disease progression, radiographic|33|||
42107554|NCT00739661|75918355|FG001|Overall Study|Disease progression, radiographic|37|||
42107555|NCT00739661|75918354|FG000|Overall Study|Reason for discontinuation not available|1|||
42107556|NCT00739661|75918355|FG001|Overall Study|Reason for discontinuation not available|1|||
42107557|NCT00615030|75918361|FG000|Period I|Administrative problem|0|||
42107558|NCT00615030|75918362|FG001|Period I|Administrative problem|0|||
42107559|NCT00615030|75918363|FG002|Period I|Administrative problem|0|||
42107560|NCT00615030|75918364|FG003|Period I|Administrative problem|0|||
42107561|NCT00615030|75918365|FG004|Period I|Administrative problem|1|||
42107562|NCT00615030|75918366|FG005|Period I|Administrative problem|0|||
42107563|NCT00615030|75918367|FG006|Period I|Administrative problem|0|||
42107564|NCT00615030|75918368|FG007|Period I|Administrative problem|0|||
42107565|NCT00615030|75918369|FG008|Period I|Administrative problem|0|||
42107566|NCT00615030|75918370|FG009|Period I|Administrative problem|0|||
42107567|NCT00615030|75918371|FG010|Period I|Administrative problem|0|||
42107568|NCT00615030|75918372|FG011|Period I|Administrative problem|0|||
42107569|NCT00615030|75918361|FG000|Period I|Protocol deviation|1|||
42107570|NCT00615030|75918362|FG001|Period I|Protocol deviation|0|||
42107571|NCT00615030|75918363|FG002|Period I|Protocol deviation|0|||
42107572|NCT00615030|75918364|FG003|Period I|Protocol deviation|0|||
42107573|NCT00615030|75918365|FG004|Period I|Protocol deviation|0|||
42107574|NCT00615030|75918366|FG005|Period I|Protocol deviation|0|||
42107575|NCT00615030|75918367|FG006|Period I|Protocol deviation|0|||
42107576|NCT00615030|75918368|FG007|Period I|Protocol deviation|0|||
42107577|NCT00615030|75918369|FG008|Period I|Protocol deviation|0|||
42202345|NCT03135548|76014765|FG002|Overall Study|Withdrawal by Subject|1|||
42202346|NCT03135548|76014763|FG000|Overall Study|Other than listed|0|||
42202347|NCT03135548|76014764|FG001|Overall Study|Other than listed|2|||
42107578|NCT00615030|75918370|FG009|Period I|Protocol deviation|0|||
42107579|NCT00615030|75918371|FG010|Period I|Protocol deviation|0|||
42107580|NCT00615030|75918372|FG011|Period I|Protocol deviation|0|||
42107581|NCT00615030|75918361|FG000|Period I|Subject withdrew consent|0|||
42107582|NCT00615030|75918362|FG001|Period I|Subject withdrew consent|0|||
42202348|NCT03135548|76014765|FG002|Overall Study|Other than listed|2|||
42202349|NCT03134222|76014776|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
42202350|NCT03134222|76014777|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
42202351|NCT03134222|76014778|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
42202352|NCT03134222|76014779|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
42202353|NCT03134222|76014780|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
42202354|NCT03134222|76014776|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
42202355|NCT03134222|76014777|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
42202356|NCT03134222|76014778|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
42202357|NCT03134222|76014779|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
42202358|NCT03134222|76014780|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
42202359|NCT03134222|76014776|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
42202360|NCT03134222|76014777|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
42202361|NCT03134222|76014778|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
42202362|NCT03134222|76014779|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
42202363|NCT03134222|76014780|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
42202364|NCT03134222|76014776|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
42202365|NCT03134222|76014777|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
42202366|NCT03134222|76014778|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
42202367|NCT03134222|76014779|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
42202368|NCT03134222|76014780|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
42202369|NCT03134222|76014776|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
42202370|NCT03134222|76014777|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
42202371|NCT03134222|76014778|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
42202372|NCT03134222|76014779|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
42202373|NCT03134222|76014780|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
42202374|NCT03134222|76014776|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
42202375|NCT03134222|76014777|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
42202376|NCT03134222|76014778|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
42202377|NCT03134222|76014779|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
42202378|NCT03134222|76014780|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
42202379|NCT03134222|76014776|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
42202380|NCT03134222|76014777|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
42202381|NCT03134222|76014778|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
42202382|NCT03134222|76014779|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
42202383|NCT03134222|76014780|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
42202384|NCT03134222|76014776|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
42202385|NCT03134222|76014777|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
42202386|NCT03134222|76014778|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
42202387|NCT03134222|76014779|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
42202388|NCT03134222|76014780|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
42202389|NCT03769753|76014790|FG000|Overall Study|Not Treated|6|||
42202390|NCT03769753|76014790|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
42202391|NCT03263923|76014805|FG000|Overall Study|Withdrawal by Subject|10|||
42202392|NCT03263923|76014806|FG001|Overall Study|Withdrawal by Subject|8|||
42202393|NCT03263923|76014805|FG000|Overall Study|Lost to Follow-up|15|||
42202394|NCT03263923|76014806|FG001|Overall Study|Lost to Follow-up|13|||
42202395|NCT03139604|76014816|FG000|Overall Study|Other|7|||
42202396|NCT03139604|76014817|FG001|Overall Study|Other|3|||
42202397|NCT03139604|76014816|FG000|Overall Study|Withdrawal by Subject|16|||
42202398|NCT03139604|76014817|FG001|Overall Study|Withdrawal by Subject|17|||
42202399|NCT03139604|76014816|FG000|Overall Study|Physician Decision|1|||
42202400|NCT03139604|76014817|FG001|Overall Study|Physician Decision|2|||
42202401|NCT03139604|76014816|FG000|Overall Study|Lost to Follow-up|3|||
42202402|NCT03139604|76014817|FG001|Overall Study|Lost to Follow-up|1|||
42202403|NCT03139604|76014816|FG000|Overall Study|Death|65|||
42202404|NCT03139604|76014817|FG001|Overall Study|Death|67|||
42202405|NCT03139604|76014816|FG000|Overall Study|Study Terminated by Sponsor|122|||
42202406|NCT03139604|76014817|FG001|Overall Study|Study Terminated by Sponsor|127|||
42202407|NCT03139604|76014816|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
42202408|NCT03139604|76014817|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
42202409|NCT03139448|76014826|FG000|Overall Study|Lack of Efficacy|6|||
42202410|NCT03139448|76014827|FG001|Overall Study|Lack of Efficacy|7|||
42202411|NCT03139448|76014826|FG000|Overall Study|Location of procedure changed|2|||
42202412|NCT03139448|76014827|FG001|Overall Study|Location of procedure changed|8|||
42202413|NCT03139448|76014826|FG000|Overall Study|Withdrawal by Subject|3|||
42202414|NCT03139448|76014827|FG001|Overall Study|Withdrawal by Subject|6|||
42202415|NCT03139448|76014826|FG000|Overall Study|Screen fail|1|||
42202416|NCT03139448|76014827|FG001|Overall Study|Screen fail|3|||
42202417|NCT03139448|76014826|FG000|Overall Study|Physician Decision|0|||
42202418|NCT03139448|76014827|FG001|Overall Study|Physician Decision|2|||
42202419|NCT02875340|76014833|FG000|Overall Study|Death|2|||
42202420|NCT02875340|76014833|FG000|Overall Study|Withdrawal by Subject|2|||
42202421|NCT02875340|76014833|FG000|Overall Study|Physician Decision|3|||
42202422|NCT02875340|76014833|FG000|Overall Study|Adverse Event|1|||
42202423|NCT03237325|76014845|FG000|Overall Study|Lost to Follow-up|3|||
42202424|NCT03237325|76014846|FG001|Overall Study|Lost to Follow-up|5|||
42107583|NCT00615030|75918363|FG002|Period I|Subject withdrew consent|0|||
42107584|NCT00615030|75918364|FG003|Period I|Subject withdrew consent|0|||
42107585|NCT00615030|75918365|FG004|Period I|Subject withdrew consent|0|||
42107586|NCT00615030|75918366|FG005|Period I|Subject withdrew consent|0|||
42107587|NCT00615030|75918367|FG006|Period I|Subject withdrew consent|0|||
42107588|NCT00615030|75918368|FG007|Period I|Subject withdrew consent|0|||
42107589|NCT00615030|75918369|FG008|Period I|Subject withdrew consent|1|||
42107590|NCT00615030|75918370|FG009|Period I|Subject withdrew consent|0|||
42107591|NCT00615030|75918371|FG010|Period I|Subject withdrew consent|1|||
42107592|NCT00615030|75918372|FG011|Period I|Subject withdrew consent|1|||
42107593|NCT00615030|75918361|FG000|Period I|Abnormal laboratory value(s)|0|||
42107594|NCT00615030|75918362|FG001|Period I|Abnormal laboratory value(s)|0|||
42107595|NCT00615030|75918363|FG002|Period I|Abnormal laboratory value(s)|0|||
42107596|NCT00615030|75918364|FG003|Period I|Abnormal laboratory value(s)|0|||
42107597|NCT00615030|75918365|FG004|Period I|Abnormal laboratory value(s)|0|||
42107598|NCT00615030|75918366|FG005|Period I|Abnormal laboratory value(s)|1|||
42107599|NCT00615030|75918367|FG006|Period I|Abnormal laboratory value(s)|0|||
42107600|NCT00615030|75918368|FG007|Period I|Abnormal laboratory value(s)|0|||
42107601|NCT00615030|75918369|FG008|Period I|Abnormal laboratory value(s)|0|||
42107602|NCT00615030|75918370|FG009|Period I|Abnormal laboratory value(s)|0|||
42107603|NCT00615030|75918371|FG010|Period I|Abnormal laboratory value(s)|0|||
42107604|NCT00615030|75918372|FG011|Period I|Abnormal laboratory value(s)|0|||
42107605|NCT00615030|75918361|FG000|Period II|Adverse Event|0|||
42107606|NCT00615030|75918362|FG001|Period II|Adverse Event|0|||
42107607|NCT00615030|75918363|FG002|Period II|Adverse Event|1|||
42107608|NCT00615030|75918364|FG003|Period II|Adverse Event|0|||
42107609|NCT00615030|75918365|FG004|Period II|Adverse Event|0|||
42107610|NCT00615030|75918366|FG005|Period II|Adverse Event|0|||
42107611|NCT00615030|75918367|FG006|Period II|Adverse Event|0|||
42107612|NCT00615030|75918368|FG007|Period II|Adverse Event|0|||
42107613|NCT00615030|75918369|FG008|Period II|Adverse Event|1|||
42107614|NCT00615030|75918370|FG009|Period II|Adverse Event|0|||
42107615|NCT00615030|75918371|FG010|Period II|Adverse Event|0|||
42107616|NCT00615030|75918372|FG011|Period II|Adverse Event|0|||
42107617|NCT00615030|75918361|FG000|Period II|Subject withdrew consent|0|||
42107618|NCT00615030|75918362|FG001|Period II|Subject withdrew consent|0|||
42107619|NCT00615030|75918363|FG002|Period II|Subject withdrew consent|0|||
42107620|NCT00615030|75918364|FG003|Period II|Subject withdrew consent|1|||
42107621|NCT00615030|75918365|FG004|Period II|Subject withdrew consent|0|||
42107622|NCT00615030|75918366|FG005|Period II|Subject withdrew consent|0|||
42107623|NCT00615030|75918367|FG006|Period II|Subject withdrew consent|1|||
42107624|NCT00615030|75918368|FG007|Period II|Subject withdrew consent|0|||
42107625|NCT00615030|75918369|FG008|Period II|Subject withdrew consent|0|||
42107626|NCT00615030|75918370|FG009|Period II|Subject withdrew consent|0|||
42107627|NCT00615030|75918371|FG010|Period II|Subject withdrew consent|0|||
42107628|NCT00615030|75918372|FG011|Period II|Subject withdrew consent|0|||
42107629|NCT00615030|75918361|FG000|Period III|Administrative problems|1|||
42107630|NCT00615030|75918362|FG001|Period III|Administrative problems|0|||
42107631|NCT00615030|75918363|FG002|Period III|Administrative problems|0|||
42107632|NCT00615030|75918364|FG003|Period III|Administrative problems|1|||
42107633|NCT00615030|75918365|FG004|Period III|Administrative problems|0|||
42107634|NCT00615030|75918366|FG005|Period III|Administrative problems|0|||
42107635|NCT00615030|75918367|FG006|Period III|Administrative problems|0|||
42107636|NCT00615030|75918368|FG007|Period III|Administrative problems|0|||
42107637|NCT00615030|75918369|FG008|Period III|Administrative problems|0|||
42107638|NCT00615030|75918370|FG009|Period III|Administrative problems|0|||
42107639|NCT00615030|75918371|FG010|Period III|Administrative problems|0|||
42202425|NCT03237325|76014845|FG000|Overall Study|Physician Decision|2|||
42202426|NCT03237325|76014846|FG001|Overall Study|Physician Decision|4|||
42107640|NCT00615030|75918372|FG011|Period III|Administrative problems|0|||
42107641|NCT00518284|75918390|FG000|Overall Study|Adverse Event|0|||
42107642|NCT00518284|75918391|FG001|Overall Study|Adverse Event|1|||
42107643|NCT00518284|75918392|FG002|Overall Study|Adverse Event|0|||
42107644|NCT00518284|75918393|FG003|Overall Study|Adverse Event|0|||
42107645|NCT00518284|75918390|FG000|Overall Study|Study Termination|0|||
42202427|NCT03237325|76014845|FG000|Overall Study|Withdrawal by Subject|9|||
42202428|NCT03237325|76014846|FG001|Overall Study|Withdrawal by Subject|12|||
42107646|NCT00518284|75918391|FG001|Overall Study|Study Termination|2|||
42107647|NCT00518284|75918392|FG002|Overall Study|Study Termination|1|||
42107648|NCT00518284|75918393|FG003|Overall Study|Study Termination|2|||
42107649|NCT00614874|75918403|FG000|Overall Study|Protocol Violation|1|||
42202429|NCT03237325|76014845|FG000|Overall Study|Noncompliance with Study Procedures|1|||
42107650|NCT00614874|75918403|FG000|Overall Study|Withdrawal by Subject|1|||
42107651|NCT00727415|75918407|FG000|Phase I|Dose Limiting Toxicity|2|||
42107652|NCT00544557|75918411|FG000|Overall Study|Adverse Event|140|||
42107653|NCT00544557|75918411|FG000|Overall Study|Lack of Efficacy|196|||
42107654|NCT00544557|75918411|FG000|Overall Study|Other|98|||
42107655|NCT00727259|75918415|FG000|Overall Study|Not all questionnaires completed|1055|||
42107656|NCT00735371|75918424|FG000|Overall Study|Adverse Event|3|||
42107657|NCT00735371|75918425|FG001|Overall Study|Adverse Event|3|||
42107658|NCT00735371|75918426|FG002|Overall Study|Adverse Event|4|||
42107659|NCT00735371|75918427|FG003|Overall Study|Adverse Event|1|||
42107660|NCT00735371|75918424|FG000|Overall Study|Protocol Violation|2|||
42107661|NCT00735371|75918425|FG001|Overall Study|Protocol Violation|2|||
42107662|NCT00735371|75918426|FG002|Overall Study|Protocol Violation|0|||
42107663|NCT00735371|75918427|FG003|Overall Study|Protocol Violation|3|||
42107664|NCT00735371|75918424|FG000|Overall Study|Withdrawal by Subject|0|||
42107665|NCT00735371|75918425|FG001|Overall Study|Withdrawal by Subject|2|||
42107666|NCT00735371|75918426|FG002|Overall Study|Withdrawal by Subject|2|||
42107667|NCT00735371|75918427|FG003|Overall Study|Withdrawal by Subject|0|||
42107668|NCT00735371|75918424|FG000|Overall Study|Lost to Follow-up|1|||
42107669|NCT00735371|75918425|FG001|Overall Study|Lost to Follow-up|1|||
42107670|NCT00735371|75918426|FG002|Overall Study|Lost to Follow-up|3|||
42107671|NCT00735371|75918427|FG003|Overall Study|Lost to Follow-up|1|||
42107672|NCT00735371|75918424|FG000|Overall Study|Lack of Efficacy|4|||
42107673|NCT00735371|75918425|FG001|Overall Study|Lack of Efficacy|2|||
42107674|NCT00735371|75918426|FG002|Overall Study|Lack of Efficacy|0|||
42107675|NCT00735371|75918427|FG003|Overall Study|Lack of Efficacy|4|||
42107676|NCT00735371|75918424|FG000|Overall Study|Sponsor Decision|3|||
42107677|NCT00735371|75918425|FG001|Overall Study|Sponsor Decision|1|||
42107678|NCT00735371|75918426|FG002|Overall Study|Sponsor Decision|0|||
42107679|NCT00735371|75918427|FG003|Overall Study|Sponsor Decision|1|||
42107680|NCT00735371|75918424|FG000|Overall Study|Protocol Violation|0|||
42107681|NCT00735371|75918425|FG001|Overall Study|Protocol Violation|1|||
42107682|NCT00735371|75918426|FG002|Overall Study|Protocol Violation|2|||
42107683|NCT00735371|75918427|FG003|Overall Study|Protocol Violation|0|||
42107684|NCT00735371|75918424|FG000|Overall Study|Prior Vyvanse Exposure|1|||
42107685|NCT00735371|75918425|FG001|Overall Study|Prior Vyvanse Exposure|1|||
42107686|NCT00735371|75918426|FG002|Overall Study|Prior Vyvanse Exposure|0|||
42107687|NCT00735371|75918427|FG003|Overall Study|Prior Vyvanse Exposure|0|||
42107688|NCT00735371|75918424|FG000|Overall Study|Exclusion criteria|1|||
42107689|NCT00735371|75918425|FG001|Overall Study|Exclusion criteria|0|||
42107690|NCT00735371|75918426|FG002|Overall Study|Exclusion criteria|0|||
42107691|NCT00735371|75918427|FG003|Overall Study|Exclusion criteria|0|||
42107692|NCT00518206|75918439|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
42107693|NCT00518206|75918440|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
42107694|NCT00518206|75918439|FG000|Overall Study|Withdrawal by Subject|2|||
42107695|NCT00518206|75918440|FG001|Overall Study|Withdrawal by Subject|0|||
42107696|NCT00518206|75918439|FG000|Overall Study|Drug Supply Issue|1|||
42107697|NCT00518206|75918440|FG001|Overall Study|Drug Supply Issue|0|||
42107698|NCT00518206|75918439|FG000|Overall Study|Reason Unknown|1|||
42107699|NCT00518206|75918440|FG001|Overall Study|Reason Unknown|0|||
42107700|NCT00518206|75918439|FG000|Overall Study|Completion Status Unknown|1|||
42107701|NCT00518206|75918440|FG001|Overall Study|Completion Status Unknown|0|||
42107702|NCT00586313|75918446|FG000|Overall Study|Lack of Efficacy|2|||
42107703|NCT00734747|75918450|FG000|SRS Procedure|No staples placed|3|||
42107704|NCT00734747|75918450|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
42107705|NCT00726557|75918454|FG000|Overall Study|Screening failure|4|||
42107706|NCT00726557|75918454|FG000|Overall Study|No end of treatment documentation|37|||
42107707|NCT00726557|75918454|FG000|Overall Study|No follow-up documentation available|55|||
42107708|NCT00726557|75918454|FG000|Overall Study|Treatment less than 3 months|17|||
42107709|NCT00726557|75918454|FG000|Overall Study|Inclusion criteria not met|15|||
42107710|NCT00738881|75918461|FG000|Overall Study|Withdrawal by Subject|0|||
42107711|NCT00738881|75918462|FG001|Overall Study|Withdrawal by Subject|2|||
42107712|NCT00657020|75918468|FG000|PERIOD 1|Adverse Event|0|||
42107713|NCT00657020|75918469|FG001|PERIOD 1|Adverse Event|1|||
42107714|NCT03921723|75918481|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
42107715|NCT03921723|75918481|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
42107716|NCT00544167|75918489|FG000|Overall Study|Adverse Event|21|||
42107717|NCT00544167|75918489|FG000|Overall Study|Physician Decision|8|||
42107718|NCT00659438|75918495|FG000|Overall Study|Withdrawal by Subject|2|||
42107719|NCT00659438|75918496|FG001|Overall Study|Withdrawal by Subject|2|||
42107720|NCT00659438|75918495|FG000|Overall Study|Death|11|||
42107721|NCT00659438|75918496|FG001|Overall Study|Death|6|||
42107722|NCT00659438|75918495|FG000|Overall Study|Lost to Follow-up|1|||
42107723|NCT00659438|75918496|FG001|Overall Study|Lost to Follow-up|0|||
42107724|NCT00543855|75918506|FG000|Overall Study|Adverse Event|3|||
42107725|NCT00543855|75918507|FG001|Overall Study|Adverse Event|1|||
42107726|NCT00543855|75918508|FG002|Overall Study|Adverse Event|3|||
42107727|NCT00543855|75918509|FG003|Overall Study|Adverse Event|4|||
42107728|NCT00543855|75918506|FG000|Overall Study|Lost to Follow-up|0|||
42107729|NCT00543855|75918507|FG001|Overall Study|Lost to Follow-up|0|||
42107730|NCT00543855|75918508|FG002|Overall Study|Lost to Follow-up|1|||
42107731|NCT00543855|75918509|FG003|Overall Study|Lost to Follow-up|0|||
42107732|NCT00543855|75918506|FG000|Overall Study|Withdrawal by Subject|0|||
42107733|NCT00543855|75918507|FG001|Overall Study|Withdrawal by Subject|1|||
42107734|NCT00543855|75918508|FG002|Overall Study|Withdrawal by Subject|2|||
42107735|NCT00543855|75918509|FG003|Overall Study|Withdrawal by Subject|0|||
42107736|NCT00543855|75918506|FG000|Overall Study|Protocol Violation|1|||
42107737|NCT00543855|75918507|FG001|Overall Study|Protocol Violation|0|||
42107738|NCT00543855|75918508|FG002|Overall Study|Protocol Violation|0|||
42107739|NCT00543855|75918509|FG003|Overall Study|Protocol Violation|0|||
42107740|NCT00656474|75918519|FG000|Overall Study|Other Reason|1|||
42107741|NCT00656084|75918524|FG000|Overall Study|Adverse Event|4|||
42107742|NCT00656084|75918524|FG000|Overall Study|Withdrawal by Subject|1|||
42107743|NCT00656084|75918524|FG000|Overall Study|Patient Request|1|||
42107744|NCT00656084|75918524|FG000|Overall Study|Investigator Request|1|||
42107745|NCT00613938|75918532|FG000|Overall Study|Withdrawal by Subject|2|||
42107746|NCT00613938|75918533|FG001|Overall Study|Withdrawal by Subject|4|||
42107747|NCT00613938|75918534|FG002|Overall Study|Withdrawal by Subject|9|||
42107748|NCT00613938|75918535|FG003|Overall Study|Withdrawal by Subject|9|||
42107749|NCT00613938|75918532|FG000|Overall Study|Adverse Event|1|||
42107750|NCT00613938|75918533|FG001|Overall Study|Adverse Event|4|||
42107751|NCT00613938|75918534|FG002|Overall Study|Adverse Event|8|||
42107752|NCT00613938|75918535|FG003|Overall Study|Adverse Event|5|||
42107753|NCT00613938|75918532|FG000|Overall Study|Lack of Efficacy|16|||
42107754|NCT00613938|75918533|FG001|Overall Study|Lack of Efficacy|18|||
42107755|NCT00613938|75918534|FG002|Overall Study|Lack of Efficacy|5|||
42107756|NCT00613938|75918535|FG003|Overall Study|Lack of Efficacy|9|||
42107757|NCT00613938|75918532|FG000|Overall Study|Other|1|||
42107758|NCT00613938|75918533|FG001|Overall Study|Other|2|||
42107759|NCT00613938|75918534|FG002|Overall Study|Other|1|||
42107760|NCT00613938|75918535|FG003|Overall Study|Other|3|||
42107761|NCT00655928|75918547|FG000|Overall Study|Withdrawal by Subject|2|||
42107762|NCT00655928|75918548|FG001|Overall Study|Withdrawal by Subject|1|||
42107763|NCT00655928|75918547|FG000|Overall Study|Physician Decision|1|||
42107764|NCT00655928|75918548|FG001|Overall Study|Physician Decision|1|||
42107765|NCT00655850|75918554|FG000|Overall Study|Death|2|||
42107766|NCT00655850|75918554|FG000|Overall Study|Withdrawal by Subject|1|||
42107767|NCT00726323|75918562|FG000|Overall Study|Withdrawal by Subject|3|||
42107768|NCT00726323|75918563|FG001|Overall Study|Withdrawal by Subject|1|||
42107769|NCT00726323|75918562|FG000|Overall Study|Physician Decision|1|||
42107770|NCT00726323|75918563|FG001|Overall Study|Physician Decision|0|||
42107771|NCT00726323|75918562|FG000|Overall Study|Progressive disease|23|||
42107772|NCT00726323|75918563|FG001|Overall Study|Progressive disease|16|||
42107773|NCT00726323|75918562|FG000|Overall Study|Clinical progression|0|||
42107774|NCT00726323|75918563|FG001|Overall Study|Clinical progression|3|||
42107775|NCT00726323|75918562|FG000|Overall Study|Adverse Event|9|||
42107776|NCT00726323|75918563|FG001|Overall Study|Adverse Event|9|||
42107777|NCT00726323|75918562|FG000|Overall Study|Death|1|||
42107778|NCT00726323|75918563|FG001|Overall Study|Death|0|||
42107779|NCT00726323|75918562|FG000|Overall Study|Participant wished to discontinue|0|||
42107780|NCT00726323|75918563|FG001|Overall Study|Participant wished to discontinue|1|||
42107781|NCT00726323|75918562|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
42107782|NCT00726323|75918563|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
42107783|NCT00246571|75918571|FG000|Overall Study|Adverse Event|7|||
42107784|NCT00246571|75918572|FG001|Overall Study|Adverse Event|0|||
42107785|NCT00246571|75918571|FG000|Overall Study|Protocol Violation|0|||
42107786|NCT00246571|75918572|FG001|Overall Study|Protocol Violation|1|||
42107787|NCT00246571|75918571|FG000|Overall Study|Withdrawal by Subject|2|||
42107788|NCT00246571|75918572|FG001|Overall Study|Withdrawal by Subject|3|||
42107789|NCT00246571|75918571|FG000|Overall Study|Lack of Efficacy|84|||
42107790|NCT00246571|75918572|FG001|Overall Study|Lack of Efficacy|21|||
42107791|NCT00246571|75918571|FG000|Overall Study|Death|17|||
42202430|NCT03237325|76014846|FG001|Overall Study|Noncompliance with Study Procedures|1|||
42202431|NCT03237325|76014845|FG000|Overall Study|Termination by Sponsor|0|||
42202432|NCT03237325|76014846|FG001|Overall Study|Termination by Sponsor|1|||
42107792|NCT00246571|75918572|FG001|Overall Study|Death|3|||
42107793|NCT00246571|75918571|FG000|Overall Study|Sponsor|0|||
42107794|NCT00246571|75918572|FG001|Overall Study|Sponsor|1|||
42107795|NCT00246571|75918571|FG000|Overall Study|Did not meet entrance criteria|2|||
42202433|NCT03237325|76014845|FG000|Overall Study|Reason other than described|0|||
42202434|NCT03237325|76014846|FG001|Overall Study|Reason other than described|2|||
42107796|NCT00246571|75918572|FG001|Overall Study|Did not meet entrance criteria|1|||
42107797|NCT00246571|75918571|FG000|Overall Study|Laboratory abnormalities|1|||
42107798|NCT00246571|75918572|FG001|Overall Study|Laboratory abnormalities|0|||
42107799|NCT00246571|75918571|FG000|Overall Study|Crossover participants|0|||
42202435|NCT03113383|76014852|FG000|Overall Study|Death|4|||
42107800|NCT00246571|75918572|FG001|Overall Study|Crossover participants|74|||
42107801|NCT00734591|75918580|FG000|Screening for Prospective Period|Site did not participate|1604|||
42107802|NCT00734591|75918581|FG001|Screening for Prospective Period|Site did not participate|1488|||
42107803|NCT00734591|75918580|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
42107804|NCT00734591|75918581|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
42107805|NCT00734591|75918580|FG000|Prospective Period|Withdrawal by Subject|11|||
42107806|NCT00734591|75918581|FG001|Prospective Period|Withdrawal by Subject|9|||
42107807|NCT00734591|75918580|FG000|Prospective Period|Lost to Follow-up|37|||
42107808|NCT00734591|75918581|FG001|Prospective Period|Lost to Follow-up|33|||
42107809|NCT00734591|75918580|FG000|Prospective Period|Study Terminated|1|||
42107810|NCT00734591|75918581|FG001|Prospective Period|Study Terminated|0|||
42107811|NCT00734591|75918580|FG000|Prospective Period|Other|2|||
42107812|NCT00734591|75918581|FG001|Prospective Period|Other|2|||
42107813|NCT00569270|75918587|FG000|Period: First Intervention|Protocol Violation|0|||
42107814|NCT00569270|75918588|FG001|Period: First Intervention|Protocol Violation|1|||
42107815|NCT00545103|75918607|FG000|Overall Study|Lack of Efficacy|48|||
42107816|NCT00545103|75918608|FG001|Overall Study|Lack of Efficacy|45|||
42107817|NCT00545103|75918609|FG002|Overall Study|Lack of Efficacy|31|||
42107818|NCT00545103|75918610|FG003|Overall Study|Lack of Efficacy|27|||
42107819|NCT00545103|75918607|FG000|Overall Study|Withdrawal by Subject|6|||
42107820|NCT00545103|75918608|FG001|Overall Study|Withdrawal by Subject|10|||
42107821|NCT00545103|75918609|FG002|Overall Study|Withdrawal by Subject|18|||
42107822|NCT00545103|75918610|FG003|Overall Study|Withdrawal by Subject|22|||
42107823|NCT00545103|75918607|FG000|Overall Study|Adverse Event|11|||
42107824|NCT00545103|75918608|FG001|Overall Study|Adverse Event|12|||
42107825|NCT00545103|75918609|FG002|Overall Study|Adverse Event|17|||
42107826|NCT00545103|75918610|FG003|Overall Study|Adverse Event|10|||
42107827|NCT00545103|75918607|FG000|Overall Study|Lost to Follow-up|4|||
42107828|NCT00545103|75918608|FG001|Overall Study|Lost to Follow-up|6|||
42107829|NCT00545103|75918609|FG002|Overall Study|Lost to Follow-up|3|||
42107830|NCT00545103|75918610|FG003|Overall Study|Lost to Follow-up|4|||
42107831|NCT00545103|75918607|FG000|Overall Study|Protocol Violation|1|||
42107832|NCT00545103|75918608|FG001|Overall Study|Protocol Violation|2|||
42107833|NCT00545103|75918609|FG002|Overall Study|Protocol Violation|3|||
42107834|NCT00545103|75918610|FG003|Overall Study|Protocol Violation|0|||
42107835|NCT00545103|75918607|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
42107836|NCT00545103|75918608|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
42107837|NCT00545103|75918609|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
42107838|NCT00545103|75918610|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
42107839|NCT00545103|75918607|FG000|Overall Study|Difficult to open package|0|||
42107840|NCT00545103|75918608|FG001|Overall Study|Difficult to open package|0|||
42107841|NCT00545103|75918609|FG002|Overall Study|Difficult to open package|0|||
42107842|NCT00545103|75918610|FG003|Overall Study|Difficult to open package|1|||
42107843|NCT00545103|75918607|FG000|Overall Study|Investigational product not taken|1|||
42107844|NCT00545103|75918608|FG001|Overall Study|Investigational product not taken|0|||
42107845|NCT00545103|75918609|FG002|Overall Study|Investigational product not taken|0|||
42107846|NCT00545103|75918610|FG003|Overall Study|Investigational product not taken|1|||
42107847|NCT00545103|75918607|FG000|Overall Study|Wish to start a family|0|||
42107848|NCT00545103|75918608|FG001|Overall Study|Wish to start a family|0|||
42107849|NCT00545103|75918609|FG002|Overall Study|Wish to start a family|0|||
42107850|NCT00545103|75918610|FG003|Overall Study|Wish to start a family|1|||
42107851|NCT00545103|75918607|FG000|Overall Study|Diverticulitis crisis|0|||
42107852|NCT00545103|75918608|FG001|Overall Study|Diverticulitis crisis|0|||
42107853|NCT00545103|75918609|FG002|Overall Study|Diverticulitis crisis|0|||
42107854|NCT00545103|75918610|FG003|Overall Study|Diverticulitis crisis|1|||
42107855|NCT00545103|75918607|FG000|Overall Study|Personal reasons|1|||
42107856|NCT00545103|75918608|FG001|Overall Study|Personal reasons|0|||
42107857|NCT00545103|75918609|FG002|Overall Study|Personal reasons|0|||
42107858|NCT00545103|75918610|FG003|Overall Study|Personal reasons|0|||
42107859|NCT00545103|75918607|FG000|Overall Study|Subject's decision|1|||
42107860|NCT00545103|75918608|FG001|Overall Study|Subject's decision|0|||
42107861|NCT00545103|75918609|FG002|Overall Study|Subject's decision|0|||
42107862|NCT00545103|75918610|FG003|Overall Study|Subject's decision|0|||
42107863|NCT00545103|75918607|FG000|Overall Study|Noncompliance|0|||
42107864|NCT00545103|75918608|FG001|Overall Study|Noncompliance|1|||
42107865|NCT00545103|75918609|FG002|Overall Study|Noncompliance|0|||
42107866|NCT00545103|75918610|FG003|Overall Study|Noncompliance|0|||
42107867|NCT00545103|75918607|FG000|Overall Study|Investigator decision|0|||
42107868|NCT00545103|75918608|FG001|Overall Study|Investigator decision|0|||
42107869|NCT00545103|75918609|FG002|Overall Study|Investigator decision|1|||
42107870|NCT00545103|75918610|FG003|Overall Study|Investigator decision|0|||
42107871|NCT00545103|75918607|FG000|Overall Study|Subject moved|0|||
42107872|NCT00545103|75918608|FG001|Overall Study|Subject moved|1|||
42107873|NCT00545103|75918609|FG002|Overall Study|Subject moved|0|||
42107874|NCT00545103|75918610|FG003|Overall Study|Subject moved|0|||
42107875|NCT00545103|75918607|FG000|Overall Study|Use of prohibited medication|0|||
42107876|NCT00545103|75918608|FG001|Overall Study|Use of prohibited medication|0|||
42107877|NCT00545103|75918609|FG002|Overall Study|Use of prohibited medication|1|||
42107878|NCT00545103|75918610|FG003|Overall Study|Use of prohibited medication|0|||
42107879|NCT00545103|75918607|FG000|Overall Study|Does not want to take study drug anymore|1|||
42107880|NCT00545103|75918608|FG001|Overall Study|Does not want to take study drug anymore|0|||
42107881|NCT00545103|75918609|FG002|Overall Study|Does not want to take study drug anymore|1|||
42107882|NCT00545103|75918610|FG003|Overall Study|Does not want to take study drug anymore|0|||
42107883|NCT00545103|75918607|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
42107884|NCT00545103|75918608|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
42107885|NCT00545103|75918609|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
42107886|NCT00545103|75918610|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
42107887|NCT00545103|75918607|FG000|Overall Study|Death|0|||
42107888|NCT00545103|75918608|FG001|Overall Study|Death|1|||
42107889|NCT00545103|75918609|FG002|Overall Study|Death|0|||
42107890|NCT00545103|75918610|FG003|Overall Study|Death|0|||
42107891|NCT00586157|75918620|FG000|First Intervention|Worsening behavior|1|||
42107892|NCT00586157|75918621|FG001|First Intervention|Worsening behavior|0|||
42107893|NCT00586157|75918620|FG000|Second Intervention|Withdrawal by Subject|1|||
42107894|NCT00586157|75918621|FG001|Second Intervention|Withdrawal by Subject|0|||
42107895|NCT00586157|75918620|FG000|Second Intervention|Worsening behavior|1|||
42107896|NCT00586157|75918621|FG001|Second Intervention|Worsening behavior|0|||
42107897|NCT00586157|75918620|FG000|Second Intervention|Adverse Event|0|||
42107898|NCT00586157|75918621|FG001|Second Intervention|Adverse Event|1|||
42107899|NCT00246337|75918636|FG000|Overall Study|Lost to Follow-up|3|||
42107900|NCT00246337|75918637|FG001|Overall Study|Lost to Follow-up|0|||
42107901|NCT00246337|75918638|FG002|Overall Study|Lost to Follow-up|0|||
42107902|NCT00246337|75918639|FG003|Overall Study|Lost to Follow-up|0|||
42107903|NCT00246337|75918640|FG004|Overall Study|Lost to Follow-up|2|||
42107904|NCT00246337|75918641|FG005|Overall Study|Lost to Follow-up|2|||
42107905|NCT00246337|75918642|FG006|Overall Study|Lost to Follow-up|1|||
42107906|NCT00246337|75918643|FG007|Overall Study|Lost to Follow-up|2|||
42107907|NCT00246337|75918644|FG008|Overall Study|Lost to Follow-up|0|||
42107908|NCT00246337|75918636|FG000|Overall Study|Protocol Violation|1|||
42107909|NCT00246337|75918637|FG001|Overall Study|Protocol Violation|0|||
42107910|NCT00246337|75918638|FG002|Overall Study|Protocol Violation|0|||
42107911|NCT00246337|75918639|FG003|Overall Study|Protocol Violation|0|||
42107912|NCT00246337|75918640|FG004|Overall Study|Protocol Violation|1|||
42107913|NCT00246337|75918641|FG005|Overall Study|Protocol Violation|0|||
42107914|NCT00246337|75918642|FG006|Overall Study|Protocol Violation|1|||
42107915|NCT00246337|75918643|FG007|Overall Study|Protocol Violation|1|||
42107916|NCT00246337|75918644|FG008|Overall Study|Protocol Violation|0|||
42107917|NCT00246337|75918636|FG000|Overall Study|Withdrawal by Subject|2|||
42107918|NCT00246337|75918637|FG001|Overall Study|Withdrawal by Subject|0|||
42107919|NCT00246337|75918638|FG002|Overall Study|Withdrawal by Subject|0|||
42107920|NCT00246337|75918639|FG003|Overall Study|Withdrawal by Subject|0|||
42107921|NCT00246337|75918640|FG004|Overall Study|Withdrawal by Subject|0|||
42107922|NCT00246337|75918641|FG005|Overall Study|Withdrawal by Subject|0|||
42107923|NCT00246337|75918642|FG006|Overall Study|Withdrawal by Subject|1|||
42107924|NCT00246337|75918643|FG007|Overall Study|Withdrawal by Subject|1|||
42107925|NCT00246337|75918644|FG008|Overall Study|Withdrawal by Subject|0|||
42107926|NCT00246337|75918636|FG000|Overall Study|Lack of Qualifying Event|8|||
42107927|NCT00246337|75918637|FG001|Overall Study|Lack of Qualifying Event|2|||
42107928|NCT00246337|75918638|FG002|Overall Study|Lack of Qualifying Event|1|||
42107929|NCT00246337|75918639|FG003|Overall Study|Lack of Qualifying Event|1|||
42107930|NCT00246337|75918640|FG004|Overall Study|Lack of Qualifying Event|1|||
42107931|NCT00246337|75918641|FG005|Overall Study|Lack of Qualifying Event|3|||
42107932|NCT00246337|75918642|FG006|Overall Study|Lack of Qualifying Event|3|||
42107933|NCT00246337|75918643|FG007|Overall Study|Lack of Qualifying Event|2|||
42107934|NCT00246337|75918644|FG008|Overall Study|Lack of Qualifying Event|5|||
42107935|NCT00246337|75918636|FG000|Overall Study|Site Terminated|10|||
42107936|NCT00246337|75918637|FG001|Overall Study|Site Terminated|0|||
42107937|NCT00246337|75918638|FG002|Overall Study|Site Terminated|0|||
42107938|NCT00246337|75918639|FG003|Overall Study|Site Terminated|0|||
42107939|NCT00246337|75918640|FG004|Overall Study|Site Terminated|0|||
42107940|NCT00246337|75918641|FG005|Overall Study|Site Terminated|7|||
42107941|NCT00246337|75918642|FG006|Overall Study|Site Terminated|1|||
42107942|NCT00246337|75918643|FG007|Overall Study|Site Terminated|6|||
42107943|NCT00246337|75918644|FG008|Overall Study|Site Terminated|2|||
42107944|NCT00246337|75918636|FG000|Overall Study|Abnormal baseline lab values|7|||
42107945|NCT00246337|75918637|FG001|Overall Study|Abnormal baseline lab values|0|||
42107946|NCT00246337|75918638|FG002|Overall Study|Abnormal baseline lab values|2|||
42107947|NCT00246337|75918639|FG003|Overall Study|Abnormal baseline lab values|0|||
42107948|NCT00246337|75918640|FG004|Overall Study|Abnormal baseline lab values|0|||
42107949|NCT00246337|75918641|FG005|Overall Study|Abnormal baseline lab values|2|||
42107950|NCT00246337|75918642|FG006|Overall Study|Abnormal baseline lab values|2|||
42107951|NCT00246337|75918643|FG007|Overall Study|Abnormal baseline lab values|0|||
42107952|NCT00246337|75918644|FG008|Overall Study|Abnormal baseline lab values|4|||
42107953|NCT00246337|75918636|FG000|Overall Study|Overwhelmed|0|||
42107954|NCT00246337|75918637|FG001|Overall Study|Overwhelmed|0|||
42107955|NCT00246337|75918638|FG002|Overall Study|Overwhelmed|0|||
42107956|NCT00246337|75918639|FG003|Overall Study|Overwhelmed|0|||
42107957|NCT00246337|75918640|FG004|Overall Study|Overwhelmed|0|||
42107958|NCT00246337|75918641|FG005|Overall Study|Overwhelmed|1|||
42107959|NCT00246337|75918642|FG006|Overall Study|Overwhelmed|0|||
42107960|NCT00246337|75918643|FG007|Overall Study|Overwhelmed|0|||
42107961|NCT00246337|75918644|FG008|Overall Study|Overwhelmed|0|||
42107962|NCT00246337|75918636|FG000|Overall Study|Protocol Violator|1|||
42107963|NCT00246337|75918637|FG001|Overall Study|Protocol Violator|0|||
42107964|NCT00246337|75918638|FG002|Overall Study|Protocol Violator|0|||
42107965|NCT00246337|75918639|FG003|Overall Study|Protocol Violator|0|||
42107966|NCT00246337|75918640|FG004|Overall Study|Protocol Violator|0|||
42107967|NCT00246337|75918641|FG005|Overall Study|Protocol Violator|0|||
42107968|NCT00246337|75918642|FG006|Overall Study|Protocol Violator|0|||
42107969|NCT00246337|75918643|FG007|Overall Study|Protocol Violator|0|||
42107970|NCT00246337|75918644|FG008|Overall Study|Protocol Violator|0|||
42107971|NCT00246337|75918636|FG000|Overall Study|Reported as completing trial in error|0|||
42107972|NCT00246337|75918637|FG001|Overall Study|Reported as completing trial in error|0|||
42107973|NCT00246337|75918638|FG002|Overall Study|Reported as completing trial in error|0|||
42107974|NCT00246337|75918639|FG003|Overall Study|Reported as completing trial in error|0|||
42107975|NCT00246337|75918640|FG004|Overall Study|Reported as completing trial in error|0|||
42107976|NCT00246337|75918641|FG005|Overall Study|Reported as completing trial in error|0|||
42107977|NCT00246337|75918642|FG006|Overall Study|Reported as completing trial in error|0|||
42107978|NCT00246337|75918643|FG007|Overall Study|Reported as completing trial in error|1|||
42107979|NCT00246337|75918644|FG008|Overall Study|Reported as completing trial in error|0|||
42107980|NCT00243919|75918667|FG000|Overall Study|Death|3|||
42107981|NCT00243919|75918668|FG001|Overall Study|Death|4|||
42107982|NCT00243919|75918669|FG002|Overall Study|Death|6|||
42107983|NCT00243919|75918667|FG000|Overall Study|Withdrawal by Subject|6|||
42107984|NCT00243919|75918668|FG001|Overall Study|Withdrawal by Subject|6|||
42107985|NCT00243919|75918669|FG002|Overall Study|Withdrawal by Subject|2|||
42107986|NCT00243919|75918667|FG000|Overall Study|Lost to Follow-up|6|||
42107987|NCT00243919|75918668|FG001|Overall Study|Lost to Follow-up|7|||
42107988|NCT00243919|75918669|FG002|Overall Study|Lost to Follow-up|3|||
42107989|NCT00243919|75918667|FG000|Overall Study|Administrative Error|1|||
42107990|NCT00243919|75918668|FG001|Overall Study|Administrative Error|0|||
42107991|NCT00243919|75918669|FG002|Overall Study|Administrative Error|0|||
42107992|NCT00243919|75918667|FG000|Overall Study|Physician Decision|1|||
42107993|NCT00243919|75918668|FG001|Overall Study|Physician Decision|1|||
42107994|NCT00243919|75918669|FG002|Overall Study|Physician Decision|0|||
42107995|NCT00725621|75918677|FG000|Overall Study|Adverse Event|25|||
42107996|NCT00725621|75918677|FG000|Overall Study|Lack of Efficacy|46|||
42107997|NCT00725621|75918677|FG000|Overall Study|Withdrawal by Subject|57|||
42107998|NCT00725621|75918677|FG000|Overall Study|Physician Decision|19|||
42107999|NCT00725621|75918677|FG000|Overall Study|Lost to Follow-up|52|||
42108000|NCT00725621|75918677|FG000|Overall Study|Non-compliance|8|||
42108001|NCT00725621|75918677|FG000|Overall Study|Continued treatment by other physician|6|||
42108002|NCT00725621|75918677|FG000|Overall Study|Switched to other study|1|||
42108003|NCT00725621|75918677|FG000|Overall Study|Switched to other drug|1|||
42108004|NCT00725621|75918677|FG000|Overall Study|Prepared for elective surgery|1|||
42108005|NCT00725621|75918677|FG000|Overall Study|Reason not specified|55|||
42108006|NCT00613626|75918688|FG000|Overall Study|Ineligible|0|||
42108007|NCT00613626|75918689|FG001|Overall Study|Ineligible|1|||
42108008|NCT00613626|75918690|FG002|Overall Study|Ineligible|0|||
42108009|NCT00725543|75918697|FG000|Overall Study|Adverse Event|10|||
42108010|NCT00725543|75918697|FG000|Overall Study|Lack of Efficacy|3|||
42108011|NCT00725543|75918697|FG000|Overall Study|Withdrawal by Subject|10|||
42108012|NCT00725543|75918697|FG000|Overall Study|Physician Decision|5|||
42108013|NCT00725543|75918697|FG000|Overall Study|Lost to Follow-up|4|||
42108014|NCT00725543|75918697|FG000|Overall Study|Non-compliance|2|||
42108015|NCT00725543|75918697|FG000|Overall Study|Other|119|||
42108016|NCT00239005|75918703|FG000|Overall Study|Adverse Event|6|||
42108017|NCT00239005|75918704|FG001|Overall Study|Adverse Event|6|||
42108018|NCT00239005|75918703|FG000|Overall Study|Withdrawal by Subject|3|||
42108019|NCT00239005|75918704|FG001|Overall Study|Withdrawal by Subject|4|||
42108020|NCT00239005|75918703|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
42108021|NCT00239005|75918704|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
42108022|NCT00239005|75918703|FG000|Overall Study|Protocol Violation|1|||
42202436|NCT03113383|76014853|FG001|Overall Study|Death|0|||
42108023|NCT00239005|75918704|FG001|Overall Study|Protocol Violation|0|||
42202437|NCT03131960|76014874|FG000|Overall Study|Adverse Event|0|||
42108024|NCT00239005|75918703|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
42108025|NCT00239005|75918704|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
42108026|NCT00239005|75918703|FG000|Overall Study|Lost to Follow-up|0|||
42108027|NCT00239005|75918704|FG001|Overall Study|Lost to Follow-up|1|||
42108028|NCT00616434|75918712|FG000|Overall Study|Adverse Event|5|||
42108029|NCT00616434|75918713|FG001|Overall Study|Adverse Event|2|||
42108030|NCT00616434|75918712|FG000|Overall Study|Physician Decision|0|||
42108031|NCT00616434|75918713|FG001|Overall Study|Physician Decision|4|||
42108032|NCT00616434|75918712|FG000|Overall Study|Withdrawal by Subject|1|||
42108033|NCT00616434|75918713|FG001|Overall Study|Withdrawal by Subject|1|||
42108034|NCT00616434|75918712|FG000|Overall Study|Protocol deviation|0|||
42108035|NCT00616434|75918713|FG001|Overall Study|Protocol deviation|1|||
42108036|NCT00652340|75918721|FG000|Overall Study|Had not progressed.|4|||
42108037|NCT00652340|75918722|FG001|Overall Study|Had not progressed.|3|||
42108038|NCT00613314|75918728|FG000|Overall Study|Adverse Event|5|||
42108039|NCT00613314|75918728|FG000|Overall Study|Protocol Violation|14|||
42108040|NCT00613314|75918728|FG000|Overall Study|Lost to Follow-up|46|||
42108041|NCT00613314|75918728|FG000|Overall Study|Other reason not defined above|90|||
42108042|NCT00257725|75918732|FG000|Overall Study|Adverse Event|3|||
42108043|NCT00544869|75918740|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
42108044|NCT00544869|75918741|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
42108045|NCT00544869|75918742|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
42108046|NCT00544869|75918740|FG000|Overall Study|Adverse Event|6|||
42108047|NCT00544869|75918741|FG001|Overall Study|Adverse Event|1|||
42108048|NCT00544869|75918742|FG002|Overall Study|Adverse Event|0|||
42108049|NCT00544869|75918740|FG000|Overall Study|Lack of Efficacy|1|||
42108050|NCT00544869|75918741|FG001|Overall Study|Lack of Efficacy|1|||
42108051|NCT00544869|75918742|FG002|Overall Study|Lack of Efficacy|0|||
42108052|NCT00544869|75918740|FG000|Overall Study|Physician Decision|2|||
42108053|NCT00544869|75918741|FG001|Overall Study|Physician Decision|0|||
42108054|NCT00544869|75918742|FG002|Overall Study|Physician Decision|0|||
42108055|NCT00725075|75918753|FG000|Overall Study|Use of Excluded Medication|0|||
42108056|NCT00725075|75918754|FG001|Overall Study|Use of Excluded Medication|1|||
42108057|NCT00725075|75918755|FG002|Overall Study|Use of Excluded Medication|0|||
42108058|NCT00725075|75918753|FG000|Overall Study|Protocol Violation|0|||
42108059|NCT00725075|75918754|FG001|Overall Study|Protocol Violation|0|||
42108060|NCT00725075|75918755|FG002|Overall Study|Protocol Violation|1|||
42108061|NCT00725075|75918753|FG000|Overall Study|Lost to Follow-up|1|||
42108062|NCT00725075|75918754|FG001|Overall Study|Lost to Follow-up|0|||
42108063|NCT00725075|75918755|FG002|Overall Study|Lost to Follow-up|0|||
42108064|NCT00725075|75918753|FG000|Overall Study|Withdrawal by Subject|4|||
42108065|NCT00725075|75918754|FG001|Overall Study|Withdrawal by Subject|5|||
42108066|NCT00725075|75918755|FG002|Overall Study|Withdrawal by Subject|4|||
42108067|NCT00725075|75918753|FG000|Overall Study|Adverse Event|2|||
42108068|NCT00725075|75918754|FG001|Overall Study|Adverse Event|1|||
42108069|NCT00725075|75918755|FG002|Overall Study|Adverse Event|1|||
42108070|NCT00725075|75918753|FG000|Overall Study|Worsening of Disease|2|||
42108071|NCT00725075|75918754|FG001|Overall Study|Worsening of Disease|1|||
42108072|NCT00725075|75918755|FG002|Overall Study|Worsening of Disease|2|||
42202438|NCT03131960|76014875|FG001|Overall Study|Adverse Event|1|||
42202439|NCT03225170|76014884|FG000|Overall Study|Lost to Follow-up|4|||
42202440|NCT03225170|76014885|FG001|Overall Study|Lost to Follow-up|4|||
42202441|NCT03225170|76014886|FG002|Overall Study|Lost to Follow-up|0|||
42202442|NCT03225170|76014884|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
42202443|NCT03225170|76014885|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
42108073|NCT00725075|75918753|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
42108074|NCT00725075|75918754|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
42108075|NCT00725075|75918755|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
42108076|NCT00725075|75918753|FG000|Overall Study|Other|1|||
42108077|NCT00725075|75918754|FG001|Overall Study|Other|0|||
42108078|NCT00725075|75918755|FG002|Overall Study|Other|0|||
42108079|NCT00733499|75918765|FG000|Pre-operative|Protocol Violation|0|||
42108080|NCT00733499|75918766|FG001|Pre-operative|Protocol Violation|1|||
42108081|NCT00733499|75918765|FG000|3 Months Follow-up|Death|1|||
42108082|NCT00733499|75918766|FG001|3 Months Follow-up|Death|2|||
42108083|NCT00733499|75918765|FG000|6 Months Follow-up|Death|0|||
42108084|NCT00733499|75918766|FG001|6 Months Follow-up|Death|2|||
42108085|NCT00733499|75918765|FG000|6 Months Follow-up|Adverse Event|0|||
42108086|NCT00733499|75918766|FG001|6 Months Follow-up|Adverse Event|1|||
42108087|NCT00733499|75918765|FG000|12 Months Follow-up|Death|2|||
42108088|NCT00733499|75918766|FG001|12 Months Follow-up|Death|1|||
42108089|NCT00733499|75918765|FG000|24 Months Follow-up|Death|0|||
42108090|NCT00733499|75918766|FG001|24 Months Follow-up|Death|1|||
42108091|NCT00733499|75918765|FG000|5 Year Followup|Adverse Event|2|||
42108092|NCT00733499|75918766|FG001|5 Year Followup|Adverse Event|2|||
42108093|NCT00733499|75918765|FG000|5 Year Followup|Non device related AE|0|||
42108094|NCT00733499|75918766|FG001|5 Year Followup|Non device related AE|1|||
42108095|NCT00733499|75918765|FG000|5 Year Followup|Revision of Study Implant|0|||
42202444|NCT03225170|76014886|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
42108096|NCT00733499|75918766|FG001|5 Year Followup|Revision of Study Implant|1|||
42108097|NCT00733499|75918765|FG000|5 Year Followup|Lost to Follow-up|2|||
42108098|NCT00733499|75918766|FG001|5 Year Followup|Lost to Follow-up|0|||
42108099|NCT00733499|75918765|FG000|5 Year Followup|Death|13|||
42108100|NCT00733499|75918766|FG001|5 Year Followup|Death|19|||
42202445|NCT02115139|76014892|FG000|Overall Study|Protocol Violation|1|||
42202446|NCT02115139|76014892|FG000|Overall Study|treatment discontinuation|6|||
42202447|NCT01763827|76014940|FG000|Overall Study|Withdrawal by Subject|1|||
42202448|NCT01763827|76014941|FG001|Overall Study|Withdrawal by Subject|0|||
42202449|NCT01763827|76014942|FG002|Overall Study|Withdrawal by Subject|0|||
42202450|NCT01763827|76014943|FG003|Overall Study|Withdrawal by Subject|0|||
42202451|NCT01763827|76014944|FG004|Overall Study|Withdrawal by Subject|2|||
42202452|NCT01763827|76014945|FG005|Overall Study|Withdrawal by Subject|0|||
42202453|NCT01763827|76014940|FG000|Overall Study|Decision by sponsor|2|||
42202454|NCT01763827|76014941|FG001|Overall Study|Decision by sponsor|0|||
42202455|NCT01763827|76014942|FG002|Overall Study|Decision by sponsor|3|||
42202456|NCT01763827|76014943|FG003|Overall Study|Decision by sponsor|0|||
42202457|NCT01763827|76014944|FG004|Overall Study|Decision by sponsor|2|||
42202458|NCT01763827|76014945|FG005|Overall Study|Decision by sponsor|1|||
42202459|NCT01763827|76014940|FG000|Overall Study|Lost to Follow-up|0|||
42202460|NCT01763827|76014941|FG001|Overall Study|Lost to Follow-up|1|||
42202461|NCT01763827|76014942|FG002|Overall Study|Lost to Follow-up|1|||
42202462|NCT01763827|76014943|FG003|Overall Study|Lost to Follow-up|1|||
42202463|NCT01763827|76014944|FG004|Overall Study|Lost to Follow-up|2|||
42202464|NCT01763827|76014945|FG005|Overall Study|Lost to Follow-up|1|||
42202465|NCT01732783|76014998|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
42202466|NCT01732783|76014999|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
42202467|NCT01732783|76015000|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
42202468|NCT01732783|76014998|FG000|Overall Study|Death|13|||
42202469|NCT01732783|76014999|FG001|Overall Study|Death|4|||
42202470|NCT01732783|76015000|FG002|Overall Study|Death|1|||
42202471|NCT01732783|76014998|FG000|Overall Study|Lost to Follow-up|7|||
42202472|NCT01732783|76014999|FG001|Overall Study|Lost to Follow-up|1|||
42202473|NCT01732783|76015000|FG002|Overall Study|Lost to Follow-up|1|||
42202474|NCT01732783|76014998|FG000|Overall Study|Administrative Decision|8|||
42202475|NCT01732783|76014999|FG001|Overall Study|Administrative Decision|2|||
42202476|NCT01732783|76015000|FG002|Overall Study|Administrative Decision|1|||
42202477|NCT01732783|76014998|FG000|Overall Study|Withdrawal by Subject|1|||
42202478|NCT01732783|76014999|FG001|Overall Study|Withdrawal by Subject|0|||
42202479|NCT01732783|76015000|FG002|Overall Study|Withdrawal by Subject|0|||
42202480|NCT02787850|76015027|FG000|Overall Study|Withdrawal by Subject|0|||
42202481|NCT02787850|76015028|FG001|Overall Study|Withdrawal by Subject|1|||
42202482|NCT01375777|76015052|FG000|Overall Study|Withdrawal by Subject|0|||
42202483|NCT01375777|76015053|FG001|Overall Study|Withdrawal by Subject|2|||
42202484|NCT01375777|76015054|FG002|Overall Study|Withdrawal by Subject|1|||
42202485|NCT01375777|76015055|FG003|Overall Study|Withdrawal by Subject|0|||
42202486|NCT01375777|76015056|FG004|Overall Study|Withdrawal by Subject|1|||
42202487|NCT01375777|76015057|FG005|Overall Study|Withdrawal by Subject|1|||
42202488|NCT01375777|76015058|FG006|Overall Study|Withdrawal by Subject|1|||
42202489|NCT01375777|76015059|FG007|Overall Study|Withdrawal by Subject|2|||
42108101|NCT00733499|75918765|FG000|5 Year Followup|missing, unable to locate|0|||
42108102|NCT00733499|75918766|FG001|5 Year Followup|missing, unable to locate|1|||
42108103|NCT00733499|75918765|FG000|5 Year Followup|Withdrawal by Subject|4|||
42108104|NCT00733499|75918766|FG001|5 Year Followup|Withdrawal by Subject|1|||
42108105|NCT00733499|75918765|FG000|10 Year Followup|Death|9|||
42108106|NCT00733499|75918766|FG001|10 Year Followup|Death|7|||
42108107|NCT00733499|75918765|FG000|10 Year Followup|Adverse Event|3|||
42108108|NCT00733499|75918766|FG001|10 Year Followup|Adverse Event|3|||
42108109|NCT00733499|75918765|FG000|10 Year Followup|Lost to Follow-up|3|||
42108110|NCT00733499|75918766|FG001|10 Year Followup|Lost to Follow-up|2|||
42108111|NCT00733499|75918765|FG000|10 Year Followup|Withdrawal by Subject|5|||
42108112|NCT00733499|75918766|FG001|10 Year Followup|Withdrawal by Subject|5|||
42108113|NCT00733499|75918765|FG000|10 Year Followup|missing, unable to locate|0|||
42108114|NCT00733499|75918766|FG001|10 Year Followup|missing, unable to locate|2|||
42108115|NCT00652028|75918776|FG000|Overall Study|Adverse Event|1|||
42108116|NCT00652028|75918777|FG001|Overall Study|Adverse Event|0|||
42108117|NCT00652028|75918778|FG002|Overall Study|Adverse Event|0|||
42108118|NCT00652028|75918779|FG003|Overall Study|Adverse Event|0|||
42202490|NCT01375777|76015060|FG008|Overall Study|Withdrawal by Subject|1|||
42202491|NCT01375777|76015052|FG000|Overall Study|Lost to Follow-up|1|||
42202492|NCT01375777|76015053|FG001|Overall Study|Lost to Follow-up|0|||
42202493|NCT01375777|76015054|FG002|Overall Study|Lost to Follow-up|0|||
42202494|NCT01375777|76015055|FG003|Overall Study|Lost to Follow-up|0|||
42202495|NCT01375777|76015056|FG004|Overall Study|Lost to Follow-up|0|||
42108119|NCT00652028|75918776|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
42108120|NCT00652028|75918777|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
42108121|NCT00652028|75918778|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
42108122|NCT00652028|75918779|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
42202496|NCT01375777|76015057|FG005|Overall Study|Lost to Follow-up|0|||
42202497|NCT01375777|76015058|FG006|Overall Study|Lost to Follow-up|1|||
42202498|NCT01375777|76015059|FG007|Overall Study|Lost to Follow-up|0|||
42202499|NCT01375777|76015060|FG008|Overall Study|Lost to Follow-up|0|||
42202500|NCT01375777|76015052|FG000|Overall Study|Other|1|||
42202501|NCT01375777|76015053|FG001|Overall Study|Other|1|||
42202502|NCT01375777|76015054|FG002|Overall Study|Other|0|||
42202503|NCT01375777|76015055|FG003|Overall Study|Other|0|||
42202504|NCT01375777|76015056|FG004|Overall Study|Other|0|||
42202505|NCT01375777|76015057|FG005|Overall Study|Other|0|||
42202506|NCT01375777|76015058|FG006|Overall Study|Other|0|||
42202507|NCT01375777|76015059|FG007|Overall Study|Other|0|||
42202508|NCT01375777|76015060|FG008|Overall Study|Other|1|||
42202509|NCT02431702|76015080|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
42202510|NCT02431702|76015081|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
42202511|NCT02431702|76015082|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
42202512|NCT02431702|76015083|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
42202513|NCT02431702|76015084|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
42202514|NCT02431702|76015085|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
42202515|NCT02431702|76015086|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
42202516|NCT02431702|76015080|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
42202517|NCT02431702|76015081|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
42202518|NCT02431702|76015082|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
42202519|NCT02431702|76015083|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
42202520|NCT02431702|76015084|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
42202521|NCT02431702|76015085|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
42202522|NCT02431702|76015086|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
42202523|NCT02431702|76015080|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
42202524|NCT02431702|76015081|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
42202525|NCT02431702|76015082|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
42202526|NCT02431702|76015083|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
42202527|NCT02431702|76015084|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
42202528|NCT02431702|76015085|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
42202529|NCT02431702|76015086|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
42202530|NCT02431702|76015080|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
42202531|NCT02431702|76015081|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
42202532|NCT02431702|76015082|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
42202533|NCT02431702|76015083|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
42202534|NCT02431702|76015084|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
42202535|NCT02431702|76015085|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
42202536|NCT02431702|76015086|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
42202537|NCT02431702|76015080|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
42202538|NCT02431702|76015081|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
42202539|NCT02431702|76015082|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
42202540|NCT02431702|76015083|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
42202541|NCT02431702|76015084|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
42202542|NCT02431702|76015085|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
42202543|NCT02431702|76015086|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
42202544|NCT02431702|76015080|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
42202545|NCT02431702|76015081|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
42202546|NCT02431702|76015082|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
42202547|NCT02431702|76015083|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
42202548|NCT02431702|76015084|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
42202549|NCT02431702|76015085|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
42202550|NCT02431702|76015086|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
42202551|NCT02431702|76015080|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
42202552|NCT02431702|76015081|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
42202553|NCT02431702|76015082|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
42202554|NCT02431702|76015083|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
42202555|NCT02431702|76015084|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
42202556|NCT02431702|76015085|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
42202557|NCT02431702|76015086|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
42202558|NCT02431702|76015080|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
42202559|NCT02431702|76015081|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
42202560|NCT02431702|76015082|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
42202561|NCT02431702|76015083|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
42202562|NCT02431702|76015084|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
42202563|NCT02431702|76015085|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
42202564|NCT02431702|76015086|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
42202565|NCT02431702|76015080|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
42202566|NCT02431702|76015081|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
42202567|NCT02431702|76015082|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
42202568|NCT02431702|76015083|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
42202569|NCT02431702|76015084|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
42202570|NCT02431702|76015085|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
42202571|NCT02431702|76015086|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
42202572|NCT02431702|76015080|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
42202573|NCT02431702|76015081|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
42202574|NCT02431702|76015082|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
42202575|NCT02431702|76015083|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
42202576|NCT02431702|76015084|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
42202577|NCT02431702|76015085|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
42202578|NCT02431702|76015086|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
42202579|NCT02431702|76015080|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
42202580|NCT02431702|76015081|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
42202581|NCT02431702|76015082|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
42202582|NCT02431702|76015083|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
42202583|NCT02431702|76015084|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
42202584|NCT02431702|76015085|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
42202585|NCT02431702|76015086|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
42202586|NCT02431702|76015080|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
42202587|NCT02431702|76015081|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
42202588|NCT02431702|76015082|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
42202589|NCT02431702|76015083|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
42202590|NCT02431702|76015084|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
42202591|NCT02431702|76015085|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
42202592|NCT02431702|76015086|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
42202593|NCT02431702|76015080|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
42202594|NCT02431702|76015081|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
42202595|NCT02431702|76015082|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
42202596|NCT02431702|76015083|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
42202597|NCT02431702|76015084|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
42202598|NCT02431702|76015085|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
42202599|NCT02431702|76015086|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
42202600|NCT02431702|76015080|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
42202601|NCT02431702|76015081|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
42202602|NCT02431702|76015082|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
42202603|NCT02431702|76015083|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
42202604|NCT02431702|76015084|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
42202605|NCT02431702|76015085|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
42202606|NCT02431702|76015086|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
42202607|NCT02431702|76015080|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
42202608|NCT02431702|76015081|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
42202609|NCT02431702|76015082|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
42202610|NCT02431702|76015083|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
42202611|NCT02431702|76015084|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
42202612|NCT02431702|76015085|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
42108123|NCT00652028|75918776|FG000|Overall Study|Physician Decision|0|||
42108124|NCT00652028|75918777|FG001|Overall Study|Physician Decision|0|||
42108125|NCT00652028|75918778|FG002|Overall Study|Physician Decision|1|||
42108126|NCT00652028|75918779|FG003|Overall Study|Physician Decision|0|||
42108127|NCT00738101|75918789|FG000|Overall Study|Physician Decision|5|||
42108128|NCT00738101|75918789|FG000|Overall Study|Death|1|||
42108129|NCT00738101|75918789|FG000|Overall Study|Repeat enrollment|1|||
42108130|NCT00733421|75918795|FG000|Overall Study|Withdrawal by Subject|1|||
42108131|NCT00733421|75918796|FG001|Overall Study|Withdrawal by Subject|1|||
42108132|NCT00613080|75918802|FG000|Overall Study|Ineligible / no protocol treatment|11|||
42108133|NCT00732875|75918806|FG000|Overall Study|Adverse Event|16|||
42108134|NCT00732875|75918806|FG000|Overall Study|Withdrawal by Subject|6|||
42108135|NCT00732875|75918806|FG000|Overall Study|Lack of Efficacy|13|||
42202613|NCT02431702|76015086|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
42202614|NCT02086552|76015102|FG000|Overall Study|Withdrawal by Subject|1|||
42202615|NCT03131570|76015147|FG000|Overall Study|Adverse Event|1|||
42202616|NCT03131570|76015148|FG001|Overall Study|Adverse Event|0|||
42202617|NCT02930018|76015158|FG000|Overall Study|Lost to Follow-up|1|||
42202618|NCT02930018|76015159|FG001|Overall Study|Lost to Follow-up|1|||
42202619|NCT02930018|76015158|FG000|Overall Study|Withdrawal by Subject|5|||
42202620|NCT02930018|76015159|FG001|Overall Study|Withdrawal by Subject|2|||
42202621|NCT02875028|76015167|FG000|Washout Period|Withdrawal by Subject|0|||
42202622|NCT02875028|76015168|FG001|Washout Period|Withdrawal by Subject|1|||
42202623|NCT00943618|76015179|FG000|Overall Study|Lost to Follow-up|38|||
42202624|NCT00943618|76015180|FG001|Overall Study|Lost to Follow-up|48|||
42202625|NCT00943618|76015181|FG002|Overall Study|Lost to Follow-up|20|||
42202626|NCT00943618|76015179|FG000|Overall Study|Discontinued Medication|17|||
42202627|NCT00943618|76015180|FG001|Overall Study|Discontinued Medication|29|||
42202628|NCT00943618|76015181|FG002|Overall Study|Discontinued Medication|11|||
42202629|NCT02710084|76015191|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
42202630|NCT02710084|76015192|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
42202631|NCT02849990|76015199|FG000|Overall Study|Adverse Event|1|||
42202632|NCT02849990|76015199|FG000|Overall Study|Withdrawal by Subject|1|||
42202633|NCT02017964|76015203|FG000|Overall Study|Patient deemed ineligible|1|||
42202634|NCT01956110|76015209|FG000|Overall Study|Protocol Violation|25|||
42202635|NCT01956110|76015210|FG001|Overall Study|Protocol Violation|11|||
42202636|NCT01956110|76015209|FG000|Overall Study|Adverse Event|9|||
42202637|NCT01956110|76015210|FG001|Overall Study|Adverse Event|10|||
42202638|NCT01956110|76015209|FG000|Overall Study|Personal reasons|1|||
42202639|NCT01956110|76015210|FG001|Overall Study|Personal reasons|1|||
42202640|NCT03116828|76015241|FG000|Overall Study|Adverse Event|1|||
42202641|NCT03116828|76015242|FG001|Overall Study|Adverse Event|10|||
42202642|NCT03116828|76015241|FG000|Overall Study|Withdrawal by Subject|4|||
42202643|NCT03116828|76015242|FG001|Overall Study|Withdrawal by Subject|8|||
42202644|NCT03116828|76015241|FG000|Overall Study|OTHER|3|||
42202645|NCT03116828|76015242|FG001|Overall Study|OTHER|3|||
42202646|NCT03938272|76015250|FG000|Overall Study|Withdrawal by Subject|1|||
42202647|NCT03938272|76015251|FG001|Overall Study|Withdrawal by Subject|0|||
42202648|NCT03938272|76015250|FG000|Overall Study|Physician Decision|0|||
42202649|NCT03938272|76015251|FG001|Overall Study|Physician Decision|2|||
42202650|NCT03938272|76015250|FG000|Overall Study|Study termination by sponsor|10|||
42202651|NCT03938272|76015251|FG001|Overall Study|Study termination by sponsor|8|||
42202652|NCT03126344|76015269|FG000|Overall Study|Lost to Follow-up|0|||
42202653|NCT03126344|76015270|FG001|Overall Study|Lost to Follow-up|0|||
42202654|NCT03126344|76015271|FG002|Overall Study|Lost to Follow-up|5|||
42202655|NCT03115112|76015292|FG000|Overall Study|Adverse Event|5|||
42202656|NCT03115112|76015293|FG001|Overall Study|Adverse Event|1|||
42202657|NCT03115112|76015292|FG000|Overall Study|Withdrawal by Subject|4|||
42202658|NCT03115112|76015293|FG001|Overall Study|Withdrawal by Subject|2|||
42202659|NCT03115112|76015292|FG000|Overall Study|Lost to Follow-up|0|||
42202660|NCT03115112|76015293|FG001|Overall Study|Lost to Follow-up|1|||
42202661|NCT03115112|76015292|FG000|Overall Study|Death|1|||
42202662|NCT03115112|76015293|FG001|Overall Study|Death|0|||
42202663|NCT03115112|76015292|FG000|Overall Study|Pregnancy|1|||
42202664|NCT03115112|76015293|FG001|Overall Study|Pregnancy|0|||
42202665|NCT03115112|76015292|FG000|Overall Study|Site closure|1|||
42202666|NCT03115112|76015293|FG001|Overall Study|Site closure|1|||
42202667|NCT03556358|76015312|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
42202668|NCT03556358|76015313|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
42202669|NCT03556358|76015312|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
42202670|NCT03556358|76015313|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
42202671|NCT03556358|76015312|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
42202672|NCT03556358|76015313|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
42202673|NCT03556358|76015312|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
42202674|NCT03556358|76015313|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
42202675|NCT03556358|76015312|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
42202676|NCT03556358|76015313|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
42202677|NCT03556358|76015312|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
42202678|NCT03556358|76015313|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
42202679|NCT03556358|76015312|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
42202680|NCT03556358|76015313|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
42202681|NCT03118934|76015340|FG000|Overall Study|Adverse Event|0|||
42202682|NCT03118934|76015341|FG001|Overall Study|Adverse Event|0|||
42202683|NCT03118934|76015342|FG002|Overall Study|Adverse Event|0|||
42202684|NCT03118934|76015343|FG003|Overall Study|Adverse Event|0|||
42202685|NCT03118934|76015344|FG004|Overall Study|Adverse Event|0|||
42202686|NCT03118934|76015345|FG005|Overall Study|Adverse Event|1|||
42202687|NCT03118934|76015340|FG000|Overall Study|Physician Decision|0|||
42202688|NCT03118934|76015341|FG001|Overall Study|Physician Decision|0|||
42202689|NCT03118934|76015342|FG002|Overall Study|Physician Decision|0|||
42202690|NCT03118934|76015343|FG003|Overall Study|Physician Decision|0|||
42202691|NCT03118934|76015344|FG004|Overall Study|Physician Decision|0|||
42202692|NCT03118934|76015345|FG005|Overall Study|Physician Decision|1|||
42202693|NCT03118934|76015340|FG000|Overall Study|Discontinued prior to exposure|0|||
42202694|NCT03118934|76015341|FG001|Overall Study|Discontinued prior to exposure|1|||
42202695|NCT03118934|76015342|FG002|Overall Study|Discontinued prior to exposure|1|||
42202696|NCT03118934|76015343|FG003|Overall Study|Discontinued prior to exposure|1|||
42202697|NCT03118934|76015344|FG004|Overall Study|Discontinued prior to exposure|2|||
42202698|NCT03118934|76015345|FG005|Overall Study|Discontinued prior to exposure|0|||
42202699|NCT03114488|76015355|FG000|Time Period 2|Withdrawal by Subject|1|||
42202700|NCT03114488|76015356|FG001|Time Period 2|Withdrawal by Subject|3|||
42202701|NCT03135262|76015375|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
42202702|NCT03135262|76015376|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
42202703|NCT03135262|76015377|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
42380930|NCT01444781|76253499|FG001|Overall Study|Withdrawal by Subject|1|||
42380931|NCT01444781|76253500|FG002|Overall Study|Withdrawal by Subject|2|||
42380932|NCT01444391|76253515|FG000|Overall Study|Death|1|||
42380933|NCT01443923|76253521|FG000|Overall Study|Adverse Event|1|||
42108136|NCT00615264|75918816|FG000|Overall Study|Withdrawal by Subject|17|||
42108137|NCT00615264|75918817|FG001|Overall Study|Withdrawal by Subject|19|||
42108138|NCT00615264|75918816|FG000|Overall Study|Lost to Follow-up|6|||
42108139|NCT00615264|75918817|FG001|Overall Study|Lost to Follow-up|13|||
42108140|NCT00615264|75918816|FG000|Overall Study|Adverse Event|8|||
42108141|NCT00615264|75918817|FG001|Overall Study|Adverse Event|5|||
42108142|NCT00615264|75918816|FG000|Overall Study|Death|1|||
42108143|NCT00615264|75918817|FG001|Overall Study|Death|1|||
42108144|NCT00615264|75918816|FG000|Overall Study|Protocol Violation|11|||
42108145|NCT00615264|75918817|FG001|Overall Study|Protocol Violation|7|||
42108146|NCT00615264|75918816|FG000|Overall Study|Not defined|7|||
42108147|NCT00615264|75918817|FG001|Overall Study|Not defined|4|||
42108148|NCT00615264|75918816|FG000|Overall Study|Dermal Hypersensitivity|0|||
42108149|NCT00615264|75918817|FG001|Overall Study|Dermal Hypersensitivity|3|||
42108150|NCT00732641|75918825|FG000|Overall Study|Relapse or Progressive Disease|65|||
42108151|NCT00732641|75918826|FG001|Overall Study|Relapse or Progressive Disease|101|||
42108152|NCT00732641|75918825|FG000|Overall Study|Serious Adverse Events|12|||
42108153|NCT00732641|75918826|FG001|Overall Study|Serious Adverse Events|3|||
42108154|NCT00732641|75918825|FG000|Overall Study|Physician Decision|6|||
42108155|NCT00732641|75918826|FG001|Overall Study|Physician Decision|0|||
42108156|NCT00732641|75918825|FG000|Overall Study|Withdrawal by Subject|4|||
42108157|NCT00732641|75918826|FG001|Overall Study|Withdrawal by Subject|2|||
42108158|NCT00732641|75918825|FG000|Overall Study|Unable to Complete|1|||
42108159|NCT00732641|75918826|FG001|Overall Study|Unable to Complete|1|||
42108160|NCT00732641|75918825|FG000|Overall Study|Other|18|||
42108161|NCT00732641|75918826|FG001|Overall Study|Other|5|||
42108162|NCT00737711|75918832|FG000|Overall Study|Adverse Event|2|||
42108163|NCT00737711|75918832|FG000|Overall Study|Death|8|||
42108164|NCT00737711|75918832|FG000|Overall Study|Failure to return|4|||
42108165|NCT00737711|75918832|FG000|Overall Study|Protocol Violation|1|||
42108166|NCT00737711|75918832|FG000|Overall Study|Withdrawal by Subject|5|||
42108167|NCT00737711|75918832|FG000|Overall Study|Blood transfusion|6|||
42108168|NCT00737711|75918832|FG000|Overall Study|Other|5|||
42108169|NCT00615108|75918836|FG000|Overall Study|Adverse Event|122|||
42108170|NCT00615108|75918836|FG000|Overall Study|Other|370|||
42108171|NCT00615108|75918836|FG000|Overall Study|Lost to Follow-up|15|||
42108172|NCT00238303|75918845|FG000|Overall Study|Withdrawal by Subject|11|||
42108173|NCT00238303|75918846|FG001|Overall Study|Withdrawal by Subject|1|||
42108174|NCT00238303|75918847|FG002|Overall Study|Withdrawal by Subject|2|||
42108175|NCT00238303|75918845|FG000|Overall Study|Death|1|||
42108176|NCT00238303|75918846|FG001|Overall Study|Death|0|||
42108177|NCT00238303|75918847|FG002|Overall Study|Death|1|||
42108178|NCT00238303|75918845|FG000|Overall Study|Other Medical Problems|2|||
42108179|NCT00238303|75918846|FG001|Overall Study|Other Medical Problems|0|||
42108180|NCT00238303|75918847|FG002|Overall Study|Other Medical Problems|2|||
42108181|NCT00238303|75918845|FG000|Overall Study|Poor tolerance of study treatment|1|||
42108182|NCT00238303|75918846|FG001|Overall Study|Poor tolerance of study treatment|0|||
42108183|NCT00238303|75918847|FG002|Overall Study|Poor tolerance of study treatment|1|||
42108184|NCT00238303|75918845|FG000|Overall Study|Adverse Event|0|||
42108185|NCT00238303|75918846|FG001|Overall Study|Adverse Event|1|||
42108186|NCT00238303|75918847|FG002|Overall Study|Adverse Event|3|||
42380934|NCT01443923|76253522|FG001|Overall Study|Adverse Event|0|||
42380935|NCT01551212|76253534|FG000|Overall Study|Graft loss/Retransplantation|0|||
42108187|NCT00737633|75918858|FG000|Overall Study|Study terminated by sponsor|44|||
42108188|NCT00737633|75918859|FG001|Overall Study|Study terminated by sponsor|55|||
42108189|NCT00737633|75918858|FG000|Overall Study|Lost to Follow-up|0|||
42108190|NCT00737633|75918859|FG001|Overall Study|Lost to Follow-up|1|||
42108191|NCT00737633|75918858|FG000|Overall Study|protocol non-compliance|0|||
42202704|NCT03135262|76015378|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
42202705|NCT03135262|76015379|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
42202706|NCT03135262|76015375|FG000|Overall Study|Progression of disease|0|||
42202707|NCT03135262|76015376|FG001|Overall Study|Progression of disease|0|||
42202708|NCT03135262|76015377|FG002|Overall Study|Progression of disease|0|||
42380936|NCT01551212|76253535|FG001|Overall Study|Graft loss/Retransplantation|1|||
42380937|NCT01551212|76253534|FG000|Overall Study|Administrative problems|1|||
42380938|NCT01551212|76253535|FG001|Overall Study|Administrative problems|2|||
42380939|NCT01551212|76253534|FG000|Overall Study|Lost to Follow-up|0|||
42108192|NCT00737633|75918859|FG001|Overall Study|protocol non-compliance|1|||
42108193|NCT00732251|75918865|FG000|Overall Study|Lost to Follow-up|3|||
42108194|NCT00732251|75918865|FG000|Overall Study|Withdrawal by Subject|3|||
42380940|NCT01551212|76253535|FG001|Overall Study|Lost to Follow-up|1|||
42380941|NCT01551212|76253534|FG000|Overall Study|Protocol Violation|0|||
42380942|NCT01551212|76253535|FG001|Overall Study|Protocol Violation|1|||
42380943|NCT01551212|76253534|FG000|Overall Study|Withdrawal by Subject|0|||
42380944|NCT01551212|76253535|FG001|Overall Study|Withdrawal by Subject|7|||
42380945|NCT01551212|76253534|FG000|Overall Study|Death|2|||
42380946|NCT01551212|76253535|FG001|Overall Study|Death|4|||
42380947|NCT01551212|76253534|FG000|Overall Study|Never Received Study Treatment|2|||
42380948|NCT01551212|76253535|FG001|Overall Study|Never Received Study Treatment|4|||
42380949|NCT01550744|76253595|FG000|Open-Label|Lost to Follow-up|7|||
42380950|NCT01550744|76253596|FG001|Open-Label|Lost to Follow-up|0|||
42380951|NCT01550744|76253597|FG002|Open-Label|Lost to Follow-up|0|||
42380952|NCT01550744|76253595|FG000|Open-Label|Withdrawal by Subject|13|||
42380953|NCT01550744|76253596|FG001|Open-Label|Withdrawal by Subject|0|||
42380954|NCT01550744|76253597|FG002|Open-Label|Withdrawal by Subject|0|||
42380955|NCT01550744|76253595|FG000|Open-Label|Adverse Event|11|||
42380956|NCT01550744|76253596|FG001|Open-Label|Adverse Event|0|||
42380957|NCT01550744|76253597|FG002|Open-Label|Adverse Event|0|||
42380958|NCT01550744|76253595|FG000|Open-Label|Lack of Efficacy|4|||
42380959|NCT01550744|76253596|FG001|Open-Label|Lack of Efficacy|0|||
42380960|NCT01550744|76253597|FG002|Open-Label|Lack of Efficacy|0|||
42380961|NCT01550744|76253595|FG000|Open-Label|Protocol Violation|4|||
42380962|NCT01550744|76253596|FG001|Open-Label|Protocol Violation|0|||
42380963|NCT01550744|76253597|FG002|Open-Label|Protocol Violation|0|||
42380964|NCT01550744|76253595|FG000|Open-Label|Not all 3 study drug injections received|2|||
42380965|NCT01550744|76253596|FG001|Open-Label|Not all 3 study drug injections received|0|||
42380966|NCT01550744|76253597|FG002|Open-Label|Not all 3 study drug injections received|0|||
42380967|NCT01550744|76253595|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
42380968|NCT01550744|76253596|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
42380969|NCT01550744|76253597|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
42380970|NCT01550744|76253595|FG000|Open-Label|Other|1|||
42380971|NCT01550744|76253596|FG001|Open-Label|Other|0|||
42380972|NCT01550744|76253597|FG002|Open-Label|Other|0|||
42380973|NCT01550744|76253595|FG000|Double-Blind|Lost to Follow-up|0|||
42380974|NCT01550744|76253596|FG001|Double-Blind|Lost to Follow-up|6|||
42380975|NCT01550744|76253597|FG002|Double-Blind|Lost to Follow-up|12|||
42380976|NCT01550744|76253595|FG000|Double-Blind|Withdrawal by Subject|0|||
42380977|NCT01550744|76253596|FG001|Double-Blind|Withdrawal by Subject|2|||
42380978|NCT01550744|76253597|FG002|Double-Blind|Withdrawal by Subject|15|||
42380979|NCT01550744|76253595|FG000|Double-Blind|Adverse Event|0|||
42380980|NCT01550744|76253596|FG001|Double-Blind|Adverse Event|4|||
42380981|NCT01550744|76253597|FG002|Double-Blind|Adverse Event|15|||
42380982|NCT01550744|76253595|FG000|Double-Blind|Death|0|||
42380983|NCT01550744|76253596|FG001|Double-Blind|Death|1|||
42380984|NCT01550744|76253597|FG002|Double-Blind|Death|0|||
42380985|NCT01550744|76253595|FG000|Double-Blind|Lack of Efficacy|0|||
42380986|NCT01550744|76253596|FG001|Double-Blind|Lack of Efficacy|2|||
42380987|NCT01550744|76253597|FG002|Double-Blind|Lack of Efficacy|8|||
42380988|NCT01550744|76253595|FG000|Double-Blind|Protocol Violation|0|||
42108195|NCT00732251|75918865|FG000|Overall Study|Early Term due to Site Closure|1|||
42380989|NCT01550744|76253596|FG001|Double-Blind|Protocol Violation|0|||
42108196|NCT00737477|75918869|FG000|Overall Study|Adverse Event|9|||
42108197|NCT00737477|75918869|FG000|Overall Study|Death|9|||
42108198|NCT00737477|75918869|FG000|Overall Study|Treatment Refusal|1|||
42108199|NCT00737477|75918869|FG000|Overall Study|Withdrawal by Subject|1|||
42108200|NCT00737477|75918869|FG000|Overall Study|Renal Transplantation|10|||
42108201|NCT00737477|75918869|FG000|Overall Study|Other|4|||
42380990|NCT01550744|76253597|FG002|Double-Blind|Protocol Violation|4|||
42380991|NCT01550744|76253595|FG000|Double-Blind|Pregnancy|0|||
42380992|NCT01550744|76253596|FG001|Double-Blind|Pregnancy|0|||
42380993|NCT01550744|76253597|FG002|Double-Blind|Pregnancy|3|||
42108202|NCT00256867|75918881|FG000|Overall Study|Adverse Event|0|||
42380994|NCT01550744|76253595|FG000|Double-Blind|Other|0|||
42380995|NCT01550744|76253596|FG001|Double-Blind|Other|2|||
42108203|NCT00256867|75918882|FG001|Overall Study|Adverse Event|1|||
42108204|NCT00256867|75918883|FG002|Overall Study|Adverse Event|1|||
42108205|NCT00256867|75918884|FG003|Overall Study|Adverse Event|1|||
42108206|NCT00256867|75918885|FG004|Overall Study|Adverse Event|2|||
42108207|NCT00256867|75918886|FG005|Overall Study|Adverse Event|2|||
42108208|NCT00256867|75918887|FG006|Overall Study|Adverse Event|1|||
42108209|NCT00256867|75918888|FG007|Overall Study|Adverse Event|4|||
42108210|NCT00256867|75918881|FG000|Overall Study|Lost to Follow-up|2|||
42108211|NCT00256867|75918882|FG001|Overall Study|Lost to Follow-up|2|||
42108212|NCT00256867|75918883|FG002|Overall Study|Lost to Follow-up|2|||
42108213|NCT00256867|75918884|FG003|Overall Study|Lost to Follow-up|3|||
42108214|NCT00256867|75918885|FG004|Overall Study|Lost to Follow-up|2|||
42108215|NCT00256867|75918886|FG005|Overall Study|Lost to Follow-up|0|||
42108216|NCT00256867|75918887|FG006|Overall Study|Lost to Follow-up|1|||
42108217|NCT00256867|75918888|FG007|Overall Study|Lost to Follow-up|2|||
42108218|NCT00256867|75918881|FG000|Overall Study|Protocol Violation|0|||
42108219|NCT00256867|75918882|FG001|Overall Study|Protocol Violation|0|||
42108220|NCT00256867|75918883|FG002|Overall Study|Protocol Violation|0|||
42108221|NCT00256867|75918884|FG003|Overall Study|Protocol Violation|1|||
42108222|NCT00256867|75918885|FG004|Overall Study|Protocol Violation|0|||
42108223|NCT00256867|75918886|FG005|Overall Study|Protocol Violation|1|||
42108224|NCT00256867|75918887|FG006|Overall Study|Protocol Violation|0|||
42108225|NCT00256867|75918888|FG007|Overall Study|Protocol Violation|1|||
42108226|NCT00256867|75918881|FG000|Overall Study|Withdrawal by Subject|0|||
42108227|NCT00256867|75918882|FG001|Overall Study|Withdrawal by Subject|0|||
42108228|NCT00256867|75918883|FG002|Overall Study|Withdrawal by Subject|1|||
42108229|NCT00256867|75918884|FG003|Overall Study|Withdrawal by Subject|1|||
42108230|NCT00256867|75918885|FG004|Overall Study|Withdrawal by Subject|2|||
42380996|NCT01550744|76253597|FG002|Double-Blind|Other|10|||
42380997|NCT01549964|76253658|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
42380998|NCT01549964|76253659|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
42380999|NCT01549964|76253660|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
42381000|NCT01549964|76253661|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
42381001|NCT01549964|76253658|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
42381002|NCT01549964|76253659|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
42381003|NCT01549964|76253660|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
42381004|NCT01549964|76253661|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
42381005|NCT01549964|76253658|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
42381006|NCT01549964|76253659|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
42381007|NCT01549964|76253660|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
42381008|NCT01549964|76253661|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
42381009|NCT01549964|76253658|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
42381010|NCT01549964|76253659|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
42381011|NCT01549964|76253660|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
42202709|NCT03135262|76015378|FG003|Overall Study|Progression of disease|1|||
42202710|NCT03135262|76015379|FG004|Overall Study|Progression of disease|0|||
42108231|NCT00256867|75918886|FG005|Overall Study|Withdrawal by Subject|2|||
42108232|NCT00256867|75918887|FG006|Overall Study|Withdrawal by Subject|3|||
42108233|NCT00256867|75918888|FG007|Overall Study|Withdrawal by Subject|2|||
42108234|NCT00256867|75918881|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
42108235|NCT00256867|75918882|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
42108236|NCT00256867|75918883|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
42202711|NCT03135262|76015375|FG000|Overall Study|Death|6|||
42381012|NCT01549964|76253661|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
42108237|NCT00256867|75918884|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
42381013|NCT01549964|76253658|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
42381014|NCT01549964|76253659|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
42381015|NCT01549964|76253660|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
42381016|NCT01549964|76253661|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
42381017|NCT01549964|76253658|FG000|24-Week Treatment Period|Other|1|||
42381018|NCT01549964|76253659|FG001|24-Week Treatment Period|Other|0|||
42381019|NCT01549964|76253660|FG002|24-Week Treatment Period|Other|1|||
42381020|NCT01549964|76253661|FG003|24-Week Treatment Period|Other|0|||
42381021|NCT01549964|76253658|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
42381022|NCT01549964|76253659|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
42381023|NCT01549964|76253660|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
42381024|NCT01549964|76253661|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
42381025|NCT01549964|76253658|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
42381026|NCT01549964|76253659|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
42381027|NCT01549964|76253660|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
42381028|NCT01549964|76253661|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
42381029|NCT01549964|76253658|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
42381030|NCT01549964|76253659|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
42381031|NCT01549964|76253660|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
42381032|NCT01549964|76253661|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
42381033|NCT01549964|76253658|FG000|80-Week Extension Period|Pregnancy|0|||
42381034|NCT01549964|76253659|FG001|80-Week Extension Period|Pregnancy|0|||
42381035|NCT01549964|76253660|FG002|80-Week Extension Period|Pregnancy|1|||
42381036|NCT01549964|76253661|FG003|80-Week Extension Period|Pregnancy|0|||
42381037|NCT01549964|76253658|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
42381038|NCT01549964|76253659|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
42381039|NCT01549964|76253660|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
42381040|NCT01549964|76253661|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
42381041|NCT01549964|76253658|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
42381042|NCT01549964|76253659|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
42381043|NCT01549964|76253660|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
42381044|NCT01549964|76253661|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
42381045|NCT01549964|76253658|FG000|80-Week Extension Period|Lost to Follow-up|1|||
42381046|NCT01549964|76253659|FG001|80-Week Extension Period|Lost to Follow-up|0|||
42381047|NCT01549964|76253660|FG002|80-Week Extension Period|Lost to Follow-up|2|||
42381048|NCT01549964|76253661|FG003|80-Week Extension Period|Lost to Follow-up|1|||
42381049|NCT01549964|76253658|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
42381050|NCT01549964|76253659|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
42381051|NCT01549964|76253660|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
42381052|NCT01549964|76253661|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
42381053|NCT01570244|76253743|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
42381054|NCT01535222|76253778|FG000|Overall Study|Inclusion/exclusion|0|||
42381055|NCT01535222|76253779|FG001|Overall Study|Inclusion/exclusion|0|||
42381056|NCT01535222|76253780|FG002|Overall Study|Inclusion/exclusion|1|||
42381057|NCT01535222|76253781|FG003|Overall Study|Inclusion/exclusion|0|||
42381058|NCT01535222|76253782|FG004|Overall Study|Inclusion/exclusion|0|||
42381059|NCT01535222|76253783|FG005|Overall Study|Inclusion/exclusion|0|||
42381060|NCT01549886|76253799|FG000|Overall Study|Sponsor's decision|2|||
42381061|NCT01549886|76253800|FG001|Overall Study|Sponsor's decision|3|||
42381062|NCT01443845|76253829|FG000|Overall Study|Protocol Violation|43|||
42381063|NCT01443845|76253830|FG001|Overall Study|Protocol Violation|45|||
42381064|NCT01443845|76253829|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
42381065|NCT01443845|76253830|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
42381066|NCT01443845|76253829|FG000|Overall Study|Deterioration in pulmonary function|1|||
42381067|NCT01443845|76253830|FG001|Overall Study|Deterioration in pulmonary function|4|||
42381068|NCT01443845|76253829|FG000|Overall Study|Lack of Efficacy|10|||
42381069|NCT01443845|76253830|FG001|Overall Study|Lack of Efficacy|5|||
42381070|NCT01443845|76253829|FG000|Overall Study|Adverse Event|64|||
42381071|NCT01443845|76253830|FG001|Overall Study|Adverse Event|138|||
42381072|NCT01443845|76253829|FG000|Overall Study|Withdrawal by Subject|63|||
42381073|NCT01443845|76253830|FG001|Overall Study|Withdrawal by Subject|67|||
42381074|NCT01443845|76253829|FG000|Overall Study|Military Conflict - Site Terminated|20|||
42381075|NCT01443845|76253830|FG001|Overall Study|Military Conflict - Site Terminated|21|||
42381076|NCT01443845|76253829|FG000|Overall Study|Lost to Follow-up|9|||
42381077|NCT01443845|76253830|FG001|Overall Study|Lost to Follow-up|13|||
42381078|NCT01549652|76253839|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
42381079|NCT01549652|76253840|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
42381080|NCT01549652|76253841|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
42381081|NCT01549652|76253842|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
42381082|NCT01549652|76253839|FG000|Overall Study|Study Drug Titration Failure|5|||
42381083|NCT01549652|76253840|FG001|Overall Study|Study Drug Titration Failure|6|||
42381084|NCT01549652|76253841|FG002|Overall Study|Study Drug Titration Failure|0|||
42381085|NCT01549652|76253842|FG003|Overall Study|Study Drug Titration Failure|0|||
42381086|NCT01549652|76253839|FG000|Overall Study|Withdrawal Effect|0|||
42381087|NCT01549652|76253840|FG001|Overall Study|Withdrawal Effect|2|||
42381088|NCT01549652|76253841|FG002|Overall Study|Withdrawal Effect|0|||
42381089|NCT01549652|76253842|FG003|Overall Study|Withdrawal Effect|0|||
42381090|NCT01549652|76253839|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
42381091|NCT01549652|76253840|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
42381092|NCT01549652|76253841|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
42381093|NCT01549652|76253842|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
42381094|NCT01549652|76253839|FG000|Overall Study|Problem with Infusion|1|||
42381095|NCT01549652|76253840|FG001|Overall Study|Problem with Infusion|0|||
42381096|NCT01549652|76253841|FG002|Overall Study|Problem with Infusion|0|||
42381097|NCT01549652|76253842|FG003|Overall Study|Problem with Infusion|0|||
42381098|NCT01549652|76253839|FG000|Overall Study|Titration Non-Compliance|1|||
42381099|NCT01549652|76253840|FG001|Overall Study|Titration Non-Compliance|3|||
42381100|NCT01549652|76253841|FG002|Overall Study|Titration Non-Compliance|4|||
42381101|NCT01549652|76253842|FG003|Overall Study|Titration Non-Compliance|5|||
42381102|NCT01549652|76253839|FG000|Overall Study|Titration Side Effects|0|||
42381103|NCT01549652|76253840|FG001|Overall Study|Titration Side Effects|0|||
42381104|NCT01549652|76253841|FG002|Overall Study|Titration Side Effects|6|||
42381105|NCT01549652|76253842|FG003|Overall Study|Titration Side Effects|3|||
42381106|NCT01549652|76253839|FG000|Overall Study|Withdrawal by Subject|0|||
42381107|NCT01549652|76253840|FG001|Overall Study|Withdrawal by Subject|0|||
42381108|NCT01549652|76253841|FG002|Overall Study|Withdrawal by Subject|5|||
42381109|NCT01549652|76253842|FG003|Overall Study|Withdrawal by Subject|3|||
42381110|NCT01569464|76253850|FG000|Overall Study|Adverse Event|4|||
42381111|NCT01569464|76253851|FG001|Overall Study|Adverse Event|0|||
42381112|NCT01569464|76253850|FG000|Overall Study|Lack of Efficacy|1|||
42381113|NCT01569464|76253851|FG001|Overall Study|Lack of Efficacy|0|||
42381114|NCT01569464|76253850|FG000|Overall Study|Protocol Violation|1|||
42381115|NCT01569464|76253851|FG001|Overall Study|Protocol Violation|0|||
42381116|NCT01569464|76253850|FG000|Overall Study|Lost to Follow-up|2|||
42381117|NCT01569464|76253851|FG001|Overall Study|Lost to Follow-up|3|||
42381118|NCT01569464|76253850|FG000|Overall Study|Withdrawal by Subject|1|||
42381119|NCT01569464|76253851|FG001|Overall Study|Withdrawal by Subject|1|||
42381120|NCT01569464|76253850|FG000|Overall Study|Other|1|||
42381121|NCT01569464|76253851|FG001|Overall Study|Other|1|||
42381122|NCT01534676|76253861|FG000|Overall Study|Study closed due to poor enrollment|2|||
42381123|NCT01534676|76253862|FG001|Overall Study|Study closed due to poor enrollment|1|||
42381124|NCT01442675|76253868|FG000|Overall Study|Protocol Violation|6|||
42381125|NCT01442675|76253868|FG000|Overall Study|Lost to Follow-up|2|||
42381126|NCT01442675|76253868|FG000|Overall Study|Withdrawal by Subject|4|||
42381127|NCT01534520|76253875|FG000|Overall Study|Adverse Event|0|||
42381128|NCT01534520|76253876|FG001|Overall Study|Adverse Event|1|||
42381129|NCT01534208|76253906|FG000|Overall Study|Lost to Follow-up|19|||
42381130|NCT01534208|76253907|FG001|Overall Study|Lost to Follow-up|14|||
42381131|NCT01534208|76253906|FG000|Overall Study|Withdrawal by Subject|6|||
42381132|NCT01534208|76253907|FG001|Overall Study|Withdrawal by Subject|20|||
42381133|NCT01534208|76253906|FG000|Overall Study|Adverse Event|15|||
42381134|NCT01534208|76253907|FG001|Overall Study|Adverse Event|8|||
42381135|NCT01534208|76253906|FG000|Overall Study|Physician Decision|2|||
42381136|NCT01534208|76253907|FG001|Overall Study|Physician Decision|0|||
42381137|NCT01534208|76253906|FG000|Overall Study|Lack of Efficacy|0|||
42381138|NCT01534208|76253907|FG001|Overall Study|Lack of Efficacy|3|||
42381139|NCT01534208|76253906|FG000|Overall Study|Protocol Violation|2|||
42381140|NCT01534208|76253907|FG001|Overall Study|Protocol Violation|2|||
42381141|NCT01534208|76253906|FG000|Overall Study|Sponsor decision|4|||
42381142|NCT01534208|76253907|FG001|Overall Study|Sponsor decision|1|||
42381143|NCT01534208|76253906|FG000|Overall Study|Subject relocation|2|||
42381144|NCT01534208|76253907|FG001|Overall Study|Subject relocation|0|||
42381145|NCT01534208|76253906|FG000|Overall Study|Lab assessment|2|||
42381146|NCT01534208|76253907|FG001|Overall Study|Lab assessment|1|||
42381147|NCT01534208|76253906|FG000|Overall Study|Eligibility error|3|||
42381148|NCT01534208|76253907|FG001|Overall Study|Eligibility error|0|||
42381149|NCT01534208|76253906|FG000|Overall Study|PCP decision|1|||
42381150|NCT01534208|76253907|FG001|Overall Study|PCP decision|0|||
42381151|NCT01534208|76253906|FG000|Overall Study|Needed prohibited meds|1|||
42381152|NCT01534208|76253907|FG001|Overall Study|Needed prohibited meds|0|||
42381153|NCT01548638|76253913|FG000|Overall Study|Protocol Violation|3|||
42381154|NCT01548638|76253913|FG000|Overall Study|Withdrawal by Subject|1|||
42381155|NCT01533428|76253937|FG000|Overall Study|Adverse Event|0|||
42381156|NCT01533428|76253938|FG001|Overall Study|Adverse Event|1|||
42381157|NCT01533428|76253937|FG000|Overall Study|Lost to Follow-up|2|||
42381158|NCT01533428|76253938|FG001|Overall Study|Lost to Follow-up|1|||
42381159|NCT01533428|76253937|FG000|Overall Study|Withdrawal by Subject|7|||
42381160|NCT01533428|76253938|FG001|Overall Study|Withdrawal by Subject|6|||
42381161|NCT01517984|76253947|FG000|Overall Study|Lost to Follow-up|0|||
42381162|NCT01517984|76253948|FG001|Overall Study|Lost to Follow-up|1|||
42381163|NCT01517984|76253949|FG002|Overall Study|Lost to Follow-up|0|||
42381164|NCT01517984|76253950|FG003|Overall Study|Lost to Follow-up|0|||
42381165|NCT01517984|76253947|FG000|Overall Study|Withdrawal by Subject|1|||
42381166|NCT01517984|76253948|FG001|Overall Study|Withdrawal by Subject|8|||
42381167|NCT01517984|76253949|FG002|Overall Study|Withdrawal by Subject|4|||
42381168|NCT01517984|76253950|FG003|Overall Study|Withdrawal by Subject|1|||
42381169|NCT01517984|76253947|FG000|Overall Study|Screen Failure|4|||
42381170|NCT01517984|76253948|FG001|Overall Study|Screen Failure|0|||
42381171|NCT01517984|76253949|FG002|Overall Study|Screen Failure|0|||
42381172|NCT01517984|76253950|FG003|Overall Study|Screen Failure|0|||
42381173|NCT01517984|76253947|FG000|Overall Study|Ineligible for randomization|0|||
42381174|NCT01517984|76253948|FG001|Overall Study|Ineligible for randomization|14|||
42381175|NCT01517984|76253949|FG002|Overall Study|Ineligible for randomization|0|||
42381176|NCT01517984|76253950|FG003|Overall Study|Ineligible for randomization|0|||
42381177|NCT01517750|76253978|FG000|Overall Study|Lost to Follow-up|1|||
42381178|NCT01517750|76253979|FG001|Overall Study|Lost to Follow-up|2|||
42381179|NCT01517750|76253980|FG002|Overall Study|Lost to Follow-up|4|||
42381180|NCT01517750|76253981|FG003|Overall Study|Lost to Follow-up|1|||
42381181|NCT01548404|76254006|FG000|Overall Study|Adverse Event|3|||
42381182|NCT01548404|76254007|FG001|Overall Study|Adverse Event|1|||
42381183|NCT01548404|76254006|FG000|Overall Study|Physician Decision|2|||
42381184|NCT01548404|76254007|FG001|Overall Study|Physician Decision|1|||
42381185|NCT01548404|76254006|FG000|Overall Study|Inadequate response to study treatment|23|||
42381186|NCT01548404|76254007|FG001|Overall Study|Inadequate response to study treatment|7|||
42381187|NCT01548404|76254006|FG000|Overall Study|Lost to Follow-up|2|||
42381188|NCT01548404|76254007|FG001|Overall Study|Lost to Follow-up|0|||
42381189|NCT01548404|76254006|FG000|Overall Study|Withdrawal by Subject|0|||
42381190|NCT01548404|76254007|FG001|Overall Study|Withdrawal by Subject|3|||
42381191|NCT01548404|76254006|FG000|Overall Study|Other than specified above|0|||
42381192|NCT01548404|76254007|FG001|Overall Study|Other than specified above|2|||
42381193|NCT01547780|76254021|FG000|Baseline PET Scan|Physician Decision|1|||
42381194|NCT01547780|76254022|FG001|Baseline PET Scan|Physician Decision|0|||
42381195|NCT01547780|76254023|FG002|Baseline PET Scan|Physician Decision|1|||
42381196|NCT01547780|76254024|FG003|Baseline PET Scan|Physician Decision|0|||
42381197|NCT01547780|76254021|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
42381198|NCT01547780|76254022|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
42381199|NCT01547780|76254023|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
42381200|NCT01547780|76254024|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
42381201|NCT01547390|76254046|FG000|Overall Study|Withdrawal by Subject|10|||
42381202|NCT01547390|76254047|FG001|Overall Study|Withdrawal by Subject|7|||
42381203|NCT01547390|76254046|FG000|Overall Study|termination of pregnancy|0|||
42381204|NCT01547390|76254047|FG001|Overall Study|termination of pregnancy|1|||
42381205|NCT01547390|76254046|FG000|Overall Study|Lost to Follow-up|0|||
42381206|NCT01547390|76254047|FG001|Overall Study|Lost to Follow-up|2|||
42381207|NCT01547390|76254046|FG000|Overall Study|Adverse Event|3|||
42381208|NCT01547390|76254047|FG001|Overall Study|Adverse Event|0|||
42381209|NCT01546922|76254053|FG000|First Period of 10 Weeks|Protocol Violation|3|||
42381210|NCT01546922|76254054|FG001|First Period of 10 Weeks|Protocol Violation|1|||
42381211|NCT01546922|76254053|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
42381212|NCT01546922|76254054|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
42381213|NCT01546922|76254053|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
42381214|NCT01546922|76254054|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
42381215|NCT01546922|76254053|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
42381216|NCT01546922|76254054|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
42381217|NCT01546922|76254053|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
42381218|NCT01546922|76254054|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
42381219|NCT01532648|76254071|FG000|Overall Study|Lost to Follow-up|3|||
42202712|NCT03135262|76015376|FG001|Overall Study|Death|2|||
42381220|NCT01532648|76254072|FG001|Overall Study|Lost to Follow-up|4|||
42381221|NCT01532648|76254071|FG000|Overall Study|Lack of Efficacy|4|||
42381222|NCT01532648|76254072|FG001|Overall Study|Lack of Efficacy|1|||
42381223|NCT01532648|76254071|FG000|Overall Study|Protocol Violation|1|||
42381224|NCT01532648|76254072|FG001|Overall Study|Protocol Violation|1|||
42381225|NCT01532648|76254071|FG000|Overall Study|Adverse Event|12|||
42381226|NCT01532648|76254072|FG001|Overall Study|Adverse Event|9|||
42381227|NCT01532648|76254071|FG000|Overall Study|Withdrawal by Subject|16|||
42381228|NCT01532648|76254072|FG001|Overall Study|Withdrawal by Subject|2|||
42108238|NCT00256867|75918885|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
42381229|NCT01532570|76254102|FG000|Overall Study|Lack of Efficacy|1|||
42381230|NCT01532570|76254103|FG001|Overall Study|Lack of Efficacy|0|||
42381231|NCT01532570|76254104|FG002|Overall Study|Lack of Efficacy|0|||
42381232|NCT01532570|76254105|FG003|Overall Study|Lack of Efficacy|0|||
42381233|NCT01532570|76254102|FG000|Overall Study|Withdrawal by Subject|0|||
42381234|NCT01532570|76254103|FG001|Overall Study|Withdrawal by Subject|1|||
42381235|NCT01532570|76254104|FG002|Overall Study|Withdrawal by Subject|0|||
42381236|NCT01532570|76254105|FG003|Overall Study|Withdrawal by Subject|0|||
42381237|NCT01532414|76254138|FG000|Overall Study|Lost to Follow-up|3|||
42381238|NCT01532414|76254139|FG001|Overall Study|Lost to Follow-up|0|||
42381239|NCT01532414|76254140|FG002|Overall Study|Lost to Follow-up|1|||
42381240|NCT01532414|76254138|FG000|Overall Study|Withdrawal by Subject|3|||
42381241|NCT01532414|76254139|FG001|Overall Study|Withdrawal by Subject|0|||
42381242|NCT01532414|76254140|FG002|Overall Study|Withdrawal by Subject|0|||
42381243|NCT01532414|76254138|FG000|Overall Study|No V6 semen sample|0|||
42381244|NCT01532414|76254139|FG001|Overall Study|No V6 semen sample|1|||
42381245|NCT01532414|76254140|FG002|Overall Study|No V6 semen sample|0|||
42381246|NCT01532414|76254138|FG000|Overall Study|Adverse Event|0|||
42381247|NCT01532414|76254139|FG001|Overall Study|Adverse Event|1|||
42381248|NCT01532414|76254140|FG002|Overall Study|Adverse Event|1|||
42381249|NCT01532414|76254138|FG000|Overall Study|Unable to complete 24 hour PK|0|||
42381250|NCT01532414|76254139|FG001|Overall Study|Unable to complete 24 hour PK|0|||
42381251|NCT01532414|76254140|FG002|Overall Study|Unable to complete 24 hour PK|1|||
42381252|NCT01532414|76254138|FG000|Overall Study|Withdrawn by sponsor|1|||
42381253|NCT01532414|76254139|FG001|Overall Study|Withdrawn by sponsor|0|||
42381254|NCT01532414|76254140|FG002|Overall Study|Withdrawn by sponsor|0|||
42381255|NCT01441973|76254150|FG000|Overall Study|Disease progression|8|||
42381256|NCT01441973|76254151|FG001|Overall Study|Disease progression|6|||
42381257|NCT01441973|76254150|FG000|Overall Study|Adverse event unrelated to study drug|3|||
42381258|NCT01441973|76254151|FG001|Overall Study|Adverse event unrelated to study drug|2|||
42381259|NCT01441973|76254150|FG000|Overall Study|Participant request to discontinue|1|||
42381260|NCT01441973|76254151|FG001|Overall Study|Participant request to discontinue|1|||
42381261|NCT01441973|76254150|FG000|Overall Study|Poor compliance/noncompliance|0|||
42381262|NCT01441973|76254151|FG001|Overall Study|Poor compliance/noncompliance|1|||
42381263|NCT01441973|76254150|FG000|Overall Study|Administrative reason by sponsor|3|||
42381264|NCT01441973|76254151|FG001|Overall Study|Administrative reason by sponsor|5|||
42381265|NCT01441973|76254150|FG000|Overall Study|Participant withdrew consent|0|||
42381266|NCT01441973|76254151|FG001|Overall Study|Participant withdrew consent|1|||
42381267|NCT01575899|76254170|FG000|Overall Study|Lost to Follow-up|3|||
42381268|NCT01575899|76254171|FG001|Overall Study|Lost to Follow-up|4|||
42381269|NCT01575899|76254172|FG002|Overall Study|Lost to Follow-up|2|||
42381270|NCT01575899|76254170|FG000|Overall Study|Protocol Violation|2|||
42381271|NCT01575899|76254171|FG001|Overall Study|Protocol Violation|1|||
42381272|NCT01575899|76254172|FG002|Overall Study|Protocol Violation|0|||
42381273|NCT01440881|76254184|FG000|Overall Study|Death|0|||
42381274|NCT01440881|76254185|FG001|Overall Study|Death|1|||
42381275|NCT01575197|76254200|FG000|Overall Study|Migration out of study area|1|||
42381276|NCT01575197|76254201|FG001|Overall Study|Migration out of study area|5|||
42381277|NCT01575197|76254202|FG002|Overall Study|Migration out of study area|4|||
42381278|NCT01575197|76254200|FG000|Overall Study|SAE|0|||
42381279|NCT01575197|76254201|FG001|Overall Study|SAE|1|||
42381280|NCT01575197|76254202|FG002|Overall Study|SAE|0|||
42381281|NCT01575197|76254200|FG000|Overall Study|Lost to Follow-up|0|||
42381282|NCT01575197|76254201|FG001|Overall Study|Lost to Follow-up|1|||
42381283|NCT01575197|76254202|FG002|Overall Study|Lost to Follow-up|0|||
42381284|NCT01575197|76254200|FG000|Overall Study|Withdrawal by Subject|0|||
42381285|NCT01575197|76254201|FG001|Overall Study|Withdrawal by Subject|1|||
42381286|NCT01575197|76254202|FG002|Overall Study|Withdrawal by Subject|1|||
42381287|NCT01575197|76254200|FG000|Overall Study|Protocol Violation|2|||
42381288|NCT01575197|76254201|FG001|Overall Study|Protocol Violation|1|||
42381289|NCT01575197|76254202|FG002|Overall Study|Protocol Violation|1|||
42381290|NCT01574651|76254233|FG000|Overall Study|Lost to Follow-up|2|||
42381291|NCT01574651|76254234|FG001|Overall Study|Lost to Follow-up|4|||
42381292|NCT01574651|76254233|FG000|Overall Study|Administrative problems|0|||
42381293|NCT01574651|76254234|FG001|Overall Study|Administrative problems|1|||
42381294|NCT01574651|76254233|FG000|Overall Study|Death|3|||
42381295|NCT01574651|76254234|FG001|Overall Study|Death|3|||
42381296|NCT01574651|76254233|FG000|Overall Study|Patient's inability to use the device|0|||
42381297|NCT01574651|76254234|FG001|Overall Study|Patient's inability to use the device|1|||
42381298|NCT01574651|76254233|FG000|Overall Study|Adverse Event|36|||
42381299|NCT01574651|76254234|FG001|Overall Study|Adverse Event|27|||
42381300|NCT01574651|76254233|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42381301|NCT01574651|76254234|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42381302|NCT01574651|76254233|FG000|Overall Study|Abnormal test procedure result(s)|1|||
42381303|NCT01574651|76254234|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42381304|NCT01574651|76254233|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
42381305|NCT01574651|76254234|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
42381306|NCT01574651|76254233|FG000|Overall Study|Protocol Violation|3|||
42381307|NCT01574651|76254234|FG001|Overall Study|Protocol Violation|5|||
42381308|NCT01574651|76254233|FG000|Overall Study|Withdrawal by Subject|9|||
42381309|NCT01574651|76254234|FG001|Overall Study|Withdrawal by Subject|10|||
42381310|NCT01440803|76254246|FG000|Overall Study|Met study stopping rule|2|||
42381311|NCT01440803|76254247|FG001|Overall Study|Met study stopping rule|1|||
42381312|NCT01440803|76254246|FG000|Overall Study|Lost to Follow-up|0|||
42381313|NCT01440803|76254247|FG001|Overall Study|Lost to Follow-up|2|||
42381314|NCT01440803|76254246|FG000|Overall Study|Withdrawal by Subject|0|||
42381315|NCT01440803|76254247|FG001|Overall Study|Withdrawal by Subject|1|||
42381316|NCT01517282|76254258|FG000|Overall Study|Consent withdrawn|0|||
42381317|NCT01517282|76254259|FG001|Overall Study|Consent withdrawn|1|||
42381318|NCT01517282|76254260|FG002|Overall Study|Consent withdrawn|1|||
42381319|NCT01517282|76254261|FG003|Overall Study|Consent withdrawn|1|||
42381320|NCT01517282|76254258|FG000|Overall Study|Physician Decision|1|||
42381321|NCT01517282|76254259|FG001|Overall Study|Physician Decision|0|||
42381322|NCT01517282|76254260|FG002|Overall Study|Physician Decision|0|||
42381323|NCT01517282|76254261|FG003|Overall Study|Physician Decision|0|||
42381324|NCT01440647|76254282|FG000|Overall Study|Death|2|||
42381325|NCT01440647|76254283|FG001|Overall Study|Death|3|||
42381326|NCT01516970|76254291|FG000|Overall Study|Lost to Follow-up|7|||
42381327|NCT01516970|76254292|FG001|Overall Study|Lost to Follow-up|8|||
42381328|NCT01516970|76254291|FG000|Overall Study|Adverse Event|1|||
42381329|NCT01516970|76254292|FG001|Overall Study|Adverse Event|5|||
42381330|NCT01516970|76254291|FG000|Overall Study|Withdrawal by Subject|1|||
42381331|NCT01516970|76254292|FG001|Overall Study|Withdrawal by Subject|1|||
42381332|NCT01516970|76254291|FG000|Overall Study|Other|9|||
42381333|NCT01516970|76254292|FG001|Overall Study|Other|7|||
42381334|NCT01516892|76254313|FG000|Overall Study|Adverse Event|25|||
42381335|NCT01516892|76254313|FG000|Overall Study|Lack of Efficacy|35|||
42381336|NCT01516892|76254313|FG000|Overall Study|Pregnancy|5|||
42381337|NCT01516892|76254313|FG000|Overall Study|Lost to Follow-up|82|||
42381338|NCT01516892|76254313|FG000|Overall Study|Subject Withdrew Consent|92|||
42381339|NCT01516892|76254313|FG000|Overall Study|Protocol Violation|60|||
42381340|NCT01516892|76254313|FG000|Overall Study|Other Miscellaneous Reasons|43|||
42381341|NCT01516892|76254313|FG000|Overall Study|Missing|1|||
42381342|NCT01516736|76254338|FG000|Overall Study|Withdrawal by Subject|10|||
42381343|NCT01516736|76254339|FG001|Overall Study|Withdrawal by Subject|4|||
42381344|NCT01516736|76254338|FG000|Overall Study|Adverse Event|4|||
42381345|NCT01516736|76254339|FG001|Overall Study|Adverse Event|5|||
42381346|NCT01516736|76254338|FG000|Overall Study|Death|3|||
42381347|NCT01516736|76254339|FG001|Overall Study|Death|1|||
42381348|NCT01516736|76254338|FG000|Overall Study|Physician Decision|2|||
42381349|NCT01516736|76254339|FG001|Overall Study|Physician Decision|1|||
42381350|NCT01516736|76254338|FG000|Overall Study|Lack of Efficacy|1|||
42381351|NCT01516736|76254339|FG001|Overall Study|Lack of Efficacy|0|||
42381352|NCT01516736|76254338|FG000|Overall Study|Protocol Violation|0|||
42381353|NCT01516736|76254339|FG001|Overall Study|Protocol Violation|1|||
42381354|NCT01516736|76254338|FG000|Overall Study|Other (not specified)|0|||
42381355|NCT01516736|76254339|FG001|Overall Study|Other (not specified)|1|||
42381356|NCT01546688|76254351|FG000|Overall Study|Adverse Event|0|||
42381357|NCT01546688|76254352|FG001|Overall Study|Adverse Event|4|||
42381358|NCT01546688|76254351|FG000|Overall Study|Withdrawal by Subject|2|||
42381359|NCT01546688|76254352|FG001|Overall Study|Withdrawal by Subject|1|||
42381360|NCT01546688|76254351|FG000|Overall Study|Lack of Efficacy|1|||
42381361|NCT01546688|76254352|FG001|Overall Study|Lack of Efficacy|0|||
42381362|NCT01516034|76254358|FG000|Overall Study|Physician Decision|1|||
42381363|NCT01516034|76254358|FG000|Overall Study|Lack of Efficacy|7|||
42381364|NCT01440569|76254369|FG000|Main Study|Enrolled but not treated|1|||
42381365|NCT01440569|76254370|FG001|Main Study|Enrolled but not treated|0|||
42381366|NCT01440569|76254369|FG000|Main Study|Adverse Event|9|||
42381367|NCT01440569|76254370|FG001|Main Study|Adverse Event|0|||
42381368|NCT01440569|76254369|FG000|Main Study|Pregnancy|1|||
42381369|NCT01440569|76254370|FG001|Main Study|Pregnancy|0|||
42381370|NCT01440569|76254369|FG000|Main Study|Investigator's Discretion|1|||
42381371|NCT01440569|76254370|FG001|Main Study|Investigator's Discretion|1|||
42381372|NCT01440569|76254369|FG000|Main Study|Withdrew Consent|7|||
42381373|NCT01440569|76254370|FG001|Main Study|Withdrew Consent|1|||
42381374|NCT01440569|76254369|FG000|Main Study|Lost to Follow-up|13|||
42381375|NCT01440569|76254370|FG001|Main Study|Lost to Follow-up|2|||
42381376|NCT01440569|76254369|FG000|Main Study|Subject Non-Compliance|3|||
42381377|NCT01440569|76254370|FG001|Main Study|Subject Non-Compliance|0|||
42381378|NCT01440569|76254369|FG000|Main Study|Protocol Violation|1|||
42381379|NCT01440569|76254370|FG001|Main Study|Protocol Violation|0|||
42381380|NCT01440569|76254369|FG000|Open-Label Rollover Phase|Adverse Event|3|||
42381381|NCT01440569|76254370|FG001|Open-Label Rollover Phase|Adverse Event|0|||
42381382|NCT01440569|76254369|FG000|Open-Label Rollover Phase|Pregnancy|1|||
42381383|NCT01440569|76254370|FG001|Open-Label Rollover Phase|Pregnancy|0|||
42381384|NCT01440569|76254369|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
42381385|NCT01440569|76254370|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
42381386|NCT01440569|76254369|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
42381387|NCT01440569|76254370|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
42381388|NCT01440569|76254369|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
42381389|NCT01440569|76254370|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
42381390|NCT01440569|76254369|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
42381391|NCT01440569|76254370|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
42381392|NCT01440569|76254369|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
42381393|NCT01440569|76254370|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
42381394|NCT01546142|76254393|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
42381395|NCT01546142|76254394|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
42381396|NCT01546142|76254393|FG000|Overall Study|Subject Noncompliance|1|||
42381397|NCT01546142|76254394|FG001|Overall Study|Subject Noncompliance|1|||
42381398|NCT01546142|76254393|FG000|Overall Study|Adverse Event|6|||
42381399|NCT01546142|76254394|FG001|Overall Study|Adverse Event|3|||
42381400|NCT01546142|76254393|FG000|Overall Study|Lost to Follow-up|20|||
42381401|NCT01546142|76254394|FG001|Overall Study|Lost to Follow-up|15|||
42381402|NCT01546142|76254393|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
42381403|NCT01546142|76254394|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
42381404|NCT01546142|76254393|FG000|Overall Study|Subject Randomized but Not Treated|1|||
42381405|NCT01546142|76254394|FG001|Overall Study|Subject Randomized but Not Treated|0|||
42381406|NCT01440101|76254428|FG000|Overall Study|Adverse Event|2|||
42381407|NCT01440101|76254429|FG001|Overall Study|Adverse Event|0|||
42381408|NCT01440101|76254430|FG002|Overall Study|Adverse Event|0|||
42381409|NCT01440101|76254428|FG000|Overall Study|Withdrawal by Subject|0|||
42381410|NCT01440101|76254429|FG001|Overall Study|Withdrawal by Subject|3|||
42381411|NCT01440101|76254430|FG002|Overall Study|Withdrawal by Subject|1|||
42381412|NCT01440101|76254428|FG000|Overall Study|Other|0|||
42381413|NCT01440101|76254429|FG001|Overall Study|Other|1|||
42381414|NCT01440101|76254430|FG002|Overall Study|Other|0|||
42108239|NCT00256867|75918886|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
42108240|NCT00256867|75918887|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
42108241|NCT00256867|75918888|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
42108242|NCT00256867|75918881|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
42108243|NCT00256867|75918882|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
42108244|NCT00256867|75918883|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
42108245|NCT00256867|75918884|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
42108246|NCT00256867|75918885|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
42108247|NCT00256867|75918886|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
42108248|NCT00256867|75918887|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
42108249|NCT00256867|75918888|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
42108250|NCT00256867|75918881|FG000|Overall Study|Investigator's Decision|0|||
42108251|NCT00256867|75918882|FG001|Overall Study|Investigator's Decision|0|||
42108252|NCT00256867|75918883|FG002|Overall Study|Investigator's Decision|0|||
42108253|NCT00256867|75918884|FG003|Overall Study|Investigator's Decision|0|||
42108254|NCT00256867|75918885|FG004|Overall Study|Investigator's Decision|1|||
42108255|NCT00256867|75918886|FG005|Overall Study|Investigator's Decision|0|||
42108256|NCT00256867|75918887|FG006|Overall Study|Investigator's Decision|0|||
42108257|NCT00256867|75918888|FG007|Overall Study|Investigator's Decision|0|||
42108258|NCT00256867|75918881|FG000|Overall Study|Non-compliance with study medication|0|||
42108259|NCT00256867|75918882|FG001|Overall Study|Non-compliance with study medication|0|||
42108260|NCT00256867|75918883|FG002|Overall Study|Non-compliance with study medication|0|||
42108261|NCT00256867|75918884|FG003|Overall Study|Non-compliance with study medication|0|||
42108262|NCT00256867|75918885|FG004|Overall Study|Non-compliance with study medication|0|||
42108263|NCT00256867|75918886|FG005|Overall Study|Non-compliance with study medication|0|||
42108264|NCT00256867|75918887|FG006|Overall Study|Non-compliance with study medication|0|||
42108265|NCT00256867|75918888|FG007|Overall Study|Non-compliance with study medication|1|||
42108266|NCT00256867|75918881|FG000|Overall Study|Participant travelled Overseas|0|||
42108267|NCT00256867|75918882|FG001|Overall Study|Participant travelled Overseas|1|||
42108268|NCT00256867|75918883|FG002|Overall Study|Participant travelled Overseas|0|||
42108269|NCT00256867|75918884|FG003|Overall Study|Participant travelled Overseas|0|||
42381415|NCT01530464|76254441|FG000|Washout (24h)|Withdrawal by Subject|1|||
42381416|NCT01530464|76254442|FG001|Washout (24h)|Withdrawal by Subject|0|||
42381417|NCT01530464|76254441|FG000|Washout (24h)|Withdrawal by Subject|0|||
42381418|NCT01530464|76254442|FG001|Washout (24h)|Withdrawal by Subject|1|||
42381419|NCT01439945|76254509|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
42381420|NCT01439945|76254510|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
42381421|NCT01439945|76254511|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
42381422|NCT01439945|76254512|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
42381423|NCT01439945|76254509|FG000|Double-Blind Treatment Phase|Ineligible|1|||
42108270|NCT00256867|75918885|FG004|Overall Study|Participant travelled Overseas|0|||
42108271|NCT00256867|75918886|FG005|Overall Study|Participant travelled Overseas|0|||
42108272|NCT00256867|75918887|FG006|Overall Study|Participant travelled Overseas|0|||
42108273|NCT00256867|75918888|FG007|Overall Study|Participant travelled Overseas|0|||
42108274|NCT00256867|75918881|FG000|Overall Study|Participant out of assessment window|0|||
42108275|NCT00256867|75918882|FG001|Overall Study|Participant out of assessment window|0|||
42108276|NCT00256867|75918883|FG002|Overall Study|Participant out of assessment window|1|||
42108277|NCT00256867|75918884|FG003|Overall Study|Participant out of assessment window|0|||
42108278|NCT00256867|75918885|FG004|Overall Study|Participant out of assessment window|0|||
42108279|NCT00256867|75918886|FG005|Overall Study|Participant out of assessment window|0|||
42108280|NCT00256867|75918887|FG006|Overall Study|Participant out of assessment window|0|||
42108281|NCT00256867|75918888|FG007|Overall Study|Participant out of assessment window|0|||
42108282|NCT00256867|75918881|FG000|Overall Study|Withdrawal by participant|0|||
42108283|NCT00256867|75918882|FG001|Overall Study|Withdrawal by participant|0|||
42108284|NCT00256867|75918883|FG002|Overall Study|Withdrawal by participant|0|||
42108285|NCT00256867|75918884|FG003|Overall Study|Withdrawal by participant|0|||
42108286|NCT00256867|75918885|FG004|Overall Study|Withdrawal by participant|0|||
42108287|NCT00256867|75918886|FG005|Overall Study|Withdrawal by participant|1|||
42108288|NCT00256867|75918887|FG006|Overall Study|Withdrawal by participant|0|||
42108289|NCT00256867|75918888|FG007|Overall Study|Withdrawal by participant|0|||
42108290|NCT00731939|75918911|FG000|Overall Study|Adverse Event|6|||
42108291|NCT00731939|75918911|FG000|Overall Study|Lost to Follow-up|15|||
42108292|NCT00731939|75918911|FG000|Overall Study|Not implanted with study device|9|||
42108293|NCT00731939|75918911|FG000|Overall Study|Withdrawal by Subject|2|||
42108294|NCT00731939|75918911|FG000|Overall Study|Did not meet enrollment criteria|2|||
42108295|NCT00731783|75918917|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
42108296|NCT00731783|75918918|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
42108297|NCT00731783|75918917|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
42108298|NCT00731783|75918918|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
42108299|NCT00731783|75918917|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
42108300|NCT00731783|75918918|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
42108301|NCT00731783|75918917|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
42108302|NCT00731783|75918918|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
42108303|NCT00724451|75918924|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
42108304|NCT00724451|75918924|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
42108305|NCT00724451|75918924|FG000|Overall Study|Not Eligible for Treatment|431|||
42108306|NCT00724451|75918924|FG000|Overall Study|Participant Refused Treatment|89|||
42108307|NCT00724451|75918924|FG000|Overall Study|Never Started Treatment|89|||
42108308|NCT00724451|75918924|FG000|Overall Study|Unknown; No Data Sources Available|9|||
42108309|NCT00724451|75918924|FG000|Overall Study|Physician Decision|116|||
42108310|NCT00724451|75918924|FG000|Overall Study|Withdrawal by Subject|45|||
42108311|NCT00724451|75918924|FG000|Overall Study|Investigator + Participant Decision|13|||
42108312|NCT00724373|75918928|FG000|Overall Study|Adverse Event|41|||
42108313|NCT00724373|75918928|FG000|Overall Study|Lack of Efficacy|82|||
42108314|NCT00724373|75918928|FG000|Overall Study|Lost to Follow-up|7|||
42108315|NCT00724373|75918928|FG000|Overall Study|Non-compliance|2|||
42108316|NCT00724373|75918928|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
42108317|NCT00724373|75918928|FG000|Overall Study|Participant moved away|1|||
42108318|NCT00724373|75918928|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
42108319|NCT00724373|75918928|FG000|Overall Study|Only to have 24 week regimen|1|||
42108320|NCT00724373|75918928|FG000|Overall Study|Viral Relapse|1|||
42108321|NCT00724373|75918928|FG000|Overall Study|Acute HCV infection|1|||
42108322|NCT00724373|75918928|FG000|Overall Study|Drug Relapse|1|||
42108323|NCT00724373|75918928|FG000|Overall Study|Tolerability|23|||
42108324|NCT00724061|75918932|FG000|Dose Escalation Phase|Adverse Event|2|||
42108325|NCT00724061|75918932|FG000|Dose Escalation Phase|Disease Progression|3|||
42108326|NCT00731549|75918936|FG000|Overall Study|Lost to Follow-up|19|||
42108327|NCT00731549|75918936|FG000|Overall Study|Met withdrawal criteria|24|||
42108328|NCT00731549|75918936|FG000|Overall Study|Physician Decision|16|||
42108329|NCT00731549|75918936|FG000|Overall Study|Withdrawal by Subject|89|||
42108330|NCT00731549|75918936|FG000|Overall Study|Protocol deviation|1|||
42108331|NCT00731549|75918936|FG000|Overall Study|Adverse Event|31|||
42108332|NCT00731549|75918936|FG000|Overall Study|Lack of efficacy with AE|37|||
42108333|NCT00731549|75918936|FG000|Overall Study|Lack of efficacy without AE|6|||
42108334|NCT00730925|75918981|FG000|Overall Study|Progressive Disease|21|||
42108335|NCT00730925|75918981|FG000|Overall Study|Dose reducing Event|2|||
42108336|NCT00730925|75918981|FG000|Overall Study|Other Averse Event|7|||
42108337|NCT00730925|75918981|FG000|Overall Study|Protocol Violation|1|||
42108338|NCT00730925|75918981|FG000|Overall Study|Withdrawal by Subject|1|||
42108339|NCT00730925|75918981|FG000|Overall Study|Switch to combination therapy|8|||
42108340|NCT00730925|75918981|FG000|Overall Study|Other|1|||
42108341|NCT00236899|75918989|FG000|Overall Study|Adverse Event (Study Related)|1|||
42108342|NCT00236899|75918990|FG001|Overall Study|Adverse Event (Study Related)|1|||
42202713|NCT03135262|76015377|FG002|Overall Study|Death|2|||
42108343|NCT00236899|75918991|FG002|Overall Study|Adverse Event (Study Related)|2|||
42108344|NCT00236899|75918992|FG003|Overall Study|Adverse Event (Study Related)|1|||
42108345|NCT00236899|75918989|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
42108346|NCT00236899|75918990|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
42108347|NCT00236899|75918991|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
42108348|NCT00236899|75918992|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
42108349|NCT00236899|75918989|FG000|Overall Study|Death (Study Disease)|1|||
42108350|NCT00236899|75918990|FG001|Overall Study|Death (Study Disease)|4|||
42108351|NCT00236899|75918991|FG002|Overall Study|Death (Study Disease)|0|||
42108352|NCT00236899|75918992|FG003|Overall Study|Death (Study Disease)|0|||
42108353|NCT00236899|75918989|FG000|Overall Study|Death (Not Study Related)|2|||
42108354|NCT00236899|75918990|FG001|Overall Study|Death (Not Study Related)|0|||
42108355|NCT00236899|75918991|FG002|Overall Study|Death (Not Study Related)|0|||
42108356|NCT00236899|75918992|FG003|Overall Study|Death (Not Study Related)|0|||
42108357|NCT00236899|75918989|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
42108358|NCT00236899|75918990|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
42108359|NCT00236899|75918991|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
42108360|NCT00236899|75918992|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
42108361|NCT00236899|75918989|FG000|Overall Study|Lost to Follow-up|0|||
42108362|NCT00236899|75918990|FG001|Overall Study|Lost to Follow-up|1|||
42108363|NCT00236899|75918991|FG002|Overall Study|Lost to Follow-up|0|||
42108364|NCT00236899|75918992|FG003|Overall Study|Lost to Follow-up|0|||
42108365|NCT00236899|75918989|FG000|Overall Study|Entry Criteria Exclusion|0|||
42108366|NCT00236899|75918990|FG001|Overall Study|Entry Criteria Exclusion|1|||
42108367|NCT00236899|75918991|FG002|Overall Study|Entry Criteria Exclusion|1|||
42108368|NCT00236899|75918992|FG003|Overall Study|Entry Criteria Exclusion|0|||
42108369|NCT00236899|75918989|FG000|Overall Study|Protocol Violation|1|||
42108370|NCT00236899|75918990|FG001|Overall Study|Protocol Violation|0|||
42108371|NCT00236899|75918991|FG002|Overall Study|Protocol Violation|0|||
42108372|NCT00236899|75918992|FG003|Overall Study|Protocol Violation|0|||
42108373|NCT00236899|75918989|FG000|Overall Study|Withdrawal by Subject|6|||
42108374|NCT00236899|75918990|FG001|Overall Study|Withdrawal by Subject|4|||
42108375|NCT00236899|75918991|FG002|Overall Study|Withdrawal by Subject|5|||
42108376|NCT00236899|75918992|FG003|Overall Study|Withdrawal by Subject|2|||
42108377|NCT00236899|75918989|FG000|Overall Study|Physician Decision|7|||
42108378|NCT00236899|75918990|FG001|Overall Study|Physician Decision|8|||
42108379|NCT00236899|75918991|FG002|Overall Study|Physician Decision|7|||
42108380|NCT00236899|75918992|FG003|Overall Study|Physician Decision|6|||
42108381|NCT00236899|75918989|FG000|Overall Study|Satisfactory Response|2|||
42108382|NCT00236899|75918990|FG001|Overall Study|Satisfactory Response|0|||
42108383|NCT00236899|75918991|FG002|Overall Study|Satisfactory Response|0|||
42108384|NCT00236899|75918992|FG003|Overall Study|Satisfactory Response|1|||
42108385|NCT00236899|75918989|FG000|Overall Study|Lack of Efficacy|18|||
42108386|NCT00236899|75918990|FG001|Overall Study|Lack of Efficacy|18|||
42108387|NCT00236899|75918991|FG002|Overall Study|Lack of Efficacy|25|||
42108388|NCT00236899|75918992|FG003|Overall Study|Lack of Efficacy|23|||
42108389|NCT00611130|75919011|FG000|Overall Study|Lost to Follow-up|25|||
42108390|NCT00611130|75919012|FG001|Overall Study|Lost to Follow-up|29|||
42108391|NCT00611130|75919011|FG000|Overall Study|Protocol noncompliance|7|||
42108392|NCT00611130|75919012|FG001|Overall Study|Protocol noncompliance|6|||
42108393|NCT00611130|75919011|FG000|Overall Study|Withdrawal by Subject|6|||
42108394|NCT00611130|75919012|FG001|Overall Study|Withdrawal by Subject|5|||
42108395|NCT00611130|75919011|FG000|Overall Study|Other|5|||
42108396|NCT00611130|75919012|FG001|Overall Study|Other|4|||
42108397|NCT00611130|75919011|FG000|Overall Study|Incarceration|3|||
42108398|NCT00611130|75919012|FG001|Overall Study|Incarceration|2|||
42108399|NCT00611130|75919011|FG000|Overall Study|Administrative|1|||
42108400|NCT00611130|75919012|FG001|Overall Study|Administrative|1|||
42108401|NCT00611130|75919011|FG000|Overall Study|Adverse Event|1|||
42108402|NCT00611130|75919012|FG001|Overall Study|Adverse Event|0|||
42108403|NCT00611130|75919011|FG000|Overall Study|Death|1|||
42108404|NCT00611130|75919012|FG001|Overall Study|Death|0|||
42108405|NCT00256243|75919019|FG000|Overall Study|Lost to Follow-up|2|||
42108406|NCT00256243|75919019|FG000|Overall Study|Death|7|||
42108407|NCT00256243|75919019|FG000|Overall Study|Not treated|1|||
42108408|NCT00236197|75919026|FG000|Overall Study|Withdrawal by Subject|3|||
42108409|NCT00236197|75919027|FG001|Overall Study|Withdrawal by Subject|2|||
42108410|NCT00236197|75919026|FG000|Overall Study|Lost to Follow-up|1|||
42108411|NCT00236197|75919027|FG001|Overall Study|Lost to Follow-up|5|||
42108412|NCT00236197|75919026|FG000|Overall Study|Protocol Violation|0|||
42108413|NCT00236197|75919027|FG001|Overall Study|Protocol Violation|3|||
42108414|NCT00236197|75919026|FG000|Overall Study|Medication non-compliance|1|||
42108415|NCT00236197|75919027|FG001|Overall Study|Medication non-compliance|2|||
42108416|NCT00236197|75919026|FG000|Overall Study|Other|0|||
42108417|NCT00236197|75919027|FG001|Overall Study|Other|2|||
42108418|NCT00278629|75919033|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
42108419|NCT00612690|75919040|FG000|Overall Study|Lost to Follow-up|72|||
42108420|NCT00612690|75919041|FG001|Overall Study|Lost to Follow-up|98|||
42108421|NCT00612690|75919040|FG000|Overall Study|Withdrawal by Subject|32|||
42108422|NCT00612690|75919041|FG001|Overall Study|Withdrawal by Subject|20|||
42108423|NCT00612690|75919040|FG000|Overall Study|Withdrawal by Site|11|||
42108424|NCT00612690|75919041|FG001|Overall Study|Withdrawal by Site|0|||
42108425|NCT00278473|75919051|FG000|Overall Study|drop out|4|||
42108426|NCT00278473|75919052|FG001|Overall Study|drop out|3|||
42108427|NCT00278395|75919058|FG000|Overall Study|Adverse Event|2|||
42108428|NCT00278395|75919058|FG000|Overall Study|Nonevaluable|1|||
42108429|NCT00612534|75919069|FG000|Overall Study|Adverse Event|0|||
42108430|NCT00612534|75919070|FG001|Overall Study|Adverse Event|4|||
42108431|NCT00612534|75919071|FG002|Overall Study|Adverse Event|2|||
42108432|NCT00612534|75919072|FG003|Overall Study|Adverse Event|1|||
42108433|NCT00612534|75919069|FG000|Overall Study|Lack of Efficacy|13|||
42108434|NCT00612534|75919070|FG001|Overall Study|Lack of Efficacy|12|||
42108435|NCT00612534|75919071|FG002|Overall Study|Lack of Efficacy|5|||
42108436|NCT00612534|75919072|FG003|Overall Study|Lack of Efficacy|16|||
42108437|NCT00612534|75919069|FG000|Overall Study|Other Reason|0|||
42108438|NCT00612534|75919070|FG001|Overall Study|Other Reason|1|||
42108439|NCT00612534|75919071|FG002|Overall Study|Other Reason|0|||
42108440|NCT00612534|75919072|FG003|Overall Study|Other Reason|0|||
42108441|NCT00736853|75919082|FG000|Open-Label Period|Physician Decision|2|||
42108442|NCT00736853|75919083|FG001|Open-Label Period|Physician Decision|0|||
42108443|NCT00736853|75919084|FG002|Open-Label Period|Physician Decision|0|||
42108444|NCT00736853|75919082|FG000|Open-Label Period|Adverse Event|31|||
42108445|NCT00736853|75919083|FG001|Open-Label Period|Adverse Event|0|||
42108446|NCT00736853|75919084|FG002|Open-Label Period|Adverse Event|0|||
42108447|NCT00736853|75919082|FG000|Open-Label Period|Withdrawal by Subject|16|||
42108448|NCT00736853|75919083|FG001|Open-Label Period|Withdrawal by Subject|0|||
42108449|NCT00736853|75919084|FG002|Open-Label Period|Withdrawal by Subject|0|||
42108450|NCT00736853|75919082|FG000|Open-Label Period|Started but not treated|42|||
42108451|NCT00736853|75919083|FG001|Open-Label Period|Started but not treated|0|||
42108452|NCT00736853|75919084|FG002|Open-Label Period|Started but not treated|0|||
42108453|NCT00736853|75919082|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
42108454|NCT00736853|75919083|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
42108455|NCT00736853|75919084|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
42108456|NCT00736853|75919082|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
42108457|NCT00736853|75919083|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
42108458|NCT00736853|75919084|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
42108459|NCT00736853|75919082|FG000|Double-Blind Period|Lack of Efficacy|0|||
42108460|NCT00736853|75919083|FG001|Double-Blind Period|Lack of Efficacy|19|||
42108461|NCT00736853|75919084|FG002|Double-Blind Period|Lack of Efficacy|42|||
42108462|NCT00736853|75919082|FG000|Double-Blind Period|Adverse Event|0|||
42108463|NCT00736853|75919083|FG001|Double-Blind Period|Adverse Event|3|||
42108464|NCT00736853|75919084|FG002|Double-Blind Period|Adverse Event|2|||
42108465|NCT00736853|75919082|FG000|Double-Blind Period|Withdrawal by Subject|0|||
42108466|NCT00736853|75919083|FG001|Double-Blind Period|Withdrawal by Subject|1|||
42108467|NCT00736853|75919084|FG002|Double-Blind Period|Withdrawal by Subject|4|||
42108468|NCT00736853|75919082|FG000|Double-Blind Period|Ineligible to participate the study|0|||
42108469|NCT00736853|75919083|FG001|Double-Blind Period|Ineligible to participate the study|1|||
42108470|NCT00736853|75919084|FG002|Double-Blind Period|Ineligible to participate the study|0|||
42108471|NCT00730847|75919093|FG000|Overall Study|Adverse Event|1|||
42108472|NCT00730847|75919093|FG000|Overall Study|Protocol Violation|2|||
42108473|NCT00730847|75919093|FG000|Overall Study|Withdrawal by Subject|16|||
42108474|NCT00730847|75919093|FG000|Overall Study|Lost to Follow-up|67|||
42108475|NCT00730847|75919093|FG000|Overall Study|Unknown completion status|21|||
42108476|NCT00730847|75919093|FG000|Overall Study|Other|24|||
42108477|NCT00573066|75919097|FG000|Overall Study|Exclusion criteria|18|||
42108478|NCT00573066|75919097|FG000|Overall Study|IV malfunction|1|||
42108479|NCT00573066|75919097|FG000|Overall Study|Postoperative bleeding|1|||
42108480|NCT00612456|75919104|FG000|Overall Study|Adverse Event|1|||
42108481|NCT00612456|75919105|FG001|Overall Study|Adverse Event|0|||
42108482|NCT00612456|75919106|FG002|Overall Study|Adverse Event|0|||
42108483|NCT00612456|75919104|FG000|Overall Study|Lack of Efficacy|1|||
42108484|NCT00612456|75919105|FG001|Overall Study|Lack of Efficacy|1|||
42381424|NCT01439945|76254510|FG001|Double-Blind Treatment Phase|Ineligible|2|||
42108485|NCT00612456|75919106|FG002|Overall Study|Lack of Efficacy|0|||
42108486|NCT00612456|75919104|FG000|Overall Study|Withdrawal by Subject|0|||
42381425|NCT01439945|76254511|FG002|Double-Blind Treatment Phase|Ineligible|0|||
42108487|NCT00612456|75919105|FG001|Overall Study|Withdrawal by Subject|1|||
42108488|NCT00612456|75919106|FG002|Overall Study|Withdrawal by Subject|0|||
42108489|NCT00730691|75919121|FG000|Overall Study|Adverse Event|4|||
42108490|NCT00730691|75919122|FG001|Overall Study|Adverse Event|8|||
42108491|NCT00730691|75919123|FG002|Overall Study|Adverse Event|11|||
42108492|NCT00730691|75919124|FG003|Overall Study|Adverse Event|11|||
42108493|NCT00730691|75919125|FG004|Overall Study|Adverse Event|23|||
42108494|NCT00730691|75919121|FG000|Overall Study|Lack of Efficacy|4|||
42108495|NCT00730691|75919122|FG001|Overall Study|Lack of Efficacy|4|||
42108496|NCT00730691|75919123|FG002|Overall Study|Lack of Efficacy|2|||
42108497|NCT00730691|75919124|FG003|Overall Study|Lack of Efficacy|1|||
42108498|NCT00730691|75919125|FG004|Overall Study|Lack of Efficacy|1|||
42108499|NCT00730691|75919121|FG000|Overall Study|Non-compliance with Study Drug|6|||
42108500|NCT00730691|75919122|FG001|Overall Study|Non-compliance with Study Drug|1|||
42108501|NCT00730691|75919123|FG002|Overall Study|Non-compliance with Study Drug|6|||
42108502|NCT00730691|75919124|FG003|Overall Study|Non-compliance with Study Drug|3|||
42108503|NCT00730691|75919125|FG004|Overall Study|Non-compliance with Study Drug|3|||
42108504|NCT00730691|75919121|FG000|Overall Study|Protocol Deviations|3|||
42108505|NCT00730691|75919122|FG001|Overall Study|Protocol Deviations|5|||
42108506|NCT00730691|75919123|FG002|Overall Study|Protocol Deviations|3|||
42108507|NCT00730691|75919124|FG003|Overall Study|Protocol Deviations|7|||
42108508|NCT00730691|75919125|FG004|Overall Study|Protocol Deviations|5|||
42108509|NCT00730691|75919121|FG000|Overall Study|Withdrawal of Consent|7|||
42108510|NCT00730691|75919122|FG001|Overall Study|Withdrawal of Consent|9|||
42108511|NCT00730691|75919123|FG002|Overall Study|Withdrawal of Consent|3|||
42108512|NCT00730691|75919124|FG003|Overall Study|Withdrawal of Consent|6|||
42108513|NCT00730691|75919125|FG004|Overall Study|Withdrawal of Consent|3|||
42108514|NCT00730691|75919121|FG000|Overall Study|Lost to Follow-up|11|||
42108515|NCT00730691|75919122|FG001|Overall Study|Lost to Follow-up|8|||
42108516|NCT00730691|75919123|FG002|Overall Study|Lost to Follow-up|13|||
42108517|NCT00730691|75919124|FG003|Overall Study|Lost to Follow-up|15|||
42108518|NCT00730691|75919125|FG004|Overall Study|Lost to Follow-up|13|||
42108519|NCT00730691|75919121|FG000|Overall Study|Other|1|||
42108520|NCT00730691|75919122|FG001|Overall Study|Other|1|||
42108521|NCT00730691|75919123|FG002|Overall Study|Other|1|||
42108522|NCT00730691|75919124|FG003|Overall Study|Other|2|||
42108523|NCT00730691|75919125|FG004|Overall Study|Other|2|||
42108524|NCT00235495|75919139|FG000|Overall Study|Death|52|||
42108525|NCT00235495|75919140|FG001|Overall Study|Death|42|||
42108526|NCT00235495|75919139|FG000|Overall Study|Withdrawal by Subject|5|||
42108527|NCT00235495|75919140|FG001|Overall Study|Withdrawal by Subject|3|||
42108528|NCT00235495|75919139|FG000|Overall Study|Lost to Follow-up|11|||
42108529|NCT00235495|75919140|FG001|Overall Study|Lost to Follow-up|13|||
42108530|NCT00235495|75919139|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
42108531|NCT00235495|75919140|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
42108532|NCT00278161|75919146|FG000|Overall Study|Death|11|||
42202714|NCT03135262|76015378|FG003|Overall Study|Death|2|||
42202715|NCT03135262|76015379|FG004|Overall Study|Death|0|||
42202716|NCT03135262|76015375|FG000|Overall Study|Withdrawal by Subject|0|||
42202717|NCT03135262|76015376|FG001|Overall Study|Withdrawal by Subject|0|||
42202718|NCT03135262|76015377|FG002|Overall Study|Withdrawal by Subject|1|||
42202719|NCT03135262|76015378|FG003|Overall Study|Withdrawal by Subject|0|||
42202720|NCT03135262|76015379|FG004|Overall Study|Withdrawal by Subject|1|||
42202721|NCT03135262|76015375|FG000|Overall Study|Study terminated by sponsor|2|||
42202722|NCT03135262|76015376|FG001|Overall Study|Study terminated by sponsor|4|||
42202723|NCT03135262|76015377|FG002|Overall Study|Study terminated by sponsor|4|||
42202724|NCT03135262|76015378|FG003|Overall Study|Study terminated by sponsor|3|||
42202725|NCT03135262|76015379|FG004|Overall Study|Study terminated by sponsor|0|||
42202726|NCT03535194|76015414|FG000|Induction Period|Adverse Event|2|||
42202727|NCT03535194|76015415|FG001|Induction Period|Adverse Event|2|||
42202728|NCT03535194|76015416|FG002|Induction Period|Adverse Event|1|||
42202729|NCT03535194|76015417|FG003|Induction Period|Adverse Event|3|||
42202730|NCT03535194|76015418|FG004|Induction Period|Adverse Event|0|||
42202731|NCT03535194|76015414|FG000|Induction Period|Death|0|||
42202732|NCT03535194|76015415|FG001|Induction Period|Death|1|||
42202733|NCT03535194|76015416|FG002|Induction Period|Death|0|||
42202734|NCT03535194|76015417|FG003|Induction Period|Death|0|||
42202735|NCT03535194|76015418|FG004|Induction Period|Death|0|||
42202736|NCT03535194|76015414|FG000|Induction Period|Lack of Efficacy|1|||
42202737|NCT03535194|76015415|FG001|Induction Period|Lack of Efficacy|3|||
42202738|NCT03535194|76015416|FG002|Induction Period|Lack of Efficacy|2|||
42202739|NCT03535194|76015417|FG003|Induction Period|Lack of Efficacy|2|||
42202740|NCT03535194|76015418|FG004|Induction Period|Lack of Efficacy|0|||
42202741|NCT03535194|76015414|FG000|Induction Period|Lost to Follow-up|3|||
42202742|NCT03535194|76015415|FG001|Induction Period|Lost to Follow-up|5|||
42202743|NCT03535194|76015416|FG002|Induction Period|Lost to Follow-up|2|||
42202744|NCT03535194|76015417|FG003|Induction Period|Lost to Follow-up|3|||
42202745|NCT03535194|76015418|FG004|Induction Period|Lost to Follow-up|0|||
42202746|NCT03535194|76015414|FG000|Induction Period|Physician Decision|1|||
42202747|NCT03535194|76015415|FG001|Induction Period|Physician Decision|1|||
42202748|NCT03535194|76015416|FG002|Induction Period|Physician Decision|0|||
42202749|NCT03535194|76015417|FG003|Induction Period|Physician Decision|0|||
42202750|NCT03535194|76015418|FG004|Induction Period|Physician Decision|0|||
42202751|NCT03535194|76015414|FG000|Induction Period|Protocol Violation|1|||
42108533|NCT00255151|75919153|FG000|Overall Study|Adverse Event|10|||
42108534|NCT00255151|75919154|FG001|Overall Study|Adverse Event|6|||
42108535|NCT00255151|75919155|FG002|Overall Study|Adverse Event|9|||
42108536|NCT00255151|75919153|FG000|Overall Study|Lost to Follow-up|4|||
42108537|NCT00255151|75919154|FG001|Overall Study|Lost to Follow-up|3|||
42108538|NCT00255151|75919155|FG002|Overall Study|Lost to Follow-up|4|||
42108539|NCT00255151|75919153|FG000|Overall Study|Withdrawal by Subject|18|||
42108540|NCT00255151|75919154|FG001|Overall Study|Withdrawal by Subject|17|||
42108541|NCT00255151|75919155|FG002|Overall Study|Withdrawal by Subject|8|||
42108542|NCT00255151|75919153|FG000|Overall Study|Noncompliance|0|||
42108543|NCT00255151|75919154|FG001|Overall Study|Noncompliance|1|||
42108544|NCT00255151|75919155|FG002|Overall Study|Noncompliance|2|||
42108545|NCT00255151|75919153|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
42108546|NCT00255151|75919154|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
42018857|NCT01254227|75826245|FG000|Overall Study|Abnormal test procedure result|5|||
42018858|NCT01254227|75826245|FG000|Overall Study|Administrative problems|2|||
42108547|NCT00255151|75919155|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
42108548|NCT00255151|75919153|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
42108549|NCT00255151|75919154|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
42108550|NCT00255151|75919155|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
42108551|NCT00255151|75919153|FG000|Overall Study|Possible Barrett's Esophagus|1|||
42381426|NCT01439945|76254512|FG003|Double-Blind Treatment Phase|Ineligible|1|||
42381427|NCT01420081|76254617|FG000|Overall Study|Death|1|||
42381428|NCT01420081|76254618|FG001|Overall Study|Death|0|||
42381429|NCT01420081|76254619|FG002|Overall Study|Death|8|||
42381430|NCT01420081|76254620|FG003|Overall Study|Death|0|||
42381431|NCT01420081|76254621|FG004|Overall Study|Death|7|||
42108552|NCT00255151|75919154|FG001|Overall Study|Possible Barrett's Esophagus|3|||
42108553|NCT00255151|75919155|FG002|Overall Study|Possible Barrett's Esophagus|8|||
42108554|NCT00255151|75919153|FG000|Overall Study|Esophageal Stricture|0|||
42108555|NCT00255151|75919154|FG001|Overall Study|Esophageal Stricture|0|||
42108556|NCT00255151|75919155|FG002|Overall Study|Esophageal Stricture|1|||
42108557|NCT00255151|75919153|FG000|Overall Study|Therapeutic Failure|11|||
42108558|NCT00255151|75919154|FG001|Overall Study|Therapeutic Failure|2|||
42108559|NCT00255151|75919155|FG002|Overall Study|Therapeutic Failure|3|||
42108560|NCT00658658|75919168|FG000|Overall Study|Withdrawal by Subject|0|||
42108561|NCT00658658|75919169|FG001|Overall Study|Withdrawal by Subject|1|||
42108562|NCT00658658|75919170|FG002|Overall Study|Withdrawal by Subject|0|||
42108563|NCT00658658|75919171|FG003|Overall Study|Withdrawal by Subject|0|||
42108564|NCT00658658|75919172|FG004|Overall Study|Withdrawal by Subject|0|||
42108565|NCT00658658|75919168|FG000|Overall Study|Death|4|||
42108566|NCT00658658|75919169|FG001|Overall Study|Death|0|||
42108567|NCT00658658|75919170|FG002|Overall Study|Death|0|||
42108568|NCT00658658|75919171|FG003|Overall Study|Death|1|||
42108569|NCT00658658|75919172|FG004|Overall Study|Death|1|||
42108570|NCT00658658|75919168|FG000|Overall Study|Disease Progression|0|||
42108571|NCT00658658|75919169|FG001|Overall Study|Disease Progression|1|||
42108572|NCT00658658|75919170|FG002|Overall Study|Disease Progression|0|||
42108573|NCT00658658|75919171|FG003|Overall Study|Disease Progression|1|||
42108574|NCT00658658|75919172|FG004|Overall Study|Disease Progression|3|||
42108575|NCT00658658|75919168|FG000|Overall Study|Protocol-specified Criteria|1|||
42108576|NCT00658658|75919169|FG001|Overall Study|Protocol-specified Criteria|0|||
42108577|NCT00658658|75919170|FG002|Overall Study|Protocol-specified Criteria|0|||
42108578|NCT00658658|75919171|FG003|Overall Study|Protocol-specified Criteria|0|||
42108579|NCT00658658|75919172|FG004|Overall Study|Protocol-specified Criteria|0|||
42108580|NCT00658658|75919168|FG000|Overall Study|Other|0|||
42108581|NCT00658658|75919169|FG001|Overall Study|Other|0|||
42108582|NCT00658658|75919170|FG002|Overall Study|Other|0|||
42108583|NCT00658658|75919171|FG003|Overall Study|Other|0|||
42108584|NCT00658658|75919172|FG004|Overall Study|Other|1|||
42108585|NCT00723203|75919184|FG000|Overall Study|Withdrawal by Subject|3|||
42108586|NCT00233389|75919190|FG000|Overall Study|Adverse Event|5|||
42108587|NCT00233389|75919191|FG001|Overall Study|Adverse Event|5|||
42108588|NCT00233389|75919190|FG000|Overall Study|Lack of Efficacy|11|||
42108589|NCT00233389|75919191|FG001|Overall Study|Lack of Efficacy|8|||
42108590|NCT00233389|75919190|FG000|Overall Study|Lost to Follow-up|1|||
42018859|NCT01254227|75826245|FG000|Overall Study|Death|1|||
42018860|NCT01254227|75826245|FG000|Overall Study|Protocol deviation|1|||
42018861|NCT00995410|75826249|FG000|Overall Study|Adverse Event|51|||
42018862|NCT00995410|75826249|FG000|Overall Study|Withdrawal by Subject|7|||
42018863|NCT00995410|75826249|FG000|Overall Study|Lost to Follow-up|2|||
42018864|NCT00995410|75826249|FG000|Overall Study|Misc|28|||
42018865|NCT00995020|75826255|FG000|Overall Study|margin analysis not performed|2|||
42018866|NCT00995020|75826256|FG001|Overall Study|margin analysis not performed|5|||
42018867|NCT00995020|75826255|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
42018868|NCT00995020|75826256|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
42018869|NCT01122381|75826266|FG000|Overall Study|study terminated early|0|||
42108591|NCT00233389|75919191|FG001|Overall Study|Lost to Follow-up|1|||
42108592|NCT00233389|75919190|FG000|Overall Study|Physician Decision|1|||
42108593|NCT00233389|75919191|FG001|Overall Study|Physician Decision|0|||
42108594|NCT00233389|75919190|FG000|Overall Study|Protocol Violation|0|||
42381432|NCT01420081|76254622|FG005|Overall Study|Death|12|||
42381433|NCT01420081|76254623|FG006|Overall Study|Death|0|||
42108595|NCT00233389|75919191|FG001|Overall Study|Protocol Violation|1|||
42108596|NCT00233389|75919190|FG000|Overall Study|Withdrawal by Subject|0|||
42108597|NCT00233389|75919191|FG001|Overall Study|Withdrawal by Subject|1|||
42108598|NCT00649220|75919197|FG000|Overall Study|Adverse Event|2|||
42108599|NCT00649220|75919197|FG000|Overall Study|Withdrawal by Subject|1|||
42108600|NCT00654368|75919204|FG000|Overall Study|Ineligibility determined|6|||
42108601|NCT00654368|75919205|FG001|Overall Study|Ineligibility determined|0|||
42108602|NCT00654368|75919206|FG002|Overall Study|Ineligibility determined|0|||
42108603|NCT00654368|75919204|FG000|Overall Study|Protocol deviation|3|||
42108604|NCT00654368|75919205|FG001|Overall Study|Protocol deviation|2|||
42108605|NCT00654368|75919206|FG002|Overall Study|Protocol deviation|1|||
42108606|NCT00654368|75919204|FG000|Overall Study|Non-compliance|2|||
42108607|NCT00654368|75919205|FG001|Overall Study|Non-compliance|1|||
42108608|NCT00654368|75919206|FG002|Overall Study|Non-compliance|2|||
42108609|NCT00654368|75919204|FG000|Overall Study|Withdrawal by Subject|5|||
42108610|NCT00654368|75919205|FG001|Overall Study|Withdrawal by Subject|2|||
42108611|NCT00654368|75919206|FG002|Overall Study|Withdrawal by Subject|2|||
42108612|NCT00654368|75919204|FG000|Overall Study|Disease progression|21|||
42108613|NCT00654368|75919205|FG001|Overall Study|Disease progression|31|||
42108614|NCT00654368|75919206|FG002|Overall Study|Disease progression|13|||
42108615|NCT00654368|75919204|FG000|Overall Study|Requirement for alternative therapy|1|||
42108616|NCT00654368|75919205|FG001|Overall Study|Requirement for alternative therapy|1|||
42108617|NCT00654368|75919206|FG002|Overall Study|Requirement for alternative therapy|1|||
42108618|NCT00654368|75919204|FG000|Overall Study|Physician Decision|0|||
42108619|NCT00654368|75919205|FG001|Overall Study|Physician Decision|0|||
42108620|NCT00654368|75919206|FG002|Overall Study|Physician Decision|2|||
42108621|NCT00654368|75919204|FG000|Overall Study|Death|1|||
42108622|NCT00654368|75919205|FG001|Overall Study|Death|0|||
42108623|NCT00654368|75919206|FG002|Overall Study|Death|0|||
42108624|NCT00654368|75919204|FG000|Overall Study|Pregnancy|0|||
42108625|NCT00654368|75919205|FG001|Overall Study|Pregnancy|0|||
42108626|NCT00654368|75919206|FG002|Overall Study|Pregnancy|2|||
42108627|NCT00654368|75919204|FG000|Overall Study|Other|0|||
42108628|NCT00654368|75919205|FG001|Overall Study|Other|2|||
42108629|NCT00654368|75919206|FG002|Overall Study|Other|3|||
42108630|NCT00654368|75919204|FG000|Overall Study|Adverse Event|14|||
42108631|NCT00654368|75919205|FG001|Overall Study|Adverse Event|9|||
42108632|NCT00654368|75919206|FG002|Overall Study|Adverse Event|6|||
42108633|NCT00647426|75919213|FG000|Overall Study|Withdrawal by Subject|2|||
42108634|NCT00647348|75919220|FG000|Overall Study|Lost to Follow-up|3|||
42108635|NCT00647348|75919221|FG001|Overall Study|Lost to Follow-up|6|||
42108636|NCT00647270|75919230|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
42108637|NCT00647270|75919231|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
42108638|NCT00647270|75919232|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
42108639|NCT00647270|75919230|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
42108640|NCT00647270|75919231|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
42108641|NCT00647270|75919232|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
42108642|NCT00647270|75919230|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
42108643|NCT00647270|75919231|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
42108644|NCT00647270|75919232|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
42108645|NCT00647270|75919230|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
42108646|NCT00647270|75919231|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
42108647|NCT00647270|75919232|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
42108648|NCT00647270|75919230|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
42108649|NCT00647270|75919231|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
42108650|NCT00647270|75919232|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
42202752|NCT03535194|76015415|FG001|Induction Period|Protocol Violation|0|||
42108651|NCT00647270|75919230|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
42108652|NCT00647270|75919231|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
42108653|NCT00647270|75919232|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
42108654|NCT00647270|75919230|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
42108655|NCT00647270|75919231|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
42202753|NCT03535194|76015416|FG002|Induction Period|Protocol Violation|0|||
42202754|NCT03535194|76015417|FG003|Induction Period|Protocol Violation|1|||
42202755|NCT03535194|76015418|FG004|Induction Period|Protocol Violation|0|||
42108656|NCT00647270|75919232|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
42108657|NCT00645944|75919245|FG000|Randomized|Withdrawal by Subject|1|||
42108658|NCT00645944|75919246|FG001|Randomized|Withdrawal by Subject|2|||
42108659|NCT00645944|75919245|FG000|Received Medication|Adverse Event|2|||
42108660|NCT00645944|75919246|FG001|Received Medication|Adverse Event|1|||
42108661|NCT00645944|75919245|FG000|Received Medication|Withdrawal by Subject|1|||
42108662|NCT00645944|75919246|FG001|Received Medication|Withdrawal by Subject|1|||
42108663|NCT00645944|75919245|FG000|Received Medication|Lost to Follow-up|1|||
42108664|NCT00645944|75919246|FG001|Received Medication|Lost to Follow-up|0|||
42108665|NCT00645944|75919245|FG000|Received Medication|Protocol Violation|2|||
42108666|NCT00645944|75919246|FG001|Received Medication|Protocol Violation|1|||
42108667|NCT00646958|75919255|FG000|Overall Study|Lack of Efficacy|1|||
42108668|NCT00646958|75919256|FG001|Overall Study|Lack of Efficacy|0|||
42108669|NCT00646958|75919257|FG002|Overall Study|Lack of Efficacy|0|||
42108670|NCT00646958|75919255|FG000|Overall Study|Adverse Event|4|||
42108671|NCT00646958|75919256|FG001|Overall Study|Adverse Event|0|||
42108672|NCT00646958|75919257|FG002|Overall Study|Adverse Event|0|||
42108673|NCT00646958|75919255|FG000|Overall Study|Lost to Follow-up|1|||
42108674|NCT00646958|75919256|FG001|Overall Study|Lost to Follow-up|5|||
42108675|NCT00646958|75919257|FG002|Overall Study|Lost to Follow-up|7|||
42108676|NCT00646958|75919255|FG000|Overall Study|Protocol Violation|1|||
42108677|NCT00646958|75919256|FG001|Overall Study|Protocol Violation|1|||
42108678|NCT00646958|75919257|FG002|Overall Study|Protocol Violation|0|||
42108679|NCT00646958|75919255|FG000|Overall Study|Abnormal screening lab tests|1|||
42108680|NCT00646958|75919256|FG001|Overall Study|Abnormal screening lab tests|1|||
42108681|NCT00646958|75919257|FG002|Overall Study|Abnormal screening lab tests|0|||
42108682|NCT00646958|75919255|FG000|Overall Study|Withdrawal by Subject|1|||
42108683|NCT00646958|75919256|FG001|Overall Study|Withdrawal by Subject|2|||
42108684|NCT00646958|75919257|FG002|Overall Study|Withdrawal by Subject|0|||
42108685|NCT00646958|75919255|FG000|Overall Study|Did not receive study drug|2|||
42108686|NCT00646958|75919256|FG001|Overall Study|Did not receive study drug|0|||
42108687|NCT00646958|75919257|FG002|Overall Study|Did not receive study drug|2|||
42108688|NCT00642746|75919267|FG000|Overall Study|Patient unevaluable|1|||
42108689|NCT00642746|75919268|FG001|Overall Study|Patient unevaluable|0|||
42108690|NCT00642668|75919274|FG000|Overall Study|Lost to Follow-up|1|||
42108691|NCT00642668|75919274|FG000|Overall Study|Adverse Event|2|||
42108692|NCT00642668|75919274|FG000|Overall Study|Death|2|||
42108693|NCT00642668|75919274|FG000|Overall Study|Insufficient Therapeutic Response|1|||
42108694|NCT00642668|75919274|FG000|Overall Study|Failure to Return|1|||
42108695|NCT00642668|75919274|FG000|Overall Study|Dialysis Initiation|5|||
42108696|NCT00642668|75919274|FG000|Overall Study|Blood Transfusion|2|||
42108697|NCT00729833|75919278|FG000|Overall Study|Death|5|||
42108698|NCT00729833|75919279|FG001|Overall Study|Death|1|||
42108699|NCT00729833|75919280|FG002|Overall Study|Death|3|||
42108700|NCT00729833|75919281|FG003|Overall Study|Death|5|||
42108701|NCT00729833|75919278|FG000|Overall Study|Study Terminated by Sponsor|0|||
42108702|NCT00729833|75919279|FG001|Overall Study|Study Terminated by Sponsor|0|||
42108703|NCT00729833|75919280|FG002|Overall Study|Study Terminated by Sponsor|1|||
42108704|NCT00729833|75919281|FG003|Overall Study|Study Terminated by Sponsor|0|||
42108705|NCT00729833|75919278|FG000|Overall Study|Lost to Follow-up|1|||
42108706|NCT00729833|75919279|FG001|Overall Study|Lost to Follow-up|0|||
42108707|NCT00729833|75919280|FG002|Overall Study|Lost to Follow-up|0|||
42108708|NCT00729833|75919281|FG003|Overall Study|Lost to Follow-up|0|||
42108709|NCT00729833|75919278|FG000|Overall Study|Withdrawal by Subject|3|||
42108710|NCT00729833|75919279|FG001|Overall Study|Withdrawal by Subject|1|||
42108711|NCT00729833|75919280|FG002|Overall Study|Withdrawal by Subject|3|||
42108712|NCT00729833|75919281|FG003|Overall Study|Withdrawal by Subject|0|||
42108713|NCT00729833|75919278|FG000|Overall Study|Unspecified Reasons|11|||
42108714|NCT00729833|75919279|FG001|Overall Study|Unspecified Reasons|5|||
42108715|NCT00729833|75919280|FG002|Overall Study|Unspecified Reasons|5|||
42108716|NCT00729833|75919281|FG003|Overall Study|Unspecified Reasons|1|||
42108717|NCT00645788|75919296|FG000|Overall Study|Did not receive study drug|1|||
42108718|NCT00645788|75919297|FG001|Overall Study|Did not receive study drug|1|||
42108719|NCT00645788|75919298|FG002|Overall Study|Did not receive study drug|0|||
42108720|NCT00645788|75919299|FG003|Overall Study|Did not receive study drug|0|||
42108721|NCT00645788|75919296|FG000|Overall Study|Adverse Event|4|||
42108722|NCT00645788|75919297|FG001|Overall Study|Adverse Event|9|||
42108723|NCT00645788|75919298|FG002|Overall Study|Adverse Event|5|||
42108724|NCT00645788|75919299|FG003|Overall Study|Adverse Event|3|||
42108725|NCT00645788|75919296|FG000|Overall Study|Lost to Follow-up|1|||
42108726|NCT00645788|75919297|FG001|Overall Study|Lost to Follow-up|0|||
42381434|NCT01420081|76254624|FG007|Overall Study|Death|1|||
42381435|NCT01420081|76254625|FG008|Overall Study|Death|1|||
42381436|NCT01420081|76254617|FG000|Overall Study|Lost to Follow-up|0|||
42108727|NCT00645788|75919298|FG002|Overall Study|Lost to Follow-up|0|||
42108728|NCT00645788|75919299|FG003|Overall Study|Lost to Follow-up|0|||
42108729|NCT00645788|75919296|FG000|Overall Study|Protocol Violation|1|||
42108730|NCT00645788|75919297|FG001|Overall Study|Protocol Violation|0|||
42108731|NCT00645788|75919298|FG002|Overall Study|Protocol Violation|2|||
42108732|NCT00645788|75919299|FG003|Overall Study|Protocol Violation|0|||
42108733|NCT00645788|75919296|FG000|Overall Study|Withdrawal by Subject|0|||
42108734|NCT00645788|75919297|FG001|Overall Study|Withdrawal by Subject|1|||
42108735|NCT00645788|75919298|FG002|Overall Study|Withdrawal by Subject|0|||
42381437|NCT01420081|76254618|FG001|Overall Study|Lost to Follow-up|0|||
42108736|NCT00645788|75919299|FG003|Overall Study|Withdrawal by Subject|2|||
42108737|NCT00645788|75919296|FG000|Overall Study|Pulmonary exacerbation|13|||
42108738|NCT00645788|75919297|FG001|Overall Study|Pulmonary exacerbation|16|||
42381438|NCT01420081|76254619|FG002|Overall Study|Lost to Follow-up|0|||
42108739|NCT00645788|75919298|FG002|Overall Study|Pulmonary exacerbation|11|||
42108740|NCT00645788|75919299|FG003|Overall Study|Pulmonary exacerbation|9|||
42108741|NCT00642356|75919311|FG000|Overall Study|Adverse Event|1|||
42108742|NCT00642356|75919312|FG001|Overall Study|Adverse Event|0|||
42108743|NCT00642356|75919311|FG000|Overall Study|Protocol Violation|0|||
42108744|NCT00642356|75919312|FG001|Overall Study|Protocol Violation|3|||
42108745|NCT00642356|75919311|FG000|Overall Study|Lack of Efficacy|1|||
42108746|NCT00642356|75919312|FG001|Overall Study|Lack of Efficacy|0|||
42108747|NCT00642278|75919325|FG000|Overall Study|Adverse Event|2|||
42108748|NCT00642278|75919326|FG001|Overall Study|Adverse Event|1|||
42108749|NCT00642278|75919327|FG002|Overall Study|Adverse Event|3|||
42108750|NCT00642278|75919328|FG003|Overall Study|Adverse Event|1|||
42108751|NCT00642278|75919329|FG004|Overall Study|Adverse Event|2|||
42108752|NCT00642278|75919330|FG005|Overall Study|Adverse Event|2|||
42108753|NCT00642278|75919331|FG006|Overall Study|Adverse Event|0|||
42108754|NCT00642278|75919325|FG000|Overall Study|Lack of Efficacy|0|||
42108755|NCT00642278|75919326|FG001|Overall Study|Lack of Efficacy|1|||
42108756|NCT00642278|75919327|FG002|Overall Study|Lack of Efficacy|0|||
42108757|NCT00642278|75919328|FG003|Overall Study|Lack of Efficacy|0|||
42108758|NCT00642278|75919329|FG004|Overall Study|Lack of Efficacy|0|||
42108759|NCT00642278|75919330|FG005|Overall Study|Lack of Efficacy|0|||
42108760|NCT00642278|75919331|FG006|Overall Study|Lack of Efficacy|0|||
42108761|NCT00642278|75919325|FG000|Overall Study|Lost to Follow-up|5|||
42108762|NCT00642278|75919326|FG001|Overall Study|Lost to Follow-up|1|||
42108763|NCT00642278|75919327|FG002|Overall Study|Lost to Follow-up|0|||
42108764|NCT00642278|75919328|FG003|Overall Study|Lost to Follow-up|1|||
42108765|NCT00642278|75919329|FG004|Overall Study|Lost to Follow-up|0|||
42108766|NCT00642278|75919330|FG005|Overall Study|Lost to Follow-up|1|||
42108767|NCT00642278|75919331|FG006|Overall Study|Lost to Follow-up|1|||
42108768|NCT00642278|75919325|FG000|Overall Study|Physician Decision|0|||
42108769|NCT00642278|75919326|FG001|Overall Study|Physician Decision|0|||
42108770|NCT00642278|75919327|FG002|Overall Study|Physician Decision|0|||
42108771|NCT00642278|75919328|FG003|Overall Study|Physician Decision|1|||
42108772|NCT00642278|75919329|FG004|Overall Study|Physician Decision|0|||
42108773|NCT00642278|75919330|FG005|Overall Study|Physician Decision|0|||
42108774|NCT00642278|75919331|FG006|Overall Study|Physician Decision|0|||
42108775|NCT00642278|75919325|FG000|Overall Study|Protocol Violation|0|||
42108776|NCT00642278|75919326|FG001|Overall Study|Protocol Violation|0|||
42108777|NCT00642278|75919327|FG002|Overall Study|Protocol Violation|1|||
42108778|NCT00642278|75919328|FG003|Overall Study|Protocol Violation|1|||
42108779|NCT00642278|75919329|FG004|Overall Study|Protocol Violation|0|||
42108780|NCT00642278|75919330|FG005|Overall Study|Protocol Violation|1|||
42108781|NCT00642278|75919331|FG006|Overall Study|Protocol Violation|2|||
42108782|NCT00642278|75919325|FG000|Overall Study|Withdrawal by Subject|1|||
42108783|NCT00642278|75919326|FG001|Overall Study|Withdrawal by Subject|1|||
42108784|NCT00642278|75919327|FG002|Overall Study|Withdrawal by Subject|1|||
42108785|NCT00642278|75919328|FG003|Overall Study|Withdrawal by Subject|3|||
42108786|NCT00642278|75919329|FG004|Overall Study|Withdrawal by Subject|6|||
42108787|NCT00642278|75919330|FG005|Overall Study|Withdrawal by Subject|2|||
42108788|NCT00642278|75919331|FG006|Overall Study|Withdrawal by Subject|2|||
42108789|NCT00642278|75919325|FG000|Overall Study|Noncompliance with study drug regimen|0|||
42108790|NCT00642278|75919326|FG001|Overall Study|Noncompliance with study drug regimen|0|||
42108791|NCT00642278|75919327|FG002|Overall Study|Noncompliance with study drug regimen|0|||
42108792|NCT00642278|75919328|FG003|Overall Study|Noncompliance with study drug regimen|1|||
42108793|NCT00642278|75919329|FG004|Overall Study|Noncompliance with study drug regimen|0|||
42108794|NCT00642278|75919330|FG005|Overall Study|Noncompliance with study drug regimen|0|||
42108795|NCT00642278|75919331|FG006|Overall Study|Noncompliance with study drug regimen|0|||
42108796|NCT00642278|75919325|FG000|Overall Study|Other|2|||
42108797|NCT00642278|75919326|FG001|Overall Study|Other|1|||
42108798|NCT00642278|75919327|FG002|Overall Study|Other|0|||
42108799|NCT00642278|75919328|FG003|Overall Study|Other|1|||
42108800|NCT00642278|75919329|FG004|Overall Study|Other|0|||
42108801|NCT00642278|75919330|FG005|Overall Study|Other|1|||
42108802|NCT00642278|75919331|FG006|Overall Study|Other|0|||
42108803|NCT00543543|75919351|FG000|Base Study|Adverse Event|1|||
42108804|NCT00543543|75919352|FG001|Base Study|Adverse Event|11|||
42108805|NCT00543543|75919353|FG002|Base Study|Adverse Event|0|||
42108806|NCT00543543|75919354|FG003|Base Study|Adverse Event|5|||
42108807|NCT00543543|75919351|FG000|Base Study|Lost to Follow-up|12|||
42108808|NCT00543543|75919352|FG001|Base Study|Lost to Follow-up|749|||
42108809|NCT00543543|75919353|FG002|Base Study|Lost to Follow-up|9|||
42108810|NCT00543543|75919354|FG003|Base Study|Lost to Follow-up|701|||
42108811|NCT00543543|75919351|FG000|Base Study|Physician Decision|0|||
42108812|NCT00543543|75919352|FG001|Base Study|Physician Decision|4|||
42108813|NCT00543543|75919353|FG002|Base Study|Physician Decision|0|||
42108814|NCT00543543|75919354|FG003|Base Study|Physician Decision|7|||
42108815|NCT00543543|75919351|FG000|Base Study|Protocol Violation|0|||
42108816|NCT00543543|75919352|FG001|Base Study|Protocol Violation|6|||
42108817|NCT00543543|75919353|FG002|Base Study|Protocol Violation|0|||
42108818|NCT00543543|75919354|FG003|Base Study|Protocol Violation|6|||
42108819|NCT00543543|75919351|FG000|Base Study|Withdrawal by Subject|7|||
42108820|NCT00543543|75919352|FG001|Base Study|Withdrawal by Subject|482|||
42108821|NCT00543543|75919353|FG002|Base Study|Withdrawal by Subject|5|||
42108822|NCT00543543|75919354|FG003|Base Study|Withdrawal by Subject|503|||
42108823|NCT00543543|75919351|FG000|Extension Study|Adverse Event|0|||
42108824|NCT00543543|75919352|FG001|Extension Study|Adverse Event|0|||
42108825|NCT00543543|75919353|FG002|Extension Study|Adverse Event|0|||
42108826|NCT00543543|75919354|FG003|Extension Study|Adverse Event|5|||
42108827|NCT00543543|75919351|FG000|Extension Study|Lost to Follow-up|0|||
42108828|NCT00543543|75919352|FG001|Extension Study|Lost to Follow-up|0|||
42108829|NCT00543543|75919353|FG002|Extension Study|Lost to Follow-up|0|||
42108830|NCT00543543|75919354|FG003|Extension Study|Lost to Follow-up|77|||
42108831|NCT00543543|75919351|FG000|Extension Study|Physician Decision|0|||
42108832|NCT00543543|75919352|FG001|Extension Study|Physician Decision|0|||
42108833|NCT00543543|75919353|FG002|Extension Study|Physician Decision|0|||
42108834|NCT00543543|75919354|FG003|Extension Study|Physician Decision|7|||
42108835|NCT00543543|75919351|FG000|Extension Study|Pregnancy|0|||
42108836|NCT00543543|75919352|FG001|Extension Study|Pregnancy|0|||
42108837|NCT00543543|75919353|FG002|Extension Study|Pregnancy|0|||
42108838|NCT00543543|75919354|FG003|Extension Study|Pregnancy|6|||
42108839|NCT00543543|75919351|FG000|Extension Study|Protocol Violation|0|||
42108840|NCT00543543|75919352|FG001|Extension Study|Protocol Violation|0|||
42108841|NCT00543543|75919353|FG002|Extension Study|Protocol Violation|0|||
42108842|NCT00543543|75919354|FG003|Extension Study|Protocol Violation|11|||
42108843|NCT00543543|75919351|FG000|Extension Study|Withdrawal by Subject|0|||
42108844|NCT00543543|75919352|FG001|Extension Study|Withdrawal by Subject|0|||
42108845|NCT00543543|75919353|FG002|Extension Study|Withdrawal by Subject|0|||
42108846|NCT00543543|75919354|FG003|Extension Study|Withdrawal by Subject|120|||
42108847|NCT00645164|75919369|FG000|Overall Study|Lost to Follow-up|2|||
42108848|NCT00645164|75919369|FG000|Overall Study|Withdrawal by Subject|4|||
42108849|NCT00645164|75919369|FG000|Overall Study|Protocol Violation|1|||
42108850|NCT00723125|75919375|FG000|Overall Study|Met Dx|1|||
42108851|NCT00723125|75919376|FG001|Overall Study|Met Dx|0|||
42108852|NCT00723125|75919375|FG000|Overall Study|Withdrawal by Subject|15|||
42108853|NCT00723125|75919376|FG001|Overall Study|Withdrawal by Subject|6|||
42108854|NCT00723125|75919375|FG000|Overall Study|Adverse Event|2|||
42108855|NCT00723125|75919376|FG001|Overall Study|Adverse Event|0|||
42108856|NCT00722423|75919390|FG000|Overall Study|Protocol Violation|0|||
42108857|NCT00722423|75919391|FG001|Overall Study|Protocol Violation|1|||
42108858|NCT00640562|75919401|FG000|Overall Study|Adverse Event|8|||
42108859|NCT00640562|75919402|FG001|Overall Study|Adverse Event|5|||
42108860|NCT00640562|75919401|FG000|Overall Study|Lack of Efficacy|1|||
42108861|NCT00640562|75919402|FG001|Overall Study|Lack of Efficacy|4|||
42108862|NCT00640562|75919401|FG000|Overall Study|Protocol Violation|2|||
42108863|NCT00640562|75919402|FG001|Overall Study|Protocol Violation|4|||
42108864|NCT00640562|75919401|FG000|Overall Study|Withdrawal by Subject|6|||
42108865|NCT00640562|75919402|FG001|Overall Study|Withdrawal by Subject|10|||
42108866|NCT00640562|75919401|FG000|Overall Study|Known risperidone intolerance|0|||
42108867|NCT00640562|75919402|FG001|Overall Study|Known risperidone intolerance|1|||
42108868|NCT00640562|75919401|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
42108869|NCT00640562|75919402|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
42108870|NCT00640562|75919401|FG000|Overall Study|Low study drug dose|0|||
42108871|NCT00640562|75919402|FG001|Overall Study|Low study drug dose|1|||
42108872|NCT00640562|75919401|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
42108873|NCT00640562|75919402|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
42108874|NCT00585923|75919410|FG000|Overall Study|Physician decided not to continue|31|||
42381439|NCT01420081|76254620|FG003|Overall Study|Lost to Follow-up|0|||
42381440|NCT01420081|76254621|FG004|Overall Study|Lost to Follow-up|1|||
42381441|NCT01420081|76254622|FG005|Overall Study|Lost to Follow-up|1|||
42381442|NCT01420081|76254623|FG006|Overall Study|Lost to Follow-up|0|||
42381443|NCT01420081|76254624|FG007|Overall Study|Lost to Follow-up|0|||
42381444|NCT01420081|76254625|FG008|Overall Study|Lost to Follow-up|0|||
42381445|NCT01420081|76254617|FG000|Overall Study|Study Terminated by Sponsor|2|||
42108875|NCT00585923|75919411|FG001|Overall Study|Physician decided not to continue|33|||
42108876|NCT00721955|75919420|FG000|Overall Study|Adverse Event|0|||
42108877|NCT00721955|75919421|FG001|Overall Study|Adverse Event|0|||
42108878|NCT00721955|75919422|FG002|Overall Study|Adverse Event|2|||
42108879|NCT00585689|75919430|FG000|Overall Study|Received different ABI-007 schedule|3|||
42108880|NCT00585689|75919430|FG000|Overall Study|Adverse Event|1|||
42108881|NCT00585689|75919430|FG000|Overall Study|Patient Declined Surgery|1|||
42108882|NCT00585689|75919430|FG000|Overall Study|Patient had unresectable disease|1|||
42381446|NCT01420081|76254618|FG001|Overall Study|Study Terminated by Sponsor|1|||
42381447|NCT01420081|76254619|FG002|Overall Study|Study Terminated by Sponsor|1|||
42381448|NCT01420081|76254620|FG003|Overall Study|Study Terminated by Sponsor|3|||
42381449|NCT01420081|76254621|FG004|Overall Study|Study Terminated by Sponsor|11|||
42381450|NCT01420081|76254622|FG005|Overall Study|Study Terminated by Sponsor|7|||
42381451|NCT01420081|76254623|FG006|Overall Study|Study Terminated by Sponsor|3|||
42381452|NCT01420081|76254624|FG007|Overall Study|Study Terminated by Sponsor|2|||
42381453|NCT01420081|76254625|FG008|Overall Study|Study Terminated by Sponsor|2|||
42381454|NCT01420081|76254617|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
42381455|NCT01420081|76254618|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
42381456|NCT01420081|76254619|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
42381457|NCT01420081|76254620|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
42381458|NCT01420081|76254621|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
42381459|NCT01420081|76254622|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
42381460|NCT01420081|76254623|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
42381461|NCT01420081|76254624|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
42381462|NCT01420081|76254625|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
42381463|NCT01420081|76254617|FG000|Overall Study|Other Reasons|0|||
42381464|NCT01420081|76254618|FG001|Overall Study|Other Reasons|0|||
42381465|NCT01420081|76254619|FG002|Overall Study|Other Reasons|1|||
42381466|NCT01420081|76254620|FG003|Overall Study|Other Reasons|0|||
42381467|NCT01420081|76254621|FG004|Overall Study|Other Reasons|0|||
42381468|NCT01420081|76254622|FG005|Overall Study|Other Reasons|0|||
42381469|NCT01420081|76254623|FG006|Overall Study|Other Reasons|0|||
42381470|NCT01420081|76254624|FG007|Overall Study|Other Reasons|0|||
42381471|NCT01420081|76254625|FG008|Overall Study|Other Reasons|0|||
42381472|NCT01439867|76254643|FG000|Overall Study|Non-compliance|0|||
42381473|NCT01439867|76254644|FG001|Overall Study|Non-compliance|1|||
42381474|NCT01439867|76254643|FG000|Overall Study|Withdrawal by Subject|1|||
42381475|NCT01439867|76254644|FG001|Overall Study|Withdrawal by Subject|2|||
42381476|NCT01439867|76254643|FG000|Overall Study|Administrative Decision|4|||
42381477|NCT01439867|76254644|FG001|Overall Study|Administrative Decision|5|||
42381478|NCT01439867|76254643|FG000|Overall Study|Protocol-specified Criteria|1|||
42381479|NCT01439867|76254644|FG001|Overall Study|Protocol-specified Criteria|0|||
42381480|NCT01439711|76254661|FG000|Overall Study|Ineligible|13|||
42381481|NCT01439711|76254661|FG000|Overall Study|Cancel|3|||
42381482|NCT01439711|76254661|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
42381483|NCT01439711|76254661|FG000|Overall Study|Adverse Event|5|||
42381484|NCT01439711|76254661|FG000|Overall Study|Withdrawal by Subject|3|||
42381485|NCT01439711|76254661|FG000|Overall Study|Progression During Active Tx|3|||
42381486|NCT01439711|76254661|FG000|Overall Study|Noncompliance|3|||
42381487|NCT01439711|76254661|FG000|Overall Study|No MRI|9|||
42381488|NCT01439555|76254665|FG000|Overall Study|Protocol Violation|1|||
42381489|NCT01544582|76254685|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
42381490|NCT01544582|76254686|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
42381491|NCT01544582|76254687|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
42381492|NCT01544582|76254688|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
42381493|NCT01544582|76254685|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
42381494|NCT01544582|76254686|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
42381495|NCT01544582|76254687|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
42381496|NCT01544582|76254688|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
42381497|NCT01544582|76254685|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
42381498|NCT01544582|76254686|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
42381499|NCT01544582|76254687|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
42381500|NCT01544582|76254688|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
42381501|NCT01544582|76254685|FG000|Analysis Population|Physician Decision|0|||
42381502|NCT01544582|76254686|FG001|Analysis Population|Physician Decision|13|||
42381503|NCT01544582|76254687|FG002|Analysis Population|Physician Decision|10|||
42381504|NCT01544582|76254688|FG003|Analysis Population|Physician Decision|9|||
42381505|NCT01544582|76254685|FG000|Analysis Population|Safety Reason|0|||
42381506|NCT01544582|76254686|FG001|Analysis Population|Safety Reason|33|||
42381507|NCT01544582|76254687|FG002|Analysis Population|Safety Reason|31|||
42381508|NCT01544582|76254688|FG003|Analysis Population|Safety Reason|8|||
42381509|NCT01544582|76254685|FG000|Analysis Population|Effectiveness Reason|0|||
42381510|NCT01544582|76254686|FG001|Analysis Population|Effectiveness Reason|48|||
42381511|NCT01544582|76254687|FG002|Analysis Population|Effectiveness Reason|29|||
42381512|NCT01544582|76254688|FG003|Analysis Population|Effectiveness Reason|12|||
42381513|NCT01544582|76254685|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
42381514|NCT01544582|76254686|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
42381515|NCT01544582|76254687|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
42018870|NCT01122381|75826267|FG001|Overall Study|study terminated early|1|||
42018871|NCT00996034|75826273|FG000|Overall Study|Lost to Follow-up|2|||
42018872|NCT00996034|75826273|FG000|Overall Study|withdrawn by PI|1|||
42018873|NCT01253447|75826277|FG000|Overall Study|Adverse Event|2|||
42018874|NCT01121991|75826282|FG000|Overall Study|Lack of Ovarian Response|2|||
42018875|NCT01121991|75826282|FG000|Overall Study|No Oocytes Retrieved|3|||
42018876|NCT01121991|75826282|FG000|Overall Study|No Fertilization|1|||
42018877|NCT00994240|75826288|FG000|Overall Study|Lost to Follow-up|3|||
42018878|NCT00994240|75826289|FG001|Overall Study|Lost to Follow-up|2|||
42108883|NCT00585689|75919430|FG000|Overall Study|Death|1|||
42108884|NCT00721799|75919434|FG000|Overall Study|Withdrawal by Subject|7|||
42108885|NCT00721799|75919434|FG000|Overall Study|withdraw by subject after scan 1|1|||
42108886|NCT00729365|75919441|FG000|Overall Study|Physician Decision|33|||
42108887|NCT00729365|75919442|FG001|Overall Study|Physician Decision|6|||
42108888|NCT00729365|75919443|FG002|Overall Study|Physician Decision|7|||
42108889|NCT00254293|75919459|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
42108890|NCT00254293|75919460|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
42108891|NCT00254293|75919461|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
42108892|NCT00254293|75919462|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
42108893|NCT00254293|75919463|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
42108894|NCT00254293|75919464|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
42108895|NCT00254293|75919465|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
42108896|NCT00254293|75919459|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
42108897|NCT00254293|75919460|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
42108898|NCT00254293|75919461|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
42108899|NCT00254293|75919462|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
42108900|NCT00254293|75919463|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
42108901|NCT00254293|75919464|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
42108902|NCT00254293|75919465|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
42108903|NCT00254293|75919459|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
42108904|NCT00254293|75919460|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
42108905|NCT00254293|75919461|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
42108906|NCT00254293|75919462|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
42108907|NCT00254293|75919463|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
42108908|NCT00254293|75919464|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
42108909|NCT00254293|75919465|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
42108910|NCT00254293|75919459|FG000|LTE Open Label Variable SC Dosing|Death|0|||
42108911|NCT00254293|75919460|FG001|LTE Open Label Variable SC Dosing|Death|0|||
42108912|NCT00254293|75919461|FG002|LTE Open Label Variable SC Dosing|Death|1|||
42108913|NCT00254293|75919462|FG003|LTE Open Label Variable SC Dosing|Death|0|||
42108914|NCT00254293|75919463|FG004|LTE Open Label Variable SC Dosing|Death|0|||
42108915|NCT00254293|75919464|FG005|LTE Open Label Variable SC Dosing|Death|0|||
42108916|NCT00254293|75919465|FG006|LTE Open Label Variable SC Dosing|Death|0|||
42108917|NCT00254293|75919459|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
42018879|NCT00994240|75826288|FG000|Overall Study|Withdrawal by Subject|1|||
42018880|NCT00994240|75826289|FG001|Overall Study|Withdrawal by Subject|0|||
42018881|NCT00994240|75826288|FG000|Overall Study|study termination|2|||
42108918|NCT00254293|75919460|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
42108919|NCT00254293|75919461|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
42108920|NCT00254293|75919462|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
42108921|NCT00254293|75919463|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
42108922|NCT00254293|75919464|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
42108923|NCT00254293|75919465|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
42108924|NCT00254293|75919459|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
42108925|NCT00254293|75919460|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
42108926|NCT00254293|75919461|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
42108927|NCT00254293|75919462|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
42108928|NCT00254293|75919463|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
42108929|NCT00254293|75919464|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
42108930|NCT00254293|75919465|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
42108931|NCT00254293|75919459|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
42108932|NCT00254293|75919460|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
42108933|NCT00254293|75919461|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
42108934|NCT00254293|75919462|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
42108935|NCT00254293|75919463|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
42108936|NCT00254293|75919464|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
42108937|NCT00254293|75919465|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
42108938|NCT00254293|75919459|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
42108939|NCT00254293|75919460|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
42108940|NCT00254293|75919461|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
42108941|NCT00254293|75919462|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
42108942|NCT00254293|75919463|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
42108943|NCT00254293|75919464|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
42108944|NCT00254293|75919465|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
42108945|NCT00254293|75919459|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
42108946|NCT00254293|75919460|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
42108947|NCT00254293|75919461|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
42108948|NCT00254293|75919462|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
42108949|NCT00254293|75919463|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
42108950|NCT00254293|75919464|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
42108951|NCT00254293|75919465|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
42108952|NCT00254293|75919459|FG000|LTE Open Label Variable SC Dosing|Other|0|||
42108953|NCT00254293|75919460|FG001|LTE Open Label Variable SC Dosing|Other|0|||
42381516|NCT01544582|76254688|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
42381517|NCT01544582|76254685|FG000|Analysis Population|Lost to Follow-up|0|||
42381518|NCT01544582|76254686|FG001|Analysis Population|Lost to Follow-up|6|||
42381519|NCT01544582|76254687|FG002|Analysis Population|Lost to Follow-up|6|||
42381520|NCT01544582|76254688|FG003|Analysis Population|Lost to Follow-up|5|||
42108954|NCT00254293|75919461|FG002|LTE Open Label Variable SC Dosing|Other|2|||
42108955|NCT00254293|75919462|FG003|LTE Open Label Variable SC Dosing|Other|0|||
42108956|NCT00254293|75919463|FG004|LTE Open Label Variable SC Dosing|Other|0|||
42108957|NCT00254293|75919464|FG005|LTE Open Label Variable SC Dosing|Other|0|||
42108958|NCT00254293|75919465|FG006|LTE Open Label Variable SC Dosing|Other|0|||
42108959|NCT00254293|75919459|FG000|LTE Open Label Fixed Dosing|Death|0|||
42108960|NCT00254293|75919460|FG001|LTE Open Label Fixed Dosing|Death|0|||
42108961|NCT00254293|75919461|FG002|LTE Open Label Fixed Dosing|Death|0|||
42108962|NCT00254293|75919462|FG003|LTE Open Label Fixed Dosing|Death|0|||
42108963|NCT00254293|75919463|FG004|LTE Open Label Fixed Dosing|Death|0|||
42108964|NCT00254293|75919464|FG005|LTE Open Label Fixed Dosing|Death|0|||
42108965|NCT00254293|75919465|FG006|LTE Open Label Fixed Dosing|Death|3|||
42108966|NCT00254293|75919459|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
42108967|NCT00254293|75919460|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
42108968|NCT00254293|75919461|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
42108969|NCT00254293|75919462|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
42108970|NCT00254293|75919463|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
42108971|NCT00254293|75919464|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
42108972|NCT00254293|75919465|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
42108973|NCT00254293|75919459|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
42108974|NCT00254293|75919460|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
42108975|NCT00254293|75919461|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
42108976|NCT00254293|75919462|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
42202756|NCT03535194|76015414|FG000|Induction Period|Screen Failure|0|||
42108977|NCT00254293|75919463|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
42108978|NCT00254293|75919464|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
42381521|NCT01544582|76254685|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
42108979|NCT00254293|75919465|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
42108980|NCT00254293|75919459|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
42108981|NCT00254293|75919460|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
42108982|NCT00254293|75919461|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
42108983|NCT00254293|75919462|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
42108984|NCT00254293|75919463|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
42108985|NCT00254293|75919464|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
42108986|NCT00254293|75919465|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
42108987|NCT00254293|75919459|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
42108988|NCT00254293|75919460|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
42108989|NCT00254293|75919461|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
42108990|NCT00254293|75919462|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
42108991|NCT00254293|75919463|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
42108992|NCT00254293|75919464|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
42108993|NCT00254293|75919465|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
42108994|NCT00254293|75919459|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
42108995|NCT00254293|75919460|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
42108996|NCT00254293|75919461|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
42108997|NCT00254293|75919462|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
42108998|NCT00254293|75919463|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
42108999|NCT00254293|75919464|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
42109000|NCT00254293|75919465|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
42109001|NCT00254293|75919459|FG000|LTE Open Label Fixed Dosing|Other|0|||
42109002|NCT00254293|75919460|FG001|LTE Open Label Fixed Dosing|Other|0|||
42109003|NCT00254293|75919461|FG002|LTE Open Label Fixed Dosing|Other|0|||
42109004|NCT00254293|75919462|FG003|LTE Open Label Fixed Dosing|Other|0|||
42109005|NCT00254293|75919463|FG004|LTE Open Label Fixed Dosing|Other|0|||
42109006|NCT00254293|75919464|FG005|LTE Open Label Fixed Dosing|Other|0|||
42109007|NCT00254293|75919465|FG006|LTE Open Label Fixed Dosing|Other|1|||
42109008|NCT00585221|75919508|FG000|Overall Study|Protocol Violation|8|||
42109009|NCT00253747|75919514|FG000|Overall Study|Lost to Follow-up|13|||
42109010|NCT00253747|75919515|FG001|Overall Study|Lost to Follow-up|14|||
42109011|NCT00253747|75919514|FG000|Overall Study|Withdrawal by Subject|10|||
42109012|NCT00253747|75919515|FG001|Overall Study|Withdrawal by Subject|11|||
42109013|NCT00253747|75919514|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
42109014|NCT00253747|75919515|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
42109015|NCT00252733|75919533|FG000|Overall Study|Withdrawal by Subject|73|||
42109016|NCT00252733|75919534|FG001|Overall Study|Withdrawal by Subject|67|||
42109017|NCT00252733|75919533|FG000|Overall Study|Death|7|||
42109018|NCT00252733|75919534|FG001|Overall Study|Death|5|||
42202757|NCT03535194|76015415|FG001|Induction Period|Screen Failure|1|||
42202758|NCT03535194|76015416|FG002|Induction Period|Screen Failure|0|||
42202759|NCT03535194|76015417|FG003|Induction Period|Screen Failure|0|||
42202760|NCT03535194|76015418|FG004|Induction Period|Screen Failure|0|||
42202761|NCT03535194|76015414|FG000|Induction Period|Withdrawal by Subject|3|||
42202762|NCT03535194|76015415|FG001|Induction Period|Withdrawal by Subject|4|||
42202763|NCT03535194|76015416|FG002|Induction Period|Withdrawal by Subject|3|||
42202764|NCT03535194|76015417|FG003|Induction Period|Withdrawal by Subject|2|||
42202765|NCT03535194|76015418|FG004|Induction Period|Withdrawal by Subject|0|||
42202766|NCT03535194|76015414|FG000|Maintenance Period|Adverse Event|6|||
42202767|NCT03535194|76015415|FG001|Maintenance Period|Adverse Event|5|||
42202768|NCT03535194|76015416|FG002|Maintenance Period|Adverse Event|1|||
42202769|NCT03535194|76015417|FG003|Maintenance Period|Adverse Event|11|||
42202770|NCT03535194|76015418|FG004|Maintenance Period|Adverse Event|4|||
42202771|NCT03535194|76015414|FG000|Maintenance Period|Lack of Efficacy|3|||
42202772|NCT03535194|76015415|FG001|Maintenance Period|Lack of Efficacy|2|||
42202773|NCT03535194|76015416|FG002|Maintenance Period|Lack of Efficacy|5|||
42202774|NCT03535194|76015417|FG003|Maintenance Period|Lack of Efficacy|9|||
42202775|NCT03535194|76015418|FG004|Maintenance Period|Lack of Efficacy|0|||
42202776|NCT03535194|76015414|FG000|Maintenance Period|Lost to Follow-up|4|||
42202777|NCT03535194|76015415|FG001|Maintenance Period|Lost to Follow-up|2|||
42202778|NCT03535194|76015416|FG002|Maintenance Period|Lost to Follow-up|1|||
42202779|NCT03535194|76015417|FG003|Maintenance Period|Lost to Follow-up|5|||
42202780|NCT03535194|76015418|FG004|Maintenance Period|Lost to Follow-up|2|||
42018882|NCT00994240|75826289|FG001|Overall Study|study termination|3|||
42018883|NCT01253369|75826295|FG000|Overall Study|Adverse Event|4|||
42018884|NCT01253369|75826295|FG000|Overall Study|Withdrawal by Subject|2|||
42018885|NCT01253369|75826295|FG000|Overall Study|Death|1|||
42018886|NCT01253369|75826295|FG000|Overall Study|Progressive disease|23|||
42018887|NCT01253369|75826295|FG000|Overall Study|Not Evaluable|3|||
42018888|NCT01121913|75826299|FG000|First Intervention Period|Adverse Event|0|||
42018889|NCT01121913|75826300|FG001|First Intervention Period|Adverse Event|0|||
42018890|NCT01121913|75826301|FG002|First Intervention Period|Adverse Event|1|||
42202781|NCT03535194|76015414|FG000|Maintenance Period|Other|1|||
42202782|NCT03535194|76015415|FG001|Maintenance Period|Other|2|||
42202783|NCT03535194|76015416|FG002|Maintenance Period|Other|0|||
42202784|NCT03535194|76015417|FG003|Maintenance Period|Other|0|||
42109019|NCT00252733|75919533|FG000|Overall Study|Lost to Follow-up|12|||
42109020|NCT00252733|75919534|FG001|Overall Study|Lost to Follow-up|6|||
42109021|NCT00252733|75919533|FG000|Overall Study|Multiple Reasons|14|||
42109022|NCT00252733|75919534|FG001|Overall Study|Multiple Reasons|14|||
42109023|NCT00275821|75919543|FG000|Overall Study|Adverse Event|4|||
42202785|NCT03535194|76015418|FG004|Maintenance Period|Other|0|||
42202786|NCT03535194|76015414|FG000|Maintenance Period|Physician Decision|1|||
42202787|NCT03535194|76015415|FG001|Maintenance Period|Physician Decision|2|||
42202788|NCT03535194|76015416|FG002|Maintenance Period|Physician Decision|0|||
42202789|NCT03535194|76015417|FG003|Maintenance Period|Physician Decision|2|||
42202790|NCT03535194|76015418|FG004|Maintenance Period|Physician Decision|0|||
42202791|NCT03535194|76015414|FG000|Maintenance Period|Pregnancy|0|||
42018891|NCT01121913|75826302|FG003|First Intervention Period|Adverse Event|0|||
42018892|NCT01121913|75826299|FG000|First Washout Period|Withdrawal by Subject|1|||
42018893|NCT01121913|75826300|FG001|First Washout Period|Withdrawal by Subject|0|||
42018894|NCT01121913|75826301|FG002|First Washout Period|Withdrawal by Subject|0|||
42018895|NCT01121913|75826302|FG003|First Washout Period|Withdrawal by Subject|0|||
42018896|NCT01121913|75826299|FG000|Second Intervention Period|Adverse Event|0|||
42018897|NCT01121913|75826300|FG001|Second Intervention Period|Adverse Event|0|||
42018898|NCT01121913|75826301|FG002|Second Intervention Period|Adverse Event|1|||
42018899|NCT01121913|75826302|FG003|Second Intervention Period|Adverse Event|0|||
42018900|NCT01121913|75826299|FG000|Second Washout Period|Withdrawal by Subject|0|||
42018901|NCT01121913|75826300|FG001|Second Washout Period|Withdrawal by Subject|0|||
42018902|NCT01121913|75826301|FG002|Second Washout Period|Withdrawal by Subject|1|||
42018903|NCT01121913|75826302|FG003|Second Washout Period|Withdrawal by Subject|0|||
42202792|NCT03535194|76015415|FG001|Maintenance Period|Pregnancy|0|||
42202793|NCT03535194|76015416|FG002|Maintenance Period|Pregnancy|0|||
42202794|NCT03535194|76015417|FG003|Maintenance Period|Pregnancy|2|||
42109024|NCT00275821|75919544|FG001|Overall Study|Adverse Event|12|||
42202795|NCT03535194|76015418|FG004|Maintenance Period|Pregnancy|0|||
42202796|NCT03535194|76015414|FG000|Maintenance Period|Protocol Violation|0|||
42202797|NCT03535194|76015415|FG001|Maintenance Period|Protocol Violation|1|||
42202798|NCT03535194|76015416|FG002|Maintenance Period|Protocol Violation|0|||
42202799|NCT03535194|76015417|FG003|Maintenance Period|Protocol Violation|0|||
42202800|NCT03535194|76015418|FG004|Maintenance Period|Protocol Violation|0|||
42202801|NCT03535194|76015414|FG000|Maintenance Period|Withdrawal by Subject|7|||
42202802|NCT03535194|76015415|FG001|Maintenance Period|Withdrawal by Subject|2|||
42202803|NCT03535194|76015416|FG002|Maintenance Period|Withdrawal by Subject|1|||
42202804|NCT03535194|76015417|FG003|Maintenance Period|Withdrawal by Subject|8|||
42202805|NCT03535194|76015418|FG004|Maintenance Period|Withdrawal by Subject|0|||
42202806|NCT03535194|76015414|FG000|Post-Treatment Followup Period|Adverse Event|4|||
42202807|NCT03535194|76015415|FG001|Post-Treatment Followup Period|Adverse Event|5|||
42202808|NCT03535194|76015416|FG002|Post-Treatment Followup Period|Adverse Event|1|||
42202809|NCT03535194|76015417|FG003|Post-Treatment Followup Period|Adverse Event|8|||
42202810|NCT03535194|76015418|FG004|Post-Treatment Followup Period|Adverse Event|0|||
42202811|NCT03535194|76015414|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
42202812|NCT03535194|76015415|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
42202813|NCT03535194|76015416|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
42202814|NCT03535194|76015417|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
42202815|NCT03535194|76015418|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
42202816|NCT03535194|76015414|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
42202817|NCT03535194|76015415|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
42202818|NCT03535194|76015416|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
42202819|NCT03535194|76015417|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
42202820|NCT03535194|76015418|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
42202821|NCT03535194|76015414|FG000|Post-Treatment Followup Period|Other|1|||
42202822|NCT03535194|76015415|FG001|Post-Treatment Followup Period|Other|0|||
42202823|NCT03535194|76015416|FG002|Post-Treatment Followup Period|Other|0|||
42202824|NCT03535194|76015417|FG003|Post-Treatment Followup Period|Other|5|||
42202825|NCT03535194|76015418|FG004|Post-Treatment Followup Period|Other|0|||
42202826|NCT03535194|76015414|FG000|Post-Treatment Followup Period|Physician Decision|0|||
42202827|NCT03535194|76015415|FG001|Post-Treatment Followup Period|Physician Decision|2|||
42202828|NCT03535194|76015416|FG002|Post-Treatment Followup Period|Physician Decision|1|||
42202829|NCT03535194|76015417|FG003|Post-Treatment Followup Period|Physician Decision|1|||
42202830|NCT03535194|76015418|FG004|Post-Treatment Followup Period|Physician Decision|0|||
42202831|NCT03535194|76015414|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
42202832|NCT03535194|76015415|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
42202833|NCT03535194|76015416|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
42202834|NCT03535194|76015417|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
42202835|NCT03535194|76015418|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
42202836|NCT03559530|76015442|FG000|Overall Study|non-location of medical records|44|||
42202837|NCT03559530|76015443|FG001|Overall Study|non-location of medical records|0|||
42202838|NCT03559530|76015442|FG000|Overall Study|culture results not considered for treat|29|||
42202839|NCT03559530|76015443|FG001|Overall Study|culture results not considered for treat|0|||
42202840|NCT03559530|76015442|FG000|Overall Study|duplicate cases|8|||
42202841|NCT03559530|76015443|FG001|Overall Study|duplicate cases|0|||
42202842|NCT03559530|76015442|FG000|Overall Study|other species of Acinetobacte|7|||
42202843|NCT03559530|76015443|FG001|Overall Study|other species of Acinetobacte|0|||
42202844|NCT03559530|76015442|FG000|Overall Study|contamination / colonization|3|||
42202845|NCT03559530|76015443|FG001|Overall Study|contamination / colonization|0|||
42202846|NCT03124784|76015471|FG000|Overall Study|Adverse Event|1|||
42202847|NCT03124784|76015471|FG000|Overall Study|Computer/Equip Malfunction|1|||
42202848|NCT03531840|76015479|FG000|Overall Study|Death on study|3|||
42202849|NCT03531840|76015480|FG001|Overall Study|Death on study|2|||
42202850|NCT03531840|76015481|FG002|Overall Study|Death on study|1|||
42202851|NCT03531840|76015482|FG003|Overall Study|Death on study|2|||
42202852|NCT03531840|76015479|FG000|Overall Study|Death during follow up|2|||
42202853|NCT03531840|76015480|FG001|Overall Study|Death during follow up|3|||
42202854|NCT03531840|76015481|FG002|Overall Study|Death during follow up|4|||
42202855|NCT03531840|76015482|FG003|Overall Study|Death during follow up|1|||
42202856|NCT03110900|76015499|FG000|Overall Study|Sponsor withdrew|1|||
42202857|NCT03110900|76015500|FG001|Overall Study|Sponsor withdrew|1|||
42202858|NCT03867734|76015506|FG000|Overall Study|Lost to Follow-up|2|||
42202859|NCT03446456|76015516|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
42202860|NCT03446456|76015517|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
42202861|NCT03446456|76015516|FG000|Overall Study|Lost to Follow-up|1|||
42202862|NCT03446456|76015517|FG001|Overall Study|Lost to Follow-up|3|||
42202863|NCT03446456|76015516|FG000|Overall Study|Participant failed the toxicology test|1|||
42202864|NCT03446456|76015517|FG001|Overall Study|Participant failed the toxicology test|0|||
42202865|NCT03446456|76015516|FG000|Overall Study|Break down of the experimental equipment|1|||
42202866|NCT03446456|76015517|FG001|Overall Study|Break down of the experimental equipment|0|||
42202867|NCT03495102|76015526|FG000|Overall Study|Adverse Event|5|||
42202868|NCT03495102|76015527|FG001|Overall Study|Adverse Event|7|||
42202869|NCT03495102|76015528|FG002|Overall Study|Adverse Event|10|||
42202870|NCT03495102|76015526|FG000|Overall Study|Death|3|||
42202871|NCT03495102|76015527|FG001|Overall Study|Death|4|||
42202872|NCT03495102|76015528|FG002|Overall Study|Death|4|||
42202873|NCT03495102|76015526|FG000|Overall Study|Lost to Follow-up|15|||
42202874|NCT03495102|76015527|FG001|Overall Study|Lost to Follow-up|16|||
42202875|NCT03495102|76015528|FG002|Overall Study|Lost to Follow-up|17|||
42202876|NCT03495102|76015526|FG000|Overall Study|Physician Decision|2|||
42202877|NCT03495102|76015527|FG001|Overall Study|Physician Decision|0|||
42202878|NCT03495102|76015528|FG002|Overall Study|Physician Decision|2|||
42202879|NCT03495102|76015526|FG000|Overall Study|Withdrawal by Subject|25|||
42202880|NCT03495102|76015527|FG001|Overall Study|Withdrawal by Subject|36|||
42202881|NCT03495102|76015528|FG002|Overall Study|Withdrawal by Subject|18|||
42202882|NCT03495102|76015526|FG000|Overall Study|Protocol Violation|1|||
42202883|NCT03495102|76015527|FG001|Overall Study|Protocol Violation|1|||
42202884|NCT03495102|76015528|FG002|Overall Study|Protocol Violation|0|||
42202885|NCT03495102|76015526|FG000|Overall Study|Site Closure|3|||
42202886|NCT03495102|76015527|FG001|Overall Study|Site Closure|1|||
42202887|NCT03495102|76015528|FG002|Overall Study|Site Closure|2|||
42202888|NCT03495102|76015526|FG000|Overall Study|Non-compliance|1|||
42202889|NCT03495102|76015527|FG001|Overall Study|Non-compliance|0|||
42202890|NCT03495102|76015528|FG002|Overall Study|Non-compliance|0|||
42202891|NCT03495102|76015526|FG000|Overall Study|Participant Duplicated at Another Site|0|||
42202892|NCT03495102|76015527|FG001|Overall Study|Participant Duplicated at Another Site|0|||
42202893|NCT03495102|76015528|FG002|Overall Study|Participant Duplicated at Another Site|1|||
42202894|NCT03495102|76015526|FG000|Overall Study|Primary Care Physician Recommendation|0|||
42202895|NCT03495102|76015527|FG001|Overall Study|Primary Care Physician Recommendation|1|||
42202896|NCT03495102|76015528|FG002|Overall Study|Primary Care Physician Recommendation|0|||
42202897|NCT03495102|76015526|FG000|Overall Study|Relocated to Another Country|0|||
42202898|NCT03495102|76015527|FG001|Overall Study|Relocated to Another Country|1|||
42202899|NCT03495102|76015528|FG002|Overall Study|Relocated to Another Country|0|||
42202900|NCT03495102|76015526|FG000|Overall Study|Participant was in Rehabilitation|1|||
42202901|NCT03495102|76015527|FG001|Overall Study|Participant was in Rehabilitation|0|||
42202902|NCT03495102|76015528|FG002|Overall Study|Participant was in Rehabilitation|0|||
42202903|NCT03105362|76015536|FG000|Overall Study|Withdrawal by Subject|1|||
42202904|NCT03105362|76015536|FG000|Overall Study|Lost to Follow-up|1|||
42202905|NCT03559218|76015545|FG000|Overall Study|Withdrawal by Subject|1|||
42202906|NCT03559218|76015546|FG001|Overall Study|Withdrawal by Subject|0|||
42202907|NCT03104816|76015555|FG000|Overall Study|Lack of Efficacy|0|||
42202908|NCT03104816|76015556|FG001|Overall Study|Lack of Efficacy|2|||
42202909|NCT03104816|76015557|FG002|Overall Study|Lack of Efficacy|0|||
42202910|NCT03104816|76015555|FG000|Overall Study|Protocol Violation|2|||
42202911|NCT03104816|76015556|FG001|Overall Study|Protocol Violation|0|||
42202912|NCT03104816|76015557|FG002|Overall Study|Protocol Violation|2|||
42202913|NCT03559062|76015568|FG000|Overall Study|Other|0|||
42202914|NCT03559062|76015569|FG001|Overall Study|Other|1|||
42202915|NCT03559062|76015570|FG002|Overall Study|Other|0|||
42202916|NCT00089791|76015581|FG000|Overall Study|Physician Decision|6|||
42202917|NCT00089791|76015582|FG001|Overall Study|Physician Decision|3|||
42202918|NCT00089791|76015581|FG000|Overall Study|Adverse Event|81|||
42202919|NCT00089791|76015582|FG001|Overall Study|Adverse Event|93|||
42202920|NCT00089791|76015581|FG000|Overall Study|Withdrawal by Subject|403|||
42202921|NCT00089791|76015582|FG001|Overall Study|Withdrawal by Subject|344|||
42202922|NCT00089791|76015581|FG000|Overall Study|Death|78|||
42202923|NCT00089791|76015582|FG001|Overall Study|Death|62|||
42202924|NCT00089791|76015581|FG000|Overall Study|Disease progression|7|||
42202925|NCT00089791|76015582|FG001|Overall Study|Disease progression|3|||
42202926|NCT00089791|76015581|FG000|Overall Study|Ineligibility determined|12|||
42202927|NCT00089791|76015582|FG001|Overall Study|Ineligibility determined|9|||
42202928|NCT00089791|76015581|FG000|Overall Study|Lost to Follow-up|57|||
42202929|NCT00089791|76015582|FG001|Overall Study|Lost to Follow-up|57|||
42202930|NCT00089791|76015581|FG000|Overall Study|Noncompliance|17|||
42202931|NCT00089791|76015582|FG001|Overall Study|Noncompliance|13|||
42202932|NCT00089791|76015581|FG000|Overall Study|Other|20|||
42202933|NCT00089791|76015582|FG001|Overall Study|Other|32|||
42202934|NCT00089791|76015581|FG000|Overall Study|Protocol deviation|12|||
42202935|NCT00089791|76015582|FG001|Overall Study|Protocol deviation|10|||
42202936|NCT00089791|76015581|FG000|Overall Study|Requirement for alternative therapy|7|||
42202937|NCT00089791|76015582|FG001|Overall Study|Requirement for alternative therapy|4|||
42202938|NCT03558672|76015588|FG000|Overall Study|Study Early Termination|10|||
42202939|NCT03558516|76015594|FG000|Overall Study|Protocol Violation|2|||
42202940|NCT03558516|76015595|FG001|Overall Study|Protocol Violation|2|||
42202941|NCT03557970|76015603|FG000|Overall Study|Study closure|1|||
42202942|NCT03557970|76015604|FG001|Overall Study|Study closure|0|||
42202943|NCT03557970|76015603|FG000|Overall Study|Physician Decision|0|||
42202944|NCT03557970|76015604|FG001|Overall Study|Physician Decision|1|||
42202945|NCT03557970|76015603|FG000|Overall Study|Death|0|||
42202946|NCT03557970|76015604|FG001|Overall Study|Death|1|||
42202947|NCT02815280|76015612|FG000|Double-Blind Phase|Adverse Event|1|||
42202948|NCT02815280|76015613|FG001|Double-Blind Phase|Adverse Event|1|||
42202949|NCT02815280|76015612|FG000|Double-Blind Phase|Lost to Follow-up|10|||
42202950|NCT02815280|76015613|FG001|Double-Blind Phase|Lost to Follow-up|9|||
42202951|NCT02815280|76015612|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
42202952|NCT02815280|76015613|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
42202953|NCT02815280|76015612|FG000|Double-Blind Phase|Protocol Violation|2|||
42202954|NCT02815280|76015613|FG001|Double-Blind Phase|Protocol Violation|2|||
42109025|NCT00275821|75919545|FG002|Overall Study|Adverse Event|5|||
42109026|NCT00275821|75919543|FG000|Overall Study|Administrative problems|3|||
42109027|NCT00275821|75919544|FG001|Overall Study|Administrative problems|4|||
42109028|NCT00275821|75919545|FG002|Overall Study|Administrative problems|4|||
42109029|NCT00275821|75919543|FG000|Overall Study|Withdrawal by Subject|0|||
42109030|NCT00275821|75919544|FG001|Overall Study|Withdrawal by Subject|2|||
42109031|NCT00275821|75919545|FG002|Overall Study|Withdrawal by Subject|1|||
42109032|NCT00275821|75919543|FG000|Overall Study|Lost to Follow-up|0|||
42109033|NCT00275821|75919544|FG001|Overall Study|Lost to Follow-up|1|||
42109034|NCT00275821|75919545|FG002|Overall Study|Lost to Follow-up|1|||
42109035|NCT00275821|75919543|FG000|Overall Study|Death|0|||
42109036|NCT00275821|75919544|FG001|Overall Study|Death|2|||
42109037|NCT00275821|75919545|FG002|Overall Study|Death|1|||
42109038|NCT00275821|75919543|FG000|Overall Study|Lack of Efficacy|2|||
42109039|NCT00275821|75919544|FG001|Overall Study|Lack of Efficacy|1|||
42109040|NCT00275821|75919545|FG002|Overall Study|Lack of Efficacy|0|||
42109041|NCT00275821|75919543|FG000|Overall Study|Protocol Violation|5|||
42109042|NCT00275821|75919544|FG001|Overall Study|Protocol Violation|1|||
42202955|NCT02815280|76015612|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
42202956|NCT02815280|76015613|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
42202957|NCT02815280|76015612|FG000|Open-Label Phase|Adverse Event|2|||
42202958|NCT02815280|76015613|FG001|Open-Label Phase|Adverse Event|3|||
42109043|NCT00275821|75919545|FG002|Overall Study|Protocol Violation|0|||
42202959|NCT02815280|76015612|FG000|Open-Label Phase|Lost to Follow-up|18|||
42202960|NCT02815280|76015613|FG001|Open-Label Phase|Lost to Follow-up|9|||
42202961|NCT02815280|76015612|FG000|Open-Label Phase|Withdrawal by Subject|33|||
42109044|NCT00275509|75919555|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
42109045|NCT00275509|75919556|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
42109046|NCT00252577|75919562|FG000|Overall Study|Lost to Follow-up|20|||
42202962|NCT02815280|76015613|FG001|Open-Label Phase|Withdrawal by Subject|18|||
42202963|NCT02815280|76015612|FG000|Open-Label Phase|Protocol Violation|3|||
42202964|NCT02815280|76015613|FG001|Open-Label Phase|Protocol Violation|0|||
42202965|NCT02815280|76015612|FG000|Open-Label Phase|Administrative|26|||
42202966|NCT02815280|76015613|FG001|Open-Label Phase|Administrative|12|||
42202967|NCT02815280|76015612|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
42202968|NCT02815280|76015613|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
42202969|NCT02737930|76015625|FG000|Overall Study|Withdrawal by Subject|0|||
42202970|NCT02737930|76015626|FG001|Overall Study|Withdrawal by Subject|1|||
42202971|NCT03493698|76015632|FG000|Treatment Period C|Adverse Event|1|||
42202972|NCT03493698|76015632|FG000|Treatment Period C|Withdrawal by Subject|1|||
42202973|NCT02737852|76015646|FG000|Overall Study|Withdrawal by Subject|2|||
42202974|NCT03528174|76015650|FG000|Overall Study|Adverse Event|1|||
42202975|NCT03528174|76015650|FG000|Overall Study|sensors dislodged|1|||
42202976|NCT03109184|76015660|FG000|Overall Study|Lost to Follow-up|6|||
42202977|NCT03109184|76015661|FG001|Overall Study|Lost to Follow-up|6|||
42202978|NCT03109184|76015660|FG000|Overall Study|Withdrawal by Subject|1|||
42202979|NCT03109184|76015661|FG001|Overall Study|Withdrawal by Subject|1|||
42202980|NCT03493386|76015679|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
42202981|NCT03493386|76015680|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
42202982|NCT03493386|76015681|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
42202983|NCT03493386|76015682|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
42202984|NCT03478644|76015701|FG000|Phase 2|Withdrawal by Subject|2|||
42202985|NCT03478644|76015702|FG001|Phase 2|Withdrawal by Subject|1|||
42202986|NCT03478644|76015701|FG000|Phase 2|Lost to Follow-up|1|||
42202987|NCT03478644|76015702|FG001|Phase 2|Lost to Follow-up|0|||
42202988|NCT03527550|76015710|FG000|Overall Study|Lost to Follow-up|4|||
42202989|NCT03527550|76015711|FG001|Overall Study|Lost to Follow-up|2|||
42202990|NCT03527550|76015710|FG000|Overall Study|Withdrawal by Subject|4|||
42202991|NCT03527550|76015711|FG001|Overall Study|Withdrawal by Subject|1|||
42202992|NCT03527550|76015710|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
42202993|NCT03527550|76015711|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
42202994|NCT03475056|76015721|FG000|Overall Study|Lost to Follow-up|0|||
42202995|NCT03475056|76015722|FG001|Overall Study|Lost to Follow-up|1|||
42202996|NCT03475056|76015721|FG000|Overall Study|Moved from Area|0|||
42202997|NCT03475056|76015722|FG001|Overall Study|Moved from Area|2|||
42202998|NCT00938912|76015729|FG000|Overall Study|Withdrawal by Subject|28|||
42202999|NCT00938912|76015729|FG000|Overall Study|Lost to Follow-up|4|||
42203000|NCT00938912|76015729|FG000|Overall Study|Lack of Efficacy|43|||
42203001|NCT00938912|76015729|FG000|Overall Study|Adverse event, non-fatal|24|||
42203002|NCT00938912|76015729|FG000|Overall Study|Adverse event, fatal|1|||
42203003|NCT00938912|76015729|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
42203004|NCT00938912|76015729|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
42203005|NCT00938912|76015729|FG000|Overall Study|Participant needed prohibit medication|1|||
42203006|NCT00938912|76015729|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
42203007|NCT00938912|76015729|FG000|Overall Study|Did not meet Eligibility criteria|1|||
42203008|NCT00938912|76015729|FG000|Overall Study|Participant relocated not related to AE|1|||
42203009|NCT00938912|76015729|FG000|Overall Study|Participant moved to another city|1|||
42203010|NCT00938912|76015729|FG000|Overall Study|Participant experienced break through seizures|1|||
42203011|NCT00938912|76015729|FG000|Overall Study|No longer wished to participate in the study|1|||
42203012|NCT00938912|76015729|FG000|Overall Study|Protocol Deviation|2|||
42203013|NCT03473808|76015736|FG000|Overall Study|Withdrawal by Subject|1|||
42203014|NCT03473340|76015742|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
42203015|NCT03473340|76015743|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
42203016|NCT03473340|76015742|FG000|Overall Study|Withdrawal by Subject|1|||
42203017|NCT03473340|76015743|FG001|Overall Study|Withdrawal by Subject|0|||
42203018|NCT03473340|76015742|FG000|Overall Study|Lost to Follow-up|1|||
42203019|NCT03473340|76015743|FG001|Overall Study|Lost to Follow-up|2|||
42203020|NCT03490032|76015752|FG000|Overall Study|family issue (child custody)|1|||
42203021|NCT03490032|76015753|FG001|Overall Study|family issue (child custody)|0|||
42203022|NCT03490032|76015754|FG002|Overall Study|family issue (child custody)|0|||
42203023|NCT03489720|76015774|FG000|Overall Study|Withdrawal by Subject|2|||
42203024|NCT03489720|76015775|FG001|Overall Study|Withdrawal by Subject|0|||
42203025|NCT03527160|76015787|FG000|Overall Study|No urine collected|13|||
42203026|NCT03527160|76015787|FG000|Overall Study|No clinical serum creatinine collected|6|||
42203027|NCT03527160|76015787|FG000|Overall Study|Did not meet inclusion|2|||
42203028|NCT03739138|76015797|FG000|Overall Study|Death|0|||
42203029|NCT03739138|76015798|FG001|Overall Study|Death|7|||
42203030|NCT03739138|76015799|FG002|Overall Study|Death|4|||
42203031|NCT03739138|76015800|FG003|Overall Study|Death|13|||
42203032|NCT03739138|76015801|FG004|Overall Study|Death|0|||
42203033|NCT03739138|76015797|FG000|Overall Study|Lost to Follow-up|0|||
42203034|NCT03739138|76015798|FG001|Overall Study|Lost to Follow-up|0|||
42203035|NCT03739138|76015799|FG002|Overall Study|Lost to Follow-up|1|||
42203036|NCT03739138|76015800|FG003|Overall Study|Lost to Follow-up|0|||
42203037|NCT03739138|76015801|FG004|Overall Study|Lost to Follow-up|0|||
42203038|NCT03739138|76015797|FG000|Overall Study|Study Terminated By Sponsor|0|||
42203039|NCT03739138|76015798|FG001|Overall Study|Study Terminated By Sponsor|0|||
42203040|NCT03739138|76015799|FG002|Overall Study|Study Terminated By Sponsor|0|||
42203041|NCT03739138|76015800|FG003|Overall Study|Study Terminated By Sponsor|4|||
42203042|NCT03739138|76015801|FG004|Overall Study|Study Terminated By Sponsor|0|||
42203043|NCT03739138|76015797|FG000|Overall Study|Withdrawal by Subject|0|||
42203044|NCT03739138|76015798|FG001|Overall Study|Withdrawal by Subject|0|||
42203045|NCT03739138|76015799|FG002|Overall Study|Withdrawal by Subject|0|||
42203046|NCT03739138|76015800|FG003|Overall Study|Withdrawal by Subject|1|||
42203047|NCT03739138|76015801|FG004|Overall Study|Withdrawal by Subject|0|||
42203048|NCT03472326|76015811|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
42203049|NCT03472326|76015812|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
42203050|NCT03472326|76015813|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
42203051|NCT03472326|76015814|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
42203052|NCT03472326|76015811|FG000|Part 2: Combination Therapy|Pregnancy|0|||
42203053|NCT03472326|76015812|FG001|Part 2: Combination Therapy|Pregnancy|0|||
42203054|NCT03472326|76015813|FG002|Part 2: Combination Therapy|Pregnancy|0|||
42203055|NCT03472326|76015814|FG003|Part 2: Combination Therapy|Pregnancy|1|||
42203056|NCT02737618|76015823|FG000|Overall Study|Withdrawal by Subject|9|||
42203057|NCT03472014|76015827|FG000|Overall Study|Lost to Follow-up|4|||
42203058|NCT03526458|76015833|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
42203059|NCT03526458|76015834|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
42203060|NCT03526458|76015833|FG000|Overall Study|Stone passed, surgery cancelled|2|||
42203061|NCT03526458|76015834|FG001|Overall Study|Stone passed, surgery cancelled|1|||
42203062|NCT03526458|76015833|FG000|Overall Study|Withdrawal by Subject|1|||
42203063|NCT03526458|76015834|FG001|Overall Study|Withdrawal by Subject|0|||
42203064|NCT03526458|76015833|FG000|Overall Study|Physician Decision|2|||
42203065|NCT03526458|76015834|FG001|Overall Study|Physician Decision|1|||
42203066|NCT03526458|76015833|FG000|Overall Study|Lack of equipment|1|||
42109047|NCT00252499|75919569|FG000|Overall Study|Lost to Follow-up|1|||
42109048|NCT00252499|75919570|FG001|Overall Study|Lost to Follow-up|0|||
42109049|NCT00252499|75919571|FG002|Overall Study|Lost to Follow-up|0|||
42109050|NCT00252187|75919581|FG000|Overall Study|Adverse Event|3|||
42109051|NCT00252187|75919582|FG001|Overall Study|Adverse Event|1|||
42109052|NCT00252187|75919581|FG000|Overall Study|Withdrawal by Subject|1|||
42109053|NCT00252187|75919582|FG001|Overall Study|Withdrawal by Subject|0|||
42109054|NCT00572910|75919594|FG000|Overall Study|Adverse Event|1|||
42109055|NCT00572910|75919595|FG001|Overall Study|Adverse Event|2|||
42109056|NCT00572910|75919596|FG002|Overall Study|Adverse Event|0|||
42109057|NCT00572910|75919597|FG003|Overall Study|Adverse Event|2|||
42109058|NCT00572910|75919598|FG004|Overall Study|Adverse Event|0|||
42109059|NCT00572910|75919599|FG005|Overall Study|Adverse Event|0|||
42109060|NCT00572910|75919600|FG006|Overall Study|Adverse Event|4|||
42109061|NCT00572910|75919601|FG007|Overall Study|Adverse Event|2|||
42109062|NCT00572910|75919602|FG008|Overall Study|Adverse Event|1|||
42109063|NCT00572910|75919603|FG009|Overall Study|Adverse Event|3|||
42109064|NCT00572910|75919604|FG010|Overall Study|Adverse Event|2|||
42109065|NCT00572910|75919594|FG000|Overall Study|Lost to Follow-up|0|||
42109066|NCT00572910|75919595|FG001|Overall Study|Lost to Follow-up|1|||
42203067|NCT03526458|76015834|FG001|Overall Study|Lack of equipment|1|||
42203068|NCT03488238|76015840|FG000|Overall Study|Equipment malfunction|1|||
42203069|NCT03488238|76015840|FG000|Overall Study|Adverse Event|1|||
42203070|NCT03525834|76015844|FG000|Overall Study|Progressive disease|1|||
42203071|NCT03525444|76015886|FG000|Overall Study|Adverse Event|0|||
42203072|NCT03525444|76015887|FG001|Overall Study|Adverse Event|1|||
42203073|NCT03525444|76015886|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
42203074|NCT03525444|76015887|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
42018904|NCT01121913|75826299|FG000|Third Washout Period|Adverse Event|1|||
42018905|NCT01121913|75826300|FG001|Third Washout Period|Adverse Event|0|||
42018906|NCT01121913|75826301|FG002|Third Washout Period|Adverse Event|0|||
42018907|NCT01121913|75826302|FG003|Third Washout Period|Adverse Event|0|||
42018908|NCT00994162|75826314|FG000|Overall Study|Withdrawal by Subject|1|||
42018909|NCT00994162|75826314|FG000|Overall Study|Lost to Follow-up|2|||
42018910|NCT00994162|75826314|FG000|Overall Study|Product Complaint|1|||
42018911|NCT00994162|75826314|FG000|Overall Study|Poor Compliance|5|||
42018912|NCT00994162|75826314|FG000|Overall Study|Lack of Response|3|||
42018913|NCT00994162|75826314|FG000|Overall Study|Discharged from Hospital|4|||
42018914|NCT00994162|75826314|FG000|Overall Study|Death|2|||
42018915|NCT00994162|75826314|FG000|Overall Study|Care Transferred to Another Physician|2|||
42018916|NCT00994162|75826314|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
42018917|NCT00994162|75826314|FG000|Overall Study|Physician Decision|2|||
42018918|NCT00994162|75826314|FG000|Overall Study|Surrounding Wound Erythematous|1|||
42018919|NCT00994162|75826314|FG000|Overall Study|Machine Losing Vaccum|1|||
42018920|NCT00994162|75826314|FG000|Overall Study|Patient Lived Too Far Away|1|||
42018921|NCT00994162|75826314|FG000|Overall Study|Above Knee Amputation|1|||
42018922|NCT00994162|75826314|FG000|Overall Study|Reason Not Reported By Site|1|||
42018923|NCT00993928|75826321|FG000|Overall Study|Withdrawal by Subject|4|||
42109067|NCT00572910|75919596|FG002|Overall Study|Lost to Follow-up|1|||
42109068|NCT00572910|75919597|FG003|Overall Study|Lost to Follow-up|2|||
42109069|NCT00572910|75919598|FG004|Overall Study|Lost to Follow-up|1|||
42109070|NCT00572910|75919599|FG005|Overall Study|Lost to Follow-up|0|||
42109071|NCT00572910|75919600|FG006|Overall Study|Lost to Follow-up|0|||
42109072|NCT00572910|75919601|FG007|Overall Study|Lost to Follow-up|0|||
42203075|NCT03525444|76015886|FG000|Overall Study|Other|0|||
42203076|NCT03525444|76015887|FG001|Overall Study|Other|1|||
42109073|NCT00572910|75919602|FG008|Overall Study|Lost to Follow-up|0|||
42203077|NCT03487848|76015894|FG000|Overall Study|Lost to Follow-up|1|||
42109074|NCT00572910|75919603|FG009|Overall Study|Lost to Follow-up|1|||
42109075|NCT00572910|75919604|FG010|Overall Study|Lost to Follow-up|0|||
42109076|NCT00572910|75919594|FG000|Overall Study|Withdrawal by Subject|3|||
42109077|NCT00572910|75919595|FG001|Overall Study|Withdrawal by Subject|0|||
42109078|NCT00572910|75919596|FG002|Overall Study|Withdrawal by Subject|1|||
42109079|NCT00572910|75919597|FG003|Overall Study|Withdrawal by Subject|0|||
42109080|NCT00572910|75919598|FG004|Overall Study|Withdrawal by Subject|1|||
42109081|NCT00572910|75919599|FG005|Overall Study|Withdrawal by Subject|3|||
42109082|NCT00572910|75919600|FG006|Overall Study|Withdrawal by Subject|0|||
42109083|NCT00572910|75919601|FG007|Overall Study|Withdrawal by Subject|2|||
42109084|NCT00572910|75919602|FG008|Overall Study|Withdrawal by Subject|2|||
42109085|NCT00572910|75919603|FG009|Overall Study|Withdrawal by Subject|2|||
42109086|NCT00572910|75919604|FG010|Overall Study|Withdrawal by Subject|1|||
42109087|NCT00163657|75919642|FG000|Overall Study|Death|12|||
42109088|NCT00163657|75919643|FG001|Overall Study|Death|14|||
42109089|NCT00163657|75919644|FG002|Overall Study|Death|19|||
42109090|NCT00163657|75919642|FG000|Overall Study|graft loss|4|||
42109091|NCT00163657|75919643|FG001|Overall Study|graft loss|1|||
42109092|NCT00163657|75919644|FG002|Overall Study|graft loss|2|||
42109093|NCT00163657|75919642|FG000|Overall Study|Withdrawal by Subject|2|||
42109094|NCT00163657|75919643|FG001|Overall Study|Withdrawal by Subject|3|||
42109095|NCT00163657|75919644|FG002|Overall Study|Withdrawal by Subject|2|||
42109096|NCT00163657|75919642|FG000|Overall Study|Physician Decision|0|||
42109097|NCT00163657|75919643|FG001|Overall Study|Physician Decision|1|||
42109098|NCT00163657|75919644|FG002|Overall Study|Physician Decision|1|||
42109099|NCT00163657|75919642|FG000|Overall Study|Non Compliance|1|||
42109100|NCT00163657|75919643|FG001|Overall Study|Non Compliance|0|||
42109101|NCT00163657|75919644|FG002|Overall Study|Non Compliance|0|||
42109102|NCT00163657|75919642|FG000|Overall Study|Lost to Follow-up|1|||
42109103|NCT00163657|75919643|FG001|Overall Study|Lost to Follow-up|3|||
42109104|NCT00163657|75919644|FG002|Overall Study|Lost to Follow-up|10|||
42109105|NCT00163657|75919642|FG000|Overall Study|Other reason|0|||
42109106|NCT00163657|75919643|FG001|Overall Study|Other reason|1|||
42109107|NCT00163657|75919644|FG002|Overall Study|Other reason|3|||
42109108|NCT00609492|75919655|FG000|Overall Study|Withdrawal by Subject|0|||
42109109|NCT00609492|75919656|FG001|Overall Study|Withdrawal by Subject|2|||
42109110|NCT00609492|75919657|FG002|Overall Study|Withdrawal by Subject|3|||
42109111|NCT00609492|75919655|FG000|Overall Study|Lost to Follow-up|1|||
42109112|NCT00609492|75919656|FG001|Overall Study|Lost to Follow-up|1|||
42109113|NCT00609492|75919657|FG002|Overall Study|Lost to Follow-up|4|||
42109114|NCT00230971|75919669|FG000|Randomization|No study drug administered|3|||
42109115|NCT00230971|75919670|FG001|Randomization|No study drug administered|3|||
42109116|NCT00230971|75919669|FG000|Baseline Participants|Lost to Follow-up|5|||
42109117|NCT00230971|75919670|FG001|Baseline Participants|Lost to Follow-up|12|||
42109118|NCT00230971|75919669|FG000|Baseline Participants|Death|6|||
42109119|NCT00230971|75919670|FG001|Baseline Participants|Death|5|||
42109120|NCT00230971|75919669|FG000|Baseline Participants|Withdrawal by Subject|7|||
42109121|NCT00230971|75919670|FG001|Baseline Participants|Withdrawal by Subject|1|||
42109122|NCT00230971|75919669|FG000|Baseline Participants|Adverse Event|1|||
42109123|NCT00230971|75919670|FG001|Baseline Participants|Adverse Event|0|||
42109124|NCT00230971|75919669|FG000|Baseline Participants|No bacteria observed|1|||
42109125|NCT00230971|75919670|FG001|Baseline Participants|No bacteria observed|0|||
42109126|NCT00230971|75919669|FG000|Baseline Participants|Failure to return|1|||
42109127|NCT00230971|75919670|FG001|Baseline Participants|Failure to return|1|||
42109128|NCT00230971|75919669|FG000|Baseline Participants|Reintervention|1|||
42109129|NCT00230971|75919670|FG001|Baseline Participants|Reintervention|0|||
42109130|NCT00211081|75919676|FG000|Overall Study|Withdrawal by Subject|2|||
42109131|NCT00609336|75919680|FG000|Overall Study|Protocol Violation|3|||
42109132|NCT00609336|75919680|FG000|Overall Study|Death|1|||
42109133|NCT00609336|75919680|FG000|Overall Study|LA or Met at Surgery|9|||
42109134|NCT00612066|75919685|FG000|Overall Study|Adverse Event|1|||
42109135|NCT00573144|75919691|FG000|Overall Study|Withdrawal by Subject|2|||
42109136|NCT00573144|75919692|FG001|Overall Study|Withdrawal by Subject|3|||
42109137|NCT00640328|75919704|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
42109138|NCT00640328|75919705|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
42109139|NCT00640328|75919706|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
42203078|NCT03524664|76015900|FG000|Overall Study|Withdrawal by Subject|1|||
42109140|NCT00640328|75919707|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
42109141|NCT00640328|75919708|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
42109142|NCT00640328|75919709|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
42109143|NCT00640328|75919704|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
42109144|NCT00640328|75919705|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
42109145|NCT00640328|75919706|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
42109146|NCT00640328|75919707|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
42109147|NCT00640328|75919708|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
42109148|NCT00640328|75919709|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
42109149|NCT00640328|75919704|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
42109150|NCT00640328|75919705|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
42109151|NCT00640328|75919706|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
42109152|NCT00640328|75919707|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
42109153|NCT00640328|75919708|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
42109154|NCT00640328|75919709|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
42109155|NCT00640328|75919704|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
42109156|NCT00640328|75919705|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
42109157|NCT00640328|75919706|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
42109158|NCT00640328|75919707|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
42109159|NCT00640328|75919708|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
42109160|NCT00640328|75919709|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
42109161|NCT00163189|75919730|FG000|Overall Study|Other|6|||
42109162|NCT00163189|75919730|FG000|Overall Study|Lost to Follow-up|1|||
42109163|NCT00163189|75919730|FG000|Overall Study|Protocol Violation|2|||
42109164|NCT00163189|75919730|FG000|Overall Study|Death|3|||
42109165|NCT00163189|75919730|FG000|Overall Study|Adverse Event|6|||
42109166|NCT00163189|75919730|FG000|Overall Study|Lack of Efficacy|7|||
42109167|NCT00163189|75919730|FG000|Overall Study|Study terminated by sponsor|11|||
42109168|NCT00163189|75919730|FG000|Overall Study|Withdrawal by Subject|11|||
42109169|NCT00163189|75919730|FG000|Overall Study|Did not meet continuation criterion|16|||
42109170|NCT00162097|75919738|FG000|Overall Study|Participant no longer met study criteria|0|||
42109171|NCT00162097|75919739|FG001|Overall Study|Participant no longer met study criteria|0|||
42109172|NCT00162097|75919740|FG002|Overall Study|Participant no longer met study criteria|0|||
42109173|NCT00162097|75919741|FG003|Overall Study|Participant no longer met study criteria|1|||
42109174|NCT00640016|75919761|FG000|Overall Study|Withdrawal by Subject|0|||
42109175|NCT00640016|75919762|FG001|Overall Study|Withdrawal by Subject|1|||
42109176|NCT00640016|75919763|FG002|Overall Study|Withdrawal by Subject|0|||
42109177|NCT00640016|75919764|FG003|Overall Study|Withdrawal by Subject|0|||
42109178|NCT00640016|75919761|FG000|Overall Study|Study termination|2|||
42109179|NCT00640016|75919762|FG001|Overall Study|Study termination|1|||
42109180|NCT00640016|75919763|FG002|Overall Study|Study termination|3|||
42109181|NCT00640016|75919764|FG003|Overall Study|Study termination|2|||
42109182|NCT00640016|75919761|FG000|Overall Study|Adverse Event|0|||
42109183|NCT00640016|75919762|FG001|Overall Study|Adverse Event|0|||
42109184|NCT00640016|75919763|FG002|Overall Study|Adverse Event|0|||
42109185|NCT00640016|75919764|FG003|Overall Study|Adverse Event|1|||
42109186|NCT00608868|75919781|FG000|Overall Study|Withdrawal by Subject|7|||
42109187|NCT00608868|75919781|FG000|Overall Study|Protocol Violation|3|||
42109188|NCT00608868|75919781|FG000|Overall Study|Lost to Follow-up|2|||
42109189|NCT00608868|75919781|FG000|Overall Study|Adverse Event|1|||
42109190|NCT00608868|75919781|FG000|Overall Study|Physician Decision|2|||
42109191|NCT00608322|75919787|FG000|Overall Study|Death|2|||
42109192|NCT00608322|75919788|FG001|Overall Study|Death|1|||
42109193|NCT00608244|75919794|FG000|Overall Study|Adverse Event|1|||
42109194|NCT00608244|75919794|FG000|Overall Study|Low trough levels|1|||
42109195|NCT00605280|75919804|FG000|Year 1|Protocol Violation|0|||
42109196|NCT00605280|75919805|FG001|Year 1|Protocol Violation|0|||
42109197|NCT00605280|75919806|FG002|Year 1|Protocol Violation|0|||
42109198|NCT00605280|75919807|FG003|Year 1|Protocol Violation|1|||
42109199|NCT00605280|75919804|FG000|Year 1|Adverse Event|3|||
42109200|NCT00605280|75919805|FG001|Year 1|Adverse Event|1|||
42109201|NCT00605280|75919806|FG002|Year 1|Adverse Event|1|||
42109202|NCT00605280|75919807|FG003|Year 1|Adverse Event|5|||
42109203|NCT00605280|75919804|FG000|Year 1|Physician Decision|7|||
42109204|NCT00605280|75919805|FG001|Year 1|Physician Decision|4|||
42109205|NCT00605280|75919806|FG002|Year 1|Physician Decision|0|||
42109206|NCT00605280|75919807|FG003|Year 1|Physician Decision|6|||
42109207|NCT00605280|75919804|FG000|Year 1|Withdrawal by Subject|2|||
42109208|NCT00605280|75919805|FG001|Year 1|Withdrawal by Subject|4|||
42109209|NCT00605280|75919806|FG002|Year 1|Withdrawal by Subject|0|||
42109210|NCT00605280|75919807|FG003|Year 1|Withdrawal by Subject|4|||
42109211|NCT00605280|75919804|FG000|Year 1|Other|2|||
42109212|NCT00605280|75919805|FG001|Year 1|Other|1|||
42109213|NCT00605280|75919806|FG002|Year 1|Other|0|||
42109214|NCT00605280|75919807|FG003|Year 1|Other|1|||
42109215|NCT00605280|75919804|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
42109216|NCT00605280|75919805|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
42109217|NCT00605280|75919806|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
42109218|NCT00605280|75919807|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
42109219|NCT00605280|75919804|FG000|Year 2|Adverse Event|4|||
42109220|NCT00605280|75919805|FG001|Year 2|Adverse Event|0|||
42109221|NCT00605280|75919806|FG002|Year 2|Adverse Event|2|||
42109222|NCT00605280|75919807|FG003|Year 2|Adverse Event|4|||
42109223|NCT00605280|75919804|FG000|Year 2|Physician Decision|11|||
42109224|NCT00605280|75919805|FG001|Year 2|Physician Decision|6|||
42109225|NCT00605280|75919806|FG002|Year 2|Physician Decision|4|||
42109226|NCT00605280|75919807|FG003|Year 2|Physician Decision|11|||
42109227|NCT00605280|75919804|FG000|Year 2|Withdrawal by Subject|4|||
42109228|NCT00605280|75919805|FG001|Year 2|Withdrawal by Subject|0|||
42109229|NCT00605280|75919806|FG002|Year 2|Withdrawal by Subject|0|||
42109230|NCT00605280|75919807|FG003|Year 2|Withdrawal by Subject|4|||
42109231|NCT00605280|75919804|FG000|Year 2|Other|1|||
42109232|NCT00605280|75919805|FG001|Year 2|Other|0|||
42109233|NCT00605280|75919806|FG002|Year 2|Other|0|||
42109234|NCT00605280|75919807|FG003|Year 2|Other|1|||
42109235|NCT00605280|75919804|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
42109236|NCT00605280|75919805|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
42109237|NCT00605280|75919806|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
42109238|NCT00605280|75919807|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
42109239|NCT00605280|75919804|FG000|Year 3 Extension|Adverse Event|2|||
42109240|NCT00605280|75919805|FG001|Year 3 Extension|Adverse Event|0|||
42109241|NCT00605280|75919806|FG002|Year 3 Extension|Adverse Event|0|||
42109242|NCT00605280|75919807|FG003|Year 3 Extension|Adverse Event|2|||
42109243|NCT00605280|75919804|FG000|Year 3 Extension|Physician Decision|0|||
42109244|NCT00605280|75919805|FG001|Year 3 Extension|Physician Decision|0|||
42109245|NCT00605280|75919806|FG002|Year 3 Extension|Physician Decision|0|||
42109246|NCT00605280|75919807|FG003|Year 3 Extension|Physician Decision|2|||
42109247|NCT00605280|75919804|FG000|Year 3 Extension|Withdrawal by Subject|2|||
42109248|NCT00605280|75919805|FG001|Year 3 Extension|Withdrawal by Subject|0|||
42109249|NCT00605280|75919806|FG002|Year 3 Extension|Withdrawal by Subject|0|||
42109250|NCT00605280|75919807|FG003|Year 3 Extension|Withdrawal by Subject|5|||
42109251|NCT00605280|75919804|FG000|Year 3 Extension|Other|2|||
42109252|NCT00605280|75919805|FG001|Year 3 Extension|Other|0|||
42109253|NCT00605280|75919806|FG002|Year 3 Extension|Other|0|||
42109254|NCT00605280|75919807|FG003|Year 3 Extension|Other|0|||
42203079|NCT03524664|76015901|FG001|Overall Study|Withdrawal by Subject|2|||
42203080|NCT03524664|76015900|FG000|Overall Study|Lost to Follow-up|4|||
42203081|NCT03524664|76015901|FG001|Overall Study|Lost to Follow-up|13|||
42203082|NCT04377620|76015910|FG000|Overall Study|Death|42|||
42203083|NCT04377620|76015911|FG001|Overall Study|Death|48|||
42203084|NCT04377620|76015912|FG002|Overall Study|Death|36|||
42203085|NCT04377620|76015910|FG000|Overall Study|Withdrawal by Subject|0|||
42203086|NCT04377620|76015911|FG001|Overall Study|Withdrawal by Subject|2|||
42203087|NCT04377620|76015912|FG002|Overall Study|Withdrawal by Subject|0|||
42203088|NCT03522948|76015921|FG000|Overall Study|Lost to Follow-up|1|||
42018924|NCT00993928|75826322|FG001|Overall Study|Withdrawal by Subject|7|||
42018925|NCT00993928|75826321|FG000|Overall Study|ineligible|1|||
42018926|NCT00993928|75826322|FG001|Overall Study|ineligible|0|||
42018927|NCT01253291|75826337|FG000|Overall Study|Withdrawal by Subject|1|||
42018928|NCT01253291|75826338|FG001|Overall Study|Withdrawal by Subject|1|||
42018929|NCT01253291|75826339|FG002|Overall Study|Withdrawal by Subject|0|||
42018930|NCT01253291|75826340|FG003|Overall Study|Withdrawal by Subject|0|||
42018931|NCT01253291|75826341|FG004|Overall Study|Withdrawal by Subject|0|||
42018932|NCT01253291|75826337|FG000|Overall Study|Adverse Event|0|||
42018933|NCT01253291|75826338|FG001|Overall Study|Adverse Event|1|||
42018934|NCT01253291|75826339|FG002|Overall Study|Adverse Event|0|||
42018935|NCT01253291|75826340|FG003|Overall Study|Adverse Event|0|||
42018936|NCT01253291|75826341|FG004|Overall Study|Adverse Event|0|||
42018937|NCT01253291|75826337|FG000|Overall Study|Lack of Efficacy|1|||
42018938|NCT01253291|75826338|FG001|Overall Study|Lack of Efficacy|0|||
42018939|NCT01253291|75826339|FG002|Overall Study|Lack of Efficacy|0|||
42018940|NCT01253291|75826340|FG003|Overall Study|Lack of Efficacy|0|||
42018941|NCT01253291|75826341|FG004|Overall Study|Lack of Efficacy|0|||
42018942|NCT01253291|75826337|FG000|Overall Study|Physician Decision|2|||
42018943|NCT01253291|75826338|FG001|Overall Study|Physician Decision|0|||
42018944|NCT01253291|75826339|FG002|Overall Study|Physician Decision|0|||
42018945|NCT01253291|75826340|FG003|Overall Study|Physician Decision|0|||
42109255|NCT00605280|75919804|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
42109256|NCT00605280|75919805|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
42109257|NCT00605280|75919806|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
42109258|NCT00605280|75919807|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
42109259|NCT00607386|75919817|FG000|Overall Study|Physician Decision|1|||
42109260|NCT00638690|75919823|FG000|Overall Study|Death|655|||
42109261|NCT00638690|75919824|FG001|Overall Study|Death|335|||
42203089|NCT03406078|76015927|FG000|Overall Study|Death|1|||
42203090|NCT03406078|76015928|FG001|Overall Study|Death|0|||
42203091|NCT03406078|76015927|FG000|Overall Study|Lost to Follow-up|0|||
42203092|NCT03406078|76015928|FG001|Overall Study|Lost to Follow-up|1|||
42203093|NCT03406078|76015927|FG000|Overall Study|Withdrawal by Subject|5|||
42203094|NCT03406078|76015928|FG001|Overall Study|Withdrawal by Subject|2|||
42203095|NCT03634033|76015941|FG000|Overall Study|Did not have a post-assessment|384|||
42381522|NCT01544582|76254686|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
42381523|NCT01544582|76254687|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
42381524|NCT01544582|76254688|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
42381525|NCT01544582|76254685|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
42381526|NCT01544582|76254686|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
42381527|NCT01544582|76254687|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
42381528|NCT01544582|76254688|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
42381529|NCT01544582|76254685|FG000|Analysis Population|Intolerance|0|||
42381530|NCT01544582|76254686|FG001|Analysis Population|Intolerance|1|||
42203096|NCT03634033|76015942|FG001|Overall Study|Did not have a post-assessment|291|||
42203097|NCT03634033|76015943|FG002|Overall Study|Did not have a post-assessment|114|||
42203098|NCT03634033|76015944|FG003|Overall Study|Did not have a post-assessment|161|||
42203099|NCT03634033|76015945|FG004|Overall Study|Did not have a post-assessment|5|||
42203100|NCT03634033|76015946|FG005|Overall Study|Did not have a post-assessment|0|||
42203101|NCT03634033|76015947|FG006|Overall Study|Did not have a post-assessment|0|||
42203102|NCT03634033|76015941|FG000|Overall Study|Death|0|||
42203103|NCT03634033|76015942|FG001|Overall Study|Death|0|||
42203104|NCT03634033|76015943|FG002|Overall Study|Death|0|||
42203105|NCT03634033|76015944|FG003|Overall Study|Death|0|||
42203106|NCT03634033|76015945|FG004|Overall Study|Death|0|||
42203107|NCT03634033|76015946|FG005|Overall Study|Death|7|||
42203108|NCT03634033|76015947|FG006|Overall Study|Death|7|||
42203109|NCT03634033|76015941|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
42203110|NCT03634033|76015942|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
42203111|NCT03634033|76015943|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
42203112|NCT03634033|76015944|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
42203113|NCT03634033|76015945|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
42203114|NCT03634033|76015946|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
42203115|NCT03634033|76015947|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
42203116|NCT03634033|76015941|FG000|Overall Study|Lost to Follow-up|0|||
42203117|NCT03634033|76015942|FG001|Overall Study|Lost to Follow-up|0|||
42203118|NCT03634033|76015943|FG002|Overall Study|Lost to Follow-up|0|||
42203119|NCT03634033|76015944|FG003|Overall Study|Lost to Follow-up|0|||
42203120|NCT03634033|76015945|FG004|Overall Study|Lost to Follow-up|0|||
42203121|NCT03634033|76015946|FG005|Overall Study|Lost to Follow-up|1|||
42203122|NCT03634033|76015947|FG006|Overall Study|Lost to Follow-up|2|||
42203123|NCT03634033|76015941|FG000|Overall Study|Withdrawal by Subject|0|||
42203124|NCT03634033|76015942|FG001|Overall Study|Withdrawal by Subject|0|||
42203125|NCT03634033|76015943|FG002|Overall Study|Withdrawal by Subject|0|||
42203126|NCT03634033|76015944|FG003|Overall Study|Withdrawal by Subject|0|||
42203127|NCT03634033|76015945|FG004|Overall Study|Withdrawal by Subject|0|||
42203128|NCT03634033|76015946|FG005|Overall Study|Withdrawal by Subject|0|||
42203129|NCT03634033|76015947|FG006|Overall Study|Withdrawal by Subject|1|||
42203130|NCT03103100|76015981|FG000|Overall Study|Adverse Event|1|||
42203131|NCT03103100|76015982|FG001|Overall Study|Adverse Event|0|||
42203132|NCT03103100|76015983|FG002|Overall Study|Adverse Event|0|||
42203133|NCT03103100|76015981|FG000|Overall Study|Physician Decision|1|||
42203134|NCT03103100|76015982|FG001|Overall Study|Physician Decision|0|||
42203135|NCT03103100|76015983|FG002|Overall Study|Physician Decision|2|||
42203136|NCT03438006|76015991|FG000|Overall Study|Adverse Event|1|||
42203137|NCT03438006|76015991|FG000|Overall Study|Lost to Follow-up|67|||
42203138|NCT03438006|76015991|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
42203139|NCT03438006|76015991|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
42203140|NCT04206020|76015997|FG000|Overall Study|Adverse Event|1|||
42203141|NCT04206020|76015998|FG001|Overall Study|Adverse Event|4|||
42203142|NCT04206020|76015997|FG000|Overall Study|Protocol Violation|2|||
42203143|NCT04206020|76015998|FG001|Overall Study|Protocol Violation|0|||
42203144|NCT04206020|76015997|FG000|Overall Study|Withdrawal by Subject|2|||
42203145|NCT04206020|76015998|FG001|Overall Study|Withdrawal by Subject|0|||
42203146|NCT04206020|76015997|FG000|Overall Study|Lost to Follow-up|2|||
42203147|NCT04206020|76015998|FG001|Overall Study|Lost to Follow-up|0|||
42203148|NCT04206020|76015997|FG000|Overall Study|Pregnancy|0|||
42203149|NCT04206020|76015998|FG001|Overall Study|Pregnancy|1|||
42203150|NCT04206020|76015997|FG000|Overall Study|Unable to attend visits|1|||
42203151|NCT04206020|76015998|FG001|Overall Study|Unable to attend visits|2|||
42203152|NCT03466086|76016004|FG000|Period 1|Sponsor decision due to study timeline|1|||
42203153|NCT03466086|76016005|FG001|Period 1|Sponsor decision due to study timeline|0|||
42203154|NCT03466086|76016004|FG000|Period 1|Withdrawal by Subject|1|||
42203155|NCT03466086|76016005|FG001|Period 1|Withdrawal by Subject|0|||
42203156|NCT03101462|76016013|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
42203157|NCT03101462|76016014|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
42203158|NCT02873936|76016023|FG000|Overall Study|Withdrew Consent|4|||
42203159|NCT02873936|76016024|FG001|Overall Study|Withdrew Consent|11|||
42203160|NCT02873936|76016025|FG002|Overall Study|Withdrew Consent|20|||
42203161|NCT02873936|76016023|FG000|Overall Study|Investigator's Discretion|3|||
42203162|NCT02873936|76016024|FG001|Overall Study|Investigator's Discretion|5|||
42203163|NCT02873936|76016025|FG002|Overall Study|Investigator's Discretion|4|||
42203164|NCT02873936|76016023|FG000|Overall Study|Adverse Event|3|||
42203165|NCT02873936|76016024|FG001|Overall Study|Adverse Event|5|||
42203166|NCT02873936|76016025|FG002|Overall Study|Adverse Event|3|||
42203167|NCT02873936|76016023|FG000|Overall Study|Protocol Violation|0|||
42203168|NCT02873936|76016024|FG001|Overall Study|Protocol Violation|1|||
42203169|NCT02873936|76016025|FG002|Overall Study|Protocol Violation|3|||
42203170|NCT02873936|76016023|FG000|Overall Study|Lost to Follow-up|1|||
42203171|NCT02873936|76016024|FG001|Overall Study|Lost to Follow-up|1|||
42203172|NCT02873936|76016025|FG002|Overall Study|Lost to Follow-up|1|||
42203173|NCT02873936|76016023|FG000|Overall Study|Non-compliance With Study Drug|1|||
42203174|NCT02873936|76016024|FG001|Overall Study|Non-compliance With Study Drug|0|||
42203175|NCT02873936|76016025|FG002|Overall Study|Non-compliance With Study Drug|1|||
42203176|NCT02873936|76016023|FG000|Overall Study|Randomized but not Dosed|1|||
42203177|NCT02873936|76016024|FG001|Overall Study|Randomized but not Dosed|0|||
42203178|NCT02873936|76016025|FG002|Overall Study|Randomized but not Dosed|0|||
42203179|NCT02874794|76016035|FG000|Overall Study|Physician Decision|3|||
42203180|NCT02874794|76016036|FG001|Overall Study|Physician Decision|2|||
42203181|NCT02874794|76016035|FG000|Overall Study|Withdrawal by Subject|2|||
42203182|NCT02874794|76016036|FG001|Overall Study|Withdrawal by Subject|8|||
42203183|NCT02874794|76016035|FG000|Overall Study|Death|2|||
42203184|NCT02874794|76016036|FG001|Overall Study|Death|1|||
42203185|NCT03102710|76016048|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
42203186|NCT03102710|76016049|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
42203187|NCT03102710|76016050|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
42203188|NCT03102710|76016048|FG000|Overall Study|Technical issues during final MRI scan|0|||
42203189|NCT03102710|76016049|FG001|Overall Study|Technical issues during final MRI scan|1|||
42203190|NCT03102710|76016050|FG002|Overall Study|Technical issues during final MRI scan|0|||
42203191|NCT03102710|76016048|FG000|Overall Study|Nausea during MRI scan|0|||
42203192|NCT03102710|76016049|FG001|Overall Study|Nausea during MRI scan|1|||
42203193|NCT03102710|76016050|FG002|Overall Study|Nausea during MRI scan|0|||
42203194|NCT03102710|76016048|FG000|Overall Study|Subject unable to attend final session|0|||
42203195|NCT03102710|76016049|FG001|Overall Study|Subject unable to attend final session|1|||
42203196|NCT03102710|76016050|FG002|Overall Study|Subject unable to attend final session|0|||
42203197|NCT03101150|76016060|FG000|Overall Study|Lost to Follow-up|2|||
42203198|NCT03101150|76016061|FG001|Overall Study|Lost to Follow-up|4|||
42203199|NCT03101150|76016060|FG000|Overall Study|Miscarriage|3|||
42203200|NCT03101150|76016061|FG001|Overall Study|Miscarriage|6|||
42018946|NCT01253291|75826341|FG004|Overall Study|Physician Decision|2|||
42018947|NCT01121757|75826356|FG000|First Drug|Death|1|||
42018948|NCT01121757|75826357|FG001|First Drug|Death|0|||
42018949|NCT01121757|75826356|FG000|First Drug|Disease Progression|0|||
42018950|NCT01121757|75826357|FG001|First Drug|Disease Progression|2|||
42018951|NCT01121757|75826356|FG000|Combination|Physician Decision|0|||
42018952|NCT01121757|75826357|FG001|Combination|Physician Decision|1|||
42018953|NCT01121757|75826356|FG000|Combination|Disease Progression|2|||
42018954|NCT01121757|75826357|FG001|Combination|Disease Progression|0|||
42018955|NCT01253135|75826365|FG000|Original Protocol|Protocol Amendment|15|||
42018956|NCT01253135|75826365|FG000|Amended Protocol|Non-compliance|1|||
42018957|NCT00993616|75826373|FG000|Overall Study|No tumor at entry|1|||
42018958|NCT00993616|75826373|FG000|Overall Study|Never treated|1|||
42109262|NCT00638690|75919823|FG000|Overall Study|Withdrawal by Subject|22|||
42109263|NCT00638690|75919824|FG001|Overall Study|Withdrawal by Subject|5|||
42109264|NCT00638690|75919823|FG000|Overall Study|Lost to Follow-up|4|||
42109265|NCT00638690|75919824|FG001|Overall Study|Lost to Follow-up|2|||
42109266|NCT00543387|75919840|FG000|Panel 1 + Panel 2|Adverse Event|0|||
42109267|NCT00543387|75919841|FG001|Panel 1 + Panel 2|Adverse Event|1|||
42109268|NCT00543387|75919842|FG002|Panel 1 + Panel 2|Adverse Event|0|||
42018959|NCT01120899|75826383|FG000|Overall Study|Withdrawal by Subject|3|||
42018960|NCT01120275|75826387|FG000|Overall Study|Adverse Event|3|||
42018961|NCT01120275|75826387|FG000|Overall Study|Progression|27|||
42018962|NCT01120275|75826387|FG000|Overall Study|Ineligible|3|||
42018963|NCT01120275|75826387|FG000|Overall Study|Withdrawal by Subject|1|||
42018964|NCT01120275|75826387|FG000|Overall Study|Refusal|1|||
42018965|NCT01120275|75826387|FG000|Overall Study|Not specific|1|||
42018966|NCT00991510|75826394|FG000|Period I (Days 1-14)|Adverse Event|1|||
42109269|NCT00543387|75919843|FG003|Panel 1 + Panel 2|Adverse Event|0|||
42203201|NCT03101930|76016070|FG000|Overall Study|Withdrawal by Subject|2|||
42203202|NCT03101930|76016071|FG001|Overall Study|Withdrawal by Subject|1|||
42018967|NCT00991510|75826395|FG001|Period I (Days 1-14)|Adverse Event|0|||
42018968|NCT00991510|75826394|FG000|Period III (Days 29-112)|Adverse Event|1|||
42203203|NCT03101930|76016072|FG002|Overall Study|Withdrawal by Subject|2|||
42018969|NCT00991510|75826395|FG001|Period III (Days 29-112)|Adverse Event|1|||
42203204|NCT02928848|76016082|FG000|Arm 2|Withdrawal by Subject|1|||
42203205|NCT02928848|76016083|FG001|Arm 2|Withdrawal by Subject|0|||
42203206|NCT02928770|76016091|FG000|Overall Study|Withdrawal by Subject|2|||
42203207|NCT03100838|76016095|FG000|Overall Study|Adverse Event|1|||
42203208|NCT03100838|76016096|FG001|Overall Study|Adverse Event|0|||
42203209|NCT03100838|76016097|FG002|Overall Study|Adverse Event|0|||
42203210|NCT03100838|76016098|FG003|Overall Study|Adverse Event|0|||
42203211|NCT03100838|76016095|FG000|Overall Study|Physician Decision|1|||
42203212|NCT03100838|76016096|FG001|Overall Study|Physician Decision|1|||
42203213|NCT03100838|76016097|FG002|Overall Study|Physician Decision|1|||
42203214|NCT03100838|76016098|FG003|Overall Study|Physician Decision|1|||
42203215|NCT03100838|76016095|FG000|Overall Study|Pregnancy|0|||
42203216|NCT03100838|76016096|FG001|Overall Study|Pregnancy|1|||
42203217|NCT03100838|76016097|FG002|Overall Study|Pregnancy|0|||
42203218|NCT03100838|76016098|FG003|Overall Study|Pregnancy|0|||
42203219|NCT03100838|76016095|FG000|Overall Study|Lost to Follow-up|0|||
42203220|NCT03100838|76016096|FG001|Overall Study|Lost to Follow-up|0|||
42203221|NCT03100838|76016097|FG002|Overall Study|Lost to Follow-up|1|||
42203222|NCT03100838|76016098|FG003|Overall Study|Lost to Follow-up|0|||
42203223|NCT03480750|76016114|FG000|Overall Study|Withdrawal by Subject|0|||
42203224|NCT03480750|76016115|FG001|Overall Study|Withdrawal by Subject|1|||
42203225|NCT03480750|76016116|FG002|Overall Study|Withdrawal by Subject|0|||
42203226|NCT03480750|76016117|FG003|Overall Study|Withdrawal by Subject|0|||
42203227|NCT03480750|76016118|FG004|Overall Study|Withdrawal by Subject|0|||
42203228|NCT03480750|76016119|FG005|Overall Study|Withdrawal by Subject|0|||
42203229|NCT03480750|76016114|FG000|Overall Study|The interruption in Trientine shippment|0|||
42203230|NCT03480750|76016115|FG001|Overall Study|The interruption in Trientine shippment|0|||
42203231|NCT03480750|76016116|FG002|Overall Study|The interruption in Trientine shippment|0|||
42203232|NCT03480750|76016117|FG003|Overall Study|The interruption in Trientine shippment|0|||
42203233|NCT03480750|76016118|FG004|Overall Study|The interruption in Trientine shippment|0|||
42203234|NCT03480750|76016119|FG005|Overall Study|The interruption in Trientine shippment|1|||
42203235|NCT03412734|76016144|FG000|Overall Study|Incorrect labeling of samples|2|||
42203236|NCT03412734|76016145|FG001|Overall Study|Incorrect labeling of samples|0|||
42203237|NCT03412734|76016144|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
42203238|NCT03412734|76016145|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
42203239|NCT02374814|76016157|FG000|Overall Study|Lost to Follow-up|1|||
42203240|NCT02374814|76016158|FG001|Overall Study|Lost to Follow-up|1|||
42203241|NCT02374814|76016159|FG002|Overall Study|Lost to Follow-up|0|||
42203242|NCT02374814|76016160|FG003|Overall Study|Lost to Follow-up|1|||
42203243|NCT02374814|76016161|FG004|Overall Study|Lost to Follow-up|0|||
42203244|NCT02374814|76016162|FG005|Overall Study|Lost to Follow-up|0|||
42203245|NCT02374814|76016157|FG000|Overall Study|Withdrawal by Subject|0|||
42203246|NCT02374814|76016158|FG001|Overall Study|Withdrawal by Subject|0|||
42203247|NCT02374814|76016159|FG002|Overall Study|Withdrawal by Subject|1|||
42203248|NCT02374814|76016160|FG003|Overall Study|Withdrawal by Subject|1|||
42203249|NCT02374814|76016161|FG004|Overall Study|Withdrawal by Subject|0|||
42203250|NCT02374814|76016162|FG005|Overall Study|Withdrawal by Subject|0|||
42203251|NCT04608344|76016186|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
42203252|NCT04608344|76016187|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
42203253|NCT04608344|76016186|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
42203254|NCT04608344|76016187|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
42203255|NCT03433482|76016205|FG000|Overall Study|Lost to Follow-up|1|||
42203256|NCT03433482|76016206|FG001|Overall Study|Lost to Follow-up|0|||
42203257|NCT03433482|76016207|FG002|Overall Study|Lost to Follow-up|1|||
42203258|NCT03433482|76016208|FG003|Overall Study|Lost to Follow-up|1|||
42203259|NCT03433482|76016205|FG000|Overall Study|Withdrawal by Subject|0|||
42203260|NCT03433482|76016206|FG001|Overall Study|Withdrawal by Subject|0|||
42109270|NCT00543387|75919844|FG004|Panel 1 + Panel 2|Adverse Event|0|||
42109271|NCT00543387|75919845|FG005|Panel 1 + Panel 2|Adverse Event|0|||
42109272|NCT00543387|75919846|FG006|Panel 1 + Panel 2|Adverse Event|0|||
42109273|NCT00543387|75919847|FG007|Panel 1 + Panel 2|Adverse Event|1|||
42109274|NCT00543387|75919848|FG008|Panel 1 + Panel 2|Adverse Event|1|||
42109275|NCT00543387|75919849|FG009|Panel 1 + Panel 2|Adverse Event|0|||
42109276|NCT00543387|75919850|FG010|Panel 1 + Panel 2|Adverse Event|0|||
42109277|NCT00543387|75919840|FG000|Panel 1 + Panel 2|Physician Decision|0|||
42109278|NCT00543387|75919841|FG001|Panel 1 + Panel 2|Physician Decision|0|||
42109279|NCT00543387|75919842|FG002|Panel 1 + Panel 2|Physician Decision|1|||
42109280|NCT00543387|75919843|FG003|Panel 1 + Panel 2|Physician Decision|0|||
42109281|NCT00543387|75919844|FG004|Panel 1 + Panel 2|Physician Decision|0|||
42109282|NCT00543387|75919845|FG005|Panel 1 + Panel 2|Physician Decision|0|||
42109283|NCT00543387|75919846|FG006|Panel 1 + Panel 2|Physician Decision|0|||
42109284|NCT00543387|75919847|FG007|Panel 1 + Panel 2|Physician Decision|1|||
42203261|NCT03433482|76016207|FG002|Overall Study|Withdrawal by Subject|1|||
42203262|NCT03433482|76016208|FG003|Overall Study|Withdrawal by Subject|0|||
42381531|NCT01544582|76254687|FG002|Analysis Population|Intolerance|0|||
42109285|NCT00543387|75919848|FG008|Panel 1 + Panel 2|Physician Decision|0|||
42203263|NCT03433482|76016205|FG000|Overall Study|Unknown reason|0|||
42203264|NCT03433482|76016206|FG001|Overall Study|Unknown reason|0|||
42203265|NCT03433482|76016207|FG002|Overall Study|Unknown reason|2|||
42203266|NCT03433482|76016208|FG003|Overall Study|Unknown reason|0|||
42203267|NCT03432858|76016221|FG000|Overall Study|Protocol Violation|2|||
42203268|NCT03432858|76016222|FG001|Overall Study|Protocol Violation|1|||
42203269|NCT03432858|76016223|FG002|Overall Study|Protocol Violation|9|||
42203270|NCT03432858|76016221|FG000|Overall Study|Withdrawal by Subject|0|||
42203271|NCT03432858|76016222|FG001|Overall Study|Withdrawal by Subject|1|||
42203272|NCT03432858|76016223|FG002|Overall Study|Withdrawal by Subject|1|||
42203273|NCT03432858|76016221|FG000|Overall Study|Procedure canceled/rescheduled|0|||
42203274|NCT03432858|76016222|FG001|Overall Study|Procedure canceled/rescheduled|9|||
42203275|NCT03432858|76016223|FG002|Overall Study|Procedure canceled/rescheduled|6|||
42203276|NCT03432858|76016221|FG000|Overall Study|Required postop mobilization with splinting|0|||
42203277|NCT03432858|76016222|FG001|Overall Study|Required postop mobilization with splinting|0|||
42203278|NCT03432858|76016223|FG002|Overall Study|Required postop mobilization with splinting|1|||
42203279|NCT03432390|76016233|FG000|Apnea Period|Protocol Violation|2|||
42203280|NCT03432390|76016234|FG001|Apnea Period|Protocol Violation|2|||
42203281|NCT03456960|76016246|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
42203282|NCT03456960|76016247|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
42203283|NCT03456960|76016248|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
42203284|NCT03456960|76016249|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
42203285|NCT03456960|76016250|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
42203286|NCT03456960|76016251|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
42203287|NCT03456960|76016246|FG000|Period 2 (1 Day)|Adverse Event|1|||
42203288|NCT03456960|76016247|FG001|Period 2 (1 Day)|Adverse Event|0|||
42203289|NCT03456960|76016248|FG002|Period 2 (1 Day)|Adverse Event|0|||
42203290|NCT03456960|76016249|FG003|Period 2 (1 Day)|Adverse Event|1|||
42203291|NCT03456960|76016250|FG004|Period 2 (1 Day)|Adverse Event|0|||
42203292|NCT03456960|76016251|FG005|Period 2 (1 Day)|Adverse Event|0|||
42203293|NCT03430986|76016269|FG000|24-week Control Period|Adverse Event|1|||
42203294|NCT03430986|76016270|FG001|24-week Control Period|Adverse Event|0|||
42203295|NCT03430986|76016269|FG000|24-week Control Period|Lost to Follow-up|2|||
42203296|NCT03430986|76016270|FG001|24-week Control Period|Lost to Follow-up|2|||
42203297|NCT03430986|76016269|FG000|24-week Control Period|Withdrawal by Participant|5|||
42203298|NCT03430986|76016270|FG001|24-week Control Period|Withdrawal by Participant|0|||
42203299|NCT03430986|76016269|FG000|24-week Control Period|Protocol Deviation|0|||
42203300|NCT03430986|76016270|FG001|24-week Control Period|Protocol Deviation|2|||
42203301|NCT03430986|76016269|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
42203302|NCT03430986|76016270|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
42203303|NCT03430986|76016269|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
42203304|NCT03430986|76016270|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
42203305|NCT03448536|76016281|FG000|Overall Study|Protocol Violation|2|||
42203306|NCT03448536|76016282|FG001|Overall Study|Protocol Violation|0|||
42203307|NCT03448536|76016281|FG000|Overall Study|Pregnancy|1|||
42203308|NCT03448536|76016282|FG001|Overall Study|Pregnancy|0|||
42203309|NCT03448536|76016281|FG000|Overall Study|Withdrawal by Subject|1|||
42203310|NCT03448536|76016282|FG001|Overall Study|Withdrawal by Subject|2|||
42203311|NCT03448536|76016281|FG000|Overall Study|Lost to Follow-up|3|||
42203312|NCT03448536|76016282|FG001|Overall Study|Lost to Follow-up|2|||
42203313|NCT03448536|76016281|FG000|Overall Study|Inadequate pain reporter|1|||
42203314|NCT03448536|76016282|FG001|Overall Study|Inadequate pain reporter|0|||
42203315|NCT03448536|76016281|FG000|Overall Study|Other|3|||
42381532|NCT01544582|76254688|FG003|Analysis Population|Intolerance|0|||
42381533|NCT01544582|76254685|FG000|Analysis Population|Liver Transplantation|0|||
42381534|NCT01544582|76254686|FG001|Analysis Population|Liver Transplantation|0|||
42203316|NCT03448536|76016282|FG001|Overall Study|Other|0|||
42203317|NCT03448536|76016281|FG000|Overall Study|Physician Decision|1|||
42203318|NCT03448536|76016282|FG001|Overall Study|Physician Decision|0|||
42203319|NCT03448224|76016290|FG000|Overall Study|Provided same answer to every question|1|||
42203320|NCT03448224|76016291|FG001|Overall Study|Provided same answer to every question|0|||
42203321|NCT03424044|76016297|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
42203322|NCT03424044|76016298|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
42203323|NCT03424044|76016299|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
42203324|NCT03424044|76016300|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
42203325|NCT03424044|76016301|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
42381535|NCT01544582|76254687|FG002|Analysis Population|Liver Transplantation|1|||
42381536|NCT01544582|76254688|FG003|Analysis Population|Liver Transplantation|0|||
42381537|NCT01544582|76254685|FG000|Analysis Population|No Social Insurance|0|||
42203326|NCT03424044|76016302|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
42203327|NCT03424044|76016303|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
42203328|NCT03424044|76016304|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
42203329|NCT03424044|76016305|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
42381538|NCT01544582|76254686|FG001|Analysis Population|No Social Insurance|0|||
42203330|NCT03424044|76016297|FG000|First Intervention (76 Hours)|Adverse Event|0|||
42203331|NCT03424044|76016298|FG001|First Intervention (76 Hours)|Adverse Event|0|||
42203332|NCT03424044|76016299|FG002|First Intervention (76 Hours)|Adverse Event|0|||
42203333|NCT03424044|76016300|FG003|First Intervention (76 Hours)|Adverse Event|0|||
42203334|NCT03424044|76016301|FG004|First Intervention (76 Hours)|Adverse Event|1|||
42203335|NCT03424044|76016302|FG005|First Intervention (76 Hours)|Adverse Event|0|||
42203336|NCT03424044|76016303|FG006|First Intervention (76 Hours)|Adverse Event|0|||
42203337|NCT03424044|76016304|FG007|First Intervention (76 Hours)|Adverse Event|0|||
42203338|NCT03424044|76016305|FG008|First Intervention (76 Hours)|Adverse Event|0|||
42381539|NCT01544582|76254687|FG002|Analysis Population|No Social Insurance|1|||
42381540|NCT01544582|76254688|FG003|Analysis Population|No Social Insurance|0|||
42381541|NCT01544582|76254685|FG000|Analysis Population|Poor Adherence|0|||
42381542|NCT01544582|76254686|FG001|Analysis Population|Poor Adherence|0|||
42381543|NCT01544582|76254687|FG002|Analysis Population|Poor Adherence|1|||
42381544|NCT01544582|76254688|FG003|Analysis Population|Poor Adherence|0|||
42381545|NCT01544582|76254685|FG000|Analysis Population|Poor Participant Compliance|0|||
42381546|NCT01544582|76254686|FG001|Analysis Population|Poor Participant Compliance|1|||
42381547|NCT01544582|76254687|FG002|Analysis Population|Poor Participant Compliance|0|||
42381548|NCT01544582|76254688|FG003|Analysis Population|Poor Participant Compliance|0|||
42381549|NCT01544582|76254685|FG000|Analysis Population|Programmed Surgery|0|||
42381550|NCT01544582|76254686|FG001|Analysis Population|Programmed Surgery|1|||
42381551|NCT01544582|76254687|FG002|Analysis Population|Programmed Surgery|0|||
42381552|NCT01544582|76254688|FG003|Analysis Population|Programmed Surgery|0|||
42381553|NCT01544582|76254685|FG000|Analysis Population|Participant in Jail|0|||
42381554|NCT01544582|76254686|FG001|Analysis Population|Participant in Jail|0|||
42381555|NCT01544582|76254687|FG002|Analysis Population|Participant in Jail|1|||
42381556|NCT01544582|76254688|FG003|Analysis Population|Participant in Jail|0|||
42381557|NCT01439165|76254716|FG000|Overall Study|Protocol Violation|3|||
42381558|NCT01439165|76254717|FG001|Overall Study|Protocol Violation|0|||
42381559|NCT01439165|76254716|FG000|Overall Study|Lost to Follow-up|11|||
42381560|NCT01439165|76254717|FG001|Overall Study|Lost to Follow-up|1|||
42381561|NCT01439165|76254716|FG000|Overall Study|Withdrawal by Subject|7|||
42381562|NCT01439165|76254717|FG001|Overall Study|Withdrawal by Subject|1|||
42381563|NCT01529606|76254731|FG000|Overall Study|Lost to Follow-up|21|||
42381564|NCT01529606|76254732|FG001|Overall Study|Lost to Follow-up|18|||
42381565|NCT01439009|76254749|FG000|Overall Study|Physician Decision|5|||
42381566|NCT01439009|76254750|FG001|Overall Study|Physician Decision|3|||
42381567|NCT01439009|76254749|FG000|Overall Study|Protocol Violation|2|||
42381568|NCT01439009|76254750|FG001|Overall Study|Protocol Violation|0|||
42381569|NCT01439009|76254749|FG000|Overall Study|Deviation of exclusion criteria|1|||
42381570|NCT01439009|76254750|FG001|Overall Study|Deviation of exclusion criteria|0|||
42381571|NCT01572389|76254769|FG000|Overall Study|Death|1|||
42381572|NCT01572389|76254770|FG001|Overall Study|Death|3|||
42381573|NCT01572389|76254769|FG000|Overall Study|Withdrawal by Subject|14|||
42381574|NCT01572389|76254770|FG001|Overall Study|Withdrawal by Subject|2|||
42381575|NCT01572389|76254769|FG000|Overall Study|Lost to Follow-up|25|||
42381576|NCT01572389|76254770|FG001|Overall Study|Lost to Follow-up|14|||
42381577|NCT01572389|76254769|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
42381578|NCT01572389|76254770|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
42381579|NCT01571453|76254782|FG000|Overall Study|Adverse Event|14|||
42381580|NCT01571453|76254783|FG001|Overall Study|Adverse Event|32|||
42381581|NCT01571453|76254782|FG000|Overall Study|Lack of Efficacy|8|||
42381582|NCT01571453|76254783|FG001|Overall Study|Lack of Efficacy|3|||
42381583|NCT01571453|76254782|FG000|Overall Study|Non-compliance|2|||
42381584|NCT01571453|76254783|FG001|Overall Study|Non-compliance|4|||
42381585|NCT01571453|76254782|FG000|Overall Study|Protocol Violation|1|||
42381586|NCT01571453|76254783|FG001|Overall Study|Protocol Violation|5|||
42381587|NCT01571453|76254782|FG000|Overall Study|Withdrawal of consent|5|||
42381588|NCT01571453|76254783|FG001|Overall Study|Withdrawal of consent|13|||
42381589|NCT01571453|76254782|FG000|Overall Study|Lost to Follow-up|4|||
42381590|NCT01571453|76254783|FG001|Overall Study|Lost to Follow-up|2|||
42381591|NCT01571453|76254782|FG000|Overall Study|Administrative or other reason(s)|4|||
42381592|NCT01571453|76254783|FG001|Overall Study|Administrative or other reason(s)|3|||
42381593|NCT01446289|76254793|FG000|Overall Study|Withdrawal by Subject|1|||
42203339|NCT03424044|76016297|FG000|First Intervention (76 Hours)|device issues|0|||
42381594|NCT01446289|76254794|FG001|Overall Study|Withdrawal by Subject|0|||
42381595|NCT01446289|76254795|FG002|Overall Study|Withdrawal by Subject|1|||
42381596|NCT01446289|76254796|FG003|Overall Study|Withdrawal by Subject|0|||
42381597|NCT01438541|76254808|FG000|Overall Study|Physician Decision|1|||
42381598|NCT01438541|76254808|FG000|Overall Study|Withdrawal by Subject|1|||
42381599|NCT01438541|76254808|FG000|Overall Study|discharge from the hospital|5|||
42381600|NCT01419769|76254812|FG000|Overall Study|Did not receive the AXIOS stent|3|||
42381601|NCT01419769|76254812|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
42381602|NCT01438307|76254818|FG000|Overall Study|Death|1|||
42381603|NCT01438307|76254819|FG001|Overall Study|Death|1|||
42381604|NCT01444651|76254827|FG000|Overall Study|Adverse Event|3|||
42381605|NCT01444651|76254828|FG001|Overall Study|Adverse Event|2|||
42381606|NCT01444651|76254827|FG000|Overall Study|Lost to Follow-up|5|||
42381607|NCT01444651|76254828|FG001|Overall Study|Lost to Follow-up|5|||
42381608|NCT01444651|76254827|FG000|Overall Study|Non-fasting|2|||
42381609|NCT01444651|76254828|FG001|Overall Study|Non-fasting|1|||
42381610|NCT01444651|76254827|FG000|Overall Study|Missing data|1|||
42381611|NCT01444651|76254828|FG001|Overall Study|Missing data|1|||
42381612|NCT01570751|76254836|FG000|Period A (16 Weeks)|Protocol Violation|1|||
42381613|NCT01570751|76254837|FG001|Period A (16 Weeks)|Protocol Violation|1|||
42381614|NCT01570751|76254836|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
42381615|NCT01570751|76254837|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
42381616|NCT01570751|76254836|FG000|Period A (16 Weeks)|Unclassified|2|||
42381617|NCT01570751|76254837|FG001|Period A (16 Weeks)|Unclassified|3|||
42381618|NCT01570751|76254836|FG000|Period B (16 Weeks)|Adverse Event|1|||
42381619|NCT01570751|76254837|FG001|Period B (16 Weeks)|Adverse Event|0|||
42381620|NCT01570751|76254836|FG000|Period B (16 Weeks)|Protocol Violation|0|||
42381621|NCT01570751|76254837|FG001|Period B (16 Weeks)|Protocol Violation|1|||
42381622|NCT01419535|76254847|FG000|Overall Study|could not maintain iv line|1|||
42381623|NCT01419535|76254848|FG001|Overall Study|could not maintain iv line|1|||
42381624|NCT01419535|76254847|FG000|Overall Study|Withdrawal by Subject|0|||
42381625|NCT01419535|76254848|FG001|Overall Study|Withdrawal by Subject|1|||
42381626|NCT01438151|76254854|FG000|Overall Study|study terminated|8|||
42381627|NCT01418365|76254880|FG000|First Intervention|Withdrawal by Subject|0|||
42381628|NCT01418365|76254881|FG001|First Intervention|Withdrawal by Subject|1|||
42381629|NCT01418365|76254880|FG000|First Intervention|Non-compliance|1|||
42381630|NCT01418365|76254881|FG001|First Intervention|Non-compliance|0|||
42381631|NCT01418365|76254880|FG000|Second Intervention|Withdrawal by Subject|0|||
42381632|NCT01418365|76254881|FG001|Second Intervention|Withdrawal by Subject|1|||
42381633|NCT01437995|76254916|FG000|Overall Study|Lost to Follow-up|11|||
42381634|NCT01437995|76254917|FG001|Overall Study|Lost to Follow-up|18|||
42381635|NCT01437995|76254918|FG002|Overall Study|Lost to Follow-up|20|||
42381636|NCT01439347|76254967|FG000|Overall Study|Death|10|||
42381637|NCT01439347|76254968|FG001|Overall Study|Death|9|||
42381638|NCT01439347|76254967|FG000|Overall Study|Withdrawal by Subject|0|||
42381639|NCT01439347|76254968|FG001|Overall Study|Withdrawal by Subject|1|||
42381640|NCT01439347|76254967|FG000|Overall Study|Physician Decision|1|||
42381641|NCT01439347|76254968|FG001|Overall Study|Physician Decision|0|||
42381642|NCT01439347|76254967|FG000|Overall Study|Sponsor Terminated Study|2|||
42381643|NCT01439347|76254968|FG001|Overall Study|Sponsor Terminated Study|3|||
42381644|NCT01438957|76255015|FG000|Overall Study|Physician Decision|1|||
42381645|NCT01438957|76255016|FG001|Overall Study|Physician Decision|1|||
42381646|NCT01438957|76255017|FG002|Overall Study|Physician Decision|0|||
42018970|NCT01119963|75826407|FG000|Overall Study|Lost to Follow-up|1|||
42203340|NCT03424044|76016298|FG001|First Intervention (76 Hours)|device issues|0|||
42203341|NCT03424044|76016299|FG002|First Intervention (76 Hours)|device issues|0|||
42203342|NCT03424044|76016300|FG003|First Intervention (76 Hours)|device issues|0|||
42203343|NCT03424044|76016301|FG004|First Intervention (76 Hours)|device issues|0|||
42203344|NCT03424044|76016302|FG005|First Intervention (76 Hours)|device issues|0|||
42203345|NCT03424044|76016303|FG006|First Intervention (76 Hours)|device issues|1|||
42203346|NCT03424044|76016304|FG007|First Intervention (76 Hours)|device issues|1|||
42203347|NCT03424044|76016305|FG008|First Intervention (76 Hours)|device issues|1|||
42203348|NCT03424044|76016297|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
42203349|NCT03424044|76016298|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
42203350|NCT03424044|76016299|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
42203351|NCT03424044|76016300|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
42203352|NCT03424044|76016301|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
42203353|NCT03424044|76016302|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
42203354|NCT03424044|76016303|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
42203355|NCT03424044|76016304|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
42109286|NCT00543387|75919849|FG009|Panel 1 + Panel 2|Physician Decision|0|||
42109287|NCT00543387|75919850|FG010|Panel 1 + Panel 2|Physician Decision|0|||
42109288|NCT00543387|75919840|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
42109289|NCT00543387|75919841|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
42109290|NCT00543387|75919842|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
42109291|NCT00543387|75919843|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
42109292|NCT00543387|75919844|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
42109293|NCT00543387|75919845|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
42109294|NCT00543387|75919846|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
42109295|NCT00543387|75919847|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
42109296|NCT00543387|75919848|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
42109297|NCT00543387|75919849|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
42109298|NCT00543387|75919850|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
42109299|NCT00543387|75919840|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
42109300|NCT00543387|75919841|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
42109301|NCT00543387|75919842|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
42109302|NCT00543387|75919843|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
42109303|NCT00543387|75919844|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
42109304|NCT00543387|75919845|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
42109305|NCT00543387|75919846|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
42109306|NCT00543387|75919847|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
42109307|NCT00543387|75919848|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
42109308|NCT00543387|75919849|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
42109309|NCT00543387|75919850|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
42109310|NCT00543387|75919840|FG000|Crossover Participants|Progressive Disease|0|||
42109311|NCT00543387|75919841|FG001|Crossover Participants|Progressive Disease|0|||
42109312|NCT00543387|75919842|FG002|Crossover Participants|Progressive Disease|0|||
42203356|NCT03424044|76016305|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
42203357|NCT03424044|76016297|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
42109313|NCT00543387|75919843|FG003|Crossover Participants|Progressive Disease|0|||
42109314|NCT00543387|75919844|FG004|Crossover Participants|Progressive Disease|0|||
42203358|NCT03424044|76016298|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
42203359|NCT03424044|76016299|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
42203360|NCT03424044|76016300|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
42203361|NCT03424044|76016301|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
42109315|NCT00543387|75919845|FG005|Crossover Participants|Progressive Disease|0|||
42109316|NCT00543387|75919846|FG006|Crossover Participants|Progressive Disease|0|||
42109317|NCT00543387|75919847|FG007|Crossover Participants|Progressive Disease|0|||
42109318|NCT00543387|75919848|FG008|Crossover Participants|Progressive Disease|0|||
42109319|NCT00543387|75919849|FG009|Crossover Participants|Progressive Disease|1|||
42109320|NCT00543387|75919850|FG010|Crossover Participants|Progressive Disease|2|||
42109321|NCT00543387|75919840|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
42109322|NCT00543387|75919841|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
42109323|NCT00543387|75919842|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
42109324|NCT00543387|75919843|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
42109325|NCT00543387|75919844|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
42109326|NCT00543387|75919845|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
42109327|NCT00543387|75919846|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
42203362|NCT03424044|76016302|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
42203363|NCT03424044|76016303|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
42381647|NCT01438957|76255018|FG003|Overall Study|Physician Decision|1|||
42381648|NCT01438957|76255019|FG004|Overall Study|Physician Decision|0|||
42381649|NCT01444417|76255068|FG000|Overall Study|Ineligibility Determined|0|||
42381650|NCT01444417|76255069|FG001|Overall Study|Ineligibility Determined|1|||
42381651|NCT01444417|76255068|FG000|Overall Study|Withdrawal by Subject|2|||
42381652|NCT01444417|76255069|FG001|Overall Study|Withdrawal by Subject|0|||
42381653|NCT01444027|76255096|FG000|Overall Study|Withdrawal by Subject|4|||
42381654|NCT01444027|76255097|FG001|Overall Study|Withdrawal by Subject|10|||
42381655|NCT01444027|76255098|FG002|Overall Study|Withdrawal by Subject|24|||
42381656|NCT01444027|76255096|FG000|Overall Study|Lost to Follow-up|26|||
42381657|NCT01444027|76255097|FG001|Overall Study|Lost to Follow-up|20|||
42381658|NCT01444027|76255098|FG002|Overall Study|Lost to Follow-up|14|||
42203364|NCT03424044|76016304|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
42203365|NCT03424044|76016305|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
42203366|NCT03422250|76016319|FG000|Intervention|Adverse Event|0|||
42203367|NCT03422250|76016320|FG001|Intervention|Adverse Event|1|||
42203368|NCT03422250|76016321|FG002|Intervention|Adverse Event|0|||
42203369|NCT03422250|76016322|FG003|Intervention|Adverse Event|1|||
42203370|NCT03422250|76016319|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
42203371|NCT03422250|76016320|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
42203372|NCT03422250|76016321|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
42203373|NCT03422250|76016322|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
42203374|NCT03422250|76016319|FG000|Follow-up|Withdrawal by Subject|0|||
42203375|NCT03422250|76016320|FG001|Follow-up|Withdrawal by Subject|0|||
42203376|NCT03422250|76016321|FG002|Follow-up|Withdrawal by Subject|0|||
42203377|NCT03422250|76016322|FG003|Follow-up|Withdrawal by Subject|1|||
42203378|NCT03422250|76016319|FG000|Follow-up|Adverse Event|0|||
42203379|NCT03422250|76016320|FG001|Follow-up|Adverse Event|0|||
42203380|NCT03422250|76016321|FG002|Follow-up|Adverse Event|0|||
42203381|NCT03422250|76016322|FG003|Follow-up|Adverse Event|1|||
42381659|NCT01438489|76255140|FG000|Overall Study|Lost to Follow-up|4|||
42018971|NCT01119963|75826408|FG001|Overall Study|Lost to Follow-up|1|||
42381660|NCT01438489|76255141|FG001|Overall Study|Lost to Follow-up|2|||
42381661|NCT01438489|76255142|FG002|Overall Study|Lost to Follow-up|2|||
42381662|NCT01438489|76255140|FG000|Overall Study|Withdrawal by Subject|11|||
42381663|NCT01438489|76255141|FG001|Overall Study|Withdrawal by Subject|3|||
42381664|NCT01438489|76255142|FG002|Overall Study|Withdrawal by Subject|8|||
42381665|NCT01438489|76255140|FG000|Overall Study|Death|0|||
42381666|NCT01438489|76255141|FG001|Overall Study|Death|0|||
42381667|NCT01438489|76255142|FG002|Overall Study|Death|1|||
42381668|NCT01438489|76255140|FG000|Overall Study|Sponsor decision|4|||
42381669|NCT01438489|76255141|FG001|Overall Study|Sponsor decision|1|||
42381670|NCT01438489|76255142|FG002|Overall Study|Sponsor decision|4|||
42381671|NCT01438489|76255140|FG000|Overall Study|Subject choice/Subject moved|2|||
42381672|NCT01438489|76255141|FG001|Overall Study|Subject choice/Subject moved|1|||
42381673|NCT01438489|76255142|FG002|Overall Study|Subject choice/Subject moved|1|||
42381674|NCT01438489|76255140|FG000|Overall Study|Investigator decision|0|||
42381675|NCT01438489|76255141|FG001|Overall Study|Investigator decision|1|||
42381676|NCT01438489|76255142|FG002|Overall Study|Investigator decision|0|||
42381677|NCT01438489|76255140|FG000|Overall Study|AE/SAEs|2|||
42381678|NCT01438489|76255141|FG001|Overall Study|AE/SAEs|1|||
42381679|NCT01438489|76255142|FG002|Overall Study|AE/SAEs|1|||
42381680|NCT01438489|76255140|FG000|Overall Study|Received prohibited medication|1|||
42381681|NCT01438489|76255141|FG001|Overall Study|Received prohibited medication|0|||
42381682|NCT01438489|76255142|FG002|Overall Study|Received prohibited medication|0|||
42381683|NCT01438489|76255140|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
42381684|NCT01438489|76255141|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
42381685|NCT01438489|76255142|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
42381686|NCT01438489|76255140|FG000|Overall Study|Inadequate venous access|0|||
42381687|NCT01438489|76255141|FG001|Overall Study|Inadequate venous access|2|||
42381688|NCT01438489|76255142|FG002|Overall Study|Inadequate venous access|0|||
42381689|NCT01418209|76255168|FG000|Overall Study|Withdrawal by Subject|1|||
42381690|NCT01418209|76255169|FG001|Overall Study|Withdrawal by Subject|0|||
42381691|NCT01418209|76255170|FG002|Overall Study|Withdrawal by Subject|1|||
42381692|NCT01418209|76255168|FG000|Overall Study|Did not provide hot flash diary data|1|||
42381693|NCT01418209|76255169|FG001|Overall Study|Did not provide hot flash diary data|3|||
42381694|NCT01418209|76255170|FG002|Overall Study|Did not provide hot flash diary data|3|||
42381695|NCT01570361|76255189|FG000|Overall Study|Subject discontinued|1|||
42381696|NCT01570361|76255190|FG001|Overall Study|Subject discontinued|2|||
42381697|NCT01570361|76255189|FG000|Overall Study|Sponsor closing the study|51|||
42381698|NCT01570361|76255190|FG001|Overall Study|Sponsor closing the study|50|||
42381699|NCT01570361|76255189|FG000|Overall Study|Subject excluded|5|||
42381700|NCT01570361|76255190|FG001|Overall Study|Subject excluded|3|||
42381701|NCT01570361|76255189|FG000|Overall Study|Subject withdrew consent|14|||
42381702|NCT01570361|76255190|FG001|Overall Study|Subject withdrew consent|9|||
42381703|NCT01570361|76255189|FG000|Overall Study|Adverse Event|2|||
42381704|NCT01570361|76255190|FG001|Overall Study|Adverse Event|1|||
42381705|NCT01570361|76255189|FG000|Overall Study|Lost to Follow-up|4|||
42381706|NCT01570361|76255190|FG001|Overall Study|Lost to Follow-up|4|||
42381707|NCT01570361|76255189|FG000|Overall Study|Death|5|||
42381708|NCT01570361|76255190|FG001|Overall Study|Death|4|||
42381709|NCT01570361|76255189|FG000|Overall Study|Other|0|||
42381710|NCT01570361|76255190|FG001|Overall Study|Other|2|||
42381711|NCT01417195|76255201|FG000|Overall Study|Stimulation failure|1|||
42381712|NCT01417195|76255202|FG001|Overall Study|Stimulation failure|0|||
42381713|NCT01417195|76255201|FG000|Overall Study|No embryos for transfer|0|||
42381714|NCT01417195|76255202|FG001|Overall Study|No embryos for transfer|1|||
42381715|NCT01417195|76255201|FG000|Overall Study|No transfer due to risk of OHSS|1|||
42109328|NCT00543387|75919847|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
42109329|NCT00543387|75919848|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
42109330|NCT00543387|75919849|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
42381716|NCT01417195|76255202|FG001|Overall Study|No transfer due to risk of OHSS|0|||
42381717|NCT01417195|76255201|FG000|Overall Study|No transfer due to elevated progesterone|1|||
42381718|NCT01417195|76255202|FG001|Overall Study|No transfer due to elevated progesterone|0|||
42381719|NCT01443403|76255235|FG000|Overall Study|Adverse Event|1|||
42109331|NCT00543387|75919850|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
42381720|NCT01443403|76255236|FG001|Overall Study|Adverse Event|1|||
42381721|NCT01443403|76255237|FG002|Overall Study|Adverse Event|4|||
42381722|NCT01443403|76255238|FG003|Overall Study|Adverse Event|5|||
42381723|NCT01443403|76255235|FG000|Overall Study|Withdrawal by Subject|0|||
42381724|NCT01443403|76255236|FG001|Overall Study|Withdrawal by Subject|1|||
42381725|NCT01443403|76255237|FG002|Overall Study|Withdrawal by Subject|2|||
42381726|NCT01443403|76255238|FG003|Overall Study|Withdrawal by Subject|1|||
42381727|NCT01443403|76255235|FG000|Overall Study|Lost to Follow-up|0|||
42381728|NCT01443403|76255236|FG001|Overall Study|Lost to Follow-up|0|||
42381729|NCT01443403|76255237|FG002|Overall Study|Lost to Follow-up|0|||
42381730|NCT01443403|76255238|FG003|Overall Study|Lost to Follow-up|1|||
42381731|NCT01443403|76255235|FG000|Overall Study|Protocol Violation|2|||
42381732|NCT01443403|76255236|FG001|Overall Study|Protocol Violation|1|||
42381733|NCT01443403|76255237|FG002|Overall Study|Protocol Violation|1|||
42381734|NCT01443403|76255238|FG003|Overall Study|Protocol Violation|1|||
42381735|NCT01443403|76255235|FG000|Overall Study|Use of Prohibited Treatment|2|||
42381736|NCT01443403|76255236|FG001|Overall Study|Use of Prohibited Treatment|3|||
42381737|NCT01443403|76255237|FG002|Overall Study|Use of Prohibited Treatment|0|||
42381738|NCT01443403|76255238|FG003|Overall Study|Use of Prohibited Treatment|0|||
42381739|NCT01443403|76255235|FG000|Overall Study|Other - Miscellaneous|1|||
42381740|NCT01443403|76255236|FG001|Overall Study|Other - Miscellaneous|0|||
42381741|NCT01443403|76255237|FG002|Overall Study|Other - Miscellaneous|0|||
42381742|NCT01443403|76255238|FG003|Overall Study|Other - Miscellaneous|1|||
42381743|NCT01438177|76255251|FG000|Overall Study|Withdrawal by Subject|1|||
42381744|NCT01438177|76255251|FG000|Overall Study|Initiation of new therapy|1|||
42381745|NCT01442779|76255255|FG000|Overall Study|Withdrawal by Subject|3|||
42381746|NCT01442779|76255255|FG000|Overall Study|Death|3|||
42381747|NCT01442779|76255255|FG000|Overall Study|Non-compliance|1|||
42381748|NCT01416805|76255261|FG000|Overall Study|Lost to Follow-up|4|||
42381749|NCT01416805|76255262|FG001|Overall Study|Lost to Follow-up|4|||
42381750|NCT01437943|76255270|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
42381751|NCT01437943|76255271|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
42381752|NCT01437943|76255270|FG000|Overall Study|Subject expressed pregnancy plans|1|||
42381753|NCT01437943|76255271|FG001|Overall Study|Subject expressed pregnancy plans|0|||
42381754|NCT01437943|76255270|FG000|Overall Study|Adverse Event|2|||
42381755|NCT01437943|76255271|FG001|Overall Study|Adverse Event|0|||
42381756|NCT01570283|76255280|FG000|Cohort 1: Dose Level 1|Death|0|||
42381757|NCT01570283|76255281|FG001|Cohort 1: Dose Level 1|Death|1|||
42381758|NCT01570283|76255282|FG002|Cohort 1: Dose Level 1|Death|0|||
42381759|NCT01570283|76255283|FG003|Cohort 1: Dose Level 1|Death|0|||
42381760|NCT01570283|76255284|FG004|Cohort 1: Dose Level 1|Death|0|||
42381761|NCT01570283|76255285|FG005|Cohort 1: Dose Level 1|Death|0|||
42381762|NCT01570283|76255280|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
42381763|NCT01570283|76255281|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
42381764|NCT01570283|76255282|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
42381765|NCT01570283|76255283|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
42381766|NCT01570283|76255284|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
42381767|NCT01570283|76255285|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
42381768|NCT01570283|76255280|FG000|Cohort 2: Dose Level 2|Death|0|||
42381769|NCT01570283|76255281|FG001|Cohort 2: Dose Level 2|Death|0|||
42381770|NCT01570283|76255282|FG002|Cohort 2: Dose Level 2|Death|1|||
42381771|NCT01570283|76255283|FG003|Cohort 2: Dose Level 2|Death|0|||
42381772|NCT01570283|76255284|FG004|Cohort 2: Dose Level 2|Death|0|||
42381773|NCT01570283|76255285|FG005|Cohort 2: Dose Level 2|Death|0|||
42381774|NCT01570283|76255280|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
42381775|NCT01570283|76255281|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
42381776|NCT01570283|76255282|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
42381777|NCT01570283|76255283|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
42381778|NCT01570283|76255284|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
42381779|NCT01570283|76255285|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
42381780|NCT01570283|76255280|FG000|Cohort 3: Dose Level 3|Death|0|||
42381781|NCT01570283|76255281|FG001|Cohort 3: Dose Level 3|Death|0|||
42381782|NCT01570283|76255282|FG002|Cohort 3: Dose Level 3|Death|0|||
42381783|NCT01570283|76255283|FG003|Cohort 3: Dose Level 3|Death|0|||
42381784|NCT01570283|76255284|FG004|Cohort 3: Dose Level 3|Death|0|||
42381785|NCT01570283|76255285|FG005|Cohort 3: Dose Level 3|Death|1|||
42381786|NCT01570283|76255280|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
42381787|NCT01570283|76255281|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
42381788|NCT01570283|76255282|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
42381789|NCT01570283|76255283|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
42381790|NCT01570283|76255284|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
42381791|NCT01570283|76255285|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
42381792|NCT01436357|76255301|FG000|Overall Study|Death|5|||
42381793|NCT01436357|76255302|FG001|Overall Study|Death|1|||
42381794|NCT01436357|76255301|FG000|Overall Study|Enrolled but not vaccinated|1|||
42381795|NCT01436357|76255302|FG001|Overall Study|Enrolled but not vaccinated|1|||
42381796|NCT01436357|76255301|FG000|Overall Study|Incarceration|18|||
42381797|NCT01436357|76255302|FG001|Overall Study|Incarceration|20|||
42381798|NCT01436357|76255301|FG000|Overall Study|Lost to Follow-up|67|||
42381799|NCT01436357|76255302|FG001|Overall Study|Lost to Follow-up|61|||
42381800|NCT01436357|76255301|FG000|Overall Study|Protocol Violation|1|||
42381801|NCT01436357|76255302|FG001|Overall Study|Protocol Violation|0|||
42381802|NCT01436357|76255301|FG000|Overall Study|Withdrawal by Subject|26|||
42381803|NCT01436357|76255302|FG001|Overall Study|Withdrawal by Subject|38|||
42381804|NCT01436357|76255301|FG000|Overall Study|Physician Decision|3|||
42381805|NCT01436357|76255302|FG001|Overall Study|Physician Decision|4|||
42381806|NCT01436357|76255301|FG000|Overall Study|Moved out of area|1|||
42381807|NCT01436357|76255302|FG001|Overall Study|Moved out of area|2|||
42381808|NCT01436357|76255301|FG000|Overall Study|Subject in rehab|0|||
42381809|NCT01436357|76255302|FG001|Overall Study|Subject in rehab|1|||
42381810|NCT01436201|76255308|FG000|Overall Study|Adverse Event|2|||
42381811|NCT01436201|76255308|FG000|Overall Study|Withdrawal by Subject|1|||
42381812|NCT01436201|76255308|FG000|Overall Study|Protocol Violation|1|||
42381813|NCT01437397|76255319|FG000|Overall Study|Lost to Follow-up|9|||
42381814|NCT01437397|76255320|FG001|Overall Study|Lost to Follow-up|4|||
42381815|NCT01437397|76255321|FG002|Overall Study|Lost to Follow-up|2|||
42381816|NCT01437397|76255322|FG003|Overall Study|Lost to Follow-up|4|||
42381817|NCT01437397|76255323|FG004|Overall Study|Lost to Follow-up|5|||
42381818|NCT01437397|76255319|FG000|Overall Study|Withdrawal by Subject|11|||
42381819|NCT01437397|76255320|FG001|Overall Study|Withdrawal by Subject|12|||
42381820|NCT01437397|76255321|FG002|Overall Study|Withdrawal by Subject|24|||
42381821|NCT01437397|76255322|FG003|Overall Study|Withdrawal by Subject|11|||
42381822|NCT01437397|76255323|FG004|Overall Study|Withdrawal by Subject|22|||
42381823|NCT01437397|76255319|FG000|Overall Study|Protocol Violation|10|||
42381824|NCT01437397|76255320|FG001|Overall Study|Protocol Violation|12|||
42381825|NCT01437397|76255321|FG002|Overall Study|Protocol Violation|13|||
42381826|NCT01437397|76255322|FG003|Overall Study|Protocol Violation|21|||
42381827|NCT01437397|76255323|FG004|Overall Study|Protocol Violation|19|||
42381828|NCT01437397|76255319|FG000|Overall Study|Lack of Efficacy|5|||
42381829|NCT01437397|76255320|FG001|Overall Study|Lack of Efficacy|4|||
42381830|NCT01437397|76255321|FG002|Overall Study|Lack of Efficacy|8|||
42381831|NCT01437397|76255322|FG003|Overall Study|Lack of Efficacy|10|||
42381832|NCT01437397|76255323|FG004|Overall Study|Lack of Efficacy|20|||
42381833|NCT01437397|76255319|FG000|Overall Study|Adverse Event|21|||
42381834|NCT01437397|76255320|FG001|Overall Study|Adverse Event|22|||
42381835|NCT01437397|76255321|FG002|Overall Study|Adverse Event|16|||
42381836|NCT01437397|76255322|FG003|Overall Study|Adverse Event|14|||
42381837|NCT01437397|76255323|FG004|Overall Study|Adverse Event|21|||
42381838|NCT01437397|76255319|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
42381839|NCT01437397|76255320|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
42381840|NCT01437397|76255321|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
42381841|NCT01437397|76255322|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
42381842|NCT01437397|76255323|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
42381843|NCT01437319|76255335|FG000|Phase I|Lost to Follow-up|2|||
42381844|NCT01437319|76255336|FG001|Phase I|Lost to Follow-up|0|||
42381845|NCT01437319|76255337|FG002|Phase I|Lost to Follow-up|0|||
42381846|NCT01437319|76255335|FG000|Phase I|Protocol Violation|1|||
42381847|NCT01437319|76255336|FG001|Phase I|Protocol Violation|0|||
42381848|NCT01437319|76255337|FG002|Phase I|Protocol Violation|0|||
42381849|NCT01437319|76255335|FG000|Phase I|Study related symptoms/complaints|27|||
42381850|NCT01437319|76255336|FG001|Phase I|Study related symptoms/complaints|0|||
42381851|NCT01437319|76255337|FG002|Phase I|Study related symptoms/complaints|0|||
42381852|NCT01437319|76255335|FG000|Phase I|Withdrawal by Subject|25|||
42381853|NCT01437319|76255336|FG001|Phase I|Withdrawal by Subject|0|||
42381854|NCT01437319|76255337|FG002|Phase I|Withdrawal by Subject|0|||
42381855|NCT01437319|76255335|FG000|Phase II|Withdrawal by Subject|0|||
42381856|NCT01437319|76255336|FG001|Phase II|Withdrawal by Subject|8|||
42381857|NCT01437319|76255337|FG002|Phase II|Withdrawal by Subject|16|||
42381858|NCT01437319|76255335|FG000|Phase II|Lost to Follow-up|0|||
42381859|NCT01437319|76255336|FG001|Phase II|Lost to Follow-up|7|||
42381860|NCT01437319|76255337|FG002|Phase II|Lost to Follow-up|2|||
42381861|NCT01437319|76255335|FG000|Phase II|Study related symptoms/complaints|0|||
42381862|NCT01437319|76255336|FG001|Phase II|Study related symptoms/complaints|28|||
42381863|NCT01437319|76255337|FG002|Phase II|Study related symptoms/complaints|19|||
42381864|NCT01437319|76255335|FG000|Phase II|Protocol Violation|0|||
42381865|NCT01437319|76255336|FG001|Phase II|Protocol Violation|1|||
42381866|NCT01437319|76255337|FG002|Phase II|Protocol Violation|0|||
42381867|NCT01416571|76255346|FG000|Overall Study|Lost to Follow-up|2|||
42381868|NCT01442155|76255367|FG000|Overall Study|Complete remission|35|||
42381869|NCT01442155|76255367|FG000|Overall Study|Recurrence|26|||
42381870|NCT01442155|76255367|FG000|Overall Study|Adverse Event|2|||
42381871|NCT01442155|76255367|FG000|Overall Study|Lost to Follow-up|2|||
42381872|NCT01416181|76255373|FG000|Part 1|Other|10|||
42381873|NCT01416181|76255374|FG001|Part 1|Other|24|||
42381874|NCT01416181|76255373|FG000|Part 1|Death|0|||
42381875|NCT01416181|76255374|FG001|Part 1|Death|1|||
42381876|NCT01416181|76255373|FG000|Part 1|Investigator Decision|7|||
42381877|NCT01416181|76255374|FG001|Part 1|Investigator Decision|6|||
42381878|NCT01416181|76255373|FG000|Part 1|Withdrawal by Subject|74|||
42381879|NCT01416181|76255374|FG001|Part 1|Withdrawal by Subject|48|||
42381880|NCT01416181|76255373|FG000|Part 1|Lack of Efficacy|16|||
42381881|NCT01416181|76255374|FG001|Part 1|Lack of Efficacy|8|||
42381882|NCT01416181|76255373|FG000|Part 1|Lost to Follow-up|1|||
42381883|NCT01416181|76255374|FG001|Part 1|Lost to Follow-up|1|||
42381884|NCT01416181|76255373|FG000|Part 1|Adverse Event|15|||
42381885|NCT01416181|76255374|FG001|Part 1|Adverse Event|18|||
42381886|NCT01416181|76255373|FG000|Part 1|Ongoing in Follow-Up|14|||
42381887|NCT01416181|76255374|FG001|Part 1|Ongoing in Follow-Up|8|||
42381888|NCT01416181|76255373|FG000|Part 2|Adverse Event|11|||
42381889|NCT01416181|76255374|FG001|Part 2|Adverse Event|4|||
42381890|NCT01416181|76255373|FG000|Part 2|Other|234|||
42381891|NCT01416181|76255374|FG001|Part 2|Other|267|||
42381892|NCT01416181|76255373|FG000|Part 2|Investigator Decision|6|||
42381893|NCT01416181|76255374|FG001|Part 2|Investigator Decision|7|||
42381894|NCT01416181|76255373|FG000|Part 2|Withdrawal by Subject|14|||
42381895|NCT01416181|76255374|FG001|Part 2|Withdrawal by Subject|5|||
42381896|NCT01416181|76255373|FG000|Part 2|Lack of Efficacy|4|||
42381897|NCT01416181|76255374|FG001|Part 2|Lack of Efficacy|1|||
42381898|NCT01416181|76255373|FG000|Part 2|Lost to Follow-up|2|||
42018972|NCT01252667|75826422|FG000|Overall Study|Transplant aborted post-conditioning|0|||
42381899|NCT01416181|76255374|FG001|Part 2|Lost to Follow-up|2|||
42381900|NCT01441765|76255382|FG000|Overall Study|Death|1|||
42381901|NCT01441765|76255383|FG001|Overall Study|Death|0|||
42381902|NCT01419665|76255391|FG000|Combination Treatment|Adverse Event|7|||
42381903|NCT01419665|76255392|FG001|Combination Treatment|Adverse Event|10|||
42381904|NCT01419665|76255391|FG000|Combination Treatment|Physician Decision|5|||
42381905|NCT01419665|76255392|FG001|Combination Treatment|Physician Decision|8|||
42203382|NCT01266031|76016337|FG000|Overall Study|Not treated|0|||
42203383|NCT01266031|76016338|FG001|Overall Study|Not treated|3|||
42203384|NCT01266031|76016339|FG002|Overall Study|Not treated|2|||
42203385|NCT00075725|76016370|FG000|Overall Study|Adverse Event|6|||
42203386|NCT00075725|76016371|FG001|Overall Study|Adverse Event|6|||
42203387|NCT00075725|76016372|FG002|Overall Study|Adverse Event|20|||
42203388|NCT00075725|76016373|FG003|Overall Study|Adverse Event|8|||
42203389|NCT00075725|76016374|FG004|Overall Study|Adverse Event|4|||
42203390|NCT00075725|76016375|FG005|Overall Study|Adverse Event|38|||
42203391|NCT00075725|76016376|FG006|Overall Study|Adverse Event|3|||
42203392|NCT00075725|76016377|FG007|Overall Study|Adverse Event|51|||
42203393|NCT00075725|76016378|FG008|Overall Study|Adverse Event|15|||
42203394|NCT00075725|76016379|FG009|Overall Study|Adverse Event|4|||
42203395|NCT00075725|76016380|FG010|Overall Study|Adverse Event|2|||
42203396|NCT00075725|76016381|FG011|Overall Study|Adverse Event|2|||
42203397|NCT00075725|76016370|FG000|Overall Study|Death|3|||
42203398|NCT00075725|76016371|FG001|Overall Study|Death|5|||
42381906|NCT01419665|76255391|FG000|Combination Treatment|Protocol Violation|6|||
42381907|NCT01419665|76255392|FG001|Combination Treatment|Protocol Violation|2|||
42381908|NCT01419665|76255391|FG000|Combination Treatment|disease progression|10|||
42381909|NCT01419665|76255392|FG001|Combination Treatment|disease progression|9|||
42381910|NCT01419665|76255391|FG000|Combination Treatment|Death|5|||
42203399|NCT00075725|76016372|FG002|Overall Study|Death|10|||
42203400|NCT00075725|76016373|FG003|Overall Study|Death|2|||
42203401|NCT00075725|76016374|FG004|Overall Study|Death|3|||
42381911|NCT01419665|76255392|FG001|Combination Treatment|Death|7|||
42203402|NCT00075725|76016375|FG005|Overall Study|Death|25|||
42203403|NCT00075725|76016376|FG006|Overall Study|Death|4|||
42109332|NCT00635570|75919880|FG000|Overall Study|Lost to Follow-up|8|||
42109333|NCT00635570|75919881|FG001|Overall Study|Lost to Follow-up|8|||
42109334|NCT00635570|75919880|FG000|Overall Study|Withdrawal by Subject|1|||
42109335|NCT00635570|75919881|FG001|Overall Study|Withdrawal by Subject|1|||
42109336|NCT00635570|75919880|FG000|Overall Study|Adverse Event|2|||
42109337|NCT00635570|75919881|FG001|Overall Study|Adverse Event|0|||
42381912|NCT01419665|76255391|FG000|Combination Treatment|administrative problems|0|||
42381913|NCT01419665|76255392|FG001|Combination Treatment|administrative problems|1|||
42381914|NCT01419665|76255391|FG000|Combination Treatment|Withdrawal by Subject|5|||
42381915|NCT01419665|76255392|FG001|Combination Treatment|Withdrawal by Subject|4|||
42381916|NCT01419665|76255391|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
42381917|NCT01419665|76255392|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
42381918|NCT01419665|76255391|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
42381919|NCT01419665|76255392|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
42381920|NCT01419665|76255391|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
42381921|NCT01419665|76255392|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
42381922|NCT01419665|76255391|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
42381923|NCT01419665|76255392|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
42381924|NCT01419665|76255391|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
42381925|NCT01419665|76255392|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
42381926|NCT01419665|76255391|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
42381927|NCT01419665|76255392|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
42381928|NCT01419665|76255391|FG000|Maintenance Treatment and/or Follow up|Death|1|||
42381929|NCT01419665|76255392|FG001|Maintenance Treatment and/or Follow up|Death|2|||
42381930|NCT01419665|76255391|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
42381931|NCT01419665|76255392|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
42381932|NCT01419665|76255391|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
42381933|NCT01419665|76255392|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
42381934|NCT01419665|76255391|FG000|Open Label Phase|Death|1|||
42381935|NCT01419665|76255392|FG001|Open Label Phase|Death|0|||
42381936|NCT01419665|76255391|FG000|Open Label Phase|disease progression|0|||
42381937|NCT01419665|76255392|FG001|Open Label Phase|disease progression|1|||
42381938|NCT01436305|76255403|FG000|Overall Study|Death|1|||
42381939|NCT01436305|76255404|FG001|Overall Study|Death|0|||
42381940|NCT01436305|76255405|FG002|Overall Study|Death|0|||
42381941|NCT01436305|76255403|FG000|Overall Study|Lost to Follow-up|0|||
42381942|NCT01436305|76255404|FG001|Overall Study|Lost to Follow-up|1|||
42381943|NCT01436305|76255405|FG002|Overall Study|Lost to Follow-up|0|||
42381944|NCT01436305|76255403|FG000|Overall Study|Withdrawal by Subject|1|||
42109338|NCT00635570|75919880|FG000|Overall Study|Physician Decision|1|||
42109339|NCT00635570|75919881|FG001|Overall Study|Physician Decision|0|||
42109340|NCT00635570|75919880|FG000|Overall Study|Did not complete survey|2|||
42109341|NCT00635570|75919881|FG001|Overall Study|Did not complete survey|1|||
42381945|NCT01436305|76255404|FG001|Overall Study|Withdrawal by Subject|3|||
42381946|NCT01436305|76255405|FG002|Overall Study|Withdrawal by Subject|0|||
42381947|NCT01436149|76255415|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
42381948|NCT01436149|76255416|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
42381949|NCT01436149|76255417|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
42381950|NCT01436149|76255415|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
42381951|NCT01436149|76255416|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
42109342|NCT00635570|75919880|FG000|Overall Study|Early termination(No sexual activity)|1|||
42109343|NCT00635570|75919881|FG001|Overall Study|Early termination(No sexual activity)|1|||
42109344|NCT00635492|75919889|FG000|Overall Study|Death|12|||
42109345|NCT00635492|75919890|FG001|Overall Study|Death|40|||
42109346|NCT00635492|75919889|FG000|Overall Study|Lost to Follow-up|151|||
42381952|NCT01436149|76255417|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
42381953|NCT01436149|76255415|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
42381954|NCT01436149|76255416|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
42381955|NCT01436149|76255417|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
42381956|NCT01436149|76255415|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
42381957|NCT01436149|76255416|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
42381958|NCT01436149|76255417|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
42381959|NCT01436149|76255415|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
42381960|NCT01436149|76255416|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
42381961|NCT01436149|76255417|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
42381962|NCT01436149|76255415|FG000|Antidepressant Lead-in Phase|Other|119|||
42381963|NCT01436149|76255416|FG001|Antidepressant Lead-in Phase|Other|0|||
42381964|NCT01436149|76255417|FG002|Antidepressant Lead-in Phase|Other|0|||
42381965|NCT01436149|76255415|FG000|Randomized Phase|Adverse Event|9|||
42381966|NCT01436149|76255416|FG001|Randomized Phase|Adverse Event|10|||
42381967|NCT01436149|76255417|FG002|Randomized Phase|Adverse Event|11|||
42381968|NCT01436149|76255415|FG000|Randomized Phase|Protocol Violation|4|||
42381969|NCT01436149|76255416|FG001|Randomized Phase|Protocol Violation|5|||
42381970|NCT01436149|76255417|FG002|Randomized Phase|Protocol Violation|0|||
42381971|NCT01436149|76255415|FG000|Randomized Phase|Withdrawal by Subject|16|||
42381972|NCT01436149|76255416|FG001|Randomized Phase|Withdrawal by Subject|10|||
42381973|NCT01436149|76255417|FG002|Randomized Phase|Withdrawal by Subject|10|||
42381974|NCT01436149|76255415|FG000|Randomized Phase|Lost to Follow-up|34|||
42381975|NCT01436149|76255416|FG001|Randomized Phase|Lost to Follow-up|5|||
42381976|NCT01436149|76255417|FG002|Randomized Phase|Lost to Follow-up|6|||
42381977|NCT01436149|76255415|FG000|Randomized Phase|Lack of Efficacy|0|||
42381978|NCT01436149|76255416|FG001|Randomized Phase|Lack of Efficacy|0|||
42381979|NCT01436149|76255417|FG002|Randomized Phase|Lack of Efficacy|1|||
42381980|NCT01436149|76255415|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
42381981|NCT01436149|76255416|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
42381982|NCT01436149|76255417|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
42381983|NCT01436149|76255415|FG000|Randomized Phase|Other|12|||
42381984|NCT01436149|76255416|FG001|Randomized Phase|Other|5|||
42381985|NCT01436149|76255417|FG002|Randomized Phase|Other|11|||
42381986|NCT01415401|76255423|FG000|Overall Study|Adverse Event|5|||
42381987|NCT01415401|76255423|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
42381988|NCT01415401|76255423|FG000|Overall Study|Terminated by Sponsor|1|||
42381989|NCT01414855|76255427|FG000|Overall Study|Death|17|||
42381990|NCT01414855|76255427|FG000|Overall Study|Lost to Follow-up|5|||
42381991|NCT01414855|76255427|FG000|Overall Study|Withdrawal by Subject|7|||
42381992|NCT01527500|76255435|FG000|Part A|Administrative|11|||
42381993|NCT01527500|76255436|FG001|Part A|Administrative|7|||
42381994|NCT01527500|76255435|FG000|Part A|Adverse Event|4|||
42381995|NCT01527500|76255436|FG001|Part A|Adverse Event|2|||
42381996|NCT01527500|76255435|FG000|Part A|Death|4|||
42381997|NCT01527500|76255436|FG001|Part A|Death|1|||
42381998|NCT01527500|76255435|FG000|Part A|Lost to Follow-up|0|||
42381999|NCT01527500|76255436|FG001|Part A|Lost to Follow-up|1|||
42382000|NCT01527500|76255435|FG000|Part A|Protocol Deviation|9|||
42382001|NCT01527500|76255436|FG001|Part A|Protocol Deviation|2|||
42382002|NCT01527500|76255435|FG000|Part A|Withdrawal by Subject|2|||
42382003|NCT01527500|76255436|FG001|Part A|Withdrawal by Subject|0|||
42382004|NCT01527500|76255435|FG000|Part B|Adverse Event|1|||
42382005|NCT01527500|76255436|FG001|Part B|Adverse Event|0|||
42382006|NCT01527110|76255461|FG000|Overall Study|Adverse Event|1|||
42382007|NCT01441063|76255465|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
42382008|NCT01441063|76255465|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
42382009|NCT01436071|76255474|FG000|Overall Study|Adverse Event|1|||
42382010|NCT01436071|76255475|FG001|Overall Study|Adverse Event|0|||
42382011|NCT01436071|76255474|FG000|Overall Study|Lack of Efficacy|16|||
42382012|NCT01436071|76255475|FG001|Overall Study|Lack of Efficacy|7|||
42382013|NCT01436071|76255474|FG000|Overall Study|Protocol Violation|0|||
42382014|NCT01436071|76255475|FG001|Overall Study|Protocol Violation|1|||
42382015|NCT01436071|76255474|FG000|Overall Study|Lost to Follow-up|3|||
42382016|NCT01436071|76255475|FG001|Overall Study|Lost to Follow-up|1|||
42382017|NCT01436071|76255474|FG000|Overall Study|Physician Decision|1|||
42382018|NCT01436071|76255475|FG001|Overall Study|Physician Decision|0|||
42382019|NCT01436071|76255474|FG000|Overall Study|Withdrawal by Subject|2|||
42382020|NCT01436071|76255475|FG001|Overall Study|Withdrawal by Subject|2|||
42382021|NCT01436071|76255474|FG000|Overall Study|Did Not Receive Trial Medication|3|||
42382022|NCT01436071|76255475|FG001|Overall Study|Did Not Receive Trial Medication|3|||
42382023|NCT01514240|76255483|FG000|Overall Study|Adverse Event|4|||
42382024|NCT01514240|76255484|FG001|Overall Study|Adverse Event|4|||
42382025|NCT01514240|76255483|FG000|Overall Study|Subject Decision|2|||
42382026|NCT01514240|76255484|FG001|Overall Study|Subject Decision|7|||
42382027|NCT01435759|76255495|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
42382028|NCT01435759|76255496|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
42382029|NCT01435759|76255497|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
42382030|NCT01435759|76255498|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
42382031|NCT01435759|76255499|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
42382032|NCT01435759|76255500|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
42382033|NCT01435759|76255495|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
42382034|NCT01435759|76255496|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
42382035|NCT01435759|76255497|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
42382036|NCT01435759|76255498|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
42382037|NCT01435759|76255499|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
42382038|NCT01435759|76255500|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
42382039|NCT01435759|76255495|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
42382040|NCT01435759|76255496|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
42382041|NCT01435759|76255497|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
42382042|NCT01435759|76255498|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
42382043|NCT01435759|76255499|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
42382044|NCT01435759|76255500|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
42382045|NCT01435759|76255495|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
42382046|NCT01435759|76255496|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
42382047|NCT01435759|76255497|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
42382048|NCT01435759|76255498|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
42382049|NCT01435759|76255499|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
42382050|NCT01435759|76255500|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
42382051|NCT01435759|76255495|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
42382052|NCT01435759|76255496|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
42382053|NCT01435759|76255497|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
42382054|NCT01435759|76255498|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
42382055|NCT01435759|76255499|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
42382056|NCT01435759|76255500|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
42382057|NCT01435759|76255495|FG000|Antidepressant Lead-in Phase|Other|119|||
42382058|NCT01435759|76255496|FG001|Antidepressant Lead-in Phase|Other|0|||
42382059|NCT01435759|76255497|FG002|Antidepressant Lead-in Phase|Other|0|||
42382060|NCT01435759|76255498|FG003|Antidepressant Lead-in Phase|Other|0|||
42382061|NCT01435759|76255499|FG004|Antidepressant Lead-in Phase|Other|0|||
42382062|NCT01435759|76255500|FG005|Antidepressant Lead-in Phase|Other|0|||
42382063|NCT01435759|76255495|FG000|Double-blind Phase|Adverse Event|7|||
42382064|NCT01435759|76255496|FG001|Double-blind Phase|Adverse Event|0|||
42382065|NCT01435759|76255497|FG002|Double-blind Phase|Adverse Event|1|||
42382066|NCT01435759|76255498|FG003|Double-blind Phase|Adverse Event|1|||
42382067|NCT01435759|76255499|FG004|Double-blind Phase|Adverse Event|1|||
42382068|NCT01435759|76255500|FG005|Double-blind Phase|Adverse Event|3|||
42382069|NCT01435759|76255495|FG000|Double-blind Phase|Protocol Violation|2|||
42382070|NCT01435759|76255496|FG001|Double-blind Phase|Protocol Violation|0|||
42382071|NCT01435759|76255497|FG002|Double-blind Phase|Protocol Violation|1|||
42382072|NCT01435759|76255498|FG003|Double-blind Phase|Protocol Violation|2|||
42382073|NCT01435759|76255499|FG004|Double-blind Phase|Protocol Violation|0|||
42382074|NCT01435759|76255500|FG005|Double-blind Phase|Protocol Violation|1|||
42382075|NCT01435759|76255495|FG000|Double-blind Phase|Withdrawal by Subject|17|||
42382076|NCT01435759|76255496|FG001|Double-blind Phase|Withdrawal by Subject|4|||
42382077|NCT01435759|76255497|FG002|Double-blind Phase|Withdrawal by Subject|3|||
42382078|NCT01435759|76255498|FG003|Double-blind Phase|Withdrawal by Subject|4|||
42382079|NCT01435759|76255499|FG004|Double-blind Phase|Withdrawal by Subject|2|||
42382080|NCT01435759|76255500|FG005|Double-blind Phase|Withdrawal by Subject|2|||
42382081|NCT01435759|76255495|FG000|Double-blind Phase|Lost to Follow-up|31|||
42382082|NCT01435759|76255496|FG001|Double-blind Phase|Lost to Follow-up|1|||
42382083|NCT01435759|76255497|FG002|Double-blind Phase|Lost to Follow-up|2|||
42382084|NCT01435759|76255498|FG003|Double-blind Phase|Lost to Follow-up|0|||
42382085|NCT01435759|76255499|FG004|Double-blind Phase|Lost to Follow-up|3|||
42382086|NCT01435759|76255500|FG005|Double-blind Phase|Lost to Follow-up|3|||
42382087|NCT01435759|76255495|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
42382088|NCT01435759|76255496|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
42382089|NCT01435759|76255497|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
42382090|NCT01435759|76255498|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
42382091|NCT01435759|76255499|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
42382092|NCT01435759|76255500|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
42382093|NCT01435759|76255495|FG000|Double-blind Phase|Other|8|||
42382094|NCT01435759|76255496|FG001|Double-blind Phase|Other|2|||
42382095|NCT01435759|76255497|FG002|Double-blind Phase|Other|0|||
42382096|NCT01435759|76255498|FG003|Double-blind Phase|Other|2|||
42382097|NCT01435759|76255499|FG004|Double-blind Phase|Other|0|||
42382098|NCT01435759|76255500|FG005|Double-blind Phase|Other|0|||
42382099|NCT01393405|76255512|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
42382100|NCT01393405|76255513|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
42382101|NCT01393405|76255514|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
42382102|NCT01393405|76255512|FG000|Induction Period (week1-16)|Adverse Event|16|||
42382103|NCT01393405|76255513|FG001|Induction Period (week1-16)|Adverse Event|0|||
42382104|NCT01393405|76255514|FG002|Induction Period (week1-16)|Adverse Event|0|||
42382105|NCT01393405|76255512|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
42382106|NCT01393405|76255513|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
42382107|NCT01393405|76255514|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
42382108|NCT01393405|76255512|FG000|Maintenance Period Week|Lack of Efficacy|0|||
42382109|NCT01393405|76255513|FG001|Maintenance Period Week|Lack of Efficacy|22|||
42382110|NCT01393405|76255514|FG002|Maintenance Period Week|Lack of Efficacy|22|||
42382111|NCT01393405|76255512|FG000|Maintenance Period Week|Adverse Event|0|||
42382112|NCT01393405|76255513|FG001|Maintenance Period Week|Adverse Event|5|||
42382113|NCT01393405|76255514|FG002|Maintenance Period Week|Adverse Event|2|||
42382114|NCT01393405|76255512|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
42382115|NCT01393405|76255513|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
42382116|NCT01393405|76255514|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
42382117|NCT01393405|76255512|FG000|Maintenance Period Week|Lost to Follow-up|0|||
42382118|NCT01393405|76255513|FG001|Maintenance Period Week|Lost to Follow-up|1|||
42382119|NCT01393405|76255514|FG002|Maintenance Period Week|Lost to Follow-up|0|||
42382120|NCT01419197|76255526|FG000|Overall Study|Death|247|||
42382121|NCT01419197|76255527|FG001|Overall Study|Death|122|||
42382122|NCT01419197|76255526|FG000|Overall Study|Physician Decision|4|||
42382123|NCT01419197|76255527|FG001|Overall Study|Physician Decision|4|||
42382124|NCT01419197|76255526|FG000|Overall Study|Non-compliance|3|||
42382125|NCT01419197|76255527|FG001|Overall Study|Non-compliance|1|||
42382126|NCT01419197|76255526|FG000|Overall Study|Withdrawal by Subject|33|||
42382127|NCT01419197|76255527|FG001|Overall Study|Withdrawal by Subject|32|||
42382128|NCT01419197|76255526|FG000|Overall Study|Study Completed by Sponsor|103|||
42382129|NCT01419197|76255527|FG001|Overall Study|Study Completed by Sponsor|34|||
42382130|NCT01419197|76255526|FG000|Overall Study|Reason Not Specified|0|||
42382131|NCT01419197|76255527|FG001|Overall Study|Reason Not Specified|1|||
42382132|NCT01419197|76255526|FG000|Overall Study|Lost to Follow-up|14|||
42382133|NCT01419197|76255527|FG001|Overall Study|Lost to Follow-up|4|||
42382134|NCT01414075|76255538|FG000|Overall Study|Adverse Event|1|||
42382135|NCT01414075|76255539|FG001|Overall Study|Adverse Event|0|||
42382136|NCT01414075|76255540|FG002|Overall Study|Adverse Event|1|||
42382137|NCT01414075|76255541|FG003|Overall Study|Adverse Event|0|||
42382138|NCT01414075|76255538|FG000|Overall Study|Death|1|||
42382139|NCT01414075|76255539|FG001|Overall Study|Death|0|||
42382140|NCT01414075|76255540|FG002|Overall Study|Death|0|||
42382141|NCT01414075|76255541|FG003|Overall Study|Death|1|||
42382142|NCT01414075|76255538|FG000|Overall Study|Withdrawal by Subject|0|||
42382143|NCT01414075|76255539|FG001|Overall Study|Withdrawal by Subject|0|||
42382144|NCT01414075|76255540|FG002|Overall Study|Withdrawal by Subject|0|||
42382145|NCT01414075|76255541|FG003|Overall Study|Withdrawal by Subject|1|||
42382146|NCT01414075|76255538|FG000|Overall Study|Other than specified|1|||
42382147|NCT01414075|76255539|FG001|Overall Study|Other than specified|0|||
42382148|NCT01414075|76255540|FG002|Overall Study|Other than specified|1|||
42382149|NCT01414075|76255541|FG003|Overall Study|Other than specified|0|||
42382150|NCT01434823|76255553|FG000|Overall Study|Incomplete data in medical record|4|||
42382151|NCT01434823|76255554|FG001|Overall Study|Incomplete data in medical record|7|||
42382152|NCT01513460|76255564|FG000|Overall Study|Death|0|||
42382153|NCT01513460|76255565|FG001|Overall Study|Death|0|||
42382154|NCT01513460|76255566|FG002|Overall Study|Death|1|||
42382155|NCT01513460|76255564|FG000|Overall Study|Lost to Follow-up|0|||
42382156|NCT01513460|76255565|FG001|Overall Study|Lost to Follow-up|0|||
42382157|NCT01513460|76255566|FG002|Overall Study|Lost to Follow-up|2|||
42382158|NCT01513460|76255564|FG000|Overall Study|Abnormal laboratory value|1|||
42382159|NCT01513460|76255565|FG001|Overall Study|Abnormal laboratory value|0|||
42382160|NCT01513460|76255566|FG002|Overall Study|Abnormal laboratory value|1|||
42382161|NCT01513460|76255564|FG000|Overall Study|Lack of Efficacy|1|||
42382162|NCT01513460|76255565|FG001|Overall Study|Lack of Efficacy|2|||
42382163|NCT01513460|76255566|FG002|Overall Study|Lack of Efficacy|5|||
42382164|NCT01513460|76255564|FG000|Overall Study|Protocol deviations|3|||
42382165|NCT01513460|76255565|FG001|Overall Study|Protocol deviations|4|||
42382166|NCT01513460|76255566|FG002|Overall Study|Protocol deviations|3|||
42382167|NCT01513460|76255564|FG000|Overall Study|Withdrawal by Subject|7|||
42382168|NCT01513460|76255565|FG001|Overall Study|Withdrawal by Subject|8|||
42382169|NCT01513460|76255566|FG002|Overall Study|Withdrawal by Subject|21|||
42382170|NCT01513460|76255564|FG000|Overall Study|Adverse Event|16|||
42382171|NCT01513460|76255565|FG001|Overall Study|Adverse Event|18|||
42382172|NCT01513460|76255566|FG002|Overall Study|Adverse Event|23|||
42382173|NCT01513460|76255564|FG000|Overall Study|Abnormal test procedure|1|||
42382174|NCT01513460|76255565|FG001|Overall Study|Abnormal test procedure|0|||
42382175|NCT01513460|76255566|FG002|Overall Study|Abnormal test procedure|0|||
42382176|NCT01392547|76255576|FG000|Overall Study|Adverse Event|2|||
42382177|NCT01392547|76255576|FG000|Overall Study|Non-compliance|2|||
42382178|NCT01392547|76255576|FG000|Overall Study|Withdrawal criteria|3|||
42382179|NCT01392547|76255576|FG000|Overall Study|Unclassified|1|||
42382180|NCT01435655|76255582|FG000|Overall Study|Death|2|||
42382181|NCT01435655|76255582|FG000|Overall Study|Other|1|||
42382182|NCT01434667|76255588|FG000|Overall Study|Lost to Follow-up|5|||
42382183|NCT01434667|76255589|FG001|Overall Study|Lost to Follow-up|10|||
42382184|NCT01513148|76255597|FG000|Overall Study|Protocol Violation|2|||
42382185|NCT01513148|76255598|FG001|Overall Study|Protocol Violation|2|||
42382186|NCT01418339|76255646|FG000|Overall Study|Adverse Event|5|||
42382187|NCT01418339|76255647|FG001|Overall Study|Adverse Event|2|||
42382188|NCT01418339|76255646|FG000|Overall Study|Subject Withdrew Consent|1|||
42382189|NCT01418339|76255647|FG001|Overall Study|Subject Withdrew Consent|2|||
42382190|NCT01418339|76255646|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
42382191|NCT01418339|76255647|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
42382192|NCT01512368|76255653|FG000|Overall Study|Protocol Violation|3|||
42382193|NCT01412983|76255657|FG000|1st Period|Ineligible|0|||
42382194|NCT01412983|76255658|FG001|1st Period|Ineligible|1|||
42382195|NCT01412983|76255657|FG000|1st Period|Positive slit lamp finding|0|||
42382196|NCT01412983|76255658|FG001|1st Period|Positive slit lamp finding|1|||
42382197|NCT01412983|76255657|FG000|1st Period|Unacceptable lens movement|0|||
42382198|NCT01412983|76255658|FG001|1st Period|Unacceptable lens movement|1|||
42382199|NCT01412983|76255657|FG000|1st Period|Inability to maintain wear|0|||
42382200|NCT01412983|76255658|FG001|1st Period|Inability to maintain wear|1|||
42382201|NCT01417481|76255667|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
42382202|NCT01417481|76255668|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
42382203|NCT01392469|76255674|FG000|Overall Study|Adverse Event|2|||
42382204|NCT01392469|76255674|FG000|Overall Study|Withdrawal by Subject|1|||
42382205|NCT01392469|76255674|FG000|Overall Study|Protocol Violation|1|||
42382206|NCT01435577|76255691|FG000|Overall Study|Adverse Event|10|||
42382207|NCT01435577|76255692|FG001|Overall Study|Adverse Event|0|||
42382208|NCT01435577|76255691|FG000|Overall Study|Lack of Efficacy|7|||
42382209|NCT01435577|76255692|FG001|Overall Study|Lack of Efficacy|51|||
42382210|NCT01435577|76255691|FG000|Overall Study|Alternative treatment started|0|||
42382211|NCT01435577|76255692|FG001|Overall Study|Alternative treatment started|1|||
42382212|NCT01411891|76255704|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
42382213|NCT01411891|76255705|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
42382214|NCT01416389|76255713|FG000|Overall Study|Lost to Follow-up|1|||
42382215|NCT01416389|76255714|FG001|Overall Study|Lost to Follow-up|0|||
42382216|NCT01416389|76255713|FG000|Overall Study|Started New Therapy|2|||
42382217|NCT01416389|76255714|FG001|Overall Study|Started New Therapy|0|||
42382218|NCT01544348|76255730|FG000|Overall Study|Lost to Follow-up|1|||
42382219|NCT01544348|76255731|FG001|Overall Study|Lost to Follow-up|0|||
42382220|NCT01544348|76255732|FG002|Overall Study|Lost to Follow-up|0|||
42382221|NCT01544348|76255733|FG003|Overall Study|Lost to Follow-up|0|||
42109347|NCT00635492|75919890|FG001|Overall Study|Lost to Follow-up|172|||
42382222|NCT01544348|76255734|FG004|Overall Study|Lost to Follow-up|0|||
42382223|NCT01544348|76255735|FG005|Overall Study|Lost to Follow-up|0|||
42382224|NCT01544348|76255736|FG006|Overall Study|Lost to Follow-up|1|||
42382225|NCT01544348|76255737|FG007|Overall Study|Lost to Follow-up|0|||
42382226|NCT01544348|76255730|FG000|Overall Study|Withdrawal by Subject|1|||
42382227|NCT01544348|76255731|FG001|Overall Study|Withdrawal by Subject|0|||
42382228|NCT01544348|76255732|FG002|Overall Study|Withdrawal by Subject|0|||
42382229|NCT01544348|76255733|FG003|Overall Study|Withdrawal by Subject|0|||
42382230|NCT01544348|76255734|FG004|Overall Study|Withdrawal by Subject|1|||
42382231|NCT01544348|76255735|FG005|Overall Study|Withdrawal by Subject|2|||
42382232|NCT01544348|76255736|FG006|Overall Study|Withdrawal by Subject|1|||
42382233|NCT01544348|76255737|FG007|Overall Study|Withdrawal by Subject|0|||
42382234|NCT01544348|76255730|FG000|Overall Study|Physician Decision|0|||
42382235|NCT01544348|76255731|FG001|Overall Study|Physician Decision|0|||
42382236|NCT01544348|76255732|FG002|Overall Study|Physician Decision|0|||
42382237|NCT01544348|76255733|FG003|Overall Study|Physician Decision|0|||
42382238|NCT01544348|76255734|FG004|Overall Study|Physician Decision|0|||
42382239|NCT01544348|76255735|FG005|Overall Study|Physician Decision|1|||
42382240|NCT01544348|76255736|FG006|Overall Study|Physician Decision|0|||
42109348|NCT00635492|75919889|FG000|Overall Study|Physician Decision|32|||
42382241|NCT01544348|76255737|FG007|Overall Study|Physician Decision|0|||
42382242|NCT01416155|76255762|FG000|Overall Study|Adverse Event|8|||
42382243|NCT01416155|76255762|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
42382244|NCT01416155|76255762|FG000|Overall Study|Withdrawal by Subject|33|||
42382245|NCT01416155|76255762|FG000|Overall Study|Investigator decision|8|||
42382246|NCT01416155|76255762|FG000|Overall Study|Other|7|||
42382247|NCT01415921|76255768|FG000|Overall Study|Adverse Event|0|||
42382248|NCT01415921|76255769|FG001|Overall Study|Adverse Event|1|||
42382249|NCT01415921|76255768|FG000|Overall Study|Physician Decision|1|||
42382250|NCT01415921|76255769|FG001|Overall Study|Physician Decision|1|||
42382251|NCT01415921|76255768|FG000|Overall Study|Withdrawal by Subject|0|||
42382252|NCT01415921|76255769|FG001|Overall Study|Withdrawal by Subject|1|||
42382253|NCT01415921|76255768|FG000|Overall Study|Other|2|||
42382254|NCT01415921|76255769|FG001|Overall Study|Other|0|||
42382255|NCT01415531|76255777|FG000|Overall Study|Adverse Event|7|||
42382256|NCT01415531|76255778|FG001|Overall Study|Adverse Event|10|||
42382257|NCT01415531|76255777|FG000|Overall Study|Lack of Efficacy|3|||
42382258|NCT01415531|76255778|FG001|Overall Study|Lack of Efficacy|2|||
42382259|NCT01415531|76255777|FG000|Overall Study|Protocol Violation|0|||
42382260|NCT01415531|76255778|FG001|Overall Study|Protocol Violation|1|||
42382261|NCT01415531|76255777|FG000|Overall Study|Withdrawal by Subject|5|||
42382262|NCT01415531|76255778|FG001|Overall Study|Withdrawal by Subject|4|||
42382263|NCT01415531|76255777|FG000|Overall Study|Lost to Follow-up|6|||
42382264|NCT01415531|76255778|FG001|Overall Study|Lost to Follow-up|14|||
42382265|NCT01415531|76255777|FG000|Overall Study|Lack of Compliance|1|||
42382266|NCT01415531|76255778|FG001|Overall Study|Lack of Compliance|4|||
42382267|NCT01415531|76255777|FG000|Overall Study|Other Reasons|3|||
42382268|NCT01415531|76255778|FG001|Overall Study|Other Reasons|2|||
42382269|NCT01544114|76255787|FG000|Overall Study|Withdrawal by Subject|0|||
42382270|NCT01544114|76255788|FG001|Overall Study|Withdrawal by Subject|0|||
42382271|NCT01544114|76255789|FG002|Overall Study|Withdrawal by Subject|3|||
42382272|NCT01544114|76255787|FG000|Overall Study|Lost to Follow-up|0|||
42382273|NCT01544114|76255788|FG001|Overall Study|Lost to Follow-up|2|||
42382274|NCT01544114|76255789|FG002|Overall Study|Lost to Follow-up|0|||
42382275|NCT01544114|76255787|FG000|Overall Study|Adverse Event|1|||
42382276|NCT01544114|76255788|FG001|Overall Study|Adverse Event|1|||
42382277|NCT01544114|76255789|FG002|Overall Study|Adverse Event|2|||
42382278|NCT01544114|76255787|FG000|Overall Study|Protocol Violation|0|||
42382279|NCT01544114|76255788|FG001|Overall Study|Protocol Violation|1|||
42382280|NCT01544114|76255789|FG002|Overall Study|Protocol Violation|0|||
42382281|NCT01435265|76255801|FG000|Overall Study|Lost to Follow-up|0|||
42382282|NCT01435265|76255802|FG001|Overall Study|Lost to Follow-up|1|||
42382283|NCT01433263|76255810|FG000|Overall Study|Adverse Event|3|||
42382284|NCT01433263|76255811|FG001|Overall Study|Adverse Event|1|||
42382285|NCT01433263|76255810|FG000|Overall Study|Death|5|||
42382286|NCT01433263|76255811|FG001|Overall Study|Death|3|||
42382287|NCT01433263|76255810|FG000|Overall Study|Lost to Follow-up|0|||
42382288|NCT01433263|76255811|FG001|Overall Study|Lost to Follow-up|1|||
42382289|NCT01433263|76255810|FG000|Overall Study|Protocol Deviation|1|||
42382290|NCT01433263|76255811|FG001|Overall Study|Protocol Deviation|0|||
42382291|NCT01433263|76255810|FG000|Overall Study|Withdrawal by Subject|10|||
42382292|NCT01433263|76255811|FG001|Overall Study|Withdrawal by Subject|7|||
42382293|NCT01432951|76255820|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
42382294|NCT01432327|76255829|FG000|Posttest 3 Months|depression|3|||
42382295|NCT01432327|76255830|FG001|Posttest 3 Months|depression|0|||
42382296|NCT01432327|76255831|FG002|Posttest 3 Months|depression|0|||
42382297|NCT01432327|76255832|FG003|Posttest 3 Months|depression|0|||
42382298|NCT01432327|76255829|FG000|Posttest 3 Months|Lost to Follow-up|1|||
42382299|NCT01432327|76255830|FG001|Posttest 3 Months|Lost to Follow-up|0|||
42382300|NCT01432327|76255831|FG002|Posttest 3 Months|Lost to Follow-up|2|||
42382301|NCT01432327|76255832|FG003|Posttest 3 Months|Lost to Follow-up|1|||
42382302|NCT01432327|76255829|FG000|Posttest 3 Months|Allergic reaction|0|||
42382303|NCT01432327|76255830|FG001|Posttest 3 Months|Allergic reaction|2|||
42382304|NCT01432327|76255831|FG002|Posttest 3 Months|Allergic reaction|0|||
42382305|NCT01432327|76255832|FG003|Posttest 3 Months|Allergic reaction|0|||
42382306|NCT01432327|76255829|FG000|Posttest 6 Months|Lost to Follow-up|0|||
42382307|NCT01432327|76255830|FG001|Posttest 6 Months|Lost to Follow-up|0|||
42382308|NCT01432327|76255831|FG002|Posttest 6 Months|Lost to Follow-up|3|||
42382309|NCT01432327|76255832|FG003|Posttest 6 Months|Lost to Follow-up|2|||
42382310|NCT01432327|76255829|FG000|Posttest 6 Months|Allergic reaction|0|||
42382311|NCT01432327|76255830|FG001|Posttest 6 Months|Allergic reaction|0|||
42382312|NCT01432327|76255831|FG002|Posttest 6 Months|Allergic reaction|1|||
42382313|NCT01432327|76255832|FG003|Posttest 6 Months|Allergic reaction|0|||
42382314|NCT01432327|76255829|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
42382315|NCT01432327|76255830|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
42109349|NCT00635492|75919890|FG001|Overall Study|Physician Decision|22|||
42109350|NCT00635492|75919889|FG000|Overall Study|Sponsor decision|2|||
42382316|NCT01432327|76255831|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
42382317|NCT01432327|76255832|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
42382318|NCT01432327|76255829|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
42382319|NCT01432327|76255830|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
42382320|NCT01432327|76255831|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
42382321|NCT01432327|76255832|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
42382322|NCT01432327|76255829|FG000|Posttest 1 Year|Lost to Follow-up|0|||
42382323|NCT01432327|76255830|FG001|Posttest 1 Year|Lost to Follow-up|0|||
42382324|NCT01432327|76255831|FG002|Posttest 1 Year|Lost to Follow-up|4|||
42382325|NCT01432327|76255832|FG003|Posttest 1 Year|Lost to Follow-up|2|||
42382326|NCT01432327|76255829|FG000|Posttest 1 Year|Allergic reaction|0|||
42382327|NCT01432327|76255830|FG001|Posttest 1 Year|Allergic reaction|0|||
42382328|NCT01432327|76255831|FG002|Posttest 1 Year|Allergic reaction|1|||
42382329|NCT01432327|76255832|FG003|Posttest 1 Year|Allergic reaction|1|||
42382330|NCT01410799|76255842|FG000|Overall Study|PI decision|13|||
42382331|NCT01432171|76255848|FG000|Overall Study|Death|1|||
42382332|NCT01432171|76255849|FG001|Overall Study|Death|2|||
42382333|NCT01432171|76255848|FG000|Overall Study|Lost to Follow-up|6|||
42382334|NCT01432171|76255849|FG001|Overall Study|Lost to Follow-up|5|||
42382335|NCT01432171|76255848|FG000|Overall Study|Withdrawal by Subject|3|||
42382336|NCT01432171|76255849|FG001|Overall Study|Withdrawal by Subject|1|||
42382337|NCT01432171|76255848|FG000|Overall Study|Noncompliance|2|||
42382338|NCT01432171|76255849|FG001|Overall Study|Noncompliance|3|||
42382339|NCT01432171|76255848|FG000|Overall Study|Insurance denial trial coverage|1|||
42382340|NCT01432171|76255849|FG001|Overall Study|Insurance denial trial coverage|0|||
42382341|NCT01432171|76255848|FG000|Overall Study|Patient moved to palliative care|1|||
42382342|NCT01432171|76255849|FG001|Overall Study|Patient moved to palliative care|0|||
42382343|NCT01435031|76255859|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
42382344|NCT01435031|76255859|FG000|ITT at 1 Month|Death|1|||
42382345|NCT01435031|76255859|FG000|ITT at 1 Month|Lost to Follow-up|4|||
42382346|NCT01435031|76255859|FG000|ITT at 6 Months|Death|2|||
42382347|NCT01435031|76255859|FG000|ITT at 6 Months|Lost to Follow-up|3|||
42382348|NCT01435031|76255859|FG000|ITT at 1 Year|Death|1|||
42382349|NCT01435031|76255859|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
42382350|NCT01435031|76255859|FG000|ITT at 1 Year|Lost to Follow-up|6|||
42382351|NCT01435031|76255859|FG000|ITT at 2 Years|Death|7|||
42382352|NCT01435031|76255859|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
42382353|NCT01435031|76255859|FG000|ITT at 2 Years|Lost to Follow-up|4|||
42382354|NCT01435031|76255859|FG000|ITT at 3 Years|Death|5|||
42382355|NCT01435031|76255859|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
42382356|NCT01435031|76255859|FG000|ITT at 3 Years|Lost to Follow-up|4|||
42382357|NCT01435031|76255859|FG000|ITT at 4 Years|Death|4|||
42382358|NCT01435031|76255859|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
42382359|NCT01435031|76255859|FG000|ITT at 4 Years|Lost to Follow-up|1|||
42382360|NCT01433549|76255863|FG000|Phase 2: Second Study Product|Adverse Event|0|||
42382361|NCT01433549|76255864|FG001|Phase 2: Second Study Product|Adverse Event|1|||
42382362|NCT01414205|76255872|FG000|Overall Study|Death|5|||
42382363|NCT01414205|76255873|FG001|Overall Study|Death|1|||
42382364|NCT01414205|76255872|FG000|Overall Study|Lost to Follow-up|1|||
42382365|NCT01414205|76255873|FG001|Overall Study|Lost to Follow-up|4|||
42382366|NCT01414205|76255872|FG000|Overall Study|Physician Decision|0|||
42382367|NCT01414205|76255873|FG001|Overall Study|Physician Decision|1|||
42382368|NCT01414205|76255872|FG000|Overall Study|Randomized but not Treated|1|||
42382369|NCT01414205|76255873|FG001|Overall Study|Randomized but not Treated|1|||
42382370|NCT01433471|76255881|FG000|Overall Study|Withdrawal by Subject|0|||
42382371|NCT01433471|76255882|FG001|Overall Study|Withdrawal by Subject|1|||
42382372|NCT01433159|76255892|FG000|Overall Study|Adverse Event|1|||
42382373|NCT01433159|76255893|FG001|Overall Study|Adverse Event|0|||
42382374|NCT01433159|76255892|FG000|Overall Study|Physician Decision|1|||
42382375|NCT01433159|76255893|FG001|Overall Study|Physician Decision|0|||
42382376|NCT01433159|76255892|FG000|Overall Study|Protocol Violation|0|||
42382377|NCT01433159|76255893|FG001|Overall Study|Protocol Violation|1|||
42382378|NCT01413503|76255908|FG000|Overall Study|Lost to Follow-up|1|||
42382379|NCT01413191|76255912|FG000|Overall Study|Lost to Follow-up|5|||
42382380|NCT01413191|76255912|FG000|Overall Study|Disease Progression|5|||
42382381|NCT01413191|76255912|FG000|Overall Study|Death|1|||
42382382|NCT01412957|76255918|FG000|Overall Study|Withdrawal by Subject|6|||
42382383|NCT01412957|76255919|FG001|Overall Study|Withdrawal by Subject|22|||
42382384|NCT01412957|76255918|FG000|Overall Study|Lost to Follow-up|7|||
42382385|NCT01412957|76255919|FG001|Overall Study|Lost to Follow-up|2|||
42382386|NCT01412957|76255918|FG000|Overall Study|Death|136|||
42382387|NCT01412957|76255919|FG001|Overall Study|Death|133|||
42382388|NCT01432457|76255932|FG000|Overall Study|Adverse Event|7|||
42109351|NCT00635492|75919890|FG001|Overall Study|Sponsor decision|3|||
42109352|NCT00635492|75919889|FG000|Overall Study|Withdrawal by Subject|82|||
42382389|NCT01432457|76255933|FG001|Overall Study|Adverse Event|10|||
42382390|NCT01432457|76255934|FG002|Overall Study|Adverse Event|16|||
42382391|NCT01432457|76255932|FG000|Overall Study|Lack of Efficacy|2|||
42382392|NCT01432457|76255933|FG001|Overall Study|Lack of Efficacy|1|||
42382393|NCT01432457|76255934|FG002|Overall Study|Lack of Efficacy|1|||
42109353|NCT00635492|75919890|FG001|Overall Study|Withdrawal by Subject|45|||
42382394|NCT01432457|76255932|FG000|Overall Study|Lost to Follow-up|11|||
42382395|NCT01432457|76255933|FG001|Overall Study|Lost to Follow-up|15|||
42382396|NCT01432457|76255934|FG002|Overall Study|Lost to Follow-up|20|||
42382397|NCT01432457|76255932|FG000|Overall Study|Protocol Violation|3|||
42382398|NCT01432457|76255933|FG001|Overall Study|Protocol Violation|2|||
42382399|NCT01432457|76255934|FG002|Overall Study|Protocol Violation|6|||
42382400|NCT01432457|76255932|FG000|Overall Study|Withdrawal by Subject|6|||
42382401|NCT01432457|76255933|FG001|Overall Study|Withdrawal by Subject|11|||
42382402|NCT01432457|76255934|FG002|Overall Study|Withdrawal by Subject|9|||
42382403|NCT01432457|76255932|FG000|Overall Study|Reasons not defined|2|||
42382404|NCT01432457|76255933|FG001|Overall Study|Reasons not defined|3|||
42382405|NCT01432457|76255934|FG002|Overall Study|Reasons not defined|4|||
42382406|NCT01432457|76255932|FG000|Overall Study|Did not take study drug|6|||
42382407|NCT01432457|76255933|FG001|Overall Study|Did not take study drug|6|||
42382408|NCT01432457|76255934|FG002|Overall Study|Did not take study drug|3|||
42382409|NCT01390441|76255956|FG000|Treatment Period|Protocol Violation|0|||
42382410|NCT01390441|76255957|FG001|Treatment Period|Protocol Violation|1|||
42382411|NCT01390441|76255958|FG002|Treatment Period|Protocol Violation|0|||
42382412|NCT01390441|76255959|FG003|Treatment Period|Protocol Violation|0|||
42382413|NCT01390441|76255960|FG004|Treatment Period|Protocol Violation|0|||
42382414|NCT01390441|76255956|FG000|Treatment Period|Physician Decision|0|||
42382415|NCT01390441|76255957|FG001|Treatment Period|Physician Decision|0|||
42382416|NCT01390441|76255958|FG002|Treatment Period|Physician Decision|0|||
42382417|NCT01390441|76255959|FG003|Treatment Period|Physician Decision|1|||
42382418|NCT01390441|76255960|FG004|Treatment Period|Physician Decision|0|||
42382419|NCT01390441|76255956|FG000|Treatment Period|Lack of Efficacy|0|||
42382420|NCT01390441|76255957|FG001|Treatment Period|Lack of Efficacy|0|||
42382421|NCT01390441|76255958|FG002|Treatment Period|Lack of Efficacy|0|||
42382422|NCT01390441|76255959|FG003|Treatment Period|Lack of Efficacy|0|||
42382423|NCT01390441|76255960|FG004|Treatment Period|Lack of Efficacy|1|||
42382424|NCT01390441|76255956|FG000|Treatment Period|Unknown due to early stopping of study|0|||
42382425|NCT01390441|76255957|FG001|Treatment Period|Unknown due to early stopping of study|0|||
42382426|NCT01390441|76255958|FG002|Treatment Period|Unknown due to early stopping of study|8|||
42382427|NCT01390441|76255959|FG003|Treatment Period|Unknown due to early stopping of study|11|||
42382428|NCT01390441|76255960|FG004|Treatment Period|Unknown due to early stopping of study|7|||
42382429|NCT01390441|76255956|FG000|Treatment Period|Adverse Event|0|||
42382430|NCT01390441|76255957|FG001|Treatment Period|Adverse Event|0|||
42382431|NCT01390441|76255958|FG002|Treatment Period|Adverse Event|1|||
42382432|NCT01390441|76255959|FG003|Treatment Period|Adverse Event|1|||
42382433|NCT01390441|76255960|FG004|Treatment Period|Adverse Event|2|||
42382434|NCT01390441|76255956|FG000|Treatment Period|Withdrawal by Subject|0|||
42382435|NCT01390441|76255957|FG001|Treatment Period|Withdrawal by Subject|0|||
42382436|NCT01390441|76255958|FG002|Treatment Period|Withdrawal by Subject|1|||
42382437|NCT01390441|76255959|FG003|Treatment Period|Withdrawal by Subject|0|||
42382438|NCT01390441|76255960|FG004|Treatment Period|Withdrawal by Subject|1|||
42382439|NCT01390441|76255956|FG000|Treatment Period|Lost to Follow-up|1|||
42382440|NCT01390441|76255957|FG001|Treatment Period|Lost to Follow-up|0|||
42382441|NCT01390441|76255958|FG002|Treatment Period|Lost to Follow-up|0|||
42382442|NCT01390441|76255959|FG003|Treatment Period|Lost to Follow-up|0|||
42382443|NCT01390441|76255960|FG004|Treatment Period|Lost to Follow-up|0|||
42382444|NCT01390441|76255956|FG000|Extension Period|Protocol Violation|3|||
42382445|NCT01390441|76255957|FG001|Extension Period|Protocol Violation|1|||
42382446|NCT01390441|76255958|FG002|Extension Period|Protocol Violation|0|||
42382447|NCT01390441|76255959|FG003|Extension Period|Protocol Violation|1|||
42382448|NCT01390441|76255960|FG004|Extension Period|Protocol Violation|0|||
42382449|NCT01412879|76256009|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
42382450|NCT01412879|76256010|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
42382451|NCT01412879|76256011|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
42382452|NCT01412879|76256009|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
42382453|NCT01412879|76256010|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
42382454|NCT01412879|76256011|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
42382455|NCT01412879|76256009|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
42382456|NCT01412879|76256010|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
42382457|NCT01412879|76256011|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
42382458|NCT01412879|76256009|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
42382459|NCT01412879|76256010|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
42382460|NCT01412879|76256011|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
42382461|NCT01412879|76256009|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
42382462|NCT01412879|76256010|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
42382463|NCT01412879|76256011|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
42382464|NCT01431079|76256023|FG000|Overall Study|Lost to Follow-up|35|||
42382465|NCT01431079|76256024|FG001|Overall Study|Lost to Follow-up|39|||
42382466|NCT01430611|76256056|FG000|Overall Study|Adverse Event|0|||
42382467|NCT01430611|76256057|FG001|Overall Study|Adverse Event|1|||
42382468|NCT01430611|76256056|FG000|Overall Study|Protocol Violation|1|||
42382469|NCT01430611|76256057|FG001|Overall Study|Protocol Violation|0|||
42382470|NCT01430611|76256056|FG000|Overall Study|Lost to Follow-up|1|||
42382471|NCT01430611|76256057|FG001|Overall Study|Lost to Follow-up|0|||
42382472|NCT01430611|76256056|FG000|Overall Study|Withdrawal by Subject|15|||
42109354|NCT00543309|75919903|FG000|Overall Study|Physician Decision|0|||
42382473|NCT01430611|76256057|FG001|Overall Study|Withdrawal by Subject|14|||
42382474|NCT01409707|76256066|FG000|Overall Study|Withdrawal by Subject|5|||
42382475|NCT01409707|76256067|FG001|Overall Study|Withdrawal by Subject|17|||
42382476|NCT01409707|76256068|FG002|Overall Study|Withdrawal by Subject|16|||
42382477|NCT01389973|76256075|FG000|Overall Study|Lost to Follow-up|1|||
42382478|NCT01389973|76256075|FG000|Overall Study|Trial Stopped by Sponsor|9|||
42382479|NCT01389973|76256075|FG000|Overall Study|Other|10|||
42382480|NCT01389817|76256095|FG000|Overall Study|Physician Decision|1|||
42382481|NCT01389817|76256096|FG001|Overall Study|Physician Decision|0|||
42382482|NCT01389817|76256095|FG000|Overall Study|Lost to Follow-up|1|||
42382483|NCT01389817|76256096|FG001|Overall Study|Lost to Follow-up|0|||
42382484|NCT01389817|76256095|FG000|Overall Study|Withdrawal by Subject|2|||
42382485|NCT01389817|76256096|FG001|Overall Study|Withdrawal by Subject|0|||
42382486|NCT01430455|76256111|FG000|Overall Study|Withdrawal by Subject|1|||
42382487|NCT01430455|76256111|FG000|Overall Study|Switched to follow-up phase|1|||
42382488|NCT01429441|76256139|FG000|Overall Study|Adverse Event|5|||
42382489|NCT01429441|76256140|FG001|Overall Study|Adverse Event|1|||
42382490|NCT01429441|76256139|FG000|Overall Study|Death|0|||
42382491|NCT01429441|76256140|FG001|Overall Study|Death|2|||
42382492|NCT01429441|76256139|FG000|Overall Study|Lost to Follow-up|5|||
42382493|NCT01429441|76256140|FG001|Overall Study|Lost to Follow-up|2|||
42382494|NCT01429441|76256139|FG000|Overall Study|Physician Decision|1|||
42382495|NCT01429441|76256140|FG001|Overall Study|Physician Decision|0|||
42382496|NCT01429441|76256139|FG000|Overall Study|Withdrawal by Subject|27|||
42382497|NCT01429441|76256140|FG001|Overall Study|Withdrawal by Subject|18|||
42382498|NCT01429285|76256175|FG000|Overall Study|Protocol Violation|9|||
42382499|NCT01429285|76256176|FG001|Overall Study|Protocol Violation|4|||
42382500|NCT01429285|76256175|FG000|Overall Study|Missing Data|5|||
42382501|NCT01429285|76256176|FG001|Overall Study|Missing Data|3|||
42382502|NCT01429285|76256175|FG000|Overall Study|Erroneously Enrolled Twice|8|||
42382503|NCT01429285|76256176|FG001|Overall Study|Erroneously Enrolled Twice|2|||
42382504|NCT01429051|76256253|FG000|Titration Phase|Death|1|||
42382505|NCT01429051|76256253|FG000|Titration Phase|Withdrawal by Subject|7|||
42382506|NCT01429051|76256253|FG000|Titration Phase|Physician Decision|1|||
42382507|NCT01429051|76256253|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
42382508|NCT01429051|76256253|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
42382509|NCT01429051|76256253|FG000|Efficacy Phase|Adverse Event|1|||
42382510|NCT01429051|76256253|FG000|Efficacy Phase|Death|1|||
42382511|NCT01429051|76256253|FG000|Tolerability Phase|Death|5|||
42382512|NCT01429051|76256253|FG000|Tolerability Phase|Adverse Event|2|||
42382513|NCT01429051|76256253|FG000|Tolerability Phase|Withdrawal by Subject|5|||
42382514|NCT01429051|76256253|FG000|Tolerability Phase|Physician Decision|1|||
42382515|NCT01429051|76256253|FG000|Tolerability Phase|Other|2|||
42382516|NCT01428661|76256286|FG000|Double-Masked Phase|Protocol Violation|9|||
42382517|NCT01428661|76256287|FG001|Double-Masked Phase|Protocol Violation|4|||
42382518|NCT01428661|76256288|FG002|Double-Masked Phase|Protocol Violation|0|||
42382519|NCT01428661|76256286|FG000|Double-Masked Phase|Adverse Event|13|||
42382520|NCT01428661|76256287|FG001|Double-Masked Phase|Adverse Event|4|||
42382521|NCT01428661|76256288|FG002|Double-Masked Phase|Adverse Event|0|||
42382522|NCT01428661|76256286|FG000|Double-Masked Phase|Lost to Follow-up|14|||
42382523|NCT01428661|76256287|FG001|Double-Masked Phase|Lost to Follow-up|14|||
42382524|NCT01428661|76256288|FG002|Double-Masked Phase|Lost to Follow-up|0|||
42382525|NCT01428661|76256286|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
42382526|NCT01428661|76256287|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
42382527|NCT01428661|76256288|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
42382528|NCT01428661|76256286|FG000|Double-Masked Phase|Lack of Efficacy|2|||
42382529|NCT01428661|76256287|FG001|Double-Masked Phase|Lack of Efficacy|1|||
42382530|NCT01428661|76256288|FG002|Double-Masked Phase|Lack of Efficacy|0|||
42382531|NCT01428661|76256286|FG000|Double-Masked Phase|*Various|1|||
42382532|NCT01428661|76256287|FG001|Double-Masked Phase|*Various|6|||
42382533|NCT01428661|76256288|FG002|Double-Masked Phase|*Various|0|||
42203404|NCT00075725|76016377|FG007|Overall Study|Death|22|||
42382534|NCT01428661|76256286|FG000|Open Label Extension|Protocol Violation|0|||
42382535|NCT01428661|76256287|FG001|Open Label Extension|Protocol Violation|0|||
42382536|NCT01428661|76256288|FG002|Open Label Extension|Protocol Violation|9|||
42382537|NCT01428661|76256286|FG000|Open Label Extension|Adverse Event|0|||
42382538|NCT01428661|76256287|FG001|Open Label Extension|Adverse Event|0|||
42382539|NCT01428661|76256288|FG002|Open Label Extension|Adverse Event|15|||
42382540|NCT01428661|76256286|FG000|Open Label Extension|Lost to Follow-up|0|||
42382541|NCT01428661|76256287|FG001|Open Label Extension|Lost to Follow-up|0|||
42382542|NCT01428661|76256288|FG002|Open Label Extension|Lost to Follow-up|38|||
42382543|NCT01428661|76256286|FG000|Open Label Extension|Withdrawal by Subject|0|||
42382544|NCT01428661|76256287|FG001|Open Label Extension|Withdrawal by Subject|0|||
42382545|NCT01428661|76256288|FG002|Open Label Extension|Withdrawal by Subject|49|||
42382546|NCT01428661|76256286|FG000|Open Label Extension|Lack of Efficacy|0|||
42382547|NCT01428661|76256287|FG001|Open Label Extension|Lack of Efficacy|0|||
42382548|NCT01428661|76256288|FG002|Open Label Extension|Lack of Efficacy|24|||
42382549|NCT01428661|76256286|FG000|Open Label Extension|**Various|0|||
42382550|NCT01428661|76256287|FG001|Open Label Extension|**Various|0|||
42382551|NCT01428661|76256288|FG002|Open Label Extension|**Various|185|||
42382552|NCT01428583|76256296|FG000|Overall Study|Adverse Event|75|||
42382553|NCT01428583|76256296|FG000|Overall Study|Withdrawal by Subject|51|||
42382554|NCT01428583|76256296|FG000|Overall Study|Lack of Efficacy|37|||
42382555|NCT01428583|76256296|FG000|Overall Study|Lost to Follow-up|17|||
42382556|NCT01428583|76256296|FG000|Overall Study|Death|1|||
42382557|NCT01428583|76256296|FG000|Overall Study|Pregnancy|1|||
42382558|NCT01428583|76256296|FG000|Overall Study|Protocol Violation|1|||
42382559|NCT01428583|76256296|FG000|Overall Study|Physician Decision|12|||
42382560|NCT01428583|76256296|FG000|Overall Study|Non-compliant|25|||
42382561|NCT01428583|76256296|FG000|Overall Study|Confirmed positive urine drug test|8|||
42382562|NCT01428583|76256296|FG000|Overall Study|Sponsor's request|3|||
42382563|NCT01428583|76256296|FG000|Overall Study|Other|6|||
42382564|NCT01428193|76256313|FG000|Overall Study|Physician Decision|1|||
42382565|NCT01428193|76256313|FG000|Overall Study|Elevated screening liver enzymes|1|||
42382566|NCT01428115|76256317|FG000|Overall Study|Lack of Efficacy|3|||
42382567|NCT01428115|76256317|FG000|Overall Study|Lost to Follow-up|10|||
42382568|NCT01428115|76256317|FG000|Overall Study|Pregnancy|1|||
42382569|NCT01428115|76256317|FG000|Overall Study|Protocol Violation|3|||
42382570|NCT01428115|76256317|FG000|Overall Study|Withdrawal by Subject|4|||
42382571|NCT01427803|76256324|FG000|Overall Study|Lost to Follow-up|32|||
42382572|NCT01427803|76256325|FG001|Overall Study|Lost to Follow-up|26|||
42382573|NCT01427803|76256324|FG000|Overall Study|Withdrawal by Subject|20|||
42382574|NCT01427803|76256325|FG001|Overall Study|Withdrawal by Subject|0|||
42382575|NCT01427803|76256324|FG000|Overall Study|Unable to complete full treatment period|6|||
42382576|NCT01427803|76256325|FG001|Overall Study|Unable to complete full treatment period|0|||
42382577|NCT01427803|76256324|FG000|Overall Study|Protocol Violation|1|||
42382578|NCT01427803|76256325|FG001|Overall Study|Protocol Violation|0|||
42382579|NCT01427803|76256324|FG000|Overall Study|Physician Decision|3|||
42382580|NCT01427803|76256325|FG001|Overall Study|Physician Decision|0|||
42382581|NCT01427803|76256324|FG000|Overall Study|did not take product|1|||
42382582|NCT01427803|76256325|FG001|Overall Study|did not take product|0|||
42382583|NCT01408537|76256329|FG000|Overall Study|Withdrawal by Subject|2|||
42382584|NCT01408537|76256329|FG000|Overall Study|Protocol Violation|3|||
42382585|NCT01408537|76256329|FG000|Overall Study|Lost to Follow-up|3|||
42382586|NCT01408459|76256362|FG000|Overall Study|Withdrawal by Subject|1|||
42382587|NCT01408459|76256363|FG001|Overall Study|Withdrawal by Subject|1|||
42382588|NCT01408303|76256382|FG000|Overall Study|Adverse Event|3|||
42382589|NCT01408303|76256383|FG001|Overall Study|Adverse Event|7|||
42382590|NCT01408303|76256384|FG002|Overall Study|Adverse Event|2|||
42382591|NCT01408303|76256382|FG000|Overall Study|Lost to Follow-up|0|||
42382592|NCT01408303|76256383|FG001|Overall Study|Lost to Follow-up|1|||
42382593|NCT01408303|76256384|FG002|Overall Study|Lost to Follow-up|2|||
42382594|NCT01408303|76256382|FG000|Overall Study|Withdrawal by Subject|2|||
42382595|NCT01408303|76256383|FG001|Overall Study|Withdrawal by Subject|3|||
42382596|NCT01408303|76256384|FG002|Overall Study|Withdrawal by Subject|1|||
42382597|NCT01408303|76256382|FG000|Overall Study|Protocol Violation|0|||
42382598|NCT01408303|76256383|FG001|Overall Study|Protocol Violation|1|||
42382599|NCT01408303|76256384|FG002|Overall Study|Protocol Violation|0|||
42382600|NCT01408303|76256382|FG000|Overall Study|Noncompliance|1|||
42382601|NCT01408303|76256383|FG001|Overall Study|Noncompliance|0|||
42382602|NCT01408303|76256384|FG002|Overall Study|Noncompliance|1|||
42382603|NCT01408147|76256405|FG000|Overall Study|Withdrawal by Subject|0|||
42382604|NCT01408147|76256406|FG001|Overall Study|Withdrawal by Subject|1|||
42382605|NCT01407367|76256414|FG000|Overall Study|Death|24|||
42382606|NCT01407367|76256415|FG001|Overall Study|Death|32|||
42382607|NCT01407367|76256414|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
42382608|NCT01407367|76256415|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
42382609|NCT01407367|76256414|FG000|Overall Study|Withdrawal by Subject|4|||
42382610|NCT01407367|76256415|FG001|Overall Study|Withdrawal by Subject|15|||
42382611|NCT01407367|76256414|FG000|Overall Study|Lost to Follow-up|0|||
42382612|NCT01407367|76256415|FG001|Overall Study|Lost to Follow-up|2|||
42382613|NCT01405027|76256451|FG000|Overall Study|Withdrawn consent|3|||
42382614|NCT01405027|76256452|FG001|Overall Study|Withdrawn consent|0|||
42382615|NCT01405027|76256451|FG000|Overall Study|Lost to Follow-up|16|||
42382616|NCT01405027|76256452|FG001|Overall Study|Lost to Follow-up|24|||
42382617|NCT01405027|76256451|FG000|Overall Study|Investigator judgement|0|||
42382618|NCT01405027|76256452|FG001|Overall Study|Investigator judgement|2|||
42382619|NCT01405027|76256451|FG000|Overall Study|Death|1|||
42382620|NCT01405027|76256452|FG001|Overall Study|Death|0|||
42382621|NCT01405027|76256451|FG000|Overall Study|Other or Unknown|12|||
42382622|NCT01405027|76256452|FG001|Overall Study|Other or Unknown|25|||
42382623|NCT01412801|76256473|FG000|Overall Study|Death|0|||
42382624|NCT01412801|76256474|FG001|Overall Study|Death|1|||
42382625|NCT01412801|76256475|FG002|Overall Study|Death|0|||
42382626|NCT01412801|76256476|FG003|Overall Study|Death|4|||
42382627|NCT01412801|76256477|FG004|Overall Study|Death|2|||
42382628|NCT01412801|76256478|FG005|Overall Study|Death|2|||
42382629|NCT01412801|76256473|FG000|Overall Study|Lost to Follow-up|1|||
42382630|NCT01412801|76256474|FG001|Overall Study|Lost to Follow-up|2|||
42382631|NCT01412801|76256475|FG002|Overall Study|Lost to Follow-up|4|||
42382632|NCT01412801|76256476|FG003|Overall Study|Lost to Follow-up|0|||
42382633|NCT01412801|76256477|FG004|Overall Study|Lost to Follow-up|1|||
42382634|NCT01412801|76256478|FG005|Overall Study|Lost to Follow-up|1|||
42382635|NCT01412801|76256473|FG000|Overall Study|Withdrawal by Subject|3|||
42382636|NCT01412801|76256474|FG001|Overall Study|Withdrawal by Subject|2|||
42382637|NCT01412801|76256475|FG002|Overall Study|Withdrawal by Subject|1|||
42382638|NCT01412801|76256476|FG003|Overall Study|Withdrawal by Subject|0|||
42382639|NCT01412801|76256477|FG004|Overall Study|Withdrawal by Subject|0|||
42382640|NCT01412801|76256478|FG005|Overall Study|Withdrawal by Subject|0|||
42382641|NCT01412801|76256473|FG000|Overall Study|Relocated to another area|0|||
42382642|NCT01412801|76256474|FG001|Overall Study|Relocated to another area|0|||
42382643|NCT01412801|76256475|FG002|Overall Study|Relocated to another area|2|||
42382644|NCT01412801|76256476|FG003|Overall Study|Relocated to another area|0|||
42382645|NCT01412801|76256477|FG004|Overall Study|Relocated to another area|0|||
42382646|NCT01412801|76256478|FG005|Overall Study|Relocated to another area|0|||
42382647|NCT01525628|76256526|FG000|Overall Study|Adverse Event|1|||
42382648|NCT01525628|76256527|FG001|Overall Study|Adverse Event|1|||
42382649|NCT01525628|76256528|FG002|Overall Study|Adverse Event|2|||
42382650|NCT01525628|76256529|FG003|Overall Study|Adverse Event|0|||
42382651|NCT01525628|76256530|FG004|Overall Study|Adverse Event|1|||
42382652|NCT01525628|76256526|FG000|Overall Study|Lack of Efficacy|0|||
42382653|NCT01525628|76256527|FG001|Overall Study|Lack of Efficacy|2|||
42382654|NCT01525628|76256528|FG002|Overall Study|Lack of Efficacy|2|||
42382655|NCT01525628|76256529|FG003|Overall Study|Lack of Efficacy|1|||
42382656|NCT01525628|76256530|FG004|Overall Study|Lack of Efficacy|2|||
42382657|NCT01525628|76256526|FG000|Overall Study|Protocol Violation|0|||
42382658|NCT01525628|76256527|FG001|Overall Study|Protocol Violation|0|||
42382659|NCT01525628|76256528|FG002|Overall Study|Protocol Violation|1|||
42382660|NCT01525628|76256529|FG003|Overall Study|Protocol Violation|0|||
42382661|NCT01525628|76256530|FG004|Overall Study|Protocol Violation|0|||
42382662|NCT01525628|76256526|FG000|Overall Study|Lost to Follow-up|1|||
42382663|NCT01525628|76256527|FG001|Overall Study|Lost to Follow-up|1|||
42382664|NCT01525628|76256528|FG002|Overall Study|Lost to Follow-up|0|||
42382665|NCT01525628|76256529|FG003|Overall Study|Lost to Follow-up|0|||
42382666|NCT01525628|76256530|FG004|Overall Study|Lost to Follow-up|0|||
42382667|NCT01525628|76256526|FG000|Overall Study|Withdrawal by Subject|0|||
42382668|NCT01525628|76256527|FG001|Overall Study|Withdrawal by Subject|1|||
42382669|NCT01525628|76256528|FG002|Overall Study|Withdrawal by Subject|0|||
42382670|NCT01525628|76256529|FG003|Overall Study|Withdrawal by Subject|0|||
42382671|NCT01525628|76256530|FG004|Overall Study|Withdrawal by Subject|0|||
42382672|NCT01525628|76256526|FG000|Overall Study|Other reason not defined above|0|||
42382673|NCT01525628|76256527|FG001|Overall Study|Other reason not defined above|0|||
42382674|NCT01525628|76256528|FG002|Overall Study|Other reason not defined above|0|||
42382675|NCT01525628|76256529|FG003|Overall Study|Other reason not defined above|3|||
42382676|NCT01525628|76256530|FG004|Overall Study|Other reason not defined above|0|||
42382677|NCT01412021|76256544|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
42382678|NCT01412021|76256544|FG000|Overall Study|Treatment Prior to Approval|3|||
42382679|NCT01412021|76256544|FG000|Overall Study|Transferred to Other Hospital|9|||
42382680|NCT01426789|76256550|FG000|Part 1|Protocol deviation|0|||
42382681|NCT01426789|76256551|FG001|Part 1|Protocol deviation|1|||
42382682|NCT01426789|76256552|FG002|Part 1|Protocol deviation|0|||
42382683|NCT01426789|76256553|FG003|Part 1|Protocol deviation|0|||
42382684|NCT01426789|76256554|FG004|Part 1|Protocol deviation|0|||
42382685|NCT01426789|76256555|FG005|Part 1|Protocol deviation|0|||
42382686|NCT01426789|76256550|FG000|Part 1|Lost to Follow-up|1|||
42382687|NCT01426789|76256551|FG001|Part 1|Lost to Follow-up|2|||
42382688|NCT01426789|76256552|FG002|Part 1|Lost to Follow-up|0|||
42382689|NCT01426789|76256553|FG003|Part 1|Lost to Follow-up|0|||
42382690|NCT01426789|76256554|FG004|Part 1|Lost to Follow-up|0|||
42382691|NCT01426789|76256555|FG005|Part 1|Lost to Follow-up|0|||
42382692|NCT01426789|76256550|FG000|Part 1|Lack of Efficacy|2|||
42382693|NCT01426789|76256551|FG001|Part 1|Lack of Efficacy|1|||
42382694|NCT01426789|76256552|FG002|Part 1|Lack of Efficacy|0|||
42382695|NCT01426789|76256553|FG003|Part 1|Lack of Efficacy|0|||
42382696|NCT01426789|76256554|FG004|Part 1|Lack of Efficacy|0|||
42382697|NCT01426789|76256555|FG005|Part 1|Lack of Efficacy|0|||
42382698|NCT01426789|76256550|FG000|Part 1|Adverse Event|3|||
42382699|NCT01426789|76256551|FG001|Part 1|Adverse Event|0|||
42382700|NCT01426789|76256552|FG002|Part 1|Adverse Event|0|||
42382701|NCT01426789|76256553|FG003|Part 1|Adverse Event|0|||
42382702|NCT01426789|76256554|FG004|Part 1|Adverse Event|0|||
42382703|NCT01426789|76256555|FG005|Part 1|Adverse Event|0|||
42382704|NCT01426789|76256550|FG000|Part 2|Protocol deviation|0|||
42382705|NCT01426789|76256551|FG001|Part 2|Protocol deviation|0|||
42382706|NCT01426789|76256552|FG002|Part 2|Protocol deviation|1|||
42382707|NCT01426789|76256553|FG003|Part 2|Protocol deviation|0|||
42382708|NCT01426789|76256554|FG004|Part 2|Protocol deviation|0|||
42382709|NCT01426789|76256555|FG005|Part 2|Protocol deviation|0|||
42382710|NCT01426789|76256550|FG000|Part 2|Death|0|||
42382711|NCT01426789|76256551|FG001|Part 2|Death|0|||
42382712|NCT01426789|76256552|FG002|Part 2|Death|1|||
42382713|NCT01426789|76256553|FG003|Part 2|Death|0|||
42382714|NCT01426789|76256554|FG004|Part 2|Death|1|||
42382715|NCT01426789|76256555|FG005|Part 2|Death|0|||
42382716|NCT01426789|76256550|FG000|Part 2|Administrative problems|0|||
42382717|NCT01426789|76256551|FG001|Part 2|Administrative problems|0|||
42382718|NCT01426789|76256552|FG002|Part 2|Administrative problems|2|||
42382719|NCT01426789|76256553|FG003|Part 2|Administrative problems|0|||
42382720|NCT01426789|76256554|FG004|Part 2|Administrative problems|1|||
42382721|NCT01426789|76256555|FG005|Part 2|Administrative problems|0|||
42382722|NCT01426789|76256550|FG000|Part 2|Lost to Follow-up|0|||
42382723|NCT01426789|76256551|FG001|Part 2|Lost to Follow-up|0|||
42382724|NCT01426789|76256552|FG002|Part 2|Lost to Follow-up|4|||
42382725|NCT01426789|76256553|FG003|Part 2|Lost to Follow-up|0|||
42382726|NCT01426789|76256554|FG004|Part 2|Lost to Follow-up|1|||
42382727|NCT01426789|76256555|FG005|Part 2|Lost to Follow-up|0|||
42382728|NCT01426789|76256550|FG000|Part 2|Withdrawal by Subject|0|||
42382729|NCT01426789|76256551|FG001|Part 2|Withdrawal by Subject|0|||
42382730|NCT01426789|76256552|FG002|Part 2|Withdrawal by Subject|0|||
42382731|NCT01426789|76256553|FG003|Part 2|Withdrawal by Subject|1|||
42382732|NCT01426789|76256554|FG004|Part 2|Withdrawal by Subject|2|||
42382733|NCT01426789|76256555|FG005|Part 2|Withdrawal by Subject|0|||
42382734|NCT01426789|76256550|FG000|Part 2|Lack of Efficacy|0|||
42382735|NCT01426789|76256551|FG001|Part 2|Lack of Efficacy|0|||
42382736|NCT01426789|76256552|FG002|Part 2|Lack of Efficacy|5|||
42382737|NCT01426789|76256553|FG003|Part 2|Lack of Efficacy|0|||
42382738|NCT01426789|76256554|FG004|Part 2|Lack of Efficacy|2|||
42382739|NCT01426789|76256555|FG005|Part 2|Lack of Efficacy|0|||
42382740|NCT01426789|76256550|FG000|Part 2|Adverse Event|0|||
42382741|NCT01426789|76256551|FG001|Part 2|Adverse Event|0|||
42382742|NCT01426789|76256552|FG002|Part 2|Adverse Event|2|||
42382743|NCT01426789|76256553|FG003|Part 2|Adverse Event|0|||
42382744|NCT01426789|76256554|FG004|Part 2|Adverse Event|1|||
42382745|NCT01426789|76256555|FG005|Part 2|Adverse Event|0|||
42382746|NCT01426009|76256576|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
42382747|NCT01426009|76256576|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
42382748|NCT01426009|76256576|FG000|Washout 1|Withdrawal by Subject|1|||
42382749|NCT01426009|76256576|FG000|Washout 1|Personal Reasons|1|||
42382750|NCT01426009|76256576|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
42382751|NCT01426009|76256576|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
42382752|NCT01426009|76256576|FG000|Washout 2|electrive surgery|1|||
42382753|NCT01426009|76256576|FG000|Washout 3|personal reasons|1|||
42382754|NCT01426009|76256576|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
42382755|NCT01426009|76256576|FG000|Washout 4|Lost to Follow-up|1|||
42382756|NCT01411319|76256605|FG000|Overall Study|Lost to Follow-up|1|||
42382757|NCT01543958|76256609|FG000|Overall Study|Loss to follow-up|3|||
42382758|NCT01543958|76256609|FG000|Overall Study|ART initiation|1|||
42382759|NCT01411085|76256613|FG000|Overall Study|Physician Decision|1|||
42382760|NCT01411085|76256613|FG000|Overall Study|Protocol Violation|1|||
42382761|NCT01411085|76256613|FG000|Overall Study|Adverse Event|1|||
42382762|NCT01543490|76256619|FG000|Overall Study|Adverse Event|4|||
42382763|NCT01543490|76256620|FG001|Overall Study|Adverse Event|0|||
42382764|NCT01543490|76256619|FG000|Overall Study|Physician Decision|1|||
42382765|NCT01543490|76256620|FG001|Overall Study|Physician Decision|0|||
42382766|NCT01543490|76256619|FG000|Overall Study|Lack of Efficacy|3|||
42382767|NCT01543490|76256620|FG001|Overall Study|Lack of Efficacy|3|||
42382768|NCT01543490|76256619|FG000|Overall Study|Lost to Follow-up|5|||
42382769|NCT01543490|76256620|FG001|Overall Study|Lost to Follow-up|0|||
42382770|NCT01543490|76256619|FG000|Overall Study|Withdrawal by Subject|2|||
42382771|NCT01543490|76256620|FG001|Overall Study|Withdrawal by Subject|0|||
42382772|NCT01543490|76256619|FG000|Overall Study|Other-Various Administrative Reasons|1|||
42382773|NCT01543490|76256620|FG001|Overall Study|Other-Various Administrative Reasons|2|||
42382774|NCT01404949|76256626|FG000|Overall Study|Not Treated|1|||
42382775|NCT01431521|76256634|FG000|Overall Study|Withdrawal by Subject|0|||
42382776|NCT01431521|76256635|FG001|Overall Study|Withdrawal by Subject|0|||
42382777|NCT01431521|76256636|FG002|Overall Study|Withdrawal by Subject|1|||
42382778|NCT01431521|76256637|FG003|Overall Study|Withdrawal by Subject|0|||
42382779|NCT01404325|76256713|FG000|Overall Study|Lost to Follow-up|1|||
42382780|NCT01404325|76256714|FG001|Overall Study|Lost to Follow-up|0|||
42382781|NCT01404325|76256713|FG000|Overall Study|Death|2|||
42382782|NCT01404325|76256714|FG001|Overall Study|Death|0|||
42382783|NCT01404325|76256713|FG000|Overall Study|Graft loss/Retransplantation|1|||
42382784|NCT01404325|76256714|FG001|Overall Study|Graft loss/Retransplantation|0|||
42382785|NCT01404325|76256713|FG000|Overall Study|non-specified reason|0|||
42382786|NCT01404325|76256714|FG001|Overall Study|non-specified reason|2|||
42382787|NCT01425463|76256735|FG000|Overall Study|Adverse Event|5|||
42382788|NCT01425463|76256736|FG001|Overall Study|Adverse Event|7|||
42382789|NCT01425463|76256735|FG000|Overall Study|Lack of Efficacy|1|||
42382790|NCT01425463|76256736|FG001|Overall Study|Lack of Efficacy|1|||
42382791|NCT01425463|76256735|FG000|Overall Study|Protocol Violation|2|||
42382792|NCT01425463|76256736|FG001|Overall Study|Protocol Violation|2|||
42382793|NCT01425463|76256735|FG000|Overall Study|Lost to Follow-up|5|||
42382794|NCT01425463|76256736|FG001|Overall Study|Lost to Follow-up|2|||
42382795|NCT01425463|76256735|FG000|Overall Study|Withdrawal by Subject|7|||
42382796|NCT01425463|76256736|FG001|Overall Study|Withdrawal by Subject|5|||
42382797|NCT01425463|76256735|FG000|Overall Study|Unknown Reason|4|||
42382798|NCT01425463|76256736|FG001|Overall Study|Unknown Reason|7|||
42382799|NCT04655586|76256758|FG000|Overall Study|Physician Decision|1|||
42382800|NCT04655586|76256759|FG001|Overall Study|Physician Decision|3|||
42382801|NCT04655586|76256760|FG002|Overall Study|Physician Decision|4|||
42382802|NCT04655586|76256758|FG000|Overall Study|Withdrawal by Subject|1|||
42382803|NCT04655586|76256759|FG001|Overall Study|Withdrawal by Subject|3|||
42382804|NCT04655586|76256760|FG002|Overall Study|Withdrawal by Subject|1|||
42382805|NCT01388647|76256783|FG000|Overall Study|Adverse Event|1|||
42382806|NCT01388647|76256784|FG001|Overall Study|Adverse Event|2|||
42382807|NCT01402063|76256859|FG000|Overall Study|Withdrawal by Subject|3|||
42382808|NCT01402063|76256860|FG001|Overall Study|Withdrawal by Subject|3|||
42382809|NCT01796301|76256868|FG000|Overall Study|Withdrawal by Subject|15|||
42382810|NCT01796301|76256869|FG001|Overall Study|Withdrawal by Subject|15|||
42382811|NCT01796301|76256868|FG000|Overall Study|Lost to Follow-up|3|||
42382812|NCT01796301|76256869|FG001|Overall Study|Lost to Follow-up|3|||
42382813|NCT01796301|76256868|FG000|Overall Study|Death|0|||
42382814|NCT01796301|76256869|FG001|Overall Study|Death|1|||
42382815|NCT01796301|76256868|FG000|Overall Study|Decision by Sponsor|0|||
42382816|NCT01796301|76256869|FG001|Overall Study|Decision by Sponsor|1|||
42382817|NCT01388335|76256888|FG000|Period 1|Progressive Disease|1|||
42382818|NCT01388335|76256888|FG000|Period 2|Progressive Disease|2|||
42382819|NCT01388335|76256888|FG000|Period 2|Sponsor Decision|1|||
42382820|NCT01388335|76256888|FG000|Safety Extension|Progressive Disease|7|||
42382821|NCT01401361|76256935|FG000|Overall Study|Withdrawal by Subject|16|||
42382822|NCT01401361|76256935|FG000|Overall Study|Lack of Efficacy|6|||
42382823|NCT01401361|76256935|FG000|Overall Study|Physician Decision|1|||
42382824|NCT01401361|76256935|FG000|Overall Study|Lost to Follow-up|3|||
42382825|NCT01401361|76256935|FG000|Overall Study|Subject/family decision post procedure|2|||
42382826|NCT01401283|76256941|FG000|Overall Study|surgery cancelled|5|||
42382827|NCT01401283|76256942|FG001|Overall Study|surgery cancelled|8|||
42382828|NCT01401283|76256941|FG000|Overall Study|preoperative arrhythmia|5|||
42382829|NCT01401283|76256942|FG001|Overall Study|preoperative arrhythmia|0|||
42382830|NCT01401283|76256941|FG000|Overall Study|no central venous access|0|||
42382831|NCT01401283|76256942|FG001|Overall Study|no central venous access|1|||
42382832|NCT01401283|76256941|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
42382833|NCT01401283|76256942|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
42382834|NCT01422889|76256965|FG000|Overall Study|No Data Entered for Study Stent|9|||
42382835|NCT01400971|76256969|FG000|Overall Study|Death|82|||
42382836|NCT01400971|76256969|FG000|Overall Study|Lost to Follow-up|196|||
42382837|NCT01400971|76256969|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
42382838|NCT01400971|76256969|FG000|Overall Study|Physician Decision|57|||
42382839|NCT01400971|76256969|FG000|Overall Study|Withdrawal by Subject|158|||
42382840|NCT01400971|76256969|FG000|Overall Study|Other|422|||
42382841|NCT01387789|76256973|FG000|Overall Study|Adverse Event|5|||
42382842|NCT01387789|76256973|FG000|Overall Study|Lack of Efficacy|2|||
42382843|NCT01387789|76256973|FG000|Overall Study|Lost to Follow-up|1|||
42382844|NCT01400893|76256984|FG000|Overall Study|Death|27|||
42382845|NCT01400893|76256985|FG001|Overall Study|Death|21|||
42382846|NCT01400893|76256984|FG000|Overall Study|Lost to Follow-up|0|||
42382847|NCT01400893|76256985|FG001|Overall Study|Lost to Follow-up|6|||
42382848|NCT01400815|76257025|FG000|Overall Study|Adverse Event|3|||
42382849|NCT01400815|76257026|FG001|Overall Study|Adverse Event|0|||
42382850|NCT01400815|76257025|FG000|Overall Study|Death|0|||
42382851|NCT01400815|76257026|FG001|Overall Study|Death|1|||
42382852|NCT01400815|76257025|FG000|Overall Study|Lost to Follow-up|18|||
42382853|NCT01400815|76257026|FG001|Overall Study|Lost to Follow-up|11|||
42382854|NCT01400815|76257025|FG000|Overall Study|Protocol Violation|0|||
42382855|NCT01400815|76257026|FG001|Overall Study|Protocol Violation|1|||
42382856|NCT01400815|76257025|FG000|Overall Study|Physician Decision|1|||
42382857|NCT01400815|76257026|FG001|Overall Study|Physician Decision|0|||
42382858|NCT01400815|76257025|FG000|Overall Study|Withdrawal by Subject|15|||
42382859|NCT01400815|76257026|FG001|Overall Study|Withdrawal by Subject|8|||
42382860|NCT01400815|76257025|FG000|Overall Study|Subject in jail|1|||
42109355|NCT00543309|75919904|FG001|Overall Study|Physician Decision|1|||
42382861|NCT01400815|76257026|FG001|Overall Study|Subject in jail|0|||
42382862|NCT01400503|76257080|FG000|Overall Study|Withdrawal by Subject|1|||
42109356|NCT00543309|75919905|FG002|Overall Study|Physician Decision|0|||
42382863|NCT01400503|76257080|FG000|Overall Study|Study Terminated by Sponsor|58|||
42382864|NCT01400503|76257080|FG000|Overall Study|Other|1|||
42382865|NCT01400425|76257096|FG000|Overall Study|Withdrawal by Subject|10|||
42382866|NCT01421719|76257102|FG000|Overall Study|Withdrawal by Subject|4|||
42382867|NCT01421641|76257109|FG000|Overall Study|Protocol Violation|2|||
42382868|NCT01421641|76257110|FG001|Overall Study|Protocol Violation|2|||
42382869|NCT01385995|76257118|FG000|Period 1, 2 Months|Physician Decision|1|||
42382870|NCT01385995|76257119|FG001|Period 1, 2 Months|Physician Decision|0|||
42382871|NCT01421017|76257130|FG000|Overall Study|Withdrawal by Subject|2|||
42382872|NCT01421017|76257131|FG001|Overall Study|Withdrawal by Subject|0|||
42382873|NCT01421017|76257132|FG002|Overall Study|Withdrawal by Subject|0|||
42382874|NCT01421017|76257130|FG000|Overall Study|POD|0|||
42382875|NCT01421017|76257131|FG001|Overall Study|POD|6|||
42382876|NCT01421017|76257132|FG002|Overall Study|POD|3|||
42382877|NCT01420627|76257179|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
42382878|NCT01400113|76257189|FG000|Overall Study|Withdrawal by Subject|1|||
42382879|NCT01400113|76257190|FG001|Overall Study|Withdrawal by Subject|1|||
42382880|NCT01399723|76257198|FG000|Overall Study|Lost to Follow-up|0|||
42382881|NCT01399723|76257199|FG001|Overall Study|Lost to Follow-up|1|||
42203405|NCT00075725|76016378|FG008|Overall Study|Death|14|||
42382882|NCT01385371|76257208|FG000|Overall Study|Adverse Event|54|||
42382883|NCT01385371|76257209|FG001|Overall Study|Adverse Event|19|||
42382884|NCT01385371|76257208|FG000|Overall Study|Lost to Follow-up|16|||
42382885|NCT01385371|76257209|FG001|Overall Study|Lost to Follow-up|16|||
42382886|NCT01385371|76257208|FG000|Overall Study|Withdrawal by Subject|52|||
42382887|NCT01385371|76257209|FG001|Overall Study|Withdrawal by Subject|39|||
42382888|NCT01385371|76257208|FG000|Overall Study|Protocol Violation|25|||
42382889|NCT01385371|76257209|FG001|Overall Study|Protocol Violation|21|||
42382890|NCT01385371|76257208|FG000|Overall Study|Administrative|2|||
42382891|NCT01385371|76257209|FG001|Overall Study|Administrative|2|||
42382892|NCT01399099|76257215|FG000|Overall Study|Lost to Follow-up|11|||
42382893|NCT01399099|76257215|FG000|Overall Study|Physician Decision|1|||
42382894|NCT01399099|76257215|FG000|Overall Study|Protocol Violation|1|||
42382895|NCT01399099|76257215|FG000|Overall Study|Skin Irritation|13|||
42382896|NCT01399099|76257215|FG000|Overall Study|Infection|1|||
42382897|NCT01399099|76257215|FG000|Overall Study|Miscellaneous|4|||
42382898|NCT01398787|76257220|FG000|Overall Study|Adverse Event|1|||
42382899|NCT01383499|76257226|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
42382900|NCT01383499|76257227|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
42382901|NCT01383499|76257228|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
42382902|NCT01383499|76257229|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
42382903|NCT01397461|76257245|FG000|Overall Study|Withdrawal by Subject|2|||
42382904|NCT01397461|76257246|FG001|Overall Study|Withdrawal by Subject|1|||
42382905|NCT01397461|76257247|FG002|Overall Study|Withdrawal by Subject|0|||
42203406|NCT00075725|76016379|FG009|Overall Study|Death|4|||
42203407|NCT00075725|76016380|FG010|Overall Study|Death|3|||
42382906|NCT01397461|76257245|FG000|Overall Study|Lost to Follow-up|0|||
42382907|NCT01397461|76257246|FG001|Overall Study|Lost to Follow-up|2|||
42018973|NCT01252667|75826423|FG001|Overall Study|Transplant aborted post-conditioning|0|||
42203408|NCT00075725|76016381|FG011|Overall Study|Death|0|||
42018974|NCT01252667|75826424|FG002|Overall Study|Transplant aborted post-conditioning|0|||
42109357|NCT00569582|75919914|FG000|Overall Study|Withdrawal by Subject|5|||
42109358|NCT00569582|75919914|FG000|Overall Study|Death|2|||
42109359|NCT00569582|75919914|FG000|Overall Study|Adverse Event|7|||
42109360|NCT00569582|75919914|FG000|Overall Study|Subject was too ill to travel.|1|||
42382908|NCT01397461|76257247|FG002|Overall Study|Lost to Follow-up|1|||
42382909|NCT01397461|76257245|FG000|Overall Study|Lack of Efficacy|0|||
42109361|NCT00569582|75919914|FG000|Overall Study|Subject was non-compliant.|1|||
42203409|NCT00075725|76016370|FG000|Overall Study|Lost to Follow-up|1|||
42109362|NCT00721409|75919921|FG000|Overall Study|Global deterioration of health status|2|||
42109363|NCT00721409|75919922|FG001|Overall Study|Global deterioration of health status|6|||
42109364|NCT00721409|75919923|FG002|Overall Study|Global deterioration of health status|3|||
42109365|NCT00721409|75919921|FG000|Overall Study|Death|0|||
42109366|NCT00721409|75919922|FG001|Overall Study|Death|1|||
42109367|NCT00721409|75919923|FG002|Overall Study|Death|0|||
42109368|NCT00721409|75919921|FG000|Overall Study|Randomized not Treated|0|||
42109369|NCT00721409|75919922|FG001|Overall Study|Randomized not Treated|1|||
42109370|NCT00721409|75919923|FG002|Overall Study|Randomized not Treated|4|||
42109371|NCT00721409|75919921|FG000|Overall Study|Reason not specified|1|||
42109372|NCT00721409|75919922|FG001|Overall Study|Reason not specified|0|||
42109373|NCT00721409|75919923|FG002|Overall Study|Reason not specified|2|||
42109374|NCT00721409|75919921|FG000|Overall Study|Adverse Event|0|||
42109375|NCT00721409|75919922|FG001|Overall Study|Adverse Event|13|||
42109376|NCT00721409|75919923|FG002|Overall Study|Adverse Event|2|||
42203410|NCT00075725|76016371|FG001|Overall Study|Lost to Follow-up|1|||
42203411|NCT00075725|76016372|FG002|Overall Study|Lost to Follow-up|4|||
42203412|NCT00075725|76016373|FG003|Overall Study|Lost to Follow-up|1|||
42109377|NCT00721409|75919921|FG000|Overall Study|Lost to Follow-up|0|||
42109378|NCT00721409|75919922|FG001|Overall Study|Lost to Follow-up|0|||
42203413|NCT00075725|76016374|FG004|Overall Study|Lost to Follow-up|0|||
42109379|NCT00721409|75919923|FG002|Overall Study|Lost to Follow-up|1|||
42203414|NCT00075725|76016375|FG005|Overall Study|Lost to Follow-up|13|||
42382910|NCT01397461|76257246|FG001|Overall Study|Lack of Efficacy|3|||
42382911|NCT01397461|76257247|FG002|Overall Study|Lack of Efficacy|0|||
42382912|NCT01397461|76257245|FG000|Overall Study|Not treated|0|||
42382913|NCT01397461|76257246|FG001|Overall Study|Not treated|0|||
42382914|NCT01397461|76257247|FG002|Overall Study|Not treated|1|||
42382915|NCT01382251|76257257|FG000|Overall Study|Surgeries cancelled or delayed|16|||
42382916|NCT01382251|76257258|FG001|Overall Study|Surgeries cancelled or delayed|16|||
42382917|NCT01382251|76257257|FG000|Overall Study|Lost to Follow-up|4|||
42382918|NCT01382251|76257258|FG001|Overall Study|Lost to Follow-up|4|||
42382919|NCT01382251|76257257|FG000|Overall Study|Contacted after study closed|1|||
42382920|NCT01382251|76257258|FG001|Overall Study|Contacted after study closed|1|||
42382921|NCT01396525|76257263|FG000|Overall Study|Withdrawal by Subject|8|||
42382922|NCT01396525|76257263|FG000|Overall Study|Death|14|||
42382923|NCT01396525|76257263|FG000|Overall Study|Lost to Follow-up|4|||
42203415|NCT00075725|76016376|FG006|Overall Study|Lost to Follow-up|2|||
42382924|NCT02849652|76257275|FG000|Overall Study|Lost to Follow-up|104|||
42382925|NCT02849652|76257276|FG001|Overall Study|Lost to Follow-up|35|||
42382926|NCT02849652|76257277|FG002|Overall Study|Lost to Follow-up|116|||
42382927|NCT02849652|76257278|FG003|Overall Study|Lost to Follow-up|22|||
42382928|NCT02849652|76257275|FG000|Overall Study|Withdrawal by Subject|10|||
42382929|NCT02849652|76257276|FG001|Overall Study|Withdrawal by Subject|2|||
42382930|NCT02849652|76257277|FG002|Overall Study|Withdrawal by Subject|8|||
42382931|NCT02849652|76257278|FG003|Overall Study|Withdrawal by Subject|4|||
42382932|NCT01396447|76257290|FG000|Overall Study|Did Not Receive Treatment|3|||
42382933|NCT01396447|76257291|FG001|Overall Study|Did Not Receive Treatment|2|||
42382934|NCT01396447|76257292|FG002|Overall Study|Did Not Receive Treatment|1|||
42382935|NCT01396447|76257293|FG003|Overall Study|Did Not Receive Treatment|0|||
42382936|NCT01396447|76257290|FG000|Overall Study|Adverse Event|15|||
42382937|NCT01396447|76257291|FG001|Overall Study|Adverse Event|12|||
42382938|NCT01396447|76257292|FG002|Overall Study|Adverse Event|12|||
42382939|NCT01396447|76257293|FG003|Overall Study|Adverse Event|17|||
42382940|NCT01396447|76257290|FG000|Overall Study|Insufficient Therapeutic Response|5|||
42382941|NCT01396447|76257291|FG001|Overall Study|Insufficient Therapeutic Response|5|||
42382942|NCT01396447|76257292|FG002|Overall Study|Insufficient Therapeutic Response|2|||
42382943|NCT01396447|76257293|FG003|Overall Study|Insufficient Therapeutic Response|4|||
42382944|NCT01396447|76257290|FG000|Overall Study|Protocol Violation|5|||
42382945|NCT01396447|76257291|FG001|Overall Study|Protocol Violation|2|||
42382946|NCT01396447|76257292|FG002|Overall Study|Protocol Violation|3|||
42382947|NCT01396447|76257293|FG003|Overall Study|Protocol Violation|7|||
42382948|NCT01396447|76257290|FG000|Overall Study|Withdrawal of Consent|11|||
42382949|NCT01396447|76257291|FG001|Overall Study|Withdrawal of Consent|9|||
42382950|NCT01396447|76257292|FG002|Overall Study|Withdrawal of Consent|4|||
42382951|NCT01396447|76257293|FG003|Overall Study|Withdrawal of Consent|15|||
42382952|NCT01396447|76257290|FG000|Overall Study|Lost to Follow-up|4|||
42382953|NCT01396447|76257291|FG001|Overall Study|Lost to Follow-up|8|||
42382954|NCT01396447|76257292|FG002|Overall Study|Lost to Follow-up|7|||
42382955|NCT01396447|76257293|FG003|Overall Study|Lost to Follow-up|9|||
42382956|NCT01396447|76257290|FG000|Overall Study|Other Miscellaneous Reasons|0|||
42382957|NCT01396447|76257291|FG001|Overall Study|Other Miscellaneous Reasons|2|||
42382958|NCT01396447|76257292|FG002|Overall Study|Other Miscellaneous Reasons|1|||
42382959|NCT01396447|76257293|FG003|Overall Study|Other Miscellaneous Reasons|0|||
42382960|NCT01678560|76257366|FG000|Overall Study|Physician Decision|4|||
42382961|NCT01678560|76257367|FG001|Overall Study|Physician Decision|4|||
42382962|NCT01678560|76257366|FG000|Overall Study|Death|0|||
42382963|NCT01678560|76257367|FG001|Overall Study|Death|1|||
42382964|NCT01678560|76257366|FG000|Overall Study|Withdrawal by Subject|0|||
42382965|NCT01678560|76257367|FG001|Overall Study|Withdrawal by Subject|1|||
42382966|NCT01381549|76257406|FG000|Overall Study|Ineligible: No organisms isolated|0|||
42382967|NCT01381549|76257407|FG001|Overall Study|Ineligible: No organisms isolated|0|||
42382968|NCT01381549|76257408|FG002|Overall Study|Ineligible: No organisms isolated|1|||
42382969|NCT00159432|76257417|FG000|Overall Study|Adverse Event|1|||
42382970|NCT00159432|76257417|FG000|Overall Study|Death|1|||
42382971|NCT00159432|76257417|FG000|Overall Study|Lack of Efficacy|8|||
42382972|NCT01396057|76257423|FG000|Overall Study|Adverse Event|2|||
42382973|NCT01396057|76257424|FG001|Overall Study|Adverse Event|6|||
42109380|NCT00721409|75919921|FG000|Overall Study|Withdrawal by Subject|1|||
42109381|NCT00721409|75919922|FG001|Overall Study|Withdrawal by Subject|6|||
42109382|NCT00721409|75919923|FG002|Overall Study|Withdrawal by Subject|5|||
42109383|NCT00721409|75919921|FG000|Overall Study|Objective progression or relapse|8|||
42109384|NCT00721409|75919922|FG001|Overall Study|Objective progression or relapse|55|||
42109385|NCT00721409|75919923|FG002|Overall Study|Objective progression or relapse|62|||
42109386|NCT00542997|75919947|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
42109387|NCT00542997|75919947|FG000|Wash in / Wash Out Period|Adverse Event|3|||
42109388|NCT00542997|75919947|FG000|Efficacy Period|Adverse Event|3|||
42109389|NCT00572832|75919956|FG000|Overall Study|Lost to Follow-up|0|||
42109390|NCT00572832|75919957|FG001|Overall Study|Lost to Follow-up|11|||
42109391|NCT00572832|75919956|FG000|Overall Study|Pregnancy|0|||
42109392|NCT00572832|75919957|FG001|Overall Study|Pregnancy|1|||
42109393|NCT03917823|75919965|FG000|Overall Study|Lost to Follow-up|1|||
42109394|NCT03917823|75919966|FG001|Overall Study|Lost to Follow-up|1|||
42109395|NCT03917823|75919965|FG000|Overall Study|Withdrawal by Subject|0|||
42109396|NCT03917823|75919966|FG001|Overall Study|Withdrawal by Subject|1|||
42109397|NCT00229723|75919979|FG000|Concomitant Phase|Adverse Event|4|||
42109398|NCT00229723|75919980|FG001|Concomitant Phase|Adverse Event|2|||
42109399|NCT00229723|75919981|FG002|Concomitant Phase|Adverse Event|5|||
42109400|NCT00229723|75919982|FG003|Concomitant Phase|Adverse Event|2|||
42109401|NCT00229723|75919983|FG004|Concomitant Phase|Adverse Event|0|||
42109402|NCT00229723|75919984|FG005|Concomitant Phase|Adverse Event|1|||
42109403|NCT00229723|75919985|FG006|Concomitant Phase|Adverse Event|2|||
42109404|NCT00229723|75919979|FG000|Concomitant Phase|Objective disease progression|0|||
42109405|NCT00229723|75919980|FG001|Concomitant Phase|Objective disease progression|0|||
42109406|NCT00229723|75919981|FG002|Concomitant Phase|Objective disease progression|0|||
42109407|NCT00229723|75919982|FG003|Concomitant Phase|Objective disease progression|0|||
42109408|NCT00229723|75919983|FG004|Concomitant Phase|Objective disease progression|0|||
42109409|NCT00229723|75919984|FG005|Concomitant Phase|Objective disease progression|0|||
42109410|NCT00229723|75919985|FG006|Concomitant Phase|Objective disease progression|0|||
42109411|NCT00229723|75919979|FG000|Concomitant Phase|Clinical progression|0|||
42109412|NCT00229723|75919980|FG001|Concomitant Phase|Clinical progression|0|||
42109413|NCT00229723|75919981|FG002|Concomitant Phase|Clinical progression|0|||
42109414|NCT00229723|75919982|FG003|Concomitant Phase|Clinical progression|0|||
42109415|NCT00229723|75919983|FG004|Concomitant Phase|Clinical progression|0|||
42109416|NCT00229723|75919984|FG005|Concomitant Phase|Clinical progression|0|||
42109417|NCT00229723|75919985|FG006|Concomitant Phase|Clinical progression|1|||
42109418|NCT00229723|75919979|FG000|Concomitant Phase|Lost to Follow-up|0|||
42109419|NCT00229723|75919980|FG001|Concomitant Phase|Lost to Follow-up|0|||
42109420|NCT00229723|75919981|FG002|Concomitant Phase|Lost to Follow-up|0|||
42109421|NCT00229723|75919982|FG003|Concomitant Phase|Lost to Follow-up|0|||
42109422|NCT00229723|75919983|FG004|Concomitant Phase|Lost to Follow-up|1|||
42109423|NCT00229723|75919984|FG005|Concomitant Phase|Lost to Follow-up|0|||
42109424|NCT00229723|75919985|FG006|Concomitant Phase|Lost to Follow-up|0|||
42109425|NCT00229723|75919979|FG000|Concomitant Phase|Informed consent withdrawn|3|||
42109426|NCT00229723|75919980|FG001|Concomitant Phase|Informed consent withdrawn|2|||
42109427|NCT00229723|75919981|FG002|Concomitant Phase|Informed consent withdrawn|0|||
42109428|NCT00229723|75919982|FG003|Concomitant Phase|Informed consent withdrawn|2|||
42109429|NCT00229723|75919983|FG004|Concomitant Phase|Informed consent withdrawn|0|||
42109430|NCT00229723|75919984|FG005|Concomitant Phase|Informed consent withdrawn|0|||
42109431|NCT00229723|75919985|FG006|Concomitant Phase|Informed consent withdrawn|0|||
42109432|NCT00229723|75919979|FG000|Concomitant Phase|Severe non-compliance|0|||
42203416|NCT00075725|76016377|FG007|Overall Study|Lost to Follow-up|4|||
42109433|NCT00229723|75919980|FG001|Concomitant Phase|Severe non-compliance|1|||
42109434|NCT00229723|75919981|FG002|Concomitant Phase|Severe non-compliance|0|||
42109435|NCT00229723|75919982|FG003|Concomitant Phase|Severe non-compliance|0|||
42109436|NCT00229723|75919983|FG004|Concomitant Phase|Severe non-compliance|1|||
42109437|NCT00229723|75919984|FG005|Concomitant Phase|Severe non-compliance|0|||
42109438|NCT00229723|75919985|FG006|Concomitant Phase|Severe non-compliance|0|||
42109439|NCT00229723|75919979|FG000|Concomitant Phase|Other|3|||
42109440|NCT00229723|75919980|FG001|Concomitant Phase|Other|0|||
42109441|NCT00229723|75919981|FG002|Concomitant Phase|Other|1|||
42109442|NCT00229723|75919982|FG003|Concomitant Phase|Other|1|||
42109443|NCT00229723|75919983|FG004|Concomitant Phase|Other|0|||
42109444|NCT00229723|75919984|FG005|Concomitant Phase|Other|2|||
42109445|NCT00229723|75919985|FG006|Concomitant Phase|Other|0|||
42203417|NCT00075725|76016378|FG008|Overall Study|Lost to Follow-up|1|||
42109446|NCT00229723|75919979|FG000|Maintenance Phase|Adverse Event|7|||
42109447|NCT00229723|75919980|FG001|Maintenance Phase|Adverse Event|2|||
42109448|NCT00229723|75919981|FG002|Maintenance Phase|Adverse Event|1|||
42109449|NCT00229723|75919982|FG003|Maintenance Phase|Adverse Event|4|||
42109450|NCT00229723|75919983|FG004|Maintenance Phase|Adverse Event|7|||
42109451|NCT00229723|75919984|FG005|Maintenance Phase|Adverse Event|5|||
42109452|NCT00229723|75919985|FG006|Maintenance Phase|Adverse Event|2|||
42109453|NCT00229723|75919979|FG000|Maintenance Phase|Objective disease progression|5|||
42109454|NCT00229723|75919980|FG001|Maintenance Phase|Objective disease progression|5|||
42109455|NCT00229723|75919981|FG002|Maintenance Phase|Objective disease progression|3|||
42109456|NCT00229723|75919982|FG003|Maintenance Phase|Objective disease progression|6|||
42109457|NCT00229723|75919983|FG004|Maintenance Phase|Objective disease progression|2|||
42109458|NCT00229723|75919984|FG005|Maintenance Phase|Objective disease progression|9|||
42109459|NCT00229723|75919985|FG006|Maintenance Phase|Objective disease progression|5|||
42109460|NCT00229723|75919979|FG000|Maintenance Phase|Clinical progression|4|||
42109461|NCT00229723|75919980|FG001|Maintenance Phase|Clinical progression|1|||
42109462|NCT00229723|75919981|FG002|Maintenance Phase|Clinical progression|2|||
42109463|NCT00229723|75919982|FG003|Maintenance Phase|Clinical progression|2|||
42109464|NCT00229723|75919983|FG004|Maintenance Phase|Clinical progression|1|||
42109465|NCT00229723|75919984|FG005|Maintenance Phase|Clinical progression|1|||
42109466|NCT00229723|75919985|FG006|Maintenance Phase|Clinical progression|1|||
42109467|NCT00229723|75919979|FG000|Maintenance Phase|Lost to Follow-up|0|||
42109468|NCT00229723|75919980|FG001|Maintenance Phase|Lost to Follow-up|1|||
42109469|NCT00229723|75919981|FG002|Maintenance Phase|Lost to Follow-up|2|||
42109470|NCT00229723|75919982|FG003|Maintenance Phase|Lost to Follow-up|2|||
42109471|NCT00229723|75919983|FG004|Maintenance Phase|Lost to Follow-up|0|||
42109472|NCT00229723|75919984|FG005|Maintenance Phase|Lost to Follow-up|0|||
42109473|NCT00229723|75919985|FG006|Maintenance Phase|Lost to Follow-up|1|||
42109474|NCT00229723|75919979|FG000|Maintenance Phase|Informed consent withdrawn|1|||
42109475|NCT00229723|75919980|FG001|Maintenance Phase|Informed consent withdrawn|0|||
42109476|NCT00229723|75919981|FG002|Maintenance Phase|Informed consent withdrawn|0|||
42109477|NCT00229723|75919982|FG003|Maintenance Phase|Informed consent withdrawn|1|||
42109478|NCT00229723|75919983|FG004|Maintenance Phase|Informed consent withdrawn|1|||
42109479|NCT00229723|75919984|FG005|Maintenance Phase|Informed consent withdrawn|1|||
42109480|NCT00229723|75919985|FG006|Maintenance Phase|Informed consent withdrawn|0|||
42109481|NCT00229723|75919979|FG000|Maintenance Phase|Severe non-compliance|3|||
42109482|NCT00229723|75919980|FG001|Maintenance Phase|Severe non-compliance|1|||
42109483|NCT00229723|75919981|FG002|Maintenance Phase|Severe non-compliance|0|||
42109484|NCT00229723|75919982|FG003|Maintenance Phase|Severe non-compliance|0|||
42109485|NCT00229723|75919983|FG004|Maintenance Phase|Severe non-compliance|1|||
42109486|NCT00229723|75919984|FG005|Maintenance Phase|Severe non-compliance|0|||
42109487|NCT00229723|75919985|FG006|Maintenance Phase|Severe non-compliance|0|||
42109488|NCT00229723|75919979|FG000|Maintenance Phase|Other|5|||
42109489|NCT00229723|75919980|FG001|Maintenance Phase|Other|4|||
42109490|NCT00229723|75919981|FG002|Maintenance Phase|Other|1|||
42109491|NCT00229723|75919982|FG003|Maintenance Phase|Other|2|||
42109492|NCT00229723|75919983|FG004|Maintenance Phase|Other|3|||
42109493|NCT00229723|75919984|FG005|Maintenance Phase|Other|3|||
42109494|NCT00229723|75919985|FG006|Maintenance Phase|Other|1|||
42109495|NCT00606684|75920007|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
42109496|NCT00606684|75920008|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
42109497|NCT00606684|75920009|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
42109498|NCT00606684|75920010|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
42109499|NCT00606684|75920011|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
42109500|NCT00606684|75920012|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
42109501|NCT00606684|75920013|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
42109502|NCT00606684|75920007|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
42109503|NCT00606684|75920008|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
42109504|NCT00606684|75920009|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
42109505|NCT00606684|75920010|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
42109506|NCT00606684|75920011|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
42109507|NCT00606684|75920012|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
42109508|NCT00606684|75920013|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
42109509|NCT00606684|75920007|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
42109510|NCT00606684|75920008|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
42109511|NCT00606684|75920009|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
42109512|NCT00606684|75920010|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
42109513|NCT00606684|75920011|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
42109514|NCT00606684|75920012|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
42109515|NCT00606684|75920013|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
42203418|NCT00075725|76016379|FG009|Overall Study|Lost to Follow-up|0|||
42109516|NCT00606684|75920007|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
42109517|NCT00606684|75920008|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
42109518|NCT00606684|75920009|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
42109519|NCT00606684|75920010|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
42109520|NCT00606684|75920011|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
42109521|NCT00606684|75920012|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
42109522|NCT00606684|75920013|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
42109523|NCT00606684|75920007|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
42109524|NCT00606684|75920008|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
42109525|NCT00606684|75920009|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
42109526|NCT00606684|75920010|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
42109527|NCT00606684|75920011|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
42109528|NCT00606684|75920012|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
42109529|NCT00606684|75920013|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
42109530|NCT00606684|75920007|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
42109531|NCT00606684|75920008|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
42109532|NCT00606684|75920009|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
42109533|NCT00606684|75920010|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
42109534|NCT00606684|75920011|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
42109535|NCT00606684|75920012|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
42109536|NCT00606684|75920013|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
42109537|NCT00606684|75920007|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
42109538|NCT00606684|75920008|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
42109539|NCT00606684|75920009|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
42109540|NCT00606684|75920010|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
42109541|NCT00606684|75920011|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
42109542|NCT00606684|75920012|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
42109543|NCT00606684|75920013|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
42109544|NCT00606684|75920007|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42109545|NCT00606684|75920008|FG001|Double-Blind Treatment Period|Adverse Event|3|||
42109546|NCT00606684|75920009|FG002|Double-Blind Treatment Period|Adverse Event|2|||
42109547|NCT00606684|75920010|FG003|Double-Blind Treatment Period|Adverse Event|4|||
42109548|NCT00606684|75920011|FG004|Double-Blind Treatment Period|Adverse Event|2|||
42109549|NCT00606684|75920012|FG005|Double-Blind Treatment Period|Adverse Event|0|||
42109550|NCT00606684|75920013|FG006|Double-Blind Treatment Period|Adverse Event|1|||
42109551|NCT00606684|75920007|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
42109552|NCT00606684|75920008|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
42203419|NCT00075725|76016380|FG010|Overall Study|Lost to Follow-up|0|||
42203420|NCT00075725|76016381|FG011|Overall Study|Lost to Follow-up|0|||
42203421|NCT00075725|76016370|FG000|Overall Study|Physician Decision|2|||
42203422|NCT00075725|76016371|FG001|Overall Study|Physician Decision|6|||
42203423|NCT00075725|76016372|FG002|Overall Study|Physician Decision|5|||
42203424|NCT00075725|76016373|FG003|Overall Study|Physician Decision|8|||
42203425|NCT00075725|76016374|FG004|Overall Study|Physician Decision|4|||
42203426|NCT00075725|76016375|FG005|Overall Study|Physician Decision|19|||
42203427|NCT00075725|76016376|FG006|Overall Study|Physician Decision|3|||
42203428|NCT00075725|76016377|FG007|Overall Study|Physician Decision|17|||
42203429|NCT00075725|76016378|FG008|Overall Study|Physician Decision|5|||
42203430|NCT00075725|76016379|FG009|Overall Study|Physician Decision|0|||
42203431|NCT00075725|76016380|FG010|Overall Study|Physician Decision|1|||
42203432|NCT00075725|76016381|FG011|Overall Study|Physician Decision|0|||
42203433|NCT00075725|76016370|FG000|Overall Study|Pregnancy|0|||
42203434|NCT00075725|76016371|FG001|Overall Study|Pregnancy|0|||
42203435|NCT00075725|76016372|FG002|Overall Study|Pregnancy|0|||
42203436|NCT00075725|76016373|FG003|Overall Study|Pregnancy|0|||
42203437|NCT00075725|76016374|FG004|Overall Study|Pregnancy|0|||
42203438|NCT00075725|76016375|FG005|Overall Study|Pregnancy|1|||
42203439|NCT00075725|76016376|FG006|Overall Study|Pregnancy|0|||
42203440|NCT00075725|76016377|FG007|Overall Study|Pregnancy|1|||
42203441|NCT00075725|76016378|FG008|Overall Study|Pregnancy|0|||
42203442|NCT00075725|76016379|FG009|Overall Study|Pregnancy|0|||
42203443|NCT00075725|76016380|FG010|Overall Study|Pregnancy|0|||
42203444|NCT00075725|76016381|FG011|Overall Study|Pregnancy|0|||
42203445|NCT00075725|76016370|FG000|Overall Study|Protocol Violation|1|||
42203446|NCT00075725|76016371|FG001|Overall Study|Protocol Violation|1|||
42203447|NCT00075725|76016372|FG002|Overall Study|Protocol Violation|0|||
42203448|NCT00075725|76016373|FG003|Overall Study|Protocol Violation|3|||
42203449|NCT00075725|76016374|FG004|Overall Study|Protocol Violation|3|||
42203450|NCT00075725|76016375|FG005|Overall Study|Protocol Violation|2|||
42203451|NCT00075725|76016376|FG006|Overall Study|Protocol Violation|1|||
42203452|NCT00075725|76016377|FG007|Overall Study|Protocol Violation|2|||
42203453|NCT00075725|76016378|FG008|Overall Study|Protocol Violation|3|||
42203454|NCT00075725|76016379|FG009|Overall Study|Protocol Violation|0|||
42109553|NCT00606684|75920009|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
42109554|NCT00606684|75920010|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
42109555|NCT00606684|75920011|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
42109556|NCT00606684|75920012|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
42109557|NCT00606684|75920013|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
42109558|NCT00606684|75920007|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
42109559|NCT00606684|75920008|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
42109560|NCT00606684|75920009|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
42109561|NCT00606684|75920010|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
42109562|NCT00606684|75920011|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
42109563|NCT00606684|75920012|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
42109564|NCT00606684|75920013|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
42109565|NCT00606684|75920007|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
42109566|NCT00606684|75920008|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
42109567|NCT00606684|75920009|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
42109568|NCT00606684|75920010|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
42109569|NCT00606684|75920011|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
42109570|NCT00606684|75920012|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
42109571|NCT00606684|75920013|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
42109572|NCT00606684|75920007|FG000|Double-Blind Treatment Period|Physician Decision|0|||
42109573|NCT00606684|75920008|FG001|Double-Blind Treatment Period|Physician Decision|5|||
42109574|NCT00606684|75920009|FG002|Double-Blind Treatment Period|Physician Decision|1|||
42109575|NCT00606684|75920010|FG003|Double-Blind Treatment Period|Physician Decision|0|||
42109576|NCT00606684|75920011|FG004|Double-Blind Treatment Period|Physician Decision|3|||
42109577|NCT00606684|75920012|FG005|Double-Blind Treatment Period|Physician Decision|1|||
42109578|NCT00606684|75920013|FG006|Double-Blind Treatment Period|Physician Decision|2|||
42109579|NCT00606684|75920007|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42109580|NCT00606684|75920008|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
42109581|NCT00606684|75920009|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
42109582|NCT00606684|75920010|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
42109583|NCT00606684|75920011|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
42109584|NCT00606684|75920012|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
42109585|NCT00606684|75920013|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42109586|NCT00627926|75920030|FG000|Overall Study|Adverse Event|26|||
42109587|NCT00627926|75920031|FG001|Overall Study|Adverse Event|37|||
42109588|NCT00627926|75920032|FG002|Overall Study|Adverse Event|36|||
42109589|NCT00627926|75920030|FG000|Overall Study|Death|1|||
42109590|NCT00627926|75920031|FG001|Overall Study|Death|0|||
42109591|NCT00627926|75920032|FG002|Overall Study|Death|0|||
42109592|NCT00627926|75920030|FG000|Overall Study|Lost to Follow-up|4|||
42109593|NCT00627926|75920031|FG001|Overall Study|Lost to Follow-up|3|||
42109594|NCT00627926|75920032|FG002|Overall Study|Lost to Follow-up|4|||
42109595|NCT00627926|75920030|FG000|Overall Study|Withdrawal by Subject|2|||
42109596|NCT00627926|75920031|FG001|Overall Study|Withdrawal by Subject|1|||
42109597|NCT00627926|75920032|FG002|Overall Study|Withdrawal by Subject|0|||
42109598|NCT00627926|75920030|FG000|Overall Study|Lack of Efficacy|118|||
42109599|NCT00627926|75920031|FG001|Overall Study|Lack of Efficacy|40|||
42109600|NCT00627926|75920032|FG002|Overall Study|Lack of Efficacy|38|||
42109601|NCT00627926|75920030|FG000|Overall Study|Noncompliance/unspecified|8|||
42109602|NCT00627926|75920031|FG001|Overall Study|Noncompliance/unspecified|23|||
42109603|NCT00627926|75920032|FG002|Overall Study|Noncompliance/unspecified|17|||
42109604|NCT00228553|75920040|FG000|Overall Study|Adverse Event|112|||
42109605|NCT00228553|75920040|FG000|Overall Study|Lack of Efficacy|34|||
42109606|NCT00228553|75920040|FG000|Overall Study|Lost to Follow-up|67|||
42109607|NCT00228553|75920040|FG000|Overall Study|Physician Decision|48|||
42109608|NCT00228553|75920040|FG000|Overall Study|Protocol Violation|6|||
42109609|NCT00228553|75920040|FG000|Overall Study|Withdrawal by Subject|115|||
42109610|NCT00228553|75920040|FG000|Overall Study|Pregnancy|2|||
42109611|NCT00228553|75920040|FG000|Overall Study|Miscellaneous|46|||
42109612|NCT00643916|75920050|FG000|Overall Study|Protocol Violation|0|||
42109613|NCT00643916|75920051|FG001|Overall Study|Protocol Violation|1|||
42109614|NCT00643916|75920052|FG002|Overall Study|Protocol Violation|1|||
42109615|NCT00643916|75920053|FG003|Overall Study|Protocol Violation|1|||
42109616|NCT00643916|75920054|FG004|Overall Study|Protocol Violation|0|||
42109617|NCT00643916|75920055|FG005|Overall Study|Protocol Violation|0|||
42109618|NCT00643916|75920050|FG000|Overall Study|Lost to Follow-up|0|||
42203455|NCT00075725|76016380|FG010|Overall Study|Protocol Violation|0|||
42109619|NCT00643916|75920051|FG001|Overall Study|Lost to Follow-up|1|||
42109620|NCT00643916|75920052|FG002|Overall Study|Lost to Follow-up|0|||
42109621|NCT00643916|75920053|FG003|Overall Study|Lost to Follow-up|0|||
42109622|NCT00643916|75920054|FG004|Overall Study|Lost to Follow-up|0|||
42109623|NCT00643916|75920055|FG005|Overall Study|Lost to Follow-up|0|||
42109624|NCT00643916|75920050|FG000|Overall Study|Withdrawal by Subject|2|||
42109625|NCT00643916|75920051|FG001|Overall Study|Withdrawal by Subject|2|||
42109626|NCT00643916|75920052|FG002|Overall Study|Withdrawal by Subject|2|||
42109627|NCT00643916|75920053|FG003|Overall Study|Withdrawal by Subject|1|||
42109628|NCT00643916|75920054|FG004|Overall Study|Withdrawal by Subject|0|||
42109629|NCT00643916|75920055|FG005|Overall Study|Withdrawal by Subject|1|||
42109630|NCT00643916|75920050|FG000|Overall Study|Not Vaccinated|2|||
42109631|NCT00643916|75920051|FG001|Overall Study|Not Vaccinated|2|||
42109632|NCT00643916|75920052|FG002|Overall Study|Not Vaccinated|3|||
42109633|NCT00643916|75920053|FG003|Overall Study|Not Vaccinated|0|||
42109634|NCT00643916|75920054|FG004|Overall Study|Not Vaccinated|2|||
42109635|NCT00643916|75920055|FG005|Overall Study|Not Vaccinated|0|||
42109636|NCT00160693|75920069|FG000|Overall Study|Adverse Event|97|||
42109637|NCT00160693|75920069|FG000|Overall Study|Lack of Efficacy|30|||
42109638|NCT00160693|75920069|FG000|Overall Study|Protocol Violation|24|||
42109639|NCT00160693|75920069|FG000|Overall Study|Lost to Follow-up|15|||
42109640|NCT00160693|75920069|FG000|Overall Study|Withdrawal by Subject|54|||
42109641|NCT00160693|75920069|FG000|Overall Study|Study terminated by sponsor|15|||
42109642|NCT00643760|75920078|FG000|Overall Study|Adverse Event|11|||
42109643|NCT00643760|75920079|FG001|Overall Study|Adverse Event|5|||
42109644|NCT00643760|75920080|FG002|Overall Study|Adverse Event|12|||
42109645|NCT00643760|75920081|FG003|Overall Study|Adverse Event|21|||
42109646|NCT00643760|75920082|FG004|Overall Study|Adverse Event|6|||
42109647|NCT00643760|75920078|FG000|Overall Study|Lack of Efficacy|3|||
42109648|NCT00643760|75920079|FG001|Overall Study|Lack of Efficacy|1|||
42109649|NCT00643760|75920080|FG002|Overall Study|Lack of Efficacy|0|||
42109650|NCT00643760|75920081|FG003|Overall Study|Lack of Efficacy|4|||
42109651|NCT00643760|75920082|FG004|Overall Study|Lack of Efficacy|3|||
42109652|NCT00643760|75920078|FG000|Overall Study|Protocol Violation|7|||
42109653|NCT00643760|75920079|FG001|Overall Study|Protocol Violation|6|||
42109654|NCT00643760|75920080|FG002|Overall Study|Protocol Violation|4|||
42109655|NCT00643760|75920081|FG003|Overall Study|Protocol Violation|4|||
42109656|NCT00643760|75920082|FG004|Overall Study|Protocol Violation|6|||
42109657|NCT00643760|75920078|FG000|Overall Study|Lost to Follow-up|6|||
42109658|NCT00643760|75920079|FG001|Overall Study|Lost to Follow-up|2|||
42109659|NCT00643760|75920080|FG002|Overall Study|Lost to Follow-up|1|||
42109660|NCT00643760|75920081|FG003|Overall Study|Lost to Follow-up|3|||
42109661|NCT00643760|75920082|FG004|Overall Study|Lost to Follow-up|3|||
42109662|NCT00643760|75920078|FG000|Overall Study|Investigator Discretion|0|||
42109663|NCT00643760|75920079|FG001|Overall Study|Investigator Discretion|0|||
42109664|NCT00643760|75920080|FG002|Overall Study|Investigator Discretion|0|||
42109665|NCT00643760|75920081|FG003|Overall Study|Investigator Discretion|2|||
42109666|NCT00643760|75920082|FG004|Overall Study|Investigator Discretion|0|||
42109667|NCT00643760|75920078|FG000|Overall Study|Withdrawal by Subject|3|||
42109668|NCT00643760|75920079|FG001|Overall Study|Withdrawal by Subject|1|||
42109669|NCT00643760|75920080|FG002|Overall Study|Withdrawal by Subject|2|||
42109670|NCT00643760|75920081|FG003|Overall Study|Withdrawal by Subject|4|||
42109671|NCT00643760|75920082|FG004|Overall Study|Withdrawal by Subject|1|||
42109672|NCT00643682|75920096|FG000|Overall Study|did not keep appointment|522|||
42109673|NCT00643682|75920097|FG001|Overall Study|did not keep appointment|509|||
42109674|NCT00603798|75920106|FG000|Overall Study|Adverse Event|4|||
42109675|NCT00603798|75920107|FG001|Overall Study|Adverse Event|2|||
42109676|NCT00603798|75920108|FG002|Overall Study|Adverse Event|1|||
42109677|NCT00603798|75920106|FG000|Overall Study|Withdrawal by Subject|4|||
42109678|NCT00603798|75920107|FG001|Overall Study|Withdrawal by Subject|3|||
42109679|NCT00603798|75920108|FG002|Overall Study|Withdrawal by Subject|4|||
42109680|NCT00603798|75920106|FG000|Overall Study|Lost to Follow-up|1|||
42109681|NCT00603798|75920107|FG001|Overall Study|Lost to Follow-up|0|||
42109682|NCT00603798|75920108|FG002|Overall Study|Lost to Follow-up|1|||
42109683|NCT00603798|75920106|FG000|Overall Study|Non-compliance with study procedures|0|||
42109684|NCT00603798|75920107|FG001|Overall Study|Non-compliance with study procedures|1|||
42109685|NCT00603798|75920108|FG002|Overall Study|Non-compliance with study procedures|0|||
42109686|NCT00603798|75920106|FG000|Overall Study|Not due to AE|1|||
42109687|NCT00603798|75920107|FG001|Overall Study|Not due to AE|1|||
42109688|NCT00603798|75920108|FG002|Overall Study|Not due to AE|4|||
42109689|NCT00630812|75920118|FG000|Randomisation to First Dose|Adverse Event|1|||
42109690|NCT00630812|75920119|FG001|Randomisation to First Dose|Adverse Event|1|||
42109691|NCT00630812|75920118|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
42109692|NCT00630812|75920119|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
42109693|NCT00630812|75920118|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
42109694|NCT00630812|75920119|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
42109695|NCT00630812|75920118|FG000|Randomisation to First Dose|Protocol Violation|4|||
42109696|NCT00630812|75920119|FG001|Randomisation to First Dose|Protocol Violation|1|||
42109697|NCT00630812|75920118|FG000|Double Blind Treatment Period|Adverse Event|13|||
42109698|NCT00630812|75920119|FG001|Double Blind Treatment Period|Adverse Event|5|||
42109699|NCT00630812|75920118|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
42109700|NCT00630812|75920119|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
42109701|NCT00630812|75920118|FG000|Double Blind Treatment Period|Physician Decision|2|||
42109702|NCT00630812|75920119|FG001|Double Blind Treatment Period|Physician Decision|1|||
42109703|NCT00630812|75920118|FG000|Double Blind Treatment Period|Protocol Violation|1|||
42109704|NCT00630812|75920119|FG001|Double Blind Treatment Period|Protocol Violation|0|||
42109705|NCT00630812|75920118|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
42109706|NCT00630812|75920119|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
42109707|NCT00630812|75920118|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
42109708|NCT00630812|75920119|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
42109709|NCT00630812|75920118|FG000|Double Blind Treatment Period|Non-compliance|0|||
42109710|NCT00630812|75920119|FG001|Double Blind Treatment Period|Non-compliance|1|||
42109711|NCT00629798|75920125|FG000|Overall Study|Not Treated|4|||
42109712|NCT00160615|75920131|FG000|Overall Study|Adverse Event|5|||
42109713|NCT00160615|75920132|FG001|Overall Study|Adverse Event|12|||
42109714|NCT00160615|75920131|FG000|Overall Study|Withdrawal by Subject|0|||
42109715|NCT00160615|75920132|FG001|Overall Study|Withdrawal by Subject|2|||
42109716|NCT00160615|75920131|FG000|Overall Study|Lack of Efficacy|11|||
42109717|NCT00160615|75920132|FG001|Overall Study|Lack of Efficacy|23|||
42109718|NCT00160615|75920131|FG000|Overall Study|Patient decision|1|||
42109719|NCT00160615|75920132|FG001|Overall Study|Patient decision|2|||
42109720|NCT00160615|75920131|FG000|Overall Study|Investigator decision|1|||
42109721|NCT00160615|75920132|FG001|Overall Study|Investigator decision|1|||
42109722|NCT00160615|75920131|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
42109723|NCT00160615|75920132|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
42109724|NCT00160615|75920131|FG000|Overall Study|Switch to surgical treatment|0|||
42109725|NCT00160615|75920132|FG001|Overall Study|Switch to surgical treatment|2|||
42109726|NCT00160615|75920131|FG000|Overall Study|Non-compliance was suspected|0|||
42109727|NCT00160615|75920132|FG001|Overall Study|Non-compliance was suspected|1|||
42109728|NCT00160615|75920131|FG000|Overall Study|Poor compliance|0|||
42109729|NCT00160615|75920132|FG001|Overall Study|Poor compliance|1|||
42109730|NCT00643448|75920143|FG000|Overall Study|Lack of Efficacy|2|||
42109731|NCT00643448|75920144|FG001|Overall Study|Lack of Efficacy|0|||
42109732|NCT00643448|75920145|FG002|Overall Study|Lack of Efficacy|4|||
42109733|NCT00643448|75920143|FG000|Overall Study|Adverse Event|2|||
42109734|NCT00643448|75920144|FG001|Overall Study|Adverse Event|2|||
42109735|NCT00643448|75920145|FG002|Overall Study|Adverse Event|2|||
42109736|NCT00643448|75920143|FG000|Overall Study|QTcF>550 ms|0|||
42109737|NCT00643448|75920144|FG001|Overall Study|QTcF>550 ms|3|||
42109738|NCT00643448|75920145|FG002|Overall Study|QTcF>550 ms|0|||
42109739|NCT00604500|75920155|FG000|Overall Study|Adverse Event|2|||
42109740|NCT00604500|75920155|FG000|Overall Study|Protocol Violation|2|||
42109741|NCT00604500|75920155|FG000|Overall Study|Treatment Failure|1|||
42109742|NCT00604500|75920155|FG000|Overall Study|Withdrawal by Subject|4|||
42109743|NCT00604500|75920155|FG000|Overall Study|Administrative|1|||
42109744|NCT00604500|75920155|FG000|Overall Study|Did not meet protocol eligibility|1|||
42109745|NCT00627458|75920162|FG000|Overall Study|Migrated from study area|1|||
42109746|NCT00627458|75920163|FG001|Overall Study|Migrated from study area|0|||
42109747|NCT00627458|75920164|FG002|Overall Study|Migrated from study area|1|||
42109748|NCT00627458|75920162|FG000|Overall Study|Withdrawal by Subject|2|||
42109749|NCT00627458|75920163|FG001|Overall Study|Withdrawal by Subject|6|||
42109750|NCT00627458|75920164|FG002|Overall Study|Withdrawal by Subject|5|||
42109751|NCT00627458|75920162|FG000|Overall Study|Lost to Follow-up|1|||
42109752|NCT00627458|75920163|FG001|Overall Study|Lost to Follow-up|1|||
42109753|NCT00627458|75920164|FG002|Overall Study|Lost to Follow-up|0|||
42109754|NCT00542919|75920176|FG000|Overall Study|Adverse Event|1|||
42109755|NCT00542919|75920177|FG001|Overall Study|Adverse Event|5|||
42109756|NCT00542919|75920178|FG002|Overall Study|Adverse Event|1|||
42109757|NCT00542919|75920176|FG000|Overall Study|Withdrawal by Subject|1|||
42109758|NCT00542919|75920177|FG001|Overall Study|Withdrawal by Subject|0|||
42109759|NCT00542919|75920178|FG002|Overall Study|Withdrawal by Subject|3|||
42109760|NCT00542919|75920176|FG000|Overall Study|Physician Decision|2|||
42109761|NCT00542919|75920177|FG001|Overall Study|Physician Decision|2|||
42109762|NCT00542919|75920178|FG002|Overall Study|Physician Decision|1|||
42109763|NCT00542919|75920176|FG000|Overall Study|Sponsor Decision|1|||
42109764|NCT00542919|75920177|FG001|Overall Study|Sponsor Decision|0|||
42109765|NCT00542919|75920178|FG002|Overall Study|Sponsor Decision|0|||
42109766|NCT00542919|75920176|FG000|Overall Study|Lost to Follow-up|2|||
42109767|NCT00542919|75920177|FG001|Overall Study|Lost to Follow-up|0|||
42109768|NCT00542919|75920178|FG002|Overall Study|Lost to Follow-up|1|||
42109769|NCT00159913|75920205|FG000|Overall Study|Adverse Event|1|||
42109770|NCT00159913|75920206|FG001|Overall Study|Adverse Event|0|||
42109771|NCT00159913|75920207|FG002|Overall Study|Adverse Event|1|||
42109772|NCT00159913|75920208|FG003|Overall Study|Adverse Event|0|||
42109773|NCT00159913|75920205|FG000|Overall Study|Withdrawal by Subject|0|||
42109774|NCT00159913|75920206|FG001|Overall Study|Withdrawal by Subject|0|||
42203456|NCT00075725|76016381|FG011|Overall Study|Protocol Violation|1|||
42203457|NCT00075725|76016370|FG000|Overall Study|Withdrawal by Subject|12|||
42109775|NCT00159913|75920207|FG002|Overall Study|Withdrawal by Subject|0|||
42203458|NCT00075725|76016371|FG001|Overall Study|Withdrawal by Subject|3|||
42109776|NCT00159913|75920208|FG003|Overall Study|Withdrawal by Subject|1|||
42109777|NCT00159913|75920205|FG000|Overall Study|Lost to Follow-up|0|||
42109778|NCT00159913|75920206|FG001|Overall Study|Lost to Follow-up|0|||
42109779|NCT00159913|75920207|FG002|Overall Study|Lost to Follow-up|0|||
42109780|NCT00159913|75920208|FG003|Overall Study|Lost to Follow-up|1|||
42109781|NCT00159913|75920205|FG000|Overall Study|Protocol Violation|1|||
42109782|NCT00159913|75920206|FG001|Overall Study|Protocol Violation|0|||
42109783|NCT00159913|75920207|FG002|Overall Study|Protocol Violation|1|||
42109784|NCT00159913|75920208|FG003|Overall Study|Protocol Violation|0|||
42109785|NCT00604188|75920222|FG000|Overall Study|Adverse Event|1|||
42109786|NCT00604188|75920223|FG001|Overall Study|Adverse Event|4|||
42109787|NCT00604188|75920222|FG000|Overall Study|Lost to Follow-up|17|||
42109788|NCT00604188|75920223|FG001|Overall Study|Lost to Follow-up|15|||
42109789|NCT00604188|75920222|FG000|Overall Study|Withdrawal by Subject|5|||
42109790|NCT00604188|75920223|FG001|Overall Study|Withdrawal by Subject|1|||
42109791|NCT00604188|75920222|FG000|Overall Study|Non-compliance with protocol|4|||
42109792|NCT00604188|75920223|FG001|Overall Study|Non-compliance with protocol|4|||
42109793|NCT00604188|75920222|FG000|Overall Study|Did not receive study drug|0|||
42109794|NCT00604188|75920223|FG001|Overall Study|Did not receive study drug|1|||
42109795|NCT03913377|75920231|FG000|Period 1|Test Article no longer available|0|||
42109796|NCT03913377|75920232|FG001|Period 1|Test Article no longer available|1|||
42109797|NCT03913377|75920233|FG002|Period 1|Test Article no longer available|0|||
42109798|NCT03913377|75920231|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
42109799|NCT03913377|75920232|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
42109800|NCT03913377|75920233|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
42109801|NCT00227539|75920240|FG000|Overall Study|Protocol Violation|1|||
42109802|NCT00227305|75920244|FG000|Overall Study|Adverse Event|40|||
42109803|NCT00227305|75920244|FG000|Overall Study|Withdrawal by Subject|42|||
42109804|NCT00227305|75920244|FG000|Overall Study|Lost to Follow-up|33|||
42109805|NCT00227305|75920244|FG000|Overall Study|Study specific discontinuation|13|||
42109806|NCT00227305|75920244|FG000|Overall Study|MOVED OUT OF AREA|3|||
42109807|NCT00227305|75920244|FG000|Overall Study|Lack of Efficacy|7|||
42109808|NCT00227305|75920244|FG000|Overall Study|Physician Decision|3|||
42109809|NCT00227305|75920244|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
42109810|NCT00227305|75920244|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
42109811|NCT00227305|75920244|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
42109812|NCT00720941|75920250|FG000|Overall Study|Death|334|||
42109813|NCT00720941|75920251|FG001|Overall Study|Death|335|||
42109814|NCT00720941|75920250|FG000|Overall Study|Protocol Violation|0|||
42109815|NCT00720941|75920251|FG001|Overall Study|Protocol Violation|2|||
42109816|NCT00720941|75920250|FG000|Overall Study|Lost to Follow-up|17|||
42109817|NCT00720941|75920251|FG001|Overall Study|Lost to Follow-up|15|||
42109818|NCT00720941|75920250|FG000|Overall Study|Physician Decision|1|||
42109819|NCT00720941|75920251|FG001|Overall Study|Physician Decision|5|||
42109820|NCT00720941|75920250|FG000|Overall Study|Withdrawal by Subject|27|||
42109821|NCT00720941|75920251|FG001|Overall Study|Withdrawal by Subject|35|||
42109822|NCT00720941|75920250|FG000|Overall Study|Ongoing|34|||
42109823|NCT00720941|75920251|FG001|Overall Study|Ongoing|23|||
42109824|NCT00585533|75920257|FG000|Overall Study|objective or symptomatic progression|9|||
42109825|NCT00628862|75920264|FG000|Overall Study|Adverse Event|6|||
42109826|NCT00628862|75920265|FG001|Overall Study|Adverse Event|8|||
42109827|NCT00628862|75920266|FG002|Overall Study|Adverse Event|10|||
42109828|NCT00628862|75920264|FG000|Overall Study|Withdrawal by Subject|4|||
42109829|NCT00628862|75920265|FG001|Overall Study|Withdrawal by Subject|6|||
42109830|NCT00628862|75920266|FG002|Overall Study|Withdrawal by Subject|11|||
42109831|NCT00628862|75920264|FG000|Overall Study|Lost to Follow-up|0|||
42109832|NCT00628862|75920265|FG001|Overall Study|Lost to Follow-up|2|||
42109833|NCT00628862|75920266|FG002|Overall Study|Lost to Follow-up|1|||
42109834|NCT00628862|75920264|FG000|Overall Study|Protocol Violation|1|||
42109835|NCT00628862|75920265|FG001|Overall Study|Protocol Violation|0|||
42109836|NCT00628862|75920266|FG002|Overall Study|Protocol Violation|0|||
42109837|NCT00628862|75920264|FG000|Overall Study|COPD Exacerbation|0|||
42109838|NCT00628862|75920265|FG001|Overall Study|COPD Exacerbation|1|||
42109839|NCT00628862|75920266|FG002|Overall Study|COPD Exacerbation|0|||
42109840|NCT00584987|75920278|FG000|Overall Study|Protocol Violation|1|||
42203459|NCT00075725|76016372|FG002|Overall Study|Withdrawal by Subject|6|||
42203460|NCT00075725|76016373|FG003|Overall Study|Withdrawal by Subject|10|||
42109841|NCT00584987|75920279|FG001|Overall Study|Protocol Violation|1|||
42109842|NCT00584987|75920280|FG002|Overall Study|Protocol Violation|1|||
42109843|NCT00584987|75920281|FG003|Overall Study|Protocol Violation|0|||
42109844|NCT00584987|75920278|FG000|Overall Study|Adverse Event|0|||
42109845|NCT00584987|75920279|FG001|Overall Study|Adverse Event|0|||
42109846|NCT00584987|75920280|FG002|Overall Study|Adverse Event|0|||
42109847|NCT00584987|75920281|FG003|Overall Study|Adverse Event|1|||
42109848|NCT00727961|75920291|FG000|Overall Study|Lost to Follow-up|1|||
42109849|NCT00727961|75920291|FG000|Overall Study|Adverse Event|4|||
42109850|NCT00727961|75920291|FG000|Overall Study|Patient's refusal|2|||
42109851|NCT00727961|75920291|FG000|Overall Study|Progression|30|||
42203461|NCT00075725|76016374|FG004|Overall Study|Withdrawal by Subject|6|||
42109852|NCT00568958|75920297|FG000|Allocation|Withdrawal by Subject|7|||
42109853|NCT00568958|75920298|FG001|Allocation|Withdrawal by Subject|3|||
42109854|NCT00568958|75920297|FG000|Allocation|Physician Decision|2|||
42109855|NCT00568958|75920298|FG001|Allocation|Physician Decision|0|||
42109856|NCT00568958|75920297|FG000|Follow-Up|Withdrawal by Subject|6|||
42109857|NCT00568958|75920298|FG001|Follow-Up|Withdrawal by Subject|6|||
42109858|NCT00568958|75920297|FG000|Follow-Up|Physician Decision|1|||
42109859|NCT00568958|75920298|FG001|Follow-Up|Physician Decision|1|||
42109860|NCT00568958|75920297|FG000|Follow-Up|Family Emergency|1|||
42109861|NCT00568958|75920298|FG001|Follow-Up|Family Emergency|0|||
42109862|NCT00568958|75920297|FG000|Follow-Up|Adverse Event|1|||
42109863|NCT00568958|75920298|FG001|Follow-Up|Adverse Event|0|||
42109864|NCT00727649|75920306|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
42109865|NCT00727649|75920307|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
42109866|NCT00727649|75920306|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
42109867|NCT00727649|75920307|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
42109868|NCT00727649|75920306|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
42109869|NCT00727649|75920307|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
42109870|NCT00727649|75920306|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
42109871|NCT00727649|75920307|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
42109872|NCT00727649|75920306|FG000|Second Intervention (4-weeks)|Death|1|||
42109873|NCT00727649|75920307|FG001|Second Intervention (4-weeks)|Death|0|||
42109874|NCT00727649|75920306|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
42109875|NCT00727649|75920307|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
42109876|NCT00727649|75920306|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
42109877|NCT00727649|75920307|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
42109878|NCT00568334|75920317|FG000|Overall Study|Withdrawal by Subject|0|||
42109879|NCT00568334|75920318|FG001|Overall Study|Withdrawal by Subject|1|||
42109880|NCT00568334|75920317|FG000|Overall Study|Lost to Follow-up|1|||
42109881|NCT00568334|75920318|FG001|Overall Study|Lost to Follow-up|0|||
42109882|NCT00727571|75920328|FG000|Overall Study|Ineligibility determined|1|||
42109883|NCT00727571|75920329|FG001|Overall Study|Ineligibility determined|1|||
42109884|NCT00727571|75920330|FG002|Overall Study|Ineligibility determined|1|||
42109885|NCT00727571|75920331|FG003|Overall Study|Ineligibility determined|0|||
42109886|NCT00727571|75920328|FG000|Overall Study|Death|0|||
42109887|NCT00727571|75920329|FG001|Overall Study|Death|19|||
42109888|NCT00727571|75920330|FG002|Overall Study|Death|5|||
42109889|NCT00727571|75920331|FG003|Overall Study|Death|1|||
42109890|NCT00727571|75920328|FG000|Overall Study|Physician Decision|0|||
42109891|NCT00727571|75920329|FG001|Overall Study|Physician Decision|5|||
42109892|NCT00727571|75920330|FG002|Overall Study|Physician Decision|0|||
42109893|NCT00727571|75920331|FG003|Overall Study|Physician Decision|0|||
42109894|NCT00727571|75920328|FG000|Overall Study|Withdrawal by Subject|0|||
42109895|NCT00727571|75920329|FG001|Overall Study|Withdrawal by Subject|10|||
42109896|NCT00727571|75920330|FG002|Overall Study|Withdrawal by Subject|11|||
42109897|NCT00727571|75920331|FG003|Overall Study|Withdrawal by Subject|0|||
42109898|NCT00727571|75920328|FG000|Overall Study|Subject Non Compliance|0|||
42109899|NCT00727571|75920329|FG001|Overall Study|Subject Non Compliance|6|||
42109900|NCT00727571|75920330|FG002|Overall Study|Subject Non Compliance|0|||
42109901|NCT00727571|75920331|FG003|Overall Study|Subject Non Compliance|4|||
42109902|NCT00727571|75920328|FG000|Overall Study|Dismissed from nursing home|0|||
42109903|NCT00727571|75920329|FG001|Overall Study|Dismissed from nursing home|9|||
42109904|NCT00727571|75920330|FG002|Overall Study|Dismissed from nursing home|5|||
42109905|NCT00727571|75920331|FG003|Overall Study|Dismissed from nursing home|0|||
42109906|NCT00727571|75920328|FG000|Overall Study|Hospitalization|0|||
42109907|NCT00727571|75920329|FG001|Overall Study|Hospitalization|1|||
42109908|NCT00727571|75920330|FG002|Overall Study|Hospitalization|0|||
42109909|NCT00727571|75920331|FG003|Overall Study|Hospitalization|1|||
42109910|NCT00727571|75920328|FG000|Overall Study|AE not leading to hospitalization|0|||
42109911|NCT00727571|75920329|FG001|Overall Study|AE not leading to hospitalization|0|||
42203462|NCT00075725|76016375|FG005|Overall Study|Withdrawal by Subject|27|||
42109912|NCT00727571|75920330|FG002|Overall Study|AE not leading to hospitalization|2|||
42109913|NCT00727571|75920331|FG003|Overall Study|AE not leading to hospitalization|0|||
42109914|NCT00727571|75920328|FG000|Overall Study|Other|0|||
42109915|NCT00727571|75920329|FG001|Overall Study|Other|4|||
42109916|NCT00727571|75920330|FG002|Overall Study|Other|6|||
42109917|NCT00727571|75920331|FG003|Overall Study|Other|0|||
42109918|NCT00225277|75920343|FG000|Overall Study|Adverse Event|30|||
42109919|NCT00225277|75920344|FG001|Overall Study|Adverse Event|34|||
42109920|NCT00225277|75920343|FG000|Overall Study|Lack of Efficacy|4|||
42109921|NCT00225277|75920344|FG001|Overall Study|Lack of Efficacy|1|||
42109922|NCT00225277|75920343|FG000|Overall Study|Lost to Follow-up|4|||
42109923|NCT00225277|75920344|FG001|Overall Study|Lost to Follow-up|6|||
42109924|NCT00225277|75920343|FG000|Overall Study|Physician Decision|6|||
42109925|NCT00225277|75920344|FG001|Overall Study|Physician Decision|8|||
42109926|NCT00225277|75920343|FG000|Overall Study|Protocol Violation|6|||
42203463|NCT00075725|76016376|FG006|Overall Study|Withdrawal by Subject|7|||
42109927|NCT00225277|75920344|FG001|Overall Study|Protocol Violation|3|||
42109928|NCT00225277|75920343|FG000|Overall Study|Withdrawal by Subject|40|||
42109929|NCT00225277|75920344|FG001|Overall Study|Withdrawal by Subject|34|||
42109930|NCT00225277|75920343|FG000|Overall Study|Other|7|||
42109931|NCT00225277|75920344|FG001|Overall Study|Other|9|||
42109932|NCT00567996|75920353|FG000|Overall Study|Adverse Event|18|||
42109933|NCT00567996|75920354|FG001|Overall Study|Adverse Event|16|||
42109934|NCT00567996|75920355|FG002|Overall Study|Adverse Event|13|||
42109935|NCT00567996|75920353|FG000|Overall Study|Protocol Deviation|9|||
42109936|NCT00567996|75920354|FG001|Overall Study|Protocol Deviation|11|||
42109937|NCT00567996|75920355|FG002|Overall Study|Protocol Deviation|13|||
42109938|NCT00567996|75920353|FG000|Overall Study|Withdrawal by Subject|8|||
42109939|NCT00567996|75920354|FG001|Overall Study|Withdrawal by Subject|12|||
42109940|NCT00567996|75920355|FG002|Overall Study|Withdrawal by Subject|22|||
42109941|NCT00567996|75920353|FG000|Overall Study|Abnormal Lab value(s)|2|||
42109942|NCT00567996|75920354|FG001|Overall Study|Abnormal Lab value(s)|1|||
42109943|NCT00567996|75920355|FG002|Overall Study|Abnormal Lab value(s)|2|||
42109944|NCT00567996|75920353|FG000|Overall Study|Abnormal test procedure result(s)|2|||
42109945|NCT00567996|75920354|FG001|Overall Study|Abnormal test procedure result(s)|1|||
42109946|NCT00567996|75920355|FG002|Overall Study|Abnormal test procedure result(s)|1|||
42109947|NCT00567996|75920353|FG000|Overall Study|Lost to Follow-up|2|||
42109948|NCT00567996|75920354|FG001|Overall Study|Lost to Follow-up|5|||
42109949|NCT00567996|75920355|FG002|Overall Study|Lost to Follow-up|2|||
42109950|NCT00567996|75920353|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
42109951|NCT00567996|75920354|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42109952|NCT00567996|75920355|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
42109953|NCT00567996|75920353|FG000|Overall Study|Administrative problems|1|||
42109954|NCT00567996|75920354|FG001|Overall Study|Administrative problems|1|||
42109955|NCT00567996|75920355|FG002|Overall Study|Administrative problems|0|||
42109956|NCT00567996|75920353|FG000|Overall Study|Death|1|||
42109957|NCT00567996|75920354|FG001|Overall Study|Death|0|||
42109958|NCT00567996|75920355|FG002|Overall Study|Death|2|||
42109959|NCT00567996|75920353|FG000|Overall Study|Patient's inability to use the device|0|||
42109960|NCT00567996|75920354|FG001|Overall Study|Patient's inability to use the device|1|||
42109961|NCT00567996|75920355|FG002|Overall Study|Patient's inability to use the device|0|||
42109962|NCT00224887|75920369|FG000|Overall Study|Pregnancy|6|||
42109963|NCT00224887|75920370|FG001|Overall Study|Pregnancy|6|||
42109964|NCT00148759|75920378|FG000|Overall Study|Withdrawal by Subject|1|||
42109965|NCT00148759|75920379|FG001|Overall Study|Withdrawal by Subject|1|||
42109966|NCT00148759|75920378|FG000|Overall Study|Lost to Follow-up|1|||
42109967|NCT00148759|75920379|FG001|Overall Study|Lost to Follow-up|0|||
42109968|NCT00717275|75920385|FG000|Overall Study|Premature study termination.|3|||
42109969|NCT00584909|75920389|FG000|Overall Study|Adverse Event|4|||
42109970|NCT00147823|75920395|FG000|Overall Study|Lost to Follow-up|6|||
42109971|NCT00147823|75920396|FG001|Overall Study|Lost to Follow-up|12|||
42109972|NCT00147823|75920395|FG000|Overall Study|Physician Decision|1|||
42109973|NCT00147823|75920396|FG001|Overall Study|Physician Decision|0|||
42109974|NCT00147823|75920395|FG000|Overall Study|Withdrawal by Subject|0|||
42109975|NCT00147823|75920396|FG001|Overall Study|Withdrawal by Subject|1|||
42109976|NCT00147823|75920395|FG000|Overall Study|Did not receive vitoss due to infection|6|||
42109977|NCT00147823|75920396|FG001|Overall Study|Did not receive vitoss due to infection|2|||
42109978|NCT00717197|75920402|FG000|Overall Study|Unable to purchase study drug|5|||
42109979|NCT00717197|75920402|FG000|Overall Study|Tumor Progression|1|||
42109980|NCT00717197|75920402|FG000|Overall Study|Physician Decision|1|||
42109981|NCT00147745|75920409|FG000|Overall Study|Withdrawal by Subject|1|||
42109982|NCT00147745|75920410|FG001|Overall Study|Withdrawal by Subject|0|||
42109983|NCT00147745|75920411|FG002|Overall Study|Withdrawal by Subject|0|||
42109984|NCT00642902|75920423|FG000|Overall Study|Adverse Event|0|||
42109985|NCT00642902|75920424|FG001|Overall Study|Adverse Event|1|||
42109986|NCT00642902|75920425|FG002|Overall Study|Adverse Event|3|||
42109987|NCT00642902|75920426|FG003|Overall Study|Adverse Event|1|||
42109988|NCT00642902|75920423|FG000|Overall Study|Lost to Follow-up|1|||
42109989|NCT00642902|75920424|FG001|Overall Study|Lost to Follow-up|1|||
42109990|NCT00642902|75920425|FG002|Overall Study|Lost to Follow-up|0|||
42109991|NCT00642902|75920426|FG003|Overall Study|Lost to Follow-up|0|||
42109992|NCT00642902|75920423|FG000|Overall Study|Lack of Efficacy|0|||
42109993|NCT00642902|75920424|FG001|Overall Study|Lack of Efficacy|3|||
42109994|NCT00642902|75920425|FG002|Overall Study|Lack of Efficacy|3|||
42109995|NCT00642902|75920426|FG003|Overall Study|Lack of Efficacy|0|||
42109996|NCT00642902|75920423|FG000|Overall Study|Death|1|||
42109997|NCT00642902|75920424|FG001|Overall Study|Death|0|||
42109998|NCT00642902|75920425|FG002|Overall Study|Death|0|||
42109999|NCT00642902|75920426|FG003|Overall Study|Death|0|||
42203464|NCT00075725|76016377|FG007|Overall Study|Withdrawal by Subject|31|||
42203465|NCT00075725|76016378|FG008|Overall Study|Withdrawal by Subject|10|||
42110000|NCT00642902|75920423|FG000|Overall Study|Premature termination of clinical trial|37|||
42203466|NCT00075725|76016379|FG009|Overall Study|Withdrawal by Subject|2|||
42110001|NCT00642902|75920424|FG001|Overall Study|Premature termination of clinical trial|32|||
42110002|NCT00642902|75920425|FG002|Overall Study|Premature termination of clinical trial|35|||
42110003|NCT00642902|75920426|FG003|Overall Study|Premature termination of clinical trial|35|||
42110004|NCT00642902|75920423|FG000|Overall Study|Randomized, but not treated|0|||
42110005|NCT00642902|75920424|FG001|Overall Study|Randomized, but not treated|0|||
42110006|NCT00642902|75920425|FG002|Overall Study|Randomized, but not treated|1|||
42110007|NCT00642902|75920426|FG003|Overall Study|Randomized, but not treated|0|||
42110008|NCT00642902|75920423|FG000|Overall Study|Other|1|||
42110009|NCT00642902|75920424|FG001|Overall Study|Other|5|||
42110010|NCT00642902|75920425|FG002|Overall Study|Other|1|||
42110011|NCT00642902|75920426|FG003|Overall Study|Other|4|||
42110012|NCT00224107|75920438|FG000|Overall Study|Adverse Event|20|||
42110013|NCT00224107|75920439|FG001|Overall Study|Adverse Event|6|||
42110014|NCT00224107|75920438|FG000|Overall Study|Protocol Violation|2|||
42110015|NCT00224107|75920439|FG001|Overall Study|Protocol Violation|3|||
42110016|NCT00224107|75920438|FG000|Overall Study|Withdrawal by Subject|1|||
42110017|NCT00224107|75920439|FG001|Overall Study|Withdrawal by Subject|4|||
42110018|NCT00224107|75920438|FG000|Overall Study|Lack of Efficacy|2|||
42110019|NCT00224107|75920439|FG001|Overall Study|Lack of Efficacy|0|||
42110020|NCT00224107|75920438|FG000|Overall Study|Lost to Follow-up|4|||
42110021|NCT00224107|75920439|FG001|Overall Study|Lost to Follow-up|0|||
42110022|NCT00224107|75920438|FG000|Overall Study|Physician Decision|1|||
42110023|NCT00224107|75920439|FG001|Overall Study|Physician Decision|0|||
42110024|NCT00224107|75920438|FG000|Overall Study|Other|1|||
42110025|NCT00224107|75920439|FG001|Overall Study|Other|1|||
42110026|NCT00720083|75920447|FG000|Overall Study|Ineligible|1|||
42110027|NCT00720083|75920448|FG001|Overall Study|Ineligible|2|||
42110028|NCT00209131|75920456|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
42110029|NCT00209131|75920457|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
42110030|NCT00224029|75920463|FG000|Overall Study|Lost to Follow-up|1|||
42110031|NCT00224029|75920463|FG000|Overall Study|Withdrawal by Subject|4|||
42110032|NCT00224029|75920463|FG000|Overall Study|Other|1|||
42110033|NCT00223795|75920467|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
42110034|NCT00223795|75920468|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
42110035|NCT00223795|75920467|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
42110036|NCT00223795|75920468|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
42110037|NCT00719849|75920477|FG000|Overall Study|Death|0|||
42110038|NCT00719849|75920478|FG001|Overall Study|Death|1|||
42110039|NCT03907683|75920484|FG000|Overall Study|Pregnancy|1|||
42110040|NCT03907683|75920484|FG000|Overall Study|Withdrawal by Subject|1|||
42110041|NCT00626522|75920494|FG000|Overall Study|Protocol Violation|0|||
42110042|NCT00626522|75920495|FG001|Overall Study|Protocol Violation|0|||
42110043|NCT00626522|75920496|FG002|Overall Study|Protocol Violation|0|||
42110044|NCT00626522|75920497|FG003|Overall Study|Protocol Violation|0|||
42110045|NCT00626522|75920498|FG004|Overall Study|Protocol Violation|1|||
42110046|NCT00626522|75920499|FG005|Overall Study|Protocol Violation|0|||
42110047|NCT00626522|75920494|FG000|Overall Study|Adverse Event|2|||
42110048|NCT00626522|75920495|FG001|Overall Study|Adverse Event|1|||
42110049|NCT00626522|75920496|FG002|Overall Study|Adverse Event|2|||
42110050|NCT00626522|75920497|FG003|Overall Study|Adverse Event|0|||
42110051|NCT00626522|75920498|FG004|Overall Study|Adverse Event|1|||
42110052|NCT00626522|75920499|FG005|Overall Study|Adverse Event|1|||
42110053|NCT00626522|75920494|FG000|Overall Study|Withdrawal by Subject|2|||
42110054|NCT00626522|75920495|FG001|Overall Study|Withdrawal by Subject|5|||
42110055|NCT00626522|75920496|FG002|Overall Study|Withdrawal by Subject|5|||
42110056|NCT00626522|75920497|FG003|Overall Study|Withdrawal by Subject|0|||
42110057|NCT00626522|75920498|FG004|Overall Study|Withdrawal by Subject|4|||
42110058|NCT00626522|75920499|FG005|Overall Study|Withdrawal by Subject|1|||
42110059|NCT00626522|75920494|FG000|Overall Study|COPD exacerbation|0|||
42110060|NCT00626522|75920495|FG001|Overall Study|COPD exacerbation|0|||
42110061|NCT00626522|75920496|FG002|Overall Study|COPD exacerbation|0|||
42110062|NCT00626522|75920497|FG003|Overall Study|COPD exacerbation|1|||
42110063|NCT00626522|75920498|FG004|Overall Study|COPD exacerbation|1|||
42110064|NCT00626522|75920499|FG005|Overall Study|COPD exacerbation|0|||
42110065|NCT00626522|75920494|FG000|Overall Study|Lost to Follow-up|0|||
42110066|NCT00626522|75920495|FG001|Overall Study|Lost to Follow-up|1|||
42110067|NCT00626522|75920496|FG002|Overall Study|Lost to Follow-up|0|||
42110068|NCT00626522|75920497|FG003|Overall Study|Lost to Follow-up|0|||
42110069|NCT00626522|75920498|FG004|Overall Study|Lost to Follow-up|0|||
42110070|NCT00626522|75920499|FG005|Overall Study|Lost to Follow-up|0|||
42110071|NCT00626522|75920494|FG000|Overall Study|Inconsistent reason reported|1|||
42110072|NCT00626522|75920495|FG001|Overall Study|Inconsistent reason reported|0|||
42110073|NCT00626522|75920496|FG002|Overall Study|Inconsistent reason reported|0|||
42110074|NCT00626522|75920497|FG003|Overall Study|Inconsistent reason reported|0|||
42110075|NCT00626522|75920498|FG004|Overall Study|Inconsistent reason reported|0|||
42110076|NCT00626522|75920499|FG005|Overall Study|Inconsistent reason reported|0|||
42110077|NCT00626522|75920494|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
42110078|NCT00626522|75920495|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
42110079|NCT00626522|75920496|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
42110080|NCT00626522|75920497|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
42110081|NCT00626522|75920498|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
42110082|NCT00626522|75920499|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
42110083|NCT00540423|75920524|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42110084|NCT00540423|75920525|FG001|Double-Blind Treatment Period|Adverse Event|1|||
42110085|NCT00540423|75920526|FG002|Double-Blind Treatment Period|Adverse Event|0|||
42110086|NCT00540423|75920524|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
42110087|NCT00540423|75920525|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
42110088|NCT00540423|75920526|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
42110089|NCT00566982|75920546|FG000|Overall Study|Adverse Event|6|||
42110090|NCT00566982|75920547|FG001|Overall Study|Adverse Event|48|||
42110091|NCT00566982|75920546|FG000|Overall Study|Withdrawal by Subject|1|||
42110092|NCT00566982|75920547|FG001|Overall Study|Withdrawal by Subject|14|||
42110093|NCT00566982|75920546|FG000|Overall Study|Protocol Violation|1|||
42110094|NCT00566982|75920547|FG001|Overall Study|Protocol Violation|4|||
42110095|NCT00566982|75920546|FG000|Overall Study|Lost to Follow-up|0|||
42110096|NCT00566982|75920547|FG001|Overall Study|Lost to Follow-up|1|||
42110097|NCT00566982|75920546|FG000|Overall Study|Other-family problems & doctor's request|0|||
42110098|NCT00566982|75920547|FG001|Overall Study|Other-family problems & doctor's request|2|||
42110099|NCT00624338|75920559|FG000|Overall Study|Adverse Event|14|||
42110100|NCT00624338|75920560|FG001|Overall Study|Adverse Event|14|||
42110101|NCT00624338|75920561|FG002|Overall Study|Adverse Event|18|||
42110102|NCT00624338|75920559|FG000|Overall Study|Lost to Follow-up|1|||
42382974|NCT01396057|76257423|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
42382975|NCT01396057|76257424|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
42382976|NCT01396057|76257423|FG000|Overall Study|Protocol deviation|4|||
42382977|NCT01396057|76257424|FG001|Overall Study|Protocol deviation|4|||
42382978|NCT01396057|76257423|FG000|Overall Study|Consent withdrawn|3|||
42382979|NCT01396057|76257424|FG001|Overall Study|Consent withdrawn|2|||
42382980|NCT01380769|76257441|FG000|Overall Study|Withdrawal by Subject|7|||
42382981|NCT01380769|76257442|FG001|Overall Study|Withdrawal by Subject|11|||
42382982|NCT01380769|76257441|FG000|Overall Study|Physician Decision|1|||
42382983|NCT01380769|76257442|FG001|Overall Study|Physician Decision|1|||
42382984|NCT01380769|76257441|FG000|Overall Study|Adverse Event|1|||
42382985|NCT01380769|76257442|FG001|Overall Study|Adverse Event|1|||
42382986|NCT01380769|76257441|FG000|Overall Study|Protocol Violation|0|||
42382987|NCT01380769|76257442|FG001|Overall Study|Protocol Violation|1|||
42382988|NCT01395901|76257450|FG000|Overall Study|Lost to Follow-up|4|||
42110103|NCT00624338|75920560|FG001|Overall Study|Lost to Follow-up|0|||
42110104|NCT00624338|75920561|FG002|Overall Study|Lost to Follow-up|0|||
42110105|NCT00624338|75920559|FG000|Overall Study|Lack of Efficacy|11|||
42110106|NCT00624338|75920560|FG001|Overall Study|Lack of Efficacy|3|||
42110107|NCT00624338|75920561|FG002|Overall Study|Lack of Efficacy|14|||
42110108|NCT00624338|75920559|FG000|Overall Study|Protocol Violation|3|||
42110109|NCT00624338|75920560|FG001|Overall Study|Protocol Violation|3|||
42110110|NCT00624338|75920561|FG002|Overall Study|Protocol Violation|2|||
42110111|NCT00624338|75920559|FG000|Overall Study|Death|0|||
42110112|NCT00624338|75920560|FG001|Overall Study|Death|2|||
42110113|NCT00624338|75920561|FG002|Overall Study|Death|0|||
42110114|NCT00624338|75920559|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
42110115|NCT00624338|75920560|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
42110116|NCT00624338|75920561|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
42110117|NCT00624338|75920559|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
42110118|NCT00624338|75920560|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
42110119|NCT00624338|75920561|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
42110120|NCT00624338|75920559|FG000|Overall Study|Other|15|||
42110121|NCT00624338|75920560|FG001|Overall Study|Other|5|||
42110122|NCT00624338|75920561|FG002|Overall Study|Other|9|||
42110123|NCT00624338|75920559|FG000|Overall Study|Randomized but not treated|2|||
42110124|NCT00624338|75920560|FG001|Overall Study|Randomized but not treated|1|||
42110125|NCT00624338|75920561|FG002|Overall Study|Randomized but not treated|3|||
42110126|NCT03977454|75920571|FG000|Overall Study|immediate postoperative revision|2|||
42110127|NCT03977454|75920572|FG001|Overall Study|immediate postoperative revision|2|||
42110128|NCT00538785|75920580|FG000|Overall Study|Death|9|||
42110129|NCT00538785|75920581|FG001|Overall Study|Death|10|||
42110130|NCT00538785|75920580|FG000|Overall Study|Withdrawal of consent|9|||
42110131|NCT00538785|75920581|FG001|Overall Study|Withdrawal of consent|7|||
42203467|NCT00075725|76016380|FG010|Overall Study|Withdrawal by Subject|0|||
42382989|NCT01395901|76257451|FG001|Overall Study|Lost to Follow-up|0|||
42382990|NCT01395901|76257450|FG000|Overall Study|Randomized but not received study drug|5|||
42382991|NCT01395901|76257451|FG001|Overall Study|Randomized but not received study drug|4|||
42382992|NCT01395901|76257450|FG000|Overall Study|Adverse Event|0|||
42110132|NCT00538785|75920580|FG000|Overall Study|Lost to Follow-up|1|||
42110133|NCT00538785|75920581|FG001|Overall Study|Lost to Follow-up|0|||
42110134|NCT00538629|75920587|FG000|Overall Study|At subject's request|1|||
42110135|NCT00538629|75920587|FG000|Overall Study|Adverse Event|2|||
42110136|NCT00538629|75920587|FG000|Overall Study|Lack of Efficacy|12|||
42110137|NCT00538629|75920587|FG000|Overall Study|Lost to Follow-up|6|||
42110138|NCT00538629|75920587|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
42110139|NCT00622700|75920594|FG000|Core Treatment Period|Randomized but Not Treated|0|||
42110140|NCT00622700|75920595|FG001|Core Treatment Period|Randomized but Not Treated|2|||
42110141|NCT00622700|75920596|FG002|Core Treatment Period|Randomized but Not Treated|2|||
42110142|NCT00622700|75920597|FG003|Core Treatment Period|Randomized but Not Treated|0|||
42110143|NCT00622700|75920598|FG004|Core Treatment Period|Randomized but Not Treated|0|||
42110144|NCT00622700|75920599|FG005|Core Treatment Period|Randomized but Not Treated|0|||
42110145|NCT00622700|75920600|FG006|Core Treatment Period|Randomized but Not Treated|0|||
42110146|NCT00622700|75920594|FG000|Core Treatment Period|Adverse Event|18|||
42110147|NCT00622700|75920595|FG001|Core Treatment Period|Adverse Event|25|||
42110148|NCT00622700|75920596|FG002|Core Treatment Period|Adverse Event|18|||
42110149|NCT00622700|75920597|FG003|Core Treatment Period|Adverse Event|0|||
42110150|NCT00622700|75920598|FG004|Core Treatment Period|Adverse Event|0|||
42110151|NCT00622700|75920599|FG005|Core Treatment Period|Adverse Event|0|||
42110152|NCT00622700|75920600|FG006|Core Treatment Period|Adverse Event|0|||
42110153|NCT00622700|75920594|FG000|Core Treatment Period|Lack of Efficacy|19|||
42110154|NCT00622700|75920595|FG001|Core Treatment Period|Lack of Efficacy|6|||
42110155|NCT00622700|75920596|FG002|Core Treatment Period|Lack of Efficacy|12|||
42110156|NCT00622700|75920597|FG003|Core Treatment Period|Lack of Efficacy|0|||
42110157|NCT00622700|75920598|FG004|Core Treatment Period|Lack of Efficacy|0|||
42110158|NCT00622700|75920599|FG005|Core Treatment Period|Lack of Efficacy|0|||
42203468|NCT00075725|76016381|FG011|Overall Study|Withdrawal by Subject|0|||
42203469|NCT00075725|76016370|FG000|Overall Study|Disease Progression, all other reasons|17|||
42203470|NCT00075725|76016371|FG001|Overall Study|Disease Progression, all other reasons|5|||
42203471|NCT00075725|76016372|FG002|Overall Study|Disease Progression, all other reasons|33|||
42203472|NCT00075725|76016373|FG003|Overall Study|Disease Progression, all other reasons|6|||
42203473|NCT00075725|76016374|FG004|Overall Study|Disease Progression, all other reasons|21|||
42203474|NCT00075725|76016375|FG005|Overall Study|Disease Progression, all other reasons|59|||
42203475|NCT00075725|76016376|FG006|Overall Study|Disease Progression, all other reasons|20|||
42203476|NCT00075725|76016377|FG007|Overall Study|Disease Progression, all other reasons|46|||
42203477|NCT00075725|76016378|FG008|Overall Study|Disease Progression, all other reasons|21|||
42203478|NCT00075725|76016379|FG009|Overall Study|Disease Progression, all other reasons|4|||
42203479|NCT00075725|76016380|FG010|Overall Study|Disease Progression, all other reasons|0|||
42203480|NCT00075725|76016381|FG011|Overall Study|Disease Progression, all other reasons|5|||
42203481|NCT00075725|76016370|FG000|Overall Study|Patient off treatment|0|||
42203482|NCT00075725|76016371|FG001|Overall Study|Patient off treatment|0|||
42203483|NCT00075725|76016372|FG002|Overall Study|Patient off treatment|1|||
42203484|NCT00075725|76016373|FG003|Overall Study|Patient off treatment|2|||
42203485|NCT00075725|76016374|FG004|Overall Study|Patient off treatment|1|||
42203486|NCT00075725|76016375|FG005|Overall Study|Patient off treatment|0|||
42203487|NCT00075725|76016376|FG006|Overall Study|Patient off treatment|0|||
42203488|NCT00075725|76016377|FG007|Overall Study|Patient off treatment|2|||
42203489|NCT00075725|76016378|FG008|Overall Study|Patient off treatment|1|||
42203490|NCT00075725|76016379|FG009|Overall Study|Patient off treatment|0|||
42203491|NCT00075725|76016380|FG010|Overall Study|Patient off treatment|0|||
42203492|NCT00075725|76016381|FG011|Overall Study|Patient off treatment|0|||
42203493|NCT00075725|76016370|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
42203494|NCT00075725|76016371|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
42203495|NCT00075725|76016372|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
42203496|NCT00075725|76016373|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
42203497|NCT00075725|76016374|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
42203498|NCT00075725|76016375|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
42203499|NCT00075725|76016376|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
42203500|NCT00075725|76016377|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
42203501|NCT00075725|76016378|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
42203502|NCT00075725|76016379|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
42203503|NCT00075725|76016380|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
42203504|NCT00075725|76016381|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
42203505|NCT00075725|76016370|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
42203506|NCT00075725|76016371|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
42110159|NCT00622700|75920600|FG006|Core Treatment Period|Lack of Efficacy|0|||
42110160|NCT00622700|75920594|FG000|Core Treatment Period|Lost to Follow-up|1|||
42110161|NCT00622700|75920595|FG001|Core Treatment Period|Lost to Follow-up|1|||
42110162|NCT00622700|75920596|FG002|Core Treatment Period|Lost to Follow-up|1|||
42110163|NCT00622700|75920597|FG003|Core Treatment Period|Lost to Follow-up|0|||
42110164|NCT00622700|75920598|FG004|Core Treatment Period|Lost to Follow-up|0|||
42203507|NCT00075725|76016372|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
42203508|NCT00075725|76016373|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
42203509|NCT00075725|76016374|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
42203510|NCT00075725|76016375|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
42203511|NCT00075725|76016376|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
42203512|NCT00075725|76016377|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
42203513|NCT00075725|76016378|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
42203514|NCT00075725|76016379|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
42203515|NCT00075725|76016380|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
42203516|NCT00075725|76016381|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
42203517|NCT00075725|76016370|FG000|Overall Study|Pt non compliant with therapy|2|||
42203518|NCT00075725|76016371|FG001|Overall Study|Pt non compliant with therapy|1|||
42203519|NCT00075725|76016372|FG002|Overall Study|Pt non compliant with therapy|1|||
42203520|NCT00075725|76016373|FG003|Overall Study|Pt non compliant with therapy|0|||
42203521|NCT00075725|76016374|FG004|Overall Study|Pt non compliant with therapy|2|||
42203522|NCT00075725|76016375|FG005|Overall Study|Pt non compliant with therapy|14|||
42203523|NCT00075725|76016376|FG006|Overall Study|Pt non compliant with therapy|2|||
42203524|NCT00075725|76016377|FG007|Overall Study|Pt non compliant with therapy|5|||
42203525|NCT00075725|76016378|FG008|Overall Study|Pt non compliant with therapy|3|||
42203526|NCT00075725|76016379|FG009|Overall Study|Pt non compliant with therapy|0|||
42203527|NCT00075725|76016380|FG010|Overall Study|Pt non compliant with therapy|0|||
42203528|NCT00075725|76016381|FG011|Overall Study|Pt non compliant with therapy|0|||
42203529|NCT00075725|76016370|FG000|Overall Study|Pt age out of range for treatment|0|||
42203530|NCT00075725|76016371|FG001|Overall Study|Pt age out of range for treatment|1|||
42203531|NCT00075725|76016372|FG002|Overall Study|Pt age out of range for treatment|0|||
42203532|NCT00075725|76016373|FG003|Overall Study|Pt age out of range for treatment|0|||
42203533|NCT00075725|76016374|FG004|Overall Study|Pt age out of range for treatment|0|||
42203534|NCT00075725|76016375|FG005|Overall Study|Pt age out of range for treatment|1|||
42203535|NCT00075725|76016376|FG006|Overall Study|Pt age out of range for treatment|0|||
42203536|NCT00075725|76016377|FG007|Overall Study|Pt age out of range for treatment|1|||
42203537|NCT00075725|76016378|FG008|Overall Study|Pt age out of range for treatment|0|||
42203538|NCT00075725|76016379|FG009|Overall Study|Pt age out of range for treatment|0|||
42203539|NCT00075725|76016380|FG010|Overall Study|Pt age out of range for treatment|0|||
42203540|NCT00075725|76016381|FG011|Overall Study|Pt age out of range for treatment|0|||
42203541|NCT00075725|76016370|FG000|Overall Study|Insurance issues|0|||
42203542|NCT00075725|76016371|FG001|Overall Study|Insurance issues|1|||
42203543|NCT00075725|76016372|FG002|Overall Study|Insurance issues|0|||
42203544|NCT00075725|76016373|FG003|Overall Study|Insurance issues|1|||
42203545|NCT00075725|76016374|FG004|Overall Study|Insurance issues|1|||
42203546|NCT00075725|76016375|FG005|Overall Study|Insurance issues|1|||
42203547|NCT00075725|76016376|FG006|Overall Study|Insurance issues|0|||
42203548|NCT00075725|76016377|FG007|Overall Study|Insurance issues|1|||
42203549|NCT00075725|76016378|FG008|Overall Study|Insurance issues|0|||
42203550|NCT00075725|76016379|FG009|Overall Study|Insurance issues|0|||
42203551|NCT00075725|76016380|FG010|Overall Study|Insurance issues|0|||
42203552|NCT00075725|76016381|FG011|Overall Study|Insurance issues|0|||
42203553|NCT00075725|76016370|FG000|Overall Study|MRD positive after extended ind|0|||
42203554|NCT00075725|76016371|FG001|Overall Study|MRD positive after extended ind|1|||
42203555|NCT00075725|76016372|FG002|Overall Study|MRD positive after extended ind|1|||
42203556|NCT00075725|76016373|FG003|Overall Study|MRD positive after extended ind|0|||
42203557|NCT00075725|76016374|FG004|Overall Study|MRD positive after extended ind|1|||
42203558|NCT00075725|76016375|FG005|Overall Study|MRD positive after extended ind|2|||
42203559|NCT00075725|76016376|FG006|Overall Study|MRD positive after extended ind|0|||
42203560|NCT00075725|76016377|FG007|Overall Study|MRD positive after extended ind|1|||
42203561|NCT00075725|76016378|FG008|Overall Study|MRD positive after extended ind|0|||
42203562|NCT00075725|76016379|FG009|Overall Study|MRD positive after extended ind|0|||
42203563|NCT00075725|76016380|FG010|Overall Study|MRD positive after extended ind|0|||
42203564|NCT00075725|76016381|FG011|Overall Study|MRD positive after extended ind|0|||
42203565|NCT00075725|76016370|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
42203566|NCT00075725|76016371|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
42203567|NCT00075725|76016372|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
42203568|NCT00075725|76016373|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
42203569|NCT00075725|76016374|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
42203570|NCT00075725|76016375|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
42203571|NCT00075725|76016376|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
42203572|NCT00075725|76016377|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
42203573|NCT00075725|76016378|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
42203574|NCT00075725|76016379|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
42203575|NCT00075725|76016380|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
42018975|NCT01252667|75826425|FG003|Overall Study|Transplant aborted post-conditioning|0|||
42203576|NCT00075725|76016381|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
42203577|NCT00075725|76016370|FG000|Overall Study|Inevaluable|1|||
42203578|NCT00075725|76016371|FG001|Overall Study|Inevaluable|1|||
42203579|NCT00075725|76016372|FG002|Overall Study|Inevaluable|4|||
42203580|NCT00075725|76016373|FG003|Overall Study|Inevaluable|2|||
42203581|NCT00075725|76016374|FG004|Overall Study|Inevaluable|2|||
42203582|NCT00075725|76016375|FG005|Overall Study|Inevaluable|9|||
42203583|NCT00075725|76016376|FG006|Overall Study|Inevaluable|1|||
42203584|NCT00075725|76016377|FG007|Overall Study|Inevaluable|11|||
42203585|NCT00075725|76016378|FG008|Overall Study|Inevaluable|2|||
42203586|NCT00075725|76016379|FG009|Overall Study|Inevaluable|0|||
42203587|NCT00075725|76016380|FG010|Overall Study|Inevaluable|1|||
42203588|NCT00075725|76016381|FG011|Overall Study|Inevaluable|0|||
42203589|NCT00075725|76016370|FG000|Overall Study|Other|4|||
42203590|NCT00075725|76016371|FG001|Overall Study|Other|2|||
42203591|NCT00075725|76016372|FG002|Overall Study|Other|1|||
42203592|NCT00075725|76016373|FG003|Overall Study|Other|1|||
42203593|NCT00075725|76016374|FG004|Overall Study|Other|1|||
42203594|NCT00075725|76016375|FG005|Overall Study|Other|4|||
42203595|NCT00075725|76016376|FG006|Overall Study|Other|2|||
42203596|NCT00075725|76016377|FG007|Overall Study|Other|9|||
42203597|NCT00075725|76016378|FG008|Overall Study|Other|2|||
42203598|NCT00075725|76016379|FG009|Overall Study|Other|1|||
42203599|NCT00075725|76016380|FG010|Overall Study|Other|0|||
42203600|NCT00075725|76016381|FG011|Overall Study|Other|3|||
42203601|NCT00075725|76016370|FG000|Overall Study|Pt trying to find a BM donor|0|||
42203602|NCT00075725|76016371|FG001|Overall Study|Pt trying to find a BM donor|1|||
42203603|NCT00075725|76016372|FG002|Overall Study|Pt trying to find a BM donor|0|||
42203604|NCT00075725|76016373|FG003|Overall Study|Pt trying to find a BM donor|0|||
42203605|NCT00075725|76016374|FG004|Overall Study|Pt trying to find a BM donor|0|||
42203606|NCT00075725|76016375|FG005|Overall Study|Pt trying to find a BM donor|0|||
42203607|NCT00075725|76016376|FG006|Overall Study|Pt trying to find a BM donor|0|||
42203608|NCT00075725|76016377|FG007|Overall Study|Pt trying to find a BM donor|0|||
42203609|NCT00075725|76016378|FG008|Overall Study|Pt trying to find a BM donor|0|||
42203610|NCT00075725|76016379|FG009|Overall Study|Pt trying to find a BM donor|0|||
42203611|NCT00075725|76016380|FG010|Overall Study|Pt trying to find a BM donor|0|||
42203612|NCT00075725|76016381|FG011|Overall Study|Pt trying to find a BM donor|0|||
42203613|NCT00075725|76016370|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
42203614|NCT00075725|76016371|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
42203615|NCT00075725|76016372|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
42203616|NCT00075725|76016373|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
42203617|NCT00075725|76016374|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
42203618|NCT00075725|76016375|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
42203619|NCT00075725|76016376|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
42203620|NCT00075725|76016377|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
42203621|NCT00075725|76016378|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
42203622|NCT00075725|76016379|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
42203623|NCT00075725|76016380|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
42203624|NCT00075725|76016381|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
42203625|NCT00075725|76016370|FG000|Overall Study|Unsuccessful institutional transfer|0|||
42203626|NCT00075725|76016371|FG001|Overall Study|Unsuccessful institutional transfer|0|||
42203627|NCT00075725|76016372|FG002|Overall Study|Unsuccessful institutional transfer|2|||
42203628|NCT00075725|76016373|FG003|Overall Study|Unsuccessful institutional transfer|0|||
42203629|NCT00075725|76016374|FG004|Overall Study|Unsuccessful institutional transfer|0|||
42203630|NCT00075725|76016375|FG005|Overall Study|Unsuccessful institutional transfer|0|||
42203631|NCT00075725|76016376|FG006|Overall Study|Unsuccessful institutional transfer|0|||
42203632|NCT00075725|76016377|FG007|Overall Study|Unsuccessful institutional transfer|0|||
42203633|NCT00075725|76016378|FG008|Overall Study|Unsuccessful institutional transfer|0|||
42203634|NCT00075725|76016379|FG009|Overall Study|Unsuccessful institutional transfer|1|||
42203635|NCT00075725|76016380|FG010|Overall Study|Unsuccessful institutional transfer|0|||
42203636|NCT00075725|76016381|FG011|Overall Study|Unsuccessful institutional transfer|0|||
42203637|NCT00075725|76016370|FG000|Overall Study|specimen(s) not submitted|0|||
42203638|NCT00075725|76016371|FG001|Overall Study|specimen(s) not submitted|0|||
42203639|NCT00075725|76016372|FG002|Overall Study|specimen(s) not submitted|2|||
42203640|NCT00075725|76016373|FG003|Overall Study|specimen(s) not submitted|0|||
42203641|NCT00075725|76016374|FG004|Overall Study|specimen(s) not submitted|0|||
42203642|NCT00075725|76016375|FG005|Overall Study|specimen(s) not submitted|0|||
42382993|NCT01395901|76257451|FG001|Overall Study|Adverse Event|1|||
42203643|NCT00075725|76016376|FG006|Overall Study|specimen(s) not submitted|0|||
42203644|NCT00075725|76016377|FG007|Overall Study|specimen(s) not submitted|0|||
42203645|NCT00075725|76016378|FG008|Overall Study|specimen(s) not submitted|0|||
42203646|NCT00075725|76016379|FG009|Overall Study|specimen(s) not submitted|0|||
42382994|NCT01395901|76257450|FG000|Overall Study|Withdrawal of consent|1|||
42203647|NCT00075725|76016380|FG010|Overall Study|specimen(s) not submitted|0|||
42203648|NCT00075725|76016381|FG011|Overall Study|specimen(s) not submitted|0|||
42203649|NCT00075725|76016370|FG000|Overall Study|Pt went to transplant|0|||
42203650|NCT00075725|76016371|FG001|Overall Study|Pt went to transplant|0|||
42203651|NCT00075725|76016372|FG002|Overall Study|Pt went to transplant|0|||
42382995|NCT01395901|76257451|FG001|Overall Study|Withdrawal of consent|0|||
42203652|NCT00075725|76016373|FG003|Overall Study|Pt went to transplant|1|||
42203653|NCT00075725|76016374|FG004|Overall Study|Pt went to transplant|0|||
42203654|NCT00075725|76016375|FG005|Overall Study|Pt went to transplant|1|||
42203655|NCT00075725|76016376|FG006|Overall Study|Pt went to transplant|0|||
42203656|NCT00075725|76016377|FG007|Overall Study|Pt went to transplant|0|||
42203657|NCT00075725|76016378|FG008|Overall Study|Pt went to transplant|0|||
42203658|NCT00075725|76016379|FG009|Overall Study|Pt went to transplant|0|||
42203659|NCT00075725|76016380|FG010|Overall Study|Pt went to transplant|0|||
42203660|NCT00075725|76016381|FG011|Overall Study|Pt went to transplant|0|||
42203661|NCT00075725|76016370|FG000|Overall Study|Pt received additional steroids|0|||
42203662|NCT00075725|76016371|FG001|Overall Study|Pt received additional steroids|0|||
42203663|NCT00075725|76016372|FG002|Overall Study|Pt received additional steroids|0|||
42203664|NCT00075725|76016373|FG003|Overall Study|Pt received additional steroids|1|||
42203665|NCT00075725|76016374|FG004|Overall Study|Pt received additional steroids|0|||
42203666|NCT00075725|76016375|FG005|Overall Study|Pt received additional steroids|0|||
42203667|NCT00075725|76016376|FG006|Overall Study|Pt received additional steroids|0|||
42203668|NCT00075725|76016377|FG007|Overall Study|Pt received additional steroids|0|||
42203669|NCT00075725|76016378|FG008|Overall Study|Pt received additional steroids|0|||
42203670|NCT00075725|76016379|FG009|Overall Study|Pt received additional steroids|0|||
42203671|NCT00075725|76016380|FG010|Overall Study|Pt received additional steroids|0|||
42203672|NCT00075725|76016381|FG011|Overall Study|Pt received additional steroids|0|||
42203673|NCT00075725|76016370|FG000|Overall Study|Pt relocated|0|||
42203674|NCT00075725|76016371|FG001|Overall Study|Pt relocated|0|||
42203675|NCT00075725|76016372|FG002|Overall Study|Pt relocated|0|||
42203676|NCT00075725|76016373|FG003|Overall Study|Pt relocated|2|||
42203677|NCT00075725|76016374|FG004|Overall Study|Pt relocated|0|||
42203678|NCT00075725|76016375|FG005|Overall Study|Pt relocated|1|||
42203679|NCT00075725|76016376|FG006|Overall Study|Pt relocated|1|||
42203680|NCT00075725|76016377|FG007|Overall Study|Pt relocated|2|||
42203681|NCT00075725|76016378|FG008|Overall Study|Pt relocated|1|||
42203682|NCT00075725|76016379|FG009|Overall Study|Pt relocated|0|||
42203683|NCT00075725|76016380|FG010|Overall Study|Pt relocated|0|||
42203684|NCT00075725|76016381|FG011|Overall Study|Pt relocated|0|||
42203685|NCT00075725|76016370|FG000|Overall Study|Institution Terminated|0|||
42203686|NCT00075725|76016371|FG001|Overall Study|Institution Terminated|0|||
42203687|NCT00075725|76016372|FG002|Overall Study|Institution Terminated|0|||
42203688|NCT00075725|76016373|FG003|Overall Study|Institution Terminated|0|||
42203689|NCT00075725|76016374|FG004|Overall Study|Institution Terminated|1|||
42203690|NCT00075725|76016375|FG005|Overall Study|Institution Terminated|0|||
42382996|NCT01395823|76257459|FG000|Overall Study|Death|4|||
42382997|NCT01395823|76257460|FG001|Overall Study|Death|4|||
42382998|NCT01395823|76257459|FG000|Overall Study|Physician Decision|3|||
42382999|NCT01395823|76257460|FG001|Overall Study|Physician Decision|1|||
42383000|NCT01395823|76257459|FG000|Overall Study|Lost to Follow-up|1|||
42383001|NCT01395823|76257460|FG001|Overall Study|Lost to Follow-up|0|||
42383002|NCT01395823|76257459|FG000|Overall Study|Transplant|1|||
42383003|NCT01395823|76257460|FG001|Overall Study|Transplant|0|||
42383004|NCT01395823|76257459|FG000|Overall Study|GI symptoms|1|||
42110165|NCT00622700|75920599|FG005|Core Treatment Period|Lost to Follow-up|0|||
42110166|NCT00622700|75920600|FG006|Core Treatment Period|Lost to Follow-up|0|||
42110167|NCT00622700|75920594|FG000|Core Treatment Period|Death|1|||
42110168|NCT00622700|75920595|FG001|Core Treatment Period|Death|0|||
42110169|NCT00622700|75920596|FG002|Core Treatment Period|Death|0|||
42110170|NCT00622700|75920597|FG003|Core Treatment Period|Death|0|||
42110171|NCT00622700|75920598|FG004|Core Treatment Period|Death|0|||
42110172|NCT00622700|75920599|FG005|Core Treatment Period|Death|0|||
42110173|NCT00622700|75920600|FG006|Core Treatment Period|Death|0|||
42110174|NCT00622700|75920594|FG000|Core Treatment Period|Progressive Disease|3|||
42110175|NCT00622700|75920595|FG001|Core Treatment Period|Progressive Disease|1|||
42110176|NCT00622700|75920596|FG002|Core Treatment Period|Progressive Disease|0|||
42110177|NCT00622700|75920597|FG003|Core Treatment Period|Progressive Disease|0|||
42110178|NCT00622700|75920598|FG004|Core Treatment Period|Progressive Disease|0|||
42110179|NCT00622700|75920599|FG005|Core Treatment Period|Progressive Disease|0|||
42110180|NCT00622700|75920600|FG006|Core Treatment Period|Progressive Disease|0|||
42203691|NCT00075725|76016376|FG006|Overall Study|Institution Terminated|0|||
42203692|NCT00075725|76016377|FG007|Overall Study|Institution Terminated|3|||
42203693|NCT00075725|76016378|FG008|Overall Study|Institution Terminated|0|||
42203694|NCT00075725|76016379|FG009|Overall Study|Institution Terminated|0|||
42203695|NCT00075725|76016380|FG010|Overall Study|Institution Terminated|0|||
42383005|NCT01395823|76257460|FG001|Overall Study|GI symptoms|0|||
42383006|NCT01395823|76257459|FG000|Overall Study|Withdrawal by Subject|5|||
42383007|NCT01395823|76257460|FG001|Overall Study|Withdrawal by Subject|4|||
42110181|NCT00622700|75920594|FG000|Core Treatment Period|Withdrawal by Subject|12|||
42110182|NCT00622700|75920595|FG001|Core Treatment Period|Withdrawal by Subject|18|||
42110183|NCT00622700|75920596|FG002|Core Treatment Period|Withdrawal by Subject|15|||
42203696|NCT00075725|76016381|FG011|Overall Study|Institution Terminated|0|||
42203697|NCT00075725|76016370|FG000|Overall Study|Study Closure|1|||
42203698|NCT00075725|76016371|FG001|Overall Study|Study Closure|0|||
42203699|NCT00075725|76016372|FG002|Overall Study|Study Closure|0|||
42203700|NCT00075725|76016373|FG003|Overall Study|Study Closure|0|||
42203701|NCT00075725|76016374|FG004|Overall Study|Study Closure|1|||
42203702|NCT00075725|76016375|FG005|Overall Study|Study Closure|3|||
42203703|NCT00075725|76016376|FG006|Overall Study|Study Closure|0|||
42203704|NCT00075725|76016377|FG007|Overall Study|Study Closure|1|||
42203705|NCT00075725|76016378|FG008|Overall Study|Study Closure|0|||
42203706|NCT00075725|76016379|FG009|Overall Study|Study Closure|0|||
42203707|NCT00075725|76016380|FG010|Overall Study|Study Closure|0|||
42203708|NCT00075725|76016381|FG011|Overall Study|Study Closure|0|||
42203709|NCT00075725|76016370|FG000|Overall Study|Other complications|0|||
42203710|NCT00075725|76016371|FG001|Overall Study|Other complications|0|||
42203711|NCT00075725|76016372|FG002|Overall Study|Other complications|0|||
42203712|NCT00075725|76016373|FG003|Overall Study|Other complications|0|||
42203713|NCT00075725|76016374|FG004|Overall Study|Other complications|0|||
42203714|NCT00075725|76016375|FG005|Overall Study|Other complications|1|||
42203715|NCT00075725|76016376|FG006|Overall Study|Other complications|0|||
42203716|NCT00075725|76016377|FG007|Overall Study|Other complications|0|||
42203717|NCT00075725|76016378|FG008|Overall Study|Other complications|0|||
42203718|NCT00075725|76016379|FG009|Overall Study|Other complications|0|||
42203719|NCT00075725|76016380|FG010|Overall Study|Other complications|0|||
42203720|NCT00075725|76016381|FG011|Overall Study|Other complications|0|||
42203721|NCT00075725|76016370|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
42203722|NCT00075725|76016371|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
42203723|NCT00075725|76016372|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
42203724|NCT00075725|76016373|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
42203725|NCT00075725|76016374|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
42203726|NCT00075725|76016375|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
42203727|NCT00075725|76016376|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
42203728|NCT00075725|76016377|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
42203729|NCT00075725|76016378|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
42203730|NCT00075725|76016379|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
42203731|NCT00075725|76016380|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
42203732|NCT00075725|76016381|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
42203733|NCT00075725|76016370|FG000|Overall Study|Pt incarcerated|0|||
42203734|NCT00075725|76016371|FG001|Overall Study|Pt incarcerated|0|||
42203735|NCT00075725|76016372|FG002|Overall Study|Pt incarcerated|0|||
42203736|NCT00075725|76016373|FG003|Overall Study|Pt incarcerated|0|||
42203737|NCT00075725|76016374|FG004|Overall Study|Pt incarcerated|0|||
42203738|NCT00075725|76016375|FG005|Overall Study|Pt incarcerated|0|||
42203739|NCT00075725|76016376|FG006|Overall Study|Pt incarcerated|0|||
42203740|NCT00075725|76016377|FG007|Overall Study|Pt incarcerated|1|||
42203741|NCT00075725|76016378|FG008|Overall Study|Pt incarcerated|0|||
42203742|NCT00075725|76016379|FG009|Overall Study|Pt incarcerated|0|||
42203743|NCT00075725|76016380|FG010|Overall Study|Pt incarcerated|0|||
42383008|NCT00158184|76257468|FG000|Overall Study|personal issues|3|||
42383009|NCT00158184|76257469|FG001|Overall Study|personal issues|1|||
42203744|NCT00075725|76016381|FG011|Overall Study|Pt incarcerated|0|||
42203745|NCT02953782|76016420|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
42203746|NCT02953782|76016421|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
42203747|NCT02953782|76016422|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
42203748|NCT02953782|76016423|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
42203749|NCT02953782|76016424|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
42203750|NCT02953782|76016425|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
42203751|NCT02953782|76016426|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
42203752|NCT02953782|76016427|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
42203753|NCT02953782|76016420|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
42203754|NCT02953782|76016421|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
42203755|NCT02953782|76016422|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
42383010|NCT00158184|76257468|FG000|Overall Study|failed for follow unit/study rules|2|||
42203756|NCT02953782|76016423|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
42203757|NCT02953782|76016424|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
42203758|NCT02953782|76016425|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
42203759|NCT02953782|76016426|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
42203760|NCT02953782|76016427|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
42203761|NCT02953782|76016420|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
42203762|NCT02953782|76016421|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
42203763|NCT02953782|76016422|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
42203764|NCT02953782|76016423|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
42203765|NCT02953782|76016424|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
42203766|NCT02953782|76016425|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
42203767|NCT02953782|76016426|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
42203768|NCT02953782|76016427|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
42203769|NCT02953782|76016420|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
42203770|NCT02953782|76016421|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
42203771|NCT02953782|76016422|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
42203772|NCT02953782|76016423|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
42203773|NCT02953782|76016424|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
42203774|NCT02953782|76016425|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
42203775|NCT02953782|76016426|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
42203776|NCT02953782|76016427|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
42203777|NCT02953782|76016420|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
42203778|NCT02953782|76016421|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
42203779|NCT02953782|76016422|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
42203780|NCT02953782|76016423|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
42203781|NCT02953782|76016424|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
42203782|NCT02953782|76016425|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
42203783|NCT02953782|76016426|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
42203784|NCT02953782|76016427|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
42203785|NCT02953782|76016420|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
42203786|NCT02953782|76016421|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
42203787|NCT02953782|76016422|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
42203788|NCT02953782|76016423|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
42203789|NCT02953782|76016424|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
42203790|NCT02953782|76016425|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
42203791|NCT02953782|76016426|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
42203792|NCT02953782|76016427|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
42203793|NCT02953782|76016420|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
42203794|NCT02953782|76016421|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
42203795|NCT02953782|76016422|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
42203796|NCT02953782|76016423|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
42203797|NCT02953782|76016424|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
42203798|NCT02953782|76016425|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
42203799|NCT02953782|76016426|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
42203800|NCT02953782|76016427|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
42203801|NCT02953782|76016420|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
42203802|NCT02953782|76016421|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
42203803|NCT02953782|76016422|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
42203804|NCT02953782|76016423|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
42203805|NCT02953782|76016424|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
42203806|NCT02953782|76016425|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
42203807|NCT02953782|76016426|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
42203808|NCT02953782|76016427|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
42203809|NCT03760081|76016450|FG000|Overall Study|Miscellaneous|0|||
42203810|NCT03760081|76016451|FG001|Overall Study|Miscellaneous|1|||
42203811|NCT03760081|76016450|FG000|Overall Study|Progressive Disease|5|||
42203812|NCT03760081|76016451|FG001|Overall Study|Progressive Disease|10|||
42203813|NCT03760081|76016450|FG000|Overall Study|Death|1|||
42203814|NCT03760081|76016451|FG001|Overall Study|Death|1|||
42203815|NCT03422172|76016459|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
42203816|NCT03422172|76016459|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
42203817|NCT03422172|76016459|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
42203818|NCT00057863|76016468|FG000|Overall Study|Death|1|||
42203819|NCT00057863|76016468|FG000|Overall Study|Withdrawal by Subject|2|||
42203820|NCT00075023|76016474|FG000|Pilot Study|Physician Decision|1|||
42383011|NCT00158184|76257469|FG001|Overall Study|failed for follow unit/study rules|0|||
42383012|NCT00158184|76257468|FG000|Overall Study|Adverse Event|1|||
42383013|NCT00158184|76257469|FG001|Overall Study|Adverse Event|1|||
42110184|NCT00622700|75920597|FG003|Core Treatment Period|Withdrawal by Subject|0|||
42110185|NCT00622700|75920598|FG004|Core Treatment Period|Withdrawal by Subject|0|||
42110186|NCT00622700|75920599|FG005|Core Treatment Period|Withdrawal by Subject|0|||
42110187|NCT00622700|75920600|FG006|Core Treatment Period|Withdrawal by Subject|0|||
42110188|NCT00622700|75920594|FG000|Core Treatment Period|Other than specified above|2|||
42110189|NCT00622700|75920595|FG001|Core Treatment Period|Other than specified above|2|||
42110190|NCT00622700|75920596|FG002|Core Treatment Period|Other than specified above|5|||
42110191|NCT00622700|75920597|FG003|Core Treatment Period|Other than specified above|0|||
42203821|NCT00075023|76016475|FG001|Pilot Study|Physician Decision|2|||
42203822|NCT00075023|76016474|FG000|Pilot Study|Withdrawal by Subject|1|||
42203823|NCT00075023|76016475|FG001|Pilot Study|Withdrawal by Subject|0|||
42203824|NCT00074711|76016484|FG000|Overall Study|Withdrawal by Subject|1|||
42203825|NCT00074711|76016485|FG001|Overall Study|Withdrawal by Subject|1|||
42203826|NCT00074711|76016484|FG000|Overall Study|Lost to Follow-up|10|||
42203827|NCT00074711|76016485|FG001|Overall Study|Lost to Follow-up|8|||
42203828|NCT00074711|76016484|FG000|Overall Study|Participant stopped study drug|4|||
42203829|NCT00074711|76016485|FG001|Overall Study|Participant stopped study drug|6|||
42203830|NCT03420300|76016491|FG000|Overall Study|Death|2|||
42203831|NCT03419598|76016495|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
42203832|NCT03407430|76016503|FG000|Washout|Protocol Violation|1|||
42203833|NCT03407430|76016504|FG001|Washout|Protocol Violation|0|||
42203834|NCT03407118|76016517|FG000|Period 2|Withdrawal by Subject|1|||
42203835|NCT03407118|76016518|FG001|Period 2|Withdrawal by Subject|0|||
42203836|NCT03406962|76016524|FG000|Overall Study|Death|2|||
42203837|NCT03406962|76016524|FG000|Overall Study|Adverse Event|1|||
42203838|NCT03406260|76016535|FG000|Period 1|Adverse Event|0|||
42203839|NCT03406260|76016536|FG001|Period 1|Adverse Event|0|||
42203840|NCT03406260|76016537|FG002|Period 1|Adverse Event|0|||
42203841|NCT03406260|76016538|FG003|Period 1|Adverse Event|0|||
42203842|NCT03406260|76016539|FG004|Period 1|Adverse Event|1|||
42203843|NCT03406260|76016540|FG005|Period 1|Adverse Event|0|||
42203844|NCT03419364|76016553|FG000|Overall Study|Delivery due to maternal condition|2|||
42203845|NCT03419364|76016554|FG001|Overall Study|Delivery due to maternal condition|0|||
42203846|NCT03419364|76016555|FG002|Overall Study|Delivery due to maternal condition|0|||
42203847|NCT02954172|76016565|FG000|Overall Study|Protocol Violation|3|||
42203848|NCT02954172|76016566|FG001|Overall Study|Protocol Violation|0|||
42203849|NCT02954172|76016565|FG000|Overall Study|allergic reaction|2|||
42203850|NCT02954172|76016566|FG001|Overall Study|allergic reaction|1|||
42203851|NCT02954172|76016565|FG000|Overall Study|non-measurable lesions at baseline|1|||
42203852|NCT02954172|76016566|FG001|Overall Study|non-measurable lesions at baseline|2|||
42203853|NCT02953938|76016575|FG000|Overall Study|Adverse Event|0|||
42203854|NCT02953938|76016576|FG001|Overall Study|Adverse Event|1|||
42018976|NCT01252667|75826426|FG004|Overall Study|Transplant aborted post-conditioning|0|||
42018977|NCT01252667|75826427|FG005|Overall Study|Transplant aborted post-conditioning|1|||
42018978|NCT01119105|75826444|FG000|Overall Study|Withdrawal by Subject|1|||
42018979|NCT01119105|75826445|FG001|Overall Study|Withdrawal by Subject|1|||
42018980|NCT01119105|75826446|FG002|Overall Study|Withdrawal by Subject|1|||
42018981|NCT01119105|75826444|FG000|Overall Study|Lost to Follow-up|0|||
42018982|NCT01119105|75826445|FG001|Overall Study|Lost to Follow-up|2|||
42018983|NCT01119105|75826446|FG002|Overall Study|Lost to Follow-up|5|||
42018984|NCT01119105|75826444|FG000|Overall Study|Adverse Event|1|||
42018985|NCT01119105|75826445|FG001|Overall Study|Adverse Event|0|||
42018986|NCT01119105|75826446|FG002|Overall Study|Adverse Event|1|||
42018987|NCT01119105|75826444|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
42018988|NCT01119105|75826445|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
42018989|NCT01119105|75826446|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
42203855|NCT02953938|76016575|FG000|Overall Study|Withdrawal by Subject|1|||
42203856|NCT02953938|76016576|FG001|Overall Study|Withdrawal by Subject|1|||
42203857|NCT03758443|76016587|FG000|Induction Period|Adverse Event|2|||
42203858|NCT03758443|76016588|FG001|Induction Period|Adverse Event|4|||
42203859|NCT03758443|76016589|FG002|Induction Period|Adverse Event|2|||
42203860|NCT03758443|76016590|FG003|Induction Period|Adverse Event|3|||
42203861|NCT03758443|76016587|FG000|Induction Period|Physician Decision|1|||
42203862|NCT03758443|76016588|FG001|Induction Period|Physician Decision|1|||
42203863|NCT03758443|76016589|FG002|Induction Period|Physician Decision|3|||
42203864|NCT03758443|76016590|FG003|Induction Period|Physician Decision|0|||
42203865|NCT03758443|76016587|FG000|Induction Period|Protocol Violation|0|||
42203866|NCT03758443|76016588|FG001|Induction Period|Protocol Violation|0|||
42203867|NCT03758443|76016589|FG002|Induction Period|Protocol Violation|0|||
42203868|NCT03758443|76016590|FG003|Induction Period|Protocol Violation|1|||
42203869|NCT03758443|76016587|FG000|Induction Period|Withdrawal by Subject|3|||
42203870|NCT03758443|76016588|FG001|Induction Period|Withdrawal by Subject|2|||
42203871|NCT03758443|76016589|FG002|Induction Period|Withdrawal by Subject|2|||
42203872|NCT03758443|76016590|FG003|Induction Period|Withdrawal by Subject|4|||
42203873|NCT03758443|76016587|FG000|Extended Induction Period|Adverse Event|1|||
42383014|NCT01380691|76257477|FG000|Washout (7 Days)|Protocol Violation|0|||
42383015|NCT01380691|76257478|FG001|Washout (7 Days)|Protocol Violation|0|||
42203874|NCT03758443|76016588|FG001|Extended Induction Period|Adverse Event|1|||
42203875|NCT03758443|76016589|FG002|Extended Induction Period|Adverse Event|0|||
42203876|NCT03758443|76016590|FG003|Extended Induction Period|Adverse Event|1|||
42203877|NCT03758443|76016587|FG000|Extended Induction Period|Lost to Follow-up|1|||
42203878|NCT03758443|76016588|FG001|Extended Induction Period|Lost to Follow-up|0|||
42203879|NCT03758443|76016589|FG002|Extended Induction Period|Lost to Follow-up|0|||
42203880|NCT03758443|76016590|FG003|Extended Induction Period|Lost to Follow-up|0|||
42203881|NCT03758443|76016587|FG000|Extended Induction Period|Physician Decision|2|||
42203882|NCT03758443|76016588|FG001|Extended Induction Period|Physician Decision|1|||
42203883|NCT03758443|76016589|FG002|Extended Induction Period|Physician Decision|2|||
42203884|NCT03758443|76016590|FG003|Extended Induction Period|Physician Decision|2|||
42203885|NCT03758443|76016587|FG000|Extended Induction Period|Protocol Violation|0|||
42203886|NCT03758443|76016588|FG001|Extended Induction Period|Protocol Violation|0|||
42203887|NCT03758443|76016589|FG002|Extended Induction Period|Protocol Violation|0|||
42203888|NCT03758443|76016590|FG003|Extended Induction Period|Protocol Violation|1|||
42203889|NCT03758443|76016587|FG000|Extended Induction Period|Withdrawal by Subject|8|||
42203890|NCT03758443|76016588|FG001|Extended Induction Period|Withdrawal by Subject|1|||
42203891|NCT03758443|76016589|FG002|Extended Induction Period|Withdrawal by Subject|7|||
42203892|NCT03758443|76016590|FG003|Extended Induction Period|Withdrawal by Subject|3|||
42203893|NCT03758443|76016587|FG000|Extended Induction Period|Miscellaneous|1|||
42203894|NCT03758443|76016588|FG001|Extended Induction Period|Miscellaneous|0|||
42203895|NCT03758443|76016589|FG002|Extended Induction Period|Miscellaneous|0|||
42203896|NCT03758443|76016590|FG003|Extended Induction Period|Miscellaneous|0|||
42203897|NCT03758443|76016587|FG000|Maintenance Period|Adverse Event|1|||
42203898|NCT03758443|76016588|FG001|Maintenance Period|Adverse Event|2|||
42203899|NCT03758443|76016589|FG002|Maintenance Period|Adverse Event|0|||
42203900|NCT03758443|76016590|FG003|Maintenance Period|Adverse Event|0|||
42203901|NCT03758443|76016587|FG000|Maintenance Period|Lost to Follow-up|0|||
42203902|NCT03758443|76016588|FG001|Maintenance Period|Lost to Follow-up|0|||
42203903|NCT03758443|76016589|FG002|Maintenance Period|Lost to Follow-up|0|||
42203904|NCT03758443|76016590|FG003|Maintenance Period|Lost to Follow-up|1|||
42203905|NCT03758443|76016587|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
42203906|NCT03758443|76016588|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
42203907|NCT03758443|76016589|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
42203908|NCT03758443|76016590|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
42203909|NCT03758443|76016587|FG000|Maintenance Period|Protocol Violation|0|||
42203910|NCT03758443|76016588|FG001|Maintenance Period|Protocol Violation|1|||
42203911|NCT03758443|76016589|FG002|Maintenance Period|Protocol Violation|0|||
42203912|NCT03758443|76016590|FG003|Maintenance Period|Protocol Violation|0|||
42203913|NCT03758443|76016587|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
42203914|NCT03758443|76016588|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
42203915|NCT03758443|76016589|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
42203916|NCT03758443|76016590|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
42203917|NCT03758443|76016587|FG000|Maintenance Period|Withdrawal by Subject|1|||
42203918|NCT03758443|76016588|FG001|Maintenance Period|Withdrawal by Subject|0|||
42203919|NCT03758443|76016589|FG002|Maintenance Period|Withdrawal by Subject|1|||
42203920|NCT03758443|76016590|FG003|Maintenance Period|Withdrawal by Subject|1|||
42203921|NCT03758443|76016587|FG000|Maintenance Period|Miscellaneous|0|||
42203922|NCT03758443|76016588|FG001|Maintenance Period|Miscellaneous|0|||
42203923|NCT03758443|76016589|FG002|Maintenance Period|Miscellaneous|1|||
42203924|NCT03758443|76016590|FG003|Maintenance Period|Miscellaneous|0|||
42203925|NCT03442764|76016612|FG000|Overall Study|Adverse Event|1|||
42203926|NCT03442764|76016613|FG001|Overall Study|Adverse Event|0|||
42203927|NCT03442764|76016614|FG002|Overall Study|Adverse Event|0|||
42203928|NCT03442296|76016625|FG000|3 Month Follow-up|Death|3|||
42203929|NCT03442296|76016626|FG001|3 Month Follow-up|Death|1|||
42203930|NCT03442296|76016625|FG000|3 Month Follow-up|Lost to Follow-up|1|||
42203931|NCT03442296|76016626|FG001|3 Month Follow-up|Lost to Follow-up|1|||
42203932|NCT03442296|76016625|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
42203933|NCT03442296|76016626|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
42203934|NCT03442296|76016625|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
42203935|NCT03442296|76016626|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
42203936|NCT03442296|76016625|FG000|12 Month Follow-up|Incomplete measurement|1|||
42203937|NCT03442296|76016626|FG001|12 Month Follow-up|Incomplete measurement|1|||
42203938|NCT03441984|76016634|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
42203939|NCT03441984|76016635|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
42203940|NCT03441984|76016636|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
42203941|NCT03441984|76016637|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
42203942|NCT03441984|76016638|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
42203943|NCT03441984|76016639|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
42203944|NCT03441984|76016640|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
42203945|NCT03441984|76016641|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
42203946|NCT03441984|76016642|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
42203947|NCT03441984|76016643|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
42203948|NCT03441984|76016644|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
42203949|NCT03441984|76016645|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
42203950|NCT03441360|76016663|FG000|Overall Study|Radiological disease progression|5|||
42203951|NCT03441360|76016664|FG001|Overall Study|Radiological disease progression|6|||
42203952|NCT03441360|76016665|FG002|Overall Study|Radiological disease progression|4|||
42203953|NCT03441360|76016663|FG000|Overall Study|Clinical disease progression|2|||
42203954|NCT03441360|76016664|FG001|Overall Study|Clinical disease progression|2|||
42203955|NCT03441360|76016665|FG002|Overall Study|Clinical disease progression|0|||
42203956|NCT03441360|76016663|FG000|Overall Study|Adverse Event|1|||
42203957|NCT03441360|76016664|FG001|Overall Study|Adverse Event|0|||
42203958|NCT03441360|76016665|FG002|Overall Study|Adverse Event|1|||
42203959|NCT01347840|76016673|FG000|Overall Study|Withdrawal by Subject|1|||
42203960|NCT01347762|76016681|FG000|Overall Study|Lost to Follow-up|0|||
42203961|NCT01347762|76016682|FG001|Overall Study|Lost to Follow-up|1|||
42203962|NCT01347762|76016683|FG002|Overall Study|Lost to Follow-up|6|||
42203963|NCT01347762|76016684|FG003|Overall Study|Lost to Follow-up|5|||
42203964|NCT01347762|76016681|FG000|Overall Study|Withdrawal by Subject|4|||
42203965|NCT01347762|76016682|FG001|Overall Study|Withdrawal by Subject|1|||
42203966|NCT01347762|76016683|FG002|Overall Study|Withdrawal by Subject|3|||
42203967|NCT01347762|76016684|FG003|Overall Study|Withdrawal by Subject|3|||
42203968|NCT03438396|76016694|FG000|Overall Study|Reason Not Specified|9|||
42203969|NCT03438396|76016694|FG000|Overall Study|Withdrawal by Subject|5|||
42203970|NCT03438396|76016694|FG000|Overall Study|Lost to Follow-up|2|||
42203971|NCT03438396|76016694|FG000|Overall Study|Death|85|||
42203972|NCT03438396|76016694|FG000|Overall Study|Not treated|1|||
42203973|NCT00073307|76016700|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
42203974|NCT00073307|76016701|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
42203975|NCT00073307|76016702|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
42203976|NCT00073307|76016700|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
42203977|NCT00073307|76016701|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
42203978|NCT00073307|76016702|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
42203979|NCT00073307|76016700|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
42203980|NCT00073307|76016701|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
42203981|NCT00073307|76016702|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
42203982|NCT00073307|76016700|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
42203983|NCT00073307|76016701|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
42203984|NCT00073307|76016702|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
42203985|NCT00073307|76016700|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
42203986|NCT00073307|76016701|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
42203987|NCT00073307|76016702|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
42383016|NCT01380691|76257479|FG002|Washout (7 Days)|Protocol Violation|0|||
42383017|NCT01380691|76257480|FG003|Washout (7 Days)|Protocol Violation|1|||
42383018|NCT01380691|76257477|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
42383019|NCT01380691|76257478|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
42383020|NCT01380691|76257479|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
42110192|NCT00622700|75920598|FG004|Core Treatment Period|Other than specified above|0|||
42110193|NCT00622700|75920599|FG005|Core Treatment Period|Other than specified above|0|||
42110194|NCT00622700|75920600|FG006|Core Treatment Period|Other than specified above|0|||
42110195|NCT00622700|75920594|FG000|Extension Treatment Period|Adverse Event|0|||
42110196|NCT00622700|75920595|FG001|Extension Treatment Period|Adverse Event|0|||
42110197|NCT00622700|75920596|FG002|Extension Treatment Period|Adverse Event|0|||
42110198|NCT00622700|75920597|FG003|Extension Treatment Period|Adverse Event|5|||
42110199|NCT00622700|75920598|FG004|Extension Treatment Period|Adverse Event|9|||
42110200|NCT00622700|75920599|FG005|Extension Treatment Period|Adverse Event|6|||
42110201|NCT00622700|75920600|FG006|Extension Treatment Period|Adverse Event|8|||
42110202|NCT00622700|75920594|FG000|Extension Treatment Period|Lack of Efficacy|0|||
42110203|NCT00622700|75920595|FG001|Extension Treatment Period|Lack of Efficacy|0|||
42110204|NCT00622700|75920596|FG002|Extension Treatment Period|Lack of Efficacy|0|||
42110205|NCT00622700|75920597|FG003|Extension Treatment Period|Lack of Efficacy|2|||
42110206|NCT00622700|75920598|FG004|Extension Treatment Period|Lack of Efficacy|8|||
42110207|NCT00622700|75920599|FG005|Extension Treatment Period|Lack of Efficacy|1|||
42203988|NCT00073307|76016700|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
42203989|NCT00073307|76016701|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
42203990|NCT00073307|76016702|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
42383021|NCT01380691|76257480|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
42383022|NCT01380535|76257506|FG000|Overall Study|Adverse Event|3|||
42383023|NCT01380535|76257507|FG001|Overall Study|Adverse Event|3|||
42383024|NCT01380535|76257506|FG000|Overall Study|Death|3|||
42383025|NCT01380535|76257507|FG001|Overall Study|Death|0|||
42018990|NCT01119105|75826444|FG000|Overall Study|Other|1|||
42110208|NCT00622700|75920600|FG006|Extension Treatment Period|Lack of Efficacy|9|||
42383026|NCT01380535|76257506|FG000|Overall Study|Study site closed|0|||
42383027|NCT01380535|76257507|FG001|Overall Study|Study site closed|5|||
42110209|NCT00622700|75920594|FG000|Extension Treatment Period|Protocol Violation|0|||
42110210|NCT00622700|75920595|FG001|Extension Treatment Period|Protocol Violation|0|||
42110211|NCT00622700|75920596|FG002|Extension Treatment Period|Protocol Violation|0|||
42383028|NCT01380535|76257506|FG000|Overall Study|Withdrawal by Subject|1|||
42383029|NCT01380535|76257507|FG001|Overall Study|Withdrawal by Subject|2|||
42383030|NCT01380535|76257506|FG000|Overall Study|Protocol Violation|0|||
42383031|NCT01380535|76257507|FG001|Overall Study|Protocol Violation|2|||
42383032|NCT01380535|76257506|FG000|Overall Study|Lack of Efficacy|0|||
42383033|NCT01380535|76257507|FG001|Overall Study|Lack of Efficacy|3|||
42383034|NCT01380379|76257517|FG000|Overall Study|Pregnancy|1|||
42383035|NCT01380145|76257521|FG000|Overall Study|Progressive disease|4|||
42383036|NCT03420222|76257547|FG000|Overall Study|Withdrawal by Subject|5|||
42383037|NCT03420222|76257548|FG001|Overall Study|Withdrawal by Subject|0|||
42383038|NCT03420222|76257547|FG000|Overall Study|Physician Decision|0|||
42383039|NCT03420222|76257548|FG001|Overall Study|Physician Decision|1|||
42383040|NCT01394185|76257554|FG000|Overall Study|Withdrawal by Subject|2|||
42383041|NCT01394185|76257555|FG001|Overall Study|Withdrawal by Subject|0|||
42383042|NCT01394185|76257556|FG002|Overall Study|Withdrawal by Subject|0|||
42383043|NCT01394185|76257557|FG003|Overall Study|Withdrawal by Subject|0|||
42383044|NCT01394185|76257558|FG004|Overall Study|Withdrawal by Subject|1|||
42383045|NCT01394185|76257559|FG005|Overall Study|Withdrawal by Subject|0|||
42383046|NCT01394185|76257554|FG000|Overall Study|Change in protocol|3|||
42383047|NCT01394185|76257555|FG001|Overall Study|Change in protocol|0|||
42383048|NCT01394185|76257556|FG002|Overall Study|Change in protocol|0|||
42383049|NCT01394185|76257557|FG003|Overall Study|Change in protocol|0|||
42383050|NCT01394185|76257558|FG004|Overall Study|Change in protocol|3|||
42383051|NCT01394185|76257559|FG005|Overall Study|Change in protocol|0|||
42383052|NCT01394185|76257554|FG000|Overall Study|Protocol Violation|1|||
42383053|NCT01394185|76257555|FG001|Overall Study|Protocol Violation|0|||
42383054|NCT01394185|76257556|FG002|Overall Study|Protocol Violation|0|||
42383055|NCT01394185|76257557|FG003|Overall Study|Protocol Violation|1|||
42383056|NCT01394185|76257558|FG004|Overall Study|Protocol Violation|0|||
42383057|NCT01394185|76257559|FG005|Overall Study|Protocol Violation|1|||
42383058|NCT01677936|76257592|FG000|Overall Study|Lost to Follow-up|4|||
42383059|NCT01677936|76257593|FG001|Overall Study|Lost to Follow-up|1|||
42383060|NCT01677936|76257592|FG000|Overall Study|Protocol Violation|3|||
42383061|NCT01677936|76257593|FG001|Overall Study|Protocol Violation|0|||
42383062|NCT01677936|76257592|FG000|Overall Study|Adverse Event|1|||
42383063|NCT01677936|76257593|FG001|Overall Study|Adverse Event|0|||
42383064|NCT01677936|76257592|FG000|Overall Study|Lost to Follow-up|1|||
42383065|NCT01677936|76257593|FG001|Overall Study|Lost to Follow-up|0|||
42383066|NCT01677936|76257592|FG000|Overall Study|Protocol Violation|0|||
42383067|NCT01677936|76257593|FG001|Overall Study|Protocol Violation|4|||
42383068|NCT01525550|76257624|FG000|Overall Study|Lost to Follow-up|8|||
42383069|NCT01525550|76257625|FG001|Overall Study|Lost to Follow-up|2|||
42383070|NCT01525550|76257624|FG000|Overall Study|Death|19|||
42383071|NCT01525550|76257625|FG001|Overall Study|Death|28|||
42383072|NCT01525550|76257624|FG000|Overall Study|Other|0|||
42383073|NCT01525550|76257625|FG001|Overall Study|Other|4|||
42383074|NCT01525550|76257624|FG000|Overall Study|Sponsor's Decision|30|||
42383075|NCT01525550|76257625|FG001|Overall Study|Sponsor's Decision|11|||
42383076|NCT01525550|76257624|FG000|Overall Study|Withdrawal by Subject|4|||
42383077|NCT01525550|76257625|FG001|Overall Study|Withdrawal by Subject|0|||
42383078|NCT00211237|76257646|FG000|Baseline|Withdrew|1|||
42383079|NCT00211237|76257647|FG001|Baseline|Withdrew|3|||
42383080|NCT00211237|76257648|FG002|Baseline|Withdrew|0|||
42383081|NCT00211237|76257646|FG000|Baseline|Refused random assignment|1|||
42383082|NCT00211237|76257647|FG001|Baseline|Refused random assignment|0|||
42383083|NCT00211237|76257648|FG002|Baseline|Refused random assignment|0|||
42383084|NCT00211237|76257646|FG000|1 Month|Death|2|||
42383085|NCT00211237|76257647|FG001|1 Month|Death|1|||
42383086|NCT00211237|76257648|FG002|1 Month|Death|0|||
42383087|NCT00211237|76257646|FG000|1 Month|Lost to Follow-up|0|||
42383088|NCT00211237|76257647|FG001|1 Month|Lost to Follow-up|2|||
42383089|NCT00211237|76257648|FG002|1 Month|Lost to Follow-up|0|||
42383090|NCT00211237|76257646|FG000|1 Month|Withdrew|0|||
42383091|NCT00211237|76257647|FG001|1 Month|Withdrew|4|||
42383092|NCT00211237|76257648|FG002|1 Month|Withdrew|0|||
42383093|NCT00211237|76257646|FG000|1 Month|Additional surgery needed|1|||
42383094|NCT00211237|76257647|FG001|1 Month|Additional surgery needed|0|||
42383095|NCT00211237|76257648|FG002|1 Month|Additional surgery needed|0|||
42383096|NCT00211237|76257646|FG000|1 Month|Non-medical problem|0|||
42383097|NCT00211237|76257647|FG001|1 Month|Non-medical problem|2|||
42383098|NCT00211237|76257648|FG002|1 Month|Non-medical problem|0|||
42383099|NCT00211237|76257646|FG000|3 Months|Death|7|||
42383100|NCT00211237|76257647|FG001|3 Months|Death|3|||
42383101|NCT00211237|76257648|FG002|3 Months|Death|0|||
42383102|NCT00211237|76257646|FG000|3 Months|Could not comply with protocol|1|||
42383103|NCT00211237|76257647|FG001|3 Months|Could not comply with protocol|0|||
42383104|NCT00211237|76257648|FG002|3 Months|Could not comply with protocol|0|||
42383105|NCT00211237|76257646|FG000|3 Months|Withdrew|0|||
42383106|NCT00211237|76257647|FG001|3 Months|Withdrew|1|||
42383107|NCT00211237|76257648|FG002|3 Months|Withdrew|0|||
42383108|NCT00211237|76257646|FG000|3 Months|Non-medical problem|0|||
42383109|NCT00211237|76257647|FG001|3 Months|Non-medical problem|0|||
42383110|NCT00211237|76257648|FG002|3 Months|Non-medical problem|1|||
42383111|NCT00211237|76257646|FG000|6 Months|Death|6|||
42383112|NCT00211237|76257647|FG001|6 Months|Death|0|||
42383113|NCT00211237|76257648|FG002|6 Months|Death|3|||
42383114|NCT00211237|76257646|FG000|6 Months|Lost to Follow-up|2|||
42383115|NCT00211237|76257647|FG001|6 Months|Lost to Follow-up|0|||
42383116|NCT00211237|76257648|FG002|6 Months|Lost to Follow-up|0|||
42383117|NCT00211237|76257646|FG000|6 Months|Could not comply with protocol|0|||
42383118|NCT00211237|76257647|FG001|6 Months|Could not comply with protocol|2|||
42383119|NCT00211237|76257648|FG002|6 Months|Could not comply with protocol|0|||
42383120|NCT00211237|76257646|FG000|12 Months|Death|8|||
42383121|NCT00211237|76257647|FG001|12 Months|Death|2|||
42383122|NCT00211237|76257648|FG002|12 Months|Death|3|||
42383123|NCT00211237|76257646|FG000|12 Months|Lost to Follow-up|1|||
42383124|NCT00211237|76257647|FG001|12 Months|Lost to Follow-up|0|||
42383125|NCT00211237|76257648|FG002|12 Months|Lost to Follow-up|1|||
42383126|NCT00211237|76257646|FG000|12 Months|Withdrew|0|||
42383127|NCT00211237|76257647|FG001|12 Months|Withdrew|0|||
42383128|NCT00211237|76257648|FG002|12 Months|Withdrew|1|||
42383129|NCT00211237|76257646|FG000|12 Months|unrelated medical problem|0|||
42383130|NCT00211237|76257647|FG001|12 Months|unrelated medical problem|0|||
42383131|NCT00211237|76257648|FG002|12 Months|unrelated medical problem|1|||
42383132|NCT01489358|76257668|FG000|Overall Study|Lost to Follow-up|0|||
42383133|NCT01489358|76257669|FG001|Overall Study|Lost to Follow-up|0|||
42383134|NCT01489358|76257670|FG002|Overall Study|Lost to Follow-up|2|||
42383135|NCT01525238|76257681|FG000|Overall Study|Withdrawal by Subject|1|||
42383136|NCT01525238|76257682|FG001|Overall Study|Withdrawal by Subject|0|||
42383137|NCT01525238|76257683|FG002|Overall Study|Withdrawal by Subject|0|||
42383138|NCT01525082|76257704|FG000|Overall Study|Death|1|||
42383139|NCT01488578|76257711|FG000|Overall Study|Protocol Violation|1836|||
42383140|NCT01524770|76257752|FG000|First Intervention|Withdrawal by Subject|1|||
42383141|NCT01524770|76257753|FG001|First Intervention|Withdrawal by Subject|0|||
42383142|NCT01524770|76257752|FG000|First Intervention|Adverse Event|1|||
42383143|NCT01524770|76257753|FG001|First Intervention|Adverse Event|1|||
42383144|NCT01524770|76257752|FG000|First Intervention|Protocol Violation|1|||
42383145|NCT01524770|76257753|FG001|First Intervention|Protocol Violation|0|||
42383146|NCT05166876|76257777|FG000|Overall Study|Withdrawal by Subject|1|||
42383147|NCT05166876|76257778|FG001|Overall Study|Withdrawal by Subject|0|||
42383148|NCT05166876|76257779|FG002|Overall Study|Withdrawal by Subject|0|||
42383149|NCT05065619|76257793|FG000|Up to Day 42|Lost to Follow-up|1|||
42383150|NCT05065619|76257794|FG001|Up to Day 42|Lost to Follow-up|0|||
42383151|NCT05065619|76257793|FG000|Up to Day 42|Withdrawal by Subject|1|||
42383152|NCT05065619|76257794|FG001|Up to Day 42|Withdrawal by Subject|0|||
42383153|NCT05065619|76257793|FG000|After Day 43|Lost to Follow-up|1|||
42383154|NCT05065619|76257794|FG001|After Day 43|Lost to Follow-up|0|||
42383155|NCT05065619|76257793|FG000|After Day 43|Physician Decision|3|||
42383156|NCT05065619|76257794|FG001|After Day 43|Physician Decision|0|||
42383157|NCT05065619|76257793|FG000|After Day 43|Withdrawal by Subject|1|||
42383158|NCT05065619|76257794|FG001|After Day 43|Withdrawal by Subject|2|||
42383159|NCT05065619|76257793|FG000|After Day 43|Public vaccination|6|||
42383160|NCT05065619|76257794|FG001|After Day 43|Public vaccination|8|||
42383161|NCT05065619|76257793|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
42383162|NCT05065619|76257794|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
42383163|NCT05065619|76257793|FG000|After Day 43|Study Terminated by Sponsor|88|||
42383164|NCT05065619|76257794|FG001|After Day 43|Study Terminated by Sponsor|16|||
42383165|NCT04581200|76257820|FG000|Overall Study|Lost to Follow-up|6|||
42383166|NCT04581200|76257821|FG001|Overall Study|Lost to Follow-up|5|||
42383167|NCT04576455|76257830|FG000|Overall Study|Ongoing in the Study|122|||
42383168|NCT04576455|76257831|FG001|Overall Study|Ongoing in the Study|135|||
42383169|NCT04576455|76257830|FG000|Overall Study|Death|18|||
42383170|NCT04576455|76257831|FG001|Overall Study|Death|12|||
42383171|NCT04576455|76257830|FG000|Overall Study|Lost to Follow-up|1|||
42383172|NCT04576455|76257831|FG001|Overall Study|Lost to Follow-up|0|||
42383173|NCT04576455|76257830|FG000|Overall Study|Withdrawal by Subject|10|||
42383174|NCT04576455|76257831|FG001|Overall Study|Withdrawal by Subject|5|||
42383175|NCT04481243|76257842|FG000|Overall Study|Withdrawal by Subject|4|||
42383176|NCT04468230|76257846|FG000|Overall Study|Adverse Event|2|||
42383177|NCT04439175|76257863|FG000|Overall Study|Never started treatment|4|||
42383178|NCT04439175|76257863|FG000|Overall Study|Ineligible|5|||
42383179|NCT04439175|76257863|FG000|Overall Study|Adverse Event|6|||
42383180|NCT04439175|76257863|FG000|Overall Study|Death|4|||
42383181|NCT04439175|76257863|FG000|Overall Study|Disease progression|44|||
42383182|NCT04439175|76257863|FG000|Overall Study|Withdrawal by Subject|4|||
42383183|NCT04439175|76257863|FG000|Overall Study|Alternative Therapy|1|||
42383184|NCT04439175|76257863|FG000|Overall Study|Other|2|||
42383185|NCT04439136|76257867|FG000|Overall Study|Ineligible|1|||
42383186|NCT04439136|76257867|FG000|Overall Study|Never Started Treatment|2|||
42383187|NCT04439136|76257867|FG000|Overall Study|Adverse Event|4|||
42383188|NCT04439136|76257867|FG000|Overall Study|Death|3|||
42383189|NCT04439136|76257867|FG000|Overall Study|Disease Progression|27|||
42383190|NCT04439136|76257867|FG000|Overall Study|Alternative Therapy|1|||
42383191|NCT04439136|76257867|FG000|Overall Study|Increased Tumor Burden|1|||
42383192|NCT04439136|76257867|FG000|Overall Study|Symptomatic Detrioration|1|||
42383193|NCT04204902|76257900|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
42383194|NCT04204902|76257901|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
42383195|NCT04191616|76257907|FG000|Overall Study|Death|26|||
42383196|NCT04191616|76257907|FG000|Overall Study|Withdrawal by Subject|1|||
42383197|NCT04191616|76257907|FG000|Overall Study|Sponsor decision|2|||
42383198|NCT04191616|76257907|FG000|Overall Study|Continuing study|25|||
42383199|NCT04166383|76257911|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
42383200|NCT04166383|76257911|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
42383201|NCT04166383|76257911|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
42383202|NCT04163458|76257932|FG000|Overall Study|Protocol Deviation|7|||
42383203|NCT04163458|76257933|FG001|Overall Study|Protocol Deviation|13|||
42383204|NCT04163458|76257932|FG000|Overall Study|Adverse Event|5|||
42383205|NCT04163458|76257933|FG001|Overall Study|Adverse Event|8|||
42383206|NCT04163458|76257932|FG000|Overall Study|Due to COVID-19 pandemic|4|||
42383207|NCT04163458|76257933|FG001|Overall Study|Due to COVID-19 pandemic|2|||
42383208|NCT04163458|76257932|FG000|Overall Study|Participant withdrew consent|2|||
42383209|NCT04163458|76257933|FG001|Overall Study|Participant withdrew consent|3|||
42383210|NCT04163458|76257932|FG000|Overall Study|Randomization failure|2|||
42383211|NCT04163458|76257933|FG001|Overall Study|Randomization failure|2|||
42383212|NCT04163458|76257932|FG000|Overall Study|Other|4|||
42383213|NCT04163458|76257933|FG001|Overall Study|Other|2|||
42383214|NCT03834519|76257986|FG000|Overall Study|Ongoing|234|||
42383215|NCT03834519|76257987|FG001|Overall Study|Ongoing|111|||
42383216|NCT03834519|76257986|FG000|Overall Study|Withdrawal by Subject|4|||
42383217|NCT03834519|76257987|FG001|Overall Study|Withdrawal by Subject|7|||
42383218|NCT03834519|76257986|FG000|Overall Study|Death|291|||
42383219|NCT03834519|76257987|FG001|Overall Study|Death|146|||
42383220|NCT03783442|76257995|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
42383221|NCT03783442|76257996|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
42383222|NCT03783442|76257995|FG000|Overall Study|Death|196|||
42383223|NCT03783442|76257996|FG001|Overall Study|Death|226|||
42383224|NCT03783442|76257995|FG000|Overall Study|Withdrawal by Subject|14|||
42383225|NCT03783442|76257996|FG001|Overall Study|Withdrawal by Subject|17|||
42383226|NCT03783442|76257995|FG000|Overall Study|Lost to Follow-up|2|||
42383227|NCT03783442|76257996|FG001|Overall Study|Lost to Follow-up|3|||
42383228|NCT03734016|76258004|FG000|Overall Study|Participants Remaining in the Study|260|||
42383229|NCT03734016|76258005|FG001|Overall Study|Participants Remaining in the Study|240|||
42383230|NCT03734016|76258004|FG000|Overall Study|Death|48|||
42383231|NCT03734016|76258005|FG001|Overall Study|Death|60|||
42383232|NCT03734016|76258004|FG000|Overall Study|Withdrawal by Subject|14|||
42383233|NCT03734016|76258005|FG001|Overall Study|Withdrawal by Subject|16|||
42383234|NCT03734016|76258004|FG000|Overall Study|Physician Decision|0|||
42383235|NCT03734016|76258005|FG001|Overall Study|Physician Decision|7|||
42383236|NCT03734016|76258004|FG000|Overall Study|Lost to Follow-up|3|||
42383237|NCT03734016|76258005|FG001|Overall Study|Lost to Follow-up|1|||
42383238|NCT03734016|76258004|FG000|Overall Study|Adverse Event|2|||
42383239|NCT03734016|76258005|FG001|Overall Study|Adverse Event|1|||
42383240|NCT03693300|76258014|FG000|Overall Study|Patients ongoing study|43|||
42383241|NCT03693300|76258015|FG001|Overall Study|Patients ongoing study|1|||
42383242|NCT03671564|76258026|FG000|Overall Study|Progressive Disease|3|||
42383243|NCT03671564|76258027|FG001|Overall Study|Progressive Disease|5|||
42383244|NCT03671564|76258028|FG002|Overall Study|Progressive Disease|3|||
42383245|NCT03671564|76258026|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
42383246|NCT03671564|76258027|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
42383247|NCT03671564|76258028|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
42383248|NCT03671564|76258026|FG000|Overall Study|Withdrawal by Subject|1|||
42383249|NCT03671564|76258027|FG001|Overall Study|Withdrawal by Subject|1|||
42383250|NCT03671564|76258028|FG002|Overall Study|Withdrawal by Subject|0|||
42383251|NCT03632720|76258048|FG000|Overall Study|Adverse Event|2|||
42383252|NCT03632720|76258049|FG001|Overall Study|Adverse Event|0|||
42383253|NCT03632720|76258050|FG002|Overall Study|Adverse Event|0|||
42383254|NCT03632720|76258048|FG000|Overall Study|Lost to Follow-up|0|||
42383255|NCT03632720|76258049|FG001|Overall Study|Lost to Follow-up|1|||
42383256|NCT03632720|76258050|FG002|Overall Study|Lost to Follow-up|0|||
42383257|NCT03632720|76258048|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
42383258|NCT03632720|76258049|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
42383259|NCT03632720|76258050|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
42383260|NCT03632720|76258048|FG000|Overall Study|Screen failure|0|||
42383261|NCT03632720|76258049|FG001|Overall Study|Screen failure|1|||
42383262|NCT03632720|76258050|FG002|Overall Study|Screen failure|0|||
42383263|NCT03606512|76258062|FG000|Overall Study|Lost to Follow-up|0|||
42383264|NCT03606512|76258063|FG001|Overall Study|Lost to Follow-up|1|||
42383265|NCT03606512|76258062|FG000|Overall Study|'moved from study area|0|||
42383266|NCT03606512|76258063|FG001|Overall Study|'moved from study area|1|||
42383267|NCT03398200|76258086|FG000|Overall Study|Withdrawal by Subject|0|||
42383268|NCT03398200|76258087|FG001|Overall Study|Withdrawal by Subject|1|||
42383269|NCT03323099|76258113|FG000|Overall Study|Withdrawal by Subject|6|||
42383270|NCT03323099|76258114|FG001|Overall Study|Withdrawal by Subject|12|||
42383271|NCT03323099|76258113|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
42383272|NCT03323099|76258114|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
42383273|NCT03323034|76258125|FG000|Overall Study|Lack of Efficacy|5|||
42383274|NCT03323034|76258126|FG001|Overall Study|Lack of Efficacy|5|||
42383275|NCT03323034|76258127|FG002|Overall Study|Lack of Efficacy|6|||
42383276|NCT03323034|76258128|FG003|Overall Study|Lack of Efficacy|5|||
42383277|NCT03323034|76258129|FG004|Overall Study|Lack of Efficacy|5|||
42383278|NCT03323034|76258125|FG000|Overall Study|Physician Decision|0|||
42383279|NCT03323034|76258126|FG001|Overall Study|Physician Decision|0|||
42383280|NCT03323034|76258127|FG002|Overall Study|Physician Decision|0|||
42383281|NCT03323034|76258128|FG003|Overall Study|Physician Decision|0|||
42383282|NCT03323034|76258129|FG004|Overall Study|Physician Decision|1|||
42383283|NCT03323034|76258125|FG000|Overall Study|Withdrawal by Subject|1|||
42383284|NCT03323034|76258126|FG001|Overall Study|Withdrawal by Subject|1|||
42383285|NCT03323034|76258127|FG002|Overall Study|Withdrawal by Subject|0|||
42383286|NCT03323034|76258128|FG003|Overall Study|Withdrawal by Subject|1|||
42383287|NCT03323034|76258129|FG004|Overall Study|Withdrawal by Subject|0|||
42383288|NCT03307252|76258153|FG000|Part 2, Period 1|Treatment not received|0|||
42383289|NCT03307252|76258154|FG001|Part 2, Period 1|Treatment not received|0|||
42383290|NCT03307252|76258155|FG002|Part 2, Period 1|Treatment not received|0|||
42383291|NCT03307252|76258156|FG003|Part 2, Period 1|Treatment not received|0|||
42383292|NCT03307252|76258157|FG004|Part 2, Period 1|Treatment not received|0|||
42383293|NCT03307252|76258158|FG005|Part 2, Period 1|Treatment not received|1|||
42383294|NCT03307252|76258159|FG006|Part 2, Period 1|Treatment not received|0|||
42383295|NCT03307252|76258160|FG007|Part 2, Period 1|Treatment not received|0|||
42383296|NCT03307252|76258161|FG008|Part 2, Period 1|Treatment not received|0|||
42383297|NCT03307252|76258162|FG009|Part 2, Period 1|Treatment not received|0|||
42383298|NCT03307252|76258163|FG010|Part 2, Period 1|Treatment not received|0|||
42383299|NCT03307252|76258153|FG000|Part 2, Period 3|Other than listed|0|||
42383300|NCT03307252|76258154|FG001|Part 2, Period 3|Other than listed|0|||
42383301|NCT03307252|76258155|FG002|Part 2, Period 3|Other than listed|0|||
42383302|NCT03307252|76258156|FG003|Part 2, Period 3|Other than listed|0|||
42383303|NCT03307252|76258157|FG004|Part 2, Period 3|Other than listed|1|||
42383304|NCT03307252|76258158|FG005|Part 2, Period 3|Other than listed|0|||
42383305|NCT03307252|76258159|FG006|Part 2, Period 3|Other than listed|0|||
42383306|NCT03307252|76258160|FG007|Part 2, Period 3|Other than listed|0|||
42383307|NCT03307252|76258161|FG008|Part 2, Period 3|Other than listed|0|||
42383308|NCT03307252|76258162|FG009|Part 2, Period 3|Other than listed|0|||
42383309|NCT03307252|76258163|FG010|Part 2, Period 3|Other than listed|0|||
42383310|NCT03307252|76258153|FG000|Part 2, Period 4|Other than listed|0|||
42383311|NCT03307252|76258154|FG001|Part 2, Period 4|Other than listed|0|||
42383312|NCT03307252|76258155|FG002|Part 2, Period 4|Other than listed|0|||
42383313|NCT03307252|76258156|FG003|Part 2, Period 4|Other than listed|0|||
42383314|NCT03307252|76258157|FG004|Part 2, Period 4|Other than listed|0|||
42383315|NCT03307252|76258158|FG005|Part 2, Period 4|Other than listed|0|||
42383316|NCT03307252|76258159|FG006|Part 2, Period 4|Other than listed|1|||
42383317|NCT03307252|76258160|FG007|Part 2, Period 4|Other than listed|0|||
42383318|NCT03307252|76258161|FG008|Part 2, Period 4|Other than listed|0|||
42383319|NCT03307252|76258162|FG009|Part 2, Period 4|Other than listed|0|||
42383320|NCT03307252|76258163|FG010|Part 2, Period 4|Other than listed|0|||
42383321|NCT03307252|76258153|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
42383322|NCT03307252|76258154|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
42383323|NCT03307252|76258155|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
42383324|NCT03307252|76258156|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
42383325|NCT03307252|76258157|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
42383326|NCT03307252|76258158|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
42383327|NCT03307252|76258159|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
42383328|NCT03307252|76258160|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
42383329|NCT03307252|76258161|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
42383330|NCT03307252|76258162|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
42383331|NCT03307252|76258163|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
42383332|NCT03286504|76258181|FG000|Overall Study|Lost to Follow-up|19|||
42383333|NCT03286504|76258182|FG001|Overall Study|Lost to Follow-up|16|||
42383334|NCT03191786|76258199|FG000|Overall Study|Death|236|||
42383335|NCT03191786|76258200|FG001|Overall Study|Death|127|||
42383336|NCT03191786|76258199|FG000|Overall Study|Lost to Follow-up|9|||
42383337|NCT03191786|76258200|FG001|Overall Study|Lost to Follow-up|3|||
42383338|NCT03191786|76258199|FG000|Overall Study|Physician Decision|1|||
42383339|NCT03191786|76258200|FG001|Overall Study|Physician Decision|0|||
42383340|NCT03191786|76258199|FG000|Overall Study|Study Terminated By Sponsor|15|||
42383341|NCT03191786|76258200|FG001|Overall Study|Study Terminated By Sponsor|5|||
42383342|NCT03191786|76258199|FG000|Overall Study|Withdrawal by Subject|26|||
42383343|NCT03191786|76258200|FG001|Overall Study|Withdrawal by Subject|16|||
42383344|NCT03138733|76258208|FG000|Overall Study|Death|17|||
42383345|NCT03138733|76258209|FG001|Overall Study|Death|18|||
42383346|NCT03138733|76258208|FG000|Overall Study|Withdrawal by Subject|11|||
42383347|NCT03138733|76258209|FG001|Overall Study|Withdrawal by Subject|6|||
42383348|NCT03138733|76258208|FG000|Overall Study|Lost to Follow-up|3|||
42383349|NCT03138733|76258209|FG001|Overall Study|Lost to Follow-up|2|||
42383350|NCT03138733|76258208|FG000|Overall Study|Adverse Event|1|||
42383351|NCT03138733|76258209|FG001|Overall Study|Adverse Event|0|||
42383352|NCT03138733|76258208|FG000|Overall Study|Protocol Violation|1|||
42383353|NCT03138733|76258209|FG001|Overall Study|Protocol Violation|3|||
42383354|NCT03138733|76258208|FG000|Overall Study|Administrative or logistical reason|1|||
42383355|NCT03138733|76258209|FG001|Overall Study|Administrative or logistical reason|0|||
42383356|NCT03138733|76258208|FG000|Overall Study|The patient was transferred to another hospital|1|||
42383357|NCT03138733|76258209|FG001|Overall Study|The patient was transferred to another hospital|0|||
42383358|NCT03057054|76258217|FG000|Overall Study|Death|4|||
42383359|NCT03057054|76258218|FG001|Overall Study|Death|4|||
42383360|NCT03057054|76258217|FG000|Overall Study|Withdrawal by Subject|6|||
42383361|NCT03057054|76258218|FG001|Overall Study|Withdrawal by Subject|3|||
42383362|NCT03057054|76258217|FG000|Overall Study|Ineligible|1|||
42383363|NCT03057054|76258218|FG001|Overall Study|Ineligible|1|||
42383364|NCT02854527|76258295|FG000|Overall Study|Adverse Event|0|||
42383365|NCT02854527|76258296|FG001|Overall Study|Adverse Event|0|||
42383366|NCT02854527|76258297|FG002|Overall Study|Adverse Event|0|||
42383367|NCT02854527|76258298|FG003|Overall Study|Adverse Event|0|||
42383368|NCT02854527|76258299|FG004|Overall Study|Adverse Event|1|||
42383369|NCT02854527|76258300|FG005|Overall Study|Adverse Event|0|||
42383370|NCT02854527|76258301|FG006|Overall Study|Adverse Event|0|||
42383371|NCT02854527|76258302|FG007|Overall Study|Adverse Event|0|||
42383372|NCT02854527|76258303|FG008|Overall Study|Adverse Event|0|||
42383373|NCT02854527|76258304|FG009|Overall Study|Adverse Event|0|||
42383374|NCT02854527|76258295|FG000|Overall Study|Lost to Follow-up|0|||
42383375|NCT02854527|76258296|FG001|Overall Study|Lost to Follow-up|0|||
42383376|NCT02854527|76258297|FG002|Overall Study|Lost to Follow-up|0|||
42383377|NCT02854527|76258298|FG003|Overall Study|Lost to Follow-up|1|||
42383378|NCT02854527|76258299|FG004|Overall Study|Lost to Follow-up|0|||
42383379|NCT02854527|76258300|FG005|Overall Study|Lost to Follow-up|0|||
42383380|NCT02854527|76258301|FG006|Overall Study|Lost to Follow-up|0|||
42383381|NCT02854527|76258302|FG007|Overall Study|Lost to Follow-up|0|||
42383382|NCT02854527|76258303|FG008|Overall Study|Lost to Follow-up|0|||
42383383|NCT02854527|76258304|FG009|Overall Study|Lost to Follow-up|0|||
42383384|NCT02772081|76258318|FG000|Overall Study|Physician Decision|1|||
42383385|NCT02772081|76258319|FG001|Overall Study|Physician Decision|1|||
42383386|NCT02772081|76258318|FG000|Overall Study|Death|1|||
42383387|NCT02772081|76258319|FG001|Overall Study|Death|1|||
42110212|NCT00622700|75920597|FG003|Extension Treatment Period|Protocol Violation|0|||
42110213|NCT00622700|75920598|FG004|Extension Treatment Period|Protocol Violation|0|||
42110214|NCT00622700|75920599|FG005|Extension Treatment Period|Protocol Violation|2|||
42110215|NCT00622700|75920600|FG006|Extension Treatment Period|Protocol Violation|0|||
42110216|NCT00622700|75920594|FG000|Extension Treatment Period|Lost to Follow-up|0|||
42110217|NCT00622700|75920595|FG001|Extension Treatment Period|Lost to Follow-up|0|||
42110218|NCT00622700|75920596|FG002|Extension Treatment Period|Lost to Follow-up|0|||
42110219|NCT00622700|75920597|FG003|Extension Treatment Period|Lost to Follow-up|0|||
42110220|NCT00622700|75920598|FG004|Extension Treatment Period|Lost to Follow-up|1|||
42110221|NCT00622700|75920599|FG005|Extension Treatment Period|Lost to Follow-up|0|||
42110222|NCT00622700|75920600|FG006|Extension Treatment Period|Lost to Follow-up|0|||
42110223|NCT00622700|75920594|FG000|Extension Treatment Period|Progressive Disease|0|||
42110224|NCT00622700|75920595|FG001|Extension Treatment Period|Progressive Disease|0|||
42110225|NCT00622700|75920596|FG002|Extension Treatment Period|Progressive Disease|0|||
42383388|NCT02639559|76258336|FG000|Overall Study|Mobilization failure|0|||
42383389|NCT02639559|76258337|FG001|Overall Study|Mobilization failure|3|||
42383390|NCT02639559|76258336|FG000|Overall Study|Issues with vascular acess|1|||
42383391|NCT02639559|76258337|FG001|Overall Study|Issues with vascular acess|0|||
42383392|NCT02581891|76258345|FG000|Overall Study|Adverse Event|4|||
42383393|NCT02581891|76258346|FG001|Overall Study|Adverse Event|6|||
42383394|NCT02581891|76258345|FG000|Overall Study|Death|3|||
42383395|NCT02581891|76258346|FG001|Overall Study|Death|4|||
42383396|NCT02581891|76258345|FG000|Overall Study|Lost to Follow-up|1|||
42383397|NCT02581891|76258346|FG001|Overall Study|Lost to Follow-up|2|||
42383398|NCT02581891|76258345|FG000|Overall Study|Physician Decision|0|||
42110226|NCT00622700|75920597|FG003|Extension Treatment Period|Progressive Disease|1|||
42110227|NCT00622700|75920598|FG004|Extension Treatment Period|Progressive Disease|2|||
42383399|NCT02581891|76258346|FG001|Overall Study|Physician Decision|1|||
42383400|NCT02581891|76258345|FG000|Overall Study|Withdrawal by Subject|4|||
42383401|NCT02581891|76258346|FG001|Overall Study|Withdrawal by Subject|5|||
42383402|NCT02581891|76258345|FG000|Overall Study|Other Reasons|3|||
42383403|NCT02581891|76258346|FG001|Overall Study|Other Reasons|1|||
42383404|NCT02581891|76258345|FG000|Overall Study|Discontinued during followup|1|||
42383405|NCT02581891|76258346|FG001|Overall Study|Discontinued during followup|0|||
42383406|NCT02576535|76258353|FG000|Overall Study|Withdrawal by Subject|2|||
42383407|NCT02574845|76258363|FG000|Overall Study|Consent withdrawn further participation|0|||
42383408|NCT02574845|76258364|FG001|Overall Study|Consent withdrawn further participation|0|||
42383409|NCT02574845|76258365|FG002|Overall Study|Consent withdrawn further participation|0|||
42383410|NCT02574845|76258366|FG003|Overall Study|Consent withdrawn further participation|0|||
42383411|NCT02574845|76258367|FG004|Overall Study|Consent withdrawn further participation|1|||
42383412|NCT02574845|76258368|FG005|Overall Study|Consent withdrawn further participation|0|||
42383413|NCT02574845|76258363|FG000|Overall Study|Adverse Event|0|||
42383414|NCT02574845|76258364|FG001|Overall Study|Adverse Event|1|||
42383415|NCT02574845|76258365|FG002|Overall Study|Adverse Event|0|||
42383416|NCT02574845|76258366|FG003|Overall Study|Adverse Event|0|||
42383417|NCT02574845|76258367|FG004|Overall Study|Adverse Event|0|||
42383418|NCT02574845|76258368|FG005|Overall Study|Adverse Event|1|||
42383419|NCT01946139|76258440|FG000|Overall Study|Withdrawal by Subject|8|||
42383420|NCT01946139|76258440|FG000|Overall Study|ineligible|8|||
42383421|NCT01946139|76258440|FG000|Overall Study|Specimens not available|4|||
42383422|NCT01685008|76258448|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
42383423|NCT01685008|76258449|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
42383424|NCT01685008|76258450|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
42383425|NCT01685008|76258451|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
42383426|NCT01685008|76258448|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
42383427|NCT01685008|76258449|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
42383428|NCT01685008|76258450|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
42383429|NCT01685008|76258451|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
42383430|NCT01685008|76258448|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
42383431|NCT01685008|76258449|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
42383432|NCT01685008|76258450|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
42383433|NCT01685008|76258451|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
42383434|NCT01685008|76258448|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
42383435|NCT01685008|76258449|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
42383436|NCT01685008|76258450|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
42383437|NCT01685008|76258451|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
42383438|NCT01685008|76258448|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
42383439|NCT01685008|76258449|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
42383440|NCT01685008|76258450|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
42383441|NCT01685008|76258451|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
42383442|NCT01556490|76258480|FG000|Randomized Patients Summary|Protocol Violation|22|||
42383443|NCT01556490|76258481|FG001|Randomized Patients Summary|Protocol Violation|23|||
42383444|NCT01556490|76258480|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
42383445|NCT01556490|76258481|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
42383446|NCT01133990|76258500|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
42383447|NCT01133990|76258501|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
42383448|NCT01133990|76258502|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
42383449|NCT01133990|76258503|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
42383450|NCT01133990|76258504|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
42383451|NCT01133990|76258505|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
42383452|NCT01133990|76258500|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
42383453|NCT01133990|76258501|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
42383454|NCT01133990|76258502|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
42383455|NCT01133990|76258503|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
42383456|NCT01133990|76258504|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
42383457|NCT01133990|76258505|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
42383458|NCT01133990|76258500|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
42383459|NCT01133990|76258501|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
42383460|NCT01133990|76258502|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
42383461|NCT01133990|76258503|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
42383462|NCT01133990|76258504|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
42383463|NCT01133990|76258505|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
42383464|NCT01133990|76258500|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
42383465|NCT01133990|76258501|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
42383466|NCT01133990|76258502|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
42383467|NCT01133990|76258503|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
42383468|NCT01133990|76258504|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
42383469|NCT01133990|76258505|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
42383470|NCT00910429|76258514|FG000|Overall Study|Death|18|||
42383471|NCT00910429|76258515|FG001|Overall Study|Death|12|||
42383472|NCT00910429|76258514|FG000|Overall Study|Withdrawal by Subject|3|||
42383473|NCT00910429|76258515|FG001|Overall Study|Withdrawal by Subject|2|||
42383474|NCT00910429|76258514|FG000|Overall Study|Protocol Violation|1|||
42383475|NCT00910429|76258515|FG001|Overall Study|Protocol Violation|0|||
42383476|NCT00910429|76258514|FG000|Overall Study|Lost to Follow-up|2|||
42383477|NCT00910429|76258515|FG001|Overall Study|Lost to Follow-up|1|||
42383478|NCT00910429|76258514|FG000|Overall Study|Adverse Event|10|||
42383479|NCT00910429|76258515|FG001|Overall Study|Adverse Event|5|||
42383480|NCT00910429|76258514|FG000|Overall Study|Drug non-compliance|1|||
42383481|NCT00910429|76258515|FG001|Overall Study|Drug non-compliance|0|||
42383482|NCT00910429|76258514|FG000|Overall Study|Lack of Efficacy|4|||
42383483|NCT00910429|76258515|FG001|Overall Study|Lack of Efficacy|1|||
42383484|NCT00863681|76258524|FG000|Overall Study|Other|2|||
42383485|NCT00863681|76258525|FG001|Overall Study|Other|0|||
42383486|NCT00863681|76258526|FG002|Overall Study|Other|0|||
42383487|NCT00863681|76258524|FG000|Overall Study|Missing|1|||
42383488|NCT00863681|76258525|FG001|Overall Study|Missing|0|||
42383489|NCT00863681|76258526|FG002|Overall Study|Missing|0|||
42383490|NCT00863681|76258524|FG000|Overall Study|Death|40|||
42383491|NCT00863681|76258525|FG001|Overall Study|Death|23|||
42383492|NCT00863681|76258526|FG002|Overall Study|Death|6|||
42383493|NCT00863681|76258524|FG000|Overall Study|Withdrawal by Subject|12|||
42383494|NCT00863681|76258525|FG001|Overall Study|Withdrawal by Subject|5|||
42383495|NCT00863681|76258526|FG002|Overall Study|Withdrawal by Subject|2|||
42383496|NCT00863681|76258524|FG000|Overall Study|Protocol Violation|2|||
42383497|NCT00863681|76258525|FG001|Overall Study|Protocol Violation|0|||
42383498|NCT00863681|76258526|FG002|Overall Study|Protocol Violation|0|||
42383499|NCT00863681|76258524|FG000|Overall Study|Lost to Follow-up|3|||
42383500|NCT00863681|76258525|FG001|Overall Study|Lost to Follow-up|0|||
42383501|NCT00863681|76258526|FG002|Overall Study|Lost to Follow-up|3|||
42383502|NCT00863681|76258524|FG000|Overall Study|Adverse Event|28|||
42383503|NCT00863681|76258525|FG001|Overall Study|Adverse Event|10|||
42383504|NCT00863681|76258526|FG002|Overall Study|Adverse Event|6|||
42383505|NCT00863681|76258524|FG000|Overall Study|Lack of Efficacy|2|||
42383506|NCT00863681|76258525|FG001|Overall Study|Lack of Efficacy|2|||
42383507|NCT00863681|76258526|FG002|Overall Study|Lack of Efficacy|1|||
42383508|NCT00863681|76258524|FG000|Overall Study|Non-compliance with study drug|1|||
42383509|NCT00863681|76258525|FG001|Overall Study|Non-compliance with study drug|3|||
42383510|NCT00863681|76258526|FG002|Overall Study|Non-compliance with study drug|0|||
42383511|NCT00846742|76258534|FG000|Overall Study|Withdrawal by Subject|1|||
42383512|NCT00734149|76258539|FG000|Overall Study|Withdrawal by Subject|1|||
42383513|NCT00587431|76258547|FG000|Overall Study|Adverse Event|1|||
42383514|NCT00587431|76258548|FG001|Overall Study|Adverse Event|0|||
42383515|NCT00587431|76258547|FG000|Overall Study|Withdrawal by Subject|0|||
42383516|NCT00587431|76258548|FG001|Overall Study|Withdrawal by Subject|1|||
42383517|NCT00097786|76258570|FG000|Overall Study|lost to follow-up for all-cause death|296|||
42383518|NCT00097786|76258571|FG001|Overall Study|lost to follow-up for all-cause death|292|||
42383519|NCT00097786|76258572|FG002|Overall Study|lost to follow-up for all-cause death|313|||
42383520|NCT00097786|76258573|FG003|Overall Study|lost to follow-up for all-cause death|310|||
42383521|NCT01524692|76258583|FG000|Overall Study|Withdrawal by Subject|3|||
42383522|NCT01431287|76258602|FG000|Overall Study|not treated|0|||
42383523|NCT01431287|76258603|FG001|Overall Study|not treated|0|||
42383524|NCT01431287|76258604|FG002|Overall Study|not treated|1|||
42383525|NCT01431287|76258605|FG003|Overall Study|not treated|0|||
42383526|NCT01431287|76258606|FG004|Overall Study|not treated|0|||
42383527|NCT01431287|76258602|FG000|Overall Study|Adverse Event|59|||
42383528|NCT01431287|76258603|FG001|Overall Study|Adverse Event|57|||
42383529|NCT01431287|76258604|FG002|Overall Study|Adverse Event|53|||
42383530|NCT01431287|76258605|FG003|Overall Study|Adverse Event|33|||
42383531|NCT01431287|76258606|FG004|Overall Study|Adverse Event|41|||
42383532|NCT01431287|76258602|FG000|Overall Study|Non compliant with protocol|6|||
42383533|NCT01431287|76258603|FG001|Overall Study|Non compliant with protocol|6|||
42383534|NCT01431287|76258604|FG002|Overall Study|Non compliant with protocol|5|||
42383535|NCT01431287|76258605|FG003|Overall Study|Non compliant with protocol|6|||
42383536|NCT01431287|76258606|FG004|Overall Study|Non compliant with protocol|5|||
42383537|NCT01431287|76258602|FG000|Overall Study|Lost to Follow-up|0|||
42383538|NCT01431287|76258603|FG001|Overall Study|Lost to Follow-up|3|||
42383539|NCT01431287|76258604|FG002|Overall Study|Lost to Follow-up|2|||
42383540|NCT01431287|76258605|FG003|Overall Study|Lost to Follow-up|3|||
42383541|NCT01431287|76258606|FG004|Overall Study|Lost to Follow-up|1|||
42383542|NCT01431287|76258602|FG000|Overall Study|Consent withdrawn not due to AE|29|||
42018991|NCT01119105|75826445|FG001|Overall Study|Other|1|||
42383543|NCT01431287|76258603|FG001|Overall Study|Consent withdrawn not due to AE|30|||
42383544|NCT01431287|76258604|FG002|Overall Study|Consent withdrawn not due to AE|34|||
42383545|NCT01431287|76258605|FG003|Overall Study|Consent withdrawn not due to AE|19|||
42383546|NCT01431287|76258606|FG004|Overall Study|Consent withdrawn not due to AE|29|||
42383547|NCT01431287|76258602|FG000|Overall Study|not stated above|4|||
42383548|NCT01431287|76258603|FG001|Overall Study|not stated above|2|||
42383549|NCT01431287|76258604|FG002|Overall Study|not stated above|2|||
42383550|NCT01431287|76258605|FG003|Overall Study|not stated above|2|||
42383551|NCT01431287|76258606|FG004|Overall Study|not stated above|1|||
42383552|NCT01274715|76258652|FG000|Overall Study|Lost to Follow-up|1|||
42383553|NCT01274715|76258652|FG000|Overall Study|After consent, met exclusion criteria.|1|||
42383554|NCT01274715|76258652|FG000|Overall Study|After consent, met exclusion criteria.|1|||
42383555|NCT01274715|76258652|FG000|Overall Study|After consent, met exclusion criteria.|1|||
42383556|NCT01410227|76258656|FG000|Overall Study|Adverse Event|1|||
42383557|NCT01410227|76258657|FG001|Overall Study|Adverse Event|0|||
42383558|NCT01410227|76258658|FG002|Overall Study|Adverse Event|0|||
42383559|NCT01410227|76258659|FG003|Overall Study|Adverse Event|0|||
42383560|NCT01410227|76258656|FG000|Overall Study|Withdrawal by Subject|3|||
42383561|NCT01410227|76258657|FG001|Overall Study|Withdrawal by Subject|0|||
42383562|NCT01410227|76258658|FG002|Overall Study|Withdrawal by Subject|1|||
42383563|NCT01410227|76258659|FG003|Overall Study|Withdrawal by Subject|0|||
42383564|NCT01410227|76258656|FG000|Overall Study|Pregnancy|0|||
42383565|NCT01410227|76258657|FG001|Overall Study|Pregnancy|0|||
42383566|NCT01410227|76258658|FG002|Overall Study|Pregnancy|0|||
42383567|NCT01410227|76258659|FG003|Overall Study|Pregnancy|1|||
42383568|NCT01410227|76258656|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
42383569|NCT01410227|76258657|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
42383570|NCT01410227|76258658|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
42383571|NCT01410227|76258659|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
42383572|NCT01274559|76258671|FG000|Overall Study|Adverse Event|57|||
42383573|NCT01274559|76258672|FG001|Overall Study|Adverse Event|13|||
42383574|NCT01274559|76258671|FG000|Overall Study|Death|1|||
42383575|NCT01274559|76258672|FG001|Overall Study|Death|1|||
42383576|NCT01274559|76258671|FG000|Overall Study|Lost to Follow-up|3|||
42383577|NCT01274559|76258672|FG001|Overall Study|Lost to Follow-up|3|||
42383578|NCT01274559|76258671|FG000|Overall Study|Non-compliance with Study Drug|2|||
42383579|NCT01274559|76258672|FG001|Overall Study|Non-compliance with Study Drug|4|||
42383580|NCT01274559|76258671|FG000|Overall Study|Physician Decision|2|||
42383581|NCT01274559|76258672|FG001|Overall Study|Physician Decision|1|||
42383582|NCT01274559|76258671|FG000|Overall Study|Protocol Violation|28|||
42383583|NCT01274559|76258672|FG001|Overall Study|Protocol Violation|23|||
42383584|NCT01274559|76258671|FG000|Overall Study|Study Terminated by Sponsor|79|||
42383585|NCT01274559|76258672|FG001|Overall Study|Study Terminated by Sponsor|87|||
42383586|NCT01274559|76258671|FG000|Overall Study|Withdrawal by Subject|25|||
42383587|NCT01274559|76258672|FG001|Overall Study|Withdrawal by Subject|13|||
42383588|NCT01409993|76258680|FG000|Overall Study|Adverse Event|4|||
42383589|NCT01409993|76258681|FG001|Overall Study|Adverse Event|4|||
42383590|NCT01409993|76258682|FG002|Overall Study|Adverse Event|3|||
42383591|NCT01409993|76258683|FG003|Overall Study|Adverse Event|1|||
42383592|NCT01409993|76258680|FG000|Overall Study|Withdrawal by Subject|0|||
42383593|NCT01409993|76258681|FG001|Overall Study|Withdrawal by Subject|0|||
42383594|NCT01409993|76258682|FG002|Overall Study|Withdrawal by Subject|0|||
42383595|NCT01409993|76258683|FG003|Overall Study|Withdrawal by Subject|4|||
42383596|NCT01409993|76258680|FG000|Overall Study|Lost to Follow-up|0|||
42383597|NCT01409993|76258681|FG001|Overall Study|Lost to Follow-up|1|||
42383598|NCT01409993|76258682|FG002|Overall Study|Lost to Follow-up|0|||
42383599|NCT01409993|76258683|FG003|Overall Study|Lost to Follow-up|0|||
42383600|NCT01273623|76258697|FG000|Overall Study|did not meet IVUS criteria|29|||
42383601|NCT01409915|76258705|FG000|Overall Study|Adverse Event|0|||
42383602|NCT01409915|76258706|FG001|Overall Study|Adverse Event|2|||
42383603|NCT01409915|76258705|FG000|Overall Study|Withdrawal by Subject|0|||
42383604|NCT01409915|76258706|FG001|Overall Study|Withdrawal by Subject|1|||
42383605|NCT01409915|76258705|FG000|Overall Study|Protocol Violation|1|||
42383606|NCT01409915|76258706|FG001|Overall Study|Protocol Violation|0|||
42383607|NCT01272921|76258714|FG000|Overall Study|Protocol Violation|2|||
42383608|NCT01272921|76258715|FG001|Overall Study|Protocol Violation|1|||
42383609|NCT01409837|76258725|FG000|Overall Study|Withdrawal by Subject|2|||
42383610|NCT01409837|76258726|FG001|Overall Study|Withdrawal by Subject|1|||
42383611|NCT01409837|76258725|FG000|Overall Study|Lost to Follow-up|1|||
42383612|NCT01409837|76258726|FG001|Overall Study|Lost to Follow-up|0|||
42383613|NCT01409837|76258725|FG000|Overall Study|Physician Decision|0|||
42383614|NCT01409837|76258726|FG001|Overall Study|Physician Decision|1|||
42383615|NCT01430585|76258745|FG000|Overall Study|Death|1|||
42383616|NCT01430585|76258745|FG000|Overall Study|Objective Progression or Relapse|3|||
42383617|NCT01430585|76258745|FG000|Overall Study|Study Terminated by Sponsor|3|||
42383618|NCT01430585|76258745|FG000|Overall Study|Other|7|||
42383619|NCT01408901|76258768|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
42383620|NCT01408901|76258769|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
42383621|NCT01408901|76258770|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
42383622|NCT01408901|76258771|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
42383623|NCT01408901|76258768|FG000|6-Week Follow-Up|Death|1|||
42383624|NCT01408901|76258769|FG001|6-Week Follow-Up|Death|0|||
42383625|NCT01408901|76258770|FG002|6-Week Follow-Up|Death|0|||
42383626|NCT01408901|76258771|FG003|6-Week Follow-Up|Death|0|||
42383627|NCT01408901|76258768|FG000|6-Week Follow-Up|Cancelled visit|0|||
42383628|NCT01408901|76258769|FG001|6-Week Follow-Up|Cancelled visit|1|||
42383629|NCT01408901|76258770|FG002|6-Week Follow-Up|Cancelled visit|0|||
42383630|NCT01408901|76258771|FG003|6-Week Follow-Up|Cancelled visit|2|||
42383631|NCT01408901|76258768|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
42383632|NCT01408901|76258769|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
42383633|NCT01408901|76258770|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
42383634|NCT01408901|76258771|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
42383635|NCT01408901|76258768|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
42383636|NCT01408901|76258769|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
42383637|NCT01408901|76258770|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
42383638|NCT01408901|76258771|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
42383639|NCT01408901|76258768|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
42383640|NCT01408901|76258769|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
42383641|NCT01408901|76258770|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
42383642|NCT01408901|76258771|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
42383643|NCT01408901|76258768|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
42383644|NCT01408901|76258769|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
42383645|NCT01408901|76258770|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
42203991|NCT00073307|76016700|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
42203992|NCT00073307|76016701|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
42203993|NCT00073307|76016702|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
42203994|NCT00073307|76016700|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
42203995|NCT00073307|76016701|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
42203996|NCT00073307|76016702|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
42203997|NCT00073307|76016700|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
42203998|NCT00073307|76016701|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
42203999|NCT00073307|76016702|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
42204000|NCT00073307|76016700|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
42204001|NCT00073307|76016701|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
42204002|NCT00073307|76016702|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
42204003|NCT00073307|76016700|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
42204004|NCT00073307|76016701|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
42204005|NCT00073307|76016702|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
42204006|NCT00073307|76016700|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
42204007|NCT00073307|76016701|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
42204008|NCT00073307|76016702|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
42204009|NCT00073307|76016700|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
42204010|NCT00073307|76016701|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
42204011|NCT00073307|76016702|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
42204012|NCT00073307|76016700|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
42204013|NCT00073307|76016701|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
42204014|NCT00073307|76016702|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
42204015|NCT00073307|76016700|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
42204016|NCT00073307|76016701|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
42204017|NCT00073307|76016702|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
42204018|NCT00073307|76016700|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
42204019|NCT00073307|76016701|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
42204020|NCT00073307|76016702|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
42204021|NCT00073307|76016700|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
42204022|NCT00073307|76016701|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
42204023|NCT00073307|76016702|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
42204024|NCT00073307|76016700|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
42383646|NCT01408901|76258771|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
42383647|NCT01408901|76258768|FG000|26-Week Follow-Up|Death|0|||
42383648|NCT01408901|76258769|FG001|26-Week Follow-Up|Death|1|||
42383649|NCT01408901|76258770|FG002|26-Week Follow-Up|Death|0|||
42383650|NCT01408901|76258771|FG003|26-Week Follow-Up|Death|0|||
42383651|NCT01428713|76258787|FG000|Overall Study|Non-compliance|2|||
42383652|NCT01428713|76258788|FG001|Overall Study|Non-compliance|2|||
42383653|NCT01428713|76258787|FG000|Overall Study|Withdrawal by Subject|1|||
42383654|NCT01428713|76258788|FG001|Overall Study|Withdrawal by Subject|1|||
42383655|NCT01428713|76258787|FG000|Overall Study|Adverse Event|0|||
42383656|NCT01428713|76258788|FG001|Overall Study|Adverse Event|2|||
42383657|NCT01408277|76258796|FG000|Overall Study|Adverse Event|3|||
42383658|NCT01408277|76258797|FG001|Overall Study|Adverse Event|4|||
42383659|NCT01408277|76258796|FG000|Overall Study|Lost to Follow-up|1|||
42383660|NCT01408277|76258797|FG001|Overall Study|Lost to Follow-up|0|||
42383661|NCT01408277|76258796|FG000|Overall Study|Withdrawal by Subject|2|||
42383662|NCT01408277|76258797|FG001|Overall Study|Withdrawal by Subject|0|||
42383663|NCT01408277|76258796|FG000|Overall Study|Protocol Violation|2|||
42383664|NCT01408277|76258797|FG001|Overall Study|Protocol Violation|0|||
42383665|NCT01408043|76258803|FG000|Overall Study|unable to collect cells|1|||
42383666|NCT01524224|76258815|FG000|Overall Study|Progressive Disease|1|||
42383667|NCT01524224|76258816|FG001|Overall Study|Progressive Disease|0|||
42383668|NCT01524224|76258817|FG002|Overall Study|Progressive Disease|2|||
42383669|NCT01524224|76258818|FG003|Overall Study|Progressive Disease|1|||
42383670|NCT01524224|76258819|FG004|Overall Study|Progressive Disease|2|||
42383671|NCT01524224|76258820|FG005|Overall Study|Progressive Disease|1|||
42383672|NCT01524224|76258821|FG006|Overall Study|Progressive Disease|1|||
42383673|NCT01524224|76258822|FG007|Overall Study|Progressive Disease|5|||
42383674|NCT01524224|76258815|FG000|Overall Study|Withdrawal by Subject|2|||
42383675|NCT01524224|76258816|FG001|Overall Study|Withdrawal by Subject|0|||
42383676|NCT01524224|76258817|FG002|Overall Study|Withdrawal by Subject|0|||
42383677|NCT01524224|76258818|FG003|Overall Study|Withdrawal by Subject|0|||
42383678|NCT01524224|76258819|FG004|Overall Study|Withdrawal by Subject|0|||
42383679|NCT01524224|76258820|FG005|Overall Study|Withdrawal by Subject|0|||
42383680|NCT01524224|76258821|FG006|Overall Study|Withdrawal by Subject|2|||
42383681|NCT01524224|76258822|FG007|Overall Study|Withdrawal by Subject|0|||
42383682|NCT01524224|76258815|FG000|Overall Study|Adverse Event|0|||
42383683|NCT01524224|76258816|FG001|Overall Study|Adverse Event|1|||
42383684|NCT01524224|76258817|FG002|Overall Study|Adverse Event|0|||
42383685|NCT01524224|76258818|FG003|Overall Study|Adverse Event|0|||
42383686|NCT01524224|76258819|FG004|Overall Study|Adverse Event|0|||
42383687|NCT01524224|76258820|FG005|Overall Study|Adverse Event|1|||
42383688|NCT01524224|76258821|FG006|Overall Study|Adverse Event|0|||
42383689|NCT01524224|76258822|FG007|Overall Study|Adverse Event|0|||
42383690|NCT01524224|76258815|FG000|Overall Study|Physician Decision|0|||
42383691|NCT01524224|76258816|FG001|Overall Study|Physician Decision|0|||
42383692|NCT01524224|76258817|FG002|Overall Study|Physician Decision|0|||
42383693|NCT01524224|76258818|FG003|Overall Study|Physician Decision|1|||
42383694|NCT01524224|76258819|FG004|Overall Study|Physician Decision|1|||
42383695|NCT01524224|76258820|FG005|Overall Study|Physician Decision|0|||
42383696|NCT01524224|76258821|FG006|Overall Study|Physician Decision|0|||
42383697|NCT01524224|76258822|FG007|Overall Study|Physician Decision|1|||
42383698|NCT01524224|76258815|FG000|Overall Study|Sponsor Decision|0|||
42383699|NCT01524224|76258816|FG001|Overall Study|Sponsor Decision|0|||
42383700|NCT01524224|76258817|FG002|Overall Study|Sponsor Decision|0|||
42383701|NCT01524224|76258818|FG003|Overall Study|Sponsor Decision|0|||
42383702|NCT01524224|76258819|FG004|Overall Study|Sponsor Decision|1|||
42383703|NCT01524224|76258820|FG005|Overall Study|Sponsor Decision|0|||
42383704|NCT01524224|76258821|FG006|Overall Study|Sponsor Decision|0|||
42383705|NCT01524224|76258822|FG007|Overall Study|Sponsor Decision|0|||
42383706|NCT00219349|76258840|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
42383707|NCT00219349|76258840|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
42383708|NCT00219349|76258840|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
42383709|NCT00219349|76258840|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
42383710|NCT01523756|76258844|FG000|Baseline Period|Adverse Event|0|||
42383711|NCT01523756|76258845|FG001|Baseline Period|Adverse Event|1|||
42383712|NCT01523756|76258844|FG000|Test Period 1|Adverse Event|1|||
42383713|NCT01523756|76258845|FG001|Test Period 1|Adverse Event|0|||
42383714|NCT01523756|76258844|FG000|Test Period 2|Withdrawal by Subject|0|||
42383715|NCT01523756|76258845|FG001|Test Period 2|Withdrawal by Subject|1|||
42383716|NCT00218257|76258853|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
42383717|NCT00218257|76258854|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
42383718|NCT01523366|76258865|FG000|Treatment Period 1|Withdrawal by Subject|1|||
42383719|NCT01523366|76258866|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42383720|NCT01523366|76258865|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
42383721|NCT01523366|76258866|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
42383722|NCT01427933|76258876|FG000|Overall Study|Withdrawal by Subject|5|||
42383723|NCT01427933|76258877|FG001|Overall Study|Withdrawal by Subject|8|||
42383724|NCT01427933|76258876|FG000|Overall Study|Lost to Follow-up|1|||
42383725|NCT01427933|76258877|FG001|Overall Study|Lost to Follow-up|5|||
42383726|NCT01427933|76258876|FG000|Overall Study|Other|1|||
42383727|NCT01427933|76258877|FG001|Overall Study|Other|0|||
42383728|NCT01427933|76258876|FG000|Overall Study|Investigator's Decision|1|||
42383729|NCT01427933|76258877|FG001|Overall Study|Investigator's Decision|0|||
42383730|NCT00217087|76258886|FG000|Overall Study|decided to have esophagectomy|1|||
42383731|NCT00217087|76258887|FG001|Overall Study|decided to have esophagectomy|2|||
42383732|NCT00217087|76258886|FG000|Overall Study|completed less than 12 months return|10|||
42383733|NCT00217087|76258887|FG001|Overall Study|completed less than 12 months return|18|||
42383734|NCT01406873|76258901|FG000|Overall Study|Withdrawal by Subject|1|||
42383735|NCT01406873|76258902|FG001|Overall Study|Withdrawal by Subject|1|||
42383736|NCT01406795|76258918|FG000|Overall Study|Withdrawal by Subject|1|||
42383737|NCT01406717|76258924|FG000|Overall Study|Subject non-compliance|4|||
42383738|NCT01406717|76258925|FG001|Overall Study|Subject non-compliance|3|||
42383739|NCT01406717|76258924|FG000|Overall Study|Protocol Violation|5|||
42383740|NCT01406717|76258925|FG001|Overall Study|Protocol Violation|1|||
42383741|NCT01406717|76258924|FG000|Overall Study|Lost to Follow-up|14|||
42383742|NCT01406717|76258925|FG001|Overall Study|Lost to Follow-up|8|||
42383743|NCT01406717|76258924|FG000|Overall Study|Withdrawal by Subject|19|||
42383744|NCT01406717|76258925|FG001|Overall Study|Withdrawal by Subject|15|||
42383745|NCT01406717|76258924|FG000|Overall Study|Adverse Event|1|||
42383746|NCT01406717|76258925|FG001|Overall Study|Adverse Event|2|||
42383747|NCT01406717|76258924|FG000|Overall Study|Lack of Efficacy|0|||
42383748|NCT01406717|76258925|FG001|Overall Study|Lack of Efficacy|1|||
42383749|NCT01406717|76258924|FG000|Overall Study|Non-completion of visit activity|0|||
42383750|NCT01406717|76258925|FG001|Overall Study|Non-completion of visit activity|1|||
42383751|NCT01406015|76258943|FG000|Overall Study|Withdrawal by Subject|3|||
42383752|NCT01406015|76258944|FG001|Overall Study|Withdrawal by Subject|3|||
42383753|NCT00215683|76258953|FG000|Overall Study|Adverse Event|15|||
42383754|NCT00215683|76258954|FG001|Overall Study|Adverse Event|16|||
42383755|NCT00215683|76258955|FG002|Overall Study|Adverse Event|15|||
42383756|NCT00215683|76258953|FG000|Overall Study|Lack of Efficacy|5|||
42383757|NCT00215683|76258954|FG001|Overall Study|Lack of Efficacy|1|||
42383758|NCT00215683|76258955|FG002|Overall Study|Lack of Efficacy|2|||
42383759|NCT00215683|76258953|FG000|Overall Study|Lost to Follow-up|0|||
42383760|NCT00215683|76258954|FG001|Overall Study|Lost to Follow-up|2|||
42383761|NCT00215683|76258955|FG002|Overall Study|Lost to Follow-up|1|||
42383762|NCT00215683|76258953|FG000|Overall Study|Withdrawal by Subject|9|||
42383763|NCT00215683|76258954|FG001|Overall Study|Withdrawal by Subject|4|||
42383764|NCT00215683|76258955|FG002|Overall Study|Withdrawal by Subject|13|||
42383765|NCT00215683|76258953|FG000|Overall Study|Physician Decision|0|||
42383766|NCT00215683|76258954|FG001|Overall Study|Physician Decision|0|||
42383767|NCT00215683|76258955|FG002|Overall Study|Physician Decision|1|||
42383768|NCT00215683|76258953|FG000|Overall Study|Difficult to attend visits|0|||
42383769|NCT00215683|76258954|FG001|Overall Study|Difficult to attend visits|1|||
42383770|NCT00215683|76258955|FG002|Overall Study|Difficult to attend visits|0|||
42383771|NCT00215683|76258953|FG000|Overall Study|No study drug available|0|||
42383772|NCT00215683|76258954|FG001|Overall Study|No study drug available|1|||
42383773|NCT00215683|76258955|FG002|Overall Study|No study drug available|0|||
42383774|NCT00215683|76258953|FG000|Overall Study|Intermittent therapy required|0|||
42383775|NCT00215683|76258954|FG001|Overall Study|Intermittent therapy required|1|||
42383776|NCT00215683|76258955|FG002|Overall Study|Intermittent therapy required|0|||
42383777|NCT00215137|76258963|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
42383778|NCT00215137|76258964|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
42383779|NCT00215137|76258965|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
42383780|NCT00215137|76258963|FG000|Randomization Period|Lost to Follow-up|0|||
42383781|NCT00215137|76258964|FG001|Randomization Period|Lost to Follow-up|1|||
42383782|NCT00215137|76258965|FG002|Randomization Period|Lost to Follow-up|0|||
42383783|NCT00215137|76258963|FG000|Randomization Period|Withdrawal by Subject|0|||
42383784|NCT00215137|76258964|FG001|Randomization Period|Withdrawal by Subject|1|||
42383785|NCT00215137|76258965|FG002|Randomization Period|Withdrawal by Subject|0|||
42383786|NCT00214201|76258975|FG000|Overall Study|Withdrawal by Subject|2|||
42383787|NCT00214201|76258976|FG001|Overall Study|Withdrawal by Subject|0|||
42383788|NCT00214201|76258975|FG000|Overall Study|Death|0|||
42383789|NCT00214201|76258976|FG001|Overall Study|Death|2|||
42383790|NCT01486784|76258989|FG000|Overall Study|Withdrawal by Subject|0|||
42383791|NCT01486784|76258990|FG001|Overall Study|Withdrawal by Subject|0|||
42383792|NCT01486784|76258991|FG002|Overall Study|Withdrawal by Subject|1|||
42383793|NCT01486784|76258992|FG003|Overall Study|Withdrawal by Subject|0|||
42383794|NCT01486784|76258993|FG004|Overall Study|Withdrawal by Subject|1|||
42383795|NCT01486784|76258994|FG005|Overall Study|Withdrawal by Subject|2|||
42383796|NCT01486784|76258989|FG000|Overall Study|Subject did not meet entry criteria|0|||
42383797|NCT01486784|76258990|FG001|Overall Study|Subject did not meet entry criteria|0|||
42383798|NCT01486784|76258991|FG002|Overall Study|Subject did not meet entry criteria|0|||
42383799|NCT01486784|76258992|FG003|Overall Study|Subject did not meet entry criteria|0|||
42383800|NCT01486784|76258993|FG004|Overall Study|Subject did not meet entry criteria|1|||
42383801|NCT01486784|76258994|FG005|Overall Study|Subject did not meet entry criteria|0|||
42383802|NCT01486784|76258989|FG000|Overall Study|Death|0|||
42383803|NCT01486784|76258990|FG001|Overall Study|Death|0|||
42383804|NCT01486784|76258991|FG002|Overall Study|Death|0|||
42383805|NCT01486784|76258992|FG003|Overall Study|Death|0|||
42383806|NCT01486784|76258993|FG004|Overall Study|Death|0|||
42383807|NCT01486784|76258994|FG005|Overall Study|Death|1|||
42018992|NCT01119105|75826446|FG002|Overall Study|Other|0|||
42383808|NCT01521884|76259008|FG000|Overall Study|Non Responders|10|||
42383809|NCT01521884|76259008|FG000|Overall Study|Adverse Event|5|||
42383810|NCT01521884|76259008|FG000|Overall Study|Pregnancy|1|||
42383811|NCT01521884|76259008|FG000|Overall Study|Withdrawal by Subject|1|||
42383812|NCT01521884|76259008|FG000|Overall Study|Physician Decision|2|||
42383813|NCT01521884|76259008|FG000|Overall Study|Protocol Violation|3|||
42383814|NCT01521884|76259008|FG000|Overall Study|Participant non-eligible|1|||
42383815|NCT01521884|76259008|FG000|Overall Study|Lost to Follow-up|4|||
42383816|NCT01677858|76259017|FG000|Overall Study|Adverse Event|0|||
42383817|NCT01677858|76259018|FG001|Overall Study|Adverse Event|0|||
42383818|NCT01677858|76259019|FG002|Overall Study|Adverse Event|2|||
42383819|NCT01677858|76259020|FG003|Overall Study|Adverse Event|3|||
42383820|NCT01677858|76259021|FG004|Overall Study|Adverse Event|13|||
42383821|NCT01677858|76259017|FG000|Overall Study|Death|0|||
42383822|NCT01677858|76259018|FG001|Overall Study|Death|0|||
42383823|NCT01677858|76259019|FG002|Overall Study|Death|0|||
42383824|NCT01677858|76259020|FG003|Overall Study|Death|0|||
42383825|NCT01677858|76259021|FG004|Overall Study|Death|1|||
42383826|NCT01677858|76259017|FG000|Overall Study|Physician Decision|1|||
42383827|NCT01677858|76259018|FG001|Overall Study|Physician Decision|0|||
42383828|NCT01677858|76259019|FG002|Overall Study|Physician Decision|2|||
42383829|NCT01677858|76259020|FG003|Overall Study|Physician Decision|0|||
42383830|NCT01677858|76259021|FG004|Overall Study|Physician Decision|12|||
42383831|NCT01677858|76259017|FG000|Overall Study|Progressive Disease|2|||
42383832|NCT01677858|76259018|FG001|Overall Study|Progressive Disease|1|||
42383833|NCT01677858|76259019|FG002|Overall Study|Progressive Disease|9|||
42383834|NCT01677858|76259020|FG003|Overall Study|Progressive Disease|3|||
42383835|NCT01677858|76259021|FG004|Overall Study|Progressive Disease|43|||
42383836|NCT01677858|76259017|FG000|Overall Study|Withdrawal by Subject|0|||
42383837|NCT01677858|76259018|FG001|Overall Study|Withdrawal by Subject|1|||
42383838|NCT01677858|76259019|FG002|Overall Study|Withdrawal by Subject|1|||
42383839|NCT01677858|76259020|FG003|Overall Study|Withdrawal by Subject|0|||
42383840|NCT01677858|76259021|FG004|Overall Study|Withdrawal by Subject|15|||
42383841|NCT01677858|76259017|FG000|Overall Study|Lost to Follow-up|0|||
42383842|NCT01677858|76259018|FG001|Overall Study|Lost to Follow-up|0|||
42383843|NCT01677858|76259019|FG002|Overall Study|Lost to Follow-up|0|||
42383844|NCT01677858|76259020|FG003|Overall Study|Lost to Follow-up|0|||
42383845|NCT01677858|76259021|FG004|Overall Study|Lost to Follow-up|1|||
42383846|NCT01486316|76259041|FG000|Overall Study|Device explanted with/without re-implant|3|||
42383847|NCT01486316|76259042|FG001|Overall Study|Device explanted with/without re-implant|2|||
42383848|NCT01486316|76259043|FG002|Overall Study|Device explanted with/without re-implant|0|||
42383849|NCT01486316|76259044|FG003|Overall Study|Device explanted with/without re-implant|2|||
42383850|NCT01486316|76259041|FG000|Overall Study|Not meeting eligibility criteria|0|||
42383851|NCT01486316|76259042|FG001|Overall Study|Not meeting eligibility criteria|0|||
42383852|NCT01486316|76259043|FG002|Overall Study|Not meeting eligibility criteria|1|||
42383853|NCT01486316|76259044|FG003|Overall Study|Not meeting eligibility criteria|0|||
42383854|NCT01486316|76259041|FG000|Overall Study|Withdrawal by Subject|1|||
42383855|NCT01486316|76259042|FG001|Overall Study|Withdrawal by Subject|0|||
42383856|NCT01486316|76259043|FG002|Overall Study|Withdrawal by Subject|3|||
42383857|NCT01486316|76259044|FG003|Overall Study|Withdrawal by Subject|0|||
42383858|NCT01486316|76259041|FG000|Overall Study|Physician Decision|0|||
42383859|NCT01486316|76259042|FG001|Overall Study|Physician Decision|0|||
42383860|NCT01486316|76259043|FG002|Overall Study|Physician Decision|1|||
42383861|NCT01486316|76259044|FG003|Overall Study|Physician Decision|0|||
42383862|NCT01486316|76259041|FG000|Overall Study|Death|0|||
42383863|NCT01486316|76259042|FG001|Overall Study|Death|1|||
42383864|NCT01486316|76259043|FG002|Overall Study|Death|0|||
42383865|NCT01486316|76259044|FG003|Overall Study|Death|0|||
42383866|NCT01486238|76259055|FG000|Overall Study|Death|0|||
42383867|NCT01486238|76259056|FG001|Overall Study|Death|2|||
42383868|NCT01486238|76259055|FG000|Overall Study|Withdrawal by Subject|2|||
42383869|NCT01486238|76259056|FG001|Overall Study|Withdrawal by Subject|1|||
42383870|NCT01486238|76259055|FG000|Overall Study|Lost to Follow-up|0|||
42383871|NCT01486238|76259056|FG001|Overall Study|Lost to Follow-up|3|||
42383872|NCT01602744|76259064|FG000|Overall Study|Death|17|||
42383873|NCT01602744|76259065|FG001|Overall Study|Death|15|||
42383874|NCT01602744|76259064|FG000|Overall Study|Lost to Follow-up|13|||
42383875|NCT01602744|76259065|FG001|Overall Study|Lost to Follow-up|8|||
42383876|NCT03598777|76259076|FG000|Overall Study|Study Terminated by Sponsor|3|||
42383877|NCT03598777|76259077|FG001|Overall Study|Study Terminated by Sponsor|0|||
42383878|NCT03598777|76259078|FG002|Overall Study|Study Terminated by Sponsor|0|||
42383879|NCT03598777|76259079|FG003|Overall Study|Study Terminated by Sponsor|0|||
42383880|NCT03598777|76259080|FG004|Overall Study|Study Terminated by Sponsor|15|||
42383881|NCT03598777|76259076|FG000|Overall Study|Withdrawal by Subject|1|||
42383882|NCT03598777|76259077|FG001|Overall Study|Withdrawal by Subject|1|||
42383883|NCT03598777|76259078|FG002|Overall Study|Withdrawal by Subject|0|||
42383884|NCT03598777|76259079|FG003|Overall Study|Withdrawal by Subject|0|||
42383885|NCT03598777|76259080|FG004|Overall Study|Withdrawal by Subject|0|||
42383886|NCT03598777|76259076|FG000|Overall Study|Adverse Event|1|||
42383887|NCT03598777|76259077|FG001|Overall Study|Adverse Event|0|||
42383888|NCT03598777|76259078|FG002|Overall Study|Adverse Event|0|||
42383889|NCT03598777|76259079|FG003|Overall Study|Adverse Event|0|||
42383890|NCT03598777|76259080|FG004|Overall Study|Adverse Event|0|||
42383891|NCT03598777|76259076|FG000|Overall Study|Lost to Follow-up|1|||
42383892|NCT03598777|76259077|FG001|Overall Study|Lost to Follow-up|0|||
42383893|NCT03598777|76259078|FG002|Overall Study|Lost to Follow-up|0|||
42383894|NCT03598777|76259079|FG003|Overall Study|Lost to Follow-up|0|||
42383895|NCT03598777|76259080|FG004|Overall Study|Lost to Follow-up|0|||
42383896|NCT04348591|76259135|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
42383897|NCT04348591|76259136|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
42383898|NCT04348591|76259135|FG000|Imaging Session (120 Min)|Physician Decision|0|||
42383899|NCT04348591|76259136|FG001|Imaging Session (120 Min)|Physician Decision|1|||
42383900|NCT04348591|76259135|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
42383901|NCT04348591|76259136|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
42383902|NCT04046250|76259155|FG000|Overall Study|Death|0|||
42383903|NCT04046250|76259156|FG001|Overall Study|Death|1|||
42383904|NCT04046250|76259155|FG000|Overall Study|Withdrawal by Subject|3|||
42383905|NCT04046250|76259156|FG001|Overall Study|Withdrawal by Subject|3|||
42383906|NCT03841526|76259164|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
42383907|NCT03841526|76259165|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
42383908|NCT03841526|76259166|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
42383909|NCT03841526|76259167|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
42383910|NCT03841526|76259168|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
42383911|NCT03841526|76259169|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
42383912|NCT03841526|76259164|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
42383913|NCT03841526|76259165|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
42383914|NCT03841526|76259166|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
42383915|NCT03841526|76259167|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
42383916|NCT03841526|76259168|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
42383917|NCT03841526|76259169|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
42383918|NCT03841526|76259164|FG000|Outpatient Phase Treatment|Physician Decision|0|||
42383919|NCT03841526|76259165|FG001|Outpatient Phase Treatment|Physician Decision|1|||
42383920|NCT03841526|76259166|FG002|Outpatient Phase Treatment|Physician Decision|0|||
42383921|NCT03841526|76259167|FG003|Outpatient Phase Treatment|Physician Decision|0|||
42383922|NCT03841526|76259168|FG004|Outpatient Phase Treatment|Physician Decision|0|||
42383923|NCT03841526|76259169|FG005|Outpatient Phase Treatment|Physician Decision|0|||
42383924|NCT03841526|76259164|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
42383925|NCT03841526|76259165|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
42383926|NCT03841526|76259166|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
42383927|NCT03841526|76259167|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
42383928|NCT03841526|76259168|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
42383929|NCT03841526|76259169|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
42383930|NCT03834506|76259192|FG000|Overall Study|Death|268|||
42383931|NCT03834506|76259193|FG001|Overall Study|Death|285|||
42383932|NCT03834506|76259192|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
42383933|NCT03834506|76259193|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
42383934|NCT03834506|76259192|FG000|Overall Study|Withdrawal by Subject|12|||
42383935|NCT03834506|76259193|FG001|Overall Study|Withdrawal by Subject|8|||
42383936|NCT03834506|76259192|FG000|Overall Study|Participants ongoing in the study|234|||
42383937|NCT03834506|76259193|FG001|Overall Study|Participants ongoing in the study|221|||
42383938|NCT03535740|76259199|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
42383939|NCT03535740|76259199|FG000|Overall Study|Death|34|||
42383940|NCT03535740|76259199|FG000|Overall Study|Lost to Follow-up|1|||
42383941|NCT03535740|76259199|FG000|Overall Study|Withdrawal by Subject|13|||
42383942|NCT03351049|76259210|FG000|Overall Study|Withdrawal|26|||
42383943|NCT03351049|76259211|FG001|Overall Study|Withdrawal|22|||
42383944|NCT03288506|76259232|FG000|Overall Study|Withdrawal by Subject|52|||
42383945|NCT03180684|76259240|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
42383946|NCT03180684|76259241|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
42383947|NCT03180684|76259240|FG000|Overall Study|Physician Decision|1|||
42383948|NCT03180684|76259241|FG001|Overall Study|Physician Decision|0|||
42383949|NCT03180684|76259240|FG000|Overall Study|Lost to Follow-up|1|||
42383950|NCT03180684|76259241|FG001|Overall Study|Lost to Follow-up|0|||
42383951|NCT03180684|76259240|FG000|Overall Study|Progressive Disease|1|||
42383952|NCT03180684|76259241|FG001|Overall Study|Progressive Disease|0|||
42383953|NCT02747927|76259285|FG000|Overall Study|Adverse Event|5|||
42383954|NCT02747927|76259286|FG001|Overall Study|Adverse Event|14|||
42383955|NCT02747927|76259285|FG000|Overall Study|Lost to Follow-up|22|||
42383956|NCT02747927|76259286|FG001|Overall Study|Lost to Follow-up|43|||
42383957|NCT02747927|76259285|FG000|Overall Study|Pregnancy|34|||
42383958|NCT02747927|76259286|FG001|Overall Study|Pregnancy|66|||
42383959|NCT02747927|76259285|FG000|Overall Study|Protocol Violation|2|||
42383960|NCT02747927|76259286|FG001|Overall Study|Protocol Violation|4|||
42383961|NCT02747927|76259285|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
42383962|NCT02747927|76259286|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
42383963|NCT02747927|76259285|FG000|Overall Study|Reason not Specified|11|||
42383964|NCT02747927|76259286|FG001|Overall Study|Reason not Specified|27|||
42383965|NCT02515227|76259298|FG000|Overall Study|Adverse Event|0|||
42383966|NCT02515227|76259299|FG001|Overall Study|Adverse Event|2|||
42383967|NCT02515227|76259298|FG000|Overall Study|Progressive disease|2|||
42383968|NCT02515227|76259299|FG001|Overall Study|Progressive disease|9|||
42383969|NCT02369458|76259309|FG000|Overall Study|Determined to be not eligible|1|||
42383970|NCT02369458|76259310|FG001|Overall Study|Determined to be not eligible|0|||
42383971|NCT01266642|76259322|FG000|Overall Study|Protocol Violation|0|||
42383972|NCT01266642|76259323|FG001|Overall Study|Protocol Violation|1|||
42383973|NCT00070499|76259363|FG000|Overall Study|Adverse Event|6|||
42383974|NCT00070499|76259364|FG001|Overall Study|Adverse Event|6|||
42383975|NCT00070499|76259365|FG002|Overall Study|Adverse Event|19|||
42383976|NCT00070499|76259366|FG003|Overall Study|Adverse Event|15|||
42383977|NCT00070499|76259363|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
42383978|NCT00070499|76259364|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
42383979|NCT00070499|76259365|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
42383980|NCT00070499|76259366|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
42383981|NCT00070499|76259363|FG000|Overall Study|Progression/relapse|4|||
42383982|NCT00070499|76259364|FG001|Overall Study|Progression/relapse|2|||
42383983|NCT00070499|76259365|FG002|Overall Study|Progression/relapse|1|||
42383984|NCT00070499|76259366|FG003|Overall Study|Progression/relapse|4|||
42383985|NCT00070499|76259363|FG000|Overall Study|Death|1|||
42383986|NCT00070499|76259364|FG001|Overall Study|Death|1|||
42383987|NCT00070499|76259365|FG002|Overall Study|Death|1|||
42383988|NCT00070499|76259366|FG003|Overall Study|Death|2|||
42383989|NCT00070499|76259363|FG000|Overall Study|Other - not protocol specified|7|||
42383990|NCT00070499|76259364|FG001|Overall Study|Other - not protocol specified|3|||
42383991|NCT00070499|76259365|FG002|Overall Study|Other - not protocol specified|12|||
42383992|NCT00070499|76259366|FG003|Overall Study|Other - not protocol specified|20|||
42383993|NCT00070499|76259363|FG000|Overall Study|Still on protocol treatment|10|||
42383994|NCT00070499|76259364|FG001|Overall Study|Still on protocol treatment|4|||
42383995|NCT00070499|76259365|FG002|Overall Study|Still on protocol treatment|79|||
42383996|NCT00070499|76259366|FG003|Overall Study|Still on protocol treatment|57|||
42383997|NCT00070499|76259363|FG000|Overall Study|Did not start treatment|1|||
42383998|NCT00070499|76259364|FG001|Overall Study|Did not start treatment|0|||
42383999|NCT00070499|76259365|FG002|Overall Study|Did not start treatment|0|||
42384000|NCT00070499|76259366|FG003|Overall Study|Did not start treatment|2|||
42384001|NCT00070499|76259363|FG000|Overall Study|Not eligible|2|||
42384002|NCT00070499|76259364|FG001|Overall Study|Not eligible|5|||
42384003|NCT00070499|76259365|FG002|Overall Study|Not eligible|3|||
42384004|NCT00070499|76259366|FG003|Overall Study|Not eligible|2|||
42384005|NCT00066573|76259386|FG000|Overall Study|Did not received protocol treatment|28|||
42384006|NCT00066573|76259387|FG001|Overall Study|Did not received protocol treatment|28|||
42384007|NCT03594955|76259393|FG000|Overall Study|Adverse Event|1|||
42384008|NCT03594955|76259393|FG000|Overall Study|Progressive disease|5|||
42384009|NCT03594955|76259393|FG000|Overall Study|Sponsor's decision|1|||
42384010|NCT01677624|76259421|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
42384011|NCT01272219|76259442|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
42384012|NCT01272219|76259443|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
42384013|NCT01272219|76259444|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
42384014|NCT01272219|76259445|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
42384015|NCT01272219|76259446|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
42384016|NCT01272219|76259447|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
42384017|NCT01272219|76259442|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
42384018|NCT01272219|76259443|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
42384019|NCT01272219|76259444|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
42384020|NCT01272219|76259445|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
42384021|NCT01272219|76259446|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
42384022|NCT01272219|76259447|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
42384023|NCT01272219|76259442|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
42384024|NCT01272219|76259443|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
42384025|NCT01272219|76259444|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
42384026|NCT01272219|76259445|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
42384027|NCT01272219|76259446|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
42384028|NCT01272219|76259447|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
42384029|NCT01272219|76259442|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
42384030|NCT01272219|76259443|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
42384031|NCT01272219|76259444|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
42384032|NCT01272219|76259445|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
42384033|NCT01272219|76259446|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
42384034|NCT01272219|76259447|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
42384035|NCT01272219|76259442|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
42384036|NCT01272219|76259443|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
42384037|NCT01272219|76259444|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
42384038|NCT01272219|76259445|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
42384039|NCT01272219|76259446|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
42384040|NCT01272219|76259447|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
42384041|NCT01272219|76259442|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
42384042|NCT01272219|76259443|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
42384043|NCT01272219|76259444|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
42384044|NCT01272219|76259445|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
42384045|NCT01272219|76259446|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
42384046|NCT01272219|76259447|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
42384047|NCT01272219|76259442|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
42384048|NCT01272219|76259443|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
42384049|NCT01272219|76259444|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
42384050|NCT01272219|76259445|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
42384051|NCT01272219|76259446|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
42384052|NCT01272219|76259447|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
42384053|NCT01272219|76259442|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
42384054|NCT01272219|76259443|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
42384055|NCT01272219|76259444|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
42384056|NCT01272219|76259445|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
42384057|NCT01272219|76259446|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
42384058|NCT01272219|76259447|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
42384059|NCT01272219|76259442|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
42384060|NCT01272219|76259443|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
42384061|NCT01272219|76259444|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
42384062|NCT01272219|76259445|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
42384063|NCT01272219|76259446|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
42384064|NCT01272219|76259447|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
42384065|NCT01272219|76259442|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
42384066|NCT01272219|76259443|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
42384067|NCT01272219|76259444|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
42384068|NCT01272219|76259445|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
42384069|NCT01272219|76259446|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
42384070|NCT01272219|76259447|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
42384071|NCT01272219|76259442|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
42384072|NCT01272219|76259443|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
42384073|NCT01272219|76259444|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
42384074|NCT01272219|76259445|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
42384075|NCT01272219|76259446|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
42384076|NCT01272219|76259447|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
42384077|NCT01272219|76259442|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
42384078|NCT01272219|76259443|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
42384079|NCT01272219|76259444|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
42384080|NCT01272219|76259445|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
42384081|NCT01272219|76259446|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
42384082|NCT01272219|76259447|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
42384083|NCT01272219|76259442|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
42384084|NCT01272219|76259443|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
42384085|NCT01272219|76259444|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
42384086|NCT01272219|76259445|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
42384087|NCT01272219|76259446|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
42384088|NCT01272219|76259447|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
42384089|NCT01272219|76259442|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
42384090|NCT01272219|76259443|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
42384091|NCT01272219|76259444|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
42384092|NCT01272219|76259445|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
42384093|NCT01272219|76259446|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
42384094|NCT01272219|76259447|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
42384095|NCT01272219|76259442|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
42384096|NCT01272219|76259443|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
42384097|NCT01272219|76259444|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
42384098|NCT01272219|76259445|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
42384099|NCT01272219|76259446|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
42384100|NCT01272219|76259447|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
42384101|NCT01272219|76259442|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
42384102|NCT01272219|76259443|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
42384103|NCT01272219|76259444|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
42384104|NCT01272219|76259445|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
42384105|NCT01272219|76259446|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
42384106|NCT01272219|76259447|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
42384107|NCT01510028|76259464|FG000|Overall Study|Lack of Efficacy|1|||
42384108|NCT01510028|76259465|FG001|Overall Study|Lack of Efficacy|0|||
42384109|NCT01510028|76259466|FG002|Overall Study|Lack of Efficacy|0|||
42384110|NCT01510028|76259467|FG003|Overall Study|Lack of Efficacy|0|||
42384111|NCT01521494|76259488|FG000|Overall Study|Adverse Event|1|||
42384112|NCT01521494|76259489|FG001|Overall Study|Adverse Event|2|||
42384113|NCT01521494|76259490|FG002|Overall Study|Adverse Event|9|||
42384114|NCT01521494|76259491|FG003|Overall Study|Adverse Event|6|||
42384115|NCT01521494|76259492|FG004|Overall Study|Adverse Event|2|||
42384116|NCT01521494|76259488|FG000|Overall Study|Lack of Efficacy|0|||
42384117|NCT01521494|76259489|FG001|Overall Study|Lack of Efficacy|0|||
42384118|NCT01521494|76259490|FG002|Overall Study|Lack of Efficacy|0|||
42384119|NCT01521494|76259491|FG003|Overall Study|Lack of Efficacy|0|||
42384120|NCT01521494|76259492|FG004|Overall Study|Lack of Efficacy|2|||
42384121|NCT01521494|76259488|FG000|Overall Study|Withdrawal by Subject|1|||
42384122|NCT01521494|76259489|FG001|Overall Study|Withdrawal by Subject|1|||
42384123|NCT01521494|76259490|FG002|Overall Study|Withdrawal by Subject|0|||
42384124|NCT01521494|76259491|FG003|Overall Study|Withdrawal by Subject|2|||
42384125|NCT01521494|76259492|FG004|Overall Study|Withdrawal by Subject|0|||
42384126|NCT01521494|76259488|FG000|Overall Study|Decrease in serum phosphate|0|||
42384127|NCT01521494|76259489|FG001|Overall Study|Decrease in serum phosphate|2|||
42384128|NCT01521494|76259490|FG002|Overall Study|Decrease in serum phosphate|3|||
42384129|NCT01521494|76259491|FG003|Overall Study|Decrease in serum phosphate|12|||
42384130|NCT01521494|76259492|FG004|Overall Study|Decrease in serum phosphate|0|||
42384131|NCT01521494|76259488|FG000|Overall Study|Decrease in serum calcium|0|||
42384132|NCT01521494|76259489|FG001|Overall Study|Decrease in serum calcium|0|||
42384133|NCT01521494|76259490|FG002|Overall Study|Decrease in serum calcium|0|||
42384134|NCT01521494|76259491|FG003|Overall Study|Decrease in serum calcium|1|||
42384135|NCT01521494|76259492|FG004|Overall Study|Decrease in serum calcium|1|||
42384136|NCT01521494|76259488|FG000|Overall Study|Physician Decision|0|||
42384137|NCT01521494|76259489|FG001|Overall Study|Physician Decision|0|||
42384138|NCT01521494|76259490|FG002|Overall Study|Physician Decision|0|||
42384139|NCT01521494|76259491|FG003|Overall Study|Physician Decision|0|||
42384140|NCT01521494|76259492|FG004|Overall Study|Physician Decision|2|||
42384141|NCT01270971|76259506|FG000|Overall Study|Withdrawal by Subject|24|||
42384142|NCT01270971|76259507|FG001|Overall Study|Withdrawal by Subject|11|||
42384143|NCT01270971|76259506|FG000|Overall Study|Lost to Follow-up|18|||
42384144|NCT01270971|76259507|FG001|Overall Study|Lost to Follow-up|5|||
42384145|NCT01270971|76259506|FG000|Overall Study|Adverse Event|1|||
42384146|NCT01270971|76259507|FG001|Overall Study|Adverse Event|2|||
42384147|NCT01270971|76259506|FG000|Overall Study|Non compliance|2|||
42384148|NCT01270971|76259507|FG001|Overall Study|Non compliance|2|||
42384149|NCT01270971|76259506|FG000|Overall Study|Non-specific|7|||
42384150|NCT01270971|76259507|FG001|Overall Study|Non-specific|3|||
42384151|NCT01270503|76259534|FG000|Overall Study|Lost to Follow-up|1|||
42384152|NCT01277211|76259551|FG000|Overall Study|Adverse Event|60|||
42384153|NCT01277211|76259552|FG001|Overall Study|Adverse Event|22|||
42384154|NCT01277211|76259551|FG000|Overall Study|Pregnancy|9|||
42384155|NCT01277211|76259552|FG001|Overall Study|Pregnancy|4|||
42384156|NCT01277211|76259551|FG000|Overall Study|Lost to Follow-up|14|||
42384157|NCT01277211|76259552|FG001|Overall Study|Lost to Follow-up|9|||
42384158|NCT01277211|76259551|FG000|Overall Study|Did not wish to continue|17|||
42384159|NCT01277211|76259552|FG001|Overall Study|Did not wish to continue|0|||
42384160|NCT01277211|76259551|FG000|Overall Study|Withdrew Consent|9|||
42384161|NCT01277211|76259552|FG001|Overall Study|Withdrew Consent|9|||
42384162|NCT01277211|76259551|FG000|Overall Study|Non-compliance with protocol|13|||
42384163|NCT01277211|76259552|FG001|Overall Study|Non-compliance with protocol|4|||
42384164|NCT01277211|76259551|FG000|Overall Study|Did not meet protocol eligibility|1|||
42384165|NCT01277211|76259552|FG001|Overall Study|Did not meet protocol eligibility|0|||
42384166|NCT01277211|76259551|FG000|Overall Study|Administrative|3|||
42384167|NCT01277211|76259552|FG001|Overall Study|Administrative|0|||
42384168|NCT01277211|76259551|FG000|Overall Study|Pregnancy wish|0|||
42384169|NCT01277211|76259552|FG001|Overall Study|Pregnancy wish|2|||
42384170|NCT01277211|76259551|FG000|Overall Study|Discontinued prior to treatment|24|||
42384171|NCT01277211|76259552|FG001|Overall Study|Discontinued prior to treatment|13|||
42384172|NCT01676220|76259560|FG000|Overall Study|Randomized But Not Treated|4|||
42384173|NCT01676220|76259561|FG001|Overall Study|Randomized But Not Treated|1|||
42384174|NCT01676220|76259560|FG000|Overall Study|Adverse Event|10|||
42384175|NCT01676220|76259561|FG001|Overall Study|Adverse Event|8|||
42384176|NCT01676220|76259560|FG000|Overall Study|Lack of Efficacy|2|||
42384177|NCT01676220|76259561|FG001|Overall Study|Lack of Efficacy|5|||
42384178|NCT01676220|76259560|FG000|Overall Study|Protocol Violation|11|||
42384179|NCT01676220|76259561|FG001|Overall Study|Protocol Violation|12|||
42384180|NCT01676220|76259560|FG000|Overall Study|Received Rescue Therapy|14|||
42384181|NCT01676220|76259561|FG001|Overall Study|Received Rescue Therapy|22|||
42384182|NCT01676220|76259560|FG000|Overall Study|Personal Reason|34|||
42384183|NCT01676220|76259561|FG001|Overall Study|Personal Reason|45|||
42384184|NCT01676220|76259560|FG000|Overall Study|Lost to Follow-up|11|||
42384185|NCT01676220|76259561|FG001|Overall Study|Lost to Follow-up|18|||
42384186|NCT01676220|76259560|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
42384187|NCT01676220|76259561|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
42384188|NCT01676220|76259560|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
42384189|NCT01676220|76259561|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
42384190|NCT01676220|76259560|FG000|Overall Study|Perceived Lack of Efficacy|3|||
42384191|NCT01676220|76259561|FG001|Overall Study|Perceived Lack of Efficacy|1|||
42384192|NCT01676220|76259560|FG000|Overall Study|Non Serious Hypoglycemia|2|||
42384193|NCT01676220|76259561|FG001|Overall Study|Non Serious Hypoglycemia|0|||
42384194|NCT01676220|76259560|FG000|Overall Study|No More Need of Insulin|1|||
42384195|NCT01676220|76259561|FG001|Overall Study|No More Need of Insulin|0|||
42384196|NCT04007094|76259587|FG000|Overall Study|Lost to Follow-up|1|||
42384197|NCT04007094|76259588|FG001|Overall Study|Lost to Follow-up|1|||
42384198|NCT01485614|76259609|FG000|Randomization|Not Treated|1|||
42384199|NCT01485614|76259610|FG001|Randomization|Not Treated|0|||
42384200|NCT01485614|76259611|FG002|Randomization|Not Treated|0|||
42384201|NCT01485614|76259612|FG003|Randomization|Not Treated|0|||
42384202|NCT01485614|76259609|FG000|Weeks 0-20|Lost to Follow-up|2|||
42384203|NCT01485614|76259610|FG001|Weeks 0-20|Lost to Follow-up|0|||
42384204|NCT01485614|76259611|FG002|Weeks 0-20|Lost to Follow-up|0|||
42384205|NCT01485614|76259612|FG003|Weeks 0-20|Lost to Follow-up|0|||
42384206|NCT01485614|76259609|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
42384207|NCT01485614|76259610|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
42384208|NCT01485614|76259611|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
42384209|NCT01485614|76259612|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
42384210|NCT01485614|76259609|FG000|Weeks 0-20|Withdrawal by Subject|3|||
42384211|NCT01485614|76259610|FG001|Weeks 0-20|Withdrawal by Subject|2|||
42384212|NCT01485614|76259611|FG002|Weeks 0-20|Withdrawal by Subject|1|||
42384213|NCT01485614|76259612|FG003|Weeks 0-20|Withdrawal by Subject|0|||
42384214|NCT01485614|76259609|FG000|Weeks 20-54|Lost to Follow-up|4|||
42384215|NCT01485614|76259610|FG001|Weeks 20-54|Lost to Follow-up|3|||
42384216|NCT01485614|76259611|FG002|Weeks 20-54|Lost to Follow-up|1|||
42384217|NCT01485614|76259612|FG003|Weeks 20-54|Lost to Follow-up|0|||
42384218|NCT01485614|76259609|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
42384219|NCT01485614|76259610|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
42384220|NCT01485614|76259611|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
42384221|NCT01485614|76259612|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
42384222|NCT01485614|76259609|FG000|Weeks 20-54|Withdrawal by Subject|5|||
42384223|NCT01485614|76259610|FG001|Weeks 20-54|Withdrawal by Subject|3|||
42384224|NCT01485614|76259611|FG002|Weeks 20-54|Withdrawal by Subject|0|||
42384225|NCT01485614|76259612|FG003|Weeks 20-54|Withdrawal by Subject|0|||
42384226|NCT01485536|76259662|FG000|Overall Study|Withdrawal by Subject|3|||
42384227|NCT01485536|76259662|FG000|Overall Study|Adverse Event|1|||
42384228|NCT02658630|76259666|FG000|Overall Study|Withdrawal by Subject|4|||
42384229|NCT01484912|76259672|FG000|Overall Study|Withdrawal by Subject|1|||
42384230|NCT01484912|76259673|FG001|Overall Study|Withdrawal by Subject|0|||
42384231|NCT01484912|76259672|FG000|Overall Study|Physician Decision|0|||
42384232|NCT01484912|76259673|FG001|Overall Study|Physician Decision|1|||
42384233|NCT01520870|76259679|FG000|Overall Study|Withdrawal by Subject|2|||
42384234|NCT01520714|76259685|FG000|Overall Study|Protocol Violation|0|||
42384235|NCT01520714|76259686|FG001|Overall Study|Protocol Violation|3|||
42384236|NCT01520714|76259685|FG000|Overall Study|Adverse Event|0|||
42384237|NCT01520714|76259686|FG001|Overall Study|Adverse Event|2|||
42384238|NCT01520714|76259685|FG000|Overall Study|Lack of Efficacy|0|||
42384239|NCT01520714|76259686|FG001|Overall Study|Lack of Efficacy|1|||
42384240|NCT02659098|76259705|FG000|Overall Study|Withdrawal by Subject|7|||
42384241|NCT01508936|76259716|FG000|Overall Study|Adverse Event|11|||
42384242|NCT01508936|76259717|FG001|Overall Study|Adverse Event|32|||
42384243|NCT01508936|76259716|FG000|Overall Study|Lack of Efficacy|0|||
42384244|NCT01508936|76259717|FG001|Overall Study|Lack of Efficacy|1|||
42384245|NCT01508936|76259716|FG000|Overall Study|Withdrawal by Subject|4|||
42384246|NCT01508936|76259717|FG001|Overall Study|Withdrawal by Subject|18|||
42018993|NCT01118949|75826454|FG000|Overall Study|Adverse Event|5|||
42384247|NCT01508936|76259716|FG000|Overall Study|Protocol Violation|2|||
42384248|NCT01508936|76259717|FG001|Overall Study|Protocol Violation|3|||
42384249|NCT01508936|76259716|FG000|Overall Study|Lost to Follow-up|2|||
42018994|NCT01118949|75826454|FG000|Overall Study|Withdrawal by Subject|4|||
42018995|NCT01252355|75826461|FG000|Overall Study|Adverse Event|9|||
42204025|NCT00073307|76016701|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
42384250|NCT01508936|76259717|FG001|Overall Study|Lost to Follow-up|9|||
42384251|NCT01508936|76259716|FG000|Overall Study|Other|0|||
42384252|NCT01508936|76259717|FG001|Overall Study|Other|5|||
42384253|NCT01508936|76259716|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
42018996|NCT01252355|75826462|FG001|Overall Study|Adverse Event|17|||
42018997|NCT01252355|75826463|FG002|Overall Study|Adverse Event|22|||
42018998|NCT01252355|75826461|FG000|Overall Study|Lack of Efficacy|6|||
42018999|NCT01252355|75826462|FG001|Overall Study|Lack of Efficacy|4|||
42019000|NCT01252355|75826463|FG002|Overall Study|Lack of Efficacy|2|||
42019001|NCT01252355|75826461|FG000|Overall Study|Lost to Follow-up|0|||
42019002|NCT01252355|75826462|FG001|Overall Study|Lost to Follow-up|0|||
42019003|NCT01252355|75826463|FG002|Overall Study|Lost to Follow-up|1|||
42019004|NCT01252355|75826461|FG000|Overall Study|Poor Compliance to Protocol|1|||
42019005|NCT01252355|75826462|FG001|Overall Study|Poor Compliance to Protocol|1|||
42019006|NCT01252355|75826463|FG002|Overall Study|Poor Compliance to Protocol|1|||
42019007|NCT01252355|75826461|FG000|Overall Study|Progressive Disease|2|||
42019008|NCT01252355|75826462|FG001|Overall Study|Progressive Disease|0|||
42019009|NCT01252355|75826463|FG002|Overall Study|Progressive Disease|0|||
42019010|NCT01252355|75826461|FG000|Overall Study|Sponsor Early Termination of Study|149|||
42019011|NCT01252355|75826462|FG001|Overall Study|Sponsor Early Termination of Study|149|||
42019012|NCT01252355|75826463|FG002|Overall Study|Sponsor Early Termination of Study|146|||
42019013|NCT01252355|75826461|FG000|Overall Study|Randomized but not Treated|2|||
42019014|NCT01252355|75826462|FG001|Overall Study|Randomized but not Treated|0|||
42019015|NCT01252355|75826463|FG002|Overall Study|Randomized but not Treated|0|||
42019016|NCT01252355|75826461|FG000|Overall Study|Other Than Above|8|||
42019017|NCT01252355|75826462|FG001|Overall Study|Other Than Above|7|||
42019018|NCT01252355|75826463|FG002|Overall Study|Other Than Above|7|||
42019019|NCT01118325|75826474|FG000|Overall Study|Adverse Event|1|||
42019020|NCT01118325|75826475|FG001|Overall Study|Adverse Event|0|||
42019021|NCT01118325|75826476|FG002|Overall Study|Adverse Event|1|||
42019022|NCT01117857|75826497|FG000|Overall Study|Lost to Follow-up|4|||
42019023|NCT01117857|75826497|FG000|Overall Study|Withdrawal by Subject|4|||
42019024|NCT01117857|75826497|FG000|Overall Study|Physician Decision|1|||
42019025|NCT01251887|75826504|FG000|Overall Study|Scheduling conflict|1|||
42019026|NCT01251887|75826505|FG001|Overall Study|Scheduling conflict|2|||
42019027|NCT01251887|75826506|FG002|Overall Study|Scheduling conflict|2|||
42019028|NCT01251887|75826504|FG000|Overall Study|Physician Decision|0|||
42019029|NCT01251887|75826505|FG001|Overall Study|Physician Decision|1|||
42019030|NCT01251887|75826506|FG002|Overall Study|Physician Decision|0|||
42019031|NCT00991276|75826520|FG000|First Intervention Period|Adverse Event|0|||
42019032|NCT00991276|75826521|FG001|First Intervention Period|Adverse Event|1|||
42019033|NCT00991276|75826522|FG002|First Intervention Period|Adverse Event|0|||
42019034|NCT00991276|75826523|FG003|First Intervention Period|Adverse Event|1|||
42019035|NCT00991276|75826524|FG004|First Intervention Period|Adverse Event|0|||
42019036|NCT00991276|75826525|FG005|First Intervention Period|Adverse Event|0|||
42019037|NCT00991276|75826520|FG000|First Intervention Period|Protocol Violation|0|||
42019038|NCT00991276|75826521|FG001|First Intervention Period|Protocol Violation|0|||
42019039|NCT00991276|75826522|FG002|First Intervention Period|Protocol Violation|0|||
42019040|NCT00991276|75826523|FG003|First Intervention Period|Protocol Violation|0|||
42019041|NCT00991276|75826524|FG004|First Intervention Period|Protocol Violation|2|||
42019042|NCT00991276|75826525|FG005|First Intervention Period|Protocol Violation|0|||
42019043|NCT00991276|75826520|FG000|First Intervention Period|Insufficient clinical response|0|||
42019044|NCT00991276|75826521|FG001|First Intervention Period|Insufficient clinical response|0|||
42019045|NCT00991276|75826522|FG002|First Intervention Period|Insufficient clinical response|0|||
42019046|NCT00991276|75826523|FG003|First Intervention Period|Insufficient clinical response|0|||
42019047|NCT00991276|75826524|FG004|First Intervention Period|Insufficient clinical response|1|||
42019048|NCT00991276|75826525|FG005|First Intervention Period|Insufficient clinical response|0|||
42019049|NCT00991276|75826520|FG000|First Intervention Period|Other|0|||
42019050|NCT00991276|75826521|FG001|First Intervention Period|Other|0|||
42019051|NCT00991276|75826522|FG002|First Intervention Period|Other|0|||
42019052|NCT00991276|75826523|FG003|First Intervention Period|Other|1|||
42019053|NCT00991276|75826524|FG004|First Intervention Period|Other|1|||
42019054|NCT00991276|75826525|FG005|First Intervention Period|Other|0|||
42019055|NCT00991276|75826520|FG000|First Intervention Period|Withdrawal by Subject|0|||
42019056|NCT00991276|75826521|FG001|First Intervention Period|Withdrawal by Subject|1|||
42019057|NCT00991276|75826522|FG002|First Intervention Period|Withdrawal by Subject|0|||
42019058|NCT00991276|75826523|FG003|First Intervention Period|Withdrawal by Subject|1|||
42019059|NCT00991276|75826524|FG004|First Intervention Period|Withdrawal by Subject|0|||
42019060|NCT00991276|75826525|FG005|First Intervention Period|Withdrawal by Subject|1|||
42019061|NCT00991276|75826520|FG000|First Intervention Period|Lost to Follow-up|0|||
42019062|NCT00991276|75826521|FG001|First Intervention Period|Lost to Follow-up|1|||
42019063|NCT00991276|75826522|FG002|First Intervention Period|Lost to Follow-up|0|||
42019064|NCT00991276|75826523|FG003|First Intervention Period|Lost to Follow-up|1|||
42019065|NCT00991276|75826524|FG004|First Intervention Period|Lost to Follow-up|0|||
42019066|NCT00991276|75826525|FG005|First Intervention Period|Lost to Follow-up|0|||
42019067|NCT00991276|75826520|FG000|Second Intervention Period|Adverse Event|0|||
42019068|NCT00991276|75826521|FG001|Second Intervention Period|Adverse Event|2|||
42019069|NCT00991276|75826522|FG002|Second Intervention Period|Adverse Event|0|||
42019070|NCT00991276|75826523|FG003|Second Intervention Period|Adverse Event|1|||
42019071|NCT00991276|75826524|FG004|Second Intervention Period|Adverse Event|1|||
42019072|NCT00991276|75826525|FG005|Second Intervention Period|Adverse Event|0|||
42019073|NCT00991276|75826520|FG000|Second Intervention Period|Protocol Violation|1|||
42019074|NCT00991276|75826521|FG001|Second Intervention Period|Protocol Violation|0|||
42019075|NCT00991276|75826522|FG002|Second Intervention Period|Protocol Violation|0|||
42019076|NCT00991276|75826523|FG003|Second Intervention Period|Protocol Violation|0|||
42019077|NCT00991276|75826524|FG004|Second Intervention Period|Protocol Violation|0|||
42019078|NCT00991276|75826525|FG005|Second Intervention Period|Protocol Violation|0|||
42019079|NCT00991276|75826520|FG000|Second Intervention Period|Other|0|||
42019080|NCT00991276|75826521|FG001|Second Intervention Period|Other|0|||
42019081|NCT00991276|75826522|FG002|Second Intervention Period|Other|0|||
42019082|NCT00991276|75826523|FG003|Second Intervention Period|Other|1|||
42019083|NCT00991276|75826524|FG004|Second Intervention Period|Other|0|||
42019084|NCT00991276|75826525|FG005|Second Intervention Period|Other|1|||
42019085|NCT00991276|75826520|FG000|Third Intervention Period|Protocol Violation|1|||
42019086|NCT00991276|75826521|FG001|Third Intervention Period|Protocol Violation|0|||
42019087|NCT00991276|75826522|FG002|Third Intervention Period|Protocol Violation|0|||
42019088|NCT00991276|75826523|FG003|Third Intervention Period|Protocol Violation|0|||
42019089|NCT00991276|75826524|FG004|Third Intervention Period|Protocol Violation|0|||
42019090|NCT00991276|75826525|FG005|Third Intervention Period|Protocol Violation|0|||
42019091|NCT00991276|75826520|FG000|Third Intervention Period|Other|0|||
42019092|NCT00991276|75826521|FG001|Third Intervention Period|Other|0|||
42019093|NCT00991276|75826522|FG002|Third Intervention Period|Other|0|||
42019094|NCT00991276|75826523|FG003|Third Intervention Period|Other|0|||
42019095|NCT00991276|75826524|FG004|Third Intervention Period|Other|0|||
42019096|NCT00991276|75826525|FG005|Third Intervention Period|Other|1|||
42019097|NCT00991276|75826520|FG000|Third Intervention Period|Adverse Event|0|||
42019098|NCT00991276|75826521|FG001|Third Intervention Period|Adverse Event|0|||
42019099|NCT00991276|75826522|FG002|Third Intervention Period|Adverse Event|1|||
42019100|NCT00991276|75826523|FG003|Third Intervention Period|Adverse Event|0|||
42019101|NCT00991276|75826524|FG004|Third Intervention Period|Adverse Event|0|||
42019102|NCT00991276|75826525|FG005|Third Intervention Period|Adverse Event|0|||
42019103|NCT00991276|75826520|FG000|Third Intervention Period|Withdrawal by Subject|0|||
42019104|NCT00991276|75826521|FG001|Third Intervention Period|Withdrawal by Subject|0|||
42019105|NCT00991276|75826522|FG002|Third Intervention Period|Withdrawal by Subject|0|||
42019106|NCT00991276|75826523|FG003|Third Intervention Period|Withdrawal by Subject|1|||
42019107|NCT00991276|75826524|FG004|Third Intervention Period|Withdrawal by Subject|0|||
42019108|NCT00991276|75826525|FG005|Third Intervention Period|Withdrawal by Subject|0|||
42019109|NCT00990652|75826534|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
42019110|NCT00990652|75826534|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
42019111|NCT00990340|75826541|FG000|First 14-day Treatment|Not Compliant|2|||
42019112|NCT00990340|75826542|FG001|First 14-day Treatment|Not Compliant|1|||
42019113|NCT00990340|75826541|FG000|First 14-day Treatment|Lost to Follow-up|2|||
42019114|NCT00990340|75826542|FG001|First 14-day Treatment|Lost to Follow-up|1|||
42019115|NCT00990340|75826541|FG000|First 14-day Treatment|Protocol Violation|2|||
42019116|NCT00990340|75826542|FG001|First 14-day Treatment|Protocol Violation|2|||
42019117|NCT01207440|75826557|FG000|Overall Study|Adverse Event|46|||
42019118|NCT01207440|75826558|FG001|Overall Study|Adverse Event|11|||
42019119|NCT01207440|75826559|FG002|Overall Study|Adverse Event|7|||
42019120|NCT01207440|75826560|FG003|Overall Study|Adverse Event|2|||
42019121|NCT01207440|75826561|FG004|Overall Study|Adverse Event|6|||
42019122|NCT01207440|75826562|FG005|Overall Study|Adverse Event|6|||
42019123|NCT01207440|75826563|FG006|Overall Study|Adverse Event|2|||
42019124|NCT01207440|75826557|FG000|Overall Study|Death|6|||
42019125|NCT01207440|75826558|FG001|Overall Study|Death|3|||
42019126|NCT01207440|75826559|FG002|Overall Study|Death|2|||
42019127|NCT01207440|75826560|FG003|Overall Study|Death|2|||
42019128|NCT01207440|75826561|FG004|Overall Study|Death|7|||
42019129|NCT01207440|75826562|FG005|Overall Study|Death|5|||
42019130|NCT01207440|75826563|FG006|Overall Study|Death|1|||
42019131|NCT01207440|75826557|FG000|Overall Study|Lack of Efficacy|13|||
42019132|NCT01207440|75826558|FG001|Overall Study|Lack of Efficacy|2|||
42019133|NCT01207440|75826559|FG002|Overall Study|Lack of Efficacy|5|||
42019134|NCT01207440|75826560|FG003|Overall Study|Lack of Efficacy|1|||
42019135|NCT01207440|75826561|FG004|Overall Study|Lack of Efficacy|2|||
42019136|NCT01207440|75826562|FG005|Overall Study|Lack of Efficacy|3|||
42019137|NCT01207440|75826563|FG006|Overall Study|Lack of Efficacy|0|||
42019138|NCT01207440|75826557|FG000|Overall Study|Lost to Follow-up|0|||
42019139|NCT01207440|75826558|FG001|Overall Study|Lost to Follow-up|0|||
42019140|NCT01207440|75826559|FG002|Overall Study|Lost to Follow-up|2|||
42019141|NCT01207440|75826560|FG003|Overall Study|Lost to Follow-up|1|||
42019142|NCT01207440|75826561|FG004|Overall Study|Lost to Follow-up|0|||
42019143|NCT01207440|75826562|FG005|Overall Study|Lost to Follow-up|0|||
42019144|NCT01207440|75826563|FG006|Overall Study|Lost to Follow-up|0|||
42019145|NCT01207440|75826557|FG000|Overall Study|Non-compliance with Study Drug|3|||
42019146|NCT01207440|75826558|FG001|Overall Study|Non-compliance with Study Drug|0|||
42019147|NCT01207440|75826559|FG002|Overall Study|Non-compliance with Study Drug|1|||
42019148|NCT01207440|75826560|FG003|Overall Study|Non-compliance with Study Drug|0|||
42019149|NCT01207440|75826561|FG004|Overall Study|Non-compliance with Study Drug|0|||
42019150|NCT01207440|75826562|FG005|Overall Study|Non-compliance with Study Drug|0|||
42019151|NCT01207440|75826563|FG006|Overall Study|Non-compliance with Study Drug|0|||
42019152|NCT01207440|75826557|FG000|Overall Study|Physician Decision|6|||
42019153|NCT01207440|75826558|FG001|Overall Study|Physician Decision|5|||
42019154|NCT01207440|75826559|FG002|Overall Study|Physician Decision|5|||
42019155|NCT01207440|75826560|FG003|Overall Study|Physician Decision|0|||
42019156|NCT01207440|75826561|FG004|Overall Study|Physician Decision|1|||
42019157|NCT01207440|75826562|FG005|Overall Study|Physician Decision|0|||
42019158|NCT01207440|75826563|FG006|Overall Study|Physician Decision|0|||
42019159|NCT01207440|75826557|FG000|Overall Study|Progressive Disease|19|||
42019160|NCT01207440|75826558|FG001|Overall Study|Progressive Disease|10|||
42019161|NCT01207440|75826559|FG002|Overall Study|Progressive Disease|19|||
42019162|NCT01207440|75826560|FG003|Overall Study|Progressive Disease|7|||
42019163|NCT01207440|75826561|FG004|Overall Study|Progressive Disease|23|||
42019164|NCT01207440|75826562|FG005|Overall Study|Progressive Disease|27|||
42019165|NCT01207440|75826563|FG006|Overall Study|Progressive Disease|0|||
42019166|NCT01207440|75826557|FG000|Overall Study|Protocol Violation|2|||
42019167|NCT01207440|75826558|FG001|Overall Study|Protocol Violation|0|||
42019168|NCT01207440|75826559|FG002|Overall Study|Protocol Violation|0|||
42019169|NCT01207440|75826560|FG003|Overall Study|Protocol Violation|0|||
42019170|NCT01207440|75826561|FG004|Overall Study|Protocol Violation|0|||
42019171|NCT01207440|75826562|FG005|Overall Study|Protocol Violation|0|||
42019172|NCT01207440|75826563|FG006|Overall Study|Protocol Violation|0|||
42019173|NCT01207440|75826557|FG000|Overall Study|Site Terminated by Sponsor|69|||
42019174|NCT01207440|75826558|FG001|Overall Study|Site Terminated by Sponsor|19|||
42019175|NCT01207440|75826559|FG002|Overall Study|Site Terminated by Sponsor|12|||
42019176|NCT01207440|75826560|FG003|Overall Study|Site Terminated by Sponsor|2|||
42019177|NCT01207440|75826561|FG004|Overall Study|Site Terminated by Sponsor|3|||
42019178|NCT01207440|75826562|FG005|Overall Study|Site Terminated by Sponsor|0|||
42019179|NCT01207440|75826563|FG006|Overall Study|Site Terminated by Sponsor|2|||
42019180|NCT01207440|75826557|FG000|Overall Study|Withdrawal by Subject|29|||
42019181|NCT01207440|75826558|FG001|Overall Study|Withdrawal by Subject|4|||
42019182|NCT01207440|75826559|FG002|Overall Study|Withdrawal by Subject|5|||
42019183|NCT01207440|75826560|FG003|Overall Study|Withdrawal by Subject|3|||
42019184|NCT01207440|75826561|FG004|Overall Study|Withdrawal by Subject|2|||
42019185|NCT01207440|75826562|FG005|Overall Study|Withdrawal by Subject|2|||
42019186|NCT01207440|75826563|FG006|Overall Study|Withdrawal by Subject|0|||
42019187|NCT01207440|75826557|FG000|Overall Study|Reason Not Specified|10|||
42019188|NCT01207440|75826558|FG001|Overall Study|Reason Not Specified|10|||
42019189|NCT01207440|75826559|FG002|Overall Study|Reason Not Specified|7|||
42019190|NCT01207440|75826560|FG003|Overall Study|Reason Not Specified|0|||
42019191|NCT01207440|75826561|FG004|Overall Study|Reason Not Specified|4|||
42019192|NCT01207440|75826562|FG005|Overall Study|Reason Not Specified|3|||
42019193|NCT01207440|75826563|FG006|Overall Study|Reason Not Specified|0|||
42019194|NCT00990184|75826585|FG000|Overall Study|Physician Decision|1|||
42019195|NCT00986830|75826591|FG000|Overall Study|Death|1|||
42019196|NCT00986830|75826591|FG000|Overall Study|Lost to Follow-up|1|||
42019197|NCT00986830|75826591|FG000|Overall Study|Lack of Efficacy|1|||
42019198|NCT00986830|75826591|FG000|Overall Study|Unable to access sinus with device|5|||
42019199|NCT00990106|75826597|FG000|Overall Study|"too busy to continue"|1|||
42019200|NCT00990106|75826598|FG001|Overall Study|"too busy to continue"|2|||
42019201|NCT00990106|75826597|FG000|Overall Study|Lost to Follow-up|1|||
42019202|NCT00990106|75826598|FG001|Overall Study|Lost to Follow-up|3|||
42019203|NCT00990106|75826597|FG000|Overall Study|Withdrawal by Subject|2|||
42019204|NCT00990106|75826598|FG001|Overall Study|Withdrawal by Subject|1|||
42019205|NCT00990106|75826597|FG000|Overall Study|opted for open label prazosin|1|||
42019206|NCT00990106|75826598|FG001|Overall Study|opted for open label prazosin|1|||
42019207|NCT00990106|75826597|FG000|Overall Study|relocation/deployment|4|||
42019208|NCT00990106|75826598|FG001|Overall Study|relocation/deployment|1|||
42019209|NCT00990106|75826597|FG000|Overall Study|started exclusionary medication|0|||
42019210|NCT00990106|75826598|FG001|Overall Study|started exclusionary medication|1|||
42019211|NCT00990106|75826597|FG000|Overall Study|planned major surgery|0|||
42019212|NCT00990106|75826598|FG001|Overall Study|planned major surgery|1|||
42019213|NCT00990106|75826597|FG000|Overall Study|scheduling conflicts|0|||
42019214|NCT00990106|75826598|FG001|Overall Study|scheduling conflicts|2|||
42019215|NCT00983476|75826607|FG000|Overall Study|Did not receive intervention|17|||
42019216|NCT00983476|75826608|FG001|Overall Study|Did not receive intervention|22|||
42019217|NCT00983476|75826609|FG002|Overall Study|Did not receive intervention|0|||
42019218|NCT00982228|75826653|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
42019219|NCT00982228|75826654|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
42019220|NCT00982228|75826653|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
42019221|NCT00982228|75826654|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
42019222|NCT00982228|75826653|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
42019223|NCT00982228|75826654|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
42019224|NCT00982228|75826653|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
42019225|NCT00982228|75826654|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
42019226|NCT00982228|75826653|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
42019227|NCT00982228|75826654|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
42019228|NCT00982228|75826653|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
42019229|NCT00982228|75826654|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
42019230|NCT00982228|75826653|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
42019231|NCT00982228|75826654|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
42019232|NCT00982228|75826653|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
42204026|NCT00073307|76016702|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
42204027|NCT00073307|76016700|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
42204028|NCT00073307|76016701|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
42204029|NCT00073307|76016702|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
42110228|NCT00622700|75920599|FG005|Extension Treatment Period|Progressive Disease|0|||
42110229|NCT00622700|75920600|FG006|Extension Treatment Period|Progressive Disease|2|||
42110230|NCT00622700|75920594|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
42110231|NCT00622700|75920595|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
42110232|NCT00622700|75920596|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
42110233|NCT00622700|75920597|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
42110234|NCT00622700|75920598|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
42110235|NCT00622700|75920599|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
42110236|NCT00622700|75920600|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
42110237|NCT00622700|75920594|FG000|Extension Treatment Period|Missing|0|||
42110238|NCT00622700|75920595|FG001|Extension Treatment Period|Missing|0|||
42110239|NCT00622700|75920596|FG002|Extension Treatment Period|Missing|0|||
42110240|NCT00622700|75920597|FG003|Extension Treatment Period|Missing|2|||
42110241|NCT00622700|75920598|FG004|Extension Treatment Period|Missing|3|||
42110242|NCT00622700|75920599|FG005|Extension Treatment Period|Missing|1|||
42110243|NCT00622700|75920600|FG006|Extension Treatment Period|Missing|0|||
42110244|NCT00622700|75920594|FG000|Extension Treatment Period|Other than specified above|0|||
42110245|NCT00622700|75920595|FG001|Extension Treatment Period|Other than specified above|0|||
42204030|NCT03388164|76016713|FG000|Overall Study|Withdrawal by Subject|3|||
42204031|NCT03388164|76016714|FG001|Overall Study|Withdrawal by Subject|1|||
42204032|NCT03403374|76016720|FG000|Overall Study|Lost to Follow-up|1|||
42204033|NCT03387462|76016724|FG000|Overall Study|Lost to Follow-up|1|||
42204034|NCT03756883|76016731|FG000|Overall Study|Adverse Event|2|||
42204035|NCT03756883|76016732|FG001|Overall Study|Adverse Event|2|||
42204036|NCT03756883|76016733|FG002|Overall Study|Adverse Event|2|||
42204037|NCT03756883|76016731|FG000|Overall Study|Lack of Efficacy|0|||
42204038|NCT03756883|76016732|FG001|Overall Study|Lack of Efficacy|1|||
42204039|NCT03756883|76016733|FG002|Overall Study|Lack of Efficacy|2|||
42204040|NCT03756883|76016731|FG000|Overall Study|Lost to Follow-up|3|||
42204041|NCT03756883|76016732|FG001|Overall Study|Lost to Follow-up|3|||
42204042|NCT03756883|76016733|FG002|Overall Study|Lost to Follow-up|0|||
42204043|NCT03756883|76016731|FG000|Overall Study|Protocol Violation|2|||
42204044|NCT03756883|76016732|FG001|Overall Study|Protocol Violation|0|||
42204045|NCT03756883|76016733|FG002|Overall Study|Protocol Violation|1|||
42204046|NCT03756883|76016731|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
42204047|NCT03756883|76016732|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
42204048|NCT03756883|76016733|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
42204049|NCT03756883|76016731|FG000|Overall Study|Withdrawal by Subject|4|||
42204050|NCT03756883|76016732|FG001|Overall Study|Withdrawal by Subject|1|||
42204051|NCT03756883|76016733|FG002|Overall Study|Withdrawal by Subject|0|||
42204052|NCT03756883|76016731|FG000|Overall Study|Other Reasons|2|||
42204053|NCT03756883|76016732|FG001|Overall Study|Other Reasons|4|||
42204054|NCT03756883|76016733|FG002|Overall Study|Other Reasons|0|||
42204055|NCT03386994|76016744|FG000|Overall Study|Lung transplant|1|||
42204056|NCT03386994|76016744|FG000|Overall Study|Adverse Event|14|||
42204057|NCT03386994|76016744|FG000|Overall Study|Lost to Follow-up|4|||
42204058|NCT03386994|76016744|FG000|Overall Study|Withdrawal by Subject|3|||
42204059|NCT03386994|76016744|FG000|Overall Study|Death|16|||
42204060|NCT03756571|76016761|FG000|Overall Study|Lost to Follow-up|1|||
42204061|NCT03756571|76016762|FG001|Overall Study|Lost to Follow-up|1|||
42204062|NCT03386448|76016770|FG000|Overall Study|Adverse Event|0|||
42204063|NCT03386448|76016771|FG001|Overall Study|Adverse Event|2|||
42204064|NCT02951988|76016780|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
42204065|NCT02951988|76016781|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
42204066|NCT02951988|76016782|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
42204067|NCT02951988|76016783|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
42204068|NCT02951988|76016780|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
42204069|NCT02951988|76016781|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
42204070|NCT02951988|76016782|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
42204071|NCT02951988|76016783|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
42204072|NCT02951988|76016780|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
42204073|NCT02951988|76016781|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
42204074|NCT02951988|76016782|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
42204075|NCT02951988|76016783|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
42204076|NCT02951988|76016780|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
42204077|NCT02951988|76016781|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
42204078|NCT02951988|76016782|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
42204079|NCT02951988|76016783|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
42204080|NCT02951988|76016780|FG000|Open-Label Treatment Period|Protocol Violation|22|||
42204081|NCT02951988|76016781|FG001|Open-Label Treatment Period|Protocol Violation|0|||
42204082|NCT02951988|76016782|FG002|Open-Label Treatment Period|Protocol Violation|0|||
42204083|NCT02951988|76016783|FG003|Open-Label Treatment Period|Protocol Violation|0|||
42204084|NCT02951988|76016780|FG000|Open-Label Treatment Period|Pregnancy|2|||
42204085|NCT02951988|76016781|FG001|Open-Label Treatment Period|Pregnancy|0|||
42204086|NCT02951988|76016782|FG002|Open-Label Treatment Period|Pregnancy|0|||
42204087|NCT02951988|76016783|FG003|Open-Label Treatment Period|Pregnancy|0|||
42204088|NCT02951988|76016780|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
42204089|NCT02951988|76016781|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
42204090|NCT02951988|76016782|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
42204091|NCT02951988|76016783|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
42204092|NCT02951988|76016780|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
42204093|NCT02951988|76016781|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
42204094|NCT02951988|76016782|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
42204095|NCT02951988|76016783|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
42204096|NCT02951988|76016780|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
42204097|NCT02951988|76016781|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
42384254|NCT01508936|76259717|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
42384255|NCT01508702|76259738|FG000|Overall Study|Adverse Event|7|||
42384256|NCT01508702|76259739|FG001|Overall Study|Adverse Event|3|||
42384257|NCT01508702|76259738|FG000|Overall Study|Gout flare|2|||
42384258|NCT01508702|76259739|FG001|Overall Study|Gout flare|0|||
42384259|NCT01508702|76259738|FG000|Overall Study|Protocol Violation|2|||
42384260|NCT01508702|76259739|FG001|Overall Study|Protocol Violation|1|||
42384261|NCT01508702|76259738|FG000|Overall Study|Lost to Follow-up|1|||
42384262|NCT01508702|76259739|FG001|Overall Study|Lost to Follow-up|2|||
42384263|NCT01508702|76259738|FG000|Overall Study|Withdrawal by Subject|11|||
42384264|NCT01508702|76259739|FG001|Overall Study|Withdrawal by Subject|7|||
42384265|NCT01484834|76259753|FG000|Overall Study|Lost to Follow-up|5|||
42384266|NCT01484834|76259754|FG001|Overall Study|Lost to Follow-up|8|||
42384267|NCT01484834|76259755|FG002|Overall Study|Lost to Follow-up|1|||
42384268|NCT01484834|76259756|FG003|Overall Study|Lost to Follow-up|4|||
42384269|NCT01484132|76259766|FG000|Overall Study|Lost to Follow-up|8|||
42384270|NCT01484132|76259766|FG000|Overall Study|Difficulty with time commitment|2|||
42384271|NCT01484132|76259766|FG000|Overall Study|Ineligible|1|||
42384272|NCT01484132|76259766|FG000|Overall Study|No pre-treatment urine sample collected|1|||
42384273|NCT01484132|76259766|FG000|Overall Study|No post-treatment urine sample collected|10|||
42384274|NCT01276041|76259770|FG000|Overall Study|Adverse Event|2|||
42204098|NCT02951988|76016782|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
42204099|NCT02951988|76016783|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
42204100|NCT02951988|76016780|FG000|Open-Label Treatment Period|Adverse Event|45|||
42384275|NCT01276041|76259770|FG000|Overall Study|Protocol Violation|1|||
42384276|NCT01275339|76259778|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
42384277|NCT01275339|76259779|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
42384278|NCT01275339|76259780|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
42384279|NCT01275339|76259781|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
42384280|NCT01275339|76259778|FG000|Overall Study|Withdrawal by Subject|0|||
42384281|NCT01275339|76259779|FG001|Overall Study|Withdrawal by Subject|0|||
42384282|NCT01275339|76259780|FG002|Overall Study|Withdrawal by Subject|1|||
42384283|NCT01275339|76259781|FG003|Overall Study|Withdrawal by Subject|0|||
42384284|NCT01520402|76259791|FG000|Overall Study|Withdrawal by Subject|2|||
42384285|NCT01520402|76259791|FG000|Overall Study|Physician Decision|3|||
42384286|NCT01520324|76259806|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
42384287|NCT01519934|76259810|FG000|Overall Study|Lost to Follow-up|3|||
42384288|NCT01484054|76259814|FG000|Period 1|Withdrawal by Subject|0|||
42384289|NCT01484054|76259815|FG001|Period 1|Withdrawal by Subject|1|||
42384290|NCT01507298|76259833|FG000|Overall Study|Protocol Violation|0|||
42384291|NCT01507298|76259834|FG001|Overall Study|Protocol Violation|6|||
42384292|NCT01483118|76259843|FG000|Overall Study|Lost to Follow-up|12|||
42384293|NCT01483118|76259844|FG001|Overall Study|Lost to Follow-up|16|||
42384294|NCT01506908|76259854|FG000|Overall Study|Adverse Event|1|||
42384295|NCT01506908|76259855|FG001|Overall Study|Adverse Event|0|||
42384296|NCT01519778|76259863|FG000|Overall Study|Withdrawal by Subject|3|||
42384297|NCT01519778|76259863|FG000|Overall Study|Lost to Follow-up|10|||
42384298|NCT01519778|76259863|FG000|Overall Study|Physician Decision|1|||
42384299|NCT01519700|76259871|FG000|Overall Study|Death|1|||
42384300|NCT01519700|76259872|FG001|Overall Study|Death|0|||
42384301|NCT01519700|76259873|FG002|Overall Study|Death|0|||
42384302|NCT01519700|76259874|FG003|Overall Study|Death|0|||
42384303|NCT01519700|76259871|FG000|Overall Study|Lost to Follow-up|0|||
42384304|NCT01519700|76259872|FG001|Overall Study|Lost to Follow-up|0|||
42384305|NCT01519700|76259873|FG002|Overall Study|Lost to Follow-up|1|||
42384306|NCT01519700|76259874|FG003|Overall Study|Lost to Follow-up|1|||
42384307|NCT01519700|76259871|FG000|Overall Study|Physician Decision|1|||
42384308|NCT01519700|76259872|FG001|Overall Study|Physician Decision|1|||
42384309|NCT01519700|76259873|FG002|Overall Study|Physician Decision|3|||
42384310|NCT01519700|76259874|FG003|Overall Study|Physician Decision|0|||
42384311|NCT01519700|76259871|FG000|Overall Study|Withdrawal by Subject|5|||
42384312|NCT01519700|76259872|FG001|Overall Study|Withdrawal by Subject|3|||
42384313|NCT01519700|76259873|FG002|Overall Study|Withdrawal by Subject|3|||
42384314|NCT01519700|76259874|FG003|Overall Study|Withdrawal by Subject|2|||
42384315|NCT01519700|76259871|FG000|Overall Study|Other Reason|2|||
42384316|NCT01519700|76259872|FG001|Overall Study|Other Reason|2|||
42384317|NCT01519700|76259873|FG002|Overall Study|Other Reason|0|||
42384318|NCT01519700|76259874|FG003|Overall Study|Other Reason|4|||
42384319|NCT02656680|76259892|FG000|Overall Study|Lost to Follow-up|0|||
42384320|NCT02656680|76259893|FG001|Overall Study|Lost to Follow-up|1|||
42384321|NCT02658084|76259929|FG000|Overall Study|Withdrawal by Subject|1|||
42384322|NCT02658084|76259930|FG001|Overall Study|Withdrawal by Subject|0|||
42384323|NCT02658084|76259929|FG000|Overall Study|Study Termination|1|||
42384324|NCT02658084|76259930|FG001|Overall Study|Study Termination|0|||
42384325|NCT01482962|76259946|FG000|Overall Study|Progressive Disease|65|||
42384326|NCT01482962|76259947|FG001|Overall Study|Progressive Disease|53|||
42384327|NCT01482962|76259946|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
42384328|NCT01482962|76259947|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
42384329|NCT01482962|76259946|FG000|Overall Study|Adverse Event|18|||
42384330|NCT01482962|76259947|FG001|Overall Study|Adverse Event|22|||
42384331|NCT01482962|76259946|FG000|Overall Study|Withdrawal by Participant|8|||
42384332|NCT01482962|76259947|FG001|Overall Study|Withdrawal by Participant|13|||
42384333|NCT01482962|76259946|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
42384334|NCT01482962|76259947|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
42384335|NCT01482962|76259946|FG000|Overall Study|Other Reason|1|||
42384336|NCT01482962|76259947|FG001|Overall Study|Other Reason|5|||
42384337|NCT01482962|76259946|FG000|Overall Study|Study Terminated by Sponsor|5|||
42384338|NCT01482962|76259947|FG001|Overall Study|Study Terminated by Sponsor|2|||
42384339|NCT01482962|76259946|FG000|Overall Study|Did not Receive Study Drug|1|||
42384340|NCT01482962|76259947|FG001|Overall Study|Did not Receive Study Drug|6|||
42384341|NCT02655666|76259955|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
42384342|NCT01506596|76259959|FG000|Overall Study|ineligible pathology|1|||
42384343|NCT01482884|76259978|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
42384344|NCT01482884|76259979|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
42384345|NCT01482884|76259978|FG000|Overall Study|Protocol Violation|1|||
42384346|NCT01482884|76259979|FG001|Overall Study|Protocol Violation|0|||
42384347|NCT01482884|76259978|FG000|Overall Study|Lost to Follow-up|2|||
42384348|NCT01482884|76259979|FG001|Overall Study|Lost to Follow-up|2|||
42384349|NCT01482884|76259978|FG000|Overall Study|Lack of Efficacy|0|||
42384350|NCT01482884|76259979|FG001|Overall Study|Lack of Efficacy|1|||
42384351|NCT01482884|76259978|FG000|Overall Study|Adverse Event|2|||
42384352|NCT01482884|76259979|FG001|Overall Study|Adverse Event|1|||
42384353|NCT01482884|76259978|FG000|Overall Study|Withdrawal by Subject|8|||
42384354|NCT01482884|76259979|FG001|Overall Study|Withdrawal by Subject|13|||
42384355|NCT01518374|76259985|FG000|Overall Study|Withdrawal by Subject|2|||
42384356|NCT01518374|76259985|FG000|Overall Study|Protocol Violation|3|||
42384357|NCT01518374|76259985|FG000|Overall Study|Lost to Follow-up|2|||
42384358|NCT01481324|76259992|FG000|Overall Study|Missing Data|0|||
42204101|NCT02951988|76016781|FG001|Open-Label Treatment Period|Adverse Event|0|||
42384359|NCT01481324|76259993|FG001|Overall Study|Missing Data|2|||
42384360|NCT01481324|76259994|FG002|Overall Study|Missing Data|2|||
42384361|NCT04591626|76260004|FG000|Overall Study|Adverse Event|4|||
42384362|NCT04591626|76260005|FG001|Overall Study|Adverse Event|0|||
42204102|NCT02951988|76016782|FG002|Open-Label Treatment Period|Adverse Event|0|||
42384363|NCT04591626|76260004|FG000|Overall Study|Withdrawal by Subject|5|||
42384364|NCT04591626|76260005|FG001|Overall Study|Withdrawal by Subject|3|||
42384365|NCT04591626|76260004|FG000|Overall Study|Physician Decision|0|||
42384366|NCT04591626|76260005|FG001|Overall Study|Physician Decision|1|||
42384367|NCT04591626|76260004|FG000|Overall Study|Death|0|||
42384368|NCT04591626|76260005|FG001|Overall Study|Death|1|||
42384369|NCT04591626|76260004|FG000|Overall Study|Non-Compliance with Study Drug|1|||
42384370|NCT04591626|76260005|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42384371|NCT03583333|76260013|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
42384372|NCT03583333|76260014|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
42384373|NCT03583333|76260013|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
42384374|NCT03583333|76260014|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
42384375|NCT03583333|76260013|FG000|Overall Study|Withdrawal by Subject|9|||
42384376|NCT03583333|76260014|FG001|Overall Study|Withdrawal by Subject|5|||
42384377|NCT03583333|76260013|FG000|Overall Study|Physician Decision|3|||
42384378|NCT03583333|76260014|FG001|Overall Study|Physician Decision|2|||
42384379|NCT03583333|76260013|FG000|Overall Study|Death|12|||
42384380|NCT03583333|76260014|FG001|Overall Study|Death|7|||
42384381|NCT01602510|76260020|FG000|Open Label Phase|Adverse Event|46|||
42384382|NCT01602510|76260021|FG001|Open Label Phase|Adverse Event|0|||
42384383|NCT01602510|76260022|FG002|Open Label Phase|Adverse Event|0|||
42384384|NCT01602510|76260020|FG000|Open Label Phase|Lack of Efficacy|22|||
42384385|NCT01602510|76260021|FG001|Open Label Phase|Lack of Efficacy|0|||
42384386|NCT01602510|76260022|FG002|Open Label Phase|Lack of Efficacy|0|||
42384387|NCT01602510|76260020|FG000|Open Label Phase|Protocol Violation|15|||
42384388|NCT01602510|76260021|FG001|Open Label Phase|Protocol Violation|0|||
42384389|NCT01602510|76260022|FG002|Open Label Phase|Protocol Violation|0|||
42384390|NCT01602510|76260020|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
42384391|NCT01602510|76260021|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
42384392|NCT01602510|76260022|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
42384393|NCT01602510|76260020|FG000|Open Label Phase|Lost to Follow-up|22|||
42384394|NCT01602510|76260021|FG001|Open Label Phase|Lost to Follow-up|0|||
42384395|NCT01602510|76260022|FG002|Open Label Phase|Lost to Follow-up|0|||
42384396|NCT01602510|76260020|FG000|Open Label Phase|Physician Decision|19|||
42384397|NCT01602510|76260021|FG001|Open Label Phase|Physician Decision|0|||
42384398|NCT01602510|76260022|FG002|Open Label Phase|Physician Decision|0|||
42384399|NCT01602510|76260020|FG000|Open Label Phase|Withdrawal by Subject|57|||
42384400|NCT01602510|76260021|FG001|Open Label Phase|Withdrawal by Subject|0|||
42384401|NCT01602510|76260022|FG002|Open Label Phase|Withdrawal by Subject|0|||
42384402|NCT01602510|76260020|FG000|Randomized Phase|Adverse Event|0|||
42384403|NCT01602510|76260021|FG001|Randomized Phase|Adverse Event|2|||
42384404|NCT01602510|76260022|FG002|Randomized Phase|Adverse Event|6|||
42384405|NCT01602510|76260020|FG000|Randomized Phase|Lack of Efficacy|0|||
42384406|NCT01602510|76260021|FG001|Randomized Phase|Lack of Efficacy|4|||
42384407|NCT01602510|76260022|FG002|Randomized Phase|Lack of Efficacy|4|||
42384408|NCT01602510|76260020|FG000|Randomized Phase|Protocol Violation|0|||
42384409|NCT01602510|76260021|FG001|Randomized Phase|Protocol Violation|3|||
42384410|NCT01602510|76260022|FG002|Randomized Phase|Protocol Violation|3|||
42384411|NCT01602510|76260020|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
42384412|NCT01602510|76260021|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
42384413|NCT01602510|76260022|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
42384414|NCT01602510|76260020|FG000|Randomized Phase|Lost to Follow-up|0|||
42384415|NCT01602510|76260021|FG001|Randomized Phase|Lost to Follow-up|1|||
42384416|NCT01602510|76260022|FG002|Randomized Phase|Lost to Follow-up|3|||
42384417|NCT01602510|76260020|FG000|Randomized Phase|Physician Decision|0|||
42384418|NCT01602510|76260021|FG001|Randomized Phase|Physician Decision|0|||
42384419|NCT01602510|76260022|FG002|Randomized Phase|Physician Decision|2|||
42384420|NCT01602510|76260020|FG000|Randomized Phase|Withdrawal by Subject|0|||
42384421|NCT01602510|76260021|FG001|Randomized Phase|Withdrawal by Subject|6|||
42384422|NCT01602510|76260022|FG002|Randomized Phase|Withdrawal by Subject|7|||
42384423|NCT01675596|76260037|FG000|Overall Study|Death|6|||
42384424|NCT01675596|76260037|FG000|Overall Study|Exit with other reason|1|||
42384425|NCT01675596|76260037|FG000|Overall Study|Missed Visit|1|||
42384426|NCT02653326|76260047|FG000|Overall Study|Lost to Follow-up|10|||
42384427|NCT02653326|76260048|FG001|Overall Study|Lost to Follow-up|7|||
42384428|NCT02653170|76260057|FG000|Overall Study|Withdrawal by Subject|3|||
42384429|NCT02653170|76260058|FG001|Overall Study|Withdrawal by Subject|8|||
42384430|NCT02653170|76260059|FG002|Overall Study|Withdrawal by Subject|3|||
42384431|NCT02653170|76260057|FG000|Overall Study|withdrawn by study team|2|||
42384432|NCT02653170|76260058|FG001|Overall Study|withdrawn by study team|4|||
42384433|NCT02653170|76260059|FG002|Overall Study|withdrawn by study team|5|||
42384434|NCT02653170|76260057|FG000|Overall Study|Lost to Follow-up|12|||
42384435|NCT02653170|76260058|FG001|Overall Study|Lost to Follow-up|4|||
42384436|NCT02653170|76260059|FG002|Overall Study|Lost to Follow-up|10|||
42384437|NCT01463696|76260079|FG000|Overall Study|Adverse Event|0|||
42384438|NCT01463696|76260080|FG001|Overall Study|Adverse Event|1|||
42384439|NCT01463696|76260081|FG002|Overall Study|Adverse Event|0|||
42384440|NCT01463696|76260082|FG003|Overall Study|Adverse Event|2|||
42019233|NCT00982228|75826654|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
42019234|NCT00982228|75826653|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
42384441|NCT01463696|76260083|FG004|Overall Study|Adverse Event|0|||
42384442|NCT01463696|76260084|FG005|Overall Study|Adverse Event|1|||
42384443|NCT01463696|76260085|FG006|Overall Study|Adverse Event|3|||
42384444|NCT01463696|76260086|FG007|Overall Study|Adverse Event|2|||
42384445|NCT01463696|76260079|FG000|Overall Study|Lost to Follow-up|0|||
42384446|NCT01463696|76260080|FG001|Overall Study|Lost to Follow-up|0|||
42384447|NCT01463696|76260081|FG002|Overall Study|Lost to Follow-up|1|||
42384448|NCT01463696|76260082|FG003|Overall Study|Lost to Follow-up|0|||
42384449|NCT01463696|76260083|FG004|Overall Study|Lost to Follow-up|0|||
42384450|NCT01463696|76260084|FG005|Overall Study|Lost to Follow-up|0|||
42384451|NCT01463696|76260085|FG006|Overall Study|Lost to Follow-up|0|||
42384452|NCT01463696|76260086|FG007|Overall Study|Lost to Follow-up|0|||
42384453|NCT01463696|76260079|FG000|Overall Study|Progressive Disease|0|||
42384454|NCT01463696|76260080|FG001|Overall Study|Progressive Disease|1|||
42384455|NCT01463696|76260081|FG002|Overall Study|Progressive Disease|0|||
42384456|NCT01463696|76260082|FG003|Overall Study|Progressive Disease|1|||
42384457|NCT01463696|76260083|FG004|Overall Study|Progressive Disease|0|||
42384458|NCT01463696|76260084|FG005|Overall Study|Progressive Disease|1|||
42384459|NCT01463696|76260085|FG006|Overall Study|Progressive Disease|4|||
42384460|NCT01463696|76260086|FG007|Overall Study|Progressive Disease|2|||
42384461|NCT01463696|76260079|FG000|Overall Study|Withdrawal by Subject|0|||
42384462|NCT01463696|76260080|FG001|Overall Study|Withdrawal by Subject|0|||
42384463|NCT01463696|76260081|FG002|Overall Study|Withdrawal by Subject|0|||
42384464|NCT01463696|76260082|FG003|Overall Study|Withdrawal by Subject|1|||
42384465|NCT01463696|76260083|FG004|Overall Study|Withdrawal by Subject|1|||
42384466|NCT01463696|76260084|FG005|Overall Study|Withdrawal by Subject|1|||
42384467|NCT01463696|76260085|FG006|Overall Study|Withdrawal by Subject|2|||
42384468|NCT01463696|76260086|FG007|Overall Study|Withdrawal by Subject|0|||
42384469|NCT01463696|76260079|FG000|Overall Study|Not Treated|0|||
42384470|NCT01463696|76260080|FG001|Overall Study|Not Treated|0|||
42384471|NCT01463696|76260081|FG002|Overall Study|Not Treated|0|||
42384472|NCT01463696|76260082|FG003|Overall Study|Not Treated|0|||
42384473|NCT01463696|76260083|FG004|Overall Study|Not Treated|0|||
42384474|NCT01463696|76260084|FG005|Overall Study|Not Treated|0|||
42384475|NCT01463696|76260085|FG006|Overall Study|Not Treated|1|||
42384476|NCT01463696|76260086|FG007|Overall Study|Not Treated|0|||
42384477|NCT02653482|76260110|FG000|Overall Study|Death|1|||
42384478|NCT02653482|76260111|FG001|Overall Study|Death|1|||
42384479|NCT01362348|76260117|FG000|Overall Study|Protocol-defined stopping criteria|9|||
42384480|NCT01362348|76260117|FG000|Overall Study|Study closed/terminated|5|||
42384481|NCT01675128|76260187|FG000|Overall Study|Disease progression on study|1|||
42384482|NCT01675128|76260188|FG001|Overall Study|Disease progression on study|1|||
42384483|NCT01675128|76260189|FG002|Overall Study|Disease progression on study|1|||
42384484|NCT01675128|76260187|FG000|Overall Study|Refused further treatment|1|||
42384485|NCT01675128|76260188|FG001|Overall Study|Refused further treatment|0|||
42384486|NCT01675128|76260189|FG002|Overall Study|Refused further treatment|0|||
42384487|NCT01675128|76260187|FG000|Overall Study|Pulmonary complication; off study|0|||
42384488|NCT01675128|76260188|FG001|Overall Study|Pulmonary complication; off study|1|||
42384489|NCT01675128|76260189|FG002|Overall Study|Pulmonary complication; off study|0|||
42384490|NCT01427309|76260235|FG000|Overall Study|Lost to Follow-up|130|||
42384491|NCT01427309|76260236|FG001|Overall Study|Lost to Follow-up|145|||
42384492|NCT01427309|76260237|FG002|Overall Study|Lost to Follow-up|122|||
42384493|NCT01427309|76260238|FG003|Overall Study|Lost to Follow-up|135|||
42384494|NCT01427309|76260235|FG000|Overall Study|Protocol Violation|42|||
42384495|NCT01427309|76260236|FG001|Overall Study|Protocol Violation|69|||
42384496|NCT01427309|76260237|FG002|Overall Study|Protocol Violation|125|||
42384497|NCT01427309|76260238|FG003|Overall Study|Protocol Violation|124|||
42384498|NCT01427309|76260235|FG000|Overall Study|Adverse Event|0|||
42384499|NCT01427309|76260236|FG001|Overall Study|Adverse Event|0|||
42384500|NCT01427309|76260237|FG002|Overall Study|Adverse Event|3|||
42384501|NCT01427309|76260238|FG003|Overall Study|Adverse Event|1|||
42384502|NCT01427309|76260235|FG000|Overall Study|Serious adverse event|52|||
42384503|NCT01427309|76260236|FG001|Overall Study|Serious adverse event|45|||
42384504|NCT01427309|76260237|FG002|Overall Study|Serious adverse event|50|||
42384505|NCT01427309|76260238|FG003|Overall Study|Serious adverse event|61|||
42384506|NCT01427309|76260235|FG000|Overall Study|Withdrawal by Subject|148|||
42384507|NCT01427309|76260236|FG001|Overall Study|Withdrawal by Subject|148|||
42384508|NCT01427309|76260237|FG002|Overall Study|Withdrawal by Subject|61|||
42384509|NCT01427309|76260238|FG003|Overall Study|Withdrawal by Subject|55|||
42384510|NCT01426373|76260248|FG000|Overall Study|Adverse Event|6|||
42384511|NCT01426373|76260248|FG000|Overall Study|Lost to Follow-up|14|||
42384512|NCT01426373|76260248|FG000|Overall Study|Participant Convenience|10|||
42384513|NCT01426373|76260248|FG000|Overall Study|Miscellaneous Reasons|4|||
42384514|NCT01426217|76260256|FG000|Overall Study|lost sample|8|||
42384515|NCT01426217|76260257|FG001|Overall Study|lost sample|14|||
42384516|NCT01425749|76260265|FG000|Overall Study|progression of melanoma|0|||
42384517|NCT01425749|76260266|FG001|Overall Study|progression of melanoma|1|||
42384518|NCT01403987|76260282|FG000|Overall Study|Residents forgot their secret PIN|18|||
42384519|NCT01403987|76260283|FG001|Overall Study|Residents forgot their secret PIN|17|||
42384520|NCT01403987|76260284|FG002|Overall Study|Residents forgot their secret PIN|18|||
42384521|NCT01425359|76260294|FG000|Overall Study|Randomized but Not Treated|2|||
42110246|NCT00622700|75920596|FG002|Extension Treatment Period|Other than specified above|0|||
42384522|NCT01425359|76260295|FG001|Overall Study|Randomized but Not Treated|3|||
42384523|NCT01425359|76260294|FG000|Overall Study|Adverse Event|9|||
42384524|NCT01425359|76260295|FG001|Overall Study|Adverse Event|8|||
42384525|NCT01425359|76260294|FG000|Overall Study|Revascularization|0|||
42384526|NCT01425359|76260295|FG001|Overall Study|Revascularization|1|||
42384527|NCT01425359|76260294|FG000|Overall Study|Death|0|||
42384528|NCT01425359|76260295|FG001|Overall Study|Death|1|||
42384529|NCT01425359|76260294|FG000|Overall Study|Unsatisfactory Response|1|||
42384530|NCT01425359|76260295|FG001|Overall Study|Unsatisfactory Response|0|||
42384531|NCT01425359|76260294|FG000|Overall Study|Protocol Violation|1|||
42384532|NCT01425359|76260295|FG001|Overall Study|Protocol Violation|2|||
42384533|NCT01425359|76260294|FG000|Overall Study|Subject Withdrew Consent|1|||
42384534|NCT01425359|76260295|FG001|Overall Study|Subject Withdrew Consent|2|||
42384535|NCT01425359|76260294|FG000|Overall Study|Investigator's Discretion|2|||
42384536|NCT01425359|76260295|FG001|Overall Study|Investigator's Discretion|0|||
42384537|NCT01425359|76260294|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
42384538|NCT01425359|76260295|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
42384539|NCT01403051|76260315|FG000|Overall Study|Protocol Violation|2|||
42384540|NCT01403051|76260316|FG001|Overall Study|Protocol Violation|0|||
42384541|NCT01403051|76260315|FG000|Overall Study|Death|1|||
42384542|NCT01403051|76260316|FG001|Overall Study|Death|0|||
42384543|NCT01403051|76260315|FG000|Overall Study|Withdrawal by Subject|2|||
42384544|NCT01403051|76260316|FG001|Overall Study|Withdrawal by Subject|1|||
42384545|NCT01403051|76260315|FG000|Overall Study|Lost to Follow-up|5|||
42384546|NCT01403051|76260316|FG001|Overall Study|Lost to Follow-up|5|||
42384547|NCT04115748|76260331|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
42384548|NCT04115748|76260332|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
42384549|NCT04115748|76260333|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
42384550|NCT04115748|76260334|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
42384551|NCT04115748|76260335|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
42384552|NCT04115748|76260336|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
42384553|NCT04115748|76260337|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
42384554|NCT04115748|76260338|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
42384555|NCT04115748|76260339|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
42384556|NCT04115748|76260340|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
42384557|NCT04115748|76260331|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
42384558|NCT04115748|76260332|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
42384559|NCT04115748|76260333|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
42384560|NCT04115748|76260334|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
42384561|NCT04115748|76260335|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
42384562|NCT04115748|76260336|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
42384563|NCT04115748|76260337|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
42384564|NCT04115748|76260338|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
42384565|NCT04115748|76260339|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
42384566|NCT04115748|76260340|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
42384567|NCT04115748|76260331|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
42384568|NCT04115748|76260332|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
42384569|NCT04115748|76260333|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
42384570|NCT04115748|76260334|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
42384571|NCT04115748|76260335|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
42384572|NCT04115748|76260336|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
42384573|NCT04115748|76260337|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
42384574|NCT04115748|76260338|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
42384575|NCT04115748|76260339|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
42384576|NCT04115748|76260340|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
42384577|NCT04115748|76260331|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
42384578|NCT04115748|76260332|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
42384579|NCT04115748|76260333|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
42384580|NCT04115748|76260334|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
42384581|NCT04115748|76260335|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
42384582|NCT04115748|76260336|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
42384583|NCT04115748|76260337|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
42384584|NCT04115748|76260338|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
42384585|NCT04115748|76260339|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
42384586|NCT04115748|76260340|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
42384587|NCT02652624|76260397|FG000|Randomized Phase|Pregnancy|3|||
42384588|NCT02652624|76260398|FG001|Randomized Phase|Pregnancy|1|||
42384589|NCT02652624|76260397|FG000|Randomized Phase|Investigator's Discretion|0|||
42384590|NCT02652624|76260398|FG001|Randomized Phase|Investigator's Discretion|2|||
42384591|NCT02652624|76260397|FG000|Randomized Phase|Death|0|||
42204103|NCT02951988|76016783|FG003|Open-Label Treatment Period|Adverse Event|0|||
42384592|NCT02652624|76260398|FG001|Randomized Phase|Death|1|||
42384593|NCT02652624|76260397|FG000|Randomized Phase|Lost to Follow-up|0|||
42384594|NCT02652624|76260398|FG001|Randomized Phase|Lost to Follow-up|1|||
42384595|NCT02652624|76260397|FG000|Extension Phase|Lost to Follow-up|3|||
42384596|NCT02652624|76260398|FG001|Extension Phase|Lost to Follow-up|1|||
42384597|NCT02652624|76260397|FG000|Extension Phase|Pregnancy|1|||
42384598|NCT02652624|76260398|FG001|Extension Phase|Pregnancy|1|||
42384599|NCT02652624|76260397|FG000|Extension Phase|Adverse Event|0|||
42384600|NCT02652624|76260398|FG001|Extension Phase|Adverse Event|1|||
42384601|NCT02652624|76260397|FG000|Extension Phase|Withdrew Consent|0|||
42384602|NCT02652624|76260398|FG001|Extension Phase|Withdrew Consent|1|||
42384603|NCT00249795|76260408|FG000|Overall Study|Not treated|16|||
42384604|NCT00249795|76260409|FG001|Overall Study|Not treated|14|||
42384605|NCT00249795|76260408|FG000|Overall Study|Symptomatic hypotension|127|||
42384606|NCT00249795|76260409|FG001|Overall Study|Symptomatic hypotension|64|||
42384607|NCT00249795|76260408|FG000|Overall Study|Other Serious Adverse Event|84|||
42384608|NCT00249795|76260409|FG001|Overall Study|Other Serious Adverse Event|93|||
42384609|NCT00249795|76260408|FG000|Overall Study|Qualifying condition not present|26|||
42384610|NCT00249795|76260409|FG001|Overall Study|Qualifying condition not present|29|||
42384611|NCT00249795|76260408|FG000|Overall Study|Withdrawal by Subject|678|||
42384612|NCT00249795|76260409|FG001|Overall Study|Withdrawal by Subject|742|||
42384613|NCT00249795|76260408|FG000|Overall Study|Thromboembolic / outcome event|39|||
42384614|NCT00249795|76260409|FG001|Overall Study|Thromboembolic / outcome event|45|||
42384615|NCT00249795|76260408|FG000|Overall Study|Oral anticoagulant required|2|||
42384616|NCT00249795|76260409|FG001|Overall Study|Oral anticoagulant required|0|||
42384617|NCT00249795|76260408|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
42384618|NCT00249795|76260409|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
42384619|NCT00249795|76260408|FG000|Overall Study|Non-compliance|71|||
42384620|NCT00249795|76260409|FG001|Overall Study|Non-compliance|69|||
42384621|NCT00249795|76260408|FG000|Overall Study|Study drug intolerance|3|||
42384622|NCT00249795|76260409|FG001|Overall Study|Study drug intolerance|3|||
42384623|NCT00249795|76260408|FG000|Overall Study|Other adverse events (non-serious)|188|||
42384624|NCT00249795|76260409|FG001|Overall Study|Other adverse events (non-serious)|159|||
42384625|NCT00249795|76260408|FG000|Overall Study|Physician withdrew consent|71|||
42384626|NCT00249795|76260409|FG001|Overall Study|Physician withdrew consent|63|||
42384627|NCT00249795|76260408|FG000|Overall Study|Surgery / procedure|4|||
42384628|NCT00249795|76260409|FG001|Overall Study|Surgery / procedure|5|||
42384629|NCT00249795|76260408|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
42384630|NCT00249795|76260409|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
42384631|NCT00249795|76260408|FG000|Overall Study|Lightheadedness / dizziness|15|||
42384632|NCT00249795|76260409|FG001|Overall Study|Lightheadedness / dizziness|11|||
42384633|NCT00249795|76260408|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
42384634|NCT00249795|76260409|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
42384635|NCT00249795|76260408|FG000|Overall Study|Other contraindicated medication|1|||
42384636|NCT00249795|76260409|FG001|Overall Study|Other contraindicated medication|1|||
42384637|NCT00249795|76260408|FG000|Overall Study|Event related to cardiac condition|17|||
42384638|NCT00249795|76260409|FG001|Overall Study|Event related to cardiac condition|16|||
42384639|NCT00249795|76260408|FG000|Overall Study|Patient not wish to continue after May08|4|||
42384640|NCT00249795|76260409|FG001|Overall Study|Patient not wish to continue after May08|6|||
42384641|NCT00249795|76260408|FG000|Overall Study|Site not agree to continue after May08|1|||
42384642|NCT00249795|76260409|FG001|Overall Study|Site not agree to continue after May08|1|||
42384643|NCT00249795|76260408|FG000|Overall Study|Lost to Follow-up|0|||
42384644|NCT00249795|76260409|FG001|Overall Study|Lost to Follow-up|2|||
42384645|NCT00249795|76260408|FG000|Overall Study|Missing|0|||
42384646|NCT00249795|76260409|FG001|Overall Study|Missing|1|||
42384647|NCT02651220|76260418|FG000|Overall Study|Adverse Event|1|||
42384648|NCT02651220|76260419|FG001|Overall Study|Adverse Event|5|||
42384649|NCT02651220|76260420|FG002|Overall Study|Adverse Event|1|||
42384650|NCT02651220|76260418|FG000|Overall Study|Lost to Follow-up|8|||
42384651|NCT02651220|76260419|FG001|Overall Study|Lost to Follow-up|14|||
42384652|NCT02651220|76260420|FG002|Overall Study|Lost to Follow-up|14|||
42384653|NCT02651220|76260418|FG000|Overall Study|Non-Compliance with Study Drug|4|||
42384654|NCT02651220|76260419|FG001|Overall Study|Non-Compliance with Study Drug|0|||
42384655|NCT02651220|76260420|FG002|Overall Study|Non-Compliance with Study Drug|1|||
42384656|NCT02651220|76260418|FG000|Overall Study|Pregnancy|1|||
42384657|NCT02651220|76260419|FG001|Overall Study|Pregnancy|0|||
42384658|NCT02651220|76260420|FG002|Overall Study|Pregnancy|1|||
42384659|NCT02651220|76260418|FG000|Overall Study|Protocol Violation|0|||
42384660|NCT02651220|76260419|FG001|Overall Study|Protocol Violation|0|||
42384661|NCT02651220|76260420|FG002|Overall Study|Protocol Violation|1|||
42384662|NCT02651220|76260418|FG000|Overall Study|Withdrawal by Subject|5|||
42384663|NCT02651220|76260419|FG001|Overall Study|Withdrawal by Subject|6|||
42384664|NCT02651220|76260420|FG002|Overall Study|Withdrawal by Subject|8|||
42384665|NCT02651220|76260418|FG000|Overall Study|Miscellaneous|4|||
42384666|NCT02651220|76260419|FG001|Overall Study|Miscellaneous|1|||
42384667|NCT02651220|76260420|FG002|Overall Study|Miscellaneous|2|||
42384668|NCT02651220|76260418|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42384669|NCT02651220|76260419|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
42384670|NCT02651220|76260420|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
42384671|NCT00247611|76260468|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
42384672|NCT00247611|76260469|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
42384673|NCT00247611|76260468|FG000|Baselined|Completed baseline only|9|||
42384674|NCT00247611|76260469|FG001|Baselined|Completed baseline only|8|||
42384675|NCT00246753|76260492|FG000|Overall Study|Withdrawal by Subject|2|||
42384676|NCT00246753|76260492|FG000|Overall Study|Physician Decision|2|||
42384677|NCT00246753|76260492|FG000|Overall Study|Adverse Event|2|||
42384678|NCT00246753|76260492|FG000|Overall Study|Unacceptable toxicity|2|||
42384679|NCT00246129|76260509|FG000|Overall Study|Lost to Follow-up|1|||
42384680|NCT00246129|76260510|FG001|Overall Study|Lost to Follow-up|0|||
42384681|NCT00246129|76260509|FG000|Overall Study|Death|2|||
42384682|NCT00246129|76260510|FG001|Overall Study|Death|1|||
42384683|NCT00246129|76260509|FG000|Overall Study|suffered primary non-function|1|||
42384684|NCT00246129|76260510|FG001|Overall Study|suffered primary non-function|0|||
42384685|NCT00246129|76260509|FG000|Overall Study|grafts failed|3|||
42384686|NCT00246129|76260510|FG001|Overall Study|grafts failed|1|||
42384687|NCT03182868|76260533|FG000|Overall Study|Protocol Violation|3|||
42384688|NCT03182868|76260534|FG001|Overall Study|Protocol Violation|0|||
42384689|NCT03182868|76260535|FG002|Overall Study|Protocol Violation|4|||
42384690|NCT03182868|76260536|FG003|Overall Study|Protocol Violation|1|||
42384691|NCT03182868|76260537|FG004|Overall Study|Protocol Violation|8|||
42384692|NCT00245583|76260561|FG000|Overall Study|Lost to Follow-up|1|||
42384693|NCT00245583|76260562|FG001|Overall Study|Lost to Follow-up|5|||
42384694|NCT00245583|76260561|FG000|Overall Study|Adverse Event|2|||
42384695|NCT00245583|76260562|FG001|Overall Study|Adverse Event|1|||
42384696|NCT00245583|76260561|FG000|Overall Study|Lack of Efficacy|1|||
42384697|NCT00245583|76260562|FG001|Overall Study|Lack of Efficacy|0|||
42384698|NCT00245583|76260561|FG000|Overall Study|Withdrawal by Subject|2|||
42384699|NCT00245583|76260562|FG001|Overall Study|Withdrawal by Subject|3|||
42384700|NCT02652156|76260571|FG000|Overall Study|Physician Decision|1|||
42384701|NCT02652156|76260572|FG001|Overall Study|Physician Decision|0|||
42384702|NCT02652156|76260573|FG002|Overall Study|Physician Decision|0|||
42384703|NCT01675050|76260620|FG000|Period One Treatment|Withdrawal by Subject|1|||
42384704|NCT01675050|76260621|FG001|Period One Treatment|Withdrawal by Subject|0|||
42384705|NCT00244881|76260640|FG000|Overall Study|Withdrawal by Subject|3|||
42384706|NCT00244725|76260671|FG000|Overall Study|Lost to Follow-up|3|||
42384707|NCT00244725|76260672|FG001|Overall Study|Lost to Follow-up|4|||
42384708|NCT00244725|76260673|FG002|Overall Study|Lost to Follow-up|9|||
42384709|NCT00244725|76260674|FG003|Overall Study|Lost to Follow-up|2|||
42384710|NCT00244725|76260671|FG000|Overall Study|Withdrawal by Subject|9|||
42384711|NCT00244725|76260672|FG001|Overall Study|Withdrawal by Subject|7|||
42384712|NCT00244725|76260673|FG002|Overall Study|Withdrawal by Subject|7|||
42384713|NCT00244725|76260674|FG003|Overall Study|Withdrawal by Subject|8|||
42384714|NCT00244725|76260671|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
42384715|NCT00244725|76260672|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
42384716|NCT00244725|76260673|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
42384717|NCT00244725|76260674|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
42384718|NCT00244725|76260671|FG000|Overall Study|Physician Decision|3|||
42384719|NCT00244725|76260672|FG001|Overall Study|Physician Decision|0|||
42384720|NCT00244725|76260673|FG002|Overall Study|Physician Decision|1|||
42384721|NCT00244725|76260674|FG003|Overall Study|Physician Decision|2|||
42384722|NCT00244725|76260671|FG000|Overall Study|Adverse Events|3|||
42384723|NCT00244725|76260672|FG001|Overall Study|Adverse Events|1|||
42384724|NCT00244725|76260673|FG002|Overall Study|Adverse Events|4|||
42384725|NCT00244725|76260674|FG003|Overall Study|Adverse Events|4|||
42384726|NCT00244725|76260671|FG000|Overall Study|Withdrwal by participant|1|||
42384727|NCT00244725|76260672|FG001|Overall Study|Withdrwal by participant|0|||
42384728|NCT00244725|76260673|FG002|Overall Study|Withdrwal by participant|0|||
42384729|NCT00244725|76260674|FG003|Overall Study|Withdrwal by participant|1|||
42384730|NCT00244725|76260671|FG000|Overall Study|Liver function test abnormality|2|||
42384731|NCT00244725|76260672|FG001|Overall Study|Liver function test abnormality|0|||
42384732|NCT00244725|76260673|FG002|Overall Study|Liver function test abnormality|0|||
42384733|NCT00244725|76260674|FG003|Overall Study|Liver function test abnormality|1|||
42384734|NCT00244725|76260671|FG000|Overall Study|Sponsor withdrew the participant|1|||
42384735|NCT00244725|76260672|FG001|Overall Study|Sponsor withdrew the participant|0|||
42384736|NCT00244725|76260673|FG002|Overall Study|Sponsor withdrew the participant|0|||
42384737|NCT00244725|76260674|FG003|Overall Study|Sponsor withdrew the participant|1|||
42384738|NCT00244725|76260671|FG000|Overall Study|Mediciation Error|0|||
42384739|NCT00244725|76260672|FG001|Overall Study|Mediciation Error|1|||
42384740|NCT00244725|76260673|FG002|Overall Study|Mediciation Error|0|||
42384741|NCT00244725|76260674|FG003|Overall Study|Mediciation Error|0|||
42384742|NCT00244725|76260671|FG000|Overall Study|Rehab Refused to allow participantion|0|||
42384743|NCT00244725|76260672|FG001|Overall Study|Rehab Refused to allow participantion|1|||
42384744|NCT00244725|76260673|FG002|Overall Study|Rehab Refused to allow participantion|0|||
42384745|NCT00244725|76260674|FG003|Overall Study|Rehab Refused to allow participantion|0|||
42384746|NCT00244725|76260671|FG000|Overall Study|Headache|0|||
42384747|NCT00244725|76260672|FG001|Overall Study|Headache|1|||
42384748|NCT00244725|76260673|FG002|Overall Study|Headache|0|||
42384749|NCT00244725|76260674|FG003|Overall Study|Headache|0|||
42384750|NCT00244725|76260671|FG000|Overall Study|Received prohibited medication|0|||
42384751|NCT00244725|76260672|FG001|Overall Study|Received prohibited medication|1|||
42384752|NCT00244725|76260673|FG002|Overall Study|Received prohibited medication|0|||
42384753|NCT00244725|76260674|FG003|Overall Study|Received prohibited medication|1|||
42384754|NCT00244725|76260671|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
42384755|NCT00244725|76260672|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
42384756|NCT00244725|76260673|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
42384757|NCT00244725|76260674|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
42384758|NCT00244725|76260671|FG000|Overall Study|Administrative reason|0|||
42384759|NCT00244725|76260672|FG001|Overall Study|Administrative reason|0|||
42384760|NCT00244725|76260673|FG002|Overall Study|Administrative reason|1|||
42384761|NCT00244725|76260674|FG003|Overall Study|Administrative reason|0|||
42384762|NCT00244725|76260671|FG000|Overall Study|Vomit|0|||
42384763|NCT00244725|76260672|FG001|Overall Study|Vomit|0|||
42384764|NCT00244725|76260673|FG002|Overall Study|Vomit|1|||
42384765|NCT00244725|76260674|FG003|Overall Study|Vomit|0|||
42384766|NCT00244725|76260671|FG000|Overall Study|Failed to follow-up|0|||
42384767|NCT00244725|76260672|FG001|Overall Study|Failed to follow-up|0|||
42384768|NCT00244725|76260673|FG002|Overall Study|Failed to follow-up|1|||
42384769|NCT00244725|76260674|FG003|Overall Study|Failed to follow-up|1|||
42384770|NCT02649894|76260686|FG000|Overall Study|Adverse Event|1|||
42384771|NCT02649894|76260687|FG001|Overall Study|Adverse Event|0|||
42384772|NCT02649894|76260686|FG000|Overall Study|Physician Decision|0|||
42384773|NCT02649894|76260687|FG001|Overall Study|Physician Decision|1|||
42384774|NCT02649894|76260686|FG000|Overall Study|Withdrawal by Subject|5|||
42384775|NCT02649894|76260687|FG001|Overall Study|Withdrawal by Subject|2|||
42384776|NCT02649894|76260686|FG000|Overall Study|Lost to Follow-up|2|||
42384777|NCT02649894|76260687|FG001|Overall Study|Lost to Follow-up|1|||
42384778|NCT02649894|76260686|FG000|Overall Study|Death|30|||
42384779|NCT02649894|76260687|FG001|Overall Study|Death|7|||
42384780|NCT02649894|76260686|FG000|Overall Study|Other, not specified|6|||
42384781|NCT02649894|76260687|FG001|Overall Study|Other, not specified|0|||
42384782|NCT01278615|76260693|FG000|Overall Study|Withdrawal by Subject|2|||
42384783|NCT01505114|76260719|FG000|Overall Study|Withdrawal by Subject|5|||
42384784|NCT01505114|76260720|FG001|Overall Study|Withdrawal by Subject|4|||
42384785|NCT01505114|76260721|FG002|Overall Study|Withdrawal by Subject|4|||
42384786|NCT01505114|76260722|FG003|Overall Study|Withdrawal by Subject|7|||
42384787|NCT01505114|76260719|FG000|Overall Study|Death|1|||
42384788|NCT01505114|76260720|FG001|Overall Study|Death|0|||
42384789|NCT01505114|76260721|FG002|Overall Study|Death|0|||
42384790|NCT01505114|76260722|FG003|Overall Study|Death|1|||
42384791|NCT01505114|76260719|FG000|Overall Study|unable to adhere to visit schedule|3|||
42384792|NCT01505114|76260720|FG001|Overall Study|unable to adhere to visit schedule|2|||
42384793|NCT01505114|76260721|FG002|Overall Study|unable to adhere to visit schedule|3|||
42384794|NCT01505114|76260722|FG003|Overall Study|unable to adhere to visit schedule|3|||
42384795|NCT01505114|76260719|FG000|Overall Study|Lost to Follow-up|11|||
42384796|NCT01505114|76260720|FG001|Overall Study|Lost to Follow-up|5|||
42384797|NCT01505114|76260721|FG002|Overall Study|Lost to Follow-up|8|||
42384798|NCT01505114|76260722|FG003|Overall Study|Lost to Follow-up|7|||
42384799|NCT01505114|76260719|FG000|Overall Study|relocated|4|||
42384800|NCT01505114|76260720|FG001|Overall Study|relocated|2|||
42384801|NCT01505114|76260721|FG002|Overall Study|relocated|2|||
42384802|NCT01505114|76260722|FG003|Overall Study|relocated|3|||
42384803|NCT01505114|76260719|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
42384804|NCT01505114|76260720|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
42384805|NCT01505114|76260721|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
42384806|NCT01505114|76260722|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
42384807|NCT01505114|76260719|FG000|Overall Study|staff safety concerns|0|||
42384808|NCT01505114|76260720|FG001|Overall Study|staff safety concerns|0|||
42384809|NCT01505114|76260721|FG002|Overall Study|staff safety concerns|0|||
42384810|NCT01505114|76260722|FG003|Overall Study|staff safety concerns|1|||
42384811|NCT01505114|76260719|FG000|Overall Study|investigator decision|1|||
42384812|NCT01505114|76260720|FG001|Overall Study|investigator decision|0|||
42384813|NCT01505114|76260721|FG002|Overall Study|investigator decision|1|||
42384814|NCT01505114|76260722|FG003|Overall Study|investigator decision|0|||
42384815|NCT02651922|76260754|FG000|Overall Study|due to exclusion criteria|2|||
42384816|NCT01277757|76260758|FG000|Overall Study|Disease Progression|1|||
42384817|NCT01277757|76260758|FG000|Overall Study|Withdrawal by Subject|1|||
42384818|NCT01276821|76260764|FG000|Overall Study|Protocol Violation|0|||
42384819|NCT01276821|76260765|FG001|Overall Study|Protocol Violation|1|||
42384820|NCT00245037|76260771|FG000|Overall Study|Death|17|||
42384821|NCT00241839|76260777|FG000|Overall Study|Withdrawal by Subject|18|||
42384822|NCT00241839|76260778|FG001|Overall Study|Withdrawal by Subject|17|||
42384823|NCT00241839|76260777|FG000|Overall Study|Adverse Event|1|||
42384824|NCT00241839|76260778|FG001|Overall Study|Adverse Event|1|||
42384825|NCT02651688|76260787|FG000|Overall Study|Non-compliance|0|||
42019235|NCT00982228|75826654|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
42019236|NCT00982228|75826653|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
42019237|NCT00982228|75826654|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
42019238|NCT01260350|75826680|FG000|Overall Study|Lack of Efficacy|0|||
42019239|NCT01260350|75826681|FG001|Overall Study|Lack of Efficacy|0|||
42019240|NCT01260350|75826682|FG002|Overall Study|Lack of Efficacy|0|||
42019241|NCT01260350|75826683|FG003|Overall Study|Lack of Efficacy|0|||
42019242|NCT01260350|75826684|FG004|Overall Study|Lack of Efficacy|0|||
42019243|NCT01260350|75826685|FG005|Overall Study|Lack of Efficacy|0|||
42019244|NCT01260350|75826686|FG006|Overall Study|Lack of Efficacy|0|||
42019245|NCT01260350|75826687|FG007|Overall Study|Lack of Efficacy|0|||
42019246|NCT01260350|75826688|FG008|Overall Study|Lack of Efficacy|0|||
42019247|NCT01260350|75826689|FG009|Overall Study|Lack of Efficacy|0|||
42019248|NCT01260350|75826690|FG010|Overall Study|Lack of Efficacy|0|||
42019249|NCT01260350|75826691|FG011|Overall Study|Lack of Efficacy|0|||
42019250|NCT01260350|75826692|FG012|Overall Study|Lack of Efficacy|0|||
42019251|NCT01260350|75826693|FG013|Overall Study|Lack of Efficacy|0|||
42019252|NCT01260350|75826694|FG014|Overall Study|Lack of Efficacy|0|||
42019253|NCT01260350|75826695|FG015|Overall Study|Lack of Efficacy|0|||
42019254|NCT01260350|75826696|FG016|Overall Study|Lack of Efficacy|0|||
42019255|NCT01260350|75826697|FG017|Overall Study|Lack of Efficacy|1|||
42019256|NCT01260350|75826698|FG018|Overall Study|Lack of Efficacy|0|||
42019257|NCT01260350|75826699|FG019|Overall Study|Lack of Efficacy|0|||
42019258|NCT01260350|75826700|FG020|Overall Study|Lack of Efficacy|3|||
42019259|NCT01260350|75826701|FG021|Overall Study|Lack of Efficacy|0|||
42019260|NCT01260350|75826680|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019261|NCT01260350|75826681|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019262|NCT01260350|75826682|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019263|NCT01260350|75826683|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019264|NCT01260350|75826684|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019265|NCT01260350|75826685|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019266|NCT01260350|75826686|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019267|NCT01260350|75826687|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019268|NCT01260350|75826688|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
42019269|NCT01260350|75826689|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019270|NCT01260350|75826690|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019271|NCT01260350|75826691|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019272|NCT01260350|75826692|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019273|NCT01260350|75826693|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019274|NCT01260350|75826694|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019275|NCT01260350|75826695|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019276|NCT01260350|75826696|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019277|NCT01260350|75826697|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019278|NCT01260350|75826698|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019279|NCT01260350|75826699|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019280|NCT01260350|75826700|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019281|NCT01260350|75826701|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
42019282|NCT01260194|75826755|FG000|Overall Study|Withdrawal of Consent|1|||
42019283|NCT01259726|75826763|FG000|Overall Study|Death|1|||
42019284|NCT01259726|75826764|FG001|Overall Study|Death|0|||
42019285|NCT01259726|75826765|FG002|Overall Study|Death|0|||
42019286|NCT01259726|75826766|FG003|Overall Study|Death|0|||
42019287|NCT01259726|75826763|FG000|Overall Study|Physician Decision|2|||
42384826|NCT02651688|76260788|FG001|Overall Study|Non-compliance|0|||
42384827|NCT02651688|76260789|FG002|Overall Study|Non-compliance|1|||
42384828|NCT02651688|76260787|FG000|Overall Study|Principal Investigator (PI) decision|0|||
42384829|NCT02651688|76260788|FG001|Overall Study|Principal Investigator (PI) decision|2|||
42019288|NCT01259726|75826764|FG001|Overall Study|Physician Decision|0|||
42384830|NCT02651688|76260789|FG002|Overall Study|Principal Investigator (PI) decision|0|||
42384831|NCT02651688|76260787|FG000|Overall Study|Lost to Follow-up|1|||
42384832|NCT02651688|76260788|FG001|Overall Study|Lost to Follow-up|3|||
42019289|NCT01259726|75826765|FG002|Overall Study|Physician Decision|1|||
42019290|NCT01259726|75826766|FG003|Overall Study|Physician Decision|1|||
42019291|NCT01259726|75826763|FG000|Overall Study|Withdrawal by Subject|1|||
42019292|NCT01259726|75826764|FG001|Overall Study|Withdrawal by Subject|3|||
42019293|NCT01259726|75826765|FG002|Overall Study|Withdrawal by Subject|2|||
42019294|NCT01259726|75826766|FG003|Overall Study|Withdrawal by Subject|1|||
42019295|NCT01259726|75826763|FG000|Overall Study|Lost to Follow-up|1|||
42019296|NCT01259726|75826764|FG001|Overall Study|Lost to Follow-up|1|||
42019297|NCT01259726|75826765|FG002|Overall Study|Lost to Follow-up|1|||
42384833|NCT02651688|76260789|FG002|Overall Study|Lost to Follow-up|0|||
42384834|NCT02651688|76260787|FG000|Overall Study|Withdrawal by Subject|1|||
42384835|NCT02651688|76260788|FG001|Overall Study|Withdrawal by Subject|0|||
42384836|NCT02651688|76260789|FG002|Overall Study|Withdrawal by Subject|2|||
42384837|NCT01276353|76260799|FG000|Double-blind|Adverse Event|2|||
42384838|NCT01276353|76260800|FG001|Double-blind|Adverse Event|0|||
42384839|NCT01276353|76260799|FG000|Double-blind|Withdrawal by Subject|1|||
42384840|NCT01276353|76260800|FG001|Double-blind|Withdrawal by Subject|0|||
42384841|NCT01276353|76260799|FG000|Extension|Adverse Event|2|||
42384842|NCT01276353|76260800|FG001|Extension|Adverse Event|5|||
42384843|NCT01276353|76260799|FG000|Extension|Withdrawal by Subject|1|||
42384844|NCT01276353|76260800|FG001|Extension|Withdrawal by Subject|2|||
42384845|NCT01276353|76260799|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
42384846|NCT01276353|76260800|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
42384847|NCT01276353|76260799|FG000|Extension|Physician Decision|1|||
42384848|NCT01276353|76260800|FG001|Extension|Physician Decision|0|||
42384849|NCT01276353|76260799|FG000|Extension|Prohibited concomitant medications|0|||
42384850|NCT01276353|76260800|FG001|Extension|Prohibited concomitant medications|1|||
42384851|NCT02536794|76260835|FG000|Reached 1st Response Assessment|Adverse Event|2|||
42384852|NCT02536794|76260835|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
42384853|NCT02536794|76260835|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
42384854|NCT02536794|76260835|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
42384855|NCT02536794|76260835|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
42384856|NCT02536794|76260835|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
42384857|NCT01480076|76260905|FG000|Overall Study|Run-in Failure|52|||
42384858|NCT01480076|76260905|FG000|Overall Study|Adverse Event|39|||
42384859|NCT01480076|76260905|FG000|Overall Study|Death|2|||
42384860|NCT01480076|76260905|FG000|Overall Study|Disease Progression|5|||
42384861|NCT01480076|76260905|FG000|Overall Study|Non-compliance With Study Protocol|15|||
42384862|NCT01480076|76260905|FG000|Overall Study|Withdrawal by Subject|105|||
42384863|NCT01480076|76260905|FG000|Overall Study|Lost to Follow-up|7|||
42384864|NCT01480076|76260905|FG000|Overall Study|Investigator Decision|13|||
42384865|NCT01480076|76260905|FG000|Overall Study|Other|52|||
42384866|NCT02650128|76260993|FG000|Overall Study|Death|2|||
42384867|NCT01362270|76261008|FG000|Overall Study|Withdrawal by Subject|1|||
42384868|NCT01362270|76261009|FG001|Overall Study|Withdrawal by Subject|0|||
42384869|NCT01362270|76261008|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
42384870|NCT01362270|76261009|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
42384871|NCT01362270|76261008|FG000|Overall Study|Met excl. criteria before 1st session|1|||
42384872|NCT01362270|76261009|FG001|Overall Study|Met excl. criteria before 1st session|1|||
42384873|NCT00089479|76261030|FG000|Overall Study|Death|108|||
42384874|NCT00089479|76261031|FG001|Overall Study|Death|75|||
42384875|NCT00089479|76261030|FG000|Overall Study|Withdrawal by Subject|86|||
42384876|NCT00089479|76261031|FG001|Overall Study|Withdrawal by Subject|107|||
42384877|NCT00089479|76261030|FG000|Overall Study|Lost to Follow-up|137|||
42384878|NCT00089479|76261031|FG001|Overall Study|Lost to Follow-up|107|||
42384879|NCT01463306|76261040|FG000|Overall Study|Adverse Event|6|||
42384880|NCT01463306|76261041|FG001|Overall Study|Adverse Event|9|||
42384881|NCT01463306|76261042|FG002|Overall Study|Adverse Event|3|||
42384882|NCT01463306|76261040|FG000|Overall Study|Death|3|||
42384883|NCT01463306|76261041|FG001|Overall Study|Death|3|||
42384884|NCT01463306|76261042|FG002|Overall Study|Death|0|||
42384885|NCT01463306|76261040|FG000|Overall Study|Lack of Efficacy|22|||
42384886|NCT01463306|76261041|FG001|Overall Study|Lack of Efficacy|16|||
42384887|NCT01463306|76261042|FG002|Overall Study|Lack of Efficacy|1|||
42384888|NCT01463306|76261040|FG000|Overall Study|Lost to Follow-up|5|||
42384889|NCT01463306|76261041|FG001|Overall Study|Lost to Follow-up|2|||
42384890|NCT01463306|76261042|FG002|Overall Study|Lost to Follow-up|0|||
42384891|NCT01463306|76261040|FG000|Overall Study|Protocol Violation|4|||
42384892|NCT01463306|76261041|FG001|Overall Study|Protocol Violation|0|||
42384893|NCT01463306|76261042|FG002|Overall Study|Protocol Violation|0|||
42384894|NCT01463306|76261040|FG000|Overall Study|Withdrawal by Subject|19|||
42384895|NCT01463306|76261041|FG001|Overall Study|Withdrawal by Subject|9|||
42384896|NCT01463306|76261042|FG002|Overall Study|Withdrawal by Subject|1|||
42384897|NCT01463306|76261040|FG000|Overall Study|Other|26|||
42384898|NCT01463306|76261041|FG001|Overall Study|Other|13|||
42384899|NCT01463306|76261042|FG002|Overall Study|Other|0|||
42384900|NCT01463306|76261040|FG000|Overall Study|Approval expiry at site|1|||
42384901|NCT01463306|76261041|FG001|Overall Study|Approval expiry at site|0|||
42384902|NCT01463306|76261042|FG002|Overall Study|Approval expiry at site|0|||
42110247|NCT00622700|75920597|FG003|Extension Treatment Period|Other than specified above|0|||
42384903|NCT01504412|76261071|FG000|Overall Study|Adverse Event|1|||
42384904|NCT01504412|76261072|FG001|Overall Study|Adverse Event|8|||
42384905|NCT01504412|76261073|FG002|Overall Study|Adverse Event|1|||
42384906|NCT01504412|76261074|FG003|Overall Study|Adverse Event|7|||
42384907|NCT01504412|76261075|FG004|Overall Study|Adverse Event|10|||
42384908|NCT01504412|76261071|FG000|Overall Study|Withdrawal by Subject|2|||
42384909|NCT01504412|76261072|FG001|Overall Study|Withdrawal by Subject|1|||
42384910|NCT01504412|76261073|FG002|Overall Study|Withdrawal by Subject|1|||
42384911|NCT01504412|76261074|FG003|Overall Study|Withdrawal by Subject|5|||
42384912|NCT01504412|76261075|FG004|Overall Study|Withdrawal by Subject|1|||
42384913|NCT01504412|76261071|FG000|Overall Study|Other|2|||
42384914|NCT01504412|76261072|FG001|Overall Study|Other|1|||
42384915|NCT01504412|76261073|FG002|Overall Study|Other|1|||
42384916|NCT01504412|76261074|FG003|Overall Study|Other|6|||
42384917|NCT01504412|76261075|FG004|Overall Study|Other|1|||
42384918|NCT01504412|76261071|FG000|Overall Study|Lost to Follow-up|0|||
42384919|NCT01504412|76261072|FG001|Overall Study|Lost to Follow-up|2|||
42384920|NCT01504412|76261073|FG002|Overall Study|Lost to Follow-up|0|||
42384921|NCT01504412|76261074|FG003|Overall Study|Lost to Follow-up|0|||
42384922|NCT01504412|76261075|FG004|Overall Study|Lost to Follow-up|0|||
42384923|NCT01504412|76261071|FG000|Overall Study|Lack of Efficacy|0|||
42384924|NCT01504412|76261072|FG001|Overall Study|Lack of Efficacy|0|||
42384925|NCT01504412|76261073|FG002|Overall Study|Lack of Efficacy|1|||
42384926|NCT01504412|76261074|FG003|Overall Study|Lack of Efficacy|0|||
42384927|NCT01504412|76261075|FG004|Overall Study|Lack of Efficacy|1|||
42384928|NCT01504412|76261071|FG000|Overall Study|Death|0|||
42384929|NCT01504412|76261072|FG001|Overall Study|Death|0|||
42384930|NCT01504412|76261073|FG002|Overall Study|Death|0|||
42384931|NCT01504412|76261074|FG003|Overall Study|Death|1|||
42384932|NCT01504412|76261075|FG004|Overall Study|Death|0|||
42384933|NCT01503164|76261105|FG000|Overall Study|Withdrawal by Subject|2|||
42384934|NCT01503164|76261106|FG001|Overall Study|Withdrawal by Subject|1|||
42384935|NCT00088465|76261112|FG000|Overall Study|Withdrawal by Subject|290|||
42384936|NCT00088465|76261112|FG000|Overall Study|Adverse Event|77|||
42384937|NCT00088465|76261112|FG000|Overall Study|Lost to Follow-up|57|||
42384938|NCT00088465|76261112|FG000|Overall Study|Physician Decision|45|||
42384939|NCT00088465|76261112|FG000|Overall Study|Sponsor Decision|37|||
42384940|NCT00088465|76261112|FG000|Overall Study|Lack of Efficacy|27|||
42384941|NCT00088465|76261112|FG000|Overall Study|Protocol Violation|17|||
42384942|NCT00088465|76261112|FG000|Overall Study|Death|11|||
42384943|NCT00088153|76261140|FG000|Overall Study|Physician Decision|3|||
42384944|NCT00088153|76261141|FG001|Overall Study|Physician Decision|3|||
42384945|NCT00088153|76261140|FG000|Overall Study|Withdrawal by Subject|10|||
42384946|NCT00088153|76261141|FG001|Overall Study|Withdrawal by Subject|10|||
42384947|NCT00088153|76261140|FG000|Overall Study|Lost to Follow-up|11|||
42384948|NCT00088153|76261141|FG001|Overall Study|Lost to Follow-up|12|||
42384949|NCT01502228|76261160|FG000|Overall Study|Death|1|||
42384950|NCT01502072|76261167|FG000|Overall Study|Withdrawal by Subject|1|||
42384951|NCT01502072|76261168|FG001|Overall Study|Withdrawal by Subject|0|||
42384952|NCT01502072|76261169|FG002|Overall Study|Withdrawal by Subject|0|||
42384953|NCT01502072|76261167|FG000|Overall Study|Death|0|||
42384954|NCT01502072|76261168|FG001|Overall Study|Death|1|||
42384955|NCT01502072|76261169|FG002|Overall Study|Death|0|||
42384956|NCT01462370|76261177|FG000|Overall Study|Lack of Qualifying Event|1|||
42384957|NCT01462370|76261178|FG001|Overall Study|Lack of Qualifying Event|1|||
42384958|NCT01462370|76261177|FG000|Overall Study|Physician Decision|0|||
42384959|NCT01462370|76261178|FG001|Overall Study|Physician Decision|1|||
42384960|NCT01462370|76261177|FG000|Overall Study|Withdrawal by Subject|0|||
42384961|NCT01462370|76261178|FG001|Overall Study|Withdrawal by Subject|3|||
42384962|NCT01479764|76261186|FG000|Randomized|Adverse Event|1|||
42384963|NCT01479764|76261187|FG001|Randomized|Adverse Event|1|||
42384964|NCT01479764|76261186|FG000|Randomized|Withdrawal by Subject|1|||
42019298|NCT01259726|75826766|FG003|Overall Study|Lost to Follow-up|3|||
42019299|NCT01259492|75826780|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
42019300|NCT01259492|75826781|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
42019301|NCT01259492|75826782|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
42019302|NCT01259492|75826783|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
42019303|NCT01259492|75826780|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
42019304|NCT01259492|75826781|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
42019305|NCT01259492|75826782|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
42019306|NCT01259492|75826783|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
42019307|NCT01259492|75826780|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
42019308|NCT01259492|75826781|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
42019309|NCT01259492|75826782|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
42019310|NCT01259492|75826783|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
42019311|NCT01259492|75826780|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
42019312|NCT01259492|75826781|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
42019313|NCT01259492|75826782|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
42019314|NCT01259492|75826783|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
42384965|NCT01479764|76261187|FG001|Randomized|Withdrawal by Subject|0|||
42384966|NCT01479764|76261186|FG000|Treated|Lost to Follow-up|0|||
42384967|NCT01479764|76261187|FG001|Treated|Lost to Follow-up|2|||
42384968|NCT01479530|76261195|FG000|Overall Study|Adverse Event|5|||
42384969|NCT01479530|76261196|FG001|Overall Study|Adverse Event|6|||
42384970|NCT01479530|76261195|FG000|Overall Study|Lack of Efficacy|0|||
42384971|NCT01479530|76261196|FG001|Overall Study|Lack of Efficacy|1|||
42384972|NCT01479530|76261195|FG000|Overall Study|Protocol Violation|2|||
42384973|NCT01479530|76261196|FG001|Overall Study|Protocol Violation|3|||
42384974|NCT01479530|76261195|FG000|Overall Study|Withdrawal of Consent|3|||
42384975|NCT01479530|76261196|FG001|Overall Study|Withdrawal of Consent|2|||
42384976|NCT01479374|76261205|FG000|Overall Study|Adverse Event|2|||
42384977|NCT01479374|76261206|FG001|Overall Study|Adverse Event|1|||
42384978|NCT01479374|76261207|FG002|Overall Study|Adverse Event|0|||
42384979|NCT01479374|76261205|FG000|Overall Study|Lost to Follow-up|1|||
42384980|NCT01479374|76261206|FG001|Overall Study|Lost to Follow-up|2|||
42384981|NCT01479374|76261207|FG002|Overall Study|Lost to Follow-up|0|||
42384982|NCT01479374|76261205|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
42384983|NCT01479374|76261206|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
42384984|NCT01479374|76261207|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
42384985|NCT01479374|76261205|FG000|Overall Study|Other|0|||
42384986|NCT01479374|76261206|FG001|Overall Study|Other|4|||
42384987|NCT01479374|76261207|FG002|Overall Study|Other|5|||
42384988|NCT00087529|76261217|FG000|Overall Study|Death|1|||
42384989|NCT00087529|76261218|FG001|Overall Study|Death|0|||
42384990|NCT00087529|76261217|FG000|Overall Study|Adverse Event|0|||
42384991|NCT00087529|76261218|FG001|Overall Study|Adverse Event|8|||
42384992|NCT00087529|76261217|FG000|Overall Study|Pregnancy|0|||
42384993|NCT00087529|76261218|FG001|Overall Study|Pregnancy|1|||
42384994|NCT00087529|76261217|FG000|Overall Study|Lost to Follow-up|2|||
42384995|NCT00087529|76261218|FG001|Overall Study|Lost to Follow-up|3|||
42384996|NCT00087529|76261217|FG000|Overall Study|Participant Decision|14|||
42384997|NCT00087529|76261218|FG001|Overall Study|Participant Decision|37|||
42384998|NCT00087529|76261217|FG000|Overall Study|Physician Decision|4|||
42384999|NCT00087529|76261218|FG001|Overall Study|Physician Decision|8|||
42385000|NCT00087529|76261217|FG000|Overall Study|Initiation of Excluded Therapy|0|||
42385001|NCT00087529|76261218|FG001|Overall Study|Initiation of Excluded Therapy|1|||
42385002|NCT00087529|76261217|FG000|Overall Study|Participant Noncompliance|0|||
42385003|NCT00087529|76261218|FG001|Overall Study|Participant Noncompliance|1|||
42385004|NCT00087529|76261217|FG000|Overall Study|Disease Progression|5|||
42385005|NCT00087529|76261218|FG001|Overall Study|Disease Progression|4|||
42385006|NCT00087529|76261217|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
42385007|NCT00087529|76261218|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
42385008|NCT01500434|76261241|FG000|Overall Study|Death|1|||
42385009|NCT01500434|76261241|FG000|Overall Study|Withdrawal by Subject|1|||
42385010|NCT01500434|76261241|FG000|Overall Study|Missed 12-month follow-up|5|||
42385011|NCT00087139|76261248|FG000|Overall Study|Adverse Event|18|||
42385012|NCT00087139|76261249|FG001|Overall Study|Adverse Event|17|||
42385013|NCT00087139|76261250|FG002|Overall Study|Adverse Event|13|||
42385014|NCT00087139|76261248|FG000|Overall Study|Death|2|||
42385015|NCT00087139|76261249|FG001|Overall Study|Death|1|||
42385016|NCT00087139|76261250|FG002|Overall Study|Death|0|||
42385017|NCT00087139|76261248|FG000|Overall Study|Withdrawal by Subject|3|||
42385018|NCT00087139|76261249|FG001|Overall Study|Withdrawal by Subject|2|||
42385019|NCT00087139|76261250|FG002|Overall Study|Withdrawal by Subject|2|||
42385020|NCT00087139|76261248|FG000|Overall Study|Physician Decision|1|||
42385021|NCT00087139|76261249|FG001|Overall Study|Physician Decision|1|||
42385022|NCT00087139|76261250|FG002|Overall Study|Physician Decision|1|||
42385023|NCT00087139|76261248|FG000|Overall Study|Disease progression|9|||
42385024|NCT00087139|76261249|FG001|Overall Study|Disease progression|19|||
42385025|NCT00087139|76261250|FG002|Overall Study|Disease progression|12|||
42385026|NCT00087139|76261248|FG000|Overall Study|Ineligible|4|||
42385027|NCT00087139|76261249|FG001|Overall Study|Ineligible|7|||
42385028|NCT00087139|76261250|FG002|Overall Study|Ineligible|4|||
42385029|NCT00087139|76261248|FG000|Overall Study|Symptomatic deterioration|1|||
42385030|NCT00087139|76261249|FG001|Overall Study|Symptomatic deterioration|1|||
42385031|NCT00087139|76261250|FG002|Overall Study|Symptomatic deterioration|3|||
42385032|NCT00087139|76261248|FG000|Overall Study|Use of coumadin|1|||
42385033|NCT00087139|76261249|FG001|Overall Study|Use of coumadin|0|||
42385034|NCT00087139|76261250|FG002|Overall Study|Use of coumadin|0|||
42385035|NCT00087139|76261248|FG000|Overall Study|Response achieved|0|||
42385036|NCT00087139|76261249|FG001|Overall Study|Response achieved|1|||
42385037|NCT00087139|76261250|FG002|Overall Study|Response achieved|0|||
42385038|NCT00087139|76261248|FG000|Overall Study|Extradural disease|0|||
42385039|NCT00087139|76261249|FG001|Overall Study|Extradural disease|0|||
42385040|NCT00087139|76261250|FG002|Overall Study|Extradural disease|1|||
42385041|NCT01500278|76261302|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
42385042|NCT01500278|76261303|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
42385043|NCT01500278|76261302|FG000|Week 0 - Week 12|Protocol Violation|10|||
42385044|NCT01500278|76261303|FG001|Week 0 - Week 12|Protocol Violation|16|||
42385045|NCT01500278|76261302|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
42385046|NCT01500278|76261303|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
42385047|NCT01500278|76261302|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
42385048|NCT01500278|76261303|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
42385049|NCT01500278|76261302|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
42385050|NCT01500278|76261303|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
42385051|NCT01500278|76261302|FG000|Week 0 - Week 12|Patient decision|1|||
42385052|NCT01500278|76261303|FG001|Week 0 - Week 12|Patient decision|0|||
42385053|NCT01500278|76261302|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
42385054|NCT01500278|76261303|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
42385055|NCT01500278|76261302|FG000|Week 0 - Week 12|Investigator decision|1|||
42385056|NCT01500278|76261303|FG001|Week 0 - Week 12|Investigator decision|0|||
42385057|NCT01500278|76261302|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
42385058|NCT01500278|76261303|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
42385059|NCT01500278|76261302|FG000|Week 0 - Week 12|Sponsor decision|1|||
42385060|NCT01500278|76261303|FG001|Week 0 - Week 12|Sponsor decision|0|||
42385061|NCT01500278|76261302|FG000|Week 0 - Week 12|Personal reason|0|||
42385062|NCT01500278|76261303|FG001|Week 0 - Week 12|Personal reason|1|||
42385063|NCT01500278|76261302|FG000|Week 0 - Week 12|Other serious disease|0|||
42385064|NCT01500278|76261303|FG001|Week 0 - Week 12|Other serious disease|1|||
42385065|NCT01500278|76261302|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
42385066|NCT01500278|76261303|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
42385067|NCT01500278|76261302|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
42385068|NCT01500278|76261303|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
42385069|NCT01500278|76261302|FG000|Week 13 - Week 104|Protocol Violation|6|||
42385070|NCT01500278|76261303|FG001|Week 13 - Week 104|Protocol Violation|6|||
42385071|NCT01500278|76261302|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
42385072|NCT01500278|76261303|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
42385073|NCT01500278|76261302|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
42385074|NCT01500278|76261303|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
42385075|NCT01500278|76261302|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
42385076|NCT01500278|76261303|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
42385077|NCT01500278|76261302|FG000|Week 13 - Week 104|Non/bad compliance|7|||
42385078|NCT01500278|76261303|FG001|Week 13 - Week 104|Non/bad compliance|5|||
42385079|NCT01500278|76261302|FG000|Week 13 - Week 104|Recurrent infections|1|||
42385080|NCT01500278|76261303|FG001|Week 13 - Week 104|Recurrent infections|0|||
42385081|NCT01500278|76261302|FG000|Week 13 - Week 104|False positive test|1|||
42385082|NCT01500278|76261303|FG001|Week 13 - Week 104|False positive test|2|||
42385083|NCT01500278|76261302|FG000|Week 13 - Week 104|Sponsor request|4|||
42385084|NCT01500278|76261303|FG001|Week 13 - Week 104|Sponsor request|0|||
42385085|NCT01500278|76261302|FG000|Week 13 - Week 104|Withdrawn in error|1|||
42385086|NCT01500278|76261303|FG001|Week 13 - Week 104|Withdrawn in error|0|||
42385087|NCT01500278|76261302|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
42385088|NCT01500278|76261303|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
42385089|NCT01500278|76261302|FG000|Week 13 - Week 104|Protocol deviation|1|||
42385090|NCT01500278|76261303|FG001|Week 13 - Week 104|Protocol deviation|0|||
42385091|NCT01500278|76261302|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
42385092|NCT01500278|76261303|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
42385093|NCT01500278|76261302|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
42385094|NCT01500278|76261303|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
42385095|NCT01500278|76261302|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
42385096|NCT01500278|76261303|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
42385097|NCT01500278|76261302|FG000|Week 13 - Week 104|Relocation|0|||
42385098|NCT01500278|76261303|FG001|Week 13 - Week 104|Relocation|1|||
42385099|NCT01500278|76261302|FG000|Week 13 - Week 104|Sponsor decision|0|||
42385100|NCT01500278|76261303|FG001|Week 13 - Week 104|Sponsor decision|2|||
42385101|NCT01500278|76261302|FG000|Week 13 - Week 104|Medical monitor decision|0|||
42385102|NCT01500278|76261303|FG001|Week 13 - Week 104|Medical monitor decision|2|||
42385103|NCT01500278|76261302|FG000|Week 13 - Week 104|Personal reason|0|||
42385104|NCT01500278|76261303|FG001|Week 13 - Week 104|Personal reason|1|||
42385105|NCT01500278|76261302|FG000|Week 13 - Week 104|Not completed|0|||
42385106|NCT01500278|76261303|FG001|Week 13 - Week 104|Not completed|1|||
42385107|NCT01500278|76261302|FG000|Week 13 - Week 104|Death|2|||
42385108|NCT01500278|76261303|FG001|Week 13 - Week 104|Death|4|||
42385109|NCT01500278|76261302|FG000|Week 13 - Week 104|Adverse Event|54|||
42385110|NCT01500278|76261303|FG001|Week 13 - Week 104|Adverse Event|54|||
42385111|NCT00086281|76261326|FG000|Phase 1|Adverse Event|0|||
42385112|NCT00086281|76261327|FG001|Phase 1|Adverse Event|0|||
42385113|NCT00086281|76261328|FG002|Phase 1|Adverse Event|0|||
42019315|NCT01259492|75826780|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
42385114|NCT00086281|76261329|FG003|Phase 1|Adverse Event|0|||
42385115|NCT00086281|76261330|FG004|Phase 1|Adverse Event|0|||
42385116|NCT00086281|76261331|FG005|Phase 1|Adverse Event|0|||
42385117|NCT00086281|76261332|FG006|Phase 1|Adverse Event|0|||
42385118|NCT00086281|76261333|FG007|Phase 1|Adverse Event|0|||
42385119|NCT00086281|76261334|FG008|Phase 1|Adverse Event|0|||
42385120|NCT00086281|76261335|FG009|Phase 1|Adverse Event|1|||
42385121|NCT00086281|76261336|FG010|Phase 1|Adverse Event|2|||
42385122|NCT00086281|76261337|FG011|Phase 1|Adverse Event|1|||
42385123|NCT00086281|76261338|FG012|Phase 1|Adverse Event|1|||
42385124|NCT00086281|76261339|FG013|Phase 1|Adverse Event|1|||
42385125|NCT00086281|76261340|FG014|Phase 1|Adverse Event|2|||
42385126|NCT00086281|76261326|FG000|Phase 1|Protocol Violation|0|||
42385127|NCT00086281|76261327|FG001|Phase 1|Protocol Violation|0|||
42385128|NCT00086281|76261328|FG002|Phase 1|Protocol Violation|0|||
42385129|NCT00086281|76261329|FG003|Phase 1|Protocol Violation|0|||
42385130|NCT00086281|76261330|FG004|Phase 1|Protocol Violation|0|||
42385131|NCT00086281|76261331|FG005|Phase 1|Protocol Violation|0|||
42385132|NCT00086281|76261332|FG006|Phase 1|Protocol Violation|0|||
42385133|NCT00086281|76261333|FG007|Phase 1|Protocol Violation|0|||
42385134|NCT00086281|76261334|FG008|Phase 1|Protocol Violation|0|||
42385135|NCT00086281|76261335|FG009|Phase 1|Protocol Violation|0|||
42385136|NCT00086281|76261336|FG010|Phase 1|Protocol Violation|1|||
42385137|NCT00086281|76261337|FG011|Phase 1|Protocol Violation|0|||
42385138|NCT00086281|76261338|FG012|Phase 1|Protocol Violation|0|||
42385139|NCT00086281|76261339|FG013|Phase 1|Protocol Violation|0|||
42385140|NCT00086281|76261340|FG014|Phase 1|Protocol Violation|0|||
42385141|NCT00086281|76261326|FG000|Phase 1|Serious Adverse Event|0|||
42385142|NCT00086281|76261327|FG001|Phase 1|Serious Adverse Event|0|||
42204104|NCT02951988|76016780|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
42204105|NCT02951988|76016781|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
42204106|NCT02951988|76016782|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
42204107|NCT02951988|76016783|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
42204108|NCT02951988|76016780|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
42385143|NCT00086281|76261328|FG002|Phase 1|Serious Adverse Event|0|||
42385144|NCT00086281|76261329|FG003|Phase 1|Serious Adverse Event|0|||
42385145|NCT00086281|76261330|FG004|Phase 1|Serious Adverse Event|0|||
42385146|NCT00086281|76261331|FG005|Phase 1|Serious Adverse Event|0|||
42385147|NCT00086281|76261332|FG006|Phase 1|Serious Adverse Event|0|||
42385148|NCT00086281|76261333|FG007|Phase 1|Serious Adverse Event|0|||
42385149|NCT00086281|76261334|FG008|Phase 1|Serious Adverse Event|0|||
42385150|NCT00086281|76261335|FG009|Phase 1|Serious Adverse Event|0|||
42385151|NCT00086281|76261336|FG010|Phase 1|Serious Adverse Event|0|||
42385152|NCT00086281|76261337|FG011|Phase 1|Serious Adverse Event|0|||
42385153|NCT00086281|76261338|FG012|Phase 1|Serious Adverse Event|0|||
42385154|NCT00086281|76261339|FG013|Phase 1|Serious Adverse Event|0|||
42385155|NCT00086281|76261340|FG014|Phase 1|Serious Adverse Event|1|||
42385156|NCT00086281|76261326|FG000|Phase 2|Adverse Event|0|||
42385157|NCT00086281|76261327|FG001|Phase 2|Adverse Event|0|||
42385158|NCT00086281|76261328|FG002|Phase 2|Adverse Event|0|||
42385159|NCT00086281|76261329|FG003|Phase 2|Adverse Event|0|||
42385160|NCT00086281|76261330|FG004|Phase 2|Adverse Event|0|||
42385161|NCT00086281|76261331|FG005|Phase 2|Adverse Event|0|||
42385162|NCT00086281|76261332|FG006|Phase 2|Adverse Event|0|||
42385163|NCT00086281|76261333|FG007|Phase 2|Adverse Event|0|||
42385164|NCT00086281|76261334|FG008|Phase 2|Adverse Event|0|||
42385165|NCT00086281|76261335|FG009|Phase 2|Adverse Event|0|||
42385166|NCT00086281|76261336|FG010|Phase 2|Adverse Event|0|||
42385167|NCT00086281|76261337|FG011|Phase 2|Adverse Event|0|||
42385168|NCT00086281|76261338|FG012|Phase 2|Adverse Event|1|||
42385169|NCT00086281|76261339|FG013|Phase 2|Adverse Event|1|||
42385170|NCT00086281|76261340|FG014|Phase 2|Adverse Event|0|||
42385171|NCT00086047|76261352|FG000|Overall Study|Lost to Follow-up|7|||
42385172|NCT00086047|76261353|FG001|Overall Study|Lost to Follow-up|6|||
42385173|NCT00086047|76261352|FG000|Overall Study|Physician Decision|0|||
42385174|NCT00086047|76261353|FG001|Overall Study|Physician Decision|1|||
42385175|NCT01478828|76261365|FG000|Overall Study|Adverse Event|1|||
42385176|NCT00085423|76261370|FG000|Overall Study|Withdrawal by Subject|1|||
42385177|NCT00085423|76261370|FG000|Overall Study|screen failure|1|||
42385178|NCT00084487|76261374|FG000|Overall Study|Death|1|||
42385179|NCT01425281|76261414|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
42385180|NCT01425281|76261415|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
42385181|NCT01425281|76261414|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
42385182|NCT01425281|76261415|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
42385183|NCT01425281|76261414|FG000|At 180-day Clinical Follow-up|Death|0|||
42385184|NCT01425281|76261415|FG001|At 180-day Clinical Follow-up|Death|1|||
42385185|NCT01425281|76261414|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
42385186|NCT01425281|76261415|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
42385187|NCT01425281|76261414|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
42385188|NCT01425281|76261415|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
42385189|NCT01425281|76261414|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
42385190|NCT01425281|76261415|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
42385191|NCT01425281|76261414|FG000|At 2-year Clinical Follow-up|Death|2|||
42385192|NCT01425281|76261415|FG001|At 2-year Clinical Follow-up|Death|0|||
42385193|NCT01425281|76261414|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
42385194|NCT01425281|76261415|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
42385195|NCT01425281|76261414|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
42385196|NCT01425281|76261415|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
42385197|NCT01425281|76261414|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
42385198|NCT01425281|76261415|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
42385199|NCT01425281|76261414|FG000|At 3-year Clinical Follow-up|Death|2|||
42385200|NCT01425281|76261415|FG001|At 3-year Clinical Follow-up|Death|3|||
42385201|NCT01425281|76261414|FG000|At 4-year Clinical Follow-up|Death|7|||
42385202|NCT01425281|76261415|FG001|At 4-year Clinical Follow-up|Death|3|||
42385203|NCT01425281|76261414|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
42385204|NCT01425281|76261415|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
42385205|NCT01425281|76261414|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
42385206|NCT01425281|76261415|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
42385207|NCT01425281|76261414|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
42385208|NCT01425281|76261415|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
42385209|NCT01425281|76261414|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
42385210|NCT01425281|76261415|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
42385211|NCT01425281|76261414|FG000|At 5-year Clinical Follow-up|Death|2|||
42385212|NCT01425281|76261415|FG001|At 5-year Clinical Follow-up|Death|0|||
42385213|NCT01425281|76261414|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
42385214|NCT01425281|76261415|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
42385215|NCT01425281|76261414|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
42385216|NCT01425281|76261415|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
42385217|NCT01425281|76261414|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
42385218|NCT01425281|76261415|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
42385219|NCT02648724|76261443|FG000|Overall Study|Withdrawal by Subject|0|||
42385220|NCT02648724|76261444|FG001|Overall Study|Withdrawal by Subject|1|||
42385221|NCT02648724|76261445|FG002|Overall Study|Withdrawal by Subject|1|||
42385222|NCT02648724|76261446|FG003|Overall Study|Withdrawal by Subject|0|||
42385223|NCT02648724|76261447|FG004|Overall Study|Withdrawal by Subject|1|||
42385224|NCT02648724|76261448|FG005|Overall Study|Withdrawal by Subject|0|||
42385225|NCT02648724|76261449|FG006|Overall Study|Withdrawal by Subject|0|||
42385226|NCT02648724|76261443|FG000|Overall Study|Progressive disease|2|||
42385227|NCT02648724|76261444|FG001|Overall Study|Progressive disease|2|||
42385228|NCT02648724|76261445|FG002|Overall Study|Progressive disease|2|||
42385229|NCT02648724|76261446|FG003|Overall Study|Progressive disease|3|||
42385230|NCT02648724|76261447|FG004|Overall Study|Progressive disease|22|||
42385231|NCT02648724|76261448|FG005|Overall Study|Progressive disease|7|||
42385232|NCT02648724|76261449|FG006|Overall Study|Progressive disease|8|||
42385233|NCT02648724|76261443|FG000|Overall Study|Other reason (unknown)|1|||
42385234|NCT02648724|76261444|FG001|Overall Study|Other reason (unknown)|0|||
42385235|NCT02648724|76261445|FG002|Overall Study|Other reason (unknown)|0|||
42385236|NCT02648724|76261446|FG003|Overall Study|Other reason (unknown)|0|||
42385237|NCT02648724|76261447|FG004|Overall Study|Other reason (unknown)|0|||
42385238|NCT02648724|76261448|FG005|Overall Study|Other reason (unknown)|0|||
42385239|NCT02648724|76261449|FG006|Overall Study|Other reason (unknown)|0|||
42385240|NCT02648724|76261443|FG000|Overall Study|Protocol Violation|0|||
42385241|NCT02648724|76261444|FG001|Overall Study|Protocol Violation|0|||
42385242|NCT02648724|76261445|FG002|Overall Study|Protocol Violation|0|||
42385243|NCT02648724|76261446|FG003|Overall Study|Protocol Violation|0|||
42385244|NCT02648724|76261447|FG004|Overall Study|Protocol Violation|1|||
42385245|NCT02648724|76261448|FG005|Overall Study|Protocol Violation|0|||
42385246|NCT02648724|76261449|FG006|Overall Study|Protocol Violation|0|||
42385247|NCT02648724|76261443|FG000|Overall Study|Death|0|||
42385248|NCT02648724|76261444|FG001|Overall Study|Death|0|||
42385249|NCT02648724|76261445|FG002|Overall Study|Death|0|||
42385250|NCT02648724|76261446|FG003|Overall Study|Death|0|||
42385251|NCT02648724|76261447|FG004|Overall Study|Death|0|||
42385252|NCT02648724|76261448|FG005|Overall Study|Death|0|||
42385253|NCT02648724|76261449|FG006|Overall Study|Death|3|||
42385254|NCT02648724|76261443|FG000|Overall Study|Physician Decision|0|||
42385255|NCT02648724|76261444|FG001|Overall Study|Physician Decision|0|||
42385256|NCT02648724|76261445|FG002|Overall Study|Physician Decision|0|||
42385257|NCT02648724|76261446|FG003|Overall Study|Physician Decision|0|||
42385258|NCT02648724|76261447|FG004|Overall Study|Physician Decision|1|||
42385259|NCT02648724|76261448|FG005|Overall Study|Physician Decision|0|||
42385260|NCT02648724|76261449|FG006|Overall Study|Physician Decision|1|||
42385261|NCT02648724|76261443|FG000|Overall Study|Transferred to named patient program|0|||
42385262|NCT02648724|76261444|FG001|Overall Study|Transferred to named patient program|0|||
42385263|NCT02648724|76261445|FG002|Overall Study|Transferred to named patient program|0|||
42385264|NCT02648724|76261446|FG003|Overall Study|Transferred to named patient program|0|||
42385265|NCT02648724|76261447|FG004|Overall Study|Transferred to named patient program|0|||
42385266|NCT02648724|76261448|FG005|Overall Study|Transferred to named patient program|1|||
42385267|NCT02648724|76261449|FG006|Overall Study|Transferred to named patient program|0|||
42385268|NCT01402817|76261481|FG000|Overall Study|Withdrawal by Subject|3|||
42385269|NCT01402817|76261481|FG000|Overall Study|Study Suspended by FDA|8|||
42385270|NCT01425203|76261488|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
42019316|NCT01259492|75826781|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
42019317|NCT01259492|75826782|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
42110248|NCT00622700|75920598|FG004|Extension Treatment Period|Other than specified above|0|||
42385271|NCT01425203|76261489|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
42385272|NCT01425203|76261490|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
42385273|NCT01425203|76261488|FG000|Treatment Phase|Failure at futility timepoint|8|||
42385274|NCT01425203|76261489|FG001|Treatment Phase|Failure at futility timepoint|27|||
42385275|NCT01425203|76261490|FG002|Treatment Phase|Failure at futility timepoint|0|||
42385276|NCT01425203|76261488|FG000|Treatment Phase|Other virologic failure criteria|5|||
42385277|NCT01425203|76261489|FG001|Treatment Phase|Other virologic failure criteria|3|||
42385278|NCT01425203|76261490|FG002|Treatment Phase|Other virologic failure criteria|0|||
42385279|NCT01425203|76261488|FG000|Treatment Phase|Unidentified reasons|11|||
42385280|NCT01425203|76261489|FG001|Treatment Phase|Unidentified reasons|5|||
42385281|NCT01425203|76261490|FG002|Treatment Phase|Unidentified reasons|0|||
42385282|NCT01425203|76261488|FG000|Treatment Phase|Did not receive treatment|0|||
42385283|NCT01425203|76261489|FG001|Treatment Phase|Did not receive treatment|1|||
42385284|NCT01425203|76261490|FG002|Treatment Phase|Did not receive treatment|0|||
42385285|NCT01425203|76261488|FG000|Crossover Phase|Failure at futility timepoint|0|||
42385286|NCT01425203|76261489|FG001|Crossover Phase|Failure at futility timepoint|0|||
42385287|NCT01425203|76261490|FG002|Crossover Phase|Failure at futility timepoint|3|||
42385288|NCT01425203|76261488|FG000|Crossover Phase|Other virologic failure criteria|0|||
42385289|NCT01425203|76261489|FG001|Crossover Phase|Other virologic failure criteria|0|||
42385290|NCT01425203|76261490|FG002|Crossover Phase|Other virologic failure criteria|3|||
42385291|NCT00081289|76261500|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
42385292|NCT00081289|76261501|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
42385293|NCT00081289|76261500|FG000|Overall Study|Ineligible / no protocol treatment|3|||
42385294|NCT00081289|76261501|FG001|Overall Study|Ineligible / no protocol treatment|4|||
42385295|NCT01478594|76261510|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
42385296|NCT01478594|76261511|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
42385297|NCT01478594|76261510|FG000|Overall Study|Death|45|||
42385298|NCT01478594|76261511|FG001|Overall Study|Death|18|||
42385299|NCT01478594|76261510|FG000|Overall Study|Lost to Follow-up|3|||
42385300|NCT01478594|76261511|FG001|Overall Study|Lost to Follow-up|1|||
42385301|NCT01478594|76261510|FG000|Overall Study|Withdrawal by Subject|9|||
42385302|NCT01478594|76261511|FG001|Overall Study|Withdrawal by Subject|3|||
42385303|NCT01478594|76261510|FG000|Overall Study|Study Closed by Sponsor|8|||
42385304|NCT01478594|76261511|FG001|Overall Study|Study Closed by Sponsor|5|||
42385305|NCT01424813|76261572|FG000|Overall Study|Withdrawal by Subject|3|||
42385306|NCT01424813|76261573|FG001|Overall Study|Withdrawal by Subject|0|||
42385307|NCT01424813|76261572|FG000|Overall Study|Protocol Violation|1|||
42385308|NCT01424813|76261573|FG001|Overall Study|Protocol Violation|0|||
42385309|NCT01424813|76261572|FG000|Overall Study|Other|1|||
42385310|NCT01424813|76261573|FG001|Overall Study|Other|2|||
42385311|NCT00080899|76261579|FG000|Overall Study|Adverse Event|1|||
42385312|NCT00089635|76261583|FG000|Overall Study|Adverse Event|2|||
42385313|NCT00089635|76261583|FG000|Overall Study|Death|17|||
42385314|NCT00089635|76261583|FG000|Overall Study|Disease Progression|12|||
42385315|NCT00089635|76261583|FG000|Overall Study|Lost to Follow-up|3|||
42385316|NCT00089635|76261583|FG000|Overall Study|Withdrawal by Subject|6|||
42385317|NCT00089635|76261583|FG000|Overall Study|Ineligibility determined|1|||
42385318|NCT00089635|76261583|FG000|Overall Study|Other|2|||
42385319|NCT01500200|76261597|FG000|Stage 1|Adverse Event|1|||
42385320|NCT01500200|76261598|FG001|Stage 1|Adverse Event|4|||
42385321|NCT01500200|76261599|FG002|Stage 1|Adverse Event|5|||
42385322|NCT01500200|76261600|FG003|Stage 1|Adverse Event|0|||
42385323|NCT01500200|76261601|FG004|Stage 1|Adverse Event|0|||
42385324|NCT01500200|76261602|FG005|Stage 1|Adverse Event|0|||
42385325|NCT01500200|76261597|FG000|Stage 1|Lost to Follow-up|2|||
42385326|NCT01500200|76261598|FG001|Stage 1|Lost to Follow-up|2|||
42385327|NCT01500200|76261599|FG002|Stage 1|Lost to Follow-up|1|||
42385328|NCT01500200|76261600|FG003|Stage 1|Lost to Follow-up|0|||
42385329|NCT01500200|76261601|FG004|Stage 1|Lost to Follow-up|0|||
42385330|NCT01500200|76261602|FG005|Stage 1|Lost to Follow-up|0|||
42385331|NCT01500200|76261597|FG000|Stage 1|Withdrawal by Subject|3|||
42385332|NCT01500200|76261598|FG001|Stage 1|Withdrawal by Subject|0|||
42385333|NCT01500200|76261599|FG002|Stage 1|Withdrawal by Subject|0|||
42385334|NCT01500200|76261600|FG003|Stage 1|Withdrawal by Subject|0|||
42385335|NCT01500200|76261601|FG004|Stage 1|Withdrawal by Subject|0|||
42385336|NCT01500200|76261602|FG005|Stage 1|Withdrawal by Subject|0|||
42385337|NCT01500200|76261597|FG000|Stage 1|Noncompliance with Study Drug|1|||
42385338|NCT01500200|76261598|FG001|Stage 1|Noncompliance with Study Drug|0|||
42385339|NCT01500200|76261599|FG002|Stage 1|Noncompliance with Study Drug|0|||
42385340|NCT01500200|76261600|FG003|Stage 1|Noncompliance with Study Drug|0|||
42385341|NCT01500200|76261601|FG004|Stage 1|Noncompliance with Study Drug|0|||
42385342|NCT01500200|76261602|FG005|Stage 1|Noncompliance with Study Drug|0|||
42385343|NCT01500200|76261597|FG000|Stage 1|Physician Decision|1|||
42385344|NCT01500200|76261598|FG001|Stage 1|Physician Decision|0|||
42385345|NCT01500200|76261599|FG002|Stage 1|Physician Decision|0|||
42385346|NCT01500200|76261600|FG003|Stage 1|Physician Decision|0|||
42385347|NCT01500200|76261601|FG004|Stage 1|Physician Decision|0|||
42385348|NCT01500200|76261602|FG005|Stage 1|Physician Decision|0|||
42385349|NCT01500200|76261597|FG000|Stage 2|Adverse Event|0|||
42385350|NCT01500200|76261598|FG001|Stage 2|Adverse Event|0|||
42385351|NCT01500200|76261599|FG002|Stage 2|Adverse Event|0|||
42385352|NCT01500200|76261600|FG003|Stage 2|Adverse Event|0|||
42385353|NCT01500200|76261601|FG004|Stage 2|Adverse Event|5|||
42385354|NCT01500200|76261602|FG005|Stage 2|Adverse Event|4|||
42385355|NCT01478360|76261618|FG000|Overall Study|Lost to Follow-up|1|||
42385356|NCT01478360|76261619|FG001|Overall Study|Lost to Follow-up|0|||
42385357|NCT01478360|76261618|FG000|Overall Study|Adverse Event|0|||
42385358|NCT01478360|76261619|FG001|Overall Study|Adverse Event|1|||
42385359|NCT01478360|76261618|FG000|Overall Study|Administrative problems|1|||
42385360|NCT01478360|76261619|FG001|Overall Study|Administrative problems|2|||
42385361|NCT01461980|76261637|FG000|Overall Study|Other|9|||
42385362|NCT01461980|76261638|FG001|Overall Study|Other|8|||
42385363|NCT01461980|76261639|FG002|Overall Study|Other|6|||
42385364|NCT01461980|76261637|FG000|Overall Study|Medication error|7|||
42385365|NCT01461980|76261638|FG001|Overall Study|Medication error|5|||
42385366|NCT01461980|76261639|FG002|Overall Study|Medication error|6|||
42385367|NCT01461980|76261637|FG000|Overall Study|Adverse Event|12|||
42385368|NCT01461980|76261638|FG001|Overall Study|Adverse Event|5|||
42385369|NCT01461980|76261639|FG002|Overall Study|Adverse Event|6|||
42385370|NCT01461980|76261637|FG000|Overall Study|Protocol Violation|12|||
42385371|NCT01461980|76261638|FG001|Overall Study|Protocol Violation|19|||
42385372|NCT01461980|76261639|FG002|Overall Study|Protocol Violation|16|||
42385373|NCT01461980|76261637|FG000|Overall Study|No longer meets eligibility criteria|18|||
42385374|NCT01461980|76261638|FG001|Overall Study|No longer meets eligibility criteria|9|||
42385375|NCT01461980|76261639|FG002|Overall Study|No longer meets eligibility criteria|19|||
42385376|NCT01461980|76261637|FG000|Overall Study|Lost to Follow-up|52|||
42385377|NCT01461980|76261638|FG001|Overall Study|Lost to Follow-up|53|||
42385378|NCT01461980|76261639|FG002|Overall Study|Lost to Follow-up|51|||
42385379|NCT01461980|76261637|FG000|Overall Study|No longer willing to participate|52|||
42385380|NCT01461980|76261638|FG001|Overall Study|No longer willing to participate|38|||
42385381|NCT01461980|76261639|FG002|Overall Study|No longer willing to participate|54|||
42385382|NCT01461980|76261637|FG000|Overall Study|Randomized but not vaccinated|4|||
42385383|NCT01461980|76261638|FG001|Overall Study|Randomized but not vaccinated|8|||
42385384|NCT01461980|76261639|FG002|Overall Study|Randomized but not vaccinated|7|||
42385385|NCT01424501|76261654|FG000|Overall Study|Withdrawal by Subject|1|||
42385386|NCT01424501|76261655|FG001|Overall Study|Withdrawal by Subject|0|||
42385387|NCT01424501|76261656|FG002|Overall Study|Withdrawal by Subject|1|||
42385388|NCT01424501|76261657|FG003|Overall Study|Withdrawal by Subject|0|||
42385389|NCT01424501|76261658|FG004|Overall Study|Withdrawal by Subject|0|||
42385390|NCT01424501|76261659|FG005|Overall Study|Withdrawal by Subject|0|||
42385391|NCT01424501|76261654|FG000|Overall Study|Lost to Follow-up|0|||
42385392|NCT01424501|76261655|FG001|Overall Study|Lost to Follow-up|1|||
42385393|NCT01424501|76261656|FG002|Overall Study|Lost to Follow-up|1|||
42385394|NCT01424501|76261657|FG003|Overall Study|Lost to Follow-up|0|||
42385395|NCT01424501|76261658|FG004|Overall Study|Lost to Follow-up|0|||
42385396|NCT01424501|76261659|FG005|Overall Study|Lost to Follow-up|0|||
42385397|NCT01401959|76261740|FG000|Enrolled|Withdrawal by Subject|1|||
42385398|NCT01401959|76261741|FG001|Enrolled|Withdrawal by Subject|0|||
42385399|NCT01401959|76261742|FG002|Enrolled|Withdrawal by Subject|0|||
42385400|NCT01401959|76261740|FG000|Treated|Disease Progression|2|||
42385401|NCT01401959|76261741|FG001|Treated|Disease Progression|2|||
42385402|NCT01401959|76261742|FG002|Treated|Disease Progression|1|||
42385403|NCT01401959|76261740|FG000|Treated|Adverse Event|4|||
42385404|NCT01401959|76261741|FG001|Treated|Adverse Event|3|||
42385405|NCT01401959|76261742|FG002|Treated|Adverse Event|2|||
42385406|NCT01401959|76261740|FG000|Treated|Withdrawal by Subject|1|||
42385407|NCT01401959|76261741|FG001|Treated|Withdrawal by Subject|2|||
42385408|NCT01401959|76261742|FG002|Treated|Withdrawal by Subject|2|||
42385409|NCT01401959|76261740|FG000|Treated|Protocol Violation|0|||
42385410|NCT01401959|76261741|FG001|Treated|Protocol Violation|1|||
42385411|NCT01401959|76261742|FG002|Treated|Protocol Violation|0|||
42385412|NCT01478048|76261772|FG000|Overall Study|Disease Progression|52|||
42385413|NCT01478048|76261773|FG001|Overall Study|Disease Progression|35|||
42385414|NCT01478048|76261772|FG000|Overall Study|study drug toxicity|11|||
42385415|NCT01478048|76261773|FG001|Overall Study|study drug toxicity|14|||
42385416|NCT01478048|76261772|FG000|Overall Study|Adverse Event|2|||
42385417|NCT01478048|76261773|FG001|Overall Study|Adverse Event|11|||
42385418|NCT01478048|76261772|FG000|Overall Study|subject request to discontinue treatment|3|||
42385419|NCT01478048|76261773|FG001|Overall Study|subject request to discontinue treatment|5|||
42385420|NCT01478048|76261772|FG000|Overall Study|Withdrawal by Subject|2|||
42385421|NCT01478048|76261773|FG001|Overall Study|Withdrawal by Subject|5|||
42385422|NCT01478048|76261772|FG000|Overall Study|non-specified|6|||
42385423|NCT01478048|76261773|FG001|Overall Study|non-specified|4|||
42385424|NCT01478048|76261772|FG000|Overall Study|poor/non-compliance|0|||
42385425|NCT01478048|76261773|FG001|Overall Study|poor/non-compliance|1|||
42385426|NCT01478048|76261772|FG000|Overall Study|no longer meets study criteria|1|||
42385427|NCT01478048|76261773|FG001|Overall Study|no longer meets study criteria|0|||
42385428|NCT01424189|76261781|FG000|Overall Study|Adverse Event|1|||
42385429|NCT01424189|76261782|FG001|Overall Study|Adverse Event|0|||
42385430|NCT01424189|76261781|FG000|Overall Study|Lost to Follow-up|4|||
42385431|NCT01424189|76261782|FG001|Overall Study|Lost to Follow-up|1|||
42385432|NCT01424189|76261781|FG000|Overall Study|Withdrawal by Subject|4|||
42019318|NCT01259492|75826783|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
42019319|NCT01259492|75826780|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
42019320|NCT01259492|75826781|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
42019321|NCT01259492|75826782|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
42019322|NCT01259492|75826783|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
42019323|NCT01259492|75826780|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
42019324|NCT01259492|75826781|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
42019325|NCT01259492|75826782|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
42019326|NCT01259492|75826783|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
42019327|NCT01259492|75826780|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
42019328|NCT01259492|75826781|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
42019329|NCT01259492|75826782|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
42019330|NCT01259492|75826783|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
42019331|NCT01259492|75826780|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
42019332|NCT01259492|75826781|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
42019333|NCT01259492|75826782|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
42019334|NCT01259492|75826783|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
42019335|NCT01259492|75826780|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
42019336|NCT01259492|75826781|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
42019337|NCT01259492|75826782|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
42019338|NCT01259492|75826783|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
42019339|NCT01259492|75826780|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
42019340|NCT01259492|75826781|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
42019341|NCT01259492|75826782|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
42019342|NCT01259492|75826783|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
42019343|NCT01259492|75826780|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
42019344|NCT01259492|75826781|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
42019345|NCT01259492|75826782|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
42019346|NCT01259492|75826783|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
42019347|NCT01259492|75826780|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
42019348|NCT01259492|75826781|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
42019349|NCT01259492|75826782|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
42019350|NCT01259492|75826783|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
42019351|NCT01259492|75826780|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
42019352|NCT01259492|75826781|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
42019353|NCT01259492|75826782|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
42019354|NCT01259492|75826783|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
42019355|NCT01259492|75826780|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
42019356|NCT01259492|75826781|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
42019357|NCT01259492|75826782|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
42019358|NCT01259492|75826783|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
42019359|NCT01259492|75826780|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
42019360|NCT01259492|75826781|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
42019361|NCT01259492|75826782|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
42019362|NCT01259492|75826783|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
42019363|NCT01259492|75826780|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
42019364|NCT01259492|75826781|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
42019365|NCT01259492|75826782|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
42019366|NCT01259492|75826783|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
42019367|NCT01259492|75826780|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
42019368|NCT01259492|75826781|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
42019369|NCT01259492|75826782|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
42019370|NCT01259492|75826783|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
42019371|NCT01259492|75826780|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
42019372|NCT01259492|75826781|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
42019373|NCT01259492|75826782|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
42385433|NCT01424189|76261782|FG001|Overall Study|Withdrawal by Subject|4|||
42385434|NCT01424189|76261781|FG000|Overall Study|Subject moved|1|||
42385435|NCT01424189|76261782|FG001|Overall Study|Subject moved|0|||
42385436|NCT01424189|76261781|FG000|Overall Study|Death|3|||
42385437|NCT01424189|76261782|FG001|Overall Study|Death|1|||
42385438|NCT01401647|76261795|FG000|Overall Study|Withdrawal by Subject|1|||
42385439|NCT01401647|76261796|FG001|Overall Study|Withdrawal by Subject|5|||
42019374|NCT01259492|75826783|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
42019375|NCT01259492|75826780|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
42019376|NCT01259492|75826781|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
42019377|NCT01259492|75826782|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
42019378|NCT01259492|75826783|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
42019379|NCT01117623|75826800|FG000|Overall Study|Adverse Event|0|||
42019380|NCT01117623|75826801|FG001|Overall Study|Adverse Event|2|||
42019381|NCT01117623|75826802|FG002|Overall Study|Adverse Event|4|||
42019382|NCT01117623|75826803|FG003|Overall Study|Adverse Event|0|||
42019383|NCT01117623|75826804|FG004|Overall Study|Adverse Event|2|||
42019384|NCT01117623|75826805|FG005|Overall Study|Adverse Event|0|||
42019385|NCT01117623|75826806|FG006|Overall Study|Adverse Event|0|||
42019386|NCT01117623|75826807|FG007|Overall Study|Adverse Event|2|||
42019387|NCT01117623|75826800|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
42019388|NCT01117623|75826801|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
42019389|NCT01117623|75826802|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
42019390|NCT01117623|75826803|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
42019391|NCT01117623|75826804|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
42019392|NCT01117623|75826805|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
42019393|NCT01117623|75826806|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
42019394|NCT01117623|75826807|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
42019395|NCT01117623|75826800|FG000|Overall Study|Withdrawal by Subject|0|||
42019396|NCT01117623|75826801|FG001|Overall Study|Withdrawal by Subject|0|||
42019397|NCT01117623|75826802|FG002|Overall Study|Withdrawal by Subject|2|||
42019398|NCT01117623|75826803|FG003|Overall Study|Withdrawal by Subject|0|||
42019399|NCT01117623|75826804|FG004|Overall Study|Withdrawal by Subject|0|||
42019400|NCT01117623|75826805|FG005|Overall Study|Withdrawal by Subject|1|||
42019401|NCT01117623|75826806|FG006|Overall Study|Withdrawal by Subject|1|||
42019402|NCT01117623|75826807|FG007|Overall Study|Withdrawal by Subject|1|||
42019403|NCT01117623|75826800|FG000|Overall Study|Non-compliance with study medication|0|||
42019404|NCT01117623|75826801|FG001|Overall Study|Non-compliance with study medication|0|||
42019405|NCT01117623|75826802|FG002|Overall Study|Non-compliance with study medication|0|||
42019406|NCT01117623|75826803|FG003|Overall Study|Non-compliance with study medication|0|||
42019407|NCT01117623|75826804|FG004|Overall Study|Non-compliance with study medication|0|||
42019408|NCT01117623|75826805|FG005|Overall Study|Non-compliance with study medication|0|||
42019409|NCT01117623|75826806|FG006|Overall Study|Non-compliance with study medication|0|||
42019410|NCT01117623|75826807|FG007|Overall Study|Non-compliance with study medication|1|||
42019411|NCT01117623|75826800|FG000|Overall Study|Invest. text: completed all planned txs|0|||
42019412|NCT01117623|75826801|FG001|Overall Study|Invest. text: completed all planned txs|0|||
42019413|NCT01117623|75826802|FG002|Overall Study|Invest. text: completed all planned txs|0|||
42019414|NCT01117623|75826803|FG003|Overall Study|Invest. text: completed all planned txs|0|||
42019415|NCT01117623|75826804|FG004|Overall Study|Invest. text: completed all planned txs|0|||
42019416|NCT01117623|75826805|FG005|Overall Study|Invest. text: completed all planned txs|1|||
42019417|NCT01117623|75826806|FG006|Overall Study|Invest. text: completed all planned txs|0|||
42019418|NCT01117623|75826807|FG007|Overall Study|Invest. text: completed all planned txs|0|||
42019419|NCT01116687|75826827|FG000|Overall Study|Withdrawal by Subject|4|||
42019420|NCT01114737|75826833|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
42019421|NCT01114737|75826834|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
42019422|NCT01114737|75826833|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
42019423|NCT01114737|75826834|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
42019424|NCT01114737|75826833|FG000|Randomized Treatment Period|Pregnancy|1|||
42019425|NCT01114737|75826834|FG001|Randomized Treatment Period|Pregnancy|0|||
42019426|NCT01114737|75826833|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
42019427|NCT01114737|75826834|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
42019428|NCT01114737|75826833|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
42019429|NCT01114737|75826834|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
42019430|NCT01114737|75826833|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
42019431|NCT01114737|75826834|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
42019432|NCT01113879|75826857|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
42019433|NCT01113879|75826858|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
42019434|NCT00979576|75826869|FG000|Combination Treatment Phase|Progressive disease|3|||
42019435|NCT00979576|75826870|FG001|Combination Treatment Phase|Progressive disease|1|||
42019436|NCT00979576|75826871|FG002|Combination Treatment Phase|Progressive disease|5|||
42019437|NCT00979576|75826869|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
42019438|NCT00979576|75826870|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
42019439|NCT00979576|75826871|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
42019440|NCT00979576|75826869|FG000|Combination Treatment Phase|Adverse Event|0|||
42019441|NCT00979576|75826870|FG001|Combination Treatment Phase|Adverse Event|2|||
42019442|NCT00979576|75826871|FG002|Combination Treatment Phase|Adverse Event|2|||
42019443|NCT00979576|75826869|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
42019444|NCT00979576|75826870|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
42385440|NCT01401647|76261797|FG002|Overall Study|Withdrawal by Subject|2|||
42385441|NCT01401647|76261795|FG000|Overall Study|Lost to Follow-up|3|||
42385442|NCT01401647|76261796|FG001|Overall Study|Lost to Follow-up|3|||
42385443|NCT01401647|76261797|FG002|Overall Study|Lost to Follow-up|1|||
42385444|NCT01499810|76261805|FG000|Overall Study|Lost to Follow-up|10|||
42385445|NCT01499810|76261805|FG000|Overall Study|Protocol Violation|1|||
42385446|NCT01499810|76261805|FG000|Overall Study|Withdrawal by Subject|1|||
42385447|NCT01423253|76261810|FG000|Overall Study|Adverse Event|2|||
42385448|NCT01423253|76261810|FG000|Overall Study|Lack of Efficacy|2|||
42385449|NCT01423253|76261810|FG000|Overall Study|Lost to Follow-up|1|||
42385450|NCT01423253|76261810|FG000|Overall Study|Protocol Violation|2|||
42385451|NCT01423253|76261810|FG000|Overall Study|Withdrawal by Subject|2|||
42385452|NCT01477892|76261816|FG000|Overall Study|Withdrawal by Subject|0|||
42385453|NCT01477892|76261817|FG001|Overall Study|Withdrawal by Subject|2|||
42385454|NCT01422239|76261830|FG000|Overall Study|Lost to Follow-up|4|||
42385455|NCT01422239|76261831|FG001|Overall Study|Lost to Follow-up|3|||
42385456|NCT01499576|76261837|FG000|Overall Study|Physician Decision|12|||
42385457|NCT01499576|76261837|FG000|Overall Study|Withdrawal by Subject|9|||
42385458|NCT01476722|76261851|FG000|Overall Study|Adverse Event|1|||
42385459|NCT01476644|76261864|FG000|Overall Study|Death|5|||
42385460|NCT01476644|76261864|FG000|Overall Study|moved to another state|2|||
42385461|NCT01476644|76261864|FG000|Overall Study|Lost to Follow-up|19|||
42385462|NCT01476644|76261864|FG000|Overall Study|Withdrawal by Subject|13|||
42385463|NCT01421459|76261888|FG000|Overall Study|Adverse Event|6|||
42385464|NCT01421459|76261889|FG001|Overall Study|Adverse Event|10|||
42385465|NCT01421459|76261888|FG000|Overall Study|Death|1|||
42385466|NCT01421459|76261889|FG001|Overall Study|Death|1|||
42385467|NCT01421459|76261888|FG000|Overall Study|Lack of Efficacy|1|||
42385468|NCT01421459|76261889|FG001|Overall Study|Lack of Efficacy|2|||
42385469|NCT01421459|76261888|FG000|Overall Study|Lost to Follow-up|8|||
42385470|NCT01421459|76261889|FG001|Overall Study|Lost to Follow-up|9|||
42385471|NCT01421459|76261888|FG000|Overall Study|Physician Decision|9|||
42385472|NCT01421459|76261889|FG001|Overall Study|Physician Decision|9|||
42385473|NCT01421459|76261888|FG000|Overall Study|Protocol Violation|8|||
42385474|NCT01421459|76261889|FG001|Overall Study|Protocol Violation|5|||
42385475|NCT01421459|76261888|FG000|Overall Study|Withdrawal by Subject|12|||
42385476|NCT01421459|76261889|FG001|Overall Study|Withdrawal by Subject|16|||
42385477|NCT01498952|76261897|FG000|Overall Study|Death|2|||
42385478|NCT01498952|76261898|FG001|Overall Study|Death|2|||
42385479|NCT01498952|76261899|FG002|Overall Study|Death|0|||
42385480|NCT01498952|76261900|FG003|Overall Study|Death|0|||
42019445|NCT00979576|75826871|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
42019446|NCT00979420|75826884|FG000|Overall Study|Adverse Event|1|||
42019447|NCT00979420|75826885|FG001|Overall Study|Adverse Event|0|||
42019448|NCT00979420|75826886|FG002|Overall Study|Adverse Event|0|||
42019449|NCT00979420|75826887|FG003|Overall Study|Adverse Event|0|||
42019450|NCT00979420|75826884|FG000|Overall Study|Lack of Efficacy|3|||
42019451|NCT00979420|75826885|FG001|Overall Study|Lack of Efficacy|0|||
42019452|NCT00979420|75826886|FG002|Overall Study|Lack of Efficacy|1|||
42019453|NCT00979420|75826887|FG003|Overall Study|Lack of Efficacy|1|||
42019454|NCT00979420|75826884|FG000|Overall Study|Other reasons not related to Viramune|3|||
42019455|NCT00979420|75826885|FG001|Overall Study|Other reasons not related to Viramune|0|||
42019456|NCT00979420|75826886|FG002|Overall Study|Other reasons not related to Viramune|0|||
42019457|NCT00979420|75826887|FG003|Overall Study|Other reasons not related to Viramune|1|||
42019458|NCT02702180|75826898|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
42019459|NCT02702180|75826899|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
42019460|NCT02702180|75826900|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
42019461|NCT02702180|75826898|FG000|Double-blind Treatment Period|Adverse Event|0|||
42019462|NCT02702180|75826899|FG001|Double-blind Treatment Period|Adverse Event|0|||
42019463|NCT02702180|75826900|FG002|Double-blind Treatment Period|Adverse Event|1|||
42019464|NCT02702180|75826898|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
42019465|NCT02702180|75826899|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
42019466|NCT02702180|75826900|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
42019467|NCT02702180|75826898|FG000|Double-blind Treatment Period|Protocol Violation|0|||
42019468|NCT02702180|75826899|FG001|Double-blind Treatment Period|Protocol Violation|0|||
42019469|NCT02702180|75826900|FG002|Double-blind Treatment Period|Protocol Violation|2|||
42019470|NCT02702180|75826898|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
42385481|NCT01498952|76261901|FG004|Overall Study|Death|0|||
42385482|NCT01461044|76261933|FG000|Overall Study|Death|58|||
42385483|NCT01461044|76261934|FG001|Overall Study|Death|35|||
42385484|NCT01461044|76261933|FG000|Overall Study|Lost to Follow-up|12|||
42385485|NCT01461044|76261934|FG001|Overall Study|Lost to Follow-up|5|||
42110249|NCT00622700|75920599|FG005|Extension Treatment Period|Other than specified above|1|||
42385486|NCT01421303|76261967|FG000|Overall Study|Lost to Follow-up|13|||
42385487|NCT01421303|76261967|FG000|Overall Study|Non compliance with study procedure|1|||
42385488|NCT01421303|76261967|FG000|Overall Study|Other|7|||
42385489|NCT01421303|76261967|FG000|Overall Study|Withdrawal by Subject|1|||
42385490|NCT01475474|76261971|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
42385491|NCT01475474|76261971|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
42385492|NCT01400243|76261978|FG000|Overall Study|Protocol Violation|8|||
42385493|NCT01400243|76261979|FG001|Overall Study|Protocol Violation|11|||
42385494|NCT01475162|76261996|FG000|Overall Study|Physician Decision|1|||
42385495|NCT01475162|76261996|FG000|Overall Study|Death|10|||
42385496|NCT01475162|76261996|FG000|Overall Study|Study closed for safety|3|||
42385497|NCT01421225|76262003|FG000|Overall Study|Withdrawal by Subject|0|||
42385498|NCT01421225|76262004|FG001|Overall Study|Withdrawal by Subject|1|||
42385499|NCT01498640|76262020|FG000|Overall Study|Lost to Follow-up|1|||
42385500|NCT01498640|76262020|FG000|Overall Study|Death|1|||
42110250|NCT00622700|75920600|FG006|Extension Treatment Period|Other than specified above|1|||
42110251|NCT00538473|75920619|FG000|Overall Study|Adverse Event|1|||
42110252|NCT00538473|75920620|FG001|Overall Study|Adverse Event|0|||
42385501|NCT01498640|76262020|FG000|Overall Study|Other|3|||
42385502|NCT01498484|76262032|FG000|Overall Study|Death|6|||
42385503|NCT01498484|76262033|FG001|Overall Study|Death|3|||
42385504|NCT01498484|76262034|FG002|Overall Study|Death|1|||
42385505|NCT01498484|76262035|FG003|Overall Study|Death|1|||
42385506|NCT01498484|76262036|FG004|Overall Study|Death|0|||
42385507|NCT01498484|76262037|FG005|Overall Study|Death|0|||
42385508|NCT01498484|76262038|FG006|Overall Study|Death|10|||
42385509|NCT01498484|76262039|FG007|Overall Study|Death|1|||
42110253|NCT00622466|75920626|FG000|Overall Study|Death|1|||
42385510|NCT01498484|76262040|FG008|Overall Study|Death|0|||
42385511|NCT01498484|76262032|FG000|Overall Study|Physician Decision|3|||
42385512|NCT01498484|76262033|FG001|Overall Study|Physician Decision|2|||
42385513|NCT01498484|76262034|FG002|Overall Study|Physician Decision|1|||
42385514|NCT01498484|76262035|FG003|Overall Study|Physician Decision|1|||
42385515|NCT01498484|76262036|FG004|Overall Study|Physician Decision|0|||
42385516|NCT01498484|76262037|FG005|Overall Study|Physician Decision|0|||
42385517|NCT01498484|76262038|FG006|Overall Study|Physician Decision|8|||
42385518|NCT01498484|76262039|FG007|Overall Study|Physician Decision|13|||
42385519|NCT01498484|76262040|FG008|Overall Study|Physician Decision|1|||
42385520|NCT01498484|76262032|FG000|Overall Study|Adverse Event|0|||
42385521|NCT01498484|76262033|FG001|Overall Study|Adverse Event|0|||
42385522|NCT01498484|76262034|FG002|Overall Study|Adverse Event|0|||
42385523|NCT01498484|76262035|FG003|Overall Study|Adverse Event|0|||
42385524|NCT01498484|76262036|FG004|Overall Study|Adverse Event|0|||
42385525|NCT01498484|76262037|FG005|Overall Study|Adverse Event|1|||
42385526|NCT01498484|76262038|FG006|Overall Study|Adverse Event|0|||
42385527|NCT01498484|76262039|FG007|Overall Study|Adverse Event|0|||
42385528|NCT01498484|76262040|FG008|Overall Study|Adverse Event|0|||
42385529|NCT01498484|76262032|FG000|Overall Study|Withdrawal by Subject|0|||
42385530|NCT01498484|76262033|FG001|Overall Study|Withdrawal by Subject|0|||
42385531|NCT01498484|76262034|FG002|Overall Study|Withdrawal by Subject|0|||
42385532|NCT01498484|76262035|FG003|Overall Study|Withdrawal by Subject|1|||
42385533|NCT01498484|76262036|FG004|Overall Study|Withdrawal by Subject|0|||
42385534|NCT01498484|76262037|FG005|Overall Study|Withdrawal by Subject|0|||
42385535|NCT01498484|76262038|FG006|Overall Study|Withdrawal by Subject|1|||
42385536|NCT01498484|76262039|FG007|Overall Study|Withdrawal by Subject|0|||
42385537|NCT01498484|76262040|FG008|Overall Study|Withdrawal by Subject|0|||
42385538|NCT01498484|76262032|FG000|Overall Study|Other|5|||
42385539|NCT01498484|76262033|FG001|Overall Study|Other|2|||
42385540|NCT01498484|76262034|FG002|Overall Study|Other|0|||
42385541|NCT01498484|76262035|FG003|Overall Study|Other|0|||
42385542|NCT01498484|76262036|FG004|Overall Study|Other|1|||
42385543|NCT01498484|76262037|FG005|Overall Study|Other|0|||
42385544|NCT01498484|76262038|FG006|Overall Study|Other|3|||
42385545|NCT01498484|76262039|FG007|Overall Study|Other|0|||
42385546|NCT01498484|76262040|FG008|Overall Study|Other|1|||
42385547|NCT01474772|76262049|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
42385548|NCT01474772|76262050|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
42385549|NCT01474772|76262049|FG000|Period 1|AE not Related to Study Drug|1|||
42385550|NCT01474772|76262050|FG001|Period 1|AE not Related to Study Drug|0|||
42385551|NCT01474772|76262049|FG000|Period 1|Withdrawal by Subject|3|||
42385552|NCT01474772|76262050|FG001|Period 1|Withdrawal by Subject|1|||
42385553|NCT01474772|76262049|FG000|Period 1|Lost to Follow-up|1|||
42110254|NCT00622466|75920626|FG000|Overall Study|Adverse Event|1|||
42385554|NCT01474772|76262050|FG001|Period 1|Lost to Follow-up|0|||
42385555|NCT01474772|76262049|FG000|Period 1|Reason not Specified|1|||
42385556|NCT01474772|76262050|FG001|Period 1|Reason not Specified|1|||
42385557|NCT01474772|76262049|FG000|Washout|AE not Related to Study Drug|2|||
42385558|NCT01474772|76262050|FG001|Washout|AE not Related to Study Drug|0|||
42385559|NCT01474772|76262049|FG000|Washout|Withdrawal by Subject|1|||
42385560|NCT01474772|76262050|FG001|Washout|Withdrawal by Subject|0|||
42385561|NCT01474772|76262049|FG000|Washout|Lost to Follow-up|0|||
42385562|NCT01474772|76262050|FG001|Washout|Lost to Follow-up|1|||
42385563|NCT01474772|76262049|FG000|Washout|Reason not Specified|0|||
42385564|NCT01474772|76262050|FG001|Washout|Reason not Specified|1|||
42385565|NCT01474772|76262049|FG000|Period 2|Death|0|||
42385566|NCT01474772|76262050|FG001|Period 2|Death|1|||
42385567|NCT01474772|76262049|FG000|Period 2|AE Related to Study Drug|0|||
42385568|NCT01474772|76262050|FG001|Period 2|AE Related to Study Drug|1|||
42385569|NCT01474772|76262049|FG000|Period 2|AE not Related to Study Drug|4|||
42385570|NCT01474772|76262050|FG001|Period 2|AE not Related to Study Drug|1|||
42385571|NCT01474772|76262049|FG000|Period 2|Lack of Efficacy|1|||
42385572|NCT01474772|76262050|FG001|Period 2|Lack of Efficacy|0|||
42385573|NCT01474772|76262049|FG000|Period 2|Withdrawal by Subject|3|||
42385574|NCT01474772|76262050|FG001|Period 2|Withdrawal by Subject|4|||
42385575|NCT01474772|76262049|FG000|Period 2|Lost to Follow-up|1|||
42385576|NCT01474772|76262050|FG001|Period 2|Lost to Follow-up|1|||
42385577|NCT01474772|76262049|FG000|Period 2|Reason not Specified|0|||
42385578|NCT01474772|76262050|FG001|Period 2|Reason not Specified|2|||
42385579|NCT01474772|76262049|FG000|Follow-up|AE not Related to Study Drug|0|||
42385580|NCT01474772|76262050|FG001|Follow-up|AE not Related to Study Drug|1|||
42385581|NCT01421147|76262058|FG000|Treatment Period|Adverse Event|2|||
42385582|NCT01421147|76262059|FG001|Treatment Period|Adverse Event|3|||
42385583|NCT01421147|76262058|FG000|Treatment Period|Lost to Follow-up|2|||
42385584|NCT01421147|76262059|FG001|Treatment Period|Lost to Follow-up|1|||
42385585|NCT01421147|76262058|FG000|Treatment Period|Physician Decision|2|||
42385586|NCT01421147|76262059|FG001|Treatment Period|Physician Decision|2|||
42385587|NCT01421147|76262058|FG000|Treatment Period|Withdrawal by Subject|10|||
42385588|NCT01421147|76262059|FG001|Treatment Period|Withdrawal by Subject|5|||
42385589|NCT01421147|76262058|FG000|Extension Period|Adverse Event|0|||
42385590|NCT01421147|76262059|FG001|Extension Period|Adverse Event|2|||
42385591|NCT01421147|76262058|FG000|Extension Period|Death|0|||
42385592|NCT01421147|76262059|FG001|Extension Period|Death|1|||
42385593|NCT01421147|76262058|FG000|Extension Period|Lost to Follow-up|2|||
42385594|NCT01421147|76262059|FG001|Extension Period|Lost to Follow-up|5|||
42385595|NCT01421147|76262058|FG000|Extension Period|Physician Decision|1|||
42385596|NCT01421147|76262059|FG001|Extension Period|Physician Decision|0|||
42385597|NCT01421147|76262058|FG000|Extension Period|Withdrawal by Subject|5|||
42385598|NCT01421147|76262059|FG001|Extension Period|Withdrawal by Subject|3|||
42385599|NCT01497938|76262076|FG000|Overall Study|Adverse Event|0|||
42385600|NCT01497938|76262077|FG001|Overall Study|Adverse Event|1|||
42385601|NCT01497938|76262076|FG000|Overall Study|Physician Decision|0|||
42385602|NCT01497938|76262077|FG001|Overall Study|Physician Decision|1|||
42385603|NCT01497938|76262076|FG000|Overall Study|Withdrawal by Subject|4|||
42385604|NCT01497938|76262077|FG001|Overall Study|Withdrawal by Subject|0|||
42385605|NCT01497938|76262076|FG000|Overall Study|Device Violation|1|||
42385606|NCT01497938|76262077|FG001|Overall Study|Device Violation|0|||
42385607|NCT01460342|76262127|FG000|Overall Study|Adverse Event|5|||
42385608|NCT01460342|76262128|FG001|Overall Study|Adverse Event|4|||
42385609|NCT01460342|76262127|FG000|Overall Study|Lost to Follow-up|1|||
42385610|NCT01460342|76262128|FG001|Overall Study|Lost to Follow-up|2|||
42385611|NCT01460342|76262127|FG000|Overall Study|Protocol Violation|0|||
42385612|NCT01460342|76262128|FG001|Overall Study|Protocol Violation|1|||
42385613|NCT01460342|76262127|FG000|Overall Study|Withdrawal by Subject|3|||
42385614|NCT01460342|76262128|FG001|Overall Study|Withdrawal by Subject|4|||
42385615|NCT01460342|76262127|FG000|Overall Study|Physician Decision|1|||
42385616|NCT01460342|76262128|FG001|Overall Study|Physician Decision|3|||
42385617|NCT01460342|76262127|FG000|Overall Study|Lack of Efficacy|1|||
42385618|NCT01460342|76262128|FG001|Overall Study|Lack of Efficacy|0|||
42385619|NCT01459796|76262160|FG000|Overall Study|Non compliance with protocol|2|||
42385620|NCT01459796|76262161|FG001|Overall Study|Non compliance with protocol|4|||
42385621|NCT01459796|76262160|FG000|Overall Study|Adverse Event|5|||
42385622|NCT01459796|76262161|FG001|Overall Study|Adverse Event|5|||
42385623|NCT01459796|76262160|FG000|Overall Study|Withdrawal by Subject|6|||
42385624|NCT01459796|76262161|FG001|Overall Study|Withdrawal by Subject|3|||
42385625|NCT01459796|76262160|FG000|Overall Study|Lost to Follow-up|5|||
42385626|NCT01459796|76262161|FG001|Overall Study|Lost to Follow-up|4|||
42385627|NCT01459796|76262160|FG000|Overall Study|Reason unspecified|1|||
42385628|NCT01459796|76262161|FG001|Overall Study|Reason unspecified|2|||
42385629|NCT01459796|76262160|FG000|Overall Study|Decision by the sponsor|75|||
42385630|NCT01459796|76262161|FG001|Overall Study|Decision by the sponsor|108|||
42385631|NCT01459718|76262171|FG000|Overall Study|Physician Decision|1|||
42385632|NCT01459718|76262171|FG000|Overall Study|Lost to Follow-up|1|||
42385633|NCT01459718|76262171|FG000|Overall Study|Adverse Event|1|||
42385634|NCT04008069|76262175|FG000|Open-Label Period|Adverse Event|1|||
42385635|NCT04008069|76262176|FG001|Open-Label Period|Adverse Event|0|||
42385636|NCT04008069|76262177|FG002|Open-Label Period|Adverse Event|0|||
42385637|NCT04008069|76262175|FG000|Open-Label Period|Lack of Efficacy|4|||
42385638|NCT04008069|76262176|FG001|Open-Label Period|Lack of Efficacy|0|||
42385639|NCT04008069|76262177|FG002|Open-Label Period|Lack of Efficacy|0|||
42385640|NCT04008069|76262175|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
42385641|NCT04008069|76262176|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
42385642|NCT04008069|76262177|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
42385643|NCT04008069|76262175|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
42385644|NCT04008069|76262176|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
42385645|NCT04008069|76262177|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
42385646|NCT01474538|76262193|FG000|Treatment Period 1|Death|1|||
42385647|NCT01474538|76262194|FG001|Treatment Period 1|Death|0|||
42385648|NCT01474538|76262193|FG000|Treatment Period 1|Physician Decision|1|||
42385649|NCT01474538|76262194|FG001|Treatment Period 1|Physician Decision|0|||
42385650|NCT01474538|76262193|FG000|Treatment Period 1|Withdrawal by Subject|1|||
42385651|NCT01474538|76262194|FG001|Treatment Period 1|Withdrawal by Subject|3|||
42385652|NCT01474538|76262193|FG000|Treatment Period 1|Protocol Violation|0|||
42385653|NCT01474538|76262194|FG001|Treatment Period 1|Protocol Violation|1|||
42385654|NCT01474538|76262193|FG000|Treatment Period 2|Death|1|||
42385655|NCT01474538|76262194|FG001|Treatment Period 2|Death|0|||
42385656|NCT01474538|76262193|FG000|Treatment Period 2|Adverse Event|1|||
42385657|NCT01474538|76262194|FG001|Treatment Period 2|Adverse Event|1|||
42385658|NCT01474538|76262193|FG000|Treatment Period 2|Withdrawal by Subject|2|||
42385659|NCT01474538|76262194|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42385660|NCT01474538|76262193|FG000|Treatment Period 2|Sponsor decision|1|||
42385661|NCT01474538|76262194|FG001|Treatment Period 2|Sponsor decision|0|||
42385662|NCT01474538|76262193|FG000|Treatment Period 2|Physician Decision|0|||
42385663|NCT01474538|76262194|FG001|Treatment Period 2|Physician Decision|1|||
42385664|NCT01474538|76262193|FG000|Treatment Period 2|Protocol Violation|1|||
42385665|NCT01474538|76262194|FG001|Treatment Period 2|Protocol Violation|0|||
42385666|NCT02647788|76262202|FG000|Overall Study|Lost to Follow-up|13|||
42385667|NCT02647788|76262203|FG001|Overall Study|Lost to Follow-up|11|||
42385668|NCT02647788|76262202|FG000|Overall Study|Did not want opiate|0|||
42385669|NCT02647788|76262203|FG001|Overall Study|Did not want opiate|1|||
42385670|NCT02647788|76262202|FG000|Overall Study|Withdrawal by Subject|1|||
42385671|NCT02647788|76262203|FG001|Overall Study|Withdrawal by Subject|0|||
42385672|NCT02647788|76262202|FG000|Overall Study|Felt itchy with assigned medication|1|||
42385673|NCT02647788|76262203|FG001|Overall Study|Felt itchy with assigned medication|0|||
42385674|NCT02647788|76262202|FG000|Overall Study|Felt nauseous with assigned medication|1|||
42385675|NCT02647788|76262203|FG001|Overall Study|Felt nauseous with assigned medication|1|||
42385676|NCT01459016|76262209|FG000|Overall Study|Withdrawal by Subject|11|||
42385677|NCT01459016|76262209|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
42385678|NCT01458392|76262251|FG000|Overall Study|Death|2|||
42385679|NCT01458392|76262252|FG001|Overall Study|Death|11|||
42385680|NCT01458392|76262253|FG002|Overall Study|Death|22|||
42385681|NCT01458392|76262251|FG000|Overall Study|At the discretion of the sponsor|0|||
42110255|NCT00622466|75920626|FG000|Overall Study|Withdrawal by Subject|2|||
42110256|NCT00537771|75920632|FG000|Overall Study|Withdrawal by Subject|6|||
42110257|NCT00537771|75920633|FG001|Overall Study|Withdrawal by Subject|23|||
42110258|NCT00537771|75920632|FG000|Overall Study|Adverse Event|8|||
42110259|NCT00537771|75920633|FG001|Overall Study|Adverse Event|15|||
42110260|NCT00537771|75920632|FG000|Overall Study|Lost to Follow-up|9|||
42110261|NCT00537771|75920633|FG001|Overall Study|Lost to Follow-up|15|||
42110262|NCT00537771|75920632|FG000|Overall Study|Protocol Violation|2|||
42110263|NCT00537771|75920633|FG001|Overall Study|Protocol Violation|6|||
42110264|NCT00537771|75920632|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
42110265|NCT00537771|75920633|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
42110266|NCT00623480|75920641|FG000|Overall Study|Lost to Follow-up|0|||
42110267|NCT00623480|75920642|FG001|Overall Study|Lost to Follow-up|1|||
42110268|NCT00623480|75920641|FG000|Overall Study|Withdrawal by Subject|2|||
42110269|NCT00623480|75920642|FG001|Overall Study|Withdrawal by Subject|4|||
42110270|NCT00623480|75920641|FG000|Overall Study|Lack of Efficacy|1|||
42110271|NCT00623480|75920642|FG001|Overall Study|Lack of Efficacy|0|||
42110272|NCT00623480|75920641|FG000|Overall Study|Non-compliant with study medication|4|||
42110273|NCT00623480|75920642|FG001|Overall Study|Non-compliant with study medication|0|||
42385682|NCT01458392|76262252|FG001|Overall Study|At the discretion of the sponsor|2|||
42385683|NCT01458392|76262253|FG002|Overall Study|At the discretion of the sponsor|7|||
42385684|NCT01458392|76262251|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
42385685|NCT01458392|76262252|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
42385686|NCT01458392|76262253|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
42110274|NCT00623480|75920641|FG000|Overall Study|Protocol Violation|0|||
42110275|NCT00623480|75920642|FG001|Overall Study|Protocol Violation|1|||
42110276|NCT00623480|75920641|FG000|Overall Study|Site closed by sponsor|0|||
42110277|NCT00623480|75920642|FG001|Overall Study|Site closed by sponsor|1|||
42204109|NCT02951988|76016781|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
42385687|NCT01421069|76262265|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
42385688|NCT01421069|76262265|FG000|Parent Study|Failed to return|3|||
42385689|NCT01421069|76262265|FG000|Parent Study|Withdrawal by Subject|1|||
42385690|NCT01421069|76262265|FG000|Parent Study|Lost to Follow-up|2|||
42385691|NCT01421069|76262265|FG000|Parent Study|Lack of Efficacy|1|||
42385692|NCT01421069|76262265|FG000|Overall Period for Extension Study|Other|2|||
42385693|NCT01421069|76262265|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
42110278|NCT02513667|75920650|FG000|Overall Study|Withdrawal by Subject|0|||
42385694|NCT01421069|76262265|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
42385695|NCT01421069|76262265|FG000|Overall Period for Extension Study|Pregnancy|1|||
42385696|NCT01421069|76262265|FG000|Overall Period for Extension Study|Adverse Event|1|||
42385697|NCT01421069|76262265|FG000|Overall Period for Extension Study|Protocol Violation|1|||
42385698|NCT01421069|76262265|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
42385699|NCT01421069|76262265|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
42385700|NCT01421069|76262265|FG000|Active Treatment Period|Other|1|||
42385701|NCT01421069|76262265|FG000|Active Treatment Period|No longer willing to participate in study|8|||
42385702|NCT01421069|76262265|FG000|Active Treatment Period|Insufficient clinical response|1|||
42385703|NCT01421069|76262265|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
42385704|NCT01421069|76262265|FG000|Active Treatment Period|Pregnancy|1|||
42385705|NCT01421069|76262265|FG000|Active Treatment Period|Adverse Event|1|||
42385706|NCT01421069|76262265|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
42385707|NCT01421069|76262265|FG000|Active Treatment Period|Enrolled in observational period|29|||
42385708|NCT01421069|76262265|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
42385709|NCT01421069|76262265|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
42385710|NCT01421069|76262265|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
42385711|NCT01421069|76262265|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
42385712|NCT01421069|76262265|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
42385713|NCT01421069|76262265|FG000|2b. Retreatment Period|Protocol Violation|1|||
42385714|NCT01421069|76262265|FG000|Observational Period|Other|1|||
42385715|NCT01421069|76262265|FG000|Observational Period|No longer willing to participate in study|4|||
42385716|NCT01421069|76262265|FG000|Observational Period|Lost to Follow-up|3|||
42385717|NCT01473836|76262297|FG000|Overall Study|Adverse Event|4|||
42385718|NCT01473836|76262297|FG000|Overall Study|Lack of Efficacy|1|||
42385719|NCT01473836|76262297|FG000|Overall Study|Does not meet entrance criteria|1|||
42385720|NCT01473758|76262322|FG000|Cycle 1|Adverse Event|10|||
42385721|NCT01473758|76262323|FG001|Cycle 1|Adverse Event|2|||
42385722|NCT01473758|76262324|FG002|Cycle 1|Adverse Event|0|||
42385723|NCT01473758|76262325|FG003|Cycle 1|Adverse Event|0|||
42385724|NCT01473758|76262322|FG000|Cycle 1|Withdrawal by Subject|1|||
42385725|NCT01473758|76262323|FG001|Cycle 1|Withdrawal by Subject|1|||
42385726|NCT01473758|76262324|FG002|Cycle 1|Withdrawal by Subject|0|||
42385727|NCT01473758|76262325|FG003|Cycle 1|Withdrawal by Subject|0|||
42385728|NCT01473758|76262322|FG000|Cycle 2|Adverse Event|0|||
42385729|NCT01473758|76262323|FG001|Cycle 2|Adverse Event|0|||
42385730|NCT01473758|76262324|FG002|Cycle 2|Adverse Event|5|||
42385731|NCT01473758|76262325|FG003|Cycle 2|Adverse Event|0|||
42385732|NCT01420679|76262335|FG000|Overall Study|Disease Progression|3|||
42385733|NCT01420679|76262336|FG001|Overall Study|Disease Progression|2|||
42385734|NCT01420679|76262335|FG000|Overall Study|Adverse Event|4|||
42385735|NCT01420679|76262336|FG001|Overall Study|Adverse Event|0|||
42385736|NCT01420679|76262335|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
42385737|NCT01420679|76262336|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
42385738|NCT01420679|76262335|FG000|Overall Study|Patient Decision|1|||
42385739|NCT01420679|76262336|FG001|Overall Study|Patient Decision|0|||
42385740|NCT01420679|76262335|FG000|Overall Study|Investigator Decision|1|||
42385741|NCT01420679|76262336|FG001|Overall Study|Investigator Decision|2|||
42385742|NCT01420679|76262335|FG000|Overall Study|Sponsor Decision|3|||
42385743|NCT01420679|76262336|FG001|Overall Study|Sponsor Decision|3|||
42385744|NCT01420679|76262335|FG000|Overall Study|Other|1|||
42385745|NCT01420679|76262336|FG001|Overall Study|Other|0|||
42385746|NCT01496846|76262353|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
42385747|NCT01496846|76262354|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
42385748|NCT01496846|76262355|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
42385749|NCT01496846|76262356|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
42385750|NCT01496846|76262357|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
42385751|NCT01496846|76262358|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
42385752|NCT00964002|76262369|FG000|Overall Study|Protocol Violation|8|||
42385753|NCT01399697|76262381|FG000|Overall Study|Adverse Event|13|||
42385754|NCT01399697|76262382|FG001|Overall Study|Adverse Event|3|||
42385755|NCT01399697|76262383|FG002|Overall Study|Adverse Event|1|||
42385756|NCT01399697|76262381|FG000|Overall Study|Lost to Follow-up|2|||
42385757|NCT01399697|76262382|FG001|Overall Study|Lost to Follow-up|0|||
42385758|NCT01399697|76262383|FG002|Overall Study|Lost to Follow-up|0|||
42385759|NCT01399697|76262381|FG000|Overall Study|Withdrawal by Subject|8|||
42385760|NCT01399697|76262382|FG001|Overall Study|Withdrawal by Subject|0|||
42385761|NCT01399697|76262383|FG002|Overall Study|Withdrawal by Subject|0|||
42385762|NCT01399697|76262381|FG000|Overall Study|Investigator Decisión|1|||
42385763|NCT01399697|76262382|FG001|Overall Study|Investigator Decisión|0|||
42385764|NCT01399697|76262383|FG002|Overall Study|Investigator Decisión|2|||
42385765|NCT01399697|76262381|FG000|Overall Study|Lack of Efficacy|9|||
42385766|NCT01399697|76262382|FG001|Overall Study|Lack of Efficacy|0|||
42385767|NCT01399697|76262383|FG002|Overall Study|Lack of Efficacy|1|||
42385768|NCT01399697|76262381|FG000|Overall Study|Protocol Violation|2|||
42385769|NCT01399697|76262382|FG001|Overall Study|Protocol Violation|0|||
42385770|NCT01399697|76262383|FG002|Overall Study|Protocol Violation|0|||
42385771|NCT01399697|76262381|FG000|Overall Study|Non-Compliant|1|||
42385772|NCT01399697|76262382|FG001|Overall Study|Non-Compliant|0|||
42385773|NCT01399697|76262383|FG002|Overall Study|Non-Compliant|0|||
42385774|NCT01399697|76262381|FG000|Overall Study|Inclusion Error|2|||
42385775|NCT01399697|76262382|FG001|Overall Study|Inclusion Error|0|||
42385776|NCT01399697|76262383|FG002|Overall Study|Inclusion Error|0|||
42385777|NCT01399697|76262381|FG000|Overall Study|Positive result for hepatitis B|1|||
42385778|NCT01399697|76262382|FG001|Overall Study|Positive result for hepatitis B|0|||
42385779|NCT01399697|76262383|FG002|Overall Study|Positive result for hepatitis B|0|||
42385780|NCT01399697|76262381|FG000|Overall Study|Clinical RA remission|1|||
42385781|NCT01399697|76262382|FG001|Overall Study|Clinical RA remission|0|||
42385782|NCT01399697|76262383|FG002|Overall Study|Clinical RA remission|0|||
42385783|NCT01399697|76262381|FG000|Overall Study|Sponsor Decision|1|||
42385784|NCT01399697|76262382|FG001|Overall Study|Sponsor Decision|0|||
42385785|NCT01399697|76262383|FG002|Overall Study|Sponsor Decision|0|||
42385786|NCT01473602|76262417|FG000|Overall Study|Adverse Event|1|||
42385787|NCT01473602|76262418|FG001|Overall Study|Adverse Event|2|||
42385788|NCT01473602|76262417|FG000|Overall Study|Death|0|||
42385789|NCT01473602|76262418|FG001|Overall Study|Death|1|||
42385790|NCT01473602|76262417|FG000|Overall Study|Lost to Follow-up|1|||
42385791|NCT01473602|76262418|FG001|Overall Study|Lost to Follow-up|1|||
42385792|NCT01473602|76262417|FG000|Overall Study|Withdrawal by Subject|5|||
42385793|NCT01473602|76262418|FG001|Overall Study|Withdrawal by Subject|4|||
42385794|NCT01473602|76262417|FG000|Overall Study|Physician Decision|1|||
42385795|NCT01473602|76262418|FG001|Overall Study|Physician Decision|0|||
42385796|NCT01496612|76262426|FG000|1st Intervention|Adverse Event|1|||
42385797|NCT01496612|76262427|FG001|1st Intervention|Adverse Event|0|||
42385798|NCT01496612|76262426|FG000|1st Intervention|Withdrawal by Subject|1|||
42385799|NCT01496612|76262427|FG001|1st Intervention|Withdrawal by Subject|0|||
42385800|NCT00790218|76262444|FG000|Overall Study|Death|1|||
42385801|NCT00790218|76262445|FG001|Overall Study|Death|0|||
42385802|NCT00790218|76262446|FG002|Overall Study|Death|0|||
42385803|NCT01457924|76262472|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
42385804|NCT01457924|76262473|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
42385805|NCT01457924|76262474|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
42385806|NCT01457924|76262475|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
42385807|NCT01457924|76262476|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
42385808|NCT01457924|76262472|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
42385809|NCT01457924|76262473|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
42385810|NCT01457924|76262474|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
42385811|NCT01457924|76262475|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
42385812|NCT01457924|76262476|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
42385813|NCT01457924|76262472|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
42385814|NCT01457924|76262473|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
42385815|NCT01457924|76262474|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
42385816|NCT01457924|76262475|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
42385817|NCT01457924|76262476|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
42385818|NCT01457924|76262472|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
42385819|NCT01457924|76262473|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
42385820|NCT01457924|76262474|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
42385821|NCT01457924|76262475|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
42385822|NCT01457924|76262476|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
42385823|NCT01457924|76262472|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
42385824|NCT01457924|76262473|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
42385825|NCT01457924|76262474|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
42385826|NCT01457924|76262475|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
42385827|NCT01457924|76262476|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
42385828|NCT01457924|76262472|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
42385829|NCT01457924|76262473|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
42385830|NCT01457924|76262474|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
42385831|NCT01457924|76262475|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
42385832|NCT01457924|76262476|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
42385833|NCT01457924|76262472|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
42385834|NCT01457924|76262473|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
42385835|NCT01457924|76262474|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
42385836|NCT01457924|76262475|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
42385837|NCT01457924|76262476|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
42385838|NCT01457924|76262472|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
42385839|NCT01457924|76262473|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
42385840|NCT01457924|76262474|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
42385841|NCT01457924|76262475|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
42385842|NCT01457924|76262476|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
42385843|NCT01457924|76262472|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
42385844|NCT01457924|76262473|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
42385845|NCT01457924|76262474|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
42385846|NCT01457924|76262475|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
42385847|NCT01457924|76262476|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
42385848|NCT01457924|76262472|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
42385849|NCT01457924|76262473|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
42385850|NCT01457924|76262474|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
42385851|NCT01457924|76262475|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
42385852|NCT01457924|76262476|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
42385853|NCT01457924|76262472|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
42385854|NCT01457924|76262473|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
42385855|NCT01457924|76262474|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
42385856|NCT01457924|76262475|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
42385857|NCT01457924|76262476|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
42385858|NCT01457924|76262472|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
42385859|NCT01457924|76262473|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
42385860|NCT01457924|76262474|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
42385861|NCT01457924|76262475|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
42385862|NCT01457924|76262476|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
42385863|NCT01457924|76262472|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
42385864|NCT01457924|76262473|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
42385865|NCT01457924|76262474|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
42385866|NCT01457924|76262475|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
42385867|NCT01457924|76262476|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
42385868|NCT01399619|76262497|FG000|Overall Study|Adverse Event|10|||
42385869|NCT01399619|76262498|FG001|Overall Study|Adverse Event|0|||
42385870|NCT01399619|76262499|FG002|Overall Study|Adverse Event|4|||
42385871|NCT01399619|76262500|FG003|Overall Study|Adverse Event|10|||
42385872|NCT01399619|76262497|FG000|Overall Study|Lack of Efficacy|9|||
42385873|NCT01399619|76262498|FG001|Overall Study|Lack of Efficacy|0|||
42385874|NCT01399619|76262499|FG002|Overall Study|Lack of Efficacy|5|||
42385875|NCT01399619|76262500|FG003|Overall Study|Lack of Efficacy|0|||
42385876|NCT01399619|76262497|FG000|Overall Study|Withdrawal by Subject|6|||
42385877|NCT01399619|76262498|FG001|Overall Study|Withdrawal by Subject|0|||
42385878|NCT01399619|76262499|FG002|Overall Study|Withdrawal by Subject|3|||
42385879|NCT01399619|76262500|FG003|Overall Study|Withdrawal by Subject|4|||
42385880|NCT01399619|76262497|FG000|Overall Study|Protocol Violation|0|||
42385881|NCT01399619|76262498|FG001|Overall Study|Protocol Violation|0|||
42385882|NCT01399619|76262499|FG002|Overall Study|Protocol Violation|0|||
42385883|NCT01399619|76262500|FG003|Overall Study|Protocol Violation|1|||
42385884|NCT01399619|76262497|FG000|Overall Study|Not treated|0|||
42385885|NCT01399619|76262498|FG001|Overall Study|Not treated|0|||
42385886|NCT01399619|76262499|FG002|Overall Study|Not treated|0|||
42385887|NCT01399619|76262500|FG003|Overall Study|Not treated|2|||
42385888|NCT01496456|76262515|FG000|Overall Study|Protocol Violation|1|||
42385889|NCT01496456|76262515|FG000|Overall Study|Lost to Follow-up|7|||
42385890|NCT01673646|76262715|FG000|Overall Study|Adverse Event|2|||
42385891|NCT01673646|76262716|FG001|Overall Study|Adverse Event|1|||
42385892|NCT01673646|76262717|FG002|Overall Study|Adverse Event|1|||
42385893|NCT01673646|76262715|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42385894|NCT01673646|76262716|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42385895|NCT01673646|76262717|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
42385896|NCT01673646|76262715|FG000|Overall Study|Condition no longer requires study drug|0|||
42385897|NCT01673646|76262716|FG001|Overall Study|Condition no longer requires study drug|1|||
42385898|NCT01673646|76262717|FG002|Overall Study|Condition no longer requires study drug|0|||
42385899|NCT01673646|76262715|FG000|Overall Study|Withdrawal by Subject|0|||
42385900|NCT01673646|76262716|FG001|Overall Study|Withdrawal by Subject|2|||
42385901|NCT01673646|76262717|FG002|Overall Study|Withdrawal by Subject|2|||
42385902|NCT01673646|76262715|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
42385903|NCT01673646|76262716|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
42385904|NCT01673646|76262717|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
42385905|NCT02647944|76262757|FG000|Overall Study|Withdrawal by Subject|0|||
42385906|NCT02647944|76262758|FG001|Overall Study|Withdrawal by Subject|3|||
42385907|NCT02647944|76262757|FG000|Overall Study|Adverse Event|2|||
42385908|NCT02647944|76262758|FG001|Overall Study|Adverse Event|0|||
42385909|NCT01397825|76262813|FG000|Overall Study|Progressive Disease|10|||
42385910|NCT01397825|76262814|FG001|Overall Study|Progressive Disease|3|||
42385911|NCT01397825|76262815|FG002|Overall Study|Progressive Disease|11|||
42385912|NCT01397825|76262816|FG003|Overall Study|Progressive Disease|1|||
42385913|NCT01397825|76262817|FG004|Overall Study|Progressive Disease|0|||
42385914|NCT01397825|76262813|FG000|Overall Study|Symptomatic Deterioration|2|||
42385915|NCT01397825|76262814|FG001|Overall Study|Symptomatic Deterioration|0|||
42385916|NCT01397825|76262815|FG002|Overall Study|Symptomatic Deterioration|4|||
42385917|NCT01397825|76262816|FG003|Overall Study|Symptomatic Deterioration|0|||
42385918|NCT01397825|76262817|FG004|Overall Study|Symptomatic Deterioration|0|||
42385919|NCT01397825|76262813|FG000|Overall Study|Adverse Event|0|||
42385920|NCT01397825|76262814|FG001|Overall Study|Adverse Event|1|||
42385921|NCT01397825|76262815|FG002|Overall Study|Adverse Event|5|||
42385922|NCT01397825|76262816|FG003|Overall Study|Adverse Event|1|||
42385923|NCT01397825|76262817|FG004|Overall Study|Adverse Event|0|||
42385924|NCT01397825|76262813|FG000|Overall Study|Withdrawal by Subject|1|||
42385925|NCT01397825|76262814|FG001|Overall Study|Withdrawal by Subject|0|||
42385926|NCT01397825|76262815|FG002|Overall Study|Withdrawal by Subject|5|||
42385927|NCT01397825|76262816|FG003|Overall Study|Withdrawal by Subject|1|||
42385928|NCT01397825|76262817|FG004|Overall Study|Withdrawal by Subject|0|||
42385929|NCT01397747|76262840|FG000|Overall Study|Multitarget DNA test excluded|689|||
42385930|NCT01397747|76262840|FG000|Overall Study|Colonoscopy excluded|304|||
42385931|NCT01397747|76262840|FG000|Overall Study|FIT excluded|34|||
42385932|NCT01397201|76262878|FG000|Overall Study|Not treated|0|||
42385933|NCT01397201|76262879|FG001|Overall Study|Not treated|0|||
42385934|NCT01397201|76262880|FG002|Overall Study|Not treated|1|||
42385935|NCT01397201|76262881|FG003|Overall Study|Not treated|0|||
42385936|NCT01397201|76262882|FG004|Overall Study|Not treated|0|||
42385937|NCT01397201|76262878|FG000|Overall Study|Not yet defined|3|||
42385938|NCT01397201|76262879|FG001|Overall Study|Not yet defined|6|||
42385939|NCT01397201|76262880|FG002|Overall Study|Not yet defined|5|||
42385940|NCT01397201|76262881|FG003|Overall Study|Not yet defined|5|||
42385941|NCT01397201|76262882|FG004|Overall Study|Not yet defined|4|||
42385942|NCT01397201|76262878|FG000|Overall Study|Adverse Event|2|||
42385943|NCT01397201|76262879|FG001|Overall Study|Adverse Event|0|||
42385944|NCT01397201|76262880|FG002|Overall Study|Adverse Event|0|||
42385945|NCT01397201|76262881|FG003|Overall Study|Adverse Event|0|||
42385946|NCT01397201|76262882|FG004|Overall Study|Adverse Event|0|||
42385947|NCT01393613|76262916|FG000|Overall Study|Adverse Event|11|||
42385948|NCT01393613|76262917|FG001|Overall Study|Adverse Event|11|||
42385949|NCT01393613|76262918|FG002|Overall Study|Adverse Event|13|||
42385950|NCT01393613|76262919|FG003|Overall Study|Adverse Event|22|||
42385951|NCT01393613|76262916|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
42385952|NCT01393613|76262917|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
42385953|NCT01393613|76262918|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
42385954|NCT01393613|76262919|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
42385955|NCT01393613|76262916|FG000|Overall Study|Physician Decision|2|||
42385956|NCT01393613|76262917|FG001|Overall Study|Physician Decision|0|||
42385957|NCT01393613|76262918|FG002|Overall Study|Physician Decision|0|||
42385958|NCT01393613|76262919|FG003|Overall Study|Physician Decision|1|||
42385959|NCT01393613|76262916|FG000|Overall Study|Withdrawal by Subject|15|||
42385960|NCT01393613|76262917|FG001|Overall Study|Withdrawal by Subject|25|||
42385961|NCT01393613|76262918|FG002|Overall Study|Withdrawal by Subject|23|||
42385962|NCT01393613|76262919|FG003|Overall Study|Withdrawal by Subject|21|||
42385963|NCT01393613|76262916|FG000|Overall Study|Protocol Deviation|2|||
42385964|NCT01393613|76262917|FG001|Overall Study|Protocol Deviation|1|||
42385965|NCT01393613|76262918|FG002|Overall Study|Protocol Deviation|0|||
42385966|NCT01393613|76262919|FG003|Overall Study|Protocol Deviation|0|||
42385967|NCT01393613|76262916|FG000|Overall Study|Lack of Efficacy|9|||
42385968|NCT01393613|76262917|FG001|Overall Study|Lack of Efficacy|20|||
42385969|NCT01393613|76262918|FG002|Overall Study|Lack of Efficacy|16|||
42385970|NCT01393613|76262919|FG003|Overall Study|Lack of Efficacy|21|||
42385971|NCT01396421|76262969|FG000|Overall Study|Lost to Follow-up|0|||
42385972|NCT01396421|76262970|FG001|Overall Study|Lost to Follow-up|0|||
42385973|NCT01396421|76262971|FG002|Overall Study|Lost to Follow-up|0|||
42385974|NCT01396421|76262972|FG003|Overall Study|Lost to Follow-up|1|||
42385975|NCT01396421|76262969|FG000|Overall Study|Adverse Event|17|||
42385976|NCT01396421|76262970|FG001|Overall Study|Adverse Event|15|||
42385977|NCT01396421|76262971|FG002|Overall Study|Adverse Event|12|||
42385978|NCT01396421|76262972|FG003|Overall Study|Adverse Event|32|||
42385979|NCT01396421|76262969|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
42385980|NCT01396421|76262970|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
42385981|NCT01396421|76262971|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
42385982|NCT01396421|76262972|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
42385983|NCT01396421|76262969|FG000|Overall Study|Physician Decision|1|||
42385984|NCT01396421|76262970|FG001|Overall Study|Physician Decision|1|||
42385985|NCT01396421|76262971|FG002|Overall Study|Physician Decision|0|||
42019471|NCT02702180|75826899|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
42110279|NCT02513667|75920651|FG001|Overall Study|Withdrawal by Subject|1|||
42385986|NCT01396421|76262972|FG003|Overall Study|Physician Decision|3|||
42385987|NCT01396421|76262969|FG000|Overall Study|Withdrawal by Subject|31|||
42385988|NCT01396421|76262970|FG001|Overall Study|Withdrawal by Subject|24|||
42019472|NCT02702180|75826900|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
42385989|NCT01396421|76262971|FG002|Overall Study|Withdrawal by Subject|13|||
42385990|NCT01396421|76262972|FG003|Overall Study|Withdrawal by Subject|21|||
42385991|NCT01396421|76262969|FG000|Overall Study|Protocol Deviation|2|||
42385992|NCT01396421|76262970|FG001|Overall Study|Protocol Deviation|1|||
42385993|NCT01396421|76262971|FG002|Overall Study|Protocol Deviation|1|||
42385994|NCT01396421|76262972|FG003|Overall Study|Protocol Deviation|0|||
42385995|NCT01396421|76262969|FG000|Overall Study|Lack of Efficacy|7|||
42385996|NCT01396421|76262970|FG001|Overall Study|Lack of Efficacy|17|||
42385997|NCT01396421|76262971|FG002|Overall Study|Lack of Efficacy|7|||
42385998|NCT01396421|76262972|FG003|Overall Study|Lack of Efficacy|18|||
42385999|NCT01396265|76263030|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
42386000|NCT02647866|76263075|FG000|Overall Study|Adverse Event|0|||
42386001|NCT02647866|76263076|FG001|Overall Study|Adverse Event|0|||
42386002|NCT02647866|76263077|FG002|Overall Study|Adverse Event|2|||
42386003|NCT02647866|76263078|FG003|Overall Study|Adverse Event|2|||
42386004|NCT02647866|76263079|FG004|Overall Study|Adverse Event|1|||
42386005|NCT02647866|76263075|FG000|Overall Study|Disease Worsening|3|||
42386006|NCT02647866|76263076|FG001|Overall Study|Disease Worsening|1|||
42386007|NCT02647866|76263077|FG002|Overall Study|Disease Worsening|0|||
42386008|NCT02647866|76263078|FG003|Overall Study|Disease Worsening|0|||
42386009|NCT02647866|76263079|FG004|Overall Study|Disease Worsening|1|||
42386010|NCT02647866|76263075|FG000|Overall Study|Withdrawal by Subject|1|||
42386011|NCT02647866|76263076|FG001|Overall Study|Withdrawal by Subject|1|||
42386012|NCT02647866|76263077|FG002|Overall Study|Withdrawal by Subject|2|||
42386013|NCT02647866|76263078|FG003|Overall Study|Withdrawal by Subject|4|||
42386014|NCT02647866|76263079|FG004|Overall Study|Withdrawal by Subject|4|||
42386015|NCT02647866|76263075|FG000|Overall Study|Physician Decision|0|||
42386016|NCT02647866|76263076|FG001|Overall Study|Physician Decision|1|||
42386017|NCT02647866|76263077|FG002|Overall Study|Physician Decision|1|||
42386018|NCT02647866|76263078|FG003|Overall Study|Physician Decision|0|||
42386019|NCT02647866|76263079|FG004|Overall Study|Physician Decision|2|||
42386020|NCT02647866|76263075|FG000|Overall Study|Death|0|||
42386021|NCT02647866|76263076|FG001|Overall Study|Death|1|||
42386022|NCT02647866|76263077|FG002|Overall Study|Death|0|||
42386023|NCT02647866|76263078|FG003|Overall Study|Death|0|||
42386024|NCT02647866|76263079|FG004|Overall Study|Death|0|||
42386025|NCT02647866|76263075|FG000|Overall Study|Subject moved to different country|1|||
42386026|NCT02647866|76263076|FG001|Overall Study|Subject moved to different country|0|||
42386027|NCT02647866|76263077|FG002|Overall Study|Subject moved to different country|0|||
42386028|NCT02647866|76263078|FG003|Overall Study|Subject moved to different country|0|||
42386029|NCT02647866|76263079|FG004|Overall Study|Subject moved to different country|0|||
42386030|NCT01396187|76263139|FG000|Overall Study|Adverse Event|0|||
42386031|NCT01396187|76263140|FG001|Overall Study|Adverse Event|1|||
42386032|NCT01396187|76263141|FG002|Overall Study|Adverse Event|0|||
42386033|NCT01396187|76263142|FG003|Overall Study|Adverse Event|0|||
42386034|NCT01396187|76263143|FG004|Overall Study|Adverse Event|0|||
42386035|NCT01396187|76263139|FG000|Overall Study|Withdrawal by Subject|0|||
42386036|NCT01396187|76263140|FG001|Overall Study|Withdrawal by Subject|1|||
42386037|NCT01396187|76263141|FG002|Overall Study|Withdrawal by Subject|1|||
42386038|NCT01396187|76263142|FG003|Overall Study|Withdrawal by Subject|0|||
42386039|NCT01396187|76263143|FG004|Overall Study|Withdrawal by Subject|0|||
42386040|NCT01396187|76263139|FG000|Overall Study|Other|1|||
42386041|NCT01396187|76263140|FG001|Overall Study|Other|1|||
42386042|NCT01396187|76263141|FG002|Overall Study|Other|0|||
42386043|NCT01396187|76263142|FG003|Overall Study|Other|0|||
42386044|NCT01396187|76263143|FG004|Overall Study|Other|1|||
42386045|NCT01392677|76263190|FG000|Overall Study|Adverse Event|3|||
42386046|NCT01392677|76263191|FG001|Overall Study|Adverse Event|1|||
42386047|NCT01392677|76263190|FG000|Overall Study|Withdrawal by Subject|0|||
42386048|NCT01392677|76263191|FG001|Overall Study|Withdrawal by Subject|2|||
42386049|NCT01392677|76263190|FG000|Overall Study|Incorrect enrollment|2|||
42386050|NCT01392677|76263191|FG001|Overall Study|Incorrect enrollment|3|||
42386051|NCT01392677|76263190|FG000|Overall Study|Other reason|3|||
42386052|NCT01392677|76263191|FG001|Overall Study|Other reason|2|||
42386053|NCT01392443|76263240|FG000|Overall Study|Disease progression|30|||
42386054|NCT01392443|76263240|FG000|Overall Study|Adverse Event|24|||
42386055|NCT01392443|76263240|FG000|Overall Study|Death|7|||
42386056|NCT01392443|76263240|FG000|Overall Study|Withdrawal by Subject|5|||
42386057|NCT01392443|76263240|FG000|Overall Study|Lost to Follow-up|1|||
42386058|NCT01392443|76263240|FG000|Overall Study|Protocol Violation|1|||
42386059|NCT01391819|76263244|FG000|Overall Study|Withdrawal by Subject|56|||
42386060|NCT01391819|76263244|FG000|Overall Study|Migrated/moved from study area|82|||
42386061|NCT01391819|76263244|FG000|Overall Study|Lost to Follow-up|252|||
42386062|NCT01391819|76263244|FG000|Overall Study|Death|3|||
42386063|NCT01391819|76263244|FG000|Overall Study|Other|9|||
42386064|NCT03845023|76263255|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
42386065|NCT03845023|76263256|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
42386066|NCT03845023|76263257|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
42386067|NCT03845023|76263258|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
42386068|NCT03845023|76263255|FG000|Follow-Up (14 Days)|Adverse Event|0|||
42386069|NCT03845023|76263256|FG001|Follow-Up (14 Days)|Adverse Event|0|||
42386070|NCT03845023|76263257|FG002|Follow-Up (14 Days)|Adverse Event|1|||
42386071|NCT03845023|76263258|FG003|Follow-Up (14 Days)|Adverse Event|1|||
42386072|NCT01395017|76263320|FG000|Overall Study|Lost to Follow-up|1|||
42386073|NCT01395017|76263321|FG001|Overall Study|Lost to Follow-up|0|||
42386074|NCT01395017|76263320|FG000|Overall Study|Adverse Event|26|||
42386075|NCT01395017|76263321|FG001|Overall Study|Adverse Event|12|||
42386076|NCT01395017|76263320|FG000|Overall Study|Physician Decision|11|||
42386077|NCT01395017|76263321|FG001|Overall Study|Physician Decision|15|||
42386078|NCT01395017|76263320|FG000|Overall Study|Withdrawal by Subject|14|||
42386079|NCT01395017|76263321|FG001|Overall Study|Withdrawal by Subject|8|||
42386080|NCT01395017|76263320|FG000|Overall Study|Protocol deviation|1|||
42386081|NCT01395017|76263321|FG001|Overall Study|Protocol deviation|2|||
42386082|NCT01395017|76263320|FG000|Overall Study|Death|4|||
42386083|NCT01395017|76263321|FG001|Overall Study|Death|3|||
42386084|NCT01395017|76263320|FG000|Overall Study|Disease progression|42|||
42386085|NCT01395017|76263321|FG001|Overall Study|Disease progression|58|||
42386086|NCT01395017|76263320|FG000|Overall Study|Sponsor discontinued study|1|||
42386087|NCT01395017|76263321|FG001|Overall Study|Sponsor discontinued study|4|||
42386088|NCT02647320|76263350|FG000|Overall Study|Adverse Event|0|||
42386089|NCT02647320|76263351|FG001|Overall Study|Adverse Event|1|||
42386090|NCT02647320|76263352|FG002|Overall Study|Adverse Event|3|||
42386091|NCT02647320|76263353|FG003|Overall Study|Adverse Event|2|||
42386092|NCT02647320|76263354|FG004|Overall Study|Adverse Event|1|||
42386093|NCT02647320|76263350|FG000|Overall Study|Protocol Violation|0|||
42386094|NCT02647320|76263351|FG001|Overall Study|Protocol Violation|0|||
42386095|NCT02647320|76263352|FG002|Overall Study|Protocol Violation|3|||
42386096|NCT02647320|76263353|FG003|Overall Study|Protocol Violation|0|||
42386097|NCT02647320|76263354|FG004|Overall Study|Protocol Violation|0|||
42386098|NCT02647320|76263350|FG000|Overall Study|Withdrawal by Subject|7|||
42386099|NCT02647320|76263351|FG001|Overall Study|Withdrawal by Subject|4|||
42386100|NCT02647320|76263352|FG002|Overall Study|Withdrawal by Subject|2|||
42386101|NCT02647320|76263353|FG003|Overall Study|Withdrawal by Subject|2|||
42386102|NCT02647320|76263354|FG004|Overall Study|Withdrawal by Subject|7|||
42386103|NCT02647320|76263350|FG000|Overall Study|Persistent hyperglycemia|0|||
42386104|NCT02647320|76263351|FG001|Overall Study|Persistent hyperglycemia|1|||
42386105|NCT02647320|76263352|FG002|Overall Study|Persistent hyperglycemia|1|||
42386106|NCT02647320|76263353|FG003|Overall Study|Persistent hyperglycemia|1|||
42386107|NCT02647320|76263354|FG004|Overall Study|Persistent hyperglycemia|1|||
42386108|NCT02647320|76263350|FG000|Overall Study|Study terminated by sponsor|1|||
42386109|NCT02647320|76263351|FG001|Overall Study|Study terminated by sponsor|1|||
42386110|NCT02647320|76263352|FG002|Overall Study|Study terminated by sponsor|1|||
42386111|NCT02647320|76263353|FG003|Overall Study|Study terminated by sponsor|1|||
42386112|NCT02647320|76263354|FG004|Overall Study|Study terminated by sponsor|2|||
42386113|NCT02647320|76263350|FG000|Overall Study|Reason not provided|0|||
42386114|NCT02647320|76263351|FG001|Overall Study|Reason not provided|0|||
42386115|NCT02647320|76263352|FG002|Overall Study|Reason not provided|1|||
42386116|NCT02647320|76263353|FG003|Overall Study|Reason not provided|0|||
42386117|NCT02647320|76263354|FG004|Overall Study|Reason not provided|2|||
42386118|NCT02647320|76263350|FG000|Overall Study|Lost to Follow-up|1|||
42386119|NCT02647320|76263351|FG001|Overall Study|Lost to Follow-up|1|||
42386120|NCT02647320|76263352|FG002|Overall Study|Lost to Follow-up|0|||
42386121|NCT02647320|76263353|FG003|Overall Study|Lost to Follow-up|0|||
42386122|NCT02647320|76263354|FG004|Overall Study|Lost to Follow-up|0|||
42386123|NCT02647320|76263350|FG000|Overall Study|Develop anemia|1|||
42386124|NCT02647320|76263351|FG001|Overall Study|Develop anemia|0|||
42386125|NCT02647320|76263352|FG002|Overall Study|Develop anemia|0|||
42386126|NCT02647320|76263353|FG003|Overall Study|Develop anemia|0|||
42386127|NCT02647320|76263354|FG004|Overall Study|Develop anemia|0|||
42386128|NCT02647320|76263350|FG000|Overall Study|Lack of Efficacy|0|||
42386129|NCT02647320|76263351|FG001|Overall Study|Lack of Efficacy|0|||
42386130|NCT02647320|76263352|FG002|Overall Study|Lack of Efficacy|0|||
42386131|NCT02647320|76263353|FG003|Overall Study|Lack of Efficacy|1|||
42386132|NCT02647320|76263354|FG004|Overall Study|Lack of Efficacy|0|||
42386133|NCT02647320|76263350|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
42386134|NCT02647320|76263351|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
42386135|NCT02647320|76263352|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
42386136|NCT02647320|76263353|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
42386137|NCT02647320|76263354|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
42386138|NCT03458325|76263377|FG000|Overall Study|Withdrawal by Subject|1|||
42386139|NCT02644122|76263412|FG000|Overall Study|Withdrawal by Subject|1|||
42386140|NCT01394939|76263438|FG000|Overall Study|Adverse Event|1|||
42386141|NCT01394939|76263439|FG001|Overall Study|Adverse Event|3|||
42386142|NCT01394939|76263440|FG002|Overall Study|Adverse Event|0|||
42386143|NCT01394939|76263441|FG003|Overall Study|Adverse Event|2|||
42386144|NCT01394939|76263438|FG000|Overall Study|Death|0|||
42386145|NCT01394939|76263439|FG001|Overall Study|Death|2|||
42386146|NCT01394939|76263440|FG002|Overall Study|Death|0|||
42386147|NCT01394939|76263441|FG003|Overall Study|Death|0|||
42386148|NCT01394939|76263438|FG000|Overall Study|Physician Decision|0|||
42386149|NCT01394939|76263439|FG001|Overall Study|Physician Decision|1|||
42386150|NCT01394939|76263440|FG002|Overall Study|Physician Decision|0|||
42386151|NCT01394939|76263441|FG003|Overall Study|Physician Decision|0|||
42386152|NCT01394939|76263438|FG000|Overall Study|Withdrawal by Subject|0|||
42386153|NCT01394939|76263439|FG001|Overall Study|Withdrawal by Subject|2|||
42386154|NCT01394939|76263440|FG002|Overall Study|Withdrawal by Subject|0|||
42386155|NCT01394939|76263441|FG003|Overall Study|Withdrawal by Subject|2|||
42386156|NCT01394939|76263438|FG000|Overall Study|Others|0|||
42386157|NCT01394939|76263439|FG001|Overall Study|Others|2|||
42386158|NCT01394939|76263440|FG002|Overall Study|Others|0|||
42386159|NCT01394939|76263441|FG003|Overall Study|Others|3|||
42386160|NCT01394627|76263459|FG000|First Intervention (1 Day)|poor intravenous access|0|||
42386161|NCT01394627|76263460|FG001|First Intervention (1 Day)|poor intravenous access|1|||
42386162|NCT01394627|76263459|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
42386163|NCT01394627|76263460|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
42386164|NCT01391663|76263479|FG000|Overall Study|Withdrawal by Subject|0|||
42386165|NCT01391663|76263480|FG001|Overall Study|Withdrawal by Subject|0|||
42386166|NCT01391663|76263481|FG002|Overall Study|Withdrawal by Subject|1|||
42386167|NCT01391663|76263482|FG003|Overall Study|Withdrawal by Subject|0|||
42386168|NCT02641392|76263503|FG000|Overall Study|Lost to Follow-up|0|||
42386169|NCT02641392|76263504|FG001|Overall Study|Lost to Follow-up|0|||
42386170|NCT02641392|76263505|FG002|Overall Study|Lost to Follow-up|2|||
42386171|NCT02641392|76263503|FG000|Overall Study|Withdrawal by Subject|0|||
42386172|NCT02641392|76263504|FG001|Overall Study|Withdrawal by Subject|0|||
42386173|NCT02641392|76263505|FG002|Overall Study|Withdrawal by Subject|17|||
42386174|NCT02641392|76263503|FG000|Overall Study|Adverse Event|0|||
42386175|NCT02641392|76263504|FG001|Overall Study|Adverse Event|1|||
42386176|NCT02641392|76263505|FG002|Overall Study|Adverse Event|25|||
42386177|NCT02641392|76263503|FG000|Overall Study|Study Terminated by Sponsor|4|||
42386178|NCT02641392|76263504|FG001|Overall Study|Study Terminated by Sponsor|12|||
42386179|NCT02641392|76263505|FG002|Overall Study|Study Terminated by Sponsor|144|||
42386180|NCT02641392|76263503|FG000|Overall Study|Lack of Efficacy|0|||
42386181|NCT02641392|76263504|FG001|Overall Study|Lack of Efficacy|0|||
42386182|NCT02641392|76263505|FG002|Overall Study|Lack of Efficacy|101|||
42386183|NCT02641392|76263503|FG000|Overall Study|Miscellaneous|0|||
42386184|NCT02641392|76263504|FG001|Overall Study|Miscellaneous|0|||
42386185|NCT02641392|76263505|FG002|Overall Study|Miscellaneous|3|||
42386186|NCT02641392|76263503|FG000|Overall Study|Death|0|||
42386187|NCT02641392|76263504|FG001|Overall Study|Death|0|||
42386188|NCT02641392|76263505|FG002|Overall Study|Death|1|||
42386189|NCT04440007|76263515|FG000|Overall Study|Adverse Event|0|||
42386190|NCT04440007|76263516|FG001|Overall Study|Adverse Event|1|||
42386191|NCT04440007|76263515|FG000|Overall Study|Lost to Follow-up|1|||
42386192|NCT04440007|76263516|FG001|Overall Study|Lost to Follow-up|3|||
42386193|NCT04440007|76263515|FG000|Overall Study|Death|7|||
42386194|NCT04440007|76263516|FG001|Overall Study|Death|2|||
42386195|NCT04440007|76263515|FG000|Overall Study|Physician Decision|1|||
42386196|NCT04440007|76263516|FG001|Overall Study|Physician Decision|1|||
42386197|NCT04440007|76263515|FG000|Overall Study|Withdrawal by Subject|2|||
42386198|NCT04440007|76263516|FG001|Overall Study|Withdrawal by Subject|1|||
42386199|NCT04440007|76263515|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
42386200|NCT04440007|76263516|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
42386201|NCT04440007|76263515|FG000|Overall Study|Discontinued prior to dosing|0|||
42386202|NCT04440007|76263516|FG001|Overall Study|Discontinued prior to dosing|2|||
42386203|NCT01391507|76263526|FG000|Overall Study|Death|0|||
42386204|NCT01391507|76263527|FG001|Overall Study|Death|0|||
42386205|NCT01391507|76263528|FG002|Overall Study|Death|0|||
42386206|NCT01391507|76263529|FG003|Overall Study|Death|1|||
42386207|NCT01391507|76263526|FG000|Overall Study|Adverse Event|1|||
42386208|NCT01391507|76263527|FG001|Overall Study|Adverse Event|1|||
42386209|NCT01391507|76263528|FG002|Overall Study|Adverse Event|2|||
42386210|NCT01391507|76263529|FG003|Overall Study|Adverse Event|2|||
42386211|NCT01391507|76263526|FG000|Overall Study|Withdrawal by Subject|1|||
42386212|NCT01391507|76263527|FG001|Overall Study|Withdrawal by Subject|2|||
42386213|NCT01391507|76263528|FG002|Overall Study|Withdrawal by Subject|1|||
42386214|NCT01391507|76263529|FG003|Overall Study|Withdrawal by Subject|1|||
42386215|NCT01391507|76263526|FG000|Overall Study|Lack of Efficacy|0|||
42386216|NCT01391507|76263527|FG001|Overall Study|Lack of Efficacy|0|||
42386217|NCT01391507|76263528|FG002|Overall Study|Lack of Efficacy|0|||
42386218|NCT01391507|76263529|FG003|Overall Study|Lack of Efficacy|1|||
42386219|NCT01391507|76263526|FG000|Overall Study|Protocol Violation|2|||
42386220|NCT01391507|76263527|FG001|Overall Study|Protocol Violation|1|||
42386221|NCT01391507|76263528|FG002|Overall Study|Protocol Violation|1|||
42386222|NCT01391507|76263529|FG003|Overall Study|Protocol Violation|2|||
42386223|NCT01473524|76263551|FG000|DB Phase|Adverse Event|4|||
42386224|NCT01473524|76263552|FG001|DB Phase|Adverse Event|8|||
42386225|NCT01473524|76263553|FG002|DB Phase|Adverse Event|2|||
42386226|NCT01473524|76263554|FG003|DB Phase|Adverse Event|0|||
42386227|NCT01473524|76263555|FG004|DB Phase|Adverse Event|0|||
42386228|NCT01473524|76263556|FG005|DB Phase|Adverse Event|0|||
42386229|NCT01473524|76263551|FG000|DB Phase|Death|1|||
42386230|NCT01473524|76263552|FG001|DB Phase|Death|0|||
42386231|NCT01473524|76263553|FG002|DB Phase|Death|0|||
42386232|NCT01473524|76263554|FG003|DB Phase|Death|0|||
42386233|NCT01473524|76263555|FG004|DB Phase|Death|0|||
42386234|NCT01473524|76263556|FG005|DB Phase|Death|0|||
42386235|NCT01473524|76263551|FG000|DB Phase|Withdrawal by Subject|2|||
42386236|NCT01473524|76263552|FG001|DB Phase|Withdrawal by Subject|1|||
42386237|NCT01473524|76263553|FG002|DB Phase|Withdrawal by Subject|1|||
42386238|NCT01473524|76263554|FG003|DB Phase|Withdrawal by Subject|0|||
42386239|NCT01473524|76263555|FG004|DB Phase|Withdrawal by Subject|0|||
42386240|NCT01473524|76263556|FG005|DB Phase|Withdrawal by Subject|0|||
42386241|NCT01473524|76263551|FG000|LTSE Phase|Withdrawal by Subject|0|||
42386242|NCT01473524|76263552|FG001|LTSE Phase|Withdrawal by Subject|0|||
42386243|NCT01473524|76263553|FG002|LTSE Phase|Withdrawal by Subject|0|||
42386244|NCT01473524|76263554|FG003|LTSE Phase|Withdrawal by Subject|3|||
42386245|NCT01473524|76263555|FG004|LTSE Phase|Withdrawal by Subject|3|||
42386246|NCT01473524|76263556|FG005|LTSE Phase|Withdrawal by Subject|6|||
42386247|NCT01473524|76263551|FG000|LTSE Phase|Death|0|||
42386248|NCT01473524|76263552|FG001|LTSE Phase|Death|0|||
42386249|NCT01473524|76263553|FG002|LTSE Phase|Death|0|||
42386250|NCT01473524|76263554|FG003|LTSE Phase|Death|0|||
42386251|NCT01473524|76263555|FG004|LTSE Phase|Death|1|||
42386252|NCT01473524|76263556|FG005|LTSE Phase|Death|0|||
42386253|NCT01473524|76263551|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
42386254|NCT01473524|76263552|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
42386255|NCT01473524|76263553|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
42386256|NCT01473524|76263554|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
42386257|NCT01473524|76263555|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
42386258|NCT01473524|76263556|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
42386259|NCT01473524|76263551|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
42386260|NCT01473524|76263552|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
42386261|NCT01473524|76263553|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
42386262|NCT01473524|76263554|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
42386263|NCT01473524|76263555|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
42386264|NCT01473524|76263556|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
42386265|NCT01473524|76263551|FG000|LTSE Phase|Lost to Follow-up|0|||
42386266|NCT01473524|76263552|FG001|LTSE Phase|Lost to Follow-up|0|||
42386267|NCT01473524|76263553|FG002|LTSE Phase|Lost to Follow-up|0|||
42386268|NCT01473524|76263554|FG003|LTSE Phase|Lost to Follow-up|1|||
42386269|NCT01473524|76263555|FG004|LTSE Phase|Lost to Follow-up|3|||
42386270|NCT01473524|76263556|FG005|LTSE Phase|Lost to Follow-up|2|||
42386271|NCT01473524|76263551|FG000|LTSE Phase|Principal Investigator Decision|0|||
42386272|NCT01473524|76263552|FG001|LTSE Phase|Principal Investigator Decision|0|||
42386273|NCT01473524|76263553|FG002|LTSE Phase|Principal Investigator Decision|0|||
42386274|NCT01473524|76263554|FG003|LTSE Phase|Principal Investigator Decision|1|||
42386275|NCT01473524|76263555|FG004|LTSE Phase|Principal Investigator Decision|1|||
42386276|NCT01473524|76263556|FG005|LTSE Phase|Principal Investigator Decision|3|||
42386277|NCT01473524|76263551|FG000|LTSE Phase|Liver Transplantation|0|||
42386278|NCT01473524|76263552|FG001|LTSE Phase|Liver Transplantation|0|||
42386279|NCT01473524|76263553|FG002|LTSE Phase|Liver Transplantation|0|||
42386280|NCT01473524|76263554|FG003|LTSE Phase|Liver Transplantation|0|||
42386281|NCT01473524|76263555|FG004|LTSE Phase|Liver Transplantation|0|||
42386282|NCT01473524|76263556|FG005|LTSE Phase|Liver Transplantation|1|||
42386283|NCT01473524|76263551|FG000|LTSE Phase|Pregnancy|0|||
42386284|NCT01473524|76263552|FG001|LTSE Phase|Pregnancy|0|||
42386285|NCT01473524|76263553|FG002|LTSE Phase|Pregnancy|0|||
42386286|NCT01473524|76263554|FG003|LTSE Phase|Pregnancy|1|||
42386287|NCT01473524|76263555|FG004|LTSE Phase|Pregnancy|0|||
42386288|NCT01473524|76263556|FG005|LTSE Phase|Pregnancy|0|||
42386289|NCT01473524|76263551|FG000|LTSE Phase|Protocol Violation|0|||
42019473|NCT02702180|75826898|FG000|Open-label Treatment Period|Withdrawn in error|0|||
42019474|NCT02702180|75826899|FG001|Open-label Treatment Period|Withdrawn in error|0|||
42019475|NCT02702180|75826900|FG002|Open-label Treatment Period|Withdrawn in error|1|||
42386290|NCT01473524|76263552|FG001|LTSE Phase|Protocol Violation|0|||
42386291|NCT01473524|76263553|FG002|LTSE Phase|Protocol Violation|0|||
42386292|NCT01473524|76263554|FG003|LTSE Phase|Protocol Violation|0|||
42386293|NCT01473524|76263555|FG004|LTSE Phase|Protocol Violation|0|||
42386294|NCT01473524|76263556|FG005|LTSE Phase|Protocol Violation|1|||
42386295|NCT01390649|76263587|FG000|Overall Study|Physician Decision|1|||
42386296|NCT01390181|76263591|FG000|Overall Study|Lost to Follow-up|1|||
42386297|NCT01390181|76263591|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
42386298|NCT02641080|76263597|FG000|Overall Study|Physician Decision|2|||
42386299|NCT02641080|76263598|FG001|Overall Study|Physician Decision|0|||
42386300|NCT02641080|76263597|FG000|Overall Study|Withdrawal by Subject|0|||
42386301|NCT02641080|76263598|FG001|Overall Study|Withdrawal by Subject|1|||
42386302|NCT02641080|76263597|FG000|Overall Study|Rehab Center denied use of pumps|0|||
42386303|NCT02641080|76263598|FG001|Overall Study|Rehab Center denied use of pumps|3|||
42386304|NCT02641080|76263597|FG000|Overall Study|Lost to Follow-up|0|||
42386305|NCT02641080|76263598|FG001|Overall Study|Lost to Follow-up|3|||
42386306|NCT01457846|76263606|FG000|Overall Study|Death before treatment|1|||
42386307|NCT01457846|76263607|FG001|Overall Study|Death before treatment|2|||
42386308|NCT01457846|76263606|FG000|Overall Study|Did not receive treatment|0|||
42386309|NCT01457846|76263607|FG001|Overall Study|Did not receive treatment|1|||
42386310|NCT01457846|76263606|FG000|Overall Study|Death|27|||
42386311|NCT01457846|76263607|FG001|Overall Study|Death|16|||
42386312|NCT01457846|76263606|FG000|Overall Study|Unclassified reason for not completed|11|||
42386313|NCT01457846|76263607|FG001|Overall Study|Unclassified reason for not completed|10|||
42386314|NCT01457846|76263606|FG000|Overall Study|Withdrawal by Subject|1|||
42386315|NCT01457846|76263607|FG001|Overall Study|Withdrawal by Subject|1|||
42386316|NCT01457846|76263606|FG000|Overall Study|Lost to Follow-up|1|||
42386317|NCT01457846|76263607|FG001|Overall Study|Lost to Follow-up|0|||
42386318|NCT01496066|76263619|FG000|Overall Study|Lost to Follow-up|8|||
42386319|NCT01496066|76263620|FG001|Overall Study|Lost to Follow-up|5|||
42386320|NCT01496066|76263619|FG000|Overall Study|Explant|3|||
42386321|NCT01496066|76263620|FG001|Overall Study|Explant|0|||
42386322|NCT01496066|76263619|FG000|Overall Study|Death|1|||
42386323|NCT01496066|76263620|FG001|Overall Study|Death|4|||
42386324|NCT01389323|76263633|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
42386325|NCT01389323|76263633|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
42386326|NCT01389323|76263633|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
42386327|NCT01389323|76263633|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
42386328|NCT01389323|76263633|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
42386329|NCT01389323|76263633|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
42386330|NCT01389323|76263633|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
42386331|NCT01389323|76263633|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
42386332|NCT01389323|76263633|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
42386333|NCT01389323|76263633|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
42386334|NCT01389323|76263633|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
42386335|NCT01389245|76263644|FG000|Overall Study|Protocol Violation|10|||
42386336|NCT01389245|76263644|FG000|Overall Study|Lost to Follow-up|3|||
42386337|NCT01389245|76263644|FG000|Overall Study|Withdrawal by Subject|2|||
42386338|NCT01494818|76263650|FG000|Overall Study|Relocation|1|||
42386339|NCT01494818|76263651|FG001|Overall Study|Relocation|2|||
42386340|NCT01494818|76263650|FG000|Overall Study|Lost to Follow-up|1|||
42386341|NCT01494818|76263651|FG001|Overall Study|Lost to Follow-up|0|||
42386342|NCT01494584|76263657|FG000|Overall Study|Study Closed/Terminated|1|||
42386343|NCT01388543|76263682|FG000|Day 14|Adverse Event|1|||
42386344|NCT01388543|76263683|FG001|Day 14|Adverse Event|4|||
42386345|NCT00512317|76263702|FG000|Overall Study|Insufficient clinical response|36|||
42386346|NCT00512317|76263702|FG000|Overall Study|Withdrawal by Subject|23|||
42386347|NCT00512317|76263702|FG000|Overall Study|Sponsor closure of study|21|||
42386348|NCT00512317|76263702|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
42386349|NCT00512317|76263702|FG000|Overall Study|Adverse Event|13|||
42386350|NCT00512317|76263702|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
42386351|NCT00512317|76263702|FG000|Overall Study|Lost to Follow-up|2|||
42386352|NCT00512317|76263702|FG000|Overall Study|Other|2|||
42386353|NCT01494506|76263718|FG000|Overall Study|Lack of Efficacy|77|||
42386354|NCT01494506|76263719|FG001|Overall Study|Lack of Efficacy|83|||
42386355|NCT01494506|76263720|FG002|Overall Study|Lack of Efficacy|57|||
42386356|NCT01494506|76263718|FG000|Overall Study|Adverse Event|17|||
42386357|NCT01494506|76263719|FG001|Overall Study|Adverse Event|10|||
42386358|NCT01494506|76263720|FG002|Overall Study|Adverse Event|11|||
42386359|NCT01494506|76263718|FG000|Overall Study|Death|9|||
42386360|NCT01494506|76263719|FG001|Overall Study|Death|5|||
42386361|NCT01494506|76263720|FG002|Overall Study|Death|2|||
42386362|NCT01494506|76263718|FG000|Overall Study|Physician Decision|7|||
42386363|NCT01494506|76263719|FG001|Overall Study|Physician Decision|5|||
42386364|NCT01494506|76263720|FG002|Overall Study|Physician Decision|4|||
42386365|NCT01494506|76263718|FG000|Overall Study|Withdrawal by Subject|17|||
42386366|NCT01494506|76263719|FG001|Overall Study|Withdrawal by Subject|20|||
42386367|NCT01494506|76263720|FG002|Overall Study|Withdrawal by Subject|14|||
42386368|NCT01494506|76263718|FG000|Overall Study|Clinical Deterioration|21|||
42386369|NCT01494506|76263719|FG001|Overall Study|Clinical Deterioration|17|||
42386370|NCT01494506|76263720|FG002|Overall Study|Clinical Deterioration|13|||
42386371|NCT01494506|76263718|FG000|Overall Study|Sponsor Decision|0|||
42204110|NCT02951988|76016782|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
42386372|NCT01494506|76263719|FG001|Overall Study|Sponsor Decision|0|||
42386373|NCT01494506|76263720|FG002|Overall Study|Sponsor Decision|1|||
42386374|NCT01494506|76263718|FG000|Overall Study|Other|0|||
42386375|NCT01494506|76263719|FG001|Overall Study|Other|3|||
42386376|NCT01494506|76263720|FG002|Overall Study|Other|1|||
42386377|NCT02643420|76263732|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
42386378|NCT02643420|76263733|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
42386379|NCT02643420|76263732|FG000|Overall Study|Withdrawal by Subject|25|||
42386380|NCT02643420|76263733|FG001|Overall Study|Withdrawal by Subject|19|||
42386381|NCT02643420|76263732|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
42386382|NCT02643420|76263733|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
42386383|NCT02643420|76263732|FG000|Overall Study|Lost to Follow-up|6|||
42386384|NCT02643420|76263733|FG001|Overall Study|Lost to Follow-up|10|||
42386385|NCT02643420|76263732|FG000|Overall Study|Investigator Decision|2|||
42386386|NCT02643420|76263733|FG001|Overall Study|Investigator Decision|4|||
42386387|NCT02643420|76263732|FG000|Overall Study|Sponsor decision|1|||
42386388|NCT02643420|76263733|FG001|Overall Study|Sponsor decision|1|||
42386389|NCT02643420|76263732|FG000|Overall Study|Death|0|||
42386390|NCT02643420|76263733|FG001|Overall Study|Death|2|||
42386391|NCT02643420|76263732|FG000|Overall Study|Reason not Specified|8|||
42386392|NCT02643420|76263733|FG001|Overall Study|Reason not Specified|7|||
42386393|NCT01456130|76263756|FG000|Overall Study|Adverse Event|4|||
42386394|NCT01456130|76263756|FG000|Overall Study|Voluntary Withdrawal|1|||
42386395|NCT01456130|76263756|FG000|Overall Study|Lack of Efficacy|4|||
42386396|NCT01456130|76263756|FG000|Overall Study|Other|1|||
42386397|NCT01456052|76263763|FG000|Overall Study|Adverse Event|1|||
42386398|NCT01456052|76263764|FG001|Overall Study|Adverse Event|1|||
42386399|NCT01456052|76263765|FG002|Overall Study|Adverse Event|2|||
42386400|NCT01456052|76263763|FG000|Overall Study|Consent withdrawn|0|||
42386401|NCT01456052|76263764|FG001|Overall Study|Consent withdrawn|2|||
42386402|NCT01456052|76263765|FG002|Overall Study|Consent withdrawn|1|||
42386403|NCT01456052|76263763|FG000|Overall Study|Protocol Violation|0|||
42386404|NCT01456052|76263764|FG001|Overall Study|Protocol Violation|1|||
42386405|NCT01456052|76263765|FG002|Overall Study|Protocol Violation|0|||
42386406|NCT01456052|76263763|FG000|Overall Study|Physician Decision|1|||
42386407|NCT01456052|76263764|FG001|Overall Study|Physician Decision|0|||
42386408|NCT01456052|76263765|FG002|Overall Study|Physician Decision|1|||
42386409|NCT01456052|76263763|FG000|Overall Study|Treatment Failure|0|||
42386410|NCT01456052|76263764|FG001|Overall Study|Treatment Failure|1|||
42386411|NCT01456052|76263765|FG002|Overall Study|Treatment Failure|1|||
42386412|NCT01387607|76263776|FG000|Overall Study|Adverse Event|23|||
42386413|NCT01387607|76263777|FG001|Overall Study|Adverse Event|11|||
42110280|NCT03823911|75920660|FG000|Overall Study|Lost to Follow-up|1|||
42110281|NCT03823911|75920661|FG001|Overall Study|Lost to Follow-up|5|||
42110282|NCT03823911|75920662|FG002|Overall Study|Lost to Follow-up|2|||
42110283|NCT03823911|75920660|FG000|Overall Study|Did not meet eligibility criteria|13|||
42110284|NCT03823911|75920661|FG001|Overall Study|Did not meet eligibility criteria|7|||
42110285|NCT03823911|75920662|FG002|Overall Study|Did not meet eligibility criteria|4|||
42110286|NCT03823911|75920660|FG000|Overall Study|Death|0|||
42110287|NCT03823911|75920661|FG001|Overall Study|Death|1|||
42110288|NCT03823911|75920662|FG002|Overall Study|Death|0|||
42110289|NCT00621764|75920673|FG000|Overall Study|Protocol Violation|0|||
42110290|NCT00621764|75920674|FG001|Overall Study|Protocol Violation|0|||
42110291|NCT00621764|75920675|FG002|Overall Study|Protocol Violation|0|||
42110292|NCT00621764|75920676|FG003|Overall Study|Protocol Violation|1|||
42386414|NCT01387607|76263776|FG000|Overall Study|Lack of Efficacy|8|||
42110293|NCT00510718|75920694|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
42110294|NCT00510718|75920695|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
42110295|NCT00510718|75920694|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
42110296|NCT00510718|75920695|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
42110297|NCT00510718|75920694|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
42110298|NCT00510718|75920695|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
42110299|NCT00510718|75920694|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
42110300|NCT00510718|75920695|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
42110301|NCT00510718|75920694|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
42110302|NCT00510718|75920695|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
42386415|NCT01387607|76263777|FG001|Overall Study|Lack of Efficacy|6|||
42386416|NCT01387607|76263776|FG000|Overall Study|Lost to Follow-up|2|||
42386417|NCT01387607|76263777|FG001|Overall Study|Lost to Follow-up|1|||
42386418|NCT01387607|76263776|FG000|Overall Study|No longer meets eligibility criteria|0|||
42386419|NCT01387607|76263777|FG001|Overall Study|No longer meets eligibility criteria|1|||
42386420|NCT01387607|76263776|FG000|Overall Study|Protocol Violation|1|||
42386421|NCT01387607|76263777|FG001|Overall Study|Protocol Violation|5|||
42019476|NCT00980980|75826912|FG000|Overall Study|Withdrawal by Hospital|0|||
42019477|NCT00980980|75826913|FG001|Overall Study|Withdrawal by Hospital|1|||
42019478|NCT00980980|75826914|FG002|Overall Study|Withdrawal by Hospital|0|||
42019479|NCT00980200|75826925|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
42019480|NCT00980200|75826926|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
42019481|NCT00980200|75826927|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
42019482|NCT00980200|75826928|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
42019483|NCT00980200|75826929|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
42019484|NCT00980200|75826925|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
42110303|NCT00510718|75920694|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
42110304|NCT00510718|75920695|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
42110305|NCT00537381|75920716|FG000|Overall Study|Adverse Event|13|||
42110306|NCT00537381|75920717|FG001|Overall Study|Adverse Event|9|||
42110307|NCT00537381|75920716|FG000|Overall Study|Death|3|||
42110308|NCT00537381|75920717|FG001|Overall Study|Death|3|||
42110309|NCT00537381|75920716|FG000|Overall Study|Withdrawal by Subject|5|||
42110310|NCT00537381|75920717|FG001|Overall Study|Withdrawal by Subject|14|||
42110311|NCT00537381|75920716|FG000|Overall Study|Physician Decision|7|||
42110312|NCT00537381|75920717|FG001|Overall Study|Physician Decision|6|||
42110313|NCT00537381|75920716|FG000|Overall Study|Disease Progression|9|||
42110314|NCT00537381|75920717|FG001|Overall Study|Disease Progression|18|||
42110315|NCT00537381|75920716|FG000|Overall Study|Sponsor decision|14|||
42110316|NCT00537381|75920717|FG001|Overall Study|Sponsor decision|9|||
42110317|NCT00537381|75920716|FG000|Overall Study|Other|5|||
42110318|NCT00537381|75920717|FG001|Overall Study|Other|3|||
42110319|NCT03791398|75920728|FG000|Overall Study|Progression of Disease Under Study|2|||
42110320|NCT03791398|75920729|FG001|Overall Study|Progression of Disease Under Study|0|||
42110321|NCT03791398|75920730|FG002|Overall Study|Progression of Disease Under Study|0|||
42110322|NCT00517192|75920736|FG000|Overall Study|Adverse Event|1|||
42110323|NCT00517192|75920737|FG001|Overall Study|Adverse Event|1|||
42110324|NCT00517192|75920736|FG000|Overall Study|Lost to Follow-up|1|||
42110325|NCT00517192|75920737|FG001|Overall Study|Lost to Follow-up|1|||
42110326|NCT00517192|75920736|FG000|Overall Study|Withdrawal by Subject|1|||
42110327|NCT00517192|75920737|FG001|Overall Study|Withdrawal by Subject|0|||
42110328|NCT00517192|75920736|FG000|Overall Study|Early termination of the trial|16|||
42110329|NCT00517192|75920737|FG001|Overall Study|Early termination of the trial|18|||
42110330|NCT00625820|75920743|FG000|Overall Study|Withdrawal by Subject|1|||
42110331|NCT00145327|75920751|FG000|Overall Study|Withdrawal by Subject|77|||
42110332|NCT00145327|75920752|FG001|Overall Study|Withdrawal by Subject|72|||
42110333|NCT00145327|75920753|FG002|Overall Study|Withdrawal by Subject|164|||
42110334|NCT00145327|75920751|FG000|Overall Study|Death|26|||
42110335|NCT00145327|75920752|FG001|Overall Study|Death|18|||
42386422|NCT01387607|76263776|FG000|Overall Study|Withdrawal by Subject|13|||
42386423|NCT01387607|76263777|FG001|Overall Study|Withdrawal by Subject|14|||
42386424|NCT01387607|76263776|FG000|Overall Study|Other|1|||
42386425|NCT01387607|76263777|FG001|Overall Study|Other|1|||
42386426|NCT01387607|76263776|FG000|Overall Study|Randomized, not treated|3|||
42386427|NCT01387607|76263777|FG001|Overall Study|Randomized, not treated|6|||
42386428|NCT03451045|76263786|FG000|Overall Study|Lack of Efficacy|3|||
42386429|NCT03451045|76263787|FG001|Overall Study|Lack of Efficacy|2|||
42386430|NCT03451045|76263788|FG002|Overall Study|Lack of Efficacy|2|||
42386431|NCT03451045|76263786|FG000|Overall Study|Physician Decision|1|||
42386432|NCT03451045|76263787|FG001|Overall Study|Physician Decision|1|||
42386433|NCT03451045|76263788|FG002|Overall Study|Physician Decision|1|||
42386434|NCT03451045|76263786|FG000|Overall Study|Withdrawal by Subject|4|||
42386435|NCT03451045|76263787|FG001|Overall Study|Withdrawal by Subject|0|||
42386436|NCT03451045|76263788|FG002|Overall Study|Withdrawal by Subject|5|||
42386437|NCT03451045|76263786|FG000|Overall Study|Pregnancy|0|||
42386438|NCT03451045|76263787|FG001|Overall Study|Pregnancy|0|||
42386439|NCT03451045|76263788|FG002|Overall Study|Pregnancy|2|||
42386440|NCT03451045|76263786|FG000|Overall Study|Adverse Event|7|||
42386441|NCT03451045|76263787|FG001|Overall Study|Adverse Event|1|||
42386442|NCT03451045|76263788|FG002|Overall Study|Adverse Event|3|||
42386443|NCT03451045|76263786|FG000|Overall Study|Non-compliance with study|2|||
42386444|NCT03451045|76263787|FG001|Overall Study|Non-compliance with study|0|||
42019485|NCT00980200|75826926|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
42019486|NCT00980200|75826927|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
42019487|NCT00980200|75826928|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
42019488|NCT00980200|75826929|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
42019489|NCT00979654|75826941|FG000|Overall Study|Lost to Follow-up|1|||
42019490|NCT00979654|75826941|FG000|Overall Study|Withdrawal by Subject|22|||
42019491|NCT00979654|75826941|FG000|Overall Study|Death|1|||
42019492|NCT00979654|75826941|FG000|Overall Study|Lack of Efficacy|6|||
42019493|NCT00979654|75826941|FG000|Overall Study|Adverse Event|1|||
42019494|NCT00979654|75826941|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
42019495|NCT00979654|75826941|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
42019496|NCT00979654|75826941|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
42019497|NCT00979654|75826941|FG000|Overall Study|Serious Adverse Event|1|||
42110336|NCT00145327|75920753|FG002|Overall Study|Death|30|||
42110337|NCT00145327|75920751|FG000|Overall Study|Adverse Event|14|||
42110338|NCT00145327|75920752|FG001|Overall Study|Adverse Event|11|||
42110339|NCT00145327|75920753|FG002|Overall Study|Adverse Event|22|||
42110340|NCT00145327|75920751|FG000|Overall Study|Lost to Follow-up|9|||
42110341|NCT00145327|75920752|FG001|Overall Study|Lost to Follow-up|14|||
42110342|NCT00145327|75920753|FG002|Overall Study|Lost to Follow-up|14|||
42204111|NCT02951988|76016783|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
42386445|NCT03451045|76263788|FG002|Overall Study|Non-compliance with study|1|||
42386446|NCT03451045|76263786|FG000|Overall Study|any other reason|10|||
42386447|NCT03451045|76263787|FG001|Overall Study|any other reason|2|||
42386448|NCT03451045|76263788|FG002|Overall Study|any other reason|13|||
42386449|NCT03219567|76263799|FG000|Overall Study|Withdrawal by Subject|0|||
42386450|NCT03219567|76263800|FG001|Overall Study|Withdrawal by Subject|1|||
42386451|NCT01386125|76263809|FG000|Overall Study|Lost to Follow-up|3|||
42386452|NCT01386125|76263810|FG001|Overall Study|Lost to Follow-up|9|||
42386453|NCT01386125|76263809|FG000|Overall Study|Physician Decision|0|||
42386454|NCT01386125|76263810|FG001|Overall Study|Physician Decision|1|||
42386455|NCT01386125|76263809|FG000|Overall Study|Protocol Violation|5|||
42386456|NCT01386125|76263810|FG001|Overall Study|Protocol Violation|7|||
42386457|NCT01386125|76263809|FG000|Overall Study|Disease Progress|1|||
42386458|NCT01386125|76263810|FG001|Overall Study|Disease Progress|2|||
42386459|NCT01386125|76263809|FG000|Overall Study|Withdrawal by Subject|13|||
42386460|NCT01386125|76263810|FG001|Overall Study|Withdrawal by Subject|12|||
42386461|NCT01386125|76263809|FG000|Overall Study|Adverse Event|2|||
42386462|NCT01386125|76263810|FG001|Overall Study|Adverse Event|5|||
42386463|NCT01386125|76263809|FG000|Overall Study|Lack of Efficacy|0|||
42386464|NCT01386125|76263810|FG001|Overall Study|Lack of Efficacy|1|||
42386465|NCT01386125|76263809|FG000|Overall Study|Participant Leaving Country|1|||
42386466|NCT01386125|76263810|FG001|Overall Study|Participant Leaving Country|0|||
42386467|NCT01384877|76263818|FG000|Treatment 2|Lost to Follow-up|2|||
42386468|NCT01384877|76263819|FG001|Treatment 2|Lost to Follow-up|2|||
42386469|NCT00114517|76263829|FG000|Overall Study|Adverse Event|6|||
42386470|NCT00114517|76263830|FG001|Overall Study|Adverse Event|1|||
42386471|NCT00114517|76263831|FG002|Overall Study|Adverse Event|6|||
42386472|NCT00114517|76263832|FG003|Overall Study|Adverse Event|3|||
42386473|NCT00114517|76263829|FG000|Overall Study|Lost to Follow-up|2|||
42386474|NCT00114517|76263830|FG001|Overall Study|Lost to Follow-up|2|||
42386475|NCT00114517|76263831|FG002|Overall Study|Lost to Follow-up|2|||
42386476|NCT00114517|76263832|FG003|Overall Study|Lost to Follow-up|1|||
42386477|NCT00114517|76263829|FG000|Overall Study|Too busy|3|||
42386478|NCT00114517|76263830|FG001|Overall Study|Too busy|1|||
42386479|NCT00114517|76263831|FG002|Overall Study|Too busy|1|||
42386480|NCT00114517|76263832|FG003|Overall Study|Too busy|2|||
42386481|NCT00114517|76263829|FG000|Overall Study|Moved from area|0|||
42386482|NCT00114517|76263830|FG001|Overall Study|Moved from area|3|||
42386483|NCT00114517|76263831|FG002|Overall Study|Moved from area|2|||
42386484|NCT00114517|76263832|FG003|Overall Study|Moved from area|1|||
42386485|NCT00114517|76263829|FG000|Overall Study|Did not want estradiol|1|||
42386486|NCT00114517|76263830|FG001|Overall Study|Did not want estradiol|1|||
42386487|NCT00114517|76263831|FG002|Overall Study|Did not want estradiol|0|||
42386488|NCT00114517|76263832|FG003|Overall Study|Did not want estradiol|0|||
42386489|NCT00114517|76263829|FG000|Overall Study|Armed-services duty|0|||
42386490|NCT00114517|76263830|FG001|Overall Study|Armed-services duty|1|||
42386491|NCT00114517|76263831|FG002|Overall Study|Armed-services duty|0|||
42386492|NCT00114517|76263832|FG003|Overall Study|Armed-services duty|1|||
42386493|NCT00114517|76263829|FG000|Overall Study|Competing family issue|0|||
42386494|NCT00114517|76263830|FG001|Overall Study|Competing family issue|1|||
42386495|NCT00114517|76263831|FG002|Overall Study|Competing family issue|0|||
42386496|NCT00114517|76263832|FG003|Overall Study|Competing family issue|1|||
42386497|NCT00114517|76263829|FG000|Overall Study|Physician Decision|0|||
42386498|NCT00114517|76263830|FG001|Overall Study|Physician Decision|1|||
42386499|NCT00114517|76263831|FG002|Overall Study|Physician Decision|0|||
42386500|NCT00114517|76263832|FG003|Overall Study|Physician Decision|0|||
42386501|NCT00114517|76263829|FG000|Overall Study|Lost interest|0|||
42386502|NCT00114517|76263830|FG001|Overall Study|Lost interest|0|||
42386503|NCT00114517|76263831|FG002|Overall Study|Lost interest|1|||
42386504|NCT00114517|76263832|FG003|Overall Study|Lost interest|0|||
42386505|NCT00114517|76263829|FG000|Overall Study|Weight increase|0|||
42386506|NCT00114517|76263830|FG001|Overall Study|Weight increase|0|||
42386507|NCT00114517|76263831|FG002|Overall Study|Weight increase|1|||
42386508|NCT00114517|76263832|FG003|Overall Study|Weight increase|0|||
42386509|NCT00114517|76263829|FG000|Overall Study|Concern about blood clots|0|||
42386510|NCT00114517|76263830|FG001|Overall Study|Concern about blood clots|0|||
42386511|NCT00114517|76263831|FG002|Overall Study|Concern about blood clots|1|||
42386512|NCT00114517|76263832|FG003|Overall Study|Concern about blood clots|0|||
42019498|NCT00979654|75826941|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
42386513|NCT00114517|76263829|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
42386514|NCT00114517|76263830|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
42386515|NCT00114517|76263831|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
42386516|NCT00114517|76263832|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
42386517|NCT01384019|76263885|FG000|Overall Study|Withdrawal by Subject|3|||
42386518|NCT01384019|76263886|FG001|Overall Study|Withdrawal by Subject|0|||
42386519|NCT01384019|76263885|FG000|Overall Study|Death|1|||
42386520|NCT01384019|76263886|FG001|Overall Study|Death|0|||
42386521|NCT01384019|76263885|FG000|Overall Study|MRI refusal|6|||
42386522|NCT01384019|76263886|FG001|Overall Study|MRI refusal|6|||
42386523|NCT00033631|76263894|FG000|Overall Study|Protocol Violation|14|||
42386524|NCT00033631|76263895|FG001|Overall Study|Protocol Violation|11|||
42386525|NCT00033631|76263894|FG000|Overall Study|Withdrawal by Subject|4|||
42386526|NCT00033631|76263895|FG001|Overall Study|Withdrawal by Subject|4|||
42386527|NCT01471574|76263906|FG000|Treatment Period|Lack of Efficacy|12|||
42386528|NCT01471574|76263907|FG001|Treatment Period|Lack of Efficacy|4|||
42386529|NCT01471574|76263908|FG002|Treatment Period|Lack of Efficacy|14|||
42386530|NCT01471574|76263909|FG003|Treatment Period|Lack of Efficacy|1|||
42386531|NCT01471574|76263906|FG000|Treatment Period|Adverse Event|7|||
42386532|NCT01471574|76263907|FG001|Treatment Period|Adverse Event|3|||
42386533|NCT01471574|76263908|FG002|Treatment Period|Adverse Event|6|||
42386534|NCT01471574|76263909|FG003|Treatment Period|Adverse Event|1|||
42386535|NCT01471574|76263906|FG000|Treatment Period|Withdrawal by Subject|5|||
42386536|NCT01471574|76263907|FG001|Treatment Period|Withdrawal by Subject|1|||
42386537|NCT01471574|76263908|FG002|Treatment Period|Withdrawal by Subject|1|||
42386538|NCT01471574|76263909|FG003|Treatment Period|Withdrawal by Subject|0|||
42386539|NCT01471574|76263906|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
42386540|NCT01471574|76263907|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
42386541|NCT01471574|76263908|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
42386542|NCT01471574|76263909|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
42386543|NCT01471574|76263906|FG000|Treatment Period|Lost to Follow-up|1|||
42386544|NCT01471574|76263907|FG001|Treatment Period|Lost to Follow-up|2|||
42386545|NCT01471574|76263908|FG002|Treatment Period|Lost to Follow-up|2|||
42386546|NCT01471574|76263909|FG003|Treatment Period|Lost to Follow-up|0|||
42386547|NCT01471574|76263906|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
42386548|NCT01471574|76263907|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
42386549|NCT01471574|76263908|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
42386550|NCT01471574|76263909|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
42386551|NCT01471574|76263906|FG000|Treatment Period|Other|1|||
42386552|NCT01471574|76263907|FG001|Treatment Period|Other|0|||
42386553|NCT01471574|76263908|FG002|Treatment Period|Other|0|||
42386554|NCT01471574|76263909|FG003|Treatment Period|Other|0|||
42386555|NCT01471574|76263906|FG000|Follow-up Period|Withdrawal by Subject|3|||
42386556|NCT01471574|76263907|FG001|Follow-up Period|Withdrawal by Subject|0|||
42386557|NCT01471574|76263908|FG002|Follow-up Period|Withdrawal by Subject|3|||
42386558|NCT01471574|76263909|FG003|Follow-up Period|Withdrawal by Subject|1|||
42386559|NCT01471574|76263906|FG000|Follow-up Period|Lost to Follow-up|4|||
42386560|NCT01471574|76263907|FG001|Follow-up Period|Lost to Follow-up|1|||
42386561|NCT01471574|76263908|FG002|Follow-up Period|Lost to Follow-up|3|||
42386562|NCT01471574|76263909|FG003|Follow-up Period|Lost to Follow-up|2|||
42386563|NCT01471574|76263906|FG000|Follow-up Period|Death|0|||
42386564|NCT01471574|76263907|FG001|Follow-up Period|Death|0|||
42386565|NCT01471574|76263908|FG002|Follow-up Period|Death|1|||
42386566|NCT01471574|76263909|FG003|Follow-up Period|Death|0|||
42386567|NCT01471574|76263906|FG000|Follow-up Period|Follow-up no longer required|0|||
42386568|NCT01471574|76263907|FG001|Follow-up Period|Follow-up no longer required|1|||
42386569|NCT01471574|76263908|FG002|Follow-up Period|Follow-up no longer required|0|||
42386570|NCT01471574|76263909|FG003|Follow-up Period|Follow-up no longer required|0|||
42386571|NCT01383707|76263925|FG000|Overall Study|Consent withdrawal|6|||
42386572|NCT01383707|76263925|FG000|Overall Study|Death|19|||
42386573|NCT01383707|76263925|FG000|Overall Study|Other|8|||
42386574|NCT01383707|76263925|FG000|Overall Study|Sponsor's decision|2|||
42386575|NCT01383707|76263925|FG000|Overall Study|Adverse Event|14|||
42386576|NCT01383707|76263925|FG000|Overall Study|Progressive disease|23|||
42386577|NCT01383317|76263931|FG000|Overall Study|Lost to Follow-up|2|||
42386578|NCT01383317|76263932|FG001|Overall Study|Lost to Follow-up|1|||
42386579|NCT01383317|76263931|FG000|Overall Study|Death|1|||
42386580|NCT01383317|76263932|FG001|Overall Study|Death|0|||
42386581|NCT01383317|76263931|FG000|Overall Study|Adverse Event|0|||
42386582|NCT01383317|76263932|FG001|Overall Study|Adverse Event|1|||
42386583|NCT01455428|76263940|FG000|Overall Study|Protocol Violation|2|||
42019499|NCT00978562|75826945|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
42019500|NCT02865460|75826953|FG000|Overall Study|Adverse Event|1|||
42110343|NCT00145327|75920751|FG000|Overall Study|Administrative problems|12|||
42110344|NCT00145327|75920752|FG001|Overall Study|Administrative problems|9|||
42110345|NCT00145327|75920753|FG002|Overall Study|Administrative problems|13|||
42019501|NCT02865460|75826954|FG001|Overall Study|Adverse Event|0|||
42019502|NCT02865460|75826953|FG000|Overall Study|Withdrawal by Subject|1|||
42019503|NCT02865460|75826954|FG001|Overall Study|Withdrawal by Subject|1|||
42019504|NCT02865460|75826953|FG000|Overall Study|Lost to Follow-up|7|||
42386584|NCT01455428|76263941|FG001|Overall Study|Protocol Violation|1|||
42386585|NCT01455428|76263940|FG000|Overall Study|Adverse Event|6|||
42386586|NCT01455428|76263941|FG001|Overall Study|Adverse Event|2|||
42386587|NCT01455428|76263940|FG000|Overall Study|Lost to Follow-up|1|||
42386588|NCT01455428|76263941|FG001|Overall Study|Lost to Follow-up|1|||
42386589|NCT01455428|76263940|FG000|Overall Study|Withdrawal by Subject|2|||
42386590|NCT01455428|76263941|FG001|Overall Study|Withdrawal by Subject|5|||
42110346|NCT00145327|75920751|FG000|Overall Study|Protocol Violation|2|||
42386591|NCT01455428|76263940|FG000|Overall Study|Did not meet entrance criteria|0|||
42386592|NCT01455428|76263941|FG001|Overall Study|Did not meet entrance criteria|2|||
42386593|NCT01455428|76263940|FG000|Overall Study|Insufficient clinical response|0|||
42386594|NCT01455428|76263941|FG001|Overall Study|Insufficient clinical response|2|||
42386595|NCT01455428|76263940|FG000|Overall Study|Did not receive treatment|1|||
42386596|NCT01455428|76263941|FG001|Overall Study|Did not receive treatment|1|||
42386597|NCT01455428|76263940|FG000|Overall Study|Other|2|||
42386598|NCT01455428|76263941|FG001|Overall Study|Other|4|||
42386599|NCT01383161|76263949|FG000|Overall Study|Adverse Event|5|||
42386600|NCT01383161|76263950|FG001|Overall Study|Adverse Event|1|||
42386601|NCT01383161|76263949|FG000|Overall Study|Withdrawal by Subject|0|||
42386602|NCT01383161|76263950|FG001|Overall Study|Withdrawal by Subject|2|||
42386603|NCT01383161|76263949|FG000|Overall Study|Lack of Efficacy|0|||
42386604|NCT01383161|76263950|FG001|Overall Study|Lack of Efficacy|1|||
42386605|NCT01382225|76263976|FG000|Overall Study|Adverse Event|3|||
42386606|NCT01382225|76263977|FG001|Overall Study|Adverse Event|2|||
42386607|NCT01382225|76263976|FG000|Overall Study|Protocol Violation|2|||
42386608|NCT01382225|76263977|FG001|Overall Study|Protocol Violation|1|||
42386609|NCT01382225|76263976|FG000|Overall Study|Subject Withdrew Consent|5|||
42386610|NCT01382225|76263977|FG001|Overall Study|Subject Withdrew Consent|2|||
42386611|NCT01382225|76263976|FG000|Overall Study|Other|4|||
42386612|NCT01382225|76263977|FG001|Overall Study|Other|2|||
42386613|NCT01381679|76263983|FG000|Overall Study|Adverse Event|3|||
42386614|NCT01381679|76263983|FG000|Overall Study|Lost to Follow-up|885|||
42386615|NCT01455194|76263990|FG000|Overall Study|Screen Failure|20|||
42386616|NCT01455194|76263991|FG001|Overall Study|Screen Failure|0|||
42386617|NCT01455194|76263992|FG002|Overall Study|Screen Failure|0|||
42386618|NCT01455194|76263993|FG003|Overall Study|Screen Failure|0|||
42386619|NCT01455194|76263990|FG000|Overall Study|Randomisation Failure|90|||
42386620|NCT01455194|76263991|FG001|Overall Study|Randomisation Failure|0|||
42386621|NCT01455194|76263992|FG002|Overall Study|Randomisation Failure|0|||
42386622|NCT01455194|76263993|FG003|Overall Study|Randomisation Failure|0|||
42386623|NCT01455194|76263990|FG000|Overall Study|Deterioration in asthma|12|||
42386624|NCT01455194|76263991|FG001|Overall Study|Deterioration in asthma|6|||
42386625|NCT01455194|76263992|FG002|Overall Study|Deterioration in asthma|14|||
42386626|NCT01455194|76263993|FG003|Overall Study|Deterioration in asthma|9|||
42386627|NCT01455194|76263990|FG000|Overall Study|Adverse Event|1|||
42386628|NCT01455194|76263991|FG001|Overall Study|Adverse Event|1|||
42386629|NCT01455194|76263992|FG002|Overall Study|Adverse Event|1|||
42386630|NCT01455194|76263993|FG003|Overall Study|Adverse Event|3|||
42386631|NCT01455194|76263990|FG000|Overall Study|Withdrawal by Subject|21|||
42386632|NCT01455194|76263991|FG001|Overall Study|Withdrawal by Subject|16|||
42386633|NCT01455194|76263992|FG002|Overall Study|Withdrawal by Subject|12|||
42386634|NCT01455194|76263993|FG003|Overall Study|Withdrawal by Subject|9|||
42386635|NCT01455194|76263990|FG000|Overall Study|Lost to Follow-up|2|||
42386636|NCT01455194|76263991|FG001|Overall Study|Lost to Follow-up|0|||
42386637|NCT01455194|76263992|FG002|Overall Study|Lost to Follow-up|1|||
42386638|NCT01455194|76263993|FG003|Overall Study|Lost to Follow-up|1|||
42386639|NCT01455194|76263990|FG000|Overall Study|Pregnancy|0|||
42386640|NCT01455194|76263991|FG001|Overall Study|Pregnancy|1|||
42386641|NCT01455194|76263992|FG002|Overall Study|Pregnancy|1|||
42386642|NCT01455194|76263993|FG003|Overall Study|Pregnancy|0|||
42386643|NCT01455194|76263990|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
42386644|NCT01455194|76263991|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
42386645|NCT01455194|76263992|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
42386646|NCT01455194|76263993|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
42386647|NCT01455194|76263990|FG000|Overall Study|Miscellaneous|4|||
42386648|NCT01455194|76263991|FG001|Overall Study|Miscellaneous|5|||
42386649|NCT01455194|76263992|FG002|Overall Study|Miscellaneous|1|||
42386650|NCT01455194|76263993|FG003|Overall Study|Miscellaneous|4|||
42386651|NCT01454726|76264017|FG000|Overall Study|Withdrawal by Subject|0|||
42386652|NCT01454726|76264018|FG001|Overall Study|Withdrawal by Subject|1|||
42386653|NCT01361568|76264030|FG000|Overall Study|Adverse Event|0|||
42386654|NCT01361568|76264031|FG001|Overall Study|Adverse Event|0|||
42386655|NCT01361568|76264032|FG002|Overall Study|Adverse Event|0|||
42386656|NCT01361568|76264033|FG003|Overall Study|Adverse Event|0|||
42386657|NCT01361568|76264034|FG004|Overall Study|Adverse Event|1|||
42386658|NCT01361568|76264035|FG005|Overall Study|Adverse Event|0|||
42386659|NCT01361568|76264030|FG000|Overall Study|Physician Decision|0|||
42386660|NCT01361568|76264031|FG001|Overall Study|Physician Decision|0|||
42386661|NCT01361568|76264032|FG002|Overall Study|Physician Decision|0|||
42386662|NCT01361568|76264033|FG003|Overall Study|Physician Decision|0|||
42386663|NCT01361568|76264034|FG004|Overall Study|Physician Decision|0|||
42386664|NCT01361568|76264035|FG005|Overall Study|Physician Decision|1|||
42110347|NCT00145327|75920752|FG001|Overall Study|Protocol Violation|0|||
42204112|NCT02951988|76016780|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
42386665|NCT01361568|76264030|FG000|Overall Study|Withdrawal by Subject|2|||
42386666|NCT01361568|76264031|FG001|Overall Study|Withdrawal by Subject|1|||
42386667|NCT01361568|76264032|FG002|Overall Study|Withdrawal by Subject|0|||
42386668|NCT01361568|76264033|FG003|Overall Study|Withdrawal by Subject|0|||
42386669|NCT01361568|76264034|FG004|Overall Study|Withdrawal by Subject|0|||
42386670|NCT01361568|76264035|FG005|Overall Study|Withdrawal by Subject|1|||
42386671|NCT03084367|76264050|FG000|Overall Study|Lost to Follow-up|32|||
42386672|NCT03084367|76264050|FG000|Overall Study|Withdrawal by Subject|4|||
42386673|NCT03084367|76264050|FG000|Overall Study|Other|1|||
42386674|NCT01454570|76264063|FG000|Overall Study|Withdrawal by Subject|2|||
42386675|NCT01454570|76264063|FG000|Overall Study|Screen Failure|7|||
42386676|NCT01494350|76264076|FG000|Overall Study|Worsening of lesion|1|||
42386677|NCT03281629|76264086|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
42386678|NCT03281629|76264087|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
42386679|NCT03281629|76264086|FG000|Overall Study|Death|0|||
42386680|NCT03281629|76264087|FG001|Overall Study|Death|1|||
42386681|NCT03281629|76264086|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
42386682|NCT03281629|76264087|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
42386683|NCT00218543|76264093|FG000|Overall Study|Lost to Follow-up|8|||
42386684|NCT00218543|76264093|FG000|Overall Study|relocated|1|||
42386685|NCT00218543|76264093|FG000|Overall Study|Withdrawal by Subject|1|||
42386686|NCT00218543|76264093|FG000|Overall Study|Physician Decision|3|||
42386687|NCT00218543|76264093|FG000|Overall Study|Adverse Event|2|||
42386688|NCT00216671|76264108|FG000|Overall Study|Adverse Event|4|||
42386689|NCT00216671|76264109|FG001|Overall Study|Adverse Event|9|||
42386690|NCT00216671|76264108|FG000|Overall Study|Pregnancy|0|||
42386691|NCT00216671|76264109|FG001|Overall Study|Pregnancy|1|||
42386692|NCT00216671|76264108|FG000|Overall Study|Withdrawal by Subject|4|||
42386693|NCT00216671|76264109|FG001|Overall Study|Withdrawal by Subject|2|||
42386694|NCT00216671|76264108|FG000|Overall Study|Refused Injections|3|||
42386695|NCT00216671|76264109|FG001|Overall Study|Refused Injections|13|||
42386696|NCT00216671|76264108|FG000|Overall Study|No Need to Continue Medication|1|||
42386697|NCT00216671|76264109|FG001|Overall Study|No Need to Continue Medication|1|||
42386698|NCT00216671|76264108|FG000|Overall Study|Insufficient Response|9|||
42386699|NCT00216671|76264109|FG001|Overall Study|Insufficient Response|4|||
42386700|NCT00216671|76264108|FG000|Overall Study|Lost to Follow-up|3|||
42386701|NCT00216671|76264109|FG001|Overall Study|Lost to Follow-up|5|||
42386702|NCT00216671|76264108|FG000|Overall Study|Non compliant|2|||
42386703|NCT00216671|76264109|FG001|Overall Study|Non compliant|2|||
42386704|NCT00216671|76264108|FG000|Overall Study|Ineligible|0|||
42386705|NCT00216671|76264109|FG001|Overall Study|Ineligible|2|||
42386706|NCT00216671|76264108|FG000|Overall Study|Physician Decision|1|||
42386707|NCT00216671|76264109|FG001|Overall Study|Physician Decision|1|||
42386708|NCT00216671|76264108|FG000|Overall Study|Protocol Violation|3|||
42386709|NCT00216671|76264109|FG001|Overall Study|Protocol Violation|5|||
42386710|NCT00216671|76264108|FG000|Overall Study|Relapse|1|||
42386711|NCT00216671|76264109|FG001|Overall Study|Relapse|0|||
42386712|NCT00216671|76264108|FG000|Overall Study|Investigator Illness|0|||
42386713|NCT00216671|76264109|FG001|Overall Study|Investigator Illness|1|||
42386714|NCT00216671|76264108|FG000|Overall Study|Patient Moved|0|||
42386715|NCT00216671|76264109|FG001|Overall Study|Patient Moved|1|||
42386716|NCT00216671|76264108|FG000|Overall Study|Ineligible, no efficacy data|2|||
42386717|NCT00216671|76264109|FG001|Overall Study|Ineligible, no efficacy data|2|||
42386718|NCT00216671|76264108|FG000|Overall Study|Insufficient Response Adverse Event|2|||
42386719|NCT00216671|76264109|FG001|Overall Study|Insufficient Response Adverse Event|1|||
42386720|NCT00216203|76264115|FG000|Overall Study|Withdrawal by Subject|2|||
42386721|NCT02644668|76264150|FG000|Overall Study|Adverse Event|2|||
42386722|NCT02644668|76264151|FG001|Overall Study|Adverse Event|0|||
42386723|NCT02644668|76264152|FG002|Overall Study|Adverse Event|1|||
42386724|NCT02644668|76264150|FG000|Overall Study|Protocol Violation|0|||
42386725|NCT02644668|76264151|FG001|Overall Study|Protocol Violation|0|||
42386726|NCT02644668|76264152|FG002|Overall Study|Protocol Violation|1|||
42386727|NCT02644668|76264150|FG000|Overall Study|Withdrawal by Subject|0|||
42386728|NCT02644668|76264151|FG001|Overall Study|Withdrawal by Subject|0|||
42386729|NCT02644668|76264152|FG002|Overall Study|Withdrawal by Subject|1|||
42386730|NCT02644356|76264171|FG000|Overall Study|Withdrawal by Subject|2|||
42386731|NCT01494038|76264212|FG000|Overall Study|Protocol Violation|1|||
42386732|NCT01494038|76264213|FG001|Overall Study|Protocol Violation|1|||
42386733|NCT01494038|76264212|FG000|Overall Study|Lost to Follow-up|18|||
42386734|NCT01494038|76264213|FG001|Overall Study|Lost to Follow-up|20|||
42386735|NCT01494038|76264212|FG000|Overall Study|Withdrawal by Subject|44|||
42386736|NCT01494038|76264213|FG001|Overall Study|Withdrawal by Subject|34|||
42386737|NCT01494038|76264212|FG000|Overall Study|Not able to get to clinic|21|||
42386738|NCT01494038|76264213|FG001|Overall Study|Not able to get to clinic|15|||
42386739|NCT01494038|76264212|FG000|Overall Study|Not willing to adhere to reqs|2|||
42386740|NCT01494038|76264213|FG001|Overall Study|Not willing to adhere to reqs|9|||
42386741|NCT01494038|76264212|FG000|Overall Study|Death|2|||
42386742|NCT01494038|76264213|FG001|Overall Study|Death|4|||
42386743|NCT02640612|76264250|FG000|Overall Study|Adverse Event|6|||
42386744|NCT02640612|76264251|FG001|Overall Study|Adverse Event|7|||
42386745|NCT02640612|76264252|FG002|Overall Study|Adverse Event|2|||
42386746|NCT02640612|76264250|FG000|Overall Study|Death|1|||
42386747|NCT02640612|76264251|FG001|Overall Study|Death|0|||
42386748|NCT02640612|76264252|FG002|Overall Study|Death|0|||
42386749|NCT02640612|76264250|FG000|Overall Study|Withdrawal by Subject|10|||
42386750|NCT02640612|76264251|FG001|Overall Study|Withdrawal by Subject|3|||
42386751|NCT02640612|76264252|FG002|Overall Study|Withdrawal by Subject|3|||
42386752|NCT02640612|76264250|FG000|Overall Study|Lost to Follow-up|4|||
42386753|NCT02640612|76264251|FG001|Overall Study|Lost to Follow-up|1|||
42386754|NCT02640612|76264252|FG002|Overall Study|Lost to Follow-up|1|||
42386755|NCT02640612|76264250|FG000|Overall Study|Protocol Violation|0|||
42386756|NCT02640612|76264251|FG001|Overall Study|Protocol Violation|2|||
42386757|NCT02640612|76264252|FG002|Overall Study|Protocol Violation|0|||
42386758|NCT02640612|76264250|FG000|Overall Study|Lack of Efficacy|1|||
42386759|NCT02640612|76264251|FG001|Overall Study|Lack of Efficacy|1|||
42386760|NCT02640612|76264252|FG002|Overall Study|Lack of Efficacy|0|||
42386761|NCT00639769|76264260|FG000|Overall Study|Death|2|||
42386762|NCT00639769|76264260|FG000|Overall Study|Adverse Event|7|||
42386763|NCT00639769|76264260|FG000|Overall Study|Lack of Efficacy|1|||
42386764|NCT00639769|76264260|FG000|Overall Study|Disease progression|26|||
42386765|NCT00639769|76264260|FG000|Overall Study|Withdrawal by Subject|4|||
42386766|NCT00639457|76264266|FG000|Overall Study|Withdrawal by Subject|2|||
42386767|NCT00639457|76264267|FG001|Overall Study|Withdrawal by Subject|3|||
42386768|NCT00639379|76264273|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
42386769|NCT00639379|76264274|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
42386770|NCT00639379|76264273|FG000|Period 1 - 2 Weeks|lens issue|3|||
42386771|NCT00639379|76264274|FG001|Period 1 - 2 Weeks|lens issue|0|||
42386772|NCT00639223|76264282|FG000|Overall Study|Lost to Follow-up|0|||
42386773|NCT00639223|76264283|FG001|Overall Study|Lost to Follow-up|2|||
42386774|NCT00638989|76264292|FG000|Overall Study|Lost to Follow-up|0|||
42386775|NCT00638989|76264293|FG001|Overall Study|Lost to Follow-up|0|||
42386776|NCT00638989|76264294|FG002|Overall Study|Lost to Follow-up|1|||
42386777|NCT00637273|76264315|FG000|Overall Study|Adverse Event|11|||
42386778|NCT00637273|76264316|FG001|Overall Study|Adverse Event|5|||
42386779|NCT00637273|76264317|FG002|Overall Study|Adverse Event|7|||
42386780|NCT00637273|76264315|FG000|Overall Study|Lost to Follow-up|8|||
42386781|NCT00637273|76264316|FG001|Overall Study|Lost to Follow-up|9|||
42386782|NCT00637273|76264317|FG002|Overall Study|Lost to Follow-up|13|||
42386783|NCT00637273|76264315|FG000|Overall Study|Protocol Violation|2|||
42386784|NCT00637273|76264316|FG001|Overall Study|Protocol Violation|4|||
42386785|NCT00637273|76264317|FG002|Overall Study|Protocol Violation|1|||
42386786|NCT00637273|76264315|FG000|Overall Study|Withdrawal of Consent|18|||
42386787|NCT00637273|76264316|FG001|Overall Study|Withdrawal of Consent|6|||
42386788|NCT00637273|76264317|FG002|Overall Study|Withdrawal of Consent|18|||
42386789|NCT00637273|76264315|FG000|Overall Study|Investigator Decision|1|||
42386790|NCT00637273|76264316|FG001|Overall Study|Investigator Decision|3|||
42386791|NCT00637273|76264317|FG002|Overall Study|Investigator Decision|1|||
42386792|NCT00637273|76264315|FG000|Overall Study|Administrative|2|||
42386793|NCT00637273|76264316|FG001|Overall Study|Administrative|0|||
42386794|NCT00637273|76264317|FG002|Overall Study|Administrative|0|||
42386795|NCT00637273|76264315|FG000|Overall Study|Loss of Glucose Control|1|||
42386796|NCT00637273|76264316|FG001|Overall Study|Loss of Glucose Control|1|||
42386797|NCT00637273|76264317|FG002|Overall Study|Loss of Glucose Control|1|||
42386798|NCT00988351|76264327|FG000|Overall Study|Withdrawal by Subject|8|||
42386799|NCT00988351|76264328|FG001|Overall Study|Withdrawal by Subject|0|||
42386800|NCT00988351|76264327|FG000|Overall Study|Lost to Follow-up|6|||
42386801|NCT00988351|76264328|FG001|Overall Study|Lost to Follow-up|9|||
42386802|NCT00988351|76264327|FG000|Overall Study|not using CPAP|5|||
42386803|NCT00988351|76264328|FG001|Overall Study|not using CPAP|3|||
42386804|NCT00988117|76264334|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
42386805|NCT00988117|76264334|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
42386806|NCT00637195|76264341|FG000|Overall Study|Lost to Follow-up|1|||
42386807|NCT00637195|76264342|FG001|Overall Study|Lost to Follow-up|0|||
42386808|NCT00637195|76264341|FG000|Overall Study|Other|2|||
42386809|NCT00637195|76264342|FG001|Overall Study|Other|0|||
42386810|NCT00637195|76264341|FG000|Overall Study|Withdrawal by Subject|0|||
42386811|NCT00637195|76264342|FG001|Overall Study|Withdrawal by Subject|1|||
42386812|NCT00636961|76264360|FG000|Period 1|Administrative problems|1|||
42386813|NCT00636961|76264361|FG001|Period 1|Administrative problems|1|||
42386814|NCT00636961|76264360|FG000|Period 2|Adverse Event|1|||
42386815|NCT00636961|76264361|FG001|Period 2|Adverse Event|0|||
42386816|NCT00635089|76264376|FG000|Overall Study|Adverse Event|7|||
42386817|NCT00635089|76264376|FG000|Overall Study|Lack of Efficacy|28|||
42386818|NCT00635089|76264376|FG000|Overall Study|Protocol Deviation|4|||
42386819|NCT00635089|76264376|FG000|Overall Study|Lost to Follow-up|8|||
42019505|NCT02865460|75826954|FG001|Overall Study|Lost to Follow-up|4|||
42386820|NCT00635089|76264376|FG000|Overall Study|Other|31|||
42386821|NCT01493414|76264393|FG000|Overall Study|Adverse Event|405|||
42386822|NCT01493414|76264393|FG000|Overall Study|Disease progression|204|||
42386823|NCT01493414|76264393|FG000|Overall Study|Death|101|||
42386824|NCT01493414|76264393|FG000|Overall Study|Physician Decision|93|||
42386825|NCT01493414|76264393|FG000|Overall Study|Withdrawal by Subject|79|||
42386826|NCT01493414|76264393|FG000|Overall Study|Protocol deviation|27|||
42386827|NCT01493414|76264393|FG000|Overall Study|Administrative problems|25|||
42386828|NCT01493414|76264393|FG000|Overall Study|Lost to Follow-up|16|||
42386829|NCT00634543|76264403|FG000|Overall Study|Other|1|||
42386830|NCT00634543|76264404|FG001|Overall Study|Other|2|||
42386831|NCT00634543|76264403|FG000|Overall Study|Protocol Violation|3|||
42386832|NCT00634543|76264404|FG001|Overall Study|Protocol Violation|3|||
42386833|NCT00634543|76264403|FG000|Overall Study|Adverse Event|11|||
42386834|NCT00634543|76264404|FG001|Overall Study|Adverse Event|11|||
42386835|NCT00634543|76264403|FG000|Overall Study|Withdrawal by Subject|4|||
42386836|NCT00634543|76264404|FG001|Overall Study|Withdrawal by Subject|4|||
42386837|NCT00634543|76264403|FG000|Overall Study|Lost to Follow-up|0|||
42386838|NCT00634543|76264404|FG001|Overall Study|Lost to Follow-up|1|||
42386839|NCT00985465|76264412|FG000|Overall Study|Withdrawal by Subject|1|||
42386840|NCT00985465|76264413|FG001|Overall Study|Withdrawal by Subject|2|||
42386841|NCT00985465|76264412|FG000|Overall Study|Considered to be part of the other group|0|||
42386842|NCT00985465|76264413|FG001|Overall Study|Considered to be part of the other group|1|||
42386843|NCT01049919|76264422|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
42386844|NCT01049919|76264423|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
42386845|NCT01049919|76264422|FG000|Overall Study|Withdrawal by Subject|5|||
42386846|NCT01049919|76264423|FG001|Overall Study|Withdrawal by Subject|0|||
42386847|NCT01049919|76264422|FG000|Overall Study|Lost to Follow-up|6|||
42386848|NCT01049919|76264423|FG001|Overall Study|Lost to Follow-up|1|||
42386849|NCT01049919|76264422|FG000|Overall Study|Physician Decision|2|||
42386850|NCT01049919|76264423|FG001|Overall Study|Physician Decision|0|||
42386851|NCT01049919|76264422|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
42386852|NCT01049919|76264423|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
42386853|NCT01049919|76264422|FG000|Overall Study|Early study termination by sponsor.|2|||
42386854|NCT01049919|76264423|FG001|Overall Study|Early study termination by sponsor.|0|||
42386855|NCT01049373|76264431|FG000|Overall Study|Protocol Violation|9|||
42386856|NCT01049373|76264432|FG001|Overall Study|Protocol Violation|9|||
42386857|NCT01049373|76264431|FG000|Overall Study|Withdrawal by Subject|8|||
42386858|NCT01049373|76264432|FG001|Overall Study|Withdrawal by Subject|5|||
42386859|NCT01049373|76264431|FG000|Overall Study|Adverse Event|3|||
42386860|NCT01049373|76264432|FG001|Overall Study|Adverse Event|3|||
42386861|NCT01049373|76264431|FG000|Overall Study|Lost to Follow-up|9|||
42386862|NCT01049373|76264432|FG001|Overall Study|Lost to Follow-up|4|||
42386863|NCT01049373|76264431|FG000|Overall Study|no evaluable study values|9|||
42386864|NCT01049373|76264432|FG001|Overall Study|no evaluable study values|21|||
42386865|NCT01049373|76264431|FG000|Overall Study|Other|1|||
42386866|NCT01049373|76264432|FG001|Overall Study|Other|1|||
42386867|NCT01049373|76264431|FG000|Overall Study|Non-cooperation|0|||
42386868|NCT01049373|76264432|FG001|Overall Study|Non-cooperation|1|||
42386869|NCT00985231|76264442|FG000|Overall Study|ineligible|1|||
42386870|NCT00985231|76264443|FG001|Overall Study|ineligible|0|||
42386871|NCT00985231|76264442|FG000|Overall Study|Protocol Violation|1|||
42386872|NCT00985231|76264443|FG001|Overall Study|Protocol Violation|0|||
42386873|NCT00985231|76264442|FG000|Overall Study|Withdrawal by Subject|1|||
42386874|NCT00985231|76264443|FG001|Overall Study|Withdrawal by Subject|0|||
42386875|NCT00985231|76264442|FG000|Overall Study|Lost to Follow-up|0|||
42386876|NCT00985231|76264443|FG001|Overall Study|Lost to Follow-up|1|||
42386877|NCT00985231|76264442|FG000|Overall Study|Study related symptoms & complaints|0|||
42386878|NCT00985231|76264443|FG001|Overall Study|Study related symptoms & complaints|2|||
42386879|NCT01048671|76264463|FG000|Overall Study|Protocol Violation|0|||
42386880|NCT01048671|76264464|FG001|Overall Study|Protocol Violation|1|||
42386881|NCT01048671|76264465|FG002|Overall Study|Protocol Violation|1|||
42386882|NCT01360866|76264477|FG000|Overall Study|Lost to Follow-up|11|||
42386883|NCT01360866|76264478|FG001|Overall Study|Lost to Follow-up|28|||
42386884|NCT01360866|76264479|FG002|Overall Study|Lost to Follow-up|41|||
42386885|NCT01360866|76264480|FG003|Overall Study|Lost to Follow-up|0|||
42386886|NCT01360866|76264477|FG000|Overall Study|Adverse Event|56|||
42019506|NCT02865460|75826953|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
42386887|NCT01360866|76264478|FG001|Overall Study|Adverse Event|61|||
42386888|NCT01360866|76264479|FG002|Overall Study|Adverse Event|134|||
42386889|NCT01360866|76264480|FG003|Overall Study|Adverse Event|6|||
42386890|NCT01360866|76264477|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
42386891|NCT01360866|76264478|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
42386892|NCT01360866|76264479|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
42386893|NCT01360866|76264480|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
42386894|NCT01360866|76264477|FG000|Overall Study|Withdrawn by Investigator|9|||
42386895|NCT01360866|76264478|FG001|Overall Study|Withdrawn by Investigator|8|||
42386896|NCT01360866|76264479|FG002|Overall Study|Withdrawn by Investigator|31|||
42386897|NCT01360866|76264480|FG003|Overall Study|Withdrawn by Investigator|2|||
42386898|NCT01360866|76264477|FG000|Overall Study|Withdrawal by participant|79|||
42386899|NCT01360866|76264478|FG001|Overall Study|Withdrawal by participant|89|||
42386900|NCT01360866|76264479|FG002|Overall Study|Withdrawal by participant|168|||
42386901|NCT01360866|76264480|FG003|Overall Study|Withdrawal by participant|8|||
42386902|NCT01360866|76264477|FG000|Overall Study|Protocol Deviation|25|||
42386903|NCT01360866|76264478|FG001|Overall Study|Protocol Deviation|33|||
42386904|NCT01360866|76264479|FG002|Overall Study|Protocol Deviation|61|||
42386905|NCT01360866|76264480|FG003|Overall Study|Protocol Deviation|2|||
42386906|NCT01360866|76264477|FG000|Overall Study|Lack of Efficacy|30|||
42386907|NCT01360866|76264478|FG001|Overall Study|Lack of Efficacy|40|||
42386908|NCT01360866|76264479|FG002|Overall Study|Lack of Efficacy|30|||
42386909|NCT01360866|76264480|FG003|Overall Study|Lack of Efficacy|4|||
42386910|NCT00985153|76264494|FG000|Overall Study|Lost to Follow-up|16|||
42386911|NCT00985153|76264495|FG001|Overall Study|Lost to Follow-up|19|||
42386912|NCT00985153|76264496|FG002|Overall Study|Lost to Follow-up|17|||
42386913|NCT00985153|76264497|FG003|Overall Study|Lost to Follow-up|20|||
42386914|NCT00985153|76264494|FG000|Overall Study|Protocol Violation|3|||
42386915|NCT00985153|76264495|FG001|Overall Study|Protocol Violation|2|||
42386916|NCT00985153|76264496|FG002|Overall Study|Protocol Violation|4|||
42386917|NCT00985153|76264497|FG003|Overall Study|Protocol Violation|3|||
42386918|NCT00985153|76264494|FG000|Overall Study|Withdrawal by Subject|6|||
42386919|NCT00985153|76264495|FG001|Overall Study|Withdrawal by Subject|11|||
42386920|NCT00985153|76264496|FG002|Overall Study|Withdrawal by Subject|11|||
42386921|NCT00985153|76264497|FG003|Overall Study|Withdrawal by Subject|10|||
42386922|NCT00985153|76264494|FG000|Overall Study|Missed One or More Bleeds|7|||
42386923|NCT00985153|76264495|FG001|Overall Study|Missed One or More Bleeds|7|||
42386924|NCT00985153|76264496|FG002|Overall Study|Missed One or More Bleeds|8|||
42386925|NCT00985153|76264497|FG003|Overall Study|Missed One or More Bleeds|10|||
42386926|NCT00985153|76264494|FG000|Overall Study|Incomplete Safety Follow-up|3|||
42386927|NCT00985153|76264495|FG001|Overall Study|Incomplete Safety Follow-up|5|||
42386928|NCT00985153|76264496|FG002|Overall Study|Incomplete Safety Follow-up|4|||
42386929|NCT00985153|76264497|FG003|Overall Study|Incomplete Safety Follow-up|4|||
42386930|NCT01047345|76264509|FG000|Base Study|Adverse Event|3|||
42386931|NCT01047345|76264510|FG001|Base Study|Adverse Event|0|||
42386932|NCT01047345|76264511|FG002|Base Study|Adverse Event|0|||
42386933|NCT01047345|76264509|FG000|Base Study|Lost to Follow-up|4|||
42386934|NCT01047345|76264510|FG001|Base Study|Lost to Follow-up|1|||
42386935|NCT01047345|76264511|FG002|Base Study|Lost to Follow-up|0|||
42386936|NCT01047345|76264509|FG000|Base Study|Protocol Violation|3|||
42386937|NCT01047345|76264510|FG001|Base Study|Protocol Violation|1|||
42386938|NCT01047345|76264511|FG002|Base Study|Protocol Violation|0|||
42386939|NCT01047345|76264509|FG000|Base Study|Withdrawal by Subject|12|||
42386940|NCT01047345|76264510|FG001|Base Study|Withdrawal by Subject|4|||
42386941|NCT01047345|76264511|FG002|Base Study|Withdrawal by Subject|0|||
42386942|NCT01047345|76264509|FG000|Extension|Withdrawal by Subject|0|||
42386943|NCT01047345|76264510|FG001|Extension|Withdrawal by Subject|0|||
42386944|NCT01047345|76264511|FG002|Extension|Withdrawal by Subject|1|||
42386945|NCT01047345|76264509|FG000|Extension|Lost to Follow-up|0|||
42386946|NCT01047345|76264510|FG001|Extension|Lost to Follow-up|0|||
42386947|NCT01047345|76264511|FG002|Extension|Lost to Follow-up|5|||
42386948|NCT01046877|76264519|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
42386949|NCT01046877|76264519|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
42386950|NCT00984061|76264523|FG000|Clarithromycin Alone|Protocol Violation|1|||
42386951|NCT01046643|76264532|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
42386952|NCT01046643|76264533|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
42386953|NCT01046643|76264534|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
42386954|NCT01046643|76264535|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
42386955|NCT00983905|76264545|FG000|Theophylline Alone|Adverse Event|1|||
42386956|NCT00983905|76264545|FG000|Colchicine Alone|Adverse Event|2|||
42386957|NCT01046565|76264552|FG000|Overall Study|Adverse Event|2|||
42386958|NCT01046565|76264552|FG000|Overall Study|Withdrawal by Subject|7|||
42386959|NCT00983827|76264561|FG000|Overall Study|Withdrawal by Subject|1|||
42386960|NCT00983749|76264567|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
42386961|NCT00983749|76264568|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
42386962|NCT01046253|76264576|FG000|Second Intervention|Adverse Event|0|||
42386963|NCT01046253|76264577|FG001|Second Intervention|Adverse Event|1|||
42386964|NCT01046253|76264576|FG000|Second Intervention|Protocol Violation|0|||
42386965|NCT01046253|76264577|FG001|Second Intervention|Protocol Violation|1|||
42386966|NCT00983515|76264583|FG000|Ritonavir Alone|liver panel out of range|6|||
42386967|NCT00983515|76264583|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
42386968|NCT00982735|76264590|FG000|Overall Study|Lost to Follow-up|6|||
42386969|NCT00982735|76264590|FG000|Overall Study|Patient ineligible for trial|224|||
42386970|NCT01361178|76264596|FG000|Overall Study|Death|13|||
42386971|NCT01361178|76264597|FG001|Overall Study|Death|0|||
42386972|NCT00981799|76264607|FG000|Overall Study|Adverse Event|1|||
42386973|NCT00981799|76264608|FG001|Overall Study|Adverse Event|1|||
42386974|NCT00981799|76264609|FG002|Overall Study|Adverse Event|0|||
42386975|NCT00981799|76264610|FG003|Overall Study|Adverse Event|0|||
42386976|NCT00981175|76264624|FG000|Primary Dose Vaccination|Adverse Event|1|||
42386977|NCT00981175|76264625|FG001|Primary Dose Vaccination|Adverse Event|0|||
42386978|NCT00981175|76264624|FG000|Primary Dose Vaccination|Protocol Violation|0|||
42386979|NCT00981175|76264625|FG001|Primary Dose Vaccination|Protocol Violation|1|||
42386980|NCT00981175|76264624|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
42386981|NCT00981175|76264625|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
42386982|NCT00981175|76264624|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
42386983|NCT00981175|76264625|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
42386984|NCT00981019|76264638|FG000|Overall Study|Did not respond|65|||
42386985|NCT00981019|76264638|FG000|Overall Study|Did not match target population|94|||
42386986|NCT00981019|76264638|FG000|Overall Study|Inadvertent exclusion|239|||
42386987|NCT00981019|76264638|FG000|Overall Study|Hit the survey after closure|79|||
42386988|NCT01045161|76264645|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
42386989|NCT01045161|76264646|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
42386990|NCT01045161|76264647|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
42386991|NCT01045161|76264645|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
42386992|NCT01045161|76264646|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
42386993|NCT01045161|76264647|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
42386994|NCT01045161|76264645|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
42386995|NCT01045161|76264646|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
42386996|NCT01045161|76264647|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
42386997|NCT01045161|76264645|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
42386998|NCT01045161|76264646|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
42386999|NCT01045161|76264647|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
42387000|NCT01045161|76264645|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
42387001|NCT01045161|76264646|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
42387002|NCT01045161|76264647|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
42387003|NCT01045161|76264645|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
42387004|NCT01045161|76264646|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
42387005|NCT01045161|76264647|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
42387006|NCT01045161|76264645|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
42387007|NCT01045161|76264646|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
42387008|NCT01045161|76264647|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
42387009|NCT01045161|76264645|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
42387010|NCT01045161|76264646|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
42387011|NCT01045161|76264647|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
42387012|NCT01045161|76264645|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
42387013|NCT01045161|76264646|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
42387014|NCT01045161|76264647|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
42387015|NCT01045161|76264645|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
42387016|NCT01045161|76264646|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
42387017|NCT01045161|76264647|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
42387018|NCT01045161|76264645|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
42387019|NCT01045161|76264646|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
42387020|NCT01045161|76264647|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
42387021|NCT01045161|76264645|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
42387022|NCT01045161|76264646|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
42019507|NCT02865460|75826954|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
42019508|NCT01206816|75826967|FG000|Overall Study|Protocol Violation|0|||
42019509|NCT01206816|75826968|FG001|Overall Study|Protocol Violation|0|||
42019510|NCT01206816|75826969|FG002|Overall Study|Protocol Violation|1|||
42019511|NCT01206816|75826970|FG003|Overall Study|Protocol Violation|0|||
42019512|NCT01206816|75826971|FG004|Overall Study|Protocol Violation|0|||
42019513|NCT01206816|75826972|FG005|Overall Study|Protocol Violation|0|||
42019514|NCT01206816|75826973|FG006|Overall Study|Protocol Violation|0|||
42019515|NCT01206816|75826967|FG000|Overall Study|Withdrawal by Subject|0|||
42019516|NCT01206816|75826968|FG001|Overall Study|Withdrawal by Subject|0|||
42019517|NCT01206816|75826969|FG002|Overall Study|Withdrawal by Subject|1|||
42019518|NCT01206816|75826970|FG003|Overall Study|Withdrawal by Subject|0|||
42019519|NCT01206816|75826971|FG004|Overall Study|Withdrawal by Subject|0|||
42019520|NCT01206816|75826972|FG005|Overall Study|Withdrawal by Subject|0|||
42019521|NCT01206816|75826973|FG006|Overall Study|Withdrawal by Subject|0|||
42019522|NCT01206816|75826967|FG000|Overall Study|Progressive disease|3|||
42019523|NCT01206816|75826968|FG001|Overall Study|Progressive disease|3|||
42019524|NCT01206816|75826969|FG002|Overall Study|Progressive disease|13|||
42019525|NCT01206816|75826970|FG003|Overall Study|Progressive disease|3|||
42019526|NCT01206816|75826971|FG004|Overall Study|Progressive disease|3|||
42019527|NCT01206816|75826972|FG005|Overall Study|Progressive disease|16|||
42019528|NCT01206816|75826973|FG006|Overall Study|Progressive disease|3|||
42019529|NCT01206816|75826967|FG000|Overall Study|Other AE|0|||
42019530|NCT01206816|75826968|FG001|Overall Study|Other AE|0|||
42019531|NCT01206816|75826969|FG002|Overall Study|Other AE|4|||
42019532|NCT01206816|75826970|FG003|Overall Study|Other AE|0|||
42019533|NCT01206816|75826971|FG004|Overall Study|Other AE|0|||
42019534|NCT01206816|75826972|FG005|Overall Study|Other AE|3|||
42019535|NCT01206816|75826973|FG006|Overall Study|Other AE|2|||
42019536|NCT01206816|75826967|FG000|Overall Study|other than stated above|0|||
42019537|NCT01206816|75826968|FG001|Overall Study|other than stated above|0|||
42019538|NCT01206816|75826969|FG002|Overall Study|other than stated above|1|||
42019539|NCT01206816|75826970|FG003|Overall Study|other than stated above|0|||
42019540|NCT01206816|75826971|FG004|Overall Study|other than stated above|0|||
42019541|NCT01206816|75826972|FG005|Overall Study|other than stated above|0|||
42019542|NCT01206816|75826973|FG006|Overall Study|other than stated above|1|||
42019543|NCT01206582|75826995|FG000|Overall Study|Withdrew prior to study|1|||
42019544|NCT01206582|75826996|FG001|Overall Study|Withdrew prior to study|0|||
42019545|NCT01206582|75826995|FG000|Overall Study|Discontinued intervention before week 8|1|||
42019546|NCT01206582|75826996|FG001|Overall Study|Discontinued intervention before week 8|2|||
42019547|NCT01259102|75827007|FG000|Overall Study|Adverse Event|1|||
42019548|NCT01259102|75827008|FG001|Overall Study|Adverse Event|0|||
42019549|NCT01259102|75827009|FG002|Overall Study|Adverse Event|1|||
42019550|NCT01259102|75827010|FG003|Overall Study|Adverse Event|1|||
42019551|NCT01259102|75827011|FG004|Overall Study|Adverse Event|0|||
42019552|NCT01259102|75827007|FG000|Overall Study|Other|0|||
42019553|NCT01259102|75827008|FG001|Overall Study|Other|0|||
42019554|NCT01259102|75827009|FG002|Overall Study|Other|1|||
42019555|NCT01259102|75827010|FG003|Overall Study|Other|1|||
42019556|NCT01259102|75827011|FG004|Overall Study|Other|1|||
42019557|NCT00978250|75827027|FG000|Overall Study|Late determination of ineligibility|0|||
42019558|NCT00978250|75827028|FG001|Overall Study|Late determination of ineligibility|1|||
42019559|NCT00978250|75827029|FG002|Overall Study|Late determination of ineligibility|0|||
42019560|NCT00978250|75827030|FG003|Overall Study|Late determination of ineligibility|1|||
42019561|NCT01259024|75827042|FG000|Overall Study|Physician Decision|1|||
42019562|NCT01257698|75827048|FG000|Overall Study|Protocol Violation|4|||
42019563|NCT01257698|75827049|FG001|Overall Study|Protocol Violation|0|||
42019564|NCT01257542|75827057|FG000|Overall Study|Protocol Violation|3|||
42019565|NCT01257542|75827058|FG001|Overall Study|Protocol Violation|5|||
42019566|NCT01257542|75827057|FG000|Overall Study|Withdrawal by Subject|0|||
42019567|NCT01257542|75827058|FG001|Overall Study|Withdrawal by Subject|2|||
42019568|NCT01257230|75827067|FG000|Overall Study|Not Treated|0|||
42019569|NCT01257230|75827068|FG001|Overall Study|Not Treated|0|||
42019570|NCT01257230|75827069|FG002|Overall Study|Not Treated|1|||
42019571|NCT01257230|75827067|FG000|Overall Study|Adverse Event|2|||
42019572|NCT01257230|75827068|FG001|Overall Study|Adverse Event|0|||
42019573|NCT01257230|75827069|FG002|Overall Study|Adverse Event|0|||
42019574|NCT01257230|75827067|FG000|Overall Study|Lack of Efficacy|0|||
42019575|NCT01257230|75827068|FG001|Overall Study|Lack of Efficacy|1|||
42019576|NCT01257230|75827069|FG002|Overall Study|Lack of Efficacy|0|||
42019577|NCT01257230|75827067|FG000|Overall Study|Protocol Violation|3|||
42019578|NCT01257230|75827068|FG001|Overall Study|Protocol Violation|0|||
42019579|NCT01257230|75827069|FG002|Overall Study|Protocol Violation|1|||
42019580|NCT01257230|75827067|FG000|Overall Study|Withdrawal by Subject|0|||
42019581|NCT01257230|75827068|FG001|Overall Study|Withdrawal by Subject|4|||
42019582|NCT01257230|75827069|FG002|Overall Study|Withdrawal by Subject|1|||
42019583|NCT01257230|75827067|FG000|Overall Study|Other reason not defined above|1|||
42019584|NCT01257230|75827068|FG001|Overall Study|Other reason not defined above|5|||
42019585|NCT01257230|75827069|FG002|Overall Study|Other reason not defined above|3|||
42019586|NCT01113801|75827082|FG000|Overall Study|Adverse Event|4|||
42019587|NCT01113801|75827083|FG001|Overall Study|Adverse Event|0|||
42019588|NCT01113801|75827084|FG002|Overall Study|Adverse Event|2|||
42019589|NCT01113801|75827085|FG003|Overall Study|Adverse Event|6|||
42019590|NCT01113801|75827082|FG000|Overall Study|Death|4|||
42019591|NCT01113801|75827083|FG001|Overall Study|Death|5|||
42019592|NCT01113801|75827084|FG002|Overall Study|Death|3|||
42019593|NCT01113801|75827085|FG003|Overall Study|Death|4|||
42019594|NCT01113801|75827082|FG000|Overall Study|Protocol Violation|0|||
42019595|NCT01113801|75827083|FG001|Overall Study|Protocol Violation|1|||
42019596|NCT01113801|75827084|FG002|Overall Study|Protocol Violation|0|||
42019597|NCT01113801|75827085|FG003|Overall Study|Protocol Violation|0|||
42019598|NCT01113801|75827082|FG000|Overall Study|Withdrawal by Subject|9|||
42019599|NCT01113801|75827083|FG001|Overall Study|Withdrawal by Subject|7|||
42019600|NCT01113801|75827084|FG002|Overall Study|Withdrawal by Subject|7|||
42019601|NCT01113801|75827085|FG003|Overall Study|Withdrawal by Subject|8|||
42019602|NCT01113801|75827082|FG000|Overall Study|Physician Decision|2|||
42019603|NCT01113801|75827083|FG001|Overall Study|Physician Decision|2|||
42019604|NCT01113801|75827084|FG002|Overall Study|Physician Decision|3|||
42019605|NCT01113801|75827085|FG003|Overall Study|Physician Decision|3|||
42019606|NCT01113801|75827082|FG000|Overall Study|Sponsor Decision|15|||
42019607|NCT01113801|75827083|FG001|Overall Study|Sponsor Decision|21|||
42019608|NCT01113801|75827084|FG002|Overall Study|Sponsor Decision|20|||
42019609|NCT01113801|75827085|FG003|Overall Study|Sponsor Decision|15|||
42019610|NCT01113801|75827082|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
42019611|NCT01113801|75827083|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
42019612|NCT01113801|75827084|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
42019613|NCT01113801|75827085|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
42019614|NCT01256684|75827098|FG000|Overall Study|Adverse Event|1|||
42019615|NCT01256684|75827099|FG001|Overall Study|Adverse Event|4|||
42019616|NCT01256684|75827100|FG002|Overall Study|Adverse Event|2|||
42019617|NCT01256684|75827098|FG000|Overall Study|Withdrawal by Subject|4|||
42019618|NCT01256684|75827099|FG001|Overall Study|Withdrawal by Subject|0|||
42019619|NCT01256684|75827100|FG002|Overall Study|Withdrawal by Subject|2|||
42019620|NCT01256684|75827098|FG000|Overall Study|Physician Decision|0|||
42019621|NCT01256684|75827099|FG001|Overall Study|Physician Decision|1|||
42019622|NCT01256684|75827100|FG002|Overall Study|Physician Decision|0|||
42019623|NCT01256684|75827098|FG000|Overall Study|Lack of Efficacy|0|||
42019624|NCT01256684|75827099|FG001|Overall Study|Lack of Efficacy|1|||
42019625|NCT01256684|75827100|FG002|Overall Study|Lack of Efficacy|1|||
42019626|NCT01256684|75827098|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
42019627|NCT01256684|75827099|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
42019628|NCT01256684|75827100|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
42019629|NCT01204710|75827110|FG000|Randomization Treatment|Lost to Follow-up|1|||
42019630|NCT01204710|75827111|FG001|Randomization Treatment|Lost to Follow-up|0|||
42019631|NCT01204710|75827110|FG000|Randomization Treatment|Withdrawal by Subject|6|||
42019632|NCT01204710|75827111|FG001|Randomization Treatment|Withdrawal by Subject|5|||
42019633|NCT01204710|75827110|FG000|Randomization Treatment|Physician Decision|3|||
42019634|NCT01204710|75827111|FG001|Randomization Treatment|Physician Decision|2|||
42019635|NCT01204710|75827110|FG000|Randomization Treatment|Entry criteria not met|0|||
42019636|NCT01204710|75827111|FG001|Randomization Treatment|Entry criteria not met|1|||
42019637|NCT01204710|75827110|FG000|Randomization Treatment|Adverse Event|4|||
42019638|NCT01204710|75827111|FG001|Randomization Treatment|Adverse Event|2|||
42019639|NCT01204710|75827110|FG000|Randomization Treatment|Sponsor Decision|0|||
42019640|NCT01204710|75827111|FG001|Randomization Treatment|Sponsor Decision|1|||
42019641|NCT01204710|75827110|FG000|Randomization Treatment|Worsening of General condition|0|||
42019642|NCT01204710|75827111|FG001|Randomization Treatment|Worsening of General condition|1|||
42019643|NCT01204710|75827110|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
42019644|NCT01204710|75827111|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
42019645|NCT01204710|75827110|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
42019646|NCT01204710|75827111|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
42019647|NCT01204710|75827110|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
42019648|NCT01204710|75827111|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
42019649|NCT01204710|75827110|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
42019650|NCT01204710|75827111|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
42019651|NCT01256450|75827126|FG000|Open-label Titration|Adverse Event|39|||
42019652|NCT01256450|75827127|FG001|Open-label Titration|Adverse Event|0|||
42019653|NCT01256450|75827128|FG002|Open-label Titration|Adverse Event|0|||
42019654|NCT01256450|75827126|FG000|Open-label Titration|Lost to Follow-up|7|||
42019655|NCT01256450|75827127|FG001|Open-label Titration|Lost to Follow-up|0|||
42019656|NCT01256450|75827128|FG002|Open-label Titration|Lost to Follow-up|0|||
42019657|NCT01256450|75827126|FG000|Open-label Titration|Lack of analgesic effect|30|||
42019658|NCT01256450|75827127|FG001|Open-label Titration|Lack of analgesic effect|0|||
42019659|NCT01256450|75827128|FG002|Open-label Titration|Lack of analgesic effect|0|||
42019660|NCT01256450|75827126|FG000|Open-label Titration|Non-compliance|9|||
42019661|NCT01256450|75827127|FG001|Open-label Titration|Non-compliance|0|||
42019662|NCT01256450|75827128|FG002|Open-label Titration|Non-compliance|0|||
42019663|NCT01256450|75827126|FG000|Open-label Titration|Screen failure|1|||
42019664|NCT01256450|75827127|FG001|Open-label Titration|Screen failure|0|||
42019665|NCT01256450|75827128|FG002|Open-label Titration|Screen failure|0|||
42019666|NCT01256450|75827126|FG000|Open-label Titration|Other|13|||
42019667|NCT01256450|75827127|FG001|Open-label Titration|Other|0|||
42019668|NCT01256450|75827128|FG002|Open-label Titration|Other|0|||
42019669|NCT01256450|75827126|FG000|Double-blind Treatment|Adverse Event|0|||
42019670|NCT01256450|75827127|FG001|Double-blind Treatment|Adverse Event|8|||
42019671|NCT01256450|75827128|FG002|Double-blind Treatment|Adverse Event|6|||
42019672|NCT01256450|75827126|FG000|Double-blind Treatment|Lost to Follow-up|0|||
42019673|NCT01256450|75827127|FG001|Double-blind Treatment|Lost to Follow-up|1|||
42019674|NCT01256450|75827128|FG002|Double-blind Treatment|Lost to Follow-up|7|||
42019675|NCT01256450|75827126|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
42019676|NCT01256450|75827127|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
42019677|NCT01256450|75827128|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
42019678|NCT01256450|75827126|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
42019679|NCT01256450|75827127|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
42019680|NCT01256450|75827128|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
42019681|NCT01256450|75827126|FG000|Double-blind Treatment|Non-compliance|0|||
42019682|NCT01256450|75827127|FG001|Double-blind Treatment|Non-compliance|5|||
42019683|NCT01256450|75827128|FG002|Double-blind Treatment|Non-compliance|4|||
42019684|NCT01256450|75827126|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
42019685|NCT01256450|75827127|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
42019686|NCT01256450|75827128|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
42019687|NCT01256450|75827126|FG000|Double-blind Treatment|Other|0|||
42019688|NCT01256450|75827127|FG001|Double-blind Treatment|Other|9|||
42019689|NCT01256450|75827128|FG002|Double-blind Treatment|Other|12|||
42019690|NCT01204398|75827135|FG000|Overall Study|Adverse Event|1|||
42019691|NCT01111851|75827141|FG000|Overall Study|All planned PET scans were not obtained.|2|||
42019692|NCT01111851|75827142|FG001|Overall Study|All planned PET scans were not obtained.|0|||
42019693|NCT01256294|75827148|FG000|Overall Study|Adverse Event|1|||
42019694|NCT01256294|75827149|FG001|Overall Study|Adverse Event|0|||
42019695|NCT01256294|75827148|FG000|Overall Study|Withdrawal by Subject|1|||
42019696|NCT01256294|75827149|FG001|Overall Study|Withdrawal by Subject|1|||
42019697|NCT01256294|75827148|FG000|Overall Study|Protocol deviation|2|||
42019698|NCT01256294|75827149|FG001|Overall Study|Protocol deviation|1|||
42019699|NCT01256060|75827155|FG000|Overall Study|Lost to Follow-up|0|||
42019700|NCT01256060|75827156|FG001|Overall Study|Lost to Follow-up|1|||
42019701|NCT01256060|75827157|FG002|Overall Study|Lost to Follow-up|0|||
42019702|NCT01256060|75827158|FG003|Overall Study|Lost to Follow-up|0|||
42019703|NCT01255904|75827166|FG000|Overall Study|Physician Decision|1|||
42019704|NCT01255904|75827167|FG001|Overall Study|Physician Decision|4|||
42019705|NCT01255670|75827175|FG000|Overall Study|Adverse Event|10|||
42019706|NCT01255670|75827176|FG001|Overall Study|Adverse Event|10|||
42019707|NCT01255670|75827175|FG000|Overall Study|Lost to Follow-up|16|||
42019708|NCT01255670|75827176|FG001|Overall Study|Lost to Follow-up|10|||
42019709|NCT01255592|75827184|FG000|Overall Study|Adverse Event|5|||
42019710|NCT01255592|75827185|FG001|Overall Study|Adverse Event|0|||
42019711|NCT01255592|75827184|FG000|Overall Study|Withdrawal by Subject|1|||
42019712|NCT01255592|75827185|FG001|Overall Study|Withdrawal by Subject|0|||
42019713|NCT01255592|75827184|FG000|Overall Study|Other|0|||
42019714|NCT01255592|75827185|FG001|Overall Study|Other|1|||
42019715|NCT01255436|75827194|FG000|Overall Study|Lost to Follow-up|178|||
42019716|NCT01255436|75827195|FG001|Overall Study|Lost to Follow-up|191|||
42019717|NCT01255436|75827194|FG000|Overall Study|Death, stroke, or MI|4|||
42019718|NCT01255436|75827195|FG001|Overall Study|Death, stroke, or MI|3|||
42019719|NCT01203930|75827203|FG000|Overall Study|Disease Progression|0|||
42019720|NCT01203930|75827204|FG001|Overall Study|Disease Progression|4|||
42019721|NCT01203930|75827203|FG000|Overall Study|Death|3|||
42019722|NCT01203930|75827204|FG001|Overall Study|Death|1|||
42019723|NCT01203930|75827203|FG000|Overall Study|Withdrew Consent|1|||
42019724|NCT01203930|75827204|FG001|Overall Study|Withdrew Consent|10|||
42019725|NCT01203930|75827203|FG000|Overall Study|Investigator Request|0|||
42019726|NCT01203930|75827204|FG001|Overall Study|Investigator Request|8|||
42019727|NCT01203930|75827203|FG000|Overall Study|Study Terminated by Sponsor|0|||
42019728|NCT01203930|75827204|FG001|Overall Study|Study Terminated by Sponsor|12|||
42019729|NCT01203930|75827203|FG000|Overall Study|Poor tolerance of study drug|0|||
42019730|NCT01203930|75827204|FG001|Overall Study|Poor tolerance of study drug|1|||
42019731|NCT01203930|75827203|FG000|Overall Study|Adverse Event|17|||
42019732|NCT01203930|75827204|FG001|Overall Study|Adverse Event|5|||
42019733|NCT01254890|75827214|FG000|Overall Study|Ineligible|0|||
42019734|NCT01254890|75827215|FG001|Overall Study|Ineligible|3|||
42019735|NCT01254890|75827214|FG000|Overall Study|Withdrawal by Subject|1|||
42019736|NCT01254890|75827215|FG001|Overall Study|Withdrawal by Subject|2|||
42019737|NCT01254890|75827214|FG000|Overall Study|Disease Progression|0|||
42019738|NCT01254890|75827215|FG001|Overall Study|Disease Progression|5|||
42019739|NCT01203852|75827220|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
42019740|NCT01203852|75827220|FG000|Washout 2 Weeks|Physician Decision|46|||
42019741|NCT01105533|75827227|FG000|Overall Study|Death|0|||
42019742|NCT01105533|75827228|FG001|Overall Study|Death|0|||
42019743|NCT01105533|75827229|FG002|Overall Study|Death|0|||
42019744|NCT01105533|75827230|FG003|Overall Study|Death|0|||
42019745|NCT01105533|75827231|FG004|Overall Study|Death|1|||
42019746|NCT01105533|75827232|FG005|Overall Study|Death|0|||
42019747|NCT01105533|75827233|FG006|Overall Study|Death|0|||
42019748|NCT01105533|75827234|FG007|Overall Study|Death|0|||
42019749|NCT01105533|75827235|FG008|Overall Study|Death|0|||
42019750|NCT01105533|75827227|FG000|Overall Study|Lack of Efficacy|1|||
42019751|NCT01105533|75827228|FG001|Overall Study|Lack of Efficacy|1|||
42019752|NCT01105533|75827229|FG002|Overall Study|Lack of Efficacy|3|||
42019753|NCT01105533|75827230|FG003|Overall Study|Lack of Efficacy|3|||
42019754|NCT01105533|75827231|FG004|Overall Study|Lack of Efficacy|4|||
42019755|NCT01105533|75827232|FG005|Overall Study|Lack of Efficacy|5|||
42019756|NCT01105533|75827233|FG006|Overall Study|Lack of Efficacy|3|||
42019757|NCT01105533|75827234|FG007|Overall Study|Lack of Efficacy|2|||
42019758|NCT01105533|75827235|FG008|Overall Study|Lack of Efficacy|9|||
42019759|NCT01105533|75827227|FG000|Overall Study|Adverse Event|0|||
42019760|NCT01105533|75827228|FG001|Overall Study|Adverse Event|0|||
42019761|NCT01105533|75827229|FG002|Overall Study|Adverse Event|0|||
42019762|NCT01105533|75827230|FG003|Overall Study|Adverse Event|0|||
42019763|NCT01105533|75827231|FG004|Overall Study|Adverse Event|1|||
42019764|NCT01105533|75827232|FG005|Overall Study|Adverse Event|2|||
42019765|NCT01105533|75827233|FG006|Overall Study|Adverse Event|2|||
42019766|NCT01105533|75827234|FG007|Overall Study|Adverse Event|0|||
42019767|NCT01105533|75827235|FG008|Overall Study|Adverse Event|1|||
42019768|NCT01105533|75827227|FG000|Overall Study|Other|0|||
42019769|NCT01105533|75827228|FG001|Overall Study|Other|0|||
42019770|NCT01105533|75827229|FG002|Overall Study|Other|0|||
42019771|NCT01105533|75827230|FG003|Overall Study|Other|0|||
42019772|NCT01105533|75827231|FG004|Overall Study|Other|1|||
42019773|NCT01105533|75827232|FG005|Overall Study|Other|0|||
42019774|NCT01105533|75827233|FG006|Overall Study|Other|3|||
42019775|NCT01105533|75827234|FG007|Overall Study|Other|1|||
42204113|NCT02951988|76016781|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
42204114|NCT02951988|76016782|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
42204115|NCT02951988|76016783|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
42204116|NCT02951988|76016780|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
42204117|NCT02951988|76016781|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
42204118|NCT02951988|76016782|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
42204119|NCT02951988|76016783|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
42204120|NCT02951988|76016780|FG000|Double-Blind Treatment Period|Pregnancy|0|||
42204121|NCT02951988|76016781|FG001|Double-Blind Treatment Period|Pregnancy|1|||
42387023|NCT01045161|76264647|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
42387024|NCT01045161|76264645|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
42204122|NCT02951988|76016782|FG002|Double-Blind Treatment Period|Pregnancy|1|||
42204123|NCT02951988|76016783|FG003|Double-Blind Treatment Period|Pregnancy|0|||
42204124|NCT02951988|76016780|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
42204125|NCT02951988|76016781|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
42204126|NCT02951988|76016782|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
42204127|NCT02951988|76016783|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
42204128|NCT02951988|76016780|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
42204129|NCT02951988|76016781|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
42204130|NCT02951988|76016782|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
42204131|NCT02951988|76016783|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
42204132|NCT02951988|76016780|FG000|Double-Blind Treatment Period|Adverse Event|0|||
42204133|NCT02951988|76016781|FG001|Double-Blind Treatment Period|Adverse Event|8|||
42204134|NCT02951988|76016782|FG002|Double-Blind Treatment Period|Adverse Event|3|||
42204135|NCT02951988|76016783|FG003|Double-Blind Treatment Period|Adverse Event|6|||
42204136|NCT02951988|76016780|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
42204137|NCT02951988|76016781|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
42204138|NCT02951988|76016782|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
42204139|NCT02951988|76016783|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
42204140|NCT00009737|76016795|FG000|Overall Study|Adverse Event|112|||
42204141|NCT00009737|76016796|FG001|Overall Study|Adverse Event|75|||
42204142|NCT00009737|76016795|FG000|Overall Study|Death|4|||
42204143|NCT00009737|76016796|FG001|Overall Study|Death|6|||
42204144|NCT00009737|76016795|FG000|Overall Study|Lack of Efficacy|17|||
42204145|NCT00009737|76016796|FG001|Overall Study|Lack of Efficacy|15|||
42204146|NCT00009737|76016795|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
42204147|NCT00009737|76016796|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
42204148|NCT00009737|76016795|FG000|Overall Study|Other Protocol Violation|1|||
42204149|NCT00009737|76016796|FG001|Overall Study|Other Protocol Violation|0|||
42387025|NCT01045161|76264646|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
42387026|NCT01045161|76264647|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
42019776|NCT01105533|75827235|FG008|Overall Study|Other|2|||
42019777|NCT01105533|75827227|FG000|Overall Study|Physician Decision|0|||
42019778|NCT01105533|75827228|FG001|Overall Study|Physician Decision|0|||
42019779|NCT01105533|75827229|FG002|Overall Study|Physician Decision|0|||
42019780|NCT01105533|75827230|FG003|Overall Study|Physician Decision|0|||
42019781|NCT01105533|75827231|FG004|Overall Study|Physician Decision|0|||
42019782|NCT01105533|75827232|FG005|Overall Study|Physician Decision|0|||
42019783|NCT01105533|75827233|FG006|Overall Study|Physician Decision|0|||
42019784|NCT01105533|75827234|FG007|Overall Study|Physician Decision|1|||
42019785|NCT01105533|75827235|FG008|Overall Study|Physician Decision|0|||
42110348|NCT00145327|75920753|FG002|Overall Study|Protocol Violation|2|||
42110349|NCT00145327|75920751|FG000|Overall Study|Abnormal laboratory value(s)|1|||
42110350|NCT00145327|75920752|FG001|Overall Study|Abnormal laboratory value(s)|0|||
42110351|NCT00145327|75920753|FG002|Overall Study|Abnormal laboratory value(s)|2|||
42110352|NCT00145327|75920751|FG000|Overall Study|Missing - not stated|1|||
42110353|NCT00145327|75920752|FG001|Overall Study|Missing - not stated|0|||
42110354|NCT00145327|75920753|FG002|Overall Study|Missing - not stated|1|||
42110355|NCT00510484|75920763|FG000|Wash-out Period|Adverse Event|0|||
42110356|NCT00510484|75920764|FG001|Wash-out Period|Adverse Event|1|||
42110357|NCT00622388|75920770|FG000|Overall Study|Disease Progression|47|||
42110358|NCT00622388|75920770|FG000|Overall Study|Adverse Event|6|||
42110359|NCT00622388|75920770|FG000|Overall Study|Protocol Violation|3|||
42110360|NCT00622388|75920770|FG000|Overall Study|Participant Refusal|1|||
42110361|NCT00622388|75920770|FG000|Overall Study|Death|3|||
42110362|NCT00622388|75920770|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
42110363|NCT00622388|75920770|FG000|Overall Study|Took Prohibited Medication|2|||
42110364|NCT00622388|75920770|FG000|Overall Study|Withdrew Consent|1|||
42110365|NCT00622388|75920770|FG000|Overall Study|Insurance Expired|1|||
42110366|NCT01156389|75920777|FG000|Overall Study|Elevated liver enzymes|4|||
42110367|NCT01156389|75920778|FG001|Overall Study|Elevated liver enzymes|0|||
42110368|NCT01156389|75920777|FG000|Overall Study|Vomiting|0|||
42110369|NCT01156389|75920778|FG001|Overall Study|Vomiting|1|||
42110370|NCT01105767|75920787|FG000|Overall Study|Lost to Follow-up|1160|||
42110371|NCT01105767|75920788|FG001|Overall Study|Lost to Follow-up|1614|||
42110372|NCT01105767|75920789|FG002|Overall Study|Lost to Follow-up|1184|||
42110373|NCT03693430|75920799|FG000|Overall Study|Lost to Follow-up|3|||
42110374|NCT03693430|75920800|FG001|Overall Study|Lost to Follow-up|14|||
42110375|NCT03693430|75920799|FG000|Overall Study|Death|1|||
42110376|NCT03693430|75920800|FG001|Overall Study|Death|0|||
42110377|NCT03693430|75920799|FG000|Overall Study|Withdrawal by Subject|0|||
42110378|NCT03693430|75920800|FG001|Overall Study|Withdrawal by Subject|4|||
42110379|NCT00625742|75920806|FG000|Overall Study|Disease Progression|2|||
42019786|NCT01203072|75827253|FG000|Overall Study|Adverse Event|5|||
42019787|NCT01203072|75827254|FG001|Overall Study|Adverse Event|3|||
42019788|NCT01203072|75827255|FG002|Overall Study|Adverse Event|2|||
42019789|NCT01203072|75827256|FG003|Overall Study|Adverse Event|4|||
42019790|NCT01203072|75827257|FG004|Overall Study|Adverse Event|2|||
42019791|NCT01203072|75827253|FG000|Overall Study|Lack of Efficacy|1|||
42019792|NCT01203072|75827254|FG001|Overall Study|Lack of Efficacy|0|||
42019793|NCT01203072|75827255|FG002|Overall Study|Lack of Efficacy|0|||
42019794|NCT01203072|75827256|FG003|Overall Study|Lack of Efficacy|0|||
42019795|NCT01203072|75827257|FG004|Overall Study|Lack of Efficacy|0|||
42019796|NCT01203072|75827253|FG000|Overall Study|Lost to Follow-up|0|||
42019797|NCT01203072|75827254|FG001|Overall Study|Lost to Follow-up|1|||
42019798|NCT01203072|75827255|FG002|Overall Study|Lost to Follow-up|0|||
42019799|NCT01203072|75827256|FG003|Overall Study|Lost to Follow-up|0|||
42019800|NCT01203072|75827257|FG004|Overall Study|Lost to Follow-up|0|||
42019801|NCT01203072|75827253|FG000|Overall Study|Protocol Violation|2|||
42019802|NCT01203072|75827254|FG001|Overall Study|Protocol Violation|0|||
42019803|NCT01203072|75827255|FG002|Overall Study|Protocol Violation|0|||
42019804|NCT01203072|75827256|FG003|Overall Study|Protocol Violation|0|||
42019805|NCT01203072|75827257|FG004|Overall Study|Protocol Violation|1|||
42019806|NCT01203072|75827253|FG000|Overall Study|Withdrawal by Subject|2|||
42019807|NCT01203072|75827254|FG001|Overall Study|Withdrawal by Subject|2|||
42019808|NCT01203072|75827255|FG002|Overall Study|Withdrawal by Subject|1|||
42019809|NCT01203072|75827256|FG003|Overall Study|Withdrawal by Subject|2|||
42019810|NCT01203072|75827257|FG004|Overall Study|Withdrawal by Subject|3|||
42019811|NCT01105377|75827271|FG000|Overall Study|Withdrawal by Subject|0|||
42019812|NCT01105377|75827272|FG001|Overall Study|Withdrawal by Subject|1|||
42019813|NCT01105065|75827278|FG000|Overall Study|Adverse Event|5|||
42019814|NCT01105065|75827278|FG000|Overall Study|Technical Problems|1|||
42019815|NCT01111539|75827284|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
42019816|NCT01111539|75827285|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
42019817|NCT01111539|75827286|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
42019818|NCT01111539|75827287|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
42019819|NCT01111539|75827288|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
42019820|NCT01111539|75827284|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
42019821|NCT01111539|75827285|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
42019822|NCT01111539|75827286|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
42019823|NCT01111539|75827287|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
42019824|NCT01111539|75827288|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
42019825|NCT01111539|75827284|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
42019826|NCT01111539|75827285|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
42019827|NCT01111539|75827286|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
42019828|NCT01111539|75827287|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
42019829|NCT01111539|75827288|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
42019830|NCT01111539|75827284|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
42110380|NCT00625742|75920806|FG000|Overall Study|Withdrawal by Subject|1|||
42110381|NCT00625742|75920806|FG000|Overall Study|Adverse Event|4|||
42110382|NCT00625742|75920806|FG000|Overall Study|Lost to Follow-up|4|||
42110383|NCT00625742|75920806|FG000|Overall Study|Ineligible|1|||
42110384|NCT00621296|75920819|FG000|Overall Study|Adverse Event|2|||
42110385|NCT00621296|75920819|FG000|Overall Study|Lack of Efficacy|1|||
42110386|NCT00621296|75920819|FG000|Overall Study|Physician Decision|7|||
42110387|NCT00621296|75920819|FG000|Overall Study|Unmatch Criteria|1|||
42110388|NCT00621296|75920819|FG000|Overall Study|Stopping Criteria|3|||
42110389|NCT00537303|75920825|FG000|Overall Study|Adverse Event|1|||
42110390|NCT00537303|75920826|FG001|Overall Study|Adverse Event|4|||
42110391|NCT00537303|75920825|FG000|Overall Study|Lack of Efficacy|6|||
42110392|NCT00537303|75920826|FG001|Overall Study|Lack of Efficacy|7|||
42110393|NCT00537303|75920825|FG000|Overall Study|Protocol Violation|8|||
42110394|NCT00537303|75920826|FG001|Overall Study|Protocol Violation|4|||
42110395|NCT00537303|75920825|FG000|Overall Study|Withdrawal criteria|3|||
42110396|NCT00537303|75920826|FG001|Overall Study|Withdrawal criteria|3|||
42110397|NCT00537303|75920825|FG000|Overall Study|Unclassified|8|||
42110398|NCT00537303|75920826|FG001|Overall Study|Unclassified|7|||
42110399|NCT00505414|75920834|FG000|Titration Phase|Adverse Event|0|||
42110400|NCT00505414|75920835|FG001|Titration Phase|Adverse Event|0|||
42110401|NCT00505414|75920836|FG002|Titration Phase|Adverse Event|0|||
42110402|NCT00505414|75920837|FG003|Titration Phase|Adverse Event|8|||
42110403|NCT00505414|75920838|FG004|Titration Phase|Adverse Event|3|||
42110404|NCT00505414|75920834|FG000|Titration Phase|Death|0|||
42110405|NCT00505414|75920835|FG001|Titration Phase|Death|0|||
42110406|NCT00505414|75920836|FG002|Titration Phase|Death|0|||
42110407|NCT00505414|75920837|FG003|Titration Phase|Death|2|||
42110408|NCT00505414|75920838|FG004|Titration Phase|Death|0|||
42110409|NCT00505414|75920834|FG000|Titration Phase|Lack of Efficacy|0|||
42110410|NCT00505414|75920835|FG001|Titration Phase|Lack of Efficacy|0|||
42110411|NCT00505414|75920836|FG002|Titration Phase|Lack of Efficacy|0|||
42110412|NCT00505414|75920837|FG003|Titration Phase|Lack of Efficacy|10|||
42110413|NCT00505414|75920838|FG004|Titration Phase|Lack of Efficacy|1|||
42110414|NCT00505414|75920834|FG000|Titration Phase|Protocol Violation|0|||
42110415|NCT00505414|75920835|FG001|Titration Phase|Protocol Violation|0|||
42110416|NCT00505414|75920836|FG002|Titration Phase|Protocol Violation|0|||
42110417|NCT00505414|75920837|FG003|Titration Phase|Protocol Violation|0|||
42110418|NCT00505414|75920838|FG004|Titration Phase|Protocol Violation|1|||
42110419|NCT00505414|75920834|FG000|Titration Phase|Withdrawal by Subject|0|||
42110420|NCT00505414|75920835|FG001|Titration Phase|Withdrawal by Subject|0|||
42110421|NCT00505414|75920836|FG002|Titration Phase|Withdrawal by Subject|0|||
42110422|NCT00505414|75920837|FG003|Titration Phase|Withdrawal by Subject|3|||
42110423|NCT00505414|75920838|FG004|Titration Phase|Withdrawal by Subject|4|||
42110424|NCT00505414|75920834|FG000|Titration Phase|Underlying disease and therapy required|0|||
42110425|NCT00505414|75920835|FG001|Titration Phase|Underlying disease and therapy required|0|||
42204150|NCT00009737|76016795|FG000|Overall Study|Refused Treatment|15|||
42204151|NCT00009737|76016796|FG001|Overall Study|Refused Treatment|16|||
42204152|NCT00009737|76016795|FG000|Overall Study|Lost to Follow-up|1|||
42204153|NCT00009737|76016796|FG001|Overall Study|Lost to Follow-up|1|||
42204154|NCT00009737|76016795|FG000|Overall Study|Administrative/Other Reasons|7|||
42204155|NCT00009737|76016796|FG001|Overall Study|Administrative/Other Reasons|1|||
42204156|NCT03417102|76016804|FG000|Overall Study|Adverse Event|0|||
42204157|NCT03417102|76016805|FG001|Overall Study|Adverse Event|1|||
42204158|NCT03417102|76016804|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
42204159|NCT03417102|76016805|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
42204160|NCT03417102|76016804|FG000|Overall Study|Other|0|||
42204161|NCT03417102|76016805|FG001|Overall Study|Other|1|||
42204162|NCT03417024|76016811|FG000|Overall Study|Study Termination prior to follow-up|11|||
42204163|NCT03417024|76016811|FG000|Overall Study|Physician Decision|2|||
42204164|NCT00028769|76016815|FG000|Overall Study|Adverse Event|2|||
42204165|NCT00028769|76016815|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
42204166|NCT00028769|76016815|FG000|Overall Study|Progression or Death|31|||
42204167|NCT00028769|76016815|FG000|Overall Study|Other - Not Protocol Specified|1|||
42204168|NCT00028769|76016815|FG000|Overall Study|Ineligible|5|||
42204169|NCT00028769|76016815|FG000|Overall Study|Not Analyzable|1|||
42204170|NCT02953314|76016821|FG000|Overall Study|Adverse Event|0|||
42110426|NCT00505414|75920836|FG002|Titration Phase|Underlying disease and therapy required|0|||
42110427|NCT00505414|75920837|FG003|Titration Phase|Underlying disease and therapy required|7|||
42110428|NCT00505414|75920838|FG004|Titration Phase|Underlying disease and therapy required|3|||
42110429|NCT00505414|75920834|FG000|Maintenance Phase|Adverse Event|2|||
42110430|NCT00505414|75920835|FG001|Maintenance Phase|Adverse Event|2|||
42110431|NCT00505414|75920836|FG002|Maintenance Phase|Adverse Event|3|||
42110432|NCT00505414|75920837|FG003|Maintenance Phase|Adverse Event|0|||
42110433|NCT00505414|75920838|FG004|Maintenance Phase|Adverse Event|0|||
42110434|NCT00505414|75920834|FG000|Maintenance Phase|Death|2|||
42204171|NCT02953314|76016822|FG001|Overall Study|Adverse Event|1|||
42204172|NCT02953314|76016821|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
42204173|NCT02953314|76016822|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
42204174|NCT03402750|76016830|FG000|Overall Study|Lost to Follow-up|2|||
42204175|NCT03402750|76016831|FG001|Overall Study|Lost to Follow-up|1|||
42204176|NCT00007475|76016840|FG000|Overall Study|Withdrawal by Subject|1|||
42204177|NCT00007475|76016841|FG001|Overall Study|Withdrawal by Subject|0|||
42204178|NCT00007475|76016842|FG002|Overall Study|Withdrawal by Subject|0|||
42204179|NCT00007475|76016843|FG003|Overall Study|Withdrawal by Subject|0|||
42204180|NCT00007475|76016840|FG000|Overall Study|Adverse Event|3|||
42204181|NCT00007475|76016841|FG001|Overall Study|Adverse Event|0|||
42204182|NCT00007475|76016842|FG002|Overall Study|Adverse Event|0|||
42204183|NCT00007475|76016843|FG003|Overall Study|Adverse Event|0|||
42204184|NCT00025883|76016855|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
42204185|NCT00025883|76016855|FG000|Overall Study|no baseline data|1|||
42204186|NCT00025883|76016855|FG000|Overall Study|Death|1|||
42204187|NCT00025883|76016855|FG000|Overall Study|Adverse Event|1|||
42204188|NCT00025883|76016855|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
42204189|NCT00072293|76016862|FG000|Overall Study|Lost to Follow-up|1|||
42204190|NCT00072293|76016863|FG001|Overall Study|Lost to Follow-up|1|||
42204191|NCT00072293|76016862|FG000|Overall Study|Withdrawal by Subject|0|||
42204192|NCT00072293|76016863|FG001|Overall Study|Withdrawal by Subject|1|||
42204193|NCT03753763|76016871|FG000|Overall Study|Adverse Event|2|||
42204194|NCT03753763|76016872|FG001|Overall Study|Adverse Event|0|||
42204195|NCT03753763|76016871|FG000|Overall Study|Withdrawal by Subject|3|||
42204196|NCT03753763|76016872|FG001|Overall Study|Withdrawal by Subject|1|||
42204197|NCT03753763|76016871|FG000|Overall Study|clinical deterioration|1|||
42204198|NCT03753763|76016872|FG001|Overall Study|clinical deterioration|0|||
42204199|NCT03384966|76016881|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
42204200|NCT03384966|76016882|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
42204201|NCT03384966|76016883|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
42204202|NCT03384966|76016881|FG000|Follow-up Period|Adverse Event|1|||
42204203|NCT03384966|76016882|FG001|Follow-up Period|Adverse Event|0|||
42204204|NCT03384966|76016883|FG002|Follow-up Period|Adverse Event|0|||
42204205|NCT03402126|76016900|FG000|Overall Study|Lost to Follow-up|6|||
42204206|NCT03402126|76016900|FG000|Overall Study|Protocol Violation|10|||
42204207|NCT03402126|76016900|FG000|Overall Study|Sponsor request/Study termination|29|||
42204208|NCT03402126|76016900|FG000|Overall Study|Study product no longer in use|1|||
42204209|NCT03402126|76016900|FG000|Overall Study|Technical problems|1|||
42204210|NCT03402126|76016900|FG000|Overall Study|Withdrawal by Subject|6|||
42204211|NCT03402126|76016900|FG000|Overall Study|Physician Decision|2|||
42204212|NCT03402126|76016900|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
42204213|NCT03402126|76016900|FG000|Overall Study|Death|4|||
42204214|NCT03355326|76016906|FG000|Overall Study|Protocol Violation|3|||
42204215|NCT03355326|76016907|FG001|Overall Study|Protocol Violation|3|||
42204216|NCT03353220|76016913|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
42204217|NCT03353220|76016914|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
42204218|NCT03751657|76016922|FG000|Overall Study|Physician Decision|0|||
42204219|NCT03751657|76016923|FG001|Overall Study|Physician Decision|1|||
42204220|NCT03751657|76016922|FG000|Overall Study|Withdrawal by Subject|1|||
42204221|NCT03751657|76016923|FG001|Overall Study|Withdrawal by Subject|1|||
42204222|NCT03751657|76016922|FG000|Overall Study|Lost to Follow-up|2|||
42204223|NCT03751657|76016923|FG001|Overall Study|Lost to Follow-up|1|||
42204224|NCT00025259|76016936|FG000|Overall Study|Death|1|||
42204225|NCT00025259|76016937|FG001|Overall Study|Death|3|||
42204226|NCT00025259|76016938|FG002|Overall Study|Death|0|||
42204227|NCT00025259|76016939|FG003|Overall Study|Death|3|||
42204228|NCT00025259|76016940|FG004|Overall Study|Death|0|||
42204229|NCT00025259|76016941|FG005|Overall Study|Death|1|||
42204230|NCT00025259|76016942|FG006|Overall Study|Death|2|||
42204231|NCT00025259|76016936|FG000|Overall Study|Lack of Efficacy|2|||
42204232|NCT00025259|76016937|FG001|Overall Study|Lack of Efficacy|46|||
42204233|NCT00025259|76016938|FG002|Overall Study|Lack of Efficacy|60|||
42204234|NCT00025259|76016939|FG003|Overall Study|Lack of Efficacy|78|||
42204235|NCT00025259|76016940|FG004|Overall Study|Lack of Efficacy|11|||
42204236|NCT00025259|76016941|FG005|Overall Study|Lack of Efficacy|30|||
42204237|NCT00025259|76016942|FG006|Overall Study|Lack of Efficacy|38|||
42204238|NCT00025259|76016936|FG000|Overall Study|Lost to Follow-up|2|||
42204239|NCT00025259|76016937|FG001|Overall Study|Lost to Follow-up|9|||
42204240|NCT00025259|76016938|FG002|Overall Study|Lost to Follow-up|13|||
42204241|NCT00025259|76016939|FG003|Overall Study|Lost to Follow-up|13|||
42204242|NCT00025259|76016940|FG004|Overall Study|Lost to Follow-up|1|||
42204243|NCT00025259|76016941|FG005|Overall Study|Lost to Follow-up|3|||
42204244|NCT00025259|76016942|FG006|Overall Study|Lost to Follow-up|1|||
42204245|NCT00025259|76016936|FG000|Overall Study|Physician Decision|12|||
42204246|NCT00025259|76016937|FG001|Overall Study|Physician Decision|1|||
42204247|NCT00025259|76016938|FG002|Overall Study|Physician Decision|0|||
42204248|NCT00025259|76016939|FG003|Overall Study|Physician Decision|5|||
42204249|NCT00025259|76016940|FG004|Overall Study|Physician Decision|4|||
42204250|NCT00025259|76016941|FG005|Overall Study|Physician Decision|2|||
42204251|NCT00025259|76016942|FG006|Overall Study|Physician Decision|1|||
42204252|NCT00025259|76016936|FG000|Overall Study|Protocol Violation|3|||
42204253|NCT00025259|76016937|FG001|Overall Study|Protocol Violation|2|||
42204254|NCT00025259|76016938|FG002|Overall Study|Protocol Violation|2|||
42204255|NCT00025259|76016939|FG003|Overall Study|Protocol Violation|1|||
42204256|NCT00025259|76016940|FG004|Overall Study|Protocol Violation|2|||
42204257|NCT00025259|76016941|FG005|Overall Study|Protocol Violation|1|||
42204258|NCT00025259|76016942|FG006|Overall Study|Protocol Violation|3|||
42204259|NCT00025259|76016936|FG000|Overall Study|Withdrawal by Subject|9|||
42204260|NCT00025259|76016937|FG001|Overall Study|Withdrawal by Subject|27|||
42204261|NCT00025259|76016938|FG002|Overall Study|Withdrawal by Subject|6|||
42204262|NCT00025259|76016939|FG003|Overall Study|Withdrawal by Subject|14|||
42204263|NCT00025259|76016940|FG004|Overall Study|Withdrawal by Subject|11|||
42204264|NCT00025259|76016941|FG005|Overall Study|Withdrawal by Subject|8|||
42204265|NCT00025259|76016942|FG006|Overall Study|Withdrawal by Subject|3|||
42204266|NCT00025259|76016936|FG000|Overall Study|Ineligible|14|||
42204267|NCT00025259|76016937|FG001|Overall Study|Ineligible|1|||
42204268|NCT00025259|76016938|FG002|Overall Study|Ineligible|0|||
42204269|NCT00025259|76016939|FG003|Overall Study|Ineligible|0|||
42204270|NCT00025259|76016940|FG004|Overall Study|Ineligible|6|||
42204271|NCT00025259|76016941|FG005|Overall Study|Ineligible|0|||
42204272|NCT00025259|76016942|FG006|Overall Study|Ineligible|1|||
42204273|NCT00025259|76016936|FG000|Overall Study|Randomization error|1|||
42204274|NCT00025259|76016937|FG001|Overall Study|Randomization error|0|||
42204275|NCT00025259|76016938|FG002|Overall Study|Randomization error|0|||
42204276|NCT00025259|76016939|FG003|Overall Study|Randomization error|0|||
42204277|NCT00025259|76016940|FG004|Overall Study|Randomization error|1|||
42204278|NCT00025259|76016941|FG005|Overall Study|Randomization error|7|||
42204279|NCT00025259|76016942|FG006|Overall Study|Randomization error|2|||
42204280|NCT00025259|76016936|FG000|Overall Study|Adverse Event|1|||
42204281|NCT00025259|76016937|FG001|Overall Study|Adverse Event|0|||
42204282|NCT00025259|76016938|FG002|Overall Study|Adverse Event|0|||
42204283|NCT00025259|76016939|FG003|Overall Study|Adverse Event|0|||
42204284|NCT00025259|76016940|FG004|Overall Study|Adverse Event|0|||
42204285|NCT00025259|76016941|FG005|Overall Study|Adverse Event|0|||
42204286|NCT00025259|76016942|FG006|Overall Study|Adverse Event|0|||
42204287|NCT03351738|76016967|FG000|Overall Study|Withdrawal by Subject|0|||
42204288|NCT03351738|76016968|FG001|Overall Study|Withdrawal by Subject|1|||
42204289|NCT03351738|76016969|FG002|Overall Study|Withdrawal by Subject|0|||
42204290|NCT03351738|76016970|FG003|Overall Study|Withdrawal by Subject|1|||
42204291|NCT03351738|76016971|FG004|Overall Study|Withdrawal by Subject|0|||
42204292|NCT03351738|76016972|FG005|Overall Study|Withdrawal by Subject|0|||
42204293|NCT03351114|76016991|FG000|Overall Study|Withdrawal by Subject|1|||
42204294|NCT03350256|76016995|FG000|Overall Study|Inclusion/exclusion violation|4|||
42204295|NCT03350256|76016995|FG000|Overall Study|Recommended for other therapies|2|||
42204296|NCT03350256|76016995|FG000|Overall Study|Protocol Violation|3|||
42204297|NCT03350256|76016995|FG000|Overall Study|Non compliance|2|||
42204298|NCT03350256|76016995|FG000|Overall Study|Denial by insurance|1|||
42204299|NCT03350256|76016995|FG000|Overall Study|Adverse Event|2|||
42019831|NCT01111539|75827285|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
42110435|NCT00505414|75920835|FG001|Maintenance Phase|Death|0|||
42110436|NCT00505414|75920836|FG002|Maintenance Phase|Death|1|||
42110437|NCT00505414|75920837|FG003|Maintenance Phase|Death|0|||
42204300|NCT03350256|76016995|FG000|Overall Study|Trial failure|12|||
42204301|NCT03350256|76016995|FG000|Overall Study|Did not proceed to permanent implant|3|||
42204302|NCT03350256|76016995|FG000|Overall Study|Withdrawal by Subject|3|||
42204303|NCT03350256|76016995|FG000|Overall Study|Subject moving out of state|1|||
42204304|NCT03350256|76016995|FG000|Overall Study|Lost to Follow-up|1|||
42204305|NCT03350256|76016995|FG000|Overall Study|Lack of Efficacy|2|||
42204306|NCT00024167|76017002|FG000|Overall Study|Death|53|||
42204307|NCT00024167|76017003|FG001|Overall Study|Death|47|||
42204308|NCT00022763|76017012|FG000|Overall Study|Adverse Event|1|||
42019832|NCT01111539|75827286|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
42019833|NCT01111539|75827287|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
42019834|NCT01111539|75827288|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
42019835|NCT01111539|75827284|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
42019836|NCT01111539|75827285|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
42019837|NCT01111539|75827286|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
42019838|NCT01111539|75827287|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
42019839|NCT01111539|75827288|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
42019840|NCT01111539|75827284|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
42019841|NCT01111539|75827285|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
42019842|NCT01111539|75827286|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
42019843|NCT01111539|75827287|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
42019844|NCT01111539|75827288|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
42204309|NCT00022763|76017013|FG001|Overall Study|Adverse Event|2|||
42204310|NCT00022763|76017012|FG000|Overall Study|Injection Site Reactions|0|||
42204311|NCT00022763|76017013|FG001|Overall Study|Injection Site Reactions|2|||
42204312|NCT00022763|76017012|FG000|Overall Study|Death|0|||
42387027|NCT01045161|76264645|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
42387028|NCT01045161|76264646|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
42387029|NCT01045161|76264647|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
42387030|NCT00633217|76264666|FG000|Overall Study|Adverse Event|5|||
42387031|NCT00633217|76264667|FG001|Overall Study|Adverse Event|9|||
42387032|NCT00633217|76264666|FG000|Overall Study|Lack of Efficacy|0|||
42387033|NCT00633217|76264667|FG001|Overall Study|Lack of Efficacy|2|||
42387034|NCT00633217|76264666|FG000|Overall Study|Protocol Violation|3|||
42387035|NCT00633217|76264667|FG001|Overall Study|Protocol Violation|7|||
42387036|NCT00633217|76264666|FG000|Overall Study|Lost to Follow-up|2|||
42387037|NCT00633217|76264667|FG001|Overall Study|Lost to Follow-up|2|||
42387038|NCT00633217|76264666|FG000|Overall Study|Investigator Discretion|2|||
42387039|NCT00633217|76264667|FG001|Overall Study|Investigator Discretion|0|||
42387040|NCT00633217|76264666|FG000|Overall Study|Withdrew Consent|3|||
42387041|NCT00633217|76264667|FG001|Overall Study|Withdrew Consent|3|||
42387042|NCT01673490|76264673|FG000|Overall Study|Lost to Follow-up|1|||
42387043|NCT01673490|76264673|FG000|Overall Study|Adverse Event|3|||
42387044|NCT01673490|76264673|FG000|Overall Study|Withdrawal by Subject|3|||
42387045|NCT00215657|76264685|FG000|Overall Study|Adverse Event|5|||
42387046|NCT00215657|76264686|FG001|Overall Study|Adverse Event|1|||
42387047|NCT00215657|76264687|FG002|Overall Study|Adverse Event|3|||
42387048|NCT00215657|76264688|FG003|Overall Study|Adverse Event|0|||
42387049|NCT00215657|76264689|FG004|Overall Study|Adverse Event|3|||
42387050|NCT00215657|76264690|FG005|Overall Study|Adverse Event|1|||
42387051|NCT00215657|76264691|FG006|Overall Study|Adverse Event|0|||
42387052|NCT00215657|76264692|FG007|Overall Study|Adverse Event|3|||
42387053|NCT00215657|76264685|FG000|Overall Study|Withdrawal by Subject|6|||
42387054|NCT00215657|76264686|FG001|Overall Study|Withdrawal by Subject|3|||
42387055|NCT00215657|76264687|FG002|Overall Study|Withdrawal by Subject|3|||
42387056|NCT00215657|76264688|FG003|Overall Study|Withdrawal by Subject|1|||
42387057|NCT00215657|76264689|FG004|Overall Study|Withdrawal by Subject|6|||
42387058|NCT00215657|76264690|FG005|Overall Study|Withdrawal by Subject|1|||
42387059|NCT00215657|76264691|FG006|Overall Study|Withdrawal by Subject|10|||
42387060|NCT00215657|76264692|FG007|Overall Study|Withdrawal by Subject|3|||
42387061|NCT00215657|76264685|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
42387062|NCT00215657|76264686|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
42387063|NCT00215657|76264687|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
42387064|NCT00215657|76264688|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
42387065|NCT00215657|76264689|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
42387066|NCT00215657|76264690|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
42387067|NCT00215657|76264691|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
42387068|NCT00215657|76264692|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
42387069|NCT00215657|76264685|FG000|Overall Study|Insufficient testosterone response|5|||
42387070|NCT00215657|76264686|FG001|Overall Study|Insufficient testosterone response|4|||
42387071|NCT00215657|76264687|FG002|Overall Study|Insufficient testosterone response|1|||
42387072|NCT00215657|76264688|FG003|Overall Study|Insufficient testosterone response|12|||
42387073|NCT00215657|76264689|FG004|Overall Study|Insufficient testosterone response|8|||
42387074|NCT00215657|76264690|FG005|Overall Study|Insufficient testosterone response|12|||
42387075|NCT00215657|76264691|FG006|Overall Study|Insufficient testosterone response|4|||
42387076|NCT00215657|76264692|FG007|Overall Study|Insufficient testosterone response|7|||
42387077|NCT00215657|76264685|FG000|Overall Study|Other|3|||
42387078|NCT00215657|76264686|FG001|Overall Study|Other|1|||
42387079|NCT00215657|76264687|FG002|Overall Study|Other|2|||
42387080|NCT00215657|76264688|FG003|Overall Study|Other|3|||
42387081|NCT00215657|76264689|FG004|Overall Study|Other|5|||
42387082|NCT00215657|76264690|FG005|Overall Study|Other|4|||
42387083|NCT00215657|76264691|FG006|Overall Study|Other|6|||
42387084|NCT00215657|76264692|FG007|Overall Study|Other|1|||
42387085|NCT00633061|76264712|FG000|Overall Study|Study closed|86|||
42387086|NCT00633061|76264713|FG001|Overall Study|Study closed|0|||
42204313|NCT00022763|76017013|FG001|Overall Study|Death|1|||
42204314|NCT00022763|76017012|FG000|Overall Study|Lost to Follow-up|0|||
42204315|NCT00022763|76017013|FG001|Overall Study|Lost to Follow-up|3|||
42204316|NCT00022763|76017012|FG000|Overall Study|Withdrawal by Subject|4|||
42110438|NCT00505414|75920838|FG004|Maintenance Phase|Death|0|||
42204317|NCT00022763|76017013|FG001|Overall Study|Withdrawal by Subject|7|||
42204318|NCT00022763|76017012|FG000|Overall Study|Insufficient Therapy|1|||
42387087|NCT00632827|76264721|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
42387088|NCT00632827|76264721|FG000|Overall Study|Death|2|||
42387089|NCT00632827|76264721|FG000|Overall Study|Adverse Event|5|||
42387090|NCT00632827|76264721|FG000|Overall Study|Lost to Follow-up|1|||
42387091|NCT00214019|76264726|FG000|Overall Study|Lost to Follow-up|11|||
42387092|NCT00214019|76264726|FG000|Overall Study|Withdrawal by Subject|2|||
42387093|NCT00214019|76264726|FG000|Overall Study|Screen Failed prior to randomization|17|||
42387094|NCT00210119|76264733|FG000|Overall Study|Protocol Violation|1|||
42387095|NCT00210119|76264733|FG000|Overall Study|Withdrawal by Subject|1|||
42387096|NCT01044459|76264739|FG000|Overall Study|Withdrawal by Subject|21|||
42387097|NCT01044459|76264740|FG001|Overall Study|Withdrawal by Subject|28|||
42387098|NCT01044459|76264739|FG000|Overall Study|Terminated by Sponsor|22|||
42387099|NCT01044459|76264740|FG001|Overall Study|Terminated by Sponsor|21|||
42387100|NCT01044459|76264739|FG000|Overall Study|Adverse Event|22|||
42387101|NCT01044459|76264740|FG001|Overall Study|Adverse Event|20|||
42387102|NCT01044459|76264739|FG000|Overall Study|Lack of Efficacy|23|||
42387103|NCT01044459|76264740|FG001|Overall Study|Lack of Efficacy|12|||
42387104|NCT01044459|76264739|FG000|Overall Study|Protocol Violation|11|||
42387105|NCT01044459|76264740|FG001|Overall Study|Protocol Violation|16|||
42387106|NCT01044459|76264739|FG000|Overall Study|Other Reason|7|||
42387107|NCT01044459|76264740|FG001|Overall Study|Other Reason|14|||
42387108|NCT01044459|76264739|FG000|Overall Study|COPD exacerbation|9|||
42387109|NCT01044459|76264740|FG001|Overall Study|COPD exacerbation|8|||
42387110|NCT01044459|76264739|FG000|Overall Study|Lost to Follow-up|18|||
42387111|NCT01044459|76264740|FG001|Overall Study|Lost to Follow-up|12|||
42387112|NCT00980005|76264748|FG000|Overall Study|Withdrawal by Subject|6|||
42387113|NCT00980005|76264749|FG001|Overall Study|Withdrawal by Subject|17|||
42387114|NCT00980005|76264748|FG000|Overall Study|Lost to Follow-up|37|||
42387115|NCT00980005|76264749|FG001|Overall Study|Lost to Follow-up|43|||
42387116|NCT00980005|76264748|FG000|Overall Study|Other|4|||
42387117|NCT00980005|76264749|FG001|Overall Study|Other|3|||
42387118|NCT01044303|76264759|FG000|Overall Study|Lost to Follow-up|2|||
42387119|NCT00983437|76264766|FG000|Overall Study|Adverse Event|9|||
42387120|NCT00983437|76264766|FG000|Overall Study|Lack of Efficacy|1|||
42387121|NCT00983437|76264766|FG000|Overall Study|Withdrawal by Subject|8|||
42387122|NCT00983437|76264766|FG000|Overall Study|Noncompliance to Study Procedures|1|||
42387123|NCT00983437|76264766|FG000|Overall Study|Lost to Follow-up|2|||
42387124|NCT00983437|76264766|FG000|Overall Study|Other Reason|26|||
42387125|NCT01042977|76264772|FG000|Overall Study|Adverse Event|4|||
42387126|NCT01042977|76264773|FG001|Overall Study|Adverse Event|12|||
42387127|NCT01042977|76264772|FG000|Overall Study|Death|2|||
42387128|NCT01042977|76264773|FG001|Overall Study|Death|1|||
42387129|NCT01042977|76264772|FG000|Overall Study|Withdrawal by Subject|8|||
42387130|NCT01042977|76264773|FG001|Overall Study|Withdrawal by Subject|16|||
42387131|NCT01042977|76264772|FG000|Overall Study|Lost to Follow-up|0|||
42387132|NCT01042977|76264773|FG001|Overall Study|Lost to Follow-up|2|||
42387133|NCT01042977|76264772|FG000|Overall Study|Poor/non-compliance|3|||
42387134|NCT01042977|76264773|FG001|Overall Study|Poor/non-compliance|4|||
42387135|NCT01042977|76264772|FG000|Overall Study|Subject no longer meets study criteria|15|||
42387136|NCT01042977|76264773|FG001|Overall Study|Subject no longer meets study criteria|13|||
42387137|NCT01042977|76264772|FG000|Overall Study|Incorrect enrollment|6|||
42387138|NCT01042977|76264773|FG001|Overall Study|Incorrect enrollment|4|||
42387139|NCT01042977|76264772|FG000|Overall Study|Safety|0|||
42387140|NCT01042977|76264773|FG001|Overall Study|Safety|2|||
42387141|NCT01042977|76264772|FG000|Overall Study|Administrative reason by sponsor|0|||
42387142|NCT01042977|76264773|FG001|Overall Study|Administrative reason by sponsor|1|||
42387143|NCT01042977|76264772|FG000|Overall Study|Various|3|||
42387144|NCT01042977|76264773|FG001|Overall Study|Various|0|||
42387145|NCT01041573|76264783|FG000|Overall Study|Withdrawal by Subject|2|||
42387146|NCT01041573|76264784|FG001|Overall Study|Withdrawal by Subject|5|||
42387147|NCT01041573|76264785|FG002|Overall Study|Withdrawal by Subject|2|||
42387148|NCT01041573|76264786|FG003|Overall Study|Withdrawal by Subject|0|||
42387149|NCT01041573|76264783|FG000|Overall Study|Death|1|||
42387150|NCT01041573|76264784|FG001|Overall Study|Death|0|||
42387151|NCT01041573|76264785|FG002|Overall Study|Death|0|||
42387152|NCT01041573|76264786|FG003|Overall Study|Death|0|||
42387153|NCT01041573|76264783|FG000|Overall Study|Lost to Follow-up|0|||
42387154|NCT01041573|76264784|FG001|Overall Study|Lost to Follow-up|1|||
42387155|NCT01041573|76264785|FG002|Overall Study|Lost to Follow-up|2|||
42387156|NCT01041573|76264786|FG003|Overall Study|Lost to Follow-up|1|||
42387157|NCT01041573|76264783|FG000|Overall Study|Adverse Event|0|||
42387158|NCT01041573|76264784|FG001|Overall Study|Adverse Event|2|||
42110439|NCT00505414|75920834|FG000|Maintenance Phase|Lack of Efficacy|2|||
42110440|NCT00505414|75920835|FG001|Maintenance Phase|Lack of Efficacy|1|||
42387159|NCT01041573|76264785|FG002|Overall Study|Adverse Event|0|||
42387160|NCT01041573|76264786|FG003|Overall Study|Adverse Event|0|||
42387161|NCT01041573|76264783|FG000|Overall Study|relocation|1|||
42387162|NCT01041573|76264784|FG001|Overall Study|relocation|4|||
42387163|NCT01041573|76264785|FG002|Overall Study|relocation|3|||
42387164|NCT01041573|76264786|FG003|Overall Study|relocation|1|||
42387165|NCT01041573|76264783|FG000|Overall Study|further blood extraction|0|||
42387166|NCT01041573|76264784|FG001|Overall Study|further blood extraction|1|||
42387167|NCT01041573|76264785|FG002|Overall Study|further blood extraction|0|||
42387168|NCT01041573|76264786|FG003|Overall Study|further blood extraction|0|||
42387169|NCT01041573|76264783|FG000|Overall Study|positive to anti-HCV|1|||
42019845|NCT01111539|75827284|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
42019846|NCT01111539|75827285|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
42019847|NCT01111539|75827286|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
42019848|NCT01111539|75827287|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
42019849|NCT01111539|75827288|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
42019850|NCT01111539|75827284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
42019851|NCT01111539|75827285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
42019852|NCT01111539|75827286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
42019853|NCT01111539|75827287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
42019854|NCT01111539|75827288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
42019855|NCT01111539|75827284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
42019856|NCT01111539|75827285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
42019857|NCT01111539|75827286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
42019858|NCT01111539|75827287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
42019859|NCT01111539|75827288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
42019860|NCT01111539|75827284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
42019861|NCT01111539|75827285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
42019862|NCT01111539|75827286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
42019863|NCT01111539|75827287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
42019864|NCT01111539|75827288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
42387170|NCT01041573|76264784|FG001|Overall Study|positive to anti-HCV|0|||
42019865|NCT01111539|75827284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
42019866|NCT01111539|75827285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
42019867|NCT01111539|75827286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
42019868|NCT01111539|75827287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
42019869|NCT01111539|75827288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
42019870|NCT01111539|75827284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
42019871|NCT01111539|75827285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
42019872|NCT01111539|75827286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
42019873|NCT01111539|75827287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
42019874|NCT01111539|75827288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
42019875|NCT01111539|75827284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
42019876|NCT01111539|75827285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
42019877|NCT01111539|75827286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
42019878|NCT01111539|75827287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
42019879|NCT01111539|75827288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
42019880|NCT01111539|75827284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
42019881|NCT01111539|75827285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
42019882|NCT01111539|75827286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
42019883|NCT01111539|75827287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
42019884|NCT01111539|75827288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
42019885|NCT01111149|75827301|FG000|Overall Study|Protocol Violation|1|||
42019886|NCT01111149|75827302|FG001|Overall Study|Protocol Violation|1|||
42019887|NCT01111149|75827303|FG002|Overall Study|Protocol Violation|2|||
42019888|NCT01111149|75827301|FG000|Overall Study|Withdrawal by Subject|1|||
42019889|NCT01111149|75827302|FG001|Overall Study|Withdrawal by Subject|0|||
42019890|NCT01111149|75827303|FG002|Overall Study|Withdrawal by Subject|2|||
42019891|NCT01254656|75827314|FG000|Overall Study|Discontinued due to termination of study|40|||
42019892|NCT01254656|75827315|FG001|Overall Study|Discontinued due to termination of study|39|||
42019893|NCT01254656|75827316|FG002|Overall Study|Discontinued due to termination of study|13|||
42019894|NCT01254656|75827314|FG000|Overall Study|Lack of Efficacy|3|||
42019895|NCT01254656|75827315|FG001|Overall Study|Lack of Efficacy|0|||
42019896|NCT01254656|75827316|FG002|Overall Study|Lack of Efficacy|0|||
42019897|NCT01254656|75827314|FG000|Overall Study|Lost to Follow-up|1|||
42019898|NCT01254656|75827315|FG001|Overall Study|Lost to Follow-up|0|||
42019899|NCT01254656|75827316|FG002|Overall Study|Lost to Follow-up|2|||
42019900|NCT01254656|75827314|FG000|Overall Study|Withdrawal by Subject|2|||
42019901|NCT01254656|75827315|FG001|Overall Study|Withdrawal by Subject|2|||
42019902|NCT01254656|75827316|FG002|Overall Study|Withdrawal by Subject|1|||
42019903|NCT01254656|75827314|FG000|Overall Study|Pregnancy|0|||
42019904|NCT01254656|75827315|FG001|Overall Study|Pregnancy|0|||
42019905|NCT01254656|75827316|FG002|Overall Study|Pregnancy|2|||
42019906|NCT01254656|75827314|FG000|Overall Study|Adverse Event|1|||
42019907|NCT01254656|75827315|FG001|Overall Study|Adverse Event|1|||
42019908|NCT01254656|75827316|FG002|Overall Study|Adverse Event|0|||
42019909|NCT01254656|75827314|FG000|Overall Study|Death|0|||
42204319|NCT00022763|76017013|FG001|Overall Study|Insufficient Therapy|0|||
42019910|NCT01254656|75827315|FG001|Overall Study|Death|1|||
42019911|NCT01254656|75827316|FG002|Overall Study|Death|0|||
42019912|NCT01110915|75827326|FG000|Overall Study|Death|2|||
42019913|NCT01110915|75827327|FG001|Overall Study|Death|1|||
42019914|NCT01110915|75827326|FG000|Overall Study|Lost to Follow-up|1|||
42019915|NCT01110915|75827327|FG001|Overall Study|Lost to Follow-up|0|||
42019916|NCT01110915|75827326|FG000|Overall Study|Withdrawal by Subject|7|||
42019917|NCT01110915|75827327|FG001|Overall Study|Withdrawal by Subject|1|||
42019918|NCT01254344|75827336|FG000|Overall Study|Adverse Event|2|||
42019919|NCT01254344|75827337|FG001|Overall Study|Adverse Event|5|||
42019920|NCT01254344|75827336|FG000|Overall Study|Physician Decision|7|||
42019921|NCT01254344|75827337|FG001|Overall Study|Physician Decision|4|||
42019922|NCT01254344|75827336|FG000|Overall Study|Protocol Violation|1|||
42019923|NCT01254344|75827337|FG001|Overall Study|Protocol Violation|4|||
42019924|NCT01254344|75827336|FG000|Overall Study|Withdrawal by Subject|3|||
42019925|NCT01254344|75827337|FG001|Overall Study|Withdrawal by Subject|6|||
42019926|NCT01102803|75827345|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
42019927|NCT01102803|75827346|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
42019928|NCT01102803|75827345|FG000|Post to Follow-Up|Lost to Follow-up|1|||
42019929|NCT01102803|75827346|FG001|Post to Follow-Up|Lost to Follow-up|3|||
42019930|NCT01254188|75827354|FG000|Overall Study|Disease Progression|6|||
42019931|NCT01254188|75827354|FG000|Overall Study|Protocol Violation|6|||
42019932|NCT01254188|75827354|FG000|Overall Study|Pregnancy|2|||
42019933|NCT01254188|75827354|FG000|Overall Study|Death|4|||
42019934|NCT01254188|75827354|FG000|Overall Study|Lost to Follow-up|5|||
42019935|NCT01254188|75827354|FG000|Overall Study|Withdrawal by Subject|7|||
42019936|NCT01254188|75827354|FG000|Overall Study|Adverse Event|43|||
42019937|NCT01254188|75827354|FG000|Overall Study|per investigator discretion|20|||
42019938|NCT01109979|75827360|FG000|Overall Study|Physician Decision|2|||
42019939|NCT01109979|75827361|FG001|Overall Study|Physician Decision|0|||
42019940|NCT01109979|75827360|FG000|Overall Study|Withdrawal by Subject|0|||
42019941|NCT01109979|75827361|FG001|Overall Study|Withdrawal by Subject|1|||
42019942|NCT01102491|75827369|FG000|Overall Study|Protocol Violation|11|||
42019943|NCT01102491|75827370|FG001|Overall Study|Protocol Violation|12|||
42019944|NCT01102257|75827378|FG000|Overall Study|Adverse Event|1|||
42019945|NCT01102257|75827379|FG001|Overall Study|Adverse Event|0|||
42019946|NCT01102257|75827378|FG000|Overall Study|Adverse Event|1|||
42019947|NCT01102257|75827379|FG001|Overall Study|Adverse Event|0|||
42019948|NCT01253564|75827385|FG000|Overall Study|Disease Progression|22|||
42019949|NCT01253564|75827385|FG000|Overall Study|Withdrawal by Subject|1|||
42019950|NCT01253564|75827385|FG000|Overall Study|Serious Adverse Event|1|||
42019951|NCT01108809|75827389|FG000|Overall Study|Adverse Event|3|||
42019952|NCT01108809|75827389|FG000|Overall Study|Lost to Follow-up|1|||
42019953|NCT01253408|75827397|FG000|Overall Study|Adverse Event|0|||
42019954|NCT01253408|75827398|FG001|Overall Study|Adverse Event|1|||
42019955|NCT01253408|75827399|FG002|Overall Study|Adverse Event|0|||
42019956|NCT01253174|75827407|FG000|Period 1|Randomized but not treated|0|||
42019957|NCT01253174|75827408|FG001|Period 1|Randomized but not treated|1|||
42019958|NCT01253174|75827409|FG002|Period 1|Randomized but not treated|1|||
42019959|NCT01253174|75827410|FG003|Period 1|Randomized but not treated|0|||
42019960|NCT01253174|75827411|FG004|Period 1|Randomized but not treated|1|||
42019961|NCT01253174|75827412|FG005|Period 1|Randomized but not treated|0|||
42019962|NCT01253174|75827407|FG000|Period 2|Adverse Event|0|||
42019963|NCT01253174|75827408|FG001|Period 2|Adverse Event|0|||
42019964|NCT01253174|75827409|FG002|Period 2|Adverse Event|1|||
42019965|NCT01253174|75827410|FG003|Period 2|Adverse Event|0|||
42019966|NCT01253174|75827411|FG004|Period 2|Adverse Event|0|||
42019967|NCT01253174|75827412|FG005|Period 2|Adverse Event|0|||
42019968|NCT01253174|75827407|FG000|Period 3|Withdrawal by Subject|0|||
42019969|NCT01253174|75827408|FG001|Period 3|Withdrawal by Subject|1|||
42019970|NCT01253174|75827409|FG002|Period 3|Withdrawal by Subject|0|||
42387171|NCT01041573|76264785|FG002|Overall Study|positive to anti-HCV|0|||
42387172|NCT01041573|76264786|FG003|Overall Study|positive to anti-HCV|0|||
42387173|NCT01041495|76264813|FG000|Overall Study|Withdrawal by Subject|2|||
42387174|NCT01041495|76264814|FG001|Overall Study|Withdrawal by Subject|5|||
42387175|NCT01041495|76264813|FG000|Overall Study|Adverse Event|2|||
42387176|NCT01041495|76264814|FG001|Overall Study|Adverse Event|1|||
42387177|NCT01041495|76264813|FG000|Overall Study|Lost to Follow-up|0|||
42387178|NCT01041495|76264814|FG001|Overall Study|Lost to Follow-up|1|||
42387179|NCT01041417|76264822|FG000|Overall Study|Adverse Event|5|||
42387180|NCT01041417|76264823|FG001|Overall Study|Adverse Event|2|||
42387181|NCT01041417|76264822|FG000|Overall Study|Lost to Follow-up|1|||
42387182|NCT01041417|76264823|FG001|Overall Study|Lost to Follow-up|1|||
42387183|NCT01041417|76264822|FG000|Overall Study|Death|1|||
42387184|NCT01041417|76264823|FG001|Overall Study|Death|0|||
42387185|NCT01040871|76264833|FG000|Overall Study|Adverse Event|6|||
42387186|NCT01040871|76264834|FG001|Overall Study|Adverse Event|2|||
42387187|NCT01040871|76264833|FG000|Overall Study|Withdrawal by Subject|2|||
42387188|NCT01040871|76264834|FG001|Overall Study|Withdrawal by Subject|0|||
42387189|NCT01040871|76264833|FG000|Overall Study|Death|1|||
42387190|NCT01040871|76264834|FG001|Overall Study|Death|3|||
42387191|NCT01040871|76264833|FG000|Overall Study|Lack of Efficacy|1|||
42387192|NCT01040871|76264834|FG001|Overall Study|Lack of Efficacy|1|||
42387193|NCT01040871|76264833|FG000|Overall Study|drug supply issue|1|||
42387194|NCT01040871|76264834|FG001|Overall Study|drug supply issue|0|||
42387195|NCT01040871|76264833|FG000|Overall Study|Randomized and Not Treated|2|||
42387196|NCT01040871|76264834|FG001|Overall Study|Randomized and Not Treated|1|||
42387197|NCT01040169|76264842|FG000|Overall Study|Lost to Follow-up|3|||
42387198|NCT01040169|76264843|FG001|Overall Study|Lost to Follow-up|8|||
42387199|NCT01673178|76264863|FG000|Overall Study|Lost to Follow-up|0|||
42387200|NCT01673178|76264864|FG001|Overall Study|Lost to Follow-up|1|||
42387201|NCT01673178|76264865|FG002|Overall Study|Lost to Follow-up|0|||
42387202|NCT01673178|76264866|FG003|Overall Study|Lost to Follow-up|0|||
42387203|NCT01673178|76264867|FG004|Overall Study|Lost to Follow-up|0|||
42387204|NCT01673178|76264863|FG000|Overall Study|Withdrawal by Subject|0|||
42387205|NCT01673178|76264864|FG001|Overall Study|Withdrawal by Subject|0|||
42387206|NCT01673178|76264865|FG002|Overall Study|Withdrawal by Subject|1|||
42387207|NCT01673178|76264866|FG003|Overall Study|Withdrawal by Subject|4|||
42387208|NCT01673178|76264867|FG004|Overall Study|Withdrawal by Subject|2|||
42387209|NCT01673178|76264863|FG000|Overall Study|Protocol Violation|1|||
42387210|NCT01673178|76264864|FG001|Overall Study|Protocol Violation|1|||
42019971|NCT01253174|75827410|FG003|Period 3|Withdrawal by Subject|0|||
42019972|NCT01253174|75827411|FG004|Period 3|Withdrawal by Subject|1|||
42019973|NCT01253174|75827412|FG005|Period 3|Withdrawal by Subject|0|||
42019974|NCT01253174|75827407|FG000|Period 3|Pregnancy|0|||
42019975|NCT01253174|75827408|FG001|Period 3|Pregnancy|0|||
42019976|NCT01253174|75827409|FG002|Period 3|Pregnancy|1|||
42019977|NCT01253174|75827410|FG003|Period 3|Pregnancy|0|||
42019978|NCT01253174|75827411|FG004|Period 3|Pregnancy|0|||
42019979|NCT01253174|75827412|FG005|Period 3|Pregnancy|0|||
42019980|NCT01108731|75827423|FG000|Overall Study|Withdrawal by Subject|1|||
42019981|NCT01108731|75827424|FG001|Overall Study|Withdrawal by Subject|1|||
42019982|NCT01108731|75827423|FG000|Overall Study|Adverse Event|3|||
42019983|NCT01108731|75827424|FG001|Overall Study|Adverse Event|3|||
42019984|NCT01253018|75827432|FG000|Overall Study|Lost to Follow-up|1|||
42019985|NCT01253018|75827433|FG001|Overall Study|Lost to Follow-up|1|||
42019986|NCT01253018|75827432|FG000|Overall Study|Robot Repair Issues|2|||
42019987|NCT01253018|75827433|FG001|Overall Study|Robot Repair Issues|0|||
42019988|NCT01253018|75827432|FG000|Overall Study|Withdrawal by Subject|1|||
42019989|NCT01253018|75827433|FG001|Overall Study|Withdrawal by Subject|1|||
42019990|NCT01108341|75827440|FG000|Overall Study|Death|2|||
42019991|NCT01108341|75827440|FG000|Overall Study|Withdrawal by Subject|1|||
42019992|NCT01108341|75827440|FG000|Overall Study|Lost to Follow-up|1|||
42019993|NCT01108341|75827440|FG000|Overall Study|Other|1|||
42019994|NCT01108263|75827446|FG000|Overall Study|Adverse Event|0|||
42019995|NCT01108263|75827447|FG001|Overall Study|Adverse Event|1|||
42019996|NCT01108185|75827453|FG000|Overall Study|Non-compliance|15|||
42019997|NCT01108185|75827453|FG000|Overall Study|Lost to Follow-up|12|||
42019998|NCT01252940|75827459|FG000|Main Study Phase|Randomized but not treated|4|||
42019999|NCT01252940|75827460|FG001|Main Study Phase|Randomized but not treated|2|||
42020000|NCT01252940|75827459|FG000|Main Study Phase|Adverse Event|3|||
42020001|NCT01252940|75827460|FG001|Main Study Phase|Adverse Event|1|||
42020002|NCT01252940|75827459|FG000|Main Study Phase|Lack of Efficacy|1|||
42020003|NCT01252940|75827460|FG001|Main Study Phase|Lack of Efficacy|0|||
42020004|NCT01252940|75827459|FG000|Main Study Phase|Lost to Follow-up|6|||
42020005|NCT01252940|75827460|FG001|Main Study Phase|Lost to Follow-up|1|||
42020006|NCT01252940|75827459|FG000|Main Study Phase|Physician Decision|1|||
42020007|NCT01252940|75827460|FG001|Main Study Phase|Physician Decision|0|||
42020008|NCT01252940|75827459|FG000|Main Study Phase|Protocol Violation|4|||
42020009|NCT01252940|75827460|FG001|Main Study Phase|Protocol Violation|2|||
42020010|NCT01252940|75827459|FG000|Main Study Phase|Withdrawal by Subject|6|||
42020011|NCT01252940|75827460|FG001|Main Study Phase|Withdrawal by Subject|5|||
42020012|NCT01252940|75827459|FG000|Main Study Phase|Subject Non-compliance|1|||
42020013|NCT01252940|75827460|FG001|Main Study Phase|Subject Non-compliance|1|||
42020014|NCT01252940|75827459|FG000|Extension Phase|Adverse Event|2|||
42020015|NCT01252940|75827460|FG001|Extension Phase|Adverse Event|1|||
42020016|NCT01252940|75827459|FG000|Extension Phase|Lack of Efficacy|1|||
42020017|NCT01252940|75827460|FG001|Extension Phase|Lack of Efficacy|0|||
42020018|NCT01252940|75827459|FG000|Extension Phase|Lost to Follow-up|5|||
42020019|NCT01252940|75827460|FG001|Extension Phase|Lost to Follow-up|0|||
42020020|NCT01252940|75827459|FG000|Extension Phase|Physician Decision|0|||
42020021|NCT01252940|75827460|FG001|Extension Phase|Physician Decision|1|||
42020022|NCT01252940|75827459|FG000|Extension Phase|Subject Non-compliance|1|||
42020023|NCT01252940|75827460|FG001|Extension Phase|Subject Non-compliance|0|||
42020024|NCT01252940|75827459|FG000|Extension Phase|Withdrawal by Subject|1|||
42020025|NCT01252940|75827460|FG001|Extension Phase|Withdrawal by Subject|1|||
42204320|NCT00022763|76017012|FG000|Overall Study|Admin|3|||
42204321|NCT00022763|76017013|FG001|Overall Study|Admin|2|||
42204322|NCT00071513|76017020|FG000|Intervention Component|Withdrawal by Subject|2|||
42204323|NCT00071513|76017021|FG001|Intervention Component|Withdrawal by Subject|3|||
42020026|NCT01252238|75827470|FG000|Overall Study|Sponsor terminated study|4|||
42020027|NCT01252238|75827471|FG001|Overall Study|Sponsor terminated study|4|||
42020028|NCT01252238|75827472|FG002|Overall Study|Sponsor terminated study|4|||
42020029|NCT01101477|75827486|FG000|Overall Study|Protocol Violation|5|||
42020030|NCT01101477|75827487|FG001|Overall Study|Protocol Violation|3|||
42020031|NCT01101477|75827488|FG002|Overall Study|Protocol Violation|1|||
42020032|NCT01251770|75827498|FG000|Overall Study|Protocol Violation|13|||
42020033|NCT01251770|75827499|FG001|Overall Study|Protocol Violation|7|||
42020034|NCT01101321|75827505|FG000|Period 1|Withdrawal by Subject|1|||
42020035|NCT01101321|75827506|FG001|Period 1|Withdrawal by Subject|1|||
42020036|NCT01101321|75827505|FG000|Period 1|Adverse Event|3|||
42020037|NCT01101321|75827506|FG001|Period 1|Adverse Event|3|||
42020038|NCT01101165|75827512|FG000|Period 1|Adverse Event|1|||
42020039|NCT01101165|75827513|FG001|Period 1|Adverse Event|2|||
42020040|NCT01101165|75827512|FG000|Period 1|Withdrawal by Subject|0|||
42020041|NCT01101165|75827513|FG001|Period 1|Withdrawal by Subject|2|||
42020042|NCT01101165|75827512|FG000|Period 1|Positive Drug Screen|0|||
42020043|NCT01101165|75827513|FG001|Period 1|Positive Drug Screen|1|||
42020044|NCT01101165|75827512|FG000|Period 1|Lost to Follow-up|1|||
42020045|NCT01101165|75827513|FG001|Period 1|Lost to Follow-up|0|||
42020046|NCT01101165|75827512|FG000|Period 2|Withdrawal by Subject|3|||
42020047|NCT01101165|75827513|FG001|Period 2|Withdrawal by Subject|1|||
42020048|NCT01101165|75827512|FG000|Period 2|Adverse Event|1|||
42020049|NCT01101165|75827513|FG001|Period 2|Adverse Event|0|||
42020050|NCT01100853|75827521|FG000|Overall Study|Lost to Follow-up|11|||
42020051|NCT01100853|75827522|FG001|Overall Study|Lost to Follow-up|6|||
42020052|NCT01100853|75827521|FG000|Overall Study|Received <4 study injections|10|||
42020053|NCT01100853|75827522|FG001|Overall Study|Received <4 study injections|13|||
42020054|NCT01100853|75827521|FG000|Overall Study|Withdrawal by Subject|6|||
42020055|NCT01100853|75827522|FG001|Overall Study|Withdrawal by Subject|4|||
42020056|NCT01100307|75827530|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
42020057|NCT01100307|75827531|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
42020058|NCT01100307|75827530|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
42020059|NCT01100307|75827531|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
42020060|NCT01100307|75827530|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
42020061|NCT01100307|75827531|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
42020062|NCT01100307|75827530|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
42020063|NCT01100307|75827531|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
42020064|NCT01100307|75827530|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
42020065|NCT01100307|75827531|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
42020066|NCT01100307|75827530|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
42020067|NCT01100307|75827531|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
42020068|NCT01100073|75827539|FG000|Overall Study|Lack of Efficacy|4|||
42020069|NCT01100073|75827539|FG000|Overall Study|Insufficient Tolerability|21|||
42020070|NCT01100073|75827539|FG000|Overall Study|Withdrawal by Subject|13|||
42020071|NCT01100073|75827539|FG000|Overall Study|Lost to Follow-up|39|||
42020072|NCT01100073|75827539|FG000|Overall Study|Lack of effect + patient's wish|2|||
42020073|NCT01100073|75827539|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
42020074|NCT01100073|75827539|FG000|Overall Study|Other|8|||
42020075|NCT01100073|75827539|FG000|Overall Study|Missing|5|||
42020076|NCT01099917|75827543|FG000|Overall Study|Adverse Event|3|||
42020077|NCT01099917|75827543|FG000|Overall Study|Not Treated|24|||
42020078|NCT01099215|75827549|FG000|Overall Study|Withdrawal by Subject|1|||
42020079|NCT01099215|75827550|FG001|Overall Study|Withdrawal by Subject|0|||
42020080|NCT01099215|75827549|FG000|Overall Study|Adverse Event|0|||
42020081|NCT01099215|75827550|FG001|Overall Study|Adverse Event|1|||
42020082|NCT01097655|75827556|FG000|Overall Study|Withdrawal by Subject|1|||
42020083|NCT01097655|75827556|FG000|Overall Study|Subject Documented Twice|1|||
42020084|NCT01097655|75827556|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
42020085|NCT01107405|75827565|FG000|Overall Study|Adverse Event|1|||
42020086|NCT01107405|75827566|FG001|Overall Study|Adverse Event|1|||
42020087|NCT01107405|75827567|FG002|Overall Study|Adverse Event|0|||
42020088|NCT01107405|75827568|FG003|Overall Study|Adverse Event|0|||
42020089|NCT01107405|75827569|FG004|Overall Study|Adverse Event|2|||
42020090|NCT01107405|75827565|FG000|Overall Study|Withdrawal by Subject|1|||
42020091|NCT01107405|75827566|FG001|Overall Study|Withdrawal by Subject|0|||
42020092|NCT01107405|75827567|FG002|Overall Study|Withdrawal by Subject|1|||
42020093|NCT01107405|75827568|FG003|Overall Study|Withdrawal by Subject|2|||
42020094|NCT01107405|75827569|FG004|Overall Study|Withdrawal by Subject|1|||
42020095|NCT01107405|75827565|FG000|Overall Study|Protocol Violation|0|||
42020096|NCT01107405|75827566|FG001|Overall Study|Protocol Violation|0|||
42020097|NCT01107405|75827567|FG002|Overall Study|Protocol Violation|1|||
42020098|NCT01107405|75827568|FG003|Overall Study|Protocol Violation|1|||
42020099|NCT01107405|75827569|FG004|Overall Study|Protocol Violation|0|||
42020100|NCT01097577|75827583|FG000|Overall Study|Adverse Event|0|||
42020101|NCT01097577|75827584|FG001|Overall Study|Adverse Event|1|||
42020102|NCT01097421|75827590|FG000|Overall Study|Adverse Event|8|||
42020103|NCT01097421|75827590|FG000|Overall Study|Protocol Violation|2|||
42020104|NCT01097421|75827590|FG000|Overall Study|Lost to Follow-up|1|||
42020105|NCT01097421|75827590|FG000|Overall Study|Withdrawal by Subject|3|||
42110441|NCT00505414|75920836|FG002|Maintenance Phase|Lack of Efficacy|1|||
42110442|NCT00505414|75920837|FG003|Maintenance Phase|Lack of Efficacy|0|||
42204324|NCT00071513|76017020|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
42204325|NCT00071513|76017021|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
42020106|NCT01251614|75827597|FG000|Overall Study|Adverse Event|1|||
42020107|NCT01251614|75827598|FG001|Overall Study|Adverse Event|0|||
42020108|NCT01251614|75827599|FG002|Overall Study|Adverse Event|1|||
42020109|NCT01251614|75827597|FG000|Overall Study|Lack of Efficacy|1|||
42020110|NCT01251614|75827598|FG001|Overall Study|Lack of Efficacy|9|||
42020111|NCT01251614|75827599|FG002|Overall Study|Lack of Efficacy|4|||
42110443|NCT00505414|75920838|FG004|Maintenance Phase|Lack of Efficacy|0|||
42110444|NCT00505414|75920834|FG000|Maintenance Phase|Withdrawal by Subject|0|||
42110445|NCT00505414|75920835|FG001|Maintenance Phase|Withdrawal by Subject|0|||
42110446|NCT00505414|75920836|FG002|Maintenance Phase|Withdrawal by Subject|1|||
42110447|NCT00505414|75920837|FG003|Maintenance Phase|Withdrawal by Subject|0|||
42110448|NCT00505414|75920838|FG004|Maintenance Phase|Withdrawal by Subject|0|||
42110449|NCT00505414|75920834|FG000|Maintenance Phase|underlying disease and therapy required|0|||
42110450|NCT00505414|75920835|FG001|Maintenance Phase|underlying disease and therapy required|2|||
42110451|NCT00505414|75920836|FG002|Maintenance Phase|underlying disease and therapy required|2|||
42110452|NCT00505414|75920837|FG003|Maintenance Phase|underlying disease and therapy required|0|||
42110453|NCT00505414|75920838|FG004|Maintenance Phase|underlying disease and therapy required|0|||
42110454|NCT00144781|75920872|FG000|Overall Study|Adverse Event|0|||
42110455|NCT00144781|75920873|FG001|Overall Study|Adverse Event|1|||
42110456|NCT00144781|75920874|FG002|Overall Study|Adverse Event|0|||
42110457|NCT00144781|75920875|FG003|Overall Study|Adverse Event|0|||
42110458|NCT00144781|75920872|FG000|Overall Study|Non-compliant|0|||
42110459|NCT00144781|75920873|FG001|Overall Study|Non-compliant|1|||
42110460|NCT00144781|75920874|FG002|Overall Study|Non-compliant|0|||
42110461|NCT00144781|75920875|FG003|Overall Study|Non-compliant|0|||
42110462|NCT00621140|75920891|FG000|Overall Study|Adverse Event|4|||
42110463|NCT00621140|75920892|FG001|Overall Study|Adverse Event|5|||
42110464|NCT00621140|75920891|FG000|Overall Study|Lost to Follow-up|1|||
42110465|NCT00621140|75920892|FG001|Overall Study|Lost to Follow-up|2|||
42110466|NCT00621140|75920891|FG000|Overall Study|Withdrawal by Subject|4|||
42110467|NCT00621140|75920892|FG001|Overall Study|Withdrawal by Subject|6|||
42110468|NCT00621140|75920891|FG000|Overall Study|Other incl. lack of efficacy|6|||
42110469|NCT00621140|75920892|FG001|Overall Study|Other incl. lack of efficacy|5|||
42110470|NCT00207727|75920903|FG000|Overall Study|Withdrawal by Subject|0|||
42110471|NCT00207727|75920904|FG001|Overall Study|Withdrawal by Subject|0|||
42110472|NCT00207727|75920905|FG002|Overall Study|Withdrawal by Subject|0|||
42110473|NCT00207727|75920906|FG003|Overall Study|Withdrawal by Subject|0|||
42110474|NCT00207727|75920907|FG004|Overall Study|Withdrawal by Subject|1|||
42110475|NCT00207727|75920903|FG000|Overall Study|Lost to Follow-up|0|||
42110476|NCT00207727|75920904|FG001|Overall Study|Lost to Follow-up|1|||
42110477|NCT00207727|75920905|FG002|Overall Study|Lost to Follow-up|0|||
42110478|NCT00207727|75920906|FG003|Overall Study|Lost to Follow-up|0|||
42110479|NCT00207727|75920907|FG004|Overall Study|Lost to Follow-up|0|||
42110480|NCT00207727|75920903|FG000|Overall Study|Other|38|||
42110481|NCT00207727|75920904|FG001|Overall Study|Other|41|||
42110482|NCT00207727|75920905|FG002|Overall Study|Other|41|||
42110483|NCT00207727|75920906|FG003|Overall Study|Other|37|||
42110484|NCT00207727|75920907|FG004|Overall Study|Other|33|||
42110485|NCT00504556|75920924|FG000|Overall Study|Adverse Event|11|||
42110486|NCT00504556|75920925|FG001|Overall Study|Adverse Event|11|||
42110487|NCT00504556|75920926|FG002|Overall Study|Adverse Event|14|||
42110488|NCT00504556|75920927|FG003|Overall Study|Adverse Event|13|||
42110489|NCT00504556|75920928|FG004|Overall Study|Adverse Event|5|||
42110490|NCT00504556|75920924|FG000|Overall Study|Death|3|||
42110491|NCT00504556|75920925|FG001|Overall Study|Death|3|||
42110492|NCT00504556|75920926|FG002|Overall Study|Death|1|||
42110493|NCT00504556|75920927|FG003|Overall Study|Death|0|||
42110494|NCT00504556|75920928|FG004|Overall Study|Death|2|||
42110495|NCT00504556|75920924|FG000|Overall Study|Protocol Violation|1|||
42110496|NCT00504556|75920925|FG001|Overall Study|Protocol Violation|3|||
42110497|NCT00504556|75920926|FG002|Overall Study|Protocol Violation|2|||
42110498|NCT00504556|75920927|FG003|Overall Study|Protocol Violation|1|||
42110499|NCT00504556|75920928|FG004|Overall Study|Protocol Violation|2|||
42110500|NCT00504556|75920924|FG000|Overall Study|Lost to Follow-up|0|||
42110501|NCT00504556|75920925|FG001|Overall Study|Lost to Follow-up|0|||
42110502|NCT00504556|75920926|FG002|Overall Study|Lost to Follow-up|1|||
42110503|NCT00504556|75920927|FG003|Overall Study|Lost to Follow-up|1|||
42110504|NCT00504556|75920928|FG004|Overall Study|Lost to Follow-up|1|||
42110505|NCT00504556|75920924|FG000|Overall Study|Withdrawal by Subject|16|||
42110506|NCT00504556|75920925|FG001|Overall Study|Withdrawal by Subject|16|||
42110507|NCT00504556|75920926|FG002|Overall Study|Withdrawal by Subject|7|||
42110508|NCT00504556|75920927|FG003|Overall Study|Withdrawal by Subject|8|||
42110509|NCT00504556|75920928|FG004|Overall Study|Withdrawal by Subject|12|||
42110510|NCT00504556|75920924|FG000|Overall Study|administrative reasons|0|||
42110511|NCT00504556|75920925|FG001|Overall Study|administrative reasons|2|||
42110512|NCT00504556|75920926|FG002|Overall Study|administrative reasons|2|||
42110513|NCT00504556|75920927|FG003|Overall Study|administrative reasons|1|||
42110514|NCT00504556|75920928|FG004|Overall Study|administrative reasons|2|||
42110515|NCT00504556|75920924|FG000|Overall Study|did not meet entry criteria|2|||
42110516|NCT00504556|75920925|FG001|Overall Study|did not meet entry criteria|0|||
42110517|NCT00504556|75920926|FG002|Overall Study|did not meet entry criteria|1|||
42110518|NCT00504556|75920927|FG003|Overall Study|did not meet entry criteria|1|||
42110519|NCT00504556|75920928|FG004|Overall Study|did not meet entry criteria|0|||
42110520|NCT00504556|75920924|FG000|Overall Study|data monitor committee decision|0|||
42110521|NCT00504556|75920925|FG001|Overall Study|data monitor committee decision|0|||
42110522|NCT00504556|75920926|FG002|Overall Study|data monitor committee decision|0|||
42110523|NCT00504556|75920927|FG003|Overall Study|data monitor committee decision|100|||
42110524|NCT00504556|75920928|FG004|Overall Study|data monitor committee decision|0|||
42110525|NCT00504556|75920924|FG000|Overall Study|Other|2|||
42110526|NCT00504556|75920925|FG001|Overall Study|Other|2|||
42110527|NCT00504556|75920926|FG002|Overall Study|Other|2|||
42110528|NCT00504556|75920927|FG003|Overall Study|Other|3|||
42110529|NCT00504556|75920928|FG004|Overall Study|Other|0|||
42110530|NCT00504556|75920924|FG000|Overall Study|not in safety analysis set|0|||
42110531|NCT00504556|75920925|FG001|Overall Study|not in safety analysis set|1|||
42110532|NCT00504556|75920926|FG002|Overall Study|not in safety analysis set|1|||
42110533|NCT00504556|75920927|FG003|Overall Study|not in safety analysis set|0|||
42110534|NCT00504556|75920928|FG004|Overall Study|not in safety analysis set|1|||
42110535|NCT00206323|75920942|FG000|Overall Study|Lack of Efficacy|4|||
42110536|NCT00206323|75920943|FG001|Overall Study|Lack of Efficacy|1|||
42110537|NCT00206323|75920942|FG000|Overall Study|Adverse Event|1|||
42110538|NCT00206323|75920943|FG001|Overall Study|Adverse Event|1|||
42110539|NCT00206323|75920942|FG000|Overall Study|Lost to Follow-up|1|||
42110540|NCT00206323|75920943|FG001|Overall Study|Lost to Follow-up|1|||
42110541|NCT03903159|75920949|FG000|Overall Study|Discharged with Staff Approval|2|||
42110542|NCT03903159|75920949|FG000|Overall Study|Discharged at Staff Request|2|||
42110543|NCT03903159|75920949|FG000|Overall Study|Discharged Against Staff Advice|1|||
42110544|NCT00205855|75920953|FG000|Overall Study|Only received temporary implants|16|||
42110545|NCT00205855|75920953|FG000|Overall Study|Withdrawal by Subject|5|||
42110546|NCT00536991|75920957|FG000|Overall Study|Withdrawal by Subject|10|||
42110547|NCT00536991|75920957|FG000|Overall Study|Physician Decision|1|||
42110548|NCT00536991|75920957|FG000|Overall Study|patient ineligible|2|||
42110549|NCT00504166|75920964|FG000|Overall Study|Adverse Event|1|||
42110550|NCT00504166|75920965|FG001|Overall Study|Adverse Event|4|||
42110551|NCT00504166|75920964|FG000|Overall Study|Withdrawal by Subject|3|||
42110552|NCT00504166|75920965|FG001|Overall Study|Withdrawal by Subject|6|||
42110553|NCT00504166|75920964|FG000|Overall Study|Physician Decision|1|||
42110554|NCT00504166|75920965|FG001|Overall Study|Physician Decision|1|||
42110555|NCT00504166|75920964|FG000|Overall Study|Lost to Follow-up|1|||
42110556|NCT00504166|75920965|FG001|Overall Study|Lost to Follow-up|3|||
42110557|NCT00509236|75920973|FG000|Overall Study|Adverse Event|7|||
42110558|NCT00509236|75920974|FG001|Overall Study|Adverse Event|9|||
42110559|NCT00509236|75920973|FG000|Overall Study|Withdrawal by Subject|5|||
42110560|NCT00509236|75920974|FG001|Overall Study|Withdrawal by Subject|10|||
42110561|NCT00509236|75920973|FG000|Overall Study|Protocol Violation|3|||
42110562|NCT00509236|75920974|FG001|Overall Study|Protocol Violation|0|||
42110563|NCT00509236|75920973|FG000|Overall Study|Excluded Medication|1|||
42204326|NCT00006389|76017029|FG000|Overall Study|Adverse Event|1|||
42204327|NCT00006305|76017038|FG000|Overall Study|Withdrawal by Subject|17|||
42204328|NCT00006305|76017039|FG001|Overall Study|Withdrawal by Subject|10|||
42204329|NCT00006305|76017040|FG002|Overall Study|Withdrawal by Subject|15|||
42204330|NCT00006305|76017041|FG003|Overall Study|Withdrawal by Subject|14|||
42204331|NCT03529773|76017091|FG000|Overall Study|Adverse Event|0|||
42204332|NCT03529773|76017092|FG001|Overall Study|Adverse Event|0|||
42204333|NCT03529773|76017093|FG002|Overall Study|Adverse Event|0|||
42204334|NCT03529773|76017094|FG003|Overall Study|Adverse Event|0|||
42204335|NCT03529773|76017095|FG004|Overall Study|Adverse Event|0|||
42204336|NCT03529773|76017096|FG005|Overall Study|Adverse Event|0|||
42204337|NCT03529773|76017097|FG006|Overall Study|Adverse Event|0|||
42204338|NCT03529773|76017098|FG007|Overall Study|Adverse Event|0|||
42204339|NCT03529773|76017099|FG008|Overall Study|Adverse Event|0|||
42204340|NCT03529773|76017100|FG009|Overall Study|Adverse Event|0|||
42204341|NCT03529773|76017101|FG010|Overall Study|Adverse Event|0|||
42204342|NCT03529773|76017102|FG011|Overall Study|Adverse Event|0|||
42204343|NCT03529773|76017103|FG012|Overall Study|Adverse Event|0|||
42204344|NCT03529773|76017104|FG013|Overall Study|Adverse Event|0|||
42204345|NCT03529773|76017105|FG014|Overall Study|Adverse Event|0|||
42204346|NCT03529773|76017106|FG015|Overall Study|Adverse Event|0|||
42204347|NCT03529773|76017107|FG016|Overall Study|Adverse Event|0|||
42204348|NCT03529773|76017108|FG017|Overall Study|Adverse Event|0|||
42204349|NCT03529773|76017109|FG018|Overall Study|Adverse Event|0|||
42204350|NCT03529773|76017110|FG019|Overall Study|Adverse Event|0|||
42204351|NCT03529773|76017111|FG020|Overall Study|Adverse Event|0|||
42204352|NCT03529773|76017112|FG021|Overall Study|Adverse Event|0|||
42204353|NCT03529773|76017113|FG022|Overall Study|Adverse Event|0|||
42204354|NCT03529773|76017114|FG023|Overall Study|Adverse Event|0|||
42204355|NCT03529773|76017115|FG024|Overall Study|Adverse Event|0|||
42204356|NCT03529773|76017116|FG025|Overall Study|Adverse Event|0|||
42110564|NCT00509236|75920974|FG001|Overall Study|Excluded Medication|1|||
42110565|NCT00509236|75920973|FG000|Overall Study|Scheduled Kidney Transplant|1|||
42110566|NCT00509236|75920974|FG001|Overall Study|Scheduled Kidney Transplant|0|||
42204357|NCT03529773|76017117|FG026|Overall Study|Adverse Event|0|||
42204358|NCT03529773|76017118|FG027|Overall Study|Adverse Event|0|||
42204359|NCT03529773|76017119|FG028|Overall Study|Adverse Event|0|||
42204360|NCT03529773|76017120|FG029|Overall Study|Adverse Event|0|||
42204361|NCT03529773|76017121|FG030|Overall Study|Adverse Event|1|||
42204362|NCT03529773|76017122|FG031|Overall Study|Adverse Event|0|||
42204363|NCT03529773|76017123|FG032|Overall Study|Adverse Event|0|||
42204364|NCT03529773|76017124|FG033|Overall Study|Adverse Event|0|||
42204365|NCT03529773|76017125|FG034|Overall Study|Adverse Event|0|||
42204366|NCT03529773|76017126|FG035|Overall Study|Adverse Event|1|||
42204367|NCT03529773|76017127|FG036|Overall Study|Adverse Event|0|||
42204368|NCT03529773|76017128|FG037|Overall Study|Adverse Event|0|||
42204369|NCT03529773|76017129|FG038|Overall Study|Adverse Event|1|||
42204370|NCT03529773|76017130|FG039|Overall Study|Adverse Event|1|||
42204371|NCT03529773|76017091|FG000|Overall Study|Death|0|||
42204372|NCT03529773|76017092|FG001|Overall Study|Death|0|||
42204373|NCT03529773|76017093|FG002|Overall Study|Death|0|||
42204374|NCT03529773|76017094|FG003|Overall Study|Death|0|||
42204375|NCT03529773|76017095|FG004|Overall Study|Death|0|||
42204376|NCT03529773|76017096|FG005|Overall Study|Death|0|||
42204377|NCT03529773|76017097|FG006|Overall Study|Death|0|||
42204378|NCT03529773|76017098|FG007|Overall Study|Death|0|||
42204379|NCT03529773|76017099|FG008|Overall Study|Death|0|||
42204380|NCT03529773|76017100|FG009|Overall Study|Death|0|||
42204381|NCT03529773|76017101|FG010|Overall Study|Death|0|||
42204382|NCT03529773|76017102|FG011|Overall Study|Death|0|||
42204383|NCT03529773|76017103|FG012|Overall Study|Death|1|||
42204384|NCT03529773|76017104|FG013|Overall Study|Death|0|||
42204385|NCT03529773|76017105|FG014|Overall Study|Death|0|||
42204386|NCT03529773|76017106|FG015|Overall Study|Death|0|||
42204387|NCT03529773|76017107|FG016|Overall Study|Death|0|||
42204388|NCT03529773|76017108|FG017|Overall Study|Death|0|||
42204389|NCT03529773|76017109|FG018|Overall Study|Death|0|||
42204390|NCT03529773|76017110|FG019|Overall Study|Death|1|||
42204391|NCT03529773|76017111|FG020|Overall Study|Death|0|||
42204392|NCT03529773|76017112|FG021|Overall Study|Death|0|||
42204393|NCT03529773|76017113|FG022|Overall Study|Death|1|||
42204394|NCT03529773|76017114|FG023|Overall Study|Death|0|||
42204395|NCT03529773|76017115|FG024|Overall Study|Death|0|||
42387211|NCT01673178|76264865|FG002|Overall Study|Protocol Violation|0|||
42387212|NCT01673178|76264866|FG003|Overall Study|Protocol Violation|1|||
42387213|NCT01673178|76264867|FG004|Overall Study|Protocol Violation|0|||
42387214|NCT01673178|76264863|FG000|Overall Study|Adverse Event|1|||
42387215|NCT01673178|76264864|FG001|Overall Study|Adverse Event|0|||
42387216|NCT01673178|76264865|FG002|Overall Study|Adverse Event|0|||
42387217|NCT01673178|76264866|FG003|Overall Study|Adverse Event|2|||
42387218|NCT01673178|76264867|FG004|Overall Study|Adverse Event|0|||
42387219|NCT01673178|76264863|FG000|Overall Study|Other|1|||
42387220|NCT01673178|76264864|FG001|Overall Study|Other|0|||
42387221|NCT01673178|76264865|FG002|Overall Study|Other|2|||
42387222|NCT01673178|76264866|FG003|Overall Study|Other|1|||
42387223|NCT01673178|76264867|FG004|Overall Study|Other|0|||
42387224|NCT03593213|76264896|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
42387225|NCT03593213|76264897|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
42387226|NCT03593213|76264898|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
42387227|NCT03593213|76264899|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
42387228|NCT03593213|76264896|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
42387229|NCT03593213|76264897|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
42387230|NCT03593213|76264898|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
42204396|NCT03529773|76017116|FG025|Overall Study|Death|0|||
42204397|NCT03529773|76017117|FG026|Overall Study|Death|0|||
42204398|NCT03529773|76017118|FG027|Overall Study|Death|0|||
42204399|NCT03529773|76017119|FG028|Overall Study|Death|0|||
42204400|NCT03529773|76017120|FG029|Overall Study|Death|0|||
42204401|NCT03529773|76017121|FG030|Overall Study|Death|0|||
42204402|NCT03529773|76017122|FG031|Overall Study|Death|0|||
42204403|NCT03529773|76017123|FG032|Overall Study|Death|0|||
42204404|NCT03529773|76017124|FG033|Overall Study|Death|1|||
42204405|NCT03529773|76017125|FG034|Overall Study|Death|1|||
42204406|NCT03529773|76017126|FG035|Overall Study|Death|0|||
42387231|NCT03593213|76264899|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
42387232|NCT03593213|76264896|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
42204407|NCT03529773|76017127|FG036|Overall Study|Death|1|||
42204408|NCT03529773|76017128|FG037|Overall Study|Death|0|||
42204409|NCT03529773|76017129|FG038|Overall Study|Death|0|||
42204410|NCT03529773|76017130|FG039|Overall Study|Death|0|||
42204411|NCT03529773|76017091|FG000|Overall Study|Lost to Follow-up|0|||
42204412|NCT03529773|76017092|FG001|Overall Study|Lost to Follow-up|0|||
42387233|NCT03593213|76264897|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
42387234|NCT03593213|76264898|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
42387235|NCT03593213|76264899|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
42387236|NCT03593213|76264896|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
42387237|NCT03593213|76264897|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
42387238|NCT03593213|76264898|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
42387239|NCT03593213|76264899|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
42387240|NCT03593213|76264896|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
42387241|NCT03593213|76264897|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
42387242|NCT03593213|76264898|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
42387243|NCT03593213|76264899|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
42387244|NCT03593213|76264896|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
42387245|NCT03593213|76264897|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
42387246|NCT03593213|76264898|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
42387247|NCT03593213|76264899|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
42387248|NCT03593213|76264896|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
42387249|NCT03593213|76264897|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
42387250|NCT03593213|76264898|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
42387251|NCT03593213|76264899|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
42387252|NCT03593213|76264896|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
42387253|NCT03593213|76264897|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
42387254|NCT03593213|76264898|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
42387255|NCT03593213|76264899|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
42387256|NCT03593213|76264896|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
42387257|NCT03593213|76264897|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
42387258|NCT03593213|76264898|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
42387259|NCT03593213|76264899|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
42387260|NCT03593213|76264896|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
42387261|NCT03593213|76264897|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
42204413|NCT03529773|76017093|FG002|Overall Study|Lost to Follow-up|1|||
42204414|NCT03529773|76017094|FG003|Overall Study|Lost to Follow-up|0|||
42204415|NCT03529773|76017095|FG004|Overall Study|Lost to Follow-up|1|||
42204416|NCT03529773|76017096|FG005|Overall Study|Lost to Follow-up|1|||
42204417|NCT03529773|76017097|FG006|Overall Study|Lost to Follow-up|0|||
42204418|NCT03529773|76017098|FG007|Overall Study|Lost to Follow-up|0|||
42204419|NCT03529773|76017099|FG008|Overall Study|Lost to Follow-up|0|||
42204420|NCT03529773|76017100|FG009|Overall Study|Lost to Follow-up|0|||
42204421|NCT03529773|76017101|FG010|Overall Study|Lost to Follow-up|0|||
42204422|NCT03529773|76017102|FG011|Overall Study|Lost to Follow-up|0|||
42204423|NCT03529773|76017103|FG012|Overall Study|Lost to Follow-up|0|||
42204424|NCT03529773|76017104|FG013|Overall Study|Lost to Follow-up|1|||
42204425|NCT03529773|76017105|FG014|Overall Study|Lost to Follow-up|4|||
42204426|NCT03529773|76017106|FG015|Overall Study|Lost to Follow-up|1|||
42204427|NCT03529773|76017107|FG016|Overall Study|Lost to Follow-up|1|||
42204428|NCT03529773|76017108|FG017|Overall Study|Lost to Follow-up|0|||
42204429|NCT03529773|76017109|FG018|Overall Study|Lost to Follow-up|1|||
42204430|NCT03529773|76017110|FG019|Overall Study|Lost to Follow-up|1|||
42204431|NCT03529773|76017111|FG020|Overall Study|Lost to Follow-up|2|||
42204432|NCT03529773|76017112|FG021|Overall Study|Lost to Follow-up|4|||
42204433|NCT03529773|76017113|FG022|Overall Study|Lost to Follow-up|3|||
42204434|NCT03529773|76017114|FG023|Overall Study|Lost to Follow-up|4|||
42204435|NCT03529773|76017115|FG024|Overall Study|Lost to Follow-up|3|||
42204436|NCT03529773|76017116|FG025|Overall Study|Lost to Follow-up|5|||
42204437|NCT03529773|76017117|FG026|Overall Study|Lost to Follow-up|5|||
42204438|NCT03529773|76017118|FG027|Overall Study|Lost to Follow-up|0|||
42204439|NCT03529773|76017119|FG028|Overall Study|Lost to Follow-up|0|||
42204440|NCT03529773|76017120|FG029|Overall Study|Lost to Follow-up|0|||
42204441|NCT03529773|76017121|FG030|Overall Study|Lost to Follow-up|1|||
42204442|NCT03529773|76017122|FG031|Overall Study|Lost to Follow-up|0|||
42204443|NCT03529773|76017123|FG032|Overall Study|Lost to Follow-up|0|||
42204444|NCT03529773|76017124|FG033|Overall Study|Lost to Follow-up|1|||
42204445|NCT03529773|76017125|FG034|Overall Study|Lost to Follow-up|1|||
42204446|NCT03529773|76017126|FG035|Overall Study|Lost to Follow-up|0|||
42204447|NCT03529773|76017127|FG036|Overall Study|Lost to Follow-up|0|||
42204448|NCT03529773|76017128|FG037|Overall Study|Lost to Follow-up|3|||
42204449|NCT03529773|76017129|FG038|Overall Study|Lost to Follow-up|1|||
42204450|NCT03529773|76017130|FG039|Overall Study|Lost to Follow-up|1|||
42204451|NCT03529773|76017091|FG000|Overall Study|No longer meets eligibility criteria|0|||
42387262|NCT03593213|76264898|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
42204452|NCT03529773|76017092|FG001|Overall Study|No longer meets eligibility criteria|0|||
42204453|NCT03529773|76017093|FG002|Overall Study|No longer meets eligibility criteria|0|||
42204454|NCT03529773|76017094|FG003|Overall Study|No longer meets eligibility criteria|0|||
42204455|NCT03529773|76017095|FG004|Overall Study|No longer meets eligibility criteria|0|||
42204456|NCT03529773|76017096|FG005|Overall Study|No longer meets eligibility criteria|0|||
42204457|NCT03529773|76017097|FG006|Overall Study|No longer meets eligibility criteria|0|||
42387263|NCT03593213|76264899|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
42387264|NCT03593213|76264896|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
42387265|NCT03593213|76264897|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
42387266|NCT03593213|76264898|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
42387267|NCT03593213|76264899|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
42387268|NCT03593213|76264896|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
42387269|NCT03593213|76264897|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
42387270|NCT03593213|76264898|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
42387271|NCT03593213|76264899|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
42387272|NCT03593213|76264896|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
42387273|NCT03593213|76264897|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
42387274|NCT03593213|76264898|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
42387275|NCT03593213|76264899|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
42387276|NCT03593213|76264896|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
42387277|NCT03593213|76264897|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
42387278|NCT03593213|76264898|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
42387279|NCT03593213|76264899|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
42387280|NCT03593213|76264896|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
42387281|NCT03593213|76264897|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
42387282|NCT03593213|76264898|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
42387283|NCT03593213|76264899|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
42387284|NCT03593213|76264896|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
42387285|NCT03593213|76264897|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
42387286|NCT03593213|76264898|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
42387287|NCT03593213|76264899|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
42387288|NCT03593213|76264896|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
42387289|NCT03593213|76264897|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
42387290|NCT03593213|76264898|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
42387291|NCT03593213|76264899|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
42387292|NCT03593213|76264896|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
42387293|NCT03593213|76264897|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
42387294|NCT03593213|76264898|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
42387295|NCT03593213|76264899|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
42387296|NCT03593213|76264896|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
42387297|NCT03593213|76264897|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
42387298|NCT03593213|76264898|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
42387299|NCT03593213|76264899|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
42387300|NCT00013611|76264943|FG000|Overall Study|Lost to Follow-up|91|||
42387301|NCT00013611|76264944|FG001|Overall Study|Lost to Follow-up|100|||
42387302|NCT00010257|76264952|FG000|Overall Study|Withdrawal by Subject|1|||
42387303|NCT00010257|76264953|FG001|Overall Study|Withdrawal by Subject|0|||
42387304|NCT00211757|76264991|FG000|Overall Study|Withdrawal by Subject|1|||
42387305|NCT00211757|76264992|FG001|Overall Study|Withdrawal by Subject|1|||
42387306|NCT00211757|76264991|FG000|Overall Study|Lack of Efficacy|0|||
42204458|NCT03529773|76017098|FG007|Overall Study|No longer meets eligibility criteria|0|||
42204459|NCT03529773|76017099|FG008|Overall Study|No longer meets eligibility criteria|0|||
42204460|NCT03529773|76017100|FG009|Overall Study|No longer meets eligibility criteria|0|||
42204461|NCT03529773|76017101|FG010|Overall Study|No longer meets eligibility criteria|0|||
42204462|NCT03529773|76017102|FG011|Overall Study|No longer meets eligibility criteria|0|||
42204463|NCT03529773|76017103|FG012|Overall Study|No longer meets eligibility criteria|0|||
42204464|NCT03529773|76017104|FG013|Overall Study|No longer meets eligibility criteria|0|||
42204465|NCT03529773|76017105|FG014|Overall Study|No longer meets eligibility criteria|0|||
42204466|NCT03529773|76017106|FG015|Overall Study|No longer meets eligibility criteria|0|||
42204467|NCT03529773|76017107|FG016|Overall Study|No longer meets eligibility criteria|0|||
42204468|NCT03529773|76017108|FG017|Overall Study|No longer meets eligibility criteria|0|||
42204469|NCT03529773|76017109|FG018|Overall Study|No longer meets eligibility criteria|0|||
42204470|NCT03529773|76017110|FG019|Overall Study|No longer meets eligibility criteria|0|||
42204471|NCT03529773|76017111|FG020|Overall Study|No longer meets eligibility criteria|0|||
42204472|NCT03529773|76017112|FG021|Overall Study|No longer meets eligibility criteria|0|||
42204473|NCT03529773|76017113|FG022|Overall Study|No longer meets eligibility criteria|1|||
42204474|NCT03529773|76017114|FG023|Overall Study|No longer meets eligibility criteria|0|||
42204475|NCT03529773|76017115|FG024|Overall Study|No longer meets eligibility criteria|0|||
42204476|NCT03529773|76017116|FG025|Overall Study|No longer meets eligibility criteria|0|||
42387307|NCT00211757|76264992|FG001|Overall Study|Lack of Efficacy|1|||
42387308|NCT02639052|76265009|FG000|Overall Study|Lost to Follow-up|1|||
42387309|NCT02635776|76265116|FG000|Overall Study|Physician Decision|1|||
42387310|NCT02635776|76265117|FG001|Overall Study|Physician Decision|0|||
42387311|NCT02635776|76265116|FG000|Overall Study|Adverse Event|51|||
42387312|NCT02635776|76265117|FG001|Overall Study|Adverse Event|3|||
42387313|NCT02635776|76265116|FG000|Overall Study|Withdrawal by Subject|41|||
42387314|NCT02635776|76265117|FG001|Overall Study|Withdrawal by Subject|7|||
42387315|NCT02635776|76265116|FG000|Overall Study|Lost to Follow-up|4|||
42387316|NCT02635776|76265117|FG001|Overall Study|Lost to Follow-up|0|||
42387317|NCT02635776|76265116|FG000|Overall Study|Other reasons|5|||
42387318|NCT02635776|76265117|FG001|Overall Study|Other reasons|1|||
42387319|NCT02704403|76265131|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
42387320|NCT02704403|76265132|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
42387321|NCT02704403|76265131|FG000|Overall Study|Administrative reasons by sponsor|1251|||
42387322|NCT02704403|76265132|FG001|Overall Study|Administrative reasons by sponsor|616|||
42387323|NCT02704403|76265131|FG000|Overall Study|Death|4|||
42387324|NCT02704403|76265132|FG001|Overall Study|Death|3|||
42387325|NCT02704403|76265131|FG000|Overall Study|Endpoint event|52|||
42387326|NCT02704403|76265132|FG001|Overall Study|Endpoint event|24|||
42387327|NCT02704403|76265131|FG000|Overall Study|Lost to Follow-up|22|||
42387328|NCT02704403|76265132|FG001|Overall Study|Lost to Follow-up|11|||
42387329|NCT02704403|76265131|FG000|Overall Study|Protocol Violation|15|||
42387330|NCT02704403|76265132|FG001|Overall Study|Protocol Violation|15|||
42387331|NCT02704403|76265131|FG000|Overall Study|Adverse Event|2|||
42387332|NCT02704403|76265132|FG001|Overall Study|Adverse Event|0|||
42387333|NCT02704403|76265131|FG000|Overall Study|Withdrawal by Subject|85|||
42387334|NCT02704403|76265132|FG001|Overall Study|Withdrawal by Subject|45|||
42387335|NCT02704403|76265131|FG000|Overall Study|Investigator decision|1|||
42387336|NCT02704403|76265132|FG001|Overall Study|Investigator decision|1|||
42387337|NCT02704403|76265131|FG000|Overall Study|Follow-up not possible|1|||
42387338|NCT02704403|76265132|FG001|Overall Study|Follow-up not possible|2|||
42387339|NCT02636868|76265167|FG000|Overall Study|Death|0|||
42387340|NCT02636868|76265168|FG001|Overall Study|Death|1|||
42387341|NCT02636868|76265169|FG002|Overall Study|Death|2|||
42387342|NCT02635386|76265250|FG000|Overall Study|Pregnancy|2|||
42387343|NCT02635386|76265251|FG001|Overall Study|Pregnancy|0|||
42387344|NCT02635386|76265252|FG002|Overall Study|Pregnancy|0|||
42387345|NCT02635386|76265253|FG003|Overall Study|Pregnancy|0|||
42387346|NCT02635386|76265254|FG004|Overall Study|Pregnancy|2|||
42387347|NCT02635386|76265250|FG000|Overall Study|Withdrawal by Subject|1|||
42387348|NCT02635386|76265251|FG001|Overall Study|Withdrawal by Subject|1|||
42387349|NCT02635386|76265252|FG002|Overall Study|Withdrawal by Subject|0|||
42387350|NCT02635386|76265253|FG003|Overall Study|Withdrawal by Subject|1|||
42387351|NCT02635386|76265254|FG004|Overall Study|Withdrawal by Subject|0|||
42387352|NCT02635386|76265250|FG000|Overall Study|Physician Decision|0|||
42387353|NCT02635386|76265251|FG001|Overall Study|Physician Decision|1|||
42387354|NCT02635386|76265252|FG002|Overall Study|Physician Decision|0|||
42387355|NCT02635386|76265253|FG003|Overall Study|Physician Decision|0|||
42387356|NCT02635386|76265254|FG004|Overall Study|Physician Decision|0|||
42387357|NCT02635386|76265250|FG000|Overall Study|Moved Out of State|0|||
42387358|NCT02635386|76265251|FG001|Overall Study|Moved Out of State|1|||
42387359|NCT02635386|76265252|FG002|Overall Study|Moved Out of State|0|||
42387360|NCT02635386|76265253|FG003|Overall Study|Moved Out of State|0|||
42387361|NCT02635386|76265254|FG004|Overall Study|Moved Out of State|0|||
42387362|NCT02635386|76265250|FG000|Overall Study|Noncompliant|0|||
42387363|NCT02635386|76265251|FG001|Overall Study|Noncompliant|2|||
42387364|NCT02635386|76265252|FG002|Overall Study|Noncompliant|1|||
42387365|NCT02635386|76265253|FG003|Overall Study|Noncompliant|1|||
42387366|NCT02635386|76265254|FG004|Overall Study|Noncompliant|1|||
42387367|NCT02635386|76265250|FG000|Overall Study|side effects|0|||
42387368|NCT02635386|76265251|FG001|Overall Study|side effects|0|||
42387369|NCT02635386|76265252|FG002|Overall Study|side effects|1|||
42387370|NCT02635386|76265253|FG003|Overall Study|side effects|4|||
42387371|NCT02635386|76265254|FG004|Overall Study|side effects|6|||
42387372|NCT02635386|76265250|FG000|Overall Study|needed other major surgery|0|||
42387373|NCT02635386|76265251|FG001|Overall Study|needed other major surgery|1|||
42387374|NCT02635386|76265252|FG002|Overall Study|needed other major surgery|0|||
42387375|NCT02635386|76265253|FG003|Overall Study|needed other major surgery|0|||
42387376|NCT02635386|76265254|FG004|Overall Study|needed other major surgery|0|||
42387377|NCT02635386|76265250|FG000|Overall Study|Other medical problems not drug related|0|||
42387378|NCT02635386|76265251|FG001|Overall Study|Other medical problems not drug related|0|||
42387379|NCT02635386|76265252|FG002|Overall Study|Other medical problems not drug related|0|||
42387380|NCT02635386|76265253|FG003|Overall Study|Other medical problems not drug related|1|||
42387381|NCT02635386|76265254|FG004|Overall Study|Other medical problems not drug related|0|||
42387382|NCT02634606|76265352|FG000|Overall Study|unable to obtain the drug at start|13|||
42387383|NCT01672866|76265398|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
42387384|NCT01672866|76265399|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
42387385|NCT01672866|76265400|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
42387386|NCT01672866|76265398|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
42387387|NCT01672866|76265399|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
42387388|NCT01672866|76265400|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
42387389|NCT01672866|76265398|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
42387390|NCT01672866|76265399|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
42387391|NCT01672866|76265400|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
42387392|NCT01672866|76265398|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
42387393|NCT01672866|76265399|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
42387394|NCT01672866|76265400|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
42387395|NCT01672866|76265398|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
42387396|NCT01672866|76265399|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
42387397|NCT01672866|76265400|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
42387398|NCT01672866|76265398|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
42387399|NCT01672866|76265399|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
42387400|NCT01672866|76265400|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
42387401|NCT01672866|76265398|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
42387402|NCT01672866|76265399|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
42387403|NCT01672866|76265400|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
42387404|NCT01672866|76265398|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
42387405|NCT01672866|76265399|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
42387406|NCT01672866|76265400|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
42387407|NCT01672866|76265398|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
42387408|NCT01672866|76265399|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
42387409|NCT01672866|76265400|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
42387410|NCT01672866|76265398|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
42387411|NCT01672866|76265399|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
42387412|NCT01672866|76265400|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
42387413|NCT01672866|76265398|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
42387414|NCT01672866|76265399|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
42387415|NCT01672866|76265400|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
42387416|NCT01672866|76265398|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
42387417|NCT01672866|76265399|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
42387418|NCT01672866|76265400|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
42387419|NCT01672866|76265398|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
42387420|NCT01672866|76265399|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
42387421|NCT01672866|76265400|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
42387422|NCT04465877|76265626|FG000|Overall Study|Noncompliant with study requirements|0|||
42387423|NCT04465877|76265627|FG001|Overall Study|Noncompliant with study requirements|0|||
42387424|NCT04465877|76265628|FG002|Overall Study|Noncompliant with study requirements|1|||
42387425|NCT04465877|76265629|FG003|Overall Study|Noncompliant with study requirements|0|||
42387426|NCT04267133|76265686|FG000|Overall Study|Withdrawal by Subject|1|||
42387427|NCT04267133|76265686|FG000|Overall Study|Adverse Event|4|||
42387428|NCT02631876|76265817|FG000|Overall Study|Death|96|||
42387429|NCT02631876|76265818|FG001|Overall Study|Death|50|||
42387430|NCT02631876|76265817|FG000|Overall Study|Investigator's discretion|1|||
42387431|NCT02631876|76265818|FG001|Overall Study|Investigator's discretion|0|||
42387432|NCT02631876|76265817|FG000|Overall Study|Lost to Follow-up|2|||
42387433|NCT02631876|76265818|FG001|Overall Study|Lost to Follow-up|0|||
42387434|NCT02631876|76265817|FG000|Overall Study|Withdrawal by Subject|16|||
42387435|NCT02631876|76265818|FG001|Overall Study|Withdrawal by Subject|9|||
42387436|NCT02631876|76265817|FG000|Overall Study|Other than specified|4|||
42387437|NCT02631876|76265818|FG001|Overall Study|Other than specified|4|||
42387438|NCT02633046|76265847|FG000|Overall Study|Adverse Event|8|||
42387439|NCT02633046|76265847|FG000|Overall Study|Physician Decision|7|||
42387440|NCT02633046|76265847|FG000|Overall Study|Withdrawal by Subject|8|||
42387441|NCT02633046|76265847|FG000|Overall Study|Increased proteinuria|2|||
42387442|NCT02633046|76265847|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
42387443|NCT02633046|76265847|FG000|Overall Study|Mutual decision patient and physician|1|||
42387444|NCT01672788|76265906|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
42387445|NCT01672788|76265907|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
42387446|NCT01672788|76265908|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
42387447|NCT01672788|76265909|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
42387448|NCT02632110|76265924|FG000|Overall Study|Withdrawal by Subject|1|||
42387449|NCT02632110|76265925|FG001|Overall Study|Withdrawal by Subject|1|||
42387450|NCT02632110|76265926|FG002|Overall Study|Withdrawal by Subject|0|||
42387451|NCT02632110|76265927|FG003|Overall Study|Withdrawal by Subject|0|||
42387452|NCT02632110|76265928|FG004|Overall Study|Withdrawal by Subject|1|||
42387453|NCT02632110|76265929|FG005|Overall Study|Withdrawal by Subject|1|||
42387454|NCT02632110|76265930|FG006|Overall Study|Withdrawal by Subject|3|||
42387455|NCT02632110|76265931|FG007|Overall Study|Withdrawal by Subject|3|||
42387456|NCT02632110|76265932|FG008|Overall Study|Withdrawal by Subject|1|||
42387457|NCT02632110|76265933|FG009|Overall Study|Withdrawal by Subject|1|||
42387458|NCT01672710|76266175|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
42387459|NCT01672710|76266176|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
42387460|NCT01672710|76266175|FG000|3 Month Follow up|Lost to Follow-up|2|||
42387461|NCT01672710|76266176|FG001|3 Month Follow up|Lost to Follow-up|3|||
42387462|NCT01672710|76266175|FG000|3 Month Follow up|follow up due after termination date|4|||
42387463|NCT01672710|76266176|FG001|3 Month Follow up|follow up due after termination date|1|||
42387464|NCT02630472|76266211|FG000|Overall Study|Physician Decision|10|||
42387465|NCT02630472|76266212|FG001|Overall Study|Physician Decision|0|||
42387466|NCT01670526|76266248|FG000|Overall Study|Withdrawal by Subject|3|||
42387467|NCT01670526|76266249|FG001|Overall Study|Withdrawal by Subject|1|||
42387468|NCT01670526|76266248|FG000|Overall Study|Lost to Follow-up|9|||
42387469|NCT01670526|76266249|FG001|Overall Study|Lost to Follow-up|5|||
42387470|NCT02630706|76266293|FG000|Overall Study|Adverse Event|2|||
42387471|NCT02630706|76266294|FG001|Overall Study|Adverse Event|1|||
42387472|NCT02630706|76266295|FG002|Overall Study|Adverse Event|1|||
42387473|NCT02630706|76266293|FG000|Overall Study|Lost to Follow-up|0|||
42387474|NCT02630706|76266294|FG001|Overall Study|Lost to Follow-up|1|||
42387475|NCT02630706|76266295|FG002|Overall Study|Lost to Follow-up|2|||
42387476|NCT02630706|76266293|FG000|Overall Study|Physician Decision|1|||
42387477|NCT02630706|76266294|FG001|Overall Study|Physician Decision|1|||
42387478|NCT02630706|76266295|FG002|Overall Study|Physician Decision|0|||
42387479|NCT02630706|76266293|FG000|Overall Study|Pregnancy|0|||
42387480|NCT02630706|76266294|FG001|Overall Study|Pregnancy|1|||
42387481|NCT02630706|76266295|FG002|Overall Study|Pregnancy|0|||
42387482|NCT02630706|76266293|FG000|Overall Study|Withdrawal by Subject|4|||
42387483|NCT02630706|76266294|FG001|Overall Study|Withdrawal by Subject|5|||
42387484|NCT02630706|76266295|FG002|Overall Study|Withdrawal by Subject|7|||
42387485|NCT02089997|76266472|FG000|Overall Study|Case report forms uncollected|99|||
42387486|NCT02089997|76266472|FG000|Overall Study|Protocol Violation|147|||
42387487|NCT01363661|76266478|FG000|Overall Study|Adverse Event|9|||
42387488|NCT01363661|76266479|FG001|Overall Study|Adverse Event|2|||
42387489|NCT01363661|76266478|FG000|Overall Study|Withdrawal by Subject|1|||
42387490|NCT01363661|76266479|FG001|Overall Study|Withdrawal by Subject|1|||
42387491|NCT01363661|76266478|FG000|Overall Study|Protocol Violation|1|||
42387492|NCT01363661|76266479|FG001|Overall Study|Protocol Violation|0|||
42387493|NCT01363661|76266478|FG000|Overall Study|Lost to Follow-up|3|||
42387494|NCT01363661|76266479|FG001|Overall Study|Lost to Follow-up|1|||
42387495|NCT02628600|76266487|FG000|Overall Study|Death|2|||
42387496|NCT02628600|76266488|FG001|Overall Study|Death|1|||
42387497|NCT02628600|76266487|FG000|Overall Study|Adverse Event|3|||
42387498|NCT02628600|76266488|FG001|Overall Study|Adverse Event|20|||
42387499|NCT02628600|76266487|FG000|Overall Study|Protocol Violation|0|||
42387500|NCT02628600|76266488|FG001|Overall Study|Protocol Violation|1|||
42387501|NCT02628600|76266487|FG000|Overall Study|Lack of Efficacy|2|||
42387502|NCT02628600|76266488|FG001|Overall Study|Lack of Efficacy|0|||
42387503|NCT02628600|76266487|FG000|Overall Study|Withdrawal by Subject|13|||
42387504|NCT02628600|76266488|FG001|Overall Study|Withdrawal by Subject|8|||
42387505|NCT02628600|76266487|FG000|Overall Study|Lost to Follow-up|1|||
42387506|NCT02628600|76266488|FG001|Overall Study|Lost to Follow-up|0|||
42387507|NCT02628600|76266487|FG000|Overall Study|Physician Decision|2|||
42387508|NCT02628600|76266488|FG001|Overall Study|Physician Decision|2|||
42387509|NCT02628600|76266487|FG000|Overall Study|Other not specified|1|||
42387510|NCT02628600|76266488|FG001|Overall Study|Other not specified|0|||
42387511|NCT00591318|76266505|FG000|Overall Study|Lack of Efficacy|2|||
42387512|NCT00591318|76266506|FG001|Overall Study|Lack of Efficacy|0|||
42387513|NCT00591318|76266505|FG000|Overall Study|Adverse Event|2|||
42387514|NCT00591318|76266506|FG001|Overall Study|Adverse Event|0|||
42387515|NCT01360632|76266519|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
42387516|NCT01360632|76266520|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
42387517|NCT01360632|76266521|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
42387518|NCT01360632|76266522|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
42387519|NCT01360632|76266523|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
42387520|NCT01360632|76266519|FG000|Phase A (8 Weeks)|Adverse Event|60|||
42387521|NCT01360632|76266520|FG001|Phase A (8 Weeks)|Adverse Event|0|||
42387522|NCT01360632|76266521|FG002|Phase A (8 Weeks)|Adverse Event|0|||
42387523|NCT01360632|76266522|FG003|Phase A (8 Weeks)|Adverse Event|0|||
42387524|NCT01360632|76266523|FG004|Phase A (8 Weeks)|Adverse Event|0|||
42387525|NCT01360632|76266519|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
42387526|NCT01360632|76266520|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
42387527|NCT01360632|76266521|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
42387528|NCT01360632|76266522|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
42387529|NCT01360632|76266523|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
42387530|NCT01360632|76266519|FG000|Phase A (8 Weeks)|Physician Decision|10|||
42387531|NCT01360632|76266520|FG001|Phase A (8 Weeks)|Physician Decision|0|||
42387532|NCT01360632|76266521|FG002|Phase A (8 Weeks)|Physician Decision|0|||
42387533|NCT01360632|76266522|FG003|Phase A (8 Weeks)|Physician Decision|0|||
42387534|NCT01360632|76266523|FG004|Phase A (8 Weeks)|Physician Decision|0|||
42387535|NCT01360632|76266519|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
42387536|NCT01360632|76266520|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
42387537|NCT01360632|76266521|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
42387538|NCT01360632|76266522|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
42387539|NCT01360632|76266523|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
42387540|NCT01360632|76266519|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
42387541|NCT01360632|76266520|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
42387542|NCT01360632|76266521|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
42387543|NCT01360632|76266522|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
42387544|NCT01360632|76266523|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
42387545|NCT01360632|76266519|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
42387546|NCT01360632|76266520|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
42387547|NCT01360632|76266521|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
42387548|NCT01360632|76266522|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
42387549|NCT01360632|76266523|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
42387550|NCT01360632|76266519|FG000|Phase B (6 Weeks)|Adverse Event|0|||
42387551|NCT01360632|76266520|FG001|Phase B (6 Weeks)|Adverse Event|3|||
42387552|NCT01360632|76266521|FG002|Phase B (6 Weeks)|Adverse Event|9|||
42387553|NCT01360632|76266522|FG003|Phase B (6 Weeks)|Adverse Event|3|||
42387554|NCT01360632|76266523|FG004|Phase B (6 Weeks)|Adverse Event|0|||
42387555|NCT01360632|76266519|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
42387556|NCT01360632|76266520|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
42387557|NCT01360632|76266521|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
42387558|NCT01360632|76266522|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
42387559|NCT01360632|76266523|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
42387560|NCT01360632|76266519|FG000|Phase B (6 Weeks)|Physician Decision|0|||
42387561|NCT01360632|76266520|FG001|Phase B (6 Weeks)|Physician Decision|0|||
42387562|NCT01360632|76266521|FG002|Phase B (6 Weeks)|Physician Decision|0|||
42387563|NCT01360632|76266522|FG003|Phase B (6 Weeks)|Physician Decision|1|||
42387564|NCT01360632|76266523|FG004|Phase B (6 Weeks)|Physician Decision|0|||
42387565|NCT01360632|76266519|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
42387566|NCT01360632|76266520|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
42387567|NCT01360632|76266521|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
42387568|NCT01360632|76266522|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
42387569|NCT01360632|76266523|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
42387570|NCT01360632|76266519|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
42387571|NCT01360632|76266520|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
42387572|NCT01360632|76266521|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
42387573|NCT01360632|76266522|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
42387574|NCT01360632|76266523|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
42387575|NCT01360632|76266519|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
42387576|NCT01360632|76266520|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
42387577|NCT01360632|76266521|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
42387578|NCT01360632|76266522|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
42387579|NCT01360632|76266523|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
42387580|NCT01360632|76266519|FG000|Phase A+|Lost to Follow-up|0|||
42387581|NCT01360632|76266520|FG001|Phase A+|Lost to Follow-up|0|||
42387582|NCT01360632|76266521|FG002|Phase A+|Lost to Follow-up|0|||
42387583|NCT01360632|76266522|FG003|Phase A+|Lost to Follow-up|0|||
42387584|NCT01360632|76266523|FG004|Phase A+|Lost to Follow-up|2|||
42387585|NCT01360632|76266519|FG000|Phase A+|Adverse Event|0|||
42387586|NCT01360632|76266520|FG001|Phase A+|Adverse Event|0|||
42387587|NCT01360632|76266521|FG002|Phase A+|Adverse Event|0|||
42387588|NCT01360632|76266522|FG003|Phase A+|Adverse Event|0|||
42387589|NCT01360632|76266523|FG004|Phase A+|Adverse Event|2|||
42387590|NCT01360632|76266519|FG000|Phase A+|Met Withdrawal Criteria|0|||
42387591|NCT01360632|76266520|FG001|Phase A+|Met Withdrawal Criteria|0|||
42387592|NCT01360632|76266521|FG002|Phase A+|Met Withdrawal Criteria|0|||
42387593|NCT01360632|76266522|FG003|Phase A+|Met Withdrawal Criteria|0|||
42387594|NCT01360632|76266523|FG004|Phase A+|Met Withdrawal Criteria|7|||
42387595|NCT01360632|76266519|FG000|Phase A+|Physician Decision|0|||
42387596|NCT01360632|76266520|FG001|Phase A+|Physician Decision|0|||
42387597|NCT01360632|76266521|FG002|Phase A+|Physician Decision|0|||
42387598|NCT01360632|76266522|FG003|Phase A+|Physician Decision|0|||
42387599|NCT01360632|76266523|FG004|Phase A+|Physician Decision|3|||
42387600|NCT01360632|76266519|FG000|Phase A+|Withdrawal by Subject|0|||
42387601|NCT01360632|76266520|FG001|Phase A+|Withdrawal by Subject|0|||
42387602|NCT01360632|76266521|FG002|Phase A+|Withdrawal by Subject|0|||
42387603|NCT01360632|76266522|FG003|Phase A+|Withdrawal by Subject|0|||
42387604|NCT01360632|76266523|FG004|Phase A+|Withdrawal by Subject|8|||
42387605|NCT01360632|76266519|FG000|Phase A+|Protocol Deviation|0|||
42387606|NCT01360632|76266520|FG001|Phase A+|Protocol Deviation|0|||
42387607|NCT01360632|76266521|FG002|Phase A+|Protocol Deviation|0|||
42387608|NCT01360632|76266522|FG003|Phase A+|Protocol Deviation|0|||
42387609|NCT01360632|76266523|FG004|Phase A+|Protocol Deviation|3|||
42387610|NCT04157400|76266569|FG000|Overall Study|Withdrawal by Subject|1|||
42387611|NCT04157400|76266569|FG000|Overall Study|Lost to Follow-up|3|||
42387612|NCT02626182|76266643|FG000|Overall Study|Adverse Event|2|||
42387613|NCT02626182|76266644|FG001|Overall Study|Adverse Event|0|||
42387614|NCT01669902|76266751|FG000|Overall Study|Adverse Event|11|||
42387615|NCT01669902|76266751|FG000|Overall Study|Lack of Efficacy|10|||
42387616|NCT01669902|76266751|FG000|Overall Study|Other|8|||
42387617|NCT01670292|76266784|FG000|Overall Study|Lost to Follow-up|14|||
42387618|NCT01360554|76267021|FG000|Overall Study|Death|359|||
42387619|NCT01360554|76267022|FG001|Overall Study|Death|371|||
42387620|NCT01360554|76267021|FG000|Overall Study|Lost to Follow-up|4|||
42387621|NCT01360554|76267022|FG001|Overall Study|Lost to Follow-up|4|||
42387622|NCT01360554|76267021|FG000|Overall Study|Withdrawal by Subject|23|||
42387623|NCT01360554|76267022|FG001|Overall Study|Withdrawal by Subject|24|||
42387624|NCT01360554|76267021|FG000|Overall Study|Study terminated by sponsor|49|||
42387625|NCT01360554|76267022|FG001|Overall Study|Study terminated by sponsor|37|||
42387626|NCT01360554|76267021|FG000|Overall Study|Other, not specified|1|||
42387627|NCT01360554|76267022|FG001|Overall Study|Other, not specified|0|||
42387628|NCT01360554|76267021|FG000|Overall Study|Randomized but not treated.|3|||
42387629|NCT01360554|76267022|FG001|Overall Study|Randomized but not treated.|3|||
42387630|NCT01360398|76267044|FG000|Overall Study|Withdrawal by Subject|14|||
42387631|NCT01360398|76267044|FG000|Overall Study|Other|7|||
42387632|NCT01360398|76267044|FG000|Overall Study|Migrated/moved from study area|1|||
42204477|NCT03529773|76017117|FG026|Overall Study|No longer meets eligibility criteria|0|||
42204478|NCT03529773|76017118|FG027|Overall Study|No longer meets eligibility criteria|0|||
42204479|NCT03529773|76017119|FG028|Overall Study|No longer meets eligibility criteria|0|||
42204480|NCT03529773|76017120|FG029|Overall Study|No longer meets eligibility criteria|0|||
42204481|NCT03529773|76017121|FG030|Overall Study|No longer meets eligibility criteria|0|||
42204482|NCT03529773|76017122|FG031|Overall Study|No longer meets eligibility criteria|0|||
42204483|NCT03529773|76017123|FG032|Overall Study|No longer meets eligibility criteria|0|||
42204484|NCT03529773|76017124|FG033|Overall Study|No longer meets eligibility criteria|0|||
42204485|NCT03529773|76017125|FG034|Overall Study|No longer meets eligibility criteria|0|||
42204486|NCT03529773|76017126|FG035|Overall Study|No longer meets eligibility criteria|0|||
42204487|NCT03529773|76017127|FG036|Overall Study|No longer meets eligibility criteria|0|||
42204488|NCT03529773|76017128|FG037|Overall Study|No longer meets eligibility criteria|0|||
42204489|NCT03529773|76017129|FG038|Overall Study|No longer meets eligibility criteria|1|||
42204490|NCT03529773|76017130|FG039|Overall Study|No longer meets eligibility criteria|0|||
42204491|NCT03529773|76017091|FG000|Overall Study|Other|0|||
42204492|NCT03529773|76017092|FG001|Overall Study|Other|0|||
42204493|NCT03529773|76017093|FG002|Overall Study|Other|0|||
42204494|NCT03529773|76017094|FG003|Overall Study|Other|0|||
42204495|NCT03529773|76017095|FG004|Overall Study|Other|0|||
42204496|NCT03529773|76017096|FG005|Overall Study|Other|0|||
42204497|NCT03529773|76017097|FG006|Overall Study|Other|0|||
42204498|NCT03529773|76017098|FG007|Overall Study|Other|0|||
42204499|NCT03529773|76017099|FG008|Overall Study|Other|0|||
42204500|NCT03529773|76017100|FG009|Overall Study|Other|0|||
42204501|NCT03529773|76017101|FG010|Overall Study|Other|0|||
42204502|NCT03529773|76017102|FG011|Overall Study|Other|0|||
42204503|NCT03529773|76017103|FG012|Overall Study|Other|1|||
42204504|NCT03529773|76017104|FG013|Overall Study|Other|0|||
42204505|NCT03529773|76017105|FG014|Overall Study|Other|2|||
42204506|NCT03529773|76017106|FG015|Overall Study|Other|0|||
42204507|NCT03529773|76017107|FG016|Overall Study|Other|0|||
42204508|NCT03529773|76017108|FG017|Overall Study|Other|3|||
42204509|NCT03529773|76017109|FG018|Overall Study|Other|0|||
42387633|NCT02626026|76267054|FG000|Overall Study|Randomized but Never Treated|0|||
42387634|NCT02626026|76267055|FG001|Overall Study|Randomized but Never Treated|0|||
42387635|NCT02626026|76267056|FG002|Overall Study|Randomized but Never Treated|0|||
42387636|NCT02626026|76267057|FG003|Overall Study|Randomized but Never Treated|0|||
42387637|NCT02626026|76267058|FG004|Overall Study|Randomized but Never Treated|1|||
42387638|NCT02626026|76267059|FG005|Overall Study|Randomized but Never Treated|0|||
42387639|NCT01765296|76267319|FG000|Overall Study|Protocol Violation|0|||
42387640|NCT01765296|76267320|FG001|Overall Study|Protocol Violation|5|||
42387641|NCT01765296|76267321|FG002|Overall Study|Protocol Violation|4|||
42387642|NCT01765296|76267319|FG000|Overall Study|Withdrawal by Subject|4|||
42387643|NCT01765296|76267320|FG001|Overall Study|Withdrawal by Subject|2|||
42387644|NCT01765296|76267321|FG002|Overall Study|Withdrawal by Subject|2|||
42387645|NCT01765296|76267319|FG000|Overall Study|Adverse Event|1|||
42387646|NCT01765296|76267320|FG001|Overall Study|Adverse Event|13|||
42387647|NCT01765296|76267321|FG002|Overall Study|Adverse Event|5|||
42387648|NCT01765296|76267319|FG000|Overall Study|Lack of Efficacy|0|||
42204510|NCT03529773|76017110|FG019|Overall Study|Other|0|||
42204511|NCT03529773|76017111|FG020|Overall Study|Other|1|||
42387649|NCT01765296|76267320|FG001|Overall Study|Lack of Efficacy|0|||
42387650|NCT01765296|76267321|FG002|Overall Study|Lack of Efficacy|2|||
42204512|NCT03529773|76017112|FG021|Overall Study|Other|0|||
42387651|NCT02089685|76267395|FG000|Overall Study|Adverse Event|1|||
42204513|NCT03529773|76017113|FG022|Overall Study|Other|1|||
42204514|NCT03529773|76017114|FG023|Overall Study|Other|0|||
42204515|NCT03529773|76017115|FG024|Overall Study|Other|3|||
42204516|NCT03529773|76017116|FG025|Overall Study|Other|2|||
42204517|NCT03529773|76017117|FG026|Overall Study|Other|2|||
42204518|NCT03529773|76017118|FG027|Overall Study|Other|0|||
42204519|NCT03529773|76017119|FG028|Overall Study|Other|0|||
42204520|NCT03529773|76017120|FG029|Overall Study|Other|0|||
42204521|NCT03529773|76017121|FG030|Overall Study|Other|0|||
42204522|NCT03529773|76017122|FG031|Overall Study|Other|0|||
42204523|NCT03529773|76017123|FG032|Overall Study|Other|0|||
42204524|NCT03529773|76017124|FG033|Overall Study|Other|0|||
42204525|NCT03529773|76017125|FG034|Overall Study|Other|1|||
42204526|NCT03529773|76017126|FG035|Overall Study|Other|1|||
42204527|NCT03529773|76017127|FG036|Overall Study|Other|0|||
42204528|NCT03529773|76017128|FG037|Overall Study|Other|0|||
42204529|NCT03529773|76017129|FG038|Overall Study|Other|0|||
42204530|NCT03529773|76017130|FG039|Overall Study|Other|0|||
42204531|NCT03529773|76017091|FG000|Overall Study|Physician Decision|0|||
42204532|NCT03529773|76017092|FG001|Overall Study|Physician Decision|0|||
42204533|NCT03529773|76017093|FG002|Overall Study|Physician Decision|0|||
42204534|NCT03529773|76017094|FG003|Overall Study|Physician Decision|0|||
42204535|NCT03529773|76017095|FG004|Overall Study|Physician Decision|0|||
42204536|NCT03529773|76017096|FG005|Overall Study|Physician Decision|0|||
42204537|NCT03529773|76017097|FG006|Overall Study|Physician Decision|0|||
42204538|NCT03529773|76017098|FG007|Overall Study|Physician Decision|0|||
42204539|NCT03529773|76017099|FG008|Overall Study|Physician Decision|0|||
42204540|NCT03529773|76017100|FG009|Overall Study|Physician Decision|0|||
42204541|NCT03529773|76017101|FG010|Overall Study|Physician Decision|0|||
42204542|NCT03529773|76017102|FG011|Overall Study|Physician Decision|0|||
42204543|NCT03529773|76017103|FG012|Overall Study|Physician Decision|0|||
42204544|NCT03529773|76017104|FG013|Overall Study|Physician Decision|0|||
42204545|NCT03529773|76017105|FG014|Overall Study|Physician Decision|0|||
42204546|NCT03529773|76017106|FG015|Overall Study|Physician Decision|0|||
42204547|NCT03529773|76017107|FG016|Overall Study|Physician Decision|0|||
42204548|NCT03529773|76017108|FG017|Overall Study|Physician Decision|0|||
42204549|NCT03529773|76017109|FG018|Overall Study|Physician Decision|0|||
42204550|NCT03529773|76017110|FG019|Overall Study|Physician Decision|1|||
42204551|NCT03529773|76017111|FG020|Overall Study|Physician Decision|1|||
42204552|NCT03529773|76017112|FG021|Overall Study|Physician Decision|0|||
42204553|NCT03529773|76017113|FG022|Overall Study|Physician Decision|0|||
42204554|NCT03529773|76017114|FG023|Overall Study|Physician Decision|0|||
42204555|NCT03529773|76017115|FG024|Overall Study|Physician Decision|0|||
42204556|NCT03529773|76017116|FG025|Overall Study|Physician Decision|0|||
42204557|NCT03529773|76017117|FG026|Overall Study|Physician Decision|0|||
42204558|NCT03529773|76017118|FG027|Overall Study|Physician Decision|0|||
42204559|NCT03529773|76017119|FG028|Overall Study|Physician Decision|0|||
42204560|NCT03529773|76017120|FG029|Overall Study|Physician Decision|0|||
42204561|NCT03529773|76017121|FG030|Overall Study|Physician Decision|0|||
42204562|NCT03529773|76017122|FG031|Overall Study|Physician Decision|0|||
42204563|NCT03529773|76017123|FG032|Overall Study|Physician Decision|0|||
42204564|NCT03529773|76017124|FG033|Overall Study|Physician Decision|0|||
42204565|NCT03529773|76017125|FG034|Overall Study|Physician Decision|0|||
42204566|NCT03529773|76017126|FG035|Overall Study|Physician Decision|0|||
42204567|NCT03529773|76017127|FG036|Overall Study|Physician Decision|0|||
42204568|NCT03529773|76017128|FG037|Overall Study|Physician Decision|0|||
42204569|NCT03529773|76017129|FG038|Overall Study|Physician Decision|0|||
42204570|NCT03529773|76017130|FG039|Overall Study|Physician Decision|0|||
42204571|NCT03529773|76017091|FG000|Overall Study|Protocol Violation|0|||
42204572|NCT03529773|76017092|FG001|Overall Study|Protocol Violation|0|||
42204573|NCT03529773|76017093|FG002|Overall Study|Protocol Violation|0|||
42204574|NCT03529773|76017094|FG003|Overall Study|Protocol Violation|0|||
42204575|NCT03529773|76017095|FG004|Overall Study|Protocol Violation|0|||
42204576|NCT03529773|76017096|FG005|Overall Study|Protocol Violation|0|||
42204577|NCT03529773|76017097|FG006|Overall Study|Protocol Violation|0|||
42204578|NCT03529773|76017098|FG007|Overall Study|Protocol Violation|0|||
42204579|NCT03529773|76017099|FG008|Overall Study|Protocol Violation|0|||
42204580|NCT03529773|76017100|FG009|Overall Study|Protocol Violation|0|||
42204581|NCT03529773|76017101|FG010|Overall Study|Protocol Violation|0|||
42204582|NCT03529773|76017102|FG011|Overall Study|Protocol Violation|0|||
42204583|NCT03529773|76017103|FG012|Overall Study|Protocol Violation|0|||
42204584|NCT03529773|76017104|FG013|Overall Study|Protocol Violation|0|||
42204585|NCT03529773|76017105|FG014|Overall Study|Protocol Violation|0|||
42204586|NCT03529773|76017106|FG015|Overall Study|Protocol Violation|0|||
42204587|NCT03529773|76017107|FG016|Overall Study|Protocol Violation|0|||
42204588|NCT03529773|76017108|FG017|Overall Study|Protocol Violation|0|||
42204589|NCT03529773|76017109|FG018|Overall Study|Protocol Violation|0|||
42204590|NCT03529773|76017110|FG019|Overall Study|Protocol Violation|0|||
42204591|NCT03529773|76017111|FG020|Overall Study|Protocol Violation|0|||
42204592|NCT03529773|76017112|FG021|Overall Study|Protocol Violation|0|||
42204593|NCT03529773|76017113|FG022|Overall Study|Protocol Violation|0|||
42204594|NCT03529773|76017114|FG023|Overall Study|Protocol Violation|0|||
42204595|NCT03529773|76017115|FG024|Overall Study|Protocol Violation|0|||
42204596|NCT03529773|76017116|FG025|Overall Study|Protocol Violation|0|||
42204597|NCT03529773|76017117|FG026|Overall Study|Protocol Violation|0|||
42204598|NCT03529773|76017118|FG027|Overall Study|Protocol Violation|0|||
42204599|NCT03529773|76017119|FG028|Overall Study|Protocol Violation|0|||
42204600|NCT03529773|76017120|FG029|Overall Study|Protocol Violation|0|||
42204601|NCT03529773|76017121|FG030|Overall Study|Protocol Violation|1|||
42204602|NCT03529773|76017122|FG031|Overall Study|Protocol Violation|0|||
42204603|NCT03529773|76017123|FG032|Overall Study|Protocol Violation|0|||
42204604|NCT03529773|76017124|FG033|Overall Study|Protocol Violation|0|||
42204605|NCT03529773|76017125|FG034|Overall Study|Protocol Violation|0|||
42204606|NCT03529773|76017126|FG035|Overall Study|Protocol Violation|0|||
42204607|NCT03529773|76017127|FG036|Overall Study|Protocol Violation|0|||
42204608|NCT03529773|76017128|FG037|Overall Study|Protocol Violation|0|||
42204609|NCT03529773|76017129|FG038|Overall Study|Protocol Violation|0|||
42204610|NCT03529773|76017130|FG039|Overall Study|Protocol Violation|0|||
42204611|NCT03529773|76017091|FG000|Overall Study|Withdrawal by Subject|0|||
42204612|NCT03529773|76017092|FG001|Overall Study|Withdrawal by Subject|0|||
42204613|NCT03529773|76017093|FG002|Overall Study|Withdrawal by Subject|0|||
42204614|NCT03529773|76017094|FG003|Overall Study|Withdrawal by Subject|0|||
42204615|NCT03529773|76017095|FG004|Overall Study|Withdrawal by Subject|0|||
42204616|NCT03529773|76017096|FG005|Overall Study|Withdrawal by Subject|0|||
42204617|NCT03529773|76017097|FG006|Overall Study|Withdrawal by Subject|0|||
42204618|NCT03529773|76017098|FG007|Overall Study|Withdrawal by Subject|1|||
42204619|NCT03529773|76017099|FG008|Overall Study|Withdrawal by Subject|0|||
42204620|NCT03529773|76017100|FG009|Overall Study|Withdrawal by Subject|1|||
42204621|NCT03529773|76017101|FG010|Overall Study|Withdrawal by Subject|1|||
42204622|NCT03529773|76017102|FG011|Overall Study|Withdrawal by Subject|0|||
42204623|NCT03529773|76017103|FG012|Overall Study|Withdrawal by Subject|0|||
42204624|NCT03529773|76017104|FG013|Overall Study|Withdrawal by Subject|0|||
42204625|NCT03529773|76017105|FG014|Overall Study|Withdrawal by Subject|0|||
42204626|NCT03529773|76017106|FG015|Overall Study|Withdrawal by Subject|3|||
42204627|NCT03529773|76017107|FG016|Overall Study|Withdrawal by Subject|0|||
42204628|NCT03529773|76017108|FG017|Overall Study|Withdrawal by Subject|2|||
42204629|NCT03529773|76017109|FG018|Overall Study|Withdrawal by Subject|3|||
42204630|NCT03529773|76017110|FG019|Overall Study|Withdrawal by Subject|1|||
42204631|NCT03529773|76017111|FG020|Overall Study|Withdrawal by Subject|3|||
42204632|NCT03529773|76017112|FG021|Overall Study|Withdrawal by Subject|1|||
42204633|NCT03529773|76017113|FG022|Overall Study|Withdrawal by Subject|1|||
42204634|NCT03529773|76017114|FG023|Overall Study|Withdrawal by Subject|2|||
42204635|NCT03529773|76017115|FG024|Overall Study|Withdrawal by Subject|2|||
42204636|NCT03529773|76017116|FG025|Overall Study|Withdrawal by Subject|4|||
42204637|NCT03529773|76017117|FG026|Overall Study|Withdrawal by Subject|2|||
42204638|NCT03529773|76017118|FG027|Overall Study|Withdrawal by Subject|1|||
42204639|NCT03529773|76017119|FG028|Overall Study|Withdrawal by Subject|1|||
42204640|NCT03529773|76017120|FG029|Overall Study|Withdrawal by Subject|0|||
42204641|NCT03529773|76017121|FG030|Overall Study|Withdrawal by Subject|0|||
42204642|NCT03529773|76017122|FG031|Overall Study|Withdrawal by Subject|0|||
42204643|NCT03529773|76017123|FG032|Overall Study|Withdrawal by Subject|0|||
42204644|NCT03529773|76017124|FG033|Overall Study|Withdrawal by Subject|0|||
42204645|NCT03529773|76017125|FG034|Overall Study|Withdrawal by Subject|1|||
42204646|NCT03529773|76017126|FG035|Overall Study|Withdrawal by Subject|2|||
42204647|NCT03529773|76017127|FG036|Overall Study|Withdrawal by Subject|0|||
42204648|NCT03529773|76017128|FG037|Overall Study|Withdrawal by Subject|2|||
42204649|NCT03529773|76017129|FG038|Overall Study|Withdrawal by Subject|1|||
42204650|NCT03529773|76017130|FG039|Overall Study|Withdrawal by Subject|1|||
42204651|NCT03529773|76017091|FG000|Overall Study|Screen Failure|0|||
42204652|NCT03529773|76017092|FG001|Overall Study|Screen Failure|0|||
42204653|NCT03529773|76017093|FG002|Overall Study|Screen Failure|0|||
42204654|NCT03529773|76017094|FG003|Overall Study|Screen Failure|0|||
42204655|NCT03529773|76017095|FG004|Overall Study|Screen Failure|0|||
42204656|NCT03529773|76017096|FG005|Overall Study|Screen Failure|0|||
42204657|NCT03529773|76017097|FG006|Overall Study|Screen Failure|0|||
42204658|NCT03529773|76017098|FG007|Overall Study|Screen Failure|0|||
42204659|NCT03529773|76017099|FG008|Overall Study|Screen Failure|0|||
42204660|NCT03529773|76017100|FG009|Overall Study|Screen Failure|0|||
42204661|NCT03529773|76017101|FG010|Overall Study|Screen Failure|0|||
42204662|NCT03529773|76017102|FG011|Overall Study|Screen Failure|0|||
42204663|NCT03529773|76017103|FG012|Overall Study|Screen Failure|0|||
42204664|NCT03529773|76017104|FG013|Overall Study|Screen Failure|0|||
42204665|NCT03529773|76017105|FG014|Overall Study|Screen Failure|0|||
42020112|NCT01251614|75827597|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
42204666|NCT03529773|76017106|FG015|Overall Study|Screen Failure|0|||
42204667|NCT03529773|76017107|FG016|Overall Study|Screen Failure|0|||
42204668|NCT03529773|76017108|FG017|Overall Study|Screen Failure|0|||
42204669|NCT03529773|76017109|FG018|Overall Study|Screen Failure|0|||
42204670|NCT03529773|76017110|FG019|Overall Study|Screen Failure|0|||
42204671|NCT03529773|76017111|FG020|Overall Study|Screen Failure|0|||
42204672|NCT03529773|76017112|FG021|Overall Study|Screen Failure|0|||
42204673|NCT03529773|76017113|FG022|Overall Study|Screen Failure|0|||
42204674|NCT03529773|76017114|FG023|Overall Study|Screen Failure|0|||
42204675|NCT03529773|76017115|FG024|Overall Study|Screen Failure|0|||
42204676|NCT03529773|76017116|FG025|Overall Study|Screen Failure|0|||
42204677|NCT03529773|76017117|FG026|Overall Study|Screen Failure|0|||
42204678|NCT03529773|76017118|FG027|Overall Study|Screen Failure|0|||
42204679|NCT03529773|76017119|FG028|Overall Study|Screen Failure|0|||
42204680|NCT03529773|76017120|FG029|Overall Study|Screen Failure|0|||
42387652|NCT02089685|76267396|FG001|Overall Study|Adverse Event|0|||
42387653|NCT02089685|76267397|FG002|Overall Study|Adverse Event|0|||
42387654|NCT02089685|76267398|FG003|Overall Study|Adverse Event|0|||
42387655|NCT02089685|76267399|FG004|Overall Study|Adverse Event|1|||
42387656|NCT02089685|76267400|FG005|Overall Study|Adverse Event|0|||
42020113|NCT01251614|75827598|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
42020114|NCT01251614|75827599|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
42020115|NCT01251614|75827597|FG000|Overall Study|Pregnancy|0|||
42020116|NCT01251614|75827598|FG001|Overall Study|Pregnancy|0|||
42020117|NCT01251614|75827599|FG002|Overall Study|Pregnancy|2|||
42020118|NCT01251614|75827597|FG000|Overall Study|Loss of Disease Control|0|||
42020119|NCT01251614|75827598|FG001|Overall Study|Loss of Disease Control|1|||
42020120|NCT01251614|75827599|FG002|Overall Study|Loss of Disease Control|0|||
42387657|NCT02089685|76267395|FG000|Overall Study|Clinical Progression|4|||
42387658|NCT02089685|76267396|FG001|Overall Study|Clinical Progression|0|||
42387659|NCT02089685|76267397|FG002|Overall Study|Clinical Progression|0|||
42387660|NCT02089685|76267398|FG003|Overall Study|Clinical Progression|5|||
42387661|NCT02089685|76267399|FG004|Overall Study|Clinical Progression|1|||
42387662|NCT02089685|76267400|FG005|Overall Study|Clinical Progression|2|||
42387663|NCT02089685|76267395|FG000|Overall Study|Excluded Medication|1|||
42387664|NCT02089685|76267396|FG001|Overall Study|Excluded Medication|0|||
42387665|NCT02089685|76267397|FG002|Overall Study|Excluded Medication|0|||
42387666|NCT02089685|76267398|FG003|Overall Study|Excluded Medication|11|||
42387667|NCT02089685|76267399|FG004|Overall Study|Excluded Medication|2|||
42387668|NCT02089685|76267400|FG005|Overall Study|Excluded Medication|1|||
42387669|NCT02089685|76267395|FG000|Overall Study|Progressive disease|13|||
42387670|NCT02089685|76267396|FG001|Overall Study|Progressive disease|10|||
42387671|NCT02089685|76267397|FG002|Overall Study|Progressive disease|3|||
42387672|NCT02089685|76267398|FG003|Overall Study|Progressive disease|51|||
42387673|NCT02089685|76267399|FG004|Overall Study|Progressive disease|17|||
42387674|NCT02089685|76267400|FG005|Overall Study|Progressive disease|12|||
42387675|NCT02089685|76267395|FG000|Overall Study|Follow up ended by sponsor|2|||
42387676|NCT02089685|76267396|FG001|Overall Study|Follow up ended by sponsor|2|||
42387677|NCT02089685|76267397|FG002|Overall Study|Follow up ended by sponsor|0|||
42387678|NCT02089685|76267398|FG003|Overall Study|Follow up ended by sponsor|70|||
42387679|NCT02089685|76267399|FG004|Overall Study|Follow up ended by sponsor|26|||
42387680|NCT02089685|76267400|FG005|Overall Study|Follow up ended by sponsor|26|||
42387681|NCT02089685|76267395|FG000|Overall Study|Withdrawal by Subject|0|||
42387682|NCT02089685|76267396|FG001|Overall Study|Withdrawal by Subject|2|||
42387683|NCT02089685|76267397|FG002|Overall Study|Withdrawal by Subject|0|||
42387684|NCT02089685|76267398|FG003|Overall Study|Withdrawal by Subject|8|||
42387685|NCT02089685|76267399|FG004|Overall Study|Withdrawal by Subject|1|||
42387686|NCT02089685|76267400|FG005|Overall Study|Withdrawal by Subject|1|||
42387687|NCT02089685|76267395|FG000|Overall Study|Status not recorded|1|||
42387688|NCT02089685|76267396|FG001|Overall Study|Status not recorded|0|||
42387689|NCT02089685|76267397|FG002|Overall Study|Status not recorded|0|||
42387690|NCT02089685|76267398|FG003|Overall Study|Status not recorded|0|||
42387691|NCT02089685|76267399|FG004|Overall Study|Status not recorded|1|||
42387692|NCT02089685|76267400|FG005|Overall Study|Status not recorded|0|||
42387693|NCT02089685|76267395|FG000|Overall Study|Death|0|||
42387694|NCT02089685|76267396|FG001|Overall Study|Death|0|||
42387695|NCT02089685|76267397|FG002|Overall Study|Death|0|||
42387696|NCT02089685|76267398|FG003|Overall Study|Death|7|||
42387697|NCT02089685|76267399|FG004|Overall Study|Death|2|||
42387698|NCT02089685|76267400|FG005|Overall Study|Death|5|||
42387699|NCT02089685|76267395|FG000|Overall Study|Lost to Follow-up|0|||
42387700|NCT02089685|76267396|FG001|Overall Study|Lost to Follow-up|0|||
42387701|NCT02089685|76267397|FG002|Overall Study|Lost to Follow-up|0|||
42387702|NCT02089685|76267398|FG003|Overall Study|Lost to Follow-up|1|||
42387703|NCT02089685|76267399|FG004|Overall Study|Lost to Follow-up|0|||
42387704|NCT02089685|76267400|FG005|Overall Study|Lost to Follow-up|0|||
42387705|NCT02089685|76267395|FG000|Overall Study|Physician Decision|0|||
42387706|NCT02089685|76267396|FG001|Overall Study|Physician Decision|0|||
42387707|NCT02089685|76267397|FG002|Overall Study|Physician Decision|0|||
42387708|NCT02089685|76267398|FG003|Overall Study|Physician Decision|0|||
42387709|NCT02089685|76267399|FG004|Overall Study|Physician Decision|0|||
42204681|NCT03529773|76017121|FG030|Overall Study|Screen Failure|0|||
42204682|NCT03529773|76017122|FG031|Overall Study|Screen Failure|0|||
42204683|NCT03529773|76017123|FG032|Overall Study|Screen Failure|0|||
42387710|NCT02089685|76267400|FG005|Overall Study|Physician Decision|4|||
42387711|NCT02089685|76267395|FG000|Overall Study|Screen failure|1|||
42387712|NCT02089685|76267396|FG001|Overall Study|Screen failure|0|||
42387713|NCT02089685|76267397|FG002|Overall Study|Screen failure|0|||
42387714|NCT02089685|76267398|FG003|Overall Study|Screen failure|0|||
42387715|NCT02089685|76267399|FG004|Overall Study|Screen failure|0|||
42387716|NCT02089685|76267400|FG005|Overall Study|Screen failure|0|||
42387717|NCT05282004|76267458|FG000|Overall Study|Adverse Event|2|||
42387718|NCT05004649|76267462|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
42387719|NCT05004649|76267462|FG000|Overall Study|Lost to Follow-up|1|||
42387720|NCT05004649|76267462|FG000|Overall Study|Withdrawal by Subject|2|||
42387721|NCT05004649|76267462|FG000|Overall Study|COVID-19|1|||
42387722|NCT04666298|76267472|FG000|Overall Study|Subject decision|1|||
42387723|NCT04666298|76267473|FG001|Overall Study|Subject decision|0|||
42387724|NCT04666298|76267474|FG002|Overall Study|Subject decision|0|||
42387725|NCT04666298|76267475|FG003|Overall Study|Subject decision|2|||
42387726|NCT04666298|76267472|FG000|Overall Study|Death|1|||
42387727|NCT04666298|76267473|FG001|Overall Study|Death|0|||
42387728|NCT04666298|76267474|FG002|Overall Study|Death|0|||
42387729|NCT04666298|76267475|FG003|Overall Study|Death|0|||
42387730|NCT04666298|76267472|FG000|Overall Study|Lost to Follow-up|0|||
42387731|NCT04666298|76267473|FG001|Overall Study|Lost to Follow-up|0|||
42387732|NCT04666298|76267474|FG002|Overall Study|Lost to Follow-up|0|||
42387733|NCT04666298|76267475|FG003|Overall Study|Lost to Follow-up|1|||
42387734|NCT04666298|76267472|FG000|Overall Study|Physician Decision|0|||
42387735|NCT04666298|76267473|FG001|Overall Study|Physician Decision|0|||
42387736|NCT04666298|76267474|FG002|Overall Study|Physician Decision|0|||
42387737|NCT04666298|76267475|FG003|Overall Study|Physician Decision|1|||
42387738|NCT04666298|76267472|FG000|Overall Study|Protocol deviation|0|||
42387739|NCT04666298|76267473|FG001|Overall Study|Protocol deviation|0|||
42387740|NCT04666298|76267474|FG002|Overall Study|Protocol deviation|1|||
42387741|NCT04666298|76267475|FG003|Overall Study|Protocol deviation|0|||
42387742|NCT04188301|76267514|FG000|Month 3|Lost to Follow-up|0|||
42387743|NCT04188301|76267515|FG001|Month 3|Lost to Follow-up|0|||
42387744|NCT04188301|76267516|FG002|Month 3|Lost to Follow-up|1|||
42387745|NCT04188301|76267514|FG000|Month 12|Lost to Follow-up|0|||
42387746|NCT04188301|76267515|FG001|Month 12|Lost to Follow-up|0|||
42387747|NCT04188301|76267516|FG002|Month 12|Lost to Follow-up|2|||
42387748|NCT04188301|76267514|FG000|Month 12|Death|1|||
42387749|NCT04188301|76267515|FG001|Month 12|Death|1|||
42387750|NCT04188301|76267516|FG002|Month 12|Death|0|||
42387751|NCT04188301|76267514|FG000|Month 18|Lost to Follow-up|6|||
42387752|NCT04188301|76267515|FG001|Month 18|Lost to Follow-up|0|||
42387753|NCT04188301|76267516|FG002|Month 18|Lost to Follow-up|0|||
42387754|NCT04006925|76267526|FG000|Overall Study|Side effects|2|||
42387755|NCT04006925|76267527|FG001|Overall Study|Side effects|0|||
42387756|NCT03597061|76267539|FG000|Overall Study|Lost to Follow-up|1|||
42387757|NCT03597061|76267540|FG001|Overall Study|Lost to Follow-up|0|||
42387758|NCT03597061|76267539|FG000|Overall Study|Protocol Violation|0|||
42387759|NCT03597061|76267540|FG001|Overall Study|Protocol Violation|1|||
42387760|NCT03148795|76267568|FG000|Overall Study|Death|6|||
42387761|NCT03148795|76267568|FG000|Overall Study|Adverse Event|5|||
42387762|NCT03148795|76267568|FG000|Overall Study|Other|15|||
42387763|NCT03148795|76267568|FG000|Overall Study|No Longer Clinically Benefitting|2|||
42387764|NCT03148795|76267568|FG000|Overall Study|Global Deterioration Of Health Status|6|||
42387765|NCT03148795|76267568|FG000|Overall Study|Withdrawal by Subject|2|||
42387766|NCT03148795|76267568|FG000|Overall Study|Progressive Disease|62|||
42387767|NCT03148795|76267568|FG000|Overall Study|Ongoing|30|||
42387768|NCT03146845|76267574|FG000|Overall Study|Reference ulcer healed|1|||
42387769|NCT03146845|76267575|FG001|Overall Study|Reference ulcer healed|0|||
42387770|NCT03146845|76267574|FG000|Overall Study|Physician Decision|1|||
42387771|NCT03146845|76267575|FG001|Overall Study|Physician Decision|0|||
42387772|NCT03146845|76267574|FG000|Overall Study|Adverse Event|1|||
42387773|NCT03146845|76267575|FG001|Overall Study|Adverse Event|0|||
42387774|NCT03146845|76267574|FG000|Overall Study|Withdrawal by Subject|2|||
42387775|NCT03146845|76267575|FG001|Overall Study|Withdrawal by Subject|0|||
42387776|NCT03146845|76267574|FG000|Overall Study|Noncompliance|0|||
42387777|NCT03146845|76267575|FG001|Overall Study|Noncompliance|1|||
42387778|NCT03146845|76267574|FG000|Overall Study|Protocol Violation|0|||
42387779|NCT03146845|76267575|FG001|Overall Study|Protocol Violation|2|||
42387780|NCT03146845|76267574|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
42020121|NCT01251614|75827597|FG000|Overall Study|Withdrawal by Subject|0|||
42020122|NCT01251614|75827598|FG001|Overall Study|Withdrawal by Subject|2|||
42387781|NCT03146845|76267575|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
42387782|NCT02975700|76267581|FG000|Overall Study|Adverse Event|1|||
42387783|NCT02975700|76267581|FG000|Overall Study|Progressive disease|3|||
42387784|NCT02975700|76267581|FG000|Overall Study|Failed screening criteria|2|||
42387785|NCT02895360|76267591|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
42387786|NCT02895360|76267592|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
42387787|NCT02895360|76267593|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
42387788|NCT02895360|76267594|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
42387789|NCT02895360|76267595|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
42020123|NCT01251614|75827599|FG002|Overall Study|Withdrawal by Subject|1|||
42020124|NCT01251614|75827597|FG000|Overall Study|Lost to Follow-up|0|||
42020125|NCT01251614|75827598|FG001|Overall Study|Lost to Follow-up|1|||
42020126|NCT01251614|75827599|FG002|Overall Study|Lost to Follow-up|0|||
42020127|NCT01106625|75827620|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
42020128|NCT01106625|75827621|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
42020129|NCT01106625|75827622|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
42020130|NCT01106625|75827620|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
42020131|NCT01106625|75827621|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
42020132|NCT01106625|75827622|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
42020133|NCT01106625|75827620|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
42020134|NCT01106625|75827621|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
42020135|NCT01106625|75827622|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
42020136|NCT01106625|75827620|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
42387790|NCT02895360|76267596|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
42387791|NCT02895360|76267591|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
42387792|NCT02895360|76267592|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
42387793|NCT02895360|76267593|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
42387794|NCT02895360|76267594|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
42387795|NCT02895360|76267595|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
42387796|NCT02895360|76267596|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
42387797|NCT02895360|76267591|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
42387798|NCT02895360|76267592|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
42387799|NCT02895360|76267593|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
42387800|NCT02895360|76267594|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
42387801|NCT02895360|76267595|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
42387802|NCT02895360|76267596|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
42387803|NCT02895360|76267591|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
42387804|NCT02895360|76267592|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
42387805|NCT02895360|76267593|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
42387806|NCT02895360|76267594|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
42387807|NCT02895360|76267595|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
42387808|NCT02895360|76267596|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
42387809|NCT02895360|76267591|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
42387810|NCT02895360|76267592|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
42387811|NCT02895360|76267593|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
42387812|NCT02895360|76267594|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
42387813|NCT02895360|76267595|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
42387814|NCT02895360|76267596|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
42387815|NCT02895360|76267591|FG000|Phase 2a|Adverse Event|0|||
42387816|NCT02895360|76267592|FG001|Phase 2a|Adverse Event|0|||
42387817|NCT02895360|76267593|FG002|Phase 2a|Adverse Event|0|||
42387818|NCT02895360|76267594|FG003|Phase 2a|Adverse Event|0|||
42387819|NCT02895360|76267595|FG004|Phase 2a|Adverse Event|0|||
42387820|NCT02895360|76267596|FG005|Phase 2a|Adverse Event|1|||
42387821|NCT02895360|76267591|FG000|Phase 2a|Progressive disease|0|||
42387822|NCT02895360|76267592|FG001|Phase 2a|Progressive disease|0|||
42387823|NCT02895360|76267593|FG002|Phase 2a|Progressive disease|0|||
42387824|NCT02895360|76267594|FG003|Phase 2a|Progressive disease|0|||
42387825|NCT02895360|76267595|FG004|Phase 2a|Progressive disease|11|||
42387826|NCT02895360|76267596|FG005|Phase 2a|Progressive disease|11|||
42387827|NCT02863809|76267630|FG000|Overall Study|Adverse Event|8|||
42387828|NCT02863809|76267631|FG001|Overall Study|Adverse Event|8|||
42387829|NCT02863809|76267630|FG000|Overall Study|Withdrawal by Subject|0|||
42387830|NCT02863809|76267631|FG001|Overall Study|Withdrawal by Subject|1|||
42387831|NCT02863809|76267630|FG000|Overall Study|Lost to Follow-up|1|||
42387832|NCT02863809|76267631|FG001|Overall Study|Lost to Follow-up|1|||
42387833|NCT02863809|76267630|FG000|Overall Study|Death|1|||
42387834|NCT02863809|76267631|FG001|Overall Study|Death|0|||
42387835|NCT02753530|76267655|FG000|Overall Study|Adverse Event|7|||
42387836|NCT02753530|76267656|FG001|Overall Study|Adverse Event|1|||
42387837|NCT02753530|76267655|FG000|Overall Study|Death|0|||
42387838|NCT02753530|76267656|FG001|Overall Study|Death|1|||
42387839|NCT02753530|76267655|FG000|Overall Study|Physician Decision|0|||
42387840|NCT02753530|76267656|FG001|Overall Study|Physician Decision|1|||
42387841|NCT02753530|76267655|FG000|Overall Study|Protocol Violation|1|||
42387842|NCT02753530|76267656|FG001|Overall Study|Protocol Violation|0|||
42387843|NCT02753530|76267655|FG000|Overall Study|Withdrawal by Subject|4|||
42387844|NCT02753530|76267656|FG001|Overall Study|Withdrawal by Subject|3|||
42387845|NCT02289079|76267668|FG000|Overall Study|Physician Decision|2|||
42387846|NCT02289079|76267669|FG001|Overall Study|Physician Decision|0|||
42387847|NCT02289079|76267668|FG000|Overall Study|Lost to Follow-up|0|||
42387848|NCT02289079|76267669|FG001|Overall Study|Lost to Follow-up|1|||
42387849|NCT00602667|76267736|FG000|Overall Study|Still on Therapy|0|||
42387850|NCT00602667|76267737|FG001|Overall Study|Still on Therapy|2|||
42387851|NCT00602667|76267738|FG002|Overall Study|Still on Therapy|2|||
42387852|NCT00602667|76267736|FG000|Overall Study|Death|0|||
42387853|NCT00602667|76267737|FG001|Overall Study|Death|1|||
42387854|NCT00602667|76267738|FG002|Overall Study|Death|1|||
42387855|NCT00602667|76267736|FG000|Overall Study|Family request|3|||
42387856|NCT00602667|76267737|FG001|Overall Study|Family request|25|||
42387857|NCT00602667|76267738|FG002|Overall Study|Family request|6|||
42387858|NCT00602667|76267736|FG000|Overall Study|Excessive toxicity|1|||
42387859|NCT00602667|76267737|FG001|Overall Study|Excessive toxicity|1|||
42387860|NCT00602667|76267738|FG002|Overall Study|Excessive toxicity|0|||
42387861|NCT00602667|76267736|FG000|Overall Study|Second malignancy|0|||
42387862|NCT00602667|76267737|FG001|Overall Study|Second malignancy|1|||
42387863|NCT00602667|76267738|FG002|Overall Study|Second malignancy|0|||
42387864|NCT00602667|76267736|FG000|Overall Study|Physician Decision|2|||
42387865|NCT00602667|76267737|FG001|Overall Study|Physician Decision|3|||
42387866|NCT00602667|76267738|FG002|Overall Study|Physician Decision|8|||
42387867|NCT00602667|76267736|FG000|Overall Study|Progressive disease|13|||
42387868|NCT00602667|76267737|FG001|Overall Study|Progressive disease|48|||
42387869|NCT00602667|76267738|FG002|Overall Study|Progressive disease|45|||
42387870|NCT00602667|76267736|FG000|Overall Study|Progressive disease prior to therapy|0|||
42387871|NCT00602667|76267737|FG001|Overall Study|Progressive disease prior to therapy|0|||
42387872|NCT00602667|76267738|FG002|Overall Study|Progressive disease prior to therapy|1|||
42387873|NCT02088905|76267781|FG000|Overall Study|Withdrawal by Subject|5|||
42387874|NCT02088905|76267782|FG001|Overall Study|Withdrawal by Subject|1|||
42387875|NCT02088047|76267790|FG000|Overall Study|Withdrawal by Subject|1|||
42387876|NCT02088047|76267791|FG001|Overall Study|Withdrawal by Subject|0|||
42387877|NCT02086565|76267817|FG000|Overall Study|Lost to Follow-up|9|||
42387878|NCT02086565|76267818|FG001|Overall Study|Lost to Follow-up|7|||
42387879|NCT02086565|76267817|FG000|Overall Study|Withdrawal by Subject|2|||
42387880|NCT02086565|76267818|FG001|Overall Study|Withdrawal by Subject|1|||
42387881|NCT02086565|76267817|FG000|Overall Study|Death|3|||
42387882|NCT02086565|76267818|FG001|Overall Study|Death|2|||
42387883|NCT02086565|76267817|FG000|Overall Study|withdrawn by research team|2|||
42387884|NCT02086565|76267818|FG001|Overall Study|withdrawn by research team|2|||
42387885|NCT02085941|76267826|FG000|Overall Study|Lack of Efficacy|1|||
42387886|NCT02085941|76267827|FG001|Overall Study|Lack of Efficacy|0|||
42387887|NCT02085941|76267826|FG000|Overall Study|Death|6|||
42387888|NCT02085941|76267827|FG001|Overall Study|Death|1|||
42387889|NCT02085941|76267826|FG000|Overall Study|Lost to Follow-up|1|||
42387890|NCT02085941|76267827|FG001|Overall Study|Lost to Follow-up|0|||
42387891|NCT02085941|76267826|FG000|Overall Study|Physician Decision|0|||
42387892|NCT02085941|76267827|FG001|Overall Study|Physician Decision|2|||
42387893|NCT02085785|76267835|FG000|Overall Study|Withdrawal by Subject|2|||
42387894|NCT02085785|76267836|FG001|Overall Study|Withdrawal by Subject|1|||
42387895|NCT02085785|76267835|FG000|Overall Study|Lost to Follow-up|0|||
42387896|NCT02085785|76267836|FG001|Overall Study|Lost to Follow-up|1|||
42387897|NCT02085161|76267864|FG000|Overall Study|Not Treated|1|||
42387898|NCT02085161|76267865|FG001|Overall Study|Not Treated|0|||
42387899|NCT02085161|76267866|FG002|Overall Study|Not Treated|0|||
42387900|NCT02085161|76267867|FG003|Overall Study|Not Treated|0|||
42387901|NCT02085161|76267864|FG000|Overall Study|Adverse Event|8|||
42387902|NCT02085161|76267865|FG001|Overall Study|Adverse Event|5|||
42387903|NCT02085161|76267866|FG002|Overall Study|Adverse Event|4|||
42387904|NCT02085161|76267867|FG003|Overall Study|Adverse Event|5|||
42387905|NCT02085161|76267864|FG000|Overall Study|Protocol Violation|0|||
42387906|NCT02085161|76267865|FG001|Overall Study|Protocol Violation|1|||
42387907|NCT02085161|76267866|FG002|Overall Study|Protocol Violation|0|||
42387908|NCT02085161|76267867|FG003|Overall Study|Protocol Violation|1|||
42387909|NCT02085161|76267864|FG000|Overall Study|Withdrawal by Subject|2|||
42387910|NCT02085161|76267865|FG001|Overall Study|Withdrawal by Subject|4|||
42387911|NCT02085161|76267866|FG002|Overall Study|Withdrawal by Subject|0|||
42387912|NCT02085161|76267867|FG003|Overall Study|Withdrawal by Subject|3|||
42387913|NCT02085161|76267864|FG000|Overall Study|Other Reason|1|||
42387914|NCT02085161|76267865|FG001|Overall Study|Other Reason|0|||
42387915|NCT02085161|76267866|FG002|Overall Study|Other Reason|1|||
42387916|NCT02085161|76267867|FG003|Overall Study|Other Reason|1|||
42387917|NCT02082977|76268750|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
42387918|NCT02082977|76268751|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
42387919|NCT02082977|76268752|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
42387920|NCT02082977|76268753|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
42387921|NCT02082977|76268754|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
42387922|NCT02082977|76268755|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
42387923|NCT02082977|76268756|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
42387924|NCT02082977|76268757|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
42387925|NCT02082977|76268758|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
42387926|NCT02082977|76268759|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
42387927|NCT02082977|76268750|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
42387928|NCT02082977|76268751|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
42387929|NCT02082977|76268752|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
42387930|NCT02082977|76268753|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
42387931|NCT02082977|76268754|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
42387932|NCT02082977|76268755|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
42387933|NCT02082977|76268756|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
42387934|NCT02082977|76268757|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
42387935|NCT02082977|76268758|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
42387936|NCT02082977|76268759|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
42387937|NCT02082977|76268750|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
42387938|NCT02082977|76268751|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
42387939|NCT02082977|76268752|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
42387940|NCT02082977|76268753|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
42387941|NCT02082977|76268754|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
42387942|NCT02082977|76268755|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
42387943|NCT02082977|76268756|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
42387944|NCT02082977|76268757|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
42387945|NCT02082977|76268758|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
42387946|NCT02082977|76268759|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
42387947|NCT02082977|76268750|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
42387948|NCT02082977|76268751|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
42387949|NCT02082977|76268752|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
42387950|NCT02082977|76268753|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
42387951|NCT02082977|76268754|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
42387952|NCT02082977|76268755|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
42387953|NCT02082977|76268756|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
42387954|NCT02082977|76268757|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
42387955|NCT02082977|76268758|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
42387956|NCT02082977|76268759|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
42387957|NCT02082977|76268750|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
42387958|NCT02082977|76268751|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
42387959|NCT02082977|76268752|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
42387960|NCT02082977|76268753|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
42387961|NCT02082977|76268754|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
42387962|NCT02082977|76268755|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
42387963|NCT02082977|76268756|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
42387964|NCT02082977|76268757|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
42387965|NCT02082977|76268758|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
42387966|NCT02082977|76268759|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
42387967|NCT01624259|76268793|FG000|Overall Study|Adverse Event|18|||
42387968|NCT01624259|76268794|FG001|Overall Study|Adverse Event|18|||
42387969|NCT01624259|76268793|FG000|Overall Study|Protocol Violation|1|||
42387970|NCT01624259|76268794|FG001|Overall Study|Protocol Violation|2|||
42387971|NCT01624259|76268793|FG000|Overall Study|Withdrawal by Subject|5|||
42387972|NCT01624259|76268794|FG001|Overall Study|Withdrawal by Subject|7|||
42387973|NCT01624259|76268793|FG000|Overall Study|Physician Decision|1|||
42387974|NCT01624259|76268794|FG001|Overall Study|Physician Decision|1|||
42387975|NCT01624259|76268793|FG000|Overall Study|Lost to Follow-up|2|||
42387976|NCT01624259|76268794|FG001|Overall Study|Lost to Follow-up|3|||
42387977|NCT01624259|76268793|FG000|Overall Study|Abnormal laboratory measure|3|||
42387978|NCT01624259|76268794|FG001|Overall Study|Abnormal laboratory measure|0|||
42387979|NCT02081417|76268804|FG000|Overall Study|Lost to Follow-up|26|||
42387980|NCT02081417|76268805|FG001|Overall Study|Lost to Follow-up|23|||
42387981|NCT02081417|76268804|FG000|Overall Study|Moved Away|1|||
42387982|NCT02081417|76268805|FG001|Overall Study|Moved Away|2|||
42387983|NCT02081417|76268804|FG000|Overall Study|Incarcerated|2|||
42387984|NCT02081417|76268805|FG001|Overall Study|Incarcerated|2|||
42387985|NCT02081417|76268804|FG000|Overall Study|Death|4|||
42387986|NCT02081417|76268805|FG001|Overall Study|Death|3|||
42387987|NCT02081417|76268804|FG000|Overall Study|Withdrawal by Subject|4|||
42387988|NCT02081417|76268805|FG001|Overall Study|Withdrawal by Subject|0|||
42387989|NCT02081417|76268804|FG000|Overall Study|Admitted to Residential Treatment|2|||
42387990|NCT02081417|76268805|FG001|Overall Study|Admitted to Residential Treatment|0|||
42387991|NCT02081417|76268804|FG000|Overall Study|Did not start treatment|17|||
42387992|NCT02081417|76268805|FG001|Overall Study|Did not start treatment|21|||
42387993|NCT02081183|76268813|FG000|Overall Study|Lost to Follow-up|0|||
42387994|NCT02081183|76268814|FG001|Overall Study|Lost to Follow-up|1|||
42387995|NCT02081183|76268813|FG000|Overall Study|Protocol Violation|1|||
42387996|NCT02081183|76268814|FG001|Overall Study|Protocol Violation|0|||
42387997|NCT02081183|76268813|FG000|Overall Study|Other|3|||
42387998|NCT02081183|76268814|FG001|Overall Study|Other|3|||
42387999|NCT02080871|76268820|FG000|Overall Study|Death|1|||
42388000|NCT02080871|76268820|FG000|Overall Study|Lost to Follow-up|1|||
42388001|NCT02080481|76268826|FG000|Overall Study|Never received a block.|1|||
42388002|NCT02080481|76268827|FG001|Overall Study|Never received a block.|0|||
42388003|NCT02080403|76268835|FG000|Overall Study|Adverse Event|5|||
42388004|NCT02080403|76268836|FG001|Overall Study|Adverse Event|1|||
42388005|NCT02080403|76268835|FG000|Overall Study|Death|0|||
42388006|NCT02080403|76268836|FG001|Overall Study|Death|2|||
42388007|NCT02080403|76268835|FG000|Overall Study|Lost to Follow-up|2|||
42388008|NCT02080403|76268836|FG001|Overall Study|Lost to Follow-up|0|||
42388009|NCT02080403|76268835|FG000|Overall Study|Pregnancy|0|||
42388010|NCT02080403|76268836|FG001|Overall Study|Pregnancy|1|||
42388011|NCT02080403|76268835|FG000|Overall Study|Protocol Violation|3|||
42388012|NCT02080403|76268836|FG001|Overall Study|Protocol Violation|7|||
42388013|NCT02080403|76268835|FG000|Overall Study|Withdrawal by Subject|5|||
42388014|NCT02080403|76268836|FG001|Overall Study|Withdrawal by Subject|1|||
42388015|NCT02080091|76268842|FG000|Overall Study|Study Terminated|22|||
42388016|NCT02080091|76268842|FG000|Overall Study|Death|1|||
42388017|NCT02080091|76268842|FG000|Overall Study|Withdrawal by Subject|1|||
42388018|NCT02080091|76268842|FG000|Overall Study|Other|1|||
42388019|NCT02079077|76268848|FG000|Overall Study|Lost to Follow-up|5|||
42388020|NCT02079077|76268849|FG001|Overall Study|Lost to Follow-up|7|||
42388021|NCT02079077|76268848|FG000|Overall Study|Became STIs Positive|1|||
42388022|NCT02079077|76268849|FG001|Overall Study|Became STIs Positive|2|||
42388023|NCT02078219|76268877|FG000|Overall Study|Other|2|||
42388024|NCT02078219|76268878|FG001|Overall Study|Other|2|||
42388025|NCT02078219|76268879|FG002|Overall Study|Other|3|||
42388026|NCT02078219|76268880|FG003|Overall Study|Other|0|||
42388027|NCT02078219|76268881|FG004|Overall Study|Other|1|||
42388028|NCT02078219|76268877|FG000|Overall Study|Withdrawal by Subject|0|||
42388029|NCT02078219|76268878|FG001|Overall Study|Withdrawal by Subject|1|||
42388030|NCT02078219|76268879|FG002|Overall Study|Withdrawal by Subject|0|||
42388031|NCT02078219|76268880|FG003|Overall Study|Withdrawal by Subject|1|||
42388032|NCT02078219|76268881|FG004|Overall Study|Withdrawal by Subject|1|||
42388033|NCT02078219|76268877|FG000|Overall Study|Protocol Violation|0|||
42388034|NCT02078219|76268878|FG001|Overall Study|Protocol Violation|0|||
42388035|NCT02078219|76268879|FG002|Overall Study|Protocol Violation|0|||
42388036|NCT02078219|76268880|FG003|Overall Study|Protocol Violation|1|||
42388037|NCT02078219|76268881|FG004|Overall Study|Protocol Violation|0|||
42388038|NCT02078219|76268877|FG000|Overall Study|Death|0|||
42388039|NCT02078219|76268878|FG001|Overall Study|Death|0|||
42388040|NCT02078219|76268879|FG002|Overall Study|Death|0|||
42388041|NCT02078219|76268880|FG003|Overall Study|Death|1|||
42388042|NCT02078219|76268881|FG004|Overall Study|Death|0|||
42388043|NCT02078219|76268877|FG000|Overall Study|Adverse Event|1|||
42388044|NCT02078219|76268878|FG001|Overall Study|Adverse Event|1|||
42388045|NCT02078219|76268879|FG002|Overall Study|Adverse Event|3|||
42388046|NCT02078219|76268880|FG003|Overall Study|Adverse Event|1|||
42388047|NCT02078219|76268881|FG004|Overall Study|Adverse Event|0|||
42388048|NCT02075255|76268896|FG000|Overall Study|Study specific withdrawal criteria|0|||
42388049|NCT02075255|76268897|FG001|Overall Study|Study specific withdrawal criteria|1|||
42388050|NCT02075255|76268898|FG002|Overall Study|Study specific withdrawal criteria|1|||
42388051|NCT02075255|76268896|FG000|Overall Study|Withdrawal by Subject|4|||
42388052|NCT02075255|76268897|FG001|Overall Study|Withdrawal by Subject|1|||
42388053|NCT02075255|76268898|FG002|Overall Study|Withdrawal by Subject|0|||
42388054|NCT02075255|76268896|FG000|Overall Study|Lost to Follow-up|0|||
42388055|NCT02075255|76268897|FG001|Overall Study|Lost to Follow-up|0|||
42388056|NCT02075255|76268898|FG002|Overall Study|Lost to Follow-up|1|||
42020137|NCT01106625|75827621|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
42110567|NCT00508924|75920984|FG000|Overall Study|Protocol Violation|0|||
42110568|NCT00508924|75920985|FG001|Overall Study|Protocol Violation|0|||
42110569|NCT00508924|75920986|FG002|Overall Study|Protocol Violation|1|||
42110570|NCT00508924|75920987|FG003|Overall Study|Protocol Violation|1|||
42110571|NCT00620750|75920997|FG000|Overall Study|Lost to Follow-up|25|||
42110572|NCT00508144|75921001|FG000|Overall Study|Not eligible|6|||
42110573|NCT00508144|75921001|FG000|Overall Study|Death|5|||
42020138|NCT01106625|75827622|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
42020139|NCT01106625|75827620|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
42020140|NCT01106625|75827621|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
42020141|NCT01106625|75827622|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
42020142|NCT01106625|75827620|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
42020143|NCT01106625|75827621|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
42020144|NCT01106625|75827622|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
42020145|NCT01106625|75827620|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
42110574|NCT00621842|75921005|FG000|Overall Study|Adverse Event|6|||
42110575|NCT00621842|75921005|FG000|Overall Study|Withdrawal by Subject|7|||
42388057|NCT02075255|76268896|FG000|Overall Study|Adverse Event|0|||
42388058|NCT02075255|76268897|FG001|Overall Study|Adverse Event|0|||
42388059|NCT02075255|76268898|FG002|Overall Study|Adverse Event|1|||
42388060|NCT02075255|76268896|FG000|Overall Study|Death|0|||
42388061|NCT02075255|76268897|FG001|Overall Study|Death|2|||
42388062|NCT02075255|76268898|FG002|Overall Study|Death|0|||
42388063|NCT02400671|76269069|FG000|Overall Study|Death|5|||
42388064|NCT02400671|76269070|FG001|Overall Study|Death|3|||
42388065|NCT02400671|76269071|FG002|Overall Study|Death|4|||
42388066|NCT02400671|76269069|FG000|Overall Study|Lost to Follow-up|20|||
42020146|NCT01106625|75827621|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
42020147|NCT01106625|75827622|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
42020148|NCT01106625|75827620|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
42020149|NCT01106625|75827621|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
42020150|NCT01106625|75827622|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
42020151|NCT01106625|75827620|FG000|Core Period: Baseline to Week 26|Other|8|||
42020152|NCT01106625|75827621|FG001|Core Period: Baseline to Week 26|Other|7|||
42020153|NCT01106625|75827622|FG002|Core Period: Baseline to Week 26|Other|4|||
42020154|NCT01106625|75827620|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
42020155|NCT01106625|75827621|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
42020156|NCT01106625|75827622|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
42020157|NCT01106625|75827620|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
42020158|NCT01106625|75827621|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
42020159|NCT01106625|75827622|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
42020160|NCT01106625|75827620|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
42020161|NCT01106625|75827621|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
42020162|NCT01106625|75827622|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
42020163|NCT01106625|75827620|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
42020164|NCT01106625|75827621|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
42020165|NCT01106625|75827622|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
42020166|NCT01106625|75827620|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
42020167|NCT01106625|75827621|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
42020168|NCT01106625|75827622|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
42020169|NCT01106625|75827620|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
42020170|NCT01106625|75827621|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
42020171|NCT01106625|75827622|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
42020172|NCT01106625|75827620|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
42020173|NCT01106625|75827621|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
42020174|NCT01106625|75827622|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
42110576|NCT00621842|75921005|FG000|Overall Study|Protocol Violation|4|||
42110577|NCT00621842|75921005|FG000|Overall Study|Lack of Efficacy|2|||
42110578|NCT00503776|75921013|FG000|Overall Study|Withdrawal by Subject|1|||
42110579|NCT00503776|75921014|FG001|Overall Study|Withdrawal by Subject|0|||
42110580|NCT00503776|75921015|FG002|Overall Study|Withdrawal by Subject|1|||
42110581|NCT00503776|75921016|FG003|Overall Study|Withdrawal by Subject|1|||
42110582|NCT00503776|75921013|FG000|Overall Study|Physician Decision|0|||
42110583|NCT00503776|75921014|FG001|Overall Study|Physician Decision|0|||
42110584|NCT00503776|75921015|FG002|Overall Study|Physician Decision|1|||
42110585|NCT00503776|75921016|FG003|Overall Study|Physician Decision|1|||
42110586|NCT00619112|75921033|FG000|Overall Study|Adverse Event|1|||
42110587|NCT00619112|75921034|FG001|Overall Study|Adverse Event|2|||
42110588|NCT00619502|75921045|FG000|Overall Study|Lost to Follow-up|8|||
42110589|NCT00619502|75921046|FG001|Overall Study|Lost to Follow-up|10|||
42110590|NCT00618956|75921056|FG000|Overall Study|Adverse Event|10|||
42110591|NCT00618956|75921057|FG001|Overall Study|Adverse Event|34|||
42110592|NCT00618956|75921056|FG000|Overall Study|Lack of Efficacy|2|||
42110593|NCT00618956|75921057|FG001|Overall Study|Lack of Efficacy|1|||
42110594|NCT00618956|75921056|FG000|Overall Study|Withdrawal by Subject|5|||
42110595|NCT00618956|75921057|FG001|Overall Study|Withdrawal by Subject|7|||
42110596|NCT00618956|75921056|FG000|Overall Study|Lost to Follow-up|4|||
42110597|NCT00618956|75921057|FG001|Overall Study|Lost to Follow-up|5|||
42110598|NCT00618956|75921056|FG000|Overall Study|Protocol Violation|2|||
42110599|NCT00618956|75921057|FG001|Overall Study|Protocol Violation|2|||
42110600|NCT00618956|75921056|FG000|Overall Study|did not meet criteria, non-compliance|2|||
42110601|NCT00618956|75921057|FG001|Overall Study|did not meet criteria, non-compliance|1|||
42110602|NCT00716417|75921079|FG000|Overall Study|Adverse Event|0|||
42110603|NCT00716417|75921080|FG001|Overall Study|Adverse Event|0|||
42110604|NCT00716417|75921081|FG002|Overall Study|Adverse Event|2|||
42110605|NCT00716417|75921082|FG003|Overall Study|Adverse Event|1|||
42110606|NCT00716417|75921083|FG004|Overall Study|Adverse Event|0|||
42110607|NCT00716417|75921084|FG005|Overall Study|Adverse Event|0|||
42110608|NCT00716417|75921085|FG006|Overall Study|Adverse Event|3|||
42110609|NCT00716417|75921086|FG007|Overall Study|Adverse Event|1|||
42110610|NCT00716417|75921087|FG008|Overall Study|Adverse Event|0|||
42110611|NCT00716417|75921088|FG009|Overall Study|Adverse Event|3|||
42388067|NCT02400671|76269070|FG001|Overall Study|Lost to Follow-up|27|||
42388068|NCT02400671|76269071|FG002|Overall Study|Lost to Follow-up|24|||
42388069|NCT02400671|76269069|FG000|Overall Study|Withdrawal by Subject|2|||
42110612|NCT00716417|75921079|FG000|Overall Study|Withdrawal by Subject|0|||
42110613|NCT00716417|75921080|FG001|Overall Study|Withdrawal by Subject|1|||
42110614|NCT00716417|75921081|FG002|Overall Study|Withdrawal by Subject|0|||
42388070|NCT02400671|76269070|FG001|Overall Study|Withdrawal by Subject|2|||
42388071|NCT02400671|76269071|FG002|Overall Study|Withdrawal by Subject|0|||
42388072|NCT00089999|76269081|FG000|Overall Study|Adverse Event|4|||
42388073|NCT00089999|76269082|FG001|Overall Study|Adverse Event|7|||
42388074|NCT00089999|76269081|FG000|Overall Study|Withdrawal by Subject|0|||
42388075|NCT00089999|76269082|FG001|Overall Study|Withdrawal by Subject|4|||
42388076|NCT00089999|76269081|FG000|Overall Study|Lost to Follow-up|2|||
42388077|NCT00089999|76269082|FG001|Overall Study|Lost to Follow-up|1|||
42388078|NCT00089999|76269081|FG000|Overall Study|Radiological Progression of Cancer|52|||
42388079|NCT00089999|76269082|FG001|Overall Study|Radiological Progression of Cancer|44|||
42388080|NCT00089999|76269081|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
42388081|NCT00089999|76269082|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
42388082|NCT00089999|76269081|FG000|Overall Study|Death|3|||
42388083|NCT00089999|76269082|FG001|Overall Study|Death|3|||
42388084|NCT00089999|76269081|FG000|Overall Study|Poor General Condition|1|||
42388085|NCT00089999|76269082|FG001|Overall Study|Poor General Condition|0|||
42388086|NCT00089999|76269081|FG000|Overall Study|Clinical Progression|1|||
42388087|NCT00089999|76269082|FG001|Overall Study|Clinical Progression|2|||
42388088|NCT00089999|76269081|FG000|Overall Study|Physician Decision|2|||
42388089|NCT00089999|76269082|FG001|Overall Study|Physician Decision|2|||
42388090|NCT00089999|76269081|FG000|Overall Study|Patient Underwent Surgery|2|||
42388091|NCT00089999|76269082|FG001|Overall Study|Patient Underwent Surgery|0|||
42388092|NCT00089999|76269081|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
42388093|NCT00089999|76269082|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
42388094|NCT00089843|76269093|FG000|Overall Study|Withdrawal by Subject|1|||
42388095|NCT00089843|76269094|FG001|Overall Study|Withdrawal by Subject|4|||
42388096|NCT00089843|76269095|FG002|Overall Study|Withdrawal by Subject|5|||
42388097|NCT00089843|76269096|FG003|Overall Study|Withdrawal by Subject|6|||
42388098|NCT00089843|76269093|FG000|Overall Study|Physician Decision|1|||
42388099|NCT00089843|76269094|FG001|Overall Study|Physician Decision|0|||
42110615|NCT00716417|75921082|FG003|Overall Study|Withdrawal by Subject|2|||
42110616|NCT00716417|75921083|FG004|Overall Study|Withdrawal by Subject|0|||
42110617|NCT00716417|75921084|FG005|Overall Study|Withdrawal by Subject|0|||
42110618|NCT00716417|75921085|FG006|Overall Study|Withdrawal by Subject|1|||
42110619|NCT00716417|75921086|FG007|Overall Study|Withdrawal by Subject|0|||
42110620|NCT00716417|75921087|FG008|Overall Study|Withdrawal by Subject|0|||
42110621|NCT00716417|75921088|FG009|Overall Study|Withdrawal by Subject|0|||
42110622|NCT00716417|75921079|FG000|Overall Study|Progressive disease|3|||
42110623|NCT00716417|75921080|FG001|Overall Study|Progressive disease|5|||
42110624|NCT00716417|75921081|FG002|Overall Study|Progressive disease|3|||
42110625|NCT00716417|75921082|FG003|Overall Study|Progressive disease|8|||
42110626|NCT00716417|75921083|FG004|Overall Study|Progressive disease|0|||
42110627|NCT00716417|75921084|FG005|Overall Study|Progressive disease|3|||
42110628|NCT00716417|75921085|FG006|Overall Study|Progressive disease|3|||
42110629|NCT00716417|75921086|FG007|Overall Study|Progressive disease|1|||
42110630|NCT00716417|75921087|FG008|Overall Study|Progressive disease|5|||
42110631|NCT00716417|75921088|FG009|Overall Study|Progressive disease|0|||
42110632|NCT00716417|75921079|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
42110633|NCT00716417|75921080|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
42110634|NCT00716417|75921081|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
42110635|NCT00716417|75921082|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
42110636|NCT00716417|75921083|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
42110637|NCT00716417|75921084|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
42110638|NCT00716417|75921085|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
42110639|NCT00716417|75921086|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
42110640|NCT00716417|75921087|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
42110641|NCT00716417|75921088|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
42110642|NCT00716417|75921079|FG000|Overall Study|On patient request due to toxicities|0|||
42110643|NCT00716417|75921080|FG001|Overall Study|On patient request due to toxicities|0|||
42110644|NCT00716417|75921081|FG002|Overall Study|On patient request due to toxicities|0|||
42110645|NCT00716417|75921082|FG003|Overall Study|On patient request due to toxicities|0|||
42110646|NCT00716417|75921083|FG004|Overall Study|On patient request due to toxicities|0|||
42110647|NCT00716417|75921084|FG005|Overall Study|On patient request due to toxicities|0|||
42110648|NCT00716417|75921085|FG006|Overall Study|On patient request due to toxicities|0|||
42110649|NCT00716417|75921086|FG007|Overall Study|On patient request due to toxicities|1|||
42110650|NCT00716417|75921087|FG008|Overall Study|On patient request due to toxicities|0|||
42110651|NCT00716417|75921088|FG009|Overall Study|On patient request due to toxicities|0|||
42110652|NCT00719537|75921114|FG000|Overall Study|Withdrawal by Subject|1|||
42110653|NCT00719537|75921115|FG001|Overall Study|Withdrawal by Subject|0|||
42110654|NCT00719537|75921114|FG000|Overall Study|Lost to Follow-up|0|||
42110655|NCT00719537|75921115|FG001|Overall Study|Lost to Follow-up|1|||
42388100|NCT00089843|76269095|FG002|Overall Study|Physician Decision|0|||
42388101|NCT00089843|76269096|FG003|Overall Study|Physician Decision|1|||
42388102|NCT00089297|76269106|FG000|Overall Study|Adverse Event|9|||
42388103|NCT00089297|76269106|FG000|Overall Study|Death|1|||
42110656|NCT00715949|75921121|FG000|Overall Study|could not finish first test|4|||
42110657|NCT00503698|75921127|FG000|Overall Study|Protocol Violation|5|||
42110658|NCT00503698|75921128|FG001|Overall Study|Protocol Violation|6|||
42110659|NCT00503698|75921127|FG000|Overall Study|Adverse Event|52|||
42110660|NCT00503698|75921128|FG001|Overall Study|Adverse Event|41|||
42110661|NCT00503698|75921127|FG000|Overall Study|Death|1|||
42110662|NCT00503698|75921128|FG001|Overall Study|Death|0|||
42110663|NCT00503698|75921127|FG000|Overall Study|Lack of Efficacy|3|||
42110664|NCT00503698|75921128|FG001|Overall Study|Lack of Efficacy|4|||
42110665|NCT00503698|75921127|FG000|Overall Study|Trial terminated|216|||
42110666|NCT00503698|75921128|FG001|Overall Study|Trial terminated|253|||
42110667|NCT00503698|75921127|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
42110668|NCT00503698|75921128|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
42110669|NCT00503698|75921127|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
42110670|NCT00503698|75921128|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
42110671|NCT00503698|75921127|FG000|Overall Study|Any condition in exclusion criteria|4|||
42110672|NCT00503698|75921128|FG001|Overall Study|Any condition in exclusion criteria|6|||
42110673|NCT00503698|75921127|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
42110674|NCT00503698|75921128|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
42110675|NCT00503698|75921127|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
42110676|NCT00503698|75921128|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
42110677|NCT00503698|75921127|FG000|Overall Study|Critically ill|2|||
42110678|NCT00503698|75921128|FG001|Overall Study|Critically ill|0|||
42110679|NCT00503698|75921127|FG000|Overall Study|Unclassified|48|||
42110680|NCT00503698|75921128|FG001|Overall Study|Unclassified|32|||
42110681|NCT00503698|75921127|FG000|Overall Study|Not exposed to trial drug|11|||
42110682|NCT00503698|75921128|FG001|Overall Study|Not exposed to trial drug|6|||
42110683|NCT00573794|75921143|FG000|Overall Study|Adverse Event|81|||
42110684|NCT00573794|75921143|FG000|Overall Study|Withdrew Consent|90|||
42110685|NCT00573794|75921143|FG000|Overall Study|Lost to Follow-up|13|||
42110686|NCT00573794|75921143|FG000|Overall Study|Protocol Violation|6|||
42110687|NCT00573794|75921143|FG000|Overall Study|Lack of Efficacy|94|||
42110688|NCT00573794|75921143|FG000|Overall Study|Other|46|||
42110689|NCT00715793|75921147|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
42110690|NCT00715793|75921148|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
42110691|NCT00715793|75921147|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
42110692|NCT00715793|75921148|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
42110693|NCT00718523|75921157|FG000|Overall Study|Withdrawal by Subject|5|||
42110694|NCT00718523|75921158|FG001|Overall Study|Withdrawal by Subject|7|||
42110695|NCT00718523|75921157|FG000|Overall Study|Death|13|||
42110696|NCT00718523|75921158|FG001|Overall Study|Death|17|||
42110697|NCT00715559|75921164|FG000|Overall Study|medication not tolerated - nausea|1|||
42110698|NCT00620282|75921171|FG000|Overall Study|Adverse Event|0|||
42110699|NCT00620282|75921172|FG001|Overall Study|Adverse Event|1|||
42110700|NCT00620282|75921173|FG002|Overall Study|Adverse Event|0|||
42110701|NCT00620282|75921171|FG000|Overall Study|Arterial line unable to be placed|0|||
42110702|NCT00620282|75921172|FG001|Overall Study|Arterial line unable to be placed|0|||
42388104|NCT00089297|76269106|FG000|Overall Study|Withdrawal by Subject|12|||
42388105|NCT00089297|76269106|FG000|Overall Study|Disease progression|2|||
42388106|NCT00089297|76269106|FG000|Overall Study|Ineligible|11|||
42388107|NCT00089297|76269106|FG000|Overall Study|Secondary malignancy|1|||
42388108|NCT00089297|76269106|FG000|Overall Study|IRB approval not ready|1|||
42388109|NCT00089297|76269106|FG000|Overall Study|Non-compliance|1|||
42388110|NCT00088907|76269148|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
42388111|NCT00088907|76269149|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
42388112|NCT00088907|76269148|FG000|Randomized Study (Step 1)|Adverse Event|14|||
42388113|NCT00088907|76269149|FG001|Randomized Study (Step 1)|Adverse Event|19|||
42388114|NCT00088907|76269148|FG000|Randomized Study (Step 1)|Death|11|||
42388115|NCT00088907|76269149|FG001|Randomized Study (Step 1)|Death|12|||
42388116|NCT00088907|76269148|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
42388117|NCT00088907|76269149|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
42388118|NCT00088907|76269148|FG000|Randomized Study (Step 1)|complicating disease|3|||
42388119|NCT00088907|76269149|FG001|Randomized Study (Step 1)|complicating disease|1|||
42388120|NCT00088907|76269148|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
42388121|NCT00088907|76269149|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
42388122|NCT00088907|76269148|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
42388123|NCT00088907|76269149|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
42388124|NCT00088907|76269148|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
42110703|NCT00620282|75921173|FG002|Overall Study|Arterial line unable to be placed|1|||
42110704|NCT00620282|75921171|FG000|Overall Study|Withdrawal by Subject|0|||
42110705|NCT00620282|75921172|FG001|Overall Study|Withdrawal by Subject|1|||
42388125|NCT00088907|76269149|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
42388126|NCT00088907|76269148|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
42388127|NCT00088907|76269149|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
42110706|NCT00620282|75921173|FG002|Overall Study|Withdrawal by Subject|0|||
42110707|NCT00515086|75921185|FG000|Overall Study|Adverse Event|1|||
42110708|NCT00515086|75921186|FG001|Overall Study|Adverse Event|1|||
42110709|NCT00515086|75921187|FG002|Overall Study|Adverse Event|2|||
42110710|NCT00515086|75921188|FG003|Overall Study|Adverse Event|3|||
42110711|NCT00515086|75921185|FG000|Overall Study|Administrative|1|||
42110712|NCT00515086|75921186|FG001|Overall Study|Administrative|1|||
42110713|NCT00515086|75921187|FG002|Overall Study|Administrative|0|||
42110714|NCT00515086|75921188|FG003|Overall Study|Administrative|0|||
42110715|NCT00515086|75921185|FG000|Overall Study|Withdrawal by Subject|1|||
42110716|NCT00515086|75921186|FG001|Overall Study|Withdrawal by Subject|0|||
42110717|NCT00515086|75921187|FG002|Overall Study|Withdrawal by Subject|0|||
42110718|NCT00515086|75921188|FG003|Overall Study|Withdrawal by Subject|1|||
42110719|NCT00515086|75921185|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
42110720|NCT00515086|75921186|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
42110721|NCT00515086|75921187|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
42110722|NCT00515086|75921188|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
42110723|NCT00515086|75921185|FG000|Overall Study|Lost to Follow-up|1|||
42110724|NCT00515086|75921186|FG001|Overall Study|Lost to Follow-up|0|||
42110725|NCT00515086|75921187|FG002|Overall Study|Lost to Follow-up|0|||
42110726|NCT00515086|75921188|FG003|Overall Study|Lost to Follow-up|0|||
42110727|NCT00515086|75921185|FG000|Overall Study|Study drug no longer required|0|||
42110728|NCT00515086|75921186|FG001|Overall Study|Study drug no longer required|1|||
42110729|NCT00515086|75921187|FG002|Overall Study|Study drug no longer required|0|||
42110730|NCT00515086|75921188|FG003|Overall Study|Study drug no longer required|0|||
42110731|NCT00515086|75921185|FG000|Overall Study|Death|2|||
42110732|NCT00515086|75921186|FG001|Overall Study|Death|0|||
42110733|NCT00515086|75921187|FG002|Overall Study|Death|0|||
42110734|NCT00515086|75921188|FG003|Overall Study|Death|0|||
42110735|NCT00618410|75921204|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
42110736|NCT00618410|75921205|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
42110737|NCT00618722|75921215|FG000|Overall Study|Refusal of Treatment|0|||
42110738|NCT00618722|75921216|FG001|Overall Study|Refusal of Treatment|0|||
42110739|NCT00618722|75921217|FG002|Overall Study|Refusal of Treatment|1|||
42110740|NCT00618722|75921218|FG003|Overall Study|Refusal of Treatment|0|||
42110741|NCT00618722|75921215|FG000|Overall Study|Patient Request|1|||
42110742|NCT00618722|75921216|FG001|Overall Study|Patient Request|1|||
42110743|NCT00618722|75921217|FG002|Overall Study|Patient Request|1|||
42110744|NCT00618722|75921218|FG003|Overall Study|Patient Request|1|||
42110745|NCT00618722|75921215|FG000|Overall Study|Inability to Complete Study Procedure|0|||
42110746|NCT00618722|75921216|FG001|Overall Study|Inability to Complete Study Procedure|1|||
42110747|NCT00618722|75921217|FG002|Overall Study|Inability to Complete Study Procedure|0|||
42110748|NCT00618722|75921218|FG003|Overall Study|Inability to Complete Study Procedure|0|||
42110749|NCT00618722|75921215|FG000|Overall Study|Lost to Follow-up|2|||
42110750|NCT00618722|75921216|FG001|Overall Study|Lost to Follow-up|0|||
42110751|NCT00618722|75921217|FG002|Overall Study|Lost to Follow-up|0|||
42110752|NCT00618722|75921218|FG003|Overall Study|Lost to Follow-up|2|||
42110753|NCT00618722|75921215|FG000|Overall Study|Miscellaneous Reasons|0|||
42110754|NCT00618722|75921216|FG001|Overall Study|Miscellaneous Reasons|0|||
42110755|NCT00618722|75921217|FG002|Overall Study|Miscellaneous Reasons|1|||
42110756|NCT00618722|75921218|FG003|Overall Study|Miscellaneous Reasons|1|||
42110757|NCT00507442|75921232|FG000|Overall Study|Adverse Event|8|||
42110758|NCT00507442|75921233|FG001|Overall Study|Adverse Event|11|||
42110759|NCT00507442|75921234|FG002|Overall Study|Adverse Event|4|||
42110760|NCT00507442|75921235|FG003|Overall Study|Adverse Event|1|||
42110761|NCT00507442|75921232|FG000|Overall Study|Protocol Violation|0|||
42110762|NCT00507442|75921233|FG001|Overall Study|Protocol Violation|1|||
42110763|NCT00507442|75921234|FG002|Overall Study|Protocol Violation|0|||
42110764|NCT00507442|75921235|FG003|Overall Study|Protocol Violation|0|||
42110765|NCT00507442|75921232|FG000|Overall Study|Lost to Follow-up|0|||
42110766|NCT00507442|75921233|FG001|Overall Study|Lost to Follow-up|0|||
42110767|NCT00507442|75921234|FG002|Overall Study|Lost to Follow-up|1|||
42388128|NCT00088907|76269148|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
42110768|NCT00507442|75921235|FG003|Overall Study|Lost to Follow-up|0|||
42110769|NCT00507442|75921232|FG000|Overall Study|Physician Decision|0|||
42110770|NCT00507442|75921233|FG001|Overall Study|Physician Decision|2|||
42110771|NCT00507442|75921234|FG002|Overall Study|Physician Decision|4|||
42110772|NCT00507442|75921235|FG003|Overall Study|Physician Decision|1|||
42110773|NCT00507442|75921232|FG000|Overall Study|Progressive Disease|2|||
42110774|NCT00507442|75921233|FG001|Overall Study|Progressive Disease|4|||
42110775|NCT00507442|75921234|FG002|Overall Study|Progressive Disease|2|||
42110776|NCT00507442|75921235|FG003|Overall Study|Progressive Disease|0|||
42110777|NCT00507442|75921232|FG000|Overall Study|Withdrawal by Subject|4|||
42110778|NCT00507442|75921233|FG001|Overall Study|Withdrawal by Subject|4|||
42110779|NCT00507442|75921234|FG002|Overall Study|Withdrawal by Subject|2|||
42110780|NCT00507442|75921235|FG003|Overall Study|Withdrawal by Subject|1|||
42110781|NCT00507442|75921232|FG000|Overall Study|Other|2|||
42110782|NCT00507442|75921233|FG001|Overall Study|Other|5|||
42110783|NCT00507442|75921234|FG002|Overall Study|Other|2|||
42110784|NCT00507442|75921235|FG003|Overall Study|Other|2|||
42110785|NCT00619892|75921251|FG000|Overall Study|Adverse Event|3|||
42110786|NCT00619892|75921252|FG001|Overall Study|Adverse Event|0|||
42110787|NCT00619892|75921251|FG000|Overall Study|Lost to Follow-up|0|||
42110788|NCT00619892|75921252|FG001|Overall Study|Lost to Follow-up|1|||
42110789|NCT00619892|75921251|FG000|Overall Study|Intercurrent illness|0|||
42110790|NCT00619892|75921252|FG001|Overall Study|Intercurrent illness|1|||
42110791|NCT00507130|75921264|FG000|Overall Study|Lost to Follow-up|0|||
42110792|NCT00507130|75921265|FG001|Overall Study|Lost to Follow-up|0|||
42110793|NCT00507130|75921266|FG002|Overall Study|Lost to Follow-up|1|||
42110794|NCT00507130|75921267|FG003|Overall Study|Lost to Follow-up|1|||
42110795|NCT00507130|75921264|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
42110796|NCT00507130|75921265|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
42110797|NCT00507130|75921266|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
42110798|NCT00507130|75921267|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
42110799|NCT00503308|75921279|FG000|Overall Study|Protocol Violation|2|||
42110800|NCT00503308|75921280|FG001|Overall Study|Protocol Violation|1|||
42110801|NCT03893565|75921291|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
42110802|NCT03893565|75921292|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
42110803|NCT03893565|75921293|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
42110804|NCT03893565|75921294|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
42110805|NCT03893565|75921295|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
42110806|NCT03893565|75921296|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
42110807|NCT03893565|75921297|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
42110808|NCT03893565|75921298|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
42110809|NCT03893565|75921299|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
42020175|NCT01106625|75827620|FG000|Extension Period: Week 26 to Week 52|Other|5|||
42020176|NCT01106625|75827621|FG001|Extension Period: Week 26 to Week 52|Other|5|||
42020177|NCT01106625|75827622|FG002|Extension Period: Week 26 to Week 52|Other|4|||
42020178|NCT01251380|75827633|FG000|Overall Study|Other (Not otherwise specified)|12|||
42020179|NCT01251380|75827633|FG000|Overall Study|Withdrawal by Subject|6|||
42020180|NCT01251380|75827633|FG000|Overall Study|Lack of Efficacy|1|||
42020181|NCT01251380|75827633|FG000|Overall Study|Adverse Event|1|||
42020182|NCT01251380|75827633|FG000|Overall Study|Lost to Follow-up|2|||
42020183|NCT01251146|75827644|FG000|Overall Study|Lost to Follow-up|3|||
42020184|NCT01251146|75827645|FG001|Overall Study|Lost to Follow-up|10|||
42020185|NCT01096017|75827651|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
42020186|NCT01096017|75827652|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
42020187|NCT01106157|75827660|FG000|Overall Study|Withdrawal by Subject|1|||
42020188|NCT01106157|75827661|FG001|Overall Study|Withdrawal by Subject|0|||
42020189|NCT01094301|75827667|FG000|Trial Stage|Withdrawal by Subject|1|||
42020190|NCT01094301|75827667|FG000|Implant Stage|Adverse Event|1|||
42020191|NCT01094301|75827667|FG000|Implant Stage|Protocol Violation|1|||
42020192|NCT01094301|75827667|FG000|Implant Stage|Withdrawal by Subject|2|||
42020193|NCT01094301|75827667|FG000|Implant Stage|No return of pain|4|||
42020194|NCT01093755|75827675|FG000|Overall Study|Withdrawal by Subject|3|||
42020195|NCT01093755|75827676|FG001|Overall Study|Withdrawal by Subject|4|||
42020196|NCT01093599|75827684|FG000|Overall Study|Lost to Follow-up|32|||
42020197|NCT01093599|75827685|FG001|Overall Study|Lost to Follow-up|46|||
42020198|NCT01092663|75827693|FG000|Overall Study|Withdrawal by Subject|3|||
42020199|NCT01092663|75827694|FG001|Overall Study|Withdrawal by Subject|2|||
42020200|NCT01092663|75827693|FG000|Overall Study|Glucose >300mg/dL|1|||
42020201|NCT01092663|75827694|FG001|Overall Study|Glucose >300mg/dL|0|||
42020202|NCT01092663|75827693|FG000|Overall Study|High fasting triglyceride|2|||
42020203|NCT01092663|75827694|FG001|Overall Study|High fasting triglyceride|0|||
42020204|NCT01092663|75827693|FG000|Overall Study|Adverse Event|1|||
42020205|NCT01092663|75827694|FG001|Overall Study|Adverse Event|1|||
42110810|NCT03893565|75921291|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
42110811|NCT03893565|75921292|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
42110812|NCT03893565|75921293|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
42110813|NCT03893565|75921294|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
42110814|NCT03893565|75921295|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
42110815|NCT03893565|75921296|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
42110816|NCT03893565|75921297|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
42110817|NCT03893565|75921298|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
42110818|NCT03893565|75921299|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
42110819|NCT03893565|75921291|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110820|NCT03893565|75921292|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
42110821|NCT03893565|75921293|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42020206|NCT01092663|75827693|FG000|Overall Study|Protocol Violation|0|||
42020207|NCT01092663|75827694|FG001|Overall Study|Protocol Violation|1|||
42110822|NCT03893565|75921294|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
42110823|NCT03893565|75921295|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110824|NCT03893565|75921296|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110825|NCT03893565|75921297|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110826|NCT03893565|75921298|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110827|NCT03893565|75921299|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110828|NCT03893565|75921291|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
42110829|NCT03893565|75921292|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
42110830|NCT03893565|75921293|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
42110831|NCT03893565|75921294|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
42110832|NCT03893565|75921295|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
42110833|NCT03893565|75921296|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
42110834|NCT03893565|75921297|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
42110835|NCT03893565|75921298|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
42110836|NCT03893565|75921299|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
42110837|NCT03893565|75921291|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
42110838|NCT03893565|75921292|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
42110839|NCT03893565|75921293|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
42110840|NCT03893565|75921294|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110841|NCT03893565|75921295|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
42110842|NCT03893565|75921296|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110843|NCT03893565|75921297|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110844|NCT03893565|75921298|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110845|NCT03893565|75921299|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110846|NCT03893565|75921291|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
42110847|NCT03893565|75921292|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
42110848|NCT03893565|75921293|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
42110849|NCT03893565|75921294|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
42110850|NCT03893565|75921295|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
42110851|NCT03893565|75921296|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
42110852|NCT03893565|75921297|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
42110853|NCT03893565|75921298|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
42110854|NCT03893565|75921299|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
42110855|NCT03893565|75921291|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110856|NCT03893565|75921292|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110857|NCT03893565|75921293|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110858|NCT03893565|75921294|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
42110859|NCT03893565|75921295|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110860|NCT03893565|75921296|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110861|NCT03893565|75921297|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110862|NCT03893565|75921298|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110863|NCT03893565|75921299|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110864|NCT03893565|75921291|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
42110865|NCT03893565|75921292|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
42110866|NCT03893565|75921293|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
42110867|NCT03893565|75921294|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
42110868|NCT03893565|75921295|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
42110869|NCT03893565|75921296|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
42110870|NCT03893565|75921297|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
42110871|NCT03893565|75921298|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
42110872|NCT03893565|75921299|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
42110873|NCT03893565|75921291|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
42110874|NCT03893565|75921292|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
42110875|NCT03893565|75921293|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
42110876|NCT03893565|75921294|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
42110877|NCT03893565|75921295|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
42110878|NCT03893565|75921296|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
42110879|NCT03893565|75921297|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
42110880|NCT03893565|75921298|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
42110881|NCT03893565|75921299|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
42110882|NCT03893565|75921291|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
42204684|NCT03529773|76017124|FG033|Overall Study|Screen Failure|0|||
42110883|NCT03893565|75921292|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
42110884|NCT03893565|75921293|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
42110885|NCT03893565|75921294|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
42110886|NCT03893565|75921295|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
42110887|NCT03893565|75921296|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
42110888|NCT03893565|75921297|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
42110889|NCT03893565|75921298|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
42110890|NCT03893565|75921299|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
42204685|NCT03529773|76017125|FG034|Overall Study|Screen Failure|0|||
42388129|NCT00088907|76269149|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
42388130|NCT00088907|76269148|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
42388131|NCT00088907|76269149|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
42388132|NCT00088829|76269156|FG000|Overall Study|PI left institution and study was close|22|||
42388133|NCT00088595|76269160|FG000|Overall Study|Adverse Event|11|||
42388134|NCT00088595|76269160|FG000|Overall Study|Withdrawal by Subject|8|||
42388135|NCT00088595|76269160|FG000|Overall Study|Ongoing (After Core)|7|||
42388136|NCT00088595|76269160|FG000|Overall Study|New Cancer Therapy|2|||
42388137|NCT00088205|76269174|FG000|Overall Study|Adverse Event|4|||
42388138|NCT00088205|76269174|FG000|Overall Study|Progressive Disease|51|||
42388139|NCT00088205|76269174|FG000|Overall Study|Physician Decision|1|||
42388140|NCT00088205|76269174|FG000|Overall Study|Death Due to Study Disease|4|||
42388141|NCT00085709|76269268|FG000|Overall Study|Adverse Event|8|||
42388142|NCT00085709|76269269|FG001|Overall Study|Adverse Event|0|||
42388143|NCT00085709|76269268|FG000|Overall Study|Death|8|||
42388144|NCT00085709|76269269|FG001|Overall Study|Death|2|||
42388145|NCT00085709|76269268|FG000|Overall Study|Refusal unrelated to adverse events|1|||
42388146|NCT00085709|76269269|FG001|Overall Study|Refusal unrelated to adverse events|2|||
42388147|NCT00085709|76269268|FG000|Overall Study|Progression|3|||
42388148|NCT00085709|76269269|FG001|Overall Study|Progression|4|||
42388149|NCT00085709|76269268|FG000|Overall Study|Not protocol specified|12|||
42388150|NCT00085709|76269269|FG001|Overall Study|Not protocol specified|22|||
42388151|NCT00085709|76269268|FG000|Overall Study|Not eligible|19|||
42388152|NCT00085709|76269269|FG001|Overall Study|Not eligible|19|||
42388153|NCT00085709|76269268|FG000|Overall Study|Withdrawal by Subject|2|||
42388154|NCT00085709|76269269|FG001|Overall Study|Withdrawal by Subject|1|||
42388155|NCT00085631|76269304|FG000|Overall Study|Missing Data|4|||
42388156|NCT00085631|76269305|FG001|Overall Study|Missing Data|11|||
42388157|NCT00085631|76269306|FG002|Overall Study|Missing Data|7|||
42388158|NCT00084929|76269322|FG000|Overall Study|ineligible - medical contraindication|1|||
42388159|NCT00084929|76269322|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
42388160|NCT00084929|76269322|FG000|Overall Study|Ineligible - Medical history|6|||
42388161|NCT00084929|76269322|FG000|Overall Study|Withdrawal by Subject|10|||
42388162|NCT00084929|76269322|FG000|Overall Study|Missing/incomplete CTC exam|9|||
42388163|NCT00084929|76269322|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
42388164|NCT00084617|76269380|FG000|Overall Study|Withdrawal by Subject|7|||
42388165|NCT00084617|76269380|FG000|Overall Study|Lack of Efficacy|1|||
42204686|NCT03529773|76017126|FG035|Overall Study|Screen Failure|0|||
42204687|NCT03529773|76017127|FG036|Overall Study|Screen Failure|1|||
42204688|NCT03529773|76017128|FG037|Overall Study|Screen Failure|1|||
42204689|NCT03529773|76017129|FG038|Overall Study|Screen Failure|0|||
42204690|NCT03529773|76017130|FG039|Overall Study|Screen Failure|1|||
42204691|NCT03529773|76017091|FG000|Overall Study|Randomized but not vaccinated|0|||
42204692|NCT03529773|76017092|FG001|Overall Study|Randomized but not vaccinated|0|||
42204693|NCT03529773|76017093|FG002|Overall Study|Randomized but not vaccinated|0|||
42204694|NCT03529773|76017094|FG003|Overall Study|Randomized but not vaccinated|0|||
42204695|NCT03529773|76017095|FG004|Overall Study|Randomized but not vaccinated|0|||
42204696|NCT03529773|76017096|FG005|Overall Study|Randomized but not vaccinated|0|||
42204697|NCT03529773|76017097|FG006|Overall Study|Randomized but not vaccinated|0|||
42204698|NCT03529773|76017098|FG007|Overall Study|Randomized but not vaccinated|0|||
42204699|NCT03529773|76017099|FG008|Overall Study|Randomized but not vaccinated|0|||
42204700|NCT03529773|76017100|FG009|Overall Study|Randomized but not vaccinated|0|||
42204701|NCT03529773|76017101|FG010|Overall Study|Randomized but not vaccinated|0|||
42204702|NCT03529773|76017102|FG011|Overall Study|Randomized but not vaccinated|0|||
42204703|NCT03529773|76017103|FG012|Overall Study|Randomized but not vaccinated|0|||
42204704|NCT03529773|76017104|FG013|Overall Study|Randomized but not vaccinated|0|||
42204705|NCT03529773|76017105|FG014|Overall Study|Randomized but not vaccinated|0|||
42204706|NCT03529773|76017106|FG015|Overall Study|Randomized but not vaccinated|0|||
42204707|NCT03529773|76017107|FG016|Overall Study|Randomized but not vaccinated|0|||
42204708|NCT03529773|76017108|FG017|Overall Study|Randomized but not vaccinated|1|||
42388166|NCT00084617|76269380|FG000|Overall Study|Protocol Violation|1|||
42388167|NCT00083915|76269474|FG000|Overall Study|Death|6|||
42388168|NCT00083915|76269475|FG001|Overall Study|Death|3|||
42204709|NCT03529773|76017109|FG018|Overall Study|Randomized but not vaccinated|0|||
42204710|NCT03529773|76017110|FG019|Overall Study|Randomized but not vaccinated|0|||
42204711|NCT03529773|76017111|FG020|Overall Study|Randomized but not vaccinated|0|||
42204712|NCT03529773|76017112|FG021|Overall Study|Randomized but not vaccinated|0|||
42204713|NCT03529773|76017113|FG022|Overall Study|Randomized but not vaccinated|0|||
42204714|NCT03529773|76017114|FG023|Overall Study|Randomized but not vaccinated|0|||
42204715|NCT03529773|76017115|FG024|Overall Study|Randomized but not vaccinated|0|||
42204716|NCT03529773|76017116|FG025|Overall Study|Randomized but not vaccinated|0|||
42204717|NCT03529773|76017117|FG026|Overall Study|Randomized but not vaccinated|0|||
42388169|NCT00083915|76269474|FG000|Overall Study|Physician Decision|11|||
42388170|NCT00083915|76269475|FG001|Overall Study|Physician Decision|6|||
42388171|NCT00083915|76269474|FG000|Overall Study|Withdrawal by Subject|8|||
42388172|NCT00083915|76269475|FG001|Overall Study|Withdrawal by Subject|3|||
42388173|NCT00083915|76269474|FG000|Overall Study|disease progression|18|||
42388174|NCT00083915|76269475|FG001|Overall Study|disease progression|23|||
42388175|NCT00083915|76269474|FG000|Overall Study|Failure to collect|3|||
42388176|NCT00083915|76269475|FG001|Overall Study|Failure to collect|0|||
42388177|NCT00083915|76269474|FG000|Overall Study|No response|3|||
42388178|NCT00083915|76269475|FG001|Overall Study|No response|1|||
42388179|NCT00083915|76269474|FG000|Overall Study|Insurance issues|1|||
42388180|NCT00083915|76269475|FG001|Overall Study|Insurance issues|1|||
42388181|NCT04505722|76269971|FG000|Overall Study|Adverse Event|1|||
42388182|NCT04505722|76269972|FG001|Overall Study|Adverse Event|2|||
42388183|NCT04505722|76269971|FG000|Overall Study|Death|34|||
42388184|NCT04505722|76269972|FG001|Overall Study|Death|63|||
42388185|NCT04505722|76269971|FG000|Overall Study|Lost to Follow-up|271|||
42388186|NCT04505722|76269972|FG001|Overall Study|Lost to Follow-up|333|||
42388187|NCT04505722|76269971|FG000|Overall Study|Physician Decision|17|||
42388188|NCT04505722|76269972|FG001|Overall Study|Physician Decision|17|||
42388189|NCT04505722|76269971|FG000|Overall Study|Protocol Violation|0|||
42388190|NCT04505722|76269972|FG001|Overall Study|Protocol Violation|1|||
42388191|NCT04505722|76269971|FG000|Overall Study|Withdrawal by Subject|376|||
42388192|NCT04505722|76269972|FG001|Overall Study|Withdrawal by Subject|714|||
42388193|NCT04505722|76269971|FG000|Overall Study|Other|61|||
42388194|NCT04505722|76269972|FG001|Overall Study|Other|98|||
42388195|NCT04505722|76269971|FG000|Overall Study|Still ongoing|21138|||
42388196|NCT04505722|76269972|FG001|Overall Study|Still ongoing|20662|||
42388197|NCT04505722|76269971|FG000|Overall Study|Randomized not vaccinated|276|||
42388198|NCT04505722|76269972|FG001|Overall Study|Randomized not vaccinated|260|||
42388199|NCT04463251|76269985|FG000|Overall Study|Death|1|||
42388200|NCT04463251|76269986|FG001|Overall Study|Death|0|||
42388201|NCT04463251|76269987|FG002|Overall Study|Death|1|||
42388202|NCT04463251|76269985|FG000|Overall Study|Adverse Event|0|||
42388203|NCT04463251|76269986|FG001|Overall Study|Adverse Event|1|||
42388204|NCT04463251|76269987|FG002|Overall Study|Adverse Event|0|||
42388205|NCT04463251|76269985|FG000|Overall Study|Lost to Follow-up|0|||
42388206|NCT04463251|76269986|FG001|Overall Study|Lost to Follow-up|1|||
42388207|NCT04463251|76269987|FG002|Overall Study|Lost to Follow-up|0|||
42388208|NCT04463251|76269985|FG000|Overall Study|Withdrawal by Subject|0|||
42388209|NCT04463251|76269986|FG001|Overall Study|Withdrawal by Subject|2|||
42388210|NCT04463251|76269987|FG002|Overall Study|Withdrawal by Subject|2|||
42388211|NCT04254913|76270000|FG000|Overall Study|Adverse Event|1|||
42388212|NCT04160091|76270012|FG000|Overall Study|Terminated by Sponsor|7|||
42388213|NCT04160091|76270013|FG001|Overall Study|Terminated by Sponsor|3|||
42388214|NCT04160091|76270014|FG002|Overall Study|Terminated by Sponsor|5|||
42388215|NCT04160091|76270015|FG003|Overall Study|Terminated by Sponsor|2|||
42388216|NCT04160091|76270012|FG000|Overall Study|Noncompliance|0|||
42388217|NCT04160091|76270013|FG001|Overall Study|Noncompliance|0|||
42388218|NCT04160091|76270014|FG002|Overall Study|Noncompliance|0|||
42388219|NCT04160091|76270015|FG003|Overall Study|Noncompliance|1|||
42388220|NCT04160091|76270012|FG000|Overall Study|Withdrawal by Subject|0|||
42388221|NCT04160091|76270013|FG001|Overall Study|Withdrawal by Subject|0|||
42020208|NCT01078623|75827705|FG000|Treatment Period 1|Adverse Event|1|||
42020209|NCT01078623|75827706|FG001|Treatment Period 1|Adverse Event|1|||
42204718|NCT03529773|76017118|FG027|Overall Study|Randomized but not vaccinated|1|||
42388222|NCT04160091|76270014|FG002|Overall Study|Withdrawal by Subject|0|||
42388223|NCT04160091|76270015|FG003|Overall Study|Withdrawal by Subject|1|||
42388224|NCT04145895|76270027|FG000|Overall Study|Physician Decision|2|||
42388225|NCT04145895|76270028|FG001|Overall Study|Physician Decision|0|||
42388226|NCT04145895|76270027|FG000|Overall Study|Withdrawal by Subject|0|||
42388227|NCT04145895|76270028|FG001|Overall Study|Withdrawal by Subject|2|||
42388228|NCT04065074|76270055|FG000|Overall Study|Adverse Event|1|||
42388229|NCT04065074|76270055|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
42388230|NCT03814746|76270062|FG000|Overall Study|Participant decision|9|||
42388231|NCT03814746|76270063|FG001|Overall Study|Participant decision|6|||
42388232|NCT03814746|76270064|FG002|Overall Study|Participant decision|15|||
42388233|NCT03814746|76270062|FG000|Overall Study|Physician Decision|2|||
42388234|NCT03814746|76270063|FG001|Overall Study|Physician Decision|2|||
42388235|NCT03814746|76270064|FG002|Overall Study|Physician Decision|4|||
42388236|NCT03814746|76270062|FG000|Overall Study|Death|2|||
42388237|NCT03814746|76270063|FG001|Overall Study|Death|2|||
42388238|NCT03814746|76270064|FG002|Overall Study|Death|2|||
42388239|NCT03814746|76270062|FG000|Overall Study|Adverse Event|2|||
42388240|NCT03814746|76270063|FG001|Overall Study|Adverse Event|2|||
42388241|NCT03814746|76270064|FG002|Overall Study|Adverse Event|1|||
42388242|NCT03814746|76270062|FG000|Overall Study|Lost to Follow-up|2|||
42388243|NCT03814746|76270063|FG001|Overall Study|Lost to Follow-up|1|||
42388244|NCT03814746|76270064|FG002|Overall Study|Lost to Follow-up|2|||
42388245|NCT03814746|76270062|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
42388246|NCT03814746|76270063|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
42388247|NCT03814746|76270064|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
42388248|NCT03814746|76270062|FG000|Overall Study|Pregnancy|0|||
42388249|NCT03814746|76270063|FG001|Overall Study|Pregnancy|1|||
42388250|NCT03814746|76270064|FG002|Overall Study|Pregnancy|1|||
42388251|NCT03814746|76270062|FG000|Overall Study|Protocol Violation|1|||
42388252|NCT03814746|76270063|FG001|Overall Study|Protocol Violation|0|||
42388253|NCT03814746|76270064|FG002|Overall Study|Protocol Violation|0|||
42388254|NCT03793010|76270075|FG000|Overall Study|Withdrawal by Subject|5|||
42388255|NCT03793010|76270076|FG001|Overall Study|Withdrawal by Subject|7|||
42388256|NCT03793010|76270075|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
42388257|NCT03793010|76270076|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
42388258|NCT03793010|76270075|FG000|Overall Study|Lost to Follow-up|1|||
42388259|NCT03793010|76270076|FG001|Overall Study|Lost to Follow-up|2|||
42388260|NCT03793010|76270075|FG000|Overall Study|Patient couldn't sit still for injection|1|||
42388261|NCT03793010|76270076|FG001|Overall Study|Patient couldn't sit still for injection|0|||
42388262|NCT03793010|76270075|FG000|Overall Study|Withdrew to pursue other treatment|1|||
42388263|NCT03793010|76270076|FG001|Overall Study|Withdrew to pursue other treatment|0|||
42388264|NCT03793010|76270075|FG000|Overall Study|Did not meet eligibility criteria|1|||
42388265|NCT03793010|76270076|FG001|Overall Study|Did not meet eligibility criteria|0|||
42388266|NCT03529942|76270125|FG000|Overall Study|Withdrawal by Subject|13|||
42388267|NCT03529942|76270125|FG000|Overall Study|Physician Decision|1|||
42388268|NCT03529942|76270125|FG000|Overall Study|Lost to Follow-up|7|||
42388269|NCT03529942|76270125|FG000|Overall Study|Needle inserted but no drug administered|1|||
42388270|NCT03529942|76270125|FG000|Overall Study|Personal reasons|1|||
42388271|NCT03484819|76270136|FG000|Overall Study|Death|2|||
42388272|NCT03484819|76270136|FG000|Overall Study|Adverse Event|2|||
42388273|NCT03484819|76270136|FG000|Overall Study|Physician Decision|1|||
42388274|NCT03484819|76270136|FG000|Overall Study|Withdrawal by Subject|2|||
42388275|NCT03484819|76270136|FG000|Overall Study|Disease Progression|4|||
42388276|NCT03484819|76270136|FG000|Overall Study|Complicating Condition|1|||
42388277|NCT03382262|76270144|FG000|Overall Study|Physician Decision|0|||
42388278|NCT03382262|76270145|FG001|Overall Study|Physician Decision|0|||
42388279|NCT03382262|76270146|FG002|Overall Study|Physician Decision|1|||
42388280|NCT03382262|76270147|FG003|Overall Study|Physician Decision|0|||
42388281|NCT03382262|76270144|FG000|Overall Study|Withdrawal by Subject|0|||
42388282|NCT03382262|76270145|FG001|Overall Study|Withdrawal by Subject|0|||
42388283|NCT03382262|76270146|FG002|Overall Study|Withdrawal by Subject|0|||
42388284|NCT03382262|76270147|FG003|Overall Study|Withdrawal by Subject|1|||
42388285|NCT03381274|76270162|FG000|Overall Study|Death|2|||
42388286|NCT03381274|76270163|FG001|Overall Study|Death|9|||
42388287|NCT03381274|76270164|FG002|Overall Study|Death|3|||
42388288|NCT03381274|76270165|FG003|Overall Study|Death|2|||
42388289|NCT03381274|76270166|FG004|Overall Study|Death|3|||
42388290|NCT03381274|76270162|FG000|Overall Study|Lost to Follow-up|0|||
42388291|NCT03381274|76270163|FG001|Overall Study|Lost to Follow-up|0|||
42388292|NCT03381274|76270164|FG002|Overall Study|Lost to Follow-up|0|||
42388293|NCT03381274|76270165|FG003|Overall Study|Lost to Follow-up|1|||
42388294|NCT03381274|76270166|FG004|Overall Study|Lost to Follow-up|0|||
42388295|NCT03381274|76270162|FG000|Overall Study|Withdrawal by Subject|2|||
42388296|NCT03381274|76270163|FG001|Overall Study|Withdrawal by Subject|1|||
42388297|NCT03381274|76270164|FG002|Overall Study|Withdrawal by Subject|3|||
42388298|NCT03381274|76270165|FG003|Overall Study|Withdrawal by Subject|1|||
42388299|NCT03381274|76270166|FG004|Overall Study|Withdrawal by Subject|0|||
42388300|NCT03381274|76270162|FG000|Overall Study|Other|1|||
42388301|NCT03381274|76270163|FG001|Overall Study|Other|11|||
42388302|NCT03381274|76270164|FG002|Overall Study|Other|0|||
42388303|NCT03381274|76270165|FG003|Overall Study|Other|2|||
42388304|NCT03381274|76270166|FG004|Overall Study|Other|2|||
42388305|NCT03365375|76270193|FG000|Overall Study|Withdrawal by Subject|0|||
42388306|NCT03365375|76270194|FG001|Overall Study|Withdrawal by Subject|1|||
42388307|NCT03365375|76270193|FG000|Overall Study|Lost to Follow-up|0|||
42388308|NCT03365375|76270194|FG001|Overall Study|Lost to Follow-up|4|||
42388309|NCT03282123|76270200|FG000|Overall Study|Withdrawal by Subject|5|||
42388310|NCT03046446|76270205|FG000|Overall Study|Lack of Efficacy|7|||
42388311|NCT03046446|76270205|FG000|Overall Study|Adverse Event|6|||
42388312|NCT03046446|76270205|FG000|Overall Study|Lost to Follow-up|3|||
42388313|NCT03046446|76270205|FG000|Overall Study|Withdrawal by Subject|14|||
42388314|NCT03046446|76270205|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
42388315|NCT03046446|76270205|FG000|Overall Study|Disease Progression (see caveats)|25|||
42388316|NCT03046446|76270205|FG000|Overall Study|Non OA related knee surgery|1|||
42388317|NCT02762370|76270234|FG000|Overall Study|Protocol Violation|1|||
42388318|NCT02762370|76270235|FG001|Overall Study|Protocol Violation|0|||
42388319|NCT02751580|76270243|FG000|Overall Study|Lost to Follow-up|4|||
42388320|NCT02751580|76270243|FG000|Overall Study|Death|2|||
42388321|NCT02717611|76270247|FG000|Overall Study|Death|13|||
42388322|NCT02717611|76270247|FG000|Overall Study|Withdrawal by Subject|6|||
42388323|NCT02717611|76270247|FG000|Overall Study|Active, not recruiting|40|||
42388324|NCT02717611|76270247|FG000|Overall Study|Complicating disease|1|||
42388325|NCT02513394|76270262|FG000|Overall Study|Withdrawal by Subject|11|||
42388326|NCT02513394|76270263|FG001|Overall Study|Withdrawal by Subject|23|||
42388327|NCT02513394|76270262|FG000|Overall Study|Ineligible|1|||
42388328|NCT02513394|76270263|FG001|Overall Study|Ineligible|0|||
42388329|NCT02284113|76270293|FG000|Overall Study|Adverse Event|1|||
42388330|NCT02284113|76270294|FG001|Overall Study|Adverse Event|0|||
42388331|NCT02284113|76270293|FG000|Overall Study|non-compliance|0|||
42388332|NCT02284113|76270294|FG001|Overall Study|non-compliance|1|||
42388333|NCT02284113|76270293|FG000|Overall Study|Withdrawal by Subject|0|||
42388334|NCT02284113|76270294|FG001|Overall Study|Withdrawal by Subject|1|||
42388335|NCT02284113|76270293|FG000|Overall Study|not provided|0|||
42388336|NCT02284113|76270294|FG001|Overall Study|not provided|1|||
42388337|NCT02284113|76270293|FG000|Overall Study|surgery cancelled|2|||
42388338|NCT02284113|76270294|FG001|Overall Study|surgery cancelled|0|||
42388339|NCT02116972|76270303|FG000|Overall Study|Adverse Event|4|||
42388340|NCT02116972|76270304|FG001|Overall Study|Adverse Event|4|||
42388341|NCT02116972|76270305|FG002|Overall Study|Adverse Event|1|||
42388342|NCT02116972|76270303|FG000|Overall Study|Withdrawal by Subject|1|||
42388343|NCT02116972|76270304|FG001|Overall Study|Withdrawal by Subject|1|||
42388344|NCT02116972|76270305|FG002|Overall Study|Withdrawal by Subject|5|||
42388345|NCT02116972|76270303|FG000|Overall Study|Protocol Violation|1|||
42388346|NCT02116972|76270304|FG001|Overall Study|Protocol Violation|0|||
42388347|NCT02116972|76270305|FG002|Overall Study|Protocol Violation|1|||
42388348|NCT02116972|76270303|FG000|Overall Study|Lost to Follow-up|4|||
42388349|NCT02116972|76270304|FG001|Overall Study|Lost to Follow-up|3|||
42388350|NCT02116972|76270305|FG002|Overall Study|Lost to Follow-up|1|||
42388351|NCT02116972|76270303|FG000|Overall Study|Lack of Efficacy|6|||
42388352|NCT02116972|76270304|FG001|Overall Study|Lack of Efficacy|6|||
42388353|NCT02116972|76270305|FG002|Overall Study|Lack of Efficacy|5|||
42388354|NCT02116972|76270303|FG000|Overall Study|scheduling conflicts and relocation|3|||
42388355|NCT02116972|76270304|FG001|Overall Study|scheduling conflicts and relocation|3|||
42388356|NCT02116972|76270305|FG002|Overall Study|scheduling conflicts and relocation|6|||
42388357|NCT02091960|76270315|FG000|Overall Study|Death|7|||
42388358|NCT02091960|76270315|FG000|Overall Study|Withdrawal by Subject|1|||
42388359|NCT02091960|76270315|FG000|Overall Study|Miscellaneous Reasons|31|||
42388360|NCT02091960|76270315|FG000|Overall Study|On Study at Data Cut-off|12|||
42388361|NCT02008396|76270321|FG000|Overall Study|Protocol Violation|0|||
42388362|NCT02008396|76270322|FG001|Overall Study|Protocol Violation|1|||
42388363|NCT01904136|76270338|FG000|Overall Study|Physician Decision|0|||
42388364|NCT01904136|76270339|FG001|Overall Study|Physician Decision|0|||
42388365|NCT01904136|76270340|FG002|Overall Study|Physician Decision|0|||
42388366|NCT01904136|76270341|FG003|Overall Study|Physician Decision|0|||
42388367|NCT01904136|76270342|FG004|Overall Study|Physician Decision|0|||
42388368|NCT01904136|76270343|FG005|Overall Study|Physician Decision|1|||
42388369|NCT01904136|76270344|FG006|Overall Study|Physician Decision|0|||
42388370|NCT01904136|76270345|FG007|Overall Study|Physician Decision|0|||
42388371|NCT01904136|76270346|FG008|Overall Study|Physician Decision|0|||
42388372|NCT01828099|76270372|FG000|Overall Study|Adverse Event|15|||
42388373|NCT01828099|76270373|FG001|Overall Study|Adverse Event|18|||
42388374|NCT01828099|76270372|FG000|Overall Study|Death|9|||
42388375|NCT01828099|76270373|FG001|Overall Study|Death|11|||
42388376|NCT01828099|76270372|FG000|Overall Study|Lost to Follow-up|2|||
42388377|NCT01828099|76270373|FG001|Overall Study|Lost to Follow-up|0|||
42388378|NCT01828099|76270372|FG000|Overall Study|Non-compliance with study treatment|2|||
42388379|NCT01828099|76270373|FG001|Overall Study|Non-compliance with study treatment|0|||
42388380|NCT01828099|76270372|FG000|Overall Study|Physician Decision|7|||
42388381|NCT01828099|76270373|FG001|Overall Study|Physician Decision|11|||
42388382|NCT01828099|76270372|FG000|Overall Study|Progressive disease|51|||
42388383|NCT01828099|76270373|FG001|Overall Study|Progressive disease|94|||
42388384|NCT01828099|76270372|FG000|Overall Study|Protocol Violation|1|||
42388385|NCT01828099|76270373|FG001|Overall Study|Protocol Violation|0|||
42388386|NCT01828099|76270372|FG000|Overall Study|Subject/guardian decision|7|||
42388387|NCT01828099|76270373|FG001|Overall Study|Subject/guardian decision|23|||
42388388|NCT01793610|76270382|FG000|Overall Study|Withdrawal by Subject|1|||
42388389|NCT01793610|76270383|FG001|Overall Study|Withdrawal by Subject|0|||
42388390|NCT01793610|76270384|FG002|Overall Study|Withdrawal by Subject|1|||
42388391|NCT01320085|76270436|FG000|Overall Study|Disease Progression|26|||
42388392|NCT01320085|76270437|FG001|Overall Study|Disease Progression|93|||
42388393|NCT01320085|76270438|FG002|Overall Study|Disease Progression|17|||
42388394|NCT01320085|76270436|FG000|Overall Study|Adverse Event|12|||
42388395|NCT01320085|76270437|FG001|Overall Study|Adverse Event|20|||
42388396|NCT01320085|76270438|FG002|Overall Study|Adverse Event|5|||
42388397|NCT01320085|76270436|FG000|Overall Study|Withdrawal by Subject|2|||
42388398|NCT01320085|76270437|FG001|Overall Study|Withdrawal by Subject|4|||
42388399|NCT01320085|76270438|FG002|Overall Study|Withdrawal by Subject|1|||
42388400|NCT01320085|76270436|FG000|Overall Study|Protocol Deviation|1|||
42388401|NCT01320085|76270437|FG001|Overall Study|Protocol Deviation|0|||
42388402|NCT01320085|76270438|FG002|Overall Study|Protocol Deviation|1|||
42388403|NCT01320085|76270436|FG000|Overall Study|Administrative problems|0|||
42388404|NCT01320085|76270437|FG001|Overall Study|Administrative problems|0|||
42388405|NCT01320085|76270438|FG002|Overall Study|Administrative problems|1|||
42388406|NCT01207492|76270459|FG000|Overall Study|Still on study|1|||
42388407|NCT01207492|76270459|FG000|Overall Study|Withdrawal by Subject|9|||
42388408|NCT01207492|76270459|FG000|Overall Study|Physician Decision|1|||
42388409|NCT01207492|76270459|FG000|Overall Study|Progressive disease|3|||
42388410|NCT01207492|76270459|FG000|Overall Study|Toxicity|1|||
42388411|NCT01167140|76270463|FG000|Overall Study|Withdrawal by Subject|1|||
42388412|NCT00402298|76270469|FG000|Overall Study|Withdrawal by Subject|1|||
42388413|NCT00402298|76270470|FG001|Overall Study|Withdrawal by Subject|0|||
42388414|NCT04362761|76270656|FG000|Part A (48 Weeks)|Adverse Event|2|||
42388415|NCT04362761|76270656|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
42388416|NCT04362761|76270656|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
42388417|NCT04362761|76270656|FG000|Part A (48 Weeks)|Other|5|||
42388418|NCT04362761|76270656|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
42388419|NCT04362761|76270656|FG000|Part B (86 Weeks)|Other|4|||
42388420|NCT00632749|76270852|FG000|Overall Study|Progressive disease|3|||
42388421|NCT00632749|76270853|FG001|Overall Study|Progressive disease|2|||
42388422|NCT00632749|76270854|FG002|Overall Study|Progressive disease|2|||
42388423|NCT00632749|76270855|FG003|Overall Study|Progressive disease|2|||
42388424|NCT00632749|76270856|FG004|Overall Study|Progressive disease|4|||
42388425|NCT00632749|76270857|FG005|Overall Study|Progressive disease|4|||
42388426|NCT00632749|76270858|FG006|Overall Study|Progressive disease|3|||
42388427|NCT00632749|76270859|FG007|Overall Study|Progressive disease|2|||
42388428|NCT00632749|76270860|FG008|Overall Study|Progressive disease|3|||
42388429|NCT00632749|76270861|FG009|Overall Study|Progressive disease|2|||
42388430|NCT00632749|76270862|FG010|Overall Study|Progressive disease|4|||
42388431|NCT00632749|76270863|FG011|Overall Study|Progressive disease|3|||
42388432|NCT00632749|76270864|FG012|Overall Study|Progressive disease|2|||
42110891|NCT03893565|75921291|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
42110892|NCT03893565|75921292|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
42110893|NCT03893565|75921293|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
42110894|NCT03893565|75921294|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
42110895|NCT03893565|75921295|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
42110896|NCT03893565|75921296|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
42110897|NCT03893565|75921297|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
42110898|NCT03893565|75921298|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
42110899|NCT03893565|75921299|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
42110900|NCT03893565|75921291|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
42110901|NCT03893565|75921292|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
42110902|NCT03893565|75921293|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
42110903|NCT03893565|75921294|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
42110904|NCT03893565|75921295|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
42110905|NCT03893565|75921296|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
42110906|NCT03893565|75921297|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
42110907|NCT03893565|75921298|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
42110908|NCT03893565|75921299|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
42110909|NCT03893565|75921291|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110910|NCT03893565|75921292|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110911|NCT03893565|75921293|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110912|NCT03893565|75921294|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110913|NCT03893565|75921295|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110914|NCT03893565|75921296|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42388433|NCT00632749|76270865|FG013|Overall Study|Progressive disease|4|||
42388434|NCT00632749|76270852|FG000|Overall Study|Other Adverse event|1|||
42388435|NCT00632749|76270853|FG001|Overall Study|Other Adverse event|1|||
42388436|NCT00632749|76270854|FG002|Overall Study|Other Adverse event|1|||
42388437|NCT00632749|76270855|FG003|Overall Study|Other Adverse event|1|||
42388438|NCT00632749|76270856|FG004|Overall Study|Other Adverse event|2|||
42388439|NCT00632749|76270857|FG005|Overall Study|Other Adverse event|4|||
42388440|NCT00632749|76270858|FG006|Overall Study|Other Adverse event|1|||
42388441|NCT00632749|76270859|FG007|Overall Study|Other Adverse event|2|||
42388442|NCT00632749|76270860|FG008|Overall Study|Other Adverse event|2|||
42388443|NCT00632749|76270861|FG009|Overall Study|Other Adverse event|0|||
42388444|NCT00632749|76270862|FG010|Overall Study|Other Adverse event|1|||
42388445|NCT00632749|76270863|FG011|Overall Study|Other Adverse event|0|||
42388446|NCT00632749|76270864|FG012|Overall Study|Other Adverse event|1|||
42388447|NCT00632749|76270865|FG013|Overall Study|Other Adverse event|0|||
42388448|NCT00632749|76270852|FG000|Overall Study|Refuse to continue medication|0|||
42388449|NCT00632749|76270853|FG001|Overall Study|Refuse to continue medication|0|||
42388450|NCT00632749|76270854|FG002|Overall Study|Refuse to continue medication|0|||
42388451|NCT00632749|76270855|FG003|Overall Study|Refuse to continue medication|1|||
42388452|NCT00632749|76270856|FG004|Overall Study|Refuse to continue medication|0|||
42388453|NCT00632749|76270857|FG005|Overall Study|Refuse to continue medication|0|||
42388454|NCT00632749|76270858|FG006|Overall Study|Refuse to continue medication|0|||
42388455|NCT00632749|76270859|FG007|Overall Study|Refuse to continue medication|0|||
42388456|NCT00632749|76270860|FG008|Overall Study|Refuse to continue medication|0|||
42388457|NCT00632749|76270861|FG009|Overall Study|Refuse to continue medication|1|||
42388458|NCT00632749|76270862|FG010|Overall Study|Refuse to continue medication|0|||
42388459|NCT00632749|76270863|FG011|Overall Study|Refuse to continue medication|0|||
42388460|NCT00632749|76270864|FG012|Overall Study|Refuse to continue medication|0|||
42388461|NCT00632749|76270865|FG013|Overall Study|Refuse to continue medication|0|||
42388462|NCT00632749|76270852|FG000|Overall Study|Reason other than those specified above|0|||
42388463|NCT00632749|76270853|FG001|Overall Study|Reason other than those specified above|2|||
42388464|NCT00632749|76270854|FG002|Overall Study|Reason other than those specified above|0|||
42388465|NCT00632749|76270855|FG003|Overall Study|Reason other than those specified above|0|||
42388466|NCT00632749|76270856|FG004|Overall Study|Reason other than those specified above|1|||
42388467|NCT00632749|76270857|FG005|Overall Study|Reason other than those specified above|0|||
42388468|NCT00632749|76270858|FG006|Overall Study|Reason other than those specified above|1|||
42388469|NCT00632749|76270859|FG007|Overall Study|Reason other than those specified above|0|||
42388470|NCT00632749|76270860|FG008|Overall Study|Reason other than those specified above|0|||
42388471|NCT00632749|76270861|FG009|Overall Study|Reason other than those specified above|0|||
42388472|NCT00632749|76270862|FG010|Overall Study|Reason other than those specified above|2|||
42388473|NCT00632749|76270863|FG011|Overall Study|Reason other than those specified above|1|||
42388474|NCT00632749|76270864|FG012|Overall Study|Reason other than those specified above|0|||
42388475|NCT00632749|76270865|FG013|Overall Study|Reason other than those specified above|2|||
42388476|NCT00632359|76270926|FG000|Overall Study|Withdrawal by Subject|2|||
42388477|NCT00632203|76270933|FG000|Overall Study|Did not start study treatment|1|||
42388478|NCT00632203|76270934|FG001|Overall Study|Did not start study treatment|0|||
42388479|NCT03830333|76270955|FG000|Overall Study|Death|0|||
42388480|NCT03830333|76270956|FG001|Overall Study|Death|1|||
42388481|NCT03830333|76270955|FG000|Overall Study|Withdrawal by Subject|5|||
42388482|NCT03830333|76270956|FG001|Overall Study|Withdrawal by Subject|1|||
42388483|NCT03830333|76270955|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
42388484|NCT03830333|76270956|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
42388485|NCT00631969|76271042|FG000|Overall Study|Adverse Event|3|||
42388486|NCT00631969|76271043|FG001|Overall Study|Adverse Event|1|||
42388487|NCT00631969|76271042|FG000|Overall Study|Lack of Efficacy|2|||
42388488|NCT00631969|76271043|FG001|Overall Study|Lack of Efficacy|8|||
42388489|NCT00631969|76271042|FG000|Overall Study|Lost to Follow-up|2|||
42388490|NCT00631969|76271043|FG001|Overall Study|Lost to Follow-up|1|||
42388491|NCT00631969|76271042|FG000|Overall Study|Protocol Violation|1|||
42388492|NCT00631969|76271043|FG001|Overall Study|Protocol Violation|1|||
42388493|NCT00631969|76271042|FG000|Overall Study|Consent Withdrawn|5|||
42388494|NCT00631969|76271043|FG001|Overall Study|Consent Withdrawn|7|||
42388495|NCT00631969|76271042|FG000|Overall Study|Noncompliant With Study Medication|0|||
42388496|NCT00631969|76271043|FG001|Overall Study|Noncompliant With Study Medication|1|||
42388497|NCT00631969|76271042|FG000|Overall Study|No Drug Exposure|2|||
42388498|NCT00631969|76271043|FG001|Overall Study|No Drug Exposure|2|||
42388499|NCT00631657|76271079|FG000|6-Month Treatment Period|Adverse Event|47|||
42388500|NCT00631657|76271080|FG001|6-Month Treatment Period|Adverse Event|0|||
42388501|NCT00631657|76271081|FG002|6-Month Treatment Period|Adverse Event|7|||
42388502|NCT00631657|76271079|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
42388503|NCT00631657|76271080|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
42388504|NCT00631657|76271081|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
42388505|NCT00631657|76271079|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
42388506|NCT00631657|76271080|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
42388507|NCT00631657|76271081|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
42388508|NCT00631657|76271079|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
42388509|NCT00631657|76271080|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
42388510|NCT00631657|76271081|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
42388511|NCT00631657|76271079|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
42204719|NCT03529773|76017119|FG028|Overall Study|Randomized but not vaccinated|0|||
42388512|NCT00631657|76271080|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
42388513|NCT00631657|76271081|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
42388514|NCT00631657|76271079|FG000|6-Month Treatment Period|Other|16|||
42388515|NCT00631657|76271080|FG001|6-Month Treatment Period|Other|0|||
42388516|NCT00631657|76271081|FG002|6-Month Treatment Period|Other|4|||
42388517|NCT00631657|76271079|FG000|6-Month Treatment Period|Not Treated|2|||
42388518|NCT00631657|76271080|FG001|6-Month Treatment Period|Not Treated|0|||
42388519|NCT00631657|76271081|FG002|6-Month Treatment Period|Not Treated|1|||
42388520|NCT00631657|76271079|FG000|7-Day Discontinuation Period|Not Treated|1|||
42388521|NCT00631657|76271080|FG001|7-Day Discontinuation Period|Not Treated|1|||
42388522|NCT00631657|76271081|FG002|7-Day Discontinuation Period|Not Treated|1|||
42388523|NCT00631657|76271079|FG000|7-Day Discontinuation Period|Other|1|||
42388524|NCT00631657|76271080|FG001|7-Day Discontinuation Period|Other|0|||
42388525|NCT00631657|76271081|FG002|7-Day Discontinuation Period|Other|0|||
42388526|NCT00631189|76271119|FG000|Initial Phase|Protocol Violation|347|||
42388527|NCT00631189|76271120|FG001|Initial Phase|Protocol Violation|0|||
42388528|NCT00631189|76271121|FG002|Initial Phase|Protocol Violation|0|||
42388529|NCT00631189|76271122|FG003|Initial Phase|Protocol Violation|0|||
42388530|NCT00631189|76271119|FG000|Initial Phase|Withdrawal by Subject|4|||
42388531|NCT00631189|76271120|FG001|Initial Phase|Withdrawal by Subject|0|||
42388532|NCT00631189|76271121|FG002|Initial Phase|Withdrawal by Subject|0|||
42388533|NCT00631189|76271122|FG003|Initial Phase|Withdrawal by Subject|0|||
42388534|NCT00631189|76271119|FG000|Treatment Phase|Withdrawal by Subject|0|||
42388535|NCT00631189|76271120|FG001|Treatment Phase|Withdrawal by Subject|2|||
42388536|NCT00631189|76271121|FG002|Treatment Phase|Withdrawal by Subject|1|||
42388537|NCT00631189|76271122|FG003|Treatment Phase|Withdrawal by Subject|1|||
42388538|NCT00631189|76271119|FG000|Treatment Phase|Protocol Violation|0|||
42388539|NCT00631189|76271120|FG001|Treatment Phase|Protocol Violation|1|||
42388540|NCT00631189|76271121|FG002|Treatment Phase|Protocol Violation|6|||
42388541|NCT00631189|76271122|FG003|Treatment Phase|Protocol Violation|2|||
42388542|NCT00631189|76271119|FG000|Treatment Phase|Adverse Event|0|||
42388543|NCT00631189|76271120|FG001|Treatment Phase|Adverse Event|3|||
42388544|NCT00631189|76271121|FG002|Treatment Phase|Adverse Event|2|||
42388545|NCT00631189|76271122|FG003|Treatment Phase|Adverse Event|4|||
42388546|NCT00631189|76271119|FG000|Treatment Phase|Lost to Follow-up|0|||
42388547|NCT00631189|76271120|FG001|Treatment Phase|Lost to Follow-up|1|||
42388548|NCT00631189|76271121|FG002|Treatment Phase|Lost to Follow-up|0|||
42388549|NCT00631189|76271122|FG003|Treatment Phase|Lost to Follow-up|0|||
42388550|NCT00631189|76271119|FG000|Treatment Phase|Pregnancy|0|||
42388551|NCT00631189|76271120|FG001|Treatment Phase|Pregnancy|0|||
42388552|NCT00631189|76271121|FG002|Treatment Phase|Pregnancy|1|||
42388553|NCT00631189|76271122|FG003|Treatment Phase|Pregnancy|0|||
42388554|NCT00631189|76271119|FG000|Treatment Phase|patient did not take pravastatin|0|||
42388555|NCT00631189|76271120|FG001|Treatment Phase|patient did not take pravastatin|0|||
42388556|NCT00631189|76271121|FG002|Treatment Phase|patient did not take pravastatin|1|||
42388557|NCT00631189|76271122|FG003|Treatment Phase|patient did not take pravastatin|0|||
42388558|NCT00630877|76271135|FG000|Overall Study|Adverse Event|11|||
42388559|NCT00630877|76271136|FG001|Overall Study|Adverse Event|8|||
42388560|NCT00630877|76271137|FG002|Overall Study|Adverse Event|7|||
42388561|NCT00630877|76271135|FG000|Overall Study|Withdrawal by Subject|3|||
42388562|NCT00630877|76271136|FG001|Overall Study|Withdrawal by Subject|4|||
42388563|NCT00630877|76271137|FG002|Overall Study|Withdrawal by Subject|0|||
42388564|NCT00630877|76271135|FG000|Overall Study|Lost to Follow-up|2|||
42388565|NCT00630877|76271136|FG001|Overall Study|Lost to Follow-up|0|||
42388566|NCT00630877|76271137|FG002|Overall Study|Lost to Follow-up|0|||
42388567|NCT00630877|76271135|FG000|Overall Study|Noncompliance|2|||
42388568|NCT00630877|76271136|FG001|Overall Study|Noncompliance|3|||
42388569|NCT00630877|76271137|FG002|Overall Study|Noncompliance|1|||
42388570|NCT00630877|76271135|FG000|Overall Study|Protocol violation|1|||
42388571|NCT00630877|76271136|FG001|Overall Study|Protocol violation|0|||
42388572|NCT00630877|76271137|FG002|Overall Study|Protocol violation|1|||
42388573|NCT00630877|76271135|FG000|Overall Study|Personal reasons|0|||
42388574|NCT00630877|76271136|FG001|Overall Study|Personal reasons|0|||
42388575|NCT00630877|76271137|FG002|Overall Study|Personal reasons|1|||
42110915|NCT03893565|75921297|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110916|NCT03893565|75921298|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
42388576|NCT02915783|76271149|FG000|Overall Study|Death|21|||
42388577|NCT02915783|76271149|FG000|Overall Study|Lost to Follow-up|1|||
42388578|NCT02915783|76271149|FG000|Overall Study|Withdrawal by Subject|2|||
42388579|NCT00630331|76271164|FG000|Overall Study|Death|2|||
42388580|NCT00630331|76271165|FG001|Overall Study|Death|1|||
42388581|NCT00630331|76271166|FG002|Overall Study|Death|1|||
42388582|NCT00630331|76271164|FG000|Overall Study|Adverse Event|1|||
42388583|NCT00630331|76271165|FG001|Overall Study|Adverse Event|0|||
42388584|NCT00630331|76271166|FG002|Overall Study|Adverse Event|0|||
42388585|NCT00630331|76271164|FG000|Overall Study|Withdrawal by Subject|12|||
42388586|NCT00630331|76271165|FG001|Overall Study|Withdrawal by Subject|7|||
42388587|NCT00630331|76271166|FG002|Overall Study|Withdrawal by Subject|5|||
42388588|NCT00630331|76271164|FG000|Overall Study|Lost to Follow-up|175|||
42388589|NCT00630331|76271165|FG001|Overall Study|Lost to Follow-up|143|||
42388590|NCT00630331|76271166|FG002|Overall Study|Lost to Follow-up|170|||
42388591|NCT00630331|76271164|FG000|Overall Study|Inappropriate enrollment|3|||
42388592|NCT00630331|76271165|FG001|Overall Study|Inappropriate enrollment|6|||
42388593|NCT00630331|76271166|FG002|Overall Study|Inappropriate enrollment|3|||
42388594|NCT00630331|76271164|FG000|Overall Study|Unable to classify|9|||
42388595|NCT00630331|76271165|FG001|Overall Study|Unable to classify|4|||
42388596|NCT00630331|76271166|FG002|Overall Study|Unable to classify|3|||
42388597|NCT00630331|76271164|FG000|Overall Study|Protocol Violation|4|||
42388598|NCT00630331|76271165|FG001|Overall Study|Protocol Violation|5|||
42388599|NCT00630331|76271166|FG002|Overall Study|Protocol Violation|6|||
42388600|NCT00639509|76271209|FG000|Overall Study|Death|1|||
42388601|NCT00638963|76271215|FG000|Overall Study|Withdrawal by Subject|1|||
42388602|NCT00638963|76271216|FG001|Overall Study|Withdrawal by Subject|0|||
42388603|NCT00638183|76271222|FG000|Overall Study|Adverse Event|23|||
42388604|NCT00638183|76271222|FG000|Overall Study|Lack of Efficacy|14|||
42388605|NCT00638183|76271222|FG000|Overall Study|Physician Decision|9|||
42388606|NCT00638183|76271222|FG000|Overall Study|Lost to Follow-up|46|||
42388607|NCT00638183|76271222|FG000|Overall Study|Other reason not defined above|27|||
42388608|NCT00638027|76271228|FG000|Overall Study|Adverse Event|0|||
42388609|NCT00638027|76271229|FG001|Overall Study|Adverse Event|2|||
42388610|NCT00636155|76271235|FG000|Overall Study|Adverse Event|8|||
42388611|NCT00636155|76271235|FG000|Overall Study|Lack of Efficacy|1|||
42388612|NCT00636155|76271235|FG000|Overall Study|Withdrawal by Subject|3|||
42388613|NCT00636155|76271235|FG000|Overall Study|Stem cell transplant|1|||
42388614|NCT00636155|76271235|FG000|Overall Study|Physician Decision|5|||
42388615|NCT00634907|76271241|FG000|Overall Study|Withdrawal by Subject|3|||
42388616|NCT00634907|76271242|FG001|Overall Study|Withdrawal by Subject|0|||
42388617|NCT00634907|76271241|FG000|Overall Study|Physician Decision|3|||
42388618|NCT00634907|76271242|FG001|Overall Study|Physician Decision|9|||
42388619|NCT00634907|76271241|FG000|Overall Study|Withdrawal by Subject|11|||
42388620|NCT00634907|76271242|FG001|Overall Study|Withdrawal by Subject|8|||
42388621|NCT00634751|76271256|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
42388622|NCT00634751|76271257|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
42388623|NCT00634751|76271258|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
42388624|NCT00634751|76271259|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
42388625|NCT00634751|76271256|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
42388626|NCT00634751|76271257|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
42388627|NCT00634751|76271258|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
42388628|NCT00634751|76271259|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
42388629|NCT00634751|76271256|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
42388630|NCT00634751|76271257|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
42388631|NCT00634751|76271258|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
42388632|NCT00634751|76271259|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
42388633|NCT00634049|76271294|FG000|Overall Study|Never received study drug|1|||
42388634|NCT00634049|76271294|FG000|Overall Study|Died prior to receiving study drug|1|||
42388635|NCT00634049|76271294|FG000|Overall Study|Screening failure|1|||
42388636|NCT00632099|76271333|FG000|Overall Study|Lost to Follow-up|3|||
42388637|NCT00632099|76271334|FG001|Overall Study|Lost to Follow-up|3|||
42388638|NCT00632021|76271342|FG000|Overall Study|Withdrawal/death|4|||
42388639|NCT00632021|76271343|FG001|Overall Study|Withdrawal/death|7|||
42110917|NCT03893565|75921299|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
42110918|NCT03893565|75921291|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110919|NCT03893565|75921292|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110920|NCT03893565|75921293|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110921|NCT03893565|75921294|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110922|NCT03893565|75921295|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110923|NCT03893565|75921296|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110924|NCT03893565|75921297|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110925|NCT03893565|75921298|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
42110926|NCT03893565|75921299|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
42110927|NCT03893565|75921291|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110928|NCT03893565|75921292|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110929|NCT03893565|75921293|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110930|NCT03893565|75921294|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110931|NCT03893565|75921295|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110932|NCT03893565|75921296|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110933|NCT03893565|75921297|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110934|NCT03893565|75921298|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
42388640|NCT00631475|76271350|FG000|Overall Study|Death|18|||
42388641|NCT00631475|76271350|FG000|Overall Study|Adverse Event|14|||
42388642|NCT00631475|76271350|FG000|Overall Study|Withdrew consent|5|||
42388643|NCT00631475|76271350|FG000|Overall Study|Preparation for lung transplant|8|||
42110935|NCT03893565|75921299|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
42110936|NCT03893565|75921291|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
42110937|NCT03893565|75921292|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
42110938|NCT03893565|75921293|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
42110939|NCT03893565|75921294|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
42110940|NCT03893565|75921295|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
42110941|NCT03893565|75921296|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
42110942|NCT03893565|75921297|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
42110943|NCT03893565|75921298|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
42110944|NCT03893565|75921299|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
42110945|NCT00502996|75921318|FG000|Overall Study|Lost to Follow-up|9|||
42110946|NCT00502996|75921318|FG000|Overall Study|Protocol Violation|2|||
42110947|NCT00502996|75921318|FG000|Overall Study|Treatment failure|25|||
42110948|NCT00502996|75921318|FG000|Overall Study|Withdrawal Informed Consent|6|||
42110949|NCT00502996|75921318|FG000|Overall Study|Adverse Event|2|||
42110950|NCT00715403|75921329|FG000|Overall Study|Progressive disease|0|||
42110951|NCT00715403|75921330|FG001|Overall Study|Progressive disease|1|||
42110952|NCT00715403|75921331|FG002|Overall Study|Progressive disease|3|||
42110953|NCT00715403|75921332|FG003|Overall Study|Progressive disease|9|||
42110954|NCT00715403|75921333|FG004|Overall Study|Progressive disease|5|||
42110955|NCT00715403|75921334|FG005|Overall Study|Progressive disease|14|||
42110956|NCT00715403|75921335|FG006|Overall Study|Progressive disease|1|||
42110957|NCT00715403|75921329|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
42110958|NCT00715403|75921330|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
42110959|NCT00715403|75921331|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
42110960|NCT00715403|75921332|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
42110961|NCT00715403|75921333|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
42110962|NCT00715403|75921334|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
42110963|NCT00715403|75921335|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
42110964|NCT00715403|75921329|FG000|Overall Study|Other Adverse Event than DLT|1|||
42110965|NCT00715403|75921330|FG001|Overall Study|Other Adverse Event than DLT|0|||
42110966|NCT00715403|75921331|FG002|Overall Study|Other Adverse Event than DLT|0|||
42110967|NCT00715403|75921332|FG003|Overall Study|Other Adverse Event than DLT|0|||
42110968|NCT00715403|75921333|FG004|Overall Study|Other Adverse Event than DLT|0|||
42110969|NCT00715403|75921334|FG005|Overall Study|Other Adverse Event than DLT|2|||
42110970|NCT00715403|75921335|FG006|Overall Study|Other Adverse Event than DLT|0|||
42110971|NCT00715403|75921329|FG000|Overall Study|Protocol Violation|0|||
42110972|NCT00715403|75921330|FG001|Overall Study|Protocol Violation|0|||
42110973|NCT00715403|75921331|FG002|Overall Study|Protocol Violation|0|||
42110974|NCT00715403|75921332|FG003|Overall Study|Protocol Violation|0|||
42110975|NCT00715403|75921333|FG004|Overall Study|Protocol Violation|0|||
42110976|NCT00715403|75921334|FG005|Overall Study|Protocol Violation|1|||
42110977|NCT00715403|75921335|FG006|Overall Study|Protocol Violation|0|||
42110978|NCT00715403|75921329|FG000|Overall Study|Other reason not defined above|0|||
42110979|NCT00715403|75921330|FG001|Overall Study|Other reason not defined above|0|||
42110980|NCT00715403|75921331|FG002|Overall Study|Other reason not defined above|1|||
42110981|NCT00715403|75921332|FG003|Overall Study|Other reason not defined above|0|||
42110982|NCT00715403|75921333|FG004|Overall Study|Other reason not defined above|1|||
42110983|NCT00715403|75921334|FG005|Overall Study|Other reason not defined above|1|||
42110984|NCT00715403|75921335|FG006|Overall Study|Other reason not defined above|0|||
42110985|NCT00502840|75921351|FG000|Overall Study|Adverse Event|5|||
42110986|NCT00502840|75921351|FG000|Overall Study|Additional or changed therapy|48|||
42110987|NCT00502840|75921351|FG000|Overall Study|Lack of Efficacy|11|||
42110988|NCT00502840|75921351|FG000|Overall Study|Protocol Violation|4|||
42110989|NCT00502840|75921351|FG000|Overall Study|Withdrawal by Subject|5|||
42110990|NCT00502840|75921351|FG000|Overall Study|Lost to Follow-up|6|||
42110991|NCT00502840|75921351|FG000|Overall Study|Administrative problems|1|||
42110992|NCT00502840|75921351|FG000|Overall Study|Other|20|||
42110993|NCT00515008|75921358|FG000|Overall Study|Lost to Follow-up|1|||
42110994|NCT00515008|75921359|FG001|Overall Study|Lost to Follow-up|0|||
42110995|NCT00515008|75921358|FG000|Overall Study|Declined|0|||
42110996|NCT00515008|75921359|FG001|Overall Study|Declined|3|||
42110997|NCT00515008|75921358|FG000|Overall Study|Left the Boston Area|1|||
42110998|NCT00515008|75921359|FG001|Overall Study|Left the Boston Area|1|||
42110999|NCT00515008|75921358|FG000|Overall Study|Scheduling conflict|1|||
42111000|NCT00515008|75921359|FG001|Overall Study|Scheduling conflict|0|||
42111001|NCT00514540|75921368|FG000|First-Line Chemo|Withdrawal by Subject|1|||
42111002|NCT00514540|75921368|FG000|First-Line Chemo|Protocol Violation|7|||
42111003|NCT00514540|75921368|FG000|Second-Line|Physician/Patient Decision|31|||
42111004|NCT00713609|75921386|FG000|Overall Study|Adverse Event|2|||
42111005|NCT00713609|75921387|FG001|Overall Study|Adverse Event|0|||
42111006|NCT00713609|75921388|FG002|Overall Study|Adverse Event|2|||
42111007|NCT00713609|75921389|FG003|Overall Study|Adverse Event|2|||
42111008|NCT00713609|75921390|FG004|Overall Study|Adverse Event|3|||
42111009|NCT00713609|75921391|FG005|Overall Study|Adverse Event|1|||
42111010|NCT00713609|75921386|FG000|Overall Study|Lost to Follow-up|5|||
42111011|NCT00713609|75921387|FG001|Overall Study|Lost to Follow-up|7|||
42111012|NCT00713609|75921388|FG002|Overall Study|Lost to Follow-up|5|||
42111013|NCT00713609|75921389|FG003|Overall Study|Lost to Follow-up|5|||
42111014|NCT00713609|75921390|FG004|Overall Study|Lost to Follow-up|7|||
42111015|NCT00713609|75921391|FG005|Overall Study|Lost to Follow-up|0|||
42111016|NCT00713609|75921386|FG000|Overall Study|Lack of Efficacy|1|||
42111017|NCT00713609|75921387|FG001|Overall Study|Lack of Efficacy|3|||
42111018|NCT00713609|75921388|FG002|Overall Study|Lack of Efficacy|0|||
42111019|NCT00713609|75921389|FG003|Overall Study|Lack of Efficacy|0|||
42111020|NCT00713609|75921390|FG004|Overall Study|Lack of Efficacy|1|||
42111021|NCT00713609|75921391|FG005|Overall Study|Lack of Efficacy|0|||
42111022|NCT00713609|75921386|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
42111023|NCT00713609|75921387|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
42111024|NCT00713609|75921388|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
42111025|NCT00713609|75921389|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
42111026|NCT00713609|75921390|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
42111027|NCT00713609|75921391|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
42111028|NCT00713609|75921386|FG000|Overall Study|Withdrawal by Subject|6|||
42111029|NCT00713609|75921387|FG001|Overall Study|Withdrawal by Subject|1|||
42111030|NCT00713609|75921388|FG002|Overall Study|Withdrawal by Subject|5|||
42111031|NCT00713609|75921389|FG003|Overall Study|Withdrawal by Subject|1|||
42111032|NCT00713609|75921390|FG004|Overall Study|Withdrawal by Subject|5|||
42111033|NCT00713609|75921391|FG005|Overall Study|Withdrawal by Subject|7|||
42111034|NCT00713609|75921386|FG000|Overall Study|Protocol Violation|6|||
42111035|NCT00713609|75921387|FG001|Overall Study|Protocol Violation|3|||
42111036|NCT00713609|75921388|FG002|Overall Study|Protocol Violation|1|||
42111037|NCT00713609|75921389|FG003|Overall Study|Protocol Violation|1|||
42111038|NCT00713609|75921390|FG004|Overall Study|Protocol Violation|2|||
42111039|NCT00713609|75921391|FG005|Overall Study|Protocol Violation|0|||
42111040|NCT00513682|75921405|FG000|Washout Phase|Adverse Event|2|||
42111041|NCT00493012|75921414|FG000|Overall Study|Lost to Follow-up|18|||
42111042|NCT00493012|75921415|FG001|Overall Study|Lost to Follow-up|17|||
42111043|NCT05144477|75921423|FG000|Overall Study|Withdrawal by Subject|1|||
42111044|NCT05144477|75921424|FG001|Overall Study|Withdrawal by Subject|1|||
42111045|NCT00617708|75921440|FG000|Overall Study|Adverse Event|0|||
42111046|NCT00617708|75921441|FG001|Overall Study|Adverse Event|6|||
42111047|NCT00617708|75921442|FG002|Overall Study|Adverse Event|9|||
42111048|NCT00617708|75921440|FG000|Overall Study|Withdrawal by Subject|1|||
42111049|NCT00617708|75921441|FG001|Overall Study|Withdrawal by Subject|1|||
42111050|NCT00617708|75921442|FG002|Overall Study|Withdrawal by Subject|7|||
42111051|NCT00617708|75921440|FG000|Overall Study|Death|0|||
42111052|NCT00617708|75921441|FG001|Overall Study|Death|6|||
42111053|NCT00617708|75921442|FG002|Overall Study|Death|5|||
42111054|NCT00617708|75921440|FG000|Overall Study|Progression/Relapse|7|||
42111055|NCT00617708|75921441|FG001|Overall Study|Progression/Relapse|40|||
42111056|NCT00617708|75921442|FG002|Overall Study|Progression/Relapse|36|||
42111057|NCT00617708|75921440|FG000|Overall Study|Not protocol specified|1|||
42111058|NCT00617708|75921441|FG001|Overall Study|Not protocol specified|4|||
42111059|NCT00617708|75921442|FG002|Overall Study|Not protocol specified|2|||
42111060|NCT00617708|75921440|FG000|Overall Study|Not eligible|1|||
42111061|NCT00617708|75921441|FG001|Overall Study|Not eligible|3|||
42388644|NCT00631163|76271371|FG000|Number of Participants in Year 1|Adverse Event|12|||
42388645|NCT00631163|76271371|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
42388646|NCT00631163|76271371|FG000|Number of Participants in Year 1|Death|6|||
42388647|NCT00631163|76271371|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
42388648|NCT00631163|76271371|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
42388649|NCT00631163|76271371|FG000|Number of Participants in Year 1|Administrative problems|6|||
42388650|NCT00631163|76271371|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
42388651|NCT00631163|76271371|FG000|Number of Participants in Year 2|Adverse Event|1|||
42388652|NCT00631163|76271371|FG000|Number of Participants in Year 2|Protocol Violation|1|||
42111062|NCT00617708|75921442|FG002|Overall Study|Not eligible|5|||
42388653|NCT00631163|76271371|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
42111063|NCT03894969|75921457|FG000|Overall Study|Adverse Event|0|||
42111064|NCT03894969|75921458|FG001|Overall Study|Adverse Event|2|||
42111065|NCT03894969|75921459|FG002|Overall Study|Adverse Event|0|||
42111066|NCT03894969|75921460|FG003|Overall Study|Adverse Event|1|||
42111067|NCT03894969|75921461|FG004|Overall Study|Adverse Event|2|||
42111068|NCT03894969|75921457|FG000|Overall Study|Lost to Follow-up|3|||
42111069|NCT03894969|75921458|FG001|Overall Study|Lost to Follow-up|1|||
42111070|NCT03894969|75921459|FG002|Overall Study|Lost to Follow-up|1|||
42111071|NCT03894969|75921460|FG003|Overall Study|Lost to Follow-up|0|||
42111072|NCT03894969|75921461|FG004|Overall Study|Lost to Follow-up|0|||
42111073|NCT03894969|75921457|FG000|Overall Study|Withdrawal by Subject|2|||
42111074|NCT03894969|75921458|FG001|Overall Study|Withdrawal by Subject|1|||
42388654|NCT00631007|76271388|FG000|Overall Study|Adverse Event|0|||
42388655|NCT00631007|76271389|FG001|Overall Study|Adverse Event|2|||
42388656|NCT00631007|76271390|FG002|Overall Study|Adverse Event|0|||
42111075|NCT03894969|75921459|FG002|Overall Study|Withdrawal by Subject|3|||
42111076|NCT03894969|75921460|FG003|Overall Study|Withdrawal by Subject|4|||
42111077|NCT03894969|75921461|FG004|Overall Study|Withdrawal by Subject|8|||
42111078|NCT03894969|75921457|FG000|Overall Study|Other|0|||
42111079|NCT03894969|75921458|FG001|Overall Study|Other|0|||
42111080|NCT03894969|75921459|FG002|Overall Study|Other|0|||
42111081|NCT03894969|75921460|FG003|Overall Study|Other|0|||
42111082|NCT03894969|75921461|FG004|Overall Study|Other|3|||
42111083|NCT03894969|75921457|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
42111084|NCT03894969|75921458|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
42111085|NCT03894969|75921459|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
42111086|NCT03894969|75921460|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
42111087|NCT03894969|75921461|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
42111088|NCT03894969|75921457|FG000|Overall Study|Solicited Adverse Event|0|||
42111089|NCT03894969|75921458|FG001|Overall Study|Solicited Adverse Event|1|||
42111090|NCT03894969|75921459|FG002|Overall Study|Solicited Adverse Event|0|||
42111091|NCT03894969|75921460|FG003|Overall Study|Solicited Adverse Event|0|||
42111092|NCT03894969|75921461|FG004|Overall Study|Solicited Adverse Event|0|||
42111093|NCT03894813|75921477|FG000|Overall Study|Adverse Event|1|||
42111094|NCT03894813|75921478|FG001|Overall Study|Adverse Event|1|||
42111095|NCT03894813|75921477|FG000|Overall Study|Lack of Efficacy|3|||
42111096|NCT03894813|75921478|FG001|Overall Study|Lack of Efficacy|3|||
42111097|NCT03894813|75921477|FG000|Overall Study|Lost to Follow-up|1|||
42111098|NCT03894813|75921478|FG001|Overall Study|Lost to Follow-up|0|||
42111099|NCT03894813|75921477|FG000|Overall Study|Pregnancy|2|||
42111100|NCT03894813|75921478|FG001|Overall Study|Pregnancy|1|||
42111101|NCT03894813|75921477|FG000|Overall Study|Protocol Violation|3|||
42111102|NCT03894813|75921478|FG001|Overall Study|Protocol Violation|7|||
42111103|NCT03894813|75921477|FG000|Overall Study|Withdrawal by Subject|1|||
42388657|NCT00631007|76271391|FG003|Overall Study|Adverse Event|2|||
42388658|NCT00631007|76271392|FG004|Overall Study|Adverse Event|3|||
42388659|NCT00631007|76271393|FG005|Overall Study|Adverse Event|2|||
42388660|NCT00631007|76271388|FG000|Overall Study|Lost to Follow-up|2|||
42388661|NCT00631007|76271389|FG001|Overall Study|Lost to Follow-up|1|||
42388662|NCT00631007|76271390|FG002|Overall Study|Lost to Follow-up|2|||
42388663|NCT00631007|76271391|FG003|Overall Study|Lost to Follow-up|4|||
42388664|NCT00631007|76271392|FG004|Overall Study|Lost to Follow-up|5|||
42388665|NCT00631007|76271393|FG005|Overall Study|Lost to Follow-up|3|||
42388666|NCT00631007|76271388|FG000|Overall Study|Physician Decision|1|||
42388667|NCT00631007|76271389|FG001|Overall Study|Physician Decision|0|||
42388668|NCT00631007|76271390|FG002|Overall Study|Physician Decision|1|||
42388669|NCT00631007|76271391|FG003|Overall Study|Physician Decision|0|||
42388670|NCT00631007|76271392|FG004|Overall Study|Physician Decision|0|||
42388671|NCT00631007|76271393|FG005|Overall Study|Physician Decision|2|||
42388672|NCT00631007|76271388|FG000|Overall Study|Persistent Hyperglycemia|2|||
42388673|NCT00631007|76271389|FG001|Overall Study|Persistent Hyperglycemia|2|||
42388674|NCT00631007|76271390|FG002|Overall Study|Persistent Hyperglycemia|5|||
42388675|NCT00631007|76271391|FG003|Overall Study|Persistent Hyperglycemia|1|||
42388676|NCT00631007|76271392|FG004|Overall Study|Persistent Hyperglycemia|2|||
42388677|NCT00631007|76271393|FG005|Overall Study|Persistent Hyperglycemia|5|||
42388678|NCT00631007|76271388|FG000|Overall Study|Withdrawal by Subject|4|||
42388679|NCT00631007|76271389|FG001|Overall Study|Withdrawal by Subject|5|||
42388680|NCT00631007|76271390|FG002|Overall Study|Withdrawal by Subject|2|||
42388681|NCT00631007|76271391|FG003|Overall Study|Withdrawal by Subject|2|||
42388682|NCT00631007|76271392|FG004|Overall Study|Withdrawal by Subject|1|||
42388683|NCT00631007|76271393|FG005|Overall Study|Withdrawal by Subject|3|||
42388684|NCT00631007|76271388|FG000|Overall Study|Other|2|||
42388685|NCT00631007|76271389|FG001|Overall Study|Other|1|||
42388686|NCT00631007|76271390|FG002|Overall Study|Other|0|||
42388687|NCT00631007|76271391|FG003|Overall Study|Other|0|||
42388688|NCT00631007|76271392|FG004|Overall Study|Other|1|||
42111104|NCT03894813|75921478|FG001|Overall Study|Withdrawal by Subject|3|||
42111105|NCT03894813|75921477|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
42388689|NCT00631007|76271393|FG005|Overall Study|Other|0|||
42388690|NCT00630539|76271411|FG000|Overall Study|Adverse Event|1|||
42388691|NCT00630539|76271412|FG001|Overall Study|Adverse Event|3|||
42388692|NCT00630539|76271413|FG002|Overall Study|Adverse Event|1|||
42388693|NCT00630539|76271414|FG003|Overall Study|Adverse Event|2|||
42111106|NCT03894813|75921478|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
42111107|NCT00615992|75921484|FG000|Overall Study|Protocol Violation|67|||
42111108|NCT03892707|75921490|FG000|Overall Study|Screen failure|6|||
42111109|NCT03892707|75921491|FG001|Overall Study|Screen failure|0|||
42388694|NCT00630539|76271411|FG000|Overall Study|Withdrawal by Subject|0|||
42388695|NCT00630539|76271412|FG001|Overall Study|Withdrawal by Subject|1|||
42388696|NCT00630539|76271413|FG002|Overall Study|Withdrawal by Subject|0|||
42388697|NCT00630539|76271414|FG003|Overall Study|Withdrawal by Subject|1|||
42388698|NCT00630305|76271492|FG000|Overall Study|Withdrawal by Subject|1|||
42388699|NCT00630305|76271492|FG000|Overall Study|Inability to insert contact lens|1|||
42388700|NCT01926197|76271718|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
42388701|NCT01926197|76271719|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
42388702|NCT01926197|76271718|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
42388703|NCT01926197|76271719|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
42388704|NCT00989963|76271744|FG000|Overall Study|Adverse Event|1|||
42388705|NCT00989963|76271745|FG001|Overall Study|Adverse Event|1|||
42388706|NCT00989963|76271746|FG002|Overall Study|Adverse Event|1|||
42388707|NCT00989573|76271784|FG000|Overall Study|Adverse Event|8|||
42388708|NCT00989573|76271785|FG001|Overall Study|Adverse Event|12|||
42388709|NCT00989573|76271786|FG002|Overall Study|Adverse Event|4|||
42388710|NCT00989573|76271784|FG000|Overall Study|Physician Decision|0|||
42388711|NCT00989573|76271785|FG001|Overall Study|Physician Decision|2|||
42388712|NCT00989573|76271786|FG002|Overall Study|Physician Decision|0|||
42388713|NCT00989573|76271784|FG000|Overall Study|Protocol Violation|1|||
42388714|NCT00989573|76271785|FG001|Overall Study|Protocol Violation|1|||
42388715|NCT00989573|76271786|FG002|Overall Study|Protocol Violation|1|||
42388716|NCT00989573|76271784|FG000|Overall Study|Withdrawal by Subject|4|||
42388717|NCT00989573|76271785|FG001|Overall Study|Withdrawal by Subject|7|||
42388718|NCT00989573|76271786|FG002|Overall Study|Withdrawal by Subject|3|||
42388719|NCT04126213|76271860|FG000|Overall Study|Lost to Follow-up|9|||
42388720|NCT04126213|76271861|FG001|Overall Study|Lost to Follow-up|1|||
42388721|NCT04126213|76271862|FG002|Overall Study|Lost to Follow-up|5|||
42388722|NCT04126213|76271863|FG003|Overall Study|Lost to Follow-up|10|||
42388723|NCT04126213|76271864|FG004|Overall Study|Lost to Follow-up|4|||
42388724|NCT04126213|76271865|FG005|Overall Study|Lost to Follow-up|7|||
42388725|NCT04126213|76271860|FG000|Overall Study|Withdrawal by Subject|3|||
42388726|NCT04126213|76271861|FG001|Overall Study|Withdrawal by Subject|2|||
42388727|NCT04126213|76271862|FG002|Overall Study|Withdrawal by Subject|1|||
42388728|NCT04126213|76271863|FG003|Overall Study|Withdrawal by Subject|1|||
42388729|NCT04126213|76271864|FG004|Overall Study|Withdrawal by Subject|1|||
42388730|NCT04126213|76271865|FG005|Overall Study|Withdrawal by Subject|1|||
42388731|NCT04126213|76271860|FG000|Overall Study|Other|0|||
42388732|NCT04126213|76271861|FG001|Overall Study|Other|0|||
42388733|NCT04126213|76271862|FG002|Overall Study|Other|2|||
42388734|NCT04126213|76271863|FG003|Overall Study|Other|2|||
42388735|NCT04126213|76271864|FG004|Overall Study|Other|0|||
42388736|NCT04126213|76271865|FG005|Overall Study|Other|1|||
42388737|NCT04126213|76271860|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42388738|NCT04126213|76271861|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
42388739|NCT04126213|76271862|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
42388740|NCT04126213|76271863|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
42388741|NCT04126213|76271864|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
42388742|NCT04126213|76271865|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
42388743|NCT04128319|76271882|FG000|Overall Study|Death|3|||
42388744|NCT05038293|76271928|FG000|Overall Study|device was not operating properly for one subject.|1|||
42388745|NCT05038293|76271929|FG001|Overall Study|device was not operating properly for one subject.|0|||
42388746|NCT05038293|76271928|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
42388747|NCT05038293|76271929|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
42388748|NCT04753164|76271946|FG000|Overall Study|Adverse Event|0|||
42388749|NCT04753164|76271947|FG001|Overall Study|Adverse Event|2|||
42388750|NCT04753164|76271946|FG000|Overall Study|Withdrawal by Subject|9|||
42388751|NCT04753164|76271947|FG001|Overall Study|Withdrawal by Subject|7|||
42388752|NCT04753164|76271946|FG000|Overall Study|Lost to Follow-up|6|||
42388753|NCT04753164|76271947|FG001|Overall Study|Lost to Follow-up|6|||
42388754|NCT04753164|76271946|FG000|Overall Study|Other|12|||
42388755|NCT04753164|76271947|FG001|Overall Study|Other|5|||
42388756|NCT04729101|76271955|FG000|Overall Study|Adverse Event|1|||
42388757|NCT04729101|76271956|FG001|Overall Study|Adverse Event|0|||
42388758|NCT04729101|76271955|FG000|Overall Study|Physician Decision|1|||
42388759|NCT04729101|76271956|FG001|Overall Study|Physician Decision|0|||
42388760|NCT04729101|76271955|FG000|Overall Study|Withdrawal by Subject|1|||
42388761|NCT04729101|76271956|FG001|Overall Study|Withdrawal by Subject|0|||
42388762|NCT04569968|76271982|FG000|Overall Study|Lost to Follow-up|2|||
42388763|NCT04569968|76271983|FG001|Overall Study|Lost to Follow-up|5|||
42388764|NCT04569968|76271982|FG000|Overall Study|Story of head and/or neck surgery|2|||
42388765|NCT04569968|76271983|FG001|Overall Study|Story of head and/or neck surgery|2|||
42388766|NCT04569968|76271982|FG000|Overall Study|Time of stroke onset|8|||
42388767|NCT04569968|76271983|FG001|Overall Study|Time of stroke onset|7|||
42388768|NCT04569968|76271982|FG000|Overall Study|Type of strokr|12|||
42388769|NCT04569968|76271983|FG001|Overall Study|Type of strokr|8|||
42388770|NCT04569968|76271982|FG000|Overall Study|Cooperation|8|||
42388771|NCT04569968|76271983|FG001|Overall Study|Cooperation|8|||
42388772|NCT04569968|76271982|FG000|Overall Study|Age interval|17|||
42388773|NCT04569968|76271983|FG001|Overall Study|Age interval|6|||
42388774|NCT04569968|76271982|FG000|Overall Study|Denial of participation to the study|0|||
42388775|NCT04569968|76271983|FG001|Overall Study|Denial of participation to the study|3|||
42388776|NCT04569968|76271982|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
42388777|NCT04569968|76271983|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
42388778|NCT04569968|76271982|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
42388779|NCT04569968|76271983|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
42388780|NCT04569968|76271982|FG000|Overall Study|Quarantine|1|||
42388781|NCT04569968|76271983|FG001|Overall Study|Quarantine|0|||
42388782|NCT04569968|76271982|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
42388783|NCT04569968|76271983|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
42388784|NCT04569968|76271982|FG000|Overall Study|Repetitive stroke|8|||
42388785|NCT04569968|76271983|FG001|Overall Study|Repetitive stroke|0|||
42388786|NCT04569968|76271982|FG000|Overall Study|Insufficient mastication|1|||
42388787|NCT04569968|76271983|FG001|Overall Study|Insufficient mastication|0|||
42388788|NCT04569968|76271982|FG000|Overall Study|Infection|1|||
42388789|NCT04569968|76271983|FG001|Overall Study|Infection|0|||
42388790|NCT03385304|76271991|FG000|Overall Study|Death|19|||
42388791|NCT03385304|76271992|FG001|Overall Study|Death|7|||
42388792|NCT03385304|76271991|FG000|Overall Study|Lost to Follow-up|17|||
42388793|NCT03385304|76271992|FG001|Overall Study|Lost to Follow-up|14|||
42388794|NCT03385304|76271991|FG000|Overall Study|Withdrawal by Subject|3|||
42388795|NCT03385304|76271992|FG001|Overall Study|Withdrawal by Subject|2|||
42388796|NCT03385304|76271991|FG000|Overall Study|Incarceration|2|||
42388797|NCT03385304|76271992|FG001|Overall Study|Incarceration|3|||
42388798|NCT03325608|76272002|FG000|Overall Study|Lost to Follow-up|47|||
42388799|NCT03325608|76272003|FG001|Overall Study|Lost to Follow-up|47|||
42388800|NCT03325608|76272004|FG002|Overall Study|Lost to Follow-up|41|||
42388801|NCT03325608|76272005|FG003|Overall Study|Lost to Follow-up|41|||
42388802|NCT03325608|76272002|FG000|Overall Study|Death|44|||
42388803|NCT03325608|76272003|FG001|Overall Study|Death|0|||
42388804|NCT03325608|76272004|FG002|Overall Study|Death|41|||
42388805|NCT03325608|76272005|FG003|Overall Study|Death|0|||
42388806|NCT03325608|76272002|FG000|Overall Study|Death of Care Recipient|0|||
42388807|NCT03325608|76272003|FG001|Overall Study|Death of Care Recipient|44|||
42388808|NCT03325608|76272004|FG002|Overall Study|Death of Care Recipient|0|||
42388809|NCT03325608|76272005|FG003|Overall Study|Death of Care Recipient|41|||
42388810|NCT03325608|76272002|FG000|Overall Study|Withdrawal by Subject|44|||
42388811|NCT03325608|76272003|FG001|Overall Study|Withdrawal by Subject|44|||
42388812|NCT03325608|76272004|FG002|Overall Study|Withdrawal by Subject|30|||
42388813|NCT03325608|76272005|FG003|Overall Study|Withdrawal by Subject|30|||
42388814|NCT03183141|76272015|FG000|Overall Study|Withdrawal by Subject|2|||
42388815|NCT03183141|76272016|FG001|Overall Study|Withdrawal by Subject|4|||
42388816|NCT03183141|76272015|FG000|Overall Study|Death|0|||
42388817|NCT03183141|76272016|FG001|Overall Study|Death|8|||
42388818|NCT02957539|76272025|FG000|Baseline to Week 16|Lost to Follow-up|8|||
42388819|NCT02957539|76272026|FG001|Baseline to Week 16|Lost to Follow-up|10|||
42388820|NCT02957539|76272027|FG002|Baseline to Week 16|Lost to Follow-up|16|||
42388821|NCT02957539|76272025|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
42388822|NCT02957539|76272026|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
42388823|NCT02957539|76272027|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
42388824|NCT02957539|76272025|FG000|Week 16 to 32|Withdrawal by Subject|3|||
42388825|NCT02957539|76272026|FG001|Week 16 to 32|Withdrawal by Subject|3|||
42388826|NCT02957539|76272027|FG002|Week 16 to 32|Withdrawal by Subject|1|||
42388827|NCT02957539|76272025|FG000|Week 16 to 32|Lost to Follow-up|8|||
42388828|NCT02957539|76272026|FG001|Week 16 to 32|Lost to Follow-up|7|||
42388829|NCT02957539|76272027|FG002|Week 16 to 32|Lost to Follow-up|5|||
42388830|NCT02957539|76272025|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
42388831|NCT02957539|76272026|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
42388832|NCT02957539|76272027|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
42388833|NCT02957539|76272025|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
42388834|NCT02957539|76272026|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
42388835|NCT02957539|76272027|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
42388836|NCT02690077|76272040|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
42388837|NCT02690077|76272041|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
42388838|NCT02690077|76272040|FG000|Overall Study|Withdrawal by Subject|0|||
42388839|NCT02690077|76272041|FG001|Overall Study|Withdrawal by Subject|5|||
42388840|NCT02690077|76272040|FG000|Overall Study|Excluded by IRB|0|||
42388841|NCT02690077|76272041|FG001|Overall Study|Excluded by IRB|2|||
42388842|NCT02275780|76272049|FG000|Base Study: 96 Weeks|Adverse Event|6|||
42388843|NCT02275780|76272050|FG001|Base Study: 96 Weeks|Adverse Event|14|||
42388844|NCT02275780|76272049|FG000|Base Study: 96 Weeks|Death|3|||
42388845|NCT02275780|76272050|FG001|Base Study: 96 Weeks|Death|1|||
42388846|NCT02275780|76272049|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
42388847|NCT02275780|76272050|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
42388848|NCT02275780|76272049|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
42388849|NCT02275780|76272050|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
42388850|NCT02275780|76272049|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
42388851|NCT02275780|76272050|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
42388852|NCT02275780|76272049|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
42388853|NCT02275780|76272050|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
42388854|NCT02275780|76272049|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
42388855|NCT02275780|76272050|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
42388856|NCT02275780|76272049|FG000|Base Study: 96 Weeks|Physician Decision|2|||
42388857|NCT02275780|76272050|FG001|Base Study: 96 Weeks|Physician Decision|4|||
42388858|NCT02275780|76272049|FG000|Base Study: 96 Weeks|Pregnancy|2|||
42388859|NCT02275780|76272050|FG001|Base Study: 96 Weeks|Pregnancy|1|||
42388860|NCT02275780|76272049|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
42388861|NCT02275780|76272050|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
42388862|NCT02275780|76272049|FG000|Extension Study: up to 192 Weeks|Ongoing|260|||
42388863|NCT02275780|76272050|FG001|Extension Study: up to 192 Weeks|Ongoing|233|||
42388864|NCT00545077|76272058|FG000|Overall Study|Treatment not received|5|||
42388865|NCT00545077|76272059|FG001|Overall Study|Treatment not received|1|||
42388866|NCT00545077|76272058|FG000|Overall Study|Disease Progression|131|||
42388867|NCT00545077|76272059|FG001|Overall Study|Disease Progression|98|||
42388868|NCT00545077|76272058|FG000|Overall Study|Withdrawal by Subject|3|||
42388869|NCT00545077|76272059|FG001|Overall Study|Withdrawal by Subject|14|||
42388870|NCT00545077|76272058|FG000|Overall Study|Physician Decision|6|||
42388871|NCT00545077|76272059|FG001|Overall Study|Physician Decision|3|||
42388872|NCT00545077|76272058|FG000|Overall Study|Lost to Follow-up|2|||
42388873|NCT00545077|76272059|FG001|Overall Study|Lost to Follow-up|0|||
42388874|NCT00545077|76272058|FG000|Overall Study|Protocol Violation|1|||
42388875|NCT00545077|76272059|FG001|Overall Study|Protocol Violation|0|||
42388876|NCT00545077|76272058|FG000|Overall Study|Adverse Event|0|||
42388877|NCT00545077|76272059|FG001|Overall Study|Adverse Event|31|||
42388878|NCT00545077|76272058|FG000|Overall Study|Death|0|||
42388879|NCT00545077|76272059|FG001|Overall Study|Death|8|||
42388880|NCT00130533|76272067|FG000|Overall Study|Withdrawal by Subject|33|||
42388881|NCT00130533|76272068|FG001|Overall Study|Withdrawal by Subject|6|||
42388882|NCT00130533|76272067|FG000|Overall Study|Adverse Event|34|||
42388883|NCT00130533|76272068|FG001|Overall Study|Adverse Event|1|||
42388884|NCT00130533|76272067|FG000|Overall Study|Disease relapse|9|||
42388885|NCT00130533|76272068|FG001|Overall Study|Disease relapse|13|||
42388886|NCT00130533|76272067|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
42388887|NCT00130533|76272068|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
42388888|NCT00130533|76272067|FG000|Overall Study|Death|4|||
42388889|NCT00130533|76272068|FG001|Overall Study|Death|2|||
42388890|NCT00130533|76272067|FG000|Overall Study|Protocol Violation|5|||
42388891|NCT00130533|76272068|FG001|Overall Study|Protocol Violation|1|||
42388892|NCT00130533|76272067|FG000|Overall Study|Lost to Follow-up|1|||
42388893|NCT00130533|76272068|FG001|Overall Study|Lost to Follow-up|1|||
42388894|NCT00130533|76272067|FG000|Overall Study|Sponsor´s decision|2|||
42388895|NCT00130533|76272068|FG001|Overall Study|Sponsor´s decision|0|||
42388896|NCT00130533|76272067|FG000|Overall Study|Second Primary Malignancy|0|||
42388897|NCT00130533|76272068|FG001|Overall Study|Second Primary Malignancy|1|||
42388898|NCT00130533|76272067|FG000|Overall Study|Other|12|||
42388899|NCT00130533|76272068|FG001|Overall Study|Other|5|||
42388900|NCT00129935|76272076|FG000|Overall Study|Adverse Event|18|||
42388901|NCT00129935|76272077|FG001|Overall Study|Adverse Event|56|||
42388902|NCT00129935|76272076|FG000|Overall Study|Death|1|||
42388903|NCT00129935|76272077|FG001|Overall Study|Death|1|||
42388904|NCT00129935|76272076|FG000|Overall Study|Withdrawal by Subject|7|||
42388905|NCT00129935|76272077|FG001|Overall Study|Withdrawal by Subject|20|||
42388906|NCT00129935|76272076|FG000|Overall Study|Protocol Violation|0|||
42388907|NCT00129935|76272077|FG001|Overall Study|Protocol Violation|4|||
42388908|NCT00129935|76272076|FG000|Overall Study|Physician Decision|3|||
42388909|NCT00129935|76272077|FG001|Overall Study|Physician Decision|4|||
42388910|NCT00129935|76272076|FG000|Overall Study|Recurrence|1|||
42388911|NCT00129935|76272077|FG001|Overall Study|Recurrence|3|||
42388912|NCT00129935|76272076|FG000|Overall Study|Second primary|0|||
42388913|NCT00129935|76272077|FG001|Overall Study|Second primary|1|||
42388914|NCT00129935|76272076|FG000|Overall Study|Other|3|||
42388915|NCT00129935|76272077|FG001|Overall Study|Other|2|||
42388916|NCT00129935|76272076|FG000|Overall Study|Crossed to the other arm|2|||
42388917|NCT00129935|76272077|FG001|Overall Study|Crossed to the other arm|1|||
42204720|NCT03529773|76017120|FG029|Overall Study|Randomized but not vaccinated|0|||
42388918|NCT00129935|76272076|FG000|Overall Study|Incorrect study treatment|1|||
42388919|NCT00129935|76272077|FG001|Overall Study|Incorrect study treatment|0|||
42388920|NCT01647828|76272092|FG000|Overall Study|Death|3|||
42388921|NCT01647828|76272093|FG001|Overall Study|Death|4|||
42388922|NCT01647828|76272094|FG002|Overall Study|Death|4|||
42388923|NCT01647828|76272095|FG003|Overall Study|Death|5|||
42388924|NCT01647828|76272096|FG004|Overall Study|Death|6|||
42388925|NCT01647828|76272097|FG005|Overall Study|Death|3|||
42388926|NCT01647828|76272098|FG006|Overall Study|Death|10|||
42388927|NCT01647828|76272099|FG007|Overall Study|Death|60|||
42388928|NCT01647828|76272100|FG008|Overall Study|Death|71|||
42388929|NCT01647828|76272092|FG000|Overall Study|Withdrawal by Subject|2|||
42388930|NCT01647828|76272093|FG001|Overall Study|Withdrawal by Subject|0|||
42388931|NCT01647828|76272094|FG002|Overall Study|Withdrawal by Subject|0|||
42388932|NCT01647828|76272095|FG003|Overall Study|Withdrawal by Subject|1|||
42388933|NCT01647828|76272096|FG004|Overall Study|Withdrawal by Subject|0|||
42388934|NCT01647828|76272097|FG005|Overall Study|Withdrawal by Subject|0|||
42388935|NCT01647828|76272098|FG006|Overall Study|Withdrawal by Subject|1|||
42388936|NCT01647828|76272099|FG007|Overall Study|Withdrawal by Subject|0|||
42388937|NCT01647828|76272100|FG008|Overall Study|Withdrawal by Subject|2|||
42388938|NCT01647828|76272092|FG000|Overall Study|Study terminated by Sponsor|0|||
42388939|NCT01647828|76272093|FG001|Overall Study|Study terminated by Sponsor|0|||
42388940|NCT01647828|76272094|FG002|Overall Study|Study terminated by Sponsor|0|||
42388941|NCT01647828|76272095|FG003|Overall Study|Study terminated by Sponsor|0|||
42388942|NCT01647828|76272096|FG004|Overall Study|Study terminated by Sponsor|0|||
42388943|NCT01647828|76272097|FG005|Overall Study|Study terminated by Sponsor|0|||
42388944|NCT01647828|76272098|FG006|Overall Study|Study terminated by Sponsor|1|||
42388945|NCT01647828|76272099|FG007|Overall Study|Study terminated by Sponsor|26|||
42388946|NCT01647828|76272100|FG008|Overall Study|Study terminated by Sponsor|16|||
42388947|NCT01647828|76272092|FG000|Overall Study|Lost to Follow-up|0|||
42388948|NCT01647828|76272093|FG001|Overall Study|Lost to Follow-up|0|||
42388949|NCT01647828|76272094|FG002|Overall Study|Lost to Follow-up|0|||
42388950|NCT01647828|76272095|FG003|Overall Study|Lost to Follow-up|0|||
42388951|NCT01647828|76272096|FG004|Overall Study|Lost to Follow-up|0|||
42388952|NCT01647828|76272097|FG005|Overall Study|Lost to Follow-up|0|||
42388953|NCT01647828|76272098|FG006|Overall Study|Lost to Follow-up|0|||
42388954|NCT01647828|76272099|FG007|Overall Study|Lost to Follow-up|2|||
42388955|NCT01647828|76272100|FG008|Overall Study|Lost to Follow-up|0|||
42388956|NCT00989261|76272122|FG000|Overall Study|Still in follow up|12|||
42388957|NCT00989261|76272123|FG001|Overall Study|Still in follow up|21|||
42388958|NCT00989261|76272122|FG000|Overall Study|Withdrawal by Subject|0|||
42388959|NCT00989261|76272123|FG001|Overall Study|Withdrawal by Subject|1|||
42388960|NCT00989261|76272122|FG000|Overall Study|Lost to Follow-up|3|||
42388961|NCT00989261|76272123|FG001|Overall Study|Lost to Follow-up|0|||
42388962|NCT00988559|76272142|FG000|Overall Study|Withdrawal by Subject|1|||
42388963|NCT00988559|76272143|FG001|Overall Study|Withdrawal by Subject|1|||
42388964|NCT00988559|76272144|FG002|Overall Study|Withdrawal by Subject|0|||
42388965|NCT00988559|76272145|FG003|Overall Study|Withdrawal by Subject|1|||
42388966|NCT00988559|76272142|FG000|Overall Study|Pregnancy|0|||
42388967|NCT00988559|76272143|FG001|Overall Study|Pregnancy|1|||
42388968|NCT00988559|76272144|FG002|Overall Study|Pregnancy|1|||
42388969|NCT00988559|76272145|FG003|Overall Study|Pregnancy|0|||
42388970|NCT00988559|76272142|FG000|Overall Study|Lost to Follow-up|0|||
42388971|NCT00988559|76272143|FG001|Overall Study|Lost to Follow-up|0|||
42388972|NCT00988559|76272144|FG002|Overall Study|Lost to Follow-up|1|||
42388973|NCT00988559|76272145|FG003|Overall Study|Lost to Follow-up|0|||
42388974|NCT00988169|76272155|FG000|Overall Study|Withdrawal by Subject|1|||
42388975|NCT00988091|76272182|FG000|Double-blind Period|Withdrawal by Subject|15|||
42388976|NCT00988091|76272183|FG001|Double-blind Period|Withdrawal by Subject|13|||
42388977|NCT00988091|76272182|FG000|Double-blind Period|Lost to Follow-up|12|||
42388978|NCT00988091|76272183|FG001|Double-blind Period|Lost to Follow-up|14|||
42388979|NCT00988091|76272182|FG000|Double-blind Period|Other|8|||
42388980|NCT00988091|76272183|FG001|Double-blind Period|Other|8|||
42388981|NCT00988091|76272182|FG000|Double-blind Period|Adverse Event|6|||
42388982|NCT00988091|76272183|FG001|Double-blind Period|Adverse Event|9|||
42388983|NCT00988091|76272182|FG000|Double-blind Period|Use of exclusionary medication|2|||
42388984|NCT00988091|76272183|FG001|Double-blind Period|Use of exclusionary medication|3|||
42388985|NCT00988091|76272182|FG000|Open-label Period|Adverse Event|4|||
42388986|NCT00988091|76272183|FG001|Open-label Period|Adverse Event|7|||
42388987|NCT00988091|76272182|FG000|Open-label Period|Use of exclusionary medication|1|||
42388988|NCT00988091|76272183|FG001|Open-label Period|Use of exclusionary medication|1|||
42388989|NCT00988091|76272182|FG000|Open-label Period|Protocol Violation|1|||
42388990|NCT00988091|76272183|FG001|Open-label Period|Protocol Violation|1|||
42388991|NCT00988091|76272182|FG000|Open-label Period|Withdrawal by Subject|10|||
42388992|NCT00988091|76272183|FG001|Open-label Period|Withdrawal by Subject|16|||
42388993|NCT00988091|76272182|FG000|Open-label Period|Lost to Follow-up|3|||
42388994|NCT00988091|76272183|FG001|Open-label Period|Lost to Follow-up|5|||
42020210|NCT01078623|75827707|FG002|Treatment Period 1|Adverse Event|1|||
42388995|NCT00988091|76272182|FG000|Open-label Period|Other|2|||
42388996|NCT00988091|76272183|FG001|Open-label Period|Other|3|||
42388997|NCT02623218|76272473|FG000|Overall Study|Lost to Follow-up|0|||
42388998|NCT02623218|76272474|FG001|Overall Study|Lost to Follow-up|1|||
42388999|NCT02623218|76272475|FG002|Overall Study|Lost to Follow-up|0|||
42389000|NCT02623218|76272476|FG003|Overall Study|Lost to Follow-up|0|||
42389001|NCT02623218|76272477|FG004|Overall Study|Lost to Follow-up|0|||
42389002|NCT02622828|76272502|FG000|Overall Study|participant withdrew|3|||
42389003|NCT02621034|76272638|FG000|Overall Study|Lost to Follow-up|3|||
42389004|NCT02621034|76272639|FG001|Overall Study|Lost to Follow-up|2|||
42389005|NCT02621034|76272640|FG002|Overall Study|Lost to Follow-up|5|||
42389006|NCT02620020|76272702|FG000|Overall Study|Adverse Event|8|||
42389007|NCT02620020|76272703|FG001|Overall Study|Adverse Event|4|||
42389008|NCT02620020|76272704|FG002|Overall Study|Adverse Event|3|||
42389009|NCT02620020|76272705|FG003|Overall Study|Adverse Event|5|||
42389010|NCT02620020|76272702|FG000|Overall Study|Lost to Follow-up|4|||
42389011|NCT02620020|76272703|FG001|Overall Study|Lost to Follow-up|8|||
42389012|NCT02620020|76272704|FG002|Overall Study|Lost to Follow-up|1|||
42389013|NCT02620020|76272705|FG003|Overall Study|Lost to Follow-up|4|||
42389014|NCT02620020|76272702|FG000|Overall Study|Physician Decision|7|||
42389015|NCT02620020|76272703|FG001|Overall Study|Physician Decision|4|||
42020211|NCT01078623|75827708|FG003|Treatment Period 1|Adverse Event|0|||
42020212|NCT01078623|75827709|FG004|Treatment Period 1|Adverse Event|0|||
42020213|NCT01078623|75827710|FG005|Treatment Period 1|Adverse Event|0|||
42020214|NCT01078623|75827711|FG006|Treatment Period 1|Adverse Event|1|||
42020215|NCT01078623|75827712|FG007|Treatment Period 1|Adverse Event|0|||
42020216|NCT01078623|75827713|FG008|Treatment Period 1|Adverse Event|1|||
42020217|NCT01078623|75827714|FG009|Treatment Period 1|Adverse Event|1|||
42020218|NCT01078623|75827715|FG010|Treatment Period 1|Adverse Event|0|||
42020219|NCT01078623|75827716|FG011|Treatment Period 1|Adverse Event|0|||
42020220|NCT01078623|75827717|FG012|Treatment Period 1|Adverse Event|0|||
42020221|NCT01078623|75827718|FG013|Treatment Period 1|Adverse Event|0|||
42020222|NCT01078623|75827719|FG014|Treatment Period 1|Adverse Event|0|||
42020223|NCT01078623|75827720|FG015|Treatment Period 1|Adverse Event|0|||
42020224|NCT01078623|75827721|FG016|Treatment Period 1|Adverse Event|0|||
42020225|NCT01078623|75827722|FG017|Treatment Period 1|Adverse Event|0|||
42020226|NCT01078623|75827723|FG018|Treatment Period 1|Adverse Event|0|||
42020227|NCT01078623|75827724|FG019|Treatment Period 1|Adverse Event|0|||
42020228|NCT01078623|75827705|FG000|Treatment Period 1|Withdrawal by Subject|0|||
42020229|NCT01078623|75827706|FG001|Treatment Period 1|Withdrawal by Subject|0|||
42020230|NCT01078623|75827707|FG002|Treatment Period 1|Withdrawal by Subject|0|||
42020231|NCT01078623|75827708|FG003|Treatment Period 1|Withdrawal by Subject|0|||
42020232|NCT01078623|75827709|FG004|Treatment Period 1|Withdrawal by Subject|0|||
42020233|NCT01078623|75827710|FG005|Treatment Period 1|Withdrawal by Subject|0|||
42020234|NCT01078623|75827711|FG006|Treatment Period 1|Withdrawal by Subject|0|||
42020235|NCT01078623|75827712|FG007|Treatment Period 1|Withdrawal by Subject|1|||
42020236|NCT01078623|75827713|FG008|Treatment Period 1|Withdrawal by Subject|0|||
42020237|NCT01078623|75827714|FG009|Treatment Period 1|Withdrawal by Subject|0|||
42020238|NCT01078623|75827715|FG010|Treatment Period 1|Withdrawal by Subject|1|||
42020239|NCT01078623|75827716|FG011|Treatment Period 1|Withdrawal by Subject|0|||
42020240|NCT01078623|75827717|FG012|Treatment Period 1|Withdrawal by Subject|0|||
42020241|NCT01078623|75827718|FG013|Treatment Period 1|Withdrawal by Subject|0|||
42020242|NCT01078623|75827719|FG014|Treatment Period 1|Withdrawal by Subject|0|||
42020243|NCT01078623|75827720|FG015|Treatment Period 1|Withdrawal by Subject|0|||
42020244|NCT01078623|75827721|FG016|Treatment Period 1|Withdrawal by Subject|0|||
42020245|NCT01078623|75827722|FG017|Treatment Period 1|Withdrawal by Subject|0|||
42020246|NCT01078623|75827723|FG018|Treatment Period 1|Withdrawal by Subject|0|||
42020247|NCT01078623|75827724|FG019|Treatment Period 1|Withdrawal by Subject|0|||
42020248|NCT01078623|75827705|FG000|Treatment Period 1|Protocol Violation|0|||
42020249|NCT01078623|75827706|FG001|Treatment Period 1|Protocol Violation|0|||
42020250|NCT01078623|75827707|FG002|Treatment Period 1|Protocol Violation|0|||
42020251|NCT01078623|75827708|FG003|Treatment Period 1|Protocol Violation|0|||
42020252|NCT01078623|75827709|FG004|Treatment Period 1|Protocol Violation|0|||
42020253|NCT01078623|75827710|FG005|Treatment Period 1|Protocol Violation|1|||
42020254|NCT01078623|75827711|FG006|Treatment Period 1|Protocol Violation|0|||
42020255|NCT01078623|75827712|FG007|Treatment Period 1|Protocol Violation|0|||
42020256|NCT01078623|75827713|FG008|Treatment Period 1|Protocol Violation|0|||
42020257|NCT01078623|75827714|FG009|Treatment Period 1|Protocol Violation|0|||
42020258|NCT01078623|75827715|FG010|Treatment Period 1|Protocol Violation|0|||
42020259|NCT01078623|75827716|FG011|Treatment Period 1|Protocol Violation|0|||
42020260|NCT01078623|75827717|FG012|Treatment Period 1|Protocol Violation|0|||
42020261|NCT01078623|75827718|FG013|Treatment Period 1|Protocol Violation|0|||
42020262|NCT01078623|75827719|FG014|Treatment Period 1|Protocol Violation|0|||
42020263|NCT01078623|75827720|FG015|Treatment Period 1|Protocol Violation|0|||
42020264|NCT01078623|75827721|FG016|Treatment Period 1|Protocol Violation|0|||
42020265|NCT01078623|75827722|FG017|Treatment Period 1|Protocol Violation|0|||
42020266|NCT01078623|75827723|FG018|Treatment Period 1|Protocol Violation|0|||
42020267|NCT01078623|75827724|FG019|Treatment Period 1|Protocol Violation|0|||
42020268|NCT01078623|75827705|FG000|Treatment Period 2|Adverse Event|0|||
42020269|NCT01078623|75827706|FG001|Treatment Period 2|Adverse Event|0|||
42020270|NCT01078623|75827707|FG002|Treatment Period 2|Adverse Event|0|||
42204721|NCT03529773|76017121|FG030|Overall Study|Randomized but not vaccinated|0|||
42389016|NCT02620020|76272704|FG002|Overall Study|Physician Decision|3|||
42389017|NCT02620020|76272705|FG003|Overall Study|Physician Decision|4|||
42389018|NCT02620020|76272702|FG000|Overall Study|Protocol Violation|5|||
42389019|NCT02620020|76272703|FG001|Overall Study|Protocol Violation|2|||
42020271|NCT01078623|75827708|FG003|Treatment Period 2|Adverse Event|0|||
42020272|NCT01078623|75827709|FG004|Treatment Period 2|Adverse Event|0|||
42020273|NCT01078623|75827710|FG005|Treatment Period 2|Adverse Event|0|||
42020274|NCT01078623|75827711|FG006|Treatment Period 2|Adverse Event|1|||
42020275|NCT01078623|75827712|FG007|Treatment Period 2|Adverse Event|0|||
42020276|NCT01078623|75827713|FG008|Treatment Period 2|Adverse Event|0|||
42020277|NCT01078623|75827714|FG009|Treatment Period 2|Adverse Event|0|||
42020278|NCT01078623|75827715|FG010|Treatment Period 2|Adverse Event|0|||
42020279|NCT01078623|75827716|FG011|Treatment Period 2|Adverse Event|0|||
42020280|NCT01078623|75827717|FG012|Treatment Period 2|Adverse Event|0|||
42020281|NCT01078623|75827718|FG013|Treatment Period 2|Adverse Event|0|||
42020282|NCT01078623|75827719|FG014|Treatment Period 2|Adverse Event|0|||
42020283|NCT01078623|75827720|FG015|Treatment Period 2|Adverse Event|0|||
42020284|NCT01078623|75827721|FG016|Treatment Period 2|Adverse Event|0|||
42020285|NCT01078623|75827722|FG017|Treatment Period 2|Adverse Event|0|||
42020286|NCT01078623|75827723|FG018|Treatment Period 2|Adverse Event|1|||
42020287|NCT01078623|75827724|FG019|Treatment Period 2|Adverse Event|0|||
42020288|NCT01078623|75827705|FG000|Treatment Period 2|Withdrawal by Subject|0|||
42020289|NCT01078623|75827706|FG001|Treatment Period 2|Withdrawal by Subject|0|||
42020290|NCT01078623|75827707|FG002|Treatment Period 2|Withdrawal by Subject|0|||
42020291|NCT01078623|75827708|FG003|Treatment Period 2|Withdrawal by Subject|0|||
42020292|NCT01078623|75827709|FG004|Treatment Period 2|Withdrawal by Subject|0|||
42020293|NCT01078623|75827710|FG005|Treatment Period 2|Withdrawal by Subject|1|||
42020294|NCT01078623|75827711|FG006|Treatment Period 2|Withdrawal by Subject|0|||
42020295|NCT01078623|75827712|FG007|Treatment Period 2|Withdrawal by Subject|0|||
42020296|NCT01078623|75827713|FG008|Treatment Period 2|Withdrawal by Subject|0|||
42020297|NCT01078623|75827714|FG009|Treatment Period 2|Withdrawal by Subject|0|||
42020298|NCT01078623|75827715|FG010|Treatment Period 2|Withdrawal by Subject|0|||
42020299|NCT01078623|75827716|FG011|Treatment Period 2|Withdrawal by Subject|0|||
42020300|NCT01078623|75827717|FG012|Treatment Period 2|Withdrawal by Subject|0|||
42020301|NCT01078623|75827718|FG013|Treatment Period 2|Withdrawal by Subject|0|||
42020302|NCT01078623|75827719|FG014|Treatment Period 2|Withdrawal by Subject|0|||
42020303|NCT01078623|75827720|FG015|Treatment Period 2|Withdrawal by Subject|0|||
42020304|NCT01078623|75827721|FG016|Treatment Period 2|Withdrawal by Subject|0|||
42020305|NCT01078623|75827722|FG017|Treatment Period 2|Withdrawal by Subject|0|||
42020306|NCT01078623|75827723|FG018|Treatment Period 2|Withdrawal by Subject|0|||
42020307|NCT01078623|75827724|FG019|Treatment Period 2|Withdrawal by Subject|0|||
42020308|NCT01078623|75827705|FG000|Treatment Period 3|Adverse Event|0|||
42020309|NCT01078623|75827706|FG001|Treatment Period 3|Adverse Event|0|||
42020310|NCT01078623|75827707|FG002|Treatment Period 3|Adverse Event|0|||
42020311|NCT01078623|75827708|FG003|Treatment Period 3|Adverse Event|0|||
42020312|NCT01078623|75827709|FG004|Treatment Period 3|Adverse Event|1|||
42020313|NCT01078623|75827710|FG005|Treatment Period 3|Adverse Event|0|||
42020314|NCT01078623|75827711|FG006|Treatment Period 3|Adverse Event|0|||
42020315|NCT01078623|75827712|FG007|Treatment Period 3|Adverse Event|0|||
42020316|NCT01078623|75827713|FG008|Treatment Period 3|Adverse Event|0|||
42020317|NCT01078623|75827714|FG009|Treatment Period 3|Adverse Event|0|||
42020318|NCT01078623|75827715|FG010|Treatment Period 3|Adverse Event|0|||
42020319|NCT01078623|75827716|FG011|Treatment Period 3|Adverse Event|0|||
42020320|NCT01078623|75827717|FG012|Treatment Period 3|Adverse Event|0|||
42020321|NCT01078623|75827718|FG013|Treatment Period 3|Adverse Event|1|||
42020322|NCT01078623|75827719|FG014|Treatment Period 3|Adverse Event|0|||
42020323|NCT01078623|75827720|FG015|Treatment Period 3|Adverse Event|0|||
42020324|NCT01078623|75827721|FG016|Treatment Period 3|Adverse Event|0|||
42020325|NCT01078623|75827722|FG017|Treatment Period 3|Adverse Event|0|||
42020326|NCT01078623|75827723|FG018|Treatment Period 3|Adverse Event|0|||
42020327|NCT01078623|75827724|FG019|Treatment Period 3|Adverse Event|0|||
42020328|NCT01078623|75827705|FG000|Treatment Period 4|Adverse Event|0|||
42020329|NCT01078623|75827706|FG001|Treatment Period 4|Adverse Event|0|||
42020330|NCT01078623|75827707|FG002|Treatment Period 4|Adverse Event|1|||
42020331|NCT01078623|75827708|FG003|Treatment Period 4|Adverse Event|0|||
42020332|NCT01078623|75827709|FG004|Treatment Period 4|Adverse Event|0|||
42020333|NCT01078623|75827710|FG005|Treatment Period 4|Adverse Event|0|||
42020334|NCT01078623|75827711|FG006|Treatment Period 4|Adverse Event|0|||
42020335|NCT01078623|75827712|FG007|Treatment Period 4|Adverse Event|0|||
42020336|NCT01078623|75827713|FG008|Treatment Period 4|Adverse Event|0|||
42020337|NCT01078623|75827714|FG009|Treatment Period 4|Adverse Event|0|||
42020338|NCT01078623|75827715|FG010|Treatment Period 4|Adverse Event|0|||
42020339|NCT01078623|75827716|FG011|Treatment Period 4|Adverse Event|0|||
42020340|NCT01078623|75827717|FG012|Treatment Period 4|Adverse Event|0|||
42020341|NCT01078623|75827718|FG013|Treatment Period 4|Adverse Event|0|||
42020342|NCT01078623|75827719|FG014|Treatment Period 4|Adverse Event|0|||
42020343|NCT01078623|75827720|FG015|Treatment Period 4|Adverse Event|0|||
42020344|NCT01078623|75827721|FG016|Treatment Period 4|Adverse Event|0|||
42020345|NCT01078623|75827722|FG017|Treatment Period 4|Adverse Event|0|||
42020346|NCT01078623|75827723|FG018|Treatment Period 4|Adverse Event|0|||
42020347|NCT01078623|75827724|FG019|Treatment Period 4|Adverse Event|0|||
42020348|NCT01078623|75827705|FG000|Treatment Period 4|Withdrawal by Subject|0|||
42020349|NCT01078623|75827706|FG001|Treatment Period 4|Withdrawal by Subject|0|||
42020350|NCT01078623|75827707|FG002|Treatment Period 4|Withdrawal by Subject|0|||
42020351|NCT01078623|75827708|FG003|Treatment Period 4|Withdrawal by Subject|0|||
42020352|NCT01078623|75827709|FG004|Treatment Period 4|Withdrawal by Subject|0|||
42020353|NCT01078623|75827710|FG005|Treatment Period 4|Withdrawal by Subject|0|||
42020354|NCT01078623|75827711|FG006|Treatment Period 4|Withdrawal by Subject|0|||
42020355|NCT01078623|75827712|FG007|Treatment Period 4|Withdrawal by Subject|0|||
42020356|NCT01078623|75827713|FG008|Treatment Period 4|Withdrawal by Subject|0|||
42020357|NCT01078623|75827714|FG009|Treatment Period 4|Withdrawal by Subject|0|||
42020358|NCT01078623|75827715|FG010|Treatment Period 4|Withdrawal by Subject|0|||
42020359|NCT01078623|75827716|FG011|Treatment Period 4|Withdrawal by Subject|0|||
42020360|NCT01078623|75827717|FG012|Treatment Period 4|Withdrawal by Subject|0|||
42020361|NCT01078623|75827718|FG013|Treatment Period 4|Withdrawal by Subject|0|||
42020362|NCT01078623|75827719|FG014|Treatment Period 4|Withdrawal by Subject|0|||
42020363|NCT01078623|75827720|FG015|Treatment Period 4|Withdrawal by Subject|1|||
42020364|NCT01078623|75827721|FG016|Treatment Period 4|Withdrawal by Subject|0|||
42020365|NCT01078623|75827722|FG017|Treatment Period 4|Withdrawal by Subject|0|||
42020366|NCT01078623|75827723|FG018|Treatment Period 4|Withdrawal by Subject|0|||
42020367|NCT01078623|75827724|FG019|Treatment Period 4|Withdrawal by Subject|0|||
42020368|NCT01092507|75827738|FG000|Overall Study|Withdrawal by Subject|2|||
42020369|NCT01092507|75827739|FG001|Overall Study|Withdrawal by Subject|0|||
42020370|NCT01078545|75827745|FG000|Overall Study|Lost to Follow-up|13|||
42020371|NCT01078545|75827745|FG000|Overall Study|Physician Decision|6|||
42020372|NCT01078545|75827745|FG000|Overall Study|Withdrawal by Subject|3|||
42020373|NCT01078545|75827745|FG000|Overall Study|Death|3|||
42020374|NCT01078545|75827745|FG000|Overall Study|Participant moved to another physician|1|||
42020375|NCT01202760|75827752|FG000|Overall Study|Entry Criteria Not Met|0|||
42020376|NCT01202760|75827753|FG001|Overall Study|Entry Criteria Not Met|3|||
42020377|NCT01202760|75827754|FG002|Overall Study|Entry Criteria Not Met|1|||
42020378|NCT01202760|75827752|FG000|Overall Study|Adverse Event|11|||
42020379|NCT01202760|75827753|FG001|Overall Study|Adverse Event|9|||
42020380|NCT01202760|75827754|FG002|Overall Study|Adverse Event|10|||
42020381|NCT01202760|75827752|FG000|Overall Study|Death|2|||
42020382|NCT01202760|75827753|FG001|Overall Study|Death|1|||
42020383|NCT01202760|75827754|FG002|Overall Study|Death|0|||
42020384|NCT01202760|75827752|FG000|Overall Study|Lack of Efficacy|6|||
42020385|NCT01202760|75827753|FG001|Overall Study|Lack of Efficacy|8|||
42020386|NCT01202760|75827754|FG002|Overall Study|Lack of Efficacy|7|||
42020387|NCT01202760|75827752|FG000|Overall Study|Lost to Follow-up|0|||
42020388|NCT01202760|75827753|FG001|Overall Study|Lost to Follow-up|2|||
42020389|NCT01202760|75827754|FG002|Overall Study|Lost to Follow-up|1|||
42020390|NCT01202760|75827752|FG000|Overall Study|Parent / Caregiver Decision|0|||
42020391|NCT01202760|75827753|FG001|Overall Study|Parent / Caregiver Decision|1|||
42020392|NCT01202760|75827754|FG002|Overall Study|Parent / Caregiver Decision|0|||
42020393|NCT01202760|75827752|FG000|Overall Study|Withdrawal by Subject|17|||
42020394|NCT01202760|75827753|FG001|Overall Study|Withdrawal by Subject|18|||
42020395|NCT01202760|75827754|FG002|Overall Study|Withdrawal by Subject|14|||
42020396|NCT01202760|75827752|FG000|Overall Study|Physician Decision|0|||
42020397|NCT01202760|75827753|FG001|Overall Study|Physician Decision|1|||
42020398|NCT01202760|75827754|FG002|Overall Study|Physician Decision|0|||
42020399|NCT01202760|75827752|FG000|Overall Study|Protocol Violation|7|||
42020400|NCT01202760|75827753|FG001|Overall Study|Protocol Violation|5|||
42020401|NCT01202760|75827754|FG002|Overall Study|Protocol Violation|2|||
42020402|NCT01202760|75827752|FG000|Overall Study|Sponsor Decision|4|||
42020403|NCT01202760|75827753|FG001|Overall Study|Sponsor Decision|4|||
42020404|NCT01202760|75827754|FG002|Overall Study|Sponsor Decision|0|||
42020405|NCT01091259|75827774|FG000|Overall Study|Adverse Event|3|||
42020406|NCT01091259|75827774|FG000|Overall Study|Lack of Efficacy|2|||
42020407|NCT01091103|75827778|FG000|Overall Study|Adverse Event|1|||
42020408|NCT01091103|75827778|FG000|Overall Study|Progressive Disease|3|||
42020409|NCT01078389|75827786|FG000|Overall Study|Adverse Event|10|||
42020410|NCT01078389|75827787|FG001|Overall Study|Adverse Event|6|||
42020411|NCT01078389|75827786|FG000|Overall Study|Major Protocol Deviation|2|||
42020412|NCT01078389|75827787|FG001|Overall Study|Major Protocol Deviation|0|||
42020413|NCT01078389|75827786|FG000|Overall Study|Lost to Follow-up|23|||
42020414|NCT01078389|75827787|FG001|Overall Study|Lost to Follow-up|23|||
42020415|NCT01078389|75827786|FG000|Overall Study|Voluntary Withdrawal|20|||
42020416|NCT01078389|75827787|FG001|Overall Study|Voluntary Withdrawal|36|||
42020417|NCT01078389|75827786|FG000|Overall Study|Other|9|||
42020418|NCT01078389|75827787|FG001|Overall Study|Other|2|||
42020419|NCT01090323|75827795|FG000|Overall Study|Adverse Event|12|||
42020420|NCT01090323|75827796|FG001|Overall Study|Adverse Event|2|||
42020421|NCT01090323|75827795|FG000|Overall Study|Abnormal Lab Values|3|||
42020422|NCT01090323|75827796|FG001|Overall Study|Abnormal Lab Values|1|||
42020423|NCT01090323|75827795|FG000|Overall Study|Abnormal Test Procedure Results|2|||
42020424|NCT01090323|75827796|FG001|Overall Study|Abnormal Test Procedure Results|0|||
42020425|NCT01090323|75827795|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
42020426|NCT01090323|75827796|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
42020427|NCT01090323|75827795|FG000|Overall Study|Condition no longer requires drug|5|||
42020428|NCT01090323|75827796|FG001|Overall Study|Condition no longer requires drug|4|||
42020429|NCT01090323|75827795|FG000|Overall Study|Protocol Violation|2|||
42020430|NCT01090323|75827796|FG001|Overall Study|Protocol Violation|1|||
42020431|NCT01090323|75827795|FG000|Overall Study|Withdrew consent|33|||
42020432|NCT01090323|75827796|FG001|Overall Study|Withdrew consent|11|||
42020433|NCT01090323|75827795|FG000|Overall Study|Lost to Follow-up|11|||
42020434|NCT01090323|75827796|FG001|Overall Study|Lost to Follow-up|6|||
42020435|NCT01090323|75827795|FG000|Overall Study|Administrative problems|6|||
42020436|NCT01090323|75827796|FG001|Overall Study|Administrative problems|4|||
42020437|NCT01090323|75827795|FG000|Overall Study|Death|1|||
42020438|NCT01090323|75827796|FG001|Overall Study|Death|2|||
42020439|NCT01090323|75827795|FG000|Overall Study|Stopped end of core|7|||
42020440|NCT01090323|75827796|FG001|Overall Study|Stopped end of core|0|||
42020441|NCT01090323|75827795|FG000|Overall Study|Stopped end of extension 1#|3|||
42020442|NCT01090323|75827796|FG001|Overall Study|Stopped end of extension 1#|1|||
42020443|NCT01078155|75827802|FG000|Overall Study|Adverse Event|7|||
42020444|NCT01078155|75827802|FG000|Overall Study|Lack of Efficacy|16|||
42020445|NCT01078155|75827802|FG000|Overall Study|Participant's Decision|6|||
42020446|NCT01078155|75827802|FG000|Overall Study|Lost to Follow-up|15|||
42020447|NCT01201356|75827806|FG000|Overall Study|Adverse Event|170|||
42020448|NCT01201356|75827806|FG000|Overall Study|Abnormal laboratory value(s)|51|||
42020449|NCT01201356|75827806|FG000|Overall Study|Abnormal test procedure result(s)|3|||
42020450|NCT01201356|75827806|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
42020451|NCT01201356|75827806|FG000|Overall Study|Condition no longer requires study drug|12|||
42020452|NCT01201356|75827806|FG000|Overall Study|Withdrawal by Subject|144|||
42020453|NCT01201356|75827806|FG000|Overall Study|Lost to Follow-up|50|||
42020454|NCT01201356|75827806|FG000|Overall Study|administrative problems|74|||
42020455|NCT01201356|75827806|FG000|Overall Study|Death|16|||
42020456|NCT01201356|75827806|FG000|Overall Study|Protocol Violation|12|||
42020457|NCT01200810|75827812|FG000|Overall Study|Physician Decision|1|||
42020458|NCT01200810|75827813|FG001|Overall Study|Physician Decision|0|||
42020459|NCT01200810|75827812|FG000|Overall Study|Withdrawal by Subject|1|||
42020460|NCT01200810|75827813|FG001|Overall Study|Withdrawal by Subject|2|||
42020461|NCT01200810|75827812|FG000|Overall Study|Sponsor stopped making study drug|3|||
42020462|NCT01200810|75827813|FG001|Overall Study|Sponsor stopped making study drug|3|||
42020463|NCT01200342|75827819|FG000|Overall Study|Disease Progression|1|||
42020464|NCT01199016|75827823|FG000|Overall Study|No longer meets eligibility criteria|4|||
42020465|NCT01199016|75827823|FG000|Overall Study|Entrance criteria|5|||
42020466|NCT01199016|75827823|FG000|Overall Study|Protocol Violation|9|||
42020467|NCT01199016|75827823|FG000|Overall Study|Other|13|||
42020468|NCT01199016|75827823|FG000|Overall Study|Withdrawal by Subject|21|||
42020469|NCT01199016|75827823|FG000|Overall Study|Lost to Follow-up|25|||
42020470|NCT01198548|75827827|FG000|Overall Study|Disease Progression|9|||
42020471|NCT01198548|75827827|FG000|Overall Study|Administrative Decision|1|||
42020472|NCT01198470|75827831|FG000|Overall Study|Adverse Event|2|||
42020473|NCT00977938|75827839|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
42020474|NCT00977938|75827840|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
42020475|NCT00977938|75827841|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
42020476|NCT00977938|75827842|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
42020477|NCT00977938|75827839|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
42020478|NCT00977938|75827840|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
42020479|NCT00977938|75827841|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
42020480|NCT00977938|75827842|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
42020481|NCT00977938|75827839|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
42020482|NCT00977938|75827840|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
42020483|NCT00977938|75827841|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
42020484|NCT00977938|75827842|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
42020485|NCT00977938|75827839|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
42020486|NCT00977938|75827840|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
42020487|NCT00977938|75827841|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
42020488|NCT00977938|75827842|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
42020489|NCT00977938|75827839|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
42020490|NCT00977938|75827840|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
42020491|NCT00977938|75827841|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
42020492|NCT00977938|75827842|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
42020493|NCT00977938|75827839|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
42020494|NCT00977938|75827840|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
42020495|NCT00977938|75827841|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
42020496|NCT00977938|75827842|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
42111110|NCT03892707|75921490|FG000|Overall Study|Pain resolution|0|||
42020497|NCT02716675|75827857|FG000|Overall Study|Death|2|||
42111111|NCT03892707|75921491|FG001|Overall Study|Pain resolution|4|||
42020498|NCT02716675|75827858|FG001|Overall Study|Death|3|||
42020499|NCT02716675|75827859|FG002|Overall Study|Death|0|||
42020500|NCT02716675|75827857|FG000|Overall Study|Physician Decision|2|||
42020501|NCT02716675|75827858|FG001|Overall Study|Physician Decision|1|||
42020502|NCT02716675|75827859|FG002|Overall Study|Physician Decision|1|||
42020503|NCT02716675|75827857|FG000|Overall Study|Lost to Follow-up|100|||
42020504|NCT02716675|75827858|FG001|Overall Study|Lost to Follow-up|87|||
42020505|NCT02716675|75827859|FG002|Overall Study|Lost to Follow-up|99|||
42020506|NCT02716675|75827857|FG000|Overall Study|Withdrawal by Subject|22|||
42020507|NCT02716675|75827858|FG001|Overall Study|Withdrawal by Subject|25|||
42020508|NCT02716675|75827859|FG002|Overall Study|Withdrawal by Subject|20|||
42020509|NCT02716675|75827857|FG000|Overall Study|Protocol Violation|0|||
42020510|NCT02716675|75827858|FG001|Overall Study|Protocol Violation|3|||
42020511|NCT02716675|75827859|FG002|Overall Study|Protocol Violation|1|||
42020512|NCT02716675|75827857|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
42020513|NCT02716675|75827858|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
42020514|NCT02716675|75827859|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
42020515|NCT02716675|75827857|FG000|Overall Study|Other|38|||
42020516|NCT02716675|75827858|FG001|Overall Study|Other|47|||
42020517|NCT02716675|75827859|FG002|Overall Study|Other|48|||
42020518|NCT00977548|75827872|FG000|Overall Study|Ineligible|4|||
42020519|NCT00977548|75827872|FG000|Overall Study|Adverse Event|8|||
42020520|NCT00977548|75827872|FG000|Overall Study|Withdrawal by Subject|1|||
42020521|NCT01090011|75827876|FG000|Overall Study|Progressive disease|128|||
42020522|NCT01090011|75827876|FG000|Overall Study|Adverse Event|32|||
42020523|NCT01090011|75827876|FG000|Overall Study|Protocol Violation|1|||
42020524|NCT01090011|75827876|FG000|Overall Study|Refusal to start/continue medication|5|||
42020525|NCT01090011|75827876|FG000|Overall Study|Other reason not defined above|5|||
42020526|NCT01251653|75827897|FG000|Overall Study|Progressive Disease|1|||
42020527|NCT01251653|75827898|FG001|Overall Study|Progressive Disease|7|||
42020528|NCT01251653|75827899|FG002|Overall Study|Progressive Disease|16|||
42020529|NCT01251653|75827900|FG003|Overall Study|Progressive Disease|4|||
42020530|NCT01251653|75827901|FG004|Overall Study|Progressive Disease|0|||
42020531|NCT01251653|75827902|FG005|Overall Study|Progressive Disease|17|||
42020532|NCT01251653|75827903|FG006|Overall Study|Progressive Disease|14|||
42020533|NCT01251653|75827904|FG007|Overall Study|Progressive Disease|7|||
42020534|NCT01251653|75827905|FG008|Overall Study|Progressive Disease|5|||
42020535|NCT01251653|75827897|FG000|Overall Study|Dose-limiting toxicity|0|||
42020536|NCT01251653|75827898|FG001|Overall Study|Dose-limiting toxicity|1|||
42020537|NCT01251653|75827899|FG002|Overall Study|Dose-limiting toxicity|1|||
42020538|NCT01251653|75827900|FG003|Overall Study|Dose-limiting toxicity|1|||
42020539|NCT01251653|75827901|FG004|Overall Study|Dose-limiting toxicity|0|||
42020540|NCT01251653|75827902|FG005|Overall Study|Dose-limiting toxicity|0|||
42020541|NCT01251653|75827903|FG006|Overall Study|Dose-limiting toxicity|2|||
42020542|NCT01251653|75827904|FG007|Overall Study|Dose-limiting toxicity|0|||
42020543|NCT01251653|75827905|FG008|Overall Study|Dose-limiting toxicity|0|||
42020544|NCT01251653|75827897|FG000|Overall Study|Adverse Event|1|||
42020545|NCT01251653|75827898|FG001|Overall Study|Adverse Event|0|||
42020546|NCT01251653|75827899|FG002|Overall Study|Adverse Event|2|||
42020547|NCT01251653|75827900|FG003|Overall Study|Adverse Event|1|||
42020548|NCT01251653|75827901|FG004|Overall Study|Adverse Event|1|||
42020549|NCT01251653|75827902|FG005|Overall Study|Adverse Event|0|||
42020550|NCT01251653|75827903|FG006|Overall Study|Adverse Event|2|||
42020551|NCT01251653|75827904|FG007|Overall Study|Adverse Event|2|||
42020552|NCT01251653|75827905|FG008|Overall Study|Adverse Event|1|||
42020553|NCT01251653|75827897|FG000|Overall Study|Withdrawal by Subject|1|||
42020554|NCT01251653|75827898|FG001|Overall Study|Withdrawal by Subject|0|||
42020555|NCT01251653|75827899|FG002|Overall Study|Withdrawal by Subject|1|||
42020556|NCT01251653|75827900|FG003|Overall Study|Withdrawal by Subject|0|||
42020557|NCT01251653|75827901|FG004|Overall Study|Withdrawal by Subject|1|||
42020558|NCT01251653|75827902|FG005|Overall Study|Withdrawal by Subject|1|||
42020559|NCT01251653|75827903|FG006|Overall Study|Withdrawal by Subject|0|||
42020560|NCT01251653|75827904|FG007|Overall Study|Withdrawal by Subject|1|||
42020561|NCT01251653|75827905|FG008|Overall Study|Withdrawal by Subject|0|||
42020562|NCT01251653|75827897|FG000|Overall Study|Other reason not mentioned above|0|||
42020563|NCT01251653|75827898|FG001|Overall Study|Other reason not mentioned above|0|||
42020564|NCT01251653|75827899|FG002|Overall Study|Other reason not mentioned above|0|||
42020565|NCT01251653|75827900|FG003|Overall Study|Other reason not mentioned above|0|||
42020566|NCT01251653|75827901|FG004|Overall Study|Other reason not mentioned above|0|||
42020567|NCT01251653|75827902|FG005|Overall Study|Other reason not mentioned above|0|||
42020568|NCT01251653|75827903|FG006|Overall Study|Other reason not mentioned above|0|||
42020569|NCT01251653|75827904|FG007|Overall Study|Other reason not mentioned above|2|||
42020570|NCT01251653|75827905|FG008|Overall Study|Other reason not mentioned above|0|||
42020571|NCT00910663|75827943|FG000|Period 1|Withdrawal by Subject|0|||
42020572|NCT00910663|75827944|FG001|Period 1|Withdrawal by Subject|1|||
42020573|NCT01077375|75827952|FG000|Overall Study|Adverse Event|2|||
42020574|NCT01077375|75827953|FG001|Overall Study|Adverse Event|15|||
42020575|NCT01077375|75827952|FG000|Overall Study|Lack of Efficacy|6|||
42020576|NCT01077375|75827953|FG001|Overall Study|Lack of Efficacy|8|||
42020577|NCT01077375|75827952|FG000|Overall Study|Withdrawal by Subject|0|||
42020578|NCT01077375|75827953|FG001|Overall Study|Withdrawal by Subject|6|||
42020579|NCT01077375|75827952|FG000|Overall Study|Lost to Follow-up|2|||
42020580|NCT01077375|75827953|FG001|Overall Study|Lost to Follow-up|5|||
42020581|NCT01077375|75827952|FG000|Overall Study|Other Reason|0|||
42020582|NCT01077375|75827953|FG001|Overall Study|Other Reason|1|||
42020583|NCT01250873|75827961|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
42020584|NCT01250873|75827961|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
42020585|NCT01250171|75827970|FG000|Overall Study|Administrative reasons|1|||
42020586|NCT01250171|75827971|FG001|Overall Study|Administrative reasons|0|||
42020587|NCT01250171|75827972|FG002|Overall Study|Administrative reasons|0|||
42020588|NCT01077063|75827982|FG000|Overall Study|Adverse Event|3|||
42020589|NCT01077063|75827983|FG001|Overall Study|Adverse Event|0|||
42020590|NCT01077063|75827982|FG000|Overall Study|Death|1|||
42020591|NCT01077063|75827983|FG001|Overall Study|Death|1|||
42020592|NCT01077063|75827982|FG000|Overall Study|Withdrawal by Subject|0|||
42020593|NCT01077063|75827983|FG001|Overall Study|Withdrawal by Subject|2|||
42020594|NCT01248065|75827991|FG000|Overall Study|Lost to Follow-up|3|||
42020595|NCT01248065|75827992|FG001|Overall Study|Lost to Follow-up|5|||
42020596|NCT01248065|75827991|FG000|Overall Study|Withdrawal by Subject|14|||
42020597|NCT01248065|75827992|FG001|Overall Study|Withdrawal by Subject|11|||
42020598|NCT01248065|75827991|FG000|Overall Study|Adverse Event|3|||
42020599|NCT01248065|75827992|FG001|Overall Study|Adverse Event|0|||
42020600|NCT01248065|75827991|FG000|Overall Study|Third treatment failure event|3|||
42020601|NCT01248065|75827992|FG001|Overall Study|Third treatment failure event|1|||
42020602|NCT01248065|75827991|FG000|Overall Study|Other|3|||
42020603|NCT01248065|75827992|FG001|Overall Study|Other|5|||
42020604|NCT01250756|75828000|FG000|Infant Series|Withdrawal by Subject|4|||
42020605|NCT01250756|75828001|FG001|Infant Series|Withdrawal by Subject|5|||
42020606|NCT01250756|75828000|FG000|Infant Series|Randomized, Not Vaccinated|2|||
42020607|NCT01250756|75828001|FG001|Infant Series|Randomized, Not Vaccinated|2|||
42020608|NCT01250756|75828000|FG000|Infant Series|Other|22|||
42020609|NCT01250756|75828001|FG001|Infant Series|Other|0|||
42020610|NCT01250756|75828000|FG000|After Infant Series|Adverse Event|5|||
42020611|NCT01250756|75828001|FG001|After Infant Series|Adverse Event|2|||
42020612|NCT01250756|75828000|FG000|After Infant Series|Withdrawal by Subject|4|||
42020613|NCT01250756|75828001|FG001|After Infant Series|Withdrawal by Subject|1|||
42020614|NCT01250756|75828000|FG000|After Infant Series|Other|2|||
42020615|NCT01250756|75828001|FG001|After Infant Series|Other|1|||
42020616|NCT01250756|75828000|FG000|Toddler Dose|Adverse Event|0|||
42020617|NCT01250756|75828001|FG001|Toddler Dose|Adverse Event|1|||
42020618|NCT01250756|75828000|FG000|After Toddler Dose|Adverse Event|0|||
42020619|NCT01250756|75828001|FG001|After Toddler Dose|Adverse Event|1|||
42020620|NCT01250054|75828013|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
42020621|NCT01250054|75828014|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
42020622|NCT00977470|75828022|FG000|Overall Study|Lack of Efficacy|32|||
42020623|NCT00977470|75828023|FG001|Overall Study|Lack of Efficacy|30|||
42020624|NCT00977470|75828022|FG000|Overall Study|Physician Decision|2|||
42020625|NCT00977470|75828023|FG001|Overall Study|Physician Decision|0|||
42020626|NCT00977470|75828022|FG000|Overall Study|Adverse Event|1|||
42020627|NCT00977470|75828023|FG001|Overall Study|Adverse Event|2|||
42020628|NCT00977470|75828022|FG000|Overall Study|Protocol Violation|1|||
42020629|NCT00977470|75828023|FG001|Overall Study|Protocol Violation|0|||
42020630|NCT00977470|75828022|FG000|Overall Study|Withdrawal by Subject|0|||
42020631|NCT00977470|75828023|FG001|Overall Study|Withdrawal by Subject|2|||
42020632|NCT00977470|75828022|FG000|Overall Study|Death|0|||
42020633|NCT00977470|75828023|FG001|Overall Study|Death|2|||
42020634|NCT00977470|75828022|FG000|Overall Study|clinical decline|0|||
42020635|NCT00977470|75828023|FG001|Overall Study|clinical decline|1|||
42020636|NCT00977470|75828022|FG000|Overall Study|prolonged recovery post-surgery|0|||
42020637|NCT00977470|75828023|FG001|Overall Study|prolonged recovery post-surgery|1|||
42020638|NCT00977470|75828022|FG000|Overall Study|Still on-study|2|||
42020639|NCT00977470|75828023|FG001|Overall Study|Still on-study|0|||
42020640|NCT01245374|75828029|FG000|Overall Study|Protocol Violation|1|||
42020641|NCT01245374|75828029|FG000|Overall Study|Withdrawal by Subject|3|||
42020642|NCT00977314|75828036|FG000|Overall Study|Withdrawal by Subject|1|||
42020643|NCT00977314|75828037|FG001|Overall Study|Withdrawal by Subject|0|||
42020644|NCT00977314|75828036|FG000|Overall Study|Physician Decision|1|||
42020645|NCT00977314|75828037|FG001|Overall Study|Physician Decision|0|||
42020646|NCT01087203|75828045|FG000|Overall Study|Lost to Follow-up|2|||
42020647|NCT01087203|75828046|FG001|Overall Study|Lost to Follow-up|0|||
42020648|NCT01087203|75828045|FG000|Overall Study|Withdrawal by Subject|2|||
42020649|NCT01087203|75828046|FG001|Overall Study|Withdrawal by Subject|6|||
42020650|NCT01087203|75828045|FG000|Overall Study|Lack of Efficacy|1|||
42020651|NCT01087203|75828046|FG001|Overall Study|Lack of Efficacy|2|||
42020652|NCT01087203|75828045|FG000|Overall Study|Study terminated by sponsor|27|||
42020653|NCT01087203|75828046|FG001|Overall Study|Study terminated by sponsor|27|||
42020654|NCT01246583|75828057|FG000|Overall Study|Lost to Follow-up|0|||
42020655|NCT01246583|75828058|FG001|Overall Study|Lost to Follow-up|0|||
42020656|NCT01246583|75828059|FG002|Overall Study|Lost to Follow-up|0|||
42020657|NCT01246583|75828060|FG003|Overall Study|Lost to Follow-up|1|||
42020658|NCT01246583|75828057|FG000|Overall Study|Protocol Violation|0|||
42020659|NCT01246583|75828058|FG001|Overall Study|Protocol Violation|0|||
42020660|NCT01246583|75828059|FG002|Overall Study|Protocol Violation|1|||
42020661|NCT01246583|75828060|FG003|Overall Study|Protocol Violation|0|||
42020662|NCT01246583|75828057|FG000|Overall Study|Withdrawal by Subject|1|||
42020663|NCT01246583|75828058|FG001|Overall Study|Withdrawal by Subject|0|||
42020664|NCT01246583|75828059|FG002|Overall Study|Withdrawal by Subject|0|||
42020665|NCT01246583|75828060|FG003|Overall Study|Withdrawal by Subject|0|||
42020666|NCT01084239|75828073|FG000|28-Day Follow-up|Lost to Follow-up|4|||
42020667|NCT01084239|75828074|FG001|28-Day Follow-up|Lost to Follow-up|9|||
42020668|NCT01244906|75828082|FG000|Overall Study|Death|2|||
42020669|NCT01244906|75828082|FG000|Overall Study|Progression of disease post treatment|6|||
42020670|NCT01080807|75828088|FG000|Overall Study|Adverse Event|9|||
42020671|NCT01080807|75828089|FG001|Overall Study|Adverse Event|1|||
42020672|NCT01080807|75828088|FG000|Overall Study|Lack of Efficacy|0|||
42020673|NCT01080807|75828089|FG001|Overall Study|Lack of Efficacy|1|||
42020674|NCT01080807|75828088|FG000|Overall Study|Withdrawal by Subject|7|||
42020675|NCT01080807|75828089|FG001|Overall Study|Withdrawal by Subject|2|||
42020676|NCT01080807|75828088|FG000|Overall Study|Protocol Violation|7|||
42020677|NCT01080807|75828089|FG001|Overall Study|Protocol Violation|6|||
42020678|NCT01080807|75828088|FG000|Overall Study|Lost to Follow-up|6|||
42020679|NCT01080807|75828089|FG001|Overall Study|Lost to Follow-up|4|||
42020680|NCT01080807|75828088|FG000|Overall Study|Noncompliance with drug administration|1|||
42020681|NCT01080807|75828089|FG001|Overall Study|Noncompliance with drug administration|1|||
42020682|NCT01080807|75828088|FG000|Overall Study|Noncompliance to study procedures|1|||
42020683|NCT01080807|75828089|FG001|Overall Study|Noncompliance to study procedures|1|||
42020684|NCT01080807|75828088|FG000|Overall Study|Began working day shift|0|||
42020685|NCT01080807|75828089|FG001|Overall Study|Began working day shift|2|||
42020686|NCT01080807|75828088|FG000|Overall Study|Laid off or terminated from job|1|||
42020687|NCT01080807|75828089|FG001|Overall Study|Laid off or terminated from job|2|||
42020688|NCT01080807|75828088|FG000|Overall Study|Stopped working consistent night shifts|0|||
42020689|NCT01080807|75828089|FG001|Overall Study|Stopped working consistent night shifts|1|||
42020690|NCT01080807|75828088|FG000|Overall Study|Work schedule changing|1|||
42020691|NCT01080807|75828089|FG001|Overall Study|Work schedule changing|1|||
42020692|NCT01080807|75828088|FG000|Overall Study|Work schedule and travel|0|||
42020693|NCT01080807|75828089|FG001|Overall Study|Work schedule and travel|1|||
42020694|NCT01080807|75828088|FG000|Overall Study|Switched to first shift|1|||
42020695|NCT01080807|75828089|FG001|Overall Study|Switched to first shift|0|||
42020696|NCT01080807|75828088|FG000|Overall Study|Moved away without notifying center|1|||
42020697|NCT01080807|75828089|FG001|Overall Study|Moved away without notifying center|0|||
42020698|NCT01076361|75828095|FG000|Overall Study|22 leads were excluded from analysis|21|||
42020699|NCT01079949|75828101|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
42020700|NCT01079949|75828102|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
42020701|NCT01079949|75828101|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
42020702|NCT01079949|75828102|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
42020703|NCT01079949|75828101|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
42020704|NCT01079949|75828102|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
42020705|NCT01079949|75828101|FG000|Overall Study|Randomized but not treated|1|||
42020706|NCT01079949|75828102|FG001|Overall Study|Randomized but not treated|0|||
42020707|NCT00909727|75828110|FG000|Overall Study|Adverse Event|1|||
42020708|NCT00909727|75828111|FG001|Overall Study|Adverse Event|0|||
42020709|NCT00909727|75828110|FG000|Overall Study|Wrong Genotype|1|||
42020710|NCT00909727|75828111|FG001|Overall Study|Wrong Genotype|0|||
42020711|NCT00909727|75828110|FG000|Overall Study|Withdrawal of Consent|1|||
42020712|NCT00909727|75828111|FG001|Overall Study|Withdrawal of Consent|0|||
42020713|NCT00909727|75828110|FG000|Overall Study|Prohibited Medication|1|||
42020714|NCT00909727|75828111|FG001|Overall Study|Prohibited Medication|0|||
42020715|NCT00977080|75828121|FG000|Overall Study|Adverse Event|2|||
42020716|NCT00977080|75828122|FG001|Overall Study|Adverse Event|7|||
42020717|NCT00977080|75828123|FG002|Overall Study|Adverse Event|7|||
42020718|NCT00977080|75828124|FG003|Overall Study|Adverse Event|7|||
42020719|NCT00977080|75828121|FG000|Overall Study|Withdrawal by Subject|1|||
42020720|NCT00977080|75828122|FG001|Overall Study|Withdrawal by Subject|5|||
42020721|NCT00977080|75828123|FG002|Overall Study|Withdrawal by Subject|1|||
42020722|NCT00977080|75828124|FG003|Overall Study|Withdrawal by Subject|5|||
42020723|NCT00977080|75828121|FG000|Overall Study|Protocol Violation|7|||
42020724|NCT00977080|75828122|FG001|Overall Study|Protocol Violation|3|||
42020725|NCT00977080|75828123|FG002|Overall Study|Protocol Violation|4|||
42020726|NCT00977080|75828124|FG003|Overall Study|Protocol Violation|3|||
42020727|NCT00977080|75828121|FG000|Overall Study|Noncompliance|0|||
42020728|NCT00977080|75828122|FG001|Overall Study|Noncompliance|2|||
42020729|NCT00977080|75828123|FG002|Overall Study|Noncompliance|1|||
42020730|NCT00977080|75828124|FG003|Overall Study|Noncompliance|0|||
42020731|NCT00977080|75828121|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
42020732|NCT00977080|75828122|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
42020733|NCT00977080|75828123|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
42020734|NCT00977080|75828124|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
42020735|NCT00977080|75828121|FG000|Overall Study|Required kidney transplantation|1|||
42020736|NCT00977080|75828122|FG001|Overall Study|Required kidney transplantation|3|||
42020737|NCT00977080|75828123|FG002|Overall Study|Required kidney transplantation|3|||
42020738|NCT00977080|75828124|FG003|Overall Study|Required kidney transplantation|1|||
42020739|NCT00977080|75828121|FG000|Overall Study|Travel for family reasons|1|||
42020740|NCT00977080|75828122|FG001|Overall Study|Travel for family reasons|0|||
42020741|NCT00977080|75828123|FG002|Overall Study|Travel for family reasons|0|||
42020742|NCT00977080|75828124|FG003|Overall Study|Travel for family reasons|0|||
42111112|NCT03892707|75921490|FG000|Overall Study|Withdrawal by Subject|0|||
42111113|NCT03892707|75921491|FG001|Overall Study|Withdrawal by Subject|1|||
42111114|NCT03892707|75921490|FG000|Overall Study|Other (long business trip)|0|||
42111115|NCT03892707|75921491|FG001|Overall Study|Other (long business trip)|1|||
42111116|NCT00615914|75921498|FG000|Overall Study|Adverse Event|274|||
42111117|NCT00615914|75921498|FG000|Overall Study|Death|20|||
42111118|NCT00615914|75921498|FG000|Overall Study|Lack of Efficacy|59|||
42111119|NCT00615914|75921498|FG000|Overall Study|Lost to Follow-up|187|||
42111120|NCT00615914|75921498|FG000|Overall Study|Withdrawal by Subject|16|||
42111121|NCT00615914|75921498|FG000|Overall Study|Physician Decision|4|||
42111122|NCT00615914|75921498|FG000|Overall Study|No data was collected.|65|||
42111123|NCT00615914|75921498|FG000|Overall Study|No treatment|2|||
42111124|NCT00615914|75921498|FG000|Overall Study|Irregularly enrolled patients|10|||
42111125|NCT00513604|75921508|FG000|Overall Study|Not treated|2|||
42111126|NCT00513604|75921509|FG001|Overall Study|Not treated|0|||
42111127|NCT00513604|75921510|FG002|Overall Study|Not treated|1|||
42111128|NCT00513604|75921511|FG003|Overall Study|Not treated|0|||
42111129|NCT00513604|75921512|FG004|Overall Study|Not treated|0|||
42111130|NCT00513604|75921508|FG000|Overall Study|Death during treatment|0|||
42111131|NCT00513604|75921509|FG001|Overall Study|Death during treatment|3|||
42111132|NCT00513604|75921510|FG002|Overall Study|Death during treatment|2|||
42111133|NCT00513604|75921511|FG003|Overall Study|Death during treatment|0|||
42111134|NCT00513604|75921512|FG004|Overall Study|Death during treatment|0|||
42111135|NCT00534105|75921526|FG000|Overall Study|Lost to Follow-up|23|||
42111136|NCT00534105|75921527|FG001|Overall Study|Lost to Follow-up|39|||
42111137|NCT00573248|75921542|FG000|Overall Study|scheduling conflicts|15|||
42111138|NCT00573248|75921543|FG001|Overall Study|scheduling conflicts|11|||
42111139|NCT00532935|75921551|FG000|Overall Study|Adverse Event|11|||
42111140|NCT00532935|75921552|FG001|Overall Study|Adverse Event|12|||
42111141|NCT00532935|75921551|FG000|Overall Study|Lack of Efficacy|0|||
42111142|NCT00532935|75921552|FG001|Overall Study|Lack of Efficacy|3|||
42111143|NCT00532935|75921551|FG000|Overall Study|Lost to Follow-up|10|||
42111144|NCT00532935|75921552|FG001|Overall Study|Lost to Follow-up|6|||
42111145|NCT00532935|75921551|FG000|Overall Study|Physician Decision|4|||
42111146|NCT00532935|75921552|FG001|Overall Study|Physician Decision|5|||
42111147|NCT00532935|75921551|FG000|Overall Study|Pregnancy|1|||
42111148|NCT00532935|75921552|FG001|Overall Study|Pregnancy|0|||
42111149|NCT00532935|75921551|FG000|Overall Study|Protocol Violation|4|||
42111150|NCT00532935|75921552|FG001|Overall Study|Protocol Violation|2|||
42111151|NCT00532935|75921551|FG000|Overall Study|Withdrawal by Subject|10|||
42111152|NCT00532935|75921552|FG001|Overall Study|Withdrawal by Subject|9|||
42111153|NCT00532935|75921551|FG000|Overall Study|Protocol Specific Criteria|11|||
42111154|NCT00532935|75921552|FG001|Overall Study|Protocol Specific Criteria|15|||
42111155|NCT03016312|75921560|FG000|Overall Study|Death|194|||
42111156|NCT03016312|75921561|FG001|Overall Study|Death|164|||
42111157|NCT03016312|75921560|FG000|Overall Study|Lost to Follow-up|11|||
42111158|NCT03016312|75921561|FG001|Overall Study|Lost to Follow-up|12|||
42111159|NCT03016312|75921560|FG000|Overall Study|Started new therapy, loss of contact|2|||
42111160|NCT03016312|75921561|FG001|Overall Study|Started new therapy, loss of contact|1|||
42111161|NCT03016312|75921560|FG000|Overall Study|Physician Decision|0|||
42111162|NCT03016312|75921561|FG001|Overall Study|Physician Decision|2|||
42111163|NCT03016312|75921560|FG000|Overall Study|Withdrawal by Subject|34|||
42111164|NCT03016312|75921561|FG001|Overall Study|Withdrawal by Subject|39|||
42111165|NCT00512902|75921567|FG000|Overall Study|Adverse Event|7|||
42111166|NCT00512902|75921567|FG000|Overall Study|Lost to Follow-up|1|||
42111167|NCT00492232|75921573|FG000|Placebo Run-in|Adverse Event|0|||
42111168|NCT00492232|75921574|FG001|Placebo Run-in|Adverse Event|2|||
42204722|NCT03529773|76017122|FG031|Overall Study|Randomized but not vaccinated|0|||
42111169|NCT00492232|75921573|FG000|Placebo Run-in|Protocol Violation|0|||
42111170|NCT00492232|75921574|FG001|Placebo Run-in|Protocol Violation|3|||
42111171|NCT00492232|75921573|FG000|Placebo Run-in|Lost to Follow-up|0|||
42111172|NCT00492232|75921574|FG001|Placebo Run-in|Lost to Follow-up|3|||
42111173|NCT00492232|75921573|FG000|Placebo Run-in|Withdrawal by Subject|0|||
42111174|NCT00492232|75921574|FG001|Placebo Run-in|Withdrawal by Subject|8|||
42111175|NCT00492232|75921573|FG000|Placebo Run-in|Pregnancy|0|||
42111176|NCT00492232|75921574|FG001|Placebo Run-in|Pregnancy|1|||
42111177|NCT00492232|75921573|FG000|Placebo Run-in|Entrance criteria not met|0|||
42111178|NCT00492232|75921574|FG001|Placebo Run-in|Entrance criteria not met|45|||
42111179|NCT00492232|75921573|FG000|Placebo Run-in|Other|0|||
42111180|NCT00492232|75921574|FG001|Placebo Run-in|Other|6|||
42111181|NCT00492232|75921573|FG000|Placebo Run-in|Missing|0|||
42111182|NCT00492232|75921574|FG001|Placebo Run-in|Missing|2|||
42111183|NCT00492232|75921573|FG000|Double-Blind Treatment|Adverse Event|1|||
42111184|NCT00492232|75921574|FG001|Double-Blind Treatment|Adverse Event|2|||
42111185|NCT00492232|75921573|FG000|Double-Blind Treatment|Protocol Violation|3|||
42111186|NCT00492232|75921574|FG001|Double-Blind Treatment|Protocol Violation|7|||
42111187|NCT00492232|75921573|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
42111188|NCT00492232|75921574|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
42111189|NCT00492232|75921573|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
42111190|NCT00492232|75921574|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
42111191|NCT00492232|75921573|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
42111192|NCT00492232|75921574|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
42111193|NCT00492232|75921573|FG000|Double-Blind Treatment|Other|6|||
42111194|NCT00492232|75921574|FG001|Double-Blind Treatment|Other|5|||
42111195|NCT00492232|75921573|FG000|Double-Blind Treatment|Randomized not treated|1|||
42111196|NCT00492232|75921574|FG001|Double-Blind Treatment|Randomized not treated|0|||
42111197|NCT00492232|75921573|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
42111198|NCT00492232|75921574|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
42111199|NCT00491764|75921586|FG000|Overall Study|Adverse Event|1|||
42111200|NCT00491764|75921587|FG001|Overall Study|Adverse Event|2|||
42111201|NCT00491764|75921588|FG002|Overall Study|Adverse Event|4|||
42111202|NCT00491764|75921589|FG003|Overall Study|Adverse Event|4|||
42111203|NCT00491764|75921590|FG004|Overall Study|Adverse Event|0|||
42111204|NCT00491764|75921591|FG005|Overall Study|Adverse Event|1|||
42111205|NCT00491764|75921586|FG000|Overall Study|Lost to Follow-up|0|||
42111206|NCT00491764|75921587|FG001|Overall Study|Lost to Follow-up|1|||
42111207|NCT00491764|75921588|FG002|Overall Study|Lost to Follow-up|0|||
42111208|NCT00491764|75921589|FG003|Overall Study|Lost to Follow-up|1|||
42111209|NCT00491764|75921590|FG004|Overall Study|Lost to Follow-up|0|||
42111210|NCT00491764|75921591|FG005|Overall Study|Lost to Follow-up|3|||
42111211|NCT00491764|75921586|FG000|Overall Study|Withdrawal by Subject|2|||
42111212|NCT00491764|75921587|FG001|Overall Study|Withdrawal by Subject|3|||
42111213|NCT00491764|75921588|FG002|Overall Study|Withdrawal by Subject|1|||
42111214|NCT00491764|75921589|FG003|Overall Study|Withdrawal by Subject|2|||
42111215|NCT00491764|75921590|FG004|Overall Study|Withdrawal by Subject|2|||
42111216|NCT00491764|75921591|FG005|Overall Study|Withdrawal by Subject|4|||
42111217|NCT00491764|75921586|FG000|Overall Study|Non Compliance with the Protocol|1|||
42111218|NCT00491764|75921587|FG001|Overall Study|Non Compliance with the Protocol|0|||
42111219|NCT00491764|75921588|FG002|Overall Study|Non Compliance with the Protocol|0|||
42111220|NCT00491764|75921589|FG003|Overall Study|Non Compliance with the Protocol|0|||
42111221|NCT00491764|75921590|FG004|Overall Study|Non Compliance with the Protocol|0|||
42111222|NCT00491764|75921591|FG005|Overall Study|Non Compliance with the Protocol|0|||
42111223|NCT00491764|75921586|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
42111224|NCT00491764|75921587|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
42111225|NCT00491764|75921588|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
42111226|NCT00491764|75921589|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
42111227|NCT00491764|75921590|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
42111228|NCT00491764|75921591|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
42111229|NCT00491764|75921586|FG000|Overall Study|Administrative|1|||
42111230|NCT00491764|75921587|FG001|Overall Study|Administrative|0|||
42111231|NCT00491764|75921588|FG002|Overall Study|Administrative|2|||
42111232|NCT00491764|75921589|FG003|Overall Study|Administrative|1|||
42111233|NCT00491764|75921590|FG004|Overall Study|Administrative|0|||
42111234|NCT00491764|75921591|FG005|Overall Study|Administrative|0|||
42111235|NCT00491608|75921605|FG000|Overall Study|Death|2|||
42111236|NCT00491608|75921605|FG000|Overall Study|Withdrawal by Subject|1|||
42111237|NCT00615836|75921613|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
42111238|NCT00615836|75921614|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
42111239|NCT00615836|75921615|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
42111240|NCT00615836|75921616|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
42111241|NCT00615836|75921617|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
42111242|NCT00615836|75921613|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
42111243|NCT00615836|75921614|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
42111244|NCT00615836|75921615|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
42111245|NCT00615836|75921616|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
42204723|NCT03529773|76017123|FG032|Overall Study|Randomized but not vaccinated|0|||
42111246|NCT00615836|75921617|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
42111247|NCT00615836|75921613|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
42111248|NCT00615836|75921614|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
42111249|NCT00615836|75921615|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
42111250|NCT00615836|75921616|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
42204724|NCT03529773|76017124|FG033|Overall Study|Randomized but not vaccinated|0|||
42111251|NCT00615836|75921617|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
42111252|NCT00615836|75921613|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
42111253|NCT00615836|75921614|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
42111254|NCT00615836|75921615|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
42111255|NCT00615836|75921616|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
42111256|NCT00615836|75921617|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
42111257|NCT00615836|75921613|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
42111258|NCT00615836|75921614|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
42111259|NCT00615836|75921615|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
42111260|NCT00615836|75921616|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
42111261|NCT00615836|75921617|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
42111262|NCT00615836|75921613|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
42111263|NCT00615836|75921614|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
42111264|NCT00615836|75921615|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
42111265|NCT00615836|75921616|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
42111266|NCT00615836|75921617|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
42111267|NCT00615836|75921613|FG000|Extension Study (FE992026 CS31)|Other|10|||
42111268|NCT00615836|75921614|FG001|Extension Study (FE992026 CS31)|Other|7|||
42111269|NCT00615836|75921615|FG002|Extension Study (FE992026 CS31)|Other|8|||
42111270|NCT00615836|75921616|FG003|Extension Study (FE992026 CS31)|Other|8|||
42111271|NCT00615836|75921617|FG004|Extension Study (FE992026 CS31)|Other|0|||
42111272|NCT00615836|75921613|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
42111273|NCT00615836|75921614|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
42111274|NCT00615836|75921615|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
42111275|NCT00615836|75921616|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
42111276|NCT00615836|75921617|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
42111277|NCT00615836|75921613|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
42111278|NCT00615836|75921614|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
42111279|NCT00615836|75921615|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
42111280|NCT00615836|75921616|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
42111281|NCT00615836|75921617|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
42111282|NCT00491530|75921636|FG000|Overall Study|Adverse Event|6|||
42111283|NCT00491530|75921637|FG001|Overall Study|Adverse Event|1|||
42111284|NCT00491530|75921638|FG002|Overall Study|Adverse Event|2|||
42111285|NCT00491530|75921636|FG000|Overall Study|Withdrawal by Subject|3|||
42111286|NCT00491530|75921637|FG001|Overall Study|Withdrawal by Subject|0|||
42111287|NCT00491530|75921638|FG002|Overall Study|Withdrawal by Subject|0|||
42111288|NCT00491530|75921636|FG000|Overall Study|Lost to Follow-up|3|||
42111289|NCT00491530|75921637|FG001|Overall Study|Lost to Follow-up|2|||
42111290|NCT00491530|75921638|FG002|Overall Study|Lost to Follow-up|2|||
42111291|NCT00491530|75921636|FG000|Overall Study|Lack of Efficacy|0|||
42111292|NCT00491530|75921637|FG001|Overall Study|Lack of Efficacy|1|||
42111293|NCT00491530|75921638|FG002|Overall Study|Lack of Efficacy|0|||
42111294|NCT00491530|75921636|FG000|Overall Study|Investigator Discretion|0|||
42111295|NCT00491530|75921637|FG001|Overall Study|Investigator Discretion|1|||
42111296|NCT00491530|75921638|FG002|Overall Study|Investigator Discretion|0|||
42111297|NCT00491530|75921636|FG000|Overall Study|Patient Request|0|||
42111298|NCT00491530|75921637|FG001|Overall Study|Patient Request|1|||
42111299|NCT00491530|75921638|FG002|Overall Study|Patient Request|0|||
42111300|NCT00491530|75921636|FG000|Overall Study|Use of Prohibited Medication|0|||
42111301|NCT00491530|75921637|FG001|Overall Study|Use of Prohibited Medication|0|||
42111302|NCT00491530|75921638|FG002|Overall Study|Use of Prohibited Medication|1|||
42111303|NCT00617240|75921648|FG000|Overall Study|Lack of Efficacy|1|||
42111304|NCT00617240|75921649|FG001|Overall Study|Lack of Efficacy|0|||
42111305|NCT00615290|75921655|FG000|Overall Study|Adverse Event|2|||
42111306|NCT00615290|75921655|FG000|Overall Study|Lost to Follow-up|3|||
42111307|NCT00615290|75921655|FG000|Overall Study|Withdrawal by Subject|1|||
42111308|NCT00615290|75921655|FG000|Overall Study|Other|2|||
42111309|NCT00501046|75921661|FG000|Overall Study|Adverse Event|21|||
42111310|NCT00501046|75921662|FG001|Overall Study|Adverse Event|25|||
42111311|NCT00501046|75921661|FG000|Overall Study|Death|23|||
42111312|NCT00501046|75921662|FG001|Overall Study|Death|30|||
42111313|NCT00501046|75921661|FG000|Overall Study|Lost to Follow-up|14|||
42111314|NCT00501046|75921662|FG001|Overall Study|Lost to Follow-up|13|||
42111315|NCT00501046|75921661|FG000|Overall Study|Physician Decision|7|||
42111316|NCT00501046|75921662|FG001|Overall Study|Physician Decision|2|||
42111317|NCT00501046|75921661|FG000|Overall Study|Pregnancy|0|||
42111318|NCT00501046|75921662|FG001|Overall Study|Pregnancy|3|||
42111319|NCT00501046|75921661|FG000|Overall Study|Protocol Violation|2|||
42111320|NCT00501046|75921662|FG001|Overall Study|Protocol Violation|1|||
42111321|NCT00501046|75921661|FG000|Overall Study|Withdrawal by Subject|84|||
42111322|NCT00501046|75921662|FG001|Overall Study|Withdrawal by Subject|83|||
42111323|NCT00501046|75921661|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
42111324|NCT00501046|75921662|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
42111325|NCT00533949|75921672|FG000|Overall Study|Protocol Violation|12|||
42111326|NCT00533949|75921673|FG001|Overall Study|Protocol Violation|12|||
42111327|NCT00533949|75921674|FG002|Overall Study|Protocol Violation|9|||
42111328|NCT00533949|75921675|FG003|Overall Study|Protocol Violation|9|||
42111329|NCT00533949|75921672|FG000|Overall Study|Withdrawal by Subject|3|||
42111330|NCT00533949|75921673|FG001|Overall Study|Withdrawal by Subject|2|||
42111331|NCT00533949|75921674|FG002|Overall Study|Withdrawal by Subject|1|||
42111332|NCT00533949|75921675|FG003|Overall Study|Withdrawal by Subject|1|||
42111333|NCT00485134|75921701|FG000|Overall Study|Lost to Follow-up|1|||
42111334|NCT00485134|75921702|FG001|Overall Study|Lost to Follow-up|0|||
42111335|NCT00485134|75921703|FG002|Overall Study|Lost to Follow-up|0|||
42111336|NCT00485134|75921704|FG003|Overall Study|Lost to Follow-up|0|||
42111337|NCT00485134|75921705|FG004|Overall Study|Lost to Follow-up|0|||
42111338|NCT00485134|75921706|FG005|Overall Study|Lost to Follow-up|0|||
42111339|NCT00485134|75921707|FG006|Overall Study|Lost to Follow-up|0|||
42111340|NCT00485134|75921708|FG007|Overall Study|Lost to Follow-up|0|||
42111341|NCT00485134|75921701|FG000|Overall Study|Withdrawal by Subject|0|||
42111342|NCT00485134|75921702|FG001|Overall Study|Withdrawal by Subject|1|||
42111343|NCT00485134|75921703|FG002|Overall Study|Withdrawal by Subject|0|||
42111344|NCT00485134|75921704|FG003|Overall Study|Withdrawal by Subject|0|||
42111345|NCT00485134|75921705|FG004|Overall Study|Withdrawal by Subject|0|||
42111346|NCT00485134|75921706|FG005|Overall Study|Withdrawal by Subject|0|||
42111347|NCT00485134|75921707|FG006|Overall Study|Withdrawal by Subject|0|||
42111348|NCT00485134|75921708|FG007|Overall Study|Withdrawal by Subject|0|||
42111349|NCT00485134|75921701|FG000|Overall Study|Change in health status|0|||
42111350|NCT00485134|75921702|FG001|Overall Study|Change in health status|1|||
42111351|NCT00485134|75921703|FG002|Overall Study|Change in health status|2|||
42111352|NCT00485134|75921704|FG003|Overall Study|Change in health status|1|||
42111353|NCT00485134|75921705|FG004|Overall Study|Change in health status|0|||
42111354|NCT00485134|75921706|FG005|Overall Study|Change in health status|1|||
42111355|NCT00485134|75921707|FG006|Overall Study|Change in health status|0|||
42111356|NCT00485134|75921708|FG007|Overall Study|Change in health status|0|||
42111357|NCT00485134|75921701|FG000|Overall Study|Withdrew for adverse event|0|||
42111358|NCT00485134|75921702|FG001|Overall Study|Withdrew for adverse event|0|||
42111359|NCT00485134|75921703|FG002|Overall Study|Withdrew for adverse event|1|||
42111360|NCT00485134|75921704|FG003|Overall Study|Withdrew for adverse event|0|||
42111361|NCT00485134|75921705|FG004|Overall Study|Withdrew for adverse event|0|||
42111362|NCT00485134|75921706|FG005|Overall Study|Withdrew for adverse event|0|||
42111363|NCT00485134|75921707|FG006|Overall Study|Withdrew for adverse event|0|||
42111364|NCT00485134|75921708|FG007|Overall Study|Withdrew for adverse event|0|||
42111365|NCT00485134|75921701|FG000|Overall Study|Positive drug test|0|||
42111366|NCT00485134|75921702|FG001|Overall Study|Positive drug test|0|||
42111367|NCT00485134|75921703|FG002|Overall Study|Positive drug test|0|||
42111368|NCT00485134|75921704|FG003|Overall Study|Positive drug test|0|||
42111369|NCT00485134|75921705|FG004|Overall Study|Positive drug test|2|||
42111370|NCT00485134|75921706|FG005|Overall Study|Positive drug test|1|||
42111371|NCT00485134|75921707|FG006|Overall Study|Positive drug test|0|||
42111372|NCT00485134|75921708|FG007|Overall Study|Positive drug test|0|||
42111373|NCT00485134|75921701|FG000|Overall Study|Non-compliance|0|||
42111374|NCT00485134|75921702|FG001|Overall Study|Non-compliance|0|||
42111375|NCT00485134|75921703|FG002|Overall Study|Non-compliance|0|||
42111376|NCT00485134|75921704|FG003|Overall Study|Non-compliance|0|||
42111377|NCT00485134|75921705|FG004|Overall Study|Non-compliance|1|||
42111378|NCT00485134|75921706|FG005|Overall Study|Non-compliance|2|||
42111379|NCT00485134|75921707|FG006|Overall Study|Non-compliance|2|||
42111380|NCT00485134|75921708|FG007|Overall Study|Non-compliance|0|||
42111381|NCT00485134|75921701|FG000|Overall Study|Unable to comply with study schedule|0|||
42111382|NCT00485134|75921702|FG001|Overall Study|Unable to comply with study schedule|0|||
42111383|NCT00485134|75921703|FG002|Overall Study|Unable to comply with study schedule|0|||
42111384|NCT00485134|75921704|FG003|Overall Study|Unable to comply with study schedule|0|||
42111385|NCT00485134|75921705|FG004|Overall Study|Unable to comply with study schedule|0|||
42111386|NCT00485134|75921706|FG005|Overall Study|Unable to comply with study schedule|0|||
42111387|NCT00485134|75921707|FG006|Overall Study|Unable to comply with study schedule|0|||
42111388|NCT00485134|75921708|FG007|Overall Study|Unable to comply with study schedule|1|||
42111389|NCT00485134|75921701|FG000|Overall Study|Pregnancy|0|||
42111390|NCT00485134|75921702|FG001|Overall Study|Pregnancy|0|||
42111391|NCT00485134|75921703|FG002|Overall Study|Pregnancy|0|||
42111392|NCT00485134|75921704|FG003|Overall Study|Pregnancy|0|||
42111393|NCT00485134|75921705|FG004|Overall Study|Pregnancy|0|||
42111394|NCT00485134|75921706|FG005|Overall Study|Pregnancy|0|||
42111395|NCT00485134|75921707|FG006|Overall Study|Pregnancy|1|||
42204725|NCT03529773|76017125|FG034|Overall Study|Randomized but not vaccinated|0|||
42111396|NCT00485134|75921708|FG007|Overall Study|Pregnancy|0|||
42111397|NCT00583115|75921720|FG000|Overall Study|Death|1|||
42111398|NCT00532779|75921727|FG000|Overall Study|Adverse Event|122|||
42111399|NCT00532779|75921728|FG001|Overall Study|Adverse Event|112|||
42389020|NCT02620020|76272704|FG002|Overall Study|Protocol Violation|1|||
42111400|NCT00532779|75921729|FG002|Overall Study|Adverse Event|56|||
42111401|NCT00532779|75921727|FG000|Overall Study|Lost to Follow-up|76|||
42111402|NCT00532779|75921728|FG001|Overall Study|Lost to Follow-up|65|||
42111403|NCT00532779|75921729|FG002|Overall Study|Lost to Follow-up|66|||
42111404|NCT00532779|75921727|FG000|Overall Study|Withdrawal by Subject|63|||
42111405|NCT00532779|75921728|FG001|Overall Study|Withdrawal by Subject|60|||
42111406|NCT00532779|75921729|FG002|Overall Study|Withdrawal by Subject|90|||
42111407|NCT00532779|75921727|FG000|Overall Study|Lack of Efficacy|12|||
42111408|NCT00532779|75921728|FG001|Overall Study|Lack of Efficacy|12|||
42111409|NCT00532779|75921729|FG002|Overall Study|Lack of Efficacy|40|||
42111410|NCT00532779|75921727|FG000|Overall Study|Protocol Violation|5|||
42111411|NCT00532779|75921728|FG001|Overall Study|Protocol Violation|9|||
42111412|NCT00532779|75921729|FG002|Overall Study|Protocol Violation|7|||
42111413|NCT00532779|75921727|FG000|Overall Study|Pregnancy|2|||
42111414|NCT00532779|75921728|FG001|Overall Study|Pregnancy|5|||
42111415|NCT00532779|75921729|FG002|Overall Study|Pregnancy|3|||
42111416|NCT00532779|75921727|FG000|Overall Study|Death|0|||
42111417|NCT00532779|75921728|FG001|Overall Study|Death|1|||
42111418|NCT00532779|75921729|FG002|Overall Study|Death|0|||
42111419|NCT00532779|75921727|FG000|Overall Study|Drug noncompliance, moved, other|14|||
42111420|NCT00532779|75921728|FG001|Overall Study|Drug noncompliance, moved, other|23|||
42111421|NCT00532779|75921729|FG002|Overall Study|Drug noncompliance, moved, other|29|||
42111422|NCT00500266|75921737|FG000|Overall Study|Death|3|||
42111423|NCT00500266|75921737|FG000|Overall Study|Lost to Follow-up|3|||
42111424|NCT00500266|75921737|FG000|Overall Study|Withdrawal by Subject|3|||
42111425|NCT00500266|75921737|FG000|Overall Study|Assigned, not treated|4|||
42111426|NCT00500110|75921742|FG000|Overall Study|Withdrawal by Subject|3|||
42111427|NCT00534495|75921748|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
42111428|NCT00534495|75921749|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
42111429|NCT00534495|75921750|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
42111430|NCT00534495|75921748|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
42111431|NCT00534495|75921749|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
42111432|NCT00534495|75921750|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
42111433|NCT00534495|75921748|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
42111434|NCT00534495|75921749|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
42111435|NCT00534495|75921750|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
42111436|NCT00534495|75921748|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
42111437|NCT00534495|75921749|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
42111438|NCT00534495|75921750|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
42111439|NCT00534495|75921748|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
42111440|NCT00534495|75921749|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
42111441|NCT00534495|75921750|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
42111442|NCT00534495|75921748|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
42111443|NCT00534495|75921749|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
42111444|NCT00534495|75921750|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
42111445|NCT00534495|75921748|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
42111446|NCT00534495|75921749|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
42111447|NCT00534495|75921750|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
42111448|NCT00534495|75921748|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
42111449|NCT00534495|75921749|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
42111450|NCT00534495|75921750|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
42111451|NCT00534495|75921748|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
42111452|NCT00534495|75921749|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
42111453|NCT00534495|75921750|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
42111454|NCT00484198|75921774|FG000|Overall Study|Participant Withdrew Consent|12|||
42111455|NCT00484198|75921775|FG001|Overall Study|Participant Withdrew Consent|21|||
42111456|NCT00484198|75921776|FG002|Overall Study|Participant Withdrew Consent|47|||
42111457|NCT00484198|75921777|FG003|Overall Study|Participant Withdrew Consent|59|||
42111458|NCT00484198|75921774|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
42111459|NCT00484198|75921775|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
42111460|NCT00484198|75921776|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
42111461|NCT00484198|75921777|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
42111462|NCT00484198|75921774|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
42111463|NCT00484198|75921775|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
42111464|NCT00484198|75921776|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
42111465|NCT00484198|75921777|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
42111466|NCT00484198|75921774|FG000|Overall Study|Adverse Event|3|||
42111467|NCT00484198|75921775|FG001|Overall Study|Adverse Event|11|||
42111468|NCT00484198|75921776|FG002|Overall Study|Adverse Event|32|||
42111469|NCT00484198|75921777|FG003|Overall Study|Adverse Event|31|||
42111470|NCT00484198|75921774|FG000|Overall Study|Protocol Violation|0|||
42111471|NCT00484198|75921775|FG001|Overall Study|Protocol Violation|5|||
42111472|NCT00484198|75921776|FG002|Overall Study|Protocol Violation|6|||
42111473|NCT00484198|75921777|FG003|Overall Study|Protocol Violation|8|||
42111474|NCT00484198|75921774|FG000|Overall Study|Other|7|||
42111475|NCT00484198|75921775|FG001|Overall Study|Other|10|||
42111476|NCT00484198|75921776|FG002|Overall Study|Other|31|||
42111477|NCT00484198|75921777|FG003|Overall Study|Other|28|||
42111478|NCT00499486|75921792|FG000|Overall Study|Withdrawal by Subject|16|||
42111479|NCT00499252|75921796|FG000|Overall Study|Adverse Event|3|||
42111480|NCT00499252|75921796|FG000|Overall Study|Refused further treatment|2|||
42111481|NCT00499252|75921796|FG000|Overall Study|Ineligible|4|||
42111482|NCT00499252|75921796|FG000|Overall Study|<no further label>|3|||
42111483|NCT00499174|75921806|FG000|Overall Study|Physician Decision|78|||
42111484|NCT00499174|75921807|FG001|Overall Study|Physician Decision|9|||
42111485|NCT03775421|75921815|FG000|Overall Study|Lost to Follow-up|2|||
42111486|NCT03775421|75921815|FG000|Overall Study|Withdrawal by Subject|10|||
42111487|NCT03775421|75921815|FG000|Overall Study|Physician Decision|3|||
42111488|NCT03775421|75921815|FG000|Overall Study|Death|1|||
42111489|NCT03775421|75921815|FG000|Overall Study|Study Terminated by Sponsor|94|||
42111490|NCT00532155|75921821|FG000|Overall Study|Adverse Event|66|||
42111491|NCT00532155|75921822|FG001|Overall Study|Adverse Event|123|||
42111492|NCT00532155|75921821|FG000|Overall Study|Lack of Efficacy|332|||
42111493|NCT00532155|75921822|FG001|Overall Study|Lack of Efficacy|255|||
42111494|NCT00532155|75921821|FG000|Overall Study|Protocol Violation|1|||
42111495|NCT00532155|75921822|FG001|Overall Study|Protocol Violation|3|||
42111496|NCT00532155|75921821|FG000|Overall Study|Lost to Follow-up|2|||
42111497|NCT00532155|75921822|FG001|Overall Study|Lost to Follow-up|0|||
42111498|NCT00532155|75921821|FG000|Overall Study|Physician Decision|16|||
42111499|NCT00532155|75921822|FG001|Overall Study|Physician Decision|15|||
42111500|NCT00532155|75921821|FG000|Overall Study|Withdrawal by Subject|23|||
42111501|NCT00532155|75921822|FG001|Overall Study|Withdrawal by Subject|44|||
42111502|NCT00532155|75921821|FG000|Overall Study|Consent withdrawn|5|||
42111503|NCT00532155|75921822|FG001|Overall Study|Consent withdrawn|7|||
42111504|NCT00532155|75921821|FG000|Overall Study|Moved|1|||
42111505|NCT00532155|75921822|FG001|Overall Study|Moved|0|||
42111506|NCT00532155|75921821|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
42111507|NCT00532155|75921822|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
42111508|NCT00532155|75921821|FG000|Overall Study|Occurence of a second cancer|0|||
42111509|NCT00532155|75921822|FG001|Overall Study|Occurence of a second cancer|1|||
42111510|NCT00532155|75921821|FG000|Overall Study|Occurence of a secondary cancer|0|||
42111511|NCT00532155|75921822|FG001|Overall Study|Occurence of a secondary cancer|1|||
42111512|NCT00532155|75921821|FG000|Overall Study|Promotor ended study|1|||
42111513|NCT00532155|75921822|FG001|Overall Study|Promotor ended study|0|||
42111514|NCT00532155|75921821|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
42111515|NCT00532155|75921822|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
42111516|NCT00532155|75921821|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
42111517|NCT00532155|75921822|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
42111518|NCT00532155|75921821|FG000|Overall Study|Study stopped|1|||
42111519|NCT00532155|75921822|FG001|Overall Study|Study stopped|0|||
42111520|NCT00532155|75921821|FG000|Overall Study|Study terminated by sponsor|1|||
42111521|NCT00532155|75921822|FG001|Overall Study|Study terminated by sponsor|0|||
42111522|NCT00532155|75921821|FG000|Overall Study|Study termination stop further treatment|4|||
42111523|NCT00532155|75921822|FG001|Overall Study|Study termination stop further treatment|0|||
42111524|NCT00532155|75921821|FG000|Overall Study|Did not receive study medication|2|||
42111525|NCT00532155|75921822|FG001|Overall Study|Did not receive study medication|6|||
42111526|NCT00205777|75921832|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
42111527|NCT00205777|75921833|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
42111528|NCT00205777|75921834|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
42111529|NCT00205777|75921835|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
42111530|NCT00205777|75921836|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
42111531|NCT00205777|75921837|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
42111532|NCT00205777|75921832|FG000|Core Study (Up to 3 Years)|Death|9|||
42111533|NCT00205777|75921833|FG001|Core Study (Up to 3 Years)|Death|7|||
42111534|NCT00205777|75921834|FG002|Core Study (Up to 3 Years)|Death|14|||
42111535|NCT00205777|75921835|FG003|Core Study (Up to 3 Years)|Death|7|||
42111536|NCT00205777|75921836|FG004|Core Study (Up to 3 Years)|Death|0|||
42111537|NCT00205777|75921837|FG005|Core Study (Up to 3 Years)|Death|0|||
42111538|NCT00205777|75921832|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
42111539|NCT00205777|75921833|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
42111540|NCT00205777|75921834|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
42111541|NCT00205777|75921835|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
42111542|NCT00205777|75921836|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
42111543|NCT00205777|75921837|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
42111544|NCT00205777|75921832|FG000|Core Study (Up to 3 Years)|Other Event|49|||
42111545|NCT00205777|75921833|FG001|Core Study (Up to 3 Years)|Other Event|52|||
42111546|NCT00205777|75921834|FG002|Core Study (Up to 3 Years)|Other Event|41|||
42111547|NCT00205777|75921835|FG003|Core Study (Up to 3 Years)|Other Event|58|||
42111548|NCT00205777|75921836|FG004|Core Study (Up to 3 Years)|Other Event|0|||
42111549|NCT00205777|75921837|FG005|Core Study (Up to 3 Years)|Other Event|0|||
42111550|NCT00205777|75921832|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
42111551|NCT00205777|75921833|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
42111552|NCT00205777|75921834|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
42111553|NCT00205777|75921835|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
42111554|NCT00205777|75921836|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
42111555|NCT00205777|75921837|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
42111556|NCT00205777|75921832|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
42111557|NCT00205777|75921833|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
42111558|NCT00205777|75921834|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
42111559|NCT00205777|75921835|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
42111560|NCT00205777|75921836|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
42111561|NCT00205777|75921837|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
42111562|NCT00205777|75921832|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
42111563|NCT00205777|75921833|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
42111564|NCT00205777|75921834|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
42111565|NCT00205777|75921835|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
42111566|NCT00205777|75921836|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
42111567|NCT00205777|75921837|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
42111568|NCT00205777|75921832|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
42111569|NCT00205777|75921833|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
42111570|NCT00205777|75921834|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
42111571|NCT00205777|75921835|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
42111572|NCT00205777|75921836|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
42111573|NCT00205777|75921837|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
42111574|NCT00205777|75921832|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
42111575|NCT00205777|75921833|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
42111576|NCT00205777|75921834|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
42111577|NCT00205777|75921835|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
42111578|NCT00205777|75921836|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
42111579|NCT00205777|75921837|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
42111580|NCT00205777|75921832|FG000|Completed Core Study, Entered SE I|Other Event|52|||
42111581|NCT00205777|75921833|FG001|Completed Core Study, Entered SE I|Other Event|46|||
42111582|NCT00205777|75921834|FG002|Completed Core Study, Entered SE I|Other Event|47|||
42111583|NCT00205777|75921835|FG003|Completed Core Study, Entered SE I|Other Event|50|||
42111584|NCT00205777|75921836|FG004|Completed Core Study, Entered SE I|Other Event|0|||
42111585|NCT00205777|75921837|FG005|Completed Core Study, Entered SE I|Other Event|0|||
42111586|NCT00205777|75921832|FG000|Study Extension I|Adverse Event|57|||
42111587|NCT00205777|75921833|FG001|Study Extension I|Adverse Event|0|||
42111588|NCT00205777|75921834|FG002|Study Extension I|Adverse Event|0|||
42111589|NCT00205777|75921835|FG003|Study Extension I|Adverse Event|61|||
42111590|NCT00205777|75921836|FG004|Study Extension I|Adverse Event|58|||
42111591|NCT00205777|75921837|FG005|Study Extension I|Adverse Event|0|||
42111592|NCT00205777|75921832|FG000|Study Extension I|Death|5|||
42111593|NCT00205777|75921833|FG001|Study Extension I|Death|0|||
42111594|NCT00205777|75921834|FG002|Study Extension I|Death|0|||
42111595|NCT00205777|75921835|FG003|Study Extension I|Death|1|||
42111596|NCT00205777|75921836|FG004|Study Extension I|Death|2|||
42111597|NCT00205777|75921837|FG005|Study Extension I|Death|0|||
42111598|NCT00205777|75921832|FG000|Study Extension I|Withdrawal by Subject|99|||
42111599|NCT00205777|75921833|FG001|Study Extension I|Withdrawal by Subject|0|||
42111600|NCT00205777|75921834|FG002|Study Extension I|Withdrawal by Subject|0|||
42111601|NCT00205777|75921835|FG003|Study Extension I|Withdrawal by Subject|106|||
42111602|NCT00205777|75921836|FG004|Study Extension I|Withdrawal by Subject|89|||
42111603|NCT00205777|75921837|FG005|Study Extension I|Withdrawal by Subject|0|||
42111604|NCT00205777|75921832|FG000|Study Extension I|Protocol Violation|4|||
42111605|NCT00205777|75921833|FG001|Study Extension I|Protocol Violation|0|||
42111606|NCT00205777|75921834|FG002|Study Extension I|Protocol Violation|0|||
42111607|NCT00205777|75921835|FG003|Study Extension I|Protocol Violation|8|||
42111608|NCT00205777|75921836|FG004|Study Extension I|Protocol Violation|8|||
42111609|NCT00205777|75921837|FG005|Study Extension I|Protocol Violation|0|||
42111610|NCT00205777|75921832|FG000|Study Extension I|Lack of Efficacy|0|||
42111611|NCT00205777|75921833|FG001|Study Extension I|Lack of Efficacy|0|||
42111612|NCT00205777|75921834|FG002|Study Extension I|Lack of Efficacy|0|||
42111613|NCT00205777|75921835|FG003|Study Extension I|Lack of Efficacy|1|||
42111614|NCT00205777|75921836|FG004|Study Extension I|Lack of Efficacy|2|||
42111615|NCT00205777|75921837|FG005|Study Extension I|Lack of Efficacy|0|||
42111616|NCT00205777|75921832|FG000|Study Extension I|Failed to return|15|||
42111617|NCT00205777|75921833|FG001|Study Extension I|Failed to return|0|||
42111618|NCT00205777|75921834|FG002|Study Extension I|Failed to return|0|||
42111619|NCT00205777|75921835|FG003|Study Extension I|Failed to return|17|||
42111620|NCT00205777|75921836|FG004|Study Extension I|Failed to return|13|||
42111621|NCT00205777|75921837|FG005|Study Extension I|Failed to return|0|||
42111622|NCT00205777|75921832|FG000|Study Extension I|Other Event|34|||
42111623|NCT00205777|75921833|FG001|Study Extension I|Other Event|0|||
42111624|NCT00205777|75921834|FG002|Study Extension I|Other Event|0|||
42111625|NCT00205777|75921835|FG003|Study Extension I|Other Event|34|||
42111626|NCT00205777|75921836|FG004|Study Extension I|Other Event|29|||
42111627|NCT00205777|75921837|FG005|Study Extension I|Other Event|0|||
42111628|NCT00205777|75921832|FG000|Study Extension I|Withdrawn as per protocol|0|||
42111629|NCT00205777|75921833|FG001|Study Extension I|Withdrawn as per protocol|0|||
42111630|NCT00205777|75921834|FG002|Study Extension I|Withdrawn as per protocol|1070|||
42111631|NCT00205777|75921835|FG003|Study Extension I|Withdrawn as per protocol|0|||
42111632|NCT00205777|75921836|FG004|Study Extension I|Withdrawn as per protocol|0|||
42111633|NCT00205777|75921837|FG005|Study Extension I|Withdrawn as per protocol|0|||
42111634|NCT00205777|75921832|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
42111635|NCT00205777|75921833|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
42111636|NCT00205777|75921834|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
42111637|NCT00205777|75921835|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
42111638|NCT00205777|75921836|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
42111639|NCT00205777|75921837|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
42111640|NCT00205777|75921832|FG000|Study Extension II|Adverse Event|0|||
42111641|NCT00205777|75921833|FG001|Study Extension II|Adverse Event|0|||
42111642|NCT00205777|75921834|FG002|Study Extension II|Adverse Event|0|||
42111643|NCT00205777|75921835|FG003|Study Extension II|Adverse Event|14|||
42111644|NCT00205777|75921836|FG004|Study Extension II|Adverse Event|0|||
42111645|NCT00205777|75921837|FG005|Study Extension II|Adverse Event|30|||
42111646|NCT00205777|75921832|FG000|Study Extension II|Death|0|||
42111647|NCT00205777|75921833|FG001|Study Extension II|Death|0|||
42111648|NCT00205777|75921834|FG002|Study Extension II|Death|0|||
42111649|NCT00205777|75921835|FG003|Study Extension II|Death|2|||
42111650|NCT00205777|75921836|FG004|Study Extension II|Death|0|||
42111651|NCT00205777|75921837|FG005|Study Extension II|Death|5|||
42111652|NCT00205777|75921832|FG000|Study Extension II|Withdrawal by Subject|0|||
42111653|NCT00205777|75921833|FG001|Study Extension II|Withdrawal by Subject|0|||
42111654|NCT00205777|75921834|FG002|Study Extension II|Withdrawal by Subject|0|||
42111655|NCT00205777|75921835|FG003|Study Extension II|Withdrawal by Subject|35|||
42111656|NCT00205777|75921836|FG004|Study Extension II|Withdrawal by Subject|0|||
42111657|NCT00205777|75921837|FG005|Study Extension II|Withdrawal by Subject|59|||
42111658|NCT00205777|75921832|FG000|Study Extension II|Protocol Violation|0|||
42111659|NCT00205777|75921833|FG001|Study Extension II|Protocol Violation|0|||
42111660|NCT00205777|75921834|FG002|Study Extension II|Protocol Violation|0|||
42111661|NCT00205777|75921835|FG003|Study Extension II|Protocol Violation|1|||
42111662|NCT00205777|75921836|FG004|Study Extension II|Protocol Violation|0|||
42111663|NCT00205777|75921837|FG005|Study Extension II|Protocol Violation|10|||
42111664|NCT00205777|75921832|FG000|Study Extension II|Lack of Efficacy|0|||
42111665|NCT00205777|75921833|FG001|Study Extension II|Lack of Efficacy|0|||
42111666|NCT00205777|75921834|FG002|Study Extension II|Lack of Efficacy|0|||
42111667|NCT00205777|75921835|FG003|Study Extension II|Lack of Efficacy|0|||
42111668|NCT00205777|75921836|FG004|Study Extension II|Lack of Efficacy|0|||
42111669|NCT00205777|75921837|FG005|Study Extension II|Lack of Efficacy|1|||
42111670|NCT00205777|75921832|FG000|Study Extension II|Failed to return|0|||
42111671|NCT00205777|75921833|FG001|Study Extension II|Failed to return|0|||
42111672|NCT00205777|75921834|FG002|Study Extension II|Failed to return|0|||
42111673|NCT00205777|75921835|FG003|Study Extension II|Failed to return|14|||
42111674|NCT00205777|75921836|FG004|Study Extension II|Failed to return|0|||
42111675|NCT00205777|75921837|FG005|Study Extension II|Failed to return|26|||
42111676|NCT00205777|75921832|FG000|Study Extension II|Other Event|0|||
42111677|NCT00205777|75921833|FG001|Study Extension II|Other Event|0|||
42111678|NCT00205777|75921834|FG002|Study Extension II|Other Event|0|||
42111679|NCT00205777|75921835|FG003|Study Extension II|Other Event|12|||
42111680|NCT00205777|75921836|FG004|Study Extension II|Other Event|0|||
42111681|NCT00205777|75921837|FG005|Study Extension II|Other Event|20|||
42111682|NCT00205777|75921832|FG000|Study Extension II|Enrolled but not treated|0|||
42111683|NCT00205777|75921833|FG001|Study Extension II|Enrolled but not treated|0|||
42111684|NCT00205777|75921834|FG002|Study Extension II|Enrolled but not treated|0|||
42111685|NCT00205777|75921835|FG003|Study Extension II|Enrolled but not treated|71|||
42111686|NCT00205777|75921836|FG004|Study Extension II|Enrolled but not treated|0|||
42111687|NCT00205777|75921837|FG005|Study Extension II|Enrolled but not treated|131|||
42111688|NCT00483652|75921854|FG000|Double-blind Treatment Period|Protocol Violation|2|||
42111689|NCT00483652|75921855|FG001|Double-blind Treatment Period|Protocol Violation|1|||
42111690|NCT00483652|75921854|FG000|Double-blind Treatment Period|Adverse Event|3|||
42111691|NCT00483652|75921855|FG001|Double-blind Treatment Period|Adverse Event|4|||
42111692|NCT00483652|75921854|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
42204726|NCT03529773|76017126|FG035|Overall Study|Randomized but not vaccinated|0|||
42204727|NCT03529773|76017127|FG036|Overall Study|Randomized but not vaccinated|0|||
42204728|NCT03529773|76017128|FG037|Overall Study|Randomized but not vaccinated|0|||
42204729|NCT03529773|76017129|FG038|Overall Study|Randomized but not vaccinated|0|||
42204730|NCT03529773|76017130|FG039|Overall Study|Randomized but not vaccinated|0|||
42204731|NCT03799211|76017235|FG000|Overall Study|Lost to Follow-up|2|||
42204732|NCT03799211|76017236|FG001|Overall Study|Lost to Follow-up|13|||
42204733|NCT03799211|76017235|FG000|Overall Study|Withdrawal by Subject|2|||
42204734|NCT03799211|76017236|FG001|Overall Study|Withdrawal by Subject|0|||
42204735|NCT03349710|76017248|FG000|Treatment Period|Death|0|||
42204736|NCT03349710|76017249|FG001|Treatment Period|Death|0|||
42204737|NCT03349710|76017250|FG002|Treatment Period|Death|1|||
42204738|NCT03349710|76017251|FG003|Treatment Period|Death|0|||
42204739|NCT03349710|76017248|FG000|Treatment Period|Disease Progression|0|||
42204740|NCT03349710|76017249|FG001|Treatment Period|Disease Progression|2|||
42204741|NCT03349710|76017250|FG002|Treatment Period|Disease Progression|0|||
42204742|NCT03349710|76017251|FG003|Treatment Period|Disease Progression|1|||
42204743|NCT03349710|76017248|FG000|Treatment Period|Study Drug Toxicity|1|||
42204744|NCT03349710|76017249|FG001|Treatment Period|Study Drug Toxicity|0|||
42204745|NCT03349710|76017250|FG002|Treatment Period|Study Drug Toxicity|1|||
42204746|NCT03349710|76017251|FG003|Treatment Period|Study Drug Toxicity|1|||
42204747|NCT03349710|76017248|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
42204748|NCT03349710|76017249|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
42204749|NCT03349710|76017250|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
42204750|NCT03349710|76017251|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
42204751|NCT03349710|76017248|FG000|Treatment Period|admin reason by sponsor|0|||
42204752|NCT03349710|76017249|FG001|Treatment Period|admin reason by sponsor|7|||
42204753|NCT03349710|76017250|FG002|Treatment Period|admin reason by sponsor|0|||
42204754|NCT03349710|76017251|FG003|Treatment Period|admin reason by sponsor|19|||
42204755|NCT03349710|76017248|FG000|Treatment Period|Other Reason|2|||
42204756|NCT03349710|76017249|FG001|Treatment Period|Other Reason|0|||
42204757|NCT03349710|76017250|FG002|Treatment Period|Other Reason|2|||
42204758|NCT03349710|76017251|FG003|Treatment Period|Other Reason|1|||
42204759|NCT03349710|76017248|FG000|Treatment Period|completed|6|||
42204760|NCT03349710|76017249|FG001|Treatment Period|completed|0|||
42204761|NCT03349710|76017250|FG002|Treatment Period|completed|18|||
42204762|NCT03349710|76017251|FG003|Treatment Period|completed|1|||
42204763|NCT03349710|76017248|FG000|Treatment Period|participant request to discontinue|0|||
42204764|NCT03349710|76017249|FG001|Treatment Period|participant request to discontinue|0|||
42204765|NCT03349710|76017250|FG002|Treatment Period|participant request to discontinue|4|||
42204766|NCT03349710|76017251|FG003|Treatment Period|participant request to discontinue|0|||
42204767|NCT03349710|76017248|FG000|Treatment Period|participant withdrew consent|1|||
42204768|NCT03349710|76017249|FG001|Treatment Period|participant withdrew consent|0|||
42204769|NCT03349710|76017250|FG002|Treatment Period|participant withdrew consent|0|||
42204770|NCT03349710|76017251|FG003|Treatment Period|participant withdrew consent|0|||
42204771|NCT03511053|76017261|FG000|Overall Study|Withdrawal by Subject|1|||
42204772|NCT03377634|76017267|FG000|Study Period|Adverse Event|1|||
42204773|NCT03377634|76017268|FG001|Study Period|Adverse Event|0|||
42204774|NCT03377634|76017267|FG000|Study Period|Withdrawal by Subject|1|||
42204775|NCT03377634|76017268|FG001|Study Period|Withdrawal by Subject|0|||
42204776|NCT03528369|76017277|FG000|Overall Study|Withdrawal by Subject|2|||
42204777|NCT03528369|76017278|FG001|Overall Study|Withdrawal by Subject|0|||
42204778|NCT03528369|76017279|FG002|Overall Study|Withdrawal by Subject|0|||
42204779|NCT03528369|76017277|FG000|Overall Study|Lost to Follow-up|1|||
42204780|NCT03528369|76017278|FG001|Overall Study|Lost to Follow-up|0|||
42204781|NCT03528369|76017279|FG002|Overall Study|Lost to Follow-up|0|||
42204782|NCT03528369|76017277|FG000|Overall Study|Adverse Event|0|||
42204783|NCT03528369|76017278|FG001|Overall Study|Adverse Event|1|||
42204784|NCT03528369|76017279|FG002|Overall Study|Adverse Event|0|||
42204785|NCT00006011|76017290|FG000|Overall Study|Disease progression|13|||
42204786|NCT00006011|76017291|FG001|Overall Study|Disease progression|6|||
42204787|NCT00006011|76017292|FG002|Overall Study|Disease progression|26|||
42204788|NCT00006011|76017290|FG000|Overall Study|Refused further treatment|15|||
42204789|NCT00006011|76017291|FG001|Overall Study|Refused further treatment|13|||
42204790|NCT00006011|76017292|FG002|Overall Study|Refused further treatment|26|||
42204791|NCT00006011|76017290|FG000|Overall Study|Adverse Event|15|||
42204792|NCT00006011|76017291|FG001|Overall Study|Adverse Event|39|||
42204793|NCT00006011|76017292|FG002|Overall Study|Adverse Event|5|||
42204794|NCT00006011|76017290|FG000|Overall Study|Death|0|||
42204795|NCT00006011|76017291|FG001|Overall Study|Death|1|||
42204796|NCT00006011|76017292|FG002|Overall Study|Death|2|||
42204797|NCT00006011|76017290|FG000|Overall Study|Other|4|||
42204798|NCT00006011|76017291|FG001|Overall Study|Other|2|||
42204799|NCT00006011|76017292|FG002|Overall Study|Other|5|||
42204800|NCT00006011|76017290|FG000|Overall Study|Ineligible|18|||
42204801|NCT00006011|76017291|FG001|Overall Study|Ineligible|16|||
42204802|NCT00006011|76017292|FG002|Overall Study|Ineligible|9|||
42204803|NCT03377556|76017298|FG000|Overall Study|Adverse Event|5|||
42204804|NCT03377556|76017298|FG000|Overall Study|Refusal unrelated to adverse events|1|||
42204805|NCT03377556|76017298|FG000|Overall Study|Progression/relapse|38|||
42204806|NCT03377556|76017298|FG000|Overall Study|Death|3|||
42204807|NCT03750955|76017304|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
42204808|NCT03750955|76017305|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
42204809|NCT03750955|76017304|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
42204810|NCT03750955|76017305|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
42204811|NCT00005879|76017315|FG000|Overall Study|Withdrawal by Subject|8|||
42204812|NCT00005879|76017316|FG001|Overall Study|Withdrawal by Subject|10|||
42204813|NCT03510663|76017330|FG000|Overall Study|Withdrawal by Subject|0|||
42204814|NCT03510663|76017331|FG001|Overall Study|Withdrawal by Subject|1|||
42204815|NCT03510663|76017332|FG002|Overall Study|Withdrawal by Subject|0|||
42204816|NCT03510663|76017333|FG003|Overall Study|Withdrawal by Subject|0|||
42204817|NCT03510663|76017334|FG004|Overall Study|Withdrawal by Subject|0|||
42204818|NCT03510663|76017335|FG005|Overall Study|Withdrawal by Subject|0|||
42204819|NCT03510663|76017336|FG006|Overall Study|Withdrawal by Subject|0|||
42204820|NCT03510663|76017337|FG007|Overall Study|Withdrawal by Subject|0|||
42204821|NCT03510273|76017347|FG000|Overall Study|Withdrawal by Subject|2|||
42204822|NCT03510273|76017347|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
42204823|NCT03510273|76017347|FG000|Overall Study|Moved away from study area|4|||
42204824|NCT03582813|76017357|FG000|Overall Study|Lost to Follow-up|18|||
42204825|NCT03582813|76017358|FG001|Overall Study|Lost to Follow-up|21|||
42204826|NCT03582813|76017357|FG000|Overall Study|Withdrawal by Subject|1|||
42204827|NCT03582813|76017358|FG001|Overall Study|Withdrawal by Subject|0|||
42204828|NCT03480009|76017368|FG000|Overall Study|Lost to Follow-up|4|||
42204829|NCT03480009|76017369|FG001|Overall Study|Lost to Follow-up|5|||
42204830|NCT03480009|76017370|FG002|Overall Study|Lost to Follow-up|4|||
42204831|NCT03480009|76017371|FG003|Overall Study|Lost to Follow-up|0|||
42204832|NCT03399786|76017386|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
42204833|NCT03399786|76017387|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
42204834|NCT03399786|76017388|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
42204835|NCT03399786|76017389|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
42204836|NCT03399786|76017386|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
42204837|NCT03399786|76017387|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
42204838|NCT03399786|76017388|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
42204839|NCT03399786|76017389|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
42111693|NCT00483652|75921855|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
42111694|NCT00483652|75921854|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
42111695|NCT00483652|75921855|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
42111696|NCT00483574|75921863|FG000|Overall Study|Adverse Event|6|||
42111697|NCT00483574|75921864|FG001|Overall Study|Adverse Event|0|||
42111698|NCT00483574|75921863|FG000|Overall Study|Protocol Violation|28|||
42111699|NCT00483574|75921864|FG001|Overall Study|Protocol Violation|9|||
42111700|NCT00483574|75921863|FG000|Overall Study|Lost to Follow-up|16|||
42111701|NCT00483574|75921864|FG001|Overall Study|Lost to Follow-up|4|||
42111702|NCT00483574|75921863|FG000|Overall Study|Withdrawal by Subject|52|||
42111703|NCT00483574|75921864|FG001|Overall Study|Withdrawal by Subject|0|||
42111704|NCT00483184|75921875|FG000|Overall Study|Withdrawal by Subject|2|||
42111705|NCT00483184|75921876|FG001|Overall Study|Withdrawal by Subject|2|||
42111706|NCT00483184|75921877|FG002|Overall Study|Withdrawal by Subject|0|||
42111707|NCT00483184|75921875|FG000|Overall Study|Lost to Follow-up|1|||
42111708|NCT00483184|75921876|FG001|Overall Study|Lost to Follow-up|0|||
42111709|NCT00483184|75921877|FG002|Overall Study|Lost to Follow-up|0|||
42111710|NCT00483184|75921875|FG000|Overall Study|Adverse Event|1|||
42111711|NCT00483184|75921876|FG001|Overall Study|Adverse Event|2|||
42111712|NCT00483184|75921877|FG002|Overall Study|Adverse Event|2|||
42111713|NCT00483184|75921875|FG000|Overall Study|Protocol Violation|1|||
42111714|NCT00483184|75921876|FG001|Overall Study|Protocol Violation|0|||
42111715|NCT00483184|75921877|FG002|Overall Study|Protocol Violation|1|||
42111716|NCT00482170|75921887|FG000|Overall Study|Adverse Event|5|||
42111717|NCT00482170|75921888|FG001|Overall Study|Adverse Event|14|||
42111718|NCT00482170|75921887|FG000|Overall Study|Withdrawal by Subject|6|||
42111719|NCT00482170|75921888|FG001|Overall Study|Withdrawal by Subject|1|||
42111720|NCT00482170|75921887|FG000|Overall Study|Protocol Violation|2|||
42111721|NCT00482170|75921888|FG001|Overall Study|Protocol Violation|3|||
42111722|NCT00482170|75921887|FG000|Overall Study|Lost to Follow-up|2|||
42111723|NCT00482170|75921888|FG001|Overall Study|Lost to Follow-up|0|||
42111724|NCT00482170|75921887|FG000|Overall Study|Unspecified reason|0|||
42111725|NCT00482170|75921888|FG001|Overall Study|Unspecified reason|2|||
42204840|NCT03399786|76017386|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
42204841|NCT03399786|76017387|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
42389021|NCT02620020|76272705|FG003|Overall Study|Protocol Violation|1|||
42389022|NCT02620020|76272702|FG000|Overall Study|Withdrawal by Subject|20|||
42389023|NCT02620020|76272703|FG001|Overall Study|Withdrawal by Subject|16|||
42389024|NCT02620020|76272704|FG002|Overall Study|Withdrawal by Subject|17|||
42111726|NCT03883113|75921896|FG000|Overall Study|Physician Decision|4|||
42111727|NCT03883113|75921897|FG001|Overall Study|Physician Decision|2|||
42111728|NCT03883113|75921896|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
42111729|NCT03883113|75921897|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
42111730|NCT03883113|75921896|FG000|Overall Study|Pregnancy|1|||
42111731|NCT03883113|75921897|FG001|Overall Study|Pregnancy|0|||
42111732|NCT03883113|75921896|FG000|Overall Study|Adverse Event|0|||
42111733|NCT03883113|75921897|FG001|Overall Study|Adverse Event|1|||
42111734|NCT03883113|75921896|FG000|Overall Study|Withdrawal by Subject|1|||
42111735|NCT03883113|75921897|FG001|Overall Study|Withdrawal by Subject|2|||
42111736|NCT03883113|75921896|FG000|Overall Study|Lost to Follow-up|1|||
42111737|NCT03883113|75921897|FG001|Overall Study|Lost to Follow-up|0|||
42111738|NCT04218695|75921919|FG000|Overall Study|Adverse Event|1|||
42111739|NCT04218695|75921920|FG001|Overall Study|Adverse Event|0|||
42111740|NCT00490282|75921926|FG000|Overall Study|Withdrawal by Subject|3|||
42111741|NCT00615056|75921935|FG000|Overall Study|Death|31|||
42111742|NCT00615056|75921936|FG001|Overall Study|Death|31|||
42111743|NCT00615056|75921937|FG002|Overall Study|Death|21|||
42111744|NCT00615056|75921938|FG003|Overall Study|Death|23|||
42111745|NCT00615056|75921935|FG000|Overall Study|Lost to Follow-up|1|||
42111746|NCT00615056|75921936|FG001|Overall Study|Lost to Follow-up|2|||
42111747|NCT00615056|75921937|FG002|Overall Study|Lost to Follow-up|4|||
42111748|NCT00615056|75921938|FG003|Overall Study|Lost to Follow-up|5|||
42111749|NCT00615056|75921935|FG000|Overall Study|Other|13|||
42111750|NCT00615056|75921936|FG001|Overall Study|Other|15|||
42111751|NCT00615056|75921937|FG002|Overall Study|Other|10|||
42111752|NCT00615056|75921938|FG003|Overall Study|Other|7|||
42111753|NCT00615056|75921935|FG000|Overall Study|Objective progression or relapse|0|||
42111754|NCT00615056|75921936|FG001|Overall Study|Objective progression or relapse|2|||
42111755|NCT00615056|75921937|FG002|Overall Study|Objective progression or relapse|0|||
42111756|NCT00615056|75921938|FG003|Overall Study|Objective progression or relapse|0|||
42111757|NCT00615056|75921935|FG000|Overall Study|Withdrawal by Subject|0|||
42111758|NCT00615056|75921936|FG001|Overall Study|Withdrawal by Subject|1|||
42111759|NCT00615056|75921937|FG002|Overall Study|Withdrawal by Subject|1|||
42111760|NCT00615056|75921938|FG003|Overall Study|Withdrawal by Subject|0|||
42111761|NCT00615056|75921935|FG000|Overall Study|Discontinued by Sponsor|1|||
42111762|NCT00615056|75921936|FG001|Overall Study|Discontinued by Sponsor|0|||
42111763|NCT00615056|75921937|FG002|Overall Study|Discontinued by Sponsor|0|||
42111764|NCT00615056|75921938|FG003|Overall Study|Discontinued by Sponsor|0|||
42111765|NCT00615056|75921935|FG000|Overall Study|Randomized but not treated|3|||
42111766|NCT00615056|75921936|FG001|Overall Study|Randomized but not treated|0|||
42111767|NCT00615056|75921937|FG002|Overall Study|Randomized but not treated|0|||
42111768|NCT00615056|75921938|FG003|Overall Study|Randomized but not treated|0|||
42111769|NCT00482014|75921952|FG000|Overall Study|Withdrawal by Subject|1|||
42111770|NCT00482014|75921953|FG001|Overall Study|Withdrawal by Subject|2|||
42111771|NCT00482014|75921954|FG002|Overall Study|Withdrawal by Subject|3|||
42111772|NCT00482014|75921955|FG003|Overall Study|Withdrawal by Subject|4|||
42111773|NCT00482014|75921952|FG000|Overall Study|Adverse Event|3|||
42111774|NCT00482014|75921953|FG001|Overall Study|Adverse Event|0|||
42111775|NCT00482014|75921954|FG002|Overall Study|Adverse Event|2|||
42111776|NCT00482014|75921955|FG003|Overall Study|Adverse Event|8|||
42111777|NCT00482014|75921952|FG000|Overall Study|Death|1|||
42111778|NCT00482014|75921953|FG001|Overall Study|Death|2|||
42111779|NCT00482014|75921954|FG002|Overall Study|Death|1|||
42111780|NCT00482014|75921955|FG003|Overall Study|Death|4|||
42111781|NCT00482014|75921952|FG000|Overall Study|Lack of Efficacy|1|||
42111782|NCT00482014|75921953|FG001|Overall Study|Lack of Efficacy|0|||
42111783|NCT00482014|75921954|FG002|Overall Study|Lack of Efficacy|4|||
42111784|NCT00482014|75921955|FG003|Overall Study|Lack of Efficacy|6|||
42111785|NCT00482014|75921952|FG000|Overall Study|Sponsor Decision|1|||
42111786|NCT00482014|75921953|FG001|Overall Study|Sponsor Decision|2|||
42111787|NCT00482014|75921954|FG002|Overall Study|Sponsor Decision|1|||
42111788|NCT00482014|75921955|FG003|Overall Study|Sponsor Decision|1|||
42111789|NCT03595553|75921969|FG000|Overall Study|Withdrawal by Subject|20|||
42111790|NCT03595553|75921970|FG001|Overall Study|Withdrawal by Subject|8|||
42111791|NCT03595553|75921969|FG000|Overall Study|Physician Decision|3|||
42111792|NCT03595553|75921970|FG001|Overall Study|Physician Decision|2|||
42111793|NCT03595553|75921969|FG000|Overall Study|Adverse Event|2|||
42111794|NCT03595553|75921970|FG001|Overall Study|Adverse Event|5|||
42111795|NCT03595553|75921969|FG000|Overall Study|Death|24|||
42389025|NCT02620020|76272705|FG003|Overall Study|Withdrawal by Subject|12|||
42389026|NCT02620020|76272702|FG000|Overall Study|Death|0|||
42111796|NCT03595553|75921970|FG001|Overall Study|Death|22|||
42111797|NCT03595553|75921969|FG000|Overall Study|Lost to Follow-up|6|||
42111798|NCT03595553|75921970|FG001|Overall Study|Lost to Follow-up|7|||
42111799|NCT03595553|75921969|FG000|Overall Study|Other as indicated in CSR|3|||
42111800|NCT03595553|75921970|FG001|Overall Study|Other as indicated in CSR|3|||
42111801|NCT03595553|75921969|FG000|Overall Study|Sponsor Decision|0|||
42111802|NCT03595553|75921970|FG001|Overall Study|Sponsor Decision|1|||
42111803|NCT00614822|75921976|FG000|Overall Study|Adverse Event|3|||
42111804|NCT00529659|75921983|FG000|Overall Study|Adverse Event|8|||
42111805|NCT00529659|75921984|FG001|Overall Study|Adverse Event|7|||
42111806|NCT00529659|75921983|FG000|Overall Study|Lost to Follow-up|0|||
42111807|NCT00529659|75921984|FG001|Overall Study|Lost to Follow-up|2|||
42111808|NCT00529659|75921983|FG000|Overall Study|Physician Decision|0|||
42111809|NCT00529659|75921984|FG001|Overall Study|Physician Decision|2|||
42111810|NCT00529659|75921983|FG000|Overall Study|Protocol Violation|2|||
42111811|NCT00529659|75921984|FG001|Overall Study|Protocol Violation|6|||
42111812|NCT00529659|75921983|FG000|Overall Study|Withdrawal by Subject|1|||
42111813|NCT00529659|75921984|FG001|Overall Study|Withdrawal by Subject|6|||
42111814|NCT00143455|75921994|FG000|Cohort 1|Adverse Event|8|||
42111815|NCT00143455|75921995|FG001|Cohort 1|Adverse Event|4|||
42111816|NCT00143455|75921996|FG002|Cohort 1|Adverse Event|0|||
42111817|NCT00143455|75921997|FG003|Cohort 1|Adverse Event|0|||
42111818|NCT00143455|75921994|FG000|Cohort 1|Death|5|||
42111819|NCT00143455|75921995|FG001|Cohort 1|Death|2|||
42111820|NCT00143455|75921996|FG002|Cohort 1|Death|0|||
42111821|NCT00143455|75921997|FG003|Cohort 1|Death|0|||
42111822|NCT00143455|75921994|FG000|Cohort 1|Progressive Disease|0|||
42111823|NCT00143455|75921995|FG001|Cohort 1|Progressive Disease|6|||
42111824|NCT00143455|75921996|FG002|Cohort 1|Progressive Disease|0|||
42111825|NCT00143455|75921997|FG003|Cohort 1|Progressive Disease|0|||
42111826|NCT00143455|75921994|FG000|Cohort 1|Withdrawal by Subject|1|||
42111827|NCT00143455|75921995|FG001|Cohort 1|Withdrawal by Subject|4|||
42111828|NCT00143455|75921996|FG002|Cohort 1|Withdrawal by Subject|0|||
42111829|NCT00143455|75921997|FG003|Cohort 1|Withdrawal by Subject|0|||
42111830|NCT00143455|75921994|FG000|Cohort 1|Randomized But Not Treated|0|||
42111831|NCT00143455|75921995|FG001|Cohort 1|Randomized But Not Treated|1|||
42111832|NCT00143455|75921996|FG002|Cohort 1|Randomized But Not Treated|0|||
42111833|NCT00143455|75921997|FG003|Cohort 1|Randomized But Not Treated|0|||
42111834|NCT00143455|75921994|FG000|Cohort 2|Adverse Event|0|||
42111835|NCT00143455|75921995|FG001|Cohort 2|Adverse Event|0|||
42111836|NCT00143455|75921996|FG002|Cohort 2|Adverse Event|42|||
42111837|NCT00143455|75921997|FG003|Cohort 2|Adverse Event|30|||
42111838|NCT00143455|75921994|FG000|Cohort 2|No Longer Required Study Treatment|0|||
42111839|NCT00143455|75921995|FG001|Cohort 2|No Longer Required Study Treatment|0|||
42111840|NCT00143455|75921996|FG002|Cohort 2|No Longer Required Study Treatment|1|||
42111841|NCT00143455|75921997|FG003|Cohort 2|No Longer Required Study Treatment|0|||
42111842|NCT00143455|75921994|FG000|Cohort 2|Protocol Violation|0|||
42111843|NCT00143455|75921995|FG001|Cohort 2|Protocol Violation|0|||
42111844|NCT00143455|75921996|FG002|Cohort 2|Protocol Violation|1|||
42111845|NCT00143455|75921997|FG003|Cohort 2|Protocol Violation|1|||
42111846|NCT00143455|75921994|FG000|Cohort 2|Lost to Follow-up|0|||
42111847|NCT00143455|75921995|FG001|Cohort 2|Lost to Follow-up|0|||
42111848|NCT00143455|75921996|FG002|Cohort 2|Lost to Follow-up|1|||
42111849|NCT00143455|75921997|FG003|Cohort 2|Lost to Follow-up|4|||
42111850|NCT00143455|75921994|FG000|Cohort 2|Death|0|||
42111851|NCT00143455|75921995|FG001|Cohort 2|Death|0|||
42111852|NCT00143455|75921996|FG002|Cohort 2|Death|20|||
42111853|NCT00143455|75921997|FG003|Cohort 2|Death|12|||
42111854|NCT00143455|75921994|FG000|Cohort 2|Progressive Disease|0|||
42111855|NCT00143455|75921995|FG001|Cohort 2|Progressive Disease|0|||
42111856|NCT00143455|75921996|FG002|Cohort 2|Progressive Disease|20|||
42111857|NCT00143455|75921997|FG003|Cohort 2|Progressive Disease|27|||
42111858|NCT00143455|75921994|FG000|Cohort 2|Withdrawal by Subject|0|||
42111859|NCT00143455|75921995|FG001|Cohort 2|Withdrawal by Subject|0|||
42111860|NCT00143455|75921996|FG002|Cohort 2|Withdrawal by Subject|13|||
42111861|NCT00143455|75921997|FG003|Cohort 2|Withdrawal by Subject|12|||
42111862|NCT00143455|75921994|FG000|Cohort 2|Other|0|||
42111863|NCT00143455|75921995|FG001|Cohort 2|Other|0|||
42111864|NCT00143455|75921996|FG002|Cohort 2|Other|7|||
42111865|NCT00143455|75921997|FG003|Cohort 2|Other|6|||
42111866|NCT00143455|75921994|FG000|Cohort 2|Randomized But Not Treated|0|||
42111867|NCT00143455|75921995|FG001|Cohort 2|Randomized But Not Treated|0|||
42111868|NCT00143455|75921996|FG002|Cohort 2|Randomized But Not Treated|1|||
42111869|NCT00143455|75921997|FG003|Cohort 2|Randomized But Not Treated|1|||
42111870|NCT03529955|75922009|FG000|Overall Study|Adverse Event|1|||
42111871|NCT03529955|75922009|FG000|Overall Study|Lack of Efficacy|1|||
42111872|NCT00142909|75922025|FG000|Randomization|Various Reasons|7|||
42111873|NCT00142909|75922026|FG001|Randomization|Various Reasons|10|||
42111874|NCT00142909|75922025|FG000|Medications Begin|Protocol Violation|2|||
42111875|NCT00142909|75922026|FG001|Medications Begin|Protocol Violation|0|||
42111876|NCT00142909|75922025|FG000|Medications Begin|Withdrawal by Subject|5|||
42111877|NCT00142909|75922026|FG001|Medications Begin|Withdrawal by Subject|3|||
42111878|NCT00142909|75922025|FG000|Medications Begin|Withdrawal by Subject|2|||
42111879|NCT00142909|75922026|FG001|Medications Begin|Withdrawal by Subject|0|||
42111880|NCT00205699|75922035|FG000|Overall Study|Lost to Follow-up|1|||
42111881|NCT00205699|75922036|FG001|Overall Study|Lost to Follow-up|3|||
42111882|NCT00205699|75922037|FG002|Overall Study|Lost to Follow-up|5|||
42111883|NCT00205699|75922035|FG000|Overall Study|Adverse Event|1|||
42111884|NCT00205699|75922036|FG001|Overall Study|Adverse Event|0|||
42111885|NCT00205699|75922037|FG002|Overall Study|Adverse Event|0|||
42111886|NCT00205699|75922035|FG000|Overall Study|Withdrawal by Subject|1|||
42111887|NCT00205699|75922036|FG001|Overall Study|Withdrawal by Subject|2|||
42111888|NCT00205699|75922037|FG002|Overall Study|Withdrawal by Subject|1|||
42111889|NCT00205699|75922035|FG000|Overall Study|Lack of Efficacy|0|||
42111890|NCT00205699|75922036|FG001|Overall Study|Lack of Efficacy|1|||
42111891|NCT00205699|75922037|FG002|Overall Study|Lack of Efficacy|0|||
42111892|NCT03882801|75922050|FG000|Period 1|Adverse Event|0|||
42111893|NCT03882801|75922051|FG001|Period 1|Adverse Event|1|||
42111894|NCT03882801|75922050|FG000|Period 1|Non-compliance with study drug|1|||
42111895|NCT03882801|75922051|FG001|Period 1|Non-compliance with study drug|1|||
42111896|NCT03882801|75922050|FG000|Period 1|Never treated with study drug|1|||
42111897|NCT03882801|75922051|FG001|Period 1|Never treated with study drug|0|||
42111898|NCT03882801|75922050|FG000|Washout Period|Physician Decision|0|||
42111899|NCT03882801|75922051|FG001|Washout Period|Physician Decision|1|||
42111900|NCT03882801|75922050|FG000|Period 2|Non-compliance with study drug|0|||
42111901|NCT03882801|75922051|FG001|Period 2|Non-compliance with study drug|1|||
42111902|NCT03880227|75922061|FG000|First Visit|Withdrawal by Subject|1|||
42111903|NCT03880227|75922062|FG001|First Visit|Withdrawal by Subject|0|||
42111904|NCT03880227|75922063|FG002|First Visit|Withdrawal by Subject|0|||
42111905|NCT03880227|75922064|FG003|First Visit|Withdrawal by Subject|0|||
42111906|NCT03880227|75922061|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
42111907|NCT03880227|75922062|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
42111908|NCT03880227|75922063|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
42111909|NCT03880227|75922064|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
42111910|NCT03880227|75922061|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
42111911|NCT03880227|75922062|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
42111912|NCT03880227|75922063|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
42111913|NCT03880227|75922064|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
42111914|NCT03880227|75922061|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
42111915|NCT03880227|75922062|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
42111916|NCT03880227|75922063|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
42111917|NCT03880227|75922064|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
42111918|NCT00530439|75922088|FG000|Overall Study|GDM|9|||
42111919|NCT00530439|75922089|FG001|Overall Study|GDM|3|||
42111920|NCT00530439|75922088|FG000|Overall Study|Withdraw|18|||
42111921|NCT00530439|75922089|FG001|Overall Study|Withdraw|14|||
42111922|NCT00530439|75922088|FG000|Overall Study|Missed abortion|1|||
42111923|NCT00530439|75922089|FG001|Overall Study|Missed abortion|4|||
42111924|NCT00530439|75922088|FG000|Overall Study|Misclassification|2|||
42111925|NCT00530439|75922089|FG001|Overall Study|Misclassification|0|||
42111926|NCT00530439|75922088|FG000|Overall Study|Twin pregnancy|0|||
42111927|NCT00530439|75922089|FG001|Overall Study|Twin pregnancy|2|||
42111928|NCT00530439|75922088|FG000|Overall Study|Severe malformation/abortion|0|||
42111929|NCT00530439|75922089|FG001|Overall Study|Severe malformation/abortion|3|||
42111930|NCT00497146|75922097|FG000|Treatment Period|Adverse Event|6|||
42111931|NCT00497146|75922098|FG001|Treatment Period|Adverse Event|2|||
42111932|NCT00497146|75922097|FG000|Treatment Period|Withdrawal by Subject|5|||
42111933|NCT00497146|75922098|FG001|Treatment Period|Withdrawal by Subject|9|||
42111934|NCT00497146|75922097|FG000|Treatment Period|Lost to Follow-up|1|||
42111935|NCT00497146|75922098|FG001|Treatment Period|Lost to Follow-up|3|||
42111936|NCT00497146|75922097|FG000|Treatment Period|Required dialysis|4|||
42111937|NCT00497146|75922098|FG001|Treatment Period|Required dialysis|1|||
42111938|NCT00497146|75922097|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
42111939|NCT00497146|75922098|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
42111940|NCT00497146|75922097|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
42111941|NCT00497146|75922098|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
42111942|NCT00497146|75922097|FG000|Treatment Period|Other Reason|2|||
42111943|NCT00497146|75922098|FG001|Treatment Period|Other Reason|3|||
42111944|NCT00497146|75922097|FG000|Long-term Follow-up Period|Adverse Event|2|||
42111945|NCT00497146|75922098|FG001|Long-term Follow-up Period|Adverse Event|2|||
42111946|NCT00497146|75922097|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
42111947|NCT00497146|75922098|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
42111948|NCT00497146|75922097|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
42111949|NCT00497146|75922098|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
42111950|NCT00497146|75922097|FG000|Long-term Follow-up Period|Other|0|||
42111951|NCT00497146|75922098|FG001|Long-term Follow-up Period|Other|1|||
42111952|NCT00489970|75922109|FG000|Persistence Year 9|Lost to Follow-up|2|||
42111953|NCT00489970|75922110|FG001|Persistence Year 9|Lost to Follow-up|2|||
42111954|NCT00489970|75922111|FG002|Persistence Year 9|Lost to Follow-up|3|||
42111955|NCT00489970|75922109|FG000|Persistence Year 9|Other|1|||
42111956|NCT00489970|75922110|FG001|Persistence Year 9|Other|0|||
42111957|NCT00489970|75922111|FG002|Persistence Year 9|Other|2|||
42111958|NCT02798471|75922124|FG000|Overall Study|Adverse Event|7|||
42111959|NCT02798471|75922125|FG001|Overall Study|Adverse Event|2|||
42111960|NCT02798471|75922124|FG000|Overall Study|Physician Decision|3|||
42111961|NCT02798471|75922125|FG001|Overall Study|Physician Decision|7|||
42111962|NCT02798471|75922124|FG000|Overall Study|Death|2|||
42111963|NCT02798471|75922125|FG001|Overall Study|Death|3|||
42111964|NCT02798471|75922124|FG000|Overall Study|Lost to Follow-up|0|||
42111965|NCT02798471|75922125|FG001|Overall Study|Lost to Follow-up|1|||
42111966|NCT02798471|75922124|FG000|Overall Study|Other|5|||
42111967|NCT02798471|75922125|FG001|Overall Study|Other|3|||
42111968|NCT02798471|75922124|FG000|Overall Study|Subject withdrew consent|0|||
42111969|NCT02798471|75922125|FG001|Overall Study|Subject withdrew consent|6|||
42111970|NCT02798471|75922124|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
42111971|NCT02798471|75922125|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
42111972|NCT02798471|75922124|FG000|Overall Study|Randomized, but not treated|0|||
42111973|NCT02798471|75922125|FG001|Overall Study|Randomized, but not treated|2|||
42111974|NCT00489736|75922133|FG000|Overall Study|Lack of Efficacy|53|||
42111975|NCT00489736|75922134|FG001|Overall Study|Lack of Efficacy|14|||
42111976|NCT00489736|75922133|FG000|Overall Study|Adverse Event|32|||
42111977|NCT00489736|75922134|FG001|Overall Study|Adverse Event|45|||
42111978|NCT00489736|75922133|FG000|Overall Study|Poor compliance|6|||
42111979|NCT00489736|75922134|FG001|Overall Study|Poor compliance|2|||
42111980|NCT00489736|75922133|FG000|Overall Study|Not coded/ Not pre-specified|5|||
42111981|NCT00489736|75922134|FG001|Overall Study|Not coded/ Not pre-specified|8|||
42111982|NCT00617084|75922142|FG000|Overall Study|Withdrawal by Subject|5|||
42111983|NCT00617084|75922143|FG001|Overall Study|Withdrawal by Subject|7|||
42111984|NCT00617084|75922142|FG000|Overall Study|Missed 12 Months visit|16|||
42111985|NCT00617084|75922143|FG001|Overall Study|Missed 12 Months visit|19|||
42111986|NCT00489424|75922152|FG000|Overall Study|Adverse Event|3|||
42111987|NCT00489424|75922153|FG001|Overall Study|Adverse Event|3|||
42111988|NCT00489424|75922154|FG002|Overall Study|Adverse Event|4|||
42111989|NCT00489424|75922152|FG000|Overall Study|Lack of Efficacy|1|||
42111990|NCT00489424|75922153|FG001|Overall Study|Lack of Efficacy|0|||
42111991|NCT00489424|75922154|FG002|Overall Study|Lack of Efficacy|0|||
42111992|NCT00489424|75922152|FG000|Overall Study|Administrative problems|0|||
42111993|NCT00489424|75922153|FG001|Overall Study|Administrative problems|2|||
42111994|NCT00489424|75922154|FG002|Overall Study|Administrative problems|1|||
42111995|NCT00614744|75922164|FG000|Overall Study|Lost to Follow-up|5|||
42111996|NCT00614744|75922165|FG001|Overall Study|Lost to Follow-up|4|||
42111997|NCT00614744|75922164|FG000|Overall Study|Incomplete for Behavior Issues|0|||
42111998|NCT00614744|75922165|FG001|Overall Study|Incomplete for Behavior Issues|2|||
42111999|NCT00565812|75922174|FG000|Overall Study|Death|2|||
42112000|NCT00565812|75922175|FG001|Overall Study|Death|1|||
42112001|NCT00565812|75922176|FG002|Overall Study|Death|3|||
42112002|NCT00565812|75922174|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
42112003|NCT00565812|75922175|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
42112004|NCT00565812|75922176|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
42112005|NCT00565812|75922174|FG000|Overall Study|Lost to Follow-up|10|||
42112006|NCT00565812|75922175|FG001|Overall Study|Lost to Follow-up|8|||
42112007|NCT00565812|75922176|FG002|Overall Study|Lost to Follow-up|8|||
42112008|NCT00565812|75922174|FG000|Overall Study|Withdrawal by Subject|58|||
42112009|NCT00565812|75922175|FG001|Overall Study|Withdrawal by Subject|47|||
42112010|NCT00565812|75922176|FG002|Overall Study|Withdrawal by Subject|48|||
42112011|NCT00565812|75922174|FG000|Overall Study|Work Schedule|5|||
42112012|NCT00565812|75922175|FG001|Overall Study|Work Schedule|3|||
42112013|NCT00565812|75922176|FG002|Overall Study|Work Schedule|1|||
42112014|NCT00565812|75922174|FG000|Overall Study|Protocol Violation|2|||
42112015|NCT00565812|75922175|FG001|Overall Study|Protocol Violation|6|||
42112016|NCT00565812|75922176|FG002|Overall Study|Protocol Violation|4|||
42112017|NCT00565812|75922174|FG000|Overall Study|Adverse Event|41|||
42112018|NCT00565812|75922175|FG001|Overall Study|Adverse Event|54|||
42112019|NCT00565812|75922176|FG002|Overall Study|Adverse Event|40|||
42112020|NCT00565812|75922174|FG000|Overall Study|Jury Duty|1|||
42112021|NCT00565812|75922175|FG001|Overall Study|Jury Duty|0|||
42112022|NCT00565812|75922176|FG002|Overall Study|Jury Duty|0|||
42112023|NCT00565812|75922174|FG000|Overall Study|Relocated Out of Area|5|||
42112024|NCT00565812|75922175|FG001|Overall Study|Relocated Out of Area|8|||
42112025|NCT00565812|75922176|FG002|Overall Study|Relocated Out of Area|9|||
42112026|NCT00565812|75922174|FG000|Overall Study|Sponsor Decision|1|||
42112027|NCT00565812|75922175|FG001|Overall Study|Sponsor Decision|5|||
42112028|NCT00565812|75922176|FG002|Overall Study|Sponsor Decision|1|||
42112029|NCT00565812|75922174|FG000|Overall Study|Domestic Reasons|7|||
42112030|NCT00565812|75922175|FG001|Overall Study|Domestic Reasons|1|||
42112031|NCT00565812|75922176|FG002|Overall Study|Domestic Reasons|3|||
42112032|NCT00565812|75922174|FG000|Overall Study|Research Site Closure|6|||
42112033|NCT00565812|75922175|FG001|Overall Study|Research Site Closure|1|||
42112034|NCT00565812|75922176|FG002|Overall Study|Research Site Closure|8|||
42112035|NCT00565812|75922174|FG000|Overall Study|Surgical Intervention|0|||
42112036|NCT00565812|75922175|FG001|Overall Study|Surgical Intervention|1|||
42112037|NCT00565812|75922176|FG002|Overall Study|Surgical Intervention|2|||
42112038|NCT00565812|75922174|FG000|Overall Study|Low Compliance|1|||
42112039|NCT00565812|75922175|FG001|Overall Study|Low Compliance|0|||
42112040|NCT00565812|75922176|FG002|Overall Study|Low Compliance|1|||
42112041|NCT00565812|75922174|FG000|Overall Study|Follow-up Visit Not Completed|2|||
42112042|NCT00565812|75922175|FG001|Overall Study|Follow-up Visit Not Completed|0|||
42112043|NCT00565812|75922176|FG002|Overall Study|Follow-up Visit Not Completed|1|||
42112044|NCT00565812|75922174|FG000|Overall Study|Physician Decision|2|||
42112045|NCT00565812|75922175|FG001|Overall Study|Physician Decision|0|||
42112046|NCT00565812|75922176|FG002|Overall Study|Physician Decision|0|||
42112047|NCT03974334|75922184|FG000|Overall Study|Lost to Follow-up|1|||
42112048|NCT03970824|75922191|FG000|Overall Study|Withdrawal by Subject|1|||
42112049|NCT03970824|75922192|FG001|Overall Study|Withdrawal by Subject|1|||
42112050|NCT03970824|75922193|FG002|Overall Study|Withdrawal by Subject|3|||
42112051|NCT03970824|75922191|FG000|Overall Study|Lost to Follow-up|0|||
42112052|NCT03970824|75922192|FG001|Overall Study|Lost to Follow-up|2|||
42112053|NCT03970824|75922193|FG002|Overall Study|Lost to Follow-up|1|||
42112054|NCT03970824|75922191|FG000|Overall Study|Adverse Event|1|||
42112055|NCT03970824|75922192|FG001|Overall Study|Adverse Event|0|||
42112056|NCT03970824|75922193|FG002|Overall Study|Adverse Event|0|||
42112057|NCT00564486|75922204|FG000|Overall Study|Adverse Event|0|||
42112058|NCT00564486|75922205|FG001|Overall Study|Adverse Event|1|||
42112059|NCT00564486|75922206|FG002|Overall Study|Adverse Event|0|||
42112060|NCT00564486|75922207|FG003|Overall Study|Adverse Event|0|||
42112061|NCT00564486|75922204|FG000|Overall Study|Withdrawal by Subject|4|||
42112062|NCT00564486|75922205|FG001|Overall Study|Withdrawal by Subject|0|||
42112063|NCT00564486|75922206|FG002|Overall Study|Withdrawal by Subject|0|||
42112064|NCT00564486|75922207|FG003|Overall Study|Withdrawal by Subject|5|||
42112065|NCT00564486|75922204|FG000|Overall Study|Subject refused to have blood drawn|0|||
42112066|NCT00564486|75922205|FG001|Overall Study|Subject refused to have blood drawn|0|||
42112067|NCT00564486|75922206|FG002|Overall Study|Subject refused to have blood drawn|1|||
42112068|NCT00564486|75922207|FG003|Overall Study|Subject refused to have blood drawn|0|||
42112069|NCT00564486|75922204|FG000|Overall Study|Lost to Follow-up|3|||
42112070|NCT00564486|75922205|FG001|Overall Study|Lost to Follow-up|0|||
42112071|NCT00564486|75922206|FG002|Overall Study|Lost to Follow-up|2|||
42112072|NCT00564486|75922207|FG003|Overall Study|Lost to Follow-up|2|||
42112073|NCT00481078|75922223|FG000|Overall Study|Progression of disease|11|||
42112074|NCT00481078|75922224|FG001|Overall Study|Progression of disease|11|||
42112075|NCT00481078|75922223|FG000|Overall Study|Adverse Event|15|||
42112076|NCT00481078|75922224|FG001|Overall Study|Adverse Event|3|||
42112077|NCT00481078|75922223|FG000|Overall Study|Death|5|||
42112078|NCT00481078|75922224|FG001|Overall Study|Death|3|||
42112079|NCT00481078|75922223|FG000|Overall Study|Intercurrent illness|1|||
42112080|NCT00481078|75922224|FG001|Overall Study|Intercurrent illness|0|||
42112081|NCT00481078|75922223|FG000|Overall Study|Withdrawal by Subject|7|||
42112082|NCT00481078|75922224|FG001|Overall Study|Withdrawal by Subject|1|||
42112083|NCT00481078|75922223|FG000|Overall Study|Information not available|1|||
42112084|NCT00481078|75922224|FG001|Overall Study|Information not available|0|||
42112085|NCT00481078|75922223|FG000|Overall Study|Received other treatment|2|||
42112086|NCT00481078|75922224|FG001|Overall Study|Received other treatment|1|||
42112087|NCT00481078|75922223|FG000|Overall Study|Brain metastasis|0|||
42112088|NCT00481078|75922224|FG001|Overall Study|Brain metastasis|1|||
42112089|NCT00480532|75922234|FG000|Overall Study|Withdrawal by Subject|2|||
42112090|NCT00480532|75922235|FG001|Overall Study|Withdrawal by Subject|4|||
42112091|NCT00480532|75922236|FG002|Overall Study|Withdrawal by Subject|3|||
42112092|NCT00480532|75922237|FG003|Overall Study|Withdrawal by Subject|1|||
42112093|NCT00480532|75922234|FG000|Overall Study|Protocol Violation|0|||
42112094|NCT00480532|75922235|FG001|Overall Study|Protocol Violation|0|||
42112095|NCT00480532|75922236|FG002|Overall Study|Protocol Violation|1|||
42112096|NCT00480532|75922237|FG003|Overall Study|Protocol Violation|0|||
42112097|NCT00496366|75922247|FG000|Overall Study|Death|1|||
42112098|NCT00488644|75922251|FG000|Overall Study|Not Eligible|1|||
42112099|NCT00488644|75922251|FG000|Overall Study|Not Evaluable|1|||
42112100|NCT00564018|75922258|FG000|Overall Study|Withdrawal by Subject|2|||
42112101|NCT00564018|75922259|FG001|Overall Study|Withdrawal by Subject|3|||
42112102|NCT00564018|75922260|FG002|Overall Study|Withdrawal by Subject|1|||
42112103|NCT03381287|75922272|FG000|Overall Study|Withdrawal by Subject|0|||
42112104|NCT03381287|75922273|FG001|Overall Study|Withdrawal by Subject|1|||
42112105|NCT03381287|75922274|FG002|Overall Study|Withdrawal by Subject|0|||
42112106|NCT03381287|75922275|FG003|Overall Study|Withdrawal by Subject|0|||
42112107|NCT03381287|75922272|FG000|Overall Study|Adverse Event|0|||
42112108|NCT03381287|75922273|FG001|Overall Study|Adverse Event|0|||
42112109|NCT03381287|75922274|FG002|Overall Study|Adverse Event|0|||
42112110|NCT03381287|75922275|FG003|Overall Study|Adverse Event|1|||
42112111|NCT03381287|75922272|FG000|Overall Study|Physician Decision|0|||
42112112|NCT03381287|75922273|FG001|Overall Study|Physician Decision|0|||
42204842|NCT03399786|76017388|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
42204843|NCT03399786|76017389|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
42204844|NCT03505593|76017397|FG000|Overall Study|Withdrawal by Subject|1|||
42204845|NCT03505593|76017397|FG000|Overall Study|Died before procedure|1|||
42204846|NCT03505593|76017397|FG000|Overall Study|Anatomical abnormality|1|||
42204847|NCT03505593|76017397|FG000|Overall Study|Unable to pass through esophagus|1|||
42204848|NCT03505593|76017397|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
42204849|NCT03504189|76017401|FG000|Overall Study|Withdrawal by Subject|1|||
42204850|NCT03504189|76017401|FG000|Overall Study|Screening Failure|1|||
42204851|NCT03504189|76017401|FG000|Overall Study|Device Failure|2|||
42204852|NCT03374358|76017412|FG000|Overall Study|Withdrawal by Subject|0|||
42204853|NCT03374358|76017413|FG001|Overall Study|Withdrawal by Subject|2|||
42204854|NCT03372096|76017419|FG000|Overall Study|Study Closed|8|||
42204855|NCT00004859|76017428|FG000|Overall Study|Lack of Efficacy|43|||
42204856|NCT00004859|76017429|FG001|Overall Study|Lack of Efficacy|113|||
42204857|NCT00004859|76017428|FG000|Overall Study|Adverse Event|31|||
42204858|NCT00004859|76017429|FG001|Overall Study|Adverse Event|93|||
42204859|NCT00004859|76017428|FG000|Overall Study|Death|5|||
42204860|NCT00004859|76017429|FG001|Overall Study|Death|5|||
42204861|NCT00004859|76017428|FG000|Overall Study|Withdrawal by Subject|7|||
42389027|NCT02620020|76272703|FG001|Overall Study|Death|1|||
42389028|NCT02620020|76272704|FG002|Overall Study|Death|0|||
42389029|NCT02620020|76272705|FG003|Overall Study|Death|0|||
42389030|NCT02549989|76272715|FG000|Overall Study|Adverse Event|4|||
42389031|NCT02549989|76272715|FG000|Overall Study|Death|1|||
42389032|NCT02549989|76272715|FG000|Overall Study|Lack of Efficacy|19|||
42389033|NCT02549989|76272715|FG000|Overall Study|Withdrawal by Subject|3|||
42389034|NCT00987935|76272874|FG000|Overall Study|Progressive disease|3|||
42389035|NCT00987935|76272875|FG001|Overall Study|Progressive disease|2|||
42389036|NCT00987935|76272876|FG002|Overall Study|Progressive disease|3|||
42389037|NCT00987935|76272877|FG003|Overall Study|Progressive disease|2|||
42389038|NCT00987935|76272878|FG004|Overall Study|Progressive disease|5|||
42389039|NCT00987935|76272879|FG005|Overall Study|Progressive disease|3|||
42389040|NCT00987935|76272880|FG006|Overall Study|Progressive disease|9|||
42389041|NCT00987935|76272881|FG007|Overall Study|Progressive disease|48|||
42389042|NCT00987935|76272882|FG008|Overall Study|Progressive disease|23|||
42389043|NCT00987935|76272874|FG000|Overall Study|Adverse Event|0|||
42389044|NCT00987935|76272875|FG001|Overall Study|Adverse Event|1|||
42389045|NCT00987935|76272876|FG002|Overall Study|Adverse Event|0|||
42389046|NCT00987935|76272877|FG003|Overall Study|Adverse Event|1|||
42389047|NCT00987935|76272878|FG004|Overall Study|Adverse Event|1|||
42389048|NCT00987935|76272879|FG005|Overall Study|Adverse Event|0|||
42389049|NCT00987935|76272880|FG006|Overall Study|Adverse Event|2|||
42389050|NCT00987935|76272881|FG007|Overall Study|Adverse Event|10|||
42389051|NCT00987935|76272882|FG008|Overall Study|Adverse Event|6|||
42389052|NCT00987935|76272874|FG000|Overall Study|Refused to continue taking trial med.|1|||
42389053|NCT00987935|76272875|FG001|Overall Study|Refused to continue taking trial med.|0|||
42389054|NCT00987935|76272876|FG002|Overall Study|Refused to continue taking trial med.|0|||
42389055|NCT00987935|76272877|FG003|Overall Study|Refused to continue taking trial med.|0|||
42389056|NCT00987935|76272878|FG004|Overall Study|Refused to continue taking trial med.|1|||
42389057|NCT00987935|76272879|FG005|Overall Study|Refused to continue taking trial med.|0|||
42389058|NCT00987935|76272880|FG006|Overall Study|Refused to continue taking trial med.|4|||
42389059|NCT00987935|76272881|FG007|Overall Study|Refused to continue taking trial med.|4|||
42389060|NCT00987935|76272882|FG008|Overall Study|Refused to continue taking trial med.|2|||
42389061|NCT00987935|76272874|FG000|Overall Study|Reason other than those specified above|0|||
42112113|NCT03381287|75922274|FG002|Overall Study|Physician Decision|0|||
42112114|NCT03381287|75922275|FG003|Overall Study|Physician Decision|1|||
42112115|NCT00616928|75922299|FG000|Overall Study|Adverse Event|6|||
42112116|NCT00616928|75922300|FG001|Overall Study|Adverse Event|3|||
42112117|NCT00616928|75922301|FG002|Overall Study|Adverse Event|2|||
42112118|NCT00616928|75922302|FG003|Overall Study|Adverse Event|2|||
42112119|NCT00616928|75922299|FG000|Overall Study|Other|51|||
42112120|NCT00616928|75922300|FG001|Overall Study|Other|8|||
42112121|NCT00616928|75922301|FG002|Overall Study|Other|15|||
42112122|NCT00616928|75922302|FG003|Overall Study|Other|5|||
42112123|NCT00616928|75922299|FG000|Overall Study|Lost to Follow-up|5|||
42204862|NCT00004859|76017429|FG001|Overall Study|Withdrawal by Subject|33|||
42389062|NCT00987935|76272875|FG001|Overall Study|Reason other than those specified above|0|||
42389063|NCT00987935|76272876|FG002|Overall Study|Reason other than those specified above|0|||
42389064|NCT00987935|76272877|FG003|Overall Study|Reason other than those specified above|0|||
42389065|NCT00987935|76272878|FG004|Overall Study|Reason other than those specified above|0|||
42389066|NCT00987935|76272879|FG005|Overall Study|Reason other than those specified above|0|||
42112124|NCT00616928|75922300|FG001|Overall Study|Lost to Follow-up|7|||
42204863|NCT00004859|76017428|FG000|Overall Study|Protocol Violation|2|||
42204864|NCT00004859|76017429|FG001|Overall Study|Protocol Violation|2|||
42204865|NCT00004859|76017428|FG000|Overall Study|other disease|0|||
42112125|NCT00616928|75922301|FG002|Overall Study|Lost to Follow-up|0|||
42112126|NCT00616928|75922302|FG003|Overall Study|Lost to Follow-up|0|||
42112127|NCT00563784|75922324|FG000|Overall Study|Withdrawal by Subject|2|||
42112128|NCT00563784|75922324|FG000|Overall Study|Screen Failures|20|||
42112129|NCT00203047|75922339|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
42112130|NCT00203047|75922340|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
42112131|NCT00203047|75922339|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
42112132|NCT00203047|75922340|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
42112133|NCT00203047|75922339|FG000|Overall Study|Withdrawal by Subject|13|||
42112134|NCT00203047|75922340|FG001|Overall Study|Withdrawal by Subject|47|||
42112135|NCT00203047|75922339|FG000|Overall Study|Teva requested participant withdrawal|1|||
42112136|NCT00203047|75922340|FG001|Overall Study|Teva requested participant withdrawal|1|||
42112137|NCT00203047|75922339|FG000|Overall Study|Physician Decision|8|||
42112138|NCT00203047|75922340|FG001|Overall Study|Physician Decision|7|||
42112139|NCT00203047|75922339|FG000|Overall Study|Non-compliance|4|||
42112140|NCT00203047|75922340|FG001|Overall Study|Non-compliance|8|||
42112141|NCT00203047|75922339|FG000|Overall Study|Protocol Violation|1|||
42112142|NCT00203047|75922340|FG001|Overall Study|Protocol Violation|0|||
42112143|NCT00203047|75922339|FG000|Overall Study|Lost to Follow-up|11|||
42112144|NCT00203047|75922340|FG001|Overall Study|Lost to Follow-up|5|||
42112145|NCT00203047|75922339|FG000|Overall Study|Adverse Event|8|||
42389067|NCT00987935|76272880|FG006|Overall Study|Reason other than those specified above|0|||
42389068|NCT00987935|76272881|FG007|Overall Study|Reason other than those specified above|0|||
42389069|NCT00987935|76272882|FG008|Overall Study|Reason other than those specified above|1|||
42389070|NCT01597050|76272910|FG000|Overall Study|Withdrawal by Subject|1|||
42389071|NCT01597050|76272911|FG001|Overall Study|Withdrawal by Subject|0|||
42389072|NCT00987623|76272928|FG000|Overall Study|Lost to Follow-up|2|||
42389073|NCT00987623|76272929|FG001|Overall Study|Lost to Follow-up|1|||
42389074|NCT00987623|76272928|FG000|Overall Study|Time/job conflict|2|||
42389075|NCT00987623|76272929|FG001|Overall Study|Time/job conflict|0|||
42389076|NCT00987623|76272928|FG000|Overall Study|Discomfort|1|||
42389077|NCT00987623|76272929|FG001|Overall Study|Discomfort|0|||
42389078|NCT00987623|76272928|FG000|Overall Study|Biomicroscopy|0|||
42389079|NCT00987623|76272929|FG001|Overall Study|Biomicroscopy|1|||
42389080|NCT00987623|76272928|FG000|Overall Study|Influenza|0|||
42389081|NCT00987623|76272929|FG001|Overall Study|Influenza|1|||
42389082|NCT00987467|76272935|FG000|Overall Study|Lost to Follow-up|2|||
42389083|NCT04990440|76272943|FG000|Overall Study|Sponsor's Decision|0|||
42389084|NCT04990440|76272944|FG001|Overall Study|Sponsor's Decision|0|||
42389085|NCT04990440|76272945|FG002|Overall Study|Sponsor's Decision|1|||
42389086|NCT04829747|76272953|FG000|Overall Study|Protocol Violation|1|||
42389087|NCT04258423|76272991|FG000|Overall Study|Study Closure|2|||
42389088|NCT04258423|76272992|FG001|Overall Study|Study Closure|2|||
42389089|NCT04178967|76273000|FG000|Induction Period|Adverse Event|4|||
42389090|NCT04178967|76273001|FG001|Induction Period|Adverse Event|6|||
42389091|NCT04178967|76273002|FG002|Induction Period|Adverse Event|0|||
42389092|NCT04178967|76273003|FG003|Induction Period|Adverse Event|0|||
42389093|NCT04178967|76273004|FG004|Induction Period|Adverse Event|0|||
42389094|NCT04178967|76273005|FG005|Induction Period|Adverse Event|0|||
42389095|NCT04178967|76273006|FG006|Induction Period|Adverse Event|0|||
42389096|NCT04178967|76273007|FG007|Induction Period|Adverse Event|0|||
42389097|NCT04178967|76273008|FG008|Induction Period|Adverse Event|0|||
42389098|NCT04178967|76273009|FG009|Induction Period|Adverse Event|0|||
42389099|NCT04178967|76273010|FG010|Induction Period|Adverse Event|0|||
42389100|NCT04178967|76273000|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
42389101|NCT04178967|76273001|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
42389102|NCT04178967|76273002|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
42389103|NCT04178967|76273003|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
42389104|NCT04178967|76273004|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
42389105|NCT04178967|76273005|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
42389106|NCT04178967|76273006|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
42389107|NCT04178967|76273007|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
42389108|NCT04178967|76273008|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
42389109|NCT04178967|76273009|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
42389110|NCT04178967|76273010|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
42389111|NCT04178967|76273000|FG000|Induction Period|Lack of Efficacy|4|||
42389112|NCT04178967|76273001|FG001|Induction Period|Lack of Efficacy|1|||
42389113|NCT04178967|76273002|FG002|Induction Period|Lack of Efficacy|0|||
42389114|NCT04178967|76273003|FG003|Induction Period|Lack of Efficacy|0|||
42389115|NCT04178967|76273004|FG004|Induction Period|Lack of Efficacy|0|||
42389116|NCT04178967|76273005|FG005|Induction Period|Lack of Efficacy|0|||
42389117|NCT04178967|76273006|FG006|Induction Period|Lack of Efficacy|0|||
42389118|NCT04178967|76273007|FG007|Induction Period|Lack of Efficacy|0|||
42112146|NCT00203047|75922340|FG001|Overall Study|Adverse Event|18|||
42389119|NCT04178967|76273008|FG008|Induction Period|Lack of Efficacy|0|||
42389120|NCT04178967|76273009|FG009|Induction Period|Lack of Efficacy|0|||
42389121|NCT04178967|76273010|FG010|Induction Period|Lack of Efficacy|0|||
42389122|NCT04178967|76273000|FG000|Induction Period|Protocol Violation|0|||
42389123|NCT04178967|76273001|FG001|Induction Period|Protocol Violation|6|||
42389124|NCT04178967|76273002|FG002|Induction Period|Protocol Violation|0|||
42389125|NCT04178967|76273003|FG003|Induction Period|Protocol Violation|0|||
42389126|NCT04178967|76273004|FG004|Induction Period|Protocol Violation|0|||
42389127|NCT04178967|76273005|FG005|Induction Period|Protocol Violation|0|||
42389128|NCT04178967|76273006|FG006|Induction Period|Protocol Violation|0|||
42389129|NCT04178967|76273007|FG007|Induction Period|Protocol Violation|0|||
42389130|NCT04178967|76273008|FG008|Induction Period|Protocol Violation|0|||
42389131|NCT04178967|76273009|FG009|Induction Period|Protocol Violation|0|||
42389132|NCT04178967|76273010|FG010|Induction Period|Protocol Violation|0|||
42389133|NCT04178967|76273000|FG000|Induction Period|Withdrawal by Subject|6|||
42389134|NCT04178967|76273001|FG001|Induction Period|Withdrawal by Subject|4|||
42389135|NCT04178967|76273002|FG002|Induction Period|Withdrawal by Subject|0|||
42389136|NCT04178967|76273003|FG003|Induction Period|Withdrawal by Subject|0|||
42389137|NCT04178967|76273004|FG004|Induction Period|Withdrawal by Subject|0|||
42389138|NCT04178967|76273005|FG005|Induction Period|Withdrawal by Subject|0|||
42389139|NCT04178967|76273006|FG006|Induction Period|Withdrawal by Subject|0|||
42389140|NCT04178967|76273007|FG007|Induction Period|Withdrawal by Subject|0|||
42389141|NCT04178967|76273008|FG008|Induction Period|Withdrawal by Subject|0|||
42389142|NCT04178967|76273009|FG009|Induction Period|Withdrawal by Subject|0|||
42389143|NCT04178967|76273010|FG010|Induction Period|Withdrawal by Subject|0|||
42389144|NCT04178967|76273000|FG000|Induction Period|Lost to Follow-up|2|||
42389145|NCT04178967|76273001|FG001|Induction Period|Lost to Follow-up|0|||
42389146|NCT04178967|76273002|FG002|Induction Period|Lost to Follow-up|0|||
42389147|NCT04178967|76273003|FG003|Induction Period|Lost to Follow-up|0|||
42389148|NCT04178967|76273004|FG004|Induction Period|Lost to Follow-up|0|||
42389149|NCT04178967|76273005|FG005|Induction Period|Lost to Follow-up|0|||
42389150|NCT04178967|76273006|FG006|Induction Period|Lost to Follow-up|0|||
42389151|NCT04178967|76273007|FG007|Induction Period|Lost to Follow-up|0|||
42389152|NCT04178967|76273008|FG008|Induction Period|Lost to Follow-up|0|||
42389153|NCT04178967|76273009|FG009|Induction Period|Lost to Follow-up|0|||
42389154|NCT04178967|76273010|FG010|Induction Period|Lost to Follow-up|0|||
42389155|NCT04178967|76273000|FG000|Induction Period|Participant Missed Study Visits|0|||
42389156|NCT04178967|76273001|FG001|Induction Period|Participant Missed Study Visits|1|||
42389157|NCT04178967|76273002|FG002|Induction Period|Participant Missed Study Visits|0|||
42389158|NCT04178967|76273003|FG003|Induction Period|Participant Missed Study Visits|0|||
42389159|NCT04178967|76273004|FG004|Induction Period|Participant Missed Study Visits|0|||
42389160|NCT04178967|76273005|FG005|Induction Period|Participant Missed Study Visits|0|||
42389161|NCT04178967|76273006|FG006|Induction Period|Participant Missed Study Visits|0|||
42389162|NCT04178967|76273007|FG007|Induction Period|Participant Missed Study Visits|0|||
42389163|NCT04178967|76273008|FG008|Induction Period|Participant Missed Study Visits|0|||
42389164|NCT04178967|76273009|FG009|Induction Period|Participant Missed Study Visits|0|||
42389165|NCT04178967|76273010|FG010|Induction Period|Participant Missed Study Visits|0|||
42389166|NCT04178967|76273000|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
42389167|NCT04178967|76273001|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
42389168|NCT04178967|76273002|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
42389169|NCT04178967|76273003|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
42389170|NCT04178967|76273004|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
42389171|NCT04178967|76273005|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
42389172|NCT04178967|76273006|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
42389173|NCT04178967|76273007|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
42389174|NCT04178967|76273008|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
42389175|NCT04178967|76273009|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
42389176|NCT04178967|76273010|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
42389177|NCT04178967|76273000|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42389178|NCT04178967|76273001|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42389179|NCT04178967|76273002|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42389180|NCT04178967|76273003|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42389181|NCT04178967|76273004|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42389182|NCT04178967|76273005|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
42389183|NCT04178967|76273006|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42389184|NCT04178967|76273007|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42389185|NCT04178967|76273008|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42389186|NCT04178967|76273009|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42389187|NCT04178967|76273010|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
42389188|NCT04178967|76273000|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42389189|NCT04178967|76273001|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42389190|NCT04178967|76273002|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42389191|NCT04178967|76273003|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
42389192|NCT04178967|76273004|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42389193|NCT04178967|76273005|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42389194|NCT04178967|76273006|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42389195|NCT04178967|76273007|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42389196|NCT04178967|76273008|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42389197|NCT04178967|76273009|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42389198|NCT04178967|76273010|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
42389199|NCT04178967|76273000|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
42389200|NCT04178967|76273001|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
42389201|NCT04178967|76273002|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
42389202|NCT04178967|76273003|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
42389203|NCT04178967|76273004|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
42389204|NCT04178967|76273005|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
42389205|NCT04178967|76273006|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
42389206|NCT04178967|76273007|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
42389207|NCT04178967|76273008|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
42389208|NCT04178967|76273009|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
42389209|NCT04178967|76273010|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
42389210|NCT04178967|76273000|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42389211|NCT04178967|76273001|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42389212|NCT04178967|76273002|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42389213|NCT04178967|76273003|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42389214|NCT04178967|76273004|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
42389215|NCT04178967|76273005|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
42389216|NCT04178967|76273006|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42389217|NCT04178967|76273007|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
42389218|NCT04178967|76273008|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42389219|NCT04178967|76273009|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42389220|NCT04178967|76273010|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
42389221|NCT04178967|76273000|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
42389222|NCT04178967|76273001|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
42389223|NCT04178967|76273002|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
42389224|NCT04178967|76273003|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
42389225|NCT04178967|76273004|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
42389226|NCT04178967|76273005|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
42389227|NCT04178967|76273006|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
42389228|NCT04178967|76273007|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
42389229|NCT04178967|76273008|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
42389230|NCT04178967|76273009|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
42389231|NCT04178967|76273010|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
42389232|NCT04178967|76273000|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42389233|NCT04178967|76273001|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42389234|NCT04178967|76273002|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42389235|NCT04178967|76273003|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
42389236|NCT04178967|76273004|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42389237|NCT04178967|76273005|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
42389238|NCT04178967|76273006|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
42389239|NCT04178967|76273007|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
42389240|NCT04178967|76273008|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42389241|NCT04178967|76273009|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42389242|NCT04178967|76273010|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
42389243|NCT04178967|76273000|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
42389244|NCT04178967|76273001|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
42389245|NCT04178967|76273002|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
42389246|NCT04178967|76273003|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
42389247|NCT04178967|76273004|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
42389248|NCT04178967|76273005|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
42389249|NCT04178967|76273006|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
42389250|NCT04178967|76273007|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
42389251|NCT04178967|76273008|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
42389252|NCT04178967|76273009|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
42389253|NCT04178967|76273010|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
42389254|NCT04178967|76273000|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42112147|NCT00203047|75922339|FG000|Overall Study|Death|1|||
42112148|NCT00203047|75922340|FG001|Overall Study|Death|2|||
42112149|NCT00203047|75922339|FG000|Overall Study|Pregnancy|3|||
42389255|NCT04178967|76273001|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42389256|NCT04178967|76273002|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42389257|NCT04178967|76273003|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42389258|NCT04178967|76273004|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42389259|NCT04178967|76273005|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42389260|NCT04178967|76273006|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42389261|NCT04178967|76273007|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
42389262|NCT04178967|76273008|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
42389263|NCT04178967|76273009|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
42389264|NCT04178967|76273010|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
42389265|NCT04178967|76273000|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42389266|NCT04178967|76273001|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42389267|NCT04178967|76273002|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42389268|NCT04178967|76273003|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42389269|NCT04178967|76273004|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42389270|NCT04178967|76273005|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42389271|NCT04178967|76273006|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42389272|NCT04178967|76273007|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42389273|NCT04178967|76273008|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42389274|NCT04178967|76273009|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
42389275|NCT04178967|76273010|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
42389276|NCT04178967|76273000|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42389277|NCT04178967|76273001|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42389278|NCT04178967|76273002|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42389279|NCT04178967|76273003|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42389280|NCT04178967|76273004|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42389281|NCT04178967|76273005|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42389282|NCT04178967|76273006|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42389283|NCT04178967|76273007|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
42389284|NCT04178967|76273008|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
42389285|NCT04178967|76273009|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
42389286|NCT04178967|76273010|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
42389287|NCT04178967|76273000|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
42389288|NCT04178967|76273001|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
42389289|NCT04178967|76273002|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
42389290|NCT04178967|76273003|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
42389291|NCT04178967|76273004|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
42389292|NCT04178967|76273005|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
42389293|NCT04178967|76273006|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
42389294|NCT04178967|76273007|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
42389295|NCT04178967|76273008|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
42389296|NCT04178967|76273009|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
42389297|NCT04178967|76273010|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
42389298|NCT04178967|76273000|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
42389299|NCT04178967|76273001|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
42389300|NCT04178967|76273002|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
42389301|NCT04178967|76273003|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
42389302|NCT04178967|76273004|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
42389303|NCT04178967|76273005|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
42389304|NCT04178967|76273006|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
42389305|NCT04178967|76273007|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
42389306|NCT04178967|76273008|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
42389307|NCT04178967|76273009|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
42389308|NCT04178967|76273010|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
42389309|NCT04163900|76273032|FG000|Overall Study|Radiological disease progression|112|||
42389310|NCT04163900|76273033|FG001|Overall Study|Radiological disease progression|127|||
42389311|NCT04163900|76273032|FG000|Overall Study|Study closure|98|||
42389312|NCT04163900|76273033|FG001|Overall Study|Study closure|133|||
42389313|NCT04163900|76273032|FG000|Overall Study|Adverse Event|78|||
42389314|NCT04163900|76273033|FG001|Overall Study|Adverse Event|32|||
42389315|NCT04163900|76273032|FG000|Overall Study|Withdrawal by Subject|37|||
42389316|NCT04163900|76273033|FG001|Overall Study|Withdrawal by Subject|34|||
42389317|NCT04163900|76273032|FG000|Overall Study|Death|29|||
42389318|NCT04163900|76273033|FG001|Overall Study|Death|16|||
42389319|NCT04163900|76273032|FG000|Overall Study|Physician Decision|17|||
42389320|NCT04163900|76273033|FG001|Overall Study|Physician Decision|25|||
42389321|NCT04163900|76273032|FG000|Overall Study|Clinical disease progression|14|||
42389322|NCT04163900|76273033|FG001|Overall Study|Clinical disease progression|13|||
42389323|NCT04163900|76273032|FG000|Overall Study|Protocol Violation|3|||
42389324|NCT04163900|76273033|FG001|Overall Study|Protocol Violation|4|||
42389325|NCT04163900|76273032|FG000|Overall Study|Lost to Follow-up|0|||
42389326|NCT04163900|76273033|FG001|Overall Study|Lost to Follow-up|1|||
42389327|NCT04161495|76273041|FG000|Overall Study|Withdrawal by Subject|3|||
42389328|NCT04161495|76273042|FG001|Overall Study|Withdrawal by Subject|0|||
42389329|NCT04161495|76273041|FG000|Overall Study|Protocol Violation|1|||
42389330|NCT04161495|76273042|FG001|Overall Study|Protocol Violation|0|||
42389331|NCT04161495|76273041|FG000|Overall Study|Prohibited concomitant medication|3|||
42389332|NCT04161495|76273042|FG001|Overall Study|Prohibited concomitant medication|0|||
42389333|NCT04161495|76273041|FG000|Overall Study|Adverse Event|1|||
42389334|NCT04161495|76273042|FG001|Overall Study|Adverse Event|0|||
42389335|NCT04161495|76273041|FG000|Overall Study|Other - Unspecified|1|||
42389336|NCT04161495|76273042|FG001|Overall Study|Other - Unspecified|0|||
42389337|NCT04161495|76273041|FG000|Overall Study|Death|0|||
42389338|NCT04161495|76273042|FG001|Overall Study|Death|1|||
42389339|NCT04108000|76273071|FG000|Overall Study|Death of patient|1|||
42389340|NCT04108000|76273072|FG001|Overall Study|Death of patient|0|||
42389341|NCT04108000|76273073|FG002|Overall Study|Death of patient|1|||
42389342|NCT04108000|76273074|FG003|Overall Study|Death of patient|0|||
42389343|NCT04108000|76273071|FG000|Overall Study|Withdrawal by Subject|2|||
42389344|NCT04108000|76273072|FG001|Overall Study|Withdrawal by Subject|2|||
42389345|NCT04108000|76273073|FG002|Overall Study|Withdrawal by Subject|0|||
42389346|NCT04108000|76273074|FG003|Overall Study|Withdrawal by Subject|0|||
42389347|NCT04108000|76273071|FG000|Overall Study|Death of surrogate partner|0|||
42389348|NCT04108000|76273072|FG001|Overall Study|Death of surrogate partner|1|||
42389349|NCT04108000|76273073|FG002|Overall Study|Death of surrogate partner|0|||
42389350|NCT04108000|76273074|FG003|Overall Study|Death of surrogate partner|1|||
42389351|NCT03945266|76273090|FG000|Overall Study|Withdrawal by Subject|1|||
42389352|NCT03945266|76273091|FG001|Overall Study|Withdrawal by Subject|0|||
42389353|NCT03945266|76273090|FG000|Overall Study|Miscarriage|0|||
42389354|NCT03945266|76273091|FG001|Overall Study|Miscarriage|2|||
42389355|NCT03945266|76273090|FG000|Overall Study|Lost to Follow-up|1|||
42389356|NCT03945266|76273091|FG001|Overall Study|Lost to Follow-up|0|||
42389357|NCT03916484|76273105|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
42389358|NCT03916484|76273106|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
42389359|NCT03916484|76273107|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
42389360|NCT03916484|76273108|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
42389361|NCT03916484|76273105|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
42389362|NCT03916484|76273106|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
42389363|NCT03916484|76273107|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
42389364|NCT03916484|76273108|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
42389365|NCT03769311|76273123|FG000|Overall Study|Withdrawal by Subject|1|||
42389366|NCT03738566|76273131|FG000|Initial Study Phase|Withdrawal by Subject|1|||
42389367|NCT03738566|76273132|FG001|Initial Study Phase|Withdrawal by Subject|1|||
42389368|NCT03738566|76273133|FG002|Initial Study Phase|Withdrawal by Subject|2|||
42389369|NCT03738566|76273134|FG003|Initial Study Phase|Withdrawal by Subject|0|||
42389370|NCT03738566|76273131|FG000|Initial Study Phase|Death|0|||
42389371|NCT03738566|76273132|FG001|Initial Study Phase|Death|1|||
42389372|NCT03738566|76273133|FG002|Initial Study Phase|Death|0|||
42389373|NCT03738566|76273134|FG003|Initial Study Phase|Death|0|||
42389374|NCT03738566|76273131|FG000|Initial Study Phase|Treatment failure|5|||
42389375|NCT03738566|76273132|FG001|Initial Study Phase|Treatment failure|0|||
42389376|NCT03738566|76273133|FG002|Initial Study Phase|Treatment failure|0|||
42389377|NCT03738566|76273134|FG003|Initial Study Phase|Treatment failure|0|||
42389378|NCT03738566|76273131|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
42389379|NCT03738566|76273132|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
42389380|NCT03738566|76273133|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
42389381|NCT03738566|76273134|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
42389382|NCT03533751|76273169|FG000|Overall Study|Withdrawal by Subject|12|||
42389383|NCT03533751|76273170|FG001|Overall Study|Withdrawal by Subject|6|||
42389384|NCT03533751|76273171|FG002|Overall Study|Withdrawal by Subject|11|||
42389385|NCT03533751|76273172|FG003|Overall Study|Withdrawal by Subject|9|||
42389386|NCT03533751|76273173|FG004|Overall Study|Withdrawal by Subject|10|||
42389387|NCT03533751|76273169|FG000|Overall Study|Adverse Event|4|||
42389388|NCT03533751|76273170|FG001|Overall Study|Adverse Event|7|||
42389389|NCT03533751|76273171|FG002|Overall Study|Adverse Event|2|||
42389390|NCT03533751|76273172|FG003|Overall Study|Adverse Event|4|||
42389391|NCT03533751|76273173|FG004|Overall Study|Adverse Event|5|||
42389392|NCT03533751|76273169|FG000|Overall Study|Physician Decision|0|||
42389393|NCT03533751|76273170|FG001|Overall Study|Physician Decision|2|||
42389394|NCT03533751|76273171|FG002|Overall Study|Physician Decision|1|||
42389395|NCT03533751|76273172|FG003|Overall Study|Physician Decision|2|||
42389396|NCT03533751|76273173|FG004|Overall Study|Physician Decision|1|||
42389397|NCT03533751|76273169|FG000|Overall Study|Sponsor Decision|0|||
42389398|NCT03533751|76273170|FG001|Overall Study|Sponsor Decision|0|||
42389399|NCT03533751|76273171|FG002|Overall Study|Sponsor Decision|1|||
42389400|NCT03533751|76273172|FG003|Overall Study|Sponsor Decision|1|||
42389401|NCT03533751|76273173|FG004|Overall Study|Sponsor Decision|0|||
42389402|NCT03533751|76273169|FG000|Overall Study|Lost to Follow-up|3|||
42389403|NCT03533751|76273170|FG001|Overall Study|Lost to Follow-up|7|||
42389404|NCT03533751|76273171|FG002|Overall Study|Lost to Follow-up|6|||
42389405|NCT03533751|76273172|FG003|Overall Study|Lost to Follow-up|4|||
42389406|NCT03533751|76273173|FG004|Overall Study|Lost to Follow-up|3|||
42389407|NCT03533751|76273169|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
42389408|NCT03533751|76273170|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
42389409|NCT03533751|76273171|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
42389410|NCT03533751|76273172|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
42389411|NCT03533751|76273173|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
42389412|NCT03533751|76273169|FG000|Overall Study|Other|0|||
42389413|NCT03533751|76273170|FG001|Overall Study|Other|2|||
42389414|NCT03533751|76273171|FG002|Overall Study|Other|1|||
42389415|NCT03533751|76273172|FG003|Overall Study|Other|0|||
42389416|NCT03533751|76273173|FG004|Overall Study|Other|3|||
42389417|NCT04856917|76273192|FG000|Overall Study|Withdrawal by Subject|4|||
42389418|NCT04856917|76273193|FG001|Overall Study|Withdrawal by Subject|3|||
42389419|NCT04856917|76273194|FG002|Overall Study|Withdrawal by Subject|1|||
42389420|NCT04856917|76273192|FG000|Overall Study|Lost to Follow-up|3|||
42389421|NCT04856917|76273193|FG001|Overall Study|Lost to Follow-up|1|||
42389422|NCT04856917|76273194|FG002|Overall Study|Lost to Follow-up|1|||
42389423|NCT04856917|76273192|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
42389424|NCT04856917|76273193|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
42389425|NCT04856917|76273194|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
42389426|NCT04856917|76273192|FG000|Overall Study|Other|1|||
42389427|NCT04856917|76273193|FG001|Overall Study|Other|1|||
42389428|NCT04856917|76273194|FG002|Overall Study|Other|0|||
42389429|NCT04615247|76273232|FG000|Overall Study|Adverse Event|0|||
42389430|NCT04615247|76273233|FG001|Overall Study|Adverse Event|2|||
42389431|NCT04615247|76273232|FG000|Overall Study|Withdrawal by Subject|1|||
42389432|NCT04615247|76273233|FG001|Overall Study|Withdrawal by Subject|1|||
42389433|NCT04552132|76273254|FG000|Overall Study|Lost to Follow-up|4|||
42389434|NCT04552132|76273255|FG001|Overall Study|Lost to Follow-up|3|||
42389435|NCT04552132|76273254|FG000|Overall Study|Protocol Violation|1|||
42389436|NCT04552132|76273255|FG001|Overall Study|Protocol Violation|0|||
42389437|NCT04421456|76273264|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
42389438|NCT04421456|76273265|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
42389439|NCT04421456|76273266|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
42389440|NCT04421456|76273264|FG000|Randomized Treatment Period|Adverse Event|0|||
42389441|NCT04421456|76273265|FG001|Randomized Treatment Period|Adverse Event|1|||
42389442|NCT04421456|76273266|FG002|Randomized Treatment Period|Adverse Event|0|||
42389443|NCT04421456|76273264|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
42389444|NCT04421456|76273265|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
42389445|NCT04421456|76273266|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
42389446|NCT04421456|76273264|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
42389447|NCT04421456|76273265|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
42389448|NCT04421456|76273266|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
42389449|NCT04421456|76273264|FG000|Randomized Treatment Period|Participant non-compliance|1|||
42389450|NCT04421456|76273265|FG001|Randomized Treatment Period|Participant non-compliance|1|||
42389451|NCT04421456|76273266|FG002|Randomized Treatment Period|Participant non-compliance|2|||
42389452|NCT04421456|76273264|FG000|Randomized Treatment Period|Other|0|||
42389453|NCT04421456|76273265|FG001|Randomized Treatment Period|Other|1|||
42389454|NCT04421456|76273266|FG002|Randomized Treatment Period|Other|3|||
42389455|NCT04341363|76273275|FG000|Overall Study|Adverse Event|1|||
42389456|NCT04341363|76273275|FG000|Overall Study|Withdrawal by Subject|1|||
42389457|NCT04268303|76273286|FG000|Overall Study|Lost to Follow-up|1|||
42389458|NCT04268303|76273287|FG001|Overall Study|Lost to Follow-up|1|||
42389459|NCT04268303|76273288|FG002|Overall Study|Lost to Follow-up|2|||
42389460|NCT04268303|76273286|FG000|Overall Study|Withdrawal by Subject|0|||
42389461|NCT04268303|76273287|FG001|Overall Study|Withdrawal by Subject|1|||
42389462|NCT04268303|76273288|FG002|Overall Study|Withdrawal by Subject|1|||
42389463|NCT04268303|76273286|FG000|Overall Study|Adverse Event|2|||
42389464|NCT04268303|76273287|FG001|Overall Study|Adverse Event|0|||
42389465|NCT04268303|76273288|FG002|Overall Study|Adverse Event|0|||
42389466|NCT04092452|76273332|FG000|Overall Study|Adverse Event|1|||
42389467|NCT04092452|76273333|FG001|Overall Study|Adverse Event|3|||
42389468|NCT04092452|76273334|FG002|Overall Study|Adverse Event|3|||
42389469|NCT04092452|76273335|FG003|Overall Study|Adverse Event|7|||
42389470|NCT04092452|76273332|FG000|Overall Study|Lack of Efficacy|1|||
42389471|NCT04092452|76273333|FG001|Overall Study|Lack of Efficacy|1|||
42389472|NCT04092452|76273334|FG002|Overall Study|Lack of Efficacy|1|||
42389473|NCT04092452|76273335|FG003|Overall Study|Lack of Efficacy|0|||
42389474|NCT04092452|76273332|FG000|Overall Study|Lost to Follow-up|4|||
42389475|NCT04092452|76273333|FG001|Overall Study|Lost to Follow-up|3|||
42389476|NCT04092452|76273334|FG002|Overall Study|Lost to Follow-up|5|||
42389477|NCT04092452|76273335|FG003|Overall Study|Lost to Follow-up|1|||
42389478|NCT04092452|76273332|FG000|Overall Study|Non-Compliance With Study Drug|0|||
42389479|NCT04092452|76273333|FG001|Overall Study|Non-Compliance With Study Drug|0|||
42389480|NCT04092452|76273334|FG002|Overall Study|Non-Compliance With Study Drug|1|||
42389481|NCT04092452|76273335|FG003|Overall Study|Non-Compliance With Study Drug|1|||
42389482|NCT04092452|76273332|FG000|Overall Study|Physician Decision|1|||
42389483|NCT04092452|76273333|FG001|Overall Study|Physician Decision|0|||
42389484|NCT04092452|76273334|FG002|Overall Study|Physician Decision|1|||
42389485|NCT04092452|76273335|FG003|Overall Study|Physician Decision|0|||
42389486|NCT04092452|76273332|FG000|Overall Study|Pregnancy|2|||
42389487|NCT04092452|76273333|FG001|Overall Study|Pregnancy|0|||
42389488|NCT04092452|76273334|FG002|Overall Study|Pregnancy|0|||
42389489|NCT04092452|76273335|FG003|Overall Study|Pregnancy|0|||
42389490|NCT04092452|76273332|FG000|Overall Study|Protocol Deviation|1|||
42389491|NCT04092452|76273333|FG001|Overall Study|Protocol Deviation|0|||
42389492|NCT04092452|76273334|FG002|Overall Study|Protocol Deviation|0|||
42389493|NCT04092452|76273335|FG003|Overall Study|Protocol Deviation|0|||
42389494|NCT04092452|76273332|FG000|Overall Study|Withdrawal by Subject|3|||
42389495|NCT04092452|76273333|FG001|Overall Study|Withdrawal by Subject|10|||
42389496|NCT04092452|76273334|FG002|Overall Study|Withdrawal by Subject|3|||
42389497|NCT04092452|76273335|FG003|Overall Study|Withdrawal by Subject|5|||
42389498|NCT04092452|76273332|FG000|Overall Study|Other|0|||
42389499|NCT04092452|76273333|FG001|Overall Study|Other|0|||
42389500|NCT04092452|76273334|FG002|Overall Study|Other|1|||
42389501|NCT04092452|76273335|FG003|Overall Study|Other|2|||
42389502|NCT04029116|76273350|FG000|Overall Study|Adverse Event|0|||
42389503|NCT04029116|76273351|FG001|Overall Study|Adverse Event|2|||
42389504|NCT04029116|76273350|FG000|Overall Study|Lost to Follow-up|3|||
42389505|NCT04029116|76273351|FG001|Overall Study|Lost to Follow-up|5|||
42389506|NCT04029116|76273350|FG000|Overall Study|Physician Decision|2|||
42389507|NCT04029116|76273351|FG001|Overall Study|Physician Decision|0|||
42389508|NCT04029116|76273350|FG000|Overall Study|Pregnancy|1|||
42389509|NCT04029116|76273351|FG001|Overall Study|Pregnancy|2|||
42389510|NCT04029116|76273350|FG000|Overall Study|Withdrawal by Subject|4|||
42389511|NCT04029116|76273351|FG001|Overall Study|Withdrawal by Subject|6|||
42389512|NCT04029116|76273350|FG000|Overall Study|Other|2|||
42389513|NCT04029116|76273351|FG001|Overall Study|Other|1|||
42389514|NCT03734029|76273382|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
42389515|NCT03734029|76273383|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
42389516|NCT03734029|76273382|FG000|Overall Study|Adverse Event|60|||
42389517|NCT03734029|76273383|FG001|Overall Study|Adverse Event|14|||
42389518|NCT03734029|76273382|FG000|Overall Study|Withdrawal by Subject|12|||
42389519|NCT03734029|76273383|FG001|Overall Study|Withdrawal by Subject|11|||
42389520|NCT03734029|76273382|FG000|Overall Study|Clinical progression by investigator|10|||
42389521|NCT03734029|76273383|FG001|Overall Study|Clinical progression by investigator|8|||
42389522|NCT03734029|76273382|FG000|Overall Study|Death|5|||
42389523|NCT03734029|76273383|FG001|Overall Study|Death|2|||
42389524|NCT03734029|76273382|FG000|Overall Study|Physician Decision|4|||
42389525|NCT03734029|76273383|FG001|Overall Study|Physician Decision|3|||
42389526|NCT03734029|76273382|FG000|Overall Study|Other|2|||
42389527|NCT03734029|76273383|FG001|Overall Study|Other|0|||
42389528|NCT03734029|76273382|FG000|Overall Study|Lost to Follow-up|0|||
42389529|NCT03734029|76273383|FG001|Overall Study|Lost to Follow-up|1|||
42389530|NCT03734029|76273382|FG000|Overall Study|Randomized, but not treated|2|||
42389531|NCT03734029|76273383|FG001|Overall Study|Randomized, but not treated|12|||
42389532|NCT03724032|76273392|FG000|Overall Study|Physician Decision|1|||
42389533|NCT03724032|76273393|FG001|Overall Study|Physician Decision|0|||
42389534|NCT03724032|76273394|FG002|Overall Study|Physician Decision|0|||
42389535|NCT03724032|76273392|FG000|Overall Study|Protocol Violation|2|||
42389536|NCT03724032|76273393|FG001|Overall Study|Protocol Violation|2|||
42389537|NCT03724032|76273394|FG002|Overall Study|Protocol Violation|1|||
42389538|NCT03657797|76273415|FG000|Overall Study|Lost to Follow-up|0|||
42389539|NCT03657797|76273416|FG001|Overall Study|Lost to Follow-up|1|||
42389540|NCT03657797|76273417|FG002|Overall Study|Lost to Follow-up|1|||
42389541|NCT03657797|76273418|FG003|Overall Study|Lost to Follow-up|0|||
42389542|NCT03657797|76273415|FG000|Overall Study|Physician Decision|0|||
42389543|NCT03657797|76273416|FG001|Overall Study|Physician Decision|1|||
42389544|NCT03657797|76273417|FG002|Overall Study|Physician Decision|0|||
42389545|NCT03657797|76273418|FG003|Overall Study|Physician Decision|0|||
42112150|NCT00203047|75922340|FG001|Overall Study|Pregnancy|0|||
42389546|NCT03657797|76273415|FG000|Overall Study|Withdrawal by Subject|0|||
42389547|NCT03657797|76273416|FG001|Overall Study|Withdrawal by Subject|1|||
42389548|NCT03657797|76273417|FG002|Overall Study|Withdrawal by Subject|2|||
42389549|NCT03657797|76273418|FG003|Overall Study|Withdrawal by Subject|0|||
42112151|NCT00203047|75922339|FG000|Overall Study|Other|5|||
42389550|NCT03657797|76273415|FG000|Overall Study|Adverse Event|0|||
42389551|NCT03657797|76273416|FG001|Overall Study|Adverse Event|0|||
42389552|NCT03657797|76273417|FG002|Overall Study|Adverse Event|2|||
42389553|NCT03657797|76273418|FG003|Overall Study|Adverse Event|0|||
42389554|NCT03551938|76273434|FG000|3-Month Follow Up|Lost to Follow-up|39|||
42389555|NCT03551938|76273435|FG001|3-Month Follow Up|Lost to Follow-up|38|||
42389556|NCT03551938|76273434|FG000|6-Month Follow Up|Lost to Follow-up|46|||
42389557|NCT03551938|76273435|FG001|6-Month Follow Up|Lost to Follow-up|42|||
42389558|NCT03551938|76273434|FG000|9-Month Follow Up|Lost to Follow-up|44|||
42389559|NCT03551938|76273435|FG001|9-Month Follow Up|Lost to Follow-up|43|||
42389560|NCT03525600|76273444|FG000|Overall Study|Adverse Event|9|||
42389561|NCT03525600|76273445|FG001|Overall Study|Adverse Event|6|||
42389562|NCT03525600|76273446|FG002|Overall Study|Adverse Event|5|||
42389563|NCT03525600|76273447|FG003|Overall Study|Adverse Event|3|||
42389564|NCT03525600|76273444|FG000|Overall Study|Lost to Follow-up|2|||
42389565|NCT03525600|76273445|FG001|Overall Study|Lost to Follow-up|4|||
42389566|NCT03525600|76273446|FG002|Overall Study|Lost to Follow-up|4|||
42389567|NCT03525600|76273447|FG003|Overall Study|Lost to Follow-up|0|||
42389568|NCT03525600|76273444|FG000|Overall Study|Physician Decision|1|||
42389569|NCT03525600|76273445|FG001|Overall Study|Physician Decision|0|||
42389570|NCT03525600|76273446|FG002|Overall Study|Physician Decision|2|||
42389571|NCT03525600|76273447|FG003|Overall Study|Physician Decision|0|||
42389572|NCT03525600|76273444|FG000|Overall Study|Consent withdrawal|36|||
42389573|NCT03525600|76273445|FG001|Overall Study|Consent withdrawal|20|||
42389574|NCT03525600|76273446|FG002|Overall Study|Consent withdrawal|6|||
42389575|NCT03525600|76273447|FG003|Overall Study|Consent withdrawal|13|||
42389576|NCT03525600|76273444|FG000|Overall Study|Death|7|||
42389577|NCT03525600|76273445|FG001|Overall Study|Death|6|||
42389578|NCT03525600|76273446|FG002|Overall Study|Death|4|||
42389579|NCT03525600|76273447|FG003|Overall Study|Death|3|||
42389580|NCT03525600|76273444|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
42389581|NCT03525600|76273445|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
42389582|NCT03525600|76273446|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
42389583|NCT03525600|76273447|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
42389584|NCT03525600|76273444|FG000|Overall Study|Other|0|||
42389585|NCT03525600|76273445|FG001|Overall Study|Other|1|||
42389586|NCT03525600|76273446|FG002|Overall Study|Other|0|||
42389587|NCT03525600|76273447|FG003|Overall Study|Other|0|||
42389588|NCT03472040|76273464|FG000|Overall Study|Physician Decision|0|||
42389589|NCT03472040|76273465|FG001|Overall Study|Physician Decision|3|||
42389590|NCT03472040|76273464|FG000|Overall Study|Withdrawal by Subject|10|||
42389591|NCT03472040|76273465|FG001|Overall Study|Withdrawal by Subject|23|||
42389592|NCT03472040|76273464|FG000|Overall Study|Perceived Lack of Efficacy|29|||
42389593|NCT03472040|76273465|FG001|Overall Study|Perceived Lack of Efficacy|30|||
42389594|NCT03472040|76273464|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
42389595|NCT03472040|76273465|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
42389596|NCT03472040|76273464|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
42389597|NCT03472040|76273465|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
42389598|NCT03472040|76273464|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
42389599|NCT03472040|76273465|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
42389600|NCT03472040|76273464|FG000|Overall Study|Subject Non-compliance|2|||
42389601|NCT03472040|76273465|FG001|Overall Study|Subject Non-compliance|5|||
42389602|NCT03472040|76273464|FG000|Overall Study|Discontinuation due to Rash|0|||
42389603|NCT03472040|76273465|FG001|Overall Study|Discontinuation due to Rash|1|||
42389604|NCT03472040|76273464|FG000|Overall Study|Subsequent Ineligibility|0|||
42389605|NCT03472040|76273465|FG001|Overall Study|Subsequent Ineligibility|2|||
42389606|NCT03472040|76273464|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
42389607|NCT03472040|76273465|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
42389608|NCT03323385|76273483|FG000|Overall Study|Withdrawal by Subject|1|||
42389609|NCT03323385|76273484|FG001|Overall Study|Withdrawal by Subject|2|||
42389610|NCT03323385|76273483|FG000|Overall Study|Noncompliance|0|||
42389611|NCT03323385|76273484|FG001|Overall Study|Noncompliance|1|||
42389612|NCT03161483|76273494|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
42389613|NCT03161483|76273495|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
42389614|NCT03161483|76273496|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
42389615|NCT03161483|76273497|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
42389616|NCT03161483|76273494|FG000|Treatment Period|Death|1|||
42389617|NCT03161483|76273495|FG001|Treatment Period|Death|0|||
42389618|NCT03161483|76273496|FG002|Treatment Period|Death|0|||
42389619|NCT03161483|76273497|FG003|Treatment Period|Death|0|||
42389620|NCT03161483|76273494|FG000|Treatment Period|Adverse Event|5|||
42389621|NCT03161483|76273495|FG001|Treatment Period|Adverse Event|2|||
42389622|NCT03161483|76273496|FG002|Treatment Period|Adverse Event|1|||
42389623|NCT03161483|76273497|FG003|Treatment Period|Adverse Event|11|||
42389624|NCT03161483|76273494|FG000|Treatment Period|Pregnancy|1|||
42389625|NCT03161483|76273495|FG001|Treatment Period|Pregnancy|0|||
42389626|NCT03161483|76273496|FG002|Treatment Period|Pregnancy|0|||
42389627|NCT03161483|76273497|FG003|Treatment Period|Pregnancy|0|||
42389628|NCT03161483|76273494|FG000|Treatment Period|Lack of Efficacy|0|||
42389629|NCT03161483|76273495|FG001|Treatment Period|Lack of Efficacy|0|||
42389630|NCT03161483|76273496|FG002|Treatment Period|Lack of Efficacy|0|||
42389631|NCT03161483|76273497|FG003|Treatment Period|Lack of Efficacy|1|||
42389632|NCT03161483|76273494|FG000|Treatment Period|Withdrawal by Subject|2|||
42389633|NCT03161483|76273495|FG001|Treatment Period|Withdrawal by Subject|5|||
42389634|NCT03161483|76273496|FG002|Treatment Period|Withdrawal by Subject|2|||
42389635|NCT03161483|76273497|FG003|Treatment Period|Withdrawal by Subject|6|||
42389636|NCT03161483|76273494|FG000|Treatment Period|Lost to Follow-up|0|||
42389637|NCT03161483|76273495|FG001|Treatment Period|Lost to Follow-up|0|||
42389638|NCT03161483|76273496|FG002|Treatment Period|Lost to Follow-up|0|||
42389639|NCT03161483|76273497|FG003|Treatment Period|Lost to Follow-up|1|||
42389640|NCT03161483|76273494|FG000|Treatment Period|Protocol Violation|0|||
42389641|NCT03161483|76273495|FG001|Treatment Period|Protocol Violation|0|||
42389642|NCT03161483|76273496|FG002|Treatment Period|Protocol Violation|0|||
42389643|NCT03161483|76273497|FG003|Treatment Period|Protocol Violation|1|||
42389644|NCT03161483|76273494|FG000|Treatment Period|Other reasons|1|||
42389645|NCT03161483|76273495|FG001|Treatment Period|Other reasons|1|||
42389646|NCT03161483|76273496|FG002|Treatment Period|Other reasons|0|||
42389647|NCT03161483|76273497|FG003|Treatment Period|Other reasons|0|||
42389648|NCT03132636|76273511|FG000|Overall Study|Adverse Event|1|||
42389649|NCT03132636|76273512|FG001|Overall Study|Adverse Event|2|||
42389650|NCT03132636|76273511|FG000|Overall Study|Death|4|||
42389651|NCT03132636|76273512|FG001|Overall Study|Death|7|||
42389652|NCT03132636|76273511|FG000|Overall Study|Lost to Follow-up|2|||
42389653|NCT03132636|76273512|FG001|Overall Study|Lost to Follow-up|2|||
42389654|NCT03132636|76273511|FG000|Overall Study|Protocol Violation|1|||
42389655|NCT03132636|76273512|FG001|Overall Study|Protocol Violation|1|||
42389656|NCT03132636|76273511|FG000|Overall Study|Participant Decision|1|||
42389657|NCT03132636|76273512|FG001|Overall Study|Participant Decision|9|||
42389658|NCT03132636|76273511|FG000|Overall Study|Sponsor Decision|0|||
42389659|NCT03132636|76273512|FG001|Overall Study|Sponsor Decision|1|||
42389660|NCT03132636|76273511|FG000|Overall Study|Progressive disease|32|||
42389661|NCT03132636|76273512|FG001|Overall Study|Progressive disease|36|||
42389662|NCT03132636|76273511|FG000|Overall Study|Withdrawal of consent|2|||
42389663|NCT03132636|76273512|FG001|Overall Study|Withdrawal of consent|5|||
42389664|NCT03132636|76273511|FG000|Overall Study|Study ongoing|9|||
42389665|NCT03132636|76273512|FG001|Overall Study|Study ongoing|10|||
42389666|NCT03132636|76273511|FG000|Overall Study|Other|1|||
42389667|NCT03132636|76273512|FG001|Overall Study|Other|2|||
42389668|NCT02906202|76273518|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
42389669|NCT02869789|76273526|FG000|Overall Study|Disease progression|184|||
42389670|NCT02869789|76273527|FG001|Overall Study|Disease progression|109|||
42389671|NCT02869789|76273528|FG002|Overall Study|Disease progression|260|||
42389672|NCT02869789|76273529|FG003|Overall Study|Disease progression|19|||
42389673|NCT02869789|76273526|FG000|Overall Study|Study drug toxicity|90|||
42389674|NCT02869789|76273527|FG001|Overall Study|Study drug toxicity|32|||
42389675|NCT02869789|76273528|FG002|Overall Study|Study drug toxicity|55|||
42389676|NCT02869789|76273529|FG003|Overall Study|Study drug toxicity|14|||
42389677|NCT02869789|76273526|FG000|Overall Study|Death|7|||
42389678|NCT02869789|76273527|FG001|Overall Study|Death|3|||
42389679|NCT02869789|76273528|FG002|Overall Study|Death|5|||
42389680|NCT02869789|76273529|FG003|Overall Study|Death|1|||
42389681|NCT02869789|76273526|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
42389682|NCT02869789|76273527|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
42389683|NCT02869789|76273528|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
42389684|NCT02869789|76273529|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
42389685|NCT02869789|76273526|FG000|Overall Study|Participant request to discontinue study treatment|10|||
42389686|NCT02869789|76273527|FG001|Overall Study|Participant request to discontinue study treatment|5|||
42389687|NCT02869789|76273528|FG002|Overall Study|Participant request to discontinue study treatment|5|||
42389688|NCT02869789|76273529|FG003|Overall Study|Participant request to discontinue study treatment|3|||
42112152|NCT00203047|75922340|FG001|Overall Study|Other|5|||
42389689|NCT02869789|76273526|FG000|Overall Study|Withdrawal by Subject|5|||
42389690|NCT02869789|76273527|FG001|Overall Study|Withdrawal by Subject|2|||
42389691|NCT02869789|76273528|FG002|Overall Study|Withdrawal by Subject|7|||
42389692|NCT02869789|76273529|FG003|Overall Study|Withdrawal by Subject|2|||
42389693|NCT02869789|76273526|FG000|Overall Study|Lost to Follow-up|0|||
42389694|NCT02869789|76273527|FG001|Overall Study|Lost to Follow-up|0|||
42389695|NCT02869789|76273528|FG002|Overall Study|Lost to Follow-up|2|||
42389696|NCT02869789|76273529|FG003|Overall Study|Lost to Follow-up|0|||
42389697|NCT02869789|76273526|FG000|Overall Study|Maximum clinical benefit|5|||
42389698|NCT02869789|76273527|FG001|Overall Study|Maximum clinical benefit|2|||
42389699|NCT02869789|76273528|FG002|Overall Study|Maximum clinical benefit|1|||
42389700|NCT02869789|76273529|FG003|Overall Study|Maximum clinical benefit|0|||
42389701|NCT02869789|76273526|FG000|Overall Study|Poor/Non-compliance|0|||
42389702|NCT02869789|76273527|FG001|Overall Study|Poor/Non-compliance|2|||
42389703|NCT02869789|76273528|FG002|Overall Study|Poor/Non-compliance|1|||
42389704|NCT02869789|76273529|FG003|Overall Study|Poor/Non-compliance|0|||
42389705|NCT02869789|76273526|FG000|Overall Study|Participant no longer meets study criteria|0|||
42389706|NCT02869789|76273527|FG001|Overall Study|Participant no longer meets study criteria|1|||
42389707|NCT02869789|76273528|FG002|Overall Study|Participant no longer meets study criteria|1|||
42389708|NCT02869789|76273529|FG003|Overall Study|Participant no longer meets study criteria|0|||
42389709|NCT02869789|76273526|FG000|Overall Study|Administrative reason by sponsor|0|||
42389710|NCT02869789|76273527|FG001|Overall Study|Administrative reason by sponsor|0|||
42389711|NCT02869789|76273528|FG002|Overall Study|Administrative reason by sponsor|1|||
42389712|NCT02869789|76273529|FG003|Overall Study|Administrative reason by sponsor|0|||
42389713|NCT02869789|76273526|FG000|Overall Study|Other reasons|4|||
42389714|NCT02869789|76273527|FG001|Overall Study|Other reasons|8|||
42389715|NCT02869789|76273528|FG002|Overall Study|Other reasons|6|||
42389716|NCT02869789|76273529|FG003|Overall Study|Other reasons|0|||
42389717|NCT02760485|76273550|FG000|Phase 1|Death|3|||
42389718|NCT02760485|76273551|FG001|Phase 1|Death|6|||
42389719|NCT02760485|76273552|FG002|Phase 1|Death|0|||
42389720|NCT02760485|76273550|FG000|Phase 1|Withdrawal by Subject|2|||
42389721|NCT02760485|76273551|FG001|Phase 1|Withdrawal by Subject|0|||
42389722|NCT02760485|76273552|FG002|Phase 1|Withdrawal by Subject|0|||
42389723|NCT02760485|76273550|FG000|Phase 1|Progressive Disease|1|||
42389724|NCT02760485|76273551|FG001|Phase 1|Progressive Disease|0|||
42389725|NCT02760485|76273552|FG002|Phase 1|Progressive Disease|0|||
42389726|NCT02760485|76273550|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
42389727|NCT02760485|76273551|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
42389728|NCT02760485|76273552|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
42389729|NCT02760485|76273550|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
42389730|NCT02760485|76273551|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
42389731|NCT02760485|76273552|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
42389732|NCT02760485|76273550|FG000|Phase 2|Death|0|||
42389733|NCT02760485|76273551|FG001|Phase 2|Death|0|||
42389734|NCT02760485|76273552|FG002|Phase 2|Death|12|||
42389735|NCT02760485|76273550|FG000|Phase 2|Withdrawal by Subject|0|||
42389736|NCT02760485|76273551|FG001|Phase 2|Withdrawal by Subject|0|||
42389737|NCT02760485|76273552|FG002|Phase 2|Withdrawal by Subject|3|||
42389738|NCT02760485|76273550|FG000|Phase 2|Progressive Disease|0|||
42389739|NCT02760485|76273551|FG001|Phase 2|Progressive Disease|0|||
42389740|NCT02760485|76273552|FG002|Phase 2|Progressive Disease|1|||
42389741|NCT02760485|76273550|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
42389742|NCT02760485|76273551|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
42389743|NCT02760485|76273552|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
42389744|NCT02634333|76273587|FG000|Overall Study|Completed out of Window|3|||
42389745|NCT02634333|76273588|FG001|Overall Study|Completed out of Window|2|||
42389746|NCT02634333|76273587|FG000|Overall Study|Missed Visit|5|||
42389747|NCT02634333|76273588|FG001|Overall Study|Missed Visit|2|||
42389748|NCT02634333|76273587|FG000|Overall Study|Lost to Follow-up|12|||
42389749|NCT02634333|76273588|FG001|Overall Study|Lost to Follow-up|7|||
42389750|NCT02634333|76273587|FG000|Overall Study|Withdrawal by Subject|9|||
42389751|NCT02634333|76273588|FG001|Overall Study|Withdrawal by Subject|13|||
42389752|NCT02634333|76273587|FG000|Overall Study|Death|11|||
42389753|NCT02634333|76273588|FG001|Overall Study|Death|8|||
42389754|NCT02515630|76273597|FG000|Overall Study|Withdrawal by Subject|5|||
42389755|NCT02515630|76273597|FG000|Overall Study|Adverse Event|4|||
42389756|NCT02515630|76273597|FG000|Overall Study|Physician Decision|4|||
42389757|NCT02515630|76273597|FG000|Overall Study|Death|2|||
42389758|NCT02515630|76273597|FG000|Overall Study|Disease Progression|1|||
42389759|NCT02450331|76273606|FG000|Overall Study|Death|162|||
42389760|NCT02450331|76273607|FG001|Overall Study|Death|171|||
42389761|NCT02450331|76273606|FG000|Overall Study|Lost to Follow-up|14|||
42389762|NCT02450331|76273607|FG001|Overall Study|Lost to Follow-up|12|||
42389763|NCT02450331|76273606|FG000|Overall Study|Withdrawal by Subject|55|||
42389764|NCT02450331|76273607|FG001|Overall Study|Withdrawal by Subject|44|||
42389765|NCT02450331|76273606|FG000|Overall Study|Non-specified other|1|||
42389766|NCT02450331|76273607|FG001|Overall Study|Non-specified other|1|||
42389767|NCT02335944|76273624|FG000|Treatment Phase|Progressive Disease|2|||
42389768|NCT02335944|76273625|FG001|Treatment Phase|Progressive Disease|5|||
42389769|NCT02335944|76273626|FG002|Treatment Phase|Progressive Disease|2|||
42389770|NCT02335944|76273627|FG003|Treatment Phase|Progressive Disease|11|||
42389771|NCT02335944|76273628|FG004|Treatment Phase|Progressive Disease|4|||
42389772|NCT02335944|76273629|FG005|Treatment Phase|Progressive Disease|25|||
42389773|NCT02335944|76273630|FG006|Treatment Phase|Progressive Disease|2|||
42389774|NCT02335944|76273631|FG007|Treatment Phase|Progressive Disease|30|||
42389775|NCT02335944|76273632|FG008|Treatment Phase|Progressive Disease|27|||
42389776|NCT02335944|76273633|FG009|Treatment Phase|Progressive Disease|0|||
42389777|NCT02335944|76273624|FG000|Treatment Phase|Adverse Event|2|||
42389778|NCT02335944|76273625|FG001|Treatment Phase|Adverse Event|0|||
42389779|NCT02335944|76273626|FG002|Treatment Phase|Adverse Event|0|||
42389780|NCT02335944|76273627|FG003|Treatment Phase|Adverse Event|2|||
42389781|NCT02335944|76273628|FG004|Treatment Phase|Adverse Event|1|||
42389782|NCT02335944|76273629|FG005|Treatment Phase|Adverse Event|15|||
42389783|NCT02335944|76273630|FG006|Treatment Phase|Adverse Event|0|||
42389784|NCT02335944|76273631|FG007|Treatment Phase|Adverse Event|5|||
42389785|NCT02335944|76273632|FG008|Treatment Phase|Adverse Event|7|||
42389786|NCT02335944|76273633|FG009|Treatment Phase|Adverse Event|0|||
42389787|NCT02335944|76273624|FG000|Treatment Phase|Physician Decision|0|||
42389788|NCT02335944|76273625|FG001|Treatment Phase|Physician Decision|0|||
42389789|NCT02335944|76273626|FG002|Treatment Phase|Physician Decision|0|||
42389790|NCT02335944|76273627|FG003|Treatment Phase|Physician Decision|1|||
42389791|NCT02335944|76273628|FG004|Treatment Phase|Physician Decision|0|||
42389792|NCT02335944|76273629|FG005|Treatment Phase|Physician Decision|6|||
42389793|NCT02335944|76273630|FG006|Treatment Phase|Physician Decision|1|||
42389794|NCT02335944|76273631|FG007|Treatment Phase|Physician Decision|2|||
42389795|NCT02335944|76273632|FG008|Treatment Phase|Physician Decision|1|||
42389796|NCT02335944|76273633|FG009|Treatment Phase|Physician Decision|0|||
42389797|NCT02335944|76273624|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
42389798|NCT02335944|76273625|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
42389799|NCT02335944|76273626|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
42389800|NCT02335944|76273627|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
42389801|NCT02335944|76273628|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
42389802|NCT02335944|76273629|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
42389803|NCT02335944|76273630|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
42389804|NCT02335944|76273631|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
42389805|NCT02335944|76273632|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
42389806|NCT02335944|76273633|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
42389807|NCT02335944|76273624|FG000|Treatment Phase|Subject/Guardian Decision|0|||
42389808|NCT02335944|76273625|FG001|Treatment Phase|Subject/Guardian Decision|0|||
42389809|NCT02335944|76273626|FG002|Treatment Phase|Subject/Guardian Decision|1|||
42389810|NCT02335944|76273627|FG003|Treatment Phase|Subject/Guardian Decision|0|||
42389811|NCT02335944|76273628|FG004|Treatment Phase|Subject/Guardian Decision|0|||
42389812|NCT02335944|76273629|FG005|Treatment Phase|Subject/Guardian Decision|1|||
42389813|NCT02335944|76273630|FG006|Treatment Phase|Subject/Guardian Decision|0|||
42389814|NCT02335944|76273631|FG007|Treatment Phase|Subject/Guardian Decision|4|||
42389815|NCT02335944|76273632|FG008|Treatment Phase|Subject/Guardian Decision|0|||
42389816|NCT02335944|76273633|FG009|Treatment Phase|Subject/Guardian Decision|0|||
42389817|NCT02335944|76273624|FG000|Post-treatment Follow-up|Progressive Disease|0|||
42389818|NCT02335944|76273625|FG001|Post-treatment Follow-up|Progressive Disease|0|||
42389819|NCT02335944|76273626|FG002|Post-treatment Follow-up|Progressive Disease|0|||
42389820|NCT02335944|76273627|FG003|Post-treatment Follow-up|Progressive Disease|1|||
42389821|NCT02335944|76273628|FG004|Post-treatment Follow-up|Progressive Disease|0|||
42389822|NCT02335944|76273629|FG005|Post-treatment Follow-up|Progressive Disease|9|||
42389823|NCT02335944|76273630|FG006|Post-treatment Follow-up|Progressive Disease|0|||
42389824|NCT02335944|76273631|FG007|Post-treatment Follow-up|Progressive Disease|2|||
42389825|NCT02335944|76273632|FG008|Post-treatment Follow-up|Progressive Disease|3|||
42389826|NCT02335944|76273633|FG009|Post-treatment Follow-up|Progressive Disease|0|||
42389827|NCT02335944|76273624|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
42389828|NCT02335944|76273625|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
42389829|NCT02335944|76273626|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
42389830|NCT02335944|76273627|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
42389831|NCT02335944|76273628|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
42389832|NCT02335944|76273629|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
42389833|NCT02335944|76273630|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
42389834|NCT02335944|76273631|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
42389835|NCT02335944|76273632|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
42389836|NCT02335944|76273633|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
42389837|NCT02335944|76273624|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
42389838|NCT02335944|76273625|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
42389839|NCT02335944|76273626|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
42389840|NCT02335944|76273627|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
42389841|NCT02335944|76273628|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
42389842|NCT02335944|76273629|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
42389843|NCT02335944|76273630|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
42389844|NCT02335944|76273631|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
42389845|NCT02335944|76273632|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
42389846|NCT02335944|76273633|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
42389847|NCT02335944|76273624|FG000|Post-treatment Follow-up|Adverse Event|0|||
42389848|NCT02335944|76273625|FG001|Post-treatment Follow-up|Adverse Event|0|||
42389849|NCT02335944|76273626|FG002|Post-treatment Follow-up|Adverse Event|0|||
42389850|NCT02335944|76273627|FG003|Post-treatment Follow-up|Adverse Event|0|||
42389851|NCT02335944|76273628|FG004|Post-treatment Follow-up|Adverse Event|0|||
42389852|NCT02335944|76273629|FG005|Post-treatment Follow-up|Adverse Event|1|||
42389853|NCT02335944|76273630|FG006|Post-treatment Follow-up|Adverse Event|0|||
42389854|NCT02335944|76273631|FG007|Post-treatment Follow-up|Adverse Event|0|||
42389855|NCT02335944|76273632|FG008|Post-treatment Follow-up|Adverse Event|0|||
42389856|NCT02335944|76273633|FG009|Post-treatment Follow-up|Adverse Event|0|||
42389857|NCT02335944|76273624|FG000|Post-treatment Follow-up|Death|0|||
42389858|NCT02335944|76273625|FG001|Post-treatment Follow-up|Death|0|||
42389859|NCT02335944|76273626|FG002|Post-treatment Follow-up|Death|0|||
42389860|NCT02335944|76273627|FG003|Post-treatment Follow-up|Death|1|||
42389861|NCT02335944|76273628|FG004|Post-treatment Follow-up|Death|0|||
42389862|NCT02335944|76273629|FG005|Post-treatment Follow-up|Death|1|||
42389863|NCT02335944|76273630|FG006|Post-treatment Follow-up|Death|0|||
42389864|NCT02335944|76273631|FG007|Post-treatment Follow-up|Death|0|||
42389865|NCT02335944|76273632|FG008|Post-treatment Follow-up|Death|0|||
42389866|NCT02335944|76273633|FG009|Post-treatment Follow-up|Death|0|||
42389867|NCT02335944|76273624|FG000|Post-treatment Follow-up|Physician Decision|1|||
42389868|NCT02335944|76273625|FG001|Post-treatment Follow-up|Physician Decision|0|||
42389869|NCT02335944|76273626|FG002|Post-treatment Follow-up|Physician Decision|0|||
42389870|NCT02335944|76273627|FG003|Post-treatment Follow-up|Physician Decision|0|||
42389871|NCT02335944|76273628|FG004|Post-treatment Follow-up|Physician Decision|0|||
42389872|NCT02335944|76273629|FG005|Post-treatment Follow-up|Physician Decision|0|||
42389873|NCT02335944|76273630|FG006|Post-treatment Follow-up|Physician Decision|0|||
42389874|NCT02335944|76273631|FG007|Post-treatment Follow-up|Physician Decision|1|||
42389875|NCT02335944|76273632|FG008|Post-treatment Follow-up|Physician Decision|0|||
42389876|NCT02335944|76273633|FG009|Post-treatment Follow-up|Physician Decision|0|||
42389877|NCT02326974|76273671|FG000|Overall Study|Withdrawal by Subject|2|||
42389878|NCT02326974|76273671|FG000|Overall Study|failed heterogenity evaluation|5|||
42389879|NCT02200445|76273719|FG000|Overall Study|Lack of Efficacy|1|||
42389880|NCT02200445|76273720|FG001|Overall Study|Lack of Efficacy|2|||
42389881|NCT02200445|76273721|FG002|Overall Study|Lack of Efficacy|2|||
42389882|NCT02200445|76273719|FG000|Overall Study|Adverse Event|0|||
42389883|NCT02200445|76273720|FG001|Overall Study|Adverse Event|2|||
42389884|NCT02200445|76273721|FG002|Overall Study|Adverse Event|0|||
42389885|NCT02120352|76273729|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
42389886|NCT02120352|76273730|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
42389887|NCT02120352|76273731|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
42389888|NCT02120352|76273732|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
42389889|NCT02120352|76273729|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
42389890|NCT02120352|76273730|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
42389891|NCT02120352|76273731|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
42389892|NCT02120352|76273732|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
42389893|NCT02120352|76273729|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
42389894|NCT02120352|76273730|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
42389895|NCT02120352|76273731|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
42389896|NCT02120352|76273732|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
42389897|NCT02120352|76273729|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
42389898|NCT02120352|76273730|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
42389899|NCT02120352|76273731|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
42389900|NCT02120352|76273732|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
42389901|NCT02120352|76273729|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
42389902|NCT02120352|76273730|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
42389903|NCT02120352|76273731|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
42389904|NCT02120352|76273732|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
42389905|NCT02120352|76273729|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
42389906|NCT02120352|76273730|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
42389907|NCT02120352|76273731|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
42389908|NCT02120352|76273732|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
42389909|NCT02120352|76273729|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
42389910|NCT02120352|76273730|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
42389911|NCT02120352|76273731|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
42389912|NCT02120352|76273732|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
42389913|NCT02120352|76273729|FG000|Maintenance Period (32 Weeks)|Adverse Event|0|||
42389914|NCT02120352|76273730|FG001|Maintenance Period (32 Weeks)|Adverse Event|0|||
42389915|NCT02120352|76273731|FG002|Maintenance Period (32 Weeks)|Adverse Event|6|||
42389916|NCT02120352|76273732|FG003|Maintenance Period (32 Weeks)|Adverse Event|1|||
42389917|NCT02120352|76273729|FG000|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
42389918|NCT02120352|76273730|FG001|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
42389919|NCT02120352|76273731|FG002|Maintenance Period (32 Weeks)|Lack of Efficacy|0|||
42389920|NCT02120352|76273732|FG003|Maintenance Period (32 Weeks)|Lack of Efficacy|1|||
42389921|NCT02120352|76273729|FG000|Maintenance Period (32 Weeks)|Protocol Violation|0|||
42389922|NCT02120352|76273730|FG001|Maintenance Period (32 Weeks)|Protocol Violation|0|||
42389923|NCT02120352|76273731|FG002|Maintenance Period (32 Weeks)|Protocol Violation|2|||
42112153|NCT00142519|75922348|FG000|Overall Study|Not Treated|7|||
42389924|NCT02120352|76273732|FG003|Maintenance Period (32 Weeks)|Protocol Violation|0|||
42389925|NCT02120352|76273729|FG000|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
42389926|NCT02120352|76273730|FG001|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0|||
42389927|NCT02120352|76273731|FG002|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
42389928|NCT02120352|76273732|FG003|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1|||
42389929|NCT02120352|76273729|FG000|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
42389930|NCT02120352|76273730|FG001|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
42389931|NCT02120352|76273731|FG002|Maintenance Period (32 Weeks)|Lost to Follow-up|0|||
42389932|NCT02120352|76273732|FG003|Maintenance Period (32 Weeks)|Lost to Follow-up|1|||
42389933|NCT02120352|76273729|FG000|Maintenance Period (32 Weeks)|Withdrawal by Subject|0|||
42389934|NCT02120352|76273730|FG001|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
42389935|NCT02120352|76273731|FG002|Maintenance Period (32 Weeks)|Withdrawal by Subject|1|||
42389936|NCT02120352|76273732|FG003|Maintenance Period (32 Weeks)|Withdrawal by Subject|2|||
42389937|NCT02120352|76273729|FG000|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0|||
42389938|NCT02120352|76273730|FG001|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112|||
42389939|NCT02120352|76273731|FG002|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105|||
42389940|NCT02120352|76273732|FG003|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50|||
42389941|NCT02058693|76273748|FG000|Phase 1|Withdrawal by Subject|3|||
42389942|NCT02058693|76273749|FG001|Phase 1|Withdrawal by Subject|2|||
42389943|NCT02058693|76273748|FG000|Phase 1|Adverse Event|0|||
42389944|NCT02058693|76273749|FG001|Phase 1|Adverse Event|1|||
42389945|NCT02058693|76273748|FG000|Phase 1|Lack of Efficacy|1|||
42389946|NCT02058693|76273749|FG001|Phase 1|Lack of Efficacy|0|||
42389947|NCT02058693|76273748|FG000|Phase 1|Physician Decision|1|||
42389948|NCT02058693|76273749|FG001|Phase 1|Physician Decision|1|||
42389949|NCT02058693|76273748|FG000|Phase 2|Withdrawal by Subject|0|||
42389950|NCT02058693|76273749|FG001|Phase 2|Withdrawal by Subject|2|||
42389951|NCT02039856|76273759|FG000|Overall Study|Death|5|||
42389952|NCT02039856|76273760|FG001|Overall Study|Death|3|||
42389953|NCT02039856|76273759|FG000|Overall Study|Partial survey completion|61|||
42389954|NCT02039856|76273760|FG001|Overall Study|Partial survey completion|26|||
42389955|NCT02039856|76273759|FG000|Overall Study|Lost to Follow-up|388|||
42389956|NCT02039856|76273760|FG001|Overall Study|Lost to Follow-up|206|||
42389957|NCT02039856|76273759|FG000|Overall Study|Withdrawal by Subject|1573|||
42389958|NCT02039856|76273760|FG001|Overall Study|Withdrawal by Subject|618|||
42389959|NCT01796392|76273770|FG000|Overall Study|Withdrawal by Subject|2|||
42389960|NCT01796392|76273771|FG001|Overall Study|Withdrawal by Subject|0|||
42389961|NCT01796392|76273770|FG000|Overall Study|Death|5|||
42389962|NCT01796392|76273771|FG001|Overall Study|Death|1|||
42389963|NCT01796392|76273770|FG000|Overall Study|Excluded for medical reasons|1|||
42389964|NCT01796392|76273771|FG001|Overall Study|Excluded for medical reasons|2|||
42389965|NCT01796392|76273770|FG000|Overall Study|Lost to Follow-up|1|||
42389966|NCT01796392|76273771|FG001|Overall Study|Lost to Follow-up|0|||
42389967|NCT01571635|76273782|FG000|Overall Study|Adverse Event|3|||
42389968|NCT01571635|76273783|FG001|Overall Study|Adverse Event|0|||
42389969|NCT01571635|76273784|FG002|Overall Study|Adverse Event|2|||
42389970|NCT01571635|76273785|FG003|Overall Study|Adverse Event|3|||
42389971|NCT01571635|76273786|FG004|Overall Study|Adverse Event|5|||
42389972|NCT01571635|76273782|FG000|Overall Study|Other reasons|2|||
42389973|NCT01571635|76273783|FG001|Overall Study|Other reasons|1|||
42389974|NCT01571635|76273784|FG002|Overall Study|Other reasons|2|||
42112154|NCT00142519|75922349|FG001|Overall Study|Not Treated|9|||
42389975|NCT01571635|76273785|FG003|Overall Study|Other reasons|2|||
42389976|NCT01571635|76273786|FG004|Overall Study|Other reasons|1|||
42389977|NCT01571635|76273782|FG000|Overall Study|Study terminated by sponsor|0|||
42389978|NCT01571635|76273783|FG001|Overall Study|Study terminated by sponsor|4|||
42389979|NCT01571635|76273784|FG002|Overall Study|Study terminated by sponsor|1|||
42389980|NCT01571635|76273785|FG003|Overall Study|Study terminated by sponsor|3|||
42389981|NCT01571635|76273786|FG004|Overall Study|Study terminated by sponsor|1|||
42389982|NCT01571635|76273782|FG000|Overall Study|Withdrew consent|1|||
42389983|NCT01571635|76273783|FG001|Overall Study|Withdrew consent|1|||
42389984|NCT01571635|76273784|FG002|Overall Study|Withdrew consent|2|||
42389985|NCT01571635|76273785|FG003|Overall Study|Withdrew consent|3|||
42389986|NCT01571635|76273786|FG004|Overall Study|Withdrew consent|0|||
42389987|NCT01571635|76273782|FG000|Overall Study|Lack of Efficacy|0|||
42389988|NCT01571635|76273783|FG001|Overall Study|Lack of Efficacy|2|||
42389989|NCT01571635|76273784|FG002|Overall Study|Lack of Efficacy|0|||
42389990|NCT01571635|76273785|FG003|Overall Study|Lack of Efficacy|1|||
42389991|NCT01571635|76273786|FG004|Overall Study|Lack of Efficacy|2|||
42389992|NCT01248715|76273800|FG000|Overall Study|Not influenza positive|501|||
42389993|NCT01248715|76273801|FG001|Overall Study|Not influenza positive|510|||
42389994|NCT00812214|76273853|FG000|Overall Study|Lost to Follow-up|3|||
42389995|NCT00812214|76273854|FG001|Overall Study|Lost to Follow-up|1|||
42389996|NCT00217425|76273861|FG000|Overall Study|Never started treatment|2|||
42389997|NCT00217425|76273861|FG000|Overall Study|Patient ineligible|5|||
42389998|NCT00217425|76273861|FG000|Overall Study|Lack of Efficacy|13|||
42389999|NCT00217425|76273861|FG000|Overall Study|Adverse Event|8|||
42390000|NCT00217425|76273861|FG000|Overall Study|Withdrawal by Subject|4|||
42390001|NCT00217425|76273861|FG000|Overall Study|Other complicating disease|1|||
42390002|NCT00217425|76273861|FG000|Overall Study|Other|4|||
42390003|NCT03208231|76273880|FG000|Overall Study|Death|1|||
42390004|NCT03208231|76273881|FG001|Overall Study|Death|2|||
42390005|NCT03208231|76273880|FG000|Overall Study|Moved and unable to get to clinic|1|||
42390006|NCT03208231|76273881|FG001|Overall Study|Moved and unable to get to clinic|0|||
42390007|NCT03208231|76273880|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
42390008|NCT03208231|76273881|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
42390009|NCT03102242|76273900|FG000|Overall Study|Adverse Event|2|||
42390010|NCT03097328|76273904|FG000|Overall Study|Still on Therapy|2|||
42390011|NCT03097328|76273904|FG000|Overall Study|Progressive Disease|29|||
42390012|NCT03097328|76273904|FG000|Overall Study|Adverse Event|4|||
42390013|NCT03097328|76273904|FG000|Overall Study|Withdrawal by Subject|1|||
42390014|NCT03097328|76273904|FG000|Overall Study|Physician Decision|1|||
42390015|NCT03097328|76273904|FG000|Overall Study|Patient Decision|1|||
42390016|NCT03097328|76273904|FG000|Overall Study|Ineligible for Study Drug|1|||
42390017|NCT03033602|76273910|FG000|Overall Study|Withdrawal by Subject|11|||
42390018|NCT03033602|76273911|FG001|Overall Study|Withdrawal by Subject|21|||
42390019|NCT03033602|76273910|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
42390020|NCT03033602|76273911|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
42390021|NCT02994784|76273922|FG000|6 Months Follow-up|Lost to Follow-up|3|||
42390022|NCT02948829|76273926|FG000|Overall Study|Lost to Follow-up|2|||
42390023|NCT02948829|76273926|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
42390024|NCT02948829|76273926|FG000|Overall Study|Pregnancy|1|||
42390025|NCT02948829|76273926|FG000|Overall Study|Other: Reason not Specified|8|||
42390026|NCT02617446|76273957|FG000|Overall Study|Withdrawal by Subject|0|||
42390027|NCT02617446|76273958|FG001|Overall Study|Withdrawal by Subject|2|||
42390028|NCT02617446|76273959|FG002|Overall Study|Withdrawal by Subject|0|||
42390029|NCT02617446|76273957|FG000|Overall Study|Adverse Event|1|||
42390030|NCT02617446|76273958|FG001|Overall Study|Adverse Event|0|||
42390031|NCT02617446|76273959|FG002|Overall Study|Adverse Event|5|||
42390032|NCT02617446|76273957|FG000|Overall Study|Lost to Follow-up|3|||
42390033|NCT02617446|76273958|FG001|Overall Study|Lost to Follow-up|0|||
42390034|NCT02617446|76273959|FG002|Overall Study|Lost to Follow-up|0|||
42390035|NCT02617446|76273957|FG000|Overall Study|Death|0|||
42390036|NCT02617446|76273958|FG001|Overall Study|Death|0|||
42390037|NCT02617446|76273959|FG002|Overall Study|Death|2|||
42390038|NCT02549170|76273973|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
42390039|NCT02549170|76273974|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
42390040|NCT02549170|76273975|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
42390041|NCT02549170|76273976|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
42390042|NCT02549170|76273977|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
42390043|NCT02549170|76273973|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
42390044|NCT02549170|76273974|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
42390045|NCT02549170|76273975|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
42390046|NCT02549170|76273976|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
42390047|NCT02549170|76273977|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
42390048|NCT02549170|76273973|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
42390049|NCT02549170|76273974|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
42390050|NCT02549170|76273975|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
42390051|NCT02549170|76273976|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
42390052|NCT02549170|76273977|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
42390053|NCT02410902|76273994|FG000|Overall Study|Adverse Event|2|||
42390054|NCT02410902|76273995|FG001|Overall Study|Adverse Event|3|||
42390055|NCT02410902|76273994|FG000|Overall Study|Lost to Follow-up|4|||
42390056|NCT02410902|76273995|FG001|Overall Study|Lost to Follow-up|1|||
42390057|NCT02410902|76273994|FG000|Overall Study|Protocol Violation|1|||
42390058|NCT02410902|76273995|FG001|Overall Study|Protocol Violation|4|||
42390059|NCT02410902|76273994|FG000|Overall Study|Withdrawal by Subject|6|||
42390060|NCT02410902|76273995|FG001|Overall Study|Withdrawal by Subject|8|||
42390061|NCT02410902|76273994|FG000|Overall Study|Non-Compliance|8|||
42390062|NCT02410902|76273995|FG001|Overall Study|Non-Compliance|2|||
42390063|NCT02101736|76274005|FG000|Overall Study|Protocol Violation|3|||
42390064|NCT02101736|76274006|FG001|Overall Study|Protocol Violation|0|||
42390065|NCT02101736|76274005|FG000|Overall Study|Withdrawal by Subject|1|||
42204866|NCT00004859|76017429|FG001|Overall Study|other disease|3|||
42390066|NCT02101736|76274006|FG001|Overall Study|Withdrawal by Subject|1|||
42390067|NCT01918397|76274018|FG000|Overall Study|Never started treatment|2|||
42390068|NCT01918397|76274019|FG001|Overall Study|Never started treatment|1|||
42390069|NCT01918397|76274020|FG002|Overall Study|Never started treatment|0|||
42390070|NCT01918397|76274021|FG003|Overall Study|Never started treatment|0|||
42390071|NCT01918397|76274018|FG000|Overall Study|Adverse Event|1|||
42390072|NCT01918397|76274019|FG001|Overall Study|Adverse Event|1|||
42390073|NCT01918397|76274020|FG002|Overall Study|Adverse Event|1|||
42390074|NCT01918397|76274021|FG003|Overall Study|Adverse Event|0|||
42390075|NCT01918397|76274018|FG000|Overall Study|Lack of compliance|2|||
42390076|NCT01918397|76274019|FG001|Overall Study|Lack of compliance|2|||
42390077|NCT01918397|76274020|FG002|Overall Study|Lack of compliance|3|||
42390078|NCT01918397|76274021|FG003|Overall Study|Lack of compliance|0|||
42390079|NCT01918397|76274018|FG000|Overall Study|Pregnancy|0|||
42390080|NCT01918397|76274019|FG001|Overall Study|Pregnancy|1|||
42390081|NCT01918397|76274020|FG002|Overall Study|Pregnancy|0|||
42390082|NCT01918397|76274021|FG003|Overall Study|Pregnancy|0|||
42390083|NCT01918397|76274018|FG000|Overall Study|Rifampin susceptible|0|||
42390084|NCT01918397|76274019|FG001|Overall Study|Rifampin susceptible|0|||
42390085|NCT01918397|76274020|FG002|Overall Study|Rifampin susceptible|0|||
42390086|NCT01918397|76274021|FG003|Overall Study|Rifampin susceptible|2|||
42390087|NCT01918397|76274018|FG000|Overall Study|Treatment failure|0|||
42390088|NCT01918397|76274019|FG001|Overall Study|Treatment failure|0|||
42390089|NCT01918397|76274020|FG002|Overall Study|Treatment failure|0|||
42390090|NCT01918397|76274021|FG003|Overall Study|Treatment failure|1|||
42390091|NCT01918397|76274018|FG000|Overall Study|Withdrawal by Subject|3|||
42390092|NCT01918397|76274019|FG001|Overall Study|Withdrawal by Subject|2|||
42390093|NCT01918397|76274020|FG002|Overall Study|Withdrawal by Subject|1|||
42390094|NCT01918397|76274021|FG003|Overall Study|Withdrawal by Subject|1|||
42390095|NCT01918397|76274018|FG000|Overall Study|XDR at baseline|0|||
42390096|NCT01918397|76274019|FG001|Overall Study|XDR at baseline|0|||
42390097|NCT01918397|76274020|FG002|Overall Study|XDR at baseline|1|||
42390098|NCT01918397|76274021|FG003|Overall Study|XDR at baseline|0|||
42390099|NCT01918397|76274018|FG000|Overall Study|Lost to Follow-up|2|||
42390100|NCT01918397|76274019|FG001|Overall Study|Lost to Follow-up|1|||
42390101|NCT01918397|76274020|FG002|Overall Study|Lost to Follow-up|1|||
42390102|NCT01918397|76274021|FG003|Overall Study|Lost to Follow-up|1|||
42390103|NCT01918397|76274018|FG000|Overall Study|Increased QTc|1|||
42390104|NCT01918397|76274019|FG001|Overall Study|Increased QTc|0|||
42390105|NCT01918397|76274020|FG002|Overall Study|Increased QTc|0|||
42390106|NCT01918397|76274021|FG003|Overall Study|Increased QTc|1|||
42390107|NCT01918397|76274018|FG000|Overall Study|Death|0|||
42390108|NCT01918397|76274019|FG001|Overall Study|Death|0|||
42390109|NCT01918397|76274020|FG002|Overall Study|Death|1|||
42390110|NCT01918397|76274021|FG003|Overall Study|Death|0|||
42390111|NCT01918397|76274018|FG000|Overall Study|Involved in another investigative trial|0|||
42390112|NCT01918397|76274019|FG001|Overall Study|Involved in another investigative trial|0|||
42390113|NCT01918397|76274020|FG002|Overall Study|Involved in another investigative trial|0|||
42390114|NCT01918397|76274021|FG003|Overall Study|Involved in another investigative trial|1|||
42390115|NCT00986921|76274055|FG000|Overall Study|Physician Decision|1|||
42390116|NCT00986921|76274056|FG001|Overall Study|Physician Decision|0|||
42390117|NCT01596972|76274067|FG000|Overall Study|Physician Decision|1|||
42390118|NCT01596972|76274068|FG001|Overall Study|Physician Decision|9|||
42390119|NCT01596972|76274067|FG000|Overall Study|Lost to Follow-up|0|||
42390120|NCT01596972|76274068|FG001|Overall Study|Lost to Follow-up|4|||
42390121|NCT01596972|76274067|FG000|Overall Study|Withdrawal by Subject|0|||
42390122|NCT01596972|76274068|FG001|Overall Study|Withdrawal by Subject|1|||
42390123|NCT00985751|76274169|FG000|Overall Study|Adverse Event|0|||
42390124|NCT00985751|76274170|FG001|Overall Study|Adverse Event|0|||
42390125|NCT00985751|76274171|FG002|Overall Study|Adverse Event|0|||
42390126|NCT00985751|76274172|FG003|Overall Study|Adverse Event|0|||
42390127|NCT00985751|76274173|FG004|Overall Study|Adverse Event|1|||
42390128|NCT01596582|76274218|FG000|Overall Study|Deemed ineligible after study visit|3|||
42390129|NCT01596582|76274219|FG001|Overall Study|Deemed ineligible after study visit|6|||
42390130|NCT01596582|76274218|FG000|Overall Study|Missing all outcome data|1|||
42390131|NCT01596582|76274219|FG001|Overall Study|Missing all outcome data|1|||
42390132|NCT01596504|76274235|FG000|Overall Study|Participant's Private Reason|0|||
42390133|NCT01596504|76274236|FG001|Overall Study|Participant's Private Reason|1|||
42390134|NCT01596504|76274237|FG002|Overall Study|Participant's Private Reason|0|||
42390135|NCT01596504|76274235|FG000|Overall Study|Adverse Event|1|||
42390136|NCT01596504|76274236|FG001|Overall Study|Adverse Event|2|||
42390137|NCT01596504|76274237|FG002|Overall Study|Adverse Event|1|||
42390138|NCT01596504|76274235|FG000|Overall Study|Withdrawal by Subject|1|||
42390139|NCT01596504|76274236|FG001|Overall Study|Withdrawal by Subject|0|||
42390140|NCT01596504|76274237|FG002|Overall Study|Withdrawal by Subject|0|||
42390141|NCT02616900|76274292|FG000|Overall Study|Lack of Efficacy|7|||
42390142|NCT02616900|76274292|FG000|Overall Study|Lost to Follow-up|2|||
42390143|NCT02616900|76274292|FG000|Overall Study|Protocol Violation|5|||
42390144|NCT02616900|76274292|FG000|Overall Study|Withdrawal by Subject|3|||
42390145|NCT02616900|76274292|FG000|Overall Study|Incomplete data|6|||
42390146|NCT00985673|76274404|FG000|Overall Study|Lost to Follow-up|6|||
42390147|NCT00985673|76274405|FG001|Overall Study|Lost to Follow-up|7|||
42390148|NCT00985673|76274406|FG002|Overall Study|Lost to Follow-up|6|||
42390149|NCT00985673|76274407|FG003|Overall Study|Lost to Follow-up|10|||
42390150|NCT00985673|76274408|FG004|Overall Study|Lost to Follow-up|5|||
42390151|NCT00985673|76274409|FG005|Overall Study|Lost to Follow-up|3|||
42390152|NCT00985673|76274404|FG000|Overall Study|Withdrawal by Subject|0|||
42390153|NCT00985673|76274405|FG001|Overall Study|Withdrawal by Subject|4|||
42390154|NCT00985673|76274406|FG002|Overall Study|Withdrawal by Subject|5|||
42390155|NCT00985673|76274407|FG003|Overall Study|Withdrawal by Subject|2|||
42390156|NCT00985673|76274408|FG004|Overall Study|Withdrawal by Subject|2|||
42390157|NCT00985673|76274409|FG005|Overall Study|Withdrawal by Subject|3|||
42390158|NCT00985673|76274404|FG000|Overall Study|Other|1|||
42390159|NCT00985673|76274405|FG001|Overall Study|Other|0|||
42390160|NCT00985673|76274406|FG002|Overall Study|Other|1|||
42390161|NCT00985673|76274407|FG003|Overall Study|Other|0|||
42390162|NCT00985673|76274408|FG004|Overall Study|Other|1|||
42390163|NCT00985673|76274409|FG005|Overall Study|Other|0|||
42390164|NCT00985439|76274455|FG000|Overall Study|Adverse Event|0|||
42390165|NCT00985439|76274456|FG001|Overall Study|Adverse Event|0|||
42390166|NCT00985439|76274457|FG002|Overall Study|Adverse Event|1|||
42390167|NCT00985439|76274458|FG003|Overall Study|Adverse Event|0|||
42390168|NCT02618928|76274468|FG000|Overall Study|Failure to Return|28|||
42390169|NCT02618928|76274468|FG000|Overall Study|Insufficient Virological Response|1|||
42390170|NCT02618928|76274468|FG000|Overall Study|Withdrawal by Subject|2|||
42390171|NCT02618928|76274468|FG000|Overall Study|Death|3|||
42390172|NCT02618928|76274468|FG000|Overall Study|Other|11|||
42390173|NCT02618928|76274468|FG000|Overall Study|Missing|6|||
42390174|NCT02618928|76274468|FG000|Overall Study|Treatment Never Started|7|||
42390175|NCT00983957|76274479|FG000|Overall Study|Adverse Event|1|||
42390176|NCT00983957|76274479|FG000|Overall Study|Personal Reasons|1|||
42390177|NCT00981149|76274533|FG000|Overall Study|Lost to Follow-up|1|||
42390178|NCT00981149|76274534|FG001|Overall Study|Lost to Follow-up|2|||
42390179|NCT00981149|76274533|FG000|Overall Study|Withdrawal by Subject|1|||
42390180|NCT00981149|76274534|FG001|Overall Study|Withdrawal by Subject|1|||
42390181|NCT01595646|76274592|FG000|Overall Study|Withdrawal by Subject|1|||
42390182|NCT01595646|76274593|FG001|Overall Study|Withdrawal by Subject|0|||
42390183|NCT01595646|76274594|FG002|Overall Study|Withdrawal by Subject|0|||
42390184|NCT00981461|76274622|FG000|Overall Study|Lost to Follow-up|5|||
42390185|NCT00981461|76274623|FG001|Overall Study|Lost to Follow-up|2|||
42390186|NCT02618616|76274640|FG000|Overall Study|Lack of Efficacy|4|||
42390187|NCT02618616|76274641|FG001|Overall Study|Lack of Efficacy|0|||
42390188|NCT02618616|76274640|FG000|Overall Study|Pregnancy|0|||
42390189|NCT02618616|76274641|FG001|Overall Study|Pregnancy|1|||
42390190|NCT02618616|76274640|FG000|Overall Study|Adverse Event|8|||
42390191|NCT02618616|76274641|FG001|Overall Study|Adverse Event|0|||
42390192|NCT02618616|76274640|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
42390193|NCT02618616|76274641|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
42390194|NCT02618616|76274640|FG000|Overall Study|Consent withdrawn by subject|8|||
42390195|NCT02618616|76274641|FG001|Overall Study|Consent withdrawn by subject|5|||
42390196|NCT02618616|76274640|FG000|Overall Study|Lost to Follow-up|0|||
42390197|NCT02618616|76274641|FG001|Overall Study|Lost to Follow-up|1|||
42390198|NCT02618382|76274720|FG000|Overall Study|Physician Decision|1|||
42390199|NCT02618382|76274720|FG000|Overall Study|Withdrawal by Subject|1|||
42390200|NCT02618382|76274720|FG000|Overall Study|Protocol Violation|1|||
42390201|NCT00980057|76274764|FG000|Overall Study|Death|13|||
42390202|NCT00980057|76274765|FG001|Overall Study|Death|3|||
42390203|NCT00980057|76274764|FG000|Overall Study|Adverse Event|0|||
42390204|NCT00980057|76274765|FG001|Overall Study|Adverse Event|1|||
42390205|NCT00980057|76274764|FG000|Overall Study|Physician Decision|4|||
42390206|NCT00980057|76274765|FG001|Overall Study|Physician Decision|0|||
42390207|NCT00980057|76274764|FG000|Overall Study|Lost to Follow-up|1|||
42390208|NCT00980057|76274765|FG001|Overall Study|Lost to Follow-up|0|||
42390209|NCT00980057|76274764|FG000|Overall Study|Withdrawal by Subject|1|||
42390210|NCT00980057|76274765|FG001|Overall Study|Withdrawal by Subject|1|||
42390211|NCT04126733|76274886|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
42390212|NCT04126733|76274886|FG000|Treatment Period|Adverse Event|8|||
42390213|NCT04126733|76274886|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
42390214|NCT04126733|76274886|FG000|Treatment Period|Physician Decision|5|||
42390215|NCT04126733|76274886|FG000|Treatment Period|Death|1|||
42390216|NCT04126733|76274886|FG000|Treatment Period|Other Reasons|2|||
42390217|NCT04126733|76274886|FG000|Active Follow-up Period|Death|13|||
42390218|NCT04126733|76274886|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
42390219|NCT04126733|76274886|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
42390220|NCT04126733|76274886|FG000|Active Follow-up Period|Other Reasons|1|||
42390221|NCT04126733|76274886|FG000|Long-term Follow-up Period|Death|22|||
42390222|NCT04126733|76274886|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
42390223|NCT04126733|76274886|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
42390224|NCT00988247|76274921|FG000|Overall Study|Adverse Event|17|||
42390225|NCT00988247|76274922|FG001|Overall Study|Adverse Event|3|||
42390226|NCT00988247|76274921|FG000|Overall Study|Withdrawal by Subject|44|||
42390227|NCT00988247|76274922|FG001|Overall Study|Withdrawal by Subject|13|||
42390228|NCT00988247|76274921|FG000|Overall Study|Pregnancy|1|||
42390229|NCT00988247|76274922|FG001|Overall Study|Pregnancy|2|||
42390230|NCT00988247|76274921|FG000|Overall Study|Lost to Follow-up|11|||
42390231|NCT00988247|76274922|FG001|Overall Study|Lost to Follow-up|2|||
42390232|NCT00988247|76274921|FG000|Overall Study|Protocol Violation|4|||
42390233|NCT00988247|76274922|FG001|Overall Study|Protocol Violation|5|||
42390234|NCT00988247|76274921|FG000|Overall Study|Sponsor requested withdrawal|3|||
42390235|NCT00988247|76274922|FG001|Overall Study|Sponsor requested withdrawal|1|||
42390236|NCT00988247|76274921|FG000|Overall Study|Other|3|||
42390237|NCT00988247|76274922|FG001|Overall Study|Other|0|||
42390238|NCT00984659|76274932|FG000|2-week Run-in Period|Adverse Event|8|||
42390239|NCT00984659|76274933|FG001|2-week Run-in Period|Adverse Event|0|||
42390240|NCT00984659|76274934|FG002|2-week Run-in Period|Adverse Event|0|||
42390241|NCT00984659|76274935|FG003|2-week Run-in Period|Adverse Event|0|||
42390242|NCT00984659|76274932|FG000|2-week Run-in Period|Protocol Violation|5|||
42390243|NCT00984659|76274933|FG001|2-week Run-in Period|Protocol Violation|0|||
42390244|NCT00984659|76274934|FG002|2-week Run-in Period|Protocol Violation|0|||
42390245|NCT00984659|76274935|FG003|2-week Run-in Period|Protocol Violation|0|||
42390246|NCT00984659|76274932|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
42390247|NCT00984659|76274933|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
42390248|NCT00984659|76274934|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
42390249|NCT00984659|76274935|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
42390250|NCT00984659|76274932|FG000|2-week Run-in Period|Lost to Follow-up|3|||
42390251|NCT00984659|76274933|FG001|2-week Run-in Period|Lost to Follow-up|0|||
42390252|NCT00984659|76274934|FG002|2-week Run-in Period|Lost to Follow-up|0|||
42390253|NCT00984659|76274935|FG003|2-week Run-in Period|Lost to Follow-up|0|||
42390254|NCT00984659|76274932|FG000|2-week Run-in Period|Physician Decision|10|||
42390255|NCT00984659|76274933|FG001|2-week Run-in Period|Physician Decision|0|||
42390256|NCT00984659|76274934|FG002|2-week Run-in Period|Physician Decision|0|||
42390257|NCT00984659|76274935|FG003|2-week Run-in Period|Physician Decision|0|||
42390258|NCT00984659|76274932|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
42390259|NCT00984659|76274933|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
42390260|NCT00984659|76274934|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
42390261|NCT00984659|76274935|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
42390262|NCT00984659|76274932|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
42390263|NCT00984659|76274933|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
42390264|NCT00984659|76274934|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
42390265|NCT00984659|76274935|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
42390266|NCT00984659|76274932|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
42390267|NCT00984659|76274933|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
42390268|NCT00984659|76274934|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
42390269|NCT00984659|76274935|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
42390270|NCT00984659|76274932|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
42390271|NCT00984659|76274933|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
42390272|NCT00984659|76274934|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
42390273|NCT00984659|76274935|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
42390274|NCT00984659|76274932|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
42390275|NCT00984659|76274933|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
42390276|NCT00984659|76274934|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
42390277|NCT00984659|76274935|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
42390278|NCT00984659|76274932|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
42390279|NCT00984659|76274933|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
42390280|NCT00984659|76274934|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
42390281|NCT00984659|76274935|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
42390282|NCT00984659|76274932|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
42390283|NCT00984659|76274933|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
42390284|NCT00984659|76274934|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
42390285|NCT00984659|76274935|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
42390286|NCT00982319|76274944|FG000|Overall Study|Surgery date change|1|||
42390287|NCT00982319|76274945|FG001|Overall Study|Surgery date change|0|||
42390288|NCT00982319|76274944|FG000|Overall Study|Preop values out of acceptable range|1|||
42390289|NCT00982319|76274945|FG001|Overall Study|Preop values out of acceptable range|1|||
42390290|NCT00982319|76274944|FG000|Overall Study|Pregnancy|0|||
42390291|NCT00982319|76274945|FG001|Overall Study|Pregnancy|1|||
42390292|NCT02612064|76274957|FG000|Overall Study|Withdrawal by Subject|1|||
42390293|NCT02612064|76274958|FG001|Overall Study|Withdrawal by Subject|1|||
42390294|NCT02612064|76274957|FG000|Overall Study|Other|0|||
42390295|NCT02612064|76274958|FG001|Overall Study|Other|2|||
42390296|NCT02614560|76274977|FG000|Overall Study|Death|6|||
42390297|NCT02614560|76274978|FG001|Overall Study|Death|2|||
42390298|NCT01669122|76274995|FG000|Period I|Lost to Follow-up|1|||
42390299|NCT01669122|76274995|FG000|Washout Period II|Protocol Violation|2|||
42390300|NCT02611752|76275028|FG000|Overall Study|Adverse Event|0|||
42390301|NCT02611752|76275029|FG001|Overall Study|Adverse Event|1|||
42390302|NCT02611362|76275050|FG000|Overall Study|Withdrawal by Subject|7|||
42390303|NCT02611362|76275051|FG001|Overall Study|Withdrawal by Subject|2|||
42390304|NCT02611362|76275050|FG000|Overall Study|Lost to Follow-up|2|||
42390305|NCT02611362|76275051|FG001|Overall Study|Lost to Follow-up|4|||
42390306|NCT01594476|76275071|FG000|Overall Study|Protocol Violation|1|||
42390307|NCT01594476|76275072|FG001|Overall Study|Protocol Violation|3|||
42390308|NCT01668966|76275086|FG000|Overall Study|Withdrawal by Subject|1|||
42390309|NCT01668966|76275086|FG000|Overall Study|Death|1|||
42390310|NCT01668966|76275086|FG000|Overall Study|Not treated|2|||
42390311|NCT02609724|76275093|FG000|Overall Study|Death|2|||
42390312|NCT02609724|76275094|FG001|Overall Study|Death|0|||
42390313|NCT02609724|76275095|FG002|Overall Study|Death|1|||
42390314|NCT02609724|76275093|FG000|Overall Study|Withdrawal by Subject|1|||
42390315|NCT02609724|76275094|FG001|Overall Study|Withdrawal by Subject|2|||
42390316|NCT02609724|76275095|FG002|Overall Study|Withdrawal by Subject|3|||
42390317|NCT02609724|76275093|FG000|Overall Study|Illness|2|||
42390318|NCT02609724|76275094|FG001|Overall Study|Illness|1|||
42390319|NCT02609724|76275095|FG002|Overall Study|Illness|0|||
42390320|NCT02610816|76275124|FG000|Phase 1|Withdrawal by Subject|2|||
42390321|NCT02610816|76275125|FG001|Phase 1|Withdrawal by Subject|6|||
42390322|NCT02610816|76275126|FG002|Phase 1|Withdrawal by Subject|0|||
42390323|NCT02610816|76275127|FG003|Phase 1|Withdrawal by Subject|0|||
42390324|NCT02610816|76275124|FG000|Phase 1|Lost to Follow-up|2|||
42390325|NCT02610816|76275125|FG001|Phase 1|Lost to Follow-up|1|||
42390326|NCT02610816|76275126|FG002|Phase 1|Lost to Follow-up|0|||
42390327|NCT02610816|76275127|FG003|Phase 1|Lost to Follow-up|0|||
42390328|NCT02610816|76275124|FG000|Phase 1|Physician Decision|0|||
42390329|NCT02610816|76275125|FG001|Phase 1|Physician Decision|1|||
42390330|NCT02610816|76275126|FG002|Phase 1|Physician Decision|0|||
42390331|NCT02610816|76275127|FG003|Phase 1|Physician Decision|0|||
42390332|NCT02610816|76275124|FG000|Phase 2|Withdrawal by Subject|0|||
42390333|NCT02610816|76275125|FG001|Phase 2|Withdrawal by Subject|0|||
42390334|NCT02610816|76275126|FG002|Phase 2|Withdrawal by Subject|9|||
42390335|NCT02610816|76275127|FG003|Phase 2|Withdrawal by Subject|3|||
42390336|NCT02610816|76275124|FG000|Phase 2|Lost to Follow-up|0|||
42390337|NCT02610816|76275125|FG001|Phase 2|Lost to Follow-up|0|||
42390338|NCT02610816|76275126|FG002|Phase 2|Lost to Follow-up|2|||
42390339|NCT02610816|76275127|FG003|Phase 2|Lost to Follow-up|0|||
42390340|NCT02610816|76275124|FG000|Phase 2|Physician Decision|0|||
42390341|NCT02610816|76275125|FG001|Phase 2|Physician Decision|0|||
42390342|NCT02610816|76275126|FG002|Phase 2|Physician Decision|0|||
42390343|NCT02610816|76275127|FG003|Phase 2|Physician Decision|2|||
42390344|NCT02610816|76275124|FG000|Phase 2|Pregnancy|0|||
42390345|NCT02610816|76275125|FG001|Phase 2|Pregnancy|0|||
42390346|NCT02610816|76275126|FG002|Phase 2|Pregnancy|0|||
42390347|NCT02610816|76275127|FG003|Phase 2|Pregnancy|1|||
42390348|NCT01896505|76275143|FG000|Overall Study|Adverse Event|1|||
42390349|NCT01896505|76275144|FG001|Overall Study|Adverse Event|0|||
42390350|NCT01896505|76275145|FG002|Overall Study|Adverse Event|2|||
42390351|NCT01896505|76275146|FG003|Overall Study|Adverse Event|1|||
42390352|NCT01896505|76275147|FG004|Overall Study|Adverse Event|1|||
42390353|NCT01896505|76275148|FG005|Overall Study|Adverse Event|0|||
42390354|NCT01896505|76275143|FG000|Overall Study|Physician Decision|1|||
42390355|NCT01896505|76275144|FG001|Overall Study|Physician Decision|3|||
42390356|NCT01896505|76275145|FG002|Overall Study|Physician Decision|2|||
42390357|NCT01896505|76275146|FG003|Overall Study|Physician Decision|0|||
42390358|NCT01896505|76275147|FG004|Overall Study|Physician Decision|0|||
42390359|NCT01896505|76275148|FG005|Overall Study|Physician Decision|1|||
42390360|NCT01896505|76275143|FG000|Overall Study|Withdrawal by Subject|1|||
42390361|NCT01896505|76275144|FG001|Overall Study|Withdrawal by Subject|0|||
42390362|NCT01896505|76275145|FG002|Overall Study|Withdrawal by Subject|3|||
42390363|NCT01896505|76275146|FG003|Overall Study|Withdrawal by Subject|1|||
42390364|NCT01896505|76275147|FG004|Overall Study|Withdrawal by Subject|0|||
42390365|NCT01896505|76275148|FG005|Overall Study|Withdrawal by Subject|0|||
42390366|NCT01896505|76275143|FG000|Overall Study|Disease Progression|7|||
42390367|NCT01896505|76275144|FG001|Overall Study|Disease Progression|5|||
42390368|NCT01896505|76275145|FG002|Overall Study|Disease Progression|8|||
42390369|NCT01896505|76275146|FG003|Overall Study|Disease Progression|4|||
42390370|NCT01896505|76275147|FG004|Overall Study|Disease Progression|4|||
42390371|NCT01896505|76275148|FG005|Overall Study|Disease Progression|4|||
42390372|NCT01896505|76275143|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
42390373|NCT01896505|76275144|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
42390374|NCT01896505|76275145|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
42390375|NCT01896505|76275146|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
42390376|NCT01896505|76275147|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
42390377|NCT01896505|76275148|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
42390378|NCT01896505|76275143|FG000|Overall Study|Intercurrent illness|0|||
42390379|NCT01896505|76275144|FG001|Overall Study|Intercurrent illness|1|||
42390380|NCT01896505|76275145|FG002|Overall Study|Intercurrent illness|0|||
42390381|NCT01896505|76275146|FG003|Overall Study|Intercurrent illness|0|||
42390382|NCT01896505|76275147|FG004|Overall Study|Intercurrent illness|0|||
42390383|NCT01896505|76275148|FG005|Overall Study|Intercurrent illness|0|||
42390384|NCT01896505|76275143|FG000|Overall Study|Death|0|||
42390385|NCT01896505|76275144|FG001|Overall Study|Death|0|||
42390386|NCT01896505|76275145|FG002|Overall Study|Death|1|||
42390387|NCT01896505|76275146|FG003|Overall Study|Death|1|||
42390388|NCT01896505|76275147|FG004|Overall Study|Death|0|||
42390389|NCT01896505|76275148|FG005|Overall Study|Death|1|||
42390390|NCT02612610|76275269|FG000|Overall Study|Withdrawal by Subject|1|||
42390391|NCT02612610|76275270|FG001|Overall Study|Withdrawal by Subject|1|||
42390392|NCT02612610|76275271|FG002|Overall Study|Withdrawal by Subject|0|||
42390393|NCT02612610|76275272|FG003|Overall Study|Withdrawal by Subject|2|||
42390394|NCT02612610|76275269|FG000|Overall Study|Adverse Event|2|||
42390395|NCT02612610|76275270|FG001|Overall Study|Adverse Event|2|||
42390396|NCT02612610|76275271|FG002|Overall Study|Adverse Event|3|||
42390397|NCT02612610|76275272|FG003|Overall Study|Adverse Event|10|||
42390398|NCT02612610|76275269|FG000|Overall Study|Lost to Follow-up|0|||
42390399|NCT02612610|76275270|FG001|Overall Study|Lost to Follow-up|1|||
42390400|NCT02612610|76275271|FG002|Overall Study|Lost to Follow-up|0|||
42390401|NCT02612610|76275272|FG003|Overall Study|Lost to Follow-up|0|||
42390402|NCT02612610|76275269|FG000|Overall Study|Protocol Violation|0|||
42390403|NCT02612610|76275270|FG001|Overall Study|Protocol Violation|1|||
42390404|NCT02612610|76275271|FG002|Overall Study|Protocol Violation|1|||
42390405|NCT02612610|76275272|FG003|Overall Study|Protocol Violation|0|||
42390406|NCT02612610|76275269|FG000|Overall Study|Lack of Efficacy|1|||
42390407|NCT02612610|76275270|FG001|Overall Study|Lack of Efficacy|2|||
42390408|NCT02612610|76275271|FG002|Overall Study|Lack of Efficacy|0|||
42390409|NCT02612610|76275272|FG003|Overall Study|Lack of Efficacy|1|||
42390410|NCT02612610|76275269|FG000|Overall Study|Physician Decision|0|||
42390411|NCT02612610|76275270|FG001|Overall Study|Physician Decision|1|||
42390412|NCT02612610|76275271|FG002|Overall Study|Physician Decision|0|||
42390413|NCT02612610|76275272|FG003|Overall Study|Physician Decision|0|||
42390414|NCT02612610|76275269|FG000|Overall Study|Noncompliance|1|||
42390415|NCT02612610|76275270|FG001|Overall Study|Noncompliance|0|||
42390416|NCT02612610|76275271|FG002|Overall Study|Noncompliance|0|||
42390417|NCT02612610|76275272|FG003|Overall Study|Noncompliance|0|||
42390418|NCT02612610|76275269|FG000|Overall Study|Cough Improvement|0|||
42390419|NCT02612610|76275270|FG001|Overall Study|Cough Improvement|0|||
42390420|NCT02612610|76275271|FG002|Overall Study|Cough Improvement|1|||
42390421|NCT02612610|76275272|FG003|Overall Study|Cough Improvement|0|||
42390422|NCT02610192|76275485|FG000|Overall Study|Received other treatment|8|||
42390423|NCT02610192|76275485|FG000|Overall Study|Physician Decision|1|||
42390424|NCT02609178|76275613|FG000|First Crown|Withdrawal by Subject|0|||
42390425|NCT02609178|76275614|FG001|First Crown|Withdrawal by Subject|0|||
42390426|NCT02609178|76275615|FG002|First Crown|Withdrawal by Subject|1|||
42390427|NCT02609178|76275616|FG003|First Crown|Withdrawal by Subject|1|||
42390428|NCT02609178|76275617|FG004|First Crown|Withdrawal by Subject|0|||
42390429|NCT02609178|76275618|FG005|First Crown|Withdrawal by Subject|0|||
42390430|NCT02607228|76275842|FG000|Overall Study|Progressive Disease|4|||
42390431|NCT02607228|76275843|FG001|Overall Study|Progressive Disease|3|||
42390432|NCT02607228|76275844|FG002|Overall Study|Progressive Disease|1|||
42390433|NCT02607228|76275845|FG003|Overall Study|Progressive Disease|5|||
42390434|NCT02607228|76275846|FG004|Overall Study|Progressive Disease|4|||
42390435|NCT02607228|76275847|FG005|Overall Study|Progressive Disease|3|||
42390436|NCT02607228|76275848|FG006|Overall Study|Progressive Disease|1|||
42390437|NCT02607228|76275842|FG000|Overall Study|Adverse Event|1|||
42390438|NCT02607228|76275843|FG001|Overall Study|Adverse Event|0|||
42390439|NCT02607228|76275844|FG002|Overall Study|Adverse Event|1|||
42112155|NCT00142519|75922348|FG000|Overall Study|Protocol Violation|1|||
42112156|NCT00142519|75922349|FG001|Overall Study|Protocol Violation|0|||
42112157|NCT00142519|75922348|FG000|Overall Study|Withdrawal by Subject|10|||
42390440|NCT02607228|76275845|FG003|Overall Study|Adverse Event|0|||
42390441|NCT02607228|76275846|FG004|Overall Study|Adverse Event|1|||
42390442|NCT02607228|76275847|FG005|Overall Study|Adverse Event|1|||
42390443|NCT02607228|76275848|FG006|Overall Study|Adverse Event|1|||
42390444|NCT02607228|76275842|FG000|Overall Study|Investigator's Discretion|0|||
42390445|NCT02607228|76275843|FG001|Overall Study|Investigator's Discretion|0|||
42390446|NCT02607228|76275844|FG002|Overall Study|Investigator's Discretion|1|||
42390447|NCT02607228|76275845|FG003|Overall Study|Investigator's Discretion|0|||
42390448|NCT02607228|76275846|FG004|Overall Study|Investigator's Discretion|0|||
42390449|NCT02607228|76275847|FG005|Overall Study|Investigator's Discretion|1|||
42390450|NCT02607228|76275848|FG006|Overall Study|Investigator's Discretion|0|||
42390451|NCT02607228|76275842|FG000|Overall Study|Withdrew Consent|0|||
42390452|NCT02607228|76275843|FG001|Overall Study|Withdrew Consent|1|||
42112158|NCT00142519|75922349|FG001|Overall Study|Withdrawal by Subject|7|||
42390453|NCT02607228|76275844|FG002|Overall Study|Withdrew Consent|0|||
42390454|NCT02607228|76275845|FG003|Overall Study|Withdrew Consent|0|||
42112159|NCT00141817|75922368|FG000|Overall Study|Protocol Violation|0|||
42112160|NCT00141817|75922369|FG001|Overall Study|Protocol Violation|0|||
42112161|NCT00141817|75922370|FG002|Overall Study|Protocol Violation|1|||
42112162|NCT00141817|75922371|FG003|Overall Study|Protocol Violation|0|||
42112163|NCT00141817|75922368|FG000|Overall Study|Parent request|1|||
42112164|NCT00141817|75922369|FG001|Overall Study|Parent request|0|||
42112165|NCT00141817|75922370|FG002|Overall Study|Parent request|0|||
42112166|NCT00141817|75922371|FG003|Overall Study|Parent request|0|||
42112167|NCT00573170|75922381|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
42112168|NCT00573170|75922382|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
42112169|NCT00573170|75922383|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
42112170|NCT00573170|75922384|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
42112171|NCT00573170|75922385|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
42112172|NCT00573170|75922386|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
42112173|NCT00573170|75922381|FG000|First Washout Period|Adverse Event|1|||
42112174|NCT00573170|75922382|FG001|First Washout Period|Adverse Event|1|||
42112175|NCT00573170|75922383|FG002|First Washout Period|Adverse Event|0|||
42112176|NCT00573170|75922384|FG003|First Washout Period|Adverse Event|0|||
42112177|NCT00573170|75922385|FG004|First Washout Period|Adverse Event|0|||
42112178|NCT00573170|75922386|FG005|First Washout Period|Adverse Event|1|||
42112179|NCT00573170|75922381|FG000|First Washout Period|Lack of Efficacy|0|||
42112180|NCT00573170|75922382|FG001|First Washout Period|Lack of Efficacy|0|||
42112181|NCT00573170|75922383|FG002|First Washout Period|Lack of Efficacy|0|||
42112182|NCT00573170|75922384|FG003|First Washout Period|Lack of Efficacy|0|||
42112183|NCT00573170|75922385|FG004|First Washout Period|Lack of Efficacy|0|||
42112184|NCT00573170|75922386|FG005|First Washout Period|Lack of Efficacy|1|||
42112185|NCT00573170|75922381|FG000|First Washout Period|Lost to Follow-up|1|||
42112186|NCT00573170|75922382|FG001|First Washout Period|Lost to Follow-up|1|||
42112187|NCT00573170|75922383|FG002|First Washout Period|Lost to Follow-up|0|||
42112188|NCT00573170|75922384|FG003|First Washout Period|Lost to Follow-up|2|||
42112189|NCT00573170|75922385|FG004|First Washout Period|Lost to Follow-up|0|||
42112190|NCT00573170|75922386|FG005|First Washout Period|Lost to Follow-up|2|||
42112191|NCT00573170|75922381|FG000|First Washout Period|Withdrawal by Subject|2|||
42112192|NCT00573170|75922382|FG001|First Washout Period|Withdrawal by Subject|0|||
42112193|NCT00573170|75922383|FG002|First Washout Period|Withdrawal by Subject|0|||
42112194|NCT00573170|75922384|FG003|First Washout Period|Withdrawal by Subject|2|||
42112195|NCT00573170|75922385|FG004|First Washout Period|Withdrawal by Subject|3|||
42112196|NCT00573170|75922386|FG005|First Washout Period|Withdrawal by Subject|3|||
42112197|NCT00573170|75922381|FG000|First Washout Period|Other|4|||
42112198|NCT00573170|75922382|FG001|First Washout Period|Other|0|||
42112199|NCT00573170|75922383|FG002|First Washout Period|Other|1|||
42112200|NCT00573170|75922384|FG003|First Washout Period|Other|1|||
42112201|NCT00573170|75922385|FG004|First Washout Period|Other|0|||
42112202|NCT00573170|75922386|FG005|First Washout Period|Other|0|||
42112203|NCT00573170|75922381|FG000|Second Washout Period|Adverse Event|1|||
42112204|NCT00573170|75922382|FG001|Second Washout Period|Adverse Event|0|||
42112205|NCT00573170|75922383|FG002|Second Washout Period|Adverse Event|0|||
42112206|NCT00573170|75922384|FG003|Second Washout Period|Adverse Event|0|||
42112207|NCT00573170|75922385|FG004|Second Washout Period|Adverse Event|1|||
42112208|NCT00573170|75922386|FG005|Second Washout Period|Adverse Event|0|||
42112209|NCT00573170|75922381|FG000|Second Washout Period|Protocol Violation|2|||
42112210|NCT00573170|75922382|FG001|Second Washout Period|Protocol Violation|1|||
42112211|NCT00573170|75922383|FG002|Second Washout Period|Protocol Violation|1|||
42112212|NCT00573170|75922384|FG003|Second Washout Period|Protocol Violation|0|||
42112213|NCT00573170|75922385|FG004|Second Washout Period|Protocol Violation|0|||
42112214|NCT00573170|75922386|FG005|Second Washout Period|Protocol Violation|0|||
42112215|NCT00573170|75922381|FG000|Second Washout Period|Withdrawal by Subject|1|||
42112216|NCT00573170|75922382|FG001|Second Washout Period|Withdrawal by Subject|1|||
42112217|NCT00573170|75922383|FG002|Second Washout Period|Withdrawal by Subject|2|||
42112218|NCT00573170|75922384|FG003|Second Washout Period|Withdrawal by Subject|0|||
42112219|NCT00573170|75922385|FG004|Second Washout Period|Withdrawal by Subject|1|||
42112220|NCT00573170|75922386|FG005|Second Washout Period|Withdrawal by Subject|0|||
42112221|NCT00573170|75922381|FG000|Second Washout Period|Lost to Follow-up|0|||
42112222|NCT00573170|75922382|FG001|Second Washout Period|Lost to Follow-up|0|||
42112223|NCT00573170|75922383|FG002|Second Washout Period|Lost to Follow-up|0|||
42112224|NCT00573170|75922384|FG003|Second Washout Period|Lost to Follow-up|1|||
42112225|NCT00573170|75922385|FG004|Second Washout Period|Lost to Follow-up|0|||
42112226|NCT00573170|75922386|FG005|Second Washout Period|Lost to Follow-up|0|||
42112227|NCT00573170|75922381|FG000|Second Washout Period|Other|1|||
42112228|NCT00573170|75922382|FG001|Second Washout Period|Other|2|||
42112229|NCT00573170|75922383|FG002|Second Washout Period|Other|1|||
42112230|NCT00573170|75922384|FG003|Second Washout Period|Other|4|||
42112231|NCT00573170|75922385|FG004|Second Washout Period|Other|6|||
42112232|NCT00573170|75922386|FG005|Second Washout Period|Other|2|||
42112233|NCT00573170|75922381|FG000|Third Treatment Period|Withdrawal by Subject|1|||
42112234|NCT00573170|75922382|FG001|Third Treatment Period|Withdrawal by Subject|0|||
42112235|NCT00573170|75922383|FG002|Third Treatment Period|Withdrawal by Subject|0|||
42112236|NCT00573170|75922384|FG003|Third Treatment Period|Withdrawal by Subject|0|||
42112237|NCT00573170|75922385|FG004|Third Treatment Period|Withdrawal by Subject|0|||
42112238|NCT00573170|75922386|FG005|Third Treatment Period|Withdrawal by Subject|0|||
42112239|NCT00573170|75922381|FG000|Third Treatment Period|Lost to Follow-up|0|||
42112240|NCT00573170|75922382|FG001|Third Treatment Period|Lost to Follow-up|0|||
42112241|NCT00573170|75922383|FG002|Third Treatment Period|Lost to Follow-up|0|||
42112242|NCT00573170|75922384|FG003|Third Treatment Period|Lost to Follow-up|0|||
42112243|NCT00573170|75922385|FG004|Third Treatment Period|Lost to Follow-up|0|||
42112244|NCT00573170|75922386|FG005|Third Treatment Period|Lost to Follow-up|2|||
42112245|NCT00201643|75922405|FG000|Overall Study|Withdrawal by Subject|5|||
42112246|NCT00201643|75922406|FG001|Overall Study|Withdrawal by Subject|4|||
42112247|NCT00130039|75922414|FG000|Overall Study|Withdrawal by Subject|15|||
42112248|NCT00130039|75922415|FG001|Overall Study|Withdrawal by Subject|11|||
42112249|NCT00130039|75922414|FG000|Overall Study|Lost to Follow-up|3|||
42112250|NCT00130039|75922415|FG001|Overall Study|Lost to Follow-up|1|||
42112251|NCT00130039|75922414|FG000|Overall Study|Adverse Event|4|||
42112252|NCT00130039|75922415|FG001|Overall Study|Adverse Event|2|||
42112253|NCT00130039|75922414|FG000|Overall Study|Physician Decision|3|||
42112254|NCT00130039|75922415|FG001|Overall Study|Physician Decision|0|||
42112255|NCT00130039|75922414|FG000|Overall Study|clinical events without follow up MRI|5|||
42112256|NCT00130039|75922415|FG001|Overall Study|clinical events without follow up MRI|4|||
42112257|NCT00475852|75922423|FG000|Overall Study|Death|444|||
42112258|NCT00475852|75922424|FG001|Overall Study|Death|456|||
42112259|NCT00475852|75922423|FG000|Overall Study|Withdrawal by Subject|19|||
42112260|NCT00475852|75922424|FG001|Overall Study|Withdrawal by Subject|24|||
42112261|NCT00475852|75922423|FG000|Overall Study|Lost to Follow-up|54|||
42112262|NCT00475852|75922424|FG001|Overall Study|Lost to Follow-up|68|||
42112263|NCT00141271|75922433|FG000|Overall Study|Adverse Event|31|||
42112264|NCT00141271|75922434|FG001|Overall Study|Adverse Event|19|||
42112265|NCT00141271|75922435|FG002|Overall Study|Adverse Event|17|||
42112266|NCT00141271|75922433|FG000|Overall Study|Laboratory Abnormality|2|||
42112267|NCT00141271|75922434|FG001|Overall Study|Laboratory Abnormality|1|||
42112268|NCT00141271|75922435|FG002|Overall Study|Laboratory Abnormality|1|||
42112269|NCT00141271|75922433|FG000|Overall Study|Lack of Efficacy|7|||
42112270|NCT00141271|75922434|FG001|Overall Study|Lack of Efficacy|7|||
42112271|NCT00141271|75922435|FG002|Overall Study|Lack of Efficacy|3|||
42112272|NCT00141271|75922433|FG000|Overall Study|Lost to Follow-up|15|||
42112273|NCT00141271|75922434|FG001|Overall Study|Lost to Follow-up|15|||
42112274|NCT00141271|75922435|FG002|Overall Study|Lost to Follow-up|21|||
42112275|NCT00141271|75922433|FG000|Overall Study|Withdrawal by Subject|14|||
42112276|NCT00141271|75922434|FG001|Overall Study|Withdrawal by Subject|9|||
42112277|NCT00141271|75922435|FG002|Overall Study|Withdrawal by Subject|10|||
42112278|NCT00141271|75922433|FG000|Overall Study|Other|11|||
42112279|NCT00141271|75922434|FG001|Overall Study|Other|12|||
42112280|NCT00141271|75922435|FG002|Overall Study|Other|5|||
42112281|NCT00614120|75922447|FG000|Overall Study|Adverse Event|9|||
42112282|NCT00614120|75922448|FG001|Overall Study|Adverse Event|22|||
42112283|NCT00614120|75922449|FG002|Overall Study|Adverse Event|30|||
42112284|NCT00614120|75922450|FG003|Overall Study|Adverse Event|3|||
42112285|NCT00614120|75922447|FG000|Overall Study|Lack of Efficacy|3|||
42112286|NCT00614120|75922448|FG001|Overall Study|Lack of Efficacy|3|||
42112287|NCT00614120|75922449|FG002|Overall Study|Lack of Efficacy|2|||
42112288|NCT00614120|75922450|FG003|Overall Study|Lack of Efficacy|2|||
42112289|NCT00614120|75922447|FG000|Overall Study|Protocol Violation|2|||
42112290|NCT00614120|75922448|FG001|Overall Study|Protocol Violation|5|||
42112291|NCT00614120|75922449|FG002|Overall Study|Protocol Violation|3|||
42112292|NCT00614120|75922450|FG003|Overall Study|Protocol Violation|1|||
42112293|NCT00614120|75922447|FG000|Overall Study|Withdrawal criteria|1|||
42112294|NCT00614120|75922448|FG001|Overall Study|Withdrawal criteria|0|||
42112295|NCT00614120|75922449|FG002|Overall Study|Withdrawal criteria|0|||
42112296|NCT00614120|75922450|FG003|Overall Study|Withdrawal criteria|0|||
42112297|NCT00614120|75922447|FG000|Overall Study|Withdrawal by Subject|9|||
42112298|NCT00614120|75922448|FG001|Overall Study|Withdrawal by Subject|10|||
42112299|NCT00614120|75922449|FG002|Overall Study|Withdrawal by Subject|16|||
42112300|NCT00614120|75922450|FG003|Overall Study|Withdrawal by Subject|3|||
42112301|NCT00614120|75922447|FG000|Overall Study|Did not meet trial criteria|0|||
42112302|NCT00614120|75922448|FG001|Overall Study|Did not meet trial criteria|1|||
42112303|NCT00614120|75922449|FG002|Overall Study|Did not meet trial criteria|1|||
42112304|NCT00614120|75922450|FG003|Overall Study|Did not meet trial criteria|1|||
42112305|NCT00614120|75922447|FG000|Overall Study|hCG positive (not pregnant)|0|||
42112306|NCT00614120|75922448|FG001|Overall Study|hCG positive (not pregnant)|0|||
42112307|NCT00614120|75922449|FG002|Overall Study|hCG positive (not pregnant)|1|||
42112308|NCT00614120|75922450|FG003|Overall Study|hCG positive (not pregnant)|0|||
42112309|NCT00614120|75922447|FG000|Overall Study|Hypoglycaemia|0|||
42112310|NCT00614120|75922448|FG001|Overall Study|Hypoglycaemia|0|||
42112311|NCT00614120|75922449|FG002|Overall Study|Hypoglycaemia|0|||
42112312|NCT00614120|75922450|FG003|Overall Study|Hypoglycaemia|1|||
42112313|NCT00614120|75922447|FG000|Overall Study|Lack of trial product|3|||
42112314|NCT00614120|75922448|FG001|Overall Study|Lack of trial product|3|||
42112315|NCT00614120|75922449|FG002|Overall Study|Lack of trial product|2|||
42112316|NCT00614120|75922450|FG003|Overall Study|Lack of trial product|0|||
42112317|NCT00614120|75922447|FG000|Overall Study|Late syphilis, latent|1|||
42112318|NCT00614120|75922448|FG001|Overall Study|Late syphilis, latent|0|||
42112319|NCT00614120|75922449|FG002|Overall Study|Late syphilis, latent|0|||
42112320|NCT00614120|75922450|FG003|Overall Study|Late syphilis, latent|0|||
42112321|NCT00614120|75922447|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
42112322|NCT00614120|75922448|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
42112323|NCT00614120|75922449|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
42112324|NCT00614120|75922450|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
42112325|NCT00614120|75922447|FG000|Overall Study|Lost to Follow-up|1|||
42112326|NCT00614120|75922448|FG001|Overall Study|Lost to Follow-up|2|||
42112327|NCT00614120|75922449|FG002|Overall Study|Lost to Follow-up|3|||
42112328|NCT00614120|75922450|FG003|Overall Study|Lost to Follow-up|4|||
42112329|NCT00496054|75922460|FG000|Overall Study|Adverse Event|1|||
42112330|NCT00496054|75922460|FG000|Overall Study|Lost to Follow-up|7|||
42112331|NCT00495820|75922466|FG000|Overall Study|Adverse Event|1|||
42112332|NCT00495820|75922467|FG001|Overall Study|Adverse Event|1|||
42112333|NCT00495586|75922475|FG000|Overall Study|Withdrawal by Subject|4|||
42112334|NCT00495586|75922476|FG001|Overall Study|Withdrawal by Subject|4|||
42112335|NCT00613730|75922484|FG000|Overall Study|Disease progression|2|||
42112336|NCT00613730|75922484|FG000|Overall Study|Administrative decision|1|||
42112337|NCT00613574|75922488|FG000|Overall Study|Adverse Event|3|||
42112338|NCT00613574|75922488|FG000|Overall Study|Lost to Follow-up|2|||
42112339|NCT00613574|75922488|FG000|Overall Study|Other|1|||
42112340|NCT00613106|75922494|FG000|Overall Study|Adverse Event|3|||
42112341|NCT00613106|75922495|FG001|Overall Study|Adverse Event|1|||
42112342|NCT00613106|75922494|FG000|Overall Study|Withdrawal by Subject|6|||
42112343|NCT00613106|75922495|FG001|Overall Study|Withdrawal by Subject|3|||
42112344|NCT00613106|75922494|FG000|Overall Study|Lost to Follow-up|7|||
42112345|NCT00613106|75922495|FG001|Overall Study|Lost to Follow-up|2|||
42112346|NCT00613106|75922494|FG000|Overall Study|misc|4|||
42112347|NCT00613106|75922495|FG001|Overall Study|misc|3|||
42112348|NCT00141037|75922503|FG000|Overall Study|Physician Decision|1|||
42112349|NCT00141037|75922504|FG001|Overall Study|Physician Decision|2|||
42112350|NCT00141037|75922503|FG000|Overall Study|Lost to Follow-up|3|||
42112351|NCT00141037|75922504|FG001|Overall Study|Lost to Follow-up|1|||
42112352|NCT00141037|75922503|FG000|Overall Study|Protocol Violation|0|||
42112353|NCT00141037|75922504|FG001|Overall Study|Protocol Violation|2|||
42112354|NCT00141037|75922503|FG000|Overall Study|Withdrawal by Subject|2|||
42112355|NCT00141037|75922504|FG001|Overall Study|Withdrawal by Subject|1|||
42112356|NCT00141037|75922503|FG000|Overall Study|Other|0|||
42112357|NCT00141037|75922504|FG001|Overall Study|Other|1|||
42112358|NCT00141037|75922503|FG000|Overall Study|Moved from area|1|||
42112359|NCT00141037|75922504|FG001|Overall Study|Moved from area|7|||
42112360|NCT00141037|75922503|FG000|Overall Study|Graft Failure|3|||
42112361|NCT00141037|75922504|FG001|Overall Study|Graft Failure|4|||
42112362|NCT00140413|75922513|FG000|Overall Study|Lost to Follow-up|1|||
42112363|NCT00140413|75922514|FG001|Overall Study|Lost to Follow-up|0|||
42112364|NCT00140413|75922513|FG000|Overall Study|Withdrawal by Subject|2|||
42112365|NCT00140413|75922514|FG001|Overall Study|Withdrawal by Subject|0|||
42112366|NCT00563706|75922530|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
42112367|NCT00563706|75922531|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
42112368|NCT00563706|75922532|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
42112369|NCT00563706|75922533|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
42112370|NCT00563706|75922534|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
42112371|NCT00563706|75922535|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
42112372|NCT00563706|75922536|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
42112373|NCT00563706|75922537|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
42112374|NCT00563706|75922538|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
42112375|NCT00563706|75922530|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
42112376|NCT00563706|75922531|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
42112377|NCT00563706|75922532|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
42112378|NCT00563706|75922533|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
42112379|NCT00563706|75922534|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
42112380|NCT00563706|75922535|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
42112381|NCT00563706|75922536|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
42390455|NCT02607228|76275846|FG004|Overall Study|Withdrew Consent|0|||
42112382|NCT00563706|75922537|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
42112383|NCT00563706|75922538|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
42112384|NCT00563706|75922530|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
42204867|NCT00004859|76017428|FG000|Overall Study|error|3|||
42112385|NCT00563706|75922531|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
42112386|NCT00563706|75922532|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
42112387|NCT00563706|75922533|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
42112388|NCT00563706|75922534|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
42112389|NCT00563706|75922535|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
42112390|NCT00563706|75922536|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
42112391|NCT00563706|75922537|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
42112392|NCT00563706|75922538|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
42112393|NCT00563706|75922530|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
42112394|NCT00563706|75922531|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
42112395|NCT00563706|75922532|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
42112396|NCT00563706|75922533|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
42112397|NCT00563706|75922534|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
42112398|NCT00563706|75922535|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
42112399|NCT00563706|75922536|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
42112400|NCT00563706|75922537|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
42112401|NCT00563706|75922538|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
42112402|NCT00563706|75922530|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
42112403|NCT00563706|75922531|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
42112404|NCT00563706|75922532|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
42112405|NCT00563706|75922533|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
42112406|NCT00563706|75922534|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
42112407|NCT00563706|75922535|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
42112408|NCT00563706|75922536|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
42112409|NCT00563706|75922537|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
42112410|NCT00563706|75922538|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
42112411|NCT00129961|75922560|FG000|Overall Study|Adverse Event|1|||
42112412|NCT00129961|75922561|FG001|Overall Study|Adverse Event|0|||
42112413|NCT00129961|75922560|FG000|Overall Study|Death|1|||
42112414|NCT00129961|75922561|FG001|Overall Study|Death|1|||
42112415|NCT00129961|75922560|FG000|Overall Study|Withdrawal by Sponsor|14|||
42112416|NCT00129961|75922561|FG001|Overall Study|Withdrawal by Sponsor|20|||
42112417|NCT00129961|75922560|FG000|Overall Study|Physician Decision|1|||
42112418|NCT00129961|75922561|FG001|Overall Study|Physician Decision|0|||
42112419|NCT00129961|75922560|FG000|Overall Study|Withdrawal by Subject|2|||
42112420|NCT00129961|75922561|FG001|Overall Study|Withdrawal by Subject|1|||
42112421|NCT00129961|75922560|FG000|Overall Study|Missing Record|0|||
42112422|NCT00129961|75922561|FG001|Overall Study|Missing Record|1|||
42112423|NCT00528567|75922569|FG000|Overall Study|Death|4|||
42112424|NCT00528567|75922570|FG001|Overall Study|Death|5|||
42112425|NCT00528567|75922569|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
42112426|NCT00528567|75922570|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
42112427|NCT00528567|75922569|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
42112428|NCT00528567|75922570|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
42112429|NCT00528567|75922569|FG000|Overall Study|Violation Criteria at Entry|3|||
42112430|NCT00528567|75922570|FG001|Overall Study|Violation Criteria at Entry|17|||
42112431|NCT00528567|75922569|FG000|Overall Study|Withdrew Consent|59|||
42112432|NCT00528567|75922570|FG001|Overall Study|Withdrew Consent|55|||
42112433|NCT00528567|75922569|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
42112434|NCT00528567|75922570|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
42112435|NCT00528567|75922569|FG000|Overall Study|Failure to Return|1|||
42112436|NCT00528567|75922570|FG001|Overall Study|Failure to Return|4|||
42112437|NCT00528567|75922569|FG000|Overall Study|Other Protocol Violation|5|||
42112438|NCT00528567|75922570|FG001|Overall Study|Other Protocol Violation|21|||
42112439|NCT00528567|75922569|FG000|Overall Study|Administrative/Other|22|||
42112440|NCT00528567|75922570|FG001|Overall Study|Administrative/Other|75|||
42112441|NCT00138151|75922583|FG000|Overall Study|Withdrawal by Subject|3|||
42112442|NCT00138151|75922583|FG000|Overall Study|Physician Decision|1|||
42112443|NCT00138073|75922587|FG000|Overall Study|lack of resources|55|||
42112444|NCT02581631|75922596|FG000|Overall Study|Disease progression|29|||
42112445|NCT02581631|75922597|FG001|Overall Study|Disease progression|19|||
42112446|NCT02581631|75922598|FG002|Overall Study|Disease progression|13|||
42112447|NCT02581631|75922599|FG003|Overall Study|Disease progression|5|||
42112448|NCT02581631|75922600|FG004|Overall Study|Disease progression|8|||
42112449|NCT02581631|75922596|FG000|Overall Study|Study drug toxicity|4|||
42112450|NCT02581631|75922597|FG001|Overall Study|Study drug toxicity|6|||
42112451|NCT02581631|75922598|FG002|Overall Study|Study drug toxicity|7|||
42112452|NCT02581631|75922599|FG003|Overall Study|Study drug toxicity|0|||
42112453|NCT02581631|75922600|FG004|Overall Study|Study drug toxicity|3|||
42112454|NCT02581631|75922596|FG000|Overall Study|AE unrelated to study drug|3|||
42390456|NCT02607228|76275847|FG005|Overall Study|Withdrew Consent|1|||
42390457|NCT02607228|76275848|FG006|Overall Study|Withdrew Consent|0|||
42390458|NCT02607228|76275842|FG000|Overall Study|Study Terminated by Sponsor|0|||
42390459|NCT02607228|76275843|FG001|Overall Study|Study Terminated by Sponsor|0|||
42390460|NCT02607228|76275844|FG002|Overall Study|Study Terminated by Sponsor|0|||
42390461|NCT02607228|76275845|FG003|Overall Study|Study Terminated by Sponsor|1|||
42390462|NCT02607228|76275846|FG004|Overall Study|Study Terminated by Sponsor|0|||
42390463|NCT02607228|76275847|FG005|Overall Study|Study Terminated by Sponsor|0|||
42390464|NCT02607228|76275848|FG006|Overall Study|Study Terminated by Sponsor|0|||
42390465|NCT01668654|76275890|FG000|Overall Study|Study Closed/Terminated|3|||
42390466|NCT01668654|76275890|FG000|Overall Study|Withdrawal by Subject|1|||
42390467|NCT02608476|76275984|FG000|Overall Study|Withdrawal by Subject|30|||
42390468|NCT02608476|76275985|FG001|Overall Study|Withdrawal by Subject|37|||
42390469|NCT02608476|76275984|FG000|Overall Study|Lost to Follow-up|24|||
42390470|NCT02608476|76275985|FG001|Overall Study|Lost to Follow-up|24|||
42390471|NCT02608476|76275984|FG000|Overall Study|Adverse Event|2|||
42390472|NCT02608476|76275985|FG001|Overall Study|Adverse Event|8|||
42390473|NCT02608476|76275984|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
42390474|NCT02608476|76275985|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
42390475|NCT02608476|76275984|FG000|Overall Study|Noncompliance with treatment|1|||
42390476|NCT02608476|76275985|FG001|Overall Study|Noncompliance with treatment|5|||
42390477|NCT02608476|76275984|FG000|Overall Study|Lack of Efficacy|3|||
42390478|NCT02608476|76275985|FG001|Overall Study|Lack of Efficacy|1|||
42390479|NCT02608476|76275984|FG000|Overall Study|Other|0|||
42390480|NCT02608476|76275985|FG001|Overall Study|Other|1|||
42390481|NCT02608476|76275984|FG000|Overall Study|Physician Decision|1|||
42390482|NCT02608476|76275985|FG001|Overall Study|Physician Decision|0|||
42390483|NCT02608476|76275984|FG000|Overall Study|Pregnancy|0|||
42390484|NCT02608476|76275985|FG001|Overall Study|Pregnancy|1|||
42390485|NCT02608476|76275984|FG000|Overall Study|Progressive disease|1|||
42390486|NCT02608476|76275985|FG001|Overall Study|Progressive disease|0|||
42390487|NCT02607306|76276123|FG000|Overall Study|Adverse Event|8|||
42390488|NCT02607306|76276124|FG001|Overall Study|Adverse Event|6|||
42390489|NCT02607306|76276125|FG002|Overall Study|Adverse Event|6|||
42390490|NCT02607306|76276123|FG000|Overall Study|Unclassified|1|||
42390491|NCT02607306|76276124|FG001|Overall Study|Unclassified|4|||
42390492|NCT02607306|76276125|FG002|Overall Study|Unclassified|0|||
42390493|NCT02607306|76276123|FG000|Overall Study|Withdrawal by Subject|8|||
42390494|NCT02607306|76276124|FG001|Overall Study|Withdrawal by Subject|10|||
42390495|NCT02607306|76276125|FG002|Overall Study|Withdrawal by Subject|2|||
42390496|NCT02607306|76276123|FG000|Overall Study|Lack of Efficacy|0|||
42390497|NCT02607306|76276124|FG001|Overall Study|Lack of Efficacy|1|||
42390498|NCT02607306|76276125|FG002|Overall Study|Lack of Efficacy|1|||
42390499|NCT02607306|76276123|FG000|Overall Study|Protocol Violation|4|||
42390500|NCT02607306|76276124|FG001|Overall Study|Protocol Violation|2|||
42390501|NCT02607306|76276125|FG002|Overall Study|Protocol Violation|1|||
42390502|NCT01495689|76276174|FG000|Overall Study|Death|0|||
42390503|NCT01495689|76276175|FG001|Overall Study|Death|1|||
42390504|NCT01495689|76276174|FG000|Overall Study|Withdrawal by Subject|3|||
42390505|NCT01495689|76276175|FG001|Overall Study|Withdrawal by Subject|0|||
42390506|NCT01495689|76276174|FG000|Overall Study|Lost to Follow-up|7|||
42390507|NCT01495689|76276175|FG001|Overall Study|Lost to Follow-up|6|||
42390508|NCT02603952|76276448|FG000|Overall Study|Withdrawal by Subject|1|||
42390509|NCT02603952|76276449|FG001|Overall Study|Withdrawal by Subject|0|||
42390510|NCT02603952|76276450|FG002|Overall Study|Withdrawal by Subject|0|||
42390511|NCT02603952|76276451|FG003|Overall Study|Withdrawal by Subject|0|||
42390512|NCT02603952|76276448|FG000|Overall Study|Received oseltamivir by error|0|||
42390513|NCT02603952|76276449|FG001|Overall Study|Received oseltamivir by error|0|||
42390514|NCT02603952|76276450|FG002|Overall Study|Received oseltamivir by error|0|||
42390515|NCT02603952|76276451|FG003|Overall Study|Received oseltamivir by error|1|||
42390516|NCT02603172|76276965|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
42390517|NCT02603172|76276966|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
42390518|NCT02603172|76276967|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
42390519|NCT02603172|76276968|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
42390520|NCT02603172|76276969|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
42390521|NCT02603172|76276970|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
42390522|NCT02603172|76276971|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
42390523|NCT02603172|76276972|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
42390524|NCT02605824|76277093|FG000|Overall Study|Physician Decision|1|||
42390525|NCT02605824|76277094|FG001|Overall Study|Physician Decision|0|||
42390526|NCT02605122|76277224|FG000|Overall Study|Withdrawal by Subject|4|||
42390527|NCT02605122|76277225|FG001|Overall Study|Withdrawal by Subject|1|||
42390528|NCT02605122|76277224|FG000|Overall Study|Lost to Follow-up|1|||
42390529|NCT02605122|76277225|FG001|Overall Study|Lost to Follow-up|1|||
42390530|NCT01454102|76277276|FG000|Overall Study|Continuing in the treatment period|0|||
42390531|NCT01454102|76277277|FG001|Overall Study|Continuing in the treatment period|0|||
42390532|NCT01454102|76277278|FG002|Overall Study|Continuing in the treatment period|0|||
42112455|NCT02581631|75922597|FG001|Overall Study|AE unrelated to study drug|1|||
42390533|NCT01454102|76277279|FG003|Overall Study|Continuing in the treatment period|0|||
42390534|NCT01454102|76277280|FG004|Overall Study|Continuing in the treatment period|3|||
42390535|NCT01454102|76277281|FG005|Overall Study|Continuing in the treatment period|3|||
42390536|NCT01454102|76277282|FG006|Overall Study|Continuing in the treatment period|2|||
42390537|NCT01454102|76277283|FG007|Overall Study|Continuing in the treatment period|0|||
42390538|NCT01454102|76277284|FG008|Overall Study|Continuing in the treatment period|1|||
42390539|NCT01454102|76277285|FG009|Overall Study|Continuing in the treatment period|0|||
42390540|NCT01454102|76277286|FG010|Overall Study|Continuing in the treatment period|0|||
42390541|NCT01454102|76277287|FG011|Overall Study|Continuing in the treatment period|4|||
42390542|NCT01454102|76277288|FG012|Overall Study|Continuing in the treatment period|7|||
42390543|NCT01454102|76277289|FG013|Overall Study|Continuing in the treatment period|4|||
42390544|NCT01454102|76277290|FG014|Overall Study|Continuing in the treatment period|3|||
42390545|NCT01454102|76277291|FG015|Overall Study|Continuing in the treatment period|1|||
42390546|NCT02602080|76277385|FG000|Overall Study|Protocol Violation|6|||
42390547|NCT02602080|76277386|FG001|Overall Study|Protocol Violation|1|||
42390548|NCT02602080|76277387|FG002|Overall Study|Protocol Violation|3|||
42390549|NCT02604342|76277471|FG000|Overall Study|Death|32|||
42390550|NCT02604342|76277472|FG001|Overall Study|Death|16|||
42390551|NCT02604342|76277471|FG000|Overall Study|Progression of disease|1|||
42390552|NCT02604342|76277472|FG001|Overall Study|Progression of disease|0|||
42390553|NCT02604342|76277471|FG000|Overall Study|Withdrawal by Subject|5|||
42390554|NCT02604342|76277472|FG001|Overall Study|Withdrawal by Subject|6|||
42390555|NCT02604342|76277471|FG000|Overall Study|Other|1|||
42390556|NCT02604342|76277472|FG001|Overall Study|Other|0|||
42390557|NCT02604342|76277471|FG000|Overall Study|Study Termination by Sponsor|1|||
42390558|NCT02604342|76277472|FG001|Overall Study|Study Termination by Sponsor|0|||
42390559|NCT02604342|76277471|FG000|Overall Study|Lost to Follow-up|1|||
42390560|NCT02604342|76277472|FG001|Overall Study|Lost to Follow-up|1|||
42390561|NCT02604342|76277471|FG000|Overall Study|Physician Decision|2|||
42390562|NCT02604342|76277472|FG001|Overall Study|Physician Decision|0|||
42390563|NCT02604264|76277501|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
42390564|NCT02604264|76277502|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
42390565|NCT02601300|76277539|FG000|Induction Phase|Lack of Efficacy|2|||
42390566|NCT02601300|76277539|FG000|Induction Phase|Protocol Violation|1|||
42390567|NCT02601300|76277539|FG000|Extension Phase|Withdrawal by Subject|3|||
42390568|NCT02601300|76277539|FG000|Extension Phase|Adverse Event|4|||
42390569|NCT02601300|76277539|FG000|Extension Phase|Lack of Efficacy|10|||
42390570|NCT01471340|76277578|FG000|Overall Study|Death|5|||
42390571|NCT01471340|76277579|FG001|Overall Study|Death|4|||
42390572|NCT01471340|76277578|FG000|Overall Study|Lost to Follow-up|0|||
42390573|NCT01471340|76277579|FG001|Overall Study|Lost to Follow-up|1|||
42390574|NCT01471340|76277578|FG000|Overall Study|Investigational site closure|0|||
42390575|NCT01471340|76277579|FG001|Overall Study|Investigational site closure|1|||
42390576|NCT01471340|76277578|FG000|Overall Study|Invalid informed consent|1|||
42390577|NCT01471340|76277579|FG001|Overall Study|Invalid informed consent|0|||
42390578|NCT01492400|76277601|FG000|Overall Study|Miscellaneous Reasons|2|||
42390579|NCT01492400|76277602|FG001|Overall Study|Miscellaneous Reasons|3|||
42390580|NCT01492400|76277601|FG000|Overall Study|Personal Reasons|0|||
42390581|NCT01492400|76277602|FG001|Overall Study|Personal Reasons|5|||
42390582|NCT01492400|76277601|FG000|Overall Study|Lost to Follow-up|3|||
42390583|NCT01492400|76277602|FG001|Overall Study|Lost to Follow-up|1|||
42390584|NCT01492400|76277601|FG000|Overall Study|Pregnancy|0|||
42390585|NCT01492400|76277602|FG001|Overall Study|Pregnancy|1|||
42390586|NCT01492400|76277601|FG000|Overall Study|Lack of Efficacy|1|||
42390587|NCT01492400|76277602|FG001|Overall Study|Lack of Efficacy|1|||
42390588|NCT01492400|76277601|FG000|Overall Study|Adverse Event|10|||
42390589|NCT01492400|76277602|FG001|Overall Study|Adverse Event|5|||
42390590|NCT02596854|76277727|FG000|Overall Study|Withdrawn|8|||
42390591|NCT02592876|76277864|FG000|Overall Study|Withdrawal by Subject|3|||
42390592|NCT02592876|76277865|FG001|Overall Study|Withdrawal by Subject|3|||
42390593|NCT02592876|76277864|FG000|Overall Study|Study Termination by Sponsor|32|||
42112456|NCT02581631|75922598|FG002|Overall Study|AE unrelated to study drug|1|||
42390594|NCT02592876|76277865|FG001|Overall Study|Study Termination by Sponsor|27|||
42390595|NCT02592876|76277864|FG000|Overall Study|Lost to Follow-up|0|||
42390596|NCT02592876|76277865|FG001|Overall Study|Lost to Follow-up|1|||
42390597|NCT02592876|76277864|FG000|Overall Study|Death|6|||
42390598|NCT02592876|76277865|FG001|Overall Study|Death|9|||
42390599|NCT01492088|76277882|FG000|Overall Study|Withdrawal by Patient|0|||
42390600|NCT01492088|76277883|FG001|Overall Study|Withdrawal by Patient|2|||
42390601|NCT01492088|76277884|FG002|Overall Study|Withdrawal by Patient|0|||
42390602|NCT01492088|76277882|FG000|Overall Study|Death|1|||
42390603|NCT01492088|76277883|FG001|Overall Study|Death|6|||
42390604|NCT01492088|76277884|FG002|Overall Study|Death|2|||
42390605|NCT01492088|76277882|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
42390606|NCT01492088|76277883|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
42390607|NCT01492088|76277884|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
42204868|NCT00004859|76017429|FG001|Overall Study|error|1|||
42390608|NCT01492088|76277882|FG000|Overall Study|Alive at Last Follow-up|0|||
42390609|NCT01492088|76277883|FG001|Overall Study|Alive at Last Follow-up|6|||
42390610|NCT01492088|76277884|FG002|Overall Study|Alive at Last Follow-up|11|||
42390611|NCT02592798|76278126|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
42390612|NCT02592798|76278127|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
42390613|NCT02592798|76278126|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
42390614|NCT02592798|76278127|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
42390615|NCT02592798|76278126|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
42390616|NCT02592798|76278127|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
42390617|NCT02592798|76278126|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
42390618|NCT02592798|76278127|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
42390619|NCT02592798|76278126|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
42390620|NCT02592798|76278127|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
42390621|NCT02592798|76278126|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
42390622|NCT02592798|76278127|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
42390623|NCT02592798|76278126|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
42390624|NCT02592798|76278127|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
42390625|NCT02592798|76278126|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
42390626|NCT02592798|76278127|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
42390627|NCT02592798|76278126|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
42390628|NCT02592798|76278127|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
42390629|NCT02592798|76278126|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
42390630|NCT02592798|76278127|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
42390631|NCT02592798|76278126|FG000|Transition From DB2 to OLE|Other reasons|1|||
42390632|NCT02592798|76278127|FG001|Transition From DB2 to OLE|Other reasons|0|||
42390633|NCT02592798|76278126|FG000|Open Label Period (OLE)|Other reasons|0|||
42390634|NCT02592798|76278127|FG001|Open Label Period (OLE)|Other reasons|2|||
42390635|NCT02592798|76278126|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
42390636|NCT02592798|76278127|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
42390637|NCT02592798|76278126|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
42390638|NCT02592798|76278127|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
42390639|NCT02592798|76278126|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
42390640|NCT02592798|76278127|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
42390641|NCT02592798|76278126|FG000|Open Label Period (OLE)|Adverse Event|0|||
42390642|NCT02592798|76278127|FG001|Open Label Period (OLE)|Adverse Event|1|||
42390643|NCT00081653|76278167|FG000|Overall Study|Adverse Event|23|||
42390644|NCT00081653|76278168|FG001|Overall Study|Adverse Event|17|||
42390645|NCT00081653|76278167|FG000|Overall Study|Lost to Follow-up|2|||
42390646|NCT00081653|76278168|FG001|Overall Study|Lost to Follow-up|4|||
42390647|NCT00081653|76278167|FG000|Overall Study|Refused Treatment|18|||
42390648|NCT00081653|76278168|FG001|Overall Study|Refused Treatment|14|||
42390649|NCT00081653|76278167|FG000|Overall Study|Low bone mineral density|1|||
42390650|NCT00081653|76278168|FG001|Overall Study|Low bone mineral density|0|||
42390651|NCT00081653|76278167|FG000|Overall Study|Bone loss|2|||
42390652|NCT00081653|76278168|FG001|Overall Study|Bone loss|0|||
42390653|NCT00081653|76278167|FG000|Overall Study|Participant leaving country|1|||
42390654|NCT00081653|76278168|FG001|Overall Study|Participant leaving country|0|||
42390655|NCT00081653|76278167|FG000|Overall Study|Loss of bone mass|0|||
42390656|NCT00081653|76278168|FG001|Overall Study|Loss of bone mass|2|||
42390657|NCT02596620|76278229|FG000|Overall Study|Lost to Follow-up|1|||
42390658|NCT02596620|76278230|FG001|Overall Study|Lost to Follow-up|1|||
42390659|NCT02596230|76278386|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
42390660|NCT02596230|76278387|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
42390661|NCT02596230|76278388|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
42390662|NCT02596230|76278389|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
42390663|NCT02596230|76278390|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
42390664|NCT02596230|76278386|FG000|Objective 2, One Year|Lost to Follow-up|0|||
42390665|NCT02596230|76278387|FG001|Objective 2, One Year|Lost to Follow-up|41|||
42390666|NCT02596230|76278388|FG002|Objective 2, One Year|Lost to Follow-up|41|||
42390667|NCT02596230|76278389|FG003|Objective 2, One Year|Lost to Follow-up|32|||
42390668|NCT02596230|76278390|FG004|Objective 2, One Year|Lost to Follow-up|46|||
42390669|NCT02596230|76278386|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
42390670|NCT02596230|76278387|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
42390671|NCT02596230|76278388|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
42390672|NCT02596230|76278389|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
42390673|NCT02596230|76278390|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
42390674|NCT02596230|76278386|FG000|Objective 2, One Year|Adverse drug reaction|0|||
42390675|NCT02596230|76278387|FG001|Objective 2, One Year|Adverse drug reaction|1|||
42390676|NCT02596230|76278388|FG002|Objective 2, One Year|Adverse drug reaction|0|||
42390677|NCT02596230|76278389|FG003|Objective 2, One Year|Adverse drug reaction|0|||
42390678|NCT02596230|76278390|FG004|Objective 2, One Year|Adverse drug reaction|0|||
42390679|NCT02596230|76278386|FG000|Objective 2, One Year|Death|0|||
42390680|NCT02596230|76278387|FG001|Objective 2, One Year|Death|12|||
42390681|NCT02596230|76278388|FG002|Objective 2, One Year|Death|41|||
42390682|NCT02596230|76278389|FG003|Objective 2, One Year|Death|21|||
42390683|NCT02596230|76278390|FG004|Objective 2, One Year|Death|30|||
42390684|NCT02596230|76278386|FG000|Objective 2, One Year|Other|0|||
42390685|NCT02596230|76278387|FG001|Objective 2, One Year|Other|3|||
42390686|NCT02596230|76278388|FG002|Objective 2, One Year|Other|2|||
42390687|NCT02596230|76278389|FG003|Objective 2, One Year|Other|0|||
42390688|NCT02596230|76278390|FG004|Objective 2, One Year|Other|0|||
42390689|NCT01667562|76278439|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
42390690|NCT01667562|76278440|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
42390691|NCT01667562|76278439|FG000|Erlotinib Phase|Lost to Follow-up|0|||
42390692|NCT01667562|76278440|FG001|Erlotinib Phase|Lost to Follow-up|1|||
42390693|NCT01667562|76278439|FG000|Erlotinib Phase|Adverse Event|0|||
42390694|NCT01667562|76278440|FG001|Erlotinib Phase|Adverse Event|1|||
42390695|NCT01667562|76278439|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
42390696|NCT01667562|76278440|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
42390697|NCT02595528|76278477|FG000|Overall Study|Withdrawal by Subject|1|||
42390698|NCT02595528|76278478|FG001|Overall Study|Withdrawal by Subject|2|||
42390699|NCT02595528|76278479|FG002|Overall Study|Withdrawal by Subject|1|||
42390700|NCT02595528|76278480|FG003|Overall Study|Withdrawal by Subject|3|||
42390701|NCT02595528|76278477|FG000|Overall Study|Lost to Follow-up|1|||
42390702|NCT02595528|76278478|FG001|Overall Study|Lost to Follow-up|1|||
42390703|NCT02595528|76278479|FG002|Overall Study|Lost to Follow-up|0|||
42390704|NCT02595528|76278480|FG003|Overall Study|Lost to Follow-up|1|||
42390705|NCT02595450|76278508|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
42390706|NCT02595450|76278508|FG000|Overall Study|Enrolled, but not treated|8|||
42390707|NCT02592018|76278512|FG000|Overall Study|Adverse Event|1|||
42390708|NCT02592018|76278512|FG000|Overall Study|Lost to Follow-up|1|||
42390709|NCT02591238|76278520|FG000|Overall Study|Pregnancy|1|||
42390710|NCT02591238|76278521|FG001|Overall Study|Pregnancy|0|||
42390711|NCT02591238|76278522|FG002|Overall Study|Pregnancy|0|||
42390712|NCT02591238|76278523|FG003|Overall Study|Pregnancy|0|||
42390713|NCT02591238|76278520|FG000|Overall Study|Withdrawal by Subject|0|||
42390714|NCT02591238|76278521|FG001|Overall Study|Withdrawal by Subject|0|||
42390715|NCT02591238|76278522|FG002|Overall Study|Withdrawal by Subject|0|||
42390716|NCT02591238|76278523|FG003|Overall Study|Withdrawal by Subject|1|||
42390717|NCT02591238|76278520|FG000|Overall Study|influenza|0|||
42390718|NCT02591238|76278521|FG001|Overall Study|influenza|0|||
42390719|NCT02591238|76278522|FG002|Overall Study|influenza|0|||
42390720|NCT02591238|76278523|FG003|Overall Study|influenza|1|||
42390721|NCT02591238|76278520|FG000|Overall Study|personal circumstances|0|||
42390722|NCT02591238|76278521|FG001|Overall Study|personal circumstances|0|||
42390723|NCT02591238|76278522|FG002|Overall Study|personal circumstances|0|||
42390724|NCT02591238|76278523|FG003|Overall Study|personal circumstances|1|||
42390725|NCT02591238|76278520|FG000|Overall Study|personal circumstances|0|||
42390726|NCT02591238|76278521|FG001|Overall Study|personal circumstances|1|||
42390727|NCT02591238|76278522|FG002|Overall Study|personal circumstances|0|||
42390728|NCT02591238|76278523|FG003|Overall Study|personal circumstances|0|||
42390729|NCT02597946|76278605|FG000|Overall Study|Withdrawal by Subject|1|||
42390730|NCT02597946|76278605|FG000|Overall Study|Progressive disease|16|||
42390731|NCT02597946|76278605|FG000|Overall Study|Other than above|1|||
42390732|NCT02597712|76278611|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
42390733|NCT02597712|76278612|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
42390734|NCT02597712|76278611|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
42390735|NCT02597712|76278612|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
42390736|NCT02597712|76278611|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
42390737|NCT02597712|76278612|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
42390738|NCT02597478|76278620|FG000|Overall Study|Withdrawal by Subject|2|||
42390739|NCT02597478|76278621|FG001|Overall Study|Withdrawal by Subject|0|||
42390740|NCT02597478|76278620|FG000|Overall Study|Change of opioid dose|1|||
42390741|NCT02597478|76278621|FG001|Overall Study|Change of opioid dose|0|||
42390742|NCT02597478|76278620|FG000|Overall Study|Insufficient exertional dyspnea|0|||
42390743|NCT02597478|76278621|FG001|Overall Study|Insufficient exertional dyspnea|1|||
42390744|NCT01471028|76278716|FG000|VTI-208|Adverse Event|39|||
42390745|NCT01471028|76278717|FG001|VTI-208|Adverse Event|41|||
42390746|NCT01471028|76278716|FG000|VTI-208|Withdrawal by Subject|0|||
42390747|NCT01471028|76278717|FG001|VTI-208|Withdrawal by Subject|2|||
42390748|NCT01471028|76278716|FG000|VTI-208|Lost to Follow-up|1|||
42390749|NCT01471028|76278717|FG001|VTI-208|Lost to Follow-up|1|||
42390750|NCT01471028|76278716|FG000|VTI-208E|Death|7|||
42390751|NCT01471028|76278717|FG001|VTI-208E|Death|10|||
42390752|NCT01471028|76278716|FG000|VTI-208E|Withdrawal by Subject|1|||
42390753|NCT01471028|76278717|FG001|VTI-208E|Withdrawal by Subject|0|||
42390754|NCT01471028|76278716|FG000|VTI-208E|Lost to Follow-up|0|||
42390755|NCT01471028|76278717|FG001|VTI-208E|Lost to Follow-up|2|||
42390756|NCT01491854|76278731|FG000|Overall Study|mainly due to premature termination|93|||
42390757|NCT01491854|76278731|FG000|Overall Study|Death|1|||
42390758|NCT01491854|76278731|FG000|Overall Study|Withdrawal by Subject|3|||
42390759|NCT01491854|76278731|FG000|Overall Study|Lost to Follow-up|33|||
42390760|NCT01470248|76278739|FG000|Overall Study|Withdrawal by Subject|1|||
42390761|NCT01490918|76278759|FG000|Overall Study|Lost to Follow-up|2|||
42390762|NCT01490918|76278760|FG001|Overall Study|Lost to Follow-up|1|||
42390763|NCT01490918|76278761|FG002|Overall Study|Lost to Follow-up|0|||
42390764|NCT01490918|76278759|FG000|Overall Study|Withdrawal by Subject|7|||
42390765|NCT01490918|76278760|FG001|Overall Study|Withdrawal by Subject|8|||
42390766|NCT01490918|76278761|FG002|Overall Study|Withdrawal by Subject|3|||
42390767|NCT01490918|76278759|FG000|Overall Study|Adverse Event|0|||
42390768|NCT01490918|76278760|FG001|Overall Study|Adverse Event|0|||
42390769|NCT01490918|76278761|FG002|Overall Study|Adverse Event|1|||
42390770|NCT01490918|76278759|FG000|Overall Study|other cause|4|||
42390771|NCT01490918|76278760|FG001|Overall Study|other cause|5|||
42390772|NCT01490918|76278761|FG002|Overall Study|other cause|8|||
42390773|NCT01490840|76278793|FG000|Phase 1|Lost to Follow-up|1|||
42390774|NCT01490840|76278794|FG001|Phase 1|Lost to Follow-up|0|||
42390775|NCT01490840|76278793|FG000|Phase 1|Adverse Event|2|||
42390776|NCT01490840|76278794|FG001|Phase 1|Adverse Event|1|||
42390777|NCT01490840|76278793|FG000|Phase 1|Withdrawal by Subject|6|||
42390778|NCT01490840|76278794|FG001|Phase 1|Withdrawal by Subject|5|||
42390779|NCT01490840|76278793|FG000|Phase 1|Visit 6a omitted|1|||
42390780|NCT01490840|76278794|FG001|Phase 1|Visit 6a omitted|0|||
42390781|NCT01490840|76278793|FG000|Phase 2|Withdrawal by Subject|4|||
42390782|NCT01490840|76278794|FG001|Phase 2|Withdrawal by Subject|3|||
42390783|NCT01490840|76278793|FG000|Phase 2|Permanent interruption of fingolimod|0|||
42390784|NCT01490840|76278794|FG001|Phase 2|Permanent interruption of fingolimod|1|||
42390785|NCT01490840|76278793|FG000|Phase 2|Lost to Follow-up|1|||
42390786|NCT01490840|76278794|FG001|Phase 2|Lost to Follow-up|1|||
42390787|NCT01490840|76278793|FG000|Phase 2|Adverse Event|1|||
42390788|NCT01490840|76278794|FG001|Phase 2|Adverse Event|1|||
42390789|NCT01490450|76278826|FG000|Period 1|Lack of Efficacy|2|||
42390790|NCT01490450|76278827|FG001|Period 1|Lack of Efficacy|0|||
42390791|NCT01490450|76278828|FG002|Period 1|Lack of Efficacy|3|||
42390792|NCT01490450|76278829|FG003|Period 1|Lack of Efficacy|0|||
42390793|NCT01490450|76278826|FG000|Period 1|Adverse Event|0|||
42390794|NCT01490450|76278827|FG001|Period 1|Adverse Event|0|||
42390795|NCT01490450|76278828|FG002|Period 1|Adverse Event|0|||
42390796|NCT01490450|76278829|FG003|Period 1|Adverse Event|5|||
42390797|NCT01490450|76278826|FG000|Period 1|Request to discontinue treatment|1|||
42390798|NCT01490450|76278827|FG001|Period 1|Request to discontinue treatment|0|||
42390799|NCT01490450|76278828|FG002|Period 1|Request to discontinue treatment|0|||
42390800|NCT01490450|76278829|FG003|Period 1|Request to discontinue treatment|0|||
42390801|NCT01490450|76278826|FG000|Period 1|Withdrawal by Subject|0|||
42390802|NCT01490450|76278827|FG001|Period 1|Withdrawal by Subject|0|||
42390803|NCT01490450|76278828|FG002|Period 1|Withdrawal by Subject|0|||
42390804|NCT01490450|76278829|FG003|Period 1|Withdrawal by Subject|3|||
42390805|NCT01490450|76278826|FG000|Period 1|No longer met study criteria|0|||
42390806|NCT01490450|76278827|FG001|Period 1|No longer met study criteria|1|||
42390807|NCT01490450|76278828|FG002|Period 1|No longer met study criteria|1|||
42390808|NCT01490450|76278829|FG003|Period 1|No longer met study criteria|0|||
42390809|NCT01490450|76278826|FG000|Period 2|Lack of Efficacy|0|||
42390810|NCT01490450|76278827|FG001|Period 2|Lack of Efficacy|0|||
42390811|NCT01490450|76278828|FG002|Period 2|Lack of Efficacy|0|||
42390812|NCT01490450|76278829|FG003|Period 2|Lack of Efficacy|1|||
42390813|NCT01490450|76278826|FG000|Period 2|Adverse Event|1|||
42390814|NCT01490450|76278827|FG001|Period 2|Adverse Event|1|||
42390815|NCT01490450|76278828|FG002|Period 2|Adverse Event|0|||
42390816|NCT01490450|76278829|FG003|Period 2|Adverse Event|1|||
42390817|NCT01490450|76278826|FG000|Period 2|Withdrawal by Subject|1|||
42390818|NCT01490450|76278827|FG001|Period 2|Withdrawal by Subject|0|||
42390819|NCT01490450|76278828|FG002|Period 2|Withdrawal by Subject|0|||
42390820|NCT01490450|76278829|FG003|Period 2|Withdrawal by Subject|0|||
42390821|NCT01490450|76278826|FG000|Period 2|Lost to Follow-up|0|||
42390822|NCT01490450|76278827|FG001|Period 2|Lost to Follow-up|0|||
42390823|NCT01490450|76278828|FG002|Period 2|Lost to Follow-up|0|||
42390824|NCT01490450|76278829|FG003|Period 2|Lost to Follow-up|2|||
42390825|NCT01469546|76278873|FG000|Received 5 mg Dose|Adverse Event|13|||
42390826|NCT01469546|76278873|FG000|Received 5 mg Dose|Death|2|||
42390827|NCT01469546|76278873|FG000|Received 5 mg Dose|Protocol Violation|2|||
42390828|NCT01469546|76278873|FG000|Received 5 mg Dose|Progressive Disease|3|||
42390829|NCT01469546|76278873|FG000|Received 5 mg Dose|Physician Decision|3|||
42390830|NCT00081497|76278879|FG000|Overall Study|Adverse Event|2|||
42390831|NCT00081497|76278880|FG001|Overall Study|Adverse Event|0|||
42390832|NCT00081497|76278879|FG000|Overall Study|Death|0|||
42390833|NCT00081497|76278880|FG001|Overall Study|Death|1|||
42390834|NCT00081497|76278879|FG000|Overall Study|Withdrawal by Subject|1|||
42390835|NCT00081497|76278880|FG001|Overall Study|Withdrawal by Subject|0|||
42390836|NCT00081497|76278879|FG000|Overall Study|Non-compliance|0|||
42390837|NCT00081497|76278880|FG001|Overall Study|Non-compliance|1|||
42390838|NCT00081263|76278894|FG000|Overall Study|clerical error|1|||
42390839|NCT00081263|76278895|FG001|Overall Study|clerical error|0|||
42390840|NCT00081263|76278894|FG000|Overall Study|wrong cell type|7|||
42390841|NCT00081263|76278895|FG001|Overall Study|wrong cell type|5|||
42390842|NCT00081263|76278894|FG000|Overall Study|improper pre-protocol therapy|0|||
42390843|NCT00081263|76278895|FG001|Overall Study|improper pre-protocol therapy|1|||
42390844|NCT00081263|76278894|FG000|Overall Study|Inadequate pathology|0|||
42390845|NCT00081263|76278895|FG001|Overall Study|Inadequate pathology|1|||
42390846|NCT00081263|76278894|FG000|Overall Study|Never treated|4|||
42390847|NCT00081263|76278895|FG001|Overall Study|Never treated|5|||
42390848|NCT00081263|76278894|FG000|Overall Study|Inadequate data|5|||
42390849|NCT00081263|76278895|FG001|Overall Study|Inadequate data|10|||
42390850|NCT01490294|76278905|FG000|Overall Study|Prematurely discontinuation|4|||
42390851|NCT01490294|76278906|FG001|Overall Study|Prematurely discontinuation|0|||
42390852|NCT01490294|76278907|FG002|Overall Study|Prematurely discontinuation|1|||
42390853|NCT01490294|76278908|FG003|Overall Study|Prematurely discontinuation|1|||
42390854|NCT01490294|76278905|FG000|Overall Study|Adverse Event|1|||
42390855|NCT01490294|76278906|FG001|Overall Study|Adverse Event|0|||
42390856|NCT01490294|76278907|FG002|Overall Study|Adverse Event|0|||
42390857|NCT01490294|76278908|FG003|Overall Study|Adverse Event|0|||
42390858|NCT00080483|76278935|FG000|Overall Study|Lost to Follow-up|1|||
42390859|NCT00080483|76278936|FG001|Overall Study|Lost to Follow-up|1|||
42390860|NCT00080483|76278935|FG000|Overall Study|Physician Decision|1|||
42390861|NCT00080483|76278936|FG001|Overall Study|Physician Decision|1|||
42390862|NCT00089141|76278957|FG000|Overall Study|Termination of trial|18|||
42390863|NCT00089141|76278958|FG001|Overall Study|Termination of trial|24|||
42390864|NCT02588664|76279004|FG000|Overall Study|Death|56|||
42390865|NCT02588664|76279005|FG001|Overall Study|Death|55|||
42390866|NCT02588664|76279004|FG000|Overall Study|Lost to Follow-up|1305|||
42390867|NCT02588664|76279005|FG001|Overall Study|Lost to Follow-up|990|||
42390868|NCT00083759|76279068|FG000|Overall Study|Adverse Event|5|||
42390869|NCT00083759|76279069|FG001|Overall Study|Adverse Event|3|||
42390870|NCT00083759|76279068|FG000|Overall Study|Lost to Follow-up|1|||
42390871|NCT00083759|76279069|FG001|Overall Study|Lost to Follow-up|0|||
42390872|NCT00083759|76279068|FG000|Overall Study|Death|1|||
42390873|NCT00083759|76279069|FG001|Overall Study|Death|1|||
42390874|NCT00083759|76279068|FG000|Overall Study|Inadequate Therapeutic Response|32|||
42390875|NCT00083759|76279069|FG001|Overall Study|Inadequate Therapeutic Response|35|||
42390876|NCT00083759|76279068|FG000|Overall Study|Subject Withdrew Consent|2|||
42390877|NCT00083759|76279069|FG001|Overall Study|Subject Withdrew Consent|2|||
42390878|NCT00083759|76279068|FG000|Overall Study|Non-Compliance|1|||
42390879|NCT00083759|76279069|FG001|Overall Study|Non-Compliance|0|||
42390880|NCT00083759|76279068|FG000|Overall Study|Sponsor's Discretion|28|||
42390881|NCT00083759|76279069|FG001|Overall Study|Sponsor's Discretion|29|||
42390882|NCT00083759|76279068|FG000|Overall Study|Other|14|||
42390883|NCT00083759|76279069|FG001|Overall Study|Other|13|||
42390884|NCT00089609|76279195|FG000|Overall Study|Withdrawal by Subject|3|||
42390885|NCT00089609|76279196|FG001|Overall Study|Withdrawal by Subject|1|||
42390886|NCT02440581|76279337|FG000|Overall Study|Death|0|||
42390887|NCT02440581|76279338|FG001|Overall Study|Death|0|||
42390888|NCT02440581|76279339|FG002|Overall Study|Death|7|||
42390889|NCT02440581|76279340|FG003|Overall Study|Death|5|||
42390890|NCT02440581|76279337|FG000|Overall Study|Transplanted|1|||
42390891|NCT02440581|76279338|FG001|Overall Study|Transplanted|0|||
42390892|NCT02440581|76279339|FG002|Overall Study|Transplanted|3|||
42390893|NCT02440581|76279340|FG003|Overall Study|Transplanted|2|||
42390894|NCT02440581|76279337|FG000|Overall Study|Withdrawal by Subject|4|||
42390895|NCT02440581|76279338|FG001|Overall Study|Withdrawal by Subject|11|||
42390896|NCT02440581|76279339|FG002|Overall Study|Withdrawal by Subject|3|||
42390897|NCT02440581|76279340|FG003|Overall Study|Withdrawal by Subject|7|||
42390898|NCT01359150|76279352|FG000|Overall Study|Lack of Efficacy|1|||
42390899|NCT01359150|76279353|FG001|Overall Study|Lack of Efficacy|1|||
42390900|NCT01359150|76279352|FG000|Overall Study|Withdrawal by Subject|1|||
42390901|NCT01359150|76279353|FG001|Overall Study|Withdrawal by Subject|1|||
42390902|NCT01359150|76279352|FG000|Overall Study|Adverse Event|4|||
42390903|NCT01359150|76279353|FG001|Overall Study|Adverse Event|3|||
42390904|NCT01359150|76279352|FG000|Overall Study|Other|1|||
42390905|NCT01359150|76279353|FG001|Overall Study|Other|0|||
42390906|NCT01469000|76279414|FG000|Overall Study|Withdrawal by Subject|16|||
42390907|NCT01469000|76279415|FG001|Overall Study|Withdrawal by Subject|3|||
42390908|NCT01469000|76279414|FG000|Overall Study|Sponsor Decision|4|||
42390909|NCT01469000|76279415|FG001|Overall Study|Sponsor Decision|1|||
42390910|NCT01490060|76279428|FG000|Cycle 1|Change of Treatment|0|||
42390911|NCT01490060|76279429|FG001|Cycle 1|Change of Treatment|1|||
42390912|NCT01490060|76279430|FG002|Cycle 1|Change of Treatment|1|||
42390913|NCT01490060|76279431|FG003|Cycle 1|Change of Treatment|1|||
42390914|NCT01490060|76279428|FG000|Cycle 1|Insurance Denied|0|||
42390915|NCT01490060|76279429|FG001|Cycle 1|Insurance Denied|0|||
42390916|NCT01490060|76279430|FG002|Cycle 1|Insurance Denied|2|||
42390917|NCT01490060|76279431|FG003|Cycle 1|Insurance Denied|0|||
42390918|NCT01490060|76279428|FG000|Cycle 1|Withdrawal by Subject|0|||
42390919|NCT01490060|76279429|FG001|Cycle 1|Withdrawal by Subject|0|||
42390920|NCT01490060|76279430|FG002|Cycle 1|Withdrawal by Subject|0|||
42390921|NCT01490060|76279431|FG003|Cycle 1|Withdrawal by Subject|1|||
42390922|NCT01490060|76279428|FG000|Cycle 1|Treatment at Another Facility|0|||
42390923|NCT01490060|76279429|FG001|Cycle 1|Treatment at Another Facility|0|||
42390924|NCT01490060|76279430|FG002|Cycle 1|Treatment at Another Facility|0|||
42390925|NCT01490060|76279431|FG003|Cycle 1|Treatment at Another Facility|1|||
42390926|NCT01490060|76279428|FG000|Cycle 2|Change of Treatment|1|||
42390927|NCT01490060|76279429|FG001|Cycle 2|Change of Treatment|1|||
42390928|NCT01490060|76279430|FG002|Cycle 2|Change of Treatment|0|||
42390929|NCT01490060|76279431|FG003|Cycle 2|Change of Treatment|0|||
42390930|NCT01490060|76279428|FG000|Cycle 2|Non-Compliance|0|||
42390931|NCT01490060|76279429|FG001|Cycle 2|Non-Compliance|0|||
42390932|NCT01490060|76279430|FG002|Cycle 2|Non-Compliance|1|||
42390933|NCT01490060|76279431|FG003|Cycle 2|Non-Compliance|0|||
42390934|NCT01490060|76279428|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
42390935|NCT01490060|76279429|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
42390936|NCT01490060|76279430|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
42390937|NCT01490060|76279431|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
42390938|NCT01452152|76279483|FG000|Overall Study|Study termination by sponsor|5|||
42390939|NCT01452152|76279484|FG001|Overall Study|Study termination by sponsor|0|||
42390940|NCT01452152|76279485|FG002|Overall Study|Study termination by sponsor|4|||
42390941|NCT01451762|76279496|FG000|Overall Study|Lost to Follow-up|3|||
42390942|NCT01451762|76279497|FG001|Overall Study|Lost to Follow-up|6|||
42390943|NCT01451762|76279498|FG002|Overall Study|Lost to Follow-up|6|||
42390944|NCT01468844|76279533|FG000|Overall Study|Adverse Event|1|||
42390945|NCT01468844|76279534|FG001|Overall Study|Adverse Event|0|||
42390946|NCT01468844|76279533|FG000|Overall Study|Withdrawal by Subject|1|||
42390947|NCT01468844|76279534|FG001|Overall Study|Withdrawal by Subject|0|||
42390948|NCT01451606|76279558|FG000|Overall Study|Withdrawal by Subject|4|||
42390949|NCT01451606|76279559|FG001|Overall Study|Withdrawal by Subject|3|||
42390950|NCT00473343|76279614|FG000|Overall Study|Adverse Event|9|||
42390951|NCT00473343|76279614|FG000|Overall Study|Lost to Follow-up|8|||
42390952|NCT00473343|76279614|FG000|Overall Study|Treatment failure|27|||
42390953|NCT00473343|76279614|FG000|Overall Study|Withdrew consent|3|||
42390954|NCT00473343|76279614|FG000|Overall Study|Other un-specified reason|3|||
42390955|NCT02587962|76280071|FG000|Overall Study|Adverse Event|0|||
42390956|NCT02587962|76280072|FG001|Overall Study|Adverse Event|0|||
42390957|NCT02587962|76280073|FG002|Overall Study|Adverse Event|1|||
42390958|NCT02587962|76280074|FG003|Overall Study|Adverse Event|0|||
42390959|NCT02587962|76280075|FG004|Overall Study|Adverse Event|0|||
42390960|NCT02587962|76280071|FG000|Overall Study|Withdrawal by Subject|0|||
42390961|NCT02587962|76280072|FG001|Overall Study|Withdrawal by Subject|0|||
42390962|NCT02587962|76280073|FG002|Overall Study|Withdrawal by Subject|1|||
42390963|NCT02587962|76280074|FG003|Overall Study|Withdrawal by Subject|1|||
42390964|NCT02587962|76280075|FG004|Overall Study|Withdrawal by Subject|4|||
42390965|NCT02587962|76280071|FG000|Overall Study|Radiological progression|2|||
42390966|NCT02587962|76280072|FG001|Overall Study|Radiological progression|2|||
42390967|NCT02587962|76280073|FG002|Overall Study|Radiological progression|2|||
42390968|NCT02587962|76280074|FG003|Overall Study|Radiological progression|5|||
42390969|NCT02587962|76280075|FG004|Overall Study|Radiological progression|10|||
42390970|NCT02587962|76280071|FG000|Overall Study|Clinical progression|0|||
42390971|NCT02587962|76280072|FG001|Overall Study|Clinical progression|1|||
42390972|NCT02587962|76280073|FG002|Overall Study|Clinical progression|2|||
42390973|NCT02587962|76280074|FG003|Overall Study|Clinical progression|0|||
42390974|NCT02587962|76280075|FG004|Overall Study|Clinical progression|1|||
42390975|NCT01440374|76280220|FG000|Part 1: Open-label Phase|Adverse Event|5|||
42390976|NCT01440374|76280221|FG001|Part 1: Open-label Phase|Adverse Event|0|||
42390977|NCT01440374|76280222|FG002|Part 1: Open-label Phase|Adverse Event|0|||
42390978|NCT01440374|76280223|FG003|Part 1: Open-label Phase|Adverse Event|0|||
42390979|NCT01440374|76280220|FG000|Part 1: Open-label Phase|Physician Decision|1|||
42390980|NCT01440374|76280221|FG001|Part 1: Open-label Phase|Physician Decision|0|||
42390981|NCT01440374|76280222|FG002|Part 1: Open-label Phase|Physician Decision|0|||
42390982|NCT01440374|76280223|FG003|Part 1: Open-label Phase|Physician Decision|0|||
42390983|NCT01440374|76280220|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
42390984|NCT01440374|76280221|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
42390985|NCT01440374|76280222|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
42390986|NCT01440374|76280223|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
42390987|NCT01440374|76280220|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
42390988|NCT01440374|76280221|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
42390989|NCT01440374|76280222|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
42390990|NCT01440374|76280223|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
42390991|NCT01440374|76280220|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
42390992|NCT01440374|76280221|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
42390993|NCT01440374|76280222|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
42390994|NCT01440374|76280223|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
42390995|NCT01440374|76280220|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
42390996|NCT01440374|76280221|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
42390997|NCT01440374|76280222|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
42390998|NCT01440374|76280223|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
42390999|NCT01440374|76280220|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
42391000|NCT01440374|76280221|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
42391001|NCT01440374|76280222|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
42391002|NCT01440374|76280223|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
42391003|NCT01440374|76280220|FG000|Part 2; Double-blind Phase|Not treated|0|||
42391004|NCT01440374|76280221|FG001|Part 2; Double-blind Phase|Not treated|0|||
42391005|NCT01440374|76280222|FG002|Part 2; Double-blind Phase|Not treated|1|||
42391006|NCT01440374|76280223|FG003|Part 2; Double-blind Phase|Not treated|0|||
42391007|NCT01440374|76280220|FG000|Part 3: Extension|Withdrawal by Subject|0|||
42391008|NCT01440374|76280221|FG001|Part 3: Extension|Withdrawal by Subject|0|||
42391009|NCT01440374|76280222|FG002|Part 3: Extension|Withdrawal by Subject|0|||
42391010|NCT01440374|76280223|FG003|Part 3: Extension|Withdrawal by Subject|5|||
42391011|NCT01440374|76280220|FG000|Part 3: Extension|Adverse Event|0|||
42391012|NCT01440374|76280221|FG001|Part 3: Extension|Adverse Event|0|||
42391013|NCT01440374|76280222|FG002|Part 3: Extension|Adverse Event|0|||
42391014|NCT01440374|76280223|FG003|Part 3: Extension|Adverse Event|13|||
42391015|NCT01440374|76280220|FG000|Part 3: Extension|Physician Decision|0|||
42391016|NCT01440374|76280221|FG001|Part 3: Extension|Physician Decision|0|||
42391017|NCT01440374|76280222|FG002|Part 3: Extension|Physician Decision|0|||
42391018|NCT01440374|76280223|FG003|Part 3: Extension|Physician Decision|14|||
42391019|NCT01666782|76280371|FG000|Overall Study|Received 2 doses of vaccine|0|||
42391020|NCT01666782|76280372|FG001|Overall Study|Received 2 doses of vaccine|1|||
42391021|NCT01666782|76280371|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
42391022|NCT01666782|76280372|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
42391023|NCT01439360|76280388|FG000|Overall Study|Adverse Event|4|||
42391024|NCT01439360|76280389|FG001|Overall Study|Adverse Event|16|||
42391025|NCT01439360|76280388|FG000|Overall Study|Lost to Follow-up|43|||
42391026|NCT01439360|76280389|FG001|Overall Study|Lost to Follow-up|58|||
42391027|NCT01439360|76280388|FG000|Overall Study|Others|10|||
42391028|NCT01439360|76280389|FG001|Overall Study|Others|5|||
42391029|NCT01439360|76280388|FG000|Overall Study|Protocol Violation|1|||
42391030|NCT01439360|76280389|FG001|Overall Study|Protocol Violation|0|||
42391031|NCT01439360|76280388|FG000|Overall Study|Withdrawal by Subject|140|||
42391032|NCT01439360|76280389|FG001|Overall Study|Withdrawal by Subject|129|||
42391033|NCT01439204|76280566|FG000|Overall Study|Withdrawal by Subject|0|||
42391034|NCT01439204|76280567|FG001|Overall Study|Withdrawal by Subject|1|||
42391035|NCT01439204|76280566|FG000|Overall Study|Lost to Follow-up|0|||
42391036|NCT01439204|76280567|FG001|Overall Study|Lost to Follow-up|2|||
42391037|NCT01439204|76280566|FG000|Overall Study|No longer meets study criteria|1|||
42391038|NCT01439204|76280567|FG001|Overall Study|No longer meets study criteria|0|||
42391039|NCT01439204|76280566|FG000|Overall Study|poor/non-compliance|3|||
42391040|NCT01439204|76280567|FG001|Overall Study|poor/non-compliance|0|||
42391041|NCT01439126|76280613|FG000|Overall Study|Adverse Event|2|||
42391042|NCT01439126|76280614|FG001|Overall Study|Adverse Event|0|||
42391043|NCT01439126|76280613|FG000|Overall Study|Withdrawal by Subject|5|||
42391044|NCT01439126|76280614|FG001|Overall Study|Withdrawal by Subject|21|||
42391045|NCT01439126|76280613|FG000|Overall Study|Protocol Violation|6|||
42391046|NCT01439126|76280614|FG001|Overall Study|Protocol Violation|4|||
42391047|NCT01439126|76280613|FG000|Overall Study|Lost to Follow-up|6|||
42391048|NCT01439126|76280614|FG001|Overall Study|Lost to Follow-up|3|||
42391049|NCT01439126|76280613|FG000|Overall Study|Other-Use of prohibited treatment|0|||
42391050|NCT01439126|76280614|FG001|Overall Study|Other-Use of prohibited treatment|2|||
42391051|NCT01439126|76280613|FG000|Overall Study|Other-Miscellaneous|12|||
42391052|NCT01439126|76280614|FG001|Overall Study|Other-Miscellaneous|12|||
42391053|NCT01449812|76280640|FG000|Overall Study|Migrated/moved from study area|1|||
42391054|NCT01449812|76280641|FG001|Overall Study|Migrated/moved from study area|0|||
42391055|NCT01449812|76280642|FG002|Overall Study|Migrated/moved from study area|0|||
42391056|NCT01449812|76280640|FG000|Overall Study|Withdrawal by Subject|0|||
42391057|NCT01449812|76280641|FG001|Overall Study|Withdrawal by Subject|0|||
42391058|NCT01449812|76280642|FG002|Overall Study|Withdrawal by Subject|1|||
42391059|NCT01449812|76280640|FG000|Overall Study|Lost to Follow-up|1|||
42391060|NCT01449812|76280641|FG001|Overall Study|Lost to Follow-up|0|||
42391061|NCT01449812|76280642|FG002|Overall Study|Lost to Follow-up|0|||
42391062|NCT01466660|76280822|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
42391063|NCT01466660|76280823|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
42391064|NCT01466660|76280822|FG000|Overall Study|Worsening of underlying cancer disease|5|||
42391065|NCT01466660|76280823|FG001|Overall Study|Worsening of underlying cancer disease|2|||
42391066|NCT01466660|76280822|FG000|Overall Study|Other adverse event|19|||
42391067|NCT01466660|76280823|FG001|Overall Study|Other adverse event|18|||
42391068|NCT01466660|76280822|FG000|Overall Study|Protocol Violation|2|||
42391069|NCT01466660|76280823|FG001|Overall Study|Protocol Violation|1|||
42391070|NCT01466660|76280822|FG000|Overall Study|Refused continuation of trial medication|4|||
42391071|NCT01466660|76280823|FG001|Overall Study|Refused continuation of trial medication|3|||
42391072|NCT01466660|76280822|FG000|Overall Study|Other reason not defined above|10|||
42391073|NCT01466660|76280823|FG001|Overall Study|Other reason not defined above|8|||
42391074|NCT01466348|76280848|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
42391075|NCT01466348|76280849|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
42391076|NCT01466270|76280872|FG000|Overall Study|Withdrawal by Subject|4|||
42391077|NCT01466270|76280873|FG001|Overall Study|Withdrawal by Subject|1|||
42391078|NCT01466270|76280872|FG000|Overall Study|Physician Decision|1|||
42391079|NCT01466270|76280873|FG001|Overall Study|Physician Decision|0|||
42391080|NCT01466270|76280872|FG000|Overall Study|Lost to Follow-up|1|||
42391081|NCT01466270|76280873|FG001|Overall Study|Lost to Follow-up|3|||
42391082|NCT01466270|76280872|FG000|Overall Study|Progression|1|||
42391083|NCT01466270|76280873|FG001|Overall Study|Progression|0|||
42391084|NCT01466270|76280872|FG000|Overall Study|Toxicity|4|||
42391085|NCT01466270|76280873|FG001|Overall Study|Toxicity|1|||
42391086|NCT01466270|76280872|FG000|Overall Study|Multiple|1|||
42391087|NCT01466270|76280873|FG001|Overall Study|Multiple|1|||
42391088|NCT01466192|76280906|FG000|Overall Study|Physician Decision|1|||
42391089|NCT01466192|76280906|FG000|Overall Study|Withdrawal by Subject|3|||
42391090|NCT01438814|76280926|FG000|Overall Study|Adverse Event|3|||
42391091|NCT01438814|76280927|FG001|Overall Study|Adverse Event|3|||
42391092|NCT01438814|76280926|FG000|Overall Study|Protocol Violation|1|||
42391093|NCT01438814|76280927|FG001|Overall Study|Protocol Violation|2|||
42391094|NCT01438814|76280926|FG000|Overall Study|Lost to Follow-up|4|||
42391095|NCT01438814|76280927|FG001|Overall Study|Lost to Follow-up|3|||
42391096|NCT01438814|76280926|FG000|Overall Study|Withdrawal by Subject|4|||
42391097|NCT01438814|76280927|FG001|Overall Study|Withdrawal by Subject|2|||
42391098|NCT01438814|76280926|FG000|Overall Study|Other|2|||
42391099|NCT01438814|76280927|FG001|Overall Study|Other|4|||
42391100|NCT02926833|76281508|FG000|Overall Study|Full Consent Withdrawal|0|||
42391101|NCT02926833|76281509|FG001|Overall Study|Full Consent Withdrawal|0|||
42391102|NCT02926833|76281510|FG002|Overall Study|Full Consent Withdrawal|0|||
42391103|NCT02926833|76281511|FG003|Overall Study|Full Consent Withdrawal|2|||
42391104|NCT02926833|76281508|FG000|Overall Study|Death|1|||
42391105|NCT02926833|76281509|FG001|Overall Study|Death|1|||
42391106|NCT02926833|76281510|FG002|Overall Study|Death|1|||
42391107|NCT02926833|76281511|FG003|Overall Study|Death|7|||
42391108|NCT02926833|76281508|FG000|Overall Study|Still on study|2|||
42391109|NCT02926833|76281509|FG001|Overall Study|Still on study|3|||
42391110|NCT02926833|76281510|FG002|Overall Study|Still on study|5|||
42391111|NCT02926833|76281511|FG003|Overall Study|Still on study|14|||
42391112|NCT02926833|76281508|FG000|Overall Study|Adverse Event|0|||
42391113|NCT02926833|76281509|FG001|Overall Study|Adverse Event|0|||
42391114|NCT02926833|76281510|FG002|Overall Study|Adverse Event|1|||
42391115|NCT02926833|76281511|FG003|Overall Study|Adverse Event|0|||
42391116|NCT02851797|76281558|FG000|Overall Study|Withdrawal by Subject|4|||
42391117|NCT02851797|76281559|FG001|Overall Study|Withdrawal by Subject|2|||
42391118|NCT02851797|76281558|FG000|Overall Study|Adverse Event|3|||
42391119|NCT02851797|76281559|FG001|Overall Study|Adverse Event|0|||
42391120|NCT01666314|76281774|FG000|Overall Study|Adverse Event|3|||
42391121|NCT01666314|76281775|FG001|Overall Study|Adverse Event|13|||
42391122|NCT01666314|76281776|FG002|Overall Study|Adverse Event|7|||
42391123|NCT01666314|76281777|FG003|Overall Study|Adverse Event|7|||
42391124|NCT01666314|76281774|FG000|Overall Study|Progressive Disease|11|||
42391125|NCT01666314|76281775|FG001|Overall Study|Progressive Disease|9|||
42391126|NCT01666314|76281776|FG002|Overall Study|Progressive Disease|19|||
42391127|NCT01666314|76281777|FG003|Overall Study|Progressive Disease|20|||
42391128|NCT01666314|76281774|FG000|Overall Study|Symptomatic Deterioration|1|||
42391129|NCT01666314|76281775|FG001|Overall Study|Symptomatic Deterioration|0|||
42391130|NCT01666314|76281776|FG002|Overall Study|Symptomatic Deterioration|2|||
42391131|NCT01666314|76281777|FG003|Overall Study|Symptomatic Deterioration|0|||
42391132|NCT01666314|76281774|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
42391133|NCT01666314|76281775|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
42391134|NCT01666314|76281776|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
42391135|NCT01666314|76281777|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
42391136|NCT01666314|76281774|FG000|Overall Study|Withdrawal by Subject|1|||
42391137|NCT01666314|76281775|FG001|Overall Study|Withdrawal by Subject|1|||
42391138|NCT01666314|76281776|FG002|Overall Study|Withdrawal by Subject|2|||
42391139|NCT01666314|76281777|FG003|Overall Study|Withdrawal by Subject|3|||
42391140|NCT01666314|76281774|FG000|Overall Study|Reason not Specified|10|||
42391141|NCT01666314|76281775|FG001|Overall Study|Reason not Specified|7|||
42391142|NCT01666314|76281776|FG002|Overall Study|Reason not Specified|5|||
42391143|NCT01666314|76281777|FG003|Overall Study|Reason not Specified|5|||
42391144|NCT01666002|76281808|FG000|Overall Study|Lost to Follow-up|5|||
42391145|NCT01666002|76281809|FG001|Overall Study|Lost to Follow-up|0|||
42391146|NCT01665768|76281881|FG000|Overall Study|Adverse Event|3|||
42391147|NCT01665768|76281881|FG000|Overall Study|Lack of Efficacy|19|||
42391148|NCT01665768|76281881|FG000|Overall Study|Withdrawal by Subject|1|||
42391149|NCT02584452|76282089|FG000|Overall Study|Physician Decision|1|||
42391150|NCT02584452|76282090|FG001|Overall Study|Physician Decision|1|||
42391151|NCT02584452|76282089|FG000|Overall Study|Lost to Follow-up|1|||
42391152|NCT02584452|76282090|FG001|Overall Study|Lost to Follow-up|1|||
42391153|NCT02586012|76282137|FG000|Overall Study|Withdrawal by Subject|1|||
42391154|NCT02586012|76282138|FG001|Overall Study|Withdrawal by Subject|1|||
42391155|NCT02586012|76282139|FG002|Overall Study|Withdrawal by Subject|0|||
42391156|NCT02586012|76282140|FG003|Overall Study|Withdrawal by Subject|1|||
42391157|NCT02586012|76282141|FG004|Overall Study|Withdrawal by Subject|0|||
42391158|NCT02586012|76282142|FG005|Overall Study|Withdrawal by Subject|2|||
42391159|NCT02586012|76282137|FG000|Overall Study|Protocol Violation|0|||
42391160|NCT02586012|76282138|FG001|Overall Study|Protocol Violation|0|||
42391161|NCT02586012|76282139|FG002|Overall Study|Protocol Violation|0|||
42391162|NCT02586012|76282140|FG003|Overall Study|Protocol Violation|0|||
42391163|NCT02586012|76282141|FG004|Overall Study|Protocol Violation|0|||
42391164|NCT02586012|76282142|FG005|Overall Study|Protocol Violation|1|||
42391165|NCT02586012|76282137|FG000|Overall Study|study terminated|0|||
42391166|NCT02586012|76282138|FG001|Overall Study|study terminated|2|||
42391167|NCT02586012|76282139|FG002|Overall Study|study terminated|1|||
42391168|NCT02586012|76282140|FG003|Overall Study|study terminated|1|||
42391169|NCT02586012|76282141|FG004|Overall Study|study terminated|1|||
42391170|NCT02586012|76282142|FG005|Overall Study|study terminated|0|||
42391171|NCT02582814|76282153|FG000|Overall Study|Study-specific withdrawal criteria|1|||
42391172|NCT02582814|76282154|FG001|Overall Study|Study-specific withdrawal criteria|0|||
42391173|NCT02582814|76282153|FG000|Overall Study|Withdrawal by Subject|4|||
42391174|NCT02582814|76282154|FG001|Overall Study|Withdrawal by Subject|3|||
42391175|NCT02582814|76282153|FG000|Overall Study|Adverse Event|4|||
42391176|NCT02582814|76282154|FG001|Overall Study|Adverse Event|4|||
42391177|NCT02585934|76282302|FG000|Overall Study|Lost to Follow-up|2|||
42391178|NCT02585934|76282303|FG001|Overall Study|Lost to Follow-up|2|||
42391179|NCT02585934|76282302|FG000|Overall Study|Protocol Violation|14|||
42391180|NCT02585934|76282303|FG001|Overall Study|Protocol Violation|11|||
42391181|NCT02585934|76282302|FG000|Overall Study|Adverse Event|21|||
42391182|NCT02585934|76282303|FG001|Overall Study|Adverse Event|22|||
42391183|NCT02585934|76282302|FG000|Overall Study|Physician Decision|3|||
42391184|NCT02585934|76282303|FG001|Overall Study|Physician Decision|2|||
42391185|NCT02585934|76282302|FG000|Overall Study|Withdrawal by Subject|7|||
42391186|NCT02585934|76282303|FG001|Overall Study|Withdrawal by Subject|21|||
42391187|NCT02585934|76282302|FG000|Overall Study|Lack of Efficacy|2|||
42391188|NCT02585934|76282303|FG001|Overall Study|Lack of Efficacy|1|||
42391189|NCT02585934|76282302|FG000|Overall Study|Death|2|||
42391190|NCT02585934|76282303|FG001|Overall Study|Death|0|||
42391191|NCT02585934|76282302|FG000|Overall Study|Caregiver Withdrew Consent|7|||
42391192|NCT02585934|76282303|FG001|Overall Study|Caregiver Withdrew Consent|7|||
42391193|NCT02585934|76282302|FG000|Overall Study|Sponsor Termination|1|||
42391194|NCT02585934|76282303|FG001|Overall Study|Sponsor Termination|2|||
42391195|NCT02585934|76282302|FG000|Overall Study|Another Reason|10|||
42391196|NCT02585934|76282303|FG001|Overall Study|Another Reason|5|||
42391197|NCT02582658|76282332|FG000|Overall Study|Failure to Return|10|||
42391198|NCT02582658|76282332|FG000|Overall Study|Insufficient Virological Response|2|||
42391199|NCT02582658|76282332|FG000|Overall Study|Withdrawn Consent|1|||
42391200|NCT02582658|76282332|FG000|Overall Study|Death|1|||
42391201|NCT02582658|76282332|FG000|Overall Study|Not further specified|11|||
42391202|NCT02585778|76282434|FG000|Overall Study|Adverse Event|17|||
42391203|NCT02585778|76282435|FG001|Overall Study|Adverse Event|4|||
42391204|NCT02585778|76282434|FG000|Overall Study|Participant did not wish to continue|9|||
42391205|NCT02585778|76282435|FG001|Overall Study|Participant did not wish to continue|4|||
42391206|NCT02585778|76282434|FG000|Overall Study|Poor compliance to study protocol|0|||
42391207|NCT02585778|76282435|FG001|Overall Study|Poor compliance to study protocol|2|||
42391208|NCT02585778|76282434|FG000|Overall Study|Death|0|||
42391209|NCT02585778|76282435|FG001|Overall Study|Death|1|||
42391210|NCT02585778|76282434|FG000|Overall Study|Randomized but not treated|1|||
42391211|NCT02585778|76282435|FG001|Overall Study|Randomized but not treated|2|||
42391212|NCT02585778|76282434|FG000|Overall Study|Other than specified above|6|||
42391213|NCT02585778|76282435|FG001|Overall Study|Other than specified above|2|||
42391214|NCT01438424|76282458|FG000|Overall Study|Continuing treatment|29|||
42391215|NCT01438424|76282458|FG000|Overall Study|Minimal virologic response|95|||
42391216|NCT01438424|76282458|FG000|Overall Study|Not identified|55|||
42391217|NCT01438424|76282458|FG000|Overall Study|Withdrawal by Subject|104|||
42391218|NCT01438424|76282458|FG000|Overall Study|Progression of chronic hepatitis B|22|||
42391219|NCT01438424|76282458|FG000|Overall Study|Death|22|||
42391220|NCT01438424|76282458|FG000|Overall Study|Adverse Event|17|||
42391221|NCT01438424|76282458|FG000|Overall Study|Lost to Follow-up|17|||
42391222|NCT01438424|76282458|FG000|Overall Study|Abnormal laboratory test result|14|||
42391223|NCT01438424|76282458|FG000|Overall Study|Need for drug prohibited by protocol|14|||
42391224|NCT01438424|76282458|FG000|Overall Study|Pregnancy|7|||
42391225|NCT01438424|76282458|FG000|Overall Study|No longer met inclusion criteria|1|||
42391226|NCT01438424|76282458|FG000|Overall Study|Participant noncompliance|20|||
42391227|NCT02580240|76282474|FG000|Overall Study|Physician Decision|2|||
42391228|NCT02580240|76282475|FG001|Overall Study|Physician Decision|0|||
42391229|NCT01465958|76282481|FG000|Run-in Phase|Protocol Violation|1|||
42391230|NCT01465958|76282482|FG001|Run-in Phase|Protocol Violation|0|||
42391231|NCT01465958|76282481|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
42391232|NCT01465958|76282482|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
42391233|NCT02581488|76282695|FG000|Overall Study|Adverse Event|6|||
42391234|NCT02581488|76282696|FG001|Overall Study|Adverse Event|7|||
42391235|NCT02581488|76282695|FG000|Overall Study|Lost to Follow-up|1|||
42391236|NCT02581488|76282696|FG001|Overall Study|Lost to Follow-up|0|||
42391237|NCT02581488|76282695|FG000|Overall Study|Withdrawal by Subject|1|||
42391238|NCT02581488|76282696|FG001|Overall Study|Withdrawal by Subject|0|||
42391239|NCT02581488|76282695|FG000|Overall Study|Non-Compliance|1|||
42391240|NCT02581488|76282696|FG001|Overall Study|Non-Compliance|0|||
42391241|NCT02581488|76282695|FG000|Overall Study|Protocol Violation|0|||
42391242|NCT02581488|76282696|FG001|Overall Study|Protocol Violation|4|||
42391243|NCT02581410|76282739|FG000|Vaccination Phase|Adverse Event|2|||
42391244|NCT02581410|76282740|FG001|Vaccination Phase|Adverse Event|1|||
42391245|NCT02581410|76282739|FG000|Vaccination Phase|Withdrawal by Subject|0|||
42391246|NCT02581410|76282740|FG001|Vaccination Phase|Withdrawal by Subject|1|||
42391247|NCT02581410|76282739|FG000|Vaccination Phase|Migrated/moved from study area|0|||
42391248|NCT02581410|76282740|FG001|Vaccination Phase|Migrated/moved from study area|1|||
42391249|NCT02581410|76282739|FG000|End of Study Phase|Adverse Event|4|||
42391250|NCT02581410|76282740|FG001|End of Study Phase|Adverse Event|3|||
42391251|NCT02581410|76282739|FG000|End of Study Phase|Withdrawal by Subject|1|||
42391252|NCT02581410|76282740|FG001|End of Study Phase|Withdrawal by Subject|2|||
42391253|NCT02581410|76282739|FG000|End of Study Phase|Migrated/moved from study area|0|||
42391254|NCT02581410|76282740|FG001|End of Study Phase|Migrated/moved from study area|3|||
42391255|NCT02581410|76282739|FG000|End of Study Phase|Lost to Follow-up|0|||
42391256|NCT02581410|76282740|FG001|End of Study Phase|Lost to Follow-up|2|||
42391257|NCT02581410|76282739|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
42391258|NCT02581410|76282740|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
42391259|NCT01664130|76282799|FG000|Overall Study|competing secondary disease|2|||
42391260|NCT02579928|76282830|FG000|Overall Study|Withdrawal by Subject|1|||
42391261|NCT02579928|76282831|FG001|Overall Study|Withdrawal by Subject|0|||
42112457|NCT02581631|75922599|FG003|Overall Study|AE unrelated to study drug|0|||
42112458|NCT02581631|75922600|FG004|Overall Study|AE unrelated to study drug|2|||
42112459|NCT02581631|75922596|FG000|Overall Study|Request to discontinue|1|||
42112460|NCT02581631|75922597|FG001|Overall Study|Request to discontinue|0|||
42112461|NCT02581631|75922598|FG002|Overall Study|Request to discontinue|3|||
42112462|NCT02581631|75922599|FG003|Overall Study|Request to discontinue|0|||
42112463|NCT02581631|75922600|FG004|Overall Study|Request to discontinue|1|||
42112464|NCT02581631|75922596|FG000|Overall Study|participant withdrew consent|3|||
42112465|NCT02581631|75922597|FG001|Overall Study|participant withdrew consent|0|||
42112466|NCT02581631|75922598|FG002|Overall Study|participant withdrew consent|1|||
42112467|NCT02581631|75922599|FG003|Overall Study|participant withdrew consent|0|||
42112468|NCT02581631|75922600|FG004|Overall Study|participant withdrew consent|0|||
42112469|NCT02581631|75922596|FG000|Overall Study|Maximum clinical benefit|1|||
42112470|NCT02581631|75922597|FG001|Overall Study|Maximum clinical benefit|7|||
42112471|NCT02581631|75922598|FG002|Overall Study|Maximum clinical benefit|1|||
42112472|NCT02581631|75922599|FG003|Overall Study|Maximum clinical benefit|3|||
42112473|NCT02581631|75922600|FG004|Overall Study|Maximum clinical benefit|13|||
42112474|NCT02581631|75922596|FG000|Overall Study|Other Reasons|1|||
42112475|NCT02581631|75922597|FG001|Overall Study|Other Reasons|0|||
42112476|NCT02581631|75922598|FG002|Overall Study|Other Reasons|2|||
42112477|NCT02581631|75922599|FG003|Overall Study|Other Reasons|2|||
42112478|NCT02581631|75922600|FG004|Overall Study|Other Reasons|3|||
42112479|NCT02581631|75922596|FG000|Overall Study|Poor/Non-Compliance|0|||
42112480|NCT02581631|75922597|FG001|Overall Study|Poor/Non-Compliance|0|||
42112481|NCT02581631|75922598|FG002|Overall Study|Poor/Non-Compliance|1|||
42112482|NCT02581631|75922599|FG003|Overall Study|Poor/Non-Compliance|0|||
42112483|NCT02581631|75922600|FG004|Overall Study|Poor/Non-Compliance|0|||
42112484|NCT00529035|75922612|FG000|Overall Study|Withdrawal by Subject|1|||
42112485|NCT00609674|75922625|FG000|Overall Study|Adverse Event|1|||
42112486|NCT00609674|75922626|FG001|Overall Study|Adverse Event|1|||
42112487|NCT00609674|75922625|FG000|Overall Study|Protocol Violation|3|||
42112488|NCT00609674|75922626|FG001|Overall Study|Protocol Violation|5|||
42112489|NCT00609674|75922625|FG000|Overall Study|Lost to Follow-up|1|||
42112490|NCT00609674|75922626|FG001|Overall Study|Lost to Follow-up|0|||
42112491|NCT00609674|75922625|FG000|Overall Study|Withdrew consent|2|||
42112492|NCT00609674|75922626|FG001|Overall Study|Withdrew consent|1|||
42112493|NCT00137839|75922632|FG000|Overall Study|Adverse Event|7|||
42112494|NCT00137839|75922632|FG000|Overall Study|Physician Decision|7|||
42112495|NCT00137839|75922632|FG000|Overall Study|Death|8|||
42112496|NCT00137839|75922632|FG000|Overall Study|Disease Progression|60|||
42112497|NCT00137839|75922632|FG000|Overall Study|Not Start Treatment|1|||
42112498|NCT00137839|75922632|FG000|Overall Study|Prolonged Treatment Delay|1|||
42112499|NCT00563316|75922639|FG000|Overall Study|Adverse Event|2|||
42112500|NCT00563316|75922639|FG000|Overall Study|Physician Decision|1|||
42112501|NCT00563316|75922639|FG000|Overall Study|Lost to Follow-up|2|||
42112502|NCT00563316|75922639|FG000|Overall Study|Death|1|||
42112503|NCT00563316|75922639|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
42112504|NCT00563316|75922639|FG000|Overall Study|Other|1|||
42112505|NCT03178487|75922649|FG000|Period 1|Adverse Event|1|||
42112506|NCT03178487|75922650|FG001|Period 1|Adverse Event|2|||
42112507|NCT03178487|75922649|FG000|Period 1|Withdrawal by Subject|2|||
42112508|NCT03178487|75922650|FG001|Period 1|Withdrawal by Subject|1|||
42112509|NCT03178487|75922649|FG000|Period 1|Lost to Follow-up|1|||
42112510|NCT03178487|75922650|FG001|Period 1|Lost to Follow-up|0|||
42112511|NCT03178487|75922649|FG000|Period 1|Other|0|||
42112512|NCT03178487|75922650|FG001|Period 1|Other|1|||
42112513|NCT03178487|75922649|FG000|Period 2|Adverse Event|4|||
42112514|NCT03178487|75922650|FG001|Period 2|Adverse Event|4|||
42112515|NCT03178487|75922649|FG000|Period 2|Withdrawal by Subject|6|||
42112516|NCT03178487|75922650|FG001|Period 2|Withdrawal by Subject|6|||
42112517|NCT03178487|75922649|FG000|Period 2|Lost to Follow-up|2|||
42112518|NCT03178487|75922650|FG001|Period 2|Lost to Follow-up|2|||
42112519|NCT03178487|75922649|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
42112520|NCT03178487|75922650|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
42112521|NCT03178487|75922649|FG000|Period 2|Other|8|||
42112522|NCT03178487|75922650|FG001|Period 2|Other|7|||
42112523|NCT00528957|75922659|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
42112524|NCT00528957|75922660|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
42112525|NCT00528957|75922659|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
42112526|NCT00528957|75922660|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
42112527|NCT00528957|75922659|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
42112528|NCT00528957|75922660|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
42112529|NCT00528957|75922659|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
42112530|NCT00528957|75922660|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
42112531|NCT00528957|75922659|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
42112532|NCT00528957|75922660|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
42112533|NCT00528957|75922659|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
42112534|NCT00528957|75922660|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
42112535|NCT00528957|75922659|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
42112536|NCT00528957|75922660|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
42112537|NCT00528957|75922659|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
42112538|NCT00528957|75922660|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
42112539|NCT00528957|75922659|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
42112540|NCT00528957|75922660|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
42112541|NCT00528957|75922659|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
42112542|NCT00528957|75922660|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
42112543|NCT00528957|75922659|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
42112544|NCT00528957|75922660|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
42112545|NCT00528957|75922659|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
42112546|NCT00528957|75922660|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
42112547|NCT00528957|75922659|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
42112548|NCT00528957|75922660|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
42112549|NCT00528957|75922659|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
42112550|NCT00528957|75922660|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
42112551|NCT00528957|75922659|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
42112552|NCT00528957|75922660|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
42112553|NCT00528957|75922659|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
42112554|NCT00528957|75922660|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
42112555|NCT00560508|75922678|FG000|12 Week Double-blind Period|Adverse Event|3|||
42112556|NCT00560508|75922679|FG001|12 Week Double-blind Period|Adverse Event|2|||
42112557|NCT00560508|75922678|FG000|12 Week Double-blind Period|Protocol Violation|1|||
42112558|NCT00560508|75922679|FG001|12 Week Double-blind Period|Protocol Violation|0|||
42112559|NCT00560508|75922678|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
42112560|NCT00560508|75922679|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
42112561|NCT00560508|75922678|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
42112562|NCT00560508|75922679|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
42112563|NCT00560508|75922678|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
42112564|NCT00560508|75922679|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
42112565|NCT00560508|75922678|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
42112566|NCT00560508|75922679|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
42112567|NCT00560508|75922678|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
42112568|NCT00560508|75922679|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
42112569|NCT03962790|75922690|FG000|Period 1|Adverse Event|0|||
42112570|NCT03962790|75922691|FG001|Period 1|Adverse Event|1|||
42112571|NCT03962790|75922690|FG000|Period 1|Failed to meet all eligibility criteria|1|||
42112572|NCT03962790|75922691|FG001|Period 1|Failed to meet all eligibility criteria|1|||
42112573|NCT03962790|75922690|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
42112574|NCT03962790|75922691|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
42112575|NCT03962790|75922690|FG000|Period 1|Withdrawal by Subject|1|||
42112576|NCT03962790|75922691|FG001|Period 1|Withdrawal by Subject|0|||
42112577|NCT00609518|75922699|FG000|Overall Study|Death from Study Disease|32|||
42112578|NCT00609518|75922700|FG001|Overall Study|Death from Study Disease|32|||
42112579|NCT00609518|75922699|FG000|Overall Study|Withdrawal by Subject|5|||
42112580|NCT00609518|75922700|FG001|Overall Study|Withdrawal by Subject|3|||
42112581|NCT00609518|75922699|FG000|Overall Study|Lost to Follow-up|3|||
42112582|NCT00609518|75922700|FG001|Overall Study|Lost to Follow-up|0|||
42112583|NCT00609518|75922699|FG000|Overall Study|Physician Decision|1|||
42112584|NCT00609518|75922700|FG001|Overall Study|Physician Decision|3|||
42112585|NCT00609518|75922699|FG000|Overall Study|Death from Adverse Event|2|||
42112586|NCT00609518|75922700|FG001|Overall Study|Death from Adverse Event|2|||
42112587|NCT00609362|75922708|FG000|Overall Study|Withdrawal by Subject|2|||
42112588|NCT00609362|75922709|FG001|Overall Study|Withdrawal by Subject|1|||
42112589|NCT00609362|75922708|FG000|Overall Study|Adverse Event|1|||
42112590|NCT00609362|75922709|FG001|Overall Study|Adverse Event|0|||
42112591|NCT00611858|75922715|FG000|Overall Study|Adverse Event|2|||
42112592|NCT00611858|75922715|FG000|Overall Study|Withdrawal by Subject|2|||
42112593|NCT00137449|75922723|FG000|Overall Study|Disease Progression|8|||
42112594|NCT00137449|75922724|FG001|Overall Study|Disease Progression|13|||
42112595|NCT00137449|75922723|FG000|Overall Study|Death|4|||
42112596|NCT00137449|75922724|FG001|Overall Study|Death|3|||
42112597|NCT00137449|75922723|FG000|Overall Study|Adverse Event|3|||
42112598|NCT00137449|75922724|FG001|Overall Study|Adverse Event|1|||
42112599|NCT00137449|75922723|FG000|Overall Study|Withdrawal by Subject|1|||
42112600|NCT00137449|75922724|FG001|Overall Study|Withdrawal by Subject|1|||
42112601|NCT00528879|75922735|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
42112602|NCT00528879|75922736|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
42112603|NCT00528879|75922737|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
42112604|NCT00528879|75922738|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
42112605|NCT00528879|75922735|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
42112606|NCT00528879|75922736|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
42112607|NCT00528879|75922737|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
42112608|NCT00528879|75922738|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
42112609|NCT00528879|75922735|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
42112610|NCT00528879|75922736|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
42112611|NCT00528879|75922737|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
42112612|NCT00528879|75922738|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
42112613|NCT00528879|75922735|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
42112614|NCT00528879|75922736|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
42112615|NCT00528879|75922737|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
42112616|NCT00528879|75922738|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
42112617|NCT00528879|75922735|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
42112618|NCT00528879|75922736|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
42112619|NCT00528879|75922737|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
42112620|NCT00528879|75922738|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
42112621|NCT00528879|75922735|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
42112622|NCT00528879|75922736|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
42112623|NCT00528879|75922737|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
42112624|NCT00528879|75922738|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
42112625|NCT00528879|75922735|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
42112626|NCT00528879|75922736|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
42112627|NCT00528879|75922737|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
42112628|NCT00528879|75922738|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
42112629|NCT00528879|75922735|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
42112630|NCT00528879|75922736|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
42112631|NCT00528879|75922737|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
42112632|NCT00528879|75922738|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
42112633|NCT00528879|75922735|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
42112634|NCT00528879|75922736|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
42112635|NCT00528879|75922737|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
42112636|NCT00528879|75922738|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
42112637|NCT00528879|75922735|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
42112638|NCT00528879|75922736|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
42112639|NCT00528879|75922737|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
42112640|NCT00528879|75922738|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
42112641|NCT00528879|75922735|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
42112642|NCT00528879|75922736|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
42112643|NCT00528879|75922737|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
42112644|NCT00528879|75922738|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
42112645|NCT00528879|75922735|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
42112646|NCT00528879|75922736|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
42112647|NCT00528879|75922737|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
42112648|NCT00528879|75922738|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
42112649|NCT00528879|75922735|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
42112650|NCT00528879|75922736|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
42112651|NCT00528879|75922737|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
42112652|NCT00528879|75922738|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
42112653|NCT00528879|75922735|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
42112654|NCT00528879|75922736|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
42112655|NCT00528879|75922737|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
42112656|NCT00528879|75922738|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
42112657|NCT00528879|75922735|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
42112658|NCT00528879|75922736|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
42112659|NCT00528879|75922737|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
42112660|NCT00528879|75922738|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
42112661|NCT00528879|75922735|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
42112662|NCT00528879|75922736|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
42112663|NCT00528879|75922737|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
42112664|NCT00528879|75922738|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
42112665|NCT00608894|75922750|FG000|Overall Study|Withdrawal by Subject|0|||
42112666|NCT00608894|75922751|FG001|Overall Study|Withdrawal by Subject|2|||
42112667|NCT00557856|75922759|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
42112668|NCT00557856|75922760|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
42112669|NCT00557856|75922761|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
42112670|NCT00557856|75922762|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
42112671|NCT00557856|75922763|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
42112672|NCT00557856|75922764|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
42112673|NCT00557856|75922765|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
42112674|NCT00557856|75922766|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
42112675|NCT00557856|75922767|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
42112676|NCT00557856|75922759|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
42112677|NCT00557856|75922760|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
42112678|NCT00557856|75922761|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
42112679|NCT00557856|75922762|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
42112680|NCT00557856|75922763|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
42112681|NCT00557856|75922764|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
42112682|NCT00557856|75922765|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
42112683|NCT00557856|75922766|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
42112684|NCT00557856|75922767|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
42112685|NCT00557856|75922759|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
42112686|NCT00557856|75922760|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
42112687|NCT00557856|75922761|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
42112688|NCT00557856|75922762|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
42112689|NCT00557856|75922763|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
42112690|NCT00557856|75922764|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
42112691|NCT00557856|75922765|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
42112692|NCT00557856|75922766|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
42112693|NCT00557856|75922767|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
42112694|NCT00557856|75922759|FG000|Part 1: Dose Escalation Phase|Other|0|||
42112695|NCT00557856|75922760|FG001|Part 1: Dose Escalation Phase|Other|0|||
42112696|NCT00557856|75922761|FG002|Part 1: Dose Escalation Phase|Other|1|||
42112697|NCT00557856|75922762|FG003|Part 1: Dose Escalation Phase|Other|1|||
42112698|NCT00557856|75922763|FG004|Part 1: Dose Escalation Phase|Other|0|||
42112699|NCT00557856|75922764|FG005|Part 1: Dose Escalation Phase|Other|0|||
42112700|NCT00557856|75922765|FG006|Part 1: Dose Escalation Phase|Other|0|||
42112701|NCT00557856|75922766|FG007|Part 1: Dose Escalation Phase|Other|1|||
42204869|NCT00004859|76017428|FG000|Overall Study|missing data|14|||
42204870|NCT00004859|76017429|FG001|Overall Study|missing data|11|||
42204871|NCT00004859|76017428|FG000|Overall Study|Other|13|||
42204872|NCT00004859|76017429|FG001|Overall Study|Other|21|||
42204873|NCT03500679|76017439|FG000|Overall Study|Lost to Follow-up|6|||
42204874|NCT03500679|76017440|FG001|Overall Study|Lost to Follow-up|3|||
42204875|NCT03500679|76017439|FG000|Overall Study|Withdrawal by Subject|3|||
42204876|NCT03500679|76017440|FG001|Overall Study|Withdrawal by Subject|0|||
42204877|NCT03348930|76017446|FG000|Washout (1 Week)|Lost to Follow-up|1|||
42204878|NCT03348930|76017447|FG001|Washout (1 Week)|Lost to Follow-up|1|||
42204879|NCT03500211|76017455|FG000|Overall Study|Withdrawal by Subject|1|||
42204880|NCT03500211|76017456|FG001|Overall Study|Withdrawal by Subject|1|||
42204881|NCT03478683|76017464|FG000|Overall Study|Adverse Event|5|||
42204882|NCT03478683|76017465|FG001|Overall Study|Adverse Event|3|||
42204883|NCT03478683|76017464|FG000|Overall Study|Lost to Follow-up|0|||
42204884|NCT03478683|76017465|FG001|Overall Study|Lost to Follow-up|5|||
42204885|NCT03478683|76017464|FG000|Overall Study|Physician Decision|1|||
42204886|NCT03478683|76017465|FG001|Overall Study|Physician Decision|3|||
42204887|NCT03478683|76017464|FG000|Overall Study|Withdrawal by Subject|7|||
42204888|NCT03478683|76017465|FG001|Overall Study|Withdrawal by Subject|7|||
42204889|NCT03478371|76017471|FG000|Overall Study|non-compliance|1|||
42204890|NCT03478371|76017471|FG000|Overall Study|Lost to Follow-up|4|||
42204891|NCT03477903|76017481|FG000|Overall Study|Study Terminated by Sponsor|1|||
42204892|NCT03475875|76017485|FG000|Period 1|Lost to Follow-up|1|||
42204893|NCT03475875|76017486|FG001|Period 1|Lost to Follow-up|0|||
42204894|NCT03475875|76017485|FG000|Period 1|Adverse Event|2|||
42204895|NCT03475875|76017486|FG001|Period 1|Adverse Event|1|||
42204896|NCT03475875|76017485|FG000|Period 2|Adverse Event|3|||
42204897|NCT03475875|76017486|FG001|Period 2|Adverse Event|0|||
42204898|NCT03475875|76017485|FG000|Period 2|Protocol Violation|0|||
42204899|NCT03475875|76017486|FG001|Period 2|Protocol Violation|1|||
42204900|NCT03474081|76017494|FG000|Overall Study|Adverse Event|6|||
42204901|NCT03474081|76017495|FG001|Overall Study|Adverse Event|3|||
42204902|NCT03474081|76017494|FG000|Overall Study|Lost to Follow-up|2|||
42204903|NCT03474081|76017495|FG001|Overall Study|Lost to Follow-up|1|||
42204904|NCT03474081|76017494|FG000|Overall Study|Physician Decision|3|||
42204905|NCT03474081|76017495|FG001|Overall Study|Physician Decision|2|||
42204906|NCT03474081|76017494|FG000|Overall Study|Withdrawal by Subject|5|||
42204907|NCT03474081|76017495|FG001|Overall Study|Withdrawal by Subject|7|||
42204908|NCT03474081|76017494|FG000|Overall Study|Investigator site closed|1|||
42204909|NCT03474081|76017495|FG001|Overall Study|Investigator site closed|0|||
42204910|NCT03346434|76017507|FG000|Overall Study|Randomized in Error|0|||
42204911|NCT03346434|76017508|FG001|Overall Study|Randomized in Error|0|||
42204912|NCT03346434|76017509|FG002|Overall Study|Randomized in Error|0|||
42204913|NCT03346434|76017510|FG003|Overall Study|Randomized in Error|0|||
42204914|NCT03346434|76017511|FG004|Overall Study|Randomized in Error|1|||
42204915|NCT03346434|76017512|FG005|Overall Study|Randomized in Error|0|||
42204916|NCT03346434|76017507|FG000|Overall Study|Withdrawal by Subject|0|||
42204917|NCT03346434|76017508|FG001|Overall Study|Withdrawal by Subject|0|||
42204918|NCT03346434|76017509|FG002|Overall Study|Withdrawal by Subject|1|||
42204919|NCT03346434|76017510|FG003|Overall Study|Withdrawal by Subject|0|||
42204920|NCT03346434|76017511|FG004|Overall Study|Withdrawal by Subject|1|||
42204921|NCT03346434|76017512|FG005|Overall Study|Withdrawal by Subject|0|||
42204922|NCT03346434|76017507|FG000|Overall Study|Lost to Follow-up|0|||
42204923|NCT03346434|76017508|FG001|Overall Study|Lost to Follow-up|0|||
42204924|NCT03346434|76017509|FG002|Overall Study|Lost to Follow-up|0|||
42204925|NCT03346434|76017510|FG003|Overall Study|Lost to Follow-up|0|||
42204926|NCT03346434|76017511|FG004|Overall Study|Lost to Follow-up|1|||
42204927|NCT03346434|76017512|FG005|Overall Study|Lost to Follow-up|1|||
42204928|NCT03346434|76017507|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
42204929|NCT03346434|76017508|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
42204930|NCT03346434|76017509|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
42204931|NCT03346434|76017510|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
42204932|NCT03346434|76017511|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
42204933|NCT03346434|76017512|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
42204934|NCT03393000|76017530|FG000|Overall Study|Death|11|||
42204935|NCT03393000|76017530|FG000|Overall Study|Withdrawal by Subject|2|||
42204936|NCT03393000|76017530|FG000|Overall Study|Physician Decision|1|||
42204937|NCT03370770|76017534|FG000|Overall Study|Patient was followed in another hospital center|1|||
42204938|NCT03370770|76017534|FG000|Overall Study|Progressive Disease|98|||
42204939|NCT03370770|76017534|FG000|Overall Study|Adverse Event|2|||
42204940|NCT03370770|76017534|FG000|Overall Study|Death|5|||
42204941|NCT03473301|76017541|FG000|Overall Study|Protocol Violation|4|||
42204942|NCT03473301|76017542|FG001|Overall Study|Protocol Violation|0|||
42204943|NCT03473301|76017543|FG002|Overall Study|Protocol Violation|0|||
42204944|NCT03473301|76017541|FG000|Overall Study|Withdrawal by Subject|0|||
42204945|NCT03473301|76017542|FG001|Overall Study|Withdrawal by Subject|1|||
42204946|NCT03473301|76017543|FG002|Overall Study|Withdrawal by Subject|0|||
42204947|NCT03473301|76017541|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
42204948|NCT03473301|76017542|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
42204949|NCT03473301|76017543|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
42204950|NCT03390426|76017555|FG000|Overall Study|Protocol Violation|0|||
42204951|NCT03390426|76017556|FG001|Overall Study|Protocol Violation|1|||
42204952|NCT03472521|76017564|FG000|Overall Study|Lost to Follow-up|3|||
42204953|NCT03472521|76017565|FG001|Overall Study|Lost to Follow-up|2|||
42204954|NCT03472521|76017564|FG000|Overall Study|Discontinued intervention|3|||
42204955|NCT03472521|76017565|FG001|Overall Study|Discontinued intervention|1|||
42204956|NCT02906020|76017581|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
42204957|NCT02906020|76017582|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
42204958|NCT02906020|76017583|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
42204959|NCT02906020|76017584|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
42204960|NCT02906020|76017585|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
42204961|NCT02906020|76017586|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
42204962|NCT02906020|76017587|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
42204963|NCT02906020|76017588|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
42204964|NCT02906020|76017589|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
42204965|NCT02906020|76017590|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
42204966|NCT02906020|76017591|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
42204967|NCT02906020|76017592|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
42204968|NCT02906020|76017593|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
42204969|NCT02906020|76017594|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
42204970|NCT02906020|76017595|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
42204971|NCT02906020|76017596|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
42204972|NCT02906020|76017581|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204973|NCT02906020|76017582|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204974|NCT02906020|76017583|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204975|NCT02906020|76017584|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204976|NCT02906020|76017585|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204977|NCT02906020|76017586|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204978|NCT02906020|76017587|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204979|NCT02906020|76017588|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204980|NCT02906020|76017589|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
42204981|NCT02906020|76017590|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
42204982|NCT02906020|76017591|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204983|NCT02906020|76017592|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204984|NCT02906020|76017593|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204985|NCT02906020|76017594|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204986|NCT02906020|76017595|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204987|NCT02906020|76017596|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
42204988|NCT02906020|76017581|FG000|Part 2: Double-blind Treatment Period|Other|0|||
42204989|NCT02906020|76017582|FG001|Part 2: Double-blind Treatment Period|Other|0|||
42204990|NCT02906020|76017583|FG002|Part 2: Double-blind Treatment Period|Other|0|||
42204991|NCT02906020|76017584|FG003|Part 2: Double-blind Treatment Period|Other|0|||
42204992|NCT02906020|76017585|FG004|Part 2: Double-blind Treatment Period|Other|0|||
42204993|NCT02906020|76017586|FG005|Part 2: Double-blind Treatment Period|Other|0|||
42204994|NCT02906020|76017587|FG006|Part 2: Double-blind Treatment Period|Other|0|||
42204995|NCT02906020|76017588|FG007|Part 2: Double-blind Treatment Period|Other|0|||
42204996|NCT02906020|76017589|FG008|Part 2: Double-blind Treatment Period|Other|6|||
42204997|NCT02906020|76017590|FG009|Part 2: Double-blind Treatment Period|Other|10|||
42204998|NCT02906020|76017591|FG010|Part 2: Double-blind Treatment Period|Other|0|||
42204999|NCT02906020|76017592|FG011|Part 2: Double-blind Treatment Period|Other|0|||
42205000|NCT02906020|76017593|FG012|Part 2: Double-blind Treatment Period|Other|0|||
42205001|NCT02906020|76017594|FG013|Part 2: Double-blind Treatment Period|Other|0|||
42205002|NCT02906020|76017595|FG014|Part 2: Double-blind Treatment Period|Other|0|||
42205003|NCT02906020|76017596|FG015|Part 2: Double-blind Treatment Period|Other|0|||
42205004|NCT02906020|76017581|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205005|NCT02906020|76017582|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205006|NCT02906020|76017583|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205007|NCT02906020|76017584|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205008|NCT02906020|76017585|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205009|NCT02906020|76017586|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205010|NCT02906020|76017587|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205011|NCT02906020|76017588|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205012|NCT02906020|76017589|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205013|NCT02906020|76017590|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205014|NCT02906020|76017591|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205015|NCT02906020|76017592|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205016|NCT02906020|76017593|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
42205017|NCT02906020|76017594|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
42205018|NCT02906020|76017595|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205019|NCT02906020|76017596|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
42205020|NCT02906020|76017581|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205021|NCT02906020|76017582|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205022|NCT02906020|76017583|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205023|NCT02906020|76017584|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205024|NCT02906020|76017585|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205025|NCT02906020|76017586|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205026|NCT02906020|76017587|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205027|NCT02906020|76017588|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205028|NCT02906020|76017589|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205029|NCT02906020|76017590|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205030|NCT02906020|76017591|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205031|NCT02906020|76017592|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205032|NCT02906020|76017593|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
42205033|NCT02906020|76017594|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
42205034|NCT02906020|76017595|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
42205035|NCT02906020|76017596|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
42205036|NCT02906020|76017581|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205037|NCT02906020|76017582|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205038|NCT02906020|76017583|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205039|NCT02906020|76017584|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205040|NCT02906020|76017585|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205041|NCT02906020|76017586|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205042|NCT02906020|76017587|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205043|NCT02906020|76017588|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205044|NCT02906020|76017589|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205045|NCT02906020|76017590|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205046|NCT02906020|76017591|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205047|NCT02906020|76017592|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205048|NCT02906020|76017593|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
42205049|NCT02906020|76017594|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
42205050|NCT02906020|76017595|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205051|NCT02906020|76017596|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
42205052|NCT02906020|76017581|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205053|NCT02906020|76017582|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205054|NCT02906020|76017583|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205055|NCT02906020|76017584|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205056|NCT02906020|76017585|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205057|NCT02906020|76017586|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205058|NCT02906020|76017587|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205059|NCT02906020|76017588|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205060|NCT02906020|76017589|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205061|NCT02906020|76017590|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205062|NCT02906020|76017591|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205063|NCT02906020|76017592|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205064|NCT02906020|76017593|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
42205065|NCT02906020|76017594|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
42205066|NCT02906020|76017595|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205067|NCT02906020|76017596|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
42205068|NCT02906020|76017581|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205069|NCT02906020|76017582|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205070|NCT02906020|76017583|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205071|NCT02906020|76017584|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205072|NCT02906020|76017585|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205073|NCT02906020|76017586|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205074|NCT02906020|76017587|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205075|NCT02906020|76017588|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205076|NCT02906020|76017589|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205077|NCT02906020|76017590|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205078|NCT02906020|76017591|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205079|NCT02906020|76017592|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
42205080|NCT02906020|76017593|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
42205081|NCT02906020|76017594|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
42205082|NCT02906020|76017595|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
42205083|NCT02906020|76017596|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
42205084|NCT02906020|76017581|FG000|Part 2: Long-term Follow-up Period|Other|0|||
42205085|NCT02906020|76017582|FG001|Part 2: Long-term Follow-up Period|Other|0|||
42205086|NCT02906020|76017583|FG002|Part 2: Long-term Follow-up Period|Other|0|||
42205087|NCT02906020|76017584|FG003|Part 2: Long-term Follow-up Period|Other|0|||
42205088|NCT02906020|76017585|FG004|Part 2: Long-term Follow-up Period|Other|0|||
42205089|NCT02906020|76017586|FG005|Part 2: Long-term Follow-up Period|Other|0|||
42205090|NCT02906020|76017587|FG006|Part 2: Long-term Follow-up Period|Other|0|||
42205091|NCT02906020|76017588|FG007|Part 2: Long-term Follow-up Period|Other|0|||
42205092|NCT02906020|76017589|FG008|Part 2: Long-term Follow-up Period|Other|0|||
42205093|NCT02906020|76017590|FG009|Part 2: Long-term Follow-up Period|Other|0|||
42205094|NCT02906020|76017591|FG010|Part 2: Long-term Follow-up Period|Other|0|||
42205095|NCT02906020|76017592|FG011|Part 2: Long-term Follow-up Period|Other|0|||
42205096|NCT02906020|76017593|FG012|Part 2: Long-term Follow-up Period|Other|13|||
42205097|NCT02906020|76017594|FG013|Part 2: Long-term Follow-up Period|Other|8|||
42205098|NCT02906020|76017595|FG014|Part 2: Long-term Follow-up Period|Other|3|||
42205099|NCT02906020|76017596|FG015|Part 2: Long-term Follow-up Period|Other|2|||
42205100|NCT03499353|76017624|FG000|Treatment|Adverse Event|3|||
42205101|NCT03499353|76017624|FG000|Treatment|Progressive Disease|10|||
42205102|NCT03499353|76017624|FG000|Treatment|Other|1|||
42205103|NCT03499353|76017624|FG000|Treatment|Withdrawal by Subject|2|||
42205104|NCT03499353|76017624|FG000|Long-Term Follow-up|Death|2|||
42205105|NCT03499353|76017624|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
42205106|NCT03499353|76017624|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
42205107|NCT00004259|76017632|FG000|Overall Study|Protocol Violation|1|||
42205108|NCT00004259|76017633|FG001|Overall Study|Protocol Violation|2|||
42205109|NCT00004259|76017634|FG002|Overall Study|Protocol Violation|0|||
42205110|NCT00004259|76017635|FG003|Overall Study|Protocol Violation|0|||
42205111|NCT00004259|76017632|FG000|Overall Study|Withdrawal by Subject|0|||
42205112|NCT00004259|76017633|FG001|Overall Study|Withdrawal by Subject|2|||
42205113|NCT00004259|76017634|FG002|Overall Study|Withdrawal by Subject|0|||
42205114|NCT00004259|76017635|FG003|Overall Study|Withdrawal by Subject|0|||
42205115|NCT03365934|76017659|FG000|Overall Study|Adverse Event|1|||
42205116|NCT03365934|76017659|FG000|Overall Study|Withdrawal by Subject|1|||
42205117|NCT03468855|76017668|FG000|Overall Study|Adverse Event|2|||
42205118|NCT03468855|76017668|FG000|Overall Study|Lost to Follow-up|5|||
42205119|NCT03468855|76017668|FG000|Overall Study|Withdrawal by Subject|3|||
42205120|NCT03468855|76017668|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
42205121|NCT03738865|76017674|FG000|Overall Study|Withdrawal by Subject|3|||
42205122|NCT03738865|76017675|FG001|Overall Study|Withdrawal by Subject|3|||
42205123|NCT03738865|76017674|FG000|Overall Study|Adverse Event|2|||
42205124|NCT03738865|76017675|FG001|Overall Study|Adverse Event|0|||
42205125|NCT03738865|76017674|FG000|Overall Study|Physician Decision|0|||
42205126|NCT03738865|76017675|FG001|Overall Study|Physician Decision|1|||
42205127|NCT03524157|76017684|FG000|Overall Study|cytology not readable|0|||
42205128|NCT03524157|76017685|FG001|Overall Study|cytology not readable|0|||
42205129|NCT03524157|76017686|FG002|Overall Study|cytology not readable|1|||
42205130|NCT03437733|76017700|FG000|Overall Study|Eligibility criteria not met|0|||
42205131|NCT03437733|76017701|FG001|Overall Study|Eligibility criteria not met|3|||
42205132|NCT03468543|76017709|FG000|Overall Study|Protocol stopping rules met|3|||
42205133|NCT03467763|76017713|FG000|Overall Study|Lost to Follow-up|1|||
42205134|NCT03467763|76017713|FG000|Overall Study|Protocol Violation|2|||
42205135|NCT00004031|76017721|FG000|Overall Study|Adverse Event|5|||
42205136|NCT00004031|76017722|FG001|Overall Study|Adverse Event|0|||
42205137|NCT00004031|76017721|FG000|Overall Study|Refusal unrelated to adverse events|2|||
42205138|NCT00004031|76017722|FG001|Overall Study|Refusal unrelated to adverse events|11|||
42205139|NCT00004031|76017721|FG000|Overall Study|Progression/relapse|9|||
42205140|NCT00004031|76017722|FG001|Overall Study|Progression/relapse|4|||
42205141|NCT00004031|76017721|FG000|Overall Study|Death|3|||
42205142|NCT00004031|76017722|FG001|Overall Study|Death|1|||
42205143|NCT00004031|76017721|FG000|Overall Study|Other- not protocol specified|3|||
42205144|NCT00004031|76017722|FG001|Overall Study|Other- not protocol specified|3|||
42205145|NCT00004031|76017721|FG000|Overall Study|Reason under review|3|||
42205146|NCT00004031|76017722|FG001|Overall Study|Reason under review|2|||
42205147|NCT03467217|76017732|FG000|Overall Study|Trial stopped early|5|||
42205148|NCT03467217|76017733|FG001|Overall Study|Trial stopped early|2|||
42205149|NCT03467217|76017732|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
42205150|NCT03467217|76017733|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
42205151|NCT03467217|76017732|FG000|Overall Study|Lost to Follow-up|0|||
42205152|NCT03467217|76017733|FG001|Overall Study|Lost to Follow-up|2|||
42205153|NCT00003875|76017739|FG000|Overall Study|Screen Failed|1|||
42205154|NCT03364686|76017743|FG000|Overall Study|Physician Decision|2|||
42205155|NCT03437577|76017750|FG000|Pre-Randomization|Withdrawal by Subject|0|||
42205156|NCT03437577|76017751|FG001|Pre-Randomization|Withdrawal by Subject|0|||
42205157|NCT03437577|76017752|FG002|Pre-Randomization|Withdrawal by Subject|10|||
42205158|NCT03437577|76017750|FG000|Post-Randomization|Physician Decision|0|||
42205159|NCT03437577|76017751|FG001|Post-Randomization|Physician Decision|2|||
42205160|NCT03437577|76017752|FG002|Post-Randomization|Physician Decision|0|||
42205161|NCT03336528|76017760|FG000|Overall Study|Protocol Violation|1|||
42205162|NCT03336528|76017761|FG001|Overall Study|Protocol Violation|1|||
42205163|NCT03336528|76017760|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
42205164|NCT03336528|76017761|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
42205165|NCT03336528|76017760|FG000|Overall Study|Did not receive study medication|1|||
42205166|NCT03336528|76017761|FG001|Overall Study|Did not receive study medication|2|||
42205167|NCT03364608|76017769|FG000|Overall Study|Withdrawal by Subject|4|||
42205168|NCT03364608|76017769|FG000|Overall Study|Protocol Violation|2|||
42205169|NCT03364608|76017769|FG000|Overall Study|Lost to Follow-up|2|||
42205170|NCT00003869|76017783|FG000|Overall Study|Adverse Event|14|||
42205171|NCT00003869|76017784|FG001|Overall Study|Adverse Event|3|||
42205172|NCT00003869|76017783|FG000|Overall Study|Withdrawal by Subject|21|||
42205173|NCT00003869|76017784|FG001|Overall Study|Withdrawal by Subject|3|||
42205174|NCT00003869|76017783|FG000|Overall Study|Death|1|||
42205175|NCT00003869|76017784|FG001|Overall Study|Death|2|||
42205176|NCT00003869|76017783|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
42205177|NCT00003869|76017784|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
42205178|NCT03344640|76017792|FG000|Overall Study|Adverse Event|1|||
42205179|NCT03344640|76017793|FG001|Overall Study|Adverse Event|0|||
42205180|NCT03344640|76017792|FG000|Overall Study|Physician Decision|1|||
42205181|NCT03344640|76017793|FG001|Overall Study|Physician Decision|1|||
42205182|NCT03344640|76017792|FG000|Overall Study|Withdrawal by Subject|1|||
42205183|NCT03344640|76017793|FG001|Overall Study|Withdrawal by Subject|2|||
42205184|NCT03344640|76017792|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
42205185|NCT03344640|76017793|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
42205186|NCT03344562|76017801|FG000|Overall Study|Withdrawal by Subject|2|||
42205187|NCT03344562|76017802|FG001|Overall Study|Withdrawal by Subject|0|||
42205188|NCT00003659|76017808|FG000|Overall Study|Withdrawal by Subject|3|||
42205189|NCT03494985|76017816|FG000|Overall Study|Adverse Event|3|||
42205190|NCT03494985|76017817|FG001|Overall Study|Adverse Event|2|||
42205191|NCT03494985|76017818|FG002|Overall Study|Adverse Event|3|||
42205192|NCT03494985|76017819|FG003|Overall Study|Adverse Event|0|||
42205193|NCT03494985|76017816|FG000|Overall Study|Other (Withdrawal of consent)|2|||
42205194|NCT03494985|76017817|FG001|Overall Study|Other (Withdrawal of consent)|3|||
42205195|NCT03494985|76017818|FG002|Overall Study|Other (Withdrawal of consent)|2|||
42205196|NCT03494985|76017819|FG003|Overall Study|Other (Withdrawal of consent)|5|||
42205197|NCT03494985|76017816|FG000|Overall Study|Other (Not specified)|0|||
42205198|NCT03494985|76017817|FG001|Overall Study|Other (Not specified)|1|||
42205199|NCT03494985|76017818|FG002|Overall Study|Other (Not specified)|1|||
42205200|NCT03494985|76017819|FG003|Overall Study|Other (Not specified)|0|||
42205201|NCT00003509|76017829|FG000|Overall Study|Not evaluable|5|||
42205202|NCT03344172|76017835|FG000|Overall Study|Received <1 dose of treatment|1|||
42205203|NCT03344172|76017836|FG001|Overall Study|Received <1 dose of treatment|0|||
42205204|NCT03465891|76017844|FG000|Overall Study|Withdrawal by Subject|0|||
42205205|NCT03465891|76017845|FG001|Overall Study|Withdrawal by Subject|1|||
42205206|NCT03465891|76017844|FG000|Overall Study|Disease progression|1|||
42205207|NCT03465891|76017845|FG001|Overall Study|Disease progression|0|||
42205208|NCT03363906|76017851|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
42205209|NCT03363906|76017852|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
42205210|NCT03363906|76017851|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
42205211|NCT03363906|76017852|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
42205212|NCT03363906|76017851|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
42205213|NCT03363906|76017852|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
42205214|NCT03363906|76017851|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
42205215|NCT03363906|76017852|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
42205216|NCT00003473|76017858|FG000|Overall Study|Three patients were not evaluable.|3|||
42205217|NCT03343626|76017870|FG000|Overall Study|Lost to Follow-up|4|||
42205218|NCT03343626|76017871|FG001|Overall Study|Lost to Follow-up|3|||
42205219|NCT03343626|76017872|FG002|Overall Study|Lost to Follow-up|2|||
42205220|NCT03343626|76017873|FG003|Overall Study|Lost to Follow-up|5|||
42205221|NCT03343626|76017874|FG004|Overall Study|Lost to Follow-up|4|||
42205222|NCT03343626|76017875|FG005|Overall Study|Lost to Follow-up|4|||
42205223|NCT03343626|76017876|FG006|Overall Study|Lost to Follow-up|4|||
42205224|NCT03343626|76017877|FG007|Overall Study|Lost to Follow-up|7|||
42205225|NCT03343626|76017870|FG000|Overall Study|Withdrawal of Consent|2|||
42205226|NCT03343626|76017871|FG001|Overall Study|Withdrawal of Consent|1|||
42205227|NCT03343626|76017872|FG002|Overall Study|Withdrawal of Consent|0|||
42205228|NCT03343626|76017873|FG003|Overall Study|Withdrawal of Consent|3|||
42205229|NCT03343626|76017874|FG004|Overall Study|Withdrawal of Consent|3|||
42205230|NCT03343626|76017875|FG005|Overall Study|Withdrawal of Consent|1|||
42205231|NCT03343626|76017876|FG006|Overall Study|Withdrawal of Consent|1|||
42205232|NCT03343626|76017877|FG007|Overall Study|Withdrawal of Consent|2|||
42205233|NCT03343626|76017870|FG000|Overall Study|Reason not Specified|0|||
42205234|NCT03343626|76017871|FG001|Overall Study|Reason not Specified|1|||
42205235|NCT03343626|76017872|FG002|Overall Study|Reason not Specified|0|||
42205236|NCT03343626|76017873|FG003|Overall Study|Reason not Specified|0|||
42205237|NCT03343626|76017874|FG004|Overall Study|Reason not Specified|0|||
42205238|NCT03343626|76017875|FG005|Overall Study|Reason not Specified|0|||
42205239|NCT03343626|76017876|FG006|Overall Study|Reason not Specified|0|||
42205240|NCT03343626|76017877|FG007|Overall Study|Reason not Specified|1|||
42205241|NCT03343626|76017870|FG000|Overall Study|Data Entry Error|0|||
42205242|NCT03343626|76017871|FG001|Overall Study|Data Entry Error|0|||
42205243|NCT03343626|76017872|FG002|Overall Study|Data Entry Error|0|||
42205244|NCT03343626|76017873|FG003|Overall Study|Data Entry Error|0|||
42205245|NCT03343626|76017874|FG004|Overall Study|Data Entry Error|0|||
42205246|NCT03343626|76017875|FG005|Overall Study|Data Entry Error|0|||
42205247|NCT03343626|76017876|FG006|Overall Study|Data Entry Error|0|||
42205248|NCT03343626|76017877|FG007|Overall Study|Data Entry Error|1|||
42205249|NCT03334422|76017902|FG000|Overall Study|Adverse Event|1|||
42205250|NCT03334422|76017903|FG001|Overall Study|Adverse Event|3|||
42205251|NCT03334422|76017904|FG002|Overall Study|Adverse Event|2|||
42205252|NCT03334422|76017905|FG003|Overall Study|Adverse Event|2|||
42205253|NCT03334422|76017902|FG000|Overall Study|Lack of Efficacy|10|||
42205254|NCT03334422|76017903|FG001|Overall Study|Lack of Efficacy|2|||
42205255|NCT03334422|76017904|FG002|Overall Study|Lack of Efficacy|7|||
42205256|NCT03334422|76017905|FG003|Overall Study|Lack of Efficacy|3|||
42205257|NCT03334422|76017902|FG000|Overall Study|Withdrawal by Subject|8|||
42205258|NCT03334422|76017903|FG001|Overall Study|Withdrawal by Subject|3|||
42205259|NCT03334422|76017904|FG002|Overall Study|Withdrawal by Subject|1|||
42205260|NCT03334422|76017905|FG003|Overall Study|Withdrawal by Subject|0|||
42205261|NCT03334422|76017902|FG000|Overall Study|Lost to Follow-up|0|||
42205262|NCT03334422|76017903|FG001|Overall Study|Lost to Follow-up|0|||
42205263|NCT03334422|76017904|FG002|Overall Study|Lost to Follow-up|0|||
42205264|NCT03334422|76017905|FG003|Overall Study|Lost to Follow-up|1|||
42205265|NCT03334422|76017902|FG000|Overall Study|Inability to obtain laboratory samples|0|||
42205266|NCT03334422|76017903|FG001|Overall Study|Inability to obtain laboratory samples|1|||
42205267|NCT03334422|76017904|FG002|Overall Study|Inability to obtain laboratory samples|0|||
42205268|NCT03334422|76017905|FG003|Overall Study|Inability to obtain laboratory samples|0|||
42205269|NCT03334422|76017902|FG000|Overall Study|Pregnancy|0|||
42205270|NCT03334422|76017903|FG001|Overall Study|Pregnancy|1|||
42205271|NCT03334422|76017904|FG002|Overall Study|Pregnancy|0|||
42205272|NCT03334422|76017905|FG003|Overall Study|Pregnancy|0|||
42205273|NCT03362190|76017924|FG000|Overall Study|Adverse Event|0|||
42205274|NCT03362190|76017925|FG001|Overall Study|Adverse Event|0|||
42205275|NCT03362190|76017926|FG002|Overall Study|Adverse Event|0|||
42205276|NCT03362190|76017927|FG003|Overall Study|Adverse Event|1|||
42205277|NCT03362190|76017924|FG000|Overall Study|Withdrawal by Subject|0|||
42205278|NCT03362190|76017925|FG001|Overall Study|Withdrawal by Subject|0|||
42205279|NCT03362190|76017926|FG002|Overall Study|Withdrawal by Subject|0|||
42205280|NCT03362190|76017927|FG003|Overall Study|Withdrawal by Subject|1|||
42205281|NCT02323126|76017943|FG000|Overall Study|Patient / guardian decision|0|||
42205282|NCT02323126|76017944|FG001|Overall Study|Patient / guardian decision|1|||
42205283|NCT02323126|76017945|FG002|Overall Study|Patient / guardian decision|2|||
42205284|NCT02323126|76017943|FG000|Overall Study|Progressive disease|14|||
42205285|NCT02323126|76017944|FG001|Overall Study|Progressive disease|8|||
42205286|NCT02323126|76017945|FG002|Overall Study|Progressive disease|14|||
42205287|NCT02323126|76017943|FG000|Overall Study|Physician Decision|0|||
42205288|NCT02323126|76017944|FG001|Overall Study|Physician Decision|1|||
42205289|NCT02323126|76017945|FG002|Overall Study|Physician Decision|3|||
42205290|NCT02323126|76017943|FG000|Overall Study|Death|1|||
42205291|NCT02323126|76017944|FG001|Overall Study|Death|1|||
42205292|NCT02323126|76017945|FG002|Overall Study|Death|4|||
42205293|NCT02323126|76017943|FG000|Overall Study|Adverse Event|3|||
42205294|NCT02323126|76017944|FG001|Overall Study|Adverse Event|5|||
42205295|NCT02323126|76017945|FG002|Overall Study|Adverse Event|7|||
42205296|NCT03491553|76017962|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
42205297|NCT03491553|76017963|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
42205298|NCT03491553|76017964|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
42205299|NCT03491553|76017965|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
42205300|NCT03491553|76017966|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
42205301|NCT03491553|76017967|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
42205302|NCT03491553|76017962|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
42205303|NCT03491553|76017963|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
42205304|NCT03491553|76017964|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
42205305|NCT03491553|76017965|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
42205306|NCT03491553|76017966|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
42205307|NCT03491553|76017967|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
42205308|NCT00003377|76017988|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
42205309|NCT00003377|76017989|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
42298661|NCT04640311|76133819|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298662|NCT04640311|76133820|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298663|NCT04640311|76133808|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
42298664|NCT04640311|76133809|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
42298665|NCT04640311|76133810|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
42298666|NCT04640311|76133811|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298667|NCT04640311|76133812|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298668|NCT04640311|76133813|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298669|NCT04640311|76133814|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298670|NCT04640311|76133815|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298671|NCT04640311|76133816|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298672|NCT04640311|76133817|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298673|NCT04640311|76133818|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298674|NCT04640311|76133819|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298675|NCT04640311|76133820|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
42298676|NCT04640311|76133808|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298677|NCT04640311|76133809|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298678|NCT04640311|76133810|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
42298679|NCT04640311|76133811|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298680|NCT04640311|76133812|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298681|NCT04640311|76133813|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298682|NCT04640311|76133814|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298683|NCT04640311|76133815|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298684|NCT04640311|76133816|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298685|NCT04640311|76133817|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298686|NCT04640311|76133818|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298687|NCT04640311|76133819|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298688|NCT04640311|76133820|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
42298689|NCT04640311|76133808|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
42298690|NCT04640311|76133809|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
42298691|NCT04640311|76133810|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
42298692|NCT04640311|76133811|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
42298693|NCT04640311|76133812|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
42298694|NCT04640311|76133813|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
42298695|NCT04640311|76133814|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
42298696|NCT04640311|76133815|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
42298697|NCT04640311|76133816|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
42298698|NCT04640311|76133817|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
42298699|NCT04640311|76133818|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
42298700|NCT04640311|76133819|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
42298701|NCT04640311|76133820|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
42298702|NCT04640311|76133808|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298703|NCT04640311|76133809|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298704|NCT04640311|76133810|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298705|NCT04640311|76133811|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298706|NCT04640311|76133812|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298707|NCT04640311|76133813|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
42298708|NCT04640311|76133814|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298709|NCT04640311|76133815|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298710|NCT04640311|76133816|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
42298711|NCT04640311|76133817|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298712|NCT04640311|76133818|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298713|NCT04640311|76133819|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298714|NCT04640311|76133820|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
42298715|NCT04640311|76133808|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
42298716|NCT04640311|76133809|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
42298717|NCT04640311|76133810|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
42298718|NCT04640311|76133811|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
42298719|NCT04640311|76133812|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
42298720|NCT04640311|76133813|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
42298721|NCT04640311|76133814|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
42298722|NCT04640311|76133815|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
42298723|NCT04640311|76133816|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
42298724|NCT04640311|76133817|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
42298725|NCT04640311|76133818|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
42298726|NCT04640311|76133819|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
42298727|NCT04640311|76133820|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
42298728|NCT04640311|76133808|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298729|NCT04640311|76133809|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298730|NCT04640311|76133810|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298731|NCT04640311|76133811|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298732|NCT04640311|76133812|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298733|NCT04640311|76133813|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298734|NCT04640311|76133814|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298735|NCT04640311|76133815|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298736|NCT04640311|76133816|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298737|NCT04640311|76133817|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298738|NCT04640311|76133818|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298739|NCT04640311|76133819|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
42298740|NCT04640311|76133820|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
42298741|NCT02334423|76133851|FG000|Overall Study|Protocol Violation|10|||
42298742|NCT02334423|76133852|FG001|Overall Study|Protocol Violation|3|||
42298743|NCT02310789|76133858|FG000|Overall Study|Adverse Event|1|||
42298744|NCT02372253|76133864|FG000|Overall Study|Non Compliance|2|||
42298745|NCT02372253|76133865|FG001|Overall Study|Non Compliance|0|||
42298746|NCT02559895|76133877|FG000|Overall Study|Adverse Event|3|||
42298747|NCT02559895|76133878|FG001|Overall Study|Adverse Event|3|||
42298748|NCT02559895|76133879|FG002|Overall Study|Adverse Event|2|||
42298749|NCT02559895|76133880|FG003|Overall Study|Adverse Event|1|||
42298750|NCT02559895|76133877|FG000|Overall Study|Lack of Efficacy|2|||
42298751|NCT02559895|76133878|FG001|Overall Study|Lack of Efficacy|3|||
42298752|NCT02559895|76133879|FG002|Overall Study|Lack of Efficacy|2|||
42298753|NCT02559895|76133880|FG003|Overall Study|Lack of Efficacy|8|||
42298754|NCT02559895|76133877|FG000|Overall Study|Lost to Follow-up|22|||
42298755|NCT02559895|76133878|FG001|Overall Study|Lost to Follow-up|16|||
42298756|NCT02559895|76133879|FG002|Overall Study|Lost to Follow-up|12|||
42298757|NCT02559895|76133880|FG003|Overall Study|Lost to Follow-up|17|||
42298758|NCT02559895|76133877|FG000|Overall Study|Physician Decision|1|||
42298759|NCT02559895|76133878|FG001|Overall Study|Physician Decision|1|||
42298760|NCT02559895|76133879|FG002|Overall Study|Physician Decision|3|||
42298761|NCT02559895|76133880|FG003|Overall Study|Physician Decision|0|||
42298762|NCT02559895|76133877|FG000|Overall Study|Withdrawal by Subject|16|||
42298763|NCT02559895|76133878|FG001|Overall Study|Withdrawal by Subject|9|||
42298764|NCT02559895|76133879|FG002|Overall Study|Withdrawal by Subject|20|||
42298765|NCT02559895|76133880|FG003|Overall Study|Withdrawal by Subject|9|||
42298766|NCT02559895|76133877|FG000|Overall Study|Study Burden|10|||
42298767|NCT02559895|76133878|FG001|Overall Study|Study Burden|16|||
42298768|NCT02559895|76133879|FG002|Overall Study|Study Burden|12|||
42298769|NCT02559895|76133880|FG003|Overall Study|Study Burden|22|||
42298770|NCT02559895|76133877|FG000|Overall Study|Other|1|||
42298771|NCT02559895|76133878|FG001|Overall Study|Other|5|||
42298772|NCT02559895|76133879|FG002|Overall Study|Other|3|||
42298773|NCT02559895|76133880|FG003|Overall Study|Other|3|||
42298774|NCT02371629|76133892|FG000|Overall Study|Patient decision|14|||
42298775|NCT02371629|76133893|FG001|Overall Study|Patient decision|10|||
42298776|NCT02371629|76133892|FG000|Overall Study|Adverse Event|8|||
42298777|NCT02371629|76133893|FG001|Overall Study|Adverse Event|8|||
42298778|NCT02371629|76133892|FG000|Overall Study|Physician Decision|2|||
42298779|NCT02371629|76133893|FG001|Overall Study|Physician Decision|3|||
42298780|NCT02371629|76133892|FG000|Overall Study|Death|1|||
42298781|NCT02371629|76133893|FG001|Overall Study|Death|1|||
42298782|NCT02371629|76133892|FG000|Overall Study|Noncompliance with study treatment|1|||
42298783|NCT02371629|76133893|FG001|Overall Study|Noncompliance with study treatment|0|||
42298784|NCT02371629|76133892|FG000|Overall Study|Lack of Efficacy|0|||
42298785|NCT02371629|76133893|FG001|Overall Study|Lack of Efficacy|2|||
42298786|NCT02371629|76133892|FG000|Overall Study|Protocol deviation|0|||
42298787|NCT02371629|76133893|FG001|Overall Study|Protocol deviation|1|||
42298788|NCT02559817|76133904|FG000|Treatment Period|Adverse Event|1|||
42298789|NCT02559817|76133905|FG001|Treatment Period|Adverse Event|0|||
42298790|NCT02559817|76133906|FG002|Treatment Period|Adverse Event|1|||
42298791|NCT02559817|76133907|FG003|Treatment Period|Adverse Event|0|||
42298792|NCT02559817|76133908|FG004|Treatment Period|Adverse Event|0|||
42298793|NCT02559817|76133904|FG000|Treatment Period|Lack of Efficacy|0|||
42298794|NCT02559817|76133905|FG001|Treatment Period|Lack of Efficacy|1|||
42298795|NCT02559817|76133906|FG002|Treatment Period|Lack of Efficacy|0|||
42298796|NCT02559817|76133907|FG003|Treatment Period|Lack of Efficacy|0|||
42298797|NCT02559817|76133908|FG004|Treatment Period|Lack of Efficacy|0|||
42298798|NCT02559817|76133904|FG000|Treatment Period|Lost to Follow-up|0|||
42298799|NCT02559817|76133905|FG001|Treatment Period|Lost to Follow-up|1|||
42298800|NCT02559817|76133906|FG002|Treatment Period|Lost to Follow-up|0|||
42298801|NCT02559817|76133907|FG003|Treatment Period|Lost to Follow-up|1|||
42298802|NCT02559817|76133908|FG004|Treatment Period|Lost to Follow-up|0|||
42298803|NCT02559817|76133904|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
42298804|NCT02559817|76133905|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
42298805|NCT02559817|76133906|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
42298806|NCT02559817|76133907|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
42298807|NCT02559817|76133908|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
42298808|NCT02559817|76133904|FG000|Treatment Period|Protocol Violation|0|||
42298809|NCT02559817|76133905|FG001|Treatment Period|Protocol Violation|0|||
42298810|NCT02559817|76133906|FG002|Treatment Period|Protocol Violation|0|||
42298811|NCT02559817|76133907|FG003|Treatment Period|Protocol Violation|1|||
42298812|NCT02559817|76133908|FG004|Treatment Period|Protocol Violation|0|||
42298813|NCT02564887|76133922|FG000|Overall Study|Lost to Follow-up|6|||
42298814|NCT02564887|76133923|FG001|Overall Study|Lost to Follow-up|0|||
42298815|NCT02333487|76133934|FG000|Overall Study|Adverse Event|0|||
42298816|NCT02333487|76133935|FG001|Overall Study|Adverse Event|2|||
42298817|NCT02333487|76133936|FG002|Overall Study|Adverse Event|0|||
42298818|NCT02333331|76133949|FG000|Overall Study|Adverse Event|1|||
42298819|NCT02333331|76133950|FG001|Overall Study|Adverse Event|0|||
42298820|NCT02333331|76133951|FG002|Overall Study|Adverse Event|4|||
42298821|NCT02333331|76133952|FG003|Overall Study|Adverse Event|1|||
42298822|NCT02333331|76133949|FG000|Overall Study|Death|0|||
42298823|NCT02333331|76133950|FG001|Overall Study|Death|0|||
42298824|NCT02333331|76133951|FG002|Overall Study|Death|2|||
42298825|NCT02333331|76133952|FG003|Overall Study|Death|0|||
42298826|NCT02333331|76133949|FG000|Overall Study|Lost to Follow-up|0|||
42298827|NCT02333331|76133950|FG001|Overall Study|Lost to Follow-up|0|||
42298828|NCT02333331|76133951|FG002|Overall Study|Lost to Follow-up|1|||
42298829|NCT02333331|76133952|FG003|Overall Study|Lost to Follow-up|0|||
42298830|NCT02333331|76133949|FG000|Overall Study|Physician Decision|0|||
42298831|NCT02333331|76133950|FG001|Overall Study|Physician Decision|1|||
42298832|NCT02333331|76133951|FG002|Overall Study|Physician Decision|0|||
42298833|NCT02333331|76133952|FG003|Overall Study|Physician Decision|0|||
42298834|NCT02333331|76133949|FG000|Overall Study|Protocol Deviation|0|||
42298835|NCT02333331|76133950|FG001|Overall Study|Protocol Deviation|3|||
42298836|NCT02333331|76133951|FG002|Overall Study|Protocol Deviation|2|||
42298837|NCT02333331|76133952|FG003|Overall Study|Protocol Deviation|1|||
42298838|NCT02333331|76133949|FG000|Overall Study|Patient/Guardian Decision|1|||
42298839|NCT02333331|76133950|FG001|Overall Study|Patient/Guardian Decision|2|||
42298840|NCT02333331|76133951|FG002|Overall Study|Patient/Guardian Decision|9|||
42298841|NCT02333331|76133952|FG003|Overall Study|Patient/Guardian Decision|1|||
42298842|NCT02563561|76133965|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
42298843|NCT02563561|76133966|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
42298844|NCT02563561|76133967|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
42298845|NCT02563561|76133965|FG000|Overall Study|Withdrew of Consent|1|||
42298846|NCT02563561|76133966|FG001|Overall Study|Withdrew of Consent|1|||
42298847|NCT02563561|76133967|FG002|Overall Study|Withdrew of Consent|2|||
42298848|NCT02563561|76133965|FG000|Overall Study|Lost to Follow-up|1|||
42298849|NCT02563561|76133966|FG001|Overall Study|Lost to Follow-up|1|||
42298850|NCT02563561|76133967|FG002|Overall Study|Lost to Follow-up|0|||
42298851|NCT02563561|76133965|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
42298852|NCT02563561|76133966|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
42298853|NCT02563561|76133967|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
42298854|NCT02563561|76133965|FG000|Overall Study|Investigator Decision|3|||
42298855|NCT02563561|76133966|FG001|Overall Study|Investigator Decision|4|||
42298856|NCT02563561|76133967|FG002|Overall Study|Investigator Decision|2|||
42298857|NCT02563561|76133965|FG000|Overall Study|Sponsor Decision|5|||
42298858|NCT02563561|76133966|FG001|Overall Study|Sponsor Decision|2|||
42298859|NCT02563561|76133967|FG002|Overall Study|Sponsor Decision|4|||
42298860|NCT02563561|76133965|FG000|Overall Study|Other|1|||
42298861|NCT02563561|76133966|FG001|Overall Study|Other|5|||
42298862|NCT02563561|76133967|FG002|Overall Study|Other|2|||
42298863|NCT02559505|76133983|FG000|Overall Study|Lost to Follow-up|23|||
42298864|NCT02559505|76133984|FG001|Overall Study|Lost to Follow-up|20|||
42298865|NCT02559505|76133983|FG000|Overall Study|Withdrawal by Subject|4|||
42298866|NCT02559505|76133984|FG001|Overall Study|Withdrawal by Subject|2|||
42298867|NCT04191967|76134006|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
42298868|NCT04191967|76134006|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
42298869|NCT02556307|76134012|FG000|Overall Study|Premature treatment interruption|11|||
42298870|NCT02556307|76134012|FG000|Overall Study|Lost to Follow-up|36|||
42298871|NCT02556307|76134012|FG000|Overall Study|Change to triple therapy|4|||
42298872|NCT02556307|76134012|FG000|Overall Study|Enrolled but not treated|2|||
42298873|NCT04364737|76134018|FG000|Overall Study|Withdrawal by Subject|4|||
42298874|NCT04364737|76134019|FG001|Overall Study|Withdrawal by Subject|9|||
42298875|NCT04364737|76134018|FG000|Overall Study|Lost to Follow-up|1|||
42298876|NCT04364737|76134019|FG001|Overall Study|Lost to Follow-up|1|||
42298877|NCT02559115|76134025|FG000|Overall Study|Withdrawal by Subject|3|||
42298878|NCT01662895|76134043|FG000|Overall Study|Lost to Follow-up|0|||
42298879|NCT01662895|76134044|FG001|Overall Study|Lost to Follow-up|1|||
42298880|NCT02557399|76134052|FG000|Overall Study|Adverse Event|6|||
42298881|NCT02557399|76134053|FG001|Overall Study|Adverse Event|5|||
42298882|NCT02557399|76134052|FG000|Overall Study|Protocol Violation|0|||
42298883|NCT02557399|76134053|FG001|Overall Study|Protocol Violation|1|||
42298884|NCT02557399|76134052|FG000|Overall Study|Protocol-defined stopping criteria|0|||
42298885|NCT02557399|76134053|FG001|Overall Study|Protocol-defined stopping criteria|1|||
42298886|NCT02557399|76134052|FG000|Overall Study|Withdrawal by Subject|1|||
42298887|NCT02557399|76134053|FG001|Overall Study|Withdrawal by Subject|1|||
42298888|NCT02555371|76134062|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
42298889|NCT02555371|76134063|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
42298890|NCT02555371|76134064|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
42298891|NCT02555371|76134065|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
42298892|NCT02555371|76134066|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
42298893|NCT02555371|76134062|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
42298894|NCT02555371|76134063|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
42298895|NCT02555371|76134064|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
42298896|NCT02555371|76134065|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
42298897|NCT02555371|76134066|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
42298898|NCT02555371|76134062|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
42298899|NCT02555371|76134063|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
42298900|NCT02555371|76134064|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
42298901|NCT02555371|76134065|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
42298902|NCT02555371|76134066|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
42298903|NCT02555371|76134062|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
42298904|NCT02555371|76134063|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
42298905|NCT02555371|76134064|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
42298906|NCT02555371|76134065|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
42298907|NCT02555371|76134066|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
42298908|NCT02555371|76134062|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
42298909|NCT02555371|76134063|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
42298910|NCT02555371|76134064|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
42298911|NCT02555371|76134065|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
42298912|NCT02555371|76134066|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
42298913|NCT02555371|76134062|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
42298914|NCT02555371|76134063|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
42298915|NCT02555371|76134064|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
42298916|NCT02555371|76134065|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
42298917|NCT02555371|76134066|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
42298918|NCT02555371|76134062|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
42298919|NCT02555371|76134063|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
42298920|NCT02555371|76134064|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
42298921|NCT02555371|76134065|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
42298922|NCT02555371|76134066|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
42298923|NCT02555371|76134062|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
42298924|NCT02555371|76134063|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
42298925|NCT02555371|76134064|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
42298926|NCT02555371|76134065|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
42298927|NCT02555371|76134066|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
42298928|NCT02555371|76134062|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
42298929|NCT02555371|76134063|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
42298930|NCT02555371|76134064|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
42298931|NCT02555371|76134065|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
42298932|NCT02555371|76134066|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
42298933|NCT02555371|76134062|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
42298934|NCT02555371|76134063|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
42298935|NCT02555371|76134064|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
42298936|NCT02555371|76134065|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
42298937|NCT02555371|76134066|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
42298938|NCT02555371|76134062|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
42298939|NCT02555371|76134063|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
42298940|NCT02555371|76134064|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
42298941|NCT02555371|76134065|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
42298942|NCT02555371|76134066|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
42298943|NCT02555371|76134062|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
42298944|NCT02555371|76134063|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
42298945|NCT02555371|76134064|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
42298946|NCT02555371|76134065|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
42298947|NCT02555371|76134066|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
42298948|NCT02555371|76134062|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
42298949|NCT02555371|76134063|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
42298950|NCT02555371|76134064|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
42298951|NCT02555371|76134065|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
42298952|NCT02555371|76134066|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
42298953|NCT02555371|76134062|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
42298954|NCT02555371|76134063|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
42298955|NCT02555371|76134064|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
42298956|NCT02555371|76134065|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
42298957|NCT02555371|76134066|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
42298958|NCT02555215|76134075|FG000|Overall Study|Other|1|||
42298959|NCT02555215|76134075|FG000|Overall Study|Investigator Decision|2|||
42298960|NCT02555683|76134082|FG000|Overall Study|Physician Decision|1|||
42298961|NCT02555683|76134083|FG001|Overall Study|Physician Decision|0|||
42298962|NCT02555683|76134084|FG002|Overall Study|Physician Decision|2|||
42298963|NCT02555683|76134082|FG000|Overall Study|Lost to Follow-up|2|||
42298964|NCT02555683|76134083|FG001|Overall Study|Lost to Follow-up|1|||
42298965|NCT02555683|76134084|FG002|Overall Study|Lost to Follow-up|2|||
42298966|NCT02555683|76134082|FG000|Overall Study|Technical Problems|1|||
42298967|NCT02555683|76134083|FG001|Overall Study|Technical Problems|1|||
42298968|NCT02555683|76134084|FG002|Overall Study|Technical Problems|0|||
42298969|NCT02555683|76134082|FG000|Overall Study|Protocol deviation|0|||
42298970|NCT02555683|76134083|FG001|Overall Study|Protocol deviation|1|||
42298971|NCT02555683|76134084|FG002|Overall Study|Protocol deviation|0|||
42298972|NCT02555683|76134082|FG000|Overall Study|Lack of Efficacy|2|||
42298973|NCT02555683|76134083|FG001|Overall Study|Lack of Efficacy|0|||
42298974|NCT02555683|76134084|FG002|Overall Study|Lack of Efficacy|0|||
42298975|NCT02555683|76134082|FG000|Overall Study|Death|0|||
42298976|NCT02555683|76134083|FG001|Overall Study|Death|1|||
42298977|NCT02555683|76134084|FG002|Overall Study|Death|2|||
42298978|NCT02555683|76134082|FG000|Overall Study|Adverse Event|1|||
42298979|NCT02555683|76134083|FG001|Overall Study|Adverse Event|0|||
42298980|NCT02555683|76134084|FG002|Overall Study|Adverse Event|1|||
42298981|NCT02555683|76134082|FG000|Overall Study|Subject/guardian decision|12|||
42298982|NCT02555683|76134083|FG001|Overall Study|Subject/guardian decision|12|||
42298983|NCT02555683|76134084|FG002|Overall Study|Subject/guardian decision|22|||
42298984|NCT02555683|76134082|FG000|Overall Study|Death post Treatment/safety period|0|||
42298985|NCT02555683|76134083|FG001|Overall Study|Death post Treatment/safety period|1|||
42298986|NCT02555683|76134084|FG002|Overall Study|Death post Treatment/safety period|0|||
42298987|NCT02554981|76134092|FG000|Overall Study|Adverse Event|1|||
42298988|NCT02554981|76134092|FG000|Overall Study|Administrative Reasons|1|||
42298989|NCT02554981|76134092|FG000|Overall Study|Other Miscellaneous Reasons|3|||
42298990|NCT02556775|76134100|FG000|Overall Study|Withdrawal by Subject|1|||
42298991|NCT02556775|76134101|FG001|Overall Study|Withdrawal by Subject|0|||
42298992|NCT02556775|76134102|FG002|Overall Study|Withdrawal by Subject|1|||
42298993|NCT02556775|76134103|FG003|Overall Study|Withdrawal by Subject|0|||
42298994|NCT02556775|76134100|FG000|Overall Study|Lost to Follow-up|1|||
42298995|NCT02556775|76134101|FG001|Overall Study|Lost to Follow-up|0|||
42298996|NCT02556775|76134102|FG002|Overall Study|Lost to Follow-up|0|||
42298997|NCT02556775|76134103|FG003|Overall Study|Lost to Follow-up|0|||
42298998|NCT01662505|76134118|FG000|Overall Study|Progressive disease|6|||
42298999|NCT01662505|76134119|FG001|Overall Study|Progressive disease|1|||
42299000|NCT01662505|76134120|FG002|Overall Study|Progressive disease|5|||
42299001|NCT01662505|76134118|FG000|Overall Study|Refused cont. medication|0|||
42299002|NCT01662505|76134119|FG001|Overall Study|Refused cont. medication|0|||
42299003|NCT01662505|76134120|FG002|Overall Study|Refused cont. medication|1|||
42299004|NCT01662505|76134118|FG000|Overall Study|Not specified above|1|||
42299005|NCT01662505|76134119|FG001|Overall Study|Not specified above|3|||
42299006|NCT01662505|76134120|FG002|Overall Study|Not specified above|2|||
42299007|NCT03796195|76134129|FG000|Overall Study|Study closed early|1|||
42299008|NCT02554513|76134133|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
42299009|NCT02554513|76134134|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
42299010|NCT02554903|76134148|FG000|Overall Study|Death|1|||
42299011|NCT02554903|76134149|FG001|Overall Study|Death|1|||
42299012|NCT02554903|76134148|FG000|Overall Study|Physician Decision|2|||
42299013|NCT02554903|76134149|FG001|Overall Study|Physician Decision|2|||
42299014|NCT02554903|76134148|FG000|Overall Study|Heart Transplant|1|||
42299015|NCT02554903|76134149|FG001|Overall Study|Heart Transplant|2|||
42391262|NCT00551460|76282925|FG000|Overall Study|Adverse Event|1|||
42391263|NCT00551460|76282925|FG000|Overall Study|Withdrawal by Subject|1|||
42391264|NCT00551460|76282925|FG000|Overall Study|Physician Decision|1|||
42391265|NCT00551460|76282925|FG000|Overall Study|Death|7|||
42391266|NCT00551460|76282925|FG000|Overall Study|Ineligible|4|||
42391267|NCT00551460|76282925|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
42391268|NCT02579772|76282986|FG000|Overall Study|Withdrawal by Subject|0|||
42391269|NCT02579772|76282987|FG001|Overall Study|Withdrawal by Subject|1|||
42391270|NCT02579772|76282986|FG000|Overall Study|Usage of additional antioxidants|1|||
42391271|NCT02579772|76282987|FG001|Overall Study|Usage of additional antioxidants|0|||
42391272|NCT02579772|76282986|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
42391273|NCT02579772|76282987|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
42391274|NCT02579616|76283060|FG000|Overall Study|Participants did not receive treatment|3|||
42391275|NCT04027608|76283120|FG000|Overall Study|Withdrawal by Subject|13|||
42391276|NCT04027608|76283121|FG001|Overall Study|Withdrawal by Subject|2|||
42391277|NCT04027608|76283120|FG000|Overall Study|Protocol Violation|2|||
42391278|NCT04027608|76283121|FG001|Overall Study|Protocol Violation|1|||
42391279|NCT04027608|76283120|FG000|Overall Study|Physician Decision|1|||
42391280|NCT04027608|76283121|FG001|Overall Study|Physician Decision|0|||
42391281|NCT04027608|76283120|FG000|Overall Study|Lost to Follow-up|20|||
42391282|NCT04027608|76283121|FG001|Overall Study|Lost to Follow-up|4|||
42391283|NCT01664052|76283212|FG000|Phase 1|No device placement|6|||
42391284|NCT01664052|76283213|FG001|Phase 1|No device placement|0|||
42391285|NCT01664052|76283212|FG000|Phase 1|No HSG 1 hr post placement|1|||
42391286|NCT01664052|76283213|FG001|Phase 1|No HSG 1 hr post placement|0|||
42391287|NCT01664052|76283212|FG000|Phase 2|No device placement|0|||
42391288|NCT01664052|76283213|FG001|Phase 2|No device placement|4|||
42391289|NCT01465802|76283260|FG000|Overall Study|Study terminated by sponsor|1|||
42391290|NCT01465802|76283261|FG001|Overall Study|Study terminated by sponsor|0|||
42391291|NCT01465802|76283262|FG002|Overall Study|Study terminated by sponsor|0|||
42391292|NCT01465802|76283263|FG003|Overall Study|Study terminated by sponsor|1|||
42391293|NCT01465802|76283264|FG004|Overall Study|Study terminated by sponsor|7|||
42391294|NCT01465802|76283260|FG000|Overall Study|Withdrawal by Subject|7|||
42391295|NCT01465802|76283261|FG001|Overall Study|Withdrawal by Subject|7|||
42391296|NCT01465802|76283262|FG002|Overall Study|Withdrawal by Subject|0|||
42391297|NCT01465802|76283263|FG003|Overall Study|Withdrawal by Subject|8|||
42391298|NCT01465802|76283264|FG004|Overall Study|Withdrawal by Subject|1|||
42391299|NCT01465802|76283260|FG000|Overall Study|Lost to Follow-up|1|||
42391300|NCT01465802|76283261|FG001|Overall Study|Lost to Follow-up|1|||
42391301|NCT01465802|76283262|FG002|Overall Study|Lost to Follow-up|0|||
42391302|NCT01465802|76283263|FG003|Overall Study|Lost to Follow-up|0|||
42391303|NCT01465802|76283264|FG004|Overall Study|Lost to Follow-up|0|||
42391304|NCT01465802|76283260|FG000|Overall Study|Reason not specified|9|||
42391305|NCT01465802|76283261|FG001|Overall Study|Reason not specified|4|||
42391306|NCT01465802|76283262|FG002|Overall Study|Reason not specified|0|||
42391307|NCT01465802|76283263|FG003|Overall Study|Reason not specified|10|||
42391308|NCT01465802|76283264|FG004|Overall Study|Reason not specified|2|||
42391309|NCT01465802|76283260|FG000|Overall Study|Death|15|||
42391310|NCT01465802|76283261|FG001|Overall Study|Death|12|||
42391311|NCT01465802|76283262|FG002|Overall Study|Death|0|||
42391312|NCT01465802|76283263|FG003|Overall Study|Death|10|||
42391313|NCT01465802|76283264|FG004|Overall Study|Death|2|||
42391314|NCT01437878|76283309|FG000|Overall Study|Withdrawal by Subject|1|||
42391315|NCT01437878|76283310|FG001|Overall Study|Withdrawal by Subject|0|||
42391316|NCT01465178|76283336|FG000|Overall Study|Withdrawal by Subject|1|||
42391317|NCT01465178|76283337|FG001|Overall Study|Withdrawal by Subject|0|||
42391318|NCT01445678|76283443|FG000|Overall Study|Adverse Event|12|||
42391319|NCT01445678|76283444|FG001|Overall Study|Adverse Event|8|||
42391320|NCT01445678|76283443|FG000|Overall Study|Lack of Efficacy|0|||
42299016|NCT02332707|76134174|FG000|Overall Study|Adverse Event|0|||
42299017|NCT02332707|76134175|FG001|Overall Study|Adverse Event|0|||
42299018|NCT02332707|76134176|FG002|Overall Study|Adverse Event|0|||
42299019|NCT02332707|76134177|FG003|Overall Study|Adverse Event|0|||
42299020|NCT02332707|76134178|FG004|Overall Study|Adverse Event|0|||
42299021|NCT02332707|76134179|FG005|Overall Study|Adverse Event|0|||
42299022|NCT02332707|76134180|FG006|Overall Study|Adverse Event|0|||
42299023|NCT02332707|76134181|FG007|Overall Study|Adverse Event|0|||
42299024|NCT02332707|76134182|FG008|Overall Study|Adverse Event|0|||
42299025|NCT02332707|76134183|FG009|Overall Study|Adverse Event|0|||
42299026|NCT02332707|76134184|FG010|Overall Study|Adverse Event|0|||
42299027|NCT02332707|76134185|FG011|Overall Study|Adverse Event|0|||
42299028|NCT02332707|76134186|FG012|Overall Study|Adverse Event|1|||
42299029|NCT02332707|76134187|FG013|Overall Study|Adverse Event|0|||
42299030|NCT02332707|76134188|FG014|Overall Study|Adverse Event|0|||
42391321|NCT01445678|76283444|FG001|Overall Study|Lack of Efficacy|2|||
42391322|NCT01445678|76283443|FG000|Overall Study|Lost to Follow-up|8|||
42391323|NCT01445678|76283444|FG001|Overall Study|Lost to Follow-up|5|||
42391324|NCT01445678|76283443|FG000|Overall Study|Protocol Violation|1|||
42391325|NCT01445678|76283444|FG001|Overall Study|Protocol Violation|1|||
42391326|NCT01445678|76283443|FG000|Overall Study|Withdrawal by Subject|9|||
42391327|NCT01445678|76283444|FG001|Overall Study|Withdrawal by Subject|5|||
42391328|NCT03769194|76283463|FG000|Overall Study|Withdrawal by Subject|0|||
42391329|NCT03769194|76283464|FG001|Overall Study|Withdrawal by Subject|7|||
42391330|NCT03769194|76283465|FG002|Overall Study|Withdrawal by Subject|4|||
42391331|NCT03769194|76283466|FG003|Overall Study|Withdrawal by Subject|1|||
42391332|NCT03769194|76283463|FG000|Overall Study|moved from study area|0|||
42391333|NCT03769194|76283464|FG001|Overall Study|moved from study area|2|||
42391334|NCT03769194|76283465|FG002|Overall Study|moved from study area|1|||
42391335|NCT03769194|76283466|FG003|Overall Study|moved from study area|1|||
42391336|NCT03769194|76283463|FG000|Overall Study|Lost to Follow-up|3|||
42391337|NCT03769194|76283464|FG001|Overall Study|Lost to Follow-up|6|||
42391338|NCT03769194|76283465|FG002|Overall Study|Lost to Follow-up|3|||
42391339|NCT03769194|76283466|FG003|Overall Study|Lost to Follow-up|6|||
42391340|NCT03769194|76283463|FG000|Overall Study|other|1|||
42391341|NCT03769194|76283464|FG001|Overall Study|other|3|||
42391342|NCT03769194|76283465|FG002|Overall Study|other|0|||
42391343|NCT03769194|76283466|FG003|Overall Study|other|1|||
42391344|NCT01465022|76283492|FG000|Overall Study|Lost to Follow-up|15|||
42391345|NCT01465022|76283493|FG001|Overall Study|Lost to Follow-up|14|||
42391346|NCT01465022|76283494|FG002|Overall Study|Lost to Follow-up|0|||
42391347|NCT01465022|76283492|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
42391348|NCT01465022|76283493|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
42391349|NCT01465022|76283494|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
42391350|NCT01465022|76283492|FG000|Overall Study|Not Randomized|0|||
42391351|NCT01465022|76283493|FG001|Overall Study|Not Randomized|0|||
42391352|NCT01465022|76283494|FG002|Overall Study|Not Randomized|70|||
42391353|NCT01464788|76283538|FG000|Overall Study|Lost to Follow-up|0|||
42391354|NCT01464788|76283539|FG001|Overall Study|Lost to Follow-up|1|||
42391355|NCT01464788|76283540|FG002|Overall Study|Lost to Follow-up|0|||
42391356|NCT01464788|76283538|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
42391357|NCT01464788|76283539|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
42391358|NCT01464788|76283540|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
42391359|NCT01444898|76283550|FG000|Overall Study|Withdrawal by Subject|1|||
42391360|NCT01419626|76283572|FG000|Overall Study|Protocol Violation|3|||
42391361|NCT01419626|76283573|FG001|Overall Study|Protocol Violation|2|||
42391362|NCT01419626|76283574|FG002|Overall Study|Protocol Violation|2|||
42391363|NCT01419626|76283572|FG000|Overall Study|Withdrawal by Subject|1|||
42391364|NCT01419626|76283573|FG001|Overall Study|Withdrawal by Subject|0|||
42391365|NCT01419626|76283574|FG002|Overall Study|Withdrawal by Subject|0|||
42391366|NCT01419626|76283572|FG000|Overall Study|Lost to Follow-up|0|||
42391367|NCT01419626|76283573|FG001|Overall Study|Lost to Follow-up|1|||
42391368|NCT01419626|76283574|FG002|Overall Study|Lost to Follow-up|1|||
42391369|NCT01444742|76283613|FG000|Overall Study|Death|1|||
42391370|NCT01444430|76283813|FG000|Overall Study|Withdrawal by Subject|53|||
42391371|NCT01444430|76283814|FG001|Overall Study|Withdrawal by Subject|72|||
42391372|NCT01444430|76283813|FG000|Overall Study|Death|6|||
42391373|NCT01444430|76283814|FG001|Overall Study|Death|8|||
42391374|NCT01444430|76283813|FG000|Overall Study|Lost to Follow-up|2|||
42391375|NCT01444430|76283814|FG001|Overall Study|Lost to Follow-up|0|||
42391376|NCT01444430|76283813|FG000|Overall Study|CRF termination module not completed.|0|||
42391377|NCT01444430|76283814|FG001|Overall Study|CRF termination module not completed.|1|||
42391378|NCT01436162|76283890|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
42391379|NCT01436162|76283891|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
42391380|NCT01436162|76283892|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
42391381|NCT01436162|76283890|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
42112702|NCT00557856|75922767|FG008|Part 1: Dose Escalation Phase|Other|0|||
42112703|NCT00557856|75922759|FG000|Part 1: Dose Escalation Phase|Death|0|||
42112704|NCT00557856|75922760|FG001|Part 1: Dose Escalation Phase|Death|0|||
42391382|NCT01436162|76283891|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
42391383|NCT01436162|76283892|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
42391384|NCT01436162|76283890|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
42391385|NCT01436162|76283891|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
42391386|NCT01436162|76283892|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
42391387|NCT01436162|76283890|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
42391388|NCT01436162|76283891|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
42391389|NCT01436162|76283892|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
42391390|NCT01436162|76283890|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
42391391|NCT01436162|76283891|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
42391392|NCT01436162|76283892|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
42391393|NCT01436162|76283890|FG000|Single-blind Lead-in Phase|Other|107|||
42112705|NCT00557856|75922761|FG002|Part 1: Dose Escalation Phase|Death|0|||
42112706|NCT00557856|75922762|FG003|Part 1: Dose Escalation Phase|Death|0|||
42112707|NCT00557856|75922763|FG004|Part 1: Dose Escalation Phase|Death|0|||
42112708|NCT00557856|75922764|FG005|Part 1: Dose Escalation Phase|Death|1|||
42112709|NCT00557856|75922765|FG006|Part 1: Dose Escalation Phase|Death|0|||
42112710|NCT00557856|75922766|FG007|Part 1: Dose Escalation Phase|Death|0|||
42112711|NCT00557856|75922767|FG008|Part 1: Dose Escalation Phase|Death|0|||
42112712|NCT00557856|75922759|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
42112713|NCT00557856|75922760|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
42112714|NCT00557856|75922761|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
42112715|NCT00557856|75922762|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
42112716|NCT00557856|75922763|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
42112717|NCT00557856|75922764|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
42112718|NCT00557856|75922765|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
42112719|NCT00557856|75922766|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
42112720|NCT00557856|75922767|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
42112721|NCT00557856|75922759|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
42112722|NCT00557856|75922760|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
42112723|NCT00557856|75922761|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
42112724|NCT00557856|75922762|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
42112725|NCT00557856|75922763|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
42112726|NCT00557856|75922764|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
42112727|NCT00557856|75922765|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
42112728|NCT00557856|75922766|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
42112729|NCT00557856|75922767|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
42112730|NCT00557856|75922759|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
42112731|NCT00557856|75922760|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
42112732|NCT00557856|75922761|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
42112733|NCT00557856|75922762|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
42112734|NCT00557856|75922763|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
42112735|NCT00557856|75922764|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
42112736|NCT00557856|75922765|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
42112737|NCT00557856|75922766|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
42112738|NCT00557856|75922767|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
42112739|NCT00557856|75922759|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
42112740|NCT00557856|75922760|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
42112741|NCT00557856|75922761|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
42112742|NCT00557856|75922762|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
42112743|NCT00557856|75922763|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
42112744|NCT00557856|75922764|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
42112745|NCT00557856|75922765|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
42112746|NCT00557856|75922766|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
42112747|NCT00557856|75922767|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
42112748|NCT00557856|75922759|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
42112749|NCT00557856|75922760|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
42112750|NCT00557856|75922761|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
42112751|NCT00557856|75922762|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
42112752|NCT00557856|75922763|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
42112753|NCT00557856|75922764|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
42112754|NCT00557856|75922765|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
42112755|NCT00557856|75922766|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
42112756|NCT00557856|75922767|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
42112757|NCT00557856|75922759|FG000|Part 2: Exploratory Phase|Other|0|||
42112758|NCT00557856|75922760|FG001|Part 2: Exploratory Phase|Other|0|||
42112759|NCT00557856|75922761|FG002|Part 2: Exploratory Phase|Other|0|||
42112760|NCT00557856|75922762|FG003|Part 2: Exploratory Phase|Other|0|||
42112761|NCT00557856|75922763|FG004|Part 2: Exploratory Phase|Other|0|||
42112762|NCT00557856|75922764|FG005|Part 2: Exploratory Phase|Other|0|||
42112763|NCT00557856|75922765|FG006|Part 2: Exploratory Phase|Other|0|||
42112764|NCT00557856|75922766|FG007|Part 2: Exploratory Phase|Other|0|||
42112765|NCT00557856|75922767|FG008|Part 2: Exploratory Phase|Other|1|||
42112766|NCT00557856|75922759|FG000|Part 2: Exploratory Phase|Death|0|||
42112767|NCT00557856|75922760|FG001|Part 2: Exploratory Phase|Death|0|||
42112768|NCT00557856|75922761|FG002|Part 2: Exploratory Phase|Death|0|||
42112769|NCT00557856|75922762|FG003|Part 2: Exploratory Phase|Death|0|||
42112770|NCT00557856|75922763|FG004|Part 2: Exploratory Phase|Death|0|||
42112771|NCT00557856|75922764|FG005|Part 2: Exploratory Phase|Death|0|||
42112772|NCT00557856|75922765|FG006|Part 2: Exploratory Phase|Death|0|||
42112773|NCT00557856|75922766|FG007|Part 2: Exploratory Phase|Death|0|||
42112774|NCT00557856|75922767|FG008|Part 2: Exploratory Phase|Death|2|||
42112775|NCT00557856|75922759|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
42112776|NCT00557856|75922760|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
42112777|NCT00557856|75922761|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
42112778|NCT00557856|75922762|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
42112779|NCT00557856|75922763|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
42112780|NCT00557856|75922764|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
42112781|NCT00557856|75922765|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
42112782|NCT00557856|75922766|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
42112783|NCT00557856|75922767|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
42112784|NCT00191113|75922784|FG000|Core Study|Withdrawal by Subject|25|||
42112785|NCT00191113|75922785|FG001|Core Study|Withdrawal by Subject|9|||
42112786|NCT00191113|75922784|FG000|Core Study|Protocol Violation|6|||
42112787|NCT00191113|75922785|FG001|Core Study|Protocol Violation|2|||
42112788|NCT00191113|75922784|FG000|Core Study|Lost to Follow-up|3|||
42112789|NCT00191113|75922785|FG001|Core Study|Lost to Follow-up|0|||
42112790|NCT00191113|75922784|FG000|Core Study|Adverse Event|0|||
42112791|NCT00191113|75922785|FG001|Core Study|Adverse Event|2|||
42112792|NCT00191113|75922784|FG000|Core Study|Lack of Efficacy|0|||
42112793|NCT00191113|75922785|FG001|Core Study|Lack of Efficacy|2|||
42112794|NCT00191113|75922784|FG000|Core Study|Death|1|||
42112795|NCT00191113|75922785|FG001|Core Study|Death|0|||
42112796|NCT00608582|75922799|FG000|Overall Study|Lost to Follow-up|2|||
42112797|NCT00608582|75922800|FG001|Overall Study|Lost to Follow-up|0|||
42112798|NCT00608582|75922799|FG000|Overall Study|No Best Response in Phase 1 located|1|||
42112799|NCT00608582|75922800|FG001|Overall Study|No Best Response in Phase 1 located|1|||
42112800|NCT00608582|75922799|FG000|Overall Study|Illicit Drug Use|1|||
42112801|NCT00608582|75922800|FG001|Overall Study|Illicit Drug Use|0|||
42112802|NCT00608582|75922799|FG000|Overall Study|Early stage Design Change|0|||
42112803|NCT00608582|75922800|FG001|Overall Study|Early stage Design Change|3|||
42112804|NCT03965052|75922810|FG000|Overall Study|Protocol Violation|1|||
42112805|NCT03965052|75922811|FG001|Overall Study|Protocol Violation|0|||
42112806|NCT03964974|75922819|FG000|Overall Study|Lost to Follow-up|3|||
42112807|NCT03964974|75922820|FG001|Overall Study|Lost to Follow-up|2|||
42112808|NCT03964974|75922819|FG000|Overall Study|Withdrawal by Subject|0|||
42112809|NCT03964974|75922820|FG001|Overall Study|Withdrawal by Subject|3|||
42112810|NCT00606320|75922826|FG000|Overall Study|Adverse Event|3|||
42112811|NCT00606320|75922826|FG000|Overall Study|Lack of Efficacy|5|||
42112812|NCT00606320|75922826|FG000|Overall Study|Physician Decision|7|||
42112813|NCT00606320|75922826|FG000|Overall Study|Protocol Violation|8|||
42112814|NCT00606320|75922826|FG000|Overall Study|Withdrawal by Subject|10|||
42112815|NCT00606320|75922826|FG000|Overall Study|Progression to depressive phase|4|||
42112816|NCT00528411|75922833|FG000|Overall Study|Adverse Event|4|||
42112817|NCT00528411|75922834|FG001|Overall Study|Adverse Event|0|||
42112818|NCT00528411|75922835|FG002|Overall Study|Adverse Event|1|||
42112819|NCT00528411|75922833|FG000|Overall Study|Incorrect Enrolment|1|||
42112820|NCT00528411|75922834|FG001|Overall Study|Incorrect Enrolment|1|||
42112821|NCT00528411|75922835|FG002|Overall Study|Incorrect Enrolment|0|||
42112822|NCT00528411|75922833|FG000|Overall Study|Severe non-compliance to protocol|0|||
42112823|NCT00528411|75922834|FG001|Overall Study|Severe non-compliance to protocol|1|||
42112824|NCT00528411|75922835|FG002|Overall Study|Severe non-compliance to protocol|0|||
42112825|NCT00528411|75922833|FG000|Overall Study|Prior commitment medication|0|||
42112826|NCT00528411|75922834|FG001|Overall Study|Prior commitment medication|1|||
42112827|NCT00528411|75922835|FG002|Overall Study|Prior commitment medication|0|||
42112828|NCT00136357|75922845|FG000|Overall Study|Withdrawal by Subject|3|||
42112829|NCT00136357|75922846|FG001|Overall Study|Withdrawal by Subject|2|||
42112830|NCT00129649|75922854|FG000|Overall Study|Withdrawal by Subject|76|||
42112831|NCT00129649|75922855|FG001|Overall Study|Withdrawal by Subject|65|||
42112832|NCT00187135|75922867|FG000|Visit One|Withdrawal by Subject|1|||
42112833|NCT00187135|75922868|FG001|Visit One|Withdrawal by Subject|0|||
42112834|NCT00187135|75922869|FG002|Visit One|Withdrawal by Subject|0|||
42112835|NCT00187135|75922870|FG003|Visit One|Withdrawal by Subject|0|||
42112836|NCT00187135|75922871|FG004|Visit One|Withdrawal by Subject|0|||
42112837|NCT00187135|75922872|FG005|Visit One|Withdrawal by Subject|1|||
42112838|NCT00187135|75922867|FG000|Visit One|Physician Decision|3|||
42112839|NCT00187135|75922868|FG001|Visit One|Physician Decision|1|||
42112840|NCT00187135|75922869|FG002|Visit One|Physician Decision|0|||
42112841|NCT00187135|75922870|FG003|Visit One|Physician Decision|0|||
42112842|NCT00187135|75922871|FG004|Visit One|Physician Decision|0|||
42112843|NCT00187135|75922872|FG005|Visit One|Physician Decision|1|||
42112844|NCT00187135|75922867|FG000|Visit Two|Death|0|||
42112845|NCT00187135|75922868|FG001|Visit Two|Death|0|||
42112846|NCT00187135|75922869|FG002|Visit Two|Death|0|||
42112847|NCT00187135|75922870|FG003|Visit Two|Death|1|||
42112848|NCT00187135|75922871|FG004|Visit Two|Death|0|||
42112849|NCT00187135|75922872|FG005|Visit Two|Death|1|||
42112850|NCT00187135|75922867|FG000|Visit Two|Physician Decision|1|||
42112851|NCT00187135|75922868|FG001|Visit Two|Physician Decision|0|||
42112852|NCT00187135|75922869|FG002|Visit Two|Physician Decision|0|||
42112853|NCT00187135|75922870|FG003|Visit Two|Physician Decision|0|||
42112854|NCT00187135|75922871|FG004|Visit Two|Physician Decision|0|||
42112855|NCT00187135|75922872|FG005|Visit Two|Physician Decision|0|||
42112856|NCT00187135|75922867|FG000|Visit Two|Withdrawal by Subject|1|||
42112857|NCT00187135|75922868|FG001|Visit Two|Withdrawal by Subject|1|||
42112858|NCT00187135|75922869|FG002|Visit Two|Withdrawal by Subject|1|||
42112859|NCT00187135|75922870|FG003|Visit Two|Withdrawal by Subject|0|||
42112860|NCT00187135|75922871|FG004|Visit Two|Withdrawal by Subject|1|||
42112861|NCT00187135|75922872|FG005|Visit Two|Withdrawal by Subject|1|||
42112862|NCT00187135|75922867|FG000|Visit Two|Study Discontinued|3|||
42112863|NCT00187135|75922868|FG001|Visit Two|Study Discontinued|2|||
42112864|NCT00187135|75922869|FG002|Visit Two|Study Discontinued|1|||
42112865|NCT00187135|75922870|FG003|Visit Two|Study Discontinued|7|||
42112866|NCT00187135|75922871|FG004|Visit Two|Study Discontinued|5|||
42112867|NCT00187135|75922872|FG005|Visit Two|Study Discontinued|6|||
42112868|NCT00187135|75922867|FG000|Visit Three|Death|0|||
42112869|NCT00187135|75922868|FG001|Visit Three|Death|0|||
42112870|NCT00187135|75922869|FG002|Visit Three|Death|1|||
42112871|NCT00187135|75922870|FG003|Visit Three|Death|0|||
42112872|NCT00187135|75922871|FG004|Visit Three|Death|1|||
42112873|NCT00187135|75922872|FG005|Visit Three|Death|0|||
42112874|NCT00187135|75922867|FG000|Visit Three|Withdrawal by Subject|0|||
42112875|NCT00187135|75922868|FG001|Visit Three|Withdrawal by Subject|1|||
42112876|NCT00187135|75922869|FG002|Visit Three|Withdrawal by Subject|1|||
42112877|NCT00187135|75922870|FG003|Visit Three|Withdrawal by Subject|2|||
42112878|NCT00187135|75922871|FG004|Visit Three|Withdrawal by Subject|0|||
42112879|NCT00187135|75922872|FG005|Visit Three|Withdrawal by Subject|0|||
42112880|NCT00187135|75922867|FG000|Visit Three|Study Discontinued|7|||
42112881|NCT00187135|75922868|FG001|Visit Three|Study Discontinued|6|||
42112882|NCT00187135|75922869|FG002|Visit Three|Study Discontinued|7|||
42112883|NCT00187135|75922870|FG003|Visit Three|Study Discontinued|7|||
42112884|NCT00187135|75922871|FG004|Visit Three|Study Discontinued|7|||
42112885|NCT00187135|75922872|FG005|Visit Three|Study Discontinued|6|||
42112886|NCT00528021|75922888|FG000|Overall Study|Lack of Efficacy|17|||
42112887|NCT00528021|75922889|FG001|Overall Study|Lack of Efficacy|13|||
42112888|NCT00528021|75922890|FG002|Overall Study|Lack of Efficacy|7|||
42112889|NCT00528021|75922891|FG003|Overall Study|Lack of Efficacy|9|||
42112890|NCT00560352|75922904|FG000|Overall Study|Adverse event unrelated to study drug|2|||
42112891|NCT00560352|75922905|FG001|Overall Study|Adverse event unrelated to study drug|1|||
42112892|NCT00560352|75922906|FG002|Overall Study|Adverse event unrelated to study drug|1|||
42112893|NCT00560352|75922904|FG000|Overall Study|Study drug toxicity|3|||
42112894|NCT00560352|75922905|FG001|Overall Study|Study drug toxicity|0|||
42112895|NCT00560352|75922906|FG002|Overall Study|Study drug toxicity|1|||
42112896|NCT00560352|75922904|FG000|Overall Study|Disease progression|0|||
42112897|NCT00560352|75922905|FG001|Overall Study|Disease progression|1|||
42112898|NCT00560352|75922906|FG002|Overall Study|Disease progression|1|||
42112899|NCT00560352|75922904|FG000|Overall Study|Withdrawal by Subject|1|||
42112900|NCT00560352|75922905|FG001|Overall Study|Withdrawal by Subject|1|||
42112901|NCT00560352|75922906|FG002|Overall Study|Withdrawal by Subject|1|||
42112902|NCT00560352|75922904|FG000|Overall Study|Maximum clinical benefit|1|||
42112903|NCT00560352|75922905|FG001|Overall Study|Maximum clinical benefit|0|||
42112904|NCT00560352|75922906|FG002|Overall Study|Maximum clinical benefit|0|||
42112905|NCT00527787|75922920|FG000|Overall Study|Adverse Event|14|||
42112906|NCT00527787|75922921|FG001|Overall Study|Adverse Event|24|||
42112907|NCT00527787|75922920|FG000|Overall Study|Withdrawal by Subject|13|||
42112908|NCT00527787|75922921|FG001|Overall Study|Withdrawal by Subject|25|||
42112909|NCT00527787|75922920|FG000|Overall Study|Lost to Follow-up|5|||
42112910|NCT00527787|75922921|FG001|Overall Study|Lost to Follow-up|2|||
42112911|NCT00527787|75922920|FG000|Overall Study|Duodenal Ulcer|1|||
42112912|NCT00527787|75922921|FG001|Overall Study|Duodenal Ulcer|10|||
42112913|NCT00527787|75922920|FG000|Overall Study|misc|5|||
42112914|NCT00527787|75922921|FG001|Overall Study|misc|2|||
42112915|NCT00608426|75922929|FG000|Overall Study|Death|32|||
42112916|NCT00608426|75922930|FG001|Overall Study|Death|36|||
42112917|NCT00608426|75922929|FG000|Overall Study|Lost to Follow-up|485|||
42112918|NCT00608426|75922930|FG001|Overall Study|Lost to Follow-up|521|||
42112919|NCT00608426|75922929|FG000|Overall Study|refused, health issues, wrong address|319|||
42112920|NCT00608426|75922930|FG001|Overall Study|refused, health issues, wrong address|348|||
42112921|NCT00557076|75922938|FG000|Overall Study|Unblinding|0|||
42112922|NCT00557076|75922939|FG001|Overall Study|Unblinding|1|||
42112923|NCT00129259|75922947|FG000|Overall Study|Lost to Follow-up|1|||
42112924|NCT00129259|75922948|FG001|Overall Study|Lost to Follow-up|1|||
42112925|NCT00129259|75922947|FG000|Overall Study|Withdrawal by Subject|2|||
42112926|NCT00129259|75922948|FG001|Overall Study|Withdrawal by Subject|1|||
42112927|NCT00129259|75922947|FG000|Overall Study|Only available minimal phone assessments|0|||
42112928|NCT00129259|75922948|FG001|Overall Study|Only available minimal phone assessments|1|||
42112929|NCT00186901|75922957|FG000|Overall Study|Pregnancy|6|||
42112930|NCT00186901|75922958|FG001|Overall Study|Pregnancy|3|||
42112931|NCT00186901|75922959|FG002|Overall Study|Pregnancy|0|||
42112932|NCT00186901|75922957|FG000|Overall Study|Lost to Follow-up|6|||
42112933|NCT00186901|75922958|FG001|Overall Study|Lost to Follow-up|3|||
42112934|NCT00186901|75922959|FG002|Overall Study|Lost to Follow-up|0|||
42112935|NCT00186901|75922957|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
42112936|NCT00186901|75922958|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
42112937|NCT00186901|75922959|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
42112938|NCT00186901|75922957|FG000|Overall Study|ALL relapse or second malignancy|1|||
42112939|NCT00186901|75922958|FG001|Overall Study|ALL relapse or second malignancy|2|||
42112940|NCT00186901|75922959|FG002|Overall Study|ALL relapse or second malignancy|0|||
42112941|NCT00186901|75922957|FG000|Overall Study|Withdrawal by Subject|4|||
42112942|NCT00186901|75922958|FG001|Overall Study|Withdrawal by Subject|5|||
42112943|NCT00186901|75922959|FG002|Overall Study|Withdrawal by Subject|0|||
42112944|NCT00186901|75922957|FG000|Overall Study|Open label|3|||
42112945|NCT00186901|75922958|FG001|Overall Study|Open label|2|||
42112946|NCT00186901|75922959|FG002|Overall Study|Open label|0|||
42112947|NCT00186901|75922957|FG000|Overall Study|Limited adherence to study requirements|20|||
42112948|NCT00186901|75922958|FG001|Overall Study|Limited adherence to study requirements|23|||
42112949|NCT00186901|75922959|FG002|Overall Study|Limited adherence to study requirements|0|||
42112950|NCT00186901|75922957|FG000|Overall Study|Bone Mineral Density > 0|0|||
42112951|NCT00186901|75922958|FG001|Overall Study|Bone Mineral Density > 0|0|||
42112952|NCT00186901|75922959|FG002|Overall Study|Bone Mineral Density > 0|149|||
42112953|NCT00186121|75922996|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
42112954|NCT00186121|75922996|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
42112955|NCT00186121|75922996|FG000|Overall Study|Not eligible (no treatment)|1|||
42112956|NCT00186043|75923002|FG000|Overall Study|Lack of Efficacy|1|||
42112957|NCT00186043|75923003|FG001|Overall Study|Lack of Efficacy|3|||
42112958|NCT00186043|75923002|FG000|Overall Study|Lost to Follow-up|4|||
42112959|NCT00186043|75923003|FG001|Overall Study|Lost to Follow-up|6|||
42112960|NCT00186043|75923002|FG000|Overall Study|Withdrawal by Subject|1|||
42112961|NCT00186043|75923003|FG001|Overall Study|Withdrawal by Subject|0|||
42112962|NCT00186043|75923002|FG000|Overall Study|Adverse Event|7|||
42112963|NCT00186043|75923003|FG001|Overall Study|Adverse Event|3|||
42112964|NCT00186043|75923002|FG000|Overall Study|Protocol Violation|2|||
42112965|NCT00186043|75923003|FG001|Overall Study|Protocol Violation|1|||
42112966|NCT00185965|75923011|FG000|Overall Study|Adverse Event|0|||
42112967|NCT00185965|75923012|FG001|Overall Study|Adverse Event|1|||
42112968|NCT00607880|75923020|FG000|Overall Study|Unable to place port due to occlusion|1|||
42112969|NCT00607880|75923021|FG001|Overall Study|Unable to place port due to occlusion|0|||
42112970|NCT00127933|75923029|FG000|Overall Study|Randomized but not dosed|1|||
42112971|NCT00127933|75923030|FG001|Overall Study|Randomized but not dosed|0|||
42112972|NCT03875313|75923041|FG000|Overall Study|Withdrawal by Subject|1|||
42112973|NCT03875313|75923042|FG001|Overall Study|Withdrawal by Subject|3|||
42112974|NCT03875313|75923043|FG002|Overall Study|Withdrawal by Subject|0|||
42112975|NCT03875313|75923044|FG003|Overall Study|Withdrawal by Subject|0|||
42112976|NCT03875313|75923045|FG004|Overall Study|Withdrawal by Subject|0|||
42112977|NCT03875313|75923041|FG000|Overall Study|Death|0|||
42112978|NCT03875313|75923042|FG001|Overall Study|Death|0|||
42112979|NCT03875313|75923043|FG002|Overall Study|Death|0|||
42112980|NCT03875313|75923044|FG003|Overall Study|Death|0|||
42112981|NCT03875313|75923045|FG004|Overall Study|Death|1|||
42112982|NCT03875313|75923041|FG000|Overall Study|Lost to Follow-up|0|||
42112983|NCT03875313|75923042|FG001|Overall Study|Lost to Follow-up|0|||
42112984|NCT03875313|75923043|FG002|Overall Study|Lost to Follow-up|0|||
42112985|NCT03875313|75923044|FG003|Overall Study|Lost to Follow-up|0|||
42112986|NCT03875313|75923045|FG004|Overall Study|Lost to Follow-up|1|||
42112987|NCT03875313|75923041|FG000|Overall Study|Study Termination by Sponsor|0|||
42112988|NCT03875313|75923042|FG001|Overall Study|Study Termination by Sponsor|1|||
42112989|NCT03875313|75923043|FG002|Overall Study|Study Termination by Sponsor|1|||
42112990|NCT03875313|75923044|FG003|Overall Study|Study Termination by Sponsor|0|||
42112991|NCT03875313|75923045|FG004|Overall Study|Study Termination by Sponsor|1|||
42112992|NCT03875313|75923041|FG000|Overall Study|New Anticancer Treatment|0|||
42112993|NCT03875313|75923042|FG001|Overall Study|New Anticancer Treatment|1|||
42112994|NCT03875313|75923043|FG002|Overall Study|New Anticancer Treatment|2|||
42112995|NCT03875313|75923044|FG003|Overall Study|New Anticancer Treatment|1|||
42112996|NCT03875313|75923045|FG004|Overall Study|New Anticancer Treatment|0|||
42112997|NCT03875313|75923041|FG000|Overall Study|Other, Not Specified|2|||
42112998|NCT03875313|75923042|FG001|Overall Study|Other, Not Specified|11|||
42112999|NCT03875313|75923043|FG002|Overall Study|Other, Not Specified|3|||
42113000|NCT03875313|75923044|FG003|Overall Study|Other, Not Specified|3|||
42113001|NCT03875313|75923045|FG004|Overall Study|Other, Not Specified|1|||
42113002|NCT04796415|75923088|FG000|Overall Study|not interested|12|||
42113003|NCT04796415|75923088|FG000|Overall Study|health issue|8|||
42113004|NCT04796415|75923088|FG000|Overall Study|Other|4|||
42113005|NCT04796415|75923088|FG000|Overall Study|discharged from home health service|3|||
42113006|NCT04796415|75923088|FG000|Overall Study|re-hospitalization|2|||
42113007|NCT04796415|75923088|FG000|Overall Study|moving to nursing home|1|||
42113008|NCT04796415|75923088|FG000|Overall Study|lost contact|1|||
42113009|NCT04678557|75923095|FG000|Overall Study|Withdrawal by Subject|1|||
42113010|NCT04678557|75923096|FG001|Overall Study|Withdrawal by Subject|0|||
42113011|NCT04678557|75923095|FG000|Overall Study|Lack of Efficacy|0|||
42113012|NCT04678557|75923096|FG001|Overall Study|Lack of Efficacy|13|||
42113013|NCT04678557|75923095|FG000|Overall Study|Safety Evaluation|0|||
42113014|NCT04678557|75923096|FG001|Overall Study|Safety Evaluation|1|||
42113015|NCT04230980|75923117|FG000|Overall Study|Lost to Follow-up|1|||
42113016|NCT04230980|75923118|FG001|Overall Study|Lost to Follow-up|2|||
42113017|NCT04230980|75923117|FG000|Overall Study|Adverse Event|0|||
42113018|NCT04230980|75923118|FG001|Overall Study|Adverse Event|1|||
42113019|NCT03997383|75923144|FG000|Double-blind Treatment Period|Adverse Event|4|||
42113020|NCT03997383|75923145|FG001|Double-blind Treatment Period|Adverse Event|3|||
42113021|NCT03997383|75923144|FG000|Double-blind Treatment Period|Death|4|||
42113022|NCT03997383|75923145|FG001|Double-blind Treatment Period|Death|4|||
42113023|NCT03997383|75923144|FG000|Double-blind Treatment Period|Physician Decision|2|||
42113024|NCT03997383|75923145|FG001|Double-blind Treatment Period|Physician Decision|0|||
42113025|NCT03997383|75923144|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
42113026|NCT03997383|75923145|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
42113027|NCT03997383|75923144|FG000|Open-label Extension Period|Ongoing|148|||
42113028|NCT03997383|75923145|FG001|Open-label Extension Period|Ongoing|151|||
42113029|NCT03997383|75923144|FG000|Open-label Extension Period|Adverse Event|4|||
42113030|NCT03997383|75923145|FG001|Open-label Extension Period|Adverse Event|1|||
42113031|NCT03997383|75923144|FG000|Open-label Extension Period|Death|8|||
42113032|NCT03997383|75923145|FG001|Open-label Extension Period|Death|9|||
42113033|NCT03997383|75923144|FG000|Open-label Extension Period|Physician Decision|1|||
42113034|NCT03997383|75923145|FG001|Open-label Extension Period|Physician Decision|1|||
42113035|NCT03997383|75923144|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
42113036|NCT03997383|75923145|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
42113037|NCT03997383|75923144|FG000|Open-label Extension Period|Reason Not Specified|2|||
42113038|NCT03997383|75923145|FG001|Open-label Extension Period|Reason Not Specified|0|||
42113039|NCT03697720|75923187|FG000|Overall Study|Lost to Follow-up|7|||
42113040|NCT03635983|75923193|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
42113041|NCT03635983|75923194|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
42113042|NCT03635983|75923193|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
42113043|NCT03635983|75923194|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
42113044|NCT03635983|75923193|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
42113045|NCT03635983|75923194|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
42113046|NCT03635983|75923193|FG000|Pre-Treatment Period|Other reasons|1|||
42113047|NCT03635983|75923194|FG001|Pre-Treatment Period|Other reasons|2|||
42113048|NCT03635983|75923193|FG000|Pre-Treatment Period|Disease Progression|0|||
42113049|NCT03635983|75923194|FG001|Pre-Treatment Period|Disease Progression|1|||
42113050|NCT03635983|75923193|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
42113051|NCT03635983|75923194|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
42113052|NCT03635983|75923193|FG000|Treatment Period|Completed treatment period|13|||
42113053|NCT03635983|75923194|FG001|Treatment Period|Completed treatment period|20|||
42113054|NCT03635983|75923193|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
42113055|NCT03635983|75923194|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
42113056|NCT03635983|75923193|FG000|Treatment Period|Withdrawal by Subject|2|||
42113057|NCT03635983|75923194|FG001|Treatment Period|Withdrawal by Subject|4|||
42113058|NCT03635983|75923193|FG000|Treatment Period|Death|3|||
42113059|NCT03635983|75923194|FG001|Treatment Period|Death|4|||
42113060|NCT03635983|75923193|FG000|Treatment Period|Poor/Non-compliance|1|||
42113061|NCT03635983|75923194|FG001|Treatment Period|Poor/Non-compliance|0|||
42113062|NCT03635983|75923193|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
42113063|NCT03635983|75923194|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
42113064|NCT03635983|75923193|FG000|Treatment Period|Other reasons|5|||
42113065|NCT03635983|75923194|FG001|Treatment Period|Other reasons|2|||
42113066|NCT03635983|75923193|FG000|Treatment Period|Disease progression|184|||
42113067|NCT03635983|75923194|FG001|Treatment Period|Disease progression|168|||
42113068|NCT03635983|75923193|FG000|Treatment Period|Study drug toxicity|26|||
42113069|NCT03635983|75923194|FG001|Treatment Period|Study drug toxicity|29|||
42113070|NCT03635983|75923193|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
42113071|NCT03635983|75923194|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
42113072|NCT03635983|75923193|FG000|Treatment Period|Maximum clinical benefit|3|||
42113073|NCT03635983|75923194|FG001|Treatment Period|Maximum clinical benefit|2|||
42113074|NCT03551496|75923211|FG000|Overall Study|Death|11|||
42113075|NCT03551496|75923212|FG001|Overall Study|Death|7|||
42113076|NCT03551496|75923211|FG000|Overall Study|Withdrawal by Subject|4|||
42113077|NCT03551496|75923212|FG001|Overall Study|Withdrawal by Subject|3|||
42113078|NCT03551496|75923211|FG000|Overall Study|Other Reasons|1|||
42113079|NCT03551496|75923212|FG001|Overall Study|Other Reasons|0|||
42113080|NCT03517449|75923220|FG000|Overall Study|Death|184|||
42113081|NCT03517449|75923221|FG001|Overall Study|Death|236|||
42113082|NCT03517449|75923220|FG000|Overall Study|Lost to Follow-up|0|||
42113083|NCT03517449|75923221|FG001|Overall Study|Lost to Follow-up|2|||
42113084|NCT03517449|75923220|FG000|Overall Study|Withdrawal by Subject|7|||
42113085|NCT03517449|75923221|FG001|Overall Study|Withdrawal by Subject|26|||
42113086|NCT03517449|75923220|FG000|Overall Study|Participants Ongoing|220|||
42113087|NCT03517449|75923221|FG001|Overall Study|Participants Ongoing|152|||
42113088|NCT03257631|75923239|FG000|Overall Study|Death|8|||
42113089|NCT03257631|75923240|FG001|Overall Study|Death|5|||
42113090|NCT03257631|75923241|FG002|Overall Study|Death|13|||
42113091|NCT03257631|75923242|FG003|Overall Study|Death|5|||
42113092|NCT03257631|75923239|FG000|Overall Study|Progressive Disease|0|||
42113093|NCT03257631|75923240|FG001|Overall Study|Progressive Disease|0|||
42113094|NCT03257631|75923241|FG002|Overall Study|Progressive Disease|1|||
42113095|NCT03257631|75923242|FG003|Overall Study|Progressive Disease|0|||
42113096|NCT03257631|75923239|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
42113097|NCT03257631|75923240|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
42113098|NCT03257631|75923241|FG002|Overall Study|Withdrawal by Parent/Guardian|4|||
42113099|NCT03257631|75923242|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
42113100|NCT03257631|75923239|FG000|Overall Study|Lost to Follow-up|0|||
42113101|NCT03257631|75923240|FG001|Overall Study|Lost to Follow-up|0|||
42113102|NCT03257631|75923241|FG002|Overall Study|Lost to Follow-up|1|||
42113103|NCT03257631|75923242|FG003|Overall Study|Lost to Follow-up|0|||
42113104|NCT03257631|75923239|FG000|Overall Study|Still on Study|3|||
42113105|NCT03257631|75923240|FG001|Overall Study|Still on Study|2|||
42113106|NCT03257631|75923241|FG002|Overall Study|Still on Study|4|||
42113107|NCT03257631|75923242|FG003|Overall Study|Still on Study|4|||
42113108|NCT03055767|75923254|FG000|Open-Label Period|Lost to Follow-up|0|||
42113109|NCT03055767|75923255|FG001|Open-Label Period|Lost to Follow-up|0|||
42113110|NCT03055767|75923256|FG002|Open-Label Period|Lost to Follow-up|2|||
42113111|NCT03055767|75923257|FG003|Open-Label Period|Lost to Follow-up|0|||
42113112|NCT03055767|75923254|FG000|Open-Label Period|Withdrawal by Subject|0|||
42113113|NCT03055767|75923255|FG001|Open-Label Period|Withdrawal by Subject|0|||
42113114|NCT03055767|75923256|FG002|Open-Label Period|Withdrawal by Subject|0|||
42113115|NCT03055767|75923257|FG003|Open-Label Period|Withdrawal by Subject|1|||
42113116|NCT02702414|75923274|FG000|Overall Study|Death|77|||
42113117|NCT02702414|75923275|FG001|Overall Study|Death|34|||
42113118|NCT02702414|75923274|FG000|Overall Study|Lost to Follow-up|0|||
42113119|NCT02702414|75923275|FG001|Overall Study|Lost to Follow-up|1|||
42113120|NCT02702414|75923274|FG000|Overall Study|Withdrawal by Subject|0|||
42113121|NCT02702414|75923275|FG001|Overall Study|Withdrawal by Subject|1|||
42113122|NCT02702414|75923274|FG000|Overall Study|Participants Ongoing in Study|27|||
42113123|NCT02702414|75923275|FG001|Overall Study|Participants Ongoing in Study|15|||
42113124|NCT02702414|75923274|FG000|Overall Study|Not Treated|1|||
42113125|NCT02702414|75923275|FG001|Overall Study|Not Treated|0|||
42113126|NCT01064479|75923305|FG000|Overall Study|Death|10|||
42113127|NCT01064479|75923306|FG001|Overall Study|Death|11|||
42113128|NCT01064479|75923305|FG000|Overall Study|Withdrawal by Subject|2|||
42113129|NCT01064479|75923306|FG001|Overall Study|Withdrawal by Subject|2|||
42113130|NCT01064479|75923305|FG000|Overall Study|Disease progression|1|||
42113131|NCT01064479|75923306|FG001|Overall Study|Disease progression|1|||
42113132|NCT01064479|75923305|FG000|Overall Study|Toxicity|1|||
42113133|NCT01064479|75923306|FG001|Overall Study|Toxicity|1|||
42113134|NCT01064479|75923305|FG000|Overall Study|Other|1|||
42113135|NCT01064479|75923306|FG001|Overall Study|Other|2|||
42113136|NCT00556998|75923320|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
42113137|NCT00556998|75923320|FG000|Voriconazole Intravenous (IV)|Other|4|||
42113138|NCT00556998|75923320|FG000|Voriconazole Oral|Adverse Event|1|||
42113139|NCT00556998|75923320|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
42113140|NCT00528801|75923330|FG000|Overall Study|Withdrawal by Subject|1|||
42113141|NCT00528801|75923331|FG001|Overall Study|Withdrawal by Subject|1|||
42113142|NCT00528801|75923330|FG000|Overall Study|Protocol Violation|11|||
42113143|NCT00528801|75923331|FG001|Overall Study|Protocol Violation|5|||
42113144|NCT00528801|75923330|FG000|Overall Study|Lost to Follow-up|15|||
42113145|NCT00528801|75923331|FG001|Overall Study|Lost to Follow-up|4|||
42113146|NCT00528801|75923330|FG000|Overall Study|Administrative Reasons|0|||
42113147|NCT00528801|75923331|FG001|Overall Study|Administrative Reasons|1|||
42113148|NCT00527397|75923337|FG000|Overall Study|Adverse Event|3|||
42113149|NCT00527397|75923337|FG000|Overall Study|Lack of Efficacy|1|||
42113150|NCT00527397|75923337|FG000|Overall Study|Protocol Violation|1|||
42113151|NCT00527397|75923337|FG000|Overall Study|Withdrawal by Subject|6|||
42113152|NCT00527397|75923337|FG000|Overall Study|Study terminated by sponsor|13|||
42113153|NCT00527319|75923347|FG000|Overall Study|Withdrawal by Subject|5|||
42113154|NCT00527319|75923348|FG001|Overall Study|Withdrawal by Subject|0|||
42113155|NCT00527319|75923349|FG002|Overall Study|Withdrawal by Subject|1|||
42113156|NCT00527319|75923347|FG000|Overall Study|Lost to Follow-up|1|||
42113157|NCT00527319|75923348|FG001|Overall Study|Lost to Follow-up|0|||
42113158|NCT00527319|75923349|FG002|Overall Study|Lost to Follow-up|0|||
42113159|NCT00527319|75923347|FG000|Overall Study|Death|0|||
42113160|NCT00527319|75923348|FG001|Overall Study|Death|3|||
42113161|NCT00527319|75923349|FG002|Overall Study|Death|1|||
42113162|NCT00527319|75923347|FG000|Overall Study|Intercurrent Medical Illness|0|||
42113163|NCT00527319|75923348|FG001|Overall Study|Intercurrent Medical Illness|1|||
42113164|NCT00527319|75923349|FG002|Overall Study|Intercurrent Medical Illness|3|||
42113165|NCT00527319|75923347|FG000|Overall Study|Adverse Event|0|||
42113166|NCT00527319|75923348|FG001|Overall Study|Adverse Event|0|||
42113167|NCT00527319|75923349|FG002|Overall Study|Adverse Event|1|||
42113168|NCT00562302|75923359|FG000|Overall Study|Lost to Follow-up|3|||
42113169|NCT00562302|75923360|FG001|Overall Study|Lost to Follow-up|3|||
42113170|NCT00562302|75923359|FG000|Overall Study|Adverse Event|0|||
42113171|NCT00562302|75923360|FG001|Overall Study|Adverse Event|6|||
42113172|NCT00562302|75923359|FG000|Overall Study|Non-compliance|1|||
42113173|NCT00562302|75923360|FG001|Overall Study|Non-compliance|2|||
42113174|NCT00562302|75923359|FG000|Overall Study|Withdrawal by Subject|7|||
42113175|NCT00562302|75923360|FG001|Overall Study|Withdrawal by Subject|8|||
42113176|NCT00562302|75923359|FG000|Overall Study|Death|1|||
42113177|NCT00562302|75923360|FG001|Overall Study|Death|2|||
42113178|NCT00562302|75923359|FG000|Overall Study|Lung resection prior to study completion|7|||
42113179|NCT00562302|75923360|FG001|Overall Study|Lung resection prior to study completion|7|||
42113180|NCT00562302|75923359|FG000|Overall Study|Not stated|1|||
42113181|NCT00562302|75923360|FG001|Overall Study|Not stated|4|||
42113182|NCT00134719|75923369|FG000|Primary Vaccination Phase|Adverse Event|4|||
42113183|NCT00134719|75923370|FG001|Primary Vaccination Phase|Adverse Event|0|||
42113184|NCT00134719|75923371|FG002|Primary Vaccination Phase|Adverse Event|0|||
42113185|NCT00134719|75923369|FG000|Primary Vaccination Phase|Protocol Violation|1|||
42113186|NCT00134719|75923370|FG001|Primary Vaccination Phase|Protocol Violation|0|||
42113187|NCT00134719|75923371|FG002|Primary Vaccination Phase|Protocol Violation|0|||
42113188|NCT00134719|75923369|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
42113189|NCT00134719|75923370|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
42113190|NCT00134719|75923371|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
42113191|NCT00134719|75923369|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
42113192|NCT00134719|75923370|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
42113193|NCT00134719|75923371|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
42113194|NCT00134719|75923369|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
42113195|NCT00134719|75923370|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
42113196|NCT00134719|75923371|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
42113197|NCT00134719|75923369|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
42113198|NCT00134719|75923370|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
42113199|NCT00134719|75923371|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
42113200|NCT00526071|75923379|FG000|Overall Study|Adverse Event|1|||
42113201|NCT00526071|75923379|FG000|Overall Study|Withdrawal by Subject|1|||
42113202|NCT00526071|75923379|FG000|Overall Study|Lack of Response to Study Drug|4|||
42113203|NCT00525915|75923389|FG000|Overall Study|Non-Compliance|0|||
42113204|NCT00525915|75923390|FG001|Overall Study|Non-Compliance|1|||
42113205|NCT00525915|75923389|FG000|Overall Study|Disease Progression|5|||
42113206|NCT00525915|75923390|FG001|Overall Study|Disease Progression|6|||
42113207|NCT00525915|75923389|FG000|Overall Study|Withdrawal by Subject|1|||
42113208|NCT00525915|75923390|FG001|Overall Study|Withdrawal by Subject|0|||
42113209|NCT00525915|75923389|FG000|Overall Study|Refused Surgery|1|||
42113210|NCT00525915|75923390|FG001|Overall Study|Refused Surgery|2|||
42113211|NCT00525915|75923389|FG000|Overall Study|Unrelated illness|1|||
42113212|NCT00525915|75923390|FG001|Overall Study|Unrelated illness|0|||
42113213|NCT00521079|75923398|FG000|Overall Study|Adverse Event|7|||
42113214|NCT00521079|75923399|FG001|Overall Study|Adverse Event|1|||
42113215|NCT00521079|75923398|FG000|Overall Study|Lost to Follow-up|2|||
42113216|NCT00521079|75923399|FG001|Overall Study|Lost to Follow-up|1|||
42113217|NCT00521079|75923398|FG000|Overall Study|Withdrawal by Subject|5|||
42113218|NCT00521079|75923399|FG001|Overall Study|Withdrawal by Subject|3|||
42113219|NCT00521001|75923405|FG000|Overall Study|Ineligible|1|||
42391394|NCT01436162|76283891|FG001|Single-blind Lead-in Phase|Other|0|||
42391395|NCT01436162|76283892|FG002|Single-blind Lead-in Phase|Other|0|||
42391396|NCT01436162|76283890|FG000|Randomized Phase|Adverse Event|1|||
42391397|NCT01436162|76283891|FG001|Randomized Phase|Adverse Event|5|||
42391398|NCT01436162|76283892|FG002|Randomized Phase|Adverse Event|6|||
42113220|NCT00134563|75923412|FG000|Overall Study|Not treated due to protocol violation|0|||
42113221|NCT00134563|75923413|FG001|Overall Study|Not treated due to protocol violation|1|||
42113222|NCT00134563|75923414|FG002|Overall Study|Not treated due to protocol violation|1|||
42113223|NCT00134563|75923412|FG000|Overall Study|Adverse Event|29|||
42113224|NCT00134563|75923413|FG001|Overall Study|Adverse Event|37|||
42113225|NCT00134563|75923414|FG002|Overall Study|Adverse Event|38|||
42113226|NCT00134563|75923412|FG000|Overall Study|Lack of Efficacy|24|||
42113227|NCT00134563|75923413|FG001|Overall Study|Lack of Efficacy|14|||
42113228|NCT00134563|75923414|FG002|Overall Study|Lack of Efficacy|17|||
42113229|NCT00134563|75923412|FG000|Overall Study|Protocol Violation|3|||
42113230|NCT00134563|75923413|FG001|Overall Study|Protocol Violation|2|||
42113231|NCT00134563|75923414|FG002|Overall Study|Protocol Violation|5|||
42391399|NCT01436162|76283890|FG000|Randomized Phase|Protocol Violation|4|||
42391400|NCT01436162|76283891|FG001|Randomized Phase|Protocol Violation|4|||
42391401|NCT01436162|76283892|FG002|Randomized Phase|Protocol Violation|2|||
42391402|NCT01436162|76283890|FG000|Randomized Phase|Withdrawal by Subject|16|||
42391403|NCT01436162|76283891|FG001|Randomized Phase|Withdrawal by Subject|9|||
42391404|NCT01436162|76283892|FG002|Randomized Phase|Withdrawal by Subject|8|||
42391405|NCT01436162|76283890|FG000|Randomized Phase|Lost to Follow-up|17|||
42391406|NCT01436162|76283891|FG001|Randomized Phase|Lost to Follow-up|5|||
42391407|NCT01436162|76283892|FG002|Randomized Phase|Lost to Follow-up|4|||
42391408|NCT01436162|76283890|FG000|Randomized Phase|Lack of Efficacy|0|||
42391409|NCT01436162|76283891|FG001|Randomized Phase|Lack of Efficacy|1|||
42391410|NCT01436162|76283892|FG002|Randomized Phase|Lack of Efficacy|1|||
42391411|NCT01436162|76283890|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
42391412|NCT01436162|76283891|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
42391413|NCT01436162|76283892|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
42391414|NCT01436162|76283890|FG000|Randomized Phase|Other|2|||
42391415|NCT01436162|76283891|FG001|Randomized Phase|Other|5|||
42391416|NCT01436162|76283892|FG002|Randomized Phase|Other|4|||
42391417|NCT02579382|76283904|FG000|Main Study Phase|Lost to Follow-up|0|||
42391418|NCT02579382|76283905|FG001|Main Study Phase|Lost to Follow-up|0|||
42391419|NCT02579382|76283906|FG002|Main Study Phase|Lost to Follow-up|2|||
42391420|NCT02579382|76283907|FG003|Main Study Phase|Lost to Follow-up|0|||
42391421|NCT02579382|76283904|FG000|Main Study Phase|Withdrew Consent|0|||
42391422|NCT02579382|76283905|FG001|Main Study Phase|Withdrew Consent|0|||
42391423|NCT02579382|76283906|FG002|Main Study Phase|Withdrew Consent|0|||
42391424|NCT02579382|76283907|FG003|Main Study Phase|Withdrew Consent|2|||
42391425|NCT02579382|76283904|FG000|Main Study Phase|Lack of Efficacy|0|||
42391426|NCT02579382|76283905|FG001|Main Study Phase|Lack of Efficacy|0|||
42391427|NCT02579382|76283906|FG002|Main Study Phase|Lack of Efficacy|0|||
42391428|NCT02579382|76283907|FG003|Main Study Phase|Lack of Efficacy|1|||
42391429|NCT02579382|76283904|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
42391430|NCT02579382|76283905|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
42391431|NCT02579382|76283906|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
42391432|NCT02579382|76283907|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
42391433|NCT02579382|76283904|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
42391434|NCT02579382|76283905|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
42391435|NCT02579382|76283906|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
42391436|NCT02579382|76283907|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
42391437|NCT02579382|76283904|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
42391438|NCT02579382|76283905|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
42391439|NCT02579382|76283906|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
42391440|NCT02579382|76283907|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
42391441|NCT02579382|76283904|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
42391442|NCT02579382|76283905|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
42391443|NCT02579382|76283906|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
42391444|NCT02579382|76283907|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
42391445|NCT02579382|76283904|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
42391446|NCT02579382|76283905|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
42391447|NCT02579382|76283906|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
42391448|NCT02579382|76283907|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
42391449|NCT02579382|76283904|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
42391450|NCT02579382|76283905|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
42391451|NCT02579382|76283906|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
42391452|NCT02579382|76283907|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
42391453|NCT01436084|76283934|FG000|Overall Study|Disease Progression|2|||
42391454|NCT01436084|76283934|FG000|Overall Study|Withdrawal by Subject|1|||
42391455|NCT01436084|76283934|FG000|Overall Study|Early Closure of Study|1|||
42391456|NCT01419314|76283949|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
42391457|NCT01419314|76283950|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
42391458|NCT01419314|76283949|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
42391459|NCT01419314|76283950|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
42391460|NCT01419314|76283949|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
42391461|NCT01419314|76283950|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
42391462|NCT01419236|76284007|FG000|Overall Study|Adverse Event|1|||
42391463|NCT01419236|76284008|FG001|Overall Study|Adverse Event|0|||
42391464|NCT01419236|76284007|FG000|Overall Study|Lack of Efficacy|0|||
42391465|NCT01419236|76284008|FG001|Overall Study|Lack of Efficacy|1|||
42391466|NCT01419236|76284007|FG000|Overall Study|Lost to Follow-up|1|||
42391467|NCT01419236|76284008|FG001|Overall Study|Lost to Follow-up|0|||
42391468|NCT01419236|76284007|FG000|Overall Study|Physician Decision|1|||
42391469|NCT01419236|76284008|FG001|Overall Study|Physician Decision|0|||
42391470|NCT01419236|76284007|FG000|Overall Study|Withdrawal by Subject|1|||
42391471|NCT01419236|76284008|FG001|Overall Study|Withdrawal by Subject|4|||
42391472|NCT01419236|76284007|FG000|Overall Study|Entry Criteria Not Met|1|||
42391473|NCT01419236|76284008|FG001|Overall Study|Entry Criteria Not Met|0|||
42391474|NCT03323658|76284021|FG000|Overall Study|Adverse Event|0|||
42391475|NCT03323658|76284022|FG001|Overall Study|Adverse Event|1|||
42391476|NCT03323658|76284023|FG002|Overall Study|Adverse Event|0|||
42391477|NCT01443026|76284048|FG000|Overall Study|Physician Decision|1|||
42391478|NCT01443026|76284049|FG001|Overall Study|Physician Decision|0|||
42391479|NCT01443026|76284048|FG000|Overall Study|Death|0|||
42391480|NCT01443026|76284049|FG001|Overall Study|Death|1|||
42391481|NCT01443026|76284048|FG000|Overall Study|Withdrawal by Subject|0|||
42391482|NCT01443026|76284049|FG001|Overall Study|Withdrawal by Subject|3|||
42391483|NCT01443026|76284048|FG000|Overall Study|Lost to Follow-up|2|||
42391484|NCT01443026|76284049|FG001|Overall Study|Lost to Follow-up|1|||
42391485|NCT01442714|76284083|FG000|Overall Study|Death|11|||
42391486|NCT01442714|76284083|FG000|Overall Study|Withdrawal by Subject|1|||
42391487|NCT01418378|76284096|FG000|Overall Study|Death|1|||
42391488|NCT01418378|76284097|FG001|Overall Study|Death|2|||
42391489|NCT01418378|76284096|FG000|Overall Study|Physician Decision|0|||
42391490|NCT01418378|76284097|FG001|Overall Study|Physician Decision|1|||
42391491|NCT01418378|76284096|FG000|Overall Study|ligament imbalance|0|||
42391492|NCT01418378|76284097|FG001|Overall Study|ligament imbalance|1|||
42391493|NCT01418378|76284096|FG000|Overall Study|developed chronic myopathy|0|||
42391494|NCT01418378|76284097|FG001|Overall Study|developed chronic myopathy|1|||
42391495|NCT01435928|76284118|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
42391496|NCT01435928|76284119|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
42391497|NCT01435928|76284120|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
42391498|NCT01435928|76284118|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
42391499|NCT01435928|76284119|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
42391500|NCT01435928|76284120|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
42391501|NCT01435928|76284118|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
42391502|NCT01435928|76284119|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
42391503|NCT01435928|76284120|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
42391504|NCT01435928|76284118|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
42391505|NCT01435928|76284119|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
42391506|NCT01435928|76284120|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
42391507|NCT01435928|76284118|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
42391508|NCT01435928|76284119|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
42391509|NCT01435928|76284120|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
42391510|NCT01435928|76284118|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
42391511|NCT01435928|76284119|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
42391512|NCT01435928|76284120|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
42391513|NCT01435928|76284118|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
42391514|NCT01435928|76284119|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
42391515|NCT01435928|76284120|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
42391516|NCT01435928|76284118|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
42391517|NCT01435928|76284119|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
42391518|NCT01435928|76284120|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
42391519|NCT01435928|76284118|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
42391520|NCT01435928|76284119|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
42391521|NCT01435928|76284120|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
42391522|NCT01435928|76284118|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
42391523|NCT01435928|76284119|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
42391524|NCT01435928|76284120|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
42391525|NCT01435928|76284118|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
42391526|NCT01435928|76284119|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
42391527|NCT01435928|76284120|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
42391528|NCT01435928|76284118|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
42391529|NCT01435928|76284119|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
42391530|NCT01435928|76284120|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
42391531|NCT01435928|76284118|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
42391532|NCT01435928|76284119|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
42391533|NCT01435928|76284120|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
42391534|NCT01435928|76284118|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
42391535|NCT01435928|76284119|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
42391536|NCT01435928|76284120|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
42391537|NCT01435928|76284118|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
42391538|NCT01435928|76284119|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
42391539|NCT01435928|76284120|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
42391540|NCT01435928|76284118|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
42391541|NCT01435928|76284119|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
42391542|NCT01435928|76284120|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
42391543|NCT01416272|76284132|FG000|Overall Study|Unacceptable distance visual acuity|2|||
42391544|NCT01416272|76284132|FG000|Overall Study|Lost to Follow-up|1|||
42391545|NCT01416272|76284132|FG000|Overall Study|Study related complaints|1|||
42391546|NCT01435772|76284622|FG000|Overall Study|Adverse Event|1|||
42391547|NCT01435772|76284623|FG001|Overall Study|Adverse Event|0|||
42391548|NCT01435772|76284624|FG002|Overall Study|Adverse Event|2|||
42391549|NCT01435772|76284622|FG000|Overall Study|Withdrawal by Subject|0|||
42391550|NCT01435772|76284623|FG001|Overall Study|Withdrawal by Subject|1|||
42391551|NCT01435772|76284624|FG002|Overall Study|Withdrawal by Subject|3|||
42391552|NCT01435772|76284622|FG000|Overall Study|Other - study termination|2|||
42391553|NCT01435772|76284623|FG001|Overall Study|Other - study termination|2|||
42391554|NCT01435772|76284624|FG002|Overall Study|Other - study termination|10|||
42113232|NCT00134563|75923412|FG000|Overall Study|Lost to Follow-up|4|||
42113233|NCT00134563|75923413|FG001|Overall Study|Lost to Follow-up|0|||
42113234|NCT00134563|75923414|FG002|Overall Study|Lost to Follow-up|2|||
42113235|NCT00134563|75923412|FG000|Overall Study|progressive disease|11|||
42113236|NCT00134563|75923413|FG001|Overall Study|progressive disease|4|||
42113237|NCT00134563|75923414|FG002|Overall Study|progressive disease|2|||
42113238|NCT00134563|75923412|FG000|Overall Study|did not wish to continue|33|||
42113239|NCT00134563|75923413|FG001|Overall Study|did not wish to continue|32|||
42113240|NCT00134563|75923414|FG002|Overall Study|did not wish to continue|26|||
42113241|NCT00134563|75923412|FG000|Overall Study|Reason other than above|0|||
42113242|NCT00134563|75923413|FG001|Overall Study|Reason other than above|2|||
42113243|NCT00134563|75923414|FG002|Overall Study|Reason other than above|5|||
42113244|NCT00520845|75923422|FG000|Overall Study|Death|3|||
42113245|NCT00520845|75923422|FG000|Overall Study|Adverse Event|4|||
42113246|NCT00520845|75923422|FG000|Overall Study|Disease Progression, relapse|13|||
42113247|NCT00520845|75923422|FG000|Overall Study|Withdrawal by Subject|1|||
42113248|NCT00520845|75923422|FG000|Overall Study|Alternative Therapy|1|||
42113249|NCT00185731|75923426|FG000|Overall Study|Withdrawal by Subject|1|||
42113250|NCT00185731|75923426|FG000|Overall Study|Not Eligible|1|||
42113251|NCT00582491|75923434|FG000|Overall Study|Withdrawal by Subject|1|||
42113252|NCT00582491|75923435|FG001|Overall Study|Withdrawal by Subject|0|||
42113253|NCT00520767|75923441|FG000|Overall Study|Death|2|||
42113254|NCT04679051|75923447|FG000|Overall Study|felt tired after restricted time in bed|3|||
42113255|NCT04679051|75923448|FG001|Overall Study|felt tired after restricted time in bed|0|||
42113256|NCT04679051|75923447|FG000|Overall Study|discomfort with blood pressure cuff|2|||
42113257|NCT04679051|75923448|FG001|Overall Study|discomfort with blood pressure cuff|0|||
42113258|NCT04679051|75923447|FG000|Overall Study|scheduling conflict|1|||
42113259|NCT04679051|75923448|FG001|Overall Study|scheduling conflict|1|||
42113260|NCT04679051|75923447|FG000|Overall Study|Protocol Violation|0|||
42113261|NCT04679051|75923448|FG001|Overall Study|Protocol Violation|4|||
42113262|NCT03873987|75923459|FG000|Overall Study|Adverse Event|1|||
42113263|NCT03873987|75923460|FG001|Overall Study|Adverse Event|0|||
42113264|NCT03873987|75923459|FG000|Overall Study|staff was unable to start a new IV line|1|||
42113265|NCT03873987|75923460|FG001|Overall Study|staff was unable to start a new IV line|0|||
42113266|NCT03873987|75923459|FG000|Overall Study|Lost to Follow-up|0|||
42113267|NCT03873987|75923460|FG001|Overall Study|Lost to Follow-up|1|||
42113268|NCT00474760|75923478|FG000|Overall Study|Death|0|||
42113269|NCT00474760|75923479|FG001|Overall Study|Death|0|||
42113270|NCT00474760|75923480|FG002|Overall Study|Death|0|||
42113271|NCT00474760|75923481|FG003|Overall Study|Death|0|||
42113272|NCT00474760|75923482|FG004|Overall Study|Death|2|||
42113273|NCT00474760|75923483|FG005|Overall Study|Death|0|||
42113274|NCT00474760|75923484|FG006|Overall Study|Death|0|||
42113275|NCT00474760|75923478|FG000|Overall Study|Adverse Event|0|||
42113276|NCT00474760|75923479|FG001|Overall Study|Adverse Event|0|||
42113277|NCT00474760|75923480|FG002|Overall Study|Adverse Event|0|||
42113278|NCT00474760|75923481|FG003|Overall Study|Adverse Event|0|||
42113279|NCT00474760|75923482|FG004|Overall Study|Adverse Event|1|||
42113280|NCT00474760|75923483|FG005|Overall Study|Adverse Event|7|||
42113281|NCT00474760|75923484|FG006|Overall Study|Adverse Event|0|||
42113282|NCT00474760|75923478|FG000|Overall Study|Laboratory abnormality|0|||
42113283|NCT00474760|75923479|FG001|Overall Study|Laboratory abnormality|0|||
42113284|NCT00474760|75923480|FG002|Overall Study|Laboratory abnormality|0|||
42113285|NCT00474760|75923481|FG003|Overall Study|Laboratory abnormality|0|||
42113286|NCT00474760|75923482|FG004|Overall Study|Laboratory abnormality|0|||
42113287|NCT00474760|75923483|FG005|Overall Study|Laboratory abnormality|1|||
42113288|NCT00474760|75923484|FG006|Overall Study|Laboratory abnormality|0|||
42113289|NCT00474760|75923478|FG000|Overall Study|Withdrawal by Subject|0|||
42113290|NCT00474760|75923479|FG001|Overall Study|Withdrawal by Subject|0|||
42113291|NCT00474760|75923480|FG002|Overall Study|Withdrawal by Subject|0|||
42113292|NCT00474760|75923481|FG003|Overall Study|Withdrawal by Subject|1|||
42113293|NCT00474760|75923482|FG004|Overall Study|Withdrawal by Subject|0|||
42113294|NCT00474760|75923483|FG005|Overall Study|Withdrawal by Subject|1|||
42113295|NCT00474760|75923484|FG006|Overall Study|Withdrawal by Subject|1|||
42113296|NCT00474760|75923478|FG000|Overall Study|Other|0|||
42113297|NCT00474760|75923479|FG001|Overall Study|Other|1|||
42113298|NCT00474760|75923480|FG002|Overall Study|Other|0|||
42113299|NCT00474760|75923481|FG003|Overall Study|Other|0|||
42113300|NCT00474760|75923482|FG004|Overall Study|Other|1|||
42113301|NCT00474760|75923483|FG005|Overall Study|Other|0|||
42113302|NCT00474760|75923484|FG006|Overall Study|Other|0|||
42113303|NCT00474760|75923478|FG000|Overall Study|Progressive disease|3|||
42113304|NCT00474760|75923479|FG001|Overall Study|Progressive disease|2|||
42113305|NCT00474760|75923480|FG002|Overall Study|Progressive disease|3|||
42113306|NCT00474760|75923481|FG003|Overall Study|Progressive disease|2|||
42113307|NCT00474760|75923482|FG004|Overall Study|Progressive disease|8|||
42113308|NCT00474760|75923483|FG005|Overall Study|Progressive disease|20|||
42113309|NCT00474760|75923484|FG006|Overall Study|Progressive disease|7|||
42113310|NCT00474760|75923478|FG000|Overall Study|Terminated by sponsor|0|||
42113311|NCT00474760|75923479|FG001|Overall Study|Terminated by sponsor|0|||
42113312|NCT00474760|75923480|FG002|Overall Study|Terminated by sponsor|0|||
42113313|NCT00474760|75923481|FG003|Overall Study|Terminated by sponsor|0|||
42113314|NCT00474760|75923482|FG004|Overall Study|Terminated by sponsor|0|||
42113315|NCT00474760|75923483|FG005|Overall Study|Terminated by sponsor|0|||
42113316|NCT00474760|75923484|FG006|Overall Study|Terminated by sponsor|2|||
42113317|NCT00528645|75923507|FG000|Overall Study|Adverse Event|3|||
42113318|NCT00524745|75923516|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
42113319|NCT00524745|75923517|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
42113320|NCT00524745|75923518|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
42113321|NCT00524745|75923519|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
42113322|NCT00495040|75923529|FG000|Overall Study|Withdrawal by Subject|3|||
42113323|NCT00494026|75923537|FG000|Overall Study|Sponsor Decision|4|||
42113324|NCT00524589|75923541|FG000|Overall Study|Withdrawal by Subject|2|||
42113325|NCT00524589|75923541|FG000|Overall Study|Disease Progression|16|||
42113326|NCT00472030|75923547|FG000|Overall Study|Physician Decision|1|||
42113327|NCT00472030|75923548|FG001|Overall Study|Physician Decision|0|||
42113328|NCT00127855|75923563|FG000|Primary Vaccination Course|Adverse Event|0|||
42113329|NCT00127855|75923564|FG001|Primary Vaccination Course|Adverse Event|0|||
42113330|NCT00127855|75923565|FG002|Primary Vaccination Course|Adverse Event|1|||
42113331|NCT00127855|75923566|FG003|Primary Vaccination Course|Adverse Event|0|||
42113332|NCT00127855|75923567|FG004|Primary Vaccination Course|Adverse Event|0|||
42113333|NCT00127855|75923563|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
42113334|NCT00127855|75923564|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
42113335|NCT00127855|75923565|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
42113336|NCT00127855|75923566|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
42113337|NCT00127855|75923567|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
42113338|NCT00127855|75923563|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
42113339|NCT00127855|75923564|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
42113340|NCT00127855|75923565|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
42113341|NCT00127855|75923566|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
42113342|NCT00127855|75923567|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
42113343|NCT00127855|75923563|FG000|Primary Vaccination Course|Other|0|||
42113344|NCT00127855|75923564|FG001|Primary Vaccination Course|Other|0|||
42113345|NCT00127855|75923565|FG002|Primary Vaccination Course|Other|0|||
42113346|NCT00127855|75923566|FG003|Primary Vaccination Course|Other|0|||
42113347|NCT00127855|75923567|FG004|Primary Vaccination Course|Other|1|||
42113348|NCT00493636|75923581|FG000|Overall Study|Withdrawal by Subject|1|||
42113349|NCT00493636|75923582|FG001|Overall Study|Withdrawal by Subject|0|||
42113350|NCT00493636|75923581|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
42113351|NCT00493636|75923582|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
42113352|NCT00493636|75923581|FG000|Overall Study|Mis-randomization|1|||
42113353|NCT00493636|75923582|FG001|Overall Study|Mis-randomization|1|||
42113354|NCT00524121|75923588|FG000|Overall Study|Disease progression|6|||
42113355|NCT00524121|75923588|FG000|Overall Study|Adverse Event|4|||
42113356|NCT00524121|75923588|FG000|Overall Study|Patient refused|2|||
42113357|NCT00524121|75923588|FG000|Overall Study|Other|1|||
42113358|NCT00524121|75923588|FG000|Overall Study|Death|1|||
42113359|NCT00524121|75923588|FG000|Overall Study|Not treated (became ineligible)|4|||
42113360|NCT00524121|75923588|FG000|Overall Study|Not treated (changed mind)|1|||
42113361|NCT00470626|75923603|FG000|Overall Study|Lost to Follow-up|10|||
42113362|NCT00470626|75923603|FG000|Overall Study|Withdrawal by Subject|7|||
42113363|NCT00132769|75923609|FG000|Overall Study|Withdrawal by Subject|1|||
42113364|NCT00132769|75923610|FG001|Overall Study|Withdrawal by Subject|3|||
42113365|NCT00132769|75923609|FG000|Overall Study|Lack of Efficacy|7|||
42113366|NCT00132769|75923610|FG001|Overall Study|Lack of Efficacy|6|||
42113367|NCT00132769|75923609|FG000|Overall Study|Adverse Event|2|||
42113368|NCT00132769|75923610|FG001|Overall Study|Adverse Event|1|||
42113369|NCT00132769|75923609|FG000|Overall Study|Protocol Violation|1|||
42113370|NCT00132769|75923610|FG001|Overall Study|Protocol Violation|1|||
42113371|NCT00520299|75923619|FG000|Overall Study|Withdrawal by Subject|0|||
42113372|NCT00520299|75923620|FG001|Overall Study|Withdrawal by Subject|0|||
42113373|NCT00520299|75923621|FG002|Overall Study|Withdrawal by Subject|2|||
42113374|NCT00520299|75923619|FG000|Overall Study|Progressive disease|0|||
42113375|NCT00520299|75923620|FG001|Overall Study|Progressive disease|3|||
42113376|NCT00520299|75923621|FG002|Overall Study|Progressive disease|4|||
42113377|NCT02478255|75923631|FG000|Overall Study|Physician Decision|6|||
42113378|NCT02478255|75923632|FG001|Overall Study|Physician Decision|0|||
42113379|NCT02478255|75923631|FG000|Overall Study|Withdrawal by Subject|2|||
42113380|NCT02478255|75923632|FG001|Overall Study|Withdrawal by Subject|0|||
42113381|NCT00132691|75923640|FG000|Overall Study|Lost to Follow-up|5|||
42113382|NCT00132691|75923641|FG001|Overall Study|Lost to Follow-up|8|||
42113383|NCT00132691|75923640|FG000|Overall Study|Missed 2-year visit|4|||
42113384|NCT00132691|75923641|FG001|Overall Study|Missed 2-year visit|4|||
42113385|NCT00132691|75923640|FG000|Overall Study|Death|2|||
42113386|NCT00132691|75923641|FG001|Overall Study|Death|0|||
42113387|NCT00125359|75923652|FG000|Overall Study|Death|4|||
42113388|NCT00125359|75923652|FG000|Overall Study|Adverse Event|5|||
42113389|NCT00125359|75923652|FG000|Overall Study|Physician Decision|14|||
42113390|NCT00524043|75923659|FG000|Overall Study|Lack of Efficacy|15|||
42113391|NCT00524043|75923660|FG001|Overall Study|Lack of Efficacy|13|||
42113392|NCT00524043|75923661|FG002|Overall Study|Lack of Efficacy|14|||
42113393|NCT00524043|75923659|FG000|Overall Study|Withdrawal by Subject|5|||
42113394|NCT00524043|75923660|FG001|Overall Study|Withdrawal by Subject|7|||
42113395|NCT00524043|75923661|FG002|Overall Study|Withdrawal by Subject|7|||
42113396|NCT00524043|75923659|FG000|Overall Study|Adverse Event|5|||
42113397|NCT00524043|75923660|FG001|Overall Study|Adverse Event|2|||
42113398|NCT00524043|75923661|FG002|Overall Study|Adverse Event|7|||
42113399|NCT00524043|75923659|FG000|Overall Study|Lost to Follow-up|3|||
42113400|NCT00524043|75923660|FG001|Overall Study|Lost to Follow-up|5|||
42113401|NCT00524043|75923661|FG002|Overall Study|Lost to Follow-up|3|||
42113402|NCT00524043|75923659|FG000|Overall Study|Various (eg, incarceration)|2|||
42113403|NCT00524043|75923660|FG001|Overall Study|Various (eg, incarceration)|1|||
42113404|NCT00524043|75923661|FG002|Overall Study|Various (eg, incarceration)|0|||
42113405|NCT00523419|75923669|FG000|Overall Study|Adverse Event|1|||
42113406|NCT00523419|75923669|FG000|Overall Study|Withdrawal by Subject|1|||
42113407|NCT00523419|75923669|FG000|Overall Study|Physician Decision|2|||
42113408|NCT00523419|75923669|FG000|Overall Study|Progressive Disease|22|||
42113409|NCT00523419|75923669|FG000|Overall Study|Death due to Study Disease|4|||
42113410|NCT00523419|75923669|FG000|Overall Study|Death due to Adverse Event|2|||
42113411|NCT03868059|75923673|FG000|Overall Study|Adverse Event|3|||
42113412|NCT03868059|75923673|FG000|Overall Study|Lost to Follow-up|3|||
42113413|NCT03868059|75923673|FG000|Overall Study|Withdrawal by Subject|6|||
42113414|NCT00522951|75923677|FG000|Period 1|body motion|0|||
42113415|NCT00522951|75923678|FG001|Period 1|body motion|1|||
42113416|NCT00522951|75923677|FG000|Washout Period|Adverse Event|0|||
42113417|NCT00522951|75923678|FG001|Washout Period|Adverse Event|1|||
42113418|NCT00522951|75923677|FG000|Washout Period|Death|0|||
42113419|NCT00522951|75923678|FG001|Washout Period|Death|1|||
42113420|NCT00522951|75923677|FG000|Period 2|Withdrawal by Subject|1|||
42113421|NCT00522951|75923678|FG001|Period 2|Withdrawal by Subject|0|||
42113422|NCT00522951|75923677|FG000|Period 2|residual contrast medium|1|||
42113423|NCT00522951|75923678|FG001|Period 2|residual contrast medium|1|||
42113424|NCT03865953|75923690|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
42113425|NCT03865953|75923691|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
42113426|NCT03865953|75923690|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
42113427|NCT03865953|75923691|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
42113428|NCT03865953|75923690|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
42113429|NCT03865953|75923691|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
42113430|NCT05439941|75923700|FG000|Overall Study|Lack of Efficacy|8|||
42113431|NCT05439941|75923701|FG001|Overall Study|Lack of Efficacy|5|||
42113432|NCT05439941|75923702|FG002|Overall Study|Lack of Efficacy|3|||
42113433|NCT05439941|75923700|FG000|Overall Study|Treatment Failure|0|||
42113434|NCT05439941|75923701|FG001|Overall Study|Treatment Failure|1|||
42113435|NCT05439941|75923702|FG002|Overall Study|Treatment Failure|0|||
42113436|NCT05439941|75923700|FG000|Overall Study|Adverse Event|1|||
42113437|NCT05439941|75923701|FG001|Overall Study|Adverse Event|3|||
42113438|NCT05439941|75923702|FG002|Overall Study|Adverse Event|0|||
42113439|NCT05439941|75923700|FG000|Overall Study|Adverse Event - Parent Study|1|||
42113440|NCT05439941|75923701|FG001|Overall Study|Adverse Event - Parent Study|0|||
42113441|NCT05439941|75923702|FG002|Overall Study|Adverse Event - Parent Study|0|||
42113442|NCT05439941|75923700|FG000|Overall Study|Pregnancy|1|||
42113443|NCT05439941|75923701|FG001|Overall Study|Pregnancy|0|||
42113444|NCT05439941|75923702|FG002|Overall Study|Pregnancy|0|||
42113445|NCT05439941|75923700|FG000|Overall Study|Withdrawal by Subject|9|||
42113446|NCT05439941|75923701|FG001|Overall Study|Withdrawal by Subject|6|||
42113447|NCT05439941|75923702|FG002|Overall Study|Withdrawal by Subject|10|||
42113448|NCT05439941|75923700|FG000|Overall Study|Non-Compliance|1|||
42113449|NCT05439941|75923701|FG001|Overall Study|Non-Compliance|1|||
42113450|NCT05439941|75923702|FG002|Overall Study|Non-Compliance|1|||
42113451|NCT05439941|75923700|FG000|Overall Study|Lost to Follow-up|2|||
42113452|NCT05439941|75923701|FG001|Overall Study|Lost to Follow-up|2|||
42113453|NCT05439941|75923702|FG002|Overall Study|Lost to Follow-up|0|||
42113454|NCT05439941|75923700|FG000|Overall Study|Physician Decision|1|||
42113455|NCT05439941|75923701|FG001|Overall Study|Physician Decision|0|||
42113456|NCT05439941|75923702|FG002|Overall Study|Physician Decision|0|||
42113457|NCT05439941|75923700|FG000|Overall Study|Trial Termination by Sponsor|78|||
42113458|NCT05439941|75923701|FG001|Overall Study|Trial Termination by Sponsor|83|||
42113459|NCT05439941|75923702|FG002|Overall Study|Trial Termination by Sponsor|65|||
42113460|NCT05439941|75923700|FG000|Overall Study|Other than Reasons Listed|2|||
42113461|NCT05439941|75923701|FG001|Overall Study|Other than Reasons Listed|1|||
42113462|NCT05439941|75923702|FG002|Overall Study|Other than Reasons Listed|0|||
42113463|NCT05091918|75923710|FG000|Overall Study|Adverse Event|1|||
42113464|NCT05091918|75923710|FG000|Overall Study|Withdrawal by Subject|81|||
42113465|NCT04912895|75923717|FG000|Overall Study|Unable to provide specimen|2|||
42113466|NCT04912895|75923718|FG001|Overall Study|Unable to provide specimen|0|||
42113467|NCT04912895|75923719|FG002|Overall Study|Unable to provide specimen|0|||
42113468|NCT04776720|75923727|FG000|Overall Study|COVID Related|4|||
42113469|NCT04776720|75923728|FG001|Overall Study|COVID Related|2|||
42113470|NCT04776720|75923727|FG000|Overall Study|Adverse Event|2|||
42113471|NCT04776720|75923728|FG001|Overall Study|Adverse Event|0|||
42113472|NCT04776720|75923727|FG000|Overall Study|Serious Adverse Event|0|||
42113473|NCT04776720|75923728|FG001|Overall Study|Serious Adverse Event|1|||
42113474|NCT04776720|75923727|FG000|Overall Study|Too Busy|3|||
42113475|NCT04776720|75923728|FG001|Overall Study|Too Busy|1|||
42113476|NCT04776720|75923727|FG000|Overall Study|Lost to Follow-up|1|||
42113477|NCT04776720|75923728|FG001|Overall Study|Lost to Follow-up|2|||
42113478|NCT04776720|75923727|FG000|Overall Study|Family|2|||
42113479|NCT04776720|75923728|FG001|Overall Study|Family|2|||
42113480|NCT04776720|75923727|FG000|Overall Study|No remote technology access|0|||
42113481|NCT04776720|75923728|FG001|Overall Study|No remote technology access|1|||
42113482|NCT04776720|75923727|FG000|Overall Study|Withdrawal by Subject|1|||
42113483|NCT04776720|75923728|FG001|Overall Study|Withdrawal by Subject|0|||
42113484|NCT04776720|75923727|FG000|Overall Study|Cannot tolerate intervention|1|||
42113485|NCT04776720|75923728|FG001|Overall Study|Cannot tolerate intervention|0|||
42113486|NCT04776720|75923727|FG000|Overall Study|Incomplete outcome data|6|||
42113487|NCT04776720|75923728|FG001|Overall Study|Incomplete outcome data|1|||
42113488|NCT04675151|75923747|FG000|Overall Study|Protocol Violation|1|||
42113489|NCT04675151|75923748|FG001|Overall Study|Protocol Violation|0|||
42113490|NCT04675151|75923749|FG002|Overall Study|Protocol Violation|0|||
42113491|NCT04675151|75923750|FG003|Overall Study|Protocol Violation|1|||
42113492|NCT04599907|75923763|FG000|Overall Study|Withdrawal by Subject|1|||
42113493|NCT04599907|75923764|FG001|Overall Study|Withdrawal by Subject|7|||
42113494|NCT04599907|75923765|FG002|Overall Study|Withdrawal by Subject|6|||
42113495|NCT04599907|75923763|FG000|Overall Study|Lost to Follow-up|0|||
42113496|NCT04599907|75923764|FG001|Overall Study|Lost to Follow-up|1|||
42113497|NCT04599907|75923765|FG002|Overall Study|Lost to Follow-up|0|||
42113498|NCT04503096|75923788|FG000|Overall Study|Withdrawal by Subject|3|||
42205310|NCT00003377|76017990|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
42205311|NCT00003377|76017991|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
42205312|NCT00003377|76017992|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
42205313|NCT00003377|76017988|FG000|Period II|Ureteral stent complications|0|||
42205314|NCT00003377|76017989|FG001|Period II|Ureteral stent complications|0|||
42205315|NCT00003377|76017990|FG002|Period II|Ureteral stent complications|0|||
42205316|NCT00003377|76017991|FG003|Period II|Ureteral stent complications|0|||
42205317|NCT00003377|76017992|FG004|Period II|Ureteral stent complications|1|||
42205318|NCT00651742|76018005|FG000|Overall Study|Objective Disease Progression|22|||
42205319|NCT00651742|76018005|FG000|Overall Study|Toxicity|3|||
42205320|NCT00651742|76018005|FG000|Overall Study|Investigator Judgment|1|||
42205321|NCT00651742|76018005|FG000|Overall Study|Withdrawal of Consent|1|||
42205322|NCT00651742|76018005|FG000|Overall Study|Enrolled but not treated|1|||
42205323|NCT00002651|76018011|FG000|Induction|Adverse Event|44|||
42205324|NCT00002651|76018012|FG001|Induction|Adverse Event|0|||
42205325|NCT00002651|76018013|FG002|Induction|Adverse Event|0|||
42205326|NCT00002651|76018011|FG000|Induction|Refusal unrelated to adverse event|50|||
42205327|NCT00002651|76018012|FG001|Induction|Refusal unrelated to adverse event|0|||
42205328|NCT00002651|76018013|FG002|Induction|Refusal unrelated to adverse event|0|||
42205329|NCT00002651|76018011|FG000|Induction|Progression/relapse|274|||
42205330|NCT00002651|76018012|FG001|Induction|Progression/relapse|0|||
42205331|NCT00002651|76018013|FG002|Induction|Progression/relapse|0|||
42205332|NCT00002651|76018011|FG000|Induction|Death|62|||
42205333|NCT00002651|76018012|FG001|Induction|Death|0|||
42205334|NCT00002651|76018013|FG002|Induction|Death|0|||
42205335|NCT00002651|76018011|FG000|Induction|Other|823|||
42205336|NCT00002651|76018012|FG001|Induction|Other|0|||
42205337|NCT00002651|76018013|FG002|Induction|Other|0|||
42205338|NCT00002651|76018011|FG000|Induction|not eligible|90|||
42205339|NCT00002651|76018012|FG001|Induction|not eligible|0|||
42205340|NCT00002651|76018013|FG002|Induction|not eligible|0|||
42205341|NCT00002651|76018011|FG000|Consolidation and Randomization|Adverse Event|0|||
42205342|NCT00002651|76018012|FG001|Consolidation and Randomization|Adverse Event|36|||
42205343|NCT00002651|76018013|FG002|Consolidation and Randomization|Adverse Event|14|||
42205344|NCT00002651|76018011|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
42205345|NCT00002651|76018012|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
42205346|NCT00002651|76018013|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
42205347|NCT00002651|76018011|FG000|Consolidation and Randomization|Progression/relapse|0|||
42205348|NCT00002651|76018012|FG001|Consolidation and Randomization|Progression/relapse|295|||
42205349|NCT00002651|76018013|FG002|Consolidation and Randomization|Progression/relapse|298|||
42205350|NCT00002651|76018011|FG000|Consolidation and Randomization|Death|0|||
42205351|NCT00002651|76018012|FG001|Consolidation and Randomization|Death|38|||
42205352|NCT00002651|76018013|FG002|Consolidation and Randomization|Death|48|||
42205353|NCT00002651|76018011|FG000|Consolidation and Randomization|Other|0|||
42391555|NCT01435616|76284843|FG000|Overall Study|Adverse Event|39|||
42205354|NCT00002651|76018012|FG001|Consolidation and Randomization|Other|314|||
42205355|NCT00002651|76018013|FG002|Consolidation and Randomization|Other|313|||
42205356|NCT00002651|76018011|FG000|Consolidation and Randomization|not eligible|0|||
42205357|NCT00002651|76018012|FG001|Consolidation and Randomization|not eligible|102|||
42205358|NCT00002651|76018013|FG002|Consolidation and Randomization|not eligible|112|||
42205359|NCT00002597|76018023|FG000|Overall Study|Protocol Violation|19|||
42205360|NCT00002597|76018024|FG001|Overall Study|Protocol Violation|17|||
42205361|NCT00002597|76018023|FG000|Overall Study|Withdrawal by Subject|7|||
42205362|NCT00002597|76018024|FG001|Overall Study|Withdrawal by Subject|6|||
42205363|NCT03435081|76018033|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
42205364|NCT03435081|76018034|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
42205365|NCT03435081|76018035|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
42205366|NCT03435081|76018033|FG000|Week 0 to Week 16|Adverse Event|2|||
42205367|NCT03435081|76018034|FG001|Week 0 to Week 16|Adverse Event|2|||
42205368|NCT03435081|76018035|FG002|Week 0 to Week 16|Adverse Event|2|||
42205369|NCT03435081|76018033|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
42205370|NCT03435081|76018034|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
42205371|NCT03435081|76018035|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
42205372|NCT03435081|76018033|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
42205373|NCT03435081|76018034|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
42205374|NCT03435081|76018035|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
42205375|NCT03435081|76018033|FG000|Week 0 to Week 16|Pregnancy|1|||
42205376|NCT03435081|76018034|FG001|Week 0 to Week 16|Pregnancy|0|||
42205377|NCT03435081|76018035|FG002|Week 0 to Week 16|Pregnancy|0|||
42205378|NCT03435081|76018033|FG000|Week 0 to Week 16|Non-compliance|1|||
42205379|NCT03435081|76018034|FG001|Week 0 to Week 16|Non-compliance|0|||
42205380|NCT03435081|76018035|FG002|Week 0 to Week 16|Non-compliance|2|||
42299031|NCT02332707|76134189|FG015|Overall Study|Adverse Event|0|||
42299032|NCT02332707|76134190|FG016|Overall Study|Adverse Event|0|||
42299033|NCT02332707|76134191|FG017|Overall Study|Adverse Event|0|||
42299034|NCT02332707|76134174|FG000|Overall Study|Lost to Follow-up|0|||
42299035|NCT02332707|76134175|FG001|Overall Study|Lost to Follow-up|0|||
42299036|NCT02332707|76134176|FG002|Overall Study|Lost to Follow-up|0|||
42299037|NCT02332707|76134177|FG003|Overall Study|Lost to Follow-up|0|||
42299038|NCT02332707|76134178|FG004|Overall Study|Lost to Follow-up|0|||
42299039|NCT02332707|76134179|FG005|Overall Study|Lost to Follow-up|1|||
42299040|NCT02332707|76134180|FG006|Overall Study|Lost to Follow-up|0|||
42299041|NCT02332707|76134181|FG007|Overall Study|Lost to Follow-up|0|||
42299042|NCT02332707|76134182|FG008|Overall Study|Lost to Follow-up|0|||
42299043|NCT02332707|76134183|FG009|Overall Study|Lost to Follow-up|0|||
42299044|NCT02332707|76134184|FG010|Overall Study|Lost to Follow-up|2|||
42299045|NCT02332707|76134185|FG011|Overall Study|Lost to Follow-up|0|||
42299046|NCT02332707|76134186|FG012|Overall Study|Lost to Follow-up|3|||
42299047|NCT02332707|76134187|FG013|Overall Study|Lost to Follow-up|0|||
42299048|NCT02332707|76134188|FG014|Overall Study|Lost to Follow-up|0|||
42299049|NCT02332707|76134189|FG015|Overall Study|Lost to Follow-up|0|||
42299050|NCT02332707|76134190|FG016|Overall Study|Lost to Follow-up|0|||
42299051|NCT02332707|76134191|FG017|Overall Study|Lost to Follow-up|0|||
42299052|NCT02332707|76134174|FG000|Overall Study|Physician Decision|0|||
42299053|NCT02332707|76134175|FG001|Overall Study|Physician Decision|0|||
42299054|NCT02332707|76134176|FG002|Overall Study|Physician Decision|0|||
42299055|NCT02332707|76134177|FG003|Overall Study|Physician Decision|1|||
42299056|NCT02332707|76134178|FG004|Overall Study|Physician Decision|0|||
42299057|NCT02332707|76134179|FG005|Overall Study|Physician Decision|0|||
42299058|NCT02332707|76134180|FG006|Overall Study|Physician Decision|0|||
42299059|NCT02332707|76134181|FG007|Overall Study|Physician Decision|0|||
42299060|NCT02332707|76134182|FG008|Overall Study|Physician Decision|0|||
42299061|NCT02332707|76134183|FG009|Overall Study|Physician Decision|0|||
42299062|NCT02332707|76134184|FG010|Overall Study|Physician Decision|0|||
42299063|NCT02332707|76134185|FG011|Overall Study|Physician Decision|0|||
42299064|NCT02332707|76134186|FG012|Overall Study|Physician Decision|1|||
42299065|NCT02332707|76134187|FG013|Overall Study|Physician Decision|0|||
42299066|NCT02332707|76134188|FG014|Overall Study|Physician Decision|0|||
42299067|NCT02332707|76134189|FG015|Overall Study|Physician Decision|0|||
42299068|NCT02332707|76134190|FG016|Overall Study|Physician Decision|0|||
42299069|NCT02332707|76134191|FG017|Overall Study|Physician Decision|0|||
42299070|NCT02332707|76134174|FG000|Overall Study|Withdrawal by Subject|0|||
42299071|NCT02332707|76134175|FG001|Overall Study|Withdrawal by Subject|0|||
42299072|NCT02332707|76134176|FG002|Overall Study|Withdrawal by Subject|1|||
42299073|NCT02332707|76134177|FG003|Overall Study|Withdrawal by Subject|0|||
42299074|NCT02332707|76134178|FG004|Overall Study|Withdrawal by Subject|0|||
42299075|NCT02332707|76134179|FG005|Overall Study|Withdrawal by Subject|0|||
42205381|NCT03435081|76018033|FG000|Week 0 to Week 16|Inadequate Response|0|||
42205382|NCT03435081|76018034|FG001|Week 0 to Week 16|Inadequate Response|1|||
42205383|NCT03435081|76018035|FG002|Week 0 to Week 16|Inadequate Response|0|||
42205384|NCT03435081|76018033|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
42205385|NCT03435081|76018034|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
42299076|NCT02332707|76134180|FG006|Overall Study|Withdrawal by Subject|0|||
42299077|NCT02332707|76134181|FG007|Overall Study|Withdrawal by Subject|0|||
42299078|NCT02332707|76134182|FG008|Overall Study|Withdrawal by Subject|0|||
42299079|NCT02332707|76134183|FG009|Overall Study|Withdrawal by Subject|3|||
42299080|NCT02332707|76134184|FG010|Overall Study|Withdrawal by Subject|0|||
42299081|NCT02332707|76134185|FG011|Overall Study|Withdrawal by Subject|0|||
42299082|NCT02332707|76134186|FG012|Overall Study|Withdrawal by Subject|0|||
42299083|NCT02332707|76134187|FG013|Overall Study|Withdrawal by Subject|0|||
42299084|NCT02332707|76134188|FG014|Overall Study|Withdrawal by Subject|0|||
42299085|NCT02332707|76134189|FG015|Overall Study|Withdrawal by Subject|0|||
42299086|NCT02332707|76134190|FG016|Overall Study|Withdrawal by Subject|0|||
42299087|NCT02332707|76134191|FG017|Overall Study|Withdrawal by Subject|0|||
42299088|NCT02370615|76134231|FG000|Overall Study|Adverse Event|1|||
42299089|NCT02370615|76134232|FG001|Overall Study|Adverse Event|0|||
42299090|NCT02307513|76134247|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
42299091|NCT02307513|76134248|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
42299092|NCT02307513|76134247|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
42299093|NCT02307513|76134248|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
42299094|NCT02307513|76134247|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
42299095|NCT02307513|76134248|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
42299096|NCT02307513|76134247|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
42299097|NCT02307513|76134248|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
42299098|NCT02307513|76134247|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
42299099|NCT02307513|76134248|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
42299100|NCT02307513|76134247|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
42299101|NCT02307513|76134248|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
42299102|NCT02307513|76134247|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
42299103|NCT02307513|76134248|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
42299104|NCT02307513|76134247|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
42299105|NCT02307513|76134248|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
42299106|NCT02307513|76134247|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
42299107|NCT02307513|76134248|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
42299108|NCT02307513|76134247|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
42299109|NCT02307513|76134248|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
42299110|NCT02307513|76134247|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
42299111|NCT02307513|76134248|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
42299112|NCT02307513|76134247|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
42299113|NCT02307513|76134248|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
42299114|NCT02307513|76134247|FG000|Long-term Extension|Physician Decision|1|||
42299115|NCT02307513|76134248|FG001|Long-term Extension|Physician Decision|0|||
42299116|NCT02332239|76134260|FG000|Overall Study|Lost to Follow-up|4|||
42299117|NCT02332239|76134261|FG001|Overall Study|Lost to Follow-up|6|||
42299118|NCT02370537|76134272|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
42299119|NCT02370537|76134273|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
42299120|NCT02370537|76134274|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
42299121|NCT02370537|76134272|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
42299122|NCT02370537|76134273|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
42299123|NCT02370537|76134274|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
42299124|NCT02370537|76134272|FG000|Part B|Not randomised to receive treatment|1|||
42299125|NCT02370537|76134273|FG001|Part B|Not randomised to receive treatment|2|||
42299126|NCT02370537|76134274|FG002|Part B|Not randomised to receive treatment|259|||
42299127|NCT02370537|76134272|FG000|Part B|Withdrawal by Subject|0|||
42299128|NCT02370537|76134273|FG001|Part B|Withdrawal by Subject|1|||
42299129|NCT02370537|76134274|FG002|Part B|Withdrawal by Subject|0|||
42299130|NCT02330055|76134293|FG000|Overall Study|technical issues|2|||
42299131|NCT02330055|76134294|FG001|Overall Study|technical issues|0|||
42299132|NCT02330055|76134293|FG000|Overall Study|participant forgot to wear device|5|||
42299133|NCT02330055|76134294|FG001|Overall Study|participant forgot to wear device|5|||
42299134|NCT02330055|76134293|FG000|Overall Study|data for less than 60 minutes|3|||
42299135|NCT02330055|76134294|FG001|Overall Study|data for less than 60 minutes|3|||
42299136|NCT02330055|76134293|FG000|Overall Study|participant did not sleep|0|||
42299137|NCT02330055|76134294|FG001|Overall Study|participant did not sleep|1|||
42299138|NCT02306265|76134300|FG000|Overall Study|Withdrawal by Subject|1|||
42299139|NCT02329743|76134308|FG000|Overall Study|Adverse Event|1|||
42299140|NCT02329743|76134309|FG001|Overall Study|Adverse Event|1|||
42299141|NCT02329743|76134310|FG002|Overall Study|Adverse Event|3|||
42299142|NCT02329743|76134308|FG000|Overall Study|Lost to Follow-up|1|||
42299143|NCT02329743|76134309|FG001|Overall Study|Lost to Follow-up|0|||
42299144|NCT02329743|76134310|FG002|Overall Study|Lost to Follow-up|1|||
42299145|NCT02329743|76134308|FG000|Overall Study|Withdrawal by Subject|4|||
42299146|NCT02329743|76134309|FG001|Overall Study|Withdrawal by Subject|4|||
42299147|NCT02329743|76134310|FG002|Overall Study|Withdrawal by Subject|1|||
42299148|NCT02329743|76134308|FG000|Overall Study|Other|0|||
42299149|NCT02329743|76134309|FG001|Overall Study|Other|2|||
42299150|NCT02329743|76134310|FG002|Overall Study|Other|3|||
42299151|NCT02329431|76134320|FG000|Overall Study|Lost to Follow-up|20|||
42299152|NCT02329431|76134321|FG001|Overall Study|Lost to Follow-up|13|||
42299153|NCT02328105|76134327|FG000|Overall Study|Death|6|||
42299154|NCT02328105|76134327|FG000|Overall Study|Withdrawal by Subject|1|||
42299155|NCT02328105|76134327|FG000|Overall Study|Still On Study in Follow-Up|4|||
42299156|NCT02305797|76134333|FG000|Overall Study|Adverse Event|11|||
42299157|NCT02305797|76134334|FG001|Overall Study|Adverse Event|2|||
42299158|NCT02305797|76134333|FG000|Overall Study|Withdrawal by Subject|9|||
42299159|NCT02305797|76134334|FG001|Overall Study|Withdrawal by Subject|10|||
42299160|NCT02305797|76134333|FG000|Overall Study|Lack of Efficacy|6|||
42299161|NCT02305797|76134334|FG001|Overall Study|Lack of Efficacy|0|||
42299162|NCT02305797|76134333|FG000|Overall Study|Lost to Follow-up|5|||
42299163|NCT02305797|76134334|FG001|Overall Study|Lost to Follow-up|11|||
42299164|NCT02305797|76134333|FG000|Overall Study|Pregnancy|0|||
42299165|NCT02305797|76134334|FG001|Overall Study|Pregnancy|2|||
42299166|NCT02305797|76134333|FG000|Overall Study|Noncompliance|14|||
42299167|NCT02305797|76134334|FG001|Overall Study|Noncompliance|12|||
42299168|NCT02305797|76134333|FG000|Overall Study|Reason not collected|0|||
42299169|NCT02305797|76134334|FG001|Overall Study|Reason not collected|1|||
42299170|NCT01646073|76134342|FG000|Period A (12 Weeks)|Adverse Event|0|||
42299171|NCT01646073|76134343|FG001|Period A (12 Weeks)|Adverse Event|2|||
42299172|NCT01646073|76134342|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
42299173|NCT01646073|76134343|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
42299174|NCT01646073|76134342|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
42299175|NCT01646073|76134343|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
42299176|NCT01646073|76134342|FG000|Period A (12 Weeks)|Protocol Violation|0|||
42299177|NCT01646073|76134343|FG001|Period A (12 Weeks)|Protocol Violation|1|||
42299178|NCT01646073|76134342|FG000|Period A (12 Weeks)|Other|0|||
42299179|NCT01646073|76134343|FG001|Period A (12 Weeks)|Other|1|||
42299180|NCT01646073|76134342|FG000|Period B (12 Weeks)|Adverse Event|0|||
42299181|NCT01646073|76134343|FG001|Period B (12 Weeks)|Adverse Event|7|||
42299182|NCT01646073|76134342|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
42299183|NCT01646073|76134343|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
42299184|NCT01646073|76134342|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
42299185|NCT01646073|76134343|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
42299186|NCT02328027|76134354|FG000|Overall Study|Withdrawal by Subject|0|||
42299187|NCT02328027|76134355|FG001|Overall Study|Withdrawal by Subject|1|||
42299188|NCT02551159|76134365|FG000|Overall Study|Death|352|||
42299189|NCT02551159|76134366|FG001|Overall Study|Death|174|||
42299190|NCT02551159|76134367|FG002|Overall Study|Death|161|||
42299191|NCT02551159|76134365|FG000|Overall Study|Withdrawal by Subject|8|||
42299192|NCT02551159|76134366|FG001|Overall Study|Withdrawal by Subject|5|||
42299193|NCT02551159|76134367|FG002|Overall Study|Withdrawal by Subject|16|||
42299194|NCT02551159|76134365|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
42299195|NCT02551159|76134366|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
42299196|NCT02551159|76134367|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
42299197|NCT02305563|76134380|FG000|Treatment Period|Disease progression|0|||
42299198|NCT02305563|76134381|FG001|Treatment Period|Disease progression|0|||
42299199|NCT02305563|76134382|FG002|Treatment Period|Disease progression|15|||
42299200|NCT02305563|76134383|FG003|Treatment Period|Disease progression|6|||
42299201|NCT02305563|76134384|FG004|Treatment Period|Disease progression|6|||
42299202|NCT02305563|76134380|FG000|Treatment Period|Study drug toxicity|0|||
42299203|NCT02305563|76134381|FG001|Treatment Period|Study drug toxicity|0|||
42299204|NCT02305563|76134382|FG002|Treatment Period|Study drug toxicity|0|||
42299205|NCT02305563|76134383|FG003|Treatment Period|Study drug toxicity|1|||
42299206|NCT02305563|76134384|FG004|Treatment Period|Study drug toxicity|2|||
42299207|NCT02305563|76134380|FG000|Treatment Period|Death|0|||
42299208|NCT02305563|76134381|FG001|Treatment Period|Death|0|||
42299209|NCT02305563|76134382|FG002|Treatment Period|Death|1|||
42299210|NCT02305563|76134383|FG003|Treatment Period|Death|2|||
42299211|NCT02305563|76134384|FG004|Treatment Period|Death|1|||
42299212|NCT02305563|76134380|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
42299213|NCT02305563|76134381|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
42299214|NCT02305563|76134382|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
42299215|NCT02305563|76134383|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
42299216|NCT02305563|76134384|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
42299217|NCT02305563|76134380|FG000|Treatment Period|Participant request to stop therapy|0|||
42299218|NCT02305563|76134381|FG001|Treatment Period|Participant request to stop therapy|2|||
42299219|NCT02305563|76134382|FG002|Treatment Period|Participant request to stop therapy|0|||
42299220|NCT02305563|76134383|FG003|Treatment Period|Participant request to stop therapy|1|||
42299221|NCT02305563|76134384|FG004|Treatment Period|Participant request to stop therapy|0|||
42299222|NCT02305563|76134380|FG000|Treatment Period|Participant withdrew consent|0|||
42299223|NCT02305563|76134381|FG001|Treatment Period|Participant withdrew consent|0|||
42299224|NCT02305563|76134382|FG002|Treatment Period|Participant withdrew consent|1|||
42299225|NCT02305563|76134383|FG003|Treatment Period|Participant withdrew consent|1|||
42299226|NCT02305563|76134384|FG004|Treatment Period|Participant withdrew consent|1|||
42299227|NCT02305563|76134380|FG000|Treatment Period|Maximum clinical benefit|0|||
42299228|NCT02305563|76134381|FG001|Treatment Period|Maximum clinical benefit|0|||
42299229|NCT02305563|76134382|FG002|Treatment Period|Maximum clinical benefit|0|||
42299230|NCT02305563|76134383|FG003|Treatment Period|Maximum clinical benefit|0|||
42299231|NCT02305563|76134384|FG004|Treatment Period|Maximum clinical benefit|1|||
42299232|NCT02305563|76134380|FG000|Treatment Period|Poor/non-compliance|0|||
42299233|NCT02305563|76134381|FG001|Treatment Period|Poor/non-compliance|0|||
42299234|NCT02305563|76134382|FG002|Treatment Period|Poor/non-compliance|0|||
42299235|NCT02305563|76134383|FG003|Treatment Period|Poor/non-compliance|0|||
42299236|NCT02305563|76134384|FG004|Treatment Period|Poor/non-compliance|1|||
42299237|NCT02305563|76134380|FG000|Treatment Period|Administrative reason by Sponsor|0|||
42299238|NCT02305563|76134381|FG001|Treatment Period|Administrative reason by Sponsor|0|||
42299239|NCT02305563|76134382|FG002|Treatment Period|Administrative reason by Sponsor|0|||
42299240|NCT02305563|76134383|FG003|Treatment Period|Administrative reason by Sponsor|0|||
42299241|NCT02305563|76134384|FG004|Treatment Period|Administrative reason by Sponsor|1|||
42299242|NCT02305563|76134380|FG000|Treatment Period|other reason|2|||
42299243|NCT02305563|76134381|FG001|Treatment Period|other reason|0|||
42299244|NCT02305563|76134382|FG002|Treatment Period|other reason|2|||
42299245|NCT02305563|76134383|FG003|Treatment Period|other reason|2|||
42299246|NCT02305563|76134384|FG004|Treatment Period|other reason|1|||
42299247|NCT02305563|76134380|FG000|Treatment Period|Randomized but not treated|0|||
42299248|NCT02305563|76134381|FG001|Treatment Period|Randomized but not treated|0|||
42299249|NCT02305563|76134382|FG002|Treatment Period|Randomized but not treated|0|||
42299250|NCT02305563|76134383|FG003|Treatment Period|Randomized but not treated|0|||
42299251|NCT02305563|76134384|FG004|Treatment Period|Randomized but not treated|2|||
42299252|NCT02305563|76134380|FG000|Treatment Period|added ULO, then disease progression|0|||
42299253|NCT02305563|76134381|FG001|Treatment Period|added ULO, then disease progression|0|||
42299254|NCT02305563|76134382|FG002|Treatment Period|added ULO, then disease progression|0|||
42299255|NCT02305563|76134383|FG003|Treatment Period|added ULO, then disease progression|0|||
42299256|NCT02305563|76134384|FG004|Treatment Period|added ULO, then disease progression|4|||
42299257|NCT02305563|76134380|FG000|Treatment Period|added ULO; then other reason|0|||
42299258|NCT02305563|76134381|FG001|Treatment Period|added ULO; then other reason|0|||
42299259|NCT02305563|76134382|FG002|Treatment Period|added ULO; then other reason|0|||
42299260|NCT02305563|76134383|FG003|Treatment Period|added ULO; then other reason|0|||
42299261|NCT02305563|76134384|FG004|Treatment Period|added ULO; then other reason|1|||
42299262|NCT02305563|76134380|FG000|Treatment Period|added ULO, then request to stop|0|||
42299263|NCT02305563|76134381|FG001|Treatment Period|added ULO, then request to stop|0|||
42299264|NCT02305563|76134382|FG002|Treatment Period|added ULO, then request to stop|0|||
42299265|NCT02305563|76134383|FG003|Treatment Period|added ULO, then request to stop|0|||
42299266|NCT02305563|76134384|FG004|Treatment Period|added ULO, then request to stop|1|||
42299267|NCT02305563|76134380|FG000|Follow-up Period|Death|0|||
42299268|NCT02305563|76134381|FG001|Follow-up Period|Death|0|||
42299269|NCT02305563|76134382|FG002|Follow-up Period|Death|5|||
42299270|NCT02305563|76134383|FG003|Follow-up Period|Death|4|||
42299271|NCT02305563|76134384|FG004|Follow-up Period|Death|7|||
42299272|NCT02305563|76134380|FG000|Follow-up Period|Participant withdrew consent|0|||
42299273|NCT02305563|76134381|FG001|Follow-up Period|Participant withdrew consent|0|||
42299274|NCT02305563|76134382|FG002|Follow-up Period|Participant withdrew consent|2|||
42299275|NCT02305563|76134383|FG003|Follow-up Period|Participant withdrew consent|1|||
42299276|NCT02305563|76134384|FG004|Follow-up Period|Participant withdrew consent|0|||
42299277|NCT02305563|76134380|FG000|Follow-up Period|other reason|0|||
42299278|NCT02305563|76134381|FG001|Follow-up Period|other reason|0|||
42299279|NCT02305563|76134382|FG002|Follow-up Period|other reason|0|||
42299280|NCT02305563|76134383|FG003|Follow-up Period|other reason|0|||
42299281|NCT02305563|76134384|FG004|Follow-up Period|other reason|1|||
42299282|NCT02305563|76134380|FG000|Follow-up Period|Followup no longer required per protocol|3|||
42299283|NCT02305563|76134381|FG001|Follow-up Period|Followup no longer required per protocol|3|||
42299284|NCT02305563|76134382|FG002|Follow-up Period|Followup no longer required per protocol|4|||
42299285|NCT02305563|76134383|FG003|Follow-up Period|Followup no longer required per protocol|1|||
42299286|NCT02305563|76134384|FG004|Follow-up Period|Followup no longer required per protocol|4|||
42299287|NCT02327325|76134403|FG000|Overall Study|Withdrawal by Subject|1|||
42299288|NCT02327325|76134404|FG001|Overall Study|Withdrawal by Subject|4|||
42299289|NCT02327325|76134405|FG002|Overall Study|Withdrawal by Subject|4|||
42299290|NCT02327325|76134403|FG000|Overall Study|Excluded by Study Team|0|||
42391556|NCT01435616|76284844|FG001|Overall Study|Adverse Event|21|||
42391557|NCT01435616|76284843|FG000|Overall Study|Death|7|||
42299291|NCT02327325|76134404|FG001|Overall Study|Excluded by Study Team|0|||
42299292|NCT02327325|76134405|FG002|Overall Study|Excluded by Study Team|1|||
42299293|NCT02304705|76134415|FG000|Overall Study|Withdrawal by Subject|2|||
42299294|NCT02304705|76134416|FG001|Overall Study|Withdrawal by Subject|0|||
42391558|NCT01435616|76284844|FG001|Overall Study|Death|2|||
42391559|NCT01435616|76284843|FG000|Overall Study|Lost to Follow-up|22|||
42391560|NCT01435616|76284844|FG001|Overall Study|Lost to Follow-up|13|||
42391561|NCT01435616|76284843|FG000|Overall Study|Protocol Violation|16|||
42391562|NCT01435616|76284844|FG001|Overall Study|Protocol Violation|13|||
42391563|NCT01435616|76284843|FG000|Overall Study|Withdrawal by Subject|66|||
42391564|NCT01435616|76284844|FG001|Overall Study|Withdrawal by Subject|24|||
42391565|NCT01435616|76284843|FG000|Overall Study|Physician Decision|20|||
42391566|NCT01435616|76284844|FG001|Overall Study|Physician Decision|7|||
42391567|NCT01435616|76284843|FG000|Overall Study|Sponsor Decision|1|||
42391568|NCT01435616|76284844|FG001|Overall Study|Sponsor Decision|0|||
42391569|NCT01435460|76284903|FG000|Overall Study|Adverse Event|2|||
42391570|NCT01435460|76284904|FG001|Overall Study|Adverse Event|1|||
42391571|NCT01435460|76284903|FG000|Overall Study|Lost to Follow-up|6|||
42391572|NCT01435460|76284904|FG001|Overall Study|Lost to Follow-up|1|||
42391573|NCT01435460|76284903|FG000|Overall Study|Withdrawal by Subject|1|||
42391574|NCT01435460|76284904|FG001|Overall Study|Withdrawal by Subject|3|||
42391575|NCT01435460|76284903|FG000|Overall Study|Protocol Violation|0|||
42391576|NCT01435460|76284904|FG001|Overall Study|Protocol Violation|1|||
42391577|NCT01435460|76284903|FG000|Overall Study|Did not meet eligibility criteria|2|||
42391578|NCT01435460|76284904|FG001|Overall Study|Did not meet eligibility criteria|0|||
42391579|NCT01435382|76284990|FG000|Overall Study|Lost to Follow-up|1|||
42391580|NCT01435382|76284991|FG001|Overall Study|Lost to Follow-up|0|||
42391581|NCT01435382|76284992|FG002|Overall Study|Lost to Follow-up|1|||
42391582|NCT01435382|76284993|FG003|Overall Study|Lost to Follow-up|0|||
42391583|NCT01435382|76284990|FG000|Overall Study|Withdrawal by Subject|0|||
42391584|NCT01435382|76284991|FG001|Overall Study|Withdrawal by Subject|2|||
42391585|NCT01435382|76284992|FG002|Overall Study|Withdrawal by Subject|0|||
42391586|NCT01435382|76284993|FG003|Overall Study|Withdrawal by Subject|1|||
42391587|NCT01414166|76285058|FG000|Overall Study|Adverse Event|10|||
42391588|NCT01414166|76285059|FG001|Overall Study|Adverse Event|2|||
42391589|NCT01414166|76285058|FG000|Overall Study|Lost to Follow-up|4|||
42391590|NCT01414166|76285059|FG001|Overall Study|Lost to Follow-up|1|||
42391591|NCT01414166|76285058|FG000|Overall Study|Non-compliance with study drug|2|||
42391592|NCT01414166|76285059|FG001|Overall Study|Non-compliance with study drug|0|||
42391593|NCT01414166|76285058|FG000|Overall Study|Physician Decision|2|||
42391594|NCT01414166|76285059|FG001|Overall Study|Physician Decision|0|||
42391595|NCT01414166|76285058|FG000|Overall Study|Protocol Violation|2|||
42391596|NCT01414166|76285059|FG001|Overall Study|Protocol Violation|0|||
42391597|NCT01414166|76285058|FG000|Overall Study|Study terminated by Sponsor|68|||
42391598|NCT01414166|76285059|FG001|Overall Study|Study terminated by Sponsor|75|||
42391599|NCT01414166|76285058|FG000|Overall Study|Withdrawal by Subject|3|||
42391600|NCT01414166|76285059|FG001|Overall Study|Withdrawal by Subject|5|||
42391601|NCT01434680|76285069|FG000|Overall Study|Withdrawal by Subject|1|||
42391602|NCT01434680|76285070|FG001|Overall Study|Withdrawal by Subject|0|||
42391603|NCT01434680|76285071|FG002|Overall Study|Withdrawal by Subject|2|||
42391604|NCT01434680|76285072|FG003|Overall Study|Withdrawal by Subject|0|||
42391605|NCT01434680|76285069|FG000|Overall Study|Lost to Follow-up|1|||
42391606|NCT01434680|76285070|FG001|Overall Study|Lost to Follow-up|1|||
42391607|NCT01434680|76285071|FG002|Overall Study|Lost to Follow-up|0|||
42391608|NCT01434680|76285072|FG003|Overall Study|Lost to Follow-up|0|||
42391609|NCT01434680|76285069|FG000|Overall Study|Protocol Violation|1|||
42391610|NCT01434680|76285070|FG001|Overall Study|Protocol Violation|1|||
42391611|NCT01434680|76285071|FG002|Overall Study|Protocol Violation|0|||
42391612|NCT01434680|76285072|FG003|Overall Study|Protocol Violation|0|||
42391613|NCT01433978|76285205|FG000|Core Study|Adverse Event, Non-Fatal|0|||
42391614|NCT01433978|76285206|FG001|Core Study|Adverse Event, Non-Fatal|1|||
42391615|NCT01433978|76285207|FG002|Core Study|Adverse Event, Non-Fatal|0|||
42391616|NCT01433978|76285205|FG000|Core Study|Lack of Efficacy|5|||
42391617|NCT01433978|76285206|FG001|Core Study|Lack of Efficacy|1|||
42391618|NCT01433978|76285207|FG002|Core Study|Lack of Efficacy|0|||
42391619|NCT01433978|76285205|FG000|Core Study|Study Terminated by Sponsor|6|||
42391620|NCT01433978|76285206|FG001|Core Study|Study Terminated by Sponsor|9|||
42391621|NCT01433978|76285207|FG002|Core Study|Study Terminated by Sponsor|0|||
42391622|NCT01433978|76285205|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
42391623|NCT01433978|76285206|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
42391624|NCT01433978|76285207|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
42391625|NCT01433978|76285205|FG000|Extension Phase|Lack of Efficacy|0|||
42391626|NCT01433978|76285206|FG001|Extension Phase|Lack of Efficacy|0|||
42391627|NCT01433978|76285207|FG002|Extension Phase|Lack of Efficacy|1|||
42391628|NCT01433978|76285205|FG000|Extension Phase|Study Terminated by Sponsor|0|||
42391629|NCT01433978|76285206|FG001|Extension Phase|Study Terminated by Sponsor|0|||
42391630|NCT01433978|76285207|FG002|Extension Phase|Study Terminated by Sponsor|4|||
42391631|NCT01433354|76285256|FG000|Overall Study|Adverse Event|6|||
42391632|NCT01433354|76285256|FG000|Overall Study|Lost to Follow-up|1|||
42391633|NCT01433354|76285256|FG000|Overall Study|Administrative problems|90|||
42391634|NCT01433354|76285256|FG000|Overall Study|Protocol Violation|2|||
42391635|NCT01433354|76285256|FG000|Overall Study|Lack of Efficacy|17|||
42391636|NCT01433354|76285256|FG000|Overall Study|Subject Withdrew Consent|3|||
42391637|NCT05209360|76285816|FG000|Overall Study|Withdrawal by Subject|0|||
42391638|NCT05209360|76285817|FG001|Overall Study|Withdrawal by Subject|0|||
42391639|NCT05209360|76285818|FG002|Overall Study|Withdrawal by Subject|1|||
42391640|NCT05209360|76285819|FG003|Overall Study|Withdrawal by Subject|0|||
42391641|NCT05209360|76285820|FG004|Overall Study|Withdrawal by Subject|0|||
42391642|NCT05209360|76285821|FG005|Overall Study|Withdrawal by Subject|0|||
42391643|NCT04644237|76285882|FG000|Overall Study|Death|3|||
42391644|NCT04644237|76285883|FG001|Overall Study|Death|2|||
42391645|NCT04644237|76285882|FG000|Overall Study|Adverse Event|15|||
42391646|NCT04644237|76285883|FG001|Overall Study|Adverse Event|12|||
42391647|NCT04644237|76285882|FG000|Overall Study|Progressive Disease|47|||
42391648|NCT04644237|76285883|FG001|Overall Study|Progressive Disease|19|||
42391649|NCT04644237|76285882|FG000|Overall Study|Clinical Progression|4|||
42391650|NCT04644237|76285883|FG001|Overall Study|Clinical Progression|1|||
42391651|NCT04644237|76285882|FG000|Overall Study|Withdrawal by Subject|1|||
42391652|NCT04644237|76285883|FG001|Overall Study|Withdrawal by Subject|2|||
42391653|NCT04644237|76285882|FG000|Overall Study|Physician Decision|3|||
42391654|NCT04644237|76285883|FG001|Overall Study|Physician Decision|0|||
42391655|NCT04644237|76285882|FG000|Overall Study|Other|1|||
42391656|NCT04644237|76285883|FG001|Overall Study|Other|0|||
42391657|NCT04644237|76285882|FG000|Overall Study|Randomized but not Treated|1|||
42391658|NCT04644237|76285883|FG001|Overall Study|Randomized but not Treated|0|||
42391659|NCT04594733|76285891|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
42391660|NCT04594733|76285892|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
42391661|NCT04594733|76285891|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
42391662|NCT04594733|76285892|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
42391663|NCT04594733|76285891|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
42391664|NCT04594733|76285892|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
42391665|NCT04570657|76285902|FG000|Overall Study|Adverse Event|0|||
42391666|NCT04570657|76285903|FG001|Overall Study|Adverse Event|0|||
42391667|NCT04570657|76285904|FG002|Overall Study|Adverse Event|1|||
42391668|NCT04570657|76285902|FG000|Overall Study|Lost to Follow-up|0|||
42391669|NCT04570657|76285903|FG001|Overall Study|Lost to Follow-up|0|||
42391670|NCT04570657|76285904|FG002|Overall Study|Lost to Follow-up|1|||
42391671|NCT04570657|76285902|FG000|Overall Study|Physician Decision|0|||
42391672|NCT04570657|76285903|FG001|Overall Study|Physician Decision|1|||
42391673|NCT04570657|76285904|FG002|Overall Study|Physician Decision|0|||
42391674|NCT04570657|76285902|FG000|Overall Study|Withdrawal by Subject|1|||
42391675|NCT04570657|76285903|FG001|Overall Study|Withdrawal by Subject|2|||
42391676|NCT04570657|76285904|FG002|Overall Study|Withdrawal by Subject|2|||
42391677|NCT04566601|76285917|FG000|Overall Study|Other than listed|13|||
42391678|NCT04566601|76285918|FG001|Overall Study|Other than listed|4|||
42391679|NCT04566601|76285919|FG002|Overall Study|Other than listed|2|||
42391680|NCT04566601|76285920|FG003|Overall Study|Other than listed|1|||
42391681|NCT04566601|76285921|FG004|Overall Study|Other than listed|4|||
42391682|NCT04566601|76285917|FG000|Overall Study|Protocol deviation|3|||
42391683|NCT04566601|76285918|FG001|Overall Study|Protocol deviation|0|||
42391684|NCT04566601|76285919|FG002|Overall Study|Protocol deviation|1|||
42391685|NCT04566601|76285920|FG003|Overall Study|Protocol deviation|1|||
42391686|NCT04566601|76285921|FG004|Overall Study|Protocol deviation|1|||
42391687|NCT04566601|76285917|FG000|Overall Study|Technical problems|0|||
42391688|NCT04566601|76285918|FG001|Overall Study|Technical problems|0|||
42391689|NCT04566601|76285919|FG002|Overall Study|Technical problems|1|||
42391690|NCT04566601|76285920|FG003|Overall Study|Technical problems|0|||
42391691|NCT04566601|76285921|FG004|Overall Study|Technical problems|0|||
42391692|NCT04566601|76285917|FG000|Overall Study|No reason available|3|||
42391693|NCT04566601|76285918|FG001|Overall Study|No reason available|2|||
42391694|NCT04566601|76285919|FG002|Overall Study|No reason available|7|||
42391695|NCT04566601|76285920|FG003|Overall Study|No reason available|1|||
42391696|NCT04566601|76285921|FG004|Overall Study|No reason available|5|||
42391697|NCT04566601|76285917|FG000|Overall Study|Burden of study procedures|3|||
42391698|NCT04566601|76285918|FG001|Overall Study|Burden of study procedures|0|||
42391699|NCT04566601|76285919|FG002|Overall Study|Burden of study procedures|0|||
42391700|NCT04566601|76285920|FG003|Overall Study|Burden of study procedures|3|||
42391701|NCT04566601|76285921|FG004|Overall Study|Burden of study procedures|1|||
42391702|NCT04566601|76285917|FG000|Overall Study|Change of residence|2|||
42391703|NCT04566601|76285918|FG001|Overall Study|Change of residence|2|||
42391704|NCT04566601|76285919|FG002|Overall Study|Change of residence|0|||
42391705|NCT04566601|76285920|FG003|Overall Study|Change of residence|1|||
42391706|NCT04566601|76285921|FG004|Overall Study|Change of residence|2|||
42391707|NCT04566601|76285917|FG000|Overall Study|Perceived lack of efficacy|2|||
42391708|NCT04566601|76285918|FG001|Overall Study|Perceived lack of efficacy|0|||
42391709|NCT04566601|76285919|FG002|Overall Study|Perceived lack of efficacy|1|||
42391710|NCT04566601|76285920|FG003|Overall Study|Perceived lack of efficacy|1|||
42391711|NCT04566601|76285921|FG004|Overall Study|Perceived lack of efficacy|2|||
42391712|NCT04566601|76285917|FG000|Overall Study|Adverse Event|7|||
42391713|NCT04566601|76285918|FG001|Overall Study|Adverse Event|4|||
42391714|NCT04566601|76285919|FG002|Overall Study|Adverse Event|6|||
42391715|NCT04566601|76285920|FG003|Overall Study|Adverse Event|5|||
42391716|NCT04566601|76285921|FG004|Overall Study|Adverse Event|12|||
42391717|NCT04168112|76285975|FG000|Overall Study|Lost to Follow-up|1|||
42391718|NCT04168112|76285976|FG001|Overall Study|Lost to Follow-up|0|||
42391719|NCT04168112|76285975|FG000|Overall Study|Withdrawal by Subject|1|||
42391720|NCT04168112|76285976|FG001|Overall Study|Withdrawal by Subject|0|||
42391721|NCT04005352|76285984|FG000|Overall Study|Adverse Event|4|||
42391722|NCT04005352|76285985|FG001|Overall Study|Adverse Event|5|||
42391723|NCT04005352|76285984|FG000|Overall Study|Death|4|||
42391724|NCT04005352|76285985|FG001|Overall Study|Death|2|||
42391725|NCT04005352|76285984|FG000|Overall Study|Lost to Follow-up|6|||
42391726|NCT04005352|76285985|FG001|Overall Study|Lost to Follow-up|2|||
42391727|NCT04005352|76285984|FG000|Overall Study|Physician Decision|7|||
42391728|NCT04005352|76285985|FG001|Overall Study|Physician Decision|13|||
42391729|NCT04005352|76285984|FG000|Overall Study|Protocol Violation|0|||
42391730|NCT04005352|76285985|FG001|Overall Study|Protocol Violation|1|||
42391731|NCT04005352|76285984|FG000|Overall Study|Withdrawal by Subject|28|||
42391732|NCT04005352|76285985|FG001|Overall Study|Withdrawal by Subject|38|||
42391733|NCT03952039|76285998|FG000|Overall Study|Adverse Event|22|||
42391734|NCT03952039|76285999|FG001|Overall Study|Adverse Event|8|||
42391735|NCT03952039|76285998|FG000|Overall Study|Withdrawal by Participant|17|||
42391736|NCT03952039|76285999|FG001|Overall Study|Withdrawal by Participant|12|||
42391737|NCT03952039|76285998|FG000|Overall Study|Death|13|||
42391738|NCT03952039|76285999|FG001|Overall Study|Death|6|||
42391739|NCT03952039|76285998|FG000|Overall Study|Lack of Efficacy|12|||
42391740|NCT03952039|76285999|FG001|Overall Study|Lack of Efficacy|2|||
42391741|NCT03952039|76285998|FG000|Overall Study|Physician Decision|9|||
42391742|NCT03952039|76285999|FG001|Overall Study|Physician Decision|3|||
42391743|NCT03952039|76285998|FG000|Overall Study|Progressive Disease|6|||
42391744|NCT03952039|76285999|FG001|Overall Study|Progressive Disease|4|||
42391745|NCT03952039|76285998|FG000|Overall Study|Other Reasons|12|||
42391746|NCT03952039|76285999|FG001|Overall Study|Other Reasons|4|||
42391747|NCT03940586|76286018|FG000|Overall Study|Death|3|||
42391748|NCT03940586|76286019|FG001|Overall Study|Death|2|||
42391749|NCT03940586|76286020|FG002|Overall Study|Death|0|||
42391750|NCT03940586|76286018|FG000|Overall Study|Physician Decision|1|||
42391751|NCT03940586|76286019|FG001|Overall Study|Physician Decision|0|||
42391752|NCT03940586|76286020|FG002|Overall Study|Physician Decision|1|||
42391753|NCT03940586|76286018|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
42391754|NCT03940586|76286019|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
42391755|NCT03940586|76286020|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
42391756|NCT03940586|76286018|FG000|Overall Study|Not Treated|0|||
42391757|NCT03940586|76286019|FG001|Overall Study|Not Treated|2|||
42391758|NCT03940586|76286020|FG002|Overall Study|Not Treated|0|||
42391759|NCT03782974|76286072|FG000|Overall Study|Withdrawal by Subject|7|||
42391760|NCT03782974|76286073|FG001|Overall Study|Withdrawal by Subject|7|||
42391761|NCT03782974|76286072|FG000|Overall Study|Pregnancy|1|||
42391762|NCT03782974|76286073|FG001|Overall Study|Pregnancy|0|||
42391763|NCT03674411|76286095|FG000|Overall Study|Non-treatment|4|||
42391764|NCT03655470|76286101|FG000|Overall Study|Lost to Follow-up|6|||
42391765|NCT03655470|76286102|FG001|Overall Study|Lost to Follow-up|7|||
42391766|NCT03570619|76286111|FG000|Overall Study|Adverse Event|2|||
42391767|NCT03570619|76286112|FG001|Overall Study|Adverse Event|0|||
42391768|NCT03570619|76286113|FG002|Overall Study|Adverse Event|1|||
42391769|NCT03570619|76286111|FG000|Overall Study|new diagnosis of new malignancy|1|||
42391770|NCT03570619|76286112|FG001|Overall Study|new diagnosis of new malignancy|0|||
42391771|NCT03570619|76286113|FG002|Overall Study|new diagnosis of new malignancy|0|||
42391772|NCT03570619|76286111|FG000|Overall Study|Physician Decision|1|||
42391773|NCT03570619|76286112|FG001|Overall Study|Physician Decision|1|||
42391774|NCT03570619|76286113|FG002|Overall Study|Physician Decision|0|||
42391775|NCT03570619|76286111|FG000|Overall Study|Withdrawal by Subject|0|||
42391776|NCT03570619|76286112|FG001|Overall Study|Withdrawal by Subject|2|||
42391777|NCT03570619|76286113|FG002|Overall Study|Withdrawal by Subject|0|||
42391778|NCT03568461|76286121|FG000|Overall Study|Death|7|||
42391779|NCT03568461|76286121|FG000|Overall Study|Physician Decision|5|||
42391780|NCT03568461|76286121|FG000|Overall Study|Subject decision|5|||
42391781|NCT03568461|76286121|FG000|Overall Study|Lost to Follow-up|1|||
42391782|NCT03543254|76286125|FG000|Overall Study|Lost to Follow-up|1|||
42391783|NCT03447769|76286136|FG000|Overall Study|Progressive disease|138|||
42391784|NCT03447769|76286137|FG001|Overall Study|Progressive disease|148|||
42391785|NCT03447769|76286136|FG000|Overall Study|Study terminated by Sponsor|60|||
42391786|NCT03447769|76286137|FG001|Overall Study|Study terminated by Sponsor|44|||
42391787|NCT03447769|76286136|FG000|Overall Study|Adverse Event|34|||
42391788|NCT03447769|76286137|FG001|Overall Study|Adverse Event|31|||
42391789|NCT03447769|76286136|FG000|Overall Study|Patient decision|27|||
42391790|NCT03447769|76286137|FG001|Overall Study|Patient decision|27|||
42391791|NCT03447769|76286136|FG000|Overall Study|Protocol deviation|4|||
42391792|NCT03447769|76286137|FG001|Overall Study|Protocol deviation|6|||
42391793|NCT03447769|76286136|FG000|Overall Study|Death|2|||
42391794|NCT03447769|76286137|FG001|Overall Study|Death|7|||
42391795|NCT03447769|76286136|FG000|Overall Study|Technical problems|1|||
42391796|NCT03447769|76286137|FG001|Overall Study|Technical problems|0|||
42391797|NCT03447769|76286136|FG000|Overall Study|Lost to Follow-up|0|||
42391798|NCT03447769|76286137|FG001|Overall Study|Lost to Follow-up|1|||
42391799|NCT03447769|76286136|FG000|Overall Study|Physician Decision|13|||
42391800|NCT03447769|76286137|FG001|Overall Study|Physician Decision|5|||
42391801|NCT03446651|76286148|FG000|Overall Study|Lost to Follow-up|4|||
42391802|NCT03446651|76286149|FG001|Overall Study|Lost to Follow-up|0|||
42391803|NCT03446651|76286148|FG000|Overall Study|Open Label Participants|5|||
42391804|NCT03446651|76286149|FG001|Overall Study|Open Label Participants|0|||
42391805|NCT03442751|76286157|FG000|Overall Study|Withdrawal by Subject|3|||
42391806|NCT03442751|76286158|FG001|Overall Study|Withdrawal by Subject|1|||
42391807|NCT03442751|76286157|FG000|Overall Study|Lost to Follow-up|3|||
42391808|NCT03442751|76286158|FG001|Overall Study|Lost to Follow-up|0|||
42391809|NCT03255967|76286175|FG000|Overall Study|Adverse Event|26|||
42391810|NCT03255967|76286176|FG001|Overall Study|Adverse Event|30|||
42391811|NCT03255967|76286175|FG000|Overall Study|Withdrawal by Subject|6|||
42391812|NCT03255967|76286176|FG001|Overall Study|Withdrawal by Subject|6|||
42391813|NCT03255967|76286175|FG000|Overall Study|Schedule conflict|6|||
42391814|NCT03255967|76286176|FG001|Overall Study|Schedule conflict|4|||
42391815|NCT03255967|76286175|FG000|Overall Study|POA did not sign consent form|2|||
42391816|NCT03255967|76286176|FG001|Overall Study|POA did not sign consent form|0|||
42391817|NCT03151811|76286186|FG000|Overall Study|Randomized But Not Treated|18|||
42391818|NCT03151811|76286187|FG001|Overall Study|Randomized But Not Treated|3|||
42391819|NCT03151811|76286186|FG000|Overall Study|Progressive Disease|130|||
42391820|NCT03151811|76286187|FG001|Overall Study|Progressive Disease|170|||
42391821|NCT03151811|76286186|FG000|Overall Study|Adverse Event|49|||
42391822|NCT03151811|76286187|FG001|Overall Study|Adverse Event|40|||
42391823|NCT03151811|76286186|FG000|Overall Study|Lack of Efficacy|6|||
42391824|NCT03151811|76286187|FG001|Overall Study|Lack of Efficacy|8|||
42391825|NCT03151811|76286186|FG000|Overall Study|Physician Decision|21|||
42391826|NCT03151811|76286187|FG001|Overall Study|Physician Decision|9|||
42391827|NCT03151811|76286186|FG000|Overall Study|Withdrawal by Subject|17|||
42391828|NCT03151811|76286187|FG001|Overall Study|Withdrawal by Subject|7|||
42391829|NCT03151811|76286186|FG000|Overall Study|Lost to Follow-up|0|||
42391830|NCT03151811|76286187|FG001|Overall Study|Lost to Follow-up|1|||
42391831|NCT03151811|76286186|FG000|Overall Study|Study Terminated by Sponsor|5|||
42391832|NCT03151811|76286187|FG001|Overall Study|Study Terminated by Sponsor|11|||
42391833|NCT03110354|76286198|FG000|Overall Study|Death|1|||
42391834|NCT03110354|76286199|FG001|Overall Study|Death|0|||
42391835|NCT03110354|76286200|FG002|Overall Study|Death|0|||
42391836|NCT03110354|76286201|FG003|Overall Study|Death|1|||
42391837|NCT03110354|76286202|FG004|Overall Study|Death|0|||
42391838|NCT03110354|76286198|FG000|Overall Study|Start of new therapy|0|||
42391839|NCT03110354|76286199|FG001|Overall Study|Start of new therapy|0|||
42391840|NCT03110354|76286200|FG002|Overall Study|Start of new therapy|0|||
42391841|NCT03110354|76286201|FG003|Overall Study|Start of new therapy|0|||
42391842|NCT03110354|76286202|FG004|Overall Study|Start of new therapy|1|||
42391843|NCT03110354|76286198|FG000|Overall Study|Failure to achieve response|2|||
42391844|NCT03110354|76286199|FG001|Overall Study|Failure to achieve response|3|||
42391845|NCT03110354|76286200|FG002|Overall Study|Failure to achieve response|0|||
42391846|NCT03110354|76286201|FG003|Overall Study|Failure to achieve response|2|||
42391847|NCT03110354|76286202|FG004|Overall Study|Failure to achieve response|1|||
42391848|NCT03110354|76286198|FG000|Overall Study|Progressive disease|1|||
42391849|NCT03110354|76286199|FG001|Overall Study|Progressive disease|1|||
42391850|NCT03110354|76286200|FG002|Overall Study|Progressive disease|3|||
42391851|NCT03110354|76286201|FG003|Overall Study|Progressive disease|4|||
42391852|NCT03110354|76286202|FG004|Overall Study|Progressive disease|2|||
42391853|NCT03110354|76286198|FG000|Overall Study|Adverse Event|0|||
42391854|NCT03110354|76286199|FG001|Overall Study|Adverse Event|0|||
42391855|NCT03110354|76286200|FG002|Overall Study|Adverse Event|0|||
42391856|NCT03110354|76286201|FG003|Overall Study|Adverse Event|2|||
42391857|NCT03110354|76286202|FG004|Overall Study|Adverse Event|2|||
42391858|NCT03110354|76286198|FG000|Overall Study|Other|0|||
42391859|NCT03110354|76286199|FG001|Overall Study|Other|0|||
42391860|NCT03110354|76286200|FG002|Overall Study|Other|0|||
42391861|NCT03110354|76286201|FG003|Overall Study|Other|1|||
42391862|NCT03110354|76286202|FG004|Overall Study|Other|1|||
42391863|NCT03064126|76286218|FG000|Overall Study|Death|6|||
42391864|NCT03064126|76286219|FG001|Overall Study|Death|2|||
42391865|NCT03064126|76286220|FG002|Overall Study|Death|2|||
42391866|NCT03064126|76286221|FG003|Overall Study|Death|1|||
42391867|NCT03064126|76286218|FG000|Overall Study|Investigator Discretion|1|||
42391868|NCT03064126|76286219|FG001|Overall Study|Investigator Discretion|0|||
42391869|NCT03064126|76286220|FG002|Overall Study|Investigator Discretion|0|||
42391870|NCT03064126|76286221|FG003|Overall Study|Investigator Discretion|0|||
42391871|NCT03064126|76286218|FG000|Overall Study|Withdrawal by Subject|7|||
42391872|NCT03064126|76286219|FG001|Overall Study|Withdrawal by Subject|4|||
42391873|NCT03064126|76286220|FG002|Overall Study|Withdrawal by Subject|0|||
42391874|NCT03064126|76286221|FG003|Overall Study|Withdrawal by Subject|0|||
42391875|NCT03064126|76286218|FG000|Overall Study|Subject moved|1|||
42391876|NCT03064126|76286219|FG001|Overall Study|Subject moved|0|||
42391877|NCT03064126|76286220|FG002|Overall Study|Subject moved|0|||
42391878|NCT03064126|76286221|FG003|Overall Study|Subject moved|0|||
42391879|NCT03064126|76286218|FG000|Overall Study|Protocol Violation|11|||
42391880|NCT03064126|76286219|FG001|Overall Study|Protocol Violation|1|||
42391881|NCT03064126|76286220|FG002|Overall Study|Protocol Violation|1|||
42391882|NCT03064126|76286221|FG003|Overall Study|Protocol Violation|0|||
42391883|NCT02706951|76286263|FG000|Period 1|Adverse Event|1|||
42391884|NCT02706951|76286264|FG001|Period 1|Adverse Event|5|||
42391885|NCT02706951|76286265|FG002|Period 1|Adverse Event|3|||
42391886|NCT02706951|76286266|FG003|Period 1|Adverse Event|0|||
42391887|NCT02706951|76286267|FG004|Period 1|Adverse Event|0|||
42391888|NCT02706951|76286263|FG000|Period 1|Withdrawal by Subject|10|||
42391889|NCT02706951|76286264|FG001|Period 1|Withdrawal by Subject|6|||
42391890|NCT02706951|76286265|FG002|Period 1|Withdrawal by Subject|6|||
42391891|NCT02706951|76286266|FG003|Period 1|Withdrawal by Subject|0|||
42391892|NCT02706951|76286267|FG004|Period 1|Withdrawal by Subject|0|||
42391893|NCT02706951|76286263|FG000|Period 1|Lost to Follow-up|0|||
42391894|NCT02706951|76286264|FG001|Period 1|Lost to Follow-up|4|||
42299295|NCT02304705|76134415|FG000|Overall Study|Physician Decision|2|||
42391895|NCT02706951|76286265|FG002|Period 1|Lost to Follow-up|1|||
42391896|NCT02706951|76286266|FG003|Period 1|Lost to Follow-up|0|||
42391897|NCT02706951|76286267|FG004|Period 1|Lost to Follow-up|0|||
42391898|NCT02706951|76286263|FG000|Period 1|Other|2|||
42391899|NCT02706951|76286264|FG001|Period 1|Other|1|||
42391900|NCT02706951|76286265|FG002|Period 1|Other|0|||
42205386|NCT03435081|76018035|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
42205387|NCT03435081|76018033|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
42205388|NCT03435081|76018034|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
42205389|NCT03435081|76018035|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
42205390|NCT03435081|76018033|FG000|Week 16 to Week 104|Adverse Event|1|||
42205391|NCT03435081|76018034|FG001|Week 16 to Week 104|Adverse Event|0|||
42205392|NCT03435081|76018035|FG002|Week 16 to Week 104|Adverse Event|2|||
42205393|NCT03435081|76018033|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
42205394|NCT03435081|76018034|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
42205395|NCT03435081|76018035|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
42205396|NCT03435081|76018033|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
42205397|NCT03435081|76018034|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
42205398|NCT03435081|76018035|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
42205399|NCT03435081|76018033|FG000|Week 16 to Week 104|Non--Compliance|0|||
42205400|NCT03435081|76018034|FG001|Week 16 to Week 104|Non--Compliance|0|||
42205401|NCT03435081|76018035|FG002|Week 16 to Week 104|Non--Compliance|1|||
42205402|NCT02738008|76018050|FG000|Overall Study|Study Terminated by Sponsor|1|||
42205403|NCT02738008|76018051|FG001|Overall Study|Study Terminated by Sponsor|5|||
42205404|NCT02738008|76018052|FG002|Overall Study|Study Terminated by Sponsor|3|||
42205405|NCT02738008|76018050|FG000|Overall Study|Adverse Event|0|||
42205406|NCT02738008|76018051|FG001|Overall Study|Adverse Event|1|||
42205407|NCT02738008|76018052|FG002|Overall Study|Adverse Event|2|||
42205408|NCT03489369|76018064|FG000|Overall Study|Documented Progressive Disease|3|||
42205409|NCT03489369|76018065|FG001|Overall Study|Documented Progressive Disease|2|||
42205410|NCT03489369|76018066|FG002|Overall Study|Documented Progressive Disease|3|||
42205411|NCT03489369|76018067|FG003|Overall Study|Documented Progressive Disease|6|||
42205412|NCT03489369|76018064|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
42205413|NCT03489369|76018065|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
42205414|NCT03489369|76018066|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
42205415|NCT03489369|76018067|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
42205416|NCT03257254|76018077|FG000|Overall Study|Withdrawal by Subject|7|||
42205417|NCT03257254|76018077|FG000|Overall Study|Lost to Follow-up|9|||
42205418|NCT03257254|76018077|FG000|Overall Study|Study discontinued by sponsor|5|||
42205419|NCT03738475|76018083|FG000|Overall Study|Participant Non-Compliance|1|||
42205420|NCT03738475|76018084|FG001|Overall Study|Participant Non-Compliance|0|||
42205421|NCT03084718|76018095|FG000|Overall Study|Withdrawal by Subject|4|||
42205422|NCT03084718|76018096|FG001|Overall Study|Withdrawal by Subject|3|||
42205423|NCT03084718|76018097|FG002|Overall Study|Withdrawal by Subject|4|||
42205424|NCT03084718|76018098|FG003|Overall Study|Withdrawal by Subject|0|||
42205425|NCT03084718|76018099|FG004|Overall Study|Withdrawal by Subject|0|||
42205426|NCT03084718|76018095|FG000|Overall Study|Physician Decision|1|||
42205427|NCT03084718|76018096|FG001|Overall Study|Physician Decision|0|||
42205428|NCT03084718|76018097|FG002|Overall Study|Physician Decision|0|||
42205429|NCT03084718|76018098|FG003|Overall Study|Physician Decision|0|||
42205430|NCT03084718|76018099|FG004|Overall Study|Physician Decision|0|||
42205431|NCT03084718|76018095|FG000|Overall Study|Adverse Event|3|||
42205432|NCT03084718|76018096|FG001|Overall Study|Adverse Event|5|||
42205433|NCT03084718|76018097|FG002|Overall Study|Adverse Event|5|||
42205434|NCT03084718|76018098|FG003|Overall Study|Adverse Event|8|||
42205435|NCT03084718|76018099|FG004|Overall Study|Adverse Event|2|||
42205436|NCT03084718|76018095|FG000|Overall Study|Lack of Efficacy|2|||
42205437|NCT03084718|76018096|FG001|Overall Study|Lack of Efficacy|0|||
42205438|NCT03084718|76018097|FG002|Overall Study|Lack of Efficacy|1|||
42205439|NCT03084718|76018098|FG003|Overall Study|Lack of Efficacy|4|||
42205440|NCT03084718|76018099|FG004|Overall Study|Lack of Efficacy|0|||
42205441|NCT03084718|76018095|FG000|Overall Study|Lost to Follow-up|0|||
42205442|NCT03084718|76018096|FG001|Overall Study|Lost to Follow-up|1|||
42205443|NCT03084718|76018097|FG002|Overall Study|Lost to Follow-up|0|||
42205444|NCT03084718|76018098|FG003|Overall Study|Lost to Follow-up|0|||
42205445|NCT03084718|76018099|FG004|Overall Study|Lost to Follow-up|2|||
42205446|NCT03084718|76018095|FG000|Overall Study|Protocol Violation|0|||
42205447|NCT03084718|76018096|FG001|Overall Study|Protocol Violation|0|||
42205448|NCT03084718|76018097|FG002|Overall Study|Protocol Violation|1|||
42205449|NCT03084718|76018098|FG003|Overall Study|Protocol Violation|0|||
42205450|NCT03084718|76018099|FG004|Overall Study|Protocol Violation|0|||
42205451|NCT03084718|76018095|FG000|Overall Study|Death|0|||
42205452|NCT03084718|76018096|FG001|Overall Study|Death|1|||
42205453|NCT03084718|76018097|FG002|Overall Study|Death|0|||
42205454|NCT03084718|76018098|FG003|Overall Study|Death|0|||
42205455|NCT03084718|76018099|FG004|Overall Study|Death|0|||
42205456|NCT03084718|76018095|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
42205457|NCT03084718|76018096|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
42205458|NCT03084718|76018097|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
42391901|NCT02706951|76286266|FG003|Period 1|Other|0|||
42391902|NCT02706951|76286267|FG004|Period 1|Other|0|||
42391903|NCT02706951|76286263|FG000|Period 2|Adverse Event|0|||
42391904|NCT02706951|76286264|FG001|Period 2|Adverse Event|0|||
42391905|NCT02706951|76286265|FG002|Period 2|Adverse Event|0|||
42391906|NCT02706951|76286266|FG003|Period 2|Adverse Event|25|||
42391907|NCT02706951|76286267|FG004|Period 2|Adverse Event|34|||
42391908|NCT02706951|76286263|FG000|Period 2|Withdrawal by Subject|0|||
42391909|NCT02706951|76286264|FG001|Period 2|Withdrawal by Subject|0|||
42391910|NCT02706951|76286265|FG002|Period 2|Withdrawal by Subject|0|||
42391911|NCT02706951|76286266|FG003|Period 2|Withdrawal by Subject|38|||
42391912|NCT02706951|76286267|FG004|Period 2|Withdrawal by Subject|44|||
42391913|NCT02706951|76286263|FG000|Period 2|Lost to Follow-up|0|||
42391914|NCT02706951|76286264|FG001|Period 2|Lost to Follow-up|0|||
42391915|NCT02706951|76286265|FG002|Period 2|Lost to Follow-up|0|||
42391916|NCT02706951|76286266|FG003|Period 2|Lost to Follow-up|17|||
42391917|NCT02706951|76286267|FG004|Period 2|Lost to Follow-up|9|||
42391918|NCT02706951|76286263|FG000|Period 2|COVID-19 Related|0|||
42391919|NCT02706951|76286264|FG001|Period 2|COVID-19 Related|0|||
42391920|NCT02706951|76286265|FG002|Period 2|COVID-19 Related|0|||
42391921|NCT02706951|76286266|FG003|Period 2|COVID-19 Related|1|||
42391922|NCT02706951|76286267|FG004|Period 2|COVID-19 Related|2|||
42391923|NCT02706951|76286263|FG000|Period 2|Other|0|||
42391924|NCT02706951|76286264|FG001|Period 2|Other|0|||
42391925|NCT02706951|76286265|FG002|Period 2|Other|0|||
42391926|NCT02706951|76286266|FG003|Period 2|Other|37|||
42391927|NCT02706951|76286267|FG004|Period 2|Other|31|||
42391928|NCT02609386|76286280|FG000|Overall Study|Withdrawal by Subject|6|||
42205459|NCT03084718|76018098|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
42205460|NCT03084718|76018099|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
42205461|NCT04321252|76018123|FG000|Overall Study|Withdrawal by Subject|0|||
42205462|NCT04321252|76018124|FG001|Overall Study|Withdrawal by Subject|0|||
42205463|NCT04321252|76018125|FG002|Overall Study|Withdrawal by Subject|0|||
42205464|NCT04321252|76018126|FG003|Overall Study|Withdrawal by Subject|0|||
42205465|NCT04321252|76018127|FG004|Overall Study|Withdrawal by Subject|0|||
42205466|NCT04321252|76018128|FG005|Overall Study|Withdrawal by Subject|1|||
42205467|NCT04321252|76018129|FG006|Overall Study|Withdrawal by Subject|0|||
42205468|NCT04321252|76018130|FG007|Overall Study|Withdrawal by Subject|0|||
42205469|NCT04321252|76018131|FG008|Overall Study|Withdrawal by Subject|0|||
42205470|NCT03433677|76018163|FG000|Period 1|Protocol Violation|1|||
42205471|NCT03433677|76018164|FG001|Period 1|Protocol Violation|0|||
42205472|NCT03433677|76018163|FG000|Period 2|Withdrawal by Subject|1|||
42205473|NCT03433677|76018164|FG001|Period 2|Withdrawal by Subject|1|||
42205474|NCT02492711|76018174|FG000|Overall Study|Adverse Event|9|||
42205475|NCT02492711|76018175|FG001|Overall Study|Adverse Event|9|||
42205476|NCT02492711|76018176|FG002|Overall Study|Adverse Event|2|||
42205477|NCT02492711|76018174|FG000|Overall Study|Death|3|||
42205478|NCT02492711|76018175|FG001|Overall Study|Death|3|||
42205479|NCT02492711|76018176|FG002|Overall Study|Death|0|||
42205480|NCT02492711|76018174|FG000|Overall Study|Withdrawal by Subject|10|||
42205481|NCT02492711|76018175|FG001|Overall Study|Withdrawal by Subject|16|||
42205482|NCT02492711|76018176|FG002|Overall Study|Withdrawal by Subject|5|||
42205483|NCT02492711|76018174|FG000|Overall Study|Physician Decision|10|||
42205484|NCT02492711|76018175|FG001|Overall Study|Physician Decision|6|||
42205485|NCT02492711|76018176|FG002|Overall Study|Physician Decision|4|||
42205486|NCT02492711|76018174|FG000|Overall Study|Lost to Follow-up|0|||
42205487|NCT02492711|76018175|FG001|Overall Study|Lost to Follow-up|0|||
42205488|NCT02492711|76018176|FG002|Overall Study|Lost to Follow-up|1|||
42205489|NCT02492711|76018174|FG000|Overall Study|study treatment delay|2|||
42205490|NCT02492711|76018175|FG001|Overall Study|study treatment delay|1|||
42205491|NCT02492711|76018176|FG002|Overall Study|study treatment delay|0|||
42205492|NCT02492711|76018174|FG000|Overall Study|change in chemotherapy|0|||
42205493|NCT02492711|76018175|FG001|Overall Study|change in chemotherapy|1|||
42205494|NCT02492711|76018176|FG002|Overall Study|change in chemotherapy|0|||
42205495|NCT02492711|76018174|FG000|Overall Study|never treated|2|||
42205496|NCT02492711|76018175|FG001|Overall Study|never treated|4|||
42205497|NCT02492711|76018176|FG002|Overall Study|never treated|0|||
42205498|NCT02492711|76018174|FG000|Overall Study|Other|0|||
42205499|NCT02492711|76018175|FG001|Overall Study|Other|0|||
42205500|NCT02492711|76018176|FG002|Overall Study|Other|1|||
42205501|NCT01147822|76018191|FG000|Overall Study|Death|66|||
42205502|NCT01147822|76018192|FG001|Overall Study|Death|59|||
42205503|NCT01147822|76018191|FG000|Overall Study|Protocol Violation|0|||
42205504|NCT01147822|76018192|FG001|Overall Study|Protocol Violation|1|||
42205505|NCT01147822|76018191|FG000|Overall Study|Lost to Follow-up|3|||
42205506|NCT01147822|76018192|FG001|Overall Study|Lost to Follow-up|2|||
42205507|NCT01147822|76018191|FG000|Overall Study|Physician Decision|0|||
42205508|NCT01147822|76018192|FG001|Overall Study|Physician Decision|2|||
42205509|NCT01147822|76018191|FG000|Overall Study|Withdrawal by Subject|8|||
42205510|NCT01147822|76018192|FG001|Overall Study|Withdrawal by Subject|13|||
42205511|NCT01147822|76018191|FG000|Overall Study|Not Completed/Ongoing|111|||
42205512|NCT01147822|76018192|FG001|Overall Study|Not Completed/Ongoing|102|||
42205513|NCT03431337|76018200|FG000|Overall Study|Lost to Follow-up|21|||
42205514|NCT03431337|76018201|FG001|Overall Study|Lost to Follow-up|19|||
42205515|NCT03431337|76018200|FG000|Overall Study|Withdrawal by Subject|8|||
42205516|NCT03431337|76018201|FG001|Overall Study|Withdrawal by Subject|3|||
42205517|NCT03738241|76018221|FG000|Overall Study|Withdrawal by Subject|0|||
42205518|NCT03738241|76018222|FG001|Overall Study|Withdrawal by Subject|0|||
42205519|NCT03738241|76018223|FG002|Overall Study|Withdrawal by Subject|0|||
42205520|NCT03738241|76018224|FG003|Overall Study|Withdrawal by Subject|0|||
42205521|NCT03738241|76018225|FG004|Overall Study|Withdrawal by Subject|0|||
42205522|NCT03738241|76018226|FG005|Overall Study|Withdrawal by Subject|0|||
42205523|NCT03738241|76018227|FG006|Overall Study|Withdrawal by Subject|0|||
42205524|NCT03738241|76018228|FG007|Overall Study|Withdrawal by Subject|0|||
42205525|NCT03738241|76018229|FG008|Overall Study|Withdrawal by Subject|0|||
42205526|NCT03738241|76018230|FG009|Overall Study|Withdrawal by Subject|1|||
42205527|NCT03738241|76018221|FG000|Overall Study|Physician Decision|0|||
42205528|NCT03738241|76018222|FG001|Overall Study|Physician Decision|0|||
42205529|NCT03738241|76018223|FG002|Overall Study|Physician Decision|0|||
42205530|NCT03738241|76018224|FG003|Overall Study|Physician Decision|0|||
42205531|NCT03738241|76018225|FG004|Overall Study|Physician Decision|0|||
42205532|NCT03738241|76018226|FG005|Overall Study|Physician Decision|0|||
42205533|NCT03738241|76018227|FG006|Overall Study|Physician Decision|0|||
42205534|NCT03738241|76018228|FG007|Overall Study|Physician Decision|0|||
42205535|NCT03738241|76018229|FG008|Overall Study|Physician Decision|1|||
42205536|NCT03738241|76018230|FG009|Overall Study|Physician Decision|0|||
42205537|NCT03738241|76018221|FG000|Overall Study|Adverse Event|1|||
42205538|NCT03738241|76018222|FG001|Overall Study|Adverse Event|0|||
42205539|NCT03738241|76018223|FG002|Overall Study|Adverse Event|0|||
42205540|NCT03738241|76018224|FG003|Overall Study|Adverse Event|0|||
42205541|NCT03738241|76018225|FG004|Overall Study|Adverse Event|0|||
42205542|NCT03738241|76018226|FG005|Overall Study|Adverse Event|0|||
42205543|NCT03738241|76018227|FG006|Overall Study|Adverse Event|0|||
42205544|NCT03738241|76018228|FG007|Overall Study|Adverse Event|0|||
42205545|NCT03738241|76018229|FG008|Overall Study|Adverse Event|0|||
42205546|NCT03738241|76018230|FG009|Overall Study|Adverse Event|0|||
42205547|NCT03430245|76018252|FG000|Overall Study|Withdrawal by Subject|6|||
42205548|NCT03430245|76018252|FG000|Overall Study|Lost to Follow-up|1|||
42205549|NCT03461289|76018256|FG000|Overall Study|Death|1|||
42205550|NCT03452943|76018262|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
42205551|NCT03452943|76018263|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
42205552|NCT03452943|76018262|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
42205553|NCT03452943|76018263|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
42205554|NCT03452943|76018262|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
42205555|NCT03452943|76018263|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
42205556|NCT03452943|76018262|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
42205557|NCT03452943|76018263|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
42205558|NCT03452943|76018262|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
42205559|NCT03452943|76018263|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
42205560|NCT03452943|76018262|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
42205561|NCT03452943|76018263|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
42205562|NCT03481725|76018271|FG000|Overall Study|Withdrawal by Subject|1|||
42205563|NCT03481725|76018272|FG001|Overall Study|Withdrawal by Subject|0|||
42205564|NCT03480243|76018280|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
42205565|NCT03480243|76018280|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
42205566|NCT03426345|76018295|FG000|Overall Study|Adverse Event|4|||
42205567|NCT03426345|76018296|FG001|Overall Study|Adverse Event|4|||
42205568|NCT03426345|76018295|FG000|Overall Study|Lack of Efficacy|1|||
42205569|NCT03426345|76018296|FG001|Overall Study|Lack of Efficacy|0|||
42205570|NCT03426345|76018295|FG000|Overall Study|Withdrawal by Subject|5|||
42205571|NCT03426345|76018296|FG001|Overall Study|Withdrawal by Subject|6|||
42205572|NCT03426345|76018295|FG000|Overall Study|Lost to Follow-up|3|||
42205573|NCT03426345|76018296|FG001|Overall Study|Lost to Follow-up|1|||
42205574|NCT03426345|76018295|FG000|Overall Study|Protocol Deviation|3|||
42205575|NCT03426345|76018296|FG001|Overall Study|Protocol Deviation|4|||
42205576|NCT03426345|76018295|FG000|Overall Study|Reason Not Specified|1|||
42205577|NCT03426345|76018296|FG001|Overall Study|Reason Not Specified|2|||
42205578|NCT03426345|76018295|FG000|Overall Study|Missing Completion Status|1|||
42205579|NCT03426345|76018296|FG001|Overall Study|Missing Completion Status|0|||
42205580|NCT03426267|76018305|FG000|Overall Study|Physician Decision|1|||
42205581|NCT03426267|76018306|FG001|Overall Study|Physician Decision|4|||
42205582|NCT03426267|76018305|FG000|Overall Study|Lost to Follow-up|1|||
42205583|NCT03426267|76018306|FG001|Overall Study|Lost to Follow-up|0|||
42205584|NCT03426267|76018305|FG000|Overall Study|Withdrawal by Subject|4|||
42205585|NCT03426267|76018306|FG001|Overall Study|Withdrawal by Subject|10|||
42205586|NCT03426267|76018305|FG000|Overall Study|Protocol Violation|1|||
42205587|NCT03426267|76018306|FG001|Overall Study|Protocol Violation|3|||
42205588|NCT03426267|76018305|FG000|Overall Study|Adverse Event|9|||
42205589|NCT03426267|76018306|FG001|Overall Study|Adverse Event|27|||
42205590|NCT03426267|76018305|FG000|Overall Study|Prohibited Treatment Intake|2|||
42205591|NCT03426267|76018306|FG001|Overall Study|Prohibited Treatment Intake|3|||
42205592|NCT03426267|76018305|FG000|Overall Study|Lack of Efficacy|0|||
42205593|NCT03426267|76018306|FG001|Overall Study|Lack of Efficacy|25|||
42205594|NCT03426267|76018305|FG000|Overall Study|other|3|||
42205595|NCT03426267|76018306|FG001|Overall Study|other|0|||
42205596|NCT03412929|76018312|FG000|Overall Study|Protocol Violation|3|||
42205597|NCT03451773|76018318|FG000|Overall Study|Death on study|1|||
42205598|NCT03451773|76018319|FG001|Overall Study|Death on study|5|||
42205599|NCT03451773|76018318|FG000|Overall Study|Death during follow-up period|0|||
42205600|NCT03451773|76018319|FG001|Overall Study|Death during follow-up period|1|||
42205601|NCT03425253|76018326|FG000|Overall Study|Adverse Event|2|||
42205602|NCT03425253|76018326|FG000|Overall Study|Lost to Follow-up|3|||
42205603|NCT03425253|76018326|FG000|Overall Study|Withdrew Consent|6|||
42205604|NCT03425253|76018326|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
42205605|NCT03424239|76018331|FG000|Overall Study|Withdrawal by Subject|2|||
42205606|NCT03451071|76018335|FG000|First Vaccine|Withdrawal by Subject|1|||
42205607|NCT03451071|76018335|FG000|Second Vaccine|Lost to Follow-up|19|||
42205608|NCT03451071|76018335|FG000|Third Vaccine|Lost to Follow-up|22|||
42205609|NCT03451071|76018335|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
42205610|NCT03449979|76018343|FG000|Overall Study|Technical difficulty|0|||
42205611|NCT03449979|76018344|FG001|Overall Study|Technical difficulty|0|||
42205612|NCT03449979|76018345|FG002|Overall Study|Technical difficulty|0|||
42205613|NCT03449979|76018346|FG003|Overall Study|Technical difficulty|1|||
42205614|NCT03449199|76018359|FG000|Overall Study|Lost to Follow-up|1|||
42205615|NCT03449199|76018360|FG001|Overall Study|Lost to Follow-up|1|||
42205616|NCT03449199|76018361|FG002|Overall Study|Lost to Follow-up|0|||
42205617|NCT03449199|76018359|FG000|Overall Study|Protocol Deviation|0|||
42205618|NCT03449199|76018360|FG001|Overall Study|Protocol Deviation|0|||
42205619|NCT03449199|76018361|FG002|Overall Study|Protocol Deviation|1|||
42205620|NCT03449199|76018359|FG000|Overall Study|Withdrawal by Subject|0|||
42205621|NCT03449199|76018360|FG001|Overall Study|Withdrawal by Subject|0|||
42205622|NCT03449199|76018361|FG002|Overall Study|Withdrawal by Subject|1|||
42205623|NCT03421431|76018375|FG000|Overall Study|Adverse Event|2|||
42205624|NCT03421431|76018376|FG001|Overall Study|Adverse Event|1|||
42205625|NCT03421431|76018377|FG002|Overall Study|Adverse Event|12|||
42205626|NCT03421431|76018375|FG000|Overall Study|Lost to Follow-up|1|||
42205627|NCT03421431|76018376|FG001|Overall Study|Lost to Follow-up|1|||
42205628|NCT03421431|76018377|FG002|Overall Study|Lost to Follow-up|1|||
42205629|NCT03421431|76018375|FG000|Overall Study|Withdrawal by Subject|3|||
42205630|NCT03421431|76018376|FG001|Overall Study|Withdrawal by Subject|2|||
42205631|NCT03421431|76018377|FG002|Overall Study|Withdrawal by Subject|1|||
42205632|NCT03421431|76018375|FG000|Overall Study|Protocol Violation|0|||
42205633|NCT03421431|76018376|FG001|Overall Study|Protocol Violation|1|||
42205634|NCT03421431|76018377|FG002|Overall Study|Protocol Violation|0|||
42205635|NCT03421431|76018375|FG000|Overall Study|Participant met Stopping Rules|0|||
42205636|NCT03421431|76018376|FG001|Overall Study|Participant met Stopping Rules|1|||
42205637|NCT03421431|76018377|FG002|Overall Study|Participant met Stopping Rules|0|||
42205638|NCT03448419|76018389|FG000|Overall Study|Adverse Event|10|||
42205639|NCT03448419|76018390|FG001|Overall Study|Adverse Event|9|||
42205640|NCT03448419|76018389|FG000|Overall Study|Lost to Follow-up|0|||
42205641|NCT03448419|76018390|FG001|Overall Study|Lost to Follow-up|2|||
42205642|NCT03448419|76018389|FG000|Overall Study|Withdrawal by Subject|3|||
42205643|NCT03448419|76018390|FG001|Overall Study|Withdrawal by Subject|1|||
42205644|NCT03448419|76018389|FG000|Overall Study|Not treated|0|||
42205645|NCT03448419|76018390|FG001|Overall Study|Not treated|1|||
42205646|NCT03448419|76018389|FG000|Overall Study|Patient did not attend all visits|0|||
42205647|NCT03448419|76018390|FG001|Overall Study|Patient did not attend all visits|2|||
42205648|NCT03448419|76018389|FG000|Overall Study|Withdrawn by Sponsor|0|||
42205649|NCT03448419|76018390|FG001|Overall Study|Withdrawn by Sponsor|1|||
42205650|NCT04816214|76018407|FG000|Overall Study|Progressive Disease|4|||
42205651|NCT04816214|76018408|FG001|Overall Study|Progressive Disease|0|||
42205652|NCT04816214|76018409|FG002|Overall Study|Progressive Disease|0|||
42205653|NCT04816214|76018407|FG000|Overall Study|Death|1|||
42205654|NCT04816214|76018408|FG001|Overall Study|Death|0|||
42205655|NCT04816214|76018409|FG002|Overall Study|Death|0|||
42205656|NCT04816214|76018407|FG000|Overall Study|Study Terminated by Sponsor|1|||
42205657|NCT04816214|76018408|FG001|Overall Study|Study Terminated by Sponsor|0|||
42205658|NCT04816214|76018409|FG002|Overall Study|Study Terminated by Sponsor|0|||
42205659|NCT04350827|76018454|FG000|Overall Study|Lost to Follow-up|1|||
42205660|NCT04350827|76018455|FG001|Overall Study|Lost to Follow-up|2|||
42205661|NCT04303000|76018463|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
42205662|NCT04303000|76018464|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
42205663|NCT04303000|76018465|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
42205664|NCT04212650|76018486|FG000|Overall Study|Withdrawal by Subject|1|||
42205665|NCT04212650|76018487|FG001|Overall Study|Withdrawal by Subject|0|||
42205666|NCT03992196|76018508|FG000|Enrollment|lost to follow-up prior dosing|1|||
42205667|NCT03992196|76018509|FG001|Enrollment|lost to follow-up prior dosing|0|||
42205668|NCT03992196|76018510|FG002|Enrollment|lost to follow-up prior dosing|0|||
42205669|NCT03992196|76018508|FG000|Treatment|Protocol Violation|0|||
42205670|NCT03992196|76018509|FG001|Treatment|Protocol Violation|0|||
42205671|NCT03992196|76018510|FG002|Treatment|Protocol Violation|1|||
42205672|NCT03992196|76018508|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
42205673|NCT03992196|76018509|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
42205674|NCT03992196|76018510|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
42205675|NCT03992196|76018508|FG000|Treatment|Withdrawal due to non-compliance|0|||
42205676|NCT03992196|76018509|FG001|Treatment|Withdrawal due to non-compliance|0|||
42205677|NCT03992196|76018510|FG002|Treatment|Withdrawal due to non-compliance|1|||
42205678|NCT03992196|76018508|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
42205679|NCT03992196|76018509|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
42205680|NCT03992196|76018510|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
42205681|NCT03992196|76018508|FG000|Treatment|Withdrawal by parent/guardian|0|||
42205682|NCT03992196|76018509|FG001|Treatment|Withdrawal by parent/guardian|0|||
42205683|NCT03992196|76018510|FG002|Treatment|Withdrawal by parent/guardian|2|||
42205684|NCT03970200|76018519|FG000|Overall Study|Death|2|||
42205685|NCT03970200|76018520|FG001|Overall Study|Death|2|||
42205686|NCT03970200|76018521|FG002|Overall Study|Death|1|||
42205687|NCT03970200|76018519|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
42205688|NCT03970200|76018520|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
42205689|NCT03970200|76018521|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
42205690|NCT03840200|76018533|FG000|Overall Study|Death|6|||
42205691|NCT03840200|76018534|FG001|Overall Study|Death|3|||
42205692|NCT03840200|76018535|FG002|Overall Study|Death|6|||
42205693|NCT03840200|76018536|FG003|Overall Study|Death|10|||
42205694|NCT03840200|76018533|FG000|Overall Study|Reason Not Specified|2|||
42205695|NCT03840200|76018534|FG001|Overall Study|Reason Not Specified|2|||
42205696|NCT03840200|76018535|FG002|Overall Study|Reason Not Specified|1|||
42205697|NCT03840200|76018536|FG003|Overall Study|Reason Not Specified|15|||
42205698|NCT03840200|76018533|FG000|Overall Study|Physician Decision|0|||
42205699|NCT03840200|76018534|FG001|Overall Study|Physician Decision|0|||
42205700|NCT03840200|76018535|FG002|Overall Study|Physician Decision|0|||
42205701|NCT03840200|76018536|FG003|Overall Study|Physician Decision|2|||
42205702|NCT03840200|76018533|FG000|Overall Study|Progressive Disease|0|||
42205703|NCT03840200|76018534|FG001|Overall Study|Progressive Disease|0|||
42205704|NCT03840200|76018535|FG002|Overall Study|Progressive Disease|0|||
42205705|NCT03840200|76018536|FG003|Overall Study|Progressive Disease|1|||
42205706|NCT03840200|76018533|FG000|Overall Study|Withdrawal by Subject|0|||
42205707|NCT03840200|76018534|FG001|Overall Study|Withdrawal by Subject|1|||
42205708|NCT03840200|76018535|FG002|Overall Study|Withdrawal by Subject|0|||
42205709|NCT03840200|76018536|FG003|Overall Study|Withdrawal by Subject|2|||
42205710|NCT03334851|76018569|FG000|Overall Study|Other|0|||
42205711|NCT03334851|76018570|FG001|Overall Study|Other|0|||
42205712|NCT03334851|76018571|FG002|Overall Study|Other|0|||
42205713|NCT03334851|76018572|FG003|Overall Study|Other|0|||
42205714|NCT03334851|76018573|FG004|Overall Study|Other|0|||
42205715|NCT03334851|76018574|FG005|Overall Study|Other|0|||
42205716|NCT03334851|76018575|FG006|Overall Study|Other|0|||
42205717|NCT03334851|76018576|FG007|Overall Study|Other|1|||
42205718|NCT03334851|76018577|FG008|Overall Study|Other|0|||
42205719|NCT03334851|76018578|FG009|Overall Study|Other|0|||
42205720|NCT03334851|76018579|FG010|Overall Study|Other|0|||
42205721|NCT03334851|76018580|FG011|Overall Study|Other|0|||
42205722|NCT03334851|76018581|FG012|Overall Study|Other|0|||
42205723|NCT03334851|76018569|FG000|Overall Study|Adverse Event|0|||
42205724|NCT03334851|76018570|FG001|Overall Study|Adverse Event|0|||
42205725|NCT03334851|76018571|FG002|Overall Study|Adverse Event|0|||
42205726|NCT03334851|76018572|FG003|Overall Study|Adverse Event|0|||
42205727|NCT03334851|76018573|FG004|Overall Study|Adverse Event|0|||
42205728|NCT03334851|76018574|FG005|Overall Study|Adverse Event|0|||
42205729|NCT03334851|76018575|FG006|Overall Study|Adverse Event|0|||
42205730|NCT03334851|76018576|FG007|Overall Study|Adverse Event|1|||
42205731|NCT03334851|76018577|FG008|Overall Study|Adverse Event|0|||
42205732|NCT03334851|76018578|FG009|Overall Study|Adverse Event|0|||
42205733|NCT03334851|76018579|FG010|Overall Study|Adverse Event|0|||
42205734|NCT03334851|76018580|FG011|Overall Study|Adverse Event|0|||
42205735|NCT03334851|76018581|FG012|Overall Study|Adverse Event|0|||
42205736|NCT03334851|76018569|FG000|Overall Study|Withdrawal by Subject|0|||
42205737|NCT03334851|76018570|FG001|Overall Study|Withdrawal by Subject|0|||
42205738|NCT03334851|76018571|FG002|Overall Study|Withdrawal by Subject|0|||
42205739|NCT03334851|76018572|FG003|Overall Study|Withdrawal by Subject|0|||
42205740|NCT03334851|76018573|FG004|Overall Study|Withdrawal by Subject|0|||
42205741|NCT03334851|76018574|FG005|Overall Study|Withdrawal by Subject|0|||
42205742|NCT03334851|76018575|FG006|Overall Study|Withdrawal by Subject|0|||
42205743|NCT03334851|76018576|FG007|Overall Study|Withdrawal by Subject|0|||
42299296|NCT02304705|76134416|FG001|Overall Study|Physician Decision|4|||
42299297|NCT02304705|76134415|FG000|Overall Study|Death|0|||
42299298|NCT02304705|76134416|FG001|Overall Study|Death|1|||
42299299|NCT02304705|76134415|FG000|Overall Study|Lost to Follow-up|0|||
42299300|NCT02304705|76134416|FG001|Overall Study|Lost to Follow-up|2|||
42299301|NCT02553499|76134436|FG000|Overall Study|Adverse Event|0|||
42299302|NCT02553499|76134437|FG001|Overall Study|Adverse Event|0|||
42299303|NCT02553499|76134438|FG002|Overall Study|Adverse Event|0|||
42299304|NCT02553499|76134439|FG003|Overall Study|Adverse Event|0|||
42299305|NCT02553499|76134440|FG004|Overall Study|Adverse Event|0|||
42299306|NCT02553499|76134441|FG005|Overall Study|Adverse Event|0|||
42299307|NCT02553499|76134442|FG006|Overall Study|Adverse Event|1|||
42299308|NCT02553499|76134443|FG007|Overall Study|Adverse Event|1|||
42299309|NCT02553499|76134444|FG008|Overall Study|Adverse Event|0|||
42299310|NCT02553499|76134445|FG009|Overall Study|Adverse Event|0|||
42299311|NCT02553499|76134446|FG010|Overall Study|Adverse Event|0|||
42299312|NCT02553499|76134447|FG011|Overall Study|Adverse Event|0|||
42205744|NCT03334851|76018577|FG008|Overall Study|Withdrawal by Subject|0|||
42205745|NCT03334851|76018578|FG009|Overall Study|Withdrawal by Subject|0|||
42205746|NCT03334851|76018579|FG010|Overall Study|Withdrawal by Subject|1|||
42205747|NCT03334851|76018580|FG011|Overall Study|Withdrawal by Subject|0|||
42205748|NCT03334851|76018581|FG012|Overall Study|Withdrawal by Subject|1|||
42205749|NCT03334851|76018569|FG000|Overall Study|Lost to Follow-up|0|||
42299313|NCT02553499|76134448|FG012|Overall Study|Adverse Event|0|||
42299314|NCT02553499|76134449|FG013|Overall Study|Adverse Event|1|||
42299315|NCT02553499|76134436|FG000|Overall Study|Death|0|||
42299316|NCT02553499|76134437|FG001|Overall Study|Death|1|||
42299317|NCT02553499|76134438|FG002|Overall Study|Death|1|||
42299318|NCT02553499|76134439|FG003|Overall Study|Death|0|||
42299319|NCT02553499|76134440|FG004|Overall Study|Death|1|||
42299320|NCT02553499|76134441|FG005|Overall Study|Death|2|||
42299321|NCT02553499|76134442|FG006|Overall Study|Death|0|||
42299322|NCT02553499|76134443|FG007|Overall Study|Death|0|||
42299323|NCT02553499|76134444|FG008|Overall Study|Death|0|||
42299324|NCT02553499|76134445|FG009|Overall Study|Death|0|||
42299325|NCT02553499|76134446|FG010|Overall Study|Death|1|||
42299326|NCT02553499|76134447|FG011|Overall Study|Death|0|||
42299327|NCT02553499|76134448|FG012|Overall Study|Death|0|||
42299328|NCT02553499|76134449|FG013|Overall Study|Death|0|||
42299329|NCT02553499|76134436|FG000|Overall Study|Lost to Follow-up|0|||
42299330|NCT02553499|76134437|FG001|Overall Study|Lost to Follow-up|0|||
42299331|NCT02553499|76134438|FG002|Overall Study|Lost to Follow-up|0|||
42299332|NCT02553499|76134439|FG003|Overall Study|Lost to Follow-up|0|||
42299333|NCT02553499|76134440|FG004|Overall Study|Lost to Follow-up|0|||
42299334|NCT02553499|76134441|FG005|Overall Study|Lost to Follow-up|0|||
42299335|NCT02553499|76134442|FG006|Overall Study|Lost to Follow-up|1|||
42299336|NCT02553499|76134443|FG007|Overall Study|Lost to Follow-up|0|||
42299337|NCT02553499|76134444|FG008|Overall Study|Lost to Follow-up|0|||
42299338|NCT02553499|76134445|FG009|Overall Study|Lost to Follow-up|0|||
42299339|NCT02553499|76134446|FG010|Overall Study|Lost to Follow-up|0|||
42299340|NCT02553499|76134447|FG011|Overall Study|Lost to Follow-up|0|||
42299341|NCT02553499|76134448|FG012|Overall Study|Lost to Follow-up|0|||
42299342|NCT02553499|76134449|FG013|Overall Study|Lost to Follow-up|0|||
42299343|NCT02553499|76134436|FG000|Overall Study|Physician Decision|0|||
42299344|NCT02553499|76134437|FG001|Overall Study|Physician Decision|1|||
42299345|NCT02553499|76134438|FG002|Overall Study|Physician Decision|1|||
42299346|NCT02553499|76134439|FG003|Overall Study|Physician Decision|0|||
42299347|NCT02553499|76134440|FG004|Overall Study|Physician Decision|1|||
42299348|NCT02553499|76134441|FG005|Overall Study|Physician Decision|0|||
42299349|NCT02553499|76134442|FG006|Overall Study|Physician Decision|0|||
42299350|NCT02553499|76134443|FG007|Overall Study|Physician Decision|1|||
42299351|NCT02553499|76134444|FG008|Overall Study|Physician Decision|1|||
42299352|NCT02553499|76134445|FG009|Overall Study|Physician Decision|2|||
42299353|NCT02553499|76134446|FG010|Overall Study|Physician Decision|1|||
42299354|NCT02553499|76134447|FG011|Overall Study|Physician Decision|3|||
42299355|NCT02553499|76134448|FG012|Overall Study|Physician Decision|1|||
42299356|NCT02553499|76134449|FG013|Overall Study|Physician Decision|0|||
42299357|NCT02553499|76134436|FG000|Overall Study|Progressive Disease|0|||
42299358|NCT02553499|76134437|FG001|Overall Study|Progressive Disease|0|||
42299359|NCT02553499|76134438|FG002|Overall Study|Progressive Disease|0|||
42299360|NCT02553499|76134439|FG003|Overall Study|Progressive Disease|2|||
42299361|NCT02553499|76134440|FG004|Overall Study|Progressive Disease|1|||
42299362|NCT02553499|76134441|FG005|Overall Study|Progressive Disease|1|||
42299363|NCT02553499|76134442|FG006|Overall Study|Progressive Disease|1|||
42299364|NCT02553499|76134443|FG007|Overall Study|Progressive Disease|0|||
42299365|NCT02553499|76134444|FG008|Overall Study|Progressive Disease|0|||
42299366|NCT02553499|76134445|FG009|Overall Study|Progressive Disease|1|||
42299367|NCT02553499|76134446|FG010|Overall Study|Progressive Disease|0|||
42299368|NCT02553499|76134447|FG011|Overall Study|Progressive Disease|0|||
42299369|NCT02553499|76134448|FG012|Overall Study|Progressive Disease|2|||
42299370|NCT02553499|76134449|FG013|Overall Study|Progressive Disease|1|||
42299371|NCT02553499|76134436|FG000|Overall Study|Study Terminated by Sponsor|0|||
42299372|NCT02553499|76134437|FG001|Overall Study|Study Terminated by Sponsor|0|||
42299373|NCT02553499|76134438|FG002|Overall Study|Study Terminated by Sponsor|0|||
42299374|NCT02553499|76134439|FG003|Overall Study|Study Terminated by Sponsor|0|||
42299375|NCT02553499|76134440|FG004|Overall Study|Study Terminated by Sponsor|0|||
42299376|NCT02553499|76134441|FG005|Overall Study|Study Terminated by Sponsor|0|||
42299377|NCT02553499|76134442|FG006|Overall Study|Study Terminated by Sponsor|0|||
42299378|NCT02553499|76134443|FG007|Overall Study|Study Terminated by Sponsor|0|||
42299379|NCT02553499|76134444|FG008|Overall Study|Study Terminated by Sponsor|1|||
42299380|NCT02553499|76134445|FG009|Overall Study|Study Terminated by Sponsor|0|||
42299381|NCT02553499|76134446|FG010|Overall Study|Study Terminated by Sponsor|0|||
42299382|NCT02553499|76134447|FG011|Overall Study|Study Terminated by Sponsor|0|||
42299383|NCT02553499|76134448|FG012|Overall Study|Study Terminated by Sponsor|0|||
42299384|NCT02553499|76134449|FG013|Overall Study|Study Terminated by Sponsor|0|||
42299385|NCT02553499|76134436|FG000|Overall Study|Withdrawal by Subject|2|||
42299386|NCT02553499|76134437|FG001|Overall Study|Withdrawal by Subject|0|||
42299387|NCT02553499|76134438|FG002|Overall Study|Withdrawal by Subject|0|||
42299388|NCT02553499|76134439|FG003|Overall Study|Withdrawal by Subject|0|||
42299389|NCT02553499|76134440|FG004|Overall Study|Withdrawal by Subject|0|||
42299390|NCT02553499|76134441|FG005|Overall Study|Withdrawal by Subject|0|||
42299391|NCT02553499|76134442|FG006|Overall Study|Withdrawal by Subject|0|||
42299392|NCT02553499|76134443|FG007|Overall Study|Withdrawal by Subject|1|||
42299393|NCT02553499|76134444|FG008|Overall Study|Withdrawal by Subject|1|||
42299394|NCT02553499|76134445|FG009|Overall Study|Withdrawal by Subject|0|||
42299395|NCT02553499|76134446|FG010|Overall Study|Withdrawal by Subject|1|||
42299396|NCT02553499|76134447|FG011|Overall Study|Withdrawal by Subject|0|||
42299397|NCT02553499|76134448|FG012|Overall Study|Withdrawal by Subject|0|||
42299398|NCT02553499|76134449|FG013|Overall Study|Withdrawal by Subject|0|||
42299399|NCT02553421|76134482|FG000|Overall Study|Lost to Follow-up|21|||
42299400|NCT02553421|76134483|FG001|Overall Study|Lost to Follow-up|1|||
42299401|NCT02553421|76134482|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
42391929|NCT02609386|76286281|FG001|Overall Study|Withdrawal by Subject|1|||
42391930|NCT02609386|76286280|FG000|Overall Study|Lost to Follow-up|3|||
42391931|NCT02609386|76286281|FG001|Overall Study|Lost to Follow-up|5|||
42391932|NCT02609386|76286280|FG000|Overall Study|Death|19|||
42391933|NCT02609386|76286281|FG001|Overall Study|Death|9|||
42391934|NCT02609386|76286280|FG000|Overall Study|Physician Decision|0|||
42391935|NCT02609386|76286281|FG001|Overall Study|Physician Decision|2|||
42391936|NCT02576717|76286291|FG000|Overall Study|Other Reasons|16|||
42391937|NCT02576717|76286292|FG001|Overall Study|Other Reasons|18|||
42391938|NCT02576717|76286293|FG002|Overall Study|Other Reasons|15|||
42391939|NCT02576717|76286291|FG000|Overall Study|Covid-19 Pandemic|0|||
42391940|NCT02576717|76286292|FG001|Overall Study|Covid-19 Pandemic|1|||
42391941|NCT02576717|76286293|FG002|Overall Study|Covid-19 Pandemic|1|||
42391942|NCT02576717|76286291|FG000|Overall Study|Sponsor Decision|0|||
42391943|NCT02576717|76286292|FG001|Overall Study|Sponsor Decision|0|||
42391944|NCT02576717|76286293|FG002|Overall Study|Sponsor Decision|1|||
42391945|NCT02576717|76286291|FG000|Overall Study|Physician Decision|3|||
42391946|NCT02576717|76286292|FG001|Overall Study|Physician Decision|8|||
42391947|NCT02576717|76286293|FG002|Overall Study|Physician Decision|9|||
42391948|NCT02576717|76286291|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
42391949|NCT02576717|76286292|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
42391950|NCT02576717|76286293|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
42391951|NCT02576717|76286291|FG000|Overall Study|Death|3|||
42391952|NCT02576717|76286292|FG001|Overall Study|Death|5|||
42391953|NCT02576717|76286293|FG002|Overall Study|Death|3|||
42391954|NCT02576717|76286291|FG000|Overall Study|Lost to Follow-up|9|||
42391955|NCT02576717|76286292|FG001|Overall Study|Lost to Follow-up|10|||
42391956|NCT02576717|76286293|FG002|Overall Study|Lost to Follow-up|19|||
42391957|NCT02576717|76286291|FG000|Overall Study|Protocol Violation|4|||
42391958|NCT02576717|76286292|FG001|Overall Study|Protocol Violation|0|||
42391959|NCT02576717|76286293|FG002|Overall Study|Protocol Violation|5|||
42391960|NCT02576717|76286291|FG000|Overall Study|Lack of Efficacy|24|||
42391961|NCT02576717|76286292|FG001|Overall Study|Lack of Efficacy|28|||
42391962|NCT02576717|76286293|FG002|Overall Study|Lack of Efficacy|20|||
42391963|NCT02576717|76286291|FG000|Overall Study|Adverse Event|26|||
42391964|NCT02576717|76286292|FG001|Overall Study|Adverse Event|32|||
42391965|NCT02576717|76286293|FG002|Overall Study|Adverse Event|26|||
42391966|NCT02554474|76286306|FG000|Overall Study|Protocol Violation|1|||
42391967|NCT02554474|76286307|FG001|Overall Study|Protocol Violation|1|||
42391968|NCT02554474|76286306|FG000|Overall Study|Health issue not related to the study|1|||
42391969|NCT02554474|76286307|FG001|Overall Study|Health issue not related to the study|0|||
42391970|NCT02554474|76286306|FG000|Overall Study|Withdrawal by Subject|1|||
42391971|NCT02554474|76286307|FG001|Overall Study|Withdrawal by Subject|1|||
42391972|NCT02517307|76286336|FG000|Overall Study|Withdrawal by Subject|1|||
42391973|NCT02517307|76286337|FG001|Overall Study|Withdrawal by Subject|0|||
42391974|NCT02517307|76286338|FG002|Overall Study|Withdrawal by Subject|1|||
42391975|NCT02517307|76286339|FG003|Overall Study|Withdrawal by Subject|0|||
42391976|NCT02517307|76286336|FG000|Overall Study|Protocol Violation|0|||
42391977|NCT02517307|76286337|FG001|Overall Study|Protocol Violation|0|||
42391978|NCT02517307|76286338|FG002|Overall Study|Protocol Violation|1|||
42391979|NCT02517307|76286339|FG003|Overall Study|Protocol Violation|1|||
42391980|NCT02499354|76286351|FG000|Overall Study|Withdrawal by Subject|1|||
42391981|NCT02499354|76286352|FG001|Overall Study|Withdrawal by Subject|0|||
42391982|NCT02362503|76286374|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
42391983|NCT02362503|76286375|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
42391984|NCT02362503|76286376|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
42391985|NCT02362503|76286374|FG000|Double-blind Period-Up to 8 Days|Death|1|||
42391986|NCT02362503|76286375|FG001|Double-blind Period-Up to 8 Days|Death|0|||
42391987|NCT02362503|76286376|FG002|Double-blind Period-Up to 8 Days|Death|0|||
42391988|NCT02362503|76286374|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
42391989|NCT02362503|76286375|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
42391990|NCT02362503|76286376|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
42391991|NCT02362503|76286374|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
42299402|NCT02553421|76134483|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
42299403|NCT02553421|76134482|FG000|Overall Study|Improper Device Placement|3|||
42299404|NCT02553421|76134483|FG001|Overall Study|Improper Device Placement|0|||
42299405|NCT02549287|76134492|FG000|Overall Study|Lost to Follow-up|65|||
42299406|NCT02549287|76134493|FG001|Overall Study|Lost to Follow-up|26|||
42299407|NCT02549287|76134492|FG000|Overall Study|Withdrawal by Subject|15|||
42299408|NCT02549287|76134493|FG001|Overall Study|Withdrawal by Subject|6|||
42391992|NCT02362503|76286375|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
42391993|NCT02362503|76286376|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
42391994|NCT02362503|76286374|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
42391995|NCT02362503|76286375|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
42391996|NCT02362503|76286376|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
42391997|NCT02362503|76286374|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
42391998|NCT02362503|76286375|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
42391999|NCT02362503|76286376|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
42392000|NCT02362503|76286374|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
42392001|NCT02362503|76286375|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
42392002|NCT02362503|76286376|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
42392003|NCT02362503|76286374|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
42392004|NCT02362503|76286375|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
42392005|NCT02362503|76286376|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
42392006|NCT02362503|76286374|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
42392007|NCT02362503|76286375|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
42392008|NCT02362503|76286376|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
42392009|NCT02362503|76286374|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
42392010|NCT02362503|76286375|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
42392011|NCT02362503|76286376|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
42392012|NCT02362503|76286374|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
42392013|NCT02362503|76286375|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
42392014|NCT02362503|76286376|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
42392015|NCT02362503|76286374|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
42392016|NCT02362503|76286375|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
42392017|NCT02362503|76286376|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
42392018|NCT02362503|76286374|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
42392019|NCT02362503|76286375|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
42392020|NCT02362503|76286376|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
42392021|NCT02362503|76286374|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
42392022|NCT02362503|76286375|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
42392023|NCT02362503|76286376|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
42392024|NCT02224924|76286389|FG000|Overall Study|Withdrawal by Subject|7|||
42392025|NCT02224924|76286390|FG001|Overall Study|Withdrawal by Subject|6|||
42392026|NCT02224924|76286389|FG000|Overall Study|Biopsy cancelled|20|||
42392027|NCT02224924|76286390|FG001|Overall Study|Biopsy cancelled|14|||
42392028|NCT02224924|76286389|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
42392029|NCT02224924|76286390|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
42392030|NCT02224924|76286389|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
42392031|NCT02224924|76286390|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
42392032|NCT02152956|76286409|FG000|Overall Study|Adverse Event|0|||
42392033|NCT02152956|76286410|FG001|Overall Study|Adverse Event|0|||
42392034|NCT02152956|76286411|FG002|Overall Study|Adverse Event|0|||
42392035|NCT02152956|76286412|FG003|Overall Study|Adverse Event|0|||
42392036|NCT02152956|76286413|FG004|Overall Study|Adverse Event|0|||
42392037|NCT02152956|76286414|FG005|Overall Study|Adverse Event|0|||
42392038|NCT02152956|76286415|FG006|Overall Study|Adverse Event|0|||
42392039|NCT02152956|76286416|FG007|Overall Study|Adverse Event|0|||
42392040|NCT02152956|76286417|FG008|Overall Study|Adverse Event|0|||
42392041|NCT02152956|76286418|FG009|Overall Study|Adverse Event|0|||
42392042|NCT02152956|76286419|FG010|Overall Study|Adverse Event|0|||
42392043|NCT02152956|76286420|FG011|Overall Study|Adverse Event|4|||
42392044|NCT02152956|76286421|FG012|Overall Study|Adverse Event|0|||
42392045|NCT02152956|76286409|FG000|Overall Study|Death|0|||
42392046|NCT02152956|76286410|FG001|Overall Study|Death|3|||
42392047|NCT02152956|76286411|FG002|Overall Study|Death|3|||
42392048|NCT02152956|76286412|FG003|Overall Study|Death|4|||
42392049|NCT02152956|76286413|FG004|Overall Study|Death|1|||
42392050|NCT02152956|76286414|FG005|Overall Study|Death|2|||
42392051|NCT02152956|76286415|FG006|Overall Study|Death|6|||
42392052|NCT02152956|76286416|FG007|Overall Study|Death|6|||
42392053|NCT02152956|76286417|FG008|Overall Study|Death|4|||
42392054|NCT02152956|76286418|FG009|Overall Study|Death|5|||
42392055|NCT02152956|76286419|FG010|Overall Study|Death|3|||
42392056|NCT02152956|76286420|FG011|Overall Study|Death|143|||
42392057|NCT02152956|76286421|FG012|Overall Study|Death|12|||
42392058|NCT02152956|76286409|FG000|Overall Study|Lost to Follow-up|0|||
42392059|NCT02152956|76286410|FG001|Overall Study|Lost to Follow-up|1|||
42392060|NCT02152956|76286411|FG002|Overall Study|Lost to Follow-up|0|||
42392061|NCT02152956|76286412|FG003|Overall Study|Lost to Follow-up|0|||
42392062|NCT02152956|76286413|FG004|Overall Study|Lost to Follow-up|0|||
42392063|NCT02152956|76286414|FG005|Overall Study|Lost to Follow-up|0|||
42392064|NCT02152956|76286415|FG006|Overall Study|Lost to Follow-up|0|||
42392065|NCT02152956|76286416|FG007|Overall Study|Lost to Follow-up|0|||
42392066|NCT02152956|76286417|FG008|Overall Study|Lost to Follow-up|0|||
42392067|NCT02152956|76286418|FG009|Overall Study|Lost to Follow-up|0|||
42392068|NCT02152956|76286419|FG010|Overall Study|Lost to Follow-up|0|||
42392069|NCT02152956|76286420|FG011|Overall Study|Lost to Follow-up|3|||
42392070|NCT02152956|76286421|FG012|Overall Study|Lost to Follow-up|0|||
42392071|NCT02152956|76286409|FG000|Overall Study|Withdrawal by Subject|1|||
42392072|NCT02152956|76286410|FG001|Overall Study|Withdrawal by Subject|0|||
42392073|NCT02152956|76286411|FG002|Overall Study|Withdrawal by Subject|1|||
42392074|NCT02152956|76286412|FG003|Overall Study|Withdrawal by Subject|0|||
42392075|NCT02152956|76286413|FG004|Overall Study|Withdrawal by Subject|2|||
42392076|NCT02152956|76286414|FG005|Overall Study|Withdrawal by Subject|2|||
42392077|NCT02152956|76286415|FG006|Overall Study|Withdrawal by Subject|0|||
42392078|NCT02152956|76286416|FG007|Overall Study|Withdrawal by Subject|0|||
42392079|NCT02152956|76286417|FG008|Overall Study|Withdrawal by Subject|1|||
42392080|NCT02152956|76286418|FG009|Overall Study|Withdrawal by Subject|0|||
42392081|NCT02152956|76286419|FG010|Overall Study|Withdrawal by Subject|0|||
42392082|NCT02152956|76286420|FG011|Overall Study|Withdrawal by Subject|4|||
42392083|NCT02152956|76286421|FG012|Overall Study|Withdrawal by Subject|0|||
42392084|NCT02152956|76286409|FG000|Overall Study|Physician Decision|0|||
42392085|NCT02152956|76286410|FG001|Overall Study|Physician Decision|0|||
42392086|NCT02152956|76286411|FG002|Overall Study|Physician Decision|0|||
42392087|NCT02152956|76286412|FG003|Overall Study|Physician Decision|0|||
42392088|NCT02152956|76286413|FG004|Overall Study|Physician Decision|0|||
42392089|NCT02152956|76286414|FG005|Overall Study|Physician Decision|0|||
42392090|NCT02152956|76286415|FG006|Overall Study|Physician Decision|0|||
42392091|NCT02152956|76286416|FG007|Overall Study|Physician Decision|0|||
42392092|NCT02152956|76286417|FG008|Overall Study|Physician Decision|0|||
42392093|NCT02152956|76286418|FG009|Overall Study|Physician Decision|0|||
42392094|NCT02152956|76286419|FG010|Overall Study|Physician Decision|0|||
42392095|NCT02152956|76286420|FG011|Overall Study|Physician Decision|1|||
42392096|NCT02152956|76286421|FG012|Overall Study|Physician Decision|0|||
42392097|NCT02152956|76286409|FG000|Overall Study|Study terminated by sponsor|0|||
42392098|NCT02152956|76286410|FG001|Overall Study|Study terminated by sponsor|0|||
42392099|NCT02152956|76286411|FG002|Overall Study|Study terminated by sponsor|0|||
42392100|NCT02152956|76286412|FG003|Overall Study|Study terminated by sponsor|0|||
42392101|NCT02152956|76286413|FG004|Overall Study|Study terminated by sponsor|0|||
42392102|NCT02152956|76286414|FG005|Overall Study|Study terminated by sponsor|0|||
42392103|NCT02152956|76286415|FG006|Overall Study|Study terminated by sponsor|0|||
42392104|NCT02152956|76286416|FG007|Overall Study|Study terminated by sponsor|0|||
42392105|NCT02152956|76286417|FG008|Overall Study|Study terminated by sponsor|0|||
42392106|NCT02152956|76286418|FG009|Overall Study|Study terminated by sponsor|0|||
42392107|NCT02152956|76286419|FG010|Overall Study|Study terminated by sponsor|0|||
42392108|NCT02152956|76286420|FG011|Overall Study|Study terminated by sponsor|29|||
42392109|NCT02152956|76286421|FG012|Overall Study|Study terminated by sponsor|0|||
42392110|NCT02152956|76286409|FG000|Overall Study|progressive disease|0|||
42392111|NCT02152956|76286410|FG001|Overall Study|progressive disease|0|||
42392112|NCT02152956|76286411|FG002|Overall Study|progressive disease|0|||
42392113|NCT02152956|76286412|FG003|Overall Study|progressive disease|0|||
42392114|NCT02152956|76286413|FG004|Overall Study|progressive disease|0|||
42392115|NCT02152956|76286414|FG005|Overall Study|progressive disease|0|||
42392116|NCT02152956|76286415|FG006|Overall Study|progressive disease|0|||
42392117|NCT02152956|76286416|FG007|Overall Study|progressive disease|0|||
42392118|NCT02152956|76286417|FG008|Overall Study|progressive disease|1|||
42392119|NCT02152956|76286418|FG009|Overall Study|progressive disease|0|||
42392120|NCT02152956|76286419|FG010|Overall Study|progressive disease|0|||
42392121|NCT02152956|76286420|FG011|Overall Study|progressive disease|1|||
42392122|NCT02152956|76286421|FG012|Overall Study|progressive disease|0|||
42392123|NCT01553149|76286511|FG000|Overall Study|Adverse Event|0|||
42392124|NCT01553149|76286512|FG001|Overall Study|Adverse Event|9|||
42392125|NCT01553149|76286511|FG000|Overall Study|Physician Decision|5|||
42392126|NCT01553149|76286512|FG001|Overall Study|Physician Decision|10|||
42392127|NCT01553149|76286511|FG000|Overall Study|Ineligible|0|||
42392128|NCT01553149|76286512|FG001|Overall Study|Ineligible|1|||
42392129|NCT01437189|76286535|FG000|Overall Study|Adverse Event|3|||
42392130|NCT01437189|76286535|FG000|Overall Study|Lack of Efficacy|4|||
42392131|NCT01437189|76286535|FG000|Overall Study|Withdrawal by Subject|8|||
42392132|NCT01311713|76286559|FG000|Overall Study|Death|0|||
42392133|NCT01311713|76286560|FG001|Overall Study|Death|0|||
42392134|NCT01311713|76286561|FG002|Overall Study|Death|1|||
42392135|NCT01311713|76286562|FG003|Overall Study|Death|1|||
42392136|NCT01311713|76286563|FG004|Overall Study|Death|0|||
42392137|NCT01311713|76286564|FG005|Overall Study|Death|1|||
42392138|NCT01311713|76286565|FG006|Overall Study|Death|0|||
42392139|NCT01311713|76286559|FG000|Overall Study|Adverse Event|0|||
42392140|NCT01311713|76286560|FG001|Overall Study|Adverse Event|1|||
42392141|NCT01311713|76286561|FG002|Overall Study|Adverse Event|0|||
42392142|NCT01311713|76286562|FG003|Overall Study|Adverse Event|2|||
42392143|NCT01311713|76286563|FG004|Overall Study|Adverse Event|0|||
42392144|NCT01311713|76286564|FG005|Overall Study|Adverse Event|0|||
42392145|NCT01311713|76286565|FG006|Overall Study|Adverse Event|2|||
42392146|NCT01311713|76286559|FG000|Overall Study|Withdrawal by Subject|0|||
42392147|NCT01311713|76286560|FG001|Overall Study|Withdrawal by Subject|1|||
42392148|NCT01311713|76286561|FG002|Overall Study|Withdrawal by Subject|1|||
42392149|NCT01311713|76286562|FG003|Overall Study|Withdrawal by Subject|0|||
42392150|NCT01311713|76286563|FG004|Overall Study|Withdrawal by Subject|0|||
42392151|NCT01311713|76286564|FG005|Overall Study|Withdrawal by Subject|1|||
42392152|NCT01311713|76286565|FG006|Overall Study|Withdrawal by Subject|2|||
42392153|NCT01311713|76286559|FG000|Overall Study|Disease progression|3|||
42392154|NCT01311713|76286560|FG001|Overall Study|Disease progression|4|||
42392155|NCT01311713|76286561|FG002|Overall Study|Disease progression|3|||
42392156|NCT01311713|76286562|FG003|Overall Study|Disease progression|2|||
42392157|NCT01311713|76286563|FG004|Overall Study|Disease progression|4|||
42392158|NCT01311713|76286564|FG005|Overall Study|Disease progression|4|||
42392159|NCT01311713|76286565|FG006|Overall Study|Disease progression|5|||
42392160|NCT01311713|76286559|FG000|Overall Study|Lost to Follow-up|0|||
42392161|NCT01311713|76286560|FG001|Overall Study|Lost to Follow-up|0|||
42392162|NCT01311713|76286561|FG002|Overall Study|Lost to Follow-up|1|||
42392163|NCT01311713|76286562|FG003|Overall Study|Lost to Follow-up|0|||
42392164|NCT01311713|76286563|FG004|Overall Study|Lost to Follow-up|0|||
42392165|NCT01311713|76286564|FG005|Overall Study|Lost to Follow-up|0|||
42392166|NCT01311713|76286565|FG006|Overall Study|Lost to Follow-up|0|||
42392167|NCT01311713|76286559|FG000|Overall Study|Stopped taking study medication|0|||
42392168|NCT01311713|76286560|FG001|Overall Study|Stopped taking study medication|0|||
42392169|NCT01311713|76286561|FG002|Overall Study|Stopped taking study medication|0|||
42392170|NCT01311713|76286562|FG003|Overall Study|Stopped taking study medication|1|||
42392171|NCT01311713|76286563|FG004|Overall Study|Stopped taking study medication|1|||
42392172|NCT01311713|76286564|FG005|Overall Study|Stopped taking study medication|0|||
42392173|NCT01311713|76286565|FG006|Overall Study|Stopped taking study medication|0|||
42392174|NCT01311713|76286559|FG000|Overall Study|Enrolled but not treated|0|||
42392175|NCT01311713|76286560|FG001|Overall Study|Enrolled but not treated|0|||
42392176|NCT01311713|76286561|FG002|Overall Study|Enrolled but not treated|1|||
42392177|NCT01311713|76286562|FG003|Overall Study|Enrolled but not treated|0|||
42392178|NCT01311713|76286563|FG004|Overall Study|Enrolled but not treated|0|||
42392179|NCT01311713|76286564|FG005|Overall Study|Enrolled but not treated|0|||
42392180|NCT01311713|76286565|FG006|Overall Study|Enrolled but not treated|0|||
42392181|NCT01311713|76286559|FG000|Overall Study|Other than specified|0|||
42392182|NCT01311713|76286560|FG001|Overall Study|Other than specified|1|||
42392183|NCT01311713|76286561|FG002|Overall Study|Other than specified|2|||
42392184|NCT01311713|76286562|FG003|Overall Study|Other than specified|0|||
42392185|NCT01311713|76286563|FG004|Overall Study|Other than specified|0|||
42392186|NCT01311713|76286564|FG005|Overall Study|Other than specified|0|||
42392187|NCT01311713|76286565|FG006|Overall Study|Other than specified|0|||
42392188|NCT00728884|76286618|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
42392189|NCT00728884|76286618|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
42392190|NCT00659776|76286625|FG000|Overall Study|Withdrawal by Subject|12|||
42392191|NCT00659776|76286626|FG001|Overall Study|Withdrawal by Subject|2|||
42392192|NCT00659776|76286627|FG002|Overall Study|Withdrawal by Subject|0|||
42392193|NCT00617656|76286637|FG000|Overall Study|Inclusion error|4|||
42392194|NCT00617656|76286638|FG001|Overall Study|Inclusion error|4|||
42392195|NCT00617656|76286639|FG002|Overall Study|Inclusion error|0|||
42392196|NCT00617656|76286640|FG003|Overall Study|Inclusion error|0|||
42392197|NCT00617656|76286637|FG000|Overall Study|Missing data|44|||
42392198|NCT00617656|76286638|FG001|Overall Study|Missing data|30|||
42392199|NCT00617656|76286639|FG002|Overall Study|Missing data|13|||
42392200|NCT00617656|76286640|FG003|Overall Study|Missing data|6|||
42392201|NCT00617656|76286637|FG000|Overall Study|Withdrawal by Subject|0|||
42392202|NCT00617656|76286638|FG001|Overall Study|Withdrawal by Subject|2|||
42392203|NCT00617656|76286639|FG002|Overall Study|Withdrawal by Subject|0|||
42392204|NCT00617656|76286640|FG003|Overall Study|Withdrawal by Subject|0|||
42205750|NCT03334851|76018570|FG001|Overall Study|Lost to Follow-up|0|||
42205751|NCT03334851|76018571|FG002|Overall Study|Lost to Follow-up|0|||
42205752|NCT03334851|76018572|FG003|Overall Study|Lost to Follow-up|0|||
42205753|NCT03334851|76018573|FG004|Overall Study|Lost to Follow-up|0|||
42205754|NCT03334851|76018574|FG005|Overall Study|Lost to Follow-up|0|||
42205755|NCT03334851|76018575|FG006|Overall Study|Lost to Follow-up|0|||
42205756|NCT03334851|76018576|FG007|Overall Study|Lost to Follow-up|0|||
42205757|NCT03334851|76018577|FG008|Overall Study|Lost to Follow-up|0|||
42205758|NCT03334851|76018578|FG009|Overall Study|Lost to Follow-up|0|||
42205759|NCT03334851|76018579|FG010|Overall Study|Lost to Follow-up|2|||
42205760|NCT03334851|76018580|FG011|Overall Study|Lost to Follow-up|1|||
42205761|NCT03334851|76018581|FG012|Overall Study|Lost to Follow-up|0|||
42205762|NCT02744612|76018643|FG000|Overall Study|Withdrawal by Subject|0|||
42205763|NCT02744612|76018644|FG001|Overall Study|Withdrawal by Subject|2|||
42205764|NCT02717507|76018652|FG000|Overall Study|Lost to Follow-up|5|||
42205765|NCT02717507|76018653|FG001|Overall Study|Lost to Follow-up|8|||
42205766|NCT02717507|76018652|FG000|Overall Study|Pregnancy|1|||
42205767|NCT02717507|76018653|FG001|Overall Study|Pregnancy|1|||
42205768|NCT02717507|76018652|FG000|Overall Study|Protocol Violation|2|||
42205769|NCT02717507|76018653|FG001|Overall Study|Protocol Violation|2|||
42205770|NCT02717507|76018652|FG000|Overall Study|Withdrawal by Subject|20|||
42205771|NCT02717507|76018653|FG001|Overall Study|Withdrawal by Subject|20|||
42205772|NCT02717507|76018652|FG000|Overall Study|Relapse|1|||
42205773|NCT02717507|76018653|FG001|Overall Study|Relapse|1|||
42205774|NCT02717507|76018652|FG000|Overall Study|Cardiac Event|2|||
42205775|NCT02717507|76018653|FG001|Overall Study|Cardiac Event|6|||
42205776|NCT02470585|76018676|FG000|Overall Study|Death|82|||
42205777|NCT02470585|76018677|FG001|Overall Study|Death|87|||
42205778|NCT02470585|76018678|FG002|Overall Study|Death|86|||
42205779|NCT02470585|76018676|FG000|Overall Study|Withdrawal by Subject|19|||
42205780|NCT02470585|76018677|FG001|Overall Study|Withdrawal by Subject|21|||
42205781|NCT02470585|76018678|FG002|Overall Study|Withdrawal by Subject|29|||
42205782|NCT02470585|76018676|FG000|Overall Study|Lost to Follow-up|2|||
42205783|NCT02470585|76018677|FG001|Overall Study|Lost to Follow-up|5|||
42205784|NCT02470585|76018678|FG002|Overall Study|Lost to Follow-up|4|||
42205785|NCT02470585|76018676|FG000|Overall Study|Other|4|||
42205786|NCT02470585|76018677|FG001|Overall Study|Other|4|||
42205787|NCT02470585|76018678|FG002|Overall Study|Other|6|||
42205788|NCT02199080|76018707|FG000|Overall Study|Protocol Violation|12|||
42205789|NCT02173379|76018715|FG000|Overall Study|Lost to Follow-up|89|||
42205790|NCT02173379|76018716|FG001|Overall Study|Lost to Follow-up|81|||
42205791|NCT02173379|76018715|FG000|Overall Study|Withdrawal by Subject|24|||
42205792|NCT02173379|76018716|FG001|Overall Study|Withdrawal by Subject|29|||
42205793|NCT02173379|76018715|FG000|Overall Study|Physician Decision|8|||
42205794|NCT02173379|76018716|FG001|Overall Study|Physician Decision|8|||
42205795|NCT02173379|76018715|FG000|Overall Study|Death|75|||
42205796|NCT02173379|76018716|FG001|Overall Study|Death|72|||
42205797|NCT02173379|76018715|FG000|Overall Study|Other Reason|1|||
42205798|NCT02173379|76018716|FG001|Overall Study|Other Reason|0|||
42205799|NCT02134925|76018727|FG000|Overall Study|Withdrawal by Subject|1|||
42205800|NCT02134925|76018728|FG001|Overall Study|Withdrawal by Subject|0|||
42205801|NCT02134925|76018727|FG000|Overall Study|Cancel|1|||
42205802|NCT02134925|76018728|FG001|Overall Study|Cancel|6|||
42205813|NCT01849874|76018745|FG000|Overall Study|Death|89|||
42205814|NCT01849874|76018746|FG001|Overall Study|Death|42|||
42205815|NCT01849874|76018745|FG000|Overall Study|Withdrawal by Subject|17|||
42205816|NCT01849874|76018746|FG001|Overall Study|Withdrawal by Subject|16|||
42205817|NCT01849874|76018745|FG000|Overall Study|Lost to Follow-up|3|||
42205818|NCT01849874|76018746|FG001|Overall Study|Lost to Follow-up|2|||
42205819|NCT01849874|76018745|FG000|Overall Study|Study Termination By Sponsor|93|||
42205820|NCT01849874|76018746|FG001|Overall Study|Study Termination By Sponsor|48|||
42205821|NCT01849874|76018745|FG000|Overall Study|Completed as per protocol amendment 6|3|||
42205822|NCT01849874|76018746|FG001|Overall Study|Completed as per protocol amendment 6|0|||
42205823|NCT01849874|76018745|FG000|Overall Study|Physician Decision|7|||
42205824|NCT01849874|76018746|FG001|Overall Study|Physician Decision|1|||
42205825|NCT01849874|76018745|FG000|Overall Study|Other|16|||
42205826|NCT01849874|76018746|FG001|Overall Study|Other|4|||
42205827|NCT01771107|76018759|FG000|Overall Study|Adverse Event|1|||
42205828|NCT01771107|76018760|FG001|Overall Study|Adverse Event|3|||
42205829|NCT01771107|76018759|FG000|Overall Study|Withdrawal by Subject|0|||
42205830|NCT01771107|76018760|FG001|Overall Study|Withdrawal by Subject|2|||
42205831|NCT01771107|76018759|FG000|Overall Study|Lost to Follow-up|0|||
42205832|NCT01771107|76018760|FG001|Overall Study|Lost to Follow-up|1|||
42205833|NCT01771107|76018759|FG000|Overall Study|participant moved|0|||
42205834|NCT01771107|76018760|FG001|Overall Study|participant moved|1|||
42205835|NCT01771107|76018759|FG000|Overall Study|Other|0|||
42205836|NCT01771107|76018760|FG001|Overall Study|Other|1|||
42205837|NCT01375114|76018771|FG000|Overall Study|Lost to Follow-up|1|||
42205838|NCT01375114|76018772|FG001|Overall Study|Lost to Follow-up|0|||
42205839|NCT01375114|76018773|FG002|Overall Study|Lost to Follow-up|1|||
42205840|NCT01375114|76018771|FG000|Overall Study|Disease Progression|3|||
42205841|NCT01375114|76018772|FG001|Overall Study|Disease Progression|2|||
42205842|NCT01375114|76018773|FG002|Overall Study|Disease Progression|2|||
42205843|NCT01375114|76018771|FG000|Overall Study|Patient Changed Mind|0|||
42205844|NCT01375114|76018772|FG001|Overall Study|Patient Changed Mind|0|||
42205845|NCT01375114|76018773|FG002|Overall Study|Patient Changed Mind|2|||
42205846|NCT01375114|76018771|FG000|Overall Study|Pruritus|0|||
42205847|NCT01375114|76018772|FG001|Overall Study|Pruritus|0|||
42205848|NCT01375114|76018773|FG002|Overall Study|Pruritus|1|||
42205849|NCT01375114|76018771|FG000|Overall Study|Restlessness|0|||
42205850|NCT01375114|76018772|FG001|Overall Study|Restlessness|0|||
42205851|NCT01375114|76018773|FG002|Overall Study|Restlessness|1|||
42205852|NCT01375114|76018771|FG000|Overall Study|Diarrhea|0|||
42205853|NCT01375114|76018772|FG001|Overall Study|Diarrhea|0|||
42205854|NCT01375114|76018773|FG002|Overall Study|Diarrhea|1|||
42205855|NCT01375114|76018771|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
42205856|NCT01375114|76018772|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
42205857|NCT01375114|76018773|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
42205858|NCT01375114|76018771|FG000|Overall Study|Nausea|0|||
42205859|NCT01375114|76018772|FG001|Overall Study|Nausea|1|||
42205860|NCT01375114|76018773|FG002|Overall Study|Nausea|0|||
42205861|NCT01375114|76018771|FG000|Overall Study|Increased AST/ALT|0|||
42205862|NCT01375114|76018772|FG001|Overall Study|Increased AST/ALT|1|||
42205863|NCT01375114|76018773|FG002|Overall Study|Increased AST/ALT|0|||
42205864|NCT01375114|76018771|FG000|Overall Study|Vaginal Hemorrhage|0|||
42205865|NCT01375114|76018772|FG001|Overall Study|Vaginal Hemorrhage|1|||
42205866|NCT01375114|76018773|FG002|Overall Study|Vaginal Hemorrhage|0|||
42205867|NCT01375114|76018771|FG000|Overall Study|Family problem|0|||
42205868|NCT01375114|76018772|FG001|Overall Study|Family problem|1|||
42205869|NCT01375114|76018773|FG002|Overall Study|Family problem|0|||
42205870|NCT01375114|76018771|FG000|Overall Study|Protocol Violation|2|||
42205871|NCT01375114|76018772|FG001|Overall Study|Protocol Violation|0|||
42205872|NCT01375114|76018773|FG002|Overall Study|Protocol Violation|0|||
42205873|NCT01009645|76018787|FG000|Overall Study|Lost to Follow-up|2|||
42205874|NCT01009645|76018788|FG001|Overall Study|Lost to Follow-up|8|||
42205875|NCT01009645|76018789|FG002|Overall Study|Lost to Follow-up|4|||
42205876|NCT01009645|76018790|FG003|Overall Study|Lost to Follow-up|5|||
42205877|NCT00950846|76018800|FG000|Overall Study|Death|6|||
42205878|NCT00950846|76018800|FG000|Overall Study|Lost to Follow-up|3|||
42205879|NCT00950846|76018800|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
42205880|NCT03419403|76018811|FG000|Overall Study|Withdrawal by Subject|5|||
42205881|NCT03419403|76018812|FG001|Overall Study|Withdrawal by Subject|2|||
42205882|NCT03419403|76018813|FG002|Overall Study|Withdrawal by Subject|5|||
42205883|NCT03419403|76018814|FG003|Overall Study|Withdrawal by Subject|1|||
42205884|NCT03419403|76018811|FG000|Overall Study|Progressive disease (per protocol)|0|||
42205885|NCT03419403|76018812|FG001|Overall Study|Progressive disease (per protocol)|2|||
42205886|NCT03419403|76018813|FG002|Overall Study|Progressive disease (per protocol)|2|||
42205887|NCT03419403|76018814|FG003|Overall Study|Progressive disease (per protocol)|0|||
42205888|NCT03419403|76018811|FG000|Overall Study|Other, not specified|6|||
42205889|NCT03419403|76018812|FG001|Overall Study|Other, not specified|4|||
42205890|NCT03419403|76018813|FG002|Overall Study|Other, not specified|5|||
42205891|NCT03419403|76018814|FG003|Overall Study|Other, not specified|1|||
42205892|NCT03419403|76018811|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
42205893|NCT03419403|76018812|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
42205894|NCT03419403|76018813|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
42205895|NCT03419403|76018814|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
42205896|NCT03447249|76018824|FG000|Overall Study|Adverse Event|1|||
42205897|NCT03447249|76018825|FG001|Overall Study|Adverse Event|0|||
42205898|NCT03447249|76018824|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
42205899|NCT03447249|76018825|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
42205900|NCT03447249|76018824|FG000|Overall Study|Other|3|||
42205901|NCT03447249|76018825|FG001|Overall Study|Other|0|||
42205902|NCT03418545|76018835|FG000|Overall Study|Withdrawal by Participant|2|||
42205903|NCT03418545|76018836|FG001|Overall Study|Withdrawal by Participant|4|||
42205904|NCT03418545|76018835|FG000|Overall Study|Lost to Follow-up|3|||
42205905|NCT03418545|76018836|FG001|Overall Study|Lost to Follow-up|5|||
42205906|NCT03418545|76018835|FG000|Overall Study|Reason Not Specified|0|||
42205907|NCT03418545|76018836|FG001|Overall Study|Reason Not Specified|1|||
42205908|NCT03418545|76018835|FG000|Overall Study|Missing Completion Status|0|||
42205909|NCT03418545|76018836|FG001|Overall Study|Missing Completion Status|1|||
42205910|NCT03446781|76018847|FG000|Overall Study|Lost to Follow-up|11|||
42205911|NCT03446781|76018848|FG001|Overall Study|Lost to Follow-up|5|||
42205912|NCT03446781|76018847|FG000|Overall Study|Withdrawal by Subject|9|||
42205913|NCT03446781|76018848|FG001|Overall Study|Withdrawal by Subject|7|||
42205914|NCT03446781|76018847|FG000|Overall Study|Adverse Event|8|||
42205915|NCT03446781|76018848|FG001|Overall Study|Adverse Event|2|||
42205916|NCT03446781|76018847|FG000|Overall Study|Protocol Violation|0|||
42205917|NCT03446781|76018848|FG001|Overall Study|Protocol Violation|3|||
42205918|NCT03445065|76018880|FG000|Overall Study|Withdrawal by Subject|3|||
42205919|NCT03445065|76018881|FG001|Overall Study|Withdrawal by Subject|6|||
42205920|NCT03445065|76018882|FG002|Overall Study|Withdrawal by Subject|2|||
42205921|NCT03445065|76018883|FG003|Overall Study|Withdrawal by Subject|2|||
42205922|NCT03445065|76018880|FG000|Overall Study|Other|4|||
42205923|NCT03445065|76018881|FG001|Overall Study|Other|3|||
42205924|NCT03445065|76018882|FG002|Overall Study|Other|3|||
42205925|NCT03445065|76018883|FG003|Overall Study|Other|1|||
42205926|NCT01224106|76018908|FG000|Double-Blind Treatment Phase|Death|3|||
42205927|NCT01224106|76018909|FG001|Double-Blind Treatment Phase|Death|0|||
42205928|NCT01224106|76018910|FG002|Double-Blind Treatment Phase|Death|0|||
42205929|NCT01224106|76018911|FG003|Double-Blind Treatment Phase|Death|0|||
42205930|NCT01224106|76018912|FG004|Double-Blind Treatment Phase|Death|0|||
42205931|NCT01224106|76018908|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
42205932|NCT01224106|76018909|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
42205933|NCT01224106|76018910|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
42205934|NCT01224106|76018911|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
42205935|NCT01224106|76018912|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
42205936|NCT01224106|76018908|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
42205937|NCT01224106|76018909|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
42205938|NCT01224106|76018910|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
42205939|NCT01224106|76018911|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
42205940|NCT01224106|76018912|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
42205941|NCT01224106|76018908|FG000|Double-Blind Treatment Phase|Other|0|||
42205942|NCT01224106|76018909|FG001|Double-Blind Treatment Phase|Other|0|||
42205943|NCT01224106|76018910|FG002|Double-Blind Treatment Phase|Other|1|||
42205944|NCT01224106|76018911|FG003|Double-Blind Treatment Phase|Other|0|||
42205945|NCT01224106|76018912|FG004|Double-Blind Treatment Phase|Other|0|||
42205946|NCT01224106|76018908|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
42205947|NCT01224106|76018909|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
42205948|NCT01224106|76018910|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
42205949|NCT01224106|76018911|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
42205950|NCT01224106|76018912|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
42205951|NCT01224106|76018908|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
42205952|NCT01224106|76018909|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
42205953|NCT01224106|76018910|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
42205954|NCT01224106|76018911|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
42205955|NCT01224106|76018912|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
42205956|NCT01224106|76018908|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
42205957|NCT01224106|76018909|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
42205958|NCT01224106|76018910|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
42205959|NCT01224106|76018911|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
42205960|NCT01224106|76018912|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
42205961|NCT01224106|76018908|FG000|Open-Label Extension (OLE) Phase|Death|0|||
42205962|NCT01224106|76018909|FG001|Open-Label Extension (OLE) Phase|Death|0|||
42205963|NCT01224106|76018910|FG002|Open-Label Extension (OLE) Phase|Death|0|||
42205964|NCT01224106|76018911|FG003|Open-Label Extension (OLE) Phase|Death|1|||
42205965|NCT01224106|76018912|FG004|Open-Label Extension (OLE) Phase|Death|3|||
42205966|NCT01224106|76018908|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
42205967|NCT01224106|76018909|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
42205968|NCT01224106|76018910|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
42205969|NCT01224106|76018911|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
42205970|NCT01224106|76018912|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
42205971|NCT01224106|76018908|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
42205972|NCT01224106|76018909|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
42205973|NCT01224106|76018910|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
42205974|NCT01224106|76018911|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
42205975|NCT01224106|76018912|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
42205976|NCT01224106|76018908|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
42205977|NCT01224106|76018909|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
42205978|NCT01224106|76018910|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
42205979|NCT01224106|76018911|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
42205980|NCT01224106|76018912|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
42205981|NCT01224106|76018908|FG000|Open-Label Extension (OLE) Phase|Other|0|||
42205982|NCT01224106|76018909|FG001|Open-Label Extension (OLE) Phase|Other|0|||
42205983|NCT01224106|76018910|FG002|Open-Label Extension (OLE) Phase|Other|0|||
42205984|NCT01224106|76018911|FG003|Open-Label Extension (OLE) Phase|Other|5|||
42205985|NCT01224106|76018912|FG004|Open-Label Extension (OLE) Phase|Other|3|||
42205986|NCT03409107|76018932|FG000|Overall Study|Withdrawal by Subject|4|||
42205987|NCT03409107|76018933|FG001|Overall Study|Withdrawal by Subject|2|||
42205988|NCT03409107|76018932|FG000|Overall Study|Physician Decision|1|||
42205989|NCT03409107|76018933|FG001|Overall Study|Physician Decision|0|||
42205990|NCT03409107|76018932|FG000|Overall Study|Lost to Follow-up|7|||
42205991|NCT03409107|76018933|FG001|Overall Study|Lost to Follow-up|2|||
42205992|NCT03409107|76018932|FG000|Overall Study|Adverse Event|5|||
42205993|NCT03409107|76018933|FG001|Overall Study|Adverse Event|3|||
42205994|NCT03408873|76018947|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
42205995|NCT03408873|76018947|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
42205996|NCT03408873|76018947|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
42205997|NCT03408873|76018947|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
42205998|NCT03408873|76018947|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
42205999|NCT03408873|76018947|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
42206000|NCT03780959|76018954|FG000|Part 1|Adverse Event|1|||
42206001|NCT03780959|76018955|FG001|Part 1|Adverse Event|0|||
42206002|NCT03780959|76018956|FG002|Part 1|Adverse Event|0|||
42206003|NCT03780959|76018954|FG000|Part 1|Withdrawal by Subject|1|||
42206004|NCT03780959|76018955|FG001|Part 1|Withdrawal by Subject|0|||
42206005|NCT03780959|76018956|FG002|Part 1|Withdrawal by Subject|0|||
42206006|NCT03780959|76018954|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
42206007|NCT03780959|76018955|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
42206008|NCT03780959|76018956|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
42206009|NCT03780959|76018954|FG000|Part 1|Response Status|2|||
42206010|NCT03780959|76018955|FG001|Part 1|Response Status|0|||
42206011|NCT03780959|76018956|FG002|Part 1|Response Status|0|||
42206012|NCT03780959|76018954|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
42206013|NCT03780959|76018955|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
42206014|NCT03780959|76018956|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
42206015|NCT03780959|76018954|FG000|Part 2|Response Status|0|||
42206016|NCT03780959|76018955|FG001|Part 2|Response Status|18|||
42206017|NCT03780959|76018956|FG002|Part 2|Response Status|6|||
42206018|NCT03408639|76018968|FG000|Overall Study|Death|5|||
42206019|NCT03408639|76018969|FG001|Overall Study|Death|5|||
42206020|NCT03408639|76018968|FG000|Overall Study|Lost to Follow-up|1|||
42206021|NCT03408639|76018969|FG001|Overall Study|Lost to Follow-up|4|||
42206022|NCT03408639|76018968|FG000|Overall Study|Withdrawal by Subject|2|||
42206023|NCT03408639|76018969|FG001|Overall Study|Withdrawal by Subject|7|||
42206024|NCT03408639|76018968|FG000|Overall Study|Physician Decision|3|||
42206025|NCT03408639|76018969|FG001|Overall Study|Physician Decision|6|||
42206026|NCT03810235|76018977|FG000|Overall Study|Withdrawal by Subject|2|||
42206027|NCT03810235|76018978|FG001|Overall Study|Withdrawal by Subject|0|||
42206028|NCT03408483|76018987|FG000|Overall Study|Physician Decision|3|||
42206029|NCT03408483|76018988|FG001|Overall Study|Physician Decision|3|||
42206030|NCT03408483|76018987|FG000|Overall Study|Lost to Follow-up|3|||
42206031|NCT03408483|76018988|FG001|Overall Study|Lost to Follow-up|0|||
42206032|NCT03777059|76018998|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
42206033|NCT03777059|76018999|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
42206034|NCT03777059|76019000|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
42206035|NCT03777059|76019001|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
42206036|NCT03777059|76018998|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
42206037|NCT03777059|76018999|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
42206038|NCT03777059|76019000|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
42206039|NCT03777059|76019001|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
42206040|NCT03777059|76018998|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
42206041|NCT03777059|76018999|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
42206042|NCT03777059|76019000|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
42206043|NCT03777059|76019001|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
42206044|NCT03777059|76018998|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
42206045|NCT03777059|76018999|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
42206046|NCT03777059|76019000|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
42206047|NCT03777059|76019001|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
42206048|NCT03777059|76018998|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
42206049|NCT03777059|76018999|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
42206050|NCT03777059|76019000|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
42206051|NCT03777059|76019001|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
42206052|NCT03777059|76018998|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
42206053|NCT03777059|76018999|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
42206054|NCT03777059|76019000|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
42206055|NCT03777059|76019001|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
42206056|NCT03777059|76018998|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
42206057|NCT03777059|76018999|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
42206058|NCT03777059|76019000|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
42206059|NCT03777059|76019001|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
42206060|NCT03777059|76018998|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
42206061|NCT03777059|76018999|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
42206062|NCT03777059|76019000|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
42206063|NCT03777059|76019001|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
42206064|NCT03777059|76018998|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
42206065|NCT03777059|76018999|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
42206066|NCT03777059|76019000|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
42206067|NCT03777059|76019001|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
42206068|NCT03777059|76018998|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
42206069|NCT03777059|76018999|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
42206070|NCT03777059|76019000|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
42206071|NCT03777059|76019001|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
42206072|NCT03777059|76018998|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
42206073|NCT03777059|76018999|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
42206074|NCT03777059|76019000|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
42206075|NCT03777059|76019001|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
42206076|NCT03100058|76019020|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
42206077|NCT03100058|76019021|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
42206078|NCT03100058|76019022|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
42206079|NCT03100058|76019023|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
42206080|NCT03100058|76019024|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
42206081|NCT03100058|76019025|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
42206082|NCT03100058|76019026|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
42206083|NCT03100058|76019027|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
42206084|NCT03100058|76019028|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
42206085|NCT03100058|76019029|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
42206086|NCT03100058|76019030|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
42206087|NCT03100058|76019031|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
42206088|NCT03100058|76019032|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
42206089|NCT03100058|76019020|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
42206090|NCT03100058|76019021|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
42206091|NCT03100058|76019022|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
42206092|NCT03100058|76019023|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
42206093|NCT03100058|76019024|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
42206094|NCT03100058|76019025|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
42206095|NCT03100058|76019026|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
42206096|NCT03100058|76019027|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
42206097|NCT03100058|76019028|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
42206098|NCT03100058|76019029|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
42206099|NCT03100058|76019030|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
42206100|NCT03100058|76019031|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
42206101|NCT03100058|76019032|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
42206102|NCT03100058|76019020|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
42206103|NCT03100058|76019021|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
42206104|NCT03100058|76019022|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
42206105|NCT03100058|76019023|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
42206106|NCT03100058|76019024|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
42206107|NCT03100058|76019025|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
42206108|NCT03100058|76019026|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
42206109|NCT03100058|76019027|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
42206110|NCT03100058|76019028|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
42206111|NCT03100058|76019029|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
42206112|NCT03100058|76019030|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
42206113|NCT03100058|76019031|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
42206114|NCT03100058|76019032|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
42206115|NCT03100058|76019020|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
42206116|NCT03100058|76019021|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
42206117|NCT03100058|76019022|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
42206118|NCT03100058|76019023|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
42206119|NCT03100058|76019024|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
42206120|NCT03100058|76019025|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
42206121|NCT03100058|76019026|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
42206122|NCT03100058|76019027|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
42206123|NCT03100058|76019028|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
42206124|NCT03100058|76019029|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
42206125|NCT03100058|76019030|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
42206126|NCT03100058|76019031|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
42206127|NCT03100058|76019032|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
42206128|NCT03100058|76019020|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
42206129|NCT03100058|76019021|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
42206130|NCT03100058|76019022|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
42206131|NCT03100058|76019023|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
42206132|NCT03100058|76019024|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
42206133|NCT03100058|76019025|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
42206134|NCT03100058|76019026|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
42206135|NCT03100058|76019027|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
42206136|NCT03100058|76019028|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
42206137|NCT03100058|76019029|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
42206138|NCT03100058|76019030|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
42206139|NCT03100058|76019031|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
42206140|NCT03100058|76019032|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
42206141|NCT03100058|76019020|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
42206142|NCT03100058|76019021|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
42206143|NCT03100058|76019022|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
42206144|NCT03100058|76019023|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
42206145|NCT03100058|76019024|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
42206146|NCT03100058|76019025|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
42206147|NCT03100058|76019026|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
42206148|NCT03100058|76019027|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
42206149|NCT03100058|76019028|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
42206150|NCT03100058|76019029|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
42206151|NCT03100058|76019030|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
42206152|NCT03100058|76019031|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
42206153|NCT03100058|76019032|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
42206154|NCT03100058|76019020|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206155|NCT03100058|76019021|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
42206156|NCT03100058|76019022|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206157|NCT03100058|76019023|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206158|NCT03100058|76019024|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206159|NCT03100058|76019025|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206160|NCT03100058|76019026|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206161|NCT03100058|76019027|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206162|NCT03100058|76019028|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206163|NCT03100058|76019029|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206164|NCT03100058|76019030|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206165|NCT03100058|76019031|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206166|NCT03100058|76019032|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
42206167|NCT03100058|76019020|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
42206168|NCT03100058|76019021|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206169|NCT03100058|76019022|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206170|NCT03100058|76019023|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206171|NCT03100058|76019024|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206172|NCT03100058|76019025|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206173|NCT03100058|76019026|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206174|NCT03100058|76019027|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206175|NCT03100058|76019028|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206176|NCT03100058|76019029|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206177|NCT03100058|76019030|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206178|NCT03100058|76019031|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206179|NCT03100058|76019032|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
42206180|NCT03100058|76019020|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206181|NCT03100058|76019021|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206182|NCT03100058|76019022|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206183|NCT03100058|76019023|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206184|NCT03100058|76019024|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206185|NCT03100058|76019025|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206186|NCT03100058|76019026|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
42206187|NCT03100058|76019027|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206188|NCT03100058|76019028|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206189|NCT03100058|76019029|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206190|NCT03100058|76019030|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206191|NCT03100058|76019031|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206192|NCT03100058|76019032|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
42206193|NCT03100058|76019020|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
42206194|NCT03100058|76019021|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
42206195|NCT03100058|76019022|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
42206196|NCT03100058|76019023|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
42206197|NCT03100058|76019024|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
42206198|NCT03100058|76019025|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
42206199|NCT03100058|76019026|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
42206200|NCT03100058|76019027|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
42206201|NCT03100058|76019028|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
42206202|NCT03100058|76019029|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
42206203|NCT03100058|76019030|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
42206204|NCT03100058|76019031|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
42206205|NCT03100058|76019032|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
42206206|NCT03100058|76019020|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
42206207|NCT03100058|76019021|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
42206208|NCT03100058|76019022|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
42206209|NCT03100058|76019023|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
42206210|NCT03100058|76019024|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
42206211|NCT03100058|76019025|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
42206212|NCT03100058|76019026|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
42206213|NCT03100058|76019027|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
42206214|NCT03100058|76019028|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
42206215|NCT03100058|76019029|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
42206216|NCT03100058|76019030|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
42206217|NCT03100058|76019031|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
42206218|NCT03100058|76019032|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
42206219|NCT03100058|76019020|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
42206220|NCT03100058|76019021|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
42206221|NCT03100058|76019022|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
42206222|NCT03100058|76019023|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
42206223|NCT03100058|76019024|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
42206224|NCT03100058|76019025|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
42206225|NCT03100058|76019026|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
42206226|NCT03100058|76019027|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
42206227|NCT03100058|76019028|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
42206228|NCT03100058|76019029|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
42206229|NCT03100058|76019030|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
42206230|NCT03100058|76019031|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
42206231|NCT03100058|76019032|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
42206232|NCT03100058|76019020|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206233|NCT03100058|76019021|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206234|NCT03100058|76019022|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206235|NCT03100058|76019023|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206236|NCT03100058|76019024|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206237|NCT03100058|76019025|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206238|NCT03100058|76019026|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206239|NCT03100058|76019027|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206240|NCT03100058|76019028|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206241|NCT03100058|76019029|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206242|NCT03100058|76019030|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
42206243|NCT03100058|76019031|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206244|NCT03100058|76019032|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
42206245|NCT03100058|76019020|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206246|NCT03100058|76019021|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206247|NCT03100058|76019022|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206248|NCT03100058|76019023|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206249|NCT03100058|76019024|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206250|NCT03100058|76019025|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206251|NCT03100058|76019026|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206252|NCT03100058|76019027|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206253|NCT03100058|76019028|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206254|NCT03100058|76019029|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206255|NCT03100058|76019030|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206256|NCT03100058|76019031|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
42206257|NCT03100058|76019032|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
42206258|NCT03100058|76019020|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206259|NCT03100058|76019021|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206260|NCT03100058|76019022|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206261|NCT03100058|76019023|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206262|NCT03100058|76019024|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206263|NCT03100058|76019025|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206264|NCT03100058|76019026|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206265|NCT03100058|76019027|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206266|NCT03100058|76019028|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206267|NCT03100058|76019029|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
42206268|NCT03100058|76019030|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206269|NCT03100058|76019031|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206270|NCT03100058|76019032|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
42206271|NCT02871778|76019078|FG000|Part A: Treatment Period 1|Adverse Event|1|||
42206272|NCT02871778|76019079|FG001|Part A: Treatment Period 1|Adverse Event|1|||
42206273|NCT02871778|76019080|FG002|Part A: Treatment Period 1|Adverse Event|1|||
42206274|NCT02871778|76019081|FG003|Part A: Treatment Period 1|Adverse Event|0|||
42206275|NCT02871778|76019082|FG004|Part A: Treatment Period 1|Adverse Event|0|||
42206276|NCT02871778|76019083|FG005|Part A: Treatment Period 1|Adverse Event|0|||
42206277|NCT02871778|76019084|FG006|Part A: Treatment Period 1|Adverse Event|0|||
42206278|NCT02871778|76019085|FG007|Part A: Treatment Period 1|Adverse Event|0|||
42206279|NCT02871778|76019078|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
42206280|NCT02871778|76019079|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
42206281|NCT02871778|76019080|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
42206282|NCT02871778|76019081|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
42206283|NCT02871778|76019082|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
42206284|NCT02871778|76019083|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
42206285|NCT02871778|76019084|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
42206286|NCT02871778|76019085|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
42206287|NCT02871778|76019078|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
42206288|NCT02871778|76019079|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
42206289|NCT02871778|76019080|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
42206290|NCT02871778|76019081|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
42206291|NCT02871778|76019082|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
42206292|NCT02871778|76019083|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
42206293|NCT02871778|76019084|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
42206294|NCT02871778|76019085|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
42206295|NCT02871778|76019078|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
42206296|NCT02871778|76019079|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
42206297|NCT02871778|76019080|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
42206298|NCT02871778|76019081|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
42206299|NCT02871778|76019082|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
42206300|NCT02871778|76019083|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
42206301|NCT02871778|76019084|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
42206302|NCT02871778|76019085|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
42206303|NCT02871778|76019078|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
42206304|NCT02871778|76019079|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
42206305|NCT02871778|76019080|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
42206306|NCT02871778|76019081|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
42206307|NCT02871778|76019082|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
42206308|NCT02871778|76019083|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
42206309|NCT02871778|76019084|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
42206310|NCT02871778|76019085|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
42206311|NCT02871778|76019078|FG000|Part A: Treatment Period 2|Adverse Event|2|||
42206312|NCT02871778|76019079|FG001|Part A: Treatment Period 2|Adverse Event|2|||
42206313|NCT02871778|76019080|FG002|Part A: Treatment Period 2|Adverse Event|0|||
42206314|NCT02871778|76019081|FG003|Part A: Treatment Period 2|Adverse Event|0|||
42206315|NCT02871778|76019082|FG004|Part A: Treatment Period 2|Adverse Event|0|||
42206316|NCT02871778|76019083|FG005|Part A: Treatment Period 2|Adverse Event|0|||
42206317|NCT02871778|76019084|FG006|Part A: Treatment Period 2|Adverse Event|0|||
42206318|NCT02871778|76019085|FG007|Part A: Treatment Period 2|Adverse Event|0|||
42206319|NCT02871778|76019078|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
42206320|NCT02871778|76019079|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
42206321|NCT02871778|76019080|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
42206322|NCT02871778|76019081|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
42206323|NCT02871778|76019082|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
42206324|NCT02871778|76019083|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
42206325|NCT02871778|76019084|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
42206326|NCT02871778|76019085|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
42206327|NCT02871778|76019078|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
42206328|NCT02871778|76019079|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
42206329|NCT02871778|76019080|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
42206330|NCT02871778|76019081|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
42206331|NCT02871778|76019082|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
42206332|NCT02871778|76019083|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
42206333|NCT02871778|76019084|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
42206334|NCT02871778|76019085|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
42206335|NCT02871778|76019078|FG000|Part B: Treatment Period 3|Adverse Event|0|||
42206336|NCT02871778|76019079|FG001|Part B: Treatment Period 3|Adverse Event|0|||
42206337|NCT02871778|76019080|FG002|Part B: Treatment Period 3|Adverse Event|0|||
42206338|NCT02871778|76019081|FG003|Part B: Treatment Period 3|Adverse Event|0|||
42206339|NCT02871778|76019082|FG004|Part B: Treatment Period 3|Adverse Event|1|||
42206340|NCT02871778|76019083|FG005|Part B: Treatment Period 3|Adverse Event|1|||
42206341|NCT02871778|76019084|FG006|Part B: Treatment Period 3|Adverse Event|1|||
42206342|NCT02871778|76019085|FG007|Part B: Treatment Period 3|Adverse Event|0|||
